Cancer_type	QTL_type	tag_SNP	LD	SNP	SNP_position	Alleles	Methylation_probe	Methylation_position	Probe_related_gene	Beta	t-stat	Correlation_coefficient (r)	p-value	Traits
SKCM	cis	rs4782151	0.631	rs4780298	chr16:9365200	T/G	cg05568466	chr16:8431529	NA	0.39	4.96	0.49	4.05e-6	Cervical cancer;
SKCM	cis	rs1799949	0.930	rs3092987	chr17:41222723	T/C	cg05368731	chr17:41323189	NBR1	0.89	7.87	0.67	1.71e-11	Menopause (age at onset);
SKCM	cis	rs7666738	0.791	rs1405766	chr4:98965389	T/C	cg17366294	chr4:99064904	C4orf37	0.59	4.89	0.48	5.36e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs561341	1.000	rs55736640	chr17:30333848	G/A	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs11662586	0.517	rs7228070	chr18:77698967	C/T	cg20368463	chr18:77673604	PQLC1	0.75	6.67	0.6	3.3e-9	Exploratory eye movement dysfunction in schizophrenia (responsive search score);
SKCM	cis	rs11098499	0.913	rs68128210	chr4:120137819	T/G	cg09307838	chr4:120376055	NA	0.88	6.32	0.58	1.52e-8	Corneal astigmatism;
SKCM	cis	rs514406	0.893	rs6588446	chr1:53425260	G/A	cg24675658	chr1:53192096	ZYG11B	0.61	4.94	0.49	4.42e-6	Monocyte count;
SKCM	cis	rs9467773	1.000	rs11756120	chr6:26529808	G/C	cg09904177	chr6:26538194	HMGN4	0.54	4.98	0.49	3.78e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs870825	0.746	rs1107908	chr4:185620113	T/C	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs8017423	0.933	rs7150378	chr14:90724566	G/A	cg04374321	chr14:90722782	PSMC1	1.03	9.44	0.73	1.55e-14	Mortality in heart failure;
SKCM	cis	rs1552244	1.000	rs7615646	chr3:10089773	A/C	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs9858542	0.953	rs9827021	chr3:49514764	C/A	cg03060546	chr3:49711283	APEH	-0.75	-5.53	-0.53	4.17e-7	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs2980439	0.818	rs2948294	chr8:8094961	A/G	cg15556689	chr8:8085844	FLJ10661	0.86	7.45	0.65	1.06e-10	Neuroticism;
SKCM	cis	rs637571	0.522	rs566590	chr11:65754062	C/T	cg02427764	chr11:65769310	BANF1;EIF1AD	0.77	5.79	0.55	1.4e-7	Eosinophil percentage of white cells;
SKCM	cis	rs939658	0.683	rs8024572	chr15:79465600	A/G	cg10259521	chr15:79428573	NA	-0.49	-5.07	-0.5	2.6e-6	Refractive error;
SKCM	cis	rs7584330	0.657	rs7599658	chr2:238352898	A/C	cg14458575	chr2:238380390	NA	-1.04	-6.94	-0.62	1e-9	Prostate cancer;
SKCM	cis	rs1577917	0.958	rs11756510	chr6:86699794	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.83	-8.23	-0.68	3.37e-12	Response to antipsychotic treatment;
SKCM	cis	rs35146811	0.586	rs12705067	chr7:99594726	T/C	cg13334819	chr7:99746414	C7orf59	-0.7	-4.83	-0.48	6.58e-6	Coronary artery disease;
SKCM	cis	rs61524473	1	rs61524473	chr15:45646283	T/C	cg10760299	chr15:45669010	GATM	0.62	6.33	0.58	1.42e-8	Metabolite levels (small molecules and protein measures);
SKCM	cis	rs9467773	0.620	rs2451731	chr6:26624822	A/C	cg09904177	chr6:26538194	HMGN4	0.58	5.01	0.49	3.28e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs6840360	0.571	rs4696279	chr4:152560449	G/A	cg22705602	chr4:152727874	NA	-0.52	-5.69	-0.54	2.15e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs1801251	1.000	rs71421663	chr2:233619131	A/G	cg25237894	chr2:233734115	C2orf82	0.56	5.33	0.52	9.23e-7	Coronary artery disease;
SKCM	cis	rs4819052	0.851	rs7279182	chr21:46656112	G/A	cg02159808	chr21:46707872	POFUT2;LOC642852	0.69	5.28	0.51	1.13e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs10540	1.000	rs79808876	chr11:465763	C/A	cg03352830	chr11:487213	PTDSS2	0.96	4.77	0.48	8.46e-6	Body mass index;
SKCM	cis	rs7772486	0.720	rs4896837	chr6:146014168	C/T	cg05347473	chr6:146136440	FBXO30	-0.65	-5.92	-0.56	8.01e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7772486	0.790	rs2485632	chr6:146193228	A/G	cg23711669	chr6:146136114	FBXO30	0.85	9.32	0.73	2.57e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs5769765	0.646	rs9627789	chr22:50300562	A/G	cg22709217	chr22:50311962	ALG12;CRELD2	-0.87	-5.82	-0.55	1.26e-7	Schizophrenia;
SKCM	cis	rs8017423	0.935	rs2149653	chr14:90669333	G/A	cg04374321	chr14:90722782	PSMC1	0.95	8.52	0.69	9.41e-13	Mortality in heart failure;
SKCM	cis	rs875971	0.638	rs10278816	chr7:66036987	T/C	cg18876405	chr7:65276391	NA	-0.8	-7.11	-0.63	4.86e-10	Aortic root size;
SKCM	cis	rs1865760	0.663	rs9379815	chr6:25980116	T/A	cg16482183	chr6:26056742	HIST1H1C	0.62	4.92	0.49	4.77e-6	Height;
SKCM	cis	rs2032447	0.714	rs199736	chr6:25936787	C/T	cg18357526	chr6:26021779	HIST1H4A	0.71	5.45	0.53	5.65e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs950776	0.518	rs12900783	chr15:78815523	G/A	cg06917634	chr15:78832804	PSMA4	1.01	10.48	0.76	1.5e-16	Sudden cardiac arrest;
SKCM	cis	rs4481887	0.861	rs6676061	chr1:248443887	G/C	cg00666640	chr1:248458726	OR2T12	0.63	5.44	0.52	6.01e-7	Common traits (Other);
SKCM	cis	rs28386778	0.863	rs2665834	chr17:61904724	T/C	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs1799949	1.000	rs9646417	chr17:41424253	G/A	cg05368731	chr17:41323189	NBR1	0.85	7.32	0.64	1.89e-10	Menopause (age at onset);
SKCM	cis	rs7408868	1.000	rs1548554	chr19:15277938	C/T	cg14696996	chr19:15285081	NOTCH3	0.82	4.92	0.49	4.7e-6	Pulse pressure;
SKCM	cis	rs28386778	0.897	rs2727290	chr17:61894728	G/T	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs7537052	0.669	rs2296263	chr1:36641729	C/T	cg24686825	chr1:36642396	MAP7D1	-0.76	-6.51	-0.59	6.72e-9	Schizophrenia;
SKCM	cis	rs9905704	0.647	rs6503892	chr17:57067086	G/A	cg12560992	chr17:57184187	TRIM37	0.74	6.07	0.57	4.34e-8	Testicular germ cell tumor;
SKCM	cis	rs1862618	0.853	rs832551	chr5:56180112	T/G	cg12311346	chr5:56204834	C5orf35	-0.76	-5.02	-0.49	3.2e-6	Initial pursuit acceleration;
SKCM	cis	rs9911578	1.000	rs11870671	chr17:56605360	A/G	cg12560992	chr17:57184187	TRIM37	-0.96	-7.74	-0.66	2.95e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs2204008	0.837	rs12581130	chr12:38319387	A/G	cg26384229	chr12:38710491	ALG10B	0.8	6.67	0.6	3.35e-9	Bladder cancer;
SKCM	cis	rs1577917	1.000	rs9647603	chr6:86639341	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.77	-0.66	2.59e-11	Response to antipsychotic treatment;
SKCM	cis	rs35306767	0.761	rs11253560	chr10:1047226	T/G	cg25614935	chr10:1084866	C10orf110	0.72	5.67	0.54	2.31e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs875971	0.965	rs7794930	chr7:65778546	A/C	cg18876405	chr7:65276391	NA	-0.66	-6.38	-0.59	1.16e-8	Aortic root size;
SKCM	cis	rs8177253	0.965	rs4854761	chr3:133498789	A/G	cg16414030	chr3:133502952	NA	0.69	5.72	0.54	1.86e-7	Iron status biomarkers;
SKCM	cis	rs8072100	0.744	rs34537623	chr17:45530203	A/G	cg25173405	chr17:45401733	C17orf57	-0.57	-4.77	-0.48	8.45e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs28595532	0.920	rs116821181	chr4:119734892	T/C	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs7666738	0.830	rs1111541	chr4:99033860	A/G	cg05340658	chr4:99064831	C4orf37	-0.66	-4.82	-0.48	7.07e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs12986445	0.711	rs3845681	chr2:26110057	G/A	cg04917511	chr2:26785460	C2orf70	0.52	4.99	0.49	3.53e-6	Multiple myeloma and monoclonal gammopathy;Multiple myeloma;
SKCM	cis	rs7811142	0.720	rs112622797	chr7:99917416	G/A	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.06	6.05	0.56	4.82e-8	Platelet count;
SKCM	cis	rs17376456	0.877	rs17083455	chr5:93446380	A/C	cg21475434	chr5:93447410	FAM172A	0.97	5.42	0.52	6.39e-7	Diabetic retinopathy;
SKCM	cis	rs910316	1.000	rs876403	chr14:75602834	A/T	cg08847533	chr14:75593920	NEK9	0.96	8.88	0.71	1.83e-13	Height;
SKCM	cis	rs6424115	0.830	rs2502995	chr1:24199290	T/C	cg15997130	chr1:24165203	NA	0.6	4.94	0.49	4.37e-6	Immature fraction of reticulocytes;
SKCM	cis	rs854765	0.647	rs62073573	chr17:17976354	G/A	cg04398451	chr17:18023971	MYO15A	-1.03	-8.95	-0.71	1.35e-13	Total body bone mineral density;
SKCM	cis	rs61021925	1	rs61021925	chr12:122863659	T/C	cg23029597	chr12:123009494	RSRC2	0.66	5.79	0.55	1.4e-7	Schizophrenia;
SKCM	cis	rs1005277	0.579	rs1740735	chr10:38497777	A/C	cg00409905	chr10:38381863	ZNF37A	-0.64	-6.35	-0.58	1.32e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs57221529	0.709	rs72703034	chr5:577101	C/T	cg26208419	chr5:473447	SLC9A3;LOC25845	1.05	5.37	0.52	7.95e-7	Lung disease severity in cystic fibrosis;
SKCM	cis	rs6582630	0.519	rs80226845	chr12:38528231	C/A	cg26384229	chr12:38710491	ALG10B	0.82	6.64	0.6	3.86e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs561341	1.000	rs508192	chr17:30315147	C/T	cg23018236	chr17:30244563	NA	0.51	5.06	0.5	2.71e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs1580019	0.922	rs1376289	chr7:32486980	C/G	cg06627557	chr7:32535165	LSM5;AVL9	-0.78	-5.6	-0.54	3.08e-7	Cognitive ability;
SKCM	cis	rs35306767	0.953	rs12259801	chr10:959306	C/G	cg26597838	chr10:835615	NA	0.67	5.22	0.51	1.44e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs8072100	0.738	rs9895509	chr17:45549618	A/T	cg08085267	chr17:45401833	C17orf57	0.64	5.2	0.51	1.54e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs1325195	0.537	rs2793805	chr1:179195777	A/G	cg26328954	chr1:179557513	NA	0.49	5.05	0.5	2.82e-6	IgE grass sensitization;
SKCM	cis	rs4523957	0.651	rs898748	chr17:2085475	G/T	cg16513277	chr17:2031491	SMG6	-0.79	-5.86	-0.55	1.07e-7	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs908922	0.605	rs3753448	chr1:152486407	A/C	cg09873164	chr1:152488093	CRCT1	0.78	6.09	0.57	3.98e-8	Hair morphology;
SKCM	cis	rs28386778	0.897	rs2597634	chr17:61878144	G/A	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs4819052	0.851	rs7279011	chr21:46655995	G/A	cg02159808	chr21:46707872	POFUT2;LOC642852	0.69	5.28	0.51	1.13e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs4242434	0.927	rs11136092	chr8:22466488	T/G	cg03733263	chr8:22462867	KIAA1967	1.09	8.99	0.71	1.11e-13	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	trans	rs8073060	0.586	rs11080356	chr17:33895309	T/C	cg19694781	chr19:47549865	TMEM160	1.08	8.69	0.7	4.26e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs2777491	0.574	rs28700583	chr15:41714072	C/T	cg18705301	chr15:41695430	NDUFAF1	-1.19	-13.25	-0.83	1.15e-21	Ulcerative colitis;
SKCM	cis	rs11673344	0.730	rs475026	chr19:37459017	T/C	cg07624650	chr19:37064219	ZNF529	-0.78	-4.82	-0.48	7.05e-6	Obesity-related traits;
SKCM	cis	rs12477438	0.501	rs7349217	chr2:99815146	T/G	cg26064155	chr2:99771622	LIPT1;TSGA10	0.97	8.85	0.71	2.11e-13	Chronic sinus infection;
SKCM	cis	rs10779751	0.734	rs2748877	chr1:11129437	T/C	cg08854313	chr1:11322531	MTOR	0.77	5.52	0.53	4.36e-7	Body mass index;
SKCM	cis	rs3784262	0.669	rs4646592	chr15:58302557	A/G	cg12031962	chr15:58353849	ALDH1A2	-0.41	-4.82	-0.48	6.93e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs6977660	0.652	rs4721826	chr7:19823804	T/C	cg07541023	chr7:19748670	TWISTNB	0.72	4.78	0.48	7.95e-6	Thyroid stimulating hormone;
SKCM	cis	rs4319547	0.656	rs9788145	chr12:122899522	C/T	cg23029597	chr12:123009494	RSRC2	-0.73	-5.37	-0.52	7.93e-7	Body mass index;
SKCM	cis	rs12477438	0.798	rs9308816	chr2:99637230	A/G	cg26064155	chr2:99771622	LIPT1;TSGA10	-0.72	-4.86	-0.48	6e-6	Chronic sinus infection;
SKCM	cis	rs2730245	0.550	rs2709860	chr7:158651156	A/T	cg24397884	chr7:158709396	WDR60	0.76	5.94	0.56	7.49e-8	Height;
SKCM	cis	rs17345786	1.000	rs55641278	chr3:101290577	G/A	cg12386194	chr3:101231763	SENP7	0.83	6.52	0.59	6.39e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2075371	1.000	rs2544221	chr7:133993014	G/C	cg20476274	chr7:133979776	SLC35B4	1.06	11.3	0.79	4.2e-18	Mean platelet volume;
SKCM	cis	rs6121246	0.909	rs8126355	chr20:30332660	C/T	cg11595048	chr20:30225325	COX4I2	0.67	5.21	0.51	1.5e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs4423214	0.592	rs10898191	chr11:71194601	G/A	cg05163923	chr11:71159392	DHCR7	-0.7	-4.93	-0.49	4.54e-6	Vitamin D levels;
SKCM	cis	rs4808199	0.895	rs2285628	chr19:19467996	T/A	cg03709012	chr19:19516395	GATAD2A	1.09	7.61	0.65	5.22e-11	Nonalcoholic fatty liver disease;
SKCM	cis	rs951366	0.903	rs708723	chr1:205739266	C/T	cg11965913	chr1:205819406	PM20D1	0.72	5.71	0.54	1.95e-7	Menarche (age at onset);
SKCM	cis	rs561341	0.941	rs17780080	chr17:30343146	G/A	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs10905065	0.965	rs10752110	chr10:5837038	T/C	cg11519256	chr10:5708881	ASB13	0.55	4.9	0.49	5.04e-6	Menopause (age at onset);
SKCM	cis	rs79040073	0.530	rs79452929	chr15:49508363	A/G	cg25951582	chr15:49913451	C15orf33;DTWD1	-0.72	-5.22	-0.51	1.44e-6	Lung cancer in ever smokers;
SKCM	cis	rs9399135	0.636	rs7749106	chr6:135268142	G/A	cg24558204	chr6:135376177	HBS1L	0.63	5.82	0.55	1.22e-7	Red blood cell count;
SKCM	cis	rs9880211	0.800	rs13314357	chr3:136487559	A/G	cg21827317	chr3:136751795	NA	-0.74	-5.48	-0.53	5.1e-7	Body mass index;Height;
SKCM	cis	rs17685	0.735	rs11763339	chr7:75761541	T/C	cg01364799	chr7:75623366	TMEM120A	-0.7	-5.69	-0.54	2.09e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs17345786	0.906	rs59359251	chr3:101146362	A/C	cg12386194	chr3:101231763	SENP7	0.73	5.3	0.51	1.06e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6951245	0.744	rs10275401	chr7:1213943	A/C	cg18402987	chr7:1209562	NA	1.17	7.46	0.65	1.04e-10	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs28595532	0.623	rs34082100	chr4:119220563	C/T	cg21605333	chr4:119757512	SEC24D	1.2	7.56	0.65	6.58e-11	Cannabis dependence symptom count;
SKCM	cis	rs9549367	0.713	rs9549352	chr13:113833221	A/G	cg18105134	chr13:113819100	PROZ	-0.91	-6.82	-0.61	1.71e-9	Platelet distribution width;
SKCM	cis	rs875971	0.522	rs1617484	chr7:65463095	G/A	cg11764359	chr7:65958608	NA	0.76	5.66	0.54	2.44e-7	Aortic root size;
SKCM	cis	rs7772486	0.719	rs7753770	chr6:146066161	G/A	cg23711669	chr6:146136114	FBXO30	-0.88	-9.55	-0.73	9.22e-15	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1635	0.655	rs77983937	chr6:28307892	A/G	cg15743358	chr6:28303923	ZNF323	-1.37	-5.17	-0.51	1.75e-6	Schizophrenia;
SKCM	cis	rs9309711	0.922	rs13431788	chr2:3482912	G/A	cg10845886	chr2:3471009	TTC15	-0.84	-6.62	-0.6	4.07e-9	Neurofibrillary tangles;
SKCM	cis	rs7954584	0.567	rs7132055	chr12:122346034	A/G	cg22618164	chr12:122356400	WDR66	-0.53	-5.31	-0.51	1.02e-6	Mean corpuscular volume;
SKCM	cis	rs4862750	0.872	rs6836781	chr4:187899701	G/A	cg10295955	chr4:187884368	NA	-1.04	-13.97	-0.85	6.27e-23	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6463523	0.525	rs11763218	chr7:852281	T/C	cg06242242	chr7:766104	PRKAR1B;HEATR2	-0.95	-5.82	-0.55	1.25e-7	Subjective well-being;
SKCM	cis	rs2836974	0.932	rs73221193	chr21:40554693	C/T	cg11644478	chr21:40555479	PSMG1	0.99	9.91	0.75	1.88e-15	Cognitive function;
SKCM	cis	rs1023500	0.551	rs2859438	chr22:42466980	A/T	cg04733989	chr22:42467013	NAGA	0.72	5.72	0.54	1.9e-7	Schizophrenia;
SKCM	cis	rs7772486	0.686	rs10872579	chr6:145966012	C/G	cg23711669	chr6:146136114	FBXO30	0.9	10.07	0.75	9.38e-16	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs62103177	0.810	rs62103194	chr18:77629482	G/A	cg27393146	chr18:77495563	CTDP1	-0.92	-5.36	-0.52	8.37e-7	Opioid sensitivity;
SKCM	cis	rs3087591	0.960	rs2953000	chr17:29509791	C/T	cg24425628	chr17:29625626	OMG;NF1	0.61	4.87	0.48	5.75e-6	Hip circumference;
SKCM	cis	rs362272	0.545	rs2749783	chr4:3326098	A/C	cg05297308	chr4:3317976	RGS12	1.05	12.82	0.82	6.95e-21	Serum sulfate level;
SKCM	cis	rs7584330	0.826	rs10187185	chr2:238416524	C/G	cg14458575	chr2:238380390	NA	1.1	7.09	0.63	5.3e-10	Prostate cancer;
SKCM	cis	rs72781680	1.000	rs72781643	chr2:24208746	G/A	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	cis	rs1878931	0.858	rs3760083	chr16:3450052	C/T	cg26668626	chr16:3451006	ZNF174;ZNF434	-0.97	-8.14	-0.68	5.15e-12	Body mass index (adult);
SKCM	cis	rs6977660	0.660	rs12531296	chr7:19816450	A/C	cg05791153	chr7:19748676	TWISTNB	0.77	5.02	0.49	3.23e-6	Thyroid stimulating hormone;
SKCM	cis	rs72634258	0.945	rs12748993	chr1:8129507	A/G	cg00042356	chr1:8021962	PARK7	1.08	7.98	0.67	1.05e-11	Inflammatory bowel disease;
SKCM	cis	rs763121	0.853	rs3747172	chr22:39067524	A/G	cg06022373	chr22:39101656	GTPBP1	0.8	5.85	0.55	1.1e-7	Menopause (age at onset);
SKCM	cis	rs10911232	0.507	rs10797820	chr1:183011366	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.64	0.6	3.83e-9	Hypertriglyceridemia;
SKCM	cis	rs6840360	0.571	rs7678080	chr4:152557350	A/G	cg22705602	chr4:152727874	NA	-0.52	-5.69	-0.54	2.15e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs34172651	0.517	rs34172679	chr16:24840381	C/T	cg00339695	chr16:24857497	SLC5A11	0.75	6.32	0.58	1.5e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs7937682	0.855	rs11213985	chr11:111581521	C/A	cg09085632	chr11:111637200	PPP2R1B	-1.11	-15.69	-0.87	7.68e-26	Primary sclerosing cholangitis;
SKCM	cis	rs10504229	0.906	rs7003276	chr8:58173089	A/T	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs2251381	0.750	rs8129616	chr21:30520085	C/T	cg24692254	chr21:30365293	RNF160	-0.81	-6.33	-0.58	1.42e-8	Selective IgA deficiency;
SKCM	cis	rs72781680	0.611	rs6720131	chr2:24364736	C/T	cg20701182	chr2:24300061	SF3B14	0.79	5.29	0.51	1.11e-6	Lymphocyte counts;
SKCM	cis	rs11608355	0.521	rs4766595	chr12:109846998	A/T	cg19025524	chr12:109796872	NA	-0.69	-6.35	-0.58	1.34e-8	Neuroticism;
SKCM	cis	rs79040073	0.563	rs7167852	chr15:49542201	A/T	cg25951582	chr15:49913451	C15orf33;DTWD1	-0.72	-5.22	-0.51	1.44e-6	Lung cancer in ever smokers;
SKCM	cis	rs10911232	0.507	rs10911198	chr1:182997318	G/T	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.64	0.6	3.83e-9	Hypertriglyceridemia;
SKCM	cis	rs929354	0.742	rs7785227	chr7:156999297	C/T	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs2858942	0.818	rs1203979	chr16:261866	T/A	cg03788090	chr16:233062	NA	0.62	5.07	0.5	2.6e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs2836950	0.545	rs2836956	chr21:40623018	C/G	cg17971929	chr21:40555470	PSMG1	0.75	6.2	0.57	2.5e-8	Menarche (age at onset);
SKCM	cis	rs3768617	0.510	rs4651142	chr1:183097386	A/T	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.69	0.66	3.68e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs9815354	0.812	rs73077386	chr3:41857652	A/G	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs1878931	0.697	rs1044390	chr16:3432594	T/A	cg26668626	chr16:3451006	ZNF174;ZNF434	1.12	11.26	0.79	5.1e-18	Body mass index (adult);
SKCM	cis	rs2032447	0.517	rs7767546	chr6:25904067	T/C	cg03517284	chr6:25882590	NA	-0.72	-6.25	-0.58	2.05e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs61776719	0.875	rs28683126	chr1:38402459	G/A	cg17077180	chr1:38461687	NA	0.5	4.92	0.49	4.63e-6	Coronary artery disease;
SKCM	cis	rs4555082	0.874	rs28625632	chr14:105748849	G/T	cg13114125	chr14:105738426	BRF1	-0.69	-5.47	-0.53	5.33e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs875971	0.522	rs7784623	chr7:65395034	T/G	cg11764359	chr7:65958608	NA	0.86	6.23	0.58	2.22e-8	Aortic root size;
SKCM	cis	rs7666738	0.830	rs10470951	chr4:99037051	G/A	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs3845702	0.668	rs6759271	chr2:180844303	T/C	cg01881094	chr2:180872142	CWC22	-1.3	-6.15	-0.57	3.07e-8	Schizophrenia;
SKCM	cis	rs7122539	0.646	rs569818	chr11:66570749	G/A	cg12372692	chr11:66233905	PELI3	-0.73	-5.48	-0.53	5.05e-7	HIV-1 susceptibility;
SKCM	cis	rs8067545	0.750	rs11869616	chr17:19992713	G/A	cg13482628	chr17:19912719	NA	0.71	6.15	0.57	3.16e-8	Schizophrenia;
SKCM	cis	rs1018836	0.923	rs13277387	chr8:91633713	C/G	cg16814680	chr8:91681699	NA	-0.67	-4.98	-0.49	3.7e-6	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs36093844	0.752	rs78589744	chr11:85555999	T/C	cg25872744	chr11:85566296	CCDC83	-0.85	-4.77	-0.48	8.27e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs6424115	0.931	rs2982390	chr1:24147830	G/C	cg15997130	chr1:24165203	NA	0.61	5.29	0.51	1.1e-6	Immature fraction of reticulocytes;
SKCM	cis	rs116095464	0.558	rs60251075	chr5:245292	T/C	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs7507204	0.723	rs12982194	chr19:3411947	G/A	cg08380311	chr19:3435252	NFIC	0.98	7.13	0.63	4.51e-10	Height;
SKCM	cis	rs2072499	0.833	rs2842873	chr1:156204653	C/T	cg25208724	chr1:156163844	SLC25A44	0.96	8.83	0.71	2.3e-13	Testicular germ cell tumor;
SKCM	cis	rs2731664	0.792	rs335468	chr5:176892349	A/G	cg23176889	chr5:176863531	GRK6	0.54	5.53	0.53	4.13e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs6088580	0.634	rs6059875	chr20:33086090	T/G	cg24642439	chr20:33292090	TP53INP2	0.75	6.02	0.56	5.32e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs2836974	0.644	rs2836982	chr21:40689171	C/A	cg11890956	chr21:40555474	PSMG1	-0.79	-7.37	-0.64	1.57e-10	Cognitive function;
SKCM	cis	rs6546550	0.901	rs11902198	chr2:70144596	C/A	cg02498382	chr2:70120550	SNRNP27	-0.45	-4.88	-0.48	5.4e-6	Prevalent atrial fibrillation;
SKCM	cis	rs7523050	0.643	rs34801874	chr1:109404382	C/T	cg08274380	chr1:109419600	GPSM2	1.18	6.44	0.59	9.12e-9	Fat distribution (HIV);
SKCM	cis	rs7772486	0.817	rs2144477	chr6:146406248	C/T	cg23711669	chr6:146136114	FBXO30	0.85	8.48	0.69	1.09e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6951245	1.000	rs78523927	chr7:1089458	T/C	cg18402987	chr7:1209562	NA	1.14	6.01	0.56	5.68e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7937682	0.889	rs11213971	chr11:111529829	A/G	cg09085632	chr11:111637200	PPP2R1B	-1.05	-12.29	-0.81	6.25e-20	Primary sclerosing cholangitis;
SKCM	cis	rs9911578	0.867	rs72628394	chr17:57121313	C/T	cg05425664	chr17:57184151	TRIM37	0.77	6.01	0.56	5.71e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs25645	0.502	rs1007654	chr17:38111354	A/G	cg17467752	chr17:38218738	THRA	0.65	5.2	0.51	1.53e-6	Myeloid white cell count;
SKCM	cis	rs2832191	0.791	rs2832179	chr21:30480366	C/T	cg24692254	chr21:30365293	RNF160	-0.9	-8.03	-0.67	8.39e-12	Dental caries;
SKCM	cis	rs2180341	0.960	rs1543432	chr6:127698018	T/C	cg24812749	chr6:127587940	RNF146	0.83	7.18	0.63	3.63e-10	Breast cancer;
SKCM	cis	rs9660180	0.868	rs12567685	chr1:1806647	T/C	cg23982607	chr1:1823379	GNB1	-0.73	-6.09	-0.57	3.97e-8	Body mass index;
SKCM	cis	rs5769765	1.000	rs768619	chr22:50287266	C/T	cg22709217	chr22:50311962	ALG12;CRELD2	-0.79	-5.71	-0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs854765	0.583	rs950966	chr17:17783748	A/G	cg04398451	chr17:18023971	MYO15A	0.79	5.86	0.55	1.04e-7	Total body bone mineral density;
SKCM	cis	rs2836974	0.555	rs35909862	chr21:40621158	G/A	cg11644478	chr21:40555479	PSMG1	-0.8	-7.6	-0.65	5.6e-11	Cognitive function;
SKCM	cis	rs7100689	0.646	rs10736348	chr10:82139244	C/A	cg01528321	chr10:82214614	TSPAN14	0.84	7.52	0.65	7.94e-11	Post bronchodilator FEV1;
SKCM	cis	rs1005277	0.579	rs2472181	chr10:38386764	T/C	cg00409905	chr10:38381863	ZNF37A	-0.64	-5.96	-0.56	6.77e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs11662586	0.517	rs11662894	chr18:77713591	G/A	cg20368463	chr18:77673604	PQLC1	0.69	5.92	0.56	8.28e-8	Exploratory eye movement dysfunction in schizophrenia (responsive search score);
SKCM	cis	rs738322	0.577	rs4820320	chr22:38572977	G/A	cg25457927	chr22:38595422	NA	-0.53	-5.55	-0.53	3.76e-7	Cutaneous nevi;
SKCM	cis	rs514406	0.505	rs6703127	chr1:53180565	C/T	cg16325326	chr1:53192061	ZYG11B	0.89	10.06	0.75	9.55e-16	Monocyte count;
SKCM	cis	rs1799949	0.929	rs799905	chr17:41277187	G/C	cg19454999	chr17:41278357	BRCA1;NBR2	0.51	4.8	0.48	7.53e-6	Menopause (age at onset);
SKCM	cis	rs9814567	1.000	rs4367113	chr3:134287975	G/A	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs847649	0.731	rs12666317	chr7:102704135	C/T	cg18108683	chr7:102477205	FBXL13	0.8	7.43	0.64	1.21e-10	Morning vs. evening chronotype;
SKCM	cis	rs684232	0.644	rs2657613	chr17:623902	T/C	cg12384639	chr17:618140	VPS53	0.73	5.63	0.54	2.71e-7	Prostate cancer;
SKCM	cis	rs12142240	0.698	rs17357676	chr1:46812444	A/G	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs4803468	1.000	rs10413735	chr19:41921071	C/T	cg09537434	chr19:41945824	ATP5SL	-1.1	-13.82	-0.84	1.16e-22	Height;
SKCM	cis	rs1218582	0.741	rs11264291	chr1:154914797	C/T	cg24250549	chr1:154909240	PMVK	0.87	8.88	0.71	1.84e-13	Prostate cancer;
SKCM	cis	rs6456156	0.586	rs6456149	chr6:167463902	T/C	cg13927040	chr6:167453801	FGFR1OP	0.66	4.85	0.48	6.24e-6	Primary biliary cholangitis;
SKCM	cis	rs7208859	0.524	rs28760584	chr17:29141017	G/A	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs637571	0.522	rs679581	chr11:65746653	A/G	cg26695010	chr11:65641043	EFEMP2	-0.68	-5.02	-0.49	3.19e-6	Eosinophil percentage of white cells;
SKCM	cis	rs2354432	0.556	rs57388899	chr1:146773422	T/C	cg25205988	chr1:146714368	CHD1L	-1.16	-8.19	-0.68	3.97e-12	Mitochondrial DNA levels;
SKCM	cis	rs2286503	0.839	rs4722189	chr7:22860474	G/A	cg15401507	chr7:22894281	NA	-0.57	-5.61	-0.54	2.99e-7	Fibrinogen;
SKCM	cis	rs870825	0.929	rs55635512	chr4:185589982	G/T	cg04058563	chr4:185651563	MLF1IP	1.09	5.66	0.54	2.4e-7	Blood protein levels;
SKCM	cis	rs17826219	0.706	rs28469200	chr17:29133572	T/A	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Body mass index;
SKCM	cis	rs6942756	1.000	rs6467233	chr7:128868656	C/T	cg02491457	chr7:128862824	NA	-0.72	-4.8	-0.48	7.49e-6	White matter hyperintensity burden;
SKCM	cis	rs951366	0.789	rs864783	chr1:205711974	T/C	cg17178900	chr1:205818956	PM20D1	0.73	5.84	0.55	1.13e-7	Menarche (age at onset);
SKCM	cis	rs9303401	0.659	rs7224276	chr17:56897827	C/T	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.35	0.52	8.54e-7	Cognitive test performance;
SKCM	cis	rs919433	0.963	rs10166569	chr2:198183439	G/A	cg04278110	chr2:198063759	ANKRD44	-0.69	-4.8	-0.48	7.58e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs5769765	1.000	rs2092982	chr22:50282204	C/A	cg22709217	chr22:50311962	ALG12;CRELD2	0.79	5.71	0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs17376456	0.877	rs10064520	chr5:93427358	T/C	cg21475434	chr5:93447410	FAM172A	0.97	5.42	0.52	6.39e-7	Diabetic retinopathy;
SKCM	cis	rs684232	0.602	rs10521107	chr17:511156	G/A	cg15660573	chr17:549704	VPS53	-0.75	-5.83	-0.55	1.18e-7	Prostate cancer;
SKCM	cis	rs4268898	0.662	rs74470633	chr2:24438712	A/G	cg06627628	chr2:24431161	ITSN2	-0.92	-7.12	-0.63	4.73e-10	Asthma;
SKCM	cis	rs7618915	0.547	rs2590846	chr3:52692359	C/G	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs854765	0.663	rs1108648	chr17:17750558	G/A	cg04398451	chr17:18023971	MYO15A	0.8	5.54	0.53	4e-7	Total body bone mineral density;
SKCM	cis	rs6754311	0.551	rs2304599	chr2:136528004	C/G	cg07169764	chr2:136633963	MCM6	-0.89	-6.61	-0.6	4.34e-9	Mosquito bite size;
SKCM	cis	rs7122539	0.646	rs608248	chr11:66562248	C/T	cg12372692	chr11:66233905	PELI3	0.68	5.19	0.51	1.62e-6	HIV-1 susceptibility;
SKCM	cis	rs875971	0.861	rs801215	chr7:66011938	A/T	cg11764359	chr7:65958608	NA	-0.75	-6.8	-0.61	1.88e-9	Aortic root size;
SKCM	cis	rs6580649	0.941	rs7296913	chr12:48488920	G/A	cg05342945	chr12:48394962	COL2A1	0.79	5.51	0.53	4.44e-7	Lung cancer;
SKCM	cis	rs13343954	0.518	rs8106293	chr19:33536376	C/T	cg17764715	chr19:33622953	WDR88	0.74	5.35	0.52	8.61e-7	Colorectal cancer;
SKCM	cis	rs62064224	0.791	rs2344977	chr17:30720573	C/G	cg25809561	chr17:30822961	MYO1D	0.62	4.81	0.48	7.31e-6	Schizophrenia;
SKCM	cis	rs1949733	0.877	rs940133	chr4:8473614	T/C	cg11789530	chr4:8429930	ACOX3	0.82	6.22	0.58	2.33e-8	Response to antineoplastic agents;
SKCM	cis	rs7937682	0.889	rs542424	chr11:111477698	T/C	cg19812747	chr11:111475976	SIK2	-0.56	-4.97	-0.49	3.89e-6	Primary sclerosing cholangitis;
SKCM	cis	rs10791097	0.694	rs7106995	chr11:130758152	G/T	cg12179176	chr11:130786555	SNX19	0.93	8.37	0.69	1.82e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs12142240	0.698	rs7525309	chr1:46809025	G/T	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs12497850	0.864	rs12493001	chr3:49181885	A/G	cg06212747	chr3:49208901	KLHDC8B	0.75	5.0	0.49	3.47e-6	Parkinson's disease;
SKCM	cis	rs9911578	1.000	rs12453049	chr17:56611372	C/T	cg05425664	chr17:57184151	TRIM37	0.69	5.2	0.51	1.56e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs6933660	0.683	rs6916340	chr6:151779064	T/C	cg02564969	chr6:151773285	C6orf211;RMND1	0.7	6.01	0.56	5.55e-8	Menarche (age at onset);
SKCM	cis	rs12478296	1.000	rs12469535	chr2:243044147	G/A	cg06360820	chr2:242988706	NA	-0.91	-5.25	-0.51	1.28e-6	Obesity-related traits;
SKCM	cis	rs870825	0.655	rs6845058	chr4:185653696	G/A	cg04058563	chr4:185651563	MLF1IP	-1.13	-7.16	-0.63	3.82e-10	Blood protein levels;
SKCM	cis	rs362296	0.615	rs34030762	chr4:3255736	C/A	cg05297308	chr4:3317976	RGS12	-0.68	-5.54	-0.53	3.93e-7	Parental longevity (mother's age at death);
SKCM	trans	rs17685	0.712	rs7778735	chr7:75770237	T/C	cg19862616	chr7:65841803	NCRNA00174	0.94	9.49	0.73	1.22e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs4319547	0.656	rs7135419	chr12:122911861	T/A	cg23029597	chr12:123009494	RSRC2	-0.77	-5.79	-0.55	1.43e-7	Body mass index;
SKCM	cis	rs73001065	0.591	rs11668386	chr19:19531910	A/G	cg03709012	chr19:19516395	GATAD2A	1.14	5.41	0.52	6.76e-7	LDL cholesterol;
SKCM	cis	rs4836694	0.517	rs1017112	chr9:132936804	A/G	cg13414629	chr9:132935646	FREQ	0.83	5.26	0.51	1.24e-6	Alzheimer's disease (cognitive decline);
SKCM	cis	rs2836950	0.545	rs2836952	chr21:40616651	G/C	cg11890956	chr21:40555474	PSMG1	-0.66	-5.26	-0.51	1.22e-6	Menarche (age at onset);
SKCM	cis	rs2836974	0.555	rs35909862	chr21:40621158	G/A	cg11890956	chr21:40555474	PSMG1	-0.88	-9.14	-0.72	5.76e-14	Cognitive function;
SKCM	cis	rs7959452	0.562	rs11177630	chr12:69767963	G/C	cg20891283	chr12:69753455	YEATS4	0.91	9.31	0.73	2.74e-14	Blood protein levels;
SKCM	cis	rs362272	0.524	rs881816	chr4:3365366	A/G	cg21096898	chr4:3318625	RGS12	1.01	12.64	0.82	1.47e-20	Serum sulfate level;
SKCM	cis	rs4242434	0.927	rs11778693	chr8:22462852	T/C	cg03733263	chr8:22462867	KIAA1967	1.09	8.99	0.71	1.11e-13	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs2645694	0.626	rs2703122	chr4:77821418	A/C	cg03477792	chr4:77819574	ANKRD56	0.57	6.38	0.59	1.18e-8	Emphysema distribution in smoking;
SKCM	trans	rs8073060	0.544	rs225252	chr17:33952401	G/A	cg19694781	chr19:47549865	TMEM160	-1.08	-8.36	-0.69	1.88e-12	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs3767633	0.528	rs4417044	chr1:161888955	T/C	cg27519958	chr1:161735129	ATF6	-0.76	-5.79	-0.55	1.4e-7	IgG glycosylation;
SKCM	cis	rs4724125	0.883	rs1156607	chr7:42682970	C/T	cg09407816	chr7:42972088	MRPL32;PSMA2	0.81	4.85	0.48	6.13e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6835098	0.924	rs13138282	chr4:174120906	C/T	cg08422745	chr4:174089978	GALNT7	0.85	6.55	0.6	5.69e-9	Dementia and core Alzheimer's disease neuropathologic changes;
SKCM	cis	rs1577917	0.655	rs9444354	chr6:86291935	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.62	5.18	0.51	1.67e-6	Response to antipsychotic treatment;
SKCM	cis	rs2811415	0.597	rs11711138	chr3:127762761	T/A	cg09089421	chr3:127803668	RUVBL1	0.99	8.52	0.69	9.09e-13	Lung function (FEV1/FVC);
SKCM	cis	rs28386778	0.897	rs57108948	chr17:61802378	T/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.13	11.24	0.79	5.56e-18	Prudent dietary pattern;
SKCM	cis	rs17376456	0.825	rs10061377	chr5:93174513	T/C	cg21475434	chr5:93447410	FAM172A	0.9	4.95	0.49	4.27e-6	Diabetic retinopathy;
SKCM	cis	rs873946	0.648	rs1543593	chr10:134553185	A/T	cg26818010	chr10:134567672	INPP5A	-0.81	-6.49	-0.59	7.12e-9	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs10752881	1.000	rs6658501	chr1:182991417	C/T	ch.1.3577855R	chr1:183094577	LAMC1	-0.74	-6.58	-0.6	4.9e-9	Colorectal cancer;
SKCM	cis	rs2180341	0.924	rs6930849	chr6:127630963	A/T	cg24812749	chr6:127587940	RNF146	0.88	7.44	0.64	1.12e-10	Breast cancer;
SKCM	cis	rs16854884	0.837	rs989665	chr3:143792854	C/T	cg06585982	chr3:143692056	C3orf58	0.72	5.63	0.54	2.78e-7	Economic and political preferences (feminism/equality);
SKCM	cis	rs7927771	1.000	rs12363232	chr11:47623890	C/T	cg05585544	chr11:47624801	NA	-0.63	-5.5	-0.53	4.73e-7	Subjective well-being;
SKCM	trans	rs561341	1.000	rs548957	chr17:30302411	G/A	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs56104184	0.830	rs17272658	chr19:49355405	C/T	cg15549821	chr19:49342101	PLEKHA4	-1.27	-7.95	-0.67	1.17e-11	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs12824058	0.831	rs12297939	chr12:130811923	G/C	cg26677194	chr12:130822605	PIWIL1	0.71	5.83	0.55	1.17e-7	Menopause (age at onset);
SKCM	cis	rs2153535	0.580	rs4639392	chr6:8446547	A/G	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs7618915	0.524	rs35249778	chr3:52661640	G/C	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs10832963	1.000	rs10128711	chr11:18632984	A/G	cg09201001	chr11:18656081	SPTY2D1	1.01	10.55	0.77	1.11e-16	Breast cancer;
SKCM	cis	rs1799949	0.930	rs4445938	chr17:41337900	A/C	cg23758822	chr17:41437982	NA	0.93	7.84	0.66	1.91e-11	Menopause (age at onset);
SKCM	cis	rs7635838	0.617	rs346085	chr3:11282724	T/C	cg00170343	chr3:11313890	ATG7	0.77	5.81	0.55	1.32e-7	HDL cholesterol;
SKCM	cis	rs4889855	0.614	rs7208670	chr17:78494220	T/G	cg16591659	chr17:78472290	NA	-0.49	-4.94	-0.49	4.32e-6	Fractional excretion of uric acid;
SKCM	cis	rs7927771	0.524	rs4752865	chr11:47759841	G/A	cg20307385	chr11:47447363	PSMC3	-0.72	-5.81	-0.55	1.31e-7	Subjective well-being;
SKCM	cis	rs4555082	0.834	rs2735816	chr14:105721603	C/G	cg13114125	chr14:105738426	BRF1	0.71	5.94	0.56	7.54e-8	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs362296	0.661	rs3121420	chr4:3264210	T/C	cg21096898	chr4:3318625	RGS12	-0.71	-6.32	-0.58	1.51e-8	Parental longevity (mother's age at death);
SKCM	cis	rs10256972	0.504	rs2949178	chr7:1209925	T/C	cg11360546	chr7:1094263	C7orf50	-0.44	-4.9	-0.48	5.17e-6	Longevity;Endometriosis;
SKCM	cis	rs61656020	1	rs61656020	chr16:1882221	C/G	cg26897989	chr16:1907736	C16orf73	-0.67	-7.7	-0.66	3.5e-11	Ankle injury;
SKCM	trans	rs17685	0.725	rs6467993	chr7:75719350	G/A	cg19862616	chr7:65841803	NCRNA00174	0.94	9.45	0.73	1.46e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs10256972	0.758	rs4723649	chr7:1071905	T/C	cg16145915	chr7:1198662	ZFAND2A	-0.46	-5.64	-0.54	2.57e-7	Longevity;Endometriosis;
SKCM	cis	rs1552244	0.882	rs67631672	chr3:10004768	G/A	cg02579736	chr3:10068473	FANCD2;CIDECP	0.98	4.89	0.48	5.25e-6	Alzheimer's disease;
SKCM	cis	rs10876993	0.855	rs10877007	chr12:58100058	T/A	cg18357645	chr12:58087776	OS9	0.68	6.27	0.58	1.83e-8	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs11098499	0.954	rs6849171	chr4:120409549	G/A	cg09307838	chr4:120376055	NA	0.97	7.65	0.65	4.54e-11	Corneal astigmatism;
SKCM	cis	rs769267	0.930	rs2301784	chr19:19390749	G/A	cg26732615	chr19:19648335	CILP2;YJEFN3	0.62	5.67	0.54	2.31e-7	Tonsillectomy;
SKCM	cis	rs7811142	1.000	rs7783159	chr7:100017454	C/T	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-0.94	-5.26	-0.51	1.23e-6	Platelet count;
SKCM	cis	rs4740619	0.619	rs10738428	chr9:16046489	T/C	cg14451791	chr9:16040625	NA	-0.47	-5.18	-0.51	1.66e-6	Body mass index;
SKCM	cis	rs1862618	0.627	rs744023	chr5:56197078	C/T	cg12311346	chr5:56204834	C5orf35	-0.85	-5.36	-0.52	8.34e-7	Initial pursuit acceleration;
SKCM	cis	rs2303759	0.918	rs1054770	chr19:49878115	G/A	cg05022225	chr19:49866942	DKKL1;TEAD2	0.69	5.26	0.51	1.25e-6	Multiple sclerosis;
SKCM	cis	rs13256369	1.000	rs10098234	chr8:8576692	G/A	cg06636001	chr8:8085503	FLJ10661	0.72	5.29	0.51	1.07e-6	Obesity-related traits;
SKCM	cis	rs6952808	0.771	rs4719336	chr7:1916397	T/C	cg02951883	chr7:2050386	MAD1L1	-0.69	-5.83	-0.55	1.18e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs11209185	0.623	rs6662264	chr1:68447276	C/T	cg17031739	chr1:67600172	NA	-0.5	-4.85	-0.48	6.17e-6	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs67311347	0.635	rs62261855	chr3:40294938	C/T	cg00091569	chr3:40428383	ENTPD3	0.66	5.32	0.52	9.56e-7	Renal cell carcinoma;
SKCM	cis	rs7809950	0.678	rs2395869	chr7:106940098	C/A	cg23024343	chr7:107201750	COG5	-0.8	-6.84	-0.61	1.59e-9	Coronary artery disease;
SKCM	cis	rs9910055	0.636	rs7089	chr17:42269017	T/C	cg08499158	chr17:42289980	UBTF	-0.73	-6.45	-0.59	8.6e-9	Total body bone mineral density;
SKCM	cis	rs2836974	0.897	rs8132295	chr21:40527774	A/G	cg11644478	chr21:40555479	PSMG1	-0.97	-10.21	-0.76	5.08e-16	Cognitive function;
SKCM	cis	rs2204008	0.774	rs4534658	chr12:38246783	G/A	cg13010199	chr12:38710504	ALG10B	0.69	4.91	0.49	4.84e-6	Bladder cancer;
SKCM	cis	rs72781680	1.000	rs72781648	chr2:24210333	T/C	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	cis	rs883565	0.771	rs2056613	chr3:39125293	G/T	cg20743662	chr3:38589496	NA	0.46	4.77	0.48	8.36e-6	Handedness;
SKCM	cis	rs2014572	0.967	rs10411941	chr19:57762886	C/T	cg24459738	chr19:57751996	ZNF805	-0.64	-5.17	-0.5	1.79e-6	Hyperactive-impulsive symptoms;
SKCM	cis	rs2894969	0.664	rs11252703	chr10:4795125	A/T	cg03039837	chr10:5690914	ASB13	0.61	4.96	0.49	4.06e-6	Major depressive disorder;
SKCM	cis	rs763014	0.898	rs4984892	chr16:622325	A/G	cg09263875	chr16:632152	PIGQ	0.68	5.71	0.54	1.98e-7	Height;
SKCM	cis	rs2070488	0.775	rs2070489	chr3:38519424	A/G	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.75	6.15	0.57	3.04e-8	Electrocardiographic conduction measures;
SKCM	cis	rs11098499	0.874	rs12509054	chr4:120115075	A/C	cg09307838	chr4:120376055	NA	0.86	6.08	0.57	4.13e-8	Corneal astigmatism;
SKCM	cis	rs7178909	0.902	rs3784386	chr15:90437426	A/G	cg19708238	chr15:90437601	AP3S2	0.72	5.22	0.51	1.43e-6	Common traits (Other);
SKCM	cis	rs3818285	0.556	rs941864	chr10:111656948	T/C	cg00817464	chr10:111662876	XPNPEP1	-0.78	-7.52	-0.65	8.1e-11	Superior crus of antihelix expression;
SKCM	cis	rs875971	0.545	rs17138156	chr7:65714695	C/T	cg18876405	chr7:65276391	NA	0.65	5.28	0.51	1.15e-6	Aortic root size;
SKCM	cis	rs28386778	0.897	rs6504177	chr17:61812655	C/T	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.13	11.24	0.79	5.56e-18	Prudent dietary pattern;
SKCM	cis	rs1707322	0.686	rs2991987	chr1:46081422	C/G	cg03146154	chr1:46216737	IPP	-0.83	-6.17	-0.57	2.83e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs9300255	0.602	rs2682431	chr12:123703226	T/A	cg00376283	chr12:123451042	ABCB9	0.83	5.49	0.53	4.74e-7	Neutrophil percentage of white cells;
SKCM	cis	rs12931792	0.846	rs9924308	chr16:30154740	C/T	cg17640201	chr16:30407289	ZNF48	-0.63	-4.85	-0.48	6.27e-6	Tonsillectomy;
SKCM	cis	rs9926296	0.508	rs1558184	chr16:89842374	T/G	cg04287289	chr16:89883240	FANCA	1.04	11.93	0.8	2.93e-19	Vitiligo;
SKCM	cis	rs1760803	0.701	rs6427509	chr1:154219718	C/T	cg26808167	chr1:154192205	UBAP2L;C1orf43	-0.55	-4.91	-0.49	4.87e-6	Nicotine dependence;
SKCM	cis	rs478304	0.654	rs10896032	chr11:65459419	C/A	cg27068330	chr11:65405492	SIPA1	-0.89	-7.62	-0.65	5.13e-11	Acne (severe);
SKCM	trans	rs8073060	0.586	rs9303690	chr17:34005513	C/T	cg19694781	chr19:47549865	TMEM160	-1.04	-8.28	-0.68	2.65e-12	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs17376456	0.825	rs10056879	chr5:93282218	C/A	cg25358565	chr5:93447407	FAM172A	1.31	7.46	0.65	1.04e-10	Diabetic retinopathy;
SKCM	cis	rs2286503	0.901	rs2286505	chr7:22854840	G/A	cg00309339	chr7:22893653	NA	-0.5	-4.77	-0.48	8.35e-6	Fibrinogen;
SKCM	cis	rs7811142	1.000	rs1000215	chr7:100004543	A/G	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.19	7.93	0.67	1.3e-11	Platelet count;
SKCM	cis	rs8014204	0.804	rs2287403	chr14:75259140	C/T	cg06637938	chr14:75390232	RPS6KL1	0.84	6.66	0.6	3.53e-9	Caffeine consumption;
SKCM	cis	rs9467773	1.000	rs10946834	chr6:26533664	G/C	cg09904177	chr6:26538194	HMGN4	0.54	4.98	0.49	3.78e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs875971	0.895	rs1974769	chr7:65950614	G/A	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	cis	rs2404602	0.692	rs2304920	chr15:76993867	T/C	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs9368481	0.761	rs3931464	chr6:26939856	C/A	cg12292205	chr6:26970375	C6orf41	0.67	6.11	0.57	3.69e-8	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs606458	0.764	rs483962	chr11:64527751	A/G	cg07674570	chr11:65346152	EHBP1L1	0.69	4.96	0.49	3.97e-6	Urate levels;
SKCM	cis	rs12120353	0.702	rs780605	chr1:4547238	C/T	cg15022359	chr1:4193126	NA	-0.62	-5.17	-0.51	1.74e-6	Anxiety disorder;
SKCM	cis	rs651907	0.535	rs11712309	chr3:101519097	T/C	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.78	6.72	0.61	2.65e-9	Colorectal cancer;
SKCM	cis	rs6951245	1.000	rs118059236	chr7:1073202	A/C	cg18402987	chr7:1209562	NA	1.15	6.02	0.56	5.38e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs1577917	0.917	rs2218594	chr6:86543766	A/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.33	-0.52	9.19e-7	Response to antipsychotic treatment;
SKCM	cis	rs10905065	0.766	rs11598374	chr10:5826986	T/C	cg09234995	chr10:5726438	C10orf18	0.66	5.69	0.54	2.15e-7	Menopause (age at onset);
SKCM	cis	rs9894429	1.000	rs9748176	chr17:79584043	C/G	cg18240062	chr17:79603768	NPLOC4	0.76	7.24	0.63	2.75e-10	Eye color traits;
SKCM	cis	rs9790314	0.967	rs1382427	chr3:161032576	T/C	cg03342759	chr3:160939853	NMD3	-0.72	-7.87	-0.67	1.65e-11	Morning vs. evening chronotype;
SKCM	cis	rs72792276	0.818	rs57249773	chr5:127463166	C/G	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.77	5.22	0.51	1.46e-6	Red cell distribution width;
SKCM	cis	rs1218582	0.772	rs2174507	chr1:154887949	C/T	cg09359103	chr1:154839909	KCNN3	-0.57	-5.3	-0.51	1.05e-6	Prostate cancer;
SKCM	cis	rs7296418	0.885	rs1790104	chr12:123709409	C/T	cg00376283	chr12:123451042	ABCB9	0.91	7.45	0.64	1.08e-10	Platelet count;
SKCM	cis	rs7772486	0.840	rs2777478	chr6:146309117	T/C	cg23711669	chr6:146136114	FBXO30	0.76	7.08	0.63	5.66e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs55962025	0.842	rs2269477	chr4:3184464	G/T	cg05297308	chr4:3317976	RGS12	-0.62	-4.85	-0.48	6.08e-6	Parental longevity (mother's age at death);
SKCM	cis	rs2841277	0.708	rs11851053	chr14:105407208	T/C	cg19901468	chr14:105411992	AHNAK2	-0.98	-7.76	-0.66	2.7e-11	Rheumatoid arthritis;
SKCM	cis	rs11098499	0.562	rs13101722	chr4:120555975	C/A	cg09307838	chr4:120376055	NA	-0.97	-8.11	-0.68	5.87e-12	Corneal astigmatism;
SKCM	trans	rs1814175	0.616	rs1722020	chr11:49904189	G/A	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs7659604	0.540	rs7699289	chr4:122671553	G/A	cg19671926	chr4:122722719	EXOSC9	0.76	6.16	0.57	3.02e-8	Type 2 diabetes;
SKCM	cis	rs9910055	0.529	rs368328	chr17:42170289	G/A	cg09913183	chr17:42254507	C17orf65;ASB16	-0.59	-4.82	-0.48	6.82e-6	Total body bone mineral density;
SKCM	cis	rs9303401	0.659	rs11079357	chr17:56902778	A/G	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.16	0.57	2.91e-8	Cognitive test performance;
SKCM	cis	rs1153858	1.000	rs3809472	chr15:45694318	G/T	cg10760299	chr15:45669010	GATM	0.6	5.93	0.56	7.69e-8	Homoarginine levels;
SKCM	cis	rs5750830	0.649	rs5750820	chr22:39825322	T/G	cg24399712	chr22:39784796	NA	-0.59	-4.8	-0.48	7.39e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs826838	0.802	rs10785619	chr12:38742897	T/A	cg13010199	chr12:38710504	ALG10B	0.74	5.44	0.52	5.95e-7	Heart rate;
SKCM	cis	rs1005277	0.579	rs2800485	chr10:38542588	G/A	cg00409905	chr10:38381863	ZNF37A	-0.62	-5.78	-0.55	1.49e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs17685	0.712	rs28456330	chr7:75810542	A/G	cg01364799	chr7:75623366	TMEM120A	-0.69	-5.81	-0.55	1.28e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7666738	0.830	rs34273190	chr4:99004568	C/T	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs13010713	0.840	rs4522566	chr2:182058191	A/G	cg21995919	chr2:182322279	ITGA4	-0.53	-5.12	-0.5	2.18e-6	Celiac disease;
SKCM	cis	rs17685	0.712	rs1859794	chr7:75821544	G/A	cg16684958	chr7:75615977	POR	0.5	4.89	0.48	5.39e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1552244	0.810	rs6809572	chr3:10100145	G/A	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs9902453	0.845	rs7221516	chr17:28232506	G/A	cg26525008	chr17:28256777	EFCAB5;SSH2	0.82	6.42	0.59	9.65e-9	Coffee consumption (cups per day);
SKCM	cis	rs2070488	0.965	rs35553573	chr3:38441439	C/T	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.97	9.35	0.73	2.28e-14	Electrocardiographic conduction measures;
SKCM	cis	rs1403694	0.515	rs1624569	chr3:186450069	A/G	cg09332604	chr3:186435400	KNG1	-0.54	-5.35	-0.52	8.42e-7	Blood protein levels;
SKCM	cis	rs7659604	0.628	rs3828485	chr4:122722368	G/A	cg20573242	chr4:122745356	CCNA2	0.76	6.61	0.6	4.4e-9	Type 2 diabetes;
SKCM	cis	rs7843479	0.601	rs11785043	chr8:21810377	C/T	cg17168535	chr8:21777572	XPO7	0.84	8.06	0.67	7.32e-12	Mean corpuscular volume;
SKCM	cis	rs1413885	0.516	rs10789183	chr1:65856779	G/C	cg14976592	chr1:65886160	LEPROT;LEPR	0.59	4.79	0.48	7.85e-6	Anticoagulant levels;
SKCM	cis	rs11690935	0.885	rs6750058	chr2:172786909	G/T	cg13550731	chr2:172543902	DYNC1I2	-0.92	-7.46	-0.65	1.03e-10	Schizophrenia;
SKCM	cis	rs709400	0.663	rs1028613	chr14:103888324	G/A	cg26031613	chr14:104095156	KLC1	0.69	5.03	0.49	3.05e-6	Body mass index;
SKCM	cis	rs2842992	0.513	rs7759086	chr6:160193853	A/G	cg16489826	chr6:160211363	TCP1;MRPL18	0.75	6.12	0.57	3.48e-8	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs208520	0.874	rs208491	chr6:66928459	C/G	cg07460842	chr6:66804631	NA	-0.98	-6.96	-0.62	9.58e-10	Exhaled nitric oxide output;
SKCM	cis	rs1577917	0.883	rs2782263	chr6:86791307	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.6	-4.87	-0.48	5.71e-6	Response to antipsychotic treatment;
SKCM	cis	rs9399135	0.967	rs4895436	chr6:135295001	G/A	cg24558204	chr6:135376177	HBS1L	0.55	4.98	0.49	3.73e-6	Red blood cell count;
SKCM	cis	rs2839186	1.000	rs2839181	chr21:47685939	A/G	cg13126279	chr21:47581558	C21orf56	-0.63	-5.42	-0.52	6.37e-7	Testicular germ cell tumor;
SKCM	cis	rs17685	0.712	rs10952842	chr7:75780413	G/A	cg16684958	chr7:75615977	POR	0.52	4.92	0.49	4.73e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs782590	0.774	rs12616629	chr2:55944293	G/C	cg18811423	chr2:55921094	PNPT1	-0.91	-6.32	-0.58	1.48e-8	Metabolic syndrome;
SKCM	cis	rs12478296	1.000	rs55732177	chr2:243040006	C/T	cg06360820	chr2:242988706	NA	-0.92	-5.32	-0.52	9.84e-7	Obesity-related traits;
SKCM	cis	rs7937682	0.883	rs11213941	chr11:111434094	T/C	cg19812747	chr11:111475976	SIK2	0.58	4.86	0.48	5.88e-6	Primary sclerosing cholangitis;
SKCM	cis	rs60871478	1.000	rs34086011	chr7:805430	C/T	cg05535760	chr7:792225	HEATR2	1.02	8.66	0.7	4.97e-13	Cerebrospinal P-tau181p levels;
SKCM	cis	rs362296	0.661	rs3095079	chr4:3265414	A/G	cg24015175	chr4:3319247	RGS12	0.58	5.27	0.51	1.17e-6	Parental longevity (mother's age at death);
SKCM	cis	rs854765	0.929	rs2955360	chr17:17974887	G/A	cg04398451	chr17:18023971	MYO15A	0.64	4.79	0.48	7.72e-6	Total body bone mineral density;
SKCM	cis	rs2075371	1.000	rs2075372	chr7:133984432	C/T	cg20476274	chr7:133979776	SLC35B4	1.01	10.44	0.76	1.77e-16	Mean platelet volume;
SKCM	cis	rs2204008	0.744	rs11519905	chr12:38222959	G/A	cg26384229	chr12:38710491	ALG10B	0.81	6.23	0.58	2.23e-8	Bladder cancer;
SKCM	cis	rs10504229	0.683	rs56211106	chr8:58113497	A/G	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs7615952	0.611	rs2947646	chr3:125593602	C/T	cg05084668	chr3:125655381	ALG1L	1.23	6.38	0.59	1.14e-8	Blood pressure (smoking interaction);
SKCM	cis	rs1577917	0.771	rs2842608	chr6:86295858	C/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.98	-10.99	-0.78	1.66e-17	Response to antipsychotic treatment;
SKCM	cis	rs2295499	0.643	rs12509102	chr4:2710962	G/C	cg19433769	chr4:2420260	ZFYVE28	0.69	4.77	0.48	8.44e-6	Cognitive ability;Cognitive ability (multi-trait analysis);Intelligence (multi-trait analysis);
SKCM	cis	rs4555082	0.834	rs2735819	chr14:105713449	C/T	cg13114125	chr14:105738426	BRF1	-0.69	-5.7	-0.54	2.07e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs6424115	0.800	rs2229583	chr1:24200983	C/T	cg15997130	chr1:24165203	NA	0.6	4.94	0.49	4.37e-6	Immature fraction of reticulocytes;
SKCM	cis	rs7208859	0.623	rs6505207	chr17:29076571	T/C	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs2153535	0.580	rs6913100	chr6:8456855	A/G	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs2072510	0.932	rs2070614	chr12:96390336	T/C	cg18817487	chr12:96390143	HAL	0.41	5.16	0.5	1.8e-6	Metabolite levels (small molecules and protein measures);
SKCM	cis	rs10752881	1.000	rs4454510	chr1:182982303	A/G	ch.1.3577855R	chr1:183094577	LAMC1	-0.72	-6.62	-0.6	4.15e-9	Colorectal cancer;
SKCM	cis	rs9910055	0.762	rs7213436	chr17:42252163	A/G	cg08499158	chr17:42289980	UBTF	0.85	7.66	0.66	4.36e-11	Total body bone mineral density;
SKCM	cis	rs9902453	0.845	rs62068583	chr17:28001482	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.82	5.78	0.55	1.47e-7	Coffee consumption (cups per day);
SKCM	cis	rs1048238	0.506	rs848212	chr1:16263452	A/G	cg21385522	chr1:16154831	NA	-0.65	-5.61	-0.54	2.91e-7	Systolic blood pressure;
SKCM	cis	rs2836974	0.829	rs34227163	chr21:40551943	A/G	cg11644478	chr21:40555479	PSMG1	0.97	10.21	0.76	5.08e-16	Cognitive function;
SKCM	cis	rs1185460	0.967	rs11217137	chr11:118931030	A/G	cg23280166	chr11:118938394	VPS11	0.57	5.11	0.5	2.21e-6	Coronary artery disease;
SKCM	cis	rs1577917	0.917	rs4707226	chr6:86527828	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.33	-0.52	9.19e-7	Response to antipsychotic treatment;
SKCM	cis	rs2857078	0.654	rs9896789	chr17:42314567	C/T	cg13607699	chr17:42295918	UBTF	0.91	7.31	0.64	2.05e-10	Red cell distribution width;Reticulocyte count;
SKCM	trans	rs1814175	0.817	rs2866863	chr11:49953242	C/T	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs7536201	0.665	rs12130556	chr1:25301370	G/A	cg24722749	chr1:24969476	SRRM1	0.62	4.9	0.49	5.06e-6	Psoriasis vulgaris;
SKCM	cis	rs1046896	0.519	rs9900369	chr17:80829807	G/A	cg02711726	chr17:80685570	FN3KRP	-0.79	-5.95	-0.56	7.17e-8	Glycated hemoglobin levels;
SKCM	cis	rs9388451	0.839	rs3757217	chr6:126069636	G/C	cg05901451	chr6:126070800	HEY2	-0.82	-7.91	-0.67	1.41e-11	Brugada syndrome;
SKCM	cis	rs4862750	0.832	rs6419953	chr4:187900509	T/A	cg10295955	chr4:187884368	NA	-1.04	-13.97	-0.85	6.27e-23	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6952808	1.000	rs4256490	chr7:1890764	G/A	cg04267008	chr7:1944627	MAD1L1	-0.76	-5.74	-0.55	1.7e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs6489882	0.902	rs1981557	chr12:113372866	G/C	cg07232103	chr12:112566177	TRAFD1	0.6	4.9	0.48	5.14e-6	Chronic lymphocytic leukemia;
SKCM	cis	rs2811415	0.597	rs13079887	chr3:127745248	G/A	cg09089421	chr3:127803668	RUVBL1	0.99	8.52	0.69	9.09e-13	Lung function (FEV1/FVC);
SKCM	cis	rs1005277	0.579	rs176838	chr10:38371899	A/T	cg00409905	chr10:38381863	ZNF37A	0.71	6.55	0.6	5.5e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs12142240	0.698	rs17361819	chr1:46828109	A/G	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs561341	0.800	rs7209766	chr17:30234848	T/A	cg00745463	chr17:30367425	LRRC37B	-0.99	-6.33	-0.58	1.46e-8	Hip circumference adjusted for BMI;
SKCM	cis	rs61776719	0.806	rs28493395	chr1:38400558	C/T	cg17077180	chr1:38461687	NA	0.5	4.92	0.49	4.63e-6	Coronary artery disease;
SKCM	cis	rs9916302	0.706	rs11657153	chr17:37699729	A/G	cg07936489	chr17:37558343	FBXL20	-1.01	-8.17	-0.68	4.34e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs57221529	0.709	rs111352378	chr5:577079	G/A	cg10555297	chr5:473380	SLC9A3;LOC25845	1.09	5.49	0.53	4.82e-7	Lung disease severity in cystic fibrosis;
SKCM	cis	rs1577917	1.000	rs6936048	chr6:86702608	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.64	-5.54	-0.53	3.92e-7	Response to antipsychotic treatment;
SKCM	cis	rs2479724	0.901	rs2185798	chr6:41773576	G/C	cg17623882	chr6:41773611	USP49	0.79	6.96	0.62	9.5e-10	Menarche (age at onset);
SKCM	cis	rs9303401	0.704	rs7359501	chr17:56641200	C/T	cg02118635	chr17:56770003	RAD51C;TEX14	0.65	4.94	0.49	4.43e-6	Cognitive test performance;
SKCM	cis	rs9430161	0.611	rs2095920	chr1:11033457	T/A	cg02454025	chr1:11042201	C1orf127	1.08	10.13	0.75	7.19e-16	Ewing sarcoma;
SKCM	cis	rs6598955	0.670	rs10794525	chr1:26537193	C/A	cg00938395	chr1:26633206	UBXN11	0.71	5.0	0.49	3.5e-6	Obesity-related traits;
SKCM	cis	rs514406	0.679	rs61768344	chr1:53229274	G/A	cg24675658	chr1:53192096	ZYG11B	0.89	8.03	0.67	8.33e-12	Monocyte count;
SKCM	cis	rs919433	0.963	rs10199410	chr2:198155776	A/T	cg04278110	chr2:198063759	ANKRD44	-0.72	-5.33	-0.52	9.25e-7	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs9399135	0.935	rs949547	chr6:135343499	C/G	cg24558204	chr6:135376177	HBS1L	0.6	5.36	0.52	8.17e-7	Red blood cell count;
SKCM	cis	rs7945705	0.875	rs10769957	chr11:8809016	A/C	cg21881798	chr11:8931708	C11orf17;ST5	-0.62	-6.23	-0.58	2.25e-8	Hemoglobin concentration;
SKCM	cis	rs28386778	0.933	rs2665804	chr17:61951836	G/T	cg26338869	chr17:61819248	STRADA	0.7	4.79	0.48	7.67e-6	Prudent dietary pattern;
SKCM	cis	rs748404	0.578	rs2584701	chr15:43684939	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	0.79	5.95	0.56	7.09e-8	Lung cancer;
SKCM	cis	rs933688	0.941	rs11948056	chr5:90680468	A/C	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.95	6.61	0.6	4.39e-9	Smoking behavior;
SKCM	cis	rs208520	0.690	rs1100981	chr6:66852052	T/C	cg07460842	chr6:66804631	NA	-1.08	-8.03	-0.67	8.38e-12	Exhaled nitric oxide output;
SKCM	cis	rs6582630	0.533	rs4103689	chr12:38702980	A/C	cg13010199	chr12:38710504	ALG10B	0.63	4.92	0.49	4.64e-6	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs72615157	0.645	rs11771660	chr7:99851269	T/A	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.03	5.73	0.54	1.79e-7	Lung function (FEV1/FVC);
SKCM	cis	rs9815354	0.812	rs73071356	chr3:41829486	C/T	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs11764590	0.694	rs55860148	chr7:2105594	G/A	cg23422044	chr7:1970798	MAD1L1	-0.83	-5.6	-0.54	3.08e-7	Neuroticism;
SKCM	cis	rs875971	1.000	rs4718343	chr7:65874288	T/G	cg11764359	chr7:65958608	NA	0.87	8.35	0.69	2.01e-12	Aortic root size;
SKCM	cis	rs7336332	0.527	rs1475219	chr13:28037415	A/G	cg22138327	chr13:27999177	GTF3A	0.89	6.57	0.6	5.21e-9	Weight;
SKCM	cis	rs28595532	0.920	rs55633605	chr4:119761589	G/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs10492096	1.000	rs12427239	chr12:6590626	C/T	cg13857086	chr12:6580257	VAMP1	0.76	5.75	0.55	1.64e-7	Hip geometry;
SKCM	cis	rs13118159	0.509	rs7688922	chr4:1361011	T/C	cg02018176	chr4:1364513	KIAA1530	0.93	7.8	0.66	2.31e-11	Longevity;
SKCM	cis	rs151997	1.000	rs27249	chr5:50232678	A/G	cg06027927	chr5:50259733	NA	0.67	5.97	0.56	6.72e-8	Callous-unemotional behaviour;
SKCM	cis	rs28595532	0.920	rs114575045	chr4:119739794	A/G	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs2072499	0.966	rs2244144	chr1:156184598	G/A	cg25208724	chr1:156163844	SLC25A44	1.0	8.52	0.69	9.03e-13	Testicular germ cell tumor;
SKCM	cis	rs644799	0.965	rs1944080	chr11:95503636	T/C	cg03916912	chr11:95522834	CEP57;FAM76B	0.96	8.72	0.7	3.77e-13	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs17376456	0.825	rs13161885	chr5:93071242	A/C	cg25358565	chr5:93447407	FAM172A	1.17	8.0	0.67	9.26e-12	Diabetic retinopathy;
SKCM	cis	rs4481887	0.927	rs7521689	chr1:248435831	G/T	cg00666640	chr1:248458726	OR2T12	0.69	5.71	0.54	1.95e-7	Common traits (Other);
SKCM	cis	rs2075371	1.000	rs2244700	chr7:133987374	A/G	cg20476274	chr7:133979776	SLC35B4	1.04	11.01	0.78	1.5e-17	Mean platelet volume;
SKCM	cis	rs28386778	0.897	rs8069969	chr17:61822223	T/G	cg01411255	chr17:61851458	DDX42;CCDC47	0.78	5.03	0.49	3.06e-6	Prudent dietary pattern;
SKCM	cis	rs2075371	1.000	rs2504	chr7:133979545	A/T	cg20476274	chr7:133979776	SLC35B4	1.01	10.44	0.76	1.77e-16	Mean platelet volume;
SKCM	cis	rs10905065	0.759	rs10905255	chr10:5870267	G/T	cg11519256	chr10:5708881	ASB13	0.58	4.95	0.49	4.23e-6	Menopause (age at onset);
SKCM	cis	rs2153535	0.580	rs6597337	chr6:8531652	C/T	cg23788917	chr6:8435910	SLC35B3	0.68	4.98	0.49	3.66e-6	Motion sickness;
SKCM	cis	rs13256369	0.851	rs13266562	chr8:8564065	T/C	cg06636001	chr8:8085503	FLJ10661	0.8	6.11	0.57	3.65e-8	Obesity-related traits;
SKCM	cis	rs9467773	0.620	rs2101581	chr6:26622769	G/T	cg09904177	chr6:26538194	HMGN4	0.58	5.01	0.49	3.28e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2832191	0.692	rs2254872	chr21:30414724	C/T	cg08807101	chr21:30365312	RNF160	0.76	6.32	0.58	1.52e-8	Dental caries;
SKCM	cis	rs9911578	1.000	rs12938772	chr17:56776320	T/C	cg05425664	chr17:57184151	TRIM37	-0.69	-5.21	-0.51	1.52e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs6835098	0.692	rs6822683	chr4:174063974	G/A	cg08422745	chr4:174089978	GALNT7	-0.82	-6.7	-0.6	2.98e-9	Dementia and core Alzheimer's disease neuropathologic changes;
SKCM	cis	rs6933660	0.800	rs9383893	chr6:151757327	T/C	cg10883421	chr6:151773342	RMND1;C6orf211	0.82	6.87	0.61	1.38e-9	Menarche (age at onset);
SKCM	cis	rs10540	0.908	rs71487293	chr11:486414	G/A	cg03576123	chr11:487126	PTDSS2	-1.4	-7.12	-0.63	4.72e-10	Body mass index;
SKCM	cis	rs870825	0.616	rs67641203	chr4:185623845	A/C	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs561341	0.883	rs4795661	chr17:30201774	T/A	cg00745463	chr17:30367425	LRRC37B	0.99	6.38	0.59	1.18e-8	Hip circumference adjusted for BMI;
SKCM	cis	rs6430585	0.941	rs7589832	chr2:136504101	A/C	cg07169764	chr2:136633963	MCM6	0.91	7.28	0.64	2.35e-10	Corneal structure;
SKCM	cis	rs760762	0.506	rs6129731	chr20:39660687	A/C	cg06424997	chr20:39929561	ZHX3	0.65	5.08	0.5	2.55e-6	Age-related diseases, mortality and associated endophenotypes;Age-related disease endophenotypes;
SKCM	cis	rs7208859	0.573	rs4055105	chr17:29102550	A/G	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs10089	1.000	rs10060390	chr5:127452947	C/T	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.91	8.89	0.71	1.79e-13	Ileal carcinoids;
SKCM	cis	rs9911578	1.000	rs9907499	chr17:56949044	A/G	cg05425664	chr17:57184151	TRIM37	-0.67	-5.04	-0.5	2.91e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs561341	0.941	rs550213	chr17:30317518	C/G	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs2836974	0.932	rs6517526	chr21:40581530	T/C	cg11890956	chr21:40555474	PSMG1	1.09	13.83	0.84	1.08e-22	Cognitive function;
SKCM	cis	rs17685	0.725	rs2302436	chr7:75676988	A/T	cg16684958	chr7:75615977	POR	-0.57	-5.6	-0.54	3.07e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs28595532	0.925	rs10000445	chr4:119485311	C/T	cg11846333	chr4:119757529	SEC24D	1.15	6.24	0.58	2.13e-8	Cannabis dependence symptom count;
SKCM	cis	rs7809950	0.862	rs2299421	chr7:106946195	C/G	cg23024343	chr7:107201750	COG5	-0.63	-5.45	-0.53	5.69e-7	Coronary artery disease;
SKCM	cis	rs7772486	0.875	rs9390371	chr6:146363180	A/G	cg05347473	chr6:146136440	FBXO30	0.57	5.12	0.5	2.13e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4727027	0.901	rs1534197	chr7:148771970	T/C	cg23583168	chr7:148888333	NA	-0.82	-6.45	-0.59	8.44e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs951366	0.789	rs1772148	chr1:205704580	A/T	cg26354017	chr1:205819088	PM20D1	1.01	8.85	0.71	2.06e-13	Menarche (age at onset);
SKCM	cis	rs12497850	0.931	rs7621015	chr3:49016056	A/G	cg06212747	chr3:49208901	KLHDC8B	0.68	4.9	0.49	5.06e-6	Parkinson's disease;
SKCM	cis	rs12478296	1.000	rs73007129	chr2:243000555	T/C	cg06360820	chr2:242988706	NA	-1.05	-5.13	-0.5	2.04e-6	Obesity-related traits;
SKCM	cis	rs6062496	0.631	rs6062484	chr20:62301980	T/C	cg27236539	chr20:62289627	RTEL1	0.73	5.03	0.49	3.06e-6	Crohn's disease;Inflammatory bowel disease;Ulcerative colitis;
SKCM	cis	rs10504073	0.647	rs12156111	chr8:50017328	G/C	cg00325661	chr8:49890786	NA	0.82	7.02	0.62	7.13e-10	Blood metabolite ratios;
SKCM	cis	rs17065868	0.685	rs9316090	chr13:45211670	G/A	cg10246903	chr13:45222710	NA	0.95	5.35	0.52	8.5e-7	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs1801251	1.000	rs283476	chr2:233650168	A/G	cg08000102	chr2:233561755	GIGYF2	0.9	6.95	0.62	9.85e-10	Coronary artery disease;
SKCM	cis	rs9300255	0.679	rs12829456	chr12:123725395	C/T	cg00376283	chr12:123451042	ABCB9	-0.85	-5.86	-0.55	1.03e-7	Neutrophil percentage of white cells;
SKCM	cis	rs6753739	0.745	rs1455839	chr2:219912509	A/C	cg09617556	chr2:219924408	IHH	0.47	4.94	0.49	4.44e-6	Height;
SKCM	cis	rs17711722	0.701	rs781143	chr7:65439879	G/C	cg18876405	chr7:65276391	NA	0.87	8.12	0.68	5.54e-12	Calcium levels;
SKCM	cis	rs8072100	0.846	rs4264433	chr17:45737275	A/T	cg08085267	chr17:45401833	C17orf57	0.65	5.93	0.56	7.91e-8	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs11098499	0.954	rs12506546	chr4:120301618	T/C	cg09307838	chr4:120376055	NA	0.97	7.49	0.65	9.08e-11	Corneal astigmatism;
SKCM	cis	rs2836974	0.666	rs4624474	chr21:40686327	T/C	cg11644478	chr21:40555479	PSMG1	-0.64	-5.33	-0.52	9.27e-7	Cognitive function;
SKCM	cis	rs4523957	0.583	rs7503141	chr17:2044645	T/C	cg16513277	chr17:2031491	SMG6	-0.91	-6.21	-0.58	2.38e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs7584330	0.740	rs12471291	chr2:238441751	T/G	cg14458575	chr2:238380390	NA	1.0	7.12	0.63	4.64e-10	Prostate cancer;
SKCM	cis	rs1552244	1.000	rs17032278	chr3:10077955	A/G	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs4665809	0.590	rs35727620	chr2:26458364	G/A	cg26119090	chr2:26468346	HADHA;HADHB	1.06	8.39	0.69	1.66e-12	Gut microbiome composition (summer);
SKCM	cis	rs1949733	0.636	rs16842498	chr4:8539529	C/T	cg11789530	chr4:8429930	ACOX3	-0.74	-4.89	-0.48	5.34e-6	Response to antineoplastic agents;
SKCM	cis	rs1707322	0.752	rs4607935	chr1:46117161	C/T	cg03146154	chr1:46216737	IPP	0.8	5.57	0.53	3.52e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs6951245	0.938	rs112425403	chr7:1071531	A/G	cg23708337	chr7:1209742	NA	0.93	4.82	0.48	6.83e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs4642101	0.640	rs12629398	chr3:12826799	A/G	cg05775895	chr3:12838266	CAND2	0.69	6.11	0.57	3.73e-8	QRS complex (12-leadsum);
SKCM	cis	rs6952808	0.531	rs4721441	chr7:2184060	A/G	cg21782813	chr7:2030301	MAD1L1	0.51	5.26	0.51	1.22e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs7833790	0.927	rs61020899	chr8:82757090	C/T	cg17211192	chr8:82754475	SNX16	0.92	4.9	0.49	5.03e-6	Diastolic blood pressure;
SKCM	cis	rs778371	0.723	rs11689851	chr2:233567342	A/G	cg08000102	chr2:233561755	GIGYF2	0.84	6.53	0.59	6.17e-9	Schizophrenia;
SKCM	cis	rs523522	0.962	rs4766969	chr12:120988238	A/G	cg27279351	chr12:120934652	DYNLL1	0.91	8.32	0.69	2.26e-12	High light scatter reticulocyte count;
SKCM	cis	rs6121246	0.520	rs6060425	chr20:30224355	C/T	cg11595048	chr20:30225325	COX4I2	0.63	4.96	0.49	4.08e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs6977660	0.943	rs10263564	chr7:19842898	G/C	cg07541023	chr7:19748670	TWISTNB	0.7	4.92	0.49	4.79e-6	Thyroid stimulating hormone;
SKCM	cis	rs2905347	0.531	rs2961289	chr7:22677755	C/T	cg00394316	chr7:22539822	MGC87042	-0.46	-4.87	-0.48	5.83e-6	Major depression and alcohol dependence;
SKCM	cis	rs597539	0.652	rs507520	chr11:68666054	C/T	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.84	5.57	0.53	3.44e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs6138458	1.000	rs6114981	chr20:24974401	C/T	cg26195577	chr20:24973756	C20orf3	-1.27	-8.87	-0.71	1.95e-13	Blood protein levels;
SKCM	cis	rs2204008	0.580	rs1315373	chr12:38179114	T/G	cg26384229	chr12:38710491	ALG10B	-0.67	-5.47	-0.53	5.23e-7	Bladder cancer;
SKCM	cis	rs1957429	0.731	rs1951495	chr14:65336690	T/C	cg23373153	chr14:65346875	NA	1.22	6.27	0.58	1.88e-8	Pediatric areal bone mineral density (radius);
SKCM	cis	rs2180341	1.000	rs6569478	chr6:127598619	G/A	cg24812749	chr6:127587940	RNF146	0.86	7.32	0.64	1.92e-10	Breast cancer;
SKCM	cis	rs6121246	0.697	rs8118150	chr20:30436088	G/A	cg11595048	chr20:30225325	COX4I2	0.67	5.17	0.51	1.74e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs58688157	0.660	rs7117022	chr11:583787	T/C	cg16486109	chr11:613632	IRF7	1.1	6.88	0.61	1.36e-9	Systemic lupus erythematosus;
SKCM	cis	rs6951245	1.000	rs74366004	chr7:1088630	A/C	cg03188948	chr7:1209495	NA	1.12	6.25	0.58	2.02e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs6951245	0.744	rs10265758	chr7:1172518	C/T	cg18402987	chr7:1209562	NA	1.15	7.39	0.64	1.39e-10	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs2228479	0.681	rs11642428	chr16:89971909	A/T	cg00800038	chr16:89945340	TCF25	-0.95	-5.72	-0.54	1.9e-7	Skin colour saturation;
SKCM	cis	rs17376456	0.877	rs12374470	chr5:93481046	A/G	cg21475434	chr5:93447410	FAM172A	0.97	5.42	0.52	6.39e-7	Diabetic retinopathy;
SKCM	cis	rs7811142	1.000	rs6962151	chr7:100028484	T/C	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.17	7.71	0.66	3.44e-11	Platelet count;
SKCM	cis	rs72781680	1.000	rs72781675	chr2:24232092	G/A	cg08917208	chr2:24149416	ATAD2B	1.07	5.99	0.56	6.1e-8	Lymphocyte counts;
SKCM	trans	rs877282	0.945	rs11253388	chr10:787852	A/G	cg22713356	chr15:30763199	NA	1.35	7.57	0.65	6.52e-11	Uric acid levels;
SKCM	cis	rs870825	0.616	rs12498890	chr4:185636096	C/G	cg04058563	chr4:185651563	MLF1IP	-0.95	-6.96	-0.62	9.21e-10	Blood protein levels;
SKCM	cis	rs4853012	0.838	rs59570457	chr2:74344282	T/C	cg01017244	chr2:74357527	NA	0.7	4.78	0.48	8.1e-6	Gestational age at birth (maternal effect);
SKCM	cis	rs116095464	0.558	rs62347683	chr5:230331	C/T	cg22857025	chr5:266934	NA	-1.37	-8.11	-0.68	5.82e-12	Breast cancer;
SKCM	cis	rs10492096	0.947	rs10849483	chr12:6635374	G/A	cg13857086	chr12:6580257	VAMP1	0.77	5.87	0.55	1.02e-7	Hip geometry;
SKCM	cis	rs9420	0.884	rs673344	chr11:57657141	G/A	cg19752551	chr11:57585705	CTNND1	0.7	6.74	0.61	2.45e-9	Schizophrenia;
SKCM	cis	rs6424115	0.830	rs2502993	chr1:24201262	A/G	cg15997130	chr1:24165203	NA	0.6	4.94	0.49	4.37e-6	Immature fraction of reticulocytes;
SKCM	cis	rs1801251	0.963	rs6739638	chr2:233576015	G/A	cg08000102	chr2:233561755	GIGYF2	0.89	6.91	0.62	1.15e-9	Coronary artery disease;
SKCM	cis	rs9916302	0.800	rs8081220	chr17:37473157	A/C	cg07936489	chr17:37558343	FBXL20	0.81	6.65	0.6	3.68e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs494003	0.553	rs10896045	chr11:65555524	A/G	cg08755490	chr11:65554678	OVOL1	0.66	5.29	0.51	1.1e-6	Systemic lupus erythematosus;
SKCM	cis	rs2811415	0.597	rs9810599	chr3:127749086	A/G	cg09089421	chr3:127803668	RUVBL1	0.99	8.52	0.69	9.09e-13	Lung function (FEV1/FVC);
SKCM	cis	rs672059	1.000	rs674343	chr1:183162052	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.65	5.49	0.53	4.81e-7	Hypertriglyceridemia;
SKCM	cis	rs798502	0.541	rs2644307	chr7:2832973	G/A	cg19717773	chr7:2847554	GNA12	-0.48	-5.65	-0.54	2.54e-7	Waist circumference adjusted for BMI (adjusted for smoking behaviour);Inflammatory bowel disease;Waist circumference adjusted for BMI in non-smokers;Ulcerative colitis;Waist circumference adjusted for body mass index;Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction);
SKCM	cis	rs4803468	0.967	rs4803462	chr19:41908936	T/A	cg14132834	chr19:41945861	ATP5SL	-0.74	-5.68	-0.54	2.24e-7	Height;
SKCM	cis	rs7927771	1.000	rs2290850	chr11:47807774	T/C	cg05585544	chr11:47624801	NA	-0.57	-4.83	-0.48	6.62e-6	Subjective well-being;
SKCM	cis	rs58688157	0.960	rs12422022	chr11:613192	A/G	cg16486109	chr11:613632	IRF7	1.07	7.29	0.64	2.17e-10	Systemic lupus erythematosus;
SKCM	cis	rs7826238	0.535	rs2979179	chr8:8320029	C/T	cg08975724	chr8:8085496	FLJ10661	0.62	4.94	0.49	4.42e-6	Systolic blood pressure;
SKCM	cis	rs28374715	1.000	rs28374715	chr15:41563950	A/G	cg18705301	chr15:41695430	NDUFAF1	-0.94	-7.92	-0.67	1.35e-11	Ulcerative colitis;
SKCM	cis	rs365132	1.000	rs2292255	chr5:176334195	C/T	cg16309518	chr5:176445507	NA	-0.52	-5.12	-0.5	2.11e-6	Menarche and menopause (age at onset);Menopause (age at onset);
SKCM	cis	rs10751667	0.621	rs7394681	chr11:952111	C/T	cg10932868	chr11:921992	NA	0.55	5.1	0.5	2.36e-6	Alzheimer's disease (late onset);
SKCM	cis	rs8103278	0.894	rs74821481	chr19:46320041	G/T	cg11657440	chr19:46296263	DMWD	-0.89	-5.84	-0.55	1.16e-7	Coronary artery disease;
SKCM	cis	rs4423214	1.000	rs4944958	chr11:71168073	A/G	cg05163923	chr11:71159392	DHCR7	0.82	8.01	0.67	8.84e-12	Vitamin D levels;
SKCM	cis	rs754466	0.606	rs55854323	chr10:79589904	C/T	cg17075019	chr10:79541650	NA	-0.81	-7.22	-0.63	3.01e-10	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs11428934	1	rs11428934	chr19:49144245	T/TG	cg06530960	chr19:49140787	SEC1;DBP	0.78	5.62	0.54	2.89e-7	Sum neutrophil eosinophil counts;Sum basophil neutrophil counts;Neutrophil count;Granulocyte count;
SKCM	cis	rs3749237	0.595	rs4855864	chr3:49521974	C/T	cg02487422	chr3:49467188	NICN1	0.64	4.79	0.48	7.67e-6	Resting heart rate;
SKCM	cis	rs10791097	0.694	rs6590520	chr11:130747386	C/G	cg12179176	chr11:130786555	SNX19	0.91	8.02	0.67	8.55e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs875971	0.660	rs801190	chr7:66033033	C/T	cg11764359	chr7:65958608	NA	-0.86	-6.6	-0.6	4.52e-9	Aortic root size;
SKCM	cis	rs55962025	0.686	rs110501	chr4:3225478	A/G	cg16987761	chr4:3318072	RGS12	-0.59	-4.82	-0.48	6.86e-6	Parental longevity (mother's age at death);
SKCM	cis	rs763014	0.966	rs35642938	chr16:642249	T/C	cg07343612	chr16:622815	PIGQ	-0.7	-6.01	-0.56	5.7e-8	Height;
SKCM	cis	rs1799949	1.000	rs33994002	chr17:41328818	T/A	cg05368731	chr17:41323189	NBR1	0.88	7.87	0.67	1.65e-11	Menopause (age at onset);
SKCM	trans	rs1814175	0.765	rs1722003	chr11:49895896	G/A	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs3820068	0.581	rs74054797	chr1:15926217	G/A	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs11673344	0.764	rs10424584	chr19:37466888	G/A	cg07624650	chr19:37064219	ZNF529	-0.78	-4.82	-0.48	7.05e-6	Obesity-related traits;
SKCM	cis	rs735396	0.770	rs1169300	chr12:121431225	G/A	cg02403541	chr12:121454288	C12orf43	0.77	6.72	0.61	2.65e-9	N-glycan levels;
SKCM	cis	rs9790314	0.846	rs7652267	chr3:160998497	A/G	cg03342759	chr3:160939853	NMD3	-0.72	-8.12	-0.68	5.59e-12	Morning vs. evening chronotype;
SKCM	cis	rs1552244	1.000	rs9875081	chr3:10083935	G/A	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs2370759	1.000	rs11008865	chr10:32574842	C/T	cg01819863	chr10:32635814	EPC1	1.05	5.81	0.55	1.27e-7	Sexual dysfunction (female);
SKCM	cis	rs73001065	0.636	rs10415849	chr19:19505087	C/T	cg03709012	chr19:19516395	GATAD2A	1.16	5.47	0.53	5.19e-7	LDL cholesterol;
SKCM	cis	rs28595532	0.541	rs114463740	chr4:119763329	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs12709013	0.792	rs11649133	chr16:58837179	G/A	cg02431531	chr16:59244939	NA	0.48	4.99	0.49	3.62e-6	Blood metabolite ratios;
SKCM	cis	rs870825	0.616	rs4594761	chr4:185643002	A/C	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs9926296	0.605	rs3743859	chr16:89846050	A/G	cg27121462	chr16:89883253	FANCA	-0.82	-7.56	-0.65	6.54e-11	Vitiligo;
SKCM	cis	rs1003719	0.788	rs2835579	chr21:38457965	T/C	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs6933660	0.800	rs6931104	chr6:151786177	C/T	cg14262678	chr6:151773367	RMND1;C6orf211	0.66	5.27	0.51	1.17e-6	Menarche (age at onset);
SKCM	cis	rs4774899	0.902	rs11633061	chr15:57488193	A/C	cg01857019	chr15:57210107	LOC145783;TCF12	0.54	4.95	0.49	4.24e-6	Urinary tract infection frequency;
SKCM	cis	rs6089829	0.962	rs6122344	chr20:61661738	C/T	cg08564027	chr20:61660810	NA	0.63	5.65	0.54	2.56e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs11105298	0.891	rs8181784	chr12:89828591	A/G	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.84	-5.91	-0.56	8.4e-8	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs13118159	0.527	rs9328733	chr4:1388583	A/G	cg02475777	chr4:1388615	CRIPAK	0.93	6.25	0.58	2e-8	Longevity;
SKCM	cis	rs3768617	0.510	rs10797844	chr1:183082067	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs847649	1.000	rs12537977	chr7:102539230	C/T	cg18108683	chr7:102477205	FBXL13	-0.81	-8.27	-0.68	2.79e-12	Morning vs. evening chronotype;
SKCM	cis	rs9814567	0.896	rs7642266	chr3:134346025	G/A	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.65	-5.25	-0.51	1.26e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs4629180	1.000	rs11123889	chr2:102107180	G/A	cg20146536	chr2:102096205	NA	-0.58	-4.89	-0.48	5.28e-6	Chronic rhinosinusitis with nasal polyps;
SKCM	cis	rs3741151	1.000	rs75114310	chr11:73042047	C/T	cg17517138	chr11:73019481	ARHGEF17	1.27	4.87	0.48	5.63e-6	GIP levels in response to oral glucose tolerance test (120 minutes);
SKCM	cis	rs7666738	0.830	rs28465658	chr4:99035866	T/C	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs514406	0.793	rs12081018	chr1:53217542	C/A	cg16325326	chr1:53192061	ZYG11B	-0.88	-8.89	-0.71	1.75e-13	Monocyte count;
SKCM	cis	rs4243830	0.850	rs10864612	chr1:6593830	C/G	cg22792644	chr1:6614718	TAS1R1;NOL9	-1.06	-5.63	-0.54	2.69e-7	Body mass index;
SKCM	cis	rs11098499	0.954	rs10031665	chr4:120422852	T/C	cg24375607	chr4:120327624	NA	0.66	5.13	0.5	2.07e-6	Corneal astigmatism;
SKCM	cis	rs9399135	0.935	rs11759999	chr6:135370495	G/T	cg24558204	chr6:135376177	HBS1L	0.58	5.05	0.5	2.86e-6	Red blood cell count;
SKCM	cis	rs2204008	0.805	rs4882575	chr12:37940573	G/A	cg26384229	chr12:38710491	ALG10B	-0.77	-6.6	-0.6	4.51e-9	Bladder cancer;
SKCM	cis	rs1185460	0.967	rs1177563	chr11:118949083	C/T	cg23280166	chr11:118938394	VPS11	0.59	5.3	0.51	1.04e-6	Coronary artery disease;
SKCM	cis	rs7829975	0.564	rs2921060	chr8:8317817	G/T	cg15556689	chr8:8085844	FLJ10661	-0.81	-7.34	-0.64	1.74e-10	Mood instability;
SKCM	cis	rs8141529	0.764	rs5762824	chr22:29222930	C/T	cg02153584	chr22:29168773	CCDC117	0.66	5.35	0.52	8.64e-7	Lymphocyte counts;
SKCM	cis	rs12477438	0.501	rs2516833	chr2:99777405	T/C	cg26064155	chr2:99771622	LIPT1;TSGA10	1.03	9.69	0.74	5.05e-15	Chronic sinus infection;
SKCM	cis	rs2204008	0.715	rs11495369	chr12:38238673	T/C	cg26384229	chr12:38710491	ALG10B	0.87	6.9	0.62	1.21e-9	Bladder cancer;
SKCM	cis	rs2730245	0.527	rs62476464	chr7:158698063	C/T	cg24397884	chr7:158709396	WDR60	0.98	5.56	0.53	3.7e-7	Height;
SKCM	cis	rs7216064	0.953	rs1599859	chr17:65837193	C/G	cg12091567	chr17:66097778	LOC651250	-0.77	-5.53	-0.53	4.06e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs1348850	0.634	rs1534304	chr2:178489264	C/T	cg27490568	chr2:178487706	NA	0.85	6.18	0.57	2.72e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs2731664	0.792	rs2544809	chr5:176885499	T/C	cg23176889	chr5:176863531	GRK6	-0.53	-5.4	-0.52	6.86e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs2836974	0.666	rs4624474	chr21:40686327	T/C	cg17971929	chr21:40555470	PSMG1	-0.69	-6.07	-0.57	4.38e-8	Cognitive function;
SKCM	cis	rs8180040	0.966	rs807932	chr3:47354241	C/T	cg27129171	chr3:47204927	SETD2	0.87	6.62	0.6	4.15e-9	Colorectal cancer;
SKCM	cis	rs5417	0.662	rs12601936	chr17:7172609	A/G	cg25256661	chr17:7137939	DVL2	-0.86	-6.58	-0.6	4.95e-9	Diastolic blood pressure;
SKCM	cis	rs2811415	0.597	rs11708842	chr3:127790625	T/C	cg09089421	chr3:127803668	RUVBL1	1.0	8.69	0.7	4.4e-13	Lung function (FEV1/FVC);
SKCM	cis	rs6879260	0.963	rs11748619	chr5:179727399	C/G	cg13944838	chr5:179740914	GFPT2	-0.74	-5.63	-0.54	2.77e-7	Height;
SKCM	cis	rs1218582	0.741	rs2335407	chr1:154843347	A/G	cg24250549	chr1:154909240	PMVK	-0.84	-8.9	-0.71	1.69e-13	Prostate cancer;
SKCM	cis	rs71520386	0.632	rs35353454	chr7:22861739	T/C	cg15401507	chr7:22894281	NA	0.67	4.96	0.49	4.03e-6	Fibrinogen levels;
SKCM	cis	rs35146811	0.771	rs6465762	chr7:99620554	G/A	cg13334819	chr7:99746414	C7orf59	-0.74	-5.25	-0.51	1.3e-6	Coronary artery disease;
SKCM	cis	rs1862618	0.802	rs252900	chr5:56185281	T/A	cg12311346	chr5:56204834	C5orf35	-0.76	-5.02	-0.49	3.2e-6	Initial pursuit acceleration;
SKCM	trans	rs3780486	0.881	rs10738906	chr9:33135634	T/C	cg04842962	chr6:43655489	MRPS18A	1.03	10.87	0.78	2.78e-17	IgG glycosylation;
SKCM	cis	rs35306767	0.855	rs35825568	chr10:950760	C/T	cg20503657	chr10:835505	NA	0.78	5.25	0.51	1.26e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs4332037	0.901	rs7791299	chr7:1935598	T/C	cg23422044	chr7:1970798	MAD1L1	-0.95	-6.45	-0.59	8.43e-9	Bipolar disorder;
SKCM	cis	rs2204008	0.692	rs11613378	chr12:38213138	T/A	cg13010199	chr12:38710504	ALG10B	0.65	4.84	0.48	6.52e-6	Bladder cancer;
SKCM	cis	rs507080	0.922	rs514143	chr11:118558449	G/A	cg18045108	chr11:118530628	TREH	-0.47	-4.82	-0.48	6.89e-6	Serum metabolite levels;
SKCM	cis	rs67311347	0.544	rs4974047	chr3:40339653	G/T	cg13409248	chr3:40428643	ENTPD3	0.57	5.57	0.53	3.48e-7	Renal cell carcinoma;
SKCM	cis	rs6598955	0.612	rs12738188	chr1:26548029	G/C	cg00938395	chr1:26633206	UBXN11	0.71	5.0	0.49	3.5e-6	Obesity-related traits;
SKCM	cis	rs1218582	0.744	rs6674853	chr1:154892753	G/C	cg09359103	chr1:154839909	KCNN3	-0.6	-5.78	-0.55	1.47e-7	Prostate cancer;
SKCM	cis	rs995000	0.965	rs1168023	chr1:63006595	A/T	cg06896770	chr1:63153194	DOCK7	-0.73	-6.62	-0.6	4.11e-9	Triglyceride levels;
SKCM	cis	rs7539542	0.556	rs3820152	chr1:202878492	A/T	cg19681188	chr1:202830198	LOC148709	-0.69	-4.95	-0.49	4.22e-6	Mean platelet volume;
SKCM	cis	rs7666738	0.791	rs2865958	chr4:99040732	G/T	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4689592	0.523	rs6446565	chr4:7074027	A/G	cg26116260	chr4:7069785	GRPEL1	1.22	9.79	0.74	3.19e-15	Monocyte percentage of white cells;
SKCM	cis	rs7809950	1.000	rs6976607	chr7:107223401	A/C	cg23024343	chr7:107201750	COG5	0.82	7.6	0.65	5.58e-11	Coronary artery disease;
SKCM	cis	rs36093844	0.706	rs75217143	chr11:85562270	T/G	cg25872744	chr11:85566296	CCDC83	-0.85	-4.77	-0.48	8.27e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs7811142	1.000	rs11771419	chr7:99988403	A/G	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.33	0.69	2.11e-12	Platelet count;
SKCM	cis	rs7811142	0.830	rs11761426	chr7:99956893	A/T	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.05	5.92	0.56	8.02e-8	Platelet count;
SKCM	cis	rs55823223	0.517	rs1551619	chr17:73885805	C/T	cg08125733	chr17:73851984	WBP2	1.01	5.53	0.53	4.13e-7	Psoriasis;
SKCM	cis	rs763121	0.853	rs5757193	chr22:39034867	A/G	cg06022373	chr22:39101656	GTPBP1	-0.72	-4.96	-0.49	4.08e-6	Menopause (age at onset);
SKCM	cis	rs2050392	0.590	rs685319	chr10:30719331	G/A	cg25182066	chr10:30743637	MAP3K8	-0.65	-5.3	-0.51	1.05e-6	Inflammatory bowel disease;
SKCM	cis	rs3087591	0.887	rs1013946	chr17:29530350	A/C	cg24425628	chr17:29625626	OMG;NF1	0.61	4.87	0.48	5.75e-6	Hip circumference;
SKCM	cis	rs4900538	0.787	rs11704	chr14:102808655	C/G	cg18135206	chr14:102964638	TECPR2	0.67	5.22	0.51	1.43e-6	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs17685	0.712	rs4732578	chr7:75721532	A/G	cg16489192	chr7:75678113	MDH2;STYXL1	-0.61	-5.55	-0.53	3.73e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1577917	0.958	rs7739241	chr6:86575796	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.81	-7.92	-0.67	1.35e-11	Response to antipsychotic treatment;
SKCM	cis	rs7216064	0.861	rs62084252	chr17:65879578	G/C	cg12091567	chr17:66097778	LOC651250	-0.75	-5.27	-0.51	1.19e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs62238980	0.614	rs77661466	chr22:32520016	A/G	cg00543991	chr22:32367038	NA	1.17	4.81	0.48	7.24e-6	Childhood ear infection;
SKCM	cis	rs9910055	0.762	rs6503489	chr17:42246289	G/A	cg08499158	chr17:42289980	UBTF	-0.85	-7.66	-0.66	4.36e-11	Total body bone mineral density;
SKCM	cis	rs4819052	0.611	rs11701605	chr21:46649808	G/A	cg19498844	chr21:46707878	POFUT2;LOC642852	0.84	6.33	0.58	1.43e-8	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs6500395	0.890	rs9936271	chr16:48601291	A/G	cg04672837	chr16:48644449	N4BP1	0.69	5.73	0.54	1.8e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs867186	1.000	rs55696836	chr20:33549887	G/A	cg04194272	chr20:33683537	NA	-1.37	-6.77	-0.61	2.18e-9	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs1032355	0.558	rs113911713	chr4:100523366	T/C	cg25391692	chr4:100495869	MTTP	-0.82	-4.97	-0.49	3.9e-6	Celiac disease;
SKCM	cis	rs6463523	0.933	rs4724821	chr7:762544	C/T	cg05729249	chr7:766119	PRKAR1B;HEATR2	0.95	7.74	0.66	3.04e-11	Subjective well-being;
SKCM	cis	rs2153535	0.580	rs7769020	chr6:8457724	G/A	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs501120	1.000	rs670056	chr10:44753375	C/T	cg09554077	chr10:44749378	NA	0.38	4.93	0.49	4.52e-6	Coronary artery disease;Coronary heart disease;
SKCM	cis	rs1005277	0.505	rs200935	chr10:38132810	T/A	cg25427524	chr10:38739819	LOC399744	-0.68	-6.52	-0.59	6.36e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs10489202	1.000	rs1846416	chr1:167905411	G/A	cg24449463	chr1:168025552	DCAF6	-0.76	-5.87	-0.55	1.02e-7	Schizophrenia;
SKCM	cis	rs6546550	0.935	rs10202159	chr2:70062454	G/T	cg02498382	chr2:70120550	SNRNP27	-0.46	-5.17	-0.51	1.75e-6	Prevalent atrial fibrillation;
SKCM	cis	rs28595532	0.920	rs114581578	chr4:119756404	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs9911578	0.967	rs57869245	chr17:57106630	A/G	cg05425664	chr17:57184151	TRIM37	0.77	6.01	0.56	5.71e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs13118159	0.527	rs9328733	chr4:1388583	A/G	cg05025164	chr4:1340916	KIAA1530	0.88	6.6	0.6	4.46e-9	Longevity;
SKCM	cis	rs6582630	0.532	rs1589394	chr12:38419700	A/C	cg26384229	chr12:38710491	ALG10B	0.69	5.16	0.5	1.85e-6	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs8016982	0.674	rs11850714	chr14:81662993	C/G	cg01989461	chr14:81687754	GTF2A1	0.88	7.42	0.64	1.26e-10	Schizophrenia;
SKCM	cis	rs6840360	0.571	rs1978955	chr4:152509509	G/A	cg22705602	chr4:152727874	NA	-0.52	-5.7	-0.54	2.03e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs10791097	0.547	rs11222371	chr11:130745719	C/T	cg12179176	chr11:130786555	SNX19	0.94	8.11	0.68	5.86e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs2739330	0.828	rs5760108	chr22:24252668	G/T	cg04234412	chr22:24373322	LOC391322	-0.59	-4.87	-0.48	5.77e-6	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs7635838	0.684	rs2606757	chr3:11358163	T/A	cg00170343	chr3:11313890	ATG7	0.72	5.5	0.53	4.68e-7	HDL cholesterol;
SKCM	cis	rs1153858	1.000	rs2467863	chr15:45641880	G/A	cg10760299	chr15:45669010	GATM	0.58	5.81	0.55	1.31e-7	Homoarginine levels;
SKCM	cis	rs7523050	0.643	rs67091034	chr1:109402567	C/G	cg08274380	chr1:109419600	GPSM2	1.13	5.57	0.53	3.54e-7	Fat distribution (HIV);
SKCM	cis	rs8103278	0.507	rs1865116	chr19:46294510	G/A	cg11657440	chr19:46296263	DMWD	1.04	9.61	0.74	7.09e-15	Coronary artery disease;
SKCM	cis	rs611744	0.647	rs864166	chr8:109249300	C/G	cg18478394	chr8:109455254	TTC35	0.66	5.33	0.52	9.43e-7	Dupuytren's disease;
SKCM	cis	rs9902453	0.904	rs4547389	chr17:28364768	T/C	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.82	-6.4	-0.59	1.06e-8	Coffee consumption (cups per day);
SKCM	cis	rs1801251	1.000	rs2012221	chr2:233566848	T/C	cg25237894	chr2:233734115	C2orf82	0.61	5.59	0.53	3.22e-7	Coronary artery disease;
SKCM	cis	rs10504229	1.000	rs66479724	chr8:58188309	T/G	cg22535103	chr8:58192502	C8orf71	-0.7	-5.02	-0.49	3.18e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs11098499	0.909	rs71614422	chr4:120359340	G/A	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs8077889	0.750	rs12453522	chr17:41931375	A/G	cg26893861	chr17:41843967	DUSP3	1.31	7.65	0.65	4.46e-11	Triglycerides;
SKCM	cis	rs1577917	0.538	rs6454483	chr6:86418283	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.62	5.13	0.5	2.08e-6	Response to antipsychotic treatment;
SKCM	cis	rs1348850	0.526	rs4243391	chr2:178468089	A/T	cg27490568	chr2:178487706	NA	0.84	6.11	0.57	3.66e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs769267	0.965	rs2315024	chr19:19423817	T/A	cg26732615	chr19:19648335	CILP2;YJEFN3	0.63	5.77	0.55	1.51e-7	Tonsillectomy;
SKCM	cis	rs28386778	1.000	rs2665810	chr17:61970210	C/G	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.02	9.11	0.72	6.49e-14	Prudent dietary pattern;
SKCM	cis	rs17826219	0.733	rs7221691	chr17:28723619	C/T	cg14067834	chr17:29058358	SUZ12P	-0.85	-4.79	-0.48	7.7e-6	Body mass index;
SKCM	cis	rs769267	0.931	rs15622	chr19:19468734	G/A	cg26732615	chr19:19648335	CILP2;YJEFN3	-0.66	-6.06	-0.57	4.59e-8	Tonsillectomy;
SKCM	cis	rs1635	1.000	rs1635	chr6:28227604	C/A	cg15743358	chr6:28303923	ZNF323	-1.1	-4.98	-0.49	3.66e-6	Schizophrenia;
SKCM	cis	rs9951698	0.667	rs567031	chr18:13093774	G/A	cg12848697	chr18:13133368	NA	0.53	4.9	0.48	5.18e-6	Intelligence (multi-trait analysis);
SKCM	trans	rs9329221	0.935	rs3750310	chr8:10283426	G/A	cg06636001	chr8:8085503	FLJ10661	-0.96	-8.72	-0.7	3.83e-13	Neuroticism;
SKCM	cis	rs2439831	1.000	rs527921	chr15:43770416	G/T	cg02155558	chr15:43621948	ADAL;LCMT2	-1.37	-9.09	-0.72	7.27e-14	Lung cancer in ever smokers;
SKCM	cis	rs798554	0.757	rs960273	chr7:2857876	T/C	cg19346786	chr7:2764209	NA	-0.64	-6.93	-0.62	1.09e-9	Height;
SKCM	cis	rs9467773	1.000	rs1884948	chr6:26567988	G/A	cg09904177	chr6:26538194	HMGN4	0.54	4.91	0.49	4.97e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs5769765	0.773	rs9616391	chr22:50314573	C/T	cg22709217	chr22:50311962	ALG12;CRELD2	-0.98	-5.94	-0.56	7.4e-8	Schizophrenia;
SKCM	cis	rs736408	0.688	rs2239551	chr3:52818579	A/G	cg18404041	chr3:52824283	ITIH1	0.54	4.92	0.49	4.79e-6	Bipolar disorder;
SKCM	cis	rs67460515	0.892	rs34771618	chr3:161059795	A/C	cg03342759	chr3:160939853	NMD3	-0.87	-7.47	-0.65	9.76e-11	Parkinson's disease;
SKCM	cis	rs9901225	1	rs9901225	chr17:40755811	C/T	cg21433558	chr17:40837037	CNTNAP1	0.58	5.45	0.53	5.71e-7	Colorectal or endometrial cancer;
SKCM	cis	rs703842	0.616	rs870392	chr12:58219173	C/A	cg00677455	chr12:58241039	CTDSP2	0.75	5.94	0.56	7.38e-8	Multiple sclerosis;
SKCM	cis	rs769267	0.896	rs7250893	chr19:19625547	A/G	cg03709012	chr19:19516395	GATAD2A	0.89	8.62	0.7	5.89e-13	Tonsillectomy;
SKCM	cis	rs919433	0.680	rs2564389	chr2:198260098	A/T	cg04278110	chr2:198063759	ANKRD44	0.7	4.79	0.48	7.87e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs151997	0.925	rs27847	chr5:50176197	G/T	cg06027927	chr5:50259733	NA	0.63	5.35	0.52	8.42e-7	Callous-unemotional behaviour;
SKCM	cis	rs7618915	0.547	rs10780035	chr3:52764624	C/T	cg18404041	chr3:52824283	ITIH1	-0.56	-4.94	-0.49	4.33e-6	Bipolar disorder;
SKCM	cis	rs9467773	0.620	rs2451744	chr6:26633463	G/T	cg15659132	chr6:26577336	NA	0.62	5.4	0.52	6.91e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs8068544	0.606	rs77681389	chr17:40154419	T/C	cg18442075	chr17:40169520	DNAJC7;NKIRAS2	-1.38	-7.28	-0.64	2.26e-10	Reticulocyte fraction of red cells;Reticulocyte count;
SKCM	cis	rs9894429	0.608	rs7406382	chr17:79597786	T/C	cg18240062	chr17:79603768	NPLOC4	0.68	5.88	0.55	9.47e-8	Eye color traits;
SKCM	cis	rs4780401	0.609	rs8055247	chr16:11827543	G/A	cg01061890	chr16:11836724	TXNDC11	-0.8	-6.08	-0.57	4.24e-8	Rheumatoid arthritis;
SKCM	cis	rs2070488	0.965	rs2300668	chr3:38540541	A/G	cg01465620	chr3:38496096	LOC100128640;ACVR2B	-0.98	-9.25	-0.72	3.55e-14	Electrocardiographic conduction measures;
SKCM	cis	rs12142240	0.659	rs111723629	chr1:46853361	G/T	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs1218582	0.741	rs10908444	chr1:154840287	G/A	cg09359103	chr1:154839909	KCNN3	-0.57	-5.42	-0.52	6.37e-7	Prostate cancer;
SKCM	cis	rs1348850	0.561	rs4893956	chr2:178373452	C/T	cg27490568	chr2:178487706	NA	0.9	6.86	0.61	1.42e-9	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs12477438	0.520	rs13031919	chr2:99848932	A/T	cg14399236	chr2:99771627	LIPT1;TSGA10	0.98	8.66	0.7	4.85e-13	Chronic sinus infection;
SKCM	trans	rs9329221	0.617	rs615632	chr8:9796321	C/T	cg06636001	chr8:8085503	FLJ10661	-0.95	-8.01	-0.67	8.96e-12	Neuroticism;
SKCM	cis	rs8180040	0.726	rs2305638	chr3:47046842	G/C	cg27129171	chr3:47204927	SETD2	0.78	5.98	0.56	6.37e-8	Colorectal cancer;
SKCM	cis	rs9910055	0.659	rs6503488	chr17:42246158	T/G	cg09913183	chr17:42254507	C17orf65;ASB16	0.67	6.36	0.58	1.27e-8	Total body bone mineral density;
SKCM	cis	rs7829975	0.840	rs555617	chr8:8592845	C/G	cg15556689	chr8:8085844	FLJ10661	-0.67	-5.96	-0.56	6.87e-8	Mood instability;
SKCM	cis	rs11690935	0.959	rs35391289	chr2:172634983	A/C	cg13550731	chr2:172543902	DYNC1I2	-0.95	-8.21	-0.68	3.64e-12	Schizophrenia;
SKCM	cis	rs2841277	0.834	rs2841281	chr14:105394669	C/T	cg19901468	chr14:105411992	AHNAK2	0.97	7.37	0.64	1.54e-10	Rheumatoid arthritis;
SKCM	cis	rs11098499	0.954	rs1022145	chr4:120230979	A/G	cg09307838	chr4:120376055	NA	0.97	7.75	0.66	2.85e-11	Corneal astigmatism;
SKCM	cis	rs36093844	0.642	rs7949837	chr11:85613792	T/C	cg02149136	chr11:85995039	NA	-0.64	-5.2	-0.51	1.58e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs1801251	1.000	rs2305137	chr2:233712049	G/A	cg25237894	chr2:233734115	C2orf82	-0.58	-5.74	-0.54	1.75e-7	Coronary artery disease;
SKCM	cis	rs801193	1.000	rs10252765	chr7:66228732	C/G	cg11987759	chr7:65425863	GUSB	-0.65	-5.9	-0.56	8.99e-8	Aortic root size;
SKCM	cis	rs9611565	0.694	rs202628	chr22:41849513	A/G	cg03806693	chr22:41940476	POLR3H	-1.07	-6.74	-0.61	2.44e-9	Vitiligo;
SKCM	cis	rs8070624	0.543	rs7219320	chr17:17880877	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.01	8.61	0.7	6.26e-13	Total body bone mineral density;
SKCM	cis	rs11227306	0.934	rs7102454	chr11:65594820	C/T	cg00576331	chr11:65640516	EFEMP2	0.75	6.2	0.57	2.54e-8	DNA methylation (variation);
SKCM	cis	rs4803468	0.967	rs13344547	chr19:41945848	G/T	cg09537434	chr19:41945824	ATP5SL	1.1	13.21	0.83	1.39e-21	Height;
SKCM	cis	rs1153858	1.000	rs28679834	chr15:45616206	C/T	cg10760299	chr15:45669010	GATM	0.55	5.38	0.52	7.45e-7	Homoarginine levels;
SKCM	cis	rs7937682	0.883	rs553632	chr11:111462897	C/T	cg09085632	chr11:111637200	PPP2R1B	-1.0	-8.74	-0.7	3.47e-13	Primary sclerosing cholangitis;
SKCM	cis	rs11098499	0.697	rs28655325	chr4:120372999	A/G	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs929354	0.742	rs2006844	chr7:157002851	G/A	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs16854884	0.657	rs34683397	chr3:143723559	C/T	cg06585982	chr3:143692056	C3orf58	0.83	7.55	0.65	6.97e-11	Economic and political preferences (feminism/equality);
SKCM	cis	rs7208859	0.623	rs7223209	chr17:29107220	C/A	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs2073499	0.935	rs28365992	chr3:50340996	T/C	cg05260129	chr3:50388622	TUSC4;CYB561D2	0.91	4.8	0.48	7.41e-6	Schizophrenia;
SKCM	cis	rs1790761	0.554	rs12787511	chr11:67401635	G/C	cg00864171	chr11:67383662	NA	-0.68	-5.54	-0.53	3.87e-7	Mean corpuscular volume;
SKCM	cis	rs561341	1.000	rs530715	chr17:30320544	T/G	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs9307551	0.576	rs13104474	chr4:80539730	C/A	cg22902505	chr4:81119473	PRDM8	-0.35	-4.78	-0.48	8.13e-6	Refractive error;
SKCM	cis	rs1801251	1.000	rs4973055	chr2:233720283	G/T	cg08000102	chr2:233561755	GIGYF2	-0.86	-6.97	-0.62	8.88e-10	Coronary artery disease;
SKCM	cis	rs4862750	0.872	rs7658314	chr4:187900356	T/C	cg10295955	chr4:187884368	NA	-1.04	-13.97	-0.85	6.27e-23	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs13118159	0.550	rs28733902	chr4:1374789	A/G	cg02018176	chr4:1364513	KIAA1530	0.89	7.24	0.63	2.72e-10	Longevity;
SKCM	cis	rs7666738	0.822	rs17484018	chr4:98988960	G/A	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10089	1.000	rs4836361	chr5:127459991	T/C	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.91	8.89	0.71	1.79e-13	Ileal carcinoids;
SKCM	cis	rs10256972	0.524	rs6945202	chr7:1116558	T/C	cg16145915	chr7:1198662	ZFAND2A	-0.49	-6.02	-0.56	5.32e-8	Longevity;Endometriosis;
SKCM	cis	rs7599312	0.534	rs10207878	chr2:213409337	A/G	cg20637307	chr2:213403960	ERBB4	0.76	5.6	0.54	3.12e-7	BMI (adjusted for smoking behaviour);BMI in non-smokers;Body mass index;Body mass index (joint analysis main effects and smoking interaction);
SKCM	cis	rs10504229	0.683	rs72650849	chr8:58140323	A/G	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs9467773	1.000	rs6922824	chr6:26553815	C/G	cg09904177	chr6:26538194	HMGN4	-0.54	-4.98	-0.49	3.78e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7927771	0.524	rs10742817	chr11:47689343	A/G	cg20307385	chr11:47447363	PSMC3	-0.71	-5.63	-0.54	2.67e-7	Subjective well-being;
SKCM	cis	rs1218582	0.772	rs12069356	chr1:154849771	C/T	cg03351412	chr1:154909251	PMVK	0.79	6.91	0.62	1.15e-9	Prostate cancer;
SKCM	cis	rs3806843	0.900	rs2563287	chr5:140124786	C/T	cg26395211	chr5:140044315	WDR55	-0.64	-4.85	-0.48	6.17e-6	Depressive symptoms (multi-trait analysis);
SKCM	cis	rs6912958	0.547	rs451089	chr6:88041859	A/G	cg08069147	chr6:88032118	GJB7;C6orf162	0.64	5.61	0.54	2.97e-7	Monocyte percentage of white cells;
SKCM	cis	rs4253772	0.550	rs6007779	chr22:46678615	A/C	cg03482458	chr22:46692211	CN5H6.4;GTSE1	1.22	5.55	0.53	3.86e-7	LDL cholesterol;Cholesterol, total;
SKCM	cis	rs2404602	0.583	rs2469542	chr15:76557476	A/G	cg22467129	chr15:76604101	ETFA	0.65	5.35	0.52	8.68e-7	Blood metabolite levels;
SKCM	cis	rs9325144	0.647	rs7316392	chr12:39064381	T/G	cg13010199	chr12:38710504	ALG10B	-0.62	-5.16	-0.5	1.8e-6	Morning vs. evening chronotype;
SKCM	cis	rs2727020	0.681	rs1976901	chr11:49378697	T/C	cg21546286	chr11:48923668	NA	-0.53	-4.77	-0.48	8.31e-6	Coronary artery disease;
SKCM	cis	rs28595532	0.920	rs114410095	chr4:119731110	G/A	cg14228332	chr4:119757509	SEC24D	1.08	5.52	0.53	4.28e-7	Cannabis dependence symptom count;
SKCM	cis	rs2836950	0.545	rs11700449	chr21:40522419	A/T	cg17971929	chr21:40555470	PSMG1	-0.78	-6.45	-0.59	8.43e-9	Menarche (age at onset);
SKCM	cis	rs9796	0.689	rs28497404	chr15:41449510	A/C	cg18705301	chr15:41695430	NDUFAF1	-0.73	-5.31	-0.52	9.91e-7	Menopause (age at onset);
SKCM	cis	rs2070488	0.804	rs7646429	chr3:38467713	A/G	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.74	6.01	0.56	5.62e-8	Electrocardiographic conduction measures;
SKCM	cis	rs55962025	0.842	rs362272	chr4:3234980	C/T	cg21096898	chr4:3318625	RGS12	-0.71	-5.47	-0.53	5.31e-7	Parental longevity (mother's age at death);
SKCM	cis	rs131777	0.575	rs131760	chr22:51011936	T/C	cg25309564	chr22:51001381	C22orf41	0.78	5.22	0.51	1.44e-6	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs9674544	0.757	rs4410130	chr17:47122942	C/T	cg22947322	chr17:47091978	IGF2BP1	0.57	5.1	0.5	2.35e-6	Primary tooth development (time to first tooth eruption);Primary tooth development (number of teeth);
SKCM	cis	rs523522	0.962	rs509445	chr12:121017243	A/C	cg27279351	chr12:120934652	DYNLL1	0.89	7.94	0.67	1.24e-11	High light scatter reticulocyte count;
SKCM	cis	rs2739330	0.760	rs5751760	chr22:24243573	G/A	cg25703541	chr22:24373054	LOC391322	-0.81	-6.62	-0.6	4.15e-9	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs9611565	0.694	rs11090056	chr22:42095904	A/C	cg03806693	chr22:41940476	POLR3H	0.91	5.69	0.54	2.12e-7	Vitiligo;
SKCM	trans	rs5756813	0.715	rs5756825	chr22:38199950	T/C	cg19894588	chr14:64061835	NA	1.07	10.06	0.75	9.89e-16	Optic cup area;Vertical cup-disc ratio;
SKCM	cis	rs9300255	0.596	rs10773002	chr12:123746961	A/T	cg00376283	chr12:123451042	ABCB9	-0.87	-7.25	-0.63	2.63e-10	Neutrophil percentage of white cells;
SKCM	cis	rs10779751	0.690	rs2791646	chr1:11133242	C/T	cg08854313	chr1:11322531	MTOR	0.77	5.52	0.53	4.36e-7	Body mass index;
SKCM	cis	rs12477438	0.765	rs72957180	chr2:99694452	G/A	cg26064155	chr2:99771622	LIPT1;TSGA10	-0.72	-4.86	-0.48	6e-6	Chronic sinus infection;
SKCM	cis	rs453301	0.571	rs2929452	chr8:9084465	G/A	cg15556689	chr8:8085844	FLJ10661	-0.66	-5.0	-0.49	3.45e-6	Joint mobility (Beighton score);
SKCM	cis	rs7618915	1.000	rs3852064	chr3:52349412	G/T	cg18404041	chr3:52824283	ITIH1	-0.62	-5.13	-0.5	2.1e-6	Bipolar disorder;
SKCM	cis	rs748404	0.697	rs555001	chr15:43545728	G/A	cg02155558	chr15:43621948	ADAL;LCMT2	0.72	5.9	0.56	8.97e-8	Lung cancer;
SKCM	cis	rs870825	0.616	rs7683537	chr4:185631998	T/C	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs8017423	0.967	rs4900033	chr14:90701963	C/A	cg04374321	chr14:90722782	PSMC1	0.97	8.87	0.71	1.91e-13	Mortality in heart failure;
SKCM	cis	rs1799949	1.000	rs1960605	chr17:41305397	C/T	cg05368731	chr17:41323189	NBR1	0.89	7.98	0.67	1.03e-11	Menopause (age at onset);
SKCM	cis	rs12497850	0.805	rs6446198	chr3:49007638	T/A	cg07636037	chr3:49044803	WDR6	1.02	11.0	0.78	1.56e-17	Parkinson's disease;
SKCM	cis	rs72615157	0.645	rs11771660	chr7:99851269	T/A	cg07160278	chr7:100027354	MEPCE;ZCWPW1	0.97	5.57	0.53	3.49e-7	Lung function (FEV1/FVC);
SKCM	cis	rs12134245	0.776	rs13447464	chr1:91968278	G/A	cg02896835	chr1:92012615	NA	-0.68	-6.41	-0.59	1.02e-8	Breast cancer;
SKCM	cis	rs1801251	1.000	rs13035829	chr2:233604487	A/T	cg08000102	chr2:233561755	GIGYF2	0.87	7.05	0.62	6.23e-10	Coronary artery disease;
SKCM	cis	rs2197308	0.565	rs12809769	chr12:37909968	C/T	cg13010199	chr12:38710504	ALG10B	0.65	4.93	0.49	4.48e-6	Morning vs. evening chronotype;
SKCM	cis	rs875971	0.540	rs35510581	chr7:65578777	G/A	cg11987759	chr7:65425863	GUSB	0.72	6.26	0.58	1.92e-8	Aortic root size;
SKCM	cis	rs6121246	0.909	rs3203770	chr20:30382315	A/G	cg11595048	chr20:30225325	COX4I2	0.67	5.21	0.51	1.5e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs9858542	0.953	rs11711485	chr3:49491983	G/T	cg03060546	chr3:49711283	APEH	-0.76	-5.59	-0.54	3.17e-7	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs12500482	0.935	rs12644638	chr4:2413461	C/T	cg26605046	chr4:2439731	NA	-0.59	-5.34	-0.52	8.96e-7	Cognitive function;
SKCM	cis	rs854765	0.547	rs12150369	chr17:17911014	G/A	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.04	9.2	0.72	4.44e-14	Total body bone mineral density;
SKCM	cis	rs2721195	0.549	rs2958492	chr8:145919126	C/T	cg15320075	chr8:145703422	NA	0.74	5.65	0.54	2.56e-7	Age at first birth;
SKCM	cis	rs7772486	0.597	rs2485631	chr6:146190077	G/C	cg05347473	chr6:146136440	FBXO30	0.68	6.17	0.57	2.78e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs35306767	0.903	rs12769873	chr10:936526	G/T	cg26597838	chr10:835615	NA	0.78	5.08	0.5	2.51e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs1577917	0.655	rs9444354	chr6:86291935	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.73	6.45	0.59	8.51e-9	Response to antipsychotic treatment;
SKCM	cis	rs8180040	0.726	rs4682837	chr3:46999707	C/T	cg27129171	chr3:47204927	SETD2	0.79	5.99	0.56	6.07e-8	Colorectal cancer;
SKCM	cis	rs4481887	1.000	rs10788775	chr1:248471945	C/G	cg00666640	chr1:248458726	OR2T12	0.61	5.6	0.54	3.11e-7	Common traits (Other);
SKCM	cis	rs1707322	0.686	rs3014235	chr1:46091512	A/G	cg03146154	chr1:46216737	IPP	-0.8	-5.59	-0.53	3.22e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs9300255	0.506	rs61388686	chr12:123810873	G/A	cg05973401	chr12:123451056	ABCB9	0.72	5.48	0.53	5.12e-7	Neutrophil percentage of white cells;
SKCM	cis	rs4665809	0.887	rs4665825	chr2:26333100	A/G	cg26119090	chr2:26468346	HADHA;HADHB	-0.76	-4.79	-0.48	7.86e-6	Gut microbiome composition (summer);
SKCM	cis	rs7811142	0.945	rs6978739	chr7:100098680	C/G	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.11	6.3	0.58	1.66e-8	Platelet count;
SKCM	cis	rs4972806	0.849	rs2071581	chr2:177026148	G/T	cg14324370	chr2:177042789	NA	0.57	4.96	0.49	4e-6	IgG glycosylation;
SKCM	cis	rs12706411	1.000	rs17463849	chr7:122052124	T/A	cg17986181	chr7:121955208	NA	-0.7	-5.19	-0.51	1.65e-6	Alzheimer disease and age of onset;
SKCM	cis	rs7523050	0.643	rs35050241	chr1:109404876	T/C	cg08274380	chr1:109419600	GPSM2	1.18	6.44	0.59	9.12e-9	Fat distribution (HIV);
SKCM	cis	rs2404602	0.647	rs3812908	chr15:77176158	C/T	cg23625390	chr15:77176239	SCAPER	0.82	7.93	0.67	1.26e-11	Blood metabolite levels;
SKCM	cis	rs6121246	0.909	rs1994251	chr20:30287328	T/G	cg11595048	chr20:30225325	COX4I2	0.67	5.21	0.51	1.5e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs2370759	1.000	rs16933225	chr10:32599464	C/T	cg01819863	chr10:32635814	EPC1	0.94	5.53	0.53	4.1e-7	Sexual dysfunction (female);
SKCM	cis	rs1461503	0.932	rs6589962	chr11:122843535	G/A	cg27398637	chr11:122830231	C11orf63	-0.63	-4.8	-0.48	7.54e-6	Menarche (age at onset);
SKCM	cis	rs9894429	0.816	rs9747093	chr17:79584280	G/A	cg18240062	chr17:79603768	NPLOC4	0.76	7.43	0.64	1.2e-10	Eye color traits;
SKCM	cis	rs854765	0.583	rs7214536	chr17:17852446	G/A	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.01	7.49	0.65	9.28e-11	Total body bone mineral density;
SKCM	cis	rs1529316	0.904	rs2554710	chr8:3831938	C/G	cg05999364	chr8:3269952	CSMD1	-0.46	-4.95	-0.49	4.12e-6	Multiple sclerosis;
SKCM	cis	rs7666738	0.830	rs17484890	chr4:99013778	T/C	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs12824058	0.831	rs4759653	chr12:130812604	T/C	cg26677194	chr12:130822605	PIWIL1	0.71	5.83	0.55	1.17e-7	Menopause (age at onset);
SKCM	cis	rs459571	0.959	rs408307	chr9:136892523	A/G	cg13789015	chr9:136890014	NCRNA00094	-0.8	-6.51	-0.59	6.71e-9	Platelet distribution width;
SKCM	cis	rs6489882	0.867	rs1859332	chr12:113371114	T/C	cg07232103	chr12:112566177	TRAFD1	0.61	4.92	0.49	4.67e-6	Chronic lymphocytic leukemia;
SKCM	cis	rs7826238	0.623	rs2976893	chr8:8338219	G/T	cg06636001	chr8:8085503	FLJ10661	-0.92	-8.38	-0.69	1.72e-12	Systolic blood pressure;
SKCM	cis	rs36093844	0.752	rs57534090	chr11:85573020	C/T	cg25872744	chr11:85566296	CCDC83	-0.85	-4.8	-0.48	7.42e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs8067545	0.750	rs4925069	chr17:19953531	C/G	cg13482628	chr17:19912719	NA	0.7	6.29	0.58	1.7e-8	Schizophrenia;
SKCM	cis	rs7927771	0.864	rs7107726	chr11:47429245	T/A	cg05585544	chr11:47624801	NA	-0.6	-5.32	-0.52	9.58e-7	Subjective well-being;
SKCM	cis	rs10489202	1.000	rs12404574	chr1:167961235	C/T	cg24449463	chr1:168025552	DCAF6	0.77	5.98	0.56	6.27e-8	Schizophrenia;
SKCM	cis	rs9910055	0.708	rs2631298	chr17:42219832	T/C	cg19774624	chr17:42201019	HDAC5	-0.93	-8.8	-0.71	2.6e-13	Total body bone mineral density;
SKCM	trans	rs9929218	0.507	rs62057805	chr16:68742390	G/C	cg04657470	chr2:198365150	HSPE1;HSPD1	0.96	9.38	0.73	1.98e-14	Colorectal cancer;
SKCM	cis	rs9796	0.689	rs576336	chr15:41452771	C/T	cg00616447	chr15:41694635	NDUFAF1	0.72	5.04	0.5	2.98e-6	Menopause (age at onset);
SKCM	cis	rs72781680	0.898	rs72780123	chr2:23996009	G/A	cg08917208	chr2:24149416	ATAD2B	0.92	4.85	0.48	6.19e-6	Lymphocyte counts;
SKCM	cis	rs17065868	1.000	rs9533909	chr13:45137894	A/G	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs870825	0.616	rs9715644	chr4:185632965	C/T	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs7618501	0.633	rs35065728	chr3:50009176	T/C	cg05072774	chr3:49840536	C3orf54	-0.68	-5.1	-0.5	2.29e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs67311347	0.544	rs6787516	chr3:40355616	C/T	cg13409248	chr3:40428643	ENTPD3	0.57	5.32	0.52	9.61e-7	Renal cell carcinoma;
SKCM	cis	rs798554	0.757	rs2533879	chr7:2859847	G/A	cg04166393	chr7:2884313	GNA12	0.71	4.92	0.49	4.62e-6	Height;
SKCM	cis	rs7917772	0.503	rs7087665	chr10:104282418	T/C	cg11453585	chr10:104263688	ACTR1A;SUFU	0.77	6.31	0.58	1.56e-8	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs13118159	0.801	rs7664474	chr4:1329116	T/A	cg02018176	chr4:1364513	KIAA1530	0.65	5.2	0.51	1.56e-6	Longevity;
SKCM	cis	rs8017423	0.967	rs7146640	chr14:90720114	C/T	cg04374321	chr14:90722782	PSMC1	-0.92	-7.86	-0.66	1.78e-11	Mortality in heart failure;
SKCM	cis	rs2153535	0.601	rs2327054	chr6:8443130	T/C	cg07606381	chr6:8435919	SLC35B3	0.96	6.98	0.62	8.76e-10	Motion sickness;
SKCM	cis	rs7188801	0.665	rs12932673	chr16:86709731	C/G	cg00354437	chr16:87133690	NA	-0.68	-5.01	-0.49	3.26e-6	Bone properties (heel);
SKCM	cis	rs6089584	0.888	rs6089623	chr20:60615759	A/G	cg06108461	chr20:60628389	TAF4	-0.89	-8.72	-0.7	3.75e-13	Body mass index;
SKCM	cis	rs473651	0.904	rs508274	chr2:239337723	G/A	cg18131467	chr2:239335373	ASB1	1.09	13.23	0.83	1.27e-21	Multiple system atrophy;
SKCM	cis	rs6558174	0.965	rs2404655	chr8:22490209	T/C	cg03733263	chr8:22462867	KIAA1967	0.74	5.27	0.51	1.17e-6	Breast cancer;
SKCM	cis	rs3741151	1.000	rs75007932	chr11:73080336	G/A	cg17517138	chr11:73019481	ARHGEF17	1.27	4.87	0.48	5.81e-6	GIP levels in response to oral glucose tolerance test (120 minutes);
SKCM	cis	rs7954584	0.626	rs12809676	chr12:122442381	C/A	cg01765077	chr12:122356316	WDR66	0.44	4.89	0.48	5.23e-6	Mean corpuscular volume;
SKCM	cis	rs7772486	0.754	rs13214277	chr6:146136125	G/T	cg05347473	chr6:146136440	FBXO30	0.6	5.64	0.54	2.64e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs10089	1.000	rs59484271	chr5:127503781	C/T	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.87	6.96	0.62	9.37e-10	Ileal carcinoids;
SKCM	cis	rs137603	0.644	rs137636	chr22:39722477	C/A	cg17798944	chr22:39715225	SNORD43;RPL3	-0.64	-5.54	-0.53	3.91e-7	Primary biliary cholangitis;
SKCM	cis	rs2243480	1.000	rs58669269	chr7:65951953	T/C	cg18252515	chr7:66147081	NA	-1.35	-8.04	-0.67	8e-12	Diabetic kidney disease;
SKCM	cis	rs7296418	0.961	rs12425850	chr12:123501972	T/C	cg00376283	chr12:123451042	ABCB9	0.92	8.07	0.67	6.77e-12	Platelet count;
SKCM	cis	rs875971	0.540	rs781152	chr7:65479572	T/A	cg18876405	chr7:65276391	NA	0.85	7.85	0.66	1.82e-11	Aortic root size;
SKCM	cis	rs2652834	1.000	rs2652834	chr15:63396867	A/G	cg04194852	chr15:63334506	TPM1	0.76	4.78	0.48	8.15e-6	HDL cholesterol;
SKCM	cis	rs8180040	0.764	rs4082155	chr3:47125385	G/A	cg27129171	chr3:47204927	SETD2	0.82	6.49	0.59	7.26e-9	Colorectal cancer;
SKCM	cis	rs703842	0.892	rs1021469	chr12:58208164	C/T	cg04478727	chr12:58166393	METTL1;FAM119B	0.69	5.59	0.53	3.26e-7	Multiple sclerosis;
SKCM	cis	rs10193935	0.901	rs6544549	chr2:42693056	C/T	cg27598129	chr2:42591480	NA	0.93	6.02	0.56	5.41e-8	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7539542	0.556	rs1539357	chr1:202878454	T/A	cg19681188	chr1:202830198	LOC148709	0.74	5.32	0.52	9.6e-7	Mean platelet volume;
SKCM	cis	rs7208859	0.573	rs56031503	chr17:29075665	T/C	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs2836974	0.897	rs2836923	chr21:40524236	T/C	cg11890956	chr21:40555474	PSMG1	1.08	12.93	0.83	4.3e-21	Cognitive function;
SKCM	cis	rs4423214	0.592	rs10898234	chr11:71236684	A/G	cg05163923	chr11:71159392	DHCR7	-0.67	-4.82	-0.48	6.99e-6	Vitamin D levels;
SKCM	cis	rs919433	1.000	rs6741380	chr2:198165121	A/G	cg04278110	chr2:198063759	ANKRD44	0.72	5.33	0.52	9.25e-7	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs1799949	1.000	rs1799966	chr17:41223094	T/C	cg25918947	chr17:41365094	TMEM106A	-0.61	-5.91	-0.56	8.59e-8	Menopause (age at onset);
SKCM	cis	rs17376456	0.825	rs34967135	chr5:93221785	G/A	cg25358565	chr5:93447407	FAM172A	1.23	7.45	0.64	1.1e-10	Diabetic retinopathy;
SKCM	cis	rs1153858	1.000	rs1145085	chr15:45657804	A/G	cg21132104	chr15:45694354	SPATA5L1	0.93	7.66	0.66	4.2e-11	Homoarginine levels;
SKCM	cis	rs873946	0.648	rs3750578	chr10:134563366	A/G	cg27286337	chr10:134555280	INPP5A	0.98	8.81	0.71	2.49e-13	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs951366	0.789	rs7536483	chr1:205718858	A/T	cg14893161	chr1:205819251	PM20D1	1.05	9.87	0.75	2.2e-15	Menarche (age at onset);
SKCM	cis	rs9926296	0.585	rs8045232	chr16:89857548	A/G	cg04287289	chr16:89883240	FANCA	1.03	12.09	0.81	1.44e-19	Vitiligo;
SKCM	cis	rs35306767	0.715	rs12777801	chr10:1036285	T/A	cg26597838	chr10:835615	NA	0.71	5.89	0.55	9.38e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs870825	0.616	rs28620459	chr4:185627132	G/C	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs72781680	0.898	rs113027486	chr2:24098371	G/A	cg08917208	chr2:24149416	ATAD2B	0.99	5.24	0.51	1.31e-6	Lymphocyte counts;
SKCM	cis	rs875971	0.660	rs10215132	chr7:66054406	C/A	cg18876405	chr7:65276391	NA	-0.82	-7.53	-0.65	7.59e-11	Aortic root size;
SKCM	cis	rs801193	0.935	rs3800820	chr7:66147178	C/T	cg00343986	chr7:65444356	GUSB	-0.7	-5.14	-0.5	1.98e-6	Aortic root size;
SKCM	cis	rs9910055	0.659	rs227584	chr17:42225547	A/C	cg10896456	chr17:42255109	ASB16;C17orf65	0.69	7.22	0.63	3e-10	Total body bone mineral density;
SKCM	cis	rs2033711	0.870	rs7409473	chr19:58939165	A/G	cg13877915	chr19:58951672	ZNF132	0.95	10.28	0.76	3.6e-16	Uric acid clearance;
SKCM	cis	rs3091242	0.933	rs11802413	chr1:25760920	A/G	cg02931644	chr1:25747376	RHCE	-0.48	-4.77	-0.48	8.28e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs10781543	0.839	rs10870071	chr9:139382184	T/C	cg14169450	chr9:139327907	INPP5E	0.51	5.51	0.53	4.45e-7	Monocyte percentage of white cells;
SKCM	cis	rs116095464	0.558	rs55776650	chr5:273826	G/A	cg22857025	chr5:266934	NA	-1.47	-8.33	-0.69	2.16e-12	Breast cancer;
SKCM	cis	rs28595532	0.688	rs116173135	chr4:119721949	C/T	cg14228332	chr4:119757509	SEC24D	1.07	5.49	0.53	4.77e-7	Cannabis dependence symptom count;
SKCM	cis	rs72781680	1.000	rs72798417	chr2:24188656	C/T	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	cis	rs4555082	0.834	rs1473672	chr14:105721981	G/T	cg13114125	chr14:105738426	BRF1	-0.69	-5.47	-0.53	5.33e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs10883723	0.810	rs1056857	chr10:104240003	C/T	cg11453585	chr10:104263688	ACTR1A;SUFU	0.69	4.79	0.48	7.69e-6	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs344364	0.511	rs911392	chr16:1947259	A/G	cg26897989	chr16:1907736	C16orf73	-0.69	-7.13	-0.63	4.45e-10	Glomerular filtration rate in chronic kidney disease;
SKCM	cis	rs778371	0.676	rs2293780	chr2:233635213	T/C	cg08000102	chr2:233561755	GIGYF2	0.9	7.59	0.65	5.78e-11	Schizophrenia;
SKCM	cis	rs6088590	0.582	rs6059909	chr20:33139691	C/A	cg24642439	chr20:33292090	TP53INP2	0.76	5.84	0.55	1.15e-7	Coronary artery disease;
SKCM	cis	rs801193	1.000	rs2659906	chr7:66165310	T/C	cg11987759	chr7:65425863	GUSB	-0.69	-5.9	-0.56	8.74e-8	Aortic root size;
SKCM	cis	rs9790314	1.000	rs28515190	chr3:161028605	G/A	cg03342759	chr3:160939853	NMD3	-0.72	-7.87	-0.67	1.65e-11	Morning vs. evening chronotype;
SKCM	cis	rs9926296	0.744	rs164749	chr16:89708224	A/C	cg01097406	chr16:89675127	NA	0.45	4.81	0.48	7.34e-6	Vitiligo;
SKCM	cis	rs16854884	0.837	rs13083224	chr3:143801696	C/T	cg06585982	chr3:143692056	C3orf58	0.7	5.52	0.53	4.29e-7	Economic and political preferences (feminism/equality);
SKCM	cis	rs992157	0.560	rs10932763	chr2:219085863	G/C	cg20019365	chr2:219134978	PNKD;AAMP	-0.66	-5.52	-0.53	4.37e-7	Colorectal cancer;
SKCM	cis	rs9906944	0.545	rs1994969	chr17:47080431	G/T	cg10950924	chr17:47092072	IGF2BP1	-0.64	-5.96	-0.56	7.04e-8	Intelligence (multi-trait analysis);Body fat percentage;
SKCM	cis	rs7659604	0.728	rs3924987	chr4:122689784	G/T	cg20573242	chr4:122745356	CCNA2	0.79	6.29	0.58	1.72e-8	Type 2 diabetes;
SKCM	cis	rs9858542	0.953	rs3811699	chr3:49396360	T/C	cg03060546	chr3:49711283	APEH	-0.67	-5.04	-0.5	2.99e-6	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs7666738	0.753	rs9991512	chr4:99007205	T/C	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1577917	1.000	rs4707239	chr6:86610717	G/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.77	-0.66	2.59e-11	Response to antipsychotic treatment;
SKCM	cis	rs1577917	0.958	rs2660576	chr6:86651603	T/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.61	-5.31	-0.52	1.02e-6	Response to antipsychotic treatment;
SKCM	cis	rs7208859	0.573	rs11656278	chr17:29075188	C/T	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs2033711	0.870	rs7409473	chr19:58939165	A/G	cg00825309	chr19:58991885	ZNF446	-0.69	-5.6	-0.54	3.08e-7	Uric acid clearance;
SKCM	cis	rs28595532	0.582	rs71608361	chr4:119224081	T/C	cg14228332	chr4:119757509	SEC24D	0.99	5.58	0.53	3.31e-7	Cannabis dependence symptom count;
SKCM	cis	rs59574136	1	rs59574136	chr7:2036460	T/C	cg04267008	chr7:1944627	MAD1L1	-0.64	-4.82	-0.48	7.03e-6	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs2812533	0.938	rs12774027	chr10:71445318	A/C	cg01040533	chr10:71339886	NA	-0.54	-5.06	-0.5	2.71e-6	Type 2 diabetes;
SKCM	cis	rs7824557	0.602	rs7839053	chr8:11207431	C/T	cg21775007	chr8:11205619	TDH	0.7	6.25	0.58	2.02e-8	Retinal vascular caliber;
SKCM	cis	rs8064299	0.597	rs2166703	chr17:72781812	G/A	cg25054828	chr17:72772726	NAT9;TMEM104	0.98	10.16	0.75	6.14e-16	Monocyte count;
SKCM	cis	rs6951245	1.000	rs76214082	chr7:1102097	T/A	cg18402987	chr7:1209562	NA	1.15	6.09	0.57	3.95e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs11098499	0.863	rs12502389	chr4:120454191	A/G	cg24375607	chr4:120327624	NA	0.68	5.27	0.51	1.16e-6	Corneal astigmatism;
SKCM	cis	rs7633770	0.805	rs11710264	chr3:46661579	T/C	cg11219411	chr3:46661640	NA	0.74	7.45	0.64	1.08e-10	Coronary artery disease;
SKCM	cis	rs6952808	0.691	rs2398709	chr7:2112548	C/T	cg02951883	chr7:2050386	MAD1L1	-0.73	-6.24	-0.58	2.08e-8	Bipolar disorder and schizophrenia;
SKCM	trans	rs3780486	0.846	rs3780490	chr9:33129839	A/G	cg20290983	chr6:43655470	MRPS18A	1.0	11.51	0.79	1.7e-18	IgG glycosylation;
SKCM	cis	rs7539542	0.556	rs4950889	chr1:202874786	T/C	cg19681188	chr1:202830198	LOC148709	0.81	5.65	0.54	2.54e-7	Mean platelet volume;
SKCM	cis	rs870825	0.616	rs7681824	chr4:185617525	A/G	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs1799949	0.965	rs799908	chr17:41278916	A/G	cg05368731	chr17:41323189	NBR1	0.88	7.51	0.65	8.26e-11	Menopause (age at onset);
SKCM	cis	rs7945705	0.935	rs11042102	chr11:8882164	C/T	cg21881798	chr11:8931708	C11orf17;ST5	0.76	7.61	0.65	5.28e-11	Hemoglobin concentration;
SKCM	cis	rs2153535	0.580	rs1855769	chr6:8473095	A/G	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs67311347	0.866	rs1454491	chr3:40352647	C/G	cg00091569	chr3:40428383	ENTPD3	0.67	5.66	0.54	2.45e-7	Renal cell carcinoma;
SKCM	cis	rs1799949	1.000	rs8176297	chr17:41203325	T/A	cg25918947	chr17:41365094	TMEM106A	-0.62	-5.89	-0.55	9.22e-8	Menopause (age at onset);
SKCM	cis	rs9402673	0.517	rs978036	chr6:135342903	C/T	cg24558204	chr6:135376177	HBS1L	0.6	5.36	0.52	8.17e-7	Reticulocyte count;High light scatter reticulocyte count;
SKCM	cis	rs17826219	0.568	rs11658027	chr17:29094882	A/G	cg14067834	chr17:29058358	SUZ12P	-1.02	-5.34	-0.52	8.9e-7	Body mass index;
SKCM	cis	rs2153535	0.580	rs1577466	chr6:8444192	T/C	cg23788917	chr6:8435910	SLC35B3	0.69	5.14	0.5	1.99e-6	Motion sickness;
SKCM	cis	rs1862618	0.853	rs863840	chr5:56128999	C/G	cg12311346	chr5:56204834	C5orf35	-0.75	-4.98	-0.49	3.75e-6	Initial pursuit acceleration;
SKCM	cis	rs10808739	0.660	rs13282180	chr8:65629801	A/T	cg05711235	chr8:65498612	NA	-0.81	-5.4	-0.52	7.01e-7	HIV-1 susceptibility;
SKCM	cis	rs1552244	1.000	rs68067759	chr3:10150535	T/C	cg02579736	chr3:10068473	FANCD2;CIDECP	1.23	6.92	0.62	1.13e-9	Alzheimer's disease;
SKCM	trans	rs11083271	0.590	rs8089446	chr18:25857674	C/T	cg00321150	chr11:62623587	SNORD27;SLC3A2;SNHG1;SNORD28;SNORD25;SNORD26	0.83	7.73	0.66	3.17e-11	Non-alcoholic fatty liver disease histology (lobular);
SKCM	cis	rs1580019	0.522	rs10951340	chr7:32562408	G/A	cg06627557	chr7:32535165	LSM5;AVL9	0.94	9.12	0.72	6.39e-14	Cognitive ability;
SKCM	cis	rs13217239	0.621	rs12527231	chr6:27001288	G/A	cg12292205	chr6:26970375	C6orf41	0.63	5.64	0.54	2.58e-7	Schizophrenia;
SKCM	cis	rs62103177	0.565	rs473119	chr18:77849459	T/G	cg06309094	chr18:77676213	PQLC1	0.79	5.05	0.5	2.81e-6	Opioid sensitivity;
SKCM	cis	rs1577917	0.958	rs1337843	chr6:86675545	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.77	-0.66	2.59e-11	Response to antipsychotic treatment;
SKCM	cis	rs4803468	0.934	rs2317131	chr19:41885151	C/T	cg14132834	chr19:41945861	ATP5SL	-0.74	-5.71	-0.54	1.99e-7	Height;
SKCM	cis	rs6500395	0.962	rs9922356	chr16:48640025	C/T	cg04672837	chr16:48644449	N4BP1	0.69	5.68	0.54	2.26e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs826838	0.967	rs826855	chr12:39114888	T/C	cg13010199	chr12:38710504	ALG10B	-0.78	-5.84	-0.55	1.14e-7	Heart rate;
SKCM	cis	rs1005277	0.522	rs289649	chr10:37975384	T/C	cg25427524	chr10:38739819	LOC399744	-0.61	-6.09	-0.57	3.93e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs2991971	0.967	rs2275276	chr1:45973928	C/T	cg24296786	chr1:45957014	TESK2	0.69	5.61	0.54	2.9e-7	High light scatter reticulocyte count;
SKCM	cis	rs2120019	1.000	rs7173833	chr15:75369618	C/T	cg17294928	chr15:75287854	SCAMP5	-0.81	-6.74	-0.61	2.47e-9	Blood trace element (Zn levels);
SKCM	cis	rs651907	0.535	rs58658478	chr3:101511667	G/A	cg12386194	chr3:101231763	SENP7	0.69	5.8	0.55	1.35e-7	Colorectal cancer;
SKCM	cis	rs4839827	1	rs4839827	chr6:96853967	C/T	cg06623918	chr6:96969491	KIAA0776	0.57	4.84	0.48	6.33e-6	Migraine;
SKCM	cis	rs2153535	0.580	rs7767780	chr6:8453462	A/G	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs875971	1.000	rs2042133	chr7:65931922	A/G	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	cis	rs1790761	0.692	rs638140	chr11:67333858	G/C	cg00290607	chr11:67383545	NA	0.51	5.38	0.52	7.43e-7	Mean corpuscular volume;
SKCM	cis	rs9467773	1.000	rs1321481	chr6:26538210	A/T	cg09904177	chr6:26538194	HMGN4	0.54	4.98	0.49	3.78e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs736408	0.736	rs4687550	chr3:52823430	T/G	cg18404041	chr3:52824283	ITIH1	-0.66	-6.05	-0.57	4.71e-8	Bipolar disorder;
SKCM	cis	rs1552244	1.000	rs3826	chr3:10141065	T/G	cg02579736	chr3:10068473	FANCD2;CIDECP	1.23	6.92	0.62	1.13e-9	Alzheimer's disease;
SKCM	cis	rs748404	0.631	rs2467745	chr15:43722742	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	0.73	5.42	0.52	6.48e-7	Lung cancer;
SKCM	cis	rs6430585	0.941	rs12469551	chr2:136510012	T/G	cg07169764	chr2:136633963	MCM6	-0.91	-7.27	-0.64	2.37e-10	Corneal structure;
SKCM	cis	rs9880211	0.800	rs17365792	chr3:136497392	C/G	cg21827317	chr3:136751795	NA	-0.74	-5.43	-0.52	6.11e-7	Body mass index;Height;
SKCM	cis	rs995000	0.965	rs10789116	chr1:63042738	A/G	cg06896770	chr1:63153194	DOCK7	0.9	7.92	0.67	1.32e-11	Triglyceride levels;
SKCM	cis	rs6912958	0.559	rs242287	chr6:88071825	C/T	cg08069147	chr6:88032118	GJB7;C6orf162	0.68	5.85	0.55	1.11e-7	Monocyte percentage of white cells;
SKCM	cis	rs2439831	0.850	rs558656	chr15:43723514	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.1	7.39	0.64	1.39e-10	Lung cancer in ever smokers;
SKCM	cis	rs9581857	0.615	rs3759435	chr13:27996813	T/G	cg22138327	chr13:27999177	GTF3A	0.84	5.95	0.56	7.05e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs362296	0.698	rs3135171	chr4:3261127	A/G	cg00764545	chr4:3318001	RGS12	-0.77	-7.14	-0.63	4.22e-10	Parental longevity (mother's age at death);
SKCM	cis	rs472402	0.560	rs2303705	chr5:6622017	A/C	cg10789808	chr5:6633262	NSUN2;SRD5A1	-0.73	-4.81	-0.48	7.09e-6	Response to amphetamines;
SKCM	cis	rs10256972	0.552	rs2960830	chr7:1200641	T/C	cg07092213	chr7:1199455	ZFAND2A	-0.65	-5.41	-0.52	6.67e-7	Longevity;Endometriosis;
SKCM	cis	rs947211	0.898	rs1772156	chr1:205752894	T/C	cg07157834	chr1:205819609	PM20D1	0.71	5.25	0.51	1.29e-6	Parkinson's disease;
SKCM	cis	rs17376456	0.935	rs13156002	chr5:93508931	G/A	cg21475434	chr5:93447410	FAM172A	0.99	5.65	0.54	2.49e-7	Diabetic retinopathy;
SKCM	cis	rs11098499	0.865	rs9994730	chr4:120381564	A/C	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs2072499	0.966	rs2842865	chr1:156159532	G/A	cg25208724	chr1:156163844	SLC25A44	1.1	9.86	0.74	2.35e-15	Testicular germ cell tumor;
SKCM	cis	rs1552244	0.938	rs7647987	chr3:10140696	A/G	cg02579736	chr3:10068473	FANCD2;CIDECP	1.23	6.92	0.62	1.13e-9	Alzheimer's disease;
SKCM	cis	rs7945705	0.783	rs11042125	chr11:8938049	A/T	cg13070366	chr11:9386451	NA	0.59	5.19	0.51	1.61e-6	Hemoglobin concentration;
SKCM	cis	rs589448	0.902	rs528974	chr12:69765918	A/T	cg22834771	chr12:69754056	YEATS4	-0.71	-5.79	-0.55	1.39e-7	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs9303401	0.659	rs8074016	chr17:56840587	A/G	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.35	0.52	8.54e-7	Cognitive test performance;
SKCM	cis	rs17685	0.753	rs4573217	chr7:75733946	G/A	cg01364799	chr7:75623366	TMEM120A	-0.79	-6.37	-0.58	1.23e-8	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs11673344	0.704	rs484001	chr19:37422222	C/T	cg07624650	chr19:37064219	ZNF529	-0.79	-5.21	-0.51	1.5e-6	Obesity-related traits;
SKCM	cis	rs2811415	0.597	rs9809087	chr3:127761128	G/A	cg09089421	chr3:127803668	RUVBL1	0.99	8.52	0.69	9.09e-13	Lung function (FEV1/FVC);
SKCM	cis	rs9660180	0.620	rs34298494	chr1:1663402	A/C	cg13866156	chr1:1669148	SLC35E2	0.69	5.46	0.53	5.39e-7	Body mass index;
SKCM	cis	rs1348850	0.872	rs13004955	chr2:178398923	A/T	cg02961200	chr2:178257176	LOC100130691;AGPS	-0.82	-6.24	-0.58	2.12e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs12824058	0.844	rs7956408	chr12:130807547	A/T	cg26677194	chr12:130822605	PIWIL1	-0.65	-5.72	-0.54	1.88e-7	Menopause (age at onset);
SKCM	cis	rs3820068	0.581	rs72645881	chr1:15928203	C/T	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs2180341	0.782	rs6912750	chr6:127723081	A/T	cg27446573	chr6:127587934	RNF146	0.68	5.3	0.51	1.06e-6	Breast cancer;
SKCM	cis	rs1040	0.727	rs9294977	chr6:169624172	A/G	cg15449391	chr6:168975151	SMOC2	0.38	5.01	0.49	3.37e-6	Joint mobility (Beighton score);
SKCM	cis	rs10779751	1.000	rs742824	chr1:11274022	G/A	cg08854313	chr1:11322531	MTOR	1.0	8.97	0.71	1.24e-13	Body mass index;
SKCM	cis	rs17376456	0.935	rs13156002	chr5:93508931	G/A	cg25358565	chr5:93447407	FAM172A	1.23	8.18	0.68	4.19e-12	Diabetic retinopathy;
SKCM	cis	rs71520386	0.632	rs1474349	chr7:22853765	G/A	cg15401507	chr7:22894281	NA	0.66	4.92	0.49	4.66e-6	Fibrinogen levels;
SKCM	cis	rs12048904	0.647	rs7528268	chr1:101329295	A/G	cg16556008	chr1:101360663	SLC30A7;EXTL2	0.95	7.84	0.66	1.93e-11	Multiple sclerosis;
SKCM	cis	rs6952808	0.792	rs13224989	chr7:1953766	C/G	cg21782813	chr7:2030301	MAD1L1	0.56	6.01	0.56	5.51e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs8072100	0.537	rs9912450	chr17:45402208	C/T	cg08085267	chr17:45401833	C17orf57	-0.91	-7.03	-0.62	6.79e-10	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs9467773	0.620	rs1027203	chr6:26639332	G/C	cg15659132	chr6:26577336	NA	0.66	5.82	0.55	1.22e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs36093844	0.752	rs79734467	chr11:85571953	C/T	cg25872744	chr11:85566296	CCDC83	-0.85	-4.8	-0.48	7.42e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs9916302	0.706	rs12937013	chr17:37665571	G/A	cg07936489	chr17:37558343	FBXL20	-1.03	-7.61	-0.65	5.23e-11	Glomerular filtration rate (creatinine);
SKCM	cis	rs25645	0.502	rs8065126	chr17:38099035	C/T	cg17467752	chr17:38218738	THRA	-0.65	-5.15	-0.5	1.91e-6	Myeloid white cell count;
SKCM	cis	rs7666738	0.830	rs6853266	chr4:99047528	G/T	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs684232	0.897	rs1237094	chr17:619842	C/T	cg12384639	chr17:618140	VPS53	-0.62	-4.77	-0.48	8.39e-6	Prostate cancer;
SKCM	cis	rs9790314	0.747	rs9820825	chr3:160848155	A/G	cg03342759	chr3:160939853	NMD3	-0.64	-6.6	-0.6	4.54e-9	Morning vs. evening chronotype;
SKCM	cis	rs6952808	0.630	rs4719443	chr7:2161099	A/G	cg21782813	chr7:2030301	MAD1L1	0.52	5.54	0.53	3.97e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs875971	0.522	rs4502988	chr7:65297746	A/G	cg11987759	chr7:65425863	GUSB	-0.75	-6.42	-0.59	9.94e-9	Aortic root size;
SKCM	cis	rs2811415	0.597	rs12695506	chr3:127791800	A/G	cg09089421	chr3:127803668	RUVBL1	1.0	8.69	0.7	4.4e-13	Lung function (FEV1/FVC);
SKCM	cis	rs4237845	0.537	rs10747787	chr12:58260657	A/G	cg02175503	chr12:58329896	NA	0.7	5.82	0.55	1.24e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs9790314	0.905	rs7633186	chr3:161003124	A/G	cg03342759	chr3:160939853	NMD3	-0.73	-8.2	-0.68	3.89e-12	Morning vs. evening chronotype;
SKCM	cis	rs67311347	0.544	rs9864664	chr3:40336226	T/C	cg02782426	chr3:40428986	ENTPD3	0.52	5.33	0.52	9.46e-7	Renal cell carcinoma;
SKCM	cis	rs9902453	0.904	rs9894893	chr17:28270350	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.8	6.3	0.58	1.61e-8	Coffee consumption (cups per day);
SKCM	cis	rs12714314	0.560	rs7355555	chr2:1946646	A/C	cg22350835	chr2:1868857	MYT1L	0.62	5.72	0.54	1.86e-7	Type 2 diabetes (age of onset);
SKCM	cis	rs875971	0.660	rs7807930	chr7:66087165	C/T	cg18876405	chr7:65276391	NA	-0.82	-7.48	-0.65	9.41e-11	Aortic root size;
SKCM	cis	rs13010713	0.840	rs56987708	chr2:182024131	A/C	cg21995919	chr2:182322279	ITGA4	-0.52	-5.08	-0.5	2.53e-6	Celiac disease;
SKCM	cis	rs36093844	0.706	rs76504433	chr11:85554260	C/T	cg25872744	chr11:85566296	CCDC83	-0.85	-4.77	-0.48	8.27e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs709400	0.658	rs72708874	chr14:103899251	T/G	cg26031613	chr14:104095156	KLC1	0.72	5.3	0.51	1.04e-6	Body mass index;
SKCM	cis	rs763121	0.853	rs5757181	chr22:39013522	G/A	cg06022373	chr22:39101656	GTPBP1	0.72	4.96	0.49	4.08e-6	Menopause (age at onset);
SKCM	cis	rs6063312	0.667	rs9679994	chr20:47281853	T/C	cg18078177	chr20:47281410	PREX1	0.85	7.83	0.66	1.99e-11	Tonometry;
SKCM	cis	rs28595532	0.841	rs114175487	chr4:119733580	C/G	cg21605333	chr4:119757512	SEC24D	1.36	8.05	0.67	7.69e-12	Cannabis dependence symptom count;
SKCM	cis	rs12464559	0.649	rs6755393	chr2:152702037	C/A	cg01189475	chr2:152685088	ARL5A	-1.37	-5.53	-0.53	4.18e-7	Response to cognitive-behavioural therapy in anxiety disorder;
SKCM	cis	rs2204008	0.747	rs11514040	chr12:38201040	G/A	cg26384229	chr12:38710491	ALG10B	0.82	6.58	0.6	4.87e-9	Bladder cancer;
SKCM	cis	rs2839186	0.739	rs7282763	chr21:47696800	C/T	cg05896524	chr21:47604654	C21orf56	0.67	5.45	0.53	5.71e-7	Testicular germ cell tumor;
SKCM	cis	rs2153535	0.580	rs4960413	chr6:8438466	C/T	cg07606381	chr6:8435919	SLC35B3	0.93	6.77	0.61	2.18e-9	Motion sickness;
SKCM	cis	rs10905065	0.759	rs1533215	chr10:5869767	T/C	cg11519256	chr10:5708881	ASB13	0.58	5.11	0.5	2.23e-6	Menopause (age at onset);
SKCM	cis	rs752010	0.714	rs7513753	chr1:42079232	A/G	cg06885757	chr1:42089581	HIVEP3	0.48	4.79	0.48	7.72e-6	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs933688	0.818	rs10052492	chr5:90759930	T/A	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.0	7.92	0.67	1.32e-11	Smoking behavior;
SKCM	cis	rs10256972	0.616	rs6463001	chr7:1108272	A/C	cg07308232	chr7:1071921	C7orf50	-0.61	-5.07	-0.5	2.65e-6	Longevity;Endometriosis;
SKCM	cis	rs7659604	0.539	rs11098646	chr4:122729301	T/C	cg20573242	chr4:122745356	CCNA2	0.74	6.25	0.58	2e-8	Type 2 diabetes;
SKCM	cis	rs7584330	0.868	rs7571898	chr2:238383028	T/C	cg14458575	chr2:238380390	NA	1.05	6.59	0.6	4.66e-9	Prostate cancer;
SKCM	cis	rs875971	0.540	rs4717275	chr7:65265180	C/T	cg18876405	chr7:65276391	NA	-0.87	-7.93	-0.67	1.31e-11	Aortic root size;
SKCM	trans	rs6101567	0.740	rs6016078	chr20:38118190	A/G	cg12399162	chr6:7141575	RREB1	-0.86	-7.29	-0.64	2.2e-10	Nose size;
SKCM	cis	rs17826219	0.706	rs609472	chr17:28951427	T/C	cg14067834	chr17:29058358	SUZ12P	1.01	4.92	0.49	4.71e-6	Body mass index;
SKCM	cis	rs951366	0.528	rs1172198	chr1:205662718	C/T	cg07167872	chr1:205819463	PM20D1	0.75	5.69	0.54	2.15e-7	Menarche (age at onset);
SKCM	cis	rs910316	0.935	rs175422	chr14:75627319	T/A	cg08847533	chr14:75593920	NEK9	-0.95	-8.8	-0.71	2.64e-13	Height;
SKCM	cis	rs514406	0.722	rs7552139	chr1:53387379	G/C	cg16325326	chr1:53192061	ZYG11B	0.91	9.81	0.74	2.88e-15	Monocyte count;
SKCM	cis	rs2842992	0.830	rs2842974	chr6:160159034	C/T	cg16489826	chr6:160211363	TCP1;MRPL18	0.7	5.17	0.51	1.75e-6	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs62103177	0.608	rs4442895	chr18:77826399	C/G	cg06309094	chr18:77676213	PQLC1	0.78	5.18	0.51	1.7e-6	Opioid sensitivity;
SKCM	cis	rs561341	0.941	rs8066558	chr17:30272879	G/T	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs1218582	0.772	rs12069356	chr1:154849771	C/T	cg16680214	chr1:154839983	KCNN3	-0.55	-4.94	-0.49	4.37e-6	Prostate cancer;
SKCM	cis	rs1568889	1.000	rs16917689	chr11:28064466	G/A	cg06544937	chr11:28130018	METT5D1;KIF18A	0.86	7.03	0.62	6.97e-10	Bipolar disorder;
SKCM	cis	rs67311347	1.000	rs9841335	chr3:40475858	G/A	cg00091569	chr3:40428383	ENTPD3	0.62	5.09	0.5	2.4e-6	Renal cell carcinoma;
SKCM	cis	rs7811142	1.000	rs11764818	chr7:100043055	G/A	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-0.99	-5.52	-0.53	4.2e-7	Platelet count;
SKCM	cis	rs2075371	1.000	rs2544211	chr7:133973230	A/G	cg20476274	chr7:133979776	SLC35B4	1.02	9.96	0.75	1.48e-15	Mean platelet volume;
SKCM	cis	rs1577917	1.000	rs13199006	chr6:86608708	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.77	-0.66	2.59e-11	Response to antipsychotic treatment;
SKCM	cis	rs60871478	0.947	rs62432862	chr7:807719	G/C	cg04727924	chr7:799746	HEATR2	-0.6	-4.82	-0.48	7.03e-6	Cerebrospinal P-tau181p levels;
SKCM	cis	rs7646501	0.765	rs12488759	chr3:24067847	T/C	cg22892432	chr3:24537792	THRB	0.57	4.87	0.48	5.64e-6	Cognitive ability;Intelligence;
SKCM	cis	rs9814567	1.000	rs7428326	chr3:134251184	A/G	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	trans	rs561341	0.883	rs4450460	chr17:30201309	C/T	cg20587970	chr11:113659929	NA	1.07	8.37	0.69	1.77e-12	Hip circumference adjusted for BMI;
SKCM	cis	rs12142240	0.698	rs72677585	chr1:46812374	T/C	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs3796619	0.924	rs11940546	chr4:1072485	C/T	cg27284194	chr4:1044797	NA	0.67	4.8	0.48	7.53e-6	Recombination rate (males);
SKCM	cis	rs2013441	1.000	rs17686798	chr17:20029170	A/C	cg13482628	chr17:19912719	NA	-0.63	-4.86	-0.48	6.06e-6	Obesity-related traits;
SKCM	cis	rs7523050	0.730	rs72984614	chr1:109435848	T/C	cg08274380	chr1:109419600	GPSM2	1.15	6.57	0.6	5.22e-9	Fat distribution (HIV);
SKCM	cis	rs873946	0.586	rs36084869	chr10:134566069	G/A	cg26818010	chr10:134567672	INPP5A	-0.8	-6.11	-0.57	3.7e-8	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	trans	rs1814175	0.645	rs1874969	chr11:49826700	G/A	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs7659604	0.502	rs4075066	chr4:122684283	T/C	cg19671926	chr4:122722719	EXOSC9	0.75	6.24	0.58	2.1e-8	Type 2 diabetes;
SKCM	cis	rs3785574	0.962	rs2247435	chr17:61892862	G/A	cg06601766	chr17:61851465	DDX42;CCDC47	0.73	5.38	0.52	7.7300000000000005e-07	Height;
SKCM	cis	rs9325144	0.624	rs12231544	chr12:38901956	C/T	cg26384229	chr12:38710491	ALG10B	-0.72	-6.11	-0.57	3.73e-8	Morning vs. evening chronotype;
SKCM	cis	rs995000	0.895	rs1168124	chr1:63139730	C/T	cg06896770	chr1:63153194	DOCK7	-0.75	-7.28	-0.64	2.33e-10	Triglyceride levels;
SKCM	cis	rs807669	0.772	rs809901	chr22:19228736	C/T	cg02655711	chr22:19163373	SLC25A1	0.58	5.32	0.52	9.67e-7	Metabolite levels;
SKCM	cis	rs1691799	0.899	rs1168317	chr12:66746225	C/T	cg16791601	chr12:66731901	HELB	-0.65	-6.09	-0.57	4.07e-8	White blood cell count (basophil);
SKCM	cis	rs6089584	0.586	rs1079755	chr20:60615262	G/A	cg16423285	chr20:60520624	NA	-0.58	-5.04	-0.5	2.91e-6	Body mass index;
SKCM	cis	rs9611565	0.649	rs5758466	chr22:42176059	G/A	cg03806693	chr22:41940476	POLR3H	0.88	5.75	0.55	1.68e-7	Vitiligo;
SKCM	cis	rs6580649	0.941	rs7971668	chr12:48469696	T/C	cg05342945	chr12:48394962	COL2A1	0.81	5.59	0.54	3.16e-7	Lung cancer;
SKCM	cis	rs362296	0.698	rs3135172	chr4:3258735	A/G	cg16987761	chr4:3318072	RGS12	-0.75	-6.27	-0.58	1.83e-8	Parental longevity (mother's age at death);
SKCM	cis	rs867186	1.000	rs79048371	chr20:33731484	T/A	cg04194272	chr20:33683537	NA	-1.11	-6.01	-0.56	5.7e-8	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs2204008	0.548	rs8189475	chr12:38037115	C/T	cg13010199	chr12:38710504	ALG10B	0.62	4.84	0.48	6.53e-6	Bladder cancer;
SKCM	cis	rs116095464	0.558	rs9687621	chr5:229194	C/T	cg22857025	chr5:266934	NA	-1.45	-7.84	-0.66	1.94e-11	Breast cancer;
SKCM	cis	rs7666738	0.753	rs2903143	chr4:99040480	C/T	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs3135063	0.504	rs3129315	chr4:3290600	C/T	cg24015175	chr4:3319247	RGS12	0.65	4.87	0.48	5.8e-6	Blood protein levels;
SKCM	cis	rs3820068	0.603	rs998032	chr1:15989918	T/C	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs116095464	0.558	rs10055405	chr5:265666	C/T	cg22857025	chr5:266934	NA	-1.35	-8.08	-0.68	6.55e-12	Breast cancer;
SKCM	cis	rs3087591	0.960	rs2905880	chr17:29546175	A/G	cg24425628	chr17:29625626	OMG;NF1	0.64	5.22	0.51	1.43e-6	Hip circumference;
SKCM	cis	rs17685	0.712	rs4552844	chr7:75718095	A/G	cg01364799	chr7:75623366	TMEM120A	-0.72	-5.81	-0.55	1.31e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7666738	0.830	rs6839203	chr4:98839814	C/G	cg05340658	chr4:99064831	C4orf37	0.6	4.81	0.48	7.19e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9902453	1.000	rs6505152	chr17:28331466	T/C	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.81	-5.78	-0.55	1.45e-7	Coffee consumption (cups per day);
SKCM	cis	rs6500602	0.647	rs4785967	chr16:4523208	G/A	cg08645402	chr16:4508243	NA	0.57	4.84	0.48	6.39e-6	Schizophrenia;
SKCM	cis	rs2228479	0.867	rs11642451	chr16:89958127	T/C	cg00800038	chr16:89945340	TCF25	-0.93	-5.34	-0.52	8.73e-7	Skin colour saturation;
SKCM	cis	rs12611334	0.964	rs56261485	chr19:40191978	C/T	cg04998674	chr19:40596855	ZNF780A	0.63	4.77	0.47	8.55e-6	Schizophrenia;
SKCM	cis	rs7811142	0.830	rs10085549	chr7:99983135	C/T	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.05	6.0	0.56	5.85e-8	Platelet count;
SKCM	cis	rs7666738	0.830	rs9992391	chr4:98916052	G/A	cg17366294	chr4:99064904	C4orf37	0.56	4.87	0.48	5.76e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs826838	0.651	rs1843892	chr12:38616965	A/G	cg26384229	chr12:38710491	ALG10B	0.7	5.97	0.56	6.57e-8	Heart rate;
SKCM	cis	rs4727027	0.865	rs12154368	chr7:148862041	C/T	cg23583168	chr7:148888333	NA	-0.8	-6.62	-0.6	4.13e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs2404602	0.735	rs62028423	chr15:76754514	G/A	cg23625390	chr15:77176239	SCAPER	-0.78	-7.58	-0.65	6.09e-11	Blood metabolite levels;
SKCM	cis	rs7666738	0.791	rs1426674	chr4:98924247	C/A	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs12971120	1.000	rs734559	chr18:72179579	G/A	cg25817165	chr18:72167213	CNDP2	-0.61	-4.8	-0.48	7.57e-6	Refractive error;
SKCM	cis	rs873946	0.504	rs3829132	chr10:134579044	A/C	cg26818010	chr10:134567672	INPP5A	-0.73	-5.56	-0.53	3.62e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs9910055	0.529	rs575798	chr17:42181796	A/C	cg19774624	chr17:42201019	HDAC5	0.83	6.53	0.59	6.08e-9	Total body bone mineral density;
SKCM	cis	rs28595532	0.920	rs114792862	chr4:119759938	G/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs34375054	0.660	rs35941060	chr12:125594245	G/A	cg25124228	chr12:125621409	AACS	-0.68	-4.98	-0.49	3.66e-6	Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs950776	0.593	rs6495306	chr15:78865893	C/T	cg06917634	chr15:78832804	PSMA4	-0.9	-7.99	-0.67	9.7e-12	Sudden cardiac arrest;
SKCM	cis	rs2645694	0.911	rs2703147	chr4:77831307	C/T	cg03477792	chr4:77819574	ANKRD56	0.56	5.71	0.54	1.98e-7	Emphysema distribution in smoking;
SKCM	cis	rs35306767	0.953	rs1106064	chr10:957211	G/A	cg25614935	chr10:1084866	C10orf110	0.67	4.85	0.48	6.07e-6	Eosinophil percentage of granulocytes;
SKCM	trans	rs208520	0.690	rs1233103	chr6:66855943	T/G	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-1.07	-7.99	-0.67	9.73e-12	Exhaled nitric oxide output;
SKCM	cis	rs1799949	1.000	rs4793197	chr17:41231902	C/T	cg23758822	chr17:41437982	NA	0.92	7.68	0.66	3.96e-11	Menopause (age at onset);
SKCM	cis	rs10489202	0.632	rs275137	chr1:168051266	A/C	cg24449463	chr1:168025552	DCAF6	0.8	7.72	0.66	3.27e-11	Schizophrenia;
SKCM	cis	rs2842992	0.789	rs9355748	chr6:160194882	G/A	cg11366901	chr6:160182831	ACAT2	0.94	7.85	0.66	1.81e-11	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs1568889	0.667	rs7123947	chr11:28399908	A/G	cg06544937	chr11:28130018	METT5D1;KIF18A	0.86	5.97	0.56	6.72e-8	Bipolar disorder;
SKCM	cis	rs752010	0.523	rs943376	chr1:42122117	A/G	cg06885757	chr1:42089581	HIVEP3	0.49	5.16	0.5	1.87e-6	Lupus nephritis in systemic lupus erythematosus;
SKCM	trans	rs208520	0.545	rs6899712	chr6:66749670	T/C	cg15611600	chr13:45563400	KIAA1704;NUFIP1	1.02	11.11	0.78	9.88e-18	Exhaled nitric oxide output;
SKCM	cis	rs362296	0.661	rs3095078	chr4:3265479	C/T	cg00764545	chr4:3318001	RGS12	-0.66	-5.86	-0.55	1.05e-7	Parental longevity (mother's age at death);
SKCM	cis	rs9894429	0.608	rs7406219	chr17:79609410	G/T	cg18240062	chr17:79603768	NPLOC4	0.68	6.07	0.57	4.41e-8	Eye color traits;
SKCM	cis	rs561341	0.843	rs2028067	chr17:30239698	T/C	cg00745463	chr17:30367425	LRRC37B	-0.99	-6.61	-0.6	4.22e-9	Hip circumference adjusted for BMI;
SKCM	cis	rs7216064	0.953	rs2086744	chr17:65849275	C/G	cg12091567	chr17:66097778	LOC651250	-0.77	-5.53	-0.53	4.06e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs9467773	0.620	rs2494716	chr6:26662736	T/C	cg09904177	chr6:26538194	HMGN4	0.57	4.82	0.48	7.06e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1843834	0.539	rs1494109	chr2:225441833	G/A	cg12698349	chr2:225449008	CUL3	0.88	7.02	0.62	7.26e-10	IgE levels in asthmatics (D.p. specific);
SKCM	cis	rs10504229	0.906	rs56138544	chr8:58184558	A/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs5769765	0.773	rs58375955	chr22:50312630	A/G	cg22709217	chr22:50311962	ALG12;CRELD2	-0.94	-5.91	-0.56	8.37e-8	Schizophrenia;
SKCM	cis	rs10089	1.000	rs1962291	chr5:127445373	A/G	cg25462716	chr5:127418816	SLC12A2;FLJ33630	-0.9	-8.78	-0.71	2.84e-13	Ileal carcinoids;
SKCM	cis	rs7589728	0.620	rs76687350	chr2:88473832	G/A	cg04511125	chr2:88470314	THNSL2	1.07	6.66	0.6	3.43e-9	Plasma clusterin levels;
SKCM	cis	rs9902453	0.967	rs28792710	chr17:28450015	T/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.5	0.53	4.74e-7	Coffee consumption (cups per day);
SKCM	cis	rs7829975	0.577	rs7816329	chr8:8543843	G/A	cg15556689	chr8:8085844	FLJ10661	-0.68	-4.84	-0.48	6.4e-6	Mood instability;
SKCM	cis	rs7524258	0.835	rs2412150	chr1:7303343	A/C	cg07173049	chr1:7289937	CAMTA1	0.42	4.85	0.48	6.16e-6	Tourette's syndrome or obsessive-compulsive disorder;
SKCM	cis	rs11662586	0.517	rs7230837	chr18:77695384	A/T	cg20368463	chr18:77673604	PQLC1	0.75	6.67	0.6	3.3e-9	Exploratory eye movement dysfunction in schizophrenia (responsive search score);
SKCM	cis	rs470903	1.000	rs470903	chr18:74715269	A/G	cg05896682	chr18:74964030	GALR1	0.56	5.34	0.52	8.97e-7	Paclitaxel disposition in epithelial ovarian cancer;
SKCM	cis	rs8180040	0.654	rs62246451	chr3:47211632	C/T	cg27129171	chr3:47204927	SETD2	-0.74	-5.3	-0.51	1.05e-6	Colorectal cancer;
SKCM	cis	rs514406	0.893	rs1242317	chr1:53414766	T/C	cg24675658	chr1:53192096	ZYG11B	-0.68	-5.58	-0.53	3.36e-7	Monocyte count;
SKCM	cis	rs1882538	0.569	rs11562036	chr7:133076862	T/C	cg10665199	chr7:133106180	EXOC4	0.78	5.1	0.5	2.3e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2842992	0.830	rs1535475	chr6:160148935	T/C	cg19482086	chr6:160211437	TCP1;MRPL18	0.84	6.38	0.59	1.18e-8	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs6809651	0.524	rs6444106	chr3:185811495	C/T	cg00760338	chr3:185826511	ETV5	-0.85	-5.19	-0.51	1.63e-6	Body mass index in physically active individuals;Glomerular filtration rate (creatinine);Body mass index (joint analysis main effects and physical activity interaction);Body mass index;Body mass index in physically inactive individuals;
SKCM	cis	rs2228479	0.850	rs11646766	chr16:89838578	A/T	cg06558623	chr16:89946397	TCF25	1.11	5.26	0.51	1.23e-6	Skin colour saturation;
SKCM	trans	rs11722228	0.508	rs3796826	chr4:10092728	G/A	cg26043149	chr18:55253948	FECH	0.93	7.87	0.67	1.66e-11	Gout;Urate levels;Serum uric acid levels;
SKCM	cis	rs7944584	0.511	rs10838725	chr11:47557871	T/C	cg20307385	chr11:47447363	PSMC3	0.97	7.44	0.64	1.15e-10	Fasting blood glucose;Fasting blood glucose (BMI interaction);
SKCM	cis	rs10254284	0.959	rs10275989	chr7:28159696	A/G	cg15170557	chr7:28214983	JAZF1	0.6	5.32	0.52	9.76e-7	Lymphocyte percentage of white cells;Systemic lupus erythematosus;
SKCM	cis	rs9399137	0.507	rs4451150	chr6:135279063	T/G	cg24558204	chr6:135376177	HBS1L	0.69	6.37	0.59	1.21e-8	Glycated hemoglobin levels;Mean corpuscular volume;Hematology traits;HbA2 levels;Mean corpuscular hemoglobin;Hemoglobin levels;F-cell distribution;Platelet count;
SKCM	cis	rs35306767	0.903	rs765867	chr10:869901	G/T	cg26597838	chr10:835615	NA	0.76	5.66	0.54	2.4e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs6087990	0.735	rs2424920	chr20:31385452	T/C	cg13636640	chr20:31349939	DNMT3B	0.83	6.24	0.58	2.13e-8	Ulcerative colitis;
SKCM	cis	rs1577917	0.727	rs9444361	chr6:86400900	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.85	7.9	0.67	1.47e-11	Response to antipsychotic treatment;
SKCM	cis	rs55962025	0.711	rs2298971	chr4:3200079	A/G	cg09735869	chr4:3319127	RGS12	-0.61	-4.96	-0.49	4.03e-6	Parental longevity (mother's age at death);
SKCM	cis	rs11098499	0.657	rs71614442	chr4:120379346	C/T	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs2836974	0.897	rs1984022	chr21:40596085	G/A	cg11890956	chr21:40555474	PSMG1	1.09	13.83	0.84	1.08e-22	Cognitive function;
SKCM	cis	rs9325144	0.505	rs826893	chr12:39100536	A/G	cg26384229	chr12:38710491	ALG10B	-0.78	-6.4	-0.59	1.07e-8	Morning vs. evening chronotype;
SKCM	cis	rs875971	0.540	rs736270	chr7:65428822	T/C	cg11764359	chr7:65958608	NA	0.89	7.03	0.62	6.77e-10	Aortic root size;
SKCM	cis	rs16940212	0.542	rs28495863	chr15:58684381	G/A	cg16767221	chr15:57769667	CGNL1	-0.62	-5.02	-0.49	3.21e-6	HDL cholesterol levels;HDL cholesterol;
SKCM	cis	rs936229	0.813	rs1350193	chr15:75084281	G/C	cg14664628	chr15:75095509	CSK	-1.15	-9.89	-0.75	2.08e-15	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin);
SKCM	cis	rs8180040	0.966	rs6792461	chr3:47473168	C/T	cg27129171	chr3:47204927	SETD2	-0.79	-5.79	-0.55	1.43e-7	Colorectal cancer;
SKCM	cis	rs736408	0.648	rs2268023	chr3:52819327	T/A	cg18404041	chr3:52824283	ITIH1	-0.55	-4.93	-0.49	4.59e-6	Bipolar disorder;
SKCM	cis	rs1062177	0.906	rs2964573	chr5:151160122	A/T	cg00977110	chr5:151150581	G3BP1	0.83	6.79	0.61	2.01e-9	Preschool internalizing problems;
SKCM	cis	rs951366	0.617	rs708727	chr1:205767885	G/A	cg14893161	chr1:205819251	PM20D1	1.05	12.72	0.82	1.03e-20	Menarche (age at onset);
SKCM	cis	rs9611565	0.527	rs73178638	chr22:41942904	T/C	cg03806693	chr22:41940476	POLR3H	-1.13	-7.48	-0.65	9.6e-11	Vitiligo;
SKCM	cis	rs34172651	0.517	rs11862923	chr16:24767303	G/T	cg00339695	chr16:24857497	SLC5A11	0.8	6.43	0.59	9.38e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs35146811	0.700	rs866500	chr7:99840461	A/G	cg22906224	chr7:99728672	NA	-0.67	-5.04	-0.5	2.99e-6	Coronary artery disease;
SKCM	cis	rs5769765	1.000	rs5770728	chr22:50259984	G/A	cg22709217	chr22:50311962	ALG12;CRELD2	0.8	5.79	0.55	1.42e-7	Schizophrenia;
SKCM	cis	rs6840360	0.615	rs7695412	chr4:152488075	A/G	cg22705602	chr4:152727874	NA	-0.51	-5.72	-0.54	1.85e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs3020736	0.500	rs6519306	chr22:42501217	T/C	cg04733989	chr22:42467013	NAGA	-0.72	-5.62	-0.54	2.87e-7	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs2836974	0.897	rs7280375	chr21:40552408	C/T	cg17971929	chr21:40555470	PSMG1	-0.88	-8.75	-0.7	3.37e-13	Cognitive function;
SKCM	cis	rs732765	0.657	rs10148524	chr14:75226002	C/T	cg25946216	chr14:74253857	C14orf43	-0.93	-5.16	-0.5	1.82e-6	Non-small cell lung cancer;
SKCM	cis	rs7809950	0.911	rs1015411	chr7:107135612	C/T	cg23024343	chr7:107201750	COG5	-0.82	-7.4	-0.64	1.38e-10	Coronary artery disease;
SKCM	cis	rs10193935	0.901	rs13384323	chr2:42631346	C/T	cg27598129	chr2:42591480	NA	-0.96	-6.71	-0.61	2.74e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2842992	0.747	rs733319	chr6:160221475	A/G	cg11366901	chr6:160182831	ACAT2	0.92	7.04	0.62	6.53e-10	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs72634258	0.842	rs7545677	chr1:8165619	C/T	cg00042356	chr1:8021962	PARK7	0.84	5.53	0.53	4.09e-7	Inflammatory bowel disease;
SKCM	cis	rs7829975	0.514	rs2920991	chr8:8259117	T/A	cg15556689	chr8:8085844	FLJ10661	0.67	5.83	0.55	1.22e-7	Mood instability;
SKCM	trans	rs1814175	0.817	rs7929173	chr11:49944007	T/C	cg15704280	chr7:45808275	SEPT13	-1.06	-11.16	-0.78	7.82e-18	Height;
SKCM	cis	rs6546550	0.867	rs4401231	chr2:70063563	G/C	cg02498382	chr2:70120550	SNRNP27	-0.46	-5.17	-0.51	1.76e-6	Prevalent atrial fibrillation;
SKCM	cis	rs561341	1.000	rs554078	chr17:30330109	A/C	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs17376456	0.877	rs10059230	chr5:93450347	A/G	cg21475434	chr5:93447410	FAM172A	0.97	5.42	0.52	6.39e-7	Diabetic retinopathy;
SKCM	cis	rs9858038	0.710	rs12486983	chr3:182733547	T/C	cg06384952	chr3:183602746	PARL	0.7	4.86	0.48	5.98e-6	Parkinson's disease;
SKCM	cis	rs77216612	0.877	rs66561220	chr12:12878765	T/C	cg04607235	chr12:12878440	APOLD1	-0.99	-7.0	-0.62	7.77e-10	Lymphocyte counts;
SKCM	cis	rs12497850	0.931	rs4974085	chr3:48924900	C/T	cg06212747	chr3:49208901	KLHDC8B	0.73	5.27	0.51	1.17e-6	Parkinson's disease;
SKCM	cis	rs6500395	0.775	rs8050844	chr16:48665696	A/G	cg04672837	chr16:48644449	N4BP1	0.6	4.88	0.48	5.59e-6	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs7296418	0.961	rs10848428	chr12:123572495	C/T	cg05973401	chr12:123451056	ABCB9	0.84	6.88	0.61	1.34e-9	Platelet count;
SKCM	cis	rs9368481	0.761	rs9348746	chr6:26970357	C/G	cg12292205	chr6:26970375	C6orf41	-0.72	-6.6	-0.6	4.58e-9	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs611744	0.625	rs6469168	chr8:109288399	G/T	cg18478394	chr8:109455254	TTC35	0.63	4.98	0.49	3.77e-6	Dupuytren's disease;
SKCM	cis	rs17376456	0.877	rs10213956	chr5:93460839	C/T	cg25358565	chr5:93447407	FAM172A	1.23	7.97	0.67	1.08e-11	Diabetic retinopathy;
SKCM	cis	rs362296	0.698	rs3135168	chr4:3262699	T/C	cg11471262	chr4:3318911	RGS12	-0.77	-7.32	-0.64	1.92e-10	Parental longevity (mother's age at death);
SKCM	cis	rs7927771	0.693	rs2856650	chr11:47365199	G/A	cg05585544	chr11:47624801	NA	-0.61	-5.06	-0.5	2.76e-6	Subjective well-being;
SKCM	cis	rs2836974	0.584	rs34436313	chr21:40685246	A/G	cg11644478	chr21:40555479	PSMG1	-0.68	-5.96	-0.56	6.94e-8	Cognitive function;
SKCM	cis	rs7824557	0.564	rs34389419	chr8:11229319	C/G	cg21775007	chr8:11205619	TDH	-0.59	-4.9	-0.48	5.19e-6	Retinal vascular caliber;
SKCM	cis	rs7684253	0.565	rs12641030	chr4:57803505	A/G	cg25313468	chr4:57773308	REST	0.4	4.89	0.48	5.24e-6	Migraine;
SKCM	cis	rs1395	0.744	rs62130709	chr2:27505782	C/T	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.56	5.2	0.51	1.56e-6	Blood metabolite levels;
SKCM	trans	rs11083271	0.590	rs4800299	chr18:25841507	A/T	cg00321150	chr11:62623587	SNORD27;SLC3A2;SNHG1;SNORD28;SNORD25;SNORD26	0.86	8.3	0.68	2.51e-12	Non-alcoholic fatty liver disease histology (lobular);
SKCM	cis	rs826838	1.000	rs34254519	chr12:39041235	G/A	cg26384229	chr12:38710491	ALG10B	1.01	9.36	0.73	2.16e-14	Heart rate;
SKCM	cis	rs7772486	0.692	rs2265915	chr6:146194332	A/T	cg05347473	chr6:146136440	FBXO30	0.58	5.56	0.53	3.57e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6088590	1.000	rs6088615	chr20:33400474	C/T	cg24642439	chr20:33292090	TP53INP2	-0.81	-5.25	-0.51	1.27e-6	Coronary artery disease;
SKCM	cis	rs6545883	0.524	rs12992614	chr2:61593076	C/T	cg15711740	chr2:61764176	XPO1	0.66	5.12	0.5	2.17e-6	Tuberculosis;
SKCM	cis	rs362272	0.524	rs3129334	chr4:3368526	T/C	cg09735869	chr4:3319127	RGS12	0.96	10.92	0.78	2.23e-17	Serum sulfate level;
SKCM	cis	rs362272	0.505	rs13104157	chr4:3366950	T/C	cg16987761	chr4:3318072	RGS12	0.96	11.3	0.79	4.33e-18	Serum sulfate level;
SKCM	cis	rs1801251	1.000	rs7592717	chr2:233577038	G/A	cg25237894	chr2:233734115	C2orf82	0.61	5.66	0.54	2.39e-7	Coronary artery disease;
SKCM	cis	rs1552244	0.872	rs35988239	chr3:10074145	G/T	cg02579736	chr3:10068473	FANCD2;CIDECP	1.35	7.51	0.65	8.29e-11	Alzheimer's disease;
SKCM	cis	rs9300255	0.543	rs655293	chr12:123528405	G/A	cg05973401	chr12:123451056	ABCB9	0.81	5.57	0.53	3.45e-7	Neutrophil percentage of white cells;
SKCM	cis	rs6951245	1.000	rs111899361	chr7:1112348	C/T	cg18402987	chr7:1209562	NA	1.15	6.09	0.57	3.95e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs62103177	0.733	rs62096748	chr18:77619699	T/C	cg27393146	chr18:77495563	CTDP1	-0.92	-5.36	-0.52	8.37e-7	Opioid sensitivity;
SKCM	cis	rs10751667	0.643	rs10902234	chr11:935578	A/G	cg10932868	chr11:921992	NA	0.54	5.05	0.5	2.81e-6	Alzheimer's disease (late onset);
SKCM	cis	rs28386778	0.897	rs2665832	chr17:61912261	C/T	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs4774899	1.000	rs12050758	chr15:57495303	A/G	cg01857019	chr15:57210107	LOC145783;TCF12	0.54	4.88	0.48	5.49e-6	Urinary tract infection frequency;
SKCM	cis	rs8072100	0.967	rs8078880	chr17:45676526	G/C	cg08085267	chr17:45401833	C17orf57	0.62	5.49	0.53	4.77e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs1552244	0.572	rs3774208	chr3:10164722	T/G	cg00149659	chr3:10157352	C3orf10	1.13	5.45	0.53	5.74e-7	Alzheimer's disease;
SKCM	cis	rs992157	1.000	rs2168704	chr2:219142492	G/A	cg20019365	chr2:219134978	PNKD;AAMP	0.75	6.99	0.62	8.08e-10	Colorectal cancer;
SKCM	cis	rs919433	0.783	rs788014	chr2:198228997	G/A	cg04278110	chr2:198063759	ANKRD44	0.79	5.34	0.52	8.88e-7	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs62238980	0.522	rs78117433	chr22:32421224	G/A	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs73001065	0.636	rs73002960	chr19:19582992	C/T	cg03709012	chr19:19516395	GATAD2A	1.16	5.47	0.53	5.19e-7	LDL cholesterol;
SKCM	cis	rs96067	0.711	rs272833	chr1:36622870	C/G	cg24686825	chr1:36642396	MAP7D1	-0.73	-5.7	-0.54	2.06e-7	Corneal structure;
SKCM	cis	rs875971	0.862	rs2420174	chr7:65645361	C/T	cg11764359	chr7:65958608	NA	-0.8	-7.66	-0.66	4.2e-11	Aortic root size;
SKCM	cis	rs9581857	0.512	rs9581874	chr13:28086956	A/G	cg22138327	chr13:27999177	GTF3A	0.84	5.53	0.53	4.15e-7	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs4560672	1.000	rs80155944	chr6:158584328	T/C	cg10592926	chr6:157876961	ZDHHC14	0.51	4.86	0.48	5.84e-6	Smoking quantity;
SKCM	cis	rs2439831	0.681	rs3742971	chr15:43622916	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	-1.13	-8.93	-0.71	1.48e-13	Lung cancer in ever smokers;
SKCM	cis	rs668210	0.793	rs1204011	chr11:65741086	G/A	cg20909159	chr11:65625947	CFL1	0.78	4.97	0.49	3.86e-6	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs7523273	0.606	rs2724382	chr1:207928635	G/C	cg22525895	chr1:207977042	MIR29B2	0.81	7.08	0.63	5.47e-10	Schizophrenia;
SKCM	cis	rs7208859	0.623	rs2035494	chr17:29130393	T/G	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs992157	0.710	rs10167446	chr2:219056866	A/G	cg20019365	chr2:219134978	PNKD;AAMP	0.72	6.34	0.58	1.38e-8	Colorectal cancer;
SKCM	cis	rs910316	0.967	rs10142770	chr14:75525449	G/A	cg08847533	chr14:75593920	NEK9	0.96	8.88	0.71	1.83e-13	Height;
SKCM	cis	rs2153535	0.541	rs9328477	chr6:8519109	T/C	cg07606381	chr6:8435919	SLC35B3	0.87	6.38	0.59	1.17e-8	Motion sickness;
SKCM	cis	rs11098499	0.687	rs71610270	chr4:120287436	A/G	cg24375607	chr4:120327624	NA	0.62	4.77	0.48	8.45e-6	Corneal astigmatism;
SKCM	cis	rs4400599	0.606	rs7542975	chr1:154204813	G/A	cg26808167	chr1:154192205	UBAP2L;C1orf43	-0.54	-4.9	-0.49	5.01e-6	Platelet distribution width;
SKCM	cis	rs7613875	0.620	rs2526747	chr3:50082914	C/G	cg24110177	chr3:50126178	RBM5	-0.76	-5.98	-0.56	6.44e-8	Body mass index;
SKCM	cis	rs11098499	0.863	rs3775845	chr4:120432447	T/C	cg09307838	chr4:120376055	NA	0.99	7.71	0.66	3.45e-11	Corneal astigmatism;
SKCM	cis	rs897984	0.762	rs2054213	chr16:30971810	A/G	cg00531865	chr16:30841666	NA	0.59	4.97	0.49	3.81e-6	Dementia with Lewy bodies;
SKCM	cis	rs6088590	0.965	rs6058108	chr20:33288655	A/G	cg24642439	chr20:33292090	TP53INP2	0.98	7.36	0.64	1.65e-10	Coronary artery disease;
SKCM	cis	rs714515	0.546	rs9425573	chr1:172330437	G/T	cg01573306	chr1:172330400	DNM3	-0.74	-5.97	-0.56	6.73e-8	Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction);Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);
SKCM	cis	rs523522	0.962	rs4767902	chr12:120910004	C/T	cg27279351	chr12:120934652	DYNLL1	0.9	7.85	0.66	1.8e-11	High light scatter reticulocyte count;
SKCM	cis	rs13040088	0.935	rs3787513	chr20:61573736	G/A	cg23096297	chr20:61557774	DIDO1	0.82	6.22	0.58	2.32e-8	Menopause (age at onset);
SKCM	trans	rs8073060	0.586	rs225288	chr17:33929291	G/A	cg19694781	chr19:47549865	TMEM160	-1.08	-8.69	-0.7	4.26e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs7659604	1.000	rs6846232	chr4:122664805	A/G	cg06713675	chr4:122721982	EXOSC9	-0.65	-5.78	-0.55	1.48e-7	Type 2 diabetes;
SKCM	cis	rs951366	0.789	rs1772148	chr1:205704580	A/T	cg07157834	chr1:205819609	PM20D1	0.82	7.17	0.63	3.7e-10	Menarche (age at onset);
SKCM	cis	rs10504073	0.647	rs7817571	chr8:50003218	T/C	cg00325661	chr8:49890786	NA	0.82	7.02	0.62	7.13e-10	Blood metabolite ratios;
SKCM	cis	rs2836950	0.527	rs2836958	chr21:40623526	T/C	cg11644478	chr21:40555479	PSMG1	-0.64	-5.02	-0.49	3.17e-6	Menarche (age at onset);
SKCM	cis	rs7937682	0.883	rs659529	chr11:111436896	T/A	cg09085632	chr11:111637200	PPP2R1B	-1.01	-9.83	-0.74	2.69e-15	Primary sclerosing cholangitis;
SKCM	cis	rs7927771	0.690	rs35496532	chr11:47450338	C/T	cg01152729	chr11:47593274	PTPMT1	-0.51	-4.88	-0.48	5.49e-6	Subjective well-being;
SKCM	cis	rs561341	0.941	rs736678	chr17:30347423	G/T	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs6089584	0.526	rs6061965	chr20:60607858	A/C	cg16423285	chr20:60520624	NA	-0.61	-5.34	-0.52	9.07e-7	Body mass index;
SKCM	cis	rs6952808	0.792	rs2056481	chr7:1955435	A/G	cg02951883	chr7:2050386	MAD1L1	-0.78	-6.73	-0.61	2.56e-9	Bipolar disorder and schizophrenia;
SKCM	cis	rs7666738	0.830	rs6854703	chr4:98977586	A/T	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4689592	0.503	rs11945642	chr4:7051065	G/C	cg19539972	chr4:7069911	GRPEL1	-0.94	-6.45	-0.59	8.58e-9	Monocyte percentage of white cells;
SKCM	cis	rs7336332	0.569	rs57724994	chr13:28010389	T/C	cg22138327	chr13:27999177	GTF3A	0.72	5.31	0.52	1.01e-6	Weight;
SKCM	cis	rs2013441	1.000	rs2158473	chr17:20139090	T/C	cg13482628	chr17:19912719	NA	-0.64	-5.04	-0.5	2.94e-6	Obesity-related traits;
SKCM	cis	rs9300255	0.770	rs12299125	chr12:123862447	C/T	cg05973401	chr12:123451056	ABCB9	-0.82	-5.72	-0.54	1.92e-7	Neutrophil percentage of white cells;
SKCM	cis	rs67460515	0.500	rs1562464	chr3:160681614	G/A	cg03342759	chr3:160939853	NMD3	-0.63	-4.8	-0.48	7.46e-6	Parkinson's disease;
SKCM	cis	rs6088580	0.634	rs1890002	chr20:32919219	A/G	cg24642439	chr20:33292090	TP53INP2	-0.72	-5.7	-0.54	2.06e-7	Glomerular filtration rate (creatinine);
SKCM	cis	rs2120019	1.000	rs2415253	chr15:75375699	A/G	cg17294928	chr15:75287854	SCAMP5	-0.82	-6.77	-0.61	2.13e-9	Blood trace element (Zn levels);
SKCM	cis	rs8067545	0.578	rs62066870	chr17:20063758	A/C	cg13482628	chr17:19912719	NA	0.66	5.5	0.53	4.72e-7	Schizophrenia;
SKCM	cis	rs2075371	0.932	rs2544215	chr7:133987896	T/C	cg20476274	chr7:133979776	SLC35B4	1.01	10.44	0.76	1.77e-16	Mean platelet volume;
SKCM	cis	rs28595532	0.920	rs115076001	chr4:119764346	T/G	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs75920871	0.588	rs7118591	chr11:116908457	A/C	cg01368799	chr11:117014884	PAFAH1B2	0.65	5.08	0.5	2.55e-6	Subjective well-being;
SKCM	cis	rs67311347	0.544	rs1902073	chr3:40333497	C/T	cg00656387	chr3:40428638	ENTPD3	0.56	5.01	0.49	3.25e-6	Renal cell carcinoma;
SKCM	cis	rs4808199	0.948	rs7250368	chr19:19452763	G/A	cg03709012	chr19:19516395	GATAD2A	1.1	7.71	0.66	3.45e-11	Nonalcoholic fatty liver disease;
SKCM	cis	rs11098499	0.863	rs36040693	chr4:120477616	A/G	cg09307838	chr4:120376055	NA	1.0	8.27	0.68	2.8e-12	Corneal astigmatism;
SKCM	cis	rs867186	1.000	rs6060236	chr20:33692618	C/A	cg04194272	chr20:33683537	NA	-1.21	-6.8	-0.61	1.89e-9	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs2836950	0.501	rs4818019	chr21:40694456	T/A	cg17971929	chr21:40555470	PSMG1	-0.65	-5.15	-0.5	1.91e-6	Menarche (age at onset);
SKCM	cis	rs10089	1.000	rs13355233	chr5:127425350	A/G	cg25462716	chr5:127418816	SLC12A2;FLJ33630	-0.93	-8.68	-0.7	4.5e-13	Ileal carcinoids;
SKCM	cis	rs28386778	0.897	rs968719	chr17:61908271	C/T	cg06873352	chr17:61820015	STRADA	0.75	6.19	0.57	2.57e-8	Prudent dietary pattern;
SKCM	cis	rs10769945	0.538	rs739906	chr11:1980568	T/C	cg23202291	chr11:1979235	NA	-0.64	-5.98	-0.56	6.24e-8	DNA methylation (variation);
SKCM	cis	rs28386778	0.901	rs2665855	chr17:61965143	A/G	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.07	9.95	0.75	1.57e-15	Prudent dietary pattern;
SKCM	cis	rs875971	0.862	rs4718383	chr7:66108409	T/C	cg11764359	chr7:65958608	NA	-0.74	-6.63	-0.6	3.89e-9	Aortic root size;
SKCM	cis	rs2242194	0.816	rs2242193	chr1:154995503	A/G	cg06221963	chr1:154839813	KCNN3	0.53	5.33	0.52	9.25e-7	Schizophrenia;
SKCM	cis	rs2991971	0.810	rs2356413	chr1:45914048	A/T	cg24296786	chr1:45957014	TESK2	-0.63	-5.01	-0.49	3.28e-6	High light scatter reticulocyte count;
SKCM	cis	rs3768617	0.546	rs2296296	chr1:183105399	C/G	ch.1.3577855R	chr1:183094577	LAMC1	0.72	6.6	0.6	4.42e-9	Fuchs's corneal dystrophy;
SKCM	cis	rs6977660	1.000	rs4719584	chr7:19823388	T/C	cg05791153	chr7:19748676	TWISTNB	0.79	5.34	0.52	9.05e-7	Thyroid stimulating hormone;
SKCM	cis	rs7428	0.527	rs1053560	chr2:85546192	C/T	cg24342717	chr2:85555507	TGOLN2	-0.61	-4.78	-0.48	8.12e-6	Ear protrusion;
SKCM	cis	rs35079168	0.923	rs12115573	chr9:137288782	G/A	cg00753924	chr9:137298813	RXRA	-0.75	-5.07	-0.5	2.57e-6	Intelligence;
SKCM	cis	rs2013441	1.000	rs8074047	chr17:20176703	G/A	cg13482628	chr17:19912719	NA	-0.64	-5.04	-0.5	2.94e-6	Obesity-related traits;
SKCM	cis	rs1401999	1.000	rs13317532	chr3:183641669	G/C	cg01324343	chr3:183735012	ABCC5	0.89	10.15	0.75	6.59e-16	Anterior chamber depth;
SKCM	cis	rs1405130	0.869	rs11687171	chr2:235566512	A/G	cg17841421	chr2:235704848	NA	-0.57	-4.95	-0.49	4.14e-6	Coronary artery disease;
SKCM	cis	rs13256369	0.802	rs11249884	chr8:8561552	C/T	cg15556689	chr8:8085844	FLJ10661	-0.65	-4.87	-0.48	5.76e-6	Obesity-related traits;
SKCM	cis	rs9581857	0.556	rs1885991	chr13:28040470	G/A	cg22138327	chr13:27999177	GTF3A	0.71	5.36	0.52	8.12e-7	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs7618501	0.633	rs2252833	chr3:50004209	C/T	cg24110177	chr3:50126178	RBM5	-0.6	-5.11	-0.5	2.25e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs11098499	0.863	rs7657849	chr4:120455494	T/C	cg09307838	chr4:120376055	NA	0.97	7.66	0.66	4.19e-11	Corneal astigmatism;
SKCM	cis	rs4803468	1.000	rs284655	chr19:41928765	C/T	cg14132834	chr19:41945861	ATP5SL	-0.77	-6.04	-0.56	4.87e-8	Height;
SKCM	cis	rs11098499	0.657	rs9996569	chr4:120299004	G/C	cg09307838	chr4:120376055	NA	0.97	7.49	0.65	9.08e-11	Corneal astigmatism;
SKCM	cis	rs4319547	0.661	rs10846830	chr12:122897220	C/G	cg23029597	chr12:123009494	RSRC2	-0.73	-5.37	-0.52	7.93e-7	Body mass index;
SKCM	cis	rs1062177	1.000	rs12515762	chr5:151209922	G/T	cg00977110	chr5:151150581	G3BP1	0.84	6.56	0.6	5.32e-9	Preschool internalizing problems;
SKCM	cis	rs9325144	0.650	rs6582631	chr12:38744135	T/C	cg26384229	chr12:38710491	ALG10B	0.78	6.83	0.61	1.68e-9	Morning vs. evening chronotype;
SKCM	cis	rs367615	0.552	rs3828603	chr5:108712068	G/C	cg17395555	chr5:108820864	NA	-0.64	-5.22	-0.51	1.45e-6	Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs2032447	0.832	rs10425	chr6:26056549	A/G	cg18357526	chr6:26021779	HIST1H4A	0.84	7.36	0.64	1.59e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs2204008	0.627	rs1851117	chr12:38398987	G/T	cg26384229	chr12:38710491	ALG10B	0.82	6.3	0.58	1.6e-8	Bladder cancer;
SKCM	cis	rs7618501	0.633	rs4688755	chr3:50064424	G/A	cg05072774	chr3:49840536	C3orf54	0.68	5.06	0.5	2.67e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs4819052	0.885	rs9980676	chr21:46665430	A/G	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.42	0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs151997	0.777	rs3846500	chr5:50254488	A/T	cg06027927	chr5:50259733	NA	-0.66	-6.04	-0.56	4.89e-8	Callous-unemotional behaviour;
SKCM	cis	rs8017423	0.967	rs6575117	chr14:90715412	G/A	cg04374321	chr14:90722782	PSMC1	0.99	9.18	0.72	4.75e-14	Mortality in heart failure;
SKCM	cis	rs7809950	1.000	rs3801944	chr7:107255548	T/C	cg23024343	chr7:107201750	COG5	0.87	7.95	0.67	1.17e-11	Coronary artery disease;
SKCM	cis	rs2354432	0.714	rs7531962	chr1:146746023	G/A	cg25205988	chr1:146714368	CHD1L	-1.13	-8.09	-0.68	6.43e-12	Mitochondrial DNA levels;
SKCM	cis	rs763014	0.931	rs11648728	chr16:635525	C/T	cg09263875	chr16:632152	PIGQ	0.67	5.82	0.55	1.24e-7	Height;
SKCM	cis	rs10256972	0.567	rs2960850	chr7:1211649	A/G	cg09177884	chr7:1199841	ZFAND2A	-0.74	-5.96	-0.56	6.8e-8	Longevity;Endometriosis;
SKCM	cis	rs1062177	1.000	rs2915882	chr5:151145436	T/C	cg00977110	chr5:151150581	G3BP1	0.81	6.32	0.58	1.51e-8	Preschool internalizing problems;
SKCM	cis	rs4925386	0.802	rs6142735	chr20:60918087	G/C	cg24112000	chr20:60950667	NA	-0.74	-7.01	-0.62	7.4e-10	Colorectal cancer;Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs870825	0.616	rs7678949	chr4:185635018	G/C	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs1799949	1.000	rs35330014	chr17:41212547	C/T	cg23758822	chr17:41437982	NA	0.94	7.89	0.67	1.51e-11	Menopause (age at onset);
SKCM	cis	rs34172651	0.517	rs2303083	chr16:24835168	G/A	cg00339695	chr16:24857497	SLC5A11	0.68	4.93	0.49	4.55e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7937682	0.855	rs539553	chr11:111477333	C/T	cg19812747	chr11:111475976	SIK2	-0.56	-4.98	-0.49	3.66e-6	Primary sclerosing cholangitis;
SKCM	cis	rs992157	0.798	rs7557709	chr2:219167529	G/A	cg00012203	chr2:219082015	ARPC2	0.73	5.72	0.54	1.84e-7	Colorectal cancer;
SKCM	cis	rs7809950	0.954	rs2894466	chr7:107242909	G/A	cg23024343	chr7:107201750	COG5	0.84	7.72	0.66	3.23e-11	Coronary artery disease;
SKCM	cis	rs854765	0.583	rs2350977	chr17:17802779	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.95	6.79	0.61	1.95e-9	Total body bone mineral density;
SKCM	cis	rs28386778	0.897	rs2584639	chr17:61863732	C/T	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs12986445	0.947	rs6728684	chr2:26150773	T/G	cg07291958	chr2:26785531	C2orf70	0.58	5.33	0.52	9.25e-7	Multiple myeloma and monoclonal gammopathy;Multiple myeloma;
SKCM	cis	rs34779708	0.966	rs17499247	chr10:35426755	A/G	cg03585969	chr10:35415529	CREM	0.74	6.04	0.56	4.96e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs7954584	0.567	rs11043243	chr12:122356370	G/C	cg22618164	chr12:122356400	WDR66	0.54	5.44	0.52	6.05e-7	Mean corpuscular volume;
SKCM	cis	rs6879260	0.963	rs11738924	chr5:179727308	A/G	cg13944838	chr5:179740914	GFPT2	-0.74	-5.63	-0.54	2.77e-7	Height;
SKCM	cis	rs17376456	0.877	rs13153245	chr5:93374891	G/A	cg21475434	chr5:93447410	FAM172A	0.95	5.36	0.52	8.36e-7	Diabetic retinopathy;
SKCM	cis	rs6952808	0.656	rs73048919	chr7:2103637	C/A	cg21782813	chr7:2030301	MAD1L1	0.56	5.86	0.55	1.05e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs514406	0.825	rs3863643	chr1:53224577	C/T	cg16325326	chr1:53192061	ZYG11B	-1.01	-11.9	-0.8	3.23e-19	Monocyte count;
SKCM	cis	rs4466137	0.868	rs4703962	chr5:82999808	A/G	cg16102102	chr5:83017553	HAPLN1	-0.55	-6.02	-0.56	5.28e-8	Prostate cancer;
SKCM	cis	rs7659604	1.000	rs10016433	chr4:122664771	A/G	cg19671926	chr4:122722719	EXOSC9	-0.64	-4.78	-0.48	8.04e-6	Type 2 diabetes;
SKCM	cis	rs7618915	0.547	rs12496634	chr3:52709259	A/C	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs875971	0.862	rs9791712	chr7:66105163	C/G	cg18876405	chr7:65276391	NA	-0.63	-6.32	-0.58	1.5e-8	Aortic root size;
SKCM	cis	rs796364	0.950	rs188146	chr2:200750444	C/T	cg12253985	chr2:200820533	C2orf60;C2orf47	0.85	5.39	0.52	7.18e-7	Schizophrenia;
SKCM	cis	rs589448	0.902	rs2603089	chr12:69776800	C/T	cg14784868	chr12:69753453	YEATS4	-0.85	-7.86	-0.66	1.79e-11	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs1799949	0.896	rs33933393	chr17:41317432	C/T	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.15	-0.57	3.16e-8	Menopause (age at onset);
SKCM	cis	rs6952808	0.609	rs12699453	chr7:1953056	C/T	cg21782813	chr7:2030301	MAD1L1	0.51	5.42	0.52	6.33e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs870825	0.655	rs2017101	chr4:185637381	G/A	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs7833790	0.963	rs10958046	chr8:82729210	A/G	cg17211192	chr8:82754475	SNX16	-0.89	-4.82	-0.48	7.03e-6	Diastolic blood pressure;
SKCM	cis	rs16854884	0.657	rs6440210	chr3:143705763	A/G	cg06585982	chr3:143692056	C3orf58	0.85	7.82	0.66	2.1e-11	Economic and political preferences (feminism/equality);
SKCM	cis	rs941873	0.868	rs7332	chr10:81114060	G/A	cg09469691	chr10:81107165	PPIF	0.71	6.8	0.61	1.89e-9	Height;
SKCM	cis	rs12142240	0.698	rs7515598	chr1:46818479	C/T	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs1957429	0.901	rs1957434	chr14:65349909	C/T	cg23373153	chr14:65346875	NA	1.11	6.32	0.58	1.52e-8	Pediatric areal bone mineral density (radius);
SKCM	cis	rs4819052	0.679	rs2838860	chr21:46684904	A/G	cg19498844	chr21:46707878	POFUT2;LOC642852	0.8	6.73	0.61	2.54e-9	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs10832963	0.847	rs4237722	chr11:18639363	T/C	cg09201001	chr11:18656081	SPTY2D1	1.02	10.81	0.77	3.53e-17	Breast cancer;
SKCM	cis	rs13424612	0.965	rs34789127	chr2:240952002	C/T	cg01812947	chr2:240904978	NDUFA10	0.65	5.02	0.49	3.23e-6	Odorant perception (isobutyraldehyde);
SKCM	cis	rs10876993	0.928	rs1689596	chr12:58053029	T/C	cg18357645	chr12:58087776	OS9	0.61	5.65	0.54	2.52e-7	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs654950	0.776	rs2759252	chr1:42021854	G/A	cg06885757	chr1:42089581	HIVEP3	-0.63	-6.32	-0.58	1.48e-8	Airway imaging phenotypes;
SKCM	cis	rs1032355	0.558	rs1491245	chr4:100534554	T/G	cg25391692	chr4:100495869	MTTP	-0.82	-4.97	-0.49	3.9e-6	Celiac disease;
SKCM	cis	rs7111031	0.866	rs2514218	chr11:113392994	A/G	cg04642306	chr11:112834466	NCAM1	0.48	5.43	0.52	6.22e-7	Subjective well-being (multi-trait analysis);Depressive symptoms (multi-trait analysis);Neuroticism;
SKCM	cis	rs1799949	1.000	rs33926631	chr17:41304463	T/C	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.15	-0.57	3.16e-8	Menopause (age at onset);
SKCM	cis	rs2842992	0.789	rs4709376	chr6:160226337	A/G	cg11366901	chr6:160182831	ACAT2	0.89	7.06	0.62	6.18e-10	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs58688157	0.705	rs7112149	chr11:595890	G/A	cg16486109	chr11:613632	IRF7	1.08	7.45	0.64	1.07e-10	Systemic lupus erythematosus;
SKCM	cis	rs6450176	1.000	rs4334836	chr5:53300835	T/C	ch.5.1024479R	chr5:53302184	ARL15	-0.71	-4.88	-0.48	5.49e-6	HDL cholesterol levels;HDL cholesterol;Adiponectin levels;
SKCM	cis	rs9311474	0.508	rs4687546	chr3:52605943	T/A	cg18404041	chr3:52824283	ITIH1	-0.53	-4.77	-0.48	8.42e-6	Electroencephalogram traits;
SKCM	cis	rs2841277	0.708	rs10083374	chr14:105402994	T/C	cg21017887	chr14:105400489	NA	0.59	5.31	0.52	1e-6	Rheumatoid arthritis;
SKCM	cis	rs854765	0.583	rs12452254	chr17:17829434	G/A	cg09796270	chr17:17721594	SREBF1	0.66	5.02	0.49	3.25e-6	Total body bone mineral density;
SKCM	cis	rs10089	1.000	rs13357268	chr5:127423051	G/A	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.91	8.39	0.69	1.67e-12	Ileal carcinoids;
SKCM	cis	rs7247513	0.859	rs35945052	chr19:12703230	G/A	cg01871581	chr19:12707946	ZNF490	-0.7	-4.91	-0.49	4.88e-6	Bipolar disorder;
SKCM	cis	rs7216064	0.953	rs4791048	chr17:65848994	G/A	cg12091567	chr17:66097778	LOC651250	-0.79	-5.72	-0.54	1.9e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs561341	1.000	rs4795670	chr17:30244839	T/C	cg23018236	chr17:30244563	NA	-0.47	-4.94	-0.49	4.29e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs7408868	1.000	rs10406754	chr19:15274201	T/A	cg14696996	chr19:15285081	NOTCH3	0.82	4.92	0.49	4.7e-6	Pulse pressure;
SKCM	cis	rs6430585	0.528	rs309151	chr2:136661150	C/T	cg07169764	chr2:136633963	MCM6	1.32	11.41	0.79	2.72e-18	Corneal structure;
SKCM	cis	rs10751667	0.621	rs11246345	chr11:934924	T/C	cg10932868	chr11:921992	NA	0.55	5.13	0.5	2.09e-6	Alzheimer's disease (late onset);
SKCM	cis	rs7772486	0.686	rs9403746	chr6:146103768	C/A	cg05347473	chr6:146136440	FBXO30	-0.56	-5.22	-0.51	1.46e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7208859	0.524	rs59923796	chr17:29064919	G/A	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs6545883	0.507	rs4672427	chr2:61469250	A/G	cg15711740	chr2:61764176	XPO1	0.64	4.88	0.48	5.56e-6	Tuberculosis;
SKCM	cis	rs12478296	0.681	rs56357900	chr2:243033966	A/C	cg06360820	chr2:242988706	NA	-0.91	-5.31	-0.52	1.01e-6	Obesity-related traits;
SKCM	cis	rs17685	0.725	rs4476928	chr7:75642107	C/A	cg01364799	chr7:75623366	TMEM120A	0.72	5.83	0.55	1.18e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1577917	0.958	rs12199832	chr6:86652748	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.66	-5.74	-0.54	1.76e-7	Response to antipsychotic treatment;
SKCM	cis	rs2153535	0.580	rs915350	chr6:8443486	A/G	cg07606381	chr6:8435919	SLC35B3	0.94	6.94	0.62	1.02e-9	Motion sickness;
SKCM	cis	rs28386778	0.897	rs2236736	chr17:61938248	G/T	cg01411255	chr17:61851458	DDX42;CCDC47	0.79	5.07	0.5	2.58e-6	Prudent dietary pattern;
SKCM	cis	rs5769765	0.819	rs9616377	chr22:50310880	T/C	cg22709217	chr22:50311962	ALG12;CRELD2	-0.94	-5.91	-0.56	8.37e-8	Schizophrenia;
SKCM	cis	rs875971	0.862	rs4718330	chr7:65715243	G/A	cg11764359	chr7:65958608	NA	-0.82	-7.9	-0.67	1.48e-11	Aortic root size;
SKCM	cis	rs10754283	0.934	rs10754284	chr1:90113702	A/C	cg21401794	chr1:90099060	LRRC8C	0.73	6.34	0.58	1.35e-8	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs4253772	0.638	rs6007845	chr22:46718417	A/T	cg03482458	chr22:46692211	CN5H6.4;GTSE1	-1.16	-5.29	-0.51	1.07e-6	LDL cholesterol;Cholesterol, total;
SKCM	cis	rs34779708	0.931	rs4934711	chr10:35360310	G/A	cg03585969	chr10:35415529	CREM	0.8	6.42	0.59	9.96e-9	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs826838	0.935	rs11169511	chr12:39175802	T/C	cg13010199	chr12:38710504	ALG10B	0.68	5.26	0.51	1.21e-6	Heart rate;
SKCM	cis	rs3785574	0.962	rs2665840	chr17:61873307	C/T	cg01411255	chr17:61851458	DDX42;CCDC47	-1.12	-12.52	-0.82	2.39e-20	Height;
SKCM	cis	rs17685	0.753	rs4573217	chr7:75733946	G/A	cg16684958	chr7:75615977	POR	0.56	5.13	0.5	2.03e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1691799	0.899	rs1168299	chr12:66736074	C/G	cg16791601	chr12:66731901	HELB	-0.66	-5.81	-0.55	1.31e-7	White blood cell count (basophil);
SKCM	cis	rs4975616	0.686	rs37011	chr5:1348798	A/T	cg06550200	chr5:1325588	CLPTM1L	-0.73	-5.92	-0.56	8.02e-8	Lung cancer;
SKCM	cis	rs9300255	0.722	rs12322888	chr12:123825559	A/G	cg00376283	chr12:123451042	ABCB9	0.82	5.67	0.54	2.35e-7	Neutrophil percentage of white cells;
SKCM	cis	rs7666738	0.791	rs7377018	chr4:99034962	C/T	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs80130819	0.515	rs1793915	chr12:48386577	G/T	cg05342945	chr12:48394962	COL2A1	-0.7	-4.92	-0.49	4.65e-6	Prostate cancer;
SKCM	cis	rs55962025	0.711	rs3856973	chr4:3080173	A/G	cg09735869	chr4:3319127	RGS12	0.59	4.84	0.48	6.49e-6	Parental longevity (mother's age at death);
SKCM	cis	rs4927850	1.000	rs6799572	chr3:195740408	C/T	cg01181863	chr3:195395398	SDHAP2	-0.84	-5.39	-0.52	7.33e-7	Pancreatic cancer;
SKCM	cis	rs9896933	0.779	rs2256316	chr17:80693805	C/G	cg20578329	chr17:80767326	TBCD	-0.91	-6.7	-0.6	2.89e-9	Bone mineral accretion in asthma (oral corticosteroid dose interaction);
SKCM	trans	rs1814175	0.645	rs7103554	chr11:50027612	G/A	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs55962025	0.711	rs363092	chr4:3196029	A/C	cg00764545	chr4:3318001	RGS12	0.6	5.21	0.51	1.52e-6	Parental longevity (mother's age at death);
SKCM	cis	rs6570726	0.577	rs399502	chr6:145805874	A/G	cg23711669	chr6:146136114	FBXO30	0.73	5.89	0.55	9.22e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs13256369	0.851	rs13255061	chr8:8563834	G/A	cg15556689	chr8:8085844	FLJ10661	0.65	4.77	0.48	8.39e-6	Obesity-related traits;
SKCM	cis	rs4689592	0.513	rs4689586	chr4:7067413	A/G	cg26116260	chr4:7069785	GRPEL1	1.21	9.51	0.73	1.09e-14	Monocyte percentage of white cells;
SKCM	cis	rs12134245	0.776	rs61548854	chr1:92001536	C/T	cg25838465	chr1:92012736	NA	-0.84	-8.87	-0.71	1.92e-13	Breast cancer;
SKCM	cis	rs1957429	0.901	rs1467570	chr14:65347858	A/G	cg23373153	chr14:65346875	NA	1.11	6.32	0.58	1.52e-8	Pediatric areal bone mineral density (radius);
SKCM	cis	rs870825	0.616	rs7668009	chr4:185641998	A/C	cg04058563	chr4:185651563	MLF1IP	1.09	7.26	0.63	2.53e-10	Blood protein levels;
SKCM	cis	rs854765	0.583	rs5002487	chr17:17832460	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.94	7.14	0.63	4.31e-10	Total body bone mineral density;
SKCM	trans	rs1814175	0.645	rs28634872	chr11:50042175	T/A	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs13392177	0.543	rs12623716	chr2:219073018	C/T	cg00012203	chr2:219082015	ARPC2	-0.65	-4.95	-0.49	4.22e-6	Pyoderma gangrenosum in inflammatory bowel disease;
SKCM	cis	rs9910055	0.683	rs7220138	chr17:42254011	C/G	cg10896456	chr17:42255109	ASB16;C17orf65	0.68	7.28	0.64	2.25e-10	Total body bone mineral density;
SKCM	cis	rs4555082	0.794	rs2735829	chr14:105708472	C/T	cg13114125	chr14:105738426	BRF1	-0.69	-5.7	-0.54	2.07e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs2228479	0.850	rs11640188	chr16:89807732	C/T	cg00800038	chr16:89945340	TCF25	-0.81	-4.79	-0.48	7.84e-6	Skin colour saturation;
SKCM	cis	rs7927771	0.524	rs10742824	chr11:47864842	C/T	cg20307385	chr11:47447363	PSMC3	0.71	5.63	0.54	2.67e-7	Subjective well-being;
SKCM	cis	rs16854884	0.632	rs1466941	chr3:143670131	A/G	cg06585982	chr3:143692056	C3orf58	0.84	8.2	0.68	3.88e-12	Economic and political preferences (feminism/equality);
SKCM	cis	rs11719291	0.833	rs34037363	chr3:48821036	C/T	cg24898236	chr3:49228699	LOC646498	0.65	4.98	0.49	3.66e-6	Cognitive function;
SKCM	cis	rs10085978	0.781	rs13280419	chr8:143225596	G/A	cg08860119	chr8:143695901	ARC	-0.77	-5.33	-0.52	9.09e-7	Mosquito bite size;
SKCM	cis	rs7772486	0.624	rs9485018	chr6:146025731	T/C	cg05347473	chr6:146136440	FBXO30	-0.55	-4.85	-0.48	6.14e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs13256369	0.756	rs13280759	chr8:8562995	G/T	cg06636001	chr8:8085503	FLJ10661	0.8	6.11	0.57	3.65e-8	Obesity-related traits;
SKCM	cis	rs2013441	1.000	rs2013576	chr17:20167692	G/C	cg13482628	chr17:19912719	NA	-0.64	-5.04	-0.5	2.94e-6	Obesity-related traits;
SKCM	cis	rs10871290	1.000	rs10871290	chr16:74472696	C/T	cg01733217	chr16:74700730	RFWD3	-0.66	-5.19	-0.51	1.64e-6	Breast cancer;
SKCM	cis	rs10256972	0.577	rs6962809	chr7:1208889	A/G	cg16145915	chr7:1198662	ZFAND2A	-0.59	-8.25	-0.68	3.07e-12	Longevity;Endometriosis;
SKCM	cis	rs175714	0.845	rs175706	chr14:75976200	G/A	cg01624173	chr14:75981868	NA	0.5	5.13	0.5	2.03e-6	Lymphocyte counts;
SKCM	cis	rs2832191	0.967	rs1999321	chr21:30530233	A/C	cg24692254	chr21:30365293	RNF160	0.76	6.81	0.61	1.81e-9	Dental caries;
SKCM	cis	rs1843834	0.539	rs10177898	chr2:225437552	C/T	cg22455342	chr2:225449267	CUL3	0.74	5.46	0.53	5.52e-7	IgE levels in asthmatics (D.p. specific);
SKCM	cis	rs1784581	0.546	rs1954917	chr6:162447490	C/T	cg17173639	chr6:162384350	PARK2	0.58	4.97	0.49	3.83e-6	Itch intensity from mosquito bite;
SKCM	cis	rs1185460	0.967	rs4545564	chr11:118937518	T/C	cg23280166	chr11:118938394	VPS11	0.59	5.41	0.52	6.78e-7	Coronary artery disease;
SKCM	cis	rs4237845	0.537	rs10747786	chr12:58260601	G/T	cg02175503	chr12:58329896	NA	0.73	5.99	0.56	5.98e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs3091242	0.933	rs11249251	chr1:25770188	C/G	cg02931644	chr1:25747376	RHCE	0.5	4.9	0.48	5.17e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs9913156	0.789	rs55999196	chr17:4600655	A/G	cg19197139	chr17:4613644	ARRB2	0.8	5.34	0.52	8.82e-7	Lymphocyte counts;
SKCM	cis	rs1707322	1.000	rs785507	chr1:46541558	C/T	cg03146154	chr1:46216737	IPP	-0.82	-5.41	-0.52	6.73e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs2991971	0.810	rs6657237	chr1:45920108	A/T	cg24296786	chr1:45957014	TESK2	-0.63	-5.13	-0.5	2.09e-6	High light scatter reticulocyte count;
SKCM	cis	rs9880211	1.000	rs6768743	chr3:136205007	C/T	cg21827317	chr3:136751795	NA	0.65	4.92	0.49	4.73e-6	Body mass index;Height;
SKCM	cis	rs2153535	0.580	rs7341383	chr6:8470634	A/C	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs6834538	0.597	rs10022515	chr4:113537710	G/A	cg05166686	chr4:113558556	LARP7;C4orf21	0.63	5.2	0.51	1.56e-6	Free thyroxine concentration;
SKCM	cis	rs11098499	0.863	rs2291185	chr4:120434833	C/A	cg09307838	chr4:120376055	NA	0.99	7.71	0.66	3.45e-11	Corneal astigmatism;
SKCM	cis	rs2243480	0.711	rs2460426	chr7:65623129	A/G	cg18252515	chr7:66147081	NA	1.34	8.14	0.68	5.02e-12	Diabetic kidney disease;
SKCM	cis	rs763121	0.853	rs3747174	chr22:39069181	T/C	cg06022373	chr22:39101656	GTPBP1	0.8	5.85	0.55	1.1e-7	Menopause (age at onset);
SKCM	cis	rs1707322	1.000	rs6672115	chr1:46272879	T/C	cg03146154	chr1:46216737	IPP	0.74	5.0	0.49	3.39e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs9810089	0.527	rs838199	chr3:135950090	T/C	cg21827317	chr3:136751795	NA	0.63	5.05	0.5	2.8e-6	Gestational age at birth (child effect);
SKCM	cis	rs7659604	0.840	rs6821305	chr4:122713863	A/C	cg20573242	chr4:122745356	CCNA2	0.63	5.11	0.5	2.22e-6	Type 2 diabetes;
SKCM	trans	rs1814175	0.765	rs1721990	chr11:49912154	G/C	cg03929089	chr4:120376271	NA	-0.88	-8.05	-0.67	7.47e-12	Height;
SKCM	cis	rs1707322	0.721	rs12037803	chr1:46156492	A/G	cg03146154	chr1:46216737	IPP	0.84	6.2	0.57	2.51e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs8053891	0.502	rs34679758	chr16:71995427	A/G	cg04254540	chr16:71951199	KIAA0174	-1.1	-6.0	-0.56	5.8e-8	Coronary artery disease;
SKCM	cis	rs10489202	1.000	rs7523437	chr1:168029365	A/G	cg24449463	chr1:168025552	DCAF6	-0.79	-6.18	-0.57	2.73e-8	Schizophrenia;
SKCM	cis	rs1577917	1.000	rs12204015	chr6:86598334	C/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.77	-0.66	2.59e-11	Response to antipsychotic treatment;
SKCM	cis	rs55823223	0.504	rs56098714	chr17:73860303	T/C	cg08125733	chr17:73851984	WBP2	1.06	6.07	0.57	4.35e-8	Psoriasis;
SKCM	cis	rs4969178	0.965	rs16971105	chr17:76393975	G/T	cg20026190	chr17:76395443	PGS1	0.63	5.45	0.53	5.6e-7	HDL cholesterol levels;
SKCM	cis	rs875971	0.862	rs10256544	chr7:65675128	A/G	cg18876405	chr7:65276391	NA	0.63	6.49	0.59	7.1e-9	Aortic root size;
SKCM	cis	rs13256369	1.000	rs4840351	chr8:8573148	A/G	cg06636001	chr8:8085503	FLJ10661	0.74	5.69	0.54	2.15e-7	Obesity-related traits;
SKCM	cis	rs3820928	1.000	rs7579961	chr2:227776976	T/A	cg11843606	chr2:227700838	RHBDD1	-0.61	-4.88	-0.48	5.44e-6	Pulmonary function;
SKCM	cis	rs4253772	0.591	rs8143066	chr22:46656607	C/T	cg03482458	chr22:46692211	CN5H6.4;GTSE1	1.13	5.41	0.52	6.8e-7	LDL cholesterol;Cholesterol, total;
SKCM	cis	rs561341	0.660	rs7406043	chr17:30220152	C/G	cg00745463	chr17:30367425	LRRC37B	-1.0	-6.56	-0.6	5.45e-9	Hip circumference adjusted for BMI;
SKCM	cis	rs66569888	0.507	rs11673736	chr2:106886935	T/C	cg23109721	chr2:106886537	NA	-0.68	-5.09	-0.5	2.4e-6	Facial morphology (factor 23);
SKCM	cis	rs5753618	0.509	rs5749224	chr22:31558549	C/T	cg02404636	chr22:31891804	SFI1	-0.57	-4.78	-0.48	8.03e-6	Colorectal cancer;
SKCM	cis	rs9303401	0.659	rs17822735	chr17:56620167	C/T	cg02118635	chr17:56770003	RAD51C;TEX14	0.8	5.51	0.53	4.41e-7	Cognitive test performance;
SKCM	cis	rs769267	1.000	rs1009136	chr19:19440428	A/G	cg03709012	chr19:19516395	GATAD2A	-0.79	-6.37	-0.59	1.19e-8	Tonsillectomy;
SKCM	cis	rs7103648	0.897	rs11606287	chr11:47407439	C/A	cg03711944	chr11:47377212	SPI1	-0.57	-5.07	-0.5	2.6e-6	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs9325144	0.560	rs1843910	chr12:38677408	T/C	cg26384229	chr12:38710491	ALG10B	-0.62	-4.79	-0.48	7.74e-6	Morning vs. evening chronotype;
SKCM	cis	rs7772486	0.790	rs9497424	chr6:146225271	C/A	cg23711669	chr6:146136114	FBXO30	-0.78	-7.7	-0.66	3.53e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6430585	0.528	rs309158	chr2:136680534	A/G	cg07169764	chr2:136633963	MCM6	1.26	10.86	0.78	2.87e-17	Corneal structure;
SKCM	cis	rs11690935	1.000	rs6757773	chr2:172549630	T/A	cg13550731	chr2:172543902	DYNC1I2	0.98	9.01	0.71	1.01e-13	Schizophrenia;
SKCM	cis	rs9894429	1.000	rs4074916	chr17:79579248	G/A	cg18240062	chr17:79603768	NPLOC4	-0.76	-7.43	-0.64	1.2e-10	Eye color traits;
SKCM	cis	rs6570726	0.755	rs451699	chr6:145830594	C/G	cg23711669	chr6:146136114	FBXO30	0.79	7.93	0.67	1.26e-11	Lobe attachment (rater-scored or self-reported);
SKCM	trans	rs1814175	0.645	rs12364337	chr11:49942580	A/T	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs55962025	0.842	rs363088	chr4:3210330	A/T	cg05297308	chr4:3317976	RGS12	-0.68	-4.93	-0.49	4.49e-6	Parental longevity (mother's age at death);
SKCM	cis	rs1862618	0.713	rs832549	chr5:56183542	C/T	cg12311346	chr5:56204834	C5orf35	-0.78	-5.03	-0.49	3.08e-6	Initial pursuit acceleration;
SKCM	cis	rs478304	0.651	rs78412025	chr11:65495696	T/C	cg17480646	chr11:65405466	SIPA1	-0.71	-5.64	-0.54	2.62e-7	Acne (severe);
SKCM	cis	rs763014	0.865	rs2018789	chr16:632051	T/C	cg09263875	chr16:632152	PIGQ	0.67	5.82	0.55	1.24e-7	Height;
SKCM	cis	rs28595532	0.920	rs116717907	chr4:119762568	A/G	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs6570726	0.905	rs452770	chr6:145847162	T/C	cg23711669	chr6:146136114	FBXO30	0.7	6.71	0.61	2.78e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9905704	0.624	rs4932691	chr17:57094617	T/C	cg05425664	chr17:57184151	TRIM37	0.58	4.8	0.48	7.36e-6	Testicular germ cell tumor;
SKCM	cis	rs1707322	0.717	rs1135812	chr1:46095272	T/C	cg03146154	chr1:46216737	IPP	0.8	5.57	0.53	3.52e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs2730245	0.550	rs2657364	chr7:158683825	T/C	cg24397884	chr7:158709396	WDR60	0.76	5.88	0.55	9.57e-8	Height;
SKCM	cis	rs9790314	0.723	rs12631850	chr3:160883062	C/T	cg03342759	chr3:160939853	NMD3	0.65	6.3	0.58	1.63e-8	Morning vs. evening chronotype;
SKCM	cis	rs4891159	0.548	rs10782013	chr18:74128348	C/T	cg24786174	chr18:74118243	ZNF516	0.79	8.44	0.69	1.31e-12	Longevity;
SKCM	cis	rs7020830	0.789	rs17408112	chr9:37114065	A/G	cg14294708	chr9:37120828	ZCCHC7	1.08	9.76	0.74	3.58e-15	Schizophrenia;
SKCM	cis	rs9902453	0.765	rs8071576	chr17:28188554	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.83	6.37	0.59	1.2e-8	Coffee consumption (cups per day);
SKCM	cis	rs2836974	0.644	rs7281853	chr21:40693490	A/G	cg11890956	chr21:40555474	PSMG1	-0.8	-7.04	-0.62	6.66e-10	Cognitive function;
SKCM	cis	rs9640161	0.830	rs35840727	chr7:150063204	A/G	cg10018233	chr7:150070692	REPIN1	0.71	6.26	0.58	1.91e-8	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs780096	0.526	rs7602534	chr2:27592423	C/T	cg05696406	chr2:27599888	SNX17	0.5	5.12	0.5	2.12e-6	Total body bone mineral density;
SKCM	cis	rs6430585	0.528	rs309152	chr2:136657252	C/T	cg07169764	chr2:136633963	MCM6	-1.23	-8.26	-0.68	2.92e-12	Corneal structure;
SKCM	cis	rs992157	0.965	rs13427681	chr2:219167563	G/C	cg20019365	chr2:219134978	PNKD;AAMP	0.75	6.89	0.61	1.3e-9	Colorectal cancer;
SKCM	cis	rs11122272	0.766	rs2808614	chr1:231550168	A/G	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	0.66	5.49	0.53	4.82e-7	Hemoglobin concentration;
SKCM	trans	rs561341	0.883	rs1034627	chr17:30219569	C/T	cg20587970	chr11:113659929	NA	-1.03	-7.96	-0.67	1.13e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs2153535	0.580	rs6938071	chr6:8464845	A/T	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs1799949	1.000	rs12936816	chr17:41301709	C/T	cg23758822	chr17:41437982	NA	0.92	7.8	0.66	2.3e-11	Menopause (age at onset);
SKCM	cis	rs1348850	0.598	rs1405717	chr2:178500101	G/T	cg02961200	chr2:178257176	LOC100130691;AGPS	0.74	4.97	0.49	3.9e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs9902453	0.765	rs2729436	chr17:28120670	C/G	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.81	-6.26	-0.58	1.93e-8	Coffee consumption (cups per day);
SKCM	cis	rs2120019	1.000	rs7168680	chr15:75369212	G/A	cg09165964	chr15:75287851	SCAMP5	-0.78	-6.63	-0.6	3.95e-9	Blood trace element (Zn levels);
SKCM	cis	rs3820928	0.874	rs10183633	chr2:227887828	A/G	cg11843606	chr2:227700838	RHBDD1	-0.62	-5.15	-0.5	1.87e-6	Pulmonary function;
SKCM	cis	rs763014	0.931	rs710925	chr16:633354	G/A	cg07343612	chr16:622815	PIGQ	-0.7	-6.0	-0.56	5.84e-8	Height;
SKCM	cis	rs12474201	1.000	rs12474201	chr2:46921285	C/T	cg06386533	chr2:46925753	SOCS5	0.99	9.18	0.72	4.76e-14	Height;
SKCM	cis	rs8067545	0.611	rs2526482	chr17:20119133	C/T	cg13482628	chr17:19912719	NA	-0.66	-5.59	-0.53	3.23e-7	Schizophrenia;
SKCM	cis	rs9926296	0.533	rs12102290	chr16:89812617	C/T	cg04287289	chr16:89883240	FANCA	1.01	12.78	0.82	8.21e-21	Vitiligo;
SKCM	cis	rs2839186	0.872	rs13052495	chr21:47707474	G/A	cg05896524	chr21:47604654	C21orf56	0.69	5.67	0.54	2.29e-7	Testicular germ cell tumor;
SKCM	cis	rs9388451	0.591	rs1268792	chr6:126042124	G/A	cg05901451	chr6:126070800	HEY2	0.76	6.8	0.61	1.92e-9	Brugada syndrome;
SKCM	cis	rs7666738	0.830	rs1559859	chr4:99024325	C/T	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4888262	0.526	rs8055803	chr16:74615190	A/G	cg01733217	chr16:74700730	RFWD3	0.91	7.17	0.63	3.79e-10	Testicular germ cell tumor;
SKCM	cis	rs7772486	0.624	rs6930154	chr6:146025662	C/T	cg05347473	chr6:146136440	FBXO30	-0.56	-4.99	-0.49	3.55e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7829975	0.557	rs7816427	chr8:8545884	T/C	cg06636001	chr8:8085503	FLJ10661	-0.68	-5.1	-0.5	2.34e-6	Mood instability;
SKCM	cis	rs1912528	0.783	rs769663	chr4:140868446	G/A	cg11128457	chr4:140864437	MAML3	0.62	5.31	0.52	1e-6	Educational attainment (years of education);
SKCM	cis	rs2033711	0.870	rs3764534	chr19:58929136	G/A	cg00825309	chr19:58991885	ZNF446	-0.69	-5.59	-0.53	3.19e-7	Uric acid clearance;
SKCM	cis	rs11148252	0.508	rs11148260	chr13:53162643	A/C	cg00495681	chr13:53174319	NA	0.66	5.24	0.51	1.31e-6	Lewy body disease;
SKCM	cis	rs1095368	0.622	rs36108296	chr10:13388644	G/C	cg25835351	chr10:13388524	SEPHS1	-0.37	-4.77	-0.48	8.48e-6	IgG glycosylation;
SKCM	cis	rs79349575	0.716	rs595767	chr17:46957987	A/G	cg16584676	chr17:46985605	UBE2Z	0.72	4.96	0.49	4.03e-6	Type 2 diabetes;
SKCM	cis	rs34779708	0.931	rs12773169	chr10:35366462	G/C	cg03585969	chr10:35415529	CREM	0.78	6.3	0.58	1.6e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs1862618	0.853	rs252916	chr5:56121788	G/C	cg12311346	chr5:56204834	C5orf35	-0.7	-4.88	-0.48	5.48e-6	Initial pursuit acceleration;
SKCM	cis	rs760805	1.000	rs10903115	chr1:25261696	A/G	cg22509179	chr1:25234806	RUNX3	-0.7	-5.64	-0.54	2.62e-7	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs17270561	0.779	rs17271767	chr6:25886921	C/T	cg17691542	chr6:26056736	HIST1H1C	0.92	5.61	0.54	2.92e-7	Iron status biomarkers;
SKCM	trans	rs1814175	0.817	rs28679516	chr11:50055998	G/A	cg15704280	chr7:45808275	SEPT13	-1.05	-11.15	-0.78	8.22e-18	Height;
SKCM	cis	rs8078723	1.000	rs4795418	chr17:38164851	T/C	cg17467752	chr17:38218738	THRA	0.68	6.3	0.58	1.61e-8	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs16854884	1.000	rs34730687	chr3:143813193	A/G	cg06585982	chr3:143692056	C3orf58	0.73	5.4	0.52	6.86e-7	Economic and political preferences (feminism/equality);
SKCM	cis	rs4900538	0.827	rs3742444	chr14:102971050	T/G	cg18135206	chr14:102964638	TECPR2	0.71	5.7	0.54	2.06e-7	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs17376456	0.877	rs17316137	chr5:93456577	C/T	cg25358565	chr5:93447407	FAM172A	1.19	8.42	0.69	1.44e-12	Diabetic retinopathy;
SKCM	cis	rs2153535	0.580	rs1414345	chr6:8471537	T/G	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs7666738	0.830	rs13144564	chr4:98939276	A/G	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7666738	0.830	rs9994346	chr4:99037986	A/G	cg05340658	chr4:99064831	C4orf37	0.7	5.18	0.51	1.7e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs344364	0.511	rs1742468	chr16:1950243	C/G	cg26897989	chr16:1907736	C16orf73	-0.69	-7.13	-0.63	4.45e-10	Glomerular filtration rate in chronic kidney disease;
SKCM	cis	rs362272	0.524	rs7435601	chr4:3369645	A/G	cg05297308	chr4:3317976	RGS12	1.06	12.67	0.82	1.27e-20	Serum sulfate level;
SKCM	cis	rs1218582	0.710	rs4845687	chr1:154878911	A/G	cg03351412	chr1:154909251	PMVK	0.77	6.28	0.58	1.8e-8	Prostate cancer;
SKCM	cis	rs3768617	0.510	rs1413387	chr1:183096774	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs155076	0.711	rs9550724	chr13:21885030	G/T	cg14456004	chr13:21872349	NA	1.38	8.99	0.71	1.13e-13	White matter hyperintensity burden;
SKCM	cis	rs1348850	0.793	rs6736390	chr2:178480314	T/C	cg02961200	chr2:178257176	LOC100130691;AGPS	0.77	5.09	0.5	2.39e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs6121246	0.559	rs1484994	chr20:30305975	A/G	cg13852791	chr20:30311386	BCL2L1	0.82	5.69	0.54	2.09e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs1032355	0.558	rs2035815	chr4:100508544	T/C	cg25391692	chr4:100495869	MTTP	-0.82	-4.97	-0.49	3.9e-6	Celiac disease;
SKCM	cis	rs7666738	0.830	rs732299	chr4:98995389	C/T	cg05340658	chr4:99064831	C4orf37	0.67	5.14	0.5	1.98e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2749592	0.550	rs4934881	chr10:37914346	A/C	cg00409905	chr10:38381863	ZNF37A	0.58	5.45	0.53	5.65e-7	Age-related hearing impairment (SNP x SNP interaction);
SKCM	cis	rs748404	0.660	rs518288	chr15:43763999	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	0.72	5.54	0.53	3.99e-7	Lung cancer;
SKCM	cis	rs7511006	0.858	rs2294399	chr22:50644969	G/A	cg16473166	chr22:50639996	SELO	0.65	5.32	0.52	9.66e-7	Obesity-related traits;
SKCM	cis	rs10256972	0.577	rs2949179	chr7:1209885	C/G	cg16145915	chr7:1198662	ZFAND2A	-0.66	-9.98	-0.75	1.35e-15	Longevity;Endometriosis;
SKCM	cis	rs769267	0.895	rs1858999	chr19:19497669	C/G	cg03709012	chr19:19516395	GATAD2A	-0.88	-8.22	-0.68	3.5e-12	Tonsillectomy;
SKCM	cis	rs870825	0.929	rs10027213	chr4:185579871	C/G	cg04058563	chr4:185651563	MLF1IP	1.03	5.09	0.5	2.4e-6	Blood protein levels;
SKCM	cis	rs6545883	0.929	rs2421203	chr2:61669248	C/A	cg15711740	chr2:61764176	XPO1	-0.68	-4.92	-0.49	4.76e-6	Tuberculosis;
SKCM	cis	rs13010713	0.840	rs10153661	chr2:182031799	G/A	cg21995919	chr2:182322279	ITGA4	-0.56	-5.38	-0.52	7.61e-7	Celiac disease;
SKCM	cis	rs2033711	0.905	rs893186	chr19:58969179	C/A	cg00825309	chr19:58991885	ZNF446	-0.71	-5.92	-0.56	8.33e-8	Uric acid clearance;
SKCM	cis	rs2228479	0.681	rs7199685	chr16:89959805	G/C	cg00800038	chr16:89945340	TCF25	-0.93	-5.57	-0.53	3.49e-7	Skin colour saturation;
SKCM	cis	rs7208859	0.623	rs216436	chr17:28922900	G/A	cg14067834	chr17:29058358	SUZ12P	1.07	4.82	0.48	6.93e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs7106204	0.590	rs28864378	chr11:24206582	C/A	ch.11.24196551F	chr11:24239977	NA	0.8	6.25	0.58	2e-8	Response to Homoharringtonine (cytotoxicity);
SKCM	cis	rs763121	0.853	rs5750659	chr22:39068789	T/C	cg06022373	chr22:39101656	GTPBP1	0.8	5.85	0.55	1.1e-7	Menopause (age at onset);
SKCM	cis	rs35306767	0.807	rs34885925	chr10:919032	G/C	cg26597838	chr10:835615	NA	0.79	5.57	0.53	3.5e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs2153535	0.580	rs1335628	chr6:8491742	A/T	cg07606381	chr6:8435919	SLC35B3	0.86	6.25	0.58	2.06e-8	Motion sickness;
SKCM	cis	rs35146811	0.961	rs35991721	chr7:99728790	G/T	cg13334819	chr7:99746414	C7orf59	-0.71	-5.14	-0.5	2.02e-6	Coronary artery disease;
SKCM	cis	rs12824058	0.831	rs4759450	chr12:130812732	G/A	cg24838063	chr12:130822603	PIWIL1	0.78	6.91	0.62	1.19e-9	Menopause (age at onset);
SKCM	cis	rs9611565	0.694	rs9607816	chr22:41950897	G/A	cg03806693	chr22:41940476	POLR3H	-1.13	-7.48	-0.65	9.6e-11	Vitiligo;
SKCM	cis	rs9910055	0.762	rs2526020	chr17:42216588	G/T	cg19774624	chr17:42201019	HDAC5	-0.91	-8.09	-0.68	6.33e-12	Total body bone mineral density;
SKCM	cis	rs28595532	0.920	rs116046128	chr4:119741990	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs6951245	1.000	rs76129108	chr7:1089159	G/A	cg18402987	chr7:1209562	NA	1.14	6.01	0.56	5.68e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs10754283	0.967	rs10737707	chr1:90119304	A/G	cg21401794	chr1:90099060	LRRC8C	0.73	6.31	0.58	1.57e-8	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs2836974	0.931	rs2776307	chr21:40713833	C/G	cg11890956	chr21:40555474	PSMG1	-0.94	-9.75	-0.74	3.78e-15	Cognitive function;
SKCM	cis	rs9916302	0.706	rs11078894	chr17:37396805	C/G	cg07936489	chr17:37558343	FBXL20	-0.99	-7.57	-0.65	6.41e-11	Glomerular filtration rate (creatinine);
SKCM	cis	rs11098499	0.866	rs72676074	chr4:120359841	A/C	cg24375607	chr4:120327624	NA	0.68	5.3	0.51	1.06e-6	Corneal astigmatism;
SKCM	cis	rs9911578	1.000	rs12938772	chr17:56776320	T/C	cg12560992	chr17:57184187	TRIM37	0.95	7.69	0.66	3.7e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs362296	0.698	rs3135168	chr4:3262699	T/C	cg05297308	chr4:3317976	RGS12	-0.74	-6.34	-0.58	1.37e-8	Parental longevity (mother's age at death);
SKCM	cis	rs1799949	1.000	rs8176242	chr17:41217874	C/T	cg25918947	chr17:41365094	TMEM106A	-0.61	-5.91	-0.56	8.59e-8	Menopause (age at onset);
SKCM	cis	rs17345786	0.667	rs7622940	chr3:101133155	T/C	cg12386194	chr3:101231763	SENP7	0.66	4.83	0.48	6.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2282032	0.527	rs2282033	chr14:90769635	G/T	cg04374321	chr14:90722782	PSMC1	-0.67	-5.37	-0.52	7.94e-7	Longevity;
SKCM	cis	rs9913156	0.748	rs72835630	chr17:4562449	C/T	cg19197139	chr17:4613644	ARRB2	0.78	5.43	0.52	6.21e-7	Lymphocyte counts;
SKCM	cis	rs67311347	0.544	rs35112505	chr3:40337075	A/G	cg00091569	chr3:40428383	ENTPD3	0.61	5.33	0.52	9.24e-7	Renal cell carcinoma;
SKCM	cis	rs2836950	0.509	rs4816618	chr21:40599529	G/A	cg17971929	chr21:40555470	PSMG1	-0.73	-6.17	-0.57	2.86e-8	Menarche (age at onset);
SKCM	cis	rs10256972	0.591	rs6968988	chr7:1169619	A/G	cg16145915	chr7:1198662	ZFAND2A	-0.59	-7.58	-0.65	6.17e-11	Longevity;Endometriosis;
SKCM	cis	rs2013441	0.670	rs4924802	chr17:19955895	G/T	cg13482628	chr17:19912719	NA	0.67	4.8	0.48	7.46e-6	Obesity-related traits;
SKCM	cis	rs2180341	1.000	rs7776136	chr6:127638348	A/T	cg24812749	chr6:127587940	RNF146	0.87	7.91	0.67	1.41e-11	Breast cancer;
SKCM	cis	rs9611565	0.546	rs739132	chr22:42123099	A/T	cg03806693	chr22:41940476	POLR3H	1.11	6.72	0.61	2.72e-9	Vitiligo;
SKCM	cis	rs6840360	0.593	rs4696103	chr4:152564611	A/G	cg22705602	chr4:152727874	NA	-0.52	-5.83	-0.55	1.21e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs12706411	0.764	rs71573097	chr7:122073526	C/G	cg17986181	chr7:121955208	NA	-0.65	-5.01	-0.49	3.36e-6	Alzheimer disease and age of onset;
SKCM	cis	rs514406	0.679	rs11585495	chr1:53244331	T/C	cg25767906	chr1:53392781	SCP2	0.6	4.84	0.48	6.54e-6	Monocyte count;
SKCM	cis	rs9913156	0.696	rs72835620	chr17:4558128	G/A	cg19197139	chr17:4613644	ARRB2	0.79	5.28	0.51	1.14e-6	Lymphocyte counts;
SKCM	cis	rs854765	0.647	rs854767	chr17:18018263	A/C	cg04398451	chr17:18023971	MYO15A	1.02	9.59	0.74	7.65e-15	Total body bone mineral density;
SKCM	cis	rs2836974	0.897	rs3945	chr21:40566067	A/G	cg11890956	chr21:40555474	PSMG1	1.09	13.83	0.84	1.08e-22	Cognitive function;
SKCM	cis	rs651907	0.514	rs34301719	chr3:101417993	C/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.81	7.06	0.62	6.04e-10	Colorectal cancer;
SKCM	cis	rs7635838	0.718	rs2248971	chr3:11403441	T/C	cg00170343	chr3:11313890	ATG7	0.7	5.58	0.53	3.29e-7	HDL cholesterol;
SKCM	cis	rs9814567	1.000	rs6802654	chr3:134217072	C/T	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.67	-5.25	-0.51	1.28e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs10540	1.000	rs79440439	chr11:478147	A/C	cg03576123	chr11:487126	PTDSS2	-1.59	-8.2	-0.68	3.85e-12	Body mass index;
SKCM	cis	rs854765	0.623	rs9893690	chr17:17753846	A/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	-1.03	-7.53	-0.65	7.57e-11	Total body bone mineral density;
SKCM	cis	rs2832191	0.791	rs2832199	chr21:30498501	G/A	cg24692254	chr21:30365293	RNF160	-0.9	-7.99	-0.67	9.72e-12	Dental caries;
SKCM	cis	rs798554	0.797	rs798486	chr7:2803037	A/G	cg14895029	chr7:2775587	GNA12	-0.68	-4.98	-0.49	3.69e-6	Height;
SKCM	trans	rs1814175	0.817	rs4881648	chr11:49812901	A/G	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs72781680	1.000	rs72781632	chr2:24198342	A/C	cg08917208	chr2:24149416	ATAD2B	1.02	5.84	0.55	1.16e-7	Lymphocyte counts;
SKCM	cis	rs17376456	0.877	rs13165147	chr5:93422214	G/A	cg21475434	chr5:93447410	FAM172A	0.97	5.42	0.52	6.39e-7	Diabetic retinopathy;
SKCM	cis	rs7786877	0.587	rs56328569	chr7:100202219	C/G	cg16850897	chr7:100343110	ZAN	-0.67	-4.84	-0.48	6.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs6087990	0.735	rs2065576	chr20:31389009	C/T	cg13636640	chr20:31349939	DNMT3B	0.83	6.25	0.58	2.06e-8	Ulcerative colitis;
SKCM	cis	rs798554	0.797	rs2107964	chr7:2863574	G/A	cg04166393	chr7:2884313	GNA12	0.72	4.99	0.49	3.52e-6	Height;
SKCM	cis	rs72781680	1.000	rs17762102	chr2:24085606	A/G	cg08917208	chr2:24149416	ATAD2B	0.99	5.24	0.51	1.31e-6	Lymphocyte counts;
SKCM	cis	rs6570726	0.738	rs7746330	chr6:145899257	A/C	cg05347473	chr6:146136440	FBXO30	0.58	5.16	0.5	1.82e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs754466	0.580	rs10824575	chr10:79549047	A/G	cg17075019	chr10:79541650	NA	-0.75	-6.6	-0.6	4.45e-9	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs7927771	1.000	rs9909	chr11:47799775	C/G	cg05585544	chr11:47624801	NA	-0.6	-5.22	-0.51	1.45e-6	Subjective well-being;
SKCM	cis	rs867186	1.000	rs17092297	chr20:33703134	A/G	cg04194272	chr20:33683537	NA	1.13	6.28	0.58	1.75e-8	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs57221529	0.664	rs72704802	chr5:554211	C/T	cg10555297	chr5:473380	SLC9A3;LOC25845	1.11	5.54	0.53	4.03e-7	Lung disease severity in cystic fibrosis;
SKCM	cis	rs929354	0.772	rs933344	chr7:157011265	A/T	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs4332037	0.805	rs10278591	chr7:1921362	A/G	cg23422044	chr7:1970798	MAD1L1	0.92	6.81	0.61	1.79e-9	Bipolar disorder;
SKCM	cis	rs933688	1.000	rs1895448	chr5:90743854	C/T	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.06	8.52	0.69	9.28e-13	Smoking behavior;
SKCM	cis	rs2842992	0.715	rs2277073	chr6:160182749	G/A	cg19482086	chr6:160211437	TCP1;MRPL18	0.86	6.82	0.61	1.71e-9	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs7666738	0.716	rs2865982	chr4:99031661	T/G	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9987353	0.544	rs2929470	chr8:9062490	A/G	cg15556689	chr8:8085844	FLJ10661	-0.61	-4.82	-0.48	6.94e-6	Recombination measurement;
SKCM	cis	rs116095464	0.558	rs9688136	chr5:229348	T/C	cg22857025	chr5:266934	NA	-1.37	-8.11	-0.68	5.82e-12	Breast cancer;
SKCM	cis	rs2842992	0.747	rs1547093	chr6:160205991	C/A	cg16489826	chr6:160211363	TCP1;MRPL18	0.73	5.42	0.52	6.39e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs7523050	0.643	rs35438081	chr1:109402831	G/T	cg08274380	chr1:109419600	GPSM2	1.13	5.57	0.53	3.54e-7	Fat distribution (HIV);
SKCM	cis	rs12586317	0.547	rs74462850	chr14:35500093	G/T	cg16230307	chr14:35515116	FAM177A1	0.81	5.88	0.55	9.47e-8	Psoriasis;
SKCM	cis	rs2404602	0.536	rs12915248	chr15:76765615	A/T	cg23625390	chr15:77176239	SCAPER	0.62	5.38	0.52	7.53e-7	Blood metabolite levels;
SKCM	cis	rs951366	0.789	rs864783	chr1:205711974	T/C	cg07167872	chr1:205819463	PM20D1	0.96	8.0	0.67	9.33e-12	Menarche (age at onset);
SKCM	cis	rs9430161	0.611	rs2003046	chr1:11032827	C/A	cg27631724	chr1:11040367	C1orf127	0.5	4.85	0.48	6.08e-6	Ewing sarcoma;
SKCM	cis	rs9368481	0.700	rs6911401	chr6:26913214	C/G	cg12292205	chr6:26970375	C6orf41	0.65	5.89	0.55	9.26e-8	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs10927875	0.793	rs1763619	chr1:16326935	A/G	cg21385522	chr1:16154831	NA	0.77	6.09	0.57	4.05e-8	Dilated cardiomyopathy;
SKCM	cis	rs3213545	0.659	rs2259690	chr12:121457914	T/G	cg02403541	chr12:121454288	C12orf43	0.8	7.04	0.62	6.62e-10	Subjective well-being;Cardiovascular disease risk factors;
SKCM	cis	rs9467773	1.000	rs12526680	chr6:26550954	A/G	cg15659132	chr6:26577336	NA	0.61	5.91	0.56	8.42e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs9420	0.961	rs11607056	chr11:57496820	C/T	cg19752551	chr11:57585705	CTNND1	-0.7	-6.84	-0.61	1.6e-9	Schizophrenia;
SKCM	cis	rs10504073	0.584	rs11776843	chr8:49928449	C/T	cg00325661	chr8:49890786	NA	0.79	7.15	0.63	3.99e-10	Blood metabolite ratios;
SKCM	cis	rs7917772	0.508	rs2252147	chr10:104467774	G/A	cg11453585	chr10:104263688	ACTR1A;SUFU	0.69	4.77	0.48	8.31e-6	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs2455601	0.744	rs11042133	chr11:8966511	A/C	cg21881798	chr11:8931708	C11orf17;ST5	-0.78	-5.54	-0.53	3.89e-7	Schizophrenia;
SKCM	cis	rs514406	0.798	rs576650	chr1:53327207	C/T	cg16325326	chr1:53192061	ZYG11B	0.86	8.09	0.68	6.32e-12	Monocyte count;
SKCM	cis	rs3862260	0.509	rs3862262	chr1:120161841	G/T	cg16322792	chr1:120165303	ZNF697	0.5	5.32	0.52	9.47e-7	Systemic lupus erythematosus;
SKCM	cis	rs2739330	0.760	rs1007888	chr22:24241101	C/T	cg04234412	chr22:24373322	LOC391322	-0.68	-5.89	-0.55	9.4e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs9467773	1.000	rs9467774	chr6:26505036	C/A	cg15659132	chr6:26577336	NA	0.61	5.82	0.55	1.24e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs10089	1.000	rs77086350	chr5:127494431	G/A	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.85	7.14	0.63	4.17e-10	Ileal carcinoids;
SKCM	cis	rs73157695	0.676	rs9984074	chr21:47328005	T/G	cg10605724	chr21:47966967	DIP2A	-0.69	-5.04	-0.5	2.89e-6	Myopia;
SKCM	cis	rs796364	1.000	rs281763	chr2:200794870	C/T	cg12253985	chr2:200820533	C2orf60;C2orf47	0.85	5.39	0.52	7.18e-7	Schizophrenia;
SKCM	cis	rs9910055	0.762	rs2526021	chr17:42213347	G/A	cg19774624	chr17:42201019	HDAC5	-0.91	-8.09	-0.68	6.33e-12	Total body bone mineral density;
SKCM	cis	rs3087591	1.000	rs2040791	chr17:29627297	G/C	cg24425628	chr17:29625626	OMG;NF1	-0.64	-4.97	-0.49	3.84e-6	Hip circumference;
SKCM	cis	rs2153535	0.580	rs9393023	chr6:8469994	T/G	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs5769765	0.773	rs9616382	chr22:50312979	C/T	cg22709217	chr22:50311962	ALG12;CRELD2	-0.94	-5.91	-0.56	8.37e-8	Schizophrenia;
SKCM	trans	rs5756813	0.661	rs11703407	chr22:38200124	C/T	cg19894588	chr14:64061835	NA	-0.88	-7.39	-0.64	1.44e-10	Optic cup area;Vertical cup-disc ratio;
SKCM	cis	rs62103177	0.810	rs62103191	chr18:77628769	C/G	cg27393146	chr18:77495563	CTDP1	-0.92	-5.36	-0.52	8.37e-7	Opioid sensitivity;
SKCM	cis	rs7809950	1.000	rs2520277	chr7:107130234	C/T	cg23024343	chr7:107201750	COG5	-0.74	-6.62	-0.6	4.19e-9	Coronary artery disease;
SKCM	trans	rs1814175	0.645	rs6486022	chr11:49776137	A/G	cg15704280	chr7:45808275	SEPT13	-0.93	-8.6	-0.7	6.36e-13	Height;
SKCM	trans	rs17685	0.712	rs7785025	chr7:75628101	C/T	cg19862616	chr7:65841803	NCRNA00174	-0.96	-9.14	-0.72	5.89e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs9611565	0.503	rs5996062	chr22:42167464	C/G	cg03806693	chr22:41940476	POLR3H	1.17	6.46	0.59	8.4e-9	Vitiligo;
SKCM	cis	rs10832963	0.961	rs10832954	chr11:18643559	G/A	cg20219074	chr11:18656078	SPTY2D1	0.8	6.7	0.6	2.86e-9	Breast cancer;
SKCM	cis	rs394563	0.591	rs237026	chr6:149720681	G/A	cg16235748	chr6:149772707	ZC3H12D	-0.43	-4.8	-0.48	7.39e-6	Dupuytren's disease;
SKCM	cis	rs459571	1.000	rs456207	chr9:136911140	G/A	cg13789015	chr9:136890014	NCRNA00094	0.7	5.65	0.54	2.48e-7	Platelet distribution width;
SKCM	cis	rs4819052	0.684	rs914216	chr21:46698298	T/G	cg02159808	chr21:46707872	POFUT2;LOC642852	0.75	5.71	0.54	1.94e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7927771	0.524	rs1056387	chr11:47681370	A/C	cg20307385	chr11:47447363	PSMC3	0.67	4.87	0.48	5.64e-6	Subjective well-being;
SKCM	cis	rs3008870	1.000	rs2755250	chr1:67495283	A/G	cg08660285	chr1:67390436	MIER1;WDR78	0.95	6.51	0.59	6.68e-9	Lymphocyte percentage of white cells;
SKCM	cis	rs854765	0.520	rs9899355	chr17:17898243	C/T	cg04398451	chr17:18023971	MYO15A	-0.98	-7.24	-0.63	2.69e-10	Total body bone mineral density;
SKCM	cis	rs116095464	0.681	rs9687745	chr5:229309	C/T	cg22496380	chr5:211416	CCDC127	-0.95	-5.22	-0.51	1.42e-6	Breast cancer;
SKCM	cis	rs12824058	0.831	rs4759653	chr12:130812604	T/C	cg24838063	chr12:130822603	PIWIL1	0.78	6.91	0.62	1.19e-9	Menopause (age at onset);
SKCM	cis	rs4268898	0.527	rs72789910	chr2:24388609	T/G	cg06627628	chr2:24431161	ITSN2	-0.88	-6.39	-0.59	1.1e-8	Asthma;
SKCM	cis	rs11690935	0.694	rs312921	chr2:172567225	T/C	cg13550731	chr2:172543902	DYNC1I2	-0.95	-8.1	-0.68	6.14e-12	Schizophrenia;
SKCM	cis	rs1580019	0.563	rs4723169	chr7:32567577	G/A	cg06627557	chr7:32535165	LSM5;AVL9	0.94	9.12	0.72	6.39e-14	Cognitive ability;
SKCM	cis	rs7777484	0.571	rs2527686	chr7:2834413	G/A	cg09658497	chr7:2847517	GNA12	-0.38	-4.83	-0.48	6.58e-6	Height;
SKCM	cis	rs11638352	1.000	rs4924729	chr15:44291244	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	-1.19	-4.87	-0.48	5.62e-6	Lipoprotein phospholipase A2 activity in cardiovascular disease;
SKCM	cis	rs875971	0.545	rs316324	chr7:65610614	A/G	cg18876405	chr7:65276391	NA	-0.64	-5.29	-0.51	1.09e-6	Aortic root size;
SKCM	cis	rs36093844	0.752	rs7127501	chr11:85564305	C/A	cg25872744	chr11:85566296	CCDC83	-0.85	-4.77	-0.48	8.27e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs6912958	0.559	rs107689	chr6:88069333	G/T	cg08069147	chr6:88032118	GJB7;C6orf162	0.72	6.76	0.61	2.24e-9	Monocyte percentage of white cells;
SKCM	cis	rs7945705	0.902	rs11042152	chr11:9020987	C/T	cg21881798	chr11:8931708	C11orf17;ST5	0.81	7.69	0.66	3.82e-11	Hemoglobin concentration;
SKCM	cis	rs10504229	0.861	rs67966192	chr8:58188172	A/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs17685	0.523	rs10246583	chr7:75746667	C/A	cg01364799	chr7:75623366	TMEM120A	-0.7	-5.69	-0.54	2.09e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1044826	0.667	rs295471	chr3:139213922	G/C	cg15131784	chr3:139108705	COPB2	0.68	4.97	0.49	3.85e-6	Obesity-related traits;
SKCM	cis	rs2180341	0.782	rs6569490	chr6:127729615	C/T	cg24812749	chr6:127587940	RNF146	0.61	4.97	0.49	3.9e-6	Breast cancer;
SKCM	cis	rs9485372	1.000	rs11965411	chr6:149608349	T/A	cg03072286	chr6:150262044	ULBP2	-0.55	-4.89	-0.48	5.3e-6	Breast cancer;
SKCM	cis	rs28595532	0.920	rs116559327	chr4:119754526	T/G	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs2033711	0.870	rs11084545	chr19:58951693	G/C	cg00825309	chr19:58991885	ZNF446	-0.62	-4.99	-0.49	3.63e-6	Uric acid clearance;
SKCM	cis	rs1218582	0.772	rs3738026	chr1:154919565	A/G	cg06221963	chr1:154839813	KCNN3	-0.55	-5.4	-0.52	7.08e-7	Prostate cancer;
SKCM	cis	rs2032447	0.531	rs428469	chr6:25898624	G/A	cg03517284	chr6:25882590	NA	-0.79	-6.62	-0.6	4.1e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs7811142	1.000	rs6975514	chr7:100056220	T/C	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.34	0.69	2.1e-12	Platelet count;
SKCM	cis	rs6570726	0.791	rs408443	chr6:145874643	T/C	cg05347473	chr6:146136440	FBXO30	0.57	5.13	0.5	2.06e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs769267	0.930	rs747050	chr19:19584987	C/G	cg03709012	chr19:19516395	GATAD2A	0.9	8.71	0.7	3.9e-13	Tonsillectomy;
SKCM	cis	rs7027203	0.828	rs10821229	chr9:96595136	A/C	cg14598338	chr9:96623480	NA	-0.52	-5.41	-0.52	6.75e-7	DNA methylation (variation);
SKCM	cis	rs10256972	0.621	rs10951594	chr7:1088607	C/G	cg16145915	chr7:1198662	ZFAND2A	-0.47	-6.3	-0.58	1.63e-8	Longevity;Endometriosis;
SKCM	cis	rs2832191	0.720	rs2832194	chr21:30494250	T/C	cg08807101	chr21:30365312	RNF160	-0.62	-4.94	-0.49	4.34e-6	Dental caries;
SKCM	cis	rs7772486	0.875	rs2814866	chr6:146339414	C/A	cg05347473	chr6:146136440	FBXO30	0.57	5.06	0.5	2.68e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs17685	0.753	rs1574107	chr7:75685047	A/C	cg16684958	chr7:75615977	POR	0.57	5.43	0.52	6.3e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2836974	0.568	rs2142111	chr21:40549289	G/C	cg17971929	chr21:40555470	PSMG1	0.76	7.16	0.63	3.94e-10	Cognitive function;
SKCM	cis	rs7829975	0.633	rs2979181	chr8:8323088	A/T	cg15556689	chr8:8085844	FLJ10661	0.89	8.44	0.69	1.29e-12	Mood instability;
SKCM	cis	rs2836633	0.929	rs58120977	chr21:40037346	C/T	cg05519781	chr21:40033154	ERG	0.78	6.88	0.61	1.33e-9	Coronary artery disease;
SKCM	cis	rs6840360	0.593	rs1366907	chr4:152682749	T/C	cg22705602	chr4:152727874	NA	-0.59	-7.95	-0.67	1.19e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs9916302	0.904	rs587343	chr17:37440603	C/T	cg07936489	chr17:37558343	FBXL20	0.81	6.87	0.61	1.4e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs951366	0.903	rs708723	chr1:205739266	C/T	cg07157834	chr1:205819609	PM20D1	0.67	5.35	0.52	8.41e-7	Menarche (age at onset);
SKCM	cis	rs208520	0.545	rs10944874	chr6:66752080	C/T	cg07460842	chr6:66804631	NA	-1.07	-11.68	-0.8	8.25e-19	Exhaled nitric oxide output;
SKCM	cis	rs1046896	0.553	rs2292965	chr17:80900645	G/A	cg02711726	chr17:80685570	FN3KRP	-0.63	-4.99	-0.49	3.64e-6	Glycated hemoglobin levels;
SKCM	cis	rs10803016	0.638	rs2252440	chr1:242292280	C/T	ch.1.4829111R	chr1:242658279	PLD5	-0.57	-4.8	-0.48	7.37e-6	Coronary artery calcification;
SKCM	cis	rs7511006	1.000	rs7364173	chr22:50681029	C/T	cg16473166	chr22:50639996	SELO	-0.61	-4.86	-0.48	5.96e-6	Obesity-related traits;
SKCM	cis	rs28386778	0.831	rs2584618	chr17:61923611	T/C	cg06873352	chr17:61820015	STRADA	0.73	6.3	0.58	1.67e-8	Prudent dietary pattern;
SKCM	cis	rs9611565	0.694	rs5758411	chr22:42079734	G/A	cg03806693	chr22:41940476	POLR3H	0.96	6.67	0.6	3.38e-9	Vitiligo;
SKCM	cis	rs589448	0.902	rs642786	chr12:69758462	T/C	cg20891283	chr12:69753455	YEATS4	0.98	9.89	0.75	2.06e-15	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs7954584	0.604	rs34159444	chr12:122416667	A/G	cg13699009	chr12:122356056	WDR66	0.58	7.36	0.64	1.62e-10	Mean corpuscular volume;
SKCM	cis	rs2228479	0.618	rs72477006	chr16:89950299	G/C	cg00800038	chr16:89945340	TCF25	-0.93	-5.34	-0.52	8.77e-7	Skin colour saturation;
SKCM	cis	rs7599312	0.534	rs10182996	chr2:213404834	T/C	cg16329650	chr2:213403929	ERBB4	0.84	6.04	0.56	4.85e-8	BMI (adjusted for smoking behaviour);BMI in non-smokers;Body mass index;Body mass index (joint analysis main effects and smoking interaction);
SKCM	cis	rs28386778	0.965	rs2854154	chr17:61981696	C/A	cg26338869	chr17:61819248	STRADA	-0.73	-4.8	-0.48	7.58e-6	Prudent dietary pattern;
SKCM	cis	rs7772486	0.875	rs1929523	chr6:146339989	T/A	cg05347473	chr6:146136440	FBXO30	0.57	5.18	0.51	1.66e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9796	0.611	rs691672	chr15:41444438	A/C	cg18705301	chr15:41695430	NDUFAF1	-0.74	-5.35	-0.52	8.47e-7	Menopause (age at onset);
SKCM	cis	rs2224391	0.704	rs9504371	chr6:5261608	T/C	cg09085698	chr6:5261316	LYRM4;FARS2	-0.75	-5.33	-0.52	9.43e-7	Height;
SKCM	cis	rs10791097	0.694	rs876641	chr11:130752040	A/C	cg12179176	chr11:130786555	SNX19	0.91	8.23	0.68	3.3e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs801193	1.000	rs13239306	chr7:66136017	T/G	cg05627663	chr7:65219948	SNORA22;CCT6P1	-0.61	-5.53	-0.53	4.03e-7	Aortic root size;
SKCM	cis	rs13118159	0.801	rs13147602	chr4:1332175	A/G	cg20887711	chr4:1340912	KIAA1530	0.68	5.05	0.5	2.83e-6	Longevity;
SKCM	cis	rs738322	0.839	rs9607517	chr22:38596100	G/A	cg25457927	chr22:38595422	NA	0.57	7.41	0.64	1.29e-10	Cutaneous nevi;
SKCM	cis	rs995000	0.931	rs1781195	chr1:62988972	T/C	cg06896770	chr1:63153194	DOCK7	-0.74	-6.81	-0.61	1.77e-9	Triglyceride levels;
SKCM	cis	rs644799	0.635	rs10831428	chr11:95508404	C/A	cg03916912	chr11:95522834	CEP57;FAM76B	0.83	7.18	0.63	3.57e-10	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs10779751	0.960	rs12739368	chr1:11288247	T/C	cg08854313	chr1:11322531	MTOR	0.92	6.94	0.62	1e-9	Body mass index;
SKCM	cis	rs709400	0.859	rs7693	chr14:104023704	C/T	cg26031613	chr14:104095156	KLC1	1.01	10.89	0.78	2.58e-17	Body mass index;
SKCM	cis	rs2075671	0.903	rs4729602	chr7:100260591	T/C	cg20848291	chr7:100343083	ZAN	-0.69	-5.28	-0.51	1.14e-6	Other erythrocyte phenotypes;
SKCM	cis	rs4974559	1.000	rs10006789	chr4:1330333	T/C	cg02980000	chr4:1222292	CTBP1	0.78	5.03	0.49	3.11e-6	Systolic blood pressure;
SKCM	cis	rs362296	0.597	rs3129320	chr4:3265130	G/C	cg21096898	chr4:3318625	RGS12	-0.66	-5.76	-0.55	1.58e-7	Parental longevity (mother's age at death);
SKCM	cis	rs62158211	1.000	rs1807282	chr2:114110036	A/T	cg17784749	chr2:114082611	LOC440839	0.8	5.62	0.54	2.9e-7	Sleep duration (oversleepers vs undersleepers);Sleep traits (multi-trait analysis);Sleep duration;
SKCM	cis	rs10779751	0.959	rs2300091	chr1:11266711	C/T	cg08854313	chr1:11322531	MTOR	1.02	9.56	0.73	8.88e-15	Body mass index;
SKCM	cis	rs62103177	1.000	rs62103177	chr18:77624479	G/A	cg27393146	chr18:77495563	CTDP1	-0.92	-5.36	-0.52	8.37e-7	Opioid sensitivity;
SKCM	cis	rs2839186	0.933	rs4818832	chr21:47708634	C/T	cg13126279	chr21:47581558	C21orf56	-0.64	-5.47	-0.53	5.17e-7	Testicular germ cell tumor;
SKCM	cis	rs6879260	1.000	rs7706951	chr5:179733407	C/T	cg02891314	chr5:179741120	GFPT2	-0.73	-5.62	-0.54	2.85e-7	Height;
SKCM	cis	rs597539	0.654	rs655816	chr11:68626405	A/G	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.82	5.51	0.53	4.49e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs6088580	0.634	rs6058051	chr20:33044862	G/A	cg24642439	chr20:33292090	TP53INP2	0.76	6.02	0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs28374715	0.783	rs11630656	chr15:41570909	T/G	cg18705301	chr15:41695430	NDUFAF1	-1.08	-11.43	-0.79	2.48e-18	Ulcerative colitis;
SKCM	cis	rs56235845	0.694	rs6875461	chr5:176754665	C/T	cg16006841	chr5:176797999	RGS14	-0.68	-6.66	-0.6	3.52e-9	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs6088580	0.634	rs4911423	chr20:32999386	T/A	cg24642439	chr20:33292090	TP53INP2	-0.76	-6.02	-0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs514406	0.621	rs881198	chr1:53196440	C/T	cg16325326	chr1:53192061	ZYG11B	-1.0	-12.3	-0.81	6.1e-20	Monocyte count;
SKCM	cis	rs4819052	0.808	rs11909411	chr21:46676556	A/C	cg02159808	chr21:46707872	POFUT2;LOC642852	0.73	5.71	0.54	1.93e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs4132509	1.000	rs4565696	chr1:243918083	C/T	cg21452805	chr1:244014465	NA	0.87	5.28	0.51	1.11e-6	RR interval (heart rate);
SKCM	cis	rs9300255	0.568	rs3018098	chr12:123654812	T/C	cg05973401	chr12:123451056	ABCB9	0.81	5.37	0.52	7.77e-7	Neutrophil percentage of white cells;
SKCM	cis	rs7590720	0.851	rs13006614	chr2:216876204	C/T	cg12620499	chr2:216877984	MREG	0.87	8.01	0.67	8.85e-12	Alcohol dependence;
SKCM	cis	rs9682041	0.932	rs6782252	chr3:170133639	C/T	cg11886554	chr3:170076028	SKIL	0.92	5.51	0.53	4.42e-7	Glomerular filtration rate in non diabetics (creatinine);Glomerular filtration rate (creatinine);
SKCM	cis	rs6547741	0.935	rs56001553	chr2:27859926	C/T	cg27432699	chr2:27873401	GPN1	-0.73	-6.64	-0.6	3.73e-9	Oral cavity cancer;
SKCM	cis	rs28595532	0.841	rs114970257	chr4:119756937	G/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs17376456	0.877	rs10072592	chr5:93405989	C/G	cg21475434	chr5:93447410	FAM172A	0.97	5.41	0.52	6.8e-7	Diabetic retinopathy;
SKCM	cis	rs7208859	0.573	rs60724269	chr17:29113273	G/T	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs2811415	0.531	rs13081382	chr3:127740304	C/G	cg09089421	chr3:127803668	RUVBL1	0.99	8.52	0.69	9.09e-13	Lung function (FEV1/FVC);
SKCM	cis	rs736408	0.609	rs2230535	chr3:52800284	T/C	cg18404041	chr3:52824283	ITIH1	-0.56	-4.94	-0.49	4.32e-6	Bipolar disorder;
SKCM	cis	rs2739330	0.731	rs4822450	chr22:24242887	C/T	cg24846343	chr22:24311635	DDTL	0.65	6.08	0.57	4.17e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs763014	0.865	rs2071979	chr16:624114	A/G	cg07343612	chr16:622815	PIGQ	-0.69	-5.73	-0.54	1.84e-7	Height;
SKCM	cis	rs9611565	0.512	rs8141103	chr22:42136930	T/C	cg03806693	chr22:41940476	POLR3H	1.18	6.79	0.61	1.97e-9	Vitiligo;
SKCM	cis	rs561341	0.714	rs55925849	chr17:30253085	C/T	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.53	-0.65	7.52e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs875971	0.790	rs10257911	chr7:65743770	A/G	cg11764359	chr7:65958608	NA	-0.76	-7.0	-0.62	8.03e-10	Aortic root size;
SKCM	cis	rs28595532	0.920	rs114564223	chr4:119729953	A/G	cg21605333	chr4:119757512	SEC24D	1.36	8.05	0.67	7.69e-12	Cannabis dependence symptom count;
SKCM	cis	rs2228479	0.867	rs12919804	chr16:89945369	G/A	cg00800038	chr16:89945340	TCF25	-0.93	-5.34	-0.52	8.73e-7	Skin colour saturation;
SKCM	cis	rs1912528	0.783	rs6536588	chr4:140862671	C/T	cg11128457	chr4:140864437	MAML3	0.6	5.24	0.51	1.31e-6	Educational attainment (years of education);
SKCM	cis	rs10848704	0.956	rs10848703	chr12:2882250	C/T	cg19995117	chr12:2880862	NA	0.56	5.3	0.51	1.04e-6	Quantitative traits;
SKCM	cis	rs2279817	1.000	rs4920620	chr1:18023154	A/G	cg17142039	chr1:18149651	ACTL8	0.58	4.88	0.48	5.6e-6	Neuroticism;
SKCM	cis	rs7666738	0.753	rs34164013	chr4:98976333	A/G	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1799949	1.000	rs16940	chr17:41245237	A/G	cg05368731	chr17:41323189	NBR1	0.89	7.49	0.65	9.23e-11	Menopause (age at onset);
SKCM	cis	rs2013441	1.000	rs2703818	chr17:20119976	T/A	cg13482628	chr17:19912719	NA	-0.65	-5.21	-0.51	1.48e-6	Obesity-related traits;
SKCM	cis	rs9916302	0.706	rs801427	chr17:37436711	A/G	cg07936489	chr17:37558343	FBXL20	-0.98	-6.58	-0.6	4.83e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs995000	0.931	rs1168042	chr1:62974150	A/T	cg06896770	chr1:63153194	DOCK7	-0.74	-6.81	-0.61	1.77e-9	Triglyceride levels;
SKCM	cis	rs4683346	0.752	rs4682868	chr3:42905515	A/T	cg06399164	chr3:42695035	ZBTB47	0.55	4.79	0.48	7.71e-6	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs9790314	0.747	rs9990242	chr3:160838461	T/C	cg03342759	chr3:160939853	NMD3	-0.62	-6.25	-0.58	2.03e-8	Morning vs. evening chronotype;
SKCM	cis	rs1160297	0.609	rs1597653	chr2:53100420	A/G	cg07782112	chr2:53107842	NA	-0.6	-6.37	-0.59	1.19e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs7772486	0.720	rs702320	chr6:146006654	G/A	cg23711669	chr6:146136114	FBXO30	-0.94	-10.38	-0.76	2.33e-16	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs362296	0.511	rs2051558	chr4:3324886	G/A	cg05297308	chr4:3317976	RGS12	0.85	8.93	0.71	1.48e-13	Parental longevity (mother's age at death);
SKCM	cis	rs344364	0.511	rs2917515	chr16:1945271	G/C	cg26897989	chr16:1907736	C16orf73	-0.69	-7.09	-0.63	5.4e-10	Glomerular filtration rate in chronic kidney disease;
SKCM	cis	rs910316	0.967	rs12147532	chr14:75651858	T/G	cg08847533	chr14:75593920	NEK9	-0.98	-9.2	-0.72	4.45e-14	Height;
SKCM	cis	rs6500395	0.926	rs7192297	chr16:48670421	G/A	cg04672837	chr16:48644449	N4BP1	0.63	5.29	0.51	1.08e-6	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs17270561	0.887	rs12201170	chr6:25866247	A/G	cg17691542	chr6:26056736	HIST1H1C	0.86	5.18	0.51	1.69e-6	Iron status biomarkers;
SKCM	cis	rs6866344	0.697	rs61247551	chr5:178133503	G/A	cg03877680	chr5:178157825	ZNF354A	0.86	6.37	0.59	1.19e-8	Neutrophil percentage of white cells;
SKCM	cis	rs9583531	0.689	rs9515273	chr13:111383427	G/C	cg24331049	chr13:111365604	ING1	0.85	6.43	0.59	9.38e-9	Coronary artery disease;
SKCM	trans	rs3780486	0.846	rs4584234	chr9:33147479	G/A	cg20290983	chr6:43655470	MRPS18A	0.93	10.53	0.77	1.21e-16	IgG glycosylation;
SKCM	cis	rs9467773	0.967	rs9295694	chr6:26512994	A/T	cg15659132	chr6:26577336	NA	0.6	5.71	0.54	1.99e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs2963155	0.518	rs853178	chr5:142634799	C/T	cg17617527	chr5:142782415	NR3C1	1.13	5.42	0.52	6.46e-7	Breast cancer;
SKCM	cis	rs1153858	1.000	rs56669689	chr15:45637729	A/C	cg10760299	chr15:45669010	GATM	0.58	6.04	0.56	4.83e-8	Homoarginine levels;
SKCM	cis	rs7937682	0.889	rs1789359	chr11:111475995	T/A	cg09085632	chr11:111637200	PPP2R1B	-0.97	-10.08	-0.75	8.74e-16	Primary sclerosing cholangitis;
SKCM	cis	rs7829975	0.711	rs12682352	chr8:8646246	A/G	cg15556689	chr8:8085844	FLJ10661	0.69	6.0	0.56	5.93e-8	Mood instability;
SKCM	cis	rs28595532	0.920	rs73842253	chr4:119721856	G/A	cg14228332	chr4:119757509	SEC24D	1.04	4.79	0.48	7.81e-6	Cannabis dependence symptom count;
SKCM	cis	rs6582630	0.555	rs11182422	chr12:38522833	A/G	cg26384229	chr12:38710491	ALG10B	0.83	6.8	0.61	1.85e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs3780486	0.846	rs10971419	chr9:33124161	T/C	cg13443165	chr9:33130375	B4GALT1	-0.54	-4.84	-0.48	6.46e-6	IgG glycosylation;
SKCM	cis	rs7772486	0.686	rs1045820	chr6:145947080	C/T	cg23711669	chr6:146136114	FBXO30	0.9	10.02	0.75	1.16e-15	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2836974	0.863	rs8128026	chr21:40533702	T/C	cg11890956	chr21:40555474	PSMG1	1.07	13.19	0.83	1.48e-21	Cognitive function;
SKCM	cis	rs244731	0.959	rs4976677	chr5:176629546	G/A	cg06060754	chr5:176797920	RGS14	-0.82	-7.22	-0.63	2.97e-10	Urate levels in lean individuals;
SKCM	cis	rs7940866	0.903	rs10791109	chr11:130850377	A/C	cg12179176	chr11:130786555	SNX19	0.74	5.58	0.53	3.32e-7	Schizophrenia;
SKCM	cis	rs2439831	0.867	rs2264876	chr15:43757419	G/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.19	7.61	0.65	5.35e-11	Lung cancer in ever smokers;
SKCM	cis	rs5769765	0.825	rs7511620	chr22:50307932	T/C	cg22709217	chr22:50311962	ALG12;CRELD2	-0.89	-5.71	-0.54	1.97e-7	Schizophrenia;
SKCM	cis	rs4423214	0.879	rs1630498	chr11:71150785	A/C	cg05163923	chr11:71159392	DHCR7	-0.68	-6.15	-0.57	3.07e-8	Vitamin D levels;
SKCM	cis	rs1029738	0.615	rs3757447	chr7:22894735	A/T	cg00309339	chr7:22893653	NA	-0.67	-6.3	-0.58	1.67e-8	Fibrinogen levels;
SKCM	cis	rs9325144	0.555	rs7301258	chr12:38706942	C/T	cg26384229	chr12:38710491	ALG10B	0.79	6.72	0.61	2.62e-9	Morning vs. evening chronotype;
SKCM	cis	rs2197308	0.765	rs11182900	chr12:37934009	C/T	cg26384229	chr12:38710491	ALG10B	0.81	6.59	0.6	4.69e-9	Morning vs. evening chronotype;
SKCM	cis	rs2739330	0.760	rs1007888	chr22:24241101	C/T	cg12419862	chr22:24373484	LOC391322	-0.8	-7.72	-0.66	3.33e-11	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs6951245	0.744	rs1133122	chr7:1192572	C/A	cg03188948	chr7:1209495	NA	1.07	6.74	0.61	2.44e-9	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs644799	1.000	rs1784135	chr11:95531748	G/A	cg25622487	chr11:95524042	FAM76B;CEP57	0.66	5.12	0.5	2.18e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs9894429	0.646	rs9904137	chr17:79613925	C/T	cg18240062	chr17:79603768	NPLOC4	0.68	6.07	0.57	4.41e-8	Eye color traits;
SKCM	cis	rs57221529	0.766	rs12522303	chr5:555564	A/C	cg26208419	chr5:473447	SLC9A3;LOC25845	0.96	4.9	0.49	5.03e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs11718455	0.767	rs4682924	chr3:43992760	G/A	cg21419209	chr3:44054225	NA	-0.62	-5.06	-0.5	2.75e-6	Coronary artery disease;
SKCM	cis	rs7772486	0.658	rs9403737	chr6:145962193	G/T	cg23711669	chr6:146136114	FBXO30	0.88	9.43	0.73	1.6e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6088590	0.735	rs6088618	chr20:33409350	G/A	cg24642439	chr20:33292090	TP53INP2	0.77	5.43	0.52	6.11e-7	Coronary artery disease;
SKCM	cis	rs1153858	1.000	rs4534782	chr15:45652933	G/A	cg21132104	chr15:45694354	SPATA5L1	0.93	7.94	0.67	1.22e-11	Homoarginine levels;
SKCM	cis	rs6539267	0.885	rs34762209	chr12:106722466	T/C	cg00173435	chr12:106696525	TCP11L2	0.84	5.48	0.53	5.02e-7	Tourette syndrome;
SKCM	cis	rs7647973	0.516	rs4955418	chr3:49200627	A/G	cg06212747	chr3:49208901	KLHDC8B	0.8	5.69	0.54	2.1e-7	Menarche (age at onset);
SKCM	cis	rs60871478	0.947	rs62432866	chr7:809281	T/G	cg05535760	chr7:792225	HEATR2	1.02	8.66	0.7	4.97e-13	Cerebrospinal P-tau181p levels;
SKCM	cis	rs7100689	0.577	rs1417219	chr10:82041409	C/T	cg01528321	chr10:82214614	TSPAN14	0.79	7.79	0.66	2.36e-11	Post bronchodilator FEV1;
SKCM	cis	rs7666738	0.830	rs11725095	chr4:99009711	T/A	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs362296	0.661	rs3095078	chr4:3265479	C/T	cg21096898	chr4:3318625	RGS12	-0.71	-6.46	-0.59	8.22e-9	Parental longevity (mother's age at death);
SKCM	cis	rs10876993	0.890	rs799575	chr12:58069107	A/G	cg18357645	chr12:58087776	OS9	0.65	6.01	0.56	5.71e-8	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs6546550	0.935	rs6546551	chr2:70073703	C/T	cg02498382	chr2:70120550	SNRNP27	-0.46	-5.17	-0.51	1.75e-6	Prevalent atrial fibrillation;
SKCM	cis	rs9911578	0.967	rs3826353	chr17:57075299	C/T	cg05425664	chr17:57184151	TRIM37	-0.8	-6.65	-0.6	3.56e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs7659604	0.967	rs34949254	chr4:122664344	G/A	cg06713675	chr4:122721982	EXOSC9	-0.65	-5.83	-0.55	1.21e-7	Type 2 diabetes;
SKCM	cis	rs2739330	0.734	rs2000467	chr22:24241533	C/T	cg25703541	chr22:24373054	LOC391322	0.7	5.4	0.52	6.97e-7	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs71327718	1	rs71327718	chr3:125592857	C/G	cg05084668	chr3:125655381	ALG1L	-1.23	-6.38	-0.59	1.14e-8	Metabolite levels (HVA/5-HIAA ratio);
SKCM	cis	rs10256972	0.577	rs2949179	chr7:1209885	C/G	cg09177884	chr7:1199841	ZFAND2A	-0.84	-6.98	-0.62	8.44e-10	Longevity;Endometriosis;
SKCM	cis	rs1707322	0.928	rs10732844	chr1:46372688	T/C	cg03146154	chr1:46216737	IPP	0.74	5.06	0.5	2.76e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7666738	0.830	rs7659593	chr4:98934823	T/C	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2952156	0.834	rs903503	chr17:37829571	C/A	cg20243544	chr17:37824526	PNMT	0.75	6.2	0.57	2.48e-8	Asthma;
SKCM	cis	rs2832191	0.755	rs55671430	chr21:30492421	G/C	cg08807101	chr21:30365312	RNF160	-0.62	-4.94	-0.49	4.34e-6	Dental caries;
SKCM	cis	rs7666738	0.927	rs6832373	chr4:99051967	A/G	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7103648	0.864	rs10742802	chr11:47432725	T/G	cg20307385	chr11:47447363	PSMC3	1.08	9.26	0.72	3.38e-14	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs34779708	0.733	rs12254018	chr10:35550641	T/A	cg03585969	chr10:35415529	CREM	0.73	5.25	0.51	1.3e-6	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs933688	1.000	rs6862125	chr5:90724598	T/C	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.94	6.54	0.6	5.73e-9	Smoking behavior;
SKCM	cis	rs11710229	1.000	rs11709042	chr3:55479649	G/C	cg04915058	chr3:55693741	C3orf51;ERC2	0.9	5.08	0.5	2.53e-6	Response to cytadine analogues (cytosine arabinoside);
SKCM	cis	rs62560775	0.688	rs3217986	chr9:22005330	G/T	cg13926295	chr9:22009595	CDKN2B;CDKN2BAS	-0.96	-5.85	-0.55	1.08e-7	Lung adenocarcinoma;Lung cancer;
SKCM	cis	rs208520	0.661	rs207111	chr6:66792513	C/T	cg07460842	chr6:66804631	NA	-1.03	-7.65	-0.65	4.49e-11	Exhaled nitric oxide output;
SKCM	cis	rs2204008	0.640	rs2320744	chr12:38162389	A/G	cg26384229	chr12:38710491	ALG10B	0.82	6.58	0.6	4.87e-9	Bladder cancer;
SKCM	cis	rs672059	0.967	rs514183	chr1:183163174	A/C	ch.1.3577855R	chr1:183094577	LAMC1	0.65	5.55	0.53	3.73e-7	Hypertriglyceridemia;
SKCM	cis	rs1005277	0.579	rs2505257	chr10:38372664	A/G	cg25427524	chr10:38739819	LOC399744	-0.69	-6.45	-0.59	8.73e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs9926296	0.605	rs8046243	chr16:89852133	A/G	cg26513180	chr16:89883248	FANCA	0.96	10.53	0.77	1.25e-16	Vitiligo;
SKCM	cis	rs13118159	0.527	rs6599309	chr4:1388115	C/G	cg16405210	chr4:1374714	KIAA1530	-0.97	-6.97	-0.62	9.15e-10	Longevity;
SKCM	cis	rs9447700	1.000	rs6453904	chr6:77173869	C/T	cg08222514	chr6:76312378	SENP6	-0.56	-4.86	-0.48	5.9e-6	Menarche (age at onset);
SKCM	cis	rs9880211	0.563	rs10512990	chr3:135814627	G/T	cg21827317	chr3:136751795	NA	-0.67	-4.9	-0.49	5.06e-6	Body mass index;Height;
SKCM	cis	rs11098499	0.820	rs6534140	chr4:120455311	C/T	cg09307838	chr4:120376055	NA	0.97	7.66	0.66	4.19e-11	Corneal astigmatism;
SKCM	cis	rs1062177	0.826	rs2915873	chr5:151156658	G/A	cg00977110	chr5:151150581	G3BP1	0.8	6.36	0.58	1.25e-8	Preschool internalizing problems;
SKCM	cis	rs16854884	0.657	rs10513235	chr3:143698664	T/C	cg06585982	chr3:143692056	C3orf58	0.82	7.39	0.64	1.41e-10	Economic and political preferences (feminism/equality);
SKCM	cis	rs10503709	0.556	rs1979450	chr8:21481330	A/G	cg23716449	chr8:21608280	GFRA2	-0.52	-5.75	-0.55	1.63e-7	Blood protein levels;
SKCM	cis	rs6952808	1.000	rs4601204	chr7:1890925	C/T	cg04267008	chr7:1944627	MAD1L1	-0.76	-5.74	-0.55	1.7e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs2243480	1.000	rs383402	chr7:65586653	A/C	cg18252515	chr7:66147081	NA	1.35	8.09	0.68	6.24e-12	Diabetic kidney disease;
SKCM	cis	rs9814567	0.896	rs6763188	chr3:134349995	G/A	cg06109529	chr3:134205091	CEP63;ANAPC13	0.63	5.1	0.5	2.35e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs1784581	0.894	rs1790001	chr6:162387504	G/T	cg17173639	chr6:162384350	PARK2	-0.61	-5.44	-0.52	5.99e-7	Itch intensity from mosquito bite;
SKCM	cis	rs9910055	0.529	rs228765	chr17:42186422	C/T	cg08499158	chr17:42289980	UBTF	0.71	5.59	0.53	3.27e-7	Total body bone mineral density;
SKCM	cis	rs7937682	0.602	rs503905	chr11:111390762	G/C	cg09085632	chr11:111637200	PPP2R1B	-0.82	-6.48	-0.59	7.43e-9	Primary sclerosing cholangitis;
SKCM	cis	rs9910055	0.530	rs7222349	chr17:42304644	C/T	cg10896456	chr17:42255109	ASB16;C17orf65	0.54	4.88	0.48	5.61e-6	Total body bone mineral density;
SKCM	cis	rs9911578	0.967	rs7503190	chr17:57184162	A/C	cg05425664	chr17:57184151	TRIM37	-0.83	-7.07	-0.62	5.91e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs9467773	0.620	rs2494696	chr6:26620894	A/G	cg15659132	chr6:26577336	NA	0.62	5.4	0.52	6.91e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs72781680	0.652	rs72794281	chr2:23893265	G/A	cg08917208	chr2:24149416	ATAD2B	0.99	4.97	0.49	3.88e-6	Lymphocyte counts;
SKCM	cis	rs8017423	0.967	rs1959002	chr14:90670994	T/A	cg04374321	chr14:90722782	PSMC1	0.95	8.52	0.69	9.41e-13	Mortality in heart failure;
SKCM	cis	rs4891159	0.790	rs683306	chr18:74112473	C/G	cg24786174	chr18:74118243	ZNF516	-0.75	-7.24	-0.63	2.73e-10	Longevity;
SKCM	cis	rs11122272	0.766	rs2790872	chr1:231540543	A/T	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	-0.64	-5.18	-0.51	1.66e-6	Hemoglobin concentration;
SKCM	cis	rs34172651	0.517	rs12920774	chr16:24830750	T/C	cg04756594	chr16:24857601	SLC5A11	0.71	5.04	0.5	2.92e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7208859	0.623	rs9896603	chr17:29078512	C/G	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs7666738	0.830	rs13110498	chr4:98959150	G/A	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs8141529	0.719	rs5762825	chr22:29223642	A/G	cg02153584	chr22:29168773	CCDC117	0.66	5.35	0.52	8.64e-7	Lymphocyte counts;
SKCM	cis	rs6582630	0.502	rs3902522	chr12:38271203	T/C	cg26384229	chr12:38710491	ALG10B	0.85	6.78	0.61	2.05e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs9790314	0.967	rs7623206	chr3:160971518	G/A	cg03342759	chr3:160939853	NMD3	-0.72	-7.89	-0.67	1.53e-11	Morning vs. evening chronotype;
SKCM	cis	rs11098499	0.754	rs1980026	chr4:120251643	C/A	cg09307838	chr4:120376055	NA	0.91	7.36	0.64	1.63e-10	Corneal astigmatism;
SKCM	cis	rs8067545	0.611	rs8078716	chr17:20044291	G/A	cg13482628	chr17:19912719	NA	0.66	5.61	0.54	2.98e-7	Schizophrenia;
SKCM	cis	rs1577917	0.633	rs7770835	chr6:86608907	A/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.67	-5.86	-0.55	1.07e-7	Response to antipsychotic treatment;
SKCM	cis	rs4819052	0.885	rs9980676	chr21:46665430	A/G	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.36	0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs2836974	0.965	rs6517538	chr21:40656242	C/T	cg11890956	chr21:40555474	PSMG1	1.09	13.83	0.84	1.08e-22	Cognitive function;
SKCM	cis	rs9308433	0.505	rs6695148	chr1:214497861	G/T	cg06198575	chr1:214491504	SMYD2	0.81	5.1	0.5	2.34e-6	IgG glycosylation;
SKCM	cis	rs2228479	0.702	rs2074903	chr16:89811663	T/C	cg06558623	chr16:89946397	TCF25	1.03	5.59	0.53	3.23e-7	Skin colour saturation;
SKCM	cis	rs8060686	0.641	rs28508024	chr16:68126606	T/C	cg09117114	chr16:67998030	SLC12A4	-0.81	-5.29	-0.51	1.07e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs10911251	0.528	rs10911255	chr1:183088868	G/C	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Colorectal cancer;
SKCM	cis	rs875971	1.000	rs35149210	chr7:65929925	T/C	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	cis	rs9915657	0.933	rs8075603	chr17:70136833	G/T	cg06234051	chr17:70120541	SOX9	-0.61	-5.1	-0.5	2.37e-6	Thyroid hormone levels;
SKCM	cis	rs2991971	0.810	rs781058	chr1:45935056	C/G	cg24296786	chr1:45957014	TESK2	-0.64	-5.19	-0.51	1.65e-6	High light scatter reticulocyte count;
SKCM	cis	rs3008870	0.583	rs3008892	chr1:67373558	A/T	cg08660285	chr1:67390436	MIER1;WDR78	0.94	6.1	0.57	3.8e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs9880211	0.562	rs13068210	chr3:135905546	T/G	cg21827317	chr3:136751795	NA	-0.68	-5.3	-0.51	1.05e-6	Body mass index;Height;
SKCM	cis	rs951366	0.764	rs823143	chr1:205743425	A/C	cg17178900	chr1:205818956	PM20D1	0.78	6.68	0.6	3.15e-9	Menarche (age at onset);
SKCM	cis	rs453301	0.624	rs4841083	chr8:8870428	A/G	cg15556689	chr8:8085844	FLJ10661	0.74	5.74	0.55	1.7e-7	Joint mobility (Beighton score);
SKCM	cis	rs1005277	0.579	rs2505194	chr10:38393881	C/T	cg00409905	chr10:38381863	ZNF37A	-0.61	-5.72	-0.54	1.92e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs9788682	0.948	rs34664138	chr15:78831624	T/G	cg06917634	chr15:78832804	PSMA4	-0.82	-4.96	-0.49	3.97e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs25645	0.502	rs8076474	chr17:38111234	G/C	cg17467752	chr17:38218738	THRA	0.65	5.2	0.51	1.53e-6	Myeloid white cell count;
SKCM	cis	rs9815354	0.723	rs79741604	chr3:41947321	C/T	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs3741151	1.000	rs7129663	chr11:73045129	C/T	cg17517138	chr11:73019481	ARHGEF17	1.27	4.87	0.48	5.63e-6	GIP levels in response to oral glucose tolerance test (120 minutes);
SKCM	cis	rs1801251	1.000	rs1947105	chr2:233721455	A/G	cg25237894	chr2:233734115	C2orf82	0.61	5.9	0.56	8.76e-8	Coronary artery disease;
SKCM	cis	rs6120849	0.754	rs6120788	chr20:33583716	C/T	cg24642439	chr20:33292090	TP53INP2	0.94	4.86	0.48	5.91e-6	Protein C levels;
SKCM	cis	rs801193	1.000	rs7789184	chr7:66210195	A/T	cg11764359	chr7:65958608	NA	0.86	6.55	0.6	5.68e-9	Aortic root size;
SKCM	cis	rs6938	0.514	rs56338926	chr15:75259335	C/A	cg09165964	chr15:75287851	SCAMP5	0.7	5.51	0.53	4.53e-7	Breast cancer;
SKCM	cis	rs2282032	1.000	rs115667214	chr14:90733890	A/G	cg04374321	chr14:90722782	PSMC1	0.69	4.86	0.48	5.87e-6	Longevity;
SKCM	cis	rs1801251	0.964	rs6748027	chr2:233629552	T/C	cg25237894	chr2:233734115	C2orf82	0.59	5.66	0.54	2.45e-7	Coronary artery disease;
SKCM	cis	rs35306767	0.761	rs1871621	chr10:1049596	C/T	cg26597838	chr10:835615	NA	0.64	5.23	0.51	1.38e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs2739330	0.731	rs4822450	chr22:24242887	C/T	cg12419862	chr22:24373484	LOC391322	-0.81	-7.89	-0.67	1.52e-11	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs738322	0.805	rs2016755	chr22:38539604	A/G	cg25457927	chr22:38595422	NA	-0.51	-5.8	-0.55	1.32e-7	Cutaneous nevi;
SKCM	cis	rs9581857	0.615	rs9581849	chr13:28005782	G/T	cg22138327	chr13:27999177	GTF3A	0.94	6.32	0.58	1.51e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs2952156	1.000	rs2643194	chr17:37853048	C/T	cg20243544	chr17:37824526	PNMT	0.7	5.61	0.54	2.92e-7	Asthma;
SKCM	cis	rs7666738	0.791	rs28858828	chr4:98950442	C/G	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10489202	0.608	rs35059151	chr1:168079393	C/A	cg24449463	chr1:168025552	DCAF6	-0.81	-7.61	-0.65	5.44e-11	Schizophrenia;
SKCM	trans	rs7618501	1.000	rs7431106	chr3:49808374	G/A	cg21659725	chr3:3221576	CRBN	0.96	9.61	0.74	7.08e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs6088580	0.634	rs6059896	chr20:33111783	T/C	cg24642439	chr20:33292090	TP53INP2	0.75	6.02	0.56	5.32e-8	Glomerular filtration rate (creatinine);
SKCM	trans	rs9929218	0.551	rs6499193	chr16:68727069	C/T	cg04657470	chr2:198365150	HSPE1;HSPD1	0.98	10.11	0.75	7.75e-16	Colorectal cancer;
SKCM	cis	rs4481887	1.000	rs4474293	chr1:248470438	T/C	cg00666640	chr1:248458726	OR2T12	0.61	5.62	0.54	2.86e-7	Common traits (Other);
SKCM	cis	rs2153535	0.580	rs1932281	chr6:8473765	A/G	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs2228479	0.541	rs9806913	chr16:89953773	A/G	cg00800038	chr16:89945340	TCF25	-0.93	-5.57	-0.53	3.49e-7	Skin colour saturation;
SKCM	cis	rs6754311	0.517	rs1865452	chr2:136539330	C/T	cg07169764	chr2:136633963	MCM6	0.89	7.01	0.62	7.69e-10	Mosquito bite size;
SKCM	cis	rs66887589	0.777	rs10015883	chr4:120268146	A/G	cg09307838	chr4:120376055	NA	0.66	4.86	0.48	5.9e-6	Diastolic blood pressure;
SKCM	cis	rs10504229	1.000	rs61733801	chr8:58192513	A/G	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs7824557	0.602	rs7820895	chr8:11206262	T/C	cg21775007	chr8:11205619	TDH	0.72	6.4	0.59	1.09e-8	Retinal vascular caliber;
SKCM	cis	rs9325144	0.671	rs7306605	chr12:38730471	C/T	cg26384229	chr12:38710491	ALG10B	0.78	6.82	0.61	1.76e-9	Morning vs. evening chronotype;
SKCM	cis	rs7618915	0.571	rs34954168	chr3:52612159	C/T	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs1325195	0.537	rs2636289	chr1:179169815	T/A	cg25467746	chr1:179556597	NA	0.65	5.86	0.55	1.04e-7	IgE grass sensitization;
SKCM	cis	rs6951245	1.000	rs118059236	chr7:1073202	A/C	cg03188948	chr7:1209495	NA	1.12	6.17	0.57	2.88e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs9549367	0.713	rs3024776	chr13:113827075	A/G	cg18105134	chr13:113819100	PROZ	0.86	6.38	0.59	1.17e-8	Platelet distribution width;
SKCM	cis	rs11892454	0.544	rs6753192	chr2:25986729	C/A	cg17263061	chr2:26915892	KCNK3	0.72	5.2	0.51	1.53e-6	Heschl's gyrus morphology;
SKCM	cis	rs6430585	0.759	rs4954623	chr2:136535876	G/A	cg07169764	chr2:136633963	MCM6	-1.31	-13.14	-0.83	1.86e-21	Corneal structure;
SKCM	cis	rs11098499	0.691	rs12510133	chr4:120271344	A/C	cg09307838	chr4:120376055	NA	0.94	7.73	0.66	3.07e-11	Corneal astigmatism;
SKCM	cis	rs8037137	0.915	rs2301825	chr15:91528070	C/G	cg15878949	chr15:91534302	PRC1	0.68	5.17	0.51	1.77e-6	Platelet count;Serous invasive ovarian cancer;High-grade serous ovarian cancer;Invasive epithelial ovarian cancer;
SKCM	cis	rs2243480	0.908	rs4718273	chr7:65216099	G/A	cg18252515	chr7:66147081	NA	1.32	8.71	0.7	3.95e-13	Diabetic kidney disease;
SKCM	cis	rs941408	0.964	rs1736186	chr19:2815372	A/G	cg17333051	chr19:2783644	SGTA	0.43	5.19	0.51	1.6e-6	Total cholesterol levels;
SKCM	cis	rs1707322	0.963	rs12076580	chr1:46258159	G/A	cg03146154	chr1:46216737	IPP	0.74	5.0	0.49	3.39e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7208859	0.623	rs9916727	chr17:29107472	A/G	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs1799949	1.000	rs4340367	chr17:41307772	G/A	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.15	-0.57	3.16e-8	Menopause (age at onset);
SKCM	cis	rs1005277	0.505	rs200939	chr10:38139483	T/C	cg25427524	chr10:38739819	LOC399744	-0.68	-6.52	-0.59	6.36e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs228769	1.000	rs228769	chr17:42193185	G/C	cg19774624	chr17:42201019	HDAC5	0.91	6.4	0.59	1.08e-8	Bone mineral density (hip);Bone mineral density (spine);
SKCM	cis	rs1160297	0.585	rs2356681	chr2:53097750	C/T	cg07782112	chr2:53107842	NA	0.59	6.3	0.58	1.63e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs7772486	0.603	rs2223411	chr6:146028767	T/C	cg05347473	chr6:146136440	FBXO30	-0.68	-5.98	-0.56	6.3e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs754466	0.580	rs10430530	chr10:79582812	T/C	cg17075019	chr10:79541650	NA	-0.81	-7.17	-0.63	3.73e-10	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs514406	0.755	rs10888754	chr1:53228751	C/G	cg24675658	chr1:53192096	ZYG11B	0.61	4.77	0.48	8.47e-6	Monocyte count;
SKCM	trans	rs12599106	0.660	rs12919333	chr16:34991336	C/T	cg03395511	chr6:291903	DUSP22	-0.71	-7.47	-0.65	9.92e-11	Menopause (age at onset);
SKCM	cis	rs769267	0.896	rs11882123	chr19:19386339	A/G	cg26732615	chr19:19648335	CILP2;YJEFN3	0.62	5.67	0.54	2.31e-7	Tonsillectomy;
SKCM	cis	rs2153535	0.601	rs9328487	chr6:8529378	G/C	cg23788917	chr6:8435910	SLC35B3	0.68	4.98	0.49	3.66e-6	Motion sickness;
SKCM	cis	rs12497850	0.931	rs9682444	chr3:48852639	A/G	cg07636037	chr3:49044803	WDR6	1.01	10.82	0.77	3.36e-17	Parkinson's disease;
SKCM	cis	rs4665809	0.590	rs10495756	chr2:26485586	A/G	cg26119090	chr2:26468346	HADHA;HADHB	1.06	8.39	0.69	1.66e-12	Gut microbiome composition (summer);
SKCM	cis	rs58688157	0.960	rs1055382	chr11:612182	T/C	cg03576123	chr11:487126	PTDSS2	-0.84	-5.45	-0.53	5.64e-7	Systemic lupus erythematosus;
SKCM	cis	rs7666738	0.830	rs17486413	chr4:99060544	G/T	cg17366294	chr4:99064904	C4orf37	0.57	4.88	0.48	5.48e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs28595532	0.920	rs115706007	chr4:119733638	C/T	cg21605333	chr4:119757512	SEC24D	1.36	8.05	0.67	7.69e-12	Cannabis dependence symptom count;
SKCM	cis	rs17376456	0.825	rs12153021	chr5:93073913	A/G	cg25358565	chr5:93447407	FAM172A	1.15	7.28	0.64	2.25e-10	Diabetic retinopathy;
SKCM	cis	rs875971	1.000	rs2036264	chr7:65799904	G/A	cg11764359	chr7:65958608	NA	-0.88	-8.54	-0.7	8.36e-13	Aortic root size;
SKCM	cis	rs2929278	0.561	rs2927071	chr15:43919081	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	0.76	5.52	0.53	4.3e-7	Schizophrenia;
SKCM	cis	rs769267	0.930	rs10422819	chr19:19643028	C/A	cg26732615	chr19:19648335	CILP2;YJEFN3	0.67	7.06	0.62	6e-10	Tonsillectomy;
SKCM	cis	rs9910055	0.708	rs2631298	chr17:42219832	T/C	cg09913183	chr17:42254507	C17orf65;ASB16	0.68	6.39	0.59	1.1e-8	Total body bone mineral density;
SKCM	trans	rs17685	0.712	rs1639620	chr7:75704090	A/G	cg19862616	chr7:65841803	NCRNA00174	0.94	9.45	0.73	1.46e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs8103278	1.000	rs9807819	chr19:46239598	C/T	cg11657440	chr19:46296263	DMWD	-0.92	-6.79	-0.61	1.97e-9	Coronary artery disease;
SKCM	cis	rs9611565	0.512	rs6519289	chr22:42170432	A/C	cg03806693	chr22:41940476	POLR3H	1.17	6.46	0.59	8.4e-9	Vitiligo;
SKCM	cis	rs1691799	0.899	rs1168303	chr12:66738586	A/G	cg16791601	chr12:66731901	HELB	-0.66	-5.81	-0.55	1.31e-7	White blood cell count (basophil);
SKCM	cis	rs28595532	0.920	rs115320476	chr4:119759680	G/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs2120019	0.938	rs35911108	chr15:75322179	G/A	cg17294928	chr15:75287854	SCAMP5	-0.89	-8.91	-0.71	1.6e-13	Blood trace element (Zn levels);
SKCM	cis	rs72634258	0.945	rs17367289	chr1:8053135	C/T	cg00042356	chr1:8021962	PARK7	-0.84	-6.19	-0.57	2.66e-8	Inflammatory bowel disease;
SKCM	cis	rs35306767	0.903	rs10508208	chr10:910983	C/T	cg26597838	chr10:835615	NA	0.76	5.64	0.54	2.61e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs7937682	0.737	rs518294	chr11:111424716	A/T	cg09085632	chr11:111637200	PPP2R1B	-0.81	-6.99	-0.62	8.14e-10	Primary sclerosing cholangitis;
SKCM	cis	rs995000	0.868	rs1168107	chr1:63161173	A/T	cg06896770	chr1:63153194	DOCK7	-0.77	-6.74	-0.61	2.41e-9	Triglyceride levels;
SKCM	cis	rs1878931	0.597	rs37816	chr16:3456371	G/A	cg26668626	chr16:3451006	ZNF174;ZNF434	-0.8	-5.69	-0.54	2.16e-7	Body mass index (adult);
SKCM	cis	rs2811415	0.597	rs9822021	chr3:127735238	T/C	cg09089421	chr3:127803668	RUVBL1	1.0	8.57	0.7	7.53e-13	Lung function (FEV1/FVC);
SKCM	cis	rs10489202	1.000	rs11587594	chr1:167989180	A/T	cg24449463	chr1:168025552	DCAF6	-0.8	-6.19	-0.57	2.58e-8	Schizophrenia;
SKCM	cis	rs1003719	0.788	rs4817845	chr21:38447132	T/C	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs2439831	1.000	rs28628574	chr15:43802038	A/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.32	8.44	0.69	1.3e-12	Lung cancer in ever smokers;
SKCM	cis	rs736408	0.609	rs1029871	chr3:52797634	G/C	cg18404041	chr3:52824283	ITIH1	-0.56	-4.94	-0.49	4.32e-6	Bipolar disorder;
SKCM	cis	rs7618915	0.571	rs12487445	chr3:52618319	A/C	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs9633740	1.000	rs7097656	chr10:82250831	T/C	cg01528321	chr10:82214614	TSPAN14	0.85	6.72	0.61	2.73e-9	Post bronchodilator FEV1;
SKCM	cis	rs7954584	0.567	rs1720037	chr12:122382229	G/T	cg01765077	chr12:122356316	WDR66	-0.44	-4.88	-0.48	5.48e-6	Mean corpuscular volume;
SKCM	cis	rs2836974	0.899	rs114399588	chr21:40653958	G/A	cg11890956	chr21:40555474	PSMG1	1.09	13.83	0.84	1.08e-22	Cognitive function;
SKCM	cis	rs8114671	0.967	rs2069945	chr20:33761837	C/A	cg04194272	chr20:33683537	NA	-1.01	-5.32	-0.52	9.6e-7	Height;
SKCM	cis	rs2228479	0.850	rs45567439	chr16:89814604	G/A	cg06558623	chr16:89946397	TCF25	1.02	4.98	0.49	3.66e-6	Skin colour saturation;
SKCM	cis	rs473651	0.935	rs559579	chr2:239339501	G/C	cg18131467	chr2:239335373	ASB1	1.09	11.83	0.8	4.46e-19	Multiple system atrophy;
SKCM	cis	rs9790314	0.779	rs12493960	chr3:160899772	T/C	cg03342759	chr3:160939853	NMD3	-0.63	-6.47	-0.59	7.84e-9	Morning vs. evening chronotype;
SKCM	cis	rs1949733	1.000	rs3103067	chr4:8511223	A/G	cg11789530	chr4:8429930	ACOX3	0.82	5.68	0.54	2.22e-7	Response to antineoplastic agents;
SKCM	cis	rs929354	0.935	rs1182392	chr7:157036200	C/T	cg17757837	chr7:157058334	UBE3C	-0.89	-6.78	-0.61	2.03e-9	Body mass index;
SKCM	cis	rs6977660	0.660	rs10269891	chr7:19816063	T/C	cg05791153	chr7:19748676	TWISTNB	0.82	5.13	0.5	2.04e-6	Thyroid stimulating hormone;
SKCM	cis	rs2050392	0.624	rs303447	chr10:30728464	T/C	cg25182066	chr10:30743637	MAP3K8	-0.65	-5.3	-0.51	1.05e-6	Inflammatory bowel disease;
SKCM	cis	rs3784262	1.000	rs9325	chr15:58245986	A/T	cg12031962	chr15:58353849	ALDH1A2	0.51	6.6	0.6	4.46e-9	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	trans	rs2727020	0.701	rs7949044	chr11:49597334	C/T	cg15704280	chr7:45808275	SEPT13	-0.93	-7.98	-0.67	1.04e-11	Coronary artery disease;
SKCM	cis	rs875971	0.545	rs7811204	chr7:65852200	G/A	cg18876405	chr7:65276391	NA	0.61	4.84	0.48	6.44e-6	Aortic root size;
SKCM	cis	rs7143963	0.636	rs7152791	chr14:103293716	C/T	cg23020514	chr14:103360112	TRAF3	0.7	6.62	0.6	4.11e-9	Body mass index;
SKCM	cis	rs875971	0.638	rs35986979	chr7:66088990	G/A	cg18876405	chr7:65276391	NA	-0.82	-7.48	-0.65	9.41e-11	Aortic root size;
SKCM	trans	rs1814175	0.591	rs11040589	chr11:49862449	A/G	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs9300255	0.566	rs10744150	chr12:123721614	A/C	cg05973401	chr12:123451056	ABCB9	0.75	5.83	0.55	1.18e-7	Neutrophil percentage of white cells;
SKCM	cis	rs2836950	0.501	rs2836983	chr21:40689336	G/A	cg17971929	chr21:40555470	PSMG1	-0.64	-5.1	-0.5	2.31e-6	Menarche (age at onset);
SKCM	trans	rs17685	0.712	rs6953342	chr7:75776753	T/C	cg19862616	chr7:65841803	NCRNA00174	0.88	8.34	0.69	2.1e-12	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs9300255	0.679	rs4759409	chr12:123719585	G/C	cg00376283	chr12:123451042	ABCB9	0.84	5.91	0.56	8.5e-8	Neutrophil percentage of white cells;
SKCM	cis	rs801193	0.935	rs2659899	chr7:66186721	A/G	cg11764359	chr7:65958608	NA	0.86	6.55	0.6	5.68e-9	Aortic root size;
SKCM	cis	rs1405130	0.869	rs12995365	chr2:235565703	A/G	cg17841421	chr2:235704848	NA	-0.57	-4.95	-0.49	4.14e-6	Coronary artery disease;
SKCM	cis	rs4423214	0.918	rs11233789	chr11:71181085	A/G	cg05163923	chr11:71159392	DHCR7	0.81	7.67	0.66	4.09e-11	Vitamin D levels;
SKCM	cis	rs2832191	0.692	rs2776240	chr21:30310639	C/T	cg08807101	chr21:30365312	RNF160	0.71	6.0	0.56	5.88e-8	Dental caries;
SKCM	cis	rs9581857	0.685	rs79699519	chr13:28023241	C/T	cg22138327	chr13:27999177	GTF3A	0.72	5.05	0.5	2.88e-6	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs7772486	0.654	rs1011597	chr6:146075672	A/C	cg05347473	chr6:146136440	FBXO30	-0.55	-5.11	-0.5	2.27e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9399135	0.967	rs9389256	chr6:135331254	A/C	cg24558204	chr6:135376177	HBS1L	0.59	5.23	0.51	1.41e-6	Red blood cell count;
SKCM	cis	rs2836950	0.520	rs11911087	chr21:40665192	G/A	cg11890956	chr21:40555474	PSMG1	-0.66	-5.26	-0.51	1.22e-6	Menarche (age at onset);
SKCM	cis	rs4665809	0.590	rs13006973	chr2:26454707	C/T	cg26119090	chr2:26468346	HADHA;HADHB	1.06	8.39	0.69	1.66e-12	Gut microbiome composition (summer);
SKCM	cis	rs898097	0.845	rs7213006	chr17:80899928	T/C	cg05255149	chr17:80675120	FN3KRP	0.73	5.52	0.53	4.25e-7	Breast cancer;
SKCM	cis	rs11718455	0.767	rs9861276	chr3:43989595	C/T	cg21419209	chr3:44054225	NA	-0.62	-5.06	-0.5	2.75e-6	Coronary artery disease;
SKCM	cis	rs7143963	1.000	rs4906267	chr14:103305077	G/T	cg23020514	chr14:103360112	TRAF3	0.9	8.54	0.7	8.45e-13	Body mass index;
SKCM	cis	rs950776	0.647	rs495956	chr15:78869930	C/T	cg06917634	chr15:78832804	PSMA4	-0.85	-6.83	-0.61	1.68e-9	Sudden cardiac arrest;
SKCM	cis	rs7208859	0.623	rs9891166	chr17:29111902	G/A	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs2354432	0.607	rs4314933	chr1:146821386	T/C	cg25205988	chr1:146714368	CHD1L	1.14	6.27	0.58	1.87e-8	Mitochondrial DNA levels;
SKCM	cis	rs951366	0.677	rs1775140	chr1:205672107	C/A	cg07167872	chr1:205819463	PM20D1	0.84	6.75	0.61	2.39e-9	Menarche (age at onset);
SKCM	cis	rs1577917	0.682	rs6909767	chr6:86228109	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.73	6.52	0.59	6.4e-9	Response to antipsychotic treatment;
SKCM	cis	rs7829975	0.514	rs2945873	chr8:8260445	C/T	cg08975724	chr8:8085496	FLJ10661	0.62	4.88	0.48	5.61e-6	Mood instability;
SKCM	cis	rs1707322	0.655	rs3014240	chr1:46089225	C/G	cg03146154	chr1:46216737	IPP	-0.8	-5.59	-0.53	3.22e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs1552244	0.882	rs36006511	chr3:10054191	C/T	cg02579736	chr3:10068473	FANCD2;CIDECP	0.98	4.84	0.48	6.48e-6	Alzheimer's disease;
SKCM	cis	rs854765	0.547	rs2955356	chr17:17964717	G/A	cg04398451	chr17:18023971	MYO15A	0.84	6.78	0.61	2.05e-9	Total body bone mineral density;
SKCM	cis	rs2033711	0.728	rs4801586	chr19:58934528	A/G	cg12042659	chr19:58951599	ZNF132	0.68	5.86	0.55	1.04e-7	Uric acid clearance;
SKCM	cis	rs992157	0.835	rs2292551	chr2:219143229	G/A	cg00012203	chr2:219082015	ARPC2	-0.74	-5.97	-0.56	6.53e-8	Colorectal cancer;
SKCM	cis	rs2839186	0.867	rs13050387	chr21:47701423	C/T	cg11766577	chr21:47581405	C21orf56	-0.68	-5.69	-0.54	2.1e-7	Testicular germ cell tumor;
SKCM	cis	rs7811142	1.000	rs113738841	chr7:100081306	C/T	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.14	6.58	0.6	4.83e-9	Platelet count;
SKCM	cis	rs9467773	1.000	rs1535277	chr6:26567802	G/T	cg09904177	chr6:26538194	HMGN4	0.54	4.91	0.49	4.97e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7809950	1.000	rs10274041	chr7:107261556	C/T	cg23024343	chr7:107201750	COG5	0.89	8.21	0.68	3.64e-12	Coronary artery disease;
SKCM	cis	rs9910055	0.762	rs227579	chr17:42223134	A/T	cg10896456	chr17:42255109	ASB16;C17orf65	-0.68	-6.7	-0.6	2.97e-9	Total body bone mineral density;
SKCM	cis	rs4148883	0.689	rs1800760	chr4:100065626	A/T	cg12011299	chr4:100065546	ADH4	0.5	4.78	0.48	8.17e-6	Alcohol dependence;
SKCM	cis	rs2153535	0.606	rs11243253	chr6:8380193	T/C	cg23788917	chr6:8435910	SLC35B3	-0.64	-5.37	-0.52	7.79e-7	Motion sickness;
SKCM	cis	rs2251381	0.722	rs2776252	chr21:30531705	G/A	cg24692254	chr21:30365293	RNF160	0.78	6.09	0.57	3.93e-8	Selective IgA deficiency;
SKCM	cis	rs898097	0.783	rs11650335	chr17:80835111	A/G	cg15369054	chr17:80825471	TBCD	0.66	6.18	0.57	2.69e-8	Breast cancer;
SKCM	cis	rs2739330	0.828	rs5751770	chr22:24252842	A/G	cg24846343	chr22:24311635	DDTL	0.61	5.9	0.56	8.97e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs11098499	0.954	rs11940028	chr4:120411907	T/C	cg24375607	chr4:120327624	NA	0.65	5.01	0.49	3.32e-6	Corneal astigmatism;
SKCM	cis	rs1476679	0.962	rs34995835	chr7:99990364	T/G	cg22906224	chr7:99728672	NA	-0.63	-4.92	-0.49	4.76e-6	Alzheimer's disease (late onset);
SKCM	cis	rs4819052	1.000	rs28628220	chr21:46663741	G/C	cg02159808	chr21:46707872	POFUT2;LOC642852	0.79	5.87	0.55	1.01e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs875971	0.867	rs1002053	chr7:65798545	G/A	cg18876405	chr7:65276391	NA	-0.68	-6.79	-0.61	1.96e-9	Aortic root size;
SKCM	cis	rs12142240	0.667	rs12062	chr1:46830447	G/T	cg14993813	chr1:46806288	NSUN4	0.69	4.77	0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs7666738	0.830	rs2019163	chr4:99022747	C/T	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.9e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2050392	0.624	rs303436	chr10:30731893	G/T	cg25182066	chr10:30743637	MAP3K8	-0.65	-5.37	-0.52	7.97e-7	Inflammatory bowel disease;
SKCM	cis	rs826838	1.000	rs1719848	chr12:39085586	A/G	cg26384229	chr12:38710491	ALG10B	-0.96	-7.96	-0.67	1.15e-11	Heart rate;
SKCM	cis	rs753778	0.628	rs11579	chr8:142205132	G/A	cg18755752	chr8:142205143	DENND3	-0.69	-5.81	-0.55	1.29e-7	Reticulocyte fraction of red cells;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs9880211	0.613	rs28535121	chr3:135892798	T/C	cg21827317	chr3:136751795	NA	-0.68	-5.3	-0.51	1.05e-6	Body mass index;Height;
SKCM	cis	rs736408	0.812	rs9881468	chr3:52828628	C/T	cg18404041	chr3:52824283	ITIH1	-0.62	-5.25	-0.51	1.26e-6	Bipolar disorder;
SKCM	cis	rs514406	0.798	rs504816	chr1:53307957	T/G	cg16325326	chr1:53192061	ZYG11B	0.81	7.43	0.64	1.19e-10	Monocyte count;
SKCM	cis	rs116095464	0.867	rs7726582	chr5:215349	C/G	cg22857025	chr5:266934	NA	-1.36	-8.0	-0.67	9.23e-12	Breast cancer;
SKCM	cis	rs8177253	0.965	rs7638018	chr3:133495461	C/T	cg16414030	chr3:133502952	NA	0.7	5.93	0.56	7.88e-8	Iron status biomarkers;
SKCM	cis	rs11112613	0.713	rs73184082	chr12:105951748	T/C	cg03607813	chr12:105948248	NA	0.84	5.44	0.52	5.84e-7	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;
SKCM	cis	rs12586317	0.547	rs115019197	chr14:35503764	G/A	cg16230307	chr14:35515116	FAM177A1	0.83	6.08	0.57	4.19e-8	Psoriasis;
SKCM	cis	rs7772486	0.754	rs2328709	chr6:146106819	A/G	cg05347473	chr6:146136440	FBXO30	-0.61	-5.73	-0.54	1.82e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6545883	0.894	rs12997538	chr2:61564249	A/C	cg15711740	chr2:61764176	XPO1	0.72	5.13	0.5	2.07e-6	Tuberculosis;
SKCM	cis	rs9543976	1.000	rs1535724	chr13:76183273	G/C	cg16409306	chr13:76195284	LMO7	0.84	4.79	0.48	7.87e-6	Diabetic retinopathy;
SKCM	cis	rs2842992	0.789	rs10945635	chr6:160214487	C/A	cg19482086	chr6:160211437	TCP1;MRPL18	0.82	6.24	0.58	2.11e-8	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs933688	1.000	rs7715402	chr5:90679504	T/A	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.12	8.63	0.7	5.55e-13	Smoking behavior;
SKCM	cis	rs6912958	0.684	rs6931069	chr6:88367082	C/T	cg08069147	chr6:88032118	GJB7;C6orf162	-0.64	-4.95	-0.49	4.14e-6	Monocyte percentage of white cells;
SKCM	cis	rs10504229	0.683	rs6999984	chr8:58115079	G/A	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs6450176	1.000	rs3776717	chr5:53298762	G/A	ch.5.1024479R	chr5:53302184	ARL15	-0.71	-4.88	-0.48	5.49e-6	HDL cholesterol levels;HDL cholesterol;Adiponectin levels;
SKCM	cis	rs9790314	1.000	rs7653361	chr3:160992291	C/T	cg03342759	chr3:160939853	NMD3	-0.72	-7.89	-0.67	1.53e-11	Morning vs. evening chronotype;
SKCM	cis	rs9788682	0.747	rs11637630	chr15:78899719	G/A	cg24631222	chr15:78858424	CHRNA5	-0.82	-6.39	-0.59	1.1e-8	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs453301	0.686	rs28482034	chr8:8869664	G/A	cg06636001	chr8:8085503	FLJ10661	-0.75	-5.62	-0.54	2.83e-7	Joint mobility (Beighton score);
SKCM	cis	rs17685	0.753	rs6951943	chr7:75772452	A/G	cg16489192	chr7:75678113	MDH2;STYXL1	-0.54	-5.07	-0.5	2.64e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2836974	0.897	rs13049280	chr21:40594656	C/G	cg11890956	chr21:40555474	PSMG1	1.09	13.83	0.84	1.08e-22	Cognitive function;
SKCM	cis	rs6866344	0.697	rs62392823	chr5:178126968	T/C	cg03877680	chr5:178157825	ZNF354A	0.82	5.7	0.54	2.03e-7	Neutrophil percentage of white cells;
SKCM	cis	rs11098499	0.618	rs28491261	chr4:120294900	C/A	cg09307838	chr4:120376055	NA	0.98	7.55	0.65	7e-11	Corneal astigmatism;
SKCM	cis	rs1005277	0.579	rs1614236	chr10:38502996	C/T	cg00409905	chr10:38381863	ZNF37A	-0.61	-5.26	-0.51	1.2e-6	Extrinsic epigenetic age acceleration;
SKCM	cis	rs3785574	0.962	rs13030	chr17:61908556	C/T	cg06873352	chr17:61820015	STRADA	0.56	4.82	0.48	6.86e-6	Height;
SKCM	cis	rs28386778	0.897	rs11654841	chr17:61838259	C/T	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs17065868	1.000	rs61949805	chr13:45052265	G/C	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs1005277	0.579	rs2472183	chr10:38392495	T/G	cg25427524	chr10:38739819	LOC399744	-0.69	-6.45	-0.59	8.73e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs2239547	0.657	rs4687672	chr3:52880543	G/A	cg11645453	chr3:52864694	ITIH4	0.79	7.19	0.63	3.41e-10	Schizophrenia;
SKCM	cis	rs16854884	0.683	rs2053211	chr3:143774592	C/T	cg06585982	chr3:143692056	C3orf58	-0.63	-5.27	-0.51	1.2e-6	Economic and political preferences (feminism/equality);
SKCM	cis	rs28374715	0.578	rs7169543	chr15:41620405	T/C	cg18705301	chr15:41695430	NDUFAF1	-1.21	-12.61	-0.82	1.61e-20	Ulcerative colitis;
SKCM	cis	rs7937682	0.889	rs7948236	chr11:111499933	C/A	cg09085632	chr11:111637200	PPP2R1B	-1.07	-11.23	-0.79	5.72e-18	Primary sclerosing cholangitis;
SKCM	cis	rs951366	0.764	rs708725	chr1:205744138	G/T	cg17178900	chr1:205818956	PM20D1	0.76	6.55	0.6	5.54e-9	Menarche (age at onset);
SKCM	cis	rs7666738	0.830	rs4699591	chr4:98974171	A/G	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1552244	0.688	rs9875667	chr3:10180041	T/C	cg02579736	chr3:10068473	FANCD2;CIDECP	0.92	5.24	0.51	1.31e-6	Alzheimer's disease;
SKCM	cis	rs6430585	0.528	rs309113	chr2:136737460	C/A	cg07169764	chr2:136633963	MCM6	1.25	10.32	0.76	3.02e-16	Corneal structure;
SKCM	cis	rs9513627	0.834	rs73556197	chr13:100128479	A/G	cg11288260	chr13:100117058	NA	-0.8	-4.77	-0.48	8.48e-6	Obesity-related traits;
SKCM	cis	rs4862750	0.872	rs6830828	chr4:187897472	T/G	cg10295955	chr4:187884368	NA	-1.04	-14.07	-0.85	4.23e-23	Lobe attachment (rater-scored or self-reported);
SKCM	trans	rs1814175	0.645	rs28441045	chr11:50048971	C/T	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs9457247	0.765	rs10484531	chr6:167454434	G/A	cg13927040	chr6:167453801	FGFR1OP	0.61	4.78	0.48	8.16e-6	Crohn's disease;
SKCM	cis	rs7086627	0.515	rs12245180	chr10:82211897	C/G	cg00277334	chr10:82204260	NA	-0.75	-8.99	-0.71	1.12e-13	Post bronchodilator FEV1;
SKCM	cis	rs2739330	0.703	rs5760112	chr22:24259772	C/G	cg12419862	chr22:24373484	LOC391322	-0.77	-7.51	-0.65	8.14e-11	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs7523273	0.606	rs2488254	chr1:207941539	A/G	cg22525895	chr1:207977042	MIR29B2	0.81	7.08	0.63	5.47e-10	Schizophrenia;
SKCM	cis	rs9902453	0.904	rs8078638	chr17:28290358	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.8	6.28	0.58	1.79e-8	Coffee consumption (cups per day);
SKCM	cis	rs7539542	0.556	rs10753926	chr1:202876085	C/T	cg19681188	chr1:202830198	LOC148709	0.81	5.65	0.54	2.54e-7	Mean platelet volume;
SKCM	cis	rs9303401	0.661	rs9902820	chr17:56637545	A/C	cg02118635	chr17:56770003	RAD51C;TEX14	0.65	4.94	0.49	4.43e-6	Cognitive test performance;
SKCM	cis	rs2050392	1.000	rs2489864	chr10:30693744	C/G	cg25182066	chr10:30743637	MAP3K8	-0.66	-5.47	-0.53	5.15e-7	Inflammatory bowel disease;
SKCM	cis	rs8077889	1.000	rs8077889	chr17:41878166	G/T	cg26893861	chr17:41843967	DUSP3	-1.14	-7.62	-0.65	5.08e-11	Triglycerides;
SKCM	cis	rs28595532	0.920	rs114940990	chr4:119758568	A/G	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs67311347	1.000	rs11715214	chr3:40403004	C/A	cg00091569	chr3:40428383	ENTPD3	0.65	5.58	0.53	3.36e-7	Renal cell carcinoma;
SKCM	cis	rs1801251	1.000	rs13035829	chr2:233604487	A/T	cg25237894	chr2:233734115	C2orf82	0.56	5.33	0.52	9.23e-7	Coronary artery disease;
SKCM	cis	rs6570726	0.791	rs11155432	chr6:145898761	T/C	cg05347473	chr6:146136440	FBXO30	0.58	5.16	0.5	1.82e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1005277	0.540	rs289638	chr10:37923731	G/A	cg00409905	chr10:38381863	ZNF37A	-0.57	-5.62	-0.54	2.86e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs992157	0.932	rs10203039	chr2:219187367	T/C	cg20019365	chr2:219134978	PNKD;AAMP	0.78	6.53	0.59	6.1e-9	Colorectal cancer;
SKCM	cis	rs7829975	0.686	rs907180	chr8:8702827	A/G	cg15556689	chr8:8085844	FLJ10661	0.74	6.06	0.57	4.5e-8	Mood instability;
SKCM	cis	rs908922	0.676	rs526099	chr1:152497811	T/C	cg09873164	chr1:152488093	CRCT1	0.76	5.93	0.56	7.7e-8	Hair morphology;
SKCM	cis	rs362272	0.505	rs2857854	chr4:3043184	G/T	cg24015175	chr4:3319247	RGS12	0.55	4.89	0.48	5.24e-6	Serum sulfate level;
SKCM	cis	rs9902453	0.967	rs8072664	chr17:28333385	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.81	-5.78	-0.55	1.45e-7	Coffee consumption (cups per day);
SKCM	cis	rs11690935	0.959	rs76324055	chr2:172620150	T/A	cg13550731	chr2:172543902	DYNC1I2	-0.94	-7.71	-0.66	3.41e-11	Schizophrenia;
SKCM	cis	rs4561483	0.801	rs251723	chr16:11953080	G/C	cg08843971	chr16:11963173	GSPT1	-0.7	-5.39	-0.52	7.27e-7	Testicular germ cell tumor;
SKCM	cis	rs589448	0.902	rs2603090	chr12:69777188	G/A	cg22834771	chr12:69754056	YEATS4	-0.72	-5.81	-0.55	1.31e-7	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs1878931	0.555	rs27228	chr16:3431933	C/T	cg26668626	chr16:3451006	ZNF174;ZNF434	-0.92	-6.57	-0.6	5.08e-9	Body mass index (adult);
SKCM	cis	rs16854884	0.582	rs35211123	chr3:143640171	A/T	cg06585982	chr3:143692056	C3orf58	0.8	7.27	0.64	2.45e-10	Economic and political preferences (feminism/equality);
SKCM	cis	rs10193935	1.000	rs12612527	chr2:42392099	T/C	cg27598129	chr2:42591480	NA	-0.92	-6.79	-0.61	1.97e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2288073	0.965	rs10199334	chr2:24392618	T/C	cg06627628	chr2:24431161	ITSN2	-0.76	-5.24	-0.51	1.31e-6	Venous thromboembolism (SNP x SNP interaction);
SKCM	cis	rs10883723	0.810	rs2296588	chr10:104248087	T/C	cg11453585	chr10:104263688	ACTR1A;SUFU	0.72	5.31	0.52	1e-6	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs769267	0.930	rs7254748	chr19:19397479	A/C	cg03709012	chr19:19516395	GATAD2A	0.82	6.73	0.61	2.6e-9	Tonsillectomy;
SKCM	cis	rs2404602	0.647	rs12904417	chr15:76964152	A/G	cg23625390	chr15:77176239	SCAPER	0.85	8.26	0.68	2.93e-12	Blood metabolite levels;
SKCM	cis	rs9611565	0.649	rs126092	chr22:42178441	A/G	cg03806693	chr22:41940476	POLR3H	0.97	6.66	0.6	3.51e-9	Vitiligo;
SKCM	trans	rs9329221	0.905	rs28712068	chr8:10251145	G/C	cg06636001	chr8:8085503	FLJ10661	-0.86	-7.65	-0.65	4.43e-11	Neuroticism;
SKCM	cis	rs7100689	0.646	rs7903701	chr10:82129268	T/C	cg01528321	chr10:82214614	TSPAN14	0.8	7.0	0.62	7.98e-10	Post bronchodilator FEV1;
SKCM	cis	rs1577917	0.771	rs2758844	chr6:86330115	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.83	-7.76	-0.66	2.77e-11	Response to antipsychotic treatment;
SKCM	cis	rs7683537	0.725	rs28837443	chr4:185641497	G/A	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Systemic lupus erythematosus;
SKCM	cis	rs614226	0.935	rs17431717	chr12:120912210	G/A	cg01236616	chr12:121019343	POP5	-1.38	-7.6	-0.65	5.55e-11	Type 1 diabetes nephropathy;
SKCM	cis	rs9475752	0.552	rs13216793	chr6:56739387	T/A	cg06815302	chr6:57335405	PRIM2	0.66	4.87	0.48	5.61e-6	Menarche (age at onset);
SKCM	cis	rs9399137	0.507	rs7745289	chr6:135380327	A/G	cg24558204	chr6:135376177	HBS1L	0.64	5.49	0.53	4.93e-7	Glycated hemoglobin levels;Mean corpuscular volume;Hematology traits;HbA2 levels;Mean corpuscular hemoglobin;Hemoglobin levels;F-cell distribution;Platelet count;
SKCM	cis	rs9902453	0.833	rs7216631	chr17:28495112	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.79	6.03	0.56	5.24e-8	Coffee consumption (cups per day);
SKCM	cis	rs873946	0.648	rs12783354	chr10:134557235	T/A	cg27286337	chr10:134555280	INPP5A	0.96	8.42	0.69	1.47e-12	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs2153535	0.580	rs6921036	chr6:8455400	G/A	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs4237845	0.537	rs11172369	chr12:58280592	T/C	cg02175503	chr12:58329896	NA	0.73	5.87	0.55	9.96e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs9818758	0.607	rs11710247	chr3:49249800	G/T	cg00383909	chr3:49044727	WDR6	0.94	5.35	0.52	8.49e-7	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs6952808	0.531	rs3800922	chr7:2184505	A/G	cg05863683	chr7:1912471	MAD1L1	0.58	4.95	0.49	4.27e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs2777491	0.707	rs1757456	chr15:41793494	A/T	cg18705301	chr15:41695430	NDUFAF1	-1.02	-10.17	-0.75	6.03e-16	Ulcerative colitis;
SKCM	cis	rs514406	0.760	rs1242198	chr1:53352016	G/A	cg08859206	chr1:53392774	SCP2	-0.61	-4.79	-0.48	7.82e-6	Monocyte count;
SKCM	cis	rs523522	0.962	rs3742052	chr12:120966921	A/G	cg27279351	chr12:120934652	DYNLL1	0.91	8.32	0.69	2.26e-12	High light scatter reticulocyte count;
SKCM	cis	rs1580019	0.563	rs2392071	chr7:32572536	G/A	cg06627557	chr7:32535165	LSM5;AVL9	0.94	9.12	0.72	6.39e-14	Cognitive ability;
SKCM	cis	rs9910055	0.509	rs9916444	chr17:42313512	C/G	cg08499158	chr17:42289980	UBTF	-0.79	-6.91	-0.62	1.15e-9	Total body bone mineral density;
SKCM	cis	rs912057	1.000	rs1294407	chr6:6738103	C/G	cg06612196	chr6:6737390	NA	0.59	4.93	0.49	4.49e-6	Waist-to-hip ratio adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);
SKCM	cis	rs3784262	0.740	rs4646600	chr15:58295616	T/A	cg12031962	chr15:58353849	ALDH1A2	-0.45	-5.45	-0.53	5.67e-7	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs75987388	0.609	rs77366373	chr14:70372161	C/G	cg05908587	chr14:69726251	GALNTL1	-0.74	-4.87	-0.48	5.83e-6	Daytime sleep phenotypes;
SKCM	cis	rs55794721	0.509	rs6699896	chr1:25762902	A/T	cg02931644	chr1:25747376	RHCE	0.5	4.9	0.48	5.17e-6	Plateletcrit;Mean corpuscular volume;
SKCM	cis	rs6089829	0.962	rs3899032	chr20:61658542	G/A	cg08564027	chr20:61660810	NA	0.62	5.55	0.53	3.75e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs7824557	0.628	rs7008205	chr8:11197323	T/G	cg21775007	chr8:11205619	TDH	0.73	6.79	0.61	1.99e-9	Retinal vascular caliber;
SKCM	cis	rs9814567	0.806	rs6799543	chr3:134216139	G/T	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.64	-5.06	-0.5	2.77e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs17376456	0.569	rs7729807	chr5:93104089	C/T	cg25358565	chr5:93447407	FAM172A	0.86	5.45	0.53	5.59e-7	Diabetic retinopathy;
SKCM	cis	rs2243480	1.000	rs781142	chr7:65438778	C/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs2354432	0.607	rs9782976	chr1:146825049	A/G	cg25205988	chr1:146714368	CHD1L	1.12	7.87	0.67	1.7e-11	Mitochondrial DNA levels;
SKCM	cis	rs6951245	1.000	rs78861357	chr7:1095418	C/T	cg24642844	chr7:1081250	C7orf50	-0.93	-6.22	-0.58	2.28e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs4891159	0.790	rs1787448	chr18:74113179	T/C	cg24786174	chr18:74118243	ZNF516	0.75	7.23	0.63	2.84e-10	Longevity;
SKCM	cis	rs1862618	0.713	rs832550	chr5:56182589	C/T	cg12311346	chr5:56204834	C5orf35	-0.76	-5.02	-0.49	3.2e-6	Initial pursuit acceleration;
SKCM	cis	rs9790314	1.000	rs7638668	chr3:161047283	G/A	cg03342759	chr3:160939853	NMD3	-0.72	-7.87	-0.67	1.65e-11	Morning vs. evening chronotype;
SKCM	cis	rs12044355	0.858	rs12040259	chr1:231826253	G/A	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	0.85	6.14	0.57	3.16e-8	Alzheimer's disease;
SKCM	cis	rs644799	1.000	rs11021319	chr11:95523123	C/G	cg03916912	chr11:95522834	CEP57;FAM76B	0.92	8.04	0.67	8e-12	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs28595532	0.841	rs116521340	chr4:119757415	C/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs2153535	0.580	rs1120392	chr6:8487053	C/A	cg07606381	chr6:8435919	SLC35B3	0.86	6.25	0.58	2.06e-8	Motion sickness;
SKCM	cis	rs644799	1.000	rs12291986	chr11:95523030	T/G	cg03916912	chr11:95522834	CEP57;FAM76B	0.93	8.24	0.68	3.25e-12	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs637571	0.780	rs677029	chr11:65683531	A/G	cg02427764	chr11:65769310	BANF1;EIF1AD	0.66	4.9	0.49	5.08e-6	Eosinophil percentage of white cells;
SKCM	cis	rs8017423	0.967	rs61996919	chr14:90701803	A/C	cg04374321	chr14:90722782	PSMC1	0.97	8.88	0.71	1.88e-13	Mortality in heart failure;
SKCM	cis	rs2153535	0.562	rs10458225	chr6:8386004	G/A	cg23788917	chr6:8435910	SLC35B3	-0.66	-5.48	-0.53	5.07e-7	Motion sickness;
SKCM	cis	rs4862750	0.914	rs1346127	chr4:187876389	C/T	cg10295955	chr4:187884368	NA	1.0	12.84	0.82	6.31e-21	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs55962025	0.883	rs3121419	chr4:3232257	C/T	cg00764545	chr4:3318001	RGS12	-0.71	-5.79	-0.55	1.39e-7	Parental longevity (mother's age at death);
SKCM	cis	rs854765	0.583	rs8070128	chr17:17804725	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	-0.96	-7.66	-0.65	4.36e-11	Total body bone mineral density;
SKCM	cis	rs2070488	0.761	rs6807940	chr3:38460062	C/G	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.81	6.53	0.59	6.22e-9	Electrocardiographic conduction measures;
SKCM	cis	rs13010713	0.840	rs10930962	chr2:182095001	G/T	cg21995919	chr2:182322279	ITGA4	-0.56	-4.83	-0.48	6.77e-6	Celiac disease;
SKCM	cis	rs6570726	0.791	rs6912079	chr6:145894949	G/A	cg05347473	chr6:146136440	FBXO30	0.57	5.08	0.5	2.47e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1218582	0.772	rs4845400	chr1:154872523	C/T	cg16680214	chr1:154839983	KCNN3	-0.56	-5.01	-0.49	3.29e-6	Prostate cancer;
SKCM	cis	rs11098499	0.908	rs11098527	chr4:120399906	A/G	cg24375607	chr4:120327624	NA	0.66	5.09	0.5	2.44e-6	Corneal astigmatism;
SKCM	cis	rs11098499	0.863	rs1552095	chr4:120460306	A/G	cg24375607	chr4:120327624	NA	0.67	5.03	0.5	3.02e-6	Corneal astigmatism;
SKCM	cis	rs17376456	0.877	rs7734897	chr5:93305402	G/A	cg21475434	chr5:93447410	FAM172A	1.04	5.55	0.53	3.82e-7	Diabetic retinopathy;
SKCM	cis	rs28386778	0.897	rs1043127	chr17:61791210	T/G	cg06873352	chr17:61820015	STRADA	0.75	6.24	0.58	2.1e-8	Prudent dietary pattern;
SKCM	cis	rs9300255	0.739	rs4759415	chr12:123743674	C/T	cg05973401	chr12:123451056	ABCB9	-0.86	-6.11	-0.57	3.69e-8	Neutrophil percentage of white cells;
SKCM	cis	rs860554	0.528	rs12120625	chr1:201306510	A/G	cg16023122	chr1:201708836	NAV1	0.48	4.99	0.49	3.55e-6	Panic disorder;
SKCM	cis	rs155076	0.702	rs482731	chr13:21846075	G/A	cg11317459	chr13:21872234	NA	-1.13	-6.57	-0.6	5.09e-9	White matter hyperintensity burden;
SKCM	cis	rs4819052	0.851	rs2838834	chr21:46665208	C/T	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.36	0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs1577917	0.785	rs1885607	chr6:86394905	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.98	11.25	0.79	5.24e-18	Response to antipsychotic treatment;
SKCM	cis	rs3749237	0.595	rs11130196	chr3:49490149	A/C	cg03060546	chr3:49711283	APEH	0.67	4.95	0.49	4.23e-6	Resting heart rate;
SKCM	cis	rs2836974	0.568	rs452377	chr21:40537183	T/C	cg17971929	chr21:40555470	PSMG1	0.76	7.16	0.63	3.94e-10	Cognitive function;
SKCM	cis	rs9325144	0.625	rs11534879	chr12:38968165	A/G	cg26384229	chr12:38710491	ALG10B	-0.72	-6.25	-0.58	2.06e-8	Morning vs. evening chronotype;
SKCM	cis	rs2842992	0.692	rs1128661	chr6:160211554	T/G	cg19482086	chr6:160211437	TCP1;MRPL18	0.87	7.46	0.65	1.04e-10	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs12497850	0.864	rs3212	chr3:49145741	T/C	cg07636037	chr3:49044803	WDR6	1.03	9.16	0.72	5.21e-14	Parkinson's disease;
SKCM	cis	rs7811142	0.830	rs76798830	chr7:99952828	C/T	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.19	7.5	0.65	8.66e-11	Platelet count;
SKCM	cis	rs10779751	0.960	rs4845860	chr1:11324193	A/G	cg08854313	chr1:11322531	MTOR	0.94	7.12	0.63	4.63e-10	Body mass index;
SKCM	cis	rs2439831	1.000	rs2256764	chr15:43735763	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.4	7.72	0.66	3.3e-11	Lung cancer in ever smokers;
SKCM	cis	rs1325195	0.537	rs2793807	chr1:179171713	C/T	cg10806749	chr1:179558114	NA	0.56	4.89	0.48	5.26e-6	IgE grass sensitization;
SKCM	cis	rs4423214	0.959	rs11606611	chr11:71164046	C/G	cg05163923	chr11:71159392	DHCR7	0.83	8.06	0.67	7.35e-12	Vitamin D levels;
SKCM	cis	rs1405130	1.000	rs6715142	chr2:235564302	A/C	cg17841421	chr2:235704848	NA	-0.59	-5.03	-0.5	3.01e-6	Coronary artery disease;
SKCM	cis	rs2204008	0.775	rs3900361	chr12:38238936	A/G	cg13010199	chr12:38710504	ALG10B	-0.69	-5.19	-0.51	1.59e-6	Bladder cancer;
SKCM	cis	rs1865760	0.827	rs9295680	chr6:25944103	T/C	cg08401836	chr6:26032486	HIST1H3B	-0.6	-4.88	-0.48	5.56e-6	Height;
SKCM	trans	rs11722228	0.539	rs62287552	chr4:10153197	C/T	cg26043149	chr18:55253948	FECH	1.0	9.24	0.72	3.76e-14	Gout;Urate levels;Serum uric acid levels;
SKCM	cis	rs959260	0.588	rs8079197	chr17:73316679	G/C	cg14668889	chr17:73230827	NUP85	-0.75	-6.29	-0.58	1.72e-8	Systemic lupus erythematosus;
SKCM	cis	rs2033711	0.840	rs10423138	chr19:58928302	T/C	cg12042659	chr19:58951599	ZNF132	0.68	5.86	0.55	1.04e-7	Uric acid clearance;
SKCM	cis	rs912057	0.671	rs1294433	chr6:6745163	G/A	cg06612196	chr6:6737390	NA	0.66	5.46	0.53	5.49e-7	Waist-to-hip ratio adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);
SKCM	cis	rs703842	0.616	rs10877023	chr12:58224199	C/A	cg00677455	chr12:58241039	CTDSP2	0.72	5.8	0.55	1.37e-7	Multiple sclerosis;
SKCM	cis	rs362296	0.698	rs362266	chr4:3259632	C/G	cg05297308	chr4:3317976	RGS12	-0.72	-5.95	-0.56	7.05e-8	Parental longevity (mother's age at death);
SKCM	cis	rs6951245	0.882	rs10252404	chr7:1209607	C/A	cg23708337	chr7:1209742	NA	0.9	5.39	0.52	7.34e-7	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs62238980	0.614	rs734091	chr22:32461891	A/T	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs7772486	0.875	rs10872582	chr6:146373061	G/A	cg05347473	chr6:146136440	FBXO30	0.62	5.54	0.53	3.88e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2842992	0.789	rs2295901	chr6:160201295	C/A	cg11366901	chr6:160182831	ACAT2	0.94	7.85	0.66	1.81e-11	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs4481887	0.893	rs10158180	chr1:248481423	C/T	cg00666640	chr1:248458726	OR2T12	0.66	6.0	0.56	5.9e-8	Common traits (Other);
SKCM	cis	rs854765	0.533	rs2955354	chr17:17948716	G/C	cg04398451	chr17:18023971	MYO15A	0.94	7.53	0.65	7.5e-11	Total body bone mineral density;
SKCM	cis	rs3789045	0.729	rs12039968	chr1:204490674	C/T	cg17419461	chr1:204415978	PIK3C2B	-0.84	-5.83	-0.55	1.19e-7	Educational attainment (college completion);
SKCM	cis	rs4927850	1.000	rs7625570	chr3:195747398	A/G	cg01181863	chr3:195395398	SDHAP2	-0.78	-5.08	-0.5	2.49e-6	Pancreatic cancer;
SKCM	cis	rs7937682	0.883	rs490492	chr11:111465150	C/T	cg19812747	chr11:111475976	SIK2	-0.61	-4.94	-0.49	4.41e-6	Primary sclerosing cholangitis;
SKCM	cis	rs7618915	1.000	rs3852063	chr3:52349204	A/G	cg14092988	chr3:52407081	DNAH1	0.65	4.84	0.48	6.49e-6	Bipolar disorder;
SKCM	cis	rs7917772	0.503	rs7078435	chr10:104304766	T/C	cg11453585	chr10:104263688	ACTR1A;SUFU	0.77	6.27	0.58	1.88e-8	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs7811142	1.000	rs4463351	chr7:100078226	G/A	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.17	7.71	0.66	3.44e-11	Platelet count;
SKCM	cis	rs950776	0.518	rs12910100	chr15:78822667	C/T	cg06917634	chr15:78832804	PSMA4	1.01	10.47	0.76	1.56e-16	Sudden cardiac arrest;
SKCM	cis	rs25645	0.830	rs3935281	chr17:38188419	C/T	cg17467752	chr17:38218738	THRA	-0.77	-6.64	-0.6	3.72e-9	Myeloid white cell count;
SKCM	trans	rs66573146	1.000	rs73088528	chr4:6967747	G/C	cg07817883	chr1:32538562	TMEM39B	2.0	8.02	0.67	8.59e-12	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs12142240	0.698	rs61519400	chr1:46855298	A/G	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs244731	0.959	rs9313752	chr5:176645435	G/T	cg06060754	chr5:176797920	RGS14	-0.74	-5.98	-0.56	6.39e-8	Urate levels in lean individuals;
SKCM	cis	rs514406	0.644	rs928451	chr1:53195800	A/G	cg16325326	chr1:53192061	ZYG11B	-1.0	-12.3	-0.81	6.1e-20	Monocyte count;
SKCM	cis	rs6952808	0.582	rs11763870	chr7:2027448	T/C	cg21782813	chr7:2030301	MAD1L1	-0.59	-6.36	-0.58	1.28e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs9640161	0.830	rs17173682	chr7:150059602	A/G	cg10018233	chr7:150070692	REPIN1	0.81	7.1	0.63	5.17e-10	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs8017423	0.967	rs11621045	chr14:90714003	C/T	cg04374321	chr14:90722782	PSMC1	0.97	9.06	0.72	8.41e-14	Mortality in heart failure;
SKCM	cis	rs2075371	1.000	rs2598296	chr7:133992985	C/T	cg20476274	chr7:133979776	SLC35B4	1.03	10.69	0.77	5.94e-17	Mean platelet volume;
SKCM	cis	rs13118159	0.509	rs7681872	chr4:1376735	G/A	cg02018176	chr4:1364513	KIAA1530	0.76	5.82	0.55	1.22e-7	Longevity;
SKCM	cis	rs875971	0.825	rs7384021	chr7:66077904	A/G	cg18876405	chr7:65276391	NA	-0.63	-6.32	-0.58	1.5e-8	Aortic root size;
SKCM	cis	rs867186	1.000	rs9941751	chr20:33645709	A/G	cg04194272	chr20:33683537	NA	-1.38	-7.2	-0.63	3.29e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs2721173	0.619	rs997258	chr8:145903077	C/A	cg15320075	chr8:145703422	NA	-0.82	-6.23	-0.58	2.19e-8	Educational attainment;Cognitive ability (multi-trait analysis);Intelligence (multi-trait analysis);
SKCM	cis	rs7954584	0.635	rs7137218	chr12:122342877	G/T	cg21171335	chr12:122356390	WDR66	0.45	4.95	0.49	4.18e-6	Mean corpuscular volume;
SKCM	cis	rs5760092	0.618	rs4461358	chr22:24260106	T/C	cg24846343	chr22:24311635	DDTL	-0.68	-5.36	-0.52	8.15e-7	Urinary 1,3-butadiene metabolite levels in smokers;
SKCM	cis	rs9682041	0.866	rs6444926	chr3:170133235	T/C	cg11886554	chr3:170076028	SKIL	0.98	5.97	0.56	6.66e-8	Glomerular filtration rate in non diabetics (creatinine);Glomerular filtration rate (creatinine);
SKCM	cis	rs1747683	0.528	rs10752299	chr10:13388578	A/G	cg25835351	chr10:13388524	SEPHS1	-0.37	-4.77	-0.48	8.48e-6	IgG glycosylation;
SKCM	cis	rs754466	0.580	rs10824571	chr10:79531931	G/A	cg17075019	chr10:79541650	NA	-0.77	-7.16	-0.63	3.97e-10	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	trans	rs12599106	0.660	rs12919333	chr16:34991336	C/T	cg15383120	chr6:291909	DUSP22	-0.75	-7.44	-0.64	1.13e-10	Menopause (age at onset);
SKCM	cis	rs9911578	0.935	rs9911753	chr17:56983174	G/A	cg12560992	chr17:57184187	TRIM37	0.92	7.21	0.63	3.16e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs11681884	0.581	rs113465881	chr2:113658710	G/T	cg09250933	chr2:114035619	PAX8;LOC440839	-0.78	-5.19	-0.51	1.59e-6	Stroke;
SKCM	cis	rs6459804	1.000	rs6459804	chr7:157510195	C/T	cg27240775	chr7:156793224	NA	-0.7	-5.02	-0.49	3.21e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs6977660	1.000	rs10279525	chr7:19822305	C/T	cg05791153	chr7:19748676	TWISTNB	0.79	5.34	0.52	9.05e-7	Thyroid stimulating hormone;
SKCM	cis	rs17376456	0.877	rs9314100	chr5:93447394	T/C	cg25358565	chr5:93447407	FAM172A	1.23	7.97	0.67	1.08e-11	Diabetic retinopathy;
SKCM	cis	rs1461503	0.966	rs11218905	chr11:122840303	A/G	cg27398637	chr11:122830231	C11orf63	0.63	4.8	0.48	7.54e-6	Menarche (age at onset);
SKCM	cis	rs854765	0.583	rs6502627	chr17:17849671	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.01	7.49	0.65	9.28e-11	Total body bone mineral density;
SKCM	cis	rs875971	0.862	rs801206	chr7:66021966	C/G	cg18876405	chr7:65276391	NA	-0.61	-6.03	-0.56	5.23e-8	Aortic root size;
SKCM	cis	rs4919087	0.926	rs953097	chr10:98981914	T/C	cg25902810	chr10:99078978	FRAT1	0.68	5.55	0.53	3.77e-7	Monocyte count;
SKCM	cis	rs362272	0.525	rs2857849	chr4:3043638	A/T	cg09735869	chr4:3319127	RGS12	0.6	4.9	0.48	5.18e-6	Serum sulfate level;
SKCM	cis	rs1552244	0.572	rs113406084	chr3:10170190	T/C	cg00149659	chr3:10157352	C3orf10	1.13	5.45	0.53	5.74e-7	Alzheimer's disease;
SKCM	cis	rs4819052	0.851	rs7276828	chr21:46695039	T/G	cg19498844	chr21:46707878	POFUT2;LOC642852	0.91	7.84	0.66	1.92e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs870825	0.860	rs72689284	chr4:185596680	A/G	cg04058563	chr4:185651563	MLF1IP	1.04	5.96	0.56	7.02e-8	Blood protein levels;
SKCM	cis	rs870825	0.860	rs2705899	chr4:185596219	A/G	cg04058563	chr4:185651563	MLF1IP	1.04	5.96	0.56	7.02e-8	Blood protein levels;
SKCM	cis	rs6570726	0.935	rs388394	chr6:145852689	C/T	cg23711669	chr6:146136114	FBXO30	0.69	6.76	0.61	2.23e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs362296	0.698	rs3095072	chr4:3263325	G/A	cg00764545	chr4:3318001	RGS12	-0.7	-6.61	-0.6	4.34e-9	Parental longevity (mother's age at death);
SKCM	cis	rs7336332	0.598	rs74563672	chr13:28010660	A/G	cg22138327	chr13:27999177	GTF3A	0.9	6.4	0.59	1.07e-8	Weight;
SKCM	cis	rs1799949	1.000	rs1545764	chr17:41424565	G/A	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.18	-0.57	2.68e-8	Menopause (age at onset);
SKCM	cis	rs4555082	0.834	rs2816653	chr14:105713973	A/G	cg13114125	chr14:105738426	BRF1	-0.69	-5.78	-0.55	1.47e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs908922	0.651	rs1337341	chr1:152508259	A/C	cg09873164	chr1:152488093	CRCT1	0.76	5.81	0.55	1.31e-7	Hair morphology;
SKCM	cis	rs4790333	1.000	rs2003968	chr17:2266812	T/C	cg02569219	chr17:2266849	SGSM2	0.76	6.52	0.59	6.36e-9	Proinsulin levels;
SKCM	cis	rs3857536	0.605	rs36040831	chr6:66876588	G/A	cg07460842	chr6:66804631	NA	-0.73	-6.57	-0.6	5.04e-9	Blood trace element (Cu levels);
SKCM	cis	rs5769765	0.955	rs8135963	chr22:50301476	T/C	cg22709217	chr22:50311962	ALG12;CRELD2	-0.82	-5.71	-0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs941408	1.000	rs941407	chr19:2812153	A/G	cg06609049	chr19:2785107	THOP1	0.8	7.11	0.63	4.82e-10	Total cholesterol levels;
SKCM	cis	rs4523957	0.651	rs7223390	chr17:2085653	T/C	cg16513277	chr17:2031491	SMG6	-0.79	-5.86	-0.55	1.07e-7	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs7937682	0.558	rs7113067	chr11:111692182	G/A	cg09085632	chr11:111637200	PPP2R1B	1.08	10.53	0.77	1.23e-16	Primary sclerosing cholangitis;
SKCM	cis	rs2952156	0.920	rs2517955	chr17:37843681	C/T	cg00129232	chr17:37814104	STARD3	-0.66	-5.38	-0.52	7.54e-7	Asthma;
SKCM	cis	rs10193935	0.901	rs10201586	chr2:42622594	C/G	cg27598129	chr2:42591480	NA	-0.88	-6.71	-0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs826838	0.967	rs826858	chr12:39116731	A/G	cg26384229	chr12:38710491	ALG10B	-0.94	-7.66	-0.65	4.36e-11	Heart rate;
SKCM	cis	rs6463523	0.898	rs66892628	chr7:759374	T/A	cg06242242	chr7:766104	PRKAR1B;HEATR2	1.04	8.41	0.69	1.52e-12	Subjective well-being;
SKCM	cis	rs12477438	0.520	rs11123761	chr2:99705903	A/G	cg26064155	chr2:99771622	LIPT1;TSGA10	1.03	9.6	0.74	7.37e-15	Chronic sinus infection;
SKCM	cis	rs9581857	0.547	rs75783371	chr13:28109961	T/C	cg22138327	chr13:27999177	GTF3A	0.86	5.56	0.53	3.62e-7	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs9611565	0.512	rs1534932	chr22:42150146	C/T	cg03806693	chr22:41940476	POLR3H	1.17	7.59	0.65	5.94e-11	Vitiligo;
SKCM	cis	rs763014	0.932	rs34498660	chr16:666149	A/G	cg00908189	chr16:619842	PIGQ	0.82	7.61	0.65	5.42e-11	Height;
SKCM	cis	rs6500395	0.890	rs3843724	chr16:48618573	C/G	cg04672837	chr16:48644449	N4BP1	0.69	5.88	0.55	9.68e-8	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs9915657	0.870	rs11077595	chr17:70130030	C/T	cg06234051	chr17:70120541	SOX9	-0.62	-5.35	-0.52	8.49e-7	Thyroid hormone levels;
SKCM	cis	rs910316	1.000	rs10138183	chr14:75615227	T/C	cg08847533	chr14:75593920	NEK9	0.95	9.18	0.72	4.88e-14	Height;
SKCM	cis	rs2075371	0.933	rs1421480	chr7:133958114	A/C	cg20476274	chr7:133979776	SLC35B4	1.03	10.88	0.78	2.61e-17	Mean platelet volume;
SKCM	cis	rs992157	0.835	rs10932768	chr2:219146199	T/A	cg00012203	chr2:219082015	ARPC2	-0.72	-5.71	-0.54	1.99e-7	Colorectal cancer;
SKCM	cis	rs11098499	0.863	rs7657849	chr4:120455494	T/C	cg24375607	chr4:120327624	NA	0.68	5.27	0.51	1.16e-6	Corneal astigmatism;
SKCM	cis	rs7811142	0.945	rs6978739	chr7:100098680	C/G	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.19	7.85	0.66	1.82e-11	Platelet count;
SKCM	cis	rs9790314	0.967	rs460165	chr3:161087710	G/A	cg03342759	chr3:160939853	NMD3	-0.72	-7.89	-0.67	1.53e-11	Morning vs. evening chronotype;
SKCM	cis	rs589448	0.902	rs315131	chr12:69761839	T/G	cg20891283	chr12:69753455	YEATS4	0.98	9.89	0.75	2.06e-15	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs4319547	1.000	rs6489071	chr12:123025576	C/G	cg23029597	chr12:123009494	RSRC2	-0.75	-5.69	-0.54	2.13e-7	Body mass index;
SKCM	cis	rs9921192	1.000	rs233950	chr16:4327397	A/G	cg00021532	chr16:4324280	TFAP4	0.86	7.79	0.66	2.4e-11	Prostate-specific antigen levels;
SKCM	cis	rs9443189	0.570	rs523465	chr6:76330434	G/C	cg01950844	chr6:76311363	SENP6	0.99	6.57	0.6	5.02e-9	Prostate cancer;
SKCM	cis	rs6951245	0.872	rs75493422	chr7:1072890	C/T	cg21664854	chr7:1097933	C7orf50;GPR146	0.89	4.79	0.48	7.66e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs2019137	0.560	rs10206269	chr2:113990393	C/A	cg11763394	chr2:113992921	PAX8;LOC440839;LOC654433	0.66	5.21	0.51	1.52e-6	Lymphocyte counts;
SKCM	cis	rs4975616	0.686	rs37008	chr5:1351538	C/T	cg26373071	chr5:1325741	CLPTM1L	0.6	5.16	0.5	1.86e-6	Lung cancer;
SKCM	cis	rs12477438	0.520	rs1133978	chr2:99741964	C/T	cg14399236	chr2:99771627	LIPT1;TSGA10	0.95	8.38	0.69	1.75e-12	Chronic sinus infection;
SKCM	cis	rs3008870	0.920	rs975452	chr1:67480190	A/T	cg08660285	chr1:67390436	MIER1;WDR78	0.91	5.96	0.56	6.81e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs798766	1.000	rs798755	chr4:1720824	A/G	cg24239225	chr4:1659016	FAM53A	-0.69	-4.87	-0.48	5.8e-6	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs55728055	0.661	rs62237765	chr22:31956981	A/G	cg01338084	chr22:32026380	PISD	1.62	5.16	0.5	1.81e-6	Age-related hearing impairment;
SKCM	cis	rs9796	0.870	rs2925345	chr15:41311799	T/C	cg00616447	chr15:41694635	NDUFAF1	-0.74	-5.2	-0.51	1.56e-6	Menopause (age at onset);
SKCM	cis	rs28386778	0.897	rs2727287	chr17:61904728	G/A	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs7666738	0.830	rs1967980	chr4:98966426	C/G	cg05340658	chr4:99064831	C4orf37	0.64	4.91	0.49	4.97e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6121246	0.909	rs6119725	chr20:30385557	G/T	cg11595048	chr20:30225325	COX4I2	0.67	5.21	0.51	1.5e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs7927771	0.832	rs4752993	chr11:47410951	T/C	cg05585544	chr11:47624801	NA	0.57	4.92	0.49	4.76e-6	Subjective well-being;
SKCM	cis	rs4925386	0.765	rs6142737	chr20:60919800	C/G	cg24112000	chr20:60950667	NA	-0.74	-7.01	-0.62	7.4e-10	Colorectal cancer;Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs6753739	0.826	rs6711613	chr2:219947691	A/G	cg09617556	chr2:219924408	IHH	0.47	4.91	0.49	4.97e-6	Height;
SKCM	cis	rs2836974	0.863	rs1065242	chr21:40567716	C/G	cg17971929	chr21:40555470	PSMG1	0.9	8.81	0.71	2.52e-13	Cognitive function;
SKCM	cis	rs7523273	0.606	rs12401619	chr1:207976276	G/C	cg22525895	chr1:207977042	MIR29B2	-0.84	-7.09	-0.63	5.4e-10	Schizophrenia;
SKCM	cis	rs910316	1.000	rs1043674	chr14:75549370	T/C	cg08847533	chr14:75593920	NEK9	0.95	9.18	0.72	4.88e-14	Height;
SKCM	cis	rs709400	1.000	rs10135248	chr14:104122310	T/C	cg26031613	chr14:104095156	KLC1	1.05	12.89	0.82	5.14e-21	Body mass index;
SKCM	cis	rs9399135	0.967	rs7741626	chr6:135314182	C/T	cg24558204	chr6:135376177	HBS1L	0.59	5.23	0.51	1.41e-6	Red blood cell count;
SKCM	cis	rs644799	0.710	rs11021311	chr11:95505227	G/A	cg03916912	chr11:95522834	CEP57;FAM76B	0.83	7.18	0.63	3.57e-10	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs8077889	0.645	rs1230396	chr17:41843029	A/C	cg26893861	chr17:41843967	DUSP3	-1.43	-12.83	-0.82	6.51e-21	Triglycerides;
SKCM	cis	rs7103648	0.966	rs874896	chr11:47418953	C/G	cg20307385	chr11:47447363	PSMC3	1.08	8.94	0.71	1.41e-13	Diastolic blood pressure;Systolic blood pressure;
SKCM	trans	rs66573146	0.831	rs56081162	chr4:6989718	C/T	cg07817883	chr1:32538562	TMEM39B	1.94	8.42	0.69	1.47e-12	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs12142240	0.698	rs932816	chr1:46859749	G/A	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs34779708	0.966	rs4934725	chr10:35398236	T/C	cg03585969	chr10:35415529	CREM	0.82	6.49	0.59	7.27e-9	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs2239547	0.607	rs9836178	chr3:52925403	T/C	cg11645453	chr3:52864694	ITIH4	-0.78	-6.96	-0.62	9.27e-10	Schizophrenia;
SKCM	cis	rs2180341	0.960	rs7745944	chr6:127709574	A/G	cg24812749	chr6:127587940	RNF146	0.82	7.12	0.63	4.57e-10	Breast cancer;
SKCM	cis	rs7149337	0.780	rs4369569	chr14:51689181	C/G	cg23942311	chr14:51606299	NA	-0.54	-5.96	-0.56	6.82e-8	Cancer;
SKCM	cis	rs4332037	0.506	rs62442924	chr7:1989976	C/T	cg02825527	chr7:2087843	MAD1L1	-0.79	-5.34	-0.52	8.76e-7	Bipolar disorder;
SKCM	cis	rs11822910	0.737	rs2581924	chr11:57208468	C/T	cg00522883	chr11:57194120	SLC43A3	0.77	6.73	0.61	2.55e-9	Platelet distribution width;
SKCM	cis	rs9926296	0.528	rs4785721	chr16:89839997	G/A	cg27121462	chr16:89883253	FANCA	0.81	7.23	0.63	2.93e-10	Vitiligo;
SKCM	cis	rs763121	0.853	rs4821812	chr22:39075235	G/C	cg06022373	chr22:39101656	GTPBP1	0.78	5.59	0.53	3.27e-7	Menopause (age at onset);
SKCM	cis	rs13278732	0.500	rs13248865	chr8:99036084	G/A	cg16297171	chr8:99017690	MATN2	-0.54	-5.13	-0.5	2.07e-6	Eosinophilic esophagitis (pediatric);
SKCM	cis	rs28386778	0.863	rs2727355	chr17:61931790	C/T	cg01411255	chr17:61851458	DDX42;CCDC47	0.78	5.03	0.49	3.06e-6	Prudent dietary pattern;
SKCM	cis	rs2836974	0.965	rs8131126	chr21:40655754	A/G	cg11890956	chr21:40555474	PSMG1	1.09	13.83	0.84	1.08e-22	Cognitive function;
SKCM	cis	rs28386778	0.897	rs6504176	chr17:61811920	T/C	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.36	0.52	8.08e-7	Prudent dietary pattern;
SKCM	cis	rs514406	0.627	rs485128	chr1:53344583	T/C	cg24675658	chr1:53192096	ZYG11B	-0.78	-6.68	-0.6	3.22e-9	Monocyte count;
SKCM	cis	rs861020	1.000	rs595918	chr1:209966843	A/G	cg09163369	chr1:210001066	C1orf107	0.83	5.44	0.52	5.83e-7	Orofacial clefts;
SKCM	cis	rs6723226	0.708	rs2710627	chr2:32758627	A/G	cg02381751	chr2:32503542	YIPF4	0.88	6.57	0.6	5.14e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs514406	0.893	rs1242315	chr1:53417181	A/G	cg16325326	chr1:53192061	ZYG11B	0.91	9.82	0.74	2.77e-15	Monocyte count;
SKCM	cis	rs6500395	1.000	rs8052640	chr16:48604096	G/T	cg04672837	chr16:48644449	N4BP1	0.68	5.76	0.55	1.6e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs60871478	0.680	rs34880331	chr7:786833	A/G	cg05535760	chr7:792225	HEATR2	1.19	9.94	0.75	1.63e-15	Cerebrospinal P-tau181p levels;
SKCM	cis	rs33794	0.836	rs33782	chr3:45290954	G/T	cg25630594	chr3:44914870	TGM4	0.58	5.06	0.5	2.7e-6	Lung function (forced expiratory volume in 1 second);
SKCM	cis	rs3820928	0.874	rs7562776	chr2:227806550	G/A	cg11843606	chr2:227700838	RHBDD1	-0.6	-4.81	-0.48	7.34e-6	Pulmonary function;
SKCM	cis	rs2180341	0.532	rs6933893	chr6:127707250	A/G	cg27446573	chr6:127587934	RNF146	0.65	5.2	0.51	1.56e-6	Breast cancer;
SKCM	cis	rs763014	1.000	rs8054842	chr16:672799	T/C	cg07343612	chr16:622815	PIGQ	-0.68	-5.87	-0.55	9.95e-8	Height;
SKCM	cis	rs5769765	0.632	rs13056783	chr22:50259152	A/T	cg22709217	chr22:50311962	ALG12;CRELD2	0.8	5.8	0.55	1.34e-7	Schizophrenia;
SKCM	cis	rs12134245	0.747	rs11164929	chr1:92012836	G/C	cg02896835	chr1:92012615	NA	-0.56	-4.9	-0.48	5.18e-6	Breast cancer;
SKCM	cis	rs4555082	0.756	rs76863138	chr14:105736379	C/T	cg13114125	chr14:105738426	BRF1	-0.69	-5.47	-0.53	5.33e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs7666738	0.830	rs28785514	chr4:98959135	G/A	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs72781680	0.898	rs17462670	chr2:24026579	T/C	cg08917208	chr2:24149416	ATAD2B	0.92	4.85	0.48	6.19e-6	Lymphocyte counts;
SKCM	cis	rs780096	0.565	rs8179252	chr2:27746832	A/C	cg05696406	chr2:27599888	SNX17	0.56	5.82	0.55	1.24e-7	Total body bone mineral density;
SKCM	cis	rs4954585	0.762	rs12986776	chr2:136991517	C/G	cg05194412	chr2:137003533	NA	0.56	4.93	0.49	4.5e-6	Colorectal cancer;
SKCM	cis	rs7727544	0.735	rs272881	chr5:131669264	G/A	cg24060327	chr5:131705240	SLC22A5	-0.7	-5.13	-0.5	2.07e-6	Blood metabolite levels;
SKCM	cis	rs9911578	0.967	rs2611781	chr17:56703124	C/G	cg05425664	chr17:57184151	TRIM37	-0.69	-5.21	-0.51	1.52e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs34779708	0.931	rs2505631	chr10:35368385	A/T	cg03585969	chr10:35415529	CREM	-0.77	-6.18	-0.57	2.74e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs62103177	0.759	rs9956512	chr18:77607517	G/A	cg27393146	chr18:77495563	CTDP1	-0.95	-5.5	-0.53	4.56e-7	Opioid sensitivity;
SKCM	cis	rs6840360	0.571	rs12650655	chr4:152556075	G/A	cg22705602	chr4:152727874	NA	-0.52	-5.69	-0.54	2.15e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs10751667	0.643	rs11246348	chr11:939476	G/C	cg06064525	chr11:970664	AP2A2	-0.55	-5.09	-0.5	2.46e-6	Alzheimer's disease (late onset);
SKCM	cis	rs1003719	0.788	rs4816560	chr21:38487561	G/T	cg10648535	chr21:38446584	PIGP;TTC3	0.66	5.27	0.51	1.16e-6	Eye color traits;
SKCM	cis	rs883565	0.771	rs1053516	chr3:39137883	G/A	cg20743662	chr3:38589496	NA	0.46	4.77	0.48	8.36e-6	Handedness;
SKCM	cis	rs7523273	0.606	rs2796266	chr1:207922945	C/T	cg22525895	chr1:207977042	MIR29B2	-0.8	-7.07	-0.63	5.72e-10	Schizophrenia;
SKCM	cis	rs6951245	1.000	rs77305932	chr7:1100861	T/A	cg18402987	chr7:1209562	NA	1.15	6.09	0.57	3.95e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs654950	0.901	rs1885654	chr1:42007188	C/A	cg06885757	chr1:42089581	HIVEP3	-0.64	-6.54	-0.6	5.83e-9	Airway imaging phenotypes;
SKCM	cis	rs28386778	0.897	rs2854214	chr17:61945449	C/G	cg06873352	chr17:61820015	STRADA	-0.74	-6.15	-0.57	3.13e-8	Prudent dietary pattern;
SKCM	trans	rs66573146	1.000	rs56178503	chr4:6961748	C/T	cg07817883	chr1:32538562	TMEM39B	2.0	8.02	0.67	8.59e-12	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs8070624	0.543	rs11078409	chr17:17876296	C/G	cg04398451	chr17:18023971	MYO15A	-0.91	-6.7	-0.6	2.96e-9	Total body bone mineral density;
SKCM	cis	rs597539	0.652	rs478647	chr11:68700424	C/T	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.76	5.06	0.5	2.74e-6	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs4975616	0.869	rs455433	chr5:1336243	A/G	cg26373071	chr5:1325741	CLPTM1L	0.74	6.91	0.62	1.18e-9	Lung cancer;
SKCM	cis	rs7683537	0.887	rs4540092	chr4:185633546	A/G	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Systemic lupus erythematosus;
SKCM	cis	rs34779708	0.733	rs7087099	chr10:35541982	C/T	cg03585969	chr10:35415529	CREM	0.74	5.42	0.52	6.41e-7	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs798554	1.000	rs798545	chr7:2762386	C/T	cg14895029	chr7:2775587	GNA12	-0.72	-5.38	-0.52	7.46e-7	Height;
SKCM	cis	rs2836974	0.897	rs6517513	chr21:40526878	A/G	cg11890956	chr21:40555474	PSMG1	1.07	13.19	0.83	1.48e-21	Cognitive function;
SKCM	cis	rs6570726	0.755	rs2092296	chr6:145893684	A/C	cg23711669	chr6:146136114	FBXO30	0.87	8.94	0.71	1.44e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9300255	0.679	rs28583837	chr12:123863620	G/A	cg00376283	chr12:123451042	ABCB9	-0.78	-5.26	-0.51	1.24e-6	Neutrophil percentage of white cells;
SKCM	cis	rs1577917	1.000	rs1857964	chr6:86635994	A/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.85	-8.62	-0.7	5.82e-13	Response to antipsychotic treatment;
SKCM	cis	rs12986445	0.711	rs6709946	chr2:26111305	A/G	cg07291958	chr2:26785531	C2orf70	0.55	4.92	0.49	4.8e-6	Multiple myeloma and monoclonal gammopathy;Multiple myeloma;
SKCM	cis	rs11098499	0.909	rs7681214	chr4:120385320	C/A	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs34779708	0.897	rs34481177	chr10:35380913	C/T	cg03585969	chr10:35415529	CREM	0.78	6.31	0.58	1.58e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs13010713	0.840	rs6735551	chr2:182039477	T/C	cg21995919	chr2:182322279	ITGA4	-0.53	-5.22	-0.51	1.43e-6	Celiac disease;
SKCM	cis	rs62103177	0.810	rs62103197	chr18:77632923	G/A	cg27393146	chr18:77495563	CTDP1	-0.92	-5.33	-0.52	9.32e-7	Opioid sensitivity;
SKCM	cis	rs60871478	0.945	rs62432254	chr7:804175	C/T	cg05535760	chr7:792225	HEATR2	1.02	8.66	0.7	4.97e-13	Cerebrospinal P-tau181p levels;
SKCM	cis	rs854765	0.583	rs9913724	chr17:17819101	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.0	7.64	0.65	4.64e-11	Total body bone mineral density;
SKCM	cis	rs7809950	0.862	rs58391518	chr7:107030787	T/C	cg23024343	chr7:107201750	COG5	-0.73	-6.12	-0.57	3.45e-8	Coronary artery disease;
SKCM	cis	rs6834538	0.577	rs10034556	chr4:113449650	T/C	cg05166686	chr4:113558556	LARP7;C4orf21	0.61	5.04	0.5	2.91e-6	Free thyroxine concentration;
SKCM	cis	rs36093844	0.527	rs80333693	chr11:85767905	G/A	cg25872744	chr11:85566296	CCDC83	-0.81	-4.79	-0.48	7.71e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs1707322	0.716	rs6694889	chr1:46101806	A/C	cg03146154	chr1:46216737	IPP	0.8	5.57	0.53	3.52e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs10905065	0.930	rs9423726	chr10:5737979	A/G	cg09234995	chr10:5726438	C10orf18	0.62	5.29	0.51	1.07e-6	Menopause (age at onset);
SKCM	cis	rs10504229	0.639	rs55687236	chr8:58105856	C/T	cg02725872	chr8:58115012	NA	-0.53	-4.91	-0.49	4.82e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs2730245	0.608	rs2657391	chr7:158741776	T/C	cg24397884	chr7:158709396	WDR60	-0.94	-7.04	-0.62	6.74e-10	Height;
SKCM	cis	rs1865760	0.827	rs9295681	chr6:25944117	T/G	cg08401836	chr6:26032486	HIST1H3B	-0.6	-4.88	-0.48	5.56e-6	Height;
SKCM	cis	rs8141529	0.732	rs11556025	chr22:29168755	T/C	cg02153584	chr22:29168773	CCDC117	0.69	5.61	0.54	2.99e-7	Lymphocyte counts;
SKCM	cis	rs6942756	0.956	rs7792317	chr7:128963971	G/A	cg02491457	chr7:128862824	NA	-0.86	-5.48	-0.53	5.11e-7	White matter hyperintensity burden;
SKCM	cis	rs864745	0.967	rs849133	chr7:28192280	C/T	cg15170557	chr7:28214983	JAZF1	-0.7	-6.83	-0.61	1.68e-9	Crohn's disease;Type 2 diabetes;
SKCM	cis	rs6121246	0.609	rs6088997	chr20:30289824	A/G	cg13852791	chr20:30311386	BCL2L1	-0.82	-5.59	-0.54	3.17e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs3771570	0.901	rs3771587	chr2:242409701	A/G	cg07612300	chr2:242033426	MTERFD2;SNED1	0.88	4.9	0.48	5.13e-6	Prostate cancer;
SKCM	cis	rs9325144	0.647	rs1386018	chr12:39104360	C/T	cg13010199	chr12:38710504	ALG10B	-0.64	-5.44	-0.52	6.02e-7	Morning vs. evening chronotype;
SKCM	trans	rs8073060	0.586	rs8064895	chr17:34001121	T/C	cg19694781	chr19:47549865	TMEM160	-1.04	-8.28	-0.68	2.65e-12	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs875971	0.505	rs1723275	chr7:65504633	G/C	cg05627663	chr7:65219948	SNORA22;CCT6P1	-0.64	-5.58	-0.53	3.37e-7	Aortic root size;
SKCM	cis	rs28595532	1.000	rs115004746	chr4:119642137	C/T	cg14228332	chr4:119757509	SEC24D	0.97	4.92	0.49	4.71e-6	Cannabis dependence symptom count;
SKCM	cis	rs826838	0.935	rs11183940	chr12:38851642	A/G	cg13010199	chr12:38710504	ALG10B	0.83	6.69	0.6	3.1e-9	Heart rate;
SKCM	cis	rs155076	1.000	rs658244	chr13:21850976	T/C	cg11317459	chr13:21872234	NA	-1.24	-6.91	-0.62	1.19e-9	White matter hyperintensity burden;
SKCM	cis	rs11249608	0.548	rs6875622	chr5:178451397	C/T	cg21905437	chr5:178450457	ZNF879	0.75	6.33	0.58	1.42e-8	Pubertal anthropometrics;
SKCM	cis	rs9467773	0.620	rs2451744	chr6:26633463	G/T	cg09904177	chr6:26538194	HMGN4	0.58	5.01	0.49	3.28e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7917772	0.503	rs746552	chr10:104342501	A/G	cg11453585	chr10:104263688	ACTR1A;SUFU	0.75	5.96	0.56	6.78e-8	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs62064224	0.720	rs8078837	chr17:30763537	A/G	cg25809561	chr17:30822961	MYO1D	0.71	5.81	0.55	1.32e-7	Schizophrenia;
SKCM	cis	rs6430585	0.878	rs9677760	chr2:136538939	T/A	cg07169764	chr2:136633963	MCM6	-0.89	-7.01	-0.62	7.69e-10	Corneal structure;
SKCM	cis	rs11662586	0.573	rs7238269	chr18:77706294	A/G	cg20368463	chr18:77673604	PQLC1	0.74	6.41	0.59	1.02e-8	Exploratory eye movement dysfunction in schizophrenia (responsive search score);
SKCM	cis	rs12971120	0.891	rs3764510	chr18:72166846	A/G	cg26446133	chr18:72167187	CNDP2	-0.67	-5.21	-0.51	1.48e-6	Refractive error;
SKCM	cis	rs7917772	0.582	rs4917976	chr10:104360518	A/G	cg11453585	chr10:104263688	ACTR1A;SUFU	-0.62	-4.81	-0.48	7.21e-6	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs2836950	0.545	rs2836940	chr21:40588696	T/C	cg17971929	chr21:40555470	PSMG1	-0.73	-6.17	-0.57	2.86e-8	Menarche (age at onset);
SKCM	cis	rs7618501	0.633	rs11925192	chr3:50038664	G/A	cg24110177	chr3:50126178	RBM5	-0.6	-5.11	-0.5	2.25e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1348850	0.597	rs4893964	chr2:178447658	G/T	cg27490568	chr2:178487706	NA	0.73	5.27	0.51	1.19e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs9682041	1.000	rs6444920	chr3:170090374	A/G	cg11886554	chr3:170076028	SKIL	0.93	5.5	0.53	4.62e-7	Glomerular filtration rate in non diabetics (creatinine);Glomerular filtration rate (creatinine);
SKCM	cis	rs2070488	0.930	rs2370840	chr3:38529825	C/T	cg01465620	chr3:38496096	LOC100128640;ACVR2B	1.0	9.25	0.72	3.48e-14	Electrocardiographic conduction measures;
SKCM	cis	rs55962025	0.842	rs363088	chr4:3210330	A/T	cg24015175	chr4:3319247	RGS12	-0.64	-5.45	-0.53	5.59e-7	Parental longevity (mother's age at death);
SKCM	cis	rs7666738	0.830	rs17027216	chr4:99009152	G/C	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1799949	0.894	rs8176160	chr17:41241503	T/C	cg23758822	chr17:41437982	NA	0.92	7.68	0.66	3.96e-11	Menopause (age at onset);
SKCM	cis	rs7772486	0.790	rs6917135	chr6:146152426	T/C	cg05347473	chr6:146136440	FBXO30	0.57	5.36	0.52	8.27e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6547631	0.622	rs1866141	chr2:85925386	T/C	cg24620635	chr2:85921963	GNLY	0.9	6.65	0.6	3.58e-9	Blood protein levels;
SKCM	cis	rs6547741	0.788	rs7595739	chr2:27874563	G/T	cg27432699	chr2:27873401	GPN1	-0.85	-7.27	-0.64	2.42e-10	Oral cavity cancer;
SKCM	cis	rs950027	0.620	rs1426932	chr15:45687256	T/C	cg10760299	chr15:45669010	GATM	0.57	5.42	0.52	6.44e-7	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs9300255	0.544	rs1716174	chr12:123660717	T/C	cg05973401	chr12:123451056	ABCB9	0.81	4.98	0.49	3.78e-6	Neutrophil percentage of white cells;
SKCM	cis	rs7666738	0.830	rs10856936	chr4:99011319	T/C	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10089	0.953	rs1432615	chr5:127395371	G/A	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.92	8.29	0.68	2.54e-12	Ileal carcinoids;
SKCM	cis	rs911263	0.961	rs17105278	chr14:68728479	T/C	cg18825221	chr14:68749962	RAD51L1	-0.49	-5.23	-0.51	1.38e-6	Primary biliary cholangitis;
SKCM	cis	rs2153535	0.601	rs7775274	chr6:8530303	A/G	cg07606381	chr6:8435919	SLC35B3	0.93	6.8	0.61	1.92e-9	Motion sickness;
SKCM	cis	rs9399135	0.967	rs45544135	chr6:135324051	T/C	cg24558204	chr6:135376177	HBS1L	0.59	5.23	0.51	1.41e-6	Red blood cell count;
SKCM	cis	rs6933660	0.646	rs3736176	chr6:151773320	T/A	cg02564969	chr6:151773285	C6orf211;RMND1	0.66	5.59	0.54	3.17e-7	Menarche (age at onset);
SKCM	cis	rs11785400	1.000	rs4297023	chr8:143733307	C/A	cg20003893	chr8:144489567	NA	-0.55	-4.81	-0.48	7.23e-6	Schizophrenia;
SKCM	cis	rs17065868	1.000	rs9533872	chr13:45053542	C/T	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs2243480	0.901	rs35256305	chr7:65306405	T/C	cg07424592	chr7:64974309	NA	0.99	4.9	0.49	5.08e-6	Diabetic kidney disease;
SKCM	cis	rs6835098	1.000	rs9990666	chr4:174083150	G/T	cg08422745	chr4:174089978	GALNT7	-0.81	-6.26	-0.58	1.96e-8	Dementia and core Alzheimer's disease neuropathologic changes;
SKCM	cis	rs13278732	0.500	rs3088121	chr8:99048049	A/G	cg16297171	chr8:99017690	MATN2	-0.53	-5.21	-0.51	1.52e-6	Eosinophilic esophagitis (pediatric);
SKCM	cis	rs7937682	0.883	rs472465	chr11:111468962	C/T	cg09085632	chr11:111637200	PPP2R1B	-1.0	-8.74	-0.7	3.47e-13	Primary sclerosing cholangitis;
SKCM	cis	rs951366	0.559	rs823101	chr1:205667006	T/C	cg11965913	chr1:205819406	PM20D1	0.75	6.12	0.57	3.47e-8	Menarche (age at onset);
SKCM	cis	rs9815354	0.812	rs73073234	chr3:42012071	C/T	cg03022575	chr3:42003672	ULK4	1.0	5.0	0.49	3.43e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs13118159	0.550	rs9685761	chr4:1377942	C/G	cg05025164	chr4:1340916	KIAA1530	0.87	7.3	0.64	2.14e-10	Longevity;
SKCM	cis	rs9549367	0.662	rs3818334	chr13:113825174	C/G	cg18105134	chr13:113819100	PROZ	-0.92	-6.96	-0.62	9.34e-10	Platelet distribution width;
SKCM	cis	rs7208859	0.562	rs8078897	chr17:29106257	T/G	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs950776	0.518	rs4887063	chr15:78839715	C/T	cg06917634	chr15:78832804	PSMA4	-0.98	-9.54	-0.73	9.84e-15	Sudden cardiac arrest;
SKCM	cis	rs28595532	0.920	rs115214765	chr4:119728167	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.52	0.53	4.28e-7	Cannabis dependence symptom count;
SKCM	cis	rs854765	0.547	rs4368210	chr17:17896090	A/G	cg04398451	chr17:18023971	MYO15A	0.96	7.56	0.65	6.76e-11	Total body bone mineral density;
SKCM	cis	rs11098499	0.863	rs11098532	chr4:120490726	C/A	cg24375607	chr4:120327624	NA	0.69	5.47	0.53	5.35e-7	Corneal astigmatism;
SKCM	cis	rs10416265	0.527	rs11084699	chr19:33538393	A/T	cg17764715	chr19:33622953	WDR88	0.75	5.31	0.52	1e-6	Bone properties (heel);
SKCM	cis	rs7098414	0.531	rs3844126	chr10:82019997	T/G	cg01528321	chr10:82214614	TSPAN14	0.63	5.32	0.52	9.68e-7	Post bronchodilator FEV1;
SKCM	cis	rs4727027	0.727	rs1568944	chr7:148873497	A/T	cg23583168	chr7:148888333	NA	-0.74	-5.19	-0.51	1.64e-6	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs1153858	1.000	rs7163720	chr15:45639374	G/A	cg21132104	chr15:45694354	SPATA5L1	0.89	7.61	0.65	5.27e-11	Homoarginine levels;
SKCM	cis	rs28595532	0.920	rs115841156	chr4:119740073	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs7561149	0.902	rs6733291	chr2:179649871	G/A	cg03991736	chr2:179345203	MIR548N;PLEKHA3	0.68	4.81	0.48	7.27e-6	QT interval;
SKCM	cis	rs651907	0.557	rs2288272	chr3:101378476	C/T	cg12386194	chr3:101231763	SENP7	0.68	5.59	0.54	3.16e-7	Colorectal cancer;
SKCM	cis	rs11122272	0.706	rs2749710	chr1:231535112	A/C	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	0.7	5.93	0.56	7.97e-8	Hemoglobin concentration;
SKCM	cis	rs28386778	0.863	rs2727355	chr17:61931790	C/T	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.36	0.52	8.06e-7	Prudent dietary pattern;
SKCM	cis	rs846858	1.000	rs846858	chr19:45128825	G/A	cg18042043	chr19:44147545	NA	0.61	4.95	0.49	4.19e-6	Late-onset Alzheimer's disease;
SKCM	cis	rs35306767	0.715	rs1250891	chr10:1040159	G/C	cg20503657	chr10:835505	NA	0.6	4.9	0.48	5.16e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs801193	0.844	rs2244022	chr7:66202430	A/G	cg11764359	chr7:65958608	NA	0.83	6.08	0.57	4.09e-8	Aortic root size;
SKCM	cis	rs873946	0.557	rs4880427	chr10:134591389	T/C	cg27286337	chr10:134555280	INPP5A	0.96	8.51	0.69	9.75e-13	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs4332037	0.851	rs10268609	chr7:1962163	A/C	cg23422044	chr7:1970798	MAD1L1	-0.99	-7.57	-0.65	6.37e-11	Bipolar disorder;
SKCM	cis	rs7100689	0.577	rs873395	chr10:82037215	C/T	cg01528321	chr10:82214614	TSPAN14	-0.93	-8.38	-0.69	1.7e-12	Post bronchodilator FEV1;
SKCM	cis	rs2760061	0.598	rs1774755	chr1:228115282	T/G	cg18477163	chr1:228402036	OBSCN	-0.46	-5.1	-0.5	2.36e-6	Diastolic blood pressure;
SKCM	cis	rs807669	0.835	rs1780639	chr22:19174603	T/C	cg02655711	chr22:19163373	SLC25A1	0.78	7.22	0.63	3.03e-10	Metabolite levels;
SKCM	cis	rs6582630	0.537	rs8189533	chr12:38391068	A/G	cg26384229	chr12:38710491	ALG10B	0.88	6.86	0.61	1.46e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs16854884	0.586	rs4561830	chr3:143735572	C/T	cg06585982	chr3:143692056	C3orf58	0.87	8.34	0.69	2.04e-12	Economic and political preferences (feminism/equality);
SKCM	cis	rs875971	1.000	rs6958271	chr7:65979331	A/C	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs7811142	0.830	rs11768967	chr7:99967644	G/A	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.2	7.87	0.67	1.7e-11	Platelet count;
SKCM	cis	rs873946	0.648	rs35417213	chr10:134553749	A/G	cg14275445	chr10:134560047	INPP5A	-0.53	-4.84	-0.48	6.34e-6	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs7124681	0.584	rs11039448	chr11:47918416	G/T	cg20307385	chr11:47447363	PSMC3	-0.68	-5.23	-0.51	1.39e-6	Body mass index (joint analysis main effects and physical activity interaction);Body mass index;Body mass index in physically active individuals;
SKCM	cis	rs6547631	0.622	rs2366807	chr2:85926598	G/A	cg24620635	chr2:85921963	GNLY	0.9	6.65	0.6	3.58e-9	Blood protein levels;
SKCM	cis	rs6598955	0.670	rs11247892	chr1:26592727	A/G	cg04990556	chr1:26633338	UBXN11	-0.6	-4.85	-0.48	6.28e-6	Obesity-related traits;
SKCM	cis	rs7811142	1.000	rs6975729	chr7:100028187	C/T	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.17	7.71	0.66	3.44e-11	Platelet count;
SKCM	cis	rs801193	1.000	rs1553609	chr7:66197139	T/C	cg18876405	chr7:65276391	NA	0.8	7.11	0.63	4.88e-10	Aortic root size;
SKCM	cis	rs2839186	0.967	rs2839191	chr21:47695395	C/G	cg13012494	chr21:47604986	C21orf56	0.65	5.5	0.53	4.73e-7	Testicular germ cell tumor;
SKCM	cis	rs7208859	0.614	rs216474	chr17:28865091	C/T	cg14067834	chr17:29058358	SUZ12P	-0.95	-4.91	-0.49	4.98e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs34779708	0.931	rs12261654	chr10:35322024	G/A	cg03585969	chr10:35415529	CREM	0.76	6.23	0.58	2.17e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs1799949	1.000	rs8176289	chr17:41206056	T/C	cg25918947	chr17:41365094	TMEM106A	-0.62	-5.89	-0.55	9.22e-8	Menopause (age at onset);
SKCM	cis	rs6977660	0.714	rs10950753	chr7:19817302	G/A	cg05791153	chr7:19748676	TWISTNB	0.77	5.02	0.49	3.23e-6	Thyroid stimulating hormone;
SKCM	cis	rs17711722	0.640	rs13237956	chr7:65318029	G/A	cg11764359	chr7:65958608	NA	0.88	6.43	0.59	9.56e-9	Calcium levels;
SKCM	cis	rs6580649	0.824	rs1635534	chr12:48386553	A/G	cg05342945	chr12:48394962	COL2A1	-0.7	-4.92	-0.49	4.65e-6	Lung cancer;
SKCM	cis	rs9611565	0.512	rs4822052	chr22:42193741	G/A	cg03806693	chr22:41940476	POLR3H	-1.04	-6.83	-0.61	1.64e-9	Vitiligo;
SKCM	cis	rs644799	1.000	rs10831431	chr11:95510089	C/T	cg25622487	chr11:95524042	FAM76B;CEP57	0.73	5.9	0.56	8.71e-8	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs2153535	0.580	rs7341381	chr6:8470537	A/G	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs1577917	0.958	rs6454487	chr6:86446868	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.58	5.12	0.5	2.16e-6	Response to antipsychotic treatment;
SKCM	cis	rs1218582	0.688	rs2135219	chr1:154857217	G/A	cg03351412	chr1:154909251	PMVK	0.69	5.45	0.52	5.77e-7	Prostate cancer;
SKCM	cis	rs4808199	0.894	rs9304960	chr19:19465529	G/A	cg03709012	chr19:19516395	GATAD2A	1.08	7.53	0.65	7.65e-11	Nonalcoholic fatty liver disease;
SKCM	cis	rs589448	0.872	rs315111	chr12:69784695	G/A	cg14784868	chr12:69753453	YEATS4	0.83	7.68	0.66	3.89e-11	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs4481887	1.000	rs4244180	chr1:248471033	A/G	cg00666640	chr1:248458726	OR2T12	0.64	5.69	0.54	2.13e-7	Common traits (Other);
SKCM	cis	rs2839186	0.934	rs17176520	chr21:47682081	T/C	cg05896524	chr21:47604654	C21orf56	0.7	5.89	0.55	9.21e-8	Testicular germ cell tumor;
SKCM	cis	rs155076	1.000	rs195570	chr13:21867580	T/G	cg14456004	chr13:21872349	NA	-1.28	-7.48	-0.65	9.62e-11	White matter hyperintensity burden;
SKCM	cis	rs2811415	0.597	rs11720351	chr3:127751252	T/C	cg09089421	chr3:127803668	RUVBL1	0.99	8.52	0.69	9.09e-13	Lung function (FEV1/FVC);
SKCM	cis	rs1218582	0.710	rs7553195	chr1:154837796	T/C	cg06221963	chr1:154839813	KCNN3	-0.61	-6.6	-0.6	4.5e-9	Prostate cancer;
SKCM	cis	rs7119	0.671	rs10152850	chr15:77904426	G/A	cg27398640	chr15:77910606	LINGO1	0.51	5.0	0.49	3.48e-6	Type 2 diabetes;
SKCM	cis	rs17376456	1.000	rs56046246	chr5:93531545	T/G	cg25358565	chr5:93447407	FAM172A	1.23	8.18	0.68	4.19e-12	Diabetic retinopathy;
SKCM	cis	rs6424115	0.557	rs35904775	chr1:24180623	T/C	cg15997130	chr1:24165203	NA	-0.57	-4.77	-0.48	8.43e-6	Immature fraction of reticulocytes;
SKCM	cis	rs6930083	0.713	rs1321309	chr6:36638636	G/A	cg08179530	chr6:36648295	CDKN1A	-0.7	-5.44	-0.52	6.04e-7	Coronary artery disease;
SKCM	cis	rs796364	0.951	rs12996313	chr2:200997916	C/T	cg12253985	chr2:200820533	C2orf60;C2orf47	-0.98	-6.28	-0.58	1.82e-8	Schizophrenia;
SKCM	cis	rs10751667	0.666	rs7936830	chr11:959686	A/G	cg10932868	chr11:921992	NA	0.55	5.1	0.5	2.36e-6	Alzheimer's disease (late onset);
SKCM	cis	rs4237845	0.551	rs116263297	chr12:58273445	A/C	cg00677455	chr12:58241039	CTDSP2	0.9	8.16	0.68	4.55e-12	Intelligence (multi-trait analysis);
SKCM	cis	rs28595532	1.000	rs115965820	chr4:119586485	G/A	cg14228332	chr4:119757509	SEC24D	0.97	4.92	0.49	4.71e-6	Cannabis dependence symptom count;
SKCM	cis	rs9815354	0.812	rs73073352	chr3:41842184	T/C	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs62238980	0.614	rs80217052	chr22:32413767	T/C	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs2404602	0.631	rs9646213	chr15:76807672	G/C	cg23625390	chr15:77176239	SCAPER	0.59	5.38	0.52	7.54e-7	Blood metabolite levels;
SKCM	cis	rs11098499	0.821	rs56155624	chr4:120291026	C/G	cg09307838	chr4:120376055	NA	0.95	7.37	0.64	1.54e-10	Corneal astigmatism;
SKCM	cis	rs7666738	0.830	rs35865860	chr4:98968822	C/T	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs738322	0.967	rs4380	chr22:38569529	T/C	cg25457927	chr22:38595422	NA	-0.5	-5.56	-0.53	3.61e-7	Cutaneous nevi;
SKCM	cis	rs7143963	1.000	rs72704731	chr14:103358070	A/C	cg23020514	chr14:103360112	TRAF3	0.9	8.63	0.7	5.58e-13	Body mass index;
SKCM	cis	rs9902453	1.000	rs60967688	chr17:28437052	G/A	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.5	0.53	4.67e-7	Coffee consumption (cups per day);
SKCM	cis	rs72634258	0.945	rs3766606	chr1:8022197	G/T	cg00042356	chr1:8021962	PARK7	1.04	7.35	0.64	1.67e-10	Inflammatory bowel disease;
SKCM	cis	rs1348850	0.632	rs1405718	chr2:178499809	C/T	cg22681709	chr2:178499509	PDE11A	-0.69	-5.98	-0.56	6.36e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs7772486	0.846	rs9373482	chr6:146363123	A/C	cg05347473	chr6:146136440	FBXO30	0.57	5.24	0.51	1.31e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1878931	0.668	rs2074366	chr16:3439676	G/A	cg26668626	chr16:3451006	ZNF174;ZNF434	1.08	10.56	0.77	1.06e-16	Body mass index (adult);
SKCM	cis	rs763121	0.853	rs5750621	chr22:38956166	C/T	cg06022373	chr22:39101656	GTPBP1	0.78	5.85	0.55	1.08e-7	Menopause (age at onset);
SKCM	trans	rs3780486	0.846	rs7865745	chr9:33140976	A/G	cg20290983	chr6:43655470	MRPS18A	-1.03	-11.24	-0.79	5.48e-18	IgG glycosylation;
SKCM	cis	rs7666738	0.830	rs28887893	chr4:98963006	G/A	cg17366294	chr4:99064904	C4orf37	0.59	4.89	0.48	5.36e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs362296	0.530	rs3129316	chr4:3287906	A/G	cg09735869	chr4:3319127	RGS12	0.82	8.1	0.68	6.07e-12	Parental longevity (mother's age at death);
SKCM	cis	rs6088590	1.000	rs28542147	chr20:33376323	G/A	cg24642439	chr20:33292090	TP53INP2	1.01	7.2	0.63	3.23e-10	Coronary artery disease;
SKCM	cis	rs28386778	0.897	rs1062791	chr17:61896487	C/T	cg01411255	chr17:61851458	DDX42;CCDC47	0.76	4.91	0.49	4.9100000000000004e-06	Prudent dietary pattern;
SKCM	cis	rs17685	0.784	rs1637043	chr7:75699099	G/A	cg16684958	chr7:75615977	POR	0.57	5.6	0.54	3.07e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs6500395	1.000	rs8059905	chr16:48629934	C/T	cg04672837	chr16:48644449	N4BP1	0.69	5.9	0.56	9.03e-8	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs8072100	0.871	rs7206971	chr17:45425115	A/G	cg25173405	chr17:45401733	C17orf57	0.61	5.36	0.52	8.08e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs11098499	0.954	rs11734241	chr4:120416872	A/G	cg24375607	chr4:120327624	NA	0.66	5.13	0.5	2.07e-6	Corneal astigmatism;
SKCM	cis	rs3784262	0.692	rs12914388	chr15:58283843	T/C	cg12031962	chr15:58353849	ALDH1A2	-0.41	-4.82	-0.48	6.93e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs4975616	0.869	rs401681	chr5:1322087	C/T	cg06550200	chr5:1325588	CLPTM1L	-0.85	-7.56	-0.65	6.56e-11	Lung cancer;
SKCM	cis	rs55962025	0.842	rs362306	chr4:3242100	C/T	cg00764545	chr4:3318001	RGS12	-0.75	-6.14	-0.57	3.29e-8	Parental longevity (mother's age at death);
SKCM	cis	rs7772486	0.754	rs702306	chr6:145991029	T/C	cg05347473	chr6:146136440	FBXO30	-0.66	-6.06	-0.57	4.63e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs3096299	0.685	rs4785568	chr16:89553707	A/G	cg02187348	chr16:89574699	SPG7	0.62	4.89	0.48	5.38e-6	Multiple myeloma (IgH translocation);
SKCM	cis	rs10752881	0.935	rs10911197	chr1:182995399	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.64	0.6	3.83e-9	Colorectal cancer;
SKCM	cis	rs3768617	0.510	rs10797852	chr1:183101302	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs7208859	0.623	rs76633166	chr17:29113365	C/T	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs597539	0.652	rs557625	chr11:68634722	G/A	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.84	5.61	0.54	3e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	trans	rs561341	1.000	rs72823787	chr17:30283809	A/T	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs9814567	0.929	rs1534027	chr3:134284662	T/A	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs6430585	0.527	rs2254780	chr2:136435526	C/T	cg07169764	chr2:136633963	MCM6	1.0	7.26	0.64	2.49e-10	Corneal structure;
SKCM	cis	rs7772486	0.641	rs2748489	chr6:146331287	T/G	cg23711669	chr6:146136114	FBXO30	0.76	6.0	0.56	5.76e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs17685	0.753	rs10476	chr7:75696420	C/T	cg01364799	chr7:75623366	TMEM120A	0.73	5.71	0.54	1.98e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs8017423	0.967	rs11626011	chr14:90693572	A/G	cg04374321	chr14:90722782	PSMC1	0.99	8.89	0.71	1.79e-13	Mortality in heart failure;
SKCM	cis	rs2153535	0.547	rs9502720	chr6:8541362	C/A	cg07606381	chr6:8435919	SLC35B3	0.91	6.28	0.58	1.77e-8	Motion sickness;
SKCM	cis	rs72634258	0.945	rs12740409	chr1:8027830	A/C	cg00042356	chr1:8021962	PARK7	1.06	7.07	0.63	5.73e-10	Inflammatory bowel disease;
SKCM	cis	rs2929278	0.589	rs2411284	chr15:44038899	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	-0.74	-5.27	-0.51	1.2e-6	Schizophrenia;
SKCM	cis	rs7809950	1.000	rs2520249	chr7:107146748	A/G	cg23024343	chr7:107201750	COG5	-0.76	-6.83	-0.61	1.64e-9	Coronary artery disease;
SKCM	cis	rs7086627	0.515	rs1870147	chr10:82212541	A/T	cg01528321	chr10:82214614	TSPAN14	0.6	4.88	0.48	5.45e-6	Post bronchodilator FEV1;
SKCM	trans	rs1814175	0.781	rs12286395	chr11:49954062	C/G	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs10489202	0.608	rs10800334	chr1:168075613	T/C	cg24449463	chr1:168025552	DCAF6	-0.8	-7.21	-0.63	3.13e-10	Schizophrenia;
SKCM	cis	rs7954584	0.567	rs1169071	chr12:122390084	G/T	cg21171335	chr12:122356390	WDR66	0.46	5.02	0.49	3.24e-6	Mean corpuscular volume;
SKCM	cis	rs10504229	1.000	rs67895971	chr8:58177994	A/G	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs752010	0.645	rs1109254	chr1:42091770	T/C	cg06885757	chr1:42089581	HIVEP3	0.72	7.64	0.65	4.6e-11	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs7927771	0.507	rs10838759	chr11:47785347	T/C	cg20307385	chr11:47447363	PSMC3	0.72	5.81	0.55	1.31e-7	Subjective well-being;
SKCM	cis	rs28386778	0.897	rs894408	chr17:61896814	C/T	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs8014204	0.901	rs6574200	chr14:75364451	C/T	cg06637938	chr14:75390232	RPS6KL1	-0.76	-5.74	-0.54	1.74e-7	Caffeine consumption;
SKCM	cis	rs2439831	0.867	rs2447208	chr15:43933895	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.31	7.12	0.63	4.58e-10	Lung cancer in ever smokers;
SKCM	cis	rs6570726	0.791	rs374478	chr6:145840022	C/T	cg05347473	chr6:146136440	FBXO30	0.53	4.78	0.48	8.07e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs10504229	0.953	rs114853497	chr8:58176176	A/T	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs1799949	1.000	rs2037075	chr17:41305826	G/T	cg19454999	chr17:41278357	BRCA1;NBR2	0.49	4.79	0.48	7.82e-6	Menopause (age at onset);
SKCM	cis	rs2204008	0.811	rs12368410	chr12:38305705	C/T	cg26384229	chr12:38710491	ALG10B	0.87	6.83	0.61	1.63e-9	Bladder cancer;
SKCM	cis	rs12586317	0.547	rs4982236	chr14:35468046	C/G	cg16230307	chr14:35515116	FAM177A1	0.81	5.88	0.55	9.47e-8	Psoriasis;
SKCM	cis	rs3845702	1.000	rs262279	chr2:180869145	G/A	cg01881094	chr2:180872142	CWC22	1.06	5.68	0.54	2.19e-7	Schizophrenia;
SKCM	cis	rs2658782	1.000	rs2605582	chr11:93163799	C/T	cg15737290	chr11:93063684	CCDC67	0.76	5.32	0.52	9.69e-7	Pulmonary function decline;
SKCM	cis	rs12474201	0.928	rs12998753	chr2:46938385	A/G	cg06386533	chr2:46925753	SOCS5	1.01	9.25	0.72	3.5e-14	Height;
SKCM	cis	rs1790761	0.501	rs4930210	chr11:67404726	G/T	cg23188684	chr11:67383651	NA	-0.55	-4.81	-0.48	7.31e-6	Mean corpuscular volume;
SKCM	cis	rs3087591	0.960	rs8067021	chr17:29555078	T/A	cg24425628	chr17:29625626	OMG;NF1	-0.64	-5.22	-0.51	1.43e-6	Hip circumference;
SKCM	cis	rs11105298	0.891	rs10777185	chr12:89921275	C/T	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.91	-5.65	-0.54	2.56e-7	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs6089584	0.527	rs927589	chr20:60606363	A/G	cg06108461	chr20:60628389	TAF4	-0.73	-6.66	-0.6	3.43e-9	Body mass index;
SKCM	cis	rs9393692	0.902	rs6456711	chr6:26302572	A/C	cg00631329	chr6:26305371	NA	-0.66	-4.81	-0.48	7.17e-6	Educational attainment;
SKCM	cis	rs9912468	0.803	rs4423457	chr17:64284000	G/A	cg19474267	chr17:64306194	PRKCA	0.65	5.6	0.54	3.11e-7	QRS duration;QRS complex (12-leadsum);QRS complex (Sokolow-Lyon);
SKCM	cis	rs4253772	0.591	rs6008361	chr22:46652372	A/G	cg03482458	chr22:46692211	CN5H6.4;GTSE1	-1.18	-5.75	-0.55	1.66e-7	LDL cholesterol;Cholesterol, total;
SKCM	cis	rs6066825	0.644	rs1040559	chr20:47314445	A/G	cg18078177	chr20:47281410	PREX1	0.64	5.15	0.5	1.9e-6	Colorectal cancer;
SKCM	cis	rs6089829	0.962	rs6089826	chr20:61668595	G/A	cg08564027	chr20:61660810	NA	0.63	5.68	0.54	2.21e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs1218582	0.772	rs1109815	chr1:154909268	A/G	cg03351412	chr1:154909251	PMVK	0.77	6.52	0.59	6.43e-9	Prostate cancer;
SKCM	cis	rs35146811	0.586	rs10267231	chr7:99595480	T/C	cg22906224	chr7:99728672	NA	0.85	6.07	0.57	4.31e-8	Coronary artery disease;
SKCM	cis	rs28595532	0.920	rs114581578	chr4:119756404	C/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs28595532	0.841	rs114465037	chr4:119778165	A/G	cg11846333	chr4:119757529	SEC24D	1.17	6.09	0.57	4.03e-8	Cannabis dependence symptom count;
SKCM	cis	rs7618501	0.602	rs6780731	chr3:50017478	A/G	cg24110177	chr3:50126178	RBM5	-0.6	-5.11	-0.5	2.25e-6	Intelligence (multi-trait analysis);
SKCM	trans	rs8073060	0.544	rs225268	chr17:33966224	A/C	cg19694781	chr19:47549865	TMEM160	-1.08	-8.36	-0.69	1.88e-12	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs12928939	0.517	rs12149325	chr16:71968147	G/C	cg03805757	chr16:71968109	PKD1L3	-0.72	-5.17	-0.51	1.78e-6	Post bronchodilator FEV1;
SKCM	cis	rs2302190	0.882	rs11656888	chr17:56546725	T/A	cg25885038	chr17:56607967	SEPT4	-0.72	-4.81	-0.48	7.23e-6	Vitamin D levels;
SKCM	cis	rs11112613	0.713	rs4015312	chr12:105948757	A/G	cg03607813	chr12:105948248	NA	0.88	6.01	0.56	5.5e-8	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;
SKCM	cis	rs9902453	0.838	rs9646437	chr17:28209065	G/A	cg26525008	chr17:28256777	EFCAB5;SSH2	0.81	5.78	0.55	1.44e-7	Coffee consumption (cups per day);
SKCM	cis	rs6463523	0.525	rs11763218	chr7:852281	T/C	cg05729249	chr7:766119	PRKAR1B;HEATR2	-0.92	-5.96	-0.56	6.89e-8	Subjective well-being;
SKCM	cis	rs6952808	0.575	rs6950330	chr7:1953606	T/C	cg02951883	chr7:2050386	MAD1L1	-0.66	-5.58	-0.53	3.29e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs7399018	0.739	rs6580811	chr12:51612501	T/C	cg25754956	chr12:51612065	POU6F1	0.81	6.23	0.58	2.25e-8	Cisplatin-induced ototoxicity;
SKCM	cis	rs10870270	1.000	rs10870232	chr10:133738537	T/G	cg17892150	chr10:133769511	PPP2R2D	-0.66	-4.89	-0.48	5.37e-6	Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals;
SKCM	cis	rs9880211	1.000	rs9869630	chr3:136248019	A/C	cg21827317	chr3:136751795	NA	-0.64	-4.78	-0.48	8.21e-6	Body mass index;Height;
SKCM	cis	rs250567	0.609	rs80096684	chr16:23525104	C/A	cg02469297	chr16:23766525	CHP2	-0.81	-5.16	-0.5	1.85e-6	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes;
SKCM	cis	rs9911578	0.967	rs11079354	chr17:56594460	G/A	cg12560992	chr17:57184187	TRIM37	-0.95	-7.69	-0.66	3.7e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs2760061	0.583	rs3094911	chr1:228210179	A/G	cg02753203	chr1:228287806	NA	0.89	8.22	0.68	3.54e-12	Diastolic blood pressure;
SKCM	cis	rs910316	1.000	rs175426	chr14:75624134	C/T	cg11812906	chr14:75593930	NEK9	-0.69	-5.24	-0.51	1.32e-6	Height;
SKCM	cis	rs12477438	0.520	rs13004491	chr2:99738008	T/C	cg14399236	chr2:99771627	LIPT1;TSGA10	0.95	8.78	0.71	2.89e-13	Chronic sinus infection;
SKCM	cis	rs7811142	1.000	rs7783550	chr7:99987805	A/G	cg23667466	chr7:100026434	MEPCE;ZCWPW1	-1.1	-6.21	-0.58	2.41e-8	Platelet count;
SKCM	cis	rs908922	0.651	rs564107	chr1:152519295	C/T	cg09873164	chr1:152488093	CRCT1	0.77	6.04	0.56	5.01e-8	Hair morphology;
SKCM	cis	rs2644899	0.750	rs2607424	chr19:41275147	C/T	cg24958765	chr19:41283667	RAB4B	-0.8	-5.04	-0.5	2.94e-6	Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs6461049	0.800	rs1860831	chr7:2160931	T/C	cg21782813	chr7:2030301	MAD1L1	0.46	4.89	0.48	5.33e-6	Schizophrenia;
SKCM	cis	rs478304	0.651	rs11227281	chr11:65496558	T/C	cg17480646	chr11:65405466	SIPA1	-0.71	-5.64	-0.54	2.62e-7	Acne (severe);
SKCM	cis	rs116095464	0.614	rs56299325	chr5:220594	C/T	cg22496380	chr5:211416	CCDC127	-0.96	-5.27	-0.51	1.18e-6	Breast cancer;
SKCM	cis	rs1799949	1.000	rs4793229	chr17:41418334	C/T	cg05368731	chr17:41323189	NBR1	-0.88	-7.29	-0.64	2.21e-10	Menopause (age at onset);
SKCM	cis	rs867186	1.000	rs6579208	chr20:33598612	C/T	cg04194272	chr20:33683537	NA	-1.39	-7.22	-0.63	3e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs854765	0.583	rs9913724	chr17:17819101	A/G	cg04398451	chr17:18023971	MYO15A	-0.85	-6.05	-0.57	4.75e-8	Total body bone mineral density;
SKCM	cis	rs35306767	0.855	rs12771179	chr10:872347	A/G	cg26597838	chr10:835615	NA	0.79	6.08	0.57	4.12e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs4727027	0.933	rs12532104	chr7:148864233	A/C	cg23583168	chr7:148888333	NA	-0.8	-6.62	-0.6	4.13e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs867186	1.000	rs80170004	chr20:33551462	G/A	cg04194272	chr20:33683537	NA	-1.37	-6.77	-0.61	2.18e-9	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs763014	0.833	rs4984891	chr16:622234	T/A	cg07343612	chr16:622815	PIGQ	-0.69	-5.73	-0.54	1.78e-7	Height;
SKCM	cis	rs2839186	0.619	rs2187118	chr21:47611310	C/T	cg13126279	chr21:47581558	C21orf56	-0.71	-6.31	-0.58	1.6e-8	Testicular germ cell tumor;
SKCM	cis	rs2836974	0.932	rs73221193	chr21:40554693	C/T	cg17971929	chr21:40555470	PSMG1	0.9	8.42	0.69	1.45e-12	Cognitive function;
SKCM	cis	rs10207060	0.500	rs72992168	chr2:240712932	G/A	cg07506560	chr2:240697449	NA	0.75	6.1	0.57	3.8e-8	Obesity-related traits;
SKCM	trans	rs2727020	0.658	rs4980442	chr11:49445016	G/T	cg15704280	chr7:45808275	SEPT13	-0.87	-7.93	-0.67	1.31e-11	Coronary artery disease;
SKCM	cis	rs4466137	0.794	rs6869296	chr5:83007333	C/G	cg16102102	chr5:83017553	HAPLN1	0.55	5.94	0.56	7.61e-8	Prostate cancer;
SKCM	cis	rs2832191	0.791	rs2832181	chr21:30481371	G/T	cg24692254	chr21:30365293	RNF160	-0.9	-8.03	-0.67	8.39e-12	Dental caries;
SKCM	trans	rs9929218	0.551	rs7201437	chr16:68727130	A/C	cg04657470	chr2:198365150	HSPE1;HSPD1	0.95	9.94	0.75	1.65e-15	Colorectal cancer;
SKCM	cis	rs854765	0.624	rs12952723	chr17:17731651	T/C	cg24612305	chr17:17875800	TOM1L2;LRRC48	-0.95	-7.1	-0.63	5e-10	Total body bone mineral density;
SKCM	cis	rs1801251	1.000	rs7558609	chr2:233700379	C/T	cg25237894	chr2:233734115	C2orf82	0.58	5.69	0.54	2.13e-7	Coronary artery disease;
SKCM	cis	rs10927875	0.965	rs3961710	chr1:16313172	C/T	cg21385522	chr1:16154831	NA	-0.94	-7.73	-0.66	3.06e-11	Dilated cardiomyopathy;
SKCM	cis	rs7811142	1.000	rs73161762	chr7:100014846	C/T	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.12	7.16	0.63	3.95e-10	Platelet count;
SKCM	cis	rs4665809	0.590	rs11897162	chr2:26503654	T/C	cg26119090	chr2:26468346	HADHA;HADHB	1.05	8.22	0.68	3.6e-12	Gut microbiome composition (summer);
SKCM	cis	rs7772486	0.875	rs2814863	chr6:146347299	C/T	cg23711669	chr6:146136114	FBXO30	-0.79	-7.57	-0.65	6.24e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7647973	0.600	rs35174559	chr3:49287759	T/C	cg06212747	chr3:49208901	KLHDC8B	0.78	5.59	0.54	3.15e-7	Menarche (age at onset);
SKCM	cis	rs55962025	0.883	rs362336	chr4:3213832	G/A	cg24015175	chr4:3319247	RGS12	-0.64	-5.45	-0.53	5.59e-7	Parental longevity (mother's age at death);
SKCM	cis	rs7927771	0.524	rs6485786	chr11:47837408	G/C	cg20307385	chr11:47447363	PSMC3	0.71	5.63	0.54	2.67e-7	Subjective well-being;
SKCM	cis	rs4819052	0.851	rs28442024	chr21:46674475	C/A	cg02159808	chr21:46707872	POFUT2;LOC642852	0.73	5.71	0.54	1.93e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs1577917	0.740	rs2758842	chr6:86308731	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.9	-8.96	-0.71	1.27e-13	Response to antipsychotic treatment;
SKCM	cis	rs3785574	0.962	rs2727280	chr17:61918082	A/G	cg01411255	chr17:61851458	DDX42;CCDC47	1.11	10.24	0.76	4.38e-16	Height;
SKCM	cis	rs12096438	1.000	rs11563	chr1:25894853	G/T	cg21452808	chr1:25900135	NA	0.45	5.03	0.49	3.06e-6	Platelet count;Mean platelet volume;
SKCM	cis	rs644799	0.965	rs11021310	chr11:95502106	A/C	cg03916912	chr11:95522834	CEP57;FAM76B	0.95	8.77	0.7	2.97e-13	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs4819052	0.851	rs28442024	chr21:46674475	C/A	cg20896738	chr21:46707857	POFUT2;LOC642852	0.64	4.82	0.48	6.85e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	trans	rs10506458	0.915	rs998506	chr12:63400017	C/T	cg03429785	chr15:59498649	MYO1E;LDHAL6B	-1.38	-7.54	-0.65	7.13e-11	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs35306767	0.903	rs12249634	chr10:872744	G/A	cg20503657	chr10:835505	NA	0.75	5.43	0.52	6.09e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs9467773	1.000	rs1321479	chr6:26501897	C/T	cg09904177	chr6:26538194	HMGN4	-0.56	-5.29	-0.51	1.08e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs17711722	0.510	rs11767457	chr7:65290615	C/T	cg18876405	chr7:65276391	NA	0.63	4.88	0.48	5.61e-6	Calcium levels;
SKCM	cis	rs2777491	0.522	rs7173571	chr15:41712807	T/C	cg18705301	chr15:41695430	NDUFAF1	-0.7	-5.3	-0.51	1.05e-6	Ulcerative colitis;
SKCM	cis	rs7811142	0.943	rs111757992	chr7:100016354	A/C	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.23	8.03	0.67	8.33e-12	Platelet count;
SKCM	cis	rs2836974	0.897	rs35386515	chr21:40532047	C/T	cg11644478	chr21:40555479	PSMG1	0.97	10.21	0.76	5.08e-16	Cognitive function;
SKCM	cis	rs7635838	0.819	rs12714866	chr3:11539058	C/T	cg00170343	chr3:11313890	ATG7	0.68	4.89	0.48	5.22e-6	HDL cholesterol;
SKCM	cis	rs7666738	0.830	rs3907020	chr4:99038583	T/C	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4888262	0.526	rs8057279	chr16:74627303	C/T	cg01733217	chr16:74700730	RFWD3	0.92	7.11	0.63	4.82e-10	Testicular germ cell tumor;
SKCM	cis	rs782590	0.764	rs2586969	chr2:55829392	G/C	cg18811423	chr2:55921094	PNPT1	0.94	6.83	0.61	1.63e-9	Metabolic syndrome;
SKCM	cis	rs80130819	0.515	rs1793917	chr12:48384944	A/T	cg05342945	chr12:48394962	COL2A1	-0.69	-4.86	-0.48	5.98e-6	Prostate cancer;
SKCM	cis	rs597539	0.690	rs1249359	chr11:68618279	C/T	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.81	5.33	0.52	9.43e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs867186	1.000	rs76850134	chr20:33671725	A/C	cg04194272	chr20:33683537	NA	-1.38	-7.2	-0.63	3.29e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs826838	0.967	rs1684415	chr12:39130099	T/C	cg13010199	chr12:38710504	ALG10B	-0.72	-5.73	-0.54	1.83e-7	Heart rate;
SKCM	cis	rs3008870	1.000	rs11208976	chr1:67434411	A/G	cg08660285	chr1:67390436	MIER1;WDR78	-0.92	-6.07	-0.57	4.27e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs523522	0.923	rs10774553	chr12:120954984	T/C	cg12219531	chr12:120966889	COQ5	0.91	7.82	0.66	2.11e-11	High light scatter reticulocyte count;
SKCM	cis	rs1801251	0.896	rs6719061	chr2:233695885	C/T	cg25237894	chr2:233734115	C2orf82	-0.53	-5.07	-0.5	2.66e-6	Coronary artery disease;
SKCM	cis	rs1949733	1.000	rs2631745	chr4:8490530	T/C	cg11789530	chr4:8429930	ACOX3	-0.83	-5.88	-0.55	9.8e-8	Response to antineoplastic agents;
SKCM	cis	rs12477438	0.520	rs13009147	chr2:99803998	T/G	cg26064155	chr2:99771622	LIPT1;TSGA10	0.97	8.85	0.71	2.11e-13	Chronic sinus infection;
SKCM	cis	rs3859192	0.539	rs2302774	chr17:38183090	G/T	cg17467752	chr17:38218738	THRA	-0.77	-6.57	-0.6	5.07e-9	White blood cell count;
SKCM	cis	rs9467773	1.000	rs9467778	chr6:26534743	T/C	cg09904177	chr6:26538194	HMGN4	0.54	4.98	0.49	3.78e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1577917	1.000	rs10944161	chr6:86630376	A/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.85	-8.62	-0.7	5.82e-13	Response to antipsychotic treatment;
SKCM	cis	rs1046896	0.739	rs2379358	chr17:80741612	G/A	cg02711726	chr17:80685570	FN3KRP	-0.76	-5.95	-0.56	7.33e-8	Glycated hemoglobin levels;
SKCM	cis	rs6952808	0.789	rs35729895	chr7:1885069	C/T	cg02951883	chr7:2050386	MAD1L1	-0.69	-5.0	-0.49	3.38e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs1005277	0.529	rs1780125	chr10:38531376	A/G	cg25427524	chr10:38739819	LOC399744	-0.72	-6.99	-0.62	8.31e-10	Extrinsic epigenetic age acceleration;
SKCM	cis	rs614226	0.935	rs2235222	chr12:120892193	G/C	cg01236616	chr12:121019343	POP5	-1.29	-8.1	-0.68	5.94e-12	Type 1 diabetes nephropathy;
SKCM	cis	rs793571	0.566	rs610877	chr15:59103328	C/A	cg05156742	chr15:59063176	FAM63B	0.73	5.18	0.51	1.7e-6	Schizophrenia;
SKCM	cis	rs28386778	0.897	rs8067102	chr17:61848779	C/G	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs7584330	0.737	rs6758246	chr2:238359891	G/C	cg14458575	chr2:238380390	NA	0.93	6.21	0.57	2.44e-8	Prostate cancer;
SKCM	cis	rs6121246	1.000	rs6121246	chr20:30433352	C/T	cg11595048	chr20:30225325	COX4I2	0.65	5.03	0.49	3.1e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs10256972	0.706	rs12701969	chr7:1121849	A/G	cg09177884	chr7:1199841	ZFAND2A	-0.76	-6.42	-0.59	9.82e-9	Longevity;Endometriosis;
SKCM	cis	rs34779708	0.931	rs11010077	chr10:35328088	C/T	cg03585969	chr10:35415529	CREM	-0.79	-6.27	-0.58	1.89e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs1799949	0.683	rs55737636	chr17:41264739	C/T	cg23758822	chr17:41437982	NA	0.93	7.42	0.64	1.24e-10	Menopause (age at onset);
SKCM	cis	rs1577917	0.629	rs7761762	chr6:86205968	C/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.69	5.98	0.56	6.44e-8	Response to antipsychotic treatment;
SKCM	cis	rs910316	1.000	rs10149880	chr14:75633008	A/G	cg08847533	chr14:75593920	NEK9	-0.94	-9.11	-0.72	6.65e-14	Height;
SKCM	cis	rs875971	0.862	rs11769079	chr7:65842128	G/A	cg11764359	chr7:65958608	NA	0.81	7.63	0.65	4.91e-11	Aortic root size;
SKCM	trans	rs1814175	0.935	rs1827017	chr11:49632592	C/G	cg03929089	chr4:120376271	NA	-0.87	-7.53	-0.65	7.64e-11	Height;
SKCM	cis	rs933688	0.639	rs332530	chr5:90789810	G/T	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.07	7.95	0.67	1.19e-11	Smoking behavior;
SKCM	cis	rs2836974	0.584	rs6517535	chr21:40653352	G/C	cg11644478	chr21:40555479	PSMG1	-0.8	-7.6	-0.65	5.6e-11	Cognitive function;
SKCM	trans	rs11083271	0.567	rs12607869	chr18:25851746	A/G	cg00321150	chr11:62623587	SNORD27;SLC3A2;SNHG1;SNORD28;SNORD25;SNORD26	0.8	7.63	0.65	4.88e-11	Non-alcoholic fatty liver disease histology (lobular);
SKCM	trans	rs1814175	0.588	rs1721994	chr11:49914050	G/A	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs9475752	0.793	rs75622343	chr6:56848052	C/G	cg06815302	chr6:57335405	PRIM2	0.65	5.03	0.49	3.12e-6	Menarche (age at onset);
SKCM	cis	rs711830	0.965	rs6755777	chr2:177043226	T/G	cg13092806	chr2:177043255	NA	0.65	5.81	0.55	1.32e-7	Serous invasive ovarian cancer;Epithelial ovarian cancer;Invasive epithelial ovarian cancer;Mucinous ovarian carcinoma;Low-grade serous and serous borderline ovarian cancer;Serous borderline ovarian cancer;High-grade serous ovarian cancer;
SKCM	cis	rs12497850	0.864	rs4513485	chr3:49139966	G/A	cg07636037	chr3:49044803	WDR6	1.03	9.16	0.72	5.21e-14	Parkinson's disease;
SKCM	cis	rs28595532	0.920	rs115430947	chr4:119737149	C/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs12986445	0.744	rs2138391	chr2:26112785	T/C	cg04917511	chr2:26785460	C2orf70	0.53	4.97	0.49	3.88e-6	Multiple myeloma and monoclonal gammopathy;Multiple myeloma;
SKCM	cis	rs875971	1.000	rs1144894	chr7:65542894	A/G	cg11764359	chr7:65958608	NA	-0.89	-8.44	-0.69	1.29e-12	Aortic root size;
SKCM	cis	rs7208859	0.623	rs9915566	chr17:29132158	G/A	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs6938	0.534	rs11072512	chr15:75204026	C/T	cg09165964	chr15:75287851	SCAMP5	0.62	4.91	0.49	4.99e-6	Breast cancer;
SKCM	cis	rs10927875	0.722	rs945425	chr1:16348412	T/C	cg21385522	chr1:16154831	NA	0.68	4.93	0.49	4.58e-6	Dilated cardiomyopathy;
SKCM	cis	rs9911578	0.757	rs117987711	chr17:57111269	A/C	cg12560992	chr17:57184187	TRIM37	-0.99	-8.05	-0.67	7.47e-12	Intelligence (multi-trait analysis);
SKCM	trans	rs208520	0.526	rs9363522	chr6:66816642	C/T	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-1.08	-11.82	-0.8	4.59e-19	Exhaled nitric oxide output;
SKCM	cis	rs8077889	0.917	rs6503479	chr17:41917003	A/G	cg26893861	chr17:41843967	DUSP3	1.22	8.23	0.68	3.35e-12	Triglycerides;
SKCM	cis	rs6834538	0.597	rs1486865	chr4:113465651	A/G	cg05166686	chr4:113558556	LARP7;C4orf21	0.63	5.21	0.51	1.48e-6	Free thyroxine concentration;
SKCM	cis	rs7847628	0.587	rs1060817	chr9:123583192	A/G	cg09419670	chr9:123605666	PSMD5;LOC253039	0.67	6.11	0.57	3.6e-8	Birth weight;
SKCM	cis	rs12928939	0.517	rs9940234	chr16:71964805	C/T	cg03805757	chr16:71968109	PKD1L3	-0.72	-5.17	-0.51	1.78e-6	Post bronchodilator FEV1;
SKCM	cis	rs6840360	0.571	rs17275598	chr4:152568478	C/A	cg22705602	chr4:152727874	NA	-0.51	-5.45	-0.52	5.78e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs9858542	0.903	rs17080528	chr3:49389842	C/T	cg03060546	chr3:49711283	APEH	-0.68	-4.99	-0.49	3.54e-6	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs6461049	0.638	rs1859993	chr7:2183702	A/G	cg21782813	chr7:2030301	MAD1L1	0.5	5.06	0.5	2.69e-6	Schizophrenia;
SKCM	cis	rs9900062	0.586	rs2676307	chr17:62690713	C/G	cg02097616	chr17:62675921	NA	0.75	6.16	0.57	2.91e-8	QT interval;
SKCM	cis	rs12134245	0.742	rs17501381	chr1:92003919	A/G	cg02896835	chr1:92012615	NA	-0.63	-5.85	-0.55	1.09e-7	Breast cancer;
SKCM	cis	rs28386778	0.897	rs2584610	chr17:61934783	T/C	cg06873352	chr17:61820015	STRADA	0.76	6.34	0.58	1.38e-8	Prudent dietary pattern;
SKCM	cis	rs4654899	0.785	rs9426656	chr1:21505932	T/G	cg01072550	chr1:21505969	NA	-0.62	-4.79	-0.48	7.86e-6	Superior frontal gyrus grey matter volume;
SKCM	cis	rs867186	1.000	rs7263203	chr20:33773375	A/C	cg04194272	chr20:33683537	NA	-1.02	-5.4	-0.52	7.03e-7	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs6088580	0.634	rs4911418	chr20:32994257	G/A	cg24642439	chr20:33292090	TP53INP2	-0.76	-6.02	-0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	trans	rs208520	0.690	rs12202805	chr6:66703903	A/G	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-0.91	-7.71	-0.66	3.48e-11	Exhaled nitric oxide output;
SKCM	cis	rs9911578	0.839	rs11658694	chr17:57205174	T/C	cg12560992	chr17:57184187	TRIM37	0.99	8.46	0.69	1.22e-12	Intelligence (multi-trait analysis);
SKCM	cis	rs9513627	1.000	rs9517755	chr13:100168408	C/A	cg11288260	chr13:100117058	NA	0.83	4.97	0.49	3.8e-6	Obesity-related traits;
SKCM	cis	rs7772486	0.727	rs4896843	chr6:146063451	T/C	cg05347473	chr6:146136440	FBXO30	-0.61	-5.77	-0.55	1.53e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs3087591	1.000	rs2525578	chr17:29711411	A/G	cg24425628	chr17:29625626	OMG;NF1	-0.63	-4.94	-0.49	4.44e-6	Hip circumference;
SKCM	cis	rs2050392	0.760	rs10826797	chr10:30690376	A/C	cg25182066	chr10:30743637	MAP3K8	-0.62	-5.24	-0.51	1.35e-6	Inflammatory bowel disease;
SKCM	cis	rs9581857	0.556	rs9581863	chr13:28040171	A/G	cg22138327	chr13:27999177	GTF3A	0.71	5.36	0.52	8.12e-7	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs208520	0.690	rs207096	chr6:66797287	T/C	cg07460842	chr6:66804631	NA	-1.02	-7.65	-0.65	4.42e-11	Exhaled nitric oxide output;
SKCM	cis	rs732765	0.657	rs11849512	chr14:75237484	C/A	cg25946216	chr14:74253857	C14orf43	-0.94	-5.23	-0.51	1.36e-6	Non-small cell lung cancer;
SKCM	cis	rs6430585	0.583	rs4988145	chr2:136632300	A/C	cg07169764	chr2:136633963	MCM6	1.34	13.59	0.84	2.91e-22	Corneal structure;
SKCM	cis	rs684232	0.602	rs8064796	chr17:525937	A/C	cg15660573	chr17:549704	VPS53	-0.75	-5.87	-0.55	1.02e-7	Prostate cancer;
SKCM	cis	rs3820928	0.874	rs6706802	chr2:227850776	A/G	cg11843606	chr2:227700838	RHBDD1	-0.61	-4.9	-0.49	5.12e-6	Pulmonary function;
SKCM	cis	rs4423214	1.000	rs12419279	chr11:71139061	T/A	cg05163923	chr11:71159392	DHCR7	0.77	7.48	0.65	9.67e-11	Vitamin D levels;
SKCM	cis	rs2760061	0.598	rs673726	chr1:228120173	T/C	cg18477163	chr1:228402036	OBSCN	-0.43	-4.87	-0.48	5.62e-6	Diastolic blood pressure;
SKCM	cis	rs2204008	0.660	rs2320745	chr12:38239101	T/C	cg13010199	chr12:38710504	ALG10B	0.69	5.19	0.51	1.59e-6	Bladder cancer;
SKCM	cis	rs9583531	0.600	rs1441042	chr13:111365589	T/G	cg15841412	chr13:111365552	ING1	0.73	4.88	0.48	5.56e-6	Coronary artery disease;
SKCM	cis	rs9790314	0.967	rs10804790	chr3:161039300	T/A	cg03342759	chr3:160939853	NMD3	-0.74	-8.01	-0.67	9.13e-12	Morning vs. evening chronotype;
SKCM	cis	rs9513627	0.920	rs6491510	chr13:100171447	C/T	cg11288260	chr13:100117058	NA	0.83	4.97	0.49	3.8e-6	Obesity-related traits;
SKCM	cis	rs1801251	1.000	rs2305137	chr2:233712049	G/A	cg08000102	chr2:233561755	GIGYF2	-0.85	-7.04	-0.62	6.74e-10	Coronary artery disease;
SKCM	cis	rs2075371	0.796	rs1643040	chr7:134011703	G/C	cg11752832	chr7:134001865	SLC35B4	0.56	4.79	0.48	7.76e-6	Mean platelet volume;
SKCM	cis	rs478304	1.000	rs478304	chr11:65494260	G/T	cg27068330	chr11:65405492	SIPA1	0.6	4.92	0.49	4.75e-6	Acne (severe);
SKCM	cis	rs55962025	0.551	rs362296	chr4:3247007	C/A	cg00764545	chr4:3318001	RGS12	-0.6	-4.94	-0.49	4.36e-6	Parental longevity (mother's age at death);
SKCM	cis	rs10883723	0.810	rs10883728	chr10:104269301	A/G	cg11453585	chr10:104263688	ACTR1A;SUFU	-0.75	-5.81	-0.55	1.27e-7	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs1843834	0.539	rs10177898	chr2:225437552	C/T	cg12698349	chr2:225449008	CUL3	0.86	6.98	0.62	8.42e-10	IgE levels in asthmatics (D.p. specific);
SKCM	cis	rs2013441	0.965	rs8068720	chr17:20214171	G/T	cg13482628	chr17:19912719	NA	-0.67	-5.24	-0.51	1.32e-6	Obesity-related traits;
SKCM	cis	rs1005277	0.579	rs1614236	chr10:38502996	C/T	cg25427524	chr10:38739819	LOC399744	-0.73	-6.68	-0.6	3.19e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs2228479	0.681	rs2270461	chr16:89972345	C/T	cg06558623	chr16:89946397	TCF25	-1.2	-6.83	-0.61	1.65e-9	Skin colour saturation;
SKCM	cis	rs6087990	0.842	rs4911105	chr20:31330413	G/A	cg13636640	chr20:31349939	DNMT3B	0.88	7.14	0.63	4.34e-10	Ulcerative colitis;
SKCM	cis	rs28595532	0.920	rs114940990	chr4:119758568	A/G	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs57221529	0.766	rs56216231	chr5:581193	G/A	cg26208419	chr5:473447	SLC9A3;LOC25845	1.01	5.18	0.51	1.7e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs4819052	0.918	rs2330013	chr21:46658662	G/T	cg20896738	chr21:46707857	POFUT2;LOC642852	0.74	5.35	0.52	8.71e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs11098499	0.954	rs9685777	chr4:120365965	C/A	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs7666738	0.830	rs113999196	chr4:99041961	C/T	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9880211	0.563	rs6769762	chr3:135908178	G/A	cg21827317	chr3:136751795	NA	-0.69	-5.3	-0.51	1.05e-6	Body mass index;Height;
SKCM	cis	rs12497850	1.000	rs6788650	chr3:48749543	T/C	cg07636037	chr3:49044803	WDR6	0.9	9.1	0.72	6.77e-14	Parkinson's disease;
SKCM	cis	rs11792861	0.591	rs11791855	chr9:111684139	C/T	cg14432460	chr9:111696404	IKBKAP;C9orf6	0.77	6.01	0.56	5.59e-8	Menarche (age at onset);
SKCM	cis	rs11098499	0.913	rs10006304	chr4:120124305	A/G	cg09307838	chr4:120376055	NA	0.88	6.32	0.58	1.52e-8	Corneal astigmatism;
SKCM	cis	rs9485372	1.000	rs62428484	chr6:149606568	C/T	cg03072286	chr6:150262044	ULBP2	-0.55	-4.89	-0.48	5.3e-6	Breast cancer;
SKCM	cis	rs1799949	0.965	rs8176323	chr17:41195711	G/C	cg23758822	chr17:41437982	NA	0.94	7.87	0.67	1.68e-11	Menopause (age at onset);
SKCM	cis	rs875971	0.577	rs35072105	chr7:65609817	A/G	cg11764359	chr7:65958608	NA	-0.93	-7.48	-0.65	9.67e-11	Aortic root size;
SKCM	cis	rs7666738	0.830	rs10021044	chr4:99002488	A/T	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2239547	0.618	rs3733047	chr3:52871929	A/G	cg11645453	chr3:52864694	ITIH4	-0.79	-7.19	-0.63	3.41e-10	Schizophrenia;
SKCM	cis	rs2737618	0.651	rs2249156	chr1:200083541	A/G	cg21825944	chr1:200113062	NR5A2	0.6	4.86	0.48	6.06e-6	Uric acid levels;
SKCM	cis	rs12541335	0.639	rs4871994	chr8:22206038	G/A	cg26039829	chr8:22132926	PIWIL2	0.64	5.64	0.54	2.63e-7	Hypertriglyceridemia;
SKCM	cis	rs875971	0.862	rs57866200	chr7:65565392	A/G	cg18876405	chr7:65276391	NA	-0.67	-6.79	-0.61	2.01e-9	Aortic root size;
SKCM	cis	rs870825	0.616	rs6552805	chr4:185637894	C/A	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs10540	1.000	rs12801271	chr11:508720	C/T	cg03576123	chr11:487126	PTDSS2	-1.45	-7.95	-0.67	1.17e-11	Body mass index;
SKCM	cis	rs933688	1.000	rs6869717	chr5:90694797	G/A	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.1	8.33	0.69	2.14e-12	Smoking behavior;
SKCM	cis	rs995000	0.899	rs10889340	chr1:63012071	A/C	cg06896770	chr1:63153194	DOCK7	-0.73	-6.54	-0.6	5.83e-9	Triglyceride levels;
SKCM	cis	rs7216064	1.000	rs8067892	chr17:65837983	A/G	cg12091567	chr17:66097778	LOC651250	-0.77	-5.53	-0.53	4.06e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs6570726	0.791	rs379040	chr6:145889035	T/C	cg23711669	chr6:146136114	FBXO30	0.86	9.05	0.72	8.81e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs12047808	0.730	rs12048994	chr1:179534540	A/C	cg09822482	chr1:179519214	C1orf125	-0.94	-4.83	-0.48	6.63e-6	Multiple sclerosis (age of onset);
SKCM	cis	rs12627970	0.565	rs2072872	chr22:39713128	A/G	cg17798944	chr22:39715225	SNORD43;RPL3	1.08	11.14	0.78	8.55e-18	Inflammatory bowel disease;
SKCM	cis	rs875971	0.895	rs6460300	chr7:65952924	A/G	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs28595532	0.920	rs115797971	chr4:119779620	A/G	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs9309711	0.922	rs11679058	chr2:3483813	C/G	cg10845886	chr2:3471009	TTC15	-0.84	-6.62	-0.6	4.07e-9	Neurofibrillary tangles;
SKCM	cis	rs16854884	0.710	rs9829796	chr3:143801416	C/T	cg06585982	chr3:143692056	C3orf58	0.63	5.11	0.5	2.24e-6	Economic and political preferences (feminism/equality);
SKCM	cis	rs4481887	0.927	rs11204637	chr1:248492581	G/A	cg00666640	chr1:248458726	OR2T12	0.61	5.25	0.51	1.28e-6	Common traits (Other);
SKCM	cis	rs8180040	0.932	rs1531875	chr3:47452786	G/A	cg16586182	chr3:47516702	SCAP	-0.76	-5.32	-0.52	9.63e-7	Colorectal cancer;
SKCM	cis	rs34779708	0.931	rs2490663	chr10:35329735	A/G	cg03585969	chr10:35415529	CREM	-0.74	-6.11	-0.57	3.71e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs1165205	0.500	rs629835	chr6:25879330	T/C	cg03264133	chr6:25882463	NA	-0.59	-5.93	-0.56	7.82e-8	Urate levels;
SKCM	cis	rs459571	0.606	rs457420	chr9:136909261	A/G	cg13789015	chr9:136890014	NCRNA00094	-0.56	-5.05	-0.5	2.84e-6	Platelet distribution width;
SKCM	cis	rs11098499	0.863	rs3775849	chr4:120450908	G/C	cg09307838	chr4:120376055	NA	0.97	7.66	0.66	4.19e-11	Corneal astigmatism;
SKCM	cis	rs362296	0.698	rs362289	chr4:3256378	G/A	cg05297308	chr4:3317976	RGS12	-0.82	-6.73	-0.61	2.55e-9	Parental longevity (mother's age at death);
SKCM	cis	rs8014204	0.935	rs2853779	chr14:75368508	G/A	cg06637938	chr14:75390232	RPS6KL1	-0.78	-5.95	-0.56	7.2e-8	Caffeine consumption;
SKCM	cis	rs801193	1.000	rs7788576	chr7:66148302	G/A	cg18876405	chr7:65276391	NA	-0.8	-7.11	-0.63	4.86e-10	Aortic root size;
SKCM	cis	rs7772486	0.597	rs9386136	chr6:146158300	A/T	cg05347473	chr6:146136440	FBXO30	0.68	6.08	0.57	4.16e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs5758511	0.689	rs17002947	chr22:42688532	C/T	cg26793846	chr22:42538988	CYP2D7P1	0.73	4.92	0.49	4.72e-6	Birth weight;
SKCM	cis	rs3780486	0.874	rs10813955	chr9:33141791	C/T	cg13443165	chr9:33130375	B4GALT1	-0.54	-4.95	-0.49	4.17e-6	IgG glycosylation;
SKCM	cis	rs2204008	0.712	rs12371182	chr12:38321143	A/C	cg13010199	chr12:38710504	ALG10B	0.68	4.9	0.49	5e-6	Bladder cancer;
SKCM	cis	rs9902453	0.904	rs4598962	chr17:28293948	C/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.8	6.28	0.58	1.79e-8	Coffee consumption (cups per day);
SKCM	cis	rs995000	0.640	rs6679002	chr1:63199936	G/T	cg06896770	chr1:63153194	DOCK7	-0.73	-5.95	-0.56	7.2e-8	Triglyceride levels;
SKCM	cis	rs9393692	0.875	rs9393690	chr6:26271713	A/T	cg00631329	chr6:26305371	NA	-0.68	-4.93	-0.49	4.49e-6	Educational attainment;
SKCM	cis	rs10905065	0.862	rs9423948	chr10:5742491	G/A	cg09234995	chr10:5726438	C10orf18	-0.57	-4.77	-0.48	8.28e-6	Menopause (age at onset);
SKCM	cis	rs951366	0.617	rs708727	chr1:205767885	G/A	cg14159672	chr1:205819179	PM20D1	1.02	11.0	0.78	1.54e-17	Menarche (age at onset);
SKCM	cis	rs6951245	1.000	rs80212261	chr7:1114012	C/T	cg03188948	chr7:1209495	NA	1.13	6.27	0.58	1.89e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs2952156	0.920	rs1565920	chr17:37831613	G/A	cg20243544	chr17:37824526	PNMT	0.75	6.2	0.57	2.45e-8	Asthma;
SKCM	cis	rs17065868	1.000	rs9533910	chr13:45137937	G/A	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs2242194	0.816	rs2242193	chr1:154995503	A/G	cg12436631	chr1:155007014	DCST1;DCST2	-0.47	-5.62	-0.54	2.87e-7	Schizophrenia;
SKCM	cis	rs860295	0.702	rs12047756	chr1:155624944	G/A	cg02153340	chr1:155202674	NA	-0.75	-5.47	-0.53	5.22e-7	Body mass index;
SKCM	cis	rs7100689	0.784	rs7895042	chr10:82095276	G/A	cg01528321	chr10:82214614	TSPAN14	0.79	6.64	0.6	3.79e-9	Post bronchodilator FEV1;
SKCM	cis	rs17685	0.753	rs4728550	chr7:75670988	C/A	cg01364799	chr7:75623366	TMEM120A	0.72	5.83	0.55	1.18e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs17065868	1.000	rs56296224	chr13:45107081	G/A	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs875971	0.597	rs11771318	chr7:66062480	G/T	cg18876405	chr7:65276391	NA	-0.76	-6.56	-0.6	5.41e-9	Aortic root size;
SKCM	cis	rs9611565	0.681	rs132918	chr22:41808350	C/T	cg03806693	chr22:41940476	POLR3H	1.02	6.92	0.62	1.13e-9	Vitiligo;
SKCM	cis	rs9910055	0.512	rs7209801	chr17:42323376	G/A	cg08499158	chr17:42289980	UBTF	-0.87	-6.8	-0.61	1.87e-9	Total body bone mineral density;
SKCM	cis	rs2836950	0.565	rs2836943	chr21:40592611	C/T	cg17971929	chr21:40555470	PSMG1	-0.71	-6.08	-0.57	4.16e-8	Menarche (age at onset);
SKCM	cis	rs936229	0.798	rs1869959	chr15:75147332	A/C	cg14664628	chr15:75095509	CSK	-1.06	-8.2	-0.68	3.77e-12	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin);
SKCM	cis	rs9467773	0.620	rs2451731	chr6:26624822	A/C	cg15659132	chr6:26577336	NA	0.62	5.4	0.52	6.91e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs2204008	0.515	rs11495471	chr12:38027178	G/A	cg26384229	chr12:38710491	ALG10B	0.83	6.72	0.61	2.69e-9	Bladder cancer;
SKCM	cis	rs12130219	0.500	rs4845743	chr1:152184149	A/G	cg20694572	chr1:152331529	FLG2	-0.54	-4.89	-0.48	5.26e-6	Inflammatory skin disease;
SKCM	cis	rs875971	0.928	rs6970357	chr7:65968878	T/C	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs58688157	0.960	rs60870990	chr11:613742	G/A	cg17114584	chr11:613792	IRF7	0.74	5.0	0.49	3.51e-6	Systemic lupus erythematosus;
SKCM	cis	rs4268898	0.662	rs56006260	chr2:24409903	A/G	cg06627628	chr2:24431161	ITSN2	-0.93	-6.91	-0.62	1.18e-9	Asthma;
SKCM	cis	rs617791	0.508	rs747526	chr11:65776071	C/A	cg27068330	chr11:65405492	SIPA1	-0.68	-4.9	-0.49	5.11e-6	Breast cancer;
SKCM	cis	rs1577917	1.000	rs4707239	chr6:86610717	G/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.61	-5.31	-0.52	1.02e-6	Response to antipsychotic treatment;
SKCM	cis	rs738321	0.725	rs4821747	chr22:38538856	T/C	cg25457927	chr22:38595422	NA	-0.49	-5.41	-0.52	6.79e-7	Breast cancer;
SKCM	cis	rs4927850	0.752	rs7624460	chr3:195748530	C/T	cg01181863	chr3:195395398	SDHAP2	-0.88	-7.22	-0.63	2.99e-10	Pancreatic cancer;
SKCM	cis	rs2836974	0.931	rs12151994	chr21:40690397	A/C	cg17971929	chr21:40555470	PSMG1	0.81	7.43	0.64	1.21e-10	Cognitive function;
SKCM	cis	rs2153535	0.563	rs1737586	chr6:8535897	C/T	cg23788917	chr6:8435910	SLC35B3	0.64	4.82	0.48	6.84e-6	Motion sickness;
SKCM	cis	rs7772486	0.846	rs7755440	chr6:146375906	T/C	cg23711669	chr6:146136114	FBXO30	0.85	8.45	0.69	1.28e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs13118159	0.550	rs2878607	chr4:1353310	G/C	cg05025164	chr4:1340916	KIAA1530	0.9	7.17	0.63	3.66e-10	Longevity;
SKCM	cis	rs1003719	0.788	rs1155785	chr21:38447939	A/G	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs28595532	0.764	rs56071514	chr4:119761833	T/C	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs873946	0.586	rs3829130	chr10:134563122	C/T	cg18305652	chr10:134549665	INPP5A	0.59	5.74	0.55	1.7e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs10905065	1.000	rs10795488	chr10:5755207	C/A	cg09234995	chr10:5726438	C10orf18	-0.68	-5.76	-0.55	1.6e-7	Menopause (age at onset);
SKCM	cis	rs9902453	0.619	rs1038088	chr17:28074563	T/G	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.82	-5.94	-0.56	7.58e-8	Coffee consumption (cups per day);
SKCM	cis	rs754466	0.580	rs10824573	chr10:79540969	T/C	cg17075019	chr10:79541650	NA	-0.78	-7.12	-0.63	4.75e-10	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs8016982	0.633	rs8019108	chr14:81716781	A/T	cg01989461	chr14:81687754	GTF2A1	0.81	6.47	0.59	7.75e-9	Schizophrenia;
SKCM	cis	rs709400	0.633	rs10135868	chr14:104004147	T/C	cg26031613	chr14:104095156	KLC1	0.74	5.79	0.55	1.42e-7	Body mass index;
SKCM	cis	rs4132509	0.696	rs10927062	chr1:243889364	A/G	cg21452805	chr1:244014465	NA	0.83	5.13	0.5	2.07e-6	RR interval (heart rate);
SKCM	cis	rs2929278	0.589	rs11638972	chr15:44074691	C/G	cg02155558	chr15:43621948	ADAL;LCMT2	-0.7	-5.03	-0.49	3.07e-6	Schizophrenia;
SKCM	cis	rs4746818	1.000	rs10998614	chr10:70923347	G/T	cg11621586	chr10:70884670	VPS26A	0.99	7.62	0.65	5.08e-11	Left atrial antero-posterior diameter;
SKCM	cis	rs8060686	0.641	rs1074143	chr16:68127278	A/G	cg04539111	chr16:67997858	SLC12A4	-0.85	-4.81	-0.48	7.14e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs6835098	0.962	rs4377567	chr4:174083590	C/G	cg08422745	chr4:174089978	GALNT7	0.81	6.26	0.58	1.96e-8	Dementia and core Alzheimer's disease neuropathologic changes;
SKCM	cis	rs4332037	0.615	rs62435134	chr7:1895463	T/G	cg23422044	chr7:1970798	MAD1L1	-0.87	-5.4	-0.52	6.95e-7	Bipolar disorder;
SKCM	cis	rs4481887	0.927	rs7524700	chr1:248472816	A/G	cg00666640	chr1:248458726	OR2T12	0.66	6.0	0.56	5.9e-8	Common traits (Other);
SKCM	cis	rs11710229	1.000	rs13086785	chr3:55473894	T/C	cg04915058	chr3:55693741	C3orf51;ERC2	0.9	5.08	0.5	2.53e-6	Response to cytadine analogues (cytosine arabinoside);
SKCM	cis	rs34172651	0.517	rs11647120	chr16:24819806	A/G	cg06028605	chr16:24865363	SLC5A11	0.59	4.98	0.49	3.66e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs36093844	0.800	rs59179556	chr11:85573897	A/G	cg25872744	chr11:85566296	CCDC83	-0.85	-4.8	-0.48	7.42e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs12188164	0.543	rs2672722	chr5:453567	G/A	cg26076054	chr5:421317	AHRR	0.6	5.18	0.51	1.68e-6	Cystic fibrosis severity;
SKCM	cis	rs7772486	0.754	rs6906258	chr6:146089356	A/G	cg23711669	chr6:146136114	FBXO30	-0.9	-10.43	-0.76	1.88e-16	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1005277	0.579	rs2474587	chr10:38420666	C/T	cg25427524	chr10:38739819	LOC399744	-0.71	-6.74	-0.61	2.44e-9	Extrinsic epigenetic age acceleration;
SKCM	trans	rs2727020	0.595	rs10839286	chr11:49497063	C/A	cg15704280	chr7:45808275	SEPT13	-0.98	-9.29	-0.72	2.93e-14	Coronary artery disease;
SKCM	cis	rs6840360	0.571	rs62327277	chr4:152555905	C/T	cg22705602	chr4:152727874	NA	-0.52	-5.69	-0.54	2.15e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs28595532	0.702	rs55981733	chr4:119306600	G/A	cg11846333	chr4:119757529	SEC24D	1.11	6.34	0.58	1.38e-8	Cannabis dependence symptom count;
SKCM	cis	rs2070488	1.000	rs1841777	chr3:38484819	T/C	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.97	8.85	0.71	2.08e-13	Electrocardiographic conduction measures;
SKCM	cis	rs12477438	0.501	rs12613624	chr2:99732741	A/G	cg26064155	chr2:99771622	LIPT1;TSGA10	-0.99	-9.2	-0.72	4.46e-14	Chronic sinus infection;
SKCM	cis	rs7020830	0.867	rs7852593	chr9:37332380	A/T	cg14294708	chr9:37120828	ZCCHC7	0.99	9.26	0.72	3.36e-14	Schizophrenia;
SKCM	cis	rs314370	0.855	rs76181418	chr7:100494960	G/T	cg10426581	chr7:100472382	SRRT	0.67	5.64	0.54	2.57e-7	Resting heart rate;
SKCM	cis	rs7100689	0.753	rs1361458	chr10:82090339	A/T	cg00277334	chr10:82204260	NA	-0.57	-5.53	-0.53	4.04e-7	Post bronchodilator FEV1;
SKCM	trans	rs1814175	0.676	rs11040647	chr11:49935947	A/C	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs9911578	0.741	rs2611776	chr17:56819636	G/T	cg12560992	chr17:57184187	TRIM37	0.96	7.71	0.66	3.49e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs4234284	1.000	rs13075436	chr3:126961148	C/T	cg04889221	chr3:126137216	CCDC37	-0.45	-4.89	-0.48	5.32e-6	Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel);
SKCM	cis	rs7811142	0.943	rs11769886	chr7:99998607	G/A	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.23	8.03	0.67	8.33e-12	Platelet count;
SKCM	trans	rs8073060	0.505	rs225276	chr17:33973034	T/C	cg19694781	chr19:47549865	TMEM160	-1.0	-8.56	-0.7	7.62e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs62244186	0.566	rs3762636	chr3:44854563	A/G	cg02073558	chr3:44770973	ZNF501	0.8	7.05	0.62	6.39e-10	Depressive symptoms;
SKCM	cis	rs561341	0.609	rs7209493	chr17:30197323	A/G	cg00745463	chr17:30367425	LRRC37B	0.84	4.92	0.49	4.66e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs4555082	0.915	rs28594491	chr14:105758018	G/A	cg13114125	chr14:105738426	BRF1	-0.65	-5.09	-0.5	2.43e-6	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs992157	0.661	rs10171839	chr2:219051314	C/T	cg00012203	chr2:219082015	ARPC2	0.89	7.4	0.64	1.35e-10	Colorectal cancer;
SKCM	cis	rs10751667	0.666	rs7934963	chr11:957220	C/T	cg10932868	chr11:921992	NA	0.54	5.22	0.51	1.43e-6	Alzheimer's disease (late onset);
SKCM	cis	rs4808199	0.948	rs12982276	chr19:19459800	T/C	cg03709012	chr19:19516395	GATAD2A	1.07	7.52	0.65	8.1e-11	Nonalcoholic fatty liver disease;
SKCM	cis	rs798554	0.797	rs1182183	chr7:2873136	C/T	cg19346786	chr7:2764209	NA	-0.63	-7.05	-0.62	6.32e-10	Height;
SKCM	cis	rs17826219	0.636	rs7221463	chr17:29080551	A/C	cg13385521	chr17:29058706	SUZ12P	1.03	5.29	0.51	1.08e-6	Body mass index;
SKCM	cis	rs5769765	0.865	rs4824108	chr22:50271428	A/G	cg22709217	chr22:50311962	ALG12;CRELD2	0.79	5.71	0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs7860634	1.000	rs7860634	chr9:139089679	C/T	cg04455058	chr9:139085579	NA	0.69	6.1	0.57	3.81e-8	Thyroid hormone levels;
SKCM	cis	rs9325144	0.647	rs870431	chr12:38953073	T/C	cg26384229	chr12:38710491	ALG10B	-0.72	-6.26	-0.58	1.96e-8	Morning vs. evening chronotype;
SKCM	cis	rs7424096	0.613	rs17332671	chr2:37244124	C/G	cg14987922	chr2:37194071	STRN	0.86	5.42	0.52	6.31e-7	High light scatter reticulocyte percentage of red cells;
SKCM	cis	rs7100689	0.646	rs10887808	chr10:82137367	G/A	cg01528321	chr10:82214614	TSPAN14	0.82	7.21	0.63	3.15e-10	Post bronchodilator FEV1;
SKCM	cis	rs2816062	0.813	rs2745318	chr1:18895844	C/T	cg18795169	chr1:18902165	NA	0.87	9.59	0.74	7.78e-15	Urate levels in lean individuals;
SKCM	cis	rs950776	0.616	rs56276142	chr15:78889795	T/C	cg06917634	chr15:78832804	PSMA4	0.9	7.99	0.67	9.7e-12	Sudden cardiac arrest;
SKCM	cis	rs66573146	0.634	rs56097119	chr4:7018692	C/G	cg00086871	chr4:6988644	TBC1D14	1.31	5.17	0.51	1.75e-6	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs10779751	1.000	rs4845859	chr1:11304873	A/G	cg08854313	chr1:11322531	MTOR	0.93	7.16	0.63	3.9e-10	Body mass index;
SKCM	cis	rs17376456	0.877	rs10062711	chr5:93348659	G/A	cg25358565	chr5:93447407	FAM172A	1.19	7.78	0.66	2.52e-11	Diabetic retinopathy;
SKCM	cis	rs1568889	0.838	rs10835273	chr11:28156598	T/C	cg06544937	chr11:28130018	METT5D1;KIF18A	0.89	8.3	0.68	2.43e-12	Bipolar disorder;
SKCM	cis	rs4619890	0.528	rs62289359	chr4:7897168	C/T	cg08722675	chr4:8412549	ACOX3	0.51	4.99	0.49	3.54e-6	Glaucoma (primary open-angle);
SKCM	cis	rs9399135	0.967	rs9389251	chr6:135325717	A/G	cg24558204	chr6:135376177	HBS1L	0.59	5.23	0.51	1.41e-6	Red blood cell count;
SKCM	cis	rs137761	0.576	rs2040400	chr22:44056703	A/G	cg12729397	chr22:44208276	EFCAB6	0.68	4.85	0.48	6.1e-6	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs2354432	0.607	rs6677679	chr1:146803630	C/T	cg25205988	chr1:146714368	CHD1L	-1.19	-6.56	-0.6	5.24e-9	Mitochondrial DNA levels;
SKCM	cis	rs1218582	0.772	rs7528532	chr1:154874440	C/T	cg24250549	chr1:154909240	PMVK	0.87	8.7	0.7	4.13e-13	Prostate cancer;
SKCM	cis	rs362272	0.524	rs3129334	chr4:3368526	T/C	cg24015175	chr4:3319247	RGS12	0.81	9.66	0.74	5.77e-15	Serum sulfate level;
SKCM	cis	rs798766	1.000	rs4865467	chr4:1745500	G/T	cg05874882	chr4:1763078	NA	0.56	4.89	0.48	5.37e-6	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs5769765	0.908	rs138864	chr22:50204712	G/A	cg22709217	chr22:50311962	ALG12;CRELD2	-0.83	-5.74	-0.55	1.71e-7	Schizophrenia;
SKCM	cis	rs9611565	0.573	rs9306355	chr22:42111896	A/T	cg03806693	chr22:41940476	POLR3H	0.79	5.05	0.5	2.87e-6	Vitiligo;
SKCM	cis	rs6952808	0.635	rs12154473	chr7:1982181	A/G	cg02951883	chr7:2050386	MAD1L1	0.72	5.55	0.53	3.71e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs9814567	1.000	rs934093	chr3:134195885	A/G	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.66	-5.47	-0.53	5.19e-7	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs933688	1.000	rs2839728	chr5:90727412	G/A	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.93	6.49	0.59	7.31e-9	Smoking behavior;
SKCM	cis	rs3820928	0.967	rs16822905	chr2:227770727	G/C	cg11843606	chr2:227700838	RHBDD1	-0.64	-5.2	-0.51	1.57e-6	Pulmonary function;
SKCM	cis	rs478304	0.651	rs11604451	chr11:65551710	C/T	cg17480646	chr11:65405466	SIPA1	-0.69	-5.16	-0.5	1.84e-6	Acne (severe);
SKCM	cis	rs992157	0.835	rs4674283	chr2:219144254	G/A	cg20019365	chr2:219134978	PNKD;AAMP	-0.72	-6.22	-0.58	2.33e-8	Colorectal cancer;
SKCM	cis	rs7666738	0.822	rs28512427	chr4:98919029	G/A	cg17366294	chr4:99064904	C4orf37	0.56	4.89	0.48	5.26e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1863824	0.625	rs10887598	chr10:88166160	T/A	cg07322936	chr10:88137208	NA	-0.59	-5.02	-0.49	3.24e-6	Schizophrenia;
SKCM	cis	rs9581857	0.685	rs11839899	chr13:28041780	G/A	cg22138327	chr13:27999177	GTF3A	0.93	6.24	0.58	2.1e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs1577917	1.000	rs2812972	chr6:86669880	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.61	-5.31	-0.52	1.02e-6	Response to antipsychotic treatment;
SKCM	cis	rs7208859	0.623	rs1061343	chr17:29114276	G/A	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs17685	0.535	rs6953065	chr7:75601169	A/G	cg01364799	chr7:75623366	TMEM120A	0.81	5.67	0.54	2.3e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs10781543	0.845	rs36066734	chr9:139340351	A/G	cg14169450	chr9:139327907	INPP5E	0.5	5.52	0.53	4.35e-7	Monocyte percentage of white cells;
SKCM	cis	rs17065868	1.000	rs61947967	chr13:45076773	G/A	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs1577917	0.816	rs9353349	chr6:86707725	T/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.59	5.08	0.5	2.55e-6	Response to antipsychotic treatment;
SKCM	cis	rs80130819	0.688	rs10783232	chr12:48583491	A/G	cg13203223	chr12:49319398	FKBP11	0.93	4.87	0.48	5.66e-6	Prostate cancer;
SKCM	cis	rs2439831	0.681	rs478104	chr15:43594900	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.19	8.52	0.69	9.21e-13	Lung cancer in ever smokers;
SKCM	cis	rs6952808	0.792	rs12536261	chr7:1953571	G/A	cg05863683	chr7:1912471	MAD1L1	0.56	4.96	0.49	4.03e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs7811142	0.775	rs1059129	chr7:99926522	A/G	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.06	6.05	0.56	4.82e-8	Platelet count;
SKCM	cis	rs9660180	0.934	rs12729990	chr1:1812035	T/A	cg17747265	chr1:1875780	NA	-0.58	-5.2	-0.51	1.55e-6	Body mass index;
SKCM	cis	rs7635838	0.587	rs1992910	chr3:11311942	C/T	cg00170343	chr3:11313890	ATG7	0.78	5.9	0.56	9.03e-8	HDL cholesterol;
SKCM	cis	rs9926296	0.533	rs12102290	chr16:89812617	C/T	cg26513180	chr16:89883248	FANCA	0.95	11.32	0.79	3.98e-18	Vitiligo;
SKCM	cis	rs13031619	1.000	rs13031619	chr2:3698371	A/G	cg16540950	chr2:3696648	NA	0.69	4.8	0.48	7.59e-6	Response to inhaled corticosteroid treatment in asthma (change in FEV1);
SKCM	cis	rs12824058	0.799	rs4759656	chr12:130815804	G/A	cg24838063	chr12:130822603	PIWIL1	0.78	6.99	0.62	8.22e-10	Menopause (age at onset);
SKCM	cis	rs459571	0.920	rs433402	chr9:136898627	A/G	cg13789015	chr9:136890014	NCRNA00094	0.77	6.5	0.59	6.92e-9	Platelet distribution width;
SKCM	cis	rs8060686	0.641	rs3785109	chr16:68118311	G/A	cg04539111	chr16:67997858	SLC12A4	-0.84	-4.78	-0.48	7.97e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs7666738	0.830	rs10000573	chr4:99048785	G/C	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	trans	rs561341	1.000	rs555629	chr17:30294136	T/C	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs7528419	0.591	rs4970837	chr1:109822008	G/T	cg00908766	chr1:109817496	CELSR2	0.46	6.08	0.57	4.17e-8	Coronary artery disease (myocardial infartum, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease);Myocardial infarction;Lipoprotein-associated phospholipase A2 activity and mass;Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease;Cholesterol, total;Coronary artery disease;
SKCM	cis	rs1799949	1.000	rs16941	chr17:41244435	T/C	cg05368731	chr17:41323189	NBR1	0.87	7.55	0.65	6.95e-11	Menopause (age at onset);
SKCM	cis	rs28386778	0.897	rs2727323	chr17:61921999	G/T	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs6463523	0.864	rs73047957	chr7:759373	A/T	cg05729249	chr7:766119	PRKAR1B;HEATR2	0.91	7.19	0.63	3.45e-10	Subjective well-being;
SKCM	cis	rs10540	1.000	rs61877760	chr11:506596	C/T	cg03352830	chr11:487213	PTDSS2	0.95	4.9	0.49	5.1e-6	Body mass index;
SKCM	cis	rs1298637	0.800	rs732385	chr1:53928180	G/A	cg09586583	chr1:54755153	SSBP3	0.6	5.04	0.5	2.98e-6	Nicotine use;
SKCM	cis	rs9814567	1.000	rs7371896	chr3:134249769	C/G	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs7811142	0.943	rs28578163	chr7:100044754	A/G	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.12	6.51	0.59	6.68e-9	Platelet count;
SKCM	cis	rs8180040	0.701	rs7617689	chr3:46996442	C/T	cg27129171	chr3:47204927	SETD2	-0.79	-6.01	-0.56	5.49e-8	Colorectal cancer;
SKCM	cis	rs561341	1.000	rs693116	chr17:30246124	C/T	cg23018236	chr17:30244563	NA	-0.53	-5.27	-0.51	1.18e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs2842992	0.673	rs6930904	chr6:160217433	T/A	cg19482086	chr6:160211437	TCP1;MRPL18	0.81	6.18	0.57	2.68e-8	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs28595532	0.841	rs114768988	chr4:119744451	T/C	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs9818758	0.607	rs34343820	chr3:49309534	C/G	cg00383909	chr3:49044727	WDR6	0.95	4.95	0.49	4.17e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs7940866	0.834	rs10894298	chr11:130840571	C/A	cg12179176	chr11:130786555	SNX19	0.79	6.17	0.57	2.88e-8	Schizophrenia;
SKCM	cis	rs6088590	1.000	rs55753039	chr20:33394940	C/T	cg24642439	chr20:33292090	TP53INP2	0.95	6.57	0.6	5.13e-9	Coronary artery disease;
SKCM	cis	rs10256972	0.552	rs2960831	chr7:1201192	A/T	cg09177884	chr7:1199841	ZFAND2A	-0.77	-6.47	-0.59	8.03e-9	Longevity;Endometriosis;
SKCM	cis	rs7100689	0.622	rs10749595	chr10:82172975	C/T	cg00277334	chr10:82204260	NA	-0.54	-5.07	-0.5	2.66e-6	Post bronchodilator FEV1;
SKCM	cis	rs9916302	0.706	rs667193	chr17:37448835	T/C	cg07936489	chr17:37558343	FBXL20	1.0	7.19	0.63	3.42e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs427394	0.632	rs2279656	chr5:6737576	G/A	cg10857441	chr5:6722123	POLS	-0.74	-7.8	-0.66	2.34e-11	Menopause (age at onset);
SKCM	cis	rs9300255	0.568	rs1047158	chr12:123644056	C/A	cg00376283	chr12:123451042	ABCB9	0.82	5.61	0.54	3e-7	Neutrophil percentage of white cells;
SKCM	cis	rs57221529	0.766	rs72703070	chr5:590458	T/C	cg09888920	chr5:474111	LOC25845;SLC9A3	0.99	4.79	0.48	7.91e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs941408	1.000	rs1736185	chr19:2813000	A/G	cg06609049	chr19:2785107	THOP1	0.8	7.11	0.63	4.82e-10	Total cholesterol levels;
SKCM	cis	rs860295	0.557	rs12035524	chr1:155667102	C/T	cg02153340	chr1:155202674	NA	-0.74	-5.05	-0.5	2.81e-6	Body mass index;
SKCM	cis	rs7659604	0.676	rs6855269	chr4:122697418	T/G	cg20573242	chr4:122745356	CCNA2	0.76	6.37	0.59	1.21e-8	Type 2 diabetes;
SKCM	cis	rs1401999	0.659	rs7622660	chr3:183753337	C/T	cg01324343	chr3:183735012	ABCC5	0.73	7.37	0.64	1.55e-10	Anterior chamber depth;
SKCM	cis	rs2739330	0.796	rs5760097	chr22:24247794	G/C	cg12419862	chr22:24373484	LOC391322	-0.66	-5.54	-0.53	3.87e-7	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs875971	0.964	rs6978429	chr7:65959876	T/G	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	cis	rs13385731	0.892	rs13425999	chr2:33702203	C/T	cg26822501	chr2:33171334	LTBP1	1.05	4.99	0.49	3.62e-6	Systemic lupus erythematosus;
SKCM	cis	rs9420	0.925	rs488769	chr11:57450720	A/C	cg19752551	chr11:57585705	CTNND1	-0.7	-6.93	-0.62	1.06e-9	Schizophrenia;
SKCM	cis	rs7772486	0.686	rs4896833	chr6:145965673	T/G	cg05347473	chr6:146136440	FBXO30	0.57	5.19	0.51	1.61e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9902453	0.845	rs10853135	chr17:28188675	G/A	cg26525008	chr17:28256777	EFCAB5;SSH2	0.83	5.76	0.55	1.61e-7	Coffee consumption (cups per day);
SKCM	cis	rs1862618	0.853	rs860580	chr5:56149429	G/T	cg12311346	chr5:56204834	C5orf35	0.77	5.08	0.5	2.55e-6	Initial pursuit acceleration;
SKCM	cis	rs6665290	0.935	rs17600669	chr1:227201871	A/G	cg10327440	chr1:227177885	CDC42BPA	-1.21	-16.02	-0.88	2.21e-26	Myeloid white cell count;
SKCM	cis	rs11098499	0.954	rs11098525	chr4:120390152	G/A	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs7772486	0.754	rs864148	chr6:145976675	T/C	cg05347473	chr6:146136440	FBXO30	-0.67	-6.11	-0.57	3.68e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4319547	0.915	rs1473553	chr12:122985057	G/T	cg23029597	chr12:123009494	RSRC2	-0.8	-6.23	-0.58	2.16e-8	Body mass index;
SKCM	cis	rs8077889	0.917	rs9894873	chr17:41911832	A/G	cg26893861	chr17:41843967	DUSP3	1.15	7.34	0.64	1.79e-10	Triglycerides;
SKCM	cis	rs80130819	0.748	rs2258342	chr12:48690363	T/C	cg13203223	chr12:49319398	FKBP11	0.88	4.86	0.48	6.03e-6	Prostate cancer;
SKCM	cis	rs7639513	0.545	rs12714874	chr3:12719928	C/T	cg23032965	chr3:12705835	RAF1	0.81	7.0	0.62	8.01e-10	Itch intensity from mosquito bite;
SKCM	cis	rs7107356	1	rs7107356	chr11:47676170	A/G	cg20307385	chr11:47447363	PSMC3	0.68	5.62	0.54	2.84e-7	Neuroticism;Neuroticism (multi-trait analysis);
SKCM	cis	rs9300255	0.830	rs28413626	chr12:123861452	G/A	cg05973401	chr12:123451056	ABCB9	-0.84	-5.89	-0.56	9.08e-8	Neutrophil percentage of white cells;
SKCM	cis	rs2980439	0.846	rs2980437	chr8:8094763	C/T	cg06636001	chr8:8085503	FLJ10661	-1.0	-8.72	-0.7	3.74e-13	Neuroticism;
SKCM	cis	rs7630852	0.965	rs6774504	chr3:196510892	C/T	cg21595543	chr3:196295373	WDR53;FBXO45	-0.63	-4.94	-0.49	4.3e-6	Eosinophil counts;
SKCM	cis	rs933688	1.000	rs1541674	chr5:90660447	T/C	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.96	6.57	0.6	5.08e-9	Smoking behavior;
SKCM	cis	rs2268241	0.938	rs7283827	chr21:34769904	A/G	cg14850771	chr21:34775459	IFNGR2	1.04	6.44	0.59	8.92e-9	Obesity-related traits;
SKCM	cis	rs2243480	1.000	rs2465120	chr7:65620974	C/G	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	trans	rs2727020	0.553	rs10839295	chr11:49527345	A/C	cg15704280	chr7:45808275	SEPT13	-0.95	-8.53	-0.69	8.99e-13	Coronary artery disease;
SKCM	cis	rs11585357	0.895	rs72633806	chr1:17617943	A/G	cg08277548	chr1:17600880	PADI3	-0.89	-6.31	-0.58	1.53e-8	Hair shape;
SKCM	trans	rs941408	1.000	rs1640271	chr19:2799979	C/T	cg22153745	chr1:153894579	GATAD2B	-0.79	-7.35	-0.64	1.66e-10	Total cholesterol levels;
SKCM	cis	rs11690935	0.959	rs6705200	chr2:172637600	A/G	cg13550731	chr2:172543902	DYNC1I2	-0.94	-7.99	-0.67	9.97e-12	Schizophrenia;
SKCM	cis	rs9303401	0.614	rs2007993	chr17:56590643	T/C	cg10487724	chr17:56770010	TEX14;RAD51C	0.85	6.03	0.56	5.14e-8	Cognitive test performance;
SKCM	cis	rs8180040	0.934	rs4858811	chr3:47480524	G/C	cg16586182	chr3:47516702	SCAP	0.76	5.32	0.52	9.63e-7	Colorectal cancer;
SKCM	cis	rs6933660	0.745	rs9322320	chr6:151751908	C/G	cg10883421	chr6:151773342	RMND1;C6orf211	0.82	6.83	0.61	1.69e-9	Menarche (age at onset);
SKCM	cis	rs7809950	0.953	rs2237670	chr7:107131485	A/G	cg23024343	chr7:107201750	COG5	-0.74	-6.62	-0.6	4.19e-9	Coronary artery disease;
SKCM	cis	rs9543976	0.920	rs9543972	chr13:76121675	T/C	cg01531495	chr13:76123901	UCHL3	0.9	4.9	0.48	5.19e-6	Diabetic retinopathy;
SKCM	cis	rs13161895	0.702	rs12652904	chr5:179496422	C/T	cg02702477	chr5:179499311	RNF130	1.02	5.13	0.5	2.03e-6	LDL cholesterol;
SKCM	cis	rs1401999	1.000	rs1402002	chr3:183642794	A/G	cg01324343	chr3:183735012	ABCC5	0.83	9.34	0.73	2.33e-14	Anterior chamber depth;
SKCM	cis	rs7208859	0.573	rs28779471	chr17:29084369	T/C	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs6461049	0.646	rs3778970	chr7:2143208	C/A	cg21782813	chr7:2030301	MAD1L1	0.53	5.68	0.54	2.25e-7	Schizophrenia;
SKCM	cis	rs9581857	0.685	rs9319373	chr13:28042835	A/G	cg22138327	chr13:27999177	GTF3A	0.9	6.21	0.58	2.42e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs8067354	0.645	rs2102507	chr17:57875907	A/G	cg02344993	chr17:57696989	CLTC	0.67	4.82	0.48	6.84e-6	Hemoglobin concentration;
SKCM	cis	rs58688157	0.705	rs12421646	chr11:578844	C/G	cg03576123	chr11:487126	PTDSS2	-0.85	-4.9	-0.48	5.15e-6	Systemic lupus erythematosus;
SKCM	cis	rs55962025	0.883	rs59613878	chr4:3139152	C/T	cg16987761	chr4:3318072	RGS12	-0.79	-6.04	-0.56	4.91e-8	Parental longevity (mother's age at death);
SKCM	cis	rs28595532	1.000	rs114912871	chr4:119697004	G/C	cg14228332	chr4:119757509	SEC24D	1.07	5.49	0.53	4.77e-7	Cannabis dependence symptom count;
SKCM	cis	rs2304069	0.954	rs6861548	chr5:149384680	A/G	cg22760475	chr5:149380129	HMGXB3;TIGD6	0.84	6.09	0.57	3.98e-8	HIV-1 control;
SKCM	cis	rs16854884	0.586	rs7634145	chr3:143754150	G/A	cg06585982	chr3:143692056	C3orf58	0.87	8.34	0.69	2.04e-12	Economic and political preferences (feminism/equality);
SKCM	cis	rs1577917	0.816	rs9353349	chr6:86707725	T/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.78	7.47	0.65	9.83e-11	Response to antipsychotic treatment;
SKCM	cis	rs1218582	0.772	rs4845400	chr1:154872523	C/T	cg09359103	chr1:154839909	KCNN3	-0.57	-5.3	-0.51	1.05e-6	Prostate cancer;
SKCM	cis	rs9916302	0.851	rs11078904	chr17:37650569	G/A	cg07936489	chr17:37558343	FBXL20	-0.9	-8.1	-0.68	6.05e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs6951245	0.706	rs1133116	chr7:1195215	A/C	cg18402987	chr7:1209562	NA	1.19	7.5	0.65	8.87e-11	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs10905065	0.735	rs10795347	chr10:5742077	C/G	cg11519256	chr10:5708881	ASB13	-0.58	-5.18	-0.51	1.69e-6	Menopause (age at onset);
SKCM	cis	rs9818758	0.607	rs35108630	chr3:49088356	T/A	cg00383909	chr3:49044727	WDR6	1.05	5.85	0.55	1.11e-7	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs28595532	0.841	rs114735834	chr4:119772722	G/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs7020830	0.898	rs7038219	chr9:37182892	C/A	cg14294708	chr9:37120828	ZCCHC7	1.07	10.85	0.78	2.98e-17	Schizophrenia;
SKCM	cis	rs7100689	0.753	rs1361458	chr10:82090339	A/T	cg03267442	chr10:82210566	NA	-0.56	-5.07	-0.5	2.58e-6	Post bronchodilator FEV1;
SKCM	cis	rs28595532	0.920	rs112016126	chr4:119726528	C/T	cg21605333	chr4:119757512	SEC24D	1.35	7.92	0.67	1.37e-11	Cannabis dependence symptom count;
SKCM	cis	rs67311347	1.000	rs951560	chr3:40463471	A/G	cg00091569	chr3:40428383	ENTPD3	0.62	5.1	0.5	2.35e-6	Renal cell carcinoma;
SKCM	trans	rs11722228	0.522	rs73212880	chr4:10115692	T/A	cg26043149	chr18:55253948	FECH	0.94	7.62	0.65	5.04e-11	Gout;Urate levels;Serum uric acid levels;
SKCM	cis	rs7555523	0.779	rs6662839	chr1:165722646	T/G	cg24409356	chr1:165738333	TMCO1	0.93	5.15	0.5	1.93e-6	Intraocular pressure;Glaucoma (high intraocular pressure);
SKCM	cis	rs1218582	0.772	rs4845690	chr1:154886817	C/T	cg03351412	chr1:154909251	PMVK	-0.77	-6.52	-0.59	6.43e-9	Prostate cancer;
SKCM	cis	rs912057	0.833	rs1294421	chr6:6743149	A/C	cg06612196	chr6:6737390	NA	0.58	4.91	0.49	4.81e-6	Waist-to-hip ratio adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);
SKCM	trans	rs7618501	1.000	rs35261599	chr3:49773236	G/A	cg21659725	chr3:3221576	CRBN	-0.96	-9.61	-0.74	7.08e-15	Intelligence (multi-trait analysis);
SKCM	trans	rs1814175	0.511	rs61905634	chr11:49819736	G/A	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs2180341	0.960	rs9401952	chr6:127677027	A/C	cg24812749	chr6:127587940	RNF146	0.83	7.24	0.63	2.76e-10	Breast cancer;
SKCM	cis	rs7674861	0.508	rs11936496	chr4:151358568	G/A	cg03779973	chr4:151001971	DCLK2	0.61	5.22	0.51	1.45e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs16949788	1.000	rs7169463	chr15:66745929	G/C	cg08120210	chr15:66682733	MAP2K1	-0.74	-5.69	-0.54	2.1e-7	Spherical equivalent (joint analysis main effects and education interaction);
SKCM	cis	rs28595532	0.841	rs114123875	chr4:119733408	A/G	cg11846333	chr4:119757529	SEC24D	1.2	6.43	0.59	9.38e-9	Cannabis dependence symptom count;
SKCM	cis	rs2075371	0.966	rs2244690	chr7:133987039	A/G	cg20476274	chr7:133979776	SLC35B4	1.01	10.44	0.76	1.77e-16	Mean platelet volume;
SKCM	cis	rs6570726	0.791	rs443628	chr6:145883484	T/C	cg23711669	chr6:146136114	FBXO30	0.87	9.14	0.72	5.82e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7208859	0.623	rs11652631	chr17:29060766	A/G	cg14067834	chr17:29058358	SUZ12P	1.19	5.71	0.54	1.94e-7	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs7552404	0.883	rs7513363	chr1:76143443	A/G	cg10523679	chr1:76189770	ACADM	0.71	5.12	0.5	2.17e-6	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs7617480	0.648	rs6806356	chr3:48727636	G/A	cg07636037	chr3:49044803	WDR6	0.91	6.74	0.61	2.42e-9	Subjective well-being (multi-trait analysis);Menarche (age at onset);
SKCM	cis	rs12477438	0.520	rs34766932	chr2:99737273	G/A	cg26064155	chr2:99771622	LIPT1;TSGA10	1.02	10.07	0.75	9.12e-16	Chronic sinus infection;
SKCM	cis	rs1153858	1.000	rs2467858	chr15:45711492	A/G	cg21132104	chr15:45694354	SPATA5L1	0.89	6.95	0.62	9.91e-10	Homoarginine levels;
SKCM	cis	rs1395	0.767	rs1821986	chr2:27405835	A/G	cg14242246	chr2:27434262	C2orf28;SLC5A6	-0.47	-4.77	-0.48	8.27e-6	Blood metabolite levels;
SKCM	cis	rs1153858	1.000	rs4271549	chr15:45652730	G/A	cg10760299	chr15:45669010	GATM	0.62	6.35	0.58	1.3e-8	Homoarginine levels;
SKCM	cis	rs1552244	0.752	rs9867091	chr3:10043429	T/C	cg02579736	chr3:10068473	FANCD2;CIDECP	0.94	4.84	0.48	6.49e-6	Alzheimer's disease;
SKCM	cis	rs10504229	0.683	rs11781690	chr8:58132931	C/G	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs1799949	0.930	rs34210004	chr17:41370337	A/T	cg23758822	chr17:41437982	NA	0.94	7.74	0.66	2.97e-11	Menopause (age at onset);
SKCM	cis	rs7618501	0.521	rs34654589	chr3:49911449	C/G	cg24110177	chr3:50126178	RBM5	-0.71	-5.36	-0.52	8.33e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs3096299	0.757	rs3102372	chr16:89398271	A/T	cg08822215	chr16:89438651	ANKRD11	-0.53	-4.89	-0.48	5.23e-6	Multiple myeloma (IgH translocation);
SKCM	cis	rs13118159	0.550	rs1137789	chr4:1381798	A/G	cg02475777	chr4:1388615	CRIPAK	0.82	5.49	0.53	4.8e-7	Longevity;
SKCM	cis	rs1691799	0.899	rs1168300	chr12:66736467	C/A	cg16791601	chr12:66731901	HELB	-0.66	-5.81	-0.55	1.31e-7	White blood cell count (basophil);
SKCM	cis	rs992157	0.585	rs62182795	chr2:219100202	C/T	cg20019365	chr2:219134978	PNKD;AAMP	-0.66	-5.49	-0.53	4.76e-7	Colorectal cancer;
SKCM	cis	rs6942756	0.806	rs9641846	chr7:128873679	G/A	cg02491457	chr7:128862824	NA	0.7	4.79	0.48	7.71e-6	White matter hyperintensity burden;
SKCM	cis	rs11098499	0.863	rs2306457	chr4:120472839	T/A	cg09307838	chr4:120376055	NA	0.99	7.85	0.66	1.8e-11	Corneal astigmatism;
SKCM	cis	rs8072100	0.967	rs4794058	chr17:45597098	C/T	cg08085267	chr17:45401833	C17orf57	0.56	4.8	0.48	7.45e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs9457247	0.602	rs10484530	chr6:167461562	C/T	cg07741184	chr6:167504864	NA	0.59	4.97	0.49	3.88e-6	Crohn's disease;
SKCM	cis	rs801193	0.569	rs881285	chr7:66119420	A/G	cg11764359	chr7:65958608	NA	-0.74	-6.63	-0.6	3.89e-9	Aortic root size;
SKCM	cis	rs67311347	1.000	rs56992941	chr3:40472434	A/T	cg00091569	chr3:40428383	ENTPD3	0.6	5.02	0.49	3.22e-6	Renal cell carcinoma;
SKCM	cis	rs9303401	0.614	rs12948536	chr17:56580413	G/T	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.35	0.52	8.42e-7	Cognitive test performance;
SKCM	cis	rs2180341	1.000	rs9285460	chr6:127640190	A/G	cg24812749	chr6:127587940	RNF146	0.85	7.3	0.64	2.08e-10	Breast cancer;
SKCM	cis	rs3820068	0.581	rs61056912	chr1:15926296	A/G	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs9611565	0.559	rs5758412	chr22:42080803	T/A	cg03806693	chr22:41940476	POLR3H	1.12	7.53	0.65	7.69e-11	Vitiligo;
SKCM	cis	rs17685	0.712	rs56965035	chr7:75795670	G/A	cg16489192	chr7:75678113	MDH2;STYXL1	-0.57	-5.49	-0.53	4.89e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2721195	0.874	rs4244610	chr8:145737514	G/A	cg15857475	chr8:145742913	RECQL4;LRRC14	0.88	8.76	0.7	3.1400000000000003e-13	Age at first birth;
SKCM	cis	rs2832191	1.000	rs2832183	chr21:30482150	G/A	cg24692254	chr21:30365293	RNF160	-0.79	-7.24	-0.63	2.72e-10	Dental caries;
SKCM	cis	rs35306767	0.855	rs34318754	chr10:890714	G/A	cg26597838	chr10:835615	NA	0.79	5.77	0.55	1.54e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs7100689	0.646	rs10749579	chr10:82140959	C/T	cg01528321	chr10:82214614	TSPAN14	0.84	7.62	0.65	5.03e-11	Post bronchodilator FEV1;
SKCM	cis	rs644799	0.562	rs1254989	chr11:95508121	A/G	cg25622487	chr11:95524042	FAM76B;CEP57	0.64	5.5	0.53	4.58e-7	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs61776719	0.905	rs17465420	chr1:38398588	T/C	cg12658694	chr1:38397304	INPP5B	0.71	6.3	0.58	1.6e-8	Coronary artery disease;
SKCM	cis	rs4819052	0.807	rs28715237	chr21:46673768	C/G	cg19498844	chr21:46707878	POFUT2;LOC642852	0.88	7.73	0.66	3.17e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs873946	0.586	rs61862838	chr10:134572282	C/T	cg26818010	chr10:134567672	INPP5A	-0.8	-6.11	-0.57	3.7e-8	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs9815354	0.761	rs12186051	chr3:41836919	G/A	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs8017423	0.935	rs59179255	chr14:90691773	A/C	cg04374321	chr14:90722782	PSMC1	0.97	8.67	0.7	4.78e-13	Mortality in heart failure;
SKCM	cis	rs763014	0.931	rs59476302	chr16:629006	C/T	cg00908189	chr16:619842	PIGQ	0.82	7.78	0.66	2.55e-11	Height;
SKCM	cis	rs6938	0.514	rs35556055	chr15:75253414	G/A	cg09165964	chr15:75287851	SCAMP5	0.68	5.38	0.52	7.65e-7	Breast cancer;
SKCM	cis	rs2228479	0.702	rs11649501	chr16:89850957	A/T	cg00800038	chr16:89945340	TCF25	-0.93	-4.8	-0.48	7.41e-6	Skin colour saturation;
SKCM	cis	rs7772486	0.875	rs2777484	chr6:146334162	A/G	cg05347473	chr6:146136440	FBXO30	0.57	5.06	0.5	2.68e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2120019	1.000	rs7175720	chr15:75348962	C/G	cg17294928	chr15:75287854	SCAMP5	0.83	7.26	0.63	2.53e-10	Blood trace element (Zn levels);
SKCM	cis	rs9858542	0.953	rs9814873	chr3:49454112	A/G	cg03060546	chr3:49711283	APEH	-0.75	-5.47	-0.53	5.2e-7	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs34779708	0.702	rs7087150	chr10:35542138	A/T	cg03585969	chr10:35415529	CREM	0.74	5.42	0.52	6.41e-7	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs7809950	1.000	rs4727680	chr7:107087407	T/G	cg23024343	chr7:107201750	COG5	-0.77	-6.85	-0.61	1.5e-9	Coronary artery disease;
SKCM	cis	rs10870270	0.912	rs7079991	chr10:133736130	A/G	cg17892150	chr10:133769511	PPP2R2D	-0.66	-4.89	-0.48	5.37e-6	Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals;
SKCM	cis	rs875971	0.862	rs10256544	chr7:65675128	A/G	cg11764359	chr7:65958608	NA	0.83	8.25	0.68	3.03e-12	Aortic root size;
SKCM	cis	rs2721195	1.000	rs2721195	chr8:145677011	T/C	cg17328964	chr8:145687451	CYHR1	0.75	6.87	0.61	1.38e-9	Age at first birth;
SKCM	cis	rs7666738	0.830	rs9998803	chr4:99002519	C/T	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs362272	0.545	rs3129308	chr4:3309272	C/T	cg11471262	chr4:3318911	RGS12	0.92	11.07	0.78	1.16e-17	Serum sulfate level;
SKCM	cis	rs67311347	0.544	rs67533651	chr3:40338367	T/A	cg00091569	chr3:40428383	ENTPD3	0.61	5.33	0.52	9.24e-7	Renal cell carcinoma;
SKCM	cis	rs6582630	0.519	rs8189618	chr12:38276281	A/C	cg26384229	chr12:38710491	ALG10B	0.87	6.83	0.61	1.63e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs7945705	0.869	rs7925728	chr11:9013002	A/G	cg21881798	chr11:8931708	C11orf17;ST5	-0.83	-8.67	-0.7	4.72e-13	Hemoglobin concentration;
SKCM	cis	rs6866344	0.697	rs72812613	chr5:178135257	G/A	cg10224037	chr5:178157518	ZNF354A	0.83	5.91	0.56	8.48e-8	Neutrophil percentage of white cells;
SKCM	cis	rs782590	0.935	rs62165197	chr2:55801812	C/T	cg18811423	chr2:55921094	PNPT1	0.88	6.98	0.62	8.55e-10	Metabolic syndrome;
SKCM	cis	rs7927771	0.832	rs7940536	chr11:47395240	G/A	cg05585544	chr11:47624801	NA	0.56	4.79	0.48	7.65e-6	Subjective well-being;
SKCM	cis	rs28386778	0.897	rs2665832	chr17:61912261	C/T	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs7647973	0.516	rs12490393	chr3:49196132	C/T	cg06212747	chr3:49208901	KLHDC8B	0.79	5.62	0.54	2.87e-7	Menarche (age at onset);
SKCM	cis	rs8072100	0.537	rs9912450	chr17:45402208	C/T	cg25173405	chr17:45401733	C17orf57	-0.78	-5.71	-0.54	1.95e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs55962025	0.711	rs82333	chr4:3225389	C/T	cg21096898	chr4:3318625	RGS12	0.62	5.2	0.51	1.56e-6	Parental longevity (mother's age at death);
SKCM	cis	rs7829975	0.807	rs519019	chr8:8595104	A/T	cg06636001	chr8:8085503	FLJ10661	-0.75	-6.9	-0.62	1.24e-9	Mood instability;
SKCM	cis	rs155076	1.000	rs2783107	chr13:21837532	C/A	cg11317459	chr13:21872234	NA	-1.25	-6.82	-0.61	1.71e-9	White matter hyperintensity burden;
SKCM	cis	rs7829975	0.624	rs7823056	chr8:8382705	A/G	cg08975724	chr8:8085496	FLJ10661	0.66	5.02	0.49	3.22e-6	Mood instability;
SKCM	cis	rs7215564	0.730	rs2316066	chr17:78659785	A/G	cg16980736	chr17:78789706	RPTOR	-0.89	-4.88	-0.48	5.41e-6	Myopia (pathological);
SKCM	cis	rs7811142	0.887	rs111972532	chr7:100069088	T/C	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.19	7.94	0.67	1.21e-11	Platelet count;
SKCM	cis	rs3784262	1.000	rs4646629	chr15:58255215	A/G	cg12031962	chr15:58353849	ALDH1A2	-0.5	-6.33	-0.58	1.42e-8	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs9902453	0.967	rs4294864	chr17:28440138	G/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.51	0.53	4.55e-7	Coffee consumption (cups per day);
SKCM	cis	rs34779708	0.966	rs2045918	chr10:35418517	T/G	cg03585969	chr10:35415529	CREM	0.76	6.1	0.57	3.82e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs2721195	0.845	rs67392224	chr8:145707044	T/C	cg11211951	chr8:145729740	GPT	-0.57	-5.17	-0.51	1.74e-6	Age at first birth;
SKCM	cis	rs6570726	0.935	rs452552	chr6:145820781	G/A	cg23711669	chr6:146136114	FBXO30	0.7	6.64	0.6	3.72e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2153535	0.601	rs2143352	chr6:8530248	G/C	cg23788917	chr6:8435910	SLC35B3	0.68	4.98	0.49	3.66e-6	Motion sickness;
SKCM	cis	rs769267	0.930	rs892022	chr19:19613381	G/A	cg03709012	chr19:19516395	GATAD2A	0.89	8.62	0.7	5.89e-13	Tonsillectomy;
SKCM	cis	rs9682041	0.808	rs9875109	chr3:170064776	A/G	cg11886554	chr3:170076028	SKIL	-0.85	-4.88	-0.48	5.45e-6	Glomerular filtration rate in non diabetics (creatinine);Glomerular filtration rate (creatinine);
SKCM	cis	rs9810089	0.527	rs895894	chr3:135955443	C/T	cg21827317	chr3:136751795	NA	0.64	5.13	0.5	2.04e-6	Gestational age at birth (child effect);
SKCM	cis	rs9814567	1.000	rs6800862	chr3:134228628	A/G	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs2832191	0.791	rs2832196	chr21:30497412	G/A	cg24692254	chr21:30365293	RNF160	-0.9	-8.01	-0.67	9.12e-12	Dental caries;
SKCM	cis	rs7618501	0.571	rs2240329	chr3:50107512	G/A	cg24110177	chr3:50126178	RBM5	0.63	5.38	0.52	7.62e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7954584	0.567	rs11043243	chr12:122356370	G/C	cg21171335	chr12:122356390	WDR66	0.46	5.02	0.49	3.25e-6	Mean corpuscular volume;
SKCM	cis	rs2463822	1.000	rs2513074	chr11:62100880	A/C	cg06239285	chr11:62104954	ASRGL1	1.27	6.04	0.56	4.98e-8	Chronic obstructive pulmonary disease-related biomarkers;
SKCM	cis	rs597539	0.617	rs686348	chr11:68636996	A/G	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.84	5.61	0.54	3e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs2153535	0.542	rs915353	chr6:8440370	A/G	cg23788917	chr6:8435910	SLC35B3	0.69	5.14	0.5	1.99e-6	Motion sickness;
SKCM	cis	rs2153535	0.580	rs2183112	chr6:8528212	G/A	cg07606381	chr6:8435919	SLC35B3	0.93	6.8	0.61	1.92e-9	Motion sickness;
SKCM	cis	rs514406	0.668	rs1672911	chr1:53340320	T/C	cg16325326	chr1:53192061	ZYG11B	0.73	5.88	0.55	9.7e-8	Monocyte count;
SKCM	cis	rs4481887	0.708	rs28729425	chr1:248563027	T/C	cg00666640	chr1:248458726	OR2T12	0.5	5.19	0.51	1.63e-6	Common traits (Other);
SKCM	cis	rs8141529	0.732	rs5752798	chr22:29181868	A/G	cg15103426	chr22:29168792	CCDC117	0.61	5.06	0.5	2.7e-6	Lymphocyte counts;
SKCM	cis	rs6088590	1.000	rs6087632	chr20:33407704	A/C	cg24642439	chr20:33292090	TP53INP2	1.01	7.37	0.64	1.54e-10	Coronary artery disease;
SKCM	cis	rs992157	1.000	rs2168704	chr2:219142492	G/A	cg00012203	chr2:219082015	ARPC2	0.77	6.53	0.59	6.11e-9	Colorectal cancer;
SKCM	cis	rs13118159	0.509	rs1882098	chr4:1352431	T/C	cg02018176	chr4:1364513	KIAA1530	0.94	7.79	0.66	2.45e-11	Longevity;
SKCM	trans	rs3780486	0.522	rs10217770	chr9:33146393	C/A	cg20290983	chr6:43655470	MRPS18A	0.85	8.92	0.71	1.55e-13	IgG glycosylation;
SKCM	cis	rs1691799	0.867	rs1039056	chr12:66760391	C/T	cg16791601	chr12:66731901	HELB	-0.58	-4.82	-0.48	6.86e-6	White blood cell count (basophil);
SKCM	cis	rs2268241	0.938	rs9974603	chr21:34776300	C/A	cg14850771	chr21:34775459	IFNGR2	1.04	6.44	0.59	8.92e-9	Obesity-related traits;
SKCM	cis	rs9880211	0.706	rs9289513	chr3:136451746	G/T	cg21827317	chr3:136751795	NA	-0.67	-4.91	-0.49	4.87e-6	Body mass index;Height;
SKCM	cis	rs11155671	0.517	rs9397058	chr6:150207249	C/T	cg05036130	chr6:150231994	NA	0.6	6.88	0.61	1.31e-9	Testicular germ cell tumor;
SKCM	cis	rs72772090	0.710	rs113710451	chr5:96060306	G/A	cg17330273	chr5:96107758	CAST;ERAP1	-0.83	-4.97	-0.49	3.86e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs7811142	0.775	rs1636980	chr7:99938864	A/G	cg23667466	chr7:100026434	MEPCE;ZCWPW1	-1.06	-6.1	-0.57	3.78e-8	Platelet count;
SKCM	cis	rs4803468	0.967	rs7259900	chr19:41889429	A/T	cg14132834	chr19:41945861	ATP5SL	-0.72	-5.38	-0.52	7.65e-7	Height;
SKCM	cis	rs10193935	0.901	rs12619348	chr2:42625586	C/T	cg27598129	chr2:42591480	NA	-0.96	-6.71	-0.61	2.74e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6430585	0.646	rs12468768	chr2:136494985	C/T	cg07169764	chr2:136633963	MCM6	1.3	12.01	0.81	2.06e-19	Corneal structure;
SKCM	cis	rs2288073	0.965	rs13395596	chr2:24410738	T/C	cg06627628	chr2:24431161	ITSN2	-0.8	-5.47	-0.53	5.21e-7	Venous thromboembolism (SNP x SNP interaction);
SKCM	cis	rs7772486	0.686	rs7739735	chr6:146123536	G/A	cg05347473	chr6:146136440	FBXO30	0.55	5.07	0.5	2.6e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs10754283	0.967	rs10922680	chr1:90101326	C/T	cg21401794	chr1:90099060	LRRC8C	-0.77	-6.98	-0.62	8.52e-10	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs7809950	0.817	rs62483725	chr7:107201575	G/A	cg23024343	chr7:107201750	COG5	-0.86	-8.01	-0.67	8.85e-12	Coronary artery disease;
SKCM	cis	rs6952808	1.000	rs10260585	chr7:1889521	G/A	cg04267008	chr7:1944627	MAD1L1	-0.76	-5.74	-0.55	1.7e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs7772486	0.790	rs6926076	chr6:146232804	C/T	cg23711669	chr6:146136114	FBXO30	-0.78	-7.74	-0.66	3.05e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1580019	0.563	rs896137	chr7:32579345	G/T	cg06627557	chr7:32535165	LSM5;AVL9	0.97	9.63	0.74	6.6e-15	Cognitive ability;
SKCM	cis	rs597539	0.615	rs583182	chr11:68678634	C/T	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.8	5.39	0.52	7.25e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs919433	1.000	rs7422899	chr2:198163527	G/C	cg04278110	chr2:198063759	ANKRD44	-0.69	-4.8	-0.48	7.58e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs67311347	0.544	rs7644643	chr3:40350209	C/T	cg00656387	chr3:40428638	ENTPD3	-0.58	-5.34	-0.52	8.77e-7	Renal cell carcinoma;
SKCM	cis	rs2486288	0.539	rs2433601	chr15:45716425	T/C	cg10760299	chr15:45669010	GATM	0.57	5.42	0.52	6.44e-7	Glomerular filtration rate;
SKCM	cis	rs2739330	0.828	rs5760102	chr22:24248761	T/C	cg12419862	chr22:24373484	LOC391322	-0.66	-5.54	-0.53	3.87e-7	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs10193935	0.901	rs222486	chr2:42649664	C/T	cg27598129	chr2:42591480	NA	-0.96	-6.71	-0.61	2.74e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1801251	1.000	rs6717841	chr2:233590255	C/T	cg25237894	chr2:233734115	C2orf82	0.6	5.52	0.53	4.24e-7	Coronary artery disease;
SKCM	cis	rs2842992	0.789	rs4709370	chr6:160210061	A/G	cg19482086	chr6:160211437	TCP1;MRPL18	0.83	6.39	0.59	1.12e-8	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs7666738	0.546	rs6827131	chr4:98744810	C/G	cg17366294	chr4:99064904	C4orf37	0.64	5.03	0.49	3.1e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6088590	0.610	rs6120663	chr20:33081906	A/C	cg24642439	chr20:33292090	TP53INP2	-0.86	-6.87	-0.61	1.39e-9	Coronary artery disease;
SKCM	cis	rs9913156	0.707	rs11657052	chr17:4570573	C/T	cg19197139	chr17:4613644	ARRB2	-0.79	-5.45	-0.53	5.64e-7	Lymphocyte counts;
SKCM	cis	rs291096	0.709	rs291084	chr1:207095623	C/G	cg06917617	chr1:207818818	CR1L	0.56	5.03	0.5	3.02e-6	Coronary atherosclerosis (increased number of diseased vessels) (traffic exposure interaction);
SKCM	cis	rs3820928	1.000	rs4675119	chr2:227774635	A/C	cg11843606	chr2:227700838	RHBDD1	-0.61	-4.88	-0.48	5.44e-6	Pulmonary function;
SKCM	cis	rs7811142	1.000	rs11764818	chr7:100043055	G/A	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.34	0.69	2.1e-12	Platelet count;
SKCM	cis	rs6598955	0.724	rs884533	chr1:26585657	G/T	cg00938395	chr1:26633206	UBXN11	0.69	4.91	0.49	4.81e-6	Obesity-related traits;
SKCM	cis	rs9875589	0.509	rs2731336	chr3:14091908	G/A	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.53	5.16	0.5	1.87e-6	Ovarian reserve;
SKCM	cis	rs7208859	0.623	rs77009951	chr17:29080650	T/C	cg14067834	chr17:29058358	SUZ12P	1.05	5.3	0.51	1.05e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs1801251	1.000	rs7587309	chr2:233705702	G/T	cg25237894	chr2:233734115	C2orf82	-0.58	-5.74	-0.54	1.75e-7	Coronary artery disease;
SKCM	cis	rs12477438	0.798	rs6759354	chr2:99632195	A/G	cg26064155	chr2:99771622	LIPT1;TSGA10	-0.72	-4.86	-0.48	6e-6	Chronic sinus infection;
SKCM	cis	rs228769	0.636	rs11656104	chr17:42258965	A/T	cg09913183	chr17:42254507	C17orf65;ASB16	0.64	5.15	0.5	1.94e-6	Bone mineral density (hip);Bone mineral density (spine);
SKCM	cis	rs4905558	0.962	rs12433112	chr14:97317923	A/G	cg11863609	chr14:97355128	NA	0.54	4.88	0.48	5.52e-6	Neutrophil count;
SKCM	trans	rs62103177	0.810	rs62103189	chr18:77627815	G/A	cg05926928	chr17:57297772	GDPD1	1.29	8.74	0.7	3.44e-13	Opioid sensitivity;
SKCM	cis	rs7666738	0.791	rs10013680	chr4:99023030	G/C	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.68e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs873946	0.648	rs1543593	chr10:134553185	A/T	cg18305652	chr10:134549665	INPP5A	0.59	5.93	0.56	7.74e-8	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs4774899	0.934	rs11636201	chr15:57470533	A/G	cg01857019	chr15:57210107	LOC145783;TCF12	0.53	4.77	0.48	8.29e-6	Urinary tract infection frequency;
SKCM	cis	rs4975616	0.807	rs28379291	chr5:1313701	A/G	cg26373071	chr5:1325741	CLPTM1L	-0.66	-5.29	-0.51	1.1e-6	Lung cancer;
SKCM	cis	rs3845702	0.736	rs6433816	chr2:180809317	G/C	cg01881094	chr2:180872142	CWC22	-1.3	-6.15	-0.57	3.07e-8	Schizophrenia;
SKCM	cis	rs7959452	0.535	rs7135092	chr12:69658330	T/C	cg14784868	chr12:69753453	YEATS4	0.63	5.53	0.53	4.18e-7	Blood protein levels;
SKCM	cis	rs782590	0.967	rs58003472	chr2:55797507	T/C	cg18811423	chr2:55921094	PNPT1	0.87	6.82	0.61	1.71e-9	Metabolic syndrome;
SKCM	cis	rs6545883	0.929	rs2694625	chr2:61616055	G/A	cg15711740	chr2:61764176	XPO1	0.7	4.93	0.49	4.5e-6	Tuberculosis;
SKCM	cis	rs763014	0.932	rs2269559	chr16:682297	T/C	cg00908189	chr16:619842	PIGQ	0.87	7.69	0.66	3.77e-11	Height;
SKCM	trans	rs12599106	0.624	rs2173885	chr16:34992749	G/A	cg15383120	chr6:291909	DUSP22	-0.72	-7.36	-0.64	1.64e-10	Menopause (age at onset);
SKCM	cis	rs11764590	0.671	rs17734969	chr7:2110517	T/C	cg23422044	chr7:1970798	MAD1L1	-0.84	-5.28	-0.51	1.15e-6	Neuroticism;
SKCM	cis	rs16854884	1.000	rs58251824	chr3:143786258	T/C	cg06585982	chr3:143692056	C3orf58	0.74	5.69	0.54	2.17e-7	Economic and political preferences (feminism/equality);
SKCM	cis	rs72634258	0.554	rs12092614	chr1:7865710	C/T	cg26816564	chr1:7831052	VAMP3	0.73	5.13	0.5	2.03e-6	Inflammatory bowel disease;
SKCM	cis	rs7666738	0.791	rs13125277	chr4:99009922	T/G	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1160297	0.576	rs6746666	chr2:53089346	C/T	cg07782112	chr2:53107842	NA	0.58	6.01	0.56	5.54e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs8017423	0.967	rs7155315	chr14:90700787	G/A	cg04374321	chr14:90722782	PSMC1	0.98	8.82	0.71	2.38e-13	Mortality in heart failure;
SKCM	cis	rs9467773	1.000	rs6940053	chr6:26562122	C/T	cg09904177	chr6:26538194	HMGN4	0.54	4.98	0.49	3.78e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs28386778	0.897	rs10221279	chr17:61806138	A/G	cg01411255	chr17:61851458	DDX42;CCDC47	0.79	5.1	0.5	2.35e-6	Prudent dietary pattern;
SKCM	cis	rs36093844	0.752	rs1445511	chr11:85548049	C/A	cg25872744	chr11:85566296	CCDC83	-0.85	-4.77	-0.48	8.27e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs72781680	0.611	rs72783625	chr2:24315540	C/T	cg20701182	chr2:24300061	SF3B14	0.74	5.03	0.49	3.09e-6	Lymphocyte counts;
SKCM	cis	rs11098499	0.588	rs6534149	chr4:120559292	T/G	cg09307838	chr4:120376055	NA	-0.97	-8.11	-0.68	5.87e-12	Corneal astigmatism;
SKCM	cis	rs1799949	0.965	rs35954893	chr17:41333786	A/G	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.29	-0.58	1.73e-8	Menopause (age at onset);
SKCM	cis	rs933688	1.000	rs1363839	chr5:90671274	A/T	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.12	8.55	0.7	7.9e-13	Smoking behavior;
SKCM	cis	rs6840360	0.615	rs4696290	chr4:152631472	A/G	cg22705602	chr4:152727874	NA	-0.61	-8.13	-0.68	5.15e-12	Intelligence (multi-trait analysis);
SKCM	cis	rs2120019	0.567	rs28844983	chr15:75178088	T/A	cg09165964	chr15:75287851	SCAMP5	-0.81	-5.8	-0.55	1.34e-7	Blood trace element (Zn levels);
SKCM	cis	rs9902453	0.765	rs2729448	chr17:28091953	T/C	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.76	-5.75	-0.55	1.69e-7	Coffee consumption (cups per day);
SKCM	cis	rs7666738	0.830	rs2865978	chr4:99017946	G/T	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs898097	0.841	rs4986136	chr17:80865119	A/G	cg15369054	chr17:80825471	TBCD	-0.66	-6.18	-0.57	2.69e-8	Breast cancer;
SKCM	cis	rs6570726	0.791	rs398408	chr6:145801020	G/A	cg23711669	chr6:146136114	FBXO30	0.78	7.23	0.63	2.87e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2243480	1.000	rs6958289	chr7:65657111	T/G	cg18252515	chr7:66147081	NA	1.36	8.16	0.68	4.6e-12	Diabetic kidney disease;
SKCM	cis	rs9788682	0.947	rs12439240	chr15:78829091	T/C	cg24631222	chr15:78858424	CHRNA5	0.96	6.69	0.6	3.03e-9	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs7027203	0.828	rs4743934	chr9:96581893	A/G	cg14396892	chr9:96623032	NA	-0.45	-4.85	-0.48	6.13e-6	DNA methylation (variation);
SKCM	cis	rs9814567	1.000	rs1874883	chr3:134205071	G/T	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.67	-5.26	-0.51	1.21e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	trans	rs1814175	0.645	rs10839448	chr11:49938930	G/A	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs514406	0.792	rs1242201	chr1:53344748	G/A	cg16325326	chr1:53192061	ZYG11B	0.83	7.76	0.66	2.69e-11	Monocyte count;
SKCM	cis	rs4073582	0.595	rs1115508	chr11:65923149	A/G	cg14036092	chr11:66035641	RAB1B	0.77	6.03	0.56	5.1e-8	Gout;
SKCM	cis	rs854765	0.583	rs11078404	chr17:17820487	A/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.0	7.64	0.65	4.64e-11	Total body bone mineral density;
SKCM	cis	rs13392177	0.672	rs1877715	chr2:219052546	C/T	cg00012203	chr2:219082015	ARPC2	0.65	4.81	0.48	7.21e-6	Pyoderma gangrenosum in inflammatory bowel disease;
SKCM	cis	rs2221651	1.000	rs9388837	chr6:131055944	T/C	cg08062526	chr6:131949551	MED23	-0.92	-4.87	-0.48	5.83e-6	Monocyte percentage of white cells;
SKCM	cis	rs7811142	1.000	rs73405353	chr7:100091215	G/A	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.14	6.58	0.6	4.83e-9	Platelet count;
SKCM	cis	rs854765	0.583	rs4925126	chr17:17798633	C/T	cg04398451	chr17:18023971	MYO15A	-0.85	-5.97	-0.56	6.59e-8	Total body bone mineral density;
SKCM	cis	rs12477438	0.834	rs1563106	chr2:99701381	C/A	cg26064155	chr2:99771622	LIPT1;TSGA10	-0.79	-5.13	-0.5	2.09e-6	Chronic sinus infection;
SKCM	cis	rs7296418	0.961	rs949143	chr12:123595163	G/A	cg06742321	chr12:123595122	PITPNM2	0.65	5.45	0.53	5.6e-7	Platelet count;
SKCM	cis	rs4319547	0.508	rs10846826	chr12:122894987	C/T	cg23029597	chr12:123009494	RSRC2	-0.73	-5.37	-0.52	7.93e-7	Body mass index;
SKCM	cis	rs9951698	0.703	rs11663049	chr18:12991393	A/G	cg12848697	chr18:13133368	NA	0.51	4.78	0.48	7.96e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs933688	1.000	rs6865495	chr5:90746424	G/A	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.01	8.43	0.69	1.41e-12	Smoking behavior;
SKCM	cis	rs951366	0.764	rs823141	chr1:205741426	T/C	cg26354017	chr1:205819088	PM20D1	1.03	9.58	0.74	7.95e-15	Menarche (age at onset);
SKCM	cis	rs614226	0.935	rs77955762	chr12:121009948	T/C	cg01236616	chr12:121019343	POP5	-1.34	-7.67	-0.66	4.14e-11	Type 1 diabetes nephropathy;
SKCM	cis	rs362272	0.545	rs3135146	chr4:3307638	C/G	cg11471262	chr4:3318911	RGS12	-0.94	-11.62	-0.8	1.06e-18	Serum sulfate level;
SKCM	cis	rs9910055	0.659	rs227580	chr17:42223068	C/T	cg08499158	chr17:42289980	UBTF	0.76	6.56	0.6	5.42e-9	Total body bone mineral density;
SKCM	cis	rs6834538	0.577	rs13106473	chr4:113542066	C/T	cg05166686	chr4:113558556	LARP7;C4orf21	0.63	5.2	0.51	1.56e-6	Free thyroxine concentration;
SKCM	cis	rs523522	0.962	rs4766966	chr12:120942911	G/C	cg12219531	chr12:120966889	COQ5	0.91	7.82	0.66	2.11e-11	High light scatter reticulocyte count;
SKCM	cis	rs1577917	0.917	rs35738006	chr6:86646309	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.85	-8.62	-0.7	5.82e-13	Response to antipsychotic treatment;
SKCM	cis	rs589448	0.967	rs2617835	chr12:69753420	C/A	cg22834771	chr12:69754056	YEATS4	-0.71	-5.79	-0.55	1.39e-7	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs8170	0.603	rs7249329	chr19:17423373	G/T	cg07830086	chr19:18107778	KCNN1	-0.8	-4.88	-0.48	5.45e-6	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Ovarian cancer;Breast cancer;Epithelial ovarian cancer;
SKCM	cis	rs6087990	0.735	rs6058883	chr20:31365719	C/T	cg13636640	chr20:31349939	DNMT3B	-0.83	-6.36	-0.58	1.28e-8	Ulcerative colitis;
SKCM	cis	rs738322	0.753	rs2267372	chr22:38598234	A/G	cg25457927	chr22:38595422	NA	0.57	7.46	0.65	1.03e-10	Cutaneous nevi;
SKCM	cis	rs7666738	0.753	rs1830230	chr4:99026186	G/C	cg05340658	chr4:99064831	C4orf37	0.66	5.07	0.5	2.6e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1046896	1.000	rs1046917	chr17:80685655	A/G	cg02711726	chr17:80685570	FN3KRP	0.7	6.06	0.57	4.54e-8	Glycated hemoglobin levels;
SKCM	cis	rs1801251	0.963	rs13021246	chr2:233623111	T/C	cg25237894	chr2:233734115	C2orf82	0.58	5.53	0.53	4.04e-7	Coronary artery disease;
SKCM	cis	rs17376456	0.825	rs13182631	chr5:93115701	A/G	cg25358565	chr5:93447407	FAM172A	1.15	7.28	0.64	2.25e-10	Diabetic retinopathy;
SKCM	cis	rs7811142	0.775	rs1636980	chr7:99938864	A/G	cg13153964	chr7:100026424	MEPCE;ZCWPW1	-1.15	-7.22	-0.63	2.95e-10	Platelet count;
SKCM	cis	rs782590	0.967	rs4672054	chr2:55773093	C/A	cg18811423	chr2:55921094	PNPT1	0.88	6.9	0.62	1.21e-9	Metabolic syndrome;
SKCM	cis	rs2243480	1.000	rs6949812	chr7:65387101	G/A	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs992157	0.835	rs2271543	chr2:219142491	C/T	cg00012203	chr2:219082015	ARPC2	-0.74	-5.97	-0.56	6.53e-8	Colorectal cancer;
SKCM	cis	rs12134245	0.874	rs61798047	chr1:92016934	C/T	cg02896835	chr1:92012615	NA	-0.59	-5.13	-0.5	2.09e-6	Breast cancer;
SKCM	cis	rs1577917	0.837	rs806529	chr6:86467121	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.6	-5.1	-0.5	2.3e-6	Response to antipsychotic treatment;
SKCM	cis	rs3785574	1.000	rs7223257	chr17:61787684	T/C	cg06601766	chr17:61851465	DDX42;CCDC47	0.66	4.98	0.49	3.74e-6	Height;
SKCM	cis	rs6500395	0.775	rs7185541	chr16:48664681	A/G	cg04672837	chr16:48644449	N4BP1	0.6	4.88	0.48	5.59e-6	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs801193	1.000	rs2659912	chr7:66157999	G/C	cg00343986	chr7:65444356	GUSB	0.7	5.14	0.5	1.98e-6	Aortic root size;
SKCM	cis	rs10089	1.000	rs2898096	chr5:127433214	C/T	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.92	8.45	0.69	1.25e-12	Ileal carcinoids;
SKCM	cis	rs9868809	0.656	rs13324119	chr3:48710606	G/C	cg00383909	chr3:49044727	WDR6	0.88	4.87	0.48	5.69e-6	Ulcerative colitis;Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs2839186	0.933	rs4818832	chr21:47708634	C/T	cg11766577	chr21:47581405	C21orf56	-0.71	-6.01	-0.56	5.6e-8	Testicular germ cell tumor;
SKCM	cis	rs1046896	0.731	rs9906115	chr17:80791469	G/A	cg02711726	chr17:80685570	FN3KRP	-0.73	-5.2	-0.51	1.59e-6	Glycated hemoglobin levels;
SKCM	cis	rs919433	0.680	rs788017	chr2:198265173	T/A	cg04278110	chr2:198063759	ANKRD44	0.7	4.79	0.48	7.87e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	trans	rs1814175	0.935	rs1827017	chr11:49632592	C/G	cg15704280	chr7:45808275	SEPT13	-1.0	-9.43	-0.73	1.61e-14	Height;
SKCM	cis	rs10155981	0.510	rs4722158	chr7:22584183	G/A	cg05062323	chr7:22590069	NA	-1.06	-6.07	-0.57	4.26e-8	Bilirubin levels;
SKCM	cis	rs9611565	0.592	rs57102627	chr22:41987627	T/C	cg03806693	chr22:41940476	POLR3H	-1.1	-7.26	-0.64	2.51e-10	Vitiligo;
SKCM	cis	rs2439831	0.867	rs3101443	chr15:43912372	C/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.41	8.33	0.69	2.19e-12	Lung cancer in ever smokers;
SKCM	cis	rs801193	1.000	rs17566701	chr7:66193183	T/C	cg00343986	chr7:65444356	GUSB	0.71	5.25	0.51	1.3e-6	Aortic root size;
SKCM	cis	rs9814567	1.000	rs4955485	chr3:134295843	G/A	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs7927771	0.965	rs4752881	chr11:47898535	A/G	cg05585544	chr11:47624801	NA	-0.6	-5.21	-0.51	1.53e-6	Subjective well-being;
SKCM	cis	rs9611565	0.649	rs9623450	chr22:42175231	G/A	cg03806693	chr22:41940476	POLR3H	0.88	5.75	0.55	1.68e-7	Vitiligo;
SKCM	cis	rs7937682	0.575	rs7107213	chr11:111750430	A/G	cg09085632	chr11:111637200	PPP2R1B	1.04	10.37	0.76	2.48e-16	Primary sclerosing cholangitis;
SKCM	cis	rs2737618	0.651	rs2816974	chr1:200082686	C/G	cg21825944	chr1:200113062	NR5A2	0.58	4.9	0.49	5.07e-6	Uric acid levels;
SKCM	cis	rs28785552	0.897	rs7259466	chr19:53239369	G/A	cg10871876	chr19:53194124	ZNF83	0.81	5.91	0.56	8.68e-8	Response to paliperidone in schizophrenia (PANSS score);
SKCM	cis	rs654950	1.000	rs679449	chr1:41988634	G/T	cg06885757	chr1:42089581	HIVEP3	-0.62	-6.51	-0.59	6.62e-9	Airway imaging phenotypes;
SKCM	cis	rs6977660	0.660	rs7357202	chr7:19817911	T/A	cg05791153	chr7:19748676	TWISTNB	0.77	5.02	0.49	3.23e-6	Thyroid stimulating hormone;
SKCM	cis	rs78498439	0.544	rs77576048	chr16:90078724	C/T	cg08547343	chr16:90038815	CENPBD1;AFG3L1	-1.38	-5.58	-0.53	3.41e-7	Monobrow;
SKCM	cis	rs10504229	1.000	rs72652905	chr8:58188355	A/G	cg22535103	chr8:58192502	C8orf71	-0.7	-5.02	-0.49	3.18e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs7193541	0.965	rs28616016	chr16:74676964	T/C	cg01733217	chr16:74700730	RFWD3	0.9	8.88	0.71	1.85e-13	Multiple myeloma;
SKCM	cis	rs35306767	0.855	rs61830900	chr10:871481	C/G	cg26597838	chr10:835615	NA	0.79	6.08	0.57	4.12e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs763014	0.931	rs2071981	chr16:630025	C/G	cg00908189	chr16:619842	PIGQ	0.82	7.78	0.66	2.55e-11	Height;
SKCM	cis	rs10779751	1.000	rs2300093	chr1:11266392	G/C	cg08854313	chr1:11322531	MTOR	1.0	8.91	0.71	1.64e-13	Body mass index;
SKCM	cis	rs1506636	0.962	rs7811830	chr7:123320183	G/C	cg03229431	chr7:123269106	ASB15	-0.62	-5.06	-0.5	2.75e-6	Plateletcrit;Platelet count;
SKCM	cis	rs1799949	1.000	rs8176269	chr17:41213626	G/T	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.06	-0.57	4.62e-8	Menopause (age at onset);
SKCM	cis	rs2811415	0.597	rs11710595	chr3:127767158	T/C	cg09089421	chr3:127803668	RUVBL1	1.01	8.79	0.71	2.72e-13	Lung function (FEV1/FVC);
SKCM	cis	rs4234284	1.000	rs10934808	chr3:126979806	G/A	cg04889221	chr3:126137216	CCDC37	-0.49	-4.96	-0.49	4.07e-6	Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel);
SKCM	cis	rs28386778	0.897	rs4968598	chr17:61835579	T/C	cg01411255	chr17:61851458	DDX42;CCDC47	0.78	5.03	0.49	3.06e-6	Prudent dietary pattern;
SKCM	cis	rs1801251	1.000	rs2592105	chr2:233645968	C/G	cg08000102	chr2:233561755	GIGYF2	0.89	7.15	0.63	4.05e-10	Coronary artery disease;
SKCM	cis	rs826838	0.900	rs1403523	chr12:39130570	T/A	cg13010199	chr12:38710504	ALG10B	-0.72	-5.73	-0.54	1.83e-7	Heart rate;
SKCM	cis	rs60871478	0.730	rs28756034	chr7:782906	A/G	cg05535760	chr7:792225	HEATR2	1.12	8.64	0.7	5.46e-13	Cerebrospinal P-tau181p levels;
SKCM	cis	rs738322	0.775	rs4375	chr22:38539041	T/C	cg25457927	chr22:38595422	NA	-0.51	-5.8	-0.55	1.32e-7	Cutaneous nevi;
SKCM	cis	rs7584330	0.737	rs12469894	chr2:238365528	T/C	cg14458575	chr2:238380390	NA	0.86	6.22	0.58	2.31e-8	Prostate cancer;
SKCM	cis	rs2836974	0.623	rs7280326	chr21:40700408	A/G	cg11644478	chr21:40555479	PSMG1	-0.67	-5.63	-0.54	2.71e-7	Cognitive function;
SKCM	cis	rs875971	0.862	rs4368860	chr7:65608482	C/G	cg18876405	chr7:65276391	NA	-0.65	-6.63	-0.6	3.96e-9	Aortic root size;
SKCM	cis	rs478304	0.651	rs10896038	chr11:65505528	G/C	cg27068330	chr11:65405492	SIPA1	-0.89	-8.21	-0.68	3.71e-12	Acne (severe);
SKCM	cis	rs1799949	0.965	rs2236762	chr17:41226675	A/T	cg19454999	chr17:41278357	BRCA1;NBR2	0.52	4.8	0.48	7.45e-6	Menopause (age at onset);
SKCM	cis	rs3820068	0.581	rs16851848	chr1:15927698	G/A	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs4803468	0.967	rs13345590	chr19:41886455	T/G	cg14132834	chr19:41945861	ATP5SL	-0.74	-5.71	-0.54	1.99e-7	Height;
SKCM	cis	rs1044826	0.597	rs6772199	chr3:139178133	C/T	cg15131784	chr3:139108705	COPB2	0.66	4.96	0.49	4.09e-6	Obesity-related traits;
SKCM	cis	rs189798	0.807	rs330909	chr8:8995387	A/G	cg06636001	chr8:8085503	FLJ10661	0.8	5.73	0.54	1.81e-7	Myopia (pathological);
SKCM	cis	rs7666738	0.791	rs2865958	chr4:99040732	G/T	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	trans	rs3780486	0.846	rs7850878	chr9:33126570	A/G	cg20290983	chr6:43655470	MRPS18A	1.0	11.51	0.79	1.7e-18	IgG glycosylation;
SKCM	cis	rs6951245	0.938	rs117729148	chr7:1108531	G/A	cg03188948	chr7:1209495	NA	1.13	6.27	0.58	1.89e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs9916302	0.904	rs620686	chr17:37453617	A/G	cg07936489	chr17:37558343	FBXL20	0.84	6.75	0.61	2.32e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs7927771	0.524	rs7933184	chr11:47682402	C/T	cg20307385	chr11:47447363	PSMC3	0.71	5.66	0.54	2.44e-7	Subjective well-being;
SKCM	cis	rs6753739	0.661	rs4674354	chr2:219903723	C/T	cg09617556	chr2:219924408	IHH	0.49	5.15	0.5	1.89e-6	Height;
SKCM	cis	rs77216612	0.835	rs56692845	chr12:12887811	C/T	cg04607235	chr12:12878440	APOLD1	-0.92	-6.84	-0.61	1.6e-9	Lymphocyte counts;
SKCM	cis	rs2857078	0.654	rs4793083	chr17:42312973	C/T	cg19774624	chr17:42201019	HDAC5	0.78	6.2	0.57	2.46e-8	Red cell distribution width;Reticulocyte count;
SKCM	cis	rs11098499	0.730	rs12505735	chr4:120532956	G/T	cg24375607	chr4:120327624	NA	0.68	5.26	0.51	1.2e-6	Corneal astigmatism;
SKCM	cis	rs7618501	0.521	rs6774354	chr3:49961780	G/A	cg24110177	chr3:50126178	RBM5	-0.71	-5.71	-0.54	1.95e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs2243480	1.000	rs1404147	chr7:65264524	C/T	cg18252515	chr7:66147081	NA	-1.32	-8.71	-0.7	3.95e-13	Diabetic kidney disease;
SKCM	cis	rs919433	0.963	rs4850430	chr2:198182796	A/T	cg04278110	chr2:198063759	ANKRD44	-0.69	-4.8	-0.48	7.58e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs4836694	0.574	rs3780712	chr9:132943082	A/G	cg13414629	chr9:132935646	FREQ	0.84	5.25	0.51	1.26e-6	Alzheimer's disease (cognitive decline);
SKCM	cis	rs790110	0.536	rs2280070	chr3:122397717	A/G	cg13745852	chr3:122399555	PARP14	0.83	4.83	0.48	6.76e-6	Acoustic startle blink response;
SKCM	cis	rs2072499	0.778	rs2247476	chr1:156190280	C/A	cg25208724	chr1:156163844	SLC25A44	0.89	6.38	0.59	1.16e-8	Testicular germ cell tumor;
SKCM	cis	rs7818345	0.608	rs10481426	chr8:19279199	A/G	cg03393445	chr8:19249545	SH2D4A	-0.61	-5.33	-0.52	9.16e-7	Language performance in older adults (adjusted for episodic memory);
SKCM	cis	rs947211	0.950	rs885224	chr1:205753097	A/G	cg07157834	chr1:205819609	PM20D1	0.66	5.01	0.49	3.31e-6	Parkinson's disease;
SKCM	cis	rs7917772	0.636	rs7911747	chr10:104528890	A/G	cg11453585	chr10:104263688	ACTR1A;SUFU	-0.69	-4.79	-0.48	7.9e-6	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs10911232	0.507	rs10797814	chr1:182990929	C/A	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.65	0.6	3.65e-9	Hypertriglyceridemia;
SKCM	cis	rs3008870	1.000	rs2985824	chr1:67410171	C/T	cg08660285	chr1:67390436	MIER1;WDR78	-0.92	-6.05	-0.57	4.69e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs8017423	0.967	rs2149655	chr14:90707246	T/C	cg04374321	chr14:90722782	PSMC1	0.97	8.87	0.71	1.91e-13	Mortality in heart failure;
SKCM	trans	rs1814175	0.817	rs1851858	chr11:49855638	G/A	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs2073499	0.872	rs2282751	chr3:50291785	A/G	cg05260129	chr3:50388622	TUSC4;CYB561D2	-0.84	-4.79	-0.48	7.72e-6	Schizophrenia;
SKCM	cis	rs17376456	0.877	rs10040648	chr5:93490301	G/C	cg25358565	chr5:93447407	FAM172A	1.25	8.09	0.68	6.32e-12	Diabetic retinopathy;
SKCM	cis	rs6138458	0.743	rs3746330	chr20:24999795	A/G	cg26195577	chr20:24973756	C20orf3	0.91	6.0	0.56	5.94e-8	Blood protein levels;
SKCM	cis	rs28386778	0.966	rs2854161	chr17:61976093	T/C	cg11494091	chr17:61959527	GH2	-0.59	-4.91	-0.49	4.92e-6	Prudent dietary pattern;
SKCM	cis	rs941408	0.515	rs1736188	chr19:2782368	A/G	cg17333051	chr19:2783644	SGTA	0.47	4.82	0.48	6.95e-6	Total cholesterol levels;
SKCM	cis	rs12986445	0.947	rs6738270	chr2:26150589	G/T	cg07291958	chr2:26785531	C2orf70	0.56	5.27	0.51	1.16e-6	Multiple myeloma and monoclonal gammopathy;Multiple myeloma;
SKCM	cis	rs9394841	0.620	rs9462746	chr6:41816279	T/A	cg08135965	chr6:41755394	TOMM6	0.74	4.88	0.48	5.45e-6	Mean corpuscular hemoglobin;Red cell distribution width;
SKCM	cis	rs763014	0.838	rs4984670	chr16:641044	A/G	cg07343612	chr16:622815	PIGQ	-0.69	-5.75	-0.55	1.64e-7	Height;
SKCM	cis	rs606458	0.920	rs620006	chr11:64530431	G/A	cg07674570	chr11:65346152	EHBP1L1	-0.68	-5.05	-0.5	2.85e-6	Urate levels;
SKCM	cis	rs11098499	0.909	rs35111518	chr4:120440682	A/G	cg24375607	chr4:120327624	NA	0.68	5.25	0.51	1.27e-6	Corneal astigmatism;
SKCM	cis	rs10752881	0.935	rs12082051	chr1:183051614	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.78	6.87	0.61	1.42e-9	Colorectal cancer;
SKCM	cis	rs1799949	1.000	rs34942571	chr17:41273379	G/C	cg25918947	chr17:41365094	TMEM106A	-0.59	-5.36	-0.52	8.17e-7	Menopause (age at onset);
SKCM	cis	rs7937682	0.961	rs11601674	chr11:111634354	C/T	cg09085632	chr11:111637200	PPP2R1B	-1.13	-13.09	-0.83	2.27e-21	Primary sclerosing cholangitis;
SKCM	cis	rs17685	0.712	rs10235738	chr7:75773460	G/A	cg16684958	chr7:75615977	POR	0.52	4.92	0.49	4.73e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1799949	0.965	rs9911630	chr17:41188342	A/G	cg23758822	chr17:41437982	NA	0.94	7.17	0.63	3.82e-10	Menopause (age at onset);
SKCM	cis	rs67460515	0.665	rs28384382	chr3:160939141	C/T	cg03342759	chr3:160939853	NMD3	-0.77	-6.57	-0.6	5.08e-9	Parkinson's disease;
SKCM	cis	rs2439831	0.681	rs884704	chr15:43691150	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.18	7.58	0.65	6.02e-11	Lung cancer in ever smokers;
SKCM	cis	rs4862750	0.872	rs6825289	chr4:187879109	T/G	cg10295955	chr4:187884368	NA	-1.04	-14.07	-0.85	4.23e-23	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1862618	0.613	rs252889	chr5:56227069	C/A	cg03609598	chr5:56110824	MAP3K1	-0.71	-5.08	-0.5	2.5e-6	Initial pursuit acceleration;
SKCM	cis	rs9325144	0.554	rs7960616	chr12:39096664	T/A	cg26384229	chr12:38710491	ALG10B	-0.73	-6.68	-0.6	3.21e-9	Morning vs. evening chronotype;
SKCM	cis	rs1218582	0.710	rs9793588	chr1:154878878	C/G	cg09359103	chr1:154839909	KCNN3	-0.56	-5.0	-0.49	3.48e-6	Prostate cancer;
SKCM	cis	rs9790314	0.934	rs462413	chr3:161101587	T/C	cg03342759	chr3:160939853	NMD3	-0.71	-7.22	-0.63	2.93e-10	Morning vs. evening chronotype;
SKCM	cis	rs798502	0.522	rs7790322	chr7:2830498	C/T	cg19717773	chr7:2847554	GNA12	-0.48	-5.65	-0.54	2.54e-7	Waist circumference adjusted for BMI (adjusted for smoking behaviour);Inflammatory bowel disease;Waist circumference adjusted for BMI in non-smokers;Ulcerative colitis;Waist circumference adjusted for body mass index;Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction);
SKCM	cis	rs951366	0.764	rs708724	chr1:205743663	A/C	cg24503407	chr1:205819492	PM20D1	0.91	7.99	0.67	9.76e-12	Menarche (age at onset);
SKCM	cis	rs6933660	0.646	rs9397410	chr6:151770503	C/T	cg10883421	chr6:151773342	RMND1;C6orf211	0.87	7.71	0.66	3.47e-11	Menarche (age at onset);
SKCM	trans	rs3780486	0.801	rs3780495	chr9:33125942	A/C	cg04842962	chr6:43655489	MRPS18A	1.03	10.85	0.78	2.95e-17	IgG glycosylation;
SKCM	cis	rs3820068	0.581	rs72645890	chr1:15930602	A/G	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs1799949	0.965	rs8176161	chr17:41241390	C/A	cg23758822	chr17:41437982	NA	0.92	7.68	0.66	3.96e-11	Menopause (age at onset);
SKCM	cis	rs1577917	0.654	rs9450284	chr6:86199329	G/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.68	5.89	0.55	9.25e-8	Response to antipsychotic treatment;
SKCM	trans	rs8073060	0.533	rs178736	chr17:33928158	G/T	cg19694781	chr19:47549865	TMEM160	-1.08	-8.69	-0.7	4.26e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs8180040	0.726	rs1869871	chr3:47023948	C/T	cg27129171	chr3:47204927	SETD2	0.83	6.19	0.57	2.6e-8	Colorectal cancer;
SKCM	cis	rs6840360	0.593	rs1429559	chr4:152681952	A/G	cg22705602	chr4:152727874	NA	-0.59	-7.95	-0.67	1.19e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs908922	0.651	rs11205035	chr1:152532832	A/G	cg09873164	chr1:152488093	CRCT1	0.72	5.62	0.54	2.85e-7	Hair morphology;
SKCM	cis	rs11098499	0.739	rs951570	chr4:120150467	T/C	cg09307838	chr4:120376055	NA	-0.78	-5.85	-0.55	1.1e-7	Corneal astigmatism;
SKCM	cis	rs9633740	0.947	rs7096909	chr10:82284512	A/T	cg01528321	chr10:82214614	TSPAN14	-0.73	-5.15	-0.5	1.9e-6	Post bronchodilator FEV1;
SKCM	cis	rs11098499	0.818	rs55825515	chr4:120486402	A/G	cg24375607	chr4:120327624	NA	0.68	5.39	0.52	7.14e-7	Corneal astigmatism;
SKCM	cis	rs2721195	0.874	rs4244610	chr8:145737514	G/A	cg15320075	chr8:145703422	NA	0.87	7.71	0.66	3.47e-11	Age at first birth;
SKCM	cis	rs7917772	0.503	rs7915589	chr10:104299264	G/A	cg11453585	chr10:104263688	ACTR1A;SUFU	0.78	6.33	0.58	1.47e-8	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs362296	0.671	rs3135173	chr4:3257373	T/C	cg09735869	chr4:3319127	RGS12	-0.8	-6.79	-0.61	1.97e-9	Parental longevity (mother's age at death);
SKCM	cis	rs1046896	0.594	rs9914570	chr17:80783721	C/T	cg02711726	chr17:80685570	FN3KRP	-0.75	-5.61	-0.54	2.96e-7	Glycated hemoglobin levels;
SKCM	cis	rs798554	0.759	rs1182189	chr7:2869522	G/A	cg19346786	chr7:2764209	NA	-0.65	-6.97	-0.62	8.82e-10	Height;
SKCM	cis	rs9475752	0.545	rs1044670	chr6:56891979	A/G	cg06815302	chr6:57335405	PRIM2	-0.7	-4.93	-0.49	4.56e-6	Menarche (age at onset);
SKCM	cis	rs12449000	1	rs12449000	chr16:89872970	T/C	cg27121462	chr16:89883253	FANCA	0.8	7.22	0.63	2.99e-10	Schizophrenia;
SKCM	cis	rs9300255	0.602	rs1402274	chr12:123686224	T/C	cg05973401	chr12:123451056	ABCB9	0.81	5.37	0.52	7.77e-7	Neutrophil percentage of white cells;
SKCM	cis	rs1005277	0.579	rs2008449	chr10:38414204	A/T	cg25427524	chr10:38739819	LOC399744	0.65	6.29	0.58	1.69e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs11718455	0.883	rs4682926	chr3:44006170	C/T	cg21419209	chr3:44054225	NA	-0.65	-5.32	-0.52	9.77e-7	Coronary artery disease;
SKCM	cis	rs11252926	0.502	rs7072510	chr10:455596	C/T	cg18196295	chr10:418757	DIP2C	0.66	5.55	0.53	3.75e-7	Psychosis in Alzheimer's disease;
SKCM	cis	rs1707322	0.506	rs2991983	chr1:46079391	T/C	cg03146154	chr1:46216737	IPP	-0.8	-5.59	-0.53	3.22e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs9309711	0.883	rs13429373	chr2:3477014	G/A	cg10845886	chr2:3471009	TTC15	-0.83	-6.51	-0.59	6.62e-9	Neurofibrillary tangles;
SKCM	cis	rs1005277	0.579	rs1740745	chr10:38520056	T/C	cg25427524	chr10:38739819	LOC399744	-0.69	-6.79	-0.61	1.96e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs4689592	0.503	rs11945642	chr4:7051065	G/C	cg26116260	chr4:7069785	GRPEL1	-1.08	-7.81	-0.66	2.18e-11	Monocyte percentage of white cells;
SKCM	cis	rs7945705	0.902	rs2012696	chr11:8995818	A/C	cg13070366	chr11:9386451	NA	-0.58	-4.93	-0.49	4.48e-6	Hemoglobin concentration;
SKCM	cis	rs651907	0.557	rs17347644	chr3:101547733	C/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.77	6.7	0.6	2.93e-9	Colorectal cancer;
SKCM	cis	rs4466137	0.904	rs6887104	chr5:83003535	G/A	cg16102102	chr5:83017553	HAPLN1	-0.58	-6.17	-0.57	2.84e-8	Prostate cancer;
SKCM	cis	rs8067545	0.611	rs2703777	chr17:20138891	C/T	cg13482628	chr17:19912719	NA	-0.65	-5.43	-0.52	6.14e-7	Schizophrenia;
SKCM	cis	rs7208859	0.524	rs60114476	chr17:29097667	A/T	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs11098499	0.738	rs28408407	chr4:120376030	C/G	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs11059919	1	rs11059919	chr12:129289190	G/A	cg09035930	chr12:129282057	SLC15A4	0.8	8.82	0.71	2.36e-13	Systemic lupus erythematosus;
SKCM	cis	rs910316	1.000	rs9805979	chr14:75566209	G/A	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.89e-7	Height;
SKCM	cis	rs16949788	1.000	rs41306345	chr15:66782048	C/T	cg08120210	chr15:66682733	MAP2K1	-0.69	-5.29	-0.51	1.08e-6	Spherical equivalent (joint analysis main effects and education interaction);
SKCM	cis	rs2243480	0.708	rs781141	chr7:65438553	A/G	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs11822910	0.737	rs2729389	chr11:57211646	A/G	cg00522883	chr11:57194120	SLC43A3	-0.76	-6.71	-0.61	2.76e-9	Platelet distribution width;
SKCM	cis	rs1577917	1.000	rs12201735	chr6:86656939	C/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.85	-8.62	-0.7	5.82e-13	Response to antipsychotic treatment;
SKCM	cis	rs12142240	0.698	rs12385696	chr1:46818836	A/G	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs12142240	0.698	rs17357676	chr1:46812444	A/G	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs6062302	0.522	rs3810492	chr20:62219740	G/A	cg09650180	chr20:62225654	GMEB2	-0.79	-6.15	-0.57	3.1e-8	Glioblastoma;
SKCM	cis	rs769267	0.895	rs2965189	chr19:19519518	G/T	cg03709012	chr19:19516395	GATAD2A	0.91	8.6	0.7	6.53e-13	Tonsillectomy;
SKCM	cis	rs523522	0.602	rs7132474	chr12:120866996	A/C	cg12219531	chr12:120966889	COQ5	0.84	5.73	0.54	1.77e-7	High light scatter reticulocyte count;
SKCM	cis	rs9467773	1.000	rs9467773	chr6:26498426	A/G	cg15659132	chr6:26577336	NA	0.61	5.82	0.55	1.24e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs8037137	0.915	rs60290423	chr15:91529452	T/C	cg15878949	chr15:91534302	PRC1	0.68	5.17	0.51	1.77e-6	Platelet count;Serous invasive ovarian cancer;High-grade serous ovarian cancer;Invasive epithelial ovarian cancer;
SKCM	cis	rs9467773	0.933	rs35355150	chr6:26526039	G/A	cg09904177	chr6:26538194	HMGN4	0.53	4.87	0.48	5.62e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7927771	1.000	rs11605774	chr11:47832793	G/A	cg05585544	chr11:47624801	NA	-0.59	-5.09	-0.5	2.43e-6	Subjective well-being;
SKCM	cis	rs7208859	0.673	rs2470251	chr17:29095061	T/C	cg14067834	chr17:29058358	SUZ12P	0.99	5.11	0.5	2.22e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs4862750	0.957	rs4861733	chr4:187903933	C/T	cg10295955	chr4:187884368	NA	-1.03	-12.6	-0.82	1.73e-20	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs17345786	0.906	rs11708616	chr3:101231731	C/T	cg11279151	chr3:101281821	RG9MTD1	-0.64	-5.14	-0.5	1.98e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7666738	0.830	rs2903154	chr4:99048151	A/G	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs735396	0.595	rs1169279	chr12:121455873	C/T	cg02403541	chr12:121454288	C12orf43	0.86	8.12	0.68	5.52e-12	N-glycan levels;
SKCM	cis	rs2153535	0.580	rs4404802	chr6:8442052	A/G	cg07606381	chr6:8435919	SLC35B3	0.94	6.94	0.62	1.02e-9	Motion sickness;
SKCM	cis	rs208515	0.525	rs10755508	chr6:66675790	T/C	cg07460842	chr6:66804631	NA	0.92	6.31	0.58	1.56e-8	Exhaled nitric oxide levels;
SKCM	cis	rs9388451	0.874	rs7739566	chr6:126094757	A/T	cg05901451	chr6:126070800	HEY2	-0.74	-6.54	-0.6	5.79e-9	Brugada syndrome;
SKCM	cis	rs10911232	0.507	rs10911206	chr1:183012423	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.64	0.6	3.83e-9	Hypertriglyceridemia;
SKCM	cis	rs362296	0.698	rs3095082	chr4:3263617	C/A	cg24015175	chr4:3319247	RGS12	-0.6	-5.81	-0.55	1.31e-7	Parental longevity (mother's age at death);
SKCM	cis	rs611744	0.647	rs11774904	chr8:109273435	G/A	cg18478394	chr8:109455254	TTC35	0.66	5.27	0.51	1.16e-6	Dupuytren's disease;
SKCM	cis	rs67311347	0.544	rs9864664	chr3:40336226	T/C	cg18306943	chr3:40428807	ENTPD3	0.56	4.8	0.48	7.56e-6	Renal cell carcinoma;
SKCM	trans	rs561341	0.941	rs2428338	chr17:30299629	T/C	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs2197308	0.659	rs11181327	chr12:37903171	C/T	cg26384229	chr12:38710491	ALG10B	-0.76	-6.24	-0.58	2.08e-8	Morning vs. evening chronotype;
SKCM	cis	rs28595532	0.920	rs114649974	chr4:119735341	T/C	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs875971	1.000	rs1183245	chr7:65541185	C/T	cg18876405	chr7:65276391	NA	-0.71	-7.04	-0.62	6.64e-10	Aortic root size;
SKCM	cis	rs35306767	0.807	rs72778228	chr10:938435	A/G	cg20503657	chr10:835505	NA	0.95	6.46	0.59	8.26e-9	Eosinophil percentage of granulocytes;
SKCM	cis	rs2839186	0.933	rs4818832	chr21:47708634	C/T	cg05896524	chr21:47604654	C21orf56	0.69	5.67	0.54	2.29e-7	Testicular germ cell tumor;
SKCM	cis	rs3820928	0.874	rs1949807	chr2:227891861	A/G	cg11843606	chr2:227700838	RHBDD1	-0.6	-5.0	-0.49	3.51e-6	Pulmonary function;
SKCM	cis	rs7937682	0.961	rs17113227	chr11:111620491	A/G	cg09085632	chr11:111637200	PPP2R1B	-1.11	-13.72	-0.84	1.7e-22	Primary sclerosing cholangitis;
SKCM	cis	rs7772486	0.558	rs2142980	chr6:146080679	G/A	cg05347473	chr6:146136440	FBXO30	-0.7	-6.14	-0.57	3.19e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7017252	0.964	rs1372450	chr8:129950399	C/T	cg08633665	chr8:128972829	MIR1205;PVT1	-0.44	-5.12	-0.5	2.12e-6	Nonsyndromic cleft lip with cleft palate;
SKCM	cis	rs6912958	0.515	rs381782	chr6:88040649	C/T	cg08069147	chr6:88032118	GJB7;C6orf162	0.63	5.54	0.53	3.96e-7	Monocyte percentage of white cells;
SKCM	cis	rs908922	0.676	rs12059256	chr1:152515431	G/A	cg09873164	chr1:152488093	CRCT1	0.76	5.93	0.56	7.7e-8	Hair morphology;
SKCM	cis	rs7666738	0.830	rs60994860	chr4:99046753	G/A	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1799949	1.000	rs11653253	chr17:41182662	G/A	cg25918947	chr17:41365094	TMEM106A	-0.61	-5.87	-0.55	1e-7	Menopause (age at onset);
SKCM	cis	rs10193935	0.901	rs871045	chr2:42609431	G/C	cg27598129	chr2:42591480	NA	-0.88	-6.71	-0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6840360	0.530	rs6839802	chr4:152485834	G/A	cg22705602	chr4:152727874	NA	-0.5	-5.38	-0.52	7.49e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs208520	1.000	rs72880045	chr6:66965232	A/C	cg07460842	chr6:66804631	NA	0.84	5.89	0.55	9.44e-8	Exhaled nitric oxide output;
SKCM	cis	rs992157	0.835	rs2292555	chr2:219146882	G/C	cg00012203	chr2:219082015	ARPC2	-0.72	-5.71	-0.54	1.99e-7	Colorectal cancer;
SKCM	cis	rs1552244	0.882	rs3755782	chr3:10029305	T/C	cg02579736	chr3:10068473	FANCD2;CIDECP	0.94	4.84	0.48	6.49e-6	Alzheimer's disease;
SKCM	cis	rs7945705	0.935	rs10769971	chr11:8925276	C/T	cg13070366	chr11:9386451	NA	-0.65	-5.57	-0.53	3.47e-7	Hemoglobin concentration;
SKCM	cis	rs4523957	0.523	rs2760746	chr17:2034806	G/C	cg16513277	chr17:2031491	SMG6	-0.91	-6.21	-0.58	2.38e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs8180040	0.620	rs11720139	chr3:47036756	C/G	cg27129171	chr3:47204927	SETD2	-0.73	-5.25	-0.51	1.29e-6	Colorectal cancer;
SKCM	cis	rs10927875	0.619	rs2102664	chr1:16130169	A/G	cg21385522	chr1:16154831	NA	-0.74	-7.18	-0.63	3.55e-10	Dilated cardiomyopathy;
SKCM	cis	rs1003719	0.713	rs7277150	chr21:38490006	T/C	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs9325144	0.555	rs2387855	chr12:38687964	T/G	cg13010199	chr12:38710504	ALG10B	0.63	5.01	0.49	3.31e-6	Morning vs. evening chronotype;
SKCM	cis	rs8180040	0.966	rs2062278	chr3:47416761	C/T	cg27129171	chr3:47204927	SETD2	0.81	6.08	0.57	4.19e-8	Colorectal cancer;
SKCM	cis	rs5769765	0.862	rs138856	chr22:50199378	G/T	cg22709217	chr22:50311962	ALG12;CRELD2	-0.83	-5.74	-0.55	1.71e-7	Schizophrenia;
SKCM	cis	rs17826219	0.636	rs4055314	chr17:29079769	T/C	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Body mass index;
SKCM	cis	rs362296	0.661	rs3095078	chr4:3265479	C/T	cg09735869	chr4:3319127	RGS12	-0.68	-5.76	-0.55	1.58e-7	Parental longevity (mother's age at death);
SKCM	cis	rs34779708	1.000	rs12769189	chr10:35399668	A/G	cg03585969	chr10:35415529	CREM	0.82	6.49	0.59	7.27e-9	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs67311347	0.544	rs13098483	chr3:40342743	G/C	cg18306943	chr3:40428807	ENTPD3	0.56	4.8	0.48	7.38e-6	Renal cell carcinoma;
SKCM	cis	rs7726839	0.540	rs3749615	chr5:601485	C/T	cg10555297	chr5:473380	SLC9A3;LOC25845	1.02	5.02	0.49	3.19e-6	Obesity-related traits;
SKCM	cis	rs9916302	0.904	rs8066704	chr17:37477218	C/T	cg07936489	chr17:37558343	FBXL20	0.84	6.75	0.61	2.32e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs28386778	0.897	rs2028567	chr17:61915326	G/A	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs12824058	0.831	rs11608407	chr12:130805869	G/A	cg24838063	chr12:130822603	PIWIL1	0.78	6.74	0.61	2.43e-9	Menopause (age at onset);
SKCM	cis	rs2228479	0.717	rs2286392	chr16:89809549	A/G	cg06558623	chr16:89946397	TCF25	1.11	6.06	0.57	4.5e-8	Skin colour saturation;
SKCM	cis	rs6591182	0.504	rs7130955	chr11:65372580	C/T	cg27068330	chr11:65405492	SIPA1	-0.71	-5.34	-0.52	8.93e-7	Non-alcoholic fatty liver disease histology (lobular);
SKCM	cis	rs7829975	0.667	rs1877119	chr8:8707197	C/G	cg15556689	chr8:8085844	FLJ10661	0.68	6.01	0.56	5.68e-8	Mood instability;
SKCM	cis	rs35306767	0.903	rs12250936	chr10:870109	C/T	cg20503657	chr10:835505	NA	0.75	5.43	0.52	6.09e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs854765	0.547	rs28537385	chr17:17902135	G/A	cg04398451	chr17:18023971	MYO15A	-0.97	-7.59	-0.65	5.89e-11	Total body bone mineral density;
SKCM	cis	rs1218582	0.772	rs906593	chr1:154885255	G/A	cg16680214	chr1:154839983	KCNN3	-0.56	-5.01	-0.49	3.29e-6	Prostate cancer;
SKCM	cis	rs1218582	0.741	rs883718	chr1:154846274	C/T	cg03351412	chr1:154909251	PMVK	0.79	6.91	0.62	1.15e-9	Prostate cancer;
SKCM	cis	rs9858542	1.000	rs1131095	chr3:49714225	T/C	cg03060546	chr3:49711283	APEH	-0.73	-5.45	-0.53	5.73e-7	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs11098499	0.954	rs12499324	chr4:120393786	C/T	cg24375607	chr4:120327624	NA	0.66	5.09	0.5	2.44e-6	Corneal astigmatism;
SKCM	cis	rs10871290	0.881	rs4099290	chr16:74468889	A/G	cg01733217	chr16:74700730	RFWD3	-0.7	-5.18	-0.51	1.7e-6	Breast cancer;
SKCM	cis	rs7216064	1.000	rs12451721	chr17:65939075	G/A	cg12091567	chr17:66097778	LOC651250	-0.75	-4.97	-0.49	3.81e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs826838	0.620	rs11614695	chr12:39331847	C/T	cg13010199	chr12:38710504	ALG10B	0.67	4.98	0.49	3.76e-6	Heart rate;
SKCM	cis	rs2153535	0.580	rs9328478	chr6:8519183	A/G	cg07606381	chr6:8435919	SLC35B3	0.87	6.38	0.59	1.17e-8	Motion sickness;
SKCM	cis	rs10256972	0.680	rs7784708	chr7:1003049	A/G	cg07930192	chr7:1003750	NA	0.54	5.41	0.52	6.73e-7	Longevity;Endometriosis;
SKCM	cis	rs9902453	0.791	rs28492945	chr17:28223982	T/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.82	6.42	0.59	9.65e-9	Coffee consumption (cups per day);
SKCM	cis	rs7772486	0.806	rs2247317	chr6:146217570	C/T	cg05347473	chr6:146136440	FBXO30	0.55	5.13	0.5	2.07e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7666738	0.830	rs4401456	chr4:98959902	C/T	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs763121	0.853	rs5757234	chr22:39072686	C/T	cg06022373	chr22:39101656	GTPBP1	0.89	6.48	0.59	7.47e-9	Menopause (age at onset);
SKCM	cis	rs17685	0.753	rs2108274	chr7:75781636	C/A	cg16489192	chr7:75678113	MDH2;STYXL1	-0.56	-5.23	-0.51	1.36e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs992157	0.804	rs7559525	chr2:219150307	A/G	cg20019365	chr2:219134978	PNKD;AAMP	-0.71	-6.08	-0.57	4.22e-8	Colorectal cancer;
SKCM	cis	rs208520	1.000	rs208523	chr6:66954195	G/C	cg07460842	chr6:66804631	NA	-0.84	-5.89	-0.55	9.44e-8	Exhaled nitric oxide output;
SKCM	cis	rs4148883	0.628	rs34195655	chr4:100073795	C/T	cg12011299	chr4:100065546	ADH4	0.48	4.78	0.48	8.14e-6	Alcohol dependence;
SKCM	cis	rs2404602	0.692	rs2137307	chr15:77149020	T/A	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs116095464	0.558	rs6879656	chr5:264428	T/C	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs1552244	1.000	rs6442146	chr3:10073544	C/T	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs9325144	0.671	rs35817541	chr12:38975001	T/C	cg13010199	chr12:38710504	ALG10B	-0.63	-5.33	-0.52	9.43e-7	Morning vs. evening chronotype;
SKCM	cis	rs4808199	0.842	rs11085259	chr19:19445856	C/T	cg03709012	chr19:19516395	GATAD2A	1.08	7.53	0.65	7.65e-11	Nonalcoholic fatty liver disease;
SKCM	cis	rs57221529	0.766	rs12521988	chr5:556421	C/T	cg26208419	chr5:473447	SLC9A3;LOC25845	0.96	4.9	0.49	5.03e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs71520386	0.632	rs10269414	chr7:22856293	G/A	cg00309339	chr7:22893653	NA	0.66	4.92	0.49	4.76e-6	Fibrinogen levels;
SKCM	cis	rs9325144	0.510	rs7952795	chr12:38720686	C/T	cg26384229	chr12:38710491	ALG10B	0.78	6.71	0.61	2.77e-9	Morning vs. evening chronotype;
SKCM	cis	rs9467773	0.620	rs2451732	chr6:26622904	A/T	cg09904177	chr6:26538194	HMGN4	-0.56	-4.91	-0.49	4.9e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs4237845	0.780	rs3751331	chr12:58290278	G/A	cg02175503	chr12:58329896	NA	0.71	6.14	0.57	3.28e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs7829975	0.714	rs11784052	chr8:8671962	C/T	cg06636001	chr8:8085503	FLJ10661	0.71	6.32	0.58	1.49e-8	Mood instability;
SKCM	cis	rs2439831	0.867	rs28415933	chr15:43635800	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.39	9.42	0.73	1.62e-14	Lung cancer in ever smokers;
SKCM	cis	rs9880211	0.606	rs28576629	chr3:135773661	G/T	cg21827317	chr3:136751795	NA	-0.7	-4.97	-0.49	3.91e-6	Body mass index;Height;
SKCM	cis	rs13064447	0.967	rs9873195	chr3:12767936	A/G	cg05775895	chr3:12838266	CAND2	-0.64	-5.42	-0.52	6.49e-7	Major depression and alcohol dependence;
SKCM	cis	rs9902453	0.765	rs2264302	chr17:28057095	G/A	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.79	-5.93	-0.56	7.67e-8	Coffee consumption (cups per day);
SKCM	cis	rs1568889	0.838	rs7121937	chr11:28359858	A/G	cg06544937	chr11:28130018	METT5D1;KIF18A	0.89	8.44	0.69	1.31e-12	Bipolar disorder;
SKCM	cis	rs5753618	0.504	rs9609303	chr22:31896309	C/T	cg02404636	chr22:31891804	SFI1	0.68	6.07	0.57	4.32e-8	Colorectal cancer;
SKCM	cis	rs636523	0.561	rs11208010	chr1:63203221	T/C	cg06896770	chr1:63153194	DOCK7	0.8	5.08	0.5	2.56e-6	Lipid traits;
SKCM	cis	rs35306767	0.953	rs12357633	chr10:957246	C/T	cg20503657	chr10:835505	NA	0.75	5.83	0.55	1.19e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs933688	1.000	rs186717	chr5:90780467	T/A	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.87	6.21	0.58	2.36e-8	Smoking behavior;
SKCM	cis	rs478304	0.654	rs7947604	chr11:65442059	G/C	cg27068330	chr11:65405492	SIPA1	-0.87	-7.38	-0.64	1.47e-10	Acne (severe);
SKCM	cis	rs6121246	0.512	rs6058384	chr20:30276409	A/T	cg11595048	chr20:30225325	COX4I2	0.54	4.77	0.48	8.4e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs1005277	0.540	rs2224248	chr10:38451886	A/G	cg00409905	chr10:38381863	ZNF37A	-0.67	-6.21	-0.58	2.41e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs9858542	0.953	rs11715915	chr3:49455330	A/G	cg03060546	chr3:49711283	APEH	0.79	5.92	0.56	8.31e-8	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs6570726	0.935	rs365658	chr6:145844588	C/T	cg23711669	chr6:146136114	FBXO30	0.69	6.39	0.59	1.1e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs28386778	0.700	rs11079515	chr17:62005645	C/G	cg23090583	chr17:61904693	PSMC5;FTSJ3	-0.78	-6.5	-0.59	6.86e-9	Prudent dietary pattern;
SKCM	cis	rs7296418	0.699	rs11057254	chr12:123794581	A/C	cg00376283	chr12:123451042	ABCB9	0.82	6.54	0.6	5.78e-9	Platelet count;
SKCM	cis	rs57221529	0.766	rs12519469	chr5:581772	A/G	cg09888920	chr5:474111	LOC25845;SLC9A3	0.99	4.79	0.48	7.91e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs6570726	0.791	rs365869	chr6:145884751	C/T	cg05347473	chr6:146136440	FBXO30	0.57	5.13	0.5	2.06e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs875971	0.862	rs10224872	chr7:65759773	T/A	cg11764359	chr7:65958608	NA	-0.81	-7.63	-0.65	4.79e-11	Aortic root size;
SKCM	cis	rs10504229	0.683	rs7822631	chr8:58130916	C/G	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs72634258	0.945	rs225120	chr1:8046378	C/T	cg00042356	chr1:8021962	PARK7	0.91	6.19	0.57	2.58e-8	Inflammatory bowel disease;
SKCM	cis	rs7937682	0.889	rs2850247	chr11:111637202	C/A	cg09085632	chr11:111637200	PPP2R1B	1.13	15.06	0.86	8.45e-25	Primary sclerosing cholangitis;
SKCM	cis	rs10751667	0.643	rs7394436	chr11:970373	G/C	cg10932868	chr11:921992	NA	0.55	5.1	0.5	2.36e-6	Alzheimer's disease (late onset);
SKCM	cis	rs4664308	0.967	rs17831329	chr2:160915819	T/C	cg03641300	chr2:160917029	PLA2R1	-0.63	-4.81	-0.48	7.36e-6	Idiopathic membranous nephropathy;
SKCM	cis	rs34779708	0.931	rs12767414	chr10:35390193	C/T	cg03585969	chr10:35415529	CREM	0.78	6.22	0.58	2.28e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs7666738	0.830	rs12233741	chr4:98950296	C/T	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10779751	0.770	rs11121695	chr1:11229515	G/A	cg08854313	chr1:11322531	MTOR	-0.75	-4.85	-0.48	6.25e-6	Body mass index;
SKCM	cis	rs11638352	1.000	rs8037441	chr15:44311916	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	-1.25	-4.88	-0.48	5.56e-6	Lipoprotein phospholipase A2 activity in cardiovascular disease;
SKCM	cis	rs763014	0.898	rs4984894	chr16:623103	T/C	cg07343612	chr16:622815	PIGQ	-0.69	-5.73	-0.54	1.84e-7	Height;
SKCM	cis	rs4481887	1.000	rs6681423	chr1:248482834	C/A	cg00666640	chr1:248458726	OR2T12	0.64	5.69	0.54	2.13e-7	Common traits (Other);
SKCM	cis	rs10504229	0.683	rs56208052	chr8:58130207	A/T	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs17685	0.753	rs1859791	chr7:75786043	T/C	cg01364799	chr7:75623366	TMEM120A	-0.69	-5.59	-0.53	3.22e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2228479	0.764	rs35518096	chr16:89961140	C/A	cg06558623	chr16:89946397	TCF25	1.27	7.17	0.63	3.78e-10	Skin colour saturation;
SKCM	cis	rs7208859	0.623	rs73269974	chr17:29112384	C/T	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs7666738	0.716	rs11721453	chr4:99045485	G/T	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs8180040	0.903	rs13094438	chr3:47277885	G/A	cg16586182	chr3:47516702	SCAP	-0.72	-4.98	-0.49	3.73e-6	Colorectal cancer;
SKCM	trans	rs1814175	0.616	rs6486011	chr11:49740230	C/T	cg03929089	chr4:120376271	NA	-0.85	-7.61	-0.65	5.27e-11	Height;
SKCM	cis	rs2197308	0.765	rs7295711	chr12:37903631	C/T	cg13010199	chr12:38710504	ALG10B	0.65	4.93	0.49	4.48e-6	Morning vs. evening chronotype;
SKCM	cis	rs1499614	0.803	rs1922723	chr7:66175063	C/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Gout;
SKCM	cis	rs9633740	1.000	rs6586028	chr10:82253984	C/T	cg01528321	chr10:82214614	TSPAN14	0.87	6.65	0.6	3.6e-9	Post bronchodilator FEV1;
SKCM	cis	rs2153535	0.601	rs4960414	chr6:8438541	A/G	cg07606381	chr6:8435919	SLC35B3	0.94	6.94	0.62	1.02e-9	Motion sickness;
SKCM	cis	rs1577917	0.876	rs4618490	chr6:86518403	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.83	-0.66	2e-11	Response to antipsychotic treatment;
SKCM	cis	rs1799949	1.000	rs67060599	chr17:41255102	A/G	cg23758822	chr17:41437982	NA	0.9	7.48	0.65	9.38e-11	Menopause (age at onset);
SKCM	cis	rs6138458	0.962	rs6036976	chr20:24901567	T/G	cg26195577	chr20:24973756	C20orf3	-1.22	-8.58	-0.7	7.01e-13	Blood protein levels;
SKCM	cis	rs709400	1.000	rs709400	chr14:104149475	A/G	cg26031613	chr14:104095156	KLC1	1.05	12.89	0.82	5.14e-21	Body mass index;
SKCM	cis	rs3820928	0.874	rs7576081	chr2:227843634	C/G	cg11843606	chr2:227700838	RHBDD1	-0.61	-4.9	-0.49	5.12e-6	Pulmonary function;
SKCM	cis	rs17376456	0.825	rs6865441	chr5:93284746	G/A	cg25358565	chr5:93447407	FAM172A	1.31	7.46	0.65	1.04e-10	Diabetic retinopathy;
SKCM	cis	rs11139399	0.602	rs922982	chr9:84348195	G/C	cg13729285	chr9:84764156	NA	0.47	4.87	0.48	5.63e-6	Hippocampal atrophy;
SKCM	cis	rs4819052	0.679	rs2838860	chr21:46684904	A/G	cg02159808	chr21:46707872	POFUT2;LOC642852	0.65	4.95	0.49	4.26e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs12709013	0.792	rs1646290	chr16:58789711	A/G	cg02431531	chr16:59244939	NA	0.49	5.13	0.5	2.07e-6	Blood metabolite ratios;
SKCM	cis	rs9300255	0.679	rs58809476	chr12:123724880	C/T	cg00376283	chr12:123451042	ABCB9	-0.85	-5.86	-0.55	1.03e-7	Neutrophil percentage of white cells;
SKCM	cis	rs950027	0.584	rs1145086	chr15:45654327	A/G	cg10760299	chr15:45669010	GATM	0.57	5.71	0.54	1.99e-7	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs4819052	0.959	rs8130866	chr21:46672112	G/A	cg02159808	chr21:46707872	POFUT2;LOC642852	0.79	5.87	0.55	1.01e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs9902453	0.967	rs8082175	chr17:28430303	C/A	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.5	0.53	4.67e-7	Coffee consumption (cups per day);
SKCM	cis	rs2836974	0.897	rs2836944	chr21:40593539	G/A	cg17971929	chr21:40555470	PSMG1	0.9	8.81	0.71	2.52e-13	Cognitive function;
SKCM	trans	rs6951643	0.967	rs6969572	chr7:126385589	A/G	cg26792900	chr1:167074894	DUSP27	-0.6	-7.31	-0.64	2e-10	Creutzfeldt-Jakob disease (sporadic);
SKCM	cis	rs9911578	1.000	rs2531729	chr17:56539890	C/T	cg12560992	chr17:57184187	TRIM37	0.92	7.26	0.64	2.5e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs1577917	0.655	rs9359658	chr6:86305769	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.75	6.74	0.61	2.43e-9	Response to antipsychotic treatment;
SKCM	cis	rs34779708	0.966	rs1478463	chr10:35473035	G/A	cg03585969	chr10:35415529	CREM	0.76	6.27	0.58	1.83e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs11098499	0.954	rs13133522	chr4:120324424	A/T	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs3768617	0.510	rs2224933	chr1:183095765	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs798554	0.642	rs2533871	chr7:2883006	C/G	cg04166393	chr7:2884313	GNA12	0.8	5.35	0.52	8.45e-7	Height;
SKCM	cis	rs7552404	0.883	rs2185436	chr1:76203783	A/G	cg10523679	chr1:76189770	ACADM	0.69	5.07	0.5	2.67e-6	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs9902453	0.967	rs1906451	chr17:28515479	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.74	5.39	0.52	7.2e-7	Coffee consumption (cups per day);
SKCM	cis	rs3784262	0.669	rs3784257	chr15:58262974	C/T	cg12031962	chr15:58353849	ALDH1A2	0.43	5.15	0.5	1.87e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs58688157	0.705	rs936469	chr11:606749	G/A	cg17114584	chr11:613792	IRF7	0.8	5.62	0.54	2.88e-7	Systemic lupus erythematosus;
SKCM	cis	rs847649	0.692	rs1541519	chr7:102466741	G/T	cg18108683	chr7:102477205	FBXL13	-0.83	-8.98	-0.71	1.2e-13	Morning vs. evening chronotype;
SKCM	cis	rs9902453	1.000	rs9890886	chr17:28391076	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.81	-5.78	-0.55	1.45e-7	Coffee consumption (cups per day);
SKCM	cis	rs7772486	0.875	rs7767660	chr6:146436550	T/C	cg23711669	chr6:146136114	FBXO30	0.76	7.49	0.65	8.96e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9435341	0.930	rs12408634	chr1:107579540	G/A	cg09367891	chr1:107599246	PRMT6	0.84	7.05	0.62	6.33e-10	Facial morphology (factor 21, depth of nasal alae);
SKCM	cis	rs11098499	0.604	rs17051352	chr4:120581427	G/A	cg24375607	chr4:120327624	NA	0.67	5.19	0.51	1.6e-6	Corneal astigmatism;
SKCM	cis	rs7932354	0.528	rs11039105	chr11:47157677	A/T	cg03339077	chr11:47165057	C11orf49	0.61	5.27	0.51	1.16e-6	Bone mineral density (hip);Bone mineral density;
SKCM	cis	rs9926296	0.529	rs7195906	chr16:89806347	A/T	cg27121462	chr16:89883253	FANCA	0.82	8.05	0.67	7.39e-12	Vitiligo;
SKCM	cis	rs9921222	0.597	rs3848369	chr16:415078	C/T	cg12437481	chr16:420112	MRPL28	-0.66	-5.64	-0.54	2.65e-7	Bone mineral density (spine);Bone mineral density;
SKCM	cis	rs7666738	0.830	rs28522896	chr4:99008243	C/T	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1801251	1.000	rs4973054	chr2:233710713	G/C	cg25237894	chr2:233734115	C2orf82	-0.61	-5.9	-0.56	8.76e-8	Coronary artery disease;
SKCM	cis	rs208520	0.661	rs1776361	chr6:66822270	G/A	cg07460842	chr6:66804631	NA	-1.02	-8.16	-0.68	4.58e-12	Exhaled nitric oxide output;
SKCM	cis	rs7523273	1.000	rs12410786	chr1:207976205	T/A	cg22525895	chr1:207977042	MIR29B2	-0.8	-5.96	-0.56	6.91e-8	Schizophrenia;
SKCM	cis	rs3845702	0.736	rs72958863	chr2:180808144	C/T	cg01881094	chr2:180872142	CWC22	1.3	6.15	0.57	3.07e-8	Schizophrenia;
SKCM	cis	rs10751667	0.666	rs7395267	chr11:962326	C/A	cg10932868	chr11:921992	NA	0.55	5.1	0.5	2.36e-6	Alzheimer's disease (late onset);
SKCM	cis	rs9435341	0.965	rs1730859	chr1:107617707	A/G	cg09367891	chr1:107599246	PRMT6	0.77	6.23	0.58	2.21e-8	Facial morphology (factor 21, depth of nasal alae);
SKCM	cis	rs507080	0.922	rs516153	chr11:118564762	C/A	cg18045108	chr11:118530628	TREH	-0.47	-4.81	-0.48	7.17e-6	Serum metabolite levels;
SKCM	cis	rs1707322	0.964	rs6697830	chr1:46290477	C/A	cg03146154	chr1:46216737	IPP	0.75	5.15	0.5	1.94e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs1153858	1.000	rs2066090	chr15:45650018	T/C	cg10760299	chr15:45669010	GATM	0.62	6.35	0.58	1.3e-8	Homoarginine levels;
SKCM	cis	rs9303401	0.659	rs12946852	chr17:57013337	G/C	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.35	0.52	8.54e-7	Cognitive test performance;
SKCM	cis	rs4268898	0.560	rs78711174	chr2:24496531	G/A	cg06627628	chr2:24431161	ITSN2	-0.91	-6.65	-0.6	3.65e-9	Asthma;
SKCM	cis	rs7424096	0.613	rs72873859	chr2:37246738	T/G	cg14987922	chr2:37194071	STRN	0.85	5.34	0.52	9.03e-7	High light scatter reticulocyte percentage of red cells;
SKCM	cis	rs701145	0.938	rs701133	chr3:154070312	A/G	cg17054900	chr3:154042577	DHX36	0.92	5.12	0.5	2.11e-6	Coronary artery disease;
SKCM	cis	rs9926296	0.605	rs886951	chr16:89836865	A/G	cg26513180	chr16:89883248	FANCA	0.94	9.97	0.75	1.44e-15	Vitiligo;
SKCM	trans	rs1814175	0.616	rs10839341	chr11:49742615	G/A	cg15704280	chr7:45808275	SEPT13	-0.97	-9.35	-0.73	2.25e-14	Height;
SKCM	cis	rs7666738	0.753	rs7657644	chr4:99057734	T/A	cg17366294	chr4:99064904	C4orf37	0.61	4.93	0.49	4.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs3820068	0.581	rs72645874	chr1:15926238	C/G	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs459571	0.876	rs2520095	chr9:136919568	A/G	cg13789015	chr9:136890014	NCRNA00094	0.73	6.35	0.58	1.31e-8	Platelet distribution width;
SKCM	cis	rs561341	1.000	rs473356	chr17:30321762	G/C	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs7937682	0.847	rs500163	chr11:111462649	T/G	cg09085632	chr11:111637200	PPP2R1B	-1.0	-8.74	-0.7	3.47e-13	Primary sclerosing cholangitis;
SKCM	cis	rs11098499	0.697	rs10020027	chr4:120381879	G/C	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs875971	0.862	rs9791713	chr7:66105198	C/A	cg11764359	chr7:65958608	NA	-0.74	-6.63	-0.6	3.89e-9	Aortic root size;
SKCM	cis	rs6500395	0.962	rs9921737	chr16:48589873	G/T	cg04672837	chr16:48644449	N4BP1	0.69	5.73	0.54	1.8e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs2204008	0.805	rs3863360	chr12:37966432	C/T	cg26384229	chr12:38710491	ALG10B	0.78	6.42	0.59	9.98e-9	Bladder cancer;
SKCM	cis	rs3829251	0.786	rs7103591	chr11:71237619	T/C	cg05163923	chr11:71159392	DHCR7	-0.71	-5.03	-0.49	3.07e-6	Vitamin D levels;
SKCM	cis	rs11892454	0.544	rs13382805	chr2:25997569	G/A	cg17263061	chr2:26915892	KCNK3	0.71	5.15	0.5	1.88e-6	Heschl's gyrus morphology;
SKCM	cis	rs514406	0.683	rs10157120	chr1:53210888	A/G	cg24675658	chr1:53192096	ZYG11B	-0.63	-5.08	-0.5	2.47e-6	Monocyte count;
SKCM	cis	rs35306767	0.761	rs12359796	chr10:1021479	G/C	cg26597838	chr10:835615	NA	0.76	6.22	0.58	2.29e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs4234284	1.000	rs11925520	chr3:126949354	C/T	cg04889221	chr3:126137216	CCDC37	0.45	4.78	0.48	8.07e-6	Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel);
SKCM	cis	rs9910055	0.659	rs8079310	chr17:42270291	A/G	cg08499158	chr17:42289980	UBTF	-0.73	-6.36	-0.58	1.29e-8	Total body bone mineral density;
SKCM	trans	rs1814175	0.817	rs1851860	chr11:49861310	A/C	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs763121	0.819	rs6001205	chr22:39100264	T/A	cg06022373	chr22:39101656	GTPBP1	0.78	5.59	0.53	3.27e-7	Menopause (age at onset);
SKCM	cis	rs9911578	1.000	rs1472288	chr17:56910720	G/A	cg12560992	chr17:57184187	TRIM37	0.94	7.55	0.65	7.01e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs7772486	0.719	rs702317	chr6:146005010	C/T	cg05347473	chr6:146136440	FBXO30	-0.65	-6.0	-0.56	5.94e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs3768617	0.510	rs12086466	chr1:183075778	C/T	ch.1.3577855R	chr1:183094577	LAMC1	-0.77	-7.1	-0.63	5e-10	Fuchs's corneal dystrophy;
SKCM	cis	rs1801516	0.950	rs12289561	chr11:108309656	G/C	cg03165700	chr11:108093220	ATM;NPAT	-1.1	-5.13	-0.5	2.03e-6	Melanoma;
SKCM	cis	rs2019137	0.560	rs7421852	chr2:113990261	G/A	cg11763394	chr2:113992921	PAX8;LOC440839;LOC654433	0.61	4.9	0.48	5.16e-6	Lymphocyte counts;
SKCM	cis	rs589448	0.535	rs12423794	chr12:69713018	G/A	cg20891283	chr12:69753455	YEATS4	0.84	7.71	0.66	3.4e-11	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs10752881	1.000	rs10737237	chr1:182989269	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.65	0.6	3.65e-9	Colorectal cancer;
SKCM	cis	rs4819052	0.851	rs8133045	chr21:46658137	A/G	cg19498844	chr21:46707878	POFUT2;LOC642852	0.84	6.96	0.62	9.53e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs4891159	0.790	rs7241485	chr18:74122325	C/T	cg24786174	chr18:74118243	ZNF516	-0.74	-7.05	-0.62	6.2e-10	Longevity;
SKCM	cis	rs854765	0.583	rs66531105	chr17:17809001	C/T	cg04398451	chr17:18023971	MYO15A	-0.85	-6.04	-0.56	5.02e-8	Total body bone mineral density;
SKCM	cis	rs748404	0.631	rs7167882	chr15:43678663	A/C	cg02155558	chr15:43621948	ADAL;LCMT2	0.8	6.08	0.57	4.11e-8	Lung cancer;
SKCM	cis	rs1003719	0.788	rs2835586	chr21:38461326	G/A	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs829883	0.934	rs249814	chr12:98892964	A/G	cg25150519	chr12:98850993	NA	0.5	5.3	0.51	1.07e-6	Colorectal adenoma (advanced);
SKCM	cis	rs6565180	0.926	rs8046445	chr16:30386262	A/G	cg17640201	chr16:30407289	ZNF48	-0.99	-8.38	-0.69	1.7e-12	Tonsillectomy;
SKCM	cis	rs17361889	0.727	rs61282805	chr7:16276606	A/C	cg09714114	chr7:16439993	ISPD	0.5	5.1	0.5	2.29e-6	Pediatric bone mineral content (hip);
SKCM	cis	rs6120849	0.754	rs8501	chr20:33590584	T/C	cg24642439	chr20:33292090	TP53INP2	0.94	4.86	0.48	5.91e-6	Protein C levels;
SKCM	cis	rs9910055	0.550	rs113844752	chr17:42297631	C/A	cg19774624	chr17:42201019	HDAC5	-0.75	-5.89	-0.56	9.12e-8	Total body bone mineral density;
SKCM	cis	rs3793683	0.556	rs2803989	chr10:134560596	C/T	cg27286337	chr10:134555280	INPP5A	0.92	8.88	0.71	1.83e-13	Migraine;
SKCM	cis	rs867186	0.920	rs75383229	chr20:33613651	T/C	cg04194272	chr20:33683537	NA	-1.38	-7.2	-0.63	3.29e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs951366	0.789	rs864783	chr1:205711974	T/C	cg14893161	chr1:205819251	PM20D1	1.04	9.81	0.74	2.9e-15	Menarche (age at onset);
SKCM	cis	rs4925386	1.000	rs2151512	chr20:60913495	T/C	cg24112000	chr20:60950667	NA	0.62	5.94	0.56	7.62e-8	Colorectal cancer;Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs778371	1.000	rs11535	chr2:233743532	G/C	cg08000102	chr2:233561755	GIGYF2	-0.84	-6.1	-0.57	3.8e-8	Schizophrenia;
SKCM	cis	rs1707322	0.721	rs6699418	chr1:46100181	G/A	cg03146154	chr1:46216737	IPP	0.82	6.1	0.57	3.89e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	trans	rs1814175	0.645	rs1721996	chr11:49915527	G/A	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs67311347	0.713	rs9861194	chr3:40309225	C/T	cg00091569	chr3:40428383	ENTPD3	0.64	5.46	0.53	5.4e-7	Renal cell carcinoma;
SKCM	cis	rs10504229	1.000	rs57941207	chr8:58169821	A/G	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs6951245	1.000	rs74652290	chr7:1090109	G/A	cg18402987	chr7:1209562	NA	1.14	6.01	0.56	5.68e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs13118159	0.550	rs10016557	chr4:1363628	C/T	cg19318889	chr4:1322082	MAEA	-0.7	-5.03	-0.49	3.12e-6	Longevity;
SKCM	cis	rs2120019	1.000	rs2120019	chr15:75334184	T/C	cg09165964	chr15:75287851	SCAMP5	-0.82	-7.72	-0.66	3.24e-11	Blood trace element (Zn levels);
SKCM	cis	rs62238980	0.614	rs79045014	chr22:32509595	C/T	cg00543991	chr22:32367038	NA	1.17	4.81	0.48	7.24e-6	Childhood ear infection;
SKCM	cis	rs6582630	0.502	rs8186661	chr12:38380781	G/A	cg13010199	chr12:38710504	ALG10B	0.69	4.89	0.48	5.2e-6	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs6088580	0.634	rs6088498	chr20:33020446	A/G	cg24642439	chr20:33292090	TP53INP2	0.7	5.68	0.54	2.21e-7	Glomerular filtration rate (creatinine);
SKCM	cis	rs654950	0.776	rs2759254	chr1:42035683	G/C	cg06885757	chr1:42089581	HIVEP3	-0.62	-6.23	-0.58	2.23e-8	Airway imaging phenotypes;
SKCM	cis	rs9914544	1.000	rs1037036	chr17:18764077	C/T	cg26306683	chr17:18585705	ZNF286B	0.73	5.42	0.52	6.53e-7	Educational attainment (years of education);
SKCM	cis	rs9322193	0.543	rs9371533	chr6:150210681	G/A	cg05036130	chr6:150231994	NA	0.6	6.54	0.6	5.76e-9	Lung cancer;
SKCM	cis	rs867186	0.920	rs8119351	chr20:33754405	G/A	cg04194272	chr20:33683537	NA	-1.06	-5.72	-0.54	1.86e-7	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs34065801	0.545	rs1936004	chr13:36521433	T/G	cg09605634	chr13:36521538	DCLK1	-0.8	-5.53	-0.53	4.16e-7	Breast size;
SKCM	cis	rs992157	0.710	rs10169718	chr2:219103580	C/T	cg20019365	chr2:219134978	PNKD;AAMP	-0.72	-6.31	-0.58	1.53e-8	Colorectal cancer;
SKCM	trans	rs7819412	0.806	rs2409689	chr8:10932868	A/G	cg06636001	chr8:8085503	FLJ10661	-0.87	-7.64	-0.65	4.66e-11	Triglycerides;
SKCM	cis	rs999943	0.846	rs10947422	chr6:33611351	G/A	cg14003231	chr6:33640908	ITPR3	0.67	6.11	0.57	3.64e-8	Obesity (extreme);
SKCM	cis	rs7666738	0.830	rs13115356	chr4:98933171	T/C	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9311474	0.508	rs12629701	chr3:52619836	T/C	cg18404041	chr3:52824283	ITIH1	-0.53	-4.77	-0.48	8.42e-6	Electroencephalogram traits;
SKCM	cis	rs7666738	0.606	rs4699611	chr4:99097492	T/G	cg05340658	chr4:99064831	C4orf37	0.62	4.77	0.47	8.51e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2204008	0.592	rs2320501	chr12:38145285	T/G	cg26384229	chr12:38710491	ALG10B	0.8	6.62	0.6	4.11e-9	Bladder cancer;
SKCM	cis	rs2204008	0.536	rs12368354	chr12:38042798	G/A	cg13010199	chr12:38710504	ALG10B	0.66	4.96	0.49	3.96e-6	Bladder cancer;
SKCM	cis	rs9911578	0.902	rs12948746	chr17:57071892	A/G	cg05425664	chr17:57184151	TRIM37	-0.84	-6.94	-0.62	1.03e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs1552244	0.748	rs113890152	chr3:10085986	A/G	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs1878931	0.582	rs27225	chr16:3428060	G/A	cg26668626	chr16:3451006	ZNF174;ZNF434	-0.78	-5.55	-0.53	3.73e-7	Body mass index (adult);
SKCM	cis	rs17688076	0.511	rs2418738	chr16:68122604	G/C	cg09117114	chr16:67998030	SLC12A4	-0.81	-5.29	-0.51	1.07e-6	C-reactive protein levels or HDL-cholesterol levels (pleiotropy);
SKCM	cis	rs6942756	1.000	rs11763056	chr7:128960871	C/A	cg02491457	chr7:128862824	NA	-0.86	-5.48	-0.53	5.11e-7	White matter hyperintensity burden;
SKCM	cis	rs5769765	0.862	rs9616392	chr22:50314705	G/A	cg22709217	chr22:50311962	ALG12;CRELD2	-0.96	-6.08	-0.57	4.21e-8	Schizophrenia;
SKCM	cis	rs4555082	0.957	rs3000073	chr14:105729792	G/A	cg13114125	chr14:105738426	BRF1	-0.73	-5.66	-0.54	2.41e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs4689592	0.587	rs6825954	chr4:7074226	T/C	cg19539972	chr4:7069911	GRPEL1	0.97	6.64	0.6	3.81e-9	Monocyte percentage of white cells;
SKCM	cis	rs11098499	0.697	rs35280960	chr4:120257059	G/A	cg09307838	chr4:120376055	NA	0.93	7.19	0.63	3.42e-10	Corneal astigmatism;
SKCM	cis	rs7772486	0.902	rs2748500	chr6:146314852	C/A	cg23711669	chr6:146136114	FBXO30	0.76	6.98	0.62	8.75e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7666738	0.861	rs10018654	chr4:99002226	A/G	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs28386778	0.897	rs2854208	chr17:61946885	C/T	cg22520471	chr17:61851767	DDX42;CCDC47	0.79	5.33	0.52	9.36e-7	Prudent dietary pattern;
SKCM	cis	rs12824058	0.831	rs11609362	chr12:130810526	T/C	cg26677194	chr12:130822605	PIWIL1	0.71	5.83	0.55	1.17e-7	Menopause (age at onset);
SKCM	trans	rs1814175	0.935	rs11040438	chr11:49622521	G/A	cg03929089	chr4:120376271	NA	-0.87	-7.53	-0.65	7.64e-11	Height;
SKCM	cis	rs8077889	0.672	rs2106764	chr17:41852717	T/A	cg26893861	chr17:41843967	DUSP3	1.37	12.61	0.82	1.65e-20	Triglycerides;
SKCM	cis	rs34172651	0.517	rs35560136	chr16:24788915	T/A	cg00339695	chr16:24857497	SLC5A11	0.8	6.43	0.59	9.38e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs6912958	0.712	rs2246113	chr6:88410050	C/T	cg08069147	chr6:88032118	GJB7;C6orf162	-0.61	-4.81	-0.48	7.25e-6	Monocyte percentage of white cells;
SKCM	cis	rs12142240	0.698	rs41294456	chr1:46809782	T/C	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs473651	0.837	rs563458	chr2:239345613	T/A	cg18131467	chr2:239335373	ASB1	1.09	13.31	0.83	8.92e-22	Multiple system atrophy;
SKCM	cis	rs1799949	1.000	rs8176233	chr17:41219804	T/C	cg25918947	chr17:41365094	TMEM106A	-0.61	-5.91	-0.56	8.59e-8	Menopause (age at onset);
SKCM	cis	rs10911232	0.560	rs10911221	chr1:183046737	G/C	ch.1.3577855R	chr1:183094577	LAMC1	0.7	5.86	0.55	1.03e-7	Hypertriglyceridemia;
SKCM	cis	rs2120019	0.938	rs1867150	chr15:75321139	T/C	cg17294928	chr15:75287854	SCAMP5	-0.89	-8.91	-0.71	1.6e-13	Blood trace element (Zn levels);
SKCM	cis	rs870825	0.587	rs35845099	chr4:185639762	A/G	cg04058563	chr4:185651563	MLF1IP	1.08	7.26	0.64	2.51e-10	Blood protein levels;
SKCM	cis	rs9467773	1.000	rs6456734	chr6:26566965	G/T	cg09904177	chr6:26538194	HMGN4	0.54	4.91	0.49	4.97e-6	Intelligence (multi-trait analysis);
SKCM	trans	rs62103177	0.810	rs62096746	chr18:77619556	T/A	cg05926928	chr17:57297772	GDPD1	1.29	8.74	0.7	3.44e-13	Opioid sensitivity;
SKCM	cis	rs1707322	0.721	rs10890344	chr1:46166090	C/T	cg03146154	chr1:46216737	IPP	0.84	6.2	0.57	2.51e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs11690935	0.959	rs12692970	chr2:172594197	T/C	cg13550731	chr2:172543902	DYNC1I2	-0.95	-8.1	-0.68	6.14e-12	Schizophrenia;
SKCM	cis	rs4319547	0.695	rs1803290	chr12:122865029	T/C	cg23029597	chr12:123009494	RSRC2	0.72	5.31	0.52	1.01e-6	Body mass index;
SKCM	cis	rs6570726	0.516	rs9322025	chr6:145729196	C/T	cg23711669	chr6:146136114	FBXO30	0.64	5.78	0.55	1.48e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1160297	0.576	rs12713233	chr2:53116767	T/A	cg07782112	chr2:53107842	NA	0.66	7.02	0.62	7.3e-10	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs9486715	0.838	rs7770889	chr6:96858453	C/T	cg06623918	chr6:96969491	KIAA0776	-0.85	-7.81	-0.66	2.16e-11	Headache;
SKCM	cis	rs854765	0.520	rs7219324	chr17:17909775	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	-1.08	-8.17	-0.68	4.43e-12	Total body bone mineral density;
SKCM	cis	rs7666738	0.822	rs28512427	chr4:98919029	G/A	cg05340658	chr4:99064831	C4orf37	0.61	4.86	0.48	5.87e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7100689	0.577	rs2342813	chr10:82046302	T/G	cg01528321	chr10:82214614	TSPAN14	0.77	7.36	0.64	1.63e-10	Post bronchodilator FEV1;
SKCM	cis	rs7208859	0.623	rs8080882	chr17:29081146	G/A	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs1799949	0.602	rs8176257	chr17:41216205	G/T	cg05368731	chr17:41323189	NBR1	0.8	6.29	0.58	1.67e-8	Menopause (age at onset);
SKCM	cis	rs798766	0.953	rs13123646	chr4:1740539	T/C	cg05874882	chr4:1763078	NA	-0.56	-4.89	-0.48	5.37e-6	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs644799	0.544	rs1527450	chr11:95467777	G/T	cg03916912	chr11:95522834	CEP57;FAM76B	0.64	4.82	0.48	6.99e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs7613875	0.620	rs7624030	chr3:50071279	A/C	cg24110177	chr3:50126178	RBM5	0.7	5.8	0.55	1.38e-7	Body mass index;
SKCM	cis	rs2075371	0.897	rs1643102	chr7:133999983	T/A	cg20476274	chr7:133979776	SLC35B4	1.03	10.69	0.77	5.94e-17	Mean platelet volume;
SKCM	cis	rs2032447	0.714	rs199734	chr6:25940393	G/C	cg12310025	chr6:25882481	NA	-0.58	-4.86	-0.48	5.96e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7927771	0.524	rs10838774	chr11:47856114	A/G	cg20307385	chr11:47447363	PSMC3	0.7	5.52	0.53	4.26e-7	Subjective well-being;
SKCM	cis	rs6500395	1.000	rs9933976	chr16:48590145	A/G	cg04672837	chr16:48644449	N4BP1	0.69	5.73	0.54	1.8e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs2115536	1.000	rs7163338	chr15:80198408	C/G	cg00225070	chr15:80189496	MTHFS	0.77	5.32	0.52	9.61e-7	Eosinophil counts;Eosinophil percentage of white cells;Sum eosinophil basophil counts;Eosinophil percentage of granulocytes;Neutrophil percentage of granulocytes;
SKCM	cis	rs8067545	0.563	rs3850780	chr17:20181902	A/C	cg13482628	chr17:19912719	NA	-0.65	-5.43	-0.52	6.15e-7	Schizophrenia;
SKCM	cis	rs17685	0.753	rs6976532	chr7:75681094	A/G	cg16684958	chr7:75615977	POR	0.55	5.6	0.54	3.13e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2050392	0.624	rs303450	chr10:30725337	C/A	cg25182066	chr10:30743637	MAP3K8	-0.65	-5.3	-0.51	1.05e-6	Inflammatory bowel disease;
SKCM	cis	rs62064224	0.546	rs1018866	chr17:30829664	A/C	cg25809561	chr17:30822961	MYO1D	0.6	5.3	0.51	1.05e-6	Schizophrenia;
SKCM	cis	rs7666738	0.830	rs1025204	chr4:99023441	G/A	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7208859	0.623	rs8081299	chr17:29104296	G/A	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs7811142	0.943	rs111493473	chr7:100049742	A/G	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.17	7.71	0.66	3.44e-11	Platelet count;
SKCM	cis	rs8060686	0.641	rs76053508	chr16:68243054	A/T	cg09117114	chr16:67998030	SLC12A4	-0.77	-5.03	-0.49	3.12e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs826838	0.935	rs1684406	chr12:39127265	A/G	cg13010199	chr12:38710504	ALG10B	-0.77	-6.19	-0.57	2.66e-8	Heart rate;
SKCM	cis	rs1577917	0.561	rs3087978	chr6:86388223	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.68	5.83	0.55	1.22e-7	Response to antipsychotic treatment;
SKCM	cis	rs3820068	0.603	rs72647118	chr1:15956535	G/T	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs7216064	0.651	rs12947658	chr17:65903006	A/G	cg12091567	chr17:66097778	LOC651250	0.66	4.91	0.49	4.9100000000000004e-06	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs6598955	0.724	rs12096059	chr1:26596709	G/A	cg04990556	chr1:26633338	UBXN11	-0.6	-4.85	-0.48	6.28e-6	Obesity-related traits;
SKCM	cis	rs875971	0.638	rs6960778	chr7:66071597	C/T	cg00343986	chr7:65444356	GUSB	-0.69	-5.05	-0.5	2.81e-6	Aortic root size;
SKCM	cis	rs10905065	0.804	rs2380202	chr10:5823397	C/T	cg09234995	chr10:5726438	C10orf18	0.63	5.49	0.53	4.9e-7	Menopause (age at onset);
SKCM	cis	rs7772486	0.686	rs9390347	chr6:146044747	G/T	cg05347473	chr6:146136440	FBXO30	-0.55	-4.85	-0.48	6.14e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6120849	0.901	rs6060266	chr20:33733078	T/C	cg24642439	chr20:33292090	TP53INP2	0.91	5.05	0.5	2.83e-6	Protein C levels;
SKCM	cis	rs394563	0.591	rs6570963	chr6:149691355	T/G	cg03678062	chr6:149772716	ZC3H12D	0.51	5.91	0.56	8.36e-8	Dupuytren's disease;
SKCM	cis	rs35306767	0.761	rs11253540	chr10:1011958	C/T	cg26597838	chr10:835615	NA	-0.78	-6.23	-0.58	2.21e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs4927850	0.521	rs4927679	chr3:195658360	C/T	cg01181863	chr3:195395398	SDHAP2	0.7	5.36	0.52	8.19e-7	Pancreatic cancer;
SKCM	cis	rs801193	0.569	rs6978178	chr7:66123084	G/A	cg11764359	chr7:65958608	NA	-0.74	-6.66	-0.6	3.49e-9	Aortic root size;
SKCM	cis	rs2404602	0.536	rs7165025	chr15:76766434	G/A	cg23625390	chr15:77176239	SCAPER	0.62	5.39	0.52	7.34e-7	Blood metabolite levels;
SKCM	cis	rs8180040	0.654	rs11714373	chr3:47214817	G/A	cg27129171	chr3:47204927	SETD2	-0.74	-5.3	-0.51	1.05e-6	Colorectal cancer;
SKCM	trans	rs1814175	0.817	rs2866545	chr11:49630824	A/C	cg03929089	chr4:120376271	NA	-0.9	-8.24	-0.68	3.23e-12	Height;
SKCM	trans	rs11722228	0.549	rs73212828	chr4:10078756	C/T	cg26043149	chr18:55253948	FECH	0.93	7.98	0.67	1.02e-11	Gout;Urate levels;Serum uric acid levels;
SKCM	cis	rs11105298	0.891	rs12369685	chr12:89928905	A/G	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.84	-5.23	-0.51	1.39e-6	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs7618501	0.633	rs11130234	chr3:50024758	G/T	cg05072774	chr3:49840536	C3orf54	-0.67	-5.06	-0.5	2.73e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9916302	0.706	rs4488484	chr17:37717377	A/T	cg07936489	chr17:37558343	FBXL20	1.03	7.96	0.67	1.12e-11	Glomerular filtration rate (creatinine);
SKCM	cis	rs9640161	0.789	rs3735174	chr7:150020489	T/C	cg10018233	chr7:150070692	REPIN1	0.75	6.05	0.56	4.81e-8	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs10416265	0.528	rs7249097	chr19:33589144	T/C	cg27124370	chr19:33622961	WDR88	0.8	5.6	0.54	3.13e-7	Bone properties (heel);
SKCM	cis	rs2439831	0.867	rs16957630	chr15:43642780	A/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.39	9.42	0.73	1.62e-14	Lung cancer in ever smokers;
SKCM	cis	rs4132509	0.744	rs6687181	chr1:243878518	C/T	cg21452805	chr1:244014465	NA	0.9	4.81	0.48	7.1e-6	RR interval (heart rate);
SKCM	cis	rs9902453	1.000	rs9890205	chr17:28382704	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.81	-5.78	-0.55	1.45e-7	Coffee consumption (cups per day);
SKCM	cis	rs7666738	0.830	rs11947027	chr4:99005941	T/C	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1799949	0.930	rs66499067	chr17:41248484	G/C	cg23758822	chr17:41437982	NA	0.94	7.65	0.65	4.42e-11	Menopause (age at onset);
SKCM	cis	rs9300255	0.509	rs641760	chr12:123518866	T/C	cg05973401	chr12:123451056	ABCB9	0.77	5.26	0.51	1.22e-6	Neutrophil percentage of white cells;
SKCM	cis	rs854765	0.583	rs6502622	chr17:17834691	A/G	cg04398451	chr17:18023971	MYO15A	-0.85	-6.05	-0.57	4.75e-8	Total body bone mineral density;
SKCM	cis	rs28595532	0.920	rs115690307	chr4:119768289	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs6089584	0.528	rs4925334	chr20:60626769	C/T	cg06108461	chr20:60628389	TAF4	-0.79	-7.45	-0.64	1.08e-10	Body mass index;
SKCM	cis	rs6942756	1.000	rs1473236	chr7:128880831	G/T	cg02491457	chr7:128862824	NA	-0.76	-4.89	-0.48	5.29e-6	White matter hyperintensity burden;
SKCM	cis	rs473651	0.716	rs548179	chr2:239320505	G/A	cg18131467	chr2:239335373	ASB1	1.04	12.42	0.81	3.62e-20	Multiple system atrophy;
SKCM	cis	rs1461503	0.934	rs7121840	chr11:122845360	A/G	cg27398637	chr11:122830231	C11orf63	-0.7	-4.97	-0.49	3.81e-6	Menarche (age at onset);
SKCM	cis	rs11083475	0.714	rs7248584	chr19:39258110	C/T	cg07403899	chr19:39283540	NA	-0.5	-4.83	-0.48	6.73e-6	Heart rate;
SKCM	cis	rs1042058	0.565	rs2480297	chr10:30754512	A/G	cg25182066	chr10:30743637	MAP3K8	-0.7	-6.29	-0.58	1.72e-8	Inflammatory bowel disease;Crohn's disease;Ulcerative colitis;
SKCM	cis	rs7811142	0.830	rs6955367	chr7:99961194	A/G	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.15	7.36	0.64	1.62e-10	Platelet count;
SKCM	cis	rs62064224	0.791	rs11653160	chr17:30717222	A/G	cg25809561	chr17:30822961	MYO1D	0.66	5.09	0.5	2.45e-6	Schizophrenia;
SKCM	cis	rs1538970	0.924	rs11211111	chr1:45908782	C/T	cg05343316	chr1:45956843	TESK2	0.92	4.94	0.49	4.42e-6	Platelet count;
SKCM	cis	rs11098499	0.954	rs10006877	chr4:120242793	C/T	cg09307838	chr4:120376055	NA	0.95	7.57	0.65	6.44e-11	Corneal astigmatism;
SKCM	cis	rs7000551	0.581	rs11136030	chr8:22254235	C/T	cg12081754	chr8:22256438	SLC39A14	1.04	11.29	0.79	4.4e-18	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs453301	0.686	rs2409120	chr8:8882571	G/C	cg06636001	chr8:8085503	FLJ10661	-0.73	-5.55	-0.53	3.74e-7	Joint mobility (Beighton score);
SKCM	cis	rs8141529	0.509	rs5762864	chr22:29253364	T/C	cg02153584	chr22:29168773	CCDC117	0.65	4.93	0.49	4.46e-6	Lymphocyte counts;
SKCM	cis	rs9303401	0.659	rs35928756	chr17:56702652	C/T	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.16	0.57	2.91e-8	Cognitive test performance;
SKCM	cis	rs11229030	0.893	rs2581925	chr11:57207414	G/A	cg00522883	chr11:57194120	SLC43A3	-0.73	-5.8	-0.55	1.34e-7	Crohn's disease;
SKCM	cis	rs6951245	0.529	rs76001997	chr7:1152615	C/T	cg18402987	chr7:1209562	NA	0.83	5.53	0.53	4.06e-7	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs12477438	0.501	rs13033012	chr2:99795149	T/C	cg14399236	chr2:99771627	LIPT1;TSGA10	0.96	8.62	0.7	5.82e-13	Chronic sinus infection;
SKCM	cis	rs478304	0.651	rs11600918	chr11:65511965	A/G	cg27068330	chr11:65405492	SIPA1	-0.89	-8.2	-0.68	3.77e-12	Acne (severe);
SKCM	cis	rs736408	0.500	rs2878762	chr3:52919002	T/C	cg18404041	chr3:52824283	ITIH1	-0.59	-4.99	-0.49	3.6e-6	Bipolar disorder;
SKCM	cis	rs12586317	0.513	rs17102962	chr14:35478782	A/T	cg16230307	chr14:35515116	FAM177A1	0.81	5.88	0.55	9.47e-8	Psoriasis;
SKCM	cis	rs4665809	0.590	rs62128457	chr2:26467347	C/A	cg26119090	chr2:26468346	HADHA;HADHB	1.06	8.39	0.69	1.66e-12	Gut microbiome composition (summer);
SKCM	cis	rs7772486	0.597	rs1970306	chr6:146154543	A/G	cg23711669	chr6:146136114	FBXO30	0.81	7.18	0.63	3.51e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7666738	0.830	rs34412187	chr4:99010454	A/G	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs684232	1.000	rs684232	chr17:618965	T/C	cg12384639	chr17:618140	VPS53	-0.71	-5.47	-0.53	5.25e-7	Prostate cancer;
SKCM	cis	rs8072100	0.745	rs7214410	chr17:45422628	A/G	cg08085267	chr17:45401833	C17orf57	-0.68	-5.6	-0.54	3.09e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs9916302	0.706	rs8073907	chr17:37424149	C/T	cg07936489	chr17:37558343	FBXL20	-0.98	-6.58	-0.6	4.83e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs9951698	0.660	rs12955780	chr18:12982760	G/A	cg12848697	chr18:13133368	NA	0.53	4.96	0.49	4.04e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7811142	0.775	rs1059129	chr7:99926522	A/G	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.21	7.77	0.66	2.57e-11	Platelet count;
SKCM	cis	rs2153535	0.580	rs2327050	chr6:8440630	A/G	cg23788917	chr6:8435910	SLC35B3	0.69	5.14	0.5	1.99e-6	Motion sickness;
SKCM	cis	rs55962025	0.883	rs82332	chr4:3225466	A/G	cg05297308	chr4:3317976	RGS12	-0.67	-4.88	-0.48	5.51e-6	Parental longevity (mother's age at death);
SKCM	cis	rs9818758	0.607	rs11552724	chr3:49156473	C/G	cg24110177	chr3:50126178	RBM5	0.87	4.86	0.48	6e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs4727027	0.901	rs7794500	chr7:148819519	C/T	cg23583168	chr7:148888333	NA	0.84	6.88	0.61	1.35e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs6840360	0.593	rs1877185	chr4:152690348	C/T	cg22705602	chr4:152727874	NA	-0.59	-7.88	-0.67	1.63e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs9611565	0.649	rs79005	chr22:41835544	G/A	cg03806693	chr22:41940476	POLR3H	1.07	6.74	0.61	2.44e-9	Vitiligo;
SKCM	cis	rs116095464	0.850	rs6896163	chr5:303686	A/G	cg22857025	chr5:266934	NA	-1.64	-6.14	-0.57	3.18e-8	Breast cancer;
SKCM	cis	rs2228479	0.702	rs62053702	chr16:89860688	G/T	cg06558623	chr16:89946397	TCF25	1.04	4.82	0.48	6.97e-6	Skin colour saturation;
SKCM	trans	rs9329221	0.617	rs483916	chr8:9793601	A/C	cg06636001	chr8:8085503	FLJ10661	-0.96	-8.59	-0.7	6.69e-13	Neuroticism;
SKCM	cis	rs7809950	1.000	rs10234355	chr7:107086517	T/G	cg23024343	chr7:107201750	COG5	-0.77	-6.85	-0.61	1.5e-9	Coronary artery disease;
SKCM	cis	rs9815354	0.812	rs73073229	chr3:42007850	T/C	cg03022575	chr3:42003672	ULK4	1.0	5.0	0.49	3.43e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs6546550	0.869	rs6720498	chr2:70124805	T/C	cg02498382	chr2:70120550	SNRNP27	-0.49	-5.37	-0.52	7.84e-7	Prevalent atrial fibrillation;
SKCM	cis	rs9581857	0.512	rs9652092	chr13:28074855	T/C	cg22138327	chr13:27999177	GTF3A	0.86	6.15	0.57	3.13e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs2721195	1.000	rs11542372	chr8:145677089	G/A	cg15857475	chr8:145742913	RECQL4;LRRC14	-0.8	-7.07	-0.62	5.82e-10	Age at first birth;
SKCM	cis	rs7666738	0.791	rs2903142	chr4:99040071	C/T	cg17366294	chr4:99064904	C4orf37	0.6	4.92	0.49	4.7e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9910055	0.762	rs184478	chr17:42209751	C/G	cg10896456	chr17:42255109	ASB16;C17orf65	-0.66	-6.3	-0.58	1.62e-8	Total body bone mineral density;
SKCM	cis	rs3091242	0.935	rs4233043	chr1:25765483	A/G	cg27572855	chr1:25598939	RHD	0.53	5.06	0.5	2.67e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs12541335	0.639	rs11135995	chr8:22200148	C/T	cg02463440	chr8:22132932	PIWIL2	-0.65	-5.87	-0.55	1.01e-7	Hypertriglyceridemia;
SKCM	cis	rs7635838	0.617	rs2606731	chr3:11291615	A/C	cg00170343	chr3:11313890	ATG7	0.77	5.96	0.56	6.82e-8	HDL cholesterol;
SKCM	cis	rs55962025	0.711	rs28867436	chr4:3085477	G/A	cg00764545	chr4:3318001	RGS12	-0.57	-4.82	-0.48	6.97e-6	Parental longevity (mother's age at death);
SKCM	cis	rs2404602	0.583	rs11072580	chr15:76540231	G/A	cg23625390	chr15:77176239	SCAPER	0.69	6.31	0.58	1.57e-8	Blood metabolite levels;
SKCM	cis	rs9896933	0.778	rs80243549	chr17:80821485	G/T	cg20578329	chr17:80767326	TBCD	-0.96	-6.27	-0.58	1.86e-8	Bone mineral accretion in asthma (oral corticosteroid dose interaction);
SKCM	cis	rs533581	0.866	rs475796	chr16:88970776	C/G	cg16701003	chr16:89028210	CBFA2T3	0.62	5.75	0.55	1.67e-7	Social autistic-like traits;
SKCM	cis	rs672059	1.000	rs559476	chr1:183160704	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.63	5.23	0.51	1.38e-6	Hypertriglyceridemia;
SKCM	cis	rs1707322	0.721	rs12069121	chr1:46231984	G/A	cg03146154	chr1:46216737	IPP	0.84	6.09	0.57	4e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs314370	0.951	rs12666989	chr7:100486754	G/C	cg10426581	chr7:100472382	SRRT	0.67	5.64	0.54	2.57e-7	Resting heart rate;
SKCM	cis	rs9902453	0.904	rs6505148	chr17:28289818	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.8	6.28	0.58	1.79e-8	Coffee consumption (cups per day);
SKCM	cis	rs6952808	0.929	rs11768206	chr7:1932151	T/G	cg02951883	chr7:2050386	MAD1L1	-0.71	-5.72	-0.54	1.86e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs875971	0.660	rs1860470	chr7:66103694	G/C	cg05627663	chr7:65219948	SNORA22;CCT6P1	-0.56	-4.81	-0.48	7.26e-6	Aortic root size;
SKCM	cis	rs11764590	0.694	rs3996323	chr7:2079428	G/T	cg23422044	chr7:1970798	MAD1L1	-0.82	-6.27	-0.58	1.82e-8	Neuroticism;
SKCM	cis	rs992157	0.804	rs6758540	chr2:219138625	A/G	cg00012203	chr2:219082015	ARPC2	-0.79	-6.25	-0.58	2.02e-8	Colorectal cancer;
SKCM	cis	rs873946	0.504	rs3829132	chr10:134579044	A/C	cg00988841	chr10:134556463	INPP5A	0.62	4.84	0.48	6.49e-6	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs7666738	0.830	rs34313689	chr4:99013689	T/C	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs644799	0.965	rs10831430	chr11:95509638	T/C	cg03916912	chr11:95522834	CEP57;FAM76B	0.94	8.53	0.69	8.87e-13	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs561341	1.000	rs113676348	chr17:30244327	A/G	cg12193833	chr17:30244370	NA	-0.47	-4.79	-0.48	7.65e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs12474201	0.928	rs12998762	chr2:46938393	A/C	cg06386533	chr2:46925753	SOCS5	1.01	9.25	0.72	3.5e-14	Height;
SKCM	cis	rs514406	0.893	rs522287	chr1:53365493	C/T	cg08859206	chr1:53392774	SCP2	-0.6	-4.82	-0.48	7.02e-6	Monocyte count;
SKCM	cis	rs4843747	0.671	rs4075599	chr16:88107423	C/G	cg09044154	chr16:88155775	NA	-0.6	-4.77	-0.48	8.29e-6	Menopause (age at onset);
SKCM	cis	rs12142240	0.698	rs17361805	chr1:46813967	C/T	cg10495392	chr1:46806563	NSUN4	0.74	5.82	0.55	1.24e-7	Menopause (age at onset);
SKCM	cis	rs4721295	0.573	rs3779000	chr7:2181628	G/A	cg05863683	chr7:1912471	MAD1L1	0.6	4.98	0.49	3.78e-6	Schizophrenia, schizoaffective disorder or bipolar disorder;
SKCM	cis	rs6977660	0.943	rs10225293	chr7:19840636	C/T	cg05791153	chr7:19748676	TWISTNB	-0.82	-5.84	-0.55	1.15e-7	Thyroid stimulating hormone;
SKCM	cis	rs9581857	0.685	rs12585587	chr13:28024694	G/A	cg22138327	chr13:27999177	GTF3A	0.72	5.05	0.5	2.88e-6	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs1707322	0.752	rs8179402	chr1:46142466	C/A	cg03146154	chr1:46216737	IPP	0.82	6.1	0.57	3.89e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs3008870	1.000	rs2815352	chr1:67482104	A/G	cg08660285	chr1:67390436	MIER1;WDR78	0.91	5.96	0.56	6.81e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs116095464	0.558	rs34629844	chr5:200829	A/G	cg22496380	chr5:211416	CCDC127	-1.0	-5.11	-0.5	2.25e-6	Breast cancer;
SKCM	cis	rs6835098	0.961	rs28709762	chr4:174099149	T/C	cg08422745	chr4:174089978	GALNT7	-0.86	-6.84	-0.61	1.61e-9	Dementia and core Alzheimer's disease neuropathologic changes;
SKCM	cis	rs2836950	0.527	rs2836958	chr21:40623526	T/C	cg11890956	chr21:40555474	PSMG1	-0.66	-5.26	-0.51	1.22e-6	Menarche (age at onset);
SKCM	cis	rs2153535	0.541	rs1414347	chr6:8471831	T/C	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs2842992	0.662	rs2273826	chr6:160211421	A/G	cg11366901	chr6:160182831	ACAT2	0.84	7.09	0.63	5.2e-10	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs514406	0.644	rs7530078	chr1:53204861	G/T	cg24675658	chr1:53192096	ZYG11B	0.64	5.3	0.51	1.04e-6	Monocyte count;
SKCM	cis	rs3857536	0.704	rs4710570	chr6:66890244	A/G	cg07460842	chr6:66804631	NA	-0.7	-5.08	-0.5	2.51e-6	Blood trace element (Cu levels);
SKCM	cis	rs3791556	1.000	rs3791568	chr2:240115701	G/A	cg14530444	chr2:239432329	NA	0.62	4.88	0.48	5.43e-6	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);
SKCM	cis	rs9790314	0.934	rs461638	chr3:161103166	A/G	cg03342759	chr3:160939853	NMD3	-0.69	-7.1	-0.63	5.19e-10	Morning vs. evening chronotype;
SKCM	cis	rs8017423	0.967	rs60548738	chr14:90724399	G/A	cg04374321	chr14:90722782	PSMC1	1.03	9.44	0.73	1.55e-14	Mortality in heart failure;
SKCM	cis	rs10779751	1.000	rs1010447	chr1:11269796	A/G	cg08854313	chr1:11322531	MTOR	0.8	6.04	0.56	4.85e-8	Body mass index;
SKCM	cis	rs12477438	0.520	rs6542864	chr2:99725223	A/G	cg26064155	chr2:99771622	LIPT1;TSGA10	1.02	10.07	0.75	9.12e-16	Chronic sinus infection;
SKCM	cis	rs1267303	0.642	rs7542296	chr1:46998009	A/G	cg25110126	chr1:46999211	NA	0.7	5.06	0.5	2.73e-6	Monobrow;
SKCM	cis	rs6121246	0.909	rs6089071	chr20:30378384	C/G	cg11595048	chr20:30225325	COX4I2	0.67	5.21	0.51	1.5e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs1568889	0.877	rs7933326	chr11:28288416	G/A	cg06544937	chr11:28130018	METT5D1;KIF18A	0.87	6.26	0.58	1.93e-8	Bipolar disorder;
SKCM	cis	rs7666738	0.830	rs6817645	chr4:99016054	T/C	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1355223	0.583	rs2956074	chr11:34864880	T/C	cg11058730	chr11:34937778	PDHX;APIP	0.59	4.77	0.47	8.55e-6	Systemic lupus erythematosus and Systemic sclerosis;
SKCM	cis	rs61776719	0.810	rs34655914	chr1:38397341	G/A	cg17077180	chr1:38461687	NA	0.51	5.0	0.49	3.39e-6	Coronary artery disease;
SKCM	cis	rs7772486	0.686	rs9497396	chr6:146014963	C/A	cg23711669	chr6:146136114	FBXO30	-0.88	-9.0	-0.71	1.08e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs208520	1.000	rs12191598	chr6:66983962	T/C	cg07460842	chr6:66804631	NA	0.87	5.96	0.56	6.95e-8	Exhaled nitric oxide output;
SKCM	cis	rs28595532	0.545	rs13144171	chr4:119257458	G/A	cg11846333	chr4:119757529	SEC24D	1.04	5.83	0.55	1.2e-7	Cannabis dependence symptom count;
SKCM	cis	rs35306767	0.807	rs11253513	chr10:968450	C/T	cg26597838	chr10:835615	NA	0.67	5.4	0.52	7e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs7618501	0.601	rs2624825	chr3:50154989	G/A	cg05072774	chr3:49840536	C3orf54	0.66	5.02	0.49	3.22e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs11103631	0.823	rs4841952	chr9:137904004	G/T	cg13822849	chr9:137999757	OLFM1	0.49	5.0	0.49	3.49e-6	Trans-epidermal water loss;
SKCM	cis	rs2739330	0.652	rs2000469	chr22:24245292	A/G	cg25703541	chr22:24373054	LOC391322	-0.67	-4.82	-0.48	6.91e-6	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	trans	rs66573146	0.901	rs55882710	chr4:7030704	G/A	cg07817883	chr1:32538562	TMEM39B	2.03	8.21	0.68	3.77e-12	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs9300255	0.507	rs1615350	chr12:123650335	C/T	cg05973401	chr12:123451056	ABCB9	0.78	5.69	0.54	2.12e-7	Neutrophil percentage of white cells;
SKCM	cis	rs1256061	0.646	rs1256056	chr14:64712626	A/G	cg21174375	chr14:64681225	SYNE2	0.46	4.97	0.49	3.85e-6	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs738322	0.555	rs5750548	chr22:38547016	C/A	cg25457927	chr22:38595422	NA	-0.56	-6.58	-0.6	4.97e-9	Cutaneous nevi;
SKCM	cis	rs9951698	0.653	rs562151	chr18:13066123	T/C	cg12848697	chr18:13133368	NA	0.55	5.19	0.51	1.62e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs11608355	0.597	rs10850070	chr12:109793882	A/G	cg19025524	chr12:109796872	NA	-0.64	-5.03	-0.49	3.11e-6	Neuroticism;
SKCM	cis	rs72781680	0.611	rs2303289	chr2:24342242	C/G	cg20701182	chr2:24300061	SF3B14	-0.74	-4.98	-0.49	3.72e-6	Lymphocyte counts;
SKCM	cis	rs7659604	0.676	rs7691955	chr4:122700462	A/T	cg06713675	chr4:122721982	EXOSC9	-0.76	-7.28	-0.64	2.34e-10	Type 2 diabetes;
SKCM	cis	rs2228479	0.702	rs78331410	chr16:89917775	C/T	cg06558623	chr16:89946397	TCF25	1.12	5.0	0.49	3.47e-6	Skin colour saturation;
SKCM	cis	rs1865760	0.929	rs1436307	chr6:25939723	C/T	cg08401836	chr6:26032486	HIST1H3B	-0.62	-5.06	-0.5	2.76e-6	Height;
SKCM	cis	rs10089	1.000	rs3792866	chr5:127479900	A/G	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.9	8.97	0.71	1.22e-13	Ileal carcinoids;
SKCM	cis	rs7647973	0.600	rs35174559	chr3:49287759	T/C	cg07636037	chr3:49044803	WDR6	0.83	6.82	0.61	1.76e-9	Menarche (age at onset);
SKCM	cis	rs7647973	0.580	rs11130184	chr3:49229930	C/T	cg07636037	chr3:49044803	WDR6	0.85	7.0	0.62	7.74e-10	Menarche (age at onset);
SKCM	cis	rs1707322	1.000	rs7538978	chr1:46505054	C/T	cg03146154	chr1:46216737	IPP	-0.72	-4.99	-0.49	3.64e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs1801251	1.000	rs7578299	chr2:233573469	G/T	cg08000102	chr2:233561755	GIGYF2	0.89	6.91	0.62	1.15e-9	Coronary artery disease;
SKCM	cis	rs9810089	0.527	rs590198	chr3:135953729	G/A	cg21827317	chr3:136751795	NA	0.65	5.32	0.52	9.81e-7	Gestational age at birth (child effect);
SKCM	cis	rs2839186	0.807	rs2032226	chr21:47680352	G/A	cg13126279	chr21:47581558	C21orf56	-0.62	-5.35	-0.52	8.43e-7	Testicular germ cell tumor;
SKCM	trans	rs8073060	0.544	rs225246	chr17:33944773	T/C	cg19694781	chr19:47549865	TMEM160	-1.08	-8.69	-0.7	4.26e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs10906466	0.869	rs10906467	chr10:13801636	A/G	cg19695507	chr10:13526193	BEND7	0.51	4.88	0.48	5.57e-6	Migraine;
SKCM	cis	rs6879260	1.000	rs1035411	chr5:179729519	A/G	cg23221052	chr5:179740743	GFPT2	-0.73	-6.03	-0.56	5.15e-8	Height;
SKCM	cis	rs35306767	0.715	rs11253550	chr10:1028288	C/G	cg26597838	chr10:835615	NA	0.76	6.22	0.58	2.29e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs1577917	0.958	rs1591438	chr6:86525214	G/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.66	-5.78	-0.55	1.44e-7	Response to antipsychotic treatment;
SKCM	cis	rs2243480	1.000	rs36068983	chr7:65408991	C/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs72615157	0.634	rs79986079	chr7:99802044	C/T	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.23	8.38	0.69	1.71e-12	Lung function (FEV1/FVC);
SKCM	cis	rs4073582	0.595	rs3016319	chr11:65981846	C/T	cg16950941	chr11:66035639	RAB1B	0.81	6.88	0.61	1.35e-9	Gout;
SKCM	cis	rs40363	0.645	rs6501177	chr16:3523681	C/T	cg22508957	chr16:3507546	NAT15	0.57	4.87	0.48	5.8e-6	Tuberculosis;
SKCM	cis	rs116095464	0.558	rs10052012	chr5:231908	T/C	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs7959452	0.590	rs7968629	chr12:69782857	G/A	cg14784868	chr12:69753453	YEATS4	0.78	7.4	0.64	1.33e-10	Blood protein levels;
SKCM	cis	rs13256369	0.802	rs1060107	chr8:8561399	G/T	cg06636001	chr8:8085503	FLJ10661	0.75	5.73	0.54	1.81e-7	Obesity-related traits;
SKCM	cis	rs9921222	0.597	rs7193109	chr16:413523	T/G	cg00101154	chr16:420108	MRPL28	-0.75	-6.35	-0.58	1.31e-8	Bone mineral density (spine);Bone mineral density;
SKCM	cis	rs7208859	0.623	rs7223404	chr17:29107363	C/T	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs28386778	0.966	rs2854206	chr17:61947203	G/A	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.38	0.52	7.59e-7	Prudent dietary pattern;
SKCM	cis	rs10540	0.915	rs35389167	chr11:460765	A/G	cg03352830	chr11:487213	PTDSS2	0.96	4.77	0.48	8.46e-6	Body mass index;
SKCM	cis	rs2013441	1.000	rs2703780	chr17:20143672	A/G	cg13482628	chr17:19912719	NA	-0.64	-5.04	-0.5	2.94e-6	Obesity-related traits;
SKCM	cis	rs2836974	0.899	rs6517514	chr21:40527095	G/T	cg11890956	chr21:40555474	PSMG1	1.07	13.19	0.83	1.48e-21	Cognitive function;
SKCM	trans	rs10506458	0.834	rs73125186	chr12:63373400	C/T	cg03429785	chr15:59498649	MYO1E;LDHAL6B	-1.39	-7.59	-0.65	5.95e-11	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs2839186	0.616	rs4819213	chr21:47619300	G/A	cg13012494	chr21:47604986	C21orf56	-0.71	-6.18	-0.57	2.77e-8	Testicular germ cell tumor;
SKCM	trans	rs1814175	0.817	rs2866545	chr11:49630824	A/C	cg15704280	chr7:45808275	SEPT13	-1.03	-10.38	-0.76	2.38e-16	Height;
SKCM	cis	rs2841277	0.712	rs2841280	chr14:105393556	G/C	cg19901468	chr14:105411992	AHNAK2	0.96	7.5	0.65	8.72e-11	Rheumatoid arthritis;
SKCM	cis	rs6942756	1.000	rs66970518	chr7:128871006	G/A	cg02491457	chr7:128862824	NA	-0.72	-4.8	-0.48	7.49e-6	White matter hyperintensity burden;
SKCM	cis	rs7208859	0.623	rs9912440	chr17:29148772	A/G	cg13385521	chr17:29058706	SUZ12P	1.04	5.29	0.51	1.11e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs9880211	0.613	rs6767060	chr3:135867090	C/G	cg21827317	chr3:136751795	NA	-0.68	-5.3	-0.51	1.05e-6	Body mass index;Height;
SKCM	cis	rs875971	0.895	rs12531677	chr7:65769086	G/A	cg11764359	chr7:65958608	NA	-0.75	-6.76	-0.61	2.26e-9	Aortic root size;
SKCM	cis	rs1005277	0.579	rs11011461	chr10:38431427	G/A	cg25427524	chr10:38739819	LOC399744	-0.71	-6.74	-0.61	2.44e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs7100689	0.646	rs4265545	chr10:82119271	G/T	cg00277334	chr10:82204260	NA	-0.53	-4.89	-0.48	5.28e-6	Post bronchodilator FEV1;
SKCM	cis	rs995000	0.931	rs1690766	chr1:62987289	T/C	cg06896770	chr1:63153194	DOCK7	-0.74	-6.81	-0.61	1.77e-9	Triglyceride levels;
SKCM	cis	rs7809950	0.954	rs2189839	chr7:107230026	A/G	cg23024343	chr7:107201750	COG5	0.83	7.65	0.65	4.44e-11	Coronary artery disease;
SKCM	cis	rs763121	0.853	rs5750662	chr22:39072472	G/A	cg06022373	chr22:39101656	GTPBP1	0.8	5.85	0.55	1.1e-7	Menopause (age at onset);
SKCM	cis	rs2731664	0.792	rs335452	chr5:176879671	C/T	cg23176889	chr5:176863531	GRK6	-0.54	-5.66	-0.54	2.41e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs4973517	0.624	rs3100614	chr2:232850728	T/C	cg13952656	chr2:232260762	B3GNT7	0.49	4.88	0.48	5.45e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs11098499	0.863	rs11731756	chr4:120478696	T/G	cg24375607	chr4:120327624	NA	0.69	5.47	0.53	5.35e-7	Corneal astigmatism;
SKCM	cis	rs2905347	0.737	rs2905349	chr7:22629285	A/G	cg00394316	chr7:22539822	MGC87042	0.46	4.78	0.48	8.13e-6	Major depression and alcohol dependence;
SKCM	cis	rs523522	0.923	rs1048830	chr12:120882217	G/T	cg27279351	chr12:120934652	DYNLL1	0.9	7.83	0.66	2.04e-11	High light scatter reticulocyte count;
SKCM	cis	rs6545883	0.929	rs1186711	chr2:61688505	T/C	cg15711740	chr2:61764176	XPO1	-0.71	-4.99	-0.49	3.56e-6	Tuberculosis;
SKCM	cis	rs1912528	0.814	rs13136239	chr4:140908755	G/A	cg11128457	chr4:140864437	MAML3	0.57	4.91	0.49	4.85e-6	Educational attainment (years of education);
SKCM	cis	rs11098499	0.954	rs2389803	chr4:120393511	A/G	cg24375607	chr4:120327624	NA	-0.68	-5.34	-0.52	9.03e-7	Corneal astigmatism;
SKCM	cis	rs9814567	1.000	rs1814336	chr3:134200823	G/C	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.7	-5.55	-0.53	3.8e-7	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs3820068	0.581	rs72645893	chr1:15930943	C/G	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs2120019	0.938	rs3850093	chr15:75318482	A/G	cg17294928	chr15:75287854	SCAMP5	0.9	8.66	0.7	4.93e-13	Blood trace element (Zn levels);
SKCM	cis	rs4423214	1.000	rs4944946	chr11:71159429	G/A	cg05163923	chr11:71159392	DHCR7	0.83	8.01	0.67	8.87e-12	Vitamin D levels;
SKCM	cis	rs7772486	0.875	rs9390377	chr6:146386932	G/A	cg23711669	chr6:146136114	FBXO30	0.85	8.45	0.69	1.28e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs12477438	0.501	rs17759607	chr2:99737005	T/C	cg14399236	chr2:99771627	LIPT1;TSGA10	0.93	8.28	0.68	2.67e-12	Chronic sinus infection;
SKCM	cis	rs8103278	1.000	rs7252126	chr19:46302374	T/A	cg11657440	chr19:46296263	DMWD	-0.94	-6.44	-0.59	8.84e-9	Coronary artery disease;
SKCM	trans	rs8073060	0.504	rs225271	chr17:33969836	C/T	cg19694781	chr19:47549865	TMEM160	-1.0	-8.56	-0.7	7.62e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs17685	0.753	rs11982200	chr7:75714883	T/C	cg16684958	chr7:75615977	POR	0.57	5.54	0.53	4e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs514406	0.893	rs6588445	chr1:53424928	T/C	cg24675658	chr1:53192096	ZYG11B	0.63	5.12	0.5	2.14e-6	Monocyte count;
SKCM	cis	rs1577917	1.000	rs35760725	chr6:86648985	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.61	-5.31	-0.52	1.02e-6	Response to antipsychotic treatment;
SKCM	cis	rs7772486	0.686	rs4895684	chr6:146114023	A/C	cg05347473	chr6:146136440	FBXO30	-0.55	-5.07	-0.5	2.6e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6088590	1.000	rs11698977	chr20:33449691	C/T	cg24642439	chr20:33292090	TP53INP2	0.98	6.92	0.62	1.11e-9	Coronary artery disease;
SKCM	cis	rs8014204	0.762	rs10138360	chr14:75293386	A/G	cg06637938	chr14:75390232	RPS6KL1	-0.7	-5.36	-0.52	8.11e-7	Caffeine consumption;
SKCM	cis	rs1799949	0.864	rs60309406	chr17:41435665	C/T	cg23758822	chr17:41437982	NA	0.95	7.96	0.67	1.13e-11	Menopause (age at onset);
SKCM	cis	rs2836974	0.644	rs9978775	chr21:40694526	A/G	cg11890956	chr21:40555474	PSMG1	-0.81	-7.38	-0.64	1.51e-10	Cognitive function;
SKCM	cis	rs13118159	0.509	rs9683830	chr4:1377873	A/G	cg02475777	chr4:1388615	CRIPAK	0.83	5.62	0.54	2.86e-7	Longevity;
SKCM	cis	rs826838	0.967	rs10875979	chr12:39095149	G/A	cg26384229	chr12:38710491	ALG10B	1.0	8.84	0.71	2.21e-13	Heart rate;
SKCM	cis	rs1707322	0.752	rs10789467	chr1:46118745	C/G	cg03146154	chr1:46216737	IPP	0.82	6.1	0.57	3.89e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs11098499	0.863	rs3775841	chr4:120425777	A/C	cg09307838	chr4:120376055	NA	0.98	7.41	0.64	1.32e-10	Corneal astigmatism;
SKCM	cis	rs703842	0.575	rs701006	chr12:58106836	C/T	cg18357645	chr12:58087776	OS9	-0.61	-5.22	-0.51	1.45e-6	Multiple sclerosis;
SKCM	cis	rs910316	1.000	rs10142865	chr14:75555624	G/A	cg08847533	chr14:75593920	NEK9	0.94	8.89	0.71	1.76e-13	Height;
SKCM	cis	rs7208859	0.623	rs77009951	chr17:29080650	T/C	cg13385521	chr17:29058706	SUZ12P	1.04	5.34	0.52	8.84e-7	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs875971	0.825	rs10281499	chr7:66048966	A/G	cg11764359	chr7:65958608	NA	-0.74	-6.67	-0.6	3.37e-9	Aortic root size;
SKCM	cis	rs4243830	0.737	rs4908926	chr1:6617041	C/T	cg22792644	chr1:6614718	TAS1R1;NOL9	-1.23	-4.81	-0.48	7.15e-6	Body mass index;
SKCM	cis	rs4925386	1.000	rs6089351	chr20:60916153	G/A	cg24112000	chr20:60950667	NA	0.63	6.16	0.57	3.02e-8	Colorectal cancer;Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs2204008	0.777	rs6582664	chr12:37947022	A/G	cg13010199	chr12:38710504	ALG10B	-0.64	-5.16	-0.5	1.81e-6	Bladder cancer;
SKCM	cis	rs17270561	0.514	rs10946805	chr6:26077891	C/T	cg16482183	chr6:26056742	HIST1H1C	0.96	7.08	0.63	5.57e-10	Iron status biomarkers;
SKCM	cis	rs228769	0.543	rs170634	chr17:42175821	C/A	cg09913183	chr17:42254507	C17orf65;ASB16	-0.59	-4.78	-0.48	8.16e-6	Bone mineral density (hip);Bone mineral density (spine);
SKCM	cis	rs2836974	0.965	rs2836967	chr21:40639102	T/G	cg17971929	chr21:40555470	PSMG1	0.9	8.87	0.71	1.93e-13	Cognitive function;
SKCM	cis	rs62238980	0.614	rs75414196	chr22:32415980	C/A	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs7129727	1	rs7129727	chr11:57484660	G/A	cg19752551	chr11:57585705	CTNND1	-0.69	-6.85	-0.61	1.52e-9	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs13040088	0.580	rs11905041	chr20:61563408	C/T	cg23096297	chr20:61557774	DIDO1	0.62	5.05	0.5	2.79e-6	Menopause (age at onset);
SKCM	cis	rs4242434	0.819	rs2306518	chr8:22470308	A/G	cg03733263	chr8:22462867	KIAA1967	1.0	8.29	0.68	2.63e-12	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs7927771	0.507	rs10838754	chr11:47758532	A/C	cg20307385	chr11:47447363	PSMC3	0.72	5.83	0.55	1.21e-7	Subjective well-being;
SKCM	cis	rs9910055	0.659	rs3826412	chr17:42255097	A/G	cg10896456	chr17:42255109	ASB16;C17orf65	0.68	7.28	0.64	2.25e-10	Total body bone mineral density;
SKCM	cis	rs9911578	0.967	rs2567892	chr17:56668929	T/C	cg05425664	chr17:57184151	TRIM37	-0.69	-5.2	-0.51	1.55e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs6089584	0.526	rs6061965	chr20:60607858	A/C	cg06108461	chr20:60628389	TAF4	-0.74	-6.72	-0.61	2.69e-9	Body mass index;
SKCM	cis	rs9902453	0.967	rs1906450	chr17:28515744	A/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.75	5.19	0.51	1.65e-6	Coffee consumption (cups per day);
SKCM	cis	rs807669	0.903	rs756651	chr22:19179367	T/C	cg02655711	chr22:19163373	SLC25A1	0.78	7.22	0.63	3.03e-10	Metabolite levels;
SKCM	cis	rs7666738	0.830	rs880470	chr4:98922522	A/T	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs736408	0.716	rs2300149	chr3:52822921	C/T	cg18404041	chr3:52824283	ITIH1	-0.54	-4.92	-0.49	4.79e-6	Bipolar disorder;
SKCM	cis	rs35306767	0.903	rs11253475	chr10:907262	C/A	cg25614935	chr10:1084866	C10orf110	0.78	5.09	0.5	2.42e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs651907	0.557	rs7651404	chr3:101393294	C/A	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.81	6.96	0.62	9.48e-10	Colorectal cancer;
SKCM	cis	rs1577917	0.958	rs1337843	chr6:86675545	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.61	-5.31	-0.52	1.02e-6	Response to antipsychotic treatment;
SKCM	cis	rs1760803	0.754	rs3762339	chr1:154208877	A/G	cg26808167	chr1:154192205	UBAP2L;C1orf43	-0.55	-4.91	-0.49	4.87e-6	Nicotine dependence;
SKCM	cis	rs12369179	0.737	rs116896792	chr12:122948907	T/C	cg18578876	chr12:123200353	GPR109B	-1.23	-7.07	-0.63	5.72e-10	Age-related diseases, mortality and associated endophenotypes;Age-related disease endophenotypes;
SKCM	cis	rs28595532	0.920	rs115076001	chr4:119764346	T/G	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs9790314	0.747	rs9848239	chr3:160823488	A/C	cg03342759	chr3:160939853	NMD3	-0.61	-5.95	-0.56	7.06e-8	Morning vs. evening chronotype;
SKCM	cis	rs514406	0.698	rs567880	chr1:53348564	T/G	cg08859206	chr1:53392774	SCP2	-0.63	-5.18	-0.51	1.7e-6	Monocyte count;
SKCM	cis	rs1801251	1.000	rs283480	chr2:233648742	G/A	cg08000102	chr2:233561755	GIGYF2	0.95	7.13	0.63	4.4e-10	Coronary artery disease;
SKCM	cis	rs847649	1.000	rs11514917	chr7:102609221	A/C	cg18108683	chr7:102477205	FBXL13	-0.82	-8.41	-0.69	1.49e-12	Morning vs. evening chronotype;
SKCM	cis	rs12477438	0.520	rs11883676	chr2:99800814	G/T	cg26064155	chr2:99771622	LIPT1;TSGA10	0.97	8.85	0.71	2.11e-13	Chronic sinus infection;
SKCM	cis	rs7100689	0.577	rs1340385	chr10:82058851	G/A	cg00277334	chr10:82204260	NA	-0.52	-5.14	-0.5	2.02e-6	Post bronchodilator FEV1;
SKCM	cis	rs6952808	0.630	rs10239050	chr7:2158390	A/G	cg21782813	chr7:2030301	MAD1L1	0.51	5.5	0.53	4.59e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs72781680	0.898	rs72780121	chr2:23995918	T/C	cg08917208	chr2:24149416	ATAD2B	0.92	4.85	0.48	6.19e-6	Lymphocyte counts;
SKCM	cis	rs6977660	1.000	rs6959889	chr7:19822024	A/C	cg07541023	chr7:19748670	TWISTNB	0.7	4.82	0.48	6.98e-6	Thyroid stimulating hormone;
SKCM	cis	rs476633	0.691	rs2164996	chr15:41536624	A/G	cg18705301	chr15:41695430	NDUFAF1	-0.64	-4.82	-0.48	7.01e-6	Glomerular filtration rate (creatinine);
SKCM	cis	rs12142240	0.698	rs12385695	chr1:46819021	A/G	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs714515	0.546	rs57668887	chr1:172327399	T/C	cg01573306	chr1:172330400	DNM3	-0.73	-5.98	-0.56	6.37e-8	Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction);Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);
SKCM	cis	rs780096	0.526	rs1406295	chr2:27689700	A/G	cg05696406	chr2:27599888	SNX17	0.51	5.22	0.51	1.46e-6	Total body bone mineral density;
SKCM	cis	rs10256972	0.616	rs3802141	chr7:1131356	T/C	cg07092213	chr7:1199455	ZFAND2A	-0.65	-5.44	-0.52	5.9e-7	Longevity;Endometriosis;
SKCM	cis	rs17711722	0.727	rs1880555	chr7:65432567	T/C	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.63	5.48	0.53	5.11e-7	Calcium levels;
SKCM	cis	rs17345786	0.861	rs17402964	chr3:101067945	C/T	cg11279151	chr3:101281821	RG9MTD1	-0.61	-4.93	-0.49	4.5e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7927771	0.524	rs7942074	chr11:47720509	T/C	cg20307385	chr11:47447363	PSMC3	0.71	5.63	0.54	2.67e-7	Subjective well-being;
SKCM	cis	rs561341	0.941	rs8081016	chr17:30331751	A/G	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs8072100	0.576	rs7216112	chr17:45406345	C/T	cg25173405	chr17:45401733	C17orf57	0.76	5.87	0.55	1.01e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs9581857	0.519	rs9581880	chr13:28105850	C/A	cg22138327	chr13:27999177	GTF3A	0.84	5.73	0.54	1.79e-7	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs12540874	0.542	rs3807562	chr7:50566671	G/A	cg18232548	chr7:50535776	DDC	-0.74	-5.52	-0.53	4.34e-7	Systemic sclerosis;
SKCM	cis	rs7666738	0.680	rs34267968	chr4:99002574	A/T	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9815354	0.812	rs10510729	chr3:41831998	G/A	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs2204008	0.658	rs11495742	chr12:38395688	C/A	cg13010199	chr12:38710504	ALG10B	0.69	4.89	0.48	5.2e-6	Bladder cancer;
SKCM	cis	rs1799949	0.965	rs8176161	chr17:41241390	C/A	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.01	-0.56	5.5e-8	Menopause (age at onset);
SKCM	cis	rs4803468	0.967	rs3786553	chr19:41902746	T/G	cg09537434	chr19:41945824	ATP5SL	-1.09	-12.85	-0.82	6.09e-21	Height;
SKCM	cis	rs7149337	1.000	rs8006432	chr14:51731306	A/T	cg23942311	chr14:51606299	NA	0.5	5.2	0.51	1.56e-6	Cancer;
SKCM	cis	rs910316	1.000	rs175492	chr14:75545220	A/C	cg08847533	chr14:75593920	NEK9	0.88	8.25	0.68	3.11e-12	Height;
SKCM	cis	rs763121	0.853	rs2294296	chr22:39053049	T/C	cg06022373	chr22:39101656	GTPBP1	0.72	4.96	0.49	4.08e-6	Menopause (age at onset);
SKCM	cis	rs4077515	0.839	rs1132005	chr9:139296927	T/C	cg14169450	chr9:139327907	INPP5E	0.51	5.17	0.5	1.79e-6	Ulcerative colitis;IgA nephropathy;Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs4727027	0.899	rs7791496	chr7:148863674	C/G	cg23583168	chr7:148888333	NA	-0.8	-6.62	-0.6	4.13e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs1395	0.848	rs6716850	chr2:27525350	G/A	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.51	5.01	0.49	3.37e-6	Blood metabolite levels;
SKCM	cis	rs62238980	0.614	rs117194706	chr22:32491317	C/G	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs9325144	0.560	rs10506125	chr12:39120287	C/T	cg13010199	chr12:38710504	ALG10B	0.69	6.05	0.57	4.65e-8	Morning vs. evening chronotype;
SKCM	cis	rs11764590	0.694	rs7801349	chr7:2085553	T/C	cg02825527	chr7:2087843	MAD1L1	-0.65	-5.12	-0.5	2.17e-6	Neuroticism;
SKCM	cis	rs4819052	0.808	rs11909411	chr21:46676556	A/C	cg20896738	chr21:46707857	POFUT2;LOC642852	0.64	4.82	0.48	6.85e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7659604	0.521	rs4833773	chr4:122689245	C/T	cg19671926	chr4:122722719	EXOSC9	0.75	6.77	0.61	2.11e-9	Type 2 diabetes;
SKCM	cis	rs6121246	0.559	rs6060950	chr20:30378031	T/C	cg13852791	chr20:30311386	BCL2L1	0.82	5.69	0.54	2.09e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs2645694	0.626	rs2703140	chr4:77830057	C/G	cg03477792	chr4:77819574	ANKRD56	0.57	6.42	0.59	9.57e-9	Emphysema distribution in smoking;
SKCM	cis	rs6570726	0.791	rs6914203	chr6:145899975	C/A	cg05347473	chr6:146136440	FBXO30	0.56	4.98	0.49	3.67e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs12477438	0.798	rs2309524	chr2:99659510	A/T	cg26064155	chr2:99771622	LIPT1;TSGA10	-0.72	-4.86	-0.48	6e-6	Chronic sinus infection;
SKCM	cis	rs801193	1.000	rs7788576	chr7:66148302	G/A	cg11764359	chr7:65958608	NA	-0.86	-6.6	-0.6	4.52e-9	Aortic root size;
SKCM	cis	rs10870270	0.917	rs9971362	chr10:133790150	T/C	cg17892150	chr10:133769511	PPP2R2D	-0.72	-5.1	-0.5	2.37e-6	Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals;
SKCM	cis	rs28595532	0.764	rs55913633	chr4:119747444	C/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs7666738	0.724	rs28451676	chr4:98966990	C/T	cg05340658	chr4:99064831	C4orf37	0.64	4.91	0.49	4.97e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2404602	0.692	rs12902452	chr15:76921465	T/C	cg23625390	chr15:77176239	SCAPER	0.61	5.33	0.52	9.13e-7	Blood metabolite levels;
SKCM	cis	rs933688	1.000	rs1035477	chr5:90743325	T/C	cg12630606	chr5:90679528	LOC100129716;ARRDC3	0.98	7.81	0.66	2.22e-11	Smoking behavior;
SKCM	cis	rs2839186	0.900	rs2839200	chr21:47709095	C/T	cg13012494	chr21:47604986	C21orf56	0.67	5.71	0.54	1.95e-7	Testicular germ cell tumor;
SKCM	cis	rs7659604	0.517	rs6856996	chr4:122671271	C/T	cg19748678	chr4:122722346	EXOSC9	0.73	5.29	0.51	1.09e-6	Type 2 diabetes;
SKCM	cis	rs73201462	1.000	rs2811522	chr3:128011423	A/G	cg09089421	chr3:127803668	RUVBL1	-1.0	-5.11	-0.5	2.22e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs2760061	0.626	rs1636192	chr1:228124688	A/G	cg18477163	chr1:228402036	OBSCN	-0.42	-4.83	-0.48	6.63e-6	Diastolic blood pressure;
SKCM	cis	rs2070488	0.775	rs4679066	chr3:38568527	A/G	cg01465620	chr3:38496096	LOC100128640;ACVR2B	-0.74	-5.79	-0.55	1.38e-7	Electrocardiographic conduction measures;
SKCM	cis	rs7666738	0.606	rs6839946	chr4:99076132	A/C	cg17366294	chr4:99064904	C4orf37	0.63	5.2	0.51	1.54e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs12464559	0.522	rs12472627	chr2:152633114	C/T	cg01189475	chr2:152685088	ARL5A	1.01	5.25	0.51	1.3e-6	Response to cognitive-behavioural therapy in anxiety disorder;
SKCM	cis	rs992157	0.731	rs1399132	chr2:219159770	G/A	cg00012203	chr2:219082015	ARPC2	0.73	5.76	0.55	1.6e-7	Colorectal cancer;
SKCM	cis	rs7937682	0.921	rs10891280	chr11:111433609	A/T	cg22437258	chr11:111473054	SIK2	-0.71	-5.15	-0.5	1.88e-6	Primary sclerosing cholangitis;
SKCM	cis	rs854765	0.547	rs2955378	chr17:17930253	G/A	cg04398451	chr17:18023971	MYO15A	-0.84	-6.78	-0.61	2.05e-9	Total body bone mineral density;
SKCM	cis	rs7659604	0.560	rs769238	chr4:122744942	G/A	cg20573242	chr4:122745356	CCNA2	0.75	6.39	0.59	1.11e-8	Type 2 diabetes;
SKCM	cis	rs1153858	1.000	rs8032904	chr15:45651309	C/T	cg21132104	chr15:45694354	SPATA5L1	0.93	7.94	0.67	1.22e-11	Homoarginine levels;
SKCM	cis	rs854765	0.693	rs11657074	chr17:17770355	G/A	cg04398451	chr17:18023971	MYO15A	0.83	6.49	0.59	7.17e-9	Total body bone mineral density;
SKCM	cis	rs909341	0.710	rs6011016	chr20:62302650	C/G	cg03999872	chr20:62272968	STMN3	0.55	4.85	0.48	6.23e-6	Atopic dermatitis;
SKCM	cis	rs875971	0.638	rs10249404	chr7:66046724	G/A	cg00343986	chr7:65444356	GUSB	-0.67	-4.93	-0.49	4.55e-6	Aortic root size;
SKCM	cis	rs12044355	0.927	rs11122321	chr1:231835610	A/C	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	0.76	5.66	0.54	2.38e-7	Alzheimer's disease;
SKCM	cis	rs1160297	0.576	rs724860	chr2:53099406	A/G	cg07782112	chr2:53107842	NA	0.59	6.33	0.58	1.41e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs9911578	1.000	rs12952832	chr17:56906254	T/C	cg12560992	chr17:57184187	TRIM37	0.94	7.55	0.65	7.01e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs6424115	1.000	rs34477640	chr1:24154067	T/C	cg15997130	chr1:24165203	NA	-0.62	-5.42	-0.52	6.33e-7	Immature fraction of reticulocytes;
SKCM	cis	rs2204008	0.720	rs11170774	chr12:38021722	C/T	cg26384229	chr12:38710491	ALG10B	-0.75	-6.26	-0.58	1.95e-8	Bladder cancer;
SKCM	cis	rs2836974	0.568	rs11910906	chr21:40685662	T/C	cg11890956	chr21:40555474	PSMG1	-0.82	-8.03	-0.67	8.09e-12	Cognitive function;
SKCM	cis	rs1577917	1.000	rs1999852	chr6:86705738	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.64	-5.54	-0.53	3.92e-7	Response to antipsychotic treatment;
SKCM	cis	rs9322193	0.923	rs9322196	chr6:149940781	T/G	cg07701084	chr6:150067640	NUP43	0.61	4.84	0.48	6.48e-6	Lung cancer;
SKCM	cis	rs11673344	0.764	rs474017	chr19:37454119	A/G	cg07624650	chr19:37064219	ZNF529	-0.78	-4.82	-0.48	7.05e-6	Obesity-related traits;
SKCM	cis	rs478304	0.651	rs7110576	chr11:65512057	T/G	cg17480646	chr11:65405466	SIPA1	-0.7	-5.63	-0.54	2.68e-7	Acne (severe);
SKCM	cis	rs3785574	0.582	rs62072238	chr17:61948841	A/T	cg06873352	chr17:61820015	STRADA	0.57	4.8	0.48	7.37e-6	Height;
SKCM	cis	rs561341	0.825	rs2008368	chr17:30347397	T/C	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs6952808	0.630	rs4719443	chr7:2161099	A/G	cg02951883	chr7:2050386	MAD1L1	-0.79	-7.44	-0.64	1.14e-10	Bipolar disorder and schizophrenia;
SKCM	cis	rs28386778	0.797	rs4968664	chr17:61851366	C/G	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs10193935	1.000	rs12618105	chr2:42414146	T/G	cg27598129	chr2:42591480	NA	-0.91	-6.64	-0.6	3.8e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7149337	0.804	rs4131981	chr14:51667504	A/T	cg23942311	chr14:51606299	NA	-0.61	-6.74	-0.61	2.46e-9	Cancer;
SKCM	cis	rs12148488	0.763	rs12900072	chr15:75307148	G/A	cg17294928	chr15:75287854	SCAMP5	0.68	4.98	0.49	3.72e-6	Caffeine consumption;
SKCM	cis	rs208520	0.690	rs6932475	chr6:66863155	G/A	cg07460842	chr6:66804631	NA	-1.06	-8.02	-0.67	8.53e-12	Exhaled nitric oxide output;
SKCM	cis	rs1218582	0.772	rs6669791	chr1:154845484	G/T	cg16680214	chr1:154839983	KCNN3	-0.55	-4.93	-0.49	4.57e-6	Prostate cancer;
SKCM	cis	rs66573146	0.901	rs55882710	chr4:7030704	G/A	cg00086871	chr4:6988644	TBC1D14	1.45	5.42	0.52	6.38e-7	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs394563	0.559	rs13219868	chr6:149686518	T/G	cg03678062	chr6:149772716	ZC3H12D	0.51	6.01	0.56	5.51e-8	Dupuytren's disease;
SKCM	cis	rs2842992	0.724	rs9347340	chr6:160188891	C/T	cg11366901	chr6:160182831	ACAT2	-0.91	-7.79	-0.66	2.35e-11	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs28386778	0.829	rs1877317	chr17:61776479	T/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	10.87	0.78	2.82e-17	Prudent dietary pattern;
SKCM	cis	rs875971	0.522	rs56028712	chr7:65466565	C/T	cg11987759	chr7:65425863	GUSB	-0.76	-6.75	-0.61	2.33e-9	Aortic root size;
SKCM	cis	rs10489202	0.513	rs4657731	chr1:168081255	C/T	cg24449463	chr1:168025552	DCAF6	-0.81	-7.61	-0.65	5.44e-11	Schizophrenia;
SKCM	cis	rs763121	0.815	rs12168758	chr22:38997269	C/G	cg06022373	chr22:39101656	GTPBP1	0.81	6.25	0.58	2.01e-8	Menopause (age at onset);
SKCM	cis	rs2739330	0.761	rs5760176	chr22:24402321	A/G	cg24846343	chr22:24311635	DDTL	-0.55	-4.94	-0.49	4.4e-6	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs7618501	0.699	rs3733135	chr3:49939587	G/A	cg24110177	chr3:50126178	RBM5	-0.63	-5.16	-0.5	1.86e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7666738	0.830	rs7662389	chr4:99019892	G/A	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs992157	0.835	rs10932768	chr2:219146199	T/A	cg20019365	chr2:219134978	PNKD;AAMP	-0.71	-6.08	-0.57	4.22e-8	Colorectal cancer;
SKCM	cis	rs62012628	0.527	rs28691842	chr15:79094196	A/G	cg04896959	chr15:78267971	NA	-0.66	-5.64	-0.54	2.66e-7	Diastolic blood pressure;
SKCM	cis	rs6952808	0.689	rs2008263	chr7:2048335	A/G	cg02951883	chr7:2050386	MAD1L1	-0.85	-8.01	-0.67	8.95e-12	Bipolar disorder and schizophrenia;
SKCM	cis	rs950776	0.790	rs2067808	chr15:78911780	G/A	cg06917634	chr15:78832804	PSMA4	0.82	6.57	0.6	5.1e-9	Sudden cardiac arrest;
SKCM	cis	rs7927771	0.770	rs11039203	chr11:47384597	A/G	cg05585544	chr11:47624801	NA	-0.59	-5.24	-0.51	1.33e-6	Subjective well-being;
SKCM	cis	rs1062177	0.855	rs6896664	chr5:151265274	A/G	cg00977110	chr5:151150581	G3BP1	0.75	6.07	0.57	4.43e-8	Preschool internalizing problems;
SKCM	cis	rs10504229	0.906	rs28447218	chr8:58170813	T/G	cg22535103	chr8:58192502	C8orf71	-0.69	-4.83	-0.48	6.72e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs9325144	0.600	rs12297194	chr12:38735803	A/G	cg26384229	chr12:38710491	ALG10B	-0.77	-6.57	-0.6	5.19e-9	Morning vs. evening chronotype;
SKCM	cis	rs1790761	0.667	rs1254123	chr11:67334812	T/C	cg00290607	chr11:67383545	NA	0.51	5.46	0.53	5.55e-7	Mean corpuscular volume;
SKCM	cis	rs7216064	1.000	rs12600941	chr17:65918807	A/G	cg12091567	chr17:66097778	LOC651250	-0.73	-4.87	-0.48	5.78e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs1577917	0.917	rs35283633	chr6:86690787	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.64	-5.54	-0.53	3.92e-7	Response to antipsychotic treatment;
SKCM	cis	rs12472274	0.941	rs36066920	chr2:239074480	T/G	cg17459225	chr2:239074497	NA	0.61	4.94	0.49	4.43e-6	Phospholipid levels (plasma);
SKCM	cis	rs2370759	1.000	rs79487858	chr10:32616405	T/C	cg01819863	chr10:32635814	EPC1	0.98	5.43	0.52	6.26e-7	Sexual dysfunction (female);
SKCM	cis	rs6977660	0.714	rs9969171	chr7:19827328	T/C	cg05791153	chr7:19748676	TWISTNB	0.77	5.02	0.49	3.23e-6	Thyroid stimulating hormone;
SKCM	cis	rs8103278	1.000	rs8109951	chr19:46289503	C/T	cg11657440	chr19:46296263	DMWD	-0.96	-6.91	-0.62	1.16e-9	Coronary artery disease;
SKCM	cis	rs873946	0.586	rs61862838	chr10:134572282	C/T	cg18305652	chr10:134549665	INPP5A	0.58	5.64	0.54	2.62e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs2412819	0.542	rs62018894	chr15:43912987	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	0.76	5.52	0.53	4.3e-7	Lung cancer;
SKCM	cis	rs611744	0.647	rs628206	chr8:109247873	A/G	cg18478394	chr8:109455254	TTC35	0.66	5.33	0.52	9.43e-7	Dupuytren's disease;
SKCM	cis	rs116095464	0.558	rs10052012	chr5:231908	T/C	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs10504229	0.683	rs67492041	chr8:58140077	G/A	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	trans	rs1814175	0.587	rs7948538	chr11:50021353	A/C	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs7666738	0.830	rs4699593	chr4:98980628	A/G	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2842992	0.724	rs2273827	chr6:160211339	C/A	cg11366901	chr6:160182831	ACAT2	0.84	7.09	0.63	5.2e-10	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs9399135	0.967	rs4895434	chr6:135293365	G/A	cg24558204	chr6:135376177	HBS1L	0.56	5.07	0.5	2.64e-6	Red blood cell count;
SKCM	cis	rs7618501	0.516	rs2856236	chr3:50161717	A/C	cg05072774	chr3:49840536	C3orf54	0.67	5.15	0.5	1.94e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9790314	0.695	rs7630763	chr3:160864865	T/C	cg03342759	chr3:160939853	NMD3	-0.66	-6.72	-0.61	2.68e-9	Morning vs. evening chronotype;
SKCM	cis	rs1790761	0.554	rs3758938	chr11:67402362	T/G	cg14500267	chr11:67383377	NA	-0.53	-5.13	-0.5	2.08e-6	Mean corpuscular volume;
SKCM	cis	rs8072100	0.811	rs9889709	chr17:45445229	C/T	cg08085267	chr17:45401833	C17orf57	-0.68	-5.66	-0.54	2.39e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	trans	rs17685	0.884	rs8565	chr7:75630274	T/C	cg19862616	chr7:65841803	NCRNA00174	-0.91	-8.07	-0.67	6.96e-12	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7666738	0.830	rs6811940	chr4:98777898	G/A	cg17366294	chr4:99064904	C4orf37	0.57	4.86	0.48	6.02e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1048238	0.506	rs1262788	chr1:16215608	G/C	cg21385522	chr1:16154831	NA	-0.65	-5.53	-0.53	4.04e-7	Systolic blood pressure;
SKCM	cis	rs7772486	0.875	rs10872583	chr6:146396699	G/T	cg23711669	chr6:146136114	FBXO30	-0.84	-7.78	-0.66	2.47e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs782590	0.764	rs935177	chr2:55826761	C/G	cg18811423	chr2:55921094	PNPT1	0.94	6.83	0.61	1.63e-9	Metabolic syndrome;
SKCM	cis	rs1218582	0.741	rs11264291	chr1:154914797	C/T	cg03351412	chr1:154909251	PMVK	0.77	6.54	0.6	5.87e-9	Prostate cancer;
SKCM	cis	rs2836950	0.520	rs1980407	chr21:40543961	T/C	cg11644478	chr21:40555479	PSMG1	-0.67	-5.3	-0.51	1.04e-6	Menarche (age at onset);
SKCM	cis	rs7635838	0.718	rs2249051	chr3:11403234	G/A	cg00170343	chr3:11313890	ATG7	0.7	5.58	0.53	3.29e-7	HDL cholesterol;
SKCM	cis	rs908922	0.676	rs545418	chr1:152497338	C/T	cg09873164	chr1:152488093	CRCT1	0.76	5.93	0.56	7.7e-8	Hair morphology;
SKCM	cis	rs7666738	0.515	rs10015315	chr4:98700137	A/G	cg17366294	chr4:99064904	C4orf37	0.62	4.95	0.49	4.19e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1552244	1.000	rs3846177	chr3:10068572	G/T	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs10540	1.000	rs12786555	chr11:506229	C/T	cg03352830	chr11:487213	PTDSS2	0.94	4.91	0.49	4.87e-6	Body mass index;
SKCM	cis	rs57221529	0.766	rs72703042	chr5:579269	C/T	cg26208419	chr5:473447	SLC9A3;LOC25845	1.05	5.37	0.52	7.95e-7	Lung disease severity in cystic fibrosis;
SKCM	cis	rs8180040	0.726	rs6774733	chr3:46991241	G/A	cg27129171	chr3:47204927	SETD2	0.82	6.47	0.59	7.73e-9	Colorectal cancer;
SKCM	trans	rs8073060	0.586	rs2523114	chr17:34023762	G/A	cg19694781	chr19:47549865	TMEM160	-1.08	-8.61	-0.7	6.04e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs801193	0.569	rs2659893	chr7:66199993	G/A	cg18876405	chr7:65276391	NA	0.61	6.02	0.56	5.36e-8	Aortic root size;
SKCM	cis	rs4819052	0.807	rs7283915	chr21:46671288	T/C	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.36	0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs2239547	0.657	rs2071040	chr3:52864860	A/G	cg11645453	chr3:52864694	ITIH4	0.81	7.49	0.65	9.22e-11	Schizophrenia;
SKCM	cis	rs2153535	0.580	rs2143356	chr6:8517675	C/T	cg07606381	chr6:8435919	SLC35B3	0.87	6.38	0.59	1.17e-8	Motion sickness;
SKCM	cis	rs1395	0.778	rs62128743	chr2:27390169	A/G	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.5	4.99	0.49	3.65e-6	Blood metabolite levels;
SKCM	cis	rs2288912	0.620	rs875255	chr19:45493635	C/G	cg26269196	chr19:45648796	NA	-0.64	-5.33	-0.52	9.09e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs2204008	0.546	rs11519978	chr12:37998170	C/T	cg26384229	chr12:38710491	ALG10B	0.8	6.2	0.57	2.47e-8	Bladder cancer;
SKCM	cis	rs941408	1.000	rs1736184	chr19:2810248	G/A	cg17333051	chr19:2783644	SGTA	0.4	4.84	0.48	6.34e-6	Total cholesterol levels;
SKCM	cis	rs13010713	0.840	rs12619531	chr2:182057640	T/G	cg21995919	chr2:182322279	ITGA4	-0.53	-5.12	-0.5	2.18e-6	Celiac disease;
SKCM	cis	rs748404	0.697	rs567357	chr15:43571390	C/G	cg02155558	chr15:43621948	ADAL;LCMT2	0.72	5.88	0.55	9.48e-8	Lung cancer;
SKCM	cis	rs2228479	0.850	rs11645916	chr16:89835234	G/A	cg06558623	chr16:89946397	TCF25	1.11	5.26	0.51	1.23e-6	Skin colour saturation;
SKCM	cis	rs914615	0.552	rs4460629	chr1:155135335	T/C	cg02153340	chr1:155202674	NA	-0.56	-4.83	-0.48	6.72e-6	Urinary albumin-to-creatinine ratio;
SKCM	cis	rs55962025	0.842	rs362306	chr4:3242100	C/T	cg11471262	chr4:3318911	RGS12	-0.74	-5.89	-0.55	9.26e-8	Parental longevity (mother's age at death);
SKCM	cis	rs35146811	0.700	rs858513	chr7:99825558	G/A	cg22906224	chr7:99728672	NA	-0.71	-5.61	-0.54	2.99e-7	Coronary artery disease;
SKCM	cis	rs801193	1.000	rs3800812	chr7:66223461	T/C	cg11764359	chr7:65958608	NA	0.82	6.23	0.58	2.18e-8	Aortic root size;
SKCM	cis	rs1405130	0.869	rs12990323	chr2:235572019	C/T	cg21542780	chr2:234763377	HJURP	-0.64	-4.89	-0.48	5.21e-6	Coronary artery disease;
SKCM	cis	rs1799949	0.930	rs4584865	chr17:41424919	C/G	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.18	-0.57	2.68e-8	Menopause (age at onset);
SKCM	cis	rs3820068	0.603	rs72647138	chr1:15980929	C/T	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs2832077	0.527	rs11088095	chr21:30223188	A/T	cg24692254	chr21:30365293	RNF160	-0.75	-5.62	-0.54	2.79e-7	Cognitive test performance;
SKCM	cis	rs6121246	0.609	rs6087783	chr20:30421224	T/G	cg13852791	chr20:30311386	BCL2L1	0.84	5.75	0.55	1.65e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs11043280	0.703	rs11043275	chr12:122402723	T/C	cg13699009	chr12:122356056	WDR66	0.54	6.53	0.59	6.11e-9	Mean platelet volume;
SKCM	cis	rs10916772	0.938	rs2296451	chr1:20685997	A/G	cg05356564	chr1:21044770	KIF17	-0.62	-5.15	-0.5	1.88e-6	Psychosis proneness (perceptual aberration scale);
SKCM	cis	rs6952808	0.582	rs11763870	chr7:2027448	T/C	cg03354898	chr7:1950403	MAD1L1	0.51	4.78	0.48	8.2e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs2050392	0.965	rs2480279	chr10:30700032	C/T	cg25182066	chr10:30743637	MAP3K8	-0.69	-5.83	-0.55	1.21e-7	Inflammatory bowel disease;
SKCM	cis	rs1580019	0.587	rs9638880	chr7:32552401	A/G	cg06627557	chr7:32535165	LSM5;AVL9	0.94	9.12	0.72	6.39e-14	Cognitive ability;
SKCM	cis	rs933688	1.000	rs10059163	chr5:90742444	C/T	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.92	6.76	0.61	2.21e-9	Smoking behavior;
SKCM	cis	rs8072100	1.000	rs3809868	chr17:45750596	G/A	cg25173405	chr17:45401733	C17orf57	0.6	5.57	0.53	3.43e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs28595532	0.920	rs114165587	chr4:119779525	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs1153858	1.000	rs3809472	chr15:45694318	G/T	cg21132104	chr15:45694354	SPATA5L1	0.89	7.21	0.63	3.12e-10	Homoarginine levels;
SKCM	cis	rs34779708	0.733	rs59287215	chr10:35543994	C/T	cg03585969	chr10:35415529	CREM	0.74	5.42	0.52	6.41e-7	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs7666738	0.830	rs6819177	chr4:99040907	T/C	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs941873	0.836	rs6480931	chr10:81108482	T/C	cg09469691	chr10:81107165	PPIF	0.7	6.59	0.6	4.65e-9	Height;
SKCM	cis	rs9611565	0.512	rs9611672	chr22:42209922	A/G	cg03806693	chr22:41940476	POLR3H	-1.08	-5.96	-0.56	7.02e-8	Vitiligo;
SKCM	cis	rs6138458	0.847	rs56312312	chr20:24959386	C/A	cg26195577	chr20:24973756	C20orf3	1.32	8.99	0.71	1.15e-13	Blood protein levels;
SKCM	cis	rs58688157	0.921	rs12805435	chr11:612355	T/C	cg03576123	chr11:487126	PTDSS2	-0.84	-5.45	-0.53	5.64e-7	Systemic lupus erythematosus;
SKCM	cis	rs654950	0.967	rs621727	chr1:41984612	C/T	cg06885757	chr1:42089581	HIVEP3	-0.56	-5.82	-0.55	1.26e-7	Airway imaging phenotypes;
SKCM	cis	rs514406	0.861	rs1571979	chr1:53237526	G/A	cg16325326	chr1:53192061	ZYG11B	-1.01	-11.9	-0.8	3.23e-19	Monocyte count;
SKCM	cis	rs8072100	0.688	rs8079142	chr17:45442049	G/A	cg25173405	chr17:45401733	C17orf57	-0.62	-4.88	-0.48	5.5e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs8177253	0.761	rs12490148	chr3:133523973	C/T	cg01448562	chr3:133502909	NA	-0.55	-4.77	-0.48	8.44e-6	Iron status biomarkers;
SKCM	cis	rs1577917	0.958	rs10944144	chr6:86537755	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.87	-8.71	-0.7	3.92e-13	Response to antipsychotic treatment;
SKCM	cis	rs561341	0.689	rs578635	chr17:30289897	A/C	cg23018236	chr17:30244563	NA	-0.5	-5.24	-0.51	1.31e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs910316	0.967	rs4903293	chr14:75656568	A/G	cg08847533	chr14:75593920	NEK9	-0.98	-9.72	-0.74	4.28e-15	Height;
SKCM	cis	rs875971	0.577	rs35072105	chr7:65609817	A/G	cg18876405	chr7:65276391	NA	-0.82	-7.56	-0.65	6.5500000000000006e-11	Aortic root size;
SKCM	cis	rs2836974	0.897	rs2836932	chr21:40546717	G/A	cg11644478	chr21:40555479	PSMG1	0.97	10.21	0.76	5.08e-16	Cognitive function;
SKCM	cis	rs597539	0.652	rs686877	chr11:68637169	G/A	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.84	5.61	0.54	3e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs2153535	0.580	rs1328862	chr6:8526681	A/T	cg23788917	chr6:8435910	SLC35B3	0.68	4.98	0.49	3.66e-6	Motion sickness;
SKCM	cis	rs7143963	0.943	rs10132977	chr14:103370119	C/T	cg23020514	chr14:103360112	TRAF3	0.79	6.88	0.61	1.34e-9	Body mass index;
SKCM	cis	rs6545883	0.965	rs6734830	chr2:61731112	G/A	cg15711740	chr2:61764176	XPO1	-0.73	-5.27	-0.51	1.19e-6	Tuberculosis;
SKCM	cis	rs10911232	0.507	rs4442336	chr1:182982538	T/G	ch.1.3577855R	chr1:183094577	LAMC1	0.72	6.43	0.59	9.39e-9	Hypertriglyceridemia;
SKCM	cis	rs1707322	0.752	rs3811435	chr1:46125790	C/A	cg03146154	chr1:46216737	IPP	0.82	6.1	0.57	3.89e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs867186	1.000	rs117316403	chr20:33693175	T/G	cg04194272	chr20:33683537	NA	-1.2	-6.6	-0.6	4.55e-9	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs2228479	0.867	rs62056110	chr16:89946388	A/C	cg06558623	chr16:89946397	TCF25	1.26	6.97	0.62	9.17e-10	Skin colour saturation;
SKCM	cis	rs1325195	0.537	rs2793804	chr1:179201000	C/T	cg10806749	chr1:179558114	NA	0.59	5.44	0.52	5.84e-7	IgE grass sensitization;
SKCM	cis	rs4919087	0.923	rs11189038	chr10:98974765	A/T	cg25902810	chr10:99078978	FRAT1	0.65	5.11	0.5	2.23e-6	Monocyte count;
SKCM	cis	rs7296418	0.816	rs1790096	chr12:123710364	C/T	cg00376283	chr12:123451042	ABCB9	0.91	7.45	0.64	1.08e-10	Platelet count;
SKCM	cis	rs1878931	0.696	rs35175748	chr16:3445427	C/G	cg26668626	chr16:3451006	ZNF174;ZNF434	1.11	11.0	0.78	1.55e-17	Body mass index (adult);
SKCM	cis	rs12541335	0.639	rs6993855	chr8:22163797	A/G	cg26039829	chr8:22132926	PIWIL2	0.64	5.58	0.53	3.36e-7	Hypertriglyceridemia;
SKCM	cis	rs12142240	0.698	rs56049453	chr1:46835468	A/G	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs1577917	1.000	rs10455456	chr6:86670322	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.66	-5.72	-0.54	1.88e-7	Response to antipsychotic treatment;
SKCM	cis	rs12047808	0.730	rs3818587	chr1:179520422	C/T	cg09822482	chr1:179519214	C1orf125	0.96	4.77	0.48	8.48e-6	Multiple sclerosis (age of onset);
SKCM	cis	rs17685	0.753	rs11982200	chr7:75714883	T/C	cg01364799	chr7:75623366	TMEM120A	-0.72	-5.81	-0.55	1.31e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs875971	1.000	rs778694	chr7:65871558	A/G	cg18876405	chr7:65276391	NA	0.67	6.65	0.6	3.61e-9	Aortic root size;
SKCM	cis	rs2075371	0.611	rs12707154	chr7:134015832	C/T	cg11752832	chr7:134001865	SLC35B4	0.56	4.82	0.48	7.07e-6	Mean platelet volume;
SKCM	cis	rs2180341	0.711	rs4371861	chr6:127568447	G/T	cg24812749	chr6:127587940	RNF146	0.62	4.93	0.49	4.51e-6	Breast cancer;
SKCM	cis	rs6879260	0.963	rs11738924	chr5:179727308	A/G	cg02891314	chr5:179741120	GFPT2	-0.74	-5.71	-0.54	1.94e-7	Height;
SKCM	cis	rs7666738	0.830	rs4699331	chr4:99059816	T/C	cg17366294	chr4:99064904	C4orf37	0.61	4.93	0.49	4.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10751667	0.666	rs7395402	chr11:950293	A/G	cg11024522	chr11:1074749	MUC2	-0.45	-4.94	-0.49	4.37e-6	Alzheimer's disease (late onset);
SKCM	trans	rs66573146	1.000	rs7686168	chr4:6986057	C/A	cg07817883	chr1:32538562	TMEM39B	2.0	8.02	0.67	8.59e-12	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs5750830	0.594	rs9611169	chr22:39783027	C/T	cg11247378	chr22:39784982	NA	-0.48	-6.04	-0.56	5.02e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs769267	0.896	rs7250893	chr19:19625547	A/G	cg26732615	chr19:19648335	CILP2;YJEFN3	0.67	7.06	0.62	6e-10	Tonsillectomy;
SKCM	cis	rs116095464	0.558	rs6878061	chr5:223072	A/G	cg22496380	chr5:211416	CCDC127	-0.96	-5.27	-0.51	1.18e-6	Breast cancer;
SKCM	cis	rs244731	0.920	rs244707	chr5:176555636	A/T	cg17509989	chr5:176798049	RGS14	0.87	6.2	0.57	2.5e-8	Urate levels in lean individuals;
SKCM	cis	rs9894429	0.966	rs7405901	chr17:79587813	T/C	cg18240062	chr17:79603768	NPLOC4	0.77	7.46	0.65	1.02e-10	Eye color traits;
SKCM	cis	rs763121	0.853	rs4821809	chr22:39065743	G/C	cg06022373	chr22:39101656	GTPBP1	0.78	5.63	0.54	2.7e-7	Menopause (age at onset);
SKCM	cis	rs2120019	0.938	rs5020842	chr15:75322310	T/C	cg17294928	chr15:75287854	SCAMP5	-0.91	-8.87	-0.71	1.97e-13	Blood trace element (Zn levels);
SKCM	cis	rs10751667	0.666	rs7483273	chr11:951127	T/C	cg06064525	chr11:970664	AP2A2	-0.54	-4.93	-0.49	4.49e-6	Alzheimer's disease (late onset);
SKCM	cis	rs2463822	0.858	rs2513037	chr11:62084822	A/T	cg06239285	chr11:62104954	ASRGL1	-1.13	-5.61	-0.54	2.92e-7	Chronic obstructive pulmonary disease-related biomarkers;
SKCM	cis	rs2243480	1.000	rs3885839	chr7:65290403	G/T	cg07424592	chr7:64974309	NA	0.99	4.9	0.49	5.08e-6	Diabetic kidney disease;
SKCM	cis	rs2721195	1.000	rs11784118	chr8:145684978	G/A	cg15857475	chr8:145742913	RECQL4;LRRC14	-0.77	-6.62	-0.6	4.13e-9	Age at first birth;
SKCM	cis	rs9902453	1.000	rs4575590	chr17:28361969	C/G	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.81	-5.78	-0.55	1.45e-7	Coffee consumption (cups per day);
SKCM	cis	rs12477438	0.520	rs8179690	chr2:99795300	A/T	cg14399236	chr2:99771627	LIPT1;TSGA10	-0.92	-7.99	-0.67	9.76e-12	Chronic sinus infection;
SKCM	cis	rs7666738	0.830	rs6854994	chr4:98977624	C/G	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4481887	0.741	rs28616194	chr1:248531904	T/A	cg22724847	chr1:248512586	OR14C36	0.59	5.07	0.5	2.63e-6	Common traits (Other);
SKCM	cis	rs7937682	0.889	rs551825	chr11:111480116	C/G	cg09085632	chr11:111637200	PPP2R1B	-0.97	-10.08	-0.75	8.74e-16	Primary sclerosing cholangitis;
SKCM	cis	rs2228479	0.717	rs1061647	chr16:89806063	G/C	cg06558623	chr16:89946397	TCF25	1.02	4.89	0.48	5.36e-6	Skin colour saturation;
SKCM	cis	rs1577917	0.958	rs12213343	chr6:86443019	C/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.37	-0.52	7.89e-7	Response to antipsychotic treatment;
SKCM	cis	rs1405130	0.869	rs11695178	chr2:235578462	G/A	cg17841421	chr2:235704848	NA	-0.59	-4.89	-0.48	5.36e-6	Coronary artery disease;
SKCM	cis	rs4665809	0.590	rs7604564	chr2:26501953	C/A	cg26119090	chr2:26468346	HADHA;HADHB	1.05	8.22	0.68	3.6e-12	Gut microbiome composition (summer);
SKCM	cis	rs34779708	0.733	rs12249814	chr10:35542757	T/C	cg03585969	chr10:35415529	CREM	0.74	5.42	0.52	6.41e-7	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs7772486	0.790	rs6924159	chr6:146267873	A/G	cg23711669	chr6:146136114	FBXO30	-0.76	-7.4	-0.64	1.38e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs10489202	1.000	rs17485889	chr1:168018840	G/T	cg24449463	chr1:168025552	DCAF6	-0.79	-6.16	-0.57	3.02e-8	Schizophrenia;
SKCM	cis	rs7618501	0.633	rs2624843	chr3:49997963	G/A	cg24110177	chr3:50126178	RBM5	-0.6	-5.1	-0.5	2.36e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1005277	0.579	rs1780137	chr10:38501475	C/G	cg25427524	chr10:38739819	LOC399744	-0.71	-6.45	-0.59	8.59e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs9581857	0.547	rs9579087	chr13:28059780	G/A	cg22138327	chr13:27999177	GTF3A	0.89	5.91	0.56	8.55e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs9902453	1.000	rs9906340	chr17:28398977	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.79	-5.82	-0.55	1.24e-7	Coffee consumption (cups per day);
SKCM	cis	rs58688157	0.960	rs10902178	chr11:612843	T/G	cg16486109	chr11:613632	IRF7	1.07	7.29	0.64	2.17e-10	Systemic lupus erythematosus;
SKCM	cis	rs9916302	0.904	rs55689507	chr17:37404436	G/C	cg07936489	chr17:37558343	FBXL20	-0.86	-6.98	-0.62	8.74e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs875971	0.522	rs781144	chr7:65440344	C/G	cg18876405	chr7:65276391	NA	0.87	8.12	0.68	5.54e-12	Aortic root size;
SKCM	cis	rs11098499	0.954	rs10006525	chr4:120408931	T/G	cg24375607	chr4:120327624	NA	0.66	5.09	0.5	2.44e-6	Corneal astigmatism;
SKCM	cis	rs28386778	0.897	rs7222189	chr17:61836372	T/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.12	11.27	0.79	4.92e-18	Prudent dietary pattern;
SKCM	cis	rs7666738	0.830	rs7696715	chr4:98938486	T/C	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	trans	rs8073060	0.544	rs7210966	chr17:33986334	G/C	cg19694781	chr19:47549865	TMEM160	-1.0	-8.56	-0.7	7.62e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs951366	0.617	rs9438393	chr1:205782718	A/G	cg24739457	chr1:205821442	NA	0.53	4.9	0.49	5.07e-6	Menarche (age at onset);
SKCM	cis	rs2836950	0.501	rs2056844	chr21:40670460	G/C	cg11644478	chr21:40555479	PSMG1	-0.64	-5.02	-0.49	3.17e-6	Menarche (age at onset);
SKCM	cis	rs637571	0.522	rs1786175	chr11:65754808	G/A	cg26695010	chr11:65641043	EFEMP2	-0.72	-5.5	-0.53	4.69e-7	Eosinophil percentage of white cells;
SKCM	cis	rs6753739	0.784	rs6730783	chr2:219922835	A/G	cg09617556	chr2:219924408	IHH	0.48	5.03	0.49	3.08e-6	Height;
SKCM	cis	rs2404602	0.716	rs4886813	chr15:76838221	C/T	cg23625390	chr15:77176239	SCAPER	-0.6	-5.24	-0.51	1.34e-6	Blood metabolite levels;
SKCM	cis	rs10411262	0.967	rs10413222	chr19:47200618	C/T	cg14189808	chr19:47611440	ZC3H4	0.46	4.8	0.48	7.42e-6	Tonsillectomy;
SKCM	cis	rs9303401	0.659	rs12944971	chr17:56988801	A/T	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.31	0.51	1.02e-6	Cognitive test performance;
SKCM	cis	rs17685	0.753	rs10085567	chr7:75734206	A/C	cg01364799	chr7:75623366	TMEM120A	-0.79	-6.37	-0.58	1.23e-8	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2463822	1.000	rs1406384	chr11:62083530	A/G	cg06239285	chr11:62104954	ASRGL1	-1.25	-5.93	-0.56	7.79e-8	Chronic obstructive pulmonary disease-related biomarkers;
SKCM	cis	rs4919087	0.923	rs11189037	chr10:98974707	C/G	cg25902810	chr10:99078978	FRAT1	0.65	5.11	0.5	2.23e-6	Monocyte count;
SKCM	cis	rs7666738	0.830	rs6855393	chr4:99056534	T/C	cg17366294	chr4:99064904	C4orf37	0.61	4.98	0.49	3.73e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs3847687	1.000	rs34853396	chr12:131519265	G/T	cg25772418	chr12:131519998	GPR133	-0.48	-4.98	-0.49	3.7e-6	Longevity;
SKCM	cis	rs2228479	0.850	rs11644213	chr16:89837367	C/T	cg06558623	chr16:89946397	TCF25	-1.11	-5.26	-0.51	1.23e-6	Skin colour saturation;
SKCM	cis	rs1568889	0.838	rs10458896	chr11:28057957	T/C	cg06544937	chr11:28130018	METT5D1;KIF18A	0.89	8.44	0.69	1.31e-12	Bipolar disorder;
SKCM	cis	rs1552244	1.000	rs7610821	chr3:10136150	C/T	cg02579736	chr3:10068473	FANCD2;CIDECP	1.23	6.92	0.62	1.13e-9	Alzheimer's disease;
SKCM	cis	rs7208859	0.623	rs55961983	chr17:29119286	G/A	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs10870270	1.000	rs11146324	chr10:133767445	A/C	cg17892150	chr10:133769511	PPP2R2D	-0.66	-4.86	-0.48	5.92e-6	Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals;
SKCM	cis	rs2204008	0.604	rs2320521	chr12:38253789	A/G	cg13010199	chr12:38710504	ALG10B	0.69	4.92	0.49	4.72e-6	Bladder cancer;
SKCM	cis	rs17065868	1.000	rs9525992	chr13:45183906	G/A	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs8072100	0.967	rs4580230	chr17:45738861	G/A	cg25173405	chr17:45401733	C17orf57	-0.59	-5.49	-0.53	4.83e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs8008758	0.517	rs1620117	chr14:101696931	C/A	cg26224664	chr14:101693935	NA	-0.43	-5.59	-0.53	3.22e-7	Body mass index (alcohol intake interaction);
SKCM	cis	rs7811142	0.830	rs28495773	chr7:99943583	A/T	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.22	8.01	0.67	9.19e-12	Platelet count;
SKCM	cis	rs55962025	0.883	rs362336	chr4:3213832	G/A	cg21096898	chr4:3318625	RGS12	-0.66	-5.04	-0.5	2.9e-6	Parental longevity (mother's age at death);
SKCM	cis	rs9300255	0.537	rs1618679	chr12:123650714	A/G	cg00376283	chr12:123451042	ABCB9	0.82	5.61	0.54	3e-7	Neutrophil percentage of white cells;
SKCM	cis	rs10751667	0.643	rs7479473	chr11:929111	C/T	cg06064525	chr11:970664	AP2A2	-0.55	-5.09	-0.5	2.46e-6	Alzheimer's disease (late onset);
SKCM	cis	rs694739	1.000	rs499425	chr11:64105929	A/G	cg23796481	chr11:64053134	BAD;GPR137	-0.79	-6.29	-0.58	1.73e-8	Alopecia areata;Crohn's disease;Psoriasis vulgaris;
SKCM	cis	rs28595532	0.844	rs115202072	chr4:119732458	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.52	0.53	4.28e-7	Cannabis dependence symptom count;
SKCM	cis	rs2857078	0.745	rs4793085	chr17:42320732	A/C	cg09913183	chr17:42254507	C17orf65;ASB16	-0.66	-5.83	-0.55	1.18e-7	Red cell distribution width;Reticulocyte count;
SKCM	cis	rs1003719	0.788	rs2835595	chr21:38466203	G/T	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs870825	0.616	rs7660939	chr4:185640792	T/C	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs9910055	0.636	rs7089	chr17:42269017	T/C	cg10896456	chr17:42255109	ASB16;C17orf65	0.68	7.28	0.64	2.25e-10	Total body bone mineral density;
SKCM	cis	rs6977660	1.000	rs6973890	chr7:19820497	T/C	cg05791153	chr7:19748676	TWISTNB	0.79	5.34	0.52	9.05e-7	Thyroid stimulating hormone;
SKCM	cis	rs7618501	0.602	rs2240326	chr3:50128386	G/A	cg05072774	chr3:49840536	C3orf54	0.71	5.48	0.53	5e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs2839186	0.934	rs17176520	chr21:47682081	T/C	cg13126279	chr21:47581558	C21orf56	-0.63	-5.42	-0.52	6.37e-7	Testicular germ cell tumor;
SKCM	cis	rs8017423	0.967	rs4904656	chr14:90721442	G/T	cg04374321	chr14:90722782	PSMC1	1.03	9.44	0.73	1.55e-14	Mortality in heart failure;
SKCM	trans	rs561341	0.941	rs736678	chr17:30347423	G/T	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs7772486	0.875	rs6913797	chr6:146413758	A/G	cg05347473	chr6:146136440	FBXO30	0.64	5.83	0.55	1.19e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2858942	0.780	rs2858014	chr16:248357	T/C	cg03788090	chr16:233062	NA	-0.6	-4.85	-0.48	6.26e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs477692	0.905	rs485579	chr10:131425492	T/G	cg11019008	chr10:131425282	MGMT	0.49	4.81	0.48	7.26e-6	Response to temozolomide;
SKCM	cis	rs420259	0.516	rs801754	chr16:23597878	T/A	cg10006042	chr16:23042421	NA	0.36	4.85	0.48	6.15e-6	Bipolar disorder;
SKCM	cis	rs17065868	0.803	rs9316089	chr13:45203538	T/C	cg10246903	chr13:45222710	NA	0.95	5.35	0.52	8.5e-7	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs3780486	0.505	rs10117038	chr9:33122626	T/C	cg13443165	chr9:33130375	B4GALT1	-0.53	-4.89	-0.48	5.23e-6	IgG glycosylation;
SKCM	cis	rs4319547	0.656	rs10734918	chr12:122921512	A/C	cg23029597	chr12:123009494	RSRC2	-0.77	-5.82	-0.55	1.22e-7	Body mass index;
SKCM	cis	rs4727027	0.933	rs757738	chr7:148872351	T/G	cg23583168	chr7:148888333	NA	-0.78	-6.54	-0.6	5.86e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs67311347	0.544	rs13097602	chr3:40339247	T/C	cg13409248	chr3:40428643	ENTPD3	-0.56	-5.22	-0.51	1.44e-6	Renal cell carcinoma;
SKCM	cis	rs9910055	0.821	rs4473241	chr17:42281282	G/T	cg19774624	chr17:42201019	HDAC5	-0.9	-7.87	-0.67	1.68e-11	Total body bone mineral density;
SKCM	cis	rs941873	0.868	rs2233718	chr10:81108956	A/G	cg09469691	chr10:81107165	PPIF	0.74	7.3	0.64	2.15e-10	Height;
SKCM	cis	rs853679	1.000	rs735765	chr6:28170297	G/A	cg06761719	chr6:27280190	POM121L2	0.79	4.85	0.48	6.3e-6	Depression;
SKCM	cis	rs7666738	0.791	rs34437628	chr4:99029232	C/G	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs854765	0.624	rs11652144	chr17:17733934	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	-0.95	-7.11	-0.63	4.78e-10	Total body bone mineral density;
SKCM	cis	rs9875589	0.509	rs2607761	chr3:14091428	A/G	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.49	4.98	0.49	3.73e-6	Ovarian reserve;
SKCM	cis	rs1971762	0.583	rs7979659	chr12:54086579	A/G	cg16917193	chr12:54089295	NA	0.59	4.85	0.48	6.15e-6	Height;
SKCM	cis	rs2204008	0.774	rs11180977	chr12:38263094	G/T	cg13010199	chr12:38710504	ALG10B	0.69	4.92	0.49	4.72e-6	Bladder cancer;
SKCM	cis	rs1451375	0.617	rs1376524	chr7:50563582	G/A	cg18232548	chr7:50535776	DDC	-0.76	-5.02	-0.49	3.23e-6	Malaria;
SKCM	cis	rs9916302	0.847	rs7218670	chr17:37500424	G/A	cg07936489	chr17:37558343	FBXL20	0.85	7.28	0.64	2.26e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs701145	0.585	rs2596629	chr3:153931142	A/C	cg17054900	chr3:154042577	DHX36	1.19	5.1	0.5	2.37e-6	Coronary artery disease;
SKCM	cis	rs4819052	0.724	rs1304487	chr21:46657283	C/G	cg02159808	chr21:46707872	POFUT2;LOC642852	-0.67	-5.09	-0.5	2.45e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7772486	0.875	rs10457796	chr6:146416087	T/G	cg05347473	chr6:146136440	FBXO30	0.63	5.58	0.53	3.4e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7811142	0.887	rs4074838	chr7:100032665	G/A	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.34	0.69	2.1e-12	Platelet count;
SKCM	cis	rs554111	0.891	rs531044	chr1:21057011	T/C	cg01072550	chr1:21505969	NA	-0.58	-5.03	-0.5	3.04e-6	Facial morphology (factor 17, height of vermillion upper lip);
SKCM	cis	rs7666738	0.830	rs4699601	chr4:99034429	G/A	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2413583	0.591	rs114556035	chr22:39734647	C/T	cg17798944	chr22:39715225	SNORD43;RPL3	0.93	5.27	0.51	1.16e-6	Ulcerative colitis;Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs875971	0.660	rs7807930	chr7:66087165	C/T	cg05627663	chr7:65219948	SNORA22;CCT6P1	-0.56	-4.81	-0.48	7.26e-6	Aortic root size;
SKCM	cis	rs4665809	0.652	rs2241739	chr2:26411894	C/T	cg26119090	chr2:26468346	HADHA;HADHB	-0.98	-7.21	-0.63	3.19e-10	Gut microbiome composition (summer);
SKCM	cis	rs72781680	1.000	rs17762782	chr2:24126493	A/G	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	cis	rs951366	0.789	rs823110	chr1:205701078	G/C	cg26354017	chr1:205819088	PM20D1	1.01	8.85	0.71	2.06e-13	Menarche (age at onset);
SKCM	cis	rs478304	0.627	rs11604568	chr11:65511336	G/A	cg17480646	chr11:65405466	SIPA1	-0.7	-5.63	-0.54	2.68e-7	Acne (severe);
SKCM	cis	rs875971	1.000	rs7789768	chr7:65938980	A/C	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs4423214	1.000	rs4944959	chr11:71168234	C/T	cg05163923	chr11:71159392	DHCR7	-0.77	-7.62	-0.65	5.02e-11	Vitamin D levels;
SKCM	cis	rs1577917	0.771	rs9362233	chr6:86358247	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-1.01	-11.41	-0.79	2.64e-18	Response to antipsychotic treatment;
SKCM	cis	rs3785574	0.962	rs2247435	chr17:61892862	G/A	cg01411255	chr17:61851458	DDX42;CCDC47	1.16	12.75	0.82	9.1e-21	Height;
SKCM	cis	rs875971	1.000	rs6460295	chr7:65882728	T/C	cg18876405	chr7:65276391	NA	0.67	6.65	0.6	3.61e-9	Aortic root size;
SKCM	cis	rs7829975	0.777	rs486781	chr8:8639740	A/G	cg06636001	chr8:8085503	FLJ10661	-0.86	-7.82	-0.66	2.09e-11	Mood instability;
SKCM	cis	rs2120019	0.938	rs2304903	chr15:75315778	A/G	cg09165964	chr15:75287851	SCAMP5	-0.85	-8.74	-0.7	3.44e-13	Blood trace element (Zn levels);
SKCM	cis	rs3820068	0.603	rs56032936	chr1:15970953	T/C	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs1801251	0.929	rs10933409	chr2:233629386	A/G	cg08000102	chr2:233561755	GIGYF2	0.89	7.19	0.63	3.47e-10	Coronary artery disease;
SKCM	cis	rs2153535	0.504	rs9405393	chr6:8467432	G/T	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs2839186	0.872	rs13052233	chr21:47707284	G/T	cg13012494	chr21:47604986	C21orf56	0.67	5.71	0.54	1.95e-7	Testicular germ cell tumor;
SKCM	cis	rs7769051	1.000	rs7765224	chr6:133101624	T/C	cg22852734	chr6:133119734	C6orf192	0.99	4.99	0.49	3.53e-6	Type 2 diabetes nephropathy;
SKCM	cis	rs2204008	0.743	rs2127952	chr12:37995364	G/T	cg26384229	chr12:38710491	ALG10B	0.79	6.58	0.6	4.85e-9	Bladder cancer;
SKCM	cis	rs2204008	0.774	rs3910796	chr12:38230660	G/T	cg13010199	chr12:38710504	ALG10B	0.65	4.84	0.48	6.52e-6	Bladder cancer;
SKCM	cis	rs2404602	0.552	rs11072613	chr15:76961526	A/C	cg23625390	chr15:77176239	SCAPER	-0.84	-7.48	-0.65	9.42e-11	Blood metabolite levels;
SKCM	cis	rs72634258	0.796	rs6703955	chr1:8165975	C/G	cg00042356	chr1:8021962	PARK7	-0.93	-6.13	-0.57	3.3e-8	Inflammatory bowel disease;
SKCM	cis	rs7811142	0.830	rs118119933	chr7:99939050	C/T	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.12	5.97	0.56	6.64e-8	Platelet count;
SKCM	cis	rs959260	0.557	rs4788887	chr17:73323876	C/G	cg14668889	chr17:73230827	NUP85	-0.75	-6.29	-0.58	1.72e-8	Systemic lupus erythematosus;
SKCM	cis	rs801193	1.000	rs1553610	chr7:66197233	T/C	cg11987759	chr7:65425863	GUSB	-0.69	-5.91	-0.56	8.69e-8	Aortic root size;
SKCM	cis	rs9389248	0.737	rs56358308	chr6:135306980	A/T	cg24558204	chr6:135376177	HBS1L	0.7	6.53	0.59	6.11e-9	High light scatter reticulocyte percentage of red cells;
SKCM	cis	rs684232	0.666	rs2254134	chr17:628664	A/G	cg12384639	chr17:618140	VPS53	0.69	5.41	0.52	6.81e-7	Prostate cancer;
SKCM	cis	rs2404602	0.692	rs12911174	chr15:77149943	G/A	cg23625390	chr15:77176239	SCAPER	0.59	5.12	0.5	2.13e-6	Blood metabolite levels;
SKCM	cis	rs11098499	0.863	rs12498539	chr4:120468370	C/T	cg24375607	chr4:120327624	NA	0.69	5.47	0.53	5.35e-7	Corneal astigmatism;
SKCM	cis	rs1707322	0.929	rs785513	chr1:46538320	T/C	cg03146154	chr1:46216737	IPP	-0.8	-5.97	-0.56	6.68e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs62238980	0.614	rs78247456	chr22:32442531	G/C	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs12497850	1.000	rs4858831	chr3:48735558	C/T	cg07636037	chr3:49044803	WDR6	0.85	8.52	0.69	9.02e-13	Parkinson's disease;
SKCM	cis	rs2032447	0.670	rs71557318	chr6:26118570	T/C	cg18357526	chr6:26021779	HIST1H4A	-0.79	-6.46	-0.59	8.1e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs2832191	0.716	rs7284006	chr21:30475186	T/A	cg08807101	chr21:30365312	RNF160	0.74	6.09	0.57	4.06e-8	Dental caries;
SKCM	cis	rs2303745	0.589	rs7246262	chr19:17392483	C/G	cg04248312	chr19:17393744	ANKLE1	-1.11	-8.18	-0.68	4.15e-12	Systemic lupus erythematosus;
SKCM	cis	rs7824557	0.767	rs17797443	chr8:11164012	T/C	cg21775007	chr8:11205619	TDH	0.72	6.0	0.56	5.73e-8	Retinal vascular caliber;
SKCM	cis	rs6951245	0.872	rs112309216	chr7:1100296	A/T	cg03188948	chr7:1209495	NA	1.13	6.27	0.58	1.89e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs6879260	1.000	rs7725605	chr5:179732678	T/G	cg23248424	chr5:179741104	GFPT2	-0.7	-6.12	-0.57	3.44e-8	Height;
SKCM	cis	rs11718455	0.960	rs1852037	chr3:44003720	G/T	cg21419209	chr3:44054225	NA	0.63	5.1	0.5	2.31e-6	Coronary artery disease;
SKCM	cis	rs28595532	0.920	rs114094671	chr4:119753540	G/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs250585	0.516	rs457683	chr16:23591215	C/A	cg09934309	chr16:23461721	COG7	-0.94	-6.12	-0.57	3.57e-8	Egg allergy;
SKCM	cis	rs9926296	0.593	rs6500456	chr16:89888341	T/C	cg01097406	chr16:89675127	NA	-0.45	-5.42	-0.52	6.52e-7	Vitiligo;
SKCM	cis	rs12142240	0.698	rs112089006	chr1:46812360	C/T	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	trans	rs3780486	0.757	rs10813949	chr9:33123464	G/A	cg20290983	chr6:43655470	MRPS18A	1.01	12.01	0.81	2.05e-19	IgG glycosylation;
SKCM	cis	rs9543976	1.000	rs8192762	chr13:76176680	A/T	cg16409306	chr13:76195284	LMO7	0.84	4.79	0.48	7.87e-6	Diabetic retinopathy;
SKCM	cis	rs34563280	1	rs34563280	chr11:47811496	CT/C	cg20307385	chr11:47447363	PSMC3	0.71	5.48	0.53	5.11e-7	Plateletcrit;
SKCM	cis	rs870825	0.616	rs55685500	chr4:185614810	G/A	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs2204008	0.805	rs2874289	chr12:38258420	G/A	cg13010199	chr12:38710504	ALG10B	0.69	4.92	0.49	4.72e-6	Bladder cancer;
SKCM	cis	rs4975616	0.773	rs414965	chr5:1324121	G/A	cg07493874	chr5:1342172	CLPTM1L	-0.66	-5.76	-0.55	1.6e-7	Lung cancer;
SKCM	cis	rs798554	0.759	rs1636255	chr7:2892804	A/C	cg19346786	chr7:2764209	NA	0.66	6.79	0.61	1.96e-9	Height;
SKCM	cis	rs62238980	0.614	rs80272272	chr22:32475924	C/T	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs9926296	0.712	rs258332	chr16:89727683	G/A	cg01097406	chr16:89675127	NA	0.56	5.66	0.54	2.41e-7	Vitiligo;
SKCM	cis	rs4803468	1.000	rs11883104	chr19:41923799	T/C	cg14132834	chr19:41945861	ATP5SL	-0.77	-6.08	-0.57	4.18e-8	Height;
SKCM	cis	rs9611565	0.546	rs34077262	chr22:42061639	A/G	cg03806693	chr22:41940476	POLR3H	1.04	7.46	0.65	1.04e-10	Vitiligo;
SKCM	cis	rs6541297	0.887	rs6541295	chr1:230281698	A/G	cg05784532	chr1:230284198	GALNT2	0.65	4.98	0.49	3.69e-6	Coronary artery disease;
SKCM	cis	rs514406	0.861	rs4926576	chr1:53226775	C/T	cg16325326	chr1:53192061	ZYG11B	-1.01	-11.9	-0.8	3.23e-19	Monocyte count;
SKCM	cis	rs1557488	0.553	rs4935993	chr11:126666284	C/A	cg12689529	chr11:126335883	KIRREL3	-0.86	-4.97	-0.49	3.87e-6	Attention deficit hyperactivity disorder and conduct disorder;
SKCM	cis	rs10504073	0.647	rs4873098	chr8:50021041	T/C	cg00325661	chr8:49890786	NA	0.82	7.02	0.62	7.13e-10	Blood metabolite ratios;
SKCM	cis	rs4660306	0.677	rs11211110	chr1:45904815	C/T	cg24296786	chr1:45957014	TESK2	0.82	4.77	0.48	8.45e-6	Homocysteine levels;
SKCM	cis	rs7666738	0.791	rs1896156	chr4:99020882	C/G	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9660180	0.967	rs9660106	chr1:1797947	A/G	cg23982607	chr1:1823379	GNB1	-0.73	-6.09	-0.57	4.08e-8	Body mass index;
SKCM	cis	rs732765	0.734	rs10142036	chr14:75126992	T/A	cg25946216	chr14:74253857	C14orf43	-0.92	-6.0	-0.56	5.93e-8	Non-small cell lung cancer;
SKCM	cis	rs1218582	0.745	rs1580943	chr1:154865125	G/A	cg06221963	chr1:154839813	KCNN3	-0.58	-5.84	-0.55	1.13e-7	Prostate cancer;
SKCM	cis	rs6977660	1.000	rs5017194	chr7:19820035	A/T	cg07541023	chr7:19748670	TWISTNB	0.71	4.86	0.48	6.02e-6	Thyroid stimulating hormone;
SKCM	cis	rs992157	0.644	rs6741757	chr2:219182748	T/C	cg20019365	chr2:219134978	PNKD;AAMP	0.73	5.88	0.55	9.69e-8	Colorectal cancer;
SKCM	cis	rs4237845	0.537	rs7969844	chr12:58278271	C/T	cg00677455	chr12:58241039	CTDSP2	0.86	7.75	0.66	2.8e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs72634258	0.519	rs4908487	chr1:7937437	C/T	cg00042356	chr1:8021962	PARK7	0.86	6.01	0.56	5.55e-8	Inflammatory bowel disease;
SKCM	cis	rs13256369	0.802	rs12541520	chr8:8564146	G/T	cg15556689	chr8:8085844	FLJ10661	0.68	4.96	0.49	3.97e-6	Obesity-related traits;
SKCM	cis	rs16866061	1.000	rs16866061	chr2:225439844	A/G	cg12698349	chr2:225449008	CUL3	1.02	8.71	0.7	4e-13	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs7666738	0.830	rs7686456	chr4:99019695	T/C	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs8017423	1.000	rs769044	chr14:90671138	A/G	cg04374321	chr14:90722782	PSMC1	0.9	7.79	0.66	2.44e-11	Mortality in heart failure;
SKCM	cis	rs28386778	0.897	rs9912557	chr17:61784963	C/A	cg06873352	chr17:61820015	STRADA	0.75	6.24	0.58	2.1e-8	Prudent dietary pattern;
SKCM	cis	rs1348850	0.632	rs1358328	chr2:178517532	G/A	cg02961200	chr2:178257176	LOC100130691;AGPS	0.72	4.8	0.48	7.54e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs992157	0.764	rs1870124	chr2:219187740	C/T	cg20019365	chr2:219134978	PNKD;AAMP	0.74	5.94	0.56	7.66e-8	Colorectal cancer;
SKCM	cis	rs950027	0.584	rs1145086	chr15:45654327	A/G	cg21132104	chr15:45694354	SPATA5L1	0.76	5.84	0.55	1.13e-7	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs3789045	0.774	rs4252697	chr1:204501383	C/T	cg17419461	chr1:204415978	PIK3C2B	-0.84	-5.96	-0.56	6.92e-8	Educational attainment (college completion);
SKCM	cis	rs501916	0.796	rs75186419	chr15:48043934	G/A	cg16110827	chr15:48056943	SEMA6D	-0.64	-5.21	-0.51	1.49e-6	Inflammatory bowel disease;Ulcerative colitis;
SKCM	cis	rs9388451	0.874	rs13209968	chr6:126089285	G/C	cg05901451	chr6:126070800	HEY2	-0.82	-8.38	-0.69	1.69e-12	Brugada syndrome;
SKCM	cis	rs10848704	1.000	rs10848704	chr12:2882544	A/G	cg19995117	chr12:2880862	NA	-0.54	-4.91	-0.49	4.93e-6	Quantitative traits;
SKCM	cis	rs12142240	0.660	rs72890715	chr1:46852077	A/G	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs4925325	0.955	rs1776262	chr20:60516023	G/T	cg13770153	chr20:60521292	NA	0.89	6.61	0.6	4.3e-9	Obesity-related traits;
SKCM	cis	rs12477438	0.520	rs7605843	chr2:99811894	C/T	cg14399236	chr2:99771627	LIPT1;TSGA10	0.92	7.99	0.67	9.76e-12	Chronic sinus infection;
SKCM	cis	rs9894429	0.634	rs9709130	chr17:79583948	C/T	cg18240062	chr17:79603768	NPLOC4	0.68	5.9	0.56	8.85e-8	Eye color traits;
SKCM	cis	rs34779708	0.931	rs68039650	chr10:35385499	C/A	cg03585969	chr10:35415529	CREM	0.79	6.34	0.58	1.4e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs28785552	0.769	rs28796114	chr19:53234319	T/C	cg10871876	chr19:53194124	ZNF83	0.67	4.83	0.48	6.73e-6	Response to paliperidone in schizophrenia (PANSS score);
SKCM	cis	rs1552244	0.515	rs67626468	chr3:10161518	C/A	cg00149659	chr3:10157352	C3orf10	1.13	5.45	0.53	5.74e-7	Alzheimer's disease;
SKCM	cis	rs2239547	0.563	rs6445547	chr3:52908577	T/C	cg11645453	chr3:52864694	ITIH4	0.76	6.87	0.61	1.4e-9	Schizophrenia;
SKCM	cis	rs2153535	0.542	rs915353	chr6:8440370	A/G	cg07606381	chr6:8435919	SLC35B3	0.94	6.94	0.62	1.02e-9	Motion sickness;
SKCM	cis	rs4242434	0.927	rs34027561	chr8:22465385	T/C	cg03733263	chr8:22462867	KIAA1967	1.09	8.91	0.71	1.6e-13	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs2180341	0.920	rs1073931	chr6:127681762	A/T	cg24812749	chr6:127587940	RNF146	0.83	7.24	0.63	2.76e-10	Breast cancer;
SKCM	cis	rs644799	1.000	rs7749	chr11:95565789	G/A	cg03916912	chr11:95522834	CEP57;FAM76B	0.88	7.53	0.65	7.59e-11	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs28595532	0.545	rs55699931	chr4:119249835	G/A	cg21605333	chr4:119757512	SEC24D	0.96	5.21	0.51	1.47e-6	Cannabis dependence symptom count;
SKCM	cis	rs861020	0.630	rs685248	chr1:210008367	C/G	cg05527609	chr1:210001259	C1orf107	0.86	6.74	0.61	2.43e-9	Orofacial clefts;
SKCM	cis	rs7569084	0.687	rs934731	chr2:65683487	T/C	cg14775296	chr2:66672841	MEIS1	0.51	4.8	0.48	7.49e-6	Sum eosinophil basophil counts;
SKCM	cis	rs7296418	0.630	rs28419092	chr12:123812629	G/C	cg05973401	chr12:123451056	ABCB9	0.72	5.48	0.53	5.12e-7	Platelet count;
SKCM	cis	rs4819052	0.851	rs2236443	chr21:46678174	T/C	cg02159808	chr21:46707872	POFUT2;LOC642852	0.72	5.6	0.54	3.13e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs1801251	1.000	rs283468	chr2:233658309	C/T	cg08000102	chr2:233561755	GIGYF2	0.94	6.85	0.61	1.49e-9	Coronary artery disease;
SKCM	cis	rs478304	0.651	rs4930312	chr11:65499719	G/A	cg17480646	chr11:65405466	SIPA1	-0.71	-5.64	-0.54	2.62e-7	Acne (severe);
SKCM	cis	rs709400	0.628	rs7150317	chr14:103921691	C/G	cg26031613	chr14:104095156	KLC1	0.69	5.13	0.5	2.09e-6	Body mass index;
SKCM	cis	rs6089584	0.888	rs6061979	chr20:60617141	C/G	cg06108461	chr20:60628389	TAF4	-0.89	-8.72	-0.7	3.75e-13	Body mass index;
SKCM	cis	rs7927771	0.507	rs11039432	chr11:47873327	G/A	cg20307385	chr11:47447363	PSMC3	0.71	5.63	0.54	2.67e-7	Subjective well-being;
SKCM	cis	rs9899728	0.665	rs2307008	chr17:73042682	G/A	cg27626185	chr17:73056755	KCTD2	-0.9	-5.94	-0.56	7.36e-8	Alzheimer's disease or small vessel stroke;
SKCM	cis	rs875971	1.000	rs7789768	chr7:65938980	A/C	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	cis	rs12497850	0.931	rs11705888	chr3:48817289	T/C	cg07636037	chr3:49044803	WDR6	0.97	10.25	0.76	4.16e-16	Parkinson's disease;
SKCM	cis	rs28374715	0.578	rs17730589	chr15:41600878	T/C	cg18705301	chr15:41695430	NDUFAF1	-1.2	-12.56	-0.82	2.04e-20	Ulcerative colitis;
SKCM	cis	rs1577917	0.958	rs34230196	chr6:86526022	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.81	-0.66	2.19e-11	Response to antipsychotic treatment;
SKCM	cis	rs548181	0.736	rs497344	chr11:125470524	T/C	cg03464685	chr11:125439445	EI24	1.34	8.64	0.7	5.33e-13	Schizophrenia;Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);
SKCM	cis	rs28595532	0.920	rs115118317	chr4:119736613	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs514406	0.760	rs475969	chr1:53292607	T/A	cg24675658	chr1:53192096	ZYG11B	-0.74	-6.36	-0.58	1.26e-8	Monocyte count;
SKCM	cis	rs62244186	0.541	rs9859879	chr3:44840166	G/A	cg02073558	chr3:44770973	ZNF501	0.8	7.05	0.62	6.39e-10	Depressive symptoms;
SKCM	cis	rs2502731	1.000	rs2502731	chr9:130976557	A/G	cg13642260	chr9:130955380	CIZ1	-0.74	-5.81	-0.55	1.32e-7	Attention deficit hyperactivity disorder;
SKCM	cis	rs2836974	0.583	rs9981884	chr21:40585633	G/A	cg11890956	chr21:40555474	PSMG1	0.77	6.54	0.59	5.91e-9	Cognitive function;
SKCM	cis	rs738322	0.870	rs5750558	chr22:38582497	G/A	cg25457927	chr22:38595422	NA	0.56	6.79	0.61	2.01e-9	Cutaneous nevi;
SKCM	cis	rs28386778	0.897	rs2665832	chr17:61912261	C/T	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs1577917	0.958	rs12209259	chr6:86502348	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.88	-0.67	1.63e-11	Response to antipsychotic treatment;
SKCM	cis	rs55823223	0.648	rs72860389	chr17:73866071	C/T	cg08125733	chr17:73851984	WBP2	1.06	5.97	0.56	6.62e-8	Psoriasis;
SKCM	cis	rs1475911	1.000	rs2839467	chr21:43513200	A/G	cg24372256	chr21:43528868	UMODL1;C21orf128	0.69	4.83	0.48	6.81e-6	IgG glycosylation;
SKCM	cis	rs362272	0.505	rs10155132	chr4:3369500	A/G	cg00764545	chr4:3318001	RGS12	1.01	13.55	0.84	3.44e-22	Serum sulfate level;
SKCM	cis	rs10504073	0.647	rs10435574	chr8:49996028	G/A	cg00325661	chr8:49890786	NA	0.78	6.77	0.61	2.18e-9	Blood metabolite ratios;
SKCM	cis	rs4423214	1.000	rs7944926	chr11:71165625	A/G	cg05163923	chr11:71159392	DHCR7	0.83	8.06	0.67	7.35e-12	Vitamin D levels;
SKCM	cis	rs1218582	0.772	rs3738026	chr1:154919565	A/G	cg03351412	chr1:154909251	PMVK	0.75	6.28	0.58	1.79e-8	Prostate cancer;
SKCM	cis	rs7772486	0.686	rs1337839	chr6:146010239	A/G	cg23711669	chr6:146136114	FBXO30	-0.89	-8.89	-0.71	1.8e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9611565	0.649	rs5758344	chr22:41817685	G/A	cg03806693	chr22:41940476	POLR3H	1.09	6.75	0.61	2.3e-9	Vitiligo;
SKCM	cis	rs651907	1.000	rs665211	chr3:101600028	C/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.78	6.42	0.59	9.74e-9	Colorectal cancer;
SKCM	cis	rs2404602	1.000	rs2404740	chr15:76852143	C/T	cg23625390	chr15:77176239	SCAPER	0.74	7.26	0.63	2.52e-10	Blood metabolite levels;
SKCM	cis	rs10489202	0.686	rs12754453	chr1:167844896	A/T	cg24449463	chr1:168025552	DCAF6	-0.8	-4.79	-0.48	7.8e-6	Schizophrenia;
SKCM	cis	rs17685	0.725	rs4728548	chr7:75654632	A/T	cg01364799	chr7:75623366	TMEM120A	0.75	6.0	0.56	5.92e-8	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs8177253	0.965	rs4854760	chr3:133498741	C/T	cg16414030	chr3:133502952	NA	0.71	5.91	0.56	8.52e-8	Iron status biomarkers;
SKCM	cis	rs3820068	0.581	rs67806552	chr1:15927138	T/C	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs899997	0.862	rs57260218	chr15:78973772	C/T	cg04896959	chr15:78267971	NA	-0.56	-4.9	-0.49	5.03e-6	Coronary artery disease or large artery stroke;
SKCM	cis	rs1568889	1.000	rs7949704	chr11:28373543	A/G	cg06544937	chr11:28130018	METT5D1;KIF18A	0.87	6.63	0.6	4e-9	Bipolar disorder;
SKCM	cis	rs514406	0.793	rs4500255	chr1:53213279	A/G	cg16325326	chr1:53192061	ZYG11B	-0.88	-8.89	-0.71	1.75e-13	Monocyte count;
SKCM	cis	rs12142240	0.698	rs56049453	chr1:46835468	A/G	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs7829975	0.846	rs6601724	chr8:8544872	C/T	cg06636001	chr8:8085503	FLJ10661	-0.85	-7.03	-0.62	6.97e-10	Mood instability;
SKCM	cis	rs7248779	0.512	rs12610522	chr19:2413228	C/T	cg22729335	chr19:2427816	TIMM13	1.08	10.44	0.76	1.83e-16	Cortisol levels (saliva);
SKCM	cis	rs13256369	0.901	rs12681327	chr8:8566414	G/T	cg06636001	chr8:8085503	FLJ10661	0.78	6.01	0.56	5.67e-8	Obesity-related traits;
SKCM	cis	rs13118159	0.527	rs6599309	chr4:1388115	C/G	cg19318889	chr4:1322082	MAEA	0.76	5.1	0.5	2.3e-6	Longevity;
SKCM	cis	rs7100689	0.622	rs2994389	chr10:82062257	C/G	cg01528321	chr10:82214614	TSPAN14	0.75	6.26	0.58	1.91e-8	Post bronchodilator FEV1;
SKCM	cis	rs9790314	1.000	rs6794601	chr3:160946769	C/T	cg03342759	chr3:160939853	NMD3	-0.72	-7.87	-0.67	1.65e-11	Morning vs. evening chronotype;
SKCM	cis	rs3768617	0.510	rs20563	chr1:183085755	C/T	ch.1.3577855R	chr1:183094577	LAMC1	-0.79	-7.54	-0.65	7.12e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs2721195	0.845	rs4244611	chr8:145739924	G/A	cg15857475	chr8:145742913	RECQL4;LRRC14	0.9	9.21	0.72	4.28e-14	Age at first birth;
SKCM	cis	rs6952808	0.601	rs3778978	chr7:2159817	A/G	cg02951883	chr7:2050386	MAD1L1	-0.76	-6.97	-0.62	9.08e-10	Bipolar disorder and schizophrenia;
SKCM	cis	rs801193	0.569	rs13242290	chr7:66121885	G/A	cg18876405	chr7:65276391	NA	-0.65	-6.44	-0.59	8.99e-9	Aortic root size;
SKCM	cis	rs6565180	1.000	rs6565180	chr16:30361341	G/T	cg17640201	chr16:30407289	ZNF48	-0.93	-7.41	-0.64	1.29e-10	Tonsillectomy;
SKCM	cis	rs9814567	1.000	rs7433991	chr3:134312292	A/T	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs6500395	1.000	rs11647048	chr16:48623227	T/G	cg04672837	chr16:48644449	N4BP1	0.69	5.88	0.55	9.68e-8	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs11098499	0.954	rs10005644	chr4:120298477	T/C	cg09307838	chr4:120376055	NA	0.97	7.49	0.65	9.08e-11	Corneal astigmatism;
SKCM	cis	rs6495122	0.532	rs2472304	chr15:75044238	G/A	cg14664628	chr15:75095509	CSK	-0.89	-6.4	-0.59	1.06e-8	Caffeine consumption;Diastolic blood pressure;Coffee consumption;
SKCM	trans	rs8073060	0.586	rs7213804	chr17:34010931	T/G	cg19694781	chr19:47549865	TMEM160	-1.04	-8.28	-0.68	2.65e-12	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs28595532	0.748	rs17594978	chr4:119336398	T/C	cg21605333	chr4:119757512	SEC24D	0.95	4.91	0.49	4.92e-6	Cannabis dependence symptom count;
SKCM	cis	rs8016982	0.674	rs61980899	chr14:81676844	T/C	cg01989461	chr14:81687754	GTF2A1	0.89	7.53	0.65	7.5e-11	Schizophrenia;
SKCM	cis	rs801193	1.000	rs62466794	chr7:66191579	G/A	cg00343986	chr7:65444356	GUSB	0.7	5.19	0.51	1.63e-6	Aortic root size;
SKCM	cis	rs951366	0.617	rs708727	chr1:205767885	G/A	cg11965913	chr1:205819406	PM20D1	0.99	12.25	0.81	7.54e-20	Menarche (age at onset);
SKCM	cis	rs4481887	0.893	rs10888348	chr1:248448610	C/G	cg00666640	chr1:248458726	OR2T12	0.58	4.83	0.48	6.68e-6	Common traits (Other);
SKCM	cis	rs4727027	0.933	rs4725800	chr7:148862516	C/G	cg23583168	chr7:148888333	NA	-0.8	-6.62	-0.6	4.13e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs4925386	1.000	rs4925389	chr20:60922512	G/A	cg24112000	chr20:60950667	NA	0.63	6.16	0.57	3.02e-8	Colorectal cancer;Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs28595532	0.920	rs55649377	chr4:119752745	T/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs951366	0.789	rs823130	chr1:205714372	C/T	cg07157834	chr1:205819609	PM20D1	0.82	7.17	0.63	3.7e-10	Menarche (age at onset);
SKCM	cis	rs7824557	0.628	rs3174048	chr8:11184937	G/A	cg21775007	chr8:11205619	TDH	0.72	6.73	0.61	2.61e-9	Retinal vascular caliber;
SKCM	cis	rs9308433	0.529	rs4655244	chr1:214497580	A/G	cg06198575	chr1:214491504	SMYD2	0.81	5.09	0.5	2.41e-6	IgG glycosylation;
SKCM	cis	rs62064224	0.714	rs4795692	chr17:30636688	G/T	cg18200150	chr17:30822561	MYO1D	0.62	4.84	0.48	6.42e-6	Schizophrenia;
SKCM	cis	rs6120849	0.708	rs6087659	chr20:33606383	C/A	cg24642439	chr20:33292090	TP53INP2	0.94	4.89	0.48	5.23e-6	Protein C levels;
SKCM	cis	rs2836974	0.831	rs6517521	chr21:40551588	A/G	cg17971929	chr21:40555470	PSMG1	0.87	8.48	0.69	1.1e-12	Cognitive function;
SKCM	trans	rs1814175	0.588	rs1794144	chr11:49918233	A/G	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs1506636	1.000	rs2402669	chr7:123297460	C/G	cg03229431	chr7:123269106	ASB15	-0.64	-5.18	-0.51	1.7e-6	Plateletcrit;Platelet count;
SKCM	cis	rs801193	0.527	rs2707837	chr7:66181073	G/C	cg18876405	chr7:65276391	NA	0.61	6.01	0.56	5.49e-8	Aortic root size;
SKCM	cis	rs10927875	0.562	rs10803401	chr1:16147377	G/A	cg21385522	chr1:16154831	NA	-0.99	-12.1	-0.81	1.42e-19	Dilated cardiomyopathy;
SKCM	cis	rs3859192	0.599	rs2270401	chr17:38176256	A/T	cg17467752	chr17:38218738	THRA	-0.75	-6.28	-0.58	1.75e-8	White blood cell count;
SKCM	cis	rs7666738	0.753	rs2865957	chr4:99040725	G/A	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10823500	0.777	rs10509321	chr10:71985733	A/G	cg04118878	chr10:71993077	PPA1	-0.63	-4.92	-0.49	4.71e-6	Blood protein levels;
SKCM	cis	rs11098499	0.754	rs2964	chr4:120240131	T/C	cg09307838	chr4:120376055	NA	0.93	7.56	0.65	6.5500000000000006e-11	Corneal astigmatism;
SKCM	cis	rs25645	0.502	rs7223318	chr17:38108553	G/C	cg17467752	chr17:38218738	THRA	0.65	5.15	0.5	1.91e-6	Myeloid white cell count;
SKCM	cis	rs34779708	0.733	rs4444023	chr10:35548354	G/A	cg03585969	chr10:35415529	CREM	0.71	5.25	0.51	1.27e-6	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs6879260	0.963	rs1035412	chr5:179729328	C/T	cg02891314	chr5:179741120	GFPT2	-0.69	-5.65	-0.54	2.53e-7	Height;
SKCM	cis	rs7100689	0.646	rs4468295	chr10:82119276	C/G	cg01528321	chr10:82214614	TSPAN14	0.85	7.69	0.66	3.77e-11	Post bronchodilator FEV1;
SKCM	cis	rs28386778	0.897	rs4968597	chr17:61805747	G/A	cg01411255	chr17:61851458	DDX42;CCDC47	0.79	5.1	0.5	2.35e-6	Prudent dietary pattern;
SKCM	cis	rs2839186	0.934	rs4819221	chr21:47695417	G/T	cg11766577	chr21:47581405	C21orf56	0.67	5.66	0.54	2.44e-7	Testicular germ cell tumor;
SKCM	cis	rs16854884	0.657	rs1979910	chr3:143710268	A/C	cg06585982	chr3:143692056	C3orf58	0.85	7.82	0.66	2.1e-11	Economic and political preferences (feminism/equality);
SKCM	cis	rs1577917	0.958	rs11756510	chr6:86699794	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.64	-5.54	-0.53	3.92e-7	Response to antipsychotic treatment;
SKCM	cis	rs56104184	0.775	rs17272707	chr19:49404535	T/G	cg19746536	chr19:49375674	PPP1R15A	1.16	5.93	0.56	7.67e-8	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	trans	rs208520	0.690	rs207107	chr6:66794385	T/C	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-1.02	-7.49	-0.65	9.2e-11	Exhaled nitric oxide output;
SKCM	cis	rs17290760	1.000	rs7034650	chr9:32504316	A/G	cg00736523	chr9:32783202	TMEM215	-0.69	-4.77	-0.47	8.52e-6	Immune response to smallpox vaccine (IL-6);
SKCM	cis	rs11098499	0.954	rs6846442	chr4:120326323	G/A	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs208520	1.000	rs28773210	chr6:66993566	C/T	cg07460842	chr6:66804631	NA	0.87	5.96	0.56	6.95e-8	Exhaled nitric oxide output;
SKCM	cis	rs6582630	0.519	rs12578283	chr12:38325349	A/T	cg26384229	chr12:38710491	ALG10B	0.81	6.67	0.6	3.38e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs8072100	1.000	rs7210738	chr17:45757598	G/A	cg25173405	chr17:45401733	C17orf57	0.6	5.57	0.53	3.43e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs72634258	0.796	rs10746475	chr1:8168261	T/A	cg00042356	chr1:8021962	PARK7	-0.86	-5.71	-0.54	1.94e-7	Inflammatory bowel disease;
SKCM	cis	rs4803468	0.901	rs3745292	chr19:41888506	A/G	cg09537434	chr19:41945824	ATP5SL	-1.08	-13.01	-0.83	3.1e-21	Height;
SKCM	cis	rs798554	0.723	rs798518	chr7:2777825	A/G	cg14895029	chr7:2775587	GNA12	-0.68	-5.23	-0.51	1.39e-6	Height;
SKCM	cis	rs763121	0.819	rs5757237	chr22:39073835	G/C	cg06022373	chr22:39101656	GTPBP1	0.8	5.79	0.55	1.42e-7	Menopause (age at onset);
SKCM	cis	rs654950	0.934	rs662999	chr1:42001160	A/C	cg06885757	chr1:42089581	HIVEP3	0.61	5.65	0.54	2.55e-7	Airway imaging phenotypes;
SKCM	cis	rs2769264	0.546	rs12071705	chr1:151430504	G/C	cg18801370	chr1:151430492	POGZ	1.02	6.9	0.62	1.2e-9	Blood trace element (Cu levels);
SKCM	cis	rs12477438	0.501	rs11683107	chr2:99759235	T/A	cg26064155	chr2:99771622	LIPT1;TSGA10	1.01	9.39	0.73	1.86e-14	Chronic sinus infection;
SKCM	cis	rs1577917	0.771	rs7762321	chr6:86412146	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.89	9.15	0.72	5.56e-14	Response to antipsychotic treatment;
SKCM	cis	rs4819052	0.851	rs1056101	chr21:46678702	C/G	cg19498844	chr21:46707878	POFUT2;LOC642852	0.87	7.55	0.65	6.99e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs910316	1.000	rs7156328	chr14:75532941	T/C	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.85e-7	Height;
SKCM	cis	rs144079028	1	rs144079028	chr2:26109750	TTTTA/T	cg04917511	chr2:26785460	C2orf70	0.52	5.02	0.49	3.15e-6	Breast cancer;
SKCM	cis	rs6121246	0.738	rs2376996	chr20:30316667	T/A	cg11595048	chr20:30225325	COX4I2	0.67	5.21	0.51	1.5e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs9325144	0.647	rs11168741	chr12:38989120	C/T	cg26384229	chr12:38710491	ALG10B	-0.72	-6.6	-0.6	4.47e-9	Morning vs. evening chronotype;
SKCM	cis	rs2072499	1.000	rs2540173	chr1:156188214	A/G	cg24450063	chr1:156163899	SLC25A44	1.04	9.67	0.74	5.49e-15	Testicular germ cell tumor;
SKCM	cis	rs2839186	0.564	rs4819215	chr21:47623573	G/A	cg05896524	chr21:47604654	C21orf56	0.71	6.13	0.57	3.4e-8	Testicular germ cell tumor;
SKCM	cis	rs1348850	1.000	rs1348850	chr2:178418575	A/G	cg02961200	chr2:178257176	LOC100130691;AGPS	0.78	5.98	0.56	6.25e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	trans	rs2886497	0.894	rs2365888	chr10:23696355	A/G	cg09938664	chr11:119662882	NA	0.8	7.36	0.64	1.61e-10	Major depression and alcohol dependence;
SKCM	cis	rs11148252	0.512	rs9526950	chr13:53174463	C/A	cg12458913	chr13:53173898	NA	0.66	6.41	0.59	1.01e-8	Lewy body disease;
SKCM	cis	rs6952808	0.689	rs871924	chr7:2047845	A/G	cg21782813	chr7:2030301	MAD1L1	0.59	6.49	0.59	7.27e-9	Bipolar disorder and schizophrenia;
SKCM	cis	rs7666738	0.830	rs11726604	chr4:99000969	T/C	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs8060686	0.641	rs28548264	chr16:68211321	A/G	cg09117114	chr16:67998030	SLC12A4	-0.78	-5.08	-0.5	2.56e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs561341	1.000	rs560132	chr17:30320019	C/T	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.65	-0.65	4.56e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs62103177	0.584	rs9956207	chr18:77968392	A/G	cg27393146	chr18:77495563	CTDP1	0.84	5.84	0.55	1.13e-7	Opioid sensitivity;
SKCM	cis	rs4423214	1.000	rs12278461	chr11:71182185	C/T	cg05163923	chr11:71159392	DHCR7	0.81	7.55	0.65	6.83e-11	Vitamin D levels;
SKCM	cis	rs875971	0.964	rs9691480	chr7:65944306	A/C	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	cis	rs7618501	0.635	rs34080578	chr3:50026029	A/C	cg24110177	chr3:50126178	RBM5	-0.6	-5.11	-0.5	2.25e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs6495122	0.699	rs1378942	chr15:75077367	A/C	cg14664628	chr15:75095509	CSK	0.93	6.94	0.62	1.03e-9	Caffeine consumption;Diastolic blood pressure;Coffee consumption;
SKCM	cis	rs116095464	0.558	rs7725227	chr5:233517	G/A	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs7772486	0.623	rs9485021	chr6:146068797	A/G	cg23711669	chr6:146136114	FBXO30	-0.84	-9.08	-0.72	7.59e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2396545	0.634	rs35788385	chr11:570094	G/A	cg17114584	chr11:613792	IRF7	0.83	5.32	0.52	9.79e-7	Systemic lupus erythematosus and Systemic sclerosis;
SKCM	cis	rs9300255	0.602	rs10744147	chr12:123643729	A/G	cg05973401	chr12:123451056	ABCB9	0.78	5.29	0.51	1.09e-6	Neutrophil percentage of white cells;
SKCM	cis	rs951366	0.677	rs1775140	chr1:205672107	C/A	cg14159672	chr1:205819179	PM20D1	0.88	7.16	0.63	3.92e-10	Menarche (age at onset);
SKCM	cis	rs7917772	0.582	rs4919665	chr10:104366042	C/T	cg11453585	chr10:104263688	ACTR1A;SUFU	-0.63	-4.96	-0.49	4e-6	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs2153535	0.580	rs1832101	chr6:8460177	A/G	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs9913156	0.670	rs7219606	chr17:4561928	T/C	cg19197139	chr17:4613644	ARRB2	0.78	5.43	0.52	6.21e-7	Lymphocyte counts;
SKCM	cis	rs2070488	0.775	rs4407366	chr3:38521425	C/T	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.73	5.78	0.55	1.47e-7	Electrocardiographic conduction measures;
SKCM	cis	rs9467773	1.000	rs1321481	chr6:26538210	A/T	cg15659132	chr6:26577336	NA	0.6	5.71	0.54	1.99e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs9640161	0.658	rs74348353	chr7:150053655	C/A	cg10018233	chr7:150070692	REPIN1	0.66	5.17	0.51	1.77e-6	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs933688	1.000	rs10474353	chr5:90732285	A/C	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.94	6.54	0.6	5.73e-9	Smoking behavior;
SKCM	cis	rs2836974	0.644	rs719230	chr21:40676307	C/T	cg11890956	chr21:40555474	PSMG1	-0.81	-8.01	-0.67	8.94e-12	Cognitive function;
SKCM	cis	rs1153858	1.000	rs7169587	chr15:45640379	A/G	cg21132104	chr15:45694354	SPATA5L1	0.89	7.61	0.65	5.27e-11	Homoarginine levels;
SKCM	cis	rs2204008	0.818	rs7313608	chr12:38383428	C/A	cg26384229	chr12:38710491	ALG10B	-0.79	-6.59	-0.6	4.66e-9	Bladder cancer;
SKCM	cis	rs8017423	0.904	rs11623741	chr14:90804474	C/T	cg04374321	chr14:90722782	PSMC1	1.03	9.78	0.74	3.36e-15	Mortality in heart failure;
SKCM	cis	rs2228479	0.850	rs62054599	chr16:89808850	C/G	cg06558623	chr16:89946397	TCF25	1.03	5.52	0.53	4.2e-7	Skin colour saturation;
SKCM	cis	rs2836950	0.501	rs4818018	chr21:40694072	C/T	cg17971929	chr21:40555470	PSMG1	-0.65	-5.15	-0.5	1.91e-6	Menarche (age at onset);
SKCM	cis	rs807669	0.749	rs361787	chr22:19263698	C/T	cg02655711	chr22:19163373	SLC25A1	0.61	5.63	0.54	2.72e-7	Metabolite levels;
SKCM	cis	rs12911832	0.958	rs12912003	chr15:58986001	A/T	cg05156742	chr15:59063176	FAM63B	0.75	5.49	0.53	4.87e-7	Schizophrenia;
SKCM	cis	rs9911578	0.967	rs7222789	chr17:56819853	C/G	cg05425664	chr17:57184151	TRIM37	-0.69	-5.21	-0.51	1.52e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs17376456	0.825	rs10078941	chr5:93279029	C/T	cg21475434	chr5:93447410	FAM172A	1.04	5.19	0.51	1.62e-6	Diabetic retinopathy;
SKCM	cis	rs67460515	0.563	rs34630898	chr3:160827038	A/G	cg03342759	chr3:160939853	NMD3	-0.73	-6.29	-0.58	1.7e-8	Parkinson's disease;
SKCM	cis	rs523522	0.962	rs4766969	chr12:120988238	A/G	cg12219531	chr12:120966889	COQ5	0.91	7.82	0.66	2.11e-11	High light scatter reticulocyte count;
SKCM	cis	rs4243830	0.850	rs3986418	chr1:6621996	G/C	cg22792644	chr1:6614718	TAS1R1;NOL9	-1.23	-4.84	-0.48	6.43e-6	Body mass index;
SKCM	cis	rs2836974	0.568	rs419469	chr21:40537234	C/T	cg11644478	chr21:40555479	PSMG1	0.81	7.8	0.66	2.28e-11	Cognitive function;
SKCM	cis	rs854765	0.647	rs854769	chr17:18019011	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	-0.89	-6.66	-0.6	3.45e-9	Total body bone mineral density;
SKCM	cis	rs4665809	0.589	rs4665841	chr2:26448950	G/A	cg04944784	chr2:26401820	FAM59B	-0.74	-4.79	-0.48	7.81e-6	Gut microbiome composition (summer);
SKCM	cis	rs79839061	0.610	rs11248051	chr4:858332	C/T	cg07828340	chr4:882639	GAK	1.06	5.32	0.52	9.74e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs651907	0.535	rs34743741	chr3:101532448	C/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.78	6.72	0.61	2.65e-9	Colorectal cancer;
SKCM	cis	rs514406	0.683	rs10157120	chr1:53210888	A/G	cg16325326	chr1:53192061	ZYG11B	0.99	12.19	0.81	9.5e-20	Monocyte count;
SKCM	cis	rs11792861	0.591	rs7044275	chr9:111717138	T/C	cg14432460	chr9:111696404	IKBKAP;C9orf6	0.77	6.58	0.6	4.9e-9	Menarche (age at onset);
SKCM	cis	rs7666738	0.830	rs4334758	chr4:98971875	A/G	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs3091242	0.933	rs61775174	chr1:25787313	G/A	cg02931644	chr1:25747376	RHCE	-0.51	-4.93	-0.49	4.47e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs55962025	0.669	rs28403215	chr4:3172439	C/T	cg00764545	chr4:3318001	RGS12	-0.59	-5.24	-0.51	1.35e-6	Parental longevity (mother's age at death);
SKCM	cis	rs2836974	0.965	rs8130984	chr21:40639966	A/C	cg17971929	chr21:40555470	PSMG1	0.9	8.87	0.71	1.93e-13	Cognitive function;
SKCM	cis	rs10256972	0.552	rs6978842	chr7:1204599	A/C	cg09177884	chr7:1199841	ZFAND2A	-0.84	-7.53	-0.65	7.5e-11	Longevity;Endometriosis;
SKCM	cis	rs11098499	0.909	rs28793658	chr4:120307214	A/C	cg24375607	chr4:120327624	NA	0.65	4.97	0.49	3.87e-6	Corneal astigmatism;
SKCM	cis	rs7402982	0.934	rs6598539	chr15:99204483	T/C	cg03437748	chr15:99193247	IGF1R	0.88	5.84	0.55	1.15e-7	Birth weight;
SKCM	cis	rs6121246	0.909	rs6060644	chr20:30265652	G/A	cg11595048	chr20:30225325	COX4I2	0.67	5.21	0.51	1.5e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs6570726	1.000	rs373778	chr6:145873252	C/T	cg23711669	chr6:146136114	FBXO30	0.69	6.67	0.6	3.39e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4808199	0.948	rs2301668	chr19:19452249	G/A	cg03709012	chr19:19516395	GATAD2A	1.08	7.53	0.65	7.65e-11	Nonalcoholic fatty liver disease;
SKCM	cis	rs1405130	0.839	rs13018428	chr2:235565891	G/A	cg21542780	chr2:234763377	HJURP	-0.64	-4.89	-0.48	5.21e-6	Coronary artery disease;
SKCM	cis	rs78456975	0.506	rs13384333	chr2:1555531	A/C	cg01028140	chr2:1542097	TPO	-0.5	-5.02	-0.49	3.21e-6	Placebo response in major depressive disorder (% change in symptom score);
SKCM	cis	rs995000	0.895	rs597470	chr1:62917796	T/G	cg06896770	chr1:63153194	DOCK7	0.77	7.38	0.64	1.45e-10	Triglyceride levels;
SKCM	cis	rs11673344	0.764	rs472226	chr19:37458713	A/C	cg07624650	chr19:37064219	ZNF529	-0.78	-4.82	-0.48	7.05e-6	Obesity-related traits;
SKCM	cis	rs1044826	0.642	rs9859864	chr3:139091219	G/T	cg15131784	chr3:139108705	COPB2	-0.72	-5.26	-0.51	1.23e-6	Obesity-related traits;
SKCM	cis	rs2153535	0.623	rs2152346	chr6:8454652	A/G	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs3091242	0.836	rs34997029	chr1:25783823	A/G	cg27572855	chr1:25598939	RHD	-0.53	-5.06	-0.5	2.67e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs4481887	0.893	rs9651175	chr1:248446888	G/T	cg00666640	chr1:248458726	OR2T12	0.58	4.88	0.48	5.46e-6	Common traits (Other);
SKCM	cis	rs72717009	0.825	rs7529425	chr1:161479599	G/A	cg23840854	chr1:161414152	NA	-0.99	-5.66	-0.54	2.44e-7	Rheumatoid arthritis;
SKCM	cis	rs7103648	0.695	rs12577643	chr11:47467172	A/T	cg20307385	chr11:47447363	PSMC3	1.09	8.04	0.67	7.87e-12	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs7959452	0.640	rs11177599	chr12:69721970	G/A	cg20891283	chr12:69753455	YEATS4	0.8	7.6	0.65	5.59e-11	Blood protein levels;
SKCM	cis	rs3087591	0.960	rs2905803	chr17:29520056	T/C	cg24425628	chr17:29625626	OMG;NF1	0.61	4.87	0.48	5.75e-6	Hip circumference;
SKCM	cis	rs40363	0.645	rs1690450	chr16:3521051	G/A	cg27500918	chr16:2933308	FLYWCH2	0.71	4.9	0.49	5.13e-6	Tuberculosis;
SKCM	cis	rs9910055	0.664	rs433610	chr17:42197281	A/G	cg19774624	chr17:42201019	HDAC5	0.91	8.1	0.68	6.14e-12	Total body bone mineral density;
SKCM	trans	rs561341	1.000	rs2470243	chr17:30290955	C/T	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs2463822	0.925	rs72923272	chr11:62166832	G/A	cg06239285	chr11:62104954	ASRGL1	-1.26	-5.85	-0.55	1.08e-7	Chronic obstructive pulmonary disease-related biomarkers;
SKCM	cis	rs12142240	0.692	rs7532149	chr1:46824932	A/C	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs2836950	0.501	rs2056844	chr21:40670460	G/C	cg17971929	chr21:40555470	PSMG1	-0.73	-6.17	-0.57	2.86e-8	Menarche (age at onset);
SKCM	cis	rs4975616	0.869	rs31484	chr5:1337906	A/T	cg26373071	chr5:1325741	CLPTM1L	0.74	6.92	0.62	1.1e-9	Lung cancer;
SKCM	cis	rs6860806	0.507	rs272882	chr5:131669161	G/T	cg24060327	chr5:131705240	SLC22A5	-0.76	-4.94	-0.49	4.42e-6	Breast cancer;
SKCM	cis	rs7666738	0.830	rs58696666	chr4:99006913	C/T	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6495122	0.662	rs12898997	chr15:75090349	C/T	cg14664628	chr15:75095509	CSK	-0.93	-6.98	-0.62	8.62e-10	Caffeine consumption;Diastolic blood pressure;Coffee consumption;
SKCM	cis	rs13256369	0.851	rs13256611	chr8:8564341	G/A	cg06636001	chr8:8085503	FLJ10661	0.8	6.11	0.57	3.65e-8	Obesity-related traits;
SKCM	cis	rs7438704	0.552	rs380016	chr4:48296382	C/T	cg15299388	chr4:48491941	ZAR1	0.47	5.48	0.53	5.01e-7	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs453301	0.598	rs2921383	chr8:8892221	C/T	cg15556689	chr8:8085844	FLJ10661	0.75	5.9	0.56	8.75e-8	Joint mobility (Beighton score);
SKCM	cis	rs6545883	0.524	rs7561697	chr2:61519165	G/C	cg15711740	chr2:61764176	XPO1	0.66	5.12	0.5	2.17e-6	Tuberculosis;
SKCM	cis	rs4481887	0.800	rs10888342	chr1:248441999	A/G	cg00666640	chr1:248458726	OR2T12	0.64	5.82	0.55	1.23e-7	Common traits (Other);
SKCM	cis	rs2836974	0.867	rs77959119	chr21:40542768	G/A	cg11890956	chr21:40555474	PSMG1	1.08	13.57	0.84	3.12e-22	Cognitive function;
SKCM	cis	rs1799949	1.000	rs8176242	chr17:41217874	C/T	cg23758822	chr17:41437982	NA	0.94	7.89	0.67	1.51e-11	Menopause (age at onset);
SKCM	cis	rs1912528	0.778	rs769657	chr4:140877659	A/G	cg11128457	chr4:140864437	MAML3	0.57	4.89	0.48	5.36e-6	Educational attainment (years of education);
SKCM	cis	rs11098499	0.863	rs10018280	chr4:120478139	T/G	cg09307838	chr4:120376055	NA	1.0	8.27	0.68	2.8e-12	Corneal astigmatism;
SKCM	cis	rs941873	0.868	rs2181080	chr10:81121960	A/G	cg09469691	chr10:81107165	PPIF	0.79	6.89	0.62	1.27e-9	Height;
SKCM	cis	rs2463822	0.920	rs7924998	chr11:62073980	C/G	cg06239285	chr11:62104954	ASRGL1	-1.47	-6.35	-0.58	1.33e-8	Chronic obstructive pulmonary disease-related biomarkers;
SKCM	cis	rs2760061	0.626	rs672907	chr1:228120345	G/A	cg02753203	chr1:228287806	NA	-0.62	-5.03	-0.5	3.03e-6	Diastolic blood pressure;
SKCM	cis	rs1707322	0.717	rs3014246	chr1:46086077	C/T	cg03146154	chr1:46216737	IPP	-0.79	-5.42	-0.52	6.34e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs4803468	1.000	rs1473248	chr19:41923314	C/T	cg14132834	chr19:41945861	ATP5SL	0.75	5.69	0.54	2.16e-7	Height;
SKCM	cis	rs1801251	0.896	rs79793315	chr2:233690864	C/T	cg08000102	chr2:233561755	GIGYF2	-0.81	-6.53	-0.59	6.21e-9	Coronary artery disease;
SKCM	cis	rs8141529	0.509	rs5762863	chr22:29253335	A/C	cg02153584	chr22:29168773	CCDC117	0.65	4.93	0.49	4.46e-6	Lymphocyte counts;
SKCM	cis	rs116095464	0.850	rs10055295	chr5:243749	G/A	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs875971	0.862	rs10261398	chr7:65750164	A/G	cg18876405	chr7:65276391	NA	-0.64	-6.38	-0.59	1.18e-8	Aortic root size;
SKCM	cis	rs11822910	0.911	rs11828218	chr11:57196223	C/G	cg00522883	chr11:57194120	SLC43A3	0.75	6.94	0.62	1.01e-9	Platelet distribution width;
SKCM	cis	rs7666738	0.830	rs36028444	chr4:98968635	G/T	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs3820068	0.581	rs72645864	chr1:15921153	C/T	cg24675056	chr1:15929824	NA	0.77	5.54	0.53	4.01e-7	Systolic blood pressure;
SKCM	cis	rs7193541	0.826	rs56143602	chr16:74694692	T/C	cg01733217	chr16:74700730	RFWD3	0.89	8.54	0.7	8.46e-13	Multiple myeloma;
SKCM	cis	rs35306767	0.761	rs12770910	chr10:1050318	A/G	cg20503657	chr10:835505	NA	0.62	4.87	0.48	5.77e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs514406	0.861	rs1412706	chr1:53237721	G/A	cg16325326	chr1:53192061	ZYG11B	-1.01	-11.9	-0.8	3.23e-19	Monocyte count;
SKCM	cis	rs2019137	0.560	rs7421852	chr2:113990261	G/A	cg21550016	chr2:113992930	PAX8;LOC440839;LOC654433	0.62	4.83	0.48	6.6e-6	Lymphocyte counts;
SKCM	cis	rs7590720	1.000	rs6435930	chr2:216885852	A/G	cg12620499	chr2:216877984	MREG	0.88	7.77	0.66	2.59e-11	Alcohol dependence;
SKCM	cis	rs2120019	0.938	rs3850093	chr15:75318482	A/G	cg09165964	chr15:75287851	SCAMP5	0.84	8.28	0.68	2.74e-12	Blood trace element (Zn levels);
SKCM	cis	rs11098499	0.954	rs6822679	chr4:120402702	A/C	cg24375607	chr4:120327624	NA	0.66	5.09	0.5	2.44e-6	Corneal astigmatism;
SKCM	cis	rs1577917	1.000	rs34281561	chr6:86701872	T/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.64	-5.54	-0.53	3.92e-7	Response to antipsychotic treatment;
SKCM	trans	rs11722228	0.521	rs56403947	chr4:10112529	T/G	cg26043149	chr18:55253948	FECH	0.95	7.82	0.66	2.12e-11	Gout;Urate levels;Serum uric acid levels;
SKCM	cis	rs9788721	0.836	rs11858836	chr15:78783277	G/A	cg06917634	chr15:78832804	PSMA4	-0.69	-4.92	-0.49	4.77e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;Emphysema imaging phenotypes;Emphysema distribution in smoking;Local histogram emphysema pattern;Post bronchodilator FEV1/FVC ratio in COPD;
SKCM	cis	rs780096	0.526	rs780117	chr2:27698343	C/G	cg05696406	chr2:27599888	SNX17	0.51	5.22	0.51	1.46e-6	Total body bone mineral density;
SKCM	cis	rs9926296	0.565	rs8055825	chr16:89832848	C/T	cg26513180	chr16:89883248	FANCA	0.97	11.0	0.78	1.59e-17	Vitiligo;
SKCM	cis	rs4853012	0.838	rs12619982	chr2:74356022	G/A	cg05890377	chr2:74357713	NA	0.61	5.41	0.52	6.67e-7	Gestational age at birth (maternal effect);
SKCM	cis	rs6951245	0.872	rs11768486	chr7:1101290	C/A	cg24642844	chr7:1081250	C7orf50	-0.93	-6.22	-0.58	2.28e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs8070128	0.534	rs2955350	chr17:17953548	G/A	cg04398451	chr17:18023971	MYO15A	0.94	7.53	0.65	7.5e-11	Total body bone mineral density;
SKCM	cis	rs12926788	0.640	rs12924246	chr16:24844629	A/G	cg00339695	chr16:24857497	SLC5A11	0.77	6.53	0.59	6.12e-9	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs796364	0.951	rs281793	chr2:200847990	G/A	cg12253985	chr2:200820533	C2orf60;C2orf47	0.89	5.47	0.53	5.29e-7	Schizophrenia;
SKCM	cis	rs8141529	0.778	rs9625566	chr22:29162506	G/A	cg02153584	chr22:29168773	CCDC117	0.69	5.61	0.54	2.99e-7	Lymphocyte counts;
SKCM	cis	rs1707322	0.627	rs3014213	chr1:46045522	T/C	cg03146154	chr1:46216737	IPP	-0.73	-4.85	-0.48	6.27e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs6066825	0.583	rs3935549	chr20:47253487	T/C	cg18078177	chr20:47281410	PREX1	0.63	5.2	0.51	1.56e-6	Colorectal cancer;
SKCM	cis	rs7106204	0.748	rs6484031	chr11:24237115	A/C	ch.11.24196551F	chr11:24239977	NA	0.77	6.13	0.57	3.44e-8	Response to Homoharringtonine (cytotoxicity);
SKCM	cis	rs34891900	0.507	rs2008085	chr22:18204316	T/G	cg19898043	chr22:18121309	BCL2L13	0.7	5.54	0.53	4.03e-7	Sum neutrophil eosinophil counts;
SKCM	cis	rs8103278	0.507	rs522769	chr19:46284520	G/A	cg11657440	chr19:46296263	DMWD	1.07	10.44	0.76	1.81e-16	Coronary artery disease;
SKCM	cis	rs28386778	0.897	rs6504184	chr17:61842408	A/T	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs4233949	0.581	rs4671925	chr2:54629081	G/A	cg14634210	chr2:54682758	SPTBN1	0.58	4.87	0.48	5.63e-6	Bone mineral density;
SKCM	cis	rs798554	0.797	rs798488	chr7:2802522	T/C	cg04166393	chr7:2884313	GNA12	0.77	5.15	0.5	1.94e-6	Height;
SKCM	cis	rs4319547	1.000	rs6489157	chr12:123101673	C/G	cg23029597	chr12:123009494	RSRC2	0.82	6.18	0.57	2.77e-8	Body mass index;
SKCM	cis	rs7811142	1.000	rs11761725	chr7:100039815	C/T	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.34	0.69	2.1e-12	Platelet count;
SKCM	cis	rs9513627	0.920	rs16956607	chr13:100120220	A/G	cg11288260	chr13:100117058	NA	-0.75	-4.98	-0.49	3.69e-6	Obesity-related traits;
SKCM	cis	rs10489202	0.608	rs7533646	chr1:168077593	A/C	cg24449463	chr1:168025552	DCAF6	-0.8	-7.21	-0.63	3.13e-10	Schizophrenia;
SKCM	cis	rs28386778	0.897	rs2584642	chr17:61942427	T/C	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.36	0.52	8.37e-7	Prudent dietary pattern;
SKCM	cis	rs2721195	0.967	rs11777703	chr8:145703508	G/A	cg11211951	chr8:145729740	GPT	-0.62	-5.8	-0.55	1.37e-7	Age at first birth;
SKCM	cis	rs1801251	1.000	rs283480	chr2:233648742	G/A	cg25237894	chr2:233734115	C2orf82	0.65	5.82	0.55	1.22e-7	Coronary artery disease;
SKCM	cis	rs10832963	1.000	rs10832962	chr11:18656271	C/T	cg09201001	chr11:18656081	SPTY2D1	1.07	10.84	0.78	3.16e-17	Breast cancer;
SKCM	cis	rs7208859	0.573	rs28779471	chr17:29084369	T/C	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs875971	0.862	rs778736	chr7:65813848	C/T	cg11764359	chr7:65958608	NA	0.75	6.78	0.61	2.1e-9	Aortic root size;
SKCM	cis	rs2739330	0.760	rs1007888	chr22:24241101	C/T	cg24846343	chr22:24311635	DDTL	0.57	5.17	0.51	1.74e-6	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs7103648	0.897	rs3758675	chr11:47400602	G/A	cg03711944	chr11:47377212	SPI1	-0.57	-5.1	-0.5	2.3e-6	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs9611565	0.765	rs132914	chr22:41805749	T/C	cg03806693	chr22:41940476	POLR3H	1.02	6.92	0.62	1.13e-9	Vitiligo;
SKCM	cis	rs11690935	0.959	rs10204502	chr2:172588866	C/G	cg13550731	chr2:172543902	DYNC1I2	-0.95	-8.21	-0.68	3.64e-12	Schizophrenia;
SKCM	cis	rs861020	1.000	rs642961	chr1:209989270	A/G	cg09163369	chr1:210001066	C1orf107	0.77	5.0	0.49	3.41e-6	Orofacial clefts;
SKCM	cis	rs4865169	0.871	rs9918067	chr4:57870544	A/G	cg13432339	chr4:58211039	NA	0.44	4.82	0.48	7.08e-6	Breast cancer;
SKCM	cis	rs12541335	0.639	rs35068739	chr8:22201719	T/C	cg26039829	chr8:22132926	PIWIL2	0.64	5.64	0.54	2.58e-7	Hypertriglyceridemia;
SKCM	cis	rs708547	0.836	rs1718882	chr4:57859533	C/G	cg16868167	chr4:57843880	C4orf14;POLR2B	1.01	10.91	0.78	2.3e-17	Response to bleomycin (chromatid breaks);
SKCM	cis	rs861020	1.000	rs595918	chr1:209966843	A/G	cg05527609	chr1:210001259	C1orf107	1.06	7.64	0.65	4.68e-11	Orofacial clefts;
SKCM	cis	rs11098499	0.754	rs7672372	chr4:120248406	A/G	cg09307838	chr4:120376055	NA	0.93	7.56	0.65	6.5500000000000006e-11	Corneal astigmatism;
SKCM	cis	rs4642101	0.793	rs6799179	chr3:12829095	A/C	cg05775895	chr3:12838266	CAND2	0.62	5.45	0.53	5.72e-7	QRS complex (12-leadsum);
SKCM	cis	rs875971	0.825	rs28480509	chr7:66099224	A/G	cg18876405	chr7:65276391	NA	-0.63	-6.32	-0.58	1.5e-8	Aortic root size;
SKCM	cis	rs55823223	0.504	rs2034946	chr17:73863589	T/G	cg08125733	chr17:73851984	WBP2	1.07	5.79	0.55	1.4e-7	Psoriasis;
SKCM	cis	rs2836974	0.563	rs997147	chr21:40695325	A/G	cg11890956	chr21:40555474	PSMG1	-0.82	-7.64	-0.65	4.75e-11	Cognitive function;
SKCM	cis	rs898097	0.805	rs60233158	chr17:80896612	A/G	cg15369054	chr17:80825471	TBCD	-0.63	-5.63	-0.54	2.7e-7	Breast cancer;
SKCM	cis	rs216205	0.547	rs2641431	chr17:2030507	C/G	cg16513277	chr17:2031491	SMG6	-0.87	-4.91	-0.49	4.99e-6	Mitral valve prolapse;
SKCM	cis	rs11764590	0.671	rs3800872	chr7:2110272	C/G	cg23422044	chr7:1970798	MAD1L1	-0.81	-5.01	-0.49	3.36e-6	Neuroticism;
SKCM	cis	rs1577917	0.771	rs12199873	chr6:86294947	C/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.79	-7.29	-0.64	2.22e-10	Response to antipsychotic treatment;
SKCM	cis	rs7932354	0.528	rs7931260	chr11:47088303	T/C	cg03339077	chr11:47165057	C11orf49	-0.59	-4.79	-0.48	7.68e-6	Bone mineral density (hip);Bone mineral density;
SKCM	cis	rs910316	1.000	rs3742773	chr14:75579643	A/G	cg08847533	chr14:75593920	NEK9	0.95	9.18	0.72	4.88e-14	Height;
SKCM	trans	rs1814175	0.935	rs11040462	chr11:49683158	G/A	cg15704280	chr7:45808275	SEPT13	-1.0	-9.38	-0.73	1.99e-14	Height;
SKCM	cis	rs9914544	1.000	rs1737944	chr17:18840433	G/A	cg26306683	chr17:18585705	ZNF286B	0.67	4.98	0.49	3.8e-6	Educational attainment (years of education);
SKCM	cis	rs4790333	0.537	rs2447106	chr17:2257819	A/T	cg02569219	chr17:2266849	SGSM2	-0.68	-5.84	-0.55	1.13e-7	Proinsulin levels;
SKCM	cis	rs9303401	1.000	rs1390006	chr17:56890663	C/T	cg10487724	chr17:56770010	TEX14;RAD51C	-0.61	-4.9	-0.48	5.18e-6	Cognitive test performance;
SKCM	cis	rs1153858	1.000	rs12440038	chr15:45706739	A/G	cg21132104	chr15:45694354	SPATA5L1	0.9	7.08	0.63	5.59e-10	Homoarginine levels;
SKCM	cis	rs17376456	0.757	rs6859757	chr5:93206042	C/T	cg21475434	chr5:93447410	FAM172A	0.95	5.31	0.51	1.02e-6	Diabetic retinopathy;
SKCM	cis	rs35306767	0.903	rs1341741	chr10:888073	A/G	cg20503657	chr10:835505	NA	0.76	5.17	0.51	1.73e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs7811142	0.830	rs10085549	chr7:99983135	C/T	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.07	6.78	0.61	2.07e-9	Platelet count;
SKCM	cis	rs9394841	0.646	rs9369313	chr6:41847065	C/T	cg08135965	chr6:41755394	TOMM6	0.77	5.05	0.5	2.85e-6	Mean corpuscular hemoglobin;Red cell distribution width;
SKCM	cis	rs9926296	1.000	rs9926296	chr16:89818089	A/G	cg04287289	chr16:89883240	FANCA	0.83	7.86	0.66	1.77e-11	Vitiligo;
SKCM	cis	rs6121246	0.909	rs57726761	chr20:30314046	A/G	cg11595048	chr20:30225325	COX4I2	0.67	5.21	0.51	1.5e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs58688157	0.960	rs1055382	chr11:612182	T/C	cg17114584	chr11:613792	IRF7	0.74	5.0	0.49	3.51e-6	Systemic lupus erythematosus;
SKCM	cis	rs9463078	0.547	rs4449629	chr6:44717808	T/C	cg25276700	chr6:44698697	NA	0.44	4.77	0.48	8.31e-6	Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder;
SKCM	cis	rs17685	0.753	rs6953665	chr7:75769049	C/T	cg16489192	chr7:75678113	MDH2;STYXL1	-0.57	-5.35	-0.52	8.63e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs9910055	0.659	rs6503488	chr17:42246158	T/G	cg10896456	chr17:42255109	ASB16;C17orf65	0.69	7.22	0.63	3e-10	Total body bone mineral density;
SKCM	cis	rs1790761	0.520	rs4930461	chr11:67394895	A/G	cg00290607	chr11:67383545	NA	0.66	6.89	0.62	1.27e-9	Mean corpuscular volume;
SKCM	cis	rs995000	0.929	rs2029763	chr1:63013134	A/G	cg06896770	chr1:63153194	DOCK7	0.89	7.69	0.66	3.79e-11	Triglyceride levels;
SKCM	trans	rs7618501	1.000	rs7649348	chr3:49772375	G/A	cg21659725	chr3:3221576	CRBN	-0.96	-9.61	-0.74	7.08e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs55823223	0.564	rs9894009	chr17:73850414	C/T	cg08125733	chr17:73851984	WBP2	1.06	6.6	0.6	4.51e-9	Psoriasis;
SKCM	trans	rs1814175	0.645	rs1608632	chr11:49967148	C/T	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs6815814	0.950	rs11722813	chr4:38810769	C/T	cg02016764	chr4:38805732	TLR1	-0.79	-5.64	-0.54	2.6e-7	Breast cancer;
SKCM	cis	rs829883	0.902	rs1620317	chr12:98890566	T/C	cg25150519	chr12:98850993	NA	0.5	5.3	0.51	1.07e-6	Colorectal adenoma (advanced);
SKCM	cis	rs9325144	0.555	rs4882279	chr12:38688918	C/A	cg13010199	chr12:38710504	ALG10B	0.63	5.01	0.49	3.31e-6	Morning vs. evening chronotype;
SKCM	cis	rs2075371	0.932	rs2241333	chr7:133970750	C/T	cg20476274	chr7:133979776	SLC35B4	1.05	11.61	0.8	1.1e-18	Mean platelet volume;
SKCM	cis	rs17685	0.753	rs10952840	chr7:75772878	C/T	cg16489192	chr7:75678113	MDH2;STYXL1	-0.56	-5.23	-0.51	1.36e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs3785574	0.582	rs62072238	chr17:61948841	A/T	cg23090583	chr17:61904693	PSMC5;FTSJ3	0.66	5.23	0.51	1.4e-6	Height;
SKCM	cis	rs11098499	0.863	rs3775858	chr4:120486028	A/G	cg24375607	chr4:120327624	NA	0.69	5.47	0.53	5.35e-7	Corneal astigmatism;
SKCM	cis	rs7945705	0.935	rs2653567	chr11:8889630	T/C	cg21881798	chr11:8931708	C11orf17;ST5	-0.79	-8.57	-0.7	7.37e-13	Hemoglobin concentration;
SKCM	cis	rs738322	0.718	rs2899297	chr22:38594668	A/G	cg25457927	chr22:38595422	NA	-0.58	-7.71	-0.66	3.47e-11	Cutaneous nevi;
SKCM	cis	rs11679564	0.714	rs4016031	chr2:37184754	C/T	cg14987922	chr2:37194071	STRN	0.84	6.3	0.58	1.66e-8	Immature fraction of reticulocytes;
SKCM	cis	rs1062177	1.000	rs973529	chr5:151188158	T/C	cg00977110	chr5:151150581	G3BP1	0.84	6.68	0.6	3.14e-9	Preschool internalizing problems;
SKCM	cis	rs4423214	0.840	rs1790343	chr11:71177207	T/C	cg05163923	chr11:71159392	DHCR7	-0.74	-6.65	-0.6	3.61e-9	Vitamin D levels;
SKCM	cis	rs854765	0.616	rs8076747	chr17:17853595	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.98	7.06	0.62	5.96e-10	Total body bone mineral density;
SKCM	cis	rs754466	0.580	rs2579178	chr10:79529215	A/G	cg17075019	chr10:79541650	NA	0.74	6.54	0.6	5.86e-9	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs11148252	0.574	rs73186430	chr13:53232891	T/C	cg00495681	chr13:53174319	NA	0.65	5.43	0.52	6.26e-7	Lewy body disease;
SKCM	cis	rs1413885	0.516	rs6659883	chr1:65838618	A/G	cg14976592	chr1:65886160	LEPROT;LEPR	0.59	5.1	0.5	2.32e-6	Anticoagulant levels;
SKCM	cis	rs6120849	0.754	rs6120793	chr20:33604407	T/C	cg24642439	chr20:33292090	TP53INP2	0.94	4.86	0.48	5.91e-6	Protein C levels;
SKCM	cis	rs735396	0.770	rs2257764	chr12:121446446	T/A	cg02403541	chr12:121454288	C12orf43	-0.73	-6.08	-0.57	4.17e-8	N-glycan levels;
SKCM	cis	rs7843479	0.965	rs3816786	chr8:21860425	A/T	cg17168535	chr8:21777572	XPO7	0.69	5.31	0.52	1.02e-6	Mean corpuscular volume;
SKCM	cis	rs2836950	0.502	rs2150411	chr21:40574552	G/T	cg17971929	chr21:40555470	PSMG1	-0.71	-5.93	-0.56	7.85e-8	Menarche (age at onset);
SKCM	cis	rs796364	0.951	rs12463436	chr2:201061962	C/G	cg12253985	chr2:200820533	C2orf60;C2orf47	0.95	6.37	0.59	1.21e-8	Schizophrenia;
SKCM	cis	rs514406	0.861	rs7518390	chr1:53233374	A/G	cg16325326	chr1:53192061	ZYG11B	-0.99	-11.68	-0.8	8.36e-19	Monocyte count;
SKCM	cis	rs992157	0.560	rs12987130	chr2:219104990	T/C	cg00012203	chr2:219082015	ARPC2	-0.78	-6.52	-0.59	6.36e-9	Colorectal cancer;
SKCM	cis	rs7208859	0.623	rs7220999	chr17:29149298	C/T	cg14067834	chr17:29058358	SUZ12P	1.0	5.15	0.5	1.88e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs2303759	1.000	rs2303759	chr19:49869051	T/G	cg05022225	chr19:49866942	DKKL1;TEAD2	0.69	5.26	0.51	1.23e-6	Multiple sclerosis;
SKCM	cis	rs7666738	0.830	rs6851253	chr4:99029980	A/G	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2354432	0.607	rs7545467	chr1:146746248	A/G	cg25205988	chr1:146714368	CHD1L	-1.17	-6.52	-0.59	6.27e-9	Mitochondrial DNA levels;
SKCM	cis	rs2228479	0.850	rs17233664	chr16:89810628	C/T	cg06558623	chr16:89946397	TCF25	1.03	5.59	0.53	3.23e-7	Skin colour saturation;
SKCM	cis	rs2839186	0.934	rs2839194	chr21:47699437	T/G	cg05896524	chr21:47604654	C21orf56	0.67	5.49	0.53	4.77e-7	Testicular germ cell tumor;
SKCM	cis	rs28595532	0.920	rs114684527	chr4:119749252	G/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs9790314	0.871	rs466626	chr3:161103629	A/C	cg03342759	chr3:160939853	NMD3	-0.72	-7.14	-0.63	4.27e-10	Morning vs. evening chronotype;
SKCM	cis	rs1799949	1.000	rs11656097	chr17:41290613	G/T	cg05368731	chr17:41323189	NBR1	0.89	7.91	0.67	1.38e-11	Menopause (age at onset);
SKCM	cis	rs55962025	0.842	rs2269477	chr4:3184464	G/T	cg11471262	chr4:3318911	RGS12	-0.61	-4.97	-0.49	3.81e-6	Parental longevity (mother's age at death);
SKCM	cis	rs860295	0.702	rs3851912	chr1:155586444	T/G	cg02153340	chr1:155202674	NA	-0.74	-5.43	-0.52	6.23e-7	Body mass index;
SKCM	cis	rs28735056	0.592	rs12455965	chr18:77688830	G/C	cg20368463	chr18:77673604	PQLC1	-0.74	-5.83	-0.55	1.19e-7	Schizophrenia;
SKCM	cis	rs9858542	0.953	rs6766131	chr3:49538932	T/C	cg03060546	chr3:49711283	APEH	-0.75	-5.53	-0.53	4.17e-7	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs473651	0.837	rs563458	chr2:239345613	T/A	cg21699342	chr2:239360505	ASB1	0.51	4.94	0.49	4.28e-6	Multiple system atrophy;
SKCM	cis	rs8017423	0.630	rs4900038	chr14:90821677	A/G	cg04374321	chr14:90722782	PSMC1	-0.73	-5.53	-0.53	4.13e-7	Mortality in heart failure;
SKCM	cis	rs67311347	0.544	rs6769627	chr3:40327845	G/A	cg00091569	chr3:40428383	ENTPD3	0.6	5.21	0.51	1.52e-6	Renal cell carcinoma;
SKCM	cis	rs4665809	0.590	rs13387855	chr2:26420708	T/G	cg26119090	chr2:26468346	HADHA;HADHB	-1.02	-8.05	-0.67	7.59e-12	Gut microbiome composition (summer);
SKCM	cis	rs9911578	0.839	rs56360354	chr17:57202927	A/G	cg12560992	chr17:57184187	TRIM37	0.99	8.46	0.69	1.22e-12	Intelligence (multi-trait analysis);
SKCM	cis	rs2842992	0.915	rs1967802	chr6:160097791	G/A	cg11366901	chr6:160182831	ACAT2	0.93	6.93	0.62	1.05e-9	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs7666738	0.830	rs13124127	chr4:98990729	G/A	cg05340658	chr4:99064831	C4orf37	0.67	5.14	0.5	1.98e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs992157	0.730	rs4280446	chr2:219184721	T/C	cg20019365	chr2:219134978	PNKD;AAMP	0.74	5.94	0.56	7.66e-8	Colorectal cancer;
SKCM	cis	rs7208859	0.623	rs9890558	chr17:29110355	T/C	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs11098499	0.863	rs13134665	chr4:120426430	T/C	cg24375607	chr4:120327624	NA	0.7	5.38	0.52	7.69e-7	Corneal astigmatism;
SKCM	cis	rs2836974	0.627	rs9981301	chr21:40686078	G/C	cg17971929	chr21:40555470	PSMG1	-0.69	-6.07	-0.57	4.38e-8	Cognitive function;
SKCM	cis	rs7829975	0.628	rs1109618	chr8:8571364	A/T	cg15556689	chr8:8085844	FLJ10661	-0.64	-5.05	-0.5	2.79e-6	Mood instability;
SKCM	cis	rs9910055	0.530	rs7222349	chr17:42304644	C/T	cg13607699	chr17:42295918	UBTF	0.86	7.36	0.64	1.62e-10	Total body bone mineral density;
SKCM	cis	rs782590	0.967	rs782588	chr2:55841640	T/C	cg18811423	chr2:55921094	PNPT1	0.9	6.98	0.62	8.78e-10	Metabolic syndrome;
SKCM	cis	rs2836974	0.836	rs8129355	chr21:40579869	A/G	cg11644478	chr21:40555479	PSMG1	0.97	10.08	0.75	8.76e-16	Cognitive function;
SKCM	cis	rs9803723	0.682	rs7514417	chr1:25447389	A/G	cg20685674	chr1:26233538	STMN1	0.49	4.8	0.48	7.4e-6	Male-pattern baldness;
SKCM	cis	rs2832191	0.646	rs2832210	chr21:30508723	T/G	cg24692254	chr21:30365293	RNF160	-0.73	-5.83	-0.55	1.18e-7	Dental caries;
SKCM	cis	rs929354	0.742	rs7807556	chr7:156934329	T/C	cg17757837	chr7:157058334	UBE3C	0.83	5.82	0.55	1.27e-7	Body mass index;
SKCM	cis	rs67311347	0.824	rs59922539	chr3:40337110	G/A	cg00091569	chr3:40428383	ENTPD3	0.64	5.45	0.52	5.82e-7	Renal cell carcinoma;
SKCM	cis	rs6952808	0.756	rs13234214	chr7:1878860	C/T	cg04267008	chr7:1944627	MAD1L1	-0.74	-5.62	-0.54	2.88e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs17065868	0.881	rs61948000	chr13:45166545	C/T	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs10946507	0.611	rs6456469	chr6:22107290	C/T	cg06057918	chr6:22070094	FLJ22536	0.55	4.8	0.48	7.64e-6	Spherical equivalent (joint analysis main effects and education interaction);
SKCM	cis	rs3087591	0.887	rs12150521	chr17:29595108	C/T	cg24425628	chr17:29625626	OMG;NF1	0.64	5.08	0.5	2.48e-6	Hip circumference;
SKCM	cis	rs2153535	0.580	rs6597335	chr6:8527714	T/C	cg07606381	chr6:8435919	SLC35B3	0.93	6.8	0.61	1.92e-9	Motion sickness;
SKCM	cis	rs4808199	0.948	rs7259434	chr19:19428805	A/T	cg03709012	chr19:19516395	GATAD2A	1.08	7.53	0.65	7.65e-11	Nonalcoholic fatty liver disease;
SKCM	cis	rs3820068	0.603	rs72647118	chr1:15956535	G/T	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs11112613	0.609	rs11112585	chr12:105933442	A/G	cg03607813	chr12:105948248	NA	-0.96	-5.74	-0.54	1.74e-7	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;
SKCM	cis	rs62244186	0.545	rs7640654	chr3:44763037	A/C	cg02073558	chr3:44770973	ZNF501	0.85	7.52	0.65	7.82e-11	Depressive symptoms;
SKCM	cis	rs10751667	0.621	rs10794348	chr11:939941	G/A	cg06064525	chr11:970664	AP2A2	-0.55	-5.09	-0.5	2.46e-6	Alzheimer's disease (late onset);
SKCM	cis	rs1005277	0.563	rs2800550	chr10:38482929	T/C	cg25427524	chr10:38739819	LOC399744	-0.79	-7.74	-0.66	3.04e-11	Extrinsic epigenetic age acceleration;
SKCM	cis	rs13010713	0.840	rs6740034	chr2:182036900	A/G	cg21995919	chr2:182322279	ITGA4	-0.55	-5.38	-0.52	7.61e-7	Celiac disease;
SKCM	cis	rs6540556	0.954	rs643118	chr1:209934841	C/T	cg05527609	chr1:210001259	C1orf107	-0.95	-5.27	-0.51	1.16e-6	Red blood cell count;
SKCM	cis	rs951366	0.617	rs823080	chr1:205789282	G/A	cg26354017	chr1:205819088	PM20D1	1.06	12.83	0.82	6.54e-21	Menarche (age at onset);
SKCM	cis	rs10503709	0.861	rs1383576	chr8:21448663	T/C	cg23716449	chr8:21608280	GFRA2	0.49	4.95	0.49	4.11e-6	Blood protein levels;
SKCM	cis	rs2303759	0.709	rs10422677	chr19:49824290	C/T	cg05022225	chr19:49866942	DKKL1;TEAD2	0.7	5.05	0.5	2.78e-6	Multiple sclerosis;
SKCM	cis	rs929354	1.000	rs1182410	chr7:157063837	C/T	cg17757837	chr7:157058334	UBE3C	-0.89	-6.71	-0.61	2.76e-9	Body mass index;
SKCM	cis	rs1062177	1.000	rs62377945	chr5:151208004	C/G	cg00977110	chr5:151150581	G3BP1	0.84	6.56	0.6	5.32e-9	Preschool internalizing problems;
SKCM	cis	rs362272	0.505	rs13104157	chr4:3366950	T/C	cg03043834	chr4:3319541	RGS12	0.58	4.93	0.49	4.59e-6	Serum sulfate level;
SKCM	cis	rs1218582	0.772	rs906593	chr1:154885255	G/A	cg09359103	chr1:154839909	KCNN3	-0.57	-5.3	-0.51	1.05e-6	Prostate cancer;
SKCM	cis	rs1799949	1.000	rs8077486	chr17:41212805	C/T	cg25918947	chr17:41365094	TMEM106A	-0.6	-5.65	-0.54	2.54e-7	Menopause (age at onset);
SKCM	cis	rs9916302	0.904	rs11078897	chr17:37415870	C/T	cg07936489	chr17:37558343	FBXL20	-0.84	-6.96	-0.62	9.48e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs2832191	0.655	rs2247110	chr21:30323888	G/A	cg24692254	chr21:30365293	RNF160	-1.0	-9.44	-0.73	1.51e-14	Dental caries;
SKCM	cis	rs2120019	0.567	rs8029351	chr15:75177237	A/C	cg17294928	chr15:75287854	SCAMP5	-0.85	-5.9	-0.56	8.72e-8	Blood trace element (Zn levels);
SKCM	cis	rs11209185	0.602	rs12034179	chr1:68433212	T/C	cg17031739	chr1:67600172	NA	0.5	4.85	0.48	6.17e-6	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs17711722	0.701	rs781143	chr7:65439879	G/C	cg11764359	chr7:65958608	NA	0.87	6.65	0.6	3.58e-9	Calcium levels;
SKCM	cis	rs12478296	1.000	rs7420157	chr2:243005204	G/A	cg06360820	chr2:242988706	NA	-1.02	-5.87	-0.55	1.03e-7	Obesity-related traits;
SKCM	cis	rs10540	1.000	rs61876340	chr11:495699	A/C	cg03352830	chr11:487213	PTDSS2	0.93	4.86	0.48	5.92e-6	Body mass index;
SKCM	cis	rs58688157	0.705	rs12419720	chr11:598205	C/G	cg17114584	chr11:613792	IRF7	0.79	5.56	0.53	3.64e-7	Systemic lupus erythematosus;
SKCM	cis	rs1568889	1.000	rs12797689	chr11:28076042	C/A	cg06544937	chr11:28130018	METT5D1;KIF18A	0.86	7.03	0.62	6.97e-10	Bipolar disorder;
SKCM	cis	rs9902453	0.838	rs8064689	chr17:28217053	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.84	6.07	0.57	4.28e-8	Coffee consumption (cups per day);
SKCM	cis	rs6951245	1.000	rs28379681	chr7:1070539	C/T	cg18402987	chr7:1209562	NA	1.15	6.02	0.56	5.38e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs12142240	0.698	rs72677592	chr1:46818288	A/G	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs372883	0.600	rs2832294	chr21:30739671	A/C	cg24692254	chr21:30365293	RNF160	0.7	5.65	0.54	2.49e-7	Pancreatic cancer;
SKCM	cis	rs6066825	0.627	rs6019349	chr20:47275245	A/G	cg18078177	chr20:47281410	PREX1	0.65	5.33	0.52	9.3e-7	Colorectal cancer;
SKCM	cis	rs1552244	0.882	rs13099136	chr3:10031431	G/A	cg02579736	chr3:10068473	FANCD2;CIDECP	0.94	4.84	0.48	6.49e-6	Alzheimer's disease;
SKCM	cis	rs2463822	1.000	rs2513071	chr11:62098387	A/C	cg06239285	chr11:62104954	ASRGL1	1.27	6.04	0.56	4.98e-8	Chronic obstructive pulmonary disease-related biomarkers;
SKCM	cis	rs3780486	0.846	rs10116966	chr9:33122370	T/A	cg13443165	chr9:33130375	B4GALT1	-0.6	-5.62	-0.54	2.85e-7	IgG glycosylation;
SKCM	cis	rs1577917	1.000	rs1999852	chr6:86705738	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.83	-8.23	-0.68	3.37e-12	Response to antipsychotic treatment;
SKCM	cis	rs2204008	0.653	rs11182569	chr12:38572452	G/A	cg26384229	chr12:38710491	ALG10B	0.83	6.78	0.61	2.08e-9	Bladder cancer;
SKCM	cis	rs801193	1.000	rs4717310	chr7:66161007	C/T	cg00343986	chr7:65444356	GUSB	0.7	5.14	0.5	1.98e-6	Aortic root size;
SKCM	cis	rs10751667	0.560	rs7924794	chr11:962745	A/T	cg10932868	chr11:921992	NA	0.55	5.1	0.5	2.36e-6	Alzheimer's disease (late onset);
SKCM	cis	rs7683537	0.554	rs55830081	chr4:185666477	A/C	cg04058563	chr4:185651563	MLF1IP	1.0	7.47	0.65	9.81e-11	Systemic lupus erythematosus;
SKCM	cis	rs453301	0.686	rs6987107	chr8:8893581	A/G	cg15556689	chr8:8085844	FLJ10661	-0.73	-5.77	-0.55	1.52e-7	Joint mobility (Beighton score);
SKCM	cis	rs4555082	1.000	rs4334224	chr14:105759198	C/T	cg13114125	chr14:105738426	BRF1	-0.67	-5.16	-0.5	1.84e-6	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs7633770	0.786	rs1520489	chr3:46677519	A/G	cg11219411	chr3:46661640	NA	-0.54	-4.86	-0.48	5.98e-6	Coronary artery disease;
SKCM	cis	rs35306767	1.000	rs35306767	chr10:989437	A/T	cg26597838	chr10:835615	NA	0.75	6.3	0.58	1.66e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs7659604	1.000	rs6823488	chr4:122664819	A/G	cg19748678	chr4:122722346	EXOSC9	0.66	5.44	0.52	5.83e-7	Type 2 diabetes;
SKCM	cis	rs9902453	1.000	rs4075623	chr17:28386526	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.81	-5.78	-0.55	1.45e-7	Coffee consumption (cups per day);
SKCM	cis	rs11098499	0.863	rs6534141	chr4:120485223	A/T	cg09307838	chr4:120376055	NA	1.0	8.27	0.68	2.8e-12	Corneal astigmatism;
SKCM	cis	rs9916302	0.706	rs2302073	chr17:37457342	A/G	cg07936489	chr17:37558343	FBXL20	1.0	7.19	0.63	3.42e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs2811415	0.597	rs56143290	chr3:127737383	A/G	cg09089421	chr3:127803668	RUVBL1	1.0	8.57	0.7	7.53e-13	Lung function (FEV1/FVC);
SKCM	cis	rs7937682	0.889	rs493810	chr11:111491888	G/T	cg19812747	chr11:111475976	SIK2	-0.56	-4.93	-0.49	4.55e-6	Primary sclerosing cholangitis;
SKCM	cis	rs9926296	0.712	rs459920	chr16:89730827	T/C	cg01097406	chr16:89675127	NA	0.56	5.66	0.54	2.41e-7	Vitiligo;
SKCM	cis	rs6952808	1.000	rs6954521	chr7:1886865	C/A	cg04267008	chr7:1944627	MAD1L1	-0.8	-6.1	-0.57	3.78e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs2455601	0.935	rs12049908	chr11:8919309	G/A	cg21881798	chr11:8931708	C11orf17;ST5	-0.78	-5.59	-0.53	3.21e-7	Schizophrenia;
SKCM	cis	rs10254118	0.757	rs13241123	chr7:133135507	A/T	cg10665199	chr7:133106180	EXOC4	0.78	5.16	0.5	1.81e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs10929159	0.928	rs6431419	chr2:236919669	C/A	cg14226755	chr2:236923322	AGAP1	0.29	4.77	0.48	8.43e-6	Parkinson's disease;
SKCM	cis	rs6951245	0.938	rs112425403	chr7:1071531	A/G	cg03188948	chr7:1209495	NA	1.17	6.45	0.59	8.61e-9	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7523050	0.643	rs34367763	chr1:109400805	C/T	cg08274380	chr1:109419600	GPSM2	1.13	5.57	0.53	3.54e-7	Fat distribution (HIV);
SKCM	cis	rs9815354	0.812	rs77047799	chr3:41958895	T/C	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs2153535	0.580	rs5001130	chr6:8442298	G/A	cg23788917	chr6:8435910	SLC35B3	0.69	5.14	0.5	1.99e-6	Motion sickness;
SKCM	cis	rs6546550	0.935	rs3214007	chr2:70098808	A/G	cg02498382	chr2:70120550	SNRNP27	-0.47	-5.25	-0.51	1.3e-6	Prevalent atrial fibrillation;
SKCM	cis	rs473651	0.935	rs515412	chr2:239345394	A/T	cg18131467	chr2:239335373	ASB1	1.13	13.5	0.84	4.21e-22	Multiple system atrophy;
SKCM	cis	rs2404602	0.647	rs11629727	chr15:77009038	G/C	cg23625390	chr15:77176239	SCAPER	-0.85	-8.26	-0.68	2.93e-12	Blood metabolite levels;
SKCM	cis	rs4819052	0.851	rs7276591	chr21:46680156	C/T	cg20896738	chr21:46707857	POFUT2;LOC642852	0.65	4.89	0.48	5.35e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs4242434	0.757	rs7005025	chr8:22519815	G/T	cg03733263	chr8:22462867	KIAA1967	0.81	6.09	0.57	3.93e-8	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs873946	0.504	rs12254034	chr10:134571007	T/C	cg26818010	chr10:134567672	INPP5A	-0.71	-5.25	-0.51	1.27e-6	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs7772486	0.692	rs2265915	chr6:146194332	A/T	cg23711669	chr6:146136114	FBXO30	0.84	9.28	0.72	3.05e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4423214	1.000	rs12806844	chr11:71170770	G/A	cg05163923	chr11:71159392	DHCR7	0.83	8.11	0.68	5.77e-12	Vitamin D levels;
SKCM	cis	rs875971	0.862	rs11760844	chr7:65739883	C/G	cg18876405	chr7:65276391	NA	-0.65	-6.57	-0.6	5.03e-9	Aortic root size;
SKCM	cis	rs1062177	1.000	rs2915869	chr5:151171509	C/T	cg00977110	chr5:151150581	G3BP1	0.82	6.75	0.61	2.32e-9	Preschool internalizing problems;
SKCM	cis	rs1218582	0.844	rs6699080	chr1:154834911	G/A	cg16680214	chr1:154839983	KCNN3	-0.52	-4.9	-0.49	5.11e-6	Prostate cancer;
SKCM	cis	rs7555523	0.887	rs10918274	chr1:165714416	T/C	cg24409356	chr1:165738333	TMCO1	0.93	5.15	0.5	1.93e-6	Intraocular pressure;Glaucoma (high intraocular pressure);
SKCM	cis	rs7811142	0.830	rs7792959	chr7:99972403	C/T	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.07	6.7	0.6	2.88e-9	Platelet count;
SKCM	cis	rs2599510	0.783	rs2710626	chr2:32758754	G/C	cg02381751	chr2:32503542	YIPF4	0.7	5.5	0.53	4.63e-7	Interleukin-18 levels;
SKCM	cis	rs6952808	0.723	rs4721282	chr7:2025040	A/G	cg21782813	chr7:2030301	MAD1L1	0.59	6.38	0.59	1.16e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs4927850	1.000	rs10881564	chr3:195750326	C/T	cg01181863	chr3:195395398	SDHAP2	-0.76	-4.85	-0.48	6.14e-6	Pancreatic cancer;
SKCM	cis	rs7809950	0.834	rs2712199	chr7:107140239	A/G	cg23024343	chr7:107201750	COG5	-0.74	-6.4	-0.59	1.08e-8	Coronary artery disease;
SKCM	cis	rs769267	0.895	rs2916069	chr19:19520358	A/G	cg03709012	chr19:19516395	GATAD2A	0.91	8.6	0.7	6.53e-13	Tonsillectomy;
SKCM	cis	rs73591976	0.539	rs12446198	chr16:68125972	G/A	cg04539111	chr16:67997858	SLC12A4	-0.85	-4.81	-0.48	7.14e-6	HDL cholesterol;
SKCM	cis	rs7106204	0.748	rs6484032	chr11:24237153	C/A	ch.11.24196551F	chr11:24239977	NA	0.77	6.13	0.57	3.44e-8	Response to Homoharringtonine (cytotoxicity);
SKCM	cis	rs992157	0.764	rs4423579	chr2:219185033	G/T	cg20019365	chr2:219134978	PNKD;AAMP	0.74	5.94	0.56	7.66e-8	Colorectal cancer;
SKCM	cis	rs7772486	0.754	rs6906258	chr6:146089356	A/G	cg05347473	chr6:146136440	FBXO30	-0.61	-5.81	-0.55	1.31e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7584330	0.666	rs7600317	chr2:238353513	C/T	cg14458575	chr2:238380390	NA	1.06	7.17	0.63	3.76e-10	Prostate cancer;
SKCM	cis	rs6121246	0.609	rs2376998	chr20:30340663	T/C	cg13852791	chr20:30311386	BCL2L1	0.82	5.64	0.54	2.59e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs7829975	0.902	rs485107	chr8:8581408	C/G	cg15556689	chr8:8085844	FLJ10661	-0.74	-6.71	-0.6	2.83e-9	Mood instability;
SKCM	cis	rs10504229	1.000	rs67188507	chr8:58187492	A/T	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs10504229	0.906	rs6990615	chr8:58182956	G/A	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs8067545	0.750	rs4925085	chr17:20000131	G/T	cg13482628	chr17:19912719	NA	0.72	6.01	0.56	5.48e-8	Schizophrenia;
SKCM	cis	rs854765	0.583	rs6502622	chr17:17834691	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.0	7.64	0.65	4.64e-11	Total body bone mineral density;
SKCM	cis	rs6449957	0.801	rs921792	chr5:67465803	C/T	cg09038926	chr5:67483109	NA	-0.65	-4.79	-0.48	7.69e-6	Cleft lip with or without cleft palate;
SKCM	cis	rs3087591	0.922	rs2953013	chr17:29496343	A/C	cg24425628	chr17:29625626	OMG;NF1	-0.61	-4.87	-0.48	5.72e-6	Hip circumference;
SKCM	cis	rs55823223	0.793	rs3744028	chr17:73888672	T/C	cg08125733	chr17:73851984	WBP2	0.98	5.18	0.51	1.72e-6	Psoriasis;
SKCM	cis	rs4790333	0.571	rs2012068	chr17:2255351	C/T	cg02569219	chr17:2266849	SGSM2	0.69	5.84	0.55	1.14e-7	Proinsulin levels;
SKCM	cis	rs2439831	1.000	rs689781	chr15:43792097	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.22	7.98	0.67	1.01e-11	Lung cancer in ever smokers;
SKCM	cis	rs11792861	0.619	rs2289480	chr9:111705501	A/C	cg14432460	chr9:111696404	IKBKAP;C9orf6	0.79	6.66	0.6	3.48e-9	Menarche (age at onset);
SKCM	cis	rs10540	0.570	rs8176330	chr11:535798	G/A	cg03576123	chr11:487126	PTDSS2	-1.44	-7.62	-0.65	5.15e-11	Body mass index;
SKCM	cis	rs8028182	0.636	rs11636199	chr15:75825337	A/G	cg20655648	chr15:75932815	IMP3	0.7	4.82	0.48	7.02e-6	Sudden cardiac arrest;
SKCM	cis	rs7809950	1.000	rs12667527	chr7:107086969	T/C	cg23024343	chr7:107201750	COG5	-0.77	-6.85	-0.61	1.5e-9	Coronary artery disease;
SKCM	cis	rs875971	0.964	rs2277911	chr7:65958625	T/G	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	cis	rs2228479	1.000	rs11642267	chr16:89957635	T/C	cg00800038	chr16:89945340	TCF25	-0.96	-5.44	-0.52	5.85e-7	Skin colour saturation;
SKCM	cis	rs1692580	0.807	rs4648627	chr1:2200404	C/T	cg21442419	chr1:2182373	SKI	-0.69	-7.27	-0.64	2.42e-10	Coronary artery disease;
SKCM	cis	rs72781680	0.898	rs111460347	chr2:24018833	G/A	cg08917208	chr2:24149416	ATAD2B	0.92	4.85	0.48	6.19e-6	Lymphocyte counts;
SKCM	cis	rs9381040	0.655	rs7738684	chr6:41038552	G/A	cg03644281	chr6:41068752	NFYA;LOC221442	-0.72	-4.81	-0.48	7.24e-6	Alzheimer's disease (late onset);
SKCM	cis	rs523522	0.962	rs4767905	chr12:120930835	C/T	cg27279351	chr12:120934652	DYNLL1	0.91	8.32	0.69	2.26e-12	High light scatter reticulocyte count;
SKCM	cis	rs55823223	0.648	rs11867560	chr17:73857206	A/G	cg10935138	chr17:73851978	WBP2	1.19	7.17	0.63	3.81e-10	Psoriasis;
SKCM	cis	rs7091068	0.536	rs6583901	chr10:95409998	C/T	cg20715218	chr10:95462985	C10orf4	-0.77	-6.67	-0.6	3.28e-9	Urinary tract infection frequency;
SKCM	cis	rs875971	0.798	rs12698522	chr7:65967341	T/C	cg18876405	chr7:65276391	NA	0.61	6.04	0.56	5.03e-8	Aortic root size;
SKCM	cis	rs898097	0.578	rs2380173	chr17:80909157	G/T	cg15369054	chr17:80825471	TBCD	0.59	5.84	0.55	1.16e-7	Breast cancer;
SKCM	cis	rs7091068	0.707	rs829107	chr10:95418102	C/T	cg20715218	chr10:95462985	C10orf4	-0.77	-4.77	-0.47	8.55e-6	Urinary tract infection frequency;
SKCM	cis	rs9880211	0.898	rs35304385	chr3:136386253	T/C	cg21827317	chr3:136751795	NA	-0.65	-4.92	-0.49	4.73e-6	Body mass index;Height;
SKCM	cis	rs2842992	0.789	rs4235925	chr6:160202860	C/T	cg11366901	chr6:160182831	ACAT2	0.92	7.61	0.65	5.33e-11	Age-related macular degeneration (geographic atrophy);
SKCM	trans	rs11083271	0.608	rs1029870	chr18:25836980	T/C	cg00321150	chr11:62623587	SNORD27;SLC3A2;SNHG1;SNORD28;SNORD25;SNORD26	0.86	8.3	0.68	2.51e-12	Non-alcoholic fatty liver disease histology (lobular);
SKCM	cis	rs12047808	0.841	rs58340590	chr1:179416568	G/A	cg08037922	chr1:179521085	C1orf125;NPHS2	-1.08	-5.8	-0.55	1.32e-7	Multiple sclerosis (age of onset);
SKCM	cis	rs13631	0.965	rs9411307	chr9:139994947	C/T	cg14289826	chr9:140003911	NA	0.45	5.15	0.5	1.93e-6	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs9910055	0.659	rs7207464	chr17:42245033	C/T	cg10896456	chr17:42255109	ASB16;C17orf65	0.69	7.22	0.63	3e-10	Total body bone mineral density;
SKCM	cis	rs208520	0.661	rs207099	chr6:66796373	A/C	cg07460842	chr6:66804631	NA	-1.11	-8.26	-0.68	2.99e-12	Exhaled nitric oxide output;
SKCM	cis	rs561341	1.000	rs498391	chr17:30328704	G/A	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs637571	0.522	rs1151512	chr11:65757533	G/A	cg02427764	chr11:65769310	BANF1;EIF1AD	0.77	5.87	0.55	1.03e-7	Eosinophil percentage of white cells;
SKCM	cis	rs7666738	0.830	rs13102652	chr4:99006737	T/G	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs12188164	0.965	rs56182240	chr5:423169	C/T	cg26076054	chr5:421317	AHRR	-0.61	-4.8	-0.48	7.47e-6	Cystic fibrosis severity;
SKCM	cis	rs6430585	0.591	rs77096272	chr2:136663605	C/A	cg07169764	chr2:136633963	MCM6	1.32	11.41	0.79	2.72e-18	Corneal structure;
SKCM	cis	rs752010	0.806	rs4457567	chr1:42091407	C/T	cg06885757	chr1:42089581	HIVEP3	0.5	4.87	0.48	5.65e-6	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs28595532	0.920	rs28538455	chr4:119486817	T/C	cg11846333	chr4:119757529	SEC24D	1.15	6.24	0.58	2.13e-8	Cannabis dependence symptom count;
SKCM	cis	rs10540	1.000	rs61876339	chr11:495283	T/C	cg03576123	chr11:487126	PTDSS2	-1.37	-7.63	-0.65	4.96e-11	Body mass index;
SKCM	cis	rs4727027	0.933	rs10238826	chr7:148830888	A/G	cg23583168	chr7:148888333	NA	-0.82	-6.56	-0.6	5.29e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs62238980	0.522	rs117215349	chr22:32412642	A/G	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs595982	0.527	rs35087747	chr19:49377918	G/T	cg19746536	chr19:49375674	PPP1R15A	1.1	5.56	0.53	3.66e-7	Red cell distribution width;
SKCM	cis	rs6430585	0.583	rs2322813	chr2:136582809	A/G	cg07169764	chr2:136633963	MCM6	1.31	13.14	0.83	1.86e-21	Corneal structure;
SKCM	cis	rs12711979	0.509	rs10187740	chr2:3823965	A/G	cg17052675	chr2:3827356	NA	0.77	8.6	0.7	6.51e-13	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs7666738	0.830	rs7672901	chr4:98938781	C/T	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7927771	0.832	rs67116452	chr11:47385194	G/A	cg05585544	chr11:47624801	NA	-0.59	-5.24	-0.51	1.33e-6	Subjective well-being;
SKCM	cis	rs10416265	0.527	rs6510337	chr19:33545701	C/T	cg27124370	chr19:33622961	WDR88	0.82	5.63	0.54	2.75e-7	Bone properties (heel);
SKCM	cis	rs9303401	0.659	rs72828726	chr17:56951217	C/G	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.35	0.52	8.54e-7	Cognitive test performance;
SKCM	cis	rs951366	0.789	rs823110	chr1:205701078	G/C	cg11965913	chr1:205819406	PM20D1	0.99	9.69	0.74	4.88e-15	Menarche (age at onset);
SKCM	cis	rs1577917	1.000	rs6914463	chr6:86653415	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.61	-5.31	-0.52	1.02e-6	Response to antipsychotic treatment;
SKCM	cis	rs4954585	0.683	rs13024450	chr2:137014611	C/T	cg05194412	chr2:137003533	NA	0.57	5.1	0.5	2.31e-6	Colorectal cancer;
SKCM	cis	rs151997	0.962	rs27476	chr5:50178160	A/T	cg06027927	chr5:50259733	NA	-0.63	-5.49	-0.53	4.89e-7	Callous-unemotional behaviour;
SKCM	cis	rs1577917	0.876	rs12201992	chr6:86618219	T/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.66	-5.74	-0.54	1.76e-7	Response to antipsychotic treatment;
SKCM	cis	rs11608355	0.508	rs11066394	chr12:109799212	C/A	cg19025524	chr12:109796872	NA	-0.71	-5.37	-0.52	7.81e-7	Neuroticism;
SKCM	trans	rs208520	0.690	rs12213561	chr6:66705646	T/C	cg15611600	chr13:45563400	KIAA1704;NUFIP1	0.94	8.03	0.67	8.3e-12	Exhaled nitric oxide output;
SKCM	cis	rs1577917	0.740	rs9353320	chr6:86244848	C/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.88	8.56	0.7	7.74e-13	Response to antipsychotic treatment;
SKCM	cis	rs9899728	0.539	rs12938889	chr17:73039929	A/C	cg27626185	chr17:73056755	KCTD2	1.22	7.67	0.66	4.17e-11	Alzheimer's disease or small vessel stroke;
SKCM	cis	rs561341	0.941	rs8066156	chr17:30361629	A/G	cg00745463	chr17:30367425	LRRC37B	-1.06	-7.23	-0.63	2.87e-10	Hip circumference adjusted for BMI;
SKCM	cis	rs6840360	0.593	rs6847844	chr4:152693246	C/T	cg22705602	chr4:152727874	NA	-0.59	-7.86	-0.66	1.79e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs28374715	0.662	rs28554139	chr15:41531084	C/T	cg18705301	chr15:41695430	NDUFAF1	-0.88	-7.3	-0.64	2.13e-10	Ulcerative colitis;
SKCM	cis	rs1348850	0.608	rs2364845	chr2:178226240	T/C	cg02961200	chr2:178257176	LOC100130691;AGPS	0.79	5.84	0.55	1.13e-7	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs67311347	0.544	rs60329764	chr3:40334621	C/T	cg02782426	chr3:40428986	ENTPD3	-0.5	-4.86	-0.48	6.03e-6	Renal cell carcinoma;
SKCM	cis	rs3784262	0.631	rs6493980	chr15:58352290	A/G	cg12031962	chr15:58353849	ALDH1A2	-0.41	-4.82	-0.48	6.93e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs7618501	0.602	rs2071207	chr3:50159844	T/C	cg24110177	chr3:50126178	RBM5	0.61	5.18	0.51	1.71e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs17065868	0.803	rs61948009	chr13:45186596	T/G	cg10246903	chr13:45222710	NA	0.95	5.35	0.52	8.5e-7	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs651907	0.557	rs7651721	chr3:101393583	C/A	cg12386194	chr3:101231763	SENP7	0.71	5.94	0.56	7.61e-8	Colorectal cancer;
SKCM	cis	rs995000	0.931	rs1748197	chr1:63056112	G/A	cg06896770	chr1:63153194	DOCK7	0.95	9.37	0.73	2.09e-14	Triglyceride levels;
SKCM	cis	rs2204008	0.654	rs1290325	chr12:38152910	C/T	cg26384229	chr12:38710491	ALG10B	-0.68	-5.48	-0.53	5.06e-7	Bladder cancer;
SKCM	cis	rs801193	1.000	rs6958520	chr7:66151453	T/C	cg00343986	chr7:65444356	GUSB	0.7	5.14	0.5	1.98e-6	Aortic root size;
SKCM	cis	rs6546550	0.933	rs57278310	chr2:70093647	T/C	cg02498382	chr2:70120550	SNRNP27	-0.47	-5.25	-0.51	1.3e-6	Prevalent atrial fibrillation;
SKCM	cis	rs7940866	0.809	rs2324317	chr11:130877142	T/C	cg12179176	chr11:130786555	SNX19	0.66	4.89	0.48	5.21e-6	Schizophrenia;
SKCM	cis	rs6539267	0.741	rs7314289	chr12:106686260	A/C	cg02476566	chr12:106696527	TCP11L2	0.71	5.03	0.49	3.1e-6	Tourette syndrome;
SKCM	cis	rs1568889	0.838	rs10835299	chr11:28277693	A/G	cg06544937	chr11:28130018	METT5D1;KIF18A	-0.88	-7.82	-0.66	2.08e-11	Bipolar disorder;
SKCM	cis	rs2243480	0.901	rs778730	chr7:65823325	T/A	cg18252515	chr7:66147081	NA	-1.33	-8.08	-0.68	6.46e-12	Diabetic kidney disease;
SKCM	cis	rs2013441	1.000	rs2526480	chr17:20130074	A/G	cg13482628	chr17:19912719	NA	0.65	5.13	0.5	2.04e-6	Obesity-related traits;
SKCM	cis	rs742320	0.756	rs4984925	chr16:839996	T/C	cg02106180	chr16:845767	CHTF18	0.68	5.3	0.51	1.06e-6	Mean corpuscular volume;
SKCM	cis	rs761746	0.672	rs5753684	chr22:31939973	A/G	cg25791279	chr22:32026902	PISD	0.82	4.9	0.49	5.11e-6	Intelligence;
SKCM	cis	rs6952808	0.656	rs73048919	chr7:2103637	C/A	cg05863683	chr7:1912471	MAD1L1	0.56	4.79	0.48	7.71e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs7659604	0.502	rs4315813	chr4:122674866	G/A	cg19671926	chr4:122722719	EXOSC9	0.77	6.27	0.58	1.89e-8	Type 2 diabetes;
SKCM	cis	rs17075286	1	rs17075286	chr3:43230723	C/G	cg02715246	chr3:42641919	NKTR	-0.99	-5.37	-0.52	7.79e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs7811142	0.830	rs73401451	chr7:99981895	T/C	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.2	7.87	0.67	1.7e-11	Platelet count;
SKCM	cis	rs7216064	0.906	rs78452260	chr17:65848522	G/T	cg12091567	chr17:66097778	LOC651250	-0.77	-5.53	-0.53	4.06e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs10911232	0.507	rs4652764	chr1:182994115	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.42	0.59	9.95e-9	Hypertriglyceridemia;
SKCM	cis	rs7829975	0.658	rs2409096	chr8:8692477	T/C	cg15556689	chr8:8085844	FLJ10661	0.73	5.98	0.56	6.24e-8	Mood instability;
SKCM	cis	rs780096	0.526	rs704791	chr2:27657167	T/C	cg05696406	chr2:27599888	SNX17	0.51	5.22	0.51	1.46e-6	Total body bone mineral density;
SKCM	cis	rs7786877	0.723	rs10487157	chr7:100214487	C/G	cg20848291	chr7:100343083	ZAN	-0.65	-5.02	-0.49	3.14e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs7124681	0.585	rs10838773	chr11:47834346	G/A	cg20307385	chr11:47447363	PSMC3	0.71	5.61	0.54	2.98e-7	Body mass index (joint analysis main effects and physical activity interaction);Body mass index;Body mass index in physically active individuals;
SKCM	cis	rs6087990	0.735	rs2424915	chr20:31378448	C/T	cg13636640	chr20:31349939	DNMT3B	0.87	6.84	0.61	1.61e-9	Ulcerative colitis;
SKCM	cis	rs780096	0.565	rs813592	chr2:27721971	T/C	cg05696406	chr2:27599888	SNX17	0.52	5.32	0.52	9.46e-7	Total body bone mineral density;
SKCM	cis	rs798554	1.000	rs798559	chr7:2758341	T/C	cg19346786	chr7:2764209	NA	-0.66	-6.72	-0.61	2.72e-9	Height;
SKCM	cis	rs1801251	0.896	rs2305141	chr2:233684402	A/G	cg08000102	chr2:233561755	GIGYF2	-0.81	-6.22	-0.58	2.33e-8	Coronary artery disease;
SKCM	cis	rs2836974	0.533	rs4817999	chr21:40554355	C/A	cg11644478	chr21:40555479	PSMG1	-0.8	-7.6	-0.65	5.6e-11	Cognitive function;
SKCM	cis	rs7178909	0.872	rs28468074	chr15:90435600	C/T	cg19708238	chr15:90437601	AP3S2	0.72	5.22	0.51	1.43e-6	Common traits (Other);
SKCM	cis	rs17065868	1.000	rs61949809	chr13:45060945	C/A	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	trans	rs1814175	0.645	rs847635	chr11:49923323	G/A	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs826838	0.967	rs1719852	chr12:39128531	A/G	cg13010199	chr12:38710504	ALG10B	-0.72	-5.73	-0.54	1.83e-7	Heart rate;
SKCM	cis	rs2645694	0.626	rs2703121	chr4:77822328	C/G	cg03477792	chr4:77819574	ANKRD56	0.57	6.37	0.58	1.22e-8	Emphysema distribution in smoking;
SKCM	cis	rs6121246	0.559	rs6060621	chr20:30261562	G/C	cg13852791	chr20:30311386	BCL2L1	0.83	5.76	0.55	1.61e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs3768617	0.510	rs2333621	chr1:183090751	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs9611565	0.512	rs139561	chr22:42195410	C/T	cg03806693	chr22:41940476	POLR3H	1.08	7.07	0.63	5.72e-10	Vitiligo;
SKCM	cis	rs2721195	0.967	rs748195	chr8:145682514	T/C	cg15320075	chr8:145703422	NA	0.88	7.52	0.65	8.13e-11	Age at first birth;
SKCM	cis	rs1048238	0.506	rs56352596	chr1:16297592	G/A	cg21385522	chr1:16154831	NA	0.62	5.26	0.51	1.24e-6	Systolic blood pressure;
SKCM	cis	rs151997	0.653	rs27611	chr5:50164814	G/A	cg06027927	chr5:50259733	NA	0.6	5.38	0.52	7.5e-7	Callous-unemotional behaviour;
SKCM	cis	rs4237845	0.788	rs1962047	chr12:58292707	G/A	cg02175503	chr12:58329896	NA	0.73	6.14	0.57	3.24e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs9300255	0.512	rs2851436	chr12:123667354	G/T	cg05973401	chr12:123451056	ABCB9	0.83	5.14	0.5	2.01e-6	Neutrophil percentage of white cells;
SKCM	cis	rs6429082	0.523	rs704718	chr1:235666159	A/T	cg26050004	chr1:235667680	B3GALNT2	0.91	8.76	0.7	3.13e-13	Adiposity;
SKCM	cis	rs3087591	0.690	rs12103621	chr17:29607235	T/A	cg24425628	chr17:29625626	OMG;NF1	-0.63	-4.79	-0.48	7.9e-6	Hip circumference;
SKCM	cis	rs7100689	0.753	rs4934125	chr10:82147466	T/C	cg00277334	chr10:82204260	NA	-0.54	-5.14	-0.5	1.95e-6	Post bronchodilator FEV1;
SKCM	cis	rs1348850	0.914	rs4893944	chr2:178289357	G/T	cg02961200	chr2:178257176	LOC100130691;AGPS	0.84	6.5	0.59	6.98e-9	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs56104184	1.000	rs56104184	chr19:49370310	C/T	cg19746536	chr19:49375674	PPP1R15A	1.08	6.83	0.61	1.68e-9	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs7772486	0.875	rs2814877	chr6:146299763	C/G	cg23711669	chr6:146136114	FBXO30	0.76	7.08	0.63	5.66e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2075371	0.966	rs1619682	chr7:133996703	T/G	cg20476274	chr7:133979776	SLC35B4	1.03	10.69	0.77	5.94e-17	Mean platelet volume;
SKCM	cis	rs6121246	0.609	rs6060627	chr20:30262159	C/T	cg13852791	chr20:30311386	BCL2L1	0.82	5.64	0.54	2.59e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs9325144	0.555	rs1825806	chr12:38692547	G/A	cg26384229	chr12:38710491	ALG10B	0.78	6.74	0.61	2.48e-9	Morning vs. evening chronotype;
SKCM	cis	rs8072100	0.701	rs10163469	chr17:45687767	G/A	cg25173405	chr17:45401733	C17orf57	0.58	5.23	0.51	1.39e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs4785763	0.570	rs4785759	chr16:90050880	G/T	cg08547343	chr16:90038815	CENPBD1;AFG3L1	-0.74	-6.16	-0.57	2.95e-8	Melanoma;
SKCM	cis	rs4862750	0.872	rs6852907	chr4:187897094	A/C	cg10295955	chr4:187884368	NA	-1.04	-14.07	-0.85	4.23e-23	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs13118159	0.509	rs9683830	chr4:1377873	A/G	cg20887711	chr4:1340912	KIAA1530	0.92	6.84	0.61	1.56e-9	Longevity;
SKCM	cis	rs6089829	0.962	rs2872543	chr20:61665017	G/A	cg08564027	chr20:61660810	NA	0.62	5.5	0.53	4.66e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs6500395	1.000	rs9930365	chr16:48682154	A/C	cg04672837	chr16:48644449	N4BP1	0.65	5.43	0.52	6.28e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs10751667	0.857	rs7481221	chr11:966813	G/C	cg10932868	chr11:921992	NA	0.55	5.1	0.5	2.36e-6	Alzheimer's disease (late onset);
SKCM	cis	rs28595532	1.000	rs41455648	chr4:119718030	A/G	cg14228332	chr4:119757509	SEC24D	1.07	5.49	0.53	4.77e-7	Cannabis dependence symptom count;
SKCM	cis	rs7927771	0.832	rs935914	chr11:47387599	C/T	cg05585544	chr11:47624801	NA	0.56	4.84	0.48	6.52e-6	Subjective well-being;
SKCM	cis	rs116095464	0.558	rs61689490	chr5:224904	T/C	cg22496380	chr5:211416	CCDC127	-0.96	-5.27	-0.51	1.18e-6	Breast cancer;
SKCM	cis	rs10504229	0.683	rs35840293	chr8:58117634	C/T	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs79040073	0.530	rs8029506	chr15:49566740	C/A	cg25951582	chr15:49913451	C15orf33;DTWD1	-0.72	-5.22	-0.51	1.44e-6	Lung cancer in ever smokers;
SKCM	cis	rs1348850	0.598	rs12616259	chr2:178503803	C/T	cg22681709	chr2:178499509	PDE11A	-0.69	-5.98	-0.56	6.36e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs2120019	1.000	rs12324912	chr15:75361006	G/A	cg17294928	chr15:75287854	SCAMP5	-0.83	-7.08	-0.63	5.44e-10	Blood trace element (Zn levels);
SKCM	cis	rs71444571	1	rs71444571	chr12:123771015	G/A	cg00376283	chr12:123451042	ABCB9	-0.78	-5.26	-0.51	1.24e-6	Lymphocyte percentage of white cells;
SKCM	cis	rs801193	1.000	rs2659909	chr7:66160279	G/A	cg11764359	chr7:65958608	NA	0.86	6.6	0.6	4.52e-9	Aortic root size;
SKCM	cis	rs3020736	0.500	rs8138678	chr22:42516229	A/G	cg04733989	chr22:42467013	NAGA	-0.72	-5.62	-0.54	2.87e-7	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs7772486	0.790	rs3923579	chr6:146230232	C/G	cg23711669	chr6:146136114	FBXO30	-0.76	-7.66	-0.66	4.34e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7829975	0.511	rs1543238	chr8:8134809	A/G	cg06636001	chr8:8085503	FLJ10661	0.93	9.26	0.72	3.33e-14	Mood instability;
SKCM	cis	rs28386778	0.897	rs9912557	chr17:61784963	C/A	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.13	11.24	0.79	5.56e-18	Prudent dietary pattern;
SKCM	cis	rs941408	1.000	rs1076448	chr19:2792343	G/A	cg06609049	chr19:2785107	THOP1	0.83	6.74	0.61	2.46e-9	Total cholesterol levels;
SKCM	cis	rs12464559	0.649	rs6433680	chr2:152706318	A/C	cg01189475	chr2:152685088	ARL5A	-1.37	-5.53	-0.53	4.18e-7	Response to cognitive-behavioural therapy in anxiety disorder;
SKCM	cis	rs514406	0.929	rs12354395	chr1:53327663	A/G	cg16325326	chr1:53192061	ZYG11B	0.94	10.05	0.75	1.02e-15	Monocyte count;
SKCM	cis	rs7100689	0.784	rs7089058	chr10:82071263	T/C	cg00277334	chr10:82204260	NA	-0.58	-5.69	-0.54	2.16e-7	Post bronchodilator FEV1;
SKCM	cis	rs6951245	0.935	rs78573577	chr7:1089087	C/A	cg24642844	chr7:1081250	C7orf50	-0.94	-6.32	-0.58	1.48e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs3784262	0.740	rs2119859	chr15:58254745	T/C	cg12031962	chr15:58353849	ALDH1A2	-0.43	-5.02	-0.49	3.2e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs60871478	1.000	rs4374882	chr7:821798	C/T	cg05535760	chr7:792225	HEATR2	1.02	8.66	0.7	4.97e-13	Cerebrospinal P-tau181p levels;
SKCM	cis	rs7824557	0.767	rs4559208	chr8:11153925	C/G	cg21775007	chr8:11205619	TDH	0.72	6.06	0.57	4.6e-8	Retinal vascular caliber;
SKCM	cis	rs1552244	1.000	rs6791810	chr3:10124444	A/G	cg02579736	chr3:10068473	FANCD2;CIDECP	-1.32	-7.35	-0.64	1.72e-10	Alzheimer's disease;
SKCM	cis	rs75229567	0.618	rs75389984	chr12:70212879	A/G	cg10114359	chr12:70132523	RAB3IP	1.24	5.19	0.51	1.6e-6	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes;
SKCM	cis	rs1799949	1.000	rs3092988	chr17:41201702	C/T	cg05368731	chr17:41323189	NBR1	0.89	7.67	0.66	4.08e-11	Menopause (age at onset);
SKCM	cis	rs4319547	0.774	rs10773394	chr12:123124778	C/A	cg23029597	chr12:123009494	RSRC2	-0.73	-5.5	-0.53	4.6e-7	Body mass index;
SKCM	cis	rs2721195	0.549	rs2620666	chr8:145703413	T/C	cg11211951	chr8:145729740	GPT	0.64	5.89	0.55	9.44e-8	Age at first birth;
SKCM	cis	rs10832963	1.000	rs10832962	chr11:18656271	C/T	cg20219074	chr11:18656078	SPTY2D1	0.83	6.62	0.6	4.18e-9	Breast cancer;
SKCM	cis	rs62103177	0.810	rs62103192	chr18:77629050	A/T	cg27393146	chr18:77495563	CTDP1	-0.92	-5.36	-0.52	8.37e-7	Opioid sensitivity;
SKCM	cis	rs12188164	1.000	rs34847072	chr5:437862	G/C	cg26076054	chr5:421317	AHRR	-0.61	-4.87	-0.48	5.68e-6	Cystic fibrosis severity;
SKCM	cis	rs7824557	0.564	rs2572392	chr8:11235605	T/G	cg21775007	chr8:11205619	TDH	-0.59	-5.03	-0.5	3.01e-6	Retinal vascular caliber;
SKCM	cis	rs8072100	0.676	rs7221345	chr17:45405144	G/A	cg25173405	chr17:45401733	C17orf57	-0.73	-5.94	-0.56	7.45e-8	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs860295	0.702	rs2025669	chr1:155357609	G/A	cg02153340	chr1:155202674	NA	-0.77	-5.48	-0.53	4.96e-7	Body mass index;
SKCM	cis	rs6866344	0.697	rs11742808	chr5:178131658	G/A	cg10224037	chr5:178157518	ZNF354A	0.76	5.31	0.52	1.01e-6	Neutrophil percentage of white cells;
SKCM	cis	rs769267	0.930	rs1054930	chr19:19648346	G/C	cg03709012	chr19:19516395	GATAD2A	0.89	8.53	0.69	9.02e-13	Tonsillectomy;
SKCM	cis	rs73201462	0.908	rs4593050	chr3:128004531	T/C	cg09089421	chr3:127803668	RUVBL1	-1.0	-5.11	-0.5	2.22e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs4555082	1.000	rs7149013	chr14:105759840	T/C	cg13114125	chr14:105738426	BRF1	-0.78	-5.9	-0.56	8.91e-8	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs72634258	0.503	rs2794666	chr1:7822009	A/G	cg26816564	chr1:7831052	VAMP3	0.82	5.46	0.53	5.53e-7	Inflammatory bowel disease;
SKCM	cis	rs561341	1.000	rs757009	chr17:30243937	A/G	cg00745463	chr17:30367425	LRRC37B	-0.98	-6.53	-0.59	6.05e-9	Hip circumference adjusted for BMI;
SKCM	cis	rs12134245	0.776	rs12137878	chr1:91973210	G/T	cg02896835	chr1:92012615	NA	-0.66	-6.48	-0.59	7.48e-9	Breast cancer;
SKCM	cis	rs950776	0.518	rs28438420	chr15:78836288	A/T	cg06917634	chr15:78832804	PSMA4	-0.99	-10.06	-0.75	9.65e-16	Sudden cardiac arrest;
SKCM	cis	rs4727443	0.866	rs2897075	chr7:99630342	C/T	cg07913999	chr7:99613796	ZKSCAN1	0.66	5.09	0.5	2.43e-6	Interstitial lung disease;
SKCM	cis	rs992157	1.000	rs4791	chr2:219138940	C/T	cg20019365	chr2:219134978	PNKD;AAMP	0.79	7.19	0.63	3.45e-10	Colorectal cancer;
SKCM	cis	rs67460515	0.892	rs13059340	chr3:161062631	T/C	cg03342759	chr3:160939853	NMD3	-0.81	-7.17	-0.63	3.82e-10	Parkinson's disease;
SKCM	cis	rs362272	0.525	rs910568	chr4:3307373	A/G	cg21096898	chr4:3318625	RGS12	1.0	12.3	0.81	6.04e-20	Serum sulfate level;
SKCM	trans	rs11083271	0.631	rs9966971	chr18:25859106	A/G	cg00321150	chr11:62623587	SNORD27;SLC3A2;SNHG1;SNORD28;SNORD25;SNORD26	0.8	7.29	0.64	2.17e-10	Non-alcoholic fatty liver disease histology (lobular);
SKCM	cis	rs6088580	0.634	rs11700221	chr20:32940320	T/C	cg24642439	chr20:33292090	TP53INP2	-0.76	-6.02	-0.56	5.31e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs514406	0.698	rs1672913	chr1:53408326	A/T	cg24675658	chr1:53192096	ZYG11B	-0.82	-7.79	-0.66	2.45e-11	Monocyte count;
SKCM	cis	rs2836974	0.897	rs34599551	chr21:40594898	C/A	cg11890956	chr21:40555474	PSMG1	1.09	13.83	0.84	1.08e-22	Cognitive function;
SKCM	cis	rs7666738	0.753	rs34164013	chr4:98976333	A/G	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4891159	0.757	rs11665018	chr18:74123589	C/T	cg24786174	chr18:74118243	ZNF516	-0.74	-7.05	-0.62	6.2e-10	Longevity;
SKCM	cis	rs2153535	0.601	rs7738877	chr6:8542230	A/G	cg07606381	chr6:8435919	SLC35B3	0.86	5.99	0.56	6.08e-8	Motion sickness;
SKCM	cis	rs2228479	0.850	rs62052212	chr16:89981960	G/A	cg06558623	chr16:89946397	TCF25	1.08	5.4	0.52	7.07e-7	Skin colour saturation;
SKCM	cis	rs57221529	0.825	rs7443550	chr5:578404	G/T	cg26208419	chr5:473447	SLC9A3;LOC25845	1.05	5.37	0.52	7.95e-7	Lung disease severity in cystic fibrosis;
SKCM	cis	rs9549367	0.713	rs9549357	chr13:113860121	C/T	cg24722198	chr13:113567732	NA	0.51	5.15	0.5	1.92e-6	Platelet distribution width;
SKCM	cis	rs9303401	0.659	rs17822908	chr17:56801778	T/C	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.35	0.52	8.54e-7	Cognitive test performance;
SKCM	cis	rs9916302	0.752	rs6503513	chr17:37561613	A/G	cg07936489	chr17:37558343	FBXL20	1.01	8.81	0.71	2.54e-13	Glomerular filtration rate (creatinine);
SKCM	cis	rs2481665	0.626	rs2481664	chr1:62593893	T/C	cg18591186	chr1:62594603	INADL	-0.63	-4.91	-0.49	4.97e-6	BMI in non-smokers;BMI (adjusted for smoking behaviour);Body mass index;Body mass index (joint analysis main effects and smoking interaction);
SKCM	cis	rs6088580	0.634	rs6579165	chr20:32994715	A/G	cg24642439	chr20:33292090	TP53INP2	-0.76	-6.02	-0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs55728055	0.661	rs1018488	chr22:31992376	A/G	cg01338084	chr22:32026380	PISD	1.4	4.87	0.48	5.71e-6	Age-related hearing impairment;
SKCM	cis	rs2239547	0.563	rs4302374	chr3:52905802	T/C	cg11645453	chr3:52864694	ITIH4	0.76	6.87	0.61	1.4e-9	Schizophrenia;
SKCM	cis	rs7772486	0.790	rs4314514	chr6:146260010	A/G	cg23711669	chr6:146136114	FBXO30	-0.77	-7.44	-0.64	1.14e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7666738	0.830	rs3911282	chr4:99037602	T/A	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7208859	0.573	rs11656278	chr17:29075188	C/T	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs13256369	1.000	rs885000	chr8:8568875	G/T	cg06636001	chr8:8085503	FLJ10661	0.75	5.78	0.55	1.44e-7	Obesity-related traits;
SKCM	cis	rs854765	0.647	rs741782	chr17:18019712	T/C	cg04398451	chr17:18023971	MYO15A	-1.03	-8.92	-0.71	1.58e-13	Total body bone mineral density;
SKCM	cis	rs1799949	0.931	rs34410138	chr17:41279770	A/G	cg05368731	chr17:41323189	NBR1	0.89	7.91	0.67	1.38e-11	Menopause (age at onset);
SKCM	cis	rs453301	0.658	rs9329175	chr8:8866661	C/T	cg15556689	chr8:8085844	FLJ10661	-0.74	-5.96	-0.56	7.02e-8	Joint mobility (Beighton score);
SKCM	cis	rs644799	1.000	rs693364	chr11:95621926	A/G	cg03916912	chr11:95522834	CEP57;FAM76B	0.84	6.63	0.6	3.93e-9	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs3768617	0.510	rs10752902	chr1:183090265	T/A	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs3785574	0.927	rs2727313	chr17:61961914	A/G	cg06601766	chr17:61851465	DDX42;CCDC47	0.67	4.84	0.48	6.35e-6	Height;
SKCM	cis	rs9611565	0.512	rs4820444	chr22:42202606	A/G	cg03806693	chr22:41940476	POLR3H	1.05	6.12	0.57	3.51e-8	Vitiligo;
SKCM	cis	rs28595532	0.920	rs115675321	chr4:119742153	A/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs9388451	0.807	rs1268065	chr6:126042783	G/A	cg05901451	chr6:126070800	HEY2	0.78	7.21	0.63	3.08e-10	Brugada syndrome;
SKCM	cis	rs4889855	0.578	rs7216808	chr17:78484187	A/G	cg16591659	chr17:78472290	NA	-0.55	-5.52	-0.53	4.2e-7	Fractional excretion of uric acid;
SKCM	cis	rs28386778	0.897	rs11654841	chr17:61838259	C/T	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs9325144	0.556	rs34565156	chr12:39028239	G/A	cg26384229	chr12:38710491	ALG10B	-0.73	-6.63	-0.6	3.88e-9	Morning vs. evening chronotype;
SKCM	trans	rs3780486	0.846	rs73484568	chr9:33132492	G/A	cg20290983	chr6:43655470	MRPS18A	1.0	11.51	0.79	1.7e-18	IgG glycosylation;
SKCM	cis	rs9818758	0.607	rs11719220	chr3:49245201	A/G	cg00383909	chr3:49044727	WDR6	0.91	5.14	0.5	1.96e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs7811142	1.000	rs67239991	chr7:100046504	A/G	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.23	7.89	0.67	1.53e-11	Platelet count;
SKCM	cis	rs4523957	0.855	rs216212	chr17:2134214	T/C	cg16513277	chr17:2031491	SMG6	0.72	4.83	0.48	6.78e-6	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs2839186	0.771	rs13049175	chr21:47641326	G/A	cg13012494	chr21:47604986	C21orf56	-0.68	-5.81	-0.55	1.3e-7	Testicular germ cell tumor;
SKCM	cis	rs684232	0.602	rs35206514	chr17:519859	T/C	cg15660573	chr17:549704	VPS53	-0.75	-5.83	-0.55	1.18e-7	Prostate cancer;
SKCM	cis	rs9910055	0.529	rs228746	chr17:42173752	T/C	cg19774624	chr17:42201019	HDAC5	0.83	6.53	0.59	6.08e-9	Total body bone mineral density;
SKCM	cis	rs8072100	0.840	rs9912311	chr17:45547132	T/C	cg25173405	chr17:45401733	C17orf57	-0.57	-4.77	-0.48	8.33e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs826838	0.967	rs2892410	chr12:38990282	A/G	cg13010199	chr12:38710504	ALG10B	-0.81	-6.32	-0.58	1.49e-8	Heart rate;
SKCM	cis	rs7829975	0.514	rs2979139	chr8:8268313	A/G	cg06636001	chr8:8085503	FLJ10661	0.8	6.93	0.62	1.08e-9	Mood instability;
SKCM	cis	rs875971	0.522	rs1917563	chr7:65415647	C/T	cg11764359	chr7:65958608	NA	-0.88	-6.84	-0.61	1.61e-9	Aortic root size;
SKCM	cis	rs2836974	0.533	rs418298	chr21:40536654	A/T	cg17971929	chr21:40555470	PSMG1	0.78	7.31	0.64	1.98e-10	Cognitive function;
SKCM	cis	rs514406	0.679	rs545719	chr1:53304922	T/C	cg16325326	chr1:53192061	ZYG11B	0.68	5.81	0.55	1.32e-7	Monocyte count;
SKCM	cis	rs9796	0.621	rs537244	chr15:41469313	G/T	cg18705301	chr15:41695430	NDUFAF1	0.7	5.18	0.51	1.67e-6	Menopause (age at onset);
SKCM	cis	rs2153535	0.547	rs9505475	chr6:8542890	A/G	cg07606381	chr6:8435919	SLC35B3	0.9	6.17	0.57	2.82e-8	Motion sickness;
SKCM	cis	rs1635	0.655	rs59598126	chr6:28303600	A/C	cg15743358	chr6:28303923	ZNF323	-1.27	-5.15	-0.5	1.92e-6	Schizophrenia;
SKCM	trans	rs8073060	0.614	rs225275	chr17:33972567	G/C	cg19694781	chr19:47549865	TMEM160	-1.0	-8.56	-0.7	7.62e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs4891159	0.548	rs11150952	chr18:74128188	T/C	cg24786174	chr18:74118243	ZNF516	0.79	8.44	0.69	1.31e-12	Longevity;
SKCM	cis	rs2839186	0.967	rs2839191	chr21:47695395	C/G	cg11766577	chr21:47581405	C21orf56	-0.68	-5.68	-0.54	2.25e-7	Testicular germ cell tumor;
SKCM	cis	rs514406	0.679	rs11585495	chr1:53244331	T/C	cg08859206	chr1:53392774	SCP2	0.68	5.31	0.52	1.01e-6	Monocyte count;
SKCM	cis	rs651907	0.557	rs11924013	chr3:101366698	G/A	cg12386194	chr3:101231763	SENP7	0.74	6.2	0.57	2.45e-8	Colorectal cancer;
SKCM	cis	rs11671005	0.695	rs8106061	chr19:58917990	G/C	cg26874164	chr19:58962979	ZNF324B	0.81	7.03	0.62	6.78e-10	Mean platelet volume;
SKCM	cis	rs2204008	0.658	rs12371956	chr12:38298010	A/T	cg26384229	chr12:38710491	ALG10B	0.81	6.57	0.6	5.18e-9	Bladder cancer;
SKCM	cis	rs7647973	0.580	rs7652746	chr3:49262307	C/T	cg07636037	chr3:49044803	WDR6	-0.81	-6.77	-0.61	2.14e-9	Menarche (age at onset);
SKCM	cis	rs12477438	0.520	rs11123765	chr2:99768064	T/C	cg26064155	chr2:99771622	LIPT1;TSGA10	1.05	10.1	0.75	7.95e-16	Chronic sinus infection;
SKCM	cis	rs10870270	1.000	rs9971066	chr10:133788233	G/A	cg17892150	chr10:133769511	PPP2R2D	-0.69	-4.84	-0.48	6.52e-6	Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals;
SKCM	trans	rs8073060	0.586	rs225298	chr17:33923946	T/G	cg19694781	chr19:47549865	TMEM160	-1.08	-8.69	-0.7	4.26e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs7100689	0.725	rs10736340	chr10:82061071	C/T	cg01528321	chr10:82214614	TSPAN14	0.81	7.3	0.64	2.14e-10	Post bronchodilator FEV1;
SKCM	cis	rs1577917	0.740	rs7752502	chr6:86410651	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.75	6.9	0.62	1.2e-9	Response to antipsychotic treatment;
SKCM	cis	rs875971	0.642	rs35526611	chr7:66094008	C/T	cg11987759	chr7:65425863	GUSB	0.67	5.8	0.55	1.36e-7	Aortic root size;
SKCM	cis	rs4820539	1.000	rs2157710	chr22:23457486	C/T	cg14186256	chr22:23484241	RTDR1	0.83	8.41	0.69	1.52e-12	Bone mineral density;
SKCM	cis	rs2295499	0.559	rs12509910	chr4:2731109	G/C	cg19433769	chr4:2420260	ZFYVE28	0.73	4.94	0.49	4.28e-6	Cognitive ability;Cognitive ability (multi-trait analysis);Intelligence (multi-trait analysis);
SKCM	cis	rs4689592	0.513	rs3857177	chr4:7066332	G/A	cg19539972	chr4:7069911	GRPEL1	1.01	6.97	0.62	8.88e-10	Monocyte percentage of white cells;
SKCM	cis	rs6582630	0.502	rs11520279	chr12:38360871	A/G	cg26384229	chr12:38710491	ALG10B	0.81	6.56	0.6	5.29e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs17711722	0.727	rs2658585	chr7:65461941	A/T	cg11764359	chr7:65958608	NA	0.87	6.65	0.6	3.58e-9	Calcium levels;
SKCM	cis	rs1801251	1.000	rs35212961	chr2:233582762	C/T	cg08000102	chr2:233561755	GIGYF2	0.89	6.91	0.62	1.15e-9	Coronary artery disease;
SKCM	cis	rs1153858	1.000	rs67744121	chr15:45677237	C/G	cg21132104	chr15:45694354	SPATA5L1	0.93	7.94	0.67	1.22e-11	Homoarginine levels;
SKCM	cis	rs644799	0.965	rs602512	chr11:95561682	G/A	cg25622487	chr11:95524042	FAM76B;CEP57	0.63	4.8	0.48	7.48e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs6952808	0.689	rs871924	chr7:2047845	A/G	cg04267008	chr7:1944627	MAD1L1	-0.64	-5.04	-0.5	2.99e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs7399018	0.643	rs6580810	chr12:51610478	C/T	cg20712883	chr12:51590929	POU6F1	0.62	4.94	0.49	4.42e-6	Cisplatin-induced ototoxicity;
SKCM	cis	rs738321	0.757	rs9622732	chr22:38524149	G/C	cg25457927	chr22:38595422	NA	-0.58	-6.78	-0.61	2.02e-9	Breast cancer;
SKCM	cis	rs4332037	0.851	rs73050128	chr7:1961882	C/A	cg02825527	chr7:2087843	MAD1L1	-0.74	-5.06	-0.5	2.68e-6	Bipolar disorder;
SKCM	cis	rs2404602	0.583	rs12907668	chr15:76589767	A/T	cg23625390	chr15:77176239	SCAPER	0.69	6.31	0.58	1.57e-8	Blood metabolite levels;
SKCM	cis	rs11690935	0.885	rs6725388	chr2:172730015	G/C	cg13550731	chr2:172543902	DYNC1I2	-0.91	-7.54	-0.65	7.32e-11	Schizophrenia;
SKCM	cis	rs2842992	0.724	rs15982	chr6:160199687	T/C	cg19482086	chr6:160211437	TCP1;MRPL18	0.9	8.21	0.68	3.64e-12	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs7216064	1.000	rs7208663	chr17:65885171	T/C	cg12091567	chr17:66097778	LOC651250	-0.75	-5.27	-0.51	1.19e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs28374715	0.787	rs11856169	chr15:41547938	C/T	cg18705301	chr15:41695430	NDUFAF1	-0.93	-8.27	-0.68	2.84e-12	Ulcerative colitis;
SKCM	cis	rs9325144	0.647	rs11169222	chr12:39105210	C/T	cg26384229	chr12:38710491	ALG10B	-0.72	-6.39	-0.59	1.12e-8	Morning vs. evening chronotype;
SKCM	cis	rs2836974	0.897	rs4817996	chr21:40525759	G/C	cg11644478	chr21:40555479	PSMG1	0.97	10.21	0.76	5.08e-16	Cognitive function;
SKCM	cis	rs10832963	1.000	rs7943121	chr11:18656062	G/C	cg20219074	chr11:18656078	SPTY2D1	0.83	6.62	0.6	4.18e-9	Breast cancer;
SKCM	cis	rs2842992	0.724	rs2273827	chr6:160211339	C/A	cg16489826	chr6:160211363	TCP1;MRPL18	0.71	5.51	0.53	4.52e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs1577917	0.655	rs2842600	chr6:86325632	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.76	-6.83	-0.61	1.68e-9	Response to antipsychotic treatment;
SKCM	cis	rs606458	0.841	rs1633462	chr11:64546257	C/G	cg07674570	chr11:65346152	EHBP1L1	0.68	4.89	0.48	5.2e-6	Urate levels;
SKCM	cis	rs7428	0.527	rs1554110	chr2:85547963	C/T	cg24342717	chr2:85555507	TGOLN2	-0.61	-4.79	-0.48	7.86e-6	Ear protrusion;
SKCM	cis	rs362296	0.698	rs3095083	chr4:3263499	G/A	cg24015175	chr4:3319247	RGS12	-0.6	-5.81	-0.55	1.31e-7	Parental longevity (mother's age at death);
SKCM	cis	rs2721195	1.000	rs1871541	chr8:145681713	G/T	cg15857475	chr8:145742913	RECQL4;LRRC14	-0.8	-7.07	-0.62	5.82e-10	Age at first birth;
SKCM	cis	rs6088590	0.965	rs13040449	chr20:33358901	T/A	cg24642439	chr20:33292090	TP53INP2	1.01	7.2	0.63	3.23e-10	Coronary artery disease;
SKCM	cis	rs644799	0.965	rs11021317	chr11:95517576	C/T	cg03916912	chr11:95522834	CEP57;FAM76B	0.94	8.46	0.69	1.18e-12	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs35146811	0.807	rs10228764	chr7:99608029	A/G	cg13334819	chr7:99746414	C7orf59	-0.74	-5.25	-0.51	1.3e-6	Coronary artery disease;
SKCM	cis	rs6500395	0.962	rs11648101	chr16:48714178	C/T	cg04672837	chr16:48644449	N4BP1	0.63	5.3	0.51	1.03e-6	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs35146811	0.844	rs13223792	chr7:99675659	T/G	cg13334819	chr7:99746414	C7orf59	-0.73	-5.28	-0.51	1.11e-6	Coronary artery disease;
SKCM	cis	rs9926296	0.527	rs1800335	chr16:89846195	A/G	cg26513180	chr16:89883248	FANCA	0.97	11.05	0.78	1.25e-17	Vitiligo;
SKCM	cis	rs3020736	0.500	rs4147640	chr22:42485292	T/C	cg04733989	chr22:42467013	NAGA	-0.72	-5.62	-0.54	2.87e-7	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs860295	0.702	rs11264386	chr1:155559170	G/T	cg02153340	chr1:155202674	NA	-0.78	-5.91	-0.56	8.65e-8	Body mass index;
SKCM	cis	rs9467773	1.000	rs1321480	chr6:26532742	A/G	cg09904177	chr6:26538194	HMGN4	0.54	4.98	0.49	3.78e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1863824	0.625	rs10887599	chr10:88168780	G/A	cg07322936	chr10:88137208	NA	-0.59	-5.0	-0.49	3.42e-6	Schizophrenia;
SKCM	cis	rs1475911	0.507	rs11702347	chr21:43526454	C/T	cg19766460	chr21:43528205	UMODL1;C21orf128	0.95	5.2	0.51	1.54e-6	IgG glycosylation;
SKCM	cis	rs4664308	0.618	rs3749117	chr2:160885442	T/C	cg03641300	chr2:160917029	PLA2R1	-0.65	-5.05	-0.5	2.78e-6	Idiopathic membranous nephropathy;
SKCM	cis	rs9611565	0.694	rs5758347	chr22:41821019	G/T	cg03806693	chr22:41940476	POLR3H	1.13	7.36	0.64	1.63e-10	Vitiligo;
SKCM	cis	rs7216064	1.000	rs58551145	chr17:65837235	A/G	cg12091567	chr17:66097778	LOC651250	-0.77	-5.53	-0.53	4.06e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs861020	0.606	rs4844903	chr1:210006267	C/T	cg05527609	chr1:210001259	C1orf107	0.86	6.74	0.61	2.43e-9	Orofacial clefts;
SKCM	cis	rs12477438	0.798	rs10196680	chr2:99628617	A/G	cg26064155	chr2:99771622	LIPT1;TSGA10	-0.72	-4.86	-0.48	6e-6	Chronic sinus infection;
SKCM	cis	rs1005277	0.579	rs1780136	chr10:38501453	A/G	cg25427524	chr10:38739819	LOC399744	-0.69	-6.79	-0.61	1.96e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs801193	1.000	rs13239306	chr7:66136017	T/G	cg18876405	chr7:65276391	NA	-0.77	-7.12	-0.63	4.57e-10	Aortic root size;
SKCM	cis	rs72615157	0.634	rs74774557	chr7:99810425	A/G	cg23667466	chr7:100026434	MEPCE;ZCWPW1	0.89	4.79	0.48	7.74e-6	Lung function (FEV1/FVC);
SKCM	cis	rs1018836	0.851	rs12548741	chr8:91628878	G/A	cg16814680	chr8:91681699	NA	-0.64	-4.85	-0.48	6.29e-6	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs6951245	1.000	rs78308415	chr7:1072634	G/A	cg18402987	chr7:1209562	NA	1.15	6.02	0.56	5.38e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs34779708	0.966	rs12773647	chr10:35440327	A/G	cg03585969	chr10:35415529	CREM	0.73	6.0	0.56	5.85e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs28595532	0.920	rs116023344	chr4:119760263	A/G	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs9303401	0.659	rs34426768	chr17:56683385	C/T	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.31	0.51	1.02e-6	Cognitive test performance;
SKCM	cis	rs10504229	0.679	rs11783965	chr8:58130510	T/G	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs2749592	0.550	rs7081464	chr10:37883937	C/T	cg00409905	chr10:38381863	ZNF37A	0.63	6.16	0.57	2.99e-8	Age-related hearing impairment (SNP x SNP interaction);
SKCM	cis	rs9467773	1.000	rs4713006	chr6:26519872	A/G	cg09904177	chr6:26538194	HMGN4	0.54	4.98	0.49	3.78e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs34779708	0.931	rs35126129	chr10:35452141	G/A	cg03585969	chr10:35415529	CREM	0.74	5.9	0.56	8.94e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs478304	0.651	rs948494	chr11:65552118	G/A	cg27068330	chr11:65405492	SIPA1	-0.92	-8.24	-0.68	3.29e-12	Acne (severe);
SKCM	cis	rs7666738	0.830	rs7680909	chr4:98934604	A/G	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1691799	0.867	rs1027400	chr12:66760922	A/T	cg16791601	chr12:66731901	HELB	-0.58	-4.82	-0.48	6.86e-6	White blood cell count (basophil);
SKCM	cis	rs4481887	0.893	rs4423045	chr1:248479495	T/C	cg00666640	chr1:248458726	OR2T12	0.63	5.91	0.56	8.65e-8	Common traits (Other);
SKCM	cis	rs7666738	0.830	rs72882693	chr4:98960804	T/A	cg05340658	chr4:99064831	C4orf37	0.64	4.91	0.49	4.97e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs875971	0.862	rs1860469	chr7:66106875	A/G	cg18876405	chr7:65276391	NA	-0.63	-6.32	-0.58	1.5e-8	Aortic root size;
SKCM	cis	rs2559856	1.000	rs2559860	chr12:102087636	C/T	cg12924262	chr12:102091054	CHPT1	0.7	5.99	0.56	5.99e-8	Blood protein levels;
SKCM	cis	rs4803468	1.000	rs4674	chr19:41930396	A/G	cg14132834	chr19:41945861	ATP5SL	-0.77	-6.04	-0.56	4.87e-8	Height;
SKCM	cis	rs752010	0.756	rs943374	chr1:42056194	A/G	cg06885757	chr1:42089581	HIVEP3	0.66	7.12	0.63	4.61e-10	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs9790314	0.715	rs9290065	chr3:160776964	A/G	cg03342759	chr3:160939853	NMD3	0.58	5.49	0.53	4.76e-7	Morning vs. evening chronotype;
SKCM	cis	rs854765	0.551	rs12600546	chr17:17867614	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.01	7.49	0.65	9.28e-11	Total body bone mineral density;
SKCM	cis	rs854765	0.616	rs8070624	chr17:17843396	G/A	cg04398451	chr17:18023971	MYO15A	-0.71	-4.8	-0.48	7.37e-6	Total body bone mineral density;
SKCM	cis	rs2013441	1.000	rs2703789	chr17:20162923	G/A	cg13482628	chr17:19912719	NA	-0.64	-5.04	-0.5	2.94e-6	Obesity-related traits;
SKCM	cis	rs1799949	0.965	rs11651623	chr17:41329847	G/A	cg05368731	chr17:41323189	NBR1	0.87	7.74	0.66	3.01e-11	Menopause (age at onset);
SKCM	cis	rs6500602	0.793	rs4785964	chr16:4484613	A/G	cg08645402	chr16:4508243	NA	0.7	4.82	0.48	6.96e-6	Schizophrenia;
SKCM	cis	rs2439831	0.850	rs61390361	chr15:44159842	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.3	6.97	0.62	9.12e-10	Lung cancer in ever smokers;
SKCM	cis	rs6545883	0.929	rs2256615	chr2:61679894	C/G	cg15711740	chr2:61764176	XPO1	-0.7	-4.93	-0.49	4.5e-6	Tuberculosis;
SKCM	cis	rs959260	0.588	rs2385263	chr17:73321117	T/C	cg14668889	chr17:73230827	NUP85	-0.75	-6.29	-0.58	1.72e-8	Systemic lupus erythematosus;
SKCM	cis	rs1801251	1.000	rs6714245	chr2:233580505	T/C	cg25237894	chr2:233734115	C2orf82	0.61	5.66	0.54	2.39e-7	Coronary artery disease;
SKCM	trans	rs1814175	0.817	rs1615305	chr11:49895222	T/A	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs5769765	0.913	rs4824111	chr22:50284305	A/G	cg22709217	chr22:50311962	ALG12;CRELD2	0.83	5.74	0.54	1.73e-7	Schizophrenia;
SKCM	cis	rs2404602	0.735	rs1607017	chr15:76726465	G/T	cg23625390	chr15:77176239	SCAPER	-0.83	-8.06	-0.67	7.18e-12	Blood metabolite levels;
SKCM	cis	rs4905558	1.000	rs10149107	chr14:97305926	T/A	cg11863609	chr14:97355128	NA	-0.54	-4.88	-0.48	5.52e-6	Neutrophil count;
SKCM	cis	rs875971	1.000	rs6958271	chr7:65979331	A/C	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	cis	rs950027	0.549	rs12909409	chr15:45608582	T/G	cg21132104	chr15:45694354	SPATA5L1	-0.77	-5.25	-0.51	1.27e-6	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs899997	1.000	rs7182567	chr15:79045054	A/G	cg04896959	chr15:78267971	NA	0.57	5.0	0.49	3.49e-6	Coronary artery disease or large artery stroke;
SKCM	cis	rs9790314	0.690	rs4679930	chr3:160842875	C/G	cg03342759	chr3:160939853	NMD3	-0.69	-6.9	-0.62	1.22e-9	Morning vs. evening chronotype;
SKCM	cis	rs28595532	0.920	rs116023344	chr4:119760263	A/G	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs17270561	0.562	rs74293932	chr6:26014811	C/A	cg17691542	chr6:26056736	HIST1H1C	1.23	9.73	0.74	4.09e-15	Iron status biomarkers;
SKCM	cis	rs6088580	0.713	rs1884669	chr20:33171287	G/A	cg24642439	chr20:33292090	TP53INP2	0.76	5.84	0.55	1.13e-7	Glomerular filtration rate (creatinine);
SKCM	cis	rs75920871	0.588	rs4938321	chr11:116852507	C/T	cg01368799	chr11:117014884	PAFAH1B2	-0.62	-4.87	-0.48	5.76e-6	Subjective well-being;
SKCM	cis	rs4727027	0.933	rs10277119	chr7:148849942	T/C	cg23583168	chr7:148888333	NA	-0.8	-6.66	-0.6	3.52e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs35306767	0.671	rs11253473	chr10:906826	A/G	cg20503657	chr10:835505	NA	0.76	5.14	0.5	1.99e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs950776	0.518	rs11630349	chr15:78824608	C/T	cg06917634	chr15:78832804	PSMA4	1.01	10.47	0.76	1.56e-16	Sudden cardiac arrest;
SKCM	cis	rs2980439	0.818	rs2945249	chr8:8094726	G/A	cg06636001	chr8:8085503	FLJ10661	1.0	8.93	0.71	1.45e-13	Neuroticism;
SKCM	cis	rs875971	0.660	rs10263935	chr7:66096028	A/G	cg11987759	chr7:65425863	GUSB	-0.59	-5.13	-0.5	2.03e-6	Aortic root size;
SKCM	cis	rs7215564	0.908	rs35884143	chr17:78656043	A/G	cg16980736	chr17:78789706	RPTOR	-0.89	-4.88	-0.48	5.41e-6	Myopia (pathological);
SKCM	trans	rs561341	1.000	rs546519	chr17:30297682	T/G	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs6088580	0.634	rs9789792	chr20:32957709	G/A	cg24642439	chr20:33292090	TP53INP2	-0.76	-6.02	-0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs6121246	0.559	rs12479491	chr20:30265450	T/C	cg11595048	chr20:30225325	COX4I2	0.54	4.77	0.48	8.4e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs995000	0.931	rs630144	chr1:62918864	A/G	cg06896770	chr1:63153194	DOCK7	0.77	7.38	0.64	1.45e-10	Triglyceride levels;
SKCM	cis	rs2153535	0.601	rs9505472	chr6:8538765	T/C	cg23788917	chr6:8435910	SLC35B3	0.7	4.93	0.49	4.59e-6	Motion sickness;
SKCM	trans	rs3780486	0.505	rs10813958	chr9:33165985	A/G	cg04842962	chr6:43655489	MRPS18A	0.83	8.07	0.67	6.8e-12	IgG glycosylation;
SKCM	cis	rs4803468	1.000	rs4803468	chr19:41922352	A/G	cg14132834	chr19:41945861	ATP5SL	-0.77	-6.08	-0.57	4.18e-8	Height;
SKCM	cis	rs11098499	0.691	rs2136911	chr4:120265859	G/A	cg09307838	chr4:120376055	NA	0.96	8.24	0.68	3.19e-12	Corneal astigmatism;
SKCM	cis	rs10504073	0.647	rs4493918	chr8:50015937	C/G	cg00325661	chr8:49890786	NA	0.79	6.79	0.61	1.99e-9	Blood metabolite ratios;
SKCM	cis	rs12709013	0.792	rs62066815	chr16:58785481	C/T	cg02431531	chr16:59244939	NA	0.49	5.13	0.5	2.07e-6	Blood metabolite ratios;
SKCM	cis	rs7666738	0.791	rs13146909	chr4:98934198	C/T	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1580019	0.885	rs1610141	chr7:32498435	C/T	cg06627557	chr7:32535165	LSM5;AVL9	0.78	5.89	0.56	9.15e-8	Cognitive ability;
SKCM	cis	rs6450176	0.951	rs5013866	chr5:53300947	A/G	ch.5.1024479R	chr5:53302184	ARL15	-0.71	-4.88	-0.48	5.49e-6	HDL cholesterol levels;HDL cholesterol;Adiponectin levels;
SKCM	cis	rs16854884	0.683	rs920968	chr3:143770698	C/G	cg06585982	chr3:143692056	C3orf58	0.63	5.27	0.51	1.2e-6	Economic and political preferences (feminism/equality);
SKCM	cis	rs7937682	0.774	rs59921976	chr11:111473088	G/A	cg19812747	chr11:111475976	SIK2	-0.6	-5.15	-0.5	1.89e-6	Primary sclerosing cholangitis;
SKCM	cis	rs6942756	0.876	rs6953598	chr7:129033741	A/G	cg02491457	chr7:128862824	NA	0.77	4.78	0.48	8.14e-6	White matter hyperintensity burden;
SKCM	cis	rs60871478	1.000	rs4720917	chr7:806998	C/G	cg05535760	chr7:792225	HEATR2	1.02	8.66	0.7	4.97e-13	Cerebrospinal P-tau181p levels;
SKCM	cis	rs362296	0.698	rs362289	chr4:3256378	G/A	cg11471262	chr4:3318911	RGS12	-0.81	-7.0	-0.62	7.86e-10	Parental longevity (mother's age at death);
SKCM	cis	rs909674	0.524	rs5750821	chr22:39825492	A/T	cg11247378	chr22:39784982	NA	-0.46	-5.41	-0.52	6.81e-7	IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis);IgG glycosylation;IgG digalactosylation phenotypes (multivariate analysis);IgG sialylation phenotypes (multivariate analysis);IgG monogalactosylation phenotypes (multivariate analysis);IgG fucosylation phenotypes (multivariate analysis);IgG N-glycosylation phenotypes (multivariate analysis);IgG disialylation phenotypes (multivariate analysis);IgG galactosylation phenotypes (multivariate analysis);Post bronchodilator FEV1;
SKCM	cis	rs910316	0.967	rs4899551	chr14:75660246	C/G	cg08847533	chr14:75593920	NEK9	-0.98	-9.72	-0.74	4.28e-15	Height;
SKCM	cis	rs1506636	1.000	rs2299984	chr7:123356921	G/T	cg03229431	chr7:123269106	ASB15	0.59	4.81	0.48	7.2e-6	Plateletcrit;Platelet count;
SKCM	cis	rs7998202	0.667	rs99126	chr13:113359336	C/G	cg02820901	chr13:113351484	ATP11A	-0.89	-4.77	-0.47	8.55e-6	Glycated hemoglobin levels;
SKCM	cis	rs8078723	0.763	rs4433838	chr17:38143532	C/T	cg17467752	chr17:38218738	THRA	-0.61	-5.5	-0.53	4.67e-7	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs6089829	0.925	rs2277767	chr20:61666937	G/A	cg08564027	chr20:61660810	NA	0.63	5.65	0.54	2.46e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs7216064	1.000	rs8082512	chr17:65837059	T/C	cg12091567	chr17:66097778	LOC651250	-0.77	-5.53	-0.53	4.06e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs228769	1.000	rs12937692	chr17:42256430	G/A	cg08499158	chr17:42289980	UBTF	-0.89	-6.61	-0.6	4.28e-9	Bone mineral density (hip);Bone mineral density (spine);
SKCM	cis	rs10504229	0.953	rs17805380	chr8:58171128	C/A	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs6445797	0.632	rs10780039	chr3:56705235	G/C	cg13616963	chr3:57583610	ARF4	-0.74	-4.78	-0.48	8.17e-6	Gastritis;
SKCM	cis	rs4665809	0.549	rs7577896	chr2:26524493	C/T	cg26119090	chr2:26468346	HADHA;HADHB	1.02	6.43	0.59	9.18e-9	Gut microbiome composition (summer);
SKCM	cis	rs7605378	0.528	rs281780	chr2:200756331	G/C	cg23649088	chr2:200775458	C2orf69	0.67	5.31	0.52	9.99e-7	Osteoporosis;
SKCM	cis	rs10754283	0.967	rs2390763	chr1:90105688	A/G	cg21401794	chr1:90099060	LRRC8C	0.78	7.17	0.63	3.72e-10	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs9300255	0.698	rs4759416	chr12:123746357	C/G	cg05973401	chr12:123451056	ABCB9	0.86	6.11	0.57	3.69e-8	Neutrophil percentage of white cells;
SKCM	cis	rs13118159	0.550	rs11946956	chr4:1369094	T/G	cg19318889	chr4:1322082	MAEA	0.8	5.88	0.55	9.62e-8	Longevity;
SKCM	cis	rs4803468	1.000	rs878083	chr19:41897688	G/A	cg14132834	chr19:41945861	ATP5SL	-0.74	-5.71	-0.54	1.99e-7	Height;
SKCM	cis	rs1059312	0.771	rs7974764	chr12:129296588	G/C	cg09035930	chr12:129282057	SLC15A4	0.77	8.03	0.67	8.18e-12	Systemic lupus erythematosus;
SKCM	cis	rs9443189	0.737	rs2842553	chr6:76456632	A/T	cg01950844	chr6:76311363	SENP6	-0.81	-5.92	-0.56	8.33e-8	Prostate cancer;
SKCM	cis	rs7617480	0.648	rs10865953	chr3:48759562	C/T	cg07636037	chr3:49044803	WDR6	0.92	6.78	0.61	2.04e-9	Subjective well-being (multi-trait analysis);Menarche (age at onset);
SKCM	cis	rs611744	0.647	rs2859813	chr8:109263497	G/A	cg18478394	chr8:109455254	TTC35	0.66	5.32	0.52	9.59e-7	Dupuytren's disease;
SKCM	cis	rs514406	0.929	rs12145105	chr1:53340564	T/C	cg16325326	chr1:53192061	ZYG11B	0.97	10.09	0.75	8.42e-16	Monocyte count;
SKCM	cis	rs2739330	0.627	rs9608219	chr22:24274119	G/C	cg24846343	chr22:24311635	DDTL	0.64	5.84	0.55	1.14e-7	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs2228479	0.681	rs3212346	chr16:89982358	G/A	cg06558623	chr16:89946397	TCF25	1.23	6.8	0.61	1.86e-9	Skin colour saturation;
SKCM	cis	rs10744422	1.000	rs3852537	chr12:123361501	T/C	cg25930673	chr12:123319894	HIP1R	-1.04	-4.98	-0.49	3.79e-6	Schizophrenia;
SKCM	cis	rs6570726	0.689	rs411785	chr6:145888398	G/A	cg05347473	chr6:146136440	FBXO30	0.59	5.36	0.52	8.23e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs995000	0.931	rs624660	chr1:62920388	C/A	cg06896770	chr1:63153194	DOCK7	0.77	7.38	0.64	1.45e-10	Triglyceride levels;
SKCM	cis	rs4790333	0.757	rs2429906	chr17:2265113	C/A	cg02569219	chr17:2266849	SGSM2	0.83	7.3	0.64	2.11e-10	Proinsulin levels;
SKCM	cis	rs9902453	0.967	rs7212741	chr17:28322941	G/A	cg26525008	chr17:28256777	EFCAB5;SSH2	0.81	5.78	0.55	1.45e-7	Coffee consumption (cups per day);
SKCM	cis	rs514406	0.698	rs11206055	chr1:53436632	A/T	cg16325326	chr1:53192061	ZYG11B	-0.64	-5.56	-0.53	3.7e-7	Monocyte count;
SKCM	cis	rs4687718	0.929	rs9858049	chr3:53277811	C/T	cg07507251	chr3:52567010	NT5DC2	0.82	5.33	0.52	9.24e-7	QRS duration;
SKCM	cis	rs67460515	0.892	rs2054710	chr3:161090616	C/T	cg03342759	chr3:160939853	NMD3	-0.82	-7.01	-0.62	7.46e-10	Parkinson's disease;
SKCM	cis	rs7811142	0.943	rs73403312	chr7:100024153	T/C	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.33	0.69	2.11e-12	Platelet count;
SKCM	cis	rs769267	0.896	rs10410664	chr19:19556651	G/A	cg03709012	chr19:19516395	GATAD2A	0.89	8.62	0.7	5.89e-13	Tonsillectomy;
SKCM	cis	rs7954584	0.635	rs7309024	chr12:122338334	C/T	cg22618164	chr12:122356400	WDR66	0.5	5.01	0.49	3.31e-6	Mean corpuscular volume;
SKCM	cis	rs2832191	0.716	rs2692625	chr21:30446360	C/G	cg24692254	chr21:30365293	RNF160	0.99	9.05	0.72	8.59e-14	Dental caries;
SKCM	cis	rs1153858	1.000	rs8032904	chr15:45651309	C/T	cg10760299	chr15:45669010	GATM	0.62	6.35	0.58	1.3e-8	Homoarginine levels;
SKCM	cis	rs28386778	0.897	rs11079510	chr17:61820902	T/C	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.36	0.52	8.06e-7	Prudent dietary pattern;
SKCM	cis	rs28595532	0.920	rs116516492	chr4:119734247	C/G	cg21605333	chr4:119757512	SEC24D	1.36	8.05	0.67	7.69e-12	Cannabis dependence symptom count;
SKCM	cis	rs2842992	0.789	rs7758895	chr6:160193465	T/C	cg19482086	chr6:160211437	TCP1;MRPL18	0.86	6.82	0.61	1.71e-9	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs9894429	1.000	rs9894429	chr17:79596811	C/T	cg18240062	chr17:79603768	NPLOC4	0.77	7.45	0.64	1.08e-10	Eye color traits;
SKCM	cis	rs12714314	0.756	rs4481014	chr2:1948892	C/T	cg22350835	chr2:1868857	MYT1L	0.66	5.2	0.51	1.54e-6	Type 2 diabetes (age of onset);
SKCM	cis	rs208520	0.742	rs208454	chr6:66907783	T/C	cg07460842	chr6:66804631	NA	-0.91	-6.87	-0.61	1.41e-9	Exhaled nitric oxide output;
SKCM	cis	rs4481887	1.000	rs4916124	chr1:248466495	T/C	cg00666640	chr1:248458726	OR2T12	0.6	5.14	0.5	1.98e-6	Common traits (Other);
SKCM	cis	rs9467773	0.620	rs2504599	chr6:26641060	C/T	cg09904177	chr6:26538194	HMGN4	0.58	5.01	0.49	3.28e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs12497850	0.966	rs6792510	chr3:48723302	G/C	cg07636037	chr3:49044803	WDR6	0.88	8.94	0.71	1.43e-13	Parkinson's disease;
SKCM	cis	rs71520386	0.607	rs4308627	chr7:22879904	C/T	cg15401507	chr7:22894281	NA	0.71	5.29	0.51	1.08e-6	Fibrinogen levels;
SKCM	cis	rs10256972	0.521	rs871019	chr7:1105230	A/G	cg16145915	chr7:1198662	ZFAND2A	-0.49	-6.35	-0.58	1.3e-8	Longevity;Endometriosis;
SKCM	cis	rs2075371	0.611	rs62462979	chr7:134019379	G/T	cg20476274	chr7:133979776	SLC35B4	0.88	8.45	0.69	1.27e-12	Mean platelet volume;
SKCM	cis	rs919433	0.680	rs2565160	chr2:198286474	A/G	cg04278110	chr2:198063759	ANKRD44	0.7	4.79	0.48	7.87e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs12044355	0.865	rs2487453	chr1:231863204	C/T	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	0.83	6.94	0.62	1.04e-9	Alzheimer's disease;
SKCM	cis	rs4975616	0.843	rs4975615	chr5:1315343	C/T	cg26373071	chr5:1325741	CLPTM1L	-0.61	-4.97	-0.49	3.83e-6	Lung cancer;
SKCM	cis	rs2836974	0.965	rs34578707	chr21:40675167	G/A	cg17971929	chr21:40555470	PSMG1	0.86	8.49	0.69	1.04e-12	Cognitive function;
SKCM	cis	rs7666738	0.830	rs13102369	chr4:99045912	A/G	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs17685	0.725	rs7795291	chr7:75725206	C/A	cg01364799	chr7:75623366	TMEM120A	-0.79	-6.37	-0.58	1.23e-8	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs17376456	0.825	rs6898842	chr5:93213221	T/C	cg25358565	chr5:93447407	FAM172A	1.23	7.26	0.63	2.53e-10	Diabetic retinopathy;
SKCM	cis	rs867186	1.000	rs75165171	chr20:33651453	G/A	cg04194272	chr20:33683537	NA	-1.38	-7.2	-0.63	3.29e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs9640161	0.750	rs4395803	chr7:150025367	A/C	cg27494647	chr7:150038898	RARRES2	0.58	4.98	0.49	3.74e-6	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs4862750	0.914	rs6553026	chr4:187875648	C/T	cg10295955	chr4:187884368	NA	-1.04	-13.63	-0.84	2.47e-22	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs933688	1.000	rs2367526	chr5:90740525	A/G	cg12630606	chr5:90679528	LOC100129716;ARRDC3	0.98	7.81	0.66	2.22e-11	Smoking behavior;
SKCM	cis	rs8060686	0.591	rs80346622	chr16:68074419	C/T	cg09117114	chr16:67998030	SLC12A4	-0.78	-5.06	-0.5	2.72e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs8017423	0.967	rs11844225	chr14:90726676	G/A	cg04374321	chr14:90722782	PSMC1	1.03	9.44	0.73	1.55e-14	Mortality in heart failure;
SKCM	cis	rs10779751	1.000	rs4845858	chr1:11304720	C/T	cg08854313	chr1:11322531	MTOR	0.99	8.73	0.7	3.67e-13	Body mass index;
SKCM	cis	rs9788333	0.695	rs12871086	chr13:21890224	A/T	cg25811766	chr13:21894605	NA	0.61	5.91	0.56	8.58e-8	Thiazide-induced adverse metabolic effects in hypertensive patients;
SKCM	cis	rs11122272	0.735	rs2808611	chr1:231548480	A/G	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	0.65	5.35	0.52	8.44e-7	Hemoglobin concentration;
SKCM	cis	rs1691799	0.899	rs1185244	chr12:66725160	C/T	cg16791601	chr12:66731901	HELB	-0.63	-5.62	-0.54	2.89e-7	White blood cell count (basophil);
SKCM	cis	rs9926296	0.586	rs1800359	chr16:89805261	A/G	cg01097406	chr16:89675127	NA	-0.45	-4.89	-0.48	5.28e-6	Vitiligo;
SKCM	cis	rs7106204	0.748	rs2403888	chr11:24208071	C/G	ch.11.24196551F	chr11:24239977	NA	-0.79	-6.34	-0.58	1.38e-8	Response to Homoharringtonine (cytotoxicity);
SKCM	cis	rs116095464	0.558	rs28636067	chr5:199415	G/A	cg22857025	chr5:266934	NA	-1.41	-7.24	-0.63	2.69e-10	Breast cancer;
SKCM	cis	rs7666738	0.830	rs10029849	chr4:99059362	T/C	cg05340658	chr4:99064831	C4orf37	0.66	4.87	0.48	5.74e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs344364	0.511	rs337286	chr16:1965719	C/T	cg26897989	chr16:1907736	C16orf73	-0.75	-7.23	-0.63	2.86e-10	Glomerular filtration rate in chronic kidney disease;
SKCM	cis	rs9905704	0.647	rs12940492	chr17:56954655	C/G	cg05425664	chr17:57184151	TRIM37	-0.61	-4.83	-0.48	6.6e-6	Testicular germ cell tumor;
SKCM	cis	rs6089584	0.816	rs6061410	chr20:60625329	A/G	cg06108461	chr20:60628389	TAF4	-0.91	-8.68	-0.7	4.57e-13	Body mass index;
SKCM	cis	rs6430585	0.583	rs7581814	chr2:136641593	C/G	cg07169764	chr2:136633963	MCM6	-1.28	-14.77	-0.86	2.68e-24	Corneal structure;
SKCM	cis	rs67311347	0.822	rs9826847	chr3:40345312	A/T	cg00091569	chr3:40428383	ENTPD3	0.65	5.53	0.53	4.15e-7	Renal cell carcinoma;
SKCM	cis	rs75229567	0.717	rs74527680	chr12:70235392	A/G	cg10114359	chr12:70132523	RAB3IP	1.42	6.21	0.58	2.41e-8	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes;
SKCM	cis	rs1799949	1.000	rs8176265	chr17:41213996	C/T	cg23758822	chr17:41437982	NA	0.94	7.87	0.67	1.68e-11	Menopause (age at onset);
SKCM	cis	rs478304	0.651	rs10896038	chr11:65505528	G/C	cg17480646	chr11:65405466	SIPA1	-0.71	-5.64	-0.54	2.62e-7	Acne (severe);
SKCM	cis	rs8037137	1.000	rs8037137	chr15:91506637	T/C	cg15878949	chr15:91534302	PRC1	0.67	5.12	0.5	2.13e-6	Platelet count;Serous invasive ovarian cancer;High-grade serous ovarian cancer;Invasive epithelial ovarian cancer;
SKCM	cis	rs17376456	0.825	rs55724660	chr5:93276636	A/G	cg21475434	chr5:93447410	FAM172A	1.02	5.17	0.51	1.74e-6	Diabetic retinopathy;
SKCM	cis	rs8067545	0.578	rs9901336	chr17:20064190	G/A	cg13482628	chr17:19912719	NA	0.66	5.5	0.53	4.72e-7	Schizophrenia;
SKCM	cis	rs651907	0.640	rs771578	chr3:101613434	C/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.75	5.24	0.51	1.34e-6	Colorectal cancer;
SKCM	cis	rs1552244	0.935	rs7621551	chr3:10114205	C/T	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs6952808	0.594	rs3778965	chr7:2138296	G/A	cg02951883	chr7:2050386	MAD1L1	-0.79	-7.4	-0.64	1.37e-10	Bipolar disorder and schizophrenia;
SKCM	cis	rs2228479	0.681	rs11641790	chr16:89961957	A/G	cg06558623	chr16:89946397	TCF25	-1.25	-7.23	-0.63	2.86e-10	Skin colour saturation;
SKCM	cis	rs73201462	0.901	rs2811486	chr3:127920075	A/G	cg09089421	chr3:127803668	RUVBL1	1.0	5.11	0.5	2.22e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs2072499	0.750	rs57056972	chr1:156159064	C/A	cg25208724	chr1:156163844	SLC25A44	0.89	6.31	0.58	1.55e-8	Testicular germ cell tumor;
SKCM	cis	rs7216064	1.000	rs3206817	chr17:65892834	A/G	cg12091567	chr17:66097778	LOC651250	-0.74	-4.93	-0.49	4.62e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs644799	0.672	rs11021347	chr11:95653494	T/C	cg25622487	chr11:95524042	FAM76B;CEP57	0.67	5.19	0.51	1.64e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs6546550	0.835	rs3752781	chr2:70124316	T/A	cg02498382	chr2:70120550	SNRNP27	-0.46	-4.9	-0.49	5.06e-6	Prevalent atrial fibrillation;
SKCM	cis	rs9300255	0.602	rs1616131	chr12:123619838	G/A	cg00376283	chr12:123451042	ABCB9	0.82	5.61	0.54	3e-7	Neutrophil percentage of white cells;
SKCM	cis	rs2739330	0.828	rs4822454	chr22:24255208	G/A	cg25703541	chr22:24373054	LOC391322	-0.75	-6.17	-0.57	2.82e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs17826219	0.636	rs2449770	chr17:29101064	G/T	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Body mass index;
SKCM	cis	rs10911232	0.507	rs61081633	chr1:182995608	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.64	0.6	3.83e-9	Hypertriglyceridemia;
SKCM	cis	rs17376456	0.569	rs10476520	chr5:93058290	A/C	cg25358565	chr5:93447407	FAM172A	0.91	6.1	0.57	3.85e-8	Diabetic retinopathy;
SKCM	cis	rs6061231	0.834	rs2427307	chr20:60966686	G/A	cg24112000	chr20:60950667	NA	-0.58	-5.54	-0.53	3.92e-7	Colorectal cancer;
SKCM	cis	rs4919087	0.683	rs1687372	chr10:98978185	A/T	cg25902810	chr10:99078978	FRAT1	-0.65	-4.97	-0.49	3.86e-6	Monocyte count;
SKCM	cis	rs4972806	0.849	rs2857535	chr2:177036211	G/A	cg14324370	chr2:177042789	NA	0.56	5.09	0.5	2.42e-6	IgG glycosylation;
SKCM	cis	rs8072100	0.576	rs12948299	chr17:45403057	T/C	cg08085267	chr17:45401833	C17orf57	-0.9	-7.37	-0.64	1.56e-10	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs763121	0.853	rs6001182	chr22:39047443	A/G	cg06022373	chr22:39101656	GTPBP1	0.72	4.96	0.49	4.08e-6	Menopause (age at onset);
SKCM	cis	rs12477438	1.000	rs12053372	chr2:99810055	C/T	cg26064155	chr2:99771622	LIPT1;TSGA10	-0.83	-5.32	-0.52	9.84e-7	Chronic sinus infection;
SKCM	cis	rs1218582	0.772	rs3738026	chr1:154919565	A/G	cg24250549	chr1:154909240	PMVK	0.85	8.48	0.69	1.13e-12	Prostate cancer;
SKCM	cis	rs7809950	0.817	rs2712230	chr7:107294151	G/A	cg23024343	chr7:107201750	COG5	0.8	7.28	0.64	2.32e-10	Coronary artery disease;
SKCM	cis	rs7824557	0.767	rs3808509	chr8:11163256	G/T	cg21775007	chr8:11205619	TDH	0.72	6.0	0.56	5.73e-8	Retinal vascular caliber;
SKCM	cis	rs13118159	0.550	rs10016557	chr4:1363628	C/T	cg20887711	chr4:1340912	KIAA1530	-0.98	-7.87	-0.67	1.71e-11	Longevity;
SKCM	cis	rs6570726	0.846	rs6899900	chr6:145883873	T/G	cg05347473	chr6:146136440	FBXO30	0.52	4.81	0.48	7.12e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4689592	0.513	rs3857178	chr4:7066516	G/A	cg26116260	chr4:7069785	GRPEL1	1.21	9.51	0.73	1.09e-14	Monocyte percentage of white cells;
SKCM	cis	rs6088580	0.634	rs62212172	chr20:32987705	G/A	cg24642439	chr20:33292090	TP53INP2	-0.76	-6.02	-0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs2070488	0.965	rs1984312	chr3:38538466	G/T	cg01465620	chr3:38496096	LOC100128640;ACVR2B	-0.98	-9.25	-0.72	3.55e-14	Electrocardiographic conduction measures;
SKCM	cis	rs4654899	0.758	rs17453044	chr1:21517361	A/G	cg01072550	chr1:21505969	NA	-0.62	-4.77	-0.47	8.55e-6	Superior frontal gyrus grey matter volume;
SKCM	cis	rs72781680	0.851	rs72796397	chr2:24178211	T/A	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	cis	rs67311347	0.713	rs4974018	chr3:40307419	G/A	cg00091569	chr3:40428383	ENTPD3	0.64	5.46	0.53	5.4e-7	Renal cell carcinoma;
SKCM	cis	rs9790314	0.690	rs7633857	chr3:160844942	C/G	cg03342759	chr3:160939853	NMD3	-0.69	-6.9	-0.62	1.22e-9	Morning vs. evening chronotype;
SKCM	cis	rs10256972	0.539	rs2949174	chr7:1213923	T/C	cg16145915	chr7:1198662	ZFAND2A	-0.57	-7.7	-0.66	3.53e-11	Longevity;Endometriosis;
SKCM	cis	rs3820068	0.559	rs6675334	chr1:15923580	A/T	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs7824557	0.628	rs17797894	chr8:11212081	A/G	cg21775007	chr8:11205619	TDH	0.68	5.95	0.56	7.3e-8	Retinal vascular caliber;
SKCM	cis	rs8038465	0.594	rs55816897	chr15:73869767	G/T	cg15420318	chr15:73925796	NPTN	0.64	5.12	0.5	2.12e-6	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs1862618	1.000	rs1862618	chr5:56096315	C/G	cg03609598	chr5:56110824	MAP3K1	-0.76	-4.94	-0.49	4.41e-6	Initial pursuit acceleration;
SKCM	cis	rs873946	0.586	rs3793685	chr10:134569316	G/A	cg27286337	chr10:134555280	INPP5A	0.99	8.98	0.71	1.2e-13	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs2297440	0.530	rs34533955	chr20:62233020	A/C	cg09650180	chr20:62225654	GMEB2	-0.78	-6.22	-0.58	2.28e-8	Glioma;Non-glioblastoma glioma;Glioblastoma;
SKCM	cis	rs2120019	0.567	rs68036747	chr15:75203200	A/C	cg09165964	chr15:75287851	SCAMP5	-0.81	-5.8	-0.55	1.34e-7	Blood trace element (Zn levels);
SKCM	cis	rs7944584	0.511	rs10838731	chr11:47607135	C/T	cg20307385	chr11:47447363	PSMC3	0.97	7.44	0.64	1.15e-10	Fasting blood glucose;Fasting blood glucose (BMI interaction);
SKCM	cis	rs1029738	0.659	rs1608553	chr7:22896231	G/C	cg15401507	chr7:22894281	NA	-0.64	-5.89	-0.55	9.27e-8	Fibrinogen levels;
SKCM	cis	rs769267	0.930	rs7254748	chr19:19397479	A/C	cg26732615	chr19:19648335	CILP2;YJEFN3	0.64	5.94	0.56	7.41e-8	Tonsillectomy;
SKCM	cis	rs12709013	0.818	rs1646273	chr16:58782222	G/A	cg02431531	chr16:59244939	NA	0.49	5.13	0.5	2.07e-6	Blood metabolite ratios;
SKCM	cis	rs9300255	0.620	rs7313483	chr12:123726834	C/T	cg05973401	chr12:123451056	ABCB9	0.88	6.28	0.58	1.79e-8	Neutrophil percentage of white cells;
SKCM	cis	rs933688	1.000	rs6866191	chr5:90746852	G/A	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.94	6.78	0.61	2.1e-9	Smoking behavior;
SKCM	cis	rs2180341	0.961	rs7775493	chr6:127615000	C/A	cg27446573	chr6:127587934	RNF146	1.0	8.68	0.7	4.48e-13	Breast cancer;
SKCM	cis	rs854765	0.583	rs7214002	chr17:17852104	G/C	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.01	7.49	0.65	9.28e-11	Total body bone mineral density;
SKCM	cis	rs9303401	0.659	rs35082010	chr17:56936867	A/G	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.35	0.52	8.54e-7	Cognitive test performance;
SKCM	cis	rs7264396	0.790	rs2425096	chr20:34308588	A/G	cg23207816	chr20:34252616	CPNE1;RBM12	0.8	4.85	0.48	6.13e-6	Total cholesterol levels;
SKCM	cis	rs11098499	0.754	rs1980025	chr4:120252806	A/G	cg09307838	chr4:120376055	NA	-0.87	-6.91	-0.62	1.19e-9	Corneal astigmatism;
SKCM	cis	rs3820928	0.874	rs7563644	chr2:227846932	A/G	cg11843606	chr2:227700838	RHBDD1	-0.61	-4.9	-0.49	5.12e-6	Pulmonary function;
SKCM	cis	rs11098499	0.774	rs73842616	chr4:120290683	G/A	cg09307838	chr4:120376055	NA	0.98	7.89	0.67	1.52e-11	Corneal astigmatism;
SKCM	cis	rs8014204	0.604	rs11625594	chr14:75389833	G/A	cg06637938	chr14:75390232	RPS6KL1	0.97	6.9	0.62	1.22e-9	Caffeine consumption;
SKCM	cis	rs1005277	0.579	rs2474594	chr10:38426661	G/C	cg00409905	chr10:38381863	ZNF37A	-0.66	-6.16	-0.57	3e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs875971	0.830	rs778711	chr7:65851657	G/A	cg11764359	chr7:65958608	NA	0.74	6.67	0.6	3.3e-9	Aortic root size;
SKCM	cis	rs1577917	1.000	rs68171315	chr6:86707400	A/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.64	-5.54	-0.53	3.92e-7	Response to antipsychotic treatment;
SKCM	cis	rs7666738	0.791	rs11735105	chr4:98937357	C/T	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7143963	0.943	rs11160699	chr14:103252270	G/A	cg23020514	chr14:103360112	TRAF3	0.71	5.1	0.5	2.29e-6	Body mass index;
SKCM	cis	rs8103278	0.507	rs8112282	chr19:46265029	C/T	cg12641515	chr19:46296257	DMWD	0.78	6.24	0.58	2.1e-8	Coronary artery disease;
SKCM	trans	rs2727020	0.563	rs10769582	chr11:49474040	T/C	cg15704280	chr7:45808275	SEPT13	-0.92	-8.55	-0.7	8.1e-13	Coronary artery disease;
SKCM	trans	rs17685	0.712	rs2158867	chr7:75815141	C/A	cg19862616	chr7:65841803	NCRNA00174	0.94	10.39	0.76	2.25e-16	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs10504229	0.683	rs11786523	chr8:58131319	G/C	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs28595532	0.841	rs114155681	chr4:119736427	A/G	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs4905558	1.000	rs2230532	chr14:97321689	C/T	cg11863609	chr14:97355128	NA	0.54	4.88	0.48	5.52e-6	Neutrophil count;
SKCM	cis	rs933688	0.759	rs1423593	chr5:90752351	T/G	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.06	8.11	0.68	5.81e-12	Smoking behavior;
SKCM	cis	rs9733	0.650	rs11204680	chr1:150587140	T/G	cg13175981	chr1:150552382	MCL1	0.72	6.31	0.58	1.57e-8	Tonsillectomy;
SKCM	cis	rs11098499	0.954	rs4345162	chr4:120312959	G/A	cg09307838	chr4:120376055	NA	0.97	7.49	0.65	9.08e-11	Corneal astigmatism;
SKCM	cis	rs7569084	0.687	rs1437462	chr2:65676693	C/A	cg10464312	chr2:66672688	MEIS1	0.45	5.09	0.5	2.39e-6	Sum eosinophil basophil counts;
SKCM	cis	rs10905065	0.759	rs1533215	chr10:5869767	T/C	cg09234995	chr10:5726438	C10orf18	-0.61	-5.12	-0.5	2.15e-6	Menopause (age at onset);
SKCM	cis	rs13343954	0.518	rs7252086	chr19:33534929	T/C	cg17764715	chr19:33622953	WDR88	0.73	5.13	0.5	2.1e-6	Colorectal cancer;
SKCM	cis	rs801193	1.000	rs6958520	chr7:66151453	T/C	cg11764359	chr7:65958608	NA	0.86	6.6	0.6	4.52e-9	Aortic root size;
SKCM	cis	rs2204008	0.623	rs1607878	chr12:38376000	A/G	cg26384229	chr12:38710491	ALG10B	0.79	6.56	0.6	5.34e-9	Bladder cancer;
SKCM	cis	rs2075371	0.966	rs2544224	chr7:133995832	A/G	cg20476274	chr7:133979776	SLC35B4	1.03	10.69	0.77	5.94e-17	Mean platelet volume;
SKCM	cis	rs6519955	0.722	rs9626908	chr22:46428306	T/C	cg05468064	chr22:46423449	NA	0.56	6.23	0.58	2.19e-8	Dupuytren's disease;
SKCM	cis	rs1278769	0.786	rs3742238	chr13:113540425	C/T	cg00823993	chr13:113535758	ATP11A	0.61	5.14	0.5	1.95e-6	Interstitial lung disease;
SKCM	cis	rs151997	0.508	rs9292165	chr5:50272619	T/C	cg06027927	chr5:50259733	NA	0.61	5.4	0.52	6.86e-7	Callous-unemotional behaviour;
SKCM	cis	rs4642101	0.765	rs9871991	chr3:12827525	C/A	cg05775895	chr3:12838266	CAND2	0.62	5.45	0.53	5.72e-7	QRS complex (12-leadsum);
SKCM	cis	rs11155671	0.530	rs9371544	chr6:150217360	A/G	cg05036130	chr6:150231994	NA	0.61	6.53	0.59	6.14e-9	Testicular germ cell tumor;
SKCM	cis	rs11155671	0.530	rs7757984	chr6:150208651	A/G	cg05036130	chr6:150231994	NA	0.6	6.7	0.6	2.91e-9	Testicular germ cell tumor;
SKCM	cis	rs3862030	0.503	rs10786673	chr10:104280537	G/A	cg11453585	chr10:104263688	ACTR1A;SUFU	0.77	6.31	0.58	1.56e-8	Waist circumference adjusted for BMI (adjusted for smoking behaviour);Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction);Waist circumference adjusted for body mass index;
SKCM	cis	rs1957429	0.901	rs1957432	chr14:65352796	A/G	cg23373153	chr14:65346875	NA	0.99	6.13	0.57	3.36e-8	Pediatric areal bone mineral density (radius);
SKCM	cis	rs919433	0.963	rs4850787	chr2:198181750	G/A	cg04278110	chr2:198063759	ANKRD44	-0.69	-4.8	-0.48	7.58e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs28595532	1.000	rs114039398	chr4:119631627	T/C	cg14228332	chr4:119757509	SEC24D	0.97	4.92	0.49	4.71e-6	Cannabis dependence symptom count;
SKCM	cis	rs7829975	0.564	rs2921060	chr8:8317817	G/T	cg08975724	chr8:8085496	FLJ10661	-0.73	-6.09	-0.57	4.07e-8	Mood instability;
SKCM	cis	rs2952156	0.920	rs2517954	chr17:37843550	T/C	cg00129232	chr17:37814104	STARD3	-0.63	-4.84	-0.48	6.46e-6	Asthma;
SKCM	cis	rs1577917	1.000	rs7760207	chr6:86721700	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.82	-8.08	-0.67	6.61e-12	Response to antipsychotic treatment;
SKCM	cis	rs875971	0.522	rs4502988	chr7:65297746	A/G	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.61	5.06	0.5	2.75e-6	Aortic root size;
SKCM	cis	rs644799	1.000	rs534497	chr11:95562868	C/G	cg03916912	chr11:95522834	CEP57;FAM76B	0.88	7.53	0.65	7.59e-11	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs654950	0.792	rs625448	chr1:41988541	A/T	cg06885757	chr1:42089581	HIVEP3	0.61	7.31	0.64	2.05e-10	Airway imaging phenotypes;
SKCM	cis	rs6580649	0.883	rs4760621	chr12:48561262	A/G	cg05342945	chr12:48394962	COL2A1	-0.79	-5.39	-0.52	7.22e-7	Lung cancer;
SKCM	cis	rs919433	0.783	rs787979	chr2:198242868	A/T	cg04278110	chr2:198063759	ANKRD44	0.74	5.14	0.5	2.01e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs2153535	0.580	rs1577468	chr6:8444266	C/A	cg07606381	chr6:8435919	SLC35B3	0.94	6.94	0.62	1.02e-9	Motion sickness;
SKCM	cis	rs7811142	0.943	rs73403312	chr7:100024153	T/C	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-1.0	-5.66	-0.54	2.36e-7	Platelet count;
SKCM	cis	rs2346177	0.519	rs4563285	chr2:46669944	C/G	cg02822958	chr2:46747628	ATP6V1E2	0.64	4.85	0.48	6.22e-6	HDL cholesterol;
SKCM	cis	rs2120019	0.638	rs12050628	chr15:75333494	G/A	cg09165964	chr15:75287851	SCAMP5	0.87	9.3	0.73	2.82e-14	Blood trace element (Zn levels);
SKCM	cis	rs71520386	0.607	rs28660425	chr7:22858151	C/T	cg15401507	chr7:22894281	NA	0.66	4.9	0.49	5.01e-6	Fibrinogen levels;
SKCM	cis	rs6545883	0.894	rs2177962	chr2:61588070	T/A	cg15711740	chr2:61764176	XPO1	0.69	4.91	0.49	4.85e-6	Tuberculosis;
SKCM	cis	rs7772486	0.743	rs9403742	chr6:146060193	A/C	cg23711669	chr6:146136114	FBXO30	0.78	8.21	0.68	3.61e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7927771	0.524	rs10458915	chr11:47864392	T/A	cg20307385	chr11:47447363	PSMC3	0.71	5.63	0.54	2.67e-7	Subjective well-being;
SKCM	cis	rs6951245	1.000	rs80031817	chr7:1096793	T/C	cg24642844	chr7:1081250	C7orf50	-0.93	-6.22	-0.58	2.28e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs1707322	1.000	rs4660903	chr1:46457601	A/G	cg03146154	chr1:46216737	IPP	0.78	5.24	0.51	1.35e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs28386778	0.805	rs9911714	chr17:61828952	G/A	cg01411255	chr17:61851458	DDX42;CCDC47	0.78	5.03	0.49	3.06e-6	Prudent dietary pattern;
SKCM	cis	rs4924935	0.581	rs8070669	chr17:18774708	A/T	cg26378065	chr17:18585709	ZNF286B	0.86	5.06	0.5	2.72e-6	Pancreatic cancer;
SKCM	cis	rs28386778	0.897	rs9915552	chr17:61869095	G/A	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs13118159	0.550	rs2336081	chr4:1350322	A/G	cg05025164	chr4:1340916	KIAA1530	-0.9	-7.72	-0.66	3.23e-11	Longevity;
SKCM	cis	rs2032447	0.702	rs199753	chr6:26001888	G/A	cg18357526	chr6:26021779	HIST1H4A	0.79	6.12	0.57	3.59e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs453301	0.686	rs3895823	chr8:8873646	T/C	cg15556689	chr8:8085844	FLJ10661	-0.77	-6.1	-0.57	3.89e-8	Joint mobility (Beighton score);
SKCM	cis	rs929354	0.772	rs1182362	chr7:157019535	A/G	cg17757837	chr7:157058334	UBE3C	-0.81	-5.67	-0.54	2.3e-7	Body mass index;
SKCM	cis	rs2483519	0.762	rs7100793	chr10:116439872	T/A	cg19615406	chr10:116164712	AFAP1L2	0.52	4.78	0.48	8.1e-6	Paclitaxel disposition in epithelial ovarian cancer;
SKCM	trans	rs561341	1.000	rs117029332	chr17:30266085	C/G	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs1559088	0.600	rs7259117	chr19:33550113	G/T	cg27124370	chr19:33622961	WDR88	0.91	6.28	0.58	1.8e-8	Bone ultrasound measurement (broadband ultrasound attenuation);
SKCM	cis	rs7590720	1.000	rs4674058	chr2:216909368	A/G	cg12620499	chr2:216877984	MREG	0.92	7.8	0.66	2.32e-11	Alcohol dependence;
SKCM	cis	rs1153858	1.000	rs10519021	chr15:45631795	G/A	cg21132104	chr15:45694354	SPATA5L1	0.89	7.18	0.63	3.58e-10	Homoarginine levels;
SKCM	cis	rs9911578	0.935	rs12948039	chr17:57045184	C/T	cg12560992	chr17:57184187	TRIM37	0.94	7.34	0.64	1.77e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs7617480	0.610	rs4955420	chr3:49208865	A/G	cg07636037	chr3:49044803	WDR6	0.78	5.81	0.55	1.29e-7	Subjective well-being (multi-trait analysis);Menarche (age at onset);
SKCM	cis	rs644799	1.000	rs563653	chr11:95561488	T/G	cg03916912	chr11:95522834	CEP57;FAM76B	0.88	7.53	0.65	7.59e-11	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	trans	rs208520	0.690	rs12209753	chr6:66703951	A/G	cg15611600	chr13:45563400	KIAA1704;NUFIP1	0.94	8.03	0.67	8.3e-12	Exhaled nitric oxide output;
SKCM	cis	rs7215564	0.730	rs2171023	chr17:78608913	A/T	cg16980736	chr17:78789706	RPTOR	-0.9	-4.93	-0.49	4.54e-6	Myopia (pathological);
SKCM	cis	rs514406	0.708	rs536621	chr1:53309097	A/G	cg16325326	chr1:53192061	ZYG11B	0.68	5.82	0.55	1.26e-7	Monocyte count;
SKCM	cis	rs3820928	0.904	rs2894623	chr2:227766112	T/C	cg11843606	chr2:227700838	RHBDD1	-0.64	-5.24	-0.51	1.3e-6	Pulmonary function;
SKCM	cis	rs6977660	1.000	rs6943114	chr7:19818354	G/T	cg05791153	chr7:19748676	TWISTNB	0.78	5.55	0.53	3.83e-7	Thyroid stimulating hormone;
SKCM	cis	rs2075371	0.796	rs35440439	chr7:134006094	C/T	cg20476274	chr7:133979776	SLC35B4	1.01	10.11	0.75	7.79e-16	Mean platelet volume;
SKCM	cis	rs17685	0.672	rs1894760	chr7:75852140	A/G	cg16489192	chr7:75678113	MDH2;STYXL1	-0.53	-4.92	-0.49	4.64e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs12477438	0.520	rs2516829	chr2:99773201	T/G	cg26064155	chr2:99771622	LIPT1;TSGA10	1.02	9.73	0.74	4.23e-15	Chronic sinus infection;
SKCM	cis	rs6952808	1.000	rs6977733	chr7:1886725	A/T	cg02951883	chr7:2050386	MAD1L1	0.72	5.42	0.52	6.47e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs55823223	0.503	rs55699990	chr17:73859186	A/G	cg08125733	chr17:73851984	WBP2	1.06	6.07	0.57	4.35e-8	Psoriasis;
SKCM	cis	rs1577917	0.740	rs12212560	chr6:86342679	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.88	-8.71	-0.7	3.98e-13	Response to antipsychotic treatment;
SKCM	cis	rs10504229	1.000	rs67705655	chr8:58177688	G/A	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs28386778	0.897	rs9915552	chr17:61869095	G/A	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs2243480	1.000	rs313814	chr7:65503293	C/A	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs8133974	0.941	rs8129889	chr21:36480229	G/A	cg00621029	chr21:35747559	FAM165B	0.71	4.87	0.48	5.72e-6	Eosinophil counts;Eosinophil percentage of granulocytes;Sum eosinophil basophil counts;
SKCM	cis	rs8017423	0.845	rs80167706	chr14:90727629	G/C	cg04374321	chr14:90722782	PSMC1	1.06	9.26	0.72	3.32e-14	Mortality in heart failure;
SKCM	cis	rs875971	1.000	rs6961990	chr7:65888570	C/A	cg11764359	chr7:65958608	NA	0.87	8.35	0.69	2.01e-12	Aortic root size;
SKCM	cis	rs826838	1.000	rs7975243	chr12:38849220	C/T	cg13010199	chr12:38710504	ALG10B	0.85	6.56	0.6	5.38e-9	Heart rate;
SKCM	cis	rs28595532	0.844	rs115573749	chr4:119756848	T/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs694739	0.628	rs538147	chr11:64129722	G/A	cg02228329	chr11:64053129	BAD;GPR137	0.85	6.14	0.57	3.24e-8	Alopecia areata;Crohn's disease;Psoriasis vulgaris;
SKCM	cis	rs614226	0.938	rs7972244	chr12:120994872	A/G	cg01236616	chr12:121019343	POP5	1.38	8.73	0.7	3.64e-13	Type 1 diabetes nephropathy;
SKCM	cis	rs9788682	0.895	rs3813570	chr15:78832832	T/C	cg24631222	chr15:78858424	CHRNA5	0.96	6.69	0.6	3.03e-9	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	trans	rs3780486	0.846	rs7036812	chr9:33143822	T/C	cg04842962	chr6:43655489	MRPS18A	1.01	11.19	0.78	6.77e-18	IgG glycosylation;
SKCM	cis	rs1799949	0.526	rs4352088	chr17:41414679	A/G	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.18	-0.57	2.68e-8	Menopause (age at onset);
SKCM	cis	rs4930103	0.619	rs739905	chr11:1980360	G/C	cg23202291	chr11:1979235	NA	0.67	6.95	0.62	9.9e-10	DNA methylation (parent-of-origin);DNA methylation (variation);
SKCM	cis	rs9814567	1.000	rs9864346	chr3:134312352	G/A	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs7843479	0.965	rs1564305	chr8:21803816	A/C	cg17168535	chr8:21777572	XPO7	0.72	5.56	0.53	3.59e-7	Mean corpuscular volume;
SKCM	cis	rs11098499	0.863	rs17050695	chr4:120489527	G/T	cg09307838	chr4:120376055	NA	0.89	7.05	0.62	6.45e-10	Corneal astigmatism;
SKCM	cis	rs6430585	0.528	rs10496738	chr2:136751488	C/T	cg07169764	chr2:136633963	MCM6	1.32	11.74	0.8	6.6e-19	Corneal structure;
SKCM	cis	rs28374715	0.662	rs8038983	chr15:41473316	G/A	cg18705301	chr15:41695430	NDUFAF1	-0.93	-7.74	-0.66	2.94e-11	Ulcerative colitis;
SKCM	cis	rs6121246	0.954	rs6089093	chr20:30421459	C/T	cg11595048	chr20:30225325	COX4I2	0.65	4.93	0.49	4.54e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs6723226	0.650	rs6729952	chr2:32764922	T/C	cg02381751	chr2:32503542	YIPF4	0.74	5.83	0.55	1.21e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs950027	0.620	rs2453533	chr15:45641225	C/A	cg10760299	chr15:45669010	GATM	0.53	5.42	0.52	6.45e-7	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs9916302	0.800	rs9892675	chr17:37549200	C/T	cg07936489	chr17:37558343	FBXL20	0.98	8.64	0.7	5.31e-13	Glomerular filtration rate (creatinine);
SKCM	cis	rs2075671	0.903	rs11973874	chr7:100263272	T/C	cg16850897	chr7:100343110	ZAN	-0.65	-4.78	-0.48	8.2e-6	Other erythrocyte phenotypes;
SKCM	cis	rs992157	0.932	rs4672884	chr2:219182481	G/A	cg20019365	chr2:219134978	PNKD;AAMP	-0.78	-6.47	-0.59	7.78e-9	Colorectal cancer;
SKCM	cis	rs2282032	0.527	rs60971518	chr14:90765745	A/G	cg04374321	chr14:90722782	PSMC1	0.69	5.58	0.53	3.29e-7	Longevity;
SKCM	cis	rs12477438	0.834	rs1563107	chr2:99701276	A/G	cg26064155	chr2:99771622	LIPT1;TSGA10	0.8	5.09	0.5	2.43e-6	Chronic sinus infection;
SKCM	cis	rs10504229	1.000	rs73607874	chr8:58173433	G/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs3857536	0.740	rs9342532	chr6:66886297	T/C	cg07460842	chr6:66804631	NA	-0.7	-5.07	-0.5	2.64e-6	Blood trace element (Cu levels);
SKCM	cis	rs644799	1.000	rs3177463	chr11:95502128	G/C	cg03916912	chr11:95522834	CEP57;FAM76B	0.95	8.77	0.7	2.97e-13	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs4664308	1.000	rs4665147	chr2:160917062	A/G	cg03641300	chr2:160917029	PLA2R1	-0.63	-4.81	-0.48	7.36e-6	Idiopathic membranous nephropathy;
SKCM	cis	rs72781680	0.898	rs72786270	chr2:24059049	G/A	cg08917208	chr2:24149416	ATAD2B	1.0	5.14	0.5	1.98e-6	Lymphocyte counts;
SKCM	cis	rs867186	0.925	rs11906160	chr20:33565755	G/A	cg04194272	chr20:33683537	NA	-0.92	-5.08	-0.5	2.52e-6	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs13010713	0.806	rs7593597	chr2:182056796	T/C	cg21995919	chr2:182322279	ITGA4	-0.53	-5.12	-0.5	2.18e-6	Celiac disease;
SKCM	cis	rs8180040	0.966	rs6792488	chr3:47503349	C/T	cg16586182	chr3:47516702	SCAP	0.76	5.32	0.52	9.63e-7	Colorectal cancer;
SKCM	cis	rs3785574	0.962	rs2727324	chr17:61922102	G/C	cg06873352	chr17:61820015	STRADA	0.57	4.94	0.49	4.36e-6	Height;
SKCM	cis	rs427394	0.659	rs274693	chr5:6734162	G/A	cg10857441	chr5:6722123	POLS	-0.71	-7.53	-0.65	7.53e-11	Menopause (age at onset);
SKCM	cis	rs208520	0.674	rs207103	chr6:66795568	G/T	cg07460842	chr6:66804631	NA	-1.03	-7.65	-0.65	4.49e-11	Exhaled nitric oxide output;
SKCM	cis	rs9467773	1.000	rs1056667	chr6:26510564	T/C	cg09904177	chr6:26538194	HMGN4	0.55	5.03	0.49	3.11e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs35146811	0.555	rs2525539	chr7:99545309	A/G	cg22906224	chr7:99728672	NA	-0.72	-4.96	-0.49	4.08e-6	Coronary artery disease;
SKCM	cis	rs11122272	0.525	rs2749713	chr1:231537921	T/C	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	-0.62	-4.91	-0.49	4.84e-6	Hemoglobin concentration;
SKCM	cis	rs7089973	0.604	rs55759483	chr10:116573423	T/C	cg03647239	chr10:116582469	FAM160B1	0.63	5.12	0.5	2.13e-6	Bipolar disorder or attention deficit hyperactivity disorder;
SKCM	cis	rs6120849	0.901	rs6088733	chr20:33744904	A/G	cg24642439	chr20:33292090	TP53INP2	0.94	5.15	0.5	1.89e-6	Protein C levels;
SKCM	cis	rs3845702	0.673	rs12468986	chr2:180862320	T/G	cg01881094	chr2:180872142	CWC22	1.26	6.25	0.58	2.01e-8	Schizophrenia;
SKCM	trans	rs208520	0.754	rs851593	chr6:66875783	C/T	cg15611600	chr13:45563400	KIAA1704;NUFIP1	1.06	8.04	0.67	7.81e-12	Exhaled nitric oxide output;
SKCM	cis	rs2836974	1.000	rs12710454	chr21:40656919	A/G	cg11890956	chr21:40555474	PSMG1	0.99	11.14	0.78	8.38e-18	Cognitive function;
SKCM	cis	rs4972806	0.814	rs1446575	chr2:177047801	A/C	cg03152288	chr2:177042942	NA	0.57	4.99	0.49	3.6e-6	IgG glycosylation;
SKCM	cis	rs12497850	0.897	rs6795025	chr3:49081247	T/C	cg06212747	chr3:49208901	KLHDC8B	0.7	4.94	0.49	4.32e-6	Parkinson's disease;
SKCM	cis	rs4233366	0.716	rs33941127	chr1:161168004	C/T	cg05410790	chr1:161067663	KLHDC9	0.82	5.27	0.51	1.19e-6	Asthma;
SKCM	cis	rs7917772	0.503	rs7902306	chr10:104290462	C/T	cg11453585	chr10:104263688	ACTR1A;SUFU	0.85	5.82	0.55	1.22e-7	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs12477438	0.520	rs6739579	chr2:99731552	C/T	cg14399236	chr2:99771627	LIPT1;TSGA10	0.95	8.78	0.71	2.89e-13	Chronic sinus infection;
SKCM	cis	rs1799949	1.000	rs8176234	chr17:41219780	T/C	cg23758822	chr17:41437982	NA	0.94	7.89	0.67	1.51e-11	Menopause (age at onset);
SKCM	cis	rs1799949	1.000	rs2037076	chr17:41305883	G/A	cg23758822	chr17:41437982	NA	0.92	7.83	0.66	1.97e-11	Menopause (age at onset);
SKCM	cis	rs870825	0.616	rs28636679	chr4:185627481	C/T	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs727563	0.594	rs5758408	chr22:42077737	A/C	cg03806693	chr22:41940476	POLR3H	1.12	7.65	0.65	4.54e-11	Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs1862618	0.671	rs2591970	chr5:56232595	T/C	cg03609598	chr5:56110824	MAP3K1	0.71	5.08	0.5	2.5e-6	Initial pursuit acceleration;
SKCM	cis	rs10751667	0.666	rs10902243	chr11:949900	T/C	cg10932868	chr11:921992	NA	0.55	5.1	0.5	2.36e-6	Alzheimer's disease (late onset);
SKCM	trans	rs561341	1.000	rs55962687	chr17:30260369	C/T	cg20587970	chr11:113659929	NA	-1.17	-9.84	-0.74	2.51e-15	Hip circumference adjusted for BMI;
SKCM	cis	rs595982	0.527	rs56021835	chr19:49369989	G/A	cg19746536	chr19:49375674	PPP1R15A	1.06	5.9	0.56	9.05e-8	Red cell distribution width;
SKCM	cis	rs4665809	1.000	rs4665309	chr2:26335502	T/C	cg26119090	chr2:26468346	HADHA;HADHB	-0.76	-4.79	-0.48	7.86e-6	Gut microbiome composition (summer);
SKCM	cis	rs12142240	0.698	rs3991877	chr1:46853749	C/A	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs2836974	0.863	rs1065242	chr21:40567716	C/G	cg11890956	chr21:40555474	PSMG1	1.09	13.83	0.84	1.08e-22	Cognitive function;
SKCM	cis	rs11098499	0.909	rs10026736	chr4:120384322	G/C	cg09307838	chr4:120376055	NA	0.98	7.48	0.65	9.57e-11	Corneal astigmatism;
SKCM	cis	rs951366	1.000	rs951366	chr1:205685352	C/T	cg11965913	chr1:205819406	PM20D1	0.64	4.9	0.49	5.03e-6	Menarche (age at onset);
SKCM	cis	rs17685	0.784	rs1637043	chr7:75699099	G/A	cg16489192	chr7:75678113	MDH2;STYXL1	-0.58	-5.44	-0.52	5.83e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs3091242	0.900	rs4649086	chr1:25778967	T/A	cg27572855	chr1:25598939	RHD	0.53	5.06	0.5	2.67e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs8067545	0.750	rs4005937	chr17:19959828	A/C	cg13482628	chr17:19912719	NA	0.7	6.29	0.58	1.7e-8	Schizophrenia;
SKCM	cis	rs12474201	0.928	rs7594523	chr2:46935791	G/C	cg06386533	chr2:46925753	SOCS5	1.01	9.13	0.72	5.95e-14	Height;
SKCM	trans	rs1814175	0.765	rs1722003	chr11:49895896	G/A	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs8064299	0.934	rs895692	chr17:72766252	G/A	cg25054828	chr17:72772726	NAT9;TMEM104	0.77	6.8	0.61	1.85e-9	Monocyte count;
SKCM	cis	rs796364	0.951	rs769952	chr2:200734368	C/T	cg12253985	chr2:200820533	C2orf60;C2orf47	0.85	5.39	0.52	7.18e-7	Schizophrenia;
SKCM	cis	rs12497850	0.931	rs9755490	chr3:48871664	A/C	cg06212747	chr3:49208901	KLHDC8B	0.68	4.89	0.48	5.28e-6	Parkinson's disease;
SKCM	cis	rs5750830	0.649	rs4337572	chr22:39800704	C/G	cg24399712	chr22:39784796	NA	-0.58	-4.99	-0.49	3.55e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7811142	1.000	rs6979335	chr7:100089860	T/C	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.14	6.58	0.6	4.83e-9	Platelet count;
SKCM	cis	rs7613875	0.600	rs7061	chr3:50114515	C/T	cg24110177	chr3:50126178	RBM5	0.73	5.58	0.53	3.4e-7	Body mass index;
SKCM	cis	rs79839061	0.610	rs3775122	chr4:893287	A/G	cg07828340	chr4:882639	GAK	-1.08	-6.12	-0.57	3.56e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs8180040	0.629	rs7426969	chr3:47091355	T/C	cg27129171	chr3:47204927	SETD2	0.74	5.37	0.52	7.84e-7	Colorectal cancer;
SKCM	cis	rs2832191	0.740	rs2853830	chr21:30416824	A/G	cg24692254	chr21:30365293	RNF160	1.08	10.2	0.76	5.14e-16	Dental caries;
SKCM	cis	rs17854409	0.536	rs3765464	chr20:61485236	T/C	cg06598544	chr20:61472147	COL9A3	-1.15	-5.39	-0.52	7.18e-7	Obesity-related traits;
SKCM	cis	rs7633770	0.769	rs3796371	chr3:46667224	C/T	cg11219411	chr3:46661640	NA	0.68	6.42	0.59	9.87e-9	Coronary artery disease;
SKCM	cis	rs7811142	0.943	rs3900792	chr7:100004577	C/G	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-1.0	-5.66	-0.54	2.36e-7	Platelet count;
SKCM	cis	rs8072100	0.817	rs11869940	chr17:45578435	T/A	cg08085267	chr17:45401833	C17orf57	0.57	4.85	0.48	6.1e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs1707322	0.964	rs10890358	chr1:46319025	T/A	cg03146154	chr1:46216737	IPP	0.74	5.0	0.49	3.39e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs2354432	0.607	rs6658763	chr1:146692373	C/T	cg25205988	chr1:146714368	CHD1L	-1.19	-6.54	-0.59	5.94e-9	Mitochondrial DNA levels;
SKCM	cis	rs7833790	1.000	rs7833790	chr8:82731157	T/C	cg17211192	chr8:82754475	SNX16	-0.94	-5.12	-0.5	2.15e-6	Diastolic blood pressure;
SKCM	cis	rs10256972	0.577	rs4999286	chr7:1199506	C/G	cg09177884	chr7:1199841	ZFAND2A	-0.77	-6.47	-0.59	8.03e-9	Longevity;Endometriosis;
SKCM	cis	rs600231	0.708	rs1784100	chr11:65249227	T/C	cg24009118	chr11:65545808	DKFZp761E198	0.66	4.94	0.49	4.36e-6	Bone mineral density;
SKCM	cis	rs899997	0.731	rs58717592	chr15:79030417	T/C	cg04896959	chr15:78267971	NA	-0.6	-4.86	-0.48	5.93e-6	Coronary artery disease or large artery stroke;
SKCM	cis	rs9303401	0.614	rs35308719	chr17:57163501	C/T	cg10487724	chr17:56770010	TEX14;RAD51C	0.79	4.97	0.49	3.86e-6	Cognitive test performance;
SKCM	cis	rs533581	0.873	rs579740	chr16:88973937	A/G	cg16701003	chr16:89028210	CBFA2T3	-0.74	-7.17	-0.63	3.71e-10	Social autistic-like traits;
SKCM	cis	rs2832191	1.000	rs2832185	chr21:30483761	C/G	cg24692254	chr21:30365293	RNF160	-0.79	-7.24	-0.63	2.72e-10	Dental caries;
SKCM	trans	rs8073060	0.586	rs225294	chr17:33925762	G/A	cg19694781	chr19:47549865	TMEM160	-1.08	-8.69	-0.7	4.26e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs3771570	1.000	rs60604866	chr2:242352257	A/G	cg07612300	chr2:242033426	MTERFD2;SNED1	0.87	4.77	0.47	8.54e-6	Prostate cancer;
SKCM	cis	rs951366	0.764	rs708724	chr1:205743663	A/C	cg17178900	chr1:205818956	PM20D1	0.78	6.68	0.6	3.15e-9	Menarche (age at onset);
SKCM	cis	rs11249608	0.548	rs62393074	chr5:178450476	G/C	cg21905437	chr5:178450457	ZNF879	0.76	6.46	0.59	8.29e-9	Pubertal anthropometrics;
SKCM	cis	rs875971	0.862	rs2460432	chr7:65554385	C/T	cg18876405	chr7:65276391	NA	-0.67	-6.84	-0.61	1.61e-9	Aortic root size;
SKCM	cis	rs13118159	0.872	rs1882105	chr4:1345956	T/C	cg20887711	chr4:1340912	KIAA1530	0.67	4.91	0.49	5e-6	Longevity;
SKCM	cis	rs116095464	0.558	rs9312957	chr5:202194	C/T	cg22857025	chr5:266934	NA	-1.44	-7.74	-0.66	2.94e-11	Breast cancer;
SKCM	cis	rs227584	0.663	rs2040810	chr17:42243771	C/T	cg19774624	chr17:42201019	HDAC5	0.75	6.43	0.59	9.5e-9	Bone mineral density (hip);Bone mineral density;
SKCM	cis	rs7772486	0.875	rs13204280	chr6:146415368	T/C	cg05347473	chr6:146136440	FBXO30	0.64	5.83	0.55	1.19e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6089584	0.889	rs6142923	chr20:60596617	C/T	cg06108461	chr20:60628389	TAF4	0.82	6.39	0.59	1.12e-8	Body mass index;
SKCM	cis	rs4721295	0.546	rs1637766	chr7:2204400	G/A	cg02951883	chr7:2050386	MAD1L1	0.61	5.04	0.5	2.94e-6	Schizophrenia, schizoaffective disorder or bipolar disorder;
SKCM	cis	rs736408	0.609	rs13061423	chr3:52790213	T/C	cg18404041	chr3:52824283	ITIH1	-0.56	-4.94	-0.49	4.32e-6	Bipolar disorder;
SKCM	cis	rs7100689	0.784	rs7895042	chr10:82095276	G/A	cg00277334	chr10:82204260	NA	-0.58	-5.37	-0.52	7.94e-7	Post bronchodilator FEV1;
SKCM	cis	rs35306767	0.903	rs12764024	chr10:922861	A/G	cg26597838	chr10:835615	NA	0.8	6.18	0.57	2.71e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs875971	0.862	rs778705	chr7:65861115	G/A	cg18876405	chr7:65276391	NA	0.63	6.34	0.58	1.39e-8	Aortic root size;
SKCM	cis	rs28595532	0.920	rs115154263	chr4:119765307	G/A	cg11846333	chr4:119757529	SEC24D	1.2	6.48	0.59	7.6e-9	Cannabis dependence symptom count;
SKCM	cis	rs2033711	0.728	rs4801586	chr19:58934528	A/G	cg03735888	chr19:58951602	ZNF132	0.7	6.07	0.57	4.34e-8	Uric acid clearance;
SKCM	cis	rs7100689	0.646	rs7894762	chr10:82086779	C/G	cg01528321	chr10:82214614	TSPAN14	0.76	6.26	0.58	1.94e-8	Post bronchodilator FEV1;
SKCM	cis	rs116095464	0.558	rs28729548	chr5:229025	C/T	cg22496380	chr5:211416	CCDC127	-0.95	-5.22	-0.51	1.42e-6	Breast cancer;
SKCM	cis	rs35146811	0.700	rs4729579	chr7:99780282	C/G	cg22906224	chr7:99728672	NA	0.65	5.19	0.51	1.6e-6	Coronary artery disease;
SKCM	cis	rs1949733	0.959	rs2688242	chr4:8429943	T/G	cg11789530	chr4:8429930	ACOX3	0.86	6.17	0.57	2.83e-8	Response to antineoplastic agents;
SKCM	cis	rs6545883	0.560	rs11677775	chr2:61503110	T/C	cg15711740	chr2:61764176	XPO1	0.66	5.12	0.5	2.17e-6	Tuberculosis;
SKCM	cis	rs6582630	0.519	rs12368889	chr12:38315160	G/A	cg13010199	chr12:38710504	ALG10B	0.69	4.92	0.49	4.72e-6	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs7811142	0.779	rs77370288	chr7:99947897	A/T	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.2	7.87	0.67	1.7e-11	Platelet count;
SKCM	cis	rs6088580	0.634	rs4911420	chr20:32998654	A/G	cg24642439	chr20:33292090	TP53INP2	-0.76	-6.02	-0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs7215564	0.908	rs35071767	chr17:78652575	A/G	cg16980736	chr17:78789706	RPTOR	-0.91	-4.92	-0.49	4.67e-6	Myopia (pathological);
SKCM	cis	rs362272	0.545	rs2749785	chr4:3325179	G/C	cg00764545	chr4:3318001	RGS12	1.0	12.81	0.82	7.21e-21	Serum sulfate level;
SKCM	cis	rs7617480	0.648	rs9859473	chr3:48837182	A/G	cg07636037	chr3:49044803	WDR6	0.83	6.05	0.57	4.68e-8	Subjective well-being (multi-trait analysis);Menarche (age at onset);
SKCM	cis	rs11098499	0.954	rs11098526	chr4:120390359	C/T	cg09307838	chr4:120376055	NA	0.97	7.49	0.65	9.08e-11	Corneal astigmatism;
SKCM	cis	rs6762	0.642	rs28692469	chr11:839675	T/C	cg16425592	chr11:842748	TSPAN4;POLR2L	-0.79	-5.82	-0.55	1.25e-7	Mean platelet volume;
SKCM	cis	rs67311347	0.544	rs2123998	chr3:40359005	C/G	cg18306943	chr3:40428807	ENTPD3	-0.57	-5.03	-0.5	3.03e-6	Renal cell carcinoma;
SKCM	cis	rs2153535	0.580	rs6905242	chr6:8471799	A/C	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs861020	0.606	rs629224	chr1:210005071	C/T	cg05527609	chr1:210001259	C1orf107	0.86	6.74	0.61	2.43e-9	Orofacial clefts;
SKCM	cis	rs4740619	0.619	rs10810517	chr9:16026664	C/T	cg14451791	chr9:16040625	NA	-0.47	-4.99	-0.49	3.56e-6	Body mass index;
SKCM	cis	rs9814567	0.806	rs7648616	chr3:134318074	C/T	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.62	-5.16	-0.5	1.86e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs13217239	0.608	rs6930508	chr6:27053142	T/C	cg12292205	chr6:26970375	C6orf41	-0.59	-5.15	-0.5	1.94e-6	Schizophrenia;
SKCM	cis	rs33794	0.934	rs33796	chr3:45302287	C/T	cg25630594	chr3:44914870	TGM4	0.6	5.1	0.5	2.33e-6	Lung function (forced expiratory volume in 1 second);
SKCM	cis	rs763121	0.853	rs5750627	chr22:38982321	A/G	cg06022373	chr22:39101656	GTPBP1	0.82	5.62	0.54	2.79e-7	Menopause (age at onset);
SKCM	cis	rs1799949	1.000	rs8176289	chr17:41206056	T/C	cg05368731	chr17:41323189	NBR1	0.89	7.67	0.66	4.08e-11	Menopause (age at onset);
SKCM	cis	rs2721195	0.845	rs3757966	chr8:145744618	G/A	cg15320075	chr8:145703422	NA	0.83	7.11	0.63	4.79e-10	Age at first birth;
SKCM	cis	rs929354	0.772	rs1182444	chr7:157024510	A/G	cg17757837	chr7:157058334	UBE3C	-0.81	-5.67	-0.54	2.3e-7	Body mass index;
SKCM	cis	rs4819052	0.851	rs8134392	chr21:46663790	A/G	cg19498844	chr21:46707878	POFUT2;LOC642852	-0.85	-7.44	-0.64	1.11e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs28386778	1.000	rs3020613	chr17:61955983	A/G	cg06873352	chr17:61820015	STRADA	0.77	6.58	0.6	4.86e-9	Prudent dietary pattern;
SKCM	cis	rs7940866	0.903	rs11222411	chr11:130838682	A/G	cg12179176	chr11:130786555	SNX19	0.77	5.87	0.55	1e-7	Schizophrenia;
SKCM	trans	rs1814175	0.645	rs1722000	chr11:49917928	A/C	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs6539267	0.741	rs35816179	chr12:106693710	T/C	cg02476566	chr12:106696527	TCP11L2	0.71	5.03	0.49	3.1e-6	Tourette syndrome;
SKCM	cis	rs4481887	1.000	rs10788781	chr1:248494262	C/T	cg00666640	chr1:248458726	OR2T12	0.59	4.96	0.49	4.04e-6	Common traits (Other);
SKCM	cis	rs7811142	1.000	rs60257855	chr7:100026780	G/C	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.23	7.89	0.67	1.53e-11	Platelet count;
SKCM	cis	rs897984	0.721	rs4889525	chr16:30989858	T/C	cg00531865	chr16:30841666	NA	0.59	4.97	0.49	3.81e-6	Dementia with Lewy bodies;
SKCM	cis	rs7772486	0.806	rs2247317	chr6:146217570	C/T	cg23711669	chr6:146136114	FBXO30	0.74	7.31	0.64	2.05e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs28374715	0.617	rs16971733	chr15:41562030	C/A	cg18705301	chr15:41695430	NDUFAF1	-0.76	-6.34	-0.58	1.39e-8	Ulcerative colitis;
SKCM	cis	rs7666738	0.791	rs1896156	chr4:99020882	C/G	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7149337	0.805	rs2999355	chr14:51607084	A/G	cg23942311	chr14:51606299	NA	0.65	7.48	0.65	9.58e-11	Cancer;
SKCM	cis	rs28595532	0.920	rs115576008	chr4:119736967	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs17270561	0.541	rs12192932	chr6:25911502	A/G	cg17691542	chr6:26056736	HIST1H1C	1.24	8.89	0.71	1.79e-13	Iron status biomarkers;
SKCM	cis	rs2033711	0.936	rs893185	chr19:58989495	A/C	cg12042659	chr19:58951599	ZNF132	0.73	6.3	0.58	1.6e-8	Uric acid clearance;
SKCM	cis	rs7216064	1.000	rs4791299	chr17:65930937	A/G	cg12091567	chr17:66097778	LOC651250	-0.78	-5.34	-0.52	8.92e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs1153858	1.000	rs11070453	chr15:45645154	C/G	cg21132104	chr15:45694354	SPATA5L1	0.92	7.81	0.66	2.22e-11	Homoarginine levels;
SKCM	cis	rs798554	0.757	rs1182198	chr7:2862906	C/T	cg04166393	chr7:2884313	GNA12	0.72	4.99	0.49	3.52e-6	Height;
SKCM	cis	rs875971	0.619	rs2302918	chr7:66000932	A/G	cg11987759	chr7:65425863	GUSB	-0.69	-5.92	-0.56	8.13e-8	Aortic root size;
SKCM	cis	rs10540	0.558	rs12806062	chr11:501429	G/A	cg03352830	chr11:487213	PTDSS2	1.03	5.34	0.52	8.87e-7	Body mass index;
SKCM	cis	rs950776	0.593	rs621849	chr15:78872861	G/A	cg06917634	chr15:78832804	PSMA4	-0.9	-7.97	-0.67	1.09e-11	Sudden cardiac arrest;
SKCM	cis	rs9371601	0.859	rs214981	chr6:152732714	A/G	cg25291603	chr6:152002969	NA	-0.45	-5.19	-0.51	1.63e-6	Bipolar disorder;Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);
SKCM	cis	rs67311347	0.544	rs2887965	chr3:40334154	A/G	cg13409248	chr3:40428643	ENTPD3	-0.57	-5.58	-0.53	3.37e-7	Renal cell carcinoma;
SKCM	cis	rs62064224	0.702	rs735555	chr17:30817450	A/G	cg18200150	chr17:30822561	MYO1D	-0.68	-5.47	-0.53	5.16e-7	Schizophrenia;
SKCM	cis	rs9467773	1.000	rs3736782	chr6:26505403	C/A	cg09904177	chr6:26538194	HMGN4	0.55	5.03	0.49	3.11e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs875971	0.545	rs316306	chr7:65618674	G/A	cg18876405	chr7:65276391	NA	-0.64	-5.29	-0.51	1.09e-6	Aortic root size;
SKCM	cis	rs2599510	0.811	rs2754520	chr2:32810293	G/A	cg02381751	chr2:32503542	YIPF4	0.76	5.93	0.56	8e-8	Interleukin-18 levels;
SKCM	cis	rs72781680	0.898	rs72786277	chr2:24062818	T/G	cg08917208	chr2:24149416	ATAD2B	1.0	5.14	0.5	1.98e-6	Lymphocyte counts;
SKCM	cis	rs898097	0.528	rs2243523	chr17:80680449	G/T	cg15369054	chr17:80825471	TBCD	0.53	4.81	0.48	7.28e-6	Breast cancer;
SKCM	cis	rs2404602	0.735	rs2048856	chr15:76800083	C/T	cg23625390	chr15:77176239	SCAPER	-0.8	-7.82	-0.66	2.05e-11	Blood metabolite levels;
SKCM	cis	rs6565180	0.962	rs6565182	chr16:30374381	C/T	cg17640201	chr16:30407289	ZNF48	-0.9	-6.68	-0.6	3.17e-9	Tonsillectomy;
SKCM	cis	rs6665290	0.901	rs61834005	chr1:227202789	C/T	cg10327440	chr1:227177885	CDC42BPA	-1.21	-16.02	-0.88	2.21e-26	Myeloid white cell count;
SKCM	cis	rs12824058	0.831	rs4759655	chr12:130815740	A/G	cg26677194	chr12:130822605	PIWIL1	-0.72	-6.22	-0.58	2.29e-8	Menopause (age at onset);
SKCM	cis	rs13118159	0.505	rs1250128	chr4:1257311	T/C	cg19318889	chr4:1322082	MAEA	-0.72	-5.41	-0.52	6.72e-7	Longevity;
SKCM	cis	rs67460515	0.892	rs4856756	chr3:160999414	G/A	cg03342759	chr3:160939853	NMD3	-0.81	-7.1	-0.63	5.14e-10	Parkinson's disease;
SKCM	cis	rs763121	0.853	rs2413546	chr22:39107001	G/A	cg06022373	chr22:39101656	GTPBP1	0.78	5.59	0.53	3.27e-7	Menopause (age at onset);
SKCM	cis	rs4332037	0.508	rs60238952	chr7:1914350	A/G	cg23422044	chr7:1970798	MAD1L1	-0.83	-5.57	-0.53	3.42e-7	Bipolar disorder;
SKCM	cis	rs7100689	0.646	rs2039757	chr10:82078868	C/A	cg01528321	chr10:82214614	TSPAN14	0.76	6.26	0.58	1.94e-8	Post bronchodilator FEV1;
SKCM	cis	rs7635838	0.819	rs4684781	chr3:11516299	G/A	cg00170343	chr3:11313890	ATG7	0.69	5.24	0.51	1.34e-6	HDL cholesterol;
SKCM	cis	rs10540	1.000	rs35231079	chr11:515224	G/A	cg03576123	chr11:487126	PTDSS2	-1.45	-7.95	-0.67	1.17e-11	Body mass index;
SKCM	cis	rs10193935	0.892	rs7574609	chr2:42388468	C/A	cg27598129	chr2:42591480	NA	-0.92	-6.79	-0.61	1.97e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7618915	0.798	rs353547	chr3:52268866	A/G	cg18404041	chr3:52824283	ITIH1	0.52	5.02	0.49	3.2e-6	Bipolar disorder;
SKCM	trans	rs17685	0.712	rs10952842	chr7:75780413	G/A	cg19862616	chr7:65841803	NCRNA00174	0.88	8.34	0.69	2.1e-12	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs738321	0.756	rs11570745	chr22:38513493	C/T	cg25457927	chr22:38595422	NA	-0.51	-5.73	-0.54	1.83e-7	Breast cancer;
SKCM	cis	rs17685	0.753	rs6951808	chr7:75772413	A/G	cg01364799	chr7:75623366	TMEM120A	-0.69	-5.59	-0.53	3.22e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7666738	0.830	rs62321565	chr4:98976571	G/A	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1979654	0.543	rs1532166	chr16:86404318	C/G	cg05448715	chr16:87090352	NA	-0.47	-4.82	-0.48	6.99e-6	Barrett's esophagus  or Esophageal adenocarcinoma;
SKCM	cis	rs2842992	0.724	rs15982	chr6:160199687	T/C	cg16489826	chr6:160211363	TCP1;MRPL18	0.75	6.12	0.57	3.48e-8	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs1005277	0.579	rs1780133	chr10:38499509	T/C	cg00409905	chr10:38381863	ZNF37A	-0.62	-5.82	-0.55	1.24e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs7408868	0.764	rs62113791	chr19:15277009	C/T	cg14696996	chr19:15285081	NOTCH3	0.82	4.92	0.49	4.7e-6	Pulse pressure;
SKCM	cis	rs2066819	1.000	rs2695788	chr12:56697110	G/A	cg26714650	chr12:56694279	CS	1.71	6.71	0.61	2.74e-9	Psoriasis vulgaris;
SKCM	cis	rs1865760	1.000	rs9467636	chr6:25919549	A/C	cg08401836	chr6:26032486	HIST1H3B	-0.6	-4.78	-0.48	8.09e-6	Height;
SKCM	cis	rs1799949	1.000	rs12944458	chr17:41180772	C/T	cg25918947	chr17:41365094	TMEM106A	-0.61	-5.87	-0.55	1e-7	Menopause (age at onset);
SKCM	cis	rs9910055	0.552	rs4793084	chr17:42317371	G/T	cg10896456	chr17:42255109	ASB16;C17orf65	-0.58	-4.85	-0.48	6.23e-6	Total body bone mineral density;
SKCM	cis	rs55962025	0.804	rs2269499	chr4:3239702	C/T	cg09735869	chr4:3319127	RGS12	-0.71	-5.6	-0.54	3.03e-7	Parental longevity (mother's age at death);
SKCM	cis	rs11638352	1.000	rs12324261	chr15:44318471	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	-1.25	-4.88	-0.48	5.56e-6	Lipoprotein phospholipase A2 activity in cardiovascular disease;
SKCM	cis	rs12705054	0.737	rs67723713	chr7:98796432	T/C	cg11543304	chr7:98729543	SMURF1	1.06	4.77	0.48	8.44e-6	Facial emotion recognition (sad faces);
SKCM	trans	rs1814175	0.702	rs4881644	chr11:49786367	C/T	cg15704280	chr7:45808275	SEPT13	-1.03	-10.73	-0.77	5.17e-17	Height;
SKCM	cis	rs2153535	0.580	rs9379215	chr6:8481225	G/A	cg07606381	chr6:8435919	SLC35B3	0.86	6.25	0.58	2.06e-8	Motion sickness;
SKCM	cis	rs1577917	0.958	rs1838958	chr6:86563968	G/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.32	-0.52	9.66e-7	Response to antipsychotic treatment;
SKCM	cis	rs7829975	0.711	rs12682352	chr8:8646246	A/G	cg06636001	chr8:8085503	FLJ10661	0.78	7.02	0.62	7.35e-10	Mood instability;
SKCM	cis	rs875971	0.895	rs6460278	chr7:65662736	T/C	cg18876405	chr7:65276391	NA	-0.65	-6.74	-0.61	2.46e-9	Aortic root size;
SKCM	cis	rs9300255	0.602	rs1716165	chr12:123648881	C/T	cg05973401	chr12:123451056	ABCB9	0.8	5.47	0.53	5.23e-7	Neutrophil percentage of white cells;
SKCM	cis	rs2243480	1.000	rs316327	chr7:65609201	G/T	cg18252515	chr7:66147081	NA	1.34	8.18	0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs875971	0.825	rs1860472	chr7:66082723	T/C	cg18876405	chr7:65276391	NA	-0.63	-6.32	-0.58	1.5e-8	Aortic root size;
SKCM	cis	rs8078723	1.000	rs709592	chr17:38175553	C/T	cg17467752	chr17:38218738	THRA	0.69	6.29	0.58	1.67e-8	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs2730245	0.527	rs2730237	chr7:158706166	A/G	cg24397884	chr7:158709396	WDR60	1.01	5.84	0.55	1.15e-7	Height;
SKCM	cis	rs763014	0.932	rs7204439	chr16:661335	T/C	cg09263875	chr16:632152	PIGQ	0.74	6.73	0.61	2.6e-9	Height;
SKCM	cis	rs67311347	0.544	rs4974040	chr3:40331059	G/A	cg00091569	chr3:40428383	ENTPD3	0.6	5.28	0.51	1.15e-6	Renal cell carcinoma;
SKCM	cis	rs2204008	0.577	rs2623049	chr12:38018831	G/A	cg13010199	chr12:38710504	ALG10B	-0.62	-4.84	-0.48	6.53e-6	Bladder cancer;
SKCM	cis	rs6840360	0.593	rs1429558	chr4:152685406	A/T	cg22705602	chr4:152727874	NA	-0.59	-7.95	-0.67	1.19e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs2836950	0.520	rs11911087	chr21:40665192	G/A	cg17971929	chr21:40555470	PSMG1	-0.73	-6.17	-0.57	2.86e-8	Menarche (age at onset);
SKCM	cis	rs6089584	0.566	rs55881457	chr20:60608424	G/A	cg06108461	chr20:60628389	TAF4	-0.73	-6.52	-0.59	6.34e-9	Body mass index;
SKCM	cis	rs732765	0.734	rs12895862	chr14:75126566	T/C	cg25946216	chr14:74253857	C14orf43	-0.88	-5.59	-0.53	3.19e-7	Non-small cell lung cancer;
SKCM	cis	rs6598955	0.543	rs57564009	chr1:26557618	A/T	cg04990556	chr1:26633338	UBXN11	0.64	4.92	0.49	4.78e-6	Obesity-related traits;
SKCM	cis	rs4237845	0.837	rs7963992	chr12:58295949	G/C	cg00677455	chr12:58241039	CTDSP2	0.7	5.58	0.53	3.38e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7772486	0.754	rs12199362	chr6:146118225	A/G	cg05347473	chr6:146136440	FBXO30	0.61	5.8	0.55	1.37e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9611565	0.512	rs139572	chr22:42214532	C/T	cg03806693	chr22:41940476	POLR3H	-1.29	-7.09	-0.63	5.28e-10	Vitiligo;
SKCM	cis	rs28386778	0.897	rs2584626	chr17:61903179	A/G	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	trans	rs1814175	0.645	rs866427	chr11:49923853	G/A	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs3892630	0.588	rs28787932	chr19:33226229	T/C	cg22980127	chr19:33182716	NUDT19	1.47	8.62	0.7	5.94e-13	Red blood cell traits;
SKCM	cis	rs7954584	0.635	rs7313252	chr12:122347600	G/A	cg22618164	chr12:122356400	WDR66	0.5	5.01	0.49	3.31e-6	Mean corpuscular volume;
SKCM	trans	rs1814175	0.817	rs7946556	chr11:49944874	G/A	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs10540	1.000	rs61876339	chr11:495283	T/C	cg03352830	chr11:487213	PTDSS2	0.93	4.93	0.49	4.49e-6	Body mass index;
SKCM	cis	rs1692580	0.807	rs12040414	chr1:2192948	T/C	cg21442419	chr1:2182373	SKI	-0.69	-7.27	-0.64	2.42e-10	Coronary artery disease;
SKCM	cis	rs9467773	1.000	rs28558133	chr6:26531433	G/C	cg15659132	chr6:26577336	NA	0.6	5.71	0.54	1.99e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs870825	0.616	rs4616798	chr4:185634144	C/T	cg04058563	chr4:185651563	MLF1IP	-1.07	-7.16	-0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs9858542	0.953	rs11713474	chr3:49611457	A/G	cg03060546	chr3:49711283	APEH	-0.69	-5.08	-0.5	2.49e-6	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs4268898	0.636	rs72787371	chr2:24570073	T/A	cg06627628	chr2:24431161	ITSN2	-0.9	-6.93	-0.62	1.07e-9	Asthma;
SKCM	cis	rs561341	0.941	rs8066558	chr17:30272879	G/T	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs11098499	0.863	rs10009626	chr4:120470005	T/C	cg09307838	chr4:120376055	NA	1.0	8.27	0.68	2.8e-12	Corneal astigmatism;
SKCM	cis	rs28374715	0.528	rs7178360	chr15:41631175	T/A	cg18705301	chr15:41695430	NDUFAF1	-1.21	-12.61	-0.82	1.61e-20	Ulcerative colitis;
SKCM	cis	rs6952407	1	rs6952407	chr7:66045512	A/G	cg11764359	chr7:65958608	NA	-0.83	-6.29	-0.58	1.71e-8	Cotinine glucuronidation;
SKCM	cis	rs769267	0.930	rs1054930	chr19:19648346	G/C	cg26732615	chr19:19648335	CILP2;YJEFN3	0.67	7.09	0.63	5.41e-10	Tonsillectomy;
SKCM	cis	rs4560672	1.000	rs2502610	chr6:158524591	G/T	cg10592926	chr6:157876961	ZDHHC14	-0.6	-5.89	-0.55	9.42e-8	Smoking quantity;
SKCM	cis	rs10876993	0.890	rs1689584	chr12:58081478	G/A	cg18357645	chr12:58087776	OS9	0.65	5.97	0.56	6.61e-8	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs651907	0.535	rs17412601	chr3:101499275	T/C	cg12386194	chr3:101231763	SENP7	0.64	5.3	0.51	1.05e-6	Colorectal cancer;
SKCM	cis	rs13118159	0.550	rs4974612	chr4:1364543	A/G	cg02475777	chr4:1388615	CRIPAK	0.82	5.44	0.52	5.83e-7	Longevity;
SKCM	cis	rs1218582	0.741	rs883718	chr1:154846274	C/T	cg16680214	chr1:154839983	KCNN3	-0.55	-4.94	-0.49	4.37e-6	Prostate cancer;
SKCM	cis	rs5769765	0.908	rs4824109	chr22:50271460	T/C	cg22709217	chr22:50311962	ALG12;CRELD2	0.79	5.71	0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs6500602	0.673	rs4786513	chr16:4576423	T/C	cg08645402	chr16:4508243	NA	0.62	4.98	0.49	3.74e-6	Schizophrenia;
SKCM	cis	rs2836974	0.526	rs418359	chr21:40536734	T/C	cg11890956	chr21:40555474	PSMG1	-0.88	-9.14	-0.72	5.76e-14	Cognitive function;
SKCM	cis	rs55962025	0.883	rs3121419	chr4:3232257	C/T	cg16987761	chr4:3318072	RGS12	-0.65	-4.81	-0.48	7.21e-6	Parental longevity (mother's age at death);
SKCM	cis	rs34779708	0.833	rs12777517	chr10:35473927	T/G	cg03585969	chr10:35415529	CREM	0.75	6.26	0.58	1.9e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs12709013	0.792	rs1646262	chr16:58794497	A/G	cg02431531	chr16:59244939	NA	0.49	5.13	0.5	2.07e-6	Blood metabolite ratios;
SKCM	cis	rs6977660	0.943	rs10225293	chr7:19840636	C/T	cg07541023	chr7:19748670	TWISTNB	-0.7	-4.96	-0.49	4.07e-6	Thyroid stimulating hormone;
SKCM	cis	rs8017423	0.647	rs12587362	chr14:90821227	G/T	cg04374321	chr14:90722782	PSMC1	-0.73	-5.54	-0.53	3.92e-7	Mortality in heart failure;
SKCM	cis	rs4819052	1.000	rs4819052	chr21:46699777	A/G	cg02159808	chr21:46707872	POFUT2;LOC642852	0.86	6.21	0.58	2.36e-8	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs12047808	0.572	rs56145419	chr1:179379405	G/A	cg08037922	chr1:179521085	C1orf125;NPHS2	-1.08	-5.8	-0.55	1.32e-7	Multiple sclerosis (age of onset);
SKCM	cis	rs72781680	0.898	rs56179550	chr2:23934867	C/T	cg08917208	chr2:24149416	ATAD2B	0.95	4.78	0.48	8.1e-6	Lymphocyte counts;
SKCM	cis	rs2836974	0.897	rs36113648	chr21:40555497	G/A	cg11890956	chr21:40555474	PSMG1	1.09	13.7	0.84	1.86e-22	Cognitive function;
SKCM	cis	rs4973517	0.719	rs35020669	chr2:232841062	A/G	cg13952656	chr2:232260762	B3GNT7	-0.49	-4.88	-0.48	5.45e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs72949976	0.646	rs13029384	chr2:214029164	G/A	cg08319019	chr2:214017104	IKZF2	0.85	6.8	0.61	1.87e-9	Lung cancer;Squamous cell lung carcinoma;
SKCM	cis	rs9660180	1.000	rs9660180	chr1:1723031	G/A	cg17747265	chr1:1875780	NA	-0.52	-4.83	-0.48	6.68e-6	Body mass index;
SKCM	cis	rs4319547	0.695	rs11836188	chr12:122865507	T/C	cg23029597	chr12:123009494	RSRC2	0.72	5.31	0.52	1.01e-6	Body mass index;
SKCM	cis	rs1790761	0.559	rs10896190	chr11:67406123	T/C	cg24690094	chr11:67383802	NA	0.51	5.5	0.53	4.72e-7	Mean corpuscular volume;
SKCM	cis	rs28386778	0.897	rs2859619	chr17:61917686	T/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs7666738	0.830	rs13148363	chr4:98847498	T/C	cg17366294	chr4:99064904	C4orf37	0.56	4.89	0.48	5.25e-6	Colonoscopy-negative controls vs population controls;
SKCM	trans	rs561341	1.000	rs8064843	chr17:30245744	A/G	cg20587970	chr11:113659929	NA	-1.11	-9.5	-0.73	1.14e-14	Hip circumference adjusted for BMI;
SKCM	cis	rs561341	0.941	rs4795664	chr17:30233467	C/T	cg00745463	chr17:30367425	LRRC37B	-1.04	-6.76	-0.61	2.28e-9	Hip circumference adjusted for BMI;
SKCM	cis	rs1325195	0.537	rs2793805	chr1:179195777	A/G	cg25467746	chr1:179556597	NA	0.62	5.77	0.55	1.51e-7	IgE grass sensitization;
SKCM	cis	rs951366	0.585	rs72750964	chr1:205675240	C/T	cg11965913	chr1:205819406	PM20D1	0.81	7.52	0.65	7.86e-11	Menarche (age at onset);
SKCM	cis	rs11626933	0.851	rs2282031	chr14:90730943	A/G	cg14092571	chr14:90743983	NA	-0.72	-7.0	-0.62	8.05e-10	Gut microbiota (bacterial taxa);
SKCM	cis	rs6088590	0.542	rs6059956	chr20:33220070	A/G	cg24642439	chr20:33292090	TP53INP2	0.75	5.91	0.56	8.61e-8	Coronary artery disease;
SKCM	cis	rs28386778	0.897	rs57108948	chr17:61802378	T/C	cg01411255	chr17:61851458	DDX42;CCDC47	0.79	5.1	0.5	2.35e-6	Prudent dietary pattern;
SKCM	cis	rs8078723	0.966	rs7021	chr17:38153875	T/A	cg17467752	chr17:38218738	THRA	0.67	6.13	0.57	3.38e-8	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs17376456	0.569	rs896729	chr5:93222178	A/G	cg25358565	chr5:93447407	FAM172A	-0.9	-5.54	-0.53	3.94e-7	Diabetic retinopathy;
SKCM	cis	rs3784262	0.669	rs7171261	chr15:58356855	C/G	cg12031962	chr15:58353849	ALDH1A2	0.43	4.95	0.49	4.23e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs28386778	0.897	rs968719	chr17:61908271	C/T	cg01411255	chr17:61851458	DDX42;CCDC47	0.77	4.88	0.48	5.54e-6	Prudent dietary pattern;
SKCM	cis	rs7666738	0.830	rs13149779	chr4:99010145	G/T	cg17366294	chr4:99064904	C4orf37	0.57	4.84	0.48	6.35e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs748404	0.631	rs1133395	chr15:43650384	G/A	cg02155558	chr15:43621948	ADAL;LCMT2	0.84	6.38	0.59	1.17e-8	Lung cancer;
SKCM	cis	rs9325144	0.560	rs1601745	chr12:38647828	G/A	cg26384229	chr12:38710491	ALG10B	-0.62	-4.96	-0.49	4e-6	Morning vs. evening chronotype;
SKCM	cis	rs17376456	0.825	rs10052662	chr5:93271385	A/G	cg25358565	chr5:93447407	FAM172A	1.3	7.53	0.65	7.57e-11	Diabetic retinopathy;
SKCM	cis	rs684232	0.666	rs838373	chr17:567171	T/C	cg12384639	chr17:618140	VPS53	0.78	6.14	0.57	3.27e-8	Prostate cancer;
SKCM	cis	rs1419980	0.673	rs7296837	chr12:7757832	A/G	cg10578777	chr12:7781093	NA	0.68	4.96	0.49	4.02e-6	HDL cholesterol levels;
SKCM	cis	rs2739330	0.828	rs5760102	chr22:24248761	T/C	cg25703541	chr22:24373054	LOC391322	-0.78	-6.14	-0.57	3.23e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs35306767	0.903	rs11813210	chr10:919796	G/A	cg26597838	chr10:835615	NA	0.75	5.51	0.53	4.53e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs57237364	1	rs57237364	chr7:102465232	CTTT/C	cg18108683	chr7:102477205	FBXL13	-0.83	-8.96	-0.71	1.3e-13	Breast cancer;
SKCM	cis	rs7589728	0.563	rs78168096	chr2:88473575	G/A	cg04511125	chr2:88470314	THNSL2	1.07	6.66	0.6	3.43e-9	Plasma clusterin levels;
SKCM	cis	rs7829975	0.688	rs7826660	chr8:8379107	C/A	cg06636001	chr8:8085503	FLJ10661	0.83	7.14	0.63	4.27e-10	Mood instability;
SKCM	cis	rs3087591	0.960	rs2285812	chr17:29533871	A/G	cg24425628	chr17:29625626	OMG;NF1	0.64	5.22	0.51	1.43e-6	Hip circumference;
SKCM	cis	rs826838	1.000	rs7299124	chr12:39002661	T/C	cg26384229	chr12:38710491	ALG10B	1.01	9.41	0.73	1.77e-14	Heart rate;
SKCM	cis	rs12477438	0.520	rs1133978	chr2:99741964	C/T	cg26064155	chr2:99771622	LIPT1;TSGA10	1.01	9.47	0.73	1.35e-14	Chronic sinus infection;
SKCM	cis	rs2032447	0.507	rs199748	chr6:25909045	C/G	cg18357526	chr6:26021779	HIST1H4A	0.69	5.05	0.5	2.81e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs5769765	1.000	rs34774661	chr22:50267508	C/G	cg22709217	chr22:50311962	ALG12;CRELD2	0.79	5.71	0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs427394	0.664	rs274722	chr5:6718668	C/T	cg10857441	chr5:6722123	POLS	-0.66	-6.72	-0.61	2.67e-9	Menopause (age at onset);
SKCM	cis	rs7103648	0.742	rs34937994	chr11:47389638	C/T	cg03711944	chr11:47377212	SPI1	-0.57	-5.06	-0.5	2.73e-6	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs28595532	0.920	rs115853212	chr4:119765354	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs9916302	0.861	rs10491129	chr17:37461643	T/G	cg07936489	chr17:37558343	FBXL20	0.84	6.75	0.61	2.32e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs2243480	1.000	rs6959002	chr7:65650496	A/G	cg18252515	chr7:66147081	NA	1.36	8.16	0.68	4.6e-12	Diabetic kidney disease;
SKCM	cis	rs4077515	0.967	rs3812558	chr9:139269135	A/G	cg14169450	chr9:139327907	INPP5E	0.47	5.27	0.51	1.2e-6	Ulcerative colitis;IgA nephropathy;Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs561341	0.739	rs8070554	chr17:30216868	A/T	cg00745463	chr17:30367425	LRRC37B	0.94	5.96	0.56	6.78e-8	Hip circumference adjusted for BMI;
SKCM	cis	rs362272	0.524	rs881816	chr4:3365366	A/G	cg16987761	chr4:3318072	RGS12	1.0	11.56	0.79	1.41e-18	Serum sulfate level;
SKCM	cis	rs1218582	0.772	rs4845690	chr1:154886817	C/T	cg06221963	chr1:154839813	KCNN3	0.59	5.97	0.56	6.76e-8	Prostate cancer;
SKCM	cis	rs36051895	0.659	rs7045491	chr9:5045658	G/A	cg02405213	chr9:5042618	JAK2	-0.65	-5.2	-0.51	1.57e-6	Pediatric autoimmune diseases;
SKCM	cis	rs6570726	0.935	rs1883406	chr6:145823205	A/G	cg23711669	chr6:146136114	FBXO30	0.7	6.64	0.6	3.72e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9888736	0.647	rs11638216	chr15:47925944	A/G	cg10864878	chr15:47477004	NA	0.6	4.87	0.48	5.63e-6	Body mass index;
SKCM	cis	rs2811415	0.597	rs3774797	chr3:127772793	G/A	cg09089421	chr3:127803668	RUVBL1	1.01	8.79	0.71	2.72e-13	Lung function (FEV1/FVC);
SKCM	cis	rs28785552	0.931	rs8113078	chr19:53239084	T/G	cg10871876	chr19:53194124	ZNF83	0.8	6.08	0.57	4.25e-8	Response to paliperidone in schizophrenia (PANSS score);
SKCM	cis	rs4803468	1.000	rs166925	chr19:41926098	T/C	cg14132834	chr19:41945861	ATP5SL	-0.77	-6.04	-0.56	4.87e-8	Height;
SKCM	cis	rs1298637	0.664	rs12032358	chr1:53891296	G/A	cg09586583	chr1:54755153	SSBP3	0.55	5.2	0.51	1.56e-6	Nicotine use;
SKCM	cis	rs3820068	0.581	rs72645895	chr1:15931709	G/A	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs708547	0.647	rs2293175	chr4:57861358	C/T	cg16868167	chr4:57843880	C4orf14;POLR2B	0.9	8.48	0.69	1.12e-12	Response to bleomycin (chromatid breaks);
SKCM	cis	rs959260	0.557	rs12946365	chr17:73317644	C/T	cg14668889	chr17:73230827	NUP85	-0.75	-6.29	-0.58	1.72e-8	Systemic lupus erythematosus;
SKCM	cis	rs9911578	0.967	rs4598970	chr17:57076893	T/A	cg12560992	chr17:57184187	TRIM37	-1.09	-10.28	-0.76	3.61e-16	Intelligence (multi-trait analysis);
SKCM	trans	rs561341	0.505	rs28708703	chr17:30386845	C/G	cg20587970	chr11:113659929	NA	-1.12	-9.6	-0.74	7.46e-15	Hip circumference adjusted for BMI;
SKCM	cis	rs362272	0.524	rs2857982	chr4:3358665	G/A	cg03043834	chr4:3319541	RGS12	0.59	4.85	0.48	6.17e-6	Serum sulfate level;
SKCM	cis	rs4727027	0.704	rs2269972	chr7:148914047	C/T	cg23583168	chr7:148888333	NA	0.74	5.77	0.55	1.53e-7	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs992157	0.735	rs13392177	chr2:219112956	C/T	cg00012203	chr2:219082015	ARPC2	-0.84	-7.31	-0.64	2.02e-10	Colorectal cancer;
SKCM	cis	rs28735056	0.620	rs12456484	chr18:77677315	C/G	cg20368463	chr18:77673604	PQLC1	0.67	5.12	0.5	2.11e-6	Schizophrenia;
SKCM	cis	rs2228479	1.000	rs4257207	chr16:89947861	T/A	cg06558623	chr16:89946397	TCF25	1.12	5.64	0.54	2.58e-7	Skin colour saturation;
SKCM	cis	rs7772486	0.846	rs2748499	chr6:146315002	T/C	cg23711669	chr6:146136114	FBXO30	0.76	7.07	0.62	5.8e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6570726	0.620	rs367693	chr6:145815949	G/A	cg23711669	chr6:146136114	FBXO30	0.8	7.12	0.63	4.74e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs3892630	0.588	rs7260037	chr19:33242701	G/A	cg22980127	chr19:33182716	NUDT19	1.47	8.62	0.7	5.94e-13	Red blood cell traits;
SKCM	cis	rs473651	0.503	rs515342	chr2:239367296	A/G	cg21699342	chr2:239360505	ASB1	-0.59	-4.86	-0.48	5.93e-6	Multiple system atrophy;
SKCM	cis	rs4689592	0.554	rs3951346	chr4:7073321	C/T	cg19539972	chr4:7069911	GRPEL1	0.99	7.03	0.62	7.06e-10	Monocyte percentage of white cells;
SKCM	cis	rs13256369	1.000	rs10103769	chr8:8573036	G/T	cg06636001	chr8:8085503	FLJ10661	0.74	5.69	0.54	2.15e-7	Obesity-related traits;
SKCM	cis	rs1912528	0.814	rs35319653	chr4:140903155	C/T	cg11128457	chr4:140864437	MAML3	0.58	4.91	0.49	4.83e-6	Educational attainment (years of education);
SKCM	cis	rs748404	0.650	rs518234	chr15:43573421	G/A	cg02155558	chr15:43621948	ADAL;LCMT2	0.72	6.07	0.57	4.3e-8	Lung cancer;
SKCM	cis	rs561341	0.700	rs6505266	chr17:30225813	G/A	cg00745463	chr17:30367425	LRRC37B	-0.82	-5.32	-0.52	9.81e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs950027	0.595	rs2486288	chr15:45712339	T/C	cg10760299	chr15:45669010	GATM	0.57	5.42	0.52	6.44e-7	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs7408868	1.000	rs2074617	chr19:15276055	C/G	cg14696996	chr19:15285081	NOTCH3	0.82	4.92	0.49	4.7e-6	Pulse pressure;
SKCM	cis	rs8014204	0.869	rs2070599	chr14:75361177	C/G	cg06637938	chr14:75390232	RPS6KL1	-0.84	-6.17	-0.57	2.87e-8	Caffeine consumption;
SKCM	cis	rs3780486	0.846	rs7864705	chr9:33140352	A/C	cg13443165	chr9:33130375	B4GALT1	-0.56	-5.14	-0.5	1.95e-6	IgG glycosylation;
SKCM	cis	rs801193	0.636	rs2659895	chr7:66196471	C/A	cg18876405	chr7:65276391	NA	0.66	6.49	0.59	7.13e-9	Aortic root size;
SKCM	cis	rs7635838	0.684	rs2606762	chr3:11343889	G/C	cg00170343	chr3:11313890	ATG7	0.72	5.5	0.53	4.68e-7	HDL cholesterol;
SKCM	cis	rs362296	0.698	rs362279	chr4:3260072	G/A	cg09735869	chr4:3319127	RGS12	-0.83	-7.27	-0.64	2.38e-10	Parental longevity (mother's age at death);
SKCM	cis	rs6570726	0.791	rs385729	chr6:145855465	T/C	cg23711669	chr6:146136114	FBXO30	0.85	8.86	0.71	1.97e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs8017423	0.607	rs10142482	chr14:90848280	G/T	cg04374321	chr14:90722782	PSMC1	-0.65	-4.89	-0.48	5.2e-6	Mortality in heart failure;
SKCM	cis	rs9325144	0.723	rs10161183	chr12:39182087	T/C	cg13010199	chr12:38710504	ALG10B	-0.58	-4.78	-0.48	8.04e-6	Morning vs. evening chronotype;
SKCM	cis	rs7772486	0.641	rs2253757	chr6:146199686	C/T	cg05347473	chr6:146136440	FBXO30	0.68	6.17	0.57	2.78e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4862750	0.872	rs6553030	chr4:187899234	T/C	cg10295955	chr4:187884368	NA	-1.04	-13.97	-0.85	6.27e-23	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs10256972	0.713	rs10435026	chr7:1065948	A/G	cg16145915	chr7:1198662	ZFAND2A	-0.45	-5.49	-0.53	4.84e-7	Longevity;Endometriosis;
SKCM	cis	rs10779751	1.000	rs7525957	chr1:11318236	C/T	cg08854313	chr1:11322531	MTOR	0.94	7.36	0.64	1.6e-10	Body mass index;
SKCM	cis	rs2180341	0.920	rs9398836	chr6:127576497	T/G	cg27446573	chr6:127587934	RNF146	1.02	9.19	0.72	4.58e-14	Breast cancer;
SKCM	cis	rs7584330	0.737	rs1497128	chr2:238369211	A/G	cg14458575	chr2:238380390	NA	0.84	6.04	0.56	5e-8	Prostate cancer;
SKCM	cis	rs2033711	0.840	rs4801590	chr19:58961813	G/C	cg12042659	chr19:58951599	ZNF132	0.67	5.92	0.56	8.02e-8	Uric acid clearance;
SKCM	cis	rs6951245	0.706	rs28483034	chr7:1170171	C/A	cg23708337	chr7:1209742	NA	0.87	5.34	0.52	8.89e-7	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs11098499	0.738	rs34566984	chr4:120361270	G/A	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs8077889	0.957	rs17742929	chr17:41891437	C/T	cg26893861	chr17:41843967	DUSP3	1.17	6.84	0.61	1.56e-9	Triglycerides;
SKCM	cis	rs7772486	0.686	rs6570705	chr6:145961201	C/T	cg05347473	chr6:146136440	FBXO30	0.57	5.19	0.51	1.61e-6	Lobe attachment (rater-scored or self-reported);
SKCM	trans	rs561341	0.843	rs879944	chr17:30242803	A/G	cg20587970	chr11:113659929	NA	-1.03	-8.22	-0.68	3.56e-12	Hip circumference adjusted for BMI;
SKCM	cis	rs11098499	0.865	rs3956464	chr4:120256764	T/C	cg09307838	chr4:120376055	NA	0.93	7.53	0.65	7.72e-11	Corneal astigmatism;
SKCM	cis	rs10752881	1.000	rs4593781	chr1:182984983	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.73	6.47	0.59	7.97e-9	Colorectal cancer;
SKCM	cis	rs1799949	1.000	rs35668327	chr17:41273095	G/A	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.01	-0.56	5.5e-8	Menopause (age at onset);
SKCM	cis	rs7143963	0.945	rs2295402	chr14:103338324	T/A	cg23020514	chr14:103360112	TRAF3	0.85	8.63	0.7	5.56e-13	Body mass index;
SKCM	cis	rs7772486	0.686	rs9373473	chr6:146082282	A/G	cg23711669	chr6:146136114	FBXO30	0.78	7.7	0.66	3.62e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs62238980	0.614	rs117826138	chr22:32398149	T/C	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs7666738	0.830	rs28444709	chr4:99028496	A/T	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2228479	0.717	rs1007932	chr16:89838541	C/T	cg00800038	chr16:89945340	TCF25	-0.93	-4.93	-0.49	4.54e-6	Skin colour saturation;
SKCM	cis	rs11785400	1.000	rs4327844	chr8:143733540	C/T	cg20003893	chr8:144489567	NA	0.57	5.13	0.5	2.1e-6	Schizophrenia;
SKCM	cis	rs9894429	1.000	rs7503679	chr17:79583843	G/C	cg18240062	chr17:79603768	NPLOC4	0.76	7.43	0.64	1.2e-10	Eye color traits;
SKCM	cis	rs2072499	0.966	rs2842869	chr1:156160696	A/G	cg24450063	chr1:156163899	SLC25A44	1.11	10.97	0.78	1.78e-17	Testicular germ cell tumor;
SKCM	cis	rs6933660	0.610	rs71549125	chr6:151770796	A/C	cg14416726	chr6:151773293	C6orf211;RMND1	-0.65	-5.21	-0.51	1.48e-6	Menarche (age at onset);
SKCM	cis	rs10911251	0.508	rs10797854	chr1:183106739	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.78	7.57	0.65	6.46e-11	Colorectal cancer;
SKCM	cis	rs950027	0.620	rs2461700	chr15:45640627	T/C	cg10760299	chr15:45669010	GATM	0.53	5.42	0.52	6.45e-7	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs9788333	0.788	rs35007728	chr13:21893221	G/C	cg23743428	chr13:21893420	NA	-0.46	-4.9	-0.49	5e-6	Thiazide-induced adverse metabolic effects in hypertensive patients;
SKCM	cis	rs870825	0.616	rs7659201	chr4:185632013	G/A	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs10504229	0.683	rs11774697	chr8:58133119	G/A	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs11098499	0.909	rs10017335	chr4:120381523	C/G	cg24375607	chr4:120327624	NA	-0.67	-5.45	-0.53	5.66e-7	Corneal astigmatism;
SKCM	cis	rs10503709	0.542	rs10112641	chr8:21445878	C/T	cg23716449	chr8:21608280	GFRA2	-0.48	-4.81	-0.48	7.25e-6	Blood protein levels;
SKCM	cis	rs6582630	0.519	rs11181998	chr12:38439970	C/A	cg26384229	chr12:38710491	ALG10B	0.82	6.3	0.58	1.6e-8	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs7811142	1.000	rs6953107	chr7:100095664	C/T	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.25	0.68	3.05e-12	Platelet count;
SKCM	cis	rs4865169	0.560	rs1277312	chr4:57902945	T/A	cg16868167	chr4:57843880	C4orf14;POLR2B	0.64	4.99	0.49	3.65e-6	Breast cancer;
SKCM	cis	rs4689592	0.554	rs3951346	chr4:7073321	C/T	cg26116260	chr4:7069785	GRPEL1	1.21	9.82	0.74	2.82e-15	Monocyte percentage of white cells;
SKCM	cis	rs651907	0.557	rs17411983	chr3:101399126	A/G	cg03837452	chr3:101395095	ZBTB11;LOC100009676	-0.81	-7.06	-0.62	6.11e-10	Colorectal cancer;
SKCM	cis	rs6952808	0.929	rs34145223	chr7:1926237	G/A	cg05863683	chr7:1912471	MAD1L1	0.64	5.76	0.55	1.61e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs2836950	0.585	rs1029004	chr21:40615343	A/G	cg11890956	chr21:40555474	PSMG1	-0.66	-5.26	-0.51	1.22e-6	Menarche (age at onset);
SKCM	cis	rs7216064	0.953	rs11871285	chr17:65840809	G/T	cg12091567	chr17:66097778	LOC651250	-0.77	-5.53	-0.53	4.06e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs17065868	1.000	rs9533911	chr13:45138096	C/A	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs17685	0.672	rs56343450	chr7:75796235	C/T	cg01364799	chr7:75623366	TMEM120A	-0.7	-5.84	-0.55	1.16e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs6088590	0.735	rs6060001	chr20:33294353	C/T	cg24642439	chr20:33292090	TP53INP2	-0.8	-5.93	-0.56	7.7e-8	Coronary artery disease;
SKCM	cis	rs1971762	0.583	rs12319789	chr12:54090450	G/C	cg16917193	chr12:54089295	NA	0.6	5.03	0.49	3.05e-6	Height;
SKCM	cis	rs2153535	0.580	rs9328486	chr6:8528008	T/C	cg07606381	chr6:8435919	SLC35B3	0.93	6.8	0.61	1.92e-9	Motion sickness;
SKCM	cis	rs10900020	1.000	rs10900020	chr10:44827197	A/T	cg25956097	chr10:44163499	NA	-0.88	-4.94	-0.49	4.38e-6	Schizophrenia;
SKCM	cis	rs4555082	0.957	rs2816609	chr14:105720803	A/C	cg13114125	chr14:105738426	BRF1	-0.74	-5.39	-0.52	7.2e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs6087990	0.806	rs6088008	chr20:31382860	A/G	cg13636640	chr20:31349939	DNMT3B	0.92	8.06	0.67	7.3e-12	Ulcerative colitis;
SKCM	trans	rs66573146	0.808	rs55942328	chr4:6990960	T/G	cg07817883	chr1:32538562	TMEM39B	1.94	8.42	0.69	1.47e-12	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs9430161	0.564	rs12081176	chr1:11034145	T/C	cg02454025	chr1:11042201	C1orf127	1.08	10.13	0.75	7.19e-16	Ewing sarcoma;
SKCM	cis	rs9303401	0.659	rs35539277	chr17:56853833	G/A	cg10487724	chr17:56770010	TEX14;RAD51C	0.85	6.03	0.56	5.18e-8	Cognitive test performance;
SKCM	cis	rs4689592	0.503	rs66885632	chr4:7053738	T/C	cg26116260	chr4:7069785	GRPEL1	-1.07	-7.29	-0.64	2.24e-10	Monocyte percentage of white cells;
SKCM	cis	rs10769945	0.679	rs7102920	chr11:1917872	C/T	cg23202291	chr11:1979235	NA	0.56	5.68	0.54	2.2e-7	DNA methylation (variation);
SKCM	cis	rs12142240	0.628	rs56126529	chr1:46808860	C/T	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs933688	0.938	rs6869048	chr5:90664322	G/C	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.96	6.57	0.6	5.08e-9	Smoking behavior;
SKCM	cis	rs10779751	0.881	rs2744820	chr1:11365015	G/A	cg08854313	chr1:11322531	MTOR	-0.86	-6.78	-0.61	2.06e-9	Body mass index;
SKCM	cis	rs1218582	0.772	rs10796934	chr1:154849479	C/G	cg06221963	chr1:154839813	KCNN3	-0.59	-5.99	-0.56	6.03e-8	Prostate cancer;
SKCM	cis	rs6835098	0.962	rs4419455	chr4:174083622	C/T	cg08422745	chr4:174089978	GALNT7	0.88	6.74	0.61	2.46e-9	Dementia and core Alzheimer's disease neuropathologic changes;
SKCM	cis	rs778371	0.723	rs1973675	chr2:233636450	C/T	cg08000102	chr2:233561755	GIGYF2	-0.88	-7.43	-0.64	1.18e-10	Schizophrenia;
SKCM	cis	rs561341	1.000	rs72821971	chr17:30269343	T/G	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs1014246	0.826	rs11197801	chr10:118471693	C/T	cg14919929	chr10:118506882	NA	-0.76	-6.54	-0.6	5.79e-9	Age at smoking initiation in chronic obstructive pulmonary disease;
SKCM	cis	rs644799	0.544	rs1727165	chr11:95521648	A/G	cg03916912	chr11:95522834	CEP57;FAM76B	0.62	4.97	0.49	3.81e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs2050392	0.557	rs306588	chr10:30723593	G/A	cg25182066	chr10:30743637	MAP3K8	-0.65	-5.3	-0.51	1.05e-6	Inflammatory bowel disease;
SKCM	cis	rs4820539	1.000	rs756631	chr22:23463183	A/G	cg14186256	chr22:23484241	RTDR1	0.86	8.68	0.7	4.58e-13	Bone mineral density;
SKCM	cis	rs1552244	0.882	rs34706481	chr3:10004123	G/A	cg02579736	chr3:10068473	FANCD2;CIDECP	0.98	4.89	0.48	5.25e-6	Alzheimer's disease;
SKCM	cis	rs28595532	0.920	rs116739193	chr4:119771024	G/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs17065868	0.803	rs9533931	chr13:45211943	T/C	cg10246903	chr13:45222710	NA	0.95	5.35	0.52	8.5e-7	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs7772486	0.875	rs1331645	chr6:146398407	C/G	cg05347473	chr6:146136440	FBXO30	0.62	5.43	0.52	6.17e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs798766	1.000	rs7682402	chr4:1743343	G/A	cg24239225	chr4:1659016	FAM53A	-0.72	-4.87	-0.48	5.66e-6	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs10504229	1.000	rs72652906	chr8:58188360	C/A	cg22535103	chr8:58192502	C8orf71	-0.7	-5.02	-0.49	3.18e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs826838	1.000	rs11168217	chr12:38884278	T/C	cg13010199	chr12:38710504	ALG10B	0.84	6.66	0.6	3.54e-9	Heart rate;
SKCM	cis	rs1801251	0.711	rs2592117	chr2:233735693	C/T	cg25237894	chr2:233734115	C2orf82	-0.59	-6.34	-0.58	1.36e-8	Coronary artery disease;
SKCM	cis	rs782590	0.902	rs782602	chr2:55849309	A/G	cg18811423	chr2:55921094	PNPT1	0.87	6.86	0.61	1.46e-9	Metabolic syndrome;
SKCM	cis	rs116095464	0.558	rs9654453	chr5:299621	T/C	cg22857025	chr5:266934	NA	-1.61	-7.96	-0.67	1.11e-11	Breast cancer;
SKCM	cis	rs763014	0.898	rs2384978	chr16:625384	T/C	cg00908189	chr16:619842	PIGQ	0.81	7.2	0.63	3.3e-10	Height;
SKCM	cis	rs2836974	0.666	rs2836975	chr21:40663620	A/G	cg11644478	chr21:40555479	PSMG1	-0.69	-6.11	-0.57	3.59e-8	Cognitive function;
SKCM	cis	rs1325195	0.537	rs2793804	chr1:179201000	C/T	cg26328954	chr1:179557513	NA	0.49	5.05	0.5	2.82e-6	IgE grass sensitization;
SKCM	cis	rs5760092	0.755	rs915589	chr22:24261004	C/T	cg04234412	chr22:24373322	LOC391322	0.76	5.92	0.56	8.01e-8	Urinary 1,3-butadiene metabolite levels in smokers;
SKCM	cis	rs7772486	0.686	rs9403739	chr6:146015357	A/G	cg05347473	chr6:146136440	FBXO30	-0.61	-5.42	-0.52	6.32e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs12044355	0.929	rs11122322	chr1:231843962	G/T	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	-0.78	-6.21	-0.58	2.4e-8	Alzheimer's disease;
SKCM	cis	rs4746818	1.000	rs7916991	chr10:70895373	C/A	cg11621586	chr10:70884670	VPS26A	0.94	5.61	0.54	2.95e-7	Left atrial antero-posterior diameter;
SKCM	cis	rs1799949	0.931	rs34474989	chr17:41445410	A/T	cg05368731	chr17:41323189	NBR1	0.92	7.26	0.63	2.56e-10	Menopause (age at onset);
SKCM	cis	rs12044355	0.929	rs6696914	chr1:231853480	G/A	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	0.76	5.49	0.53	4.81e-7	Alzheimer's disease;
SKCM	cis	rs1461503	0.966	rs10790545	chr11:122838350	G/C	cg27398637	chr11:122830231	C11orf63	-0.63	-4.8	-0.48	7.54e-6	Menarche (age at onset);
SKCM	cis	rs2599510	0.811	rs2710615	chr2:32791222	A/T	cg02381751	chr2:32503542	YIPF4	0.78	6.0	0.56	5.94e-8	Interleukin-18 levels;
SKCM	trans	rs61776290	0.764	rs481453	chr1:10672935	A/G	cg14144564	chr19:12405570	ZNF44	1.12	7.36	0.64	1.63e-10	Alcohol dependence (age at onset);
SKCM	cis	rs67460515	0.630	rs7638370	chr3:160921793	G/T	cg03342759	chr3:160939853	NMD3	-0.72	-6.14	-0.57	3.19e-8	Parkinson's disease;
SKCM	cis	rs67311347	0.955	rs12487955	chr3:40412853	T/C	cg00091569	chr3:40428383	ENTPD3	0.64	5.35	0.52	8.54e-7	Renal cell carcinoma;
SKCM	cis	rs6547741	1.000	rs6547740	chr2:27854369	C/T	cg27432699	chr2:27873401	GPN1	0.74	6.78	0.61	2.08e-9	Oral cavity cancer;
SKCM	cis	rs17376456	0.877	rs7701011	chr5:93311456	G/A	cg21475434	chr5:93447410	FAM172A	1.04	5.55	0.53	3.82e-7	Diabetic retinopathy;
SKCM	cis	rs2153535	0.580	rs7748455	chr6:8453625	C/T	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs9611565	0.659	rs56364401	chr22:41951243	T/G	cg03806693	chr22:41940476	POLR3H	-1.13	-7.48	-0.65	9.6e-11	Vitiligo;
SKCM	cis	rs16866061	1.000	rs17480230	chr2:225399864	G/A	cg12698349	chr2:225449008	CUL3	1.01	8.51	0.69	9.75e-13	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs9914544	0.628	rs9908821	chr17:18679404	A/G	cg26306683	chr17:18585705	ZNF286B	0.64	4.88	0.48	5.59e-6	Educational attainment (years of education);
SKCM	cis	rs2243480	1.000	rs778691	chr7:65873092	G/C	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs2204008	0.580	rs11520047	chr12:38051778	T/A	cg26384229	chr12:38710491	ALG10B	0.81	6.45	0.59	8.61e-9	Bladder cancer;
SKCM	trans	rs1814175	0.647	rs28456013	chr11:50047629	T/C	cg15704280	chr7:45808275	SEPT13	-0.84	-8.02	-0.67	8.61e-12	Height;
SKCM	cis	rs7647973	0.769	rs11130181	chr3:49109919	G/A	cg07636037	chr3:49044803	WDR6	0.97	7.24	0.63	2.76e-10	Menarche (age at onset);
SKCM	cis	rs7772486	0.840	rs2814867	chr6:146334030	C/A	cg23711669	chr6:146136114	FBXO30	0.76	7.15	0.63	4.1e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9788682	1.000	rs61204066	chr15:78815298	G/A	cg24631222	chr15:78858424	CHRNA5	0.94	6.59	0.6	4.67e-9	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs7937682	0.883	rs1612013	chr11:111456293	A/G	cg19812747	chr11:111475976	SIK2	-0.59	-4.86	-0.48	6.06e-6	Primary sclerosing cholangitis;
SKCM	cis	rs6951245	0.935	rs76525951	chr7:1096013	C/T	cg24642844	chr7:1081250	C7orf50	-0.93	-6.22	-0.58	2.28e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs6977660	0.660	rs12531278	chr7:19816439	A/T	cg05791153	chr7:19748676	TWISTNB	0.77	5.02	0.49	3.23e-6	Thyroid stimulating hormone;
SKCM	cis	rs7824557	0.564	rs4631424	chr8:11236809	T/C	cg21775007	chr8:11205619	TDH	-0.59	-5.03	-0.5	3.01e-6	Retinal vascular caliber;
SKCM	cis	rs34779708	0.766	rs35308730	chr10:35549796	C/T	cg03585969	chr10:35415529	CREM	0.73	5.25	0.51	1.3e-6	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs28386778	0.897	rs2584635	chr17:61865934	A/G	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs7937682	1.000	rs11213973	chr11:111538903	A/T	cg09085632	chr11:111637200	PPP2R1B	-1.03	-11.65	-0.8	9.4e-19	Primary sclerosing cholangitis;
SKCM	cis	rs3784262	0.967	rs11630835	chr15:58269462	C/T	cg12031962	chr15:58353849	ALDH1A2	-0.51	-6.6	-0.6	4.46e-9	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs7100689	0.622	rs10749595	chr10:82172975	C/T	cg01528321	chr10:82214614	TSPAN14	0.92	9.06	0.72	8.17e-14	Post bronchodilator FEV1;
SKCM	cis	rs8072100	0.688	rs12602134	chr17:45582136	C/G	cg25173405	chr17:45401733	C17orf57	0.57	5.02	0.49	3.16e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs55794721	0.509	rs6699113	chr1:25777743	C/T	cg02931644	chr1:25747376	RHCE	0.5	4.9	0.48	5.17e-6	Plateletcrit;Mean corpuscular volume;
SKCM	cis	rs9674544	0.757	rs4410130	chr17:47122942	C/T	cg11673840	chr17:47092156	IGF2BP1	0.52	5.04	0.5	2.96e-6	Primary tooth development (time to first tooth eruption);Primary tooth development (number of teeth);
SKCM	cis	rs17345786	0.906	rs72944107	chr3:101197190	C/T	cg12386194	chr3:101231763	SENP7	0.76	5.58	0.53	3.35e-7	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs13256369	0.802	rs11249887	chr8:8562184	T/C	cg06636001	chr8:8085503	FLJ10661	0.8	6.11	0.57	3.65e-8	Obesity-related traits;
SKCM	cis	rs2839186	0.588	rs2839140	chr21:47616080	G/A	cg11766577	chr21:47581405	C21orf56	0.78	6.92	0.62	1.14e-9	Testicular germ cell tumor;
SKCM	cis	rs1799949	0.965	rs11650913	chr17:41331597	T/C	cg05368731	chr17:41323189	NBR1	0.87	7.74	0.66	3.01e-11	Menopause (age at onset);
SKCM	cis	rs3785574	0.962	rs13030	chr17:61908556	C/T	cg06601766	chr17:61851465	DDX42;CCDC47	0.73	5.38	0.52	7.7300000000000005e-07	Height;
SKCM	cis	rs801193	0.569	rs10950050	chr7:66239588	A/C	cg11987759	chr7:65425863	GUSB	-0.49	-4.8	-0.48	7.38e-6	Aortic root size;
SKCM	cis	rs7772486	0.590	rs1890170	chr6:146071839	G/C	cg05347473	chr6:146136440	FBXO30	-0.68	-6.19	-0.57	2.58e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9300255	0.739	rs6633	chr12:123745809	G/T	cg00376283	chr12:123451042	ABCB9	-0.82	-5.73	-0.54	1.83e-7	Neutrophil percentage of white cells;
SKCM	cis	rs763014	0.966	rs4984677	chr16:671682	A/G	cg07343612	chr16:622815	PIGQ	-0.69	-5.84	-0.55	1.15e-7	Height;
SKCM	cis	rs7666738	0.830	rs890470	chr4:98923435	A/C	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6570726	0.791	rs387376	chr6:145822565	T/C	cg05347473	chr6:146136440	FBXO30	0.53	4.78	0.48	8.07e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2295499	0.678	rs12503560	chr4:2714482	T/C	cg19433769	chr4:2420260	ZFYVE28	0.69	4.77	0.48	8.44e-6	Cognitive ability;Cognitive ability (multi-trait analysis);Intelligence (multi-trait analysis);
SKCM	cis	rs7618915	0.547	rs2164884	chr3:52629633	C/T	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs2286503	0.780	rs1304431	chr7:22865412	T/C	cg15401507	chr7:22894281	NA	-0.55	-4.97	-0.49	3.88e-6	Fibrinogen;
SKCM	cis	rs2180341	0.782	rs6912006	chr6:127722631	C/T	cg27446573	chr6:127587934	RNF146	0.68	5.31	0.52	9.99e-7	Breast cancer;
SKCM	cis	rs651907	1.000	rs662792	chr3:101599608	T/C	cg12386194	chr3:101231763	SENP7	0.63	4.91	0.49	4.83e-6	Colorectal cancer;
SKCM	cis	rs6087990	0.899	rs998382	chr20:31384136	C/T	cg13636640	chr20:31349939	DNMT3B	-0.94	-8.53	-0.69	8.87e-13	Ulcerative colitis;
SKCM	cis	rs394563	0.591	rs237028	chr6:149718650	C/T	cg03678062	chr6:149772716	ZC3H12D	-0.5	-5.91	-0.56	8.69e-8	Dupuytren's disease;
SKCM	cis	rs2777491	1.000	rs316613	chr15:41747598	G/A	cg18705301	chr15:41695430	NDUFAF1	-0.89	-9.04	-0.72	9.17e-14	Ulcerative colitis;
SKCM	cis	rs208520	0.909	rs62414639	chr6:67023706	G/A	cg07460842	chr6:66804631	NA	0.82	5.4	0.52	7e-7	Exhaled nitric oxide output;
SKCM	cis	rs9303401	0.659	rs17822807	chr17:56687190	A/C	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.31	0.51	1.02e-6	Cognitive test performance;
SKCM	cis	rs1476670	1.000	rs1476670	chr1:44508195	A/C	cg09470012	chr1:44509516	NA	0.52	5.37	0.52	7.94e-7	Eotaxin levels;
SKCM	cis	rs7772486	0.875	rs1412081	chr6:146409733	A/G	cg23711669	chr6:146136114	FBXO30	0.86	8.52	0.69	9.39e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs17376456	0.877	rs10060462	chr5:93455073	C/T	cg25358565	chr5:93447407	FAM172A	1.23	7.97	0.67	1.08e-11	Diabetic retinopathy;
SKCM	cis	rs875971	1.000	rs10215948	chr7:65747786	G/A	cg18876405	chr7:65276391	NA	-0.68	-6.79	-0.61	1.94e-9	Aortic root size;
SKCM	cis	rs75804782	0.625	rs11889723	chr2:239471469	A/G	cg10769615	chr2:239990350	HDAC4	-0.92	-5.05	-0.5	2.82e-6	Morning vs. evening chronotype;Chronotype;
SKCM	trans	rs208520	0.661	rs7747492	chr6:66857788	A/T	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-1.07	-7.99	-0.67	9.73e-12	Exhaled nitric oxide output;
SKCM	cis	rs1405130	0.869	rs13019592	chr2:235565760	C/G	cg21542780	chr2:234763377	HJURP	-0.64	-4.89	-0.48	5.21e-6	Coronary artery disease;
SKCM	cis	rs362272	0.505	rs3129310	chr4:3301388	T/G	cg11471262	chr4:3318911	RGS12	0.96	11.6	0.8	1.2e-18	Serum sulfate level;
SKCM	cis	rs344364	0.511	rs2982455	chr16:1950498	T/G	cg26897989	chr16:1907736	C16orf73	-0.69	-7.13	-0.63	4.45e-10	Glomerular filtration rate in chronic kidney disease;
SKCM	cis	rs3816788	0.792	rs10097055	chr8:21872328	A/G	cg17168535	chr8:21777572	XPO7	0.87	7.33	0.64	1.88e-10	Lung cancer in ever smokers;
SKCM	cis	rs1577917	0.958	rs7453105	chr6:86500761	A/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.38	-0.52	7.52e-7	Response to antipsychotic treatment;
SKCM	cis	rs13256369	0.802	rs2280560	chr8:8560602	C/T	cg06636001	chr8:8085503	FLJ10661	0.74	5.55	0.53	3.72e-7	Obesity-related traits;
SKCM	cis	rs6547741	0.967	rs4665986	chr2:27755168	G/A	cg27432699	chr2:27873401	GPN1	0.75	6.65	0.6	3.68e-9	Oral cavity cancer;
SKCM	cis	rs3785574	0.962	rs2665835	chr17:61903258	C/T	cg06601766	chr17:61851465	DDX42;CCDC47	0.73	5.38	0.52	7.7300000000000005e-07	Height;
SKCM	cis	rs35306767	0.855	rs11253465	chr10:897208	A/C	cg26597838	chr10:835615	NA	0.76	5.33	0.52	9.2e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs9910055	0.639	rs227583	chr17:42231698	C/G	cg19774624	chr17:42201019	HDAC5	-0.9	-8.49	-0.69	1.04e-12	Total body bone mineral density;
SKCM	cis	rs6570726	0.935	rs12663211	chr6:145818427	G/A	cg23711669	chr6:146136114	FBXO30	0.7	6.64	0.6	3.72e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6424115	0.830	rs6680132	chr1:24198804	T/C	cg15997130	chr1:24165203	NA	0.6	4.94	0.49	4.37e-6	Immature fraction of reticulocytes;
SKCM	cis	rs2033711	0.902	rs4801589	chr19:58953398	C/G	cg26874164	chr19:58962979	ZNF324B	0.63	5.22	0.51	1.47e-6	Uric acid clearance;
SKCM	cis	rs9325144	0.555	rs1813392	chr12:38692203	C/T	cg26384229	chr12:38710491	ALG10B	-0.79	-6.91	-0.62	1.17e-9	Morning vs. evening chronotype;
SKCM	cis	rs7646501	0.765	rs4356765	chr3:24052025	C/T	cg22892432	chr3:24537792	THRB	0.58	4.96	0.49	4.09e-6	Cognitive ability;Intelligence;
SKCM	cis	rs12497850	0.805	rs11130176	chr3:48844077	A/G	cg07636037	chr3:49044803	WDR6	0.97	10.25	0.76	4.16e-16	Parkinson's disease;
SKCM	cis	rs1065656	0.581	rs344353	chr16:1846636	C/G	cg26897989	chr16:1907736	C16orf73	0.74	7.2	0.63	3.25e-10	Insulin-like growth factors;
SKCM	cis	rs9815354	0.680	rs79211428	chr3:41921810	C/T	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs9790314	0.812	rs7631479	chr3:161139566	C/T	cg03342759	chr3:160939853	NMD3	-0.66	-6.53	-0.59	6.07e-9	Morning vs. evening chronotype;
SKCM	cis	rs6121246	0.865	rs6089055	chr20:30324045	C/T	cg11595048	chr20:30225325	COX4I2	0.67	5.21	0.51	1.5e-6	Mean corpuscular hemoglobin;
SKCM	trans	rs2727020	0.595	rs10769583	chr11:49483193	G/A	cg15704280	chr7:45808275	SEPT13	-0.98	-9.29	-0.72	2.93e-14	Coronary artery disease;
SKCM	cis	rs7212938	0.509	rs62068170	chr17:38103210	G/A	cg17467752	chr17:38218738	THRA	0.63	5.21	0.51	1.5e-6	Asthma and hay fever;
SKCM	cis	rs12497850	0.897	rs6446252	chr3:48911125	C/T	cg07636037	chr3:49044803	WDR6	1.0	10.63	0.77	8.01e-17	Parkinson's disease;
SKCM	cis	rs7945705	0.747	rs1980429	chr11:9010474	C/A	cg21881798	chr11:8931708	C11orf17;ST5	-0.84	-8.88	-0.71	1.84e-13	Hemoglobin concentration;
SKCM	cis	rs7829975	0.623	rs7010753	chr8:8373956	A/G	cg15556689	chr8:8085844	FLJ10661	0.69	5.33	0.52	9.15e-7	Mood instability;
SKCM	cis	rs2279817	0.863	rs2270976	chr1:18023690	A/G	cg17142039	chr1:18149651	ACTL8	0.58	4.88	0.48	5.6e-6	Neuroticism;
SKCM	cis	rs9913156	0.793	rs7210953	chr17:4608870	C/T	cg19197139	chr17:4613644	ARRB2	0.8	5.34	0.52	8.82e-7	Lymphocyte counts;
SKCM	cis	rs1426153	0.606	rs1365196	chr11:125158049	A/G	cg04366300	chr11:125157962	PKNOX2	-0.65	-4.8	-0.48	7.46e-6	Alcohol and nicotine co-dependence;
SKCM	cis	rs1568889	1.000	rs12797155	chr11:28290866	A/T	cg06544937	chr11:28130018	METT5D1;KIF18A	0.87	6.26	0.58	1.93e-8	Bipolar disorder;
SKCM	cis	rs2811415	0.597	rs6801215	chr3:127762336	C/T	cg09089421	chr3:127803668	RUVBL1	0.99	8.52	0.69	9.09e-13	Lung function (FEV1/FVC);
SKCM	cis	rs11098499	0.954	rs71614438	chr4:120371252	G/A	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs7833790	0.963	rs2400473	chr8:82703403	C/T	cg17211192	chr8:82754475	SNX16	-0.9	-4.89	-0.48	5.24e-6	Diastolic blood pressure;
SKCM	cis	rs28386778	0.724	rs35092235	chr17:61944621	T/C	cg01411255	chr17:61851458	DDX42;CCDC47	0.78	5.01	0.49	3.26e-6	Prudent dietary pattern;
SKCM	cis	rs9926296	0.546	rs7187436	chr16:89845110	A/T	cg07402062	chr16:89894098	SPIRE2	0.4	4.88	0.48	5.58e-6	Vitiligo;
SKCM	cis	rs9880211	0.800	rs36109616	chr3:136492403	G/A	cg21827317	chr3:136751795	NA	-0.74	-5.43	-0.52	6.11e-7	Body mass index;Height;
SKCM	cis	rs28386778	0.897	rs716880	chr17:61902822	C/G	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs7811142	0.830	rs11768967	chr7:99967644	G/A	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.07	6.7	0.6	2.88e-9	Platelet count;
SKCM	cis	rs72827839	0.748	rs72833470	chr17:45950721	A/G	cg23391107	chr17:45924227	SP6	0.76	6.9	0.62	1.2e-9	Ease of getting up in the morning;
SKCM	cis	rs4919694	1.000	rs77505796	chr10:104647774	A/T	cg04362960	chr10:104952993	NT5C2	0.79	4.95	0.49	4.22e-6	Arsenic metabolism;
SKCM	cis	rs9911578	1.000	rs2055779	chr17:57030561	A/G	cg05425664	chr17:57184151	TRIM37	-0.67	-5.04	-0.5	2.91e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9902453	0.967	rs9913074	chr17:28481199	T/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.5	0.53	4.74e-7	Coffee consumption (cups per day);
SKCM	cis	rs7927771	0.524	rs6485773	chr11:47763509	A/G	cg20307385	chr11:47447363	PSMC3	0.71	5.63	0.54	2.67e-7	Subjective well-being;
SKCM	cis	rs453301	0.653	rs7005133	chr8:8901222	T/G	cg15556689	chr8:8085844	FLJ10661	0.72	5.76	0.55	1.62e-7	Joint mobility (Beighton score);
SKCM	cis	rs12824058	0.831	rs4759655	chr12:130815740	A/G	cg24838063	chr12:130822603	PIWIL1	-0.78	-7.34	-0.64	1.74e-10	Menopause (age at onset);
SKCM	cis	rs992157	0.560	rs6436048	chr2:219109033	C/T	cg20019365	chr2:219134978	PNKD;AAMP	0.66	5.38	0.52	7.61e-7	Colorectal cancer;
SKCM	cis	rs7666738	0.791	rs1115615	chr4:99006614	G/A	cg05340658	chr4:99064831	C4orf37	0.66	5.07	0.5	2.64e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9682041	0.825	rs6785326	chr3:170095145	T/C	cg11886554	chr3:170076028	SKIL	0.93	5.5	0.53	4.62e-7	Glomerular filtration rate in non diabetics (creatinine);Glomerular filtration rate (creatinine);
SKCM	cis	rs7843479	0.931	rs1031883	chr8:21788936	G/A	cg17168535	chr8:21777572	XPO7	0.76	6.4	0.59	1.04e-8	Mean corpuscular volume;
SKCM	cis	rs2153535	0.580	rs2143355	chr6:8517856	T/A	cg07606381	chr6:8435919	SLC35B3	0.87	6.38	0.59	1.17e-8	Motion sickness;
SKCM	cis	rs8017423	0.967	rs59980414	chr14:90687738	G/C	cg04374321	chr14:90722782	PSMC1	1.0	8.88	0.71	1.88e-13	Mortality in heart failure;
SKCM	cis	rs7826238	0.535	rs2979179	chr8:8320029	C/T	cg06636001	chr8:8085503	FLJ10661	0.8	7.0	0.62	7.84e-10	Systolic blood pressure;
SKCM	cis	rs7584330	0.554	rs76408976	chr2:238384784	C/T	cg08992911	chr2:238395768	MLPH	0.94	4.9	0.48	5.18e-6	Prostate cancer;
SKCM	cis	rs362296	0.698	rs3135172	chr4:3258735	A/G	cg00764545	chr4:3318001	RGS12	-0.74	-6.48	-0.59	7.39e-9	Parental longevity (mother's age at death);
SKCM	cis	rs28386778	0.897	rs7222189	chr17:61836372	T/C	cg01411255	chr17:61851458	DDX42;CCDC47	0.78	5.03	0.49	3.06e-6	Prudent dietary pattern;
SKCM	cis	rs6952808	0.595	rs3778984	chr7:2166514	T/C	cg02951883	chr7:2050386	MAD1L1	-0.76	-6.91	-0.62	1.14e-9	Bipolar disorder and schizophrenia;
SKCM	cis	rs6570726	0.791	rs1280275	chr6:145892402	C/T	cg05347473	chr6:146136440	FBXO30	0.57	5.08	0.5	2.47e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9475752	0.793	rs17685380	chr6:56875789	T/G	cg06815302	chr6:57335405	PRIM2	0.7	5.13	0.5	2.09e-6	Menarche (age at onset);
SKCM	cis	rs7666738	0.830	rs2865951	chr4:99040191	C/T	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7829975	0.560	rs4841013	chr8:8552013	A/G	cg06636001	chr8:8085503	FLJ10661	-0.7	-5.1	-0.5	2.36e-6	Mood instability;
SKCM	cis	rs875971	1.000	rs12532998	chr7:65967459	A/C	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	trans	rs12599106	0.584	rs12929704	chr16:34898258	C/A	cg15383120	chr6:291909	DUSP22	-0.75	-7.54	-0.65	7.12e-11	Menopause (age at onset);
SKCM	trans	rs3780486	0.846	rs10738905	chr9:33123627	A/G	cg04842962	chr6:43655489	MRPS18A	1.03	11.27	0.79	4.92e-18	IgG glycosylation;
SKCM	cis	rs9611565	0.694	rs5758389	chr22:41941749	T/C	cg03806693	chr22:41940476	POLR3H	-0.83	-5.51	-0.53	4.43e-7	Vitiligo;
SKCM	cis	rs7772486	0.875	rs2777479	chr6:146309178	C/A	cg23711669	chr6:146136114	FBXO30	0.77	7.12	0.63	4.66e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2303759	0.626	rs12982246	chr19:49801169	A/G	cg05022225	chr19:49866942	DKKL1;TEAD2	0.74	5.4	0.52	7.07e-7	Multiple sclerosis;
SKCM	cis	rs870825	0.581	rs7675106	chr4:185652388	C/G	cg04058563	chr4:185651563	MLF1IP	-1.07	-7.16	-0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs9485372	0.838	rs4895781	chr6:149608126	A/G	cg03072286	chr6:150262044	ULBP2	-0.55	-4.89	-0.48	5.3e-6	Breast cancer;
SKCM	cis	rs75229567	0.618	rs11177819	chr12:70134836	T/G	cg10114359	chr12:70132523	RAB3IP	1.36	5.92	0.56	8.25e-8	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes;
SKCM	cis	rs28595532	0.841	rs55744948	chr4:119769243	T/C	cg14228332	chr4:119757509	SEC24D	1.1	5.22	0.51	1.44e-6	Cannabis dependence symptom count;
SKCM	cis	rs9894429	0.646	rs6565612	chr17:79602820	C/T	cg18240062	chr17:79603768	NPLOC4	-0.69	-5.96	-0.56	6.78e-8	Eye color traits;
SKCM	cis	rs3096299	0.658	rs4785679	chr16:89566113	G/T	cg02187348	chr16:89574699	SPG7	0.61	4.96	0.49	3.97e-6	Multiple myeloma (IgH translocation);
SKCM	cis	rs7927771	0.965	rs12364432	chr11:47902883	G/A	cg05585544	chr11:47624801	NA	-0.6	-5.23	-0.51	1.39e-6	Subjective well-being;
SKCM	cis	rs738321	0.757	rs2284062	chr22:38544221	A/G	cg25457927	chr22:38595422	NA	-0.58	-6.73	-0.61	2.6e-9	Breast cancer;
SKCM	cis	rs6545883	0.825	rs7578139	chr2:61564121	G/A	cg15711740	chr2:61764176	XPO1	0.68	4.82	0.48	6.94e-6	Tuberculosis;
SKCM	cis	rs6435862	0.593	rs34732883	chr2:215674371	C/T	cg04004882	chr2:215674386	BARD1	-0.82	-6.14	-0.57	3.26e-8	Neuroblastoma (high-risk);
SKCM	cis	rs10540	0.558	rs12806062	chr11:501429	G/A	cg03576123	chr11:487126	PTDSS2	-1.51	-8.42	-0.69	1.47e-12	Body mass index;
SKCM	cis	rs11098499	0.954	rs11734241	chr4:120416872	A/G	cg09307838	chr4:120376055	NA	0.99	8.1	0.68	6.11e-12	Corneal astigmatism;
SKCM	cis	rs8017423	0.935	rs7144335	chr14:90732280	A/G	cg04374321	chr14:90722782	PSMC1	-1.03	-9.53	-0.73	1.01e-14	Mortality in heart failure;
SKCM	cis	rs9611565	0.546	rs739134	chr22:42089623	T/C	cg03806693	chr22:41940476	POLR3H	1.11	6.82	0.61	1.74e-9	Vitiligo;
SKCM	cis	rs1552244	0.832	rs66597916	chr3:10195407	T/C	cg02579736	chr3:10068473	FANCD2;CIDECP	1.23	6.74	0.61	2.48e-9	Alzheimer's disease;
SKCM	cis	rs2836974	0.897	rs13047678	chr21:40708853	C/T	cg17971929	chr21:40555470	PSMG1	0.83	7.56	0.65	6.6e-11	Cognitive function;
SKCM	cis	rs1403694	0.515	rs710448	chr3:186452885	A/G	cg09332604	chr3:186435400	KNG1	-0.55	-5.52	-0.53	4.25e-7	Blood protein levels;
SKCM	cis	rs9311474	0.607	rs34005367	chr3:52558904	A/T	cg18404041	chr3:52824283	ITIH1	-0.55	-4.98	-0.49	3.8e-6	Electroencephalogram traits;
SKCM	cis	rs1801251	0.727	rs283482	chr2:233646920	A/T	cg08000102	chr2:233561755	GIGYF2	0.74	6.45	0.59	8.55e-9	Coronary artery disease;
SKCM	cis	rs912057	0.671	rs1294420	chr6:6742752	C/T	cg06612196	chr6:6737390	NA	0.67	5.71	0.54	1.97e-7	Waist-to-hip ratio adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);
SKCM	cis	rs28374715	0.681	rs28712264	chr15:41588797	T/C	cg18705301	chr15:41695430	NDUFAF1	-1.13	-12.2	-0.81	9.24e-20	Ulcerative colitis;
SKCM	cis	rs10256972	0.616	rs4585652	chr7:1145396	A/G	cg16145915	chr7:1198662	ZFAND2A	-0.58	-8.02	-0.67	8.77e-12	Longevity;Endometriosis;
SKCM	cis	rs8068544	0.818	rs79892925	chr17:40171819	A/G	cg18442075	chr17:40169520	DNAJC7;NKIRAS2	-1.37	-6.99	-0.62	8.4e-10	Reticulocyte fraction of red cells;Reticulocyte count;
SKCM	cis	rs7829975	0.714	rs6994038	chr8:8660538	C/A	cg06636001	chr8:8085503	FLJ10661	0.75	6.59	0.6	4.72e-9	Mood instability;
SKCM	cis	rs933688	0.818	rs10052492	chr5:90759930	T/A	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.04	8.0	0.67	9.48e-12	Smoking behavior;
SKCM	cis	rs7666738	0.791	rs1896155	chr4:99020948	C/A	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs950027	0.620	rs1145084	chr15:45675440	G/A	cg21132104	chr15:45694354	SPATA5L1	0.76	5.84	0.55	1.13e-7	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs1799949	1.000	rs33918839	chr17:41329172	T/C	cg05368731	chr17:41323189	NBR1	0.88	7.87	0.67	1.65e-11	Menopause (age at onset);
SKCM	cis	rs6062302	0.522	rs2297427	chr20:62221364	G/A	cg09650180	chr20:62225654	GMEB2	-0.79	-6.23	-0.58	2.2e-8	Glioblastoma;
SKCM	cis	rs514406	0.668	rs520281	chr1:53365235	G/C	cg04310824	chr1:53393297	SCP2	-0.6	-4.88	-0.48	5.44e-6	Monocyte count;
SKCM	cis	rs2072499	0.778	rs2247476	chr1:156190280	C/A	cg24450063	chr1:156163899	SLC25A44	0.82	6.01	0.56	5.64e-8	Testicular germ cell tumor;
SKCM	cis	rs72781680	1.000	rs72788278	chr2:24095285	A/C	cg08917208	chr2:24149416	ATAD2B	0.99	5.24	0.51	1.31e-6	Lymphocyte counts;
SKCM	cis	rs72781680	0.898	rs72798041	chr2:23953076	T/C	cg08917208	chr2:24149416	ATAD2B	0.96	4.79	0.48	7.67e-6	Lymphocyte counts;
SKCM	cis	rs7100689	0.646	rs1934694	chr10:82125325	G/A	cg01528321	chr10:82214614	TSPAN14	0.8	7.0	0.62	7.98e-10	Post bronchodilator FEV1;
SKCM	cis	rs975739	0.737	rs9544656	chr13:78550841	C/T	cg11801572	chr13:77601451	FBXL3	-0.75	-4.89	-0.48	5.37e-6	Hair color;
SKCM	trans	rs11083271	0.608	rs17463847	chr18:25856770	A/G	cg00321150	chr11:62623587	SNORD27;SLC3A2;SNHG1;SNORD28;SNORD25;SNORD26	0.8	7.63	0.65	4.88e-11	Non-alcoholic fatty liver disease histology (lobular);
SKCM	cis	rs17376456	1.000	rs34854140	chr5:93538169	G/A	cg21475434	chr5:93447410	FAM172A	0.99	5.65	0.54	2.49e-7	Diabetic retinopathy;
SKCM	cis	rs7772486	0.790	rs1062068	chr6:146207465	A/G	cg23711669	chr6:146136114	FBXO30	0.75	7.51	0.65	8.38e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs908922	0.676	rs1337340	chr1:152508260	T/C	cg09873164	chr1:152488093	CRCT1	0.76	5.93	0.56	7.7e-8	Hair morphology;
SKCM	cis	rs2153535	0.601	rs718504	chr6:8527512	A/G	cg07606381	chr6:8435919	SLC35B3	0.93	6.8	0.61	1.92e-9	Motion sickness;
SKCM	cis	rs208520	0.690	rs12208310	chr6:66730108	G/C	cg07460842	chr6:66804631	NA	0.92	7.49	0.65	8.93e-11	Exhaled nitric oxide output;
SKCM	cis	rs514406	0.825	rs6693210	chr1:53223398	A/G	cg16325326	chr1:53192061	ZYG11B	-0.99	-11.08	-0.78	1.12e-17	Monocyte count;
SKCM	cis	rs72634258	0.945	rs35675666	chr1:8021973	G/T	cg00042356	chr1:8021962	PARK7	1.04	7.35	0.64	1.67e-10	Inflammatory bowel disease;
SKCM	trans	rs312274	0.546	rs11178979	chr12:41299357	A/G	cg13470333	chr7:1908714	MAD1L1	-0.65	-7.28	-0.64	2.28e-10	Metabolite levels  (X-11787);
SKCM	cis	rs2841277	0.646	rs2819419	chr14:105406238	A/C	cg21017887	chr14:105400489	NA	0.58	5.36	0.52	8.24e-7	Rheumatoid arthritis;
SKCM	cis	rs2228479	0.764	rs11641201	chr16:89983276	T/C	cg06558623	chr16:89946397	TCF25	1.23	6.8	0.61	1.86e-9	Skin colour saturation;
SKCM	cis	rs6500395	0.962	rs1115759	chr16:48599530	A/G	cg04672837	chr16:48644449	N4BP1	0.69	5.73	0.54	1.8e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs7772486	0.846	rs2144478	chr6:146381445	A/G	cg05347473	chr6:146136440	FBXO30	0.63	5.7	0.54	2.05e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7927771	0.832	rs10769262	chr11:47411581	G/A	cg05585544	chr11:47624801	NA	0.57	4.92	0.49	4.76e-6	Subjective well-being;
SKCM	cis	rs1153858	1.000	rs1153858	chr15:45652703	A/G	cg10760299	chr15:45669010	GATM	-0.63	-6.32	-0.58	1.49e-8	Homoarginine levels;
SKCM	cis	rs9880211	1.000	rs28641809	chr3:136290489	G/A	cg21827317	chr3:136751795	NA	-0.65	-4.92	-0.49	4.73e-6	Body mass index;Height;
SKCM	cis	rs7811142	1.000	rs11761784	chr7:100039970	C/T	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.17	7.71	0.66	3.44e-11	Platelet count;
SKCM	cis	rs826838	0.967	rs11168985	chr12:39045983	A/C	cg13010199	chr12:38710504	ALG10B	-0.74	-5.79	-0.55	1.42e-7	Heart rate;
SKCM	cis	rs2072499	0.750	rs55910626	chr1:156159909	C/G	cg25208724	chr1:156163844	SLC25A44	0.89	6.31	0.58	1.55e-8	Testicular germ cell tumor;
SKCM	trans	rs208520	0.633	rs79679034	chr6:66701724	A/C	cg15611600	chr13:45563400	KIAA1704;NUFIP1	1.01	8.43	0.69	1.41e-12	Exhaled nitric oxide output;
SKCM	cis	rs4975616	0.804	rs457130	chr5:1336178	A/T	cg26373071	chr5:1325741	CLPTM1L	0.68	5.7	0.54	2.02e-7	Lung cancer;
SKCM	cis	rs12478296	0.681	rs73007114	chr2:242984903	T/C	cg06360820	chr2:242988706	NA	-1.04	-5.67	-0.54	2.29e-7	Obesity-related traits;
SKCM	cis	rs4900538	0.855	rs72698597	chr14:102868633	C/T	cg18135206	chr14:102964638	TECPR2	-0.71	-5.36	-0.52	8.09e-7	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs1843834	0.539	rs6739735	chr2:225405253	A/G	cg12698349	chr2:225449008	CUL3	-0.86	-6.98	-0.62	8.42e-10	IgE levels in asthmatics (D.p. specific);
SKCM	cis	rs10504229	0.639	rs56825757	chr8:58106469	A/G	cg02725872	chr8:58115012	NA	-0.53	-4.91	-0.49	4.82e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs9660180	0.967	rs6603803	chr1:1812688	A/G	cg17747265	chr1:1875780	NA	-0.62	-5.77	-0.55	1.51e-7	Body mass index;
SKCM	cis	rs1707322	0.717	rs3014249	chr1:46079493	A/G	cg03146154	chr1:46216737	IPP	-0.79	-5.42	-0.52	6.34e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7208859	0.623	rs7503335	chr17:29073962	G/A	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs7618915	0.547	rs11130315	chr3:52697163	A/G	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs9814567	1.000	rs2056603	chr3:134312749	T/C	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs2304069	0.954	rs216125	chr5:149428395	C/G	cg22760475	chr5:149380129	HMGXB3;TIGD6	0.9	6.11	0.57	3.63e-8	HIV-1 control;
SKCM	cis	rs910316	0.763	rs6574205	chr14:75453039	G/C	cg08847533	chr14:75593920	NEK9	0.8	6.94	0.62	1.01e-9	Height;
SKCM	cis	rs1529316	1.000	rs1529316	chr8:3828138	C/T	cg05999364	chr8:3269952	CSMD1	0.49	4.84	0.48	6.54e-6	Multiple sclerosis;
SKCM	cis	rs6840360	0.517	rs4399967	chr4:152729312	T/A	cg22705602	chr4:152727874	NA	0.56	7.64	0.65	4.64e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs28595532	0.841	rs114175487	chr4:119733580	C/G	cg14228332	chr4:119757509	SEC24D	1.08	5.52	0.53	4.28e-7	Cannabis dependence symptom count;
SKCM	cis	rs7666738	0.791	rs10033211	chr4:98995624	T/A	cg05340658	chr4:99064831	C4orf37	0.67	5.14	0.5	1.98e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7428	0.527	rs4459734	chr2:85547429	G/T	cg24342717	chr2:85555507	TGOLN2	-0.61	-4.78	-0.48	8.12e-6	Ear protrusion;
SKCM	cis	rs17685	0.753	rs4732595	chr7:75755139	A/G	cg16489192	chr7:75678113	MDH2;STYXL1	-0.57	-5.35	-0.52	8.63e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs8067545	0.611	rs12949481	chr17:20190974	C/A	cg13482628	chr17:19912719	NA	-0.68	-5.76	-0.55	1.57e-7	Schizophrenia;
SKCM	cis	rs10426930	0.607	rs858415	chr19:5055996	C/T	cg15621731	chr19:5074616	KDM4B	0.56	5.0	0.49	3.39e-6	Monocyte percentage of white cells;
SKCM	cis	rs8017423	0.586	rs2896134	chr14:90831293	G/A	cg04374321	chr14:90722782	PSMC1	-0.73	-5.53	-0.53	4.04e-7	Mortality in heart failure;
SKCM	cis	rs1062177	0.756	rs2964588	chr5:151118386	C/T	cg00977110	chr5:151150581	G3BP1	-0.81	-6.51	-0.59	6.76e-9	Preschool internalizing problems;
SKCM	cis	rs6952808	0.595	rs3800917	chr7:2167939	A/G	cg02951883	chr7:2050386	MAD1L1	0.77	6.8	0.61	1.88e-9	Bipolar disorder and schizophrenia;
SKCM	cis	rs4689592	0.619	rs2359011	chr4:7066052	T/G	cg19539972	chr4:7069911	GRPEL1	1.01	6.97	0.62	8.88e-10	Monocyte percentage of white cells;
SKCM	cis	rs514406	0.929	rs1672908	chr1:53340885	A/G	cg16325326	chr1:53192061	ZYG11B	0.96	10.07	0.75	9.32e-16	Monocyte count;
SKCM	cis	rs62244186	0.541	rs62244226	chr3:44831831	G/A	cg15225532	chr3:44803084	KIF15;KIAA1143	0.62	4.85	0.48	6.14e-6	Depressive symptoms;
SKCM	cis	rs73110464	0.609	rs4919752	chr12:53359229	G/C	cg05393297	chr12:53359155	NA	-0.65	-5.98	-0.56	6.35e-8	Cancer (pleiotropy);
SKCM	cis	rs4727027	0.835	rs6959224	chr7:148784495	A/G	cg23583168	chr7:148888333	NA	-0.82	-6.57	-0.6	5.2e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs6545883	0.826	rs2694617	chr2:61537214	G/A	cg15711740	chr2:61764176	XPO1	0.74	5.05	0.5	2.79e-6	Tuberculosis;
SKCM	cis	rs72615157	0.634	rs7789890	chr7:99800559	G/T	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.1	6.69	0.6	3.04e-9	Lung function (FEV1/FVC);
SKCM	cis	rs908922	0.676	rs4845443	chr1:152507156	C/T	cg09873164	chr1:152488093	CRCT1	0.76	5.99	0.56	6.14e-8	Hair morphology;
SKCM	cis	rs801193	1.000	rs3800812	chr7:66223461	T/C	cg11987759	chr7:65425863	GUSB	-0.67	-5.76	-0.55	1.59e-7	Aortic root size;
SKCM	cis	rs3008870	1.000	rs2985821	chr1:67403787	G/A	cg08660285	chr1:67390436	MIER1;WDR78	0.92	6.05	0.57	4.69e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs10256972	0.567	rs2949185	chr7:1209013	A/G	cg09177884	chr7:1199841	ZFAND2A	-0.75	-6.1	-0.57	3.75e-8	Longevity;Endometriosis;
SKCM	cis	rs28386778	0.897	rs2665833	chr17:61906846	T/C	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs875971	1.000	rs9986696	chr7:65704576	C/A	cg11764359	chr7:65958608	NA	-0.9	-8.65	-0.7	5.25e-13	Aortic root size;
SKCM	cis	rs1850744	0.702	rs2077679	chr4:9608089	G/A	cg15442990	chr4:9534313	NA	-1.55	-5.83	-0.55	1.18e-7	Economic and political preferences;
SKCM	cis	rs6424115	0.830	rs2502999	chr1:24198321	A/G	cg15997130	chr1:24165203	NA	0.6	4.94	0.49	4.37e-6	Immature fraction of reticulocytes;
SKCM	cis	rs875971	0.755	rs10228885	chr7:65780529	C/G	cg18876405	chr7:65276391	NA	-0.64	-6.42	-0.59	9.88e-9	Aortic root size;
SKCM	cis	rs6088580	0.634	rs4911152	chr20:32955024	T/C	cg24642439	chr20:33292090	TP53INP2	-0.76	-6.02	-0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs26868	0.742	rs26848	chr16:2263516	A/G	cg27608139	chr16:2294856	DCI	0.69	6.16	0.57	2.94e-8	Height;
SKCM	cis	rs796364	1.000	rs769950	chr2:200730028	A/G	cg12253985	chr2:200820533	C2orf60;C2orf47	0.85	5.39	0.52	7.18e-7	Schizophrenia;
SKCM	cis	rs9902453	1.000	rs9912741	chr17:28359511	G/A	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.81	-5.78	-0.55	1.45e-7	Coffee consumption (cups per day);
SKCM	cis	rs908922	0.676	rs7550769	chr1:152531213	G/A	cg09873164	chr1:152488093	CRCT1	0.72	5.62	0.54	2.85e-7	Hair morphology;
SKCM	cis	rs5750830	0.649	rs5750813	chr22:39795228	G/C	cg11247378	chr22:39784982	NA	-0.47	-5.43	-0.52	6.26e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs17685	0.712	rs60721456	chr7:75743820	T/A	cg16489192	chr7:75678113	MDH2;STYXL1	-0.54	-4.9	-0.49	5.05e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7666738	0.753	rs7659724	chr4:98944063	C/T	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs910316	1.000	rs28626045	chr14:75589195	G/C	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.85e-7	Height;
SKCM	trans	rs208520	0.690	rs12192710	chr6:66718137	C/T	cg15611600	chr13:45563400	KIAA1704;NUFIP1	0.92	7.5	0.65	8.69e-11	Exhaled nitric oxide output;
SKCM	cis	rs7980687	0.627	rs1727325	chr12:123698332	G/C	cg05973401	chr12:123451056	ABCB9	0.81	5.37	0.52	7.77e-7	Height;Educational attainment;Head circumference (infant);
SKCM	cis	rs6489882	0.902	rs3759375	chr12:113373588	A/G	cg07232103	chr12:112566177	TRAFD1	0.6	4.9	0.48	5.14e-6	Chronic lymphocytic leukemia;
SKCM	cis	rs55962025	0.883	rs82332	chr4:3225466	A/G	cg24015175	chr4:3319247	RGS12	-0.63	-5.42	-0.52	6.54e-7	Parental longevity (mother's age at death);
SKCM	cis	rs801193	1.000	rs2659889	chr7:66217112	A/G	cg11987759	chr7:65425863	GUSB	-0.67	-5.75	-0.55	1.67e-7	Aortic root size;
SKCM	cis	rs28595532	0.920	rs55901549	chr4:119770172	T/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs244731	0.920	rs72813185	chr5:176739110	C/A	cg16006841	chr5:176797999	RGS14	0.85	6.29	0.58	1.72e-8	Urate levels in lean individuals;
SKCM	cis	rs7633857	0.512	rs1374787	chr3:160700144	C/T	cg03342759	chr3:160939853	NMD3	-0.61	-4.91	-0.49	4.84e-6	Educational attainment (years of education);
SKCM	cis	rs9467773	0.967	rs1056347	chr6:26527524	G/C	cg09904177	chr6:26538194	HMGN4	0.54	4.98	0.49	3.78e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2228479	0.717	rs11649210	chr16:89807233	C/G	cg04287289	chr16:89883240	FANCA	0.83	4.9	0.48	5.15e-6	Skin colour saturation;
SKCM	cis	rs597539	0.652	rs584108	chr11:68630282	A/T	cg11716795	chr11:68671300	MRPL21;IGHMBP2	-0.81	-5.52	-0.53	4.26e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs9910055	0.502	rs1684662	chr17:42180822	T/A	cg19774624	chr17:42201019	HDAC5	0.81	6.39	0.59	1.12e-8	Total body bone mineral density;
SKCM	cis	rs155076	0.666	rs2015241	chr13:21888254	A/G	cg14456004	chr13:21872349	NA	1.38	8.99	0.71	1.13e-13	White matter hyperintensity burden;
SKCM	cis	rs7666738	0.830	rs10028505	chr4:98962310	C/A	cg05340658	chr4:99064831	C4orf37	0.64	4.91	0.49	4.97e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs672059	1.000	rs563026	chr1:183161037	A/T	ch.1.3577855R	chr1:183094577	LAMC1	-0.64	-5.24	-0.51	1.35e-6	Hypertriglyceridemia;
SKCM	cis	rs1005277	0.602	rs1740743	chr10:38519222	C/T	cg00409905	chr10:38381863	ZNF37A	-0.62	-5.82	-0.55	1.24e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs860295	0.629	rs12026638	chr1:155401260	T/C	cg02153340	chr1:155202674	NA	-0.77	-5.48	-0.53	4.96e-7	Body mass index;
SKCM	cis	rs55962025	0.842	rs363088	chr4:3210330	A/T	cg16987761	chr4:3318072	RGS12	-0.66	-4.86	-0.48	6.06e-6	Parental longevity (mother's age at death);
SKCM	trans	rs561341	1.000	rs4795670	chr17:30244839	T/C	cg20587970	chr11:113659929	NA	-0.99	-8.05	-0.67	7.57e-12	Hip circumference adjusted for BMI;
SKCM	cis	rs12472274	0.941	rs2880131	chr2:239089151	A/C	cg17459225	chr2:239074497	NA	0.65	4.99	0.49	3.56e-6	Phospholipid levels (plasma);
SKCM	cis	rs875971	0.638	rs10249404	chr7:66046724	G/A	cg11987759	chr7:65425863	GUSB	0.67	5.75	0.55	1.68e-7	Aortic root size;
SKCM	cis	rs11718455	0.960	rs11917885	chr3:44008013	A/G	cg21419209	chr3:44054225	NA	0.65	5.32	0.52	9.77e-7	Coronary artery disease;
SKCM	cis	rs12048904	0.541	rs6699536	chr1:101276544	A/G	cg00063077	chr1:101360652	SLC30A7;EXTL2	0.77	5.44	0.52	6.05e-7	Multiple sclerosis;
SKCM	cis	rs28386778	0.897	rs2727323	chr17:61921999	G/T	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs875971	0.830	rs1167406	chr7:65556936	G/C	cg18876405	chr7:65276391	NA	-0.67	-6.79	-0.61	2.01e-9	Aortic root size;
SKCM	cis	rs11718455	0.960	rs4682712	chr3:43997971	T/C	cg21419209	chr3:44054225	NA	-0.64	-5.28	-0.51	1.15e-6	Coronary artery disease;
SKCM	cis	rs4555082	0.834	rs2816631	chr14:105739477	G/A	cg13114125	chr14:105738426	BRF1	-0.72	-5.59	-0.54	3.16e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs11585357	0.947	rs3003441	chr1:17611869	C/T	cg08277548	chr1:17600880	PADI3	0.9	6.35	0.58	1.34e-8	Hair shape;
SKCM	cis	rs2034088	0.833	rs9748016	chr17:410451	G/T	cg06217071	chr17:408420	NA	0.49	5.32	0.52	9.55e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs7086627	0.515	rs11202957	chr10:82209592	A/G	cg00277334	chr10:82204260	NA	-0.74	-8.56	-0.7	7.89e-13	Post bronchodilator FEV1;
SKCM	cis	rs67311347	0.568	rs57287242	chr3:40335538	T/C	cg18306943	chr3:40428807	ENTPD3	0.56	4.8	0.48	7.56e-6	Renal cell carcinoma;
SKCM	cis	rs6545883	0.894	rs2694632	chr2:61558682	T/C	cg15711740	chr2:61764176	XPO1	0.68	4.82	0.48	6.94e-6	Tuberculosis;
SKCM	cis	rs1336900	0.637	rs35967040	chr1:150555588	A/C	cg17724175	chr1:150552817	MCL1	-0.66	-5.3	-0.51	1.06e-6	Blood protein levels;
SKCM	cis	rs56104184	0.775	rs73061692	chr19:49399676	T/C	cg19746536	chr19:49375674	PPP1R15A	1.16	5.93	0.56	7.67e-8	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs6546550	0.901	rs13028508	chr2:70118427	A/T	cg02498382	chr2:70120550	SNRNP27	0.46	5.06	0.5	2.7e-6	Prevalent atrial fibrillation;
SKCM	cis	rs10540	1.000	rs35255804	chr11:492617	G/A	cg03352830	chr11:487213	PTDSS2	0.93	4.88	0.48	5.56e-6	Body mass index;
SKCM	cis	rs9790314	0.967	rs457272	chr3:161096746	A/G	cg03342759	chr3:160939853	NMD3	-0.75	-7.89	-0.67	1.52e-11	Morning vs. evening chronotype;
SKCM	cis	rs1850744	0.826	rs115847566	chr4:9579226	C/T	cg15442990	chr4:9534313	NA	-1.43	-5.75	-0.55	1.68e-7	Economic and political preferences;
SKCM	cis	rs704795	0.867	rs7566052	chr2:27628635	A/G	cg05696406	chr2:27599888	SNX17	0.47	4.92	0.49	4.75e-6	Menopause (age at onset);
SKCM	cis	rs2033711	0.840	rs10423138	chr19:58928302	T/C	cg13877915	chr19:58951672	ZNF132	0.95	10.28	0.76	3.72e-16	Uric acid clearance;
SKCM	cis	rs3771570	0.901	rs35256094	chr2:242439938	A/C	cg07612300	chr2:242033426	MTERFD2;SNED1	0.89	4.98	0.49	3.78e-6	Prostate cancer;
SKCM	cis	rs908922	0.676	rs2146120	chr1:152504200	A/T	cg09873164	chr1:152488093	CRCT1	0.86	6.23	0.58	2.18e-8	Hair morphology;
SKCM	cis	rs7824557	0.675	rs2736265	chr8:11186674	A/G	cg21775007	chr8:11205619	TDH	0.71	6.41	0.59	1.03e-8	Retinal vascular caliber;
SKCM	cis	rs116095464	0.614	rs10059220	chr5:242813	C/T	cg22857025	chr5:266934	NA	-1.43	-7.97	-0.67	1.07e-11	Breast cancer;
SKCM	cis	rs769267	0.965	rs4808937	chr19:19398005	A/G	cg03709012	chr19:19516395	GATAD2A	0.82	6.73	0.61	2.6e-9	Tonsillectomy;
SKCM	cis	rs9300255	0.602	rs1616181	chr12:123619856	T/A	cg05973401	chr12:123451056	ABCB9	0.8	5.47	0.53	5.23e-7	Neutrophil percentage of white cells;
SKCM	cis	rs1395	0.778	rs1439767	chr2:27389634	A/G	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.5	4.99	0.49	3.65e-6	Blood metabolite levels;
SKCM	cis	rs9916302	0.555	rs12940193	chr17:37652178	T/G	cg07936489	chr17:37558343	FBXL20	-0.86	-7.39	-0.64	1.42e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs9815354	0.812	rs73069292	chr3:41973963	T/C	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	trans	rs1814175	0.533	rs4528310	chr11:49983106	C/A	cg15704280	chr7:45808275	SEPT13	-0.93	-8.64	-0.7	5.46e-13	Height;
SKCM	cis	rs7666738	0.830	rs3907021	chr4:99038668	C/T	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9308433	0.529	rs4655336	chr1:214499667	A/C	cg06198575	chr1:214491504	SMYD2	0.81	5.09	0.5	2.41e-6	IgG glycosylation;
SKCM	cis	rs17685	0.712	rs1859794	chr7:75821544	G/A	cg01364799	chr7:75623366	TMEM120A	-0.7	-5.91	-0.56	8.65e-8	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs9399135	1.000	rs4475342	chr6:135283348	T/C	cg24558204	chr6:135376177	HBS1L	0.56	5.07	0.5	2.64e-6	Red blood cell count;
SKCM	cis	rs752010	1.000	rs4999015	chr1:42093547	G/A	cg06885757	chr1:42089581	HIVEP3	0.62	6.25	0.58	2.04e-8	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs6547741	0.935	rs2384626	chr2:27773648	A/G	cg27432699	chr2:27873401	GPN1	0.73	6.55	0.6	5.7e-9	Oral cavity cancer;
SKCM	cis	rs17376456	0.569	rs6895356	chr5:93060781	A/G	cg21475434	chr5:93447410	FAM172A	0.8	5.02	0.49	3.21e-6	Diabetic retinopathy;
SKCM	cis	rs9926296	0.605	rs6500449	chr16:89856393	T/C	cg27121462	chr16:89883253	FANCA	0.81	7.0	0.62	7.91e-10	Vitiligo;
SKCM	cis	rs7216064	1.000	rs58122682	chr17:65876915	T/C	cg12091567	chr17:66097778	LOC651250	-0.75	-5.27	-0.51	1.19e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs459571	0.920	rs460154	chr9:136909309	C/T	cg13789015	chr9:136890014	NCRNA00094	0.73	5.9	0.56	8.78e-8	Platelet distribution width;
SKCM	cis	rs9640161	0.789	rs3735172	chr7:150028958	C/T	cg10018233	chr7:150070692	REPIN1	-0.65	-5.42	-0.52	6.56e-7	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs7639513	0.737	rs13070228	chr3:12706914	G/A	cg23032965	chr3:12705835	RAF1	0.81	7.08	0.63	5.53e-10	Itch intensity from mosquito bite;
SKCM	cis	rs7124681	0.528	rs74608150	chr11:47696214	A/T	cg20307385	chr11:47447363	PSMC3	0.72	5.81	0.55	1.31e-7	Body mass index (joint analysis main effects and physical activity interaction);Body mass index;Body mass index in physically active individuals;
SKCM	cis	rs9916302	0.706	rs8069074	chr17:37685401	C/T	cg07936489	chr17:37558343	FBXL20	1.01	8.17	0.68	4.34e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs2739330	0.828	rs4820572	chr22:24250355	T/C	cg25703541	chr22:24373054	LOC391322	-0.76	-6.14	-0.57	3.27e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs372883	0.530	rs2832305	chr21:30752964	G/A	cg24692254	chr21:30365293	RNF160	0.73	5.56	0.53	3.63e-7	Pancreatic cancer;
SKCM	cis	rs910316	0.699	rs175039	chr14:75468950	G/C	cg08847533	chr14:75593920	NEK9	-0.8	-6.59	-0.6	4.76e-9	Height;
SKCM	cis	rs6815814	0.898	rs5743592	chr4:38803063	A/G	cg02016764	chr4:38805732	TLR1	-0.78	-5.74	-0.54	1.76e-7	Breast cancer;
SKCM	cis	rs4237845	0.816	rs61935769	chr12:58294344	G/A	cg02175503	chr12:58329896	NA	0.73	5.98	0.56	6.27e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs34779708	0.966	rs1148245	chr10:35511894	C/T	cg03585969	chr10:35415529	CREM	0.8	6.4	0.59	1.07e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs11640734	0.609	rs11647746	chr16:89806343	C/A	cg06558623	chr16:89946397	TCF25	1.07	5.72	0.54	1.85e-7	Interleukin-17 levels;
SKCM	cis	rs763121	0.785	rs5750646	chr22:39013830	T/C	cg06022373	chr22:39101656	GTPBP1	0.82	5.62	0.54	2.79e-7	Menopause (age at onset);
SKCM	cis	rs6921919	0.583	rs2027361	chr6:28388308	A/G	cg14547644	chr6:28411285	ZSCAN23	-0.58	-4.8	-0.48	7.46e-6	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs362272	0.524	rs2749781	chr4:3346617	T/C	cg24015175	chr4:3319247	RGS12	0.85	10.87	0.78	2.81e-17	Serum sulfate level;
SKCM	cis	rs17065868	0.892	rs9525980	chr13:45119719	A/G	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs7824557	0.564	rs2736301	chr8:11236413	C/T	cg21775007	chr8:11205619	TDH	-0.59	-5.03	-0.5	3.01e-6	Retinal vascular caliber;
SKCM	cis	rs7953508	0.506	rs2053196	chr12:93962959	T/C	cg18151635	chr12:93972918	NA	-0.71	-6.95	-0.62	9.98e-10	Pubertal anthropometrics;
SKCM	cis	rs12714314	0.535	rs6741568	chr2:1933008	C/A	cg22350835	chr2:1868857	MYT1L	0.57	5.44	0.52	5.86e-7	Type 2 diabetes (age of onset);
SKCM	cis	rs34065801	0.526	rs8001225	chr13:36514506	C/A	cg09605634	chr13:36521538	DCLK1	-0.83	-5.97	-0.56	6.74e-8	Breast size;
SKCM	cis	rs4900538	0.821	rs7012	chr14:102814945	C/T	cg18135206	chr14:102964638	TECPR2	-0.74	-5.7	-0.54	2.06e-7	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs2228479	0.850	rs11649162	chr16:89807131	C/A	cg06558623	chr16:89946397	TCF25	1.03	5.59	0.53	3.23e-7	Skin colour saturation;
SKCM	cis	rs17376456	0.877	rs12153506	chr5:93360953	T/G	cg21475434	chr5:93447410	FAM172A	0.95	5.36	0.52	8.36e-7	Diabetic retinopathy;
SKCM	cis	rs992157	0.767	rs2014615	chr2:219171191	A/G	cg20019365	chr2:219134978	PNKD;AAMP	0.69	5.97	0.56	6.7e-8	Colorectal cancer;
SKCM	cis	rs1023500	0.573	rs13057094	chr22:42470317	T/C	cg04733989	chr22:42467013	NAGA	0.72	5.7	0.54	2.07e-7	Schizophrenia;
SKCM	cis	rs2404602	0.669	rs12441484	chr15:77109875	G/A	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs875971	0.964	rs6978721	chr7:65883204	A/G	cg11764359	chr7:65958608	NA	0.87	8.35	0.69	2.01e-12	Aortic root size;
SKCM	cis	rs67311347	1.000	rs12638199	chr3:40475285	A/G	cg00091569	chr3:40428383	ENTPD3	0.62	5.09	0.5	2.4e-6	Renal cell carcinoma;
SKCM	cis	rs9910055	0.762	rs2240226	chr17:42266218	C/T	cg13607699	chr17:42295918	UBTF	0.79	6.25	0.58	2.03e-8	Total body bone mineral density;
SKCM	cis	rs2228479	0.702	rs11076621	chr16:89837927	A/G	cg06558623	chr16:89946397	TCF25	1.11	5.26	0.51	1.23e-6	Skin colour saturation;
SKCM	cis	rs17376456	1.000	rs13163610	chr5:93548877	A/C	cg25358565	chr5:93447407	FAM172A	1.22	8.06	0.67	7.15e-12	Diabetic retinopathy;
SKCM	cis	rs1218582	0.596	rs11264275	chr1:154825270	G/T	cg24250549	chr1:154909240	PMVK	-0.65	-5.94	-0.56	7.66e-8	Prostate cancer;
SKCM	cis	rs9393692	0.846	rs7771202	chr6:26279907	A/G	cg00631329	chr6:26305371	NA	-0.68	-4.93	-0.49	4.49e-6	Educational attainment;
SKCM	cis	rs2479724	0.905	rs2274578	chr6:41888827	C/G	cg17623882	chr6:41773611	USP49	-0.78	-6.84	-0.61	1.57e-9	Menarche (age at onset);
SKCM	cis	rs11718455	0.960	rs11921942	chr3:44007957	T/C	cg21419209	chr3:44054225	NA	-0.65	-5.32	-0.52	9.77e-7	Coronary artery disease;
SKCM	cis	rs732765	0.657	rs73303999	chr14:75235746	T/A	cg25946216	chr14:74253857	C14orf43	-0.94	-5.23	-0.51	1.36e-6	Non-small cell lung cancer;
SKCM	cis	rs2760061	0.659	rs708107	chr1:228189495	C/T	cg18477163	chr1:228402036	OBSCN	0.49	5.7	0.54	2.02e-7	Diastolic blood pressure;
SKCM	cis	rs2153535	0.601	rs4140584	chr6:8540614	C/G	cg23788917	chr6:8435910	SLC35B3	-0.7	-4.96	-0.49	3.98e-6	Motion sickness;
SKCM	cis	rs875971	0.862	rs1695820	chr7:65844563	G/A	cg11764359	chr7:65958608	NA	0.8	7.47	0.65	1.01e-10	Aortic root size;
SKCM	cis	rs561341	0.769	rs9899093	chr17:30191954	C/G	cg00745463	chr17:30367425	LRRC37B	-0.93	-5.56	-0.53	3.64e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs875971	0.545	rs11767262	chr7:65767224	T/A	cg18876405	chr7:65276391	NA	0.63	5.07	0.5	2.57e-6	Aortic root size;
SKCM	cis	rs1348850	0.574	rs13431105	chr2:178434674	A/G	cg27490568	chr2:178487706	NA	0.84	5.76	0.55	1.6e-7	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs10779751	0.960	rs2076657	chr1:11318763	C/G	cg08854313	chr1:11322531	MTOR	1.04	10.13	0.75	7.04e-16	Body mass index;
SKCM	cis	rs1153858	1.000	rs60476496	chr15:45713801	C/T	cg10760299	chr15:45669010	GATM	0.61	5.94	0.56	7.67e-8	Homoarginine levels;
SKCM	cis	rs11098499	0.954	rs10518331	chr4:120323595	C/T	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	trans	rs561341	0.714	rs111760509	chr17:30304320	A/G	cg20587970	chr11:113659929	NA	-1.14	-9.85	-0.74	2.43e-15	Hip circumference adjusted for BMI;
SKCM	cis	rs947211	0.898	rs1775146	chr1:205756168	A/G	cg07157834	chr1:205819609	PM20D1	0.67	5.03	0.49	3.09e-6	Parkinson's disease;
SKCM	cis	rs3087591	0.810	rs2269856	chr17:29482701	C/T	cg24425628	chr17:29625626	OMG;NF1	0.64	4.97	0.49	3.87e-6	Hip circumference;
SKCM	cis	rs1969363	0.509	rs8189633	chr12:38065155	C/G	cg26384229	chr12:38710491	ALG10B	0.81	6.45	0.59	8.61e-9	Morning vs. evening chronotype;
SKCM	cis	rs6582630	0.502	rs11495393	chr12:38341194	T/C	cg26384229	chr12:38710491	ALG10B	0.81	6.67	0.6	3.38e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs7208859	0.623	rs56812022	chr17:29068733	A/G	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs7811142	0.943	rs73403312	chr7:100024153	T/C	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.11	6.45	0.59	8.66e-9	Platelet count;
SKCM	cis	rs9443189	0.530	rs614065	chr6:76315633	G/A	cg01950844	chr6:76311363	SENP6	0.99	6.59	0.6	4.64e-9	Prostate cancer;
SKCM	cis	rs228769	0.792	rs454192	chr17:42171206	T/C	cg08499158	chr17:42289980	UBTF	0.71	4.78	0.48	8.16e-6	Bone mineral density (hip);Bone mineral density (spine);
SKCM	cis	rs763014	1.000	rs763014	chr16:675680	T/C	cg07343612	chr16:622815	PIGQ	-0.68	-5.72	-0.54	1.91e-7	Height;
SKCM	cis	rs12142240	0.698	rs17357683	chr1:46815378	C/T	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs801193	0.839	rs12534943	chr7:66070520	A/G	cg11764359	chr7:65958608	NA	-0.8	-5.9	-0.56	9.06e-8	Aortic root size;
SKCM	cis	rs453301	0.686	rs11787026	chr8:8902371	A/T	cg15556689	chr8:8085844	FLJ10661	0.71	5.26	0.51	1.22e-6	Joint mobility (Beighton score);
SKCM	cis	rs3784262	0.740	rs8032572	chr15:58311280	A/G	cg12031962	chr15:58353849	ALDH1A2	0.45	5.42	0.52	6.41e-7	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs995000	0.931	rs10889347	chr1:63075826	G/A	cg06896770	chr1:63153194	DOCK7	0.76	7.17	0.63	3.77e-10	Triglyceride levels;
SKCM	cis	rs9399135	0.967	rs4388304	chr6:135309597	T/A	cg24558204	chr6:135376177	HBS1L	0.56	5.01	0.49	3.31e-6	Red blood cell count;
SKCM	cis	rs2811415	0.597	rs1007233	chr3:127801776	G/T	cg09089421	chr3:127803668	RUVBL1	1.0	8.69	0.7	4.4e-13	Lung function (FEV1/FVC);
SKCM	cis	rs1799949	0.965	rs6503727	chr17:41312859	C/T	cg25918947	chr17:41365094	TMEM106A	-0.63	-5.76	-0.55	1.58e-7	Menopause (age at onset);
SKCM	cis	rs60871478	0.898	rs35928069	chr7:823067	G/C	cg05535760	chr7:792225	HEATR2	1.01	8.26	0.68	2.97e-12	Cerebrospinal P-tau181p levels;
SKCM	cis	rs11098499	0.954	rs4309825	chr4:120314881	C/T	cg09307838	chr4:120376055	NA	-0.94	-7.7	-0.66	3.57e-11	Corneal astigmatism;
SKCM	cis	rs870825	0.860	rs2696052	chr4:185604356	G/A	cg04058563	chr4:185651563	MLF1IP	-1.02	-5.81	-0.55	1.27e-7	Blood protein levels;
SKCM	cis	rs8180040	0.932	rs12489046	chr3:47527683	T/G	cg27129171	chr3:47204927	SETD2	0.79	5.79	0.55	1.43e-7	Colorectal cancer;
SKCM	cis	rs13108904	0.557	rs1680030	chr4:1245500	A/T	cg02018176	chr4:1364513	KIAA1530	-0.68	-5.4	-0.52	6.97e-7	Obesity-related traits;
SKCM	cis	rs12142240	0.698	rs13374893	chr1:46843800	A/G	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs3820068	0.532	rs1547034	chr1:15919049	T/A	cg24675056	chr1:15929824	NA	0.74	5.45	0.53	5.67e-7	Systolic blood pressure;
SKCM	cis	rs2836950	0.565	rs4816617	chr21:40540690	T/C	cg17971929	chr21:40555470	PSMG1	-0.76	-6.53	-0.59	6.19e-9	Menarche (age at onset);
SKCM	cis	rs4253772	0.637	rs6008357	chr22:46652104	T/G	cg03482458	chr22:46692211	CN5H6.4;GTSE1	1.11	4.96	0.49	4.03e-6	LDL cholesterol;Cholesterol, total;
SKCM	cis	rs875971	0.862	rs10950043	chr7:65988610	T/C	cg11764359	chr7:65958608	NA	0.75	6.8	0.61	1.86e-9	Aortic root size;
SKCM	cis	rs13118159	0.573	rs7664763	chr4:1352305	A/G	cg02475777	chr4:1388615	CRIPAK	0.8	5.25	0.51	1.3e-6	Longevity;
SKCM	cis	rs854765	0.547	rs7209003	chr17:17907393	T/A	cg04398451	chr17:18023971	MYO15A	-0.87	-6.78	-0.61	2.05e-9	Total body bone mineral density;
SKCM	cis	rs701145	0.640	rs1657621	chr3:153929795	T/C	cg17054900	chr3:154042577	DHX36	1.19	5.1	0.5	2.37e-6	Coronary artery disease;
SKCM	cis	rs57221529	0.766	rs12522140	chr5:587261	C/A	cg26208419	chr5:473447	SLC9A3;LOC25845	1.01	5.18	0.51	1.7e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs738321	0.690	rs11570750	chr22:38513138	G/A	cg25457927	chr22:38595422	NA	-0.51	-5.73	-0.54	1.83e-7	Breast cancer;
SKCM	cis	rs7659604	0.539	rs11098645	chr4:122729251	G/A	cg06713675	chr4:122721982	EXOSC9	-0.75	-7.31	-0.64	2.01e-10	Type 2 diabetes;
SKCM	cis	rs854765	0.647	rs712267	chr17:18021607	G/A	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.88	6.66	0.6	3.51e-9	Total body bone mineral density;
SKCM	cis	rs7666738	0.830	rs10019087	chr4:99030211	C/T	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs854765	0.583	rs8073001	chr17:17831716	A/C	cg24612305	chr17:17875800	TOM1L2;LRRC48	-1.0	-7.64	-0.65	4.64e-11	Total body bone mineral density;
SKCM	cis	rs875971	0.895	rs4145009	chr7:65726615	T/C	cg18876405	chr7:65276391	NA	-0.64	-6.41	-0.59	1.01e-8	Aortic root size;
SKCM	cis	rs28386778	0.966	rs2854161	chr17:61976093	T/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	-1.02	-9.05	-0.72	8.76e-14	Prudent dietary pattern;
SKCM	cis	rs2842992	0.789	rs9365093	chr6:160175819	C/G	cg11366901	chr6:160182831	ACAT2	0.94	7.85	0.66	1.81e-11	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs4819052	1.000	rs2297286	chr21:46707897	C/G	cg20896738	chr21:46707857	POFUT2;LOC642852	0.73	4.97	0.49	3.88e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs10504229	0.679	rs111843870	chr8:58126798	A/G	cg02725872	chr8:58115012	NA	-0.52	-4.97	-0.49	3.92e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs11822910	0.911	rs61886978	chr11:57194848	G/C	cg00522883	chr11:57194120	SLC43A3	0.76	6.93	0.62	1.06e-9	Platelet distribution width;
SKCM	cis	rs1799949	0.896	rs35908185	chr17:41255111	A/T	cg25918947	chr17:41365094	TMEM106A	-0.62	-5.98	-0.56	6.24e-8	Menopause (age at onset);
SKCM	cis	rs875971	0.660	rs10215132	chr7:66054406	C/A	cg05627663	chr7:65219948	SNORA22;CCT6P1	-0.56	-4.84	-0.48	6.39e-6	Aortic root size;
SKCM	cis	rs478304	0.654	rs6591187	chr11:65460086	C/G	cg27068330	chr11:65405492	SIPA1	-0.89	-7.62	-0.65	5.13e-11	Acne (severe);
SKCM	cis	rs9611565	0.559	rs132771	chr22:42025350	A/G	cg03806693	chr22:41940476	POLR3H	1.11	7.56	0.65	6.74e-11	Vitiligo;
SKCM	cis	rs875971	1.000	rs1144895	chr7:65541307	C/G	cg11764359	chr7:65958608	NA	-0.89	-8.44	-0.69	1.29e-12	Aortic root size;
SKCM	cis	rs1218582	0.774	rs4845681	chr1:154868055	G/T	cg16680214	chr1:154839983	KCNN3	-0.56	-5.26	-0.51	1.23e-6	Prostate cancer;
SKCM	cis	rs7937682	0.814	rs1619652	chr11:111469757	G/A	cg09085632	chr11:111637200	PPP2R1B	-1.0	-8.74	-0.7	3.47e-13	Primary sclerosing cholangitis;
SKCM	cis	rs62012628	0.527	rs6495329	chr15:79092603	G/A	cg04896959	chr15:78267971	NA	-0.69	-6.05	-0.56	4.81e-8	Diastolic blood pressure;
SKCM	trans	rs7618501	1.000	rs34614773	chr3:49753003	T/G	cg21659725	chr3:3221576	CRBN	-0.96	-9.61	-0.74	7.08e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs35306767	0.953	rs1539174	chr10:974870	C/G	cg20503657	chr10:835505	NA	0.72	5.21	0.51	1.52e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs78456975	0.506	rs10206900	chr2:1552841	T/C	cg01028140	chr2:1542097	TPO	-0.53	-4.96	-0.49	4.07e-6	Placebo response in major depressive disorder (% change in symptom score);
SKCM	cis	rs71520386	0.530	rs10256628	chr7:22883259	G/C	cg04907244	chr7:22894795	SNORD93	0.67	4.97	0.49	3.93e-6	Fibrinogen levels;
SKCM	cis	rs10876993	0.890	rs1585781	chr12:58056701	T/G	cg18357645	chr12:58087776	OS9	0.61	5.65	0.54	2.52e-7	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs34779708	0.966	rs12769484	chr10:35465746	G/A	cg03585969	chr10:35415529	CREM	0.75	6.26	0.58	1.9e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs3845702	1.000	rs3738943	chr2:180846743	G/T	cg01881094	chr2:180872142	CWC22	-1.02	-5.29	-0.51	1.07e-6	Schizophrenia;
SKCM	cis	rs372883	0.580	rs2254038	chr21:30745722	C/T	cg24692254	chr21:30365293	RNF160	0.64	5.07	0.5	2.67e-6	Pancreatic cancer;
SKCM	cis	rs4481887	1.000	rs10888351	chr1:248451608	G/A	cg00666640	chr1:248458726	OR2T12	0.6	4.9	0.49	5.01e-6	Common traits (Other);
SKCM	cis	rs10876993	0.893	rs3825078	chr12:58089413	A/T	cg18357645	chr12:58087776	OS9	0.67	6.23	0.58	2.19e-8	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs4724125	0.883	rs35120307	chr7:42674506	G/A	cg09407816	chr7:42972088	MRPL32;PSMA2	0.81	4.85	0.48	6.13e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs11098499	0.954	rs28572238	chr4:120316686	T/G	cg09307838	chr4:120376055	NA	0.97	7.49	0.65	9.08e-11	Corneal astigmatism;
SKCM	cis	rs4819052	0.819	rs13046807	chr21:46672286	A/G	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.42	0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs1577917	0.566	rs2842611	chr6:86302034	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.18	-0.51	1.67e-6	Response to antipsychotic treatment;
SKCM	cis	rs17376456	0.877	rs9314099	chr5:93447375	T/C	cg25358565	chr5:93447407	FAM172A	1.23	7.97	0.67	1.08e-11	Diabetic retinopathy;
SKCM	cis	rs28595532	1.000	rs114778020	chr4:119662584	C/A	cg14228332	chr4:119757509	SEC24D	1.06	5.41	0.52	6.75e-7	Cannabis dependence symptom count;
SKCM	cis	rs11585357	0.895	rs34324150	chr1:17632464	C/G	cg08277548	chr1:17600880	PADI3	-0.89	-6.31	-0.58	1.53e-8	Hair shape;
SKCM	cis	rs9513627	0.512	rs9517759	chr13:100180108	T/G	cg00096104	chr13:100547897	CLYBL	0.61	4.78	0.48	8.08e-6	Obesity-related traits;
SKCM	cis	rs2479724	0.870	rs6902650	chr6:41764080	G/A	cg17623882	chr6:41773611	USP49	0.79	6.94	0.62	1.03e-9	Menarche (age at onset);
SKCM	cis	rs9443189	0.570	rs7755068	chr6:76405700	A/G	cg01950844	chr6:76311363	SENP6	0.98	6.54	0.59	5.95e-9	Prostate cancer;
SKCM	cis	rs1577917	1.000	rs2324843	chr6:86617501	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.66	-5.74	-0.54	1.76e-7	Response to antipsychotic treatment;
SKCM	cis	rs28595532	0.920	rs115878132	chr4:119756239	T/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs10779751	1.000	rs12730522	chr1:11284091	G/A	cg08854313	chr1:11322531	MTOR	1.03	9.63	0.74	6.61e-15	Body mass index;
SKCM	cis	rs1218582	0.682	rs12144978	chr1:154850445	G/A	cg09359103	chr1:154839909	KCNN3	-0.59	-5.61	-0.54	3e-7	Prostate cancer;
SKCM	cis	rs11105298	0.891	rs3741899	chr12:89933931	G/A	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.83	-5.18	-0.51	1.66e-6	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs57221529	0.766	rs56216231	chr5:581193	G/A	cg10555297	chr5:473380	SLC9A3;LOC25845	1.01	5.03	0.49	3.1e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs7106204	0.800	rs6484026	chr11:24214633	G/A	ch.11.24196551F	chr11:24239977	NA	0.77	6.39	0.59	1.09e-8	Response to Homoharringtonine (cytotoxicity);
SKCM	cis	rs2153535	0.580	rs1414340	chr6:8491139	G/A	cg07606381	chr6:8435919	SLC35B3	0.86	6.25	0.58	2.06e-8	Motion sickness;
SKCM	cis	rs362296	0.583	rs35658829	chr4:3255738	T/G	cg24015175	chr4:3319247	RGS12	-0.61	-5.68	-0.54	2.2e-7	Parental longevity (mother's age at death);
SKCM	cis	rs6952808	0.965	rs4719318	chr7:1887930	G/A	cg02951883	chr7:2050386	MAD1L1	-0.71	-5.35	-0.52	8.61e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs554111	0.963	rs710312	chr1:21042462	A/G	cg01072550	chr1:21505969	NA	-0.62	-4.98	-0.49	3.77e-6	Facial morphology (factor 17, height of vermillion upper lip);
SKCM	cis	rs6952808	0.743	rs10266703	chr7:1918941	C/A	cg03354898	chr7:1950403	MAD1L1	-0.53	-5.22	-0.51	1.45e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs6952808	0.594	rs3778965	chr7:2138296	G/A	cg21782813	chr7:2030301	MAD1L1	0.53	5.68	0.54	2.25e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs1577917	0.771	rs12199873	chr6:86294947	C/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.98	-10.99	-0.78	1.66e-17	Response to antipsychotic treatment;
SKCM	cis	rs2559856	0.967	rs2695290	chr12:102087844	A/G	cg12924262	chr12:102091054	CHPT1	-0.67	-5.34	-0.52	9.08e-7	Blood protein levels;
SKCM	cis	rs11098499	0.865	rs10032158	chr4:120391632	C/T	cg24375607	chr4:120327624	NA	0.65	4.97	0.49	3.87e-6	Corneal astigmatism;
SKCM	cis	rs11105298	0.891	rs4842662	chr12:89933446	T/C	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.83	-5.18	-0.51	1.66e-6	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs2396545	0.634	rs35788385	chr11:570094	G/A	cg16486109	chr11:613632	IRF7	1.08	6.49	0.59	7.18e-9	Systemic lupus erythematosus and Systemic sclerosis;
SKCM	cis	rs9913156	0.948	rs28365160	chr17:4622551	A/G	cg19197139	chr17:4613644	ARRB2	0.93	6.13	0.57	3.38e-8	Lymphocyte counts;
SKCM	cis	rs3820068	0.603	rs3766163	chr1:15986547	T/C	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs7666738	0.791	rs7665273	chr4:98997413	C/A	cg17366294	chr4:99064904	C4orf37	0.63	5.23	0.51	1.4e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7937682	0.575	rs10789851	chr11:111750955	G/C	cg09085632	chr11:111637200	PPP2R1B	1.07	10.16	0.75	6.25e-16	Primary sclerosing cholangitis;
SKCM	cis	rs1348850	0.747	rs1047884	chr2:178488281	C/G	cg02961200	chr2:178257176	LOC100130691;AGPS	0.76	5.25	0.51	1.28e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs7191700	0.674	rs12597893	chr16:11426331	A/G	cg00044050	chr16:11439710	C16orf75	0.72	5.03	0.5	3.01e-6	Multiple sclerosis;
SKCM	cis	rs4803468	1.000	rs10413735	chr19:41921071	C/T	cg14132834	chr19:41945861	ATP5SL	-0.77	-6.08	-0.57	4.18e-8	Height;
SKCM	cis	rs155076	1.000	rs261406	chr13:21855854	G/A	cg14456004	chr13:21872349	NA	-1.22	-6.76	-0.61	2.24e-9	White matter hyperintensity burden;
SKCM	cis	rs801193	1.000	rs2659906	chr7:66165310	T/C	cg00343986	chr7:65444356	GUSB	0.7	5.14	0.5	1.98e-6	Aortic root size;
SKCM	cis	rs908922	0.676	rs1001834	chr1:152495940	C/A	cg09873164	chr1:152488093	CRCT1	0.76	5.93	0.56	7.7e-8	Hair morphology;
SKCM	cis	rs8060686	0.641	rs79323429	chr16:68084594	A/G	cg04539111	chr16:67997858	SLC12A4	-0.85	-4.79	-0.48	7.74e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs62238980	0.614	rs10483162	chr22:32394890	G/C	cg00543991	chr22:32367038	NA	1.15	4.87	0.48	5.76e-6	Childhood ear infection;
SKCM	cis	rs8180040	0.966	rs7628631	chr3:47560863	C/T	cg16586182	chr3:47516702	SCAP	0.73	4.88	0.48	5.5e-6	Colorectal cancer;
SKCM	cis	rs2014572	0.967	rs11667407	chr19:57763122	C/T	cg24459738	chr19:57751996	ZNF805	-0.64	-5.17	-0.5	1.79e-6	Hyperactive-impulsive symptoms;
SKCM	cis	rs909674	0.818	rs5757678	chr22:39843409	A/G	cg11247378	chr22:39784982	NA	0.43	4.97	0.49	3.89e-6	IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis);IgG glycosylation;IgG digalactosylation phenotypes (multivariate analysis);IgG sialylation phenotypes (multivariate analysis);IgG monogalactosylation phenotypes (multivariate analysis);IgG fucosylation phenotypes (multivariate analysis);IgG N-glycosylation phenotypes (multivariate analysis);IgG disialylation phenotypes (multivariate analysis);IgG galactosylation phenotypes (multivariate analysis);Post bronchodilator FEV1;
SKCM	cis	rs9814567	1.000	rs2887797	chr3:134202506	T/G	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.69	-5.48	-0.53	4.97e-7	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs8177253	0.965	rs8177245	chr3:133479230	A/G	cg16414030	chr3:133502952	NA	-0.7	-5.93	-0.56	7.88e-8	Iron status biomarkers;
SKCM	cis	rs1218582	0.741	rs10908444	chr1:154840287	G/A	cg16680214	chr1:154839983	KCNN3	-0.55	-4.94	-0.49	4.37e-6	Prostate cancer;
SKCM	cis	rs523522	0.962	rs10849757	chr12:120964014	G/A	cg27279351	chr12:120934652	DYNLL1	0.91	8.32	0.69	2.26e-12	High light scatter reticulocyte count;
SKCM	cis	rs9300255	0.569	rs1790115	chr12:123620270	C/G	cg00376283	chr12:123451042	ABCB9	0.82	5.61	0.54	3e-7	Neutrophil percentage of white cells;
SKCM	trans	rs3780486	0.846	rs10813954	chr9:33137596	A/C	cg20290983	chr6:43655470	MRPS18A	1.0	11.51	0.79	1.75e-18	IgG glycosylation;
SKCM	cis	rs10880689	1	rs10880689	chr12:37930102	A/G	cg26384229	chr12:38710491	ALG10B	0.8	6.92	0.62	1.14e-9	Resting heart rate;
SKCM	cis	rs801193	0.901	rs4273746	chr7:66301111	C/T	cg00343986	chr7:65444356	GUSB	-0.7	-5.11	-0.5	2.23e-6	Aortic root size;
SKCM	cis	rs3820928	0.874	rs1320407	chr2:227867385	G/T	cg11843606	chr2:227700838	RHBDD1	-0.61	-4.89	-0.48	5.28e-6	Pulmonary function;
SKCM	cis	rs992157	0.767	rs2382822	chr2:219173327	T/C	cg20019365	chr2:219134978	PNKD;AAMP	-0.69	-5.97	-0.56	6.7e-8	Colorectal cancer;
SKCM	cis	rs8067545	0.750	rs34290687	chr17:19991211	G/A	cg13482628	chr17:19912719	NA	0.73	6.54	0.6	5.78e-9	Schizophrenia;
SKCM	cis	rs910316	0.934	rs8006587	chr14:75664939	A/G	cg11812906	chr14:75593930	NEK9	0.75	5.81	0.55	1.27e-7	Height;
SKCM	cis	rs2180341	0.961	rs910720	chr6:127619070	T/C	cg27446573	chr6:127587934	RNF146	1.0	8.68	0.7	4.48e-13	Breast cancer;
SKCM	cis	rs10504073	0.647	rs1511359	chr8:50006448	T/A	cg00325661	chr8:49890786	NA	0.79	6.79	0.61	1.99e-9	Blood metabolite ratios;
SKCM	cis	rs9300255	0.596	rs1727331	chr12:123718879	C/G	cg05973401	chr12:123451056	ABCB9	-0.8	-5.94	-0.56	7.61e-8	Neutrophil percentage of white cells;
SKCM	cis	rs7666738	0.830	rs7662218	chr4:98983126	T/G	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4481887	1.000	rs4244179	chr1:248470984	T/A	cg00666640	chr1:248458726	OR2T12	0.64	5.69	0.54	2.13e-7	Common traits (Other);
SKCM	cis	rs9611565	0.579	rs73178621	chr22:41921665	A/G	cg03806693	chr22:41940476	POLR3H	-1.11	-7.56	-0.65	6.67e-11	Vitiligo;
SKCM	cis	rs28386778	0.830	rs2597637	chr17:61875066	T/G	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs314370	0.951	rs12705092	chr7:100473550	G/A	cg10426581	chr7:100472382	SRRT	0.73	6.19	0.57	2.59e-8	Resting heart rate;
SKCM	cis	rs9790314	0.580	rs960212	chr3:161047974	C/T	cg03342759	chr3:160939853	NMD3	-0.76	-6.78	-0.61	2.08e-9	Morning vs. evening chronotype;
SKCM	cis	rs2243480	0.901	rs58207111	chr7:65486723	C/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs2885056	0.739	rs4363951	chr19:10649473	G/A	cg04833646	chr19:10679720	CDKN2D	0.87	7.11	0.63	4.91e-10	Red cell distribution width;
SKCM	cis	rs62238980	0.614	rs4821027	chr22:32442074	G/A	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs2404602	0.647	rs1443115	chr15:77041829	T/C	cg23625390	chr15:77176239	SCAPER	-0.85	-8.26	-0.68	2.93e-12	Blood metabolite levels;
SKCM	cis	rs116095464	0.558	rs6555055	chr5:226160	A/C	cg22857025	chr5:266934	NA	-1.36	-8.0	-0.67	9.23e-12	Breast cancer;
SKCM	cis	rs2153535	0.601	rs1928183	chr6:8530018	A/G	cg07606381	chr6:8435919	SLC35B3	0.93	6.8	0.61	1.92e-9	Motion sickness;
SKCM	cis	rs7829975	0.593	rs2921077	chr8:8304502	C/T	cg08975724	chr8:8085496	FLJ10661	0.66	5.03	0.5	3e-6	Mood instability;
SKCM	cis	rs709400	0.663	rs72708893	chr14:103929535	G/A	cg26031613	chr14:104095156	KLC1	0.73	5.62	0.54	2.87e-7	Body mass index;
SKCM	cis	rs9902453	0.845	rs58606097	chr17:28020379	G/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.82	5.78	0.55	1.47e-7	Coffee consumption (cups per day);
SKCM	cis	rs4689592	0.622	rs2276968	chr4:7070118	T/G	cg19539972	chr4:7069911	GRPEL1	0.97	6.62	0.6	4.18e-9	Monocyte percentage of white cells;
SKCM	cis	rs7666738	0.830	rs17558151	chr4:99048699	T/C	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2075371	0.829	rs727202	chr7:133947942	A/G	cg20476274	chr7:133979776	SLC35B4	0.96	9.41	0.73	1.72e-14	Mean platelet volume;
SKCM	cis	rs7811142	0.830	rs6965458	chr7:99973402	G/A	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.05	5.92	0.56	8.02e-8	Platelet count;
SKCM	cis	rs912057	0.932	rs1294404	chr6:6735022	G/A	cg06612196	chr6:6737390	NA	0.59	4.93	0.49	4.49e-6	Waist-to-hip ratio adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);
SKCM	cis	rs2439831	0.850	rs12440573	chr15:44108997	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.38	7.95	0.67	1.17e-11	Lung cancer in ever smokers;
SKCM	cis	rs9309711	0.736	rs13412581	chr2:3497187	G/A	cg10845886	chr2:3471009	TTC15	-0.78	-5.14	-0.5	1.96e-6	Neurofibrillary tangles;
SKCM	cis	rs9303401	0.659	rs12602808	chr17:56698420	A/G	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.16	0.57	2.91e-8	Cognitive test performance;
SKCM	cis	rs829883	0.664	rs829876	chr12:98842138	A/G	cg25150519	chr12:98850993	NA	0.51	5.06	0.5	2.7e-6	Colorectal adenoma (advanced);
SKCM	cis	rs4683346	0.731	rs11129983	chr3:42924683	C/G	cg06399164	chr3:42695035	ZBTB47	0.55	5.06	0.5	2.74e-6	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs4253772	0.591	rs6008546	chr22:46686377	T/G	cg03482458	chr22:46692211	CN5H6.4;GTSE1	1.2	5.67	0.54	2.3e-7	LDL cholesterol;Cholesterol, total;
SKCM	cis	rs11098499	0.644	rs2389880	chr4:120559870	T/A	cg09307838	chr4:120376055	NA	0.98	8.18	0.68	4.13e-12	Corneal astigmatism;
SKCM	cis	rs597539	0.690	rs1272609	chr11:68618182	T/C	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.81	5.33	0.52	9.43e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs116095464	0.558	rs59284383	chr5:284525	C/G	cg22857025	chr5:266934	NA	-1.47	-8.33	-0.69	2.16e-12	Breast cancer;
SKCM	cis	rs873946	0.648	rs12766166	chr10:134556403	G/C	cg18305652	chr10:134549665	INPP5A	0.58	5.74	0.55	1.7e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	trans	rs941408	1.000	rs1640272	chr19:2800192	A/T	cg22153745	chr1:153894579	GATAD2B	-0.79	-7.32	-0.64	1.97e-10	Total cholesterol levels;
SKCM	cis	rs1348850	0.651	rs1901824	chr2:178225466	T/C	cg02961200	chr2:178257176	LOC100130691;AGPS	0.79	5.84	0.55	1.13e-7	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs875971	0.505	rs1167386	chr7:65513096	G/A	cg18876405	chr7:65276391	NA	-0.84	-7.85	-0.66	1.81e-11	Aortic root size;
SKCM	cis	rs12497850	0.931	rs13064911	chr3:48952385	A/G	cg06212747	chr3:49208901	KLHDC8B	0.68	4.9	0.49	5.06e-6	Parkinson's disease;
SKCM	cis	rs2439831	0.850	rs28413881	chr15:44174099	G/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.38	5.87	0.55	1.01e-7	Lung cancer in ever smokers;
SKCM	cis	rs2070488	0.965	rs9877282	chr3:38541452	A/G	cg01465620	chr3:38496096	LOC100128640;ACVR2B	-0.98	-9.25	-0.72	3.55e-14	Electrocardiographic conduction measures;
SKCM	cis	rs6951245	1.000	rs78628466	chr7:1068453	G/C	cg24642844	chr7:1081250	C7orf50	-0.95	-6.4	-0.59	1.06e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7811142	0.830	rs7341507	chr7:99951315	A/G	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.12	6.82	0.61	1.73e-9	Platelet count;
SKCM	cis	rs870825	0.860	rs10015194	chr4:185598925	C/T	cg04058563	chr4:185651563	MLF1IP	1.02	5.81	0.55	1.27e-7	Blood protein levels;
SKCM	cis	rs6089829	0.851	rs6089827	chr20:61668845	C/T	cg08564027	chr20:61660810	NA	0.63	5.68	0.54	2.21e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs9611565	0.512	rs5751147	chr22:42139054	G/A	cg03806693	chr22:41940476	POLR3H	1.15	7.18	0.63	3.65e-10	Vitiligo;
SKCM	cis	rs17685	0.712	rs10952842	chr7:75780413	G/A	cg16489192	chr7:75678113	MDH2;STYXL1	-0.52	-4.78	-0.48	8.22e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs11690935	0.959	rs6758704	chr2:172655097	T/C	cg13550731	chr2:172543902	DYNC1I2	-0.95	-8.21	-0.68	3.64e-12	Schizophrenia;
SKCM	cis	rs58688157	0.705	rs936469	chr11:606749	G/A	cg16486109	chr11:613632	IRF7	1.07	7.28	0.64	2.33e-10	Systemic lupus erythematosus;
SKCM	cis	rs1461503	0.966	rs11218908	chr11:122841687	A/G	cg27398637	chr11:122830231	C11orf63	-0.63	-4.8	-0.48	7.54e-6	Menarche (age at onset);
SKCM	cis	rs9467773	0.620	rs2498351	chr6:26659642	C/T	cg09904177	chr6:26538194	HMGN4	0.58	5.01	0.49	3.28e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7945705	0.719	rs2012680	chr11:8996059	G/A	cg13070366	chr11:9386451	NA	0.58	5.09	0.5	2.42e-6	Hemoglobin concentration;
SKCM	cis	rs11098499	0.780	rs7680914	chr4:120563053	A/G	cg24375607	chr4:120327624	NA	0.63	4.85	0.48	6.29e-6	Corneal astigmatism;
SKCM	cis	rs10752881	0.933	rs2027086	chr1:183057933	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.78	6.87	0.61	1.42e-9	Colorectal cancer;
SKCM	cis	rs10504229	0.817	rs55949560	chr8:58167603	T/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.82	-0.48	7.06e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs7959452	0.590	rs56054057	chr12:69775972	C/T	cg20891283	chr12:69753455	YEATS4	0.91	9.3	0.73	2.78e-14	Blood protein levels;
SKCM	cis	rs873946	0.517	rs2803990	chr10:134560340	A/G	cg14275445	chr10:134560047	INPP5A	-0.52	-4.77	-0.48	8.48e-6	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs4332037	0.510	rs11762803	chr7:1886805	A/G	cg02825527	chr7:2087843	MAD1L1	-0.68	-4.94	-0.49	4.36e-6	Bipolar disorder;
SKCM	cis	rs9809213	0.943	rs9876321	chr3:72357163	G/A	cg09429735	chr3:71752026	EIF4E3	-0.57	-5.18	-0.51	1.71e-6	Cognitive ability;Cognitive ability (multi-trait analysis);
SKCM	cis	rs6866344	0.697	rs56159071	chr5:178127246	T/A	cg03877680	chr5:178157825	ZNF354A	0.82	5.7	0.54	2.03e-7	Neutrophil percentage of white cells;
SKCM	cis	rs1218582	0.772	rs2174507	chr1:154887949	C/T	cg16680214	chr1:154839983	KCNN3	-0.56	-5.01	-0.49	3.29e-6	Prostate cancer;
SKCM	trans	rs1814175	0.791	rs10219223	chr11:49791468	A/T	cg03929089	chr4:120376271	NA	-0.9	-8.5	-0.69	9.91e-13	Height;
SKCM	cis	rs7945705	0.902	rs2016942	chr11:8938787	A/G	cg21881798	chr11:8931708	C11orf17;ST5	0.77	7.16	0.63	3.87e-10	Hemoglobin concentration;
SKCM	trans	rs17685	0.743	rs10277259	chr7:75802674	A/C	cg19862616	chr7:65841803	NCRNA00174	0.97	10.73	0.77	5.13e-17	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs634534	0.622	rs1308733	chr11:65720841	T/C	cg02427764	chr11:65769310	BANF1;EIF1AD	-0.68	-5.13	-0.5	2.03e-6	Sum eosinophil basophil counts;Eosinophil counts;
SKCM	cis	rs763014	0.932	rs2269560	chr16:682442	A/C	cg00908189	chr16:619842	PIGQ	0.87	7.69	0.66	3.77e-11	Height;
SKCM	cis	rs2645694	0.626	rs2645684	chr4:77819892	A/C	cg03477792	chr4:77819574	ANKRD56	0.56	6.18	0.57	2.75e-8	Emphysema distribution in smoking;
SKCM	cis	rs754466	0.580	rs11002301	chr10:79574078	G/A	cg17075019	chr10:79541650	NA	-0.77	-6.6	-0.6	4.48e-9	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs7216064	1.000	rs12602655	chr17:65909442	A/G	cg12091567	chr17:66097778	LOC651250	-0.75	-4.97	-0.49	3.81e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs2404602	0.669	rs12438540	chr15:76943213	C/G	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs11585357	0.947	rs6666990	chr1:17611520	G/A	cg08277548	chr1:17600880	PADI3	0.9	6.35	0.58	1.34e-8	Hair shape;
SKCM	cis	rs7659604	1.000	rs6823488	chr4:122664819	A/G	cg19671926	chr4:122722719	EXOSC9	-0.64	-4.78	-0.48	8.04e-6	Type 2 diabetes;
SKCM	cis	rs2228479	0.850	rs12598316	chr16:89916600	C/A	cg00800038	chr16:89945340	TCF25	-1.0	-5.06	-0.5	2.75e-6	Skin colour saturation;
SKCM	cis	rs2153535	0.504	rs9328472	chr6:8470848	G/A	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs11892454	0.543	rs9941574	chr2:26055668	C/T	cg17263061	chr2:26915892	KCNK3	0.69	4.98	0.49	3.73e-6	Heschl's gyrus morphology;
SKCM	cis	rs826838	0.967	rs7970069	chr12:38810631	T/C	cg13010199	chr12:38710504	ALG10B	0.86	6.84	0.61	1.61e-9	Heart rate;
SKCM	cis	rs875971	0.660	rs801211	chr7:66015689	T/G	cg11987759	chr7:65425863	GUSB	0.69	5.9	0.56	8.74e-8	Aortic root size;
SKCM	cis	rs873946	0.586	rs12770021	chr10:134562021	G/A	cg14275445	chr10:134560047	INPP5A	-0.54	-4.86	-0.48	6e-6	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs4555082	0.874	rs2816611	chr14:105722976	G/C	cg13114125	chr14:105738426	BRF1	-0.69	-5.39	-0.52	7.2e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs6546550	1.000	rs6546550	chr2:70038232	C/G	cg02498382	chr2:70120550	SNRNP27	-0.46	-5.07	-0.5	2.61e-6	Prevalent atrial fibrillation;
SKCM	cis	rs995000	0.931	rs1184547	chr1:63007228	G/A	cg06896770	chr1:63153194	DOCK7	-0.73	-6.62	-0.6	4.11e-9	Triglyceride levels;
SKCM	cis	rs2239547	0.657	rs2072391	chr3:52862200	C/T	cg11645453	chr3:52864694	ITIH4	0.79	7.19	0.63	3.41e-10	Schizophrenia;
SKCM	cis	rs9583531	0.527	rs2391866	chr13:111363294	A/T	cg15841412	chr13:111365552	ING1	0.73	4.81	0.48	7.36e-6	Coronary artery disease;
SKCM	cis	rs3820068	0.603	rs1122387	chr1:15947282	T/C	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs11764590	0.671	rs12669370	chr7:2081914	G/A	cg23422044	chr7:1970798	MAD1L1	-0.84	-6.03	-0.56	5.11e-8	Neuroticism;
SKCM	cis	rs7937682	0.793	rs4581484	chr11:111415822	G/A	cg09085632	chr11:111637200	PPP2R1B	0.71	5.68	0.54	2.23e-7	Primary sclerosing cholangitis;
SKCM	cis	rs3820928	0.934	rs66959645	chr2:227761582	C/A	cg11843606	chr2:227700838	RHBDD1	-0.62	-4.99	-0.49	3.52e-6	Pulmonary function;
SKCM	cis	rs654950	0.806	rs2759251	chr1:42041749	C/G	cg06885757	chr1:42089581	HIVEP3	-0.63	-6.41	-0.59	1.01e-8	Airway imaging phenotypes;
SKCM	cis	rs2204008	0.744	rs1115514	chr12:38280140	C/T	cg26384229	chr12:38710491	ALG10B	0.85	6.78	0.61	2.05e-9	Bladder cancer;
SKCM	cis	rs9910055	0.540	rs609292	chr17:42180436	G/A	cg19774624	chr17:42201019	HDAC5	0.83	6.53	0.59	5.96e-9	Total body bone mineral density;
SKCM	cis	rs3818285	0.556	rs944966	chr10:111658334	C/G	cg00817464	chr10:111662876	XPNPEP1	-0.76	-7.58	-0.65	5.99e-11	Superior crus of antihelix expression;
SKCM	cis	rs9910055	0.676	rs11079983	chr17:42198170	C/T	cg13607699	chr17:42295918	UBTF	0.78	6.13	0.57	3.38e-8	Total body bone mineral density;
SKCM	cis	rs11585357	1.000	rs72646785	chr1:17603472	G/T	cg08277548	chr1:17600880	PADI3	-0.9	-6.36	-0.58	1.26e-8	Hair shape;
SKCM	cis	rs2188420	0.935	rs117046255	chr7:106484822	C/T	cg23615938	chr7:105753134	SYPL1	-1.02	-5.05	-0.5	2.79e-6	Interferon gamma levels;
SKCM	cis	rs4975616	0.869	rs452384	chr5:1330840	T/C	cg07493874	chr5:1342172	CLPTM1L	-0.7	-6.57	-0.6	5.12e-9	Lung cancer;
SKCM	cis	rs6540556	0.724	rs6679631	chr1:209935491	C/A	cg05527609	chr1:210001259	C1orf107	-0.86	-4.8	-0.48	7.39e-6	Red blood cell count;
SKCM	cis	rs2732480	0.557	rs2732484	chr12:48737245	A/C	cg21348975	chr12:48724119	NA	-0.62	-5.32	-0.52	9.82e-7	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs28595532	0.920	rs114796605	chr4:119744472	C/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs709400	0.520	rs28583452	chr14:103938664	C/A	cg26031613	chr14:104095156	KLC1	0.77	5.96	0.56	6.87e-8	Body mass index;
SKCM	cis	rs72781680	1.000	rs17712391	chr2:24245659	C/T	cg08917208	chr2:24149416	ATAD2B	1.06	5.98	0.56	6.3e-8	Lymphocyte counts;
SKCM	cis	rs17685	0.753	rs11764129	chr7:75761890	T/C	cg01364799	chr7:75623366	TMEM120A	-0.7	-5.69	-0.54	2.09e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs898097	0.841	rs55810435	chr17:80836722	G/C	cg15369054	chr17:80825471	TBCD	0.68	6.38	0.59	1.17e-8	Breast cancer;
SKCM	cis	rs1153858	0.943	rs7402632	chr15:45701913	A/T	cg10760299	chr15:45669010	GATM	0.6	5.93	0.56	7.69e-8	Homoarginine levels;
SKCM	cis	rs6565180	1.000	rs12930787	chr16:30381303	C/G	cg17640201	chr16:30407289	ZNF48	-0.9	-6.68	-0.6	3.17e-9	Tonsillectomy;
SKCM	cis	rs7954584	0.626	rs12809676	chr12:122442381	C/A	cg22618164	chr12:122356400	WDR66	0.53	5.31	0.52	1.02e-6	Mean corpuscular volume;
SKCM	cis	rs769267	0.965	rs2017964	chr19:19387149	T/C	cg03709012	chr19:19516395	GATAD2A	0.81	6.49	0.59	7.18e-9	Tonsillectomy;
SKCM	cis	rs3768617	0.510	rs4651143	chr1:183097398	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.69	0.66	3.68e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs7772486	0.625	rs9390355	chr6:146112942	C/T	cg05347473	chr6:146136440	FBXO30	-0.56	-5.22	-0.51	1.47e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2404602	0.647	rs116505114	chr15:77074794	T/C	cg23625390	chr15:77176239	SCAPER	-0.82	-7.93	-0.67	1.26e-11	Blood metabolite levels;
SKCM	cis	rs17685	0.753	rs1639617	chr7:75701728	A/G	cg16489192	chr7:75678113	MDH2;STYXL1	-0.58	-5.46	-0.53	5.43e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2243480	1.000	rs34577383	chr7:65385726	C/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs3820068	0.581	rs72645871	chr1:15926142	G/A	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs116095464	1.000	rs28416084	chr5:217640	G/A	cg22496380	chr5:211416	CCDC127	-1.0	-5.11	-0.5	2.25e-6	Breast cancer;
SKCM	cis	rs7296418	0.961	rs10773921	chr12:123541606	C/T	cg05973401	chr12:123451056	ABCB9	0.84	6.88	0.61	1.34e-9	Platelet count;
SKCM	cis	rs710865	0.966	rs709683	chr1:19565344	C/G	cg13387374	chr1:19411106	UBR4	0.65	4.86	0.48	6.02e-6	Brain structure;
SKCM	cis	rs992157	1.000	rs736730	chr2:219120255	C/T	cg20019365	chr2:219134978	PNKD;AAMP	0.81	7.35	0.64	1.68e-10	Colorectal cancer;
SKCM	cis	rs365132	1.000	rs353490	chr5:176433063	C/T	cg16309518	chr5:176445507	NA	-0.52	-4.99	-0.49	3.54e-6	Menarche and menopause (age at onset);Menopause (age at onset);
SKCM	cis	rs1348850	0.757	rs4893969	chr2:178478476	T/A	cg02961200	chr2:178257176	LOC100130691;AGPS	0.78	5.46	0.53	5.54e-7	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs826838	1.000	rs7953227	chr12:38946193	G/A	cg13010199	chr12:38710504	ALG10B	0.85	6.38	0.59	1.14e-8	Heart rate;
SKCM	cis	rs1552244	1.000	rs6804473	chr3:10060425	C/T	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs6665290	0.669	rs7552783	chr1:227174145	T/C	cg10327440	chr1:227177885	CDC42BPA	-1.08	-9.9	-0.75	1.95e-15	Myeloid white cell count;
SKCM	cis	rs7100689	0.622	rs1340383	chr10:82095968	T/G	cg01528321	chr10:82214614	TSPAN14	0.75	6.03	0.56	5.23e-8	Post bronchodilator FEV1;
SKCM	trans	rs8073060	0.660	rs34184070	chr17:34003810	A/G	cg19694781	chr19:47549865	TMEM160	-1.04	-8.28	-0.68	2.65e-12	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs6951245	0.554	rs10270249	chr7:1151886	G/T	cg18402987	chr7:1209562	NA	0.83	5.53	0.53	4.06e-7	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs6545883	0.894	rs9677047	chr2:61585295	C/G	cg15711740	chr2:61764176	XPO1	0.68	4.83	0.48	6.8e-6	Tuberculosis;
SKCM	cis	rs3008870	1.000	rs2065000	chr1:67468124	G/C	cg08660285	chr1:67390436	MIER1;WDR78	-0.91	-5.96	-0.56	6.81e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs6933660	0.720	rs6914656	chr6:151753421	C/G	cg10883421	chr6:151773342	RMND1;C6orf211	0.82	6.83	0.61	1.69e-9	Menarche (age at onset);
SKCM	cis	rs992157	0.835	rs2271543	chr2:219142491	C/T	cg20019365	chr2:219134978	PNKD;AAMP	-0.72	-6.22	-0.58	2.33e-8	Colorectal cancer;
SKCM	cis	rs7953249	0.618	rs2650000	chr12:121388962	G/T	cg02403541	chr12:121454288	C12orf43	0.64	4.98	0.49	3.79e-6	Invasive epithelial ovarian cancer;High-grade serous ovarian cancer;Chronic obstructive pulmonary disease-related biomarkers;N-glycan levels;Serous invasive ovarian cancer;Epithelial ovarian cancer;
SKCM	cis	rs11098499	0.909	rs28555550	chr4:120211040	C/G	cg09307838	chr4:120376055	NA	0.96	8.12	0.68	5.43e-12	Corneal astigmatism;
SKCM	cis	rs2455601	0.744	rs2163626	chr11:8983547	A/G	cg21881798	chr11:8931708	C11orf17;ST5	-0.77	-5.18	-0.51	1.66e-6	Schizophrenia;
SKCM	cis	rs3785574	0.962	rs2584630	chr17:61887561	T/A	cg01411255	chr17:61851458	DDX42;CCDC47	1.14	12.68	0.82	1.2e-20	Height;
SKCM	cis	rs10779751	0.734	rs1130683	chr1:11132217	G/A	cg08854313	chr1:11322531	MTOR	0.77	5.52	0.53	4.36e-7	Body mass index;
SKCM	cis	rs867186	0.925	rs6120844	chr20:33720240	G/T	cg04194272	chr20:33683537	NA	-1.01	-5.89	-0.56	9.09e-8	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs7927771	1.000	rs12361031	chr11:47783076	G/A	cg05585544	chr11:47624801	NA	-0.6	-5.22	-0.51	1.45e-6	Subjective well-being;
SKCM	cis	rs2243480	0.803	rs35480979	chr7:65357084	A/G	cg18252515	chr7:66147081	NA	-1.29	-7.41	-0.64	1.3e-10	Diabetic kidney disease;
SKCM	cis	rs2732480	0.577	rs2732466	chr12:48732459	A/G	cg21348975	chr12:48724119	NA	-0.58	-4.88	-0.48	5.47e-6	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs6753739	0.784	rs11690649	chr2:219947771	T/C	cg09617556	chr2:219924408	IHH	0.47	4.91	0.49	4.97e-6	Height;
SKCM	cis	rs394563	0.591	rs237026	chr6:149720681	G/A	cg03678062	chr6:149772716	ZC3H12D	-0.5	-5.73	-0.54	1.83e-7	Dupuytren's disease;
SKCM	cis	rs4803468	1.000	rs10422783	chr19:41906436	T/C	cg14132834	chr19:41945861	ATP5SL	-0.74	-5.71	-0.54	1.99e-7	Height;
SKCM	cis	rs8180040	0.966	rs3736177	chr3:47451411	C/T	cg16586182	chr3:47516702	SCAP	0.76	5.32	0.52	9.63e-7	Colorectal cancer;
SKCM	cis	rs1552244	0.572	rs67227131	chr3:10172744	G/A	cg00149659	chr3:10157352	C3orf10	1.23	5.46	0.53	5.43e-7	Alzheimer's disease;
SKCM	cis	rs28386778	0.863	rs58269663	chr17:61843130	G/A	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs829883	0.738	rs249854	chr12:98862772	G/A	cg25150519	chr12:98850993	NA	0.52	5.1	0.5	2.34e-6	Colorectal adenoma (advanced);
SKCM	cis	rs8017423	0.967	rs2277515	chr14:90723000	A/G	cg04374321	chr14:90722782	PSMC1	1.03	9.44	0.73	1.55e-14	Mortality in heart failure;
SKCM	cis	rs10256972	0.681	rs6979076	chr7:1116247	C/T	cg07092213	chr7:1199455	ZFAND2A	0.6	4.83	0.48	6.6e-6	Longevity;Endometriosis;
SKCM	cis	rs2839186	0.814	rs13052376	chr21:47707403	G/C	cg11766577	chr21:47581405	C21orf56	-0.71	-6.01	-0.56	5.6e-8	Testicular germ cell tumor;
SKCM	cis	rs6952808	0.723	rs1107592	chr7:2041432	C/T	cg21782813	chr7:2030301	MAD1L1	-0.58	-6.21	-0.58	2.38e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs4819052	0.808	rs2246697	chr21:46689999	G/A	cg02159808	chr21:46707872	POFUT2;LOC642852	0.74	5.68	0.54	2.22e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs17685	0.753	rs10264760	chr7:75749694	A/G	cg16684958	chr7:75615977	POR	0.55	5.27	0.51	1.19e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs25645	0.502	rs7207600	chr17:38091660	G/A	cg17467752	chr17:38218738	THRA	0.63	4.94	0.49	4.35e-6	Myeloid white cell count;
SKCM	cis	rs1167827	1.000	rs1167827	chr7:75163169	A/G	cg09988129	chr7:74988866	PMS2L2;STAG3L1	0.68	5.39	0.52	7.32e-7	Body mass index;BMI (adjusted for smoking behaviour);BMI in non-smokers;Body mass index (joint analysis main effects and physical activity interaction);Body mass index in physically active individuals;Body mass index (joint analysis main effects and smoking interaction);
SKCM	cis	rs801193	0.569	rs4717315	chr7:66178325	C/T	cg18876405	chr7:65276391	NA	0.61	6.01	0.56	5.49e-8	Aortic root size;
SKCM	cis	rs6977660	0.714	rs9969171	chr7:19827328	T/C	cg07541023	chr7:19748670	TWISTNB	0.72	4.78	0.48	7.95e-6	Thyroid stimulating hormone;
SKCM	cis	rs9834970	0.815	rs1553656	chr3:36859705	C/T	cg25202636	chr3:37035158	MLH1;EPM2AIP1	-0.65	-4.96	-0.49	3.96e-6	Bipolar disorder with mood-incongruent psychosis;Subjective response to lithium treatment;Bipolar disorder;Schizophrenia or bipolar disorder;Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);
SKCM	cis	rs151997	0.925	rs27579	chr5:50165147	G/A	cg06027927	chr5:50259733	NA	0.62	5.36	0.52	8.37e-7	Callous-unemotional behaviour;
SKCM	cis	rs137603	0.644	rs137619	chr22:39706360	A/C	cg17798944	chr22:39715225	SNORD43;RPL3	-0.61	-4.97	-0.49	3.92e-6	Primary biliary cholangitis;
SKCM	cis	rs2832191	0.716	rs2692625	chr21:30446360	C/G	cg08807101	chr21:30365312	RNF160	0.74	6.09	0.57	4.06e-8	Dental caries;
SKCM	cis	rs9880211	0.613	rs12695644	chr3:135844938	C/T	cg21827317	chr3:136751795	NA	-0.65	-4.96	-0.49	4.1e-6	Body mass index;Height;
SKCM	cis	rs11098499	0.775	rs2002049	chr4:120257417	A/G	cg09307838	chr4:120376055	NA	0.93	7.53	0.65	7.72e-11	Corneal astigmatism;
SKCM	cis	rs28595532	0.764	rs116788606	chr4:119748849	G/C	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs12464559	0.522	rs7583060	chr2:152620943	C/A	cg01189475	chr2:152685088	ARL5A	1.03	5.27	0.51	1.18e-6	Response to cognitive-behavioural therapy in anxiety disorder;
SKCM	cis	rs12824058	0.831	rs12831363	chr12:130814013	C/T	cg26677194	chr12:130822605	PIWIL1	-0.75	-6.17	-0.57	2.84e-8	Menopause (age at onset);
SKCM	cis	rs4555082	0.957	rs2816629	chr14:105737261	G/A	cg13114125	chr14:105738426	BRF1	-0.73	-5.66	-0.54	2.41e-7	Mean platelet volume;Platelet distribution width;
SKCM	trans	rs1814175	0.653	rs10839480	chr11:50034556	C/T	cg03929089	chr4:120376271	NA	-0.9	-8.13	-0.68	5.17e-12	Height;
SKCM	cis	rs2243480	1.000	rs316329	chr7:65608416	A/C	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs12824058	0.831	rs11608406	chr12:130805866	G/C	cg26677194	chr12:130822605	PIWIL1	0.7	5.64	0.54	2.66e-7	Menopause (age at onset);
SKCM	cis	rs7666738	0.753	rs35194639	chr4:99053819	G/C	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1577917	0.958	rs67024565	chr6:86553997	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.68	-5.91	-0.56	8.36e-8	Response to antipsychotic treatment;
SKCM	cis	rs7216064	1.000	rs11079707	chr17:65835617	A/G	cg12091567	chr17:66097778	LOC651250	0.7	4.93	0.49	4.61e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs1552244	1.000	rs13433680	chr3:10136390	T/A	cg02579736	chr3:10068473	FANCD2;CIDECP	1.27	6.34	0.58	1.38e-8	Alzheimer's disease;
SKCM	cis	rs2180341	1.000	rs13218061	chr6:127653758	G/A	cg27446573	chr6:127587934	RNF146	0.94	8.08	0.68	6.49e-12	Breast cancer;
SKCM	cis	rs2839186	0.771	rs13049175	chr21:47641326	G/A	cg11766577	chr21:47581405	C21orf56	0.69	5.81	0.55	1.29e-7	Testicular germ cell tumor;
SKCM	cis	rs2180341	1.000	rs7453272	chr6:127633959	C/T	cg24812749	chr6:127587940	RNF146	-0.91	-8.22	-0.68	3.56e-12	Breast cancer;
SKCM	cis	rs11105298	0.891	rs10777163	chr12:89830720	T/C	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.88	-6.03	-0.56	5.22e-8	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs1799949	0.931	rs9912203	chr17:41445145	A/G	cg23758822	chr17:41437982	NA	-0.95	-7.28	-0.64	2.27e-10	Menopause (age at onset);
SKCM	cis	rs7772486	0.658	rs4895683	chr6:146113654	T/A	cg05347473	chr6:146136440	FBXO30	-0.56	-5.22	-0.51	1.47e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9910055	0.529	rs2523161	chr17:42179405	C/T	cg08499158	chr17:42289980	UBTF	0.72	5.62	0.54	2.9e-7	Total body bone mineral density;
SKCM	cis	rs2153535	0.580	rs1414345	chr6:8471537	T/G	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs992157	0.687	rs35271699	chr2:219117482	G/A	cg20019365	chr2:219134978	PNKD;AAMP	0.72	6.4	0.59	1.07e-8	Colorectal cancer;
SKCM	cis	rs7927771	0.864	rs2293577	chr11:47437202	C/T	cg05585544	chr11:47624801	NA	0.57	4.92	0.49	4.76e-6	Subjective well-being;
SKCM	cis	rs801193	0.935	rs11772264	chr7:66176387	T/C	cg11764359	chr7:65958608	NA	0.86	6.55	0.6	5.68e-9	Aortic root size;
SKCM	cis	rs10416265	0.503	rs1981818	chr19:33615122	C/T	cg17764715	chr19:33622953	WDR88	-0.99	-8.27	-0.68	2.77e-12	Bone properties (heel);
SKCM	cis	rs7772486	0.875	rs9403770	chr6:146423334	C/T	cg05347473	chr6:146136440	FBXO30	0.65	5.96	0.56	6.79e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs10256972	0.621	rs2363285	chr7:1091644	C/T	cg07308232	chr7:1071921	C7orf50	-0.58	-5.11	-0.5	2.23e-6	Longevity;Endometriosis;
SKCM	cis	rs7100689	0.622	rs1417221	chr10:82100428	G/A	cg01528321	chr10:82214614	TSPAN14	0.76	6.06	0.57	4.54e-8	Post bronchodilator FEV1;
SKCM	cis	rs2224391	1.000	rs2773320	chr6:5261681	A/G	cg09085698	chr6:5261316	LYRM4;FARS2	-0.75	-5.33	-0.52	9.43e-7	Height;
SKCM	cis	rs7772486	0.806	rs4075696	chr6:146250947	T/C	cg23711669	chr6:146136114	FBXO30	-0.74	-6.96	-0.62	9.36e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7208859	0.623	rs3752020	chr17:29111125	T/G	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs801193	0.844	rs732465	chr7:65998450	T/C	cg18876405	chr7:65276391	NA	0.78	6.84	0.61	1.57e-9	Aortic root size;
SKCM	cis	rs7927771	0.832	rs10838699	chr11:47386073	T/C	cg05585544	chr11:47624801	NA	0.56	4.84	0.48	6.52e-6	Subjective well-being;
SKCM	cis	rs11690935	0.959	rs6745143	chr2:172650382	G/A	cg13550731	chr2:172543902	DYNC1I2	-0.95	-8.21	-0.68	3.64e-12	Schizophrenia;
SKCM	cis	rs1691799	0.867	rs1027399	chr12:66760942	G/A	cg16791601	chr12:66731901	HELB	-0.63	-5.63	-0.54	2.69e-7	White blood cell count (basophil);
SKCM	cis	rs208520	0.507	rs3903670	chr6:66812183	T/C	cg07460842	chr6:66804631	NA	-1.12	-13.09	-0.83	2.28e-21	Exhaled nitric oxide output;
SKCM	cis	rs7824557	0.591	rs2043510	chr8:11225168	G/A	cg21775007	chr8:11205619	TDH	-0.67	-6.13	-0.57	3.37e-8	Retinal vascular caliber;
SKCM	cis	rs4925325	0.741	rs6142886	chr20:60511190	A/G	cg16423285	chr20:60520624	NA	0.99	7.35	0.64	1.69e-10	Obesity-related traits;
SKCM	cis	rs4242434	0.927	rs11781149	chr8:22473158	C/T	cg03733263	chr8:22462867	KIAA1967	1.12	9.48	0.73	1.25e-14	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs72634258	0.572	rs66692705	chr1:7938565	T/C	cg00042356	chr1:8021962	PARK7	0.86	6.01	0.56	5.55e-8	Inflammatory bowel disease;
SKCM	cis	rs4242434	0.672	rs10099266	chr8:22484268	C/G	cg03733263	chr8:22462867	KIAA1967	0.71	4.98	0.49	3.76e-6	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs1691799	0.899	rs903589	chr12:66745835	C/T	cg16791601	chr12:66731901	HELB	-0.59	-5.17	-0.51	1.74e-6	White blood cell count (basophil);
SKCM	cis	rs1568889	1.000	rs9783281	chr11:28033786	T/C	cg06544937	chr11:28130018	METT5D1;KIF18A	0.83	6.32	0.58	1.5e-8	Bipolar disorder;
SKCM	cis	rs2777491	0.915	rs7178777	chr15:41634588	C/A	cg18705301	chr15:41695430	NDUFAF1	-0.96	-9.11	-0.72	6.65e-14	Ulcerative colitis;
SKCM	cis	rs7100689	0.577	rs10749551	chr10:82054001	A/C	cg01528321	chr10:82214614	TSPAN14	0.77	7.36	0.64	1.63e-10	Post bronchodilator FEV1;
SKCM	cis	rs2921036	0.545	rs4840975	chr8:8363258	C/T	cg15556689	chr8:8085844	FLJ10661	-0.63	-4.99	-0.49	3.64e-6	Neuroticism;
SKCM	cis	rs28386778	0.863	rs3760256	chr17:61821161	A/G	cg01411255	chr17:61851458	DDX42;CCDC47	0.78	5.03	0.49	3.06e-6	Prudent dietary pattern;
SKCM	cis	rs6500395	0.775	rs13331298	chr16:48661489	G/A	cg04672837	chr16:48644449	N4BP1	0.59	4.89	0.48	5.37e-6	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs908922	0.887	rs1415432	chr1:152480654	G/A	cg09873164	chr1:152488093	CRCT1	0.85	4.95	0.49	4.13e-6	Hair morphology;
SKCM	cis	rs8103278	0.507	rs62111759	chr19:46296230	A/T	cg11657440	chr19:46296263	DMWD	1.07	10.44	0.76	1.85e-16	Coronary artery disease;
SKCM	cis	rs13108904	0.651	rs875475	chr4:1192409	G/A	cg02018176	chr4:1364513	KIAA1530	0.75	6.02	0.56	5.45e-8	Obesity-related traits;
SKCM	cis	rs763014	0.966	rs4984903	chr16:680695	A/G	cg09263875	chr16:632152	PIGQ	0.75	6.45	0.59	8.51e-9	Height;
SKCM	cis	rs13256369	0.802	rs11249884	chr8:8561552	C/T	cg06636001	chr8:8085503	FLJ10661	-0.79	-6.11	-0.57	3.72e-8	Obesity-related traits;
SKCM	cis	rs12142240	0.698	rs17361819	chr1:46828109	A/G	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	trans	rs1814175	0.817	rs10769618	chr11:49822336	A/G	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs2286503	1.000	rs2286499	chr7:22857477	A/G	cg15401507	chr7:22894281	NA	-0.57	-5.58	-0.53	3.39e-7	Fibrinogen;
SKCM	cis	rs72781680	0.898	rs17762609	chr2:24114729	G/T	cg08917208	chr2:24149416	ATAD2B	0.99	5.24	0.51	1.31e-6	Lymphocyte counts;
SKCM	cis	rs875971	0.638	rs35986979	chr7:66088990	G/A	cg00343986	chr7:65444356	GUSB	-0.68	-4.99	-0.49	3.65e-6	Aortic root size;
SKCM	cis	rs875971	0.540	rs1723268	chr7:65473080	A/C	cg18876405	chr7:65276391	NA	0.86	8.04	0.67	8.05e-12	Aortic root size;
SKCM	cis	rs10751667	0.600	rs10794342	chr11:924904	C/T	cg06064525	chr11:970664	AP2A2	-0.55	-5.08	-0.5	2.47e-6	Alzheimer's disease (late onset);
SKCM	cis	rs67311347	1.000	rs7636719	chr3:40432084	C/T	cg00091569	chr3:40428383	ENTPD3	0.61	5.36	0.52	8.37e-7	Renal cell carcinoma;
SKCM	cis	rs28386778	0.863	rs2727355	chr17:61931790	C/T	cg06873352	chr17:61820015	STRADA	0.76	6.34	0.58	1.38e-8	Prudent dietary pattern;
SKCM	cis	rs2153535	0.601	rs9379224	chr6:8538413	A/G	cg07606381	chr6:8435919	SLC35B3	0.93	6.41	0.59	1e-8	Motion sickness;
SKCM	cis	rs2153535	0.580	rs6597322	chr6:8449952	T/G	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs875971	1.000	rs7792762	chr7:66004138	T/C	cg11764359	chr7:65958608	NA	0.83	7.67	0.66	4.11e-11	Aortic root size;
SKCM	cis	rs9926296	0.712	rs258319	chr16:89732024	A/T	cg01097406	chr16:89675127	NA	0.56	5.72	0.54	1.87e-7	Vitiligo;
SKCM	cis	rs9858542	0.953	rs6779524	chr3:49450449	C/T	cg03060546	chr3:49711283	APEH	-0.7	-5.18	-0.51	1.71e-6	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs12047808	0.841	rs73052637	chr1:179382552	G/C	cg08037922	chr1:179521085	C1orf125;NPHS2	-1.08	-5.8	-0.55	1.32e-7	Multiple sclerosis (age of onset);
SKCM	cis	rs11098499	0.657	rs4463052	chr4:120313258	T/C	cg24375607	chr4:120327624	NA	0.65	4.97	0.49	3.87e-6	Corneal astigmatism;
SKCM	cis	rs6570726	0.526	rs7755237	chr6:145731852	T/C	cg23711669	chr6:146136114	FBXO30	-0.69	-6.54	-0.6	5.87e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9611565	0.512	rs139566	chr22:42199277	A/G	cg03806693	chr22:41940476	POLR3H	-1.08	-5.96	-0.56	7.02e-8	Vitiligo;
SKCM	cis	rs4481887	0.927	rs12731721	chr1:248474210	G/A	cg00666640	chr1:248458726	OR2T12	0.63	5.91	0.56	8.65e-8	Common traits (Other);
SKCM	cis	rs4237845	0.837	rs7971877	chr12:58287630	T/G	cg00677455	chr12:58241039	CTDSP2	0.69	5.74	0.54	1.74e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs950776	0.518	rs62008174	chr15:78808947	C/T	cg06917634	chr15:78832804	PSMA4	1.01	10.48	0.76	1.5e-16	Sudden cardiac arrest;
SKCM	cis	rs12130219	0.500	rs1552991	chr1:152165878	C/T	cg20694572	chr1:152331529	FLG2	-0.55	-4.85	-0.48	6.23e-6	Inflammatory skin disease;
SKCM	cis	rs16866061	1.000	rs11686590	chr2:225334070	A/G	cg02879423	chr2:224806760	WDFY1	0.69	5.03	0.5	3.03e-6	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs7843479	0.965	rs17616085	chr8:21857267	C/T	cg17168535	chr8:21777572	XPO7	0.82	7.07	0.63	5.69e-10	Mean corpuscular volume;
SKCM	cis	rs11690935	0.632	rs1607254	chr2:172626552	A/G	cg13550731	chr2:172543902	DYNC1I2	0.61	5.31	0.52	1.02e-6	Schizophrenia;
SKCM	cis	rs763014	0.932	rs2384972	chr16:674424	G/A	cg09263875	chr16:632152	PIGQ	0.72	6.45	0.59	8.62e-9	Height;
SKCM	cis	rs7659604	0.540	rs28672860	chr4:122705051	G/A	cg19671926	chr4:122722719	EXOSC9	0.76	6.97	0.62	9.04e-10	Type 2 diabetes;
SKCM	cis	rs9325144	0.671	rs35817541	chr12:38975001	T/C	cg26384229	chr12:38710491	ALG10B	-0.73	-6.59	-0.6	4.68e-9	Morning vs. evening chronotype;
SKCM	cis	rs9788682	1.000	rs2036534	chr15:78826948	T/C	cg06917634	chr15:78832804	PSMA4	-0.83	-5.02	-0.49	3.13e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs13118159	0.550	rs2336081	chr4:1350322	A/G	cg16405210	chr4:1374714	KIAA1530	0.91	7.02	0.62	7.26e-10	Longevity;
SKCM	cis	rs9790314	1.000	rs336589	chr3:161080358	C/T	cg03342759	chr3:160939853	NMD3	-0.72	-7.89	-0.67	1.53e-11	Morning vs. evening chronotype;
SKCM	cis	rs9309711	0.544	rs9309712	chr2:3491327	G/T	cg15506890	chr2:3487001	NA	-0.65	-5.42	-0.52	6.44e-7	Neurofibrillary tangles;
SKCM	cis	rs3785574	0.635	rs2532111	chr17:62017421	A/G	cg01411255	chr17:61851458	DDX42;CCDC47	-0.71	-5.26	-0.51	1.23e-6	Height;
SKCM	cis	rs4237845	0.537	rs9645819	chr12:58270063	T/C	cg02175503	chr12:58329896	NA	0.7	5.82	0.55	1.24e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs2404602	0.647	rs7165053	chr15:76978918	A/G	cg23625390	chr15:77176239	SCAPER	-0.82	-7.93	-0.67	1.26e-11	Blood metabolite levels;
SKCM	cis	rs2070488	0.965	rs7640050	chr3:38525864	A/C	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.98	9.25	0.72	3.55e-14	Electrocardiographic conduction measures;
SKCM	cis	rs2629540	0.924	rs1545910	chr10:126428145	G/C	cg08799069	chr10:126477246	METTL10	-0.61	-4.98	-0.49	3.67e-6	Cocaine dependence;
SKCM	cis	rs870825	0.655	rs28555435	chr4:185647300	C/A	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs10905065	0.965	rs2890365	chr10:5773876	C/A	cg11519256	chr10:5708881	ASB13	-0.58	-5.26	-0.51	1.23e-6	Menopause (age at onset);
SKCM	cis	rs10752881	1.000	rs10797807	chr1:182978873	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.74	6.71	0.6	2.83e-9	Colorectal cancer;
SKCM	cis	rs992157	0.710	rs12612347	chr2:219057338	C/T	cg00012203	chr2:219082015	ARPC2	-0.89	-7.9	-0.67	1.49e-11	Colorectal cancer;
SKCM	cis	rs6762477	0.748	rs11711407	chr3:50225029	A/G	cg04682699	chr3:50248845	SLC38A3	-0.5	-4.85	-0.48	6.21e-6	Menarche (age at onset);
SKCM	cis	rs10504229	0.683	rs2318143	chr8:58114660	C/T	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs734999	0.588	rs6701238	chr1:2520500	G/A	cg18163442	chr1:2779061	NA	-0.43	-4.8	-0.48	7.59e-6	Ulcerative colitis;
SKCM	cis	rs9300255	0.569	rs1716170	chr12:123716513	C/T	cg00376283	chr12:123451042	ABCB9	0.83	5.37	0.52	8.04e-7	Neutrophil percentage of white cells;
SKCM	cis	rs1799949	1.000	rs12950607	chr17:41299928	G/C	cg23758822	chr17:41437982	NA	0.92	7.8	0.66	2.3e-11	Menopause (age at onset);
SKCM	cis	rs1801251	1.000	rs6724117	chr2:233593660	T/G	cg25237894	chr2:233734115	C2orf82	0.58	5.23	0.51	1.36e-6	Coronary artery disease;
SKCM	cis	rs7726839	0.540	rs72703095	chr5:601789	T/C	cg10555297	chr5:473380	SLC9A3;LOC25845	1.0	4.81	0.48	7.1e-6	Obesity-related traits;
SKCM	cis	rs3771570	1.000	rs73004382	chr2:242382192	C/T	cg07612300	chr2:242033426	MTERFD2;SNED1	0.88	4.93	0.49	4.46e-6	Prostate cancer;
SKCM	cis	rs11098499	0.909	rs10014719	chr4:120320715	G/A	cg09307838	chr4:120376055	NA	0.97	7.49	0.65	9.08e-11	Corneal astigmatism;
SKCM	cis	rs2980436	1	rs2980436	chr8:8092025	A/G	cg06636001	chr8:8085503	FLJ10661	-0.94	-8.06	-0.67	7.25e-12	Schizophrenia;
SKCM	cis	rs11098499	0.754	rs28652763	chr4:120242312	C/T	cg09307838	chr4:120376055	NA	0.93	7.56	0.65	6.5500000000000006e-11	Corneal astigmatism;
SKCM	cis	rs10256972	0.577	rs2949179	chr7:1209885	C/G	cg11360546	chr7:1094263	C7orf50	-0.44	-4.9	-0.48	5.17e-6	Longevity;Endometriosis;
SKCM	cis	rs55823223	0.564	rs1463485	chr17:73851791	C/G	cg08125733	chr17:73851984	WBP2	1.06	6.6	0.6	4.51e-9	Psoriasis;
SKCM	cis	rs2404602	0.569	rs2469249	chr15:76772062	C/T	cg23625390	chr15:77176239	SCAPER	-0.84	-7.86	-0.66	1.74e-11	Blood metabolite levels;
SKCM	cis	rs2439831	0.867	rs28461955	chr15:43661459	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.39	9.42	0.73	1.62e-14	Lung cancer in ever smokers;
SKCM	trans	rs1814175	0.645	rs7123448	chr11:49764865	T/G	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs8756	0.689	rs7959830	chr12:66347368	G/T	cg06712651	chr12:66351869	HMGA2	-0.64	-5.14	-0.5	1.94e-6	Height;
SKCM	cis	rs9467773	0.595	rs2451736	chr6:26620544	G/A	cg15659132	chr6:26577336	NA	0.62	5.4	0.52	6.91e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs4746818	1.000	rs6480384	chr10:70890757	C/T	cg11621586	chr10:70884670	VPS26A	1.0	7.68	0.66	3.84e-11	Left atrial antero-posterior diameter;
SKCM	cis	rs9916302	0.861	rs4795376	chr17:37669043	T/C	cg07936489	chr17:37558343	FBXL20	-0.91	-8.19	-0.68	4e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs28386778	0.897	rs8069969	chr17:61822223	T/G	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.12	11.27	0.79	4.92e-18	Prudent dietary pattern;
SKCM	cis	rs4819052	0.819	rs34818688	chr21:46672416	C/T	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.42	0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs763121	0.853	rs5757253	chr22:39104320	C/T	cg06022373	chr22:39101656	GTPBP1	0.85	6.3	0.58	1.65e-8	Menopause (age at onset);
SKCM	cis	rs7666738	0.830	rs7669407	chr4:98750251	G/A	cg17366294	chr4:99064904	C4orf37	0.59	5.09	0.5	2.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs17685	0.712	rs10271413	chr7:75754858	G/A	cg01364799	chr7:75623366	TMEM120A	-0.7	-5.69	-0.54	2.09e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1707322	0.752	rs8179296	chr1:46143791	G/A	cg03146154	chr1:46216737	IPP	0.82	6.1	0.57	3.89e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs2070488	0.965	rs3762791	chr3:38568828	T/C	cg01465620	chr3:38496096	LOC100128640;ACVR2B	-1.03	-9.12	-0.72	6.37e-14	Electrocardiographic conduction measures;
SKCM	cis	rs35146811	0.660	rs6465760	chr7:99591418	A/G	cg22906224	chr7:99728672	NA	-0.77	-5.54	-0.53	3.96e-7	Coronary artery disease;
SKCM	cis	rs6088580	0.609	rs6058029	chr20:32969643	T/C	cg24642439	chr20:33292090	TP53INP2	-0.76	-6.02	-0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs2204008	0.594	rs2711545	chr12:38061039	C/T	cg26384229	chr12:38710491	ALG10B	0.7	5.7	0.54	2.02e-7	Bladder cancer;
SKCM	cis	rs62158211	0.908	rs62158169	chr2:114081827	C/T	cg17784749	chr2:114082611	LOC440839	0.82	5.71	0.54	1.97e-7	Sleep duration (oversleepers vs undersleepers);Sleep traits (multi-trait analysis);Sleep duration;
SKCM	cis	rs9910055	0.552	rs4793084	chr17:42317371	G/T	cg09913183	chr17:42254507	C17orf65;ASB16	-0.61	-4.8	-0.48	7.61e-6	Total body bone mineral density;
SKCM	cis	rs62064224	0.818	rs35677406	chr17:30665005	T/C	cg25809561	chr17:30822961	MYO1D	0.67	4.9	0.49	5.1e-6	Schizophrenia;
SKCM	cis	rs867186	0.764	rs78517073	chr20:33683430	G/A	cg04194272	chr20:33683537	NA	-1.21	-6.8	-0.61	1.89e-9	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs17685	0.712	rs9800948	chr7:75810473	A/G	cg16684958	chr7:75615977	POR	0.5	5.0	0.49	3.46e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs3785574	0.962	rs56295011	chr17:61850359	A/G	cg06601766	chr17:61851465	DDX42;CCDC47	0.64	4.77	0.48	8.35e-6	Height;
SKCM	cis	rs701145	0.938	rs813141	chr3:154066521	T/C	cg17054900	chr3:154042577	DHX36	0.92	5.12	0.5	2.11e-6	Coronary artery disease;
SKCM	cis	rs2153535	0.580	rs1414348	chr6:8471940	A/G	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs807669	0.933	rs712959	chr22:19159015	C/T	cg02655711	chr22:19163373	SLC25A1	0.6	5.75	0.55	1.69e-7	Metabolite levels;
SKCM	cis	rs941408	1.000	rs1736185	chr19:2813000	A/G	cg17333051	chr19:2783644	SGTA	0.42	5.21	0.51	1.48e-6	Total cholesterol levels;
SKCM	cis	rs2153535	0.580	rs1119688	chr6:8460850	T/C	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs694739	0.628	rs645078	chr11:64135298	A/C	cg02228329	chr11:64053129	BAD;GPR137	0.81	5.74	0.55	1.7e-7	Alopecia areata;Crohn's disease;Psoriasis vulgaris;
SKCM	cis	rs6951245	1.000	rs28379681	chr7:1070539	C/T	cg21664854	chr7:1097933	C7orf50;GPR146	0.89	4.79	0.48	7.66e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs9906944	0.545	rs11079850	chr17:47092252	G/T	cg20966754	chr17:47091339	IGF2BP1	-0.5	-4.86	-0.48	5.86e-6	Intelligence (multi-trait analysis);Body fat percentage;
SKCM	cis	rs9911578	1.000	rs9902994	chr17:56948722	T/A	cg05425664	chr17:57184151	TRIM37	-0.67	-5.04	-0.5	2.91e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs4862750	0.837	rs1863404	chr4:187874654	T/C	cg10295955	chr4:187884368	NA	-1.04	-14.14	-0.85	3.15e-23	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs995000	0.868	rs1168017	chr1:63002551	A/G	cg06896770	chr1:63153194	DOCK7	-0.75	-6.89	-0.61	1.29e-9	Triglyceride levels;
SKCM	cis	rs2839186	0.814	rs2276257	chr21:47711229	A/G	cg11766577	chr21:47581405	C21orf56	-0.71	-6.02	-0.56	5.26e-8	Testicular germ cell tumor;
SKCM	cis	rs1062177	1.000	rs2964578	chr5:151147198	T/A	cg00977110	chr5:151150581	G3BP1	0.81	6.32	0.58	1.51e-8	Preschool internalizing problems;
SKCM	cis	rs7945705	0.869	rs2742471	chr11:9003953	C/T	cg21881798	chr11:8931708	C11orf17;ST5	-0.79	-8.45	-0.69	1.26e-12	Hemoglobin concentration;
SKCM	cis	rs28595532	0.668	rs58467651	chr4:119349011	T/G	cg21605333	chr4:119757512	SEC24D	1.1	5.75	0.55	1.63e-7	Cannabis dependence symptom count;
SKCM	cis	rs6582630	0.555	rs10748382	chr12:38504529	C/T	cg26384229	chr12:38710491	ALG10B	0.82	6.43	0.59	9.2e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs995000	0.931	rs12062275	chr1:62991905	T/C	cg06896770	chr1:63153194	DOCK7	-0.74	-6.81	-0.61	1.77e-9	Triglyceride levels;
SKCM	cis	rs4481887	0.962	rs12037921	chr1:248454167	T/G	cg00666640	chr1:248458726	OR2T12	0.58	4.83	0.48	6.68e-6	Common traits (Other);
SKCM	cis	rs3789045	0.560	rs4553256	chr1:204411144	C/T	cg17419461	chr1:204415978	PIK3C2B	-0.88	-6.53	-0.59	6.19e-9	Educational attainment (college completion);
SKCM	cis	rs7772486	0.805	rs4896831	chr6:145959481	T/C	cg05347473	chr6:146136440	FBXO30	0.53	4.93	0.49	4.57e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9388451	0.805	rs1028481	chr6:126106573	G/T	cg05901451	chr6:126070800	HEY2	-0.78	-6.9	-0.62	1.22e-9	Brugada syndrome;
SKCM	cis	rs28595532	0.841	rs114363775	chr4:119765587	G/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs2197308	0.740	rs11182251	chr12:37919611	C/T	cg26384229	chr12:38710491	ALG10B	-0.76	-6.24	-0.58	2.08e-8	Morning vs. evening chronotype;
SKCM	cis	rs4865169	0.934	rs3796531	chr4:57850846	A/G	cg16868167	chr4:57843880	C4orf14;POLR2B	-0.68	-5.43	-0.52	6.27e-7	Breast cancer;
SKCM	cis	rs870825	0.587	rs6826883	chr4:185616167	A/C	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs7666738	0.830	rs13130923	chr4:99046281	T/C	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9880211	0.904	rs9857833	chr3:136404467	T/C	cg21827317	chr3:136751795	NA	-0.65	-4.92	-0.49	4.73e-6	Body mass index;Height;
SKCM	cis	rs7772486	0.654	rs6928007	chr6:146074941	G/A	cg23711669	chr6:146136114	FBXO30	-0.84	-9.08	-0.72	7.59e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs10256972	0.591	rs6950319	chr7:1161324	A/G	cg07092213	chr7:1199455	ZFAND2A	-0.65	-5.17	-0.5	1.78e-6	Longevity;Endometriosis;
SKCM	cis	rs9513627	1.000	rs7322368	chr13:100213990	T/C	cg11288260	chr13:100117058	NA	0.79	4.78	0.48	8.1e-6	Obesity-related traits;
SKCM	cis	rs362296	0.698	rs362279	chr4:3260072	G/A	cg11471262	chr4:3318911	RGS12	-0.79	-7.01	-0.62	7.49e-10	Parental longevity (mother's age at death);
SKCM	cis	rs55962025	0.804	rs3775061	chr4:3238754	A/G	cg16987761	chr4:3318072	RGS12	-0.65	-4.86	-0.48	5.98e-6	Parental longevity (mother's age at death);
SKCM	cis	rs6818397	1.000	rs6818397	chr4:3434885	A/C	cg24015175	chr4:3319247	RGS12	-0.55	-4.96	-0.49	4.02e-6	LDL cholesterol levels;Total cholesterol levels;
SKCM	cis	rs763014	0.898	rs8060921	chr16:635988	C/A	cg00908189	chr16:619842	PIGQ	0.82	7.78	0.66	2.55e-11	Height;
SKCM	cis	rs4819052	0.851	rs2838842	chr21:46669217	C/T	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.44	0.64	1.11e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs1153858	1.000	rs16942000	chr15:45633003	C/T	cg10760299	chr15:45669010	GATM	0.58	6.04	0.56	4.83e-8	Homoarginine levels;
SKCM	cis	rs6977660	1.000	rs6977660	chr7:19805480	C/T	cg05791153	chr7:19748676	TWISTNB	0.79	5.53	0.53	4.14e-7	Thyroid stimulating hormone;
SKCM	cis	rs1506636	1.000	rs2429616	chr7:123406034	C/T	cg03229431	chr7:123269106	ASB15	0.64	5.21	0.51	1.48e-6	Plateletcrit;Platelet count;
SKCM	cis	rs6879260	1.000	rs6879260	chr5:179731014	A/G	cg13944838	chr5:179740914	GFPT2	-0.65	-5.45	-0.53	5.65e-7	Height;
SKCM	cis	rs7811142	0.830	rs28495773	chr7:99943583	A/T	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.08	6.14	0.57	3.23e-8	Platelet count;
SKCM	cis	rs9394841	0.692	rs9349202	chr6:41805581	A/C	cg08135965	chr6:41755394	TOMM6	0.76	4.97	0.49	3.95e-6	Mean corpuscular hemoglobin;Red cell distribution width;
SKCM	cis	rs1568889	0.838	rs11030265	chr11:28296168	A/T	cg06544937	chr11:28130018	METT5D1;KIF18A	0.89	8.2	0.68	3.84e-12	Bipolar disorder;
SKCM	cis	rs752010	0.875	rs11210502	chr1:42093712	A/C	cg06885757	chr1:42089581	HIVEP3	0.56	5.31	0.52	1.02e-6	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs3785574	0.962	rs2727329	chr17:61924566	C/T	cg26338869	chr17:61819248	STRADA	0.63	4.81	0.48	7.11e-6	Height;
SKCM	cis	rs4332037	0.538	rs6951956	chr7:1934131	C/T	cg23422044	chr7:1970798	MAD1L1	-0.8	-5.47	-0.53	5.34e-7	Bipolar disorder;
SKCM	cis	rs7829975	0.511	rs1401390	chr8:8136410	C/T	cg08975724	chr8:8085496	FLJ10661	0.76	6.62	0.6	4.08e-9	Mood instability;
SKCM	cis	rs4972806	0.776	rs2072589	chr2:177042871	C/T	cg13092806	chr2:177043255	NA	0.57	5.37	0.52	7.9e-7	IgG glycosylation;
SKCM	cis	rs826838	0.967	rs1684411	chr12:39128494	C/T	cg13010199	chr12:38710504	ALG10B	-0.72	-5.73	-0.54	1.83e-7	Heart rate;
SKCM	cis	rs6088580	0.634	rs6059905	chr20:33126946	T/C	cg24642439	chr20:33292090	TP53INP2	0.76	6.02	0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs951366	0.622	rs11580015	chr1:205676088	G/C	cg11965913	chr1:205819406	PM20D1	0.79	7.01	0.62	7.7e-10	Menarche (age at onset);
SKCM	cis	rs2204008	0.754	rs11514074	chr12:38401128	C/T	cg26384229	chr12:38710491	ALG10B	0.88	6.86	0.61	1.46e-9	Bladder cancer;
SKCM	cis	rs62103177	0.564	rs7228971	chr18:77738025	C/T	cg14987283	chr18:76906367	ATP9B	0.8	4.77	0.48	8.51e-6	Opioid sensitivity;
SKCM	cis	rs2777491	0.707	rs1622914	chr15:41789212	A/G	cg18705301	chr15:41695430	NDUFAF1	-1.02	-10.17	-0.75	6.03e-16	Ulcerative colitis;
SKCM	cis	rs2228479	0.850	rs62056069	chr16:89912000	C/T	cg06558623	chr16:89946397	TCF25	1.12	5.0	0.49	3.47e-6	Skin colour saturation;
SKCM	cis	rs1577917	0.771	rs9362230	chr6:86305013	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.98	-11.08	-0.78	1.13e-17	Response to antipsychotic treatment;
SKCM	cis	rs637571	0.522	rs3016868	chr11:65764383	C/T	cg26695010	chr11:65641043	EFEMP2	-0.69	-5.21	-0.51	1.5e-6	Eosinophil percentage of white cells;
SKCM	cis	rs4925386	0.681	rs2427295	chr20:60927431	G/A	cg24112000	chr20:60950667	NA	-0.7	-6.79	-0.61	1.99e-9	Colorectal cancer;Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs2836950	0.565	rs2836942	chr21:40591381	A/G	cg17971929	chr21:40555470	PSMG1	-0.73	-6.17	-0.57	2.86e-8	Menarche (age at onset);
SKCM	cis	rs614226	0.744	rs787832	chr12:120986801	A/G	cg01236616	chr12:121019343	POP5	1.34	8.54	0.7	8.29e-13	Type 1 diabetes nephropathy;
SKCM	cis	rs9303401	0.659	rs17222523	chr17:56620501	A/G	cg02118635	chr17:56770003	RAD51C;TEX14	0.8	5.51	0.53	4.41e-7	Cognitive test performance;
SKCM	cis	rs10751667	0.666	rs7105477	chr11:964271	C/G	cg11024522	chr11:1074749	MUC2	0.44	4.79	0.48	7.77e-6	Alzheimer's disease (late onset);
SKCM	cis	rs12477438	0.501	rs11692336	chr2:99740606	T/C	cg14399236	chr2:99771627	LIPT1;TSGA10	0.93	8.28	0.68	2.67e-12	Chronic sinus infection;
SKCM	cis	rs4905558	1.000	rs4905552	chr14:97307224	A/G	cg11863609	chr14:97355128	NA	-0.54	-4.88	-0.48	5.52e-6	Neutrophil count;
SKCM	cis	rs67311347	0.568	rs9864544	chr3:40336204	T/C	cg13409248	chr3:40428643	ENTPD3	0.58	5.63	0.54	2.68e-7	Renal cell carcinoma;
SKCM	cis	rs4319547	0.737	rs4758646	chr12:122946507	G/A	cg23029597	chr12:123009494	RSRC2	-0.82	-6.23	-0.58	2.18e-8	Body mass index;
SKCM	cis	rs7940866	0.874	rs10791113	chr11:130873165	A/G	cg12179176	chr11:130786555	SNX19	0.76	5.96	0.56	6.98e-8	Schizophrenia;
SKCM	cis	rs589448	0.902	rs315134	chr12:69762713	G/A	cg20891283	chr12:69753455	YEATS4	0.98	9.89	0.75	2.06e-15	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs7843479	0.965	rs11785657	chr8:21859485	G/A	cg17168535	chr8:21777572	XPO7	0.75	6.06	0.57	4.62e-8	Mean corpuscular volume;
SKCM	cis	rs561341	0.700	rs2074101	chr17:30228656	G/A	cg13647721	chr17:30228624	UTP6	0.78	4.94	0.49	4.28e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs6938	0.534	rs1127796	chr15:75193004	C/T	cg09165964	chr15:75287851	SCAMP5	-0.62	-4.91	-0.49	4.99e-6	Breast cancer;
SKCM	cis	rs2243480	1.000	rs4718269	chr7:65200778	C/G	cg18252515	chr7:66147081	NA	1.3	8.11	0.68	5.8e-12	Diabetic kidney disease;
SKCM	cis	rs96067	0.772	rs6700737	chr1:36598214	A/G	cg24686825	chr1:36642396	MAP7D1	-0.72	-4.86	-0.48	5.98e-6	Corneal structure;
SKCM	cis	rs2739330	0.828	rs4822454	chr22:24255208	G/A	cg04234412	chr22:24373322	LOC391322	-0.58	-4.79	-0.48	7.84e-6	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs6545883	0.542	rs2593628	chr2:61573287	T/A	cg15711740	chr2:61764176	XPO1	0.66	5.12	0.5	2.17e-6	Tuberculosis;
SKCM	cis	rs6951245	1.000	rs6951245	chr7:1058193	G/A	cg21664854	chr7:1097933	C7orf50;GPR146	0.9	4.86	0.48	6.05e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs1799949	1.000	rs16942	chr17:41244000	T/C	cg25918947	chr17:41365094	TMEM106A	-0.62	-5.85	-0.55	1.1e-7	Menopause (age at onset);
SKCM	cis	rs6089829	0.962	rs6011548	chr20:61666063	C/T	cg03213289	chr20:61660250	NA	0.49	4.82	0.48	7.06e-6	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs6120849	0.754	rs6120804	chr20:33623701	C/A	cg24642439	chr20:33292090	TP53INP2	0.94	4.86	0.48	5.91e-6	Protein C levels;
SKCM	cis	rs10916772	0.938	rs12045792	chr1:20687285	A/G	cg05356564	chr1:21044770	KIF17	0.62	5.15	0.5	1.88e-6	Psychosis proneness (perceptual aberration scale);
SKCM	cis	rs7308116	0.546	rs7294794	chr12:108232388	C/T	cg24830367	chr12:108083606	PWP1	-0.68	-4.91	-0.49	4.98e-6	Pelvic organ prolapse (moderate/severe);
SKCM	cis	rs561341	1.000	rs561341	chr17:30316385	T/G	cg23018236	chr17:30244563	NA	-0.55	-5.64	-0.54	2.59e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs2463822	1.000	rs2463822	chr11:62103420	T/C	cg06239285	chr11:62104954	ASRGL1	1.27	6.04	0.56	4.98e-8	Chronic obstructive pulmonary disease-related biomarkers;
SKCM	trans	rs1814175	0.588	rs10839463	chr11:49971643	A/G	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs514406	0.505	rs6688064	chr1:53165609	C/T	cg16325326	chr1:53192061	ZYG11B	0.91	10.29	0.76	3.51e-16	Monocyte count;
SKCM	cis	rs1801251	0.752	rs709938	chr2:233746457	C/T	cg25237894	chr2:233734115	C2orf82	-0.6	-6.29	-0.58	1.69e-8	Coronary artery disease;
SKCM	cis	rs9486715	0.838	rs9320127	chr6:96865358	G/A	cg06623918	chr6:96969491	KIAA0776	0.8	7.22	0.63	2.98e-10	Headache;
SKCM	cis	rs6580649	0.941	rs60681522	chr12:48464195	T/C	cg05342945	chr12:48394962	COL2A1	0.73	5.2	0.51	1.53e-6	Lung cancer;
SKCM	cis	rs8017423	0.647	rs4900037	chr14:90821478	A/G	cg04374321	chr14:90722782	PSMC1	0.73	5.53	0.53	4.04e-7	Mortality in heart failure;
SKCM	cis	rs801193	1.000	rs7789184	chr7:66210195	A/T	cg18876405	chr7:65276391	NA	0.8	7.11	0.63	4.88e-10	Aortic root size;
SKCM	cis	rs8067545	0.750	rs4925077	chr17:19982276	C/T	cg13482628	chr17:19912719	NA	0.74	6.68	0.6	3.12e-9	Schizophrenia;
SKCM	cis	rs3768617	0.565	rs7542277	chr1:183063527	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.76	6.82	0.61	1.73e-9	Fuchs's corneal dystrophy;
SKCM	cis	rs10504229	0.609	rs56289889	chr8:58116276	G/C	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs992157	0.764	rs2891079	chr2:219184691	A/G	cg00012203	chr2:219082015	ARPC2	0.75	5.54	0.53	3.92e-7	Colorectal cancer;
SKCM	cis	rs2439831	0.850	rs2439832	chr15:43779686	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.21	7.96	0.67	1.1e-11	Lung cancer in ever smokers;
SKCM	cis	rs6500602	0.627	rs6500610	chr16:4529613	A/G	cg08645402	chr16:4508243	NA	0.64	4.95	0.49	4.26e-6	Schizophrenia;
SKCM	cis	rs9674544	0.757	rs6504593	chr17:47132819	T/C	cg22947322	chr17:47091978	IGF2BP1	-0.55	-4.81	-0.48	7.2e-6	Primary tooth development (time to first tooth eruption);Primary tooth development (number of teeth);
SKCM	cis	rs2941509	1.000	rs3169572	chr17:38077412	G/A	cg12655416	chr17:38077870	ORMDL3	-0.48	-5.27	-0.51	1.17e-6	Systemic lupus erythematosus;
SKCM	cis	rs67311347	0.544	rs60329764	chr3:40334621	C/T	cg00091569	chr3:40428383	ENTPD3	-0.6	-5.1	-0.5	2.36e-6	Renal cell carcinoma;
SKCM	cis	rs4243830	0.850	rs4908915	chr1:6601607	T/C	cg22792644	chr1:6614718	TAS1R1;NOL9	-1.06	-5.63	-0.54	2.69e-7	Body mass index;
SKCM	cis	rs4073582	1.000	rs801732	chr11:65935502	T/A	cg16950941	chr11:66035639	RAB1B	0.75	5.28	0.51	1.14e-6	Gout;
SKCM	cis	rs12611334	0.964	rs3810396	chr19:40189338	T/C	cg04998674	chr19:40596855	ZNF780A	0.63	4.77	0.47	8.55e-6	Schizophrenia;
SKCM	trans	rs561341	0.783	rs512698	chr17:30292507	G/T	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs826838	0.967	rs2069211	chr12:39128892	C/T	cg26384229	chr12:38710491	ALG10B	-0.91	-8.28	-0.68	2.74e-12	Heart rate;
SKCM	cis	rs7811142	0.830	rs28495773	chr7:99943583	A/T	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.22	7.84	0.66	1.95e-11	Platelet count;
SKCM	cis	rs9818758	0.556	rs9814987	chr3:49207849	T/C	cg00383909	chr3:49044727	WDR6	0.95	5.43	0.52	6.25e-7	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs10256972	0.721	rs2030959	chr7:1075906	T/C	cg16145915	chr7:1198662	ZFAND2A	-0.44	-5.32	-0.52	9.47e-7	Longevity;Endometriosis;
SKCM	cis	rs7843479	0.543	rs10866823	chr8:21781629	C/T	cg17168535	chr8:21777572	XPO7	0.82	7.57	0.65	6.34e-11	Mean corpuscular volume;
SKCM	cis	rs6724607	1.000	rs6724607	chr2:191466532	C/T	cg21644426	chr2:191273491	MFSD6	0.69	4.98	0.49	3.71e-6	Pulse pressure;
SKCM	cis	rs7647973	0.696	rs3087866	chr3:49054692	A/G	cg07636037	chr3:49044803	WDR6	0.93	6.7	0.6	2.89e-9	Menarche (age at onset);
SKCM	cis	rs6582630	0.502	rs7312212	chr12:38274760	T/G	cg26384229	chr12:38710491	ALG10B	0.85	6.78	0.61	2.05e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs7524258	0.778	rs12028181	chr1:7315085	C/T	cg07173049	chr1:7289937	CAMTA1	-0.41	-4.95	-0.49	4.16e-6	Tourette's syndrome or obsessive-compulsive disorder;
SKCM	cis	rs9916302	0.904	rs6503507	chr17:37525274	C/T	cg07936489	chr17:37558343	FBXL20	0.85	7.3	0.64	2.13e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs9911578	1.000	rs1267545	chr17:56646909	A/G	cg12560992	chr17:57184187	TRIM37	0.91	7.38	0.64	1.48e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs9834970	0.787	rs11129735	chr3:36870230	A/G	cg25202636	chr3:37035158	MLH1;EPM2AIP1	0.66	5.01	0.49	3.31e-6	Bipolar disorder with mood-incongruent psychosis;Subjective response to lithium treatment;Bipolar disorder;Schizophrenia or bipolar disorder;Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);
SKCM	cis	rs3820928	0.845	rs13384342	chr2:227805010	G/A	cg11843606	chr2:227700838	RHBDD1	-0.6	-4.81	-0.48	7.17e-6	Pulmonary function;
SKCM	cis	rs7811142	1.000	rs4472444	chr7:100070758	T/C	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.17	7.71	0.66	3.44e-11	Platelet count;
SKCM	cis	rs2658782	0.547	rs3020064	chr11:93060851	A/G	cg15737290	chr11:93063684	CCDC67	1.0	9.43	0.73	1.58e-14	Pulmonary function decline;
SKCM	cis	rs9814567	1.000	rs9813774	chr3:134227100	G/A	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs17376456	1.000	rs34068652	chr5:93563319	G/A	cg25358565	chr5:93447407	FAM172A	1.3	8.21	0.68	3.63e-12	Diabetic retinopathy;
SKCM	cis	rs7633770	0.841	rs6774048	chr3:46702202	C/G	cg11219411	chr3:46661640	NA	0.65	5.88	0.55	9.6e-8	Coronary artery disease;
SKCM	cis	rs10779751	0.770	rs2261434	chr1:11170131	A/C	cg08854313	chr1:11322531	MTOR	0.87	6.81	0.61	1.83e-9	Body mass index;
SKCM	cis	rs1801251	1.000	rs6745879	chr2:233590007	A/G	cg25237894	chr2:233734115	C2orf82	0.6	5.52	0.53	4.24e-7	Coronary artery disease;
SKCM	cis	rs523522	0.962	rs509445	chr12:121017243	A/C	cg12219531	chr12:120966889	COQ5	0.89	7.48	0.65	9.44e-11	High light scatter reticulocyte count;
SKCM	cis	rs11098499	0.955	rs1397608	chr4:120161744	A/G	cg09307838	chr4:120376055	NA	0.95	8.14	0.68	4.98e-12	Corneal astigmatism;
SKCM	trans	rs7618501	1.000	rs9855505	chr3:49792158	T/G	cg21659725	chr3:3221576	CRBN	-0.96	-9.61	-0.74	7.08e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs11098499	0.909	rs10017335	chr4:120381523	C/G	cg09307838	chr4:120376055	NA	-0.93	-7.63	-0.65	4.9e-11	Corneal astigmatism;
SKCM	cis	rs8072100	0.688	rs8075843	chr17:45442363	C/T	cg25173405	chr17:45401733	C17orf57	-0.62	-4.88	-0.48	5.5e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs911263	0.961	rs1950897	chr14:68760141	C/T	cg18825221	chr14:68749962	RAD51L1	0.47	5.04	0.5	2.98e-6	Primary biliary cholangitis;
SKCM	cis	rs9300255	0.602	rs2851435	chr12:123712416	G/A	cg00376283	chr12:123451042	ABCB9	0.8	5.29	0.51	1.08e-6	Neutrophil percentage of white cells;
SKCM	cis	rs8060686	0.565	rs75735284	chr16:68126635	C/A	cg09117114	chr16:67998030	SLC12A4	-0.81	-5.29	-0.51	1.07e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs7953508	0.711	rs11611927	chr12:93977591	A/G	cg18151635	chr12:93972918	NA	-0.73	-6.1	-0.57	3.89e-8	Pubertal anthropometrics;
SKCM	cis	rs8072100	0.840	rs9893901	chr17:45506682	T/G	cg08085267	chr17:45401833	C17orf57	-0.62	-5.16	-0.5	1.82e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs28386778	0.830	rs2854210	chr17:61946338	C/A	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.11	11.22	0.79	6.02e-18	Prudent dietary pattern;
SKCM	cis	rs1153858	0.723	rs11855527	chr15:45606685	G/A	cg21132104	chr15:45694354	SPATA5L1	-0.9	-6.8	-0.61	1.88e-9	Homoarginine levels;
SKCM	cis	rs62064224	1.000	rs62064224	chr17:30635115	G/A	cg18200150	chr17:30822561	MYO1D	0.72	5.65	0.54	2.5e-7	Schizophrenia;
SKCM	cis	rs9549367	0.577	rs3024711	chr13:113813268	A/G	cg18105134	chr13:113819100	PROZ	-0.8	-5.76	-0.55	1.58e-7	Platelet distribution width;
SKCM	cis	rs4481887	0.800	rs4278391	chr1:248450495	C/T	cg00666640	chr1:248458726	OR2T12	0.6	4.9	0.49	5.01e-6	Common traits (Other);
SKCM	cis	rs5769765	0.865	rs9616369	chr22:50304591	A/C	cg22709217	chr22:50311962	ALG12;CRELD2	-0.87	-5.83	-0.55	1.18e-7	Schizophrenia;
SKCM	cis	rs7945705	0.902	rs10743093	chr11:8869129	A/G	cg21881798	chr11:8931708	C11orf17;ST5	0.77	7.47	0.65	9.8e-11	Hemoglobin concentration;
SKCM	cis	rs9389248	0.690	rs728030	chr6:135246294	G/T	cg24558204	chr6:135376177	HBS1L	-0.57	-4.78	-0.48	8.1e-6	High light scatter reticulocyte percentage of red cells;
SKCM	cis	rs10489202	0.644	rs11584210	chr1:167846853	A/G	cg24449463	chr1:168025552	DCAF6	-0.81	-4.96	-0.49	4.02e-6	Schizophrenia;
SKCM	cis	rs4836694	0.689	rs4837479	chr9:132940007	C/T	cg13414629	chr9:132935646	FREQ	0.87	4.93	0.49	4.54e-6	Alzheimer's disease (cognitive decline);
SKCM	cis	rs6952808	0.595	rs2398705	chr7:2164995	G/A	cg21782813	chr7:2030301	MAD1L1	0.53	5.64	0.54	2.58e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs3087591	0.960	rs12943508	chr17:29599954	C/G	cg24425628	chr17:29625626	OMG;NF1	0.64	5.08	0.5	2.48e-6	Hip circumference;
SKCM	cis	rs11098499	0.954	rs7656252	chr4:120404268	T/C	cg09307838	chr4:120376055	NA	0.97	7.65	0.65	4.54e-11	Corneal astigmatism;
SKCM	cis	rs1691799	0.899	rs2951656	chr12:66732273	T/G	cg16791601	chr12:66731901	HELB	-0.59	-4.97	-0.49	3.83e-6	White blood cell count (basophil);
SKCM	cis	rs763014	0.931	rs2071980	chr16:626346	A/C	cg09263875	chr16:632152	PIGQ	0.67	5.82	0.55	1.24e-7	Height;
SKCM	cis	rs36093844	0.800	rs112468922	chr11:85576694	A/G	cg25872744	chr11:85566296	CCDC83	-0.85	-4.83	-0.48	6.66e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs57221529	0.766	rs1399381	chr5:589853	G/T	cg10555297	chr5:473380	SLC9A3;LOC25845	1.01	5.03	0.49	3.1e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs3091242	1.000	rs9689	chr1:25688276	A/G	cg27572855	chr1:25598939	RHD	0.53	5.15	0.5	1.92e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs10927875	0.632	rs1122068	chr1:16127480	G/C	cg21385522	chr1:16154831	NA	-0.98	-11.21	-0.79	6.28e-18	Dilated cardiomyopathy;
SKCM	cis	rs4481887	1.000	rs7525344	chr1:248467565	C/T	cg00666640	chr1:248458726	OR2T12	-0.63	-6.29	-0.58	1.69e-8	Common traits (Other);
SKCM	cis	rs2243480	1.000	rs313824	chr7:65581207	C/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs4664308	1.000	rs16844715	chr2:160915106	A/G	cg03641300	chr2:160917029	PLA2R1	0.63	5.1	0.5	2.35e-6	Idiopathic membranous nephropathy;
SKCM	cis	rs2857078	0.720	rs9901595	chr17:42305699	G/A	cg13607699	chr17:42295918	UBTF	0.86	7.36	0.64	1.62e-10	Red cell distribution width;Reticulocyte count;
SKCM	cis	rs137603	0.644	rs94852	chr22:39712334	T/C	cg17798944	chr22:39715225	SNORD43;RPL3	-0.64	-5.5	-0.53	4.74e-7	Primary biliary cholangitis;
SKCM	cis	rs7824557	0.602	rs7819395	chr8:11211068	T/C	cg21775007	chr8:11205619	TDH	0.68	5.96	0.56	6.98e-8	Retinal vascular caliber;
SKCM	cis	rs875971	0.830	rs427973	chr7:65526648	C/A	cg18876405	chr7:65276391	NA	0.75	7.32	0.64	1.93e-10	Aortic root size;
SKCM	cis	rs17765925	0.605	rs35652218	chr7:14260560	T/C	cg11279021	chr7:14028690	ETV1	0.52	4.77	0.48	8.28e-6	Verbal declarative memory;
SKCM	cis	rs7632954	0.567	rs6793940	chr3:8535006	C/A	cg06697448	chr3:8544912	LMCD1	-0.56	-4.9	-0.49	5.06e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs2032447	0.670	rs198850	chr6:26104670	A/C	cg12310025	chr6:25882481	NA	0.54	4.77	0.48	8.41e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs4523957	0.583	rs9303251	chr17:2047214	C/T	cg16513277	chr17:2031491	SMG6	-0.88	-5.81	-0.55	1.28e-7	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs473651	0.506	rs561264	chr2:239329979	G/T	cg18131467	chr2:239335373	ASB1	0.86	5.99	0.56	6.21e-8	Multiple system atrophy;
SKCM	cis	rs9790314	0.628	rs4342141	chr3:160783922	T/C	cg03342759	chr3:160939853	NMD3	-0.59	-5.67	-0.54	2.31e-7	Morning vs. evening chronotype;
SKCM	cis	rs155076	1.000	rs261404	chr13:21858162	T/G	cg11317459	chr13:21872234	NA	-1.24	-6.91	-0.62	1.19e-9	White matter hyperintensity burden;
SKCM	cis	rs7208859	0.573	rs8078656	chr17:29080971	A/T	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs2370759	1.000	rs11599522	chr10:32568434	G/C	cg01819863	chr10:32635814	EPC1	1.0	5.08	0.5	2.48e-6	Sexual dysfunction (female);
SKCM	cis	rs561341	1.000	rs693116	chr17:30246124	C/T	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.53	-0.65	7.52e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs1801251	1.000	rs11676216	chr2:233706368	C/T	cg08000102	chr2:233561755	GIGYF2	-0.89	-7.22	-0.63	3.02e-10	Coronary artery disease;
SKCM	cis	rs7811142	0.830	rs73401450	chr7:99981859	G/C	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.19	7.5	0.65	8.66e-11	Platelet count;
SKCM	cis	rs4481887	0.741	rs6682957	chr1:248535639	T/G	cg22724847	chr1:248512586	OR14C36	0.59	5.16	0.5	1.84e-6	Common traits (Other);
SKCM	cis	rs12142240	0.698	rs58162700	chr1:46816659	T/A	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs4819052	0.851	rs2838844	chr21:46670733	A/C	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.42	0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7617480	0.616	rs7429596	chr3:48808531	T/C	cg07636037	chr3:49044803	WDR6	0.9	6.65	0.6	3.64e-9	Subjective well-being (multi-trait analysis);Menarche (age at onset);
SKCM	cis	rs6121246	0.909	rs6060979	chr20:30417522	C/T	cg11595048	chr20:30225325	COX4I2	0.65	5.03	0.49	3.1e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs8180040	0.676	rs7633698	chr3:47013452	A/T	cg27129171	chr3:47204927	SETD2	0.79	6.01	0.56	5.49e-8	Colorectal cancer;
SKCM	cis	rs7954584	0.523	rs11043280	chr12:122426643	T/C	cg22618164	chr12:122356400	WDR66	0.54	5.43	0.52	6.17e-7	Mean corpuscular volume;
SKCM	cis	rs3785574	0.962	rs8066463	chr17:61818390	A/G	cg01411255	chr17:61851458	DDX42;CCDC47	1.11	12.47	0.82	2.97e-20	Height;
SKCM	cis	rs9902453	0.791	rs57719820	chr17:28335088	A/C	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.81	-5.78	-0.55	1.45e-7	Coffee consumption (cups per day);
SKCM	cis	rs3091242	0.933	rs9438905	chr1:25764177	A/G	cg02931644	chr1:25747376	RHCE	0.5	4.9	0.48	5.17e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs4555082	0.830	rs2735812	chr14:105727575	A/G	cg13114125	chr14:105738426	BRF1	-0.69	-5.39	-0.52	7.2e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs826838	1.000	rs1963562	chr12:38662896	C/T	cg26384229	chr12:38710491	ALG10B	0.95	7.92	0.67	1.32e-11	Heart rate;
SKCM	cis	rs6952808	0.723	rs60995052	chr7:2030007	G/C	cg02951883	chr7:2050386	MAD1L1	-0.85	-7.58	-0.65	6.15e-11	Bipolar disorder and schizophrenia;
SKCM	cis	rs6459788	0.527	rs6980250	chr7:157228710	C/T	cg03453431	chr7:157225567	NA	-0.63	-5.48	-0.53	5.08e-7	Epstein-Barr virus copy number in lymphoblastoid cell lines;
SKCM	cis	rs870825	0.616	rs4386643	chr4:185624281	A/T	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs2153535	0.601	rs4140584	chr6:8540614	C/G	cg07606381	chr6:8435919	SLC35B3	-0.92	-6.38	-0.59	1.16e-8	Motion sickness;
SKCM	cis	rs6570726	0.905	rs388728	chr6:145816419	T/C	cg23711669	chr6:146136114	FBXO30	0.71	6.77	0.61	2.18e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs28386778	0.562	rs721575	chr17:61782920	A/G	cg26338869	chr17:61819248	STRADA	-0.67	-4.84	-0.48	6.43e-6	Prudent dietary pattern;
SKCM	cis	rs7772486	0.681	rs9390343	chr6:146010527	A/T	cg23711669	chr6:146136114	FBXO30	-0.83	-8.26	-0.68	3e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs5769765	0.955	rs6520066	chr22:50294988	C/T	cg22709217	chr22:50311962	ALG12;CRELD2	-0.78	-5.53	-0.53	4.14e-7	Schizophrenia;
SKCM	cis	rs7100689	0.646	rs1953971	chr10:82145647	G/C	cg01528321	chr10:82214614	TSPAN14	0.84	7.53	0.65	7.69e-11	Post bronchodilator FEV1;
SKCM	cis	rs2842992	0.750	rs2758354	chr6:160125854	A/G	cg11366901	chr6:160182831	ACAT2	0.89	6.97	0.62	8.9e-10	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs9399135	0.967	rs2297338	chr6:135375762	G/A	cg24558204	chr6:135376177	HBS1L	0.58	5.05	0.5	2.86e-6	Red blood cell count;
SKCM	cis	rs7953508	0.750	rs7977788	chr12:93982332	G/A	cg18151635	chr12:93972918	NA	-0.73	-6.41	-0.59	1.02e-8	Pubertal anthropometrics;
SKCM	cis	rs4237845	0.636	rs11172371	chr12:58286188	C/T	cg02175503	chr12:58329896	NA	0.7	5.84	0.55	1.14e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs9910055	1.000	rs2071167	chr17:42287519	A/G	cg08499158	chr17:42289980	UBTF	0.87	8.39	0.69	1.68e-12	Total body bone mineral density;
SKCM	cis	rs593982	1.000	rs118030231	chr11:65501905	G/A	cg08755490	chr11:65554678	OVOL1	-0.95	-7.42	-0.64	1.22e-10	Atopic dermatitis;
SKCM	cis	rs25645	0.830	rs4072639	chr17:38189049	G/A	cg17467752	chr17:38218738	THRA	-0.77	-6.64	-0.6	3.72e-9	Myeloid white cell count;
SKCM	cis	rs9435341	0.965	rs1335053	chr1:107622823	C/T	cg09367891	chr1:107599246	PRMT6	-0.77	-5.93	-0.56	7.68e-8	Facial morphology (factor 21, depth of nasal alae);
SKCM	cis	rs6951245	1.000	rs11761941	chr7:1097183	G/A	cg03188948	chr7:1209495	NA	1.13	6.27	0.58	1.89e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs992157	0.835	rs7559416	chr2:219150211	A/G	cg20019365	chr2:219134978	PNKD;AAMP	-0.71	-6.08	-0.57	4.22e-8	Colorectal cancer;
SKCM	cis	rs7809950	0.723	rs62483633	chr7:106876644	T/G	cg23024343	chr7:107201750	COG5	-0.79	-6.77	-0.61	2.16e-9	Coronary artery disease;
SKCM	cis	rs8017423	0.935	rs3742668	chr14:90767759	G/A	cg04374321	chr14:90722782	PSMC1	-0.95	-8.73	-0.7	3.68e-13	Mortality in heart failure;
SKCM	cis	rs3820068	0.581	rs6692461	chr1:15928449	A/G	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs10905065	0.829	rs6602278	chr10:5868361	A/G	cg11519256	chr10:5708881	ASB13	-0.61	-5.46	-0.53	5.49e-7	Menopause (age at onset);
SKCM	cis	rs1799949	1.000	rs34059614	chr17:41303071	C/T	cg05368731	chr17:41323189	NBR1	0.89	7.91	0.67	1.38e-11	Menopause (age at onset);
SKCM	cis	rs11792861	0.816	rs17792434	chr9:111667319	C/T	cg14432460	chr9:111696404	IKBKAP;C9orf6	0.68	4.86	0.48	5.88e-6	Menarche (age at onset);
SKCM	cis	rs9475752	0.793	rs56381984	chr6:56832708	T/C	cg06815302	chr6:57335405	PRIM2	0.59	4.78	0.48	8.1e-6	Menarche (age at onset);
SKCM	cis	rs1160297	0.576	rs6754423	chr2:53096730	G/A	cg07782112	chr2:53107842	NA	0.59	6.3	0.58	1.63e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs780096	0.546	rs1260320	chr2:27722416	A/G	cg05696406	chr2:27599888	SNX17	-0.52	-5.32	-0.52	9.46e-7	Total body bone mineral density;
SKCM	cis	rs2386661	0.547	rs11259582	chr10:5646767	C/T	cg12223502	chr10:5658492	NA	-0.54	-5.09	-0.5	2.38e-6	Breast cancer;
SKCM	cis	rs11098499	0.775	rs67281037	chr4:120281157	G/C	cg09307838	chr4:120376055	NA	0.98	7.89	0.67	1.52e-11	Corneal astigmatism;
SKCM	cis	rs362296	0.624	rs362287	chr4:3257593	C/T	cg09735869	chr4:3319127	RGS12	-0.8	-6.79	-0.61	1.97e-9	Parental longevity (mother's age at death);
SKCM	cis	rs2762353	0.603	rs10946798	chr6:25781853	T/G	cg16906712	chr6:26217615	HIST1H2BG;HIST1H2AE	-0.51	-4.85	-0.48	6.14e-6	Blood metabolite levels;
SKCM	cis	rs67311347	0.544	rs9864601	chr3:40345318	C/T	cg02782426	chr3:40428986	ENTPD3	0.53	5.47	0.53	5.31e-7	Renal cell carcinoma;
SKCM	cis	rs7937682	0.711	rs4938792	chr11:111420936	T/C	cg09085632	chr11:111637200	PPP2R1B	0.81	6.96	0.62	9.31e-10	Primary sclerosing cholangitis;
SKCM	cis	rs12497850	0.931	rs7628719	chr3:48995487	C/T	cg06212747	chr3:49208901	KLHDC8B	0.68	4.9	0.49	5.06e-6	Parkinson's disease;
SKCM	cis	rs854765	0.583	rs4341796	chr17:17839024	C/A	cg04398451	chr17:18023971	MYO15A	-0.79	-5.68	-0.54	2.25e-7	Total body bone mineral density;
SKCM	cis	rs1003719	0.788	rs60447195	chr21:38448600	A/T	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs514406	0.607	rs11206000	chr1:53205923	A/C	cg24675658	chr1:53192096	ZYG11B	0.64	5.3	0.51	1.04e-6	Monocyte count;
SKCM	cis	rs801193	1.000	rs11773829	chr7:66141074	G/A	cg11987759	chr7:65425863	GUSB	0.69	5.9	0.56	8.74e-8	Aortic root size;
SKCM	cis	rs651907	0.535	rs34648996	chr3:101511202	A/G	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.78	6.72	0.61	2.65e-9	Colorectal cancer;
SKCM	cis	rs1218582	0.772	rs1976559	chr1:154879788	A/T	cg09359103	chr1:154839909	KCNN3	-0.57	-5.3	-0.51	1.05e-6	Prostate cancer;
SKCM	cis	rs2013441	1.000	rs34089239	chr17:20057959	G/T	cg13482628	chr17:19912719	NA	0.67	5.24	0.51	1.32e-6	Obesity-related traits;
SKCM	cis	rs6835098	1.000	rs10027708	chr4:174083116	T/C	cg08422745	chr4:174089978	GALNT7	-0.81	-6.26	-0.58	1.96e-8	Dementia and core Alzheimer's disease neuropathologic changes;
SKCM	cis	rs11718455	0.960	rs3843373	chr3:44011053	C/T	cg21419209	chr3:44054225	NA	0.62	4.82	0.48	6.95e-6	Coronary artery disease;
SKCM	trans	rs2727020	0.553	rs7479975	chr11:49581964	C/G	cg15704280	chr7:45808275	SEPT13	-0.96	-8.57	-0.7	7.28e-13	Coronary artery disease;
SKCM	cis	rs738322	0.640	rs738321	chr22:38568833	C/G	cg25457927	chr22:38595422	NA	-0.5	-5.64	-0.54	2.58e-7	Cutaneous nevi;
SKCM	cis	rs12044355	0.927	rs61835384	chr1:231833422	T/C	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	0.84	6.65	0.6	3.58e-9	Alzheimer's disease;
SKCM	cis	rs951366	0.617	rs823075	chr1:205774897	C/T	cg07157834	chr1:205819609	PM20D1	0.92	10.72	0.77	5.29e-17	Menarche (age at onset);
SKCM	cis	rs951366	0.903	rs823116	chr1:205720483	G/A	cg14893161	chr1:205819251	PM20D1	0.74	5.37	0.52	7.9e-7	Menarche (age at onset);
SKCM	cis	rs1153858	1.000	rs4774577	chr15:45644685	A/C	cg21132104	chr15:45694354	SPATA5L1	0.92	7.81	0.66	2.22e-11	Homoarginine levels;
SKCM	cis	rs12142240	0.698	rs1057534	chr1:46815880	A/C	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs9818758	0.607	rs35673421	chr3:49139406	G/A	cg00383909	chr3:49044727	WDR6	1.05	5.85	0.55	1.11e-7	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs5769765	1.000	rs8184990	chr22:50273174	A/G	cg22709217	chr22:50311962	ALG12;CRELD2	0.79	5.71	0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs4423214	0.650	rs7940244	chr11:71221574	C/T	cg05163923	chr11:71159392	DHCR7	-0.78	-6.15	-0.57	3.12e-8	Vitamin D levels;
SKCM	cis	rs7980687	0.628	rs2102949	chr12:123676763	G/A	cg05973401	chr12:123451056	ABCB9	0.72	5.07	0.5	2.61e-6	Height;Educational attainment;Head circumference (infant);
SKCM	cis	rs951366	0.617	rs9438393	chr1:205782718	A/G	cg14159672	chr1:205819179	PM20D1	1.06	11.74	0.8	6.36e-19	Menarche (age at onset);
SKCM	cis	rs936229	0.813	rs8033381	chr15:75080685	G/A	cg14664628	chr15:75095509	CSK	-1.15	-9.89	-0.75	2.08e-15	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin);
SKCM	cis	rs208515	0.525	rs9453538	chr6:66668508	G/A	cg07460842	chr6:66804631	NA	0.95	6.02	0.56	5.37e-8	Exhaled nitric oxide levels;
SKCM	cis	rs995000	0.931	rs11207996	chr1:63055470	G/A	cg06896770	chr1:63153194	DOCK7	0.93	9.04	0.72	8.97e-14	Triglyceride levels;
SKCM	cis	rs4683346	0.752	rs4683341	chr3:42877394	C/T	cg06399164	chr3:42695035	ZBTB47	0.56	5.0	0.49	3.51e-6	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs11098499	0.562	rs58583086	chr4:120556362	A/G	cg09307838	chr4:120376055	NA	-0.97	-8.11	-0.68	5.87e-12	Corneal astigmatism;
SKCM	cis	rs6545883	0.929	rs1186700	chr2:61663372	A/C	cg15711740	chr2:61764176	XPO1	-0.7	-4.93	-0.49	4.5e-6	Tuberculosis;
SKCM	cis	rs2228479	0.867	rs62052168	chr16:89947203	G/A	cg00800038	chr16:89945340	TCF25	-0.96	-5.44	-0.52	5.85e-7	Skin colour saturation;
SKCM	cis	rs13217239	0.646	rs7451149	chr6:27057518	A/G	cg12292205	chr6:26970375	C6orf41	-0.57	-4.88	-0.48	5.56e-6	Schizophrenia;
SKCM	cis	rs3784262	0.740	rs4646596	chr15:58300895	G/C	cg12031962	chr15:58353849	ALDH1A2	-0.45	-5.37	-0.52	7.83e-7	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs13108904	0.935	rs1620928	chr4:1279124	C/T	cg05025164	chr4:1340916	KIAA1530	-0.6	-4.82	-0.48	6.9e-6	Obesity-related traits;
SKCM	cis	rs61935443	0.832	rs11107773	chr12:95282000	C/T	cg21533806	chr12:95267307	NA	0.92	5.32	0.52	9.53e-7	Schizophrenia;
SKCM	cis	rs2404602	0.647	rs11072618	chr15:77019342	A/G	cg23625390	chr15:77176239	SCAPER	-0.85	-8.26	-0.68	2.93e-12	Blood metabolite levels;
SKCM	cis	rs10832963	0.924	rs10832950	chr11:18635815	A/G	cg20219074	chr11:18656078	SPTY2D1	0.8	6.7	0.6	2.86e-9	Breast cancer;
SKCM	cis	rs6424115	0.931	rs2473377	chr1:24148260	T/C	cg15997130	chr1:24165203	NA	0.61	5.29	0.51	1.1e-6	Immature fraction of reticulocytes;
SKCM	cis	rs5769765	0.773	rs9616383	chr22:50313014	T/C	cg22709217	chr22:50311962	ALG12;CRELD2	-0.94	-5.91	-0.56	8.37e-8	Schizophrenia;
SKCM	cis	rs2354432	0.556	rs2353977	chr1:146839637	G/T	cg25205988	chr1:146714368	CHD1L	1.11	5.59	0.53	3.21e-7	Mitochondrial DNA levels;
SKCM	cis	rs55962025	0.883	rs61792530	chr4:3145866	T/C	cg24015175	chr4:3319247	RGS12	-0.6	-5.22	-0.51	1.43e-6	Parental longevity (mother's age at death);
SKCM	cis	rs7826238	0.601	rs2979206	chr8:8345581	G/C	cg15556689	chr8:8085844	FLJ10661	0.81	6.95	0.62	9.82e-10	Systolic blood pressure;
SKCM	trans	rs208520	0.526	rs6913344	chr6:66754285	A/C	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-0.93	-9.66	-0.74	5.8e-15	Exhaled nitric oxide output;
SKCM	cis	rs554111	0.656	rs17450813	chr1:21264308	T/C	cg01072550	chr1:21505969	NA	0.62	4.87	0.48	5.62e-6	Facial morphology (factor 17, height of vermillion upper lip);
SKCM	cis	rs7954584	0.626	rs12809676	chr12:122442381	C/A	cg13699009	chr12:122356056	WDR66	0.57	7.05	0.62	6.22e-10	Mean corpuscular volume;
SKCM	cis	rs4481887	0.741	rs6421453	chr1:248533285	A/G	cg00666640	chr1:248458726	OR2T12	0.49	5.16	0.5	1.81e-6	Common traits (Other);
SKCM	cis	rs10754283	0.967	rs7528433	chr1:90114071	T/C	cg21401794	chr1:90099060	LRRC8C	0.73	6.34	0.58	1.35e-8	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs1691799	0.899	rs1168295	chr12:66734151	G/C	cg16791601	chr12:66731901	HELB	-0.66	-5.75	-0.55	1.67e-7	White blood cell count (basophil);
SKCM	cis	rs1801251	0.656	rs10211596	chr2:233699415	C/T	cg08000102	chr2:233561755	GIGYF2	-0.77	-6.65	-0.6	3.68e-9	Coronary artery disease;
SKCM	cis	rs7666738	0.924	rs13124368	chr4:99039615	T/C	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs28595532	0.920	rs116231457	chr4:119762396	A/C	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs9300255	0.602	rs1727313	chr12:123640853	C/G	cg05973401	chr12:123451056	ABCB9	0.79	5.4	0.52	7e-7	Neutrophil percentage of white cells;
SKCM	cis	rs2730245	0.505	rs2657360	chr7:158673604	A/G	cg24397884	chr7:158709396	WDR60	0.76	5.88	0.55	9.57e-8	Height;
SKCM	cis	rs28374715	0.662	rs113913466	chr15:41483100	A/G	cg18705301	chr15:41695430	NDUFAF1	-0.93	-7.74	-0.66	2.94e-11	Ulcerative colitis;
SKCM	cis	rs873946	0.586	rs12776770	chr10:134564831	T/C	cg18305652	chr10:134549665	INPP5A	0.58	5.67	0.54	2.29e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs1799949	0.965	rs8176310	chr17:41199913	T/C	cg23758822	chr17:41437982	NA	0.93	7.48	0.65	9.37e-11	Menopause (age at onset);
SKCM	cis	rs7811142	1.000	rs6975729	chr7:100028187	C/T	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-0.99	-5.52	-0.53	4.2e-7	Platelet count;
SKCM	cis	rs6982751	0.673	rs55968942	chr8:10811638	T/A	cg01383082	chr8:11323474	FAM167A	0.86	4.99	0.49	3.58e-6	Asthma and hay fever;
SKCM	cis	rs8141529	0.584	rs58004020	chr22:29257050	A/T	cg15103426	chr22:29168792	CCDC117	0.62	5.1	0.5	2.31e-6	Lymphocyte counts;
SKCM	cis	rs1577917	1.000	rs7766645	chr6:86622238	T/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.77	-0.66	2.59e-11	Response to antipsychotic treatment;
SKCM	cis	rs4481887	1.000	rs10788782	chr1:248496132	C/A	cg00666640	chr1:248458726	OR2T12	0.59	4.94	0.49	4.38e-6	Common traits (Other);
SKCM	cis	rs8078723	1.000	rs56922390	chr17:38157021	C/G	cg17467752	chr17:38218738	THRA	0.67	6.13	0.57	3.38e-8	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs910316	1.000	rs3742773	chr14:75579643	A/G	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.89e-7	Height;
SKCM	cis	rs4888262	0.564	rs6564147	chr16:74622586	G/A	cg01733217	chr16:74700730	RFWD3	0.87	6.93	0.62	1.08e-9	Testicular germ cell tumor;
SKCM	cis	rs2180341	0.596	rs12215298	chr6:127676833	C/T	cg24812749	chr6:127587940	RNF146	0.66	5.94	0.56	7.53e-8	Breast cancer;
SKCM	cis	rs7296418	0.961	rs11613937	chr12:123520071	C/T	cg00376283	chr12:123451042	ABCB9	0.92	8.05	0.67	7.56e-12	Platelet count;
SKCM	cis	rs6089584	0.566	rs2181589	chr20:60622817	C/T	cg16423285	chr20:60520624	NA	0.57	4.93	0.49	4.5e-6	Body mass index;
SKCM	cis	rs17685	0.753	rs1639617	chr7:75701728	A/G	cg16684958	chr7:75615977	POR	0.57	5.54	0.53	4e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2857078	0.772	rs4793086	chr17:42320751	C/T	cg19774624	chr17:42201019	HDAC5	0.79	5.72	0.54	1.88e-7	Red cell distribution width;Reticulocyte count;
SKCM	cis	rs6570726	0.935	rs384453	chr6:145815145	G/C	cg23711669	chr6:146136114	FBXO30	0.71	6.77	0.61	2.18e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6138458	1.000	rs2387362	chr20:24899906	C/T	cg26195577	chr20:24973756	C20orf3	-1.22	-8.58	-0.7	7.01e-13	Blood protein levels;
SKCM	cis	rs2952156	0.920	rs2517954	chr17:37843550	T/C	cg20243544	chr17:37824526	PNMT	0.69	5.24	0.51	1.33e-6	Asthma;
SKCM	cis	rs2019137	0.560	rs10206269	chr2:113990393	C/A	cg21550016	chr2:113992930	PAX8;LOC440839;LOC654433	0.66	5.12	0.5	2.13e-6	Lymphocyte counts;
SKCM	cis	rs7666738	0.830	rs6831219	chr4:98993576	C/A	cg05340658	chr4:99064831	C4orf37	0.67	5.14	0.5	1.98e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9309711	0.698	rs9750503	chr2:3491772	A/G	cg10845886	chr2:3471009	TTC15	0.73	5.26	0.51	1.21e-6	Neurofibrillary tangles;
SKCM	cis	rs11626933	0.885	rs6575125	chr14:90802463	C/T	cg14092571	chr14:90743983	NA	-0.81	-8.01	-0.67	9.18e-12	Gut microbiota (bacterial taxa);
SKCM	cis	rs8180040	1.000	rs295449	chr3:47375955	G/A	cg16586182	chr3:47516702	SCAP	-0.72	-4.93	-0.49	4.51e-6	Colorectal cancer;
SKCM	cis	rs13118159	0.509	rs4974556	chr4:1358141	G/C	cg20887711	chr4:1340912	KIAA1530	0.98	7.46	0.65	1.04e-10	Longevity;
SKCM	cis	rs4481887	1.000	rs4589143	chr1:248470446	A/G	cg00666640	chr1:248458726	OR2T12	0.64	5.71	0.54	1.99e-7	Common traits (Other);
SKCM	cis	rs4481887	0.741	rs6587467	chr1:248550976	T/G	cg00666640	chr1:248458726	OR2T12	0.51	5.21	0.51	1.47e-6	Common traits (Other);
SKCM	cis	rs992157	1.000	rs4791	chr2:219138940	C/T	cg00012203	chr2:219082015	ARPC2	0.82	6.96	0.62	9.29e-10	Colorectal cancer;
SKCM	cis	rs2727020	0.681	rs2866362	chr11:49379316	A/G	cg21546286	chr11:48923668	NA	-0.53	-4.77	-0.48	8.31e-6	Coronary artery disease;
SKCM	cis	rs6762	0.748	rs1130719	chr11:838760	T/A	cg16425592	chr11:842748	TSPAN4;POLR2L	-0.8	-5.91	-0.56	8.5e-8	Mean platelet volume;
SKCM	cis	rs17854409	1.000	rs66956644	chr20:61484499	T/C	cg06598544	chr20:61472147	COL9A3	-1.13	-5.08	-0.5	2.47e-6	Obesity-related traits;
SKCM	cis	rs763121	0.785	rs5757199	chr22:39040617	T/G	cg06022373	chr22:39101656	GTPBP1	0.72	4.96	0.49	4.08e-6	Menopause (age at onset);
SKCM	cis	rs13424612	0.965	rs4149541	chr2:240957734	G/A	cg01812947	chr2:240904978	NDUFA10	0.64	4.92	0.49	4.71e-6	Odorant perception (isobutyraldehyde);
SKCM	cis	rs910316	0.789	rs12894419	chr14:75471802	C/T	cg08847533	chr14:75593920	NEK9	0.82	7.06	0.62	6.19e-10	Height;
SKCM	cis	rs55962025	0.686	rs110501	chr4:3225478	A/G	cg00764545	chr4:3318001	RGS12	-0.63	-5.5	-0.53	4.72e-7	Parental longevity (mother's age at death);
SKCM	cis	rs6840360	0.533	rs13145446	chr4:152729035	G/A	cg22705602	chr4:152727874	NA	0.57	7.74	0.66	2.98e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs9880211	1.000	rs4038586	chr3:136363291	T/C	cg21827317	chr3:136751795	NA	-0.65	-4.92	-0.49	4.73e-6	Body mass index;Height;
SKCM	cis	rs10927875	0.688	rs2009371	chr1:16348083	A/T	cg21385522	chr1:16154831	NA	0.67	4.9	0.48	5.15e-6	Dilated cardiomyopathy;
SKCM	cis	rs9910055	0.676	rs11079983	chr17:42198170	C/T	cg09913183	chr17:42254507	C17orf65;ASB16	0.71	6.5	0.59	6.96e-9	Total body bone mineral density;
SKCM	cis	rs8016982	0.633	rs9944085	chr14:81717620	A/T	cg01989461	chr14:81687754	GTF2A1	-0.8	-6.39	-0.59	1.11e-8	Schizophrenia;
SKCM	cis	rs910316	0.967	rs10142770	chr14:75525449	G/A	cg11812906	chr14:75593930	NEK9	0.72	5.45	0.53	5.7e-7	Height;
SKCM	cis	rs9911578	0.934	rs58092632	chr17:57111101	T/C	cg12560992	chr17:57184187	TRIM37	-1.09	-10.28	-0.76	3.61e-16	Intelligence (multi-trait analysis);
SKCM	cis	rs561341	0.714	rs75861674	chr17:30304317	A/G	cg23018236	chr17:30244563	NA	-0.51	-5.13	-0.5	2.05e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs10905065	0.965	rs7100576	chr10:5784649	G/A	cg11519256	chr10:5708881	ASB13	0.59	5.32	0.52	9.75e-7	Menopause (age at onset);
SKCM	cis	rs11227306	0.934	rs2303384	chr11:65640204	C/T	cg00576331	chr11:65640516	EFEMP2	0.65	5.23	0.51	1.4e-6	DNA methylation (variation);
SKCM	cis	rs11098499	0.909	rs78332141	chr4:120375782	C/T	cg24375607	chr4:120327624	NA	0.68	5.45	0.53	5.66e-7	Corneal astigmatism;
SKCM	cis	rs11098499	1.000	rs1011054	chr4:120202387	A/G	cg09307838	chr4:120376055	NA	-0.98	-8.2	-0.68	3.79e-12	Corneal astigmatism;
SKCM	cis	rs56235845	0.694	rs9313758	chr5:176773091	T/G	cg06060754	chr5:176797920	RGS14	0.64	6.32	0.58	1.5e-8	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs8077889	0.871	rs17675370	chr17:41900030	T/C	cg26893861	chr17:41843967	DUSP3	1.15	7.34	0.64	1.79e-10	Triglycerides;
SKCM	cis	rs873946	0.648	rs3750578	chr10:134563366	A/G	cg18305652	chr10:134549665	INPP5A	0.59	5.74	0.55	1.7e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs4332037	0.523	rs11770148	chr7:1899447	A/G	cg23422044	chr7:1970798	MAD1L1	-0.95	-5.8	-0.55	1.34e-7	Bipolar disorder;
SKCM	cis	rs17711722	0.701	rs781143	chr7:65439879	G/C	cg11987759	chr7:65425863	GUSB	-0.75	-6.72	-0.61	2.68e-9	Calcium levels;
SKCM	cis	rs1878931	0.580	rs3848355	chr16:3407489	A/C	cg26668626	chr16:3451006	ZNF174;ZNF434	0.92	8.15	0.68	4.88e-12	Body mass index (adult);
SKCM	cis	rs7772486	0.875	rs854145	chr6:146349650	C/T	cg23711669	chr6:146136114	FBXO30	0.78	7.48	0.65	9.35e-11	Lobe attachment (rater-scored or self-reported);
SKCM	trans	rs66573146	1.000	rs67405518	chr4:6965930	C/T	cg07817883	chr1:32538562	TMEM39B	2.0	8.02	0.67	8.59e-12	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs62238980	0.614	rs76349379	chr22:32415063	A/G	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs11651000	0.625	rs11079786	chr17:45805916	A/G	cg03474202	chr17:45855739	NA	0.43	5.0	0.49	3.39e-6	IgG glycosylation;
SKCM	cis	rs9300255	0.602	rs10846486	chr12:123709927	G/A	cg05973401	chr12:123451056	ABCB9	0.81	5.37	0.52	7.77e-7	Neutrophil percentage of white cells;
SKCM	cis	rs362272	0.545	rs3135146	chr4:3307638	C/G	cg16987761	chr4:3318072	RGS12	-0.95	-11.15	-0.78	8.21e-18	Serum sulfate level;
SKCM	cis	rs2832191	0.636	rs8131283	chr21:30516796	A/G	cg24692254	chr21:30365293	RNF160	-0.76	-6.41	-0.59	1.03e-8	Dental caries;
SKCM	cis	rs801193	0.935	rs2659899	chr7:66186721	A/G	cg00343986	chr7:65444356	GUSB	0.7	5.19	0.51	1.63e-6	Aortic root size;
SKCM	cis	rs992157	0.560	rs4674275	chr2:219097738	G/A	cg20019365	chr2:219134978	PNKD;AAMP	-0.66	-5.49	-0.53	4.76e-7	Colorectal cancer;
SKCM	cis	rs1538970	0.924	rs1006216	chr1:45909994	A/G	cg05343316	chr1:45956843	TESK2	0.92	4.94	0.49	4.42e-6	Platelet count;
SKCM	cis	rs7829975	0.714	rs11784052	chr8:8671962	C/T	cg15556689	chr8:8085844	FLJ10661	0.65	5.76	0.55	1.56e-7	Mood instability;
SKCM	cis	rs6570726	1.000	rs450076	chr6:145847655	G/T	cg23711669	chr6:146136114	FBXO30	0.71	6.93	0.62	1.06e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7618915	0.501	rs1866268	chr3:52719398	C/A	cg18404041	chr3:52824283	ITIH1	-0.53	-4.77	-0.48	8.42e-6	Bipolar disorder;
SKCM	cis	rs10876993	0.789	rs1689600	chr12:58049645	A/T	cg18357645	chr12:58087776	OS9	0.61	5.65	0.54	2.52e-7	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs10808739	0.660	rs13266737	chr8:65653299	C/G	cg05711235	chr8:65498612	NA	-0.81	-5.4	-0.52	7.01e-7	HIV-1 susceptibility;
SKCM	cis	rs7193541	0.965	rs7184423	chr16:74709737	C/A	cg01733217	chr16:74700730	RFWD3	0.9	8.46	0.69	1.19e-12	Multiple myeloma;
SKCM	cis	rs10540	0.730	rs12789735	chr11:518509	G/A	cg03576123	chr11:487126	PTDSS2	-1.45	-7.95	-0.67	1.17e-11	Body mass index;
SKCM	cis	rs769267	0.965	rs2315025	chr19:19426609	C/T	cg26732615	chr19:19648335	CILP2;YJEFN3	0.65	6.08	0.57	4.12e-8	Tonsillectomy;
SKCM	cis	rs4319547	0.656	rs7294559	chr12:122837564	C/A	cg23029597	chr12:123009494	RSRC2	-0.72	-5.06	-0.5	2.67e-6	Body mass index;
SKCM	cis	rs72772090	0.710	rs11750399	chr5:96077940	A/G	cg17330273	chr5:96107758	CAST;ERAP1	-0.84	-5.14	-0.5	1.96e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs4665809	0.531	rs12990692	chr2:26464939	C/T	cg26119090	chr2:26468346	HADHA;HADHB	1.03	7.99	0.67	9.69e-12	Gut microbiome composition (summer);
SKCM	cis	rs1005277	0.505	rs7917943	chr10:38195811	T/A	cg00409905	chr10:38381863	ZNF37A	0.63	5.85	0.55	1.09e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs116095464	0.558	rs112343653	chr5:257174	G/A	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs12497850	0.931	rs7616815	chr3:48779715	C/T	cg07636037	chr3:49044803	WDR6	0.97	9.89	0.75	2.01e-15	Parkinson's disease;
SKCM	cis	rs644799	1.000	rs1784135	chr11:95531748	G/A	cg03916912	chr11:95522834	CEP57;FAM76B	0.92	8.04	0.67	8e-12	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs1799949	0.930	rs3765640	chr17:41276247	A/G	cg23758822	chr17:41437982	NA	0.92	7.8	0.66	2.3e-11	Menopause (age at onset);
SKCM	cis	rs4481887	0.927	rs7555310	chr1:248487638	A/G	cg00666640	chr1:248458726	OR2T12	0.59	5.17	0.5	1.79e-6	Common traits (Other);
SKCM	cis	rs763121	0.819	rs5757133	chr22:38947835	A/G	cg06022373	chr22:39101656	GTPBP1	-0.65	-5.17	-0.5	1.79e-6	Menopause (age at onset);
SKCM	cis	rs2839186	0.900	rs2839196	chr21:47708037	G/A	cg11766577	chr21:47581405	C21orf56	-0.67	-5.7	-0.54	2.04e-7	Testicular germ cell tumor;
SKCM	cis	rs9467773	0.935	rs4573	chr6:26546808	A/G	cg15659132	chr6:26577336	NA	0.58	5.61	0.54	2.93e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs959260	0.528	rs4559942	chr17:73309269	G/A	cg14668889	chr17:73230827	NUP85	-0.79	-6.46	-0.59	8.09e-9	Systemic lupus erythematosus;
SKCM	cis	rs7216064	0.817	rs12603589	chr17:65825248	T/C	cg12091567	chr17:66097778	LOC651250	-0.75	-5.28	-0.51	1.11e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs11585357	0.895	rs112208664	chr1:17632010	G/A	cg08277548	chr1:17600880	PADI3	-0.89	-6.31	-0.58	1.53e-8	Hair shape;
SKCM	cis	rs651907	0.557	rs34457525	chr3:101435225	C/T	cg12386194	chr3:101231763	SENP7	0.69	5.68	0.54	2.23e-7	Colorectal cancer;
SKCM	cis	rs7100689	0.646	rs6585967	chr10:82139791	A/G	cg01528321	chr10:82214614	TSPAN14	-0.97	-9.05	-0.72	8.57e-14	Post bronchodilator FEV1;
SKCM	cis	rs2404602	0.647	rs118129828	chr15:77015200	T/C	cg23625390	chr15:77176239	SCAPER	-0.82	-7.93	-0.67	1.26e-11	Blood metabolite levels;
SKCM	trans	rs7618501	1.000	rs6785549	chr3:49736565	G/A	cg21659725	chr3:3221576	CRBN	-0.96	-9.58	-0.74	8.03e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs28595532	0.623	rs34531766	chr4:119230339	T/C	cg14228332	chr4:119757509	SEC24D	0.99	5.58	0.53	3.31e-7	Cannabis dependence symptom count;
SKCM	cis	rs8180040	0.800	rs62248905	chr3:47274082	A/G	cg27129171	chr3:47204927	SETD2	-0.79	-5.38	-0.52	7.6e-7	Colorectal cancer;
SKCM	cis	rs2333194	0.846	rs7159794	chr14:73804443	G/A	cg08936952	chr14:74026160	HEATR4	0.53	4.88	0.48	5.59e-6	Bipolar disorder with mood-incongruent psychosis;
SKCM	cis	rs754466	0.651	rs11002317	chr10:79617648	G/A	cg17075019	chr10:79541650	NA	-0.72	-6.51	-0.59	6.75e-9	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs35306767	0.855	rs11253468	chr10:903261	G/A	cg26597838	chr10:835615	NA	0.76	5.3	0.51	1.05e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs548181	0.545	rs76179820	chr11:125616379	A/G	cg03464685	chr11:125439445	EI24	-1.26	-6.58	-0.6	4.85e-9	Schizophrenia;Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);
SKCM	cis	rs6598955	0.543	rs6690461	chr1:26543097	T/A	cg04990556	chr1:26633338	UBXN11	0.68	5.08	0.5	2.55e-6	Obesity-related traits;
SKCM	cis	rs2289583	0.544	rs12050759	chr15:75265191	G/A	cg18866210	chr15:74343476	NA	0.63	4.93	0.49	4.52e-6	Systemic lupus erythematosus;
SKCM	cis	rs798554	0.757	rs1713919	chr7:2864706	C/A	cg19346786	chr7:2764209	NA	-0.64	-6.92	-0.62	1.12e-9	Height;
SKCM	cis	rs9788682	0.747	rs7177514	chr15:78907406	C/G	cg24631222	chr15:78858424	CHRNA5	0.8	5.81	0.55	1.3e-7	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs6665290	0.904	rs6664955	chr1:227183434	T/C	cg10327440	chr1:227177885	CDC42BPA	-1.25	-17.46	-0.89	1.15e-28	Myeloid white cell count;
SKCM	cis	rs9916302	0.861	rs8081033	chr17:37506650	A/G	cg07936489	chr17:37558343	FBXL20	0.85	7.28	0.64	2.26e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs7103648	0.966	rs874896	chr11:47418953	C/G	cg03711944	chr11:47377212	SPI1	-0.53	-4.8	-0.48	7.43e-6	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs2836974	0.604	rs2854727	chr21:40713787	A/G	cg17971929	chr21:40555470	PSMG1	0.71	5.83	0.55	1.19e-7	Cognitive function;
SKCM	cis	rs651907	0.557	rs35850993	chr3:101437433	A/G	cg12386194	chr3:101231763	SENP7	0.68	5.59	0.54	3.16e-7	Colorectal cancer;
SKCM	cis	rs62103177	0.733	rs62103193	chr18:77629217	C/T	cg27393146	chr18:77495563	CTDP1	-0.92	-5.36	-0.52	8.37e-7	Opioid sensitivity;
SKCM	cis	rs208520	0.661	rs207079	chr6:66770462	C/T	cg07460842	chr6:66804631	NA	-1.03	-7.66	-0.66	4.26e-11	Exhaled nitric oxide output;
SKCM	cis	rs17065868	1.000	rs9525983	chr13:45148257	G/A	cg10246903	chr13:45222710	NA	0.89	4.91	0.49	4.85e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs561341	0.629	rs7216107	chr17:30224419	G/A	cg13647721	chr17:30228624	UTP6	0.72	4.78	0.48	7.97e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs9435341	0.929	rs1762509	chr1:107592959	A/G	cg09367891	chr1:107599246	PRMT6	-0.84	-7.05	-0.62	6.33e-10	Facial morphology (factor 21, depth of nasal alae);
SKCM	cis	rs62238980	0.614	rs2018440	chr22:32433889	G/A	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs1760803	0.754	rs10158820	chr1:154217763	C/T	cg26808167	chr1:154192205	UBAP2L;C1orf43	-0.55	-4.91	-0.49	4.87e-6	Nicotine dependence;
SKCM	cis	rs7666738	0.830	rs17484966	chr4:99014432	T/C	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2439831	0.867	rs16957627	chr15:43642657	G/A	cg02155558	chr15:43621948	ADAL;LCMT2	1.39	9.42	0.73	1.62e-14	Lung cancer in ever smokers;
SKCM	cis	rs11098499	0.865	rs2389809	chr4:120377399	T/C	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs10779751	0.734	rs2791657	chr1:11128001	A/G	cg08854313	chr1:11322531	MTOR	0.77	5.52	0.53	4.36e-7	Body mass index;
SKCM	cis	rs7927771	1.000	rs12421210	chr11:47779586	C/T	cg05585544	chr11:47624801	NA	-0.6	-5.22	-0.51	1.45e-6	Subjective well-being;
SKCM	cis	rs561341	0.714	rs547473	chr17:30297560	T/G	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs7927771	0.507	rs3740699	chr11:47504075	G/T	cg20307385	chr11:47447363	PSMC3	0.83	6.35	0.58	1.34e-8	Subjective well-being;
SKCM	cis	rs67311347	0.568	rs9864544	chr3:40336204	T/C	cg02782426	chr3:40428986	ENTPD3	0.52	5.33	0.52	9.46e-7	Renal cell carcinoma;
SKCM	trans	rs11722228	0.508	rs2241472	chr4:10085902	C/G	cg26043149	chr18:55253948	FECH	0.93	7.87	0.67	1.66e-11	Gout;Urate levels;Serum uric acid levels;
SKCM	cis	rs2153535	0.580	rs1410766	chr6:8525360	T/C	cg23788917	chr6:8435910	SLC35B3	0.68	4.98	0.49	3.66e-6	Motion sickness;
SKCM	cis	rs1506636	1.000	rs600774	chr7:123397831	C/T	cg03229431	chr7:123269106	ASB15	0.66	5.31	0.51	1.02e-6	Plateletcrit;Platelet count;
SKCM	cis	rs75920871	0.588	rs721783	chr11:116907449	C/T	cg01368799	chr11:117014884	PAFAH1B2	-0.65	-5.08	-0.5	2.55e-6	Subjective well-being;
SKCM	cis	rs523522	0.962	rs9788155	chr12:120938408	G/A	cg27279351	chr12:120934652	DYNLL1	0.91	8.32	0.69	2.26e-12	High light scatter reticulocyte count;
SKCM	cis	rs17376456	0.569	rs2045021	chr5:93224222	G/A	cg25358565	chr5:93447407	FAM172A	-0.92	-5.69	-0.54	2.17e-7	Diabetic retinopathy;
SKCM	cis	rs3091242	0.809	rs660129	chr1:25727438	C/T	cg27572855	chr1:25598939	RHD	0.53	5.11	0.5	2.22e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs6547631	0.592	rs13408224	chr2:85923936	C/T	cg24620635	chr2:85921963	GNLY	0.9	6.65	0.6	3.58e-9	Blood protein levels;
SKCM	cis	rs12200782	0.530	rs9379892	chr6:26582414	G/A	cg11502198	chr6:26597334	ABT1	0.84	5.04	0.5	2.91e-6	Small cell lung carcinoma;
SKCM	cis	rs8064299	0.597	rs4789097	chr17:72781208	C/T	cg25054828	chr17:72772726	NAT9;TMEM104	-0.98	-9.73	-0.74	4.14e-15	Monocyte count;
SKCM	cis	rs40363	0.645	rs1690446	chr16:3519009	T/C	cg22508957	chr16:3507546	NAT15	0.56	4.85	0.48	6.08e-6	Tuberculosis;
SKCM	cis	rs62238980	0.614	rs117017176	chr22:32400725	T/G	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs12047808	0.841	rs55708548	chr1:179398932	G/C	cg08037922	chr1:179521085	C1orf125;NPHS2	-1.08	-5.8	-0.55	1.32e-7	Multiple sclerosis (age of onset);
SKCM	cis	rs7635838	0.573	rs73019547	chr3:11493323	A/C	cg00170343	chr3:11313890	ATG7	0.75	5.78	0.55	1.46e-7	HDL cholesterol;
SKCM	cis	rs3820928	0.874	rs56324594	chr2:227868854	C/T	cg11843606	chr2:227700838	RHBDD1	-0.61	-4.9	-0.49	5.12e-6	Pulmonary function;
SKCM	cis	rs9790314	0.934	rs465985	chr3:161098552	T/C	cg03342759	chr3:160939853	NMD3	-0.69	-7.06	-0.62	5.97e-10	Morning vs. evening chronotype;
SKCM	cis	rs72615157	0.634	rs11762932	chr7:99792666	C/T	cg21679810	chr7:100027352	MEPCE;ZCWPW1	-1.14	-7.49	-0.65	9.25e-11	Lung function (FEV1/FVC);
SKCM	cis	rs10754283	0.935	rs10801756	chr1:90101832	C/T	cg21401794	chr1:90099060	LRRC8C	0.78	7.17	0.63	3.72e-10	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs561341	1.000	rs546748	chr17:30324293	A/C	cg23018236	chr17:30244563	NA	-0.54	-5.47	-0.53	5.29e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs9611565	0.659	rs169361	chr22:41877989	A/G	cg03806693	chr22:41940476	POLR3H	1.15	7.45	0.64	1.08e-10	Vitiligo;
SKCM	cis	rs907612	0.638	rs11041476	chr11:1875067	C/T	cg02118564	chr11:1241341	NA	-0.44	-4.93	-0.49	4.45e-6	Monocyte percentage of white cells;Monocyte count;Granulocyte percentage of myeloid white cells;
SKCM	cis	rs7772486	0.719	rs2206141	chr6:146086192	A/G	cg23711669	chr6:146136114	FBXO30	-0.9	-10.43	-0.76	1.88e-16	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6598955	0.670	rs3795685	chr1:26601385	A/G	cg00938395	chr1:26633206	UBXN11	-0.67	-4.9	-0.49	5.13e-6	Obesity-related traits;
SKCM	cis	rs2811415	0.597	rs13092555	chr3:127738638	T/A	cg09089421	chr3:127803668	RUVBL1	1.0	8.57	0.7	7.53e-13	Lung function (FEV1/FVC);
SKCM	cis	rs6977660	0.507	rs72591450	chr7:19775480	A/G	cg05791153	chr7:19748676	TWISTNB	0.93	4.92	0.49	4.79e-6	Thyroid stimulating hormone;
SKCM	cis	rs9815354	0.812	rs73071358	chr3:41830487	G/A	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs10793273	1	rs10793273	chr11:77742595	T/C	cg09721595	chr11:77773924	THRSP	-0.7	-6.03	-0.56	5.2e-8	Pelvic organ prolapse;
SKCM	cis	rs7552404	0.924	rs114752222	chr1:76180878	C/T	cg10523679	chr1:76189770	ACADM	0.71	5.11	0.5	2.21e-6	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs12762955	0.561	rs6560863	chr10:1013535	C/A	cg25614935	chr10:1084866	C10orf110	-0.65	-4.83	-0.48	6.77e-6	Response to angiotensin II receptor blocker therapy;
SKCM	cis	rs1185460	0.967	rs1786684	chr11:118938435	G/A	cg23280166	chr11:118938394	VPS11	0.59	5.41	0.52	6.78e-7	Coronary artery disease;
SKCM	cis	rs898097	0.544	rs6502022	chr17:80908652	C/T	cg15369054	chr17:80825471	TBCD	-0.6	-5.91	-0.56	8.53e-8	Breast cancer;
SKCM	cis	rs2120019	0.938	rs5020842	chr15:75322310	T/C	cg09165964	chr15:75287851	SCAMP5	-0.87	-8.61	-0.7	6.3e-13	Blood trace element (Zn levels);
SKCM	cis	rs28374715	0.532	rs28584379	chr15:41670408	C/G	cg18705301	chr15:41695430	NDUFAF1	-1.21	-13.94	-0.84	7.01e-23	Ulcerative colitis;
SKCM	cis	rs754466	0.651	rs11813532	chr10:79637991	T/C	cg17075019	chr10:79541650	NA	-0.73	-6.34	-0.58	1.41e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs28595532	0.841	rs116582665	chr4:119487248	G/C	cg21605333	chr4:119757512	SEC24D	1.24	7.1	0.63	5.16e-10	Cannabis dependence symptom count;
SKCM	cis	rs1577917	0.771	rs9362237	chr6:86409064	G/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	1.02	11.54	0.79	1.55e-18	Response to antipsychotic treatment;
SKCM	cis	rs1405130	0.900	rs35282172	chr2:235587930	G/T	cg17841421	chr2:235704848	NA	-0.57	-4.79	-0.48	7.65e-6	Coronary artery disease;
SKCM	cis	rs9485372	1.000	rs55687017	chr6:149606817	C/T	cg03072286	chr6:150262044	ULBP2	-0.55	-4.89	-0.48	5.3e-6	Breast cancer;
SKCM	cis	rs2404602	0.716	rs67920045	chr15:76800084	G/A	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs7618501	0.633	rs7628058	chr3:50039474	C/T	cg05072774	chr3:49840536	C3orf54	-0.67	-5.06	-0.5	2.73e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1577917	0.740	rs2475792	chr6:86392102	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.86	8.96	0.71	1.3e-13	Response to antipsychotic treatment;
SKCM	cis	rs1691799	0.899	rs1168307	chr12:66739539	A/G	cg16791601	chr12:66731901	HELB	-0.66	-5.81	-0.55	1.31e-7	White blood cell count (basophil);
SKCM	cis	rs66573146	1.000	rs67067921	chr4:6984341	A/T	cg00086871	chr4:6988644	TBC1D14	1.43	5.33	0.52	9.25e-7	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs11690935	0.851	rs7581072	chr2:172859849	C/T	cg13550731	chr2:172543902	DYNC1I2	-0.92	-7.66	-0.66	4.32e-11	Schizophrenia;
SKCM	cis	rs4803468	1.000	rs284654	chr19:41928724	G/A	cg14132834	chr19:41945861	ATP5SL	-0.77	-6.04	-0.56	4.87e-8	Height;
SKCM	cis	rs10911232	0.507	rs2151669	chr1:183055398	T/G	ch.1.3577855R	chr1:183094577	LAMC1	0.78	6.87	0.61	1.42e-9	Hypertriglyceridemia;
SKCM	cis	rs2243480	0.901	rs3813708	chr7:65305632	C/A	cg07424592	chr7:64974309	NA	0.99	4.9	0.49	5.08e-6	Diabetic kidney disease;
SKCM	trans	rs10506458	1.000	rs17763435	chr12:63416511	A/G	cg03429785	chr15:59498649	MYO1E;LDHAL6B	1.37	7.49	0.65	9.28e-11	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs6545883	0.524	rs12713435	chr2:61499789	C/T	cg15711740	chr2:61764176	XPO1	0.66	5.12	0.5	2.17e-6	Tuberculosis;
SKCM	cis	rs394563	0.690	rs237010	chr6:149758750	G/T	cg03678062	chr6:149772716	ZC3H12D	-0.5	-5.57	-0.53	3.55e-7	Dupuytren's disease;
SKCM	cis	rs9300255	0.699	rs11057204	chr12:123725827	T/C	cg05973401	chr12:123451056	ABCB9	0.88	6.28	0.58	1.79e-8	Neutrophil percentage of white cells;
SKCM	cis	rs1577917	0.771	rs9353318	chr6:86231721	T/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.98	10.89	0.78	2.49e-17	Response to antipsychotic treatment;
SKCM	cis	rs12926788	0.542	rs11862971	chr16:24767574	C/A	cg06028605	chr16:24865363	SLC5A11	0.59	4.98	0.49	3.66e-6	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs1799949	1.000	rs11653253	chr17:41182662	G/A	cg05368731	chr17:41323189	NBR1	0.86	7.39	0.64	1.39e-10	Menopause (age at onset);
SKCM	cis	rs10089	0.953	rs4835940	chr5:127406596	A/G	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.92	8.29	0.68	2.54e-12	Ileal carcinoids;
SKCM	cis	rs6500395	1.000	rs4785247	chr16:48687732	A/C	cg04672837	chr16:48644449	N4BP1	-0.65	-5.43	-0.52	6.28e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs995000	0.640	rs4915853	chr1:63191577	C/A	cg06896770	chr1:63153194	DOCK7	-0.73	-5.95	-0.56	7.2e-8	Triglyceride levels;
SKCM	cis	rs7659604	0.539	rs7660548	chr4:122730821	G/C	cg19748678	chr4:122722346	EXOSC9	0.68	5.71	0.54	2e-7	Type 2 diabetes;
SKCM	cis	rs2177596	0.595	rs1917124	chr2:227937611	C/T	cg11843606	chr2:227700838	RHBDD1	-0.76	-5.22	-0.51	1.47e-6	Body mass index;
SKCM	cis	rs9399135	1.000	rs9399135	chr6:135368314	G/A	cg24558204	chr6:135376177	HBS1L	0.57	5.01	0.49	3.34e-6	Red blood cell count;
SKCM	cis	rs7937682	0.924	rs10891283	chr11:111527672	A/G	cg09085632	chr11:111637200	PPP2R1B	-1.05	-12.29	-0.81	6.25e-20	Primary sclerosing cholangitis;
SKCM	cis	rs1577917	0.958	rs12213331	chr6:86504797	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.66	-5.8	-0.55	1.37e-7	Response to antipsychotic treatment;
SKCM	cis	rs17685	0.753	rs1637044	chr7:75703744	T/C	cg16489192	chr7:75678113	MDH2;STYXL1	-0.58	-5.46	-0.53	5.43e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2153535	0.562	rs9379211	chr6:8463927	C/T	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs62238980	0.614	rs7289853	chr22:32427773	C/G	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs1635	0.655	rs1416919	chr6:28302884	T/G	cg15743358	chr6:28303923	ZNF323	-1.27	-5.15	-0.5	1.92e-6	Schizophrenia;
SKCM	cis	rs365132	1.000	rs402511	chr5:176434440	G/A	cg16309518	chr5:176445507	NA	-0.52	-4.99	-0.49	3.54e-6	Menarche and menopause (age at onset);Menopause (age at onset);
SKCM	cis	rs7659604	0.539	rs3217753	chr4:122746325	A/G	cg19748678	chr4:122722346	EXOSC9	0.65	5.4	0.52	7.02e-7	Type 2 diabetes;
SKCM	cis	rs1005277	0.603	rs1998062	chr10:38457652	G/C	cg25427524	chr10:38739819	LOC399744	-0.71	-6.67	-0.6	3.26e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs9803723	0.682	rs2753320	chr1:25459432	A/G	cg20685674	chr1:26233538	STMN1	0.5	4.79	0.48	7.91e-6	Male-pattern baldness;
SKCM	cis	rs1862618	0.853	rs252919	chr5:56124111	T/C	cg12311346	chr5:56204834	C5orf35	-0.7	-4.88	-0.48	5.48e-6	Initial pursuit acceleration;
SKCM	cis	rs9322193	0.961	rs9285521	chr6:149906712	T/G	cg07701084	chr6:150067640	NUP43	0.69	5.55	0.53	3.71e-7	Lung cancer;
SKCM	cis	rs4819052	0.851	rs13047104	chr21:46673562	T/G	cg19498844	chr21:46707878	POFUT2;LOC642852	0.88	7.69	0.66	3.74e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7666738	0.830	rs7664051	chr4:98766970	C/G	cg17366294	chr4:99064904	C4orf37	0.59	5.18	0.51	1.72e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs12142240	0.698	rs1053628	chr1:46827769	C/T	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs2180341	1.000	rs6569479	chr6:127606588	A/G	cg24812749	chr6:127587940	RNF146	0.85	7.42	0.64	1.24e-10	Breast cancer;
SKCM	cis	rs8177253	1.000	rs8177247	chr3:133479499	T/G	cg16414030	chr3:133502952	NA	-0.7	-5.93	-0.56	7.88e-8	Iron status biomarkers;
SKCM	cis	rs72634258	0.554	rs12061787	chr1:7888730	G/C	cg26816564	chr1:7831052	VAMP3	0.75	5.36	0.52	8.06e-7	Inflammatory bowel disease;
SKCM	cis	rs8014204	1.000	rs8014374	chr14:75322914	G/A	cg06637938	chr14:75390232	RPS6KL1	-0.8	-6.28	-0.58	1.77e-8	Caffeine consumption;
SKCM	cis	rs8180040	0.967	rs17411375	chr3:47395135	C/T	cg16586182	chr3:47516702	SCAP	0.71	4.85	0.48	6.25e-6	Colorectal cancer;
SKCM	cis	rs9660180	0.837	rs915292	chr1:1792157	A/C	cg17747265	chr1:1875780	NA	-0.58	-5.19	-0.51	1.63e-6	Body mass index;
SKCM	cis	rs6840360	0.593	rs59350867	chr4:152695935	G/A	cg22705602	chr4:152727874	NA	-0.57	-7.62	-0.65	5.18e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs58688157	0.924	rs35865896	chr11:584591	A/G	cg03576123	chr11:487126	PTDSS2	-0.83	-5.01	-0.49	3.31e-6	Systemic lupus erythematosus;
SKCM	cis	rs854765	0.575	rs2955357	chr17:17946401	T/C	cg04398451	chr17:18023971	MYO15A	0.84	6.78	0.61	2.05e-9	Total body bone mineral density;
SKCM	cis	rs4423214	0.840	rs1790340	chr11:71182589	T/C	cg05163923	chr11:71159392	DHCR7	-0.68	-5.67	-0.54	2.28e-7	Vitamin D levels;
SKCM	cis	rs4780401	0.609	rs35649585	chr16:11813899	G/A	cg01061890	chr16:11836724	TXNDC11	-0.77	-5.59	-0.54	3.18e-7	Rheumatoid arthritis;
SKCM	cis	rs9381040	0.655	rs7738684	chr6:41038552	G/A	cg04346459	chr6:41068666	NFYA;LOC221442	-0.71	-5.0	-0.49	3.5e-6	Alzheimer's disease (late onset);
SKCM	cis	rs7584330	0.910	rs66509917	chr2:238395394	T/G	cg14458575	chr2:238380390	NA	0.98	6.47	0.59	7.93e-9	Prostate cancer;
SKCM	cis	rs12971120	0.947	rs4891559	chr18:72170397	C/T	cg25817165	chr18:72167213	CNDP2	-0.65	-5.24	-0.51	1.35e-6	Refractive error;
SKCM	cis	rs9926296	0.585	rs6500450	chr16:89858024	A/G	cg27121462	chr16:89883253	FANCA	0.84	8.02	0.67	8.58e-12	Vitiligo;
SKCM	cis	rs7666738	0.830	rs60994860	chr4:99046753	G/A	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2204008	0.775	rs11514369	chr12:38305411	C/T	cg26384229	chr12:38710491	ALG10B	0.81	6.57	0.6	5.18e-9	Bladder cancer;
SKCM	cis	rs13256369	1.000	rs12550762	chr8:8576535	T/A	cg06636001	chr8:8085503	FLJ10661	0.75	5.68	0.54	2.2e-7	Obesity-related traits;
SKCM	cis	rs898097	0.841	rs2271918	chr17:80861206	A/G	cg15369054	chr17:80825471	TBCD	0.67	6.55	0.6	5.65e-9	Breast cancer;
SKCM	cis	rs2811415	0.597	rs9837457	chr3:127777040	G/A	cg09089421	chr3:127803668	RUVBL1	1.02	8.85	0.71	2.14e-13	Lung function (FEV1/FVC);
SKCM	cis	rs8067545	0.611	rs2107565	chr17:20088492	C/T	cg13482628	chr17:19912719	NA	-0.66	-5.58	-0.53	3.37e-7	Schizophrenia;
SKCM	cis	rs763121	0.819	rs5750629	chr22:38985065	T/C	cg06022373	chr22:39101656	GTPBP1	0.82	5.62	0.54	2.79e-7	Menopause (age at onset);
SKCM	cis	rs11098499	0.954	rs10518328	chr4:120401779	G/A	cg09307838	chr4:120376055	NA	0.97	7.65	0.65	4.54e-11	Corneal astigmatism;
SKCM	cis	rs17765925	0.605	rs17167987	chr7:14270263	T/C	cg11279021	chr7:14028690	ETV1	0.51	4.85	0.48	6.17e-6	Verbal declarative memory;
SKCM	cis	rs9858542	0.953	rs71324979	chr3:49619651	T/C	cg03060546	chr3:49711283	APEH	-0.69	-5.08	-0.5	2.49e-6	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	trans	rs3780486	0.505	rs10117038	chr9:33122626	T/C	cg20290983	chr6:43655470	MRPS18A	0.91	9.69	0.74	5.08e-15	IgG glycosylation;
SKCM	cis	rs9325144	0.505	rs7955162	chr12:38711658	G/A	cg26384229	chr12:38710491	ALG10B	0.96	8.07	0.67	6.89e-12	Morning vs. evening chronotype;
SKCM	cis	rs11098499	0.863	rs11098532	chr4:120490726	C/A	cg09307838	chr4:120376055	NA	1.0	8.27	0.68	2.8e-12	Corneal astigmatism;
SKCM	cis	rs7106204	0.748	rs11827778	chr11:24211321	G/A	ch.11.24196551F	chr11:24239977	NA	0.77	5.97	0.56	6.6e-8	Response to Homoharringtonine (cytotoxicity);
SKCM	cis	rs7618501	0.602	rs2240327	chr3:50113034	C/T	cg05072774	chr3:49840536	C3orf54	-0.72	-5.52	-0.53	4.31e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs763014	0.898	rs4984895	chr16:623238	T/C	cg09263875	chr16:632152	PIGQ	0.68	5.71	0.54	1.98e-7	Height;
SKCM	cis	rs7216064	0.953	rs80135947	chr17:65836001	A/C	cg12091567	chr17:66097778	LOC651250	-0.77	-5.53	-0.53	4.06e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs7772486	0.875	rs2748490	chr6:146329681	G/T	cg23711669	chr6:146136114	FBXO30	0.76	6.84	0.61	1.56e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7552404	0.924	rs1146588	chr1:76229787	C/G	cg03433033	chr1:76189801	ACADM	0.76	5.36	0.52	8.17e-7	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs28595532	0.920	rs116366070	chr4:119764180	A/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs4905558	1.000	rs10131630	chr14:97286105	A/G	cg11863609	chr14:97355128	NA	-0.56	-4.87	-0.48	5.81e-6	Neutrophil count;
SKCM	cis	rs780096	0.526	rs11127013	chr2:27692973	A/G	cg05696406	chr2:27599888	SNX17	0.51	5.06	0.5	2.75e-6	Total body bone mineral density;
SKCM	cis	rs7811142	1.000	rs113738841	chr7:100081306	C/T	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-1.02	-5.76	-0.55	1.59e-7	Platelet count;
SKCM	cis	rs116095464	0.558	rs62347678	chr5:227496	A/G	cg22496380	chr5:211416	CCDC127	-0.95	-5.22	-0.51	1.42e-6	Breast cancer;
SKCM	cis	rs875971	0.862	rs3893216	chr7:65790707	G/C	cg18876405	chr7:65276391	NA	-0.64	-6.42	-0.59	9.88e-9	Aortic root size;
SKCM	cis	rs11764590	0.950	rs55683212	chr7:2078855	G/C	cg23422044	chr7:1970798	MAD1L1	-0.91	-6.18	-0.57	2.67e-8	Neuroticism;
SKCM	cis	rs6582630	0.519	rs7294300	chr12:38277359	C/A	cg26384229	chr12:38710491	ALG10B	0.87	6.83	0.61	1.63e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs35306767	0.903	rs17159950	chr10:875287	T/G	cg26597838	chr10:835615	NA	0.76	5.44	0.52	5.82e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs752010	0.714	rs6658500	chr1:42088344	A/G	cg06885757	chr1:42089581	HIVEP3	-0.5	-5.16	-0.5	1.85e-6	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs6879260	0.682	rs12173080	chr5:179741411	A/C	cg23248424	chr5:179741104	GFPT2	-0.73	-4.94	-0.49	4.31e-6	Height;
SKCM	cis	rs684232	0.644	rs870183	chr17:599811	A/G	cg12384639	chr17:618140	VPS53	0.66	5.2	0.51	1.56e-6	Prostate cancer;
SKCM	cis	rs6977660	1.000	rs12666159	chr7:19804199	T/C	cg05791153	chr7:19748676	TWISTNB	0.79	5.53	0.53	4.14e-7	Thyroid stimulating hormone;
SKCM	cis	rs6951245	1.000	rs11763020	chr7:1060288	C/T	cg03188948	chr7:1209495	NA	1.11	6.11	0.57	3.68e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs2345546	1	rs2345546	chr16:25427472	C/T	cg08360281	chr16:25269390	ZKSCAN2	1.35	5.99	0.56	5.99e-8	Major depression and alcohol dependence;
SKCM	cis	rs4253772	0.550	rs9615913	chr22:46668515	A/T	cg03482458	chr22:46692211	CN5H6.4;GTSE1	-1.21	-6.03	-0.56	5.06e-8	LDL cholesterol;Cholesterol, total;
SKCM	cis	rs1799949	1.000	rs3092994	chr17:41215825	C/T	cg23758822	chr17:41437982	NA	0.94	7.89	0.67	1.51e-11	Menopause (age at onset);
SKCM	cis	rs644799	0.710	rs3748253	chr11:95519506	G/A	cg03916912	chr11:95522834	CEP57;FAM76B	0.82	6.96	0.62	9.22e-10	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs7119	0.667	rs2867312	chr15:77902293	A/G	cg27398640	chr15:77910606	LINGO1	-0.5	-5.14	-0.5	1.98e-6	Type 2 diabetes;
SKCM	cis	rs7824557	0.564	rs55758514	chr8:11230259	A/T	cg21775007	chr8:11205619	TDH	-0.61	-5.1	-0.5	2.28e-6	Retinal vascular caliber;
SKCM	cis	rs780096	0.647	rs11682083	chr2:27752296	A/G	cg05696406	chr2:27599888	SNX17	0.51	5.3	0.51	1.03e-6	Total body bone mineral density;
SKCM	cis	rs58688157	0.774	rs59115876	chr11:613757	A/G	cg16486109	chr11:613632	IRF7	1.07	7.29	0.64	2.17e-10	Systemic lupus erythematosus;
SKCM	cis	rs796364	0.813	rs7565417	chr2:201057491	G/A	cg12253985	chr2:200820533	C2orf60;C2orf47	0.94	6.15	0.57	3.08e-8	Schizophrenia;
SKCM	cis	rs8067545	0.750	rs7208025	chr17:19997870	T/C	cg13482628	chr17:19912719	NA	0.71	6.15	0.57	3.07e-8	Schizophrenia;
SKCM	cis	rs12497850	0.864	rs4279134	chr3:49156676	A/G	cg06212747	chr3:49208901	KLHDC8B	0.75	4.97	0.49	3.91e-6	Parkinson's disease;
SKCM	cis	rs1799949	1.000	rs12936816	chr17:41301709	C/T	cg05368731	chr17:41323189	NBR1	0.89	7.91	0.67	1.38e-11	Menopause (age at onset);
SKCM	cis	rs668210	0.643	rs549334	chr11:65774659	C/G	cg20909159	chr11:65625947	CFL1	-0.69	-4.79	-0.48	7.93e-6	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs5769765	1.000	rs8138941	chr22:50290678	G/A	cg22709217	chr22:50311962	ALG12;CRELD2	-0.79	-5.71	-0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs10484885	0.648	rs2777848	chr6:90535993	G/A	cg13799429	chr6:90582589	CASP8AP2	-0.7	-6.01	-0.56	5.52e-8	QRS interval (sulfonylurea treatment interaction);
SKCM	cis	rs6952808	0.723	rs57216949	chr7:2030287	G/T	cg02951883	chr7:2050386	MAD1L1	-0.85	-7.58	-0.65	6.15e-11	Bipolar disorder and schizophrenia;
SKCM	cis	rs12477438	0.501	rs6751927	chr2:99740175	T/C	cg26064155	chr2:99771622	LIPT1;TSGA10	1.05	10.46	0.76	1.63e-16	Chronic sinus infection;
SKCM	cis	rs7143963	0.636	rs6575933	chr14:103346616	A/G	cg23020514	chr14:103360112	TRAF3	0.74	6.99	0.62	8.38e-10	Body mass index;
SKCM	cis	rs738322	0.718	rs3761445	chr22:38595411	G/A	cg25457927	chr22:38595422	NA	0.58	7.88	0.67	1.59e-11	Cutaneous nevi;
SKCM	cis	rs28595532	0.748	rs72670249	chr4:119336823	G/T	cg11846333	chr4:119757529	SEC24D	1.19	6.71	0.6	2.81e-9	Cannabis dependence symptom count;
SKCM	cis	rs55962025	0.711	rs4690010	chr4:3159719	G/T	cg21096898	chr4:3318625	RGS12	-0.57	-4.96	-0.49	4.05e-6	Parental longevity (mother's age at death);
SKCM	cis	rs867186	0.920	rs11905081	chr20:33640920	C/T	cg04194272	chr20:33683537	NA	-1.38	-7.2	-0.63	3.29e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs854765	0.647	rs9303144	chr17:17977355	T/C	cg04398451	chr17:18023971	MYO15A	-1.03	-8.98	-0.71	1.16e-13	Total body bone mineral density;
SKCM	cis	rs1878931	1.000	rs1878931	chr16:3450907	G/C	cg26668626	chr16:3451006	ZNF174;ZNF434	0.92	7.41	0.64	1.32e-10	Body mass index (adult);
SKCM	cis	rs1577917	1.000	rs12203924	chr6:86776412	A/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.64	-5.49	-0.53	4.77e-7	Response to antipsychotic treatment;
SKCM	cis	rs933688	1.000	rs1895448	chr5:90743854	C/T	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.01	8.32	0.69	2.23e-12	Smoking behavior;
SKCM	cis	rs6977660	0.607	rs7357321	chr7:19817636	C/T	cg05791153	chr7:19748676	TWISTNB	0.77	5.02	0.49	3.23e-6	Thyroid stimulating hormone;
SKCM	cis	rs2645694	0.533	rs2645680	chr4:77820956	T/C	cg06046430	chr4:77819534	ANKRD56	0.54	5.83	0.55	1.18e-7	Emphysema distribution in smoking;
SKCM	cis	rs8067545	0.611	rs1974745	chr17:20059824	C/G	cg13482628	chr17:19912719	NA	0.66	5.57	0.53	3.54e-7	Schizophrenia;
SKCM	cis	rs4665809	0.627	rs7562192	chr2:26469457	C/G	cg26119090	chr2:26468346	HADHA;HADHB	1.03	7.99	0.67	9.69e-12	Gut microbiome composition (summer);
SKCM	cis	rs8017423	0.565	rs4904681	chr14:90835566	A/T	cg04374321	chr14:90722782	PSMC1	-0.71	-5.43	-0.52	6.11e-7	Mortality in heart failure;
SKCM	cis	rs12477438	0.798	rs1349778	chr2:99645011	G/C	cg26064155	chr2:99771622	LIPT1;TSGA10	-0.72	-4.86	-0.48	6e-6	Chronic sinus infection;
SKCM	cis	rs6424115	0.830	rs2502991	chr1:24202318	A/G	cg15997130	chr1:24165203	NA	0.6	4.94	0.49	4.37e-6	Immature fraction of reticulocytes;
SKCM	cis	rs1707322	1.000	rs2458400	chr1:46530798	C/T	cg03146154	chr1:46216737	IPP	-0.83	-5.56	-0.53	3.62e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs16854884	0.657	rs16854816	chr3:143734147	A/G	cg06585982	chr3:143692056	C3orf58	0.87	8.11	0.68	5.72e-12	Economic and political preferences (feminism/equality);
SKCM	cis	rs7618915	0.547	rs4687548	chr3:52666650	A/T	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs10504229	0.906	rs66480865	chr8:58187100	C/T	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs7296418	0.663	rs11057284	chr12:123830692	G/C	cg05973401	chr12:123451056	ABCB9	0.72	5.48	0.53	5.12e-7	Platelet count;
SKCM	cis	rs2832191	0.703	rs2853827	chr21:30443596	T/C	cg24692254	chr21:30365293	RNF160	0.98	8.98	0.71	1.17e-13	Dental caries;
SKCM	cis	rs796364	1.000	rs1509835	chr2:200814809	C/G	cg12253985	chr2:200820533	C2orf60;C2orf47	0.85	5.33	0.52	9.14e-7	Schizophrenia;
SKCM	cis	rs6500602	1.000	rs7204827	chr16:4467533	C/T	cg09069446	chr16:4462122	CORO7	-0.46	-4.8	-0.48	7.56e-6	Schizophrenia;
SKCM	cis	rs995000	0.895	rs783291	chr1:62914978	G/A	cg06896770	chr1:63153194	DOCK7	0.77	7.26	0.64	2.49e-10	Triglyceride levels;
SKCM	cis	rs6430585	0.583	rs73957037	chr2:136588031	C/A	cg07169764	chr2:136633963	MCM6	1.31	12.59	0.82	1.78e-20	Corneal structure;
SKCM	cis	rs2072499	0.966	rs887953	chr1:156191149	T/C	cg25208724	chr1:156163844	SLC25A44	1.0	8.52	0.69	9.03e-13	Testicular germ cell tumor;
SKCM	cis	rs28595532	0.688	rs116566508	chr4:119619195	G/A	cg14228332	chr4:119757509	SEC24D	0.97	4.92	0.49	4.71e-6	Cannabis dependence symptom count;
SKCM	cis	rs1799949	1.000	rs8176120	chr17:41261233	C/T	cg05368731	chr17:41323189	NBR1	0.88	7.75	0.66	2.84e-11	Menopause (age at onset);
SKCM	cis	rs28386778	0.687	rs59596917	chr17:61806264	T/A	cg01411255	chr17:61851458	DDX42;CCDC47	0.79	5.1	0.5	2.35e-6	Prudent dietary pattern;
SKCM	cis	rs1799949	0.965	rs9646413	chr17:41426157	A/G	cg25072359	chr17:41440525	NA	0.63	4.99	0.49	3.61e-6	Menopause (age at onset);
SKCM	cis	rs362296	0.698	rs362282	chr4:3259671	G/A	cg09735869	chr4:3319127	RGS12	-0.79	-6.74	-0.61	2.47e-9	Parental longevity (mother's age at death);
SKCM	cis	rs2228479	0.571	rs62052183	chr16:89966921	C/A	cg00800038	chr16:89945340	TCF25	-0.93	-5.34	-0.52	8.73e-7	Skin colour saturation;
SKCM	cis	rs2439831	1.000	rs2467740	chr15:43746792	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.1	7.54	0.65	7.34e-11	Lung cancer in ever smokers;
SKCM	cis	rs9790314	0.967	rs336586	chr3:161081347	G/A	cg03342759	chr3:160939853	NMD3	-0.72	-7.89	-0.67	1.53e-11	Morning vs. evening chronotype;
SKCM	cis	rs514406	0.679	rs499239	chr1:53310594	A/G	cg24675658	chr1:53192096	ZYG11B	-0.86	-7.98	-0.67	1.04e-11	Monocyte count;
SKCM	cis	rs362272	0.524	rs2749781	chr4:3346617	T/C	cg11471262	chr4:3318911	RGS12	0.96	11.76	0.8	5.86e-19	Serum sulfate level;
SKCM	cis	rs155076	1.000	rs155076	chr13:21870114	A/G	cg14456004	chr13:21872349	NA	-1.28	-7.48	-0.65	9.62e-11	White matter hyperintensity burden;
SKCM	cis	rs9910055	0.718	rs2526022	chr17:42213216	C/T	cg19774624	chr17:42201019	HDAC5	-0.91	-8.09	-0.68	6.33e-12	Total body bone mineral density;
SKCM	cis	rs7829975	0.564	rs2976855	chr8:8301794	G/A	cg06636001	chr8:8085503	FLJ10661	0.8	6.72	0.61	2.71e-9	Mood instability;
SKCM	cis	rs1799949	1.000	rs12944597	chr17:41187684	A/C	cg05368731	chr17:41323189	NBR1	0.86	7.39	0.64	1.39e-10	Menopause (age at onset);
SKCM	cis	rs3820928	0.874	rs2272198	chr2:227893017	A/G	cg11843606	chr2:227700838	RHBDD1	0.62	4.98	0.49	3.71e-6	Pulmonary function;
SKCM	cis	rs2251381	0.606	rs8129515	chr21:30520167	C/G	cg24692254	chr21:30365293	RNF160	0.78	5.72	0.54	1.87e-7	Selective IgA deficiency;
SKCM	cis	rs12926788	0.640	rs12924246	chr16:24844629	A/G	cg06028605	chr16:24865363	SLC5A11	0.56	4.97	0.49	3.88e-6	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs2361718	0.564	rs2304844	chr17:78084507	G/C	cg09238746	chr17:78121135	EIF4A3	-0.89	-6.81	-0.61	1.77e-9	Yeast infection;
SKCM	cis	rs7772486	0.764	rs2247211	chr6:146216379	G/A	cg23711669	chr6:146136114	FBXO30	0.78	7.7	0.66	3.53e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs875971	0.660	rs801193	chr7:66030612	A/C	cg11987759	chr7:65425863	GUSB	0.69	6.08	0.57	4.12e-8	Aortic root size;
SKCM	cis	rs1552244	0.572	rs68013239	chr3:10165711	G/T	cg00149659	chr3:10157352	C3orf10	1.13	5.45	0.53	5.74e-7	Alzheimer's disease;
SKCM	cis	rs479844	1.000	rs479844	chr11:65551957	A/G	cg27068330	chr11:65405492	SIPA1	-0.73	-5.63	-0.54	2.78e-7	Allergic disease (asthma, hay fever or eczema);Atopic march;Atopic dermatitis;
SKCM	cis	rs10504229	1.000	rs949848	chr8:58169125	A/G	cg22535103	chr8:58192502	C8orf71	-0.68	-4.82	-0.48	7.06e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs40363	0.645	rs1690450	chr16:3521051	G/A	cg22508957	chr16:3507546	NAT15	0.58	5.01	0.49	3.33e-6	Tuberculosis;
SKCM	cis	rs10088262	0.629	rs7015861	chr8:124795613	C/T	cg20713898	chr8:124780851	FAM91A1	-0.72	-5.48	-0.53	5.15e-7	Pancreatic cancer;
SKCM	cis	rs1843834	0.505	rs940317	chr2:225358118	C/T	cg22455342	chr2:225449267	CUL3	0.71	5.32	0.52	9.67e-7	IgE levels in asthmatics (D.p. specific);
SKCM	cis	rs8177253	1.000	rs8177253	chr3:133480192	A/G	cg16414030	chr3:133502952	NA	0.71	6.0	0.56	5.88e-8	Iron status biomarkers;
SKCM	cis	rs10504229	0.683	rs17194995	chr8:58109220	A/C	cg02725872	chr8:58115012	NA	0.53	4.91	0.49	4.82e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs9399135	0.967	rs2297340	chr6:135376058	T/C	cg24558204	chr6:135376177	HBS1L	0.58	5.05	0.5	2.86e-6	Red blood cell count;
SKCM	cis	rs9325144	0.600	rs12227663	chr12:38734922	C/T	cg13010199	chr12:38710504	ALG10B	-0.65	-5.36	-0.52	8.31e-7	Morning vs. evening chronotype;
SKCM	cis	rs10256972	0.552	rs2960831	chr7:1201192	A/T	cg16145915	chr7:1198662	ZFAND2A	-0.57	-8.17	-0.68	4.34e-12	Longevity;Endometriosis;
SKCM	cis	rs3785574	0.962	rs2665842	chr17:61878535	G/A	cg01411255	chr17:61851458	DDX42;CCDC47	1.15	13.4	0.83	6.26e-22	Height;
SKCM	cis	rs10540	1.000	rs116876680	chr11:517473	G/T	cg03576123	chr11:487126	PTDSS2	-1.45	-7.95	-0.67	1.17e-11	Body mass index;
SKCM	trans	rs66573146	0.831	rs11546450	chr4:7032180	G/A	cg07817883	chr1:32538562	TMEM39B	1.98	8.65	0.7	5.13e-13	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs6952808	0.771	rs10950415	chr7:1914477	A/G	cg03354898	chr7:1950403	MAD1L1	-0.54	-5.4	-0.52	6.92e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs10779751	0.734	rs2791650	chr1:11132541	G/C	cg08854313	chr1:11322531	MTOR	0.77	5.52	0.53	4.36e-7	Body mass index;
SKCM	cis	rs1577917	0.771	rs2842602	chr6:86331887	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-1.02	-11.61	-0.8	1.14e-18	Response to antipsychotic treatment;
SKCM	cis	rs7666738	0.830	rs10470951	chr4:99037051	G/A	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2180341	1.000	rs2326567	chr6:127606160	G/A	cg24812749	chr6:127587940	RNF146	0.87	7.33	0.64	1.85e-10	Breast cancer;
SKCM	cis	rs2777491	0.574	rs72739644	chr15:41719706	A/G	cg18705301	chr15:41695430	NDUFAF1	-1.19	-13.25	-0.83	1.15e-21	Ulcerative colitis;
SKCM	cis	rs62064224	0.765	rs11650584	chr17:30679330	T/G	cg25809561	chr17:30822961	MYO1D	0.67	5.15	0.5	1.9e-6	Schizophrenia;
SKCM	cis	rs651907	0.535	rs17347156	chr3:101504674	G/A	cg12386194	chr3:101231763	SENP7	0.65	5.35	0.52	8.54e-7	Colorectal cancer;
SKCM	cis	rs17685	0.753	rs1104879	chr7:75685568	C/T	cg01364799	chr7:75623366	TMEM120A	-0.75	-6.05	-0.56	4.78e-8	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2652834	1.000	rs7182618	chr15:63398622	T/C	cg04194852	chr15:63334506	TPM1	0.76	4.78	0.48	8.15e-6	HDL cholesterol;
SKCM	cis	rs28386778	0.897	rs2584640	chr17:61863488	C/T	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs933688	1.000	rs10041402	chr5:90738948	A/T	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.01	8.43	0.69	1.41e-12	Smoking behavior;
SKCM	cis	rs9894429	1.000	rs3935543	chr17:79579874	T/C	cg18240062	chr17:79603768	NPLOC4	0.76	7.43	0.64	1.2e-10	Eye color traits;
SKCM	cis	rs7772486	0.806	rs7740785	chr6:146171299	C/A	cg05347473	chr6:146136440	FBXO30	0.56	5.38	0.52	7.57e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7954584	0.635	rs3847694	chr12:122325820	A/G	cg21171335	chr12:122356390	WDR66	0.45	4.95	0.49	4.19e-6	Mean corpuscular volume;
SKCM	cis	rs875971	0.862	rs4718383	chr7:66108409	T/C	cg18876405	chr7:65276391	NA	-0.63	-6.32	-0.58	1.5e-8	Aortic root size;
SKCM	cis	rs151997	0.777	rs3846499	chr5:50254200	G/A	cg01829002	chr5:50259133	NA	0.51	4.93	0.49	4.54e-6	Callous-unemotional behaviour;
SKCM	cis	rs752010	1.000	rs6664724	chr1:42093821	G/A	cg06885757	chr1:42089581	HIVEP3	0.62	6.25	0.58	2.04e-8	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs35306767	0.903	rs13377166	chr10:886259	G/A	cg20503657	chr10:835505	NA	0.76	5.17	0.51	1.73e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs6570726	0.935	rs454614	chr6:145832633	C/T	cg23711669	chr6:146136114	FBXO30	0.7	6.64	0.6	3.72e-9	Lobe attachment (rater-scored or self-reported);
SKCM	trans	rs12599106	0.560	rs34151874	chr16:34989694	G/A	cg03395511	chr6:291903	DUSP22	-0.72	-7.94	-0.67	1.22e-11	Menopause (age at onset);
SKCM	cis	rs7666738	0.830	rs6832568	chr4:98994061	G/A	cg17366294	chr4:99064904	C4orf37	0.6	4.98	0.49	3.8e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs8180040	0.715	rs6772670	chr3:47191349	G/A	cg27129171	chr3:47204927	SETD2	0.82	6.44	0.59	9.04e-9	Colorectal cancer;
SKCM	cis	rs3087591	0.960	rs7212264	chr17:29454766	C/T	cg24425628	chr17:29625626	OMG;NF1	0.65	5.17	0.5	1.79e-6	Hip circumference;
SKCM	cis	rs7666738	0.791	rs7660866	chr4:98961335	G/A	cg05340658	chr4:99064831	C4orf37	0.64	4.91	0.49	4.97e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10504229	1.000	rs17816781	chr8:58186161	A/T	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs782590	0.902	rs7582278	chr2:55742924	C/G	cg18811423	chr2:55921094	PNPT1	0.79	5.94	0.56	7.6e-8	Metabolic syndrome;
SKCM	cis	rs2739330	0.828	rs5760102	chr22:24248761	T/C	cg24846343	chr22:24311635	DDTL	0.7	6.75	0.61	2.4e-9	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs9300255	0.602	rs941305	chr12:123715266	T/C	cg00376283	chr12:123451042	ABCB9	0.83	5.37	0.52	8.04e-7	Neutrophil percentage of white cells;
SKCM	cis	rs2204008	0.869	rs34438288	chr12:38211582	G/T	cg26384229	chr12:38710491	ALG10B	0.82	6.58	0.6	4.87e-9	Bladder cancer;
SKCM	cis	rs7772486	0.754	rs10872580	chr6:146140281	C/T	cg23711669	chr6:146136114	FBXO30	-0.88	-9.76	-0.74	3.66e-15	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs12047808	0.841	rs10913751	chr1:179393393	T/A	cg08037922	chr1:179521085	C1orf125;NPHS2	-1.08	-5.8	-0.55	1.32e-7	Multiple sclerosis (age of onset);
SKCM	cis	rs8017423	0.967	rs4904658	chr14:90721640	C/T	cg04374321	chr14:90722782	PSMC1	1.03	9.44	0.73	1.55e-14	Mortality in heart failure;
SKCM	cis	rs7937682	0.883	rs12804962	chr11:111442683	A/T	cg22437258	chr11:111473054	SIK2	-0.62	-4.79	-0.48	7.93e-6	Primary sclerosing cholangitis;
SKCM	cis	rs7811142	0.830	rs77861211	chr7:99962096	T/C	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.2	7.87	0.67	1.7e-11	Platelet count;
SKCM	cis	rs1153858	1.000	rs1618874	chr15:45622786	A/G	cg21132104	chr15:45694354	SPATA5L1	0.89	7.18	0.63	3.58e-10	Homoarginine levels;
SKCM	cis	rs2455826	1.000	rs2455822	chr3:15674669	A/G	cg21141587	chr3:14755007	C3orf20	-0.58	-4.8	-0.48	7.65e-6	Inflammatory skin disease;
SKCM	cis	rs9910055	0.659	rs227578	chr17:42210189	C/A	cg10896456	chr17:42255109	ASB16;C17orf65	-0.69	-7.12	-0.63	4.69e-10	Total body bone mineral density;
SKCM	cis	rs3820928	0.839	rs12151848	chr2:227859326	G/A	cg11843606	chr2:227700838	RHBDD1	-0.61	-4.89	-0.48	5.28e-6	Pulmonary function;
SKCM	cis	rs854765	0.552	rs11078407	chr17:17841083	T/C	cg04398451	chr17:18023971	MYO15A	-0.85	-6.05	-0.57	4.75e-8	Total body bone mineral density;
SKCM	cis	rs1799949	1.000	rs11659028	chr17:41195025	T/A	cg05368731	chr17:41323189	NBR1	0.89	7.68	0.66	3.96e-11	Menopause (age at onset);
SKCM	cis	rs2204008	0.840	rs7957966	chr12:37953629	A/G	cg13010199	chr12:38710504	ALG10B	-0.64	-5.16	-0.5	1.85e-6	Bladder cancer;
SKCM	cis	rs10883723	0.810	rs6584508	chr10:104258567	A/G	cg11453585	chr10:104263688	ACTR1A;SUFU	0.75	5.7	0.54	2.03e-7	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs854765	0.583	rs8073001	chr17:17831716	A/C	cg04398451	chr17:18023971	MYO15A	0.85	6.05	0.57	4.75e-8	Total body bone mineral density;
SKCM	cis	rs7945705	0.902	rs1560569	chr11:8939887	C/T	cg21881798	chr11:8931708	C11orf17;ST5	-0.8	-7.93	-0.67	1.29e-11	Hemoglobin concentration;
SKCM	cis	rs11608355	0.521	rs6606706	chr12:109830173	C/T	cg19025524	chr12:109796872	NA	-0.68	-6.2	-0.57	2.49e-8	Neuroticism;
SKCM	cis	rs72781680	1.000	rs72796337	chr2:24142957	G/A	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	trans	rs1814175	0.646	rs1722010	chr11:49897958	A/G	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs453301	0.653	rs7853	chr8:8890814	A/G	cg15556689	chr8:8085844	FLJ10661	0.75	6.06	0.57	4.55e-8	Joint mobility (Beighton score);
SKCM	cis	rs2842992	0.789	rs2475566	chr6:160148741	C/T	cg16489826	chr6:160211363	TCP1;MRPL18	0.72	5.16	0.5	1.82e-6	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs6546550	0.935	rs3771541	chr2:70031797	C/G	cg02498382	chr2:70120550	SNRNP27	-0.46	-5.07	-0.5	2.61e-6	Prevalent atrial fibrillation;
SKCM	cis	rs28386778	0.966	rs2854161	chr17:61976093	T/C	cg22520471	chr17:61851767	DDX42;CCDC47	-0.75	-4.98	-0.49	3.73e-6	Prudent dietary pattern;
SKCM	cis	rs7086627	0.515	rs10887903	chr10:82210641	C/T	cg01528321	chr10:82214614	TSPAN14	0.58	4.98	0.49	3.8e-6	Post bronchodilator FEV1;
SKCM	cis	rs2014572	0.933	rs8107516	chr19:57758445	A/G	cg24459738	chr19:57751996	ZNF805	-0.64	-5.17	-0.5	1.79e-6	Hyperactive-impulsive symptoms;
SKCM	cis	rs9788682	0.747	rs8043009	chr15:78908154	G/C	cg24631222	chr15:78858424	CHRNA5	0.8	5.81	0.55	1.3e-7	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs72945132	0.579	rs61341131	chr11:70246956	C/A	cg14191688	chr11:70257035	CTTN	0.83	4.91	0.49	4.88e-6	Coronary artery disease;
SKCM	cis	rs617791	0.508	rs2276132	chr11:65770545	G/A	cg27068330	chr11:65405492	SIPA1	-0.69	-4.94	-0.49	4.35e-6	Breast cancer;
SKCM	cis	rs5753618	0.583	rs5753612	chr22:31821479	T/C	cg02404636	chr22:31891804	SFI1	0.6	5.21	0.51	1.52e-6	Colorectal cancer;
SKCM	cis	rs736408	0.736	rs4687550	chr3:52823430	T/G	cg11645453	chr3:52864694	ITIH4	0.58	4.92	0.49	4.71e-6	Bipolar disorder;
SKCM	cis	rs8042680	0.554	rs59278520	chr15:91514707	G/A	cg15878949	chr15:91534302	PRC1	0.61	5.07	0.5	2.61e-6	Type 2 diabetes;
SKCM	cis	rs62238980	0.614	rs117721418	chr22:32394519	C/T	cg00543991	chr22:32367038	NA	1.15	4.87	0.48	5.76e-6	Childhood ear infection;
SKCM	cis	rs9911578	0.935	rs9893351	chr17:57023326	G/A	cg12560992	chr17:57184187	TRIM37	0.92	7.21	0.63	3.16e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs6665290	0.904	rs1045252	chr1:227181555	A/G	cg10327440	chr1:227177885	CDC42BPA	-1.22	-17.41	-0.89	1.36e-28	Myeloid white cell count;
SKCM	cis	rs2839186	0.934	rs4819221	chr21:47695417	G/T	cg13126279	chr21:47581558	C21orf56	0.62	5.32	0.52	9.68e-7	Testicular germ cell tumor;
SKCM	cis	rs2404602	0.530	rs11072614	chr15:76967205	G/A	cg23625390	chr15:77176239	SCAPER	-0.86	-8.0	-0.67	9.21e-12	Blood metabolite levels;
SKCM	cis	rs2070488	1.000	rs3792528	chr3:38493303	T/C	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.99	8.89	0.71	1.79e-13	Electrocardiographic conduction measures;
SKCM	cis	rs1799949	0.896	rs8176098	chr17:41268206	A/C	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.06	-0.57	4.54e-8	Menopause (age at onset);
SKCM	cis	rs9611565	0.694	rs202631	chr22:41863423	A/G	cg03806693	chr22:41940476	POLR3H	0.94	5.95	0.56	7.21e-8	Vitiligo;
SKCM	cis	rs9902453	0.967	rs4429345	chr17:28458105	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.74	-5.07	-0.5	2.61e-6	Coffee consumption (cups per day);
SKCM	cis	rs453301	0.606	rs6601279	chr8:8908231	G/A	cg15556689	chr8:8085844	FLJ10661	-0.66	-4.8	-0.48	7.5e-6	Joint mobility (Beighton score);
SKCM	cis	rs9790314	0.730	rs4856705	chr3:161100219	T/G	cg03342759	chr3:160939853	NMD3	-0.68	-6.18	-0.57	2.73e-8	Morning vs. evening chronotype;
SKCM	cis	rs2239547	0.522	rs9865094	chr3:52985319	G/C	cg11645453	chr3:52864694	ITIH4	-0.58	-4.96	-0.49	3.98e-6	Schizophrenia;
SKCM	cis	rs4819052	0.851	rs2838843	chr21:46669284	T/C	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.36	0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs2836950	0.565	rs2836934	chr21:40564885	A/C	cg17971929	chr21:40555470	PSMG1	-0.73	-6.17	-0.57	2.86e-8	Menarche (age at onset);
SKCM	cis	rs7917772	0.565	rs61869210	chr10:104437175	A/C	cg11453585	chr10:104263688	ACTR1A;SUFU	0.72	5.32	0.52	9.63e-7	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs7666738	0.830	rs6831219	chr4:98993576	C/A	cg17366294	chr4:99064904	C4orf37	0.6	4.98	0.49	3.8e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7100689	0.753	rs1572816	chr10:82137600	A/G	cg01528321	chr10:82214614	TSPAN14	0.84	7.95	0.67	1.17e-11	Post bronchodilator FEV1;
SKCM	cis	rs4794106	0.792	rs847682	chr17:48208274	C/T	cg13127421	chr17:48202128	SAMD14	-0.75	-6.03	-0.56	5.12e-8	Temporomandibular joint disorder;
SKCM	cis	rs2243480	1.000	rs160642	chr7:65558373	C/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs6121246	0.559	rs6058352	chr20:30269179	T/C	cg13852791	chr20:30311386	BCL2L1	0.82	5.69	0.54	2.09e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs11718455	0.960	rs13065591	chr3:43996585	T/C	cg21419209	chr3:44054225	NA	-0.64	-5.28	-0.51	1.15e-6	Coronary artery disease;
SKCM	cis	rs709400	0.894	rs56017123	chr14:104075277	G/A	cg26031613	chr14:104095156	KLC1	1.11	12.72	0.82	1.04e-20	Body mass index;
SKCM	cis	rs9640161	0.659	rs59572505	chr7:150014986	C/T	cg10018233	chr7:150070692	REPIN1	0.7	5.72	0.54	1.88e-7	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs870825	0.616	rs6843185	chr4:185649878	A/C	cg04058563	chr4:185651563	MLF1IP	1.05	7.51	0.65	8.39e-11	Blood protein levels;
SKCM	cis	rs709400	1.000	rs861538	chr14:104166733	C/T	cg26031613	chr14:104095156	KLC1	1.05	12.89	0.82	5.14e-21	Body mass index;
SKCM	cis	rs12464559	0.649	rs4664496	chr2:152522556	T/C	cg01189475	chr2:152685088	ARL5A	-0.92	-4.78	-0.48	7.99e-6	Response to cognitive-behavioural therapy in anxiety disorder;
SKCM	cis	rs9467773	1.000	rs9461259	chr6:26504835	C/A	cg09904177	chr6:26538194	HMGN4	0.55	5.03	0.49	3.11e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7296418	0.961	rs10848428	chr12:123572495	C/T	cg00376283	chr12:123451042	ABCB9	0.96	8.66	0.7	5.01e-13	Platelet count;
SKCM	cis	rs3087591	0.960	rs9303642	chr17:29578360	A/G	cg24425628	chr17:29625626	OMG;NF1	-0.64	-5.17	-0.51	1.74e-6	Hip circumference;
SKCM	cis	rs55962025	0.686	rs362314	chr4:3235241	A/G	cg00764545	chr4:3318001	RGS12	-0.63	-5.44	-0.52	5.85e-7	Parental longevity (mother's age at death);
SKCM	cis	rs1799949	1.000	rs33945274	chr17:41280073	G/A	cg23758822	chr17:41437982	NA	0.92	7.8	0.66	2.3e-11	Menopause (age at onset);
SKCM	cis	rs4891159	0.790	rs72975925	chr18:74143902	G/A	cg24786174	chr18:74118243	ZNF516	-0.75	-6.98	-0.62	8.67e-10	Longevity;
SKCM	cis	rs72634258	0.945	rs12757968	chr1:8106201	A/G	cg00042356	chr1:8021962	PARK7	1.11	7.92	0.67	1.33e-11	Inflammatory bowel disease;
SKCM	cis	rs2836974	0.831	rs2836964	chr21:40631006	T/C	cg11890956	chr21:40555474	PSMG1	1.09	13.73	0.84	1.66e-22	Cognitive function;
SKCM	cis	rs2832077	0.527	rs2250141	chr21:30241984	A/T	cg24692254	chr21:30365293	RNF160	0.66	5.06	0.5	2.73e-6	Cognitive test performance;
SKCM	cis	rs2204008	0.837	rs11495548	chr12:38076756	C/T	cg26384229	chr12:38710491	ALG10B	0.81	6.45	0.59	8.61e-9	Bladder cancer;
SKCM	cis	rs4808199	0.689	rs12979148	chr19:19406869	T/C	cg03709012	chr19:19516395	GATAD2A	1.17	5.69	0.54	2.11e-7	Nonalcoholic fatty liver disease;
SKCM	cis	rs1580019	0.921	rs1580023	chr7:32497881	G/A	cg06627557	chr7:32535165	LSM5;AVL9	0.75	5.74	0.55	1.7e-7	Cognitive ability;
SKCM	cis	rs6835098	0.692	rs10520252	chr4:174070959	T/C	cg08422745	chr4:174089978	GALNT7	-0.85	-7.05	-0.62	6.23e-10	Dementia and core Alzheimer's disease neuropathologic changes;
SKCM	cis	rs2439831	0.681	rs511673	chr15:43618863	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.2	8.73	0.7	3.66e-13	Lung cancer in ever smokers;
SKCM	cis	rs7959452	0.684	rs11177615	chr12:69754189	G/A	cg20891283	chr12:69753455	YEATS4	0.9	9.18	0.72	4.79e-14	Blood protein levels;
SKCM	cis	rs62103177	0.525	rs1835410	chr18:77702025	T/C	cg27393146	chr18:77495563	CTDP1	0.79	5.04	0.5	2.9e-6	Opioid sensitivity;
SKCM	cis	rs8177253	0.761	rs13079426	chr3:133522334	A/G	cg16414030	chr3:133502952	NA	-0.72	-5.97	-0.56	6.59e-8	Iron status biomarkers;
SKCM	cis	rs9814567	1.000	rs6787371	chr3:134254991	A/G	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs12682352	0.602	rs13260419	chr8:8675176	A/G	cg15556689	chr8:8085844	FLJ10661	0.63	5.05	0.5	2.82e-6	Neuroticism;
SKCM	cis	rs13010713	0.840	rs12620692	chr2:182038445	G/T	cg21995919	chr2:182322279	ITGA4	-0.53	-5.22	-0.51	1.43e-6	Celiac disease;
SKCM	cis	rs7833790	0.963	rs1451997	chr8:82774053	A/T	cg17211192	chr8:82754475	SNX16	0.88	4.97	0.49	3.81e-6	Diastolic blood pressure;
SKCM	cis	rs2180341	1.000	rs7756336	chr6:127650299	T/C	cg27446573	chr6:127587934	RNF146	0.94	8.08	0.68	6.49e-12	Breast cancer;
SKCM	cis	rs478304	0.651	rs4930313	chr11:65500428	C/T	cg17480646	chr11:65405466	SIPA1	-0.71	-5.64	-0.54	2.62e-7	Acne (severe);
SKCM	cis	rs28595532	0.920	rs116023902	chr4:119725131	A/G	cg21605333	chr4:119757512	SEC24D	1.35	7.92	0.67	1.37e-11	Cannabis dependence symptom count;
SKCM	cis	rs7927771	0.524	rs4539273	chr11:47694699	C/T	cg20307385	chr11:47447363	PSMC3	-0.72	-5.81	-0.55	1.31e-7	Subjective well-being;
SKCM	cis	rs2857078	0.772	rs4793086	chr17:42320751	C/T	cg09913183	chr17:42254507	C17orf65;ASB16	-0.63	-5.06	-0.5	2.71e-6	Red cell distribution width;Reticulocyte count;
SKCM	cis	rs2721195	1.000	rs1871541	chr8:145681713	G/T	cg17328964	chr8:145687451	CYHR1	0.75	6.87	0.61	1.38e-9	Age at first birth;
SKCM	cis	rs12369179	1.000	rs12369179	chr12:122963550	C/T	cg18578876	chr12:123200353	GPR109B	-1.15	-7.11	-0.63	4.76e-10	Age-related diseases, mortality and associated endophenotypes;Age-related disease endophenotypes;
SKCM	cis	rs9910055	0.529	rs368328	chr17:42170289	G/A	cg19774624	chr17:42201019	HDAC5	0.83	6.53	0.59	6.08e-9	Total body bone mineral density;
SKCM	cis	rs1801251	0.896	rs2197563	chr2:233687080	G/A	cg25237894	chr2:233734115	C2orf82	-0.51	-4.97	-0.49	3.91e-6	Coronary artery disease;
SKCM	cis	rs12497850	0.931	rs7430501	chr3:48890119	C/T	cg07636037	chr3:49044803	WDR6	1.01	10.82	0.77	3.36e-17	Parkinson's disease;
SKCM	cis	rs10504229	0.679	rs6995378	chr8:58113933	C/T	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs995000	0.931	rs1168085	chr1:63112320	C/G	cg06896770	chr1:63153194	DOCK7	-0.76	-7.17	-0.63	3.77e-10	Triglyceride levels;
SKCM	cis	rs72781680	1.000	rs55982282	chr2:24188128	G/A	cg08917208	chr2:24149416	ATAD2B	1.02	5.84	0.55	1.16e-7	Lymphocyte counts;
SKCM	cis	rs897984	0.762	rs7204459	chr16:30984212	G/A	cg00531865	chr16:30841666	NA	0.59	4.98	0.49	3.69e-6	Dementia with Lewy bodies;
SKCM	cis	rs9921192	0.967	rs3747571	chr16:4323983	A/G	cg00021532	chr16:4324280	TFAP4	0.89	8.3	0.68	2.52e-12	Prostate-specific antigen levels;
SKCM	cis	rs854765	0.583	rs11078406	chr17:17840823	G/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.0	7.64	0.65	4.64e-11	Total body bone mineral density;
SKCM	cis	rs644799	0.965	rs10831426	chr11:95505888	G/A	cg03916912	chr11:95522834	CEP57;FAM76B	0.96	8.72	0.7	3.77e-13	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs9916302	0.718	rs10445306	chr17:37591422	A/G	cg07936489	chr17:37558343	FBXL20	-0.85	-7.35	-0.64	1.71e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs2115536	0.967	rs4778734	chr15:80210851	A/G	cg00225070	chr15:80189496	MTHFS	0.77	5.32	0.52	9.75e-7	Eosinophil counts;Eosinophil percentage of white cells;Sum eosinophil basophil counts;Eosinophil percentage of granulocytes;Neutrophil percentage of granulocytes;
SKCM	cis	rs2282032	0.527	rs55664487	chr14:90765880	C/T	cg04374321	chr14:90722782	PSMC1	0.69	5.58	0.53	3.29e-7	Longevity;
SKCM	cis	rs9815354	0.812	rs56290987	chr3:42004882	T/C	cg03022575	chr3:42003672	ULK4	1.0	5.0	0.49	3.43e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs941408	1.000	rs1624295	chr19:2792034	G/A	cg06609049	chr19:2785107	THOP1	0.86	7.04	0.62	6.59e-10	Total cholesterol levels;
SKCM	cis	rs62238980	0.614	rs78680556	chr22:32395329	T/C	cg00543991	chr22:32367038	NA	1.15	4.87	0.48	5.76e-6	Childhood ear infection;
SKCM	cis	rs4975616	0.836	rs460073	chr5:1336459	T/C	cg06550200	chr5:1325588	CLPTM1L	-0.86	-7.74	-0.66	2.94e-11	Lung cancer;
SKCM	cis	rs155076	0.711	rs4769158	chr13:21881975	T/C	cg11317459	chr13:21872234	NA	1.34	7.87	0.67	1.71e-11	White matter hyperintensity burden;
SKCM	cis	rs2842992	0.830	rs2758320	chr6:160070676	T/G	cg19482086	chr6:160211437	TCP1;MRPL18	0.83	5.78	0.55	1.45e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs7666738	0.791	rs13120773	chr4:98972589	C/T	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9300255	0.537	rs1727334	chr12:123714236	A/G	cg00376283	chr12:123451042	ABCB9	0.83	5.37	0.52	8.04e-7	Neutrophil percentage of white cells;
SKCM	cis	rs1577917	0.740	rs9353327	chr6:86394066	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.86	-8.66	-0.7	4.87e-13	Response to antipsychotic treatment;
SKCM	cis	rs7772486	0.686	rs1292334	chr6:145968288	A/G	cg23711669	chr6:146136114	FBXO30	0.9	9.5	0.73	1.16e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9467773	1.000	rs6940188	chr6:26562029	G/C	cg09904177	chr6:26538194	HMGN4	0.54	4.98	0.49	3.78e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9475752	0.947	rs35961728	chr6:56806562	A/C	cg06815302	chr6:57335405	PRIM2	0.63	4.84	0.48	6.4e-6	Menarche (age at onset);
SKCM	cis	rs1005277	0.505	rs1208689	chr10:38097775	C/G	cg00409905	chr10:38381863	ZNF37A	-0.62	-5.81	-0.55	1.29e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs6547741	1.000	rs6756238	chr2:27841305	G/A	cg27432699	chr2:27873401	GPN1	0.75	6.74	0.61	2.45e-9	Oral cavity cancer;
SKCM	cis	rs35306767	0.903	rs12778891	chr10:950130	T/A	cg20503657	chr10:835505	NA	0.76	5.17	0.51	1.73e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs2991971	0.967	rs644915	chr1:46007002	T/C	cg24296786	chr1:45957014	TESK2	0.67	5.45	0.52	5.81e-7	High light scatter reticulocyte count;
SKCM	cis	rs644799	0.965	rs566877	chr11:95528045	G/A	cg25622487	chr11:95524042	FAM76B;CEP57	0.66	5.12	0.5	2.18e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs7772486	0.754	rs697053	chr6:145989807	T/C	cg05347473	chr6:146136440	FBXO30	-0.66	-6.03	-0.56	5.24e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2439831	0.850	rs28858500	chr15:44156942	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.3	6.97	0.62	9.12e-10	Lung cancer in ever smokers;
SKCM	cis	rs838147	0.844	rs12611203	chr19:49248295	G/A	cg13540341	chr19:49222985	MAMSTR	0.56	5.06	0.5	2.77e-6	Dietary macronutrient intake;
SKCM	trans	rs1814175	0.645	rs4598671	chr11:50003191	C/A	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs4150161	0.656	rs2288025	chr16:84211735	A/C	cg10106505	chr16:84220380	TAF1C	-1.29	-5.36	-0.52	8.36e-7	Systolic blood pressure response to hydrochlorothiazide in hypertension;
SKCM	cis	rs4900538	0.855	rs60215817	chr14:102873886	A/G	cg18135206	chr14:102964638	TECPR2	-0.71	-5.36	-0.52	8.09e-7	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs1801251	1.000	rs67013068	chr2:233608253	G/C	cg08000102	chr2:233561755	GIGYF2	0.87	7.05	0.62	6.23e-10	Coronary artery disease;
SKCM	cis	rs1577917	0.771	rs12205013	chr6:86333029	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.82	-7.56	-0.65	6.7e-11	Response to antipsychotic treatment;
SKCM	cis	rs3784262	0.934	rs7164408	chr15:58259336	A/G	cg12031962	chr15:58353849	ALDH1A2	-0.52	-7.2	-0.63	3.23e-10	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs1691799	0.867	rs1168356	chr12:66750469	A/G	cg16791601	chr12:66731901	HELB	-0.57	-4.84	-0.48	6.5e-6	White blood cell count (basophil);
SKCM	cis	rs6951245	0.786	rs77943789	chr7:1140158	C/T	cg23708337	chr7:1209742	NA	0.85	5.04	0.5	2.9e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs67311347	0.544	rs2278930	chr3:40351092	C/T	cg00656387	chr3:40428638	ENTPD3	0.55	4.77	0.48	8.39e-6	Renal cell carcinoma;
SKCM	cis	rs7215564	0.908	rs35542453	chr17:78687242	T/G	cg16980736	chr17:78789706	RPTOR	-0.88	-4.83	-0.48	6.66e-6	Myopia (pathological);
SKCM	cis	rs7523273	0.606	rs1970530	chr1:207924066	G/A	cg22525895	chr1:207977042	MIR29B2	0.81	7.13	0.63	4.49e-10	Schizophrenia;
SKCM	cis	rs4132509	1.000	rs10927067	chr1:243923244	C/T	cg21452805	chr1:244014465	NA	0.85	5.26	0.51	1.21e-6	RR interval (heart rate);
SKCM	cis	rs9733	0.818	rs12130363	chr1:150688596	T/C	cg13175981	chr1:150552382	MCL1	0.64	4.86	0.48	5.85e-6	Tonsillectomy;
SKCM	cis	rs12042938	0.507	rs1765776	chr1:231731607	A/C	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	-0.55	-4.77	-0.48	8.27e-6	Neuranatomic and neurocognitive phenotypes;
SKCM	cis	rs7666738	0.822	rs11097599	chr4:98959562	T/A	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs597539	0.652	rs646586	chr11:68681653	C/T	cg11716795	chr11:68671300	MRPL21;IGHMBP2	-0.76	-4.8	-0.48	7.58e-6	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs6951245	1.000	rs6951245	chr7:1058193	G/A	cg03188948	chr7:1209495	NA	1.11	6.11	0.57	3.68e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs6951245	0.872	rs57068908	chr7:1060084	A/C	cg24642844	chr7:1081250	C7orf50	-0.95	-6.39	-0.59	1.13e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7666738	0.830	rs880472	chr4:98922595	C/A	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs16866061	0.515	rs114968850	chr2:225352461	C/G	cg12698349	chr2:225449008	CUL3	0.92	10.3	0.76	3.38e-16	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs4268898	0.662	rs55661701	chr2:24400769	A/C	cg06627628	chr2:24431161	ITSN2	-0.89	-6.69	-0.6	2.98e-9	Asthma;
SKCM	cis	rs2839186	0.814	rs12482209	chr21:47664275	C/G	cg11766577	chr21:47581405	C21orf56	0.69	5.92	0.56	8.12e-8	Testicular germ cell tumor;
SKCM	cis	rs2153535	0.580	rs2143357	chr6:8497196	A/G	cg07606381	chr6:8435919	SLC35B3	0.85	6.21	0.58	2.39e-8	Motion sickness;
SKCM	cis	rs7811142	1.000	rs2406253	chr7:100077273	A/G	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-0.99	-5.52	-0.53	4.2e-7	Platelet count;
SKCM	cis	rs3087591	0.960	rs2952979	chr17:29474298	T/A	cg24425628	chr17:29625626	OMG;NF1	0.64	5.26	0.51	1.21e-6	Hip circumference;
SKCM	cis	rs9325144	0.560	rs10506125	chr12:39120287	C/T	cg26384229	chr12:38710491	ALG10B	0.8	7.46	0.65	1.02e-10	Morning vs. evening chronotype;
SKCM	cis	rs6450176	0.904	rs6889847	chr5:53303452	G/C	ch.5.1024479R	chr5:53302184	ARL15	-0.72	-5.01	-0.49	3.31e-6	HDL cholesterol levels;HDL cholesterol;Adiponectin levels;
SKCM	cis	rs561341	0.769	rs559228	chr17:30294527	T/C	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs6840360	0.593	rs1877186	chr4:152692418	C/G	cg22705602	chr4:152727874	NA	-0.59	-7.86	-0.66	1.79e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs116095464	0.558	rs10059907	chr5:205360	G/C	cg22496380	chr5:211416	CCDC127	-1.0	-5.11	-0.5	2.25e-6	Breast cancer;
SKCM	cis	rs17376456	0.569	rs7702348	chr5:93065683	A/G	cg21475434	chr5:93447410	FAM172A	-0.83	-5.27	-0.51	1.19e-6	Diabetic retinopathy;
SKCM	trans	rs12599106	0.707	rs2163977	chr16:34916134	A/G	cg03395511	chr6:291903	DUSP22	-0.72	-7.64	-0.65	4.57e-11	Menopause (age at onset);
SKCM	cis	rs860295	0.836	rs1360554	chr1:155473356	C/T	cg02153340	chr1:155202674	NA	0.73	5.64	0.54	2.59e-7	Body mass index;
SKCM	cis	rs875971	1.000	rs10244498	chr7:66116056	A/G	cg18876405	chr7:65276391	NA	0.67	6.69	0.6	3.03e-9	Aortic root size;
SKCM	cis	rs208515	0.525	rs10455593	chr6:66691341	C/T	cg07460842	chr6:66804631	NA	0.93	6.34	0.58	1.37e-8	Exhaled nitric oxide levels;
SKCM	cis	rs2894969	0.664	rs11252717	chr10:4800190	A/G	cg10503599	chr10:4193868	NA	0.61	4.88	0.48	5.43e-6	Major depressive disorder;
SKCM	cis	rs6088580	0.634	rs2424992	chr20:33012060	C/T	cg24642439	chr20:33292090	TP53INP2	0.76	6.02	0.56	5.28e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs933688	1.000	rs6867091	chr5:90734333	C/G	cg12630606	chr5:90679528	LOC100129716;ARRDC3	0.99	8.74	0.7	3.41e-13	Smoking behavior;
SKCM	cis	rs9300255	0.544	rs1790130	chr12:123701270	A/C	cg05973401	chr12:123451056	ABCB9	0.81	5.37	0.52	7.77e-7	Neutrophil percentage of white cells;
SKCM	cis	rs2749592	0.550	rs4934881	chr10:37914346	A/C	cg25427524	chr10:38739819	LOC399744	0.53	4.8	0.48	7.57e-6	Age-related hearing impairment (SNP x SNP interaction);
SKCM	cis	rs4803468	1.000	rs11883104	chr19:41923799	T/C	cg09537434	chr19:41945824	ATP5SL	-1.1	-13.82	-0.84	1.16e-22	Height;
SKCM	cis	rs867186	1.000	rs117249133	chr20:33773630	A/G	cg04194272	chr20:33683537	NA	-1.02	-5.4	-0.52	7.03e-7	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs55823223	0.648	rs936393	chr17:73847613	A/G	cg10935138	chr17:73851978	WBP2	1.15	7.57	0.65	6.31e-11	Psoriasis;
SKCM	cis	rs9325144	0.505	rs826893	chr12:39100536	A/G	cg13010199	chr12:38710504	ALG10B	-0.67	-5.2	-0.51	1.59e-6	Morning vs. evening chronotype;
SKCM	cis	rs8017423	0.967	rs4904657	chr14:90721600	A/G	cg04374321	chr14:90722782	PSMC1	1.03	9.44	0.73	1.55e-14	Mortality in heart failure;
SKCM	trans	rs1814175	0.645	rs1874969	chr11:49826700	G/A	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs1062177	1.000	rs2347596	chr5:151179199	T/C	cg00977110	chr5:151150581	G3BP1	0.82	6.75	0.61	2.32e-9	Preschool internalizing problems;
SKCM	cis	rs35306767	0.903	rs35567307	chr10:915804	G/C	cg26597838	chr10:835615	NA	0.78	5.5	0.53	4.73e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs2739330	0.828	rs4822451	chr22:24248166	T/G	cg04234412	chr22:24373322	LOC391322	-0.64	-5.14	-0.5	1.97e-6	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs2072499	0.966	rs2842882	chr1:156165342	T/G	cg24450063	chr1:156163899	SLC25A44	1.12	11.06	0.78	1.23e-17	Testicular germ cell tumor;
SKCM	cis	rs11105298	0.786	rs10777186	chr12:89921277	G/A	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.91	-5.65	-0.54	2.56e-7	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs2153535	0.541	rs1414352	chr6:8485547	A/C	cg07606381	chr6:8435919	SLC35B3	0.86	6.25	0.58	2.06e-8	Motion sickness;
SKCM	cis	rs1325195	0.520	rs410589	chr1:179232077	A/G	cg10806749	chr1:179558114	NA	0.54	5.12	0.5	2.16e-6	IgE grass sensitization;
SKCM	cis	rs854765	0.583	rs12452219	chr17:17829423	C/T	cg09796270	chr17:17721594	SREBF1	0.66	5.02	0.49	3.25e-6	Total body bone mineral density;
SKCM	cis	rs870825	0.616	rs6834156	chr4:185639903	G/C	cg04058563	chr4:185651563	MLF1IP	1.08	7.26	0.64	2.51e-10	Blood protein levels;
SKCM	cis	rs59918340	0.714	rs3824235	chr8:142222261	A/G	cg23750338	chr8:142222470	SLC45A4	0.59	5.33	0.52	9.34e-7	Immature fraction of reticulocytes;
SKCM	cis	rs12220238	0.841	rs10824163	chr10:76136589	G/A	cg19889307	chr10:75911429	ADK;AP3M1	0.8	4.8	0.48	7.44e-6	Soluble interleukin-2 receptor subunit alpha;
SKCM	cis	rs644799	0.965	rs502521	chr11:95533557	T/A	cg25622487	chr11:95524042	FAM76B;CEP57	0.66	5.12	0.5	2.18e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs2836950	0.545	rs2836952	chr21:40616651	G/C	cg17971929	chr21:40555470	PSMG1	-0.73	-6.17	-0.57	2.86e-8	Menarche (age at onset);
SKCM	cis	rs17376456	0.825	rs13156202	chr5:93157721	C/T	cg25358565	chr5:93447407	FAM172A	-1.21	-7.73	-0.66	3.18e-11	Diabetic retinopathy;
SKCM	cis	rs10089	1.000	rs4836366	chr5:127482494	A/T	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.9	8.98	0.71	1.17e-13	Ileal carcinoids;
SKCM	cis	rs9951698	0.678	rs554854	chr18:13101168	A/G	cg12848697	chr18:13133368	NA	0.58	5.53	0.53	4.14e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs8180040	0.620	rs11709660	chr3:47074927	G/A	cg27129171	chr3:47204927	SETD2	-0.74	-5.37	-0.52	7.84e-7	Colorectal cancer;
SKCM	cis	rs1707322	0.752	rs28719889	chr1:46202283	C/T	cg03146154	chr1:46216737	IPP	0.8	5.47	0.53	5.19e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs6120849	0.754	rs752448	chr20:33592248	C/T	cg24642439	chr20:33292090	TP53INP2	0.94	4.86	0.48	5.91e-6	Protein C levels;
SKCM	cis	rs8072100	0.811	rs1912483	chr17:45443494	A/G	cg08085267	chr17:45401833	C17orf57	-0.68	-5.6	-0.54	3.09e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs55962025	0.883	rs2298967	chr4:3185747	T/C	cg00764545	chr4:3318001	RGS12	-0.61	-5.25	-0.51	1.3e-6	Parental longevity (mother's age at death);
SKCM	cis	rs208520	1.000	rs12189683	chr6:66977716	A/C	cg07460842	chr6:66804631	NA	-0.87	-6.25	-0.58	2.01e-8	Exhaled nitric oxide output;
SKCM	cis	rs72615157	0.634	rs11762932	chr7:99792666	C/T	cg13153964	chr7:100026424	MEPCE;ZCWPW1	-0.98	-5.82	-0.55	1.25e-7	Lung function (FEV1/FVC);
SKCM	cis	rs1949733	1.000	rs2631740	chr4:8484106	C/A	cg11789530	chr4:8429930	ACOX3	-0.83	-5.75	-0.55	1.66e-7	Response to antineoplastic agents;
SKCM	cis	rs933688	0.941	rs6452954	chr5:90735692	G/A	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.92	6.76	0.61	2.21e-9	Smoking behavior;
SKCM	cis	rs1256061	0.603	rs1256038	chr14:64740739	T/C	cg21174375	chr14:64681225	SYNE2	0.47	4.95	0.49	4.15e-6	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs72781680	1.000	rs17711825	chr2:24124578	A/G	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	cis	rs56011263	0.532	rs4690189	chr4:732899	T/G	cg17689763	chr4:710664	PCGF3	-0.66	-4.79	-0.48	7.67e-6	White blood cell count;
SKCM	cis	rs854765	0.647	rs4349203	chr17:17989425	T/A	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.86	6.4	0.59	1.07e-8	Total body bone mineral density;
SKCM	cis	rs711830	0.931	rs6755766	chr2:177043205	T/C	cg13092806	chr2:177043255	NA	0.65	5.81	0.55	1.32e-7	Serous invasive ovarian cancer;Epithelial ovarian cancer;Invasive epithelial ovarian cancer;Mucinous ovarian carcinoma;Low-grade serous and serous borderline ovarian cancer;Serous borderline ovarian cancer;High-grade serous ovarian cancer;
SKCM	cis	rs672059	1.000	rs3118181	chr1:183166970	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.65	5.48	0.53	5.04e-7	Hypertriglyceridemia;
SKCM	cis	rs13118159	0.550	rs10016557	chr4:1363628	C/T	cg02475777	chr4:1388615	CRIPAK	-0.76	-5.11	-0.5	2.26e-6	Longevity;
SKCM	cis	rs1799949	0.930	rs33968979	chr17:41297992	G/T	cg23758822	chr17:41437982	NA	0.92	7.8	0.66	2.3e-11	Menopause (age at onset);
SKCM	cis	rs7618915	0.532	rs13060675	chr3:52674300	T/G	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs7927771	1.000	rs12419692	chr11:47624714	A/C	cg05585544	chr11:47624801	NA	0.63	5.3	0.51	1.06e-6	Subjective well-being;
SKCM	cis	rs867186	1.000	rs78967641	chr20:33783053	G/T	cg04194272	chr20:33683537	NA	-1.02	-5.4	-0.52	7.03e-7	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs151997	0.962	rs27844	chr5:50190680	T/G	cg06027927	chr5:50259733	NA	0.63	5.52	0.53	4.27e-7	Callous-unemotional behaviour;
SKCM	cis	rs62238980	0.614	rs78593283	chr22:32365433	C/T	cg00543991	chr22:32367038	NA	1.28	5.18	0.51	1.68e-6	Childhood ear infection;
SKCM	cis	rs362272	0.505	rs10155132	chr4:3369500	A/G	cg03043834	chr4:3319541	RGS12	0.59	4.85	0.48	6.17e-6	Serum sulfate level;
SKCM	cis	rs28595532	0.841	rs115725150	chr4:119768647	T/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs8177253	1.000	rs6439439	chr3:133481498	G/T	cg16414030	chr3:133502952	NA	-0.69	-5.78	-0.55	1.49e-7	Iron status biomarkers;
SKCM	cis	rs910316	1.000	rs12889472	chr14:75543979	A/G	cg08847533	chr14:75593920	NEK9	0.95	9.18	0.72	4.8e-14	Height;
SKCM	cis	rs2404602	0.647	rs11072610	chr15:76930805	C/A	cg23625390	chr15:77176239	SCAPER	-0.85	-8.26	-0.68	2.93e-12	Blood metabolite levels;
SKCM	cis	rs12148488	0.763	rs4886648	chr15:75308837	G/A	cg09165964	chr15:75287851	SCAMP5	0.69	5.31	0.52	9.92e-7	Caffeine consumption;
SKCM	cis	rs875971	0.660	rs79009421	chr7:66068509	G/C	cg05627663	chr7:65219948	SNORA22;CCT6P1	-0.56	-4.81	-0.48	7.26e-6	Aortic root size;
SKCM	trans	rs1814175	0.817	rs10839401	chr11:49876144	C/T	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs3008870	0.959	rs2985810	chr1:67376162	T/C	cg08660285	chr1:67390436	MIER1;WDR78	0.97	6.52	0.59	6.39e-9	Lymphocyte percentage of white cells;
SKCM	cis	rs9902453	0.817	rs880749	chr17:28059970	T/C	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.83	-5.77	-0.55	1.5e-7	Coffee consumption (cups per day);
SKCM	cis	rs10489202	0.657	rs201540	chr1:167992883	G/A	cg24449463	chr1:168025552	DCAF6	-0.81	-7.88	-0.67	1.58e-11	Schizophrenia;
SKCM	cis	rs28386778	0.897	rs4638645	chr17:61828349	T/C	cg06873352	chr17:61820015	STRADA	0.76	6.34	0.58	1.38e-8	Prudent dietary pattern;
SKCM	cis	rs1348850	0.914	rs1453370	chr2:178327727	C/T	cg02961200	chr2:178257176	LOC100130691;AGPS	0.83	6.14	0.57	3.21e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs34779708	0.931	rs4934731	chr10:35431636	T/C	cg03585969	chr10:35415529	CREM	0.75	6.12	0.57	3.45e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs17065868	1.000	rs61947966	chr13:45076592	A/G	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs17376456	0.877	rs10476526	chr5:93461916	G/A	cg21475434	chr5:93447410	FAM172A	0.97	5.42	0.52	6.39e-7	Diabetic retinopathy;
SKCM	cis	rs7179456	0.547	rs653765	chr15:59042012	T/C	cg05156742	chr15:59063176	FAM63B	0.78	5.61	0.54	3e-7	Asperger disorder;
SKCM	trans	rs62103177	1.000	rs62103177	chr18:77624479	G/A	cg05926928	chr17:57297772	GDPD1	1.29	8.74	0.7	3.44e-13	Opioid sensitivity;
SKCM	cis	rs7772486	0.686	rs9399565	chr6:146081906	G/T	cg05347473	chr6:146136440	FBXO30	-0.55	-5.07	-0.5	2.6e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs651907	0.557	rs2318090	chr3:101474933	A/G	cg12386194	chr3:101231763	SENP7	0.66	5.4	0.52	6.96e-7	Colorectal cancer;
SKCM	cis	rs7772486	0.754	rs702304	chr6:145990797	A/G	cg05347473	chr6:146136440	FBXO30	-0.68	-6.35	-0.58	1.34e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs3768617	0.510	rs1413390	chr1:183096634	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs3785574	0.962	rs2584621	chr17:61912436	G/A	cg01411255	chr17:61851458	DDX42;CCDC47	1.16	12.75	0.82	9.1e-21	Height;
SKCM	cis	rs12142240	0.698	rs17357683	chr1:46815378	C/T	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	trans	rs1814175	0.817	rs11040474	chr11:49708441	G/A	cg03929089	chr4:120376271	NA	-0.9	-8.54	-0.7	8.58e-13	Height;
SKCM	cis	rs2019137	0.539	rs4849181	chr2:113991970	A/G	cg23156509	chr2:114033830	PAX8;LOC440839	-0.58	-4.88	-0.48	5.47e-6	Lymphocyte counts;
SKCM	cis	rs9303401	0.614	rs3087762	chr17:56568680	C/T	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.19	0.57	2.61e-8	Cognitive test performance;
SKCM	trans	rs9929218	0.551	rs4783663	chr16:68720271	T/C	cg04657470	chr2:198365150	HSPE1;HSPD1	1.01	11.28	0.79	4.59e-18	Colorectal cancer;
SKCM	cis	rs7772486	0.790	rs7753696	chr6:146279098	G/T	cg23711669	chr6:146136114	FBXO30	-0.78	-7.4	-0.64	1.36e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs56104184	0.723	rs73063522	chr19:49408358	C/G	cg19746536	chr19:49375674	PPP1R15A	1.16	5.93	0.56	7.67e-8	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs1160297	0.609	rs12622966	chr2:53078420	G/C	cg07782112	chr2:53107842	NA	0.57	5.87	0.55	1.01e-7	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs801193	0.569	rs7800620	chr7:66223688	T/C	cg11764359	chr7:65958608	NA	0.75	6.82	0.61	1.71e-9	Aortic root size;
SKCM	cis	rs4332037	0.539	rs11764780	chr7:2020904	G/C	cg02825527	chr7:2087843	MAD1L1	-0.75	-5.12	-0.5	2.13e-6	Bipolar disorder;
SKCM	cis	rs611744	0.538	rs59930666	chr8:109262296	T/C	cg18478394	chr8:109455254	TTC35	0.65	5.48	0.53	5e-7	Dupuytren's disease;
SKCM	cis	rs686320	0.667	rs666834	chr11:65183815	A/G	cg13521124	chr11:66064082	TMEM151A	-0.85	-4.8	-0.48	7.6e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs9910055	0.659	rs721769	chr17:42261588	T/G	cg08499158	chr17:42289980	UBTF	-0.73	-6.45	-0.59	8.6e-9	Total body bone mineral density;
SKCM	cis	rs763014	0.966	rs7185390	chr16:666382	A/G	cg09263875	chr16:632152	PIGQ	0.72	6.45	0.59	8.69e-9	Height;
SKCM	cis	rs1577917	0.883	rs2660575	chr6:86684995	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.67	-5.86	-0.55	1.07e-7	Response to antipsychotic treatment;
SKCM	cis	rs6545883	0.894	rs778158	chr2:61555421	A/G	cg15711740	chr2:61764176	XPO1	0.68	4.82	0.48	6.94e-6	Tuberculosis;
SKCM	cis	rs782590	0.967	rs10496050	chr2:55806313	C/T	cg18811423	chr2:55921094	PNPT1	0.88	6.98	0.62	8.55e-10	Metabolic syndrome;
SKCM	cis	rs2404602	0.735	rs2454450	chr15:76831236	G/A	cg23625390	chr15:77176239	SCAPER	-0.83	-8.16	-0.68	4.7e-12	Blood metabolite levels;
SKCM	cis	rs7552404	0.924	rs1313071	chr1:76195542	C/G	cg03433033	chr1:76189801	ACADM	0.76	5.6	0.54	3.12e-7	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs7666738	0.800	rs11941885	chr4:99072921	A/C	cg05340658	chr4:99064831	C4orf37	0.66	4.9	0.49	5.03e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9311474	0.508	rs1570	chr3:52586682	T/A	cg18404041	chr3:52824283	ITIH1	-0.53	-4.77	-0.47	8.52e-6	Electroencephalogram traits;
SKCM	cis	rs9913156	0.841	rs7223840	chr17:4562150	T/C	cg19197139	chr17:4613644	ARRB2	0.79	5.28	0.51	1.14e-6	Lymphocyte counts;
SKCM	cis	rs4900538	0.855	rs762105	chr14:102830175	A/G	cg18135206	chr14:102964638	TECPR2	-0.71	-5.36	-0.52	8.09e-7	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs701145	0.938	rs789380	chr3:154081424	G/A	cg17054900	chr3:154042577	DHX36	0.89	4.98	0.49	3.78e-6	Coronary artery disease;
SKCM	cis	rs736408	0.812	rs9324	chr3:52825585	T/C	cg11645453	chr3:52864694	ITIH4	0.58	4.87	0.48	5.71e-6	Bipolar disorder;
SKCM	cis	rs870825	0.616	rs7694899	chr4:185625390	C/T	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs2836950	0.545	rs1888489	chr21:40533164	T/C	cg17971929	chr21:40555470	PSMG1	-0.76	-6.57	-0.6	5.21e-9	Menarche (age at onset);
SKCM	cis	rs2386661	0.826	rs2386651	chr10:5678031	C/A	cg12223502	chr10:5658492	NA	-0.56	-4.79	-0.48	7.72e-6	Breast cancer;
SKCM	cis	rs9910055	0.659	rs8079310	chr17:42270291	A/G	cg13607699	chr17:42295918	UBTF	0.69	5.47	0.53	5.22e-7	Total body bone mineral density;
SKCM	cis	rs2439831	0.702	rs7175032	chr15:44060236	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.35	7.75	0.66	2.9e-11	Lung cancer in ever smokers;
SKCM	cis	rs4523957	0.620	rs9912385	chr17:2062591	T/G	cg16513277	chr17:2031491	SMG6	-0.79	-5.63	-0.54	2.7e-7	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs6904897	0.563	rs4896117	chr6:135229400	T/C	cg22676075	chr6:135203613	NA	-0.69	-6.37	-0.59	1.2e-8	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs7208859	0.623	rs8068645	chr17:29104342	T/A	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs507080	0.885	rs693037	chr11:118553326	C/T	cg18045108	chr11:118530628	TREH	-0.47	-4.81	-0.48	7.24e-6	Serum metabolite levels;
SKCM	cis	rs10883723	0.810	rs11191304	chr10:104255284	C/T	cg11453585	chr10:104263688	ACTR1A;SUFU	0.75	5.7	0.54	2.03e-7	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs12142240	0.659	rs1984491	chr1:46858607	T/G	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs59918340	0.728	rs59172574	chr8:142231945	C/G	cg23750338	chr8:142222470	SLC45A4	0.62	6.04	0.56	4.98e-8	Immature fraction of reticulocytes;
SKCM	cis	rs2721195	0.549	rs2620666	chr8:145703413	T/C	cg15857475	chr8:145742913	RECQL4;LRRC14	0.9	8.25	0.68	3.04e-12	Age at first birth;
SKCM	cis	rs2737618	0.674	rs2249150	chr1:200083654	G/A	cg21825944	chr1:200113062	NR5A2	-0.6	-4.92	-0.49	4.66e-6	Uric acid levels;
SKCM	cis	rs9467773	0.620	rs2494701	chr6:26634432	C/T	cg09904177	chr6:26538194	HMGN4	0.58	5.01	0.49	3.28e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1552244	0.872	rs115331527	chr3:10154504	G/A	cg02579736	chr3:10068473	FANCD2;CIDECP	1.23	6.8	0.61	1.9e-9	Alzheimer's disease;
SKCM	cis	rs7666738	0.830	rs13108705	chr4:99044438	T/C	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6088580	0.634	rs6142159	chr20:32993035	G/A	cg24642439	chr20:33292090	TP53INP2	-0.76	-6.02	-0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs12477438	0.501	rs13000731	chr2:99795231	G/T	cg26064155	chr2:99771622	LIPT1;TSGA10	1.03	9.76	0.74	3.61e-15	Chronic sinus infection;
SKCM	cis	rs116095464	0.558	rs10080225	chr5:232175	A/G	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs908922	0.702	rs569232	chr1:152526643	A/G	cg09873164	chr1:152488093	CRCT1	0.96	6.77	0.61	2.15e-9	Hair morphology;
SKCM	cis	rs8072100	0.640	rs3851808	chr17:45425144	C/T	cg08085267	chr17:45401833	C17orf57	-0.7	-5.58	-0.53	3.33e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs11098499	0.644	rs3806808	chr4:120551085	A/C	cg09307838	chr4:120376055	NA	0.94	7.77	0.66	2.64e-11	Corneal astigmatism;
SKCM	cis	rs4478137	0.824	rs10857353	chr4:164215835	A/G	cg06758707	chr4:164254230	NPY1R	-0.95	-6.27	-0.58	1.86e-8	Subjective well-being (multi-trait analysis);Subjective well-being;
SKCM	cis	rs3820068	0.603	rs72645900	chr1:15931980	A/T	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs7666738	0.830	rs1559859	chr4:99024325	C/T	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs644799	0.710	rs12273579	chr11:95524421	G/A	cg25622487	chr11:95524042	FAM76B;CEP57	0.7	5.67	0.54	2.28e-7	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs7552404	0.889	rs1250874	chr1:76190978	A/G	cg10523679	chr1:76189770	ACADM	0.7	5.18	0.51	1.72e-6	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs951366	0.789	rs1772148	chr1:205704580	A/T	cg14893161	chr1:205819251	PM20D1	1.04	9.81	0.74	2.9e-15	Menarche (age at onset);
SKCM	cis	rs1799949	1.000	rs34534709	chr17:41302940	C/G	cg05368731	chr17:41323189	NBR1	0.89	7.91	0.67	1.38e-11	Menopause (age at onset);
SKCM	cis	rs875971	0.862	rs778707	chr7:65857027	G/A	cg18876405	chr7:65276391	NA	0.63	6.34	0.58	1.39e-8	Aortic root size;
SKCM	cis	rs6570726	0.846	rs9399559	chr6:145945778	C/T	cg05347473	chr6:146136440	FBXO30	0.57	5.19	0.51	1.61e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs10504229	0.683	rs72649192	chr8:58110490	T/C	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs561341	1.000	rs72825740	chr17:30338356	A/G	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs7959452	0.557	rs899224	chr12:69784774	A/G	cg14784868	chr12:69753453	YEATS4	0.8	7.6	0.65	5.66e-11	Blood protein levels;
SKCM	cis	rs7618915	1.000	rs3844291	chr3:52341215	A/C	cg18404041	chr3:52824283	ITIH1	-0.61	-5.12	-0.5	2.15e-6	Bipolar disorder;
SKCM	cis	rs10911232	0.507	rs10752891	chr1:183023283	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.65	0.6	3.59e-9	Hypertriglyceridemia;
SKCM	cis	rs875971	0.638	rs10249404	chr7:66046724	G/A	cg05627663	chr7:65219948	SNORA22;CCT6P1	-0.56	-4.84	-0.48	6.39e-6	Aortic root size;
SKCM	cis	rs7809950	0.817	rs3779495	chr7:107250260	G/A	cg23024343	chr7:107201750	COG5	0.89	8.28	0.68	2.7e-12	Coronary artery disease;
SKCM	cis	rs7772486	0.625	rs2050027	chr6:146116113	C/G	cg23711669	chr6:146136114	FBXO30	-0.85	-9.35	-0.73	2.22e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9467773	0.620	rs2494716	chr6:26662736	T/C	cg15659132	chr6:26577336	NA	0.62	5.42	0.52	6.53e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs709400	0.628	rs11621510	chr14:103869620	T/C	cg26031613	chr14:104095156	KLC1	0.68	5.17	0.51	1.75e-6	Body mass index;
SKCM	cis	rs8016982	0.674	rs1951614	chr14:81672106	A/G	cg01989461	chr14:81687754	GTF2A1	-0.88	-7.42	-0.64	1.26e-10	Schizophrenia;
SKCM	cis	rs9910055	0.762	rs184478	chr17:42209751	C/G	cg13607699	chr17:42295918	UBTF	-0.78	-6.13	-0.57	3.38e-8	Total body bone mineral density;
SKCM	cis	rs8017423	0.647	rs4904673	chr14:90817338	G/A	cg04374321	chr14:90722782	PSMC1	-0.76	-5.95	-0.56	7.2e-8	Mortality in heart failure;
SKCM	cis	rs6696846	0.749	rs11578293	chr1:205070178	T/C	cg03948781	chr1:205179583	DSTYK	0.56	5.28	0.51	1.14e-6	Red blood cell count;
SKCM	cis	rs4319547	1.000	rs6489156	chr12:123100397	C/T	cg23029597	chr12:123009494	RSRC2	-0.8	-6.24	-0.58	2.08e-8	Body mass index;
SKCM	cis	rs860295	0.702	rs56675301	chr1:155364327	T/C	cg02153340	chr1:155202674	NA	-0.77	-5.48	-0.53	4.96e-7	Body mass index;
SKCM	cis	rs12950390	0.893	rs4794110	chr17:45847230	A/G	cg03474202	chr17:45855739	NA	-0.51	-5.79	-0.55	1.4e-7	IgG glycosylation;
SKCM	cis	rs9910055	0.659	rs721769	chr17:42261588	T/G	cg19774624	chr17:42201019	HDAC5	-0.87	-8.15	-0.68	4.72e-12	Total body bone mineral density;
SKCM	cis	rs9910055	0.718	rs2526022	chr17:42213216	C/T	cg09913183	chr17:42254507	C17orf65;ASB16	0.71	6.52	0.59	6.37e-9	Total body bone mineral density;
SKCM	cis	rs2991971	0.810	rs12119202	chr1:45925931	A/T	cg24296786	chr1:45957014	TESK2	-0.64	-5.04	-0.5	2.99e-6	High light scatter reticulocyte count;
SKCM	cis	rs854765	0.583	rs4925129	chr17:17807186	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.01	7.61	0.65	5.31e-11	Total body bone mineral density;
SKCM	cis	rs17685	0.735	rs11763339	chr7:75761541	T/C	cg16489192	chr7:75678113	MDH2;STYXL1	-0.57	-5.35	-0.52	8.63e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1005277	0.579	rs2504140	chr10:38387579	T/G	cg00409905	chr10:38381863	ZNF37A	-0.64	-5.96	-0.56	6.77e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs1048238	0.506	rs848194	chr1:16285342	G/A	cg21385522	chr1:16154831	NA	-0.64	-5.51	-0.53	4.45e-7	Systolic blood pressure;
SKCM	cis	rs2455601	0.786	rs11042127	chr11:8947586	C/G	cg21881798	chr11:8931708	C11orf17;ST5	-0.74	-5.29	-0.51	1.07e-6	Schizophrenia;
SKCM	cis	rs1707322	1.000	rs4298677	chr1:46306619	G/A	cg03146154	chr1:46216737	IPP	0.78	5.29	0.51	1.08e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs8180040	0.966	rs12632132	chr3:47477019	C/T	cg16586182	chr3:47516702	SCAP	-0.76	-5.32	-0.52	9.63e-7	Colorectal cancer;
SKCM	cis	rs6500602	0.674	rs8051695	chr16:4536621	T/C	cg08645402	chr16:4508243	NA	0.63	4.89	0.48	5.39e-6	Schizophrenia;
SKCM	cis	rs3845702	1.000	rs3845702	chr2:180848488	A/C	cg01881094	chr2:180872142	CWC22	1.0	5.48	0.53	5.1e-7	Schizophrenia;
SKCM	cis	rs4782309	0.544	rs6500488	chr16:88753865	A/G	cg02389323	chr16:88786976	FAM38A	1.28	4.81	0.48	7.09e-6	Hair color;
SKCM	cis	rs3820928	0.874	rs4675132	chr2:227841792	A/C	cg11843606	chr2:227700838	RHBDD1	-0.61	-4.97	-0.49	3.83e-6	Pulmonary function;
SKCM	cis	rs748404	0.690	rs2924369	chr15:43777985	G/A	cg02155558	chr15:43621948	ADAL;LCMT2	-0.72	-5.54	-0.53	3.99e-7	Lung cancer;
SKCM	cis	rs873946	0.504	rs3829132	chr10:134579044	A/C	cg18305652	chr10:134549665	INPP5A	0.6	6.18	0.57	2.72e-8	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs6879260	1.000	rs7725605	chr5:179732678	T/G	cg13944838	chr5:179740914	GFPT2	-0.67	-5.67	-0.54	2.29e-7	Height;
SKCM	cis	rs3820928	0.874	rs12467261	chr2:227888838	T/C	cg11843606	chr2:227700838	RHBDD1	-0.61	-5.0	-0.49	3.48e-6	Pulmonary function;
SKCM	cis	rs1185460	0.904	rs1003081	chr11:118913993	A/G	cg23280166	chr11:118938394	VPS11	-0.53	-4.91	-0.49	4.98e-6	Coronary artery disease;
SKCM	cis	rs6750795	0.870	rs6754952	chr2:232381245	G/T	cg19187155	chr2:232395269	NMUR1	-1.0	-9.47	-0.73	1.32e-14	Height;
SKCM	cis	rs7811142	1.000	rs28490152	chr7:100020982	G/A	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.11	6.45	0.59	8.66e-9	Platelet count;
SKCM	cis	rs2836974	0.836	rs8129355	chr21:40579869	A/G	cg11890956	chr21:40555474	PSMG1	1.09	13.83	0.84	1.08e-22	Cognitive function;
SKCM	cis	rs7927771	0.894	rs12798346	chr11:47583121	C/T	cg05585544	chr11:47624801	NA	-0.63	-5.5	-0.53	4.73e-7	Subjective well-being;
SKCM	cis	rs7618501	0.633	rs6792892	chr3:49995518	T/C	cg05072774	chr3:49840536	C3orf54	-0.66	-5.03	-0.49	3.12e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs11122272	0.668	rs1538664	chr1:231555295	C/T	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	-0.63	-5.36	-0.52	8.13e-7	Hemoglobin concentration;
SKCM	cis	rs10088262	0.629	rs9918907	chr8:124816862	A/G	cg20713898	chr8:124780851	FAM91A1	-0.7	-5.15	-0.5	1.88e-6	Pancreatic cancer;
SKCM	cis	rs12474201	0.630	rs897529	chr2:46948175	T/C	cg06386533	chr2:46925753	SOCS5	0.73	6.12	0.57	3.46e-8	Height;
SKCM	cis	rs1799949	0.965	rs799917	chr17:41244936	G/A	cg25072359	chr17:41440525	NA	0.65	4.89	0.48	5.31e-6	Menopause (age at onset);
SKCM	cis	rs732765	0.657	rs10139082	chr14:75223338	C/A	cg25946216	chr14:74253857	C14orf43	-0.93	-5.16	-0.5	1.82e-6	Non-small cell lung cancer;
SKCM	cis	rs28595532	0.920	rs116105567	chr4:119746204	C/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs112427907	1	rs112427907	chr3:47995270	G/A	cg09665691	chr3:47563885	NA	1.48	5.6	0.54	3.14e-7	Stem cell growth factor beta levels;
SKCM	trans	rs3780486	0.801	rs56687083	chr9:33132134	A/G	cg20290983	chr6:43655470	MRPS18A	1.0	11.51	0.79	1.7e-18	IgG glycosylation;
SKCM	cis	rs561341	0.941	rs17780086	chr17:30343282	G/A	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs6942756	1.000	rs12112374	chr7:128950071	A/G	cg02491457	chr7:128862824	NA	-0.83	-5.19	-0.51	1.65e-6	White matter hyperintensity burden;
SKCM	cis	rs2842992	0.662	rs2273825	chr6:160211424	A/C	cg19482086	chr6:160211437	TCP1;MRPL18	0.87	7.46	0.65	1.04e-10	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs1797081	0.967	rs811912	chr10:16859618	G/C	cg23933602	chr10:16859644	RSU1	1.04	16.32	0.88	7.08e-27	Platelet distribution width;
SKCM	cis	rs4820539	0.934	rs3788348	chr22:23467946	G/C	cg14186256	chr22:23484241	RTDR1	0.85	8.17	0.68	4.37e-12	Bone mineral density;
SKCM	cis	rs9921222	0.500	rs8046256	chr16:393948	C/T	cg00101154	chr16:420108	MRPL28	-0.67	-5.53	-0.53	4.03e-7	Bone mineral density (spine);Bone mineral density;
SKCM	cis	rs1062177	0.901	rs1549622	chr5:151266049	A/G	cg00977110	chr5:151150581	G3BP1	0.78	6.28	0.58	1.82e-8	Preschool internalizing problems;
SKCM	cis	rs34375054	0.553	rs12581512	chr12:125622262	G/A	cg25124228	chr12:125621409	AACS	-0.8	-6.26	-0.58	1.92e-8	Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs155076	1.000	rs564685	chr13:21846879	A/G	cg11317459	chr13:21872234	NA	-1.24	-6.91	-0.62	1.19e-9	White matter hyperintensity burden;
SKCM	cis	rs1577917	0.958	rs12198971	chr6:86525445	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.33	-0.52	9.19e-7	Response to antipsychotic treatment;
SKCM	cis	rs2836974	0.644	rs4818017	chr21:40690561	G/T	cg11890956	chr21:40555474	PSMG1	-0.79	-7.37	-0.64	1.57e-10	Cognitive function;
SKCM	cis	rs4862750	0.832	rs4862744	chr4:187877074	T/A	cg11301795	chr4:187892539	NA	-0.45	-5.29	-0.51	1.08e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1153858	0.943	rs4774580	chr15:45652086	G/A	cg21132104	chr15:45694354	SPATA5L1	0.92	7.95	0.67	1.16e-11	Homoarginine levels;
SKCM	cis	rs7598759	0.712	rs6727510	chr2:232332016	T/C	cg19187155	chr2:232395269	NMUR1	0.61	5.13	0.5	2.07e-6	Noise-induced hearing loss;
SKCM	cis	rs9916302	0.808	rs12948906	chr17:37644854	C/T	cg07936489	chr17:37558343	FBXL20	-0.9	-8.1	-0.68	6.05e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs33794	0.901	rs33774	chr3:45286107	C/T	cg25630594	chr3:44914870	TGM4	0.58	4.98	0.49	3.73e-6	Lung function (forced expiratory volume in 1 second);
SKCM	cis	rs1451375	0.756	rs11761683	chr7:50542879	C/T	cg18232548	chr7:50535776	DDC	-0.69	-5.17	-0.51	1.75e-6	Malaria;
SKCM	cis	rs2839186	0.708	rs17183123	chr21:47671961	G/C	cg13012494	chr21:47604986	C21orf56	0.7	5.8	0.55	1.34e-7	Testicular germ cell tumor;
SKCM	cis	rs7666738	0.830	rs6852015	chr4:99054373	C/A	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11112613	0.653	rs941101	chr12:105937098	T/G	cg03607813	chr12:105948248	NA	0.89	5.69	0.54	2.11e-7	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;
SKCM	cis	rs1635	0.655	rs16893975	chr6:28302278	C/T	cg15743358	chr6:28303923	ZNF323	1.15	5.02	0.49	3.15e-6	Schizophrenia;
SKCM	cis	rs67311347	0.955	rs6599100	chr3:40447362	C/T	cg00091569	chr3:40428383	ENTPD3	0.61	5.36	0.52	8.37e-7	Renal cell carcinoma;
SKCM	cis	rs11776272	0.927	rs11135789	chr8:21878607	C/T	cg17168535	chr8:21777572	XPO7	-0.77	-5.32	-0.52	9.55e-7	Obesity-related traits;
SKCM	cis	rs875971	0.862	rs1695820	chr7:65844563	G/A	cg18876405	chr7:65276391	NA	0.63	6.25	0.58	2.06e-8	Aortic root size;
SKCM	cis	rs28595532	0.920	rs116023902	chr4:119725131	A/G	cg11846333	chr4:119757529	SEC24D	1.19	6.39	0.59	1.12e-8	Cannabis dependence symptom count;
SKCM	cis	rs2842992	0.724	rs1128670	chr6:160211636	G/A	cg16489826	chr6:160211363	TCP1;MRPL18	0.71	5.51	0.53	4.52e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs7940866	0.874	rs7111478	chr11:130819628	A/G	cg12179176	chr11:130786555	SNX19	0.79	5.86	0.55	1.06e-7	Schizophrenia;
SKCM	cis	rs7193541	0.929	rs12933037	chr16:74660174	G/A	cg01733217	chr16:74700730	RFWD3	0.89	8.4	0.69	1.59e-12	Multiple myeloma;
SKCM	trans	rs1814175	0.676	rs11040647	chr11:49935947	A/C	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs10256972	0.706	rs4285396	chr7:1123738	A/G	cg07092213	chr7:1199455	ZFAND2A	-0.65	-5.41	-0.52	6.75e-7	Longevity;Endometriosis;
SKCM	cis	rs28595532	0.920	rs56104443	chr4:119752052	G/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs35146811	0.586	rs1076237	chr7:99585441	A/C	cg13334819	chr7:99746414	C7orf59	-0.7	-4.86	-0.48	5.97e-6	Coronary artery disease;
SKCM	cis	rs8180040	0.903	rs6791842	chr3:47279810	T/C	cg16586182	chr3:47516702	SCAP	-0.72	-4.98	-0.49	3.73e-6	Colorectal cancer;
SKCM	cis	rs9790314	0.663	rs4557202	chr3:160820524	G/C	cg03342759	chr3:160939853	NMD3	-0.67	-6.68	-0.6	3.16e-9	Morning vs. evening chronotype;
SKCM	cis	rs208520	0.909	rs62414636	chr6:67015723	T/G	cg07460842	chr6:66804631	NA	0.82	5.43	0.52	6.08e-7	Exhaled nitric oxide output;
SKCM	cis	rs34779708	0.966	rs4934735	chr10:35496730	C/T	cg03585969	chr10:35415529	CREM	-0.76	-5.93	-0.56	7.83e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs4740619	0.625	rs3008686	chr9:15916844	C/G	cg14451791	chr9:16040625	NA	0.4	4.77	0.47	8.52e-6	Body mass index;
SKCM	cis	rs1799949	0.965	rs12947782	chr17:41279882	A/G	cg05368731	chr17:41323189	NBR1	0.89	7.91	0.67	1.38e-11	Menopause (age at onset);
SKCM	cis	rs4919087	1.000	rs4919090	chr10:99088419	C/G	cg25902810	chr10:99078978	FRAT1	-0.62	-4.96	-0.49	4.06e-6	Monocyte count;
SKCM	cis	rs17376456	0.825	rs28412976	chr5:93248377	T/C	cg21475434	chr5:93447410	FAM172A	1.02	5.17	0.51	1.74e-6	Diabetic retinopathy;
SKCM	cis	rs8016982	0.633	rs72695758	chr14:81720146	T/C	cg01989461	chr14:81687754	GTF2A1	0.81	6.48	0.59	7.53e-9	Schizophrenia;
SKCM	cis	rs2255932	0.947	rs2686428	chr3:183213743	A/G	cg20852557	chr3:184035519	EIF4G1	0.57	4.96	0.49	4.09e-6	Interleukin-1-beta levels;
SKCM	cis	rs4242434	0.889	rs11785755	chr8:22453223	C/A	cg03733263	chr8:22462867	KIAA1967	1.05	8.96	0.71	1.28e-13	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs12048904	0.505	rs10493936	chr1:101213335	A/T	cg16556008	chr1:101360663	SLC30A7;EXTL2	-0.78	-5.7	-0.54	2.05e-7	Multiple sclerosis;
SKCM	cis	rs7937682	0.921	rs12806479	chr11:111443192	G/C	cg09085632	chr11:111637200	PPP2R1B	0.97	8.62	0.7	5.94e-13	Primary sclerosing cholangitis;
SKCM	cis	rs9611565	0.694	rs5751107	chr22:41857812	A/G	cg03806693	chr22:41940476	POLR3H	1.13	7.36	0.64	1.63e-10	Vitiligo;
SKCM	cis	rs12709013	0.792	rs1364346	chr16:58790324	C/T	cg02431531	chr16:59244939	NA	0.49	5.13	0.5	2.07e-6	Blood metabolite ratios;
SKCM	cis	rs9388451	0.657	rs4895799	chr6:126052729	C/T	cg05901451	chr6:126070800	HEY2	-0.76	-7.37	-0.64	1.52e-10	Brugada syndrome;
SKCM	cis	rs769267	0.929	rs2965180	chr19:19491973	T/C	cg03709012	chr19:19516395	GATAD2A	-0.9	-8.51	-0.69	9.68e-13	Tonsillectomy;
SKCM	cis	rs72781680	0.898	rs17762651	chr2:24115922	A/G	cg08917208	chr2:24149416	ATAD2B	0.99	5.24	0.51	1.31e-6	Lymphocyte counts;
SKCM	cis	rs1790761	0.520	rs12800028	chr11:67403285	A/G	cg14500267	chr11:67383377	NA	-0.55	-5.05	-0.5	2.85e-6	Mean corpuscular volume;
SKCM	cis	rs7843479	0.965	rs733544	chr8:21835628	A/G	cg17168535	chr8:21777572	XPO7	0.77	6.37	0.58	1.22e-8	Mean corpuscular volume;
SKCM	cis	rs6089829	0.962	rs6062780	chr20:61666648	T/C	cg08564027	chr20:61660810	NA	0.63	5.65	0.54	2.46e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs875971	0.929	rs778712	chr7:65849978	C/T	cg18876405	chr7:65276391	NA	0.67	6.65	0.6	3.61e-9	Aortic root size;
SKCM	cis	rs2072499	0.750	rs2241109	chr1:156173082	C/T	cg25208724	chr1:156163844	SLC25A44	0.92	6.63	0.6	3.98e-9	Testicular germ cell tumor;
SKCM	cis	rs11098499	1.000	rs35643470	chr4:120184948	T/C	cg09307838	chr4:120376055	NA	0.95	7.75	0.66	2.84e-11	Corneal astigmatism;
SKCM	cis	rs2762353	0.603	rs12201071	chr6:25778055	C/T	cg16906712	chr6:26217615	HIST1H2BG;HIST1H2AE	-0.52	-5.0	-0.49	3.47e-6	Blood metabolite levels;
SKCM	cis	rs372883	0.648	rs11088117	chr21:30737816	G/C	cg24692254	chr21:30365293	RNF160	0.63	5.02	0.49	3.25e-6	Pancreatic cancer;
SKCM	cis	rs8017423	0.608	rs12589866	chr14:90820977	T/C	cg04374321	chr14:90722782	PSMC1	-0.71	-5.03	-0.49	3.11e-6	Mortality in heart failure;
SKCM	cis	rs1559088	0.625	rs10411739	chr19:33616327	T/C	cg17764715	chr19:33622953	WDR88	0.99	8.06	0.67	7.32e-12	Bone ultrasound measurement (broadband ultrasound attenuation);
SKCM	cis	rs2857078	0.745	rs4793085	chr17:42320732	A/C	cg19774624	chr17:42201019	HDAC5	0.78	6.09	0.57	3.92e-8	Red cell distribution width;Reticulocyte count;
SKCM	cis	rs394563	0.591	rs11964335	chr6:149658101	A/T	cg03678062	chr6:149772716	ZC3H12D	0.51	5.97	0.56	6.61e-8	Dupuytren's disease;
SKCM	cis	rs6879260	1.000	rs6879260	chr5:179731014	A/G	cg23248424	chr5:179741104	GFPT2	-0.68	-5.83	-0.55	1.17e-7	Height;
SKCM	cis	rs9368481	0.729	rs9379950	chr6:26961548	T/C	cg12292205	chr6:26970375	C6orf41	-0.71	-6.4	-0.59	1.05e-8	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs9325144	0.534	rs4882283	chr12:38710249	C/T	cg13010199	chr12:38710504	ALG10B	0.63	4.84	0.48	6.49e-6	Morning vs. evening chronotype;
SKCM	cis	rs2228479	0.850	rs2238525	chr16:89809902	T/C	cg06558623	chr16:89946397	TCF25	1.03	5.59	0.53	3.23e-7	Skin colour saturation;
SKCM	cis	rs16854884	0.710	rs6782558	chr3:143817462	G/C	cg06585982	chr3:143692056	C3orf58	0.63	5.19	0.51	1.64e-6	Economic and political preferences (feminism/equality);
SKCM	cis	rs10504073	0.584	rs4873306	chr8:49950369	T/C	cg00325661	chr8:49890786	NA	0.8	6.81	0.61	1.83e-9	Blood metabolite ratios;
SKCM	cis	rs2050392	0.789	rs303438	chr10:30733493	C/T	cg25182066	chr10:30743637	MAP3K8	0.61	5.35	0.52	8.47e-7	Inflammatory bowel disease;
SKCM	cis	rs2120019	1.000	rs1867146	chr15:75354971	C/G	cg17294928	chr15:75287854	SCAMP5	-0.83	-7.08	-0.63	5.44e-10	Blood trace element (Zn levels);
SKCM	cis	rs28595532	0.920	rs17259173	chr4:119777232	T/C	cg11846333	chr4:119757529	SEC24D	1.17	6.09	0.57	4.03e-8	Cannabis dependence symptom count;
SKCM	cis	rs2153535	0.542	rs9505465	chr6:8510846	C/T	cg07606381	chr6:8435919	SLC35B3	0.86	6.25	0.58	2.06e-8	Motion sickness;
SKCM	cis	rs7726839	0.540	rs72703083	chr5:595365	C/T	cg10555297	chr5:473380	SLC9A3;LOC25845	1.02	4.87	0.48	5.72e-6	Obesity-related traits;
SKCM	cis	rs72634258	0.945	rs7522911	chr1:8097145	C/T	cg00042356	chr1:8021962	PARK7	1.1	7.69	0.66	3.76e-11	Inflammatory bowel disease;
SKCM	cis	rs9906944	0.545	rs11079850	chr17:47092252	G/T	cg11673840	chr17:47092156	IGF2BP1	-0.53	-5.22	-0.51	1.46e-6	Intelligence (multi-trait analysis);Body fat percentage;
SKCM	cis	rs1395	0.778	rs2580759	chr2:27432500	G/T	cg14242246	chr2:27434262	C2orf28;SLC5A6	-0.5	-4.98	-0.49	3.77e-6	Blood metabolite levels;
SKCM	cis	rs7829975	0.659	rs4382480	chr8:8721473	C/T	cg15556689	chr8:8085844	FLJ10661	0.7	6.16	0.57	2.9e-8	Mood instability;
SKCM	cis	rs9640161	0.750	rs4395803	chr7:150025367	A/C	cg10018233	chr7:150070692	REPIN1	0.68	5.27	0.51	1.18e-6	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs9926296	0.585	rs8045232	chr16:89857548	A/G	cg26513180	chr16:89883248	FANCA	0.97	10.72	0.77	5.25e-17	Vitiligo;
SKCM	cis	rs7020830	0.516	rs36047049	chr9:37375472	G/T	cg14294708	chr9:37120828	ZCCHC7	0.94	5.49	0.53	4.91e-7	Schizophrenia;
SKCM	cis	rs1348850	0.789	rs2197611	chr2:178369036	G/C	cg02961200	chr2:178257176	LOC100130691;AGPS	0.83	6.14	0.57	3.21e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs4073582	0.595	rs801737	chr11:65928193	T/C	cg14036092	chr11:66035641	RAB1B	0.74	5.8	0.55	1.34e-7	Gout;
SKCM	cis	rs4803468	0.904	rs60781668	chr19:41944842	A/T	cg09537434	chr19:41945824	ATP5SL	1.1	13.21	0.83	1.39e-21	Height;
SKCM	cis	rs9309711	0.961	rs11890651	chr2:3482796	T/G	cg10845886	chr2:3471009	TTC15	-0.84	-6.62	-0.6	4.07e-9	Neurofibrillary tangles;
SKCM	cis	rs7584330	0.541	rs10202181	chr2:238352099	A/G	cg14458575	chr2:238380390	NA	1.01	6.74	0.61	2.45e-9	Prostate cancer;
SKCM	cis	rs7208859	0.623	rs7220999	chr17:29149298	C/T	cg13385521	chr17:29058706	SUZ12P	1.02	5.45	0.52	5.8e-7	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs4819052	0.851	rs4819049	chr21:46673086	C/G	cg02159808	chr21:46707872	POFUT2;LOC642852	0.73	5.71	0.54	1.93e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs4466137	0.953	rs1420654	chr5:82975793	G/A	cg16102102	chr5:83017553	HAPLN1	-0.54	-5.73	-0.54	1.79e-7	Prostate cancer;
SKCM	trans	rs1814175	0.645	rs11040703	chr11:50024961	C/T	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs28595532	0.545	rs13101451	chr4:119253427	A/G	cg21605333	chr4:119757512	SEC24D	0.96	5.21	0.51	1.47e-6	Cannabis dependence symptom count;
SKCM	cis	rs4819052	0.788	rs9978857	chr21:46705155	T/G	cg02159808	chr21:46707872	POFUT2;LOC642852	0.78	5.84	0.55	1.15e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs738322	0.934	rs84473	chr22:38557326	T/C	cg25457927	chr22:38595422	NA	-0.48	-5.41	-0.52	6.57e-7	Cutaneous nevi;
SKCM	cis	rs6545883	0.929	rs3732171	chr2:61749690	C/T	cg15711740	chr2:61764176	XPO1	-0.73	-5.27	-0.51	1.19e-6	Tuberculosis;
SKCM	cis	rs151997	0.962	rs27271	chr5:50183369	A/G	cg06027927	chr5:50259733	NA	0.63	5.45	0.53	5.64e-7	Callous-unemotional behaviour;
SKCM	cis	rs10911251	0.528	rs6669199	chr1:183082421	C/A	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Colorectal cancer;
SKCM	cis	rs6500395	1.000	rs4517800	chr16:48677404	T/A	cg04672837	chr16:48644449	N4BP1	0.65	5.43	0.52	6.28e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs11690935	0.632	rs12991740	chr2:172885996	C/T	cg13550731	chr2:172543902	DYNC1I2	0.62	5.5	0.53	4.62e-7	Schizophrenia;
SKCM	cis	rs7555523	0.778	rs4233408	chr1:165712960	G/A	cg24409356	chr1:165738333	TMCO1	0.93	5.15	0.5	1.93e-6	Intraocular pressure;Glaucoma (high intraocular pressure);
SKCM	cis	rs12911832	0.701	rs452698	chr15:59105571	A/G	cg05156742	chr15:59063176	FAM63B	0.76	6.05	0.57	4.74e-8	Schizophrenia;
SKCM	cis	rs644799	0.601	rs568878	chr11:95578694	G/T	cg03916912	chr11:95522834	CEP57;FAM76B	0.65	5.05	0.5	2.85e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs9902453	1.000	rs4465650	chr17:28396721	C/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.27	0.51	1.18e-6	Coffee consumption (cups per day);
SKCM	cis	rs11098499	0.954	rs10008459	chr4:120394231	T/C	cg24375607	chr4:120327624	NA	0.66	5.09	0.5	2.44e-6	Corneal astigmatism;
SKCM	cis	rs2479724	0.905	rs2251274	chr6:41839438	T/G	cg17623882	chr6:41773611	USP49	-0.79	-6.75	-0.61	2.37e-9	Menarche (age at onset);
SKCM	cis	rs4555082	0.874	rs760270	chr14:105737785	A/G	cg13114125	chr14:105738426	BRF1	-0.69	-5.47	-0.53	5.33e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs2836974	0.932	rs6517527	chr21:40581751	G/A	cg17971929	chr21:40555470	PSMG1	0.9	8.81	0.71	2.52e-13	Cognitive function;
SKCM	cis	rs9951698	0.687	rs498685	chr18:13088673	T/C	cg12848697	chr18:13133368	NA	0.56	5.08	0.5	2.51e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs514406	0.708	rs480299	chr1:53320274	G/T	cg24675658	chr1:53192096	ZYG11B	-0.87	-8.34	-0.69	2.11e-12	Monocyte count;
SKCM	cis	rs2991971	1.000	rs606542	chr1:46013933	T/C	cg24296786	chr1:45957014	TESK2	0.65	5.25	0.51	1.28e-6	High light scatter reticulocyte count;
SKCM	cis	rs9910055	0.762	rs6503489	chr17:42246289	G/A	cg19774624	chr17:42201019	HDAC5	-0.89	-7.83	-0.66	1.97e-11	Total body bone mineral density;
SKCM	cis	rs477895	0.838	rs11607007	chr11:64007976	C/T	cg07220939	chr11:64358617	SLC22A12	0.72	4.77	0.48	8.37e-6	Mean platelet volume;
SKCM	trans	rs3780486	0.505	rs1411609	chr9:33137303	C/T	cg04842962	chr6:43655489	MRPS18A	0.87	8.03	0.67	8.26e-12	IgG glycosylation;
SKCM	cis	rs7811142	1.000	rs4472444	chr7:100070758	T/C	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.12	6.51	0.59	6.68e-9	Platelet count;
SKCM	cis	rs13118159	0.556	rs4974615	chr4:1373551	A/G	cg02475777	chr4:1388615	CRIPAK	-0.82	-5.74	-0.54	1.76e-7	Longevity;
SKCM	cis	rs6951245	1.000	rs78143408	chr7:1096846	G/A	cg24642844	chr7:1081250	C7orf50	-0.93	-6.22	-0.58	2.28e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs4819052	0.851	rs28676615	chr21:46676576	G/C	cg19498844	chr21:46707878	POFUT2;LOC642852	0.88	7.69	0.66	3.74e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs8141529	0.778	rs7287806	chr22:29213011	G/A	cg15103426	chr22:29168792	CCDC117	0.62	5.2	0.51	1.57e-6	Lymphocyte counts;
SKCM	cis	rs4808199	0.947	rs10404728	chr19:19595014	C/T	cg03709012	chr19:19516395	GATAD2A	1.13	8.66	0.7	4.94e-13	Nonalcoholic fatty liver disease;
SKCM	cis	rs72781680	0.898	rs72786278	chr2:24063243	C/T	cg08917208	chr2:24149416	ATAD2B	1.0	4.97	0.49	3.82e-6	Lymphocyte counts;
SKCM	cis	rs7927771	0.524	rs10838771	chr11:47831332	A/G	cg20307385	chr11:47447363	PSMC3	-0.72	-5.81	-0.55	1.31e-7	Subjective well-being;
SKCM	cis	rs514406	0.708	rs514881	chr1:53336737	A/G	cg24675658	chr1:53192096	ZYG11B	0.88	7.79	0.66	2.35e-11	Monocyte count;
SKCM	cis	rs4555082	0.874	rs2245329	chr14:105719181	T/C	cg13114125	chr14:105738426	BRF1	-0.69	-5.29	-0.51	1.08e-6	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs28386778	0.897	rs7207005	chr17:61860355	A/G	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs2658782	0.724	rs2658770	chr11:93261886	A/G	cg15737290	chr11:93063684	CCDC67	0.74	4.92	0.49	4.68e-6	Pulmonary function decline;
SKCM	cis	rs829883	0.934	rs1641642	chr12:98898726	A/G	cg25150519	chr12:98850993	NA	0.5	5.27	0.51	1.19e-6	Colorectal adenoma (advanced);
SKCM	cis	rs910316	0.737	rs175084	chr14:75519175	C/T	cg08847533	chr14:75593920	NEK9	-0.82	-6.74	-0.61	2.5e-9	Height;
SKCM	cis	rs35306767	0.761	rs12773961	chr10:1013215	C/G	cg20503657	chr10:835505	NA	0.76	6.08	0.57	4.18e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs6952808	0.575	rs6950330	chr7:1953606	T/C	cg04267008	chr7:1944627	MAD1L1	-0.6	-4.81	-0.48	7.27e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs36093844	0.527	rs56187740	chr11:85764650	C/G	cg25872744	chr11:85566296	CCDC83	-0.81	-4.79	-0.48	7.71e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs1218582	0.772	rs4845688	chr1:154884142	T/C	cg03351412	chr1:154909251	PMVK	0.77	6.52	0.59	6.43e-9	Prostate cancer;
SKCM	cis	rs11155671	0.530	rs2342770	chr6:150216685	C/T	cg09699651	chr6:150184138	LRP11	0.62	4.82	0.48	6.9e-6	Testicular germ cell tumor;
SKCM	cis	rs7937682	0.921	rs688354	chr11:111438762	A/G	cg09085632	chr11:111637200	PPP2R1B	-0.96	-8.47	-0.69	1.15e-12	Primary sclerosing cholangitis;
SKCM	cis	rs12928939	0.517	rs12934512	chr16:71965230	C/G	cg03805757	chr16:71968109	PKD1L3	-0.72	-5.17	-0.51	1.78e-6	Post bronchodilator FEV1;
SKCM	cis	rs7666738	0.822	rs28367231	chr4:98845726	G/T	cg05340658	chr4:99064831	C4orf37	0.6	4.81	0.48	7.19e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10256972	0.552	rs6978842	chr7:1204599	A/C	cg07092213	chr7:1199455	ZFAND2A	-0.68	-5.79	-0.55	1.39e-7	Longevity;Endometriosis;
SKCM	cis	rs748404	0.631	rs7166812	chr15:43644760	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	0.84	6.38	0.59	1.17e-8	Lung cancer;
SKCM	cis	rs60871478	0.636	rs4276575	chr7:900035	C/T	cg05535760	chr7:792225	HEATR2	-1.2	-7.02	-0.62	7.07e-10	Cerebrospinal P-tau181p levels;
SKCM	cis	rs1048257	0.682	rs55797226	chr14:105413223	A/G	cg19901468	chr14:105411992	AHNAK2	-0.86	-6.62	-0.6	4.13e-9	Systemic lupus erythematosus;
SKCM	cis	rs7143963	1.000	rs72704741	chr14:103381882	C/T	cg23020514	chr14:103360112	TRAF3	0.82	6.77	0.61	2.13e-9	Body mass index;
SKCM	trans	rs1814175	0.645	rs1851857	chr11:49855589	A/C	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs3091242	0.933	rs35403885	chr1:25784551	G/A	cg02931644	chr1:25747376	RHCE	-0.5	-4.9	-0.48	5.17e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs7646501	0.798	rs10865793	chr3:24057925	G/C	cg22892432	chr3:24537792	THRB	0.57	4.84	0.48	6.39e-6	Cognitive ability;Intelligence;
SKCM	cis	rs7569084	0.687	rs12614851	chr2:65685184	T/C	cg10464312	chr2:66672688	MEIS1	0.45	5.09	0.5	2.39e-6	Sum eosinophil basophil counts;
SKCM	cis	rs17685	0.753	rs2868203	chr7:75680026	G/A	cg16684958	chr7:75615977	POR	-0.57	-5.6	-0.54	3.07e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7399018	0.739	rs7399073	chr12:51614050	C/A	cg25754956	chr12:51612065	POU6F1	0.9	8.01	0.67	9.08e-12	Cisplatin-induced ototoxicity;
SKCM	cis	rs67311347	0.544	rs2278930	chr3:40351092	C/T	cg13409248	chr3:40428643	ENTPD3	0.57	5.32	0.52	9.61e-7	Renal cell carcinoma;
SKCM	trans	rs208520	0.690	rs207096	chr6:66797287	T/C	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-1.01	-7.5	-0.65	8.58e-11	Exhaled nitric oxide output;
SKCM	cis	rs7819412	0.806	rs2409689	chr8:10932868	A/G	cg22647929	chr8:10583326	SOX7	-0.54	-5.22	-0.51	1.46e-6	Triglycerides;
SKCM	cis	rs4819052	0.851	rs2838831	chr21:46664775	C/T	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.42	0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs1218582	0.772	rs2174507	chr1:154887949	C/T	cg06221963	chr1:154839813	KCNN3	-0.59	-5.97	-0.56	6.76e-8	Prostate cancer;
SKCM	cis	rs7659604	0.643	rs6839054	chr4:122663628	C/T	cg19748678	chr4:122722346	EXOSC9	0.73	5.81	0.55	1.28e-7	Type 2 diabetes;
SKCM	cis	rs1395	0.778	rs724311	chr2:27441645	A/G	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.51	5.14	0.5	1.96e-6	Blood metabolite levels;
SKCM	cis	rs2180341	1.000	rs3798853	chr6:127636823	C/T	cg27446573	chr6:127587934	RNF146	-0.99	-7.44	-0.64	1.12e-10	Breast cancer;
SKCM	cis	rs10751667	0.666	rs11246358	chr11:967349	G/A	cg06064525	chr11:970664	AP2A2	-0.54	-5.12	-0.5	2.13e-6	Alzheimer's disease (late onset);
SKCM	cis	rs780096	0.506	rs1262430	chr2:27673798	T/C	cg05696406	chr2:27599888	SNX17	0.51	5.22	0.51	1.46e-6	Total body bone mineral density;
SKCM	cis	rs62238980	0.614	rs4821003	chr22:32362709	G/A	cg00543991	chr22:32367038	NA	1.28	5.18	0.51	1.68e-6	Childhood ear infection;
SKCM	cis	rs2204008	0.605	rs4608149	chr12:38132057	G/C	cg26384229	chr12:38710491	ALG10B	0.82	6.58	0.6	4.87e-9	Bladder cancer;
SKCM	cis	rs6500395	0.962	rs1477135	chr16:48726823	C/T	cg04672837	chr16:48644449	N4BP1	0.63	5.3	0.51	1.03e-6	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs870825	0.616	rs6817521	chr4:185649827	A/G	cg04058563	chr4:185651563	MLF1IP	-1.07	-7.16	-0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs2836974	0.897	rs14194	chr21:40549466	T/C	cg11890956	chr21:40555474	PSMG1	1.07	13.19	0.83	1.48e-21	Cognitive function;
SKCM	cis	rs314370	0.904	rs13244629	chr7:100509253	A/C	cg10426581	chr7:100472382	SRRT	0.67	5.63	0.54	2.75e-7	Resting heart rate;
SKCM	cis	rs4819052	1.000	rs2297285	chr21:46705621	A/G	cg19498844	chr21:46707878	POFUT2;LOC642852	-0.94	-7.71	-0.66	3.45e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs875971	0.505	rs1167385	chr7:65513308	G/A	cg11764359	chr7:65958608	NA	-0.88	-6.85	-0.61	1.53e-9	Aortic root size;
SKCM	cis	rs611744	0.647	rs585077	chr8:109245497	C/T	cg18478394	chr8:109455254	TTC35	0.66	5.33	0.52	9.43e-7	Dupuytren's disease;
SKCM	cis	rs4319547	0.695	rs7969429	chr12:122875606	A/G	cg23029597	chr12:123009494	RSRC2	-0.72	-5.31	-0.52	1.01e-6	Body mass index;
SKCM	cis	rs2894969	0.664	rs11252703	chr10:4795125	A/T	cg19138900	chr10:3826266	KLF6	-0.58	-4.9	-0.48	5.15e-6	Major depressive disorder;
SKCM	cis	rs16854884	0.802	rs6786460	chr3:143805895	A/G	cg06585982	chr3:143692056	C3orf58	0.72	5.54	0.53	3.87e-7	Economic and political preferences (feminism/equality);
SKCM	cis	rs9911578	0.967	rs7222789	chr17:56819853	C/G	cg12560992	chr17:57184187	TRIM37	0.95	7.69	0.66	3.7e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs1799949	1.000	rs12936831	chr17:41331816	C/T	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.29	-0.58	1.73e-8	Menopause (age at onset);
SKCM	cis	rs6912958	0.512	rs910563	chr6:88058885	G/A	cg08069147	chr6:88032118	GJB7;C6orf162	0.7	6.49	0.59	7.24e-9	Monocyte percentage of white cells;
SKCM	cis	rs12142240	0.698	rs10158572	chr1:46822440	G/T	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs7811142	0.830	rs6945952	chr7:99981775	A/G	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.05	5.92	0.56	8.02e-8	Platelet count;
SKCM	cis	rs9399135	0.933	rs28384512	chr6:135376232	C/T	cg24558204	chr6:135376177	HBS1L	0.58	5.05	0.5	2.86e-6	Red blood cell count;
SKCM	cis	rs7659604	0.676	rs4077102	chr4:122699830	A/G	cg06713675	chr4:122721982	EXOSC9	-0.76	-7.28	-0.64	2.34e-10	Type 2 diabetes;
SKCM	cis	rs1707322	1.000	rs11211244	chr1:46456673	G/A	cg03146154	chr1:46216737	IPP	0.78	5.24	0.51	1.35e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs9916302	0.904	rs9905432	chr17:37555918	C/A	cg07936489	chr17:37558343	FBXL20	0.85	7.35	0.64	1.71e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs367615	0.704	rs7705399	chr5:108850351	G/C	cg17395555	chr5:108820864	NA	0.77	6.99	0.62	8.1e-10	Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs362296	0.661	rs3095077	chr4:3265710	A/G	cg11471262	chr4:3318911	RGS12	0.66	5.84	0.55	1.15e-7	Parental longevity (mother's age at death);
SKCM	cis	rs55962025	0.883	rs362336	chr4:3213832	G/A	cg09735869	chr4:3319127	RGS12	-0.75	-5.74	-0.54	1.73e-7	Parental longevity (mother's age at death);
SKCM	cis	rs10781543	0.776	rs4378078	chr9:139375962	A/G	cg14169450	chr9:139327907	INPP5E	0.52	5.64	0.54	2.62e-7	Monocyte percentage of white cells;
SKCM	cis	rs8072100	0.967	rs7219303	chr17:45737701	A/G	cg08085267	chr17:45401833	C17orf57	0.61	5.44	0.52	5.83e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs6547631	0.836	rs4832180	chr2:85911629	A/G	cg24620635	chr2:85921963	GNLY	0.74	6.03	0.56	5.05e-8	Blood protein levels;
SKCM	cis	rs8017423	0.967	rs11628812	chr14:90713720	G/T	cg04374321	chr14:90722782	PSMC1	-0.97	-9.06	-0.72	8.41e-14	Mortality in heart failure;
SKCM	cis	rs8180040	0.966	rs11130129	chr3:47489885	G/C	cg27129171	chr3:47204927	SETD2	-0.79	-5.79	-0.55	1.43e-7	Colorectal cancer;
SKCM	cis	rs7208859	0.623	rs11650982	chr17:29129955	A/G	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs2836974	0.931	rs2776309	chr21:40715791	A/G	cg11644478	chr21:40555479	PSMG1	0.76	6.47	0.59	7.89e-9	Cognitive function;
SKCM	cis	rs2228479	0.867	rs57492102	chr16:89975572	A/G	cg06558623	chr16:89946397	TCF25	1.23	6.7	0.6	2.88e-9	Skin colour saturation;
SKCM	cis	rs28386778	0.897	rs2584642	chr17:61942427	T/C	cg06873352	chr17:61820015	STRADA	0.75	6.22	0.58	2.35e-8	Prudent dietary pattern;
SKCM	cis	rs7296418	0.961	rs7957096	chr12:123544878	A/G	cg00376283	chr12:123451042	ABCB9	0.96	8.66	0.7	5.01e-13	Platelet count;
SKCM	cis	rs644799	0.710	rs11021309	chr11:95501898	C/A	cg03916912	chr11:95522834	CEP57;FAM76B	0.83	7.24	0.63	2.69e-10	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs17376456	0.825	rs55947981	chr5:93278104	G/T	cg21475434	chr5:93447410	FAM172A	1.04	5.19	0.51	1.62e-6	Diabetic retinopathy;
SKCM	trans	rs561341	0.825	rs2008368	chr17:30347397	T/C	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs2153535	0.580	rs9406158	chr6:8464152	C/T	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs7100689	0.556	rs3120976	chr10:82025682	C/A	cg01528321	chr10:82214614	TSPAN14	0.78	7.27	0.64	2.46e-10	Post bronchodilator FEV1;
SKCM	cis	rs11651000	0.857	rs16947078	chr17:45825500	A/G	cg24803719	chr17:45855879	NA	-0.53	-5.04	-0.5	2.93e-6	IgG glycosylation;
SKCM	cis	rs2070488	0.775	rs6794397	chr3:38559307	A/G	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.74	5.88	0.55	9.48e-8	Electrocardiographic conduction measures;
SKCM	cis	rs7772486	0.875	rs9403765	chr6:146368041	C/T	cg23711669	chr6:146136114	FBXO30	-0.79	-7.29	-0.64	2.18e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7772486	0.743	rs9390344	chr6:146012755	C/G	cg05347473	chr6:146136440	FBXO30	-0.54	-4.88	-0.48	5.47e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs58688157	0.705	rs12421646	chr11:578844	C/G	cg16486109	chr11:613632	IRF7	1.08	6.3	0.58	1.64e-8	Systemic lupus erythematosus;
SKCM	cis	rs7666738	0.830	rs62321569	chr4:98984250	T/A	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4790333	0.562	rs2447108	chr17:2257993	C/T	cg02569219	chr17:2266849	SGSM2	0.67	5.74	0.55	1.7e-7	Proinsulin levels;
SKCM	cis	rs6674970	0.748	rs56299877	chr1:151115645	C/T	cg11822372	chr1:151115635	SEMA6C	-0.96	-7.98	-0.67	1.04e-11	Childhood ear infection;
SKCM	cis	rs10256972	0.640	rs10271082	chr7:1081562	G/C	cg02733842	chr7:1102375	C7orf50	-0.46	-4.82	-0.48	6.85e-6	Longevity;Endometriosis;
SKCM	cis	rs2075371	0.829	rs11770764	chr7:134003308	T/C	cg20476274	chr7:133979776	SLC35B4	1.01	10.1	0.75	8.14e-16	Mean platelet volume;
SKCM	cis	rs28595532	0.920	rs115530096	chr4:119760512	T/G	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs16854884	0.657	rs1025984	chr3:143756187	C/G	cg06585982	chr3:143692056	C3orf58	-0.86	-7.69	-0.66	3.66e-11	Economic and political preferences (feminism/equality);
SKCM	cis	rs7296418	0.699	rs11608297	chr12:123826642	T/C	cg05973401	chr12:123451056	ABCB9	0.72	5.48	0.53	5.12e-7	Platelet count;
SKCM	cis	rs7143963	0.945	rs8013266	chr14:103326780	T/C	cg23020514	chr14:103360112	TRAF3	0.85	8.12	0.68	5.42e-12	Body mass index;
SKCM	cis	rs28595532	0.920	rs114696063	chr4:119760624	T/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs28386778	0.897	rs1062787	chr17:61896004	T/C	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs7296418	0.663	rs4553407	chr12:123750748	G/C	cg05973401	chr12:123451056	ABCB9	0.71	5.39	0.52	7.21e-7	Platelet count;
SKCM	cis	rs2239547	0.522	rs2581801	chr3:52972907	G/T	cg11645453	chr3:52864694	ITIH4	-0.58	-4.96	-0.49	3.98e-6	Schizophrenia;
SKCM	cis	rs11098499	0.954	rs3890049	chr4:120326283	T/A	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs9399135	0.967	rs6902438	chr6:135336587	C/T	cg24558204	chr6:135376177	HBS1L	0.59	5.22	0.51	1.42e-6	Red blood cell count;
SKCM	cis	rs867186	1.000	rs74599371	chr20:33561495	G/A	cg04194272	chr20:33683537	NA	-1.37	-6.77	-0.61	2.18e-9	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs7945705	0.846	rs11042055	chr11:8756856	G/A	cg21881798	chr11:8931708	C11orf17;ST5	0.58	5.25	0.51	1.26e-6	Hemoglobin concentration;
SKCM	cis	rs11098499	0.954	rs11098524	chr4:120390032	A/G	cg24375607	chr4:120327624	NA	0.71	5.84	0.55	1.15e-7	Corneal astigmatism;
SKCM	cis	rs244731	0.959	rs3105419	chr5:176551396	G/C	cg06060754	chr5:176797920	RGS14	0.84	6.44	0.59	8.98e-9	Urate levels in lean individuals;
SKCM	cis	rs1552244	0.882	rs3732966	chr3:10015740	C/T	cg02579736	chr3:10068473	FANCD2;CIDECP	0.94	4.84	0.48	6.49e-6	Alzheimer's disease;
SKCM	cis	rs72781680	1.000	rs72781653	chr2:24215633	T/C	cg08917208	chr2:24149416	ATAD2B	1.03	5.73	0.54	1.83e-7	Lymphocyte counts;
SKCM	cis	rs12142240	0.698	rs56063031	chr1:46825433	C/T	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs6088590	0.931	rs6088624	chr20:33436852	T/A	cg24642439	chr20:33292090	TP53INP2	1.0	7.11	0.63	4.79e-10	Coronary artery disease;
SKCM	cis	rs7829975	0.686	rs907180	chr8:8702827	A/G	cg06636001	chr8:8085503	FLJ10661	0.83	7.04	0.62	6.6e-10	Mood instability;
SKCM	cis	rs17376456	0.825	rs10058331	chr5:93279115	T/G	cg25358565	chr5:93447407	FAM172A	1.31	7.46	0.65	1.04e-10	Diabetic retinopathy;
SKCM	cis	rs2404602	0.716	rs7179142	chr15:76698268	G/A	cg23625390	chr15:77176239	SCAPER	0.6	5.46	0.53	5.44e-7	Blood metabolite levels;
SKCM	cis	rs17685	0.753	rs1637051	chr7:75730659	G/A	cg16684958	chr7:75615977	POR	0.56	5.13	0.5	2.03e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs6951245	1.000	rs76804143	chr7:1082021	C/T	cg03188948	chr7:1209495	NA	1.12	6.25	0.58	2.02e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs875971	0.660	rs3764903	chr7:66098482	G/A	cg05627663	chr7:65219948	SNORA22;CCT6P1	-0.56	-4.81	-0.48	7.26e-6	Aortic root size;
SKCM	cis	rs995000	0.931	rs2479464	chr1:63130991	G/A	cg06896770	chr1:63153194	DOCK7	-0.75	-7.28	-0.64	2.33e-10	Triglyceride levels;
SKCM	cis	rs7100689	0.646	rs10749581	chr10:82141651	A/G	cg01528321	chr10:82214614	TSPAN14	-0.83	-7.28	-0.64	2.32e-10	Post bronchodilator FEV1;
SKCM	cis	rs9790314	0.715	rs898681	chr3:160773098	A/G	cg03342759	chr3:160939853	NMD3	-0.6	-5.62	-0.54	2.79e-7	Morning vs. evening chronotype;
SKCM	cis	rs35306767	0.761	rs12773961	chr10:1013215	C/G	cg26597838	chr10:835615	NA	0.76	6.32	0.58	1.52e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs17376456	0.825	rs10058331	chr5:93279115	T/G	cg21475434	chr5:93447410	FAM172A	1.04	5.19	0.51	1.62e-6	Diabetic retinopathy;
SKCM	cis	rs7106204	0.748	rs28656439	chr11:24207653	G/C	ch.11.24196551F	chr11:24239977	NA	0.79	6.34	0.58	1.38e-8	Response to Homoharringtonine (cytotoxicity);
SKCM	cis	rs4819052	0.851	rs8130285	chr21:46671701	G/C	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.42	0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs62238980	0.614	rs79343805	chr22:32522040	A/C	cg00543991	chr22:32367038	NA	1.17	4.81	0.48	7.24e-6	Childhood ear infection;
SKCM	cis	rs9303401	0.659	rs61291849	chr17:56909867	T/C	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.35	0.52	8.54e-7	Cognitive test performance;
SKCM	cis	rs4319547	1.000	rs7309390	chr12:123110422	A/G	cg23029597	chr12:123009494	RSRC2	-0.78	-5.99	-0.56	6.19e-8	Body mass index;
SKCM	cis	rs55728055	0.661	rs12165609	chr22:32036332	T/C	cg01338084	chr22:32026380	PISD	1.62	5.14	0.5	1.99e-6	Age-related hearing impairment;
SKCM	cis	rs7772486	0.692	rs1577916	chr6:146069789	G/A	cg05347473	chr6:146136440	FBXO30	-0.6	-5.68	-0.54	2.21e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7647973	0.580	rs11130184	chr3:49229930	C/T	cg06212747	chr3:49208901	KLHDC8B	0.79	5.72	0.54	1.89e-7	Menarche (age at onset);
SKCM	cis	rs1707322	1.000	rs34694458	chr1:46332696	G/A	cg03146154	chr1:46216737	IPP	0.73	4.91	0.49	4.93e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs2228479	0.850	rs11644526	chr16:89898660	C/T	cg06558623	chr16:89946397	TCF25	1.1	4.95	0.49	4.17e-6	Skin colour saturation;
SKCM	cis	rs943437	0.866	rs481262	chr6:112261489	T/C	cg25325257	chr6:112272685	NA	-0.84	-4.81	-0.48	7.24e-6	Parkinson's disease;
SKCM	cis	rs9902453	1.000	rs4581755	chr17:28427898	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.5	0.53	4.67e-7	Coffee consumption (cups per day);
SKCM	cis	rs6580649	0.657	rs57863747	chr12:48470425	G/T	cg05342945	chr12:48394962	COL2A1	0.81	5.59	0.54	3.16e-7	Lung cancer;
SKCM	cis	rs7647973	0.516	rs4955418	chr3:49200627	A/G	cg07636037	chr3:49044803	WDR6	0.88	7.34	0.64	1.74e-10	Menarche (age at onset);
SKCM	cis	rs919433	0.889	rs6711624	chr2:198207607	C/G	cg04278110	chr2:198063759	ANKRD44	-0.72	-5.02	-0.49	3.21e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs1046896	0.731	rs9906115	chr17:80791469	G/A	cg22027946	chr17:80790580	TBCD;ZNF750	0.78	5.97	0.56	6.6e-8	Glycated hemoglobin levels;
SKCM	cis	rs1183201	0.505	rs1165201	chr6:25874823	A/C	cg03517284	chr6:25882590	NA	-0.54	-5.02	-0.49	3.14e-6	Uric acid levels;
SKCM	cis	rs7111031	1.000	rs6589377	chr11:113355736	G/A	cg04642306	chr11:112834466	NCAM1	0.45	5.03	0.5	3.03e-6	Subjective well-being (multi-trait analysis);Depressive symptoms (multi-trait analysis);Neuroticism;
SKCM	cis	rs79839061	0.610	rs62297087	chr4:913289	T/A	cg07828340	chr4:882639	GAK	1.03	5.74	0.55	1.72e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs10751667	0.621	rs11246345	chr11:934924	T/C	cg06064525	chr11:970664	AP2A2	-0.55	-5.09	-0.5	2.46e-6	Alzheimer's disease (late onset);
SKCM	cis	rs5769765	0.955	rs5769767	chr22:50276909	G/A	cg22709217	chr22:50311962	ALG12;CRELD2	0.79	5.71	0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs13392177	0.684	rs11695527	chr2:219068103	A/G	cg00012203	chr2:219082015	ARPC2	0.66	4.94	0.49	4.39e-6	Pyoderma gangrenosum in inflammatory bowel disease;
SKCM	cis	rs2268241	0.938	rs2268242	chr21:34781104	C/T	cg14850771	chr21:34775459	IFNGR2	1.09	6.8	0.61	1.9e-9	Obesity-related traits;
SKCM	cis	rs9916302	0.904	rs8065879	chr17:37515978	G/A	cg07936489	chr17:37558343	FBXL20	0.85	7.28	0.64	2.26e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs4803468	1.000	rs284648	chr19:41926790	T/C	cg09537434	chr19:41945824	ATP5SL	-1.1	-13.85	-0.84	1.02e-22	Height;
SKCM	cis	rs7937682	0.881	rs4936678	chr11:111625085	C/T	cg09085632	chr11:111637200	PPP2R1B	1.12	9.8	0.74	3.04e-15	Primary sclerosing cholangitis;
SKCM	cis	rs2836974	0.897	rs8132419	chr21:40527827	C/T	cg11644478	chr21:40555479	PSMG1	0.97	10.21	0.76	5.08e-16	Cognitive function;
SKCM	cis	rs9910055	0.573	rs228768	chr17:42191893	A/C	cg13607699	chr17:42295918	UBTF	0.67	4.91	0.49	4.96e-6	Total body bone mineral density;
SKCM	cis	rs3784262	1.000	rs4646640	chr15:58247563	C/G	cg12031962	chr15:58353849	ALDH1A2	0.5	6.1	0.57	3.75e-8	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs1348850	0.793	rs12990917	chr2:178487259	T/G	cg02961200	chr2:178257176	LOC100130691;AGPS	0.76	5.33	0.52	9.09e-7	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs10911232	0.507	rs3934697	chr1:183027512	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.77	6.89	0.62	1.27e-9	Hypertriglyceridemia;
SKCM	cis	rs12986445	0.744	rs7574200	chr2:26142055	G/A	cg07291958	chr2:26785531	C2orf70	0.53	4.91	0.49	4.95e-6	Multiple myeloma and monoclonal gammopathy;Multiple myeloma;
SKCM	cis	rs1003719	0.788	rs2835588	chr21:38462716	A/G	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs6570726	0.599	rs9403725	chr6:145897622	A/T	cg05347473	chr6:146136440	FBXO30	-0.7	-5.78	-0.55	1.44e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9815354	0.812	rs55788971	chr3:41843965	T/A	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs933688	0.938	rs7708782	chr5:90718517	T/C	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.1	8.33	0.69	2.14e-12	Smoking behavior;
SKCM	cis	rs854765	0.647	rs854817	chr17:18021882	T/C	cg04398451	chr17:18023971	MYO15A	-1.07	-9.28	-0.72	3.1e-14	Total body bone mineral density;
SKCM	cis	rs11149178	0.514	rs35149201	chr13:81264371	A/G	cg13081381	chr13:82264192	NA	0.71	4.82	0.48	6.86e-6	Major depressive disorder;
SKCM	cis	rs763014	0.931	rs7191939	chr16:630089	C/T	cg00908189	chr16:619842	PIGQ	0.82	7.78	0.66	2.55e-11	Height;
SKCM	cis	rs9300255	0.544	rs10772995	chr12:123671761	T/C	cg00376283	chr12:123451042	ABCB9	0.86	5.28	0.51	1.12e-6	Neutrophil percentage of white cells;
SKCM	cis	rs6121246	0.559	rs1484994	chr20:30305975	A/G	cg11595048	chr20:30225325	COX4I2	0.54	4.77	0.48	8.4e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs801193	1.000	rs10274773	chr7:66133578	G/A	cg05627663	chr7:65219948	SNORA22;CCT6P1	-0.56	-4.84	-0.48	6.39e-6	Aortic root size;
SKCM	cis	rs4975616	0.714	rs27069	chr5:1347128	C/T	cg06550200	chr5:1325588	CLPTM1L	-0.76	-6.14	-0.57	3.23e-8	Lung cancer;
SKCM	cis	rs28595532	0.764	rs56071514	chr4:119761833	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs673604	1.000	rs925718	chr1:35675764	C/G	cg12633102	chr1:35676489	NA	-0.67	-5.38	-0.52	7.52e-7	Endometrial cancer;
SKCM	cis	rs28595532	0.920	rs114696063	chr4:119760624	T/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs694739	0.892	rs647152	chr11:64109118	T/G	cg23796481	chr11:64053134	BAD;GPR137	0.76	5.95	0.56	7.21e-8	Alopecia areata;Crohn's disease;Psoriasis vulgaris;
SKCM	cis	rs116095464	0.558	rs73029475	chr5:206969	T/C	cg22496380	chr5:211416	CCDC127	-1.0	-5.11	-0.5	2.25e-6	Breast cancer;
SKCM	cis	rs7666738	0.830	rs10012167	chr4:99048579	T/C	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7829975	0.684	rs488904	chr8:8587571	T/G	cg06636001	chr8:8085503	FLJ10661	-0.69	-5.73	-0.54	1.82e-7	Mood instability;
SKCM	cis	rs6809651	0.524	rs1356292	chr3:185824903	C/T	cg00760338	chr3:185826511	ETV5	0.89	5.67	0.54	2.28e-7	Body mass index in physically active individuals;Glomerular filtration rate (creatinine);Body mass index (joint analysis main effects and physical activity interaction);Body mass index;Body mass index in physically inactive individuals;
SKCM	cis	rs1552244	1.000	rs9809061	chr3:10085130	C/G	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs7954584	0.813	rs11043288	chr12:122451187	C/T	cg22618164	chr12:122356400	WDR66	-0.49	-4.84	-0.48	6.52e-6	Mean corpuscular volume;
SKCM	cis	rs10256972	0.521	rs7457418	chr7:1110255	C/T	cg16145915	chr7:1198662	ZFAND2A	-0.49	-6.35	-0.58	1.3e-8	Longevity;Endometriosis;
SKCM	cis	rs3785574	0.582	rs62072238	chr17:61948841	A/T	cg01411255	chr17:61851458	DDX42;CCDC47	1.15	11.7	0.8	7.71e-19	Height;
SKCM	cis	rs651907	0.557	rs13077925	chr3:101488181	T/A	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.81	7.11	0.63	4.78e-10	Colorectal cancer;
SKCM	cis	rs514406	0.621	rs2003250	chr1:53196666	T/C	cg24675658	chr1:53192096	ZYG11B	0.62	4.98	0.49	3.72e-6	Monocyte count;
SKCM	cis	rs208520	0.779	rs208451	chr6:66906155	G/A	cg07460842	chr6:66804631	NA	-0.91	-6.87	-0.61	1.41e-9	Exhaled nitric oxide output;
SKCM	cis	rs7216064	0.953	rs11079705	chr17:65835452	A/T	cg12091567	chr17:66097778	LOC651250	-0.77	-5.53	-0.53	4.06e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs137603	0.602	rs137654	chr22:39732413	C/T	cg17798944	chr22:39715225	SNORD43;RPL3	-0.63	-5.36	-0.52	8.08e-7	Primary biliary cholangitis;
SKCM	cis	rs6503525	0.628	rs62068171	chr17:38103242	G/A	cg17467752	chr17:38218738	THRA	0.63	5.21	0.51	1.5e-6	Asthma;
SKCM	cis	rs1577917	0.917	rs1584273	chr6:86524577	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.33	-0.52	9.19e-7	Response to antipsychotic treatment;
SKCM	cis	rs873946	0.529	rs12258248	chr10:134573767	A/G	cg18305652	chr10:134549665	INPP5A	0.6	6.05	0.57	4.69e-8	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs148803332	1	rs148803332	chr17:65958250	CAAAAGAAA/C	cg12091567	chr17:66097778	LOC651250	0.78	5.3	0.51	1.06e-6	Eosinophil percentage of white cells;Neutrophil percentage of granulocytes;
SKCM	cis	rs9880211	0.613	rs9834966	chr3:135808620	T/G	cg21827317	chr3:136751795	NA	-0.67	-4.9	-0.49	5.06e-6	Body mass index;Height;
SKCM	trans	rs7618501	1.000	rs34451146	chr3:49813013	C/T	cg21659725	chr3:3221576	CRBN	0.96	9.61	0.74	7.08e-15	Intelligence (multi-trait analysis);
SKCM	trans	rs62103177	0.810	rs62103197	chr18:77632923	G/A	cg05926928	chr17:57297772	GDPD1	1.29	8.83	0.71	2.34e-13	Opioid sensitivity;
SKCM	cis	rs9790314	0.875	rs55688744	chr3:160944222	G/A	cg03342759	chr3:160939853	NMD3	-0.71	-7.69	-0.66	3.79e-11	Morning vs. evening chronotype;
SKCM	trans	rs1814175	0.647	rs61306292	chr11:49856040	G/C	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs854765	0.583	rs11869536	chr17:17826528	T/A	cg04398451	chr17:18023971	MYO15A	-0.85	-6.05	-0.57	4.75e-8	Total body bone mineral density;
SKCM	cis	rs941408	1.000	rs1640272	chr19:2800192	A/T	cg17333051	chr19:2783644	SGTA	0.4	4.81	0.48	7.09e-6	Total cholesterol levels;
SKCM	cis	rs769267	0.965	rs2916068	chr19:19516433	A/G	cg03709012	chr19:19516395	GATAD2A	0.9	8.06	0.67	7.08e-12	Tonsillectomy;
SKCM	cis	rs908922	0.676	rs569032	chr1:152508615	C/T	cg09873164	chr1:152488093	CRCT1	0.76	5.93	0.56	7.7e-8	Hair morphology;
SKCM	cis	rs6545883	0.965	rs6718887	chr2:61727215	G/A	cg15711740	chr2:61764176	XPO1	-0.73	-5.27	-0.51	1.19e-6	Tuberculosis;
SKCM	cis	rs11249608	0.548	rs7733072	chr5:178456007	A/G	cg21905437	chr5:178450457	ZNF879	0.72	5.65	0.54	2.5e-7	Pubertal anthropometrics;
SKCM	cis	rs875971	0.830	rs427575	chr7:65519219	A/G	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.54	5.01	0.49	3.28e-6	Aortic root size;
SKCM	cis	rs9581857	1.000	rs9581857	chr13:28027714	A/C	cg22138327	chr13:27999177	GTF3A	0.93	6.24	0.58	2.1e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs67311347	0.544	rs6769627	chr3:40327845	G/A	cg13409248	chr3:40428643	ENTPD3	0.56	5.44	0.52	6.01e-7	Renal cell carcinoma;
SKCM	cis	rs10791097	0.568	rs4411284	chr11:130738568	A/C	cg12179176	chr11:130786555	SNX19	0.93	8.18	0.68	4.15e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs3749237	0.595	rs3870337	chr3:49557095	G/T	cg03060546	chr3:49711283	APEH	0.67	4.82	0.48	7.06e-6	Resting heart rate;
SKCM	cis	rs231361	0.608	rs231840	chr11:2724130	C/T	cg07882535	chr11:2445392	TRPM5	-0.51	-4.94	-0.49	4.28e-6	Type 2 diabetes;
SKCM	cis	rs2404602	0.692	rs10444858	chr15:76962504	T/C	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs17711722	0.585	rs6942660	chr7:65302406	C/T	cg18876405	chr7:65276391	NA	0.86	7.56	0.65	6.53e-11	Calcium levels;
SKCM	cis	rs9389248	0.623	rs2142725	chr6:135258942	T/G	cg24558204	chr6:135376177	HBS1L	-0.67	-5.95	-0.56	7.32e-8	High light scatter reticulocyte percentage of red cells;
SKCM	cis	rs1580019	0.844	rs1584615	chr7:32503258	G/C	cg06627557	chr7:32535165	LSM5;AVL9	0.77	5.86	0.55	1.03e-7	Cognitive ability;
SKCM	cis	rs11249608	0.590	rs36051170	chr5:178447971	T/C	cg21905437	chr5:178450457	ZNF879	0.71	6.0	0.56	5.81e-8	Pubertal anthropometrics;
SKCM	cis	rs2153535	0.546	rs1335640	chr6:8485325	A/C	cg07606381	chr6:8435919	SLC35B3	0.86	6.25	0.58	2.06e-8	Motion sickness;
SKCM	cis	rs1577917	1.000	rs12215037	chr6:86727631	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.63	-5.38	-0.52	7.46e-7	Response to antipsychotic treatment;
SKCM	cis	rs208520	0.690	rs2144081	chr6:66824972	G/A	cg07460842	chr6:66804631	NA	-1.02	-7.98	-0.67	1.02e-11	Exhaled nitric oxide output;
SKCM	cis	rs7666738	0.753	rs13120995	chr4:98972762	A/G	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9325144	0.647	rs12424190	chr12:39111206	A/T	cg13010199	chr12:38710504	ALG10B	-0.63	-5.41	-0.52	6.62e-7	Morning vs. evening chronotype;
SKCM	cis	rs875971	0.617	rs810400	chr7:66022889	G/C	cg00343986	chr7:65444356	GUSB	-0.7	-5.14	-0.5	1.98e-6	Aortic root size;
SKCM	cis	rs12142240	0.698	rs112068407	chr1:46822291	T/C	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs1799949	0.965	rs799916	chr17:41243190	G/T	cg23758822	chr17:41437982	NA	-0.9	-7.28	-0.64	2.31e-10	Menopause (age at onset);
SKCM	trans	rs1814175	0.935	rs7950947	chr11:49668369	C/T	cg15704280	chr7:45808275	SEPT13	-1.0	-9.38	-0.73	1.99e-14	Height;
SKCM	cis	rs7617480	0.648	rs4858830	chr3:48734002	T/C	cg07636037	chr3:49044803	WDR6	0.91	6.74	0.61	2.42e-9	Subjective well-being (multi-trait analysis);Menarche (age at onset);
SKCM	cis	rs11098499	0.866	rs7677068	chr4:120291704	C/T	cg24375607	chr4:120327624	NA	0.62	4.77	0.48	8.45e-6	Corneal astigmatism;
SKCM	cis	rs2243480	1.000	rs2462569	chr7:65474846	C/T	cg18252515	chr7:66147081	NA	1.34	8.18	0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs7208859	0.623	rs73269988	chr17:29118145	G/A	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs826838	0.967	rs11183577	chr12:38781887	A/G	cg26384229	chr12:38710491	ALG10B	1.06	10.14	0.75	6.67e-16	Heart rate;
SKCM	cis	rs4665809	0.627	rs1465720	chr2:26412638	G/T	cg26119090	chr2:26468346	HADHA;HADHB	-1.0	-7.55	-0.65	7e-11	Gut microbiome composition (summer);
SKCM	cis	rs16949788	1.000	rs11071885	chr15:66625161	A/G	cg08120210	chr15:66682733	MAP2K1	-0.74	-5.82	-0.55	1.23e-7	Spherical equivalent (joint analysis main effects and education interaction);
SKCM	cis	rs55962025	0.686	rs4690073	chr4:3160150	G/A	cg00764545	chr4:3318001	RGS12	-0.58	-5.19	-0.51	1.65e-6	Parental longevity (mother's age at death);
SKCM	cis	rs2197308	0.765	rs12370231	chr12:37917881	T/C	cg26384229	chr12:38710491	ALG10B	0.81	6.57	0.6	5.01e-9	Morning vs. evening chronotype;
SKCM	cis	rs9303401	0.614	rs3803753	chr17:56540110	G/A	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.19	0.57	2.61e-8	Cognitive test performance;
SKCM	cis	rs2439831	0.681	rs2278858	chr15:43632755	G/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.27	7.14	0.63	4.2e-10	Lung cancer in ever smokers;
SKCM	trans	rs7618501	1.000	rs4855867	chr3:49745822	C/T	cg21659725	chr3:3221576	CRBN	-0.97	-9.69	-0.74	4.96e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs2832191	0.791	rs2832199	chr21:30498501	G/A	cg08807101	chr21:30365312	RNF160	-0.61	-4.77	-0.48	8.43e-6	Dental caries;
SKCM	cis	rs3820928	0.605	rs13410141	chr2:227805529	A/G	cg11843606	chr2:227700838	RHBDD1	-0.61	-4.8	-0.48	7.36e-6	Pulmonary function;
SKCM	cis	rs478304	0.651	rs11604462	chr11:65551648	G/A	cg17480646	chr11:65405466	SIPA1	-0.69	-5.16	-0.5	1.84e-6	Acne (severe);
SKCM	cis	rs4319547	0.695	rs6489002	chr12:122929822	T/C	cg23029597	chr12:123009494	RSRC2	-0.77	-5.53	-0.53	4.13e-7	Body mass index;
SKCM	cis	rs17685	0.753	rs4732542	chr7:75663203	A/G	cg16684958	chr7:75615977	POR	0.55	5.36	0.52	8.16e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2836974	0.644	rs61300849	chr21:40680194	G/A	cg11890956	chr21:40555474	PSMG1	-0.81	-8.01	-0.67	8.94e-12	Cognitive function;
SKCM	cis	rs801193	1.000	rs2707836	chr7:66160435	A/C	cg00343986	chr7:65444356	GUSB	0.7	5.14	0.5	1.98e-6	Aortic root size;
SKCM	cis	rs637571	0.522	rs556643	chr11:65733289	C/T	cg02427764	chr11:65769310	BANF1;EIF1AD	0.71	5.81	0.55	1.27e-7	Eosinophil percentage of white cells;
SKCM	cis	rs12497850	0.931	rs28642807	chr3:48926816	A/G	cg07636037	chr3:49044803	WDR6	1.02	11.0	0.78	1.56e-17	Parkinson's disease;
SKCM	cis	rs13108904	0.604	rs11946375	chr4:1313488	T/C	cg10457066	chr4:2065925	NAT8L	0.58	4.8	0.48	7.56e-6	Obesity-related traits;
SKCM	cis	rs9581857	0.685	rs78595793	chr13:28031881	C/T	cg22138327	chr13:27999177	GTF3A	0.93	6.24	0.58	2.1e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs3857536	0.740	rs7763555	chr6:66889930	C/T	cg07460842	chr6:66804631	NA	-0.7	-5.07	-0.5	2.64e-6	Blood trace element (Cu levels);
SKCM	cis	rs17685	0.753	rs6976532	chr7:75681094	A/G	cg16489192	chr7:75678113	MDH2;STYXL1	-0.53	-5.04	-0.5	2.95e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs673604	1.000	rs10908387	chr1:35677039	C/T	cg12633102	chr1:35676489	NA	-0.68	-5.35	-0.52	8.54e-7	Endometrial cancer;
SKCM	cis	rs2404602	0.583	rs12592501	chr15:76554790	C/A	cg23625390	chr15:77176239	SCAPER	0.69	6.31	0.58	1.57e-8	Blood metabolite levels;
SKCM	cis	rs16854884	0.632	rs35362423	chr3:143687441	C/A	cg06585982	chr3:143692056	C3orf58	0.81	7.63	0.65	4.89e-11	Economic and political preferences (feminism/equality);
SKCM	cis	rs6062302	0.522	rs4809312	chr20:62234240	C/T	cg09650180	chr20:62225654	GMEB2	-0.78	-6.22	-0.58	2.28e-8	Glioblastoma;
SKCM	cis	rs2333194	0.739	rs61987083	chr14:73915861	T/C	cg08936952	chr14:74026160	HEATR4	0.56	5.08	0.5	2.5e-6	Bipolar disorder with mood-incongruent psychosis;
SKCM	cis	rs1005277	0.579	rs932538	chr10:38381314	T/C	cg25427524	chr10:38739819	LOC399744	-0.68	-6.49	-0.59	7.18e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs55962025	1.000	rs55962025	chr4:3112109	A/C	cg00764545	chr4:3318001	RGS12	-0.61	-4.78	-0.48	8.11e-6	Parental longevity (mother's age at death);
SKCM	cis	rs1862618	0.573	rs832532	chr5:56221938	T/C	cg20203395	chr5:56204925	C5orf35	-0.76	-4.84	-0.48	6.32e-6	Initial pursuit acceleration;
SKCM	cis	rs763121	0.853	rs138709	chr22:39139216	C/G	cg06022373	chr22:39101656	GTPBP1	0.8	4.94	0.49	4.38e-6	Menopause (age at onset);
SKCM	cis	rs763121	0.853	rs5750669	chr22:39080638	T/A	cg06022373	chr22:39101656	GTPBP1	0.78	5.59	0.53	3.27e-7	Menopause (age at onset);
SKCM	cis	rs17376456	0.877	rs66696214	chr5:93424533	G/A	cg21475434	chr5:93447410	FAM172A	0.97	5.42	0.52	6.39e-7	Diabetic retinopathy;
SKCM	cis	rs735396	1.000	rs1169306	chr12:121438311	C/T	cg02403541	chr12:121454288	C12orf43	0.61	4.8	0.48	7.56e-6	N-glycan levels;
SKCM	cis	rs7666738	0.830	rs4334758	chr4:98971875	A/G	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs12706411	1.000	rs34252702	chr7:122048924	A/T	cg17986181	chr7:121955208	NA	-0.7	-5.19	-0.51	1.65e-6	Alzheimer disease and age of onset;
SKCM	cis	rs2836974	0.897	rs35123057	chr21:40711689	C/T	cg11644478	chr21:40555479	PSMG1	0.8	6.9	0.62	1.21e-9	Cognitive function;
SKCM	cis	rs16854884	0.837	rs4380409	chr3:143800896	A/G	cg06585982	chr3:143692056	C3orf58	0.72	5.63	0.54	2.78e-7	Economic and political preferences (feminism/equality);
SKCM	cis	rs7589728	0.563	rs78685993	chr2:88447026	T/C	cg04511125	chr2:88470314	THNSL2	1.07	6.66	0.6	3.43e-9	Plasma clusterin levels;
SKCM	cis	rs801193	0.569	rs7782587	chr7:66166472	C/T	cg11764359	chr7:65958608	NA	0.75	6.79	0.61	1.95e-9	Aortic root size;
SKCM	cis	rs875971	0.505	rs1723275	chr7:65504633	G/C	cg18876405	chr7:65276391	NA	-0.86	-8.04	-0.67	7.9e-12	Aortic root size;
SKCM	cis	rs611744	0.647	rs702808	chr8:109252554	T/C	cg18478394	chr8:109455254	TTC35	0.66	5.33	0.52	9.43e-7	Dupuytren's disease;
SKCM	cis	rs2832191	0.692	rs2245734	chr21:30359965	C/T	cg24692254	chr21:30365293	RNF160	1.01	9.45	0.73	1.44e-14	Dental caries;
SKCM	cis	rs7428	0.545	rs7572750	chr2:85552186	C/A	cg24342717	chr2:85555507	TGOLN2	-0.61	-4.79	-0.48	7.86e-6	Ear protrusion;
SKCM	trans	rs1814175	0.717	rs11040450	chr11:49650638	G/A	cg15704280	chr7:45808275	SEPT13	-1.0	-9.43	-0.73	1.61e-14	Height;
SKCM	cis	rs1799949	1.000	rs12936831	chr17:41331816	C/T	cg05368731	chr17:41323189	NBR1	0.87	7.74	0.66	3.01e-11	Menopause (age at onset);
SKCM	cis	rs116095464	0.558	rs62344345	chr5:257420	C/T	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs28386778	0.897	rs8079818	chr17:61824667	C/G	cg06873352	chr17:61820015	STRADA	0.76	6.34	0.58	1.38e-8	Prudent dietary pattern;
SKCM	cis	rs2013441	0.932	rs2526479	chr17:20130221	T/G	cg13482628	chr17:19912719	NA	-0.65	-5.21	-0.51	1.48e-6	Obesity-related traits;
SKCM	cis	rs9325144	0.647	rs7487395	chr12:38865660	C/A	cg13010199	chr12:38710504	ALG10B	-0.66	-5.27	-0.51	1.2e-6	Morning vs. evening chronotype;
SKCM	cis	rs2644899	0.785	rs2604895	chr19:41292263	T/A	cg24958765	chr19:41283667	RAB4B	-0.82	-5.17	-0.51	1.73e-6	Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs11112613	0.713	rs10507192	chr12:105948247	A/G	cg03607813	chr12:105948248	NA	0.9	6.59	0.6	4.72e-9	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;
SKCM	cis	rs2444217	0.872	rs2531977	chr16:4043701	C/G	cg09300795	chr16:4042428	ADCY9	0.66	4.83	0.48	6.6e-6	Body mass index;
SKCM	cis	rs929354	1.000	rs1182384	chr7:157040642	A/G	cg17757837	chr7:157058334	UBE3C	-0.86	-6.5	-0.59	6.99e-9	Body mass index;
SKCM	cis	rs2811415	0.597	rs10934847	chr3:127788955	G/A	cg09089421	chr3:127803668	RUVBL1	0.99	8.3	0.68	2.47e-12	Lung function (FEV1/FVC);
SKCM	cis	rs55962025	0.804	rs3775061	chr4:3238754	A/G	cg21096898	chr4:3318625	RGS12	-0.64	-4.92	-0.49	4.73e-6	Parental longevity (mother's age at death);
SKCM	cis	rs11098499	0.954	rs10006706	chr4:120409152	A/G	cg24375607	chr4:120327624	NA	0.66	5.09	0.5	2.44e-6	Corneal astigmatism;
SKCM	cis	rs2842992	0.789	rs6908680	chr6:160218209	G/T	cg19482086	chr6:160211437	TCP1;MRPL18	0.81	6.18	0.57	2.68e-8	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs12950390	0.853	rs56137679	chr17:45862112	C/G	cg03474202	chr17:45855739	NA	-0.48	-5.39	-0.52	7.29e-7	IgG glycosylation;
SKCM	cis	rs2034088	0.965	rs11653961	chr17:440108	A/C	cg06217071	chr17:408420	NA	0.49	5.41	0.52	6.64e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs1805008	0.608	rs80006713	chr16:89856032	G/C	cg08547343	chr16:90038815	CENPBD1;AFG3L1	-1.13	-5.09	-0.5	2.44e-6	Skin colour saturation;
SKCM	cis	rs3818285	0.556	rs3758409	chr10:111669239	A/C	cg00817464	chr10:111662876	XPNPEP1	-0.73	-6.85	-0.61	1.54e-9	Superior crus of antihelix expression;
SKCM	cis	rs7666738	0.830	rs991169	chr4:98928567	C/A	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7296418	0.961	rs1790122	chr12:123606739	G/A	cg05973401	chr12:123451056	ABCB9	0.83	6.72	0.61	2.67e-9	Platelet count;
SKCM	cis	rs4925166	1	rs4925166	chr17:18210810	T/G	cg26763362	chr17:18266135	SHMT1	-0.49	-5.27	-0.51	1.19e-6	Multiple sclerosis;
SKCM	cis	rs6952808	0.723	rs11766575	chr7:2005747	T/C	cg02951883	chr7:2050386	MAD1L1	-0.79	-6.9	-0.62	1.23e-9	Bipolar disorder and schizophrenia;
SKCM	cis	rs6430585	0.591	rs724326	chr2:136485971	T/C	cg07169764	chr2:136633963	MCM6	0.79	5.31	0.51	1.02e-6	Corneal structure;
SKCM	cis	rs3789045	0.560	rs4626956	chr1:204407298	T/C	cg17419461	chr1:204415978	PIK3C2B	-0.89	-6.64	-0.6	3.74e-9	Educational attainment (college completion);
SKCM	cis	rs2842992	0.789	rs3818300	chr6:160201677	G/A	cg11366901	chr6:160182831	ACAT2	0.94	7.85	0.66	1.81e-11	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs6430585	0.941	rs6708957	chr2:136520043	C/T	cg07169764	chr2:136633963	MCM6	0.91	7.21	0.63	3.09e-10	Corneal structure;
SKCM	cis	rs55962025	0.723	rs2269478	chr4:3234828	G/T	cg16987761	chr4:3318072	RGS12	-0.62	-4.98	-0.49	3.76e-6	Parental longevity (mother's age at death);
SKCM	cis	rs459571	0.629	rs441233	chr9:136876021	A/G	cg13789015	chr9:136890014	NCRNA00094	-0.75	-6.37	-0.59	1.2e-8	Platelet distribution width;
SKCM	cis	rs4724125	0.921	rs34092536	chr7:42710749	A/T	cg09407816	chr7:42972088	MRPL32;PSMA2	0.85	5.27	0.51	1.2e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9788721	0.836	rs72738736	chr15:78765122	G/T	cg18825076	chr15:78729989	IREB2	-0.62	-4.92	-0.49	4.67e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;Emphysema imaging phenotypes;Emphysema distribution in smoking;Local histogram emphysema pattern;Post bronchodilator FEV1/FVC ratio in COPD;
SKCM	cis	rs17685	0.623	rs7782808	chr7:75768645	C/T	cg01364799	chr7:75623366	TMEM120A	-0.7	-5.69	-0.54	2.09e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2180341	0.960	rs9398842	chr6:127674662	T/C	cg24812749	chr6:127587940	RNF146	0.83	7.24	0.63	2.76e-10	Breast cancer;
SKCM	cis	rs523522	0.962	rs12371550	chr12:120987643	C/T	cg12219531	chr12:120966889	COQ5	0.91	7.82	0.66	2.11e-11	High light scatter reticulocyte count;
SKCM	cis	rs2652834	0.519	rs4075584	chr15:63340292	C/T	cg05507819	chr15:63340323	TPM1	0.87	4.9	0.49	5.07e-6	HDL cholesterol;
SKCM	cis	rs1577917	1.000	rs9647603	chr6:86639341	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.61	-5.31	-0.52	1.02e-6	Response to antipsychotic treatment;
SKCM	cis	rs1850744	0.702	rs7668469	chr4:9744530	T/C	cg15442990	chr4:9534313	NA	1.33	5.1	0.5	2.33e-6	Economic and political preferences;
SKCM	cis	rs12478296	1.000	rs12474070	chr2:243039738	C/T	cg06360820	chr2:242988706	NA	-0.92	-5.32	-0.52	9.84e-7	Obesity-related traits;
SKCM	cis	rs782590	0.935	rs2586954	chr2:55892261	A/C	cg18811423	chr2:55921094	PNPT1	0.9	7.23	0.63	2.85e-10	Metabolic syndrome;
SKCM	cis	rs3096299	0.685	rs4785675	chr16:89539974	T/C	cg02187348	chr16:89574699	SPG7	0.56	4.81	0.48	7.17e-6	Multiple myeloma (IgH translocation);
SKCM	cis	rs1218582	0.772	rs10796935	chr1:154891363	G/T	cg06221963	chr1:154839813	KCNN3	-0.59	-5.97	-0.56	6.76e-8	Prostate cancer;
SKCM	cis	rs10155981	0.510	rs75613086	chr7:22584526	A/C	cg05062323	chr7:22590069	NA	-1.06	-6.07	-0.57	4.26e-8	Bilirubin levels;
SKCM	cis	rs6500395	0.962	rs1564979	chr16:48647017	C/A	cg04672837	chr16:48644449	N4BP1	0.69	5.68	0.54	2.26e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs12971120	0.783	rs7229256	chr18:72169129	T/A	cg25817165	chr18:72167213	CNDP2	-0.65	-5.21	-0.51	1.51e-6	Refractive error;
SKCM	cis	rs8060686	0.641	rs113502835	chr16:68238965	A/T	cg09117114	chr16:67998030	SLC12A4	-0.77	-5.03	-0.49	3.12e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs12477438	0.953	rs3851334	chr2:99794704	T/C	cg26064155	chr2:99771622	LIPT1;TSGA10	-0.83	-5.3	-0.51	1.04e-6	Chronic sinus infection;
SKCM	cis	rs4803468	0.935	rs284660	chr19:41932084	G/T	cg14132834	chr19:41945861	ATP5SL	-0.77	-6.04	-0.56	4.87e-8	Height;
SKCM	cis	rs6665290	0.669	rs3768421	chr1:227177193	G/A	cg10327440	chr1:227177885	CDC42BPA	-1.08	-9.54	-0.73	9.67e-15	Myeloid white cell count;
SKCM	cis	rs861020	1.000	rs674433	chr1:209964875	A/C	cg09163369	chr1:210001066	C1orf107	-0.82	-5.56	-0.53	3.56e-7	Orofacial clefts;
SKCM	cis	rs4970988	0.526	rs6655975	chr1:150542128	A/G	cg17724175	chr1:150552817	MCL1	-0.64	-5.06	-0.5	2.67e-6	Urate levels;
SKCM	cis	rs12188164	0.812	rs9313065	chr5:423426	T/C	cg26076054	chr5:421317	AHRR	-0.58	-5.16	-0.5	1.83e-6	Cystic fibrosis severity;
SKCM	cis	rs12477438	0.798	rs6736064	chr2:99658201	G/A	cg26064155	chr2:99771622	LIPT1;TSGA10	-0.72	-4.86	-0.48	6e-6	Chronic sinus infection;
SKCM	cis	rs10461617	0.531	rs2662033	chr5:56213410	T/G	cg12311346	chr5:56204834	C5orf35	-0.85	-5.81	-0.55	1.27e-7	Type 2 diabetes;
SKCM	cis	rs8070624	0.502	rs12951376	chr17:17752809	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.89	6.2	0.57	2.54e-8	Total body bone mineral density;
SKCM	cis	rs6762	0.748	rs3059	chr11:840319	C/T	cg16425592	chr11:842748	TSPAN4;POLR2L	-0.79	-5.8	-0.55	1.33e-7	Mean platelet volume;
SKCM	cis	rs11098499	0.863	rs10018280	chr4:120478139	T/G	cg24375607	chr4:120327624	NA	0.69	5.47	0.53	5.35e-7	Corneal astigmatism;
SKCM	cis	rs6540556	0.954	rs3753606	chr1:209937212	C/T	cg05527609	chr1:210001259	C1orf107	0.87	4.9	0.49	5.1e-6	Red blood cell count;
SKCM	trans	rs1814175	0.935	rs10839329	chr11:49694206	G/A	cg15704280	chr7:45808275	SEPT13	-1.01	-9.52	-0.73	1.08e-14	Height;
SKCM	cis	rs1862618	0.756	rs832548	chr5:56183637	G/C	cg12311346	chr5:56204834	C5orf35	-0.76	-5.02	-0.49	3.2e-6	Initial pursuit acceleration;
SKCM	cis	rs4478137	1.000	rs4478137	chr4:164238385	G/A	cg06758707	chr4:164254230	NPY1R	0.93	6.88	0.61	1.35e-9	Subjective well-being (multi-trait analysis);Subjective well-being;
SKCM	cis	rs1799949	1.000	rs11649954	chr17:41420035	A/G	cg05368731	chr17:41323189	NBR1	0.85	7.32	0.64	1.89e-10	Menopause (age at onset);
SKCM	cis	rs11764590	0.694	rs11762413	chr7:2090387	C/G	cg02825527	chr7:2087843	MAD1L1	-0.65	-5.12	-0.5	2.17e-6	Neuroticism;
SKCM	cis	rs10193935	0.901	rs2088281	chr2:42672731	A/G	cg27598129	chr2:42591480	NA	0.88	6.71	0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2629540	0.882	rs10901813	chr10:126429875	G/A	cg08799069	chr10:126477246	METTL10	-0.61	-5.05	-0.5	2.83e-6	Cocaine dependence;
SKCM	cis	rs2842992	0.714	rs2495278	chr6:160123674	G/A	cg19482086	chr6:160211437	TCP1;MRPL18	0.78	5.83	0.55	1.17e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs875971	1.000	rs1565531	chr7:65663113	T/A	cg18876405	chr7:65276391	NA	-0.68	-6.85	-0.61	1.51e-9	Aortic root size;
SKCM	cis	rs10754283	0.967	rs7513928	chr1:90104834	A/G	cg21401794	chr1:90099060	LRRC8C	0.78	7.17	0.63	3.72e-10	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs4466137	0.951	rs336958	chr5:82973396	A/G	cg16102102	chr5:83017553	HAPLN1	-0.46	-5.07	-0.5	2.57e-6	Prostate cancer;
SKCM	cis	rs7666738	0.830	rs13102369	chr4:99045912	A/G	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs796364	1.000	rs281774	chr2:200814572	C/T	cg12253985	chr2:200820533	C2orf60;C2orf47	0.85	5.39	0.52	7.18e-7	Schizophrenia;
SKCM	cis	rs6545883	0.894	rs2593633	chr2:61571513	T/C	cg15711740	chr2:61764176	XPO1	0.68	4.82	0.48	6.94e-6	Tuberculosis;
SKCM	cis	rs561341	1.000	rs484175	chr17:30309041	G/A	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs11671005	0.695	rs8106061	chr19:58917990	G/C	cg13877915	chr19:58951672	ZNF132	0.68	5.41	0.52	6.72e-7	Mean platelet volume;
SKCM	cis	rs12188164	0.965	rs56346498	chr5:423595	C/T	cg26076054	chr5:421317	AHRR	-0.61	-4.8	-0.48	7.47e-6	Cystic fibrosis severity;
SKCM	cis	rs606458	0.841	rs523752	chr11:64548584	A/G	cg07674570	chr11:65346152	EHBP1L1	0.67	5.03	0.49	3.11e-6	Urate levels;
SKCM	cis	rs1475911	1.000	rs34421316	chr21:43513989	C/T	cg24372256	chr21:43528868	UMODL1;C21orf128	-0.69	-4.83	-0.48	6.81e-6	IgG glycosylation;
SKCM	cis	rs1044826	0.642	rs6771831	chr3:139177585	C/T	cg15131784	chr3:139108705	COPB2	0.66	4.96	0.49	4.09e-6	Obesity-related traits;
SKCM	cis	rs1003719	0.788	rs2835605	chr21:38490734	T/A	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs1153858	1.000	rs12594857	chr15:45667178	A/G	cg21132104	chr15:45694354	SPATA5L1	0.93	7.94	0.67	1.22e-11	Homoarginine levels;
SKCM	cis	rs910316	0.967	rs11624893	chr14:75660124	A/G	cg11812906	chr14:75593930	NEK9	-0.77	-5.84	-0.55	1.13e-7	Height;
SKCM	cis	rs561341	1.000	rs8069199	chr17:30281845	A/G	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs801193	1.000	rs2659909	chr7:66160279	G/A	cg11987759	chr7:65425863	GUSB	-0.69	-5.9	-0.56	8.74e-8	Aortic root size;
SKCM	cis	rs7103648	0.712	rs10838703	chr11:47422861	C/G	cg20307385	chr11:47447363	PSMC3	0.93	6.51	0.59	6.55e-9	Diastolic blood pressure;Systolic blood pressure;
SKCM	trans	rs17685	0.725	rs1044483	chr7:75659815	T/C	cg19862616	chr7:65841803	NCRNA00174	-0.94	-9.39	-0.73	1.88e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1401999	1.000	rs1401999	chr3:183678342	C/G	cg01324343	chr3:183735012	ABCC5	0.93	10.78	0.77	4.03e-17	Anterior chamber depth;
SKCM	cis	rs8077889	0.750	rs4793041	chr17:41932829	C/G	cg26893861	chr17:41843967	DUSP3	1.23	6.83	0.61	1.63e-9	Triglycerides;
SKCM	cis	rs1577917	0.958	rs1816937	chr6:86557251	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.81	-7.82	-0.66	2.07e-11	Response to antipsychotic treatment;
SKCM	cis	rs875971	1.000	rs11974219	chr7:65647410	C/T	cg11764359	chr7:65958608	NA	-0.86	-8.23	-0.68	3.44e-12	Aortic root size;
SKCM	cis	rs875971	0.862	rs6944374	chr7:65686929	C/G	cg11764359	chr7:65958608	NA	-0.75	-6.99	-0.62	8.29e-10	Aortic root size;
SKCM	cis	rs55962025	0.804	rs2269499	chr4:3239702	C/T	cg05297308	chr4:3317976	RGS12	-0.64	-4.78	-0.48	8.23e-6	Parental longevity (mother's age at death);
SKCM	cis	rs1577917	0.740	rs2842614	chr6:86306069	G/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.9	-8.96	-0.71	1.27e-13	Response to antipsychotic treatment;
SKCM	cis	rs2115536	0.606	rs8024713	chr15:80206958	C/G	cg00225070	chr15:80189496	MTHFS	0.88	7.03	0.62	6.9e-10	Eosinophil counts;Eosinophil percentage of white cells;Sum eosinophil basophil counts;Eosinophil percentage of granulocytes;Neutrophil percentage of granulocytes;
SKCM	cis	rs4746818	1.000	rs4746818	chr10:70884687	G/T	cg11621586	chr10:70884670	VPS26A	1.04	8.25	0.68	3.05e-12	Left atrial antero-posterior diameter;
SKCM	cis	rs514406	0.698	rs576891	chr1:53364976	A/G	cg24675658	chr1:53192096	ZYG11B	-0.82	-7.55	-0.65	7.03e-11	Monocyte count;
SKCM	cis	rs7959452	0.535	rs7133487	chr12:69774377	G/A	cg14784868	chr12:69753453	YEATS4	0.78	7.38	0.64	1.5e-10	Blood protein levels;
SKCM	cis	rs9910055	0.659	rs112114764	chr17:42201041	G/T	cg13607699	chr17:42295918	UBTF	-0.71	-5.51	-0.53	4.46e-7	Total body bone mineral density;
SKCM	cis	rs769267	0.965	rs4808200	chr19:19554803	C/T	cg26732615	chr19:19648335	CILP2;YJEFN3	0.67	7.06	0.62	6e-10	Tonsillectomy;
SKCM	cis	rs2404602	0.647	rs11855296	chr15:77092962	C/T	cg23625390	chr15:77176239	SCAPER	-0.85	-8.26	-0.68	2.93e-12	Blood metabolite levels;
SKCM	cis	rs2282032	0.550	rs58363992	chr14:90766361	T/C	cg04374321	chr14:90722782	PSMC1	0.69	5.54	0.53	3.96e-7	Longevity;
SKCM	cis	rs826838	1.000	rs10506122	chr12:38699232	A/G	cg13010199	chr12:38710504	ALG10B	0.83	6.69	0.6	3.1e-9	Heart rate;
SKCM	cis	rs7772486	0.754	rs6937661	chr6:146113299	T/C	cg05347473	chr6:146136440	FBXO30	-0.61	-5.8	-0.55	1.37e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs362272	0.545	rs2749782	chr4:3339761	A/G	cg11471262	chr4:3318911	RGS12	0.96	11.76	0.8	5.86e-19	Serum sulfate level;
SKCM	cis	rs854765	0.647	rs7211714	chr17:17986955	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.88	6.64	0.6	3.8e-9	Total body bone mineral density;
SKCM	cis	rs910316	0.967	rs4899545	chr14:75568138	A/G	cg08847533	chr14:75593920	NEK9	0.95	9.18	0.72	4.88e-14	Height;
SKCM	cis	rs71520386	0.632	rs9691076	chr7:22869361	A/C	cg00309339	chr7:22893653	NA	0.66	4.94	0.49	4.33e-6	Fibrinogen levels;
SKCM	cis	rs733592	0.524	rs10875727	chr12:48426143	T/C	cg24011408	chr12:48396354	COL2A1	-0.66	-4.92	-0.49	4.68e-6	Plateletcrit;
SKCM	cis	rs7953249	0.564	rs11065385	chr12:121423386	A/G	cg02403541	chr12:121454288	C12orf43	-0.66	-5.39	-0.52	7.29e-7	Invasive epithelial ovarian cancer;High-grade serous ovarian cancer;Chronic obstructive pulmonary disease-related biomarkers;N-glycan levels;Serous invasive ovarian cancer;Epithelial ovarian cancer;
SKCM	cis	rs9368481	0.761	rs9379952	chr6:26987900	A/T	cg12292205	chr6:26970375	C6orf41	-0.72	-6.6	-0.6	4.58e-9	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs3784262	0.564	rs34958088	chr15:58328332	G/C	cg12031962	chr15:58353849	ALDH1A2	-0.4	-5.01	-0.49	3.34e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs2120019	1.000	rs2120019	chr15:75334184	T/C	cg17294928	chr15:75287854	SCAMP5	-0.91	-8.76	-0.7	3.17e-13	Blood trace element (Zn levels);
SKCM	cis	rs10267417	0.514	rs2072184	chr7:19748883	A/G	cg05791153	chr7:19748676	TWISTNB	1.14	7.76	0.66	2.8e-11	Night sleep phenotypes;
SKCM	cis	rs9921222	0.564	rs9923059	chr16:381590	C/A	cg12437481	chr16:420112	MRPL28	-0.64	-5.71	-0.54	1.94e-7	Bone mineral density (spine);Bone mineral density;
SKCM	cis	rs362296	0.671	rs3095074	chr4:3261152	G/A	cg05297308	chr4:3317976	RGS12	-0.78	-6.73	-0.61	2.57e-9	Parental longevity (mother's age at death);
SKCM	cis	rs2731664	0.792	rs335432	chr5:176866258	G/A	cg06532880	chr5:176731545	PRELID1;RAB24	-0.53	-4.78	-0.48	8.18e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs3785574	0.962	rs8079161	chr17:61808561	C/G	cg01411255	chr17:61851458	DDX42;CCDC47	1.13	12.96	0.83	3.89e-21	Height;
SKCM	cis	rs10479542	0.784	rs4701132	chr5:178985270	A/G	cg22764044	chr5:178986830	RUFY1	-0.49	-4.79	-0.48	7.69e-6	Lung cancer;
SKCM	cis	rs2836974	0.897	rs2836927	chr21:40543216	T/C	cg11890956	chr21:40555474	PSMG1	1.07	13.19	0.83	1.48e-21	Cognitive function;
SKCM	cis	rs870825	0.616	rs2141257	chr4:185609463	C/T	cg04058563	chr4:185651563	MLF1IP	-1.08	-7.44	-0.64	1.13e-10	Blood protein levels;
SKCM	cis	rs2153535	0.580	rs9393025	chr6:8490618	G/A	cg07606381	chr6:8435919	SLC35B3	0.86	6.25	0.58	2.06e-8	Motion sickness;
SKCM	cis	rs16949788	0.793	rs78483581	chr15:66769365	C/T	cg08120210	chr15:66682733	MAP2K1	-0.74	-5.69	-0.54	2.1e-7	Spherical equivalent (joint analysis main effects and education interaction);
SKCM	cis	rs7953508	0.506	rs930316	chr12:93967035	A/G	cg18151635	chr12:93972918	NA	-0.65	-5.83	-0.55	1.2e-7	Pubertal anthropometrics;
SKCM	cis	rs2760061	0.819	rs708114	chr1:228197496	G/A	cg02753203	chr1:228287806	NA	0.73	6.3	0.58	1.66e-8	Diastolic blood pressure;
SKCM	cis	rs1218582	0.772	rs6686873	chr1:154913404	C/G	cg03351412	chr1:154909251	PMVK	0.76	6.45	0.59	8.5e-9	Prostate cancer;
SKCM	cis	rs514406	0.861	rs11206026	chr1:53281708	G/A	cg16325326	chr1:53192061	ZYG11B	0.99	11.71	0.8	7.39e-19	Monocyte count;
SKCM	cis	rs1577917	0.771	rs7452605	chr6:86240951	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.98	10.89	0.78	2.49e-17	Response to antipsychotic treatment;
SKCM	cis	rs9325144	0.560	rs11183189	chr12:38683770	T/A	cg26384229	chr12:38710491	ALG10B	0.78	6.65	0.6	3.69e-9	Morning vs. evening chronotype;
SKCM	cis	rs1298637	0.800	rs11579521	chr1:53936383	A/G	cg09586583	chr1:54755153	SSBP3	-0.57	-4.85	-0.48	6.26e-6	Nicotine use;
SKCM	cis	rs17711722	0.727	rs2658585	chr7:65461941	A/T	cg18876405	chr7:65276391	NA	0.87	8.12	0.68	5.54e-12	Calcium levels;
SKCM	cis	rs10211296	0.932	rs7578761	chr2:166478624	T/C	ch.2.3376566R	chr2:166772260	TTC21B	0.65	4.82	0.48	6.94e-6	Risky sexual behaviors in alcohol dependence;
SKCM	cis	rs1153858	1.000	rs7167900	chr15:45639471	A/G	cg21132104	chr15:45694354	SPATA5L1	0.89	7.61	0.65	5.27e-11	Homoarginine levels;
SKCM	cis	rs867186	1.000	rs58088385	chr20:33748229	T/A	cg04194272	chr20:33683537	NA	-1.12	-5.84	-0.55	1.16e-7	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs9815354	0.812	rs113528686	chr3:41951547	T/C	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs28374715	0.578	rs72739630	chr15:41631064	G/A	cg18705301	chr15:41695430	NDUFAF1	-1.21	-12.61	-0.82	1.61e-20	Ulcerative colitis;
SKCM	cis	rs9911578	0.967	rs4932693	chr17:57110327	T/C	cg12560992	chr17:57184187	TRIM37	-1.09	-10.28	-0.76	3.61e-16	Intelligence (multi-trait analysis);
SKCM	cis	rs5750830	0.594	rs5757650	chr22:39778419	A/G	cg11247378	chr22:39784982	NA	-0.46	-5.53	-0.53	4.07e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7584330	0.737	rs1497129	chr2:238369184	C/T	cg14458575	chr2:238380390	NA	0.83	6.04	0.56	4.88e-8	Prostate cancer;
SKCM	cis	rs2644899	0.793	rs2644916	chr19:41309211	A/G	cg24958765	chr19:41283667	RAB4B	-0.85	-4.95	-0.49	4.19e-6	Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs28595532	0.920	rs115986613	chr4:119752156	G/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs12477438	0.501	rs34272114	chr2:99737443	A/C	cg14399236	chr2:99771627	LIPT1;TSGA10	0.93	8.28	0.68	2.67e-12	Chronic sinus infection;
SKCM	cis	rs4665809	0.590	rs36064164	chr2:26502768	C/T	cg26119090	chr2:26468346	HADHA;HADHB	1.08	8.63	0.7	5.67e-13	Gut microbiome composition (summer);
SKCM	cis	rs208520	0.690	rs207091	chr6:66799847	G/T	cg07460842	chr6:66804631	NA	-1.02	-7.65	-0.65	4.42e-11	Exhaled nitric oxide output;
SKCM	cis	rs10089	1.000	rs4835943	chr5:127457569	A/G	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.91	8.89	0.71	1.79e-13	Ileal carcinoids;
SKCM	cis	rs611744	0.517	rs62537573	chr8:109269281	C/T	cg18478394	chr8:109455254	TTC35	0.64	5.45	0.53	5.7e-7	Dupuytren's disease;
SKCM	cis	rs4819052	1.000	rs4818769	chr21:46667451	C/T	cg02159808	chr21:46707872	POFUT2;LOC642852	0.79	5.87	0.55	1.01e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7937682	0.824	rs539524	chr11:111477325	A/G	cg19812747	chr11:111475976	SIK2	-0.56	-4.97	-0.49	3.89e-6	Primary sclerosing cholangitis;
SKCM	cis	rs1348850	0.567	rs3821006	chr2:178537694	G/A	cg22681709	chr2:178499509	PDE11A	-0.57	-5.15	-0.5	1.87e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs1348850	0.602	rs1453373	chr2:178221668	G/A	cg02961200	chr2:178257176	LOC100130691;AGPS	0.82	5.99	0.56	5.97e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs1577917	1.000	rs1337850	chr6:86729103	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.63	-5.38	-0.52	7.46e-7	Response to antipsychotic treatment;
SKCM	cis	rs3820928	0.904	rs59135978	chr2:227857763	T/C	cg11843606	chr2:227700838	RHBDD1	-0.61	-4.89	-0.48	5.28e-6	Pulmonary function;
SKCM	cis	rs7954584	0.813	rs12827200	chr12:122451278	G/A	cg13699009	chr12:122356056	WDR66	0.53	6.53	0.59	6.15e-9	Mean corpuscular volume;
SKCM	cis	rs7786877	0.680	rs12532878	chr7:100212254	G/A	cg16850897	chr7:100343110	ZAN	-0.67	-5.0	-0.49	3.42e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs6121246	0.609	rs6087783	chr20:30421224	T/G	cg11595048	chr20:30225325	COX4I2	0.56	4.91	0.49	4.84e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs9902453	0.967	rs11080121	chr17:28528842	T/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.78	5.31	0.52	1.01e-6	Coffee consumption (cups per day);
SKCM	cis	rs10089	1.000	rs6887847	chr5:127473807	A/G	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.89	8.95	0.71	1.34e-13	Ileal carcinoids;
SKCM	cis	rs10256972	0.630	rs13235747	chr7:1129123	T/C	cg16145915	chr7:1198662	ZFAND2A	-0.56	-7.9	-0.67	1.47e-11	Longevity;Endometriosis;
SKCM	cis	rs362296	0.624	rs362287	chr4:3257593	C/T	cg00764545	chr4:3318001	RGS12	-0.75	-6.58	-0.6	4.99e-9	Parental longevity (mother's age at death);
SKCM	cis	rs16866061	0.888	rs6748341	chr2:225377574	C/G	cg12698349	chr2:225449008	CUL3	1.02	8.25	0.68	3.08e-12	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs9902453	0.967	rs8067576	chr17:28444254	T/A	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.5	0.53	4.74e-7	Coffee consumption (cups per day);
SKCM	cis	rs12926788	0.542	rs6497759	chr16:24801737	G/A	cg06028605	chr16:24865363	SLC5A11	0.59	4.98	0.49	3.66e-6	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs11098499	0.954	rs10518331	chr4:120323595	C/T	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs3820068	0.581	rs72645889	chr1:15930251	T/G	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs9394841	0.667	rs1891453	chr6:41765265	T/C	cg08135965	chr6:41755394	TOMM6	0.75	4.96	0.49	3.96e-6	Mean corpuscular hemoglobin;Red cell distribution width;
SKCM	cis	rs8017423	0.740	rs8003095	chr14:90680643	A/T	cg04374321	chr14:90722782	PSMC1	0.95	8.38	0.69	1.69e-12	Mortality in heart failure;
SKCM	cis	rs7586085	0.522	rs12471746	chr2:166471015	C/A	cg01770810	chr2:165769913	SLC38A11	-0.49	-4.98	-0.49	3.72e-6	Total body bone mineral density;
SKCM	cis	rs9910055	0.639	rs7217858	chr17:42254527	T/G	cg09913183	chr17:42254507	C17orf65;ASB16	0.67	6.53	0.59	6.13e-9	Total body bone mineral density;
SKCM	trans	rs561341	1.000	rs72823789	chr17:30284084	G/A	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs6138458	1.000	rs11906373	chr20:24938832	A/G	cg26195577	chr20:24973756	C20orf3	1.29	8.85	0.71	2.07e-13	Blood protein levels;
SKCM	cis	rs523522	0.673	rs643372	chr12:121022640	C/G	cg27279351	chr12:120934652	DYNLL1	0.91	8.36	0.69	1.88e-12	High light scatter reticulocyte count;
SKCM	cis	rs6463523	0.933	rs4724821	chr7:762544	C/T	cg06242242	chr7:766104	PRKAR1B;HEATR2	1.08	9.17	0.72	5.16e-14	Subjective well-being;
SKCM	cis	rs228769	0.792	rs454192	chr17:42171206	T/C	cg19774624	chr17:42201019	HDAC5	0.78	5.15	0.5	1.93e-6	Bone mineral density (hip);Bone mineral density (spine);
SKCM	cis	rs13118159	0.509	rs10023473	chr4:1375285	C/T	cg02018176	chr4:1364513	KIAA1530	0.85	6.98	0.62	8.52e-10	Longevity;
SKCM	cis	rs7811142	1.000	rs73161759	chr7:100009994	T/C	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.16	7.68	0.66	3.87e-11	Platelet count;
SKCM	cis	rs57221529	0.766	rs17497684	chr5:558307	T/C	cg10555297	chr5:473380	SLC9A3;LOC25845	1.05	5.35	0.52	8.71e-7	Lung disease severity in cystic fibrosis;
SKCM	cis	rs7927771	0.524	rs10838763	chr11:47794802	C/T	cg20307385	chr11:47447363	PSMC3	0.71	5.63	0.54	2.67e-7	Subjective well-being;
SKCM	cis	rs8072100	0.870	rs10432035	chr17:45624913	G/C	cg08085267	chr17:45401833	C17orf57	0.56	4.8	0.48	7.45e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs35146811	0.625	rs858514	chr7:99825748	A/G	cg22906224	chr7:99728672	NA	-0.71	-5.61	-0.54	2.99e-7	Coronary artery disease;
SKCM	cis	rs1419980	0.673	rs2377086	chr12:7753798	C/T	cg10578777	chr12:7781093	NA	0.68	4.96	0.49	4.02e-6	HDL cholesterol levels;
SKCM	cis	rs870825	0.616	rs7680835	chr4:185652992	C/G	cg04058563	chr4:185651563	MLF1IP	-1.07	-7.16	-0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs11734570	0.581	rs75356782	chr4:38600053	T/G	cg18361445	chr4:38666374	KLF3;FLJ13197	0.86	5.8	0.55	1.35e-7	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs1062177	1.000	rs2915887	chr5:151205504	C/T	cg00977110	chr5:151150581	G3BP1	0.86	6.7	0.6	2.97e-9	Preschool internalizing problems;
SKCM	cis	rs9513627	1.000	rs7985908	chr13:100186218	T/C	cg11288260	chr13:100117058	NA	0.79	4.78	0.48	8.1e-6	Obesity-related traits;
SKCM	cis	rs6952808	0.529	rs73038442	chr7:2139457	C/T	cg02951883	chr7:2050386	MAD1L1	-0.79	-7.4	-0.64	1.37e-10	Bipolar disorder and schizophrenia;
SKCM	cis	rs72615157	0.561	rs113401658	chr7:99858505	C/T	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.18	7.4	0.64	1.33e-10	Lung function (FEV1/FVC);
SKCM	cis	rs2839186	0.934	rs2839194	chr21:47699437	T/G	cg11766577	chr21:47581405	C21orf56	-0.68	-5.69	-0.54	2.1e-7	Testicular germ cell tumor;
SKCM	cis	rs6500395	0.926	rs11643272	chr16:48639723	T/C	cg04672837	chr16:48644449	N4BP1	0.69	5.75	0.55	1.65e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs1577917	0.687	rs1470531	chr6:86507369	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.84	-0.66	1.96e-11	Response to antipsychotic treatment;
SKCM	cis	rs208520	0.661	rs7740835	chr6:66865548	G/A	cg07460842	chr6:66804631	NA	-1.02	-7.16	-0.63	3.84e-10	Exhaled nitric oxide output;
SKCM	cis	rs9399135	0.967	rs13218642	chr6:135309940	A/G	cg24558204	chr6:135376177	HBS1L	0.56	5.01	0.49	3.31e-6	Red blood cell count;
SKCM	cis	rs4319547	0.656	rs4997380	chr12:122838956	A/G	cg23029597	chr12:123009494	RSRC2	-0.72	-5.06	-0.5	2.67e-6	Body mass index;
SKCM	cis	rs870825	1.000	rs72689245	chr4:185579788	G/A	cg04058563	chr4:185651563	MLF1IP	1.03	5.09	0.5	2.4e-6	Blood protein levels;
SKCM	cis	rs28595532	0.920	rs56283736	chr4:119747268	A/G	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs4905558	0.927	rs4905557	chr14:97341828	A/T	cg11863609	chr14:97355128	NA	-0.56	-5.04	-0.5	3e-6	Neutrophil count;
SKCM	cis	rs28386778	0.897	rs1043127	chr17:61791210	T/G	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.36	0.52	8.08e-7	Prudent dietary pattern;
SKCM	cis	rs12044355	0.927	rs11585981	chr1:231833962	T/C	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	0.77	5.67	0.54	2.28e-7	Alzheimer's disease;
SKCM	cis	rs1843834	0.539	rs6749402	chr2:225443901	T/G	cg22455342	chr2:225449267	CUL3	0.76	5.56	0.53	3.62e-7	IgE levels in asthmatics (D.p. specific);
SKCM	cis	rs35306767	0.761	rs12770173	chr10:1027108	A/C	cg20503657	chr10:835505	NA	0.75	5.94	0.56	7.41e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs35306767	0.903	rs4522091	chr10:874116	G/T	cg26597838	chr10:835615	NA	0.76	5.66	0.54	2.4e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs9393692	0.875	rs12526215	chr6:26262916	T/C	cg00631329	chr6:26305371	NA	-0.67	-4.95	-0.49	4.18e-6	Educational attainment;
SKCM	cis	rs1218582	0.710	rs9794000	chr1:154878876	T/A	cg06221963	chr1:154839813	KCNN3	-0.59	-5.78	-0.55	1.49e-7	Prostate cancer;
SKCM	cis	rs7772486	0.790	rs9791313	chr6:146266172	T/C	cg23711669	chr6:146136114	FBXO30	-0.77	-7.44	-0.64	1.14e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6840360	0.571	rs17275577	chr4:152519899	G/A	cg22705602	chr4:152727874	NA	-0.52	-5.7	-0.54	2.03e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7103648	1.000	rs7947450	chr11:47429904	G/A	cg20307385	chr11:47447363	PSMC3	1.08	9.26	0.72	3.38e-14	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs13392177	0.684	rs6720449	chr2:219080978	G/A	cg00012203	chr2:219082015	ARPC2	-0.64	-4.89	-0.48	5.39e-6	Pyoderma gangrenosum in inflammatory bowel disease;
SKCM	cis	rs9303401	0.659	rs34556735	chr17:56694447	A/C	cg10487724	chr17:56770010	TEX14;RAD51C	0.85	6.03	0.56	5.18e-8	Cognitive test performance;
SKCM	cis	rs9814567	0.964	rs9820425	chr3:134223018	G/C	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.63	-4.96	-0.49	4.06e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs10927875	1.000	rs10927875	chr1:16299312	A/G	cg21385522	chr1:16154831	NA	1.0	8.52	0.69	9.29e-13	Dilated cardiomyopathy;
SKCM	cis	rs9399135	0.660	rs4440481	chr6:135276696	A/G	cg24558204	chr6:135376177	HBS1L	0.67	6.16	0.57	2.99e-8	Red blood cell count;
SKCM	cis	rs7659604	0.791	rs57316471	chr4:122663939	A/G	cg06713675	chr4:122721982	EXOSC9	-0.75	-6.99	-0.62	8.25e-10	Type 2 diabetes;
SKCM	cis	rs2204008	0.806	rs1589382	chr12:38408565	T/A	cg26384229	chr12:38710491	ALG10B	0.82	6.3	0.58	1.6e-8	Bladder cancer;
SKCM	cis	rs28386778	0.897	rs1062788	chr17:61896127	C/G	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs9894429	0.966	rs6565605	chr17:79589359	C/T	cg18240062	chr17:79603768	NPLOC4	0.77	7.47	0.65	9.79e-11	Eye color traits;
SKCM	cis	rs2354432	0.599	rs6693667	chr1:146817245	A/T	cg25205988	chr1:146714368	CHD1L	1.12	7.87	0.67	1.7e-11	Mitochondrial DNA levels;
SKCM	cis	rs514406	0.792	rs481440	chr1:53344976	C/T	cg24675658	chr1:53192096	ZYG11B	-0.8	-7.24	-0.63	2.79e-10	Monocyte count;
SKCM	cis	rs2599510	0.811	rs2243844	chr2:32775984	G/T	cg02381751	chr2:32503542	YIPF4	0.7	5.61	0.54	3.01e-7	Interleukin-18 levels;
SKCM	cis	rs13108904	0.557	rs1680030	chr4:1245500	A/T	cg16405210	chr4:1374714	KIAA1530	0.68	4.94	0.49	4.34e-6	Obesity-related traits;
SKCM	cis	rs644799	0.511	rs11021302	chr11:95485768	G/A	cg03916912	chr11:95522834	CEP57;FAM76B	0.68	5.15	0.5	1.93e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs7598759	0.527	rs12987949	chr2:232367511	A/G	cg19187155	chr2:232395269	NMUR1	0.89	7.72	0.66	3.28e-11	Noise-induced hearing loss;
SKCM	cis	rs933688	1.000	rs1035477	chr5:90743325	T/C	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.07	8.52	0.69	9.25e-13	Smoking behavior;
SKCM	cis	rs1799949	1.000	rs915945	chr17:41179864	C/T	cg25918947	chr17:41365094	TMEM106A	-0.61	-5.87	-0.55	1e-7	Menopause (age at onset);
SKCM	cis	rs754466	0.580	rs10824576	chr10:79566040	G/C	cg17075019	chr10:79541650	NA	-0.81	-7.53	-0.65	7.5e-11	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs55879323	1	rs55879323	chr1:152168740	C/T	cg20694572	chr1:152331529	FLG2	-0.55	-4.85	-0.48	6.23e-6	Inflammatory skin disease;
SKCM	cis	rs17376456	0.877	rs12374470	chr5:93481046	A/G	cg25358565	chr5:93447407	FAM172A	1.23	7.97	0.67	1.08e-11	Diabetic retinopathy;
SKCM	cis	rs801193	0.967	rs2707849	chr7:66152712	T/C	cg18876405	chr7:65276391	NA	0.8	7.11	0.63	4.86e-10	Aortic root size;
SKCM	cis	rs7208859	0.623	rs426434	chr17:28925353	C/T	cg14067834	chr17:29058358	SUZ12P	1.01	4.92	0.49	4.71e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs7824557	0.602	rs10096194	chr8:11207672	C/G	cg21775007	chr8:11205619	TDH	0.7	6.25	0.58	2.02e-8	Retinal vascular caliber;
SKCM	cis	rs5769765	0.773	rs11090920	chr22:50320105	A/G	cg22709217	chr22:50311962	ALG12;CRELD2	-0.99	-6.09	-0.57	4.04e-8	Schizophrenia;
SKCM	cis	rs7647973	0.961	rs56324858	chr3:49544229	A/G	cg07636037	chr3:49044803	WDR6	-0.86	-5.08	-0.5	2.48e-6	Menarche (age at onset);
SKCM	cis	rs11098499	0.863	rs3822192	chr4:120445720	A/C	cg09307838	chr4:120376055	NA	0.97	7.66	0.66	4.19e-11	Corneal astigmatism;
SKCM	cis	rs1005277	0.505	rs200939	chr10:38139483	T/C	cg00409905	chr10:38381863	ZNF37A	-0.62	-5.81	-0.55	1.29e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs7811142	0.720	rs112622797	chr7:99917416	G/A	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.21	7.77	0.66	2.57e-11	Platelet count;
SKCM	cis	rs2858942	0.818	rs1203979	chr16:261866	T/A	cg08400316	chr16:204221	HBZ	-0.72	-5.08	-0.5	2.5e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs7666738	0.830	rs9995370	chr4:98732145	T/G	cg17366294	chr4:99064904	C4orf37	0.59	5.11	0.5	2.25e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7666738	0.830	rs35531558	chr4:98938217	A/G	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4974559	0.790	rs2293631	chr4:1315917	C/A	cg02980000	chr4:1222292	CTBP1	0.89	5.33	0.52	9.41e-7	Systolic blood pressure;
SKCM	cis	rs12541335	0.615	rs4872464	chr8:22153381	G/A	cg02463440	chr8:22132932	PIWIL2	0.61	5.32	0.52	9.83e-7	Hypertriglyceridemia;
SKCM	cis	rs1153858	1.000	rs2461702	chr15:45647427	A/G	cg21132104	chr15:45694354	SPATA5L1	0.92	7.54	0.65	7.3e-11	Homoarginine levels;
SKCM	cis	rs28595532	0.841	rs115233595	chr4:119744214	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.43	0.59	9.27e-9	Cannabis dependence symptom count;
SKCM	cis	rs1691799	0.867	rs1168339	chr12:66759236	T/G	cg16791601	chr12:66731901	HELB	-0.63	-5.63	-0.54	2.72e-7	White blood cell count (basophil);
SKCM	cis	rs9549367	0.601	rs558869	chr13:113849932	G/T	cg18105134	chr13:113819100	PROZ	0.88	6.6	0.6	4.59e-9	Platelet distribution width;
SKCM	cis	rs2204008	0.687	rs1733404	chr12:38123395	G/T	cg26384229	chr12:38710491	ALG10B	-0.81	-6.95	-0.62	9.67e-10	Bladder cancer;
SKCM	cis	rs9921222	0.500	rs11645742	chr16:367516	C/T	cg00101154	chr16:420108	MRPL28	-0.67	-5.53	-0.53	4.15e-7	Bone mineral density (spine);Bone mineral density;
SKCM	cis	rs7980687	0.657	rs10744151	chr12:123723735	G/C	cg00376283	chr12:123451042	ABCB9	0.89	7.44	0.64	1.15e-10	Height;Educational attainment;Head circumference (infant);
SKCM	cis	rs2013441	1.000	rs2703804	chr17:20107195	T/C	cg13482628	chr17:19912719	NA	-0.65	-5.21	-0.51	1.48e-6	Obesity-related traits;
SKCM	cis	rs4790333	1.000	rs2248821	chr17:2268311	G/A	cg02569219	chr17:2266849	SGSM2	0.79	6.77	0.61	2.17e-9	Proinsulin levels;
SKCM	cis	rs17685	0.753	rs4732542	chr7:75663203	A/G	cg01364799	chr7:75623366	TMEM120A	-0.67	-5.35	-0.52	8.38e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7666738	0.830	rs35560671	chr4:99069095	G/A	cg17366294	chr4:99064904	C4orf37	0.61	4.93	0.49	4.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10754283	0.934	rs7529653	chr1:90111851	G/A	cg21401794	chr1:90099060	LRRC8C	0.73	6.34	0.58	1.35e-8	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs9894429	0.621	rs9747119	chr17:79607017	A/G	cg18240062	chr17:79603768	NPLOC4	0.68	6.0	0.56	5.88e-8	Eye color traits;
SKCM	cis	rs2842992	0.872	rs2758315	chr6:160158640	T/C	cg19482086	chr6:160211437	TCP1;MRPL18	0.82	6.43	0.59	9.54e-9	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs951366	0.528	rs1172198	chr1:205662718	C/T	cg26354017	chr1:205819088	PM20D1	0.88	7.17	0.63	3.79e-10	Menarche (age at onset);
SKCM	cis	rs1577917	1.000	rs12215037	chr6:86727631	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.83	-8.07	-0.67	6.96e-12	Response to antipsychotic treatment;
SKCM	cis	rs1577917	0.740	rs2758843	chr6:86328431	A/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.74	-6.58	-0.6	4.87e-9	Response to antipsychotic treatment;
SKCM	cis	rs34172651	0.517	rs11639856	chr16:24788645	A/T	cg04756594	chr16:24857601	SLC5A11	-0.72	-5.19	-0.51	1.65e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1005277	0.579	rs1780115	chr10:38524773	C/T	cg25427524	chr10:38739819	LOC399744	-0.69	-6.79	-0.61	1.96e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs6835098	0.828	rs28612521	chr4:174085294	G/A	cg08422745	chr4:174089978	GALNT7	-0.83	-6.46	-0.59	8.18e-9	Dementia and core Alzheimer's disease neuropathologic changes;
SKCM	cis	rs2197308	0.692	rs67352173	chr12:37906912	A/T	cg26384229	chr12:38710491	ALG10B	0.8	6.92	0.62	1.14e-9	Morning vs. evening chronotype;
SKCM	cis	rs10927875	0.722	rs6660685	chr1:16346988	A/G	cg21385522	chr1:16154831	NA	0.67	4.9	0.48	5.15e-6	Dilated cardiomyopathy;
SKCM	cis	rs11098499	1.000	rs11098499	chr4:120187611	C/T	cg09307838	chr4:120376055	NA	0.95	7.75	0.66	2.84e-11	Corneal astigmatism;
SKCM	cis	rs614226	1.000	rs1167725	chr12:120968559	A/T	cg01236616	chr12:121019343	POP5	1.34	8.54	0.7	8.29e-13	Type 1 diabetes nephropathy;
SKCM	cis	rs9300255	0.620	rs1727311	chr12:123660716	T/G	cg05973401	chr12:123451056	ABCB9	0.81	4.98	0.49	3.78e-6	Neutrophil percentage of white cells;
SKCM	cis	rs2811415	0.597	rs13070488	chr3:127784118	T/C	cg09089421	chr3:127803668	RUVBL1	1.0	8.69	0.7	4.4e-13	Lung function (FEV1/FVC);
SKCM	cis	rs1348850	0.626	rs1901825	chr2:178225331	A/T	cg02961200	chr2:178257176	LOC100130691;AGPS	0.79	5.84	0.55	1.13e-7	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs709400	0.930	rs10149249	chr14:104047757	C/T	cg26031613	chr14:104095156	KLC1	1.07	11.44	0.79	2.36e-18	Body mass index;
SKCM	cis	rs4740619	0.619	rs1887667	chr9:16033109	T/G	cg14451791	chr9:16040625	NA	-0.47	-4.81	-0.48	7.13e-6	Body mass index;
SKCM	cis	rs2832191	0.511	rs7278227	chr21:30482707	C/T	cg08807101	chr21:30365312	RNF160	-0.66	-5.23	-0.51	1.39e-6	Dental caries;
SKCM	cis	rs34779708	0.931	rs13376871	chr10:35369056	A/G	cg03585969	chr10:35415529	CREM	0.79	6.4	0.59	1.08e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs2816062	0.775	rs2816046	chr1:18893708	A/G	cg18795169	chr1:18902165	NA	-0.79	-7.89	-0.67	1.51e-11	Urate levels in lean individuals;
SKCM	cis	rs7208859	0.524	rs11653605	chr17:29088385	T/G	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs6951245	0.935	rs78573577	chr7:1089087	C/A	cg03188948	chr7:1209495	NA	1.12	6.25	0.58	2.02e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs35306767	0.953	rs12762973	chr10:960761	C/G	cg26597838	chr10:835615	NA	0.67	5.22	0.51	1.44e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs4642101	0.680	rs7626609	chr3:12806080	A/G	cg05775895	chr3:12838266	CAND2	-0.59	-4.93	-0.49	4.56e-6	QRS complex (12-leadsum);
SKCM	cis	rs9325144	0.555	rs12424003	chr12:38688140	C/T	cg26384229	chr12:38710491	ALG10B	-0.75	-6.43	-0.59	9.47e-9	Morning vs. evening chronotype;
SKCM	cis	rs4803468	1.000	rs284663	chr19:41932612	C/T	cg14132834	chr19:41945861	ATP5SL	-0.77	-6.04	-0.56	4.87e-8	Height;
SKCM	cis	rs9910055	0.529	rs170637	chr17:42186868	C/T	cg09913183	chr17:42254507	C17orf65;ASB16	-0.58	-4.79	-0.48	7.84e-6	Total body bone mineral density;
SKCM	cis	rs13126513	0.708	rs7665289	chr4:100448167	G/T	cg05468953	chr4:100565104	NA	0.48	4.98	0.49	3.74e-6	Metabolite levels (MHPG);
SKCM	trans	rs1814175	0.817	rs10769617	chr11:49810421	G/A	cg03929089	chr4:120376271	NA	-0.9	-8.5	-0.69	9.91e-13	Height;
SKCM	cis	rs28386778	0.897	rs4968662	chr17:61834537	A/G	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.36	0.52	8.06e-7	Prudent dietary pattern;
SKCM	cis	rs995000	0.899	rs1184865	chr1:62973795	A/G	cg06896770	chr1:63153194	DOCK7	-0.63	-5.65	-0.54	2.5e-7	Triglyceride levels;
SKCM	cis	rs933688	0.938	rs12110065	chr5:90718474	A/G	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.1	8.5	0.69	1.01e-12	Smoking behavior;
SKCM	cis	rs854765	0.583	rs8080823	chr17:17864048	T/C	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.93	7.3	0.64	2.06e-10	Total body bone mineral density;
SKCM	cis	rs17711722	0.653	rs2460421	chr7:65491123	A/T	cg18876405	chr7:65276391	NA	-0.8	-7.72	-0.66	3.26e-11	Calcium levels;
SKCM	cis	rs9399135	0.967	rs9389253	chr6:135329755	T/C	cg24558204	chr6:135376177	HBS1L	0.59	5.23	0.51	1.41e-6	Red blood cell count;
SKCM	cis	rs10781543	0.753	rs7020201	chr9:139377498	G/C	cg14169450	chr9:139327907	INPP5E	0.53	5.73	0.54	1.81e-7	Monocyte percentage of white cells;
SKCM	cis	rs801193	0.904	rs4718403	chr7:66242729	C/G	cg11987759	chr7:65425863	GUSB	-0.67	-5.8	-0.55	1.35e-7	Aortic root size;
SKCM	cis	rs1218582	0.774	rs4845683	chr1:154877407	T/C	cg03351412	chr1:154909251	PMVK	0.73	6.28	0.58	1.81e-8	Prostate cancer;
SKCM	cis	rs55962025	0.846	rs363066	chr4:3135953	G/T	cg09735869	chr4:3319127	RGS12	0.83	6.58	0.6	4.92e-9	Parental longevity (mother's age at death);
SKCM	cis	rs7811142	1.000	rs1073	chr7:100031612	G/A	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.17	7.71	0.66	3.44e-11	Platelet count;
SKCM	cis	rs10927875	0.631	rs28579893	chr1:16347534	A/G	cg21385522	chr1:16154831	NA	0.67	4.9	0.48	5.15e-6	Dilated cardiomyopathy;
SKCM	cis	rs2730245	1.000	rs2657365	chr7:158722753	A/T	cg24397884	chr7:158709396	WDR60	-1.03	-9.95	-0.75	1.54e-15	Height;
SKCM	cis	rs17685	0.712	rs6953342	chr7:75776753	T/C	cg16684958	chr7:75615977	POR	0.52	4.92	0.49	4.73e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs826838	0.967	rs34496261	chr12:39023829	G/A	cg26384229	chr12:38710491	ALG10B	1.01	9.41	0.73	1.77e-14	Heart rate;
SKCM	cis	rs501120	1.000	rs554568	chr10:44755446	C/T	cg09554077	chr10:44749378	NA	0.38	4.93	0.49	4.52e-6	Coronary artery disease;Coronary heart disease;
SKCM	cis	rs910316	1.000	rs10143132	chr14:75525850	G/A	cg08847533	chr14:75593920	NEK9	0.95	9.18	0.72	4.8e-14	Height;
SKCM	cis	rs637571	0.522	rs493899	chr11:65747952	A/C	cg26695010	chr11:65641043	EFEMP2	-0.72	-5.47	-0.53	5.29e-7	Eosinophil percentage of white cells;
SKCM	cis	rs314370	0.818	rs13245899	chr7:100497131	A/G	cg10426581	chr7:100472382	SRRT	0.69	6.05	0.57	4.69e-8	Resting heart rate;
SKCM	cis	rs1862618	0.671	rs2591964	chr5:56236900	T/G	cg03609598	chr5:56110824	MAP3K1	0.68	4.79	0.48	7.77e-6	Initial pursuit acceleration;
SKCM	cis	rs12709013	0.792	rs1657170	chr16:58785986	C/T	cg02431531	chr16:59244939	NA	0.49	5.1	0.5	2.32e-6	Blood metabolite ratios;
SKCM	cis	rs951366	0.789	rs823121	chr1:205724302	A/G	cg14893161	chr1:205819251	PM20D1	-1.05	-10.11	-0.75	7.93e-16	Menarche (age at onset);
SKCM	cis	rs694739	1.000	rs1783521	chr11:64106291	T/C	cg02228329	chr11:64053129	BAD;GPR137	1.0	8.98	0.71	1.17e-13	Alopecia areata;Crohn's disease;Psoriasis vulgaris;
SKCM	cis	rs9611565	0.527	rs2234053	chr22:41777315	G/T	cg03806693	chr22:41940476	POLR3H	-0.86	-5.89	-0.55	9.19e-8	Vitiligo;
SKCM	cis	rs6088580	0.602	rs6059834	chr20:33019299	A/G	cg24642439	chr20:33292090	TP53INP2	0.76	6.02	0.56	5.28e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs1062177	0.826	rs2053063	chr5:151166764	T/C	cg00977110	chr5:151150581	G3BP1	0.79	6.33	0.58	1.42e-8	Preschool internalizing problems;
SKCM	cis	rs12142240	0.698	rs72677599	chr1:46834251	G/A	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs951366	0.617	rs823075	chr1:205774897	C/T	cg24739457	chr1:205821442	NA	0.53	4.9	0.49	5.07e-6	Menarche (age at onset);
SKCM	cis	rs4820539	0.966	rs2283803	chr22:23454881	G/A	cg14186256	chr22:23484241	RTDR1	0.81	7.77	0.66	2.66e-11	Bone mineral density;
SKCM	cis	rs1005277	0.579	rs2472173	chr10:38374638	G/A	cg25427524	chr10:38739819	LOC399744	-0.69	-6.45	-0.59	8.73e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs6547631	0.622	rs10192752	chr2:85926142	T/G	cg24620635	chr2:85921963	GNLY	0.9	6.65	0.6	3.58e-9	Blood protein levels;
SKCM	cis	rs151997	0.777	rs3846500	chr5:50254488	A/T	cg01829002	chr5:50259133	NA	-0.5	-4.83	-0.48	6.63e-6	Callous-unemotional behaviour;
SKCM	cis	rs6088580	0.634	rs6087577	chr20:32955423	C/T	cg24642439	chr20:33292090	TP53INP2	0.75	5.92	0.56	8.34e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs1790761	0.505	rs34721562	chr11:67312708	T/C	cg00290607	chr11:67383545	NA	-0.52	-4.85	-0.48	6.13e-6	Mean corpuscular volume;
SKCM	cis	rs2120019	0.935	rs34835684	chr15:75331805	T/G	cg09165964	chr15:75287851	SCAMP5	-0.82	-7.72	-0.66	3.24e-11	Blood trace element (Zn levels);
SKCM	cis	rs9300255	0.722	rs11830103	chr12:123823546	A/G	cg05973401	chr12:123451056	ABCB9	-0.82	-5.72	-0.54	1.92e-7	Neutrophil percentage of white cells;
SKCM	cis	rs1467026	0.584	rs9880453	chr3:12804060	C/T	cg05775895	chr3:12838266	CAND2	0.61	4.8	0.48	7.43e-6	P wave duration;
SKCM	cis	rs4925114	0.568	rs4925109	chr17:17661802	A/G	cg04398451	chr17:18023971	MYO15A	0.8	5.31	0.51	1.02e-6	Body mass index;
SKCM	trans	rs3780486	0.846	rs3824458	chr9:33144809	C/T	cg04842962	chr6:43655489	MRPS18A	1.01	11.19	0.78	6.77e-18	IgG glycosylation;
SKCM	cis	rs2652834	1.000	rs36116701	chr15:63397494	T/C	cg04194852	chr15:63334506	TPM1	0.76	4.78	0.48	8.15e-6	HDL cholesterol;
SKCM	cis	rs6951245	1.000	rs11763835	chr7:1094513	A/G	cg18402987	chr7:1209562	NA	1.15	6.09	0.57	3.95e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs4919087	0.962	rs3814164	chr10:98982749	G/A	cg25902810	chr10:99078978	FRAT1	0.68	5.55	0.53	3.77e-7	Monocyte count;
SKCM	cis	rs2857078	0.745	rs4793085	chr17:42320732	A/C	cg13607699	chr17:42295918	UBTF	-0.88	-7.3	-0.64	2.14e-10	Red cell distribution width;Reticulocyte count;
SKCM	cis	rs1395	0.744	rs72817536	chr2:27497548	A/G	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.61	5.59	0.53	3.19e-7	Blood metabolite levels;
SKCM	cis	rs208520	0.770	rs2153941	chr6:66885521	A/T	cg07460842	chr6:66804631	NA	-0.91	-7.07	-0.63	5.76e-10	Exhaled nitric oxide output;
SKCM	cis	rs7980687	0.527	rs28533432	chr12:123873242	C/T	cg00376283	chr12:123451042	ABCB9	0.79	5.81	0.55	1.27e-7	Height;Educational attainment;Head circumference (infant);
SKCM	cis	rs8180040	1.000	rs807931	chr3:47389317	C/T	cg27129171	chr3:47204927	SETD2	0.87	6.62	0.6	4.15e-9	Colorectal cancer;
SKCM	cis	rs9814567	1.000	rs6439484	chr3:134249899	A/G	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs2836974	0.897	rs2776308	chr21:40715175	A/G	cg11644478	chr21:40555479	PSMG1	0.74	6.37	0.58	1.21e-8	Cognitive function;
SKCM	cis	rs1707322	1.000	rs10890378	chr1:46410657	A/G	cg03146154	chr1:46216737	IPP	-0.8	-5.44	-0.52	5.87e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7786877	0.761	rs11772705	chr7:100298904	T/C	cg20848291	chr7:100343083	ZAN	-0.71	-5.53	-0.53	4.16e-7	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs2153535	0.601	rs718504	chr6:8527512	A/G	cg23788917	chr6:8435910	SLC35B3	0.68	4.98	0.49	3.66e-6	Motion sickness;
SKCM	cis	rs7615952	0.515	rs4441610	chr3:125681307	C/G	cg05084668	chr3:125655381	ALG1L	-0.93	-5.13	-0.5	2.09e-6	Blood pressure (smoking interaction);
SKCM	trans	rs561341	1.000	rs546748	chr17:30324293	A/C	cg20587970	chr11:113659929	NA	-1.14	-9.67	-0.74	5.51e-15	Hip circumference adjusted for BMI;
SKCM	cis	rs3793683	0.545	rs12784407	chr10:134589631	A/G	cg18305652	chr10:134549665	INPP5A	0.6	6.16	0.57	2.97e-8	Migraine;
SKCM	cis	rs732765	0.734	rs7153812	chr14:75173490	G/A	cg25946216	chr14:74253857	C14orf43	-0.79	-5.06	-0.5	2.71e-6	Non-small cell lung cancer;
SKCM	cis	rs7523050	0.643	rs35860016	chr1:109404639	C/T	cg08274380	chr1:109419600	GPSM2	1.18	6.44	0.59	9.12e-9	Fat distribution (HIV);
SKCM	cis	rs3020736	0.500	rs11090076	chr22:42514190	T/C	cg04733989	chr22:42467013	NAGA	-0.72	-5.62	-0.54	2.87e-7	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs9303401	0.614	rs3803752	chr17:56540267	C/T	cg10487724	chr17:56770010	TEX14;RAD51C	0.85	6.07	0.57	4.34e-8	Cognitive test performance;
SKCM	cis	rs13256369	1.000	rs9329165	chr8:8576642	C/T	cg06636001	chr8:8085503	FLJ10661	-0.76	-5.49	-0.53	4.86e-7	Obesity-related traits;
SKCM	cis	rs9814567	0.964	rs9833753	chr3:134213665	A/G	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.67	-5.25	-0.51	1.28e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs10905065	0.931	rs11255228	chr10:5837671	T/C	cg09234995	chr10:5726438	C10orf18	-0.59	-5.03	-0.49	3.1e-6	Menopause (age at onset);
SKCM	cis	rs6840360	0.533	rs13121190	chr4:152729072	T/G	cg22705602	chr4:152727874	NA	0.56	7.69	0.66	3.7e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs854765	0.583	rs8078138	chr17:17811251	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.93	7.3	0.64	2.06e-10	Total body bone mineral density;
SKCM	cis	rs7811142	0.830	rs6979910	chr7:99940630	A/C	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.21	7.77	0.66	2.57e-11	Platelet count;
SKCM	trans	rs208520	0.690	rs866452	chr6:66849936	A/T	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-1.09	-8.36	-0.69	1.9e-12	Exhaled nitric oxide output;
SKCM	cis	rs9660180	0.837	rs915292	chr1:1792157	A/C	cg13866156	chr1:1669148	SLC35E2	-0.79	-6.51	-0.59	6.53e-9	Body mass index;
SKCM	cis	rs7811142	1.000	rs7783159	chr7:100017454	C/T	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.2	7.93	0.67	1.29e-11	Platelet count;
SKCM	cis	rs1577917	0.740	rs7775864	chr6:86247759	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.88	8.56	0.7	7.74e-13	Response to antipsychotic treatment;
SKCM	cis	rs4132509	0.744	rs7519673	chr1:243993123	A/G	cg21452805	chr1:244014465	NA	1.0	5.91	0.56	8.69e-8	RR interval (heart rate);
SKCM	cis	rs10791097	0.694	rs10791100	chr11:130738946	T/A	cg12179176	chr11:130786555	SNX19	0.93	8.2	0.68	3.79e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs6430585	0.697	rs7607174	chr2:136513670	T/A	cg07169764	chr2:136633963	MCM6	1.31	13.14	0.83	1.86e-21	Corneal structure;
SKCM	cis	rs1552244	0.935	rs7649243	chr3:10089470	T/A	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs2839186	0.967	rs9637172	chr21:47685787	T/C	cg13012494	chr21:47604986	C21orf56	0.67	5.78	0.55	1.44e-7	Testicular germ cell tumor;
SKCM	cis	rs7523273	0.627	rs2724389	chr1:207933648	T/C	cg22525895	chr1:207977042	MIR29B2	0.81	7.08	0.63	5.47e-10	Schizophrenia;
SKCM	cis	rs7927771	0.524	rs7939420	chr11:47723938	A/G	cg20307385	chr11:47447363	PSMC3	-0.72	-5.81	-0.55	1.31e-7	Subjective well-being;
SKCM	cis	rs10256972	0.616	rs7806746	chr7:1075573	A/C	cg07308232	chr7:1071921	C7orf50	-0.59	-5.19	-0.51	1.65e-6	Longevity;Endometriosis;
SKCM	cis	rs459571	0.959	rs2520099	chr9:136918139	T/C	cg13789015	chr9:136890014	NCRNA00094	0.73	5.93	0.56	7.71e-8	Platelet distribution width;
SKCM	cis	rs644799	1.000	rs580255	chr11:95577929	T/C	cg03916912	chr11:95522834	CEP57;FAM76B	0.88	7.53	0.65	7.59e-11	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs798502	0.522	rs7790322	chr7:2830498	C/T	cg09658497	chr7:2847517	GNA12	-0.42	-5.41	-0.52	6.68e-7	Waist circumference adjusted for BMI (adjusted for smoking behaviour);Inflammatory bowel disease;Waist circumference adjusted for BMI in non-smokers;Ulcerative colitis;Waist circumference adjusted for body mass index;Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction);
SKCM	cis	rs9875589	0.509	rs1386932	chr3:14061369	G/A	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.5	5.15	0.5	1.9e-6	Ovarian reserve;
SKCM	cis	rs763121	0.853	rs3827357	chr22:39079413	A/G	cg06022373	chr22:39101656	GTPBP1	0.78	5.59	0.53	3.27e-7	Menopause (age at onset);
SKCM	cis	rs826838	0.967	rs11183022	chr12:38652519	G/A	cg13010199	chr12:38710504	ALG10B	0.72	5.27	0.51	1.19e-6	Heart rate;
SKCM	cis	rs7216064	1.000	rs1976054	chr17:65833224	T/G	cg12091567	chr17:66097778	LOC651250	-0.77	-5.53	-0.53	4.06e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs62238980	0.522	rs75380258	chr22:32413280	C/T	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs999943	0.846	rs2274200	chr6:33625696	T/C	cg14003231	chr6:33640908	ITPR3	0.62	5.62	0.54	2.82e-7	Obesity (extreme);
SKCM	cis	rs801193	1.000	rs3778909	chr7:66255646	G/C	cg18876405	chr7:65276391	NA	0.82	7.48	0.65	9.41e-11	Aortic root size;
SKCM	cis	rs3785574	0.962	rs2584614	chr17:61929445	C/T	cg06601766	chr17:61851465	DDX42;CCDC47	0.72	5.36	0.52	8.34e-7	Height;
SKCM	cis	rs4319547	0.737	rs7964138	chr12:122950375	A/G	cg23029597	chr12:123009494	RSRC2	-0.8	-6.03	-0.56	5.25e-8	Body mass index;
SKCM	cis	rs12047808	0.841	rs79893062	chr1:179378787	C/T	cg09822482	chr1:179519214	C1orf125	-0.95	-5.17	-0.51	1.78e-6	Multiple sclerosis (age of onset);
SKCM	cis	rs2739330	0.789	rs5760109	chr22:24252938	C/G	cg25703541	chr22:24373054	LOC391322	-0.76	-6.25	-0.58	2e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs2288073	0.965	rs10192600	chr2:24396680	A/G	cg06627628	chr2:24431161	ITSN2	-0.76	-5.24	-0.51	1.31e-6	Venous thromboembolism (SNP x SNP interaction);
SKCM	cis	rs861020	0.883	rs680331	chr1:209959872	G/A	cg09163369	chr1:210001066	C1orf107	0.87	5.78	0.55	1.45e-7	Orofacial clefts;
SKCM	cis	rs823143	0.570	rs823082	chr1:205786935	C/T	cg24503407	chr1:205819492	PM20D1	-0.92	-9.35	-0.73	2.29e-14	Monocyte percentage of white cells;
SKCM	cis	rs2842992	0.789	rs2295901	chr6:160201295	C/A	cg16489826	chr6:160211363	TCP1;MRPL18	0.73	5.42	0.52	6.39e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs6582630	0.502	rs4385963	chr12:38295264	G/A	cg26384229	chr12:38710491	ALG10B	0.81	6.57	0.6	5.18e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs72781680	0.898	rs72796396	chr2:24178154	G/A	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	cis	rs2153535	0.580	rs9406169	chr6:8509470	A/T	cg07606381	chr6:8435919	SLC35B3	0.89	6.83	0.61	1.66e-9	Motion sickness;
SKCM	cis	rs634534	0.562	rs642293	chr11:65730217	G/A	cg02427764	chr11:65769310	BANF1;EIF1AD	0.76	5.82	0.55	1.26e-7	Sum eosinophil basophil counts;Eosinophil counts;
SKCM	cis	rs4969178	0.965	rs8072632	chr17:76397830	T/C	cg20026190	chr17:76395443	PGS1	0.61	5.29	0.51	1.08e-6	HDL cholesterol levels;
SKCM	cis	rs867186	1.000	rs78055011	chr20:33618606	G/A	cg04194272	chr20:33683537	NA	-1.38	-7.2	-0.63	3.29e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs1707322	1.000	rs6429580	chr1:46275648	A/G	cg03146154	chr1:46216737	IPP	0.74	5.0	0.49	3.39e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs2153535	0.601	rs2015281	chr6:8539673	G/A	cg07606381	chr6:8435919	SLC35B3	0.91	6.31	0.58	1.56e-8	Motion sickness;
SKCM	cis	rs860295	0.702	rs12043132	chr1:155562367	T/C	cg02153340	chr1:155202674	NA	-0.78	-5.91	-0.56	8.65e-8	Body mass index;
SKCM	cis	rs34779708	0.733	rs7914468	chr10:35548071	G/A	cg03585969	chr10:35415529	CREM	0.71	5.25	0.51	1.27e-6	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs362296	0.671	rs1006798	chr4:3258373	A/G	cg09735869	chr4:3319127	RGS12	-0.79	-6.74	-0.61	2.47e-9	Parental longevity (mother's age at death);
SKCM	cis	rs2696842	1.000	rs2696838	chr16:86366001	C/T	cg09550945	chr16:86806068	NA	-0.81	-5.14	-0.5	1.99e-6	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;
SKCM	cis	rs875971	1.000	rs4718344	chr7:65874381	C/A	cg11764359	chr7:65958608	NA	0.87	8.35	0.69	2.01e-12	Aortic root size;
SKCM	cis	rs9660180	0.967	rs6687065	chr1:1778469	A/G	cg17747265	chr1:1875780	NA	-0.56	-5.15	-0.5	1.87e-6	Body mass index;
SKCM	cis	rs8180040	0.676	rs1108301	chr3:47029426	G/A	cg27129171	chr3:47204927	SETD2	-0.83	-6.19	-0.57	2.6e-8	Colorectal cancer;
SKCM	cis	rs875971	0.929	rs778692	chr7:65872449	A/G	cg18876405	chr7:65276391	NA	0.67	6.65	0.6	3.61e-9	Aortic root size;
SKCM	cis	rs11105298	0.891	rs10777162	chr12:89830523	A/G	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.88	-6.03	-0.56	5.22e-8	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs798554	0.836	rs798526	chr7:2775542	G/C	cg19346786	chr7:2764209	NA	-0.6	-6.35	-0.58	1.33e-8	Height;
SKCM	cis	rs875971	0.508	rs10242423	chr7:66059175	A/G	cg11764359	chr7:65958608	NA	-0.79	-5.88	-0.55	9.67e-8	Aortic root size;
SKCM	cis	rs611744	0.647	rs1448151	chr8:109276283	C/A	cg18478394	chr8:109455254	TTC35	0.66	5.31	0.52	1.02e-6	Dupuytren's disease;
SKCM	cis	rs514406	0.893	rs6588445	chr1:53424928	T/C	cg16325326	chr1:53192061	ZYG11B	-0.91	-9.82	-0.74	2.77e-15	Monocyte count;
SKCM	cis	rs9868809	0.772	rs9812200	chr3:48695667	A/G	cg00383909	chr3:49044727	WDR6	-1.17	-5.15	-0.5	1.93e-6	Ulcerative colitis;Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs17376456	0.877	rs12716460	chr5:93416733	A/G	cg21475434	chr5:93447410	FAM172A	0.97	5.41	0.52	6.8e-7	Diabetic retinopathy;
SKCM	cis	rs2463822	0.920	rs72923207	chr11:62117959	A/G	cg06239285	chr11:62104954	ASRGL1	-1.26	-5.85	-0.55	1.08e-7	Chronic obstructive pulmonary disease-related biomarkers;
SKCM	cis	rs7215564	0.908	rs35363308	chr17:78687190	A/T	cg16980736	chr17:78789706	RPTOR	-0.88	-4.83	-0.48	6.66e-6	Myopia (pathological);
SKCM	cis	rs7772486	0.875	rs10457795	chr6:146415665	A/G	cg23711669	chr6:146136114	FBXO30	0.85	8.48	0.69	1.09e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6582630	0.519	rs8189599	chr12:38280748	A/G	cg13010199	chr12:38710504	ALG10B	0.68	4.93	0.49	4.6e-6	Drug-induced liver injury (flucloxacillin);
SKCM	trans	rs7618501	0.815	rs3819325	chr3:49843723	T/C	cg21659725	chr3:3221576	CRBN	0.94	8.64	0.7	5.35e-13	Intelligence (multi-trait analysis);
SKCM	cis	rs6598955	0.724	rs12754536	chr1:26639605	T/C	cg04990556	chr1:26633338	UBXN11	-0.59	-4.85	-0.48	6.08e-6	Obesity-related traits;
SKCM	cis	rs875971	0.862	rs778697	chr7:65870426	G/A	cg11764359	chr7:65958608	NA	0.74	6.67	0.6	3.3e-9	Aortic root size;
SKCM	cis	rs860295	0.702	rs11264383	chr1:155545346	C/T	cg02153340	chr1:155202674	NA	-0.78	-5.91	-0.56	8.65e-8	Body mass index;
SKCM	cis	rs1801251	0.964	rs13007783	chr2:233566679	G/A	cg08000102	chr2:233561755	GIGYF2	0.89	6.75	0.61	2.35e-9	Coronary artery disease;
SKCM	cis	rs10860964	0.605	rs7975993	chr12:103562911	C/T	cg20635409	chr12:103359273	NA	-0.56	-4.94	-0.49	4.35e-6	Schizophrenia;
SKCM	cis	rs6089584	0.888	rs2386555	chr20:60612373	C/T	cg06108461	chr20:60628389	TAF4	-0.89	-8.72	-0.7	3.75e-13	Body mass index;
SKCM	cis	rs2286503	0.839	rs2270107	chr7:22862183	G/A	cg15401507	chr7:22894281	NA	-0.57	-5.61	-0.54	2.99e-7	Fibrinogen;
SKCM	cis	rs2019137	0.560	rs10175462	chr2:113988492	G/A	cg12889195	chr2:113992843	PAX8;LOC440839;LOC654433	0.72	5.34	0.52	9.06e-7	Lymphocyte counts;
SKCM	cis	rs2721195	0.874	rs2721173	chr8:145744429	C/T	cg11211951	chr8:145729740	GPT	0.52	4.81	0.48	7.31e-6	Age at first birth;
SKCM	cis	rs2836974	0.932	rs2836955	chr21:40619887	G/A	cg17971929	chr21:40555470	PSMG1	0.9	8.81	0.71	2.52e-13	Cognitive function;
SKCM	cis	rs7824557	0.602	rs1435273	chr8:11209499	T/C	cg21775007	chr8:11205619	TDH	0.7	6.25	0.58	2.02e-8	Retinal vascular caliber;
SKCM	cis	rs7772486	0.659	rs9376957	chr6:146011064	C/T	cg05347473	chr6:146136440	FBXO30	-0.58	-5.15	-0.5	1.92e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7666738	0.830	rs13110498	chr4:98959150	G/A	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11098499	0.909	rs9994810	chr4:120381590	A/G	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs9921222	0.632	rs11649268	chr16:398643	A/C	cg00101154	chr16:420108	MRPL28	-0.74	-6.19	-0.57	2.65e-8	Bone mineral density (spine);Bone mineral density;
SKCM	cis	rs2180341	1.000	rs6569478	chr6:127598619	G/A	cg27446573	chr6:127587934	RNF146	0.99	8.51	0.69	9.46e-13	Breast cancer;
SKCM	cis	rs1790761	0.559	rs10896190	chr11:67406123	T/C	cg23188684	chr11:67383651	NA	0.55	4.92	0.49	4.76e-6	Mean corpuscular volume;
SKCM	cis	rs1799949	1.000	rs4793189	chr17:41190715	G/A	cg05368731	chr17:41323189	NBR1	0.86	7.39	0.64	1.39e-10	Menopause (age at onset);
SKCM	cis	rs7937682	0.883	rs568506	chr11:111466429	C/T	cg09085632	chr11:111637200	PPP2R1B	-1.0	-8.74	-0.7	3.47e-13	Primary sclerosing cholangitis;
SKCM	cis	rs798554	0.757	rs2644312	chr7:2841164	G/A	cg14895029	chr7:2775587	GNA12	-0.64	-4.81	-0.48	7.08e-6	Height;
SKCM	cis	rs9911578	1.000	rs368186	chr17:56736659	A/G	cg05425664	chr17:57184151	TRIM37	-0.69	-5.21	-0.51	1.52e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7408868	0.764	rs45504393	chr19:15277010	A/G	cg14696996	chr19:15285081	NOTCH3	0.82	4.92	0.49	4.7e-6	Pulse pressure;
SKCM	cis	rs1577917	1.000	rs12203493	chr6:86758642	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.64	-5.48	-0.53	5.09e-7	Response to antipsychotic treatment;
SKCM	cis	rs9916302	0.904	rs4795357	chr17:37569551	T/C	cg07936489	chr17:37558343	FBXL20	-0.82	-7.23	-0.63	2.84e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs995000	0.868	rs1168114	chr1:63156043	C/T	cg06896770	chr1:63153194	DOCK7	0.81	6.89	0.62	1.26e-9	Triglyceride levels;
SKCM	cis	rs9818758	0.607	rs11710247	chr3:49249800	G/T	cg24898236	chr3:49228699	LOC646498	0.64	4.94	0.49	4.39e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs875971	0.862	rs778705	chr7:65861115	G/A	cg11764359	chr7:65958608	NA	0.74	6.67	0.6	3.3e-9	Aortic root size;
SKCM	cis	rs9611565	0.559	rs4822049	chr22:41993496	G/A	cg03806693	chr22:41940476	POLR3H	-1.12	-7.23	-0.63	2.84e-10	Vitiligo;
SKCM	cis	rs10089	0.953	rs13358455	chr5:127365786	C/T	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.91	8.09	0.68	6.28e-12	Ileal carcinoids;
SKCM	cis	rs72781680	1.000	rs72781679	chr2:24237712	G/A	cg08917208	chr2:24149416	ATAD2B	1.07	5.99	0.56	6.1e-8	Lymphocyte counts;
SKCM	cis	rs2204008	0.685	rs4556621	chr12:38187236	C/A	cg26384229	chr12:38710491	ALG10B	0.81	6.16	0.57	2.93e-8	Bladder cancer;
SKCM	cis	rs826838	0.967	rs34496261	chr12:39023829	G/A	cg13010199	chr12:38710504	ALG10B	0.78	6.13	0.57	3.37e-8	Heart rate;
SKCM	cis	rs8067545	0.750	rs4925072	chr17:19956899	C/T	cg13482628	chr17:19912719	NA	-0.7	-6.29	-0.58	1.7e-8	Schizophrenia;
SKCM	cis	rs7569084	0.687	rs7577452	chr2:65683828	C/T	cg10464312	chr2:66672688	MEIS1	0.45	5.09	0.5	2.39e-6	Sum eosinophil basophil counts;
SKCM	cis	rs6951245	0.872	rs76713558	chr7:1095866	A/G	cg18402987	chr7:1209562	NA	1.15	6.09	0.57	3.95e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs427394	0.582	rs274662	chr5:6704860	G/A	cg10857441	chr5:6722123	POLS	-0.69	-7.42	-0.64	1.24e-10	Menopause (age at onset);
SKCM	cis	rs2730245	0.563	rs2709857	chr7:158685257	T/C	cg24397884	chr7:158709396	WDR60	0.67	5.18	0.51	1.68e-6	Height;
SKCM	cis	rs870825	0.616	rs12502860	chr4:185636105	T/C	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	trans	rs62103177	0.513	rs9945153	chr18:77598450	C/T	cg05926928	chr17:57297772	GDPD1	1.27	8.28	0.68	2.73e-12	Opioid sensitivity;
SKCM	cis	rs6951245	0.935	rs79143504	chr7:1110212	A/G	cg24642844	chr7:1081250	C7orf50	-0.93	-6.22	-0.58	2.28e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs2652834	1.000	rs2652832	chr15:63396928	T/C	cg04194852	chr15:63334506	TPM1	0.76	4.78	0.48	8.15e-6	HDL cholesterol;
SKCM	cis	rs78456975	0.506	rs6756310	chr2:1549809	A/G	cg01028140	chr2:1542097	TPO	-0.53	-5.06	-0.5	2.74e-6	Placebo response in major depressive disorder (% change in symptom score);
SKCM	cis	rs10911232	0.507	rs4483371	chr1:182988352	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.73	6.47	0.59	7.97e-9	Hypertriglyceridemia;
SKCM	cis	rs478304	0.651	rs4014192	chr11:65498915	C/T	cg17480646	chr11:65405466	SIPA1	-0.71	-5.64	-0.54	2.62e-7	Acne (severe);
SKCM	cis	rs992157	0.560	rs6738394	chr2:219110625	G/A	cg20019365	chr2:219134978	PNKD;AAMP	-0.66	-5.49	-0.53	4.76e-7	Colorectal cancer;
SKCM	cis	rs4919694	1.000	rs11191445	chr10:104651055	C/T	cg04362960	chr10:104952993	NT5C2	0.79	4.95	0.49	4.22e-6	Arsenic metabolism;
SKCM	cis	rs6977660	0.652	rs58559474	chr7:19751569	C/T	cg02470904	chr7:20686108	ABCB5	1.14	5.27	0.51	1.16e-6	Thyroid stimulating hormone;
SKCM	cis	rs394563	0.591	rs11964335	chr6:149658101	A/T	cg16235748	chr6:149772707	ZC3H12D	0.44	4.93	0.49	4.51e-6	Dupuytren's disease;
SKCM	cis	rs6089584	0.526	rs6089619	chr20:60610916	C/T	cg06108461	chr20:60628389	TAF4	-0.73	-6.87	-0.61	1.36e-9	Body mass index;
SKCM	cis	rs3008870	1.000	rs2815351	chr1:67477980	A/G	cg08660285	chr1:67390436	MIER1;WDR78	0.83	5.24	0.51	1.32e-6	Lymphocyte percentage of white cells;
SKCM	cis	rs826838	0.935	rs1160162	chr12:38959795	G/A	cg13010199	chr12:38710504	ALG10B	0.8	6.24	0.58	2.1e-8	Heart rate;
SKCM	cis	rs7590720	0.731	rs1864253	chr2:216878008	C/G	cg12620499	chr2:216877984	MREG	0.97	10.93	0.78	2.09e-17	Alcohol dependence;
SKCM	cis	rs6138458	1.000	rs6138458	chr20:24973769	C/T	cg26195577	chr20:24973756	C20orf3	1.29	8.85	0.71	2.07e-13	Blood protein levels;
SKCM	cis	rs933688	1.000	rs6866191	chr5:90746852	G/A	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.07	8.52	0.69	9.25e-13	Smoking behavior;
SKCM	cis	rs12931792	0.875	rs58175255	chr16:30155290	C/A	cg17640201	chr16:30407289	ZNF48	0.67	5.19	0.51	1.64e-6	Tonsillectomy;
SKCM	cis	rs4523957	0.928	rs375245	chr17:2199754	G/A	cg16513277	chr17:2031491	SMG6	0.68	4.78	0.48	8.02e-6	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs2228479	0.764	rs7184960	chr16:89961661	C/T	cg00800038	chr16:89945340	TCF25	-0.85	-5.19	-0.51	1.65e-6	Skin colour saturation;
SKCM	cis	rs17711722	0.701	rs781145	chr7:65440370	A/C	cg11764359	chr7:65958608	NA	0.87	6.65	0.6	3.58e-9	Calcium levels;
SKCM	cis	rs4268898	0.717	rs3731626	chr2:24427864	G/A	cg06627628	chr2:24431161	ITSN2	-0.84	-6.87	-0.61	1.37e-9	Asthma;
SKCM	cis	rs801193	0.773	rs801207	chr7:66020590	T/C	cg11987759	chr7:65425863	GUSB	0.7	6.12	0.57	3.47e-8	Aortic root size;
SKCM	cis	rs1029738	0.615	rs3757447	chr7:22894735	A/T	cg04907244	chr7:22894795	SNORD93	-0.58	-5.14	-0.5	1.98e-6	Fibrinogen levels;
SKCM	cis	rs28386778	0.897	rs8066754	chr17:61816590	T/C	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.36	0.52	8.06e-7	Prudent dietary pattern;
SKCM	cis	rs4925386	1.000	rs4925382	chr20:60918542	G/C	cg24112000	chr20:60950667	NA	0.63	6.16	0.57	3.02e-8	Colorectal cancer;Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs3820068	0.581	rs72645888	chr1:15929922	C/A	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs9911578	1.000	rs2531732	chr17:56548420	T/A	cg05425664	chr17:57184151	TRIM37	0.69	5.23	0.51	1.38e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs6598955	0.515	rs61776655	chr1:26541430	T/C	cg00938395	chr1:26633206	UBXN11	0.75	5.25	0.51	1.27e-6	Obesity-related traits;
SKCM	cis	rs597539	0.652	rs611046	chr11:68631704	A/G	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.86	6.01	0.56	5.7e-8	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs13010713	0.773	rs4524093	chr2:182055300	G/T	cg21995919	chr2:182322279	ITGA4	-0.53	-5.14	-0.5	2.01e-6	Celiac disease;
SKCM	cis	rs1799949	0.965	rs4793230	chr17:41427403	A/C	cg23758822	chr17:41437982	NA	0.92	7.82	0.66	2.09e-11	Menopause (age at onset);
SKCM	cis	rs933688	1.000	rs6867219	chr5:90718008	T/G	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.1	8.33	0.69	2.14e-12	Smoking behavior;
SKCM	cis	rs11098499	0.866	rs10518329	chr4:120401835	A/G	cg24375607	chr4:120327624	NA	0.63	4.85	0.48	6.19e-6	Corneal astigmatism;
SKCM	cis	rs11098499	0.754	rs1849457	chr4:120254355	A/G	cg09307838	chr4:120376055	NA	0.92	7.01	0.62	7.48e-10	Corneal astigmatism;
SKCM	cis	rs13256369	0.756	rs13282580	chr8:8562903	C/T	cg06636001	chr8:8085503	FLJ10661	0.8	6.11	0.57	3.65e-8	Obesity-related traits;
SKCM	cis	rs36093844	0.706	rs79907592	chr11:85558067	G/A	cg25872744	chr11:85566296	CCDC83	-0.85	-4.77	-0.48	8.27e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs6977660	0.714	rs6977079	chr7:19818207	G/A	cg05791153	chr7:19748676	TWISTNB	0.77	5.02	0.49	3.23e-6	Thyroid stimulating hormone;
SKCM	cis	rs9815354	0.812	rs73081361	chr3:41912535	G/A	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs2739330	0.892	rs4822455	chr22:24255296	C/T	cg24846343	chr22:24311635	DDTL	0.63	5.98	0.56	6.27e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs11098499	0.954	rs6822679	chr4:120402702	A/C	cg09307838	chr4:120376055	NA	0.97	7.65	0.65	4.54e-11	Corneal astigmatism;
SKCM	cis	rs427394	0.802	rs274712	chr5:6723950	G/A	cg10857441	chr5:6722123	POLS	-0.71	-7.33	-0.64	1.82e-10	Menopause (age at onset);
SKCM	cis	rs2731664	0.792	rs337374	chr5:176890416	A/G	cg23176889	chr5:176863531	GRK6	0.52	5.22	0.51	1.43e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2243480	1.000	rs316313	chr7:65593548	G/A	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs6952808	0.692	rs11773316	chr7:2027354	C/T	cg02951883	chr7:2050386	MAD1L1	-0.84	-7.52	-0.65	7.81e-11	Bipolar disorder and schizophrenia;
SKCM	cis	rs7809950	0.817	rs4727678	chr7:107083635	C/G	cg23024343	chr7:107201750	COG5	-0.88	-8.2	-0.68	3.87e-12	Coronary artery disease;
SKCM	trans	rs561341	0.714	rs55925849	chr17:30253085	C/T	cg20587970	chr11:113659929	NA	-1.19	-10.36	-0.76	2.61e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs6463523	0.864	rs73047957	chr7:759373	A/T	cg06242242	chr7:766104	PRKAR1B;HEATR2	1.04	8.41	0.69	1.52e-12	Subjective well-being;
SKCM	cis	rs28595532	0.920	rs115090643	chr4:119729825	C/T	cg21605333	chr4:119757512	SEC24D	1.36	8.05	0.67	7.69e-12	Cannabis dependence symptom count;
SKCM	cis	rs933688	0.938	rs6866923	chr5:90669352	A/C	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.96	6.57	0.6	5.08e-9	Smoking behavior;
SKCM	cis	rs6087990	0.568	rs853854	chr20:31420757	T/A	cg13636640	chr20:31349939	DNMT3B	0.7	5.18	0.51	1.68e-6	Ulcerative colitis;
SKCM	cis	rs6665290	0.669	rs3768419	chr1:227173477	C/G	cg10327440	chr1:227177885	CDC42BPA	-1.07	-9.68	-0.74	5.28e-15	Myeloid white cell count;
SKCM	cis	rs1799949	0.965	rs11650132	chr17:41326087	T/G	cg05368731	chr17:41323189	NBR1	0.88	7.87	0.67	1.65e-11	Menopause (age at onset);
SKCM	cis	rs6665290	0.669	rs3795446	chr1:227180981	C/T	cg10327440	chr1:227177885	CDC42BPA	1.1	10.53	0.77	1.2e-16	Myeloid white cell count;
SKCM	cis	rs3862030	0.720	rs11593526	chr10:104228017	G/T	cg11453585	chr10:104263688	ACTR1A;SUFU	-0.58	-4.82	-0.48	6.94e-6	Waist circumference adjusted for BMI (adjusted for smoking behaviour);Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction);Waist circumference adjusted for body mass index;
SKCM	cis	rs8014204	0.905	rs8014289	chr14:75377352	A/G	cg06637938	chr14:75390232	RPS6KL1	-0.85	-6.51	-0.59	6.76e-9	Caffeine consumption;
SKCM	cis	rs9399135	0.967	rs6925424	chr6:135313948	T/A	cg24558204	chr6:135376177	HBS1L	0.59	5.23	0.51	1.41e-6	Red blood cell count;
SKCM	cis	rs17376456	0.877	rs10059630	chr5:93459807	C/A	cg25358565	chr5:93447407	FAM172A	1.23	7.97	0.67	1.08e-11	Diabetic retinopathy;
SKCM	trans	rs17685	0.753	rs7788763	chr7:75651665	T/C	cg19862616	chr7:65841803	NCRNA00174	-0.93	-8.85	-0.71	2.12e-13	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs9325144	0.555	rs6582576	chr12:38701230	C/T	cg26384229	chr12:38710491	ALG10B	-0.65	-5.05	-0.5	2.83e-6	Morning vs. evening chronotype;
SKCM	cis	rs6500395	1.000	rs4785535	chr16:48707659	A/G	cg04672837	chr16:48644449	N4BP1	-0.63	-5.37	-0.52	8.01e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs514406	0.621	rs881198	chr1:53196440	C/T	cg24675658	chr1:53192096	ZYG11B	0.62	4.98	0.49	3.72e-6	Monocyte count;
SKCM	cis	rs7772486	0.720	rs9403757	chr6:146261271	C/T	cg05347473	chr6:146136440	FBXO30	-0.55	-4.97	-0.49	3.86e-6	Lobe attachment (rater-scored or self-reported);
SKCM	trans	rs1814175	0.791	rs9787917	chr11:49937281	C/T	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs6840360	0.550	rs6816471	chr4:152494869	A/G	cg22705602	chr4:152727874	NA	-0.51	-5.51	-0.53	4.46e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs9911578	0.741	rs2611776	chr17:56819636	G/T	cg05425664	chr17:57184151	TRIM37	-0.7	-5.2	-0.51	1.54e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs6540556	0.954	rs654984	chr1:209937382	C/T	cg05527609	chr1:210001259	C1orf107	0.91	5.14	0.5	1.97e-6	Red blood cell count;
SKCM	cis	rs2999052	0.526	rs1473246	chr3:127769408	G/A	cg09089421	chr3:127803668	RUVBL1	-0.59	-5.69	-0.54	2.14e-7	Hypospadias;
SKCM	cis	rs1153858	1.000	rs60476496	chr15:45713801	C/T	cg21132104	chr15:45694354	SPATA5L1	0.9	7.08	0.63	5.59e-10	Homoarginine levels;
SKCM	cis	rs17065868	1.000	rs9595157	chr13:45144344	A/G	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs7666738	0.830	rs4699601	chr4:99034429	G/A	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7336332	0.511	rs7998978	chr13:27999457	T/C	cg22138327	chr13:27999177	GTF3A	0.91	6.81	0.61	1.82e-9	Weight;
SKCM	cis	rs4819052	0.765	rs2838854	chr21:46680364	A/G	cg20896738	chr21:46707857	POFUT2;LOC642852	0.65	4.89	0.48	5.35e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7523273	1.000	rs12184327	chr1:207978780	A/G	cg22525895	chr1:207977042	MIR29B2	-0.8	-5.96	-0.56	6.91e-8	Schizophrenia;
SKCM	cis	rs1401999	1.000	rs6804242	chr3:183659463	A/T	cg01324343	chr3:183735012	ABCC5	0.91	10.19	0.76	5.48e-16	Anterior chamber depth;
SKCM	cis	rs2439831	0.681	rs524527	chr15:43599116	C/G	cg02155558	chr15:43621948	ADAL;LCMT2	-1.29	-9.4	-0.73	1.78e-14	Lung cancer in ever smokers;
SKCM	cis	rs7666738	0.830	rs13328042	chr4:99055406	A/G	cg17366294	chr4:99064904	C4orf37	0.61	4.98	0.49	3.73e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs116095464	0.619	rs28731093	chr5:241028	T/C	cg22857025	chr5:266934	NA	-1.38	-6.49	-0.59	7.12e-9	Breast cancer;
SKCM	cis	rs7829975	0.711	rs4481596	chr8:8704330	G/C	cg06636001	chr8:8085503	FLJ10661	0.78	6.98	0.62	8.43e-10	Mood instability;
SKCM	cis	rs514406	0.621	rs2003250	chr1:53196666	T/C	cg16325326	chr1:53192061	ZYG11B	-1.0	-12.3	-0.81	6.1e-20	Monocyte count;
SKCM	cis	rs11690935	0.921	rs4668414	chr2:172704291	A/C	cg13550731	chr2:172543902	DYNC1I2	-0.93	-7.97	-0.67	1.07e-11	Schizophrenia;
SKCM	cis	rs2839186	0.771	rs2280959	chr21:47641996	C/G	cg11766577	chr21:47581405	C21orf56	-0.73	-6.37	-0.58	1.24e-8	Testicular germ cell tumor;
SKCM	cis	rs1799949	1.000	rs12950607	chr17:41299928	G/C	cg05368731	chr17:41323189	NBR1	0.89	7.91	0.67	1.38e-11	Menopause (age at onset);
SKCM	cis	rs9475752	0.744	rs17685338	chr6:56850869	C/A	cg06815302	chr6:57335405	PRIM2	0.65	5.03	0.49	3.12e-6	Menarche (age at onset);
SKCM	cis	rs7666738	0.830	rs4292342	chr4:98959870	A/T	cg05340658	chr4:99064831	C4orf37	0.64	4.94	0.49	4.32e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs3784262	0.757	rs74655564	chr15:58325512	G/C	cg12031962	chr15:58353849	ALDH1A2	-0.51	-6.79	-0.61	1.94e-9	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs4555082	0.874	rs11622166	chr14:105759763	C/A	cg13114125	chr14:105738426	BRF1	-0.75	-5.78	-0.55	1.48e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs9911578	0.900	rs8067264	chr17:57182793	G/C	cg12560992	chr17:57184187	TRIM37	1.06	10.05	0.75	1.01e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs6570726	0.791	rs9403734	chr6:145931459	C/G	cg23711669	chr6:146136114	FBXO30	0.87	8.2	0.68	3.83e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs951366	0.789	rs1772148	chr1:205704580	A/T	cg17178900	chr1:205818956	PM20D1	0.73	5.84	0.55	1.13e-7	Menarche (age at onset);
SKCM	cis	rs4423214	1.000	rs732934	chr11:71186476	G/A	cg05163923	chr11:71159392	DHCR7	0.81	7.55	0.65	6.83e-11	Vitamin D levels;
SKCM	cis	rs2180341	0.618	rs6683	chr6:127610021	G/A	cg27446573	chr6:127587934	RNF146	0.7	5.59	0.53	3.22e-7	Breast cancer;
SKCM	cis	rs67311347	1.000	rs2168111	chr3:40395325	T/G	cg00091569	chr3:40428383	ENTPD3	0.61	5.36	0.52	8.37e-7	Renal cell carcinoma;
SKCM	cis	rs11098499	0.955	rs1511019	chr4:120166007	T/G	cg09307838	chr4:120376055	NA	0.95	7.75	0.66	2.84e-11	Corneal astigmatism;
SKCM	cis	rs4919694	1.000	rs76255497	chr10:104651955	T/C	cg04362960	chr10:104952993	NT5C2	0.76	4.85	0.48	6.19e-6	Arsenic metabolism;
SKCM	cis	rs12142240	0.698	rs55971480	chr1:46823206	G/T	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs7216064	1.000	rs8074078	chr17:65838743	A/C	cg12091567	chr17:66097778	LOC651250	-0.77	-5.53	-0.53	4.06e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs9815354	0.767	rs73071238	chr3:41992243	A/G	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs875971	0.929	rs10950041	chr7:65973875	T/C	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs7772486	0.875	rs10457794	chr6:146415608	A/G	cg05347473	chr6:146136440	FBXO30	0.65	5.96	0.56	6.79e-8	Lobe attachment (rater-scored or self-reported);
SKCM	trans	rs11722228	0.508	rs3756227	chr4:10087995	C/A	cg26043149	chr18:55253948	FECH	0.93	7.87	0.67	1.66e-11	Gout;Urate levels;Serum uric acid levels;
SKCM	cis	rs2228479	0.681	rs7196840	chr16:89959647	A/G	cg00800038	chr16:89945340	TCF25	-0.93	-5.57	-0.53	3.49e-7	Skin colour saturation;
SKCM	cis	rs1862618	0.853	rs2113078	chr5:56087190	C/T	cg12311346	chr5:56204834	C5orf35	-0.8	-5.39	-0.52	7.19e-7	Initial pursuit acceleration;
SKCM	cis	rs6951245	1.000	rs79422648	chr7:1080241	T/C	cg03188948	chr7:1209495	NA	1.12	6.25	0.58	2.02e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs11098499	0.866	rs9991221	chr4:120292107	G/C	cg09307838	chr4:120376055	NA	0.98	7.89	0.67	1.52e-11	Corneal astigmatism;
SKCM	cis	rs992157	0.835	rs2292551	chr2:219143229	G/A	cg20019365	chr2:219134978	PNKD;AAMP	-0.72	-6.22	-0.58	2.33e-8	Colorectal cancer;
SKCM	cis	rs875971	1.000	rs2420591	chr7:65912381	T/C	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs2816062	0.760	rs2745319	chr1:18895078	G/A	cg18795169	chr1:18902165	NA	-0.83	-9.02	-0.71	1.01e-13	Urate levels in lean individuals;
SKCM	cis	rs28595532	0.920	rs116149978	chr4:119761069	A/C	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs2243480	1.000	rs4718270	chr7:65202407	A/G	cg18252515	chr7:66147081	NA	-1.32	-8.71	-0.7	3.95e-13	Diabetic kidney disease;
SKCM	cis	rs10504229	0.683	rs56408763	chr8:58137276	G/A	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs7847628	0.587	rs4837796	chr9:123610288	A/G	cg09419670	chr9:123605666	PSMD5;LOC253039	-0.63	-5.61	-0.54	2.93e-7	Birth weight;
SKCM	cis	rs12971120	0.891	rs4891558	chr18:72170359	A/G	cg26446133	chr18:72167187	CNDP2	-0.64	-4.87	-0.48	5.71e-6	Refractive error;
SKCM	cis	rs10870270	1.000	rs11146354	chr10:133774757	A/G	cg17892150	chr10:133769511	PPP2R2D	-0.66	-4.86	-0.48	5.92e-6	Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals;
SKCM	cis	rs17685	0.753	rs6465000	chr7:75787417	G/A	cg16684958	chr7:75615977	POR	0.52	5.03	0.49	3.11e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs17685	0.753	rs1806885	chr7:75785612	T/G	cg01364799	chr7:75623366	TMEM120A	-0.69	-5.59	-0.53	3.22e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7809950	0.678	rs62482499	chr7:106975059	C/G	cg23024343	chr7:107201750	COG5	-0.82	-7.0	-0.62	7.72e-10	Coronary artery disease;
SKCM	cis	rs4523957	0.583	rs2641442	chr17:2035071	C/T	cg16513277	chr17:2031491	SMG6	-0.91	-6.21	-0.58	2.38e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs9916302	0.571	rs28799952	chr17:37533056	C/T	cg07936489	chr17:37558343	FBXL20	0.96	6.76	0.61	2.28e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs9640161	0.742	rs2159236	chr7:150017214	A/G	cg10018233	chr7:150070692	REPIN1	0.69	5.73	0.54	1.78e-7	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs28386778	0.897	rs11079510	chr17:61820902	T/C	cg06873352	chr17:61820015	STRADA	0.76	6.34	0.58	1.38e-8	Prudent dietary pattern;
SKCM	trans	rs637571	0.780	rs677029	chr11:65683531	A/G	cg17712092	chr4:129076599	LARP1B	0.91	8.0	0.67	9.21e-12	Eosinophil percentage of white cells;
SKCM	cis	rs992157	1.000	rs4674280	chr2:219141458	C/G	cg20019365	chr2:219134978	PNKD;AAMP	-0.77	-6.94	-0.62	1e-9	Colorectal cancer;
SKCM	cis	rs2836974	0.899	rs68004583	chr21:40659587	T/C	cg11644478	chr21:40555479	PSMG1	0.83	7.69	0.66	3.66e-11	Cognitive function;
SKCM	cis	rs62238980	0.614	rs79397654	chr22:32468027	C/T	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs72781680	0.948	rs72781652	chr2:24213754	G/A	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	cis	rs2228479	0.850	rs2286393	chr16:89809548	C/A	cg06558623	chr16:89946397	TCF25	1.03	5.59	0.53	3.23e-7	Skin colour saturation;
SKCM	cis	rs8180040	0.903	rs11130124	chr3:47292183	T/C	cg27129171	chr3:47204927	SETD2	0.85	6.39	0.59	1.11e-8	Colorectal cancer;
SKCM	cis	rs9325144	0.534	rs1843887	chr12:38692380	T/C	cg26384229	chr12:38710491	ALG10B	0.78	6.74	0.61	2.48e-9	Morning vs. evening chronotype;
SKCM	cis	rs6089584	0.893	rs6089305	chr20:60571817	T/C	cg23262073	chr20:60523788	NA	-0.51	-4.84	-0.48	6.48e-6	Body mass index;
SKCM	cis	rs10193935	0.892	rs12622152	chr2:42482929	C/A	cg27598129	chr2:42591480	NA	-0.97	-6.7	-0.6	2.93e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7208859	0.623	rs77544470	chr17:28934550	C/A	cg14067834	chr17:29058358	SUZ12P	1.25	5.05	0.5	2.78e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs6582630	0.519	rs7305570	chr12:38349285	G/A	cg26384229	chr12:38710491	ALG10B	0.81	6.56	0.6	5.29e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs28595532	0.920	rs115118317	chr4:119736613	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs644799	0.965	rs607039	chr11:95547086	G/A	cg25622487	chr11:95524042	FAM76B;CEP57	0.66	5.12	0.5	2.18e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs7027203	0.797	rs57882762	chr9:96580825	T/G	cg14598338	chr9:96623480	NA	-0.51	-4.95	-0.49	4.16e-6	DNA methylation (variation);
SKCM	cis	rs748404	0.697	rs564946	chr15:43556272	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	0.7	5.77	0.55	1.53e-7	Lung cancer;
SKCM	cis	rs10504229	0.683	rs61201557	chr8:58138370	T/C	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs8072100	0.713	rs4968257	chr17:45430534	A/G	cg25173405	chr17:45401733	C17orf57	-0.61	-4.81	-0.48	7.08e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs7824557	0.564	rs7828263	chr8:11231886	A/G	cg21775007	chr8:11205619	TDH	-0.6	-4.99	-0.49	3.57e-6	Retinal vascular caliber;
SKCM	cis	rs6951245	0.882	rs10256720	chr7:1210825	C/G	cg03188948	chr7:1209495	NA	1.11	6.38	0.59	1.16e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs2760061	0.545	rs1745423	chr1:228224153	G/T	cg18477163	chr1:228402036	OBSCN	-0.43	-5.35	-0.52	8.4e-7	Diastolic blood pressure;
SKCM	cis	rs7208859	0.623	rs73269913	chr17:29092183	T/C	cg13385521	chr17:29058706	SUZ12P	1.03	5.22	0.51	1.46e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs9943753	0.508	rs2075433	chr12:109833920	A/G	cg19025524	chr12:109796872	NA	-0.63	-5.92	-0.56	8.31e-8	HDL cholesterol;
SKCM	cis	rs1799949	1.000	rs11656097	chr17:41290613	G/T	cg23758822	chr17:41437982	NA	0.92	7.8	0.66	2.3e-11	Menopause (age at onset);
SKCM	cis	rs2013441	1.000	rs972966	chr17:20030992	G/C	cg13482628	chr17:19912719	NA	0.65	5.21	0.51	1.48e-6	Obesity-related traits;
SKCM	cis	rs1832871	0.619	rs262825	chr6:158678631	C/T	cg20364594	chr6:158981615	TMEM181	-0.57	-5.17	-0.5	1.79e-6	Height;
SKCM	cis	rs6809651	0.524	rs7622914	chr3:185790895	T/C	cg00760338	chr3:185826511	ETV5	-0.83	-5.21	-0.51	1.52e-6	Body mass index in physically active individuals;Glomerular filtration rate (creatinine);Body mass index (joint analysis main effects and physical activity interaction);Body mass index;Body mass index in physically inactive individuals;
SKCM	cis	rs6430585	0.528	rs115553816	chr2:136692893	G/A	cg07169764	chr2:136633963	MCM6	1.32	11.41	0.79	2.72e-18	Corneal structure;
SKCM	cis	rs754466	1.000	rs754466	chr10:79680434	A/T	cg17075019	chr10:79541650	NA	-0.71	-5.9	-0.56	8.76e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs9902453	0.967	rs12150261	chr17:28320473	A/C	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.85	-6.23	-0.58	2.22e-8	Coffee consumption (cups per day);
SKCM	cis	rs17345786	0.511	rs12639028	chr3:101346033	G/C	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.78	6.36	0.58	1.26e-8	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9926296	0.542	rs12599531	chr16:89909401	C/T	cg01097406	chr16:89675127	NA	0.48	5.3	0.51	1.05e-6	Vitiligo;
SKCM	cis	rs637571	0.522	rs1786175	chr11:65754808	G/A	cg02427764	chr11:65769310	BANF1;EIF1AD	0.77	5.87	0.55	1.03e-7	Eosinophil percentage of white cells;
SKCM	cis	rs28595532	0.920	rs114966881	chr4:119761078	C/G	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs864745	0.967	rs849135	chr7:28196413	G/A	cg15170557	chr7:28214983	JAZF1	-0.72	-7.29	-0.64	2.17e-10	Crohn's disease;Type 2 diabetes;
SKCM	cis	rs2721195	0.967	rs10108150	chr8:145687475	A/G	cg15320075	chr8:145703422	NA	-0.94	-8.05	-0.67	7.43e-12	Age at first birth;
SKCM	cis	rs72781680	0.528	rs56258075	chr2:24104256	C/G	cg08917208	chr2:24149416	ATAD2B	1.0	5.41	0.52	6.82e-7	Lymphocyte counts;
SKCM	cis	rs6066825	0.644	rs6019380	chr20:47318845	A/G	cg18078177	chr20:47281410	PREX1	0.64	5.2	0.51	1.57e-6	Colorectal cancer;
SKCM	cis	rs362296	0.550	rs3135064	chr4:3285389	T/C	cg24015175	chr4:3319247	RGS12	0.65	6.43	0.59	9.22e-9	Parental longevity (mother's age at death);
SKCM	cis	rs6430585	0.527	rs12467569	chr2:136413847	T/C	cg07169764	chr2:136633963	MCM6	1.02	7.7	0.66	3.66e-11	Corneal structure;
SKCM	cis	rs2239547	0.522	rs2336162	chr3:52951519	C/T	cg11645453	chr3:52864694	ITIH4	-0.73	-6.54	-0.6	5.74e-9	Schizophrenia;
SKCM	cis	rs36093844	0.527	rs17817956	chr11:85761370	G/T	cg25872744	chr11:85566296	CCDC83	-0.81	-4.79	-0.48	7.71e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs2463822	1.000	rs118049526	chr11:62107508	C/T	cg06239285	chr11:62104954	ASRGL1	-1.25	-5.93	-0.56	7.79e-8	Chronic obstructive pulmonary disease-related biomarkers;
SKCM	cis	rs4727027	0.870	rs1534196	chr7:148790591	G/A	cg23583168	chr7:148888333	NA	-0.81	-6.35	-0.58	1.3e-8	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs7247513	0.701	rs8107642	chr19:12766370	C/T	cg11738485	chr19:12877000	HOOK2	0.68	4.95	0.49	4.12e-6	Bipolar disorder;
SKCM	cis	rs28386778	0.897	rs2584610	chr17:61934783	T/C	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.36	0.52	8.06e-7	Prudent dietary pattern;
SKCM	cis	rs950027	0.620	rs1153855	chr15:45660758	C/G	cg10760299	chr15:45669010	GATM	0.57	5.71	0.54	1.99e-7	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs2404602	0.735	rs4886798	chr15:76673226	A/G	cg23625390	chr15:77176239	SCAPER	0.8	7.85	0.66	1.83e-11	Blood metabolite levels;
SKCM	cis	rs7666738	0.606	rs7663216	chr4:99088385	A/C	cg17366294	chr4:99064904	C4orf37	0.59	4.85	0.48	6.14e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1046896	0.731	rs8067667	chr17:80785875	A/G	cg22027946	chr17:80790580	TBCD;ZNF750	0.7	5.29	0.51	1.09e-6	Glycated hemoglobin levels;
SKCM	cis	rs2153535	0.580	rs2184582	chr6:8447793	G/A	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs34779708	0.931	rs7920095	chr10:35303334	G/A	cg03585969	chr10:35415529	CREM	0.75	6.23	0.58	2.2e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs12142240	0.698	rs7515598	chr1:46818479	C/T	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs9303401	0.625	rs10515159	chr17:56802693	G/C	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.16	0.57	2.91e-8	Cognitive test performance;
SKCM	cis	rs7618501	0.665	rs7621352	chr3:50070763	A/C	cg05072774	chr3:49840536	C3orf54	0.65	4.95	0.49	4.22e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs780096	0.527	rs11127044	chr2:27740404	C/G	cg05696406	chr2:27599888	SNX17	0.51	5.09	0.5	2.45e-6	Total body bone mineral density;
SKCM	cis	rs11098499	0.863	rs7699064	chr4:120428309	A/G	cg24375607	chr4:120327624	NA	-0.7	-5.0	-0.49	3.49e-6	Corneal astigmatism;
SKCM	cis	rs7143963	0.832	rs4906272	chr14:103376031	C/T	cg23020514	chr14:103360112	TRAF3	0.75	6.14	0.57	3.25e-8	Body mass index;
SKCM	cis	rs1218582	0.741	rs705094	chr1:154917314	G/A	cg03351412	chr1:154909251	PMVK	0.75	6.28	0.58	1.82e-8	Prostate cancer;
SKCM	cis	rs7666738	0.830	rs17550735	chr4:99014076	T/G	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1506636	0.962	rs1019220	chr7:123365122	G/A	cg03229431	chr7:123269106	ASB15	-0.6	-4.83	-0.48	6.69e-6	Plateletcrit;Platelet count;
SKCM	cis	rs951366	0.677	rs1775140	chr1:205672107	C/A	cg14893161	chr1:205819251	PM20D1	0.91	7.99	0.67	9.88e-12	Menarche (age at onset);
SKCM	cis	rs7666738	0.830	rs7678557	chr4:99057329	A/G	cg05340658	chr4:99064831	C4orf37	0.66	4.87	0.48	5.74e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7666738	0.712	rs34043080	chr4:99008748	G/C	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs12497850	0.931	rs7647813	chr3:48833348	G/T	cg07636037	chr3:49044803	WDR6	0.97	10.25	0.76	4.16e-16	Parkinson's disease;
SKCM	cis	rs9611565	0.608	rs2003816	chr22:42095140	T/G	cg03806693	chr22:41940476	POLR3H	0.91	5.69	0.54	2.12e-7	Vitiligo;
SKCM	cis	rs801193	1.000	rs62466794	chr7:66191579	G/A	cg11764359	chr7:65958608	NA	0.86	6.55	0.6	5.68e-9	Aortic root size;
SKCM	cis	rs4819052	0.679	rs8132135	chr21:46694782	C/T	cg19498844	chr21:46707878	POFUT2;LOC642852	0.83	7.01	0.62	7.55e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs12911832	1.000	rs4774310	chr15:58985164	T/G	cg05156742	chr15:59063176	FAM63B	0.74	5.38	0.52	7.59e-7	Schizophrenia;
SKCM	cis	rs7824557	0.591	rs2572452	chr8:11228254	C/T	cg21775007	chr8:11205619	TDH	-0.65	-5.97	-0.56	6.72e-8	Retinal vascular caliber;
SKCM	cis	rs796364	0.951	rs11675980	chr2:201051150	A/G	cg12253985	chr2:200820533	C2orf60;C2orf47	-0.94	-6.25	-0.58	2e-8	Schizophrenia;
SKCM	cis	rs727563	0.648	rs6002406	chr22:41965237	A/T	cg03806693	chr22:41940476	POLR3H	-1.05	-6.9	-0.62	1.21e-9	Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs6570726	0.935	rs12663205	chr6:145818378	G/A	cg23711669	chr6:146136114	FBXO30	0.7	6.64	0.6	3.72e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1059312	0.808	rs2306683	chr12:129299675	C/G	cg09035930	chr12:129282057	SLC15A4	0.77	8.03	0.67	8.18e-12	Systemic lupus erythematosus;
SKCM	cis	rs1799949	1.000	rs34534709	chr17:41302940	C/G	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.11	-0.57	3.67e-8	Menopause (age at onset);
SKCM	cis	rs2073499	0.872	rs77097132	chr3:50301050	C/T	cg08207895	chr3:50388901	TUSC4;CYB561D2	0.82	4.99	0.49	3.56e-6	Schizophrenia;
SKCM	cis	rs28595532	0.841	rs114965278	chr4:119743694	T/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs2980439	0.870	rs2945230	chr8:8109936	A/G	cg08975724	chr8:8085496	FLJ10661	0.92	7.49	0.65	8.89e-11	Neuroticism;
SKCM	cis	rs933688	1.000	rs4382199	chr5:90744228	A/G	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.07	8.52	0.69	9.25e-13	Smoking behavior;
SKCM	cis	rs2739330	0.892	rs4822455	chr22:24255296	C/T	cg12419862	chr22:24373484	LOC391322	-0.7	-6.38	-0.59	1.15e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs72792276	0.908	rs10478797	chr5:127442066	G/T	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.76	5.57	0.53	3.51e-7	Red cell distribution width;
SKCM	cis	rs1850744	0.826	rs9291607	chr4:9708798	C/G	cg15442990	chr4:9534313	NA	-1.15	-5.11	-0.5	2.25e-6	Economic and political preferences;
SKCM	cis	rs910316	1.000	rs12589376	chr14:75561152	C/T	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.89e-7	Height;
SKCM	cis	rs875971	0.706	rs1643374	chr7:65872682	T/A	cg11987759	chr7:65425863	GUSB	-0.67	-5.85	-0.55	1.1e-7	Aortic root size;
SKCM	cis	rs875971	0.862	rs6460306	chr7:66060793	T/C	cg18876405	chr7:65276391	NA	-0.63	-6.33	-0.58	1.43e-8	Aortic root size;
SKCM	cis	rs7811142	0.720	rs7795656	chr7:99950297	A/T	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.05	5.92	0.56	8.02e-8	Platelet count;
SKCM	cis	rs2836974	0.583	rs8132993	chr21:40716410	T/C	cg17971929	chr21:40555470	PSMG1	0.71	5.83	0.55	1.2e-7	Cognitive function;
SKCM	cis	rs793571	0.590	rs618684	chr15:59115922	A/G	cg05156742	chr15:59063176	FAM63B	0.73	5.08	0.5	2.53e-6	Schizophrenia;
SKCM	cis	rs8180040	0.932	rs11711265	chr3:47558448	T/C	cg16586182	chr3:47516702	SCAP	-0.73	-4.95	-0.49	4.12e-6	Colorectal cancer;
SKCM	cis	rs3087591	0.960	rs2905794	chr17:29470002	G/A	cg24425628	chr17:29625626	OMG;NF1	0.64	5.21	0.51	1.49e-6	Hip circumference;
SKCM	cis	rs28595532	0.920	rs114165587	chr4:119779525	C/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs9880211	0.800	rs79876804	chr3:136494150	A/G	cg21827317	chr3:136751795	NA	-0.74	-5.43	-0.52	6.11e-7	Body mass index;Height;
SKCM	cis	rs17345786	1.000	rs58907984	chr3:101305170	T/G	cg12386194	chr3:101231763	SENP7	0.79	6.03	0.56	5.2e-8	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs873946	0.517	rs7071784	chr10:134559980	T/C	cg00988841	chr10:134556463	INPP5A	0.62	4.99	0.49	3.52e-6	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs17711722	0.585	rs6942660	chr7:65302406	C/T	cg11764359	chr7:65958608	NA	0.88	6.43	0.59	9.56e-9	Calcium levels;
SKCM	cis	rs2999052	0.526	rs11717102	chr3:127727752	A/G	cg09089421	chr3:127803668	RUVBL1	0.57	5.15	0.5	1.9e-6	Hypospadias;
SKCM	cis	rs9815354	0.812	rs73077365	chr3:41851559	T/C	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs9788682	1.000	rs7181245	chr15:78814389	C/T	cg06917634	chr15:78832804	PSMA4	-0.85	-5.3	-0.51	1.05e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs5769765	0.908	rs9627788	chr22:50300438	T/C	cg22709217	chr22:50311962	ALG12;CRELD2	-0.84	-5.85	-0.55	1.11e-7	Schizophrenia;
SKCM	cis	rs62238980	0.614	rs77896321	chr22:32413371	C/T	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs11673344	0.797	rs3745768	chr19:37488809	A/G	cg07624650	chr19:37064219	ZNF529	-0.78	-4.82	-0.48	7.05e-6	Obesity-related traits;
SKCM	cis	rs9902453	0.817	rs1842026	chr17:28188111	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.83	5.76	0.55	1.61e-7	Coffee consumption (cups per day);
SKCM	cis	rs4481887	0.927	rs7534188	chr1:248434303	C/T	cg00666640	chr1:248458726	OR2T12	-0.66	-4.95	-0.49	4.12e-6	Common traits (Other);
SKCM	cis	rs72634258	0.699	rs12128234	chr1:8170219	T/C	cg00042356	chr1:8021962	PARK7	-0.84	-5.53	-0.53	4.17e-7	Inflammatory bowel disease;
SKCM	cis	rs2836974	1.000	rs2836974	chr21:40663181	A/G	cg17971929	chr21:40555470	PSMG1	-0.86	-8.49	-0.69	1.04e-12	Cognitive function;
SKCM	cis	rs514406	0.929	rs1672909	chr1:53340824	A/G	cg16325326	chr1:53192061	ZYG11B	0.96	10.07	0.75	9.32e-16	Monocyte count;
SKCM	cis	rs875971	0.862	rs4149461	chr7:65744732	T/C	cg11764359	chr7:65958608	NA	-0.82	-7.87	-0.67	1.68e-11	Aortic root size;
SKCM	cis	rs7772486	0.622	rs1292333	chr6:145982344	C/T	cg23711669	chr6:146136114	FBXO30	-0.9	-9.54	-0.73	9.76e-15	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs35306767	0.855	rs34318754	chr10:890714	G/A	cg20503657	chr10:835505	NA	0.79	5.57	0.53	3.52e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs7937682	0.593	rs1944123	chr11:111356407	T/C	cg09085632	chr11:111637200	PPP2R1B	0.71	5.46	0.53	5.42e-7	Primary sclerosing cholangitis;
SKCM	cis	rs1707322	0.721	rs10890343	chr1:46157922	C/T	cg03146154	chr1:46216737	IPP	0.84	6.2	0.57	2.51e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs9581857	0.512	rs9652091	chr13:28073509	G/A	cg22138327	chr13:27999177	GTF3A	0.86	6.15	0.57	3.13e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs8067545	0.516	rs11869258	chr17:20206898	G/A	cg13482628	chr17:19912719	NA	-0.67	-5.7	-0.54	2.04e-7	Schizophrenia;
SKCM	cis	rs28595532	0.920	rs114639588	chr4:119736176	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs1348850	0.914	rs1374437	chr2:178363423	T/C	cg02961200	chr2:178257176	LOC100130691;AGPS	0.82	5.92	0.56	8.05e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs72634258	0.945	rs12735338	chr1:8078569	T/C	cg00042356	chr1:8021962	PARK7	1.09	7.71	0.66	3.35e-11	Inflammatory bowel disease;
SKCM	cis	rs1552244	0.938	rs56274701	chr3:10167790	G/A	cg02579736	chr3:10068473	FANCD2;CIDECP	1.16	6.72	0.61	2.65e-9	Alzheimer's disease;
SKCM	cis	rs686320	1.000	rs616599	chr11:65254025	T/G	cg13521124	chr11:66064082	TMEM151A	0.79	4.83	0.48	6.75e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs2255932	1.000	rs11075	chr3:183213236	G/A	cg20852557	chr3:184035519	EIF4G1	-0.65	-5.51	-0.53	4.48e-7	Interleukin-1-beta levels;
SKCM	cis	rs992157	0.710	rs56364928	chr2:219059058	G/A	cg00012203	chr2:219082015	ARPC2	0.85	7.47	0.65	1.01e-10	Colorectal cancer;
SKCM	cis	rs9905704	0.647	rs11650809	chr17:56972741	A/G	cg12560992	chr17:57184187	TRIM37	0.76	6.03	0.56	5.1e-8	Testicular germ cell tumor;
SKCM	cis	rs16854884	0.770	rs13091882	chr3:143818661	C/T	cg06585982	chr3:143692056	C3orf58	0.7	5.58	0.53	3.36e-7	Economic and political preferences (feminism/equality);
SKCM	cis	rs11651000	0.817	rs7502875	chr17:45823227	A/C	cg24803719	chr17:45855879	NA	-0.52	-4.85	-0.48	6.28e-6	IgG glycosylation;
SKCM	cis	rs875971	0.660	rs1860470	chr7:66103694	G/C	cg00343986	chr7:65444356	GUSB	-0.68	-4.99	-0.49	3.65e-6	Aortic root size;
SKCM	cis	rs7666738	0.753	rs13137152	chr4:98938044	A/T	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs3785574	0.582	rs62072238	chr17:61948841	A/T	cg11494091	chr17:61959527	GH2	0.53	4.78	0.48	8.14e-6	Height;
SKCM	cis	rs9910055	0.659	rs7214540	chr17:42256604	A/G	cg13607699	chr17:42295918	UBTF	0.71	5.74	0.55	1.72e-7	Total body bone mineral density;
SKCM	cis	rs4319547	0.586	rs7956480	chr12:122817507	A/G	cg23029597	chr12:123009494	RSRC2	-0.74	-5.22	-0.51	1.43e-6	Body mass index;
SKCM	cis	rs4481887	0.962	rs10749653	chr1:248481384	C/G	cg00666640	chr1:248458726	OR2T12	0.64	5.69	0.54	2.13e-7	Common traits (Other);
SKCM	cis	rs2439831	1.000	rs537115	chr15:43729948	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.14	7.92	0.67	1.34e-11	Lung cancer in ever smokers;
SKCM	cis	rs6547741	1.000	rs10165098	chr2:27796526	C/T	cg27432699	chr2:27873401	GPN1	0.73	6.64	0.6	3.76e-9	Oral cavity cancer;
SKCM	cis	rs1801251	1.000	rs1044480	chr2:233633736	A/G	cg08000102	chr2:233561755	GIGYF2	0.89	7.19	0.63	3.47e-10	Coronary artery disease;
SKCM	cis	rs1348850	0.526	rs4144278	chr2:178412378	C/T	cg27490568	chr2:178487706	NA	0.84	5.52	0.53	4.21e-7	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs2836974	0.602	rs2836987	chr21:40706594	C/T	cg11644478	chr21:40555479	PSMG1	-0.66	-5.44	-0.52	5.98e-7	Cognitive function;
SKCM	cis	rs2033711	0.870	rs1465789	chr19:58946056	C/T	cg13877915	chr19:58951672	ZNF132	0.95	9.91	0.75	1.86e-15	Uric acid clearance;
SKCM	cis	rs7953249	0.564	rs1183910	chr12:121420807	G/A	cg02403541	chr12:121454288	C12orf43	0.67	5.32	0.52	9.74e-7	Invasive epithelial ovarian cancer;High-grade serous ovarian cancer;Chronic obstructive pulmonary disease-related biomarkers;N-glycan levels;Serous invasive ovarian cancer;Epithelial ovarian cancer;
SKCM	cis	rs2204008	0.603	rs4397954	chr12:38089157	T/C	cg26384229	chr12:38710491	ALG10B	0.8	5.91	0.56	8.58e-8	Bladder cancer;
SKCM	cis	rs1799949	1.000	rs8176202	chr17:41230228	G/A	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.06	-0.57	4.62e-8	Menopause (age at onset);
SKCM	cis	rs3771570	1.000	rs17386555	chr2:242371825	G/A	cg07612300	chr2:242033426	MTERFD2;SNED1	0.88	4.93	0.49	4.46e-6	Prostate cancer;
SKCM	cis	rs8180209	0.506	rs12646270	chr4:90857479	G/A	cg04360675	chr4:90630122	NA	0.78	4.86	0.48	5.99e-6	Parkinson's disease;
SKCM	cis	rs7927771	0.864	rs7937331	chr11:47430458	T/C	cg05585544	chr11:47624801	NA	0.57	4.92	0.49	4.76e-6	Subjective well-being;
SKCM	cis	rs2404602	0.647	rs8025991	chr15:77155268	C/T	cg23625390	chr15:77176239	SCAPER	-0.85	-8.34	-0.69	2.02e-12	Blood metabolite levels;
SKCM	cis	rs62103177	0.608	rs613847	chr18:77845644	A/G	cg06309094	chr18:77676213	PQLC1	0.82	5.02	0.49	3.21e-6	Opioid sensitivity;
SKCM	cis	rs9910055	0.529	rs228749	chr17:42174570	A/G	cg09913183	chr17:42254507	C17orf65;ASB16	-0.59	-4.82	-0.48	6.82e-6	Total body bone mineral density;
SKCM	cis	rs6089829	0.926	rs6062395	chr20:61667904	A/G	cg08564027	chr20:61660810	NA	0.63	5.65	0.54	2.46e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs920590	0.679	rs4577973	chr8:19658017	A/G	cg17202879	chr8:19095161	NA	-0.5	-4.87	-0.48	5.67e-6	Acute lymphoblastic leukemia (childhood);
SKCM	cis	rs4523957	0.583	rs2760738	chr17:2024600	A/G	cg16513277	chr17:2031491	SMG6	-0.81	-5.98	-0.56	6.24e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs7666738	0.830	rs10005120	chr4:99038200	A/G	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs12701220	0.894	rs8591	chr7:1036799	C/T	cg02733842	chr7:1102375	C7orf50	-0.58	-4.99	-0.49	3.52e-6	Bronchopulmonary dysplasia;
SKCM	cis	rs67311347	0.869	rs9832311	chr3:40381322	A/T	cg00091569	chr3:40428383	ENTPD3	0.66	5.59	0.54	3.16e-7	Renal cell carcinoma;
SKCM	cis	rs10256972	0.758	rs7799391	chr7:1082566	C/G	cg07308232	chr7:1071921	C7orf50	-0.62	-5.41	-0.52	6.64e-7	Longevity;Endometriosis;
SKCM	cis	rs875971	1.000	rs11971949	chr7:65626014	A/G	cg11764359	chr7:65958608	NA	-0.86	-8.23	-0.68	3.44e-12	Aortic root size;
SKCM	trans	rs3780486	0.713	rs3780489	chr9:33129844	G/T	cg20290983	chr6:43655470	MRPS18A	1.0	11.51	0.79	1.7e-18	IgG glycosylation;
SKCM	cis	rs1577917	0.958	rs12665542	chr6:86544443	G/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.87	-8.71	-0.7	3.92e-13	Response to antipsychotic treatment;
SKCM	cis	rs951366	0.617	rs823075	chr1:205774897	C/T	cg07167872	chr1:205819463	PM20D1	1.01	10.8	0.77	3.79e-17	Menarche (age at onset);
SKCM	cis	rs2836974	0.897	rs8133146	chr21:40614298	T/C	cg11644478	chr21:40555479	PSMG1	0.97	10.08	0.75	8.76e-16	Cognitive function;
SKCM	cis	rs8017423	0.605	rs2149652	chr14:90813429	T/C	cg04374321	chr14:90722782	PSMC1	-0.77	-5.92	-0.56	8.06e-8	Mortality in heart failure;
SKCM	cis	rs1799949	1.000	rs11653460	chr17:41331306	C/T	cg05368731	chr17:41323189	NBR1	0.87	7.74	0.66	3.01e-11	Menopause (age at onset);
SKCM	cis	rs4924935	0.683	rs34413375	chr17:18802028	C/A	cg26378065	chr17:18585709	ZNF286B	-0.86	-5.06	-0.5	2.72e-6	Pancreatic cancer;
SKCM	cis	rs28374715	0.662	rs521890	chr15:41473143	C/T	cg18705301	chr15:41695430	NDUFAF1	-0.93	-7.74	-0.66	2.94e-11	Ulcerative colitis;
SKCM	cis	rs2479724	1.000	rs2254479	chr6:41831143	G/A	cg17623882	chr6:41773611	USP49	-0.73	-6.21	-0.58	2.42e-8	Menarche (age at onset);
SKCM	cis	rs11098499	0.530	rs114866537	chr4:120258608	A/T	cg09307838	chr4:120376055	NA	0.97	8.31	0.69	2.31e-12	Corneal astigmatism;
SKCM	cis	rs7590368	1.000	rs7576898	chr2:10958956	A/G	cg15705551	chr2:10952987	PDIA6	0.76	4.88	0.48	5.52e-6	Educational attainment (years of education);
SKCM	cis	rs2197308	0.610	rs10880837	chr12:37864924	C/T	cg26384229	chr12:38710491	ALG10B	0.82	6.88	0.61	1.35e-9	Morning vs. evening chronotype;
SKCM	cis	rs832540	0.669	rs173764	chr5:56198920	C/T	cg03609598	chr5:56110824	MAP3K1	-0.92	-5.75	-0.55	1.64e-7	Coronary artery disease;
SKCM	cis	rs2836974	0.584	rs7276774	chr21:40628725	T/G	cg11644478	chr21:40555479	PSMG1	-0.8	-7.6	-0.65	5.6e-11	Cognitive function;
SKCM	cis	rs4888262	0.564	rs8062404	chr16:74611675	T/C	cg01733217	chr16:74700730	RFWD3	0.88	7.23	0.63	2.91e-10	Testicular germ cell tumor;
SKCM	cis	rs28386778	0.897	rs2584626	chr17:61903179	A/G	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs6665290	0.558	rs1319103	chr1:227219314	A/G	cg10327440	chr1:227177885	CDC42BPA	-1.07	-8.95	-0.71	1.34e-13	Myeloid white cell count;
SKCM	cis	rs1395	0.922	rs13404446	chr2:27519254	C/T	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.52	4.9	0.49	5.03e-6	Blood metabolite levels;
SKCM	cis	rs2075371	0.611	rs12707154	chr7:134015832	C/T	cg20476274	chr7:133979776	SLC35B4	0.9	8.75	0.7	3.37e-13	Mean platelet volume;
SKCM	cis	rs7399018	1.000	rs7399018	chr12:51610365	C/T	cg25754956	chr12:51612065	POU6F1	-0.74	-5.87	-0.55	9.9e-8	Cisplatin-induced ototoxicity;
SKCM	cis	rs11673344	0.670	rs568654	chr19:37431187	G/A	cg07624650	chr19:37064219	ZNF529	-0.8	-5.23	-0.51	1.41e-6	Obesity-related traits;
SKCM	cis	rs116095464	0.558	rs6555058	chr5:226376	C/T	cg22857025	chr5:266934	NA	1.34	6.72	0.61	2.7e-9	Breast cancer;
SKCM	cis	rs9309711	0.544	rs9752130	chr2:3488502	A/G	cg15506890	chr2:3487001	NA	-0.62	-4.78	-0.48	8.07e-6	Neurofibrillary tangles;
SKCM	cis	rs2439831	0.681	rs1837960	chr15:43698602	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.21	7.84	0.66	1.9e-11	Lung cancer in ever smokers;
SKCM	cis	rs10504229	0.954	rs903717	chr8:58167856	A/G	cg22535103	chr8:58192502	C8orf71	-0.68	-4.82	-0.48	7.06e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs2721195	0.683	rs6989368	chr8:145813457	A/G	cg11211951	chr8:145729740	GPT	0.56	5.0	0.49	3.39e-6	Age at first birth;
SKCM	cis	rs6952808	1.000	rs10233560	chr7:1885415	T/C	cg02951883	chr7:2050386	MAD1L1	-0.71	-5.35	-0.52	8.61e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs1348850	0.914	rs4893950	chr2:178304885	T/C	cg02961200	chr2:178257176	LOC100130691;AGPS	0.83	6.14	0.57	3.21e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs654950	0.783	rs639298	chr1:42001530	A/G	cg06885757	chr1:42089581	HIVEP3	-0.59	-6.35	-0.58	1.32e-8	Airway imaging phenotypes;
SKCM	cis	rs9611565	0.694	rs2142505	chr22:41820541	A/G	cg03806693	chr22:41940476	POLR3H	1.09	6.86	0.61	1.46e-9	Vitiligo;
SKCM	cis	rs951366	0.559	rs823101	chr1:205667006	T/C	cg14893161	chr1:205819251	PM20D1	0.79	6.13	0.57	3.42e-8	Menarche (age at onset);
SKCM	cis	rs9303401	0.659	rs12952325	chr17:56899371	G/A	cg10487724	chr17:56770010	TEX14;RAD51C	0.87	6.18	0.57	2.75e-8	Cognitive test performance;
SKCM	cis	rs2153535	0.580	rs7767926	chr6:8453557	A/G	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs9818758	0.607	rs35060561	chr3:49255503	T/C	cg00383909	chr3:49044727	WDR6	0.95	5.43	0.52	6.25e-7	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs2180341	0.960	rs7753913	chr6:127671296	A/G	cg24812749	chr6:127587940	RNF146	0.83	7.24	0.63	2.76e-10	Breast cancer;
SKCM	cis	rs6952808	0.964	rs6945719	chr7:1932688	G/A	cg21782813	chr7:2030301	MAD1L1	0.56	5.64	0.54	2.64e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs4888262	0.526	rs8062959	chr16:74627628	T/C	cg01733217	chr16:74700730	RFWD3	0.92	7.11	0.63	4.82e-10	Testicular germ cell tumor;
SKCM	cis	rs796364	1.000	rs281783	chr2:200751582	G/A	cg12253985	chr2:200820533	C2orf60;C2orf47	0.85	5.39	0.52	7.18e-7	Schizophrenia;
SKCM	cis	rs7927771	0.832	rs1317164	chr11:47419757	G/T	cg01152729	chr11:47593274	PTPMT1	-0.51	-4.92	-0.49	4.64e-6	Subjective well-being;
SKCM	cis	rs801193	1.000	rs2003301	chr7:66147656	G/C	cg11764359	chr7:65958608	NA	-0.86	-6.6	-0.6	4.52e-9	Aortic root size;
SKCM	cis	rs208515	0.525	rs1351866	chr6:66696969	A/G	cg07460842	chr6:66804631	NA	0.93	6.34	0.58	1.37e-8	Exhaled nitric oxide levels;
SKCM	cis	rs7336332	0.598	rs9581852	chr13:28013748	A/G	cg22138327	chr13:27999177	GTF3A	0.9	6.4	0.59	1.07e-8	Weight;
SKCM	trans	rs3780486	0.846	rs12554995	chr9:33132044	A/G	cg04842962	chr6:43655489	MRPS18A	1.03	10.85	0.78	2.95e-17	IgG glycosylation;
SKCM	cis	rs7215564	0.908	rs2315923	chr17:78693678	A/G	cg16980736	chr17:78789706	RPTOR	-0.87	-4.81	-0.48	7.12e-6	Myopia (pathological);
SKCM	cis	rs4423214	0.879	rs1790330	chr11:71147825	C/T	cg05163923	chr11:71159392	DHCR7	-0.7	-6.35	-0.58	1.35e-8	Vitamin D levels;
SKCM	cis	rs58688157	0.960	rs10902178	chr11:612843	T/G	cg17114584	chr11:613792	IRF7	0.74	5.0	0.49	3.51e-6	Systemic lupus erythematosus;
SKCM	cis	rs9788721	0.836	rs17483686	chr15:78733390	A/T	cg18825076	chr15:78729989	IREB2	-0.61	-4.85	-0.48	6.1e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;Emphysema imaging phenotypes;Emphysema distribution in smoking;Local histogram emphysema pattern;Post bronchodilator FEV1/FVC ratio in COPD;
SKCM	cis	rs514406	0.929	rs485631	chr1:53330245	A/G	cg24675658	chr1:53192096	ZYG11B	-0.62	-4.8	-0.48	7.64e-6	Monocyte count;
SKCM	cis	rs2921036	0.529	rs2979192	chr8:8338147	C/T	cg06636001	chr8:8085503	FLJ10661	0.7	5.44	0.52	5.85e-7	Neuroticism;
SKCM	cis	rs9324022	0.580	rs10151519	chr14:101175798	G/A	cg18089426	chr14:101175970	NA	0.69	5.17	0.5	1.79e-6	Plateletcrit;
SKCM	cis	rs2295499	0.738	rs34108851	chr4:2730710	T/C	cg19433769	chr4:2420260	ZFYVE28	0.66	4.91	0.49	4.85e-6	Cognitive ability;Cognitive ability (multi-trait analysis);Intelligence (multi-trait analysis);
SKCM	cis	rs910316	0.967	rs11159121	chr14:75666029	A/T	cg11812906	chr14:75593930	NEK9	-0.72	-5.73	-0.54	1.83e-7	Height;
SKCM	cis	rs6545883	0.929	rs778154	chr2:61646631	T/C	cg15711740	chr2:61764176	XPO1	0.7	4.93	0.49	4.5e-6	Tuberculosis;
SKCM	cis	rs9796	0.689	rs13329537	chr15:41449211	C/G	cg18705301	chr15:41695430	NDUFAF1	0.7	5.0	0.49	3.46e-6	Menopause (age at onset);
SKCM	cis	rs4803468	1.000	rs4803463	chr19:41911040	C/G	cg14132834	chr19:41945861	ATP5SL	-0.77	-6.08	-0.57	4.18e-8	Height;
SKCM	cis	rs11718455	0.585	rs17076170	chr3:43917946	C/T	cg21419209	chr3:44054225	NA	-0.62	-5.06	-0.5	2.71e-6	Coronary artery disease;
SKCM	cis	rs11764590	0.756	rs17132130	chr7:2108036	G/C	cg23422044	chr7:1970798	MAD1L1	-0.86	-5.96	-0.56	6.86e-8	Neuroticism;
SKCM	cis	rs2243480	1.000	rs465359	chr7:65558164	C/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs873946	0.504	rs12775990	chr10:134575836	C/T	cg27286337	chr10:134555280	INPP5A	1.04	9.17	0.72	5.05e-14	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs17685	0.672	rs1639623	chr7:75707951	A/G	cg16684958	chr7:75615977	POR	0.57	5.54	0.53	4e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs9916302	0.904	rs6503506	chr17:37524653	C/A	cg07936489	chr17:37558343	FBXL20	0.85	7.3	0.64	2.13e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs1267303	0.642	rs3737740	chr1:47000596	G/A	cg25110126	chr1:46999211	NA	0.75	5.57	0.53	3.51e-7	Monobrow;
SKCM	cis	rs7613875	0.578	rs4688753	chr3:50074773	A/G	cg24110177	chr3:50126178	RBM5	0.74	5.95	0.56	7.25e-8	Body mass index;
SKCM	cis	rs589448	0.933	rs2249093	chr12:69753512	G/C	cg14784868	chr12:69753453	YEATS4	0.84	7.65	0.65	4.54e-11	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs1850744	0.536	rs6855045	chr4:9583518	T/C	cg15442990	chr4:9534313	NA	1.18	4.96	0.49	4e-6	Economic and political preferences;
SKCM	cis	rs6951245	0.808	rs79672483	chr7:994756	G/A	cg18402987	chr7:1209562	NA	1.07	5.36	0.52	8.29e-7	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs453301	0.624	rs2915251	chr8:8867411	G/C	cg15556689	chr8:8085844	FLJ10661	0.71	5.46	0.53	5.46e-7	Joint mobility (Beighton score);
SKCM	cis	rs1005277	0.579	rs2472178	chr10:38384750	T/C	cg25427524	chr10:38739819	LOC399744	-0.68	-6.49	-0.59	7.18e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs55823223	0.618	rs11867339	chr17:73862093	A/G	cg08125733	chr17:73851984	WBP2	1.1	6.1	0.57	3.75e-8	Psoriasis;
SKCM	cis	rs7633770	0.805	rs12330414	chr3:46662428	T/C	cg11219411	chr3:46661640	NA	0.74	7.44	0.64	1.13e-10	Coronary artery disease;
SKCM	cis	rs2952156	1.000	rs2643195	chr17:37853118	A/G	cg20243544	chr17:37824526	PNMT	0.7	5.4	0.52	6.94e-7	Asthma;
SKCM	cis	rs4237845	0.537	rs7312623	chr12:58262523	G/T	cg02175503	chr12:58329896	NA	0.73	5.92	0.56	8.27e-8	Intelligence (multi-trait analysis);
SKCM	trans	rs561341	0.830	rs7218801	chr17:30217778	A/G	cg20587970	chr11:113659929	NA	1.07	8.37	0.69	1.77e-12	Hip circumference adjusted for BMI;
SKCM	cis	rs1805008	0.564	rs17226082	chr16:89862155	G/C	cg02628002	chr16:89649608	CPNE7	1.08	4.92	0.49	4.76e-6	Skin colour saturation;
SKCM	cis	rs66725070	1	rs66725070	chr15:58267416	GACAT/G	cg12031962	chr15:58353849	ALDH1A2	-0.51	-6.6	-0.6	4.46e-9	Barrett's esophagus;
SKCM	cis	rs36093844	0.706	rs76852274	chr11:85543760	T/G	cg25872744	chr11:85566296	CCDC83	-0.85	-4.77	-0.48	8.27e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs7666738	0.830	rs13106434	chr4:98991651	T/A	cg05340658	chr4:99064831	C4orf37	0.67	5.14	0.5	1.98e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7633857	0.532	rs9873705	chr3:160768818	A/T	cg03342759	chr3:160939853	NMD3	-0.66	-5.12	-0.5	2.16e-6	Educational attainment (years of education);
SKCM	cis	rs7772486	0.754	rs9386134	chr6:146145508	G/A	cg05347473	chr6:146136440	FBXO30	0.59	5.52	0.53	4.35e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7666738	0.830	rs13137859	chr4:99050319	A/G	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6088590	1.000	rs3787222	chr20:33333040	T/A	cg24642439	chr20:33292090	TP53INP2	1.02	7.56	0.65	6.73e-11	Coronary artery disease;
SKCM	cis	rs12142240	0.698	rs72677596	chr1:46833930	C/T	cg10495392	chr1:46806563	NSUN4	0.75	5.6	0.54	3.1e-7	Menopause (age at onset);
SKCM	cis	rs6951245	0.935	rs61753396	chr7:1105372	A/G	cg24642844	chr7:1081250	C7orf50	-0.93	-6.22	-0.58	2.28e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs6138458	0.626	rs6050261	chr20:25014206	C/T	cg26195577	chr20:24973756	C20orf3	0.88	5.67	0.54	2.36e-7	Blood protein levels;
SKCM	cis	rs35306767	0.953	rs11253517	chr10:970524	A/G	cg26597838	chr10:835615	NA	-0.67	-5.45	-0.53	5.67e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs56235845	0.685	rs35630910	chr5:176757841	A/C	cg06060754	chr5:176797920	RGS14	0.74	6.73	0.61	2.55e-9	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs11098499	0.954	rs1480931	chr4:120395809	G/T	cg09307838	chr4:120376055	NA	0.92	7.44	0.64	1.14e-10	Corneal astigmatism;
SKCM	cis	rs2811415	0.597	rs9839092	chr3:127742108	C/T	cg09089421	chr3:127803668	RUVBL1	0.99	8.52	0.69	9.09e-13	Lung function (FEV1/FVC);
SKCM	cis	rs1003719	0.762	rs2835590	chr21:38463406	A/G	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs6951245	0.580	rs77101766	chr7:1122438	A/G	cg03188948	chr7:1209495	NA	0.83	5.83	0.55	1.19e-7	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7635838	0.718	rs2594991	chr3:11362704	G/A	cg00170343	chr3:11313890	ATG7	0.72	5.5	0.53	4.68e-7	HDL cholesterol;
SKCM	cis	rs11945232	0.624	rs10035024	chr4:88367469	C/T	cg23841344	chr4:88312519	HSD17B11	-0.75	-4.97	-0.49	3.89e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7945705	0.747	rs1980429	chr11:9010474	C/A	cg13070366	chr11:9386451	NA	0.62	5.33	0.52	9.13e-7	Hemoglobin concentration;
SKCM	trans	rs3780486	0.846	rs6476402	chr9:33148552	G/A	cg04842962	chr6:43655489	MRPS18A	0.95	10.49	0.76	1.46e-16	IgG glycosylation;
SKCM	cis	rs55962025	0.883	rs362273	chr4:3227419	A/G	cg09735869	chr4:3319127	RGS12	-0.73	-5.58	-0.53	3.31e-7	Parental longevity (mother's age at death);
SKCM	cis	rs875971	0.862	rs1167390	chr7:65575893	G/A	cg18876405	chr7:65276391	NA	-0.65	-6.63	-0.6	3.96e-9	Aortic root size;
SKCM	cis	rs10754283	0.967	rs1934045	chr1:90107799	A/C	cg21401794	chr1:90099060	LRRC8C	-0.74	-6.52	-0.59	6.4e-9	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs2921073	0.510	rs2976945	chr8:8270871	G/T	cg08975724	chr8:8085496	FLJ10661	0.62	4.85	0.48	6.28e-6	Parkinson's disease;
SKCM	cis	rs7635838	0.686	rs347588	chr3:11287504	C/T	cg00170343	chr3:11313890	ATG7	0.8	5.69	0.54	2.11e-7	HDL cholesterol;
SKCM	cis	rs2228479	0.867	rs34272502	chr16:89949000	G/C	cg00800038	chr16:89945340	TCF25	-0.93	-5.34	-0.52	8.73e-7	Skin colour saturation;
SKCM	cis	rs28386778	1.000	rs3020613	chr17:61955983	A/G	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.11	10.96	0.78	1.87e-17	Prudent dietary pattern;
SKCM	cis	rs11098499	0.697	rs6832410	chr4:120296800	A/G	cg09307838	chr4:120376055	NA	0.97	7.49	0.65	9.08e-11	Corneal astigmatism;
SKCM	cis	rs62238980	0.614	rs75321866	chr22:32460707	C/T	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs2153535	0.541	rs9392222	chr6:8467649	G/A	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs870825	0.929	rs870822	chr4:185588200	C/T	cg04058563	chr4:185651563	MLF1IP	1.2	6.16	0.57	2.99e-8	Blood protein levels;
SKCM	cis	rs10818894	1.000	rs10818894	chr9:126695770	A/G	cg16191174	chr9:126692580	DENND1A	-0.82	-7.49	-0.65	9.05e-11	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU);
SKCM	cis	rs4665809	0.589	rs4665842	chr2:26448954	A/G	cg26119090	chr2:26468346	HADHA;HADHB	-1.06	-8.39	-0.69	1.66e-12	Gut microbiome composition (summer);
SKCM	cis	rs4072980	0.545	rs16824518	chr1:38415315	A/C	cg12658694	chr1:38397304	INPP5B	-0.68	-4.81	-0.48	7.24e-6	Coronary artery disease;
SKCM	cis	rs2404602	0.591	rs11635162	chr15:76951105	C/T	cg23625390	chr15:77176239	SCAPER	-0.86	-8.0	-0.67	9.21e-12	Blood metabolite levels;
SKCM	cis	rs2228479	0.764	rs7191836	chr16:89961597	T/C	cg06558623	chr16:89946397	TCF25	1.27	7.17	0.63	3.78e-10	Skin colour saturation;
SKCM	cis	rs62238980	0.614	rs79065504	chr22:32486442	A/G	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs2439831	0.867	rs3213991	chr15:43670280	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.22	8.33	0.69	2.19e-12	Lung cancer in ever smokers;
SKCM	cis	rs3845702	1.000	rs3845697	chr2:180798553	C/T	cg01881094	chr2:180872142	CWC22	1.02	5.38	0.52	7.71e-7	Schizophrenia;
SKCM	cis	rs7193541	0.646	rs4888267	chr16:74687906	A/G	cg01733217	chr16:74700730	RFWD3	1.02	11.62	0.8	1.08e-18	Multiple myeloma;
SKCM	cis	rs9911578	0.842	rs12450766	chr17:56832965	G/C	cg12560992	chr17:57184187	TRIM37	-0.85	-6.22	-0.58	2.35e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs614226	0.516	rs1794748	chr12:120953758	A/G	cg01236616	chr12:121019343	POP5	1.34	8.54	0.7	8.29e-13	Type 1 diabetes nephropathy;
SKCM	cis	rs10256972	0.721	rs6975972	chr7:1070468	A/G	cg16145915	chr7:1198662	ZFAND2A	-0.46	-5.54	-0.53	3.94e-7	Longevity;Endometriosis;
SKCM	cis	rs2228479	0.681	rs8044906	chr16:89969603	T/C	cg00800038	chr16:89945340	TCF25	-0.95	-5.72	-0.54	1.9e-7	Skin colour saturation;
SKCM	cis	rs1577917	0.958	rs2197648	chr6:86543887	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.33	-0.52	9.19e-7	Response to antipsychotic treatment;
SKCM	cis	rs1707322	0.758	rs10789474	chr1:46250040	G/T	cg03146154	chr1:46216737	IPP	0.81	5.78	0.55	1.47e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs6570726	0.935	rs387965	chr6:145869366	A/G	cg23711669	chr6:146136114	FBXO30	0.7	6.76	0.61	2.23e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs3008870	1.000	rs3008873	chr1:67425770	G/A	cg08660285	chr1:67390436	MIER1;WDR78	0.92	6.05	0.57	4.69e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs6121246	0.954	rs6060992	chr20:30431255	G/T	cg11595048	chr20:30225325	COX4I2	0.65	5.03	0.49	3.1e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs651907	0.967	rs641432	chr3:101587566	C/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.74	5.96	0.56	7.05e-8	Colorectal cancer;
SKCM	cis	rs7829975	0.688	rs7837587	chr8:8378992	T/C	cg15556689	chr8:8085844	FLJ10661	0.85	7.66	0.66	4.35e-11	Mood instability;
SKCM	cis	rs9485372	1.000	rs59574684	chr6:149606514	C/T	cg03072286	chr6:150262044	ULBP2	-0.55	-4.89	-0.48	5.3e-6	Breast cancer;
SKCM	cis	rs12714314	0.560	rs3748988	chr2:1946914	A/G	cg22350835	chr2:1868857	MYT1L	0.6	5.7	0.54	2.04e-7	Type 2 diabetes (age of onset);
SKCM	cis	rs2153535	0.580	rs9379213	chr6:8474945	G/A	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs7149337	0.805	rs2999354	chr14:51607179	C/G	cg23942311	chr14:51606299	NA	0.65	7.48	0.65	9.58e-11	Cancer;
SKCM	cis	rs9868809	0.505	rs35064573	chr3:48740280	C/A	cg00383909	chr3:49044727	WDR6	0.89	5.09	0.5	2.44e-6	Ulcerative colitis;Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs1577917	0.740	rs2842604	chr6:86336300	T/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.83	-7.64	-0.65	4.74e-11	Response to antipsychotic treatment;
SKCM	trans	rs1814175	0.781	rs28681334	chr11:50051177	C/T	cg03929089	chr4:120376271	NA	-0.93	-8.77	-0.7	3.08e-13	Height;
SKCM	cis	rs6952808	1.000	rs4449693	chr7:1884630	G/C	cg04267008	chr7:1944627	MAD1L1	-0.76	-5.45	-0.53	5.61e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs28595532	0.920	rs114390336	chr4:119771452	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs9796	0.840	rs1009913	chr15:41331050	C/T	cg00616447	chr15:41694635	NDUFAF1	-0.71	-4.97	-0.49	3.83e-6	Menopause (age at onset);
SKCM	cis	rs8103278	0.826	rs11669442	chr19:46374557	A/G	cg11657440	chr19:46296263	DMWD	-0.74	-4.9	-0.49	5.06e-6	Coronary artery disease;
SKCM	cis	rs28595532	0.748	rs72670249	chr4:119336823	G/T	cg21605333	chr4:119757512	SEC24D	0.95	4.91	0.49	4.92e-6	Cannabis dependence symptom count;
SKCM	cis	rs58688157	0.880	rs12272314	chr11:590648	A/G	cg17114584	chr11:613792	IRF7	0.76	4.95	0.49	4.12e-6	Systemic lupus erythematosus;
SKCM	cis	rs55962025	0.804	rs362268	chr4:3242148	C/G	cg21096898	chr4:3318625	RGS12	-0.72	-5.61	-0.54	2.98e-7	Parental longevity (mother's age at death);
SKCM	cis	rs7599312	0.534	rs2371615	chr2:213405660	G/T	cg20637307	chr2:213403960	ERBB4	0.76	5.6	0.54	3.12e-7	BMI (adjusted for smoking behaviour);BMI in non-smokers;Body mass index;Body mass index (joint analysis main effects and smoking interaction);
SKCM	cis	rs12477438	0.765	rs12468807	chr2:99691994	C/A	cg26064155	chr2:99771622	LIPT1;TSGA10	-0.72	-4.86	-0.48	6e-6	Chronic sinus infection;
SKCM	cis	rs2228479	0.717	rs17226274	chr16:89850170	C/T	cg00800038	chr16:89945340	TCF25	-0.96	-5.08	-0.5	2.52e-6	Skin colour saturation;
SKCM	cis	rs2228479	1.000	rs12596492	chr16:89957169	T/G	cg06558623	chr16:89946397	TCF25	1.12	5.64	0.54	2.58e-7	Skin colour saturation;
SKCM	cis	rs908922	0.676	rs6687126	chr1:152530894	T/G	cg09873164	chr1:152488093	CRCT1	0.72	5.62	0.54	2.85e-7	Hair morphology;
SKCM	cis	rs2033711	0.840	rs4801590	chr19:58961813	G/C	cg03735888	chr19:58951602	ZNF132	0.71	6.38	0.59	1.15e-8	Uric acid clearance;
SKCM	cis	rs12986445	0.894	rs12713700	chr2:26135996	G/T	cg07291958	chr2:26785531	C2orf70	0.57	5.18	0.51	1.68e-6	Multiple myeloma and monoclonal gammopathy;Multiple myeloma;
SKCM	cis	rs2841277	0.708	rs11623422	chr14:105407031	A/G	cg19901468	chr14:105411992	AHNAK2	-0.98	-7.76	-0.66	2.7e-11	Rheumatoid arthritis;
SKCM	cis	rs9790314	1.000	rs975323	chr3:161021322	A/G	cg03342759	chr3:160939853	NMD3	-0.72	-7.87	-0.67	1.65e-11	Morning vs. evening chronotype;
SKCM	cis	rs2013441	1.000	rs2526460	chr17:20086352	G/A	cg13482628	chr17:19912719	NA	-0.67	-5.24	-0.51	1.32e-6	Obesity-related traits;
SKCM	cis	rs17685	0.712	rs60721456	chr7:75743820	T/A	cg01364799	chr7:75623366	TMEM120A	-0.66	-5.17	-0.5	1.78e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs6582630	0.555	rs10785443	chr12:38463792	A/C	cg26384229	chr12:38710491	ALG10B	0.8	6.28	0.58	1.77e-8	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs1401999	1.000	rs1533684	chr3:183635815	A/G	cg01324343	chr3:183735012	ABCC5	0.89	9.99	0.75	1.35e-15	Anterior chamber depth;
SKCM	cis	rs394563	0.781	rs61516098	chr6:149794289	A/T	cg03678062	chr6:149772716	ZC3H12D	-0.48	-4.94	-0.49	4.4e-6	Dupuytren's disease;
SKCM	cis	rs62238980	0.614	rs76474221	chr22:32415212	C/G	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs6495122	0.699	rs4886410	chr15:75065644	G/C	cg14664628	chr15:75095509	CSK	-0.95	-6.96	-0.62	9.26e-10	Caffeine consumption;Diastolic blood pressure;Coffee consumption;
SKCM	cis	rs2404602	0.583	rs2176623	chr15:76568579	C/T	cg22467129	chr15:76604101	ETFA	-0.63	-5.2	-0.51	1.58e-6	Blood metabolite levels;
SKCM	cis	rs7809950	0.637	rs2701685	chr7:107299584	A/G	cg23024343	chr7:107201750	COG5	0.72	6.28	0.58	1.75e-8	Coronary artery disease;
SKCM	cis	rs2811415	0.597	rs2053014	chr3:127760006	A/G	cg09089421	chr3:127803668	RUVBL1	0.99	8.52	0.69	9.09e-13	Lung function (FEV1/FVC);
SKCM	cis	rs9788682	1.000	rs7163730	chr15:78814681	A/G	cg06917634	chr15:78832804	PSMA4	-0.85	-5.3	-0.51	1.05e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	trans	rs1814175	0.645	rs28445479	chr11:50047999	A/G	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs1878931	0.507	rs4429296	chr16:3408277	T/G	cg26668626	chr16:3451006	ZNF174;ZNF434	-0.82	-5.78	-0.55	1.44e-7	Body mass index (adult);
SKCM	cis	rs2777491	0.915	rs9302109	chr15:41612180	G/T	cg18705301	chr15:41695430	NDUFAF1	-0.96	-9.11	-0.72	6.65e-14	Ulcerative colitis;
SKCM	cis	rs6547741	1.000	rs6718128	chr2:27833752	A/G	cg27432699	chr2:27873401	GPN1	-0.74	-6.64	-0.6	3.83e-9	Oral cavity cancer;
SKCM	cis	rs78456975	0.574	rs13412980	chr2:1545231	C/A	cg01028140	chr2:1542097	TPO	-0.6	-5.63	-0.54	2.78e-7	Placebo response in major depressive disorder (% change in symptom score);
SKCM	cis	rs1865760	0.516	rs9393683	chr6:26066198	A/G	cg16482183	chr6:26056742	HIST1H1C	0.61	4.85	0.48	6.08e-6	Height;
SKCM	cis	rs7020830	0.898	rs13289199	chr9:37278064	A/T	cg14294708	chr9:37120828	ZCCHC7	1.01	9.52	0.73	1.08e-14	Schizophrenia;
SKCM	cis	rs2204008	0.692	rs11613378	chr12:38213138	T/A	cg26384229	chr12:38710491	ALG10B	0.82	6.58	0.6	4.87e-9	Bladder cancer;
SKCM	cis	rs116095464	0.558	rs2288458	chr5:231260	C/T	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs6951245	1.000	rs78628466	chr7:1068453	G/C	cg21664854	chr7:1097933	C7orf50;GPR146	0.89	4.79	0.48	7.66e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs55962025	0.723	rs2269478	chr4:3234828	G/T	cg00764545	chr4:3318001	RGS12	-0.64	-5.46	-0.53	5.36e-7	Parental longevity (mother's age at death);
SKCM	cis	rs28595532	0.920	rs115690307	chr4:119768289	C/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs12134245	0.776	rs12122066	chr1:92005140	C/T	cg25838465	chr1:92012736	NA	-0.84	-8.87	-0.71	1.92e-13	Breast cancer;
SKCM	cis	rs4689592	0.503	rs3857180	chr4:7073899	T/G	cg19539972	chr4:7069911	GRPEL1	-0.95	-6.19	-0.57	2.58e-8	Monocyte percentage of white cells;
SKCM	cis	rs244731	0.959	rs11740250	chr5:176721272	G/C	cg17509989	chr5:176798049	RGS14	0.9	6.83	0.61	1.67e-9	Urate levels in lean individuals;
SKCM	cis	rs3008870	1.000	rs2755246	chr1:67488984	A/G	cg08660285	chr1:67390436	MIER1;WDR78	0.92	6.5	0.59	6.94e-9	Lymphocyte percentage of white cells;
SKCM	cis	rs7092929	0.941	rs575738	chr10:3579283	C/A	cg14308648	chr10:3568949	NA	0.72	4.81	0.48	7.12e-6	Coronary artery calcification;
SKCM	cis	rs3785574	0.962	rs2955235	chr17:61966950	A/C	cg01411255	chr17:61851458	DDX42;CCDC47	1.01	9.09	0.72	7.29e-14	Height;
SKCM	cis	rs11098499	0.505	rs75122014	chr4:120362426	G/C	cg09307838	chr4:120376055	NA	0.95	7.42	0.64	1.26e-10	Corneal astigmatism;
SKCM	cis	rs4141404	0.604	rs2103853	chr22:31855475	T/C	cg07713946	chr22:31675144	LIMK2	0.51	5.18	0.51	1.68e-6	Paclitaxel-induced neuropathy;
SKCM	cis	rs1046896	0.586	rs9897951	chr17:80810662	T/C	cg22027946	chr17:80790580	TBCD;ZNF750	0.68	5.2	0.51	1.53e-6	Glycated hemoglobin levels;
SKCM	cis	rs7208859	0.623	rs216446	chr17:28933718	T/G	cg14067834	chr17:29058358	SUZ12P	1.08	4.95	0.49	4.21e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs2439831	0.867	rs2412779	chr15:43655927	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.39	9.42	0.73	1.62e-14	Lung cancer in ever smokers;
SKCM	cis	rs1005277	0.522	rs11011343	chr10:38002698	A/G	cg25427524	chr10:38739819	LOC399744	-0.62	-6.15	-0.57	3.03e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs929354	0.772	rs10228145	chr7:157007337	A/G	cg17757837	chr7:157058334	UBE3C	0.72	5.38	0.52	7.43e-7	Body mass index;
SKCM	cis	rs951366	0.789	rs823110	chr1:205701078	G/C	cg07167872	chr1:205819463	PM20D1	0.96	8.0	0.67	9.33e-12	Menarche (age at onset);
SKCM	cis	rs738321	0.756	rs12169611	chr22:38513735	T/C	cg25457927	chr22:38595422	NA	-0.51	-5.73	-0.54	1.83e-7	Breast cancer;
SKCM	cis	rs801193	0.591	rs721717	chr7:66130292	G/T	cg18876405	chr7:65276391	NA	-0.63	-6.29	-0.58	1.68e-8	Aortic root size;
SKCM	cis	rs12478296	1.000	rs12478296	chr2:243048760	A/G	cg06360820	chr2:242988706	NA	0.91	5.25	0.51	1.28e-6	Obesity-related traits;
SKCM	cis	rs4727027	0.901	rs4727018	chr7:148822247	G/C	cg23583168	chr7:148888333	NA	-0.82	-6.56	-0.6	5.29e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs826838	0.935	rs11169508	chr12:39173385	C/T	cg26384229	chr12:38710491	ALG10B	0.91	8.42	0.69	1.43e-12	Heart rate;
SKCM	cis	rs6088590	1.000	rs2378256	chr20:33292127	G/C	cg24642439	chr20:33292090	TP53INP2	0.99	7.53	0.65	7.63e-11	Coronary artery disease;
SKCM	cis	rs2836974	0.965	rs2836965	chr21:40633631	C/G	cg11890956	chr21:40555474	PSMG1	-1.11	-14.55	-0.85	6.21e-24	Cognitive function;
SKCM	cis	rs6942756	1.000	rs6980385	chr7:128943615	G/A	cg02491457	chr7:128862824	NA	-0.8	-4.87	-0.48	5.68e-6	White matter hyperintensity burden;
SKCM	cis	rs860295	0.580	rs11264361	chr1:155289545	T/G	cg02153340	chr1:155202674	NA	-0.78	-5.57	-0.53	3.5e-7	Body mass index;
SKCM	cis	rs919433	0.750	rs788010	chr2:198230949	T/C	cg04278110	chr2:198063759	ANKRD44	0.74	5.13	0.5	2.06e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs1635	0.512	rs73742545	chr6:28319023	T/G	cg15743358	chr6:28303923	ZNF323	-1.27	-5.15	-0.5	1.92e-6	Schizophrenia;
SKCM	cis	rs826838	0.935	rs11169508	chr12:39173385	C/T	cg13010199	chr12:38710504	ALG10B	0.66	5.19	0.51	1.63e-6	Heart rate;
SKCM	cis	rs2836633	0.929	rs4514962	chr21:40041753	C/T	cg05519781	chr21:40033154	ERG	0.78	6.9	0.62	1.24e-9	Coronary artery disease;
SKCM	cis	rs17685	0.712	rs6954569	chr7:75738885	T/A	cg16489192	chr7:75678113	MDH2;STYXL1	-0.58	-5.46	-0.53	5.43e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs10504229	0.683	rs16921810	chr8:58106067	A/G	cg02725872	chr8:58115012	NA	-0.53	-4.91	-0.49	4.82e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs2228479	1.000	rs2228479	chr16:89985940	G/A	cg00800038	chr16:89945340	TCF25	-0.99	-5.64	-0.54	2.57e-7	Skin colour saturation;
SKCM	cis	rs72781680	1.000	rs72796357	chr2:24160131	A/G	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	cis	rs4481887	0.927	rs4292985	chr1:248473692	T/A	cg00666640	chr1:248458726	OR2T12	0.63	5.91	0.56	8.65e-8	Common traits (Other);
SKCM	cis	rs9325144	0.600	rs10785621	chr12:38744912	C/T	cg26384229	chr12:38710491	ALG10B	0.78	6.83	0.61	1.68e-9	Morning vs. evening chronotype;
SKCM	cis	rs9815354	0.812	rs57809229	chr3:41840162	G/A	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs4243830	0.850	rs12744992	chr1:6601290	G/A	cg22792644	chr1:6614718	TAS1R1;NOL9	-1.06	-5.63	-0.54	2.69e-7	Body mass index;
SKCM	cis	rs244731	0.919	rs12652509	chr5:176626441	A/G	cg16006841	chr5:176797999	RGS14	-0.82	-6.91	-0.62	1.15e-9	Urate levels in lean individuals;
SKCM	cis	rs2255932	0.735	rs10513793	chr3:183224103	C/T	cg20852557	chr3:184035519	EIF4G1	-0.72	-4.92	-0.49	4.78e-6	Interleukin-1-beta levels;
SKCM	cis	rs28386778	0.831	rs2584618	chr17:61923611	T/C	cg22520471	chr17:61851767	DDX42;CCDC47	0.73	4.99	0.49	3.63e-6	Prudent dietary pattern;
SKCM	cis	rs2832191	0.740	rs13048618	chr21:30458684	A/G	cg08807101	chr21:30365312	RNF160	0.74	6.08	0.57	4.17e-8	Dental caries;
SKCM	cis	rs1413885	0.516	rs6588137	chr1:65837282	A/G	cg14976592	chr1:65886160	LEPROT;LEPR	0.63	5.21	0.51	1.51e-6	Anticoagulant levels;
SKCM	cis	rs11098499	0.874	rs6851169	chr4:120117510	T/C	cg09307838	chr4:120376055	NA	0.86	6.08	0.57	4.13e-8	Corneal astigmatism;
SKCM	cis	rs7666738	0.830	rs11944855	chr4:99068258	G/A	cg17366294	chr4:99064904	C4orf37	0.61	4.93	0.49	4.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11249608	0.548	rs11960161	chr5:178453837	A/G	cg21905437	chr5:178450457	ZNF879	0.73	5.93	0.56	7.89e-8	Pubertal anthropometrics;
SKCM	cis	rs6500395	1.000	rs12919520	chr16:48705760	G/C	cg04672837	chr16:48644449	N4BP1	-0.63	-5.37	-0.52	8.01e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs8078723	0.690	rs56326707	chr17:38130139	C/T	cg17467752	chr17:38218738	THRA	0.6	5.19	0.51	1.66e-6	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs6977660	1.000	rs714239	chr7:19803944	C/T	cg05791153	chr7:19748676	TWISTNB	0.79	5.53	0.53	4.14e-7	Thyroid stimulating hormone;
SKCM	trans	rs7618501	1.000	rs7372730	chr3:49790682	C/G	cg21659725	chr3:3221576	CRBN	-0.96	-9.61	-0.74	7.08e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs1401999	1.000	rs2176824	chr3:183654029	C/G	cg01324343	chr3:183735012	ABCC5	0.9	10.25	0.76	4.24e-16	Anterior chamber depth;
SKCM	cis	rs7666738	0.830	rs11944035	chr4:98931618	C/T	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9303401	0.659	rs34382037	chr17:56643550	G/T	cg10487724	chr17:56770010	TEX14;RAD51C	0.84	6.24	0.58	2.07e-8	Cognitive test performance;
SKCM	cis	rs2204008	0.729	rs2892365	chr12:38446760	G/C	cg26384229	chr12:38710491	ALG10B	-0.8	-6.31	-0.58	1.56e-8	Bladder cancer;
SKCM	cis	rs453301	0.653	rs1562211	chr8:8902424	A/G	cg06636001	chr8:8085503	FLJ10661	-0.76	-6.02	-0.56	5.35e-8	Joint mobility (Beighton score);
SKCM	cis	rs514406	0.547	rs377808	chr1:53190359	T/G	cg16325326	chr1:53192061	ZYG11B	1.02	13.86	0.84	9.71e-23	Monocyte count;
SKCM	cis	rs6951245	1.000	rs77083167	chr7:1071823	C/T	cg18402987	chr7:1209562	NA	1.15	6.02	0.56	5.38e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7100689	0.646	rs4265545	chr10:82119271	G/T	cg01528321	chr10:82214614	TSPAN14	0.85	7.69	0.66	3.77e-11	Post bronchodilator FEV1;
SKCM	cis	rs651907	0.535	rs11919389	chr3:101424458	T/C	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.81	7.06	0.62	6.11e-10	Colorectal cancer;
SKCM	cis	rs2204008	0.659	rs4002655	chr12:38169881	T/G	cg13010199	chr12:38710504	ALG10B	0.65	4.84	0.48	6.52e-6	Bladder cancer;
SKCM	cis	rs5769765	0.862	rs56377703	chr22:50306940	C/T	cg22709217	chr22:50311962	ALG12;CRELD2	-0.89	-5.71	-0.54	1.97e-7	Schizophrenia;
SKCM	cis	rs9443189	0.570	rs485906	chr6:76300550	A/C	cg01950844	chr6:76311363	SENP6	0.95	5.85	0.55	1.09e-7	Prostate cancer;
SKCM	cis	rs7215564	0.908	rs34932625	chr17:78653155	A/G	cg16980736	chr17:78789706	RPTOR	-0.91	-4.92	-0.49	4.67e-6	Myopia (pathological);
SKCM	cis	rs10489202	0.608	rs6659593	chr1:168072152	A/T	cg24449463	chr1:168025552	DCAF6	-0.78	-7.5	-0.65	8.66e-11	Schizophrenia;
SKCM	cis	rs1348850	0.801	rs11890163	chr2:178327134	G/A	cg27490568	chr2:178487706	NA	0.81	5.08	0.5	2.53e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs6750795	0.746	rs1667301	chr2:232423717	C/T	cg19187155	chr2:232395269	NMUR1	1.01	10.17	0.76	5.95e-16	Height;
SKCM	cis	rs4795419	1	rs4795419	chr17:38166003	G/A	cg17467752	chr17:38218738	THRA	0.68	6.3	0.58	1.61e-8	Monocyte percentage of white cells;
SKCM	cis	rs2243480	1.000	rs316331	chr7:65604622	A/G	cg18252515	chr7:66147081	NA	1.34	8.18	0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs3820068	0.581	rs68052904	chr1:15916714	T/C	cg24675056	chr1:15929824	NA	0.75	4.78	0.48	8e-6	Systolic blood pressure;
SKCM	cis	rs4819052	0.851	rs9974891	chr21:46680767	T/A	cg02159808	chr21:46707872	POFUT2;LOC642852	0.75	5.99	0.56	6.11e-8	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs9467773	1.000	rs4871	chr6:26545632	G/A	cg15659132	chr6:26577336	NA	0.6	5.71	0.54	1.99e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs2153535	0.580	rs1414351	chr6:8476634	T/C	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs7149337	1.000	rs35567150	chr14:51725944	A/G	cg23942311	chr14:51606299	NA	0.5	5.2	0.51	1.56e-6	Cancer;
SKCM	cis	rs10193935	0.786	rs72796504	chr2:42406728	T/C	cg27598129	chr2:42591480	NA	-0.92	-6.79	-0.61	1.97e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1160297	0.575	rs6725912	chr2:53097030	A/G	cg07782112	chr2:53107842	NA	0.59	6.3	0.58	1.63e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs9818758	0.607	rs11706189	chr3:49210833	C/A	cg24898236	chr3:49228699	LOC646498	0.65	4.98	0.49	3.66e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs2204008	0.774	rs12810027	chr12:38212165	A/G	cg13010199	chr12:38710504	ALG10B	0.65	4.84	0.48	6.52e-6	Bladder cancer;
SKCM	cis	rs929354	0.739	rs1182439	chr7:157027367	G/A	cg17757837	chr7:157058334	UBE3C	-0.81	-5.67	-0.54	2.3e-7	Body mass index;
SKCM	cis	rs9420	0.961	rs79260745	chr11:57612960	T/C	cg19752551	chr11:57585705	CTNND1	-0.71	-7.24	-0.63	2.77e-10	Schizophrenia;
SKCM	cis	rs9486715	0.867	rs1127175	chr6:96999725	C/T	cg06623918	chr6:96969491	KIAA0776	-0.83	-7.53	-0.65	7.59e-11	Headache;
SKCM	cis	rs873946	0.586	rs3793685	chr10:134569316	G/A	cg18305652	chr10:134549665	INPP5A	0.58	5.64	0.54	2.62e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs8014204	0.762	rs2359237	chr14:75245002	G/A	cg06637938	chr14:75390232	RPS6KL1	0.73	5.62	0.54	2.82e-7	Caffeine consumption;
SKCM	cis	rs2153535	0.580	rs6900007	chr6:8474035	C/T	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs875971	1.000	rs4718357	chr7:65960878	A/G	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	cis	rs12477438	0.520	rs7572660	chr2:99788582	A/G	cg26064155	chr2:99771622	LIPT1;TSGA10	1.0	8.59	0.7	6.85e-13	Chronic sinus infection;
SKCM	cis	rs6500395	1.000	rs9938633	chr16:48682093	G/C	cg04672837	chr16:48644449	N4BP1	0.65	5.43	0.52	6.28e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs11148252	0.904	rs9568734	chr13:53004222	G/A	cg00495681	chr13:53174319	NA	0.61	5.19	0.51	1.63e-6	Lewy body disease;
SKCM	cis	rs17376456	0.825	rs13165400	chr5:93091427	G/A	cg21475434	chr5:93447410	FAM172A	0.9	4.99	0.49	3.65e-6	Diabetic retinopathy;
SKCM	cis	rs950776	0.714	rs660652	chr15:78887832	A/G	cg06917634	chr15:78832804	PSMA4	-0.85	-6.82	-0.61	1.7e-9	Sudden cardiac arrest;
SKCM	cis	rs12048904	0.595	rs10493937	chr1:101342650	A/T	cg00063077	chr1:101360652	SLC30A7;EXTL2	-0.74	-6.25	-0.58	2.02e-8	Multiple sclerosis;
SKCM	cis	rs2303745	0.841	rs10409801	chr19:17407415	A/G	cg04248312	chr19:17393744	ANKLE1	-1.01	-6.56	-0.6	5.43e-9	Systemic lupus erythematosus;
SKCM	cis	rs933688	1.000	rs2059208	chr5:90732065	A/T	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.1	8.58	0.7	7.11e-13	Smoking behavior;
SKCM	cis	rs2832191	1.000	rs2832189	chr21:30487414	C/T	cg24692254	chr21:30365293	RNF160	-0.79	-7.24	-0.63	2.72e-10	Dental caries;
SKCM	cis	rs12477438	0.520	rs720229	chr2:99704273	T/C	cg26064155	chr2:99771622	LIPT1;TSGA10	1.02	9.25	0.72	3.57e-14	Chronic sinus infection;
SKCM	cis	rs7927771	0.524	rs61895760	chr11:47794538	G/C	cg20307385	chr11:47447363	PSMC3	0.71	5.63	0.54	2.67e-7	Subjective well-being;
SKCM	cis	rs9611565	0.512	rs132767	chr22:42009520	C/T	cg03806693	chr22:41940476	POLR3H	-1.11	-7.56	-0.65	6.74e-11	Vitiligo;
SKCM	cis	rs6570726	0.577	rs867056	chr6:145784805	A/C	cg05347473	chr6:146136440	FBXO30	-0.61	-5.24	-0.51	1.33e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9443189	0.855	rs2842554	chr6:76455557	C/A	cg01950844	chr6:76311363	SENP6	-0.81	-5.92	-0.56	8.33e-8	Prostate cancer;
SKCM	cis	rs6750795	0.569	rs1797387	chr2:232414692	A/G	cg19187155	chr2:232395269	NMUR1	0.94	8.27	0.68	2.84e-12	Height;
SKCM	cis	rs2841277	0.708	rs4465542	chr14:105407798	A/G	cg19901468	chr14:105411992	AHNAK2	-0.98	-7.78	-0.66	2.48e-11	Rheumatoid arthritis;
SKCM	cis	rs4780401	0.632	rs7192366	chr16:11835209	C/G	cg01061890	chr16:11836724	TXNDC11	-0.77	-5.59	-0.53	3.23e-7	Rheumatoid arthritis;
SKCM	cis	rs4819052	0.704	rs2297283	chr21:46683590	G/A	cg19498844	chr21:46707878	POFUT2;LOC642852	0.81	6.19	0.57	2.67e-8	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs898097	1.000	rs898098	chr17:80904564	G/A	cg15369054	chr17:80825471	TBCD	-0.56	-5.2	-0.51	1.58e-6	Breast cancer;
SKCM	cis	rs7811142	0.887	rs35111986	chr7:100000274	C/A	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-1.04	-5.91	-0.56	8.4e-8	Platelet count;
SKCM	cis	rs498872	1.000	rs498872	chr11:118477367	A/G	cg09803002	chr11:119039103	NLRX1	0.52	4.77	0.48	8.49e-6	Glioma;
SKCM	cis	rs919433	0.854	rs787994	chr2:198223121	T/C	cg04278110	chr2:198063759	ANKRD44	0.73	5.0	0.49	3.51e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs55962025	0.842	rs2269477	chr4:3184464	G/T	cg24015175	chr4:3319247	RGS12	-0.57	-5.08	-0.5	2.56e-6	Parental longevity (mother's age at death);
SKCM	cis	rs3785574	0.962	rs7215915	chr17:61828385	C/T	cg01411255	chr17:61851458	DDX42;CCDC47	1.11	12.47	0.82	2.97e-20	Height;
SKCM	cis	rs17685	0.753	rs1637039	chr7:75693009	C/T	cg16489192	chr7:75678113	MDH2;STYXL1	-0.6	-5.51	-0.53	4.43e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs854765	0.534	rs7207461	chr17:17949789	T/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	-1.05	-9.29	-0.72	2.92e-14	Total body bone mineral density;
SKCM	cis	rs2479724	0.935	rs7753507	chr6:41784094	C/T	cg17623882	chr6:41773611	USP49	0.79	6.83	0.61	1.67e-9	Menarche (age at onset);
SKCM	cis	rs1707322	0.752	rs11211147	chr1:46110094	A/G	cg03146154	chr1:46216737	IPP	0.79	5.42	0.52	6.34e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs12478296	0.892	rs60042638	chr2:243038707	G/A	cg06360820	chr2:242988706	NA	-0.92	-5.32	-0.52	9.84e-7	Obesity-related traits;
SKCM	cis	rs1023500	0.596	rs5751204	chr22:42433801	C/T	cg04733989	chr22:42467013	NAGA	0.77	5.8	0.55	1.33e-7	Schizophrenia;
SKCM	cis	rs4911259	0.552	rs11700082	chr20:31460244	A/G	cg13636640	chr20:31349939	DNMT3B	-0.71	-5.71	-0.54	2e-7	Inflammatory bowel disease;
SKCM	cis	rs208520	0.690	rs1351867	chr6:66760995	A/G	cg07460842	chr6:66804631	NA	0.92	6.93	0.62	1.09e-9	Exhaled nitric oxide output;
SKCM	cis	rs7945705	0.934	rs1988709	chr11:8882890	A/T	cg13070366	chr11:9386451	NA	-0.59	-5.11	-0.5	2.25e-6	Hemoglobin concentration;
SKCM	cis	rs1395	0.922	rs6547521	chr2:27488432	G/C	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.47	4.77	0.48	8.27e-6	Blood metabolite levels;
SKCM	cis	rs13118159	0.550	rs2878607	chr4:1353310	G/C	cg02018176	chr4:1364513	KIAA1530	0.94	7.79	0.66	2.45e-11	Longevity;
SKCM	cis	rs16949788	0.826	rs74245473	chr15:66708775	C/A	cg08120210	chr15:66682733	MAP2K1	-0.74	-5.69	-0.54	2.1e-7	Spherical equivalent (joint analysis main effects and education interaction);
SKCM	cis	rs597539	0.652	rs660614	chr11:68659488	G/A	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.82	5.44	0.52	5.87e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	trans	rs561341	0.941	rs2428341	chr17:30317295	C/T	cg20587970	chr11:113659929	NA	-1.14	-9.67	-0.74	5.51e-15	Hip circumference adjusted for BMI;
SKCM	cis	rs2760061	0.626	rs591582	chr1:228117360	C/A	cg02753203	chr1:228287806	NA	-0.63	-4.96	-0.49	3.99e-6	Diastolic blood pressure;
SKCM	cis	rs6921919	0.583	rs2071965	chr6:28403225	C/T	cg14547644	chr6:28411285	ZSCAN23	-0.58	-4.8	-0.48	7.46e-6	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs12926788	0.546	rs200531	chr16:24756172	G/A	cg00339695	chr16:24857497	SLC5A11	-0.8	-6.43	-0.59	9.38e-9	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs1912528	1.000	rs17314832	chr4:140946939	C/T	cg11128457	chr4:140864437	MAML3	0.59	4.96	0.49	4.02e-6	Educational attainment (years of education);
SKCM	cis	rs2228479	1.000	rs62052213	chr16:89991963	C/T	cg00800038	chr16:89945340	TCF25	-0.99	-5.64	-0.54	2.57e-7	Skin colour saturation;
SKCM	cis	rs11673344	0.704	rs540451	chr19:37435521	C/T	cg07624650	chr19:37064219	ZNF529	-0.8	-5.23	-0.51	1.41e-6	Obesity-related traits;
SKCM	cis	rs7020830	0.898	rs13284651	chr9:37222681	G/T	cg14294708	chr9:37120828	ZCCHC7	-1.11	-10.63	-0.77	7.73e-17	Schizophrenia;
SKCM	cis	rs17270561	0.779	rs12209218	chr6:25887776	C/A	cg17691542	chr6:26056736	HIST1H1C	0.92	5.61	0.54	2.92e-7	Iron status biomarkers;
SKCM	cis	rs7959452	0.590	rs11177628	chr12:69765421	G/A	cg20891283	chr12:69753455	YEATS4	0.91	9.31	0.73	2.74e-14	Blood protein levels;
SKCM	cis	rs9916302	0.904	rs7503069	chr17:37697128	C/G	cg07936489	chr17:37558343	FBXL20	-0.9	-8.11	-0.68	5.65e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs1577917	0.559	rs1173418	chr6:86402916	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.77	7.09	0.63	5.31e-10	Response to antipsychotic treatment;
SKCM	cis	rs4237845	0.537	rs9645819	chr12:58270063	T/C	cg00677455	chr12:58241039	CTDSP2	0.86	7.75	0.66	2.8e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs55962025	0.855	rs6855981	chr4:3148276	A/G	cg24015175	chr4:3319247	RGS12	0.54	4.86	0.48	6.02e-6	Parental longevity (mother's age at death);
SKCM	cis	rs9814567	1.000	rs4974484	chr3:134219019	C/T	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.63	-4.96	-0.49	4.06e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs1692580	0.840	rs262679	chr1:2169792	C/T	cg21442419	chr1:2182373	SKI	-0.69	-6.97	-0.62	9.09e-10	Coronary artery disease;
SKCM	trans	rs17685	0.725	rs7795291	chr7:75725206	C/A	cg19862616	chr7:65841803	NCRNA00174	0.95	9.02	0.71	9.98e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs12682352	0.602	rs6993494	chr8:8667444	C/T	cg06636001	chr8:8085503	FLJ10661	0.75	6.19	0.57	2.58e-8	Neuroticism;
SKCM	cis	rs1401999	0.714	rs1533683	chr3:183635488	C/T	cg01324343	chr3:183735012	ABCC5	0.66	6.27	0.58	1.86e-8	Anterior chamber depth;
SKCM	cis	rs2303759	0.918	rs4802597	chr19:49872085	C/T	cg05022225	chr19:49866942	DKKL1;TEAD2	0.65	4.94	0.49	4.32e-6	Multiple sclerosis;
SKCM	cis	rs16866061	0.926	rs17479770	chr2:225335814	A/G	cg02879423	chr2:224806760	WDFY1	0.65	4.83	0.48	6.67e-6	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs12824058	0.831	rs1390849	chr12:130811547	A/G	cg26677194	chr12:130822605	PIWIL1	0.71	5.83	0.55	1.17e-7	Menopause (age at onset);
SKCM	cis	rs10256972	0.721	rs4720249	chr7:1072563	C/G	cg16145915	chr7:1198662	ZFAND2A	-0.46	-5.64	-0.54	2.57e-7	Longevity;Endometriosis;
SKCM	cis	rs950776	0.518	rs12916999	chr15:78826912	C/T	cg06917634	chr15:78832804	PSMA4	1.01	10.47	0.76	1.56e-16	Sudden cardiac arrest;
SKCM	cis	rs12627970	0.565	rs5757613	chr22:39715262	G/A	cg17798944	chr22:39715225	SNORD43;RPL3	1.09	11.02	0.78	1.43e-17	Inflammatory bowel disease;
SKCM	cis	rs4746818	1.000	rs4284308	chr10:70884861	C/T	cg11621586	chr10:70884670	VPS26A	0.96	6.89	0.62	1.28e-9	Left atrial antero-posterior diameter;
SKCM	cis	rs7811142	0.830	rs73401451	chr7:99981895	T/C	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.05	5.92	0.56	8.02e-8	Platelet count;
SKCM	cis	rs644799	0.932	rs523934	chr11:95641775	G/A	cg03916912	chr11:95522834	CEP57;FAM76B	0.8	6.11	0.57	3.69e-8	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs1577917	0.518	rs6454482	chr6:86418188	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.76	6.81	0.61	1.8e-9	Response to antipsychotic treatment;
SKCM	cis	rs10876993	0.893	rs4760168	chr12:58087737	T/G	cg18357645	chr12:58087776	OS9	0.67	6.23	0.58	2.19e-8	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs1405130	0.727	rs4233610	chr2:235573045	G/A	cg17841421	chr2:235704848	NA	-0.57	-4.95	-0.49	4.14e-6	Coronary artery disease;
SKCM	cis	rs10883723	0.810	rs13287	chr10:104240438	A/G	cg11453585	chr10:104263688	ACTR1A;SUFU	0.69	4.77	0.48	8.44e-6	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs13256369	0.802	rs13255789	chr8:8562791	T/C	cg15556689	chr8:8085844	FLJ10661	0.65	4.77	0.48	8.39e-6	Obesity-related traits;
SKCM	cis	rs7618501	0.571	rs2240329	chr3:50107512	G/A	cg05072774	chr3:49840536	C3orf54	0.67	5.06	0.5	2.7e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs116095464	0.558	rs62347677	chr5:227453	A/G	cg22857025	chr5:266934	NA	-1.45	-8.02	-0.67	8.77e-12	Breast cancer;
SKCM	cis	rs17065868	1.000	rs17210766	chr13:45049002	C/G	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs17685	0.743	rs10277259	chr7:75802674	A/C	cg16684958	chr7:75615977	POR	0.53	5.3	0.51	1.06e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7424096	0.515	rs17497343	chr2:37173032	T/C	cg14987922	chr2:37194071	STRN	0.88	6.66	0.6	3.5e-9	High light scatter reticulocyte percentage of red cells;
SKCM	cis	rs763014	0.931	rs3752568	chr16:628302	A/G	cg07343612	chr16:622815	PIGQ	-0.7	-6.0	-0.56	5.84e-8	Height;
SKCM	cis	rs733592	0.507	rs7299704	chr12:48444488	A/G	cg24011408	chr12:48396354	COL2A1	0.69	5.47	0.53	5.31e-7	Plateletcrit;
SKCM	cis	rs7937682	0.924	rs7938360	chr11:111539875	A/G	cg09085632	chr11:111637200	PPP2R1B	-1.04	-12.4	-0.81	3.87e-20	Primary sclerosing cholangitis;
SKCM	cis	rs709400	0.628	rs2010281	chr14:103862322	G/A	cg26031613	chr14:104095156	KLC1	0.71	5.42	0.52	6.49e-7	Body mass index;
SKCM	cis	rs79040073	0.530	rs57560518	chr15:49510957	G/A	cg25951582	chr15:49913451	C15orf33;DTWD1	-0.72	-5.22	-0.51	1.44e-6	Lung cancer in ever smokers;
SKCM	cis	rs6951245	1.000	rs78861357	chr7:1095418	C/T	cg03188948	chr7:1209495	NA	1.13	6.27	0.58	1.89e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7617480	0.617	rs7610519	chr3:48746427	C/G	cg07636037	chr3:49044803	WDR6	0.91	6.74	0.61	2.42e-9	Subjective well-being (multi-trait analysis);Menarche (age at onset);
SKCM	cis	rs6840360	0.571	rs718801	chr4:152549247	C/T	cg22705602	chr4:152727874	NA	-0.53	-5.78	-0.55	1.45e-7	Intelligence (multi-trait analysis);
SKCM	trans	rs12599106	0.709	rs1501462	chr16:34964515	A/T	cg03395511	chr6:291903	DUSP22	-0.72	-7.85	-0.66	1.85e-11	Menopause (age at onset);
SKCM	cis	rs2559856	1.000	rs2695298	chr12:102082589	G/A	cg12924262	chr12:102091054	CHPT1	0.71	5.71	0.54	1.97e-7	Blood protein levels;
SKCM	cis	rs2404602	0.647	rs62026889	chr15:76917885	C/T	cg23625390	chr15:77176239	SCAPER	-0.84	-7.98	-0.67	1.04e-11	Blood metabolite levels;
SKCM	cis	rs2481665	0.608	rs2457815	chr1:62596679	C/T	cg18591186	chr1:62594603	INADL	-0.64	-4.87	-0.48	5.67e-6	BMI in non-smokers;BMI (adjusted for smoking behaviour);Body mass index;Body mass index (joint analysis main effects and smoking interaction);
SKCM	cis	rs6570726	0.599	rs426371	chr6:145886469	A/G	cg23711669	chr6:146136114	FBXO30	-0.76	-6.23	-0.58	2.17e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs769267	0.965	rs6511026	chr19:19391402	C/T	cg26732615	chr19:19648335	CILP2;YJEFN3	0.62	5.67	0.54	2.31e-7	Tonsillectomy;
SKCM	cis	rs2075371	0.932	rs2241332	chr7:133969439	A/G	cg20476274	chr7:133979776	SLC35B4	0.97	10.1	0.75	8.23e-16	Mean platelet volume;
SKCM	cis	rs3091242	0.933	rs12402120	chr1:25751632	C/T	cg02931644	chr1:25747376	RHCE	0.53	5.35	0.52	8.54e-7	Erythrocyte sedimentation rate;
SKCM	cis	rs3820068	0.603	rs7536654	chr1:15989141	C/G	cg24675056	chr1:15929824	NA	0.73	5.44	0.52	6.03e-7	Systolic blood pressure;
SKCM	cis	rs6089584	0.566	rs6061963	chr20:60607480	C/G	cg16423285	chr20:60520624	NA	-0.58	-4.99	-0.49	3.55e-6	Body mass index;
SKCM	cis	rs654950	0.807	rs61773660	chr1:41993298	C/T	cg06885757	chr1:42089581	HIVEP3	-0.63	-6.82	-0.61	1.73e-9	Airway imaging phenotypes;
SKCM	cis	rs1062177	1.000	rs12518722	chr5:151231460	A/G	cg00977110	chr5:151150581	G3BP1	0.8	6.4	0.59	1.08e-8	Preschool internalizing problems;
SKCM	cis	rs12044355	0.927	rs11585959	chr1:231833718	C/T	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	-0.82	-6.45	-0.59	8.52e-9	Alzheimer's disease;
SKCM	cis	rs35306767	0.855	rs11253465	chr10:897208	A/C	cg20503657	chr10:835505	NA	0.76	5.14	0.5	1.99e-6	Eosinophil percentage of granulocytes;
SKCM	trans	rs1814175	0.650	rs6486000	chr11:49659090	T/A	cg15704280	chr7:45808275	SEPT13	-0.94	-7.91	-0.67	1.42e-11	Height;
SKCM	cis	rs2842992	0.789	rs4709370	chr6:160210061	A/G	cg11366901	chr6:160182831	ACAT2	0.91	7.48	0.65	9.57e-11	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs4746818	0.892	rs2394505	chr10:70871598	A/G	cg11621586	chr10:70884670	VPS26A	-0.85	-5.64	-0.54	2.63e-7	Left atrial antero-posterior diameter;
SKCM	cis	rs2303745	0.589	rs751599	chr19:17396549	A/G	cg04248312	chr19:17393744	ANKLE1	-1.03	-7.14	-0.63	4.23e-10	Systemic lupus erythematosus;
SKCM	cis	rs4891159	0.790	rs17059379	chr18:74160316	A/T	cg24786174	chr18:74118243	ZNF516	0.71	7.03	0.62	6.78e-10	Longevity;
SKCM	cis	rs10808739	0.660	rs34700548	chr8:65632184	T/C	cg05711235	chr8:65498612	NA	-0.81	-5.4	-0.52	7.01e-7	HIV-1 susceptibility;
SKCM	cis	rs2228479	1.000	rs62052186	chr16:89969567	A/T	cg00800038	chr16:89945340	TCF25	-0.96	-5.44	-0.52	5.85e-7	Skin colour saturation;
SKCM	cis	rs2645694	0.626	rs2645708	chr4:77822682	G/A	cg06046430	chr4:77819534	ANKRD56	0.54	5.85	0.55	1.09e-7	Emphysema distribution in smoking;
SKCM	cis	rs4803468	1.000	rs284651	chr19:41928336	T/C	cg14132834	chr19:41945861	ATP5SL	-0.77	-6.04	-0.56	4.87e-8	Height;
SKCM	cis	rs875971	0.862	rs9791713	chr7:66105198	C/A	cg18876405	chr7:65276391	NA	-0.63	-6.32	-0.58	1.5e-8	Aortic root size;
SKCM	trans	rs1814175	0.645	rs847630	chr11:49926360	C/T	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs561341	1.000	rs527256	chr17:30321293	C/G	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs155076	0.938	rs261375	chr13:21871882	A/G	cg14456004	chr13:21872349	NA	1.15	7.23	0.63	2.82e-10	White matter hyperintensity burden;
SKCM	cis	rs10791097	0.748	rs2282579	chr11:130735482	C/T	cg12179176	chr11:130786555	SNX19	0.93	8.4	0.69	1.6e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs995000	0.931	rs11207992	chr1:63041800	T/G	cg06896770	chr1:63153194	DOCK7	0.9	7.92	0.67	1.32e-11	Triglyceride levels;
SKCM	cis	rs11098499	0.697	rs11941899	chr4:120382758	C/A	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs425277	0.565	rs3128293	chr1:2065339	A/G	cg03732007	chr1:2071316	PRKCZ	-0.5	-4.82	-0.48	6.82e-6	Height;
SKCM	cis	rs4819052	0.851	rs2255766	chr21:46683777	C/T	cg02159808	chr21:46707872	POFUT2;LOC642852	0.73	5.65	0.54	2.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7507204	0.906	rs1860323	chr19:3424799	G/C	cg08380311	chr19:3435252	NFIC	0.99	7.79	0.66	2.45e-11	Height;
SKCM	cis	rs6570726	0.791	rs6915094	chr6:145883540	C/G	cg05347473	chr6:146136440	FBXO30	0.57	5.13	0.5	2.06e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs67460515	0.892	rs7610985	chr3:161062848	G/A	cg03342759	chr3:160939853	NMD3	-0.81	-7.2	-0.63	3.29e-10	Parkinson's disease;
SKCM	cis	rs7843479	0.601	rs10866837	chr8:21861663	G/C	cg17168535	chr8:21777572	XPO7	0.79	6.96	0.62	9.55e-10	Mean corpuscular volume;
SKCM	cis	rs12142240	0.698	rs61519400	chr1:46855298	A/G	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs3087591	1.000	rs2057769	chr17:29691368	C/A	cg24425628	chr17:29625626	OMG;NF1	-0.62	-4.8	-0.48	7.51e-6	Hip circumference;
SKCM	cis	rs8103278	1.000	rs35302007	chr19:46219145	G/C	cg11657440	chr19:46296263	DMWD	-0.89	-6.38	-0.59	1.18e-8	Coronary artery disease;
SKCM	cis	rs2836974	0.897	rs35391055	chr21:40525516	G/A	cg11890956	chr21:40555474	PSMG1	1.07	13.19	0.83	1.48e-21	Cognitive function;
SKCM	cis	rs4642101	0.628	rs1003080	chr3:12811628	C/T	cg05775895	chr3:12838266	CAND2	-0.65	-5.43	-0.52	6.3e-7	QRS complex (12-leadsum);
SKCM	cis	rs7772486	0.846	rs2892453	chr6:146377717	C/A	cg23711669	chr6:146136114	FBXO30	0.86	8.52	0.69	9.13e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1405130	0.839	rs13018428	chr2:235565891	G/A	cg17841421	chr2:235704848	NA	-0.57	-4.95	-0.49	4.14e-6	Coronary artery disease;
SKCM	cis	rs7772486	0.875	rs6914813	chr6:146397798	A/G	cg23711669	chr6:146136114	FBXO30	0.84	8.41	0.69	1.49e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1405130	0.869	rs11682735	chr2:235566830	C/A	cg17841421	chr2:235704848	NA	-0.57	-4.95	-0.49	4.14e-6	Coronary artery disease;
SKCM	cis	rs637571	0.558	rs10896064	chr11:65641033	G/C	cg26695010	chr11:65641043	EFEMP2	0.71	5.87	0.55	1.03e-7	Eosinophil percentage of white cells;
SKCM	cis	rs7666738	0.830	rs13110903	chr4:98946373	A/G	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4481887	0.893	rs6681339	chr1:248482761	C/G	cg00666640	chr1:248458726	OR2T12	0.63	5.91	0.56	8.65e-8	Common traits (Other);
SKCM	cis	rs7659604	0.517	rs56311153	chr4:122729685	T/C	cg19748678	chr4:122722346	EXOSC9	0.68	5.71	0.54	2e-7	Type 2 diabetes;
SKCM	cis	rs7811142	1.000	rs7794485	chr7:100068936	T/C	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.34	0.69	2.1e-12	Platelet count;
SKCM	cis	rs1799949	1.000	rs11659028	chr17:41195025	T/A	cg25918947	chr17:41365094	TMEM106A	-0.63	-5.99	-0.56	6.21e-8	Menopause (age at onset);
SKCM	cis	rs5758659	0.652	rs133349	chr22:42428727	A/T	cg21144673	chr22:42017783	PPPDE2;XRCC6	-0.65	-4.94	-0.49	4.42e-6	Cognitive function;
SKCM	cis	rs3768617	0.510	rs6424885	chr1:183066254	T/G	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs9381040	0.655	rs2268193	chr6:41024625	A/G	cg04346459	chr6:41068666	NFYA;LOC221442	-0.69	-4.8	-0.48	7.61e-6	Alzheimer's disease (late onset);
SKCM	cis	rs2836974	0.644	rs2836982	chr21:40689171	C/A	cg11644478	chr21:40555479	PSMG1	-0.64	-5.33	-0.52	9.27e-7	Cognitive function;
SKCM	cis	rs2832077	0.527	rs2142375	chr21:30223742	G/A	cg24692254	chr21:30365293	RNF160	-0.75	-5.62	-0.54	2.79e-7	Cognitive test performance;
SKCM	cis	rs28595532	0.920	rs115271785	chr4:119735748	A/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs1799949	0.965	rs799912	chr17:41257134	T/C	cg23758822	chr17:41437982	NA	0.93	7.51	0.65	8.5e-11	Menopause (age at onset);
SKCM	cis	rs12714314	0.560	rs1864881	chr2:1940723	G/A	cg22350835	chr2:1868857	MYT1L	0.59	5.61	0.54	2.94e-7	Type 2 diabetes (age of onset);
SKCM	cis	rs8078723	1.000	rs4795416	chr17:38158133	C/T	cg17467752	chr17:38218738	THRA	0.67	6.13	0.57	3.38e-8	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs9905704	0.624	rs8080071	chr17:57093825	C/T	cg05425664	chr17:57184151	TRIM37	0.58	4.8	0.48	7.36e-6	Testicular germ cell tumor;
SKCM	cis	rs1577917	0.917	rs35038582	chr6:86721305	T/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.63	-5.4	-0.52	7.05e-7	Response to antipsychotic treatment;
SKCM	cis	rs28374715	0.681	rs7168307	chr15:41620534	A/G	cg18705301	chr15:41695430	NDUFAF1	-1.01	-10.03	-0.75	1.1e-15	Ulcerative colitis;
SKCM	cis	rs2404602	0.698	rs12909656	chr15:76664378	A/T	cg23625390	chr15:77176239	SCAPER	-0.82	-8.05	-0.67	7.68e-12	Blood metabolite levels;
SKCM	trans	rs3780486	0.541	rs10738909	chr9:33148834	T/C	cg20290983	chr6:43655470	MRPS18A	0.82	8.72	0.7	3.79e-13	IgG glycosylation;
SKCM	cis	rs9300255	0.602	rs1727315	chr12:123638930	A/G	cg00376283	chr12:123451042	ABCB9	-0.86	-5.7	-0.54	2.02e-7	Neutrophil percentage of white cells;
SKCM	cis	rs7666738	0.830	rs62318906	chr4:99037110	C/T	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10905065	0.965	rs10752110	chr10:5837038	T/C	cg09234995	chr10:5726438	C10orf18	-0.59	-5.03	-0.49	3.1e-6	Menopause (age at onset);
SKCM	cis	rs870825	0.616	rs28375770	chr4:185647395	C/T	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs6815814	0.950	rs5743565	chr4:38805983	T/C	cg02016764	chr4:38805732	TLR1	-0.77	-5.52	-0.53	4.24e-7	Breast cancer;
SKCM	cis	rs2658782	0.547	rs3133454	chr11:93059019	A/C	cg15737290	chr11:93063684	CCDC67	1.0	9.41	0.73	1.76e-14	Pulmonary function decline;
SKCM	cis	rs933688	1.000	rs332531	chr5:90790451	G/C	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.88	5.95	0.56	7.21e-8	Smoking behavior;
SKCM	cis	rs514406	0.584	rs11205997	chr1:53195271	G/C	cg24675658	chr1:53192096	ZYG11B	0.62	4.98	0.49	3.72e-6	Monocyte count;
SKCM	trans	rs3780486	0.874	rs10813955	chr9:33141791	C/T	cg04842962	chr6:43655489	MRPS18A	1.01	11.0	0.78	1.57e-17	IgG glycosylation;
SKCM	cis	rs995000	0.931	rs10889349	chr1:63081919	A/G	cg06896770	chr1:63153194	DOCK7	0.76	7.17	0.63	3.77e-10	Triglyceride levels;
SKCM	cis	rs10751667	0.621	rs4075990	chr11:976614	T/C	cg10932868	chr11:921992	NA	0.55	5.1	0.5	2.36e-6	Alzheimer's disease (late onset);
SKCM	cis	rs7143963	0.943	rs12433126	chr14:103265867	A/T	cg23020514	chr14:103360112	TRAF3	0.84	7.73	0.66	3.2e-11	Body mass index;
SKCM	cis	rs2645694	0.626	rs2703118	chr4:77823672	A/G	cg06046430	chr4:77819534	ANKRD56	0.54	5.85	0.55	1.09e-7	Emphysema distribution in smoking;
SKCM	cis	rs8017423	0.967	rs57793584	chr14:90714833	G/A	cg04374321	chr14:90722782	PSMC1	0.97	8.97	0.71	1.25e-13	Mortality in heart failure;
SKCM	cis	rs4481887	0.676	rs7527991	chr1:248527649	T/A	cg22724847	chr1:248512586	OR14C36	0.62	5.32	0.52	9.49e-7	Common traits (Other);
SKCM	cis	rs2153535	0.580	rs9328484	chr6:8524843	A/T	cg23788917	chr6:8435910	SLC35B3	0.69	5.04	0.5	2.93e-6	Motion sickness;
SKCM	cis	rs801193	1.000	rs2286684	chr7:66129830	G/T	cg18876405	chr7:65276391	NA	-0.82	-7.53	-0.65	7.59e-11	Aortic root size;
SKCM	cis	rs854765	0.583	rs8080823	chr17:17864048	T/C	cg04398451	chr17:18023971	MYO15A	-0.79	-5.68	-0.54	2.25e-7	Total body bone mineral density;
SKCM	cis	rs7659604	1.000	rs34952897	chr4:122664409	C/T	cg19748678	chr4:122722346	EXOSC9	0.68	5.59	0.53	3.23e-7	Type 2 diabetes;
SKCM	cis	rs6062302	0.534	rs1556456	chr20:62216289	T/C	cg09650180	chr20:62225654	GMEB2	-0.81	-6.61	-0.6	4.23e-9	Glioblastoma;
SKCM	cis	rs2019137	0.560	rs7578633	chr2:113978650	C/T	cg12889195	chr2:113992843	PAX8;LOC440839;LOC654433	0.75	5.59	0.53	3.21e-7	Lymphocyte counts;
SKCM	cis	rs7666738	0.800	rs7684523	chr4:98983175	G/T	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11122272	0.668	rs2808616	chr1:231554993	C/G	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	0.63	5.54	0.53	3.92e-7	Hemoglobin concentration;
SKCM	cis	rs6088590	1.000	rs6058111	chr20:33310999	T/C	cg24642439	chr20:33292090	TP53INP2	1.01	7.39	0.64	1.39e-10	Coronary artery disease;
SKCM	cis	rs3744061	0.569	rs2240769	chr17:74718155	C/T	cg27546012	chr17:74684504	MXRA7	-0.61	-5.19	-0.51	1.6e-6	Retinal arteriolar caliber;
SKCM	cis	rs55728055	0.661	rs62239172	chr22:32047941	G/A	cg01338084	chr22:32026380	PISD	1.62	5.14	0.5	1.99e-6	Age-related hearing impairment;
SKCM	cis	rs62238980	0.614	rs1547411	chr22:32443590	T/C	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs2842992	0.830	rs2025189	chr6:160137518	C/T	cg19482086	chr6:160211437	TCP1;MRPL18	0.79	5.86	0.55	1.07e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs2204008	0.687	rs1733404	chr12:38123395	G/T	cg13010199	chr12:38710504	ALG10B	-0.65	-5.11	-0.5	2.19e-6	Bladder cancer;
SKCM	cis	rs796364	0.951	rs11680258	chr2:200996976	T/C	cg12253985	chr2:200820533	C2orf60;C2orf47	-0.94	-6.2	-0.57	2.47e-8	Schizophrenia;
SKCM	cis	rs2019137	0.539	rs11123170	chr2:113978940	C/G	cg11763394	chr2:113992921	PAX8;LOC440839;LOC654433	0.63	5.03	0.49	3.11e-6	Lymphocyte counts;
SKCM	cis	rs6120849	1.000	rs6120849	chr20:33730387	C/T	cg24642439	chr20:33292090	TP53INP2	0.91	5.05	0.5	2.83e-6	Protein C levels;
SKCM	cis	rs1153858	0.887	rs28569043	chr15:45730926	A/T	cg10760299	chr15:45669010	GATM	0.58	4.99	0.49	3.65e-6	Homoarginine levels;
SKCM	cis	rs55962025	0.686	rs4690073	chr4:3160150	G/A	cg09735869	chr4:3319127	RGS12	-0.59	-5.06	-0.5	2.76e-6	Parental longevity (mother's age at death);
SKCM	cis	rs763014	0.931	rs56048717	chr16:634867	A/G	cg09263875	chr16:632152	PIGQ	0.67	5.82	0.55	1.24e-7	Height;
SKCM	cis	rs11679564	0.714	rs10490657	chr2:37178255	C/T	cg14987922	chr2:37194071	STRN	0.84	6.31	0.58	1.59e-8	Immature fraction of reticulocytes;
SKCM	cis	rs3784262	0.669	rs34226780	chr15:58280168	G/A	cg12031962	chr15:58353849	ALDH1A2	-0.42	-4.9	-0.48	5.17e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs644799	1.000	rs472231	chr11:95532166	A/G	cg25622487	chr11:95524042	FAM76B;CEP57	0.66	5.12	0.5	2.18e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs2354432	0.546	rs11240030	chr1:146882616	G/A	cg25205988	chr1:146714368	CHD1L	1.03	6.76	0.61	2.25e-9	Mitochondrial DNA levels;
SKCM	cis	rs867186	1.000	rs114007205	chr20:33647503	G/T	cg04194272	chr20:33683537	NA	-1.38	-7.2	-0.63	3.29e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs7772486	0.641	rs2748489	chr6:146331287	T/G	cg05347473	chr6:146136440	FBXO30	0.67	5.59	0.53	3.22e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs208520	0.690	rs207102	chr6:66795671	G/A	cg07460842	chr6:66804631	NA	-1.03	-7.65	-0.65	4.49e-11	Exhaled nitric oxide output;
SKCM	cis	rs9790314	1.000	rs4350933	chr3:160955879	G/T	cg03342759	chr3:160939853	NMD3	-0.72	-7.87	-0.67	1.65e-11	Morning vs. evening chronotype;
SKCM	cis	rs7809950	1.000	rs2178497	chr7:107278901	T/C	cg23024343	chr7:107201750	COG5	0.88	8.12	0.68	5.39e-12	Coronary artery disease;
SKCM	cis	rs6565180	0.888	rs8060853	chr16:30403858	A/G	cg17640201	chr16:30407289	ZNF48	0.9	6.74	0.61	2.46e-9	Tonsillectomy;
SKCM	cis	rs12824058	0.831	rs12829373	chr12:130814114	G/C	cg26677194	chr12:130822605	PIWIL1	0.71	5.91	0.56	8.57e-8	Menopause (age at onset);
SKCM	cis	rs7633770	0.786	rs9845998	chr3:46683710	G/A	cg11219411	chr3:46661640	NA	0.54	4.86	0.48	5.98e-6	Coronary artery disease;
SKCM	cis	rs7829975	0.688	rs7826654	chr8:8379106	C/T	cg15556689	chr8:8085844	FLJ10661	0.83	7.47	0.65	9.86e-11	Mood instability;
SKCM	cis	rs72781680	1.000	rs74704838	chr2:24158270	C/A	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	cis	rs12586317	0.586	rs74243590	chr14:35513246	G/A	cg16230307	chr14:35515116	FAM177A1	0.84	6.22	0.58	2.29e-8	Psoriasis;
SKCM	cis	rs7772486	0.597	rs2246132	chr6:146182515	C/G	cg05347473	chr6:146136440	FBXO30	0.66	5.9	0.56	8.98e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs3785574	0.962	rs2584633	chr17:61879501	T/C	cg01411255	chr17:61851458	DDX42;CCDC47	1.13	13.06	0.83	2.55e-21	Height;
SKCM	cis	rs10504073	0.647	rs4873317	chr8:50021111	C/T	cg00325661	chr8:49890786	NA	0.79	6.79	0.61	1.99e-9	Blood metabolite ratios;
SKCM	cis	rs2832191	0.720	rs7277028	chr21:30494604	T/C	cg08807101	chr21:30365312	RNF160	-0.62	-4.94	-0.49	4.34e-6	Dental caries;
SKCM	cis	rs28595532	1.000	rs115004746	chr4:119642137	C/T	cg21605333	chr4:119757512	SEC24D	1.24	7.1	0.63	5.16e-10	Cannabis dependence symptom count;
SKCM	cis	rs9902453	0.904	rs12951836	chr17:28410277	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.84	-6.23	-0.58	2.22e-8	Coffee consumption (cups per day);
SKCM	cis	rs6545883	0.965	rs1562308	chr2:61768421	A/C	cg15711740	chr2:61764176	XPO1	-0.76	-5.3	-0.51	1.03e-6	Tuberculosis;
SKCM	cis	rs3091242	0.934	rs666686	chr1:25719511	A/G	cg27572855	chr1:25598939	RHD	0.54	5.27	0.51	1.18e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs4481887	0.927	rs6671702	chr1:248482851	G/A	cg00666640	chr1:248458726	OR2T12	0.63	5.91	0.56	8.65e-8	Common traits (Other);
SKCM	cis	rs854765	0.583	rs4925130	chr17:17807858	G/A	cg09796270	chr17:17721594	SREBF1	0.65	4.87	0.48	5.64e-6	Total body bone mineral density;
SKCM	cis	rs4423214	0.959	rs11606033	chr11:71154204	A/G	cg05163923	chr11:71159392	DHCR7	0.8	7.94	0.67	1.23e-11	Vitamin D levels;
SKCM	cis	rs9911578	0.813	rs8066773	chr17:56601552	A/G	cg12560992	chr17:57184187	TRIM37	0.82	5.97	0.56	6.72e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs1405130	0.900	rs4663470	chr2:235587540	C/T	cg17841421	chr2:235704848	NA	-0.58	-5.07	-0.5	2.6e-6	Coronary artery disease;
SKCM	cis	rs11155671	0.530	rs7758020	chr6:150208111	T/C	cg05036130	chr6:150231994	NA	0.6	6.88	0.61	1.31e-9	Testicular germ cell tumor;
SKCM	cis	rs1506636	1.000	rs666266	chr7:123417759	A/G	cg03229431	chr7:123269106	ASB15	0.66	5.29	0.51	1.1e-6	Plateletcrit;Platelet count;
SKCM	cis	rs1018836	0.923	rs10956748	chr8:91621537	T/A	cg16814680	chr8:91681699	NA	-0.62	-4.83	-0.48	6.67e-6	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs9303401	0.614	rs17175663	chr17:57108437	G/C	cg10487724	chr17:56770010	TEX14;RAD51C	0.79	4.97	0.49	3.86e-6	Cognitive test performance;
SKCM	cis	rs9814567	1.000	rs55913793	chr3:134285968	G/T	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs1395	0.778	rs6709602	chr2:27405497	C/T	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.51	5.14	0.5	1.96e-6	Blood metabolite levels;
SKCM	cis	rs72615157	0.664	rs6953580	chr7:99825275	A/G	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.04	6.43	0.59	9.47e-9	Lung function (FEV1/FVC);
SKCM	cis	rs56235845	0.694	rs4976643	chr5:176760227	A/C	cg17509989	chr5:176798049	RGS14	0.7	5.74	0.55	1.7e-7	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs2777491	0.874	rs13379756	chr15:41663896	A/C	cg18705301	chr15:41695430	NDUFAF1	-0.88	-8.22	-0.68	3.53e-12	Ulcerative colitis;
SKCM	cis	rs13256369	1.000	rs873064	chr8:8572380	G/A	cg06636001	chr8:8085503	FLJ10661	0.74	5.74	0.54	1.75e-7	Obesity-related traits;
SKCM	cis	rs2070488	0.965	rs7372386	chr3:38484175	C/G	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.98	9.09	0.72	7.18e-14	Electrocardiographic conduction measures;
SKCM	cis	rs28374715	0.635	rs8023530	chr15:41647775	T/C	cg18705301	chr15:41695430	NDUFAF1	-1.02	-10.11	-0.75	7.77e-16	Ulcerative colitis;
SKCM	cis	rs9633740	0.945	rs6586030	chr10:82254047	C/T	cg01528321	chr10:82214614	TSPAN14	-0.85	-6.81	-0.61	1.82e-9	Post bronchodilator FEV1;
SKCM	cis	rs13256369	1.000	rs4841017	chr8:8577093	A/G	cg06636001	chr8:8085503	FLJ10661	0.71	5.44	0.52	5.89e-7	Obesity-related traits;
SKCM	cis	rs6977660	1.000	rs2107403	chr7:19819025	G/C	cg05791153	chr7:19748676	TWISTNB	0.79	5.34	0.52	9.05e-7	Thyroid stimulating hormone;
SKCM	cis	rs875971	0.862	rs13536	chr7:66019190	G/A	cg18876405	chr7:65276391	NA	-0.61	-6.03	-0.56	5.23e-8	Aortic root size;
SKCM	cis	rs9895661	0.762	rs1990292	chr17:59444758	A/G	cg12435611	chr17:59941052	BRIP1	0.71	4.77	0.48	8.42e-6	Red blood cell count;Renal function-related traits (sCR);Hematocrit;Chronic kidney disease;Glomerular filtration rate in non diabetics (creatinine);Glomerular filtration rate;Renal function-related traits (eGRFcrea);Glomerular filtration rate (creatinine);
SKCM	cis	rs769267	0.899	rs3934667	chr19:19431423	T/G	cg26732615	chr19:19648335	CILP2;YJEFN3	-0.65	-6.08	-0.57	4.12e-8	Tonsillectomy;
SKCM	cis	rs9583531	0.600	rs1441042	chr13:111365589	T/G	cg24331049	chr13:111365604	ING1	0.88	6.6	0.6	4.45e-9	Coronary artery disease;
SKCM	cis	rs867186	0.920	rs6579216	chr20:33668297	T/C	cg04194272	chr20:33683537	NA	-1.38	-7.2	-0.63	3.29e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs4974559	0.740	rs11933854	chr4:1315172	G/A	cg02980000	chr4:1222292	CTBP1	0.89	5.33	0.52	9.41e-7	Systolic blood pressure;
SKCM	trans	rs1814175	0.817	rs7483795	chr11:49704930	G/A	cg15704280	chr7:45808275	SEPT13	-1.02	-10.75	-0.77	4.66e-17	Height;
SKCM	cis	rs7666738	0.830	rs6819047	chr4:98866902	G/A	cg17366294	chr4:99064904	C4orf37	0.56	4.87	0.48	5.62e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4891159	0.548	rs689902	chr18:74119969	C/T	cg24786174	chr18:74118243	ZNF516	-0.8	-8.57	-0.7	7.48e-13	Longevity;
SKCM	cis	rs4423214	1.000	rs2852853	chr11:71150217	C/T	cg05163923	chr11:71159392	DHCR7	0.8	7.82	0.66	2.06e-11	Vitamin D levels;
SKCM	cis	rs11792861	0.926	rs58795279	chr9:111851902	A/T	cg14432460	chr9:111696404	IKBKAP;C9orf6	0.66	4.8	0.48	7.37e-6	Menarche (age at onset);
SKCM	cis	rs7843479	0.965	rs2291317	chr8:21827162	C/T	cg17168535	chr8:21777572	XPO7	0.8	6.76	0.61	2.26e-9	Mean corpuscular volume;
SKCM	cis	rs7100689	0.754	rs10736339	chr10:82059970	G/C	cg01528321	chr10:82214614	TSPAN14	0.79	7.01	0.62	7.62e-10	Post bronchodilator FEV1;
SKCM	cis	rs7727544	0.735	rs272884	chr5:131668654	G/C	cg24060327	chr5:131705240	SLC22A5	-0.7	-5.13	-0.5	2.07e-6	Blood metabolite levels;
SKCM	cis	rs9467773	1.000	rs2255070	chr6:26501777	C/G	cg09904177	chr6:26538194	HMGN4	0.56	5.18	0.51	1.66e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs763014	0.966	rs4984675	chr16:670117	T/C	cg00908189	chr16:619842	PIGQ	0.82	7.61	0.65	5.42e-11	Height;
SKCM	cis	rs362272	0.505	rs3129310	chr4:3301388	T/G	cg03043834	chr4:3319541	RGS12	0.6	5.16	0.5	1.82e-6	Serum sulfate level;
SKCM	cis	rs34779708	0.931	rs12268745	chr10:35305989	C/G	cg03585969	chr10:35415529	CREM	0.76	6.23	0.58	2.17e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs1018836	0.564	rs7821994	chr8:91700916	C/T	cg16814680	chr8:91681699	NA	-1.03	-11.86	-0.8	3.93e-19	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs9611565	0.592	rs5751139	chr22:42099981	G/C	cg03806693	chr22:41940476	POLR3H	1.11	6.72	0.61	2.72e-9	Vitiligo;
SKCM	cis	rs4819052	0.851	rs2236445	chr21:46678453	T/C	cg20896738	chr21:46707857	POFUT2;LOC642852	0.64	4.77	0.48	8.5e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7639513	0.767	rs6784168	chr3:12702847	T/G	cg23032965	chr3:12705835	RAF1	0.81	7.01	0.62	7.4e-10	Itch intensity from mosquito bite;
SKCM	cis	rs2204008	0.777	rs11179774	chr12:38219559	A/C	cg26384229	chr12:38710491	ALG10B	0.82	6.58	0.6	4.87e-9	Bladder cancer;
SKCM	cis	rs11673344	0.734	rs2551047	chr19:37426076	G/A	cg07624650	chr19:37064219	ZNF529	-0.8	-5.23	-0.51	1.41e-6	Obesity-related traits;
SKCM	cis	rs561341	0.941	rs7215147	chr17:30266711	G/A	cg00745463	chr17:30367425	LRRC37B	-1.0	-6.95	-0.62	9.86e-10	Hip circumference adjusted for BMI;
SKCM	cis	rs4820539	0.966	rs5759594	chr22:23470660	G/A	cg14186256	chr22:23484241	RTDR1	0.85	8.15	0.68	4.91e-12	Bone mineral density;
SKCM	cis	rs12142240	0.660	rs6679080	chr1:46819779	A/T	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs9858542	0.953	rs9827708	chr3:49649989	C/G	cg03060546	chr3:49711283	APEH	-0.71	-5.15	-0.5	1.92e-6	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs4819052	0.807	rs4819047	chr21:46665139	C/T	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.36	0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs2204008	0.837	rs11172728	chr12:38070042	C/A	cg13010199	chr12:38710504	ALG10B	0.65	5.04	0.5	2.98e-6	Bladder cancer;
SKCM	cis	rs1843834	0.574	rs6436499	chr2:225456551	A/T	cg12698349	chr2:225449008	CUL3	0.87	6.96	0.62	9.19e-10	IgE levels in asthmatics (D.p. specific);
SKCM	cis	rs362296	0.661	rs3121420	chr4:3264210	T/C	cg00764545	chr4:3318001	RGS12	-0.65	-5.73	-0.54	1.81e-7	Parental longevity (mother's age at death);
SKCM	cis	rs782590	0.967	rs11125579	chr2:55739804	T/C	cg18811423	chr2:55921094	PNPT1	0.75	5.87	0.55	1.03e-7	Metabolic syndrome;
SKCM	cis	rs4905558	1.000	rs2180896	chr14:97304453	T/C	cg11863609	chr14:97355128	NA	-0.54	-4.88	-0.48	5.52e-6	Neutrophil count;
SKCM	cis	rs6545883	0.931	rs778765	chr2:61786385	A/T	cg15711740	chr2:61764176	XPO1	-0.71	-5.02	-0.49	3.15e-6	Tuberculosis;
SKCM	cis	rs4481887	0.732	rs6703399	chr1:248416343	T/C	cg00666640	chr1:248458726	OR2T12	0.61	4.86	0.48	5.9e-6	Common traits (Other);
SKCM	cis	rs769267	0.930	rs1063966	chr19:19616742	G/A	cg03709012	chr19:19516395	GATAD2A	0.89	8.62	0.7	5.89e-13	Tonsillectomy;
SKCM	cis	rs6938	0.534	rs1133322	chr15:75212357	A/G	cg09165964	chr15:75287851	SCAMP5	0.62	4.91	0.49	4.99e-6	Breast cancer;
SKCM	cis	rs763121	0.853	rs6001185	chr22:39052155	G/A	cg06022373	chr22:39101656	GTPBP1	0.72	4.96	0.49	4.08e-6	Menopause (age at onset);
SKCM	cis	rs6951245	1.000	rs884977	chr7:1066410	T/C	cg18402987	chr7:1209562	NA	1.08	5.55	0.53	3.8e-7	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs6500395	1.000	rs2111243	chr16:48724897	C/T	cg04672837	chr16:48644449	N4BP1	-0.63	-5.37	-0.52	8.01e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs10905065	0.804	rs2380203	chr10:5810897	A/G	cg09234995	chr10:5726438	C10orf18	-0.59	-4.85	-0.48	6.13e-6	Menopause (age at onset);
SKCM	cis	rs11098499	0.909	rs28581362	chr4:120283548	T/A	cg24375607	chr4:120327624	NA	0.62	4.77	0.48	8.45e-6	Corneal astigmatism;
SKCM	cis	rs2224391	0.911	rs6925249	chr6:5262510	G/T	cg09085698	chr6:5261316	LYRM4;FARS2	-0.77	-5.73	-0.54	1.79e-7	Height;
SKCM	cis	rs6753739	0.871	rs9784128	chr2:219978638	C/T	cg09617556	chr2:219924408	IHH	-0.47	-5.14	-0.5	1.96e-6	Height;
SKCM	cis	rs11098499	0.820	rs2389885	chr4:120533931	C/T	cg24375607	chr4:120327624	NA	0.66	5.19	0.51	1.64e-6	Corneal astigmatism;
SKCM	cis	rs7772486	0.790	rs2247429	chr6:146217769	T/C	cg23711669	chr6:146136114	FBXO30	0.76	7.66	0.66	4.34e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7584330	0.554	rs6740722	chr2:238393288	T/C	cg08992911	chr2:238395768	MLPH	0.95	5.1	0.5	2.3e-6	Prostate cancer;
SKCM	cis	rs6430585	0.527	rs2289959	chr2:136423904	C/T	cg07169764	chr2:136633963	MCM6	1.0	7.26	0.64	2.49e-10	Corneal structure;
SKCM	cis	rs2075371	0.501	rs1421469	chr7:134028260	C/G	cg20476274	chr7:133979776	SLC35B4	0.83	6.86	0.61	1.43e-9	Mean platelet volume;
SKCM	cis	rs6977660	1.000	rs6943114	chr7:19818354	G/T	cg07541023	chr7:19748670	TWISTNB	0.71	5.08	0.5	2.49e-6	Thyroid stimulating hormone;
SKCM	cis	rs2235573	0.625	rs3026677	chr22:38432725	C/G	cg03683946	chr22:38051826	SH3BP1	-0.48	-4.84	-0.48	6.32e-6	Glioblastoma;Glioma;
SKCM	cis	rs6665290	0.904	rs11578103	chr1:227189642	C/A	cg10327440	chr1:227177885	CDC42BPA	-1.24	-16.77	-0.88	1.35e-27	Myeloid white cell count;
SKCM	cis	rs6696846	0.777	rs9651228	chr1:205049383	A/G	cg03948781	chr1:205179583	DSTYK	0.54	5.01	0.49	3.37e-6	Red blood cell count;
SKCM	cis	rs28595532	0.920	rs115744897	chr4:119749064	A/G	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs4774899	0.934	rs745652	chr15:57470298	A/G	cg01857019	chr15:57210107	LOC145783;TCF12	0.54	4.84	0.48	6.54e-6	Urinary tract infection frequency;
SKCM	cis	rs12478296	0.605	rs35046041	chr2:242986505	A/G	cg06360820	chr2:242988706	NA	-0.77	-5.07	-0.5	2.58e-6	Obesity-related traits;
SKCM	cis	rs9902453	0.934	rs12453172	chr17:28441590	G/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.5	0.53	4.74e-7	Coffee consumption (cups per day);
SKCM	cis	rs523522	0.962	rs10774549	chr12:120891172	C/T	cg12219531	chr12:120966889	COQ5	0.88	7.17	0.63	3.67e-10	High light scatter reticulocyte count;
SKCM	cis	rs7811142	0.830	rs7792525	chr7:99972122	A/G	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.2	7.87	0.67	1.7e-11	Platelet count;
SKCM	cis	rs2836974	0.897	rs2776308	chr21:40715175	A/G	cg17971929	chr21:40555470	PSMG1	0.82	7.62	0.65	5.11e-11	Cognitive function;
SKCM	cis	rs3820068	0.603	rs6429767	chr1:15963334	G/A	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs2731664	0.756	rs4976695	chr5:176862963	T/A	cg06532880	chr5:176731545	PRELID1;RAB24	-0.53	-4.77	-0.47	8.52e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs6570726	0.967	rs9497316	chr6:145792387	G/T	cg23711669	chr6:146136114	FBXO30	-0.73	-6.8	-0.61	1.89e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2842992	0.662	rs2273825	chr6:160211424	A/C	cg11366901	chr6:160182831	ACAT2	0.84	7.09	0.63	5.2e-10	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs514406	0.763	rs6685599	chr1:53213172	G/A	cg16325326	chr1:53192061	ZYG11B	-1.01	-11.9	-0.8	3.23e-19	Monocyte count;
SKCM	cis	rs60871478	0.588	rs73038184	chr7:845094	G/A	cg05535760	chr7:792225	HEATR2	-1.11	-7.35	-0.64	1.68e-10	Cerebrospinal P-tau181p levels;
SKCM	cis	rs1568889	0.838	rs7933991	chr11:28059761	T/C	cg06544937	chr11:28130018	METT5D1;KIF18A	0.89	8.44	0.69	1.31e-12	Bipolar disorder;
SKCM	cis	rs28595532	0.920	rs115506655	chr4:119757667	A/G	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs453301	0.686	rs6748	chr8:8890802	C/T	cg06636001	chr8:8085503	FLJ10661	-0.73	-5.55	-0.53	3.74e-7	Joint mobility (Beighton score);
SKCM	cis	rs4072980	0.524	rs28477803	chr1:38398694	C/T	cg12658694	chr1:38397304	INPP5B	0.63	4.8	0.48	7.58e-6	Coronary artery disease;
SKCM	cis	rs7824557	0.628	rs11991153	chr8:11203107	A/T	cg21775007	chr8:11205619	TDH	0.71	6.33	0.58	1.47e-8	Retinal vascular caliber;
SKCM	cis	rs10489202	0.954	rs12403023	chr1:168086999	A/G	cg24449463	chr1:168025552	DCAF6	-0.91	-6.44	-0.59	9.03e-9	Schizophrenia;
SKCM	cis	rs1005277	0.579	rs2504148	chr10:38400788	A/G	cg25427524	chr10:38739819	LOC399744	-0.71	-6.74	-0.61	2.44e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs10927875	0.864	rs6674071	chr1:16144855	G/C	cg21385522	chr1:16154831	NA	-1.03	-8.46	-0.69	1.22e-12	Dilated cardiomyopathy;
SKCM	cis	rs478304	0.580	rs11606947	chr11:65508237	A/C	cg17480646	chr11:65405466	SIPA1	-0.7	-5.63	-0.54	2.68e-7	Acne (severe);
SKCM	cis	rs1005277	0.579	rs2505241	chr10:38442421	T/C	cg25427524	chr10:38739819	LOC399744	-0.71	-6.71	-0.61	2.75e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs4803468	1.000	rs1043413	chr19:41939297	C/G	cg14132834	chr19:41945861	ATP5SL	0.77	5.9	0.56	9.04e-8	Height;
SKCM	cis	rs10416265	0.528	rs7249097	chr19:33589144	T/C	cg17764715	chr19:33622953	WDR88	0.93	6.71	0.61	2.74e-9	Bone properties (heel);
SKCM	cis	rs4975616	0.869	rs466502	chr5:1325767	C/T	cg06550200	chr5:1325588	CLPTM1L	0.84	7.26	0.64	2.46e-10	Lung cancer;
SKCM	cis	rs244731	0.959	rs6556307	chr5:176641434	C/T	cg06060754	chr5:176797920	RGS14	0.79	6.95	0.62	9.84e-10	Urate levels in lean individuals;
SKCM	cis	rs11098499	0.644	rs7676296	chr4:120555687	A/G	cg09307838	chr4:120376055	NA	0.94	7.77	0.66	2.64e-11	Corneal astigmatism;
SKCM	cis	rs73201462	1.000	rs2955126	chr3:127926254	A/G	cg09089421	chr3:127803668	RUVBL1	-1.0	-5.11	-0.5	2.22e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs1801251	1.000	rs283484	chr2:233646505	A/G	cg25237894	chr2:233734115	C2orf82	0.6	5.8	0.55	1.36e-7	Coronary artery disease;
SKCM	cis	rs6724607	1.000	rs11680758	chr2:191446268	T/G	cg27211696	chr2:191398769	TMEM194B	0.8	6.53	0.59	6.07e-9	Pulse pressure;
SKCM	cis	rs6461049	0.800	rs3800913	chr7:2163237	A/G	cg21782813	chr7:2030301	MAD1L1	0.49	5.22	0.51	1.42e-6	Schizophrenia;
SKCM	cis	rs11098499	0.754	rs10518300	chr4:120249499	G/T	cg09307838	chr4:120376055	NA	-0.9	-7.14	-0.63	4.26e-10	Corneal astigmatism;
SKCM	cis	rs7772486	0.655	rs2142981	chr6:146071695	G/C	cg05347473	chr6:146136440	FBXO30	-0.6	-5.68	-0.54	2.21e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2730245	0.527	rs62475645	chr7:158656825	G/A	cg24397884	chr7:158709396	WDR60	0.99	5.61	0.54	2.97e-7	Height;
SKCM	cis	rs6120849	0.754	rs6120797	chr20:33606002	G/A	cg24642439	chr20:33292090	TP53INP2	0.94	4.86	0.48	5.91e-6	Protein C levels;
SKCM	cis	rs67311347	0.866	rs9826419	chr3:40352051	G/A	cg00091569	chr3:40428383	ENTPD3	0.67	5.66	0.54	2.45e-7	Renal cell carcinoma;
SKCM	cis	rs1707322	0.752	rs11211173	chr1:46219376	C/T	cg03146154	chr1:46216737	IPP	0.8	5.47	0.53	5.19e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7824557	0.614	rs5029571	chr8:11213389	C/T	cg21775007	chr8:11205619	TDH	0.66	5.72	0.54	1.91e-7	Retinal vascular caliber;
SKCM	cis	rs910316	1.000	rs175442	chr14:75603564	T/C	cg08847533	chr14:75593920	NEK9	-0.96	-8.88	-0.71	1.88e-13	Height;
SKCM	cis	rs11098499	1.000	rs11098500	chr4:120219239	T/A	cg09307838	chr4:120376055	NA	0.95	7.94	0.67	1.2e-11	Corneal astigmatism;
SKCM	cis	rs2290405	0.527	rs4690329	chr4:931385	T/A	cg11016749	chr4:921637	GAK	-0.59	-4.89	-0.48	5.37e-6	Systemic sclerosis;
SKCM	cis	rs6912958	0.535	rs1753153	chr6:88032834	T/G	cg08069147	chr6:88032118	GJB7;C6orf162	0.63	5.7	0.54	2.05e-7	Monocyte percentage of white cells;
SKCM	cis	rs4774899	0.934	rs11071309	chr15:57482877	G/T	cg01857019	chr15:57210107	LOC145783;TCF12	0.52	4.79	0.48	7.67e-6	Urinary tract infection frequency;
SKCM	cis	rs2243480	0.803	rs36004293	chr7:65416512	T/C	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs951366	0.589	rs823099	chr1:205669322	C/A	cg07157834	chr1:205819609	PM20D1	0.66	5.64	0.54	2.63e-7	Menarche (age at onset);
SKCM	trans	rs1814175	0.645	rs10839448	chr11:49938930	G/A	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs4819052	0.765	rs2838854	chr21:46680364	A/G	cg02159808	chr21:46707872	POFUT2;LOC642852	0.75	5.99	0.56	6.11e-8	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs908922	0.887	rs4596895	chr1:152528075	T/G	cg09873164	chr1:152488093	CRCT1	0.83	4.87	0.48	5.78e-6	Hair morphology;
SKCM	cis	rs2075671	0.855	rs11974395	chr7:100282538	G/A	cg20848291	chr7:100343083	ZAN	-0.71	-5.38	-0.52	7.64e-7	Other erythrocyte phenotypes;
SKCM	cis	rs28386778	1.000	rs2665810	chr17:61970210	C/G	cg22520471	chr17:61851767	DDX42;CCDC47	0.75	4.97	0.49	3.82e-6	Prudent dietary pattern;
SKCM	cis	rs55962025	0.842	rs363088	chr4:3210330	A/T	cg11471262	chr4:3318911	RGS12	-0.66	-4.98	-0.49	3.72e-6	Parental longevity (mother's age at death);
SKCM	cis	rs11112613	0.818	rs117644588	chr12:106022040	G/C	cg03607813	chr12:105948248	NA	1.01	4.82	0.48	6.94e-6	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;
SKCM	cis	rs4919694	1.000	rs77969925	chr10:104649357	C/T	cg04362960	chr10:104952993	NT5C2	0.77	4.89	0.48	5.28e-6	Arsenic metabolism;
SKCM	cis	rs9910055	0.573	rs228768	chr17:42191893	A/C	cg19774624	chr17:42201019	HDAC5	-0.77	-6.06	-0.57	4.61e-8	Total body bone mineral density;
SKCM	cis	rs7208859	0.562	rs8078897	chr17:29106257	T/G	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	trans	rs1814175	0.781	rs2866734	chr11:49886338	A/G	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs9875589	0.509	rs7653289	chr3:13986333	C/T	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.51	5.17	0.51	1.73e-6	Ovarian reserve;
SKCM	cis	rs28386778	0.897	rs3785572	chr17:61829989	C/T	cg06873352	chr17:61820015	STRADA	0.76	6.34	0.58	1.38e-8	Prudent dietary pattern;
SKCM	cis	rs67460515	0.563	rs6794882	chr3:160851849	G/A	cg03342759	chr3:160939853	NMD3	-0.72	-6.17	-0.57	2.79e-8	Parkinson's disease;
SKCM	cis	rs6866344	0.661	rs72812606	chr5:178129094	A/T	cg10224037	chr5:178157518	ZNF354A	0.75	4.92	0.49	4.75e-6	Neutrophil percentage of white cells;
SKCM	cis	rs28386778	0.897	rs4968663	chr17:61835603	A/T	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.36	0.52	8.06e-7	Prudent dietary pattern;
SKCM	cis	rs8180040	0.620	rs9844122	chr3:47108330	C/T	cg27129171	chr3:47204927	SETD2	0.74	5.37	0.52	7.84e-7	Colorectal cancer;
SKCM	trans	rs1814175	0.645	rs1851857	chr11:49855589	A/C	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs7216064	1.000	rs56404791	chr17:65893019	T/G	cg12091567	chr17:66097778	LOC651250	-0.78	-5.34	-0.52	8.92e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs9435341	0.965	rs56111229	chr1:107566689	T/A	cg09367891	chr1:107599246	PRMT6	0.82	6.58	0.6	4.8e-9	Facial morphology (factor 21, depth of nasal alae);
SKCM	cis	rs12048904	0.619	rs3737581	chr1:101341083	A/G	cg16556008	chr1:101360663	SLC30A7;EXTL2	1.0	8.03	0.67	8.16e-12	Multiple sclerosis;
SKCM	cis	rs2645694	0.626	rs12502590	chr4:77823642	G/A	cg03477792	chr4:77819574	ANKRD56	0.57	6.37	0.58	1.22e-8	Emphysema distribution in smoking;
SKCM	cis	rs9902453	0.740	rs2729446	chr17:28102499	A/C	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.78	-5.89	-0.56	9.1e-8	Coffee consumption (cups per day);
SKCM	cis	rs995000	0.931	rs10493322	chr1:62905893	C/T	cg06896770	chr1:63153194	DOCK7	0.91	8.52	0.69	9.41e-13	Triglyceride levels;
SKCM	cis	rs3008870	1.000	rs3008894	chr1:67377739	A/G	cg08660285	chr1:67390436	MIER1;WDR78	0.96	6.42	0.59	9.91e-9	Lymphocyte percentage of white cells;
SKCM	cis	rs60871478	0.786	rs11974995	chr7:838609	G/C	cg05535760	chr7:792225	HEATR2	-1.13	-9.07	-0.72	7.74e-14	Cerebrospinal P-tau181p levels;
SKCM	cis	rs7216064	1.000	rs62084249	chr17:65874998	A/G	cg12091567	chr17:66097778	LOC651250	-0.75	-5.27	-0.51	1.19e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs11098499	0.863	rs10004484	chr4:120442428	C/T	cg24375607	chr4:120327624	NA	0.68	5.27	0.51	1.16e-6	Corneal astigmatism;
SKCM	cis	rs1801251	1.000	rs10933412	chr2:233707226	G/C	cg25237894	chr2:233734115	C2orf82	-0.61	-5.9	-0.56	8.76e-8	Coronary artery disease;
SKCM	cis	rs9325144	0.600	rs10785615	chr12:38733627	G/C	cg26384229	chr12:38710491	ALG10B	0.78	6.82	0.61	1.76e-9	Morning vs. evening chronotype;
SKCM	trans	rs1814175	0.791	rs7395713	chr11:49877887	A/G	cg15704280	chr7:45808275	SEPT13	-1.06	-11.16	-0.78	7.82e-18	Height;
SKCM	cis	rs7811142	1.000	rs67315960	chr7:100015124	A/G	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.33	0.69	2.11e-12	Platelet count;
SKCM	cis	rs6519955	0.897	rs4073601	chr22:46434686	A/G	cg05468064	chr22:46423449	NA	0.45	5.2	0.51	1.54e-6	Dupuytren's disease;
SKCM	cis	rs9399135	0.933	rs4559100	chr6:135324085	T/C	cg24558204	chr6:135376177	HBS1L	0.59	5.23	0.51	1.41e-6	Red blood cell count;
SKCM	cis	rs72949976	1.000	rs6747328	chr2:214032156	C/G	cg08319019	chr2:214017104	IKZF2	-0.73	-5.49	-0.53	4.85e-7	Lung cancer;Squamous cell lung carcinoma;
SKCM	cis	rs12497850	0.797	rs61583136	chr3:49189195	C/T	cg06212747	chr3:49208901	KLHDC8B	0.75	5.0	0.49	3.47e-6	Parkinson's disease;
SKCM	cis	rs763121	0.853	rs5750630	chr22:38985818	A/C	cg06022373	chr22:39101656	GTPBP1	0.73	4.79	0.48	7.65e-6	Menopause (age at onset);
SKCM	cis	rs10504229	0.683	rs17194529	chr8:58105647	A/G	cg02725872	chr8:58115012	NA	-0.53	-4.91	-0.49	4.82e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs7613875	0.663	rs6762477	chr3:50093209	G/A	cg24110177	chr3:50126178	RBM5	0.74	5.95	0.56	7.25e-8	Body mass index;
SKCM	cis	rs2777491	1.000	rs316610	chr15:41752852	C/T	cg18705301	chr15:41695430	NDUFAF1	-0.89	-9.04	-0.72	9.17e-14	Ulcerative colitis;
SKCM	cis	rs4925325	0.741	rs6142886	chr20:60511190	A/G	cg23262073	chr20:60523788	NA	0.69	5.55	0.53	3.86e-7	Obesity-related traits;
SKCM	cis	rs66573146	0.831	rs67602077	chr4:7024244	A/G	cg00086871	chr4:6988644	TBC1D14	1.45	5.42	0.52	6.38e-7	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs2730245	0.505	rs1188956	chr7:158690576	G/A	cg24397884	chr7:158709396	WDR60	0.77	5.79	0.55	1.42e-7	Height;
SKCM	cis	rs6089584	0.927	rs2296081	chr20:60572663	G/T	cg13770153	chr20:60521292	NA	-0.58	-4.91	-0.49	4.85e-6	Body mass index;
SKCM	cis	rs2243480	1.000	rs56985706	chr7:65394562	C/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs782590	0.748	rs782634	chr2:55897700	T/C	cg18811423	chr2:55921094	PNPT1	0.89	6.67	0.6	3.38e-9	Metabolic syndrome;
SKCM	cis	rs10155981	0.510	rs41398948	chr7:22591226	A/T	cg05062323	chr7:22590069	NA	1.04	6.24	0.58	2.13e-8	Bilirubin levels;
SKCM	cis	rs867186	1.000	rs7265317	chr20:33768523	T/C	cg04194272	chr20:33683537	NA	-1.02	-5.4	-0.52	7.03e-7	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs2811415	0.531	rs13099396	chr3:127795972	G/A	cg09089421	chr3:127803668	RUVBL1	0.87	7.28	0.64	2.26e-10	Lung function (FEV1/FVC);
SKCM	cis	rs10791097	0.694	rs7125622	chr11:130743388	T/C	cg12179176	chr11:130786555	SNX19	0.93	8.16	0.68	4.62e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs28595532	0.764	rs115986119	chr4:119767785	C/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs3091242	0.933	rs11249250	chr1:25767609	G/A	cg02931644	chr1:25747376	RHCE	0.5	4.9	0.48	5.17e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs796364	1.000	rs4410273	chr2:200818258	T/C	cg12253985	chr2:200820533	C2orf60;C2orf47	0.93	5.65	0.54	2.48e-7	Schizophrenia;
SKCM	cis	rs28386778	0.863	rs9897229	chr17:61782325	T/C	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.27	0.51	1.2e-6	Prudent dietary pattern;
SKCM	cis	rs4727027	0.704	rs4727031	chr7:148908305	T/C	cg23583168	chr7:148888333	NA	-0.77	-6.04	-0.56	4.93e-8	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs826838	0.935	rs1719855	chr12:39127242	C/T	cg26384229	chr12:38710491	ALG10B	-0.96	-8.83	-0.71	2.26e-13	Heart rate;
SKCM	cis	rs1395	1.000	rs1141313	chr2:27460968	A/G	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.47	4.77	0.48	8.27e-6	Blood metabolite levels;
SKCM	cis	rs5769765	0.955	rs9616394	chr22:50314927	G/C	cg22709217	chr22:50311962	ALG12;CRELD2	-0.96	-6.08	-0.57	4.21e-8	Schizophrenia;
SKCM	cis	rs12950390	0.893	rs11079789	chr17:45849715	A/G	cg03474202	chr17:45855739	NA	-0.49	-5.58	-0.53	3.34e-7	IgG glycosylation;
SKCM	cis	rs7772486	0.875	rs11755334	chr6:146399297	T/C	cg05347473	chr6:146136440	FBXO30	0.63	5.7	0.54	2.05e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9316337	0.500	rs9316334	chr13:21952240	T/G	cg05830425	chr13:21654356	NA	0.52	5.15	0.5	1.94e-6	Schizophrenia;
SKCM	cis	rs2228479	0.618	rs34689166	chr16:89860697	C/T	cg00800038	chr16:89945340	TCF25	-0.93	-4.9	-0.48	5.16e-6	Skin colour saturation;
SKCM	cis	rs2153535	0.541	rs5026687	chr6:8473957	A/T	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs595982	0.527	rs55670257	chr19:49382654	G/A	cg19746536	chr19:49375674	PPP1R15A	1.13	5.53	0.53	4.16e-7	Red cell distribution width;
SKCM	cis	rs10791097	0.694	rs10894273	chr11:130742155	G/T	cg12179176	chr11:130786555	SNX19	0.93	8.16	0.68	4.62e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs17376456	0.825	rs6874766	chr5:93213807	C/G	cg25358565	chr5:93447407	FAM172A	-1.26	-7.82	-0.66	2.11e-11	Diabetic retinopathy;
SKCM	cis	rs6066825	0.644	rs6125442	chr20:47331210	C/G	cg18078177	chr20:47281410	PREX1	0.63	4.96	0.49	4.07e-6	Colorectal cancer;
SKCM	cis	rs7945705	0.902	rs7930026	chr11:9013639	T/C	cg13070366	chr11:9386451	NA	-0.63	-5.3	-0.51	1.05e-6	Hemoglobin concentration;
SKCM	cis	rs9916302	0.851	rs11078907	chr17:37662954	C/T	cg07936489	chr17:37558343	FBXL20	-0.9	-8.1	-0.68	6.05e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs703842	0.585	rs10877022	chr12:58223937	A/G	cg00677455	chr12:58241039	CTDSP2	0.72	5.8	0.55	1.37e-7	Multiple sclerosis;
SKCM	cis	rs873946	0.564	rs12263364	chr10:134555548	G/T	cg18305652	chr10:134549665	INPP5A	0.58	5.9	0.56	8.82e-8	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs6474412	0.581	rs4737068	chr8:42626424	C/T	cg11207534	chr8:41686438	ANK1	-0.78	-4.94	-0.49	4.43e-6	Smoking behavior;
SKCM	cis	rs782590	0.837	rs809732	chr2:55914621	T/C	cg18811423	chr2:55921094	PNPT1	0.95	8.0	0.67	9.22e-12	Metabolic syndrome;
SKCM	cis	rs9660180	0.934	rs34849348	chr1:1762757	C/T	cg17747265	chr1:1875780	NA	-0.56	-5.15	-0.5	1.91e-6	Body mass index;
SKCM	cis	rs763121	0.853	rs1569492	chr22:38975511	A/G	cg06022373	chr22:39101656	GTPBP1	-0.88	-7.2	-0.63	3.23e-10	Menopause (age at onset);
SKCM	cis	rs7829975	0.807	rs519019	chr8:8595104	A/T	cg15556689	chr8:8085844	FLJ10661	-0.67	-5.96	-0.56	7.05e-8	Mood instability;
SKCM	cis	rs3008870	1.000	rs2755256	chr1:67471692	A/T	cg08660285	chr1:67390436	MIER1;WDR78	0.91	5.96	0.56	6.81e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs4237845	0.537	rs4237844	chr12:58267987	A/G	cg00677455	chr12:58241039	CTDSP2	-0.91	-8.34	-0.69	2.06e-12	Intelligence (multi-trait analysis);
SKCM	cis	rs6061231	0.740	rs11698650	chr20:60958374	A/T	cg24112000	chr20:60950667	NA	-0.6	-6.44	-0.59	9.06e-9	Colorectal cancer;
SKCM	cis	rs1348850	0.918	rs12622298	chr2:178450651	C/T	cg02961200	chr2:178257176	LOC100130691;AGPS	0.81	6.35	0.58	1.33e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs28386778	0.897	rs6504176	chr17:61811920	T/C	cg01411255	chr17:61851458	DDX42;CCDC47	0.79	5.1	0.5	2.35e-6	Prudent dietary pattern;
SKCM	cis	rs7809950	0.678	rs7790080	chr7:107031322	G/A	cg23024343	chr7:107201750	COG5	-0.84	-7.33	-0.64	1.84e-10	Coronary artery disease;
SKCM	cis	rs12541335	0.639	rs4871994	chr8:22206038	G/A	cg02463440	chr8:22132932	PIWIL2	0.64	5.61	0.54	3e-7	Hypertriglyceridemia;
SKCM	cis	rs3741151	0.773	rs73544767	chr11:73204619	C/T	cg17517138	chr11:73019481	ARHGEF17	1.2	4.78	0.48	8.2e-6	GIP levels in response to oral glucose tolerance test (120 minutes);
SKCM	cis	rs7216064	0.953	rs4790981	chr17:65921834	A/G	cg12091567	chr17:66097778	LOC651250	-0.78	-5.34	-0.52	8.92e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs7937682	0.889	rs487985	chr11:111517908	G/A	cg09085632	chr11:111637200	PPP2R1B	-1.07	-11.3	-0.79	4.28e-18	Primary sclerosing cholangitis;
SKCM	cis	rs12142240	0.698	rs9661240	chr1:46827050	G/A	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs10504229	1.000	rs76023408	chr8:58193345	A/G	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs6495122	0.644	rs62029217	chr15:75261899	C/T	cg09165964	chr15:75287851	SCAMP5	0.68	5.38	0.52	7.65e-7	Caffeine consumption;Diastolic blood pressure;Coffee consumption;
SKCM	cis	rs597539	0.652	rs501799	chr11:68631240	G/T	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.84	5.71	0.54	1.96e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs1707322	0.691	rs11211175	chr1:46220884	C/G	cg03146154	chr1:46216737	IPP	0.81	6.0	0.56	5.79e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs1062177	1.000	rs41494545	chr5:151235094	A/G	cg00977110	chr5:151150581	G3BP1	-0.8	-6.34	-0.58	1.35e-8	Preschool internalizing problems;
SKCM	cis	rs754466	1.000	rs12220902	chr10:79682918	C/T	cg17075019	chr10:79541650	NA	-0.72	-5.97	-0.56	6.62e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs55962025	0.711	rs7691627	chr4:3111410	G/A	cg00764545	chr4:3318001	RGS12	-0.58	-4.97	-0.49	3.93e-6	Parental longevity (mother's age at death);
SKCM	cis	rs35306767	0.903	rs7074642	chr10:878359	A/G	cg20503657	chr10:835505	NA	0.75	5.18	0.51	1.71e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs1577917	1.000	rs955197	chr6:86729675	G/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.83	-8.07	-0.67	6.96e-12	Response to antipsychotic treatment;
SKCM	cis	rs7666738	0.822	rs979946	chr4:98921235	C/A	cg17366294	chr4:99064904	C4orf37	0.56	4.87	0.48	5.62e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs860295	0.836	rs35615695	chr1:155501014	T/C	cg02153340	chr1:155202674	NA	0.69	5.21	0.51	1.48e-6	Body mass index;
SKCM	cis	rs8017423	0.647	rs11623736	chr14:90746471	G/T	cg04374321	chr14:90722782	PSMC1	-0.95	-8.73	-0.7	3.68e-13	Mortality in heart failure;
SKCM	cis	rs3096299	0.933	rs3096297	chr16:89453155	T/G	cg02187348	chr16:89574699	SPG7	0.63	4.99	0.49	3.61e-6	Multiple myeloma (IgH translocation);
SKCM	cis	rs7124681	0.584	rs1471712	chr11:47912150	G/A	cg20307385	chr11:47447363	PSMC3	-0.67	-5.22	-0.51	1.41e-6	Body mass index (joint analysis main effects and physical activity interaction);Body mass index;Body mass index in physically active individuals;
SKCM	cis	rs651907	0.512	rs771324	chr3:101610365	T/A	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.76	5.43	0.52	6.19e-7	Colorectal cancer;
SKCM	trans	rs561341	1.000	rs117979353	chr17:30272866	A/G	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs7829975	0.688	rs7826660	chr8:8379107	C/A	cg15556689	chr8:8085844	FLJ10661	0.83	7.47	0.65	9.86e-11	Mood instability;
SKCM	cis	rs854765	0.856	rs2955382	chr17:17947710	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	-0.86	-6.43	-0.59	9.2e-9	Total body bone mineral density;
SKCM	cis	rs12497850	0.931	rs9835307	chr3:48857805	T/C	cg07636037	chr3:49044803	WDR6	1.01	10.82	0.77	3.36e-17	Parkinson's disease;
SKCM	cis	rs742614	0.533	rs6087526	chr20:32398295	A/C	cg06304546	chr20:32448765	NA	-0.73	-5.88	-0.55	9.54e-8	Stearic acid (18:0) levels;
SKCM	cis	rs7829975	0.688	rs7837587	chr8:8378992	T/C	cg08975724	chr8:8085496	FLJ10661	0.67	5.31	0.52	1e-6	Mood instability;
SKCM	cis	rs854765	0.647	rs721669	chr17:18005073	A/G	cg04398451	chr17:18023971	MYO15A	-0.99	-8.76	-0.7	3.19e-13	Total body bone mineral density;
SKCM	cis	rs7666738	0.830	rs13102652	chr4:99006737	T/G	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1029738	0.615	rs717624	chr7:22894487	T/C	cg00626422	chr7:22894849	SNORD93	-0.61	-5.28	-0.51	1.14e-6	Fibrinogen levels;
SKCM	cis	rs397020	0.904	rs203547	chr20:1195245	T/A	cg03932398	chr20:1206703	RAD21L1	0.74	6.48	0.59	7.63e-9	Multiple sclerosis;
SKCM	cis	rs7552404	0.924	rs7546641	chr1:76158035	T/C	cg03433033	chr1:76189801	ACADM	0.78	5.67	0.54	2.36e-7	Blood metabolite levels;Acylcarnitine levels;
SKCM	trans	rs877282	0.945	rs10904556	chr10:789429	A/G	cg22713356	chr15:30763199	NA	1.35	7.57	0.65	6.52e-11	Uric acid levels;
SKCM	cis	rs7772486	0.790	rs1832362	chr6:146179955	C/T	cg23711669	chr6:146136114	FBXO30	0.85	9.32	0.73	2.57e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6912958	0.535	rs242283	chr6:88030931	C/T	cg08069147	chr6:88032118	GJB7;C6orf162	0.65	5.89	0.56	9.08e-8	Monocyte percentage of white cells;
SKCM	cis	rs1862618	0.853	rs11739344	chr5:56111087	A/C	cg12311346	chr5:56204834	C5orf35	-0.71	-4.79	-0.48	7.79e-6	Initial pursuit acceleration;
SKCM	cis	rs62238980	0.522	rs76859275	chr22:32515891	G/A	cg00543991	chr22:32367038	NA	1.17	4.81	0.48	7.24e-6	Childhood ear infection;
SKCM	cis	rs10492096	1.000	rs10492096	chr12:6580582	A/G	cg13857086	chr12:6580257	VAMP1	0.97	7.41	0.64	1.3100000000000001e-10	Hip geometry;
SKCM	cis	rs7584330	0.704	rs60079197	chr2:238358584	A/T	cg14458575	chr2:238380390	NA	1.12	6.8	0.61	1.87e-9	Prostate cancer;
SKCM	cis	rs6089829	0.888	rs4809468	chr20:61673566	T/C	cg08564027	chr20:61660810	NA	0.64	5.85	0.55	1.11e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs769267	0.929	rs2965180	chr19:19491973	T/C	cg26732615	chr19:19648335	CILP2;YJEFN3	-0.69	-7.16	-0.63	3.82e-10	Tonsillectomy;
SKCM	cis	rs4819052	0.851	rs58644915	chr21:46669912	T/C	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.42	0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs1799949	0.965	rs34616041	chr17:41188786	G/A	cg23758822	chr17:41437982	NA	0.91	7.51	0.65	8.13e-11	Menopause (age at onset);
SKCM	cis	rs66887589	0.748	rs28439855	chr4:120262256	G/A	cg09307838	chr4:120376055	NA	0.7	5.09	0.5	2.46e-6	Diastolic blood pressure;
SKCM	cis	rs1153858	1.000	rs11070457	chr15:45686943	A/C	cg21132104	chr15:45694354	SPATA5L1	0.89	7.21	0.63	3.12e-10	Homoarginine levels;
SKCM	cis	rs9788682	0.748	rs569207	chr15:78873119	A/G	cg24631222	chr15:78858424	CHRNA5	-0.87	-6.62	-0.6	4.19e-9	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs727563	0.635	rs5751141	chr22:42107745	A/G	cg03806693	chr22:41940476	POLR3H	1.09	6.54	0.59	5.92e-9	Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs7193541	0.691	rs3851728	chr16:74480660	C/T	cg01733217	chr16:74700730	RFWD3	0.88	8.05	0.67	7.42e-12	Multiple myeloma;
SKCM	cis	rs9902453	0.935	rs4310926	chr17:28433275	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.79	6.04	0.56	5.02e-8	Coffee consumption (cups per day);
SKCM	cis	rs362272	0.505	rs3129310	chr4:3301388	T/G	cg21096898	chr4:3318625	RGS12	0.99	12.61	0.82	1.62e-20	Serum sulfate level;
SKCM	cis	rs17376456	0.877	rs10070390	chr5:93452345	G/A	cg21475434	chr5:93447410	FAM172A	0.97	5.42	0.52	6.39e-7	Diabetic retinopathy;
SKCM	cis	rs854765	0.583	rs8078583	chr17:17811465	C/T	cg04398451	chr17:18023971	MYO15A	-0.79	-5.68	-0.54	2.25e-7	Total body bone mineral density;
SKCM	cis	rs7937682	0.855	rs539693	chr11:111477387	A/G	cg19812747	chr11:111475976	SIK2	-0.56	-4.97	-0.49	3.89e-6	Primary sclerosing cholangitis;
SKCM	cis	rs1461503	0.932	rs11218909	chr11:122842613	C/T	cg27398637	chr11:122830231	C11orf63	-0.63	-4.8	-0.48	7.54e-6	Menarche (age at onset);
SKCM	cis	rs995000	0.931	rs10889336	chr1:62980410	T/C	cg06896770	chr1:63153194	DOCK7	0.74	6.38	0.59	1.16e-8	Triglyceride levels;
SKCM	cis	rs9457247	0.602	rs4710175	chr6:167467800	A/G	cg07741184	chr6:167504864	NA	0.57	4.89	0.48	5.4e-6	Crohn's disease;
SKCM	cis	rs778371	0.723	rs35491427	chr2:233688542	C/T	cg08000102	chr2:233561755	GIGYF2	-0.8	-6.41	-0.59	1.04e-8	Schizophrenia;
SKCM	cis	rs28595532	0.920	rs116047800	chr4:119773569	G/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs7027203	0.828	rs4744291	chr9:96598297	A/G	cg14598338	chr9:96623480	NA	-0.52	-5.41	-0.52	6.75e-7	DNA methylation (variation);
SKCM	cis	rs10883723	0.810	rs2281879	chr10:104268877	C/G	cg11453585	chr10:104263688	ACTR1A;SUFU	0.76	6.01	0.56	5.48e-8	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs919433	0.680	rs2244271	chr2:198286581	C/T	cg04278110	chr2:198063759	ANKRD44	0.7	4.79	0.48	7.87e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs7937682	0.824	rs510866	chr11:111484113	A/C	cg19812747	chr11:111475976	SIK2	-0.56	-4.93	-0.49	4.55e-6	Primary sclerosing cholangitis;
SKCM	cis	rs28595532	0.841	rs114465037	chr4:119778165	A/G	cg21605333	chr4:119757512	SEC24D	1.41	8.39	0.69	1.68e-12	Cannabis dependence symptom count;
SKCM	cis	rs736408	0.812	rs1075653	chr3:52825528	T/C	cg11645453	chr3:52864694	ITIH4	0.58	4.87	0.48	5.71e-6	Bipolar disorder;
SKCM	cis	rs1707322	1.000	rs4660336	chr1:46487976	T/C	cg03146154	chr1:46216737	IPP	-0.77	-5.36	-0.52	8.35e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs17685	0.753	rs4728550	chr7:75670988	C/A	cg16684958	chr7:75615977	POR	-0.57	-5.6	-0.54	3.07e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs4523957	0.583	rs2760740	chr17:2020989	A/G	cg16513277	chr17:2031491	SMG6	-0.8	-5.78	-0.55	1.5e-7	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs11764590	0.694	rs7801349	chr7:2085553	T/C	cg23422044	chr7:1970798	MAD1L1	-0.85	-6.45	-0.59	8.53e-9	Neuroticism;
SKCM	cis	rs2439831	0.702	rs8033995	chr15:44013509	G/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.23	7.3	0.64	2.1e-10	Lung cancer in ever smokers;
SKCM	cis	rs16949788	0.793	rs62625675	chr15:66629020	A/G	cg08120210	chr15:66682733	MAP2K1	-0.75	-5.83	-0.55	1.21e-7	Spherical equivalent (joint analysis main effects and education interaction);
SKCM	cis	rs1850744	1.000	rs114290083	chr4:9597994	C/T	cg15442990	chr4:9534313	NA	-1.3	-4.84	-0.48	6.55e-6	Economic and political preferences;
SKCM	cis	rs73001065	0.636	rs28720066	chr19:19572220	G/T	cg03709012	chr19:19516395	GATAD2A	1.16	5.47	0.53	5.19e-7	LDL cholesterol;
SKCM	cis	rs561341	0.941	rs8066156	chr17:30361629	A/G	cg23018236	chr17:30244563	NA	-0.53	-5.45	-0.53	5.66e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs1003719	0.762	rs8130846	chr21:38480242	G/A	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs763014	0.593	rs28455838	chr16:681966	T/C	cg09263875	chr16:632152	PIGQ	0.77	6.52	0.59	6.39e-9	Height;
SKCM	cis	rs1707322	0.686	rs2991986	chr1:46081282	A/G	cg03146154	chr1:46216737	IPP	-0.83	-6.0	-0.56	5.85e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs10193935	0.786	rs10178087	chr2:42409631	C/A	cg27598129	chr2:42591480	NA	-0.91	-6.64	-0.6	3.8e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs12497850	0.931	rs6446253	chr3:48911443	C/T	cg06212747	chr3:49208901	KLHDC8B	0.68	4.89	0.48	5.28e-6	Parkinson's disease;
SKCM	cis	rs12142240	0.660	rs112560929	chr1:46822297	A/G	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs2204008	0.807	rs12816136	chr12:38456037	A/G	cg26384229	chr12:38710491	ALG10B	-0.8	-6.31	-0.58	1.56e-8	Bladder cancer;
SKCM	cis	rs2180341	0.960	rs6913424	chr6:127707010	A/C	cg27446573	chr6:127587934	RNF146	0.93	8.1	0.68	5.98e-12	Breast cancer;
SKCM	cis	rs9583531	0.689	rs9521913	chr13:111382058	C/T	cg24331049	chr13:111365604	ING1	-0.81	-6.03	-0.56	5.2100000000000003e-08	Coronary artery disease;
SKCM	cis	rs4803468	1.000	rs9304593	chr19:41942875	A/C	cg14132834	chr19:41945861	ATP5SL	0.77	5.9	0.56	9.04e-8	Height;
SKCM	cis	rs28595532	0.841	rs115209862	chr4:119742225	G/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs910316	0.737	rs2098251	chr14:75492696	G/A	cg08847533	chr14:75593920	NEK9	0.8	6.59	0.6	4.76e-9	Height;
SKCM	cis	rs9916302	0.904	rs4795356	chr17:37535631	C/T	cg07936489	chr17:37558343	FBXL20	0.84	7.23	0.63	2.81e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs6912958	0.559	rs445434	chr6:88041849	A/G	cg08069147	chr6:88032118	GJB7;C6orf162	0.64	5.61	0.54	2.97e-7	Monocyte percentage of white cells;
SKCM	cis	rs1878931	0.582	rs10048083	chr16:3417465	A/C	cg26668626	chr16:3451006	ZNF174;ZNF434	0.82	6.01	0.56	5.69e-8	Body mass index (adult);
SKCM	cis	rs13217239	0.646	rs12209886	chr6:26984757	G/A	cg12292205	chr6:26970375	C6orf41	0.63	5.64	0.54	2.58e-7	Schizophrenia;
SKCM	cis	rs7937682	0.889	rs516263	chr11:111484719	A/C	cg09085632	chr11:111637200	PPP2R1B	-0.97	-10.08	-0.75	8.74e-16	Primary sclerosing cholangitis;
SKCM	cis	rs763121	0.853	rs5750649	chr22:39036769	T/C	cg06022373	chr22:39101656	GTPBP1	0.82	5.62	0.54	2.8e-7	Menopause (age at onset);
SKCM	cis	rs35306767	0.903	rs10508208	chr10:910983	C/T	cg20503657	chr10:835505	NA	0.76	5.49	0.53	4.78e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs12142240	0.659	rs72677591	chr1:46818219	T/G	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs9309711	0.770	rs13409323	chr2:3488184	C/T	cg10845886	chr2:3471009	TTC15	-0.73	-4.87	-0.48	5.83e-6	Neurofibrillary tangles;
SKCM	cis	rs9910055	0.762	rs2526021	chr17:42213347	G/A	cg10896456	chr17:42255109	ASB16;C17orf65	0.66	6.39	0.59	1.12e-8	Total body bone mineral density;
SKCM	cis	rs826838	0.834	rs826874	chr12:39122599	C/A	cg26384229	chr12:38710491	ALG10B	-0.76	-6.66	-0.6	3.46e-9	Heart rate;
SKCM	cis	rs870825	0.616	rs7667449	chr4:185641711	T/C	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs11098499	0.754	rs11732087	chr4:120239831	A/G	cg09307838	chr4:120376055	NA	0.93	7.56	0.65	6.5500000000000006e-11	Corneal astigmatism;
SKCM	cis	rs9916302	0.904	rs6503519	chr17:37706578	A/G	cg07936489	chr17:37558343	FBXL20	-0.9	-8.15	-0.68	4.86e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs36093844	0.752	rs74404559	chr11:85565669	G/A	cg25872744	chr11:85566296	CCDC83	-0.85	-4.77	-0.48	8.27e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs10489202	0.608	rs6657019	chr1:168079669	T/C	cg24449463	chr1:168025552	DCAF6	-0.81	-7.61	-0.65	5.44e-11	Schizophrenia;
SKCM	cis	rs950027	0.620	rs1145080	chr15:45681338	C/T	cg10760299	chr15:45669010	GATM	0.57	5.71	0.54	1.99e-7	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs9951698	0.667	rs9961669	chr18:13020881	T/A	cg12848697	chr18:13133368	NA	0.53	4.96	0.49	4.04e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1344694	0.566	rs13029765	chr2:216894976	A/T	cg12620499	chr2:216877984	MREG	0.77	6.87	0.61	1.42e-9	Alcohol dependence;
SKCM	cis	rs4423214	1.000	rs12789751	chr11:71164471	G/A	cg05163923	chr11:71159392	DHCR7	0.83	8.06	0.67	7.35e-12	Vitamin D levels;
SKCM	cis	rs12824058	0.549	rs4759453	chr12:130824565	C/G	cg26677194	chr12:130822605	PIWIL1	0.67	5.77	0.55	1.5e-7	Menopause (age at onset);
SKCM	cis	rs4975616	0.804	rs381949	chr5:1322468	G/A	cg07493874	chr5:1342172	CLPTM1L	-0.66	-5.75	-0.55	1.66e-7	Lung cancer;
SKCM	cis	rs6951245	0.554	rs35126802	chr7:1134842	C/T	cg03188948	chr7:1209495	NA	0.82	5.79	0.55	1.4e-7	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs4819052	0.851	rs2236444	chr21:46678226	T/C	cg02159808	chr21:46707872	POFUT2;LOC642852	0.73	5.68	0.54	2.18e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs10197940	0.901	rs2290367	chr2:152266731	T/A	cg19508488	chr2:152266495	RIF1	0.64	5.43	0.52	6.14e-7	Lung cancer;
SKCM	cis	rs3741151	0.773	rs6592526	chr11:73208911	C/T	cg17517138	chr11:73019481	ARHGEF17	1.2	4.78	0.48	8.2e-6	GIP levels in response to oral glucose tolerance test (120 minutes);
SKCM	cis	rs2153535	0.580	rs9393021	chr6:8466123	A/G	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs12458462	0.892	rs58675823	chr18:77463672	G/A	cg11879182	chr18:77439856	CTDP1	0.87	7.23	0.63	2.88e-10	Monocyte count;
SKCM	cis	rs1707322	1.000	rs785467	chr1:46521559	A/T	cg03146154	chr1:46216737	IPP	-0.76	-5.21	-0.51	1.53e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs798554	0.797	rs798494	chr7:2798294	C/A	cg19346786	chr7:2764209	NA	-0.64	-6.81	-0.61	1.79e-9	Height;
SKCM	cis	rs17854409	0.803	rs1063246	chr20:61472116	G/A	cg06598544	chr20:61472147	COL9A3	-1.14	-5.6	-0.54	3.08e-7	Obesity-related traits;
SKCM	cis	rs11249608	0.548	rs6860309	chr5:178451428	T/C	cg21905437	chr5:178450457	ZNF879	0.75	6.33	0.58	1.42e-8	Pubertal anthropometrics;
SKCM	cis	rs459571	0.959	rs467379	chr9:136905474	C/T	cg13789015	chr9:136890014	NCRNA00094	0.74	6.32	0.58	1.53e-8	Platelet distribution width;
SKCM	cis	rs1580019	0.844	rs1901202	chr7:32503724	A/T	cg06627557	chr7:32535165	LSM5;AVL9	0.77	5.86	0.55	1.03e-7	Cognitive ability;
SKCM	cis	rs6121246	0.909	rs6060633	chr20:30263317	G/T	cg11595048	chr20:30225325	COX4I2	0.67	5.21	0.51	1.5e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs3749237	0.595	rs4855839	chr3:49507847	G/A	cg02487422	chr3:49467188	NICN1	0.64	4.79	0.48	7.67e-6	Resting heart rate;
SKCM	cis	rs34172651	0.517	rs3803716	chr16:24802325	C/T	cg04756594	chr16:24857601	SLC5A11	0.72	5.19	0.51	1.65e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs62103177	0.810	rs62096745	chr18:77619135	A/G	cg27393146	chr18:77495563	CTDP1	-0.92	-5.36	-0.52	8.37e-7	Opioid sensitivity;
SKCM	cis	rs1862618	0.853	rs252910	chr5:56192983	G/A	cg12311346	chr5:56204834	C5orf35	-0.76	-5.02	-0.49	3.2e-6	Initial pursuit acceleration;
SKCM	cis	rs3741151	1.000	rs75109191	chr11:73023532	T/C	cg17517138	chr11:73019481	ARHGEF17	1.35	5.17	0.51	1.74e-6	GIP levels in response to oral glucose tolerance test (120 minutes);
SKCM	cis	rs281408	0.559	rs204248	chr19:49216224	G/C	cg13540341	chr19:49222985	MAMSTR	0.58	5.65	0.54	2.52e-7	Urinary metabolites (H-NMR features);
SKCM	cis	rs9937943	0.615	rs12925346	chr16:74492495	G/C	cg01733217	chr16:74700730	RFWD3	0.95	5.04	0.5	3e-6	Neutrophil percentage of white cells;
SKCM	cis	rs3820068	0.603	rs927207	chr1:15990552	A/G	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs4237845	0.761	rs11172378	chr12:58298161	C/T	cg00677455	chr12:58241039	CTDSP2	0.73	6.11	0.57	3.72e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs7635838	0.654	rs347585	chr3:11286220	C/T	cg00170343	chr3:11313890	ATG7	0.82	5.55	0.53	3.83e-7	HDL cholesterol;
SKCM	cis	rs11673344	0.704	rs551717	chr19:37427879	A/G	cg07624650	chr19:37064219	ZNF529	-0.8	-5.23	-0.51	1.41e-6	Obesity-related traits;
SKCM	cis	rs1801251	1.000	rs283474	chr2:233654627	A/G	cg08000102	chr2:233561755	GIGYF2	0.91	7.02	0.62	7.26e-10	Coronary artery disease;
SKCM	cis	rs12477438	0.798	rs12477754	chr2:99628073	G/A	cg26064155	chr2:99771622	LIPT1;TSGA10	-0.72	-4.86	-0.48	6e-6	Chronic sinus infection;
SKCM	cis	rs59918340	0.764	rs10107024	chr8:142227592	T/C	cg23750338	chr8:142222470	SLC45A4	0.61	6.04	0.56	5.01e-8	Immature fraction of reticulocytes;
SKCM	cis	rs995000	0.899	rs1168032	chr1:62967747	A/G	cg06896770	chr1:63153194	DOCK7	-0.62	-5.59	-0.54	3.15e-7	Triglyceride levels;
SKCM	cis	rs2980439	0.556	rs2921059	chr8:8317887	G/T	cg06636001	chr8:8085503	FLJ10661	0.79	6.68	0.6	3.19e-9	Neuroticism;
SKCM	cis	rs7945705	0.840	rs10840136	chr11:8885024	C/T	cg21881798	chr11:8931708	C11orf17;ST5	-0.81	-8.74	-0.7	3.49e-13	Hemoglobin concentration;
SKCM	trans	rs1814175	0.817	rs28525029	chr11:50045815	A/G	cg03929089	chr4:120376271	NA	-0.93	-8.77	-0.7	3.08e-13	Height;
SKCM	cis	rs9814567	0.806	rs1880374	chr3:134322113	G/A	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.65	-5.19	-0.51	1.6e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs6138458	0.585	rs1007881	chr20:25014385	A/G	cg26195577	chr20:24973756	C20orf3	0.86	5.48	0.53	4.98e-7	Blood protein levels;
SKCM	cis	rs67460515	0.563	rs9876142	chr3:160780968	A/G	cg03342759	chr3:160939853	NMD3	0.71	6.07	0.57	4.28e-8	Parkinson's disease;
SKCM	cis	rs394563	0.726	rs6942381	chr6:149662991	G/C	cg03678062	chr6:149772716	ZC3H12D	0.5	5.89	0.56	9.15e-8	Dupuytren's disease;
SKCM	cis	rs752010	0.695	rs10789408	chr1:42106579	T/C	cg06885757	chr1:42089581	HIVEP3	0.51	6.04	0.56	4.83e-8	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs523522	0.962	rs3893104	chr12:120903936	G/A	cg12219531	chr12:120966889	COQ5	0.89	7.38	0.64	1.46e-10	High light scatter reticulocyte count;
SKCM	cis	rs7772486	0.712	rs1292335	chr6:145967877	G/T	cg23711669	chr6:146136114	FBXO30	0.66	6.09	0.57	4.01e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs870825	0.616	rs7678616	chr4:185648714	T/G	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs6088590	0.965	rs6119534	chr20:33441257	C/T	cg24642439	chr20:33292090	TP53INP2	0.97	6.72	0.61	2.65e-9	Coronary artery disease;
SKCM	cis	rs314370	0.855	rs17883557	chr7:100494949	G/T	cg10426581	chr7:100472382	SRRT	0.67	5.64	0.54	2.57e-7	Resting heart rate;
SKCM	cis	rs9287719	0.639	rs2357649	chr2:10696788	C/T	cg01299579	chr2:10830716	NOL10	0.51	4.9	0.48	5.19e-6	Prostate cancer;
SKCM	cis	rs1707322	1.000	rs4660906	chr1:46470860	C/T	cg03146154	chr1:46216737	IPP	0.77	5.28	0.51	1.15e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs9902453	0.934	rs7213902	chr17:28322935	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.81	5.78	0.55	1.45e-7	Coffee consumption (cups per day);
SKCM	cis	rs9649213	0.519	rs3735258	chr7:97866291	G/A	cg09267113	chr7:98030324	BAIAP2L1	-0.64	-4.79	-0.48	7.87e-6	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs4242434	0.787	rs1545837	chr8:22477807	T/C	cg03733263	chr8:22462867	KIAA1967	0.88	6.32	0.58	1.5e-8	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs28595532	0.920	rs115446044	chr4:119754635	T/C	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs11098499	0.865	rs28845498	chr4:120405186	G/A	cg09307838	chr4:120376055	NA	0.97	7.65	0.65	4.54e-11	Corneal astigmatism;
SKCM	cis	rs910316	1.000	rs28626045	chr14:75589195	G/C	cg08847533	chr14:75593920	NEK9	0.95	9.18	0.72	4.8e-14	Height;
SKCM	cis	rs2836974	0.863	rs6517519	chr21:40540245	A/G	cg17971929	chr21:40555470	PSMG1	0.87	8.48	0.69	1.1e-12	Cognitive function;
SKCM	cis	rs875971	0.522	rs4718285	chr7:65292005	A/G	cg11764359	chr7:65958608	NA	0.88	6.43	0.59	9.56e-9	Aortic root size;
SKCM	cis	rs28386778	0.897	rs2236736	chr17:61938248	G/T	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.13	11.24	0.79	5.64e-18	Prudent dietary pattern;
SKCM	cis	rs55962025	0.711	rs363063	chr4:3141488	G/A	cg05297308	chr4:3317976	RGS12	-0.61	-4.86	-0.48	5.96e-6	Parental longevity (mother's age at death);
SKCM	cis	rs10256972	0.577	rs4999286	chr7:1199506	C/G	cg16145915	chr7:1198662	ZFAND2A	-0.57	-8.17	-0.68	4.34e-12	Longevity;Endometriosis;
SKCM	cis	rs28595532	0.920	rs115076001	chr4:119764346	T/G	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs7193541	0.585	rs3851729	chr16:74485529	A/G	cg01733217	chr16:74700730	RFWD3	-0.97	-9.3	-0.73	2.84e-14	Multiple myeloma;
SKCM	cis	rs644799	0.687	rs11021318	chr11:95522996	T/C	cg25622487	chr11:95524042	FAM76B;CEP57	0.71	5.94	0.56	7.65e-8	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs17826219	0.500	rs2449749	chr17:29078298	C/T	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Body mass index;
SKCM	cis	rs9910055	1.000	rs9910055	chr17:42283037	C/T	cg10896456	chr17:42255109	ASB16;C17orf65	0.62	5.67	0.54	2.35e-7	Total body bone mineral density;
SKCM	cis	rs9300255	0.639	rs941306	chr12:123715113	C/T	cg00376283	chr12:123451042	ABCB9	0.83	5.37	0.52	8.04e-7	Neutrophil percentage of white cells;
SKCM	cis	rs514406	0.708	rs480299	chr1:53320274	G/T	cg16325326	chr1:53192061	ZYG11B	0.66	5.64	0.54	2.66e-7	Monocyte count;
SKCM	cis	rs875971	0.545	rs73376401	chr7:65639828	G/A	cg18876405	chr7:65276391	NA	0.64	5.29	0.51	1.09e-6	Aortic root size;
SKCM	cis	rs28374715	0.578	rs7165914	chr15:41632451	C/T	cg18705301	chr15:41695430	NDUFAF1	-1.21	-12.61	-0.82	1.61e-20	Ulcerative colitis;
SKCM	cis	rs4900538	0.892	rs4906208	chr14:102956489	G/C	cg18135206	chr14:102964638	TECPR2	0.79	6.53	0.59	6.09e-9	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs61935443	0.673	rs11107770	chr12:95275147	C/T	cg21533806	chr12:95267307	NA	-0.92	-5.35	-0.52	8.41e-7	Schizophrenia;
SKCM	cis	rs9926296	0.712	rs258330	chr16:89729574	T/G	cg01097406	chr16:89675127	NA	0.56	5.72	0.54	1.87e-7	Vitiligo;
SKCM	cis	rs838147	0.760	rs12979144	chr19:49237547	G/A	cg13540341	chr19:49222985	MAMSTR	0.68	5.88	0.55	9.73e-8	Dietary macronutrient intake;
SKCM	cis	rs9926296	0.533	rs10852623	chr16:89865242	T/C	cg27121462	chr16:89883253	FANCA	0.82	7.47	0.65	9.85e-11	Vitiligo;
SKCM	cis	rs11638352	1.000	rs4924731	chr15:44296724	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	-1.25	-4.88	-0.48	5.56e-6	Lipoprotein phospholipase A2 activity in cardiovascular disease;
SKCM	cis	rs6500395	1.000	rs12598514	chr16:48689319	T/C	cg04672837	chr16:48644449	N4BP1	-0.65	-5.43	-0.52	6.29e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	trans	rs561341	0.941	rs72825736	chr17:30330286	G/A	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs4728302	0.583	rs58955798	chr7:133158420	C/T	cg10665199	chr7:133106180	EXOC4	0.84	5.27	0.51	1.2e-6	Intelligence;Intelligence (multi-trait analysis);
SKCM	cis	rs1805008	0.568	rs118174802	chr16:90143567	C/T	cg08547343	chr16:90038815	CENPBD1;AFG3L1	-1.35	-5.3	-0.51	1.04e-6	Skin colour saturation;
SKCM	cis	rs941408	0.963	rs1640268	chr19:2791469	T/C	cg06609049	chr19:2785107	THOP1	0.82	6.64	0.6	3.79e-9	Total cholesterol levels;
SKCM	cis	rs35306767	0.903	rs61833260	chr10:975148	T/G	cg26597838	chr10:835615	NA	0.73	5.98	0.56	6.25e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs7772486	0.558	rs2142980	chr6:146080679	G/A	cg23711669	chr6:146136114	FBXO30	-0.85	-7.45	-0.64	1.09e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7100689	0.784	rs4934153	chr10:82191255	T/C	cg01528321	chr10:82214614	TSPAN14	0.98	10.94	0.78	2.01e-17	Post bronchodilator FEV1;
SKCM	cis	rs1799949	0.965	rs8070179	chr17:41202688	G/A	cg25918947	chr17:41365094	TMEM106A	-0.61	-5.63	-0.54	2.76e-7	Menopause (age at onset);
SKCM	trans	rs1814175	0.619	rs847644	chr11:49918418	G/A	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	trans	rs561341	0.941	rs8081016	chr17:30331751	A/G	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs3776081	0.734	rs9324641	chr5:149527844	A/G	cg11060666	chr5:148851518	NA	-0.37	-4.85	-0.48	6.3e-6	Blood protein levels;
SKCM	cis	rs28386778	0.863	rs9897229	chr17:61782325	T/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.06	9.5	0.73	1.15e-14	Prudent dietary pattern;
SKCM	cis	rs1568889	0.712	rs10835306	chr11:28302410	A/G	cg06544937	chr11:28130018	METT5D1;KIF18A	0.89	8.44	0.69	1.31e-12	Bipolar disorder;
SKCM	cis	rs9913156	0.748	rs7213896	chr17:4562082	G/A	cg19197139	chr17:4613644	ARRB2	0.79	5.28	0.51	1.14e-6	Lymphocyte counts;
SKCM	cis	rs2836974	0.796	rs77153312	chr21:40695499	G/A	cg11644478	chr21:40555479	PSMG1	0.82	7.19	0.63	3.43e-10	Cognitive function;
SKCM	cis	rs7659604	0.539	rs2063165	chr4:122750005	A/G	cg20573242	chr4:122745356	CCNA2	0.75	6.39	0.59	1.11e-8	Type 2 diabetes;
SKCM	cis	rs1461503	0.934	rs7107560	chr11:122845380	T/C	cg27398637	chr11:122830231	C11orf63	-0.7	-4.97	-0.49	3.8e-6	Menarche (age at onset);
SKCM	cis	rs2243480	1.000	rs937108	chr7:65428452	G/A	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs62064224	0.658	rs62065460	chr17:30715007	A/G	cg18200150	chr17:30822561	MYO1D	0.78	6.32	0.58	1.49e-8	Schizophrenia;
SKCM	cis	rs9913156	0.670	rs4416072	chr17:4570036	C/T	cg19197139	chr17:4613644	ARRB2	0.79	5.45	0.53	5.64e-7	Lymphocyte counts;
SKCM	cis	rs17376456	0.569	rs11948511	chr5:93286601	A/C	cg25358565	chr5:93447407	FAM172A	-0.71	-4.82	-0.48	7.02e-6	Diabetic retinopathy;
SKCM	cis	rs7178909	0.902	rs8033554	chr15:90441569	C/A	cg19708238	chr15:90437601	AP3S2	0.7	5.12	0.5	2.19e-6	Common traits (Other);
SKCM	cis	rs6840360	0.571	rs718800	chr4:152549307	A/T	cg22705602	chr4:152727874	NA	0.56	6.17	0.57	2.87e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs7659604	0.540	rs4075065	chr4:122683906	A/G	cg19671926	chr4:122722719	EXOSC9	0.74	6.26	0.58	1.97e-8	Type 2 diabetes;
SKCM	cis	rs7772486	0.846	rs6908063	chr6:146403618	T/C	cg23711669	chr6:146136114	FBXO30	0.86	8.52	0.69	9.39e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1218582	0.772	rs4845693	chr1:154911257	A/G	cg03351412	chr1:154909251	PMVK	-0.76	-6.47	-0.59	8.04e-9	Prostate cancer;
SKCM	cis	rs11155671	0.530	rs9969044	chr6:150209204	A/G	cg05036130	chr6:150231994	NA	0.61	6.58	0.6	4.87e-9	Testicular germ cell tumor;
SKCM	cis	rs2836974	0.568	rs2183573	chr21:40574305	A/G	cg11890956	chr21:40555474	PSMG1	-0.88	-8.91	-0.71	1.58e-13	Cognitive function;
SKCM	cis	rs9300255	0.699	rs11057204	chr12:123725827	T/C	cg00376283	chr12:123451042	ABCB9	0.87	6.06	0.57	4.57e-8	Neutrophil percentage of white cells;
SKCM	cis	rs7584330	0.704	rs7598954	chr2:238364776	C/T	cg14458575	chr2:238380390	NA	1.07	7.26	0.64	2.49e-10	Prostate cancer;
SKCM	cis	rs992157	0.735	rs13393821	chr2:219076742	C/G	cg00012203	chr2:219082015	ARPC2	0.84	7.36	0.64	1.6e-10	Colorectal cancer;
SKCM	cis	rs1451375	0.642	rs6963996	chr7:50559300	T/C	cg18232548	chr7:50535776	DDC	-0.71	-4.89	-0.48	5.33e-6	Malaria;
SKCM	cis	rs7659604	1.000	rs28618203	chr4:122663935	T/C	cg19671926	chr4:122722719	EXOSC9	-0.66	-4.98	-0.49	3.71e-6	Type 2 diabetes;
SKCM	cis	rs7772486	0.875	rs9399572	chr6:146362945	T/G	cg23711669	chr6:146136114	FBXO30	0.78	7.48	0.65	9.35e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs644799	0.965	rs573758	chr11:95539591	G/T	cg25622487	chr11:95524042	FAM76B;CEP57	0.66	5.12	0.5	2.18e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs362296	0.698	rs3095083	chr4:3263499	G/A	cg05297308	chr4:3317976	RGS12	-0.74	-6.57	-0.6	5.2e-9	Parental longevity (mother's age at death);
SKCM	cis	rs9467773	0.935	rs9461270	chr6:26544110	A/G	cg15659132	chr6:26577336	NA	0.6	5.71	0.54	1.99e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs1577917	0.740	rs9450302	chr6:86289673	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.74	6.44	0.59	9e-9	Response to antipsychotic treatment;
SKCM	cis	rs9325144	0.647	rs4616077	chr12:39092364	T/C	cg26384229	chr12:38710491	ALG10B	-0.73	-6.68	-0.6	3.21e-9	Morning vs. evening chronotype;
SKCM	cis	rs9467773	1.000	rs1884949	chr6:26568067	G/A	cg15659132	chr6:26577336	NA	0.61	5.76	0.55	1.6e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7216064	0.532	rs3890640	chr17:66053028	C/T	cg12091567	chr17:66097778	LOC651250	1.01	6.71	0.6	2.84e-9	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs1801251	1.000	rs991873	chr2:233711046	A/G	cg08000102	chr2:233561755	GIGYF2	-0.89	-7.22	-0.63	3.02e-10	Coronary artery disease;
SKCM	cis	rs2075371	0.933	rs431306	chr7:133955974	A/T	cg20476274	chr7:133979776	SLC35B4	1.03	10.88	0.78	2.61e-17	Mean platelet volume;
SKCM	cis	rs644799	0.687	rs3748252	chr11:95519195	A/T	cg03916912	chr11:95522834	CEP57;FAM76B	-0.84	-7.69	-0.66	3.76e-11	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs523522	1.000	rs1563333	chr12:120934407	C/T	cg27279351	chr12:120934652	DYNLL1	0.91	8.32	0.69	2.26e-12	High light scatter reticulocyte count;
SKCM	cis	rs875971	1.000	rs6946143	chr7:65579722	A/C	cg18876405	chr7:65276391	NA	0.64	6.33	0.58	1.45e-8	Aortic root size;
SKCM	cis	rs778371	1.000	rs709937	chr2:233744021	A/G	cg08000102	chr2:233561755	GIGYF2	0.8	5.71	0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs7438704	0.552	rs13110483	chr4:48312522	C/T	cg15299388	chr4:48491941	ZAR1	-0.44	-5.13	-0.5	2.07e-6	Inflammatory bowel disease;Crohn's disease;
SKCM	trans	rs3780486	0.713	rs3780489	chr9:33129844	G/T	cg04842962	chr6:43655489	MRPS18A	1.03	10.85	0.78	2.95e-17	IgG glycosylation;
SKCM	cis	rs6866344	0.697	rs11748495	chr5:178130000	A/G	cg03877680	chr5:178157825	ZNF354A	-0.81	-5.97	-0.56	6.55e-8	Neutrophil percentage of white cells;
SKCM	cis	rs2839186	0.560	rs9975345	chr21:47843004	T/C	cg12379764	chr21:47803548	PCNT	0.67	5.07	0.5	2.64e-6	Testicular germ cell tumor;
SKCM	cis	rs1964356	0.967	rs2953802	chr8:8851881	G/A	cg15556689	chr8:8085844	FLJ10661	0.66	5.18	0.51	1.67e-6	Mean corpuscular volume;
SKCM	cis	rs6087990	0.735	rs4911261	chr20:31391360	A/G	cg13636640	chr20:31349939	DNMT3B	0.83	6.25	0.58	2.06e-8	Ulcerative colitis;
SKCM	cis	rs3785574	1.000	rs3785574	chr17:61763185	T/C	cg01411255	chr17:61851458	DDX42;CCDC47	1.08	10.84	0.78	3.17e-17	Height;
SKCM	cis	rs936229	0.813	rs4886619	chr15:75106138	C/T	cg14664628	chr15:75095509	CSK	-1.16	-10.49	-0.77	1.43e-16	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin);
SKCM	cis	rs7555523	0.887	rs2814471	chr1:165739598	C/T	cg24409356	chr1:165738333	TMCO1	0.93	5.15	0.5	1.93e-6	Intraocular pressure;Glaucoma (high intraocular pressure);
SKCM	cis	rs245880	0.740	rs245885	chr7:29188554	A/G	cg17163760	chr7:29186267	CPVL	-0.4	-5.26	-0.51	1.23e-6	Warfarin maintenance dose;
SKCM	cis	rs6815814	0.950	rs45588337	chr4:38807328	A/G	cg02016764	chr4:38805732	TLR1	-0.76	-5.4	-0.52	6.95e-7	Breast cancer;
SKCM	cis	rs941408	0.890	rs1640269	chr19:2793194	A/C	cg06609049	chr19:2785107	THOP1	0.89	7.52	0.65	7.79e-11	Total cholesterol levels;
SKCM	cis	rs28595532	0.920	rs116717907	chr4:119762568	A/G	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs9311474	0.508	rs7652191	chr3:52610415	T/C	cg18404041	chr3:52824283	ITIH1	-0.53	-4.77	-0.48	8.42e-6	Electroencephalogram traits;
SKCM	cis	rs8180040	0.932	rs62248599	chr3:47516728	G/A	cg27129171	chr3:47204927	SETD2	-0.79	-5.79	-0.55	1.43e-7	Colorectal cancer;
SKCM	cis	rs1153858	1.000	rs2066090	chr15:45650018	T/C	cg21132104	chr15:45694354	SPATA5L1	0.93	7.94	0.67	1.22e-11	Homoarginine levels;
SKCM	cis	rs10794720	0.541	rs59686718	chr10:1166600	G/A	cg19207066	chr10:1251074	ADARB2	-0.62	-5.3	-0.51	1.05e-6	Glomerular filtration rate in non diabetics (creatinine);Chronic kidney disease;
SKCM	cis	rs28595532	1.000	rs116030177	chr4:119650768	T/C	cg21605333	chr4:119757512	SEC24D	1.24	7.1	0.63	5.16e-10	Cannabis dependence symptom count;
SKCM	cis	rs17711722	0.565	rs73372653	chr7:65442795	A/T	cg18876405	chr7:65276391	NA	0.63	5.0	0.49	3.5e-6	Calcium levels;
SKCM	cis	rs709400	0.628	rs3783394	chr14:103858673	G/A	cg26031613	chr14:104095156	KLC1	0.71	5.42	0.52	6.49e-7	Body mass index;
SKCM	cis	rs2842992	0.672	rs7738253	chr6:160193917	G/T	cg11366901	chr6:160182831	ACAT2	0.96	7.55	0.65	6.97e-11	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs10870270	1.000	rs4880250	chr10:133773919	G/A	cg17892150	chr10:133769511	PPP2R2D	-0.66	-4.86	-0.48	5.92e-6	Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals;
SKCM	cis	rs4481887	0.741	rs7417519	chr1:248550370	C/T	cg00666640	chr1:248458726	OR2T12	-0.47	-4.9	-0.49	5.07e-6	Common traits (Other);
SKCM	cis	rs933688	0.938	rs6869048	chr5:90664322	G/C	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.05	8.27	0.68	2.79e-12	Smoking behavior;
SKCM	cis	rs67311347	1.000	rs11914297	chr3:40410070	T/C	cg00091569	chr3:40428383	ENTPD3	0.65	5.58	0.53	3.36e-7	Renal cell carcinoma;
SKCM	cis	rs4077515	0.901	rs11791262	chr9:139271919	C/T	cg14169450	chr9:139327907	INPP5E	0.46	5.29	0.51	1.1e-6	Ulcerative colitis;IgA nephropathy;Inflammatory bowel disease;Crohn's disease;
SKCM	trans	rs2727020	0.576	rs1814175	chr11:49559172	T/C	cg15704280	chr7:45808275	SEPT13	-0.97	-8.53	-0.69	8.83e-13	Coronary artery disease;
SKCM	cis	rs826838	0.967	rs1719852	chr12:39128531	A/G	cg26384229	chr12:38710491	ALG10B	-0.92	-8.32	-0.69	2.26e-12	Heart rate;
SKCM	cis	rs950027	0.620	rs1145084	chr15:45675440	G/A	cg10760299	chr15:45669010	GATM	0.57	5.71	0.54	1.99e-7	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs7772486	0.641	rs67882056	chr6:146416301	T/C	cg05347473	chr6:146136440	FBXO30	0.76	6.39	0.59	1.1e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2073499	0.872	rs77097132	chr3:50301050	C/T	cg05260129	chr3:50388622	TUSC4;CYB561D2	0.94	4.86	0.48	5.86e-6	Schizophrenia;
SKCM	cis	rs7618915	0.547	rs2336542	chr3:52710636	A/G	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs2286503	1.000	rs1029740	chr7:22873586	C/A	cg15401507	chr7:22894281	NA	-0.57	-5.52	-0.53	4.35e-7	Fibrinogen;
SKCM	cis	rs116095464	0.558	rs13356367	chr5:242395	C/T	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	trans	rs10506458	0.915	rs2013050	chr12:63394310	C/T	cg03429785	chr15:59498649	MYO1E;LDHAL6B	-1.39	-7.59	-0.65	5.95e-11	Hemostatic factors and hematological phenotypes;
SKCM	trans	rs5756813	0.635	rs11089856	chr22:38205784	A/C	cg19894588	chr14:64061835	NA	-0.89	-7.5	-0.65	8.56e-11	Optic cup area;Vertical cup-disc ratio;
SKCM	cis	rs875971	0.862	rs7809814	chr7:65615397	G/A	cg11764359	chr7:65958608	NA	-0.8	-7.66	-0.66	4.2e-11	Aortic root size;
SKCM	cis	rs870825	0.616	rs4519838	chr4:185628457	A/G	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs7959452	0.868	rs10878967	chr12:69740869	T/C	cg14784868	chr12:69753453	YEATS4	0.59	4.79	0.48	7.86e-6	Blood protein levels;
SKCM	trans	rs1814175	0.817	rs10128730	chr11:50023369	G/T	cg15704280	chr7:45808275	SEPT13	-1.05	-11.07	-0.78	1.14e-17	Height;
SKCM	cis	rs208520	0.754	rs851594	chr6:66876695	A/G	cg07460842	chr6:66804631	NA	-0.91	-7.07	-0.63	5.76e-10	Exhaled nitric oxide output;
SKCM	cis	rs7772486	0.686	rs9376961	chr6:146048737	C/T	cg23711669	chr6:146136114	FBXO30	0.77	7.16	0.63	3.97e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1005277	0.579	rs2474580	chr10:38398713	G/A	cg00409905	chr10:38381863	ZNF37A	-0.66	-6.12	-0.57	3.52e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs72634258	0.836	rs9658012	chr1:7989022	C/T	cg00042356	chr1:8021962	PARK7	0.99	7.24	0.63	2.76e-10	Inflammatory bowel disease;
SKCM	cis	rs4888262	0.508	rs6564153	chr16:74658723	A/C	cg01733217	chr16:74700730	RFWD3	0.88	7.39	0.64	1.41e-10	Testicular germ cell tumor;
SKCM	cis	rs2180341	0.782	rs6912196	chr6:127722732	C/G	cg27446573	chr6:127587934	RNF146	0.68	5.19	0.51	1.63e-6	Breast cancer;
SKCM	cis	rs4555082	0.874	rs4677	chr14:105717279	T/C	cg13114125	chr14:105738426	BRF1	-0.68	-5.57	-0.53	3.53e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs2153535	0.580	rs1034273	chr6:8468145	A/G	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs5769765	0.955	rs8135816	chr22:50291976	G/C	cg22709217	chr22:50311962	ALG12;CRELD2	-0.79	-5.71	-0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs694739	0.964	rs2510066	chr11:64052447	C/T	cg23796481	chr11:64053134	BAD;GPR137	0.74	5.59	0.53	3.23e-7	Alopecia areata;Crohn's disease;Psoriasis vulgaris;
SKCM	cis	rs9911578	1.000	rs4398153	chr17:56968181	T/C	cg12560992	chr17:57184187	TRIM37	-0.94	-7.55	-0.65	7.01e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs4925325	0.956	rs1776263	chr20:60515820	A/G	cg25789511	chr20:60757919	GTPBP5	0.78	4.91	0.49	4.97e-6	Obesity-related traits;
SKCM	cis	rs2180341	0.960	rs7751865	chr6:127683040	G/A	cg27446573	chr6:127587934	RNF146	0.94	8.11	0.68	5.63e-12	Breast cancer;
SKCM	cis	rs7927771	0.832	rs6485753	chr11:47410200	C/T	cg05585544	chr11:47624801	NA	0.57	4.92	0.49	4.76e-6	Subjective well-being;
SKCM	cis	rs2999052	0.526	rs1030655	chr3:127773676	T/C	cg09089421	chr3:127803668	RUVBL1	-0.59	-5.69	-0.54	2.14e-7	Hypospadias;
SKCM	cis	rs7829975	0.514	rs2976926	chr8:8261624	T/C	cg06636001	chr8:8085503	FLJ10661	0.78	6.9	0.62	1.24e-9	Mood instability;
SKCM	cis	rs2952156	0.920	rs732083	chr17:37834367	G/A	cg20243544	chr17:37824526	PNMT	0.69	5.52	0.53	4.34e-7	Asthma;
SKCM	cis	rs9857592	1.000	rs895941	chr3:16846216	A/C	cg17339521	chr3:16555597	RFTN1	0.56	4.87	0.48	5.71e-6	Neuroticism;
SKCM	cis	rs875971	1.000	rs12533997	chr7:65965377	A/G	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs9303401	0.614	rs34683543	chr17:56520036	C/A	cg02118635	chr17:56770003	RAD51C;TEX14	0.78	5.17	0.51	1.73e-6	Cognitive test performance;
SKCM	cis	rs875971	0.862	rs949930	chr7:65766822	C/G	cg18876405	chr7:65276391	NA	-0.64	-6.35	-0.58	1.3e-8	Aortic root size;
SKCM	cis	rs1062177	1.000	rs2964571	chr5:151171256	C/T	cg00977110	chr5:151150581	G3BP1	0.82	6.75	0.61	2.32e-9	Preschool internalizing problems;
SKCM	cis	rs28595532	0.920	rs112016126	chr4:119726528	C/T	cg11846333	chr4:119757529	SEC24D	1.19	6.39	0.59	1.12e-8	Cannabis dependence symptom count;
SKCM	cis	rs2721195	1.000	rs2721195	chr8:145677011	T/C	cg15320075	chr8:145703422	NA	-0.86	-7.3	-0.64	2.1e-10	Age at first birth;
SKCM	cis	rs3820928	0.874	rs4675134	chr2:227843489	C/T	cg11843606	chr2:227700838	RHBDD1	-0.61	-4.97	-0.49	3.83e-6	Pulmonary function;
SKCM	cis	rs7659604	0.676	rs4516739	chr4:122699741	G/T	cg20573242	chr4:122745356	CCNA2	0.74	6.24	0.58	2.09e-8	Type 2 diabetes;
SKCM	cis	rs36093844	0.752	rs56036199	chr11:85548763	C/T	cg25872744	chr11:85566296	CCDC83	-0.85	-4.77	-0.48	8.27e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs7666738	0.830	rs17027225	chr4:99028564	C/T	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11098499	0.820	rs28394116	chr4:120524283	T/G	cg09307838	chr4:120376055	NA	0.99	8.0	0.67	9.34e-12	Corneal astigmatism;
SKCM	cis	rs71520386	0.632	rs12532938	chr7:22860495	A/C	cg15401507	chr7:22894281	NA	0.67	4.96	0.49	4.03e-6	Fibrinogen levels;
SKCM	cis	rs4819052	0.851	rs2838826	chr21:46655785	A/G	cg02159808	chr21:46707872	POFUT2;LOC642852	0.69	5.18	0.51	1.69e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs10421328	0.784	rs12983292	chr19:19787767	G/A	cg26732615	chr19:19648335	CILP2;YJEFN3	0.63	4.97	0.49	3.82e-6	Parental longevity (combined parental age at death);
SKCM	cis	rs4900538	0.963	rs2273905	chr14:102974999	T/C	cg18135206	chr14:102964638	TECPR2	0.79	6.53	0.59	6.09e-9	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs28595532	0.920	rs115446044	chr4:119754635	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs514406	0.698	rs11206043	chr1:53402552	C/T	cg08859206	chr1:53392774	SCP2	-0.63	-5.3	-0.51	1.07e-6	Monocyte count;
SKCM	cis	rs35079168	0.923	rs10858277	chr9:137287959	G/A	cg00753924	chr9:137298813	RXRA	-0.75	-5.07	-0.5	2.57e-6	Intelligence;
SKCM	cis	rs2228479	0.618	rs17233623	chr16:89811209	C/T	cg06558623	chr16:89946397	TCF25	1.11	6.06	0.57	4.5e-8	Skin colour saturation;
SKCM	trans	rs1814175	0.645	rs28454367	chr11:50045708	G/A	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs11717455	1.000	rs3922579	chr3:38861273	A/C	cg15678707	chr3:39149194	GORASP1;TTC21A	-0.84	-5.12	-0.5	2.12e-6	Systemic lupus erythematosus;
SKCM	cis	rs6951245	1.000	rs76129108	chr7:1089159	G/A	cg03188948	chr7:1209495	NA	1.12	6.25	0.58	2.02e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs9325144	0.624	rs10783329	chr12:39113951	C/T	cg13010199	chr12:38710504	ALG10B	-0.63	-5.35	-0.52	8.4e-7	Morning vs. evening chronotype;
SKCM	cis	rs3847687	0.901	rs12370258	chr12:131527301	G/T	cg13586425	chr12:131519906	GPR133	-0.47	-5.11	-0.5	2.19e-6	Longevity;
SKCM	cis	rs7811142	1.000	rs11769700	chr7:100090049	T/C	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-1.02	-5.76	-0.55	1.59e-7	Platelet count;
SKCM	cis	rs4665809	0.590	rs62128455	chr2:26466530	G/A	cg26119090	chr2:26468346	HADHA;HADHB	1.06	8.39	0.69	1.66e-12	Gut microbiome composition (summer);
SKCM	cis	rs2120019	0.935	rs8043181	chr15:75380424	T/C	cg17294928	chr15:75287854	SCAMP5	-0.82	-6.77	-0.61	2.13e-9	Blood trace element (Zn levels);
SKCM	cis	rs13108904	0.557	rs1680030	chr4:1245500	A/T	cg05025164	chr4:1340916	KIAA1530	-0.65	-5.11	-0.5	2.21e-6	Obesity-related traits;
SKCM	cis	rs1865760	0.534	rs72834629	chr6:26023032	C/T	cg17691542	chr6:26056736	HIST1H1C	0.77	5.93	0.56	7.77e-8	Height;
SKCM	cis	rs2832191	0.716	rs1984012	chr21:30392472	T/C	cg08807101	chr21:30365312	RNF160	0.76	6.32	0.58	1.52e-8	Dental caries;
SKCM	cis	rs1707322	0.721	rs9793568	chr1:46130373	G/A	cg03146154	chr1:46216737	IPP	0.82	6.1	0.57	3.89e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs9911578	0.803	rs8069033	chr17:57131581	T/A	cg05425664	chr17:57184151	TRIM37	0.84	6.99	0.62	8.23e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs7618915	0.547	rs11709448	chr3:52647449	T/C	cg18404041	chr3:52824283	ITIH1	-0.57	-5.07	-0.5	2.62e-6	Bipolar disorder;
SKCM	cis	rs589448	0.967	rs634512	chr12:69754012	C/T	cg22834771	chr12:69754056	YEATS4	-0.71	-5.79	-0.55	1.39e-7	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs1760803	0.754	rs12062977	chr1:154211516	C/T	cg26808167	chr1:154192205	UBAP2L;C1orf43	-0.55	-4.91	-0.49	4.87e-6	Nicotine dependence;
SKCM	cis	rs950776	0.518	rs12903129	chr15:78819606	C/T	cg06917634	chr15:78832804	PSMA4	1.02	10.37	0.76	2.46e-16	Sudden cardiac arrest;
SKCM	cis	rs7824557	0.527	rs11785394	chr8:11238029	C/T	cg21775007	chr8:11205619	TDH	-0.57	-4.8	-0.48	7.47e-6	Retinal vascular caliber;
SKCM	cis	rs7178909	0.872	rs10852124	chr15:90430464	C/T	cg19708238	chr15:90437601	AP3S2	0.72	5.22	0.51	1.43e-6	Common traits (Other);
SKCM	cis	rs4268898	0.662	rs17733015	chr2:24509370	A/G	cg06627628	chr2:24431161	ITSN2	-0.96	-7.33	-0.64	1.83e-10	Asthma;
SKCM	cis	rs2739330	0.828	rs5751770	chr22:24252842	A/G	cg12419862	chr22:24373484	LOC391322	-0.66	-6.02	-0.56	5.41e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs2014572	1.000	rs2014572	chr19:57760018	G/A	cg24459738	chr19:57751996	ZNF805	-0.64	-5.17	-0.5	1.79e-6	Hyperactive-impulsive symptoms;
SKCM	cis	rs72615157	0.561	rs113844570	chr7:99873778	A/C	cg07160278	chr7:100027354	MEPCE;ZCWPW1	0.97	5.63	0.54	2.73e-7	Lung function (FEV1/FVC);
SKCM	cis	rs12142240	0.698	rs72679807	chr1:46846490	G/A	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs1577917	0.958	rs12199832	chr6:86652748	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.85	-8.62	-0.7	5.82e-13	Response to antipsychotic treatment;
SKCM	cis	rs2842992	1.000	rs2842992	chr6:160071159	G/A	cg11366901	chr6:160182831	ACAT2	0.77	5.65	0.54	2.51e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs7552404	0.924	rs2173378	chr1:76201992	G/T	cg10523679	chr1:76189770	ACADM	0.69	5.07	0.5	2.67e-6	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs2228479	0.541	rs9922515	chr16:89954138	G/C	cg06558623	chr16:89946397	TCF25	1.25	7.18	0.63	3.53e-10	Skin colour saturation;
SKCM	cis	rs7726839	0.540	rs72703078	chr5:594987	A/C	cg10555297	chr5:473380	SLC9A3;LOC25845	1.02	4.88	0.48	5.45e-6	Obesity-related traits;
SKCM	cis	rs548181	0.736	rs540436	chr11:125512619	A/G	cg03464685	chr11:125439445	EI24	1.35	9.08	0.72	7.44e-14	Schizophrenia;Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);
SKCM	cis	rs16854884	0.657	rs6791078	chr3:143736876	A/G	cg06585982	chr3:143692056	C3orf58	0.87	8.11	0.68	5.72e-12	Economic and political preferences (feminism/equality);
SKCM	cis	rs4332037	0.950	rs11771828	chr7:1941003	T/C	cg02825527	chr7:2087843	MAD1L1	-0.73	-5.11	-0.5	2.22e-6	Bipolar disorder;
SKCM	cis	rs1865760	0.820	rs9348697	chr6:25890834	C/T	cg08401836	chr6:26032486	HIST1H3B	-0.65	-4.93	-0.49	4.55e-6	Height;
SKCM	cis	rs933688	0.938	rs1477348	chr5:90707823	G/A	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.96	6.6	0.6	4.58e-9	Smoking behavior;
SKCM	cis	rs854765	0.647	rs6826	chr17:18011140	C/T	cg04398451	chr17:18023971	MYO15A	-1.0	-9.22	-0.72	4.08e-14	Total body bone mineral density;
SKCM	cis	rs4927850	1.000	rs10881564	chr3:195750326	C/T	cg12923728	chr3:195709715	SDHAP1	-0.93	-6.36	-0.58	1.24e-8	Pancreatic cancer;
SKCM	cis	rs7666738	0.830	rs1349757	chr4:99058763	C/G	cg17366294	chr4:99064904	C4orf37	0.61	4.93	0.49	4.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7829975	0.514	rs2979151	chr8:8258019	A/G	cg15556689	chr8:8085844	FLJ10661	-0.65	-5.56	-0.53	3.62e-7	Mood instability;
SKCM	cis	rs116095464	0.558	rs2162870	chr5:228129	G/A	cg22857025	chr5:266934	NA	-1.37	-8.11	-0.68	5.82e-12	Breast cancer;
SKCM	cis	rs875971	0.862	rs1167399	chr7:65561877	G/A	cg11764359	chr7:65958608	NA	-0.83	-7.86	-0.66	1.78e-11	Aortic root size;
SKCM	cis	rs28595532	0.920	rs114653217	chr4:119769216	G/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs17818399	0.612	rs4952834	chr2:46777462	C/G	cg02822958	chr2:46747628	ATP6V1E2	0.71	5.33	0.52	9.21e-7	Height;
SKCM	cis	rs11098499	1.000	rs13435802	chr4:120177960	A/T	cg09307838	chr4:120376055	NA	-0.96	-7.62	-0.65	5.13e-11	Corneal astigmatism;
SKCM	cis	rs6121246	0.559	rs6121172	chr20:30296095	A/C	cg11595048	chr20:30225325	COX4I2	0.54	4.77	0.48	8.4e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs2836950	0.565	rs8134214	chr21:40542367	A/C	cg17971929	chr21:40555470	PSMG1	-0.76	-6.53	-0.59	6.19e-9	Menarche (age at onset);
SKCM	cis	rs11098499	0.954	rs10017543	chr4:120321420	G/A	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs854765	0.647	rs6502637	chr17:17986098	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.88	6.64	0.6	3.8e-9	Total body bone mineral density;
SKCM	cis	rs8017423	0.967	rs11159956	chr14:90715890	C/T	cg04374321	chr14:90722782	PSMC1	-0.97	-8.91	-0.71	1.61e-13	Mortality in heart failure;
SKCM	cis	rs992157	0.700	rs10165153	chr2:219159629	T/C	cg20019365	chr2:219134978	PNKD;AAMP	0.71	6.11	0.57	3.64e-8	Colorectal cancer;
SKCM	cis	rs793571	0.590	rs4775094	chr15:59115995	A/G	cg05156742	chr15:59063176	FAM63B	0.74	5.18	0.51	1.7e-6	Schizophrenia;
SKCM	cis	rs4727027	0.716	rs4727020	chr7:148837317	C/T	cg23583168	chr7:148888333	NA	-0.81	-5.58	-0.53	3.41e-7	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs1799949	0.965	rs6503727	chr17:41312859	C/T	cg05368731	chr17:41323189	NBR1	0.92	7.72	0.66	3.26e-11	Menopause (age at onset);
SKCM	cis	rs57221529	0.766	rs1399381	chr5:589853	G/T	cg09888920	chr5:474111	LOC25845;SLC9A3	0.99	4.79	0.48	7.91e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs11924390	0.789	rs822366	chr3:186452490	A/G	cg09332604	chr3:186435400	KNG1	-0.55	-5.52	-0.53	4.25e-7	Adiponectin levels;
SKCM	cis	rs854765	0.547	rs4643387	chr17:17972973	C/T	cg04398451	chr17:18023971	MYO15A	-0.82	-6.59	-0.6	4.64e-9	Total body bone mineral density;
SKCM	cis	rs1215050	1.000	rs1215050	chr4:98849826	A/G	cg17366294	chr4:99064904	C4orf37	-0.54	-4.81	-0.48	7.09e-6	Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs2243480	1.000	rs4149468	chr7:65825690	T/C	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs6545883	0.895	rs796597	chr2:61681060	A/G	cg15711740	chr2:61764176	XPO1	-0.7	-4.93	-0.49	4.5e-6	Tuberculosis;
SKCM	cis	rs2811415	0.531	rs13063727	chr3:127767618	C/G	cg09089421	chr3:127803668	RUVBL1	1.01	8.79	0.71	2.72e-13	Lung function (FEV1/FVC);
SKCM	cis	rs11098499	0.554	rs2175381	chr4:120265967	T/C	cg09307838	chr4:120376055	NA	0.96	8.24	0.68	3.19e-12	Corneal astigmatism;
SKCM	cis	rs2839186	0.900	rs56840278	chr21:47708933	T/G	cg11766577	chr21:47581405	C21orf56	-0.71	-6.01	-0.56	5.6e-8	Testicular germ cell tumor;
SKCM	cis	rs7618501	0.602	rs10049087	chr3:50123417	A/G	cg05072774	chr3:49840536	C3orf54	0.71	5.48	0.53	5e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs2836974	0.627	rs8127986	chr21:40687211	A/T	cg11890956	chr21:40555474	PSMG1	-0.79	-7.37	-0.64	1.57e-10	Cognitive function;
SKCM	cis	rs17065868	1.000	rs9533926	chr13:45190035	G/C	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs2732480	0.577	rs1489109	chr12:48738780	C/A	cg21348975	chr12:48724119	NA	-0.61	-5.2	-0.51	1.58e-6	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs3820068	0.554	rs60233444	chr1:15921330	A/C	cg13390004	chr1:15929781	NA	0.67	5.29	0.51	1.11e-6	Systolic blood pressure;
SKCM	cis	rs3768617	0.510	rs3765522	chr1:183077618	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs9611565	0.607	rs132792	chr22:42062822	C/T	cg03806693	chr22:41940476	POLR3H	0.92	6.72	0.61	2.64e-9	Vitiligo;
SKCM	cis	rs8042680	0.554	rs8036115	chr15:91528961	G/A	cg15878949	chr15:91534302	PRC1	0.58	4.87	0.48	5.82e-6	Type 2 diabetes;
SKCM	cis	rs67460515	0.892	rs6780536	chr3:161058726	T/C	cg03342759	chr3:160939853	NMD3	-0.81	-7.1	-0.63	5.14e-10	Parkinson's disease;
SKCM	cis	rs28595532	1.000	rs73842212	chr4:119638122	A/G	cg11846333	chr4:119757529	SEC24D	1.15	6.24	0.58	2.13e-8	Cannabis dependence symptom count;
SKCM	cis	rs9325144	0.602	rs10785590	chr12:38694145	C/T	cg13010199	chr12:38710504	ALG10B	0.63	5.01	0.49	3.31e-6	Morning vs. evening chronotype;
SKCM	cis	rs7829975	0.744	rs2409092	chr8:8682192	A/T	cg06636001	chr8:8085503	FLJ10661	0.79	7.34	0.64	1.8e-10	Mood instability;
SKCM	cis	rs62238980	0.614	rs116872567	chr22:32460255	G/A	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs9911578	1.000	rs11079365	chr17:56945430	T/C	cg12560992	chr17:57184187	TRIM37	0.94	7.55	0.65	7.01e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs2153535	0.563	rs3117071	chr6:8537908	C/T	cg07606381	chr6:8435919	SLC35B3	0.94	6.9	0.62	1.24e-9	Motion sickness;
SKCM	cis	rs514406	0.689	rs7548389	chr1:53404211	C/T	cg08859206	chr1:53392774	SCP2	-0.62	-4.98	-0.49	3.68e-6	Monocyte count;
SKCM	cis	rs12541335	0.639	rs68063696	chr8:22153236	A/G	cg26039829	chr8:22132926	PIWIL2	0.61	5.15	0.5	1.87e-6	Hypertriglyceridemia;
SKCM	cis	rs67311347	1.000	rs7648952	chr3:40457038	C/T	cg00091569	chr3:40428383	ENTPD3	-0.58	-4.96	-0.49	4.04e-6	Renal cell carcinoma;
SKCM	cis	rs875971	0.862	rs12537823	chr7:65720884	C/T	cg11764359	chr7:65958608	NA	0.84	8.35	0.69	1.94e-12	Aortic root size;
SKCM	cis	rs12120353	0.702	rs780611	chr1:4551455	A/G	cg15022359	chr1:4193126	NA	-0.6	-5.21	-0.51	1.47e-6	Anxiety disorder;
SKCM	cis	rs514406	0.661	rs550561	chr1:53375134	C/T	cg24675658	chr1:53192096	ZYG11B	-0.82	-7.84	-0.66	1.89e-11	Monocyte count;
SKCM	cis	rs7659604	0.967	rs34949254	chr4:122664344	G/A	cg19671926	chr4:122722719	EXOSC9	-0.66	-4.98	-0.49	3.71e-6	Type 2 diabetes;
SKCM	cis	rs514406	0.679	rs960570	chr1:53237763	A/G	cg24675658	chr1:53192096	ZYG11B	0.89	8.03	0.67	8.33e-12	Monocyte count;
SKCM	cis	rs1348850	0.645	rs11889272	chr2:178432378	C/T	cg02961200	chr2:178257176	LOC100130691;AGPS	0.85	4.97	0.49	3.91e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs6545883	0.859	rs62149714	chr2:61603869	T/G	cg15711740	chr2:61764176	XPO1	0.68	4.82	0.48	6.94e-6	Tuberculosis;
SKCM	cis	rs703842	0.616	rs4760171	chr12:58225904	A/G	cg00677455	chr12:58241039	CTDSP2	0.73	5.82	0.55	1.25e-7	Multiple sclerosis;
SKCM	cis	rs10870270	0.956	rs7904594	chr10:133734671	C/T	cg17892150	chr10:133769511	PPP2R2D	-0.66	-4.89	-0.48	5.37e-6	Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals;
SKCM	cis	rs7811142	1.000	rs11773661	chr7:100073069	G/C	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.12	6.51	0.59	6.68e-9	Platelet count;
SKCM	cis	rs873946	0.586	rs3793685	chr10:134569316	G/A	cg26818010	chr10:134567672	INPP5A	-0.8	-6.11	-0.57	3.7e-8	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs2153535	0.580	rs7767926	chr6:8453557	A/G	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs12477438	0.520	rs2516835	chr2:99779131	T/C	cg26064155	chr2:99771622	LIPT1;TSGA10	1.03	9.69	0.74	5.05e-15	Chronic sinus infection;
SKCM	cis	rs80282103	0.618	rs74117850	chr10:1165777	T/C	cg19207066	chr10:1251074	ADARB2	-0.76	-4.94	-0.49	4.41e-6	Glomerular filtration rate (creatinine);
SKCM	cis	rs875971	1.000	rs6460295	chr7:65882728	T/C	cg11764359	chr7:65958608	NA	0.87	8.35	0.69	2.01e-12	Aortic root size;
SKCM	cis	rs854765	0.724	rs62072049	chr17:17906520	T/C	cg04398451	chr17:18023971	MYO15A	-0.84	-6.21	-0.58	2.42e-8	Total body bone mineral density;
SKCM	cis	rs10779751	0.734	rs6701726	chr1:11126941	C/T	cg08854313	chr1:11322531	MTOR	0.77	5.52	0.53	4.36e-7	Body mass index;
SKCM	cis	rs2066819	1.000	rs2695789	chr12:56694261	C/A	cg26714650	chr12:56694279	CS	1.71	6.71	0.61	2.74e-9	Psoriasis vulgaris;
SKCM	cis	rs1862618	0.671	rs252897	chr5:56223000	G/A	cg03609598	chr5:56110824	MAP3K1	-0.75	-5.29	-0.51	1.09e-6	Initial pursuit acceleration;
SKCM	cis	rs12497850	0.865	rs13072911	chr3:48962128	T/G	cg06212747	chr3:49208901	KLHDC8B	0.68	4.9	0.49	5.06e-6	Parkinson's disease;
SKCM	cis	rs2072510	0.722	rs2540490	chr12:96426272	C/T	cg18817487	chr12:96390143	HAL	0.43	5.68	0.54	2.18e-7	Metabolite levels (small molecules and protein measures);
SKCM	cis	rs10751667	0.643	rs11246344	chr11:933783	A/C	cg10932868	chr11:921992	NA	0.55	5.13	0.5	2.09e-6	Alzheimer's disease (late onset);
SKCM	cis	rs7937682	0.737	rs679032	chr11:111423286	G/T	cg09085632	chr11:111637200	PPP2R1B	-0.81	-6.99	-0.62	8.14e-10	Primary sclerosing cholangitis;
SKCM	cis	rs8177253	0.763	rs6797713	chr3:133474832	T/C	cg16414030	chr3:133502952	NA	-0.58	-4.8	-0.48	7.46e-6	Iron status biomarkers;
SKCM	cis	rs595982	0.702	rs609985	chr19:49370648	A/G	cg19746536	chr19:49375674	PPP1R15A	1.26	15.59	0.87	1.12e-25	Red cell distribution width;
SKCM	cis	rs6087771	0.821	rs6058444	chr20:30315137	A/G	cg11595048	chr20:30225325	COX4I2	0.55	4.81	0.48	7.22e-6	Subcortical brain region volumes;Putamen volume;
SKCM	cis	rs908922	0.676	rs1123567	chr1:152516023	G/A	cg09873164	chr1:152488093	CRCT1	0.76	5.93	0.56	7.7e-8	Hair morphology;
SKCM	cis	rs25645	0.760	rs11870683	chr17:38129841	T/A	cg17467752	chr17:38218738	THRA	-0.75	-6.0	-0.56	5.86e-8	Myeloid white cell count;
SKCM	cis	rs7618915	0.501	rs62253740	chr3:52684128	A/T	cg18404041	chr3:52824283	ITIH1	-0.53	-4.77	-0.48	8.42e-6	Bipolar disorder;
SKCM	cis	rs2153535	0.541	rs9328471	chr6:8468842	T/C	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs1799949	1.000	rs8176145	chr17:41249094	A/G	cg05368731	chr17:41323189	NBR1	0.89	7.49	0.65	9.23e-11	Menopause (age at onset);
SKCM	cis	rs2836974	0.965	rs2836967	chr21:40639102	T/G	cg11890956	chr21:40555474	PSMG1	1.09	13.73	0.84	1.66e-22	Cognitive function;
SKCM	cis	rs9399137	0.507	rs13197750	chr6:135312380	G/A	cg24558204	chr6:135376177	HBS1L	0.7	6.53	0.59	6.11e-9	Glycated hemoglobin levels;Mean corpuscular volume;Hematology traits;HbA2 levels;Mean corpuscular hemoglobin;Hemoglobin levels;F-cell distribution;Platelet count;
SKCM	cis	rs28595532	1.000	rs28595532	chr4:119716950	A/C	cg14228332	chr4:119757509	SEC24D	1.07	5.49	0.53	4.77e-7	Cannabis dependence symptom count;
SKCM	cis	rs6545883	0.929	rs10200055	chr2:61628017	T/A	cg15711740	chr2:61764176	XPO1	0.71	5.03	0.49	3.1e-6	Tuberculosis;
SKCM	cis	rs17376456	0.877	rs10055340	chr5:93317644	T/C	cg25358565	chr5:93447407	FAM172A	1.23	7.26	0.63	2.53e-10	Diabetic retinopathy;
SKCM	cis	rs9467773	0.620	rs2494700	chr6:26631306	C/T	cg09904177	chr6:26538194	HMGN4	0.58	5.01	0.49	3.28e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7811142	1.000	rs7783159	chr7:100017454	C/T	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.22	7.89	0.67	1.53e-11	Platelet count;
SKCM	cis	rs59918340	0.738	rs3739235	chr8:142229145	A/G	cg23750338	chr8:142222470	SLC45A4	0.61	5.82	0.55	1.24e-7	Immature fraction of reticulocytes;
SKCM	cis	rs7772486	0.875	rs2777477	chr6:146305491	A/G	cg23711669	chr6:146136114	FBXO30	0.76	6.83	0.61	1.66e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6121246	0.559	rs6060932	chr20:30350545	A/G	cg11595048	chr20:30225325	COX4I2	0.54	4.77	0.48	8.4e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs2739330	0.731	rs5751792	chr22:24401542	G/A	cg24846343	chr22:24311635	DDTL	0.56	5.05	0.5	2.87e-6	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs6430585	0.527	rs1438303	chr2:136429857	C/T	cg07169764	chr2:136633963	MCM6	1.02	7.68	0.66	3.84e-11	Corneal structure;
SKCM	cis	rs769267	0.965	rs4808200	chr19:19554803	C/T	cg03709012	chr19:19516395	GATAD2A	0.89	8.62	0.7	5.89e-13	Tonsillectomy;
SKCM	cis	rs7599312	0.534	rs6751692	chr2:213408120	C/T	cg20637307	chr2:213403960	ERBB4	0.76	5.6	0.54	3.12e-7	BMI (adjusted for smoking behaviour);BMI in non-smokers;Body mass index;Body mass index (joint analysis main effects and smoking interaction);
SKCM	cis	rs2777491	1.000	rs66538814	chr15:41685917	G/T	cg18705301	chr15:41695430	NDUFAF1	-0.93	-9.74	-0.74	4e-15	Ulcerative colitis;
SKCM	cis	rs6598955	0.515	rs61776655	chr1:26541430	T/C	cg04990556	chr1:26633338	UBXN11	-0.65	-5.12	-0.5	2.12e-6	Obesity-related traits;
SKCM	cis	rs12477438	0.834	rs10179043	chr2:99687490	T/C	cg26064155	chr2:99771622	LIPT1;TSGA10	-0.72	-4.86	-0.48	6e-6	Chronic sinus infection;
SKCM	cis	rs2816062	0.813	rs6698315	chr1:18895806	A/G	cg18795169	chr1:18902165	NA	-0.82	-8.63	-0.7	5.69e-13	Urate levels in lean individuals;
SKCM	cis	rs7447593	0.626	rs3812036	chr5:176813404	C/T	cg17509989	chr5:176798049	RGS14	0.8	7.0	0.62	7.98e-10	Urinary electrolytes (magnesium/calcium ratio);
SKCM	cis	rs10504229	1.000	rs74546828	chr8:58171678	A/G	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs910316	0.737	rs175043	chr14:75471803	G/A	cg08847533	chr14:75593920	NEK9	-0.8	-6.59	-0.6	4.76e-9	Height;
SKCM	cis	rs748404	0.560	rs529611	chr15:43805988	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	0.71	5.37	0.52	7.82e-7	Lung cancer;
SKCM	cis	rs875971	0.830	rs7799834	chr7:65880694	A/C	cg11764359	chr7:65958608	NA	0.87	8.35	0.69	2.01e-12	Aortic root size;
SKCM	cis	rs2070488	0.689	rs6809352	chr3:38544349	G/A	cg01465620	chr3:38496096	LOC100128640;ACVR2B	-0.74	-5.92	-0.56	8.05e-8	Electrocardiographic conduction measures;
SKCM	cis	rs55962025	0.883	rs3121419	chr4:3232257	C/T	cg05297308	chr4:3317976	RGS12	-0.67	-4.88	-0.48	5.51e-6	Parental longevity (mother's age at death);
SKCM	cis	rs72634258	0.786	rs6682709	chr1:8173796	A/C	cg00042356	chr1:8021962	PARK7	-0.79	-5.1	-0.5	2.3e-6	Inflammatory bowel disease;
SKCM	cis	rs2404602	0.583	rs12898415	chr15:76574232	C/T	cg22467129	chr15:76604101	ETFA	-0.65	-5.35	-0.52	8.68e-7	Blood metabolite levels;
SKCM	cis	rs314370	0.818	rs12705091	chr7:100472380	C/T	cg10426581	chr7:100472382	SRRT	0.75	5.4	0.52	6.98e-7	Resting heart rate;
SKCM	cis	rs10504229	0.906	rs903718	chr8:58167726	A/G	cg22535103	chr8:58192502	C8orf71	-0.68	-4.82	-0.48	7.06e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs4319547	0.626	rs11057882	chr12:122875046	A/G	cg23029597	chr12:123009494	RSRC2	-0.72	-5.31	-0.52	1.01e-6	Body mass index;
SKCM	cis	rs738321	0.794	rs6001026	chr22:38545363	C/T	cg25457927	chr22:38595422	NA	-0.58	-6.88	-0.61	1.34e-9	Breast cancer;
SKCM	cis	rs7927771	0.832	rs11601603	chr11:47401171	A/C	cg01152729	chr11:47593274	PTPMT1	-0.51	-4.88	-0.48	5.49e-6	Subjective well-being;
SKCM	cis	rs7666738	0.830	rs60391193	chr4:98933912	T/G	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs947211	0.750	rs5014255	chr1:205753870	C/A	cg07157834	chr1:205819609	PM20D1	0.68	5.19	0.51	1.62e-6	Parkinson's disease;
SKCM	cis	rs9457247	0.544	rs6920858	chr6:167464630	G/A	cg13927040	chr6:167453801	FGFR1OP	0.67	4.81	0.48	7.25e-6	Crohn's disease;
SKCM	cis	rs701145	0.585	rs1713846	chr3:153787632	C/T	cg17054900	chr3:154042577	DHX36	1.12	5.04	0.5	2.91e-6	Coronary artery disease;
SKCM	cis	rs2935183	1	rs2935183	chr17:45607572	T/G	cg25173405	chr17:45401733	C17orf57	0.56	5.13	0.5	2.07e-6	Multiple sclerosis or amyotrophic lateral sclerosis;
SKCM	cis	rs854765	0.583	rs9908832	chr17:17871068	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.01	7.49	0.65	9.28e-11	Total body bone mineral density;
SKCM	cis	rs2204008	0.694	rs10880262	chr12:38328696	C/T	cg26384229	chr12:38710491	ALG10B	0.77	6.03	0.56	5.2100000000000003e-08	Bladder cancer;
SKCM	cis	rs1799949	1.000	rs33945274	chr17:41280073	G/A	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.11	-0.57	3.67e-8	Menopause (age at onset);
SKCM	cis	rs71520386	0.632	rs12535331	chr7:22878104	G/T	cg15401507	chr7:22894281	NA	-0.65	-4.88	-0.48	5.54e-6	Fibrinogen levels;
SKCM	cis	rs7618501	0.633	rs13060128	chr3:50025028	A/G	cg05072774	chr3:49840536	C3orf54	-0.67	-5.06	-0.5	2.73e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9300255	0.544	rs1716175	chr12:123658388	A/T	cg05973401	chr12:123451056	ABCB9	0.83	5.14	0.5	2.01e-6	Neutrophil percentage of white cells;
SKCM	cis	rs1843834	0.505	rs940317	chr2:225358118	C/T	cg12698349	chr2:225449008	CUL3	0.84	6.93	0.62	1.09e-9	IgE levels in asthmatics (D.p. specific);
SKCM	cis	rs17376456	0.866	rs13356088	chr5:93423479	C/T	cg25358565	chr5:93447407	FAM172A	1.29	8.23	0.68	3.32e-12	Diabetic retinopathy;
SKCM	cis	rs2204008	0.576	rs11519979	chr12:37999413	C/T	cg26384229	chr12:38710491	ALG10B	0.8	6.2	0.57	2.47e-8	Bladder cancer;
SKCM	cis	rs1048238	0.525	rs848214	chr1:16265422	A/G	cg21385522	chr1:16154831	NA	-0.65	-5.61	-0.54	2.91e-7	Systolic blood pressure;
SKCM	cis	rs8072100	0.840	rs9900360	chr17:45491979	C/T	cg08085267	chr17:45401833	C17orf57	-0.62	-5.15	-0.5	1.88e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs1577917	0.958	rs1591438	chr6:86525214	G/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.86	-8.7	-0.7	4.12e-13	Response to antipsychotic treatment;
SKCM	cis	rs2153535	0.580	rs1115079	chr6:8449615	G/C	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs910316	0.935	rs175076	chr14:75505486	A/G	cg08847533	chr14:75593920	NEK9	-0.93	-8.59	-0.7	6.87e-13	Height;
SKCM	cis	rs2204008	0.837	rs12146734	chr12:38237079	A/G	cg13010199	chr12:38710504	ALG10B	0.69	4.99	0.49	3.57e-6	Bladder cancer;
SKCM	cis	rs2836974	0.644	rs2410123	chr21:40700093	C/T	cg17971929	chr21:40555470	PSMG1	-0.71	-6.2	-0.57	2.5e-8	Cognitive function;
SKCM	cis	rs208520	0.526	rs7771233	chr6:66819784	A/G	cg07460842	chr6:66804631	NA	-1.07	-12.27	-0.81	6.87e-20	Exhaled nitric oxide output;
SKCM	cis	rs3784262	0.904	rs12901462	chr15:58316487	A/G	cg12031962	chr15:58353849	ALDH1A2	-0.5	-6.27	-0.58	1.85e-8	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs6500395	0.735	rs74017013	chr16:48664120	G/A	cg04672837	chr16:48644449	N4BP1	0.6	4.88	0.48	5.59e-6	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs533581	0.866	rs865102	chr16:88969969	A/G	cg16701003	chr16:89028210	CBFA2T3	0.54	5.03	0.49	3.05e-6	Social autistic-like traits;
SKCM	cis	rs4803468	1.000	rs2231940	chr19:41944237	T/C	cg09537434	chr19:41945824	ATP5SL	1.1	13.21	0.83	1.39e-21	Height;
SKCM	cis	rs7666738	0.791	rs34088022	chr4:99001508	G/T	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs55823223	0.838	rs61510938	chr17:73882692	T/A	cg08125733	chr17:73851984	WBP2	1.0	5.3	0.51	1.03e-6	Psoriasis;
SKCM	cis	rs6840360	0.554	rs10222838	chr4:152690099	T/C	cg22705602	chr4:152727874	NA	-0.59	-7.93	-0.67	1.3e-11	Intelligence (multi-trait analysis);
SKCM	trans	rs208520	0.690	rs12197578	chr6:66725905	C/T	cg15611600	chr13:45563400	KIAA1704;NUFIP1	0.92	7.5	0.65	8.68e-11	Exhaled nitric oxide output;
SKCM	cis	rs801193	0.839	rs6968619	chr7:66068867	T/C	cg11987759	chr7:65425863	GUSB	0.69	6.02	0.56	5.47e-8	Aortic root size;
SKCM	cis	rs6430585	0.527	rs7592050	chr2:136459227	C/T	cg07169764	chr2:136633963	MCM6	-1.02	-7.68	-0.66	3.84e-11	Corneal structure;
SKCM	cis	rs870825	0.860	rs60523653	chr4:185604676	T/C	cg04058563	chr4:185651563	MLF1IP	1.04	5.96	0.56	7.02e-8	Blood protein levels;
SKCM	cis	rs11209185	0.563	rs10889735	chr1:68435400	T/C	cg17031739	chr1:67600172	NA	0.5	4.84	0.48	6.45e-6	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs7829975	0.577	rs7816329	chr8:8543843	G/A	cg06636001	chr8:8085503	FLJ10661	-0.7	-4.87	-0.48	5.71e-6	Mood instability;
SKCM	cis	rs992157	0.717	rs3817266	chr2:219142594	C/T	cg20019365	chr2:219134978	PNKD;AAMP	-0.72	-6.22	-0.58	2.33e-8	Colorectal cancer;
SKCM	cis	rs992157	0.764	rs10193189	chr2:219187603	C/A	cg20019365	chr2:219134978	PNKD;AAMP	0.7	5.52	0.53	4.3e-7	Colorectal cancer;
SKCM	cis	rs2836974	0.865	rs7282624	chr21:40667040	C/T	cg11890956	chr21:40555474	PSMG1	0.99	11.14	0.78	8.38e-18	Cognitive function;
SKCM	cis	rs9463078	0.774	rs6934594	chr6:45319876	A/G	cg25276700	chr6:44698697	NA	-0.41	-5.01	-0.49	3.29e-6	Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder;
SKCM	cis	rs12478296	1.000	rs56136197	chr2:243043877	T/C	cg06360820	chr2:242988706	NA	-0.92	-5.32	-0.52	9.84e-7	Obesity-related traits;
SKCM	cis	rs1790761	0.520	rs12800028	chr11:67403285	A/G	cg24690094	chr11:67383802	NA	-0.64	-6.18	-0.57	2.74e-8	Mean corpuscular volume;
SKCM	cis	rs12477438	0.520	rs11890338	chr2:99767868	C/T	cg14399236	chr2:99771627	LIPT1;TSGA10	0.97	8.9	0.71	1.72e-13	Chronic sinus infection;
SKCM	cis	rs35306767	0.855	rs12770190	chr10:951262	C/T	cg25614935	chr10:1084866	C10orf110	0.82	5.33	0.52	9.4e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs9916302	0.851	rs2338795	chr17:37399364	T/G	cg07936489	chr17:37558343	FBXL20	-0.89	-7.66	-0.66	4.35e-11	Glomerular filtration rate (creatinine);
SKCM	cis	rs6570726	0.846	rs409553	chr6:145886963	C/T	cg23711669	chr6:146136114	FBXO30	0.81	8.51	0.69	9.71e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs8060686	0.641	rs79719939	chr16:68240216	A/G	cg09117114	chr16:67998030	SLC12A4	-0.77	-5.03	-0.49	3.12e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs34779708	0.931	rs11010067	chr10:35295431	C/G	cg03585969	chr10:35415529	CREM	-0.72	-5.75	-0.55	1.67e-7	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs72949976	0.584	rs12467619	chr2:214022933	T/C	cg08319019	chr2:214017104	IKZF2	0.84	6.86	0.61	1.47e-9	Lung cancer;Squamous cell lung carcinoma;
SKCM	cis	rs28595532	0.920	rs115242199	chr4:119728652	A/C	cg21605333	chr4:119757512	SEC24D	1.36	8.05	0.67	7.69e-12	Cannabis dependence symptom count;
SKCM	cis	rs10744422	1.000	rs7972447	chr12:123354545	C/G	cg25930673	chr12:123319894	HIP1R	-0.89	-4.84	-0.48	6.38e-6	Schizophrenia;
SKCM	cis	rs2836974	0.602	rs8130854	chr21:40707041	G/A	cg11644478	chr21:40555479	PSMG1	-0.66	-5.44	-0.52	5.98e-7	Cognitive function;
SKCM	cis	rs7772486	0.875	rs2814872	chr6:146310234	T/C	cg23711669	chr6:146136114	FBXO30	0.75	6.79	0.61	1.99e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6547631	0.682	rs4832187	chr2:85929675	A/G	cg24620635	chr2:85921963	GNLY	0.97	8.42	0.69	1.45e-12	Blood protein levels;
SKCM	cis	rs12497850	0.931	rs9311433	chr3:48863835	T/C	cg07636037	chr3:49044803	WDR6	1.01	10.82	0.77	3.36e-17	Parkinson's disease;
SKCM	cis	rs2404602	0.709	rs11072597	chr15:76763514	C/A	cg23625390	chr15:77176239	SCAPER	-0.83	-8.16	-0.68	4.7e-12	Blood metabolite levels;
SKCM	cis	rs7613875	0.600	rs1061474	chr3:50144951	T/C	cg24110177	chr3:50126178	RBM5	0.73	5.81	0.55	1.28e-7	Body mass index;
SKCM	cis	rs67311347	1.000	rs977652	chr3:40479169	A/G	cg00091569	chr3:40428383	ENTPD3	0.6	5.02	0.49	3.22e-6	Renal cell carcinoma;
SKCM	cis	rs6570726	0.902	rs406979	chr6:145838983	G/T	cg23711669	chr6:146136114	FBXO30	0.73	7.14	0.63	4.25e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs12142240	0.698	rs1135460	chr1:46815970	T/C	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs875971	1.000	rs2420820	chr7:66091907	T/C	cg18876405	chr7:65276391	NA	-0.68	-6.83	-0.61	1.63e-9	Aortic root size;
SKCM	cis	rs2832191	0.903	rs11700687	chr21:30486767	A/G	cg24692254	chr21:30365293	RNF160	-0.79	-7.24	-0.63	2.71e-10	Dental caries;
SKCM	cis	rs2032447	0.869	rs199752	chr6:26012875	C/T	cg18357526	chr6:26021779	HIST1H4A	0.83	6.24	0.58	2.07e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs637571	0.522	rs528736	chr11:65705108	A/G	cg02427764	chr11:65769310	BANF1;EIF1AD	0.8	6.35	0.58	1.33e-8	Eosinophil percentage of white cells;
SKCM	cis	rs9814567	1.000	rs10804632	chr3:134294501	T/A	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs9303401	0.659	rs62081316	chr17:56781499	C/T	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.16	0.57	2.91e-8	Cognitive test performance;
SKCM	cis	rs62238980	0.614	rs117628874	chr22:32452970	T/C	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs1799949	0.683	rs55737636	chr17:41264739	C/T	cg05368731	chr17:41323189	NBR1	0.87	7.28	0.64	2.33e-10	Menopause (age at onset);
SKCM	cis	rs1348850	0.645	rs4893963	chr2:178430747	A/G	cg05310760	chr2:178500282	PDE11A	0.61	4.87	0.48	5.72e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs7103648	0.966	rs1534576	chr11:47419663	A/C	cg20307385	chr11:47447363	PSMC3	-1.06	-9.06	-0.72	8.24e-14	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs2243480	1.000	rs55895244	chr7:65387678	C/G	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs933360	0.585	rs10281065	chr7:50829973	G/T	cg01220564	chr7:50633119	DDC	-0.41	-4.85	-0.48	6.12e-6	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;Area under the curve of insulin levels;Insulin levels adjusted for BMI;Ratio of the area under the curve for insulin and the area under the curve for glucose;Incremental insulin;
SKCM	cis	rs1506636	1.000	rs689341	chr7:123403974	C/A	cg03229431	chr7:123269106	ASB15	0.64	5.21	0.51	1.48e-6	Plateletcrit;Platelet count;
SKCM	cis	rs56104184	0.775	rs55981795	chr19:49401952	A/C	cg19746536	chr19:49375674	PPP1R15A	1.16	5.93	0.56	7.67e-8	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs440932	0.717	rs330944	chr8:9021293	C/T	cg06636001	chr8:8085503	FLJ10661	0.64	4.82	0.48	6.95e-6	High light scatter reticulocyte percentage of red cells;
SKCM	cis	rs651907	0.514	rs12636047	chr3:101434449	T/C	cg12386194	chr3:101231763	SENP7	0.69	5.68	0.54	2.23e-7	Colorectal cancer;
SKCM	cis	rs875971	0.638	rs801205	chr7:66022144	C/A	cg18876405	chr7:65276391	NA	-0.8	-7.11	-0.63	4.86e-10	Aortic root size;
SKCM	cis	rs35306767	0.812	rs1013504	chr10:952816	T/C	cg26597838	chr10:835615	NA	0.85	6.07	0.57	4.39e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs9880211	0.563	rs67589653	chr3:135811574	T/C	cg21827317	chr3:136751795	NA	-0.67	-4.9	-0.49	5.06e-6	Body mass index;Height;
SKCM	cis	rs9951698	0.703	rs9949589	chr18:12999754	C/T	cg12848697	chr18:13133368	NA	0.53	4.9	0.48	5.18e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs28595532	0.920	rs55671478	chr4:119753811	A/G	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs1218582	0.741	rs4339857	chr1:154888962	A/G	cg24250549	chr1:154909240	PMVK	0.87	8.7	0.7	4.13e-13	Prostate cancer;
SKCM	cis	rs8072100	0.967	rs8072644	chr17:45653364	A/T	cg25173405	chr17:45401733	C17orf57	0.56	5.05	0.5	2.8e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs4819052	0.679	rs2255761	chr21:46683622	A/G	cg02159808	chr21:46707872	POFUT2;LOC642852	0.65	5.0	0.49	3.44e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs6977660	0.652	rs12673842	chr7:19747437	T/C	cg02470904	chr7:20686108	ABCB5	1.14	5.27	0.51	1.16e-6	Thyroid stimulating hormone;
SKCM	cis	rs28595532	0.920	rs114162429	chr4:119741078	T/C	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs727563	0.565	rs132774	chr22:42031953	C/G	cg03806693	chr22:41940476	POLR3H	-0.97	-6.34	-0.58	1.4e-8	Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs8180040	0.726	rs7610636	chr3:47064436	A/C	cg27129171	chr3:47204927	SETD2	-0.77	-5.77	-0.55	1.51e-7	Colorectal cancer;
SKCM	cis	rs854765	0.547	rs2955372	chr17:17970229	T/C	cg24612305	chr17:17875800	TOM1L2;LRRC48	-1.05	-9.29	-0.72	2.92e-14	Total body bone mineral density;
SKCM	cis	rs57221529	0.664	rs72704802	chr5:554211	C/T	cg26208419	chr5:473447	SLC9A3;LOC25845	1.03	5.12	0.5	2.11e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs2180341	1.000	rs7756336	chr6:127650299	T/C	cg24812749	chr6:127587940	RNF146	0.85	7.3	0.64	2.08e-10	Breast cancer;
SKCM	cis	rs875971	0.862	rs949930	chr7:65766822	C/G	cg11764359	chr7:65958608	NA	-0.81	-7.61	-0.65	5.44e-11	Aortic root size;
SKCM	cis	rs2905347	0.560	rs2961293	chr7:22684084	G/A	cg11983867	chr7:22539820	MGC87042	-0.48	-4.86	-0.48	5.88e-6	Major depression and alcohol dependence;
SKCM	cis	rs7208859	0.673	rs56846352	chr17:29119188	C/T	cg14067834	chr17:29058358	SUZ12P	0.98	5.1	0.5	2.3e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs9467773	0.596	rs2494693	chr6:26619226	T/C	cg09904177	chr6:26538194	HMGN4	0.58	5.01	0.49	3.28e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7666738	0.830	rs11721726	chr4:98996314	T/C	cg17366294	chr4:99064904	C4orf37	0.6	4.98	0.49	3.8e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs3749237	0.595	rs1464566	chr3:49459376	T/C	cg02487422	chr3:49467188	NICN1	0.64	4.79	0.48	7.67e-6	Resting heart rate;
SKCM	cis	rs9910055	0.593	rs58392387	chr17:42297889	A/G	cg08499158	chr17:42289980	UBTF	-0.86	-7.69	-0.66	3.74e-11	Total body bone mineral density;
SKCM	cis	rs4665809	0.556	rs10221814	chr2:26442759	C/T	cg26119090	chr2:26468346	HADHA;HADHB	-1.03	-7.99	-0.67	9.69e-12	Gut microbiome composition (summer);
SKCM	cis	rs4481887	0.927	rs4537599	chr1:248508741	G/A	cg00666640	chr1:248458726	OR2T12	0.63	5.39	0.52	7.39e-7	Common traits (Other);
SKCM	cis	rs12971120	0.947	rs8084109	chr18:72168312	T/A	cg26446133	chr18:72167187	CNDP2	-0.67	-5.65	-0.54	2.54e-7	Refractive error;
SKCM	cis	rs10927875	0.619	rs1806991	chr1:16129441	T/C	cg21385522	chr1:16154831	NA	-0.75	-7.13	-0.63	4.51e-10	Dilated cardiomyopathy;
SKCM	cis	rs17065868	0.881	rs7325282	chr13:45070519	T/A	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs9322193	0.567	rs7742692	chr6:150213499	A/G	cg05036130	chr6:150231994	NA	0.61	6.58	0.6	4.87e-9	Lung cancer;
SKCM	cis	rs995000	0.931	rs10889339	chr1:63012056	A/G	cg06896770	chr1:63153194	DOCK7	-0.73	-6.54	-0.6	5.83e-9	Triglyceride levels;
SKCM	trans	rs17685	0.712	rs1859794	chr7:75821544	G/A	cg19862616	chr7:65841803	NCRNA00174	0.94	10.39	0.76	2.25e-16	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs6089584	0.528	rs4925335	chr20:60627034	G/A	cg16423285	chr20:60520624	NA	-0.58	-4.92	-0.49	4.77e-6	Body mass index;
SKCM	cis	rs763121	0.853	rs2179142	chr22:39037954	G/A	cg06022373	chr22:39101656	GTPBP1	0.77	5.22	0.51	1.46e-6	Menopause (age at onset);
SKCM	cis	rs4665809	0.567	rs6711402	chr2:26430983	A/G	cg26119090	chr2:26468346	HADHA;HADHB	-1.0	-7.59	-0.65	5.9e-11	Gut microbiome composition (summer);
SKCM	cis	rs17685	0.753	rs11764129	chr7:75761890	T/C	cg16684958	chr7:75615977	POR	0.55	5.27	0.51	1.19e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs367615	0.552	rs10042721	chr5:108713970	C/T	cg17395555	chr5:108820864	NA	-0.65	-5.34	-0.52	8.86e-7	Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs453301	0.686	rs3895823	chr8:8873646	T/C	cg06636001	chr8:8085503	FLJ10661	-0.76	-5.76	-0.55	1.58e-7	Joint mobility (Beighton score);
SKCM	cis	rs7772486	0.764	rs7745696	chr6:146162829	T/C	cg05347473	chr6:146136440	FBXO30	0.57	5.44	0.52	5.87e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2413583	0.591	rs115371106	chr22:39726809	G/A	cg17798944	chr22:39715225	SNORD43;RPL3	0.93	5.29	0.51	1.11e-6	Ulcerative colitis;Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs7523273	0.586	rs2796276	chr1:207951513	G/A	cg22525895	chr1:207977042	MIR29B2	0.81	7.08	0.63	5.47e-10	Schizophrenia;
SKCM	cis	rs2153535	0.580	rs2327057	chr6:8443319	G/A	cg23788917	chr6:8435910	SLC35B3	0.69	5.14	0.5	1.99e-6	Motion sickness;
SKCM	cis	rs2836974	0.568	rs2836969	chr21:40648265	G/A	cg11890956	chr21:40555474	PSMG1	-0.88	-9.02	-0.71	9.89e-14	Cognitive function;
SKCM	cis	rs6545883	0.929	rs3732170	chr2:61749716	C/T	cg15711740	chr2:61764176	XPO1	-0.75	-5.3	-0.51	1.06e-6	Tuberculosis;
SKCM	cis	rs769267	0.965	rs2074299	chr19:19380646	T/C	cg03709012	chr19:19516395	GATAD2A	0.81	6.49	0.59	7.18e-9	Tonsillectomy;
SKCM	cis	rs2839186	0.872	rs2250213	chr21:47674275	G/A	cg11766577	chr21:47581405	C21orf56	-0.68	-5.78	-0.55	1.47e-7	Testicular germ cell tumor;
SKCM	cis	rs11098499	0.820	rs28394116	chr4:120524283	T/G	cg24375607	chr4:120327624	NA	0.66	5.19	0.51	1.64e-6	Corneal astigmatism;
SKCM	cis	rs13336428	0.696	rs17808854	chr16:1528387	T/C	cg07835181	chr16:1525278	CLCN7	0.78	6.73	0.61	2.61e-9	Bone mineral density;
SKCM	cis	rs933688	1.000	rs10474353	chr5:90732285	A/C	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.05	8.54	0.7	8.25e-13	Smoking behavior;
SKCM	cis	rs1691799	0.899	rs1168325	chr12:66728234	C/G	cg16791601	chr12:66731901	HELB	-0.63	-5.46	-0.53	5.43e-7	White blood cell count (basophil);
SKCM	cis	rs4819052	0.684	rs914216	chr21:46698298	T/G	cg19498844	chr21:46707878	POFUT2;LOC642852	0.91	7.86	0.66	1.78e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7666738	0.830	rs1593570	chr4:99017058	T/C	cg05340658	chr4:99064831	C4orf37	0.67	5.16	0.5	1.85e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6570726	0.764	rs367065	chr6:145882309	T/G	cg05347473	chr6:146136440	FBXO30	0.57	5.13	0.5	2.06e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs908922	0.676	rs7529441	chr1:152531629	A/G	cg09873164	chr1:152488093	CRCT1	-0.75	-5.74	-0.55	1.7e-7	Hair morphology;
SKCM	cis	rs782590	0.934	rs62165184	chr2:55788253	G/C	cg18811423	chr2:55921094	PNPT1	0.84	6.59	0.6	4.8e-9	Metabolic syndrome;
SKCM	cis	rs7772486	0.622	rs1292333	chr6:145982344	C/T	cg05347473	chr6:146136440	FBXO30	-0.61	-5.46	-0.53	5.55e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs116095464	0.558	rs7708182	chr5:234788	C/G	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs514406	0.825	rs28817407	chr1:53226116	G/A	cg16325326	chr1:53192061	ZYG11B	-1.01	-11.9	-0.8	3.23e-19	Monocyte count;
SKCM	cis	rs514406	0.698	rs11206055	chr1:53436632	A/T	cg24675658	chr1:53192096	ZYG11B	0.83	7.84	0.66	1.88e-11	Monocyte count;
SKCM	cis	rs8060686	0.641	rs7193935	chr16:68071147	C/T	cg09117114	chr16:67998030	SLC12A4	-0.78	-5.06	-0.5	2.72e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs17685	0.712	rs1859794	chr7:75821544	G/A	cg16489192	chr7:75678113	MDH2;STYXL1	-0.55	-5.31	-0.52	9.92e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7772486	0.806	rs4075696	chr6:146250947	T/C	cg05347473	chr6:146136440	FBXO30	-0.54	-4.86	-0.48	6.05e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs372883	0.613	rs1153289	chr21:30686212	G/T	cg24692254	chr21:30365293	RNF160	-0.67	-5.31	-0.52	1.01e-6	Pancreatic cancer;
SKCM	cis	rs1062177	1.000	rs2964585	chr5:151141895	C/T	cg00977110	chr5:151150581	G3BP1	0.81	6.32	0.58	1.51e-8	Preschool internalizing problems;
SKCM	cis	rs2153535	0.580	rs962590	chr6:8450899	A/G	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs8756	0.689	rs1480474	chr12:66326943	A/G	cg06712651	chr12:66351869	HMGA2	-0.62	-4.87	-0.48	5.75e-6	Height;
SKCM	cis	rs8141529	0.753	rs5752813	chr22:29226570	T/G	cg02153584	chr22:29168773	CCDC117	0.62	5.02	0.49	3.15e-6	Lymphocyte counts;
SKCM	cis	rs7523273	0.925	rs4844394	chr1:208000625	C/T	cg22525895	chr1:207977042	MIR29B2	-0.78	-5.76	-0.55	1.57e-7	Schizophrenia;
SKCM	cis	rs9911578	1.000	rs12453459	chr17:56624291	C/T	cg12560992	chr17:57184187	TRIM37	-0.95	-7.69	-0.66	3.7e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs951366	0.585	rs72750964	chr1:205675240	C/T	cg14893161	chr1:205819251	PM20D1	0.87	7.82	0.66	2.1e-11	Menarche (age at onset);
SKCM	cis	rs7945705	0.837	rs2742474	chr11:9002089	A/G	cg21881798	chr11:8931708	C11orf17;ST5	-0.79	-8.45	-0.69	1.26e-12	Hemoglobin concentration;
SKCM	cis	rs9325144	0.647	rs12831609	chr12:39051576	C/A	cg26384229	chr12:38710491	ALG10B	-0.7	-6.26	-0.58	1.92e-8	Morning vs. evening chronotype;
SKCM	cis	rs6815814	1.000	rs11722836	chr4:38811529	T/A	cg02016764	chr4:38805732	TLR1	-0.77	-5.49	-0.53	4.78e-7	Breast cancer;
SKCM	cis	rs137761	0.576	rs6006524	chr22:44058677	C/T	cg12729397	chr22:44208276	EFCAB6	-0.67	-4.79	-0.48	7.85e-6	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs2404602	0.583	rs35707798	chr15:76565026	G/C	cg23625390	chr15:77176239	SCAPER	0.69	6.31	0.58	1.57e-8	Blood metabolite levels;
SKCM	cis	rs1801251	1.000	rs6738386	chr2:233602028	T/C	cg08000102	chr2:233561755	GIGYF2	0.87	7.05	0.62	6.23e-10	Coronary artery disease;
SKCM	cis	rs6580649	0.941	rs72644845	chr12:48503881	G/A	cg05342945	chr12:48394962	COL2A1	0.79	5.36	0.52	8.37e-7	Lung cancer;
SKCM	cis	rs6952808	0.689	rs58227534	chr7:2046328	A/G	cg02951883	chr7:2050386	MAD1L1	-0.89	-8.13	-0.68	5.16e-12	Bipolar disorder and schizophrenia;
SKCM	cis	rs875971	0.793	rs460678	chr7:65527200	C/G	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.54	5.01	0.49	3.28e-6	Aortic root size;
SKCM	cis	rs8072100	0.967	rs4580230	chr17:45738861	G/A	cg08085267	chr17:45401833	C17orf57	-0.63	-5.86	-0.55	1.06e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	trans	rs66573146	1.000	rs66519732	chr4:6990569	C/G	cg07817883	chr1:32538562	TMEM39B	2.0	8.02	0.67	8.59e-12	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs7666738	0.830	rs13144771	chr4:99026935	G/C	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs801193	0.569	rs2659892	chr7:66200305	A/G	cg18876405	chr7:65276391	NA	0.61	6.02	0.56	5.36e-8	Aortic root size;
SKCM	cis	rs9926296	0.533	rs12102297	chr16:89812762	C/A	cg26513180	chr16:89883248	FANCA	0.95	11.32	0.79	3.98e-18	Vitiligo;
SKCM	cis	rs8067545	0.611	rs16960697	chr17:20027718	A/G	cg13482628	chr17:19912719	NA	0.66	5.61	0.54	2.98e-7	Schizophrenia;
SKCM	cis	rs4925114	0.568	rs941448	chr17:17654542	C/G	cg04398451	chr17:18023971	MYO15A	0.79	5.23	0.51	1.41e-6	Body mass index;
SKCM	cis	rs16949788	1.000	rs9806600	chr15:66594447	G/A	cg08120210	chr15:66682733	MAP2K1	-0.73	-5.55	-0.53	3.77e-7	Spherical equivalent (joint analysis main effects and education interaction);
SKCM	cis	rs155076	1.000	rs12870992	chr13:21846019	A/G	cg14456004	chr13:21872349	NA	1.22	6.76	0.61	2.24e-9	White matter hyperintensity burden;
SKCM	cis	rs8180040	0.620	rs749511	chr3:47035735	A/C	cg27129171	chr3:47204927	SETD2	-0.74	-5.37	-0.52	7.84e-7	Colorectal cancer;
SKCM	cis	rs4243830	0.737	rs925745	chr1:6615690	A/G	cg22792644	chr1:6614718	TAS1R1;NOL9	-1.23	-4.81	-0.48	7.15e-6	Body mass index;
SKCM	cis	rs7666738	0.830	rs13149404	chr4:99070236	A/G	cg05340658	chr4:99064831	C4orf37	0.66	4.87	0.48	5.74e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10876993	0.784	rs7314152	chr12:58017701	T/G	cg04478727	chr12:58166393	METTL1;FAM119B	0.69	5.32	0.52	9.61e-7	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs2153535	0.580	rs9505450	chr6:8469902	C/T	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs4523957	0.583	rs2760744	chr17:2017029	T/C	cg16513277	chr17:2031491	SMG6	-0.81	-5.92	-0.56	8.11e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs7811142	1.000	rs11771241	chr7:99994785	G/A	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.33	0.69	2.11e-12	Platelet count;
SKCM	trans	rs3780486	0.505	rs959749	chr9:33147858	T/C	cg20290983	chr6:43655470	MRPS18A	0.82	8.72	0.7	3.79e-13	IgG glycosylation;
SKCM	cis	rs860295	0.678	rs1749405	chr1:155860091	C/T	cg02153340	chr1:155202674	NA	0.64	5.2	0.51	1.53e-6	Body mass index;
SKCM	cis	rs17608059	0.545	rs736261	chr17:13936404	A/G	cg11395062	chr17:14139857	CDRT15	0.68	5.58	0.53	3.29e-7	Temperament;
SKCM	cis	rs9905704	0.647	rs9901655	chr17:56987142	G/A	cg12560992	chr17:57184187	TRIM37	0.74	5.71	0.54	1.94e-7	Testicular germ cell tumor;
SKCM	cis	rs7000551	0.556	rs35359294	chr8:22249755	G/A	cg12081754	chr8:22256438	SLC39A14	1.09	12.4	0.81	3.96e-20	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs7937682	0.632	rs4936800	chr11:111734097	T/A	cg09085632	chr11:111637200	PPP2R1B	1.12	10.71	0.77	5.54e-17	Primary sclerosing cholangitis;
SKCM	cis	rs950776	0.518	rs11632604	chr15:78821914	T/C	cg06917634	chr15:78832804	PSMA4	1.01	10.42	0.76	1.94e-16	Sudden cardiac arrest;
SKCM	cis	rs8067354	0.645	rs2645489	chr17:57883371	T/G	cg02344993	chr17:57696989	CLTC	0.67	4.79	0.48	7.85e-6	Hemoglobin concentration;
SKCM	cis	rs10503709	0.581	rs13258281	chr8:21473286	C/T	cg23716449	chr8:21608280	GFRA2	-0.51	-5.09	-0.5	2.46e-6	Blood protein levels;
SKCM	cis	rs28595532	0.688	rs116053430	chr4:119731375	G/A	cg11846333	chr4:119757529	SEC24D	1.2	6.43	0.59	9.38e-9	Cannabis dependence symptom count;
SKCM	cis	rs910316	0.763	rs175435	chr14:75612025	A/G	cg08847533	chr14:75593920	NEK9	0.81	6.79	0.61	2e-9	Height;
SKCM	cis	rs9300255	0.596	rs11057207	chr12:123730891	T/G	cg00376283	chr12:123451042	ABCB9	0.87	7.25	0.63	2.63e-10	Neutrophil percentage of white cells;
SKCM	trans	rs1814175	0.817	rs6486044	chr11:49982718	C/T	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs2070488	0.804	rs1817364	chr3:38474513	T/G	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.72	5.81	0.55	1.3e-7	Electrocardiographic conduction measures;
SKCM	cis	rs875971	0.660	rs2013222	chr7:66035936	C/G	cg00343986	chr7:65444356	GUSB	-0.7	-5.14	-0.5	1.98e-6	Aortic root size;
SKCM	cis	rs6951245	1.000	rs78896566	chr7:1080182	C/G	cg03188948	chr7:1209495	NA	1.12	6.25	0.58	2.02e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs28595532	0.920	rs56124677	chr4:119772213	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs9910055	0.552	rs12937114	chr17:42325073	A/G	cg13607699	chr17:42295918	UBTF	0.92	6.95	0.62	9.88e-10	Total body bone mineral density;
SKCM	cis	rs2180341	0.960	rs7766942	chr6:127691323	G/T	cg27446573	chr6:127587934	RNF146	0.93	8.09	0.68	6.27e-12	Breast cancer;
SKCM	cis	rs2839186	0.771	rs13049175	chr21:47641326	G/A	cg05896524	chr21:47604654	C21orf56	-0.67	-5.47	-0.53	5.25e-7	Testicular germ cell tumor;
SKCM	cis	rs7586085	0.522	rs10930173	chr2:166466363	T/C	cg01770810	chr2:165769913	SLC38A11	-0.49	-4.98	-0.49	3.72e-6	Total body bone mineral density;
SKCM	cis	rs11673344	0.764	rs1644643	chr19:37463171	G/A	cg07624650	chr19:37064219	ZNF529	-0.78	-4.82	-0.48	7.05e-6	Obesity-related traits;
SKCM	cis	rs8180040	0.676	rs66564457	chr3:47020072	G/A	cg27129171	chr3:47204927	SETD2	0.79	6.01	0.56	5.49e-8	Colorectal cancer;
SKCM	cis	rs9611565	0.918	rs9611561	chr22:41757234	C/G	cg03806693	chr22:41940476	POLR3H	-0.84	-5.67	-0.54	2.28e-7	Vitiligo;
SKCM	cis	rs9581857	0.547	rs9319374	chr13:28047587	A/C	cg22138327	chr13:27999177	GTF3A	0.93	6.24	0.58	2.1e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs28595532	0.920	rs55869953	chr4:119751893	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs7937682	0.961	rs491937	chr11:111494947	A/T	cg19812747	chr11:111475976	SIK2	-0.56	-4.97	-0.49	3.82e-6	Primary sclerosing cholangitis;
SKCM	trans	rs1814175	0.645	rs11040699	chr11:50023798	C/G	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs2760061	0.626	rs596208	chr1:228117982	G/C	cg02753203	chr1:228287806	NA	-0.63	-4.96	-0.49	3.99e-6	Diastolic blood pressure;
SKCM	cis	rs3820928	0.874	rs55959848	chr2:227805426	C/A	cg11843606	chr2:227700838	RHBDD1	-0.6	-4.81	-0.48	7.34e-6	Pulmonary function;
SKCM	cis	rs1059312	0.545	rs12303387	chr12:129276733	C/T	cg09035930	chr12:129282057	SLC15A4	-0.86	-7.04	-0.62	6.74e-10	Systemic lupus erythematosus;
SKCM	cis	rs17818399	0.788	rs17818315	chr2:46818992	C/T	cg02822958	chr2:46747628	ATP6V1E2	0.7	5.84	0.55	1.14e-7	Height;
SKCM	cis	rs6500602	0.623	rs9929311	chr16:4510426	T/C	cg08645402	chr16:4508243	NA	0.65	5.11	0.5	2.28e-6	Schizophrenia;
SKCM	cis	rs56235845	0.694	rs4532376	chr5:176774403	G/A	cg06060754	chr5:176797920	RGS14	0.69	6.56	0.6	5.28e-9	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs6120849	0.707	rs6120826	chr20:33671831	G/A	cg24642439	chr20:33292090	TP53INP2	0.94	4.86	0.48	5.91e-6	Protein C levels;
SKCM	cis	rs7809950	1.000	rs2808	chr7:107260856	A/G	cg23024343	chr7:107201750	COG5	0.89	8.3	0.69	2.42e-12	Coronary artery disease;
SKCM	cis	rs9297145	0.761	rs62473015	chr7:98763301	G/A	cg05967295	chr7:98741636	SMURF1	1.07	7.92	0.67	1.33e-11	Crohn's disease;Inflammatory bowel disease;Ulcerative colitis;
SKCM	cis	rs11700980	0.748	rs17734876	chr21:30260144	C/T	cg24692254	chr21:30365293	RNF160	-0.89	-5.0	-0.49	3.51e-6	QRS complex (12-leadsum);
SKCM	cis	rs4819052	1.000	rs2838847	chr21:46670958	G/C	cg19498844	chr21:46707878	POFUT2;LOC642852	0.87	6.8	0.61	1.88e-9	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs995000	0.965	rs10789119	chr1:63098235	G/A	cg06896770	chr1:63153194	DOCK7	0.95	8.93	0.71	1.48e-13	Triglyceride levels;
SKCM	cis	rs362296	0.698	rs3095083	chr4:3263499	G/A	cg11471262	chr4:3318911	RGS12	-0.73	-6.85	-0.61	1.51e-9	Parental longevity (mother's age at death);
SKCM	cis	rs7659604	0.540	rs4361412	chr4:122669403	C/T	cg19671926	chr4:122722719	EXOSC9	0.75	6.11	0.57	3.68e-8	Type 2 diabetes;
SKCM	cis	rs10254284	1.000	rs1985152	chr7:28166534	G/A	cg15170557	chr7:28214983	JAZF1	-0.61	-5.2	-0.51	1.54e-6	Lymphocyte percentage of white cells;Systemic lupus erythematosus;
SKCM	cis	rs28386778	0.700	rs12452767	chr17:62010503	G/A	cg23090583	chr17:61904693	PSMC5;FTSJ3	-0.78	-6.42	-0.59	9.98e-9	Prudent dietary pattern;
SKCM	cis	rs7927771	0.524	rs7123952	chr11:47852057	T/C	cg20307385	chr11:47447363	PSMC3	0.72	5.81	0.55	1.31e-7	Subjective well-being;
SKCM	cis	rs9611565	0.559	rs132768	chr22:42013523	C/A	cg03806693	chr22:41940476	POLR3H	1.11	7.56	0.65	6.74e-11	Vitiligo;
SKCM	cis	rs72781680	0.846	rs72782114	chr2:24025740	G/A	cg08917208	chr2:24149416	ATAD2B	0.92	4.85	0.48	6.19e-6	Lymphocyte counts;
SKCM	cis	rs9911578	1.000	rs2567905	chr17:56782297	T/C	cg05425664	chr17:57184151	TRIM37	-0.69	-5.15	-0.5	1.93e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs738322	0.555	rs6001029	chr22:38555193	C/A	cg25457927	chr22:38595422	NA	-0.57	-6.83	-0.61	1.64e-9	Cutaneous nevi;
SKCM	cis	rs7828089	0.935	rs2293144	chr8:22262418	A/G	cg12081754	chr8:22256438	SLC39A14	0.7	5.49	0.53	4.79e-7	Verbal declarative memory;
SKCM	cis	rs2286503	0.839	rs2270103	chr7:22862722	C/T	cg15401507	chr7:22894281	NA	-0.57	-5.61	-0.54	2.99e-7	Fibrinogen;
SKCM	cis	rs1577917	1.000	rs2166663	chr6:86593896	G/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.61	-5.27	-0.51	1.18e-6	Response to antipsychotic treatment;
SKCM	cis	rs6088590	1.000	rs11696546	chr20:33452999	C/G	cg24642439	chr20:33292090	TP53INP2	0.98	6.92	0.62	1.11e-9	Coronary artery disease;
SKCM	cis	rs1124769	0.871	rs2619695	chr15:51160090	C/G	cg21246271	chr15:51200259	AP4E1	0.78	4.89	0.48	5.3e-6	Cognitive performance;
SKCM	cis	rs116095464	0.510	rs60844864	chr5:267000	A/G	cg22857025	chr5:266934	NA	-1.34	-7.52	-0.65	7.89e-11	Breast cancer;
SKCM	cis	rs651907	0.557	rs12629954	chr3:101360623	C/A	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.8	6.77	0.61	2.11e-9	Colorectal cancer;
SKCM	cis	rs9910055	1.000	rs2071167	chr17:42287519	A/G	cg09913183	chr17:42254507	C17orf65;ASB16	-0.59	-5.36	-0.52	8.29e-7	Total body bone mineral density;
SKCM	cis	rs40363	0.645	rs4786421	chr16:3522303	A/G	cg27500918	chr16:2933308	FLYWCH2	-0.72	-5.03	-0.5	3.05e-6	Tuberculosis;
SKCM	cis	rs875971	0.929	rs12535036	chr7:65964063	G/T	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	cis	rs6500395	1.000	rs7196823	chr16:48616278	G/A	cg04672837	chr16:48644449	N4BP1	0.69	5.88	0.55	9.68e-8	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs6951245	1.000	rs11764748	chr7:1094508	T/C	cg03188948	chr7:1209495	NA	1.13	6.27	0.58	1.89e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs503734	0.846	rs6795427	chr3:100913241	T/G	cg08422054	chr3:100875565	NA	-0.41	-4.81	-0.48	7.14e-6	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs2839186	0.732	rs55904887	chr21:47707811	A/G	cg13012494	chr21:47604986	C21orf56	0.67	5.71	0.54	1.95e-7	Testicular germ cell tumor;
SKCM	cis	rs7523050	0.554	rs34086470	chr1:109485991	C/A	cg08274380	chr1:109419600	GPSM2	0.98	5.45	0.53	5.7e-7	Fat distribution (HIV);
SKCM	cis	rs12477438	0.501	rs1133977	chr2:99741984	G/T	cg14399236	chr2:99771627	LIPT1;TSGA10	-0.98	-8.6	-0.7	6.55e-13	Chronic sinus infection;
SKCM	cis	rs10256972	0.553	rs4236381	chr7:1165723	A/C	cg09177884	chr7:1199841	ZFAND2A	-0.77	-6.14	-0.57	3.17e-8	Longevity;Endometriosis;
SKCM	cis	rs1799949	0.965	rs9646418	chr17:41425901	A/G	cg05368731	chr17:41323189	NBR1	0.85	7.26	0.64	2.48e-10	Menopause (age at onset);
SKCM	cis	rs748404	0.587	rs9920879	chr15:43639770	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	0.84	6.38	0.59	1.17e-8	Lung cancer;
SKCM	cis	rs1862618	0.756	rs9292125	chr5:56107200	C/T	cg12311346	chr5:56204834	C5orf35	-0.72	-4.92	-0.49	4.63e-6	Initial pursuit acceleration;
SKCM	cis	rs2354432	0.607	rs7511989	chr1:146720160	A/G	cg25205988	chr1:146714368	CHD1L	-1.19	-6.56	-0.6	5.34e-9	Mitochondrial DNA levels;
SKCM	cis	rs12478296	0.786	rs13409307	chr2:242995499	G/C	cg06360820	chr2:242988706	NA	-1.01	-6.11	-0.57	3.7e-8	Obesity-related traits;
SKCM	cis	rs7927771	0.864	rs10838724	chr11:47527052	G/T	cg05585544	chr11:47624801	NA	-0.67	-5.73	-0.54	1.83e-7	Subjective well-being;
SKCM	cis	rs367615	0.552	rs2963025	chr5:108733256	A/C	cg17395555	chr5:108820864	NA	-0.65	-5.34	-0.52	8.86e-7	Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs1018836	0.545	rs4236827	chr8:91688943	A/T	cg16814680	chr8:91681699	NA	-0.96	-11.57	-0.79	1.34e-18	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs7772486	0.754	rs9390358	chr6:146145678	C/T	cg05347473	chr6:146136440	FBXO30	0.58	5.35	0.52	8.51e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4237845	0.735	rs11172375	chr12:58291574	G/C	cg02175503	chr12:58329896	NA	0.74	6.18	0.57	2.69e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs1153858	1.000	rs7179743	chr15:45638331	G/C	cg21132104	chr15:45694354	SPATA5L1	0.92	8.33	0.69	2.14e-12	Homoarginine levels;
SKCM	cis	rs823143	0.570	rs823084	chr1:205798313	G/T	cg26354017	chr1:205819088	PM20D1	1.02	10.65	0.77	7.37e-17	Monocyte percentage of white cells;
SKCM	cis	rs4803468	1.000	rs10422783	chr19:41906436	T/C	cg09537434	chr19:41945824	ATP5SL	-1.08	-13.01	-0.83	3.1e-21	Height;
SKCM	cis	rs10504073	0.669	rs11779189	chr8:50030592	C/G	cg00325661	chr8:49890786	NA	-0.74	-6.51	-0.59	6.6e-9	Blood metabolite ratios;
SKCM	cis	rs1865760	0.786	rs1436308	chr6:25939567	T/G	cg08401836	chr6:26032486	HIST1H3B	-0.62	-5.06	-0.5	2.76e-6	Height;
SKCM	cis	rs11098499	0.865	rs28634456	chr4:120375778	A/G	cg24375607	chr4:120327624	NA	0.68	5.45	0.53	5.66e-7	Corneal astigmatism;
SKCM	cis	rs7811142	0.830	rs6979910	chr7:99940630	A/C	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.21	8.05	0.67	7.68e-12	Platelet count;
SKCM	cis	rs1707322	0.721	rs10789471	chr1:46215619	G/A	cg03146154	chr1:46216737	IPP	0.8	5.47	0.53	5.19e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs9815354	0.812	rs60659106	chr3:41949569	G/C	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs2153535	0.601	rs9505451	chr6:8469950	C/T	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs1552244	1.000	rs17032283	chr3:10081545	C/G	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs9611565	0.921	rs3927	chr22:41722864	A/G	cg03806693	chr22:41940476	POLR3H	-0.79	-4.87	-0.48	5.69e-6	Vitiligo;
SKCM	cis	rs6952808	0.595	rs3800916	chr7:2166072	C/T	cg21782813	chr7:2030301	MAD1L1	0.53	5.64	0.54	2.58e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs1062177	1.000	rs17804178	chr5:151197729	T/G	cg00977110	chr5:151150581	G3BP1	0.87	6.78	0.61	2.07e-9	Preschool internalizing problems;
SKCM	cis	rs769267	0.965	rs6511026	chr19:19391402	C/T	cg03709012	chr19:19516395	GATAD2A	0.81	6.49	0.59	7.18e-9	Tonsillectomy;
SKCM	cis	rs10256972	0.577	rs4999286	chr7:1199506	C/G	cg07092213	chr7:1199455	ZFAND2A	-0.65	-5.41	-0.52	6.67e-7	Longevity;Endometriosis;
SKCM	cis	rs826838	0.967	rs11168299	chr12:38902028	G/T	cg26384229	chr12:38710491	ALG10B	1.04	9.75	0.74	3.88e-15	Heart rate;
SKCM	cis	rs2811415	0.597	rs9819833	chr3:127793408	G/A	cg09089421	chr3:127803668	RUVBL1	1.0	8.69	0.7	4.4e-13	Lung function (FEV1/FVC);
SKCM	cis	rs67311347	0.544	rs9868700	chr3:40345408	G/A	cg02782426	chr3:40428986	ENTPD3	0.53	5.33	0.52	9.33e-7	Renal cell carcinoma;
SKCM	cis	rs67311347	0.544	rs1902073	chr3:40333497	C/T	cg00091569	chr3:40428383	ENTPD3	0.6	5.28	0.51	1.15e-6	Renal cell carcinoma;
SKCM	cis	rs57221529	0.713	rs12522724	chr5:590742	T/C	cg09888920	chr5:474111	LOC25845;SLC9A3	0.99	4.79	0.48	7.91e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs6060987	1	rs6060987	chr20:30427077	T/A	cg11595048	chr20:30225325	COX4I2	0.65	5.03	0.49	3.1e-6	Mean corpuscular volume;
SKCM	cis	rs2404602	0.716	rs66754747	chr15:76828568	G/A	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs873946	0.586	rs2001426	chr10:134563871	G/A	cg18305652	chr10:134549665	INPP5A	0.59	5.74	0.55	1.7e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs7590368	0.962	rs13431633	chr2:10960225	T/C	cg15705551	chr2:10952987	PDIA6	0.76	4.88	0.48	5.52e-6	Educational attainment (years of education);
SKCM	cis	rs9910055	0.659	rs227584	chr17:42225547	A/C	cg09913183	chr17:42254507	C17orf65;ASB16	0.67	6.36	0.58	1.27e-8	Total body bone mineral density;
SKCM	cis	rs4560672	1.000	rs35728263	chr6:158584058	C/T	cg10592926	chr6:157876961	ZDHHC14	0.51	4.86	0.48	5.84e-6	Smoking quantity;
SKCM	cis	rs4927850	0.918	rs4361313	chr3:195752260	A/G	cg12923728	chr3:195709715	SDHAP1	-0.92	-6.11	-0.57	3.61e-8	Pancreatic cancer;
SKCM	cis	rs208515	0.525	rs10944869	chr6:66687576	G/T	cg07460842	chr6:66804631	NA	0.93	6.34	0.58	1.35e-8	Exhaled nitric oxide levels;
SKCM	cis	rs10504229	1.000	rs56168206	chr8:58184485	G/A	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs6089829	0.962	rs9679865	chr20:61666132	C/G	cg03213289	chr20:61660250	NA	0.49	4.82	0.48	7.06e-6	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs2885056	0.783	rs12459941	chr19:10666112	A/G	cg04833646	chr19:10679720	CDKN2D	-1.03	-8.59	-0.7	6.63e-13	Red cell distribution width;
SKCM	cis	rs2921073	0.605	rs2976933	chr8:8254875	A/G	cg06636001	chr8:8085503	FLJ10661	0.8	6.05	0.57	4.63e-8	Parkinson's disease;
SKCM	cis	rs10256972	0.621	rs10951594	chr7:1088607	C/G	cg07308232	chr7:1071921	C7orf50	-0.56	-4.84	-0.48	6.33e-6	Longevity;Endometriosis;
SKCM	cis	rs10193935	0.901	rs62142561	chr2:42477808	G/C	cg27598129	chr2:42591480	NA	-0.97	-6.7	-0.6	2.93e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs397020	0.904	rs203547	chr20:1195245	T/A	cg22227354	chr20:1206682	RAD21L1	0.58	4.95	0.49	4.18e-6	Multiple sclerosis;
SKCM	cis	rs7635838	0.750	rs7625680	chr3:11378069	G/A	cg00170343	chr3:11313890	ATG7	0.7	5.54	0.53	3.93e-7	HDL cholesterol;
SKCM	cis	rs950027	0.620	rs1617634	chr15:45615578	A/G	cg10760299	chr15:45669010	GATM	0.51	4.8	0.48	7.54e-6	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs992157	0.672	rs2382829	chr2:219184617	G/A	cg00012203	chr2:219082015	ARPC2	0.75	5.54	0.53	3.92e-7	Colorectal cancer;
SKCM	cis	rs10489202	0.683	rs2294817	chr1:168073601	C/A	cg24449463	chr1:168025552	DCAF6	-0.79	-7.2	-0.63	3.27e-10	Schizophrenia;
SKCM	cis	rs1218582	0.711	rs4845677	chr1:154838050	C/T	cg06221963	chr1:154839813	KCNN3	-0.61	-6.6	-0.6	4.5e-9	Prostate cancer;
SKCM	cis	rs1799949	1.000	rs12951869	chr17:41187567	T/G	cg23758822	chr17:41437982	NA	0.91	7.51	0.65	8.13e-11	Menopause (age at onset);
SKCM	cis	rs7953508	0.711	rs11107116	chr12:93978504	G/T	cg18151635	chr12:93972918	NA	-0.73	-6.41	-0.59	1.02e-8	Pubertal anthropometrics;
SKCM	cis	rs8067545	0.532	rs3862151	chr17:19957289	A/G	cg13482628	chr17:19912719	NA	0.67	4.8	0.48	7.46e-6	Schizophrenia;
SKCM	cis	rs1218582	0.772	rs4240874	chr1:154885779	C/T	cg24250549	chr1:154909240	PMVK	0.87	8.7	0.7	4.13e-13	Prostate cancer;
SKCM	cis	rs6121246	0.954	rs6058470	chr20:30416827	A/T	cg11595048	chr20:30225325	COX4I2	0.67	5.21	0.51	1.5e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs826838	0.967	rs73096706	chr12:38860563	G/A	cg13010199	chr12:38710504	ALG10B	0.86	6.37	0.59	1.19e-8	Heart rate;
SKCM	cis	rs28386778	0.897	rs6504185	chr17:61848792	A/G	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs28595532	0.920	rs116366070	chr4:119764180	A/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs897984	0.762	rs1870293	chr16:30970941	T/C	cg00531865	chr16:30841666	NA	0.58	4.9	0.48	5.17e-6	Dementia with Lewy bodies;
SKCM	cis	rs1005277	0.522	rs200943	chr10:38148730	A/G	cg00409905	chr10:38381863	ZNF37A	-0.6	-5.6	-0.54	3.07e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs6762	0.748	rs28636471	chr11:840639	T/A	cg16425592	chr11:842748	TSPAN4;POLR2L	-0.8	-5.96	-0.56	6.94e-8	Mean platelet volume;
SKCM	cis	rs10927875	0.632	rs10927864	chr1:16165661	C/G	cg21385522	chr1:16154831	NA	-0.99	-12.29	-0.81	6.21e-20	Dilated cardiomyopathy;
SKCM	cis	rs6723226	0.732	rs390480	chr2:32510072	A/C	cg02381751	chr2:32503542	YIPF4	-0.98	-7.42	-0.64	1.22e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs2386661	0.591	rs11255051	chr10:5653450	A/G	cg12223502	chr10:5658492	NA	-0.58	-5.35	-0.52	8.65e-7	Breast cancer;
SKCM	cis	rs2836974	0.897	rs2026267	chr21:40711477	C/A	cg11890956	chr21:40555474	PSMG1	0.98	10.34	0.76	2.82e-16	Cognitive function;
SKCM	cis	rs523522	0.602	rs7132474	chr12:120866996	A/C	cg27279351	chr12:120934652	DYNLL1	0.85	6.14	0.57	3.29e-8	High light scatter reticulocyte count;
SKCM	cis	rs7208487	0.684	rs12449852	chr17:37632088	A/G	cg07936489	chr17:37558343	FBXL20	-1.02	-7.52	-0.65	7.79e-11	Primary biliary cholangitis;Glomerular filtration rate in non diabetics (creatinine);
SKCM	cis	rs6545883	0.894	rs12620105	chr2:61512321	A/T	cg15711740	chr2:61764176	XPO1	0.68	4.82	0.48	6.94e-6	Tuberculosis;
SKCM	cis	rs919433	0.783	rs55725278	chr2:198238223	C/T	cg04278110	chr2:198063759	ANKRD44	0.74	5.13	0.5	2.06e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs6461049	0.608	rs3800923	chr7:2184673	A/G	cg02951883	chr7:2050386	MAD1L1	-0.71	-6.09	-0.57	3.92e-8	Schizophrenia;
SKCM	cis	rs561341	0.941	rs72825746	chr17:30364610	G/A	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs1799949	0.587	rs1824890	chr17:41421904	T/C	cg23758822	chr17:41437982	NA	0.79	5.27	0.51	1.16e-6	Menopause (age at onset);
SKCM	cis	rs28595532	0.841	rs10019311	chr4:119785458	G/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs12453682	0.568	rs3794712	chr17:37791487	A/C	cg00129232	chr17:37814104	STARD3	-0.7	-5.11	-0.5	2.19e-6	Mean corpuscular hemoglobin;Red blood cell count;
SKCM	cis	rs4888262	0.526	rs7191754	chr16:74610850	G/T	cg01733217	chr16:74700730	RFWD3	0.89	7.21	0.63	3.07e-10	Testicular germ cell tumor;
SKCM	cis	rs67311347	0.568	rs57287242	chr3:40335538	T/C	cg00091569	chr3:40428383	ENTPD3	0.61	5.37	0.52	7.7300000000000005e-07	Renal cell carcinoma;
SKCM	cis	rs611744	0.604	rs6469170	chr8:109305277	T/C	cg21045802	chr8:109455806	TTC35	0.63	4.81	0.48	7.32e-6	Dupuytren's disease;
SKCM	trans	rs3749237	0.964	rs11714957	chr3:49776178	C/T	cg21659725	chr3:3221576	CRBN	0.99	7.4	0.64	1.35e-10	Resting heart rate;
SKCM	cis	rs7811142	0.830	rs3087502	chr7:99955364	G/A	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.05	5.92	0.56	8.02e-8	Platelet count;
SKCM	cis	rs7772486	0.686	rs1011596	chr6:146076433	A/G	cg23711669	chr6:146136114	FBXO30	0.84	9.08	0.72	7.59e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4423214	0.559	rs10898228	chr11:71228358	A/T	cg05163923	chr11:71159392	DHCR7	-0.67	-4.82	-0.48	6.99e-6	Vitamin D levels;
SKCM	cis	rs35306767	0.761	rs12770910	chr10:1050318	A/G	cg25614935	chr10:1084866	C10orf110	0.72	5.67	0.54	2.31e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs1348850	0.554	rs1374438	chr2:178376684	A/G	cg02961200	chr2:178257176	LOC100130691;AGPS	0.83	4.86	0.48	5.99e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs7829975	0.714	rs6994038	chr8:8660538	C/A	cg15556689	chr8:8085844	FLJ10661	0.68	5.88	0.55	9.84e-8	Mood instability;
SKCM	cis	rs56011263	0.687	rs11734460	chr4:705074	C/T	cg17689763	chr4:710664	PCGF3	-0.63	-5.06	-0.5	2.68e-6	White blood cell count;
SKCM	cis	rs875971	0.660	rs79009421	chr7:66068509	G/C	cg11987759	chr7:65425863	GUSB	0.67	5.8	0.55	1.36e-7	Aortic root size;
SKCM	cis	rs28386778	0.901	rs2854194	chr17:61952110	T/G	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.06	0.78	1.21e-17	Prudent dietary pattern;
SKCM	cis	rs798554	0.724	rs798498	chr7:2795882	T/G	cg14895029	chr7:2775587	GNA12	-0.66	-4.92	-0.49	4.64e-6	Height;
SKCM	cis	rs6951245	0.678	rs28600085	chr7:1169636	C/T	cg03188948	chr7:1209495	NA	1.04	6.69	0.6	3.04e-9	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	trans	rs1814175	0.616	rs10839342	chr11:49742687	A/C	cg03929089	chr4:120376271	NA	-0.85	-7.61	-0.65	5.27e-11	Height;
SKCM	cis	rs6952808	0.689	rs12668156	chr7:2019875	G/A	cg05863683	chr7:1912471	MAD1L1	0.62	5.45	0.53	5.6e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs7552404	0.924	rs2173378	chr1:76201992	G/T	cg03433033	chr1:76189801	ACADM	0.73	5.33	0.52	9.12e-7	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs2204008	0.715	rs11525003	chr12:38332359	G/A	cg26384229	chr12:38710491	ALG10B	0.81	6.67	0.6	3.38e-9	Bladder cancer;
SKCM	cis	rs782590	0.935	rs782606	chr2:55886602	T/C	cg18811423	chr2:55921094	PNPT1	0.88	7.32	0.64	1.89e-10	Metabolic syndrome;
SKCM	cis	rs6951245	0.882	rs10256720	chr7:1210825	C/G	cg24642844	chr7:1081250	C7orf50	-0.82	-5.41	-0.52	6.77e-7	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs763014	1.000	rs2269558	chr16:682250	C/T	cg07343612	chr16:622815	PIGQ	-0.65	-5.01	-0.49	3.37e-6	Height;
SKCM	cis	rs28386778	0.897	rs6504176	chr17:61811920	T/C	cg06873352	chr17:61820015	STRADA	0.75	6.24	0.58	2.1e-8	Prudent dietary pattern;
SKCM	cis	rs8060686	0.668	rs12448991	chr16:68218894	T/A	cg09117114	chr16:67998030	SLC12A4	-0.77	-5.03	-0.49	3.12e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs861020	0.883	rs680331	chr1:209959872	G/A	cg05527609	chr1:210001259	C1orf107	1.08	7.82	0.66	2.15e-11	Orofacial clefts;
SKCM	cis	rs2075371	0.932	rs11766132	chr7:133993062	T/C	cg20476274	chr7:133979776	SLC35B4	1.0	9.99	0.75	1.32e-15	Mean platelet volume;
SKCM	cis	rs6696846	0.777	rs6664397	chr1:205051871	C/T	cg03948781	chr1:205179583	DSTYK	0.54	5.01	0.49	3.37e-6	Red blood cell count;
SKCM	cis	rs7618915	0.501	rs3774366	chr3:52641255	T/C	cg18404041	chr3:52824283	ITIH1	-0.53	-4.77	-0.48	8.42e-6	Bipolar disorder;
SKCM	cis	rs79839061	0.562	rs10516158	chr4:942439	A/G	cg07828340	chr4:882639	GAK	-0.97	-5.4	-0.52	7.1e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs514406	0.893	rs522287	chr1:53365493	C/T	cg24675658	chr1:53192096	ZYG11B	-0.61	-4.93	-0.49	4.54e-6	Monocyte count;
SKCM	cis	rs1799949	0.929	rs799905	chr17:41277187	G/C	cg05368731	chr17:41323189	NBR1	0.88	7.51	0.65	8.26e-11	Menopause (age at onset);
SKCM	cis	rs11098499	0.954	rs3733524	chr4:120423729	T/C	cg09307838	chr4:120376055	NA	1.0	8.05	0.67	7.65e-12	Corneal astigmatism;
SKCM	cis	rs2952156	0.920	rs2934951	chr17:37833328	A/G	cg00129232	chr17:37814104	STARD3	-0.69	-5.63	-0.54	2.69e-7	Asthma;
SKCM	cis	rs2153535	0.580	rs1932279	chr6:8473653	T/C	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs7100689	0.622	rs1890890	chr10:82090643	A/T	cg00277334	chr10:82204260	NA	-0.57	-5.34	-0.52	9.02e-7	Post bronchodilator FEV1;
SKCM	cis	rs910316	0.819	rs175461	chr14:75581816	G/A	cg08847533	chr14:75593920	NEK9	-0.96	-8.88	-0.71	1.88e-13	Height;
SKCM	cis	rs28595532	0.920	rs114094671	chr4:119753540	G/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs6952808	0.717	rs12534679	chr7:1926745	G/A	cg21782813	chr7:2030301	MAD1L1	0.52	5.29	0.51	1.08e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs3784262	0.512	rs4646572	chr15:58343021	T/C	cg12031962	chr15:58353849	ALDH1A2	-0.4	-5.16	-0.5	1.8e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs548181	0.673	rs12288034	chr11:125570941	A/T	cg03464685	chr11:125439445	EI24	-1.23	-7.36	-0.64	1.59e-10	Schizophrenia;Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);
SKCM	cis	rs1218582	0.772	rs11264290	chr1:154912300	C/T	cg24250549	chr1:154909240	PMVK	0.87	8.96	0.71	1.3e-13	Prostate cancer;
SKCM	cis	rs1160297	0.552	rs6732467	chr2:53223652	C/T	cg07782112	chr2:53107842	NA	-0.5	-4.77	-0.48	8.37e-6	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs6951245	0.554	rs75075857	chr7:1140298	C/T	cg18402987	chr7:1209562	NA	0.82	5.43	0.52	6.18e-7	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs12044355	0.827	rs16854783	chr1:231827371	A/G	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	-0.83	-6.07	-0.57	4.31e-8	Alzheimer's disease;
SKCM	cis	rs17685	0.884	rs3823882	chr7:75631913	T/C	cg01364799	chr7:75623366	TMEM120A	0.77	5.96	0.56	6.93e-8	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs6952808	0.531	rs3800922	chr7:2184505	A/G	cg02951883	chr7:2050386	MAD1L1	-0.76	-6.32	-0.58	1.52e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs1499614	1.000	rs1882655	chr7:66147057	T/C	cg18252515	chr7:66147081	NA	1.34	8.18	0.68	4.2e-12	Gout;
SKCM	cis	rs1707322	0.686	rs1084086	chr1:46041100	A/C	cg03146154	chr1:46216737	IPP	-0.72	-4.94	-0.49	4.4e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs9910055	0.614	rs12944572	chr17:42245241	T/C	cg10896456	chr17:42255109	ASB16;C17orf65	0.69	7.34	0.64	1.78e-10	Total body bone mineral density;
SKCM	cis	rs637571	0.522	rs12797319	chr11:65735672	G/A	cg26695010	chr11:65641043	EFEMP2	-0.69	-5.27	-0.51	1.17e-6	Eosinophil percentage of white cells;
SKCM	cis	rs17376456	1.000	rs59472588	chr5:93511981	A/G	cg25358565	chr5:93447407	FAM172A	1.23	8.18	0.68	4.19e-12	Diabetic retinopathy;
SKCM	cis	rs651907	0.557	rs62284198	chr3:101474699	G/A	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.81	7.11	0.63	4.78e-10	Colorectal cancer;
SKCM	cis	rs514406	0.893	rs2897561	chr1:53388747	C/A	cg16325326	chr1:53192061	ZYG11B	0.91	9.82	0.74	2.8e-15	Monocyte count;
SKCM	cis	rs9388451	0.839	rs1811852	chr6:126071575	G/C	cg05901451	chr6:126070800	HEY2	-0.82	-7.91	-0.67	1.41e-11	Brugada syndrome;
SKCM	cis	rs10832963	1.000	rs10128711	chr11:18632984	A/G	cg20219074	chr11:18656078	SPTY2D1	0.78	6.48	0.59	7.48e-9	Breast cancer;
SKCM	cis	rs7772486	0.902	rs1331643	chr6:146398873	T/A	cg05347473	chr6:146136440	FBXO30	0.61	5.47	0.53	5.24e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1862618	0.573	rs2591962	chr5:56237155	G/A	cg12311346	chr5:56204834	C5orf35	0.75	5.5	0.53	4.69e-7	Initial pursuit acceleration;
SKCM	cis	rs769267	0.965	rs12460764	chr19:19431963	G/T	cg03709012	chr19:19516395	GATAD2A	-0.84	-6.97	-0.62	9.13e-10	Tonsillectomy;
SKCM	cis	rs1218582	0.772	rs4845693	chr1:154911257	A/G	cg24250549	chr1:154909240	PMVK	-0.87	-8.96	-0.71	1.3e-13	Prostate cancer;
SKCM	cis	rs951366	0.789	rs823130	chr1:205714372	C/T	cg11965913	chr1:205819406	PM20D1	0.99	9.69	0.74	4.88e-15	Menarche (age at onset);
SKCM	cis	rs2842992	0.830	rs2842966	chr6:160141592	C/T	cg19482086	chr6:160211437	TCP1;MRPL18	0.81	5.76	0.55	1.61e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs4332037	0.664	rs56259105	chr7:1978002	T/C	cg02825527	chr7:2087843	MAD1L1	-0.71	-4.9	-0.49	5.04e-6	Bipolar disorder;
SKCM	cis	rs6570726	0.846	rs6914304	chr6:145921017	T/C	cg23711669	chr6:146136114	FBXO30	0.81	7.92	0.67	1.35e-11	Lobe attachment (rater-scored or self-reported);
SKCM	trans	rs17685	0.816	rs11763076	chr7:75765963	C/T	cg19862616	chr7:65841803	NCRNA00174	0.94	9.49	0.73	1.22e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs9858542	0.953	rs67216675	chr3:49493151	G/T	cg03060546	chr3:49711283	APEH	-0.75	-5.53	-0.53	4.17e-7	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs9543976	1.000	rs8192762	chr13:76176680	A/T	cg01531495	chr13:76123901	UCHL3	0.9	4.99	0.49	3.52e-6	Diabetic retinopathy;
SKCM	cis	rs644799	0.623	rs17207890	chr11:95490754	C/T	cg03916912	chr11:95522834	CEP57;FAM76B	0.74	5.76	0.55	1.59e-7	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs2836950	0.520	rs8133928	chr21:40689963	G/A	cg17971929	chr21:40555470	PSMG1	-0.64	-5.1	-0.5	2.31e-6	Menarche (age at onset);
SKCM	cis	rs9910055	0.530	rs11652651	chr17:42302907	A/G	cg19774624	chr17:42201019	HDAC5	0.77	6.29	0.58	1.69e-8	Total body bone mineral density;
SKCM	cis	rs9486715	0.867	rs4839834	chr6:96882109	C/A	cg06623918	chr6:96969491	KIAA0776	0.8	7.22	0.63	2.98e-10	Headache;
SKCM	cis	rs7824557	0.564	rs2572399	chr8:11234520	A/G	cg21775007	chr8:11205619	TDH	-0.59	-5.04	-0.5	2.91e-6	Retinal vascular caliber;
SKCM	cis	rs4332037	0.950	rs11767515	chr7:1941051	C/T	cg23422044	chr7:1970798	MAD1L1	-0.96	-6.52	-0.59	6.37e-9	Bipolar disorder;
SKCM	cis	rs17376456	0.866	rs13356088	chr5:93423479	C/T	cg21475434	chr5:93447410	FAM172A	0.96	5.16	0.5	1.8e-6	Diabetic retinopathy;
SKCM	cis	rs1005277	0.579	rs2474594	chr10:38426661	G/C	cg25427524	chr10:38739819	LOC399744	-0.71	-6.74	-0.61	2.44e-9	Extrinsic epigenetic age acceleration;
SKCM	trans	rs8073060	0.859	rs17550268	chr17:33874678	T/C	cg19694781	chr19:47549865	TMEM160	1.09	8.61	0.7	6.06e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs4974559	0.947	rs28418481	chr4:1330975	C/G	cg02980000	chr4:1222292	CTBP1	0.8	5.18	0.51	1.68e-6	Systolic blood pressure;
SKCM	cis	rs873946	0.504	rs3793681	chr10:134564451	T/C	cg00988841	chr10:134556463	INPP5A	0.63	4.89	0.48	5.4e-6	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs7208859	0.623	rs73271872	chr17:29152228	C/G	cg13385521	chr17:29058706	SUZ12P	0.9	4.78	0.48	8.1e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs9880211	0.563	rs1393787	chr3:135854201	G/A	cg21827317	chr3:136751795	NA	-0.68	-5.3	-0.51	1.05e-6	Body mass index;Height;
SKCM	cis	rs17376456	0.825	rs10054903	chr5:93281491	C/A	cg25358565	chr5:93447407	FAM172A	1.31	7.46	0.65	1.04e-10	Diabetic retinopathy;
SKCM	cis	rs34779708	0.966	rs6481941	chr10:35440141	G/A	cg03585969	chr10:35415529	CREM	0.75	6.12	0.57	3.45e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs1865760	0.516	rs9358903	chr6:26061949	A/C	cg16482183	chr6:26056742	HIST1H1C	0.61	4.85	0.48	6.08e-6	Height;
SKCM	cis	rs933688	1.000	rs6452951	chr5:90653868	T/G	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.05	8.21	0.68	3.73e-12	Smoking behavior;
SKCM	cis	rs780096	0.506	rs1647286	chr2:27714517	A/T	cg05696406	chr2:27599888	SNX17	0.51	5.21	0.51	1.49e-6	Total body bone mineral density;
SKCM	cis	rs12142240	0.698	rs6696777	chr1:46810970	A/G	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs1799949	1.000	rs9646412	chr17:41425893	A/T	cg23758822	chr17:41437982	NA	0.94	8.03	0.67	8.39e-12	Menopause (age at onset);
SKCM	cis	rs1799949	1.000	rs9646417	chr17:41424253	G/A	cg23758822	chr17:41437982	NA	0.93	7.88	0.67	1.62e-11	Menopause (age at onset);
SKCM	cis	rs17270561	0.723	rs12192635	chr6:25880907	A/T	cg17691542	chr6:26056736	HIST1H1C	0.88	5.26	0.51	1.23e-6	Iron status biomarkers;
SKCM	cis	rs7111031	1.000	rs4245150	chr11:113364647	A/C	cg04642306	chr11:112834466	NCAM1	-0.43	-4.8	-0.48	7.44e-6	Subjective well-being (multi-trait analysis);Depressive symptoms (multi-trait analysis);Neuroticism;
SKCM	cis	rs2841277	0.708	rs10083374	chr14:105402994	T/C	cg19901468	chr14:105411992	AHNAK2	-0.98	-7.76	-0.66	2.7e-11	Rheumatoid arthritis;
SKCM	cis	rs9916302	0.904	rs3964723	chr17:37403979	C/T	cg07936489	chr17:37558343	FBXL20	-0.84	-7.33	-0.64	1.82e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs7666738	0.830	rs35865860	chr4:98968822	C/T	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs12971120	0.891	rs2278159	chr18:72178161	T/C	cg26446133	chr18:72167187	CNDP2	-0.68	-5.34	-0.52	8.81e-7	Refractive error;
SKCM	cis	rs1691799	0.867	rs1183274	chr12:66732057	C/G	cg16791601	chr12:66731901	HELB	-0.66	-5.81	-0.55	1.31e-7	White blood cell count (basophil);
SKCM	cis	rs113352275	1	rs113352275	chr15:78840567	C/T	cg24631222	chr15:78858424	CHRNA5	1.03	6.77	0.61	2.18e-9	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs8067545	0.532	rs4925074	chr17:19962554	C/T	cg13482628	chr17:19912719	NA	0.67	4.8	0.48	7.46e-6	Schizophrenia;
SKCM	cis	rs9300255	0.543	rs520088	chr12:123522150	C/G	cg00376283	chr12:123451042	ABCB9	0.84	5.87	0.55	1e-7	Neutrophil percentage of white cells;
SKCM	cis	rs875971	0.830	rs28714531	chr7:65968237	G/A	cg11764359	chr7:65958608	NA	0.75	6.79	0.61	1.95e-9	Aortic root size;
SKCM	cis	rs2836974	0.831	rs34294410	chr21:40555160	C/G	cg11890956	chr21:40555474	PSMG1	1.09	13.7	0.84	1.86e-22	Cognitive function;
SKCM	cis	rs4481887	0.927	rs4347240	chr1:248475403	C/G	cg00666640	chr1:248458726	OR2T12	0.66	6.0	0.56	5.9e-8	Common traits (Other);
SKCM	cis	rs2929278	0.562	rs8033846	chr15:44035363	A/C	cg02155558	chr15:43621948	ADAL;LCMT2	-0.76	-5.17	-0.51	1.74e-6	Schizophrenia;
SKCM	cis	rs3785574	0.962	rs7219920	chr17:61811642	C/G	cg01411255	chr17:61851458	DDX42;CCDC47	1.13	12.96	0.83	3.89e-21	Height;
SKCM	cis	rs17376456	0.825	rs10038831	chr5:93124115	C/T	cg25358565	chr5:93447407	FAM172A	1.15	7.28	0.64	2.25e-10	Diabetic retinopathy;
SKCM	cis	rs2228479	0.850	rs12600051	chr16:89992072	G/T	cg06558623	chr16:89946397	TCF25	1.08	5.4	0.52	7.07e-7	Skin colour saturation;
SKCM	cis	rs7772486	0.875	rs969694	chr6:146394655	A/G	cg05347473	chr6:146136440	FBXO30	0.66	6.0	0.56	5.9e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs763014	0.966	rs4984675	chr16:670117	T/C	cg09263875	chr16:632152	PIGQ	0.72	6.45	0.59	8.69e-9	Height;
SKCM	cis	rs9834970	0.760	rs4072458	chr3:36862680	T/C	cg25202636	chr3:37035158	MLH1;EPM2AIP1	0.65	4.83	0.48	6.59e-6	Bipolar disorder with mood-incongruent psychosis;Subjective response to lithium treatment;Bipolar disorder;Schizophrenia or bipolar disorder;Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);
SKCM	cis	rs2963155	0.518	rs174048	chr5:142650404	T/C	cg17617527	chr5:142782415	NR3C1	1.05	4.88	0.48	5.42e-6	Breast cancer;
SKCM	cis	rs2354432	0.556	rs72710311	chr1:146698256	A/G	cg25205988	chr1:146714368	CHD1L	-1.19	-6.54	-0.59	5.94e-9	Mitochondrial DNA levels;
SKCM	cis	rs6500395	0.925	rs12920170	chr16:48701530	A/G	cg04672837	chr16:48644449	N4BP1	-0.63	-5.37	-0.52	8.01e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs6500395	1.000	rs1486411	chr16:48587083	T/C	cg04672837	chr16:48644449	N4BP1	0.7	5.69	0.54	2.16e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs875971	0.642	rs35526611	chr7:66094008	C/T	cg00343986	chr7:65444356	GUSB	-0.68	-4.99	-0.49	3.65e-6	Aortic root size;
SKCM	cis	rs3087591	0.960	rs8080679	chr17:29602610	A/G	cg24425628	chr17:29625626	OMG;NF1	0.64	5.08	0.5	2.48e-6	Hip circumference;
SKCM	cis	rs33794	0.901	rs33780	chr3:45289715	C/T	cg25630594	chr3:44914870	TGM4	0.58	5.06	0.5	2.7e-6	Lung function (forced expiratory volume in 1 second);
SKCM	trans	rs1814175	0.765	rs11493326	chr11:50018063	T/C	cg15704280	chr7:45808275	SEPT13	-1.07	-10.79	-0.77	3.94e-17	Height;
SKCM	cis	rs1005277	0.563	rs2505215	chr10:38481273	A/G	cg00409905	chr10:38381863	ZNF37A	-0.65	-5.92	-0.56	8.04e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs2032447	0.613	rs6456708	chr6:26032847	G/C	cg18357526	chr6:26021779	HIST1H4A	0.65	4.82	0.48	7.07e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1552244	0.882	rs13063098	chr3:10009919	G/A	cg02579736	chr3:10068473	FANCD2;CIDECP	0.98	4.84	0.48	6.48e-6	Alzheimer's disease;
SKCM	cis	rs11623869	0.711	rs2403173	chr14:103909289	T/C	cg26031613	chr14:104095156	KLC1	0.74	5.44	0.52	5.98e-7	Bone mineral density;
SKCM	cis	rs7666738	0.791	rs10017624	chr4:98984009	G/T	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs5769765	0.740	rs2103932	chr22:50272515	A/G	cg22709217	chr22:50311962	ALG12;CRELD2	0.79	5.71	0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs28386778	0.897	rs4638645	chr17:61828349	T/C	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.36	0.52	8.06e-7	Prudent dietary pattern;
SKCM	cis	rs5753618	0.504	rs7284622	chr22:31907985	G/A	cg02404636	chr22:31891804	SFI1	0.68	6.07	0.57	4.32e-8	Colorectal cancer;
SKCM	cis	rs9912468	0.933	rs17633437	chr17:64301842	A/G	cg19474267	chr17:64306194	PRKCA	0.63	5.48	0.53	4.96e-7	QRS duration;QRS complex (12-leadsum);QRS complex (Sokolow-Lyon);
SKCM	cis	rs4774899	1.000	rs12899036	chr15:57476452	C/A	cg01857019	chr15:57210107	LOC145783;TCF12	0.53	4.9	0.49	5.12e-6	Urinary tract infection frequency;
SKCM	cis	rs763121	0.925	rs5757165	chr22:38994577	C/T	cg06022373	chr22:39101656	GTPBP1	0.78	5.3	0.51	1.03e-6	Menopause (age at onset);
SKCM	cis	rs7216064	0.553	rs62084690	chr17:66035411	A/G	cg12091567	chr17:66097778	LOC651250	0.82	6.71	0.6	2.83e-9	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs6088590	1.000	rs1998028	chr20:33344595	A/T	cg24642439	chr20:33292090	TP53INP2	1.01	7.39	0.64	1.39e-10	Coronary artery disease;
SKCM	cis	rs1577917	1.000	rs6933377	chr6:86705255	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.63	5.7	0.54	2e-7	Response to antipsychotic treatment;
SKCM	cis	rs362272	0.545	rs2236052	chr4:3318413	C/T	cg00764545	chr4:3318001	RGS12	-0.95	-12.73	-0.82	1.01e-20	Serum sulfate level;
SKCM	cis	rs9581857	0.579	rs1759861	chr13:27996406	A/C	cg22138327	chr13:27999177	GTF3A	-0.85	-5.74	-0.55	1.71e-7	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs1568889	1.000	rs12803655	chr11:28060785	G/A	cg06544937	chr11:28130018	METT5D1;KIF18A	0.86	7.03	0.62	6.97e-10	Bipolar disorder;
SKCM	cis	rs7613875	0.580	rs12634780	chr3:50043341	A/T	cg24110177	chr3:50126178	RBM5	0.69	5.51	0.53	4.54e-7	Body mass index;
SKCM	cis	rs8180040	0.701	rs11917474	chr3:47010491	G/A	cg27129171	chr3:47204927	SETD2	0.79	6.01	0.56	5.49e-8	Colorectal cancer;
SKCM	cis	rs4237845	0.742	rs3751330	chr12:58290226	T/C	cg00677455	chr12:58241039	CTDSP2	0.65	5.41	0.52	6.69e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs151997	0.893	rs27607	chr5:50228977	A/G	cg06027927	chr5:50259733	NA	-0.67	-5.97	-0.56	6.72e-8	Callous-unemotional behaviour;
SKCM	cis	rs7772486	0.875	rs10457795	chr6:146415665	A/G	cg05347473	chr6:146136440	FBXO30	0.65	5.96	0.56	6.79e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1005277	0.522	rs7072977	chr10:37940440	C/A	cg00409905	chr10:38381863	ZNF37A	-0.6	-5.59	-0.53	3.22e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs6570726	0.967	rs418662	chr6:145848832	A/C	cg23711669	chr6:146136114	FBXO30	0.71	6.93	0.62	1.06e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs67311347	1.000	rs2305521	chr3:40429183	A/G	cg00091569	chr3:40428383	ENTPD3	0.64	5.47	0.53	5.17e-7	Renal cell carcinoma;
SKCM	trans	rs4863687	0.752	rs4863507	chr4:140643322	A/G	cg01963906	chr1:27677240	SYTL1	-0.69	-7.79	-0.66	2.38e-11	Chronic mucus hypersecretion;
SKCM	cis	rs4819052	0.851	rs13049337	chr21:46663460	T/G	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.36	0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs2243480	1.000	rs13247184	chr7:65358928	A/G	cg18252515	chr7:66147081	NA	-1.29	-7.41	-0.64	1.3e-10	Diabetic kidney disease;
SKCM	cis	rs9325144	0.647	rs35138700	chr12:38804474	C/T	cg26384229	chr12:38710491	ALG10B	-0.75	-6.52	-0.59	6.23e-9	Morning vs. evening chronotype;
SKCM	cis	rs2075371	0.871	rs418135	chr7:133949898	A/G	cg20476274	chr7:133979776	SLC35B4	1.03	9.72	0.74	4.3e-15	Mean platelet volume;
SKCM	cis	rs7666738	0.791	rs4699329	chr4:99056212	G/A	cg17366294	chr4:99064904	C4orf37	0.61	4.98	0.49	3.73e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1707322	0.721	rs4564187	chr1:46166861	G/C	cg03146154	chr1:46216737	IPP	0.84	6.2	0.57	2.51e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs28386778	0.897	rs2727333	chr17:61876023	G/A	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs9910055	0.529	rs170637	chr17:42186868	C/T	cg08499158	chr17:42289980	UBTF	0.72	5.62	0.54	2.9e-7	Total body bone mineral density;
SKCM	cis	rs1862618	0.853	rs252904	chr5:56118733	A/T	cg12311346	chr5:56204834	C5orf35	-0.73	-5.08	-0.5	2.49e-6	Initial pursuit acceleration;
SKCM	cis	rs763014	0.966	rs4984904	chr16:680809	C/G	cg09263875	chr16:632152	PIGQ	0.75	6.45	0.59	8.51e-9	Height;
SKCM	cis	rs12142240	0.698	rs1057535	chr1:46815898	T/C	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs995000	0.931	rs2366638	chr1:63099577	G/A	cg06896770	chr1:63153194	DOCK7	0.77	7.31	0.64	2.05e-10	Triglyceride levels;
SKCM	cis	rs9880211	0.613	rs13079205	chr3:135800693	A/G	cg21827317	chr3:136751795	NA	-0.67	-4.9	-0.49	5.06e-6	Body mass index;Height;
SKCM	cis	rs17376456	0.757	rs10476591	chr5:93333723	G/C	cg25358565	chr5:93447407	FAM172A	1.2	7.45	0.64	1.1e-10	Diabetic retinopathy;
SKCM	cis	rs10256972	0.616	rs7806746	chr7:1075573	A/C	cg16145915	chr7:1198662	ZFAND2A	-0.41	-5.04	-0.5	2.9e-6	Longevity;Endometriosis;
SKCM	cis	rs1218582	0.741	rs2335407	chr1:154843347	A/G	cg06221963	chr1:154839813	KCNN3	0.61	6.6	0.6	4.5e-9	Prostate cancer;
SKCM	cis	rs3785574	0.962	rs2727331	chr17:61926990	G/T	cg26338869	chr17:61819248	STRADA	0.63	4.81	0.48	7.11e-6	Height;
SKCM	cis	rs561341	0.769	rs8074383	chr17:30178793	C/T	cg00745463	chr17:30367425	LRRC37B	0.86	4.89	0.48	5.2e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs1005277	0.540	rs2474598	chr10:38430296	C/T	cg00409905	chr10:38381863	ZNF37A	0.67	6.54	0.6	5.8e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs35146811	0.695	rs858508	chr7:99821381	C/G	cg22906224	chr7:99728672	NA	-0.71	-5.61	-0.54	2.99e-7	Coronary artery disease;
SKCM	cis	rs72615157	0.561	rs113401658	chr7:99858505	C/T	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.05	5.98	0.56	6.25e-8	Lung function (FEV1/FVC);
SKCM	cis	rs4523957	0.583	rs2641444	chr17:2037402	T/C	cg16513277	chr17:2031491	SMG6	-0.91	-6.21	-0.58	2.38e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs58785573	0.504	rs11947292	chr4:38634749	A/T	cg18361445	chr4:38666374	KLF3;FLJ13197	0.62	4.99	0.49	3.53e-6	Lymphocyte percentage of white cells;
SKCM	cis	rs644799	0.965	rs11021305	chr11:95498269	A/G	cg03916912	chr11:95522834	CEP57;FAM76B	0.87	7.85	0.66	1.81e-11	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs3008870	1.000	rs17497828	chr1:67452322	G/A	cg08660285	chr1:67390436	MIER1;WDR78	-0.92	-6.07	-0.57	4.27e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs2354432	0.505	rs3737845	chr1:146724408	A/G	cg25205988	chr1:146714368	CHD1L	1.17	6.52	0.59	6.27e-9	Mitochondrial DNA levels;
SKCM	cis	rs2072499	0.695	rs112223391	chr1:156156094	G/A	cg25208724	chr1:156163844	SLC25A44	0.9	6.62	0.6	4.06e-9	Testicular germ cell tumor;
SKCM	cis	rs13256369	0.708	rs11249886	chr8:8562021	T/A	cg15556689	chr8:8085844	FLJ10661	0.65	4.77	0.48	8.39e-6	Obesity-related traits;
SKCM	cis	rs4790333	0.692	rs2003969	chr17:2266709	T/C	cg02569219	chr17:2266849	SGSM2	0.7	6.14	0.57	3.25e-8	Proinsulin levels;
SKCM	cis	rs62103177	0.608	rs4799115	chr18:77736365	A/T	cg27393146	chr18:77495563	CTDP1	0.9	6.11	0.57	3.69e-8	Opioid sensitivity;
SKCM	cis	rs1577917	0.682	rs6935918	chr6:86283575	G/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.89	8.58	0.7	7.11e-13	Response to antipsychotic treatment;
SKCM	cis	rs1413885	0.516	rs11208637	chr1:65836553	C/T	cg14976592	chr1:65886160	LEPROT;LEPR	0.62	5.25	0.51	1.28e-6	Anticoagulant levels;
SKCM	cis	rs16854884	0.657	rs35085196	chr3:143712210	C/T	cg06585982	chr3:143692056	C3orf58	0.85	7.82	0.66	2.1e-11	Economic and political preferences (feminism/equality);
SKCM	cis	rs838147	0.844	rs8102032	chr19:49249795	C/T	cg13540341	chr19:49222985	MAMSTR	0.56	4.98	0.49	3.74e-6	Dietary macronutrient intake;
SKCM	cis	rs1153858	0.943	rs28605551	chr15:45641720	C/T	cg10760299	chr15:45669010	GATM	0.58	5.81	0.55	1.31e-7	Homoarginine levels;
SKCM	cis	rs875971	0.520	rs160645	chr7:65556307	A/G	cg18876405	chr7:65276391	NA	-0.67	-5.32	-0.52	9.82e-7	Aortic root size;
SKCM	cis	rs8060686	0.641	rs9932251	chr16:68131732	G/A	cg09117114	chr16:67998030	SLC12A4	-0.81	-5.29	-0.51	1.07e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs9463078	0.665	rs9472339	chr6:44711791	A/G	cg25276700	chr6:44698697	NA	0.44	4.77	0.48	8.31e-6	Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder;
SKCM	cis	rs6951245	0.872	rs77569514	chr7:1085508	G/A	cg24642844	chr7:1081250	C7orf50	-0.94	-6.32	-0.58	1.48e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs875971	0.545	rs73376394	chr7:65637681	C/T	cg18876405	chr7:65276391	NA	0.65	5.3	0.51	1.03e-6	Aortic root size;
SKCM	cis	rs10779751	0.666	rs77270747	chr1:11214584	A/C	cg08854313	chr1:11322531	MTOR	-0.94	-6.76	-0.61	2.26e-9	Body mass index;
SKCM	cis	rs826838	0.967	rs1352122	chr12:39130885	G/A	cg26384229	chr12:38710491	ALG10B	-0.91	-8.28	-0.68	2.74e-12	Heart rate;
SKCM	cis	rs28386778	0.897	rs894406	chr17:61901657	A/G	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs7618501	0.633	rs9814664	chr3:50078541	C/T	cg24110177	chr3:50126178	RBM5	0.63	5.38	0.52	7.62e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7937682	0.883	rs631490	chr11:111452040	G/C	cg19812747	chr11:111475976	SIK2	-0.57	-4.83	-0.48	6.76e-6	Primary sclerosing cholangitis;
SKCM	cis	rs870825	0.929	rs72689273	chr4:185592750	C/T	cg04058563	chr4:185651563	MLF1IP	1.03	5.09	0.5	2.4e-6	Blood protein levels;
SKCM	cis	rs9300255	0.602	rs949142	chr12:123634043	T/C	cg05973401	chr12:123451056	ABCB9	0.79	5.37	0.52	8.03e-7	Neutrophil percentage of white cells;
SKCM	cis	rs62103177	0.535	rs4799109	chr18:77675188	A/T	cg27393146	chr18:77495563	CTDP1	-0.84	-5.51	-0.53	4.48e-7	Opioid sensitivity;
SKCM	cis	rs1635	0.655	rs2281041	chr6:28303845	G/C	cg15743358	chr6:28303923	ZNF323	-1.27	-5.15	-0.5	1.92e-6	Schizophrenia;
SKCM	cis	rs514406	0.893	rs4584343	chr1:53434539	A/C	cg24675658	chr1:53192096	ZYG11B	0.63	5.12	0.5	2.14e-6	Monocyte count;
SKCM	cis	rs244731	0.959	rs7724098	chr5:176659570	G/A	cg16006841	chr5:176797999	RGS14	-0.8	-6.68	-0.6	3.24e-9	Urate levels in lean individuals;
SKCM	cis	rs9322193	0.923	rs10782310	chr6:149943594	A/G	cg07701084	chr6:150067640	NUP43	0.61	4.84	0.48	6.48e-6	Lung cancer;
SKCM	cis	rs12472274	0.941	rs11677230	chr2:239092054	T/C	cg17459225	chr2:239074497	NA	0.67	4.87	0.48	5.71e-6	Phospholipid levels (plasma);
SKCM	cis	rs7635838	0.617	rs346071	chr3:11305584	A/T	cg00170343	chr3:11313890	ATG7	-0.77	-5.97	-0.56	6.63e-8	HDL cholesterol;
SKCM	cis	rs67311347	0.910	rs13089215	chr3:40495894	T/C	cg00091569	chr3:40428383	ENTPD3	-0.61	-4.94	-0.49	4.31e-6	Renal cell carcinoma;
SKCM	cis	rs6546550	0.901	rs10167142	chr2:70062360	T/C	cg02498382	chr2:70120550	SNRNP27	-0.46	-5.17	-0.51	1.75e-6	Prevalent atrial fibrillation;
SKCM	cis	rs1707322	0.964	rs1768802	chr1:46547868	A/G	cg03146154	chr1:46216737	IPP	-0.81	-5.43	-0.52	6.11e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs875971	1.000	rs4717292	chr7:65895598	G/A	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs17376456	0.778	rs10440717	chr5:93424852	C/A	cg25358565	chr5:93447407	FAM172A	1.23	7.97	0.67	1.08e-11	Diabetic retinopathy;
SKCM	cis	rs1577917	1.000	rs12154056	chr6:86634094	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.85	-8.62	-0.7	5.82e-13	Response to antipsychotic treatment;
SKCM	cis	rs9902453	0.935	rs7220151	chr17:28334710	G/A	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.81	-5.78	-0.55	1.45e-7	Coffee consumption (cups per day);
SKCM	cis	rs248381	0.713	rs586199	chr5:78397980	G/A	cg17568934	chr5:77892219	LHFPL2	0.51	4.77	0.47	8.55e-6	Toenail selenium levels;
SKCM	cis	rs4073582	0.555	rs521109	chr11:66030948	G/A	cg16950941	chr11:66035639	RAB1B	0.84	7.09	0.63	5.35e-10	Gout;
SKCM	cis	rs4523957	0.553	rs2131702	chr17:2025458	T/C	cg16513277	chr17:2031491	SMG6	-0.91	-6.21	-0.58	2.38e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs6582630	0.502	rs12815350	chr12:38439921	A/T	cg26384229	chr12:38710491	ALG10B	0.81	6.22	0.58	2.33e-8	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs367615	0.704	rs17161885	chr5:108852642	A/G	cg17395555	chr5:108820864	NA	0.76	6.98	0.62	8.46e-10	Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs992157	0.560	rs10932763	chr2:219085863	G/C	cg00012203	chr2:219082015	ARPC2	-0.77	-6.29	-0.58	1.73e-8	Colorectal cancer;
SKCM	cis	rs1153858	0.945	rs16943246	chr15:45720597	G/A	cg10760299	chr15:45669010	GATM	0.61	5.58	0.53	3.33e-7	Homoarginine levels;
SKCM	cis	rs13108904	0.936	rs4974540	chr4:1213463	C/T	cg05665937	chr4:1216051	CTBP1	0.58	5.0	0.49	3.49e-6	Obesity-related traits;
SKCM	cis	rs11585357	0.947	rs11585118	chr1:17605774	C/A	cg08277548	chr1:17600880	PADI3	-0.9	-6.36	-0.58	1.26e-8	Hair shape;
SKCM	cis	rs1005277	0.522	rs9418276	chr10:37940116	G/T	cg25427524	chr10:38739819	LOC399744	-0.61	-5.68	-0.54	2.21e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs4481887	0.741	rs11488135	chr1:248568961	G/A	cg00666640	chr1:248458726	OR2T12	0.5	5.11	0.5	2.24e-6	Common traits (Other);
SKCM	cis	rs854765	0.565	rs4072738	chr17:17884547	A/C	cg04398451	chr17:18023971	MYO15A	-0.86	-6.34	-0.58	1.38e-8	Total body bone mineral density;
SKCM	cis	rs644799	1.000	rs680134	chr11:95559517	T/C	cg03916912	chr11:95522834	CEP57;FAM76B	0.88	7.53	0.65	7.59e-11	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs459571	0.959	rs455381	chr9:136905577	C/A	cg13789015	chr9:136890014	NCRNA00094	0.75	6.35	0.58	1.34e-8	Platelet distribution width;
SKCM	cis	rs17376456	0.932	rs3940842	chr5:93534858	C/A	cg25358565	chr5:93447407	FAM172A	1.23	8.18	0.68	4.19e-12	Diabetic retinopathy;
SKCM	cis	rs6570726	0.791	rs401561	chr6:145835917	G/T	cg23711669	chr6:146136114	FBXO30	0.79	7.93	0.67	1.26e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9325144	0.555	rs4882359	chr12:38726679	T/C	cg13010199	chr12:38710504	ALG10B	0.64	5.11	0.5	2.28e-6	Morning vs. evening chronotype;
SKCM	cis	rs2228479	0.850	rs76075456	chr16:89834270	T/C	cg06558623	chr16:89946397	TCF25	1.11	5.26	0.51	1.23e-6	Skin colour saturation;
SKCM	cis	rs4332037	0.624	rs73046339	chr7:1889300	G/A	cg23422044	chr7:1970798	MAD1L1	-0.89	-5.73	-0.54	1.8e-7	Bipolar disorder;
SKCM	cis	rs6120849	0.754	rs6088691	chr20:33633758	C/T	cg24642439	chr20:33292090	TP53INP2	0.94	4.86	0.48	5.91e-6	Protein C levels;
SKCM	cis	rs3780486	0.846	rs7036812	chr9:33143822	T/C	cg13443165	chr9:33130375	B4GALT1	-0.53	-4.98	-0.49	3.77e-6	IgG glycosylation;
SKCM	cis	rs5753618	0.504	rs5753659	chr22:31893613	A/G	cg02404636	chr22:31891804	SFI1	0.63	4.85	0.48	6.22e-6	Colorectal cancer;
SKCM	cis	rs2730245	0.527	rs2527187	chr7:158716912	T/C	cg24397884	chr7:158709396	WDR60	-1.01	-5.84	-0.55	1.15e-7	Height;
SKCM	cis	rs10781543	0.839	rs4379550	chr9:139376426	C/T	cg14169450	chr9:139327907	INPP5E	-0.5	-5.45	-0.53	5.59e-7	Monocyte percentage of white cells;
SKCM	cis	rs10779751	0.960	rs4845988	chr1:11319587	A/G	cg08854313	chr1:11322531	MTOR	1.02	9.43	0.73	1.61e-14	Body mass index;
SKCM	cis	rs8016982	0.633	rs8015423	chr14:81719357	C/T	cg01989461	chr14:81687754	GTF2A1	0.81	6.48	0.59	7.53e-9	Schizophrenia;
SKCM	cis	rs11585357	0.947	rs11584287	chr1:17607501	G/C	cg08277548	chr1:17600880	PADI3	-0.9	-6.36	-0.58	1.26e-8	Hair shape;
SKCM	cis	rs9910055	0.502	rs1684662	chr17:42180822	T/A	cg09913183	chr17:42254507	C17orf65;ASB16	-0.58	-4.83	-0.48	6.59e-6	Total body bone mineral density;
SKCM	cis	rs7829975	0.658	rs907181	chr8:8702875	T/C	cg06636001	chr8:8085503	FLJ10661	0.8	6.84	0.61	1.6e-9	Mood instability;
SKCM	cis	rs769267	1.000	rs769267	chr19:19446936	A/G	cg26732615	chr19:19648335	CILP2;YJEFN3	0.69	6.21	0.58	2.36e-8	Tonsillectomy;
SKCM	cis	rs514406	0.621	rs928452	chr1:53195926	G/C	cg24675658	chr1:53192096	ZYG11B	0.62	4.98	0.49	3.72e-6	Monocyte count;
SKCM	cis	rs898097	0.737	rs3785521	chr17:80895769	A/G	cg15369054	chr17:80825471	TBCD	-0.63	-5.63	-0.54	2.7e-7	Breast cancer;
SKCM	cis	rs2228479	0.618	rs17233623	chr16:89811209	C/T	cg00800038	chr16:89945340	TCF25	-0.85	-4.99	-0.49	3.65e-6	Skin colour saturation;
SKCM	cis	rs67614146	1	rs67614146	chr6:87821827	AC/A	cg08069147	chr6:88032118	GJB7;C6orf162	-0.65	-5.52	-0.53	4.22e-7	Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs3845702	0.736	rs6433821	chr2:180837806	T/A	cg01881094	chr2:180872142	CWC22	-1.3	-6.15	-0.57	3.07e-8	Schizophrenia;
SKCM	cis	rs362296	0.698	rs362283	chr4:3259558	T/C	cg05297308	chr4:3317976	RGS12	-0.75	-6.12	-0.57	3.58e-8	Parental longevity (mother's age at death);
SKCM	cis	rs2115536	0.967	rs3826008	chr15:80189805	G/T	cg00225070	chr15:80189496	MTHFS	0.76	5.1	0.5	2.31e-6	Eosinophil counts;Eosinophil percentage of white cells;Sum eosinophil basophil counts;Eosinophil percentage of granulocytes;Neutrophil percentage of granulocytes;
SKCM	cis	rs72717009	0.825	rs7552317	chr1:161479438	C/T	cg23840854	chr1:161414152	NA	-0.94	-5.26	-0.51	1.21e-6	Rheumatoid arthritis;
SKCM	cis	rs6951245	1.000	rs28528096	chr7:1070912	G/C	cg18402987	chr7:1209562	NA	1.15	6.02	0.56	5.38e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs6951245	0.872	rs113119264	chr7:1080564	G/A	cg24642844	chr7:1081250	C7orf50	-0.94	-6.32	-0.58	1.48e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs6570726	0.935	rs436212	chr6:145849400	G/A	cg23711669	chr6:146136114	FBXO30	0.7	6.71	0.61	2.78e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs10911251	0.546	rs2027085	chr1:183108611	G/T	ch.1.3577855R	chr1:183094577	LAMC1	-0.77	-7.34	-0.64	1.75e-10	Colorectal cancer;
SKCM	cis	rs5750830	0.649	rs5757657	chr22:39798429	G/T	cg11247378	chr22:39784982	NA	-0.46	-5.4	-0.52	6.86e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs826838	0.967	rs7136593	chr12:39128265	C/T	cg26384229	chr12:38710491	ALG10B	-0.91	-8.28	-0.68	2.74e-12	Heart rate;
SKCM	cis	rs2404602	0.692	rs56193230	chr15:76934472	C/T	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs1005277	0.579	rs1780138	chr10:38501654	A/G	cg25427524	chr10:38739819	LOC399744	-0.69	-6.79	-0.61	1.96e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs6834538	0.597	rs13146963	chr4:113558602	A/G	cg05166686	chr4:113558556	LARP7;C4orf21	0.63	5.2	0.51	1.56e-6	Free thyroxine concentration;
SKCM	cis	rs1348850	0.567	rs880898	chr2:178532470	C/T	cg22681709	chr2:178499509	PDE11A	-0.56	-4.96	-0.49	3.99e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs4560672	1.000	rs1951543	chr6:158555641	A/G	cg10592926	chr6:157876961	ZDHHC14	-0.53	-5.21	-0.51	1.49e-6	Smoking quantity;
SKCM	cis	rs4332037	0.722	rs28705934	chr7:1916116	T/A	cg23422044	chr7:1970798	MAD1L1	-0.95	-6.54	-0.6	5.79e-9	Bipolar disorder;
SKCM	cis	rs35306767	0.855	rs35825568	chr10:950760	C/T	cg26597838	chr10:835615	NA	0.79	5.5	0.53	4.64e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs514406	0.644	rs7552663	chr1:53204352	C/T	cg24675658	chr1:53192096	ZYG11B	0.64	5.3	0.51	1.04e-6	Monocyte count;
SKCM	cis	rs7666738	0.830	rs4619898	chr4:98959646	G/A	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	trans	rs208520	0.690	rs2144081	chr6:66824972	G/A	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-1.02	-8.06	-0.67	7.31e-12	Exhaled nitric oxide output;
SKCM	cis	rs28386778	0.830	rs2597636	chr17:61876010	A/G	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs2991971	1.000	rs9147	chr1:46016687	T/C	cg24296786	chr1:45957014	TESK2	0.65	5.25	0.51	1.28e-6	High light scatter reticulocyte count;
SKCM	cis	rs651907	0.967	rs694936	chr3:101587793	A/T	cg12386194	chr3:101231763	SENP7	0.65	5.03	0.5	3.02e-6	Colorectal cancer;
SKCM	cis	rs13256369	0.755	rs12680167	chr8:8562467	A/G	cg15556689	chr8:8085844	FLJ10661	0.65	4.77	0.48	8.39e-6	Obesity-related traits;
SKCM	cis	rs7584330	0.955	rs13432426	chr2:238388631	T/G	cg14458575	chr2:238380390	NA	0.99	6.47	0.59	7.76e-9	Prostate cancer;
SKCM	cis	rs2228479	0.702	rs78331410	chr16:89917775	C/T	cg00800038	chr16:89945340	TCF25	-1.0	-5.06	-0.5	2.75e-6	Skin colour saturation;
SKCM	cis	rs933688	0.759	rs1423593	chr5:90752351	T/G	cg12630606	chr5:90679528	LOC100129716;ARRDC3	0.99	7.75	0.66	2.82e-11	Smoking behavior;
SKCM	cis	rs58688157	0.705	rs11539530	chr11:609353	G/A	cg03576123	chr11:487126	PTDSS2	-0.8	-5.15	-0.5	1.88e-6	Systemic lupus erythematosus;
SKCM	cis	rs1153858	0.943	rs11070454	chr15:45680252	C/T	cg21132104	chr15:45694354	SPATA5L1	0.93	7.94	0.67	1.22e-11	Homoarginine levels;
SKCM	cis	rs644799	1.000	rs516551	chr11:95588626	C/T	cg03916912	chr11:95522834	CEP57;FAM76B	0.88	7.53	0.65	7.59e-11	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs9300255	0.550	rs10772997	chr12:123719880	C/A	cg05973401	chr12:123451056	ABCB9	0.75	5.83	0.55	1.18e-7	Neutrophil percentage of white cells;
SKCM	cis	rs10911232	0.507	rs10911194	chr1:182993025	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.64	0.6	3.83e-9	Hypertriglyceridemia;
SKCM	cis	rs7786877	0.521	rs4729606	chr7:100321790	T/C	cg20848291	chr7:100343083	ZAN	-0.66	-5.12	-0.5	2.19e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs12044355	0.892	rs10429979	chr1:231843569	A/G	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	0.76	5.49	0.53	4.81e-7	Alzheimer's disease;
SKCM	cis	rs589448	0.902	rs315138	chr12:69764850	A/T	cg22834771	chr12:69754056	YEATS4	-0.71	-5.79	-0.55	1.39e-7	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs2439831	0.850	rs11070408	chr15:44034788	G/A	cg02155558	chr15:43621948	ADAL;LCMT2	1.35	7.72	0.66	3.27e-11	Lung cancer in ever smokers;
SKCM	cis	rs9910055	0.552	rs4793084	chr17:42317371	G/T	cg19774624	chr17:42201019	HDAC5	0.75	5.35	0.52	8.65e-7	Total body bone mineral density;
SKCM	trans	rs66573146	0.803	rs60228659	chr4:7031704	G/A	cg07817883	chr1:32538562	TMEM39B	2.03	8.21	0.68	3.77e-12	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs12497850	0.931	rs3774628	chr3:48801840	C/T	cg06212747	chr3:49208901	KLHDC8B	0.66	4.77	0.47	8.53e-6	Parkinson's disease;
SKCM	cis	rs873946	0.586	rs12774727	chr10:134569910	T/C	cg18305652	chr10:134549665	INPP5A	0.58	5.64	0.54	2.62e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs2032447	0.507	rs478349	chr6:25894057	T/C	cg12310025	chr6:25882481	NA	-0.67	-5.68	-0.54	2.21e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs910316	0.935	rs2268620	chr14:75640403	G/A	cg11812906	chr14:75593930	NEK9	-0.7	-5.28	-0.51	1.12e-6	Height;
SKCM	cis	rs55728055	0.661	rs62237775	chr22:31965401	A/G	cg01338084	chr22:32026380	PISD	1.5	5.03	0.49	3.11e-6	Age-related hearing impairment;
SKCM	cis	rs17065868	1.000	rs9533896	chr13:45106511	A/G	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs1506636	1.000	rs644958	chr7:123400873	C/T	cg03229431	chr7:123269106	ASB15	0.64	5.21	0.51	1.48e-6	Plateletcrit;Platelet count;
SKCM	cis	rs2439831	0.681	rs2242067	chr15:43699303	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.5	6.26	0.58	1.98e-8	Lung cancer in ever smokers;
SKCM	cis	rs7617480	0.544	rs6442129	chr3:48735256	T/C	cg07636037	chr3:49044803	WDR6	0.91	6.74	0.61	2.42e-9	Subjective well-being (multi-trait analysis);Menarche (age at onset);
SKCM	cis	rs1692580	1.000	rs1692580	chr1:2157948	T/C	cg21442419	chr1:2182373	SKI	-0.51	-4.96	-0.49	4.05e-6	Coronary artery disease;
SKCM	cis	rs2404602	0.608	rs17361504	chr15:76601871	A/G	cg23625390	chr15:77176239	SCAPER	0.69	6.31	0.58	1.57e-8	Blood metabolite levels;
SKCM	cis	rs2652834	1.000	rs2134265	chr15:63398196	G/A	cg04194852	chr15:63334506	TPM1	0.76	4.78	0.48	8.15e-6	HDL cholesterol;
SKCM	cis	rs9300255	0.722	rs28592876	chr12:123866429	G/A	cg05973401	chr12:123451056	ABCB9	-0.82	-5.72	-0.54	1.92e-7	Neutrophil percentage of white cells;
SKCM	cis	rs2204008	0.599	rs2320526	chr12:38220405	T/A	cg13010199	chr12:38710504	ALG10B	0.65	5.11	0.5	2.19e-6	Bladder cancer;
SKCM	cis	rs2204008	0.744	rs11182316	chr12:38499552	G/A	cg13010199	chr12:38710504	ALG10B	0.66	4.77	0.48	8.48e-6	Bladder cancer;
SKCM	cis	rs2354432	0.607	rs6683243	chr1:146733422	A/T	cg25205988	chr1:146714368	CHD1L	-1.17	-6.52	-0.59	6.27e-9	Mitochondrial DNA levels;
SKCM	cis	rs72781680	1.000	rs12617839	chr2:24166277	A/T	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	cis	rs870825	0.929	rs1405941	chr4:185591518	A/C	cg04058563	chr4:185651563	MLF1IP	-0.86	-5.37	-0.52	7.79e-7	Blood protein levels;
SKCM	cis	rs595982	0.527	rs17206707	chr19:49361441	A/C	cg19746536	chr19:49375674	PPP1R15A	0.97	5.37	0.52	7.86e-7	Red cell distribution width;
SKCM	cis	rs10489202	0.608	rs4657733	chr1:168086434	G/A	cg24449463	chr1:168025552	DCAF6	-0.85	-7.86	-0.66	1.75e-11	Schizophrenia;
SKCM	cis	rs34779708	0.801	rs12246600	chr10:35538121	A/C	cg03585969	chr10:35415529	CREM	0.74	5.42	0.52	6.41e-7	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs1862618	0.802	rs832560	chr5:56124423	T/A	cg12311346	chr5:56204834	C5orf35	-0.7	-4.88	-0.48	5.48e-6	Initial pursuit acceleration;
SKCM	cis	rs867186	1.000	rs76648234	chr20:33689941	T/A	cg04194272	chr20:33683537	NA	-1.21	-6.8	-0.61	1.89e-9	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs7927771	0.542	rs11039336	chr11:47706141	A/G	cg20307385	chr11:47447363	PSMC3	-0.72	-5.81	-0.55	1.31e-7	Subjective well-being;
SKCM	cis	rs2153535	0.580	rs1577472	chr6:8486215	G/A	cg07606381	chr6:8435919	SLC35B3	0.86	6.25	0.58	2.06e-8	Motion sickness;
SKCM	cis	rs3181245	0.641	rs3756821	chr6:24646821	C/T	cg16906346	chr6:24646782	KIAA0319	-0.58	-5.54	-0.53	3.89e-7	Colorectal or endometrial cancer;
SKCM	cis	rs3820068	0.603	rs927207	chr1:15990552	A/G	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs1850744	0.609	rs2037315	chr4:9722408	C/G	cg15442990	chr4:9534313	NA	1.43	5.56	0.53	3.71e-7	Economic and political preferences;
SKCM	cis	rs7829975	0.688	rs13270194	chr8:8378102	T/C	cg08975724	chr8:8085496	FLJ10661	0.67	5.31	0.52	1e-6	Mood instability;
SKCM	cis	rs7927771	0.832	rs896816	chr11:47394338	T/C	cg05585544	chr11:47624801	NA	0.56	4.79	0.48	7.65e-6	Subjective well-being;
SKCM	cis	rs2404602	0.692	rs4383105	chr15:77055510	T/C	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs1218582	0.741	rs11264281	chr1:154867221	A/G	cg24250549	chr1:154909240	PMVK	0.82	8.28	0.68	2.7e-12	Prostate cancer;
SKCM	cis	rs2153535	0.580	rs7753192	chr6:8482637	G/A	cg07606381	chr6:8435919	SLC35B3	0.86	6.25	0.58	2.06e-8	Motion sickness;
SKCM	cis	rs8067545	0.611	rs2703812	chr17:20114803	A/G	cg13482628	chr17:19912719	NA	-0.66	-5.5	-0.53	4.72e-7	Schizophrenia;
SKCM	cis	rs11585357	1.000	rs11203346	chr1:17600822	A/G	cg08277548	chr1:17600880	PADI3	-0.82	-6.1	-0.57	3.84e-8	Hair shape;
SKCM	cis	rs1577917	0.958	rs10455448	chr6:86533611	T/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.81	-0.66	2.19e-11	Response to antipsychotic treatment;
SKCM	cis	rs55962025	0.883	rs3755883	chr4:3223250	A/G	cg00764545	chr4:3318001	RGS12	-0.71	-5.51	-0.53	4.38e-7	Parental longevity (mother's age at death);
SKCM	cis	rs8014204	0.836	rs7150254	chr14:75299101	G/A	cg06637938	chr14:75390232	RPS6KL1	0.83	6.65	0.6	3.64e-9	Caffeine consumption;
SKCM	cis	rs3785574	0.962	rs2727331	chr17:61926990	G/T	cg01411255	chr17:61851458	DDX42;CCDC47	1.15	12.64	0.82	1.42e-20	Height;
SKCM	cis	rs7847628	0.587	rs12684934	chr9:123593159	C/T	cg09419670	chr9:123605666	PSMD5;LOC253039	0.67	6.11	0.57	3.6e-8	Birth weight;
SKCM	cis	rs13118159	0.509	rs10023473	chr4:1375285	C/T	cg19318889	chr4:1322082	MAEA	0.77	5.66	0.54	2.37e-7	Longevity;
SKCM	cis	rs1801251	1.000	rs283484	chr2:233646505	A/G	cg08000102	chr2:233561755	GIGYF2	0.89	7.15	0.63	4.05e-10	Coronary artery disease;
SKCM	cis	rs1401999	0.934	rs1132776	chr3:183696402	A/G	cg01324343	chr3:183735012	ABCC5	0.93	10.78	0.77	4.03e-17	Anterior chamber depth;
SKCM	cis	rs950776	0.518	rs12914694	chr15:78814444	G/A	cg06917634	chr15:78832804	PSMA4	1.01	10.48	0.76	1.5e-16	Sudden cardiac arrest;
SKCM	cis	rs55962025	0.842	rs362272	chr4:3234980	C/T	cg09735869	chr4:3319127	RGS12	-0.78	-5.99	-0.56	6.16e-8	Parental longevity (mother's age at death);
SKCM	cis	rs742614	0.533	rs6059496	chr20:32446931	T/C	cg06304546	chr20:32448765	NA	-0.72	-5.88	-0.55	9.49e-8	Stearic acid (18:0) levels;
SKCM	cis	rs9921222	0.597	rs7193109	chr16:413523	T/G	cg26944245	chr16:421049	TMEM8A;MRPL28	0.64	4.97	0.49	3.82e-6	Bone mineral density (spine);Bone mineral density;
SKCM	cis	rs7618501	0.633	rs6772095	chr3:49978069	C/T	cg24110177	chr3:50126178	RBM5	-0.6	-5.1	-0.5	2.36e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs870825	0.548	rs12513029	chr4:185665118	G/A	cg04058563	chr4:185651563	MLF1IP	0.99	6.86	0.61	1.47e-9	Blood protein levels;
SKCM	cis	rs9790314	0.746	rs898680	chr3:160772853	G/A	cg03342759	chr3:160939853	NMD3	-0.61	-5.59	-0.53	3.25e-7	Morning vs. evening chronotype;
SKCM	cis	rs763014	0.966	rs35642938	chr16:642249	T/C	cg09263875	chr16:632152	PIGQ	0.67	5.82	0.55	1.25e-7	Height;
SKCM	cis	rs9790314	0.659	rs13066683	chr3:160847410	A/G	cg03342759	chr3:160939853	NMD3	-0.64	-6.6	-0.6	4.54e-9	Morning vs. evening chronotype;
SKCM	cis	rs847649	0.692	rs6949391	chr7:102446863	C/T	cg18108683	chr7:102477205	FBXL13	-0.83	-9.35	-0.73	2.31e-14	Morning vs. evening chronotype;
SKCM	cis	rs2072499	0.778	rs2842868	chr1:156196407	A/C	cg24450063	chr1:156163899	SLC25A44	0.68	5.27	0.51	1.2e-6	Testicular germ cell tumor;
SKCM	cis	rs4803468	0.967	rs284661	chr19:41932120	C/T	cg14132834	chr19:41945861	ATP5SL	-0.77	-6.04	-0.56	4.87e-8	Height;
SKCM	cis	rs4919087	1.000	rs7076523	chr10:99089296	T/C	cg25902810	chr10:99078978	FRAT1	-0.62	-4.96	-0.49	4.06e-6	Monocyte count;
SKCM	cis	rs9910055	0.639	rs7217858	chr17:42254527	T/G	cg13607699	chr17:42295918	UBTF	0.71	5.74	0.55	1.72e-7	Total body bone mineral density;
SKCM	cis	rs7296418	0.961	rs4148863	chr12:123569375	A/G	cg06742321	chr12:123595122	PITPNM2	0.65	5.45	0.52	5.77e-7	Platelet count;
SKCM	cis	rs12706411	0.764	rs13239116	chr7:122087676	C/T	cg17986181	chr7:121955208	NA	-0.65	-5.01	-0.49	3.36e-6	Alzheimer disease and age of onset;
SKCM	cis	rs365132	0.967	rs353471	chr5:176363429	T/C	cg16309518	chr5:176445507	NA	-0.51	-4.95	-0.49	4.21e-6	Menarche and menopause (age at onset);Menopause (age at onset);
SKCM	cis	rs1405130	0.869	rs13019592	chr2:235565760	C/G	cg17841421	chr2:235704848	NA	-0.57	-4.95	-0.49	4.14e-6	Coronary artery disease;
SKCM	cis	rs1850744	0.826	rs4554078	chr4:9701544	A/G	cg15442990	chr4:9534313	NA	1.18	4.93	0.49	4.5e-6	Economic and political preferences;
SKCM	cis	rs1218582	0.600	rs72702224	chr1:154911689	G/A	cg09359103	chr1:154839909	KCNN3	-0.53	-4.81	-0.48	7.13e-6	Prostate cancer;
SKCM	cis	rs7143963	1.000	rs3783384	chr14:103351830	C/T	cg23020514	chr14:103360112	TRAF3	0.89	9.01	0.71	1.03e-13	Body mass index;
SKCM	cis	rs2070488	0.965	rs1065800	chr3:38566480	C/T	cg01465620	chr3:38496096	LOC100128640;ACVR2B	-1.03	-9.12	-0.72	6.37e-14	Electrocardiographic conduction measures;
SKCM	cis	rs9325144	0.647	rs7957185	chr12:38909710	G/A	cg26384229	chr12:38710491	ALG10B	-0.7	-5.84	-0.55	1.13e-7	Morning vs. evening chronotype;
SKCM	cis	rs9916302	0.904	rs9904334	chr17:37468336	G/A	cg07936489	chr17:37558343	FBXL20	0.84	6.75	0.61	2.32e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs1218582	0.740	rs1977879	chr1:154879743	G/A	cg03351412	chr1:154909251	PMVK	0.77	6.52	0.59	6.43e-9	Prostate cancer;
SKCM	cis	rs2033711	0.783	rs8113810	chr19:58932106	A/G	cg13877915	chr19:58951672	ZNF132	0.95	10.27	0.76	3.77e-16	Uric acid clearance;
SKCM	cis	rs8180040	0.903	rs11130124	chr3:47292183	T/C	cg16586182	chr3:47516702	SCAP	-0.72	-4.98	-0.49	3.73e-6	Colorectal cancer;
SKCM	cis	rs7216064	0.861	rs73352810	chr17:65875184	G/A	cg12091567	chr17:66097778	LOC651250	-0.75	-5.27	-0.51	1.19e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs10751667	0.577	rs7946461	chr11:974035	A/G	cg10932868	chr11:921992	NA	0.55	5.1	0.5	2.36e-6	Alzheimer's disease (late onset);
SKCM	cis	rs1506636	1.000	rs646753	chr7:123401237	G/T	cg03229431	chr7:123269106	ASB15	0.64	5.21	0.51	1.48e-6	Plateletcrit;Platelet count;
SKCM	cis	rs2404602	0.735	rs4886493	chr15:76679026	A/G	cg23625390	chr15:77176239	SCAPER	-0.8	-7.85	-0.66	1.83e-11	Blood metabolite levels;
SKCM	cis	rs9394841	0.692	rs9357371	chr6:41885319	A/C	cg08135965	chr6:41755394	TOMM6	0.76	4.95	0.49	4.23e-6	Mean corpuscular hemoglobin;Red cell distribution width;
SKCM	cis	rs561341	1.000	rs8064843	chr17:30245744	A/G	cg23018236	chr17:30244563	NA	-0.52	-5.34	-0.52	8.83e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs7666738	0.830	rs3852122	chr4:98697400	T/C	cg17366294	chr4:99064904	C4orf37	0.58	5.11	0.5	2.2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11105298	0.891	rs1054807	chr12:89913419	C/T	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.91	-5.65	-0.54	2.56e-7	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs3820068	0.603	rs3795763	chr1:15959977	C/T	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs11249608	0.548	rs62393072	chr5:178450056	C/T	cg21905437	chr5:178450457	ZNF879	0.76	6.46	0.59	8.29e-9	Pubertal anthropometrics;
SKCM	cis	rs1707322	1.000	rs9793167	chr1:46446800	G/A	cg03146154	chr1:46216737	IPP	0.79	5.34	0.52	8.73e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs1395	0.634	rs72817542	chr2:27526681	C/G	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.57	5.24	0.51	1.33e-6	Blood metabolite levels;
SKCM	cis	rs1850744	0.702	rs73802906	chr4:9598448	C/T	cg15442990	chr4:9534313	NA	-1.3	-4.84	-0.48	6.55e-6	Economic and political preferences;
SKCM	cis	rs2885056	0.699	rs34275421	chr19:10644812	T/A	cg04833646	chr19:10679720	CDKN2D	0.87	7.09	0.63	5.25e-10	Red cell distribution width;
SKCM	cis	rs3785574	0.962	rs4480868	chr17:61788859	C/T	cg01411255	chr17:61851458	DDX42;CCDC47	1.19	13.46	0.84	4.96e-22	Height;
SKCM	cis	rs2180341	0.920	rs6906717	chr6:127596782	C/A	cg24812749	chr6:127587940	RNF146	0.86	7.32	0.64	1.92e-10	Breast cancer;
SKCM	cis	rs1799949	0.930	rs3092987	chr17:41222723	T/C	cg23758822	chr17:41437982	NA	0.94	7.89	0.67	1.51e-11	Menopause (age at onset);
SKCM	cis	rs7945705	0.747	rs1123936	chr11:9003306	A/G	cg21881798	chr11:8931708	C11orf17;ST5	-0.84	-9.3	-0.72	2.89e-14	Hemoglobin concentration;
SKCM	cis	rs9549367	0.713	rs3024761	chr13:113824090	C/G	cg24722198	chr13:113567732	NA	-0.49	-5.06	-0.5	2.75e-6	Platelet distribution width;
SKCM	cis	rs2952156	0.684	rs1877031	chr17:37814080	G/A	cg00129232	chr17:37814104	STARD3	-0.77	-6.36	-0.58	1.27e-8	Asthma;
SKCM	cis	rs992157	0.965	rs62182826	chr2:219148723	C/A	cg00012203	chr2:219082015	ARPC2	0.75	6.25	0.58	2.02e-8	Colorectal cancer;
SKCM	cis	rs10808739	0.702	rs34484820	chr8:65633400	G/A	cg05711235	chr8:65498612	NA	-0.81	-5.4	-0.52	7.01e-7	HIV-1 susceptibility;
SKCM	trans	rs561341	0.714	rs547473	chr17:30297560	T/G	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs2836974	0.666	rs35182074	chr21:40685284	A/C	cg11890956	chr21:40555474	PSMG1	-0.82	-8.03	-0.67	8.09e-12	Cognitive function;
SKCM	cis	rs9926296	0.607	rs2079672	chr16:89884917	A/G	cg01097406	chr16:89675127	NA	0.46	5.64	0.54	2.61e-7	Vitiligo;
SKCM	trans	rs1814175	0.645	rs4411280	chr11:49962750	A/G	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs11719291	0.504	rs34571182	chr3:49209057	T/A	cg24110177	chr3:50126178	RBM5	0.88	5.26	0.51	1.23e-6	Cognitive function;
SKCM	cis	rs1843834	0.539	rs2068244	chr2:225440011	A/G	cg12698349	chr2:225449008	CUL3	-0.86	-7.0	-0.62	7.82e-10	IgE levels in asthmatics (D.p. specific);
SKCM	cis	rs17685	0.712	rs6976236	chr7:75741087	G/T	cg16684958	chr7:75615977	POR	0.55	5.37	0.52	7.82e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs992157	0.730	rs2382828	chr2:219184492	A/G	cg00012203	chr2:219082015	ARPC2	0.75	5.54	0.53	3.92e-7	Colorectal cancer;
SKCM	cis	rs2153535	0.504	rs9405393	chr6:8467432	G/T	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs12047808	0.841	rs55708548	chr1:179398932	G/C	cg09822482	chr1:179519214	C1orf125	-0.95	-5.17	-0.51	1.78e-6	Multiple sclerosis (age of onset);
SKCM	cis	rs1153858	1.000	rs4625670	chr15:45652926	C/T	cg21132104	chr15:45694354	SPATA5L1	0.93	7.94	0.67	1.22e-11	Homoarginine levels;
SKCM	cis	rs8177253	0.965	rs8177260	chr3:133480458	T/A	cg16414030	chr3:133502952	NA	-0.71	-6.03	-0.56	5.17e-8	Iron status biomarkers;
SKCM	cis	rs28386778	0.901	rs2854194	chr17:61952110	T/G	cg26338869	chr17:61819248	STRADA	0.7	4.79	0.48	7.67e-6	Prudent dietary pattern;
SKCM	cis	rs9796	0.576	rs13329511	chr15:41299121	T/C	cg18705301	chr15:41695430	NDUFAF1	-0.71	-5.77	-0.55	1.52e-7	Menopause (age at onset);
SKCM	cis	rs2842992	0.724	rs9347340	chr6:160188891	C/T	cg19482086	chr6:160211437	TCP1;MRPL18	-0.96	-8.49	-0.69	1.07e-12	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs898097	0.841	rs12453162	chr17:80859971	C/T	cg15369054	chr17:80825471	TBCD	0.67	5.95	0.56	7.08e-8	Breast cancer;
SKCM	trans	rs1814175	0.586	rs2866862	chr11:49954588	T/C	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs7945705	0.846	rs905290	chr11:8753729	A/G	cg21881798	chr11:8931708	C11orf17;ST5	0.61	5.59	0.53	3.27e-7	Hemoglobin concentration;
SKCM	cis	rs1218582	0.710	rs9793588	chr1:154878878	C/G	cg24250549	chr1:154909240	PMVK	0.85	7.96	0.67	1.11e-11	Prostate cancer;
SKCM	cis	rs1160297	0.576	rs67939368	chr2:53093152	G/C	cg07782112	chr2:53107842	NA	0.58	6.05	0.56	4.79e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs2991971	0.967	rs10789465	chr1:45971759	T/C	cg24296786	chr1:45957014	TESK2	0.69	5.65	0.54	2.47e-7	High light scatter reticulocyte count;
SKCM	cis	rs7927771	0.832	rs55677087	chr11:47397714	C/G	cg05585544	chr11:47624801	NA	-0.58	-5.19	-0.51	1.61e-6	Subjective well-being;
SKCM	cis	rs6087990	0.735	rs2064350	chr20:31390533	T/C	cg13636640	chr20:31349939	DNMT3B	0.83	6.25	0.58	2.06e-8	Ulcerative colitis;
SKCM	cis	rs5750830	0.649	rs5757664	chr22:39821536	A/G	cg24399712	chr22:39784796	NA	-0.6	-5.01	-0.49	3.31e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs155076	1.000	rs261369	chr13:21868420	C/A	cg14456004	chr13:21872349	NA	-1.28	-7.48	-0.65	9.62e-11	White matter hyperintensity burden;
SKCM	cis	rs4819052	0.851	rs34101026	chr21:46662200	C/T	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.36	0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7937682	0.847	rs11213948	chr11:111464401	G/A	cg19812747	chr11:111475976	SIK2	-0.61	-4.94	-0.49	4.41e-6	Primary sclerosing cholangitis;
SKCM	cis	rs10504073	0.647	rs4873314	chr8:50011656	A/C	cg00325661	chr8:49890786	NA	0.79	6.79	0.61	1.99e-9	Blood metabolite ratios;
SKCM	cis	rs3749237	0.595	rs2878298	chr3:49406080	T/C	cg03060546	chr3:49711283	APEH	0.67	4.86	0.48	5.96e-6	Resting heart rate;
SKCM	cis	rs1707322	1.000	rs11211236	chr1:46443767	C/A	cg03146154	chr1:46216737	IPP	0.79	5.34	0.52	8.73e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs6445797	0.632	rs2054988	chr3:56593170	G/A	cg13616963	chr3:57583610	ARF4	-0.79	-5.1	-0.5	2.35e-6	Gastritis;
SKCM	cis	rs7618915	0.547	rs34610142	chr3:52708429	G/A	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs992157	0.697	rs13384682	chr2:219069137	G/A	cg00012203	chr2:219082015	ARPC2	0.84	7.36	0.64	1.6e-10	Colorectal cancer;
SKCM	cis	rs12464559	0.522	rs6715027	chr2:152626657	T/C	cg01189475	chr2:152685088	ARL5A	1.03	5.27	0.51	1.18e-6	Response to cognitive-behavioural therapy in anxiety disorder;
SKCM	cis	rs6933660	0.760	rs1825368	chr6:151775259	C/A	cg10883421	chr6:151773342	RMND1;C6orf211	0.81	6.76	0.61	2.24e-9	Menarche (age at onset);
SKCM	cis	rs9910055	0.639	rs7217858	chr17:42254527	T/G	cg19774624	chr17:42201019	HDAC5	-0.87	-8.15	-0.68	4.72e-12	Total body bone mineral density;
SKCM	cis	rs10193935	0.901	rs2118889	chr2:42451683	G/T	cg27598129	chr2:42591480	NA	-0.84	-6.21	-0.58	2.39e-8	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9926296	0.546	rs6500442	chr16:89828862	T/C	cg26513180	chr16:89883248	FANCA	0.96	11.79	0.8	5.26e-19	Vitiligo;
SKCM	cis	rs244731	0.920	rs244707	chr5:176555636	A/T	cg06060754	chr5:176797920	RGS14	0.8	6.53	0.59	6.17e-9	Urate levels in lean individuals;
SKCM	cis	rs9926296	0.533	rs9938865	chr16:89867797	A/G	cg27121462	chr16:89883253	FANCA	0.82	7.47	0.65	9.85e-11	Vitiligo;
SKCM	cis	rs7208859	0.623	rs73269923	chr17:29102571	C/T	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs763014	0.898	rs916416	chr16:632198	T/A	cg00908189	chr16:619842	PIGQ	0.82	7.78	0.66	2.55e-11	Height;
SKCM	cis	rs4925386	0.512	rs2274933	chr20:60897488	G/A	cg09594475	chr20:60884601	LAMA5	0.7	5.21	0.51	1.51e-6	Colorectal cancer;Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs2645694	0.651	rs2703144	chr4:77830505	C/G	cg03477792	chr4:77819574	ANKRD56	0.57	6.42	0.59	9.57e-9	Emphysema distribution in smoking;
SKCM	cis	rs9475752	0.793	rs7760385	chr6:56834185	G/A	cg06815302	chr6:57335405	PRIM2	0.65	5.03	0.49	3.12e-6	Menarche (age at onset);
SKCM	cis	rs34891900	0.507	rs2535679	chr22:18202850	A/G	cg19898043	chr22:18121309	BCL2L13	0.7	5.54	0.53	4.03e-7	Sum neutrophil eosinophil counts;
SKCM	cis	rs7809950	1.000	rs28714607	chr7:107106253	T/C	cg23024343	chr7:107201750	COG5	-0.74	-6.61	-0.6	4.39e-9	Coronary artery disease;
SKCM	cis	rs2479724	1.000	rs2479724	chr6:41890982	T/C	cg17623882	chr6:41773611	USP49	-0.7	-6.01	-0.56	5.67e-8	Menarche (age at onset);
SKCM	cis	rs6951245	1.000	rs28379681	chr7:1070539	C/T	cg03188948	chr7:1209495	NA	1.12	6.17	0.57	2.88e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs651907	0.557	rs1031710	chr3:101463895	C/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.81	7.11	0.63	4.78e-10	Colorectal cancer;
SKCM	cis	rs8014204	0.836	rs11159099	chr14:75235397	A/G	cg06637938	chr14:75390232	RPS6KL1	0.8	6.33	0.58	1.43e-8	Caffeine consumption;
SKCM	cis	rs131777	0.708	rs131749	chr22:51024624	C/T	cg25309564	chr22:51001381	C22orf41	-0.79	-5.23	-0.51	1.39e-6	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs9303401	0.592	rs66583824	chr17:56639853	C/T	cg10487724	chr17:56770010	TEX14;RAD51C	0.84	6.24	0.58	2.07e-8	Cognitive test performance;
SKCM	cis	rs17685	0.735	rs11763339	chr7:75761541	T/C	cg16684958	chr7:75615977	POR	0.55	5.27	0.51	1.19e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7191439	0.858	rs2340973	chr16:88773396	G/A	cg02389323	chr16:88786976	FAM38A	1.5	6.05	0.57	4.7e-8	Plateletcrit;
SKCM	cis	rs2404602	0.647	rs12898810	chr15:76904738	T/C	cg23625390	chr15:77176239	SCAPER	-0.85	-8.26	-0.68	2.93e-12	Blood metabolite levels;
SKCM	cis	rs6977660	0.714	rs6959039	chr7:19818182	T/C	cg07541023	chr7:19748670	TWISTNB	0.72	4.78	0.48	7.95e-6	Thyroid stimulating hormone;
SKCM	cis	rs748404	0.660	rs548704	chr15:43791706	A/C	cg02155558	chr15:43621948	ADAL;LCMT2	0.72	5.5	0.53	4.7e-7	Lung cancer;
SKCM	cis	rs507080	0.922	rs478371	chr11:118565336	G/A	cg18045108	chr11:118530628	TREH	-0.47	-4.81	-0.48	7.17e-6	Serum metabolite levels;
SKCM	cis	rs9951698	0.703	rs9964466	chr18:13030383	G/A	cg12848697	chr18:13133368	NA	0.53	4.96	0.49	4.04e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs709400	0.859	rs942863	chr14:104021268	C/T	cg26031613	chr14:104095156	KLC1	1.01	10.65	0.77	7.3e-17	Body mass index;
SKCM	cis	rs7111031	1.000	rs61902787	chr11:113337058	C/A	cg04642306	chr11:112834466	NCAM1	-0.45	-4.96	-0.49	4.06e-6	Subjective well-being (multi-trait analysis);Depressive symptoms (multi-trait analysis);Neuroticism;
SKCM	cis	rs2427308	0.607	rs1741635	chr20:60938197	C/G	cg09594475	chr20:60884601	LAMA5	-0.6	-4.97	-0.49	3.82e-6	Colorectal cancer;
SKCM	cis	rs17685	0.753	rs4732595	chr7:75755139	A/G	cg16684958	chr7:75615977	POR	0.55	5.27	0.51	1.19e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2777491	0.957	rs7163788	chr15:41704789	A/G	cg18705301	chr15:41695430	NDUFAF1	-0.9	-9.24	-0.72	3.67e-14	Ulcerative colitis;
SKCM	cis	rs10504073	0.584	rs10957337	chr8:49959027	G/T	cg00325661	chr8:49890786	NA	0.8	6.81	0.61	1.83e-9	Blood metabolite ratios;
SKCM	cis	rs7772486	0.686	rs9399564	chr6:146078907	C/T	cg05347473	chr6:146136440	FBXO30	-0.56	-5.22	-0.51	1.42e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs951366	0.617	rs823080	chr1:205789282	G/A	cg17178900	chr1:205818956	PM20D1	0.85	9.1	0.72	7.06e-14	Menarche (age at onset);
SKCM	cis	rs780096	0.506	rs1647265	chr2:27692261	A/G	cg05696406	chr2:27599888	SNX17	0.51	5.22	0.51	1.46e-6	Total body bone mineral density;
SKCM	cis	rs8180040	0.739	rs11719306	chr3:47184182	G/A	cg27129171	chr3:47204927	SETD2	0.82	6.44	0.59	9.04e-9	Colorectal cancer;
SKCM	cis	rs7811142	1.000	rs2406253	chr7:100077273	A/G	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.12	6.51	0.59	6.68e-9	Platelet count;
SKCM	cis	rs12824058	0.737	rs11060829	chr12:130814996	G/T	cg24838063	chr12:130822603	PIWIL1	0.78	6.99	0.62	8.22e-10	Menopause (age at onset);
SKCM	cis	rs12458462	0.892	rs2007483	chr18:77476131	A/T	cg11879182	chr18:77439856	CTDP1	0.87	7.22	0.63	3.06e-10	Monocyte count;
SKCM	cis	rs478304	0.651	rs4930319	chr11:65555458	G/C	cg17480646	chr11:65405466	SIPA1	-0.67	-4.94	-0.49	4.28e-6	Acne (severe);
SKCM	cis	rs514406	0.679	rs541852	chr1:53256834	A/G	cg16325326	chr1:53192061	ZYG11B	-0.61	-4.94	-0.49	4.34e-6	Monocyte count;
SKCM	cis	rs10504073	0.647	rs10504072	chr8:49993083	G/A	cg00325661	chr8:49890786	NA	0.78	6.77	0.61	2.18e-9	Blood metabolite ratios;
SKCM	cis	rs6088580	0.668	rs1205340	chr20:32923871	G/A	cg24642439	chr20:33292090	TP53INP2	-0.7	-5.34	-0.52	9.05e-7	Glomerular filtration rate (creatinine);
SKCM	cis	rs7772486	0.790	rs2253307	chr6:146196181	T/G	cg23711669	chr6:146136114	FBXO30	0.85	9.32	0.73	2.57e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs637571	0.522	rs538954	chr11:65756808	A/G	cg02427764	chr11:65769310	BANF1;EIF1AD	0.77	5.87	0.55	1.03e-7	Eosinophil percentage of white cells;
SKCM	cis	rs4665809	0.627	rs7562192	chr2:26469457	C/G	cg04944784	chr2:26401820	FAM59B	0.74	4.79	0.48	7.81e-6	Gut microbiome composition (summer);
SKCM	cis	rs11098499	0.955	rs11931312	chr4:120159023	T/C	cg09307838	chr4:120376055	NA	0.93	7.99	0.67	9.9e-12	Corneal astigmatism;
SKCM	cis	rs933688	0.877	rs1477349	chr5:90707773	G/A	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.1	8.33	0.69	2.14e-12	Smoking behavior;
SKCM	cis	rs75920871	0.528	rs4388921	chr11:116976778	T/C	cg01368799	chr11:117014884	PAFAH1B2	-0.66	-4.77	-0.48	8.3e-6	Subjective well-being;
SKCM	cis	rs6952808	0.771	rs10275045	chr7:1920826	C/T	cg05863683	chr7:1912471	MAD1L1	0.54	4.77	0.47	8.54e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs3820928	1.000	rs2396433	chr2:227772502	A/G	cg11843606	chr2:227700838	RHBDD1	-0.64	-5.2	-0.51	1.53e-6	Pulmonary function;
SKCM	cis	rs6754311	0.509	rs10188066	chr2:136539513	G/A	cg07169764	chr2:136633963	MCM6	-0.86	-6.37	-0.59	1.2e-8	Mosquito bite size;
SKCM	cis	rs28595532	0.920	rs115506655	chr4:119757667	A/G	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs7635838	0.617	rs347587	chr3:11287155	A/G	cg00170343	chr3:11313890	ATG7	-0.75	-5.9	-0.56	9.05e-8	HDL cholesterol;
SKCM	cis	rs801193	0.844	rs7779971	chr7:66161790	T/C	cg00343986	chr7:65444356	GUSB	0.7	5.14	0.5	1.98e-6	Aortic root size;
SKCM	cis	rs9435341	0.826	rs1730858	chr1:107619244	T/C	cg09367891	chr1:107599246	PRMT6	-0.77	-5.93	-0.56	7.68e-8	Facial morphology (factor 21, depth of nasal alae);
SKCM	cis	rs12477438	0.520	rs11692699	chr2:99730657	T/C	cg26064155	chr2:99771622	LIPT1;TSGA10	1.02	10.07	0.75	9.12e-16	Chronic sinus infection;
SKCM	cis	rs28386778	0.897	rs2584617	chr17:61925298	C/T	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs7811142	0.830	rs11761253	chr7:99939321	C/T	cg00814883	chr7:100076585	TSC22D4	-0.84	-4.78	-0.48	8.01e-6	Platelet count;
SKCM	cis	rs801193	0.548	rs7805152	chr7:66209253	C/T	cg18876405	chr7:65276391	NA	0.61	6.02	0.56	5.36e-8	Aortic root size;
SKCM	cis	rs7216064	1.000	rs9912770	chr17:65868233	C/T	cg12091567	chr17:66097778	LOC651250	-0.75	-5.27	-0.51	1.19e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs453301	0.571	rs2929305	chr8:9085217	G/A	cg15556689	chr8:8085844	FLJ10661	-0.66	-5.01	-0.49	3.32e-6	Joint mobility (Beighton score);
SKCM	cis	rs2228479	0.717	rs62052210	chr16:89980158	A/G	cg00800038	chr16:89945340	TCF25	-0.96	-5.55	-0.53	3.79e-7	Skin colour saturation;
SKCM	cis	rs9513627	0.920	rs7320057	chr13:100155586	G/A	cg11288260	chr13:100117058	NA	0.79	4.78	0.48	8.1e-6	Obesity-related traits;
SKCM	cis	rs2304069	0.954	rs9324640	chr5:149413186	C/T	cg22760475	chr5:149380129	HMGXB3;TIGD6	-0.84	-6.01	-0.56	5.63e-8	HIV-1 control;
SKCM	cis	rs7590368	0.961	rs12474895	chr2:10957848	A/C	cg15705551	chr2:10952987	PDIA6	0.76	4.82	0.48	6.86e-6	Educational attainment (years of education);
SKCM	cis	rs6951245	0.935	rs11766669	chr7:1063593	C/T	cg21664854	chr7:1097933	C7orf50;GPR146	0.9	4.86	0.48	6.05e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs1552244	0.882	rs2030564	chr3:10039044	A/G	cg02579736	chr3:10068473	FANCD2;CIDECP	0.94	4.84	0.48	6.49e-6	Alzheimer's disease;
SKCM	cis	rs1568889	1.000	rs61889054	chr11:28333000	A/C	cg06544937	chr11:28130018	METT5D1;KIF18A	0.87	6.67	0.6	3.33e-9	Bipolar disorder;
SKCM	cis	rs9325144	0.555	rs2387847	chr12:38687434	C/T	cg26384229	chr12:38710491	ALG10B	0.78	6.74	0.61	2.48e-9	Morning vs. evening chronotype;
SKCM	cis	rs59043219	1	rs59043219	chr1:209970610	G/A	cg12034118	chr1:209979487	IRF6	0.58	5.86	0.55	1.04e-7	Crohn's disease;Inflammatory bowel disease;Alzheimer's disease (APOE e4 interaction);
SKCM	cis	rs875971	1.000	rs6956179	chr7:65806659	C/T	cg18876405	chr7:65276391	NA	-0.68	-6.79	-0.61	1.96e-9	Aortic root size;
SKCM	cis	rs801193	0.935	rs11772264	chr7:66176387	T/C	cg00343986	chr7:65444356	GUSB	0.7	5.19	0.51	1.63e-6	Aortic root size;
SKCM	cis	rs17376456	0.877	rs35747258	chr5:93310129	C/T	cg25358565	chr5:93447407	FAM172A	1.23	7.26	0.63	2.53e-10	Diabetic retinopathy;
SKCM	cis	rs11098499	0.954	rs12510138	chr4:120423935	C/G	cg24375607	chr4:120327624	NA	0.67	5.39	0.52	7.13e-7	Corneal astigmatism;
SKCM	cis	rs523522	0.962	rs655530	chr12:121022275	T/C	cg12219531	chr12:120966889	COQ5	0.9	7.63	0.65	4.83e-11	High light scatter reticulocyte count;
SKCM	cis	rs6121246	0.559	rs6060922	chr20:30333909	C/T	cg13852791	chr20:30311386	BCL2L1	0.82	5.69	0.54	2.09e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs7829975	0.777	rs560544	chr8:8637429	G/A	cg15556689	chr8:8085844	FLJ10661	-0.78	-6.82	-0.61	1.76e-9	Mood instability;
SKCM	cis	rs854765	0.547	rs2955380	chr17:17944349	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	-1.05	-9.29	-0.72	2.92e-14	Total body bone mineral density;
SKCM	cis	rs1278769	0.735	rs9577395	chr13:113534984	C/G	cg00823993	chr13:113535758	ATP11A	0.58	4.88	0.48	5.6e-6	Interstitial lung disease;
SKCM	cis	rs2075371	0.611	rs11762920	chr7:134018514	C/T	cg20476274	chr7:133979776	SLC35B4	0.9	8.75	0.7	3.37e-13	Mean platelet volume;
SKCM	cis	rs1850744	0.609	rs6448959	chr4:9683927	T/C	cg15442990	chr4:9534313	NA	1.1	4.86	0.48	5.98e-6	Economic and political preferences;
SKCM	cis	rs28386778	0.830	rs67905415	chr17:61841236	G/A	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs867186	1.000	rs11167260	chr20:33775200	C/T	cg04194272	chr20:33683537	NA	-0.98	-5.07	-0.5	2.57e-6	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs28595532	0.702	rs55981733	chr4:119306600	G/A	cg21605333	chr4:119757512	SEC24D	0.94	5.05	0.5	2.85e-6	Cannabis dependence symptom count;
SKCM	cis	rs6500395	1.000	rs8058362	chr16:48645316	T/C	cg04672837	chr16:48644449	N4BP1	0.69	5.75	0.55	1.65e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs910316	1.000	rs11623413	chr14:75588824	C/T	cg11812906	chr14:75593930	NEK9	-0.72	-5.44	-0.52	6.03e-7	Height;
SKCM	cis	rs4808199	0.895	rs4808194	chr19:19435680	T/G	cg03709012	chr19:19516395	GATAD2A	1.08	7.53	0.65	7.65e-11	Nonalcoholic fatty liver disease;
SKCM	cis	rs769267	0.895	rs2905435	chr19:19495954	G/A	cg26732615	chr19:19648335	CILP2;YJEFN3	-0.69	-7.02	-0.62	7.14e-10	Tonsillectomy;
SKCM	cis	rs709400	0.633	rs10141433	chr14:103962559	A/G	cg26031613	chr14:104095156	KLC1	0.77	5.96	0.56	6.87e-8	Body mass index;
SKCM	cis	rs7954584	0.531	rs10840631	chr12:122373729	C/T	cg13699009	chr12:122356056	WDR66	0.59	7.37	0.64	1.54e-10	Mean corpuscular volume;
SKCM	cis	rs2885056	0.830	rs7259124	chr19:10671664	T/C	cg04833646	chr19:10679720	CDKN2D	1.03	8.45	0.69	1.24e-12	Red cell distribution width;
SKCM	cis	rs3744028	0.598	rs8066711	chr17:73885038	G/A	cg08125733	chr17:73851984	WBP2	1.01	5.53	0.53	4.13e-7	White matter hyperintensity burden;
SKCM	cis	rs2204008	0.754	rs11514074	chr12:38401128	C/T	cg13010199	chr12:38710504	ALG10B	0.69	4.89	0.48	5.2e-6	Bladder cancer;
SKCM	cis	rs6723226	0.750	rs10182170	chr2:32704186	G/A	cg02381751	chr2:32503542	YIPF4	0.9	6.54	0.6	5.78e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs9486715	0.659	rs9399930	chr6:96854444	G/T	cg06623918	chr6:96969491	KIAA0776	0.77	6.69	0.6	3.1e-9	Headache;
SKCM	cis	rs7208859	0.573	rs4055105	chr17:29102550	A/G	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs1707322	0.752	rs28812624	chr1:46203736	T/A	cg03146154	chr1:46216737	IPP	0.8	5.47	0.53	5.19e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs11650776	1	rs11650776	chr17:37641402	G/A	cg07936489	chr17:37558343	FBXL20	-0.91	-8.36	-0.69	1.91e-12	Lung function (FEV1);
SKCM	cis	rs9911578	0.765	rs66954617	chr17:56999427	A/G	cg05425664	chr17:57184151	TRIM37	-0.67	-5.04	-0.5	2.91e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9902453	0.935	rs9905950	chr17:28431198	T/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.79	6.04	0.56	5.02e-8	Coffee consumption (cups per day);
SKCM	cis	rs7100689	0.784	rs10736341	chr10:82061206	C/G	cg00277334	chr10:82204260	NA	-0.58	-5.69	-0.54	2.16e-7	Post bronchodilator FEV1;
SKCM	cis	rs875971	0.825	rs801202	chr7:66023929	C/T	cg18876405	chr7:65276391	NA	-0.61	-6.03	-0.56	5.23e-8	Aortic root size;
SKCM	cis	rs634534	0.622	rs1192168	chr11:65730945	T/G	cg17985854	chr11:65770987	BANF1;EIF1AD	0.51	5.16	0.5	1.85e-6	Sum eosinophil basophil counts;Eosinophil counts;
SKCM	cis	rs6942756	0.876	rs822039	chr7:129065774	A/G	cg02491457	chr7:128862824	NA	-0.78	-4.89	-0.48	5.27e-6	White matter hyperintensity burden;
SKCM	cis	rs7208859	0.623	rs8082537	chr17:29015932	T/C	cg14067834	chr17:29058358	SUZ12P	1.0	5.43	0.52	6.23e-7	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs1218582	0.682	rs12144978	chr1:154850445	G/A	cg24250549	chr1:154909240	PMVK	0.84	8.33	0.69	2.19e-12	Prostate cancer;
SKCM	cis	rs2032447	0.839	rs199751	chr6:26015583	T/C	cg03517284	chr6:25882590	NA	-0.61	-4.79	-0.48	7.7e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs8016982	0.634	rs1035948	chr14:81682392	C/T	cg01989461	chr14:81687754	GTF2A1	0.88	7.42	0.64	1.26e-10	Schizophrenia;
SKCM	cis	rs9581857	0.579	rs75024088	chr13:27970105	G/T	cg22138327	chr13:27999177	GTF3A	0.97	5.85	0.55	1.07e-7	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs2295499	0.673	rs4690016	chr4:2707132	G/A	cg19433769	chr4:2420260	ZFYVE28	0.69	4.77	0.48	8.44e-6	Cognitive ability;Cognitive ability (multi-trait analysis);Intelligence (multi-trait analysis);
SKCM	cis	rs7666738	0.830	rs115279324	chr4:99042114	T/C	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs72615157	0.634	rs2272343	chr7:99778285	A/C	cg07160278	chr7:100027354	MEPCE;ZCWPW1	0.97	5.98	0.56	6.44e-8	Lung function (FEV1/FVC);
SKCM	cis	rs10256972	0.616	rs6957733	chr7:1106327	T/G	cg16145915	chr7:1198662	ZFAND2A	-0.49	-6.3	-0.58	1.63e-8	Longevity;Endometriosis;
SKCM	cis	rs6121246	0.909	rs6060793	chr20:30288830	T/G	cg11595048	chr20:30225325	COX4I2	0.67	5.12	0.5	2.18e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs4423214	0.569	rs12806918	chr11:71119018	G/T	cg05163923	chr11:71159392	DHCR7	0.59	5.4	0.52	6.88e-7	Vitamin D levels;
SKCM	cis	rs7100689	0.784	rs6585986	chr10:82171559	T/C	cg00277334	chr10:82204260	NA	-0.54	-5.07	-0.5	2.66e-6	Post bronchodilator FEV1;
SKCM	cis	rs13118159	0.550	rs13123016	chr4:1340889	T/C	cg19318889	chr4:1322082	MAEA	0.8	5.81	0.55	1.3e-7	Longevity;
SKCM	cis	rs7829975	0.560	rs56094035	chr8:8551622	G/A	cg15556689	chr8:8085844	FLJ10661	-0.68	-5.12	-0.5	2.18e-6	Mood instability;
SKCM	cis	rs870825	0.655	rs28604350	chr4:185638723	G/A	cg04058563	chr4:185651563	MLF1IP	1.08	7.26	0.64	2.51e-10	Blood protein levels;
SKCM	trans	rs2727020	0.658	rs7111215	chr11:49430552	T/C	cg15704280	chr7:45808275	SEPT13	-0.88	-7.95	-0.67	1.16e-11	Coronary artery disease;
SKCM	cis	rs28785552	0.765	rs28850924	chr19:53234323	T/G	cg10871876	chr19:53194124	ZNF83	0.67	4.8	0.48	7.63e-6	Response to paliperidone in schizophrenia (PANSS score);
SKCM	cis	rs910316	1.000	rs12589876	chr14:75544189	G/A	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.85e-7	Height;
SKCM	cis	rs1692580	0.840	rs696094	chr1:2169215	G/A	cg21442419	chr1:2182373	SKI	-0.69	-7.02	-0.62	7.1e-10	Coronary artery disease;
SKCM	cis	rs514406	0.644	rs7529978	chr1:53204705	G/A	cg24675658	chr1:53192096	ZYG11B	0.64	5.3	0.51	1.04e-6	Monocyte count;
SKCM	cis	rs28595532	0.920	rs114928651	chr4:119734194	T/C	cg21605333	chr4:119757512	SEC24D	1.36	8.05	0.67	7.69e-12	Cannabis dependence symptom count;
SKCM	cis	rs1568889	0.838	rs6484359	chr11:28262328	A/T	cg06544937	chr11:28130018	METT5D1;KIF18A	0.86	7.4	0.64	1.37e-10	Bipolar disorder;
SKCM	cis	rs2153535	0.580	rs9406162	chr6:8466196	C/T	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs9611565	0.512	rs1983576	chr22:42166486	G/A	cg03806693	chr22:41940476	POLR3H	1.17	6.7	0.6	2.92e-9	Vitiligo;
SKCM	cis	rs9902453	1.000	rs4350617	chr17:28423088	G/A	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.5	0.53	4.67e-7	Coffee consumption (cups per day);
SKCM	cis	rs6952808	0.895	rs4513875	chr7:1928159	C/T	cg02951883	chr7:2050386	MAD1L1	-0.73	-5.95	-0.56	7.11e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs2153535	0.504	rs9328472	chr6:8470848	G/A	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs3771570	0.901	rs73006381	chr2:242406654	G/C	cg07612300	chr2:242033426	MTERFD2;SNED1	0.86	5.03	0.49	3.06e-6	Prostate cancer;
SKCM	cis	rs7769051	1.000	rs9493445	chr6:133125409	C/T	cg22852734	chr6:133119734	C6orf192	1.0	5.39	0.52	7.39e-7	Type 2 diabetes nephropathy;
SKCM	cis	rs6495122	0.699	rs34862454	chr15:75101530	C/T	cg14664628	chr15:75095509	CSK	-0.93	-6.98	-0.62	8.62e-10	Caffeine consumption;Diastolic blood pressure;Coffee consumption;
SKCM	cis	rs28595532	0.920	rs114938162	chr4:119756407	T/G	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs7811142	1.000	rs67040465	chr7:100083078	G/A	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.24	7.92	0.67	1.36e-11	Platelet count;
SKCM	cis	rs908922	0.573	rs7544564	chr1:152527007	A/C	cg09873164	chr1:152488093	CRCT1	0.73	5.45	0.53	5.67e-7	Hair morphology;
SKCM	cis	rs12142240	0.659	rs17361873	chr1:46832686	A/G	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs4891159	0.526	rs2848961	chr18:74129886	C/G	cg24786174	chr18:74118243	ZNF516	-0.79	-8.45	-0.69	1.26e-12	Longevity;
SKCM	cis	rs17376456	1.000	rs17376456	chr5:93557702	C/T	cg25358565	chr5:93447407	FAM172A	-1.22	-8.06	-0.67	7.15e-12	Diabetic retinopathy;
SKCM	cis	rs1577917	0.727	rs9444361	chr6:86400900	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	1.02	11.53	0.79	1.6e-18	Response to antipsychotic treatment;
SKCM	cis	rs1577917	1.000	rs6454513	chr6:86720049	C/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.81	7.91	0.67	1.44e-11	Response to antipsychotic treatment;
SKCM	cis	rs7829975	0.540	rs2976909	chr8:8346690	C/T	cg06636001	chr8:8085503	FLJ10661	-0.8	-6.52	-0.59	6.24e-9	Mood instability;
SKCM	cis	rs11112613	0.775	rs12371537	chr12:105971425	T/C	cg03607813	chr12:105948248	NA	0.87	6.2	0.57	2.55e-8	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;
SKCM	cis	rs16854884	0.632	rs34038325	chr3:143685097	G/A	cg06585982	chr3:143692056	C3orf58	0.81	7.63	0.65	4.89e-11	Economic and political preferences (feminism/equality);
SKCM	cis	rs12478296	1.000	rs59036157	chr2:243040228	C/A	cg06360820	chr2:242988706	NA	-1.0	-5.02	-0.49	3.14e-6	Obesity-related traits;
SKCM	cis	rs7119	0.717	rs12899390	chr15:77815238	A/C	cg27398640	chr15:77910606	LINGO1	-0.53	-4.9	-0.49	5.02e-6	Type 2 diabetes;
SKCM	cis	rs1691799	0.899	rs1168318	chr12:66745269	A/G	cg16791601	chr12:66731901	HELB	0.68	6.64	0.6	3.82e-9	White blood cell count (basophil);
SKCM	cis	rs12709013	0.792	rs62064901	chr16:58810662	G/A	cg02431531	chr16:59244939	NA	0.5	5.26	0.51	1.21e-6	Blood metabolite ratios;
SKCM	cis	rs12477438	0.748	rs7558239	chr2:99640581	G/C	cg26064155	chr2:99771622	LIPT1;TSGA10	-0.72	-4.86	-0.48	6e-6	Chronic sinus infection;
SKCM	cis	rs7100689	0.516	rs3862532	chr10:82015725	A/C	cg01528321	chr10:82214614	TSPAN14	0.81	7.37	0.64	1.56e-10	Post bronchodilator FEV1;
SKCM	cis	rs3785574	0.927	rs2008018	chr17:61954471	C/T	cg01411255	chr17:61851458	DDX42;CCDC47	1.06	9.14	0.72	5.79e-14	Height;
SKCM	cis	rs245880	0.740	rs245902	chr7:29194919	T/A	cg17163760	chr7:29186267	CPVL	-0.44	-5.73	-0.54	1.84e-7	Warfarin maintenance dose;
SKCM	cis	rs11098499	0.954	rs12505469	chr4:120249585	C/T	cg09307838	chr4:120376055	NA	0.95	7.57	0.65	6.44e-11	Corneal astigmatism;
SKCM	cis	rs1577917	0.916	rs7759727	chr6:86518878	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.34	-0.52	8.89e-7	Response to antipsychotic treatment;
SKCM	cis	rs7666738	0.830	rs7657982	chr4:99044015	G/A	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1218582	0.804	rs4845398	chr1:154859038	G/C	cg06221963	chr1:154839813	KCNN3	-0.58	-5.84	-0.55	1.13e-7	Prostate cancer;
SKCM	cis	rs10927875	0.726	rs1763603	chr1:16339809	T/C	cg21385522	chr1:16154831	NA	0.66	4.77	0.48	8.39e-6	Dilated cardiomyopathy;
SKCM	trans	rs1814175	0.791	rs10769625	chr11:49869887	G/A	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs3820068	0.603	rs17448778	chr1:15985306	A/G	cg13390004	chr1:15929781	NA	0.64	5.19	0.51	1.61e-6	Systolic blood pressure;
SKCM	cis	rs2836974	0.897	rs1541102	chr21:40628765	C/T	cg17971929	chr21:40555470	PSMG1	0.9	8.81	0.71	2.52e-13	Cognitive function;
SKCM	cis	rs13118159	0.550	rs28522910	chr4:1374774	C/T	cg19318889	chr4:1322082	MAEA	0.77	5.71	0.54	1.98e-7	Longevity;
SKCM	cis	rs10193935	0.901	rs222483	chr2:42652184	T/G	cg27598129	chr2:42591480	NA	-0.88	-6.71	-0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6570726	0.791	rs10872577	chr6:145900560	G/T	cg23711669	chr6:146136114	FBXO30	0.88	9.09	0.72	7.08e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7336332	0.598	rs7669	chr13:28009851	C/T	cg22138327	chr13:27999177	GTF3A	0.91	6.31	0.58	1.53e-8	Weight;
SKCM	cis	rs4319547	0.774	rs7959238	chr12:123131498	A/T	cg23029597	chr12:123009494	RSRC2	-0.71	-4.97	-0.49	3.91e-6	Body mass index;
SKCM	cis	rs7216064	0.532	rs8065296	chr17:66018562	T/A	cg12091567	chr17:66097778	LOC651250	0.88	6.63	0.6	3.92e-9	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs8180040	0.739	rs4683320	chr3:47152992	C/T	cg27129171	chr3:47204927	SETD2	0.82	6.49	0.59	7.26e-9	Colorectal cancer;
SKCM	cis	rs34779708	0.966	rs12775759	chr10:35400183	G/T	cg03585969	chr10:35415529	CREM	0.82	6.49	0.59	7.27e-9	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs10504073	0.631	rs341813	chr8:50039916	T/C	cg00325661	chr8:49890786	NA	0.8	6.91	0.62	1.16e-9	Blood metabolite ratios;
SKCM	cis	rs7772486	0.790	rs7753092	chr6:146248863	C/T	cg05347473	chr6:146136440	FBXO30	-0.55	-4.97	-0.49	3.82e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7786877	0.953	rs7457024	chr7:100215220	A/G	cg20848291	chr7:100343083	ZAN	-0.66	-5.32	-0.52	9.75e-7	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs9790314	0.502	rs7647118	chr3:161016165	T/C	cg03342759	chr3:160939853	NMD3	-0.81	-7.1	-0.63	5.14e-10	Morning vs. evening chronotype;
SKCM	cis	rs1160297	0.517	rs1451462	chr2:53123412	C/T	cg07782112	chr2:53107842	NA	-0.59	-5.94	-0.56	7.63e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs763121	0.813	rs4821807	chr22:39065582	A/G	cg06022373	chr22:39101656	GTPBP1	0.8	5.63	0.54	2.72e-7	Menopause (age at onset);
SKCM	cis	rs11734570	0.581	rs73811715	chr4:38590569	A/C	cg18361445	chr4:38666374	KLF3;FLJ13197	0.86	5.85	0.55	1.08e-7	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs12497850	0.931	rs11705888	chr3:48817289	T/C	cg06212747	chr3:49208901	KLHDC8B	0.66	4.81	0.48	7.08e-6	Parkinson's disease;
SKCM	cis	rs35306767	0.855	rs12771179	chr10:872347	A/G	cg20503657	chr10:835505	NA	0.79	5.87	0.55	1.02e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs7666738	0.830	rs1025204	chr4:99023441	G/A	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs854765	0.583	rs6502619	chr17:17779704	C/G	cg04398451	chr17:18023971	MYO15A	0.79	5.86	0.55	1.04e-7	Total body bone mineral density;
SKCM	cis	rs801193	1.000	rs1553610	chr7:66197233	T/C	cg00343986	chr7:65444356	GUSB	0.7	5.19	0.51	1.63e-6	Aortic root size;
SKCM	cis	rs4132509	1.000	rs12049228	chr1:243995271	C/A	cg21452805	chr1:244014465	NA	0.9	5.5	0.53	4.65e-7	RR interval (heart rate);
SKCM	cis	rs9916302	0.904	rs8065963	chr17:37681332	C/T	cg07936489	chr17:37558343	FBXL20	-0.9	-8.11	-0.68	5.65e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs875971	0.862	rs10274883	chr7:66116091	C/T	cg11764359	chr7:65958608	NA	-0.74	-6.63	-0.6	3.89e-9	Aortic root size;
SKCM	cis	rs4481887	0.962	rs10788769	chr1:248457426	C/T	cg00666640	chr1:248458726	OR2T12	0.58	4.83	0.48	6.68e-6	Common traits (Other);
SKCM	cis	rs7666738	0.791	rs1593571	chr4:98963763	T/C	cg05340658	chr4:99064831	C4orf37	0.64	4.91	0.49	4.97e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7617480	0.648	rs9864243	chr3:48982732	G/A	cg07636037	chr3:49044803	WDR6	0.92	6.9	0.62	1.24e-9	Subjective well-being (multi-trait analysis);Menarche (age at onset);
SKCM	cis	rs11626933	0.959	rs2149649	chr14:90774974	A/G	cg14092571	chr14:90743983	NA	0.86	8.45	0.69	1.24e-12	Gut microbiota (bacterial taxa);
SKCM	cis	rs67311347	0.956	rs11714871	chr3:40428938	T/G	cg00091569	chr3:40428383	ENTPD3	0.64	5.47	0.53	5.17e-7	Renal cell carcinoma;
SKCM	cis	rs9902453	0.868	rs7212162	chr17:28321328	T/A	cg26525008	chr17:28256777	EFCAB5;SSH2	0.82	6.4	0.59	1.06e-8	Coffee consumption (cups per day);
SKCM	cis	rs3820068	0.581	rs111699992	chr1:15927158	G/A	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs7618501	0.521	rs55692411	chr3:49911155	G/A	cg24110177	chr3:50126178	RBM5	-0.71	-5.36	-0.52	8.33e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs911555	0.511	rs2296483	chr14:104029792	G/A	cg24130564	chr14:104152367	KLC1	-0.55	-5.02	-0.49	3.23e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs28386778	0.897	rs2727327	chr17:61923422	G/A	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs28386778	0.863	rs2727288	chr17:61901197	T/A	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs35146811	0.807	rs6953441	chr7:99617067	G/A	cg13334819	chr7:99746414	C7orf59	-0.74	-5.25	-0.51	1.3e-6	Coronary artery disease;
SKCM	cis	rs6952808	0.630	rs1860832	chr7:2161849	G/A	cg21782813	chr7:2030301	MAD1L1	0.52	5.53	0.53	4.09e-7	Bipolar disorder and schizophrenia;
SKCM	trans	rs17685	0.712	rs9800948	chr7:75810473	A/G	cg19862616	chr7:65841803	NCRNA00174	0.91	10.17	0.76	5.84e-16	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs757110	0.866	rs5213	chr11:17408404	C/T	cg15432903	chr11:17409602	KCNJ11	0.56	5.54	0.53	4.03e-7	Type 2 diabetes;
SKCM	cis	rs7666738	0.830	rs35939134	chr4:98980311	A/G	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6120849	0.663	rs13041792	chr20:33545055	G/A	cg24642439	chr20:33292090	TP53INP2	0.99	5.46	0.53	5.54e-7	Protein C levels;
SKCM	cis	rs12714314	0.756	rs13389573	chr2:1936113	G/T	cg22350835	chr2:1868857	MYT1L	-0.62	-5.2	-0.51	1.54e-6	Type 2 diabetes (age of onset);
SKCM	cis	rs6762477	0.748	rs11717349	chr3:50223977	C/T	cg04682699	chr3:50248845	SLC38A3	-0.48	-4.8	-0.48	7.52e-6	Menarche (age at onset);
SKCM	cis	rs9467773	0.967	rs6456732	chr6:26514445	T/C	cg15659132	chr6:26577336	NA	0.6	5.71	0.54	1.99e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs1577917	1.000	rs12664335	chr6:86597774	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.62	5.47	0.53	5.2e-7	Response to antipsychotic treatment;
SKCM	cis	rs10254284	0.959	rs1109483	chr7:28145031	C/T	cg15170557	chr7:28214983	JAZF1	0.6	5.14	0.5	2e-6	Lymphocyte percentage of white cells;Systemic lupus erythematosus;
SKCM	cis	rs12474201	0.963	rs11676737	chr2:46929873	T/C	cg06386533	chr2:46925753	SOCS5	1.01	9.25	0.72	3.5e-14	Height;
SKCM	cis	rs2120019	1.000	rs7173833	chr15:75369618	C/T	cg09165964	chr15:75287851	SCAMP5	-0.79	-6.76	-0.61	2.21e-9	Blood trace element (Zn levels);
SKCM	cis	rs13118159	0.550	rs9685761	chr4:1377942	C/G	cg02018176	chr4:1364513	KIAA1530	0.89	7.56	0.65	6.77e-11	Longevity;
SKCM	cis	rs2739330	0.828	rs2154593	chr22:24252085	A/G	cg12419862	chr22:24373484	LOC391322	-0.66	-5.8	-0.55	1.35e-7	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs60871478	0.735	rs7802011	chr7:760442	A/G	cg05535760	chr7:792225	HEATR2	1.12	9.63	0.74	6.58e-15	Cerebrospinal P-tau181p levels;
SKCM	cis	rs12586317	0.547	rs2273154	chr14:35433187	C/T	cg16230307	chr14:35515116	FAM177A1	0.75	5.07	0.5	2.65e-6	Psoriasis;
SKCM	cis	rs7216064	0.953	rs62086043	chr17:65968003	A/G	cg12091567	chr17:66097778	LOC651250	-0.79	-5.51	-0.53	4.43e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs875971	0.505	rs1167386	chr7:65513096	G/A	cg11987759	chr7:65425863	GUSB	0.74	6.61	0.6	4.28e-9	Aortic root size;
SKCM	cis	rs2153535	0.580	rs2152347	chr6:8474281	A/G	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs9911578	1.000	rs10401050	chr17:56953786	A/C	cg12560992	chr17:57184187	TRIM37	0.94	7.55	0.65	7.01e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs1707322	0.752	rs28545085	chr1:46201950	G/A	cg03146154	chr1:46216737	IPP	0.81	5.62	0.54	2.87e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs1707322	0.721	rs11211158	chr1:46132850	C/G	cg03146154	chr1:46216737	IPP	0.82	6.1	0.57	3.89e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs9467773	1.000	rs6910899	chr6:26524339	A/G	cg09904177	chr6:26538194	HMGN4	0.54	4.98	0.49	3.78e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9303401	0.659	rs9303399	chr17:56672309	C/T	cg02118635	chr17:56770003	RAD51C;TEX14	0.78	5.17	0.51	1.78e-6	Cognitive test performance;
SKCM	cis	rs116095464	0.558	rs9312977	chr5:221916	G/C	cg22857025	chr5:266934	NA	-1.36	-8.0	-0.67	9.23e-12	Breast cancer;
SKCM	cis	rs34779708	0.966	rs10827493	chr10:35454976	C/T	cg03585969	chr10:35415529	CREM	0.75	5.94	0.56	7.46e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs7829975	0.501	rs74345345	chr8:8578435	C/G	cg15556689	chr8:8085844	FLJ10661	-0.64	-4.93	-0.49	4.49e-6	Mood instability;
SKCM	cis	rs6951245	0.882	rs10256720	chr7:1210825	C/G	cg18402987	chr7:1209562	NA	1.17	6.51	0.59	6.66e-9	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs6089584	0.888	rs6061981	chr20:60618973	T/C	cg06108461	chr20:60628389	TAF4	-0.89	-8.72	-0.7	3.75e-13	Body mass index;
SKCM	cis	rs11760633	0.526	rs7800019	chr7:1824028	C/T	cg02825527	chr7:2087843	MAD1L1	-0.68	-5.15	-0.5	1.9e-6	Coronary artery disease;
SKCM	cis	rs7937682	0.575	rs7124696	chr11:111747297	A/G	cg09085632	chr11:111637200	PPP2R1B	1.07	10.16	0.75	6.25e-16	Primary sclerosing cholangitis;
SKCM	cis	rs72634258	0.945	rs161802	chr1:8042826	G/T	cg00042356	chr1:8021962	PARK7	0.91	6.19	0.57	2.58e-8	Inflammatory bowel disease;
SKCM	cis	rs1580019	0.534	rs13237495	chr7:32560687	A/G	cg06627557	chr7:32535165	LSM5;AVL9	0.94	9.12	0.72	6.39e-14	Cognitive ability;
SKCM	cis	rs2836633	1.000	rs2836634	chr21:40068230	T/A	cg05519781	chr21:40033154	ERG	0.72	6.16	0.57	2.96e-8	Coronary artery disease;
SKCM	cis	rs2404602	0.564	rs8024737	chr15:77249703	T/C	cg23625390	chr15:77176239	SCAPER	0.66	5.52	0.53	4.3e-7	Blood metabolite levels;
SKCM	cis	rs2243480	1.000	rs402418	chr7:65509469	G/A	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs1799949	0.965	rs799912	chr17:41257134	T/C	cg25918947	chr17:41365094	TMEM106A	-0.62	-5.81	-0.55	1.31e-7	Menopause (age at onset);
SKCM	cis	rs28595532	0.920	rs115738062	chr4:119725490	C/T	cg21605333	chr4:119757512	SEC24D	1.26	6.29	0.58	1.71e-8	Cannabis dependence symptom count;
SKCM	cis	rs1577917	0.629	rs7761762	chr6:86205968	C/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.84	8.05	0.67	7.65e-12	Response to antipsychotic treatment;
SKCM	cis	rs10911251	0.528	rs2182020	chr1:183074964	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Colorectal cancer;
SKCM	cis	rs66573146	1.000	rs6812391	chr4:6963893	G/A	cg00086871	chr4:6988644	TBC1D14	1.43	5.33	0.52	9.25e-7	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs2014572	0.967	rs10426174	chr19:57756055	G/A	cg24459738	chr19:57751996	ZNF805	-0.64	-5.29	-0.51	1.1e-6	Hyperactive-impulsive symptoms;
SKCM	cis	rs6942756	1.000	rs6974155	chr7:128914545	C/G	cg02491457	chr7:128862824	NA	-0.76	-4.89	-0.48	5.2e-6	White matter hyperintensity burden;
SKCM	cis	rs2839186	0.807	rs2032226	chr21:47680352	G/A	cg05896524	chr21:47604654	C21orf56	0.69	5.88	0.55	9.5e-8	Testicular germ cell tumor;
SKCM	cis	rs7772486	0.875	rs9390371	chr6:146363180	A/G	cg23711669	chr6:146136114	FBXO30	0.78	7.48	0.65	9.35e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2120019	0.938	rs8033925	chr15:75311959	A/G	cg09165964	chr15:75287851	SCAMP5	-0.85	-8.74	-0.7	3.44e-13	Blood trace element (Zn levels);
SKCM	cis	rs7937682	0.889	rs1784787	chr11:111486125	T/A	cg19812747	chr11:111475976	SIK2	-0.56	-4.93	-0.49	4.55e-6	Primary sclerosing cholangitis;
SKCM	cis	rs992157	0.932	rs10194082	chr2:219188577	C/T	cg20019365	chr2:219134978	PNKD;AAMP	0.81	6.8	0.61	1.88e-9	Colorectal cancer;
SKCM	cis	rs6121246	0.559	rs6119728	chr20:30413121	G/A	cg13852791	chr20:30311386	BCL2L1	0.82	5.64	0.54	2.59e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs801193	0.569	rs4717315	chr7:66178325	C/T	cg11764359	chr7:65958608	NA	0.75	6.79	0.61	1.95e-9	Aortic root size;
SKCM	cis	rs950776	0.714	rs472054	chr15:78887994	A/G	cg06917634	chr15:78832804	PSMA4	-0.85	-6.82	-0.61	1.7e-9	Sudden cardiac arrest;
SKCM	cis	rs6952808	0.929	rs11761270	chr7:1923695	C/T	cg02951883	chr7:2050386	MAD1L1	-0.72	-5.95	-0.56	7.18e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs3785574	0.962	rs16947051	chr17:61790917	G/C	cg06601766	chr17:61851465	DDX42;CCDC47	0.66	4.98	0.49	3.74e-6	Height;
SKCM	cis	rs62238980	0.522	rs117086479	chr22:32389342	A/G	cg00543991	chr22:32367038	NA	1.15	4.87	0.48	5.76e-6	Childhood ear infection;
SKCM	cis	rs5417	0.636	rs222851	chr17:7139238	G/A	cg25256661	chr17:7137939	DVL2	0.94	7.1	0.63	5.11e-10	Diastolic blood pressure;
SKCM	cis	rs12142240	0.698	rs1135459	chr1:46815930	C/T	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs3741151	1.000	rs3741151	chr11:73020846	G/T	cg17517138	chr11:73019481	ARHGEF17	1.35	5.2	0.51	1.58e-6	GIP levels in response to oral glucose tolerance test (120 minutes);
SKCM	cis	rs6952808	0.771	rs10269191	chr7:1915731	A/G	cg05863683	chr7:1912471	MAD1L1	0.58	5.25	0.51	1.28e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs17826219	0.706	rs73271850	chr17:29142140	A/G	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Body mass index;
SKCM	trans	rs1814175	0.616	rs6486011	chr11:49740230	C/T	cg15704280	chr7:45808275	SEPT13	-0.97	-9.35	-0.73	2.25e-14	Height;
SKCM	cis	rs1046896	1.000	rs9909940	chr17:80689036	C/T	cg22027946	chr17:80790580	TBCD;ZNF750	0.58	4.85	0.48	6.11e-6	Glycated hemoglobin levels;
SKCM	cis	rs10504229	0.906	rs17805439	chr8:58172400	T/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs10193935	0.901	rs13384404	chr2:42601147	G/T	cg27598129	chr2:42591480	NA	-0.88	-6.71	-0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs244731	0.959	rs6872021	chr5:176610012	G/A	cg16006841	chr5:176797999	RGS14	-0.82	-6.91	-0.62	1.15e-9	Urate levels in lean individuals;
SKCM	cis	rs62064224	0.902	rs17732573	chr17:30627664	C/T	cg18200150	chr17:30822561	MYO1D	-0.71	-6.01	-0.56	5.61e-8	Schizophrenia;
SKCM	cis	rs8180040	0.620	rs9875235	chr3:47083621	G/A	cg27129171	chr3:47204927	SETD2	0.75	5.35	0.52	8.64e-7	Colorectal cancer;
SKCM	cis	rs6942756	0.955	rs68187585	chr7:129002211	T/C	cg02491457	chr7:128862824	NA	-0.81	-5.12	-0.5	2.19e-6	White matter hyperintensity burden;
SKCM	cis	rs6952808	1.000	rs6978048	chr7:1886872	T/G	cg04267008	chr7:1944627	MAD1L1	-0.8	-6.1	-0.57	3.78e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs17376456	0.778	rs72786662	chr5:93137630	C/T	cg21475434	chr5:93447410	FAM172A	0.95	5.36	0.52	8.36e-7	Diabetic retinopathy;
SKCM	cis	rs13108904	0.710	rs11937232	chr4:1207597	G/C	cg05665937	chr4:1216051	CTBP1	0.61	5.24	0.51	1.31e-6	Obesity-related traits;
SKCM	cis	rs757110	0.770	rs11024268	chr11:17387982	A/G	cg15432903	chr11:17409602	KCNJ11	0.51	4.86	0.48	5.99e-6	Type 2 diabetes;
SKCM	cis	rs875971	0.706	rs1643374	chr7:65872682	T/A	cg18876405	chr7:65276391	NA	0.81	7.45	0.64	1.1e-10	Aortic root size;
SKCM	cis	rs13108904	0.935	rs2293633	chr4:1291640	T/C	cg05025164	chr4:1340916	KIAA1530	0.6	4.82	0.48	6.93e-6	Obesity-related traits;
SKCM	cis	rs9297145	0.724	rs62473013	chr7:98762418	G/T	cg05967295	chr7:98741636	SMURF1	1.07	7.92	0.67	1.33e-11	Crohn's disease;Inflammatory bowel disease;Ulcerative colitis;
SKCM	cis	rs116095464	0.558	rs9687898	chr5:253952	A/G	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs1577917	0.771	rs9353318	chr6:86231721	T/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.78	7.21	0.63	3.17e-10	Response to antipsychotic treatment;
SKCM	cis	rs6545883	0.965	rs778752	chr2:61776902	C/G	cg15711740	chr2:61764176	XPO1	-0.76	-5.41	-0.52	6.72e-7	Tuberculosis;
SKCM	cis	rs4808199	0.948	rs2023883	chr19:19405480	G/A	cg03709012	chr19:19516395	GATAD2A	1.08	7.44	0.64	1.12e-10	Nonalcoholic fatty liver disease;
SKCM	cis	rs28595532	0.623	rs34958556	chr4:119222074	C/T	cg11846333	chr4:119757529	SEC24D	0.97	5.33	0.52	9.45e-7	Cannabis dependence symptom count;
SKCM	cis	rs2228479	0.681	rs10153055	chr16:89965842	C/T	cg06558623	chr16:89946397	TCF25	1.04	5.81	0.55	1.3e-7	Skin colour saturation;
SKCM	cis	rs28374715	0.617	rs16971735	chr15:41563970	C/G	cg18705301	chr15:41695430	NDUFAF1	-0.75	-6.35	-0.58	1.3e-8	Ulcerative colitis;
SKCM	cis	rs2839186	0.771	rs2839155	chr21:47639992	A/G	cg11766577	chr21:47581405	C21orf56	-0.73	-6.37	-0.58	1.24e-8	Testicular germ cell tumor;
SKCM	cis	rs912057	1.000	rs912056	chr6:6736197	A/T	cg06612196	chr6:6737390	NA	0.59	4.93	0.49	4.51e-6	Waist-to-hip ratio adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);
SKCM	cis	rs11098499	0.955	rs1511018	chr4:120161580	G/T	cg09307838	chr4:120376055	NA	0.95	8.14	0.68	4.98e-12	Corneal astigmatism;
SKCM	cis	rs2180341	1.000	rs6569477	chr6:127589302	T/A	cg24812749	chr6:127587940	RNF146	0.93	7.6	0.65	5.66e-11	Breast cancer;
SKCM	cis	rs1801251	1.000	rs35212961	chr2:233582762	C/T	cg25237894	chr2:233734115	C2orf82	0.61	5.66	0.54	2.39e-7	Coronary artery disease;
SKCM	cis	rs8077889	0.871	rs7212648	chr17:41917962	A/C	cg26893861	chr17:41843967	DUSP3	1.15	7.34	0.64	1.79e-10	Triglycerides;
SKCM	cis	rs6951245	0.935	rs61910751	chr7:1097895	A/G	cg03188948	chr7:1209495	NA	1.13	6.27	0.58	1.89e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs651907	0.557	rs2303474	chr3:101371899	G/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.81	7.01	0.62	7.47e-10	Colorectal cancer;
SKCM	cis	rs2404602	0.710	rs2469541	chr15:76562118	C/T	cg23625390	chr15:77176239	SCAPER	-0.7	-6.92	-0.62	1.12e-9	Blood metabolite levels;
SKCM	cis	rs8017423	0.626	rs8003363	chr14:90826840	T/C	cg04374321	chr14:90722782	PSMC1	-0.73	-5.53	-0.53	4.04e-7	Mortality in heart failure;
SKCM	cis	rs3820068	0.603	rs6696286	chr1:15968770	C/T	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs908922	0.676	rs549044	chr1:152514332	C/T	cg09873164	chr1:152488093	CRCT1	0.76	5.93	0.56	7.7e-8	Hair morphology;
SKCM	cis	rs2050392	0.517	rs2489847	chr10:30743673	G/A	cg25182066	chr10:30743637	MAP3K8	-0.73	-6.17	-0.57	2.88e-8	Inflammatory bowel disease;
SKCM	cis	rs66573146	0.831	rs67665838	chr4:7064870	G/A	cg26116260	chr4:7069785	GRPEL1	-1.12	-5.02	-0.49	3.15e-6	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs1577917	0.958	rs12660846	chr6:86573809	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.32	-0.52	9.66e-7	Response to antipsychotic treatment;
SKCM	cis	rs1218582	0.710	rs9793588	chr1:154878878	C/G	cg06221963	chr1:154839813	KCNN3	-0.59	-5.78	-0.55	1.49e-7	Prostate cancer;
SKCM	cis	rs910316	0.712	rs175074	chr14:75504454	G/A	cg08847533	chr14:75593920	NEK9	-0.8	-6.62	-0.6	4.21e-9	Height;
SKCM	cis	rs7208859	0.524	rs11653098	chr17:29122501	C/T	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs875971	0.545	rs4718325	chr7:65680310	G/A	cg18876405	chr7:65276391	NA	0.64	5.29	0.51	1.09e-6	Aortic root size;
SKCM	cis	rs7613875	0.521	rs4688754	chr3:50074641	G/T	cg24110177	chr3:50126178	RBM5	0.74	5.95	0.56	7.25e-8	Body mass index;
SKCM	cis	rs7100689	0.646	rs10466235	chr10:82149655	C/T	cg01528321	chr10:82214614	TSPAN14	-0.81	-6.56	-0.6	5.41e-9	Post bronchodilator FEV1;
SKCM	cis	rs9815354	0.904	rs73073235	chr3:42012693	C/A	cg03022575	chr3:42003672	ULK4	1.0	5.0	0.49	3.43e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs5750830	0.594	rs6001587	chr22:39819008	T/C	cg24399712	chr22:39784796	NA	-0.6	-5.01	-0.49	3.31e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2354432	0.607	rs11587707	chr1:146707186	T/C	cg25205988	chr1:146714368	CHD1L	-1.19	-6.54	-0.59	5.94e-9	Mitochondrial DNA levels;
SKCM	cis	rs4819052	1.000	rs9984901	chr21:46663952	C/T	cg20896738	chr21:46707857	POFUT2;LOC642852	0.74	5.35	0.52	8.71e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs9815354	0.812	rs55916855	chr3:42002761	A/G	cg03022575	chr3:42003672	ULK4	1.0	5.0	0.49	3.43e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs875971	0.862	rs6959268	chr7:65812966	G/A	cg11764359	chr7:65958608	NA	-0.81	-7.62	-0.65	5.08e-11	Aortic root size;
SKCM	cis	rs1577917	0.958	rs1447160	chr6:86546123	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.32	-0.52	9.66e-7	Response to antipsychotic treatment;
SKCM	cis	rs7809950	1.000	rs4730245	chr7:107087294	C/T	cg23024343	chr7:107201750	COG5	-0.77	-6.85	-0.61	1.5e-9	Coronary artery disease;
SKCM	cis	rs7208859	0.623	rs8075163	chr17:29106310	A/G	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs910316	0.967	rs175432	chr14:75615246	C/G	cg11812906	chr14:75593930	NEK9	-0.7	-5.3	-0.51	1.06e-6	Height;
SKCM	cis	rs9467773	0.967	rs9358954	chr6:26531178	A/G	cg09904177	chr6:26538194	HMGN4	0.54	4.98	0.49	3.78e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1707322	1.000	rs4074225	chr1:46392364	G/C	cg03146154	chr1:46216737	IPP	0.73	4.91	0.49	4.98e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs1862618	0.853	rs832584	chr5:56179212	A/G	cg12311346	chr5:56204834	C5orf35	0.74	5.1	0.5	2.33e-6	Initial pursuit acceleration;
SKCM	cis	rs9911578	0.967	rs7503190	chr17:57184162	A/C	cg12560992	chr17:57184187	TRIM37	1.06	10.05	0.75	1.01e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs2153535	0.580	rs9378551	chr6:8463744	A/G	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs7772486	0.790	rs7753092	chr6:146248863	C/T	cg23711669	chr6:146136114	FBXO30	-0.75	-7.24	-0.63	2.71e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs10479542	0.683	rs7380706	chr5:178961872	C/T	cg19723775	chr5:179050963	HNRNPH1	0.62	4.85	0.48	6.23e-6	Lung cancer;
SKCM	cis	rs17685	0.712	rs7785025	chr7:75628101	C/T	cg16684958	chr7:75615977	POR	-0.6	-5.66	-0.54	2.37e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs67460515	0.563	rs1599388	chr3:160846866	A/G	cg03342759	chr3:160939853	NMD3	-0.72	-6.17	-0.57	2.79e-8	Parkinson's disease;
SKCM	cis	rs1348850	0.567	rs7605493	chr2:178534983	C/G	cg22681709	chr2:178499509	PDE11A	-0.69	-6.21	-0.57	2.44e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs17376456	1.000	rs13174700	chr5:93554644	G/A	cg21475434	chr5:93447410	FAM172A	0.98	5.23	0.51	1.4e-6	Diabetic retinopathy;
SKCM	cis	rs7100689	0.646	rs1538815	chr10:82137670	A/G	cg00277334	chr10:82204260	NA	-0.52	-4.77	-0.47	8.54e-6	Post bronchodilator FEV1;
SKCM	cis	rs2559856	1.000	rs2559856	chr12:102089561	A/G	cg12924262	chr12:102091054	CHPT1	0.66	5.55	0.53	3.86e-7	Blood protein levels;
SKCM	cis	rs12477438	0.520	rs6739579	chr2:99731552	C/T	cg26064155	chr2:99771622	LIPT1;TSGA10	1.02	10.07	0.75	9.12e-16	Chronic sinus infection;
SKCM	cis	rs7809950	1.000	rs4727681	chr7:107096144	T/C	cg23024343	chr7:107201750	COG5	-0.74	-6.61	-0.6	4.39e-9	Coronary artery disease;
SKCM	cis	rs10089	0.953	rs2190797	chr5:127352875	C/A	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.88	7.64	0.65	4.76e-11	Ileal carcinoids;
SKCM	cis	rs478304	0.627	rs1073602	chr11:65455386	G/C	cg27068330	chr11:65405492	SIPA1	-0.88	-7.54	-0.65	7.28e-11	Acne (severe);
SKCM	cis	rs28595532	0.920	rs115688334	chr4:119770805	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	trans	rs561341	0.882	rs111484028	chr17:30287701	G/A	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs2839186	0.588	rs7280110	chr21:47619039	G/A	cg13012494	chr21:47604986	C21orf56	-0.71	-6.18	-0.57	2.77e-8	Testicular germ cell tumor;
SKCM	cis	rs875971	1.000	rs697970	chr7:65560052	G/C	cg11764359	chr7:65958608	NA	-0.89	-8.44	-0.69	1.29e-12	Aortic root size;
SKCM	cis	rs55962025	0.883	rs3121419	chr4:3232257	C/T	cg21096898	chr4:3318625	RGS12	-0.65	-4.98	-0.49	3.75e-6	Parental longevity (mother's age at death);
SKCM	cis	rs1005277	0.579	rs2474588	chr10:38420870	A/G	cg25427524	chr10:38739819	LOC399744	-0.71	-6.74	-0.61	2.44e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs55823223	0.648	rs11869977	chr17:73857382	C/G	cg08125733	chr17:73851984	WBP2	1.04	5.78	0.55	1.5e-7	Psoriasis;
SKCM	cis	rs1580019	0.713	rs2167274	chr7:32524844	A/G	cg06627557	chr7:32535165	LSM5;AVL9	0.89	7.62	0.65	5.1e-11	Cognitive ability;
SKCM	cis	rs10504229	0.906	rs114810777	chr8:58185298	A/G	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs4253772	0.591	rs6008538	chr22:46685963	G/A	cg03482458	chr22:46692211	CN5H6.4;GTSE1	1.2	5.67	0.54	2.3e-7	LDL cholesterol;Cholesterol, total;
SKCM	cis	rs6582630	0.519	rs8189609	chr12:38281408	A/G	cg13010199	chr12:38710504	ALG10B	0.69	4.92	0.49	4.72e-6	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs9814567	1.000	rs9883753	chr3:134247231	T/C	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs9902453	0.817	rs62068625	chr17:28176581	G/A	cg26525008	chr17:28256777	EFCAB5;SSH2	0.83	5.76	0.55	1.61e-7	Coffee consumption (cups per day);
SKCM	cis	rs10089	1.000	rs6595800	chr5:127411647	C/T	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.92	8.29	0.68	2.54e-12	Ileal carcinoids;
SKCM	trans	rs1814175	0.645	rs7115592	chr11:50013243	A/G	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs1153858	1.000	rs12437840	chr15:45669055	C/A	cg21132104	chr15:45694354	SPATA5L1	0.93	7.94	0.67	1.22e-11	Homoarginine levels;
SKCM	cis	rs1577917	0.771	rs9294337	chr6:86248460	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.78	7.21	0.63	3.17e-10	Response to antipsychotic treatment;
SKCM	cis	rs7618915	0.547	rs11130317	chr3:52731483	C/T	cg18404041	chr3:52824283	ITIH1	-0.56	-4.94	-0.49	4.32e-6	Bipolar disorder;
SKCM	cis	rs9486715	0.867	rs9373829	chr6:96897201	A/C	cg06623918	chr6:96969491	KIAA0776	-0.8	-6.71	-0.6	2.8e-9	Headache;
SKCM	cis	rs2839186	0.900	rs2839200	chr21:47709095	C/T	cg13126279	chr21:47581558	C21orf56	-0.64	-5.47	-0.53	5.17e-7	Testicular germ cell tumor;
SKCM	cis	rs35306767	0.903	rs11253460	chr10:887382	C/G	cg26597838	chr10:835615	NA	0.77	5.39	0.52	7.26e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs10752881	1.000	rs10797810	chr1:182980950	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.74	6.71	0.6	2.81e-9	Colorectal cancer;
SKCM	cis	rs1153858	1.000	rs67461176	chr15:45676819	C/T	cg21132104	chr15:45694354	SPATA5L1	0.93	7.94	0.67	1.22e-11	Homoarginine levels;
SKCM	cis	rs798554	0.679	rs11973498	chr7:2886873	C/A	cg19346786	chr7:2764209	NA	-0.65	-6.79	-0.61	1.96e-9	Height;
SKCM	cis	rs910316	0.967	rs8007539	chr14:75664953	T/C	cg08847533	chr14:75593920	NEK9	-0.96	-9.69	-0.74	4.89e-15	Height;
SKCM	cis	rs17376456	0.825	rs12153021	chr5:93073913	A/G	cg21475434	chr5:93447410	FAM172A	0.9	4.99	0.49	3.65e-6	Diabetic retinopathy;
SKCM	trans	rs3780486	0.757	rs10758189	chr9:33125804	A/G	cg20290983	chr6:43655470	MRPS18A	1.02	10.76	0.77	4.45e-17	IgG glycosylation;
SKCM	cis	rs854765	0.594	rs8066560	chr17:17728043	A/G	cg04398451	chr17:18023971	MYO15A	0.73	4.83	0.48	6.63e-6	Total body bone mineral density;
SKCM	cis	rs6089584	0.924	rs6142906	chr20:60552554	G/C	cg06108461	chr20:60628389	TAF4	-0.81	-7.11	-0.63	4.79e-10	Body mass index;
SKCM	cis	rs7811142	1.000	rs7794485	chr7:100068936	T/C	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-0.99	-5.52	-0.53	4.2e-7	Platelet count;
SKCM	cis	rs854765	0.618	rs9908017	chr17:17774422	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	-1.02	-8.27	-0.68	2.82e-12	Total body bone mineral density;
SKCM	cis	rs17376456	0.825	rs17374166	chr5:93238655	T/C	cg25358565	chr5:93447407	FAM172A	1.3	7.53	0.65	7.57e-11	Diabetic retinopathy;
SKCM	cis	rs4803468	0.763	rs17318596	chr19:41937095	A/G	cg09537434	chr19:41945824	ATP5SL	-1.03	-11.2	-0.79	6.64e-18	Height;
SKCM	cis	rs1850744	0.793	rs34495260	chr4:9595324	T/C	cg15442990	chr4:9534313	NA	-1.3	-4.84	-0.48	6.55e-6	Economic and political preferences;
SKCM	cis	rs55962025	0.883	rs59613878	chr4:3139152	C/T	cg11471262	chr4:3318911	RGS12	-0.74	-5.66	-0.54	2.46e-7	Parental longevity (mother's age at death);
SKCM	cis	rs7584330	0.826	rs72620824	chr2:238381083	G/A	cg14458575	chr2:238380390	NA	1.07	6.62	0.6	4.08e-9	Prostate cancer;
SKCM	cis	rs6547741	0.904	rs2384659	chr2:27856793	G/A	cg27432699	chr2:27873401	GPN1	0.73	6.65	0.6	3.7e-9	Oral cavity cancer;
SKCM	cis	rs4804155	0.590	rs17766692	chr19:11342599	C/T	cg00586551	chr19:11347513	LOC55908;DOCK6	0.82	4.78	0.48	8.18e-6	HDL cholesterol;Total cholesterol levels;
SKCM	cis	rs1843834	0.539	rs2047135	chr2:225427302	G/C	cg22455342	chr2:225449267	CUL3	0.74	5.46	0.53	5.52e-7	IgE levels in asthmatics (D.p. specific);
SKCM	cis	rs7247513	0.759	rs73002392	chr19:12768391	G/A	cg04657146	chr19:12876947	HOOK2	0.66	4.81	0.48	7.35e-6	Bipolar disorder;
SKCM	cis	rs2070488	1.000	rs3792527	chr3:38493212	T/C	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.97	8.85	0.71	2.08e-13	Electrocardiographic conduction measures;
SKCM	cis	rs7177699	0.526	rs7182529	chr15:79123631	T/C	cg04896959	chr15:78267971	NA	-0.54	-4.84	-0.48	6.39e-6	Post bronchodilator FEV1/FVC ratio;Post bronchodilator FEV1;
SKCM	cis	rs6570726	0.791	rs9497357	chr6:145912888	G/A	cg23711669	chr6:146136114	FBXO30	0.85	7.97	0.67	1.05e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs10504229	0.683	rs35244711	chr8:58117762	T/G	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs9325144	0.560	rs10785586	chr12:38676197	G/A	cg26384229	chr12:38710491	ALG10B	-0.73	-6.11	-0.57	3.71e-8	Morning vs. evening chronotype;
SKCM	cis	rs7020830	0.858	rs13293465	chr9:37127678	C/T	cg14294708	chr9:37120828	ZCCHC7	1.1	9.85	0.74	2.48e-15	Schizophrenia;
SKCM	cis	rs1005277	0.579	rs2472183	chr10:38392495	T/G	cg00409905	chr10:38381863	ZNF37A	-0.64	-5.96	-0.56	6.77e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs1790761	0.802	rs2276118	chr11:67288594	A/G	cg00290607	chr11:67383545	NA	-0.5	-4.9	-0.49	5.02e-6	Mean corpuscular volume;
SKCM	cis	rs2739330	0.828	rs5760107	chr22:24252597	T/C	cg12419862	chr22:24373484	LOC391322	-0.64	-5.56	-0.53	3.66e-7	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs9485372	0.945	rs4897113	chr6:149607913	C/T	cg03072286	chr6:150262044	ULBP2	-0.55	-4.89	-0.48	5.3e-6	Breast cancer;
SKCM	cis	rs17685	0.753	rs1104878	chr7:75685593	G/T	cg16684958	chr7:75615977	POR	0.59	5.63	0.54	2.69e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs3809912	0.595	rs12605006	chr18:12992261	C/G	cg12848697	chr18:13133368	NA	0.55	5.12	0.5	2.11e-6	Cognitive ability (multi-trait analysis);Cognitive ability;
SKCM	cis	rs801193	1.000	rs2003301	chr7:66147656	G/C	cg11987759	chr7:65425863	GUSB	0.69	5.9	0.56	8.74e-8	Aortic root size;
SKCM	cis	rs2599510	0.811	rs176413	chr2:32646847	G/A	cg02381751	chr2:32503542	YIPF4	-0.69	-5.64	-0.54	2.66e-7	Interleukin-18 levels;
SKCM	cis	rs11764590	0.666	rs7787359	chr7:2090849	A/G	cg23422044	chr7:1970798	MAD1L1	-0.82	-6.27	-0.58	1.82e-8	Neuroticism;
SKCM	cis	rs860295	0.650	rs488079	chr1:155890581	G/A	cg02153340	chr1:155202674	NA	0.68	4.99	0.49	3.64e-6	Body mass index;
SKCM	cis	rs1256061	0.624	rs1152586	chr14:64690784	T/C	cg21174375	chr14:64681225	SYNE2	0.47	4.83	0.48	6.66e-6	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs28595532	0.920	rs56331118	chr4:119767054	G/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs1801251	1.000	rs12990821	chr2:233617585	C/G	cg25237894	chr2:233734115	C2orf82	0.56	5.33	0.52	9.23e-7	Coronary artery disease;
SKCM	cis	rs35146811	0.961	rs35991721	chr7:99728790	G/T	cg22906224	chr7:99728672	NA	0.76	5.69	0.54	2.17e-7	Coronary artery disease;
SKCM	cis	rs867186	1.000	rs8124662	chr20:33639256	G/A	cg04194272	chr20:33683537	NA	-1.38	-7.2	-0.63	3.29e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs561341	0.843	rs879945	chr17:30242796	G/A	cg00745463	chr17:30367425	LRRC37B	-0.99	-6.61	-0.6	4.22e-9	Hip circumference adjusted for BMI;
SKCM	cis	rs2361718	0.501	rs8065486	chr17:78138196	A/G	cg09238746	chr17:78121135	EIF4A3	0.86	6.31	0.58	1.54e-8	Yeast infection;
SKCM	cis	rs7959452	0.868	rs12812860	chr12:69746671	T/C	cg14784868	chr12:69753453	YEATS4	0.59	4.79	0.48	7.86e-6	Blood protein levels;
SKCM	cis	rs11626933	0.959	rs8005973	chr14:90774951	C/T	cg14092571	chr14:90743983	NA	-0.87	-8.58	-0.7	7e-13	Gut microbiota (bacterial taxa);
SKCM	cis	rs7769051	1.000	rs5006218	chr6:133126220	T/G	cg22852734	chr6:133119734	C6orf192	0.96	4.85	0.48	6.3e-6	Type 2 diabetes nephropathy;
SKCM	cis	rs1797081	1.000	rs1797081	chr10:16874565	A/G	cg23933602	chr10:16859644	RSU1	1.03	13.72	0.84	1.69e-22	Platelet distribution width;
SKCM	cis	rs7811142	1.000	rs11771419	chr7:99988403	A/G	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.23	8.03	0.67	8.33e-12	Platelet count;
SKCM	cis	rs1506636	1.000	rs635072	chr7:123403255	G/A	cg03229431	chr7:123269106	ASB15	0.64	5.21	0.51	1.48e-6	Plateletcrit;Platelet count;
SKCM	cis	rs3820068	0.581	rs72645881	chr1:15928203	C/T	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs28386778	0.830	rs2584625	chr17:61903445	G/C	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs4319547	0.728	rs61954974	chr12:123074169	T/C	cg23029597	chr12:123009494	RSRC2	-0.81	-5.99	-0.56	6.21e-8	Body mass index;
SKCM	cis	rs12044355	0.827	rs7552630	chr1:231824286	G/C	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	0.82	6.24	0.58	2.14e-8	Alzheimer's disease;
SKCM	cis	rs793571	0.669	rs28864995	chr15:58945671	T/G	cg05156742	chr15:59063176	FAM63B	0.7	4.77	0.47	8.52e-6	Schizophrenia;
SKCM	cis	rs62238980	0.521	rs78249378	chr22:32409893	C/G	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs6500602	0.673	rs1861652	chr16:4505331	C/T	cg08645402	chr16:4508243	NA	0.64	5.0	0.49	3.47e-6	Schizophrenia;
SKCM	cis	rs11419537	1	rs11419537	chr22:44154000	A/AT	cg12729397	chr22:44208276	EFCAB6	-0.64	-5.02	-0.49	3.14e-6	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs7940866	0.770	rs10791104	chr11:130814893	A/T	cg12179176	chr11:130786555	SNX19	0.76	6.04	0.56	4.89e-8	Schizophrenia;
SKCM	cis	rs208520	0.690	rs12213581	chr6:66735818	T/C	cg07460842	chr6:66804631	NA	0.92	7.44	0.64	1.12e-10	Exhaled nitric oxide output;
SKCM	cis	rs3816788	0.792	rs7013323	chr8:21869024	C/G	cg17168535	chr8:21777572	XPO7	0.93	8.92	0.71	1.55e-13	Lung cancer in ever smokers;
SKCM	cis	rs4234284	0.931	rs35011618	chr3:126955627	A/G	cg04889221	chr3:126137216	CCDC37	-0.47	-4.86	-0.48	6e-6	Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel);
SKCM	cis	rs11719291	0.833	rs34037363	chr3:48821036	C/T	cg00383909	chr3:49044727	WDR6	0.95	5.43	0.52	6.25e-7	Cognitive function;
SKCM	cis	rs875971	0.522	rs2008188	chr7:65429013	G/C	cg11764359	chr7:65958608	NA	0.9	6.97	0.62	8.91e-10	Aortic root size;
SKCM	cis	rs1799949	0.965	rs2236762	chr17:41226675	A/T	cg25918947	chr17:41365094	TMEM106A	-0.62	-5.81	-0.55	1.32e-7	Menopause (age at onset);
SKCM	cis	rs4819052	1.000	rs2838830	chr21:46664227	T/G	cg20896738	chr21:46707857	POFUT2;LOC642852	0.74	5.35	0.52	8.71e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs1559088	0.576	rs7251626	chr19:33578470	C/A	cg27124370	chr19:33622961	WDR88	0.77	5.59	0.54	3.16e-7	Bone ultrasound measurement (broadband ultrasound attenuation);
SKCM	cis	rs950776	0.518	rs3813571	chr15:78832792	G/T	cg06917634	chr15:78832804	PSMA4	1.01	10.48	0.76	1.5e-16	Sudden cardiac arrest;
SKCM	cis	rs6723226	0.732	rs6747560	chr2:32784766	T/G	cg02381751	chr2:32503542	YIPF4	0.94	6.33	0.58	1.46e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs10752881	0.935	rs4652771	chr1:183023503	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.65	0.6	3.59e-9	Colorectal cancer;
SKCM	cis	rs3796619	0.503	rs13147452	chr4:1078124	G/A	cg27284194	chr4:1044797	NA	0.81	8.24	0.68	3.2e-12	Recombination rate (males);
SKCM	cis	rs3008870	1.000	rs2009319	chr1:67481070	G/T	cg08660285	chr1:67390436	MIER1;WDR78	0.91	5.96	0.56	6.81e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs2836974	0.829	rs8128191	chr21:40527311	A/G	cg11890956	chr21:40555474	PSMG1	1.07	13.19	0.83	1.48e-21	Cognitive function;
SKCM	cis	rs3776081	0.734	rs3776079	chr5:149528319	G/A	cg11060666	chr5:148851518	NA	-0.37	-4.8	-0.48	7.64e-6	Blood protein levels;
SKCM	cis	rs7666738	0.715	rs116787789	chr4:98718720	G/A	cg17366294	chr4:99064904	C4orf37	0.59	5.11	0.5	2.25e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1799949	0.965	rs33988650	chr17:41287880	A/G	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.11	-0.57	3.67e-8	Menopause (age at onset);
SKCM	cis	rs941408	0.515	rs759067	chr19:2775668	C/T	cg06609049	chr19:2785107	THOP1	1.09	9.98	0.75	1.38e-15	Total cholesterol levels;
SKCM	cis	rs12706411	0.764	rs28406245	chr7:122093637	C/T	cg17986181	chr7:121955208	NA	-0.65	-5.01	-0.49	3.36e-6	Alzheimer disease and age of onset;
SKCM	cis	rs7829975	0.577	rs79495969	chr8:8545250	G/A	cg15556689	chr8:8085844	FLJ10661	-0.69	-5.26	-0.51	1.21e-6	Mood instability;
SKCM	cis	rs1577917	1.000	rs12201571	chr6:86609750	A/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.85	-8.62	-0.7	5.82e-13	Response to antipsychotic treatment;
SKCM	cis	rs4746818	1.000	rs10762259	chr10:70890929	C/T	cg11621586	chr10:70884670	VPS26A	1.0	7.68	0.66	3.84e-11	Left atrial antero-posterior diameter;
SKCM	cis	rs7206961	0.707	rs6501687	chr17:72048359	A/C	cg02890566	chr17:71434142	SDK2	-0.43	-4.79	-0.48	7.84e-6	Electrodermal activity;
SKCM	cis	rs57221529	0.766	rs56278696	chr5:582669	A/G	cg26208419	chr5:473447	SLC9A3;LOC25845	1.01	5.18	0.51	1.7e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs7809950	0.678	rs62483640	chr7:106900214	T/G	cg23024343	chr7:107201750	COG5	-0.79	-6.77	-0.61	2.16e-9	Coronary artery disease;
SKCM	cis	rs9300255	0.537	rs2682429	chr12:123642955	C/G	cg05973401	chr12:123451056	ABCB9	0.8	5.47	0.53	5.23e-7	Neutrophil percentage of white cells;
SKCM	cis	rs1499614	1.000	rs2141924	chr7:66186246	C/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Gout;
SKCM	cis	rs72781680	1.000	rs72781663	chr2:24221694	C/G	cg08917208	chr2:24149416	ATAD2B	1.03	5.69	0.54	2.14e-7	Lymphocyte counts;
SKCM	cis	rs13118159	0.509	rs4974554	chr4:1356967	A/C	cg02475777	chr4:1388615	CRIPAK	0.8	5.27	0.51	1.17e-6	Longevity;
SKCM	cis	rs2032447	0.670	rs198834	chr6:26114372	G/A	cg18357526	chr6:26021779	HIST1H4A	-0.79	-6.46	-0.59	8.1e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs7659604	0.592	rs56077950	chr4:122721412	C/T	cg20573242	chr4:122745356	CCNA2	0.76	6.61	0.6	4.4e-9	Type 2 diabetes;
SKCM	cis	rs748404	0.660	rs2249952	chr15:43720533	G/C	cg02155558	chr15:43621948	ADAL;LCMT2	0.73	5.42	0.52	6.48e-7	Lung cancer;
SKCM	cis	rs28386778	0.897	rs8081454	chr17:61842646	A/G	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs7659604	0.846	rs35986491	chr4:122664528	A/T	cg19671926	chr4:122722719	EXOSC9	-0.66	-4.98	-0.49	3.71e-6	Type 2 diabetes;
SKCM	cis	rs501120	1.000	rs534079	chr10:44752558	G/T	cg09554077	chr10:44749378	NA	0.38	4.93	0.49	4.52e-6	Coronary artery disease;Coronary heart disease;
SKCM	cis	rs2404602	0.716	rs284895	chr15:76751225	C/G	cg23625390	chr15:77176239	SCAPER	-0.59	-5.31	-0.52	9.87e-7	Blood metabolite levels;
SKCM	cis	rs6724607	0.905	rs7603849	chr2:191438741	A/C	cg21644426	chr2:191273491	MFSD6	0.7	4.93	0.49	4.6e-6	Pulse pressure;
SKCM	cis	rs66569888	0.507	rs11673736	chr2:106886935	T/C	cg16099169	chr2:106886729	NA	-0.69	-5.91	-0.56	8.49e-8	Facial morphology (factor 23);
SKCM	cis	rs12971120	0.947	rs3764509	chr18:72167124	C/G	cg26446133	chr18:72167187	CNDP2	-0.67	-5.65	-0.54	2.54e-7	Refractive error;
SKCM	cis	rs1160297	0.609	rs1376563	chr2:53104749	C/G	cg07782112	chr2:53107842	NA	0.55	5.57	0.53	3.51e-7	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs1799949	1.000	rs72829113	chr17:41181835	C/T	cg25918947	chr17:41365094	TMEM106A	-0.61	-5.87	-0.55	1e-7	Menopause (age at onset);
SKCM	cis	rs4665809	0.627	rs13014338	chr2:26463024	C/T	cg26119090	chr2:26468346	HADHA;HADHB	1.06	8.39	0.69	1.66e-12	Gut microbiome composition (summer);
SKCM	cis	rs1160297	0.609	rs10168840	chr2:53084498	A/G	cg07782112	chr2:53107842	NA	0.58	5.86	0.55	1.07e-7	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs116095464	0.558	rs10055993	chr5:264296	A/C	cg22857025	chr5:266934	NA	-1.43	-7.97	-0.67	1.07e-11	Breast cancer;
SKCM	cis	rs473651	0.935	rs477041	chr2:239355995	C/G	cg18131467	chr2:239335373	ASB1	-1.09	-13.66	-0.84	2.21e-22	Multiple system atrophy;
SKCM	cis	rs4319547	0.695	rs10734915	chr12:122873408	A/C	cg23029597	chr12:123009494	RSRC2	-0.74	-5.43	-0.52	6.08e-7	Body mass index;
SKCM	cis	rs1580019	0.844	rs4723159	chr7:32512804	T/C	cg06627557	chr7:32535165	LSM5;AVL9	0.78	5.94	0.56	7.66e-8	Cognitive ability;
SKCM	cis	rs28595532	0.920	rs116108618	chr4:119763585	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs10779751	1.000	rs7524202	chr1:11297762	T/C	cg08854313	chr1:11322531	MTOR	0.92	7.09	0.63	5.2400000000000005e-10	Body mass index;
SKCM	cis	rs6089584	0.586	rs6089606	chr20:60586045	G/A	cg06108461	chr20:60628389	TAF4	-0.61	-5.24	-0.51	1.32e-6	Body mass index;
SKCM	cis	rs2075371	0.796	rs1978504	chr7:134006933	C/T	cg20476274	chr7:133979776	SLC35B4	-0.98	-9.85	-0.74	2.41e-15	Mean platelet volume;
SKCM	cis	rs2737618	0.674	rs2821334	chr1:200093887	G/T	cg21825944	chr1:200113062	NR5A2	-0.6	-4.88	-0.48	5.58e-6	Uric acid levels;
SKCM	cis	rs72781680	0.611	rs7596820	chr2:24335036	G/C	cg20701182	chr2:24300061	SF3B14	0.74	5.03	0.49	3.09e-6	Lymphocyte counts;
SKCM	cis	rs6582618	1	rs6582618	chr12:38726137	A/G	cg26384229	chr12:38710491	ALG10B	0.76	6.33	0.58	1.46e-8	Morning vs. evening chronotype;
SKCM	cis	rs7615952	0.515	rs4267608	chr3:125680500	C/T	cg05084668	chr3:125655381	ALG1L	-0.96	-4.94	-0.49	4.34e-6	Blood pressure (smoking interaction);
SKCM	cis	rs12145833	0.538	rs10926977	chr1:243411367	T/G	cg02356786	chr1:243265016	LOC731275	1.62	5.97	0.56	6.55e-8	Obesity (early onset extreme);
SKCM	cis	rs6430585	0.941	rs60963894	chr2:136539670	T/G	cg07169764	chr2:136633963	MCM6	0.89	7.01	0.62	7.69e-10	Corneal structure;
SKCM	cis	rs1218582	0.741	rs11264281	chr1:154867221	A/G	cg06221963	chr1:154839813	KCNN3	-0.6	-6.46	-0.59	8.23e-9	Prostate cancer;
SKCM	cis	rs208520	0.690	rs12194057	chr6:66745616	A/G	cg07460842	chr6:66804631	NA	0.9	7.2	0.63	3.26e-10	Exhaled nitric oxide output;
SKCM	cis	rs10779751	0.734	rs2748878	chr1:11129434	T/C	cg08854313	chr1:11322531	MTOR	0.77	5.52	0.53	4.36e-7	Body mass index;
SKCM	cis	rs7659604	0.676	rs6855269	chr4:122697418	T/G	cg06713675	chr4:122721982	EXOSC9	-0.77	-7.39	-0.64	1.44e-10	Type 2 diabetes;
SKCM	cis	rs2180341	0.532	rs6933893	chr6:127707250	A/G	cg24812749	chr6:127587940	RNF146	0.63	5.29	0.51	1.08e-6	Breast cancer;
SKCM	cis	rs6582630	0.502	rs10880092	chr12:38262965	A/T	cg26384229	chr12:38710491	ALG10B	0.87	6.83	0.61	1.63e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs7264396	0.733	rs6058305	chr20:34310757	C/G	cg23207816	chr20:34252616	CPNE1;RBM12	0.8	4.85	0.48	6.13e-6	Total cholesterol levels;
SKCM	cis	rs7666738	0.800	rs28427190	chr4:98989106	A/G	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2832191	0.511	rs7278227	chr21:30482707	C/T	cg24692254	chr21:30365293	RNF160	-0.83	-6.74	-0.61	2.41e-9	Dental caries;
SKCM	cis	rs6088590	0.965	rs6120730	chr20:33385102	G/C	cg24642439	chr20:33292090	TP53INP2	1.01	7.2	0.63	3.23e-10	Coronary artery disease;
SKCM	cis	rs2739330	0.627	rs9608219	chr22:24274119	G/C	cg12419862	chr22:24373484	LOC391322	-0.79	-7.24	-0.63	2.8e-10	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs801193	1.000	rs2707836	chr7:66160435	A/C	cg11764359	chr7:65958608	NA	0.86	6.6	0.6	4.52e-9	Aortic root size;
SKCM	cis	rs754466	0.580	rs11002293	chr10:79537965	C/T	cg17075019	chr10:79541650	NA	-0.78	-7.12	-0.63	4.75e-10	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs7829975	0.593	rs2921061	chr8:8317615	A/T	cg15556689	chr8:8085844	FLJ10661	0.82	7.46	0.65	1.04e-10	Mood instability;
SKCM	cis	rs208520	0.526	rs9294682	chr6:66795159	G/A	cg07460842	chr6:66804631	NA	-1.17	-12.95	-0.83	3.93e-21	Exhaled nitric oxide output;
SKCM	cis	rs9857592	0.956	rs9867227	chr3:16866253	G/A	cg17339521	chr3:16555597	RFTN1	0.58	4.83	0.48	6.79e-6	Neuroticism;
SKCM	cis	rs17685	0.702	rs6960598	chr7:75772991	T/C	cg01364799	chr7:75623366	TMEM120A	-0.65	-5.06	-0.5	2.73e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs13118159	0.527	rs6599309	chr4:1388115	C/G	cg05025164	chr4:1340916	KIAA1530	0.88	6.6	0.6	4.46e-9	Longevity;
SKCM	cis	rs11608355	0.618	rs11066368	chr12:109790342	C/T	cg19025524	chr12:109796872	NA	-0.64	-5.11	-0.5	2.21e-6	Neuroticism;
SKCM	cis	rs2013441	1.000	rs2703810	chr17:20113715	C/T	cg13482628	chr17:19912719	NA	-0.65	-5.21	-0.51	1.48e-6	Obesity-related traits;
SKCM	cis	rs1218582	0.772	rs906593	chr1:154885255	G/A	cg03351412	chr1:154909251	PMVK	0.77	6.52	0.59	6.43e-9	Prostate cancer;
SKCM	cis	rs28595532	0.841	rs115725150	chr4:119768647	T/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs7937682	0.883	rs1784775	chr11:111472460	T/C	cg19812747	chr11:111475976	SIK2	-0.59	-5.0	-0.49	3.44e-6	Primary sclerosing cholangitis;
SKCM	cis	rs9457247	0.582	rs9459855	chr6:167466150	G/T	cg13927040	chr6:167453801	FGFR1OP	0.67	4.81	0.48	7.25e-6	Crohn's disease;
SKCM	cis	rs12142240	0.698	rs67941619	chr1:46838219	A/G	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs473651	0.904	rs551859	chr2:239371836	T/C	cg21699342	chr2:239360505	ASB1	0.56	5.49	0.53	4.93e-7	Multiple system atrophy;
SKCM	cis	rs4819052	0.851	rs2255774	chr21:46683851	A/T	cg02159808	chr21:46707872	POFUT2;LOC642852	0.64	4.86	0.48	6.06e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7824557	0.583	rs2736292	chr8:11234500	A/T	cg21775007	chr8:11205619	TDH	0.59	4.98	0.49	3.79e-6	Retinal vascular caliber;
SKCM	cis	rs4975616	0.804	rs462608	chr5:1336626	T/A	cg07493874	chr5:1342172	CLPTM1L	-0.66	-5.75	-0.55	1.66e-7	Lung cancer;
SKCM	cis	rs4975616	0.804	rs456366	chr5:1337070	T/C	cg06550200	chr5:1325588	CLPTM1L	-0.86	-7.74	-0.66	2.94e-11	Lung cancer;
SKCM	cis	rs4862750	0.881	rs6813866	chr4:187872161	T/G	cg10295955	chr4:187884368	NA	-0.9	-10.27	-0.76	3.85e-16	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs875971	0.964	rs160635	chr7:65528918	T/C	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.54	5.01	0.49	3.28e-6	Aortic root size;
SKCM	cis	rs1577917	1.000	rs12212733	chr6:86726013	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.63	-5.38	-0.52	7.46e-7	Response to antipsychotic treatment;
SKCM	cis	rs7143963	0.580	rs9671376	chr14:103370163	C/T	cg23020514	chr14:103360112	TRAF3	0.64	5.51	0.53	4.39e-7	Body mass index;
SKCM	cis	rs2404602	0.583	rs4381566	chr15:76589262	A/G	cg22467129	chr15:76604101	ETFA	-0.65	-5.35	-0.52	8.68e-7	Blood metabolite levels;
SKCM	trans	rs8073060	0.544	rs9912939	chr17:34005264	T/G	cg19694781	chr19:47549865	TMEM160	-1.04	-8.28	-0.68	2.65e-12	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs9611565	0.649	rs2413659	chr22:42164862	A/G	cg03806693	chr22:41940476	POLR3H	0.81	4.99	0.49	3.58e-6	Vitiligo;
SKCM	cis	rs9394841	0.667	rs3827633	chr6:41759846	A/C	cg08135965	chr6:41755394	TOMM6	0.75	4.96	0.49	3.96e-6	Mean corpuscular hemoglobin;Red cell distribution width;
SKCM	cis	rs4888262	0.545	rs4243108	chr16:74692453	A/G	cg01733217	chr16:74700730	RFWD3	-0.89	-7.1	-0.63	5.03e-10	Testicular germ cell tumor;
SKCM	cis	rs4481887	0.741	rs6587458	chr1:248532290	T/A	cg00666640	chr1:248458726	OR2T12	0.49	5.16	0.5	1.81e-6	Common traits (Other);
SKCM	cis	rs11690935	0.877	rs72890834	chr2:172835802	G/T	cg13550731	chr2:172543902	DYNC1I2	-0.95	-8.29	-0.68	2.61e-12	Schizophrenia;
SKCM	cis	rs2952156	0.959	rs1565922	chr17:37831035	A/G	cg20243544	chr17:37824526	PNMT	0.74	5.61	0.54	2.97e-7	Asthma;
SKCM	cis	rs6565180	0.962	rs6565183	chr16:30382755	T/C	cg17640201	chr16:30407289	ZNF48	-0.92	-7.32	-0.64	1.92e-10	Tonsillectomy;
SKCM	cis	rs17685	0.712	rs4732578	chr7:75721532	A/G	cg16684958	chr7:75615977	POR	0.56	5.13	0.5	2.03e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs11690935	0.959	rs10194102	chr2:172626143	G/C	cg13550731	chr2:172543902	DYNC1I2	-0.95	-8.21	-0.68	3.64e-12	Schizophrenia;
SKCM	cis	rs7811142	0.830	rs6975660	chr7:99975266	A/G	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.19	7.5	0.65	8.66e-11	Platelet count;
SKCM	cis	rs7824557	0.603	rs2246606	chr8:11219334	G/A	cg21775007	chr8:11205619	TDH	0.6	5.06	0.5	2.71e-6	Retinal vascular caliber;
SKCM	cis	rs860295	0.702	rs2048431	chr1:155618630	G/A	cg02153340	chr1:155202674	NA	-0.76	-5.61	-0.54	2.96e-7	Body mass index;
SKCM	cis	rs9815354	0.812	rs60927633	chr3:41844010	C/T	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs13118159	0.527	rs1250119	chr4:1261336	G/A	cg02475777	chr4:1388615	CRIPAK	-0.75	-5.17	-0.5	1.78e-6	Longevity;
SKCM	cis	rs60871478	0.735	rs4721301	chr7:838768	C/G	cg05535760	chr7:792225	HEATR2	-0.84	-5.87	-0.55	1.01e-7	Cerebrospinal P-tau181p levels;
SKCM	cis	rs1003719	0.788	rs1543748	chr21:38446581	T/C	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.03	0.49	3.09e-6	Eye color traits;
SKCM	cis	rs2239547	0.522	rs6768844	chr3:53004620	A/G	cg11645453	chr3:52864694	ITIH4	-0.59	-4.95	-0.49	4.26e-6	Schizophrenia;
SKCM	cis	rs1577917	0.958	rs11755048	chr6:86514334	A/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.94	-9.01	-0.71	1.02e-13	Response to antipsychotic treatment;
SKCM	cis	rs11098499	0.779	rs7674500	chr4:120303593	C/T	cg09307838	chr4:120376055	NA	0.97	7.49	0.65	9.08e-11	Corneal astigmatism;
SKCM	cis	rs11098499	0.779	rs6815934	chr4:120267310	T/C	cg09307838	chr4:120376055	NA	0.96	8.24	0.68	3.19e-12	Corneal astigmatism;
SKCM	cis	rs7100689	0.754	rs1934695	chr10:82125230	T/C	cg01528321	chr10:82214614	TSPAN14	0.82	7.43	0.64	1.2e-10	Post bronchodilator FEV1;
SKCM	cis	rs4423214	0.840	rs1790339	chr11:71182761	C/A	cg05163923	chr11:71159392	DHCR7	-0.71	-6.07	-0.57	4.35e-8	Vitamin D levels;
SKCM	cis	rs1218582	0.772	rs10908445	chr1:154849590	A/G	cg09359103	chr1:154839909	KCNN3	0.57	5.6	0.54	3.1e-7	Prostate cancer;
SKCM	cis	rs2811415	0.597	rs9819960	chr3:127784513	T/C	cg09089421	chr3:127803668	RUVBL1	1.0	8.69	0.7	4.4e-13	Lung function (FEV1/FVC);
SKCM	cis	rs2032447	0.531	rs428469	chr6:25898624	G/A	cg12310025	chr6:25882481	NA	-0.74	-6.49	-0.59	7.21e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs7809950	1.000	rs10267907	chr7:107184466	C/T	cg23024343	chr7:107201750	COG5	-0.77	-6.95	-0.62	9.61e-10	Coronary artery disease;
SKCM	cis	rs1862618	0.756	rs13356762	chr5:56110992	G/T	cg12311346	chr5:56204834	C5orf35	-0.71	-4.79	-0.48	7.79e-6	Initial pursuit acceleration;
SKCM	cis	rs7122539	0.768	rs7931485	chr11:66578635	G/A	cg24851651	chr11:66362959	CCS	0.66	4.91	0.49	4.92e-6	HIV-1 susceptibility;
SKCM	cis	rs9911578	1.000	rs12947785	chr17:57045160	A/C	cg05425664	chr17:57184151	TRIM37	-0.67	-5.04	-0.5	2.91e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9300255	0.739	rs4759417	chr12:123746510	C/T	cg05973401	chr12:123451056	ABCB9	0.86	6.11	0.57	3.69e-8	Neutrophil percentage of white cells;
SKCM	cis	rs10492096	0.947	rs10774435	chr12:6616120	G/T	cg13857086	chr12:6580257	VAMP1	0.76	5.75	0.55	1.64e-7	Hip geometry;
SKCM	cis	rs9322193	0.923	rs1080670	chr6:149941297	C/G	cg07701084	chr6:150067640	NUP43	0.61	4.84	0.48	6.48e-6	Lung cancer;
SKCM	cis	rs28595532	0.920	rs56104443	chr4:119752052	G/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs17854409	1.000	rs16983290	chr20:61478894	A/G	cg06598544	chr20:61472147	COL9A3	1.04	5.98	0.56	6.37e-8	Obesity-related traits;
SKCM	cis	rs10905065	0.866	rs10795547	chr10:5827074	A/G	cg11519256	chr10:5708881	ASB13	-0.57	-5.01	-0.49	3.29e-6	Menopause (age at onset);
SKCM	cis	rs8017423	0.967	rs11849641	chr14:90727647	T/C	cg04374321	chr14:90722782	PSMC1	1.06	9.26	0.72	3.32e-14	Mortality in heart failure;
SKCM	cis	rs1620921	0.505	rs1344730	chr6:161204995	G/A	cg01280913	chr6:161186852	NA	0.57	5.27	0.51	1.19e-6	Lipoprotein (a) - cholesterol levels;
SKCM	cis	rs1153858	0.887	rs7171163	chr15:45636395	A/C	cg10760299	chr15:45669010	GATM	0.58	6.04	0.56	4.83e-8	Homoarginine levels;
SKCM	cis	rs3087591	0.960	rs2952991	chr17:29526742	T/C	cg24425628	chr17:29625626	OMG;NF1	0.61	4.87	0.48	5.75e-6	Hip circumference;
SKCM	cis	rs4561483	0.815	rs11646545	chr16:11934594	T/G	cg08843971	chr16:11963173	GSPT1	0.67	4.89	0.48	5.36e-6	Testicular germ cell tumor;
SKCM	cis	rs9660180	0.935	rs9786942	chr1:1759213	A/G	cg23982607	chr1:1823379	GNB1	-0.67	-5.61	-0.54	3.02e-7	Body mass index;
SKCM	cis	rs854765	0.583	rs9635697	chr17:17870394	T/A	cg04398451	chr17:18023971	MYO15A	-0.86	-5.91	-0.56	8.41e-8	Total body bone mineral density;
SKCM	cis	rs1799949	0.965	rs4793230	chr17:41427403	A/C	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.07	-0.57	4.29e-8	Menopause (age at onset);
SKCM	cis	rs17711722	0.727	rs2658585	chr7:65461941	A/T	cg11987759	chr7:65425863	GUSB	-0.75	-6.72	-0.61	2.68e-9	Calcium levels;
SKCM	cis	rs9611565	0.649	rs202645	chr22:41798520	A/G	cg03806693	chr22:41940476	POLR3H	1.1	7.47	0.65	9.78e-11	Vitiligo;
SKCM	cis	rs4819052	0.851	rs2838831	chr21:46664775	C/T	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.36	0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs10504229	0.610	rs6999661	chr8:58127391	C/G	cg02725872	chr8:58115012	NA	-0.52	-4.97	-0.49	3.92e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs12497850	0.764	rs6784111	chr3:49178846	T/C	cg06212747	chr3:49208901	KLHDC8B	0.75	5.0	0.49	3.47e-6	Parkinson's disease;
SKCM	cis	rs941408	0.515	rs12610096	chr19:2778129	C/T	cg06609049	chr19:2785107	THOP1	1.09	9.98	0.75	1.38e-15	Total cholesterol levels;
SKCM	cis	rs10779751	0.690	rs2791659	chr1:11126569	C/A	cg08854313	chr1:11322531	MTOR	0.77	5.52	0.53	4.36e-7	Body mass index;
SKCM	cis	rs1577917	0.958	rs884842	chr6:86680397	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.84	-8.35	-0.69	1.97e-12	Response to antipsychotic treatment;
SKCM	cis	rs62238980	0.614	rs75426883	chr22:32434795	C/G	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs9894429	0.646	rs9902264	chr17:79613828	G/A	cg18240062	chr17:79603768	NPLOC4	0.68	6.07	0.57	4.41e-8	Eye color traits;
SKCM	cis	rs9916302	0.706	rs4794808	chr17:37531916	C/T	cg07936489	chr17:37558343	FBXL20	0.96	6.76	0.61	2.28e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs453301	0.522	rs2929455	chr8:9083433	A/T	cg06636001	chr8:8085503	FLJ10661	-0.64	-5.02	-0.49	3.14e-6	Joint mobility (Beighton score);
SKCM	cis	rs701145	0.537	rs377565	chr3:153921953	A/G	cg17054900	chr3:154042577	DHX36	1.25	5.36	0.52	8.3e-7	Coronary artery disease;
SKCM	cis	rs2228479	0.850	rs11640336	chr16:89941153	T/C	cg00800038	chr16:89945340	TCF25	-0.97	-5.45	-0.53	5.72e-7	Skin colour saturation;
SKCM	cis	rs6429082	0.623	rs7547849	chr1:235564254	G/A	cg26050004	chr1:235667680	B3GALNT2	-0.8	-7.11	-0.63	4.83e-10	Adiposity;
SKCM	cis	rs5753618	0.583	rs8141150	chr22:31800336	C/T	cg02404636	chr22:31891804	SFI1	0.58	4.97	0.49	3.86e-6	Colorectal cancer;
SKCM	cis	rs2153535	0.580	rs1119689	chr6:8460754	C/G	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs4689592	0.546	rs10937784	chr4:7060935	G/C	cg26116260	chr4:7069785	GRPEL1	1.16	8.69	0.7	4.35e-13	Monocyte percentage of white cells;
SKCM	cis	rs7937682	0.632	rs2070894	chr11:111780837	G/A	cg09085632	chr11:111637200	PPP2R1B	1.09	9.02	0.71	1e-13	Primary sclerosing cholangitis;
SKCM	cis	rs708547	0.735	rs1277280	chr4:57866872	T/G	cg16868167	chr4:57843880	C4orf14;POLR2B	0.94	8.62	0.7	5.89e-13	Response to bleomycin (chromatid breaks);
SKCM	cis	rs941873	0.868	rs7898	chr10:81114959	C/T	cg09469691	chr10:81107165	PPIF	0.74	7.33	0.64	1.81e-10	Height;
SKCM	cis	rs17685	0.753	rs10245584	chr7:75745866	C/T	cg16489192	chr7:75678113	MDH2;STYXL1	-0.57	-5.38	-0.52	7.48e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2153535	0.505	rs1737583	chr6:8536812	G/A	cg07606381	chr6:8435919	SLC35B3	0.87	6.38	0.59	1.17e-8	Motion sickness;
SKCM	cis	rs2836974	0.897	rs13052882	chr21:40555351	G/C	cg11890956	chr21:40555474	PSMG1	1.09	13.7	0.84	1.86e-22	Cognitive function;
SKCM	cis	rs13256369	0.851	rs13258283	chr8:8563630	T/C	cg15556689	chr8:8085844	FLJ10661	0.65	4.77	0.48	8.39e-6	Obesity-related traits;
SKCM	cis	rs10911232	0.507	rs10797815	chr1:182996827	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.64	0.6	3.83e-9	Hypertriglyceridemia;
SKCM	cis	rs7193541	0.564	rs4888274	chr16:74706298	A/T	cg01733217	chr16:74700730	RFWD3	1.04	11.61	0.8	1.11e-18	Multiple myeloma;
SKCM	cis	rs1568889	0.938	rs7128045	chr11:28190180	C/G	cg06544937	chr11:28130018	METT5D1;KIF18A	0.87	7.0	0.62	7.86e-10	Bipolar disorder;
SKCM	cis	rs2760061	0.626	rs594916	chr1:228133544	C/A	cg18477163	chr1:228402036	OBSCN	-0.43	-4.86	-0.48	5.88e-6	Diastolic blood pressure;
SKCM	cis	rs2836974	0.644	rs2836986	chr21:40702136	A/C	cg11644478	chr21:40555479	PSMG1	-0.67	-5.63	-0.54	2.71e-7	Cognitive function;
SKCM	cis	rs7809950	0.678	rs2237665	chr7:106906998	T/C	cg23024343	chr7:107201750	COG5	-0.79	-6.77	-0.61	2.16e-9	Coronary artery disease;
SKCM	cis	rs4523957	0.583	rs2984939	chr17:2023965	T/C	cg16513277	chr17:2031491	SMG6	-0.81	-5.98	-0.56	6.24e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs2842992	0.915	rs2842980	chr6:160100116	A/T	cg19482086	chr6:160211437	TCP1;MRPL18	0.86	5.9	0.56	8.73e-8	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs637571	0.522	rs606978	chr11:65711517	A/C	cg26695010	chr11:65641043	EFEMP2	-0.66	-5.04	-0.5	2.96e-6	Eosinophil percentage of white cells;
SKCM	cis	rs11098499	0.954	rs11722872	chr4:120233030	G/C	cg09307838	chr4:120376055	NA	0.94	7.43	0.64	1.16e-10	Corneal astigmatism;
SKCM	cis	rs10779751	0.879	rs7543400	chr1:11283964	C/G	cg08854313	chr1:11322531	MTOR	1.0	8.95	0.71	1.38e-13	Body mass index;
SKCM	cis	rs9640161	0.636	rs3735171	chr7:150033882	A/G	cg27494647	chr7:150038898	RARRES2	0.62	5.43	0.52	6.21e-7	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs1461503	0.932	rs56778812	chr11:122840491	C/T	cg27398637	chr11:122830231	C11orf63	-0.63	-4.8	-0.48	7.54e-6	Menarche (age at onset);
SKCM	cis	rs62064224	0.818	rs11080180	chr17:30682998	G/A	cg25809561	chr17:30822961	MYO1D	0.67	5.15	0.5	1.9e-6	Schizophrenia;
SKCM	cis	rs10929159	0.928	rs34769167	chr2:236920442	A/G	cg14226755	chr2:236923322	AGAP1	0.29	4.77	0.48	8.43e-6	Parkinson's disease;
SKCM	cis	rs7296418	0.961	rs4275659	chr12:123447928	C/T	cg00376283	chr12:123451042	ABCB9	-0.97	-8.54	-0.7	8.34e-13	Platelet count;
SKCM	cis	rs7296418	0.885	rs1716184	chr12:123637509	G/C	cg06742321	chr12:123595122	PITPNM2	0.66	5.38	0.52	7.49e-7	Platelet count;
SKCM	cis	rs2243480	1.000	rs313802	chr7:65516373	A/G	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs6500395	1.000	rs924476	chr16:48556847	C/T	cg04672837	chr16:48644449	N4BP1	0.66	5.45	0.53	5.72e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs11098499	0.955	rs13114751	chr4:120156617	G/A	cg09307838	chr4:120376055	NA	0.91	7.22	0.63	2.98e-10	Corneal astigmatism;
SKCM	cis	rs478304	0.651	rs4930313	chr11:65500428	C/T	cg27068330	chr11:65405492	SIPA1	-0.89	-8.21	-0.68	3.71e-12	Acne (severe);
SKCM	cis	rs933688	1.000	rs10058025	chr5:90689052	A/G	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.96	6.6	0.6	4.58e-9	Smoking behavior;
SKCM	cis	rs1029738	0.615	rs3757447	chr7:22894735	A/T	cg06980547	chr7:22894557	NA	-0.61	-5.15	-0.5	1.88e-6	Fibrinogen levels;
SKCM	cis	rs1419980	0.673	rs10845432	chr12:7728131	T/C	cg10578777	chr12:7781093	NA	0.75	5.21	0.51	1.52e-6	HDL cholesterol levels;
SKCM	cis	rs908922	0.676	rs12116609	chr1:152497685	C/T	cg09873164	chr1:152488093	CRCT1	0.76	5.93	0.56	7.7e-8	Hair morphology;
SKCM	cis	rs503341	0.756	rs480874	chr11:63591965	A/T	cg04362095	chr11:63592001	C11orf84	-0.82	-9.64	-0.74	6.15e-15	Pulse pressure;
SKCM	cis	rs9640161	0.789	rs2098053	chr7:150043205	G/A	cg10018233	chr7:150070692	REPIN1	0.72	5.77	0.55	1.52e-7	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs933688	1.000	rs2059207	chr5:90731931	C/A	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.05	8.46	0.69	1.19e-12	Smoking behavior;
SKCM	cis	rs9814567	0.806	rs1880375	chr3:134322163	C/A	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.65	-5.19	-0.51	1.6e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs951366	0.559	rs823101	chr1:205667006	T/C	cg26354017	chr1:205819088	PM20D1	0.81	6.28	0.58	1.8e-8	Menarche (age at onset);
SKCM	cis	rs1801251	1.000	rs6437074	chr2:233712296	C/T	cg08000102	chr2:233561755	GIGYF2	-0.87	-7.05	-0.62	6.23e-10	Coronary artery disease;
SKCM	cis	rs7927771	1.000	rs4752873	chr11:47857520	C/T	cg05585544	chr11:47624801	NA	-0.6	-5.22	-0.51	1.45e-6	Subjective well-being;
SKCM	cis	rs3784262	1.000	rs4646622	chr15:58257199	A/G	cg12031962	chr15:58353849	ALDH1A2	-0.51	-6.6	-0.6	4.46e-9	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs9899728	0.539	rs113775187	chr17:73047290	A/G	cg27626185	chr17:73056755	KCTD2	-1.22	-7.67	-0.66	4.17e-11	Alzheimer's disease or small vessel stroke;
SKCM	cis	rs12458462	0.851	rs3859317	chr18:77443093	A/C	cg11879182	chr18:77439856	CTDP1	0.88	7.5	0.65	8.74e-11	Monocyte count;
SKCM	cis	rs807669	0.903	rs807668	chr22:19162686	A/G	cg02655711	chr22:19163373	SLC25A1	0.78	7.4	0.64	1.34e-10	Metabolite levels;
SKCM	cis	rs2841277	0.720	rs11160827	chr14:105422228	C/T	cg19901468	chr14:105411992	AHNAK2	-1.03	-11.15	-0.78	8.14e-18	Rheumatoid arthritis;
SKCM	cis	rs1395	0.922	rs11898114	chr2:27515527	C/T	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.5	4.83	0.48	6.55e-6	Blood metabolite levels;
SKCM	cis	rs9902453	0.791	rs3115086	chr17:28025949	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.65	0.54	2.52e-7	Coffee consumption (cups per day);
SKCM	cis	rs9583531	0.689	rs9588247	chr13:111375571	G/T	cg24331049	chr13:111365604	ING1	-0.85	-6.32	-0.58	1.48e-8	Coronary artery disease;
SKCM	cis	rs5750830	0.649	rs4821893	chr22:39797779	G/A	cg11247378	chr22:39784982	NA	-0.48	-5.53	-0.53	4.08e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs6461049	0.800	rs2398706	chr7:2156338	A/T	cg02951883	chr7:2050386	MAD1L1	-0.75	-6.96	-0.62	9.25e-10	Schizophrenia;
SKCM	cis	rs2463822	0.920	rs11828383	chr11:62067818	C/T	cg06239285	chr11:62104954	ASRGL1	-1.22	-5.61	-0.54	3.01e-7	Chronic obstructive pulmonary disease-related biomarkers;
SKCM	cis	rs367615	0.679	rs11241021	chr5:108812090	T/G	cg17395555	chr5:108820864	NA	0.74	6.62	0.6	4.21e-9	Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs72615157	0.664	rs6953580	chr7:99825275	A/G	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.08	6.51	0.59	6.7e-9	Lung function (FEV1/FVC);
SKCM	cis	rs362296	0.698	rs3129319	chr4:3265381	A/G	cg00764545	chr4:3318001	RGS12	-0.66	-5.86	-0.55	1.05e-7	Parental longevity (mother's age at death);
SKCM	cis	rs870825	0.616	rs2310108	chr4:185639475	C/T	cg04058563	chr4:185651563	MLF1IP	1.08	7.26	0.64	2.51e-10	Blood protein levels;
SKCM	cis	rs7584330	0.657	rs10202292	chr2:238352185	A/T	cg14458575	chr2:238380390	NA	1.01	6.75	0.61	2.34e-9	Prostate cancer;
SKCM	cis	rs2404602	0.647	rs11072625	chr15:77084984	A/G	cg23625390	chr15:77176239	SCAPER	0.83	7.79	0.66	2.37e-11	Blood metabolite levels;
SKCM	cis	rs992157	0.798	rs10206064	chr2:219157959	T/C	cg00012203	chr2:219082015	ARPC2	0.73	5.76	0.55	1.6e-7	Colorectal cancer;
SKCM	cis	rs6815814	0.950	rs114719937	chr4:38808585	G/C	cg02016764	chr4:38805732	TLR1	-0.76	-5.4	-0.52	6.95e-7	Breast cancer;
SKCM	cis	rs453301	0.606	rs7462373	chr8:8899318	G/C	cg15556689	chr8:8085844	FLJ10661	-0.76	-5.74	-0.54	1.75e-7	Joint mobility (Beighton score);
SKCM	cis	rs2836950	0.545	rs2836922	chr21:40516308	C/T	cg17971929	chr21:40555470	PSMG1	-0.78	-6.31	-0.58	1.54e-8	Menarche (age at onset);
SKCM	cis	rs854765	0.547	rs8075189	chr17:17901946	C/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.04	9.2	0.72	4.44e-14	Total body bone mineral density;
SKCM	cis	rs28386778	0.734	rs7210724	chr17:61799198	T/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.13	11.24	0.79	5.56e-18	Prudent dietary pattern;
SKCM	cis	rs826838	0.967	rs6580726	chr12:39108623	T/C	cg26384229	chr12:38710491	ALG10B	-0.92	-7.9	-0.67	1.47e-11	Heart rate;
SKCM	cis	rs6558174	0.965	rs4072394	chr8:22490800	C/T	cg03733263	chr8:22462867	KIAA1967	0.73	5.07	0.5	2.57e-6	Breast cancer;
SKCM	cis	rs10256972	0.552	rs2949192	chr7:1203841	C/T	cg09177884	chr7:1199841	ZFAND2A	-0.76	-6.39	-0.59	1.12e-8	Longevity;Endometriosis;
SKCM	cis	rs362272	0.524	rs2857982	chr4:3358665	G/A	cg05297308	chr4:3317976	RGS12	1.05	12.84	0.82	6.19e-21	Serum sulfate level;
SKCM	cis	rs10752881	0.967	rs8179284	chr1:182974707	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.74	6.71	0.6	2.83e-9	Colorectal cancer;
SKCM	cis	rs4822044	0.561	rs132781	chr22:42046122	T/G	cg03806693	chr22:41940476	POLR3H	1.05	6.85	0.61	1.5e-9	Cannabis dependence symptom count;
SKCM	cis	rs11098499	0.863	rs1480936	chr4:120462861	C/T	cg24375607	chr4:120327624	NA	0.69	5.45	0.53	5.61e-7	Corneal astigmatism;
SKCM	cis	rs7208859	0.673	rs56146117	chr17:29153325	C/T	cg13385521	chr17:29058706	SUZ12P	0.9	4.78	0.48	8.1e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs7523273	0.526	rs2724375	chr1:207997973	C/A	cg22525895	chr1:207977042	MIR29B2	-0.84	-7.0	-0.62	7.87e-10	Schizophrenia;
SKCM	cis	rs2836974	0.899	rs2836938	chr21:40574191	C/T	cg11644478	chr21:40555479	PSMG1	0.98	9.83	0.74	2.68e-15	Cognitive function;
SKCM	cis	rs28386778	0.797	rs4968664	chr17:61851366	C/G	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs951366	0.764	rs708725	chr1:205744138	G/T	cg14893161	chr1:205819251	PM20D1	1.03	10.3	0.76	3.38e-16	Menarche (age at onset);
SKCM	cis	rs7635838	0.586	rs379241	chr3:11291565	G/A	cg00170343	chr3:11313890	ATG7	0.79	6.19	0.57	2.62e-8	HDL cholesterol;
SKCM	cis	rs2072732	0.861	rs41334845	chr1:2950370	A/C	cg23686029	chr1:3435989	MEGF6	-0.55	-5.01	-0.49	3.38e-6	Plateletcrit;
SKCM	cis	rs9322193	0.886	rs9485408	chr6:149940024	T/C	cg07701084	chr6:150067640	NUP43	0.61	4.84	0.48	6.48e-6	Lung cancer;
SKCM	cis	rs933688	1.000	rs12651840	chr5:90729592	T/C	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.1	8.62	0.7	5.93e-13	Smoking behavior;
SKCM	trans	rs1116547	0.531	rs7707443	chr5:112790219	C/T	cg09257824	chr11:32455642	WT1	-0.91	-7.41	-0.64	1.32e-10	Cerebral amyloid angiopathy;
SKCM	cis	rs644799	0.710	rs12272061	chr11:95524067	G/T	cg25622487	chr11:95524042	FAM76B;CEP57	0.7	5.67	0.54	2.28e-7	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs10876993	0.890	rs2640630	chr12:58067267	T/C	cg18357645	chr12:58087776	OS9	0.65	6.01	0.56	5.71e-8	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs11718455	0.960	rs1852036	chr3:44003862	C/T	cg21419209	chr3:44054225	NA	-0.65	-5.32	-0.52	9.77e-7	Coronary artery disease;
SKCM	cis	rs7666738	0.830	rs2114426	chr4:98933130	C/T	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs60871478	1.000	rs62432224	chr7:788284	G/A	cg05535760	chr7:792225	HEATR2	1.01	8.42	0.69	1.45e-12	Cerebrospinal P-tau181p levels;
SKCM	cis	rs17685	0.702	rs6960598	chr7:75772991	T/C	cg16489192	chr7:75678113	MDH2;STYXL1	-0.52	-4.78	-0.48	8.22e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs10791097	0.653	rs11222362	chr11:130731425	T/C	cg12179176	chr11:130786555	SNX19	0.72	5.67	0.54	2.28e-7	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs9912468	0.933	rs12601850	chr17:64302652	C/T	cg19474267	chr17:64306194	PRKCA	0.63	5.4	0.52	6.93e-7	QRS duration;QRS complex (12-leadsum);QRS complex (Sokolow-Lyon);
SKCM	cis	rs6665290	0.594	rs17592479	chr1:227173892	T/A	cg10327440	chr1:227177885	CDC42BPA	-1.11	-10.3	-0.76	3.34e-16	Myeloid white cell count;
SKCM	cis	rs72781680	0.898	rs72788302	chr2:24107246	C/T	cg08917208	chr2:24149416	ATAD2B	1.07	5.83	0.55	1.17e-7	Lymphocyte counts;
SKCM	cis	rs6120849	0.754	rs3746446	chr20:33574765	T/C	cg24642439	chr20:33292090	TP53INP2	0.94	4.86	0.48	5.91e-6	Protein C levels;
SKCM	cis	rs17376456	0.877	rs10060160	chr5:93387879	G/A	cg21475434	chr5:93447410	FAM172A	0.95	5.35	0.52	8.56e-7	Diabetic retinopathy;
SKCM	cis	rs3096299	0.730	rs11076780	chr16:89397954	A/C	cg08822215	chr16:89438651	ANKRD11	-0.53	-4.89	-0.48	5.23e-6	Multiple myeloma (IgH translocation);
SKCM	cis	rs910316	0.935	rs175448	chr14:75591071	G/A	cg11812906	chr14:75593930	NEK9	-0.72	-5.45	-0.53	5.72e-7	Height;
SKCM	cis	rs1878931	0.513	rs35160989	chr16:3405506	G/A	cg26668626	chr16:3451006	ZNF174;ZNF434	0.94	8.3	0.68	2.48e-12	Body mass index (adult);
SKCM	cis	rs7666738	0.830	rs13145011	chr4:98993410	G/A	cg05340658	chr4:99064831	C4orf37	0.67	5.14	0.5	1.98e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs55728055	0.661	rs73162106	chr22:32034875	A/G	cg01338084	chr22:32026380	PISD	1.62	5.14	0.5	1.99e-6	Age-related hearing impairment;
SKCM	cis	rs7122539	0.646	rs543191	chr11:66583779	T/G	cg12372692	chr11:66233905	PELI3	-0.72	-5.42	-0.52	6.5e-7	HIV-1 susceptibility;
SKCM	cis	rs1878931	0.697	rs10048148	chr16:3417450	C/G	cg26668626	chr16:3451006	ZNF174;ZNF434	1.02	9.41	0.73	1.75e-14	Body mass index (adult);
SKCM	cis	rs6540556	0.954	rs6540555	chr1:209936571	A/G	cg05527609	chr1:210001259	C1orf107	-0.86	-4.8	-0.48	7.39e-6	Red blood cell count;
SKCM	cis	rs854765	0.583	rs7214002	chr17:17852104	G/C	cg04398451	chr17:18023971	MYO15A	-0.86	-5.91	-0.56	8.41e-8	Total body bone mineral density;
SKCM	cis	rs9300255	0.602	rs2695478	chr12:123689521	C/T	cg00376283	chr12:123451042	ABCB9	0.78	5.09	0.5	2.43e-6	Neutrophil percentage of white cells;
SKCM	cis	rs4478037	0.818	rs11558338	chr3:33155782	G/A	cg19404215	chr3:33155277	CRTAP	1.07	5.21	0.51	1.52e-6	Major depressive disorder;
SKCM	cis	rs1801251	1.000	rs2592113	chr2:233669553	C/T	cg25237894	chr2:233734115	C2orf82	0.58	5.74	0.54	1.75e-7	Coronary artery disease;
SKCM	cis	rs8078723	0.714	rs9915252	chr17:38145088	C/G	cg17467752	chr17:38218738	THRA	-0.61	-5.5	-0.53	4.67e-7	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs55823223	0.564	rs9894009	chr17:73850414	C/T	cg10935138	chr17:73851978	WBP2	1.13	7.39	0.64	1.43e-10	Psoriasis;
SKCM	cis	rs9303401	0.580	rs2013166	chr17:56637630	C/T	cg10487724	chr17:56770010	TEX14;RAD51C	0.84	6.24	0.58	2.07e-8	Cognitive test performance;
SKCM	cis	rs3771570	0.901	rs869943	chr2:242431585	C/G	cg07612300	chr2:242033426	MTERFD2;SNED1	0.87	4.83	0.48	6.68e-6	Prostate cancer;
SKCM	cis	rs2836974	0.931	rs13047663	chr21:40708818	C/T	cg11890956	chr21:40555474	PSMG1	1.0	10.51	0.77	1.33e-16	Cognitive function;
SKCM	cis	rs7811142	0.887	rs35111986	chr7:100000274	C/A	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.25	8.07	0.67	7e-12	Platelet count;
SKCM	cis	rs2288073	0.965	rs10469924	chr2:24416230	G/A	cg06627628	chr2:24431161	ITSN2	-0.85	-5.85	-0.55	1.09e-7	Venous thromboembolism (SNP x SNP interaction);
SKCM	cis	rs2806561	0.704	rs588387	chr1:23523689	A/G	cg12483005	chr1:23474871	LUZP1	0.68	5.24	0.51	1.34e-6	Height;
SKCM	cis	rs9910055	0.639	rs11656871	chr17:42269141	G/C	cg13607699	chr17:42295918	UBTF	0.71	5.74	0.55	1.72e-7	Total body bone mineral density;
SKCM	cis	rs4481887	0.962	rs5009868	chr1:248474495	A/G	cg00666640	chr1:248458726	OR2T12	0.64	5.69	0.54	2.13e-7	Common traits (Other);
SKCM	cis	rs9900062	0.586	rs11653958	chr17:62686730	G/A	cg02097616	chr17:62675921	NA	0.7	5.38	0.52	7.47e-7	QT interval;
SKCM	cis	rs7666738	0.830	rs2015828	chr4:98984594	A/G	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9815354	0.812	rs12186050	chr3:41836879	G/C	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs870825	0.655	rs6844929	chr4:185653809	C/G	cg04058563	chr4:185651563	MLF1IP	-1.13	-7.16	-0.63	3.82e-10	Blood protein levels;
SKCM	cis	rs2439831	0.681	rs1549523	chr15:43624189	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.17	8.81	0.71	2.55e-13	Lung cancer in ever smokers;
SKCM	cis	rs523522	0.962	rs10849759	chr12:120994488	T/A	cg27279351	chr12:120934652	DYNLL1	0.9	8.2	0.68	3.93e-12	High light scatter reticulocyte count;
SKCM	cis	rs9880211	0.846	rs73230043	chr3:136407159	G/T	cg21827317	chr3:136751795	NA	-0.64	-4.78	-0.48	8.21e-6	Body mass index;Height;
SKCM	cis	rs28595532	0.920	rs114584210	chr4:119773363	G/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs1865760	1.000	rs1865760	chr6:25916979	C/T	cg08401836	chr6:26032486	HIST1H3B	-0.6	-4.78	-0.48	8.09e-6	Height;
SKCM	cis	rs3820928	0.839	rs35068645	chr2:227844265	T/C	cg11843606	chr2:227700838	RHBDD1	-0.61	-4.9	-0.49	5.12e-6	Pulmonary function;
SKCM	cis	rs1707322	1.000	rs785490	chr1:46577124	T/C	cg03146154	chr1:46216737	IPP	-0.78	-5.14	-0.5	2.02e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs2439831	0.867	rs45585139	chr15:43700427	G/A	cg02155558	chr15:43621948	ADAL;LCMT2	1.37	7.21	0.63	3.19e-10	Lung cancer in ever smokers;
SKCM	cis	rs6951245	0.554	rs10270249	chr7:1151886	G/T	cg03188948	chr7:1209495	NA	0.85	6.02	0.56	5.43e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs10911251	0.546	rs3359	chr1:183112041	G/C	ch.1.3577855R	chr1:183094577	LAMC1	0.76	7.28	0.64	2.26e-10	Colorectal cancer;
SKCM	cis	rs2836974	0.899	rs34433511	chr21:40618883	A/C	cg11890956	chr21:40555474	PSMG1	1.09	13.83	0.84	1.08e-22	Cognitive function;
SKCM	cis	rs3091242	0.933	rs932372	chr1:25755014	G/A	cg27572855	chr1:25598939	RHD	0.56	5.38	0.52	7.64e-7	Erythrocyte sedimentation rate;
SKCM	cis	rs62238980	0.614	rs76222062	chr22:32457049	T/G	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs748404	0.660	rs493377	chr15:43773467	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	0.69	5.13	0.5	2.09e-6	Lung cancer;
SKCM	cis	rs34779708	1.000	rs34779708	chr10:35466185	T/G	cg03585969	chr10:35415529	CREM	0.75	6.26	0.58	1.9e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs1538970	0.924	rs11211117	chr1:45930246	C/T	cg05343316	chr1:45956843	TESK2	0.99	5.13	0.5	2.07e-6	Platelet count;
SKCM	cis	rs4689592	0.503	rs2292461	chr4:7058473	C/T	cg26116260	chr4:7069785	GRPEL1	1.08	7.25	0.63	2.6e-10	Monocyte percentage of white cells;
SKCM	cis	rs9300255	0.537	rs1790101	chr12:123704844	T/C	cg00376283	chr12:123451042	ABCB9	0.83	5.51	0.53	4.48e-7	Neutrophil percentage of white cells;
SKCM	cis	rs1059312	0.808	rs12831705	chr12:129294905	G/A	cg09035930	chr12:129282057	SLC15A4	0.77	8.03	0.67	8.18e-12	Systemic lupus erythematosus;
SKCM	cis	rs8063761	1.000	rs8063761	chr16:90027626	A/T	cg08547343	chr16:90038815	CENPBD1;AFG3L1	0.73	6.13	0.57	3.44e-8	Squamous cell carcinoma;
SKCM	cis	rs7122539	0.839	rs6591223	chr11:66609289	C/T	cg12372692	chr11:66233905	PELI3	-0.68	-5.06	-0.5	2.76e-6	HIV-1 susceptibility;
SKCM	cis	rs12477438	0.520	rs13022329	chr2:99731189	A/T	cg14399236	chr2:99771627	LIPT1;TSGA10	0.95	8.78	0.71	2.89e-13	Chronic sinus infection;
SKCM	cis	rs7824557	0.767	rs11775635	chr8:11164865	G/A	cg21775007	chr8:11205619	TDH	0.72	6.0	0.56	5.73e-8	Retinal vascular caliber;
SKCM	cis	rs4665809	0.590	rs1056389	chr2:26502875	T/C	cg26119090	chr2:26468346	HADHA;HADHB	1.08	8.63	0.7	5.67e-13	Gut microbiome composition (summer);
SKCM	cis	rs2033711	0.870	rs6510152	chr19:58953319	C/T	cg26874164	chr19:58962979	ZNF324B	0.63	5.22	0.51	1.47e-6	Uric acid clearance;
SKCM	cis	rs2836633	0.965	rs2836615	chr21:40048039	C/T	cg05519781	chr21:40033154	ERG	0.75	6.66	0.6	3.47e-9	Coronary artery disease;
SKCM	cis	rs10489202	0.683	rs4657730	chr1:168072738	A/T	cg24449463	chr1:168025552	DCAF6	-0.77	-7.11	-0.63	4.89e-10	Schizophrenia;
SKCM	cis	rs4927850	0.752	rs7624460	chr3:195748530	C/T	cg12923728	chr3:195709715	SDHAP1	-0.88	-7.24	-0.63	2.8e-10	Pancreatic cancer;
SKCM	cis	rs7772486	0.654	rs702321	chr6:146006695	A/G	cg23711669	chr6:146136114	FBXO30	-0.89	-9.14	-0.72	5.88e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs28595532	0.920	rs116548907	chr4:119735285	G/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs34172651	0.517	rs7204288	chr16:24784531	A/G	cg06028605	chr16:24865363	SLC5A11	0.59	4.98	0.49	3.66e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs769267	0.965	rs1010207	chr19:19416045	T/C	cg26732615	chr19:19648335	CILP2;YJEFN3	0.65	6.06	0.57	4.61e-8	Tonsillectomy;
SKCM	cis	rs875971	0.545	rs75840613	chr7:65841386	G/A	cg18876405	chr7:65276391	NA	0.63	5.0	0.49	3.41e-6	Aortic root size;
SKCM	cis	rs2760061	0.598	rs590657	chr1:228117581	A/C	cg02753203	chr1:228287806	NA	-0.63	-4.96	-0.49	3.99e-6	Diastolic blood pressure;
SKCM	cis	rs9611565	0.512	rs5758450	chr22:42141640	G/A	cg03806693	chr22:41940476	POLR3H	1.14	7.07	0.63	5.69e-10	Vitiligo;
SKCM	cis	rs11848070	1.000	rs11848070	chr14:71507601	C/T	cg15816911	chr14:71606274	NA	0.73	4.78	0.48	8.11e-6	Alzheimer's disease (late onset);
SKCM	cis	rs7666738	0.830	rs62321570	chr4:98984276	G/A	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs8014204	0.967	rs2359240	chr14:75328247	T/C	cg06637938	chr14:75390232	RPS6KL1	-0.8	-5.85	-0.55	1.08e-7	Caffeine consumption;
SKCM	cis	rs7811142	1.000	rs11761784	chr7:100039970	C/T	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-0.99	-5.52	-0.53	4.2e-7	Platelet count;
SKCM	cis	rs597539	0.652	rs654071	chr11:68653432	A/C	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.82	5.44	0.52	5.87e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs6752107	1.000	rs2241880	chr2:234183368	A/G	cg07618928	chr2:234183455	ATG16L1;SCARNA5	0.56	4.77	0.48	8.37e-6	Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs1552244	0.572	rs3894322	chr3:10168965	G/A	cg00149659	chr3:10157352	C3orf10	1.13	5.45	0.53	5.74e-7	Alzheimer's disease;
SKCM	cis	rs12714314	0.756	rs11687068	chr2:1948949	A/G	cg22350835	chr2:1868857	MYT1L	0.65	5.12	0.5	2.16e-6	Type 2 diabetes (age of onset);
SKCM	cis	rs3087591	1.000	rs2854332	chr17:29712378	A/T	cg24425628	chr17:29625626	OMG;NF1	-0.61	-4.83	-0.48	6.71e-6	Hip circumference;
SKCM	cis	rs2075671	0.903	rs11973874	chr7:100263272	T/C	cg20848291	chr7:100343083	ZAN	-0.72	-5.55	-0.53	3.84e-7	Other erythrocyte phenotypes;
SKCM	cis	rs58688157	0.960	rs1051390	chr11:613165	G/C	cg17114584	chr11:613792	IRF7	0.74	5.0	0.49	3.51e-6	Systemic lupus erythematosus;
SKCM	cis	rs10504229	1.000	rs67546820	chr8:58168567	G/A	cg22535103	chr8:58192502	C8orf71	-0.68	-4.82	-0.48	7.06e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs9611565	0.694	rs202664	chr22:41813886	C/T	cg03806693	chr22:41940476	POLR3H	1.05	7.43	0.64	1.17e-10	Vitiligo;
SKCM	trans	rs1814175	0.712	rs9665784	chr11:50030617	C/T	cg03929089	chr4:120376271	NA	-0.93	-8.77	-0.7	3.08e-13	Height;
SKCM	cis	rs2455601	0.882	rs10840139	chr11:8894838	T/G	cg21881798	chr11:8931708	C11orf17;ST5	-0.77	-5.55	-0.53	3.79e-7	Schizophrenia;
SKCM	cis	rs17711722	0.701	rs781145	chr7:65440370	A/C	cg11987759	chr7:65425863	GUSB	-0.75	-6.72	-0.61	2.68e-9	Calcium levels;
SKCM	cis	rs2180341	0.960	rs9398840	chr6:127669744	G/A	cg24812749	chr6:127587940	RNF146	0.83	7.24	0.63	2.76e-10	Breast cancer;
SKCM	cis	rs9469913	0.604	rs11755266	chr6:35162141	A/G	cg16257762	chr6:35748837	C6orf127	0.68	5.0	0.49	3.42e-6	Body mass index (joint analysis main effects and physical activity interaction);Body mass index;Body mass index in physically active individuals;
SKCM	trans	rs9929218	0.581	rs12185157	chr16:68784587	G/A	cg04657470	chr2:198365150	HSPE1;HSPD1	0.93	9.46	0.73	1.38e-14	Colorectal cancer;
SKCM	cis	rs7666738	0.606	rs28625338	chr4:99076996	A/G	cg17366294	chr4:99064904	C4orf37	0.61	5.06	0.5	2.73e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2204008	0.744	rs66474616	chr12:38461564	G/A	cg13010199	chr12:38710504	ALG10B	0.69	4.9	0.49	5.02e-6	Bladder cancer;
SKCM	cis	rs8072100	0.748	rs9908016	chr17:45551361	G/A	cg25173405	chr17:45401733	C17orf57	-0.58	-4.77	-0.48	8.26e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs7666738	0.830	rs1124253	chr4:98949682	C/T	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7811142	1.000	rs11559117	chr7:100076614	A/G	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.17	7.71	0.66	3.44e-11	Platelet count;
SKCM	cis	rs7666738	0.830	rs13129479	chr4:98987860	T/C	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6951245	0.872	rs75493422	chr7:1072890	C/T	cg18402987	chr7:1209562	NA	1.15	6.02	0.56	5.38e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs10504229	0.683	rs55868006	chr8:58135703	C/T	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs3820928	0.934	rs1366756	chr2:227772038	G/A	cg11843606	chr2:227700838	RHBDD1	-0.64	-5.2	-0.51	1.53e-6	Pulmonary function;
SKCM	cis	rs1153858	1.000	rs66528868	chr15:45668547	A/C	cg10760299	chr15:45669010	GATM	0.62	6.35	0.58	1.3e-8	Homoarginine levels;
SKCM	trans	rs1814175	0.817	rs7929173	chr11:49944007	T/C	cg03929089	chr4:120376271	NA	-0.93	-8.8	-0.71	2.58e-13	Height;
SKCM	cis	rs6582630	0.555	rs10880421	chr12:38423015	C/T	cg13010199	chr12:38710504	ALG10B	0.69	4.89	0.48	5.2e-6	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs9303401	0.659	rs16943176	chr17:56769887	G/A	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.16	0.57	2.91e-8	Cognitive test performance;
SKCM	trans	rs561341	0.700	rs886223	chr17:30229877	G/T	cg20587970	chr11:113659929	NA	-0.95	-7.58	-0.65	6.16e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs801193	0.548	rs2659891	chr7:66201114	A/G	cg18876405	chr7:65276391	NA	0.61	6.02	0.56	5.36e-8	Aortic root size;
SKCM	cis	rs9902453	0.935	rs9911794	chr17:28349466	T/C	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.81	-5.78	-0.55	1.45e-7	Coffee consumption (cups per day);
SKCM	cis	rs56011263	0.687	rs4690187	chr4:703813	C/T	cg17689763	chr4:710664	PCGF3	-0.6	-4.78	-0.48	8.12e-6	White blood cell count;
SKCM	cis	rs514406	0.798	rs504816	chr1:53307957	T/G	cg24675658	chr1:53192096	ZYG11B	-0.82	-7.27	-0.64	2.35e-10	Monocyte count;
SKCM	cis	rs56235845	0.694	rs4532376	chr5:176774403	G/A	cg16006841	chr5:176797999	RGS14	0.7	6.47	0.59	7.95e-9	Hemoglobin concentration;Hematocrit;
SKCM	trans	rs17685	0.753	rs2108274	chr7:75781636	C/A	cg19862616	chr7:65841803	NCRNA00174	0.92	9.38	0.73	2.02e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs28386778	0.863	rs2251164	chr17:61884120	G/A	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs12142240	0.730	rs56030283	chr1:46823093	C/G	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs7666738	0.830	rs6843777	chr4:98866635	T/A	cg17366294	chr4:99064904	C4orf37	0.56	4.87	0.48	5.62e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7191439	0.584	rs11076698	chr16:88752693	T/G	cg02389323	chr16:88786976	FAM38A	1.28	4.83	0.48	6.68e-6	Plateletcrit;
SKCM	cis	rs7208859	0.573	rs79505916	chr17:29062326	C/T	cg13385521	chr17:29058706	SUZ12P	1.01	5.02	0.49	3.2e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs798554	0.836	rs798500	chr7:2790685	C/T	cg19346786	chr7:2764209	NA	0.64	6.81	0.61	1.79e-9	Height;
SKCM	cis	rs7772486	0.790	rs3924499	chr6:146232978	A/T	cg05347473	chr6:146136440	FBXO30	-0.58	-5.17	-0.51	1.73e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs5769765	0.908	rs138866	chr22:50205903	A/G	cg22709217	chr22:50311962	ALG12;CRELD2	0.85	5.85	0.55	1.12e-7	Schizophrenia;
SKCM	cis	rs2346177	0.519	rs13003074	chr2:46671420	A/T	cg02822958	chr2:46747628	ATP6V1E2	-0.64	-4.85	-0.48	6.22e-6	HDL cholesterol;
SKCM	cis	rs9611565	0.659	rs4822034	chr22:41931010	T/C	cg03806693	chr22:41940476	POLR3H	-1.11	-7.56	-0.65	6.67e-11	Vitiligo;
SKCM	cis	rs9916302	0.851	rs612209	chr17:37442713	G/C	cg07936489	chr17:37558343	FBXL20	0.84	6.75	0.61	2.32e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs55962025	0.804	rs2071703	chr4:3241413	A/C	cg11471262	chr4:3318911	RGS12	-0.71	-5.52	-0.53	4.29e-7	Parental longevity (mother's age at death);
SKCM	cis	rs7408868	1.000	rs7249525	chr19:15277309	G/A	cg14696996	chr19:15285081	NOTCH3	0.82	4.92	0.49	4.7e-6	Pulse pressure;
SKCM	cis	rs951366	0.789	rs823094	chr1:205689807	G/T	cg14893161	chr1:205819251	PM20D1	-0.8	-6.8	-0.61	1.88e-9	Menarche (age at onset);
SKCM	cis	rs875971	0.545	rs313830	chr7:65551931	T/C	cg18876405	chr7:65276391	NA	-0.67	-5.32	-0.52	9.82e-7	Aortic root size;
SKCM	cis	rs7772486	0.686	rs9390348	chr6:146044748	C/T	cg05347473	chr6:146136440	FBXO30	-0.55	-4.85	-0.48	6.14e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7666738	0.830	rs10031751	chr4:98939134	G/A	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2836950	0.520	rs59916147	chr21:40634702	T/G	cg11644478	chr21:40555479	PSMG1	-0.66	-5.1	-0.5	2.31e-6	Menarche (age at onset);
SKCM	cis	rs875971	1.000	rs2077593	chr7:65892530	A/G	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs995000	0.868	rs1168002	chr1:62934308	A/G	cg06896770	chr1:63153194	DOCK7	-0.64	-6.07	-0.57	4.37e-8	Triglyceride levels;
SKCM	cis	rs7811142	0.830	rs41280971	chr7:99954457	G/T	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.05	5.92	0.56	8.02e-8	Platelet count;
SKCM	cis	rs654950	0.875	rs689076	chr1:41999127	C/T	cg06885757	chr1:42089581	HIVEP3	0.64	6.91	0.62	1.15e-9	Airway imaging phenotypes;
SKCM	cis	rs514406	0.607	rs6665324	chr1:53201610	G/A	cg24675658	chr1:53192096	ZYG11B	0.64	5.3	0.51	1.04e-6	Monocyte count;
SKCM	cis	rs13256369	0.950	rs12548792	chr8:8568031	T/C	cg06636001	chr8:8085503	FLJ10661	0.77	5.93	0.56	7.8e-8	Obesity-related traits;
SKCM	cis	rs3785574	0.962	rs9944483	chr17:61783553	G/T	cg06601766	chr17:61851465	DDX42;CCDC47	-0.7	-5.26	-0.51	1.24e-6	Height;
SKCM	cis	rs1799949	0.602	rs8176235	chr17:41219560	C/T	cg05368731	chr17:41323189	NBR1	0.8	6.29	0.58	1.72e-8	Menopause (age at onset);
SKCM	cis	rs1801251	1.000	rs6724117	chr2:233593660	T/G	cg08000102	chr2:233561755	GIGYF2	0.88	6.76	0.61	2.28e-9	Coronary artery disease;
SKCM	cis	rs35306767	0.903	rs12240651	chr10:943656	A/G	cg25614935	chr10:1084866	C10orf110	0.82	5.39	0.52	7.4e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs12701220	0.894	rs12701348	chr7:1039457	C/T	cg02733842	chr7:1102375	C7orf50	-0.56	-5.01	-0.49	3.36e-6	Bronchopulmonary dysplasia;
SKCM	cis	rs763014	0.966	rs4984904	chr16:680809	C/G	cg07343612	chr16:622815	PIGQ	-0.7	-5.64	-0.54	2.59e-7	Height;
SKCM	cis	rs951366	0.617	rs823080	chr1:205789282	G/A	cg24739457	chr1:205821442	NA	0.58	5.61	0.54	2.99e-7	Menarche (age at onset);
SKCM	cis	rs9916302	0.861	rs644173	chr17:37430519	T/C	cg07936489	chr17:37558343	FBXL20	-0.84	-6.92	-0.62	1.11e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs7605378	0.528	rs7592587	chr2:200786516	C/G	cg23649088	chr2:200775458	C2orf69	0.67	5.31	0.52	9.99e-7	Osteoporosis;
SKCM	cis	rs4319547	0.695	rs12314643	chr12:122917423	C/T	cg23029597	chr12:123009494	RSRC2	-0.77	-5.82	-0.55	1.22e-7	Body mass index;
SKCM	cis	rs2228479	0.702	rs62056087	chr16:89920383	C/A	cg06558623	chr16:89946397	TCF25	1.12	5.0	0.49	3.47e-6	Skin colour saturation;
SKCM	cis	rs7618915	0.547	rs13085331	chr3:52627486	G/C	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs2243480	1.000	rs35825738	chr7:65318027	A/G	cg18252515	chr7:66147081	NA	-1.29	-7.41	-0.64	1.3e-10	Diabetic kidney disease;
SKCM	cis	rs6500395	0.962	rs7499213	chr16:48680597	T/C	cg04672837	chr16:48644449	N4BP1	0.65	5.36	0.52	8.23e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs6582630	0.519	rs12372510	chr12:38293074	T/C	cg26384229	chr12:38710491	ALG10B	0.79	6.35	0.58	1.33e-8	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs2070488	0.804	rs2268755	chr3:38501916	A/G	cg01465620	chr3:38496096	LOC100128640;ACVR2B	-0.79	-6.42	-0.59	9.63e-9	Electrocardiographic conduction measures;
SKCM	cis	rs16866061	0.855	rs11687736	chr2:225405122	A/T	cg12698349	chr2:225449008	CUL3	1.01	8.51	0.69	9.75e-13	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs1862618	0.573	rs832532	chr5:56221938	T/C	cg12311346	chr5:56204834	C5orf35	-0.84	-6.18	-0.57	2.75e-8	Initial pursuit acceleration;
SKCM	cis	rs362296	0.698	rs362266	chr4:3259632	C/G	cg09735869	chr4:3319127	RGS12	-0.71	-6.01	-0.56	5.58e-8	Parental longevity (mother's age at death);
SKCM	cis	rs28386778	0.897	rs4968597	chr17:61805747	G/A	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.36	0.52	8.08e-7	Prudent dietary pattern;
SKCM	cis	rs7100689	0.646	rs1340382	chr10:82096997	G/C	cg01528321	chr10:82214614	TSPAN14	0.75	6.03	0.56	5.23e-8	Post bronchodilator FEV1;
SKCM	cis	rs1799949	0.602	rs8176235	chr17:41219560	C/T	cg23758822	chr17:41437982	NA	0.81	6.01	0.56	5.52e-8	Menopause (age at onset);
SKCM	cis	rs1348850	0.574	rs2365617	chr2:178421934	C/A	cg27490568	chr2:178487706	NA	0.83	5.67	0.54	2.3e-7	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs3780486	0.846	rs4584234	chr9:33147479	G/A	cg13443165	chr9:33130375	B4GALT1	-0.52	-4.91	-0.49	4.99e-6	IgG glycosylation;
SKCM	cis	rs860295	0.871	rs34632540	chr1:155612197	G/T	cg02153340	chr1:155202674	NA	0.76	5.84	0.55	1.16e-7	Body mass index;
SKCM	cis	rs13064447	0.753	rs9811396	chr3:12747915	A/G	cg05775895	chr3:12838266	CAND2	-0.71	-5.13	-0.5	2.07e-6	Major depression and alcohol dependence;
SKCM	cis	rs9911578	1.000	rs12602346	chr17:56901713	T/C	cg12560992	chr17:57184187	TRIM37	0.94	7.55	0.65	7.01e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs782590	0.967	rs17278044	chr2:55748217	G/C	cg18811423	chr2:55921094	PNPT1	0.79	5.93	0.56	7.68e-8	Metabolic syndrome;
SKCM	cis	rs6977660	0.714	rs10224920	chr7:19816173	A/T	cg05791153	chr7:19748676	TWISTNB	0.8	5.01	0.49	3.37e-6	Thyroid stimulating hormone;
SKCM	cis	rs11710229	0.535	rs35100202	chr3:55400853	T/C	cg04915058	chr3:55693741	C3orf51;ERC2	0.76	4.87	0.48	5.7e-6	Response to cytadine analogues (cytosine arabinoside);
SKCM	cis	rs9467773	0.620	rs2504540	chr6:26641626	A/G	cg09904177	chr6:26538194	HMGN4	0.58	5.01	0.49	3.28e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs4774899	0.934	rs11636348	chr15:57470630	G/T	cg01857019	chr15:57210107	LOC145783;TCF12	0.53	4.77	0.48	8.29e-6	Urinary tract infection frequency;
SKCM	cis	rs9435341	0.965	rs1762485	chr1:107625056	C/T	cg09367891	chr1:107599246	PRMT6	-0.78	-6.14	-0.57	3.29e-8	Facial morphology (factor 21, depth of nasal alae);
SKCM	cis	rs6445797	0.632	rs9811046	chr3:56588949	T/A	cg13616963	chr3:57583610	ARF4	-0.78	-5.17	-0.51	1.76e-6	Gastritis;
SKCM	cis	rs1799949	1.000	rs11659028	chr17:41195025	T/A	cg23758822	chr17:41437982	NA	0.94	7.79	0.66	2.4e-11	Menopause (age at onset);
SKCM	cis	rs9506514	0.617	rs9509352	chr13:21295149	A/G	cg22053796	chr13:21304026	N6AMT2	-0.69	-5.52	-0.53	4.3e-7	Coronary artery calcification;
SKCM	cis	rs672059	0.966	rs689375	chr1:183160973	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.63	5.23	0.51	1.38e-6	Hypertriglyceridemia;
SKCM	cis	rs17065868	0.730	rs77026857	chr13:45204440	G/A	cg10246903	chr13:45222710	NA	0.95	5.35	0.52	8.5e-7	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs2108225	0.872	rs2051954	chr7:107441097	G/C	cg18560240	chr7:107437656	SLC26A3	-0.65	-5.36	-0.52	8.13e-7	Ulcerative colitis;
SKCM	cis	rs1577917	0.545	rs9450325	chr6:86475814	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.67	5.76	0.55	1.6e-7	Response to antipsychotic treatment;
SKCM	cis	rs9913156	0.670	rs4470203	chr17:4567798	G/A	cg19197139	chr17:4613644	ARRB2	-0.79	-5.45	-0.53	5.64e-7	Lymphocyte counts;
SKCM	cis	rs2439831	0.681	rs956391	chr15:43617493	C/T	cg27015174	chr15:43622946	ADAL;LCMT2	-0.88	-5.01	-0.49	3.36e-6	Lung cancer in ever smokers;
SKCM	cis	rs7927771	0.801	rs12798028	chr11:47604639	C/T	cg05585544	chr11:47624801	NA	-0.64	-5.52	-0.53	4.33e-7	Subjective well-being;
SKCM	cis	rs7552404	0.883	rs11161493	chr1:76206254	T/A	cg03433033	chr1:76189801	ACADM	0.73	5.33	0.52	9.12e-7	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs4268898	0.662	rs17789375	chr2:24502554	G/T	cg06627628	chr2:24431161	ITSN2	-0.98	-7.71	-0.66	3.49e-11	Asthma;
SKCM	cis	rs2836974	0.863	rs6517519	chr21:40540245	A/G	cg11644478	chr21:40555479	PSMG1	0.97	10.21	0.76	5.08e-16	Cognitive function;
SKCM	cis	rs7772486	0.624	rs6930154	chr6:146025662	C/T	cg23711669	chr6:146136114	FBXO30	-0.82	-8.12	-0.68	5.44e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6088580	0.634	rs4911153	chr20:32961547	C/T	cg24642439	chr20:33292090	TP53INP2	-0.76	-6.02	-0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs992157	0.835	rs2045434	chr2:219144498	A/G	cg00012203	chr2:219082015	ARPC2	-0.74	-5.97	-0.56	6.53e-8	Colorectal cancer;
SKCM	cis	rs9399135	0.967	rs12661423	chr6:135349570	C/T	cg24558204	chr6:135376177	HBS1L	0.61	5.22	0.51	1.43e-6	Red blood cell count;
SKCM	cis	rs3087591	1.000	rs7226006	chr17:29650656	A/G	cg24425628	chr17:29625626	OMG;NF1	-0.63	-4.93	-0.49	4.59e-6	Hip circumference;
SKCM	cis	rs11608355	0.557	rs759971	chr12:109826046	A/T	cg19025524	chr12:109796872	NA	-0.68	-6.2	-0.57	2.49e-8	Neuroticism;
SKCM	cis	rs2760061	0.599	rs644794	chr1:228148670	T/C	cg18477163	chr1:228402036	OBSCN	-0.43	-4.97	-0.49	3.87e-6	Diastolic blood pressure;
SKCM	cis	rs2070488	0.775	rs6599211	chr3:38558830	A/G	cg01465620	chr3:38496096	LOC100128640;ACVR2B	-0.74	-5.88	-0.55	9.48e-8	Electrocardiographic conduction measures;
SKCM	cis	rs826838	1.000	rs1684416	chr12:39130301	G/A	cg13010199	chr12:38710504	ALG10B	-0.72	-5.73	-0.54	1.83e-7	Heart rate;
SKCM	cis	rs10754283	0.967	rs7546518	chr1:90109956	C/T	cg21401794	chr1:90099060	LRRC8C	0.73	6.34	0.58	1.35e-8	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs12044355	0.929	rs6667123	chr1:231851991	C/G	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	0.76	5.49	0.53	4.81e-7	Alzheimer's disease;
SKCM	cis	rs9818758	0.607	rs13087930	chr3:48961726	A/G	cg24898236	chr3:49228699	LOC646498	0.65	4.98	0.49	3.66e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs12586317	0.547	rs77262907	chr14:35495734	C/G	cg16230307	chr14:35515116	FAM177A1	0.81	5.88	0.55	9.47e-8	Psoriasis;
SKCM	cis	rs1580019	0.922	rs59938271	chr7:32484844	T/C	cg06627557	chr7:32535165	LSM5;AVL9	0.74	5.21	0.51	1.49e-6	Cognitive ability;
SKCM	cis	rs1577917	0.958	rs7453105	chr6:86500761	A/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.88	-0.67	1.63e-11	Response to antipsychotic treatment;
SKCM	cis	rs2153535	0.580	rs6941670	chr6:8446346	G/A	cg07606381	chr6:8435919	SLC35B3	0.95	6.88	0.61	1.35e-9	Motion sickness;
SKCM	cis	rs8008758	0.500	rs1763212	chr14:101693911	G/A	cg26224664	chr14:101693935	NA	-0.45	-6.08	-0.57	4.15e-8	Body mass index (alcohol intake interaction);
SKCM	cis	rs7100689	0.646	rs4601708	chr10:82119583	G/T	cg01528321	chr10:82214614	TSPAN14	0.8	7.0	0.62	7.98e-10	Post bronchodilator FEV1;
SKCM	cis	rs1801251	1.000	rs1446311	chr2:233705071	G/A	cg25237894	chr2:233734115	C2orf82	-0.61	-5.9	-0.56	8.76e-8	Coronary artery disease;
SKCM	cis	rs2832191	0.646	rs2832214	chr21:30517127	C/T	cg24692254	chr21:30365293	RNF160	-0.76	-6.41	-0.59	1.03e-8	Dental caries;
SKCM	cis	rs28595532	0.920	rs115850161	chr4:119732447	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.52	0.53	4.28e-7	Cannabis dependence symptom count;
SKCM	cis	rs7659604	0.702	rs61217486	chr4:122693973	T/C	cg06713675	chr4:122721982	EXOSC9	-0.73	-6.65	-0.6	3.56e-9	Type 2 diabetes;
SKCM	cis	rs908922	0.676	rs4240887	chr1:152530510	C/T	cg09873164	chr1:152488093	CRCT1	-0.75	-5.86	-0.55	1.07e-7	Hair morphology;
SKCM	cis	rs72781680	1.000	rs115861480	chr2:24129464	T/A	cg08917208	chr2:24149416	ATAD2B	1.02	5.84	0.55	1.16e-7	Lymphocyte counts;
SKCM	cis	rs951366	0.764	rs823143	chr1:205743425	A/C	cg07167872	chr1:205819463	PM20D1	0.97	8.43	0.69	1.39e-12	Menarche (age at onset);
SKCM	trans	rs1814175	0.817	rs1851860	chr11:49861310	A/C	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs6430585	0.528	rs309142	chr2:136715324	T/C	cg07169764	chr2:136633963	MCM6	1.26	10.86	0.78	2.87e-17	Corneal structure;
SKCM	cis	rs2836974	0.666	rs1888487	chr21:40683259	A/G	cg17971929	chr21:40555470	PSMG1	-0.74	-6.92	-0.62	1.14e-9	Cognitive function;
SKCM	cis	rs26868	0.740	rs26869	chr16:2248786	T/C	cg27608139	chr16:2294856	DCI	0.64	5.34	0.52	8.93e-7	Height;
SKCM	cis	rs4561483	0.801	rs33631	chr16:11995387	G/C	cg08843971	chr16:11963173	GSPT1	-0.66	-5.08	-0.5	2.49e-6	Testicular germ cell tumor;
SKCM	trans	rs2727020	0.729	rs10839283	chr11:49490943	T/C	cg15704280	chr7:45808275	SEPT13	0.93	7.97	0.67	1.07e-11	Coronary artery disease;
SKCM	cis	rs854765	0.693	rs8079321	chr17:17760789	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.07	8.12	0.68	5.53e-12	Total body bone mineral density;
SKCM	cis	rs1707322	0.927	rs11211194	chr1:46282084	C/T	cg03146154	chr1:46216737	IPP	0.75	5.15	0.5	1.94e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs995000	0.895	rs597076	chr1:62917865	T/A	cg06896770	chr1:63153194	DOCK7	0.77	7.38	0.64	1.45e-10	Triglyceride levels;
SKCM	cis	rs1801251	1.000	rs2012221	chr2:233566848	T/C	cg08000102	chr2:233561755	GIGYF2	0.89	6.75	0.61	2.35e-9	Coronary artery disease;
SKCM	trans	rs7618501	1.000	rs7634902	chr3:49762662	G/T	cg21659725	chr3:3221576	CRBN	-0.96	-9.61	-0.74	7.08e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs4595586	0.546	rs10876163	chr12:39244915	G/A	cg26384229	chr12:38710491	ALG10B	0.68	5.11	0.5	2.27e-6	Morning vs. evening chronotype;
SKCM	cis	rs2228479	0.850	rs17227263	chr16:89810598	G/A	cg00800038	chr16:89945340	TCF25	-0.81	-4.79	-0.48	7.84e-6	Skin colour saturation;
SKCM	cis	rs7618501	0.521	rs3774759	chr3:49939120	G/T	cg24110177	chr3:50126178	RBM5	-0.77	-5.85	-0.55	1.11e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs2439831	1.000	rs2467743	chr15:43750346	T/A	cg02155558	chr15:43621948	ADAL;LCMT2	1.19	7.61	0.65	5.35e-11	Lung cancer in ever smokers;
SKCM	cis	rs35146811	0.586	rs6964754	chr7:99589404	G/A	cg22906224	chr7:99728672	NA	0.76	5.48	0.53	5.14e-7	Coronary artery disease;
SKCM	cis	rs941408	1.000	rs1736182	chr19:2798686	T/G	cg17333051	chr19:2783644	SGTA	0.42	4.93	0.49	4.45e-6	Total cholesterol levels;
SKCM	cis	rs798554	0.759	rs2644309	chr7:2889034	T/C	cg04166393	chr7:2884313	GNA12	0.73	4.93	0.49	4.54e-6	Height;
SKCM	cis	rs16854884	0.657	rs13086088	chr3:143723942	G/A	cg06585982	chr3:143692056	C3orf58	0.87	8.11	0.68	5.72e-12	Economic and political preferences (feminism/equality);
SKCM	cis	rs42490	0.868	rs1605997	chr8:90668113	A/G	cg17816771	chr8:91099036	NA	0.51	4.8	0.48	7.62e-6	Leprosy;
SKCM	cis	rs6815814	0.950	rs5743580	chr4:38804405	C/T	cg02016764	chr4:38805732	TLR1	-0.76	-5.4	-0.52	6.95e-7	Breast cancer;
SKCM	cis	rs1843834	0.898	rs11887386	chr2:225526975	T/G	cg22455342	chr2:225449267	CUL3	0.61	4.8	0.48	7.53e-6	IgE levels in asthmatics (D.p. specific);
SKCM	cis	rs742614	0.533	rs6059499	chr20:32447920	C/T	cg06304546	chr20:32448765	NA	0.73	5.91	0.56	8.51e-8	Stearic acid (18:0) levels;
SKCM	cis	rs427394	0.659	rs274675	chr5:6755319	C/T	cg10857441	chr5:6722123	POLS	-0.68	-7.13	-0.63	4.4e-10	Menopause (age at onset);
SKCM	cis	rs9902453	0.791	rs2729451	chr17:28131334	T/C	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.83	-5.76	-0.55	1.61e-7	Coffee consumption (cups per day);
SKCM	cis	rs7428	0.527	rs7607284	chr2:85547376	C/G	cg24342717	chr2:85555507	TGOLN2	-0.61	-4.78	-0.48	8.12e-6	Ear protrusion;
SKCM	cis	rs7843479	1.000	rs1032094	chr8:21820479	A/T	cg17168535	chr8:21777572	XPO7	0.72	5.64	0.54	2.65e-7	Mean corpuscular volume;
SKCM	cis	rs7552404	0.924	rs7535991	chr1:76162624	C/T	cg03433033	chr1:76189801	ACADM	0.78	5.67	0.54	2.36e-7	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs12047808	0.841	rs56253737	chr1:179342634	A/G	cg08037922	chr1:179521085	C1orf125;NPHS2	-1.08	-5.8	-0.55	1.32e-7	Multiple sclerosis (age of onset);
SKCM	cis	rs12047808	0.730	rs2274624	chr1:179520660	C/G	cg09822482	chr1:179519214	C1orf125	-0.96	-4.77	-0.48	8.48e-6	Multiple sclerosis (age of onset);
SKCM	cis	rs4319547	0.915	rs7314638	chr12:122983460	A/G	cg23029597	chr12:123009494	RSRC2	-0.82	-6.33	-0.58	1.46e-8	Body mass index;
SKCM	cis	rs9910055	0.659	rs7214540	chr17:42256604	A/G	cg09913183	chr17:42254507	C17orf65;ASB16	0.67	6.53	0.59	6.13e-9	Total body bone mineral density;
SKCM	cis	rs427394	0.802	rs200841	chr5:6737134	A/G	cg10857441	chr5:6722123	POLS	-0.7	-7.63	-0.65	4.81e-11	Menopause (age at onset);
SKCM	cis	rs11098499	0.754	rs34425882	chr4:120253177	G/A	cg09307838	chr4:120376055	NA	0.91	7.36	0.64	1.63e-10	Corneal astigmatism;
SKCM	cis	rs66573146	0.831	rs56320732	chr4:6974319	G/A	cg00086871	chr4:6988644	TBC1D14	1.29	5.03	0.5	3.04e-6	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs17376456	0.825	rs6898842	chr5:93213221	T/C	cg21475434	chr5:93447410	FAM172A	1.04	5.55	0.53	3.82e-7	Diabetic retinopathy;
SKCM	cis	rs2180341	1.000	rs6569483	chr6:127658855	G/A	cg27446573	chr6:127587934	RNF146	0.94	8.08	0.68	6.49e-12	Breast cancer;
SKCM	cis	rs801193	0.660	rs1962050	chr7:66240008	C/T	cg11764359	chr7:65958608	NA	-0.82	-7.97	-0.67	1.06e-11	Aortic root size;
SKCM	cis	rs7927771	0.864	rs3781625	chr11:47443080	T/C	cg05585544	chr11:47624801	NA	-0.58	-5.19	-0.51	1.61e-6	Subjective well-being;
SKCM	cis	rs7584330	0.657	rs10202599	chr2:238352465	A/C	cg14458575	chr2:238380390	NA	1.04	6.94	0.62	1e-9	Prostate cancer;
SKCM	cis	rs6952808	0.689	rs12670737	chr7:2046830	C/T	cg02951883	chr7:2050386	MAD1L1	-0.83	-7.55	-0.65	6.9e-11	Bipolar disorder and schizophrenia;
SKCM	cis	rs2952156	0.920	rs732084	chr17:37834357	A/C	cg20243544	chr17:37824526	PNMT	0.71	5.74	0.54	1.74e-7	Asthma;
SKCM	cis	rs929354	0.772	rs1182438	chr7:157027438	G/A	cg17757837	chr7:157058334	UBE3C	-0.81	-5.67	-0.54	2.3e-7	Body mass index;
SKCM	cis	rs117526668	0.737	rs79678353	chr11:44252717	G/T	cg09249837	chr11:43544472	NA	-0.83	-4.84	-0.48	6.42e-6	Response to abacavir-containing treatment in HIV-1 infection (virologic failure);Response to efavirenz-containing treatment in HIV 1 infection (virologic failure);
SKCM	cis	rs10504229	0.906	rs2270607	chr8:58194699	A/G	cg22535103	chr8:58192502	C8orf71	-0.82	-5.42	-0.52	6.35e-7	Developmental language disorder (linguistic errors);
SKCM	cis	rs2991971	0.901	rs11211122	chr1:45954650	C/T	cg24296786	chr1:45957014	TESK2	0.69	5.87	0.55	1.01e-7	High light scatter reticulocyte count;
SKCM	cis	rs7523273	0.606	rs1830764	chr1:207917052	G/A	cg22525895	chr1:207977042	MIR29B2	0.77	6.33	0.58	1.45e-8	Schizophrenia;
SKCM	trans	rs1814175	0.585	rs4881661	chr11:50000117	A/G	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs7945705	0.791	rs6484484	chr11:8817206	A/G	cg21881798	chr11:8931708	C11orf17;ST5	0.64	6.21	0.58	2.39e-8	Hemoglobin concentration;
SKCM	cis	rs507080	0.883	rs693306	chr11:118558333	A/G	cg18045108	chr11:118530628	TREH	-0.47	-4.81	-0.48	7.24e-6	Serum metabolite levels;
SKCM	cis	rs9905704	0.647	rs8077332	chr17:57105223	A/G	cg05425664	chr17:57184151	TRIM37	-0.58	-4.8	-0.48	7.36e-6	Testicular germ cell tumor;
SKCM	cis	rs35306767	0.953	rs35174953	chr10:961191	C/A	cg26597838	chr10:835615	NA	0.67	5.22	0.51	1.44e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs55962025	0.842	rs362306	chr4:3242100	C/T	cg09735869	chr4:3319127	RGS12	-0.79	-6.29	-0.58	1.67e-8	Parental longevity (mother's age at death);
SKCM	cis	rs13108904	0.775	rs2279282	chr4:1216033	G/C	cg05665937	chr4:1216051	CTBP1	0.61	5.21	0.51	1.47e-6	Obesity-related traits;
SKCM	cis	rs644799	0.710	rs10765771	chr11:95521044	A/G	cg03916912	chr11:95522834	CEP57;FAM76B	0.79	6.71	0.61	2.73e-9	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs1348850	0.632	rs12467363	chr2:178502512	C/T	cg22681709	chr2:178499509	PDE11A	-0.69	-5.98	-0.56	6.36e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs459571	0.839	rs2519831	chr9:136886257	T/A	cg13789015	chr9:136890014	NCRNA00094	0.77	6.63	0.6	3.95e-9	Platelet distribution width;
SKCM	cis	rs9790314	0.747	rs7650703	chr3:160851639	T/C	cg03342759	chr3:160939853	NMD3	-0.62	-6.25	-0.58	2.03e-8	Morning vs. evening chronotype;
SKCM	cis	rs2357013	0.752	rs4672085	chr2:53154899	G/A	cg07782112	chr2:53107842	NA	-0.61	-5.97	-0.56	6.54e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs4819052	0.851	rs35871601	chr21:46675214	C/T	cg20896738	chr21:46707857	POFUT2;LOC642852	0.64	4.82	0.48	6.85e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs6547631	0.622	rs4240201	chr2:85925667	G/A	cg24620635	chr2:85921963	GNLY	0.9	6.65	0.6	3.58e-9	Blood protein levels;
SKCM	cis	rs2153535	0.580	rs6597325	chr6:8461053	A/C	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs1927702	0.721	rs17353213	chr9:16017055	C/G	cg14451791	chr9:16040625	NA	-0.47	-5.15	-0.5	1.87e-6	Body mass index;
SKCM	cis	rs1401999	1.000	rs7632670	chr3:183713877	A/G	cg01324343	chr3:183735012	ABCC5	0.85	9.82	0.74	2.76e-15	Anterior chamber depth;
SKCM	cis	rs7523273	0.925	rs6540443	chr1:208002010	T/A	cg22525895	chr1:207977042	MIR29B2	-0.78	-5.76	-0.55	1.57e-7	Schizophrenia;
SKCM	cis	rs8042680	0.554	rs73502775	chr15:91536225	G/A	cg15878949	chr15:91534302	PRC1	0.59	4.94	0.49	4.33e-6	Type 2 diabetes;
SKCM	cis	rs1799949	0.965	rs4793234	chr17:41436183	A/G	cg25918947	chr17:41365094	TMEM106A	-0.71	-6.96	-0.62	9.59e-10	Menopause (age at onset);
SKCM	cis	rs6424115	0.830	rs2501431	chr1:24201643	G/A	cg15997130	chr1:24165203	NA	0.6	4.94	0.49	4.37e-6	Immature fraction of reticulocytes;
SKCM	cis	rs362272	0.505	rs13104157	chr4:3366950	T/C	cg21096898	chr4:3318625	RGS12	0.99	13.17	0.83	1.62e-21	Serum sulfate level;
SKCM	cis	rs6546550	0.935	rs4853027	chr2:70039224	A/G	cg02498382	chr2:70120550	SNRNP27	0.46	5.05	0.5	2.88e-6	Prevalent atrial fibrillation;
SKCM	cis	rs727563	0.569	rs73178647	chr22:41964168	G/A	cg03806693	chr22:41940476	POLR3H	-1.05	-6.9	-0.62	1.21e-9	Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs11249608	0.510	rs6861539	chr5:178452307	A/G	cg21905437	chr5:178450457	ZNF879	0.73	5.93	0.56	7.89e-8	Pubertal anthropometrics;
SKCM	cis	rs7149337	0.805	rs3007069	chr14:51597392	G/A	cg23942311	chr14:51606299	NA	0.65	7.52	0.65	7.89e-11	Cancer;
SKCM	cis	rs875971	0.862	rs2460432	chr7:65554385	C/T	cg11764359	chr7:65958608	NA	-0.81	-7.68	-0.66	3.92e-11	Aortic root size;
SKCM	cis	rs995000	0.931	rs656297	chr1:62907595	A/G	cg06896770	chr1:63153194	DOCK7	0.76	7.24	0.63	2.71e-10	Triglyceride levels;
SKCM	cis	rs394563	0.602	rs409099	chr6:149766863	T/G	cg03678062	chr6:149772716	ZC3H12D	-0.5	-5.48	-0.53	5.08e-7	Dupuytren's disease;
SKCM	cis	rs9868809	0.772	rs9809222	chr3:48714411	C/T	cg00383909	chr3:49044727	WDR6	0.89	4.92	0.49	4.79e-6	Ulcerative colitis;Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs9300255	0.516	rs6488868	chr12:123799974	A/G	cg05973401	chr12:123451056	ABCB9	0.69	4.87	0.48	5.66e-6	Neutrophil percentage of white cells;
SKCM	cis	rs701145	0.938	rs701138	chr3:154063609	T/C	cg17054900	chr3:154042577	DHX36	0.92	5.12	0.5	2.11e-6	Coronary artery disease;
SKCM	cis	rs12541335	0.590	rs11136002	chr8:22217082	C/T	cg02788857	chr8:22132959	PIWIL2	0.54	4.99	0.49	3.57e-6	Hypertriglyceridemia;
SKCM	cis	rs1552244	1.000	rs28684871	chr3:10072635	C/A	cg02579736	chr3:10068473	FANCD2;CIDECP	1.23	6.92	0.62	1.13e-9	Alzheimer's disease;
SKCM	cis	rs6951245	0.872	rs112309216	chr7:1100296	A/T	cg18402987	chr7:1209562	NA	1.15	6.09	0.57	3.95e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs798554	0.836	rs13243214	chr7:2817455	G/T	cg19346786	chr7:2764209	NA	-0.66	-7.43	-0.64	1.18e-10	Height;
SKCM	cis	rs6982751	0.611	rs56173641	chr8:10807320	A/G	cg01383082	chr8:11323474	FAM167A	0.86	4.98	0.49	3.74e-6	Asthma and hay fever;
SKCM	cis	rs9814567	1.000	rs6439487	chr3:134260860	G/A	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs10504229	0.683	rs67077711	chr8:58139769	G/T	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs7829975	0.871	rs7829826	chr8:8578120	T/A	cg15556689	chr8:8085844	FLJ10661	-0.72	-6.41	-0.59	1.04e-8	Mood instability;
SKCM	cis	rs453301	0.686	rs11785634	chr8:8892597	G/T	cg15556689	chr8:8085844	FLJ10661	-0.73	-5.77	-0.55	1.52e-7	Joint mobility (Beighton score);
SKCM	cis	rs55823223	0.648	rs11867582	chr17:73857306	A/G	cg10935138	chr17:73851978	WBP2	1.19	7.17	0.63	3.81e-10	Psoriasis;
SKCM	cis	rs2836974	0.966	rs2836977	chr21:40666066	T/C	cg17971929	chr21:40555470	PSMG1	0.86	8.49	0.69	1.04e-12	Cognitive function;
SKCM	cis	rs600231	0.708	rs661403	chr11:65242478	A/G	cg24009118	chr11:65545808	DKFZp761E198	0.66	4.94	0.49	4.36e-6	Bone mineral density;
SKCM	cis	rs870825	0.616	rs2090590	chr4:185647850	A/C	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs7937682	0.889	rs7926485	chr11:111536670	G/A	cg09085632	chr11:111637200	PPP2R1B	-1.05	-12.29	-0.81	6.25e-20	Primary sclerosing cholangitis;
SKCM	cis	rs67311347	0.568	rs9864544	chr3:40336204	T/C	cg18306943	chr3:40428807	ENTPD3	0.56	4.8	0.48	7.56e-6	Renal cell carcinoma;
SKCM	cis	rs933688	1.000	rs11950530	chr5:90688740	A/G	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.02	7.81	0.66	2.22e-11	Smoking behavior;
SKCM	cis	rs9475752	0.552	rs13209099	chr6:56734052	A/T	cg06815302	chr6:57335405	PRIM2	0.66	4.88	0.48	5.58e-6	Menarche (age at onset);
SKCM	cis	rs4803468	1.000	rs2288871	chr19:41917868	C/T	cg14132834	chr19:41945861	ATP5SL	-0.77	-6.08	-0.57	4.18e-8	Height;
SKCM	cis	rs7584330	0.617	rs10202195	chr2:238352128	A/G	cg14458575	chr2:238380390	NA	1.01	6.75	0.61	2.34e-9	Prostate cancer;
SKCM	cis	rs8180040	0.726	rs13094672	chr3:47149439	C/T	cg27129171	chr3:47204927	SETD2	0.79	6.11	0.57	3.69e-8	Colorectal cancer;
SKCM	cis	rs1790761	0.505	rs7938563	chr11:67304131	A/G	cg00290607	chr11:67383545	NA	-0.51	-4.85	-0.48	6.16e-6	Mean corpuscular volume;
SKCM	trans	rs11722228	0.508	rs3796825	chr4:10092879	T/A	cg26043149	chr18:55253948	FECH	0.93	7.87	0.67	1.66e-11	Gout;Urate levels;Serum uric acid levels;
SKCM	cis	rs2439831	0.850	rs28509275	chr15:44098105	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.35	7.75	0.66	2.9e-11	Lung cancer in ever smokers;
SKCM	cis	rs11608355	0.538	rs11611957	chr12:109801803	A/G	cg19025524	chr12:109796872	NA	-0.69	-6.29	-0.58	1.73e-8	Neuroticism;
SKCM	cis	rs826838	0.900	rs11169301	chr12:39128497	C/A	cg13010199	chr12:38710504	ALG10B	0.71	5.46	0.53	5.43e-7	Heart rate;
SKCM	cis	rs11764590	0.694	rs2056477	chr7:2079744	G/C	cg23422044	chr7:1970798	MAD1L1	-0.82	-5.52	-0.53	4.21e-7	Neuroticism;
SKCM	cis	rs10929159	0.928	rs6431418	chr2:236919559	C/T	cg14226755	chr2:236923322	AGAP1	0.29	4.77	0.48	8.43e-6	Parkinson's disease;
SKCM	cis	rs72772090	1.000	rs72772095	chr5:96053853	T/C	cg17330273	chr5:96107758	CAST;ERAP1	-0.84	-5.06	-0.5	2.77e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs3087591	0.960	rs12945157	chr17:29603631	G/A	cg24425628	chr17:29625626	OMG;NF1	0.64	5.08	0.5	2.48e-6	Hip circumference;
SKCM	cis	rs9611565	0.559	rs739136	chr22:42100275	C/T	cg03806693	chr22:41940476	POLR3H	-1.04	-7.27	-0.64	2.43e-10	Vitiligo;
SKCM	cis	rs1707322	0.721	rs12049027	chr1:46118184	A/T	cg03146154	chr1:46216737	IPP	0.82	6.1	0.57	3.89e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs4665809	0.590	rs5001914	chr2:26415429	A/G	cg26119090	chr2:26468346	HADHA;HADHB	-1.02	-7.92	-0.67	1.35e-11	Gut microbiome composition (summer);
SKCM	cis	rs28595532	1.000	rs11931194	chr4:119631160	C/T	cg14228332	chr4:119757509	SEC24D	0.97	4.92	0.49	4.71e-6	Cannabis dependence symptom count;
SKCM	cis	rs6547631	0.628	rs2886768	chr2:85927555	A/C	cg24620635	chr2:85921963	GNLY	0.91	6.73	0.61	2.59e-9	Blood protein levels;
SKCM	cis	rs17213078	0.510	rs17032713	chr2:106886839	T/C	cg15412446	chr2:106886593	NA	-0.88	-7.41	-0.64	1.29e-10	Facial morphology (factor 23);
SKCM	cis	rs7772486	0.754	rs2064185	chr6:146066814	G/A	cg23711669	chr6:146136114	FBXO30	-0.89	-10.15	-0.75	6.48e-16	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2836633	0.859	rs8132069	chr21:40032611	T/C	cg05519781	chr21:40033154	ERG	0.75	6.8	0.61	1.86e-9	Coronary artery disease;
SKCM	cis	rs995000	0.931	rs7539035	chr1:63106767	G/T	cg06896770	chr1:63153194	DOCK7	0.76	7.52	0.65	8.12e-11	Triglyceride levels;
SKCM	cis	rs11098499	0.697	rs10016448	chr4:120298845	A/G	cg09307838	chr4:120376055	NA	0.97	7.49	0.65	9.08e-11	Corneal astigmatism;
SKCM	cis	rs6546550	0.901	rs6546558	chr2:70145717	C/T	cg02498382	chr2:70120550	SNRNP27	-0.48	-5.28	-0.51	1.12e-6	Prevalent atrial fibrillation;
SKCM	cis	rs4819052	0.851	rs1056100	chr21:46678711	A/C	cg20896738	chr21:46707857	POFUT2;LOC642852	0.67	5.04	0.5	2.93e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7927771	0.524	rs7929014	chr11:47776283	C/T	cg20307385	chr11:47447363	PSMC3	0.71	5.63	0.54	2.67e-7	Subjective well-being;
SKCM	cis	rs1707322	1.000	rs6693336	chr1:46354595	C/T	cg03146154	chr1:46216737	IPP	0.75	5.15	0.5	1.94e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs2268241	0.938	rs9978166	chr21:34770516	A/G	cg14850771	chr21:34775459	IFNGR2	1.08	5.84	0.55	1.16e-7	Obesity-related traits;
SKCM	cis	rs9872440	1	rs9872440	chr3:42896451	T/C	cg06399164	chr3:42695035	ZBTB47	0.55	4.79	0.48	7.71e-6	Myeloid white cell count;Granulocyte count;
SKCM	cis	rs9875589	0.509	rs4685062	chr3:14066409	T/C	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.52	5.24	0.51	1.34e-6	Ovarian reserve;
SKCM	cis	rs10779751	1.000	rs7544489	chr1:11299511	A/G	cg08854313	chr1:11322531	MTOR	-1.05	-9.98	-0.75	1.39e-15	Body mass index;
SKCM	cis	rs7666738	0.791	rs2081621	chr4:98926753	C/A	cg05340658	chr4:99064831	C4orf37	0.64	4.96	0.49	4.04e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1348850	0.668	rs6734426	chr2:178493770	C/T	cg27490568	chr2:178487706	NA	0.92	6.67	0.6	3.26e-9	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs1799949	1.000	rs2037075	chr17:41305826	G/T	cg25067162	chr17:41277974	BRCA1;NBR2	0.44	4.78	0.48	8.22e-6	Menopause (age at onset);
SKCM	cis	rs6089829	0.962	rs4809455	chr20:61660781	G/C	cg08564027	chr20:61660810	NA	0.62	5.55	0.53	3.75e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs854765	0.663	rs4925120	chr17:17754633	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	-1.03	-7.53	-0.65	7.57e-11	Total body bone mineral density;
SKCM	cis	rs2032447	0.507	rs478349	chr6:25894057	T/C	cg03517284	chr6:25882590	NA	-0.69	-5.53	-0.53	4.18e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs3809863	0.602	rs2317677	chr17:45393407	G/A	cg25173405	chr17:45401733	C17orf57	-0.71	-5.26	-0.51	1.22e-6	Glaucoma (primary open-angle);
SKCM	cis	rs453301	0.686	rs13252797	chr8:8861430	A/G	cg06636001	chr8:8085503	FLJ10661	0.76	6.06	0.57	4.58e-8	Joint mobility (Beighton score);
SKCM	cis	rs9880211	0.613	rs9653930	chr3:135810314	C/T	cg21827317	chr3:136751795	NA	-0.67	-4.9	-0.49	5.06e-6	Body mass index;Height;
SKCM	cis	rs4927850	1.000	rs10881563	chr3:195750225	A/G	cg12923728	chr3:195709715	SDHAP1	-0.93	-6.5	-0.59	6.87e-9	Pancreatic cancer;
SKCM	cis	rs11098499	0.874	rs12502503	chr4:120116255	C/T	cg09307838	chr4:120376055	NA	0.86	6.08	0.57	4.13e-8	Corneal astigmatism;
SKCM	cis	rs7020830	0.931	rs6476613	chr9:37084340	A/G	cg14294708	chr9:37120828	ZCCHC7	1.04	9.32	0.73	2.57e-14	Schizophrenia;
SKCM	cis	rs9987353	0.566	rs34491841	chr8:9065510	C/A	cg15556689	chr8:8085844	FLJ10661	-0.66	-4.96	-0.49	3.99e-6	Recombination measurement;
SKCM	cis	rs7584330	0.738	rs13398506	chr2:238374824	A/G	cg14458575	chr2:238380390	NA	0.91	6.4	0.59	1.07e-8	Prostate cancer;
SKCM	cis	rs763121	1.000	rs1946990	chr22:38912771	C/T	cg06022373	chr22:39101656	GTPBP1	-0.84	-5.8	-0.55	1.34e-7	Menopause (age at onset);
SKCM	cis	rs6489882	0.779	rs57484342	chr12:113371973	A/G	cg07232103	chr12:112566177	TRAFD1	0.61	4.93	0.49	4.58e-6	Chronic lymphocytic leukemia;
SKCM	cis	rs6665290	0.904	rs3768425	chr1:227178127	A/G	cg10327440	chr1:227177885	CDC42BPA	-1.22	-17.17	-0.89	3.2e-28	Myeloid white cell count;
SKCM	cis	rs860554	0.528	rs12120625	chr1:201306510	A/G	cg14377596	chr1:201709135	NAV1	0.45	5.47	0.53	5.23e-7	Panic disorder;
SKCM	cis	rs28595532	0.920	rs17257945	chr4:119666465	T/A	cg14228332	chr4:119757509	SEC24D	1.06	5.41	0.52	6.75e-7	Cannabis dependence symptom count;
SKCM	cis	rs16854884	0.657	rs35796781	chr3:143731662	T/C	cg06585982	chr3:143692056	C3orf58	0.83	7.55	0.65	6.97e-11	Economic and political preferences (feminism/equality);
SKCM	cis	rs7552404	0.924	rs2153126	chr1:76199345	C/G	cg10523679	chr1:76189770	ACADM	0.7	5.19	0.51	1.64e-6	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs11098499	0.731	rs9995026	chr4:120490499	T/A	cg24375607	chr4:120327624	NA	0.69	5.47	0.53	5.35e-7	Corneal astigmatism;
SKCM	cis	rs10791097	0.608	rs12363140	chr11:130744268	A/C	cg12179176	chr11:130786555	SNX19	0.93	8.16	0.68	4.62e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs28386778	0.897	rs2727328	chr17:61923564	G/A	cg22520471	chr17:61851767	DDX42;CCDC47	0.73	4.99	0.49	3.63e-6	Prudent dietary pattern;
SKCM	cis	rs2839186	0.721	rs3788252	chr21:47661235	C/T	cg11766577	chr21:47581405	C21orf56	-0.69	-5.92	-0.56	8.12e-8	Testicular germ cell tumor;
SKCM	cis	rs12048904	0.541	rs6699536	chr1:101276544	A/G	cg16556008	chr1:101360663	SLC30A7;EXTL2	0.92	6.84	0.61	1.59e-9	Multiple sclerosis;
SKCM	cis	rs34172651	0.583	rs200541	chr16:24733141	A/G	cg06028605	chr16:24865363	SLC5A11	-0.59	-4.87	-0.48	5.67e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9790314	0.747	rs1599386	chr3:160856314	C/T	cg03342759	chr3:160939853	NMD3	0.64	6.49	0.59	7.23e-9	Morning vs. evening chronotype;
SKCM	cis	rs1577917	0.837	rs806529	chr6:86467121	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.78	-7.41	-0.64	1.3100000000000001e-10	Response to antipsychotic treatment;
SKCM	cis	rs854765	0.693	rs8080061	chr17:17776389	C/T	cg04398451	chr17:18023971	MYO15A	0.89	6.71	0.61	2.75e-9	Total body bone mineral density;
SKCM	cis	rs4905558	1.000	rs12882853	chr14:97330150	T/C	cg11863609	chr14:97355128	NA	-0.54	-4.81	-0.48	7.11e-6	Neutrophil count;
SKCM	cis	rs17376456	0.542	rs10070350	chr5:93103753	C/G	cg25358565	chr5:93447407	FAM172A	0.86	5.45	0.53	5.59e-7	Diabetic retinopathy;
SKCM	cis	rs2032447	0.802	rs198853	chr6:26104096	T/C	cg18357526	chr6:26021779	HIST1H4A	-0.82	-7.02	-0.62	7.19e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs503341	0.756	rs612010	chr11:63591005	G/A	cg04362095	chr11:63592001	C11orf84	-0.82	-9.64	-0.74	6.15e-15	Pulse pressure;
SKCM	cis	rs3087591	0.762	rs7502029	chr17:29590791	T/A	cg24425628	chr17:29625626	OMG;NF1	0.64	4.97	0.49	3.95e-6	Hip circumference;
SKCM	cis	rs3091242	1.000	rs646867	chr1:25709258	A/C	cg27572855	chr1:25598939	RHD	0.54	5.17	0.5	1.79e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs6840360	0.533	rs1397683	chr4:152715916	T/C	cg22705602	chr4:152727874	NA	0.59	7.76	0.66	2.74e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs4423214	0.840	rs4435028	chr11:71183690	C/A	cg05163923	chr11:71159392	DHCR7	-0.71	-6.07	-0.57	4.35e-8	Vitamin D levels;
SKCM	cis	rs6598955	0.724	rs12096059	chr1:26596709	G/A	cg00938395	chr1:26633206	UBXN11	0.7	4.92	0.49	4.63e-6	Obesity-related traits;
SKCM	cis	rs798554	0.679	rs1614791	chr7:2888057	G/T	cg19346786	chr7:2764209	NA	-0.65	-6.79	-0.61	1.96e-9	Height;
SKCM	cis	rs7618915	0.621	rs6788993	chr3:52605136	T/C	cg18404041	chr3:52824283	ITIH1	-0.53	-4.77	-0.48	8.42e-6	Bipolar disorder;
SKCM	cis	rs116095464	0.764	rs28710899	chr5:241029	G/A	cg22857025	chr5:266934	NA	-1.38	-6.49	-0.59	7.12e-9	Breast cancer;
SKCM	cis	rs854765	0.964	rs854813	chr17:18003845	C/T	cg04398451	chr17:18023971	MYO15A	0.62	4.85	0.48	6.29e-6	Total body bone mineral density;
SKCM	cis	rs11098499	0.697	rs10016448	chr4:120298845	A/G	cg24375607	chr4:120327624	NA	0.65	4.97	0.49	3.87e-6	Corneal astigmatism;
SKCM	cis	rs854765	0.583	rs9890341	chr17:17823175	G/C	cg04398451	chr17:18023971	MYO15A	-0.85	-6.05	-0.57	4.75e-8	Total body bone mineral density;
SKCM	cis	rs7772486	0.754	rs702324	chr6:146008793	A/G	cg05347473	chr6:146136440	FBXO30	-0.69	-6.37	-0.59	1.2e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7666738	0.791	rs13128640	chr4:99003918	A/C	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9910055	0.659	rs8079310	chr17:42270291	A/G	cg19774624	chr17:42201019	HDAC5	-0.84	-7.56	-0.65	6.71e-11	Total body bone mineral density;
SKCM	cis	rs7811142	1.000	rs6962151	chr7:100028484	T/C	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.34	0.69	2.1e-12	Platelet count;
SKCM	cis	rs1005277	0.522	rs289648	chr10:37971837	T/C	cg00409905	chr10:38381863	ZNF37A	-0.58	-5.75	-0.55	1.64e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs672059	1.000	rs510642	chr1:183162776	A/C	ch.1.3577855R	chr1:183094577	LAMC1	0.65	5.56	0.53	3.69e-7	Hypertriglyceridemia;
SKCM	cis	rs7829975	0.535	rs4841005	chr8:8501230	A/G	cg15556689	chr8:8085844	FLJ10661	-0.66	-5.45	-0.53	5.62e-7	Mood instability;
SKCM	cis	rs10492096	1.000	rs10849462	chr12:6575992	C/T	cg07142400	chr12:6602447	NCAPD2;MRPL51	-0.74	-4.8	-0.48	7.42e-6	Hip geometry;
SKCM	cis	rs933688	1.000	rs2367353	chr5:90686568	G/C	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.05	8.45	0.69	1.26e-12	Smoking behavior;
SKCM	cis	rs3096299	0.692	rs4785565	chr16:89515759	T/C	cg02187348	chr16:89574699	SPG7	0.56	4.78	0.48	8.19e-6	Multiple myeloma (IgH translocation);
SKCM	cis	rs1639906	0.965	rs1639908	chr7:2230644	C/G	cg02951883	chr7:2050386	MAD1L1	0.61	4.91	0.49	5e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs13118159	1.000	rs13118159	chr4:1365127	A/G	cg02018176	chr4:1364513	KIAA1530	0.68	5.28	0.51	1.14e-6	Longevity;
SKCM	cis	rs4423214	0.879	rs1792277	chr11:71138918	C/T	cg05163923	chr11:71159392	DHCR7	-0.67	-6.0	-0.56	5.84e-8	Vitamin D levels;
SKCM	cis	rs151997	0.962	rs152687	chr5:50208563	A/G	cg06027927	chr5:50259733	NA	0.66	5.78	0.55	1.45e-7	Callous-unemotional behaviour;
SKCM	cis	rs1577917	0.681	rs4707211	chr6:86232710	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.64	5.42	0.52	6.36e-7	Response to antipsychotic treatment;
SKCM	cis	rs11098499	0.644	rs6855918	chr4:120546299	C/T	cg09307838	chr4:120376055	NA	0.94	7.77	0.66	2.64e-11	Corneal astigmatism;
SKCM	cis	rs6459804	1.000	rs6459806	chr7:157510483	C/G	cg27240775	chr7:156793224	NA	-0.71	-5.29	-0.51	1.07e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs2739330	0.796	rs5760106	chr22:24250645	A/C	cg04234412	chr22:24373322	LOC391322	0.59	4.9	0.48	5.19e-6	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs12477438	0.520	rs11685759	chr2:99766217	T/C	cg26064155	chr2:99771622	LIPT1;TSGA10	1.05	10.1	0.75	7.95e-16	Chronic sinus infection;
SKCM	cis	rs34779708	0.931	rs11010125	chr10:35502953	A/G	cg03585969	chr10:35415529	CREM	0.78	6.28	0.58	1.75e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs7937682	0.883	rs631490	chr11:111452040	G/C	cg09085632	chr11:111637200	PPP2R1B	-1.02	-10.33	-0.76	2.93e-16	Primary sclerosing cholangitis;
SKCM	cis	rs1405130	0.869	rs13016360	chr2:235572104	A/G	cg21542780	chr2:234763377	HJURP	-0.64	-4.89	-0.48	5.21e-6	Coronary artery disease;
SKCM	cis	rs995000	0.965	rs10889353	chr1:63118196	A/C	cg06896770	chr1:63153194	DOCK7	0.93	9.04	0.72	8.97e-14	Triglyceride levels;
SKCM	cis	rs55962025	0.883	rs3755883	chr4:3223250	A/G	cg09735869	chr4:3319127	RGS12	-0.71	-5.24	-0.51	1.32e-6	Parental longevity (mother's age at death);
SKCM	cis	rs2204008	0.617	rs11831608	chr12:38210687	C/T	cg26384229	chr12:38710491	ALG10B	-0.68	-5.41	-0.52	6.64e-7	Bladder cancer;
SKCM	cis	rs1325195	0.537	rs1325194	chr1:179071918	G/T	cg10806749	chr1:179558114	NA	-0.58	-5.06	-0.5	2.73e-6	IgE grass sensitization;
SKCM	cis	rs1577917	0.958	rs72907388	chr6:86440207	C/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.95	-9.86	-0.74	2.39e-15	Response to antipsychotic treatment;
SKCM	cis	rs798554	0.757	rs1182185	chr7:2872233	A/G	cg04166393	chr7:2884313	GNA12	0.68	4.85	0.48	6.16e-6	Height;
SKCM	cis	rs7772486	0.790	rs9376971	chr6:146259505	C/T	cg23711669	chr6:146136114	FBXO30	-0.77	-7.44	-0.64	1.14e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs769267	0.859	rs2916076	chr19:19545990	T/C	cg03709012	chr19:19516395	GATAD2A	0.9	8.7	0.7	4.14e-13	Tonsillectomy;
SKCM	cis	rs1799949	1.000	rs8176318	chr17:41197274	G/T	cg05368731	chr17:41323189	NBR1	0.9	7.94	0.67	1.23e-11	Menopause (age at onset);
SKCM	cis	rs3820068	0.603	rs59558854	chr1:15971399	T/G	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs10504229	0.683	rs2873638	chr8:58114593	G/A	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	trans	rs11722228	0.522	rs73212808	chr4:10055439	G/C	cg26043149	chr18:55253948	FECH	0.87	7.9	0.67	1.48e-11	Gout;Urate levels;Serum uric acid levels;
SKCM	cis	rs1348850	0.526	rs59972556	chr2:178399561	A/G	cg02961200	chr2:178257176	LOC100130691;AGPS	0.83	4.86	0.48	5.99e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs2658782	0.547	rs3020065	chr11:93059899	A/G	cg15737290	chr11:93063684	CCDC67	1.0	9.41	0.73	1.76e-14	Pulmonary function decline;
SKCM	cis	rs2239547	0.603	rs6805298	chr3:53096552	A/G	cg11645453	chr3:52864694	ITIH4	-0.62	-5.05	-0.5	2.86e-6	Schizophrenia;
SKCM	cis	rs36093844	0.706	rs17817230	chr11:85554057	A/G	cg25872744	chr11:85566296	CCDC83	-0.85	-4.77	-0.48	8.27e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs7666738	0.753	rs35194639	chr4:99053819	G/C	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9896933	0.667	rs2253131	chr17:80696547	T/A	cg20578329	chr17:80767326	TBCD	-0.91	-6.7	-0.6	2.89e-9	Bone mineral accretion in asthma (oral corticosteroid dose interaction);
SKCM	cis	rs2032447	0.966	rs9358901	chr6:26024436	G/T	cg18357526	chr6:26021779	HIST1H4A	0.83	7.32	0.64	1.97e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs9311474	0.607	rs11711421	chr3:52561779	C/T	cg18404041	chr3:52824283	ITIH1	-0.55	-4.98	-0.49	3.8e-6	Electroencephalogram traits;
SKCM	cis	rs478304	0.593	rs9666878	chr11:65475816	A/C	cg27068330	chr11:65405492	SIPA1	0.86	7.43	0.64	1.21e-10	Acne (severe);
SKCM	cis	rs12709013	0.686	rs244919	chr16:58738050	A/G	cg02431531	chr16:59244939	NA	-0.49	-5.03	-0.49	3.08e-6	Blood metabolite ratios;
SKCM	cis	rs910316	1.000	rs4903281	chr14:75554361	G/C	cg08847533	chr14:75593920	NEK9	0.95	9.18	0.72	4.88e-14	Height;
SKCM	cis	rs1185460	0.967	rs4454730	chr11:118937444	G/A	cg23280166	chr11:118938394	VPS11	0.59	5.41	0.52	6.78e-7	Coronary artery disease;
SKCM	cis	rs1577917	0.958	rs11756615	chr6:86679835	G/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.65	-5.59	-0.54	3.16e-7	Response to antipsychotic treatment;
SKCM	cis	rs727563	0.593	rs5758461	chr22:42162189	G/C	cg03806693	chr22:41940476	POLR3H	1.17	6.7	0.6	2.92e-9	Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs8067545	0.611	rs2703786	chr17:20156369	T/C	cg13482628	chr17:19912719	NA	-0.65	-5.44	-0.52	5.84e-7	Schizophrenia;
SKCM	cis	rs611744	0.647	rs2594357	chr8:109255989	A/G	cg18478394	chr8:109455254	TTC35	0.71	5.65	0.54	2.47e-7	Dupuytren's disease;
SKCM	cis	rs3820928	0.874	rs10933165	chr2:227883648	C/G	cg11843606	chr2:227700838	RHBDD1	0.69	5.83	0.55	1.2e-7	Pulmonary function;
SKCM	cis	rs7680126	0.596	rs17198547	chr4:10141419	A/G	cg09374173	chr4:9383942	NA	-0.7	-4.91	-0.49	4.93e-6	Urate levels in lean individuals;Urate levels in overweight individuals;Urate levels in obese individuals;
SKCM	cis	rs875971	0.660	rs801193	chr7:66030612	A/C	cg11764359	chr7:65958608	NA	-0.81	-6.2	-0.57	2.51e-8	Aortic root size;
SKCM	cis	rs763121	0.853	rs10135	chr22:39082174	C/T	cg06022373	chr22:39101656	GTPBP1	-0.88	-6.33	-0.58	1.46e-8	Menopause (age at onset);
SKCM	trans	rs12599106	0.624	rs56403495	chr16:34450108	A/T	cg15383120	chr6:291909	DUSP22	-0.83	-8.04	-0.67	7.71e-12	Menopause (age at onset);
SKCM	cis	rs28595532	0.841	rs10019311	chr4:119785458	G/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs10911232	0.524	rs10911229	chr1:183050368	C/G	ch.1.3577855R	chr1:183094577	LAMC1	0.78	6.87	0.61	1.42e-9	Hypertriglyceridemia;
SKCM	cis	rs35146811	0.735	rs2528900	chr7:99805319	A/G	cg22906224	chr7:99728672	NA	-0.65	-5.19	-0.51	1.6e-6	Coronary artery disease;
SKCM	cis	rs13108904	0.846	rs3775100	chr4:1225106	T/C	cg02018176	chr4:1364513	KIAA1530	0.61	5.02	0.49	3.13e-6	Obesity-related traits;
SKCM	cis	rs2836974	0.831	rs34592564	chr21:40516288	G/C	cg11890956	chr21:40555474	PSMG1	1.1	13.26	0.83	1.1e-21	Cognitive function;
SKCM	cis	rs9815354	0.812	rs73077358	chr3:41850005	C/T	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs6942756	1.000	rs67853067	chr7:128862327	G/A	cg02491457	chr7:128862824	NA	-0.74	-4.93	-0.49	4.47e-6	White matter hyperintensity burden;
SKCM	cis	rs7772486	0.790	rs6917482	chr6:146243581	C/T	cg05347473	chr6:146136440	FBXO30	-0.55	-4.88	-0.48	5.48e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9911578	0.967	rs686425	chr17:56776730	A/G	cg05425664	chr17:57184151	TRIM37	-0.69	-5.21	-0.51	1.52e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2760061	0.655	rs686533	chr1:228119604	A/G	cg02753203	chr1:228287806	NA	-0.62	-4.86	-0.48	5.89e-6	Diastolic blood pressure;
SKCM	cis	rs929354	0.713	rs10085650	chr7:156993413	T/C	cg17757837	chr7:157058334	UBE3C	0.81	5.64	0.54	2.57e-7	Body mass index;
SKCM	cis	rs992157	0.687	rs10206984	chr2:219066980	C/T	cg00012203	chr2:219082015	ARPC2	0.84	7.36	0.64	1.6e-10	Colorectal cancer;
SKCM	cis	rs36093844	0.642	rs7108491	chr11:85612839	G/A	cg02149136	chr11:85995039	NA	-0.64	-5.2	-0.51	1.58e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs7659604	0.502	rs4516738	chr4:122669177	T/C	cg19671926	chr4:122722719	EXOSC9	0.74	5.88	0.55	9.73e-8	Type 2 diabetes;
SKCM	cis	rs1580019	0.587	rs7805311	chr7:32558302	A/G	cg06627557	chr7:32535165	LSM5;AVL9	-0.94	-9.12	-0.72	6.39e-14	Cognitive ability;
SKCM	cis	rs6582630	0.555	rs1906260	chr12:38601013	T/G	cg26384229	chr12:38710491	ALG10B	0.81	6.79	0.61	1.94e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs12464559	0.522	rs13016166	chr2:152624144	G/A	cg01189475	chr2:152685088	ARL5A	1.06	5.28	0.51	1.14e-6	Response to cognitive-behavioural therapy in anxiety disorder;
SKCM	cis	rs10860964	0.605	rs7976163	chr12:103563123	A/G	cg20635409	chr12:103359273	NA	-0.56	-4.94	-0.49	4.35e-6	Schizophrenia;
SKCM	cis	rs9921192	1.000	rs251736	chr16:4318455	A/G	cg00021532	chr16:4324280	TFAP4	0.91	8.56	0.7	7.82e-13	Prostate-specific antigen levels;
SKCM	cis	rs2032447	0.714	rs199726	chr6:25953360	G/A	cg18357526	chr6:26021779	HIST1H4A	0.69	5.33	0.52	9.32e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7666738	0.830	rs10021709	chr4:99030587	G/A	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4975616	0.869	rs452384	chr5:1330840	T/C	cg26373071	chr5:1325741	CLPTM1L	0.74	6.91	0.62	1.18e-9	Lung cancer;
SKCM	cis	rs9303401	0.614	rs35057477	chr17:57097064	G/A	cg10487724	chr17:56770010	TEX14;RAD51C	0.79	4.97	0.49	3.86e-6	Cognitive test performance;
SKCM	cis	rs1005277	0.691	rs2474558	chr10:38486141	A/C	cg00409905	chr10:38381863	ZNF37A	0.64	5.2	0.51	1.56e-6	Extrinsic epigenetic age acceleration;
SKCM	cis	rs1799949	0.965	rs11656945	chr17:41330265	A/G	cg05368731	chr17:41323189	NBR1	0.87	7.74	0.66	3.01e-11	Menopause (age at onset);
SKCM	cis	rs3847687	1.000	rs3847688	chr12:131525310	C/T	cg25772418	chr12:131519998	GPR133	-0.5	-5.05	-0.5	2.81e-6	Longevity;
SKCM	cis	rs2072499	0.750	rs55910626	chr1:156159909	C/G	cg24450063	chr1:156163899	SLC25A44	0.88	6.55	0.6	5.55e-9	Testicular germ cell tumor;
SKCM	cis	rs801193	0.935	rs2659916	chr7:66151352	C/G	cg18876405	chr7:65276391	NA	0.8	7.11	0.63	4.86e-10	Aortic root size;
SKCM	cis	rs10870270	1.000	rs4880263	chr10:133787629	C/T	cg17892150	chr10:133769511	PPP2R2D	-0.69	-4.84	-0.48	6.52e-6	Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals;
SKCM	cis	rs7106204	0.748	rs11027755	chr11:24203857	C/T	ch.11.24196551F	chr11:24239977	NA	0.83	6.17	0.57	2.83e-8	Response to Homoharringtonine (cytotoxicity);
SKCM	cis	rs11945232	1.000	rs11945232	chr4:88342369	A/G	cg23841344	chr4:88312519	HSD17B11	-0.66	-4.93	-0.49	4.48e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs6545883	0.931	rs7557230	chr2:61736652	A/T	cg15711740	chr2:61764176	XPO1	-0.71	-4.91	-0.49	4.9e-6	Tuberculosis;
SKCM	cis	rs4689592	0.523	rs3857179	chr4:7070496	T/A	cg26116260	chr4:7069785	GRPEL1	1.22	9.95	0.75	1.56e-15	Monocyte percentage of white cells;
SKCM	trans	rs7618501	1.000	rs9872864	chr3:49792023	A/G	cg21659725	chr3:3221576	CRBN	-0.96	-9.61	-0.74	7.08e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs6582630	0.519	rs11514056	chr12:38284001	G/T	cg13010199	chr12:38710504	ALG10B	0.66	4.8	0.48	7.64e-6	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs11700980	0.636	rs115245768	chr21:30256118	T/G	cg24692254	chr21:30365293	RNF160	-0.89	-5.17	-0.51	1.73e-6	QRS complex (12-leadsum);
SKCM	cis	rs11098499	0.820	rs11737395	chr4:120520704	C/G	cg09307838	chr4:120376055	NA	1.0	8.16	0.68	4.57e-12	Corneal astigmatism;
SKCM	cis	rs2559856	1.000	rs2559857	chr12:102089399	A/C	cg12924262	chr12:102091054	CHPT1	0.69	5.85	0.55	1.08e-7	Blood protein levels;
SKCM	cis	rs796364	1.000	rs281785	chr2:200749566	A/G	cg12253985	chr2:200820533	C2orf60;C2orf47	0.85	5.39	0.52	7.18e-7	Schizophrenia;
SKCM	cis	rs854765	0.693	rs35451946	chr17:17764061	C/G	cg04398451	chr17:18023971	MYO15A	0.92	6.67	0.6	3.3e-9	Total body bone mineral density;
SKCM	cis	rs1957429	0.731	rs10144554	chr14:65321514	T/G	cg23373153	chr14:65346875	NA	1.07	5.91	0.56	8.58e-8	Pediatric areal bone mineral density (radius);
SKCM	cis	rs1912528	0.963	rs67600240	chr4:140932086	G/A	cg11128457	chr4:140864437	MAML3	0.58	4.84	0.48	6.41e-6	Educational attainment (years of education);
SKCM	cis	rs2072499	0.554	rs1052067	chr1:156206121	C/T	cg25208724	chr1:156163844	SLC25A44	0.68	5.49	0.53	4.86e-7	Testicular germ cell tumor;
SKCM	cis	rs6545883	0.929	rs1900572	chr2:61650715	T/G	cg15711740	chr2:61764176	XPO1	0.7	4.93	0.49	4.5e-6	Tuberculosis;
SKCM	cis	rs28595532	0.546	rs17516389	chr4:119239267	T/C	cg14228332	chr4:119757509	SEC24D	1.0	5.57	0.53	3.51e-7	Cannabis dependence symptom count;
SKCM	cis	rs7666738	0.830	rs7663661	chr4:99014761	A/G	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1799949	1.000	rs11652332	chr17:41295489	G/A	cg23758822	chr17:41437982	NA	0.92	7.8	0.66	2.3e-11	Menopause (age at onset);
SKCM	cis	rs28595532	0.920	rs115860303	chr4:119734526	T/C	cg21605333	chr4:119757512	SEC24D	1.36	8.05	0.67	7.69e-12	Cannabis dependence symptom count;
SKCM	trans	rs17685	0.671	rs10274404	chr7:75706634	G/A	cg19862616	chr7:65841803	NCRNA00174	0.94	9.45	0.73	1.46e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs585510	1	rs585510	chr12:121000133	A/G	cg12219531	chr12:120966889	COQ5	0.89	7.53	0.65	7.52e-11	Reticulocyte fraction of red cells;
SKCM	cis	rs738321	0.701	rs4821754	chr22:38581503	A/G	cg25457927	chr22:38595422	NA	0.67	8.83	0.71	2.29e-13	Breast cancer;
SKCM	cis	rs2228479	0.850	rs62056102	chr16:89941438	T/C	cg00800038	chr16:89945340	TCF25	-0.96	-5.44	-0.52	5.85e-7	Skin colour saturation;
SKCM	cis	rs870825	0.932	rs28702958	chr4:185575562	C/T	cg04058563	chr4:185651563	MLF1IP	1.03	5.09	0.5	2.4e-6	Blood protein levels;
SKCM	cis	rs606458	0.841	rs674297	chr11:64549514	C/T	cg07674570	chr11:65346152	EHBP1L1	0.68	4.89	0.48	5.2e-6	Urate levels;
SKCM	cis	rs2839186	0.934	rs13049797	chr21:47707582	T/C	cg13126279	chr21:47581558	C21orf56	-0.64	-5.47	-0.53	5.17e-7	Testicular germ cell tumor;
SKCM	cis	rs1325195	0.537	rs2793808	chr1:179170249	T/C	cg10806749	chr1:179558114	NA	0.55	4.84	0.48	6.32e-6	IgE grass sensitization;
SKCM	cis	rs6545883	0.929	rs1186710	chr2:61688727	T/A	cg15711740	chr2:61764176	XPO1	-0.69	-4.98	-0.49	3.75e-6	Tuberculosis;
SKCM	cis	rs7659604	0.676	rs4077102	chr4:122699830	A/G	cg19748678	chr4:122722346	EXOSC9	0.69	5.66	0.54	2.42e-7	Type 2 diabetes;
SKCM	cis	rs4237845	0.537	rs11172367	chr12:58272486	T/G	cg02175503	chr12:58329896	NA	0.7	5.82	0.55	1.24e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs523522	0.962	rs11065145	chr12:120947419	A/G	cg12219531	chr12:120966889	COQ5	0.91	7.82	0.66	2.11e-11	High light scatter reticulocyte count;
SKCM	cis	rs12044355	0.858	rs1538975	chr1:231828372	C/T	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	0.89	6.96	0.62	9.23e-10	Alzheimer's disease;
SKCM	cis	rs6582630	0.502	rs1115515	chr12:38279830	C/T	cg13010199	chr12:38710504	ALG10B	0.69	4.92	0.49	4.72e-6	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs6570726	0.577	rs9497315	chr6:145791967	C/T	cg23711669	chr6:146136114	FBXO30	-0.71	-5.73	-0.54	1.81e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1355223	0.583	rs2941058	chr11:34880245	C/G	cg11058730	chr11:34937778	PDHX;APIP	0.63	5.04	0.5	2.9e-6	Systemic lupus erythematosus and Systemic sclerosis;
SKCM	cis	rs2370759	1.000	rs79578760	chr10:32611264	C/A	cg01819863	chr10:32635814	EPC1	1.04	5.71	0.54	1.93e-7	Sexual dysfunction (female);
SKCM	cis	rs6565180	0.632	rs8050812	chr16:30385837	C/T	cg17640201	chr16:30407289	ZNF48	-0.77	-4.96	-0.49	3.99e-6	Tonsillectomy;
SKCM	cis	rs2228479	0.717	rs1800358	chr16:89809319	T/C	cg00800038	chr16:89945340	TCF25	-0.85	-4.99	-0.49	3.65e-6	Skin colour saturation;
SKCM	cis	rs514406	0.767	rs551591	chr1:53301876	A/G	cg08859206	chr1:53392774	SCP2	-0.64	-5.03	-0.5	3.04e-6	Monocyte count;
SKCM	cis	rs60871478	0.853	rs62432222	chr7:787194	T/C	cg05535760	chr7:792225	HEATR2	1.15	9.71	0.74	4.47e-15	Cerebrospinal P-tau181p levels;
SKCM	cis	rs17685	0.753	rs6465000	chr7:75787417	G/A	cg01364799	chr7:75623366	TMEM120A	-0.69	-5.59	-0.53	3.22e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2836950	0.501	rs2056844	chr21:40670460	G/C	cg11890956	chr21:40555474	PSMG1	-0.66	-5.26	-0.51	1.22e-6	Menarche (age at onset);
SKCM	cis	rs34779708	0.931	rs10508815	chr10:35332621	A/C	cg03585969	chr10:35415529	CREM	0.73	6.02	0.56	5.27e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs2836974	0.897	rs13339986	chr21:40605982	T/C	cg17971929	chr21:40555470	PSMG1	0.9	8.76	0.7	3.13e-13	Cognitive function;
SKCM	cis	rs1005277	0.579	rs1621040	chr10:38497232	T/C	cg00409905	chr10:38381863	ZNF37A	-0.64	-6.22	-0.58	2.26e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs4819052	1.000	rs13047688	chr21:46669290	G/A	cg20896738	chr21:46707857	POFUT2;LOC642852	0.74	5.34	0.52	9.02e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs854765	0.583	rs8065970	chr17:17858771	A/G	cg04398451	chr17:18023971	MYO15A	-0.86	-5.91	-0.56	8.41e-8	Total body bone mineral density;
SKCM	trans	rs17685	0.712	rs4552844	chr7:75718095	A/G	cg19862616	chr7:65841803	NCRNA00174	0.94	9.45	0.73	1.46e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2180341	1.000	rs4897207	chr6:127605898	C/T	cg24812749	chr6:127587940	RNF146	0.87	7.33	0.64	1.85e-10	Breast cancer;
SKCM	cis	rs9916302	0.861	rs3889368	chr17:37683231	C/T	cg07936489	chr17:37558343	FBXL20	-0.91	-8.19	-0.68	4e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs4234284	1.000	rs58726206	chr3:126976898	T/C	cg04889221	chr3:126137216	CCDC37	-0.49	-5.08	-0.5	2.51e-6	Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel);
SKCM	cis	rs7214628	1	rs7214628	chr17:73882148	A/G	cg10935138	chr17:73851978	WBP2	1.13	6.37	0.59	1.19e-8	White matter hyperintensity burden;
SKCM	cis	rs9581857	0.547	rs9581882	chr13:28110682	C/G	cg22138327	chr13:27999177	GTF3A	0.88	5.77	0.55	1.5e-7	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs28595532	0.920	rs116612909	chr4:119749823	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs2050392	1.000	rs2250714	chr10:30697396	G/C	cg25182066	chr10:30743637	MAP3K8	-0.71	-5.96	-0.56	6.91e-8	Inflammatory bowel disease;
SKCM	cis	rs7811142	0.779	rs77370288	chr7:99947897	A/T	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.07	6.7	0.6	2.88e-9	Platelet count;
SKCM	cis	rs6088590	0.561	rs3891369	chr20:33161127	C/T	cg24642439	chr20:33292090	TP53INP2	0.76	5.84	0.55	1.13e-7	Coronary artery disease;
SKCM	cis	rs6879260	1.000	rs7730585	chr5:179733440	T/C	cg23248424	chr5:179741104	GFPT2	-0.75	-5.92	-0.56	8.17e-8	Height;
SKCM	cis	rs7635838	0.684	rs2594965	chr3:11323799	G/C	cg00170343	chr3:11313890	ATG7	0.73	5.55	0.53	3.74e-7	HDL cholesterol;
SKCM	cis	rs4803468	0.967	rs16975238	chr19:41944985	T/A	cg09537434	chr19:41945824	ATP5SL	1.1	13.21	0.83	1.39e-21	Height;
SKCM	cis	rs1577917	0.958	rs1838955	chr6:86565449	T/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.81	-7.82	-0.66	2.07e-11	Response to antipsychotic treatment;
SKCM	cis	rs12464559	0.522	rs4316939	chr2:152525120	C/T	cg01189475	chr2:152685088	ARL5A	-0.92	-4.78	-0.48	7.99e-6	Response to cognitive-behavioural therapy in anxiety disorder;
SKCM	cis	rs10089	0.953	rs72794400	chr5:127516028	C/G	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.87	7.37	0.64	1.58e-10	Ileal carcinoids;
SKCM	cis	rs1797081	1.000	rs812426	chr10:16857133	C/G	cg23933602	chr10:16859644	RSU1	1.04	15.83	0.87	4.49e-26	Platelet distribution width;
SKCM	cis	rs9788682	0.747	rs3743078	chr15:78894759	C/G	cg24631222	chr15:78858424	CHRNA5	-0.87	-6.04	-0.56	4.98e-8	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs1707322	0.721	rs10890337	chr1:46124527	C/T	cg03146154	chr1:46216737	IPP	0.82	6.1	0.57	3.89e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs899997	0.906	rs1809415	chr15:79028201	C/T	cg04896959	chr15:78267971	NA	-0.6	-4.87	-0.48	5.83e-6	Coronary artery disease or large artery stroke;
SKCM	cis	rs1348850	1.000	rs3927978	chr2:178443854	A/G	cg02961200	chr2:178257176	LOC100130691;AGPS	-0.78	-6.01	-0.56	5.57e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs4481887	0.741	rs6682957	chr1:248535639	T/G	cg00666640	chr1:248458726	OR2T12	0.49	5.16	0.5	1.84e-6	Common traits (Other);
SKCM	cis	rs2013441	0.613	rs888424	chr17:19985427	C/T	cg13482628	chr17:19912719	NA	0.75	5.95	0.56	7.26e-8	Obesity-related traits;
SKCM	cis	rs1506636	1.000	rs10225428	chr7:123357646	A/G	cg03229431	chr7:123269106	ASB15	-0.6	-4.83	-0.48	6.69e-6	Plateletcrit;Platelet count;
SKCM	cis	rs7811142	1.000	rs11763511	chr7:100081944	G/A	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.14	6.58	0.6	4.83e-9	Platelet count;
SKCM	cis	rs1957429	1.000	rs1957429	chr14:65354033	C/T	cg23373153	chr14:65346875	NA	1.03	6.23	0.58	2.18e-8	Pediatric areal bone mineral density (radius);
SKCM	trans	rs561341	1.000	rs498391	chr17:30328704	G/A	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs4242434	0.889	rs11783129	chr8:22453426	G/A	cg03733263	chr8:22462867	KIAA1967	1.05	9.19	0.72	4.52e-14	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs6866344	0.570	rs11740283	chr5:178136440	T/C	cg10224037	chr5:178157518	ZNF354A	0.84	6.3	0.58	1.65e-8	Neutrophil percentage of white cells;
SKCM	cis	rs4975616	0.686	rs37008	chr5:1351538	C/T	cg06550200	chr5:1325588	CLPTM1L	-0.67	-5.37	-0.52	7.82e-7	Lung cancer;
SKCM	cis	rs7811142	0.830	rs76798830	chr7:99952828	C/T	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.07	6.7	0.6	2.88e-9	Platelet count;
SKCM	cis	rs1348850	0.632	rs13009207	chr2:178501632	A/G	cg22681709	chr2:178499509	PDE11A	-0.56	-4.91	-0.49	4.99e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs7208859	0.623	rs609063	chr17:28951513	A/G	cg14067834	chr17:29058358	SUZ12P	1.08	4.95	0.49	4.21e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs2243480	1.000	rs160633	chr7:65528228	T/C	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs12611334	1.000	rs17709242	chr19:40181873	T/A	cg04998674	chr19:40596855	ZNF780A	0.63	4.77	0.47	8.55e-6	Schizophrenia;
SKCM	cis	rs11673344	0.730	rs826314	chr19:37450435	C/T	cg07624650	chr19:37064219	ZNF529	-0.78	-4.82	-0.48	7.05e-6	Obesity-related traits;
SKCM	cis	rs7843479	0.562	rs4872191	chr8:21824547	A/G	cg17168535	chr8:21777572	XPO7	0.8	7.3	0.64	2.15e-10	Mean corpuscular volume;
SKCM	cis	rs6582630	0.593	rs11182590	chr12:38574274	A/T	cg26384229	chr12:38710491	ALG10B	0.66	5.62	0.54	2.79e-7	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs9818758	0.607	rs66991555	chr3:49228643	A/G	cg00383909	chr3:49044727	WDR6	0.94	5.35	0.52	8.49e-7	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs17376456	0.825	rs12716454	chr5:93272279	A/C	cg21475434	chr5:93447410	FAM172A	1.02	5.17	0.51	1.74e-6	Diabetic retinopathy;
SKCM	cis	rs6121246	0.909	rs7354225	chr20:30296881	C/T	cg11595048	chr20:30225325	COX4I2	0.67	5.21	0.51	1.5e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs7980687	0.627	rs1727325	chr12:123698332	G/C	cg00376283	chr12:123451042	ABCB9	0.83	5.49	0.53	4.74e-7	Height;Educational attainment;Head circumference (infant);
SKCM	cis	rs642803	1.000	rs642803	chr11:65560620	C/T	cg27068330	chr11:65405492	SIPA1	0.75	5.14	0.5	2e-6	Urate levels;
SKCM	cis	rs7937682	0.883	rs529529	chr11:111461128	C/T	cg09085632	chr11:111637200	PPP2R1B	-1.0	-8.75	-0.7	3.35e-13	Primary sclerosing cholangitis;
SKCM	cis	rs7772486	0.754	rs4896832	chr6:145964151	G/A	cg23711669	chr6:146136114	FBXO30	0.88	9.43	0.73	1.6e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs12706411	1.000	rs71573096	chr7:122049844	C/T	cg17986181	chr7:121955208	NA	-0.7	-5.19	-0.51	1.65e-6	Alzheimer disease and age of onset;
SKCM	cis	rs6545883	0.507	rs2123111	chr2:61450454	A/G	cg15711740	chr2:61764176	XPO1	0.64	4.89	0.48	5.33e-6	Tuberculosis;
SKCM	cis	rs7959452	0.649	rs4761239	chr12:69776886	T/A	cg14784868	chr12:69753453	YEATS4	0.78	7.39	0.64	1.43e-10	Blood protein levels;
SKCM	cis	rs17685	0.753	rs10264760	chr7:75749694	A/G	cg16489192	chr7:75678113	MDH2;STYXL1	-0.57	-5.35	-0.52	8.63e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7811142	1.000	rs7794485	chr7:100068936	T/C	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.12	6.51	0.59	6.68e-9	Platelet count;
SKCM	cis	rs12602172	1	rs12602172	chr17:38163567	G/A	cg17467752	chr17:38218738	THRA	0.68	6.3	0.58	1.61e-8	Neutrophil percentage of white cells;Granulocyte percentage of myeloid white cells;
SKCM	cis	rs10504229	0.953	rs66815941	chr8:58187306	C/T	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs151997	0.925	rs26090	chr5:50170071	C/T	cg06027927	chr5:50259733	NA	-0.59	-5.03	-0.5	3.04e-6	Callous-unemotional behaviour;
SKCM	cis	rs854765	0.647	rs854791	chr17:18029857	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.86	6.02	0.56	5.29e-8	Total body bone mineral density;
SKCM	cis	rs1005277	0.522	rs9417256	chr10:37976990	A/G	cg00409905	chr10:38381863	ZNF37A	-0.58	-5.76	-0.55	1.61e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs6951245	1.000	rs77760339	chr7:1083927	G/T	cg03188948	chr7:1209495	NA	1.12	6.25	0.58	2.02e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs28595532	0.920	rs116108618	chr4:119763585	C/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs9325144	0.560	rs7980358	chr12:38640396	C/G	cg26384229	chr12:38710491	ALG10B	0.68	5.43	0.52	6.19e-7	Morning vs. evening chronotype;
SKCM	cis	rs1577917	0.883	rs13212415	chr6:86608083	A/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.67	-5.86	-0.55	1.07e-7	Response to antipsychotic treatment;
SKCM	cis	rs854765	0.583	rs4553680	chr17:17857722	A/G	cg09796270	chr17:17721594	SREBF1	0.65	4.87	0.48	5.79e-6	Total body bone mineral density;
SKCM	cis	rs2180341	0.883	rs7760748	chr6:127690062	C/T	cg24812749	chr6:127587940	RNF146	0.83	7.18	0.63	3.63e-10	Breast cancer;
SKCM	cis	rs8037137	0.915	rs79253100	chr15:91551876	C/T	cg15878949	chr15:91534302	PRC1	0.67	5.12	0.5	2.11e-6	Platelet count;Serous invasive ovarian cancer;High-grade serous ovarian cancer;Invasive epithelial ovarian cancer;
SKCM	cis	rs9790314	0.846	rs1478568	chr3:161014276	C/T	cg03342759	chr3:160939853	NMD3	-0.72	-7.96	-0.67	1.13e-11	Morning vs. evening chronotype;
SKCM	cis	rs7959452	0.640	rs12370042	chr12:69692420	C/G	cg20891283	chr12:69753455	YEATS4	0.76	6.95	0.62	9.76e-10	Blood protein levels;
SKCM	cis	rs28595532	0.688	rs116173135	chr4:119721949	C/T	cg11846333	chr4:119757529	SEC24D	1.19	6.39	0.59	1.12e-8	Cannabis dependence symptom count;
SKCM	cis	rs1691799	0.899	rs1168328	chr12:66729250	T/C	cg16791601	chr12:66731901	HELB	-0.62	-5.53	-0.53	4.17e-7	White blood cell count (basophil);
SKCM	cis	rs2228479	0.717	rs12917681	chr16:89810941	C/A	cg00800038	chr16:89945340	TCF25	-0.85	-4.99	-0.49	3.65e-6	Skin colour saturation;
SKCM	cis	rs6952808	0.573	rs12668848	chr7:2020995	G/A	cg02951883	chr7:2050386	MAD1L1	-0.81	-7.1	-0.63	5.06e-10	Bipolar disorder and schizophrenia;
SKCM	cis	rs3820068	0.603	rs72647128	chr1:15963908	T/C	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs7635838	0.819	rs2454482	chr3:11534031	C/T	cg00170343	chr3:11313890	ATG7	0.68	4.89	0.48	5.22e-6	HDL cholesterol;
SKCM	cis	rs7772486	0.790	rs2265919	chr6:146221753	A/G	cg23711669	chr6:146136114	FBXO30	0.78	7.7	0.66	3.53e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9303401	0.659	rs7216648	chr17:56790858	C/T	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.16	0.57	2.91e-8	Cognitive test performance;
SKCM	cis	rs8072100	0.935	rs78551919	chr17:45626002	A/C	cg08085267	chr17:45401833	C17orf57	0.59	5.24	0.51	1.35e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs875971	0.929	rs778682	chr7:65837934	A/G	cg18876405	chr7:65276391	NA	0.68	6.79	0.61	2.01e-9	Aortic root size;
SKCM	cis	rs2836974	0.897	rs1541102	chr21:40628765	C/T	cg11890956	chr21:40555474	PSMG1	1.09	13.83	0.84	1.08e-22	Cognitive function;
SKCM	cis	rs4927850	0.752	rs7618864	chr3:195749561	G/A	cg01181863	chr3:195395398	SDHAP2	-0.88	-7.22	-0.63	2.99e-10	Pancreatic cancer;
SKCM	cis	rs2645694	0.626	rs12502590	chr4:77823642	G/A	cg06046430	chr4:77819534	ANKRD56	0.54	5.85	0.55	1.09e-7	Emphysema distribution in smoking;
SKCM	cis	rs6743226	0.603	rs11675957	chr2:242208792	A/G	cg10021735	chr2:242295487	FARP2	-0.56	-4.86	-0.48	5.99e-6	Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction);Waist circumference adjusted for BMI (adjusted for smoking behaviour);Waist circumference adjusted for BMI in non-smokers;
SKCM	cis	rs2721195	0.549	rs2620666	chr8:145703413	T/C	cg17328964	chr8:145687451	CYHR1	-0.64	-5.26	-0.51	1.21e-6	Age at first birth;
SKCM	cis	rs7215564	0.908	rs901066	chr17:78659617	C/G	cg16980736	chr17:78789706	RPTOR	-0.89	-4.88	-0.48	5.41e-6	Myopia (pathological);
SKCM	cis	rs9916302	0.904	rs12450559	chr17:37694709	G/A	cg07936489	chr17:37558343	FBXL20	-0.9	-8.11	-0.68	5.65e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs909674	0.818	rs5757681	chr22:39845547	A/G	cg11247378	chr22:39784982	NA	-0.45	-5.14	-0.5	2e-6	IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis);IgG glycosylation;IgG digalactosylation phenotypes (multivariate analysis);IgG sialylation phenotypes (multivariate analysis);IgG monogalactosylation phenotypes (multivariate analysis);IgG fucosylation phenotypes (multivariate analysis);IgG N-glycosylation phenotypes (multivariate analysis);IgG disialylation phenotypes (multivariate analysis);IgG galactosylation phenotypes (multivariate analysis);Post bronchodilator FEV1;
SKCM	cis	rs7584330	0.554	rs6739456	chr2:238385092	G/C	cg08992911	chr2:238395768	MLPH	0.95	5.1	0.5	2.3e-6	Prostate cancer;
SKCM	cis	rs8067545	0.611	rs12942568	chr17:20117893	G/T	cg13482628	chr17:19912719	NA	-0.66	-5.59	-0.53	3.23e-7	Schizophrenia;
SKCM	cis	rs58688157	0.705	rs12421646	chr11:578844	C/G	cg17114584	chr11:613792	IRF7	0.84	5.21	0.51	1.49e-6	Systemic lupus erythematosus;
SKCM	cis	rs7726839	0.540	rs72703079	chr5:595173	T/C	cg10555297	chr5:473380	SLC9A3;LOC25845	1.02	4.88	0.48	5.45e-6	Obesity-related traits;
SKCM	cis	rs10256972	0.721	rs10435145	chr7:1065988	C/T	cg16145915	chr7:1198662	ZFAND2A	-0.5	-6.69	-0.6	3.05e-9	Longevity;Endometriosis;
SKCM	cis	rs7927771	0.832	rs2071304	chr11:47372377	G/C	cg01152729	chr11:47593274	PTPMT1	-0.52	-4.8	-0.48	7.62e-6	Subjective well-being;
SKCM	cis	rs9899728	0.539	rs57813751	chr17:73053512	C/T	cg27626185	chr17:73056755	KCTD2	-1.22	-7.67	-0.66	4.17e-11	Alzheimer's disease or small vessel stroke;
SKCM	cis	rs7618915	0.571	rs12632381	chr3:52607685	G/A	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs875971	0.545	rs316328	chr7:65608838	A/G	cg18876405	chr7:65276391	NA	-0.66	-5.56	-0.53	3.63e-7	Aortic root size;
SKCM	cis	rs7829975	0.714	rs11777085	chr8:8672429	G/C	cg06636001	chr8:8085503	FLJ10661	0.71	6.16	0.57	2.96e-8	Mood instability;
SKCM	cis	rs16854884	0.584	rs2164554	chr3:143755528	A/G	cg06585982	chr3:143692056	C3orf58	0.83	7.55	0.65	6.97e-11	Economic and political preferences (feminism/equality);
SKCM	cis	rs1862618	0.620	rs189695	chr5:56225769	T/C	cg03609598	chr5:56110824	MAP3K1	-0.71	-5.08	-0.5	2.5e-6	Initial pursuit acceleration;
SKCM	cis	rs9300255	0.602	rs884548	chr12:123634122	A/G	cg00376283	chr12:123451042	ABCB9	0.8	5.4	0.52	7.12e-7	Neutrophil percentage of white cells;
SKCM	cis	rs2180341	1.000	rs2144743	chr6:127633810	A/T	cg24812749	chr6:127587940	RNF146	0.84	7.25	0.63	2.6e-10	Breast cancer;
SKCM	cis	rs8078723	1.000	rs3826331	chr17:38150492	T/C	cg17467752	chr17:38218738	THRA	-0.68	-6.11	-0.57	3.65e-8	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs7666738	0.830	rs7657490	chr4:99043973	C/T	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs992157	0.700	rs10165153	chr2:219159629	T/C	cg00012203	chr2:219082015	ARPC2	0.73	5.76	0.55	1.6e-7	Colorectal cancer;
SKCM	cis	rs2839186	0.934	rs17176520	chr21:47682081	T/C	cg11766577	chr21:47581405	C21orf56	-0.7	-6.02	-0.56	5.28e-8	Testicular germ cell tumor;
SKCM	cis	rs7829975	0.582	rs11783950	chr8:8597831	A/C	cg06636001	chr8:8085503	FLJ10661	-0.74	-6.05	-0.57	4.74e-8	Mood instability;
SKCM	cis	rs7811142	0.943	rs111493473	chr7:100049742	A/G	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.12	6.51	0.59	6.68e-9	Platelet count;
SKCM	cis	rs35306767	0.715	rs17221456	chr10:1037234	T/C	cg20503657	chr10:835505	NA	0.69	5.47	0.53	5.29e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs10256972	0.616	rs4585652	chr7:1145396	A/G	cg07092213	chr7:1199455	ZFAND2A	-0.64	-5.09	-0.5	2.39e-6	Longevity;Endometriosis;
SKCM	cis	rs2013441	0.613	rs7215803	chr17:19998377	C/T	cg13482628	chr17:19912719	NA	0.68	5.37	0.52	7.85e-7	Obesity-related traits;
SKCM	cis	rs6121246	0.609	rs6060983	chr20:30420924	T/C	cg11595048	chr20:30225325	COX4I2	0.58	5.09	0.5	2.39e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs9715521	0.677	rs6822690	chr4:59853530	A/G	cg11281224	chr4:60001000	NA	-0.61	-4.82	-0.48	6.94e-6	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs12477438	0.501	rs6542868	chr2:99782848	A/C	cg14399236	chr2:99771627	LIPT1;TSGA10	0.97	8.66	0.7	4.83e-13	Chronic sinus infection;
SKCM	cis	rs9549367	0.713	rs1755690	chr13:113824266	T/C	cg18105134	chr13:113819100	PROZ	0.88	6.69	0.6	3e-9	Platelet distribution width;
SKCM	cis	rs9611565	0.918	rs4822024	chr22:41757647	G/A	cg03806693	chr22:41940476	POLR3H	-0.84	-5.67	-0.54	2.28e-7	Vitiligo;
SKCM	cis	rs7937682	0.889	rs1784785	chr11:111483306	A/G	cg19812747	chr11:111475976	SIK2	-0.56	-4.93	-0.49	4.55e-6	Primary sclerosing cholangitis;
SKCM	cis	rs6435862	0.500	rs6756902	chr2:215672827	C/T	cg04004882	chr2:215674386	BARD1	-0.83	-6.36	-0.58	1.26e-8	Neuroblastoma (high-risk);
SKCM	cis	rs2952156	0.883	rs907088	chr17:37833567	G/C	cg20243544	chr17:37824526	PNMT	0.71	5.74	0.54	1.74e-7	Asthma;
SKCM	cis	rs2857078	0.745	rs4793085	chr17:42320732	A/C	cg08499158	chr17:42289980	UBTF	0.8	6.68	0.6	3.13e-9	Red cell distribution width;Reticulocyte count;
SKCM	cis	rs2594989	0.779	rs61275424	chr3:11595585	G/C	cg00170343	chr3:11313890	ATG7	-0.95	-5.21	-0.51	1.47e-6	Circulating chemerin levels;
SKCM	cis	rs6495367	0.898	rs1443657	chr15:79386946	C/A	cg10259521	chr15:79428573	NA	-0.54	-5.44	-0.52	5.95e-7	Spherical equivalent (joint analysis main effects and education interaction);
SKCM	cis	rs7945705	0.747	rs1980428	chr11:9010497	A/G	cg21881798	chr11:8931708	C11orf17;ST5	0.87	9.66	0.74	5.65e-15	Hemoglobin concentration;
SKCM	cis	rs7772486	0.713	rs79248977	chr6:146319388	C/A	cg23711669	chr6:146136114	FBXO30	0.73	6.58	0.6	4.81e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9796	0.717	rs476633	chr15:41392134	C/G	cg00616447	chr15:41694635	NDUFAF1	0.75	4.77	0.48	8.36e-6	Menopause (age at onset);
SKCM	cis	rs6570726	0.755	rs2092296	chr6:145893684	A/C	cg05347473	chr6:146136440	FBXO30	0.57	5.08	0.5	2.47e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs28386778	0.799	rs2727322	chr17:61921706	G/A	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs873946	0.648	rs35417213	chr10:134553749	A/G	cg27286337	chr10:134555280	INPP5A	0.92	8.36	0.69	1.85e-12	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs7208859	0.623	rs75136574	chr17:28934549	C/A	cg14067834	chr17:29058358	SUZ12P	1.25	5.05	0.5	2.78e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs2413583	0.536	rs17304621	chr22:39690791	C/T	cg17798944	chr22:39715225	SNORD43;RPL3	0.92	5.12	0.5	2.12e-6	Ulcerative colitis;Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs12142240	0.698	rs1053628	chr1:46827769	C/T	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs6754311	0.517	rs1469995	chr2:136542559	G/A	cg07169764	chr2:136633963	MCM6	0.89	7.01	0.62	7.67e-10	Mosquito bite size;
SKCM	cis	rs9926296	0.568	rs4420527	chr16:89814188	C/T	cg27121462	chr16:89883253	FANCA	-0.82	-7.55	-0.65	6.84e-11	Vitiligo;
SKCM	cis	rs2013441	0.965	rs9896221	chr17:20180337	G/A	cg13482628	chr17:19912719	NA	-0.66	-5.11	-0.5	2.25e-6	Obesity-related traits;
SKCM	cis	rs151997	0.962	rs27268	chr5:50184778	T/C	cg06027927	chr5:50259733	NA	0.63	5.52	0.53	4.27e-7	Callous-unemotional behaviour;
SKCM	cis	rs6547741	0.844	rs9941696	chr2:27920064	C/T	cg27432699	chr2:27873401	GPN1	-0.84	-7.14	-0.63	4.26e-10	Oral cavity cancer;
SKCM	cis	rs16867321	0.588	rs2368175	chr2:181493763	G/C	cg23363182	chr2:181467187	NA	-0.56	-4.85	-0.48	6.07e-6	Obesity;
SKCM	cis	rs10504229	1.000	rs55944282	chr8:58180821	A/G	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs2816062	0.786	rs2745316	chr1:18896830	G/A	cg18795169	chr1:18902165	NA	-0.8	-8.35	-0.69	1.98e-12	Urate levels in lean individuals;
SKCM	cis	rs826838	1.000	rs34254519	chr12:39041235	G/A	cg13010199	chr12:38710504	ALG10B	0.8	6.34	0.58	1.35e-8	Heart rate;
SKCM	cis	rs9902453	0.967	rs4994355	chr17:28386284	T/A	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.81	-5.78	-0.55	1.45e-7	Coffee consumption (cups per day);
SKCM	cis	rs2033711	0.870	rs11084545	chr19:58951693	G/C	cg12042659	chr19:58951599	ZNF132	0.66	5.75	0.55	1.63e-7	Uric acid clearance;
SKCM	cis	rs7829975	0.626	rs907183	chr8:8729761	C/G	cg06636001	chr8:8085503	FLJ10661	-0.87	-7.79	-0.66	2.39e-11	Mood instability;
SKCM	cis	rs1044826	0.619	rs6439856	chr3:139134868	A/T	cg15131784	chr3:139108705	COPB2	-0.68	-5.03	-0.49	3.1e-6	Obesity-related traits;
SKCM	cis	rs11105298	0.891	rs11105310	chr12:89918677	C/A	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.91	-5.65	-0.54	2.56e-7	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs13118159	0.550	rs4974612	chr4:1364543	A/G	cg05025164	chr4:1340916	KIAA1530	0.9	7.32	0.64	1.91e-10	Longevity;
SKCM	cis	rs12824058	0.678	rs11614163	chr12:130814621	C/G	cg26677194	chr12:130822605	PIWIL1	0.7	5.29	0.51	1.08e-6	Menopause (age at onset);
SKCM	cis	rs35306767	0.903	rs11253494	chr10:937047	C/T	cg20503657	chr10:835505	NA	0.84	5.55	0.53	3.74e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs873946	0.586	rs12774727	chr10:134569910	T/C	cg26818010	chr10:134567672	INPP5A	-0.8	-6.11	-0.57	3.7e-8	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs6121246	0.559	rs6121038	chr20:30254773	T/G	cg13852791	chr20:30311386	BCL2L1	0.83	5.71	0.54	2e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs1348850	0.914	rs10497503	chr2:178371739	G/T	cg02961200	chr2:178257176	LOC100130691;AGPS	0.82	5.79	0.55	1.41e-7	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs7932354	0.528	rs4752952	chr11:47082858	T/C	cg03339077	chr11:47165057	C11orf49	-0.59	-4.79	-0.48	7.68e-6	Bone mineral density (hip);Bone mineral density;
SKCM	cis	rs870825	0.616	rs57271221	chr4:185627198	C/T	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs1850744	0.702	rs57171822	chr4:9596455	T/A	cg15442990	chr4:9534313	NA	-1.3	-4.84	-0.48	6.55e-6	Economic and political preferences;
SKCM	cis	rs12464559	0.522	rs10180065	chr2:152619007	A/G	cg01189475	chr2:152685088	ARL5A	-1.02	-5.23	-0.51	1.38e-6	Response to cognitive-behavioural therapy in anxiety disorder;
SKCM	cis	rs4969178	0.965	rs3817295	chr17:76394526	T/A	cg20026190	chr17:76395443	PGS1	0.61	5.29	0.51	1.08e-6	HDL cholesterol levels;
SKCM	cis	rs1912528	0.963	rs12646543	chr4:140937114	T/C	cg11128457	chr4:140864437	MAML3	0.58	4.82	0.48	6.87e-6	Educational attainment (years of education);
SKCM	cis	rs11098499	0.909	rs35111518	chr4:120440682	A/G	cg09307838	chr4:120376055	NA	1.0	7.87	0.67	1.69e-11	Corneal astigmatism;
SKCM	cis	rs1153858	0.945	rs2467854	chr15:45701597	A/G	cg10760299	chr15:45669010	GATM	0.61	5.9	0.56	8.99e-8	Homoarginine levels;
SKCM	cis	rs1218582	0.772	rs11264282	chr1:154867370	G/A	cg03351412	chr1:154909251	PMVK	0.78	6.55	0.6	5.5e-9	Prostate cancer;
SKCM	cis	rs72781680	0.644	rs72783627	chr2:24315685	A/C	cg20701182	chr2:24300061	SF3B14	0.74	5.03	0.49	3.09e-6	Lymphocyte counts;
SKCM	cis	rs9682041	1.000	rs4955588	chr3:170072864	C/A	cg11886554	chr3:170076028	SKIL	0.83	5.01	0.49	3.28e-6	Glomerular filtration rate in non diabetics (creatinine);Glomerular filtration rate (creatinine);
SKCM	cis	rs1577917	0.655	rs9444351	chr6:86247799	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.76	6.82	0.61	1.72e-9	Response to antipsychotic treatment;
SKCM	cis	rs1405130	1.000	rs4663459	chr2:235563427	A/G	cg17841421	chr2:235704848	NA	-0.57	-4.77	-0.48	8.35e-6	Coronary artery disease;
SKCM	cis	rs763014	0.932	rs2384972	chr16:674424	G/A	cg07343612	chr16:622815	PIGQ	-0.7	-5.95	-0.56	7.3e-8	Height;
SKCM	cis	rs11098499	0.908	rs28559989	chr4:120386627	C/T	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs1395	0.778	rs11693660	chr2:27468856	T/C	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.51	5.14	0.5	1.96e-6	Blood metabolite levels;
SKCM	cis	rs12142240	0.738	rs67545510	chr1:46806242	G/T	cg10495392	chr1:46806563	NSUN4	0.74	5.37	0.52	7.75e-7	Menopause (age at onset);
SKCM	cis	rs28595532	0.920	rs115706007	chr4:119733638	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.43	0.59	9.38e-9	Cannabis dependence symptom count;
SKCM	cis	rs2204008	0.774	rs11615665	chr12:38328162	T/A	cg26384229	chr12:38710491	ALG10B	0.81	6.67	0.6	3.38e-9	Bladder cancer;
SKCM	cis	rs796364	1.000	rs166845	chr2:200823360	T/A	cg12253985	chr2:200820533	C2orf60;C2orf47	0.92	5.62	0.54	2.83e-7	Schizophrenia;
SKCM	cis	rs10781543	0.810	rs11145756	chr9:139364585	A/G	cg14169450	chr9:139327907	INPP5E	0.51	5.4	0.52	6.97e-7	Monocyte percentage of white cells;
SKCM	cis	rs7772486	0.790	rs2265474	chr6:146182092	G/A	cg05347473	chr6:146136440	FBXO30	0.58	5.56	0.53	3.57e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9911578	0.967	rs302842	chr17:56728102	C/G	cg12560992	chr17:57184187	TRIM37	0.95	7.69	0.66	3.7e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs9910055	0.762	rs1135215	chr17:42253519	T/C	cg13607699	chr17:42295918	UBTF	0.79	6.25	0.58	2.03e-8	Total body bone mineral density;
SKCM	cis	rs11098499	0.954	rs17006190	chr4:120418838	C/G	cg09307838	chr4:120376055	NA	1.0	8.05	0.67	7.65e-12	Corneal astigmatism;
SKCM	cis	rs9894429	0.550	rs6565617	chr17:79612333	G/A	cg18240062	chr17:79603768	NPLOC4	0.68	6.07	0.57	4.41e-8	Eye color traits;
SKCM	cis	rs1862618	0.853	rs832553	chr5:56114786	A/G	cg12311346	chr5:56204834	C5orf35	-0.71	-4.79	-0.48	7.79e-6	Initial pursuit acceleration;
SKCM	cis	rs72634258	0.519	rs744001	chr1:7934557	G/A	cg00042356	chr1:8021962	PARK7	0.86	6.01	0.56	5.55e-8	Inflammatory bowel disease;
SKCM	cis	rs2730245	0.527	rs2527202	chr7:158738849	T/C	cg24397884	chr7:158709396	WDR60	-1.07	-5.43	-0.52	6.1e-7	Height;
SKCM	cis	rs4727027	0.901	rs6943937	chr7:148869915	A/G	cg23583168	chr7:148888333	NA	-0.78	-6.54	-0.6	5.86e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs941408	1.000	rs1736176	chr19:2790394	G/A	cg06609049	chr19:2785107	THOP1	0.87	7.07	0.62	5.79e-10	Total cholesterol levels;
SKCM	cis	rs10131894	0.611	rs175002	chr14:75436466	C/G	cg08847533	chr14:75593920	NEK9	0.67	4.91	0.49	4.87e-6	Coronary artery disease;
SKCM	cis	rs875971	0.660	rs10950044	chr7:66042976	A/G	cg18876405	chr7:65276391	NA	-0.82	-7.53	-0.65	7.59e-11	Aortic root size;
SKCM	cis	rs9660180	0.967	rs9660106	chr1:1797947	A/G	cg13866156	chr1:1669148	SLC35E2	-0.79	-6.51	-0.59	6.53e-9	Body mass index;
SKCM	cis	rs28386778	1.000	rs2955241	chr17:61968113	G/C	cg11494091	chr17:61959527	GH2	0.59	4.87	0.48	5.68e-6	Prudent dietary pattern;
SKCM	cis	rs7666738	0.830	rs4292342	chr4:98959870	A/T	cg17366294	chr4:99064904	C4orf37	0.63	5.29	0.51	1.09e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2072499	0.833	rs2251847	chr1:156204047	G/A	cg24450063	chr1:156163899	SLC25A44	0.79	6.7	0.6	2.87e-9	Testicular germ cell tumor;
SKCM	cis	rs9325144	0.723	rs11169518	chr12:39177237	C/A	cg26384229	chr12:38710491	ALG10B	-0.7	-6.42	-0.59	9.71e-9	Morning vs. evening chronotype;
SKCM	cis	rs2303745	0.622	rs1864113	chr19:17393504	G/C	cg04248312	chr19:17393744	ANKLE1	-1.11	-8.18	-0.68	4.15e-12	Systemic lupus erythematosus;
SKCM	cis	rs2013441	1.000	rs4924808	chr17:20026548	C/T	cg13482628	chr17:19912719	NA	-0.67	-5.41	-0.52	6.77e-7	Obesity-related traits;
SKCM	cis	rs860295	0.871	rs6696888	chr1:155508882	G/A	cg02153340	chr1:155202674	NA	0.69	5.21	0.51	1.48e-6	Body mass index;
SKCM	trans	rs1814175	0.615	rs7113020	chr11:49746540	C/T	cg03929089	chr4:120376271	NA	-0.89	-8.07	-0.67	7.01e-12	Height;
SKCM	cis	rs151997	0.962	rs27256	chr5:50190264	G/C	cg06027927	chr5:50259733	NA	0.63	5.52	0.53	4.27e-7	Callous-unemotional behaviour;
SKCM	cis	rs1912528	0.963	rs6823515	chr4:140925403	G/C	cg11128457	chr4:140864437	MAML3	0.58	4.9	0.49	5e-6	Educational attainment (years of education);
SKCM	cis	rs7103648	0.630	rs7120548	chr11:47662932	A/G	cg20307385	chr11:47447363	PSMC3	0.97	7.44	0.64	1.15e-10	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs2463822	1.000	rs2463821	chr11:62111662	T/C	cg06239285	chr11:62104954	ASRGL1	1.25	5.93	0.56	7.79e-8	Chronic obstructive pulmonary disease-related biomarkers;
SKCM	cis	rs6570726	0.516	rs10457779	chr6:145736663	C/T	cg23711669	chr6:146136114	FBXO30	0.66	5.97	0.56	6.73e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs34779708	0.966	rs1545757	chr10:35445588	A/T	cg03585969	chr10:35415529	CREM	0.72	5.89	0.56	9.14e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs10905065	0.610	rs4748307	chr10:5747701	C/T	cg09234995	chr10:5726438	C10orf18	0.64	5.34	0.52	8.82e-7	Menopause (age at onset);
SKCM	cis	rs4253772	0.614	rs11090859	chr22:46687460	T/G	cg03482458	chr22:46692211	CN5H6.4;GTSE1	1.2	5.67	0.54	2.3e-7	LDL cholesterol;Cholesterol, total;
SKCM	cis	rs11098499	0.954	rs28429722	chr4:120300093	G/A	cg09307838	chr4:120376055	NA	0.97	7.49	0.65	9.08e-11	Corneal astigmatism;
SKCM	cis	rs60871478	0.786	rs55899111	chr7:827843	C/G	cg05535760	chr7:792225	HEATR2	-1.21	-10.42	-0.76	1.96e-16	Cerebrospinal P-tau181p levels;
SKCM	cis	rs362272	0.525	rs910568	chr4:3307373	A/G	cg00764545	chr4:3318001	RGS12	0.96	11.6	0.8	1.17e-18	Serum sulfate level;
SKCM	cis	rs11098499	0.954	rs13107475	chr4:120393011	A/T	cg24375607	chr4:120327624	NA	0.66	5.09	0.5	2.44e-6	Corneal astigmatism;
SKCM	cis	rs13118159	0.550	rs2336081	chr4:1350322	A/G	cg02475777	chr4:1388615	CRIPAK	-0.77	-5.27	-0.51	1.17e-6	Longevity;
SKCM	cis	rs57221529	0.766	rs56278696	chr5:582669	A/G	cg09888920	chr5:474111	LOC25845;SLC9A3	0.99	4.79	0.48	7.91e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs12142240	0.698	rs932816	chr1:46859749	G/A	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs10504073	0.647	rs4873312	chr8:49991145	A/G	cg00325661	chr8:49890786	NA	0.78	6.77	0.61	2.18e-9	Blood metabolite ratios;
SKCM	cis	rs4555082	0.834	rs2816651	chr14:105708470	A/G	cg13114125	chr14:105738426	BRF1	-0.67	-5.51	-0.53	4.39e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs7100689	0.622	rs1340379	chr10:82121455	G/A	cg01528321	chr10:82214614	TSPAN14	0.8	7.0	0.62	7.98e-10	Post bronchodilator FEV1;
SKCM	cis	rs7937682	0.883	rs484834	chr11:111465761	G/C	cg09085632	chr11:111637200	PPP2R1B	-1.0	-8.77	-0.7	2.99e-13	Primary sclerosing cholangitis;
SKCM	cis	rs514406	0.798	rs576650	chr1:53327207	C/T	cg08859206	chr1:53392774	SCP2	-0.64	-4.91	-0.49	4.97e-6	Monocyte count;
SKCM	cis	rs2019137	0.539	rs11123170	chr2:113978940	C/G	cg12889195	chr2:113992843	PAX8;LOC440839;LOC654433	0.75	5.59	0.53	3.21e-7	Lymphocyte counts;
SKCM	cis	rs4242434	0.597	rs1877675	chr8:22533947	C/T	cg03733263	chr8:22462867	KIAA1967	-0.69	-5.05	-0.5	2.81e-6	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs2075371	1.000	rs2075373	chr7:133984683	A/C	cg20476274	chr7:133979776	SLC35B4	1.01	10.44	0.76	1.77e-16	Mean platelet volume;
SKCM	cis	rs801193	0.660	rs974239	chr7:66213491	G/A	cg11764359	chr7:65958608	NA	0.83	7.69	0.66	3.75e-11	Aortic root size;
SKCM	cis	rs7666738	0.830	rs4619898	chr4:98959646	G/A	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs732765	0.657	rs10137224	chr14:75247703	G/A	cg25946216	chr14:74253857	C14orf43	-0.94	-5.23	-0.51	1.36e-6	Non-small cell lung cancer;
SKCM	cis	rs7178909	0.872	rs7179633	chr15:90434877	T/C	cg19708238	chr15:90437601	AP3S2	0.72	5.22	0.51	1.43e-6	Common traits (Other);
SKCM	cis	rs11098499	0.863	rs34868248	chr4:120442430	A/G	cg24375607	chr4:120327624	NA	0.68	5.27	0.51	1.16e-6	Corneal astigmatism;
SKCM	cis	rs7829975	0.536	rs2980439	chr8:8094870	G/A	cg08975724	chr8:8085496	FLJ10661	0.83	6.69	0.6	3.08e-9	Mood instability;
SKCM	cis	rs6952808	0.635	rs12154473	chr7:1982181	A/G	cg21782813	chr7:2030301	MAD1L1	-0.57	-5.51	-0.53	4.46e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs769267	0.930	rs1047361	chr19:19606634	G/A	cg03709012	chr19:19516395	GATAD2A	0.89	8.62	0.7	5.89e-13	Tonsillectomy;
SKCM	cis	rs344364	0.511	rs1657132	chr16:1949924	C/T	cg26897989	chr16:1907736	C16orf73	-0.69	-7.13	-0.63	4.45e-10	Glomerular filtration rate in chronic kidney disease;
SKCM	cis	rs4237845	0.591	rs4760344	chr12:58320783	A/T	cg23860436	chr12:58378763	NA	0.45	4.91	0.49	4.81e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs742614	0.533	rs2747536	chr20:32404128	C/G	cg06304546	chr20:32448765	NA	-0.73	-5.9	-0.56	8.93e-8	Stearic acid (18:0) levels;
SKCM	cis	rs1568889	1.000	rs12790932	chr11:28046189	G/T	cg06544937	chr11:28130018	METT5D1;KIF18A	0.87	7.0	0.62	7.86e-10	Bipolar disorder;
SKCM	cis	rs611744	0.529	rs13282825	chr8:109263237	T/C	cg18478394	chr8:109455254	TTC35	0.66	5.32	0.52	9.59e-7	Dupuytren's disease;
SKCM	cis	rs911555	0.504	rs61995761	chr14:104075712	T/C	cg24130564	chr14:104152367	KLC1	-0.58	-5.11	-0.5	2.27e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2836974	0.666	rs11910705	chr21:40685604	C/T	cg11890956	chr21:40555474	PSMG1	-0.82	-8.04	-0.67	7.71e-12	Cognitive function;
SKCM	cis	rs11623869	0.614	rs11627052	chr14:103863476	A/G	cg25964908	chr14:103967516	MARK3	0.69	5.67	0.54	2.31e-7	Bone mineral density;
SKCM	cis	rs1062177	1.000	rs2915878	chr5:151149662	A/G	cg00977110	chr5:151150581	G3BP1	0.79	6.51	0.59	6.71e-9	Preschool internalizing problems;
SKCM	cis	rs2153535	0.580	rs6921964	chr6:8446395	A/G	cg23788917	chr6:8435910	SLC35B3	0.69	5.04	0.5	2.93e-6	Motion sickness;
SKCM	cis	rs870825	0.616	rs6852082	chr4:185645783	T/C	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs864745	0.967	rs34824357	chr7:28174264	C/T	cg15170557	chr7:28214983	JAZF1	-0.66	-6.96	-0.62	9.39e-10	Crohn's disease;Type 2 diabetes;
SKCM	cis	rs7666738	0.830	rs7657497	chr4:99044028	A/G	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1005277	0.505	rs200937	chr10:38135772	T/C	cg00409905	chr10:38381863	ZNF37A	-0.62	-5.81	-0.55	1.29e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs875971	0.508	rs10258739	chr7:66062935	A/T	cg11764359	chr7:65958608	NA	-0.8	-5.88	-0.55	9.52e-8	Aortic root size;
SKCM	cis	rs7809950	1.000	rs2107713	chr7:107232369	C/T	cg23024343	chr7:107201750	COG5	-0.76	-6.79	-0.61	1.97e-9	Coronary artery disease;
SKCM	cis	rs7552404	0.924	rs1498317	chr1:76171984	A/C	cg10523679	chr1:76189770	ACADM	0.7	5.05	0.5	2.83e-6	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs7811142	0.887	rs4074838	chr7:100032665	G/A	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.17	7.71	0.66	3.44e-11	Platelet count;
SKCM	cis	rs7296418	0.885	rs1051434	chr12:123641200	C/T	cg05973401	chr12:123451056	ABCB9	0.81	6.39	0.59	1.1e-8	Platelet count;
SKCM	cis	rs7666738	0.830	rs11725477	chr4:98803266	G/T	cg17366294	chr4:99064904	C4orf37	0.57	4.87	0.48	5.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1218582	0.774	rs4845679	chr1:154861187	G/T	cg09359103	chr1:154839909	KCNN3	-0.59	-5.76	-0.55	1.56e-7	Prostate cancer;
SKCM	cis	rs6951245	0.580	rs10257426	chr7:1213694	G/A	cg18402987	chr7:1209562	NA	0.86	5.28	0.51	1.11e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs9303401	0.659	rs7210700	chr17:56668186	G/A	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.13	0.57	3.42e-8	Cognitive test performance;
SKCM	cis	rs12477438	0.501	rs12619780	chr2:99707307	C/T	cg26064155	chr2:99771622	LIPT1;TSGA10	1.03	9.27	0.72	3.23e-14	Chronic sinus infection;
SKCM	cis	rs2075671	0.903	rs11760602	chr7:100264128	G/C	cg20848291	chr7:100343083	ZAN	-0.72	-5.55	-0.53	3.84e-7	Other erythrocyte phenotypes;
SKCM	cis	rs1707322	0.835	rs946525	chr1:46487277	A/T	cg03146154	chr1:46216737	IPP	-0.77	-5.36	-0.52	8.35e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs4481887	0.861	rs7412034	chr1:248434150	G/C	cg00666640	chr1:248458726	OR2T12	0.68	5.97	0.56	6.72e-8	Common traits (Other);
SKCM	cis	rs6539267	0.741	rs7314289	chr12:106686260	A/C	cg00173435	chr12:106696525	TCP11L2	0.85	6.21	0.58	2.39e-8	Tourette syndrome;
SKCM	cis	rs4911259	0.552	rs13038881	chr20:31468113	T/C	cg13636640	chr20:31349939	DNMT3B	-0.74	-6.15	-0.57	3.04e-8	Inflammatory bowel disease;
SKCM	cis	rs2180341	1.000	rs2180341	chr6:127600630	C/T	cg24812749	chr6:127587940	RNF146	0.84	6.31	0.58	1.59e-8	Breast cancer;
SKCM	cis	rs2404602	0.692	rs8043474	chr15:76974723	T/C	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs826838	1.000	rs7299124	chr12:39002661	T/C	cg13010199	chr12:38710504	ALG10B	0.78	6.13	0.57	3.37e-8	Heart rate;
SKCM	cis	rs875971	0.545	rs4718335	chr7:65804606	C/T	cg18876405	chr7:65276391	NA	0.63	5.03	0.49	3.07e-6	Aortic root size;
SKCM	cis	rs35306767	0.714	rs67696450	chr10:1090684	C/T	cg25614935	chr10:1084866	C10orf110	0.71	5.46	0.53	5.39e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs3768617	0.510	rs10911254	chr1:183088627	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	trans	rs8073060	0.586	rs225257	chr17:33956625	G/A	cg19694781	chr19:47549865	TMEM160	-1.08	-8.36	-0.69	1.88e-12	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs7772486	0.790	rs2253880	chr6:146200774	T/C	cg23711669	chr6:146136114	FBXO30	0.85	9.32	0.73	2.57e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs12497850	0.864	rs3212	chr3:49145741	T/C	cg06212747	chr3:49208901	KLHDC8B	0.75	4.97	0.49	3.91e-6	Parkinson's disease;
SKCM	cis	rs11139399	0.626	rs2086831	chr9:84345126	T/C	cg13729285	chr9:84764156	NA	0.54	5.56	0.53	3.58e-7	Hippocampal atrophy;
SKCM	cis	rs9910055	0.659	rs2251165	chr17:42234748	T/C	cg08499158	chr17:42289980	UBTF	-0.73	-6.34	-0.58	1.37e-8	Total body bone mineral density;
SKCM	cis	rs10504229	0.636	rs115738451	chr8:58055133	A/T	cg02725872	chr8:58115012	NA	-0.54	-5.04	-0.5	2.97e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs1153858	0.943	rs1145079	chr15:45681761	T/C	cg10760299	chr15:45669010	GATM	0.63	6.32	0.58	1.49e-8	Homoarginine levels;
SKCM	cis	rs7208859	0.623	rs12006	chr17:29110652	G/A	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs10871290	0.881	rs3863439	chr16:74470644	T/C	cg01733217	chr16:74700730	RFWD3	-0.71	-5.23	-0.51	1.4e-6	Breast cancer;
SKCM	cis	rs7336332	0.517	rs9581842	chr13:27978953	G/C	cg22138327	chr13:27999177	GTF3A	0.84	5.59	0.53	3.18e-7	Weight;
SKCM	cis	rs4332037	0.707	rs11763813	chr7:1896690	C/T	cg23422044	chr7:1970798	MAD1L1	-0.86	-5.36	-0.52	8.25e-7	Bipolar disorder;
SKCM	cis	rs3008870	0.792	rs72673729	chr1:67441673	T/TG	cg08660285	chr1:67390436	MIER1;WDR78	-0.9	-5.88	-0.55	9.75e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs9913156	0.948	rs28365160	chr17:4622551	A/G	cg00122941	chr17:4613640	ARRB2	0.83	5.03	0.49	3.07e-6	Lymphocyte counts;
SKCM	cis	rs7937682	0.737	rs518294	chr11:111424716	A/T	cg19812747	chr11:111475976	SIK2	-0.56	-4.88	-0.48	5.57e-6	Primary sclerosing cholangitis;
SKCM	cis	rs1979654	0.543	rs4843933	chr16:86401190	A/G	cg05448715	chr16:87090352	NA	0.5	5.7	0.54	2.05e-7	Barrett's esophagus  or Esophageal adenocarcinoma;
SKCM	cis	rs2836974	0.965	rs8130984	chr21:40639966	A/C	cg11890956	chr21:40555474	PSMG1	1.09	13.73	0.84	1.66e-22	Cognitive function;
SKCM	cis	rs757110	0.770	rs2051772	chr11:17389850	G/A	cg15432903	chr11:17409602	KCNJ11	0.51	4.86	0.48	6.04e-6	Type 2 diabetes;
SKCM	cis	rs10752881	1.000	rs10737236	chr1:182988608	C/T	ch.1.3577855R	chr1:183094577	LAMC1	-0.72	-6.74	-0.61	2.46e-9	Colorectal cancer;
SKCM	cis	rs28386778	0.897	rs4968599	chr17:61835992	T/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.12	11.27	0.79	4.92e-18	Prudent dietary pattern;
SKCM	cis	rs67311347	0.544	rs6599088	chr3:40329288	T/C	cg02782426	chr3:40428986	ENTPD3	0.51	5.2	0.51	1.57e-6	Renal cell carcinoma;
SKCM	cis	rs7666738	0.710	rs7674407	chr4:98838522	A/G	cg05340658	chr4:99064831	C4orf37	0.6	4.81	0.48	7.19e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2832191	0.791	rs2832179	chr21:30480366	C/T	cg08807101	chr21:30365312	RNF160	-0.62	-4.94	-0.49	4.34e-6	Dental caries;
SKCM	cis	rs9910055	0.659	rs7216294	chr17:42251095	T/C	cg13607699	chr17:42295918	UBTF	0.71	5.74	0.55	1.72e-7	Total body bone mineral density;
SKCM	cis	rs367615	0.704	rs7704824	chr5:108850278	A/G	cg17395555	chr5:108820864	NA	0.79	7.23	0.63	2.89e-10	Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs28386778	1.000	rs2665810	chr17:61970210	C/G	cg06873352	chr17:61820015	STRADA	0.7	5.7	0.54	2.07e-7	Prudent dietary pattern;
SKCM	cis	rs1267303	0.675	rs2476164	chr1:46985274	T/C	cg25110126	chr1:46999211	NA	-0.68	-4.99	-0.49	3.57e-6	Monobrow;
SKCM	cis	rs1153858	1.000	rs1554521	chr15:45664189	A/T	cg10760299	chr15:45669010	GATM	-0.59	-5.89	-0.55	9.23e-8	Homoarginine levels;
SKCM	cis	rs2180341	0.960	rs7745944	chr6:127709574	A/G	cg27446573	chr6:127587934	RNF146	0.9	7.59	0.65	5.96e-11	Breast cancer;
SKCM	cis	rs4819052	1.000	rs2297285	chr21:46705621	A/G	cg20896738	chr21:46707857	POFUT2;LOC642852	-0.77	-5.6	-0.54	3.08e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs2050392	0.624	rs303435	chr10:30731491	T/C	cg25182066	chr10:30743637	MAP3K8	-0.65	-5.37	-0.52	7.97e-7	Inflammatory bowel disease;
SKCM	cis	rs16854884	0.657	rs13078840	chr3:143700753	A/G	cg06585982	chr3:143692056	C3orf58	0.82	7.39	0.64	1.41e-10	Economic and political preferences (feminism/equality);
SKCM	cis	rs2033711	0.870	rs11084545	chr19:58951693	G/C	cg03735888	chr19:58951602	ZNF132	0.7	6.24	0.58	2.08e-8	Uric acid clearance;
SKCM	cis	rs854765	0.583	rs8078138	chr17:17811251	C/T	cg04398451	chr17:18023971	MYO15A	-0.79	-5.68	-0.54	2.25e-7	Total body bone mineral density;
SKCM	cis	rs7666738	0.924	rs13124368	chr4:99039615	T/C	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6500395	0.963	rs12444902	chr16:48667126	G/T	cg04672837	chr16:48644449	N4BP1	0.6	4.88	0.48	5.59e-6	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs7843479	0.582	rs13439690	chr8:21778082	T/C	cg17168535	chr8:21777572	XPO7	0.77	6.72	0.61	2.67e-9	Mean corpuscular volume;
SKCM	cis	rs5760092	0.755	rs4585126	chr22:24270005	T/C	cg24846343	chr22:24311635	DDTL	-0.6	-4.83	-0.48	6.68e-6	Urinary 1,3-butadiene metabolite levels in smokers;
SKCM	cis	rs206936	0.571	rs78454682	chr6:34393866	G/A	cg12284521	chr6:34113943	NA	-0.8	-5.06	-0.5	2.76e-6	Body mass index;
SKCM	cis	rs2832191	0.791	rs57721945	chr21:30498744	T/C	cg08807101	chr21:30365312	RNF160	-0.61	-4.78	-0.48	8.17e-6	Dental caries;
SKCM	cis	rs13040088	0.872	rs13039291	chr20:61572760	C/T	cg23096297	chr20:61557774	DIDO1	0.82	6.22	0.58	2.32e-8	Menopause (age at onset);
SKCM	cis	rs9325144	0.624	rs7312879	chr12:39150752	G/A	cg26384229	chr12:38710491	ALG10B	-0.7	-6.43	-0.59	9.34e-9	Morning vs. evening chronotype;
SKCM	cis	rs6951245	1.000	rs79443843	chr7:1075245	G/A	cg18402987	chr7:1209562	NA	1.14	6.01	0.56	5.68e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs736408	0.812	rs2240920	chr3:52831009	A/G	cg18404041	chr3:52824283	ITIH1	0.63	5.54	0.53	3.96e-7	Bipolar disorder;
SKCM	cis	rs9611565	0.659	rs9611610	chr22:41949259	A/G	cg03806693	chr22:41940476	POLR3H	-1.2	-7.79	-0.66	2.4e-11	Vitiligo;
SKCM	cis	rs2739330	0.828	rs5760098	chr22:24248314	A/G	cg25703541	chr22:24373054	LOC391322	-0.78	-6.14	-0.57	3.23e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs12541335	0.615	rs4872464	chr8:22153381	G/A	cg26039829	chr8:22132926	PIWIL2	0.64	5.58	0.53	3.36e-7	Hypertriglyceridemia;
SKCM	cis	rs35306767	0.903	rs10904577	chr10:922077	A/G	cg20503657	chr10:835505	NA	0.75	5.36	0.52	8.31e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs6582630	0.555	rs11182217	chr12:38480030	G/A	cg26384229	chr12:38710491	ALG10B	0.87	6.82	0.61	1.76e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs2180341	1.000	rs9375499	chr6:127618072	T/C	cg24812749	chr6:127587940	RNF146	0.87	7.33	0.64	1.85e-10	Breast cancer;
SKCM	cis	rs854765	0.547	rs7212167	chr17:17913504	G/A	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.04	9.2	0.72	4.44e-14	Total body bone mineral density;
SKCM	cis	rs950776	0.518	rs1979907	chr15:78842239	T/C	cg06917634	chr15:78832804	PSMA4	-1.01	-10.48	-0.76	1.5e-16	Sudden cardiac arrest;
SKCM	trans	rs1814175	0.727	rs2140597	chr11:49873946	G/A	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs1799949	1.000	rs11657053	chr17:41191129	G/T	cg25072359	chr17:41440525	NA	0.63	4.88	0.48	5.43e-6	Menopause (age at onset);
SKCM	cis	rs651907	0.557	rs13099674	chr3:101489629	G/A	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.81	7.11	0.63	4.78e-10	Colorectal cancer;
SKCM	cis	rs55962025	0.842	rs73193303	chr4:3192200	A/G	cg05297308	chr4:3317976	RGS12	-0.65	-4.95	-0.49	4.17e-6	Parental longevity (mother's age at death);
SKCM	cis	rs9902453	0.765	rs2250320	chr17:28128657	G/C	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.83	-6.37	-0.59	1.2e-8	Coffee consumption (cups per day);
SKCM	cis	rs1005277	0.579	rs2472175	chr10:38382901	T/G	cg25427524	chr10:38739819	LOC399744	-0.69	-6.45	-0.59	8.73e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs10504229	1.000	rs116444534	chr8:58181915	A/G	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs6977660	0.714	rs10950753	chr7:19817302	G/A	cg07541023	chr7:19748670	TWISTNB	0.72	4.78	0.48	7.95e-6	Thyroid stimulating hormone;
SKCM	cis	rs12474201	0.928	rs13429704	chr2:46960329	G/T	cg06386533	chr2:46925753	SOCS5	1.01	9.59	0.74	7.91e-15	Height;
SKCM	cis	rs116095464	0.558	rs113796397	chr5:246503	A/G	cg22857025	chr5:266934	NA	-1.37	-8.31	-0.69	2.38e-12	Breast cancer;
SKCM	cis	rs2354432	0.607	rs2297752	chr1:146765454	C/G	cg25205988	chr1:146714368	CHD1L	-1.16	-8.19	-0.68	3.97e-12	Mitochondrial DNA levels;
SKCM	cis	rs2404602	0.655	rs4886824	chr15:76969256	A/G	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs12145833	0.596	rs1060643	chr1:243429976	G/C	cg02356786	chr1:243265016	LOC731275	1.7	5.93	0.56	7.73e-8	Obesity (early onset extreme);
SKCM	cis	rs2857078	0.654	rs4793083	chr17:42312973	C/T	cg09913183	chr17:42254507	C17orf65;ASB16	-0.59	-5.02	-0.49	3.14e-6	Red cell distribution width;Reticulocyte count;
SKCM	cis	rs2642660	0.539	rs157292	chr5:156017089	A/G	cg15611624	chr5:156886970	NIPAL4	-0.51	-4.97	-0.49	3.89e-6	Airway responsiveness in chronic obstructive pulmonary disease;
SKCM	cis	rs2404602	0.735	rs2468130	chr15:76796496	T/C	cg23625390	chr15:77176239	SCAPER	-0.81	-7.92	-0.67	1.32e-11	Blood metabolite levels;
SKCM	cis	rs7666738	0.830	rs2865977	chr4:99017916	C/T	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs113352275	1	rs113352275	chr15:78840567	C/T	cg06917634	chr15:78832804	PSMA4	-0.88	-5.04	-0.5	2.94e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs798554	0.759	rs2644309	chr7:2889034	T/C	cg19346786	chr7:2764209	NA	-0.66	-6.79	-0.61	1.94e-9	Height;
SKCM	cis	rs6545883	0.929	rs12617911	chr2:61740825	A/G	cg15711740	chr2:61764176	XPO1	-0.73	-5.27	-0.51	1.19e-6	Tuberculosis;
SKCM	cis	rs362296	0.590	rs4690081	chr4:3262105	T/G	cg16987761	chr4:3318072	RGS12	-0.76	-6.67	-0.6	3.31e-9	Parental longevity (mother's age at death);
SKCM	cis	rs72772090	0.710	rs17400741	chr5:96066576	C/G	cg17330273	chr5:96107758	CAST;ERAP1	-0.84	-5.14	-0.5	1.96e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs6121246	0.633	rs6060986	chr20:30426297	G/A	cg13852791	chr20:30311386	BCL2L1	0.84	5.75	0.55	1.65e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs6696846	0.749	rs61822566	chr1:205078660	T/C	cg00857998	chr1:205179979	DSTYK	0.59	4.83	0.48	6.79e-6	Red blood cell count;
SKCM	cis	rs11098499	0.730	rs78971550	chr4:120281041	C/T	cg24375607	chr4:120327624	NA	0.62	4.77	0.48	8.45e-6	Corneal astigmatism;
SKCM	cis	rs17685	0.753	rs4728550	chr7:75670988	C/A	cg16489192	chr7:75678113	MDH2;STYXL1	0.58	5.44	0.52	5.83e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs873946	0.586	rs12774727	chr10:134569910	T/C	cg27286337	chr10:134555280	INPP5A	0.99	8.98	0.71	1.2e-13	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs11792861	0.888	rs57314245	chr9:111813832	G/A	cg14432460	chr9:111696404	IKBKAP;C9orf6	0.66	4.93	0.49	4.62e-6	Menarche (age at onset);
SKCM	cis	rs7020830	0.898	rs12555207	chr9:37315476	C/T	cg14294708	chr9:37120828	ZCCHC7	0.99	9.26	0.72	3.36e-14	Schizophrenia;
SKCM	cis	rs11098499	0.818	rs12498599	chr4:120468503	C/T	cg09307838	chr4:120376055	NA	1.0	8.27	0.68	2.8e-12	Corneal astigmatism;
SKCM	cis	rs9790314	0.902	rs9863590	chr3:161116445	T/C	cg03342759	chr3:160939853	NMD3	-0.69	-7.1	-0.63	5.15e-10	Morning vs. evening chronotype;
SKCM	cis	rs736408	0.609	rs13082960	chr3:52785168	A/C	cg18404041	chr3:52824283	ITIH1	-0.56	-4.94	-0.49	4.32e-6	Bipolar disorder;
SKCM	cis	rs7824557	0.602	rs7816636	chr8:11205654	T/A	cg21775007	chr8:11205619	TDH	0.72	6.4	0.59	1.09e-8	Retinal vascular caliber;
SKCM	cis	rs1003719	0.788	rs3787783	chr21:38462959	T/A	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs9788682	1.000	rs34138960	chr15:78831668	A/G	cg06917634	chr15:78832804	PSMA4	-0.82	-4.96	-0.49	3.97e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs2204008	0.555	rs7310307	chr12:38107497	G/T	cg26384229	chr12:38710491	ALG10B	0.8	5.91	0.56	8.58e-8	Bladder cancer;
SKCM	cis	rs362272	0.524	rs10937924	chr4:3374898	T/C	cg11471262	chr4:3318911	RGS12	0.93	10.83	0.77	3.32e-17	Serum sulfate level;
SKCM	cis	rs2072499	0.966	rs2984615	chr1:156165317	G/C	cg24450063	chr1:156163899	SLC25A44	1.12	11.06	0.78	1.23e-17	Testicular germ cell tumor;
SKCM	cis	rs7811142	1.000	rs7809801	chr7:100072031	T/C	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.23	7.89	0.67	1.53e-11	Platelet count;
SKCM	cis	rs12148488	0.763	rs12900072	chr15:75307148	G/A	cg09165964	chr15:75287851	SCAMP5	0.69	5.31	0.52	9.92e-7	Caffeine consumption;
SKCM	cis	rs9926296	0.548	rs6500439	chr16:89808275	A/C	cg04287289	chr16:89883240	FANCA	1.02	13.21	0.83	1.34e-21	Vitiligo;
SKCM	cis	rs9300255	0.739	rs1980252	chr12:123745178	C/G	cg00376283	chr12:123451042	ABCB9	0.84	5.91	0.56	8.5e-8	Neutrophil percentage of white cells;
SKCM	cis	rs66573146	1.000	rs59683609	chr4:6964910	C/G	cg00086871	chr4:6988644	TBC1D14	1.43	5.33	0.52	9.25e-7	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs2836974	0.568	rs452377	chr21:40537183	T/C	cg11644478	chr21:40555479	PSMG1	0.8	7.6	0.65	5.6e-11	Cognitive function;
SKCM	cis	rs2153535	0.580	rs7745043	chr6:8513507	T/C	cg07606381	chr6:8435919	SLC35B3	0.86	6.25	0.58	2.06e-8	Motion sickness;
SKCM	cis	rs1799949	0.931	rs9912203	chr17:41445145	A/G	cg05368731	chr17:41323189	NBR1	-0.86	-6.79	-0.61	1.95e-9	Menopause (age at onset);
SKCM	cis	rs34779708	0.931	rs4934524	chr10:35270921	G/C	cg03585969	chr10:35415529	CREM	0.73	5.98	0.56	6.4e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs801193	0.660	rs2659897	chr7:66187715	A/G	cg18876405	chr7:65276391	NA	-0.65	-6.37	-0.58	1.24e-8	Aortic root size;
SKCM	cis	rs28386778	0.897	rs57108948	chr17:61802378	T/C	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.36	0.52	8.08e-7	Prudent dietary pattern;
SKCM	cis	rs36207871	1	rs36207871	chr12:56684496	TAGGAA/T	cg26714650	chr12:56694279	CS	1.71	6.71	0.61	2.74e-9	Inflammatory skin disease;
SKCM	cis	rs6430585	0.591	rs12475553	chr2:136483355	G/T	cg07169764	chr2:136633963	MCM6	1.15	8.6	0.7	6.43e-13	Corneal structure;
SKCM	cis	rs1395	1.000	rs1275538	chr2:27441397	C/T	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.49	4.97	0.49	3.84e-6	Blood metabolite levels;
SKCM	cis	rs2228479	0.867	rs76885005	chr16:89966668	A/G	cg00800038	chr16:89945340	TCF25	-0.93	-5.34	-0.52	8.73e-7	Skin colour saturation;
SKCM	cis	rs4665809	0.590	rs7579504	chr2:26439995	T/C	cg26119090	chr2:26468346	HADHA;HADHB	-1.06	-8.39	-0.69	1.66e-12	Gut microbiome composition (summer);
SKCM	cis	rs2839186	0.619	rs55689527	chr21:47622727	A/G	cg13126279	chr21:47581558	C21orf56	-0.69	-6.1	-0.57	3.8e-8	Testicular germ cell tumor;
SKCM	cis	rs9926296	0.565	rs8055825	chr16:89832848	C/T	cg27121462	chr16:89883253	FANCA	0.81	7.28	0.64	2.3e-10	Vitiligo;
SKCM	cis	rs1850744	0.702	rs55916508	chr4:9589334	C/A	cg15442990	chr4:9534313	NA	-1.4	-5.12	-0.5	2.11e-6	Economic and political preferences;
SKCM	cis	rs12711979	0.509	rs10192699	chr2:3824297	A/G	cg17052675	chr2:3827356	NA	-0.82	-8.9	-0.71	1.66e-13	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs4523957	0.651	rs4790316	chr17:2074977	T/C	cg16513277	chr17:2031491	SMG6	-0.79	-5.88	-0.55	9.52e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs7635838	0.722	rs2594982	chr3:11379958	C/T	cg00170343	chr3:11313890	ATG7	0.7	5.54	0.53	3.93e-7	HDL cholesterol;
SKCM	cis	rs7772486	0.764	rs2265468	chr6:146218346	A/C	cg05347473	chr6:146136440	FBXO30	0.56	5.28	0.51	1.12e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7829975	0.533	rs1039917	chr8:8718850	C/T	cg06636001	chr8:8085503	FLJ10661	0.76	6.35	0.58	1.34e-8	Mood instability;
SKCM	cis	rs60871478	0.636	rs12532761	chr7:905229	C/T	cg05535760	chr7:792225	HEATR2	-1.34	-8.04	-0.67	7.79e-12	Cerebrospinal P-tau181p levels;
SKCM	cis	rs3820928	0.874	rs10210963	chr2:227821845	A/G	cg11843606	chr2:227700838	RHBDD1	-0.6	-4.81	-0.48	7.17e-6	Pulmonary function;
SKCM	cis	rs4665809	0.590	rs10179959	chr2:26426403	G/A	cg26119090	chr2:26468346	HADHA;HADHB	-1.02	-8.05	-0.67	7.59e-12	Gut microbiome composition (summer);
SKCM	cis	rs1850744	0.702	rs6836184	chr4:9633711	A/C	cg15442990	chr4:9534313	NA	1.4	5.34	0.52	9.08e-7	Economic and political preferences;
SKCM	cis	rs12682352	0.652	rs3789843	chr8:8724257	C/T	cg06636001	chr8:8085503	FLJ10661	0.69	5.43	0.52	6.17e-7	Neuroticism;
SKCM	cis	rs7666738	0.791	rs13146909	chr4:98934198	C/T	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2842992	0.915	rs1322427	chr6:160075454	C/A	cg11366901	chr6:160182831	ACAT2	0.93	6.93	0.62	1.05e-9	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs2153535	0.580	rs1414349	chr6:8472290	A/G	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs3818285	0.679	rs2475275	chr10:111633979	C/T	cg00817464	chr10:111662876	XPNPEP1	0.74	8.48	0.69	1.1e-12	Superior crus of antihelix expression;
SKCM	cis	rs4819052	0.851	rs12626188	chr21:46669258	A/G	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.36	0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs4237845	0.537	rs4237844	chr12:58267987	A/G	cg02175503	chr12:58329896	NA	-0.74	-6.02	-0.56	5.42e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs642803	1.000	rs557675	chr11:65566719	G/T	cg27068330	chr11:65405492	SIPA1	-0.76	-5.32	-0.52	9.73e-7	Urate levels;
SKCM	cis	rs1790761	0.520	rs12805884	chr11:67387977	G/A	cg24690094	chr11:67383802	NA	-0.57	-5.96	-0.56	6.91e-8	Mean corpuscular volume;
SKCM	cis	rs11098499	0.865	rs4001305	chr4:120359236	G/T	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs10927875	0.619	rs7546589	chr1:16129530	A/G	cg21385522	chr1:16154831	NA	-0.73	-7.11	-0.63	4.96e-10	Dilated cardiomyopathy;
SKCM	cis	rs11112613	0.713	rs11112589	chr12:105951226	C/G	cg03607813	chr12:105948248	NA	-0.82	-5.59	-0.54	3.18e-7	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;
SKCM	cis	rs1568889	1.000	rs34667360	chr11:28055650	T/G	cg06544937	chr11:28130018	METT5D1;KIF18A	0.86	7.03	0.62	6.97e-10	Bipolar disorder;
SKCM	cis	rs7659604	0.540	rs13113421	chr4:122670064	G/A	cg19671926	chr4:122722719	EXOSC9	0.76	6.16	0.57	3.02e-8	Type 2 diabetes;
SKCM	cis	rs10089	0.552	rs1351141	chr5:127550055	A/C	cg25462716	chr5:127418816	SLC12A2;FLJ33630	-0.63	-5.25	-0.51	1.27e-6	Ileal carcinoids;
SKCM	cis	rs1639906	0.895	rs35038526	chr7:2213106	A/G	cg02951883	chr7:2050386	MAD1L1	0.66	5.36	0.52	8.14e-7	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs35306767	0.903	rs12249828	chr10:894838	C/T	cg25614935	chr10:1084866	C10orf110	0.78	4.94	0.49	4.29e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs28595532	1.000	rs56225646	chr4:119651217	T/C	cg14228332	chr4:119757509	SEC24D	0.97	4.92	0.49	4.71e-6	Cannabis dependence symptom count;
SKCM	cis	rs9815354	0.812	rs56332587	chr3:42012714	T/C	cg03022575	chr3:42003672	ULK4	1.0	5.0	0.49	3.43e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs17376456	0.825	rs17372649	chr5:93126096	C/G	cg21475434	chr5:93447410	FAM172A	0.9	4.99	0.49	3.65e-6	Diabetic retinopathy;
SKCM	cis	rs9858542	0.953	rs7622302	chr3:49547561	T/C	cg03060546	chr3:49711283	APEH	-0.75	-5.53	-0.53	4.17e-7	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs2836974	0.590	rs9974757	chr21:40617244	T/C	cg11890956	chr21:40555474	PSMG1	-0.88	-9.14	-0.72	5.76e-14	Cognitive function;
SKCM	cis	rs1348850	0.914	rs7591807	chr2:178252986	A/G	cg02961200	chr2:178257176	LOC100130691;AGPS	0.94	7.09	0.63	5.29e-10	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs56104184	0.775	rs56317021	chr19:49395960	C/T	cg19746536	chr19:49375674	PPP1R15A	1.13	5.5	0.53	4.69e-7	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	trans	rs208520	0.690	rs12213575	chr6:66735989	A/G	cg15611600	chr13:45563400	KIAA1704;NUFIP1	0.93	7.71	0.66	3.36e-11	Exhaled nitric oxide output;
SKCM	cis	rs362272	0.524	rs6819202	chr4:3368264	G/A	cg21096898	chr4:3318625	RGS12	0.99	12.57	0.82	1.9e-20	Serum sulfate level;
SKCM	cis	rs7666738	0.830	rs921522	chr4:98841608	C/T	cg17366294	chr4:99064904	C4orf37	0.55	4.86	0.48	6e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2288073	0.965	rs10185445	chr2:24410976	A/C	cg06627628	chr2:24431161	ITSN2	0.74	5.04	0.5	2.91e-6	Venous thromboembolism (SNP x SNP interaction);
SKCM	cis	rs941408	1.000	rs1736181	chr19:2797703	C/T	cg17333051	chr19:2783644	SGTA	0.42	4.93	0.49	4.45e-6	Total cholesterol levels;
SKCM	cis	rs4808199	1.000	rs60003758	chr19:19557353	A/G	cg03709012	chr19:19516395	GATAD2A	1.13	8.66	0.7	4.94e-13	Nonalcoholic fatty liver disease;
SKCM	cis	rs28595532	0.920	rs115226628	chr4:119639818	A/G	cg11846333	chr4:119757529	SEC24D	1.15	6.24	0.58	2.13e-8	Cannabis dependence symptom count;
SKCM	cis	rs28386778	0.897	rs896064	chr17:61860932	C/T	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs7666738	0.830	rs13112037	chr4:98976986	A/T	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2075671	0.903	rs11983334	chr7:100302434	C/T	cg20848291	chr7:100343083	ZAN	-0.71	-5.36	-0.52	8.19e-7	Other erythrocyte phenotypes;
SKCM	cis	rs10929159	0.928	rs2123513	chr2:236920638	T/C	cg14226755	chr2:236923322	AGAP1	0.29	4.77	0.48	8.43e-6	Parkinson's disease;
SKCM	cis	rs11112613	0.609	rs6539218	chr12:105934875	C/T	cg03607813	chr12:105948248	NA	0.92	5.03	0.49	3.07e-6	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;
SKCM	cis	rs951366	0.589	rs823099	chr1:205669322	C/A	cg14893161	chr1:205819251	PM20D1	0.89	7.95	0.67	1.2e-11	Menarche (age at onset);
SKCM	cis	rs8072100	0.570	rs9905073	chr17:45468296	G/A	cg08085267	chr17:45401833	C17orf57	-0.62	-4.98	-0.49	3.79e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs514406	0.505	rs269292	chr1:53187911	T/C	cg16325326	chr1:53192061	ZYG11B	0.92	10.34	0.76	2.75e-16	Monocyte count;
SKCM	cis	rs4819052	0.851	rs28616694	chr21:46674786	G/C	cg19498844	chr21:46707878	POFUT2;LOC642852	0.88	7.76	0.66	2.78e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs2243480	1.000	rs73150014	chr7:65450919	A/C	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs752010	0.806	rs943375	chr1:42092152	A/G	cg06885757	chr1:42089581	HIVEP3	0.5	4.87	0.48	5.65e-6	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs7772486	0.686	rs9399564	chr6:146078907	C/T	cg23711669	chr6:146136114	FBXO30	-0.85	-9.39	-0.73	1.91e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7666738	0.830	rs1593569	chr4:99017485	C/G	cg05340658	chr4:99064831	C4orf37	0.67	5.16	0.5	1.85e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2737618	0.674	rs2821332	chr1:200085714	A/T	cg21825944	chr1:200113062	NR5A2	-0.59	-4.93	-0.49	4.55e-6	Uric acid levels;
SKCM	cis	rs34779708	0.733	rs7083266	chr10:35541632	C/A	cg03585969	chr10:35415529	CREM	0.74	5.42	0.52	6.41e-7	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs11098499	0.908	rs71614449	chr4:120387055	C/T	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs941408	1.000	rs1640272	chr19:2800192	A/T	cg06609049	chr19:2785107	THOP1	0.82	7.33	0.64	1.86e-10	Total cholesterol levels;
SKCM	cis	rs9814567	0.727	rs4437193	chr3:134352344	A/G	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.62	-5.0	-0.49	3.46e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs116095464	0.614	rs62344292	chr5:244630	G/A	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs6815814	0.950	rs67206233	chr4:38807853	T/C	cg02016764	chr4:38805732	TLR1	-0.76	-5.4	-0.52	6.95e-7	Breast cancer;
SKCM	cis	rs9913156	0.793	rs55974786	chr17:4567564	T/C	cg19197139	chr17:4613644	ARRB2	0.79	5.45	0.53	5.64e-7	Lymphocyte counts;
SKCM	cis	rs2243480	0.522	rs778717	chr7:65848151	G/C	cg18252515	chr7:66147081	NA	-1.42	-7.62	-0.65	5.04e-11	Diabetic kidney disease;
SKCM	cis	rs35146811	0.844	rs4424195	chr7:99642745	A/G	cg13334819	chr7:99746414	C7orf59	-0.75	-5.48	-0.53	5.02e-7	Coronary artery disease;
SKCM	cis	rs708547	0.647	rs781666	chr4:57830981	A/G	cg16868167	chr4:57843880	C4orf14;POLR2B	0.73	5.45	0.52	5.77e-7	Response to bleomycin (chromatid breaks);
SKCM	cis	rs6951245	1.000	rs74369356	chr7:1071711	T/C	cg03188948	chr7:1209495	NA	1.12	6.17	0.57	2.88e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7927771	0.524	rs7933896	chr11:47882782	C/T	cg20307385	chr11:47447363	PSMC3	0.71	5.65	0.54	2.55e-7	Subjective well-being;
SKCM	cis	rs67311347	1.000	rs10510708	chr3:40404770	A/G	cg00091569	chr3:40428383	ENTPD3	0.58	5.22	0.51	1.45e-6	Renal cell carcinoma;
SKCM	cis	rs2204008	0.743	rs2132212	chr12:38039405	G/A	cg26384229	chr12:38710491	ALG10B	0.75	6.26	0.58	1.95e-8	Bladder cancer;
SKCM	cis	rs838147	0.524	rs281395	chr19:49222483	C/G	cg13540341	chr19:49222985	MAMSTR	0.6	5.78	0.55	1.46e-7	Dietary macronutrient intake;
SKCM	cis	rs5769765	1.000	rs5770755	chr22:50280136	T/C	cg22709217	chr22:50311962	ALG12;CRELD2	0.78	5.62	0.54	2.89e-7	Schizophrenia;
SKCM	cis	rs1801251	1.000	rs67013068	chr2:233608253	G/C	cg25237894	chr2:233734115	C2orf82	0.56	5.33	0.52	9.23e-7	Coronary artery disease;
SKCM	cis	rs4332037	0.802	rs12113633	chr7:1932936	G/A	cg23422044	chr7:1970798	MAD1L1	-0.98	-6.76	-0.61	2.24e-9	Bipolar disorder;
SKCM	cis	rs7809950	1.000	rs2712201	chr7:107145564	T/C	cg23024343	chr7:107201750	COG5	-0.76	-6.83	-0.61	1.64e-9	Coronary artery disease;
SKCM	cis	rs9818758	0.607	rs5030795	chr3:49141116	C/T	cg24110177	chr3:50126178	RBM5	0.88	4.9	0.48	5.16e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs9906944	0.545	rs1994969	chr17:47080431	G/T	cg07075026	chr17:47091521	IGF2BP1	-0.53	-4.79	-0.48	7.8e-6	Intelligence (multi-trait analysis);Body fat percentage;
SKCM	cis	rs873946	0.586	rs3793686	chr10:134569559	A/G	cg18305652	chr10:134549665	INPP5A	0.58	5.57	0.53	3.49e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs7772486	0.790	rs6926657	chr6:146255794	G/A	cg23711669	chr6:146136114	FBXO30	-0.77	-7.33	-0.64	1.83e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1707322	1.000	rs10890353	chr1:46298383	G/T	cg03146154	chr1:46216737	IPP	0.75	5.15	0.5	1.94e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs8017423	0.935	rs8012299	chr14:90715822	G/T	cg04374321	chr14:90722782	PSMC1	0.97	8.91	0.71	1.61e-13	Mortality in heart failure;
SKCM	cis	rs6545883	0.894	rs4672436	chr2:61603357	A/C	cg15711740	chr2:61764176	XPO1	0.68	4.82	0.48	6.94e-6	Tuberculosis;
SKCM	cis	rs9926296	0.632	rs2011925	chr16:89814064	T/G	cg01097406	chr16:89675127	NA	-0.46	-5.0	-0.49	3.46e-6	Vitiligo;
SKCM	cis	rs12134245	0.776	rs12124682	chr1:91995542	A/G	cg25838465	chr1:92012736	NA	-0.84	-9.34	-0.73	2.32e-14	Breast cancer;
SKCM	cis	rs10197940	0.550	rs77233070	chr2:152416477	G/A	cg19508488	chr2:152266495	RIF1	0.58	4.78	0.48	7.99e-6	Lung cancer;
SKCM	cis	rs807669	0.935	rs712963	chr22:19156543	A/G	cg02655711	chr22:19163373	SLC25A1	0.6	5.7	0.54	2e-7	Metabolite levels;
SKCM	cis	rs7932354	0.528	rs10769234	chr11:47084061	G/C	cg03339077	chr11:47165057	C11orf49	-0.59	-4.79	-0.48	7.68e-6	Bone mineral density (hip);Bone mineral density;
SKCM	cis	rs7927771	0.524	rs10838758	chr11:47771476	T/C	cg20307385	chr11:47447363	PSMC3	0.71	5.63	0.54	2.67e-7	Subjective well-being;
SKCM	cis	rs826838	0.967	rs1352122	chr12:39130885	G/A	cg13010199	chr12:38710504	ALG10B	-0.72	-5.73	-0.54	1.83e-7	Heart rate;
SKCM	cis	rs7666738	0.830	rs13116691	chr4:98929771	A/C	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs3820068	0.581	rs6429762	chr1:15945595	A/C	cg24675056	chr1:15929824	NA	0.73	5.44	0.52	6.03e-7	Systolic blood pressure;
SKCM	cis	rs1325195	0.537	rs61821690	chr1:179188006	C/T	cg25467746	chr1:179556597	NA	0.65	5.86	0.55	1.04e-7	IgE grass sensitization;
SKCM	cis	rs561341	1.000	rs4795667	chr17:30244443	T/C	cg13647721	chr17:30228624	UTP6	0.77	4.81	0.48	7.1e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs7213347	0.780	rs1555568	chr17:2149505	T/C	cg18413116	chr17:2293477	MNT	-0.65	-4.92	-0.49	4.74e-6	Total body bone mineral density;
SKCM	cis	rs79040073	0.530	rs113085328	chr15:49515901	C/T	cg25951582	chr15:49913451	C15orf33;DTWD1	-0.72	-5.22	-0.51	1.44e-6	Lung cancer in ever smokers;
SKCM	cis	rs7666738	0.830	rs6823718	chr4:99063202	C/T	cg05340658	chr4:99064831	C4orf37	0.66	4.87	0.48	5.74e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7214628	1	rs7214628	chr17:73882148	A/G	cg08125733	chr17:73851984	WBP2	1.0	5.3	0.51	1.03e-6	White matter hyperintensity burden;
SKCM	cis	rs10751667	0.643	rs11246344	chr11:933783	A/C	cg06064525	chr11:970664	AP2A2	-0.55	-5.09	-0.5	2.46e-6	Alzheimer's disease (late onset);
SKCM	cis	rs7000551	0.505	rs13258195	chr8:22227271	A/G	cg12081754	chr8:22256438	SLC39A14	-0.98	-9.4	-0.73	1.82e-14	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs55962025	0.644	rs6446723	chr4:3126813	T/C	cg00764545	chr4:3318001	RGS12	-0.59	-5.12	-0.5	2.15e-6	Parental longevity (mother's age at death);
SKCM	cis	rs2857078	0.772	rs2079008	chr17:42322132	C/A	cg13607699	chr17:42295918	UBTF	-0.93	-7.19	-0.63	3.43e-10	Red cell distribution width;Reticulocyte count;
SKCM	trans	rs3780486	0.846	rs10758192	chr9:33131651	G/A	cg04842962	chr6:43655489	MRPS18A	1.03	10.85	0.78	2.95e-17	IgG glycosylation;
SKCM	cis	rs8077889	0.956	rs6503476	chr17:41850163	C/T	cg26893861	chr17:41843967	DUSP3	1.25	7.71	0.66	3.36e-11	Triglycerides;
SKCM	cis	rs7829975	0.782	rs6990746	chr8:8547811	A/G	cg06636001	chr8:8085503	FLJ10661	-0.76	-6.16	-0.57	2.99e-8	Mood instability;
SKCM	cis	rs116095464	0.558	rs7725227	chr5:233517	G/A	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs838147	0.844	rs12611201	chr19:49248255	G/A	cg13540341	chr19:49222985	MAMSTR	0.56	5.06	0.5	2.77e-6	Dietary macronutrient intake;
SKCM	cis	rs10752881	0.775	rs2147585	chr1:183074875	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Colorectal cancer;
SKCM	cis	rs1348850	0.874	rs13013752	chr2:178456862	A/G	cg02961200	chr2:178257176	LOC100130691;AGPS	0.83	6.69	0.6	3.08e-9	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs2839186	0.771	rs13046451	chr21:47641373	T/A	cg05896524	chr21:47604654	C21orf56	-0.68	-5.63	-0.54	2.78e-7	Testicular germ cell tumor;
SKCM	cis	rs1865760	0.623	rs12216125	chr6:25997458	C/T	cg16482183	chr6:26056742	HIST1H1C	0.64	5.2	0.51	1.58e-6	Height;
SKCM	cis	rs1218582	0.741	rs10908444	chr1:154840287	G/A	cg06221963	chr1:154839813	KCNN3	-0.59	-5.99	-0.56	6.03e-8	Prostate cancer;
SKCM	cis	rs3820068	0.581	rs16849152	chr1:15921774	A/C	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs2295499	0.643	rs59609182	chr4:2721530	C/T	cg19433769	chr4:2420260	ZFYVE28	0.69	4.78	0.48	8.08e-6	Cognitive ability;Cognitive ability (multi-trait analysis);Intelligence (multi-trait analysis);
SKCM	cis	rs7511006	0.893	rs2272854	chr22:50658274	C/G	cg16473166	chr22:50639996	SELO	0.71	5.86	0.55	1.06e-7	Obesity-related traits;
SKCM	cis	rs2243480	1.000	rs7795242	chr7:65390094	T/C	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs60871478	0.898	rs62432225	chr7:789433	G/A	cg05535760	chr7:792225	HEATR2	1.15	9.71	0.74	4.47e-15	Cerebrospinal P-tau181p levels;
SKCM	cis	rs7772486	0.754	rs697055	chr6:146003790	C/G	cg23711669	chr6:146136114	FBXO30	0.89	9.02	0.71	9.97e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2304069	0.837	rs10041451	chr5:149385197	A/C	cg22760475	chr5:149380129	HMGXB3;TIGD6	0.78	5.88	0.55	9.64e-8	HIV-1 control;
SKCM	cis	rs10752881	1.000	rs12133714	chr1:182988252	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.73	6.47	0.59	7.97e-9	Colorectal cancer;
SKCM	cis	rs6582630	0.519	rs11609739	chr12:38547969	G/A	cg26384229	chr12:38710491	ALG10B	0.82	6.52	0.59	6.37e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs4423214	0.879	rs1792281	chr11:71135496	G/A	cg05163923	chr11:71159392	DHCR7	-0.65	-5.79	-0.55	1.38e-7	Vitamin D levels;
SKCM	cis	rs7809950	0.678	rs13230144	chr7:106909172	T/C	cg23024343	chr7:107201750	COG5	-0.79	-6.77	-0.61	2.16e-9	Coronary artery disease;
SKCM	cis	rs763014	0.931	rs2071982	chr16:630405	T/G	cg00908189	chr16:619842	PIGQ	0.82	7.78	0.66	2.55e-11	Height;
SKCM	cis	rs7824557	0.544	rs1865521	chr8:11231249	T/C	cg21775007	chr8:11205619	TDH	0.59	4.92	0.49	4.7e-6	Retinal vascular caliber;
SKCM	cis	rs4900538	0.927	rs2403058	chr14:102964654	A/G	cg18135206	chr14:102964638	TECPR2	0.8	6.44	0.59	9.14e-9	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs875971	0.660	rs801193	chr7:66030612	A/C	cg00343986	chr7:65444356	GUSB	-0.65	-4.77	-0.48	8.32e-6	Aortic root size;
SKCM	cis	rs6912958	0.525	rs586771	chr6:88064971	C/T	cg08069147	chr6:88032118	GJB7;C6orf162	0.77	7.31	0.64	1.98e-10	Monocyte percentage of white cells;
SKCM	cis	rs1577917	0.958	rs34765423	chr6:86484448	C/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.9	-9.12	-0.72	6.31e-14	Response to antipsychotic treatment;
SKCM	cis	rs950027	0.595	rs2486288	chr15:45712339	T/C	cg21132104	chr15:45694354	SPATA5L1	0.74	5.41	0.52	6.68e-7	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs4237845	0.844	rs7306124	chr12:58303349	A/T	cg00677455	chr12:58241039	CTDSP2	0.72	6.21	0.58	2.41e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs57994353	0.508	rs7874956	chr9:139336813	T/G	cg14169450	chr9:139327907	INPP5E	0.49	5.04	0.5	2.99e-6	Eosinophil counts;Cutaneous squamous cell carcinoma;
SKCM	cis	rs704795	0.902	rs11887784	chr2:27679919	A/G	cg05696406	chr2:27599888	SNX17	0.52	5.13	0.5	2.1e-6	Menopause (age at onset);
SKCM	cis	rs1691799	0.899	rs1168305	chr12:66738714	A/G	cg16791601	chr12:66731901	HELB	-0.66	-5.81	-0.55	1.31e-7	White blood cell count (basophil);
SKCM	cis	rs523522	0.962	rs4767914	chr12:120993817	C/T	cg27279351	chr12:120934652	DYNLL1	0.91	8.32	0.69	2.26e-12	High light scatter reticulocyte count;
SKCM	cis	rs4803468	1.000	rs2241706	chr19:41912807	A/G	cg14132834	chr19:41945861	ATP5SL	-0.77	-6.08	-0.57	4.18e-8	Height;
SKCM	cis	rs6977660	0.943	rs10249996	chr7:19844935	G/A	cg07541023	chr7:19748670	TWISTNB	0.7	4.92	0.49	4.79e-6	Thyroid stimulating hormone;
SKCM	cis	rs9399135	0.967	rs9376085	chr6:135371224	T/C	cg24558204	chr6:135376177	HBS1L	0.58	5.05	0.5	2.86e-6	Red blood cell count;
SKCM	cis	rs58688157	0.705	rs12795572	chr11:590999	G/A	cg16486109	chr11:613632	IRF7	1.0	6.16	0.57	2.96e-8	Systemic lupus erythematosus;
SKCM	cis	rs2404602	0.669	rs12916324	chr15:77179603	G/A	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs7829975	0.564	rs2921057	chr8:8318667	C/T	cg15556689	chr8:8085844	FLJ10661	0.84	7.8	0.66	2.27e-11	Mood instability;
SKCM	cis	rs7829975	0.811	rs7011229	chr8:8543324	T/C	cg06636001	chr8:8085503	FLJ10661	-0.76	-6.21	-0.58	2.4e-8	Mood instability;
SKCM	cis	rs7772486	0.686	rs2142983	chr6:146069701	G/C	cg23711669	chr6:146136114	FBXO30	-0.84	-9.08	-0.72	7.59e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2404602	0.735	rs12903874	chr15:76693318	A/T	cg23625390	chr15:77176239	SCAPER	-0.83	-8.07	-0.67	6.97e-12	Blood metabolite levels;
SKCM	cis	rs826838	1.000	rs4575342	chr12:38663831	G/A	cg13010199	chr12:38710504	ALG10B	0.72	5.27	0.51	1.19e-6	Heart rate;
SKCM	cis	rs12478296	0.901	rs73007142	chr2:243010852	T/C	cg06360820	chr2:242988706	NA	-1.12	-5.57	-0.53	3.55e-7	Obesity-related traits;
SKCM	cis	rs651907	0.557	rs11925001	chr3:101373966	C/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.81	7.02	0.62	7.26e-10	Colorectal cancer;
SKCM	trans	rs1814175	0.817	rs4084376	chr11:49831160	T/C	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs9443189	0.763	rs2748952	chr6:76444360	G/A	cg01950844	chr6:76311363	SENP6	-0.75	-5.29	-0.51	1.1e-6	Prostate cancer;
SKCM	cis	rs7843479	0.562	rs2127206	chr8:21786989	C/T	cg17168535	chr8:21777572	XPO7	0.75	6.9	0.62	1.2e-9	Mean corpuscular volume;
SKCM	cis	rs6570726	0.738	rs6925594	chr6:145898454	T/C	cg23711669	chr6:146136114	FBXO30	0.88	9.09	0.72	7.08e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs55794721	0.509	rs909834	chr1:25757996	A/G	cg27572855	chr1:25598939	RHD	0.53	4.96	0.49	4.07e-6	Plateletcrit;Mean corpuscular volume;
SKCM	cis	rs116095464	0.558	rs10080225	chr5:232175	A/G	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs7937682	0.961	rs11828343	chr11:111491322	A/G	cg09085632	chr11:111637200	PPP2R1B	0.96	9.84	0.74	2.58e-15	Primary sclerosing cholangitis;
SKCM	cis	rs9916302	0.784	rs34473775	chr17:37396201	G/T	cg07936489	chr17:37558343	FBXL20	-0.89	-7.67	-0.66	4.08e-11	Glomerular filtration rate (creatinine);
SKCM	cis	rs10504073	0.584	rs11784268	chr8:49956339	T/G	cg00325661	chr8:49890786	NA	0.8	6.81	0.61	1.83e-9	Blood metabolite ratios;
SKCM	cis	rs1707322	1.000	rs4660331	chr1:46458783	A/C	cg03146154	chr1:46216737	IPP	0.77	5.1	0.5	2.36e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs12950390	0.853	rs12450729	chr17:45855363	A/G	cg03474202	chr17:45855739	NA	-0.49	-5.58	-0.53	3.34e-7	IgG glycosylation;
SKCM	cis	rs2811415	0.597	rs67527747	chr3:127803083	G/A	cg09089421	chr3:127803668	RUVBL1	1.0	8.69	0.7	4.4e-13	Lung function (FEV1/FVC);
SKCM	cis	rs12477438	0.520	rs6712704	chr2:99719687	C/T	cg26064155	chr2:99771622	LIPT1;TSGA10	1.02	10.07	0.75	9.12e-16	Chronic sinus infection;
SKCM	cis	rs9486715	0.809	rs9486467	chr6:96971803	C/T	cg06623918	chr6:96969491	KIAA0776	0.82	7.27	0.64	2.38e-10	Headache;
SKCM	cis	rs4803468	0.934	rs8103531	chr19:41891974	C/T	cg09537434	chr19:41945824	ATP5SL	-1.07	-11.75	-0.8	6.27e-19	Height;
SKCM	cis	rs11148252	0.904	rs3892337	chr13:53029485	C/G	cg00495681	chr13:53174319	NA	0.61	5.18	0.51	1.71e-6	Lewy body disease;
SKCM	cis	rs3743104	1.000	rs3743105	chr15:33023951	T/C	cg07179000	chr15:33023586	GREM1	-0.62	-6.86	-0.61	1.47e-9	Hypospadias;
SKCM	cis	rs4077515	0.839	rs10781518	chr9:139300547	C/T	cg21253087	chr9:139290292	SNAPC4	-0.63	-4.78	-0.48	8.18e-6	Ulcerative colitis;IgA nephropathy;Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs4481887	0.893	rs4297335	chr1:248473421	C/T	cg00666640	chr1:248458726	OR2T12	0.66	6.0	0.56	5.9e-8	Common traits (Other);
SKCM	cis	rs9814567	0.929	rs9855013	chr3:134240414	C/T	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	trans	rs3780486	0.846	rs6476399	chr9:33123013	A/G	cg20290983	chr6:43655470	MRPS18A	0.98	10.97	0.78	1.78e-17	IgG glycosylation;
SKCM	cis	rs7666738	0.570	rs1869351	chr4:99077286	T/C	cg17366294	chr4:99064904	C4orf37	0.61	5.06	0.5	2.73e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1942	0.837	rs12440045	chr15:41782684	A/C	cg18705301	chr15:41695430	NDUFAF1	-0.74	-5.45	-0.53	5.65e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs911263	0.961	rs7148416	chr14:68747868	A/T	cg18825221	chr14:68749962	RAD51L1	0.47	5.16	0.5	1.81e-6	Primary biliary cholangitis;
SKCM	cis	rs2279817	1.000	rs2279817	chr1:18021858	T/C	cg17142039	chr1:18149651	ACTL8	-0.57	-4.77	-0.48	8.4e-6	Neuroticism;
SKCM	cis	rs6951245	0.554	rs76243429	chr7:1152543	C/T	cg23708337	chr7:1209742	NA	0.73	5.05	0.5	2.78e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs35306767	0.953	rs1106064	chr10:957211	G/A	cg26597838	chr10:835615	NA	0.67	5.22	0.51	1.44e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs6138458	1.000	rs227629	chr20:24913551	G/T	cg26195577	chr20:24973756	C20orf3	1.29	8.69	0.7	4.32e-13	Blood protein levels;
SKCM	cis	rs4803468	0.901	rs3745292	chr19:41888506	A/G	cg14132834	chr19:41945861	ATP5SL	-0.74	-5.71	-0.54	1.99e-7	Height;
SKCM	cis	rs9311474	0.967	rs610060	chr3:52273421	G/A	cg18404041	chr3:52824283	ITIH1	0.53	4.84	0.48	6.39e-6	Electroencephalogram traits;
SKCM	cis	rs4803468	0.967	rs3826713	chr19:41892269	C/T	cg14132834	chr19:41945861	ATP5SL	-0.74	-5.71	-0.54	1.99e-7	Height;
SKCM	cis	rs738322	0.935	rs75387	chr22:38572057	C/T	cg25457927	chr22:38595422	NA	-0.56	-6.49	-0.59	7.23e-9	Cutaneous nevi;
SKCM	cis	rs1799949	1.000	rs8070085	chr17:41341984	C/T	cg05368731	chr17:41323189	NBR1	-0.84	-6.88	-0.61	1.34e-9	Menopause (age at onset);
SKCM	cis	rs4319547	0.619	rs10744208	chr12:122931559	C/A	cg23029597	chr12:123009494	RSRC2	-0.77	-5.53	-0.53	4.13e-7	Body mass index;
SKCM	cis	rs12142240	0.698	rs72677600	chr1:46834449	G/A	cg10495392	chr1:46806563	NSUN4	0.75	5.6	0.54	3.1e-7	Menopause (age at onset);
SKCM	cis	rs35146811	0.844	rs10281368	chr7:99655897	A/G	cg22906224	chr7:99728672	NA	0.79	5.89	0.55	9.18e-8	Coronary artery disease;
SKCM	cis	rs651907	0.557	rs3094297	chr3:101399260	A/G	cg12386194	chr3:101231763	SENP7	0.69	5.68	0.54	2.23e-7	Colorectal cancer;
SKCM	cis	rs72781680	0.752	rs56152044	chr2:23927680	A/G	cg08917208	chr2:24149416	ATAD2B	0.95	4.78	0.48	8.1e-6	Lymphocyte counts;
SKCM	cis	rs2836974	0.899	rs8127087	chr21:40544502	C/T	cg17971929	chr21:40555470	PSMG1	0.87	8.48	0.69	1.1e-12	Cognitive function;
SKCM	cis	rs644799	0.511	rs12791736	chr11:95475399	C/G	cg03916912	chr11:95522834	CEP57;FAM76B	0.67	5.05	0.5	2.81e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs6088590	0.523	rs6058084	chr20:33183804	C/T	cg24642439	chr20:33292090	TP53INP2	0.76	5.84	0.55	1.13e-7	Coronary artery disease;
SKCM	trans	rs66573146	1.000	rs67067921	chr4:6984341	A/T	cg07817883	chr1:32538562	TMEM39B	2.0	8.02	0.67	8.59e-12	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs561341	1.000	rs7210970	chr17:30262169	G/A	cg23018236	chr17:30244563	NA	-0.53	-5.54	-0.53	3.96e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs4642101	0.597	rs9839768	chr3:12821403	C/T	cg05775895	chr3:12838266	CAND2	0.68	6.16	0.57	2.99e-8	QRS complex (12-leadsum);
SKCM	cis	rs995000	0.931	rs11208000	chr1:63108374	A/G	cg06896770	chr1:63153194	DOCK7	0.77	7.31	0.64	2.05e-10	Triglyceride levels;
SKCM	cis	rs861020	0.677	rs12723578	chr1:210032392	G/A	cg05527609	chr1:210001259	C1orf107	-1.18	-7.72	-0.66	3.34e-11	Orofacial clefts;
SKCM	cis	rs8037137	0.731	rs78029804	chr15:91538920	C/T	cg15878949	chr15:91534302	PRC1	0.68	5.23	0.51	1.38e-6	Platelet count;Serous invasive ovarian cancer;High-grade serous ovarian cancer;Invasive epithelial ovarian cancer;
SKCM	cis	rs362272	0.524	rs6819202	chr4:3368264	G/A	cg24015175	chr4:3319247	RGS12	0.81	9.66	0.74	5.77e-15	Serum sulfate level;
SKCM	cis	rs11960470	1.000	rs11960470	chr5:50328257	A/C	cg06027927	chr5:50259733	NA	0.62	5.88	0.55	9.58e-8	Breast cancer;
SKCM	cis	rs951366	0.677	rs1775140	chr1:205672107	C/A	cg24503407	chr1:205819492	PM20D1	0.78	6.41	0.59	1.01e-8	Menarche (age at onset);
SKCM	cis	rs6570726	0.720	rs412623	chr6:145883257	C/A	cg23711669	chr6:146136114	FBXO30	0.8	8.34	0.69	2.02e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4481887	0.962	rs6663952	chr1:248465682	A/G	cg00666640	chr1:248458726	OR2T12	0.59	4.98	0.49	3.72e-6	Common traits (Other);
SKCM	cis	rs10779751	0.770	rs6701524	chr1:11198502	A/G	cg08854313	chr1:11322531	MTOR	-0.79	-5.1	-0.5	2.31e-6	Body mass index;
SKCM	cis	rs9300255	0.569	rs1727320	chr12:123700476	T/A	cg00376283	chr12:123451042	ABCB9	0.83	5.49	0.53	4.74e-7	Neutrophil percentage of white cells;
SKCM	cis	rs35306767	0.807	rs72778228	chr10:938435	A/G	cg26597838	chr10:835615	NA	0.86	5.69	0.54	2.12e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs28595532	0.920	rs56303276	chr4:119723514	C/T	cg21605333	chr4:119757512	SEC24D	1.35	7.92	0.67	1.37e-11	Cannabis dependence symptom count;
SKCM	cis	rs12474201	0.928	rs12999586	chr2:46938736	C/T	cg06386533	chr2:46925753	SOCS5	1.01	9.25	0.72	3.5e-14	Height;
SKCM	cis	rs7811142	0.830	rs78256546	chr7:99952970	A/G	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.07	6.7	0.6	2.88e-9	Platelet count;
SKCM	cis	rs6665290	0.835	rs7549465	chr1:227214399	A/C	cg10327440	chr1:227177885	CDC42BPA	-1.18	-15.59	-0.87	1.13e-25	Myeloid white cell count;
SKCM	cis	rs7208859	0.623	rs9893422	chr17:29111715	A/G	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs6951245	1.000	rs76804143	chr7:1082021	C/T	cg18402987	chr7:1209562	NA	1.14	6.01	0.56	5.68e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs2180341	0.960	rs9398839	chr6:127665863	G/A	cg27446573	chr6:127587934	RNF146	0.95	8.22	0.68	3.46e-12	Breast cancer;
SKCM	cis	rs763014	0.898	rs35666389	chr16:629458	A/G	cg00908189	chr16:619842	PIGQ	0.82	7.78	0.66	2.54e-11	Height;
SKCM	cis	rs1957429	1.000	rs1998333	chr14:65353632	A/G	cg23373153	chr14:65346875	NA	1.03	6.23	0.58	2.18e-8	Pediatric areal bone mineral density (radius);
SKCM	cis	rs8133974	0.887	rs73205303	chr21:36467830	G/A	cg00621029	chr21:35747559	FAM165B	0.75	4.98	0.49	3.66e-6	Eosinophil counts;Eosinophil percentage of granulocytes;Sum eosinophil basophil counts;
SKCM	cis	rs2836950	0.520	rs59916147	chr21:40634702	T/G	cg17971929	chr21:40555470	PSMG1	-0.75	-6.24	-0.58	2.1e-8	Menarche (age at onset);
SKCM	cis	rs10448080	0.879	rs240946	chr8:28568905	A/G	cg12116192	chr8:27730485	SCARA5	-0.4	-5.02	-0.49	3.16e-6	Height;
SKCM	cis	rs11098499	0.863	rs13134665	chr4:120426430	T/C	cg09307838	chr4:120376055	NA	1.0	7.66	0.66	4.31e-11	Corneal astigmatism;
SKCM	cis	rs9733	0.650	rs9803935	chr1:150552622	T/G	cg13175981	chr1:150552382	MCL1	0.75	6.6	0.6	4.55e-9	Tonsillectomy;
SKCM	cis	rs897984	0.759	rs13708	chr16:31000809	G/A	cg00531865	chr16:30841666	NA	0.59	4.97	0.49	3.81e-6	Dementia with Lewy bodies;
SKCM	cis	rs8077889	0.703	rs231534	chr17:41945564	C/T	cg26893861	chr17:41843967	DUSP3	-0.92	-5.02	-0.49	3.23e-6	Triglycerides;
SKCM	trans	rs1814175	0.645	rs4625470	chr11:49983769	T/C	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs7666738	0.830	rs10009943	chr4:99021475	G/A	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4523957	0.583	rs923863	chr17:2031387	A/G	cg16513277	chr17:2031491	SMG6	-0.91	-6.21	-0.58	2.38e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs8067545	0.611	rs7219615	chr17:20132558	T/A	cg13482628	chr17:19912719	NA	-0.65	-5.44	-0.52	5.84e-7	Schizophrenia;
SKCM	cis	rs870825	0.929	rs2310102	chr4:185595141	C/G	cg04058563	chr4:185651563	MLF1IP	-0.99	-6.16	-0.57	2.95e-8	Blood protein levels;
SKCM	cis	rs72615157	0.697	rs2056726	chr7:99780283	G/A	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.07	6.59	0.6	4.62e-9	Lung function (FEV1/FVC);
SKCM	cis	rs4237845	0.844	rs4628718	chr12:58301600	A/C	cg02175503	chr12:58329896	NA	0.74	6.71	0.6	2.82e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs9633740	0.545	rs2343306	chr10:82230146	A/G	cg01528321	chr10:82214614	TSPAN14	-1.11	-9.08	-0.72	7.64e-14	Post bronchodilator FEV1;
SKCM	cis	rs4740619	0.619	rs1359956	chr9:16044097	A/G	cg14451791	chr9:16040625	NA	-0.46	-4.86	-0.48	5.94e-6	Body mass index;
SKCM	cis	rs4523957	0.620	rs8070272	chr17:2063117	A/G	cg16513277	chr17:2031491	SMG6	-0.79	-5.63	-0.54	2.7e-7	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs67311347	0.544	rs1454492	chr3:40352884	C/T	cg00656387	chr3:40428638	ENTPD3	0.55	4.77	0.48	8.39e-6	Renal cell carcinoma;
SKCM	cis	rs28386778	0.897	rs2854213	chr17:61945631	T/C	cg01411255	chr17:61851458	DDX42;CCDC47	0.78	5.01	0.49	3.26e-6	Prudent dietary pattern;
SKCM	trans	rs3780486	0.846	rs10758192	chr9:33131651	G/A	cg20290983	chr6:43655470	MRPS18A	1.0	11.51	0.79	1.7e-18	IgG glycosylation;
SKCM	cis	rs7666738	0.830	rs28451001	chr4:98924544	T/A	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs12971120	0.947	rs8084410	chr18:72168486	T/C	cg26446133	chr18:72167187	CNDP2	-0.67	-5.65	-0.54	2.54e-7	Refractive error;
SKCM	cis	rs4481887	0.927	rs4307598	chr1:248474544	T/C	cg00666640	chr1:248458726	OR2T12	0.66	6.0	0.56	5.9e-8	Common traits (Other);
SKCM	cis	rs1577917	0.917	rs35038582	chr6:86721305	T/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.82	-8.08	-0.67	6.61e-12	Response to antipsychotic treatment;
SKCM	cis	rs738322	0.967	rs4385	chr22:38573229	T/C	cg25457927	chr22:38595422	NA	-0.56	-6.41	-0.59	1.03e-8	Cutaneous nevi;
SKCM	cis	rs10256972	0.684	rs10264122	chr7:1009337	T/C	cg07930192	chr7:1003750	NA	0.52	5.07	0.5	2.63e-6	Longevity;Endometriosis;
SKCM	cis	rs4905558	1.000	rs1951312	chr14:97334742	A/G	cg11863609	chr14:97355128	NA	-0.54	-4.81	-0.48	7.32e-6	Neutrophil count;
SKCM	cis	rs4724125	0.883	rs1156606	chr7:42682878	A/C	cg09407816	chr7:42972088	MRPL32;PSMA2	0.81	4.85	0.48	6.13e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs11690935	0.686	rs10165126	chr2:172820315	C/T	cg13550731	chr2:172543902	DYNC1I2	-0.77	-5.4	-0.52	6.98e-7	Schizophrenia;
SKCM	cis	rs2120019	0.935	rs12591119	chr15:75355944	A/G	cg17294928	chr15:75287854	SCAMP5	-0.83	-7.08	-0.63	5.44e-10	Blood trace element (Zn levels);
SKCM	cis	rs6952808	0.771	rs10265944	chr7:1918337	C/T	cg02951883	chr7:2050386	MAD1L1	-0.69	-5.82	-0.55	1.24e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs10791097	0.694	rs7106684	chr11:130758153	A/T	cg12179176	chr11:130786555	SNX19	0.93	8.37	0.69	1.82e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs7586085	0.522	rs1026328	chr2:166474601	G/A	cg01770810	chr2:165769913	SLC38A11	-0.5	-5.08	-0.5	2.52e-6	Total body bone mineral density;
SKCM	cis	rs2839186	0.900	rs2839196	chr21:47708037	G/A	cg13126279	chr21:47581558	C21orf56	-0.61	-5.19	-0.51	1.65e-6	Testicular germ cell tumor;
SKCM	cis	rs1160297	0.585	rs12713228	chr2:53090032	T/C	cg07782112	chr2:53107842	NA	0.59	6.26	0.58	1.91e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs7945705	0.837	rs10769981	chr11:9024460	T/C	cg13070366	chr11:9386451	NA	-0.61	-4.95	-0.49	4.22e-6	Hemoglobin concentration;
SKCM	trans	rs6481128	0.778	rs1670826	chr10:56699297	T/C	cg04272632	chr1:34629400	CSMD2	0.69	7.66	0.66	4.34e-11	Extraversion;
SKCM	cis	rs7811142	0.887	rs111972532	chr7:100069088	T/C	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.08	6.88	0.61	1.31e-9	Platelet count;
SKCM	cis	rs9814567	1.000	rs9851441	chr3:134315091	C/A	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs12142240	0.698	rs1475389	chr1:46816429	T/C	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs9902453	0.817	rs2617880	chr17:28106118	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.78	-5.29	-0.51	1.07e-6	Coffee consumption (cups per day);
SKCM	cis	rs7635838	0.650	rs1375206	chr3:11339117	C/G	cg00170343	chr3:11313890	ATG7	0.72	5.5	0.53	4.63e-7	HDL cholesterol;
SKCM	cis	rs2153535	0.580	rs9406159	chr6:8464859	C/G	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs9325144	0.581	rs2653758	chr12:38946233	G/T	cg26384229	chr12:38710491	ALG10B	-0.85	-8.36	-0.69	1.88e-12	Morning vs. evening chronotype;
SKCM	cis	rs10254284	0.921	rs2391591	chr7:28157664	G/T	cg15170557	chr7:28214983	JAZF1	-0.58	-4.78	-0.48	7.97e-6	Lymphocyte percentage of white cells;Systemic lupus erythematosus;
SKCM	cis	rs7633770	0.841	rs11709020	chr3:46680063	A/G	cg11219411	chr3:46661640	NA	-0.62	-5.64	-0.54	2.65e-7	Coronary artery disease;
SKCM	cis	rs854765	0.551	rs8070748	chr17:17859421	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.01	7.49	0.65	9.28e-11	Total body bone mineral density;
SKCM	cis	rs7940866	0.845	rs1991899	chr11:130801649	C/T	cg12179176	chr11:130786555	SNX19	-0.68	-5.11	-0.5	2.28e-6	Schizophrenia;
SKCM	cis	rs7937682	0.855	rs527078	chr11:111479713	T/C	cg09085632	chr11:111637200	PPP2R1B	-0.96	-9.87	-0.75	2.29e-15	Primary sclerosing cholangitis;
SKCM	cis	rs4975616	0.869	rs370348	chr5:1331219	A/G	cg07493874	chr5:1342172	CLPTM1L	-0.7	-6.57	-0.6	5.12e-9	Lung cancer;
SKCM	cis	rs7811142	1.000	rs11761725	chr7:100039815	C/T	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.23	7.89	0.67	1.53e-11	Platelet count;
SKCM	cis	rs17376456	0.569	rs13186432	chr5:93336940	G/A	cg25358565	chr5:93447407	FAM172A	-0.85	-5.33	-0.52	9.37e-7	Diabetic retinopathy;
SKCM	cis	rs798554	0.757	rs1182179	chr7:2873648	A/G	cg04166393	chr7:2884313	GNA12	0.67	4.8	0.48	7.51e-6	Height;
SKCM	cis	rs3091242	0.967	rs665372	chr1:25719235	A/C	cg02931644	chr1:25747376	RHCE	0.51	5.11	0.5	2.27e-6	Erythrocyte sedimentation rate;
SKCM	trans	rs941408	1.000	rs941406	chr19:2803623	A/G	cg22153745	chr1:153894579	GATAD2B	-0.8	-7.44	-0.64	1.15e-10	Total cholesterol levels;
SKCM	cis	rs11892454	0.544	rs34921778	chr2:26011810	A/G	cg17263061	chr2:26915892	KCNK3	0.71	5.13	0.5	2.1e-6	Heschl's gyrus morphology;
SKCM	cis	rs875971	0.666	rs13242072	chr7:65765988	A/G	cg18876405	chr7:65276391	NA	-0.8	-7.39	-0.64	1.43e-10	Aortic root size;
SKCM	cis	rs2303745	0.544	rs6512180	chr19:17399153	C/T	cg04248312	chr19:17393744	ANKLE1	-1.12	-8.3	-0.69	2.42e-12	Systemic lupus erythematosus;
SKCM	cis	rs2070488	0.775	rs7644530	chr3:38558316	C/T	cg01465620	chr3:38496096	LOC100128640;ACVR2B	-0.74	-5.88	-0.55	9.48e-8	Electrocardiographic conduction measures;
SKCM	cis	rs597539	0.690	rs578791	chr11:68625809	C/T	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.82	5.51	0.53	4.49e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs10504229	0.683	rs61306359	chr8:58134646	G/A	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs597205	0.881	rs4839176	chr1:112393253	G/A	cg22162010	chr1:113249994	RHOC	0.84	4.82	0.48	7.04e-6	Gut microbiota (bacterial taxa);
SKCM	cis	rs4689592	0.503	rs66885632	chr4:7053738	T/C	cg19539972	chr4:7069911	GRPEL1	-0.97	-6.3	-0.58	1.62e-8	Monocyte percentage of white cells;
SKCM	cis	rs8072100	0.754	rs8081717	chr17:45653921	T/A	cg25173405	chr17:45401733	C17orf57	0.59	5.44	0.52	5.84e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs4242434	0.927	rs2291234	chr8:22464390	T/C	cg03733263	chr8:22462867	KIAA1967	1.07	9.15	0.72	5.54e-14	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs2404602	0.716	rs17364076	chr15:76760891	C/T	cg23625390	chr15:77176239	SCAPER	0.59	5.38	0.52	7.54e-7	Blood metabolite levels;
SKCM	cis	rs453301	0.571	rs2929454	chr8:9083854	A/C	cg15556689	chr8:8085844	FLJ10661	-0.65	-5.06	-0.5	2.74e-6	Joint mobility (Beighton score);
SKCM	cis	rs7927771	1.000	rs10838738	chr11:47663049	A/G	cg05585544	chr11:47624801	NA	-0.63	-5.5	-0.53	4.73e-7	Subjective well-being;
SKCM	cis	rs861020	0.771	rs674804	chr1:210014603	C/G	cg09163369	chr1:210001066	C1orf107	0.71	4.77	0.48	8.3e-6	Orofacial clefts;
SKCM	cis	rs6087771	0.890	rs6089056	chr20:30325773	A/G	cg11595048	chr20:30225325	COX4I2	0.54	4.77	0.48	8.4e-6	Subcortical brain region volumes;Putamen volume;
SKCM	cis	rs1691799	0.831	rs6581678	chr12:66776656	A/G	cg16791601	chr12:66731901	HELB	-0.64	-5.98	-0.56	6.41e-8	White blood cell count (basophil);
SKCM	cis	rs6495122	0.699	rs1378941	chr15:75080150	C/A	cg14664628	chr15:75095509	CSK	-0.93	-6.98	-0.62	8.62e-10	Caffeine consumption;Diastolic blood pressure;Coffee consumption;
SKCM	cis	rs763014	0.833	rs3743902	chr16:632728	T/C	cg09263875	chr16:632152	PIGQ	0.67	5.82	0.55	1.24e-7	Height;
SKCM	cis	rs9467773	0.620	rs2504600	chr6:26648334	C/A	cg15659132	chr6:26577336	NA	0.62	5.4	0.52	6.91e-7	Intelligence (multi-trait analysis);
SKCM	trans	rs208520	0.690	rs851459	chr6:66813989	A/G	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-0.98	-7.67	-0.66	4.02e-11	Exhaled nitric oxide output;
SKCM	cis	rs2836974	0.897	rs8132568	chr21:40527916	C/T	cg11644478	chr21:40555479	PSMG1	0.97	10.21	0.76	5.08e-16	Cognitive function;
SKCM	cis	rs9910055	0.960	rs9911991	chr17:42278916	G/C	cg19774624	chr17:42201019	HDAC5	-0.89	-7.39	-0.64	1.4e-10	Total body bone mineral density;
SKCM	cis	rs4975616	0.869	rs370348	chr5:1331219	A/G	cg26373071	chr5:1325741	CLPTM1L	0.74	6.91	0.62	1.18e-9	Lung cancer;
SKCM	cis	rs4689592	0.587	rs6825954	chr4:7074226	T/C	cg26116260	chr4:7069785	GRPEL1	1.15	8.71	0.7	3.86e-13	Monocyte percentage of white cells;
SKCM	cis	rs1461503	0.900	rs10892935	chr11:122838590	C/T	cg27398637	chr11:122830231	C11orf63	-0.63	-4.8	-0.48	7.54e-6	Menarche (age at onset);
SKCM	cis	rs28595532	0.764	rs116302502	chr4:119748848	T/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs4072980	0.545	rs10890285	chr1:38453576	A/C	cg12658694	chr1:38397304	INPP5B	-0.65	-4.86	-0.48	6.06e-6	Coronary artery disease;
SKCM	cis	rs7954584	0.567	rs11612028	chr12:122387872	C/G	cg01765077	chr12:122356316	WDR66	0.44	4.91	0.49	4.96e-6	Mean corpuscular volume;
SKCM	cis	rs1152591	0.811	rs1255984	chr14:64654431	C/T	cg21174375	chr14:64681225	SYNE2	-0.45	-4.86	-0.48	5.95e-6	Atrial fibrillation;
SKCM	cis	rs11585357	0.895	rs72633828	chr1:17632251	G/A	cg08277548	chr1:17600880	PADI3	-0.89	-6.31	-0.58	1.53e-8	Hair shape;
SKCM	cis	rs2243480	1.000	rs313798	chr7:65493031	A/G	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs1065656	0.581	rs1065663	chr16:1839023	G/A	cg26897989	chr16:1907736	C16orf73	0.62	6.51	0.59	6.53e-9	Insulin-like growth factors;
SKCM	cis	rs9828933	0.516	rs704371	chr3:63867528	G/A	cg16258503	chr3:63850278	ATXN7;THOC7	0.81	5.09	0.5	2.44e-6	Type 2 diabetes;
SKCM	cis	rs10207060	0.500	rs28540721	chr2:240714045	C/T	cg07506560	chr2:240697449	NA	0.75	6.1	0.57	3.8e-8	Obesity-related traits;
SKCM	cis	rs1805008	0.640	rs17226232	chr16:89851574	A/G	cg02628002	chr16:89649608	CPNE7	1.1	4.97	0.49	3.93e-6	Skin colour saturation;
SKCM	cis	rs1160297	0.609	rs17504530	chr2:53092800	C/G	cg07782112	chr2:53107842	NA	0.55	5.57	0.53	3.5e-7	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs12477438	0.520	rs13023744	chr2:99738224	C/T	cg26064155	chr2:99771622	LIPT1;TSGA10	1.05	10.46	0.76	1.63e-16	Chronic sinus infection;
SKCM	cis	rs6570726	0.935	rs422540	chr6:145837815	G/T	cg23711669	chr6:146136114	FBXO30	0.7	6.64	0.6	3.72e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs875971	1.000	rs3735148	chr7:65971009	T/G	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs10256972	0.616	rs3802141	chr7:1131356	T/C	cg09177884	chr7:1199841	ZFAND2A	-0.76	-6.43	-0.59	9.31e-9	Longevity;Endometriosis;
SKCM	cis	rs2228479	0.850	rs11639788	chr16:89807543	G/A	cg06558623	chr16:89946397	TCF25	1.03	5.59	0.53	3.23e-7	Skin colour saturation;
SKCM	cis	rs1577917	0.637	rs1838957	chr6:86565056	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.69	-6.15	-0.57	3.1e-8	Response to antipsychotic treatment;
SKCM	cis	rs2075371	0.796	rs1646644	chr7:134011817	A/T	cg20476274	chr7:133979776	SLC35B4	0.93	9.67	0.74	5.55e-15	Mean platelet volume;
SKCM	cis	rs2721173	0.619	rs997258	chr8:145903077	C/A	cg11211951	chr8:145729740	GPT	-0.58	-4.92	-0.49	4.69e-6	Educational attainment;Cognitive ability (multi-trait analysis);Intelligence (multi-trait analysis);
SKCM	cis	rs4523957	0.553	rs2476355	chr17:2029559	A/G	cg16513277	chr17:2031491	SMG6	-0.91	-6.21	-0.58	2.38e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs10916772	0.877	rs60573766	chr1:20688352	C/T	cg05356564	chr1:21044770	KIF17	-0.6	-5.02	-0.49	3.25e-6	Psychosis proneness (perceptual aberration scale);
SKCM	cis	rs3008870	1.000	rs2755245	chr1:67487964	C/G	cg08660285	chr1:67390436	MIER1;WDR78	0.95	6.5	0.59	6.96e-9	Lymphocyte percentage of white cells;
SKCM	cis	rs6489882	0.902	rs4767037	chr12:113372804	A/C	cg07232103	chr12:112566177	TRAFD1	0.6	4.9	0.48	5.14e-6	Chronic lymphocytic leukemia;
SKCM	cis	rs11098499	0.909	rs11723757	chr4:120299669	C/T	cg24375607	chr4:120327624	NA	0.65	4.97	0.49	3.87e-6	Corneal astigmatism;
SKCM	cis	rs2439831	0.850	rs7169988	chr15:44060435	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.36	7.69	0.66	3.73e-11	Lung cancer in ever smokers;
SKCM	cis	rs17685	0.672	rs6465011	chr7:75811297	T/C	cg16489192	chr7:75678113	MDH2;STYXL1	-0.54	-5.21	-0.51	1.48e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs3845702	0.733	rs12693217	chr2:180841914	T/G	cg01881094	chr2:180872142	CWC22	-1.3	-6.15	-0.57	3.07e-8	Schizophrenia;
SKCM	cis	rs10197940	0.578	rs6718653	chr2:152346118	C/A	cg19508488	chr2:152266495	RIF1	0.59	4.78	0.48	8.2e-6	Lung cancer;
SKCM	cis	rs2180341	0.814	rs6905553	chr6:127727407	A/G	cg27446573	chr6:127587934	RNF146	0.69	5.49	0.53	4.79e-7	Breast cancer;
SKCM	trans	rs561341	0.700	rs79272796	chr17:30226974	T/C	cg20587970	chr11:113659929	NA	-0.93	-7.38	-0.64	1.45e-10	Hip circumference adjusted for BMI;
SKCM	cis	rs10751667	0.600	rs10751665	chr11:941300	G/A	cg06064525	chr11:970664	AP2A2	-0.55	-5.09	-0.5	2.46e-6	Alzheimer's disease (late onset);
SKCM	cis	rs2841277	0.771	rs2819469	chr14:105394859	G/A	cg15352829	chr14:105391018	PLD4	0.6	5.05	0.5	2.8e-6	Rheumatoid arthritis;
SKCM	cis	rs2739330	0.753	rs4822452	chr22:24254363	C/T	cg12419862	chr22:24373484	LOC391322	-0.66	-5.89	-0.55	9.18e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs7666738	0.830	rs28497822	chr4:98906873	C/T	cg17366294	chr4:99064904	C4orf37	0.56	4.92	0.49	4.8e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2836974	0.897	rs1571709	chr21:40553980	T/C	cg11644478	chr21:40555479	PSMG1	0.97	10.17	0.75	5.99e-16	Cognitive function;
SKCM	cis	rs10197940	0.810	rs4664045	chr2:152267072	T/G	cg06191203	chr2:152266755	RIF1	-0.64	-4.79	-0.48	7.68e-6	Lung cancer;
SKCM	cis	rs10911232	0.507	rs10911212	chr1:183024469	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.77	6.87	0.61	1.37e-9	Hypertriglyceridemia;
SKCM	cis	rs4481887	0.676	rs946764	chr1:248522033	A/C	cg22724847	chr1:248512586	OR14C36	0.58	4.8	0.48	7.64e-6	Common traits (Other);
SKCM	cis	rs1147199	0.585	rs726433	chr9:87247336	C/T	cg13486759	chr9:86751815	NA	0.64	4.81	0.48	7.23e-6	Body mass index;
SKCM	cis	rs1048238	0.506	rs698890	chr1:16267371	C/G	cg21385522	chr1:16154831	NA	-0.64	-5.56	-0.53	3.64e-7	Systolic blood pressure;
SKCM	cis	rs7945705	0.935	rs2568062	chr11:8887945	A/G	cg21881798	chr11:8931708	C11orf17;ST5	-0.79	-8.52	-0.69	9.25e-13	Hemoglobin concentration;
SKCM	cis	rs2836974	0.644	rs2836986	chr21:40702136	A/C	cg11890956	chr21:40555474	PSMG1	-0.82	-7.64	-0.65	4.75e-11	Cognitive function;
SKCM	cis	rs910316	0.967	rs119076	chr14:75572419	G/T	cg08847533	chr14:75593920	NEK9	-0.95	-8.8	-0.71	2.64e-13	Height;
SKCM	cis	rs9911578	1.000	rs9901114	chr17:56575208	G/A	cg12560992	chr17:57184187	TRIM37	-0.95	-7.57	-0.65	6.39e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs1799949	1.000	rs34534709	chr17:41302940	C/G	cg23758822	chr17:41437982	NA	0.92	7.8	0.66	2.3e-11	Menopause (age at onset);
SKCM	cis	rs10937913	0.792	rs13145281	chr4:2746285	A/C	cg19433769	chr4:2420260	ZFYVE28	0.65	4.82	0.48	7.05e-6	Extrinsic epigenetic age acceleration;
SKCM	cis	rs1862618	0.853	rs9283717	chr5:56078659	G/A	cg12311346	chr5:56204834	C5orf35	-0.75	-5.15	-0.5	1.94e-6	Initial pursuit acceleration;
SKCM	cis	rs514406	0.929	rs555741	chr1:53318851	T/G	cg16325326	chr1:53192061	ZYG11B	0.92	9.93	0.75	1.75e-15	Monocyte count;
SKCM	cis	rs11931598	0.511	rs4689576	chr4:7025523	T/C	cg04207632	chr4:6986609	TBC1D14	-0.54	-5.07	-0.5	2.64e-6	Sum basophil neutrophil counts;Sum neutrophil eosinophil counts;Granulocyte count;Neutrophil count;Myeloid white cell count;
SKCM	cis	rs4819052	1.000	rs733739	chr21:46666210	A/G	cg20896738	chr21:46707857	POFUT2;LOC642852	0.74	5.35	0.52	8.71e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs12472274	0.817	rs34791859	chr2:239070919	G/C	cg17459225	chr2:239074497	NA	0.62	5.0	0.49	3.41e-6	Phospholipid levels (plasma);
SKCM	cis	rs1153858	0.895	rs12593402	chr15:45617392	G/A	cg10760299	chr15:45669010	GATM	0.55	5.38	0.52	7.45e-7	Homoarginine levels;
SKCM	cis	rs9868809	0.505	rs9882549	chr3:48749358	C/T	cg00383909	chr3:49044727	WDR6	0.89	5.09	0.5	2.44e-6	Ulcerative colitis;Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs10911232	0.507	rs10911195	chr1:182993438	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.64	0.6	3.83e-9	Hypertriglyceridemia;
SKCM	cis	rs735396	0.595	rs2258287	chr12:121454313	G/T	cg02403541	chr12:121454288	C12orf43	0.86	8.12	0.68	5.52e-12	N-glycan levels;
SKCM	cis	rs7666738	0.830	rs11735193	chr4:98761900	C/T	cg17366294	chr4:99064904	C4orf37	0.59	5.09	0.5	2.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1550582	0.548	rs7828645	chr8:135497385	A/G	cg17885191	chr8:135476712	NA	-0.91	-6.05	-0.57	4.75e-8	Educational attainment;
SKCM	cis	rs372883	0.564	rs766928	chr21:30753606	A/G	cg24692254	chr21:30365293	RNF160	0.73	5.56	0.53	3.63e-7	Pancreatic cancer;
SKCM	cis	rs644799	0.763	rs2950521	chr11:95536870	G/A	cg03916912	chr11:95522834	CEP57;FAM76B	0.92	8.04	0.67	8e-12	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs9913156	0.793	rs72835644	chr17:4573667	G/A	cg19197139	chr17:4613644	ARRB2	0.79	5.45	0.53	5.64e-7	Lymphocyte counts;
SKCM	cis	rs7618501	0.633	rs6792892	chr3:49995518	T/C	cg24110177	chr3:50126178	RBM5	-0.6	-5.1	-0.5	2.36e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs10504073	0.584	rs62507210	chr8:49946601	C/T	cg00325661	chr8:49890786	NA	0.8	6.81	0.61	1.83e-9	Blood metabolite ratios;
SKCM	cis	rs2188420	0.872	rs76458297	chr7:106503674	A/C	cg23615938	chr7:105753134	SYPL1	-1.07	-5.88	-0.55	9.55e-8	Interferon gamma levels;
SKCM	cis	rs12477438	0.834	rs1563108	chr2:99701153	A/G	cg26064155	chr2:99771622	LIPT1;TSGA10	-0.76	-4.9	-0.49	5.08e-6	Chronic sinus infection;
SKCM	cis	rs7208859	0.623	rs1061342	chr17:29114463	G/A	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs561341	1.000	rs537166	chr17:30326827	C/T	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs875971	0.964	rs11765965	chr7:65842221	A/G	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	7.89e-13	Aortic root size;
SKCM	cis	rs5769765	0.908	rs138889	chr22:50226673	T/C	cg22709217	chr22:50311962	ALG12;CRELD2	-0.87	-6.04	-0.56	4.96e-8	Schizophrenia;
SKCM	cis	rs7507204	1.000	rs7507204	chr19:3428834	G/C	cg08380311	chr19:3435252	NFIC	0.99	8.14	0.68	5.13e-12	Height;
SKCM	cis	rs362272	0.524	rs2749781	chr4:3346617	T/C	cg09735869	chr4:3319127	RGS12	0.97	11.46	0.79	2.17e-18	Serum sulfate level;
SKCM	cis	rs28386778	0.863	rs9897229	chr17:61782325	T/C	cg01411255	chr17:61851458	DDX42;CCDC47	0.79	4.97	0.49	3.86e-6	Prudent dietary pattern;
SKCM	cis	rs1499614	1.000	rs60326618	chr7:66166358	G/A	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Gout;
SKCM	cis	rs7772486	0.875	rs6938972	chr6:146410608	G/A	cg23711669	chr6:146136114	FBXO30	0.85	8.48	0.69	1.09e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9858542	0.953	rs6766581	chr3:49539401	T/C	cg03060546	chr3:49711283	APEH	-0.75	-5.53	-0.53	4.17e-7	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	trans	rs1814175	0.935	rs10839317	chr11:49657228	A/C	cg03929089	chr4:120376271	NA	-0.87	-7.53	-0.65	7.64e-11	Height;
SKCM	cis	rs28595532	0.920	rs55633605	chr4:119761589	G/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs738322	0.600	rs6001035	chr22:38562425	A/G	cg25457927	chr22:38595422	NA	-0.53	-6.14	-0.57	3.24e-8	Cutaneous nevi;
SKCM	cis	rs7923452	0.507	rs612802	chr10:30756441	G/A	cg25182066	chr10:30743637	MAP3K8	-0.71	-6.43	-0.59	9.2e-9	Itch intensity from mosquito bite;
SKCM	cis	rs12134245	0.747	rs17501512	chr1:92012481	C/G	cg25838465	chr1:92012736	NA	0.85	8.81	0.71	2.56e-13	Breast cancer;
SKCM	cis	rs561341	1.000	rs542132	chr17:30307193	A/T	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs7408868	0.764	rs12610803	chr19:15260682	A/C	cg14696996	chr19:15285081	NOTCH3	0.84	4.89	0.48	5.33e-6	Pulse pressure;
SKCM	cis	rs7666738	0.830	rs11932942	chr4:98998939	T/C	cg05340658	chr4:99064831	C4orf37	0.67	5.14	0.5	1.98e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs514406	0.607	rs6665324	chr1:53201610	G/A	cg16325326	chr1:53192061	ZYG11B	-0.86	-9.02	-0.71	9.97e-14	Monocyte count;
SKCM	cis	rs7954584	0.567	rs1720033	chr12:122384344	C/T	cg22618164	chr12:122356400	WDR66	-0.52	-5.23	-0.51	1.37e-6	Mean corpuscular volume;
SKCM	cis	rs12764182	0.851	rs12764787	chr10:77916490	C/T	cg07200060	chr10:78483672	NA	-0.59	-5.04	-0.5	2.97e-6	QRS complex (Cornell);
SKCM	cis	rs4819052	0.645	rs2838817	chr21:46631698	C/T	cg19498844	chr21:46707878	POFUT2;LOC642852	0.72	5.05	0.5	2.83e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs4727027	0.782	rs10245343	chr7:148796333	T/C	cg23583168	chr7:148888333	NA	-0.81	-5.57	-0.53	3.52e-7	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs2836950	0.565	rs2836926	chr21:40536790	G/A	cg11644478	chr21:40555479	PSMG1	-0.67	-5.3	-0.51	1.04e-6	Menarche (age at onset);
SKCM	cis	rs2721195	0.967	rs748193	chr8:145682115	C/T	cg17328964	chr8:145687451	CYHR1	-0.73	-6.58	-0.6	5.01e-9	Age at first birth;
SKCM	cis	rs9660180	1.000	rs3737628	chr1:1722932	C/T	cg13866156	chr1:1669148	SLC35E2	-0.65	-5.49	-0.53	4.86e-7	Body mass index;
SKCM	cis	rs2836974	0.899	rs34978594	chr21:40580003	C/T	cg17971929	chr21:40555470	PSMG1	0.9	8.81	0.71	2.52e-13	Cognitive function;
SKCM	cis	rs73001065	0.636	rs8182472	chr19:19539891	A/G	cg03709012	chr19:19516395	GATAD2A	1.02	5.44	0.52	6.01e-7	LDL cholesterol;
SKCM	cis	rs28595532	0.920	rs56283736	chr4:119747268	A/G	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs7666738	0.753	rs28463863	chr4:98844444	T/C	cg17366294	chr4:99064904	C4orf37	0.57	4.97	0.49	3.83e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6545883	0.965	rs3771258	chr2:61764140	C/T	cg15711740	chr2:61764176	XPO1	-0.76	-5.3	-0.51	1.04e-6	Tuberculosis;
SKCM	cis	rs9902453	0.934	rs7223645	chr17:28491029	A/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.5	0.53	4.74e-7	Coffee consumption (cups per day);
SKCM	cis	rs8179	0.700	rs42041	chr7:92246744	C/G	cg27455918	chr7:92370191	CDK6	-0.52	-4.79	-0.48	7.91e-6	Sum neutrophil eosinophil counts;Sum basophil neutrophil counts;Neutrophil count;White blood cell count;Myeloid white cell count;Granulocyte count;White blood cell count (basophil);
SKCM	cis	rs6061231	0.834	rs2427311	chr20:60970123	A/G	cg24112000	chr20:60950667	NA	-0.58	-5.53	-0.53	4.18e-7	Colorectal cancer;
SKCM	cis	rs2836633	0.929	rs2836610	chr21:40044502	C/T	cg05519781	chr21:40033154	ERG	0.75	6.66	0.6	3.4e-9	Coronary artery disease;
SKCM	cis	rs2354432	0.607	rs11239980	chr1:146782698	G/A	cg25205988	chr1:146714368	CHD1L	-1.19	-6.56	-0.6	5.24e-9	Mitochondrial DNA levels;
SKCM	cis	rs4975616	0.804	rs31489	chr5:1342714	C/A	cg07493874	chr5:1342172	CLPTM1L	-0.66	-5.75	-0.55	1.65e-7	Lung cancer;
SKCM	cis	rs11098499	0.955	rs7684942	chr4:120162201	C/T	cg09307838	chr4:120376055	NA	0.95	7.75	0.66	2.84e-11	Corneal astigmatism;
SKCM	cis	rs7829975	0.742	rs12547493	chr8:8661534	C/T	cg15556689	chr8:8085844	FLJ10661	-0.68	-5.75	-0.55	1.67e-7	Mood instability;
SKCM	cis	rs7100689	0.784	rs10749562	chr10:82108253	G/T	cg03267442	chr10:82210566	NA	-0.56	-4.98	-0.49	3.69e-6	Post bronchodilator FEV1;
SKCM	cis	rs9325144	0.600	rs7312522	chr12:38730423	A/G	cg13010199	chr12:38710504	ALG10B	0.64	5.11	0.5	2.28e-6	Morning vs. evening chronotype;
SKCM	cis	rs1577917	0.958	rs12196377	chr6:86566775	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.68	-5.91	-0.56	8.36e-8	Response to antipsychotic treatment;
SKCM	cis	rs908922	0.627	rs1053588	chr1:152488063	C/T	cg09873164	chr1:152488093	CRCT1	0.78	6.09	0.57	3.98e-8	Hair morphology;
SKCM	cis	rs9300255	0.568	rs1790090	chr12:123633424	G/A	cg05973401	chr12:123451056	ABCB9	0.79	5.37	0.52	8.03e-7	Neutrophil percentage of white cells;
SKCM	cis	rs684232	0.666	rs1227028	chr17:573298	G/A	cg12384639	chr17:618140	VPS53	0.79	6.18	0.57	2.74e-8	Prostate cancer;
SKCM	cis	rs62238980	0.614	rs77630998	chr22:32452744	T/C	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs67311347	0.544	rs4974047	chr3:40339653	G/T	cg00091569	chr3:40428383	ENTPD3	0.61	5.33	0.52	9.24e-7	Renal cell carcinoma;
SKCM	cis	rs6120849	0.707	rs6120799	chr20:33614955	T/C	cg24642439	chr20:33292090	TP53INP2	0.94	4.86	0.48	5.91e-6	Protein C levels;
SKCM	cis	rs4689592	0.503	rs3857180	chr4:7073899	T/G	cg26116260	chr4:7069785	GRPEL1	-1.05	-7.09	-0.63	5.2400000000000005e-10	Monocyte percentage of white cells;
SKCM	cis	rs12134245	0.874	rs61798047	chr1:92016934	C/T	cg25838465	chr1:92012736	NA	-0.85	-8.82	-0.71	2.38e-13	Breast cancer;
SKCM	cis	rs875971	0.508	rs6947808	chr7:66045082	A/G	cg11764359	chr7:65958608	NA	-0.78	-5.82	-0.55	1.23e-7	Aortic root size;
SKCM	cis	rs28386778	0.897	rs2727327	chr17:61923422	G/A	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs9467773	1.000	rs2224380	chr6:26553943	G/A	cg09904177	chr6:26538194	HMGN4	0.54	4.98	0.49	3.78e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1801251	0.963	rs35362030	chr2:233612845	A/G	cg25237894	chr2:233734115	C2orf82	0.56	5.33	0.52	9.23e-7	Coronary artery disease;
SKCM	cis	rs4242434	0.819	rs6999893	chr8:22465427	T/C	cg03733263	chr8:22462867	KIAA1967	1.0	8.26	0.68	2.89e-12	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs7296418	0.754	rs1619283	chr12:123717362	A/G	cg05973401	chr12:123451056	ABCB9	0.78	6.03	0.56	5.17e-8	Platelet count;
SKCM	cis	rs8141529	0.732	rs2239815	chr22:29192670	C/T	cg15103426	chr22:29168792	CCDC117	-0.6	-5.07	-0.5	2.59e-6	Lymphocyte counts;
SKCM	cis	rs1348850	0.645	rs7571386	chr2:178442687	A/C	cg02961200	chr2:178257176	LOC100130691;AGPS	0.84	5.13	0.5	2.03e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs875971	0.862	rs6959268	chr7:65812966	G/A	cg18876405	chr7:65276391	NA	-0.64	-6.32	-0.58	1.47e-8	Aortic root size;
SKCM	cis	rs644799	0.710	rs564480	chr11:95561741	C/T	cg25622487	chr11:95524042	FAM76B;CEP57	0.65	5.15	0.5	1.91e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs1059312	0.808	rs12816551	chr12:129295616	T/C	cg09035930	chr12:129282057	SLC15A4	0.77	8.03	0.67	8.18e-12	Systemic lupus erythematosus;
SKCM	cis	rs6723226	0.766	rs398290	chr2:32503526	T/C	cg02381751	chr2:32503542	YIPF4	0.94	7.05	0.62	6.31e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs427394	0.659	rs274717	chr5:6721067	C/T	cg10857441	chr5:6722123	POLS	0.69	7.62	0.65	5.06e-11	Menopause (age at onset);
SKCM	cis	rs67311347	0.544	rs12054197	chr3:40337562	C/T	cg00091569	chr3:40428383	ENTPD3	0.61	5.33	0.52	9.24e-7	Renal cell carcinoma;
SKCM	cis	rs9910055	0.659	rs721769	chr17:42261588	T/G	cg13607699	chr17:42295918	UBTF	0.71	5.74	0.55	1.72e-7	Total body bone mineral density;
SKCM	cis	rs589448	0.967	rs2617834	chr12:69753365	T/C	cg14784868	chr12:69753453	YEATS4	0.84	7.65	0.65	4.54e-11	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs8016982	0.674	rs8004096	chr14:81701082	T/G	cg01989461	chr14:81687754	GTF2A1	0.88	6.89	0.62	1.26e-9	Schizophrenia;
SKCM	cis	rs1153858	1.000	rs56806728	chr15:45637814	A/G	cg21132104	chr15:45694354	SPATA5L1	0.92	8.33	0.69	2.14e-12	Homoarginine levels;
SKCM	cis	rs28386778	0.863	rs11649912	chr17:61797515	T/A	cg01411255	chr17:61851458	DDX42;CCDC47	0.79	5.1	0.5	2.35e-6	Prudent dietary pattern;
SKCM	cis	rs644799	1.000	rs12786522	chr11:95522858	G/C	cg03916912	chr11:95522834	CEP57;FAM76B	0.92	8.28	0.68	2.67e-12	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs28595532	0.920	rs116091383	chr4:119635518	A/G	cg21605333	chr4:119757512	SEC24D	1.24	7.1	0.63	5.16e-10	Cannabis dependence symptom count;
SKCM	cis	rs10900020	1.000	rs10900022	chr10:44828980	C/T	cg25956097	chr10:44163499	NA	0.92	4.79	0.48	7.85e-6	Schizophrenia;
SKCM	cis	rs6933660	0.745	rs6912830	chr6:151743629	A/C	cg10883421	chr6:151773342	RMND1;C6orf211	0.82	7.0	0.62	7.73e-10	Menarche (age at onset);
SKCM	cis	rs6088590	0.561	rs6088528	chr20:33156742	G/A	cg24642439	chr20:33292090	TP53INP2	0.73	5.58	0.53	3.32e-7	Coronary artery disease;
SKCM	cis	rs703842	0.963	rs923829	chr12:58174306	T/C	cg04478727	chr12:58166393	METTL1;FAM119B	0.72	5.87	0.55	1.02e-7	Multiple sclerosis;
SKCM	cis	rs769267	0.965	rs8101938	chr19:19390497	G/A	cg03709012	chr19:19516395	GATAD2A	0.81	6.49	0.59	7.18e-9	Tonsillectomy;
SKCM	cis	rs798554	0.644	rs1639040	chr7:2884116	G/T	cg19346786	chr7:2764209	NA	-0.65	-6.79	-0.61	1.96e-9	Height;
SKCM	cis	rs362272	0.545	rs2239725	chr4:3305739	C/T	cg16987761	chr4:3318072	RGS12	0.94	10.48	0.76	1.54e-16	Serum sulfate level;
SKCM	cis	rs1801251	0.896	rs6719061	chr2:233695885	C/T	cg08000102	chr2:233561755	GIGYF2	-0.81	-6.53	-0.59	6.21e-9	Coronary artery disease;
SKCM	cis	rs6952808	0.689	rs11771625	chr7:2050401	C/T	cg02951883	chr7:2050386	MAD1L1	-0.91	-8.68	-0.7	4.42e-13	Bipolar disorder and schizophrenia;
SKCM	cis	rs826838	1.000	rs11609286	chr12:38875511	A/G	cg13010199	chr12:38710504	ALG10B	-0.86	-6.53	-0.59	6.05e-9	Heart rate;
SKCM	cis	rs4819052	0.851	rs2877020	chr21:46658742	C/T	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.36	0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs950027	0.620	rs35861938	chr15:45637343	T/C	cg21132104	chr15:45694354	SPATA5L1	0.76	6.14	0.57	3.2e-8	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs7772486	0.875	rs854146	chr6:146341033	A/G	cg23711669	chr6:146136114	FBXO30	0.76	7.15	0.63	4.1e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1160297	0.552	rs6545313	chr2:53222840	A/G	cg07782112	chr2:53107842	NA	-0.51	-4.8	-0.48	7.4e-6	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs7216064	1.000	rs62084251	chr17:65878736	G/A	cg12091567	chr17:66097778	LOC651250	-0.75	-5.27	-0.51	1.19e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs826838	0.967	rs11183514	chr12:38760744	A/T	cg26384229	chr12:38710491	ALG10B	1.06	10.14	0.75	6.67e-16	Heart rate;
SKCM	cis	rs72781680	0.898	rs17509001	chr2:24021231	T/C	cg08917208	chr2:24149416	ATAD2B	0.92	4.85	0.48	6.19e-6	Lymphocyte counts;
SKCM	cis	rs908922	0.651	rs1988805	chr1:152531495	T/G	cg09873164	chr1:152488093	CRCT1	0.72	5.62	0.54	2.85e-7	Hair morphology;
SKCM	cis	rs244731	0.920	rs72813185	chr5:176739110	C/A	cg17509989	chr5:176798049	RGS14	0.94	6.49	0.59	7.16e-9	Urate levels in lean individuals;
SKCM	cis	rs2153535	0.580	rs9379210	chr6:8461928	C/G	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs7811142	0.943	rs67196635	chr7:100025564	T/C	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.17	7.71	0.66	3.44e-11	Platelet count;
SKCM	cis	rs735396	0.770	rs1169315	chr12:121443753	T/G	cg02403541	chr12:121454288	C12orf43	0.73	6.08	0.57	4.17e-8	N-glycan levels;
SKCM	cis	rs28386778	0.863	rs6919	chr17:61909485	A/T	cg06873352	chr17:61820015	STRADA	-0.74	-6.15	-0.57	3.13e-8	Prudent dietary pattern;
SKCM	cis	rs1801251	0.893	rs11687128	chr2:233608901	T/C	cg08000102	chr2:233561755	GIGYF2	0.87	7.05	0.62	6.23e-10	Coronary artery disease;
SKCM	cis	rs2153535	0.580	rs9505446	chr6:8448691	T/C	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs56104184	0.775	rs55737338	chr19:49403141	A/G	cg19746536	chr19:49375674	PPP1R15A	1.16	5.93	0.56	7.67e-8	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs28386778	0.965	rs2854154	chr17:61981696	C/A	cg23090583	chr17:61904693	PSMC5;FTSJ3	-1.01	-8.34	-0.69	2.1e-12	Prudent dietary pattern;
SKCM	cis	rs673604	0.881	rs7512559	chr1:35677753	T/C	cg12633102	chr1:35676489	NA	-0.68	-5.35	-0.52	8.54e-7	Endometrial cancer;
SKCM	cis	rs561341	0.882	rs16967101	chr17:30377162	A/G	cg00745463	chr17:30367425	LRRC37B	-1.04	-7.13	-0.63	4.54e-10	Hip circumference adjusted for BMI;
SKCM	cis	rs6952808	0.717	rs6967442	chr7:1926090	A/G	cg02951883	chr7:2050386	MAD1L1	-0.74	-6.39	-0.59	1.12e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs1153858	1.000	rs1980288	chr15:45620612	T/C	cg10760299	chr15:45669010	GATM	0.56	5.36	0.52	8.35e-7	Homoarginine levels;
SKCM	cis	rs854765	0.583	rs7214536	chr17:17852446	G/A	cg04398451	chr17:18023971	MYO15A	-0.86	-5.91	-0.56	8.41e-8	Total body bone mineral density;
SKCM	cis	rs7666738	0.791	rs34790496	chr4:98930516	C/T	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9900062	1.000	rs9900062	chr17:62739574	G/A	cg02097616	chr17:62675921	NA	0.72	5.91	0.56	8.54e-8	QT interval;
SKCM	cis	rs7208859	0.524	rs11653098	chr17:29122501	C/T	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs1552244	0.938	rs9873794	chr3:10074153	T/G	cg02579736	chr3:10068473	FANCD2;CIDECP	1.32	6.98	0.62	8.63e-10	Alzheimer's disease;
SKCM	cis	rs4820539	1.000	rs885963	chr22:23460939	G/T	cg14186256	chr22:23484241	RTDR1	0.86	8.68	0.7	4.58e-13	Bone mineral density;
SKCM	cis	rs7923452	0.507	rs103441	chr10:30778184	C/T	cg25182066	chr10:30743637	MAP3K8	-0.63	-5.23	-0.51	1.41e-6	Itch intensity from mosquito bite;
SKCM	cis	rs8038465	0.615	rs6495076	chr15:73982965	G/A	cg15420318	chr15:73925796	NPTN	0.62	4.92	0.49	4.68e-6	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs7666738	0.830	rs35213297	chr4:98984049	T/C	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7940866	0.838	rs12790299	chr11:130803634	A/G	cg12179176	chr11:130786555	SNX19	0.77	5.85	0.55	1.09e-7	Schizophrenia;
SKCM	cis	rs7666738	0.753	rs13137152	chr4:98938044	A/T	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4803468	0.967	rs3745290	chr19:41890003	C/T	cg09537434	chr19:41945824	ATP5SL	-1.08	-13.01	-0.83	3.1e-21	Height;
SKCM	cis	rs6952808	0.723	rs55689856	chr7:2037215	G/A	cg02951883	chr7:2050386	MAD1L1	-0.88	-8.14	-0.68	5.12e-12	Bipolar disorder and schizophrenia;
SKCM	cis	rs62238980	0.614	rs117534689	chr22:32392350	T/C	cg00543991	chr22:32367038	NA	1.15	4.87	0.48	5.76e-6	Childhood ear infection;
SKCM	cis	rs6424115	0.800	rs6665733	chr1:24200158	T/C	cg15997130	chr1:24165203	NA	0.6	4.94	0.49	4.37e-6	Immature fraction of reticulocytes;
SKCM	cis	rs9790314	1.000	rs336591	chr3:161078080	A/G	cg03342759	chr3:160939853	NMD3	-0.72	-7.89	-0.67	1.53e-11	Morning vs. evening chronotype;
SKCM	cis	rs7216064	0.589	rs8072723	chr17:66056970	T/A	cg12091567	chr17:66097778	LOC651250	1.01	6.71	0.6	2.84e-9	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs2370759	1.000	rs11594459	chr10:32561858	A/C	cg01819863	chr10:32635814	EPC1	1.04	5.4	0.52	6.94e-7	Sexual dysfunction (female);
SKCM	cis	rs4740619	0.557	rs1328296	chr9:16046292	G/C	cg14451791	chr9:16040625	NA	-0.47	-5.18	-0.51	1.66e-6	Body mass index;
SKCM	cis	rs4481887	1.000	rs6697863	chr1:248495588	G/A	cg00666640	chr1:248458726	OR2T12	0.59	4.94	0.49	4.38e-6	Common traits (Other);
SKCM	cis	rs4803468	0.935	rs13346603	chr19:41945837	T/A	cg09537434	chr19:41945824	ATP5SL	1.1	13.21	0.83	1.39e-21	Height;
SKCM	cis	rs10504229	0.638	rs6981055	chr8:58113941	T/C	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs3741404	0.665	rs12418535	chr11:63910980	A/G	cg19465662	chr11:63993652	NUDT22;TRPT1	0.79	5.27	0.51	1.19e-6	Platelet count;
SKCM	cis	rs2180341	0.566	rs982306	chr6:127777039	T/C	cg24812749	chr6:127587940	RNF146	0.67	5.47	0.53	5.19e-7	Breast cancer;
SKCM	cis	rs1048257	0.553	rs2819421	chr14:105408811	A/G	cg21017887	chr14:105400489	NA	0.57	5.13	0.5	2.08e-6	Systemic lupus erythematosus;
SKCM	cis	rs9914544	0.628	rs4924924	chr17:18677774	C/G	cg26306683	chr17:18585705	ZNF286B	0.62	4.91	0.49	4.86e-6	Educational attainment (years of education);
SKCM	cis	rs1691799	0.899	rs1168322	chr12:66743769	C/T	cg16791601	chr12:66731901	HELB	-0.65	-6.09	-0.57	4.07e-8	White blood cell count (basophil);
SKCM	cis	rs1577917	1.000	rs12201880	chr6:86627007	G/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.85	-8.62	-0.7	5.82e-13	Response to antipsychotic treatment;
SKCM	cis	rs3784262	0.669	rs4646594	chr15:58302386	C/A	cg12031962	chr15:58353849	ALDH1A2	-0.42	-4.89	-0.48	5.38e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs10256972	0.616	rs3802141	chr7:1131356	T/C	cg16145915	chr7:1198662	ZFAND2A	-0.56	-7.9	-0.67	1.47e-11	Longevity;Endometriosis;
SKCM	cis	rs6089584	0.816	rs744778	chr20:60631365	A/G	cg06108461	chr20:60628389	TAF4	-0.89	-9.05	-0.72	8.53e-14	Body mass index;
SKCM	cis	rs9290877	0.667	rs6766661	chr3:188456581	T/C	cg17392043	chr3:188495102	LPP	-0.64	-4.93	-0.49	4.6e-6	IgE levels;
SKCM	cis	rs870825	0.616	rs56232457	chr4:185628153	T/G	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs6500602	0.674	rs7191664	chr16:4541924	T/C	cg08645402	chr16:4508243	NA	0.63	5.03	0.49	3.09e-6	Schizophrenia;
SKCM	cis	rs62238980	0.614	rs117067740	chr22:32407944	C/A	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs2243480	1.000	rs1979823	chr7:65704613	G/A	cg18252515	chr7:66147081	NA	1.36	8.16	0.68	4.6e-12	Diabetic kidney disease;
SKCM	cis	rs13118159	0.527	rs6599308	chr4:1387780	A/G	cg19318889	chr4:1322082	MAEA	0.76	5.1	0.5	2.3e-6	Longevity;
SKCM	cis	rs3768617	0.510	rs3768616	chr1:183103551	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.79	7.59	0.65	5.75e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs17376456	0.877	rs10514380	chr5:93409370	C/T	cg25358565	chr5:93447407	FAM172A	1.22	7.9	0.67	1.49e-11	Diabetic retinopathy;
SKCM	cis	rs2439831	0.681	rs484846	chr15:43600803	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.2	8.73	0.7	3.66e-13	Lung cancer in ever smokers;
SKCM	cis	rs9457247	0.624	rs9457260	chr6:167466665	C/T	cg07741184	chr6:167504864	NA	0.6	5.11	0.5	2.22e-6	Crohn's disease;
SKCM	cis	rs62064224	0.702	rs2302277	chr17:30791509	C/G	cg25809561	chr17:30822961	MYO1D	0.7	6.21	0.58	2.41e-8	Schizophrenia;
SKCM	cis	rs2439831	0.850	rs28476182	chr15:44139643	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.3	6.97	0.62	9.12e-10	Lung cancer in ever smokers;
SKCM	cis	rs9911578	1.000	rs304296	chr17:56834229	G/T	cg12560992	chr17:57184187	TRIM37	0.95	7.69	0.66	3.7e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs6951245	0.706	rs1133116	chr7:1195215	A/C	cg23708337	chr7:1209742	NA	0.91	5.49	0.53	4.9e-7	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7666738	0.830	rs4472144	chr4:98956494	G/A	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9796	0.745	rs2947493	chr15:41375694	G/A	cg18705301	chr15:41695430	NDUFAF1	-0.78	-5.56	-0.53	3.68e-7	Menopause (age at onset);
SKCM	cis	rs12142240	0.698	rs17357621	chr1:46807697	C/T	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs3768617	0.510	rs3818417	chr1:183079376	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs11098499	0.954	rs2892848	chr4:120381341	C/T	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs28595532	0.920	rs114670456	chr4:119771202	A/G	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs7811142	0.943	rs11769886	chr7:99998607	G/A	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.16	7.68	0.66	3.87e-11	Platelet count;
SKCM	cis	rs763014	0.898	rs1981484	chr16:630710	A/G	cg09263875	chr16:632152	PIGQ	0.67	5.82	0.55	1.24e-7	Height;
SKCM	cis	rs10905065	0.761	rs10905234	chr10:5860282	A/T	cg09234995	chr10:5726438	C10orf18	-0.63	-5.18	-0.51	1.7e-6	Menopause (age at onset);
SKCM	cis	rs12971120	1.000	rs12971120	chr18:72174023	A/G	cg26446133	chr18:72167187	CNDP2	-0.67	-5.62	-0.54	2.8e-7	Refractive error;
SKCM	cis	rs7959452	0.868	rs10784774	chr12:69737879	C/T	cg20891283	chr12:69753455	YEATS4	-0.72	-6.03	-0.56	5.15e-8	Blood protein levels;
SKCM	cis	rs9818758	0.607	rs67831908	chr3:49313513	T/G	cg00383909	chr3:49044727	WDR6	0.95	4.95	0.49	4.17e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs17270561	0.541	rs17586946	chr6:25939053	C/T	cg17691542	chr6:26056736	HIST1H1C	1.23	8.83	0.71	2.35e-13	Iron status biomarkers;
SKCM	cis	rs11098499	0.909	rs28714195	chr4:120316950	A/T	cg09307838	chr4:120376055	NA	0.97	7.49	0.65	9.08e-11	Corneal astigmatism;
SKCM	cis	rs2816062	0.786	rs2816055	chr1:18898248	A/G	cg18795169	chr1:18902165	NA	-0.83	-8.77	-0.7	2.96e-13	Urate levels in lean individuals;
SKCM	cis	rs7215564	0.908	rs7503757	chr17:78685599	A/G	cg16980736	chr17:78789706	RPTOR	-0.88	-4.83	-0.48	6.66e-6	Myopia (pathological);
SKCM	cis	rs1267303	0.675	rs1267308	chr1:46987718	A/G	cg25110126	chr1:46999211	NA	-0.71	-5.2	-0.51	1.57e-6	Monobrow;
SKCM	cis	rs7954584	0.531	rs1154514	chr12:122374888	C/T	cg13699009	chr12:122356056	WDR66	0.59	7.37	0.64	1.54e-10	Mean corpuscular volume;
SKCM	cis	rs7666738	0.830	rs4440224	chr4:99044924	G/A	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs12477438	0.520	rs6743355	chr2:99732360	C/G	cg26064155	chr2:99771622	LIPT1;TSGA10	1.02	10.07	0.75	9.12e-16	Chronic sinus infection;
SKCM	cis	rs2019137	0.560	rs10175462	chr2:113988492	G/A	cg21550016	chr2:113992930	PAX8;LOC440839;LOC654433	0.62	4.86	0.48	6.01e-6	Lymphocyte counts;
SKCM	cis	rs116095464	0.558	rs10475136	chr5:232796	A/G	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs57221529	0.766	rs1399381	chr5:589853	G/T	cg26208419	chr5:473447	SLC9A3;LOC25845	1.01	5.18	0.51	1.7e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs9611565	0.643	rs202634	chr22:41809623	A/G	cg03806693	chr22:41940476	POLR3H	1.02	6.92	0.62	1.13e-9	Vitiligo;
SKCM	cis	rs9325144	0.555	rs4882358	chr12:38726640	A/G	cg26384229	chr12:38710491	ALG10B	0.78	6.82	0.61	1.76e-9	Morning vs. evening chronotype;
SKCM	cis	rs6570726	0.791	rs405206	chr6:145836873	C/A	cg05347473	chr6:146136440	FBXO30	0.53	4.78	0.48	8.07e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs684232	0.666	rs461521	chr17:622497	G/T	cg12384639	chr17:618140	VPS53	0.73	5.64	0.54	2.61e-7	Prostate cancer;
SKCM	cis	rs34339938	1	rs34339938	chr12:123678364	GAC/G	cg05973401	chr12:123451056	ABCB9	0.79	5.08	0.5	2.48e-6	Plateletcrit;
SKCM	cis	rs7811142	1.000	rs66632384	chr7:100018904	G/A	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.23	8.03	0.67	8.33e-12	Platelet count;
SKCM	cis	rs13118159	0.573	rs7657357	chr4:1372939	C/T	cg05025164	chr4:1340916	KIAA1530	0.65	4.81	0.48	7.2e-6	Longevity;
SKCM	cis	rs10504073	0.584	rs55838473	chr8:49948281	C/A	cg00325661	chr8:49890786	NA	0.8	6.81	0.61	1.83e-9	Blood metabolite ratios;
SKCM	cis	rs6545883	0.929	rs2593627	chr2:61618574	T/C	cg15711740	chr2:61764176	XPO1	0.7	4.93	0.49	4.5e-6	Tuberculosis;
SKCM	cis	rs2013441	1.000	rs9900166	chr17:20192969	G/A	cg13482628	chr17:19912719	NA	-0.66	-5.12	-0.5	2.18e-6	Obesity-related traits;
SKCM	cis	rs10489202	0.683	rs202260	chr1:167956167	G/T	cg24449463	chr1:168025552	DCAF6	-0.8	-7.62	-0.65	5.14e-11	Schizophrenia;
SKCM	cis	rs17376456	0.877	rs9314095	chr5:93425495	T/C	cg21475434	chr5:93447410	FAM172A	0.97	5.42	0.52	6.39e-7	Diabetic retinopathy;
SKCM	cis	rs3008870	1.000	rs975451	chr1:67480060	T/C	cg08660285	chr1:67390436	MIER1;WDR78	0.91	5.96	0.56	6.81e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs523522	1.000	rs523522	chr12:121020250	A/T	cg27279351	chr12:120934652	DYNLL1	0.91	8.36	0.69	1.88e-12	High light scatter reticulocyte count;
SKCM	cis	rs28830936	0.528	rs11630242	chr15:42124643	T/C	cg17847044	chr15:42102381	MAPKBP1	-0.49	-6.02	-0.56	5.33e-8	Diastolic blood pressure;
SKCM	cis	rs17376456	1.000	rs61132622	chr5:93539684	G/A	cg25358565	chr5:93447407	FAM172A	1.28	7.97	0.67	1.07e-11	Diabetic retinopathy;
SKCM	cis	rs910316	1.000	rs11159117	chr14:75584867	C/T	cg08847533	chr14:75593920	NEK9	0.95	9.18	0.72	4.8e-14	Height;
SKCM	cis	rs1577917	0.958	rs12198061	chr6:86550985	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.32	-0.52	9.66e-7	Response to antipsychotic treatment;
SKCM	cis	rs28386778	0.897	rs2854221	chr17:61941445	G/T	cg01411255	chr17:61851458	DDX42;CCDC47	0.79	5.07	0.5	2.58e-6	Prudent dietary pattern;
SKCM	cis	rs9926296	0.744	rs164746	chr16:89709019	C/T	cg08949735	chr16:89699720	DPEP1	-0.58	-5.19	-0.51	1.64e-6	Vitiligo;
SKCM	cis	rs1707322	0.691	rs61784803	chr1:46179271	C/A	cg03146154	chr1:46216737	IPP	-0.84	-6.2	-0.57	2.51e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs2836950	0.565	rs7279497	chr21:40531306	A/G	cg11644478	chr21:40555479	PSMG1	0.67	5.33	0.52	9.15e-7	Menarche (age at onset);
SKCM	cis	rs12477438	0.798	rs1580068	chr2:99649969	T/C	cg26064155	chr2:99771622	LIPT1;TSGA10	-0.72	-4.86	-0.48	6e-6	Chronic sinus infection;
SKCM	cis	rs7666738	0.800	rs2839836	chr4:98970512	A/G	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4808199	0.895	rs12981405	chr19:19651577	C/T	cg03709012	chr19:19516395	GATAD2A	1.17	8.53	0.69	8.66e-13	Nonalcoholic fatty liver disease;
SKCM	cis	rs11098499	0.866	rs12501602	chr4:120287935	A/T	cg09307838	chr4:120376055	NA	0.97	7.99	0.67	9.84e-12	Corneal astigmatism;
SKCM	cis	rs1005277	0.579	rs1740747	chr10:38520465	G/A	cg25427524	chr10:38739819	LOC399744	-0.69	-6.79	-0.61	1.96e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs875971	0.545	rs10950029	chr7:65634321	A/C	cg18876405	chr7:65276391	NA	0.65	5.3	0.51	1.04e-6	Aortic root size;
SKCM	cis	rs992157	0.735	rs13430006	chr2:219113089	A/C	cg20019365	chr2:219134978	PNKD;AAMP	-0.69	-5.9	-0.56	8.83e-8	Colorectal cancer;
SKCM	cis	rs1577917	0.958	rs12196230	chr6:86519960	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.33	-0.52	9.19e-7	Response to antipsychotic treatment;
SKCM	trans	rs9929218	0.551	rs8051095	chr16:68722049	G/A	cg04657470	chr2:198365150	HSPE1;HSPD1	1.01	11.2	0.79	6.66e-18	Colorectal cancer;
SKCM	cis	rs7937682	0.889	rs10749984	chr11:111492861	T/C	cg09085632	chr11:111637200	PPP2R1B	-0.97	-10.08	-0.75	8.74e-16	Primary sclerosing cholangitis;
SKCM	cis	rs13217239	0.646	rs11756275	chr6:27007113	A/C	cg12292205	chr6:26970375	C6orf41	-0.6	-5.29	-0.51	1.1e-6	Schizophrenia;
SKCM	cis	rs7829975	0.502	rs11785183	chr8:8565957	G/A	cg15556689	chr8:8085844	FLJ10661	-0.7	-5.27	-0.51	1.19e-6	Mood instability;
SKCM	cis	rs116095464	0.558	rs10065239	chr5:275288	C/T	cg22857025	chr5:266934	NA	-1.58	-8.14	-0.68	4.99e-12	Breast cancer;
SKCM	cis	rs754466	0.651	rs10762767	chr10:79645070	C/A	cg17075019	chr10:79541650	NA	-0.73	-6.27	-0.58	1.86e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs2070488	0.965	rs2284820	chr3:38562579	C/T	cg01465620	chr3:38496096	LOC100128640;ACVR2B	-1.0	-8.71	-0.7	3.92e-13	Electrocardiographic conduction measures;
SKCM	cis	rs28530618	0.580	rs11167174	chr20:31248879	G/A	cg25730142	chr20:32031702	SNTA1	0.6	4.8	0.48	7.5e-6	Birth weight;
SKCM	cis	rs13118159	0.509	rs1882098	chr4:1352431	T/C	cg19318889	chr4:1322082	MAEA	0.77	5.48	0.53	4.99e-7	Longevity;
SKCM	cis	rs4481887	1.000	rs4244178	chr1:248468441	A/G	cg00666640	chr1:248458726	OR2T12	0.64	5.69	0.54	2.13e-7	Common traits (Other);
SKCM	cis	rs8077889	1.000	rs2066725	chr17:41891473	A/G	cg26893861	chr17:41843967	DUSP3	1.2	7.87	0.67	1.67e-11	Triglycerides;
SKCM	cis	rs9389248	0.690	rs2072826	chr6:135253558	G/C	cg24558204	chr6:135376177	HBS1L	-0.59	-5.27	-0.51	1.17e-6	High light scatter reticulocyte percentage of red cells;
SKCM	cis	rs1568889	1.000	rs12808162	chr11:28067027	A/G	cg06544937	chr11:28130018	METT5D1;KIF18A	0.86	7.03	0.62	6.97e-10	Bipolar disorder;
SKCM	cis	rs875971	0.964	rs2161065	chr7:65932905	A/G	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	cis	rs1577917	0.958	rs13213551	chr6:86608701	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.66	-5.74	-0.54	1.76e-7	Response to antipsychotic treatment;
SKCM	cis	rs1529316	0.904	rs2554709	chr8:3830421	A/C	cg05999364	chr8:3269952	CSMD1	0.49	4.94	0.49	4.41e-6	Multiple sclerosis;
SKCM	cis	rs854765	0.686	rs8065497	chr17:17782649	A/G	cg04398451	chr17:18023971	MYO15A	0.71	4.81	0.48	7.2e-6	Total body bone mineral density;
SKCM	cis	rs3784262	1.000	rs4646619	chr15:58258342	A/G	cg12031962	chr15:58353849	ALDH1A2	-0.51	-6.6	-0.6	4.46e-9	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs9916302	0.904	rs4239222	chr17:37696235	A/C	cg07936489	chr17:37558343	FBXL20	0.86	7.81	0.66	2.16e-11	Glomerular filtration rate (creatinine);
SKCM	cis	rs4077515	0.967	rs11145874	chr9:139290011	G/A	cg14169450	chr9:139327907	INPP5E	0.46	4.94	0.49	4.38e-6	Ulcerative colitis;IgA nephropathy;Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs1559088	0.522	rs7254912	chr19:33554151	A/G	cg27124370	chr19:33622961	WDR88	0.83	6.0	0.56	5.76e-8	Bone ultrasound measurement (broadband ultrasound attenuation);
SKCM	cis	rs6138458	1.000	rs2387361	chr20:24899905	C/T	cg26195577	chr20:24973756	C20orf3	-1.22	-8.58	-0.7	7.01e-13	Blood protein levels;
SKCM	cis	rs933688	1.000	rs11959525	chr5:90703840	A/G	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.0	7.66	0.66	4.32e-11	Smoking behavior;
SKCM	cis	rs951366	0.789	rs823095	chr1:205679239	G/A	cg11965913	chr1:205819406	PM20D1	0.88	7.93	0.67	1.27e-11	Menarche (age at onset);
SKCM	cis	rs7666738	0.822	rs6815312	chr4:99058220	T/C	cg17366294	chr4:99064904	C4orf37	0.61	4.93	0.49	4.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4423214	1.000	rs2276361	chr11:71169648	A/G	cg05163923	chr11:71159392	DHCR7	0.83	8.11	0.68	5.77e-12	Vitamin D levels;
SKCM	cis	rs1552244	0.572	rs68121641	chr3:10165845	T/A	cg00149659	chr3:10157352	C3orf10	1.13	5.45	0.53	5.74e-7	Alzheimer's disease;
SKCM	cis	rs8017423	0.967	rs8022531	chr14:90729931	T/C	cg04374321	chr14:90722782	PSMC1	1.0	9.0	0.71	1.09e-13	Mortality in heart failure;
SKCM	cis	rs12709013	0.792	rs1836877	chr16:58803725	T/G	cg02431531	chr16:59244939	NA	0.48	4.99	0.49	3.62e-6	Blood metabolite ratios;
SKCM	cis	rs1029738	0.615	rs717624	chr7:22894487	T/C	cg06980547	chr7:22894557	NA	-0.61	-5.15	-0.5	1.88e-6	Fibrinogen levels;
SKCM	cis	rs753778	0.628	rs1045248	chr8:142204326	C/G	cg18755752	chr8:142205143	DENND3	-0.69	-5.77	-0.55	1.51e-7	Reticulocyte fraction of red cells;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs28386778	0.724	rs35092235	chr17:61944621	T/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.12	11.2	0.79	6.65e-18	Prudent dietary pattern;
SKCM	cis	rs10504229	1.000	rs67913746	chr8:58177825	A/G	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs10911232	0.507	rs9787327	chr1:182978459	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.74	6.71	0.6	2.83e-9	Hypertriglyceridemia;
SKCM	cis	rs7666738	0.761	rs28758886	chr4:99059704	C/T	cg05340658	chr4:99064831	C4orf37	0.66	4.87	0.48	5.74e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs13118159	0.742	rs7679860	chr4:1333987	C/T	cg20887711	chr4:1340912	KIAA1530	0.68	5.05	0.5	2.83e-6	Longevity;
SKCM	cis	rs754466	0.580	rs11002294	chr10:79540588	T/C	cg17075019	chr10:79541650	NA	-0.78	-7.12	-0.63	4.75e-10	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs4819052	0.851	rs2236444	chr21:46678226	T/C	cg19498844	chr21:46707878	POFUT2;LOC642852	0.88	7.78	0.66	2.5e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7811142	1.000	rs7787620	chr7:100089234	A/G	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.19	7.92	0.67	1.33e-11	Platelet count;
SKCM	cis	rs523522	0.962	rs55848094	chr12:120966659	G/A	cg12219531	chr12:120966889	COQ5	0.91	7.82	0.66	2.11e-11	High light scatter reticulocyte count;
SKCM	cis	rs684232	0.602	rs34167561	chr17:509268	G/A	cg15660573	chr17:549704	VPS53	-0.67	-4.99	-0.49	3.63e-6	Prostate cancer;
SKCM	cis	rs12477438	0.798	rs1453562	chr2:99615850	G/A	cg26064155	chr2:99771622	LIPT1;TSGA10	-0.72	-4.86	-0.48	6e-6	Chronic sinus infection;
SKCM	cis	rs6942756	0.956	rs13235668	chr7:128879710	A/G	cg02491457	chr7:128862824	NA	-0.76	-4.84	-0.48	6.51e-6	White matter hyperintensity burden;
SKCM	cis	rs4481887	0.893	rs4512685	chr1:248446246	C/T	cg00666640	chr1:248458726	OR2T12	0.58	4.88	0.48	5.46e-6	Common traits (Other);
SKCM	cis	rs826838	0.934	rs10875647	chr12:38856995	G/A	cg26384229	chr12:38710491	ALG10B	1.07	9.83	0.74	2.73e-15	Heart rate;
SKCM	cis	rs9300255	0.506	rs61388686	chr12:123810873	G/A	cg00376283	chr12:123451042	ABCB9	0.82	6.54	0.6	5.78e-9	Neutrophil percentage of white cells;
SKCM	cis	rs6582630	0.555	rs11182148	chr12:38464883	A/C	cg26384229	chr12:38710491	ALG10B	0.81	6.22	0.58	2.31e-8	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs473651	0.904	rs551859	chr2:239371836	T/C	cg18131467	chr2:239335373	ASB1	1.12	13.27	0.83	1.07e-21	Multiple system atrophy;
SKCM	cis	rs7772486	0.686	rs857882	chr6:145969716	T/G	cg05347473	chr6:146136440	FBXO30	-0.61	-5.46	-0.53	5.55e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs208520	1.000	rs12200490	chr6:66976084	G/A	cg07460842	chr6:66804631	NA	0.85	6.05	0.56	4.8e-8	Exhaled nitric oxide output;
SKCM	cis	rs6089584	0.606	rs7270469	chr20:60577258	G/A	cg06108461	chr20:60628389	TAF4	-0.73	-6.37	-0.59	1.2e-8	Body mass index;
SKCM	cis	rs1964356	0.967	rs17701675	chr8:8850633	A/G	cg15556689	chr8:8085844	FLJ10661	-0.66	-5.33	-0.52	9.09e-7	Mean corpuscular volume;
SKCM	cis	rs1401999	1.000	rs4148571	chr3:183720576	A/C	cg01324343	chr3:183735012	ABCC5	0.85	9.82	0.74	2.76e-15	Anterior chamber depth;
SKCM	cis	rs1790761	0.559	rs10896190	chr11:67406123	T/C	cg00864171	chr11:67383662	NA	0.59	5.15	0.5	1.89e-6	Mean corpuscular volume;
SKCM	cis	rs2836974	0.613	rs2245455	chr21:40548087	A/T	cg11890956	chr21:40555474	PSMG1	-0.69	-5.91	-0.56	8.46e-8	Cognitive function;
SKCM	cis	rs2303745	0.589	rs1864116	chr19:17393015	C/T	cg04248312	chr19:17393744	ANKLE1	-1.11	-8.18	-0.68	4.15e-12	Systemic lupus erythematosus;
SKCM	cis	rs1577917	0.876	rs12190735	chr6:86686467	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.6	-5.15	-0.5	1.93e-6	Response to antipsychotic treatment;
SKCM	cis	rs79839061	0.610	rs11731387	chr4:851357	C/T	cg07828340	chr4:882639	GAK	1.09	5.68	0.54	2.23e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs780096	0.506	rs2303369	chr2:27715416	C/T	cg05696406	chr2:27599888	SNX17	0.51	5.06	0.5	2.75e-6	Total body bone mineral density;
SKCM	cis	rs7208859	0.524	rs8069400	chr17:29075967	G/T	cg14067834	chr17:29058358	SUZ12P	1.1	5.11	0.5	2.25e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs6753739	0.784	rs437512	chr2:219926168	T/C	cg09617556	chr2:219924408	IHH	0.47	5.03	0.5	3.01e-6	Height;
SKCM	cis	rs2645694	0.626	rs2703151	chr4:77834095	A/G	cg06046430	chr4:77819534	ANKRD56	0.53	5.7	0.54	2.07e-7	Emphysema distribution in smoking;
SKCM	cis	rs9796	0.621	rs1659227	chr15:41472398	G/A	cg18705301	chr15:41695430	NDUFAF1	0.7	5.18	0.51	1.67e-6	Menopause (age at onset);
SKCM	trans	rs17685	0.712	rs10271413	chr7:75754858	G/A	cg19862616	chr7:65841803	NCRNA00174	0.94	9.49	0.73	1.22e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs16866061	1.000	rs1568750	chr2:225342597	A/T	cg02879423	chr2:224806760	WDFY1	0.69	5.03	0.5	3.03e-6	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs28595532	0.920	rs116231457	chr4:119762396	A/C	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs6546550	0.901	rs3771531	chr2:70164034	T/C	cg02498382	chr2:70120550	SNRNP27	-0.44	-4.84	-0.48	6.4e-6	Prevalent atrial fibrillation;
SKCM	cis	rs10751667	0.643	rs6597970	chr11:928669	C/A	cg10932868	chr11:921992	NA	0.55	5.13	0.5	2.09e-6	Alzheimer's disease (late onset);
SKCM	cis	rs4481887	0.927	rs4551626	chr1:248489128	G/T	cg00666640	chr1:248458726	OR2T12	0.62	5.27	0.51	1.2e-6	Common traits (Other);
SKCM	cis	rs796364	0.664	rs4673660	chr2:200915395	C/T	cg17644776	chr2:200775616	C2orf69	0.72	4.84	0.48	6.43e-6	Schizophrenia;
SKCM	cis	rs16854884	0.582	rs34402874	chr3:143643249	T/A	cg06585982	chr3:143692056	C3orf58	0.78	6.82	0.61	1.7e-9	Economic and political preferences (feminism/equality);
SKCM	trans	rs1814175	0.803	rs11040451	chr11:49650639	C/T	cg15704280	chr7:45808275	SEPT13	-1.0	-9.43	-0.73	1.61e-14	Height;
SKCM	cis	rs2228479	0.850	rs17226666	chr16:89835401	G/A	cg06558623	chr16:89946397	TCF25	1.11	5.26	0.51	1.23e-6	Skin colour saturation;
SKCM	cis	rs72781680	1.000	rs72796388	chr2:24171509	A/C	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	cis	rs9906944	0.545	rs11079851	chr17:47092310	G/C	cg20966754	chr17:47091339	IGF2BP1	-0.5	-4.86	-0.48	5.86e-6	Intelligence (multi-trait analysis);Body fat percentage;
SKCM	cis	rs3008870	1.000	rs2182143	chr1:67378936	T/C	cg08660285	chr1:67390436	MIER1;WDR78	0.97	6.52	0.59	6.39e-9	Lymphocyte percentage of white cells;
SKCM	cis	rs501916	0.833	rs3809486	chr15:48051549	G/T	cg16110827	chr15:48056943	SEMA6D	-0.61	-4.91	-0.49	4.89e-6	Inflammatory bowel disease;Ulcerative colitis;
SKCM	cis	rs9399135	0.935	rs11754504	chr6:135321509	C/T	cg24558204	chr6:135376177	HBS1L	0.59	5.23	0.51	1.41e-6	Red blood cell count;
SKCM	cis	rs7843479	0.524	rs1031884	chr8:21788984	C/T	cg17168535	chr8:21777572	XPO7	0.83	8.27	0.68	2.81e-12	Mean corpuscular volume;
SKCM	cis	rs933688	1.000	rs933688	chr5:90762748	G/A	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.0	7.92	0.67	1.32e-11	Smoking behavior;
SKCM	cis	rs16866061	1.000	rs11686590	chr2:225334070	A/G	cg12698349	chr2:225449008	CUL3	1.02	8.77	0.7	3.04e-13	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs9611565	0.649	rs6002480	chr22:42176917	A/T	cg03806693	chr22:41940476	POLR3H	-0.88	-5.75	-0.55	1.68e-7	Vitiligo;
SKCM	cis	rs77106637	1.000	rs613937	chr11:72474839	A/G	cg03713592	chr11:72463424	ARAP1	1.09	5.58	0.53	3.41e-7	Type 2 diabetes;
SKCM	cis	rs2857078	0.886	rs2072081	chr17:42327493	G/T	cg19774624	chr17:42201019	HDAC5	-0.78	-5.09	-0.5	2.46e-6	Red cell distribution width;Reticulocyte count;
SKCM	cis	rs4927850	0.709	rs6783079	chr3:195652708	T/C	cg01181863	chr3:195395398	SDHAP2	-0.91	-5.92	-0.56	8.09e-8	Pancreatic cancer;
SKCM	cis	rs5769765	0.865	rs3788730	chr22:50244695	C/T	cg22709217	chr22:50311962	ALG12;CRELD2	0.76	5.43	0.52	6.21e-7	Schizophrenia;
SKCM	cis	rs1265120	0.702	rs1111911	chr8:103165116	A/T	cg19365151	chr8:103254722	NA	0.59	4.94	0.49	4.28e-6	Chronic obstructive pulmonary disease;
SKCM	cis	rs6570726	0.934	rs9484995	chr6:145781114	T/A	cg23711669	chr6:146136114	FBXO30	-0.68	-6.55	-0.6	5.51e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4916588	0.697	rs4916586	chr3:196660820	C/T	cg05556202	chr3:196065106	TM4SF19	-0.68	-4.92	-0.49	4.67e-6	Night sleep phenotypes;
SKCM	cis	rs1044826	0.642	rs295478	chr3:139223135	G/A	cg15131784	chr3:139108705	COPB2	0.68	4.97	0.49	3.85e-6	Obesity-related traits;
SKCM	cis	rs7937682	0.889	rs567859	chr11:111486738	A/G	cg19812747	chr11:111475976	SIK2	-0.56	-4.93	-0.49	4.55e-6	Primary sclerosing cholangitis;
SKCM	cis	rs28595532	1.000	rs114682099	chr4:119702004	C/T	cg21605333	chr4:119757512	SEC24D	1.35	7.92	0.67	1.37e-11	Cannabis dependence symptom count;
SKCM	cis	rs1577917	0.958	rs34795473	chr6:86461799	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.78	-7.41	-0.64	1.3100000000000001e-10	Response to antipsychotic treatment;
SKCM	trans	rs1814175	0.647	rs2903409	chr11:49953612	C/G	cg15704280	chr7:45808275	SEPT13	-0.85	-8.29	-0.68	2.59e-12	Height;
SKCM	cis	rs10876993	0.890	rs7963927	chr12:58046272	T/G	cg18357645	chr12:58087776	OS9	0.62	5.65	0.54	2.56e-7	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs2652834	1.000	rs34575783	chr15:63397686	G/C	cg04194852	chr15:63334506	TPM1	0.76	4.78	0.48	8.15e-6	HDL cholesterol;
SKCM	cis	rs8077889	0.672	rs15359	chr17:41843979	C/G	cg26893861	chr17:41843967	DUSP3	-1.43	-12.83	-0.82	6.51e-21	Triglycerides;
SKCM	cis	rs6754311	0.509	rs12616520	chr2:136516748	A/T	cg07169764	chr2:136633963	MCM6	-0.85	-6.11	-0.57	3.66e-8	Mosquito bite size;
SKCM	cis	rs514406	0.825	rs497535	chr1:53284677	A/G	cg16325326	chr1:53192061	ZYG11B	-0.99	-11.71	-0.8	7.39e-19	Monocyte count;
SKCM	cis	rs9790314	0.690	rs9860738	chr3:160843290	G/A	cg03342759	chr3:160939853	NMD3	-0.69	-6.9	-0.62	1.22e-9	Morning vs. evening chronotype;
SKCM	cis	rs875971	0.577	rs34888281	chr7:65585771	C/T	cg00343986	chr7:65444356	GUSB	-0.68	-4.94	-0.49	4.44e-6	Aortic root size;
SKCM	cis	rs28595532	0.841	rs56046449	chr4:119769302	T/C	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs7772486	0.790	rs2253307	chr6:146196181	T/G	cg05347473	chr6:146136440	FBXO30	0.58	5.45	0.53	5.72e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2180341	0.924	rs877661	chr6:127587915	T/G	cg27446573	chr6:127587934	RNF146	1.02	8.51	0.69	9.79e-13	Breast cancer;
SKCM	cis	rs2014572	0.967	rs7259978	chr19:57756129	C/T	cg24459738	chr19:57751996	ZNF805	-0.64	-5.29	-0.51	1.1e-6	Hyperactive-impulsive symptoms;
SKCM	cis	rs16866061	0.515	rs13020268	chr2:225437923	C/T	cg12698349	chr2:225449008	CUL3	0.94	10.01	0.75	1.22e-15	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs7666738	0.927	rs6832373	chr4:99051967	A/G	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs3820928	0.904	rs60906902	chr2:227760034	C/T	cg11843606	chr2:227700838	RHBDD1	-0.62	-5.04	-0.5	2.95e-6	Pulmonary function;
SKCM	cis	rs7927771	0.524	rs9633830	chr11:47849470	T/G	cg20307385	chr11:47447363	PSMC3	0.71	5.63	0.54	2.67e-7	Subjective well-being;
SKCM	cis	rs2836974	0.899	rs34978594	chr21:40580003	C/T	cg11644478	chr21:40555479	PSMG1	0.97	10.08	0.75	8.76e-16	Cognitive function;
SKCM	cis	rs4481887	0.741	rs28616194	chr1:248531904	T/A	cg00666640	chr1:248458726	OR2T12	0.49	5.16	0.5	1.81e-6	Common traits (Other);
SKCM	cis	rs7659604	0.517	rs56311153	chr4:122729685	T/C	cg06713675	chr4:122721982	EXOSC9	-0.75	-7.31	-0.64	2.01e-10	Type 2 diabetes;
SKCM	trans	rs7618501	1.000	rs1491986	chr3:49739086	C/T	cg21659725	chr3:3221576	CRBN	-0.96	-9.58	-0.74	8.03e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs9910055	0.571	rs28897216	chr17:42240824	A/G	cg10896456	chr17:42255109	ASB16;C17orf65	0.69	7.34	0.64	1.78e-10	Total body bone mineral density;
SKCM	cis	rs7584330	0.868	rs6760842	chr2:238398165	C/T	cg14458575	chr2:238380390	NA	-0.94	-6.16	-0.57	3.01e-8	Prostate cancer;
SKCM	cis	rs6866344	0.697	rs11748497	chr5:178130012	C/G	cg10224037	chr5:178157518	ZNF354A	0.77	5.38	0.52	7.71e-7	Neutrophil percentage of white cells;
SKCM	cis	rs7208859	0.524	rs11653605	chr17:29088385	T/G	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs11098499	0.618	rs28491261	chr4:120294900	C/A	cg24375607	chr4:120327624	NA	0.67	5.05	0.5	2.8e-6	Corneal astigmatism;
SKCM	cis	rs28595532	0.925	rs28627331	chr4:119665345	T/C	cg21605333	chr4:119757512	SEC24D	1.34	7.8	0.66	2.27e-11	Cannabis dependence symptom count;
SKCM	cis	rs760805	1.000	rs4648884	chr1:25261386	C/T	cg22509179	chr1:25234806	RUNX3	0.69	5.68	0.54	2.23e-7	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs2836974	0.966	rs7283420	chr21:40666865	T/C	cg17971929	chr21:40555470	PSMG1	0.86	8.49	0.69	1.04e-12	Cognitive function;
SKCM	cis	rs798554	0.679	rs1636249	chr7:2884283	T/G	cg19346786	chr7:2764209	NA	-0.65	-6.7	-0.6	2.9e-9	Height;
SKCM	cis	rs875971	0.862	rs2088655	chr7:65795711	T/C	cg18876405	chr7:65276391	NA	-0.64	-6.42	-0.59	9.88e-9	Aortic root size;
SKCM	cis	rs2279817	0.863	rs2354291	chr1:18027554	G/T	cg17142039	chr1:18149651	ACTL8	-0.59	-5.15	-0.5	1.87e-6	Neuroticism;
SKCM	cis	rs362272	0.545	rs2749782	chr4:3339761	A/G	cg05297308	chr4:3317976	RGS12	1.05	13.75	0.84	1.54e-22	Serum sulfate level;
SKCM	cis	rs10504229	0.683	rs56192850	chr8:58135356	A/G	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs7772486	0.846	rs9403767	chr6:146402386	G/T	cg05347473	chr6:146136440	FBXO30	0.62	5.59	0.53	3.25e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2404602	0.647	rs11072612	chr15:76960984	A/T	cg23625390	chr15:77176239	SCAPER	-0.85	-8.26	-0.68	2.93e-12	Blood metabolite levels;
SKCM	cis	rs9640161	0.789	rs34728606	chr7:150054694	G/A	cg10018233	chr7:150070692	REPIN1	0.67	5.27	0.51	1.17e-6	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs9910055	0.529	rs850851	chr17:42177674	C/T	cg09913183	chr17:42254507	C17orf65;ASB16	-0.58	-4.83	-0.48	6.59e-6	Total body bone mineral density;
SKCM	cis	rs12714314	0.756	rs10175420	chr2:1938138	C/T	cg22350835	chr2:1868857	MYT1L	0.64	5.08	0.5	2.49e-6	Type 2 diabetes (age of onset);
SKCM	cis	rs7523050	0.643	rs34096625	chr1:109401101	G/A	cg08274380	chr1:109419600	GPSM2	1.13	5.57	0.53	3.54e-7	Fat distribution (HIV);
SKCM	cis	rs7191439	0.858	rs11076701	chr16:88774525	A/G	cg02389323	chr16:88786976	FAM38A	1.34	6.31	0.58	1.56e-8	Plateletcrit;
SKCM	cis	rs875971	0.660	rs801193	chr7:66030612	A/C	cg18876405	chr7:65276391	NA	-0.73	-6.43	-0.59	9.42e-9	Aortic root size;
SKCM	cis	rs2404602	0.692	rs3816266	chr15:76993835	T/G	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs875971	1.000	rs2420820	chr7:66091907	T/C	cg05627663	chr7:65219948	SNORA22;CCT6P1	-0.53	-5.26	-0.51	1.22e-6	Aortic root size;
SKCM	cis	rs8072100	0.934	rs9905583	chr17:45741016	C/T	cg08085267	chr17:45401833	C17orf57	-0.64	-5.93	-0.56	7.83e-8	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs1863918	0.659	rs4700779	chr5:178494058	A/G	cg21905437	chr5:178450457	ZNF879	-0.62	-5.54	-0.53	4.02e-7	Depression in response to interferon-based therapy in chronic hepatitis C;
SKCM	cis	rs28386778	0.863	rs2597633	chr17:61872871	T/C	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs6921919	0.583	rs6922429	chr6:28381345	T/C	cg14547644	chr6:28411285	ZSCAN23	-0.58	-4.8	-0.48	7.46e-6	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs2197308	0.765	rs11182434	chr12:37923968	C/A	cg26384229	chr12:38710491	ALG10B	0.82	6.88	0.61	1.35e-9	Morning vs. evening chronotype;
SKCM	cis	rs7666738	0.830	rs10031190	chr4:98908683	C/A	cg17366294	chr4:99064904	C4orf37	0.56	4.87	0.48	5.76e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs826838	0.967	rs11183514	chr12:38760744	A/T	cg13010199	chr12:38710504	ALG10B	0.86	6.84	0.61	1.61e-9	Heart rate;
SKCM	cis	rs7524258	0.835	rs7521425	chr1:7306543	C/T	cg07173049	chr1:7289937	CAMTA1	0.43	4.86	0.48	5.86e-6	Tourette's syndrome or obsessive-compulsive disorder;
SKCM	cis	rs4555082	0.830	rs2255575	chr14:105727251	T/C	cg13114125	chr14:105738426	BRF1	-0.69	-5.39	-0.52	7.2e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs12044355	0.789	rs11589082	chr1:231824656	C/A	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	0.83	6.52	0.59	6.26e-9	Alzheimer's disease;
SKCM	cis	rs7811142	1.000	rs11766752	chr7:100073292	A/G	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-0.99	-5.52	-0.53	4.2e-7	Platelet count;
SKCM	cis	rs9858542	0.953	rs12330269	chr3:49513910	G/A	cg03060546	chr3:49711283	APEH	-0.75	-5.53	-0.53	4.17e-7	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs11098499	0.955	rs11944880	chr4:120159334	A/G	cg09307838	chr4:120376055	NA	-0.98	-8.58	-0.7	6.9e-13	Corneal astigmatism;
SKCM	cis	rs7937682	0.710	rs674230	chr11:111437887	A/G	cg22437258	chr11:111473054	SIK2	0.64	4.85	0.48	6.21e-6	Primary sclerosing cholangitis;
SKCM	cis	rs1153858	1.000	rs1719247	chr15:45620985	C/T	cg10760299	chr15:45669010	GATM	0.52	4.95	0.49	4.27e-6	Homoarginine levels;
SKCM	cis	rs7216064	1.000	rs9897982	chr17:65879592	G/T	cg12091567	chr17:66097778	LOC651250	-0.76	-5.42	-0.52	6.34e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs9911578	0.967	rs4598970	chr17:57076893	T/A	cg05425664	chr17:57184151	TRIM37	0.84	6.99	0.62	8.23e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs561341	0.941	rs4525554	chr17:30312819	T/C	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs28386778	0.687	rs59596917	chr17:61806264	T/A	cg06873352	chr17:61820015	STRADA	0.75	6.24	0.58	2.1e-8	Prudent dietary pattern;
SKCM	cis	rs6866344	0.697	rs62392833	chr5:178135452	T/A	cg03877680	chr5:178157825	ZNF354A	0.88	6.61	0.6	4.35e-9	Neutrophil percentage of white cells;
SKCM	cis	rs11098499	0.820	rs28578366	chr4:120536905	A/G	cg09307838	chr4:120376055	NA	-0.96	-7.65	-0.65	4.56e-11	Corneal astigmatism;
SKCM	cis	rs2032447	0.517	rs7767546	chr6:25904067	T/C	cg03264133	chr6:25882463	NA	-0.63	-5.71	-0.54	1.94e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs1760803	0.754	rs9803857	chr1:154191791	A/G	cg26808167	chr1:154192205	UBAP2L;C1orf43	0.55	4.91	0.49	4.87e-6	Nicotine dependence;
SKCM	cis	rs875971	0.862	rs778684	chr7:65836403	A/T	cg11764359	chr7:65958608	NA	0.81	7.63	0.65	4.91e-11	Aortic root size;
SKCM	cis	rs2075371	0.863	rs12672691	chr7:133954431	C/T	cg20476274	chr7:133979776	SLC35B4	0.96	9.42	0.73	1.63e-14	Mean platelet volume;
SKCM	cis	rs7523273	0.606	rs1962149	chr1:207956559	G/A	cg22525895	chr1:207977042	MIR29B2	-0.83	-6.91	-0.62	1.19e-9	Schizophrenia;
SKCM	trans	rs3780486	0.846	rs6476402	chr9:33148552	G/A	cg20290983	chr6:43655470	MRPS18A	0.9	10.43	0.76	1.9e-16	IgG glycosylation;
SKCM	cis	rs873946	0.586	rs3793682	chr10:134564563	C/T	cg18305652	chr10:134549665	INPP5A	0.59	5.74	0.55	1.7e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs10193935	0.579	rs62142594	chr2:42524531	G/A	cg27598129	chr2:42591480	NA	-1.04	-6.37	-0.59	1.2e-8	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7086627	0.515	rs10887905	chr10:82210855	A/T	cg00277334	chr10:82204260	NA	-0.75	-8.99	-0.71	1.12e-13	Post bronchodilator FEV1;
SKCM	cis	rs6450176	1.000	rs9687611	chr5:53300288	C/T	ch.5.1024479R	chr5:53302184	ARL15	-0.71	-4.88	-0.48	5.49e-6	HDL cholesterol levels;HDL cholesterol;Adiponectin levels;
SKCM	cis	rs6952808	0.929	rs12532128	chr7:1925454	T/C	cg05863683	chr7:1912471	MAD1L1	0.64	5.76	0.55	1.61e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs6088580	0.634	rs6142157	chr20:32984172	C/G	cg24642439	chr20:33292090	TP53INP2	-0.76	-6.02	-0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs4689592	0.622	rs2276968	chr4:7070118	T/G	cg26116260	chr4:7069785	GRPEL1	1.09	7.87	0.67	1.68e-11	Monocyte percentage of white cells;
SKCM	cis	rs748404	0.697	rs471122	chr15:43558574	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	-0.69	-5.75	-0.55	1.68e-7	Lung cancer;
SKCM	cis	rs4972806	0.668	rs2072588	chr2:177042930	G/C	cg14324370	chr2:177042789	NA	0.58	5.31	0.52	1.01e-6	IgG glycosylation;
SKCM	cis	rs875971	0.928	rs2036263	chr7:65800197	C/T	cg11764359	chr7:65958608	NA	-0.81	-7.6	-0.65	5.6e-11	Aortic root size;
SKCM	cis	rs10256972	0.591	rs11766651	chr7:1161646	A/G	cg07092213	chr7:1199455	ZFAND2A	-0.63	-4.96	-0.49	4.02e-6	Longevity;Endometriosis;
SKCM	cis	rs2033711	0.503	rs6510141	chr19:58885786	C/G	cg13877915	chr19:58951672	ZNF132	-0.75	-5.91	-0.56	8.44e-8	Uric acid clearance;
SKCM	cis	rs7811142	1.000	rs28490152	chr7:100020982	G/A	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.33	0.69	2.11e-12	Platelet count;
SKCM	cis	rs1218582	0.772	rs2335408	chr1:154915977	G/A	cg03351412	chr1:154909251	PMVK	0.77	6.54	0.6	5.87e-9	Prostate cancer;
SKCM	cis	rs12134245	0.874	rs34842487	chr1:92021611	C/T	cg02896835	chr1:92012615	NA	-0.58	-5.11	-0.5	2.26e-6	Breast cancer;
SKCM	cis	rs8014204	0.836	rs8021280	chr14:75290018	C/G	cg06637938	chr14:75390232	RPS6KL1	0.83	6.65	0.6	3.64e-9	Caffeine consumption;
SKCM	cis	rs1005277	0.505	rs7099777	chr10:38183569	A/C	cg00409905	chr10:38381863	ZNF37A	0.63	5.85	0.55	1.09e-7	Extrinsic epigenetic age acceleration;
SKCM	trans	rs7618501	0.933	rs3811695	chr3:49761613	C/T	cg21659725	chr3:3221576	CRBN	-0.96	-9.61	-0.74	7.08e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs1799949	0.965	rs799917	chr17:41244936	G/A	cg23758822	chr17:41437982	NA	0.93	7.35	0.64	1.69e-10	Menopause (age at onset);
SKCM	cis	rs34172651	0.517	rs12920774	chr16:24830750	T/C	cg00339695	chr16:24857497	SLC5A11	0.78	6.22	0.58	2.3e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs4237845	0.513	rs7134797	chr12:58263852	C/T	cg00677455	chr12:58241039	CTDSP2	0.91	8.28	0.68	2.66e-12	Intelligence (multi-trait analysis);
SKCM	cis	rs7811142	0.830	rs118119933	chr7:99939050	C/T	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.05	5.05	0.5	2.87e-6	Platelet count;
SKCM	cis	rs1801251	0.929	rs12694917	chr2:233707611	C/T	cg08000102	chr2:233561755	GIGYF2	-0.85	-7.04	-0.62	6.74e-10	Coronary artery disease;
SKCM	cis	rs919433	0.783	rs787980	chr2:198239225	C/T	cg04278110	chr2:198063759	ANKRD44	0.74	5.13	0.5	2.06e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs2836974	0.568	rs429955	chr21:40539760	G/A	cg11644478	chr21:40555479	PSMG1	0.8	7.6	0.65	5.6e-11	Cognitive function;
SKCM	cis	rs7927771	1.000	rs34128973	chr11:47851376	C/T	cg05585544	chr11:47624801	NA	-0.59	-5.09	-0.5	2.43e-6	Subjective well-being;
SKCM	cis	rs12142240	0.698	rs72885198	chr1:46812888	C/T	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs1552244	0.882	rs67762674	chr3:10014485	C/T	cg02579736	chr3:10068473	FANCD2;CIDECP	0.98	4.84	0.48	6.48e-6	Alzheimer's disease;
SKCM	cis	rs4925325	0.915	rs2427246	chr20:60517047	T/C	cg13770153	chr20:60521292	NA	-1.09	-8.55	-0.7	8.07e-13	Obesity-related traits;
SKCM	cis	rs17826219	0.706	rs55764512	chr17:29085758	G/A	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Body mass index;
SKCM	cis	rs7937682	0.889	rs3017767	chr11:111508098	A/G	cg09085632	chr11:111637200	PPP2R1B	-1.07	-11.3	-0.79	4.28e-18	Primary sclerosing cholangitis;
SKCM	cis	rs6977660	0.714	rs6970798	chr7:19816741	G/C	cg07541023	chr7:19748670	TWISTNB	0.72	4.78	0.48	7.95e-6	Thyroid stimulating hormone;
SKCM	cis	rs2730245	0.527	rs2036582	chr7:158701708	A/T	cg24397884	chr7:158709396	WDR60	0.88	5.33	0.52	9.42e-7	Height;
SKCM	cis	rs798554	0.679	rs1614791	chr7:2888057	G/T	cg04166393	chr7:2884313	GNA12	0.79	5.54	0.53	3.9e-7	Height;
SKCM	cis	rs4423214	0.840	rs1792234	chr11:71182018	T/C	cg05163923	chr11:71159392	DHCR7	-0.71	-6.16	-0.57	2.96e-8	Vitamin D levels;
SKCM	cis	rs2070488	0.775	rs961179	chr3:38509618	G/A	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.74	5.96	0.56	6.8e-8	Electrocardiographic conduction measures;
SKCM	cis	rs1218582	0.741	rs7544528	chr1:154844585	C/T	cg24250549	chr1:154909240	PMVK	0.84	8.9	0.71	1.69e-13	Prostate cancer;
SKCM	trans	rs1814175	0.586	rs2866862	chr11:49954588	T/C	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs2153535	0.580	rs9392223	chr6:8468650	G/A	cg07606381	chr6:8435919	SLC35B3	0.94	6.72	0.61	2.69e-9	Motion sickness;
SKCM	cis	rs1568889	1.000	rs34337978	chr11:28136746	A/G	cg06544937	chr11:28130018	METT5D1;KIF18A	0.87	7.0	0.62	7.86e-10	Bipolar disorder;
SKCM	cis	rs2842992	0.724	rs4709368	chr6:160204127	C/T	cg11366901	chr6:160182831	ACAT2	-0.84	-7.43	-0.64	1.18e-10	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs11646917	0.620	rs62038920	chr16:51448826	C/T	cg01194320	chr16:50493166	NA	-0.59	-4.91	-0.49	4.95e-6	Optic cup area;
SKCM	cis	rs3857536	0.505	rs208459	chr6:66911055	C/T	cg07460842	chr6:66804631	NA	-0.75	-5.71	-0.54	1.98e-7	Blood trace element (Cu levels);
SKCM	cis	rs10197940	0.510	rs7602715	chr2:152421937	A/G	cg19508488	chr2:152266495	RIF1	0.6	4.86	0.48	5.98e-6	Lung cancer;
SKCM	cis	rs4683346	0.731	rs35807837	chr3:42920235	C/T	cg06399164	chr3:42695035	ZBTB47	0.55	5.11	0.5	2.22e-6	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs2228479	0.681	rs8044906	chr16:89969603	T/C	cg06558623	chr16:89946397	TCF25	1.26	7.26	0.64	2.51e-10	Skin colour saturation;
SKCM	cis	rs910316	0.737	rs91144	chr14:75449517	G/A	cg08847533	chr14:75593920	NEK9	-0.82	-6.97	-0.62	8.84e-10	Height;
SKCM	cis	rs7772486	0.790	rs2265469	chr6:146219049	T/C	cg23711669	chr6:146136114	FBXO30	0.78	7.7	0.66	3.53e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4841097	0.876	rs6601288	chr8:8943430	A/T	cg08975724	chr8:8085496	FLJ10661	0.67	4.99	0.49	3.65e-6	Platelet distribution width;
SKCM	cis	rs826838	0.935	rs1843639	chr12:39178919	C/A	cg13010199	chr12:38710504	ALG10B	0.68	5.26	0.51	1.21e-6	Heart rate;
SKCM	cis	rs1348850	0.567	rs3770005	chr2:178528874	A/G	cg22681709	chr2:178499509	PDE11A	-0.57	-5.21	-0.51	1.49e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs28374715	0.528	rs7181982	chr15:41623020	C/G	cg18705301	chr15:41695430	NDUFAF1	-1.21	-12.61	-0.82	1.61e-20	Ulcerative colitis;
SKCM	cis	rs40363	0.645	rs250629	chr16:3525431	C/A	cg22508957	chr16:3507546	NAT15	0.57	4.87	0.48	5.8e-6	Tuberculosis;
SKCM	cis	rs6500602	0.963	rs7201012	chr16:4480682	C/G	cg09069446	chr16:4462122	CORO7	-0.46	-4.89	-0.48	5.32e-6	Schizophrenia;
SKCM	cis	rs7143963	0.580	rs6575931	chr14:103301574	A/G	cg23020514	chr14:103360112	TRAF3	0.73	6.9	0.62	1.23e-9	Body mass index;
SKCM	cis	rs854765	0.693	rs4924823	chr17:17764502	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	-1.05	-8.25	-0.68	3.1e-12	Total body bone mineral density;
SKCM	cis	rs8103278	0.507	rs3745802	chr19:46271177	G/T	cg11657440	chr19:46296263	DMWD	1.06	10.49	0.76	1.48e-16	Coronary artery disease;
SKCM	cis	rs9900062	0.546	rs2428352	chr17:62694738	C/T	cg02097616	chr17:62675921	NA	-0.76	-6.81	-0.61	1.83e-9	QT interval;
SKCM	cis	rs798554	0.797	rs798494	chr7:2798294	C/A	cg04166393	chr7:2884313	GNA12	0.72	4.99	0.49	3.52e-6	Height;
SKCM	cis	rs1005277	0.579	rs2023351	chr10:38378814	A/G	cg00409905	chr10:38381863	ZNF37A	-0.64	-5.96	-0.56	6.77e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs1160297	0.576	rs12990843	chr2:53108688	A/G	cg07782112	chr2:53107842	NA	0.6	6.39	0.59	1.1e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs34779708	0.868	rs2384352	chr10:35492832	A/G	cg03585969	chr10:35415529	CREM	0.7	5.23	0.51	1.4e-6	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs2180341	1.000	rs2038378	chr6:127590400	C/T	cg24812749	chr6:127587940	RNF146	0.93	7.6	0.65	5.66e-11	Breast cancer;
SKCM	cis	rs13256369	0.755	rs12550057	chr8:8562268	G/A	cg15556689	chr8:8085844	FLJ10661	0.65	4.77	0.48	8.39e-6	Obesity-related traits;
SKCM	cis	rs9393692	0.905	rs7769028	chr6:26267568	C/T	cg00631329	chr6:26305371	NA	-0.7	-5.03	-0.49	3.07e-6	Educational attainment;
SKCM	cis	rs8014204	0.762	rs12889665	chr14:75234830	T/G	cg06637938	chr14:75390232	RPS6KL1	0.7	5.36	0.52	8.27e-7	Caffeine consumption;
SKCM	cis	rs33794	0.901	rs33778	chr3:45287918	A/G	cg25630594	chr3:44914870	TGM4	0.57	4.91	0.49	4.97e-6	Lung function (forced expiratory volume in 1 second);
SKCM	cis	rs7772486	0.875	rs9390372	chr6:146363638	G/C	cg23711669	chr6:146136114	FBXO30	0.78	7.48	0.65	9.35e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs589448	0.967	rs2617834	chr12:69753365	T/C	cg20891283	chr12:69753455	YEATS4	0.98	9.89	0.75	2.06e-15	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs55823223	0.590	rs11870142	chr17:73859002	A/G	cg10935138	chr17:73851978	WBP2	1.18	7.17	0.63	3.66e-10	Psoriasis;
SKCM	cis	rs992157	0.835	rs6707559	chr2:219142773	C/T	cg00012203	chr2:219082015	ARPC2	0.74	5.97	0.56	6.53e-8	Colorectal cancer;
SKCM	cis	rs933688	1.000	rs10041402	chr5:90738948	A/T	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.07	8.69	0.7	4.41e-13	Smoking behavior;
SKCM	cis	rs4242434	0.819	rs2291230	chr8:22463697	C/G	cg03733263	chr8:22462867	KIAA1967	1.0	8.29	0.68	2.63e-12	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs67311347	0.544	rs67533651	chr3:40338367	T/A	cg02782426	chr3:40428986	ENTPD3	0.52	5.3	0.51	1.06e-6	Renal cell carcinoma;
SKCM	cis	rs769267	0.895	rs2916074	chr19:19530270	C/T	cg26732615	chr19:19648335	CILP2;YJEFN3	0.67	6.92	0.62	1.13e-9	Tonsillectomy;
SKCM	cis	rs3847687	1.000	rs11061303	chr12:131526322	A/G	cg25772418	chr12:131519998	GPR133	-0.52	-5.22	-0.51	1.44e-6	Longevity;
SKCM	cis	rs12682352	0.602	rs11783966	chr8:8665147	A/G	cg06636001	chr8:8085503	FLJ10661	-0.76	-5.91	-0.56	8.43e-8	Neuroticism;
SKCM	cis	rs561341	0.609	rs7214626	chr17:30190989	G/A	cg00745463	chr17:30367425	LRRC37B	0.88	5.18	0.51	1.66e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs4905558	1.000	rs10146571	chr14:97338777	G/A	cg11863609	chr14:97355128	NA	-0.54	-4.81	-0.48	7.32e-6	Neutrophil count;
SKCM	cis	rs9815354	0.812	rs73073371	chr3:41843443	A/G	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs9911578	0.933	rs2632508	chr17:56533235	G/A	cg12560992	chr17:57184187	TRIM37	0.95	7.52	0.65	7.96e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs7811142	0.943	rs111493473	chr7:100049742	A/G	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-0.99	-5.52	-0.53	4.2e-7	Platelet count;
SKCM	cis	rs9910055	0.529	rs228764	chr17:42185469	A/G	cg09913183	chr17:42254507	C17orf65;ASB16	-0.59	-4.82	-0.48	6.82e-6	Total body bone mineral density;
SKCM	cis	rs704	0.585	rs2227735	chr17:26693258	C/T	cg27392559	chr17:27410759	MYO18A	-0.54	-5.0	-0.49	3.44e-6	Osteoprotegerin levels;
SKCM	cis	rs2836950	0.545	rs8132143	chr21:40584258	A/T	cg11890956	chr21:40555474	PSMG1	-0.66	-5.26	-0.51	1.22e-6	Menarche (age at onset);
SKCM	cis	rs870825	0.616	rs61539306	chr4:185650276	C/T	cg04058563	chr4:185651563	MLF1IP	1.13	7.57	0.65	6.42e-11	Blood protein levels;
SKCM	cis	rs860295	0.812	rs12131079	chr1:155319668	C/T	cg03737080	chr1:154956500	FLAD1	-0.63	-4.91	-0.49	4.84e-6	Body mass index;
SKCM	cis	rs875971	0.898	rs6977501	chr7:65693342	T/C	cg18876405	chr7:65276391	NA	-0.67	-6.66	-0.6	3.48e-9	Aortic root size;
SKCM	cis	rs4332037	0.539	rs55993248	chr7:2071132	A/G	cg23422044	chr7:1970798	MAD1L1	-0.91	-6.07	-0.57	4.38e-8	Bipolar disorder;
SKCM	cis	rs79839061	0.563	rs55728587	chr4:843674	G/A	cg07828340	chr4:882639	GAK	1.06	5.32	0.52	9.74e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs4423214	1.000	rs12793530	chr11:71161656	G/A	cg05163923	chr11:71159392	DHCR7	0.83	8.06	0.67	7.35e-12	Vitamin D levels;
SKCM	cis	rs709400	0.832	rs55864158	chr14:104068579	G/A	cg26031613	chr14:104095156	KLC1	1.11	12.72	0.82	1.04e-20	Body mass index;
SKCM	cis	rs244731	0.959	rs4976677	chr5:176629546	G/A	cg16006841	chr5:176797999	RGS14	-0.82	-6.91	-0.62	1.15e-9	Urate levels in lean individuals;
SKCM	cis	rs2153535	0.580	rs6926759	chr6:8456176	G/A	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs2075371	0.931	rs1646697	chr7:133999930	G/A	cg20476274	chr7:133979776	SLC35B4	1.03	10.69	0.77	5.94e-17	Mean platelet volume;
SKCM	cis	rs4727027	0.933	rs62505074	chr7:148834780	C/T	cg23583168	chr7:148888333	NA	-0.82	-6.56	-0.6	5.29e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs763121	0.853	rs8140617	chr22:38970439	A/G	cg06022373	chr22:39101656	GTPBP1	-0.86	-6.96	-0.62	9.25e-10	Menopause (age at onset);
SKCM	cis	rs11585357	0.947	rs2977304	chr1:17611615	T/C	cg08277548	chr1:17600880	PADI3	0.9	6.35	0.58	1.34e-8	Hair shape;
SKCM	cis	rs1348850	0.837	rs4243388	chr2:178284604	T/G	cg02961200	chr2:178257176	LOC100130691;AGPS	0.84	6.22	0.58	2.27e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs8037137	0.915	rs79548680	chr15:91505779	G/C	cg15878949	chr15:91534302	PRC1	0.66	4.99	0.49	3.6e-6	Platelet count;Serous invasive ovarian cancer;High-grade serous ovarian cancer;Invasive epithelial ovarian cancer;
SKCM	cis	rs17345786	1.000	rs58907984	chr3:101305170	T/G	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.69	4.91	0.49	4.87e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7666738	0.830	rs10050008	chr4:99025313	T/G	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9430161	0.579	rs6694011	chr1:11036935	G/A	cg02454025	chr1:11042201	C1orf127	1.02	9.27	0.72	3.19e-14	Ewing sarcoma;
SKCM	cis	rs6570726	0.967	rs7772286	chr6:145930423	A/T	cg23711669	chr6:146136114	FBXO30	-0.73	-7.11	-0.63	4.77e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7829975	0.501	rs4840353	chr8:8580570	A/G	cg15556689	chr8:8085844	FLJ10661	-0.63	-4.9	-0.48	5.15e-6	Mood instability;
SKCM	cis	rs6430585	0.528	rs3099429	chr2:136655582	T/A	cg07169764	chr2:136633963	MCM6	1.27	10.82	0.77	3.46e-17	Corneal structure;
SKCM	cis	rs2836950	0.565	rs2150414	chr21:40614988	A/G	cg11644478	chr21:40555479	PSMG1	-0.68	-5.32	-0.52	9.84e-7	Menarche (age at onset);
SKCM	cis	rs763014	0.931	rs56048717	chr16:634867	A/G	cg00908189	chr16:619842	PIGQ	0.82	7.78	0.66	2.55e-11	Height;
SKCM	cis	rs12497850	0.931	rs28642807	chr3:48926816	A/G	cg06212747	chr3:49208901	KLHDC8B	0.68	4.9	0.49	5.06e-6	Parkinson's disease;
SKCM	cis	rs7772486	0.558	rs7753273	chr6:146066039	C/T	cg23711669	chr6:146136114	FBXO30	-0.83	-7.58	-0.65	6.13e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1348850	0.914	rs1975544	chr2:178465423	G/A	cg02961200	chr2:178257176	LOC100130691;AGPS	0.76	5.49	0.53	4.9e-7	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs7408868	0.831	rs11672004	chr19:15277282	T/A	cg14696996	chr19:15285081	NOTCH3	0.82	4.92	0.49	4.7e-6	Pulse pressure;
SKCM	cis	rs1413885	0.516	rs1591364	chr1:65842364	T/G	cg14976592	chr1:65886160	LEPROT;LEPR	0.59	5.04	0.5	2.95e-6	Anticoagulant levels;
SKCM	cis	rs919433	0.963	rs2043016	chr2:198146381	C/T	cg13941760	chr2:198063781	ANKRD44	-0.62	-4.77	-0.48	8.47e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs1691799	0.899	rs1168315	chr12:66746694	A/G	cg16791601	chr12:66731901	HELB	-0.65	-6.09	-0.57	4.07e-8	White blood cell count (basophil);
SKCM	cis	rs9814567	1.000	rs9289475	chr3:134236459	G/A	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs2153535	0.580	rs1932285	chr6:8477719	T/G	cg07606381	chr6:8435919	SLC35B3	0.95	6.78	0.61	2.09e-9	Motion sickness;
SKCM	cis	rs5417	0.788	rs2654185	chr17:7183362	G/T	cg25256661	chr17:7137939	DVL2	0.84	6.7	0.6	2.89e-9	Diastolic blood pressure;
SKCM	cis	rs3087591	0.920	rs4795592	chr17:29612620	C/G	cg24425628	chr17:29625626	OMG;NF1	-0.64	-5.08	-0.5	2.48e-6	Hip circumference;
SKCM	cis	rs6570726	0.967	rs6903252	chr6:145922777	A/G	cg23711669	chr6:146136114	FBXO30	0.74	7.28	0.64	2.31e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs10504229	1.000	rs72650899	chr8:58180525	G/T	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs7772486	0.790	rs2253654	chr6:146199445	T/C	cg05347473	chr6:146136440	FBXO30	0.58	5.56	0.53	3.57e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs875971	0.862	rs1968126	chr7:66057004	A/G	cg11764359	chr7:65958608	NA	-0.74	-6.64	-0.6	3.76e-9	Aortic root size;
SKCM	cis	rs2180341	1.000	rs2144743	chr6:127633810	A/T	cg27446573	chr6:127587934	RNF146	0.94	8.06	0.67	7.08e-12	Breast cancer;
SKCM	cis	rs2180341	1.000	rs3798850	chr6:127613966	C/T	cg27446573	chr6:127587934	RNF146	1.0	8.68	0.7	4.48e-13	Breast cancer;
SKCM	cis	rs1552244	0.882	rs9312044	chr3:10037481	T/C	cg02579736	chr3:10068473	FANCD2;CIDECP	0.94	4.84	0.48	6.49e-6	Alzheimer's disease;
SKCM	cis	rs4132509	1.000	rs7514984	chr1:243965623	C/T	cg21452805	chr1:244014465	NA	0.9	5.56	0.53	3.7e-7	RR interval (heart rate);
SKCM	cis	rs2243480	0.803	rs55700941	chr7:65389800	T/A	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs28595532	0.920	rs114093638	chr4:119729819	T/C	cg21605333	chr4:119757512	SEC24D	1.36	8.05	0.67	7.69e-12	Cannabis dependence symptom count;
SKCM	cis	rs7098414	0.511	rs10466236	chr10:82149717	C/T	cg01528321	chr10:82214614	TSPAN14	-0.63	-5.3	-0.51	1.04e-6	Post bronchodilator FEV1;
SKCM	cis	rs4808199	0.739	rs2240117	chr19:19418916	C/T	cg03709012	chr19:19516395	GATAD2A	1.17	5.67	0.54	2.33e-7	Nonalcoholic fatty liver disease;
SKCM	cis	rs3771570	1.000	rs62193256	chr2:242362168	C/T	cg07612300	chr2:242033426	MTERFD2;SNED1	0.87	4.77	0.47	8.54e-6	Prostate cancer;
SKCM	cis	rs826838	0.967	rs1684413	chr12:39128704	G/A	cg26384229	chr12:38710491	ALG10B	-0.91	-8.28	-0.68	2.74e-12	Heart rate;
SKCM	cis	rs28386778	0.831	rs2584618	chr17:61923611	T/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.07	10.78	0.77	4.13e-17	Prudent dietary pattern;
SKCM	cis	rs28595532	0.920	rs115500312	chr4:119752551	G/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs72781680	1.000	rs72788280	chr2:24095907	A/G	cg08917208	chr2:24149416	ATAD2B	0.99	5.24	0.51	1.31e-6	Lymphocyte counts;
SKCM	cis	rs17376456	0.877	rs12109629	chr5:93359702	A/G	cg21475434	chr5:93447410	FAM172A	0.95	5.36	0.52	8.36e-7	Diabetic retinopathy;
SKCM	cis	rs801193	1.000	rs7782320	chr7:66177098	C/T	cg11987759	chr7:65425863	GUSB	-0.69	-5.91	-0.56	8.69e-8	Aortic root size;
SKCM	cis	rs28595532	0.920	rs114333298	chr4:119765305	C/A	cg21605333	chr4:119757512	SEC24D	1.39	8.45	0.69	1.25e-12	Cannabis dependence symptom count;
SKCM	cis	rs12971120	0.947	rs34676212	chr18:72170006	A/G	cg25817165	chr18:72167213	CNDP2	-0.65	-5.3	-0.51	1.03e-6	Refractive error;
SKCM	cis	rs9790314	0.875	rs336580	chr3:161082982	A/T	cg03342759	chr3:160939853	NMD3	-0.73	-8.2	-0.68	3.89e-12	Morning vs. evening chronotype;
SKCM	cis	rs798554	1.000	rs798540	chr7:2764130	G/A	cg19346786	chr7:2764209	NA	-0.64	-6.41	-0.59	1.01e-8	Height;
SKCM	cis	rs7100689	0.784	rs3802638	chr10:82179689	T/C	cg00277334	chr10:82204260	NA	-0.53	-4.89	-0.48	5.39e-6	Post bronchodilator FEV1;
SKCM	cis	rs9788682	0.748	rs667282	chr15:78863472	T/C	cg24631222	chr15:78858424	CHRNA5	0.87	6.62	0.6	4.19e-9	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs7786877	0.680	rs28584500	chr7:100216341	G/A	cg20848291	chr7:100343083	ZAN	-0.66	-5.04	-0.5	2.9e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs6580649	0.943	rs1859444	chr12:48399403	T/C	cg05342945	chr12:48394962	COL2A1	-0.73	-5.4	-0.52	7.06e-7	Lung cancer;
SKCM	cis	rs597539	0.652	rs553875	chr11:68695144	T/G	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.82	5.41	0.52	6.82e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs2463822	1.000	rs2513052	chr11:62108248	C/G	cg06239285	chr11:62104954	ASRGL1	1.25	5.93	0.56	7.79e-8	Chronic obstructive pulmonary disease-related biomarkers;
SKCM	cis	rs4481887	0.772	rs4916127	chr1:248466615	A/G	cg00666640	chr1:248458726	OR2T12	0.6	5.14	0.5	1.98e-6	Common traits (Other);
SKCM	cis	rs7092929	0.941	rs668923	chr10:3575664	G/T	cg14308648	chr10:3568949	NA	0.72	4.81	0.48	7.12e-6	Coronary artery calcification;
SKCM	cis	rs28595532	0.841	rs114465037	chr4:119778165	A/G	cg14228332	chr4:119757509	SEC24D	1.06	5.32	0.52	9.61e-7	Cannabis dependence symptom count;
SKCM	cis	rs362296	0.671	rs3095074	chr4:3261152	G/A	cg24015175	chr4:3319247	RGS12	-0.64	-5.96	-0.56	6.95e-8	Parental longevity (mother's age at death);
SKCM	cis	rs4819052	0.851	rs4819040	chr21:46659762	T/C	cg02159808	chr21:46707872	POFUT2;LOC642852	0.68	5.17	0.5	1.78e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs10416265	0.527	rs7508599	chr19:33546512	A/T	cg27124370	chr19:33622961	WDR88	0.82	5.63	0.54	2.75e-7	Bone properties (heel);
SKCM	cis	rs4073582	0.576	rs556595	chr11:66058082	T/G	cg16950941	chr11:66035639	RAB1B	0.9	7.64	0.65	4.68e-11	Gout;
SKCM	cis	rs7666738	0.791	rs34088022	chr4:99001508	G/T	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7809950	0.817	rs10224503	chr7:107075569	A/C	cg23024343	chr7:107201750	COG5	-0.87	-8.16	-0.68	4.68e-12	Coronary artery disease;
SKCM	cis	rs1046896	0.503	rs12947062	chr17:80686370	A/G	cg02711726	chr17:80685570	FN3KRP	0.7	6.06	0.57	4.54e-8	Glycated hemoglobin levels;
SKCM	cis	rs8067545	0.750	rs4570919	chr17:20000815	C/T	cg13482628	chr17:19912719	NA	0.72	6.01	0.56	5.48e-8	Schizophrenia;
SKCM	cis	rs826838	0.967	rs1684414	chr12:39129553	A/G	cg13010199	chr12:38710504	ALG10B	-0.72	-5.73	-0.54	1.83e-7	Heart rate;
SKCM	cis	rs611744	0.506	rs13280454	chr8:109263240	A/G	cg18478394	chr8:109455254	TTC35	0.66	5.32	0.52	9.59e-7	Dupuytren's disease;
SKCM	cis	rs6545883	0.929	rs7561229	chr2:61737990	A/T	cg15711740	chr2:61764176	XPO1	-0.73	-5.27	-0.51	1.19e-6	Tuberculosis;
SKCM	cis	rs6938	0.514	rs35556055	chr15:75253414	G/A	cg17294928	chr15:75287854	SCAMP5	0.7	5.35	0.52	8.66e-7	Breast cancer;
SKCM	cis	rs7811142	1.000	rs74460138	chr7:100027339	C/G	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-0.99	-5.52	-0.53	4.2e-7	Platelet count;
SKCM	cis	rs4319547	0.695	rs4758666	chr12:122902840	C/T	cg23029597	chr12:123009494	RSRC2	-0.73	-5.37	-0.52	7.93e-7	Body mass index;
SKCM	cis	rs9902453	0.765	rs62068653	chr17:28212663	G/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.86	6.61	0.6	4.35e-9	Coffee consumption (cups per day);
SKCM	cis	rs873946	0.586	rs2001426	chr10:134563871	G/A	cg14275445	chr10:134560047	INPP5A	-0.55	-4.8	-0.48	7.38e-6	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs2243480	1.000	rs34637256	chr7:65360131	G/A	cg18252515	chr7:66147081	NA	-1.29	-7.41	-0.64	1.3e-10	Diabetic kidney disease;
SKCM	cis	rs7811142	0.830	rs3087502	chr7:99955364	G/A	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.07	6.7	0.6	2.88e-9	Platelet count;
SKCM	trans	rs1814175	0.791	rs10769593	chr11:49616217	T/C	cg03929089	chr4:120376271	NA	-0.84	-7.33	-0.64	1.8e-10	Height;
SKCM	cis	rs875971	1.000	rs1544549	chr7:66090663	T/A	cg05627663	chr7:65219948	SNORA22;CCT6P1	-0.53	-5.26	-0.51	1.22e-6	Aortic root size;
SKCM	cis	rs56235845	0.694	rs9313758	chr5:176773091	T/G	cg16006841	chr5:176797999	RGS14	0.67	6.4	0.59	1.08e-8	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs2645694	0.533	rs2645674	chr4:77818202	T/C	cg03477792	chr4:77819574	ANKRD56	0.57	6.38	0.59	1.18e-8	Emphysema distribution in smoking;
SKCM	cis	rs7143963	1.000	rs72704726	chr14:103353101	A/G	cg23020514	chr14:103360112	TRAF3	0.89	9.01	0.71	1.03e-13	Body mass index;
SKCM	cis	rs2235573	0.570	rs5995529	chr22:38415721	A/G	cg03683946	chr22:38051826	SH3BP1	0.48	4.89	0.48	5.21e-6	Glioblastoma;Glioma;
SKCM	cis	rs9549367	0.577	rs3024718	chr13:113813853	C/T	cg18105134	chr13:113819100	PROZ	0.81	5.92	0.56	8.07e-8	Platelet distribution width;
SKCM	cis	rs1799949	1.000	rs1135214	chr17:41292323	T/C	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.11	-0.57	3.67e-8	Menopause (age at onset);
SKCM	cis	rs523522	0.962	rs2235218	chr12:120888619	A/C	cg27279351	chr12:120934652	DYNLL1	0.9	7.79	0.66	2.42e-11	High light scatter reticulocyte count;
SKCM	cis	rs875971	0.522	rs9530	chr7:65425894	A/G	cg11987759	chr7:65425863	GUSB	-0.75	-6.65	-0.6	3.61e-9	Aortic root size;
SKCM	cis	rs9899728	0.539	rs11077772	chr17:73035698	C/T	cg27626185	chr17:73056755	KCTD2	-1.3	-7.74	-0.66	2.96e-11	Alzheimer's disease or small vessel stroke;
SKCM	cis	rs17711722	0.701	rs55773927	chr7:65337902	T/C	cg11764359	chr7:65958608	NA	0.88	6.43	0.59	9.56e-9	Calcium levels;
SKCM	cis	rs798554	0.797	rs798486	chr7:2803037	A/G	cg04166393	chr7:2884313	GNA12	0.77	5.26	0.51	1.23e-6	Height;
SKCM	cis	rs12986445	0.744	rs3845683	chr2:26110351	C/G	cg07291958	chr2:26785531	C2orf70	0.53	4.9	0.49	5.04e-6	Multiple myeloma and monoclonal gammopathy;Multiple myeloma;
SKCM	cis	rs9467773	1.000	rs6932156	chr6:26571506	T/G	cg15659132	chr6:26577336	NA	0.61	5.76	0.55	1.6e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs6951245	1.000	rs77346188	chr7:1114023	C/A	cg18402987	chr7:1209562	NA	1.16	6.13	0.57	3.42e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs634534	0.562	rs1151505	chr11:65734539	C/T	cg17985854	chr11:65770987	BANF1;EIF1AD	0.51	5.16	0.5	1.85e-6	Sum eosinophil basophil counts;Eosinophil counts;
SKCM	trans	rs1814175	0.817	rs7947526	chr11:49983654	T/C	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs9916302	0.904	rs35335692	chr17:37710006	A/G	cg07936489	chr17:37558343	FBXL20	-0.9	-8.15	-0.68	4.86e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs58688157	0.705	rs7943546	chr11:612148	T/C	cg03576123	chr11:487126	PTDSS2	-0.81	-5.15	-0.5	1.88e-6	Systemic lupus erythematosus;
SKCM	cis	rs427394	0.796	rs274683	chr5:6747950	T/A	cg10857441	chr5:6722123	POLS	-0.62	-6.65	-0.6	3.56e-9	Menopause (age at onset);
SKCM	cis	rs910316	1.000	rs10143132	chr14:75525850	G/A	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.85e-7	Height;
SKCM	cis	rs941408	0.928	rs2741991	chr19:2802092	T/C	cg17333051	chr19:2783644	SGTA	0.41	4.85	0.48	6.08e-6	Total cholesterol levels;
SKCM	trans	rs7618501	1.000	rs3749241	chr3:49744392	A/G	cg21659725	chr3:3221576	CRBN	-0.97	-9.69	-0.74	4.96e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs2153535	0.580	rs7767780	chr6:8453462	A/G	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs1552244	0.515	rs67342818	chr3:10166406	G/A	cg00149659	chr3:10157352	C3orf10	1.13	5.45	0.53	5.74e-7	Alzheimer's disease;
SKCM	cis	rs2013441	1.000	rs9915059	chr17:20177104	G/T	cg13482628	chr17:19912719	NA	-0.69	-5.38	-0.52	7.47e-7	Obesity-related traits;
SKCM	cis	rs2357013	0.752	rs35254490	chr2:53152835	G/A	cg07782112	chr2:53107842	NA	-0.61	-5.97	-0.56	6.54e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs9513627	0.573	rs12431100	chr13:100184918	C/G	cg25919922	chr13:100150906	NA	-0.9	-5.41	-0.52	6.71e-7	Obesity-related traits;
SKCM	cis	rs8180040	1.000	rs553989	chr3:47400328	A/G	cg27129171	chr3:47204927	SETD2	-0.87	-6.62	-0.6	4.15e-9	Colorectal cancer;
SKCM	cis	rs9300255	0.544	rs2049114	chr12:123657338	T/C	cg00376283	chr12:123451042	ABCB9	0.86	5.28	0.51	1.12e-6	Neutrophil percentage of white cells;
SKCM	cis	rs711830	1.000	rs1549334	chr2:177039197	G/A	cg13092806	chr2:177043255	NA	0.65	5.86	0.55	1.07e-7	Serous invasive ovarian cancer;Epithelial ovarian cancer;Invasive epithelial ovarian cancer;Mucinous ovarian carcinoma;Low-grade serous and serous borderline ovarian cancer;Serous borderline ovarian cancer;High-grade serous ovarian cancer;
SKCM	cis	rs2188420	0.872	rs3757714	chr7:106507080	A/T	cg23615938	chr7:105753134	SYPL1	-1.07	-5.88	-0.55	9.55e-8	Interferon gamma levels;
SKCM	cis	rs1577917	0.958	rs2324839	chr6:86536942	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.33	-0.52	9.19e-7	Response to antipsychotic treatment;
SKCM	cis	rs6879260	0.963	rs11748619	chr5:179727399	C/G	cg02891314	chr5:179741120	GFPT2	-0.74	-5.71	-0.54	1.94e-7	Height;
SKCM	cis	rs11626933	1.000	rs4559843	chr14:90747488	T/C	cg14092571	chr14:90743983	NA	-0.92	-8.33	-0.69	2.11e-12	Gut microbiota (bacterial taxa);
SKCM	cis	rs6570726	0.791	rs11155433	chr6:145907831	A/G	cg23711669	chr6:146136114	FBXO30	-0.85	-8.03	-0.67	8.26e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs208515	0.525	rs12193034	chr6:66677866	C/T	cg07460842	chr6:66804631	NA	0.93	6.34	0.58	1.35e-8	Exhaled nitric oxide levels;
SKCM	cis	rs12762955	0.529	rs2387213	chr10:1051420	C/T	cg26597838	chr10:835615	NA	0.55	4.93	0.49	4.58e-6	Response to angiotensin II receptor blocker therapy;
SKCM	cis	rs4481887	0.861	rs4575112	chr1:248473534	A/G	cg00666640	chr1:248458726	OR2T12	0.63	5.91	0.56	8.65e-8	Common traits (Other);
SKCM	cis	rs2832191	0.755	rs2832193	chr21:30493589	T/C	cg24692254	chr21:30365293	RNF160	-0.9	-8.03	-0.67	8.39e-12	Dental caries;
SKCM	cis	rs867186	1.000	rs73905041	chr20:33592148	G/A	cg04194272	chr20:33683537	NA	-1.36	-7.01	-0.62	7.44e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs25645	0.823	rs12453334	chr17:38153473	C/T	cg17467752	chr17:38218738	THRA	-0.74	-6.28	-0.58	1.78e-8	Myeloid white cell count;
SKCM	trans	rs1814175	0.715	rs10839409	chr11:49884647	G/T	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs6089584	0.527	rs927589	chr20:60606363	A/G	cg16423285	chr20:60520624	NA	-0.57	-4.93	-0.49	4.5e-6	Body mass index;
SKCM	cis	rs1552244	0.935	rs35515831	chr3:10071362	G/A	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs7659604	0.582	rs3217780	chr4:122737278	T/C	cg19748678	chr4:122722346	EXOSC9	0.65	5.4	0.52	7.02e-7	Type 2 diabetes;
SKCM	cis	rs3091242	0.904	rs6661533	chr1:25771715	A/G	cg02931644	chr1:25747376	RHCE	0.5	4.9	0.48	5.17e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs2033711	0.905	rs1077420	chr19:58968875	A/C	cg13877915	chr19:58951672	ZNF132	0.87	8.53	0.69	8.78e-13	Uric acid clearance;
SKCM	cis	rs1669338	0.510	rs3804788	chr3:3169466	C/A	cg16797762	chr3:3221439	CRBN	-1.09	-5.88	-0.55	9.51e-8	White matter integrity;
SKCM	cis	rs6120849	0.754	rs17319032	chr20:33643296	T/C	cg24642439	chr20:33292090	TP53INP2	0.94	4.86	0.48	5.91e-6	Protein C levels;
SKCM	cis	rs2811415	0.597	rs6796874	chr3:127801198	C/T	cg09089421	chr3:127803668	RUVBL1	1.0	8.69	0.7	4.4e-13	Lung function (FEV1/FVC);
SKCM	cis	rs6430585	0.583	rs78364332	chr2:136640101	T/C	cg07169764	chr2:136633963	MCM6	1.36	15.07	0.86	8.33e-25	Corneal structure;
SKCM	cis	rs1801251	1.000	rs56777991	chr2:233635388	A/C	cg08000102	chr2:233561755	GIGYF2	0.89	7.15	0.63	4.05e-10	Coronary artery disease;
SKCM	cis	rs644799	1.000	rs632388	chr11:95563775	A/G	cg03916912	chr11:95522834	CEP57;FAM76B	0.88	7.53	0.65	7.59e-11	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs11608355	0.521	rs1119271	chr12:109819727	A/T	cg19025524	chr12:109796872	NA	-0.68	-6.2	-0.57	2.49e-8	Neuroticism;
SKCM	cis	rs34779708	0.733	rs16935948	chr10:35549748	C/G	cg03585969	chr10:35415529	CREM	0.75	4.78	0.48	8e-6	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs28595532	0.841	rs115852209	chr4:119753465	A/G	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs7523050	0.643	rs35885176	chr1:109401868	G/A	cg08274380	chr1:109419600	GPSM2	1.13	5.57	0.53	3.54e-7	Fat distribution (HIV);
SKCM	cis	rs8180040	0.934	rs62260710	chr3:47564462	C/G	cg16586182	chr3:47516702	SCAP	0.74	5.04	0.5	2.89e-6	Colorectal cancer;
SKCM	cis	rs765787	0.530	rs1706832	chr15:45517173	C/T	cg24006582	chr15:45444508	DUOX1	-0.7	-4.79	-0.48	7.84e-6	Uric acid levels;
SKCM	cis	rs10503709	0.556	rs13257658	chr8:21473085	C/G	cg15997512	chr8:21608254	GFRA2	-0.5	-4.79	-0.48	7.82e-6	Blood protein levels;
SKCM	cis	rs9443189	0.615	rs618239	chr6:76350038	A/G	cg01950844	chr6:76311363	SENP6	1.02	6.34	0.58	1.39e-8	Prostate cancer;
SKCM	trans	rs66573146	1.000	rs28384174	chr4:6961107	G/T	cg07817883	chr1:32538562	TMEM39B	2.0	8.02	0.67	8.59e-12	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs7552404	0.924	rs1303169	chr1:76195041	T/C	cg03433033	chr1:76189801	ACADM	0.76	5.6	0.54	3.12e-7	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs2228479	0.681	rs10153055	chr16:89965842	C/T	cg00800038	chr16:89945340	TCF25	-0.86	-5.3	-0.51	1.04e-6	Skin colour saturation;
SKCM	cis	rs28595532	0.841	rs114768988	chr4:119744451	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs2050392	0.767	rs10763787	chr10:30700753	G/A	cg25182066	chr10:30743637	MAP3K8	0.67	5.5	0.53	4.68e-7	Inflammatory bowel disease;
SKCM	cis	rs910316	1.000	rs175425	chr14:75626131	T/C	cg08847533	chr14:75593920	NEK9	-0.95	-8.8	-0.71	2.64e-13	Height;
SKCM	cis	rs9325144	0.678	rs7315271	chr12:39164731	A/G	cg13010199	chr12:38710504	ALG10B	-0.57	-4.85	-0.48	6.29e-6	Morning vs. evening chronotype;
SKCM	cis	rs2832191	0.716	rs2249028	chr21:30365322	G/A	cg24692254	chr21:30365293	RNF160	1.01	9.45	0.73	1.44e-14	Dental caries;
SKCM	cis	rs672059	1.000	rs547905	chr1:183157924	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.63	5.23	0.51	1.38e-6	Hypertriglyceridemia;
SKCM	cis	rs7100689	0.622	rs2342816	chr10:82086546	G/A	cg00277334	chr10:82204260	NA	-0.57	-5.34	-0.52	8.88e-7	Post bronchodilator FEV1;
SKCM	cis	rs4319547	0.626	rs12423420	chr12:122938466	G/A	cg23029597	chr12:123009494	RSRC2	-0.76	-5.56	-0.53	3.6e-7	Body mass index;
SKCM	cis	rs1799949	1.000	rs11657053	chr17:41191129	G/T	cg25918947	chr17:41365094	TMEM106A	-0.61	-5.87	-0.55	1e-7	Menopause (age at onset);
SKCM	cis	rs875971	0.660	rs10281080	chr7:66042441	T/C	cg11987759	chr7:65425863	GUSB	0.67	5.75	0.55	1.68e-7	Aortic root size;
SKCM	cis	rs1568889	1.000	rs12796293	chr11:28177723	C/T	cg06544937	chr11:28130018	METT5D1;KIF18A	-0.89	-6.93	-0.62	1.08e-9	Bipolar disorder;
SKCM	cis	rs6089584	0.816	rs4134440	chr20:60624296	A/G	cg06108461	chr20:60628389	TAF4	-0.91	-9.04	-0.72	8.9e-14	Body mass index;
SKCM	cis	rs7809950	1.000	rs2520260	chr7:107172794	A/G	cg23024343	chr7:107201750	COG5	-0.77	-6.95	-0.62	9.61e-10	Coronary artery disease;
SKCM	cis	rs2991971	0.967	rs12743512	chr1:45954033	A/G	cg24296786	chr1:45957014	TESK2	-0.71	-5.98	-0.56	6.22e-8	High light scatter reticulocyte count;
SKCM	cis	rs5769765	0.862	rs7410537	chr22:50317330	G/A	cg22709217	chr22:50311962	ALG12;CRELD2	-0.99	-5.91	-0.56	8.35e-8	Schizophrenia;
SKCM	cis	rs28785552	0.769	rs7253672	chr19:53243212	G/C	cg10871876	chr19:53194124	ZNF83	0.77	5.4	0.52	6.93e-7	Response to paliperidone in schizophrenia (PANSS score);
SKCM	trans	rs561341	0.739	rs1978116	chr17:30220978	A/C	cg20587970	chr11:113659929	NA	-1.03	-7.91	-0.67	1.42e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs801193	1.000	rs7785213	chr7:66138978	A/C	cg05627663	chr7:65219948	SNORA22;CCT6P1	-0.56	-4.84	-0.48	6.39e-6	Aortic root size;
SKCM	cis	rs9611565	0.559	rs7290991	chr22:41964361	C/G	cg03806693	chr22:41940476	POLR3H	-1.04	-6.96	-0.62	9.22e-10	Vitiligo;
SKCM	cis	rs4423214	1.000	rs2276360	chr11:71169547	C/G	cg05163923	chr11:71159392	DHCR7	0.83	8.06	0.67	7.35e-12	Vitamin D levels;
SKCM	cis	rs7927771	0.800	rs12146565	chr11:47398963	G/A	cg05585544	chr11:47624801	NA	-0.58	-5.01	-0.49	3.29e-6	Subjective well-being;
SKCM	cis	rs17376456	0.877	rs67066109	chr5:93494101	G/C	cg21475434	chr5:93447410	FAM172A	0.99	5.62	0.54	2.81e-7	Diabetic retinopathy;
SKCM	cis	rs2204008	0.536	rs12368354	chr12:38042798	G/A	cg26384229	chr12:38710491	ALG10B	0.83	6.72	0.61	2.69e-9	Bladder cancer;
SKCM	cis	rs12971120	0.947	rs8084109	chr18:72168312	T/A	cg25817165	chr18:72167213	CNDP2	-0.65	-5.21	-0.51	1.51e-6	Refractive error;
SKCM	cis	rs514406	0.661	rs562641	chr1:53374666	C/T	cg24675658	chr1:53192096	ZYG11B	-0.82	-7.84	-0.66	1.89e-11	Monocyte count;
SKCM	cis	rs12142240	0.698	rs41294476	chr1:46818374	C/A	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs71520386	0.632	rs1029738	chr7:22874047	C/A	cg00309339	chr7:22893653	NA	0.67	5.13	0.5	2.1e-6	Fibrinogen levels;
SKCM	cis	rs2811415	0.627	rs1549873	chr3:127769599	G/A	cg09089421	chr3:127803668	RUVBL1	1.01	8.79	0.71	2.72e-13	Lung function (FEV1/FVC);
SKCM	cis	rs55962025	0.628	rs67950027	chr4:3152786	A/C	cg11471262	chr4:3318911	RGS12	-0.6	-4.77	-0.48	8.37e-6	Parental longevity (mother's age at death);
SKCM	cis	rs3820928	0.874	rs10933163	chr2:227815286	A/G	cg11843606	chr2:227700838	RHBDD1	-0.6	-4.81	-0.48	7.17e-6	Pulmonary function;
SKCM	cis	rs9814567	1.000	rs7637227	chr3:134244155	G/A	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs992157	0.932	rs1870125	chr2:219187901	C/T	cg00012203	chr2:219082015	ARPC2	0.78	5.81	0.55	1.31e-7	Colorectal cancer;
SKCM	cis	rs992157	0.965	rs13427681	chr2:219167563	G/C	cg00012203	chr2:219082015	ARPC2	0.75	6.27	0.58	1.88e-8	Colorectal cancer;
SKCM	cis	rs1005277	0.579	rs2505237	chr10:38438898	T/G	cg00409905	chr10:38381863	ZNF37A	-0.67	-6.21	-0.58	2.41e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs12142240	0.698	rs6659228	chr1:46811027	C/G	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs2760061	0.626	rs594916	chr1:228133544	C/A	cg02753203	chr1:228287806	NA	-0.62	-5.02	-0.49	3.13e-6	Diastolic blood pressure;
SKCM	cis	rs1403694	0.695	rs11924390	chr3:186433099	T/C	cg09332604	chr3:186435400	KNG1	-0.49	-4.85	-0.48	6.09e-6	Blood protein levels;
SKCM	cis	rs6952808	0.723	rs55689856	chr7:2037215	G/A	cg04267008	chr7:1944627	MAD1L1	-0.64	-4.82	-0.48	7.03e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs7980687	0.638	rs7299943	chr12:123593485	A/T	cg05973401	chr12:123451056	ABCB9	0.8	5.48	0.53	5.11e-7	Height;Educational attainment;Head circumference (infant);
SKCM	cis	rs28595532	0.925	rs28627331	chr4:119665345	T/C	cg11846333	chr4:119757529	SEC24D	1.19	6.39	0.59	1.09e-8	Cannabis dependence symptom count;
SKCM	cis	rs7940866	1.000	rs7940866	chr11:130817579	A/T	cg12179176	chr11:130786555	SNX19	-0.71	-5.13	-0.5	2.08e-6	Schizophrenia;
SKCM	cis	rs16854884	0.789	rs34096668	chr3:143794483	C/T	cg06585982	chr3:143692056	C3orf58	0.72	5.63	0.54	2.78e-7	Economic and political preferences (feminism/equality);
SKCM	cis	rs10193935	0.901	rs10200000	chr2:42442212	A/G	cg27598129	chr2:42591480	NA	-0.88	-6.71	-0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7666738	0.800	rs2865988	chr4:99067807	T/C	cg17366294	chr4:99064904	C4orf37	0.61	4.93	0.49	4.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1005277	0.557	rs2983338	chr10:38550734	C/T	cg00409905	chr10:38381863	ZNF37A	-0.59	-5.24	-0.51	1.36e-6	Extrinsic epigenetic age acceleration;
SKCM	cis	rs55962025	0.804	rs2071703	chr4:3241413	A/C	cg00764545	chr4:3318001	RGS12	-0.74	-6.02	-0.56	5.32e-8	Parental longevity (mother's age at death);
SKCM	cis	rs7811142	0.830	rs73401443	chr7:99977582	T/G	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.19	7.5	0.65	8.66e-11	Platelet count;
SKCM	cis	rs4740619	0.619	rs1410453	chr9:16042191	T/A	cg14451791	chr9:16040625	NA	-0.47	-5.03	-0.49	3.07e-6	Body mass index;
SKCM	cis	rs9910055	0.659	rs227580	chr17:42223068	C/T	cg13607699	chr17:42295918	UBTF	-0.7	-5.42	-0.52	6.52e-7	Total body bone mineral density;
SKCM	cis	rs4740619	0.619	rs10738425	chr9:16041576	T/C	cg14451791	chr9:16040625	NA	-0.47	-5.03	-0.49	3.07e-6	Body mass index;
SKCM	cis	rs5753618	0.583	rs7293171	chr22:31802324	T/C	cg02404636	chr22:31891804	SFI1	0.62	5.34	0.52	9.02e-7	Colorectal cancer;
SKCM	cis	rs951366	0.585	rs72750964	chr1:205675240	C/T	cg26354017	chr1:205819088	PM20D1	0.82	6.99	0.62	8.19e-10	Menarche (age at onset);
SKCM	cis	rs7829975	0.535	rs4841005	chr8:8501230	A/G	cg06636001	chr8:8085503	FLJ10661	-0.73	-6.12	-0.57	3.54e-8	Mood instability;
SKCM	cis	rs4954585	0.708	rs10200263	chr2:137007429	C/T	cg05194412	chr2:137003533	NA	0.55	4.83	0.48	6.74e-6	Colorectal cancer;
SKCM	cis	rs1799949	1.000	rs12516	chr17:41196408	G/A	cg23758822	chr17:41437982	NA	0.94	7.87	0.67	1.68e-11	Menopause (age at onset);
SKCM	cis	rs2836974	0.545	rs2776311	chr21:40716885	A/G	cg11644478	chr21:40555479	PSMG1	0.63	4.88	0.48	5.57e-6	Cognitive function;
SKCM	cis	rs12497850	0.931	rs13064784	chr3:49135961	C/G	cg06212747	chr3:49208901	KLHDC8B	0.7	4.99	0.49	3.6e-6	Parkinson's disease;
SKCM	cis	rs7829975	0.714	rs4841042	chr8:8664622	A/G	cg06636001	chr8:8085503	FLJ10661	-0.78	-6.88	-0.61	1.35e-9	Mood instability;
SKCM	cis	rs7980687	0.657	rs2851447	chr12:123665113	G/C	cg05973401	chr12:123451056	ABCB9	0.72	5.07	0.5	2.61e-6	Height;Educational attainment;Head circumference (infant);
SKCM	cis	rs9611565	0.918	rs9611566	chr22:41768625	A/G	cg03806693	chr22:41940476	POLR3H	0.88	6.03	0.56	5.05e-8	Vitiligo;
SKCM	cis	rs4969178	0.896	rs12602206	chr17:76397133	A/G	cg20026190	chr17:76395443	PGS1	0.61	5.29	0.51	1.08e-6	HDL cholesterol levels;
SKCM	cis	rs9311474	0.607	rs28661185	chr3:52567188	G/T	cg18404041	chr3:52824283	ITIH1	-0.55	-4.98	-0.49	3.8e-6	Electroencephalogram traits;
SKCM	cis	rs7106204	0.748	rs6484028	chr11:24222438	A/G	ch.11.24196551F	chr11:24239977	NA	0.77	6.39	0.59	1.09e-8	Response to Homoharringtonine (cytotoxicity);
SKCM	cis	rs8180040	0.620	rs9858443	chr3:47086048	G/A	cg27129171	chr3:47204927	SETD2	0.74	5.37	0.52	7.84e-7	Colorectal cancer;
SKCM	cis	rs7829975	0.688	rs6995407	chr8:8384647	C/G	cg08975724	chr8:8085496	FLJ10661	0.66	4.83	0.48	6.62e-6	Mood instability;
SKCM	cis	rs2811415	0.597	rs13083602	chr3:127758532	A/G	cg09089421	chr3:127803668	RUVBL1	0.99	8.52	0.69	9.09e-13	Lung function (FEV1/FVC);
SKCM	cis	rs7937682	0.883	rs553632	chr11:111462897	C/T	cg19812747	chr11:111475976	SIK2	-0.61	-4.94	-0.49	4.41e-6	Primary sclerosing cholangitis;
SKCM	cis	rs12682352	0.650	rs13265731	chr8:8673320	T/C	cg06636001	chr8:8085503	FLJ10661	0.72	5.76	0.55	1.6e-7	Neuroticism;
SKCM	cis	rs116095464	0.558	rs73031482	chr5:227594	G/A	cg22857025	chr5:266934	NA	-1.37	-8.11	-0.68	5.82e-12	Breast cancer;
SKCM	cis	rs2832191	1.000	rs9984793	chr21:30486471	T/C	cg24692254	chr21:30365293	RNF160	-0.79	-7.24	-0.63	2.72e-10	Dental caries;
SKCM	cis	rs9467773	0.620	rs2130657	chr6:26650826	C/T	cg09904177	chr6:26538194	HMGN4	0.58	5.01	0.49	3.28e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7315438	0.785	rs7956509	chr12:115910853	C/T	cg04892836	chr12:115174285	NA	0.4	4.81	0.48	7.18e-6	Colorectal cancer;
SKCM	cis	rs2732480	0.577	rs2732486	chr12:48737834	G/A	cg21348975	chr12:48724119	NA	-0.61	-5.23	-0.51	1.37e-6	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs6570726	0.738	rs6925594	chr6:145898454	T/C	cg05347473	chr6:146136440	FBXO30	0.58	5.16	0.5	1.82e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9715521	0.677	rs4490528	chr4:59854572	T/G	cg11281224	chr4:60001000	NA	-0.61	-4.82	-0.48	6.94e-6	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs16854884	0.657	rs62269895	chr3:143749085	C/G	cg06585982	chr3:143692056	C3orf58	0.87	8.11	0.68	5.72e-12	Economic and political preferences (feminism/equality);
SKCM	cis	rs208520	0.690	rs4710564	chr6:66823478	A/G	cg07460842	chr6:66804631	NA	1.08	7.56	0.65	6.7e-11	Exhaled nitric oxide output;
SKCM	cis	rs752010	0.967	rs2038978	chr1:42094719	A/G	cg06885757	chr1:42089581	HIVEP3	0.62	6.26	0.58	1.91e-8	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs8077889	0.750	rs746742	chr17:41935629	A/G	cg26893861	chr17:41843967	DUSP3	1.31	7.65	0.65	4.46e-11	Triglycerides;
SKCM	cis	rs8017423	0.872	rs7492857	chr14:90684867	T/G	cg04374321	chr14:90722782	PSMC1	-0.97	-8.64	-0.7	5.3e-13	Mortality in heart failure;
SKCM	cis	rs2204008	0.693	rs12372025	chr12:38202028	G/A	cg13010199	chr12:38710504	ALG10B	0.65	4.84	0.48	6.52e-6	Bladder cancer;
SKCM	cis	rs11892454	0.515	rs7609004	chr2:25969050	T/C	cg17263061	chr2:26915892	KCNK3	0.71	5.07	0.5	2.6e-6	Heschl's gyrus morphology;
SKCM	cis	rs12220238	0.915	rs11001014	chr10:76128832	A/G	cg19889307	chr10:75911429	ADK;AP3M1	-0.87	-4.92	-0.49	4.77e-6	Soluble interleukin-2 receptor subunit alpha;
SKCM	trans	rs3780486	0.505	rs10217267	chr9:33146528	T/C	cg20290983	chr6:43655470	MRPS18A	0.82	8.83	0.71	2.32e-13	IgG glycosylation;
SKCM	cis	rs1882538	0.596	rs10281827	chr7:133081810	A/G	cg10665199	chr7:133106180	EXOC4	0.75	4.81	0.48	7.11e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs8078723	0.714	rs12940405	chr17:38143768	C/T	cg17467752	chr17:38218738	THRA	-0.61	-5.5	-0.53	4.67e-7	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs7829975	0.514	rs2979139	chr8:8268313	A/G	cg15556689	chr8:8085844	FLJ10661	0.7	5.85	0.55	1.11e-7	Mood instability;
SKCM	cis	rs2180341	0.594	rs7738385	chr6:127777516	T/C	cg24812749	chr6:127587940	RNF146	0.66	5.4	0.52	6.91e-7	Breast cancer;
SKCM	cis	rs4665809	0.759	rs62128394	chr2:26364026	T/G	cg26119090	chr2:26468346	HADHA;HADHB	0.86	5.29	0.51	1.1e-6	Gut microbiome composition (summer);
SKCM	cis	rs1218582	0.774	rs2335409	chr1:154916106	G/A	cg09359103	chr1:154839909	KCNN3	-0.55	-5.16	-0.5	1.82e-6	Prostate cancer;
SKCM	cis	rs8180040	0.701	rs1079276	chr3:47045739	C/G	cg27129171	chr3:47204927	SETD2	0.78	5.98	0.56	6.37e-8	Colorectal cancer;
SKCM	cis	rs6951245	0.529	rs10262070	chr7:1141738	C/T	cg03188948	chr7:1209495	NA	0.83	5.88	0.55	9.86e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs4808199	0.947	rs2163804	chr19:19575965	G/A	cg03709012	chr19:19516395	GATAD2A	1.13	8.68	0.7	4.53e-13	Nonalcoholic fatty liver disease;
SKCM	cis	rs7666738	0.830	rs10021709	chr4:99030587	G/A	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4819052	0.851	rs9974891	chr21:46680767	T/A	cg20896738	chr21:46707857	POFUT2;LOC642852	0.65	4.89	0.48	5.35e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs6724607	1.000	rs7598979	chr2:191453375	A/G	cg21644426	chr2:191273491	MFSD6	0.69	4.94	0.49	4.28e-6	Pulse pressure;
SKCM	cis	rs7149337	0.836	rs11622116	chr14:51670744	C/T	cg23942311	chr14:51606299	NA	0.61	6.58	0.6	4.84e-9	Cancer;
SKCM	cis	rs4905558	0.962	rs9323954	chr14:97292974	G/A	cg11863609	chr14:97355128	NA	-0.54	-4.88	-0.48	5.52e-6	Neutrophil count;
SKCM	cis	rs4077515	0.870	rs11793497	chr9:139271850	A/G	cg14169450	chr9:139327907	INPP5E	0.46	5.29	0.51	1.1e-6	Ulcerative colitis;IgA nephropathy;Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs7539542	0.556	rs10753928	chr1:202891045	A/C	cg19681188	chr1:202830198	LOC148709	-0.71	-5.26	-0.51	1.24e-6	Mean platelet volume;
SKCM	cis	rs9300255	0.602	rs1727306	chr12:123665695	A/G	cg05973401	chr12:123451056	ABCB9	0.83	5.14	0.5	2.01e-6	Neutrophil percentage of white cells;
SKCM	cis	rs10911232	0.524	rs4487994	chr1:182982173	T/A	ch.1.3577855R	chr1:183094577	LAMC1	0.74	6.71	0.6	2.83e-9	Hypertriglyceridemia;
SKCM	cis	rs4724125	0.883	rs12537626	chr7:42694779	T/A	cg09407816	chr7:42972088	MRPL32;PSMA2	0.82	4.94	0.49	4.3e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs3008870	1.000	rs1925408	chr1:67365034	C/T	cg08660285	chr1:67390436	MIER1;WDR78	0.96	6.83	0.61	1.68e-9	Lymphocyte percentage of white cells;
SKCM	cis	rs2733310	0.793	rs1660950	chr15:57117207	A/G	cg01857019	chr15:57210107	LOC145783;TCF12	0.67	4.83	0.48	6.81e-6	Mean platelet volume;
SKCM	cis	rs561341	1.000	rs1557731	chr17:30321567	T/G	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs7191700	0.712	rs7187741	chr16:11433103	C/G	cg00044050	chr16:11439710	C16orf75	-0.72	-5.03	-0.5	3.01e-6	Multiple sclerosis;
SKCM	cis	rs17826219	0.561	rs4085382	chr17:29071202	T/C	cg14067834	chr17:29058358	SUZ12P	0.99	5.11	0.5	2.22e-6	Body mass index;
SKCM	cis	rs6582630	0.519	rs11495373	chr12:38275470	T/C	cg26384229	chr12:38710491	ALG10B	0.87	6.83	0.61	1.63e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs4319547	1.000	rs4319547	chr12:123079035	A/G	cg23029597	chr12:123009494	RSRC2	-0.79	-5.76	-0.55	1.59e-7	Body mass index;
SKCM	cis	rs9485372	0.945	rs4897112	chr6:149607838	C/T	cg03072286	chr6:150262044	ULBP2	-0.55	-4.89	-0.48	5.3e-6	Breast cancer;
SKCM	cis	rs7191439	0.728	rs8043637	chr16:88781125	T/C	cg02389323	chr16:88786976	FAM38A	1.47	6.49	0.59	7.17e-9	Plateletcrit;
SKCM	cis	rs4253772	0.591	rs6008545	chr22:46686375	C/T	cg03482458	chr22:46692211	CN5H6.4;GTSE1	1.21	5.66	0.54	2.44e-7	LDL cholesterol;Cholesterol, total;
SKCM	cis	rs1160297	0.539	rs7559124	chr2:53134517	C/G	cg07782112	chr2:53107842	NA	-0.6	-5.9	-0.56	8.98e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs66573146	1.000	rs28729690	chr4:6962061	C/T	cg00086871	chr4:6988644	TBC1D14	1.43	5.33	0.52	9.25e-7	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs67311347	0.955	rs6764102	chr3:40378153	C/G	cg00091569	chr3:40428383	ENTPD3	0.65	5.58	0.53	3.36e-7	Renal cell carcinoma;
SKCM	cis	rs9303401	0.659	rs17222621	chr17:56695923	C/T	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.35	0.52	8.54e-7	Cognitive test performance;
SKCM	trans	rs1814175	0.817	rs28594987	chr11:50045181	C/T	cg03929089	chr4:120376271	NA	-0.93	-8.77	-0.7	3.08e-13	Height;
SKCM	cis	rs9303401	0.659	rs11079358	chr17:56920949	G/T	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.16	0.57	2.91e-8	Cognitive test performance;
SKCM	cis	rs60871478	1.000	rs62432223	chr7:787959	A/G	cg05535760	chr7:792225	HEATR2	1.01	8.42	0.69	1.45e-12	Cerebrospinal P-tau181p levels;
SKCM	cis	rs7772486	0.790	rs6570723	chr6:146151230	A/T	cg05347473	chr6:146136440	FBXO30	0.57	5.36	0.52	8.27e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9911578	0.935	rs6503878	chr17:56884581	T/G	cg05425664	chr17:57184151	TRIM37	-0.69	-5.21	-0.51	1.52e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs11098499	0.863	rs3736115	chr4:120488703	A/G	cg09307838	chr4:120376055	NA	-1.02	-8.18	-0.68	4.26e-12	Corneal astigmatism;
SKCM	cis	rs17711722	0.727	rs35850374	chr7:65357776	A/G	cg11764359	chr7:65958608	NA	0.88	6.43	0.59	9.56e-9	Calcium levels;
SKCM	cis	rs2836974	0.545	rs2776311	chr21:40716885	A/G	cg17971929	chr21:40555470	PSMG1	0.71	5.83	0.55	1.2e-7	Cognitive function;
SKCM	cis	rs3809863	0.646	rs9899121	chr17:45395144	C/T	cg25173405	chr17:45401733	C17orf57	-0.69	-5.1	-0.5	2.35e-6	Glaucoma (primary open-angle);
SKCM	cis	rs151997	0.509	rs11744954	chr5:50296729	A/G	cg06027927	chr5:50259733	NA	-0.61	-5.02	-0.49	3.21e-6	Callous-unemotional behaviour;
SKCM	cis	rs4150161	0.656	rs3743642	chr16:84212928	G/A	cg10106505	chr16:84220380	TAF1C	-1.29	-5.35	-0.52	8.52e-7	Systolic blood pressure response to hydrochlorothiazide in hypertension;
SKCM	cis	rs897984	0.762	rs4889599	chr16:30968589	C/T	cg00531865	chr16:30841666	NA	0.59	4.98	0.49	3.7e-6	Dementia with Lewy bodies;
SKCM	cis	rs951366	0.764	rs823143	chr1:205743425	A/C	cg14893161	chr1:205819251	PM20D1	1.06	10.63	0.77	8.03e-17	Menarche (age at onset);
SKCM	cis	rs28386778	0.897	rs2584640	chr17:61863488	C/T	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs7954584	0.567	rs1169071	chr12:122390084	G/T	cg01765077	chr12:122356316	WDR66	0.44	4.91	0.49	4.96e-6	Mean corpuscular volume;
SKCM	cis	rs847649	0.548	rs10953380	chr7:102747149	C/G	cg18108683	chr7:102477205	FBXL13	0.76	7.12	0.63	4.58e-10	Morning vs. evening chronotype;
SKCM	cis	rs6089584	0.888	rs6142927	chr20:60605848	A/G	cg06108461	chr20:60628389	TAF4	-0.82	-6.7	-0.6	2.91e-9	Body mass index;
SKCM	cis	rs11585357	0.895	rs72646797	chr1:17613838	C/G	cg08277548	chr1:17600880	PADI3	-0.89	-6.31	-0.58	1.53e-8	Hair shape;
SKCM	cis	rs16866061	1.000	rs11694987	chr2:225397409	C/G	cg12698349	chr2:225449008	CUL3	1.02	8.83	0.71	2.35e-13	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs1005277	0.522	rs1208681	chr10:38092975	C/T	cg25427524	chr10:38739819	LOC399744	-0.66	-6.51	-0.59	6.55e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs4862750	0.872	rs9998172	chr4:187898773	T/C	cg10295955	chr4:187884368	NA	-1.05	-14.11	-0.85	3.63e-23	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9300255	0.739	rs10846491	chr12:123753492	C/G	cg05973401	chr12:123451056	ABCB9	0.84	5.92	0.56	8.12e-8	Neutrophil percentage of white cells;
SKCM	cis	rs17376456	0.809	rs13177800	chr5:93307350	T/C	cg25358565	chr5:93447407	FAM172A	1.23	7.26	0.63	2.53e-10	Diabetic retinopathy;
SKCM	cis	rs2594989	0.779	rs2596815	chr3:11594930	A/G	cg00170343	chr3:11313890	ATG7	-0.95	-5.0	-0.49	3.51e-6	Circulating chemerin levels;
SKCM	cis	rs57221529	0.766	rs72703075	chr5:592819	C/T	cg26208419	chr5:473447	SLC9A3;LOC25845	0.98	4.8	0.48	7.37e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs6732795	0.896	rs6546485	chr2:69413745	A/G	cg12784598	chr2:69240042	ANTXR1	0.73	5.34	0.52	8.95e-7	Intraocular pressure;
SKCM	cis	rs36093844	0.706	rs76407487	chr11:85550632	T/G	cg25872744	chr11:85566296	CCDC83	-0.85	-4.77	-0.48	8.27e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs995000	0.899	rs1305520	chr1:62926057	A/T	cg06896770	chr1:63153194	DOCK7	-0.64	-6.07	-0.57	4.37e-8	Triglyceride levels;
SKCM	cis	rs55962025	0.842	rs2269477	chr4:3184464	G/T	cg16987761	chr4:3318072	RGS12	-0.61	-4.88	-0.48	5.53e-6	Parental longevity (mother's age at death);
SKCM	cis	rs7811142	1.000	rs112317829	chr7:100043173	A/G	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.12	6.51	0.59	6.68e-9	Platelet count;
SKCM	cis	rs8180040	0.800	rs11130126	chr3:47306894	A/G	cg27129171	chr3:47204927	SETD2	-0.79	-5.38	-0.52	7.6e-7	Colorectal cancer;
SKCM	cis	rs6424115	0.830	rs2501370	chr1:24206053	T/C	cg15997130	chr1:24165203	NA	0.58	4.77	0.48	8.43e-6	Immature fraction of reticulocytes;
SKCM	cis	rs933688	1.000	rs933688	chr5:90762748	G/A	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.04	8.0	0.67	9.48e-12	Smoking behavior;
SKCM	cis	rs9303401	0.614	rs2333409	chr17:57139134	G/A	cg10487724	chr17:56770010	TEX14;RAD51C	0.79	4.97	0.49	3.86e-6	Cognitive test performance;
SKCM	cis	rs13031619	1.000	rs6724730	chr2:3697987	G/C	cg16540950	chr2:3696648	NA	0.7	4.95	0.49	4.27e-6	Response to inhaled corticosteroid treatment in asthma (change in FEV1);
SKCM	cis	rs28595532	0.920	rs116799007	chr4:119763562	A/G	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs1348850	0.914	rs2060929	chr2:178280031	T/C	cg02961200	chr2:178257176	LOC100130691;AGPS	0.84	6.22	0.58	2.27e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs1062177	1.000	rs2964612	chr5:151198750	G/A	cg00977110	chr5:151150581	G3BP1	0.87	6.78	0.61	2.07e-9	Preschool internalizing problems;
SKCM	cis	rs589448	0.933	rs2249093	chr12:69753512	G/C	cg22834771	chr12:69754056	YEATS4	-0.71	-5.79	-0.55	1.39e-7	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs606458	0.920	rs3809076	chr11:64482546	G/A	cg07674570	chr11:65346152	EHBP1L1	0.69	4.79	0.48	7.77e-6	Urate levels;
SKCM	cis	rs9896933	0.830	rs8074277	chr17:80789628	T/C	cg20578329	chr17:80767326	TBCD	-0.94	-6.51	-0.59	6.62e-9	Bone mineral accretion in asthma (oral corticosteroid dose interaction);
SKCM	cis	rs2242116	0.932	rs4683301	chr3:46931478	A/T	cg02527881	chr3:46936655	PTH1R	0.54	5.24	0.51	1.34e-6	Birth weight;
SKCM	cis	rs4481887	0.708	rs6587463	chr1:248544452	G/C	cg00666640	chr1:248458726	OR2T12	0.47	4.85	0.48	6.07e-6	Common traits (Other);
SKCM	cis	rs1005277	0.579	rs2472181	chr10:38386764	T/C	cg25427524	chr10:38739819	LOC399744	-0.69	-6.45	-0.59	8.73e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs28595532	0.920	rs116516492	chr4:119734247	C/G	cg11846333	chr4:119757529	SEC24D	1.2	6.43	0.59	9.38e-9	Cannabis dependence symptom count;
SKCM	cis	rs6087990	0.735	rs4911260	chr20:31376490	T/C	cg13636640	chr20:31349939	DNMT3B	0.83	6.36	0.58	1.28e-8	Ulcerative colitis;
SKCM	cis	rs2153535	0.601	rs9505473	chr6:8538777	T/C	cg23788917	chr6:8435910	SLC35B3	0.7	4.93	0.49	4.59e-6	Motion sickness;
SKCM	cis	rs7772486	0.720	rs6570713	chr6:146075085	G/A	cg23711669	chr6:146136114	FBXO30	-0.89	-10.12	-0.75	7.58e-16	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs992157	0.796	rs55680399	chr2:219160621	T/C	cg00012203	chr2:219082015	ARPC2	0.73	5.76	0.55	1.6e-7	Colorectal cancer;
SKCM	cis	rs2286503	0.650	rs1990279	chr7:22890742	A/G	cg15401507	chr7:22894281	NA	-0.53	-4.77	-0.48	8.36e-6	Fibrinogen;
SKCM	cis	rs12142240	0.731	rs6658556	chr1:46844180	A/C	cg10495392	chr1:46806563	NSUN4	0.75	5.6	0.54	3.1e-7	Menopause (age at onset);
SKCM	cis	rs709400	0.603	rs2296486	chr14:104003070	A/G	cg26031613	chr14:104095156	KLC1	0.75	5.73	0.54	1.84e-7	Body mass index;
SKCM	cis	rs6570726	0.846	rs6570700	chr6:145931552	A/G	cg23711669	chr6:146136114	FBXO30	0.78	7.37	0.64	1.56e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs362296	0.698	rs362279	chr4:3260072	G/A	cg00764545	chr4:3318001	RGS12	-0.78	-7.05	-0.62	6.27e-10	Parental longevity (mother's age at death);
SKCM	cis	rs644799	0.648	rs1255178	chr11:95471908	A/G	cg03916912	chr11:95522834	CEP57;FAM76B	0.62	5.01	0.49	3.31e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs55962025	0.711	rs2071662	chr4:3223891	T/C	cg16987761	chr4:3318072	RGS12	-0.6	-4.83	-0.48	6.61e-6	Parental longevity (mother's age at death);
SKCM	cis	rs17376456	0.877	rs10066791	chr5:93350255	G/T	cg25358565	chr5:93447407	FAM172A	1.19	7.78	0.66	2.52e-11	Diabetic retinopathy;
SKCM	cis	rs11098499	0.863	rs2127823	chr4:120485670	G/T	cg24375607	chr4:120327624	NA	0.69	5.47	0.53	5.35e-7	Corneal astigmatism;
SKCM	cis	rs1801251	1.000	rs13003675	chr2:233584109	C/T	cg08000102	chr2:233561755	GIGYF2	0.89	6.91	0.62	1.15e-9	Coronary artery disease;
SKCM	cis	rs2842992	0.789	rs2277072	chr6:160182845	A/G	cg19482086	chr6:160211437	TCP1;MRPL18	0.86	6.71	0.61	2.75e-9	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs9325144	0.534	rs4882283	chr12:38710249	C/T	cg26384229	chr12:38710491	ALG10B	0.78	6.56	0.6	5.41e-9	Morning vs. evening chronotype;
SKCM	cis	rs7100689	0.516	rs10788546	chr10:82034854	T/C	cg01528321	chr10:82214614	TSPAN14	0.81	7.62	0.65	5.06e-11	Post bronchodilator FEV1;
SKCM	cis	rs4766646	0.619	rs4766637	chr12:110292155	A/C	cg08114617	chr12:110271441	TRPV4	0.51	4.85	0.48	6.08e-6	Metabolite levels (MHPG);
SKCM	cis	rs782590	0.967	rs1975484	chr2:55803167	T/A	cg18811423	chr2:55921094	PNPT1	0.88	6.98	0.62	8.55e-10	Metabolic syndrome;
SKCM	cis	rs1218582	0.741	rs10908447	chr1:154869742	C/T	cg03351412	chr1:154909251	PMVK	0.73	6.28	0.58	1.81e-8	Prostate cancer;
SKCM	cis	rs10504229	0.683	rs67048677	chr8:58140023	C/G	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs910316	0.967	rs1071989	chr14:75564659	G/T	cg08847533	chr14:75593920	NEK9	0.95	9.18	0.72	4.88e-14	Height;
SKCM	cis	rs8017423	0.967	rs11845329	chr14:90727749	C/T	cg04374321	chr14:90722782	PSMC1	1.03	9.44	0.73	1.55e-14	Mortality in heart failure;
SKCM	cis	rs28595532	0.920	rs114751999	chr4:119759651	G/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs523522	0.962	rs4767912	chr12:120981202	A/G	cg27279351	chr12:120934652	DYNLL1	0.91	8.32	0.69	2.26e-12	High light scatter reticulocyte count;
SKCM	cis	rs7772486	0.719	rs702307	chr6:145993454	C/G	cg23711669	chr6:146136114	FBXO30	-0.94	-10.42	-0.76	1.95e-16	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs10751667	0.643	rs10902244	chr11:949981	A/G	cg10932868	chr11:921992	NA	0.54	5.22	0.51	1.43e-6	Alzheimer's disease (late onset);
SKCM	cis	rs3091242	0.934	rs686631	chr1:25719599	A/T	cg02931644	chr1:25747376	RHCE	0.49	4.9	0.49	5.09e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs28595532	0.858	rs58613168	chr4:119487013	T/G	cg14228332	chr4:119757509	SEC24D	1.12	5.06	0.5	2.77e-6	Cannabis dependence symptom count;
SKCM	cis	rs6545883	0.507	rs62149712	chr2:61601272	T/C	cg15711740	chr2:61764176	XPO1	0.68	5.26	0.51	1.22e-6	Tuberculosis;
SKCM	cis	rs9311474	0.508	rs6788887	chr3:52605005	T/C	cg18404041	chr3:52824283	ITIH1	-0.53	-4.77	-0.48	8.42e-6	Electroencephalogram traits;
SKCM	cis	rs9814567	0.806	rs4955526	chr3:134317337	A/G	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.65	-5.29	-0.51	1.1e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs12497850	0.931	rs9867373	chr3:48960938	A/T	cg06212747	chr3:49208901	KLHDC8B	0.68	4.9	0.49	5.06e-6	Parkinson's disease;
SKCM	trans	rs561341	0.941	rs17780086	chr17:30343282	G/A	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs995000	0.931	rs1167996	chr1:62927797	T/G	cg06896770	chr1:63153194	DOCK7	-0.77	-7.43	-0.64	1.2e-10	Triglyceride levels;
SKCM	cis	rs7786877	0.503	rs4729601	chr7:100251141	C/T	cg20848291	chr7:100343083	ZAN	-0.71	-5.37	-0.52	7.88e-7	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs7937682	0.889	rs1789361	chr11:111485334	T/C	cg09085632	chr11:111637200	PPP2R1B	-0.97	-10.08	-0.75	8.74e-16	Primary sclerosing cholangitis;
SKCM	cis	rs6088580	0.634	rs6120644	chr20:33023810	G/A	cg24642439	chr20:33292090	TP53INP2	0.76	6.02	0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs10504229	1.000	rs113379801	chr8:58173686	C/G	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs736408	0.511	rs12637632	chr3:52708073	A/T	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs2836974	0.897	rs7280375	chr21:40552408	C/T	cg11644478	chr21:40555479	PSMG1	-0.98	-10.62	-0.77	8.06e-17	Cognitive function;
SKCM	cis	rs4150161	0.656	rs4150162	chr16:84214214	A/T	cg10106505	chr16:84220380	TAF1C	-1.29	-5.55	-0.53	3.72e-7	Systolic blood pressure response to hydrochlorothiazide in hypertension;
SKCM	cis	rs3091242	0.933	rs9438904	chr1:25756860	T/C	cg27572855	chr1:25598939	RHD	0.56	5.39	0.52	7.34e-7	Erythrocyte sedimentation rate;
SKCM	cis	rs6912958	0.703	rs9362427	chr6:88097634	G/T	cg08069147	chr6:88032118	GJB7;C6orf162	0.61	5.13	0.5	2.1e-6	Monocyte percentage of white cells;
SKCM	cis	rs7769051	1.000	rs9399041	chr6:133096233	T/G	cg22852734	chr6:133119734	C6orf192	0.93	5.16	0.5	1.8e-6	Type 2 diabetes nephropathy;
SKCM	cis	rs116095464	0.558	rs6879656	chr5:264428	T/C	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs2224391	0.822	rs36055504	chr6:5262230	A/G	cg09085698	chr6:5261316	LYRM4;FARS2	-0.78	-5.8	-0.55	1.34e-7	Height;
SKCM	cis	rs2302190	0.882	rs7221464	chr17:56552353	A/T	cg25885038	chr17:56607967	SEPT4	-0.72	-4.81	-0.48	7.23e-6	Vitamin D levels;
SKCM	cis	rs561341	1.000	rs2470243	chr17:30290955	C/T	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs13256369	0.901	rs4841015	chr8:8567140	C/G	cg06636001	chr8:8085503	FLJ10661	0.77	5.89	0.55	9.31e-8	Obesity-related traits;
SKCM	cis	rs9914544	0.550	rs7215492	chr17:18655487	C/T	cg26306683	chr17:18585705	ZNF286B	0.73	5.73	0.54	1.83e-7	Educational attainment (years of education);
SKCM	cis	rs617791	0.530	rs55947178	chr11:65754230	G/A	cg27068330	chr11:65405492	SIPA1	-0.69	-5.0	-0.49	3.41e-6	Breast cancer;
SKCM	cis	rs11155671	0.530	rs7756850	chr6:150212596	G/C	cg05036130	chr6:150231994	NA	0.61	6.58	0.6	4.87e-9	Testicular germ cell tumor;
SKCM	cis	rs28386778	0.897	rs5020097	chr17:61814198	G/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	9.64	0.74	6.19e-15	Prudent dietary pattern;
SKCM	cis	rs7824557	0.602	rs7815463	chr8:11210983	A/G	cg21775007	chr8:11205619	TDH	0.68	5.96	0.56	6.98e-8	Retinal vascular caliber;
SKCM	cis	rs999943	0.774	rs12205634	chr6:33611667	C/G	cg14003231	chr6:33640908	ITPR3	0.64	5.27	0.51	1.19e-6	Obesity (extreme);
SKCM	cis	rs2439831	0.850	rs60883262	chr15:44076503	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.35	7.75	0.66	2.9e-11	Lung cancer in ever smokers;
SKCM	cis	rs1577917	0.958	rs13201730	chr6:86556647	T/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.87	-8.71	-0.7	3.92e-13	Response to antipsychotic treatment;
SKCM	cis	rs1577917	0.876	rs1582126	chr6:86697205	C/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.64	-5.54	-0.53	3.92e-7	Response to antipsychotic treatment;
SKCM	cis	rs28386778	0.897	rs2727290	chr17:61894728	G/T	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs2839186	0.934	rs13049797	chr21:47707582	T/C	cg05896524	chr21:47604654	C21orf56	0.69	5.67	0.54	2.29e-7	Testicular germ cell tumor;
SKCM	cis	rs17376456	0.825	rs28610997	chr5:93248374	T/C	cg25358565	chr5:93447407	FAM172A	1.3	7.53	0.65	7.57e-11	Diabetic retinopathy;
SKCM	cis	rs6547741	1.000	rs13026621	chr2:27807624	G/A	cg27432699	chr2:27873401	GPN1	0.73	6.64	0.6	3.76e-9	Oral cavity cancer;
SKCM	cis	rs12148488	0.738	rs4886417	chr15:75330159	T/G	cg17294928	chr15:75287854	SCAMP5	0.66	4.9	0.48	5.14e-6	Caffeine consumption;
SKCM	cis	rs12142240	0.698	rs6695043	chr1:46844530	A/G	cg14993813	chr1:46806288	NSUN4	0.69	4.77	0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs9926296	0.533	rs9938865	chr16:89867797	A/G	cg04287289	chr16:89883240	FANCA	1.04	12.66	0.82	1.33e-20	Vitiligo;
SKCM	cis	rs769267	0.930	rs7256149	chr19:19566255	T/C	cg26732615	chr19:19648335	CILP2;YJEFN3	0.67	7.06	0.62	6e-10	Tonsillectomy;
SKCM	trans	rs561341	1.000	rs561341	chr17:30316385	T/G	cg20587970	chr11:113659929	NA	-1.18	-10.63	-0.77	7.95e-17	Hip circumference adjusted for BMI;
SKCM	cis	rs1153858	1.000	rs1049503	chr15:45653707	T/C	cg21132104	chr15:45694354	SPATA5L1	0.93	7.94	0.67	1.22e-11	Homoarginine levels;
SKCM	cis	rs9858542	1.000	rs9812791	chr3:49682311	G/A	cg03060546	chr3:49711283	APEH	-0.76	-5.67	-0.54	2.31e-7	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs644799	0.930	rs631099	chr11:95563482	T/C	cg03916912	chr11:95522834	CEP57;FAM76B	0.88	7.53	0.65	7.59e-11	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs9513627	1.000	rs9517758	chr13:100179397	T/A	cg11288260	chr13:100117058	NA	0.79	4.78	0.48	8.1e-6	Obesity-related traits;
SKCM	cis	rs8060686	0.641	rs1074143	chr16:68127278	A/G	cg09117114	chr16:67998030	SLC12A4	-0.81	-5.29	-0.51	1.07e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs7618915	0.547	rs11130314	chr3:52697082	T/C	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs2644899	0.859	rs2545757	chr19:41297302	A/G	cg24958765	chr19:41283667	RAB4B	-0.85	-5.39	-0.52	7.21e-7	Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs6546550	0.935	rs2168115	chr2:70034793	A/G	cg02498382	chr2:70120550	SNRNP27	-0.46	-5.07	-0.5	2.61e-6	Prevalent atrial fibrillation;
SKCM	cis	rs6500395	1.000	rs9933187	chr16:48556573	A/C	cg04672837	chr16:48644449	N4BP1	-0.67	-5.69	-0.54	2.17e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs6545883	0.826	rs2694651	chr2:61588642	T/C	cg15711740	chr2:61764176	XPO1	0.69	4.91	0.49	4.85e-6	Tuberculosis;
SKCM	cis	rs362272	0.505	rs3129310	chr4:3301388	T/G	cg00764545	chr4:3318001	RGS12	0.94	11.44	0.79	2.29e-18	Serum sulfate level;
SKCM	cis	rs10779751	1.000	rs718206	chr1:11294474	T/A	cg08854313	chr1:11322531	MTOR	0.92	7.09	0.63	5.2400000000000005e-10	Body mass index;
SKCM	cis	rs7772486	0.875	rs1412080	chr6:146417304	T/C	cg05347473	chr6:146136440	FBXO30	0.64	5.83	0.55	1.19e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2842992	0.747	rs1547093	chr6:160205991	C/A	cg11366901	chr6:160182831	ACAT2	0.94	7.85	0.66	1.81e-11	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs782590	0.934	rs17369191	chr2:55757885	T/C	cg18811423	chr2:55921094	PNPT1	0.82	6.25	0.58	2.04e-8	Metabolic syndrome;
SKCM	cis	rs9916302	0.861	rs9903363	chr17:37499604	C/G	cg07936489	chr17:37558343	FBXL20	0.85	7.28	0.64	2.26e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs7829975	0.774	rs11775523	chr8:8679176	A/G	cg06636001	chr8:8085503	FLJ10661	0.78	7.27	0.64	2.37e-10	Mood instability;
SKCM	cis	rs28386778	0.897	rs2727295	chr17:61887693	C/T	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.08	10.63	0.77	7.76e-17	Prudent dietary pattern;
SKCM	cis	rs7599312	0.534	rs7596285	chr2:213406961	G/A	cg20637307	chr2:213403960	ERBB4	0.76	5.6	0.54	3.12e-7	BMI (adjusted for smoking behaviour);BMI in non-smokers;Body mass index;Body mass index (joint analysis main effects and smoking interaction);
SKCM	cis	rs9875589	0.509	rs2733555	chr3:14099649	C/T	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.5	5.13	0.5	2.03e-6	Ovarian reserve;
SKCM	cis	rs7954584	0.813	rs1523261	chr12:122462877	C/A	cg13699009	chr12:122356056	WDR66	0.49	5.74	0.54	1.75e-7	Mean corpuscular volume;
SKCM	cis	rs9911578	1.000	rs6503870	chr17:56659018	C/T	cg12560992	chr17:57184187	TRIM37	0.95	7.67	0.66	4.15e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs854765	0.583	rs6502619	chr17:17779704	C/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	-0.99	-8.26	-0.68	2.96e-12	Total body bone mineral density;
SKCM	cis	rs1799949	0.965	rs8176322	chr17:41195773	A/G	cg23758822	chr17:41437982	NA	0.94	7.87	0.67	1.68e-11	Menopause (age at onset);
SKCM	cis	rs2652834	1.000	rs68088462	chr15:63397617	T/C	cg04194852	chr15:63334506	TPM1	0.76	4.78	0.48	8.15e-6	HDL cholesterol;
SKCM	cis	rs2769264	0.505	rs11801791	chr1:151387508	C/T	cg18801370	chr1:151430492	POGZ	0.87	6.04	0.56	4.89e-8	Blood trace element (Cu levels);
SKCM	cis	rs2836950	0.545	rs4818001	chr21:40575088	T/C	cg17971929	chr21:40555470	PSMG1	-0.71	-5.93	-0.56	7.85e-8	Menarche (age at onset);
SKCM	cis	rs9325144	1.000	rs9325144	chr12:39018673	C/T	cg26384229	chr12:38710491	ALG10B	-0.61	-4.77	-0.48	8.43e-6	Morning vs. evening chronotype;
SKCM	cis	rs11098499	0.863	rs3822191	chr4:120428101	A/T	cg24375607	chr4:120327624	NA	0.7	5.38	0.52	7.69e-7	Corneal astigmatism;
SKCM	cis	rs7772486	0.558	rs702322	chr6:146007166	G/A	cg05347473	chr6:146136440	FBXO30	-0.69	-6.04	-0.56	4.85e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2842992	0.724	rs9365097	chr6:160211259	G/A	cg16489826	chr6:160211363	TCP1;MRPL18	0.71	5.51	0.53	4.52e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs672059	1.000	rs479994	chr1:183161729	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.65	5.49	0.53	4.87e-7	Hypertriglyceridemia;
SKCM	cis	rs17376456	0.825	rs7715562	chr5:93222034	C/T	cg21475434	chr5:93447410	FAM172A	-0.95	-5.36	-0.52	8.36e-7	Diabetic retinopathy;
SKCM	cis	rs778371	0.659	rs2289911	chr2:233704252	A/G	cg08000102	chr2:233561755	GIGYF2	-0.8	-6.41	-0.59	1.04e-8	Schizophrenia;
SKCM	cis	rs12458462	0.859	rs34242155	chr18:77425192	G/A	cg11879182	chr18:77439856	CTDP1	0.87	7.14	0.63	4.25e-10	Monocyte count;
SKCM	cis	rs28386778	0.897	rs1877318	chr17:61819960	G/A	cg01411255	chr17:61851458	DDX42;CCDC47	0.78	5.03	0.49	3.06e-6	Prudent dietary pattern;
SKCM	cis	rs8067545	0.611	rs2703800	chr17:20086562	C/T	cg13482628	chr17:19912719	NA	0.66	5.5	0.53	4.67e-7	Schizophrenia;
SKCM	cis	rs9910055	0.762	rs184478	chr17:42209751	C/G	cg19774624	chr17:42201019	HDAC5	0.93	8.25	0.68	3.08e-12	Total body bone mineral density;
SKCM	cis	rs9902453	0.808	rs1986555	chr17:28014448	T/A	cg26525008	chr17:28256777	EFCAB5;SSH2	0.82	5.78	0.55	1.47e-7	Coffee consumption (cups per day);
SKCM	cis	rs4481887	1.000	rs6683717	chr1:248476792	A/G	cg00666640	chr1:248458726	OR2T12	0.64	5.69	0.54	2.13e-7	Common traits (Other);
SKCM	cis	rs28595532	0.844	rs55845920	chr4:119490085	C/T	cg21605333	chr4:119757512	SEC24D	1.24	7.1	0.63	5.16e-10	Cannabis dependence symptom count;
SKCM	cis	rs1580019	0.961	rs766660	chr7:32499077	A/G	cg06627557	chr7:32535165	LSM5;AVL9	0.75	5.74	0.55	1.7e-7	Cognitive ability;
SKCM	cis	rs12142240	0.621	rs13374968	chr1:46843908	T/G	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs2952156	0.883	rs12150603	chr17:37834715	G/A	cg00129232	chr17:37814104	STARD3	-0.73	-6.23	-0.58	2.2e-8	Asthma;
SKCM	cis	rs8017423	0.967	rs7142513	chr14:90705182	T/C	cg04374321	chr14:90722782	PSMC1	0.97	8.87	0.71	1.91e-13	Mortality in heart failure;
SKCM	cis	rs1865760	0.892	rs9379806	chr6:25940958	G/A	cg08401836	chr6:26032486	HIST1H3B	-0.62	-5.06	-0.5	2.76e-6	Height;
SKCM	cis	rs668210	0.793	rs622779	chr11:65744247	G/A	cg20909159	chr11:65625947	CFL1	0.78	4.97	0.49	3.86e-6	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs394563	0.810	rs480870	chr6:149784818	T/C	cg03678062	chr6:149772716	ZC3H12D	-0.48	-4.96	-0.49	4.11e-6	Dupuytren's disease;
SKCM	cis	rs58688157	0.960	rs60870990	chr11:613742	G/A	cg03576123	chr11:487126	PTDSS2	-0.84	-5.45	-0.53	5.64e-7	Systemic lupus erythematosus;
SKCM	cis	rs7523050	0.730	rs72984612	chr1:109434826	T/C	cg08274380	chr1:109419600	GPSM2	1.15	6.57	0.6	5.22e-9	Fat distribution (HIV);
SKCM	cis	rs2952156	0.920	rs2941506	chr17:37833035	A/G	cg00129232	chr17:37814104	STARD3	-0.69	-5.63	-0.54	2.69e-7	Asthma;
SKCM	cis	rs11785400	1.000	rs6997670	chr8:143737915	G/A	cg20003893	chr8:144489567	NA	-0.55	-4.79	-0.48	7.95e-6	Schizophrenia;
SKCM	cis	rs763121	0.626	rs5757236	chr22:39073824	T/C	cg06022373	chr22:39101656	GTPBP1	0.8	5.79	0.55	1.42e-7	Menopause (age at onset);
SKCM	cis	rs9910055	0.762	rs4239142	chr17:42205876	A/G	cg08499158	chr17:42289980	UBTF	0.85	7.48	0.65	9.37e-11	Total body bone mineral density;
SKCM	cis	rs3008870	1.000	rs12740884	chr1:67459855	C/A	cg08660285	chr1:67390436	MIER1;WDR78	-0.92	-6.07	-0.57	4.27e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs7666738	0.800	rs13107586	chr4:99028788	G/C	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs470903	0.773	rs470681	chr18:74717937	C/T	cg05896682	chr18:74964030	GALR1	0.51	5.15	0.5	1.94e-6	Paclitaxel disposition in epithelial ovarian cancer;
SKCM	cis	rs7659604	0.628	rs3828485	chr4:122722368	G/A	cg06713675	chr4:122721982	EXOSC9	-0.74	-7.2	-0.63	3.21e-10	Type 2 diabetes;
SKCM	cis	rs33794	0.935	rs33789	chr3:45296367	A/G	cg25630594	chr3:44914870	TGM4	0.57	4.84	0.48	6.39e-6	Lung function (forced expiratory volume in 1 second);
SKCM	cis	rs62064224	0.902	rs35830939	chr17:30627564	A/C	cg18200150	chr17:30822561	MYO1D	0.71	6.01	0.56	5.51e-8	Schizophrenia;
SKCM	cis	rs9790314	0.875	rs163327	chr3:161062724	A/G	cg03342759	chr3:160939853	NMD3	-0.67	-6.75	-0.61	2.35e-9	Morning vs. evening chronotype;
SKCM	cis	rs10916772	0.938	rs12046639	chr1:20687755	C/T	cg05356564	chr1:21044770	KIF17	-0.62	-5.15	-0.5	1.88e-6	Psychosis proneness (perceptual aberration scale);
SKCM	cis	rs6087990	0.842	rs6119279	chr20:31330612	A/G	cg13636640	chr20:31349939	DNMT3B	0.88	7.14	0.63	4.34e-10	Ulcerative colitis;
SKCM	cis	rs34779708	0.733	rs4102764	chr10:35545392	T/C	cg03585969	chr10:35415529	CREM	0.72	5.29	0.51	1.08e-6	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs7811142	1.000	rs1000215	chr7:100004543	A/G	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.23	8.14	0.68	5.06e-12	Platelet count;
SKCM	cis	rs8017423	0.967	rs7160032	chr14:90708472	A/G	cg04374321	chr14:90722782	PSMC1	0.97	8.87	0.71	1.91e-13	Mortality in heart failure;
SKCM	cis	rs875971	0.619	rs10278371	chr7:66051540	C/A	cg00343986	chr7:65444356	GUSB	-0.67	-4.93	-0.49	4.55e-6	Aortic root size;
SKCM	cis	rs473651	0.935	rs474478	chr2:239335473	C/T	cg21699342	chr2:239360505	ASB1	0.49	4.79	0.48	7.71e-6	Multiple system atrophy;
SKCM	cis	rs950027	0.620	rs1153857	chr15:45659095	G/T	cg21132104	chr15:45694354	SPATA5L1	0.76	5.84	0.55	1.13e-7	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs1461503	0.966	rs1461501	chr11:122844416	A/G	cg27398637	chr11:122830231	C11orf63	-0.63	-4.8	-0.48	7.54e-6	Menarche (age at onset);
SKCM	cis	rs514406	0.861	rs2065477	chr1:53250213	C/T	cg16325326	chr1:53192061	ZYG11B	0.99	11.71	0.8	7.39e-19	Monocyte count;
SKCM	cis	rs1405130	0.900	rs12692149	chr2:235587090	T/C	cg17841421	chr2:235704848	NA	-0.58	-4.88	-0.48	5.48e-6	Coronary artery disease;
SKCM	cis	rs6445797	0.574	rs72877266	chr3:56590826	T/G	cg13616963	chr3:57583610	ARF4	-0.78	-5.17	-0.51	1.76e-6	Gastritis;
SKCM	cis	rs6665290	0.904	rs1045286	chr1:227179037	A/C	cg10327440	chr1:227177885	CDC42BPA	1.2	18.84	0.91	9.27e-31	Myeloid white cell count;
SKCM	cis	rs1552244	0.872	rs7646073	chr3:10097405	G/A	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs6570726	0.846	rs372904	chr6:145887425	T/C	cg05347473	chr6:146136440	FBXO30	0.57	5.18	0.51	1.67e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4132509	0.793	rs7538011	chr1:243703344	A/G	cg21452805	chr1:244014465	NA	0.85	5.13	0.5	2.09e-6	RR interval (heart rate);
SKCM	trans	rs66573146	1.000	rs66712119	chr4:6965428	A/T	cg07817883	chr1:32538562	TMEM39B	2.0	8.02	0.67	8.59e-12	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs6598955	0.670	rs4659366	chr1:26542572	G/A	cg00938395	chr1:26633206	UBXN11	0.71	5.0	0.49	3.5e-6	Obesity-related traits;
SKCM	cis	rs597539	0.652	rs622082	chr11:68703959	A/G	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.85	5.67	0.54	2.32e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs10791097	0.609	rs3751039	chr11:130773076	A/G	cg12179176	chr11:130786555	SNX19	-1.06	-10.93	-0.78	2.12e-17	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs7666738	0.830	rs13137859	chr4:99050319	A/G	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6132905	0.590	rs112911492	chr20:2627936	T/C	cg10544093	chr20:2632942	MIR1292;NOP56	-1.08	-5.06	-0.5	2.75e-6	Mumps;
SKCM	cis	rs1023500	0.573	rs2413666	chr22:42459622	C/T	cg04733989	chr22:42467013	NAGA	0.72	5.71	0.54	2e-7	Schizophrenia;
SKCM	cis	rs910316	0.737	rs175077	chr14:75506875	G/A	cg08847533	chr14:75593920	NEK9	-0.8	-6.61	-0.6	4.34e-9	Height;
SKCM	cis	rs951366	0.789	rs7536483	chr1:205718858	A/T	cg26354017	chr1:205819088	PM20D1	1.02	8.93	0.71	1.48e-13	Menarche (age at onset);
SKCM	cis	rs778371	0.676	rs11688166	chr2:233566210	A/G	cg08000102	chr2:233561755	GIGYF2	0.84	6.45	0.59	8.53e-9	Schizophrenia;
SKCM	cis	rs5769765	0.908	rs9616216	chr22:50318927	T/C	cg22709217	chr22:50311962	ALG12;CRELD2	-0.99	-6.09	-0.57	4.04e-8	Schizophrenia;
SKCM	cis	rs28374715	0.662	rs28587487	chr15:41495460	C/T	cg18705301	chr15:41695430	NDUFAF1	-0.93	-7.81	-0.66	2.19e-11	Ulcerative colitis;
SKCM	cis	rs62103177	0.564	rs1864529	chr18:77748975	G/A	cg27393146	chr18:77495563	CTDP1	0.83	5.38	0.52	7.65e-7	Opioid sensitivity;
SKCM	cis	rs2243480	0.803	rs36127118	chr7:65565505	A/G	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs798554	0.679	rs13230995	chr7:2887284	G/A	cg19346786	chr7:2764209	NA	-0.65	-6.79	-0.61	1.96e-9	Height;
SKCM	cis	rs1577917	0.917	rs1414201	chr6:86500316	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.88	-0.67	1.63e-11	Response to antipsychotic treatment;
SKCM	cis	rs11112613	0.713	rs12321309	chr12:105943263	T/G	cg03607813	chr12:105948248	NA	0.88	5.92	0.56	8.1e-8	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;
SKCM	cis	rs1552244	0.744	rs6763366	chr3:10033544	T/C	cg02579736	chr3:10068473	FANCD2;CIDECP	0.95	4.85	0.48	6.17e-6	Alzheimer's disease;
SKCM	cis	rs17685	0.725	rs1044483	chr7:75659815	T/C	cg16489192	chr7:75678113	MDH2;STYXL1	0.58	5.44	0.52	5.83e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs12709013	0.792	rs1646289	chr16:58789593	G/A	cg02431531	chr16:59244939	NA	0.49	5.13	0.5	2.07e-6	Blood metabolite ratios;
SKCM	cis	rs651907	0.712	rs796410	chr3:101610189	C/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.8	6.22	0.58	2.25e-8	Colorectal cancer;
SKCM	cis	rs754466	0.580	rs2289311	chr10:79565655	G/A	cg17075019	chr10:79541650	NA	-0.81	-7.33	-0.64	1.81e-10	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs6879260	1.000	rs729568	chr5:179732350	C/T	cg02891314	chr5:179741120	GFPT2	0.71	6.04	0.56	5.03e-8	Height;
SKCM	cis	rs7772486	0.754	rs4896841	chr6:146041522	T/C	cg05347473	chr6:146136440	FBXO30	-0.62	-5.62	-0.54	2.8e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6598955	0.543	rs6699798	chr1:26556442	G/T	cg04990556	chr1:26633338	UBXN11	0.65	4.8	0.48	7.56e-6	Obesity-related traits;
SKCM	cis	rs28595532	0.764	rs115916994	chr4:119688758	A/G	cg11846333	chr4:119757529	SEC24D	1.19	6.39	0.59	1.12e-8	Cannabis dependence symptom count;
SKCM	cis	rs16854884	0.633	rs6779321	chr3:143736676	T/C	cg06585982	chr3:143692056	C3orf58	0.87	8.11	0.68	5.72e-12	Economic and political preferences (feminism/equality);
SKCM	cis	rs9911578	0.740	rs368243	chr17:56708979	T/C	cg12560992	chr17:57184187	TRIM37	0.7	4.94	0.49	4.3e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs10876993	0.928	rs10877001	chr12:58083077	T/C	cg18357645	chr12:58087776	OS9	-0.65	-5.97	-0.56	6.61e-8	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs7208859	0.623	rs8075163	chr17:29106310	A/G	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs16854884	0.558	rs60367530	chr3:143719294	G/A	cg06585982	chr3:143692056	C3orf58	0.83	7.55	0.65	6.97e-11	Economic and political preferences (feminism/equality);
SKCM	cis	rs7726839	0.555	rs7720419	chr5:589343	A/T	cg09021430	chr5:549028	NA	-0.69	-5.58	-0.53	3.38e-7	Obesity-related traits;
SKCM	cis	rs754466	0.651	rs11002316	chr10:79617511	C/G	cg17075019	chr10:79541650	NA	-0.72	-6.51	-0.59	6.75e-9	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs1348850	0.558	rs4337505	chr2:178529714	A/T	cg22681709	chr2:178499509	PDE11A	-0.66	-5.79	-0.55	1.4e-7	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs2650000	0.798	rs2701175	chr12:121391671	C/A	cg02403541	chr12:121454288	C12orf43	-0.68	-5.07	-0.5	2.65e-6	Metabolic traits;LDL cholesterol;
SKCM	cis	rs6089829	0.962	rs6122352	chr20:61668284	T/C	cg08564027	chr20:61660810	NA	0.63	5.65	0.54	2.46e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs801193	0.935	rs2659916	chr7:66151352	C/G	cg11764359	chr7:65958608	NA	0.86	6.6	0.6	4.52e-9	Aortic root size;
SKCM	cis	rs7336332	0.598	rs76790205	chr13:28002885	C/T	cg22138327	chr13:27999177	GTF3A	0.91	6.51	0.59	6.52e-9	Weight;
SKCM	cis	rs28595532	0.920	rs115354352	chr4:119750358	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs11690935	0.959	rs1113389	chr2:172635365	C/T	cg13550731	chr2:172543902	DYNC1I2	-0.94	-7.99	-0.67	9.97e-12	Schizophrenia;
SKCM	cis	rs7615952	0.673	rs9821905	chr3:125620850	A/G	cg05084668	chr3:125655381	ALG1L	1.33	6.26	0.58	1.98e-8	Blood pressure (smoking interaction);
SKCM	cis	rs9300255	0.568	rs1727300	chr12:123664205	C/T	cg05973401	chr12:123451056	ABCB9	0.81	5.37	0.52	7.77e-7	Neutrophil percentage of white cells;
SKCM	cis	rs28386778	0.897	rs6504187	chr17:61917099	G/A	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs9430161	0.579	rs10864486	chr1:11040979	A/G	cg02454025	chr1:11042201	C1orf127	0.96	8.83	0.71	2.31e-13	Ewing sarcoma;
SKCM	cis	rs2180341	0.814	rs9401959	chr6:127736464	T/C	cg24812749	chr6:127587940	RNF146	0.61	4.97	0.49	3.9e-6	Breast cancer;
SKCM	cis	rs17376456	0.825	rs17372057	chr5:93071916	C/A	cg21475434	chr5:93447410	FAM172A	0.9	4.99	0.49	3.65e-6	Diabetic retinopathy;
SKCM	cis	rs28785552	0.931	rs10406850	chr19:53240807	A/C	cg10871876	chr19:53194124	ZNF83	0.81	5.88	0.55	9.76e-8	Response to paliperidone in schizophrenia (PANSS score);
SKCM	cis	rs1348850	0.872	rs10165785	chr2:178293295	C/T	cg02961200	chr2:178257176	LOC100130691;AGPS	0.82	6.16	0.57	2.93e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs1799949	1.000	rs8176265	chr17:41213996	C/T	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.06	-0.57	4.62e-8	Menopause (age at onset);
SKCM	cis	rs9910055	0.683	rs7220138	chr17:42254011	C/G	cg19774624	chr17:42201019	HDAC5	-0.87	-8.15	-0.68	4.72e-12	Total body bone mineral density;
SKCM	cis	rs17345786	0.906	rs58835747	chr3:101243634	T/C	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.72	5.43	0.52	6.18e-7	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7020830	0.867	rs56098516	chr9:37362220	A/G	cg14294708	chr9:37120828	ZCCHC7	1.06	10.71	0.77	5.47e-17	Schizophrenia;
SKCM	cis	rs7208859	0.623	rs8075341	chr17:29136565	A/G	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs28386778	0.897	rs8081454	chr17:61842646	A/G	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs55794721	0.509	rs2375313	chr1:25748235	G/A	cg27572855	chr1:25598939	RHD	0.56	5.48	0.53	4.99e-7	Plateletcrit;Mean corpuscular volume;
SKCM	cis	rs6977660	1.000	rs35784097	chr7:19818848	A/G	cg05791153	chr7:19748676	TWISTNB	0.79	5.34	0.52	9.05e-7	Thyroid stimulating hormone;
SKCM	cis	rs4891159	0.790	rs56077581	chr18:74116865	T/G	cg24786174	chr18:74118243	ZNF516	-0.75	-7.23	-0.63	2.84e-10	Longevity;
SKCM	cis	rs13118159	0.527	rs9328733	chr4:1388583	A/G	cg02018176	chr4:1364513	KIAA1530	0.91	6.98	0.62	8.54e-10	Longevity;
SKCM	cis	rs10489202	1.000	rs17557135	chr1:167985888	A/G	cg24449463	chr1:168025552	DCAF6	-0.74	-5.9	-0.56	8.97e-8	Schizophrenia;
SKCM	cis	rs10751667	0.643	rs10902238	chr11:944810	G/A	cg10932868	chr11:921992	NA	0.55	5.13	0.5	2.09e-6	Alzheimer's disease (late onset);
SKCM	cis	rs28595532	0.748	rs55949457	chr4:119336174	A/G	cg11846333	chr4:119757529	SEC24D	1.19	6.71	0.6	2.81e-9	Cannabis dependence symptom count;
SKCM	cis	rs4332037	0.510	rs11764040	chr7:1884830	G/C	cg02825527	chr7:2087843	MAD1L1	-0.68	-4.94	-0.49	4.36e-6	Bipolar disorder;
SKCM	cis	rs34779708	0.966	rs7077242	chr10:35481965	A/C	cg03585969	chr10:35415529	CREM	-0.78	-6.53	-0.59	6.16e-9	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs478304	0.654	rs11227260	chr11:65461158	G/T	cg27068330	chr11:65405492	SIPA1	-0.89	-7.49	-0.65	9.25e-11	Acne (severe);
SKCM	cis	rs1552244	0.572	rs3843008	chr3:10173742	C/T	cg00149659	chr3:10157352	C3orf10	1.13	5.72	0.54	1.88e-7	Alzheimer's disease;
SKCM	cis	rs73157695	0.676	rs9306144	chr21:47341116	A/T	cg10605724	chr21:47966967	DIP2A	-0.7	-5.17	-0.51	1.75e-6	Myopia;
SKCM	cis	rs28386778	0.863	rs2584637	chr17:61942952	T/C	cg01411255	chr17:61851458	DDX42;CCDC47	0.78	5.01	0.49	3.26e-6	Prudent dietary pattern;
SKCM	cis	rs9902453	0.874	rs4474741	chr17:28148117	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.8	-5.4	-0.52	6.96e-7	Coffee consumption (cups per day);
SKCM	cis	rs8180040	0.800	rs56250009	chr3:47279497	G/C	cg27129171	chr3:47204927	SETD2	-0.79	-5.38	-0.52	7.6e-7	Colorectal cancer;
SKCM	cis	rs999943	0.846	rs999942	chr6:33624902	G/C	cg14003231	chr6:33640908	ITPR3	0.62	5.62	0.54	2.82e-7	Obesity (extreme);
SKCM	cis	rs748404	0.660	rs509306	chr15:43715171	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	0.73	5.42	0.52	6.48e-7	Lung cancer;
SKCM	cis	rs10504229	1.000	rs17217033	chr8:58180061	G/T	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs34375054	0.641	rs34624329	chr12:125608028	T/G	cg25124228	chr12:125621409	AACS	-0.65	-5.19	-0.51	1.61e-6	Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs807669	0.903	rs807667	chr22:19161327	A/G	cg02655711	chr22:19163373	SLC25A1	-0.8	-7.89	-0.67	1.57e-11	Metabolite levels;
SKCM	cis	rs9300255	0.544	rs1790123	chr12:123659542	C/T	cg00376283	chr12:123451042	ABCB9	0.84	5.1	0.5	2.35e-6	Neutrophil percentage of white cells;
SKCM	cis	rs7829975	0.774	rs35039922	chr8:8675325	A/T	cg15556689	chr8:8085844	FLJ10661	0.74	6.95	0.62	9.98e-10	Mood instability;
SKCM	cis	rs1387259	0.758	rs2634670	chr12:48771877	G/A	cg21466736	chr12:48725269	NA	-0.6	-4.77	-0.48	8.28e-6	Obstructive sleep apnea trait (apnea hypopnea index);
SKCM	cis	rs561341	0.883	rs7406056	chr17:30220224	C/T	cg00745463	chr17:30367425	LRRC37B	-1.0	-6.56	-0.6	5.45e-9	Hip circumference adjusted for BMI;
SKCM	cis	rs6951245	0.872	rs75398423	chr7:1098414	T/G	cg03188948	chr7:1209495	NA	1.13	6.27	0.58	1.89e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs208520	0.837	rs208486	chr6:66926255	A/T	cg07460842	chr6:66804631	NA	-1.02	-7.27	-0.64	2.35e-10	Exhaled nitric oxide output;
SKCM	cis	rs2839186	0.749	rs62226489	chr21:47710519	T/C	cg05896524	chr21:47604654	C21orf56	0.69	5.67	0.54	2.29e-7	Testicular germ cell tumor;
SKCM	cis	rs9911578	0.967	rs6503890	chr17:57064167	A/G	cg12560992	chr17:57184187	TRIM37	0.98	7.99	0.67	9.86e-12	Intelligence (multi-trait analysis);
SKCM	cis	rs1577917	1.000	rs35797755	chr6:86706554	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.64	-5.54	-0.53	3.92e-7	Response to antipsychotic treatment;
SKCM	cis	rs12047808	0.841	rs55637213	chr1:179373680	T/A	cg08037922	chr1:179521085	C1orf125;NPHS2	-1.08	-5.8	-0.55	1.32e-7	Multiple sclerosis (age of onset);
SKCM	cis	rs2239547	0.563	rs9876403	chr3:52916916	C/T	cg11645453	chr3:52864694	ITIH4	0.77	6.95	0.62	9.78e-10	Schizophrenia;
SKCM	cis	rs11098499	0.818	rs7688802	chr4:120451668	G/A	cg09307838	chr4:120376055	NA	0.97	7.66	0.66	4.19e-11	Corneal astigmatism;
SKCM	cis	rs561341	0.882	rs72825748	chr17:30367396	G/A	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs9300255	0.830	rs28413626	chr12:123861452	G/A	cg00376283	chr12:123451042	ABCB9	-0.8	-5.44	-0.52	5.89e-7	Neutrophil percentage of white cells;
SKCM	cis	rs7666738	0.830	rs10010223	chr4:99021758	G/A	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4862750	0.872	rs56389997	chr4:187894796	A/C	cg10295955	chr4:187884368	NA	-1.04	-13.91	-0.84	7.95e-23	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs651907	0.535	rs36060163	chr3:101360963	C/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.81	6.95	0.62	9.97e-10	Colorectal cancer;
SKCM	cis	rs801193	0.742	rs9969300	chr7:65781646	G/A	cg18876405	chr7:65276391	NA	-0.62	-4.98	-0.49	3.71e-6	Aortic root size;
SKCM	cis	rs9815354	1.000	rs56207540	chr3:41976627	G/C	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs6952808	0.609	rs12699453	chr7:1953056	C/T	cg04267008	chr7:1944627	MAD1L1	-0.6	-4.81	-0.48	7.27e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs9902453	0.967	rs60176674	chr17:28479854	T/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.5	0.53	4.74e-7	Coffee consumption (cups per day);
SKCM	cis	rs995000	0.931	rs1168021	chr1:63009900	A/G	cg06896770	chr1:63153194	DOCK7	-0.73	-6.54	-0.6	5.83e-9	Triglyceride levels;
SKCM	cis	rs860295	0.702	rs12746592	chr1:155505967	G/A	cg02153340	chr1:155202674	NA	-0.78	-5.52	-0.53	4.25e-7	Body mass index;
SKCM	cis	rs2075371	0.966	rs722657	chr7:133994956	T/C	cg20476274	chr7:133979776	SLC35B4	1.03	10.69	0.77	5.94e-17	Mean platelet volume;
SKCM	cis	rs4819052	0.766	rs4819035	chr21:46645715	A/C	cg02159808	chr21:46707872	POFUT2;LOC642852	0.83	5.84	0.55	1.12e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs829883	0.664	rs829874	chr12:98840615	G/A	cg25150519	chr12:98850993	NA	0.51	5.06	0.5	2.71e-6	Colorectal adenoma (advanced);
SKCM	cis	rs2645694	0.626	rs904050	chr4:77826089	T/G	cg06046430	chr4:77819534	ANKRD56	0.54	5.94	0.56	7.49e-8	Emphysema distribution in smoking;
SKCM	cis	rs806215	0.813	rs806175	chr7:127289435	A/G	cg20391126	chr7:127831430	NA	0.47	4.83	0.48	6.71e-6	Type 2 diabetes;
SKCM	cis	rs13064447	0.967	rs113886525	chr3:12762356	A/G	cg05775895	chr3:12838266	CAND2	0.65	5.25	0.51	1.29e-6	Major depression and alcohol dependence;
SKCM	cis	rs854765	0.583	rs62064156	chr17:17822480	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.93	7.3	0.64	2.06e-10	Total body bone mineral density;
SKCM	cis	rs72781680	0.611	rs56113233	chr2:24341085	A/C	cg20701182	chr2:24300061	SF3B14	0.74	5.01	0.49	3.27e-6	Lymphocyte counts;
SKCM	cis	rs910316	0.904	rs7156089	chr14:75645527	A/G	cg11812906	chr14:75593930	NEK9	-0.74	-5.65	-0.54	2.49e-7	Height;
SKCM	cis	rs1413885	0.516	rs9326063	chr1:65835911	T/C	cg14976592	chr1:65886160	LEPROT;LEPR	0.63	5.27	0.51	1.16e-6	Anticoagulant levels;
SKCM	cis	rs1405130	0.869	rs13001109	chr2:235569646	A/G	cg17841421	chr2:235704848	NA	-0.57	-4.95	-0.49	4.14e-6	Coronary artery disease;
SKCM	cis	rs1801251	1.000	rs13013142	chr2:233600606	A/G	cg25237894	chr2:233734115	C2orf82	0.56	5.33	0.52	9.23e-7	Coronary artery disease;
SKCM	cis	rs9325144	0.505	rs901635	chr12:38646572	A/C	cg13010199	chr12:38710504	ALG10B	-0.64	-5.19	-0.51	1.6e-6	Morning vs. evening chronotype;
SKCM	cis	rs6952808	0.689	rs4719391	chr7:2048136	T/C	cg02951883	chr7:2050386	MAD1L1	-0.85	-8.01	-0.67	8.95e-12	Bipolar disorder and schizophrenia;
SKCM	cis	rs2731664	0.756	rs2545796	chr5:176864269	T/C	cg23176889	chr5:176863531	GRK6	-0.5	-5.31	-0.52	1.02e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs8180040	0.654	rs9837343	chr3:47177388	C/T	cg27129171	chr3:47204927	SETD2	0.74	5.37	0.52	7.84e-7	Colorectal cancer;
SKCM	cis	rs867186	1.000	rs867186	chr20:33764554	C/T	cg04194272	chr20:33683537	NA	0.99	5.24	0.51	1.31e-6	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs701145	0.938	rs701131	chr3:154086138	C/G	cg17054900	chr3:154042577	DHX36	0.89	4.98	0.49	3.78e-6	Coronary artery disease;
SKCM	cis	rs8017423	0.967	rs11621364	chr14:90709115	A/G	cg04374321	chr14:90722782	PSMC1	0.97	8.87	0.71	1.91e-13	Mortality in heart failure;
SKCM	cis	rs11718455	0.960	rs3843372	chr3:43997666	C/T	cg21419209	chr3:44054225	NA	-0.64	-5.28	-0.51	1.15e-6	Coronary artery disease;
SKCM	cis	rs2279817	0.863	rs28481933	chr1:18026277	A/G	cg17142039	chr1:18149651	ACTL8	0.6	5.1	0.5	2.32e-6	Neuroticism;
SKCM	cis	rs752010	0.838	rs11210505	chr1:42104731	G/C	cg06885757	chr1:42089581	HIVEP3	0.53	5.96	0.56	6.97e-8	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs55962025	0.883	rs363099	chr4:3162056	C/T	cg00764545	chr4:3318001	RGS12	-0.65	-5.47	-0.53	5.2e-7	Parental longevity (mother's age at death);
SKCM	cis	rs11249608	0.548	rs6867208	chr5:178455575	G/A	cg21905437	chr5:178450457	ZNF879	0.73	5.93	0.56	7.89e-8	Pubertal anthropometrics;
SKCM	cis	rs28595532	0.925	rs115651057	chr4:119486708	A/G	cg11846333	chr4:119757529	SEC24D	1.15	6.24	0.58	2.13e-8	Cannabis dependence symptom count;
SKCM	cis	rs7811142	1.000	rs60844404	chr7:100080474	A/T	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.24	7.92	0.67	1.36e-11	Platelet count;
SKCM	trans	rs10506458	1.000	rs12580997	chr12:63433420	G/A	cg03429785	chr15:59498649	MYO1E;LDHAL6B	-1.38	-7.54	-0.65	7.13e-11	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs34779708	0.966	rs17500582	chr10:35498788	T/A	cg03585969	chr10:35415529	CREM	0.78	6.28	0.58	1.75e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs11792861	0.591	rs2282206	chr9:111746267	A/G	cg14432460	chr9:111696404	IKBKAP;C9orf6	0.78	6.42	0.59	9.66e-9	Menarche (age at onset);
SKCM	cis	rs60871478	0.636	rs4721834	chr7:896142	C/T	cg05535760	chr7:792225	HEATR2	-1.3	-7.8	-0.66	2.27e-11	Cerebrospinal P-tau181p levels;
SKCM	cis	rs28595532	0.920	rs116047800	chr4:119773569	G/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs9818758	0.607	rs9880088	chr3:49178990	G/A	cg24110177	chr3:50126178	RBM5	0.87	4.86	0.48	6e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	trans	rs17685	0.753	rs1637045	chr7:75703895	T/C	cg19862616	chr7:65841803	NCRNA00174	0.92	9.14	0.72	5.79e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs10193935	1.000	rs13424523	chr2:42413562	T/G	cg27598129	chr2:42591480	NA	-0.91	-6.64	-0.6	3.8e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs951366	0.585	rs72750964	chr1:205675240	C/T	cg07167872	chr1:205819463	PM20D1	0.79	6.48	0.59	7.53e-9	Menarche (age at onset);
SKCM	cis	rs62064224	0.818	rs11080181	chr17:30701210	C/T	cg25809561	chr17:30822961	MYO1D	0.65	4.97	0.49	3.88e-6	Schizophrenia;
SKCM	cis	rs6834538	0.597	rs7676819	chr4:113552891	G/A	cg05166686	chr4:113558556	LARP7;C4orf21	0.63	5.2	0.51	1.56e-6	Free thyroxine concentration;
SKCM	cis	rs9297145	0.678	rs62473048	chr7:98775511	T/C	cg05967295	chr7:98741636	SMURF1	1.09	7.88	0.67	1.58e-11	Crohn's disease;Inflammatory bowel disease;Ulcerative colitis;
SKCM	cis	rs6866344	0.697	rs11743893	chr5:178125194	C/T	cg03877680	chr5:178157825	ZNF354A	0.81	5.38	0.52	7.49e-7	Neutrophil percentage of white cells;
SKCM	cis	rs11098499	0.866	rs12374352	chr4:120281977	C/T	cg09307838	chr4:120376055	NA	0.98	7.89	0.67	1.52e-11	Corneal astigmatism;
SKCM	cis	rs28386778	0.863	rs3826341	chr17:61819222	C/A	cg01411255	chr17:61851458	DDX42;CCDC47	0.78	5.03	0.49	3.06e-6	Prudent dietary pattern;
SKCM	cis	rs2204008	0.774	rs2387811	chr12:38369794	C/A	cg13010199	chr12:38710504	ALG10B	0.68	4.85	0.48	6.3e-6	Bladder cancer;
SKCM	cis	rs10905065	0.610	rs55913768	chr10:5749449	G/A	cg09234995	chr10:5726438	C10orf18	0.62	5.13	0.5	2.08e-6	Menopause (age at onset);
SKCM	cis	rs1568889	0.592	rs17652117	chr11:28483645	C/T	cg06544937	chr11:28130018	METT5D1;KIF18A	-0.91	-5.68	-0.54	2.22e-7	Bipolar disorder;
SKCM	cis	rs6754311	0.510	rs1374329	chr2:136421323	A/G	cg07169764	chr2:136633963	MCM6	0.73	5.32	0.52	9.78e-7	Mosquito bite size;
SKCM	cis	rs28386778	0.897	rs2028567	chr17:61915326	G/A	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs7772486	0.806	rs7740785	chr6:146171299	C/A	cg23711669	chr6:146136114	FBXO30	0.81	8.76	0.7	3.2e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1862618	0.573	rs1550821	chr5:56242323	C/T	cg12311346	chr5:56204834	C5orf35	0.74	5.36	0.52	8.18e-7	Initial pursuit acceleration;
SKCM	cis	rs2836974	0.932	rs2150415	chr21:40615367	A/G	cg17971929	chr21:40555470	PSMG1	0.99	9.94	0.75	1.61e-15	Cognitive function;
SKCM	cis	rs7666738	0.753	rs11097594	chr4:98944486	A/G	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs17376456	0.877	rs28633397	chr5:93447048	A/G	cg25358565	chr5:93447407	FAM172A	1.23	7.97	0.67	1.08e-11	Diabetic retinopathy;
SKCM	cis	rs8180040	0.726	rs10461018	chr3:46995242	C/T	cg27129171	chr3:47204927	SETD2	-0.8	-6.14	-0.57	3.2e-8	Colorectal cancer;
SKCM	cis	rs12142240	0.638	rs6662982	chr1:46877180	G/A	cg10495392	chr1:46806563	NSUN4	0.77	5.82	0.55	1.26e-7	Menopause (age at onset);
SKCM	cis	rs55794721	0.509	rs2982358	chr1:25745204	G/T	cg27572855	chr1:25598939	RHD	0.53	5.11	0.5	2.22e-6	Plateletcrit;Mean corpuscular volume;
SKCM	cis	rs11098499	0.821	rs28665282	chr4:120384186	C/T	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs7589728	0.748	rs35051888	chr2:88482258	G/A	cg04511125	chr2:88470314	THNSL2	1.05	5.71	0.54	1.92e-7	Plasma clusterin levels;
SKCM	cis	rs11249608	0.789	rs6868425	chr5:178446708	A/G	cg21905437	chr5:178450457	ZNF879	0.75	5.79	0.55	1.4e-7	Pubertal anthropometrics;
SKCM	cis	rs10540	1.000	rs61876326	chr11:467368	A/G	cg03352830	chr11:487213	PTDSS2	0.96	4.77	0.48	8.46e-6	Body mass index;
SKCM	cis	rs1707322	1.000	rs11211204	chr1:46317864	A/G	cg03146154	chr1:46216737	IPP	0.75	5.15	0.5	1.94e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs752010	0.905	rs10890150	chr1:42095603	A/C	cg06885757	chr1:42089581	HIVEP3	0.6	5.88	0.55	9.65e-8	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs58688157	0.660	rs7117022	chr11:583787	T/C	cg17114584	chr11:613792	IRF7	0.87	5.81	0.55	1.32e-7	Systemic lupus erythematosus;
SKCM	cis	rs10193935	0.901	rs55978605	chr2:42573402	C/A	cg27598129	chr2:42591480	NA	-0.88	-6.71	-0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs3784262	0.692	rs1822205	chr15:58284657	C/A	cg12031962	chr15:58353849	ALDH1A2	-0.42	-4.89	-0.48	5.38e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs7811142	0.943	rs11769886	chr7:99998607	G/A	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-1.0	-5.66	-0.54	2.36e-7	Platelet count;
SKCM	cis	rs523522	0.962	rs4767914	chr12:120993817	C/T	cg12219531	chr12:120966889	COQ5	0.91	7.82	0.66	2.11e-11	High light scatter reticulocyte count;
SKCM	cis	rs7613875	0.600	rs2624832	chr3:50030858	C/T	cg24110177	chr3:50126178	RBM5	-0.7	-5.58	-0.53	3.34e-7	Body mass index;
SKCM	cis	rs7215564	0.908	rs34084509	chr17:78696577	C/A	cg16980736	chr17:78789706	RPTOR	-0.87	-4.81	-0.48	7.12e-6	Myopia (pathological);
SKCM	cis	rs16854884	0.632	rs10513234	chr3:143670957	A/G	cg06585982	chr3:143692056	C3orf58	-0.78	-6.86	-0.61	1.48e-9	Economic and political preferences (feminism/equality);
SKCM	cis	rs9611565	0.729	rs137831	chr22:41903813	A/C	cg03806693	chr22:41940476	POLR3H	-0.81	-5.21	-0.51	1.48e-6	Vitiligo;
SKCM	cis	rs9911578	1.000	rs4793952	chr17:56608465	C/T	cg05425664	chr17:57184151	TRIM37	0.67	5.04	0.5	2.91e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs875971	0.862	rs2088653	chr7:65808608	G/A	cg11764359	chr7:65958608	NA	-0.74	-6.75	-0.61	2.36e-9	Aortic root size;
SKCM	cis	rs910316	0.737	rs108621	chr14:75480637	T/C	cg08847533	chr14:75593920	NEK9	-0.81	-6.52	-0.59	6.23e-9	Height;
SKCM	cis	rs875971	0.638	rs7793569	chr7:66116633	T/G	cg11764359	chr7:65958608	NA	-0.84	-6.37	-0.59	1.2e-8	Aortic root size;
SKCM	cis	rs6120849	0.950	rs6088732	chr20:33744134	A/G	cg24642439	chr20:33292090	TP53INP2	-0.93	-5.18	-0.51	1.7e-6	Protein C levels;
SKCM	cis	rs694739	0.541	rs61886926	chr11:64133552	C/T	cg02228329	chr11:64053129	BAD;GPR137	0.86	6.0	0.56	5.79e-8	Alopecia areata;Crohn's disease;Psoriasis vulgaris;
SKCM	cis	rs8014204	0.748	rs12889277	chr14:75229376	A/T	cg06637938	chr14:75390232	RPS6KL1	0.79	6.03	0.56	5.07e-8	Caffeine consumption;
SKCM	cis	rs7811142	1.000	rs1073	chr7:100031612	G/A	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-0.99	-5.52	-0.53	4.2e-7	Platelet count;
SKCM	cis	rs875971	0.522	rs1917563	chr7:65415647	C/T	cg11987759	chr7:65425863	GUSB	0.74	6.56	0.6	5.45e-9	Aortic root size;
SKCM	cis	rs933688	0.938	rs6869048	chr5:90664322	G/C	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.12	8.55	0.7	7.9e-13	Smoking behavior;
SKCM	cis	rs8180040	0.932	rs62246474	chr3:47398130	C/T	cg27129171	chr3:47204927	SETD2	-0.87	-6.62	-0.6	4.15e-9	Colorectal cancer;
SKCM	cis	rs9788682	0.948	rs59683676	chr15:78833453	T/C	cg24631222	chr15:78858424	CHRNA5	0.96	6.69	0.6	3.03e-9	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs7659604	1.000	rs28640980	chr4:122664284	T/C	cg19748678	chr4:122722346	EXOSC9	0.68	5.59	0.53	3.23e-7	Type 2 diabetes;
SKCM	cis	rs17685	0.712	rs11764119	chr7:75812358	T/G	cg16489192	chr7:75678113	MDH2;STYXL1	-0.54	-5.21	-0.51	1.48e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs752010	0.574	rs12130138	chr1:42117792	A/C	cg06885757	chr1:42089581	HIVEP3	0.49	5.24	0.51	1.35e-6	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs3820068	0.559	rs6675334	chr1:15923580	A/T	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs826838	0.967	rs1719853	chr12:39128515	A/G	cg26384229	chr12:38710491	ALG10B	-0.92	-8.32	-0.69	2.26e-12	Heart rate;
SKCM	cis	rs1577917	1.000	rs2816821	chr6:86657084	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.61	-5.31	-0.52	1.02e-6	Response to antipsychotic treatment;
SKCM	cis	rs12586317	0.547	rs114371385	chr14:35503724	G/A	cg16230307	chr14:35515116	FAM177A1	0.83	6.08	0.57	4.19e-8	Psoriasis;
SKCM	cis	rs1403694	0.695	rs13095338	chr3:186435583	T/C	cg09332604	chr3:186435400	KNG1	-0.5	-5.07	-0.5	2.57e-6	Blood protein levels;
SKCM	cis	rs2727020	0.688	rs11040338	chr11:49360601	A/G	cg21546286	chr11:48923668	NA	0.53	4.84	0.48	6.33e-6	Coronary artery disease;
SKCM	cis	rs6866344	0.570	rs1132336	chr5:178140090	C/T	cg10224037	chr5:178157518	ZNF354A	0.83	6.14	0.57	3.17e-8	Neutrophil percentage of white cells;
SKCM	cis	rs28374715	0.532	rs11854820	chr15:41676526	G/A	cg18705301	chr15:41695430	NDUFAF1	-1.21	-13.94	-0.84	7.01e-23	Ulcerative colitis;
SKCM	cis	rs9858542	0.953	rs9853683	chr3:49512588	A/G	cg03060546	chr3:49711283	APEH	-0.75	-5.53	-0.53	4.17e-7	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs2811415	0.597	rs67786346	chr3:127794654	C/G	cg09089421	chr3:127803668	RUVBL1	1.0	8.6	0.7	6.45e-13	Lung function (FEV1/FVC);
SKCM	cis	rs2180341	1.000	rs3798853	chr6:127636823	C/T	cg24812749	chr6:127587940	RNF146	-0.9	-6.94	-0.62	1.02e-9	Breast cancer;
SKCM	cis	rs4819052	0.851	rs2838834	chr21:46665208	C/T	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.42	0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs17685	0.753	rs3757593	chr7:75678735	G/A	cg16489192	chr7:75678113	MDH2;STYXL1	0.58	5.44	0.52	5.83e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs6088590	0.561	rs6087605	chr20:33180624	G/T	cg24642439	chr20:33292090	TP53INP2	0.76	5.84	0.55	1.13e-7	Coronary artery disease;
SKCM	cis	rs2243480	1.000	rs4718316	chr7:65648731	A/G	cg18252515	chr7:66147081	NA	1.36	8.16	0.68	4.6e-12	Diabetic kidney disease;
SKCM	cis	rs362296	0.661	rs3095079	chr4:3265414	A/G	cg05297308	chr4:3317976	RGS12	0.72	6.02	0.56	5.48e-8	Parental longevity (mother's age at death);
SKCM	cis	rs7954584	0.813	rs11043288	chr12:122451187	C/T	cg13699009	chr12:122356056	WDR66	-0.56	-6.91	-0.62	1.18e-9	Mean corpuscular volume;
SKCM	trans	rs3780486	0.846	rs6476399	chr9:33123013	A/G	cg04842962	chr6:43655489	MRPS18A	1.02	10.79	0.77	3.86e-17	IgG glycosylation;
SKCM	cis	rs16854884	1.000	rs17668478	chr3:143794370	G/A	cg06585982	chr3:143692056	C3orf58	0.74	5.69	0.54	2.17e-7	Economic and political preferences (feminism/equality);
SKCM	cis	rs9815354	0.761	rs73083329	chr3:41927151	C/T	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs7811142	1.000	rs11763511	chr7:100081944	G/A	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.25	0.68	3.05e-12	Platelet count;
SKCM	cis	rs6570726	0.905	rs375692	chr6:145840368	A/G	cg23711669	chr6:146136114	FBXO30	0.71	6.9	0.62	1.21e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs10193935	0.792	rs2053349	chr2:42516205	G/A	cg27598129	chr2:42591480	NA	-0.95	-6.75	-0.61	2.38e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs875971	0.964	rs6945032	chr7:65922486	C/T	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	cis	rs9815354	0.812	rs73073355	chr3:41842332	G/A	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs1577917	0.958	rs12197463	chr6:86445242	T/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.79	-7.75	-0.66	2.89e-11	Response to antipsychotic treatment;
SKCM	cis	rs72781680	1.000	rs56068891	chr2:24230633	A/G	cg08917208	chr2:24149416	ATAD2B	1.07	5.99	0.56	6.1e-8	Lymphocyte counts;
SKCM	cis	rs2479724	0.901	rs33954419	chr6:41786136	A/G	cg17623882	chr6:41773611	USP49	-0.78	-6.76	-0.61	2.27e-9	Menarche (age at onset);
SKCM	cis	rs7618501	0.633	rs11925192	chr3:50038664	G/A	cg05072774	chr3:49840536	C3orf54	-0.67	-5.06	-0.5	2.73e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs798502	0.541	rs2644307	chr7:2832973	G/A	cg09658497	chr7:2847517	GNA12	-0.42	-5.41	-0.52	6.68e-7	Waist circumference adjusted for BMI (adjusted for smoking behaviour);Inflammatory bowel disease;Waist circumference adjusted for BMI in non-smokers;Ulcerative colitis;Waist circumference adjusted for body mass index;Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction);
SKCM	cis	rs2404602	0.735	rs12906143	chr15:76709523	T/A	cg23625390	chr15:77176239	SCAPER	-0.83	-8.06	-0.67	7.18e-12	Blood metabolite levels;
SKCM	cis	rs10504229	0.683	rs6995355	chr8:58113870	C/T	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs62238980	0.614	rs76853252	chr22:32455857	T/C	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs9303401	0.659	rs7224276	chr17:56897827	C/T	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.16	0.57	2.91e-8	Cognitive test performance;
SKCM	cis	rs1580019	0.961	rs1580022	chr7:32497712	C/A	cg06627557	chr7:32535165	LSM5;AVL9	0.75	5.74	0.55	1.7e-7	Cognitive ability;
SKCM	cis	rs1023500	0.551	rs133355	chr22:42440285	G/A	cg04733989	chr22:42467013	NAGA	0.77	6.09	0.57	3.97e-8	Schizophrenia;
SKCM	cis	rs7635838	0.617	rs346076	chr3:11292682	A/G	cg00170343	chr3:11313890	ATG7	-0.82	-6.43	-0.59	9.23e-9	HDL cholesterol;
SKCM	cis	rs7726839	0.578	rs10080150	chr5:593160	C/T	cg09021430	chr5:549028	NA	0.65	5.49	0.53	4.87e-7	Obesity-related traits;
SKCM	cis	rs7143963	0.636	rs28372031	chr14:103335242	T/C	cg23020514	chr14:103360112	TRAF3	0.72	6.73	0.61	2.52e-9	Body mass index;
SKCM	cis	rs7824557	0.527	rs4634600	chr8:11239017	T/A	cg21775007	chr8:11205619	TDH	-0.57	-4.8	-0.48	7.38e-6	Retinal vascular caliber;
SKCM	cis	rs8060686	0.641	rs76419201	chr16:68153553	G/A	cg09117114	chr16:67998030	SLC12A4	-0.81	-5.29	-0.51	1.07e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs2243480	0.831	rs57294491	chr7:65684901	T/A	cg18252515	chr7:66147081	NA	1.37	8.17	0.68	4.35e-12	Diabetic kidney disease;
SKCM	cis	rs7296418	0.922	rs1790134	chr12:123697898	T/C	cg05973401	chr12:123451056	ABCB9	0.75	5.64	0.54	2.61e-7	Platelet count;
SKCM	cis	rs1707322	0.963	rs34907901	chr1:46405214	T/G	cg03146154	chr1:46216737	IPP	0.73	5.42	0.52	6.55e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs1005277	0.541	rs2263163	chr10:38389887	G/A	cg00409905	chr10:38381863	ZNF37A	-0.64	-5.96	-0.56	6.77e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs6547631	0.622	rs34943381	chr2:85923997	A/G	cg24620635	chr2:85921963	GNLY	0.9	6.65	0.6	3.58e-9	Blood protein levels;
SKCM	cis	rs933688	1.000	rs6869717	chr5:90694797	G/A	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.02	7.81	0.66	2.22e-11	Smoking behavior;
SKCM	cis	rs7091068	0.532	rs1018634	chr10:95401292	G/A	cg20715218	chr10:95462985	C10orf4	-0.83	-7.06	-0.62	5.97e-10	Urinary tract infection frequency;
SKCM	cis	rs7213347	0.780	rs216224	chr17:2156285	T/C	cg18413116	chr17:2293477	MNT	0.65	4.85	0.48	6.19e-6	Total body bone mineral density;
SKCM	cis	rs793571	0.523	rs7161889	chr15:58983425	C/G	cg05156742	chr15:59063176	FAM63B	0.69	5.08	0.5	2.5e-6	Schizophrenia;
SKCM	cis	rs9943753	0.525	rs6606708	chr12:109833146	T/C	cg19025524	chr12:109796872	NA	-0.63	-5.92	-0.56	8.31e-8	HDL cholesterol;
SKCM	cis	rs3785574	0.886	rs62077504	chr17:61837734	A/G	cg06601766	chr17:61851465	DDX42;CCDC47	0.64	4.77	0.48	8.35e-6	Height;
SKCM	cis	rs1707322	1.000	rs10890382	chr1:46469674	A/G	cg03146154	chr1:46216737	IPP	0.77	5.14	0.5	2.01e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7208859	0.623	rs1054397	chr17:29110196	T/C	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs6449957	0.832	rs11742365	chr5:67470244	C/G	cg09038926	chr5:67483109	NA	-0.67	-5.26	-0.51	1.23e-6	Cleft lip with or without cleft palate;
SKCM	cis	rs4746818	1.000	rs9299502	chr10:70876934	C/T	cg11621586	chr10:70884670	VPS26A	1.12	8.51	0.69	9.48e-13	Left atrial antero-posterior diameter;
SKCM	cis	rs654950	0.875	rs2759248	chr1:41990795	T/C	cg06885757	chr1:42089581	HIVEP3	-0.64	-7.14	-0.63	4.34e-10	Airway imaging phenotypes;
SKCM	cis	rs7811142	1.000	rs60257855	chr7:100026780	G/C	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.34	0.69	2.1e-12	Platelet count;
SKCM	cis	rs11122272	0.735	rs2790873	chr1:231539685	A/G	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	-0.64	-5.18	-0.51	1.66e-6	Hemoglobin concentration;
SKCM	cis	rs2836974	0.829	rs34227163	chr21:40551943	A/G	cg11890956	chr21:40555474	PSMG1	1.07	13.19	0.83	1.48e-21	Cognitive function;
SKCM	cis	rs6088580	0.634	rs6087588	chr20:33066369	T/C	cg24642439	chr20:33292090	TP53INP2	0.75	6.02	0.56	5.32e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs9486715	0.867	rs9372106	chr6:96875058	T/C	cg06623918	chr6:96969491	KIAA0776	0.8	6.99	0.62	8.13e-10	Headache;
SKCM	cis	rs66887589	0.934	rs7681980	chr4:120533223	G/A	cg09307838	chr4:120376055	NA	-0.65	-4.82	-0.48	6.89e-6	Diastolic blood pressure;
SKCM	cis	rs2836974	0.568	rs11910906	chr21:40685662	T/C	cg17971929	chr21:40555470	PSMG1	-0.73	-6.88	-0.61	1.32e-9	Cognitive function;
SKCM	cis	rs2279817	0.863	rs1416854	chr1:18024675	G/A	cg17142039	chr1:18149651	ACTL8	0.58	4.88	0.48	5.6e-6	Neuroticism;
SKCM	cis	rs951366	0.617	rs823074	chr1:205774839	T/C	cg07167872	chr1:205819463	PM20D1	1.01	10.8	0.77	3.79e-17	Menarche (age at onset);
SKCM	cis	rs548181	0.736	rs540723	chr11:125489621	A/G	cg03464685	chr11:125439445	EI24	1.41	8.27	0.68	2.84e-12	Schizophrenia;Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);
SKCM	cis	rs709400	0.827	rs2274269	chr14:104029246	G/A	cg26031613	chr14:104095156	KLC1	1.06	11.49	0.79	1.88e-18	Body mass index;
SKCM	cis	rs28595532	0.764	rs115011450	chr4:119778171	C/T	cg14228332	chr4:119757509	SEC24D	1.06	5.32	0.52	9.61e-7	Cannabis dependence symptom count;
SKCM	cis	rs838147	0.733	rs12978499	chr19:49237552	A/C	cg13540341	chr19:49222985	MAMSTR	0.68	5.88	0.55	9.73e-8	Dietary macronutrient intake;
SKCM	cis	rs2836950	0.545	rs11700449	chr21:40522419	A/T	cg11644478	chr21:40555479	PSMG1	-0.69	-5.34	-0.52	8.94e-7	Menarche (age at onset);
SKCM	cis	rs13118159	0.550	rs2878607	chr4:1353310	G/C	cg19318889	chr4:1322082	MAEA	0.77	5.48	0.53	4.99e-7	Longevity;
SKCM	cis	rs10876993	0.890	rs774891	chr12:58068571	G/A	cg18357645	chr12:58087776	OS9	0.65	6.01	0.56	5.71e-8	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs2153535	0.580	rs718503	chr6:8527463	A/T	cg23788917	chr6:8435910	SLC35B3	0.68	4.98	0.49	3.66e-6	Motion sickness;
SKCM	cis	rs17065868	1.000	rs7322132	chr13:45074212	G/A	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs34779708	0.966	rs11010095	chr10:35395948	A/G	cg03585969	chr10:35415529	CREM	0.8	6.37	0.59	1.2e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs2073499	1.000	rs2236948	chr3:50409826	A/G	cg08207895	chr3:50388901	TUSC4;CYB561D2	0.7	5.15	0.5	1.9e-6	Schizophrenia;
SKCM	cis	rs10504229	0.906	rs58559296	chr8:58171714	T/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs7659604	0.728	rs6852923	chr4:122688324	G/A	cg19748678	chr4:122722346	EXOSC9	0.69	5.39	0.52	7.3e-7	Type 2 diabetes;
SKCM	cis	rs2832191	0.671	rs73346699	chr21:30515529	C/T	cg24692254	chr21:30365293	RNF160	-0.76	-6.41	-0.59	1.03e-8	Dental caries;
SKCM	cis	rs1577917	0.958	rs12192546	chr6:86476484	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.7	6.13	0.57	3.37e-8	Response to antipsychotic treatment;
SKCM	cis	rs66861122	0.843	rs35932576	chr12:101379702	A/C	cg14107382	chr12:101189608	ANO4	0.92	4.97	0.49	3.92e-6	Response to methotrexate in juvenile idiopathic arthritis;
SKCM	cis	rs769267	0.831	rs2872878	chr19:19480521	G/C	cg26732615	chr19:19648335	CILP2;YJEFN3	-0.69	-7.06	-0.62	6.14e-10	Tonsillectomy;
SKCM	cis	rs10503709	0.829	rs10095809	chr8:21448080	C/G	cg23716449	chr8:21608280	GFRA2	0.49	4.81	0.48	7.13e-6	Blood protein levels;
SKCM	cis	rs11112613	0.713	rs12316204	chr12:105944244	G/A	cg03607813	chr12:105948248	NA	0.87	5.83	0.55	1.21e-7	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;
SKCM	cis	rs9926296	0.744	rs154657	chr16:89708096	A/G	cg08949735	chr16:89699720	DPEP1	0.49	4.81	0.48	7.28e-6	Vitiligo;
SKCM	cis	rs1506636	0.962	rs1472808	chr7:123354536	A/G	cg03229431	chr7:123269106	ASB15	-0.6	-4.83	-0.48	6.69e-6	Plateletcrit;Platelet count;
SKCM	cis	rs12142240	0.698	rs56284503	chr1:46847127	C/G	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs595982	0.546	rs10401443	chr19:49402059	C/A	cg19746536	chr19:49375674	PPP1R15A	1.13	8.49	0.69	1.06e-12	Red cell distribution width;
SKCM	cis	rs7937682	0.883	rs1784775	chr11:111472460	T/C	cg09085632	chr11:111637200	PPP2R1B	-1.02	-10.03	-0.75	1.11e-15	Primary sclerosing cholangitis;
SKCM	cis	rs11945232	0.624	rs9654160	chr4:88377324	G/C	cg23841344	chr4:88312519	HSD17B11	-0.75	-5.0	-0.49	3.48e-6	Intelligence (multi-trait analysis);
SKCM	trans	rs17685	0.753	rs6951808	chr7:75772413	A/G	cg19862616	chr7:65841803	NCRNA00174	0.92	9.38	0.73	2.02e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs9902453	0.904	rs7219456	chr17:28374112	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.82	-6.4	-0.59	1.06e-8	Coffee consumption (cups per day);
SKCM	cis	rs10489202	1.000	rs66950781	chr1:168018779	C/A	cg24449463	chr1:168025552	DCAF6	-0.79	-6.16	-0.57	3.02e-8	Schizophrenia;
SKCM	cis	rs17826219	0.706	rs2322197	chr17:29105805	T/C	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Body mass index;
SKCM	cis	rs8017423	0.967	rs8016385	chr14:90721946	G/A	cg04374321	chr14:90722782	PSMC1	1.03	9.44	0.73	1.55e-14	Mortality in heart failure;
SKCM	cis	rs910316	1.000	rs12897094	chr14:75579416	C/T	cg08847533	chr14:75593920	NEK9	0.95	9.18	0.72	4.8e-14	Height;
SKCM	cis	rs1707322	1.000	rs785470	chr1:46519622	C/A	cg03146154	chr1:46216737	IPP	-0.77	-5.36	-0.52	8.35e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs826838	0.967	rs7963716	chr12:38876090	C/T	cg26384229	chr12:38710491	ALG10B	1.04	9.4	0.73	1.79e-14	Heart rate;
SKCM	cis	rs9308433	0.529	rs17022608	chr1:214500907	A/C	cg06198575	chr1:214491504	SMYD2	0.81	5.09	0.5	2.41e-6	IgG glycosylation;
SKCM	cis	rs7296418	0.699	rs11057219	chr12:123750073	T/C	cg00376283	chr12:123451042	ABCB9	0.8	6.34	0.58	1.38e-8	Platelet count;
SKCM	cis	rs9902453	0.933	rs7224199	chr17:28523726	G/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.75	5.19	0.51	1.65e-6	Coffee consumption (cups per day);
SKCM	cis	rs8067545	0.640	rs17759083	chr17:19963605	T/A	cg13482628	chr17:19912719	NA	0.76	6.15	0.57	3.05e-8	Schizophrenia;
SKCM	cis	rs1023500	0.529	rs133375	chr22:42466509	C/G	cg04733989	chr22:42467013	NAGA	0.72	5.62	0.54	2.87e-7	Schizophrenia;
SKCM	cis	rs1577917	0.874	rs1838954	chr6:86565478	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.81	-7.82	-0.66	2.07e-11	Response to antipsychotic treatment;
SKCM	cis	rs7843479	1.000	rs13248727	chr8:21842063	T/C	cg17168535	chr8:21777572	XPO7	0.77	6.47	0.59	7.79e-9	Mean corpuscular volume;
SKCM	cis	rs854765	0.583	rs11650890	chr17:17790882	C/T	cg09796270	chr17:17721594	SREBF1	-0.66	-4.9	-0.49	5.07e-6	Total body bone mineral density;
SKCM	cis	rs2739330	0.828	rs2154593	chr22:24252085	A/G	cg24846343	chr22:24311635	DDTL	0.63	6.04	0.56	4.9e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs58688157	0.705	rs7112149	chr11:595890	G/A	cg17114584	chr11:613792	IRF7	0.77	5.35	0.52	8.67e-7	Systemic lupus erythematosus;
SKCM	cis	rs2963155	0.518	rs865482	chr5:142640317	C/A	cg17617527	chr5:142782415	NR3C1	1.13	5.41	0.52	6.65e-7	Breast cancer;
SKCM	cis	rs2070488	0.965	rs6599209	chr3:38558197	A/G	cg01465620	chr3:38496096	LOC100128640;ACVR2B	-0.99	-8.6	-0.7	6.51e-13	Electrocardiographic conduction measures;
SKCM	cis	rs28595532	0.920	rs56162974	chr4:119742333	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs1568889	0.775	rs35243076	chr11:28250618	G/A	cg06544937	chr11:28130018	METT5D1;KIF18A	0.87	8.02	0.67	8.66e-12	Bipolar disorder;
SKCM	cis	rs10752881	0.967	rs4652758	chr1:182975100	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.74	6.71	0.6	2.83e-9	Colorectal cancer;
SKCM	cis	rs1850744	0.536	rs10014408	chr4:9695145	T/C	cg15442990	chr4:9534313	NA	1.19	5.18	0.51	1.68e-6	Economic and political preferences;
SKCM	cis	rs8141529	0.778	rs5762795	chr22:29182500	C/A	cg02153584	chr22:29168773	CCDC117	0.68	5.57	0.53	3.52e-7	Lymphocyte counts;
SKCM	cis	rs769267	0.899	rs67720221	chr19:19440864	C/T	cg26732615	chr19:19648335	CILP2;YJEFN3	-0.66	-6.14	-0.57	3.23e-8	Tonsillectomy;
SKCM	cis	rs514406	0.505	rs431427	chr1:53179094	C/A	cg16325326	chr1:53192061	ZYG11B	0.89	10.06	0.75	9.55e-16	Monocyte count;
SKCM	cis	rs2243480	1.000	rs4718334	chr7:65789454	G/A	cg18252515	chr7:66147081	NA	1.34	8.18	0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs13010713	0.840	rs4667127	chr2:182059823	A/C	cg21995919	chr2:182322279	ITGA4	-0.53	-5.12	-0.5	2.18e-6	Celiac disease;
SKCM	cis	rs9443189	0.570	rs7765254	chr6:76398143	T/C	cg01950844	chr6:76311363	SENP6	0.97	6.63	0.6	4.02e-9	Prostate cancer;
SKCM	cis	rs7215564	0.908	rs35821645	chr17:78652479	G/A	cg16980736	chr17:78789706	RPTOR	-0.91	-4.92	-0.49	4.67e-6	Myopia (pathological);
SKCM	cis	rs8072100	0.875	rs9635762	chr17:45648446	A/C	cg25173405	chr17:45401733	C17orf57	0.56	5.06	0.5	2.76e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs2836950	0.545	rs4818001	chr21:40575088	T/C	cg11890956	chr21:40555474	PSMG1	-0.65	-5.09	-0.5	2.44e-6	Menarche (age at onset);
SKCM	cis	rs870825	0.698	rs7673203	chr4:185625397	T/C	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs5753618	0.583	rs7285619	chr22:31842554	C/T	cg02404636	chr22:31891804	SFI1	0.61	5.21	0.51	1.52e-6	Colorectal cancer;
SKCM	cis	rs9393692	0.645	rs28446029	chr6:26305801	C/G	cg00631329	chr6:26305371	NA	-0.7	-4.84	-0.48	6.33e-6	Educational attainment;
SKCM	cis	rs2857078	0.772	rs2079008	chr17:42322132	C/A	cg10896456	chr17:42255109	ASB16;C17orf65	-0.65	-5.62	-0.54	2.84e-7	Red cell distribution width;Reticulocyte count;
SKCM	cis	rs703842	1.000	rs4646536	chr12:58157988	A/G	cg04478727	chr12:58166393	METTL1;FAM119B	0.71	5.73	0.54	1.82e-7	Multiple sclerosis;
SKCM	cis	rs34426467	1	rs34426467	chr2:242634122	T/A	cg11463903	chr2:242641003	ING5	0.95	7.21	0.63	3.07e-10	Platelet distribution width;
SKCM	cis	rs7826238	0.509	rs2948288	chr8:8115304	A/G	cg08975724	chr8:8085496	FLJ10661	0.8	6.41	0.59	1.04e-8	Systolic blood pressure;
SKCM	cis	rs10254118	0.757	rs6467491	chr7:133138761	A/G	cg10665199	chr7:133106180	EXOC4	0.78	5.16	0.5	1.81e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1577917	0.545	rs9344548	chr6:86487337	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.7	6.23	0.58	2.17e-8	Response to antipsychotic treatment;
SKCM	cis	rs3091242	0.967	rs3093614	chr1:25677844	T/A	cg27572855	chr1:25598939	RHD	-0.54	-5.27	-0.51	1.16e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs992157	0.835	rs13031757	chr2:219151926	T/C	cg20019365	chr2:219134978	PNKD;AAMP	-0.71	-6.08	-0.57	4.22e-8	Colorectal cancer;
SKCM	cis	rs9420	0.961	rs12146541	chr11:57508678	G/C	cg19752551	chr11:57585705	CTNND1	-0.71	-7.21	-0.63	3.15e-10	Schizophrenia;
SKCM	cis	rs2304069	0.954	rs2340462	chr5:149415219	G/A	cg22760475	chr5:149380129	HMGXB3;TIGD6	0.9	6.15	0.57	3.11e-8	HIV-1 control;
SKCM	cis	rs55962025	0.723	rs2269478	chr4:3234828	G/T	cg09735869	chr4:3319127	RGS12	-0.68	-5.64	-0.54	2.58e-7	Parental longevity (mother's age at death);
SKCM	cis	rs7666738	0.830	rs11944855	chr4:99068258	G/A	cg05340658	chr4:99064831	C4orf37	0.66	4.87	0.48	5.74e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs72781680	1.000	rs72781631	chr2:24195064	G/A	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	cis	rs9399135	0.507	rs2072825	chr6:135253451	A/G	cg24558204	chr6:135376177	HBS1L	-0.59	-5.27	-0.51	1.17e-6	Red blood cell count;
SKCM	cis	rs34779708	0.966	rs878264	chr10:35440581	T/C	cg03585969	chr10:35415529	CREM	0.73	6.02	0.56	5.28e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs12709013	0.729	rs34324769	chr16:58812035	T/C	cg02431531	chr16:59244939	NA	0.48	5.0	0.49	3.5e-6	Blood metabolite ratios;
SKCM	cis	rs651907	0.514	rs12636046	chr3:101434448	T/G	cg12386194	chr3:101231763	SENP7	0.69	5.68	0.54	2.23e-7	Colorectal cancer;
SKCM	cis	rs257016	0.634	rs7717565	chr5:123183833	A/C	cg22589697	chr5:123975123	ZNF608	0.55	5.17	0.51	1.76e-6	Psychosis in Alzheimer's disease;
SKCM	cis	rs763121	0.853	rs6519120	chr22:38991393	A/C	cg06022373	chr22:39101656	GTPBP1	-0.75	-5.5	-0.53	4.63e-7	Menopause (age at onset);
SKCM	cis	rs870825	0.929	rs72689261	chr4:185590897	C/A	cg04058563	chr4:185651563	MLF1IP	1.09	5.66	0.54	2.4e-7	Blood protein levels;
SKCM	cis	rs748404	0.723	rs560134	chr15:43555699	A/T	cg02155558	chr15:43621948	ADAL;LCMT2	0.7	5.77	0.55	1.53e-7	Lung cancer;
SKCM	cis	rs7772486	0.846	rs2892453	chr6:146377717	C/A	cg05347473	chr6:146136440	FBXO30	0.63	5.7	0.54	2.05e-7	Lobe attachment (rater-scored or self-reported);
SKCM	trans	rs1814175	0.904	rs7924371	chr11:49620595	C/T	cg03929089	chr4:120376271	NA	-0.87	-7.53	-0.65	7.64e-11	Height;
SKCM	cis	rs1348850	0.831	rs7606235	chr2:178401288	T/C	cg02961200	chr2:178257176	LOC100130691;AGPS	0.78	5.81	0.55	1.28e-7	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs12682352	0.652	rs3827806	chr8:8724276	C/T	cg06636001	chr8:8085503	FLJ10661	0.69	5.43	0.52	6.17e-7	Neuroticism;
SKCM	cis	rs9581857	0.725	rs9319366	chr13:28017722	C/T	cg22138327	chr13:27999177	GTF3A	0.93	6.24	0.58	2.1e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs748404	0.697	rs524547	chr15:43551023	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	0.69	5.79	0.55	1.41e-7	Lung cancer;
SKCM	cis	rs61776719	0.875	rs28435150	chr1:38407014	C/T	cg12658694	chr1:38397304	INPP5B	0.71	6.3	0.58	1.6e-8	Coronary artery disease;
SKCM	cis	rs7666738	0.830	rs28622458	chr4:98916651	A/G	cg05340658	chr4:99064831	C4orf37	0.6	4.83	0.48	6.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs13010713	0.840	rs10189776	chr2:182030229	C/T	cg21995919	chr2:182322279	ITGA4	-0.56	-5.39	-0.52	7.39e-7	Celiac disease;
SKCM	cis	rs734999	0.870	rs3748825	chr1:2483270	T/C	cg12593511	chr1:3276753	PRDM16	0.4	4.91	0.49	4.96e-6	Ulcerative colitis;
SKCM	cis	rs28386778	0.863	rs6919	chr17:61909485	A/T	cg23090583	chr17:61904693	PSMC5;FTSJ3	-1.12	-11.2	-0.79	6.65e-18	Prudent dietary pattern;
SKCM	cis	rs57221529	0.713	rs12522724	chr5:590742	T/C	cg10555297	chr5:473380	SLC9A3;LOC25845	1.01	5.03	0.49	3.1e-6	Lung disease severity in cystic fibrosis;
SKCM	trans	rs208520	0.526	rs7775830	chr6:66755249	A/G	cg15611600	chr13:45563400	KIAA1704;NUFIP1	1.01	10.9	0.78	2.39e-17	Exhaled nitric oxide output;
SKCM	cis	rs28595532	0.764	rs56309519	chr4:119754158	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs6088590	1.000	rs6119535	chr20:33442138	A/C	cg24642439	chr20:33292090	TP53INP2	1.0	7.11	0.63	4.79e-10	Coronary artery disease;
SKCM	cis	rs9660180	1.000	rs9660180	chr1:1723031	G/A	cg13866156	chr1:1669148	SLC35E2	-0.72	-6.13	-0.57	3.32e-8	Body mass index;
SKCM	cis	rs17711722	0.740	rs7809991	chr7:65406218	A/G	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.6	5.14	0.5	2.02e-6	Calcium levels;
SKCM	cis	rs910316	0.726	rs61979167	chr14:75663610	C/T	cg08847533	chr14:75593920	NEK9	-0.86	-7.26	-0.63	2.55e-10	Height;
SKCM	cis	rs8060686	0.641	rs76419201	chr16:68153553	G/A	cg04539111	chr16:67997858	SLC12A4	-0.85	-4.81	-0.48	7.14e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs8180040	0.800	rs11921117	chr3:47294000	T/C	cg27129171	chr3:47204927	SETD2	-0.79	-5.38	-0.52	7.6e-7	Colorectal cancer;
SKCM	cis	rs12986445	0.744	rs10209951	chr2:26144986	C/G	cg04917511	chr2:26785460	C2orf70	0.5	4.87	0.48	5.74e-6	Multiple myeloma and monoclonal gammopathy;Multiple myeloma;
SKCM	cis	rs6088590	1.000	rs10048849	chr20:33419680	C/T	cg24642439	chr20:33292090	TP53INP2	1.01	7.31	0.64	1.99e-10	Coronary artery disease;
SKCM	cis	rs919433	0.927	rs13032495	chr2:198189346	C/T	cg04278110	chr2:198063759	ANKRD44	-0.71	-4.94	-0.49	4.44e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs2836974	0.897	rs2026265	chr21:40595517	G/A	cg11644478	chr21:40555479	PSMG1	0.97	10.08	0.75	8.76e-16	Cognitive function;
SKCM	cis	rs3785574	0.650	rs3815358	chr17:62010270	A/G	cg11494091	chr17:61959527	GH2	-0.57	-5.47	-0.53	5.25e-7	Height;
SKCM	cis	rs7192750	0.617	rs9929256	chr16:72040032	A/C	cg14768367	chr16:72042858	DHODH	1.04	4.99	0.49	3.6e-6	LDL cholesterol levels;Total cholesterol levels;
SKCM	cis	rs9916302	0.706	rs7503081	chr17:37482673	A/G	cg07936489	chr17:37558343	FBXL20	1.0	7.19	0.63	3.42e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs1062177	1.000	rs12653926	chr5:151250248	C/A	cg00977110	chr5:151150581	G3BP1	0.85	6.44	0.59	9.14e-9	Preschool internalizing problems;
SKCM	trans	rs3780486	0.846	rs7864705	chr9:33140352	A/C	cg04842962	chr6:43655489	MRPS18A	1.03	11.19	0.78	6.84e-18	IgG glycosylation;
SKCM	cis	rs9467773	0.620	rs2451732	chr6:26622904	A/T	cg15659132	chr6:26577336	NA	-0.61	-5.5	-0.53	4.71e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs28386778	1.000	rs2665810	chr17:61970210	C/G	cg11494091	chr17:61959527	GH2	0.58	4.83	0.48	6.58e-6	Prudent dietary pattern;
SKCM	cis	rs4774899	0.966	rs4774910	chr15:57410217	T/C	cg01857019	chr15:57210107	LOC145783;TCF12	0.53	4.92	0.49	4.69e-6	Urinary tract infection frequency;
SKCM	cis	rs1577917	0.771	rs2842602	chr6:86331887	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.83	-7.76	-0.66	2.77e-11	Response to antipsychotic treatment;
SKCM	cis	rs9894429	0.646	rs8080391	chr17:79566319	A/T	cg18240062	chr17:79603768	NPLOC4	-0.91	-10.36	-0.76	2.55e-16	Eye color traits;
SKCM	cis	rs2153535	0.580	rs6912374	chr6:8456423	T/C	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs6951245	0.748	rs79658522	chr7:1095877	A/G	cg18402987	chr7:1209562	NA	1.15	6.09	0.57	3.95e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs3091242	0.933	rs35148262	chr1:25766623	A/G	cg27572855	chr1:25598939	RHD	0.53	5.06	0.5	2.67e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs9788682	1.000	rs12438181	chr15:78812098	G/A	cg24631222	chr15:78858424	CHRNA5	0.93	6.3	0.58	1.66e-8	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs6570726	0.791	rs9373466	chr6:145912016	T/C	cg23711669	chr6:146136114	FBXO30	0.88	8.37	0.69	1.84e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2204008	0.837	rs7974888	chr12:37945215	A/G	cg26384229	chr12:38710491	ALG10B	0.8	7.0	0.62	8.01e-10	Bladder cancer;
SKCM	cis	rs12142240	0.698	rs1475390	chr1:46816340	A/G	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs9393692	0.557	rs56763414	chr6:26286468	T/C	cg00631329	chr6:26305371	NA	-0.66	-5.16	-0.5	1.85e-6	Educational attainment;
SKCM	cis	rs28595532	0.623	rs34284204	chr4:119227672	C/T	cg14228332	chr4:119757509	SEC24D	0.99	5.58	0.53	3.31e-7	Cannabis dependence symptom count;
SKCM	cis	rs6001027	0.589	rs5756931	chr22:38546033	T/C	cg25457927	chr22:38595422	NA	-0.6	-6.6	-0.6	4.44e-9	Melanoma;
SKCM	cis	rs910316	1.000	rs4903275	chr14:75512509	C/T	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.89e-7	Height;
SKCM	cis	rs796364	1.000	rs281760	chr2:200787804	A/G	cg12253985	chr2:200820533	C2orf60;C2orf47	0.85	5.39	0.52	7.18e-7	Schizophrenia;
SKCM	cis	rs11252926	0.673	rs10795161	chr10:497748	G/T	cg18196295	chr10:418757	DIP2C	0.61	4.96	0.49	3.99e-6	Psychosis in Alzheimer's disease;
SKCM	cis	rs10769945	0.834	rs217207	chr11:1974831	G/A	cg23202291	chr11:1979235	NA	-0.59	-6.27	-0.58	1.89e-8	DNA methylation (variation);
SKCM	cis	rs72781680	0.611	rs72797810	chr2:24336469	G/A	cg20701182	chr2:24300061	SF3B14	0.74	5.03	0.49	3.09e-6	Lymphocyte counts;
SKCM	cis	rs12478296	1.000	rs56387669	chr2:243043889	T/C	cg06360820	chr2:242988706	NA	-0.91	-5.25	-0.51	1.28e-6	Obesity-related traits;
SKCM	cis	rs2836950	0.565	rs7276046	chr21:40581293	T/C	cg11644478	chr21:40555479	PSMG1	-0.64	-5.02	-0.49	3.17e-6	Menarche (age at onset);
SKCM	cis	rs6489882	0.966	rs7955267	chr12:113379039	C/T	cg07232103	chr12:112566177	TRAFD1	0.6	4.78	0.48	8.16e-6	Chronic lymphocytic leukemia;
SKCM	cis	rs6088580	0.601	rs6059827	chr20:33016358	C/T	cg24642439	chr20:33292090	TP53INP2	0.76	6.02	0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs11098499	0.865	rs10032158	chr4:120391632	C/T	cg09307838	chr4:120376055	NA	0.97	7.49	0.65	9.08e-11	Corneal astigmatism;
SKCM	cis	rs80282103	0.867	rs7075830	chr10:1091650	G/C	cg19207066	chr10:1251074	ADARB2	-0.69	-4.78	-0.48	8.06e-6	Glomerular filtration rate (creatinine);
SKCM	cis	rs28595532	0.920	rs116834347	chr4:119774155	C/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs4523957	0.651	rs9894613	chr17:2071058	C/T	cg16513277	chr17:2031491	SMG6	-0.82	-6.05	-0.57	4.65e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs35273427	1	rs35273427	chr1:120436751	T/C	cg09815769	chr1:119539738	NA	1.23	4.77	0.48	8.39e-6	Breast cancer;
SKCM	cis	rs7264396	0.733	rs2425105	chr20:34312834	C/T	cg23207816	chr20:34252616	CPNE1;RBM12	0.8	4.85	0.48	6.13e-6	Total cholesterol levels;
SKCM	cis	rs854765	0.724	rs62072049	chr17:17906520	T/C	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.95	7.46	0.65	1.06e-10	Total body bone mineral density;
SKCM	cis	rs4332037	0.624	rs11764124	chr7:1891723	C/G	cg23422044	chr7:1970798	MAD1L1	-0.88	-5.68	-0.54	2.19e-7	Bipolar disorder;
SKCM	cis	rs11098499	0.863	rs1383533	chr4:120434576	G/A	cg24375607	chr4:120327624	NA	0.7	5.37	0.52	7.82e-7	Corneal astigmatism;
SKCM	cis	rs6942756	1.000	rs67820265	chr7:128887925	A/G	cg02491457	chr7:128862824	NA	-0.77	-4.9	-0.49	5.12e-6	White matter hyperintensity burden;
SKCM	cis	rs2836974	0.568	rs7282604	chr21:40536910	C/T	cg11890956	chr21:40555474	PSMG1	-0.88	-9.33	-0.73	2.48e-14	Cognitive function;
SKCM	cis	rs2019137	0.539	rs4849181	chr2:113991970	A/G	cg12889195	chr2:113992843	PAX8;LOC440839;LOC654433	0.78	5.78	0.55	1.48e-7	Lymphocyte counts;
SKCM	cis	rs9815354	0.812	rs17215988	chr3:41851320	A/C	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs9926296	0.508	rs1558184	chr16:89842374	T/G	cg27121462	chr16:89883253	FANCA	0.81	7.11	0.63	4.97e-10	Vitiligo;
SKCM	cis	rs13118159	0.509	rs10023473	chr4:1375285	C/T	cg16405210	chr4:1374714	KIAA1530	-0.89	-6.66	-0.6	3.42e-9	Longevity;
SKCM	cis	rs1348850	0.632	rs10167783	chr2:178519041	G/A	cg22681709	chr2:178499509	PDE11A	-0.69	-5.98	-0.56	6.36e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs910316	0.737	rs108621	chr14:75480637	T/C	cg11812906	chr14:75593930	NEK9	-0.69	-5.09	-0.5	2.38e-6	Height;
SKCM	cis	rs6430585	0.528	rs115469964	chr2:136696608	A/C	cg07169764	chr2:136633963	MCM6	1.35	12.22	0.81	8.51e-20	Corneal structure;
SKCM	cis	rs7786877	0.554	rs2075671	chr7:100345106	G/A	cg20848291	chr7:100343083	ZAN	-0.63	-4.83	-0.48	6.74e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs6723226	0.772	rs2366894	chr2:32713706	A/T	cg02381751	chr2:32503542	YIPF4	0.9	6.83	0.61	1.64e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs7666738	0.830	rs10001702	chr4:99065160	T/G	cg17366294	chr4:99064904	C4orf37	0.61	4.93	0.49	4.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs3820068	0.581	rs12385690	chr1:15932932	A/T	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.14e-7	Systolic blood pressure;
SKCM	cis	rs6449957	0.832	rs960383	chr5:67450986	A/G	cg09038926	chr5:67483109	NA	-0.72	-5.66	-0.54	2.44e-7	Cleft lip with or without cleft palate;
SKCM	cis	rs8017423	0.900	rs7141887	chr14:90705364	G/T	cg04374321	chr14:90722782	PSMC1	0.97	8.87	0.71	1.91e-13	Mortality in heart failure;
SKCM	cis	rs995000	0.931	rs1168047	chr1:62983751	C/T	cg06896770	chr1:63153194	DOCK7	-0.74	-6.81	-0.61	1.77e-9	Triglyceride levels;
SKCM	cis	rs10089	0.951	rs736969	chr5:127466347	G/C	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.91	8.89	0.71	1.79e-13	Ileal carcinoids;
SKCM	cis	rs1218582	0.741	rs705094	chr1:154917314	G/A	cg24250549	chr1:154909240	PMVK	0.85	8.49	0.69	1.07e-12	Prostate cancer;
SKCM	cis	rs6835098	0.692	rs1316411	chr4:174075143	A/G	cg08422745	chr4:174089978	GALNT7	-0.85	-7.05	-0.62	6.23e-10	Dementia and core Alzheimer's disease neuropathologic changes;
SKCM	cis	rs4906332	0.782	rs12891288	chr14:103999750	C/T	cg04998671	chr14:104000505	TRMT61A	-0.72	-4.84	-0.48	6.32e-6	Coronary artery disease;
SKCM	cis	rs5750830	0.649	rs4821895	chr22:39823015	A/G	cg11247378	chr22:39784982	NA	-0.45	-5.31	-0.51	1.02e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs793571	0.521	rs12594872	chr15:58912749	T/C	cg05156742	chr15:59063176	FAM63B	0.74	5.35	0.52	8.57e-7	Schizophrenia;
SKCM	cis	rs13118159	0.556	rs4974615	chr4:1373551	A/G	cg20887711	chr4:1340912	KIAA1530	-0.91	-6.93	-0.62	1.06e-9	Longevity;
SKCM	cis	rs35146811	0.555	rs1981550	chr7:99541952	G/A	cg22906224	chr7:99728672	NA	0.72	4.96	0.49	4.08e-6	Coronary artery disease;
SKCM	cis	rs2832191	0.791	rs2832182	chr21:30481612	G/A	cg24692254	chr21:30365293	RNF160	-0.9	-8.03	-0.67	8.39e-12	Dental caries;
SKCM	cis	rs2549003	1.000	rs2548997	chr5:131835395	C/T	cg21138405	chr5:131827807	IRF1	-0.42	-4.87	-0.48	5.75e-6	Asthma (sex interaction);
SKCM	cis	rs2014572	1.000	rs3746231	chr19:57760057	G/A	cg24459738	chr19:57751996	ZNF805	-0.64	-5.17	-0.5	1.79e-6	Hyperactive-impulsive symptoms;
SKCM	cis	rs870825	0.616	rs1401359	chr4:185640216	T/C	cg04058563	chr4:185651563	MLF1IP	1.08	7.17	0.63	3.75e-10	Blood protein levels;
SKCM	cis	rs72781680	0.611	rs72797818	chr2:24351107	G/A	cg20701182	chr2:24300061	SF3B14	0.77	5.22	0.51	1.45e-6	Lymphocyte counts;
SKCM	cis	rs793571	0.568	rs6494029	chr15:58923206	T/C	cg05156742	chr15:59063176	FAM63B	0.74	5.72	0.54	1.87e-7	Schizophrenia;
SKCM	cis	rs7904368	0.614	rs4747285	chr10:16871936	G/T	cg23933602	chr10:16859644	RSU1	1.01	5.29	0.51	1.1e-6	Ratio of the peak velocity of the mitral E-Wave divided by the peak velocity of the mitral A-wave.;
SKCM	cis	rs9300255	0.602	rs1617434	chr12:123649486	A/G	cg05973401	chr12:123451056	ABCB9	0.78	5.29	0.51	1.09e-6	Neutrophil percentage of white cells;
SKCM	cis	rs7618501	0.633	rs2526751	chr3:50064867	T/C	cg24110177	chr3:50126178	RBM5	0.6	5.06	0.5	2.68e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2839186	0.900	rs56840278	chr21:47708933	T/G	cg05896524	chr21:47604654	C21orf56	0.69	5.67	0.54	2.29e-7	Testicular germ cell tumor;
SKCM	cis	rs7772486	0.846	rs866473	chr6:146353414	A/C	cg23711669	chr6:146136114	FBXO30	0.77	7.48	0.65	9.65e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs854765	0.647	rs7211714	chr17:17986955	A/G	cg04398451	chr17:18023971	MYO15A	-1.02	-8.72	-0.7	3.81e-13	Total body bone mineral density;
SKCM	cis	rs2842992	0.915	rs1967802	chr6:160097791	G/A	cg19482086	chr6:160211437	TCP1;MRPL18	0.82	5.72	0.54	1.86e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs11126435	0.591	rs6546909	chr2:74746322	A/T	cg03813688	chr2:74740991	TLX2	0.66	5.35	0.52	8.55e-7	Age-related hearing impairment (SNP x SNP interaction);
SKCM	cis	rs12134245	0.776	rs12125947	chr1:91990487	T/C	cg02896835	chr1:92012615	NA	-0.66	-6.35	-0.58	1.3e-8	Breast cancer;
SKCM	cis	rs2228479	0.850	rs62054599	chr16:89808850	C/G	cg00800038	chr16:89945340	TCF25	-0.82	-4.8	-0.48	7.36e-6	Skin colour saturation;
SKCM	cis	rs854765	0.583	rs11871899	chr17:17826748	C/G	cg09796270	chr17:17721594	SREBF1	0.65	4.87	0.48	5.79e-6	Total body bone mineral density;
SKCM	cis	rs9902453	0.765	rs2729447	chr17:28099002	T/C	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.79	-5.93	-0.56	7.67e-8	Coffee consumption (cups per day);
SKCM	cis	rs2645694	0.626	rs2703151	chr4:77834095	A/G	cg03477792	chr4:77819574	ANKRD56	0.59	6.67	0.6	3.3e-9	Emphysema distribution in smoking;
SKCM	cis	rs9814567	0.806	rs9839705	chr3:134323819	T/C	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.65	-5.19	-0.51	1.6e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs2839186	0.872	rs13046834	chr21:47701485	T/C	cg13126279	chr21:47581558	C21orf56	-0.62	-5.25	-0.51	1.29e-6	Testicular germ cell tumor;
SKCM	cis	rs56011263	0.532	rs6845891	chr4:744233	T/C	cg17689763	chr4:710664	PCGF3	-0.65	-4.84	-0.48	6.44e-6	White blood cell count;
SKCM	cis	rs801193	0.660	rs1962050	chr7:66240008	C/T	cg18876405	chr7:65276391	NA	-0.65	-6.65	-0.6	3.59e-9	Aortic root size;
SKCM	cis	rs853679	0.599	rs149949	chr6:28011516	T/C	cg06761719	chr6:27280190	POM121L2	0.89	4.99	0.49	3.55e-6	Depression;
SKCM	cis	rs1799949	0.894	rs36062488	chr17:41337472	C/T	cg25918947	chr17:41365094	TMEM106A	0.63	6.08	0.57	4.18e-8	Menopause (age at onset);
SKCM	cis	rs28386778	0.830	rs67905415	chr17:61841236	G/A	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs7940866	0.903	rs2324316	chr11:130872353	G/T	cg12179176	chr11:130786555	SNX19	0.76	5.96	0.56	6.98e-8	Schizophrenia;
SKCM	cis	rs8180040	0.966	rs11914795	chr3:47557722	G/A	cg27129171	chr3:47204927	SETD2	0.81	5.82	0.55	1.26e-7	Colorectal cancer;
SKCM	cis	rs1218582	0.772	rs2061690	chr1:154919080	C/T	cg24250549	chr1:154909240	PMVK	0.85	8.48	0.69	1.13e-12	Prostate cancer;
SKCM	cis	rs4975616	0.804	rs462608	chr5:1336626	T/A	cg26373071	chr5:1325741	CLPTM1L	0.68	5.69	0.54	2.15e-7	Lung cancer;
SKCM	cis	rs6840360	0.571	rs72730104	chr4:152543857	A/G	cg22705602	chr4:152727874	NA	-0.52	-5.7	-0.54	2.03e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs780096	0.526	rs13472	chr2:27600239	G/A	cg05696406	chr2:27599888	SNX17	0.49	4.85	0.48	6.23e-6	Total body bone mineral density;
SKCM	cis	rs56104184	0.615	rs73061693	chr19:49399941	C/A	cg19746536	chr19:49375674	PPP1R15A	1.16	5.93	0.56	7.67e-8	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs6570726	0.935	rs447247	chr6:145812678	G/T	cg23711669	chr6:146136114	FBXO30	0.71	6.93	0.62	1.09e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1218582	0.688	rs58629129	chr1:154910930	T/C	cg24250549	chr1:154909240	PMVK	0.82	7.77	0.66	2.57e-11	Prostate cancer;
SKCM	cis	rs2204008	0.837	rs55962152	chr12:38234281	G/A	cg26384229	chr12:38710491	ALG10B	0.87	6.9	0.62	1.21e-9	Bladder cancer;
SKCM	cis	rs1707322	0.752	rs12062535	chr1:46222880	G/A	cg03146154	chr1:46216737	IPP	0.8	5.47	0.53	5.19e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7772486	0.875	rs7739371	chr6:146424353	C/G	cg23711669	chr6:146136114	FBXO30	0.85	8.48	0.69	1.09e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7769051	0.808	rs1467403	chr6:133089952	T/A	cg22852734	chr6:133119734	C6orf192	0.91	4.98	0.49	3.73e-6	Type 2 diabetes nephropathy;
SKCM	cis	rs7772486	0.686	rs1292334	chr6:145968288	A/G	cg05347473	chr6:146136440	FBXO30	0.61	5.49	0.53	4.93e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7829975	0.846	rs1879957	chr8:8544808	T/C	cg15556689	chr8:8085844	FLJ10661	-0.77	-6.28	-0.58	1.77e-8	Mood instability;
SKCM	cis	rs7247513	0.964	rs4804200	chr19:12710752	C/G	cg01871581	chr19:12707946	ZNF490	-0.68	-4.86	-0.48	6.02e-6	Bipolar disorder;
SKCM	cis	rs561341	0.882	rs563539	chr17:30307958	A/G	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs801193	0.569	rs11772819	chr7:66217970	T/C	cg18876405	chr7:65276391	NA	0.61	6.02	0.56	5.36e-8	Aortic root size;
SKCM	cis	rs1401999	1.000	rs4148575	chr3:183702275	A/G	cg01324343	chr3:183735012	ABCC5	0.86	9.5	0.73	1.18e-14	Anterior chamber depth;
SKCM	cis	rs4268898	0.662	rs9917315	chr2:24431501	C/A	cg06627628	chr2:24431161	ITSN2	-0.92	-7.12	-0.63	4.73e-10	Asthma;
SKCM	cis	rs2243480	1.000	rs1715235	chr7:65488394	T/C	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs2041840	0.520	rs4670670	chr2:37396361	G/T	cg14987922	chr2:37194071	STRN	-0.74	-5.05	-0.5	2.84e-6	Chronic lymphocytic leukemia;
SKCM	cis	rs1760803	0.754	rs6657214	chr1:154206538	C/T	cg26808167	chr1:154192205	UBAP2L;C1orf43	-0.57	-5.04	-0.5	2.97e-6	Nicotine dependence;
SKCM	cis	rs7666738	0.830	rs4699584	chr4:98952019	A/G	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs561341	1.000	rs15654	chr17:30326360	A/C	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs7811142	0.779	rs77370288	chr7:99947897	A/T	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.05	5.92	0.56	8.02e-8	Platelet count;
SKCM	cis	rs2243480	1.000	rs316334	chr7:65602126	G/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs55962025	0.711	rs82333	chr4:3225389	C/T	cg09735869	chr4:3319127	RGS12	0.66	5.42	0.52	6.54e-7	Parental longevity (mother's age at death);
SKCM	cis	rs1499614	1.000	rs2707832	chr7:66136549	C/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Gout;
SKCM	cis	rs2153535	0.580	rs6913100	chr6:8456855	A/G	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs7208859	0.673	rs216424	chr17:28943064	T/G	cg14067834	chr17:29058358	SUZ12P	1.06	4.8	0.48	7.45e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs1046896	0.562	rs2380172	chr17:80887719	C/A	cg02711726	chr17:80685570	FN3KRP	-0.62	-4.88	-0.48	5.57e-6	Glycated hemoglobin levels;
SKCM	cis	rs6570726	0.764	rs9403731	chr6:145907937	G/A	cg23711669	chr6:146136114	FBXO30	0.85	7.99	0.67	9.7e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs11764590	0.694	rs4721321	chr7:2068470	A/G	cg23422044	chr7:1970798	MAD1L1	-0.81	-6.16	-0.57	2.96e-8	Neuroticism;
SKCM	cis	rs17376456	0.825	rs17372057	chr5:93071916	C/A	cg25358565	chr5:93447407	FAM172A	1.15	7.28	0.64	2.25e-10	Diabetic retinopathy;
SKCM	cis	rs7178909	0.872	rs3784387	chr15:90437370	G/A	cg19708238	chr15:90437601	AP3S2	0.72	5.22	0.51	1.43e-6	Common traits (Other);
SKCM	cis	rs1559088	0.545	rs7257431	chr19:33566924	A/G	cg27124370	chr19:33622961	WDR88	0.83	6.0	0.56	5.76e-8	Bone ultrasound measurement (broadband ultrasound attenuation);
SKCM	cis	rs9815354	0.767	rs75651509	chr3:41953564	A/G	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs62238980	0.614	rs17682819	chr22:32424794	T/C	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs3091242	0.933	rs61775167	chr1:25780893	A/G	cg27572855	chr1:25598939	RHD	-0.53	-5.06	-0.5	2.67e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs12477438	0.798	rs4850894	chr2:99629396	A/T	cg26064155	chr2:99771622	LIPT1;TSGA10	-0.72	-4.86	-0.48	6e-6	Chronic sinus infection;
SKCM	cis	rs919433	0.889	rs12693816	chr2:198208420	T/A	cg04278110	chr2:198063759	ANKRD44	-0.72	-5.02	-0.49	3.21e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs9467773	1.000	rs6456734	chr6:26566965	G/T	cg15659132	chr6:26577336	NA	0.61	5.76	0.55	1.6e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs11098499	0.954	rs12507964	chr4:120413061	T/A	cg24375607	chr4:120327624	NA	0.65	5.01	0.49	3.32e-6	Corneal astigmatism;
SKCM	cis	rs7666738	0.830	rs35491210	chr4:99003364	T/C	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2816062	0.813	rs742485	chr1:18900943	A/T	cg18795169	chr1:18902165	NA	-0.85	-8.22	-0.68	3.46e-12	Urate levels in lean individuals;
SKCM	cis	rs8067545	0.750	rs9897246	chr17:19965702	T/G	cg13482628	chr17:19912719	NA	0.73	6.54	0.6	5.78e-9	Schizophrenia;
SKCM	cis	rs672059	0.967	rs657901	chr1:183163411	T/G	ch.1.3577855R	chr1:183094577	LAMC1	0.65	5.56	0.53	3.7e-7	Hypertriglyceridemia;
SKCM	cis	rs55962025	0.883	rs363099	chr4:3162056	C/T	cg11471262	chr4:3318911	RGS12	-0.6	-4.89	-0.48	5.33e-6	Parental longevity (mother's age at death);
SKCM	cis	rs7772486	0.686	rs7739735	chr6:146123536	G/A	cg23711669	chr6:146136114	FBXO30	0.85	9.32	0.73	2.62e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6598955	0.640	rs1577507	chr1:26547179	C/T	cg00938395	chr1:26633206	UBXN11	0.71	5.0	0.49	3.5e-6	Obesity-related traits;
SKCM	cis	rs3820928	0.904	rs4414671	chr2:227816200	T/A	cg11843606	chr2:227700838	RHBDD1	-0.6	-4.81	-0.48	7.17e-6	Pulmonary function;
SKCM	cis	rs7666738	0.747	rs2865955	chr4:99040518	A/C	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1707322	0.717	rs28396194	chr1:46213227	C/T	cg03146154	chr1:46216737	IPP	0.81	5.62	0.54	2.87e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs1799949	1.000	rs8176233	chr17:41219804	T/C	cg05368731	chr17:41323189	NBR1	0.89	7.87	0.67	1.71e-11	Menopause (age at onset);
SKCM	cis	rs8077889	1.000	rs17742905	chr17:41891143	C/A	cg26893861	chr17:41843967	DUSP3	1.13	7.37	0.64	1.58e-10	Triglycerides;
SKCM	cis	rs67311347	1.000	rs9860162	chr3:40403875	C/T	cg00091569	chr3:40428383	ENTPD3	0.65	5.58	0.53	3.36e-7	Renal cell carcinoma;
SKCM	cis	rs7829975	0.593	rs2921077	chr8:8304502	C/T	cg15556689	chr8:8085844	FLJ10661	0.68	5.3	0.51	1.03e-6	Mood instability;
SKCM	cis	rs7666738	0.830	rs4699592	chr4:98974202	A/C	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs854765	0.718	rs7224815	chr17:17845800	A/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.84	6.04	0.56	4.92e-8	Total body bone mineral density;
SKCM	cis	rs34779708	0.966	rs12769575	chr10:35435927	A/T	cg03585969	chr10:35415529	CREM	0.73	6.0	0.56	5.85e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs644799	1.000	rs560854	chr11:95584905	G/A	cg03916912	chr11:95522834	CEP57;FAM76B	0.88	7.53	0.65	7.59e-11	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs8072100	0.651	rs1912484	chr17:45443664	C/G	cg08085267	chr17:45401833	C17orf57	-0.7	-5.58	-0.53	3.33e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs28595532	0.920	rs56212415	chr4:119737731	C/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs1707322	1.000	rs11211243	chr1:46455433	G/C	cg03146154	chr1:46216737	IPP	0.78	5.24	0.51	1.35e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs1707322	1.000	rs10158032	chr1:46332701	T/C	cg03146154	chr1:46216737	IPP	0.74	5.05	0.5	2.82e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs561341	1.000	rs4795670	chr17:30244839	T/C	cg00745463	chr17:30367425	LRRC37B	-0.89	-5.93	-0.56	7.85e-8	Hip circumference adjusted for BMI;
SKCM	cis	rs1577917	0.771	rs4383777	chr6:86435960	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.76	6.64	0.6	3.86e-9	Response to antipsychotic treatment;
SKCM	cis	rs7659604	0.935	rs73844280	chr4:122664687	G/A	cg19671926	chr4:122722719	EXOSC9	-0.64	-4.78	-0.48	8.04e-6	Type 2 diabetes;
SKCM	cis	rs523522	0.962	rs12309824	chr12:120990582	A/C	cg12219531	chr12:120966889	COQ5	0.91	7.82	0.66	2.11e-11	High light scatter reticulocyte count;
SKCM	cis	rs4141404	0.737	rs5998067	chr22:32043630	C/T	cg02404636	chr22:31891804	SFI1	-0.54	-4.78	-0.48	8.19e-6	Paclitaxel-induced neuropathy;
SKCM	cis	rs1348850	0.526	rs2293475	chr2:178407897	C/T	cg02961200	chr2:178257176	LOC100130691;AGPS	-0.87	-4.9	-0.49	5.06e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs7193541	0.662	rs8052367	chr16:74658867	G/A	cg01733217	chr16:74700730	RFWD3	1.01	11.69	0.8	8.05e-19	Multiple myeloma;
SKCM	cis	rs7772486	0.790	rs80050589	chr6:146230454	T/C	cg23711669	chr6:146136114	FBXO30	-0.76	-7.66	-0.66	4.34e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2204008	0.744	rs11495519	chr12:38060546	C/A	cg26384229	chr12:38710491	ALG10B	0.81	6.45	0.59	8.61e-9	Bladder cancer;
SKCM	cis	rs9682041	0.877	rs6804688	chr3:170071191	T/G	cg11886554	chr3:170076028	SKIL	0.84	5.1	0.5	2.36e-6	Glomerular filtration rate in non diabetics (creatinine);Glomerular filtration rate (creatinine);
SKCM	cis	rs2239547	0.603	rs17304995	chr3:53070755	A/G	cg11645453	chr3:52864694	ITIH4	0.61	5.11	0.5	2.26e-6	Schizophrenia;
SKCM	cis	rs459571	1.000	rs2810489	chr9:136922700	C/T	cg13789015	chr9:136890014	NCRNA00094	0.77	6.94	0.62	1.01e-9	Platelet distribution width;
SKCM	cis	rs5769765	1.000	rs761879	chr22:50241210	G/A	cg22709217	chr22:50311962	ALG12;CRELD2	0.88	5.85	0.55	1.09e-7	Schizophrenia;
SKCM	cis	rs4889855	0.614	rs7221663	chr17:78484166	T/C	cg16591659	chr17:78472290	NA	-0.55	-5.52	-0.53	4.2e-7	Fractional excretion of uric acid;
SKCM	cis	rs28374715	0.532	rs28463309	chr15:41666716	A/G	cg18705301	chr15:41695430	NDUFAF1	-1.16	-12.24	-0.81	7.71e-20	Ulcerative colitis;
SKCM	cis	rs2033711	0.905	rs1077420	chr19:58968875	A/C	cg26874164	chr19:58962979	ZNF324B	0.61	5.0	0.49	3.43e-6	Uric acid clearance;
SKCM	cis	rs644799	1.000	rs586238	chr11:95560371	C/T	cg03916912	chr11:95522834	CEP57;FAM76B	0.87	7.55	0.65	7.01e-11	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs10818894	0.611	rs10117455	chr9:126692599	G/T	cg16191174	chr9:126692580	DENND1A	0.83	6.83	0.61	1.63e-9	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU);
SKCM	cis	rs1707322	1.000	rs4660896	chr1:46372416	A/G	cg03146154	chr1:46216737	IPP	0.74	5.06	0.5	2.76e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs2404602	0.692	rs8037005	chr15:76951109	C/T	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs8060686	0.641	rs12598274	chr16:68084099	G/A	cg09117114	chr16:67998030	SLC12A4	-0.81	-5.34	-0.52	8.73e-7	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs9399137	0.507	rs11757723	chr6:135291293	C/T	cg24558204	chr6:135376177	HBS1L	0.69	6.37	0.59	1.19e-8	Glycated hemoglobin levels;Mean corpuscular volume;Hematology traits;HbA2 levels;Mean corpuscular hemoglobin;Hemoglobin levels;F-cell distribution;Platelet count;
SKCM	cis	rs867186	1.000	rs11907011	chr20:33767770	C/T	cg04194272	chr20:33683537	NA	-1.02	-5.4	-0.52	7.03e-7	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs28785552	0.800	rs1971063	chr19:53232854	G/C	cg10871876	chr19:53194124	ZNF83	0.67	4.89	0.48	5.35e-6	Response to paliperidone in schizophrenia (PANSS score);
SKCM	cis	rs7666738	0.830	rs62321597	chr4:99014221	C/A	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs13086611	1	rs13086611	chr3:49385417	A/T	cg03060546	chr3:49711283	APEH	-0.68	-4.99	-0.49	3.54e-6	Educational attainment;
SKCM	cis	rs6951245	1.000	rs80212261	chr7:1114012	C/T	cg24642844	chr7:1081250	C7orf50	-0.93	-6.24	-0.58	2.11e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs738322	1.000	rs133009	chr22:38569653	G/C	cg25457927	chr22:38595422	NA	-0.5	-5.56	-0.53	3.61e-7	Cutaneous nevi;
SKCM	cis	rs3820928	1.000	rs978909	chr2:227771389	A/C	cg11843606	chr2:227700838	RHBDD1	-0.62	-5.0	-0.49	3.42e-6	Pulmonary function;
SKCM	cis	rs367615	0.731	rs58241713	chr5:108853664	G/A	cg17395555	chr5:108820864	NA	0.78	7.2	0.63	3.22e-10	Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs3091242	0.804	rs631133	chr1:25724146	T/C	cg02931644	chr1:25747376	RHCE	0.53	5.48	0.53	5.13e-7	Erythrocyte sedimentation rate;
SKCM	cis	rs12478296	0.901	rs7420176	chr2:243005277	G/A	cg06360820	chr2:242988706	NA	-1.01	-5.78	-0.55	1.46e-7	Obesity-related traits;
SKCM	cis	rs4972806	0.814	rs4246626	chr2:177046430	A/C	cg13092806	chr2:177043255	NA	0.57	5.37	0.52	7.9e-7	IgG glycosylation;
SKCM	cis	rs2070488	0.965	rs7433277	chr3:38529818	C/T	cg01465620	chr3:38496096	LOC100128640;ACVR2B	1.0	9.25	0.72	3.58e-14	Electrocardiographic conduction measures;
SKCM	cis	rs28386778	0.863	rs3760252	chr17:61852186	G/C	cg22520471	chr17:61851767	DDX42;CCDC47	0.76	5.07	0.5	2.64e-6	Prudent dietary pattern;
SKCM	cis	rs2033711	0.870	rs4801270	chr19:58932762	C/A	cg03735888	chr19:58951602	ZNF132	0.7	6.07	0.57	4.34e-8	Uric acid clearance;
SKCM	cis	rs2243480	0.901	rs3813708	chr7:65305632	C/A	cg18252515	chr7:66147081	NA	-1.29	-7.41	-0.64	1.3e-10	Diabetic kidney disease;
SKCM	cis	rs1577917	0.916	rs7759727	chr6:86518878	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.83	-0.66	2e-11	Response to antipsychotic treatment;
SKCM	cis	rs2658782	1.000	rs2019814	chr11:93168885	A/G	cg15737290	chr11:93063684	CCDC67	0.76	5.37	0.52	7.9e-7	Pulmonary function decline;
SKCM	cis	rs13108904	0.604	rs13103860	chr4:1320120	G/A	cg10457066	chr4:2065925	NAT8L	0.59	4.89	0.48	5.35e-6	Obesity-related traits;
SKCM	cis	rs910316	0.737	rs398896	chr14:75482827	C/A	cg08847533	chr14:75593920	NEK9	-0.8	-6.59	-0.6	4.76e-9	Height;
SKCM	cis	rs501916	0.634	rs1561480	chr15:48070050	C/G	cg16110827	chr15:48056943	SEMA6D	-0.63	-4.82	-0.48	6.85e-6	Inflammatory bowel disease;Ulcerative colitis;
SKCM	cis	rs9902453	0.933	rs7225462	chr17:28321226	G/A	cg26525008	chr17:28256777	EFCAB5;SSH2	0.82	6.4	0.59	1.06e-8	Coffee consumption (cups per day);
SKCM	cis	rs9902453	0.845	rs3115101	chr17:28041627	G/A	cg26525008	chr17:28256777	EFCAB5;SSH2	0.82	5.78	0.55	1.47e-7	Coffee consumption (cups per day);
SKCM	trans	rs7819412	0.775	rs4545055	chr8:10935366	T/C	cg06636001	chr8:8085503	FLJ10661	-0.88	-7.8	-0.66	2.25e-11	Triglycerides;
SKCM	cis	rs3793683	0.571	rs12781152	chr10:134590257	G/C	cg26818010	chr10:134567672	INPP5A	-0.73	-5.37	-0.52	7.87e-7	Migraine;
SKCM	cis	rs1707322	1.000	rs1707338	chr1:46511981	T/G	cg03146154	chr1:46216737	IPP	-0.77	-5.36	-0.52	8.35e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7809950	0.723	rs62483634	chr7:106878516	G/A	cg23024343	chr7:107201750	COG5	-0.78	-6.7	-0.6	2.97e-9	Coronary artery disease;
SKCM	cis	rs10155981	0.510	rs4719704	chr7:22588827	T/G	cg05062323	chr7:22590069	NA	-1.05	-6.05	-0.57	4.69e-8	Bilirubin levels;
SKCM	cis	rs2836974	0.644	rs11088471	chr21:40699313	A/G	cg11644478	chr21:40555479	PSMG1	-0.67	-5.63	-0.54	2.71e-7	Cognitive function;
SKCM	cis	rs11858159	0.545	rs6576303	chr15:24641281	G/A	cg24138476	chr15:25312939	SNORD116-5;SNORD116-7	0.58	4.98	0.49	3.8e-6	Platelet thrombus formation;
SKCM	cis	rs6450176	1.000	rs6876198	chr5:53303595	A/G	ch.5.1024479R	chr5:53302184	ARL15	-0.72	-5.02	-0.49	3.18e-6	HDL cholesterol levels;HDL cholesterol;Adiponectin levels;
SKCM	trans	rs17685	0.712	rs6464994	chr7:75784668	C/T	cg19862616	chr7:65841803	NCRNA00174	0.88	8.34	0.69	2.1e-12	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs6951245	0.744	rs1133122	chr7:1192572	C/A	cg18402987	chr7:1209562	NA	1.18	7.4	0.64	1.36e-10	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7618501	0.633	rs4688690	chr3:50022292	G/A	cg24110177	chr3:50126178	RBM5	-0.6	-5.11	-0.5	2.25e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs801193	0.844	rs2244022	chr7:66202430	A/G	cg11987759	chr7:65425863	GUSB	-0.71	-6.12	-0.57	3.5e-8	Aortic root size;
SKCM	cis	rs6831352	0.704	rs1800759	chr4:100065509	T/G	cg12011299	chr4:100065546	ADH4	0.48	5.07	0.5	2.61e-6	Alcohol dependence;
SKCM	cis	rs9325144	0.560	rs10506127	chr12:39126686	C/G	cg13010199	chr12:38710504	ALG10B	-0.68	-5.98	-0.56	6.29e-8	Morning vs. evening chronotype;
SKCM	cis	rs13256369	0.802	rs11781257	chr8:8559663	A/T	cg06636001	chr8:8085503	FLJ10661	0.74	5.58	0.53	3.4e-7	Obesity-related traits;
SKCM	cis	rs4819052	1.000	rs9306123	chr21:46709922	A/G	cg02159808	chr21:46707872	POFUT2;LOC642852	0.85	6.31	0.58	1.6e-8	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs910316	0.935	rs175422	chr14:75627319	T/A	cg11812906	chr14:75593930	NEK9	-0.71	-5.34	-0.52	9.01e-7	Height;
SKCM	cis	rs62238980	0.614	rs4821018	chr22:32403318	A/G	cg00543991	chr22:32367038	NA	-1.19	-5.21	-0.51	1.48e-6	Childhood ear infection;
SKCM	cis	rs3087591	1.000	rs2905800	chr17:29531980	A/G	cg24425628	chr17:29625626	OMG;NF1	0.69	5.61	0.54	2.94e-7	Hip circumference;
SKCM	cis	rs433852	0.718	rs386551	chr19:49138286	C/G	cg06677660	chr19:49140777	SEC1;DBP	-0.87	-6.34	-0.58	1.35e-8	Elevated serum carcinoembryonic antigen levels;Posterior cortical atrophy and Alzheimer's disease;
SKCM	cis	rs992157	0.735	rs2271541	chr2:219082119	G/T	cg20019365	chr2:219134978	PNKD;AAMP	0.73	6.42	0.59	9.59e-9	Colorectal cancer;
SKCM	cis	rs28386778	0.830	rs2854210	chr17:61946338	C/A	cg22520471	chr17:61851767	DDX42;CCDC47	0.79	5.33	0.52	9.36e-7	Prudent dietary pattern;
SKCM	trans	rs561341	1.000	rs1681718	chr17:30296445	G/A	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs801193	0.569	rs10950050	chr7:66239588	A/C	cg18876405	chr7:65276391	NA	0.59	5.97	0.56	6.73e-8	Aortic root size;
SKCM	cis	rs959260	0.557	rs12936583	chr17:73304710	A/C	cg14668889	chr17:73230827	NUP85	0.8	7.01	0.62	7.45e-10	Systemic lupus erythematosus;
SKCM	cis	rs1568889	1.000	rs7934085	chr11:28369660	G/C	cg06544937	chr11:28130018	METT5D1;KIF18A	0.86	6.53	0.59	5.96e-9	Bipolar disorder;
SKCM	cis	rs1577917	0.740	rs9353327	chr6:86394066	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.75	-7.0	-0.62	7.76e-10	Response to antipsychotic treatment;
SKCM	cis	rs3793683	0.545	rs12784446	chr10:134589094	T/G	cg27286337	chr10:134555280	INPP5A	0.98	9.06	0.72	8.31e-14	Migraine;
SKCM	cis	rs1218582	0.710	rs4845687	chr1:154878911	A/G	cg06221963	chr1:154839813	KCNN3	-0.59	-5.78	-0.55	1.49e-7	Prostate cancer;
SKCM	cis	rs11638352	1.000	rs6493093	chr15:44305495	C/G	cg02155558	chr15:43621948	ADAL;LCMT2	-1.25	-4.88	-0.48	5.56e-6	Lipoprotein phospholipase A2 activity in cardiovascular disease;
SKCM	cis	rs10754283	0.535	rs1215507	chr1:90088895	A/G	cg21401794	chr1:90099060	LRRC8C	0.72	6.18	0.57	2.69e-8	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs589448	0.538	rs622656	chr12:69753595	C/T	cg20891283	chr12:69753455	YEATS4	0.74	5.64	0.54	2.65e-7	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs56235845	0.694	rs4532376	chr5:176774403	G/A	cg17509989	chr5:176798049	RGS14	0.72	5.9	0.56	8.83e-8	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs7824557	0.564	rs2572389	chr8:11236392	T/C	cg21775007	chr8:11205619	TDH	-0.59	-5.03	-0.5	3.01e-6	Retinal vascular caliber;
SKCM	cis	rs10089	1.000	rs10061367	chr5:127449021	T/C	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.91	8.88	0.71	1.84e-13	Ileal carcinoids;
SKCM	cis	rs2013441	1.000	rs9905493	chr17:20188581	C/G	cg13482628	chr17:19912719	NA	-0.66	-5.12	-0.5	2.18e-6	Obesity-related traits;
SKCM	cis	rs10654220	1	rs10654220	chr12:123703422	A/AGTT	cg00376283	chr12:123451042	ABCB9	0.8	5.29	0.51	1.08e-6	Platelet count;
SKCM	cis	rs6582630	0.533	rs4103689	chr12:38702980	A/C	cg26384229	chr12:38710491	ALG10B	0.78	6.71	0.61	2.77e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs2013441	1.000	rs1373147	chr17:20206645	T/A	cg13482628	chr17:19912719	NA	-0.67	-5.24	-0.51	1.32e-6	Obesity-related traits;
SKCM	cis	rs1577917	0.958	rs67024565	chr6:86553997	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.87	-8.71	-0.7	3.92e-13	Response to antipsychotic treatment;
SKCM	cis	rs1218582	1.000	rs1218582	chr1:154834183	G/A	cg06221963	chr1:154839813	KCNN3	0.52	5.0	0.49	3.4e-6	Prostate cancer;
SKCM	cis	rs929354	0.742	rs3808317	chr7:156944460	A/G	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs2832191	0.740	rs2853830	chr21:30416824	A/G	cg08807101	chr21:30365312	RNF160	0.79	6.37	0.58	1.21e-8	Dental caries;
SKCM	cis	rs9916302	0.808	rs12947281	chr17:37652210	G/T	cg07936489	chr17:37558343	FBXL20	-0.86	-7.39	-0.64	1.42e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs28386778	0.897	rs8077013	chr17:61850392	C/T	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs57221529	0.766	rs72706610	chr5:561111	G/A	cg10555297	chr5:473380	SLC9A3;LOC25845	1.02	5.1	0.5	2.37e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs7772486	0.875	rs864390	chr6:146315035	G/T	cg23711669	chr6:146136114	FBXO30	0.77	7.11	0.63	4.82e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs3087591	1.000	rs2905884	chr17:29512476	A/G	cg24425628	chr17:29625626	OMG;NF1	0.61	4.87	0.48	5.75e-6	Hip circumference;
SKCM	cis	rs2760061	0.626	rs1636192	chr1:228124688	A/G	cg02753203	chr1:228287806	NA	-0.62	-5.07	-0.5	2.64e-6	Diastolic blood pressure;
SKCM	cis	rs9910055	0.573	rs113184718	chr17:42206543	A/T	cg19774624	chr17:42201019	HDAC5	0.93	8.8	0.71	2.68e-13	Total body bone mineral density;
SKCM	cis	rs2153535	0.580	rs1889715	chr6:8443475	G/A	cg23788917	chr6:8435910	SLC35B3	0.69	5.14	0.5	1.99e-6	Motion sickness;
SKCM	cis	rs11673344	0.704	rs485034	chr19:37422357	T/G	cg07624650	chr19:37064219	ZNF529	-0.8	-5.24	-0.51	1.31e-6	Obesity-related traits;
SKCM	cis	rs9611565	0.559	rs4822048	chr22:41988225	C/T	cg03806693	chr22:41940476	POLR3H	-1.12	-7.23	-0.63	2.84e-10	Vitiligo;
SKCM	cis	rs6500395	1.000	rs9930199	chr16:48571263	A/G	cg04672837	chr16:48644449	N4BP1	0.72	6.04	0.56	4.96e-8	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs7208859	0.623	rs9914499	chr17:29107588	G/A	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs13010713	0.840	rs4667129	chr2:182060320	A/G	cg21995919	chr2:182322279	ITGA4	-0.53	-5.12	-0.5	2.18e-6	Celiac disease;
SKCM	cis	rs12709013	0.693	rs1627257	chr16:58797668	C/T	cg02431531	chr16:59244939	NA	0.49	5.13	0.5	2.07e-6	Blood metabolite ratios;
SKCM	cis	rs9809213	1.000	rs9809213	chr3:72353932	G/A	cg09429735	chr3:71752026	EIF4E3	-0.57	-5.18	-0.51	1.71e-6	Cognitive ability;Cognitive ability (multi-trait analysis);
SKCM	cis	rs10769945	0.592	rs1706873	chr11:1970731	A/G	cg23202291	chr11:1979235	NA	-0.53	-5.36	-0.52	8.3e-7	DNA methylation (variation);
SKCM	cis	rs523522	0.962	rs651627	chr12:121009198	C/T	cg27279351	chr12:120934652	DYNLL1	0.91	8.36	0.69	1.88e-12	High light scatter reticulocyte count;
SKCM	cis	rs4820539	1.000	rs4822362	chr22:23482744	C/A	cg14186256	chr22:23484241	RTDR1	0.83	8.13	0.68	5.29e-12	Bone mineral density;
SKCM	cis	rs9914544	1.000	rs8066385	chr17:18761133	C/T	cg26378065	chr17:18585709	ZNF286B	0.71	4.8	0.48	7.54e-6	Educational attainment (years of education);
SKCM	cis	rs11792861	0.781	rs874864	chr9:111728718	C/T	cg14432460	chr9:111696404	IKBKAP;C9orf6	0.68	5.02	0.49	3.17e-6	Menarche (age at onset);
SKCM	cis	rs826838	1.000	rs826889	chr12:39101076	G/A	cg26384229	chr12:38710491	ALG10B	-0.97	-7.97	-0.67	1.05e-11	Heart rate;
SKCM	cis	rs1499614	1.000	rs2659913	chr7:66157336	T/A	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Gout;
SKCM	cis	rs28595532	0.920	rs116046128	chr4:119741990	C/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs1580019	0.885	rs4460270	chr7:32496450	C/T	cg06627557	chr7:32535165	LSM5;AVL9	0.76	5.85	0.55	1.09e-7	Cognitive ability;
SKCM	cis	rs936229	0.784	rs12906946	chr15:75153140	A/G	cg14664628	chr15:75095509	CSK	-0.98	-7.16	-0.63	3.83e-10	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin);
SKCM	cis	rs17608059	0.679	rs9898056	chr17:13951966	C/G	cg27005118	chr17:13972210	COX10	-0.42	-4.85	-0.48	6.22e-6	Temperament;
SKCM	cis	rs28595532	0.925	rs2728305	chr4:119487022	T/G	cg21605333	chr4:119757512	SEC24D	1.28	6.08	0.57	4.22e-8	Cannabis dependence symptom count;
SKCM	cis	rs12477438	0.798	rs9808541	chr2:99642179	A/T	cg26064155	chr2:99771622	LIPT1;TSGA10	-0.72	-4.86	-0.48	6e-6	Chronic sinus infection;
SKCM	cis	rs362296	0.698	rs3095080	chr4:3264418	C/T	cg11471262	chr4:3318911	RGS12	-0.61	-4.93	-0.49	4.56e-6	Parental longevity (mother's age at death);
SKCM	cis	rs1799949	1.000	rs16942	chr17:41244000	T/C	cg23758822	chr17:41437982	NA	0.94	7.65	0.65	4.42e-11	Menopause (age at onset);
SKCM	cis	rs2841277	0.708	rs28600075	chr14:105408315	T/C	cg15352829	chr14:105391018	PLD4	-0.58	-4.81	-0.48	7.35e-6	Rheumatoid arthritis;
SKCM	cis	rs7310409	0.544	rs1169292	chr12:121426478	C/T	cg02403541	chr12:121454288	C12orf43	0.69	5.63	0.54	2.68e-7	Liver enzyme levels (gamma-glutamyl transferase);C-reactive protein;Pancreatic cancer;
SKCM	cis	rs2836974	0.602	rs8130854	chr21:40707041	G/A	cg17971929	chr21:40555470	PSMG1	-0.71	-6.15	-0.57	3.14e-8	Cognitive function;
SKCM	cis	rs1325195	0.537	rs3818433	chr1:179079190	C/T	cg25467746	chr1:179556597	NA	0.61	5.83	0.55	1.19e-7	IgE grass sensitization;
SKCM	cis	rs28595532	0.920	rs114564223	chr4:119729953	A/G	cg14228332	chr4:119757509	SEC24D	1.08	5.52	0.53	4.28e-7	Cannabis dependence symptom count;
SKCM	cis	rs6951245	1.000	rs76388414	chr7:1100694	G/A	cg24642844	chr7:1081250	C7orf50	-0.93	-6.22	-0.58	2.28e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs244731	0.959	rs7721671	chr5:176630984	A/G	cg17509989	chr5:176798049	RGS14	-0.89	-6.92	-0.62	1.11e-9	Urate levels in lean individuals;
SKCM	cis	rs704795	0.805	rs1728926	chr2:27612937	A/G	cg05696406	chr2:27599888	SNX17	0.49	5.07	0.5	2.62e-6	Menopause (age at onset);
SKCM	cis	rs7927771	0.524	rs7936948	chr11:47704200	T/G	cg20307385	chr11:47447363	PSMC3	0.71	5.63	0.54	2.67e-7	Subjective well-being;
SKCM	cis	rs72772090	0.710	rs11739280	chr5:96074147	C/T	cg17330273	chr5:96107758	CAST;ERAP1	0.82	5.06	0.5	2.72e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs7659604	0.540	rs28615388	chr4:122678418	C/T	cg19671926	chr4:122722719	EXOSC9	0.76	6.17	0.57	2.84e-8	Type 2 diabetes;
SKCM	cis	rs3784262	0.679	rs11071365	chr15:58334126	G/A	cg12031962	chr15:58353849	ALDH1A2	-0.46	-6.01	-0.56	5.67e-8	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	trans	rs1814175	0.817	rs7932683	chr11:49983640	G/A	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs854765	0.547	rs2955385	chr17:17939247	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.05	9.29	0.72	2.92e-14	Total body bone mineral density;
SKCM	cis	rs7248779	0.512	rs7250002	chr19:2413188	A/G	cg22729335	chr19:2427816	TIMM13	1.07	10.01	0.75	1.21e-15	Cortisol levels (saliva);
SKCM	cis	rs7178909	0.866	rs3784388	chr15:90437301	C/T	cg19708238	chr15:90437601	AP3S2	0.72	5.22	0.51	1.43e-6	Common traits (Other);
SKCM	cis	rs6879260	1.000	rs10903252	chr5:179733934	T/C	cg02891314	chr5:179741120	GFPT2	-0.73	-5.62	-0.54	2.85e-7	Height;
SKCM	cis	rs2836974	0.931	rs2836972	chr21:40652142	G/A	cg11890956	chr21:40555474	PSMG1	1.09	13.83	0.84	1.08e-22	Cognitive function;
SKCM	cis	rs561341	0.843	rs4795666	chr17:30241409	A/G	cg12193833	chr17:30244370	NA	-0.49	-4.92	-0.49	4.75e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs12586317	0.547	rs2254990	chr14:35465565	T/C	cg16230307	chr14:35515116	FAM177A1	0.81	5.88	0.55	9.47e-8	Psoriasis;
SKCM	cis	rs6724607	1.000	rs7598979	chr2:191453375	A/G	cg27211696	chr2:191398769	TMEM194B	0.8	6.53	0.59	5.99e-9	Pulse pressure;
SKCM	cis	rs28595532	0.920	rs17324884	chr4:119771477	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs933688	1.000	rs1964292	chr5:90743608	T/C	cg12630606	chr5:90679528	LOC100129716;ARRDC3	0.98	7.81	0.66	2.22e-11	Smoking behavior;
SKCM	cis	rs732765	0.644	rs10483860	chr14:75119507	G/C	cg25946216	chr14:74253857	C14orf43	-0.87	-5.45	-0.53	5.68e-7	Non-small cell lung cancer;
SKCM	cis	rs4332037	0.539	rs3823624	chr7:2110346	T/C	cg23422044	chr7:1970798	MAD1L1	-0.95	-6.02	-0.56	5.26e-8	Bipolar disorder;
SKCM	cis	rs3809863	0.646	rs9899121	chr17:45395144	C/T	cg08085267	chr17:45401833	C17orf57	-0.84	-6.46	-0.59	8.13e-9	Glaucoma (primary open-angle);
SKCM	cis	rs2836974	0.931	rs2735306	chr21:40713134	A/G	cg11890956	chr21:40555474	PSMG1	-0.94	-9.75	-0.74	3.78e-15	Cognitive function;
SKCM	cis	rs2180341	0.960	rs7766802	chr6:127709871	T/G	cg24812749	chr6:127587940	RNF146	0.82	7.12	0.63	4.57e-10	Breast cancer;
SKCM	cis	rs2404602	0.692	rs36070630	chr15:76949259	T/C	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs951366	0.789	rs823152	chr1:205736285	G/A	cg11965913	chr1:205819406	PM20D1	1.0	10.25	0.76	4.15e-16	Menarche (age at onset);
SKCM	cis	rs6665290	0.669	rs12406714	chr1:227177061	T/C	cg10327440	chr1:227177885	CDC42BPA	-1.08	-9.54	-0.73	9.9e-15	Myeloid white cell count;
SKCM	cis	rs4523957	0.855	rs12602764	chr17:2123200	A/T	cg16513277	chr17:2031491	SMG6	-0.73	-4.95	-0.49	4.13e-6	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs116095464	0.558	rs12173015	chr5:269967	A/C	cg22857025	chr5:266934	NA	1.22	6.34	0.58	1.35e-8	Breast cancer;
SKCM	cis	rs1045529	0.524	rs34251783	chr8:8891376	T/C	cg06636001	chr8:8085503	FLJ10661	-0.73	-5.55	-0.53	3.74e-7	Myopia;Myopia (pathological);
SKCM	cis	rs7216064	1.000	rs12602912	chr17:65870073	C/T	cg12091567	chr17:66097778	LOC651250	-0.75	-5.27	-0.51	1.19e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs2204008	0.683	rs11519834	chr12:38053575	T/A	cg26384229	chr12:38710491	ALG10B	0.81	6.45	0.59	8.61e-9	Bladder cancer;
SKCM	cis	rs2857078	0.654	rs9896789	chr17:42314567	C/T	cg08499158	chr17:42289980	UBTF	-0.87	-7.42	-0.64	1.25e-10	Red cell distribution width;Reticulocyte count;
SKCM	cis	rs4132509	0.744	rs12047209	chr1:243954407	A/C	cg21452805	chr1:244014465	NA	0.97	6.01	0.56	5.49e-8	RR interval (heart rate);
SKCM	cis	rs875971	1.000	rs6979382	chr7:65886375	C/T	cg11764359	chr7:65958608	NA	0.87	8.35	0.69	2.01e-12	Aortic root size;
SKCM	cis	rs6952808	0.601	rs3800882	chr7:2120758	G/A	cg02951883	chr7:2050386	MAD1L1	-0.76	-7.04	-0.62	6.51e-10	Bipolar disorder and schizophrenia;
SKCM	cis	rs2204008	0.870	rs12369578	chr12:38444227	C/T	cg26384229	chr12:38710491	ALG10B	0.81	6.22	0.58	2.33e-8	Bladder cancer;
SKCM	cis	rs9815354	0.812	rs55682201	chr3:41848497	A/G	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs1153858	1.000	rs16942568	chr15:45677390	T/C	cg21132104	chr15:45694354	SPATA5L1	0.93	7.94	0.67	1.22e-11	Homoarginine levels;
SKCM	cis	rs7811142	0.775	rs1636980	chr7:99938864	A/G	cg00814883	chr7:100076585	TSC22D4	0.85	4.91	0.49	4.81e-6	Platelet count;
SKCM	cis	rs6580649	0.941	rs72644844	chr12:48465425	A/C	cg05342945	chr12:48394962	COL2A1	0.73	5.2	0.51	1.53e-6	Lung cancer;
SKCM	cis	rs6952808	0.792	rs12531315	chr7:1953650	C/G	cg02951883	chr7:2050386	MAD1L1	-0.7	-5.94	-0.56	7.54e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs1461503	0.966	rs1461504	chr11:122845129	T/C	cg27398637	chr11:122830231	C11orf63	-0.63	-4.8	-0.48	7.54e-6	Menarche (age at onset);
SKCM	cis	rs35766269	0.541	rs80146554	chr10:9043614	G/A	cg05671070	chr10:8095960	FLJ45983;GATA3	0.95	4.77	0.48	8.45e-6	Recalcitrant atopic dermatitis;
SKCM	cis	rs11673344	0.764	rs826304	chr19:37443583	T/G	cg07624650	chr19:37064219	ZNF529	-0.78	-4.82	-0.48	7.05e-6	Obesity-related traits;
SKCM	cis	rs634534	0.563	rs470192	chr11:65724291	C/T	cg26695010	chr11:65641043	EFEMP2	-0.7	-5.32	-0.52	9.78e-7	Sum eosinophil basophil counts;Eosinophil counts;
SKCM	cis	rs867186	1.000	rs11907010	chr20:33737661	C/T	cg04194272	chr20:33683537	NA	-1.11	-6.01	-0.56	5.7e-8	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs28595532	0.764	rs55913633	chr4:119747444	C/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs11098499	0.865	rs4507344	chr4:120307485	C/A	cg09307838	chr4:120376055	NA	0.97	7.47	0.65	9.97e-11	Corneal astigmatism;
SKCM	cis	rs8017423	0.967	rs61989980	chr14:90727635	C/T	cg04374321	chr14:90722782	PSMC1	1.06	9.26	0.72	3.32e-14	Mortality in heart failure;
SKCM	cis	rs875971	0.862	rs1612452	chr7:65573896	T/A	cg18876405	chr7:65276391	NA	-0.65	-6.63	-0.6	3.96e-9	Aortic root size;
SKCM	cis	rs1927702	0.591	rs72708861	chr9:15897290	C/A	cg14451791	chr9:16040625	NA	0.43	5.06	0.5	2.76e-6	Body mass index;
SKCM	cis	rs34172651	0.517	rs1465423	chr16:24772680	C/G	cg00339695	chr16:24857497	SLC5A11	-0.8	-6.43	-0.59	9.38e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs7809950	0.678	rs77395658	chr7:107000651	G/A	cg23024343	chr7:107201750	COG5	-0.82	-7.0	-0.62	7.72e-10	Coronary artery disease;
SKCM	cis	rs6088580	0.634	rs2225837	chr20:33005634	C/T	cg24642439	chr20:33292090	TP53INP2	-0.76	-6.02	-0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs2404602	0.622	rs11637296	chr15:77207885	C/A	cg23625390	chr15:77176239	SCAPER	-0.83	-8.01	-0.67	9.15e-12	Blood metabolite levels;
SKCM	cis	rs1799949	0.965	rs35954893	chr17:41333786	A/G	cg23758822	chr17:41437982	NA	0.93	7.84	0.66	1.91e-11	Menopause (age at onset);
SKCM	cis	rs8016982	0.657	rs11625861	chr14:81735001	C/T	cg01989461	chr14:81687754	GTF2A1	-0.71	-5.67	-0.54	2.36e-7	Schizophrenia;
SKCM	cis	rs908922	0.676	rs11205031	chr1:152527662	C/T	cg09873164	chr1:152488093	CRCT1	0.72	5.62	0.54	2.85e-7	Hair morphology;
SKCM	cis	rs67460515	0.563	rs4679672	chr3:160901020	G/A	cg03342759	chr3:160939853	NMD3	-0.73	-6.13	-0.57	3.34e-8	Parkinson's disease;
SKCM	cis	rs4919087	0.962	rs10882891	chr10:99059645	C/A	cg25902810	chr10:99078978	FRAT1	0.65	4.99	0.49	3.65e-6	Monocyte count;
SKCM	cis	rs9910055	0.552	rs12937114	chr17:42325073	A/G	cg10896456	chr17:42255109	ASB16;C17orf65	0.6	4.89	0.48	5.2e-6	Total body bone mineral density;
SKCM	cis	rs6933660	0.800	rs963193	chr6:151789355	G/T	cg10883421	chr6:151773342	RMND1;C6orf211	-0.79	-6.86	-0.61	1.46e-9	Menarche (age at onset);
SKCM	cis	rs7618915	0.508	rs13065851	chr3:52644836	T/A	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs4968361	0.892	rs4968363	chr17:57511073	T/C	cg02573089	chr17:57233042	PRR11;SKA2	1.18	5.16	0.5	1.81e-6	Schizophrenia;
SKCM	cis	rs17608059	0.611	rs62052300	chr17:13916799	G/A	cg11395062	chr17:14139857	CDRT15	0.64	5.36	0.52	8.32e-7	Temperament;
SKCM	cis	rs3091242	0.933	rs28633797	chr1:25741629	C/A	cg27572855	chr1:25598939	RHD	0.53	5.11	0.5	2.22e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs2243480	1.000	rs2257790	chr7:65600450	C/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs6489882	0.867	rs4766672	chr12:113365148	A/G	cg07232103	chr12:112566177	TRAFD1	0.61	4.84	0.48	6.34e-6	Chronic lymphocytic leukemia;
SKCM	cis	rs7208859	0.623	rs9894709	chr17:29078454	G/A	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs1348850	0.632	rs13009207	chr2:178501632	A/G	cg02961200	chr2:178257176	LOC100130691;AGPS	0.71	5.13	0.5	2.06e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs62344088	0.590	rs62345236	chr5:283519	G/A	cg22857025	chr5:266934	NA	-1.57	-5.52	-0.53	4.32e-7	Asthma (childhood onset);
SKCM	cis	rs12477438	0.834	rs11903311	chr2:99701807	T/C	cg26064155	chr2:99771622	LIPT1;TSGA10	-0.79	-5.13	-0.5	2.09e-6	Chronic sinus infection;
SKCM	cis	rs28595532	0.920	rs55668908	chr4:119769799	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs7408868	0.908	rs62113793	chr19:15277336	G/A	cg14696996	chr19:15285081	NOTCH3	0.83	4.91	0.49	4.84e-6	Pulse pressure;
SKCM	cis	rs2013441	0.579	rs34370440	chr17:20003430	A/G	cg13482628	chr17:19912719	NA	0.7	5.29	0.51	1.1e-6	Obesity-related traits;
SKCM	cis	rs9902453	1.000	rs62070270	chr17:28263980	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.81	5.79	0.55	1.43e-7	Coffee consumption (cups per day);
SKCM	cis	rs7666738	0.570	rs10032272	chr4:99095601	T/C	cg17366294	chr4:99064904	C4orf37	0.62	5.28	0.51	1.13e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6570726	0.818	rs412350	chr6:145852409	T/C	cg23711669	chr6:146136114	FBXO30	0.85	8.86	0.71	1.97e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs28595532	0.920	rs115472708	chr4:119773407	C/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs362272	0.524	rs10937924	chr4:3374898	T/C	cg16987761	chr4:3318072	RGS12	0.93	10.25	0.76	4.21e-16	Serum sulfate level;
SKCM	cis	rs997295	0.513	rs11635495	chr15:67804682	T/C	cg24247231	chr15:67904302	MAP2K5	-0.61	-5.03	-0.49	3.06e-6	Motion sickness;
SKCM	cis	rs9325144	0.671	rs7306605	chr12:38730471	C/T	cg13010199	chr12:38710504	ALG10B	0.64	5.11	0.5	2.28e-6	Morning vs. evening chronotype;
SKCM	cis	rs8063761	0.576	rs4238832	chr16:90050261	C/T	cg08547343	chr16:90038815	CENPBD1;AFG3L1	1.14	11.19	0.79	6.77e-18	Squamous cell carcinoma;
SKCM	cis	rs9611565	0.659	rs12483998	chr22:41935362	A/G	cg03806693	chr22:41940476	POLR3H	-1.16	-7.72	-0.66	3.31e-11	Vitiligo;
SKCM	cis	rs4891159	0.548	rs617823	chr18:74120233	A/G	cg24786174	chr18:74118243	ZNF516	0.8	8.56	0.7	7.64e-13	Longevity;
SKCM	cis	rs2153535	0.580	rs6914276	chr6:8450435	A/T	cg23788917	chr6:8435910	SLC35B3	-0.66	-4.78	-0.48	8.07e-6	Motion sickness;
SKCM	cis	rs35306767	0.855	rs61830931	chr10:932497	T/C	cg20503657	chr10:835505	NA	0.92	6.59	0.6	4.73e-9	Eosinophil percentage of granulocytes;
SKCM	cis	rs4819052	1.000	rs2297284	chr21:46705345	G/A	cg02159808	chr21:46707872	POFUT2;LOC642852	0.87	6.61	0.6	4.23e-9	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs28386778	0.897	rs2156903	chr17:61937179	G/A	cg01411255	chr17:61851458	DDX42;CCDC47	0.79	5.1	0.5	2.35e-6	Prudent dietary pattern;
SKCM	cis	rs11155671	0.530	rs7768626	chr6:150207962	G/T	cg05036130	chr6:150231994	NA	0.6	6.88	0.61	1.31e-9	Testicular germ cell tumor;
SKCM	cis	rs597539	0.617	rs672853	chr11:68636362	G/A	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.84	5.61	0.54	3e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs6753739	0.871	rs10174319	chr2:220005308	T/C	cg09617556	chr2:219924408	IHH	-0.47	-4.8	-0.48	7.61e-6	Height;
SKCM	cis	rs79040073	0.530	rs3784630	chr15:49615149	A/G	cg25951582	chr15:49913451	C15orf33;DTWD1	-0.69	-5.05	-0.5	2.85e-6	Lung cancer in ever smokers;
SKCM	cis	rs4975616	0.869	rs31490	chr5:1344458	G/A	cg06550200	chr5:1325588	CLPTM1L	-0.86	-7.79	-0.66	2.45e-11	Lung cancer;
SKCM	cis	rs245880	0.740	rs245888	chr7:29190414	C/T	cg17163760	chr7:29186267	CPVL	-0.4	-5.37	-0.52	7.91e-7	Warfarin maintenance dose;
SKCM	cis	rs7215564	0.908	rs34914062	chr17:78655909	C/T	cg16980736	chr17:78789706	RPTOR	-0.89	-4.88	-0.48	5.41e-6	Myopia (pathological);
SKCM	cis	rs4689592	0.523	rs4256224	chr4:7074583	T/C	cg26116260	chr4:7069785	GRPEL1	1.21	8.46	0.69	1.23e-12	Monocyte percentage of white cells;
SKCM	cis	rs72781680	0.898	rs7589440	chr2:24038595	G/A	cg08917208	chr2:24149416	ATAD2B	1.0	4.97	0.49	3.82e-6	Lymphocyte counts;
SKCM	cis	rs870825	1.000	rs870821	chr4:185587377	T/C	cg04058563	chr4:185651563	MLF1IP	1.09	5.66	0.54	2.4e-7	Blood protein levels;
SKCM	cis	rs2204008	0.627	rs11176531	chr12:38152166	T/G	cg26384229	chr12:38710491	ALG10B	0.87	6.62	0.6	4.16e-9	Bladder cancer;
SKCM	cis	rs1799949	0.859	rs11657004	chr17:41442751	A/G	cg25918947	chr17:41365094	TMEM106A	-0.68	-6.5	-0.59	6.92e-9	Menopause (age at onset);
SKCM	cis	rs4808199	0.948	rs757000	chr19:19448301	A/G	cg03709012	chr19:19516395	GATAD2A	1.08	7.53	0.65	7.65e-11	Nonalcoholic fatty liver disease;
SKCM	trans	rs1814175	0.817	rs10769598	chr11:49669326	C/G	cg03929089	chr4:120376271	NA	-0.9	-8.23	-0.68	3.36e-12	Height;
SKCM	cis	rs9902453	0.904	rs12948898	chr17:28410324	G/A	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.84	-6.23	-0.58	2.22e-8	Coffee consumption (cups per day);
SKCM	cis	rs2204008	0.594	rs11531211	chr12:37998007	T/G	cg26384229	chr12:38710491	ALG10B	-0.74	-6.1	-0.57	3.77e-8	Bladder cancer;
SKCM	cis	rs9910055	0.762	rs6503489	chr17:42246289	G/A	cg10896456	chr17:42255109	ASB16;C17orf65	0.66	6.43	0.59	9.35e-9	Total body bone mineral density;
SKCM	cis	rs116095464	1.000	rs7736	chr5:314935	T/C	cg22857025	chr5:266934	NA	-1.64	-6.14	-0.57	3.18e-8	Breast cancer;
SKCM	cis	rs28595532	0.844	rs116721336	chr4:119536538	A/G	cg14228332	chr4:119757509	SEC24D	0.97	4.92	0.49	4.71e-6	Cannabis dependence symptom count;
SKCM	cis	rs4930103	0.711	rs217710	chr11:2007244	C/T	cg23202291	chr11:1979235	NA	0.64	6.22	0.58	2.28e-8	DNA methylation (parent-of-origin);DNA methylation (variation);
SKCM	cis	rs7772486	0.686	rs857875	chr6:145980033	T/G	cg05347473	chr6:146136440	FBXO30	-0.61	-5.46	-0.53	5.55e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs17572109	0.666	rs4674297	chr2:219229147	A/G	cg00012203	chr2:219082015	ARPC2	0.76	4.92	0.49	4.66e-6	Platelet count;Platelet distribution width;Mean platelet volume;
SKCM	cis	rs910316	1.000	rs1043674	chr14:75549370	T/C	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.89e-7	Height;
SKCM	cis	rs7666738	0.606	rs13108868	chr4:99083753	C/T	cg17366294	chr4:99064904	C4orf37	0.61	5.06	0.5	2.73e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs35306767	0.903	rs11253504	chr10:956046	A/G	cg20503657	chr10:835505	NA	0.75	5.83	0.55	1.19e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs919433	0.680	rs788021	chr2:198293691	T/C	cg04278110	chr2:198063759	ANKRD44	0.7	4.79	0.48	7.87e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs4927850	1.000	rs4927848	chr3:195738406	A/G	cg01181863	chr3:195395398	SDHAP2	-0.91	-6.17	-0.57	2.8e-8	Pancreatic cancer;
SKCM	cis	rs1580019	0.844	rs1376290	chr7:32486922	C/T	cg06627557	chr7:32535165	LSM5;AVL9	0.74	5.21	0.51	1.49e-6	Cognitive ability;
SKCM	cis	rs523522	0.962	rs10774549	chr12:120891172	C/T	cg27279351	chr12:120934652	DYNLL1	0.9	7.79	0.66	2.42e-11	High light scatter reticulocyte count;
SKCM	cis	rs951366	0.903	rs823116	chr1:205720483	G/A	cg07157834	chr1:205819609	PM20D1	0.68	5.33	0.52	9.26e-7	Menarche (age at onset);
SKCM	cis	rs6500395	1.000	rs7190106	chr16:48705542	C/T	cg04672837	chr16:48644449	N4BP1	0.65	5.52	0.53	4.23e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs10911251	0.508	rs2296297	chr1:183105324	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.76	7.47	0.65	1e-10	Colorectal cancer;
SKCM	cis	rs28386778	0.830	rs6504180	chr17:61813169	T/C	cg06873352	chr17:61820015	STRADA	0.76	6.34	0.58	1.38e-8	Prudent dietary pattern;
SKCM	cis	rs17685	0.712	rs56088021	chr7:75852480	C/T	cg01364799	chr7:75623366	TMEM120A	-0.7	-5.66	-0.54	2.39e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs116095464	0.558	rs10060089	chr5:205565	G/A	cg22496380	chr5:211416	CCDC127	-1.0	-5.11	-0.5	2.25e-6	Breast cancer;
SKCM	cis	rs6121246	0.559	rs6087779	chr20:30370566	T/C	cg13852791	chr20:30311386	BCL2L1	0.82	5.69	0.54	2.09e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs951366	0.646	rs1772159	chr1:205759195	G/A	cg14893161	chr1:205819251	PM20D1	1.03	11.24	0.79	5.49e-18	Menarche (age at onset);
SKCM	cis	rs9389248	0.690	rs6569982	chr6:135256495	C/G	cg24558204	chr6:135376177	HBS1L	0.63	6.0	0.56	5.78e-8	High light scatter reticulocyte percentage of red cells;
SKCM	cis	rs2658782	0.789	rs3020057	chr11:93118515	C/T	cg15737290	chr11:93063684	CCDC67	0.72	5.04	0.5	3e-6	Pulmonary function decline;
SKCM	cis	rs1577917	0.958	rs6900436	chr6:86506288	T/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.37	-0.52	7.87e-7	Response to antipsychotic treatment;
SKCM	cis	rs72772090	0.908	rs17086588	chr5:96044914	C/T	cg17330273	chr5:96107758	CAST;ERAP1	0.82	4.98	0.49	3.73e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs60871478	1.000	rs62432242	chr7:797715	G/A	cg05535760	chr7:792225	HEATR2	1.02	8.66	0.7	4.97e-13	Cerebrospinal P-tau181p levels;
SKCM	cis	rs2120019	1.000	rs12898259	chr15:75369780	G/A	cg09165964	chr15:75287851	SCAMP5	-0.78	-6.63	-0.6	3.95e-9	Blood trace element (Zn levels);
SKCM	cis	rs1552244	1.000	rs7628448	chr3:10146828	G/A	cg02579736	chr3:10068473	FANCD2;CIDECP	1.23	6.92	0.62	1.13e-9	Alzheimer's disease;
SKCM	cis	rs17685	0.753	rs2868203	chr7:75680026	G/A	cg16489192	chr7:75678113	MDH2;STYXL1	0.58	5.44	0.52	5.83e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7590720	1.000	rs4674048	chr2:216900023	G/A	cg12620499	chr2:216877984	MREG	0.9	7.96	0.67	1.13e-11	Alcohol dependence;
SKCM	cis	rs6430585	0.536	rs60397494	chr2:136470219	C/T	cg07169764	chr2:136633963	MCM6	1.15	8.6	0.7	6.43e-13	Corneal structure;
SKCM	cis	rs11690935	0.959	rs12692973	chr2:172642057	A/G	cg13550731	chr2:172543902	DYNC1I2	0.95	8.21	0.68	3.64e-12	Schizophrenia;
SKCM	cis	rs6952808	0.723	rs4721282	chr7:2025040	A/G	cg02951883	chr7:2050386	MAD1L1	-0.79	-7.06	-0.62	6.04e-10	Bipolar disorder and schizophrenia;
SKCM	cis	rs7772486	0.686	rs4895684	chr6:146114023	A/C	cg23711669	chr6:146136114	FBXO30	-0.85	-9.32	-0.73	2.62e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1801251	0.896	rs2305141	chr2:233684402	A/G	cg25237894	chr2:233734115	C2orf82	-0.54	-5.0	-0.49	3.39e-6	Coronary artery disease;
SKCM	cis	rs9902453	0.834	rs9901694	chr17:28271645	G/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.65	0.54	2.48e-7	Coffee consumption (cups per day);
SKCM	cis	rs4821897	0.514	rs739141	chr22:39824450	A/G	cg11247378	chr22:39784982	NA	0.45	4.91	0.49	4.82e-6	IgG glycosylation;
SKCM	cis	rs1256061	0.603	rs1256044	chr14:64734027	G/A	cg21174375	chr14:64681225	SYNE2	0.47	4.95	0.49	4.15e-6	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs1850744	0.826	rs13101880	chr4:9707827	A/G	cg15442990	chr4:9534313	NA	1.2	5.22	0.51	1.44e-6	Economic and political preferences;
SKCM	cis	rs7927771	0.689	rs10734557	chr11:47380061	A/C	cg05585544	chr11:47624801	NA	0.57	4.86	0.48	6.06e-6	Subjective well-being;
SKCM	cis	rs2180341	1.000	rs4897207	chr6:127605898	C/T	cg27446573	chr6:127587934	RNF146	1.0	8.68	0.7	4.48e-13	Breast cancer;
SKCM	cis	rs2842992	0.830	rs1475123	chr6:160178007	A/G	cg19482086	chr6:160211437	TCP1;MRPL18	0.86	5.99	0.56	6.17e-8	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs3816788	0.792	rs13257744	chr8:21872853	T/C	cg17168535	chr8:21777572	XPO7	0.87	7.33	0.64	1.88e-10	Lung cancer in ever smokers;
SKCM	cis	rs2346177	0.542	rs6757564	chr2:46702619	G/C	cg02822958	chr2:46747628	ATP6V1E2	0.7	5.19	0.51	1.61e-6	HDL cholesterol;
SKCM	cis	rs7917772	0.503	rs2031602	chr10:104307955	G/C	cg11453585	chr10:104263688	ACTR1A;SUFU	0.76	6.2	0.57	2.5e-8	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs875971	0.571	rs160641	chr7:65577346	G/A	cg18876405	chr7:65276391	NA	-0.64	-5.29	-0.51	1.09e-6	Aortic root size;
SKCM	cis	rs793571	0.590	rs442495	chr15:59022615	T/C	cg05156742	chr15:59063176	FAM63B	0.69	4.81	0.48	7.28e-6	Schizophrenia;
SKCM	cis	rs3213545	0.700	rs2260399	chr12:121469653	C/T	cg02403541	chr12:121454288	C12orf43	0.75	6.31	0.58	1.56e-8	Subjective well-being;Cardiovascular disease risk factors;
SKCM	cis	rs10540	1.000	rs61876342	chr11:496193	T/G	cg03352830	chr11:487213	PTDSS2	0.94	4.91	0.49	4.87e-6	Body mass index;
SKCM	cis	rs910316	0.763	rs2080201	chr14:75629972	C/T	cg08847533	chr14:75593920	NEK9	-0.83	-6.78	-0.61	2.02e-9	Height;
SKCM	cis	rs7927771	0.864	rs755554	chr11:47432034	G/C	cg05585544	chr11:47624801	NA	0.56	4.84	0.48	6.36e-6	Subjective well-being;
SKCM	cis	rs5750830	0.649	rs4821895	chr22:39823015	A/G	cg24399712	chr22:39784796	NA	-0.6	-5.19	-0.51	1.65e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs999943	0.810	rs62407648	chr6:33622436	C/G	cg14003231	chr6:33640908	ITPR3	0.67	5.44	0.52	5.86e-7	Obesity (extreme);
SKCM	cis	rs2404602	0.647	rs920712	chr15:77033934	G/A	cg23625390	chr15:77176239	SCAPER	-0.85	-8.26	-0.68	2.93e-12	Blood metabolite levels;
SKCM	cis	rs1801251	0.778	rs709933	chr2:233733144	G/A	cg25237894	chr2:233734115	C2orf82	-0.58	-6.13	-0.57	3.39e-8	Coronary artery disease;
SKCM	trans	rs1814175	0.765	rs1721990	chr11:49912154	G/C	cg15704280	chr7:45808275	SEPT13	-1.01	-10.01	-0.75	1.21e-15	Height;
SKCM	cis	rs60871478	0.731	rs71518343	chr7:755652	T/A	cg05535760	chr7:792225	HEATR2	1.11	9.42	0.73	1.66e-14	Cerebrospinal P-tau181p levels;
SKCM	cis	rs10504229	0.683	rs16921937	chr8:58145010	A/G	cg02725872	chr8:58115012	NA	-0.53	-4.91	-0.49	4.82e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs9611565	0.592	rs9611612	chr22:41961189	T/C	cg03806693	chr22:41940476	POLR3H	-1.03	-6.86	-0.61	1.45e-9	Vitiligo;
SKCM	cis	rs12541335	0.639	rs11135995	chr8:22200148	C/T	cg26039829	chr8:22132926	PIWIL2	-0.65	-5.86	-0.55	1.07e-7	Hypertriglyceridemia;
SKCM	cis	rs1949733	0.635	rs4358384	chr4:8536913	C/T	cg11789530	chr4:8429930	ACOX3	-0.74	-4.87	-0.48	5.82e-6	Response to antineoplastic agents;
SKCM	cis	rs8177253	0.829	rs9882812	chr3:133506127	A/G	cg16414030	chr3:133502952	NA	-0.7	-5.61	-0.54	2.99e-7	Iron status biomarkers;
SKCM	cis	rs1401999	0.606	rs939335	chr3:183745663	A/G	cg01324343	chr3:183735012	ABCC5	0.64	6.59	0.6	4.67e-9	Anterior chamber depth;
SKCM	cis	rs6500395	0.925	rs16946342	chr16:48668542	G/A	cg04672837	chr16:48644449	N4BP1	0.63	5.29	0.51	1.08e-6	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs7666738	0.830	rs2019163	chr4:99022747	C/T	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	1.98e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs8180040	0.620	rs17784127	chr3:47061700	T/C	cg27129171	chr3:47204927	SETD2	-0.74	-5.37	-0.52	7.84e-7	Colorectal cancer;
SKCM	cis	rs6977660	1.000	rs13237667	chr7:19820288	G/C	cg07541023	chr7:19748670	TWISTNB	0.7	4.82	0.48	6.98e-6	Thyroid stimulating hormone;
SKCM	cis	rs7296418	0.961	rs1790094	chr12:123586688	T/C	cg06742321	chr12:123595122	PITPNM2	0.66	5.52	0.53	4.24e-7	Platelet count;
SKCM	cis	rs2197308	0.765	rs7295711	chr12:37903631	C/T	cg26384229	chr12:38710491	ALG10B	0.82	6.88	0.61	1.35e-9	Morning vs. evening chronotype;
SKCM	cis	rs6952808	0.964	rs6945719	chr7:1932688	G/A	cg05863683	chr7:1912471	MAD1L1	0.64	5.63	0.54	2.78e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs28595532	0.920	rs56150431	chr4:119764786	T/C	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs1325195	0.537	rs2793805	chr1:179195777	A/G	cg10806749	chr1:179558114	NA	0.59	5.44	0.52	5.84e-7	IgE grass sensitization;
SKCM	cis	rs873946	0.529	rs12258248	chr10:134573767	A/G	cg26818010	chr10:134567672	INPP5A	-0.72	-5.44	-0.52	5.84e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs644799	1.000	rs474442	chr11:95583995	A/G	cg03916912	chr11:95522834	CEP57;FAM76B	0.89	7.87	0.67	1.69e-11	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs703842	0.928	rs724834	chr12:58180416	G/C	cg04478727	chr12:58166393	METTL1;FAM119B	0.73	5.84	0.55	1.15e-7	Multiple sclerosis;
SKCM	cis	rs2120019	1.000	rs7162900	chr15:75368017	T/C	cg09165964	chr15:75287851	SCAMP5	-0.78	-6.63	-0.6	3.95e-9	Blood trace element (Zn levels);
SKCM	cis	rs17376456	0.877	rs10073039	chr5:93467709	A/G	cg25358565	chr5:93447407	FAM172A	1.23	7.97	0.67	1.08e-11	Diabetic retinopathy;
SKCM	cis	rs2839186	0.732	rs55904887	chr21:47707811	A/G	cg11766577	chr21:47581405	C21orf56	-0.71	-6.01	-0.56	5.6e-8	Testicular germ cell tumor;
SKCM	cis	rs873946	0.648	rs3750578	chr10:134563366	A/G	cg26818010	chr10:134567672	INPP5A	-0.79	-6.06	-0.57	4.54e-8	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	trans	rs1814175	0.692	rs1851873	chr11:49937767	A/G	cg15704280	chr7:45808275	SEPT13	-0.86	-8.14	-0.68	5.04e-12	Height;
SKCM	cis	rs847649	0.767	rs11972261	chr7:102641244	T/G	cg18108683	chr7:102477205	FBXL13	0.82	7.72	0.66	3.33e-11	Morning vs. evening chronotype;
SKCM	cis	rs16854884	0.632	rs34071449	chr3:143662861	C/T	cg06585982	chr3:143692056	C3orf58	0.81	7.63	0.65	4.89e-11	Economic and political preferences (feminism/equality);
SKCM	cis	rs12682352	0.602	rs13260419	chr8:8675176	A/G	cg06636001	chr8:8085503	FLJ10661	0.72	5.76	0.55	1.6e-7	Neuroticism;
SKCM	cis	rs2013441	1.000	rs3850783	chr17:20184501	C/T	cg13482628	chr17:19912719	NA	0.65	4.96	0.49	4.1e-6	Obesity-related traits;
SKCM	cis	rs2721195	0.967	rs1480000	chr8:145702007	C/T	cg15320075	chr8:145703422	NA	-0.98	-9.14	-0.72	5.79e-14	Age at first birth;
SKCM	cis	rs992157	0.560	rs6738394	chr2:219110625	G/A	cg00012203	chr2:219082015	ARPC2	-0.78	-6.52	-0.59	6.36e-9	Colorectal cancer;
SKCM	cis	rs9399137	0.507	rs11154791	chr6:135379148	A/G	cg24558204	chr6:135376177	HBS1L	0.64	5.52	0.53	4.34e-7	Glycated hemoglobin levels;Mean corpuscular volume;Hematology traits;HbA2 levels;Mean corpuscular hemoglobin;Hemoglobin levels;F-cell distribution;Platelet count;
SKCM	cis	rs6570726	0.902	rs9390326	chr6:145791222	A/G	cg23711669	chr6:146136114	FBXO30	-0.68	-6.55	-0.6	5.51e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs12188164	0.931	rs72717407	chr5:424653	G/A	cg26076054	chr5:421317	AHRR	-0.61	-4.8	-0.48	7.47e-6	Cystic fibrosis severity;
SKCM	cis	rs992157	1.000	rs736731	chr2:219120588	A/G	cg00012203	chr2:219082015	ARPC2	0.83	6.98	0.62	8.66e-10	Colorectal cancer;
SKCM	cis	rs12188164	0.840	rs67665078	chr5:428754	G/A	cg26076054	chr5:421317	AHRR	-0.56	-5.11	-0.5	2.22e-6	Cystic fibrosis severity;
SKCM	cis	rs908922	0.676	rs1053590	chr1:152488428	T/C	cg09873164	chr1:152488093	CRCT1	0.78	6.09	0.57	3.98e-8	Hair morphology;
SKCM	cis	rs7811142	1.000	rs11769700	chr7:100090049	T/C	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.19	7.92	0.67	1.33e-11	Platelet count;
SKCM	cis	rs951366	0.677	rs1775140	chr1:205672107	C/A	cg17178900	chr1:205818956	PM20D1	0.64	5.13	0.5	2.06e-6	Menarche (age at onset);
SKCM	trans	rs1814175	0.645	rs847630	chr11:49926360	C/T	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs12047808	0.841	rs73052637	chr1:179382552	G/C	cg09822482	chr1:179519214	C1orf125	-0.95	-5.17	-0.51	1.78e-6	Multiple sclerosis (age of onset);
SKCM	cis	rs11098499	0.955	rs35434465	chr4:120169378	C/G	cg09307838	chr4:120376055	NA	0.94	7.67	0.66	4.16e-11	Corneal astigmatism;
SKCM	cis	rs12142240	0.698	rs57267378	chr1:46816644	A/G	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs644799	0.710	rs56384142	chr11:95502075	G/T	cg25622487	chr11:95524042	FAM76B;CEP57	0.75	6.45	0.59	8.58e-9	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs6547631	0.622	rs61191323	chr2:85928631	G/A	cg24620635	chr2:85921963	GNLY	0.9	6.65	0.6	3.58e-9	Blood protein levels;
SKCM	cis	rs9308433	0.529	rs55760458	chr1:214491536	G/C	cg06198575	chr1:214491504	SMYD2	0.79	4.94	0.49	4.44e-6	IgG glycosylation;
SKCM	cis	rs10504229	1.000	rs72650900	chr8:58185675	T/A	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs7296418	0.961	rs1790106	chr12:123591596	G/T	cg00376283	chr12:123451042	ABCB9	0.96	8.66	0.7	5.01e-13	Platelet count;
SKCM	cis	rs1218582	0.772	rs6656435	chr1:154876869	G/A	cg24250549	chr1:154909240	PMVK	0.87	8.7	0.7	4.13e-13	Prostate cancer;
SKCM	cis	rs2153535	0.601	rs9406160	chr6:8464907	A/C	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs732765	0.734	rs12323528	chr14:75152068	G/T	cg25946216	chr14:74253857	C14orf43	-0.84	-5.21	-0.51	1.5e-6	Non-small cell lung cancer;
SKCM	cis	rs2070488	0.965	rs1058945	chr3:38532511	A/G	cg01465620	chr3:38496096	LOC100128640;ACVR2B	-0.97	-9.01	-0.71	1.04e-13	Electrocardiographic conduction measures;
SKCM	cis	rs875971	0.660	rs801192	chr7:66031952	C/G	cg00343986	chr7:65444356	GUSB	-0.7	-5.14	-0.5	1.98e-6	Aortic root size;
SKCM	cis	rs7811142	0.830	rs11761426	chr7:99956893	A/T	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.2	7.87	0.67	1.7e-11	Platelet count;
SKCM	cis	rs1707322	0.752	rs12024590	chr1:46127496	A/C	cg03146154	chr1:46216737	IPP	0.79	5.42	0.52	6.34e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs28386778	0.863	rs3760252	chr17:61852186	G/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.09	10.68	0.77	6.33e-17	Prudent dietary pattern;
SKCM	trans	rs208520	0.690	rs207102	chr6:66795671	G/A	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-1.02	-7.49	-0.65	9.2e-11	Exhaled nitric oxide output;
SKCM	cis	rs2839186	0.814	rs12482209	chr21:47664275	C/G	cg05896524	chr21:47604654	C21orf56	-0.69	-5.89	-0.55	9.17e-8	Testicular germ cell tumor;
SKCM	cis	rs908922	0.676	rs1538083	chr1:152517116	A/G	cg09873164	chr1:152488093	CRCT1	0.76	5.93	0.56	7.7e-8	Hair morphology;
SKCM	cis	rs9926296	0.548	rs6500439	chr16:89808275	A/C	cg27121462	chr16:89883253	FANCA	0.82	8.07	0.67	6.84e-12	Vitiligo;
SKCM	cis	rs4561483	0.798	rs456325	chr16:12012562	C/G	cg08843971	chr16:11963173	GSPT1	-0.68	-5.04	-0.5	2.91e-6	Testicular germ cell tumor;
SKCM	cis	rs2760061	0.766	rs947631	chr1:228223547	G/C	cg02753203	chr1:228287806	NA	0.71	6.04	0.56	4.87e-8	Diastolic blood pressure;
SKCM	cis	rs10751667	0.643	rs10794352	chr11:946294	T/C	cg10932868	chr11:921992	NA	0.55	5.1	0.5	2.36e-6	Alzheimer's disease (late onset);
SKCM	cis	rs7632954	0.588	rs35426335	chr3:8539240	T/C	cg06697448	chr3:8544912	LMCD1	-0.56	-4.96	-0.49	4.09e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs12497850	0.931	rs13064911	chr3:48952385	A/G	cg07636037	chr3:49044803	WDR6	1.02	11.0	0.78	1.56e-17	Parkinson's disease;
SKCM	cis	rs1552244	1.000	rs7615764	chr3:10082592	C/T	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs28595532	0.920	rs116205107	chr4:119730910	G/A	cg21605333	chr4:119757512	SEC24D	1.36	8.05	0.67	7.69e-12	Cannabis dependence symptom count;
SKCM	cis	rs7811142	0.887	rs35111986	chr7:100000274	C/A	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.19	7.91	0.67	1.4e-11	Platelet count;
SKCM	cis	rs7666738	0.800	rs1559858	chr4:99024075	A/G	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2645694	0.626	rs2703115	chr4:77824442	C/T	cg06046430	chr4:77819534	ANKRD56	0.52	5.66	0.54	2.43e-7	Emphysema distribution in smoking;
SKCM	cis	rs2070488	1.000	rs34258593	chr3:38464565	T/C	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.97	8.85	0.71	2.1e-13	Electrocardiographic conduction measures;
SKCM	cis	rs9911578	1.000	rs172565	chr17:56808996	A/T	cg05425664	chr17:57184151	TRIM37	-0.69	-5.21	-0.51	1.52e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs35146811	0.961	rs11771139	chr7:99736059	C/T	cg22906224	chr7:99728672	NA	0.64	4.98	0.49	3.67e-6	Coronary artery disease;
SKCM	cis	rs28386778	0.933	rs2665801	chr17:61952100	C/T	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.06	0.78	1.21e-17	Prudent dietary pattern;
SKCM	cis	rs1153858	1.000	rs1820518	chr15:45694579	C/T	cg21132104	chr15:45694354	SPATA5L1	0.89	7.21	0.63	3.12e-10	Homoarginine levels;
SKCM	cis	rs1805008	0.568	rs17232826	chr16:89842784	C/T	cg08547343	chr16:90038815	CENPBD1;AFG3L1	-1.13	-5.11	-0.5	2.26e-6	Skin colour saturation;
SKCM	cis	rs2228479	0.717	rs9282682	chr16:89805794	A/G	cg00800038	chr16:89945340	TCF25	-0.85	-4.9	-0.48	5.16e-6	Skin colour saturation;
SKCM	cis	rs7811142	0.830	rs705866	chr7:99965285	T/C	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.2	7.87	0.67	1.7e-11	Platelet count;
SKCM	cis	rs763014	0.865	rs710924	chr16:633353	T/C	cg07343612	chr16:622815	PIGQ	-0.7	-6.0	-0.56	5.84e-8	Height;
SKCM	cis	rs995000	0.868	rs4409689	chr1:63177365	A/G	cg06896770	chr1:63153194	DOCK7	0.75	6.28	0.58	1.79e-8	Triglyceride levels;
SKCM	cis	rs9916302	0.904	rs55660616	chr17:37684990	C/A	cg07936489	chr17:37558343	FBXL20	-0.9	-8.11	-0.68	5.65e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs1552244	0.572	rs6785976	chr3:10168647	A/G	cg00149659	chr3:10157352	C3orf10	1.13	5.45	0.53	5.74e-7	Alzheimer's disease;
SKCM	cis	rs2839186	0.934	rs13046494	chr21:47707430	A/C	cg11766577	chr21:47581405	C21orf56	-0.71	-6.01	-0.56	5.6e-8	Testicular germ cell tumor;
SKCM	cis	rs8180040	0.966	rs59586735	chr3:47518325	C/T	cg16586182	chr3:47516702	SCAP	0.76	5.32	0.52	9.63e-7	Colorectal cancer;
SKCM	cis	rs6546550	0.935	rs2872075	chr2:70068635	G/T	cg02498382	chr2:70120550	SNRNP27	-0.47	-5.2	-0.51	1.55e-6	Prevalent atrial fibrillation;
SKCM	cis	rs2180341	0.960	rs1964130	chr6:127677391	C/G	cg24812749	chr6:127587940	RNF146	0.84	5.79	0.55	1.38e-7	Breast cancer;
SKCM	cis	rs13256369	1.000	rs873063	chr8:8572447	A/G	cg06636001	chr8:8085503	FLJ10661	0.74	5.74	0.54	1.75e-7	Obesity-related traits;
SKCM	cis	rs1801251	0.574	rs2250660	chr2:233752551	G/C	cg25237894	chr2:233734115	C2orf82	-0.47	-4.92	-0.49	4.66e-6	Coronary artery disease;
SKCM	cis	rs8180040	0.603	rs9854790	chr3:47101306	T/G	cg27129171	chr3:47204927	SETD2	0.74	5.37	0.52	7.84e-7	Colorectal cancer;
SKCM	cis	rs933688	1.000	rs2059208	chr5:90732065	A/T	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.03	8.22	0.68	3.52e-12	Smoking behavior;
SKCM	cis	rs801193	1.000	rs10274773	chr7:66133578	G/A	cg00343986	chr7:65444356	GUSB	-0.67	-4.93	-0.49	4.55e-6	Aortic root size;
SKCM	cis	rs9300255	0.596	rs10773002	chr12:123746961	A/T	cg05973401	chr12:123451056	ABCB9	-0.75	-5.83	-0.55	1.18e-7	Neutrophil percentage of white cells;
SKCM	cis	rs6445797	0.574	rs3732512	chr3:56674524	C/T	cg13616963	chr3:57583610	ARF4	-0.73	-4.8	-0.48	7.61e-6	Gastritis;
SKCM	cis	rs1298637	0.800	rs8179495	chr1:53938221	G/C	cg09586583	chr1:54755153	SSBP3	0.57	4.86	0.48	5.88e-6	Nicotine use;
SKCM	cis	rs3845702	0.736	rs12465592	chr2:180862654	C/G	cg01881094	chr2:180872142	CWC22	1.26	6.25	0.58	2.01e-8	Schizophrenia;
SKCM	cis	rs28386778	0.897	rs2584615	chr17:61927774	T/C	cg01411255	chr17:61851458	DDX42;CCDC47	0.78	5.03	0.49	3.06e-6	Prudent dietary pattern;
SKCM	cis	rs10088262	0.629	rs12549683	chr8:124798276	G/C	cg20713898	chr8:124780851	FAM91A1	-0.7	-5.08	-0.5	2.55e-6	Pancreatic cancer;
SKCM	cis	rs7599312	0.517	rs10192988	chr2:213407782	T/G	cg20637307	chr2:213403960	ERBB4	0.76	5.6	0.54	3.12e-7	BMI (adjusted for smoking behaviour);BMI in non-smokers;Body mass index;Body mass index (joint analysis main effects and smoking interaction);
SKCM	cis	rs11155671	0.530	rs2342767	chr6:150209717	C/G	cg05036130	chr6:150231994	NA	0.61	6.58	0.6	4.87e-9	Testicular germ cell tumor;
SKCM	cis	rs748404	0.697	rs572959	chr15:43550502	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	0.69	5.79	0.55	1.41e-7	Lung cancer;
SKCM	cis	rs2905347	0.737	rs2010437	chr7:22631180	C/G	cg00394316	chr7:22539822	MGC87042	0.47	4.93	0.49	4.58e-6	Major depression and alcohol dependence;
SKCM	cis	rs7666738	0.606	rs10006414	chr4:99101401	T/C	cg17366294	chr4:99064904	C4orf37	0.63	5.34	0.52	8.85e-7	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9309711	0.961	rs11678655	chr2:3476234	T/G	cg10845886	chr2:3471009	TTC15	-0.84	-6.61	-0.6	4.32e-9	Neurofibrillary tangles;
SKCM	cis	rs2204008	0.837	rs11180482	chr12:38235950	G/A	cg26384229	chr12:38710491	ALG10B	0.87	6.9	0.62	1.21e-9	Bladder cancer;
SKCM	cis	rs910316	0.934	rs8006587	chr14:75664939	A/G	cg08847533	chr14:75593920	NEK9	0.98	9.37	0.73	2.08e-14	Height;
SKCM	cis	rs62244186	0.541	rs62244226	chr3:44831831	G/A	cg02073558	chr3:44770973	ZNF501	0.81	7.14	0.63	4.32e-10	Depressive symptoms;
SKCM	cis	rs8072100	0.935	rs4793978	chr17:45698175	G/A	cg25173405	chr17:45401733	C17orf57	0.58	5.23	0.51	1.37e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs4423214	0.879	rs1790345	chr11:71145941	G/A	cg05163923	chr11:71159392	DHCR7	-0.7	-6.35	-0.58	1.35e-8	Vitamin D levels;
SKCM	cis	rs2070488	0.775	rs7374458	chr3:38531211	T/G	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.75	6.03	0.56	5.19e-8	Electrocardiographic conduction measures;
SKCM	cis	rs6977660	0.941	rs5017197	chr7:19819967	T/A	cg07541023	chr7:19748670	TWISTNB	0.71	4.86	0.48	6.02e-6	Thyroid stimulating hormone;
SKCM	cis	rs17065868	0.881	rs9533892	chr13:45099358	T/C	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs9325144	0.671	rs7485963	chr12:38768254	C/G	cg26384229	chr12:38710491	ALG10B	-0.75	-6.52	-0.59	6.23e-9	Morning vs. evening chronotype;
SKCM	cis	rs28595532	0.920	rs10018977	chr4:119785229	C/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs11098499	0.863	rs3775841	chr4:120425777	A/C	cg24375607	chr4:120327624	NA	0.7	5.3	0.51	1.06e-6	Corneal astigmatism;
SKCM	cis	rs28595532	0.920	rs115046587	chr4:119779604	T/C	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs9911578	0.813	rs12452313	chr17:57129882	C/A	cg05425664	chr17:57184151	TRIM37	0.8	6.37	0.59	1.2e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs478304	0.654	rs1074156	chr11:65458169	G/T	cg27068330	chr11:65405492	SIPA1	-0.89	-7.48	-0.65	9.71e-11	Acne (severe);
SKCM	cis	rs1707322	1.000	rs4641257	chr1:46353589	G/A	cg03146154	chr1:46216737	IPP	0.75	5.15	0.5	1.94e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs8180040	0.654	rs6791062	chr3:47174343	T/A	cg27129171	chr3:47204927	SETD2	0.74	5.37	0.52	7.84e-7	Colorectal cancer;
SKCM	cis	rs7811142	0.830	rs11769057	chr7:99964661	A/G	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.07	6.7	0.6	2.88e-9	Platelet count;
SKCM	cis	rs55962025	0.711	rs7691627	chr4:3111410	G/A	cg09735869	chr4:3319127	RGS12	-0.6	-4.82	-0.48	7.03e-6	Parental longevity (mother's age at death);
SKCM	cis	rs3820068	0.506	rs17448966	chr1:15990983	T/G	cg24675056	chr1:15929824	NA	0.73	5.44	0.52	6.03e-7	Systolic blood pressure;
SKCM	cis	rs1005277	0.505	rs10827836	chr10:38215441	A/G	cg00409905	chr10:38381863	ZNF37A	0.63	5.89	0.56	9.1e-8	Extrinsic epigenetic age acceleration;
SKCM	trans	rs7618501	1.000	rs7618519	chr3:49772708	A/T	cg21659725	chr3:3221576	CRBN	-0.96	-9.61	-0.74	7.08e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs2228479	0.867	rs57940434	chr16:89975496	G/A	cg06558623	chr16:89946397	TCF25	1.27	7.17	0.63	3.78e-10	Skin colour saturation;
SKCM	cis	rs6430585	0.640	rs58301703	chr2:136532225	G/A	cg07169764	chr2:136633963	MCM6	1.31	13.14	0.83	1.86e-21	Corneal structure;
SKCM	cis	rs367615	0.704	rs55956735	chr5:108845042	A/G	cg17395555	chr5:108820864	NA	0.76	6.91	0.62	1.17e-9	Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs1005277	0.579	rs2474572	chr10:38385316	A/G	cg25427524	chr10:38739819	LOC399744	-0.68	-6.49	-0.59	7.18e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs3741404	1.000	rs11603042	chr11:64003843	G/T	cg19465662	chr11:63993652	NUDT22;TRPT1	0.82	5.8	0.55	1.33e-7	Platelet count;
SKCM	cis	rs28386778	0.897	rs1062790	chr17:61896455	A/G	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs2228479	0.557	rs57071566	chr16:89889327	T/G	cg06558623	chr16:89946397	TCF25	1.1	4.95	0.49	4.17e-6	Skin colour saturation;
SKCM	cis	rs6089584	0.893	rs6089306	chr20:60574868	G/A	cg23262073	chr20:60523788	NA	-0.51	-4.86	-0.48	5.9e-6	Body mass index;
SKCM	cis	rs875971	0.540	rs1723268	chr7:65473080	A/C	cg11764359	chr7:65958608	NA	0.88	6.67	0.6	3.32e-9	Aortic root size;
SKCM	cis	rs6089584	0.606	rs2144674	chr20:60576579	G/A	cg06108461	chr20:60628389	TAF4	-0.68	-5.6	-0.54	3.07e-7	Body mass index;
SKCM	cis	rs2354432	0.607	rs6689243	chr1:146710559	A/T	cg25205988	chr1:146714368	CHD1L	-1.19	-6.54	-0.59	5.94e-9	Mitochondrial DNA levels;
SKCM	cis	rs634534	0.563	rs470192	chr11:65724291	C/T	cg02427764	chr11:65769310	BANF1;EIF1AD	0.76	5.82	0.55	1.26e-7	Sum eosinophil basophil counts;Eosinophil counts;
SKCM	trans	rs10506458	0.915	rs79133015	chr12:63396838	G/A	cg03429785	chr15:59498649	MYO1E;LDHAL6B	-1.38	-7.54	-0.65	7.13e-11	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs10504229	1.000	rs66731170	chr8:58187895	C/G	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs11126435	0.641	rs6709863	chr2:74746080	C/T	cg03813688	chr2:74740991	TLX2	0.65	5.29	0.51	1.09e-6	Age-related hearing impairment (SNP x SNP interaction);
SKCM	cis	rs17345786	0.511	rs1138818	chr3:101399583	C/G	cg12386194	chr3:101231763	SENP7	0.69	5.68	0.54	2.23e-7	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs875971	0.638	rs3898855	chr7:66036398	G/C	cg00343986	chr7:65444356	GUSB	-0.7	-5.14	-0.5	1.98e-6	Aortic root size;
SKCM	cis	rs3020736	0.500	rs2413672	chr22:42513261	C/T	cg04733989	chr22:42467013	NAGA	-0.72	-5.62	-0.54	2.87e-7	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs3091242	0.933	rs11249250	chr1:25767609	G/A	cg27572855	chr1:25598939	RHD	0.53	5.06	0.5	2.67e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs595982	0.559	rs4802516	chr19:49366170	T/C	cg15549821	chr19:49342101	PLEKHA4	-0.87	-5.28	-0.51	1.14e-6	Red cell distribution width;
SKCM	cis	rs28374715	0.662	rs1554445	chr15:41503198	A/C	cg18705301	chr15:41695430	NDUFAF1	-0.93	-7.74	-0.66	2.94e-11	Ulcerative colitis;
SKCM	trans	rs2324229	0.861	rs1180184	chr6:83970665	A/C	cg16424311	chr6:49700271	CRISP3	0.73	7.85	0.66	1.8e-11	Platelet-derived growth factor BB levels;
SKCM	cis	rs9910055	0.529	rs228767	chr17:42188311	C/G	cg08499158	chr17:42289980	UBTF	0.75	6.12	0.57	3.53e-8	Total body bone mineral density;
SKCM	cis	rs10905065	1.000	rs7913067	chr10:5787305	C/T	cg11519256	chr10:5708881	ASB13	0.62	5.61	0.54	2.97e-7	Menopause (age at onset);
SKCM	cis	rs2929278	0.561	rs62018952	chr15:44080737	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	-0.76	-5.25	-0.51	1.3e-6	Schizophrenia;
SKCM	cis	rs7809950	0.906	rs62483723	chr7:107186358	A/C	cg23024343	chr7:107201750	COG5	-0.77	-6.95	-0.62	9.61e-10	Coronary artery disease;
SKCM	cis	rs6952808	0.771	rs4719336	chr7:1916397	T/C	cg03354898	chr7:1950403	MAD1L1	-0.54	-5.4	-0.52	6.92e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs17376456	0.825	rs72786702	chr5:93254656	A/C	cg25358565	chr5:93447407	FAM172A	1.3	7.53	0.65	7.57e-11	Diabetic retinopathy;
SKCM	cis	rs7860087	1	rs7860087	chr9:4500231	C/G	cg01036173	chr9:5437898	C9orf46	-1.34	-4.92	-0.49	4.77e-6	Interleukin-17 levels;
SKCM	cis	rs9300255	0.770	rs12299125	chr12:123862447	C/T	cg00376283	chr12:123451042	ABCB9	-0.78	-5.26	-0.51	1.24e-6	Neutrophil percentage of white cells;
SKCM	cis	rs9388451	0.839	rs980014	chr6:126068001	T/G	cg05901451	chr6:126070800	HEY2	-0.82	-8.2	-0.68	3.9e-12	Brugada syndrome;
SKCM	cis	rs7666738	0.830	rs28852677	chr4:99039509	T/G	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs801193	0.660	rs974239	chr7:66213491	G/A	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.52	5.03	0.5	3.01e-6	Aortic root size;
SKCM	cis	rs2153535	0.580	rs1328862	chr6:8526681	A/T	cg07606381	chr6:8435919	SLC35B3	0.93	6.8	0.61	1.92e-9	Motion sickness;
SKCM	cis	rs7666738	0.830	rs4392515	chr4:98957431	A/G	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9796	0.689	rs8032195	chr15:41448790	G/A	cg18705301	chr15:41695430	NDUFAF1	-0.74	-5.35	-0.52	8.47e-7	Menopause (age at onset);
SKCM	cis	rs9916302	0.851	rs4390625	chr17:37620347	A/G	cg07936489	chr17:37558343	FBXL20	-0.86	-7.39	-0.64	1.42e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs9790314	0.846	rs4290817	chr3:160967354	G/A	cg03342759	chr3:160939853	NMD3	-0.72	-8.12	-0.68	5.59e-12	Morning vs. evening chronotype;
SKCM	cis	rs17345786	0.906	rs72946021	chr3:101250008	T/G	cg12386194	chr3:101231763	SENP7	0.84	6.79	0.61	1.93e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7824557	0.527	rs2736296	chr8:11234844	G/A	cg21775007	chr8:11205619	TDH	-0.59	-5.04	-0.5	3e-6	Retinal vascular caliber;
SKCM	cis	rs2120019	0.608	rs4886414	chr15:75308650	C/T	cg09165964	chr15:75287851	SCAMP5	0.93	10.74	0.77	4.82e-17	Blood trace element (Zn levels);
SKCM	cis	rs9788682	1.000	rs12441354	chr15:78821016	G/A	cg24631222	chr15:78858424	CHRNA5	0.94	6.59	0.6	4.67e-9	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs344364	0.511	rs1742467	chr16:1950187	G/T	cg26897989	chr16:1907736	C16orf73	-0.69	-7.13	-0.63	4.45e-10	Glomerular filtration rate in chronic kidney disease;
SKCM	cis	rs910316	0.870	rs7147712	chr14:75670707	C/G	cg08847533	chr14:75593920	NEK9	-0.95	-8.63	-0.7	5.73e-13	Height;
SKCM	cis	rs763121	0.853	rs5757196	chr22:39039855	G/C	cg06022373	chr22:39101656	GTPBP1	0.72	4.96	0.49	4.08e-6	Menopause (age at onset);
SKCM	cis	rs7726839	0.507	rs56282020	chr5:596701	T/C	cg10555297	chr5:473380	SLC9A3;LOC25845	1.02	4.87	0.48	5.72e-6	Obesity-related traits;
SKCM	cis	rs514406	0.929	rs1242224	chr1:53314887	G/A	cg16325326	chr1:53192061	ZYG11B	0.92	9.93	0.75	1.75e-15	Monocyte count;
SKCM	cis	rs12477438	0.501	rs11123770	chr2:99825102	A/G	cg26064155	chr2:99771622	LIPT1;TSGA10	1.01	9.17	0.72	5.04e-14	Chronic sinus infection;
SKCM	cis	rs28595532	0.920	rs115294251	chr4:119772833	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs9399135	0.967	rs4376365	chr6:135307740	T/C	cg24558204	chr6:135376177	HBS1L	0.56	5.01	0.49	3.31e-6	Red blood cell count;
SKCM	cis	rs873946	0.586	rs3793682	chr10:134564563	C/T	cg26818010	chr10:134567672	INPP5A	-0.79	-6.06	-0.57	4.54e-8	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs3820068	0.603	rs3766163	chr1:15986547	T/C	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs6570726	0.599	rs455001	chr6:145854450	A/T	cg23711669	chr6:146136114	FBXO30	0.8	7.03	0.62	6.89e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1405130	0.967	rs11674748	chr2:235569445	G/A	cg21542780	chr2:234763377	HJURP	-0.65	-4.93	-0.49	4.59e-6	Coronary artery disease;
SKCM	cis	rs6582630	0.519	rs11495700	chr12:38288240	A/G	cg13010199	chr12:38710504	ALG10B	0.68	4.93	0.49	4.6e-6	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs7100689	0.753	rs1856773	chr10:82060484	T/A	cg00277334	chr10:82204260	NA	-0.58	-5.69	-0.54	2.16e-7	Post bronchodilator FEV1;
SKCM	cis	rs854765	0.647	rs854769	chr17:18019011	A/G	cg04398451	chr17:18023971	MYO15A	1.05	9.09	0.72	7.26e-14	Total body bone mineral density;
SKCM	cis	rs778371	0.697	rs11893358	chr2:233636922	T/C	cg08000102	chr2:233561755	GIGYF2	0.88	7.39	0.64	1.41e-10	Schizophrenia;
SKCM	cis	rs875971	0.660	rs13224319	chr7:66007363	A/G	cg00343986	chr7:65444356	GUSB	0.7	5.14	0.5	1.98e-6	Aortic root size;
SKCM	cis	rs4819052	0.851	rs7275870	chr21:46671214	C/T	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.42	0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs875971	0.830	rs427973	chr7:65526648	C/A	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.54	5.01	0.49	3.28e-6	Aortic root size;
SKCM	cis	rs1218582	0.741	rs6656494	chr1:154839799	A/G	cg09359103	chr1:154839909	KCNN3	-0.57	-5.42	-0.52	6.37e-7	Prostate cancer;
SKCM	cis	rs7666738	0.830	rs7686456	chr4:99019695	T/C	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6121246	0.954	rs6121245	chr20:30432060	G/A	cg11595048	chr20:30225325	COX4I2	0.65	5.03	0.49	3.1e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs6495122	0.630	rs12912343	chr15:75251041	C/G	cg09165964	chr15:75287851	SCAMP5	0.65	4.92	0.49	4.66e-6	Caffeine consumption;Diastolic blood pressure;Coffee consumption;
SKCM	cis	rs9900062	0.546	rs2676289	chr17:62705738	A/G	cg02097616	chr17:62675921	NA	-0.74	-6.25	-0.58	2.01e-8	QT interval;
SKCM	cis	rs910316	1.000	rs10142626	chr14:75555636	A/T	cg08847533	chr14:75593920	NEK9	0.94	8.89	0.71	1.76e-13	Height;
SKCM	trans	rs3749237	1.000	rs2291542	chr3:49751585	C/T	cg21659725	chr3:3221576	CRBN	0.99	7.4	0.64	1.35e-10	Resting heart rate;
SKCM	cis	rs910316	0.692	rs7156586	chr14:75506230	A/T	cg08847533	chr14:75593920	NEK9	0.76	6.55	0.6	5.68e-9	Height;
SKCM	cis	rs11651000	0.817	rs11657479	chr17:45822901	T/C	cg03474202	chr17:45855739	NA	-0.44	-4.8	-0.48	7.51e-6	IgG glycosylation;
SKCM	cis	rs10256972	0.552	rs2960830	chr7:1200641	T/C	cg09177884	chr7:1199841	ZFAND2A	-0.77	-6.47	-0.59	8.03e-9	Longevity;Endometriosis;
SKCM	trans	rs2289681	1.000	rs2289681	chr17:42989088	C/T	cg14595786	chr19:51626986	SIGLEC9	-1.09	-7.59	-0.65	5.95e-11	Cognitive function;
SKCM	cis	rs910316	1.000	rs12588240	chr14:75612083	C/A	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.89e-7	Height;
SKCM	trans	rs8073060	0.586	rs6505484	chr17:33993152	G/A	cg19694781	chr19:47549865	TMEM160	-1.04	-8.28	-0.68	2.65e-12	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs2739330	0.828	rs5760099	chr22:24248414	G/A	cg25703541	chr22:24373054	LOC391322	-0.81	-6.47	-0.59	7.97e-9	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs769267	0.896	rs11882123	chr19:19386339	A/G	cg03709012	chr19:19516395	GATAD2A	0.81	6.49	0.59	7.18e-9	Tonsillectomy;
SKCM	cis	rs1153858	0.621	rs2413769	chr15:45561868	A/C	cg21132104	chr15:45694354	SPATA5L1	0.76	5.25	0.51	1.3e-6	Homoarginine levels;
SKCM	cis	rs6952808	0.689	rs58227534	chr7:2046328	A/G	cg21782813	chr7:2030301	MAD1L1	0.59	6.14	0.57	3.23e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs9303401	0.659	rs36093395	chr17:56957357	C/T	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.16	0.57	2.91e-8	Cognitive test performance;
SKCM	cis	rs854765	0.647	rs854808	chr17:18006634	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.83	6.5	0.59	6.85e-9	Total body bone mineral density;
SKCM	cis	rs7111031	0.967	rs7121986	chr11:113355444	T/C	cg04642306	chr11:112834466	NCAM1	0.45	5.03	0.5	3.03e-6	Subjective well-being (multi-trait analysis);Depressive symptoms (multi-trait analysis);Neuroticism;
SKCM	cis	rs10197940	0.578	rs6718372	chr2:152345871	C/G	cg19508488	chr2:152266495	RIF1	0.59	4.78	0.48	8.2e-6	Lung cancer;
SKCM	cis	rs40363	0.523	rs757270	chr16:3534451	C/T	cg22508957	chr16:3507546	NAT15	-0.64	-5.06	-0.5	2.74e-6	Tuberculosis;
SKCM	cis	rs4862750	0.914	rs7658351	chr4:187875680	G/T	cg10295955	chr4:187884368	NA	-1.05	-13.85	-0.84	1.01e-22	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs55962025	0.883	rs82334	chr4:3225371	A/C	cg00764545	chr4:3318001	RGS12	-0.71	-5.79	-0.55	1.39e-7	Parental longevity (mother's age at death);
SKCM	cis	rs736408	0.812	rs9881468	chr3:52828628	C/T	cg11645453	chr3:52864694	ITIH4	0.61	4.89	0.48	5.4e-6	Bipolar disorder;
SKCM	cis	rs96067	0.711	rs7521145	chr1:36622903	A/G	cg24686825	chr1:36642396	MAP7D1	-0.66	-4.94	-0.49	4.28e-6	Corneal structure;
SKCM	cis	rs1552244	1.000	rs67852463	chr3:10157205	G/C	cg02579736	chr3:10068473	FANCD2;CIDECP	1.23	6.8	0.61	1.9e-9	Alzheimer's disease;
SKCM	cis	rs2463822	0.844	rs2513737	chr11:62119495	G/C	cg06239285	chr11:62104954	ASRGL1	1.26	5.85	0.55	1.08e-7	Chronic obstructive pulmonary disease-related biomarkers;
SKCM	cis	rs9910055	0.659	rs6503488	chr17:42246158	T/G	cg19774624	chr17:42201019	HDAC5	-0.9	-8.49	-0.69	1.04e-12	Total body bone mineral density;
SKCM	cis	rs7552404	0.824	rs1251079	chr1:76189445	C/T	cg10523679	chr1:76189770	ACADM	0.85	6.63	0.6	3.91e-9	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs748404	0.723	rs11853991	chr15:43557549	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	0.73	5.9	0.56	8.7e-8	Lung cancer;
SKCM	cis	rs2839186	1.000	rs2839181	chr21:47685939	A/G	cg11766577	chr21:47581405	C21orf56	-0.7	-6.02	-0.56	5.28e-8	Testicular germ cell tumor;
SKCM	cis	rs801193	1.000	rs2659909	chr7:66160279	G/A	cg00343986	chr7:65444356	GUSB	0.7	5.14	0.5	1.98e-6	Aortic root size;
SKCM	cis	rs9790314	1.000	rs336579	chr3:161086610	G/A	cg03342759	chr3:160939853	NMD3	-0.72	-7.89	-0.67	1.53e-11	Morning vs. evening chronotype;
SKCM	cis	rs2180341	0.920	rs4472373	chr6:127705983	G/A	cg27446573	chr6:127587934	RNF146	0.92	7.98	0.67	1.02e-11	Breast cancer;
SKCM	cis	rs10752881	1.000	rs10911191	chr1:182984524	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.67	6.2	0.57	2.46e-8	Colorectal cancer;
SKCM	cis	rs28386778	0.897	rs9906247	chr17:61857314	T/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs6450176	1.000	rs12521454	chr5:53297304	T/C	ch.5.1024479R	chr5:53302184	ARL15	-0.73	-5.04	-0.5	2.91e-6	HDL cholesterol levels;HDL cholesterol;Adiponectin levels;
SKCM	cis	rs16940212	0.505	rs75437656	chr15:58681128	A/C	cg16767221	chr15:57769667	CGNL1	-0.68	-5.28	-0.51	1.13e-6	HDL cholesterol levels;HDL cholesterol;
SKCM	cis	rs11785400	1.000	rs4557682	chr8:143738182	T/C	cg20003893	chr8:144489567	NA	-0.55	-4.79	-0.48	7.95e-6	Schizophrenia;
SKCM	cis	rs28386778	0.897	rs2584624	chr17:61904546	A/G	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs8103278	0.507	rs8112282	chr19:46265029	C/T	cg14061069	chr19:46274453	DMPK	0.52	5.4	0.52	7.04e-7	Coronary artery disease;
SKCM	cis	rs1552244	0.882	rs55808392	chr3:10054681	C/T	cg02579736	chr3:10068473	FANCD2;CIDECP	0.94	4.84	0.48	6.49e-6	Alzheimer's disease;
SKCM	cis	rs672059	1.000	rs3120034	chr1:183167051	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.65	5.49	0.53	4.85e-7	Hypertriglyceridemia;
SKCM	cis	rs1218582	0.772	rs4845688	chr1:154884142	T/C	cg09359103	chr1:154839909	KCNN3	-0.57	-5.3	-0.51	1.05e-6	Prostate cancer;
SKCM	trans	rs1814175	0.791	rs11040472	chr11:49703116	C/T	cg15704280	chr7:45808275	SEPT13	-1.02	-10.75	-0.77	4.66e-17	Height;
SKCM	cis	rs7208859	0.623	rs1054400	chr17:29109954	A/G	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs10254118	0.757	rs7788086	chr7:133135206	C/T	cg10665199	chr7:133106180	EXOC4	0.78	5.16	0.5	1.81e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs6088580	0.634	rs6059892	chr20:33105766	A/G	cg24642439	chr20:33292090	TP53INP2	0.76	6.02	0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs11098499	0.866	rs13105020	chr4:120285688	G/T	cg09307838	chr4:120376055	NA	0.98	7.89	0.67	1.52e-11	Corneal astigmatism;
SKCM	cis	rs2204008	0.641	rs66876045	chr12:38205713	G/A	cg13010199	chr12:38710504	ALG10B	0.65	4.84	0.48	6.52e-6	Bladder cancer;
SKCM	cis	rs1552244	1.000	rs67006488	chr3:10152993	T/C	cg02579736	chr3:10068473	FANCD2;CIDECP	1.23	6.92	0.62	1.13e-9	Alzheimer's disease;
SKCM	cis	rs1023500	0.552	rs5758566	chr22:42454354	G/A	cg04733989	chr22:42467013	NAGA	0.73	5.84	0.55	1.14e-7	Schizophrenia;
SKCM	cis	rs4132509	1.000	rs10927078	chr1:243983830	C/T	cg21452805	chr1:244014465	NA	0.88	5.2	0.51	1.58e-6	RR interval (heart rate);
SKCM	cis	rs7666738	0.830	rs114722517	chr4:99042061	G/A	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1577917	0.958	rs13201730	chr6:86556647	T/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.68	-5.91	-0.56	8.36e-8	Response to antipsychotic treatment;
SKCM	cis	rs7191439	0.789	rs4598894	chr16:88776141	G/A	cg02389323	chr16:88786976	FAM38A	1.34	6.31	0.58	1.56e-8	Plateletcrit;
SKCM	cis	rs12709013	0.792	rs11644344	chr16:58836984	A/G	cg02431531	chr16:59244939	NA	0.48	4.99	0.49	3.62e-6	Blood metabolite ratios;
SKCM	cis	rs55823223	0.793	rs3744028	chr17:73888672	T/C	cg10935138	chr17:73851978	WBP2	1.13	6.35	0.58	1.31e-8	Psoriasis;
SKCM	cis	rs10540	1.000	rs117339389	chr11:505025	T/A	cg03352830	chr11:487213	PTDSS2	0.94	4.91	0.49	4.87e-6	Body mass index;
SKCM	trans	rs17685	0.725	rs4476928	chr7:75642107	C/A	cg19862616	chr7:65841803	NCRNA00174	-0.94	-9.39	-0.73	1.88e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7811142	0.943	rs66958101	chr7:100074020	G/A	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.23	7.89	0.67	1.53e-11	Platelet count;
SKCM	cis	rs9394841	0.667	rs3747750	chr6:41760372	C/G	cg08135965	chr6:41755394	TOMM6	0.75	4.96	0.49	3.96e-6	Mean corpuscular hemoglobin;Red cell distribution width;
SKCM	cis	rs9290877	0.965	rs17671434	chr3:188445439	A/C	cg17392043	chr3:188495102	LPP	0.62	4.99	0.49	3.59e-6	IgE levels;
SKCM	cis	rs644799	0.544	rs1622515	chr11:95523433	A/G	cg03916912	chr11:95522834	CEP57;FAM76B	0.61	4.87	0.48	5.73e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs651907	0.535	rs12631513	chr3:101517476	A/C	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.78	6.72	0.61	2.65e-9	Colorectal cancer;
SKCM	cis	rs514406	0.679	rs960570	chr1:53237763	A/G	cg25767906	chr1:53392781	SCP2	0.61	4.89	0.48	5.25e-6	Monocyte count;
SKCM	cis	rs7618501	0.633	rs2252833	chr3:50004209	C/T	cg05072774	chr3:49840536	C3orf54	-0.67	-5.06	-0.5	2.73e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7216064	0.684	rs62084675	chr17:66027025	A/G	cg12091567	chr17:66097778	LOC651250	0.89	6.71	0.6	2.8e-9	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs9809213	1.000	rs11709621	chr3:72344601	C/T	cg09429735	chr3:71752026	EIF4E3	-0.54	-5.36	-0.52	8.07e-7	Cognitive ability;Cognitive ability (multi-trait analysis);
SKCM	cis	rs7143963	0.945	rs10144464	chr14:103331590	A/T	cg23020514	chr14:103360112	TRAF3	-0.83	-7.69	-0.66	3.81e-11	Body mass index;
SKCM	cis	rs9880211	1.000	rs28750366	chr3:136361055	T/C	cg21827317	chr3:136751795	NA	-0.64	-4.78	-0.48	8.21e-6	Body mass index;Height;
SKCM	cis	rs4481887	0.893	rs10888347	chr1:248448566	T/C	cg00666640	chr1:248458726	OR2T12	0.61	4.96	0.49	4.11e-6	Common traits (Other);
SKCM	cis	rs1355223	0.583	rs2915238	chr11:34884405	C/A	cg11058730	chr11:34937778	PDHX;APIP	0.63	5.08	0.5	2.5e-6	Systemic lupus erythematosus and Systemic sclerosis;
SKCM	cis	rs10751667	0.643	rs6597969	chr11:928843	C/T	cg06064525	chr11:970664	AP2A2	-0.55	-5.09	-0.5	2.46e-6	Alzheimer's disease (late onset);
SKCM	cis	rs4819052	0.851	rs2838858	chr21:46681093	T/A	cg20896738	chr21:46707857	POFUT2;LOC642852	0.65	4.89	0.48	5.35e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs1325195	0.520	rs410589	chr1:179232077	A/G	cg25467746	chr1:179556597	NA	0.59	5.64	0.54	2.59e-7	IgE grass sensitization;
SKCM	cis	rs420259	0.516	rs4968008	chr16:23490353	G/T	cg10006042	chr16:23042421	NA	0.37	4.9	0.48	5.14e-6	Bipolar disorder;
SKCM	cis	rs995000	0.931	rs7548877	chr1:63005950	T/C	cg06896770	chr1:63153194	DOCK7	-0.75	-6.89	-0.61	1.29e-9	Triglyceride levels;
SKCM	cis	rs6545883	0.524	rs17482440	chr2:61548857	C/T	cg15711740	chr2:61764176	XPO1	0.66	5.12	0.5	2.17e-6	Tuberculosis;
SKCM	cis	rs7666738	0.830	rs7672127	chr4:98938477	A/G	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1707322	0.717	rs12023439	chr1:46104636	C/T	cg03146154	chr1:46216737	IPP	0.79	5.42	0.52	6.34e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs875971	0.862	rs6460279	chr7:65662761	T/C	cg18876405	chr7:65276391	NA	-0.65	-6.74	-0.61	2.46e-9	Aortic root size;
SKCM	cis	rs748404	0.578	rs512628	chr15:43618734	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	0.82	6.24	0.58	2.08e-8	Lung cancer;
SKCM	cis	rs6430585	0.528	rs309120	chr2:136708787	G/C	cg07169764	chr2:136633963	MCM6	1.24	10.24	0.76	4.47e-16	Corneal structure;
SKCM	cis	rs1577917	0.837	rs10944157	chr6:86577199	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.81	-7.92	-0.67	1.35e-11	Response to antipsychotic treatment;
SKCM	cis	rs2439831	0.850	rs8032649	chr15:44134922	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	-1.3	-6.97	-0.62	9.12e-10	Lung cancer in ever smokers;
SKCM	cis	rs28595532	0.920	rs115154263	chr4:119765307	G/A	cg14228332	chr4:119757509	SEC24D	1.09	5.59	0.53	3.22e-7	Cannabis dependence symptom count;
SKCM	cis	rs10791097	0.547	rs3829271	chr11:130753912	T/A	cg12179176	chr11:130786555	SNX19	0.93	8.26	0.68	2.91e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs7179456	0.557	rs446126	chr15:59113102	A/G	cg05156742	chr15:59063176	FAM63B	0.76	6.14	0.57	3.29e-8	Asperger disorder;
SKCM	cis	rs6089584	0.888	rs2146853	chr20:60617908	A/T	cg06108461	chr20:60628389	TAF4	-0.89	-8.72	-0.7	3.75e-13	Body mass index;
SKCM	cis	rs1801251	1.000	rs12474040	chr2:233615345	T/G	cg08000102	chr2:233561755	GIGYF2	0.87	7.05	0.62	6.23e-10	Coronary artery disease;
SKCM	cis	rs801193	1.000	rs3778909	chr7:66255646	G/C	cg11987759	chr7:65425863	GUSB	-0.67	-5.8	-0.55	1.36e-7	Aortic root size;
SKCM	cis	rs1153858	1.000	rs2461702	chr15:45647427	A/G	cg10760299	chr15:45669010	GATM	0.63	6.3	0.58	1.6e-8	Homoarginine levels;
SKCM	cis	rs2180341	0.782	rs6912552	chr6:127722946	C/G	cg24812749	chr6:127587940	RNF146	-0.66	-5.25	-0.51	1.3e-6	Breast cancer;
SKCM	cis	rs1153858	0.943	rs28605551	chr15:45641720	C/T	cg21132104	chr15:45694354	SPATA5L1	0.89	7.48	0.65	9.43e-11	Homoarginine levels;
SKCM	cis	rs7143963	0.945	rs56083744	chr14:103292191	G/A	cg23020514	chr14:103360112	TRAF3	0.9	8.54	0.7	8.45e-13	Body mass index;
SKCM	cis	rs362296	0.698	rs3095072	chr4:3263325	G/A	cg09735869	chr4:3319127	RGS12	-0.71	-6.3	-0.58	1.65e-8	Parental longevity (mother's age at death);
SKCM	cis	rs2980439	0.607	rs2980419	chr8:8114141	A/T	cg15556689	chr8:8085844	FLJ10661	0.82	6.41	0.59	1.03e-8	Neuroticism;
SKCM	cis	rs9611565	0.649	rs202614	chr22:41822150	A/C	cg03806693	chr22:41940476	POLR3H	1.13	7.36	0.64	1.63e-10	Vitiligo;
SKCM	cis	rs1577917	0.727	rs2758840	chr6:86304625	A/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.79	-7.4	-0.64	1.34e-10	Response to antipsychotic treatment;
SKCM	cis	rs367615	0.704	rs60538082	chr5:108829101	A/G	cg17395555	chr5:108820864	NA	0.74	6.65	0.6	3.62e-9	Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs28595532	0.841	rs114965278	chr4:119743694	T/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs4332037	0.950	rs7807014	chr7:1939021	T/C	cg23422044	chr7:1970798	MAD1L1	-0.96	-6.52	-0.59	6.37e-9	Bipolar disorder;
SKCM	cis	rs3947	0.653	rs1293296	chr8:11711157	A/C	cg00262122	chr8:11665843	FDFT1	-0.7	-4.96	-0.49	3.98e-6	Blood protein levels;
SKCM	cis	rs6582630	0.519	rs4406888	chr12:38293312	A/C	cg26384229	chr12:38710491	ALG10B	0.8	6.55	0.6	5.47e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs4803468	0.967	rs4803461	chr19:41908871	G/A	cg09537434	chr19:41945824	ATP5SL	-1.08	-12.99	-0.83	3.39e-21	Height;
SKCM	cis	rs561341	1.000	rs2344312	chr17:30243583	G/T	cg23018236	chr17:30244563	NA	-0.53	-5.18	-0.51	1.68e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs734999	0.870	rs2147905	chr1:2482921	C/T	cg12690016	chr1:1507138	SSU72	0.49	4.87	0.48	5.77e-6	Ulcerative colitis;
SKCM	cis	rs1957429	0.808	rs1467573	chr14:65347583	T/C	cg23373153	chr14:65346875	NA	1.11	6.32	0.58	1.52e-8	Pediatric areal bone mineral density (radius);
SKCM	cis	rs2952156	1.000	rs1810132	chr17:37866005	C/T	cg20243544	chr17:37824526	PNMT	0.7	5.6	0.54	3.07e-7	Asthma;
SKCM	cis	rs1580019	0.568	rs2122633	chr7:32523870	G/T	cg06627557	chr7:32535165	LSM5;AVL9	0.89	7.62	0.65	5.1e-11	Cognitive ability;
SKCM	cis	rs561341	0.609	rs739800	chr17:30190083	T/A	cg00745463	chr17:30367425	LRRC37B	0.88	5.18	0.51	1.66e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs10256972	0.552	rs6953538	chr7:1196974	A/G	cg16145915	chr7:1198662	ZFAND2A	-0.57	-7.94	-0.67	1.22e-11	Longevity;Endometriosis;
SKCM	cis	rs2288073	0.896	rs13404513	chr2:24410780	G/A	cg06627628	chr2:24431161	ITSN2	-0.8	-5.47	-0.53	5.21e-7	Venous thromboembolism (SNP x SNP interaction);
SKCM	cis	rs1707322	0.721	rs6697821	chr1:46216722	A/G	cg03146154	chr1:46216737	IPP	0.84	6.2	0.57	2.51e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs8017423	0.935	rs7154695	chr14:90795705	C/G	cg04374321	chr14:90722782	PSMC1	0.95	7.65	0.65	4.45e-11	Mortality in heart failure;
SKCM	cis	rs1005277	0.579	rs2474568	chr10:38383147	A/T	cg25427524	chr10:38739819	LOC399744	-0.72	-6.48	-0.59	7.54e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs644799	1.000	rs593665	chr11:95574302	A/G	cg03916912	chr11:95522834	CEP57;FAM76B	0.88	7.53	0.65	7.59e-11	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs11098499	0.955	rs1511015	chr4:120170473	A/C	cg09307838	chr4:120376055	NA	0.94	7.67	0.66	4.16e-11	Corneal astigmatism;
SKCM	cis	rs651907	0.535	rs34648996	chr3:101511202	A/G	cg12386194	chr3:101231763	SENP7	0.68	5.74	0.54	1.73e-7	Colorectal cancer;
SKCM	cis	rs28386778	0.863	rs8076760	chr17:61920497	T/C	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs1577917	1.000	rs1415753	chr6:86753074	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.64	-5.48	-0.53	5.09e-7	Response to antipsychotic treatment;
SKCM	cis	rs1577917	0.958	rs34994386	chr6:86524135	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.33	-0.52	9.19e-7	Response to antipsychotic treatment;
SKCM	cis	rs8180040	0.966	rs6787422	chr3:47418509	G/T	cg16586182	chr3:47516702	SCAP	-0.76	-5.32	-0.52	9.63e-7	Colorectal cancer;
SKCM	cis	rs6866344	0.697	rs62392823	chr5:178126968	T/C	cg10224037	chr5:178157518	ZNF354A	0.75	4.92	0.49	4.75e-6	Neutrophil percentage of white cells;
SKCM	cis	rs62244186	0.520	rs2372828	chr3:44784949	A/G	cg02073558	chr3:44770973	ZNF501	-0.85	-7.47	-0.65	9.93e-11	Depressive symptoms;
SKCM	cis	rs4237845	0.537	rs12312955	chr12:58265223	A/G	cg02175503	chr12:58329896	NA	0.73	5.88	0.55	9.8e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs62103177	0.568	rs2365388	chr18:77973702	G/T	cg27393146	chr18:77495563	CTDP1	-0.86	-5.89	-0.56	9.08e-8	Opioid sensitivity;
SKCM	cis	rs10504073	0.669	rs818559	chr8:50035806	C/T	cg00325661	chr8:49890786	NA	0.8	6.91	0.62	1.16e-9	Blood metabolite ratios;
SKCM	cis	rs17345786	0.861	rs79181492	chr3:101216021	G/A	cg12386194	chr3:101231763	SENP7	0.8	6.04	0.56	4.96e-8	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9322193	0.851	rs9322194	chr6:149920249	C/T	cg07701084	chr6:150067640	NUP43	0.64	5.16	0.5	1.85e-6	Lung cancer;
SKCM	cis	rs10754283	0.967	rs1320563	chr1:90121032	G/A	cg21401794	chr1:90099060	LRRC8C	0.73	6.31	0.58	1.57e-8	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs208520	1.000	rs12195505	chr6:66986279	T/A	cg07460842	chr6:66804631	NA	0.87	5.96	0.56	6.95e-8	Exhaled nitric oxide output;
SKCM	cis	rs28386778	0.897	rs894406	chr17:61901657	A/G	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs1568889	0.938	rs12795971	chr11:28355104	G/A	cg06544937	chr11:28130018	METT5D1;KIF18A	0.86	7.03	0.62	6.97e-10	Bipolar disorder;
SKCM	cis	rs3820928	1.000	rs2163041	chr2:227772480	T/C	cg11843606	chr2:227700838	RHBDD1	-0.64	-5.2	-0.51	1.53e-6	Pulmonary function;
SKCM	cis	rs62238980	1.000	rs62239001	chr22:32590150	T/C	cg00543991	chr22:32367038	NA	1.33	5.19	0.51	1.6e-6	Childhood ear infection;
SKCM	cis	rs4819052	0.808	rs2838825	chr21:46655651	C/T	cg02159808	chr21:46707872	POFUT2;LOC642852	0.76	5.66	0.54	2.42e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs3847687	1.000	rs3847688	chr12:131525310	C/T	cg13586425	chr12:131519906	GPR133	-0.54	-5.98	-0.56	6.43e-8	Longevity;
SKCM	cis	rs9911578	0.874	rs302874	chr17:56767996	A/G	cg12560992	chr17:57184187	TRIM37	0.9	7.46	0.65	1.05e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs11148252	0.532	rs9536190	chr13:53181044	T/C	cg00495681	chr13:53174319	NA	0.86	7.82	0.66	2.07e-11	Lewy body disease;
SKCM	cis	rs7980687	0.574	rs10744149	chr12:123708490	T/A	cg05973401	chr12:123451056	ABCB9	0.81	5.34	0.52	8.88e-7	Height;Educational attainment;Head circumference (infant);
SKCM	trans	rs1814175	0.817	rs7924619	chr11:49620632	G/A	cg03929089	chr4:120376271	NA	-0.9	-8.24	-0.68	3.23e-12	Height;
SKCM	cis	rs7666738	0.830	rs1115616	chr4:99006603	A/C	cg17366294	chr4:99064904	C4orf37	0.59	4.89	0.48	5.25e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11822910	0.737	rs2584858	chr11:57207077	C/T	cg00522883	chr11:57194120	SLC43A3	0.74	6.62	0.6	4.15e-9	Platelet distribution width;
SKCM	cis	rs7086627	0.515	rs11202960	chr10:82209807	G/A	cg00277334	chr10:82204260	NA	-0.74	-8.56	-0.7	7.89e-13	Post bronchodilator FEV1;
SKCM	cis	rs3892630	0.878	rs66788054	chr19:33190146	G/T	cg22980127	chr19:33182716	NUDT19	1.39	8.08	0.67	6.68e-12	Red blood cell traits;
SKCM	cis	rs7208859	0.623	rs55938328	chr17:29117010	T/C	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs8103278	0.507	rs4802276	chr19:46260748	T/C	cg12641515	chr19:46296257	DMWD	0.78	6.24	0.58	2.1e-8	Coronary artery disease;
SKCM	cis	rs3784262	0.669	rs12915821	chr15:58315685	A/G	cg12031962	chr15:58353849	ALDH1A2	-0.41	-4.82	-0.48	6.93e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs3020736	0.500	rs6002618	chr22:42507859	G/C	cg04733989	chr22:42467013	NAGA	-0.72	-5.62	-0.54	2.87e-7	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs875971	0.862	rs778702	chr7:65864835	G/A	cg18876405	chr7:65276391	NA	0.63	6.25	0.58	2.06e-8	Aortic root size;
SKCM	cis	rs561341	0.882	rs16967101	chr17:30377162	A/G	cg23018236	chr17:30244563	NA	-0.54	-5.57	-0.53	3.46e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs7027203	0.797	rs3996254	chr9:96591239	A/G	cg14598338	chr9:96623480	NA	-0.52	-5.41	-0.52	6.75e-7	DNA methylation (variation);
SKCM	cis	rs7208859	0.623	rs7220289	chr17:29103762	G/T	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs8072100	0.967	rs4793842	chr17:45671506	G/A	cg08085267	chr17:45401833	C17orf57	0.62	5.49	0.53	4.77e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs703842	1.000	rs10877015	chr12:58167788	A/G	cg04478727	chr12:58166393	METTL1;FAM119B	0.72	5.72	0.54	1.85e-7	Multiple sclerosis;
SKCM	cis	rs17376456	0.825	rs13361613	chr5:93272176	C/T	cg21475434	chr5:93447410	FAM172A	1.02	5.17	0.51	1.74e-6	Diabetic retinopathy;
SKCM	cis	rs910316	0.967	rs2268619	chr14:75640354	C/G	cg11812906	chr14:75593930	NEK9	-0.73	-5.27	-0.51	1.19e-6	Height;
SKCM	cis	rs875971	0.660	rs801217	chr7:66010577	C/T	cg18876405	chr7:65276391	NA	-0.8	-7.11	-0.63	4.86e-10	Aortic root size;
SKCM	cis	rs7615952	0.611	rs7632305	chr3:125634767	C/T	cg05084668	chr3:125655381	ALG1L	-1.25	-6.57	-0.6	5.19e-9	Blood pressure (smoking interaction);
SKCM	cis	rs875971	0.619	rs2302918	chr7:66000932	A/G	cg00343986	chr7:65444356	GUSB	0.69	5.06	0.5	2.7e-6	Aortic root size;
SKCM	cis	rs1799949	1.000	rs12942277	chr17:41187974	G/C	cg25072359	chr17:41440525	NA	0.63	4.88	0.48	5.43e-6	Menopause (age at onset);
SKCM	cis	rs1577917	0.958	rs34795473	chr6:86461799	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.6	-5.1	-0.5	2.3e-6	Response to antipsychotic treatment;
SKCM	cis	rs1348850	0.914	rs4893938	chr2:178250095	T/C	cg02961200	chr2:178257176	LOC100130691;AGPS	0.93	6.87	0.61	1.42e-9	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs7772486	0.790	rs2814880	chr6:146208937	T/G	cg05347473	chr6:146136440	FBXO30	0.55	5.12	0.5	2.16e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7635838	0.653	rs2606749	chr3:11373635	A/G	cg00170343	chr3:11313890	ATG7	0.71	5.45	0.52	5.76e-7	HDL cholesterol;
SKCM	cis	rs6840360	0.571	rs10026670	chr4:152539212	C/T	cg22705602	chr4:152727874	NA	-0.52	-5.69	-0.54	2.15e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs782590	0.807	rs782572	chr2:55912120	T/C	cg18811423	chr2:55921094	PNPT1	0.95	8.0	0.67	9.22e-12	Metabolic syndrome;
SKCM	cis	rs7809950	0.773	rs2237668	chr7:107050209	A/G	cg23024343	chr7:107201750	COG5	-0.88	-8.05	-0.67	7.69e-12	Coronary artery disease;
SKCM	cis	rs6582630	0.555	rs10880602	chr12:38505660	T/C	cg26384229	chr12:38710491	ALG10B	0.8	6.24	0.58	2.15e-8	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs807669	0.548	rs762522	chr22:19180575	C/T	cg02655711	chr22:19163373	SLC25A1	0.64	5.68	0.54	2.2e-7	Metabolite levels;
SKCM	cis	rs11113894	0.901	rs17040591	chr12:108860695	A/T	cg20982606	chr12:109535391	UNG	1.0	4.83	0.48	6.79e-6	Obesity-related traits;
SKCM	cis	rs1046896	0.586	rs9897951	chr17:80810662	T/C	cg02711726	chr17:80685570	FN3KRP	-0.74	-5.61	-0.54	2.92e-7	Glycated hemoglobin levels;
SKCM	cis	rs3768617	0.510	rs1886501	chr1:183095234	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs1639906	0.895	rs78469080	chr7:2200729	G/A	cg02951883	chr7:2050386	MAD1L1	0.65	5.23	0.51	1.4e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs854765	0.647	rs854790	chr17:18028318	C/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.79	5.58	0.53	3.42e-7	Total body bone mineral density;
SKCM	cis	rs208520	0.690	rs10455595	chr6:66738034	T/C	cg07460842	chr6:66804631	NA	0.9	7.2	0.63	3.26e-10	Exhaled nitric oxide output;
SKCM	cis	rs514406	0.505	rs395169	chr1:53174071	G/A	cg16325326	chr1:53192061	ZYG11B	0.89	10.06	0.75	9.55e-16	Monocyte count;
SKCM	cis	rs2242194	0.816	rs11264296	chr1:154994750	T/C	cg06221963	chr1:154839813	KCNN3	-0.53	-5.33	-0.52	9.25e-7	Schizophrenia;
SKCM	cis	rs9399135	0.967	rs2183709	chr6:135377091	C/T	cg24558204	chr6:135376177	HBS1L	0.56	4.77	0.48	8.29e-6	Red blood cell count;
SKCM	cis	rs7945705	0.902	rs10769979	chr11:9010659	C/T	cg13070366	chr11:9386451	NA	-0.62	-5.06	-0.5	2.68e-6	Hemoglobin concentration;
SKCM	cis	rs11098499	0.818	rs55825515	chr4:120486402	A/G	cg09307838	chr4:120376055	NA	1.0	8.22	0.68	3.48e-12	Corneal astigmatism;
SKCM	cis	rs11098499	0.691	rs9307471	chr4:120261262	G/A	cg09307838	chr4:120376055	NA	0.97	8.31	0.69	2.31e-12	Corneal astigmatism;
SKCM	cis	rs75229567	0.717	rs77874289	chr12:70234203	A/G	cg10114359	chr12:70132523	RAB3IP	1.42	6.21	0.58	2.41e-8	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes;
SKCM	cis	rs6580649	0.941	rs57380031	chr12:48452237	C/T	cg05342945	chr12:48394962	COL2A1	0.73	5.2	0.51	1.53e-6	Lung cancer;
SKCM	cis	rs1218582	0.803	rs7531728	chr1:154840516	C/A	cg06221963	chr1:154839813	KCNN3	-0.61	-6.6	-0.6	4.5e-9	Prostate cancer;
SKCM	cis	rs9902453	0.933	rs8080343	chr17:28456758	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.5	0.53	4.74e-7	Coffee consumption (cups per day);
SKCM	cis	rs4746818	0.818	rs7076011	chr10:70900430	T/C	cg11621586	chr10:70884670	VPS26A	0.99	7.62	0.65	5.08e-11	Left atrial antero-posterior diameter;
SKCM	cis	rs11690935	0.959	rs7597387	chr2:172577116	T/C	cg13550731	chr2:172543902	DYNC1I2	-0.99	-8.78	-0.7	2.9e-13	Schizophrenia;
SKCM	cis	rs7769051	1.000	rs12203977	chr6:133122760	A/G	cg22852734	chr6:133119734	C6orf192	1.0	5.39	0.52	7.39e-7	Type 2 diabetes nephropathy;
SKCM	cis	rs12120353	0.702	rs780609	chr1:4551334	C/T	cg15022359	chr1:4193126	NA	-0.6	-5.21	-0.51	1.47e-6	Anxiety disorder;
SKCM	cis	rs950027	0.620	rs1049518	chr15:45653367	G/A	cg10760299	chr15:45669010	GATM	0.57	5.71	0.54	1.99e-7	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs116095464	0.558	rs10475136	chr5:232796	A/G	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs6089584	0.566	rs11699442	chr20:60623268	A/G	cg06108461	chr20:60628389	TAF4	-0.69	-6.08	-0.57	4.17e-8	Body mass index;
SKCM	cis	rs7208859	0.623	rs9896603	chr17:29078512	C/G	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs995000	0.965	rs11207981	chr1:63006087	C/A	cg06896770	chr1:63153194	DOCK7	-0.73	-6.62	-0.6	4.11e-9	Triglyceride levels;
SKCM	cis	rs2404602	0.583	rs35707798	chr15:76565026	G/C	cg22467129	chr15:76604101	ETFA	-0.65	-5.35	-0.52	8.68e-7	Blood metabolite levels;
SKCM	cis	rs1348850	0.958	rs10930799	chr2:178459325	G/C	cg02961200	chr2:178257176	LOC100130691;AGPS	0.8	6.33	0.58	1.43e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs1577917	1.000	rs13196930	chr6:86652245	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.66	-5.74	-0.54	1.76e-7	Response to antipsychotic treatment;
SKCM	cis	rs10911232	0.507	rs4422969	chr1:183020762	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.65	0.6	3.59e-9	Hypertriglyceridemia;
SKCM	cis	rs16854884	0.690	rs35885310	chr3:143771333	A/G	cg06585982	chr3:143692056	C3orf58	0.77	6.35	0.58	1.34e-8	Economic and political preferences (feminism/equality);
SKCM	cis	rs2153535	0.580	rs1410766	chr6:8525360	T/C	cg07606381	chr6:8435919	SLC35B3	0.93	6.8	0.61	1.92e-9	Motion sickness;
SKCM	cis	rs4819052	0.851	rs2838832	chr21:46664904	A/G	cg19498844	chr21:46707878	POFUT2;LOC642852	-0.83	-6.99	-0.62	8.28e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs28386778	0.897	rs6504185	chr17:61848792	A/G	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs9611565	0.802	rs4822028	chr22:41789408	A/G	cg03806693	chr22:41940476	POLR3H	-0.93	-5.97	-0.56	6.68e-8	Vitiligo;
SKCM	cis	rs6582630	0.502	rs10880092	chr12:38262965	A/T	cg13010199	chr12:38710504	ALG10B	0.69	4.92	0.49	4.72e-6	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs6570726	0.791	rs446362	chr6:145878716	G/T	cg05347473	chr6:146136440	FBXO30	0.57	5.13	0.5	2.06e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs10256972	0.521	rs10280960	chr7:1103697	A/G	cg16145915	chr7:1198662	ZFAND2A	-0.49	-6.3	-0.58	1.63e-8	Longevity;Endometriosis;
SKCM	cis	rs72717009	0.825	rs61802846	chr1:161473873	A/C	cg23840854	chr1:161414152	NA	-0.99	-5.66	-0.54	2.44e-7	Rheumatoid arthritis;
SKCM	cis	rs9467773	0.620	rs2498351	chr6:26659642	C/T	cg15659132	chr6:26577336	NA	0.62	5.4	0.52	6.91e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs548181	0.736	rs543389	chr11:125464841	A/G	cg03464685	chr11:125439445	EI24	1.33	8.19	0.68	4.06e-12	Schizophrenia;Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);
SKCM	trans	rs8073060	0.545	rs3859282	chr17:34006111	T/C	cg19694781	chr19:47549865	TMEM160	-1.04	-8.28	-0.68	2.65e-12	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs9911578	1.000	rs7207693	chr17:57016525	C/T	cg05425664	chr17:57184151	TRIM37	-0.67	-5.04	-0.5	2.91e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9611565	0.559	rs132761	chr22:42004371	C/T	cg03806693	chr22:41940476	POLR3H	1.11	7.56	0.65	6.74e-11	Vitiligo;
SKCM	cis	rs28374715	0.635	rs112547435	chr15:41648737	C/G	cg18705301	chr15:41695430	NDUFAF1	-1.05	-10.64	-0.77	7.53e-17	Ulcerative colitis;
SKCM	cis	rs6942756	0.806	rs7788327	chr7:128986519	C/T	cg02491457	chr7:128862824	NA	-0.73	-4.77	-0.48	8.26e-6	White matter hyperintensity burden;
SKCM	cis	rs28386778	0.863	rs2251164	chr17:61884120	G/A	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs2439831	0.614	rs2467733	chr15:43693328	C/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.21	7.89	0.67	1.51e-11	Lung cancer in ever smokers;
SKCM	cis	rs10256972	0.786	rs3735686	chr7:1062527	G/A	cg16145915	chr7:1198662	ZFAND2A	-0.45	-5.63	-0.54	2.73e-7	Longevity;Endometriosis;
SKCM	cis	rs4803468	1.000	rs284657	chr19:41929915	G/C	cg14132834	chr19:41945861	ATP5SL	-0.77	-6.04	-0.56	4.87e-8	Height;
SKCM	cis	rs11139399	0.650	rs6559638	chr9:84349669	T/A	cg13729285	chr9:84764156	NA	0.46	4.79	0.48	7.83e-6	Hippocampal atrophy;
SKCM	cis	rs7811142	0.830	rs73401450	chr7:99981859	G/C	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.07	6.7	0.6	2.88e-9	Platelet count;
SKCM	cis	rs6762	0.550	rs8672	chr11:838634	C/G	cg16425592	chr11:842748	TSPAN4;POLR2L	-0.78	-5.67	-0.54	2.27e-7	Mean platelet volume;
SKCM	cis	rs1799949	1.000	rs11651341	chr17:41428061	T/C	cg23758822	chr17:41437982	NA	0.92	7.82	0.66	2.13e-11	Menopause (age at onset);
SKCM	cis	rs1218582	0.774	rs4845680	chr1:154863195	A/G	cg06221963	chr1:154839813	KCNN3	-0.58	-5.84	-0.55	1.13e-7	Prostate cancer;
SKCM	cis	rs875971	1.000	rs6957199	chr7:65978519	T/C	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	cis	rs5753618	0.607	rs5753621	chr22:31847647	T/C	cg02404636	chr22:31891804	SFI1	0.59	5.12	0.5	2.18e-6	Colorectal cancer;
SKCM	cis	rs910316	1.000	rs12889472	chr14:75543979	A/G	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.85e-7	Height;
SKCM	cis	rs6977660	1.000	rs10249989	chr7:19822296	A/G	cg07541023	chr7:19748670	TWISTNB	0.7	4.82	0.48	6.98e-6	Thyroid stimulating hormone;
SKCM	cis	rs281408	0.559	rs281386	chr19:49217305	A/G	cg13540341	chr19:49222985	MAMSTR	0.6	5.85	0.55	1.08e-7	Urinary metabolites (H-NMR features);
SKCM	cis	rs3820068	0.554	rs60233444	chr1:15921330	A/C	cg24675056	chr1:15929824	NA	0.77	5.54	0.53	4.01e-7	Systolic blood pressure;
SKCM	cis	rs2204008	0.777	rs114096617	chr12:38342557	A/C	cg26384229	chr12:38710491	ALG10B	0.81	6.67	0.6	3.38e-9	Bladder cancer;
SKCM	cis	rs13118159	0.934	rs4974608	chr4:1356780	C/T	cg02018176	chr4:1364513	KIAA1530	0.61	4.82	0.48	6.85e-6	Longevity;
SKCM	cis	rs769267	0.930	rs10402451	chr19:19608537	A/G	cg26732615	chr19:19648335	CILP2;YJEFN3	0.67	7.06	0.62	6e-10	Tonsillectomy;
SKCM	cis	rs4808199	0.895	rs8105984	chr19:19374068	T/C	cg03709012	chr19:19516395	GATAD2A	1.09	7.02	0.62	7.15e-10	Nonalcoholic fatty liver disease;
SKCM	cis	rs9325144	0.600	rs11183505	chr12:38759110	G/T	cg13010199	chr12:38710504	ALG10B	-0.66	-5.44	-0.52	5.88e-7	Morning vs. evening chronotype;
SKCM	cis	rs684232	0.666	rs2657629	chr17:602261	G/T	cg12384639	chr17:618140	VPS53	0.68	5.33	0.52	9.45e-7	Prostate cancer;
SKCM	cis	rs35306767	0.855	rs2050944	chr10:918910	T/C	cg26597838	chr10:835615	NA	0.77	5.52	0.53	4.35e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs1218582	0.711	rs4845677	chr1:154838050	C/T	cg16680214	chr1:154839983	KCNN3	-0.54	-5.01	-0.49	3.36e-6	Prostate cancer;
SKCM	cis	rs12824058	0.831	rs4759451	chr12:130812739	G/A	cg24838063	chr12:130822603	PIWIL1	0.78	6.91	0.62	1.19e-9	Menopause (age at onset);
SKCM	cis	rs11098499	0.863	rs3822195	chr4:120471660	C/T	cg09307838	chr4:120376055	NA	1.0	8.27	0.68	2.8e-12	Corneal astigmatism;
SKCM	cis	rs11690935	0.610	rs3770458	chr2:172651287	C/T	cg13550731	chr2:172543902	DYNC1I2	0.6	5.19	0.51	1.62e-6	Schizophrenia;
SKCM	cis	rs7772486	0.686	rs1337841	chr6:146059487	A/G	cg05347473	chr6:146136440	FBXO30	-0.56	-5.12	-0.5	2.11e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs362272	0.545	rs2239725	chr4:3305739	C/T	cg24015175	chr4:3319247	RGS12	0.77	8.68	0.7	4.47e-13	Serum sulfate level;
SKCM	cis	rs35306767	0.904	rs10904584	chr10:983747	A/T	cg20503657	chr10:835505	NA	0.65	5.2	0.51	1.56e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs7177699	0.581	rs7165081	chr15:79123396	C/G	cg04896959	chr15:78267971	NA	-0.54	-4.84	-0.48	6.39e-6	Post bronchodilator FEV1/FVC ratio;Post bronchodilator FEV1;
SKCM	cis	rs929354	0.742	rs11980541	chr7:156988776	G/C	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs28386778	0.897	rs57108948	chr17:61802378	T/C	cg06873352	chr17:61820015	STRADA	0.75	6.24	0.58	2.1e-8	Prudent dietary pattern;
SKCM	cis	rs4862750	0.872	rs4862748	chr4:187877388	C/T	cg10295955	chr4:187884368	NA	0.66	6.05	0.57	4.69e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs12477438	0.520	rs4340581	chr2:99725025	C/T	cg14399236	chr2:99771627	LIPT1;TSGA10	1.0	9.4	0.73	1.85e-14	Chronic sinus infection;
SKCM	cis	rs735396	0.595	rs1169279	chr12:121455873	C/T	cg15155738	chr12:121454335	C12orf43	0.67	5.12	0.5	2.18e-6	N-glycan levels;
SKCM	cis	rs6840360	0.615	rs66852535	chr4:152472227	C/A	cg22705602	chr4:152727874	NA	-0.51	-5.78	-0.55	1.48e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs3741404	0.620	rs2236647	chr11:63964605	A/G	cg05555928	chr11:63887634	MACROD1	0.78	5.02	0.49	3.13e-6	Platelet count;
SKCM	cis	rs12477438	0.520	rs6542869	chr2:99783403	G/A	cg26064155	chr2:99771622	LIPT1;TSGA10	0.97	8.75	0.7	3.29e-13	Chronic sinus infection;
SKCM	cis	rs12478296	1.000	rs6743297	chr2:243013814	A/G	cg06360820	chr2:242988706	NA	-1.01	-5.87	-0.55	1e-7	Obesity-related traits;
SKCM	cis	rs11098499	0.566	rs17051356	chr4:120585308	C/T	cg24375607	chr4:120327624	NA	0.62	4.82	0.48	7.04e-6	Corneal astigmatism;
SKCM	cis	rs1005277	0.579	rs2474574	chr10:38387295	C/T	cg00409905	chr10:38381863	ZNF37A	-0.64	-5.96	-0.56	6.77e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs7539542	0.556	rs1042990	chr1:202861566	C/T	cg19681188	chr1:202830198	LOC148709	-0.72	-5.32	-0.52	9.55e-7	Mean platelet volume;
SKCM	cis	rs6951245	0.935	rs118132455	chr7:1068232	C/A	cg24642844	chr7:1081250	C7orf50	-0.95	-6.4	-0.59	1.06e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs992157	0.735	rs10932765	chr2:219099484	T/C	cg20019365	chr2:219134978	PNKD;AAMP	0.73	6.49	0.59	7.1e-9	Colorectal cancer;
SKCM	cis	rs7647973	0.580	rs12637576	chr3:49237334	C/T	cg07636037	chr3:49044803	WDR6	0.8	6.26	0.58	1.96e-8	Menarche (age at onset);
SKCM	cis	rs60871478	1.000	rs34260834	chr7:822958	A/G	cg05535760	chr7:792225	HEATR2	1.02	8.66	0.7	4.97e-13	Cerebrospinal P-tau181p levels;
SKCM	trans	rs208520	0.526	rs9351542	chr6:66788571	A/G	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-1.12	-11.47	-0.79	2.01e-18	Exhaled nitric oxide output;
SKCM	cis	rs362296	0.698	rs3095081	chr4:3263776	C/T	cg00764545	chr4:3318001	RGS12	-0.72	-6.74	-0.61	2.48e-9	Parental longevity (mother's age at death);
SKCM	cis	rs2204008	0.837	rs4432085	chr12:38181146	C/T	cg26384229	chr12:38710491	ALG10B	0.82	6.58	0.6	4.87e-9	Bladder cancer;
SKCM	cis	rs501916	0.796	rs55961203	chr15:48050518	G/T	cg16110827	chr15:48056943	SEMA6D	-0.62	-5.02	-0.49	3.25e-6	Inflammatory bowel disease;Ulcerative colitis;
SKCM	cis	rs1577917	1.000	rs12201571	chr6:86609750	A/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.66	-5.74	-0.54	1.76e-7	Response to antipsychotic treatment;
SKCM	cis	rs4727027	0.899	rs6464942	chr7:148826368	T/C	cg23583168	chr7:148888333	NA	-0.82	-6.56	-0.6	5.29e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs6089829	0.962	rs2277769	chr20:61666805	C/T	cg08564027	chr20:61660810	NA	0.66	6.13	0.57	3.42e-8	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs933688	1.000	rs186717	chr5:90780467	T/A	cg12630606	chr5:90679528	LOC100129716;ARRDC3	0.98	8.03	0.67	8.3e-12	Smoking behavior;
SKCM	cis	rs10540	0.908	rs12792111	chr11:520921	G/C	cg03576123	chr11:487126	PTDSS2	-1.45	-7.95	-0.67	1.17e-11	Body mass index;
SKCM	cis	rs9857592	1.000	rs9858071	chr3:16845406	T/C	cg17339521	chr3:16555597	RFTN1	0.56	4.87	0.48	5.71e-6	Neuroticism;
SKCM	cis	rs611744	0.647	rs676654	chr8:109242303	A/G	cg18478394	chr8:109455254	TTC35	0.69	5.56	0.53	3.65e-7	Dupuytren's disease;
SKCM	cis	rs1580019	0.587	rs2392069	chr7:32547154	A/G	cg06627557	chr7:32535165	LSM5;AVL9	0.95	9.08	0.72	7.65e-14	Cognitive ability;
SKCM	cis	rs1153858	0.621	rs1706824	chr15:45579948	C/T	cg21132104	chr15:45694354	SPATA5L1	0.74	4.87	0.48	5.79e-6	Homoarginine levels;
SKCM	cis	rs2013441	1.000	rs2703772	chr17:20131453	C/A	cg13482628	chr17:19912719	NA	-0.65	-5.21	-0.51	1.48e-6	Obesity-related traits;
SKCM	cis	rs7772486	0.686	rs2142983	chr6:146069701	G/C	cg05347473	chr6:146136440	FBXO30	-0.54	-4.96	-0.49	3.97e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6495122	0.699	rs2168518	chr15:75081078	G/A	cg14664628	chr15:75095509	CSK	-0.93	-6.98	-0.62	8.62e-10	Caffeine consumption;Diastolic blood pressure;Coffee consumption;
SKCM	cis	rs826838	0.900	rs9739128	chr12:38948960	A/T	cg26384229	chr12:38710491	ALG10B	1.09	9.59	0.74	7.6e-15	Heart rate;
SKCM	cis	rs2836950	0.545	rs11701805	chr21:40618683	T/C	cg17971929	chr21:40555470	PSMG1	-0.73	-6.17	-0.57	2.86e-8	Menarche (age at onset);
SKCM	cis	rs7824557	0.510	rs2736297	chr8:11234885	C/G	cg21775007	chr8:11205619	TDH	-0.59	-5.04	-0.5	3e-6	Retinal vascular caliber;
SKCM	cis	rs13256369	1.000	rs4841016	chr8:8572561	C/T	cg06636001	chr8:8085503	FLJ10661	0.74	5.74	0.54	1.75e-7	Obesity-related traits;
SKCM	cis	rs16949788	1.000	rs7182169	chr15:66748213	C/A	cg08120210	chr15:66682733	MAP2K1	-0.74	-5.69	-0.54	2.1e-7	Spherical equivalent (joint analysis main effects and education interaction);
SKCM	cis	rs6582630	0.519	rs12368889	chr12:38315160	G/A	cg26384229	chr12:38710491	ALG10B	0.87	6.83	0.61	1.63e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs2228479	0.850	rs11644804	chr16:89976224	G/A	cg00800038	chr16:89945340	TCF25	-0.99	-5.68	-0.54	2.21e-7	Skin colour saturation;
SKCM	cis	rs860295	0.650	rs12024880	chr1:155908910	T/C	cg02153340	chr1:155202674	NA	0.74	5.33	0.52	9.15e-7	Body mass index;
SKCM	cis	rs2153535	0.563	rs1737585	chr6:8536594	A/G	cg07606381	chr6:8435919	SLC35B3	-0.87	-6.63	-0.6	4.01e-9	Motion sickness;
SKCM	cis	rs2857078	0.772	rs4793086	chr17:42320751	C/T	cg08499158	chr17:42289980	UBTF	0.82	6.35	0.58	1.32e-8	Red cell distribution width;Reticulocyte count;
SKCM	cis	rs968451	0.547	rs738331	chr22:39714216	A/G	cg17798944	chr22:39715225	SNORD43;RPL3	1.08	11.14	0.78	8.55e-18	Primary biliary cholangitis;
SKCM	cis	rs6087990	0.806	rs4911254	chr20:31357579	C/A	cg13636640	chr20:31349939	DNMT3B	0.91	7.97	0.67	1.06e-11	Ulcerative colitis;
SKCM	cis	rs1552244	0.572	rs7645759	chr3:10157368	C/T	cg00149659	chr3:10157352	C3orf10	1.1	5.1	0.5	2.31e-6	Alzheimer's disease;
SKCM	cis	rs10504229	0.906	rs58251024	chr8:58172259	G/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs634534	0.622	rs501353	chr11:65739549	T/G	cg17985854	chr11:65770987	BANF1;EIF1AD	0.51	5.16	0.5	1.85e-6	Sum eosinophil basophil counts;Eosinophil counts;
SKCM	cis	rs6951245	0.872	rs75398423	chr7:1098414	T/G	cg24642844	chr7:1081250	C7orf50	-0.93	-6.22	-0.58	2.28e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	trans	rs208520	0.690	rs207114	chr6:66791703	C/T	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-0.99	-7.7	-0.66	3.56e-11	Exhaled nitric oxide output;
SKCM	cis	rs651907	0.935	rs2926538	chr3:101587585	A/G	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.74	5.96	0.56	7.05e-8	Colorectal cancer;
SKCM	cis	rs7954584	0.567	rs11612028	chr12:122387872	C/G	cg21171335	chr12:122356390	WDR66	0.46	5.02	0.49	3.24e-6	Mean corpuscular volume;
SKCM	cis	rs701145	0.938	rs1515653	chr3:154076654	A/G	cg17054900	chr3:154042577	DHX36	0.89	4.98	0.49	3.78e-6	Coronary artery disease;
SKCM	cis	rs2243480	1.000	rs2243480	chr7:65599196	C/T	cg18252515	chr7:66147081	NA	-1.35	-8.02	-0.67	8.45e-12	Diabetic kidney disease;
SKCM	cis	rs344364	0.636	rs344363	chr16:1972548	C/T	cg26897989	chr16:1907736	C16orf73	-0.59	-5.07	-0.5	2.62e-6	Glomerular filtration rate in chronic kidney disease;
SKCM	cis	rs7177699	0.550	rs4468572	chr15:79124475	C/T	cg04896959	chr15:78267971	NA	0.54	4.84	0.48	6.39e-6	Post bronchodilator FEV1/FVC ratio;Post bronchodilator FEV1;
SKCM	cis	rs9818758	0.556	rs116432667	chr3:48947589	C/T	cg24898236	chr3:49228699	LOC646498	0.65	4.98	0.49	3.66e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs992157	0.735	rs13392177	chr2:219112956	C/T	cg20019365	chr2:219134978	PNKD;AAMP	-0.7	-6.01	-0.56	5.6e-8	Colorectal cancer;
SKCM	cis	rs2072499	0.898	rs2736609	chr1:156202640	C/T	cg25208724	chr1:156163844	SLC25A44	0.91	7.9	0.67	1.46e-11	Testicular germ cell tumor;
SKCM	cis	rs7772486	0.875	rs9322045	chr6:146384950	C/G	cg23711669	chr6:146136114	FBXO30	0.86	8.52	0.69	9.13e-13	Lobe attachment (rater-scored or self-reported);
SKCM	trans	rs17685	0.884	rs3823882	chr7:75631913	T/C	cg19862616	chr7:65841803	NCRNA00174	-0.91	-8.07	-0.67	6.96e-12	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs11098499	0.754	rs12509621	chr4:120249660	T/C	cg09307838	chr4:120376055	NA	0.91	7.36	0.64	1.63e-10	Corneal astigmatism;
SKCM	cis	rs1405130	0.869	rs11682735	chr2:235566830	C/A	cg21542780	chr2:234763377	HJURP	-0.64	-4.89	-0.48	5.21e-6	Coronary artery disease;
SKCM	cis	rs6951245	0.554	rs2070118	chr7:1132505	G/A	cg18402987	chr7:1209562	NA	0.83	5.42	0.52	6.45e-7	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs28386778	0.897	rs5020097	chr17:61814198	G/C	cg22520471	chr17:61851767	DDX42;CCDC47	0.76	4.78	0.48	8.03e-6	Prudent dietary pattern;
SKCM	cis	rs36093844	0.527	rs4944554	chr11:85757892	C/T	cg25872744	chr11:85566296	CCDC83	-0.81	-4.79	-0.48	7.71e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs4319547	0.915	rs10773208	chr12:122970156	T/C	cg23029597	chr12:123009494	RSRC2	-0.82	-6.33	-0.58	1.46e-8	Body mass index;
SKCM	cis	rs12142240	0.698	rs10158236	chr1:46820896	G/T	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs11098499	0.866	rs72676074	chr4:120359841	A/C	cg09307838	chr4:120376055	NA	0.97	7.65	0.65	4.39e-11	Corneal astigmatism;
SKCM	cis	rs6952808	0.531	rs1107351	chr7:2177093	G/A	cg05863683	chr7:1912471	MAD1L1	0.6	4.98	0.49	3.78e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs6088580	0.634	rs6059851	chr20:33047945	G/A	cg24642439	chr20:33292090	TP53INP2	0.76	6.02	0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs71520386	0.632	rs12532922	chr7:22860415	A/G	cg15401507	chr7:22894281	NA	0.67	4.96	0.49	4.03e-6	Fibrinogen levels;
SKCM	cis	rs6977660	0.943	rs9639334	chr7:19838810	G/A	cg07541023	chr7:19748670	TWISTNB	0.72	5.02	0.49	3.24e-6	Thyroid stimulating hormone;
SKCM	cis	rs995000	0.826	rs7555577	chr1:63034363	A/C	cg06896770	chr1:63153194	DOCK7	-0.72	-6.46	-0.59	8.17e-9	Triglyceride levels;
SKCM	cis	rs2413583	0.591	rs75378967	chr22:39735210	T/G	cg17798944	chr22:39715225	SNORD43;RPL3	0.93	5.27	0.51	1.16e-6	Ulcerative colitis;Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs11098499	0.863	rs7669520	chr4:120515278	T/C	cg24375607	chr4:120327624	NA	0.69	5.47	0.53	5.35e-7	Corneal astigmatism;
SKCM	cis	rs7633770	0.786	rs4683256	chr3:46683617	T/G	cg11219411	chr3:46661640	NA	0.54	4.86	0.48	5.98e-6	Coronary artery disease;
SKCM	cis	rs17685	0.712	rs10271413	chr7:75754858	G/A	cg16489192	chr7:75678113	MDH2;STYXL1	-0.57	-5.35	-0.52	8.63e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1552244	0.510	rs13075308	chr3:10034925	G/C	cg02579736	chr3:10068473	FANCD2;CIDECP	0.94	4.84	0.48	6.49e-6	Alzheimer's disease;
SKCM	cis	rs2228479	0.850	rs11639925	chr16:89908250	C/T	cg00800038	chr16:89945340	TCF25	-0.97	-4.94	-0.49	4.39e-6	Skin colour saturation;
SKCM	cis	rs5769765	0.955	rs2319465	chr22:50265784	A/C	cg22709217	chr22:50311962	ALG12;CRELD2	0.79	5.71	0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs7635838	0.684	rs2606750	chr3:11372151	T/C	cg00170343	chr3:11313890	ATG7	0.72	5.5	0.53	4.68e-7	HDL cholesterol;
SKCM	cis	rs2072499	0.966	rs2853646	chr1:156189626	C/T	cg24450063	chr1:156163899	SLC25A44	1.03	9.33	0.73	2.47e-14	Testicular germ cell tumor;
SKCM	cis	rs12047808	0.841	rs73036715	chr1:179417735	C/T	cg08037922	chr1:179521085	C1orf125;NPHS2	-1.02	-5.17	-0.51	1.77e-6	Multiple sclerosis (age of onset);
SKCM	cis	rs13217239	0.646	rs7768407	chr6:27016795	G/A	cg12292205	chr6:26970375	C6orf41	0.58	5.09	0.5	2.39e-6	Schizophrenia;
SKCM	cis	rs769267	0.899	rs3934667	chr19:19431423	T/G	cg03709012	chr19:19516395	GATAD2A	-0.84	-6.97	-0.62	9.13e-10	Tonsillectomy;
SKCM	cis	rs17376456	1.000	rs17376207	chr5:93545524	C/T	cg25358565	chr5:93447407	FAM172A	-1.13	-8.2	-0.68	3.91e-12	Diabetic retinopathy;
SKCM	cis	rs7208859	0.573	rs60724269	chr17:29113273	G/T	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs523522	0.962	rs2168319	chr12:120933217	C/T	cg27279351	chr12:120934652	DYNLL1	0.91	8.32	0.69	2.26e-12	High light scatter reticulocyte count;
SKCM	cis	rs7666738	0.830	rs7672127	chr4:98938477	A/G	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10808739	1.000	rs34781030	chr8:65641102	G/A	cg05711235	chr8:65498612	NA	-0.76	-4.88	-0.48	5.4e-6	HIV-1 susceptibility;
SKCM	cis	rs910316	1.000	rs175425	chr14:75626131	T/C	cg11812906	chr14:75593930	NEK9	-0.71	-5.34	-0.52	9.01e-7	Height;
SKCM	cis	rs1801251	1.000	rs12990821	chr2:233617585	C/G	cg08000102	chr2:233561755	GIGYF2	0.87	7.05	0.62	6.23e-10	Coronary artery disease;
SKCM	cis	rs2013441	1.000	rs2526458	chr17:20092200	C/T	cg13482628	chr17:19912719	NA	-0.65	-5.21	-0.51	1.48e-6	Obesity-related traits;
SKCM	cis	rs56235845	0.964	rs11741640	chr5:176792743	G/A	cg17509989	chr5:176798049	RGS14	0.91	7.02	0.62	7.11e-10	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs8072100	0.875	rs4794047	chr17:45763005	A/T	cg08085267	chr17:45401833	C17orf57	0.61	4.95	0.49	4.23e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs10193935	1.000	rs10190326	chr2:42388262	A/C	cg27598129	chr2:42591480	NA	0.92	6.79	0.61	1.97e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7927771	1.000	rs7120333	chr11:47817441	C/T	cg05585544	chr11:47624801	NA	-0.6	-5.22	-0.51	1.45e-6	Subjective well-being;
SKCM	cis	rs9899728	0.764	rs9660	chr17:73038746	A/G	cg27626185	chr17:73056755	KCTD2	-0.88	-6.24	-0.58	2.09e-8	Alzheimer's disease or small vessel stroke;
SKCM	cis	rs1843834	0.539	rs6713629	chr2:225410973	A/T	cg22455342	chr2:225449267	CUL3	0.69	5.13	0.5	2.05e-6	IgE levels in asthmatics (D.p. specific);
SKCM	cis	rs801193	0.636	rs2659895	chr7:66196471	C/A	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.52	5.03	0.49	3.12e-6	Aortic root size;
SKCM	cis	rs9858542	1.000	rs6770670	chr3:49686682	T/C	cg03060546	chr3:49711283	APEH	-0.76	-5.67	-0.54	2.31e-7	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs11718455	0.921	rs1404482	chr3:43997282	A/G	cg21419209	chr3:44054225	NA	-0.64	-5.28	-0.51	1.15e-6	Coronary artery disease;
SKCM	cis	rs1577917	0.958	rs1838955	chr6:86565449	T/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.32	-0.52	9.66e-7	Response to antipsychotic treatment;
SKCM	cis	rs7216064	1.000	rs11869819	chr17:65868669	A/C	cg12091567	chr17:66097778	LOC651250	-0.75	-5.27	-0.51	1.19e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs367615	0.679	rs10070786	chr5:108815081	T/G	cg17395555	chr5:108820864	NA	0.74	6.62	0.6	4.21e-9	Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs9300255	0.508	rs1716176	chr12:123655467	T/G	cg05973401	chr12:123451056	ABCB9	0.83	5.5	0.53	4.69e-7	Neutrophil percentage of white cells;
SKCM	cis	rs7811142	0.830	rs6975660	chr7:99975266	A/G	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.2	7.87	0.67	1.7e-11	Platelet count;
SKCM	cis	rs28386778	0.863	rs9207	chr17:61823899	C/T	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.36	0.52	8.06e-7	Prudent dietary pattern;
SKCM	cis	rs801193	0.613	rs2659900	chr7:66184443	G/C	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.52	5.03	0.49	3.12e-6	Aortic root size;
SKCM	cis	rs67311347	0.955	rs6773383	chr3:40377412	A/T	cg00091569	chr3:40428383	ENTPD3	0.61	5.4	0.52	7.01e-7	Renal cell carcinoma;
SKCM	cis	rs10504073	0.584	rs74457150	chr8:49890753	C/G	cg00325661	chr8:49890786	NA	0.79	7.17	0.63	3.75e-10	Blood metabolite ratios;
SKCM	cis	rs9902453	0.542	rs3809789	chr17:27955761	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.89	6.31	0.58	1.55e-8	Coffee consumption (cups per day);
SKCM	cis	rs7809950	0.817	rs2807	chr7:107260778	G/A	cg23024343	chr7:107201750	COG5	0.89	8.28	0.68	2.7e-12	Coronary artery disease;
SKCM	cis	rs941408	0.928	rs2741991	chr19:2802092	T/C	cg06609049	chr19:2785107	THOP1	0.82	7.05	0.62	6.37e-10	Total cholesterol levels;
SKCM	cis	rs4808199	1.000	rs17288409	chr19:19504167	T/C	cg03709012	chr19:19516395	GATAD2A	1.13	8.66	0.7	4.94e-13	Nonalcoholic fatty liver disease;
SKCM	cis	rs12142240	0.698	rs17357711	chr1:46829013	A/G	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs9733	0.540	rs4971041	chr1:150537357	C/T	cg13175981	chr1:150552382	MCL1	0.69	5.87	0.55	1.02e-7	Tonsillectomy;
SKCM	cis	rs7829975	0.536	rs2980439	chr8:8094870	G/A	cg06636001	chr8:8085503	FLJ10661	1.05	10.18	0.76	5.58e-16	Mood instability;
SKCM	cis	rs7143963	0.666	rs2092973	chr14:103320961	G/A	cg23020514	chr14:103360112	TRAF3	0.76	7.28	0.64	2.32e-10	Body mass index;
SKCM	cis	rs9486715	0.964	rs6921480	chr6:97066329	C/G	cg06623918	chr6:96969491	KIAA0776	-0.74	-6.6	-0.6	4.58e-9	Headache;
SKCM	cis	rs9467773	0.620	rs9461276	chr6:26595168	T/C	cg15659132	chr6:26577336	NA	0.63	5.57	0.53	3.56e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs36093844	0.576	rs17745153	chr11:85723527	C/T	cg25872744	chr11:85566296	CCDC83	-0.81	-4.79	-0.48	7.84e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs7927771	0.931	rs12361256	chr11:47910823	A/C	cg05585544	chr11:47624801	NA	-0.64	-5.77	-0.55	1.53e-7	Subjective well-being;
SKCM	cis	rs769267	0.896	rs2315610	chr19:19597240	T/C	cg03709012	chr19:19516395	GATAD2A	0.89	8.62	0.7	5.89e-13	Tonsillectomy;
SKCM	cis	rs7937682	0.774	rs59921976	chr11:111473088	G/A	cg09085632	chr11:111637200	PPP2R1B	-1.02	-10.07	-0.75	9.14e-16	Primary sclerosing cholangitis;
SKCM	cis	rs6723226	0.593	rs176401	chr2:32636511	A/T	cg02381751	chr2:32503542	YIPF4	-0.89	-6.55	-0.6	5.5e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs7811142	0.775	rs6946768	chr7:99954393	G/A	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.05	5.92	0.56	8.02e-8	Platelet count;
SKCM	cis	rs4819052	1.000	rs2838830	chr21:46664227	T/G	cg02159808	chr21:46707872	POFUT2;LOC642852	0.79	5.87	0.55	1.01e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7666738	0.791	rs11729596	chr4:99045461	A/G	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9910055	0.529	rs850851	chr17:42177674	C/T	cg19774624	chr17:42201019	HDAC5	0.81	6.39	0.59	1.12e-8	Total body bone mineral density;
SKCM	cis	rs2070488	1.000	rs13072809	chr3:38468171	G/A	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.96	8.89	0.71	1.76e-13	Electrocardiographic conduction measures;
SKCM	cis	rs6921919	0.559	rs13210866	chr6:28383842	G/A	cg14547644	chr6:28411285	ZSCAN23	-0.58	-4.8	-0.48	7.46e-6	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs7100689	0.646	rs1953972	chr10:82145666	A/G	cg00277334	chr10:82204260	NA	-0.53	-4.96	-0.49	4.02e-6	Post bronchodilator FEV1;
SKCM	cis	rs9910055	0.920	rs2855818	chr17:42290015	G/A	cg08499158	chr17:42289980	UBTF	-0.88	-8.38	-0.69	1.74e-12	Total body bone mineral density;
SKCM	cis	rs71007656	1	rs71007656	chr10:37970845	CGGCTG/C	cg25427524	chr10:38739819	LOC399744	-0.61	-6.06	-0.57	4.6e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs5769765	0.955	rs5769761	chr22:50263641	G/T	cg22709217	chr22:50311962	ALG12;CRELD2	0.79	5.71	0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs7927771	1.000	rs12787330	chr11:47812311	C/T	cg05585544	chr11:47624801	NA	-0.6	-5.22	-0.51	1.45e-6	Subjective well-being;
SKCM	cis	rs6089584	0.853	rs1746280	chr20:60577821	C/G	cg06108461	chr20:60628389	TAF4	-0.85	-6.7	-0.6	2.89e-9	Body mass index;
SKCM	cis	rs4746818	0.901	rs4746816	chr10:70874866	G/T	cg11621586	chr10:70884670	VPS26A	0.91	5.88	0.55	9.55e-8	Left atrial antero-posterior diameter;
SKCM	cis	rs2811415	0.597	rs6770188	chr3:127754676	A/G	cg09089421	chr3:127803668	RUVBL1	0.99	8.52	0.69	9.09e-13	Lung function (FEV1/FVC);
SKCM	cis	rs1032355	0.558	rs1491246	chr4:100534482	A/T	cg25391692	chr4:100495869	MTTP	-0.82	-4.97	-0.49	3.9e-6	Celiac disease;
SKCM	cis	rs2836633	0.895	rs2836598	chr21:40024758	C/G	cg05519781	chr21:40033154	ERG	0.82	7.1	0.63	5.14e-10	Coronary artery disease;
SKCM	cis	rs651907	0.557	rs62284199	chr3:101478531	T/G	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.81	7.08	0.63	5.59e-10	Colorectal cancer;
SKCM	cis	rs362272	0.545	rs2236052	chr4:3318413	C/T	cg16987761	chr4:3318072	RGS12	-0.94	-11.1	-0.78	1.01e-17	Serum sulfate level;
SKCM	cis	rs854765	0.551	rs6502626	chr17:17849450	C/T	cg04398451	chr17:18023971	MYO15A	-0.89	-6.32	-0.58	1.48e-8	Total body bone mineral density;
SKCM	cis	rs9486715	0.867	rs2223238	chr6:96871855	G/A	cg06623918	chr6:96969491	KIAA0776	0.79	7.09	0.63	5.34e-10	Headache;
SKCM	cis	rs9815354	0.597	rs60690674	chr3:41997811	G/C	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs7666738	0.716	rs35195511	chr4:98859660	G/A	cg17366294	chr4:99064904	C4orf37	0.56	4.87	0.48	5.62e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs919433	0.680	rs8539	chr2:198362018	A/G	cg04278110	chr2:198063759	ANKRD44	0.73	4.84	0.48	6.47e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs6582630	0.519	rs1851121	chr12:38389467	T/C	cg26384229	chr12:38710491	ALG10B	0.81	6.6	0.6	4.58e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs9457247	0.602	rs12208359	chr6:167458455	G/A	cg07741184	chr6:167504864	NA	0.57	4.93	0.49	4.54e-6	Crohn's disease;
SKCM	cis	rs11098499	0.657	rs7664458	chr4:120371967	A/G	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs873946	0.586	rs12770021	chr10:134562021	G/A	cg26818010	chr10:134567672	INPP5A	-0.78	-6.22	-0.58	2.3e-8	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs6724607	1.000	rs13410230	chr2:191446252	A/G	cg21644426	chr2:191273491	MFSD6	0.69	4.94	0.49	4.42e-6	Pulse pressure;
SKCM	cis	rs742614	0.533	rs6059498	chr20:32447282	T/C	cg06304546	chr20:32448765	NA	-0.73	-5.91	-0.56	8.51e-8	Stearic acid (18:0) levels;
SKCM	cis	rs10504073	0.609	rs17644494	chr8:50019679	T/C	cg00325661	chr8:49890786	NA	0.79	6.79	0.61	1.99e-9	Blood metabolite ratios;
SKCM	cis	rs7772486	0.869	rs2777473	chr6:146301494	G/A	cg23711669	chr6:146136114	FBXO30	0.76	6.98	0.62	8.54e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7666738	0.830	rs11727653	chr4:99001774	T/C	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs941408	0.515	rs4624312	chr19:2774460	T/C	cg06609049	chr19:2785107	THOP1	1.09	10.19	0.76	5.37e-16	Total cholesterol levels;
SKCM	cis	rs686320	0.667	rs2904976	chr11:65185387	G/A	cg13521124	chr11:66064082	TMEM151A	-0.85	-4.8	-0.48	7.6e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs1153858	1.000	rs4775907	chr15:45638647	G/A	cg21132104	chr15:45694354	SPATA5L1	0.92	8.33	0.69	2.14e-12	Homoarginine levels;
SKCM	cis	rs2842992	0.672	rs7738253	chr6:160193917	G/T	cg16489826	chr6:160211363	TCP1;MRPL18	0.75	5.25	0.51	1.26e-6	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs11608355	0.521	rs7978210	chr12:109835990	A/G	cg19025524	chr12:109796872	NA	-0.69	-6.3	-0.58	1.62e-8	Neuroticism;
SKCM	cis	rs9309711	0.736	rs13409102	chr2:3496321	G/A	cg10845886	chr2:3471009	TTC15	-0.86	-5.65	-0.54	2.55e-7	Neurofibrillary tangles;
SKCM	cis	rs2836974	0.644	rs719230	chr21:40676307	C/T	cg11644478	chr21:40555479	PSMG1	-0.69	-6.11	-0.57	3.59e-8	Cognitive function;
SKCM	cis	rs936229	0.813	rs4886629	chr15:75072558	G/C	cg14664628	chr15:75095509	CSK	-1.08	-9.0	-0.71	1.07e-13	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin);
SKCM	cis	rs6866344	0.697	rs62392831	chr5:178134365	A/G	cg10224037	chr5:178157518	ZNF354A	0.81	5.68	0.54	2.26e-7	Neutrophil percentage of white cells;
SKCM	cis	rs7811142	0.945	rs34989573	chr7:100097895	C/T	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.19	7.85	0.66	1.82e-11	Platelet count;
SKCM	cis	rs2354432	0.825	rs10900347	chr1:146800107	G/C	cg25205988	chr1:146714368	CHD1L	1.22	9.57	0.73	8.41e-15	Mitochondrial DNA levels;
SKCM	cis	rs13278732	0.553	rs13263078	chr8:99071049	G/A	cg16297171	chr8:99017690	MATN2	-0.6	-4.86	-0.48	5.84e-6	Eosinophilic esophagitis (pediatric);
SKCM	cis	rs11098499	0.780	rs7692994	chr4:120427489	C/A	cg09307838	chr4:120376055	NA	1.03	8.34	0.69	2.09e-12	Corneal astigmatism;
SKCM	cis	rs2120019	1.000	rs60425110	chr15:75333000	T/A	cg17294928	chr15:75287854	SCAMP5	-0.91	-8.76	-0.7	3.17e-13	Blood trace element (Zn levels);
SKCM	cis	rs2836974	0.931	rs2836968	chr21:40642386	A/G	cg11644478	chr21:40555479	PSMG1	0.99	10.48	0.76	1.51e-16	Cognitive function;
SKCM	cis	rs9790314	0.715	rs7622047	chr3:160770505	G/A	cg03342759	chr3:160939853	NMD3	-0.6	-5.64	-0.54	2.62e-7	Morning vs. evening chronotype;
SKCM	cis	rs8180040	0.764	rs2132173	chr3:47247060	C/T	cg27129171	chr3:47204927	SETD2	-0.75	-5.97	-0.56	6.58e-8	Colorectal cancer;
SKCM	cis	rs11098499	0.863	rs13149407	chr4:120437825	A/G	cg24375607	chr4:120327624	NA	0.68	5.12	0.5	2.11e-6	Corneal astigmatism;
SKCM	cis	rs3008870	0.677	rs2815354	chr1:67483642	A/T	cg08660285	chr1:67390436	MIER1;WDR78	0.93	5.93	0.56	7.75e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs4319547	0.656	rs6488951	chr12:122873928	A/G	cg23029597	chr12:123009494	RSRC2	-0.72	-5.31	-0.52	1.01e-6	Body mass index;
SKCM	cis	rs6121246	0.559	rs6060962	chr20:30397847	A/G	cg13852791	chr20:30311386	BCL2L1	0.82	5.69	0.54	2.09e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs17376456	0.825	rs56108532	chr5:93276342	C/T	cg21475434	chr5:93447410	FAM172A	1.02	5.17	0.51	1.74e-6	Diabetic retinopathy;
SKCM	cis	rs2033711	0.936	rs882609	chr19:58991479	G/A	cg13877915	chr19:58951672	ZNF132	0.88	8.32	0.69	2.23e-12	Uric acid clearance;
SKCM	trans	rs1814175	0.645	rs1851849	chr11:50012164	G/A	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs11785400	1.000	rs9720653	chr8:143731939	T/G	cg20003893	chr8:144489567	NA	-0.55	-4.77	-0.48	8.29e-6	Schizophrenia;
SKCM	cis	rs75804782	0.522	rs11889150	chr2:239324542	A/G	cg18131467	chr2:239335373	ASB1	-0.96	-5.14	-0.5	2.01e-6	Morning vs. evening chronotype;Chronotype;
SKCM	cis	rs1577917	0.739	rs6922	chr6:86205323	T/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.97	10.74	0.77	4.95e-17	Response to antipsychotic treatment;
SKCM	cis	rs1790761	0.658	rs684928	chr11:67329742	G/A	cg00290607	chr11:67383545	NA	0.53	5.65	0.54	2.5e-7	Mean corpuscular volume;
SKCM	cis	rs6120849	0.901	rs6060278	chr20:33753262	T/C	cg24642439	chr20:33292090	TP53INP2	0.95	5.17	0.51	1.74e-6	Protein C levels;
SKCM	cis	rs11098499	0.954	rs2306455	chr4:120421969	G/A	cg24375607	chr4:120327624	NA	0.66	5.13	0.5	2.07e-6	Corneal astigmatism;
SKCM	cis	rs7811142	1.000	rs7783159	chr7:100017454	C/T	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.12	6.53	0.59	6.17e-9	Platelet count;
SKCM	cis	rs6087990	0.735	rs6057647	chr20:31381690	A/T	cg13636640	chr20:31349939	DNMT3B	0.83	6.24	0.58	2.13e-8	Ulcerative colitis;
SKCM	cis	rs11098499	0.909	rs2127821	chr4:120394535	T/C	cg09307838	chr4:120376055	NA	0.97	7.65	0.65	4.54e-11	Corneal astigmatism;
SKCM	cis	rs9611565	0.512	rs5751153	chr22:42156561	T/C	cg03806693	chr22:41940476	POLR3H	1.16	6.72	0.61	2.63e-9	Vitiligo;
SKCM	cis	rs11098499	0.863	rs1155576	chr4:120450159	A/C	cg09307838	chr4:120376055	NA	0.97	7.66	0.66	4.19e-11	Corneal astigmatism;
SKCM	cis	rs9902453	0.791	rs3115100	chr17:28045744	T/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.79	5.93	0.56	7.67e-8	Coffee consumption (cups per day);
SKCM	cis	rs7811142	1.000	rs1073	chr7:100031612	G/A	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.34	0.69	2.1e-12	Platelet count;
SKCM	cis	rs9790314	0.586	rs16832279	chr3:161120483	C/T	cg03342759	chr3:160939853	NMD3	-0.74	-6.62	-0.6	4.08e-9	Morning vs. evening chronotype;
SKCM	cis	rs8103278	0.507	rs7246377	chr19:46292259	G/A	cg12641515	chr19:46296257	DMWD	0.8	6.39	0.59	1.13e-8	Coronary artery disease;
SKCM	cis	rs3859192	0.599	rs2227319	chr17:38170845	G/A	cg17467752	chr17:38218738	THRA	-0.74	-6.28	-0.58	1.78e-8	White blood cell count;
SKCM	cis	rs9467773	0.620	rs1027203	chr6:26639332	G/C	cg09904177	chr6:26538194	HMGN4	0.57	4.8	0.48	7.58e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9300255	0.739	rs1969354	chr12:123741776	T/C	cg05973401	chr12:123451056	ABCB9	0.86	6.11	0.57	3.69e-8	Neutrophil percentage of white cells;
SKCM	cis	rs861020	0.916	rs669694	chr1:209950760	C/G	cg05527609	chr1:210001259	C1orf107	1.06	7.64	0.65	4.68e-11	Orofacial clefts;
SKCM	cis	rs66887589	0.934	rs4834792	chr4:120555696	T/A	cg09307838	chr4:120376055	NA	-0.65	-4.82	-0.48	6.89e-6	Diastolic blood pressure;
SKCM	cis	rs9640161	0.750	rs3735167	chr7:150039555	C/T	cg27494647	chr7:150038898	RARRES2	0.55	4.9	0.49	5.07e-6	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs2832191	0.791	rs2832182	chr21:30481612	G/A	cg08807101	chr21:30365312	RNF160	-0.62	-4.94	-0.49	4.34e-6	Dental caries;
SKCM	cis	rs4242434	0.854	rs34268501	chr8:22460204	A/G	cg03733263	chr8:22462867	KIAA1967	1.05	8.78	0.71	2.86e-13	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs765787	0.530	rs12905246	chr15:45500841	C/T	cg24006582	chr15:45444508	DUOX1	0.66	4.82	0.48	6.83e-6	Uric acid levels;
SKCM	cis	rs4790333	1.000	rs4790332	chr17:2262611	G/A	cg02569219	chr17:2266849	SGSM2	0.78	7.05	0.62	6.21e-10	Proinsulin levels;
SKCM	cis	rs8180040	1.000	rs295461	chr3:47368010	T/C	cg27129171	chr3:47204927	SETD2	0.87	6.62	0.6	4.2e-9	Colorectal cancer;
SKCM	cis	rs2836974	0.568	rs377098	chr21:40535216	G/A	cg11644478	chr21:40555479	PSMG1	-0.8	-7.6	-0.65	5.6e-11	Cognitive function;
SKCM	cis	rs651907	0.737	rs9844218	chr3:101584983	C/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	-0.76	-5.9	-0.56	8.92e-8	Colorectal cancer;
SKCM	cis	rs992157	0.560	rs4674274	chr2:219089131	A/T	cg20019365	chr2:219134978	PNKD;AAMP	-0.66	-5.49	-0.53	4.76e-7	Colorectal cancer;
SKCM	cis	rs763121	0.853	rs5750673	chr22:39110124	G/A	cg06022373	chr22:39101656	GTPBP1	0.76	5.57	0.53	3.54e-7	Menopause (age at onset);
SKCM	cis	rs9911578	1.000	rs9902994	chr17:56948722	T/A	cg12560992	chr17:57184187	TRIM37	0.94	7.55	0.65	7.01e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs9399135	0.622	rs3817776	chr6:135256756	C/T	cg24558204	chr6:135376177	HBS1L	-0.61	-5.93	-0.56	7.79e-8	Red blood cell count;
SKCM	cis	rs7590368	1.000	rs72779469	chr2:10963764	C/G	cg15705551	chr2:10952987	PDIA6	0.76	4.88	0.48	5.52e-6	Educational attainment (years of education);
SKCM	cis	rs7811142	1.000	rs2406253	chr7:100077273	A/G	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.34	0.69	2.1e-12	Platelet count;
SKCM	cis	rs13010713	0.870	rs13405121	chr2:182019687	T/A	cg21995919	chr2:182322279	ITGA4	-0.56	-5.22	-0.51	1.47e-6	Celiac disease;
SKCM	cis	rs3087591	0.960	rs2905787	chr17:29482381	G/A	cg24425628	chr17:29625626	OMG;NF1	0.64	4.97	0.49	3.87e-6	Hip circumference;
SKCM	cis	rs703842	1.000	rs8181644	chr12:58173466	A/G	cg04478727	chr12:58166393	METTL1;FAM119B	0.73	5.84	0.55	1.15e-7	Multiple sclerosis;
SKCM	cis	rs3785574	0.962	rs62077509	chr17:61848973	A/G	cg01411255	chr17:61851458	DDX42;CCDC47	1.11	12.47	0.82	2.97e-20	Height;
SKCM	cis	rs28595532	0.764	rs115916994	chr4:119688758	A/G	cg21605333	chr4:119757512	SEC24D	1.35	7.92	0.67	1.37e-11	Cannabis dependence symptom count;
SKCM	cis	rs763014	0.932	rs2269560	chr16:682442	A/C	cg07343612	chr16:622815	PIGQ	-0.67	-5.2	-0.51	1.58e-6	Height;
SKCM	cis	rs17685	0.753	rs4728586	chr7:75802869	T/C	cg16684958	chr7:75615977	POR	0.53	5.3	0.51	1.06e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs4073582	0.595	rs2508657	chr11:66043898	G/A	cg16950941	chr11:66035639	RAB1B	0.82	7.01	0.62	7.59e-10	Gout;
SKCM	cis	rs9916302	0.904	rs7208274	chr17:37513796	C/T	cg07936489	chr17:37558343	FBXL20	0.85	7.28	0.64	2.26e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs4819052	0.724	rs9753962	chr21:46661384	G/T	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.36	0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs5766691	0.644	rs6007607	chr22:47529288	C/G	cg15757745	chr22:47558489	TBC1D22A	-0.67	-5.54	-0.53	3.88e-7	Longevity;
SKCM	cis	rs11112613	0.713	rs11112586	chr12:105939816	C/T	cg03607813	chr12:105948248	NA	0.79	5.11	0.5	2.24e-6	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;
SKCM	trans	rs17685	0.712	rs6954569	chr7:75738885	T/A	cg19862616	chr7:65841803	NCRNA00174	0.94	9.45	0.73	1.46e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs9902453	0.904	rs12103671	chr17:28408217	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.81	-6.24	-0.58	2.15e-8	Coffee consumption (cups per day);
SKCM	cis	rs7811142	0.830	rs6955367	chr7:99961194	A/G	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.12	6.82	0.61	1.73e-9	Platelet count;
SKCM	cis	rs6430585	0.583	rs3087343	chr2:136622543	T/G	cg07169764	chr2:136633963	MCM6	1.31	13.05	0.83	2.59e-21	Corneal structure;
SKCM	cis	rs1451375	0.527	rs6950777	chr7:50597056	G/A	cg18232548	chr7:50535776	DDC	0.69	4.82	0.48	6.82e-6	Malaria;
SKCM	cis	rs9910055	0.550	rs81367	chr17:42159109	A/G	cg19774624	chr17:42201019	HDAC5	0.79	5.23	0.51	1.37e-6	Total body bone mineral density;
SKCM	cis	rs7618501	0.633	rs7621026	chr3:49975334	A/G	cg05072774	chr3:49840536	C3orf54	-0.66	-5.03	-0.49	3.12e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs561341	1.000	rs473356	chr17:30321762	G/C	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs9300255	0.602	rs1727294	chr12:123616514	A/G	cg00376283	chr12:123451042	ABCB9	0.82	5.61	0.54	3e-7	Neutrophil percentage of white cells;
SKCM	cis	rs1325195	0.520	rs2783389	chr1:179228396	G/A	cg25467746	chr1:179556597	NA	0.59	5.65	0.54	2.48e-7	IgE grass sensitization;
SKCM	cis	rs11717455	1.000	rs6804644	chr3:38858047	T/C	cg15678707	chr3:39149194	GORASP1;TTC21A	-0.81	-4.86	-0.48	5.88e-6	Systemic lupus erythematosus;
SKCM	cis	rs738322	0.600	rs5995542	chr22:38558141	C/T	cg25457927	chr22:38595422	NA	-0.53	-6.14	-0.57	3.24e-8	Cutaneous nevi;
SKCM	cis	rs4727027	0.933	rs917122	chr7:148848257	T/C	cg23583168	chr7:148888333	NA	-0.8	-6.59	-0.6	4.64e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs1964356	0.967	rs2953802	chr8:8851881	G/A	cg06636001	chr8:8085503	FLJ10661	0.65	4.97	0.49	3.94e-6	Mean corpuscular volume;
SKCM	cis	rs875971	0.505	rs2462573	chr7:65507392	C/T	cg11987759	chr7:65425863	GUSB	0.74	6.61	0.6	4.28e-9	Aortic root size;
SKCM	cis	rs870825	0.655	rs67380800	chr4:185623788	T/C	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs6570726	0.846	rs9399559	chr6:145945778	C/T	cg23711669	chr6:146136114	FBXO30	0.9	10.02	0.75	1.16e-15	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs933688	1.000	rs2052553	chr5:90729906	C/T	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.93	6.49	0.59	7.31e-9	Smoking behavior;
SKCM	cis	rs2404602	0.536	rs17364330	chr15:76765385	A/T	cg23625390	chr15:77176239	SCAPER	0.62	5.38	0.52	7.53e-7	Blood metabolite levels;
SKCM	cis	rs1801251	0.778	rs2592115	chr2:233736349	C/T	cg25237894	chr2:233734115	C2orf82	-0.56	-5.97	-0.56	6.74e-8	Coronary artery disease;
SKCM	cis	rs9790314	0.740	rs4856767	chr3:161004379	C/T	cg03342759	chr3:160939853	NMD3	-0.72	-8.12	-0.68	5.59e-12	Morning vs. evening chronotype;
SKCM	cis	rs7772486	0.632	rs9386128	chr6:146049053	G/A	cg05347473	chr6:146136440	FBXO30	-0.55	-4.85	-0.48	6.14e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1395	0.961	rs4665963	chr2:27528692	T/C	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.5	4.83	0.48	6.55e-6	Blood metabolite levels;
SKCM	cis	rs7438704	0.552	rs309884	chr4:48326517	A/G	cg15299388	chr4:48491941	ZAR1	-0.45	-5.5	-0.53	4.7e-7	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs2228479	0.681	rs3212346	chr16:89982358	G/A	cg00800038	chr16:89945340	TCF25	-0.97	-5.76	-0.55	1.59e-7	Skin colour saturation;
SKCM	cis	rs10207060	0.500	rs6731870	chr2:240708096	C/A	cg07506560	chr2:240697449	NA	0.75	6.1	0.57	3.8e-8	Obesity-related traits;
SKCM	cis	rs4969178	0.930	rs11077363	chr17:76397309	C/T	cg20026190	chr17:76395443	PGS1	0.61	5.29	0.51	1.08e-6	HDL cholesterol levels;
SKCM	cis	rs5743890	1.000	rs5743890	chr11:1325829	A/G	cg23449764	chr11:915337	CHID1	0.69	5.24	0.51	1.35e-6	Idiopathic pulmonary fibrosis;
SKCM	cis	rs1577917	0.958	rs10455448	chr6:86533611	T/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.33	-0.52	9.19e-7	Response to antipsychotic treatment;
SKCM	cis	rs58688157	0.592	rs12803048	chr11:584243	C/T	cg16486109	chr11:613632	IRF7	1.09	6.84	0.61	1.6e-9	Systemic lupus erythematosus;
SKCM	cis	rs11122272	0.735	rs973254	chr1:231521149	T/A	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	-0.64	-5.31	-0.52	9.86e-7	Hemoglobin concentration;
SKCM	cis	rs28595532	0.541	rs114463740	chr4:119763329	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs7208859	0.623	rs9912283	chr17:29110373	A/G	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs1707322	1.000	rs946524	chr1:46487560	A/G	cg03146154	chr1:46216737	IPP	-0.77	-5.36	-0.52	8.35e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs3784262	0.679	rs4238326	chr15:58336000	C/T	cg12031962	chr15:58353849	ALDH1A2	0.47	6.03	0.56	5.16e-8	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs995000	0.931	rs636497	chr1:62920029	A/G	cg06896770	chr1:63153194	DOCK7	0.77	7.38	0.64	1.45e-10	Triglyceride levels;
SKCM	cis	rs10838687	0.673	rs17790204	chr11:46969281	C/G	cg05584439	chr11:47213196	NA	0.8	4.84	0.48	6.53e-6	Proinsulin levels;
SKCM	cis	rs875971	0.965	rs697968	chr7:65535033	G/A	cg11764359	chr7:65958608	NA	-0.89	-8.44	-0.69	1.29e-12	Aortic root size;
SKCM	cis	rs7590368	0.961	rs2357815	chr2:10959769	C/T	cg15705551	chr2:10952987	PDIA6	0.76	4.88	0.48	5.52e-6	Educational attainment (years of education);
SKCM	cis	rs875971	0.862	rs11984115	chr7:65773859	C/T	cg18876405	chr7:65276391	NA	-0.64	-6.42	-0.59	9.88e-9	Aortic root size;
SKCM	cis	rs7618915	0.570	rs11714088	chr3:52758942	A/C	cg18404041	chr3:52824283	ITIH1	-0.56	-4.94	-0.49	4.33e-6	Bipolar disorder;
SKCM	cis	rs4423214	0.802	rs2276358	chr11:71184498	G/A	cg05163923	chr11:71159392	DHCR7	-0.71	-6.07	-0.57	4.35e-8	Vitamin D levels;
SKCM	cis	rs73001065	0.591	rs57009615	chr19:19613622	A/G	cg03709012	chr19:19516395	GATAD2A	1.2	5.88	0.55	9.48e-8	LDL cholesterol;
SKCM	cis	rs7208859	0.623	rs9890558	chr17:29110355	T/C	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs3784262	1.000	rs3784262	chr15:58253106	T/C	cg12031962	chr15:58353849	ALDH1A2	-0.5	-6.33	-0.58	1.42e-8	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs899997	1.000	rs7182694	chr15:79045030	C/T	cg04896959	chr15:78267971	NA	0.57	5.0	0.49	3.49e-6	Coronary artery disease or large artery stroke;
SKCM	cis	rs11950121	0.738	rs11738015	chr5:53162560	G/C	cg06476337	chr5:52856530	NDUFS4	-0.66	-4.95	-0.49	4.19e-6	Alcoholic chronic pancreatitis;
SKCM	cis	rs57221529	0.713	rs56328416	chr5:591138	G/A	cg10555297	chr5:473380	SLC9A3;LOC25845	1.01	5.03	0.49	3.1e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs7666738	0.830	rs7698771	chr4:98986479	T/G	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7666738	0.791	rs7377018	chr4:99034962	C/T	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs738321	0.757	rs3788535	chr22:38534045	T/C	cg25457927	chr22:38595422	NA	-0.58	-6.78	-0.61	2.02e-9	Breast cancer;
SKCM	cis	rs1048238	0.506	rs598371	chr1:16212739	G/A	cg21385522	chr1:16154831	NA	-0.65	-5.53	-0.53	4.04e-7	Systolic blood pressure;
SKCM	cis	rs137761	0.535	rs35269212	chr22:44103293	G/A	cg12729397	chr22:44208276	EFCAB6	0.69	5.07	0.5	2.62e-6	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs2286503	1.000	rs2286503	chr7:22856606	C/T	cg15401507	chr7:22894281	NA	-0.57	-5.6	-0.54	3.12e-7	Fibrinogen;
SKCM	cis	rs9583531	0.689	rs6492308	chr13:111377829	T/C	cg24331049	chr13:111365604	ING1	0.85	6.43	0.59	9.38e-9	Coronary artery disease;
SKCM	cis	rs7408868	1.000	rs10420466	chr19:15261371	G/T	cg14696996	chr19:15285081	NOTCH3	0.84	4.89	0.48	5.33e-6	Pulse pressure;
SKCM	cis	rs1850744	0.702	rs114945335	chr4:9598191	C/T	cg15442990	chr4:9534313	NA	-1.3	-4.84	-0.48	6.55e-6	Economic and political preferences;
SKCM	cis	rs1799949	0.965	rs9911630	chr17:41188342	A/G	cg25072359	chr17:41440525	NA	0.69	5.11	0.5	2.27e-6	Menopause (age at onset);
SKCM	cis	rs1799949	0.550	rs2343818	chr17:41409774	G/A	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.18	-0.57	2.68e-8	Menopause (age at onset);
SKCM	cis	rs4975616	0.869	rs465498	chr5:1325803	A/G	cg26373071	chr5:1325741	CLPTM1L	0.74	6.91	0.62	1.18e-9	Lung cancer;
SKCM	cis	rs4819052	0.851	rs4819041	chr21:46659955	C/T	cg02159808	chr21:46707872	POFUT2;LOC642852	0.68	5.17	0.5	1.78e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7772486	0.875	rs9390372	chr6:146363638	G/C	cg05347473	chr6:146136440	FBXO30	0.57	5.12	0.5	2.13e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9902453	0.967	rs3813034	chr17:28524804	A/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.75	5.19	0.51	1.65e-6	Coffee consumption (cups per day);
SKCM	cis	rs2952156	0.959	rs1495101	chr17:37832103	C/A	cg20243544	chr17:37824526	PNMT	0.77	5.81	0.55	1.3e-7	Asthma;
SKCM	cis	rs9443189	0.570	rs569731	chr6:76357593	G/A	cg01950844	chr6:76311363	SENP6	1.02	6.34	0.58	1.39e-8	Prostate cancer;
SKCM	cis	rs9368481	0.761	rs9357028	chr6:26967224	T/G	cg12292205	chr6:26970375	C6orf41	-0.71	-6.4	-0.59	1.05e-8	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs8103278	0.860	rs11669073	chr19:46324880	C/T	cg11657440	chr19:46296263	DMWD	-0.89	-5.76	-0.55	1.58e-7	Coronary artery disease;
SKCM	cis	rs12986445	0.947	rs12713690	chr2:26118096	T/C	cg04917511	chr2:26785460	C2orf70	0.52	4.77	0.48	8.44e-6	Multiple myeloma and monoclonal gammopathy;Multiple myeloma;
SKCM	cis	rs11098499	0.644	rs10009566	chr4:120558608	A/G	cg09307838	chr4:120376055	NA	0.95	7.62	0.65	5.07e-11	Corneal astigmatism;
SKCM	cis	rs9911578	0.839	rs7214098	chr17:57204632	C/T	cg05425664	chr17:57184151	TRIM37	-0.77	-6.13	-0.57	3.37e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs9325144	0.555	rs6582607	chr12:38717678	T/C	cg13010199	chr12:38710504	ALG10B	-0.65	-5.17	-0.51	1.73e-6	Morning vs. evening chronotype;
SKCM	cis	rs875971	0.545	rs1065265	chr7:65841203	C/T	cg18876405	chr7:65276391	NA	0.63	5.0	0.49	3.41e-6	Aortic root size;
SKCM	cis	rs2070488	0.931	rs6599212	chr3:38558906	T/C	cg01465620	chr3:38496096	LOC100128640;ACVR2B	-1.02	-9.28	-0.72	3.06e-14	Electrocardiographic conduction measures;
SKCM	cis	rs1153858	1.000	rs11070453	chr15:45645154	C/G	cg10760299	chr15:45669010	GATM	0.62	6.33	0.58	1.42e-8	Homoarginine levels;
SKCM	cis	rs17711722	0.701	rs55773927	chr7:65337902	T/C	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.61	5.06	0.5	2.75e-6	Calcium levels;
SKCM	cis	rs35955747	0.677	rs4820974	chr22:31869467	A/C	cg22777020	chr22:31556080	RNF185	-0.68	-4.93	-0.49	4.53e-6	Neutrophil count;Sum basophil neutrophil counts;
SKCM	cis	rs7666738	0.830	rs4440224	chr4:99044924	G/A	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7086627	0.515	rs1870147	chr10:82212541	A/T	cg00277334	chr10:82204260	NA	-0.69	-7.69	-0.66	3.78e-11	Post bronchodilator FEV1;
SKCM	cis	rs56011263	0.532	rs73221200	chr4:743826	G/A	cg17689763	chr4:710664	PCGF3	-0.65	-4.84	-0.48	6.44e-6	White blood cell count;
SKCM	cis	rs7772486	0.686	rs9403746	chr6:146103768	C/A	cg23711669	chr6:146136114	FBXO30	-0.85	-9.37	-0.73	2.03e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2439831	0.850	rs3097773	chr15:43893072	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	-1.28	-7.81	-0.66	2.15e-11	Lung cancer in ever smokers;
SKCM	cis	rs9910055	0.762	rs6503489	chr17:42246289	G/A	cg09913183	chr17:42254507	C17orf65;ASB16	0.7	6.49	0.59	7.35e-9	Total body bone mineral density;
SKCM	cis	rs8180040	0.764	rs11130115	chr3:47181661	C/A	cg27129171	chr3:47204927	SETD2	0.82	6.44	0.59	9.04e-9	Colorectal cancer;
SKCM	cis	rs1799949	0.965	rs4239149	chr17:41328095	A/G	cg25918947	chr17:41365094	TMEM106A	0.63	6.04	0.56	4.91e-8	Menopause (age at onset);
SKCM	cis	rs9875589	0.509	rs9824910	chr3:14040136	C/T	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.52	5.13	0.5	2.08e-6	Ovarian reserve;
SKCM	cis	rs9660180	0.868	rs12567685	chr1:1806647	T/C	cg13866156	chr1:1669148	SLC35E2	-0.79	-6.52	-0.59	6.44e-9	Body mass index;
SKCM	cis	rs3008870	1.000	rs3008858	chr1:67390416	G/C	cg08660285	chr1:67390436	MIER1;WDR78	0.98	6.56	0.6	5.45e-9	Lymphocyte percentage of white cells;
SKCM	cis	rs28386778	0.897	rs968719	chr17:61908271	C/T	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.16	0.5	1.8e-6	Prudent dietary pattern;
SKCM	cis	rs1577917	0.771	rs2475791	chr6:86368164	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-1.02	-11.58	-0.8	1.29e-18	Response to antipsychotic treatment;
SKCM	cis	rs875971	1.000	rs3735148	chr7:65971009	T/G	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	cis	rs17711722	0.640	rs13237956	chr7:65318029	G/A	cg11987759	chr7:65425863	GUSB	-0.75	-6.42	-0.59	9.94e-9	Calcium levels;
SKCM	cis	rs1635	0.655	rs73742541	chr6:28310615	T/C	cg15743358	chr6:28303923	ZNF323	-1.27	-5.15	-0.5	1.92e-6	Schizophrenia;
SKCM	cis	rs2032447	0.802	rs198853	chr6:26104096	T/C	cg03517284	chr6:25882590	NA	0.59	5.02	0.49	3.24e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs4808199	0.895	rs10419672	chr19:19471241	T/C	cg03709012	chr19:19516395	GATAD2A	1.08	7.57	0.65	6.39e-11	Nonalcoholic fatty liver disease;
SKCM	cis	rs3820928	0.874	rs4423583	chr2:227874957	A/G	cg11843606	chr2:227700838	RHBDD1	0.64	5.28	0.51	1.15e-6	Pulmonary function;
SKCM	cis	rs2842992	0.672	rs4708845	chr6:160219601	T/G	cg19482086	chr6:160211437	TCP1;MRPL18	0.81	5.82	0.55	1.23e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs4332037	0.539	rs57148375	chr7:2025001	G/C	cg02825527	chr7:2087843	MAD1L1	-0.75	-5.12	-0.5	2.13e-6	Bipolar disorder;
SKCM	cis	rs9300255	0.566	rs10744150	chr12:123721614	A/C	cg00376283	chr12:123451042	ABCB9	0.87	7.25	0.63	2.63e-10	Neutrophil percentage of white cells;
SKCM	cis	rs4924935	0.851	rs966811	chr17:18830287	G/A	cg26378065	chr17:18585709	ZNF286B	-0.8	-5.41	-0.52	6.83e-7	Pancreatic cancer;
SKCM	cis	rs3789045	0.774	rs12039365	chr1:204488687	A/G	cg17419461	chr1:204415978	PIK3C2B	-0.86	-5.92	-0.56	8.07e-8	Educational attainment (college completion);
SKCM	trans	rs1814175	0.765	rs1794141	chr11:49914135	G/C	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs1005277	0.579	rs116912400	chr10:38479207	G/T	cg00409905	chr10:38381863	ZNF37A	-0.65	-5.92	-0.56	8.04e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs2613514	1.000	rs2613513	chr17:76105731	A/G	cg06643271	chr17:76128170	TMC8;TMC6	0.62	4.87	0.48	5.64e-6	Thiazide-induced adverse metabolic effects in hypertensive patients;
SKCM	cis	rs2304069	0.909	rs30831	chr5:149359053	C/T	cg22760475	chr5:149380129	HMGXB3;TIGD6	-0.83	-5.79	-0.55	1.4e-7	HIV-1 control;
SKCM	cis	rs875971	0.862	rs10263690	chr7:65766453	G/C	cg11764359	chr7:65958608	NA	-0.75	-6.76	-0.61	2.26e-9	Aortic root size;
SKCM	cis	rs9814567	1.000	rs6804770	chr3:134230234	A/T	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs7143963	0.609	rs3783386	chr14:103367708	C/T	cg23020514	chr14:103360112	TRAF3	0.64	5.51	0.53	4.39e-7	Body mass index;
SKCM	cis	rs6087990	0.871	rs4911252	chr20:31330115	A/G	cg13636640	chr20:31349939	DNMT3B	-0.85	-6.94	-0.62	1.03e-9	Ulcerative colitis;
SKCM	cis	rs10504229	1.000	rs66672857	chr8:58179817	G/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs17685	0.753	rs1637051	chr7:75730659	G/A	cg16489192	chr7:75678113	MDH2;STYXL1	-0.61	-5.55	-0.53	3.73e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs4332037	0.950	rs62442895	chr7:1936938	G/A	cg23422044	chr7:1970798	MAD1L1	-0.95	-6.45	-0.59	8.43e-9	Bipolar disorder;
SKCM	cis	rs10504073	0.584	rs10957356	chr8:49980634	G/A	cg00325661	chr8:49890786	NA	0.8	6.81	0.61	1.83e-9	Blood metabolite ratios;
SKCM	trans	rs1814175	0.645	rs12364337	chr11:49942580	A/T	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs7408868	1.000	rs2074622	chr19:15277620	G/C	cg14696996	chr19:15285081	NOTCH3	0.82	4.92	0.49	4.7e-6	Pulse pressure;
SKCM	cis	rs10751667	0.666	rs7396059	chr11:970490	C/A	cg10932868	chr11:921992	NA	0.55	5.1	0.5	2.36e-6	Alzheimer's disease (late onset);
SKCM	cis	rs3087591	1.000	rs2012988	chr17:29547296	T/C	cg24425628	chr17:29625626	OMG;NF1	0.64	5.22	0.51	1.43e-6	Hip circumference;
SKCM	cis	rs7727544	0.684	rs272869	chr5:131677997	A/G	cg24060327	chr5:131705240	SLC22A5	-0.69	-4.8	-0.48	7.37e-6	Blood metabolite levels;
SKCM	cis	rs28386778	0.966	rs2854206	chr17:61947203	G/A	cg01411255	chr17:61851458	DDX42;CCDC47	0.79	5.1	0.5	2.36e-6	Prudent dietary pattern;
SKCM	cis	rs801193	0.839	rs6968619	chr7:66068867	T/C	cg18876405	chr7:65276391	NA	-0.8	-7.2	-0.63	3.28e-10	Aortic root size;
SKCM	cis	rs12709013	0.792	rs12325510	chr16:58783611	T/C	cg02431531	chr16:59244939	NA	0.49	5.13	0.5	2.07e-6	Blood metabolite ratios;
SKCM	trans	rs877282	0.945	rs10904555	chr10:787740	C/A	cg22713356	chr15:30763199	NA	1.35	7.57	0.65	6.52e-11	Uric acid levels;
SKCM	cis	rs8077889	0.750	rs231541	chr17:41941788	C/G	cg26893861	chr17:41843967	DUSP3	-1.24	-6.57	-0.6	5.17e-9	Triglycerides;
SKCM	trans	rs1814175	0.817	rs6486046	chr11:49997017	T/C	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs6570726	0.526	rs9376928	chr6:145724403	T/G	cg23711669	chr6:146136114	FBXO30	-0.65	-6.06	-0.57	4.5e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6582630	0.555	rs1829583	chr12:38423161	T/C	cg26384229	chr12:38710491	ALG10B	-0.8	-6.31	-0.58	1.56e-8	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs3820068	0.581	rs6693694	chr1:15980135	G/T	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs72781680	1.000	rs12620594	chr2:24194490	G/A	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	cis	rs7666738	0.830	rs13148363	chr4:98847498	T/C	cg05340658	chr4:99064831	C4orf37	0.6	4.81	0.48	7.19e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs367615	0.704	rs11747622	chr5:108844720	G/A	cg17395555	chr5:108820864	NA	0.75	6.87	0.61	1.39e-9	Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs6500395	1.000	rs9936467	chr16:48677983	T/C	cg04672837	chr16:48644449	N4BP1	0.65	5.43	0.52	6.28e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs2841277	0.738	rs1036713	chr14:105396693	C/G	cg19901468	chr14:105411992	AHNAK2	0.91	7.22	0.63	2.95e-10	Rheumatoid arthritis;
SKCM	cis	rs10929159	0.928	rs10929157	chr2:236920156	C/G	cg14226755	chr2:236923322	AGAP1	0.29	4.77	0.48	8.43e-6	Parkinson's disease;
SKCM	cis	rs2842992	0.789	rs9364536	chr6:160225559	G/C	cg11366901	chr6:160182831	ACAT2	0.9	7.3	0.64	2.06e-10	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs2180341	0.843	rs4895821	chr6:127572761	T/A	cg27446573	chr6:127587934	RNF146	1.02	9.19	0.72	4.58e-14	Breast cancer;
SKCM	cis	rs4819052	0.851	rs35064782	chr21:46674360	G/A	cg19498844	chr21:46707878	POFUT2;LOC642852	0.88	7.69	0.66	3.74e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7666738	0.830	rs11097600	chr4:98959564	T/G	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7666738	0.791	rs6532725	chr4:99061479	T/C	cg17366294	chr4:99064904	C4orf37	0.61	4.93	0.49	4.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2721195	0.654	rs4610795	chr8:145881333	C/T	cg15320075	chr8:145703422	NA	-0.75	-5.61	-0.54	2.91e-7	Age at first birth;
SKCM	cis	rs6912958	0.559	rs376633	chr6:88042785	T/C	cg08069147	chr6:88032118	GJB7;C6orf162	0.65	5.77	0.55	1.55e-7	Monocyte percentage of white cells;
SKCM	cis	rs1552244	1.000	rs9811771	chr3:10133949	A/G	cg02579736	chr3:10068473	FANCD2;CIDECP	1.23	6.92	0.62	1.13e-9	Alzheimer's disease;
SKCM	cis	rs7904368	0.568	rs7075036	chr10:16864810	C/T	cg23933602	chr10:16859644	RSU1	1.01	7.94	0.67	1.23e-11	Ratio of the peak velocity of the mitral E-Wave divided by the peak velocity of the mitral A-wave.;
SKCM	cis	rs11734570	0.581	rs55958238	chr4:38604331	A/G	cg18361445	chr4:38666374	KLF3;FLJ13197	0.85	5.74	0.55	1.72e-7	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs10540	1.000	rs61876333	chr11:487136	G/A	cg03576123	chr11:487126	PTDSS2	-1.55	-7.65	-0.65	4.55e-11	Body mass index;
SKCM	cis	rs17065868	0.881	rs9595145	chr13:45107348	A/G	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs9911578	0.935	rs34523895	chr17:57034095	T/C	cg12560992	chr17:57184187	TRIM37	0.94	7.34	0.64	1.77e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs1200821	0.535	rs1208784	chr10:37768433	A/G	cg25427524	chr10:38739819	LOC399744	-0.53	-5.4	-0.52	7.06e-7	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs13118159	0.550	rs9685761	chr4:1377942	C/G	cg16405210	chr4:1374714	KIAA1530	-0.86	-6.49	-0.59	7.32e-9	Longevity;
SKCM	cis	rs2354432	0.607	rs59606861	chr1:146761478	G/A	cg25205988	chr1:146714368	CHD1L	-1.14	-6.04	-0.56	4.85e-8	Mitochondrial DNA levels;
SKCM	cis	rs7666738	0.791	rs10010438	chr4:99022177	C/T	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs28595532	0.920	rs115681185	chr4:119757700	G/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs9810089	0.527	rs3957816	chr3:135955852	C/T	cg21827317	chr3:136751795	NA	0.64	4.93	0.49	4.56e-6	Gestational age at birth (child effect);
SKCM	cis	rs11764590	0.694	rs4721321	chr7:2068470	A/G	cg02825527	chr7:2087843	MAD1L1	-0.65	-5.18	-0.51	1.66e-6	Neuroticism;
SKCM	cis	rs7772486	0.790	rs2253654	chr6:146199445	T/C	cg23711669	chr6:146136114	FBXO30	0.84	9.28	0.72	3.05e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs17685	0.725	rs2302436	chr7:75676988	A/T	cg16489192	chr7:75678113	MDH2;STYXL1	0.58	5.44	0.52	5.83e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs4819052	0.851	rs13047104	chr21:46673562	T/G	cg20896738	chr21:46707857	POFUT2;LOC642852	0.64	4.82	0.48	6.85e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs35306767	0.903	rs12761424	chr10:967295	C/T	cg26597838	chr10:835615	NA	0.67	5.4	0.52	7e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs365132	0.875	rs2456178	chr5:176413570	C/G	cg16309518	chr5:176445507	NA	-0.52	-4.99	-0.49	3.54e-6	Menarche and menopause (age at onset);Menopause (age at onset);
SKCM	cis	rs1577917	1.000	rs12209127	chr6:86724427	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.83	-8.07	-0.67	6.96e-12	Response to antipsychotic treatment;
SKCM	cis	rs6951245	1.000	rs11763020	chr7:1060288	C/T	cg18402987	chr7:1209562	NA	1.14	5.99	0.56	6.11e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs801193	1.000	rs2420824	chr7:66131116	G/A	cg18876405	chr7:65276391	NA	-0.82	-7.53	-0.65	7.59e-11	Aortic root size;
SKCM	cis	rs2075064	0.500	rs10986190	chr9:126818818	A/G	cg14112217	chr9:126806003	NA	0.53	4.81	0.48	7.14e-6	Waist circumference;
SKCM	cis	rs7100689	0.646	rs1340380	chr10:82115619	T/C	cg00277334	chr10:82204260	NA	-0.54	-5.01	-0.49	3.25e-6	Post bronchodilator FEV1;
SKCM	trans	rs11722228	0.521	rs62288520	chr4:10099674	G/A	cg26043149	chr18:55253948	FECH	0.93	7.98	0.67	1.02e-11	Gout;Urate levels;Serum uric acid levels;
SKCM	cis	rs2180341	0.722	rs9388555	chr6:127576363	G/A	cg27446573	chr6:127587934	RNF146	0.86	6.94	0.62	1.03e-9	Breast cancer;
SKCM	cis	rs6545883	0.899	rs12473030	chr2:61720497	T/A	cg15711740	chr2:61764176	XPO1	-0.75	-5.3	-0.51	1.06e-6	Tuberculosis;
SKCM	cis	rs7772486	0.659	rs9376957	chr6:146011064	C/T	cg23711669	chr6:146136114	FBXO30	-0.88	-9.0	-0.71	1.08e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7584330	0.704	rs7602387	chr2:238356795	A/G	cg14458575	chr2:238380390	NA	0.88	5.97	0.56	6.6e-8	Prostate cancer;
SKCM	cis	rs12142240	0.692	rs7532149	chr1:46824932	A/C	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs35306767	0.903	rs12769431	chr10:922633	T/C	cg26597838	chr10:835615	NA	0.8	6.17	0.57	2.9e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs67311347	1.000	rs6762997	chr3:40478151	C/T	cg00091569	chr3:40428383	ENTPD3	0.6	5.02	0.49	3.22e-6	Renal cell carcinoma;
SKCM	cis	rs7103648	1.000	rs7103648	chr11:47461783	A/G	cg20307385	chr11:47447363	PSMC3	1.08	9.26	0.72	3.38e-14	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs10905065	0.965	rs10795541	chr10:5811954	A/G	cg11519256	chr10:5708881	ASB13	-0.56	-4.99	-0.49	3.52e-6	Menopause (age at onset);
SKCM	cis	rs7828089	0.935	rs896375	chr8:22262098	A/G	cg12081754	chr8:22256438	SLC39A14	0.7	5.49	0.53	4.79e-7	Verbal declarative memory;
SKCM	cis	rs6840360	0.593	rs7654294	chr4:152690975	T/C	cg22705602	chr4:152727874	NA	-0.59	-7.93	-0.67	1.3e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs6951245	0.872	rs77569514	chr7:1085508	G/A	cg03188948	chr7:1209495	NA	1.12	6.25	0.58	2.02e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs860295	0.702	rs12039893	chr1:155614815	A/C	cg02153340	chr1:155202674	NA	-0.76	-5.61	-0.54	2.96e-7	Body mass index;
SKCM	cis	rs6545883	0.929	rs2593625	chr2:61668769	C/T	cg15711740	chr2:61764176	XPO1	-0.7	-4.93	-0.49	4.5e-6	Tuberculosis;
SKCM	cis	rs28386778	0.897	rs2584615	chr17:61927774	T/C	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.36	0.52	8.06e-7	Prudent dietary pattern;
SKCM	cis	rs7584330	0.554	rs7587496	chr2:238387632	A/G	cg08992911	chr2:238395768	MLPH	0.95	5.1	0.5	2.3e-6	Prostate cancer;
SKCM	cis	rs7191439	0.728	rs8043924	chr16:88787704	G/C	cg27087555	chr16:88793112	FAM38A	-1.23	-5.52	-0.53	4.32e-7	Plateletcrit;
SKCM	cis	rs1577917	0.727	rs9351065	chr6:86360428	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-1.01	-11.41	-0.79	2.64e-18	Response to antipsychotic treatment;
SKCM	cis	rs2228479	0.717	rs34027607	chr16:89808939	T/C	cg04287289	chr16:89883240	FANCA	0.89	4.92	0.49	4.64e-6	Skin colour saturation;
SKCM	cis	rs7208859	0.524	rs57670615	chr17:29069498	A/G	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs875971	0.830	rs4718358	chr7:65973668	T/C	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	cis	rs2836974	0.899	rs6517514	chr21:40527095	G/T	cg11644478	chr21:40555479	PSMG1	0.97	10.21	0.76	5.08e-16	Cognitive function;
SKCM	cis	rs3087591	0.960	rs12942397	chr17:29462498	C/A	cg24425628	chr17:29625626	OMG;NF1	0.65	5.15	0.5	1.94e-6	Hip circumference;
SKCM	cis	rs2354432	0.556	rs6593777	chr1:146884013	C/G	cg25205988	chr1:146714368	CHD1L	1.08	5.32	0.52	9.52e-7	Mitochondrial DNA levels;
SKCM	cis	rs597539	0.652	rs516425	chr11:68715675	G/A	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.79	5.25	0.51	1.27e-6	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs2204008	0.665	rs11179830	chr12:38220966	T/C	cg13010199	chr12:38710504	ALG10B	0.65	5.11	0.5	2.19e-6	Bladder cancer;
SKCM	cis	rs1048238	0.506	rs848210	chr1:16259813	A/G	cg21385522	chr1:16154831	NA	-0.65	-5.62	-0.54	2.9e-7	Systolic blood pressure;
SKCM	cis	rs2721195	0.683	rs6989368	chr8:145813457	A/G	cg15857475	chr8:145742913	RECQL4;LRRC14	0.91	9.0	0.71	1.07e-13	Age at first birth;
SKCM	cis	rs7144547	0.950	rs8004137	chr14:81884857	A/G	cg02996355	chr14:81879375	NA	-0.82	-5.84	-0.55	1.16e-7	Prudent dietary pattern;
SKCM	cis	rs9640161	0.659	rs11975886	chr7:150010362	G/A	cg27494647	chr7:150038898	RARRES2	0.55	4.9	0.49	5.02e-6	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs2070488	0.965	rs1046048	chr3:38524742	C/T	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.98	9.25	0.72	3.55e-14	Electrocardiographic conduction measures;
SKCM	cis	rs6952808	0.608	rs6461049	chr7:2017445	C/T	cg03354898	chr7:1950403	MAD1L1	0.53	4.94	0.49	4.28e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs7829975	0.510	rs332037	chr8:8722675	C/T	cg06636001	chr8:8085503	FLJ10661	0.7	5.5	0.53	4.7e-7	Mood instability;
SKCM	cis	rs9910055	0.683	rs7220138	chr17:42254011	C/G	cg09913183	chr17:42254507	C17orf65;ASB16	0.67	6.53	0.59	6.13e-9	Total body bone mineral density;
SKCM	cis	rs1799949	1.000	rs8176077	chr17:41276348	T/C	cg05368731	chr17:41323189	NBR1	0.89	7.91	0.67	1.38e-11	Menopause (age at onset);
SKCM	cis	rs11098499	0.754	rs7672778	chr4:120248585	A/G	cg09307838	chr4:120376055	NA	0.93	7.56	0.65	6.5500000000000006e-11	Corneal astigmatism;
SKCM	cis	rs3780486	0.846	rs10113903	chr9:33122645	C/G	cg13443165	chr9:33130375	B4GALT1	0.55	4.8	0.48	7.6e-6	IgG glycosylation;
SKCM	cis	rs7618915	0.501	rs3733039	chr3:52719088	C/T	cg18404041	chr3:52824283	ITIH1	-0.53	-4.77	-0.48	8.42e-6	Bipolar disorder;
SKCM	cis	rs1577917	0.958	rs34230196	chr6:86526022	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.33	-0.52	9.19e-7	Response to antipsychotic treatment;
SKCM	cis	rs6665290	0.904	rs9727512	chr1:227185375	G/T	cg10327440	chr1:227177885	CDC42BPA	-1.25	-17.46	-0.89	1.15e-28	Myeloid white cell count;
SKCM	cis	rs12824058	0.767	rs4759654	chr12:130815559	A/G	cg24838063	chr12:130822603	PIWIL1	0.78	6.99	0.62	8.22e-10	Menopause (age at onset);
SKCM	cis	rs7811142	0.943	rs28578163	chr7:100044754	A/G	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.34	0.69	2.1e-12	Platelet count;
SKCM	cis	rs28595532	0.920	rs17258830	chr4:119725543	A/T	cg21605333	chr4:119757512	SEC24D	-1.35	-7.92	-0.67	1.37e-11	Cannabis dependence symptom count;
SKCM	cis	rs908922	0.676	rs2181172	chr1:152491794	A/G	cg09873164	chr1:152488093	CRCT1	0.76	5.94	0.56	7.4e-8	Hair morphology;
SKCM	cis	rs7666738	0.830	rs7678911	chr4:99057430	C/T	cg17366294	chr4:99064904	C4orf37	0.61	4.93	0.49	4.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11139399	0.613	rs10780529	chr9:84338430	T/C	cg13729285	chr9:84764156	NA	0.55	5.37	0.52	7.9e-7	Hippocampal atrophy;
SKCM	cis	rs6840360	0.550	rs4696269	chr4:152481704	T/A	cg22705602	chr4:152727874	NA	-0.49	-5.34	-0.52	8.94e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs748404	0.518	rs480108	chr15:43817406	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	0.68	5.14	0.5	1.98e-6	Lung cancer;
SKCM	cis	rs2836633	1.000	rs11088437	chr21:40053372	A/G	cg05519781	chr21:40033154	ERG	0.76	6.68	0.6	3.17e-9	Coronary artery disease;
SKCM	cis	rs1799949	1.000	rs8176126	chr17:41259049	A/G	cg23758822	chr17:41437982	NA	-0.93	-8.0	-0.67	9.32e-12	Menopause (age at onset);
SKCM	cis	rs28386778	0.863	rs3826341	chr17:61819222	C/A	cg06873352	chr17:61820015	STRADA	0.76	6.34	0.58	1.38e-8	Prudent dietary pattern;
SKCM	cis	rs11690935	0.851	rs6731562	chr2:172798262	T/C	cg13550731	chr2:172543902	DYNC1I2	-0.79	-5.87	-0.55	1.02e-7	Schizophrenia;
SKCM	cis	rs6463523	0.933	rs79984239	chr7:766220	A/G	cg11064039	chr7:766100	PRKAR1B;HEATR2	1.04	9.58	0.74	8.01e-15	Subjective well-being;
SKCM	cis	rs3008870	1.000	rs1118393	chr1:67366668	A/G	cg08660285	chr1:67390436	MIER1;WDR78	0.95	6.45	0.59	8.62e-9	Lymphocyte percentage of white cells;
SKCM	cis	rs6835098	0.816	rs13111572	chr4:174159788	G/A	cg08422745	chr4:174089978	GALNT7	0.77	5.55	0.53	3.85e-7	Dementia and core Alzheimer's disease neuropathologic changes;
SKCM	cis	rs1799949	0.930	rs66499067	chr17:41248484	G/C	cg25918947	chr17:41365094	TMEM106A	-0.62	-5.85	-0.55	1.1e-7	Menopause (age at onset);
SKCM	cis	rs4819052	0.851	rs1999334	chr21:46670457	A/G	cg19498844	chr21:46707878	POFUT2;LOC642852	0.8	6.79	0.61	1.96e-9	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs16866061	0.515	rs3738951	chr2:225368321	A/G	cg12698349	chr2:225449008	CUL3	0.92	10.3	0.76	3.38e-16	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs9486715	0.867	rs9373887	chr6:96957004	C/T	cg06623918	chr6:96969491	KIAA0776	0.82	6.67	0.6	3.34e-9	Headache;
SKCM	cis	rs13118159	0.550	rs11941200	chr4:1369093	C/G	cg20887711	chr4:1340912	KIAA1530	0.96	7.3	0.64	2.14e-10	Longevity;
SKCM	cis	rs10504229	0.773	rs1874373	chr8:58194423	T/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs798766	0.779	rs55895920	chr4:1735930	C/T	cg24239225	chr4:1659016	FAM53A	-0.72	-4.87	-0.48	5.66e-6	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs9611565	0.568	rs2413656	chr22:42129357	G/T	cg03806693	chr22:41940476	POLR3H	0.79	5.05	0.5	2.87e-6	Vitiligo;
SKCM	cis	rs561341	0.941	rs2428338	chr17:30299629	T/C	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs2732480	1.000	rs2732480	chr12:48736303	A/C	cg21466736	chr12:48725269	NA	0.6	5.16	0.5	1.87e-6	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs11945232	0.929	rs28736552	chr4:88356111	T/C	cg23841344	chr4:88312519	HSD17B11	-0.64	-4.77	-0.47	8.55e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs4724125	0.782	rs62457837	chr7:42720079	C/T	cg09407816	chr7:42972088	MRPL32;PSMA2	0.79	4.98	0.49	3.67e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs17345786	1.000	rs17345528	chr3:101294830	A/C	cg12386194	chr3:101231763	SENP7	-0.77	-5.25	-0.51	1.29e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs910316	1.000	rs3742780	chr14:75505008	G/C	cg08847533	chr14:75593920	NEK9	0.95	9.18	0.72	4.92e-14	Height;
SKCM	cis	rs826838	1.000	rs1393537	chr12:38920961	C/T	cg26384229	chr12:38710491	ALG10B	1.04	9.75	0.74	3.88e-15	Heart rate;
SKCM	cis	rs6089584	0.819	rs1467593	chr20:60601432	T/G	cg06108461	chr20:60628389	TAF4	0.82	6.39	0.59	1.12e-8	Body mass index;
SKCM	cis	rs727563	0.638	rs5996058	chr22:42141452	A/G	cg03806693	chr22:41940476	POLR3H	1.14	7.07	0.63	5.69e-10	Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs11098499	0.863	rs10034450	chr4:120455649	A/G	cg09307838	chr4:120376055	NA	0.97	7.66	0.66	4.19e-11	Corneal astigmatism;
SKCM	cis	rs12120353	0.702	rs780614	chr1:4551679	A/G	cg15022359	chr1:4193126	NA	-0.56	-4.83	-0.48	6.77e-6	Anxiety disorder;
SKCM	cis	rs28595532	0.920	rs114019902	chr4:119755564	G/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs6951245	1.000	rs79765398	chr7:1073764	A/G	cg21664854	chr7:1097933	C7orf50;GPR146	0.89	4.79	0.48	7.66e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs910316	0.737	rs175499	chr14:75535927	G/A	cg08847533	chr14:75593920	NEK9	-0.82	-6.74	-0.61	2.5e-9	Height;
SKCM	cis	rs1559088	0.600	rs7259117	chr19:33550113	G/T	cg17764715	chr19:33622953	WDR88	0.94	6.39	0.59	1.1e-8	Bone ultrasound measurement (broadband ultrasound attenuation);
SKCM	cis	rs28595532	0.920	rs115576008	chr4:119736967	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs875971	0.505	rs1167385	chr7:65513308	G/A	cg11987759	chr7:65425863	GUSB	0.74	6.61	0.6	4.28e-9	Aortic root size;
SKCM	cis	rs9300255	0.739	rs4759415	chr12:123743674	C/T	cg00376283	chr12:123451042	ABCB9	-0.84	-5.91	-0.56	8.5e-8	Neutrophil percentage of white cells;
SKCM	cis	rs16949788	1.000	rs74521803	chr15:66832261	T/G	cg08120210	chr15:66682733	MAP2K1	-0.68	-5.22	-0.51	1.46e-6	Spherical equivalent (joint analysis main effects and education interaction);
SKCM	cis	rs10492096	0.947	rs11559082	chr12:6602367	C/T	cg13857086	chr12:6580257	VAMP1	0.76	5.75	0.55	1.64e-7	Hip geometry;
SKCM	cis	rs151997	0.671	rs27845	chr5:50197420	A/C	cg06027927	chr5:50259733	NA	0.64	5.93	0.56	7.69e-8	Callous-unemotional behaviour;
SKCM	cis	rs9467773	1.000	rs9467796	chr6:26568411	A/G	cg15659132	chr6:26577336	NA	0.61	5.76	0.55	1.6e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs4243830	0.850	rs1010584	chr1:6579843	C/T	cg22792644	chr1:6614718	TAS1R1;NOL9	-1.01	-4.94	-0.49	4.4e-6	Body mass index;
SKCM	cis	rs28595532	0.920	rs114639588	chr4:119736176	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs208520	0.690	rs10455194	chr6:66743356	A/G	cg07460842	chr6:66804631	NA	0.9	7.2	0.63	3.26e-10	Exhaled nitric oxide output;
SKCM	cis	rs6952808	0.501	rs3778999	chr7:2180885	G/A	cg05863683	chr7:1912471	MAD1L1	0.58	4.95	0.49	4.27e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs1799949	1.000	rs1799966	chr17:41223094	T/C	cg23758822	chr17:41437982	NA	0.94	7.89	0.67	1.51e-11	Menopause (age at onset);
SKCM	cis	rs372883	0.648	rs2832296	chr21:30741454	C/T	cg24692254	chr21:30365293	RNF160	-0.64	-5.1	-0.5	2.29e-6	Pancreatic cancer;
SKCM	cis	rs8072100	0.967	rs4793842	chr17:45671506	G/A	cg25173405	chr17:45401733	C17orf57	0.58	5.23	0.51	1.39e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs9388451	0.807	rs1268070	chr6:126041164	A/G	cg05901451	chr6:126070800	HEY2	-0.78	-7.18	-0.63	3.58e-10	Brugada syndrome;
SKCM	cis	rs2832191	0.967	rs2898160	chr21:30487496	A/G	cg24692254	chr21:30365293	RNF160	-0.79	-7.24	-0.63	2.72e-10	Dental caries;
SKCM	cis	rs16854884	1.000	rs62269906	chr3:143808812	A/G	cg06585982	chr3:143692056	C3orf58	0.76	5.59	0.53	3.18e-7	Economic and political preferences (feminism/equality);
SKCM	cis	rs72799341	1.000	rs1458201	chr16:30916129	G/A	cg00531865	chr16:30841666	NA	-0.57	-4.82	-0.48	6.99e-6	Diastolic blood pressure;
SKCM	cis	rs854765	0.506	rs7210400	chr17:17949957	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	-1.02	-9.54	-0.73	9.55e-15	Total body bone mineral density;
SKCM	cis	rs9880211	1.000	rs9880211	chr3:136107549	G/A	cg21827317	chr3:136751795	NA	-0.65	-4.92	-0.49	4.73e-6	Body mass index;Height;
SKCM	cis	rs1707322	1.000	rs4660895	chr1:46329739	C/T	cg03146154	chr1:46216737	IPP	0.75	5.15	0.5	1.94e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs9868809	0.505	rs13434258	chr3:48738491	T/C	cg00383909	chr3:49044727	WDR6	0.89	5.09	0.5	2.44e-6	Ulcerative colitis;Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs2354432	1.000	rs10900325	chr1:146692174	C/T	cg25205988	chr1:146714368	CHD1L	-1.25	-7.62	-0.65	5e-11	Mitochondrial DNA levels;
SKCM	cis	rs7829975	0.501	rs74345345	chr8:8578435	C/G	cg06636001	chr8:8085503	FLJ10661	-0.66	-4.97	-0.49	3.89e-6	Mood instability;
SKCM	cis	rs867186	1.000	rs17310467	chr20:33545616	A/G	cg04194272	chr20:33683537	NA	-1.37	-6.77	-0.61	2.18e-9	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs709400	0.628	rs12879085	chr14:103874420	G/A	cg26031613	chr14:104095156	KLC1	-0.72	-5.27	-0.51	1.16e-6	Body mass index;
SKCM	cis	rs4523957	0.890	rs8076939	chr17:2099931	C/A	cg16513277	chr17:2031491	SMG6	-0.78	-5.24	-0.51	1.31e-6	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs3008870	0.958	rs12131222	chr1:67438535	A/T	cg08660285	chr1:67390436	MIER1;WDR78	-0.92	-6.07	-0.57	4.27e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs11098499	0.604	rs12642411	chr4:120580525	T/C	cg24375607	chr4:120327624	NA	0.63	4.83	0.48	6.74e-6	Corneal astigmatism;
SKCM	cis	rs2836974	0.897	rs8132295	chr21:40527774	A/G	cg17971929	chr21:40555470	PSMG1	-0.87	-8.48	-0.69	1.1e-12	Cognitive function;
SKCM	cis	rs11098499	0.954	rs7656252	chr4:120404268	T/C	cg24375607	chr4:120327624	NA	0.66	5.09	0.5	2.44e-6	Corneal astigmatism;
SKCM	cis	rs1949733	0.958	rs2631731	chr4:8429817	A/G	cg11789530	chr4:8429930	ACOX3	0.86	6.34	0.58	1.37e-8	Response to antineoplastic agents;
SKCM	cis	rs992157	0.835	rs7585702	chr2:219146607	T/C	cg20019365	chr2:219134978	PNKD;AAMP	-0.71	-6.08	-0.57	4.22e-8	Colorectal cancer;
SKCM	cis	rs8017423	0.647	rs4904674	chr14:90817412	G/A	cg04374321	chr14:90722782	PSMC1	-0.76	-5.95	-0.56	7.2e-8	Mortality in heart failure;
SKCM	cis	rs3859192	0.599	rs34933056	chr17:38162983	G/A	cg17467752	chr17:38218738	THRA	-0.74	-6.28	-0.58	1.78e-8	White blood cell count;
SKCM	cis	rs7829975	0.714	rs11777085	chr8:8672429	G/C	cg15556689	chr8:8085844	FLJ10661	0.69	6.21	0.58	2.35e-8	Mood instability;
SKCM	cis	rs10751667	0.621	rs10794353	chr11:948740	A/G	cg06064525	chr11:970664	AP2A2	-0.54	-5.12	-0.5	2.13e-6	Alzheimer's disease (late onset);
SKCM	cis	rs7191439	0.583	rs9935872	chr16:88788477	A/G	cg02389323	chr16:88786976	FAM38A	1.23	5.35	0.52	8.43e-7	Plateletcrit;
SKCM	cis	rs1799949	1.000	rs11079056	chr17:41300799	C/A	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.11	-0.57	3.67e-8	Menopause (age at onset);
SKCM	cis	rs7772486	0.875	rs9322043	chr6:146352690	A/G	cg23711669	chr6:146136114	FBXO30	0.77	7.48	0.65	9.65e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4888262	0.526	rs12921903	chr16:74625575	C/T	cg01733217	chr16:74700730	RFWD3	0.92	7.11	0.63	4.82e-10	Testicular germ cell tumor;
SKCM	cis	rs1552244	1.000	rs6414438	chr3:10073824	G/C	cg02579736	chr3:10068473	FANCD2;CIDECP	1.23	6.92	0.62	1.13e-9	Alzheimer's disease;
SKCM	cis	rs1298908	0.639	rs2236568	chr10:82035923	C/A	cg01528321	chr10:82214614	TSPAN14	0.66	6.09	0.57	4.01e-8	Diabetic kidney disease;
SKCM	cis	rs2050392	0.544	rs598672	chr10:30742388	C/T	cg25182066	chr10:30743637	MAP3K8	-0.69	-5.99	-0.56	6.06e-8	Inflammatory bowel disease;
SKCM	cis	rs10905065	0.793	rs10508296	chr10:5864500	C/A	cg09234995	chr10:5726438	C10orf18	-0.63	-5.18	-0.51	1.67e-6	Menopause (age at onset);
SKCM	cis	rs7772486	0.754	rs1055212	chr6:146058315	A/T	cg23711669	chr6:146136114	FBXO30	-0.88	-8.81	-0.71	2.53e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs801193	1.000	rs6975195	chr7:66124774	T/A	cg05627663	chr7:65219948	SNORA22;CCT6P1	-0.56	-4.84	-0.48	6.39e-6	Aortic root size;
SKCM	cis	rs9611565	0.532	rs4401299	chr22:42156517	A/G	cg03806693	chr22:41940476	POLR3H	0.81	5.03	0.49	3.08e-6	Vitiligo;
SKCM	cis	rs763014	1.000	rs7205409	chr16:642610	A/G	cg09263875	chr16:632152	PIGQ	0.65	5.37	0.52	8.02e-7	Height;
SKCM	cis	rs6942756	1.000	rs66864889	chr7:128952560	G/A	cg02491457	chr7:128862824	NA	-0.82	-5.16	-0.5	1.81e-6	White matter hyperintensity burden;
SKCM	cis	rs637571	0.522	rs542332	chr11:65744421	C/T	cg26695010	chr11:65641043	EFEMP2	-0.71	-5.35	-0.52	8.54e-7	Eosinophil percentage of white cells;
SKCM	cis	rs4243830	0.571	rs60256927	chr1:6614747	G/A	cg22792644	chr1:6614718	TAS1R1;NOL9	1.23	4.88	0.48	5.42e-6	Body mass index;
SKCM	cis	rs870825	0.929	rs72689263	chr4:185590961	C/T	cg04058563	chr4:185651563	MLF1IP	1.09	5.66	0.54	2.4e-7	Blood protein levels;
SKCM	cis	rs2842992	0.789	rs9364536	chr6:160225559	G/C	cg19482086	chr6:160211437	TCP1;MRPL18	0.81	6.18	0.57	2.68e-8	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs4746818	0.711	rs4745976	chr10:70845181	A/G	cg11621586	chr10:70884670	VPS26A	0.72	5.0	0.49	3.4e-6	Left atrial antero-posterior diameter;
SKCM	cis	rs7103648	0.897	rs2278890	chr11:47399602	G/A	cg03711944	chr11:47377212	SPI1	-0.57	-5.1	-0.5	2.3e-6	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs7569084	0.687	rs7562559	chr2:65679853	G/A	cg10464312	chr2:66672688	MEIS1	0.45	5.11	0.5	2.25e-6	Sum eosinophil basophil counts;
SKCM	cis	rs4319547	0.656	rs1553179	chr12:122831073	A/G	cg23029597	chr12:123009494	RSRC2	-0.73	-5.22	-0.51	1.41e-6	Body mass index;
SKCM	cis	rs933688	0.639	rs332530	chr5:90789810	G/T	cg12630606	chr5:90679528	LOC100129716;ARRDC3	0.99	7.5	0.65	8.83e-11	Smoking behavior;
SKCM	cis	rs17376456	0.877	rs10040648	chr5:93490301	G/C	cg21475434	chr5:93447410	FAM172A	1.0	5.59	0.53	3.27e-7	Diabetic retinopathy;
SKCM	cis	rs7100689	0.577	rs9420359	chr10:82054873	C/T	cg01528321	chr10:82214614	TSPAN14	0.77	7.36	0.64	1.63e-10	Post bronchodilator FEV1;
SKCM	cis	rs1153858	1.000	rs1145081	chr15:45679667	C/G	cg21132104	chr15:45694354	SPATA5L1	0.93	7.66	0.66	4.2e-11	Homoarginine levels;
SKCM	cis	rs7932354	0.528	rs7479189	chr11:47057009	T/A	cg03339077	chr11:47165057	C11orf49	-0.59	-4.79	-0.48	7.68e-6	Bone mineral density (hip);Bone mineral density;
SKCM	cis	rs28510890	0.688	rs28438060	chr15:93159406	A/G	cg23043611	chr15:93139145	NA	-0.75	-5.28	-0.51	1.12e-6	Lung cancer in ever smokers;
SKCM	cis	rs10504229	0.683	rs11786843	chr8:58133629	T/C	cg02725872	chr8:58115012	NA	-0.54	-5.22	-0.51	1.44e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs13256369	0.802	rs13281933	chr8:8562665	C/A	cg15556689	chr8:8085844	FLJ10661	0.65	4.77	0.48	8.39e-6	Obesity-related traits;
SKCM	cis	rs6753739	0.745	rs6436104	chr2:219915767	A/G	cg09617556	chr2:219924408	IHH	0.47	4.94	0.49	4.44e-6	Height;
SKCM	cis	rs10752881	1.000	rs6424879	chr1:182986592	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.73	6.47	0.59	7.97e-9	Colorectal cancer;
SKCM	cis	rs4819052	0.851	rs10470258	chr21:46658989	C/T	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.42	0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs2303759	0.709	rs10414921	chr19:49823047	C/T	cg05022225	chr19:49866942	DKKL1;TEAD2	0.7	5.05	0.5	2.78e-6	Multiple sclerosis;
SKCM	cis	rs933688	1.000	rs889213	chr5:90682151	C/T	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.12	8.45	0.69	1.25e-12	Smoking behavior;
SKCM	cis	rs72781680	1.000	rs12623496	chr2:24181583	C/T	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	cis	rs6933660	0.745	rs9371517	chr6:151739810	G/T	cg14262678	chr6:151773367	RMND1;C6orf211	0.62	4.8	0.48	7.38e-6	Menarche (age at onset);
SKCM	cis	rs9581857	0.579	rs75326986	chr13:27997758	C/T	cg22138327	chr13:27999177	GTF3A	0.95	6.38	0.59	1.14e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs1348850	0.874	rs1348848	chr2:178358233	A/C	cg02961200	chr2:178257176	LOC100130691;AGPS	-0.84	-6.25	-0.58	2.02e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs10089	0.953	rs6879970	chr5:127387178	A/G	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.92	8.29	0.68	2.54e-12	Ileal carcinoids;
SKCM	cis	rs7523273	0.606	rs2796262	chr1:207915180	G/A	cg22525895	chr1:207977042	MIR29B2	0.77	6.46	0.59	8.11e-9	Schizophrenia;
SKCM	cis	rs9290877	0.667	rs6444324	chr3:188457961	C/G	cg17392043	chr3:188495102	LPP	-0.64	-4.93	-0.49	4.6e-6	IgE levels;
SKCM	cis	rs826838	0.806	rs826873	chr12:39121305	G/A	cg13010199	chr12:38710504	ALG10B	-0.78	-6.06	-0.57	4.53e-8	Heart rate;
SKCM	cis	rs854765	0.663	rs4925120	chr17:17754633	C/T	cg04398451	chr17:18023971	MYO15A	0.87	5.86	0.55	1.04e-7	Total body bone mineral density;
SKCM	cis	rs4819052	0.851	rs2236443	chr21:46678174	T/C	cg20896738	chr21:46707857	POFUT2;LOC642852	0.65	4.85	0.48	6.22e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs16949788	0.793	rs8035939	chr15:66609740	G/A	cg08120210	chr15:66682733	MAP2K1	-0.73	-5.49	-0.53	4.93e-7	Spherical equivalent (joint analysis main effects and education interaction);
SKCM	cis	rs62012628	0.527	rs12438008	chr15:79084680	C/T	cg04896959	chr15:78267971	NA	-0.68	-6.03	-0.56	5.22e-8	Diastolic blood pressure;
SKCM	cis	rs3820068	0.603	rs72647128	chr1:15963908	T/C	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs644799	0.582	rs1727149	chr11:95497171	C/T	cg25622487	chr11:95524042	FAM76B;CEP57	-0.62	-4.98	-0.49	3.78e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs9388451	0.874	rs3734634	chr6:126111800	G/A	cg05901451	chr6:126070800	HEY2	-0.78	-6.97	-0.62	9.07e-10	Brugada syndrome;
SKCM	cis	rs9611565	0.729	rs73176689	chr22:41782633	T/C	cg03806693	chr22:41940476	POLR3H	-0.99	-6.37	-0.58	1.23e-8	Vitiligo;
SKCM	cis	rs6424115	0.737	rs10917430	chr1:24170458	C/T	cg15997130	chr1:24165203	NA	-0.63	-5.16	-0.5	1.8e-6	Immature fraction of reticulocytes;
SKCM	cis	rs6121246	0.512	rs45443696	chr20:30311396	A/C	cg13852791	chr20:30311386	BCL2L1	0.82	5.69	0.54	2.09e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs651907	0.535	rs13065944	chr3:101473088	G/A	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.81	7.11	0.63	4.78e-10	Colorectal cancer;
SKCM	cis	rs6545883	0.859	rs7561672	chr2:61519094	G/A	cg15711740	chr2:61764176	XPO1	0.68	4.82	0.48	6.94e-6	Tuberculosis;
SKCM	cis	rs9303401	0.659	rs16943176	chr17:56769887	G/A	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.35	0.52	8.54e-7	Cognitive test performance;
SKCM	cis	rs2354432	0.607	rs12402309	chr1:146721983	T/A	cg25205988	chr1:146714368	CHD1L	-1.19	-6.56	-0.6	5.24e-9	Mitochondrial DNA levels;
SKCM	cis	rs7809950	0.678	rs62482507	chr7:107024488	T/G	cg23024343	chr7:107201750	COG5	-0.84	-7.35	-0.64	1.66e-10	Coronary artery disease;
SKCM	cis	rs875971	0.862	rs4236208	chr7:65749078	C/T	cg18876405	chr7:65276391	NA	-0.64	-6.38	-0.59	1.18e-8	Aortic root size;
SKCM	cis	rs72781680	0.898	rs72796166	chr2:23939311	G/C	cg08917208	chr2:24149416	ATAD2B	0.95	4.78	0.48	8.1e-6	Lymphocyte counts;
SKCM	cis	rs7772486	0.597	rs2485631	chr6:146190077	G/C	cg23711669	chr6:146136114	FBXO30	0.81	7.34	0.64	1.8e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs11105298	0.891	rs11105325	chr12:89938590	G/A	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.84	-5.19	-0.51	1.63e-6	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs7666738	0.606	rs3846446	chr4:99099768	C/A	cg05340658	chr4:99064831	C4orf37	0.62	4.77	0.47	8.51e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs17685	0.753	rs55812043	chr7:75747241	T/C	cg01364799	chr7:75623366	TMEM120A	-0.7	-5.69	-0.54	2.09e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs35306767	0.951	rs55742421	chr10:961037	A/C	cg20503657	chr10:835505	NA	0.75	5.83	0.55	1.19e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs9911578	0.933	rs2531725	chr17:56517962	G/A	cg05425664	chr17:57184151	TRIM37	-0.66	-4.95	-0.49	4.2e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7927771	0.524	rs7943213	chr11:47715524	T/C	cg20307385	chr11:47447363	PSMC3	0.71	5.63	0.54	2.67e-7	Subjective well-being;
SKCM	cis	rs6977660	1.000	rs12666159	chr7:19804199	T/C	cg07541023	chr7:19748670	TWISTNB	0.72	5.03	0.5	3.01e-6	Thyroid stimulating hormone;
SKCM	cis	rs651907	0.535	rs13094911	chr3:101519021	T/C	cg12386194	chr3:101231763	SENP7	0.68	5.74	0.54	1.73e-7	Colorectal cancer;
SKCM	cis	rs13118159	0.836	rs2293630	chr4:1342521	G/A	cg02018176	chr4:1364513	KIAA1530	0.67	5.54	0.53	4e-7	Longevity;
SKCM	cis	rs155076	1.000	rs567166	chr13:21837519	T/C	cg11317459	chr13:21872234	NA	-1.25	-6.82	-0.61	1.71e-9	White matter hyperintensity burden;
SKCM	cis	rs6450176	1.000	rs58369491	chr5:53297295	T/C	ch.5.1024479R	chr5:53302184	ARL15	-0.73	-5.04	-0.5	2.91e-6	HDL cholesterol levels;HDL cholesterol;Adiponectin levels;
SKCM	cis	rs11148252	0.904	rs9536079	chr13:53030565	G/A	cg00495681	chr13:53174319	NA	0.61	5.19	0.51	1.63e-6	Lewy body disease;
SKCM	cis	rs3768617	0.510	rs3768615	chr1:183103604	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.79	7.59	0.65	5.75e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs637571	0.522	rs491973	chr11:65727301	A/G	cg26695010	chr11:65641043	EFEMP2	-0.7	-5.32	-0.52	9.78e-7	Eosinophil percentage of white cells;
SKCM	cis	rs1413885	0.516	rs10158873	chr1:65836244	T/C	cg14976592	chr1:65886160	LEPROT;LEPR	0.62	5.19	0.51	1.6e-6	Anticoagulant levels;
SKCM	cis	rs72772090	0.710	rs112178674	chr5:96060355	C/T	cg17330273	chr5:96107758	CAST;ERAP1	-0.83	-4.97	-0.49	3.86e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs4891159	0.790	rs11150953	chr18:74145491	G/A	cg24786174	chr18:74118243	ZNF516	-0.74	-6.91	-0.62	1.16e-9	Longevity;
SKCM	cis	rs684232	0.602	rs416662	chr17:535699	A/G	cg15660573	chr17:549704	VPS53	-0.76	-6.08	-0.57	4.15e-8	Prostate cancer;
SKCM	cis	rs10540	0.908	rs1044707	chr11:491334	G/T	cg03352830	chr11:487213	PTDSS2	-0.97	-5.19	-0.51	1.63e-6	Body mass index;
SKCM	cis	rs72634258	0.842	rs4325151	chr1:8168917	T/A	cg00042356	chr1:8021962	PARK7	-0.86	-5.71	-0.54	1.94e-7	Inflammatory bowel disease;
SKCM	cis	rs12706411	1.000	rs12706411	chr7:122065219	C/T	cg17986181	chr7:121955208	NA	-0.68	-4.94	-0.49	4.3e-6	Alzheimer disease and age of onset;
SKCM	cis	rs4819052	0.851	rs914214	chr21:46697820	G/T	cg19498844	chr21:46707878	POFUT2;LOC642852	0.91	7.84	0.66	1.92e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs28595532	0.844	rs115411027	chr4:119490685	T/C	cg11846333	chr4:119757529	SEC24D	1.15	6.24	0.58	2.13e-8	Cannabis dependence symptom count;
SKCM	cis	rs4665809	0.556	rs4665314	chr2:26415912	T/C	cg26119090	chr2:26468346	HADHA;HADHB	-1.02	-7.92	-0.67	1.35e-11	Gut microbiome composition (summer);
SKCM	cis	rs58688157	0.705	rs936469	chr11:606749	G/A	cg03576123	chr11:487126	PTDSS2	-0.8	-5.15	-0.5	1.88e-6	Systemic lupus erythematosus;
SKCM	cis	rs1799949	0.965	rs35521261	chr17:41313612	A/G	cg23758822	chr17:41437982	NA	0.92	7.83	0.66	1.97e-11	Menopause (age at onset);
SKCM	cis	rs6459804	0.967	rs10233396	chr7:157512290	C/T	cg27240775	chr7:156793224	NA	-0.69	-4.94	-0.49	4.32e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs11608355	0.618	rs60819157	chr12:109795766	G/A	cg19025524	chr12:109796872	NA	-0.64	-5.03	-0.49	3.11e-6	Neuroticism;
SKCM	cis	rs155076	1.000	rs261431	chr13:21865738	A/G	cg14456004	chr13:21872349	NA	1.23	7.17	0.63	3.82e-10	White matter hyperintensity burden;
SKCM	cis	rs9921222	0.632	rs11649268	chr16:398643	A/C	cg26944245	chr16:421049	TMEM8A;MRPL28	0.63	4.85	0.48	6.15e-6	Bone mineral density (spine);Bone mineral density;
SKCM	cis	rs9549367	0.713	rs3024747	chr13:113821787	C/G	cg18105134	chr13:113819100	PROZ	-0.88	-6.51	-0.59	6.68e-9	Platelet distribution width;
SKCM	cis	rs2839186	0.721	rs13051200	chr21:47701693	A/T	cg05896524	chr21:47604654	C21orf56	0.67	5.49	0.53	4.77e-7	Testicular germ cell tumor;
SKCM	cis	rs7296418	0.961	rs10773921	chr12:123541606	C/T	cg00376283	chr12:123451042	ABCB9	0.96	8.66	0.7	5.01e-13	Platelet count;
SKCM	cis	rs7216064	1.000	rs12451511	chr17:65874861	T/G	cg12091567	chr17:66097778	LOC651250	-0.75	-5.27	-0.51	1.19e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs60871478	0.635	rs4311567	chr7:792295	T/C	cg05535760	chr7:792225	HEATR2	1.19	9.94	0.75	1.65e-15	Cerebrospinal P-tau181p levels;
SKCM	cis	rs2760061	0.598	rs2796056	chr1:228122901	G/A	cg18477163	chr1:228402036	OBSCN	-0.42	-4.85	-0.48	6.2e-6	Diastolic blood pressure;
SKCM	cis	rs829883	0.867	rs1641640	chr12:98896017	A/G	cg25150519	chr12:98850993	NA	0.5	5.3	0.51	1.07e-6	Colorectal adenoma (advanced);
SKCM	cis	rs3845702	0.736	rs2678936	chr2:180872179	G/C	cg01881094	chr2:180872142	CWC22	1.26	6.25	0.58	2.01e-8	Schizophrenia;
SKCM	cis	rs10193935	0.901	rs6733914	chr2:42674741	A/G	cg27598129	chr2:42591480	NA	0.88	6.71	0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs440932	0.717	rs330944	chr8:9021293	C/T	cg15556689	chr8:8085844	FLJ10661	0.63	4.91	0.49	4.9100000000000004e-06	High light scatter reticulocyte percentage of red cells;
SKCM	cis	rs6835098	0.924	rs13125240	chr4:174151619	T/C	cg08422745	chr4:174089978	GALNT7	0.82	6.21	0.58	2.38e-8	Dementia and core Alzheimer's disease neuropathologic changes;
SKCM	cis	rs362272	0.505	rs10155132	chr4:3369500	A/G	cg21096898	chr4:3318625	RGS12	1.01	12.88	0.82	5.24e-21	Serum sulfate level;
SKCM	cis	rs6089829	0.962	rs3746749	chr20:61667333	T/C	cg08564027	chr20:61660810	NA	0.63	5.65	0.54	2.46e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs2070488	0.804	rs13063978	chr3:38476538	A/G	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.72	5.81	0.55	1.3e-7	Electrocardiographic conduction measures;
SKCM	cis	rs4925386	0.819	rs2890083	chr20:60911958	G/A	cg24112000	chr20:60950667	NA	0.63	6.01	0.56	5.66e-8	Colorectal cancer;Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs34311866	0.808	rs11248059	chr4:960331	C/G	cg07828340	chr4:882639	GAK	0.89	4.83	0.48	6.7e-6	Parkinson's disease;
SKCM	cis	rs7811142	0.943	rs67196635	chr7:100025564	T/C	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.12	6.51	0.59	6.68e-9	Platelet count;
SKCM	cis	rs8062405	0.540	rs193628	chr16:28582142	G/T	cg09445799	chr16:28968168	NFATC2IP	0.51	4.82	0.48	6.9e-6	Cognitive ability (multi-trait analysis);Cognitive ability;
SKCM	cis	rs910316	0.967	rs12147532	chr14:75651858	T/G	cg11812906	chr14:75593930	NEK9	-0.75	-5.65	-0.54	2.53e-7	Height;
SKCM	cis	rs7959452	0.535	rs4761228	chr12:69682327	G/A	cg14784868	chr12:69753453	YEATS4	0.6	5.08	0.5	2.49e-6	Blood protein levels;
SKCM	cis	rs6121246	0.559	rs6119652	chr20:30259445	C/G	cg13852791	chr20:30311386	BCL2L1	0.83	5.76	0.55	1.61e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs1023500	0.506	rs6002625	chr22:42517689	A/G	cg04733989	chr22:42467013	NAGA	-0.72	-5.58	-0.53	3.42e-7	Schizophrenia;
SKCM	cis	rs875971	0.619	rs2302918	chr7:66000932	A/G	cg18876405	chr7:65276391	NA	0.8	7.03	0.62	6.92e-10	Aortic root size;
SKCM	cis	rs951366	0.789	rs864783	chr1:205711974	T/C	cg11965913	chr1:205819406	PM20D1	0.99	9.69	0.74	4.88e-15	Menarche (age at onset);
SKCM	cis	rs62103177	0.789	rs7242289	chr18:77603291	C/T	cg27393146	chr18:77495563	CTDP1	-0.95	-5.5	-0.53	4.56e-7	Opioid sensitivity;
SKCM	cis	rs208520	0.526	rs9354366	chr6:66788559	C/T	cg07460842	chr6:66804631	NA	-1.17	-12.95	-0.83	3.93e-21	Exhaled nitric oxide output;
SKCM	cis	rs2739330	0.828	rs5751770	chr22:24252842	A/G	cg04234412	chr22:24373322	LOC391322	-0.62	-5.29	-0.51	1.09e-6	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs10492096	1.000	rs10492096	chr12:6580582	A/G	cg07142400	chr12:6602447	NCAPD2;MRPL51	-0.75	-4.92	-0.49	4.74e-6	Hip geometry;
SKCM	cis	rs2180341	0.920	rs4472373	chr6:127705983	G/A	cg24812749	chr6:127587940	RNF146	0.81	7.04	0.62	6.51e-10	Breast cancer;
SKCM	cis	rs7408868	1.000	rs10418305	chr19:15278808	C/G	cg14696996	chr19:15285081	NOTCH3	0.82	4.92	0.49	4.7e-6	Pulse pressure;
SKCM	cis	rs116095464	0.558	rs6866776	chr5:264495	C/T	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs2404602	0.647	rs11072636	chr15:77185786	A/G	cg23625390	chr15:77176239	SCAPER	-0.82	-7.93	-0.67	1.26e-11	Blood metabolite levels;
SKCM	cis	rs367615	0.537	rs10463600	chr5:108663636	G/A	cg17395555	chr5:108820864	NA	0.71	5.78	0.55	1.47e-7	Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs9926296	0.605	rs886951	chr16:89836865	A/G	cg27121462	chr16:89883253	FANCA	0.8	7.15	0.63	4.03e-10	Vitiligo;
SKCM	cis	rs1552244	1.000	rs55822690	chr3:10128003	A/G	cg02579736	chr3:10068473	FANCD2;CIDECP	1.34	7.21	0.63	3.15e-10	Alzheimer's disease;
SKCM	cis	rs826838	0.935	rs10875816	chr12:38955014	C/A	cg26384229	chr12:38710491	ALG10B	1.08	9.74	0.74	4.07e-15	Heart rate;
SKCM	cis	rs1790761	0.692	rs614080	chr11:67347287	G/A	cg00290607	chr11:67383545	NA	0.51	5.4	0.52	7e-7	Mean corpuscular volume;
SKCM	cis	rs875971	0.558	rs4433015	chr7:65639723	A/C	cg11987759	chr7:65425863	GUSB	0.71	6.22	0.58	2.33e-8	Aortic root size;
SKCM	cis	rs7809950	0.678	rs12670688	chr7:106821016	A/G	cg23024343	chr7:107201750	COG5	0.74	5.69	0.54	2.12e-7	Coronary artery disease;
SKCM	cis	rs9858542	1.000	rs13316695	chr3:49684917	C/G	cg03060546	chr3:49711283	APEH	-0.76	-5.67	-0.54	2.31e-7	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs36093844	0.904	rs7101889	chr11:85595579	C/G	cg25872744	chr11:85566296	CCDC83	0.69	5.06	0.5	2.7e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs7618915	0.547	rs62253703	chr3:52632357	T/C	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs7772486	0.875	rs2748482	chr6:146336532	T/C	cg23711669	chr6:146136114	FBXO30	0.76	7.15	0.63	4.1e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1218582	0.688	rs58629129	chr1:154910930	T/C	cg16680214	chr1:154839983	KCNN3	-0.56	-4.94	-0.49	4.31e-6	Prostate cancer;
SKCM	cis	rs9926296	0.533	rs12102290	chr16:89812617	C/T	cg27121462	chr16:89883253	FANCA	0.83	8.18	0.68	4.26e-12	Vitiligo;
SKCM	cis	rs2070488	0.699	rs13064938	chr3:38440237	T/C	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.74	6.15	0.57	3.15e-8	Electrocardiographic conduction measures;
SKCM	cis	rs3789045	0.560	rs2271424	chr1:204403311	A/G	cg17419461	chr1:204415978	PIK3C2B	-0.81	-6.22	-0.58	2.34e-8	Educational attainment (college completion);
SKCM	cis	rs10883723	0.810	rs10786671	chr10:104271303	G/A	cg11453585	chr10:104263688	ACTR1A;SUFU	0.77	6.29	0.58	1.73e-8	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs995000	0.783	rs993013	chr1:63111069	G/T	cg06896770	chr1:63153194	DOCK7	-0.76	-7.17	-0.63	3.77e-10	Triglyceride levels;
SKCM	cis	rs3789045	0.729	rs16853822	chr1:204450341	C/G	cg17419461	chr1:204415978	PIK3C2B	-0.84	-5.48	-0.53	4.96e-7	Educational attainment (college completion);
SKCM	cis	rs34375054	0.660	rs12578446	chr12:125605887	A/G	cg25124228	chr12:125621409	AACS	-0.74	-6.02	-0.56	5.28e-8	Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs9325144	0.555	rs10748433	chr12:38696352	C/G	cg13010199	chr12:38710504	ALG10B	0.63	5.01	0.49	3.31e-6	Morning vs. evening chronotype;
SKCM	cis	rs9911578	1.000	rs7223955	chr17:56917053	C/A	cg05425664	chr17:57184151	TRIM37	-0.67	-5.04	-0.5	2.91e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs6952808	0.609	rs12699453	chr7:1953056	C/T	cg03354898	chr7:1950403	MAD1L1	-0.55	-5.65	-0.54	2.56e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs7666738	0.791	rs17549003	chr4:98969132	A/C	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7659604	0.537	rs6815973	chr4:122663430	A/T	cg06713675	chr4:122721982	EXOSC9	0.65	5.18	0.51	1.7e-6	Type 2 diabetes;
SKCM	cis	rs10504229	1.000	rs57261109	chr8:58172152	C/T	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs10179986	0.930	rs56190064	chr2:134870498	A/G	cg14579516	chr2:135677120	CCNT2	0.72	4.77	0.48	8.36e-6	Glucose homeostasis traits;
SKCM	cis	rs9467773	0.584	rs1021372	chr6:26632444	T/C	cg15659132	chr6:26577336	NA	0.62	5.4	0.52	6.91e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs35146811	0.696	rs1727124	chr7:99804104	T/G	cg22906224	chr7:99728672	NA	-0.65	-5.19	-0.51	1.6e-6	Coronary artery disease;
SKCM	cis	rs9814567	0.806	rs9857242	chr3:134316378	A/G	cg06109529	chr3:134205091	CEP63;ANAPC13	0.62	5.08	0.5	2.49e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs7843479	1.000	rs7821592	chr8:21811530	C/G	cg17168535	chr8:21777572	XPO7	0.75	6.18	0.57	2.75e-8	Mean corpuscular volume;
SKCM	cis	rs4243830	0.850	rs12410405	chr1:6581283	C/G	cg22792644	chr1:6614718	TAS1R1;NOL9	1.11	5.99	0.56	6.12e-8	Body mass index;
SKCM	cis	rs9399135	0.967	rs9376077	chr6:135299713	C/G	cg24558204	chr6:135376177	HBS1L	0.56	5.01	0.49	3.3e-6	Red blood cell count;
SKCM	cis	rs6977660	0.943	rs10240816	chr7:19819620	A/C	cg07541023	chr7:19748670	TWISTNB	0.7	4.82	0.48	6.98e-6	Thyroid stimulating hormone;
SKCM	cis	rs1949733	0.628	rs1543246	chr4:8504909	A/T	cg11789530	chr4:8429930	ACOX3	0.7	5.23	0.51	1.4e-6	Response to antineoplastic agents;
SKCM	cis	rs778371	0.723	rs6704763	chr2:233592487	C/T	cg08000102	chr2:233561755	GIGYF2	0.83	6.71	0.61	2.74e-9	Schizophrenia;
SKCM	cis	rs1799949	1.000	rs11658754	chr17:41292739	G/A	cg23758822	chr17:41437982	NA	0.92	7.8	0.66	2.3e-11	Menopause (age at onset);
SKCM	cis	rs798554	0.959	rs798556	chr7:2759002	C/A	cg19346786	chr7:2764209	NA	-0.67	-6.94	-0.62	1.01e-9	Height;
SKCM	cis	rs9902453	1.000	rs8065261	chr17:28418041	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.77	-5.5	-0.53	4.67e-7	Coffee consumption (cups per day);
SKCM	cis	rs9399137	0.507	rs6569986	chr6:135311641	T/C	cg24558204	chr6:135376177	HBS1L	0.7	6.53	0.59	6.11e-9	Glycated hemoglobin levels;Mean corpuscular volume;Hematology traits;HbA2 levels;Mean corpuscular hemoglobin;Hemoglobin levels;F-cell distribution;Platelet count;
SKCM	cis	rs875971	0.862	rs2088655	chr7:65795711	T/C	cg11764359	chr7:65958608	NA	-0.74	-6.75	-0.61	2.36e-9	Aortic root size;
SKCM	trans	rs8073060	0.586	rs225256	chr17:33955756	C/T	cg19694781	chr19:47549865	TMEM160	-1.08	-8.36	-0.69	1.88e-12	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs28595532	0.920	rs115437723	chr4:119741828	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs7100689	0.784	rs1870142	chr10:82182296	G/A	cg01528321	chr10:82214614	TSPAN14	0.98	10.35	0.76	2.69e-16	Post bronchodilator FEV1;
SKCM	cis	rs4523957	0.620	rs9894215	chr17:2070698	G/A	cg16513277	chr17:2031491	SMG6	-0.92	-6.31	-0.58	1.54e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs9640161	0.702	rs3735175	chr7:150020457	C/T	cg10018233	chr7:150070692	REPIN1	0.75	6.05	0.56	4.81e-8	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs780096	0.526	rs1647276	chr2:27688601	C/T	cg05696406	chr2:27599888	SNX17	0.51	5.22	0.51	1.46e-6	Total body bone mineral density;
SKCM	cis	rs1577917	0.917	rs12665464	chr6:86574133	C/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.81	-7.92	-0.67	1.35e-11	Response to antipsychotic treatment;
SKCM	cis	rs9910055	0.529	rs368328	chr17:42170289	G/A	cg08499158	chr17:42289980	UBTF	0.72	5.61	0.54	2.95e-7	Total body bone mineral density;
SKCM	cis	rs6942756	0.876	rs2303303	chr7:129019736	G/A	cg02491457	chr7:128862824	NA	-0.77	-4.77	-0.47	8.53e-6	White matter hyperintensity burden;
SKCM	cis	rs1568889	1.000	rs1464897	chr11:28034844	C/G	cg06544937	chr11:28130018	METT5D1;KIF18A	0.83	6.32	0.58	1.5e-8	Bipolar disorder;
SKCM	cis	rs6424115	0.708	rs12755062	chr1:24185025	T/A	cg15997130	chr1:24165203	NA	-0.63	-5.07	-0.5	2.64e-6	Immature fraction of reticulocytes;
SKCM	cis	rs860295	0.650	rs670523	chr1:155878732	A/G	cg02153340	chr1:155202674	NA	0.74	5.29	0.51	1.09e-6	Body mass index;
SKCM	cis	rs362296	0.671	rs3135173	chr4:3257373	T/C	cg16987761	chr4:3318072	RGS12	-0.76	-6.39	-0.59	1.1e-8	Parental longevity (mother's age at death);
SKCM	cis	rs2836974	0.899	rs2836938	chr21:40574191	C/T	cg17971929	chr21:40555470	PSMG1	0.9	8.51	0.69	9.85e-13	Cognitive function;
SKCM	cis	rs478304	0.651	rs11537193	chr11:65500003	A/C	cg27068330	chr11:65405492	SIPA1	-0.89	-8.21	-0.68	3.71e-12	Acne (severe);
SKCM	trans	rs1814175	0.616	rs10839349	chr11:49753748	C/A	cg03929089	chr4:120376271	NA	-0.89	-8.07	-0.67	7.01e-12	Height;
SKCM	cis	rs4400599	0.758	rs60633748	chr1:154121510	T/C	cg26808167	chr1:154192205	UBAP2L;C1orf43	-0.54	-4.87	-0.48	5.75e-6	Platelet distribution width;
SKCM	cis	rs208520	0.909	rs58958359	chr6:67021381	A/C	cg07460842	chr6:66804631	NA	0.82	5.43	0.52	6.08e-7	Exhaled nitric oxide output;
SKCM	cis	rs1550582	0.548	rs11538239	chr8:135490539	A/G	cg17885191	chr8:135476712	NA	-0.93	-6.47	-0.59	7.94e-9	Educational attainment;
SKCM	cis	rs9300255	0.566	rs1716169	chr12:123716930	A/T	cg05973401	chr12:123451056	ABCB9	0.79	5.11	0.5	2.19e-6	Neutrophil percentage of white cells;
SKCM	cis	rs62238980	0.614	rs17745543	chr22:32475456	G/A	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs2153535	0.580	rs7747306	chr6:8453663	C/G	cg23788917	chr6:8435910	SLC35B3	-0.68	-4.96	-0.49	3.97e-6	Motion sickness;
SKCM	cis	rs10504229	0.953	rs75585481	chr8:58192202	T/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs2836974	0.863	rs8132333	chr21:40527900	A/G	cg11644478	chr21:40555479	PSMG1	0.97	10.21	0.76	5.08e-16	Cognitive function;
SKCM	cis	rs1577917	0.958	rs12207374	chr6:86656645	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.66	-5.74	-0.54	1.76e-7	Response to antipsychotic treatment;
SKCM	cis	rs33794	0.534	rs245215	chr3:45239835	C/T	cg05470468	chr3:44620074	ZNF167	0.69	4.79	0.48	7.78e-6	Lung function (forced expiratory volume in 1 second);
SKCM	cis	rs3741151	1.000	rs75004180	chr11:73024739	A/G	cg17517138	chr11:73019481	ARHGEF17	1.32	5.07	0.5	2.6e-6	GIP levels in response to oral glucose tolerance test (120 minutes);
SKCM	cis	rs589448	0.900	rs588493	chr12:69751986	G/A	cg22834771	chr12:69754056	YEATS4	-0.71	-5.79	-0.55	1.39e-7	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs6866344	0.570	rs4266420	chr5:178137161	C/G	cg03877680	chr5:178157825	ZNF354A	0.93	7.63	0.65	4.84e-11	Neutrophil percentage of white cells;
SKCM	cis	rs17376456	0.825	rs13155452	chr5:93164449	C/T	cg21475434	chr5:93447410	FAM172A	-0.86	-5.07	-0.5	2.62e-6	Diabetic retinopathy;
SKCM	cis	rs2180341	0.814	rs9401958	chr6:127736357	T/G	cg24812749	chr6:127587940	RNF146	0.61	4.97	0.49	3.9e-6	Breast cancer;
SKCM	cis	rs561341	1.000	rs530209	chr17:30315287	A/G	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs3796619	0.924	rs4690209	chr4:1077575	G/A	cg27284194	chr4:1044797	NA	0.67	4.8	0.48	7.53e-6	Recombination rate (males);
SKCM	cis	rs34779708	0.677	rs112355105	chr10:35550294	A/T	cg03585969	chr10:35415529	CREM	0.73	5.24	0.51	1.34e-6	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs2204008	0.639	rs7311462	chr12:38278130	G/A	cg13010199	chr12:38710504	ALG10B	0.69	4.92	0.49	4.72e-6	Bladder cancer;
SKCM	cis	rs72781680	0.898	rs72782113	chr2:24024952	G/C	cg08917208	chr2:24149416	ATAD2B	0.92	4.85	0.48	6.19e-6	Lymphocyte counts;
SKCM	cis	rs9388451	1.000	rs9388451	chr6:126090377	A/G	cg05901451	chr6:126070800	HEY2	-0.79	-7.71	-0.66	3.36e-11	Brugada syndrome;
SKCM	cis	rs67460515	0.892	rs34896809	chr3:161059804	C/T	cg03342759	chr3:160939853	NMD3	-0.87	-7.47	-0.65	9.76e-11	Parkinson's disease;
SKCM	cis	rs12044355	0.896	rs12723735	chr1:231860372	A/G	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	0.83	6.33	0.58	1.45e-8	Alzheimer's disease;
SKCM	cis	rs1475911	1.000	rs12482477	chr21:43517233	T/A	cg24372256	chr21:43528868	UMODL1;C21orf128	-0.7	-4.94	-0.49	4.33e-6	IgG glycosylation;
SKCM	cis	rs7666738	0.830	rs62321598	chr4:99014237	C/T	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs763014	0.898	rs4984896	chr16:625493	C/T	cg00908189	chr16:619842	PIGQ	0.81	7.2	0.63	3.3e-10	Height;
SKCM	cis	rs9303401	0.659	rs12940212	chr17:56674474	T/C	cg10487724	chr17:56770010	TEX14;RAD51C	0.85	6.08	0.57	4.14e-8	Cognitive test performance;
SKCM	cis	rs2777491	1.000	rs11631770	chr15:41737059	T/C	cg18705301	chr15:41695430	NDUFAF1	-0.82	-7.93	-0.67	1.26e-11	Ulcerative colitis;
SKCM	cis	rs9303401	0.615	rs35288118	chr17:56600748	A/C	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.55	0.53	3.73e-7	Cognitive test performance;
SKCM	cis	rs12047808	0.841	rs16854035	chr1:179349559	G/C	cg08037922	chr1:179521085	C1orf125;NPHS2	-1.08	-5.8	-0.55	1.32e-7	Multiple sclerosis (age of onset);
SKCM	cis	rs28595532	0.545	rs17516512	chr4:119258491	T/C	cg11846333	chr4:119757529	SEC24D	1.04	5.83	0.55	1.2e-7	Cannabis dependence symptom count;
SKCM	cis	rs5769765	0.819	rs9616379	chr22:50312035	C/T	cg22709217	chr22:50311962	ALG12;CRELD2	-0.94	-5.91	-0.56	8.37e-8	Schizophrenia;
SKCM	cis	rs826838	1.000	rs2129627	chr12:38653036	C/T	cg13010199	chr12:38710504	ALG10B	0.72	5.27	0.51	1.19e-6	Heart rate;
SKCM	trans	rs561341	0.824	rs1978115	chr17:30220776	A/C	cg20587970	chr11:113659929	NA	-1.14	-8.9	-0.71	1.67e-13	Hip circumference adjusted for BMI;
SKCM	cis	rs1862618	0.853	rs252898	chr5:56188931	T/C	cg12311346	chr5:56204834	C5orf35	-0.76	-5.02	-0.49	3.2e-6	Initial pursuit acceleration;
SKCM	cis	rs4972806	0.814	rs966801	chr2:177037827	G/A	cg03152288	chr2:177042942	NA	0.57	4.99	0.49	3.6e-6	IgG glycosylation;
SKCM	cis	rs10256972	0.577	rs2949179	chr7:1209885	C/G	cg03188948	chr7:1209495	NA	0.59	4.81	0.48	7.18e-6	Longevity;Endometriosis;
SKCM	cis	rs3820928	0.874	rs55748731	chr2:227818629	C/A	cg11843606	chr2:227700838	RHBDD1	-0.6	-4.81	-0.48	7.34e-6	Pulmonary function;
SKCM	cis	rs10416265	0.527	rs7508599	chr19:33546512	A/T	cg17764715	chr19:33622953	WDR88	0.9	6.27	0.58	1.9e-8	Bone properties (heel);
SKCM	cis	rs478304	0.654	rs12289836	chr11:65436888	C/T	cg27068330	chr11:65405492	SIPA1	0.86	7.72	0.66	3.25e-11	Acne (severe);
SKCM	cis	rs72781680	0.898	rs56216411	chr2:23934533	G/A	cg08917208	chr2:24149416	ATAD2B	0.95	4.78	0.48	8.1e-6	Lymphocyte counts;
SKCM	cis	rs9915657	0.966	rs8071725	chr17:70128726	C/T	cg06234051	chr17:70120541	SOX9	-0.59	-5.1	-0.5	2.32e-6	Thyroid hormone levels;
SKCM	cis	rs9435341	0.896	rs1730851	chr1:107596443	A/G	cg09367891	chr1:107599246	PRMT6	-0.87	-7.57	-0.65	6.3e-11	Facial morphology (factor 21, depth of nasal alae);
SKCM	cis	rs8060686	0.698	rs8044558	chr16:68210165	T/C	cg09117114	chr16:67998030	SLC12A4	-0.78	-5.08	-0.5	2.56e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs6062302	0.548	rs4809310	chr20:62228745	G/A	cg09650180	chr20:62225654	GMEB2	-0.77	-6.11	-0.57	3.64e-8	Glioblastoma;
SKCM	cis	rs9517302	0.847	rs9517300	chr13:99095057	T/C	cg22223119	chr13:99095684	FARP1	-0.95	-7.47	-0.65	1e-10	Obesity-related traits;
SKCM	cis	rs9902453	0.838	rs9646436	chr17:28209059	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.81	5.78	0.55	1.44e-7	Coffee consumption (cups per day);
SKCM	cis	rs2014572	0.967	rs10413037	chr19:57771883	A/G	cg24459738	chr19:57751996	ZNF805	-0.61	-4.93	-0.49	4.5e-6	Hyperactive-impulsive symptoms;
SKCM	cis	rs1801516	0.950	rs72992175	chr11:108331371	C/T	cg03165700	chr11:108093220	ATM;NPAT	-1.18	-5.35	-0.52	8.63e-7	Melanoma;
SKCM	cis	rs17688076	0.511	rs2418738	chr16:68122604	G/C	cg04539111	chr16:67997858	SLC12A4	-0.85	-4.81	-0.48	7.14e-6	C-reactive protein levels or HDL-cholesterol levels (pleiotropy);
SKCM	cis	rs7618501	0.633	rs9861216	chr3:50059339	A/G	cg05072774	chr3:49840536	C3orf54	0.67	5.06	0.5	2.73e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9880211	0.644	rs35352346	chr3:135881488	G/A	cg21827317	chr3:136751795	NA	-0.66	-5.22	-0.51	1.44e-6	Body mass index;Height;
SKCM	cis	rs8072100	0.935	rs78551919	chr17:45626002	A/C	cg25173405	chr17:45401733	C17orf57	0.56	5.13	0.5	2.07e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs10883723	0.703	rs7898410	chr10:104245858	T/C	cg11453585	chr10:104263688	ACTR1A;SUFU	0.73	5.41	0.52	6.74e-7	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs1577917	1.000	rs6923148	chr6:86767786	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.59	5.13	0.5	2.07e-6	Response to antipsychotic treatment;
SKCM	cis	rs7149337	0.836	rs34953083	chr14:51672432	A/G	cg23942311	chr14:51606299	NA	0.61	6.58	0.6	4.84e-9	Cancer;
SKCM	cis	rs2153535	0.580	rs6912193	chr6:8456306	T/G	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs7772486	0.754	rs4360151	chr6:146255079	A/C	cg23711669	chr6:146136114	FBXO30	-0.77	-7.33	-0.64	1.83e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7020830	0.825	rs7036132	chr9:37317241	A/G	cg14294708	chr9:37120828	ZCCHC7	1.06	10.67	0.77	6.51e-17	Schizophrenia;
SKCM	cis	rs951366	0.764	rs823141	chr1:205741426	T/C	cg07167872	chr1:205819463	PM20D1	0.97	8.43	0.69	1.39e-12	Menarche (age at onset);
SKCM	cis	rs35146811	0.555	rs2527898	chr7:99534030	C/G	cg22906224	chr7:99728672	NA	0.72	4.96	0.49	4.08e-6	Coronary artery disease;
SKCM	cis	rs11098499	0.754	rs17049949	chr4:120255290	A/G	cg09307838	chr4:120376055	NA	0.93	7.53	0.65	7.72e-11	Corneal astigmatism;
SKCM	cis	rs793571	0.544	rs12912699	chr15:58917021	T/C	cg05156742	chr15:59063176	FAM63B	0.73	5.67	0.54	2.31e-7	Schizophrenia;
SKCM	cis	rs875971	0.660	rs10950044	chr7:66042976	A/G	cg00343986	chr7:65444356	GUSB	-0.67	-4.93	-0.49	4.55e-6	Aortic root size;
SKCM	cis	rs4819052	0.851	rs3673	chr21:46681775	C/T	cg19498844	chr21:46707878	POFUT2;LOC642852	0.89	7.71	0.66	3.36e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs11252926	0.537	rs61836851	chr10:447231	T/C	cg18196295	chr10:418757	DIP2C	0.66	5.38	0.52	7.58e-7	Psychosis in Alzheimer's disease;
SKCM	cis	rs12586317	0.586	rs2295103	chr14:35515920	C/G	cg16230307	chr14:35515116	FAM177A1	0.83	6.08	0.57	4.19e-8	Psoriasis;
SKCM	cis	rs2243480	1.000	rs34702770	chr7:65344823	T/C	cg18252515	chr7:66147081	NA	-1.29	-7.41	-0.64	1.3e-10	Diabetic kidney disease;
SKCM	cis	rs7647973	0.771	rs9865051	chr3:49166069	C/T	cg07636037	chr3:49044803	WDR6	0.9	5.42	0.52	6.38e-7	Menarche (age at onset);
SKCM	cis	rs7523273	0.606	rs761275	chr1:207972154	A/C	cg22525895	chr1:207977042	MIR29B2	-0.84	-7.09	-0.63	5.4e-10	Schizophrenia;
SKCM	cis	rs798554	0.797	rs798491	chr7:2800521	A/G	cg04166393	chr7:2884313	GNA12	0.75	5.01	0.49	3.38e-6	Height;
SKCM	cis	rs10504229	0.911	rs77203035	chr8:58175458	C/A	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs7829975	0.774	rs57312668	chr8:8680477	G/A	cg06636001	chr8:8085503	FLJ10661	0.79	7.34	0.64	1.8e-10	Mood instability;
SKCM	cis	rs875971	0.660	rs28698552	chr7:66005018	A/G	cg00343986	chr7:65444356	GUSB	0.7	5.14	0.5	1.98e-6	Aortic root size;
SKCM	cis	rs9910055	0.529	rs408282	chr17:42182267	A/G	cg09913183	chr17:42254507	C17orf65;ASB16	-0.59	-4.82	-0.48	6.82e-6	Total body bone mineral density;
SKCM	cis	rs72634258	0.740	rs4489581	chr1:8174495	A/C	cg00042356	chr1:8021962	PARK7	-0.81	-5.27	-0.51	1.16e-6	Inflammatory bowel disease;
SKCM	cis	rs8180040	0.966	rs6790763	chr3:47572585	C/A	cg16586182	chr3:47516702	SCAP	-0.74	-5.04	-0.5	2.89e-6	Colorectal cancer;
SKCM	cis	rs801193	1.000	rs7789184	chr7:66210195	A/T	cg00343986	chr7:65444356	GUSB	0.7	5.19	0.51	1.63e-6	Aortic root size;
SKCM	cis	rs10089	1.000	rs17764954	chr5:127514436	A/T	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.87	7.69	0.66	3.82e-11	Ileal carcinoids;
SKCM	cis	rs2721195	0.719	rs4925811	chr8:145802447	G/T	cg15857475	chr8:145742913	RECQL4;LRRC14	-0.91	-9.08	-0.72	7.46e-14	Age at first birth;
SKCM	cis	rs6445797	0.603	rs11706624	chr3:56584341	T/C	cg13616963	chr3:57583610	ARF4	-0.81	-5.38	-0.52	7.69e-7	Gastritis;
SKCM	cis	rs56104184	0.775	rs17272700	chr19:49391770	G/A	cg19746536	chr19:49375674	PPP1R15A	1.13	5.5	0.53	4.69e-7	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs870825	0.655	rs2310104	chr4:185619967	A/G	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs854765	0.693	rs8079418	chr17:17924060	C/T	cg04398451	chr17:18023971	MYO15A	-0.74	-5.3	-0.51	1.05e-6	Total body bone mineral density;
SKCM	cis	rs6840360	0.593	rs28602726	chr4:152499788	T/C	cg22705602	chr4:152727874	NA	-0.52	-5.6	-0.54	3.08e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs684232	0.666	rs838371	chr17:609275	T/C	cg12384639	chr17:618140	VPS53	0.68	5.33	0.52	9.45e-7	Prostate cancer;
SKCM	cis	rs72949976	0.584	rs12471471	chr2:214023052	C/T	cg08319019	chr2:214017104	IKZF2	-0.82	-6.45	-0.59	8.52e-9	Lung cancer;Squamous cell lung carcinoma;
SKCM	cis	rs7824557	0.628	rs11250129	chr8:11202154	G/A	cg21775007	chr8:11205619	TDH	0.71	6.33	0.58	1.47e-8	Retinal vascular caliber;
SKCM	cis	rs7772486	0.686	rs857883	chr6:145969214	G/T	cg23711669	chr6:146136114	FBXO30	-0.9	-9.54	-0.73	9.76e-15	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2050392	0.517	rs687036	chr10:30761249	G/A	cg25182066	chr10:30743637	MAP3K8	-0.71	-6.41	-0.59	1e-8	Inflammatory bowel disease;
SKCM	cis	rs250585	0.736	rs465193	chr16:23596983	A/G	cg10006042	chr16:23042421	NA	0.36	4.85	0.48	6.15e-6	Egg allergy;
SKCM	cis	rs3087591	0.919	rs2952983	chr17:29470288	G/C	cg24425628	chr17:29625626	OMG;NF1	0.63	4.91	0.49	4.82e-6	Hip circumference;
SKCM	cis	rs763014	0.931	rs7192508	chr16:630367	C/T	cg07343612	chr16:622815	PIGQ	-0.7	-6.0	-0.56	5.84e-8	Height;
SKCM	cis	rs7824557	0.545	rs2572380	chr8:11237477	A/G	cg21775007	chr8:11205619	TDH	-0.58	-4.77	-0.48	8.29e-6	Retinal vascular caliber;
SKCM	cis	rs7584330	0.736	rs6431541	chr2:238376190	A/T	cg14458575	chr2:238380390	NA	0.84	6.04	0.56	5e-8	Prostate cancer;
SKCM	cis	rs9381040	0.655	rs2268190	chr6:41030226	C/T	cg03644281	chr6:41068752	NFYA;LOC221442	-0.72	-4.82	-0.48	6.83e-6	Alzheimer's disease (late onset);
SKCM	cis	rs10193935	0.792	rs13430031	chr2:42499968	C/T	cg27598129	chr2:42591480	NA	-0.95	-6.71	-0.6	2.81e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1707322	0.716	rs28370457	chr1:46172062	C/T	cg03146154	chr1:46216737	IPP	0.8	5.47	0.53	5.19e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs9951698	0.634	rs9952698	chr18:13021630	G/A	cg12848697	chr18:13133368	NA	0.55	4.9	0.48	5.17e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs763121	0.853	rs5757208	chr22:39049230	A/C	cg06022373	chr22:39101656	GTPBP1	0.72	4.96	0.49	4.08e-6	Menopause (age at onset);
SKCM	cis	rs17685	0.753	rs10952840	chr7:75772878	C/T	cg01364799	chr7:75623366	TMEM120A	-0.69	-5.59	-0.53	3.22e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs28595532	0.920	rs114584210	chr4:119773363	G/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs17065868	1.000	rs9645990	chr13:45130934	G/A	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs798554	1.000	rs798536	chr7:2766383	G/A	cg14895029	chr7:2775587	GNA12	-0.75	-5.82	-0.55	1.25e-7	Height;
SKCM	cis	rs9325144	0.555	rs61929925	chr12:38698828	C/A	cg13010199	chr12:38710504	ALG10B	-0.65	-5.26	-0.51	1.22e-6	Morning vs. evening chronotype;
SKCM	cis	rs2836950	0.565	rs7278297	chr21:40625752	A/C	cg11644478	chr21:40555479	PSMG1	-0.64	-5.02	-0.49	3.17e-6	Menarche (age at onset);
SKCM	cis	rs17685	0.753	rs869806	chr7:75688623	C/T	cg16489192	chr7:75678113	MDH2;STYXL1	-0.6	-5.51	-0.53	4.43e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7772486	0.875	rs9403770	chr6:146423334	C/T	cg23711669	chr6:146136114	FBXO30	0.85	8.48	0.69	1.09e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2832191	0.716	rs2297252	chr21:30377104	G/A	cg24692254	chr21:30365293	RNF160	1.01	9.45	0.73	1.43e-14	Dental caries;
SKCM	cis	rs28386778	0.897	rs8067102	chr17:61848779	C/G	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs57221529	0.766	rs12518859	chr5:587432	C/T	cg26208419	chr5:473447	SLC9A3;LOC25845	1.01	5.18	0.51	1.7e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs1707322	0.964	rs796773	chr1:46564475	C/T	cg03146154	chr1:46216737	IPP	-0.81	-5.43	-0.52	6.11e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs6951245	1.000	rs76804143	chr7:1082021	C/T	cg24642844	chr7:1081250	C7orf50	-0.94	-6.32	-0.58	1.48e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs6952808	0.636	rs6964522	chr7:1953523	C/T	cg21782813	chr7:2030301	MAD1L1	0.51	5.42	0.52	6.33e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs28595532	0.920	rs115317002	chr4:119722809	T/C	cg11846333	chr4:119757529	SEC24D	1.19	6.39	0.59	1.12e-8	Cannabis dependence symptom count;
SKCM	cis	rs1005277	0.522	rs1208767	chr10:38042295	G/T	cg00409905	chr10:38381863	ZNF37A	-0.63	-6.05	-0.57	4.71e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs9910055	0.512	rs7209801	chr17:42323376	G/A	cg09913183	chr17:42254507	C17orf65;ASB16	0.64	5.05	0.5	2.87e-6	Total body bone mineral density;
SKCM	cis	rs60871478	0.679	rs62432240	chr7:794813	A/G	cg05535760	chr7:792225	HEATR2	1.24	9.63	0.74	6.44e-15	Cerebrospinal P-tau181p levels;
SKCM	cis	rs875971	1.000	rs7781698	chr7:65896312	A/T	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.51e-8	Aortic root size;
SKCM	cis	rs6502050	0.736	rs12150322	chr17:80061582	T/G	cg13939156	chr17:80058883	NA	0.51	4.77	0.48	8.29e-6	Life satisfaction;
SKCM	cis	rs7824557	0.564	rs7821459	chr8:11236681	T/G	cg21775007	chr8:11205619	TDH	-0.59	-5.03	-0.5	3.01e-6	Retinal vascular caliber;
SKCM	cis	rs4665809	0.590	rs2033317	chr2:26477650	G/A	cg04944784	chr2:26401820	FAM59B	0.74	4.79	0.48	7.81e-6	Gut microbiome composition (summer);
SKCM	cis	rs6545883	0.894	rs6545867	chr2:61651027	C/T	cg15711740	chr2:61764176	XPO1	0.7	4.93	0.49	4.5e-6	Tuberculosis;
SKCM	cis	rs7927771	0.698	rs34467936	chr11:47915299	A/G	cg05585544	chr11:47624801	NA	-0.67	-5.77	-0.55	1.53e-7	Subjective well-being;
SKCM	cis	rs7617480	0.648	rs4858800	chr3:48755820	A/G	cg07636037	chr3:49044803	WDR6	0.91	6.74	0.61	2.42e-9	Subjective well-being (multi-trait analysis);Menarche (age at onset);
SKCM	cis	rs28374715	0.681	rs7162231	chr15:41591859	G/A	cg18705301	chr15:41695430	NDUFAF1	-1.13	-12.2	-0.81	9.24e-20	Ulcerative colitis;
SKCM	cis	rs6087990	0.735	rs2889703	chr20:31379184	C/A	cg13636640	chr20:31349939	DNMT3B	0.87	6.84	0.61	1.61e-9	Ulcerative colitis;
SKCM	cis	rs6430585	0.702	rs2015532	chr2:136555525	G/T	cg07169764	chr2:136633963	MCM6	-1.28	-11.56	-0.79	1.4e-18	Corneal structure;
SKCM	cis	rs7659604	1.000	rs7689714	chr4:122665943	T/A	cg19748678	chr4:122722346	EXOSC9	0.64	5.4	0.52	7.11e-7	Type 2 diabetes;
SKCM	cis	rs4268898	0.662	rs2303297	chr2:24432937	C/T	cg06627628	chr2:24431161	ITSN2	-0.92	-7.12	-0.63	4.73e-10	Asthma;
SKCM	cis	rs1059312	0.808	rs4482069	chr12:129294252	G/C	cg09035930	chr12:129282057	SLC15A4	0.77	8.03	0.67	8.18e-12	Systemic lupus erythematosus;
SKCM	cis	rs2228479	0.718	rs11645376	chr16:89912281	G/C	cg06558623	chr16:89946397	TCF25	1.12	5.0	0.49	3.47e-6	Skin colour saturation;
SKCM	cis	rs6951245	1.000	rs77083167	chr7:1071823	C/T	cg21664854	chr7:1097933	C7orf50;GPR146	0.89	4.79	0.48	7.66e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs116095464	0.614	rs10061564	chr5:271329	T/C	cg22857025	chr5:266934	NA	-1.47	-8.33	-0.69	2.16e-12	Breast cancer;
SKCM	cis	rs62244186	0.541	rs3804583	chr3:44884647	G/T	cg02073558	chr3:44770973	ZNF501	0.82	7.25	0.63	2.61e-10	Depressive symptoms;
SKCM	cis	rs13256369	0.951	rs12679360	chr8:8566269	G/T	cg17143192	chr8:8559678	CLDN23	-0.63	-4.88	-0.48	5.5e-6	Obesity-related traits;
SKCM	cis	rs1790761	0.501	rs4930210	chr11:67404726	G/T	cg00290607	chr11:67383545	NA	-0.51	-5.1	-0.5	2.29e-6	Mean corpuscular volume;
SKCM	cis	rs376008	0.963	rs375947	chr19:18180451	A/G	cg20557202	chr19:17982930	SLC5A5	-0.39	-4.8	-0.48	7.59e-6	Blood protein levels;
SKCM	cis	rs1692580	0.777	rs7547453	chr1:2195117	C/T	cg24578937	chr1:2090814	PRKCZ	0.47	5.16	0.5	1.81e-6	Coronary artery disease;
SKCM	cis	rs910316	0.967	rs8013444	chr14:75661981	A/G	cg08847533	chr14:75593920	NEK9	-0.96	-9.7	-0.74	4.77e-15	Height;
SKCM	trans	rs208520	0.690	rs1738970	chr6:66809491	T/G	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-0.95	-7.55	-0.65	7.04e-11	Exhaled nitric oxide output;
SKCM	cis	rs4665809	1.000	rs6720314	chr2:26334852	G/A	cg26119090	chr2:26468346	HADHA;HADHB	-0.76	-4.79	-0.48	7.86e-6	Gut microbiome composition (summer);
SKCM	cis	rs2153535	0.580	rs9393019	chr6:8462091	G/A	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs13118159	0.550	rs28733902	chr4:1374789	A/G	cg16405210	chr4:1374714	KIAA1530	-0.95	-7.27	-0.64	2.43e-10	Longevity;
SKCM	cis	rs4819052	0.840	rs914217	chr21:46698299	A/G	cg20896738	chr21:46707857	POFUT2;LOC642852	0.74	5.11	0.5	2.25e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs4523957	0.651	rs1994883	chr17:2083881	T/A	cg16513277	chr17:2031491	SMG6	-0.79	-5.86	-0.55	1.07e-7	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs17345786	1.000	rs11715368	chr3:101336380	G/A	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.73	5.22	0.51	1.44e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11690935	0.959	rs2292815	chr2:172586651	C/G	cg13550731	chr2:172543902	DYNC1I2	-0.95	-8.21	-0.68	3.64e-12	Schizophrenia;
SKCM	trans	rs1814175	0.717	rs11040450	chr11:49650638	G/A	cg03929089	chr4:120376271	NA	-0.87	-7.53	-0.65	7.64e-11	Height;
SKCM	cis	rs3784262	0.740	rs12898976	chr15:58276358	A/G	cg12031962	chr15:58353849	ALDH1A2	-0.46	-5.72	-0.54	1.85e-7	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs2153535	0.580	rs6902001	chr6:8477055	T/G	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs7953249	0.618	rs7954331	chr12:121398657	G/T	cg02403541	chr12:121454288	C12orf43	-0.65	-4.92	-0.49	4.66e-6	Invasive epithelial ovarian cancer;High-grade serous ovarian cancer;Chronic obstructive pulmonary disease-related biomarkers;N-glycan levels;Serous invasive ovarian cancer;Epithelial ovarian cancer;
SKCM	trans	rs6481128	0.801	rs1670827	chr10:56701059	C/A	cg04272632	chr1:34629400	CSMD2	0.69	7.49	0.65	9.04e-11	Extraversion;
SKCM	cis	rs376008	0.963	rs391410	chr19:18180646	G/A	cg20557202	chr19:17982930	SLC5A5	-0.38	-4.83	-0.48	6.71e-6	Blood protein levels;
SKCM	cis	rs10206020	0.921	rs2280127	chr2:1546531	C/T	cg01028140	chr2:1542097	TPO	-0.53	-5.06	-0.5	2.74e-6	IgG glycosylation;
SKCM	cis	rs17711722	0.653	rs2460421	chr7:65491123	A/T	cg11764359	chr7:65958608	NA	-0.72	-5.39	-0.52	7.39e-7	Calcium levels;
SKCM	cis	rs12497850	0.931	rs7647813	chr3:48833348	G/T	cg06212747	chr3:49208901	KLHDC8B	0.66	4.81	0.48	7.08e-6	Parkinson's disease;
SKCM	cis	rs1153858	0.723	rs4580098	chr15:45596909	T/A	cg21132104	chr15:45694354	SPATA5L1	0.86	5.9	0.56	8.95e-8	Homoarginine levels;
SKCM	cis	rs6089584	0.526	rs6089619	chr20:60610916	C/T	cg16423285	chr20:60520624	NA	-0.58	-5.04	-0.5	2.91e-6	Body mass index;
SKCM	cis	rs6598955	0.543	rs12125620	chr1:26552238	G/A	cg04990556	chr1:26633338	UBXN11	0.66	4.88	0.48	5.46e-6	Obesity-related traits;
SKCM	cis	rs2811415	0.597	rs9834124	chr3:127741260	C/G	cg09089421	chr3:127803668	RUVBL1	0.99	8.52	0.69	9.09e-13	Lung function (FEV1/FVC);
SKCM	cis	rs2153535	0.580	rs2327053	chr6:8443127	A/G	cg23788917	chr6:8435910	SLC35B3	0.73	5.44	0.52	5.82e-7	Motion sickness;
SKCM	cis	rs7944584	0.551	rs12224672	chr11:47500400	C/T	cg20307385	chr11:47447363	PSMC3	0.86	5.81	0.55	1.28e-7	Fasting blood glucose;Fasting blood glucose (BMI interaction);
SKCM	cis	rs1949733	0.598	rs55765509	chr4:8532732	T/A	cg11789530	chr4:8429930	ACOX3	-0.73	-4.85	-0.48	6.29e-6	Response to antineoplastic agents;
SKCM	cis	rs11764590	0.694	rs4721359	chr7:2104951	A/G	cg02825527	chr7:2087843	MAD1L1	-0.62	-4.88	-0.48	5.61e-6	Neuroticism;
SKCM	cis	rs12682352	0.602	rs6993494	chr8:8667444	C/T	cg15556689	chr8:8085844	FLJ10661	0.62	4.86	0.48	5.85e-6	Neuroticism;
SKCM	cis	rs752010	0.619	rs7539238	chr1:42113572	A/C	cg06885757	chr1:42089581	HIVEP3	0.57	6.4	0.59	1.07e-8	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs6840360	0.571	rs7674244	chr4:152488302	T/C	cg22705602	chr4:152727874	NA	-0.5	-5.38	-0.52	7.49e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs644799	0.687	rs3748252	chr11:95519195	A/T	cg25622487	chr11:95524042	FAM76B;CEP57	-0.78	-7.11	-0.63	4.94e-10	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs6089584	0.861	rs2180302	chr20:60576369	A/G	cg23262073	chr20:60523788	NA	-0.51	-4.86	-0.48	5.9e-6	Body mass index;
SKCM	cis	rs6489882	0.934	rs7299132	chr12:113376913	T/A	cg07232103	chr12:112566177	TRAFD1	0.59	4.78	0.48	8.01e-6	Chronic lymphocytic leukemia;
SKCM	cis	rs703842	0.616	rs1875125	chr12:58227241	T/G	cg00677455	chr12:58241039	CTDSP2	0.75	5.94	0.56	7.38e-8	Multiple sclerosis;
SKCM	cis	rs951366	0.589	rs823099	chr1:205669322	C/A	cg24503407	chr1:205819492	PM20D1	0.74	6.0	0.56	5.85e-8	Menarche (age at onset);
SKCM	cis	rs7927771	0.756	rs10742803	chr11:47439938	A/G	cg05585544	chr11:47624801	NA	0.57	4.92	0.49	4.76e-6	Subjective well-being;
SKCM	cis	rs7000551	0.505	rs4872499	chr8:22293306	A/G	cg12081754	chr8:22256438	SLC39A14	-0.79	-6.4	-0.59	1.05e-8	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs72781680	0.800	rs56398785	chr2:24091515	T/A	cg08917208	chr2:24149416	ATAD2B	1.07	5.67	0.54	2.28e-7	Lymphocyte counts;
SKCM	cis	rs13217239	0.646	rs10946891	chr6:26973215	T/C	cg12292205	chr6:26970375	C6orf41	0.63	5.64	0.54	2.58e-7	Schizophrenia;
SKCM	cis	rs11249608	0.548	rs10479520	chr5:178451447	C/A	cg21905437	chr5:178450457	ZNF879	0.75	6.33	0.58	1.42e-8	Pubertal anthropometrics;
SKCM	cis	rs10256972	0.552	rs2960837	chr7:1203957	A/G	cg07092213	chr7:1199455	ZFAND2A	-0.66	-5.52	-0.53	4.21e-7	Longevity;Endometriosis;
SKCM	cis	rs17065868	1.000	rs17278115	chr13:45128221	C/T	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs61612642	0.590	rs6931028	chr6:42193064	A/T	cg01092361	chr6:42185687	MRPS10	0.97	5.41	0.52	6.71e-7	Eosinophil percentage of white cells;Sum eosinophil basophil counts;Eosinophil percentage of granulocytes;Eosinophil counts;
SKCM	cis	rs17065868	0.667	rs9533936	chr13:45214195	C/T	cg10246903	chr13:45222710	NA	0.95	5.35	0.52	8.5e-7	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs9325144	0.600	rs6582634	chr12:38748041	G/A	cg13010199	chr12:38710504	ALG10B	0.64	5.18	0.51	1.7e-6	Morning vs. evening chronotype;
SKCM	cis	rs10256972	0.567	rs7782651	chr7:1159895	T/G	cg07092213	chr7:1199455	ZFAND2A	-0.67	-5.32	-0.52	9.84e-7	Longevity;Endometriosis;
SKCM	cis	rs4803468	0.967	rs892044	chr19:41903671	A/G	cg14132834	chr19:41945861	ATP5SL	-0.74	-5.71	-0.54	1.99e-7	Height;
SKCM	cis	rs34779708	0.966	rs11592567	chr10:35409369	C/T	cg03585969	chr10:35415529	CREM	0.82	6.49	0.59	7.27e-9	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs2836974	0.627	rs8127986	chr21:40687211	A/T	cg11644478	chr21:40555479	PSMG1	-0.64	-5.33	-0.52	9.27e-7	Cognitive function;
SKCM	cis	rs4332037	0.762	rs11770612	chr7:1915493	A/C	cg23422044	chr7:1970798	MAD1L1	-0.95	-6.54	-0.6	5.79e-9	Bipolar disorder;
SKCM	cis	rs9814567	1.000	rs9819532	chr3:134288644	G/C	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs4975616	0.869	rs466502	chr5:1325767	C/T	cg07493874	chr5:1342172	CLPTM1L	0.68	6.24	0.58	2.14e-8	Lung cancer;
SKCM	cis	rs3784262	0.740	rs12917536	chr15:58288247	T/C	cg12031962	chr15:58353849	ALDH1A2	-0.45	-5.37	-0.52	7.83e-7	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs748404	0.697	rs475261	chr15:43546456	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	0.72	5.9	0.56	8.97e-8	Lung cancer;
SKCM	cis	rs9467773	0.595	rs13207371	chr6:26591074	G/A	cg15659132	chr6:26577336	NA	0.64	5.66	0.54	2.4e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7666738	0.830	rs991168	chr4:98928293	T/C	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs875971	0.964	rs778708	chr7:65856319	T/C	cg18876405	chr7:65276391	NA	0.67	6.65	0.6	3.61e-9	Aortic root size;
SKCM	cis	rs12047808	0.730	rs12021876	chr1:179541741	A/T	cg09822482	chr1:179519214	C1orf125	-0.96	-4.77	-0.48	8.48e-6	Multiple sclerosis (age of onset);
SKCM	cis	rs2952156	0.920	rs2517959	chr17:37846512	A/T	cg20243544	chr17:37824526	PNMT	0.69	5.24	0.51	1.33e-6	Asthma;
SKCM	cis	rs3020736	0.519	rs5996116	chr22:42517492	G/A	cg04733989	chr22:42467013	NAGA	-0.72	-5.62	-0.54	2.87e-7	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs7613875	0.600	rs1138536	chr3:50153356	C/T	cg24110177	chr3:50126178	RBM5	-0.69	-5.52	-0.53	4.35e-7	Body mass index;
SKCM	cis	rs617791	0.508	rs10896074	chr11:65776304	C/T	cg27068330	chr11:65405492	SIPA1	-0.66	-4.77	-0.47	8.53e-6	Breast cancer;
SKCM	cis	rs34779708	0.931	rs12248333	chr10:35362977	A/G	cg03585969	chr10:35415529	CREM	0.76	6.1	0.57	3.85e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs2153535	0.580	rs9393022	chr6:8466588	T/C	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs11677370	0.561	rs12711973	chr2:3825339	C/G	cg17052675	chr2:3827356	NA	-0.62	-5.14	-0.5	1.97e-6	Type 2 diabetes;
SKCM	cis	rs997295	0.592	rs12594849	chr15:67716572	T/A	cg24247231	chr15:67904302	MAP2K5	-0.66	-5.69	-0.54	2.16e-7	Motion sickness;
SKCM	cis	rs10927875	0.526	rs2179615	chr1:16282426	G/A	cg21385522	chr1:16154831	NA	-1.0	-8.6	-0.7	6.47e-13	Dilated cardiomyopathy;
SKCM	cis	rs9300255	0.602	rs1051431	chr12:123645803	G/A	cg00376283	chr12:123451042	ABCB9	0.82	5.61	0.54	3e-7	Neutrophil percentage of white cells;
SKCM	cis	rs7618501	0.602	rs9311446	chr3:50092226	G/A	cg05072774	chr3:49840536	C3orf54	0.67	5.06	0.5	2.7e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1850744	0.536	rs10010844	chr4:9559610	A/G	cg15442990	chr4:9534313	NA	1.42	5.75	0.55	1.64e-7	Economic and political preferences;
SKCM	cis	rs6547741	1.000	rs10205364	chr2:27794233	C/T	cg27432699	chr2:27873401	GPN1	0.73	6.64	0.6	3.76e-9	Oral cavity cancer;
SKCM	cis	rs9581857	0.579	rs76614377	chr13:27974251	A/T	cg22138327	chr13:27999177	GTF3A	0.97	5.85	0.55	1.07e-7	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs6570726	0.935	rs419854	chr6:145844085	A/C	cg23711669	chr6:146136114	FBXO30	0.69	6.39	0.59	1.1e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9916302	0.768	rs62077464	chr17:37656056	C/G	cg07936489	chr17:37558343	FBXL20	-0.9	-7.67	-0.66	4.04e-11	Glomerular filtration rate (creatinine);
SKCM	cis	rs62238980	0.614	rs117629537	chr22:32400579	C/T	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs2952156	0.876	rs903501	chr17:37839493	T/C	cg00129232	chr17:37814104	STARD3	-0.67	-5.28	-0.51	1.14e-6	Asthma;
SKCM	cis	rs11585357	0.947	rs72646789	chr1:17610030	C/T	cg08277548	chr1:17600880	PADI3	-0.9	-6.35	-0.58	1.34e-8	Hair shape;
SKCM	cis	rs2836974	0.899	rs8127087	chr21:40544502	C/T	cg11890956	chr21:40555474	PSMG1	1.07	13.19	0.83	1.48e-21	Cognitive function;
SKCM	cis	rs4665809	0.652	rs6728090	chr2:26524726	C/T	cg26119090	chr2:26468346	HADHA;HADHB	-1.03	-6.77	-0.61	2.11e-9	Gut microbiome composition (summer);
SKCM	cis	rs9828933	0.577	rs704374	chr3:63865947	C/T	cg16258503	chr3:63850278	ATXN7;THOC7	0.86	5.18	0.51	1.69e-6	Type 2 diabetes;
SKCM	cis	rs875971	0.638	rs10278816	chr7:66036987	T/C	cg11764359	chr7:65958608	NA	-0.86	-6.6	-0.6	4.52e-9	Aortic root size;
SKCM	cis	rs11098499	0.866	rs12510451	chr4:120289143	C/T	cg09307838	chr4:120376055	NA	0.98	7.89	0.67	1.52e-11	Corneal astigmatism;
SKCM	cis	rs798766	1.000	rs798719	chr4:1698183	C/T	cg05874882	chr4:1763078	NA	-0.6	-5.42	-0.52	6.31e-7	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs1218582	0.741	rs6656494	chr1:154839799	A/G	cg16680214	chr1:154839983	KCNN3	-0.55	-4.94	-0.49	4.37e-6	Prostate cancer;
SKCM	cis	rs2074977	0.500	rs10153493	chr19:3447745	C/T	cg08380311	chr19:3435252	NFIC	-0.79	-6.03	-0.56	5.14e-8	Height;
SKCM	cis	rs2228479	0.541	rs13335395	chr16:89952843	T/A	cg06558623	chr16:89946397	TCF25	1.25	7.24	0.63	2.8e-10	Skin colour saturation;
SKCM	cis	rs7809950	1.000	rs7793613	chr7:107250484	C/T	cg23024343	chr7:107201750	COG5	-0.79	-7.13	-0.63	4.47e-10	Coronary artery disease;
SKCM	cis	rs17376456	0.757	rs1031424	chr5:93139706	G/C	cg25358565	chr5:93447407	FAM172A	1.19	7.78	0.66	2.52e-11	Diabetic retinopathy;
SKCM	cis	rs17065868	1.000	rs9533924	chr13:45169705	C/T	cg10246903	chr13:45222710	NA	0.9	4.85	0.48	6.19e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs2404602	0.563	rs12914005	chr15:76765667	A/G	cg23625390	chr15:77176239	SCAPER	0.62	5.38	0.52	7.53e-7	Blood metabolite levels;
SKCM	cis	rs7772486	0.875	rs13204280	chr6:146415368	T/C	cg23711669	chr6:146136114	FBXO30	0.86	8.52	0.69	9.39e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs875971	0.800	rs427557	chr7:65519250	A/G	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.54	5.01	0.49	3.28e-6	Aortic root size;
SKCM	cis	rs6585827	0.565	rs4751889	chr10:124132188	T/C	cg17834180	chr10:124768240	IKZF5;ACADSB	0.63	4.95	0.49	4.19e-6	Height;
SKCM	cis	rs2991971	0.933	rs2356553	chr1:46009313	G/C	cg24296786	chr1:45957014	TESK2	0.71	5.8	0.55	1.33e-7	High light scatter reticulocyte count;
SKCM	cis	rs738322	0.533	rs2284064	chr22:38547395	A/C	cg25457927	chr22:38595422	NA	-0.5	-5.55	-0.53	3.85e-7	Cutaneous nevi;
SKCM	cis	rs28595532	0.920	rs55649377	chr4:119752745	T/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs1577917	0.958	rs2225754	chr6:86449698	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.87	-8.83	-0.71	2.27e-13	Response to antipsychotic treatment;
SKCM	cis	rs4319547	0.695	rs10846699	chr12:122853073	A/G	cg23029597	chr12:123009494	RSRC2	0.72	5.37	0.52	8.04e-7	Body mass index;
SKCM	cis	rs4969178	0.965	rs11077362	chr17:76397219	A/T	cg20026190	chr17:76395443	PGS1	0.61	5.29	0.51	1.08e-6	HDL cholesterol levels;
SKCM	cis	rs6546550	0.867	rs1048266	chr2:70132676	A/G	cg02498382	chr2:70120550	SNRNP27	-0.45	-4.88	-0.48	5.4e-6	Prevalent atrial fibrillation;
SKCM	cis	rs782590	0.902	rs782595	chr2:55845596	C/G	cg18811423	chr2:55921094	PNPT1	0.91	7.02	0.62	7.21e-10	Metabolic syndrome;
SKCM	cis	rs6121246	0.542	rs2376990	chr20:30238744	G/A	cg11595048	chr20:30225325	COX4I2	0.65	5.17	0.51	1.75e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs2404602	0.692	rs60658665	chr15:77042508	T/C	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs453301	0.686	rs2409120	chr8:8882571	G/C	cg15556689	chr8:8085844	FLJ10661	-0.73	-5.77	-0.55	1.52e-7	Joint mobility (Beighton score);
SKCM	cis	rs6121246	0.559	rs6060857	chr20:30300222	A/G	cg11595048	chr20:30225325	COX4I2	0.54	4.77	0.48	8.4e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs6066825	0.569	rs2281288	chr20:47343460	T/G	cg18078177	chr20:47281410	PREX1	0.64	5.11	0.5	2.26e-6	Colorectal cancer;
SKCM	cis	rs7945705	0.870	rs1109305	chr11:8955272	C/T	cg13070366	chr11:9386451	NA	-0.64	-5.53	-0.53	4.05e-7	Hemoglobin concentration;
SKCM	cis	rs6942756	0.806	rs6467237	chr7:128964831	A/G	cg02491457	chr7:128862824	NA	-0.76	-4.96	-0.49	4.07e-6	White matter hyperintensity burden;
SKCM	cis	rs67311347	0.544	rs9877105	chr3:40333366	T/C	cg00656387	chr3:40428638	ENTPD3	0.56	5.01	0.49	3.25e-6	Renal cell carcinoma;
SKCM	cis	rs501916	0.833	rs59184310	chr15:48050205	A/T	cg16110827	chr15:48056943	SEMA6D	-0.61	-4.91	-0.49	4.89e-6	Inflammatory bowel disease;Ulcerative colitis;
SKCM	cis	rs2463822	0.925	rs17157227	chr11:62169772	A/G	cg06239285	chr11:62104954	ASRGL1	1.07	5.33	0.52	9.37e-7	Chronic obstructive pulmonary disease-related biomarkers;
SKCM	cis	rs1348850	0.526	rs7588049	chr2:178390778	C/T	cg02961200	chr2:178257176	LOC100130691;AGPS	-0.93	-5.3	-0.51	1.03e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs2811415	0.597	rs55662362	chr3:127774723	A/C	cg09089421	chr3:127803668	RUVBL1	1.02	8.85	0.71	2.14e-13	Lung function (FEV1/FVC);
SKCM	cis	rs9815354	0.812	rs73071239	chr3:41992610	C/A	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs11252926	0.589	rs12359901	chr10:475068	A/G	cg18196295	chr10:418757	DIP2C	-0.69	-5.83	-0.55	1.2e-7	Psychosis in Alzheimer's disease;
SKCM	cis	rs58688157	0.924	rs35865896	chr11:584591	A/G	cg17114584	chr11:613792	IRF7	0.79	5.12	0.5	2.17e-6	Systemic lupus erythematosus;
SKCM	cis	rs1799949	0.965	rs12947782	chr17:41279882	A/G	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.11	-0.57	3.67e-8	Menopause (age at onset);
SKCM	cis	rs6089829	0.962	rs9680064	chr20:61666168	G/A	cg08564027	chr20:61660810	NA	0.63	5.65	0.54	2.46e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs7615952	0.673	rs9289270	chr3:125636979	A/T	cg05084668	chr3:125655381	ALG1L	-1.25	-6.57	-0.6	5.19e-9	Blood pressure (smoking interaction);
SKCM	cis	rs17376456	0.569	rs10057664	chr5:93182274	C/T	cg25358565	chr5:93447407	FAM172A	-0.88	-5.63	-0.54	2.71e-7	Diabetic retinopathy;
SKCM	cis	rs6840360	0.615	rs72728171	chr4:152469372	C/A	cg22705602	chr4:152727874	NA	-0.51	-5.78	-0.55	1.45e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs10028773	0.556	rs4473640	chr4:120260437	G/A	cg09307838	chr4:120376055	NA	0.97	8.31	0.69	2.31e-12	Educational attainment;
SKCM	cis	rs9660180	0.839	rs12040826	chr1:1705287	A/C	cg13866156	chr1:1669148	SLC35E2	-0.72	-6.04	-0.56	4.85e-8	Body mass index;
SKCM	cis	rs7143963	0.636	rs7147531	chr14:103299716	T/C	cg23020514	chr14:103360112	TRAF3	0.73	6.9	0.62	1.23e-9	Body mass index;
SKCM	cis	rs2072499	0.865	rs2758608	chr1:156202860	A/T	cg24450063	chr1:156163899	SLC25A44	0.78	6.43	0.59	9.49e-9	Testicular germ cell tumor;
SKCM	cis	rs8064299	0.597	rs6501736	chr17:72775358	G/A	cg25054828	chr17:72772726	NAT9;TMEM104	0.95	9.31	0.73	2.66e-14	Monocyte count;
SKCM	cis	rs7953249	0.656	rs6489786	chr12:121397875	A/G	cg02403541	chr12:121454288	C12orf43	-0.65	-4.92	-0.49	4.66e-6	Invasive epithelial ovarian cancer;High-grade serous ovarian cancer;Chronic obstructive pulmonary disease-related biomarkers;N-glycan levels;Serous invasive ovarian cancer;Epithelial ovarian cancer;
SKCM	cis	rs10871290	0.507	rs3851731	chr16:74485788	C/T	cg01733217	chr16:74700730	RFWD3	0.74	5.04	0.5	2.94e-6	Breast cancer;
SKCM	cis	rs7937682	1.000	rs11608149	chr11:111535102	G/A	cg09085632	chr11:111637200	PPP2R1B	1.03	11.65	0.8	9.4e-19	Primary sclerosing cholangitis;
SKCM	cis	rs870825	0.587	rs35377170	chr4:185639728	T/C	cg04058563	chr4:185651563	MLF1IP	1.08	7.26	0.64	2.51e-10	Blood protein levels;
SKCM	cis	rs763014	0.865	rs2384977	chr16:625388	C/T	cg00908189	chr16:619842	PIGQ	0.81	7.2	0.63	3.3e-10	Height;
SKCM	cis	rs35306767	0.855	rs61830932	chr10:934183	T/C	cg26597838	chr10:835615	NA	0.77	5.25	0.51	1.27e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs9910055	0.636	rs7089	chr17:42269017	T/C	cg19774624	chr17:42201019	HDAC5	-0.87	-8.15	-0.68	4.72e-12	Total body bone mineral density;
SKCM	cis	rs7811142	1.000	rs11771241	chr7:99994785	G/A	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-1.0	-5.66	-0.54	2.36e-7	Platelet count;
SKCM	cis	rs6598955	0.640	rs4233460	chr1:26633387	A/G	cg04990556	chr1:26633338	UBXN11	-0.59	-4.85	-0.48	6.08e-6	Obesity-related traits;
SKCM	cis	rs2952156	0.920	rs1476278	chr17:37836243	C/T	cg20243544	chr17:37824526	PNMT	0.67	5.35	0.52	8.48e-7	Asthma;
SKCM	cis	rs4242434	0.757	rs2280104	chr8:22525980	C/T	cg03733263	chr8:22462867	KIAA1967	0.97	8.36	0.69	1.86e-12	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs61776719	0.875	rs28683126	chr1:38402459	G/A	cg12658694	chr1:38397304	INPP5B	0.71	6.3	0.58	1.6e-8	Coronary artery disease;
SKCM	cis	rs1799949	0.794	rs116409325	chr17:41445460	C/A	cg05368731	chr17:41323189	NBR1	0.93	7.36	0.64	1.64e-10	Menopause (age at onset);
SKCM	cis	rs2479724	0.792	rs7739064	chr6:41834037	C/A	cg17623882	chr6:41773611	USP49	-0.79	-6.77	-0.61	2.19e-9	Menarche (age at onset);
SKCM	cis	rs4969178	0.930	rs7208596	chr17:76396528	C/G	cg20026190	chr17:76395443	PGS1	0.61	5.29	0.51	1.08e-6	HDL cholesterol levels;
SKCM	cis	rs7555523	0.943	rs4537525	chr1:165711089	T/G	cg24409356	chr1:165738333	TMCO1	0.93	5.15	0.5	1.93e-6	Intraocular pressure;Glaucoma (high intraocular pressure);
SKCM	cis	rs873946	0.648	rs12767126	chr10:134556992	C/T	cg26818010	chr10:134567672	INPP5A	-0.8	-6.13	-0.57	3.38e-8	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs548181	0.611	rs562599	chr11:125459951	A/C	cg03464685	chr11:125439445	EI24	1.48	8.61	0.7	6.27e-13	Schizophrenia;Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);
SKCM	cis	rs2050392	0.517	rs593400	chr10:30762088	A/G	cg25182066	chr10:30743637	MAP3K8	0.7	6.39	0.59	1.12e-8	Inflammatory bowel disease;
SKCM	cis	rs9902453	1.000	rs6505158	chr17:28403348	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.81	-5.78	-0.55	1.45e-7	Coffee consumption (cups per day);
SKCM	cis	rs6580649	0.941	rs11612970	chr12:48451009	T/C	cg05342945	chr12:48394962	COL2A1	0.73	5.2	0.51	1.53e-6	Lung cancer;
SKCM	cis	rs1461503	0.932	rs7107575	chr11:122845406	C/T	cg27398637	chr11:122830231	C11orf63	0.63	4.9	0.49	5.07e-6	Menarche (age at onset);
SKCM	cis	rs7772486	0.790	rs6917482	chr6:146243581	C/T	cg23711669	chr6:146136114	FBXO30	-0.77	-7.3	-0.64	2.15e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7843479	0.965	rs13269198	chr8:21823025	G/A	cg17168535	chr8:21777572	XPO7	0.72	5.64	0.54	2.65e-7	Mean corpuscular volume;
SKCM	cis	rs4481887	0.741	rs11485458	chr1:248569050	A/G	cg22724847	chr1:248512586	OR14C36	0.58	4.87	0.48	5.72e-6	Common traits (Other);
SKCM	trans	rs1814175	0.588	rs1721994	chr11:49914050	G/A	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs2153535	0.580	rs6421949	chr6:8531769	G/A	cg23788917	chr6:8435910	SLC35B3	0.68	4.98	0.49	3.66e-6	Motion sickness;
SKCM	cis	rs867186	1.000	rs11908232	chr20:33729477	C/G	cg04194272	chr20:33683537	NA	-1.11	-6.01	-0.56	5.7e-8	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs2839186	0.771	rs2280957	chr21:47642272	A/G	cg05896524	chr21:47604654	C21orf56	-0.68	-5.63	-0.54	2.78e-7	Testicular germ cell tumor;
SKCM	cis	rs6977660	0.891	rs10226962	chr7:19819464	T/C	cg07541023	chr7:19748670	TWISTNB	0.74	5.06	0.5	2.73e-6	Thyroid stimulating hormone;
SKCM	cis	rs798766	1.000	rs1665362	chr4:1726367	T/A	cg24239225	chr4:1659016	FAM53A	-0.69	-4.87	-0.48	5.8e-6	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs4665809	0.589	rs4665841	chr2:26448950	G/A	cg26119090	chr2:26468346	HADHA;HADHB	-1.03	-7.99	-0.67	9.69e-12	Gut microbiome composition (summer);
SKCM	cis	rs798766	1.000	rs798767	chr4:1734281	A/G	cg24239225	chr4:1659016	FAM53A	-0.72	-4.87	-0.48	5.66e-6	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs7937682	0.632	rs57414412	chr11:111769431	G/A	cg09085632	chr11:111637200	PPP2R1B	1.1	10.72	0.77	5.29e-17	Primary sclerosing cholangitis;
SKCM	cis	rs826838	1.000	rs11183941	chr12:38851692	G/C	cg13010199	chr12:38710504	ALG10B	0.83	6.69	0.6	3.1e-9	Heart rate;
SKCM	cis	rs1153858	1.000	rs28679834	chr15:45616206	C/T	cg21132104	chr15:45694354	SPATA5L1	0.91	7.64	0.65	4.71e-11	Homoarginine levels;
SKCM	cis	rs1003719	0.751	rs10154032	chr21:38453459	T/C	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs2153535	0.541	rs945304	chr6:8442892	A/G	cg23788917	chr6:8435910	SLC35B3	0.69	5.14	0.5	1.99e-6	Motion sickness;
SKCM	cis	rs933688	1.000	rs11950530	chr5:90688740	A/G	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.96	6.6	0.6	4.58e-9	Smoking behavior;
SKCM	cis	rs11229030	0.893	rs2264054	chr11:57209488	G/A	cg00522883	chr11:57194120	SLC43A3	-0.71	-5.34	-0.52	8.87e-7	Crohn's disease;
SKCM	cis	rs860295	0.557	rs10796941	chr1:155284261	C/T	cg02153340	chr1:155202674	NA	-0.78	-5.57	-0.53	3.5e-7	Body mass index;
SKCM	cis	rs2228479	0.557	rs62056064	chr16:89903843	G/A	cg06558623	chr16:89946397	TCF25	1.1	4.97	0.49	3.93e-6	Skin colour saturation;
SKCM	cis	rs6582630	0.519	rs12366667	chr12:38332632	C/T	cg26384229	chr12:38710491	ALG10B	0.81	6.67	0.6	3.38e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs875971	0.505	rs1167386	chr7:65513096	G/A	cg05627663	chr7:65219948	SNORA22;CCT6P1	-0.59	-5.08	-0.5	2.48e-6	Aortic root size;
SKCM	cis	rs9300255	0.510	rs1790086	chr12:123672518	A/G	cg05973401	chr12:123451056	ABCB9	0.83	5.24	0.51	1.31e-6	Neutrophil percentage of white cells;
SKCM	cis	rs7584330	0.666	rs72620816	chr2:238353604	C/T	cg14458575	chr2:238380390	NA	1.13	7.32	0.64	1.97e-10	Prostate cancer;
SKCM	cis	rs2251381	0.778	rs2471947	chr21:30534219	G/T	cg24692254	chr21:30365293	RNF160	0.78	6.33	0.58	1.46e-8	Selective IgA deficiency;
SKCM	cis	rs6942756	1.000	rs68076553	chr7:128959632	A/G	cg02491457	chr7:128862824	NA	-0.86	-5.48	-0.53	5.11e-7	White matter hyperintensity burden;
SKCM	cis	rs11249608	0.548	rs12152869	chr5:178462520	A/G	cg21905437	chr5:178450457	ZNF879	0.71	5.45	0.53	5.65e-7	Pubertal anthropometrics;
SKCM	cis	rs6952808	0.609	rs4721190	chr7:1954732	A/G	cg02951883	chr7:2050386	MAD1L1	0.64	5.48	0.53	5.04e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs1218582	0.772	rs10796935	chr1:154891363	G/T	cg24250549	chr1:154909240	PMVK	0.87	8.7	0.7	4.13e-13	Prostate cancer;
SKCM	cis	rs17685	0.816	rs11763076	chr7:75765963	C/T	cg16489192	chr7:75678113	MDH2;STYXL1	-0.57	-5.35	-0.52	8.63e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs9309711	0.666	rs6767	chr2:3483205	C/T	cg15506890	chr2:3487001	NA	-0.62	-5.04	-0.5	2.89e-6	Neurofibrillary tangles;
SKCM	cis	rs778371	0.723	rs1078323	chr2:233681512	T/G	cg08000102	chr2:233561755	GIGYF2	-0.76	-5.94	-0.56	7.47e-8	Schizophrenia;
SKCM	cis	rs826838	1.000	rs11609286	chr12:38875511	A/G	cg26384229	chr12:38710491	ALG10B	-1.09	-9.99	-0.75	1.31e-15	Heart rate;
SKCM	cis	rs875971	0.862	rs10282433	chr7:65721439	G/A	cg11764359	chr7:65958608	NA	-0.82	-7.93	-0.67	1.28e-11	Aortic root size;
SKCM	cis	rs2658782	1.000	rs2658778	chr11:93148948	C/G	cg15737290	chr11:93063684	CCDC67	0.76	5.32	0.52	9.69e-7	Pulmonary function decline;
SKCM	cis	rs8017423	0.935	rs59444150	chr14:90767175	T/C	cg04374321	chr14:90722782	PSMC1	0.95	8.73	0.7	3.68e-13	Mortality in heart failure;
SKCM	cis	rs10503709	0.542	rs2035358	chr8:21445088	G/A	cg23716449	chr8:21608280	GFRA2	-0.48	-4.81	-0.48	7.25e-6	Blood protein levels;
SKCM	cis	rs875971	0.862	rs10240949	chr7:65804417	A/G	cg18876405	chr7:65276391	NA	-0.64	-6.34	-0.58	1.35e-8	Aortic root size;
SKCM	cis	rs910316	0.934	rs8016330	chr14:75657507	G/T	cg11812906	chr14:75593930	NEK9	-0.77	-5.84	-0.55	1.13e-7	Height;
SKCM	trans	rs1814175	0.653	rs10839480	chr11:50034556	C/T	cg15704280	chr7:45808275	SEPT13	-1.03	-10.03	-0.75	1.1e-15	Height;
SKCM	cis	rs7424096	0.613	rs111805423	chr2:37248924	G/T	cg14987922	chr2:37194071	STRN	0.86	5.42	0.52	6.31e-7	High light scatter reticulocyte percentage of red cells;
SKCM	cis	rs57221529	0.766	rs56350081	chr5:583198	G/A	cg09888920	chr5:474111	LOC25845;SLC9A3	0.99	4.79	0.48	7.91e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs28374715	0.662	rs11852419	chr15:41456374	A/T	cg18705301	chr15:41695430	NDUFAF1	0.98	8.41	0.69	1.53e-12	Ulcerative colitis;
SKCM	cis	rs2354432	0.607	rs6694347	chr1:146751140	T/C	cg25205988	chr1:146714368	CHD1L	-1.17	-6.52	-0.59	6.27e-9	Mitochondrial DNA levels;
SKCM	cis	rs61332075	0.531	rs11885695	chr2:239338632	G/A	cg18131467	chr2:239335373	ASB1	-0.91	-5.02	-0.49	3.22e-6	Lung function (FEV1/FVC);
SKCM	cis	rs6696846	0.749	rs6692170	chr1:205074019	G/A	cg00857998	chr1:205179979	DSTYK	0.59	4.83	0.48	6.79e-6	Red blood cell count;
SKCM	cis	rs10504229	0.645	rs35142596	chr8:58128151	C/T	cg02725872	chr8:58115012	NA	-0.52	-5.04	-0.5	3e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs11098499	0.954	rs10008392	chr4:120318839	G/A	cg09307838	chr4:120376055	NA	0.95	7.12	0.63	4.64e-10	Corneal astigmatism;
SKCM	cis	rs8072100	0.688	rs7221224	chr17:45419061	T/G	cg08085267	chr17:45401833	C17orf57	0.67	5.37	0.52	7.84e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs2730245	0.527	rs2709858	chr7:158675266	C/G	cg24397884	chr7:158709396	WDR60	0.98	5.56	0.53	3.7e-7	Height;
SKCM	cis	rs4319547	0.656	rs7397299	chr12:122821649	G/T	cg23029597	chr12:123009494	RSRC2	-0.73	-5.22	-0.51	1.41e-6	Body mass index;
SKCM	cis	rs6087771	0.714	rs6058259	chr20:30235302	A/G	cg13852791	chr20:30311386	BCL2L1	0.72	5.08	0.5	2.47e-6	Subcortical brain region volumes;Putamen volume;
SKCM	cis	rs9309711	0.961	rs35067331	chr2:3474085	C/T	cg10845886	chr2:3471009	TTC15	-0.8	-6.26	-0.58	1.91e-8	Neurofibrillary tangles;
SKCM	cis	rs2072499	0.833	rs2842873	chr1:156204653	C/T	cg24450063	chr1:156163899	SLC25A44	0.86	7.62	0.65	5.01e-11	Testicular germ cell tumor;
SKCM	cis	rs28595532	0.920	rs114684527	chr4:119749252	G/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs7666738	0.830	rs10001701	chr4:98918871	G/C	cg05340658	chr4:99064831	C4orf37	0.61	4.86	0.48	5.87e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs28386778	0.863	rs7221573	chr17:61859390	G/A	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs2839186	1.000	rs2839186	chr21:47690068	C/T	cg05896524	chr21:47604654	C21orf56	0.7	5.89	0.55	9.21e-8	Testicular germ cell tumor;
SKCM	cis	rs7188801	0.665	rs10048146	chr16:86710660	C/T	cg00354437	chr16:87133690	NA	0.68	5.13	0.5	2.09e-6	Bone properties (heel);
SKCM	cis	rs1401999	1.000	rs6802849	chr3:183698943	A/C	cg01324343	chr3:183735012	ABCC5	0.93	10.77	0.77	4.25e-17	Anterior chamber depth;
SKCM	cis	rs9543976	1.000	rs4885324	chr13:76173747	G/A	cg01531495	chr13:76123901	UCHL3	0.9	4.99	0.49	3.52e-6	Diabetic retinopathy;
SKCM	cis	rs4774899	0.966	rs12914418	chr15:57506355	C/G	cg01857019	chr15:57210107	LOC145783;TCF12	0.53	4.94	0.49	4.38e-6	Urinary tract infection frequency;
SKCM	cis	rs1639906	0.895	rs34255795	chr7:2207416	A/G	cg21782813	chr7:2030301	MAD1L1	-0.52	-5.38	-0.52	7.71e-7	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs910316	0.839	rs35977276	chr14:75637359	A/C	cg11812906	chr14:75593930	NEK9	-0.7	-5.28	-0.51	1.12e-6	Height;
SKCM	cis	rs875971	0.545	rs6979636	chr7:65741625	A/G	cg18876405	chr7:65276391	NA	0.59	5.06	0.5	2.77e-6	Aortic root size;
SKCM	cis	rs28595532	0.920	rs56150431	chr4:119764786	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs208520	0.545	rs6899712	chr6:66749670	T/C	cg07460842	chr6:66804631	NA	1.04	11.36	0.79	3.26e-18	Exhaled nitric oxide output;
SKCM	cis	rs8072100	1.000	rs4794016	chr17:45725931	T/A	cg25173405	chr17:45401733	C17orf57	0.59	5.49	0.53	4.83e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs1799949	0.894	rs36062488	chr17:41337472	C/T	cg19454999	chr17:41278357	BRCA1;NBR2	-0.52	-4.83	-0.48	6.65e-6	Menopause (age at onset);
SKCM	cis	rs8072100	0.713	rs1912486	chr17:45515167	A/G	cg08085267	chr17:45401833	C17orf57	-0.62	-5.06	-0.5	2.76e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs7666738	0.830	rs7696686	chr4:98938445	T/C	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6547741	0.816	rs7560847	chr2:27882700	A/G	cg27432699	chr2:27873401	GPN1	-0.84	-7.18	-0.63	3.52e-10	Oral cavity cancer;
SKCM	cis	rs7927771	0.793	rs12803525	chr11:47413475	G/A	cg05585544	chr11:47624801	NA	-0.6	-5.32	-0.52	9.58e-7	Subjective well-being;
SKCM	cis	rs992157	0.798	rs2382819	chr2:219155909	G/T	cg20019365	chr2:219134978	PNKD;AAMP	-0.71	-6.09	-0.57	3.95e-8	Colorectal cancer;
SKCM	cis	rs2836974	0.897	rs1984022	chr21:40596085	G/A	cg17971929	chr21:40555470	PSMG1	0.9	8.81	0.71	2.52e-13	Cognitive function;
SKCM	cis	rs72615157	0.634	rs74774557	chr7:99810425	A/G	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.02	6.32	0.58	1.52e-8	Lung function (FEV1/FVC);
SKCM	cis	rs2180341	0.883	rs9388568	chr6:127690694	C/A	cg24812749	chr6:127587940	RNF146	0.83	7.18	0.63	3.63e-10	Breast cancer;
SKCM	cis	rs6840360	0.571	rs1822346	chr4:152525303	G/C	cg22705602	chr4:152727874	NA	-0.52	-5.69	-0.54	2.15e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7809950	0.954	rs3779494	chr7:107250355	G/A	cg23024343	chr7:107201750	COG5	0.84	7.72	0.66	3.23e-11	Coronary artery disease;
SKCM	cis	rs13256369	1.000	rs13267501	chr8:8574058	G/A	cg06636001	chr8:8085503	FLJ10661	0.72	5.31	0.52	9.88e-7	Obesity-related traits;
SKCM	cis	rs875971	0.638	rs6960778	chr7:66071597	C/T	cg05627663	chr7:65219948	SNORA22;CCT6P1	-0.57	-4.84	-0.48	6.43e-6	Aortic root size;
SKCM	cis	rs367615	0.506	rs2914680	chr5:108787146	A/G	cg17395555	chr5:108820864	NA	-0.8	-7.23	-0.63	2.87e-10	Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs2070488	1.000	rs4147024	chr3:38456664	C/T	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.97	9.16	0.72	5.28e-14	Electrocardiographic conduction measures;
SKCM	cis	rs4423214	1.000	rs12790010	chr11:71170653	T/C	cg05163923	chr11:71159392	DHCR7	0.83	8.11	0.68	5.77e-12	Vitamin D levels;
SKCM	cis	rs4242434	0.927	rs10099846	chr8:22534178	C/T	cg03733263	chr8:22462867	KIAA1967	-0.99	-8.69	-0.7	4.3e-13	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	trans	rs11722228	0.508	rs9732	chr4:10076658	T/C	cg26043149	chr18:55253948	FECH	0.93	7.93	0.67	1.28e-11	Gout;Urate levels;Serum uric acid levels;
SKCM	cis	rs6815814	0.950	rs66922907	chr4:38812537	A/G	cg02016764	chr4:38805732	TLR1	-0.78	-5.54	-0.53	4.02e-7	Breast cancer;
SKCM	cis	rs6088590	0.603	rs6579186	chr20:33282198	G/C	cg24642439	chr20:33292090	TP53INP2	0.79	5.66	0.54	2.45e-7	Coronary artery disease;
SKCM	cis	rs703842	1.000	rs11172342	chr12:58187758	G/T	cg04478727	chr12:58166393	METTL1;FAM119B	0.73	5.84	0.55	1.15e-7	Multiple sclerosis;
SKCM	cis	rs9814567	0.964	rs9841180	chr3:134191880	C/G	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.62	-5.07	-0.5	2.57e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs17685	0.753	rs6976532	chr7:75681094	A/G	cg01364799	chr7:75623366	TMEM120A	-0.66	-5.45	-0.53	5.7e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7336332	0.598	rs12018313	chr13:28012266	C/A	cg22138327	chr13:27999177	GTF3A	0.9	6.4	0.59	1.07e-8	Weight;
SKCM	cis	rs13256369	0.774	rs13260303	chr8:8587342	A/C	cg06636001	chr8:8085503	FLJ10661	0.72	5.38	0.52	7.51e-7	Obesity-related traits;
SKCM	cis	rs995000	0.931	rs11207979	chr1:62982994	G/A	cg06896770	chr1:63153194	DOCK7	0.72	6.64	0.6	3.74e-9	Triglyceride levels;
SKCM	cis	rs9311474	0.659	rs7638808	chr3:52572056	C/T	cg18404041	chr3:52824283	ITIH1	0.52	4.79	0.48	7.82e-6	Electroencephalogram traits;
SKCM	cis	rs17685	0.753	rs55812043	chr7:75747241	T/C	cg16489192	chr7:75678113	MDH2;STYXL1	-0.57	-5.35	-0.52	8.63e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1577917	0.655	rs7742691	chr6:86278691	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.74	6.54	0.59	5.95e-9	Response to antipsychotic treatment;
SKCM	cis	rs7927771	0.832	rs4752994	chr11:47411065	A/T	cg05585544	chr11:47624801	NA	0.57	4.92	0.49	4.76e-6	Subjective well-being;
SKCM	cis	rs362296	0.583	rs35658829	chr4:3255738	T/G	cg05297308	chr4:3317976	RGS12	-0.68	-5.54	-0.53	3.93e-7	Parental longevity (mother's age at death);
SKCM	cis	rs763014	0.898	rs4984894	chr16:623103	T/C	cg00908189	chr16:619842	PIGQ	0.81	7.2	0.63	3.3e-10	Height;
SKCM	cis	rs734999	0.870	rs1974044	chr1:2479983	A/G	cg12690016	chr1:1507138	SSU72	-0.49	-4.85	-0.48	6.18e-6	Ulcerative colitis;
SKCM	cis	rs6500395	1.000	rs12597928	chr16:48714366	G/A	cg04672837	chr16:48644449	N4BP1	-0.63	-5.37	-0.52	8.01e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs1059312	0.932	rs4760593	chr12:129287220	A/G	cg09035930	chr12:129282057	SLC15A4	0.8	8.82	0.71	2.36e-13	Systemic lupus erythematosus;
SKCM	cis	rs1801251	1.000	rs11679079	chr2:233612656	C/T	cg25237894	chr2:233734115	C2orf82	0.56	5.33	0.52	9.23e-7	Coronary artery disease;
SKCM	cis	rs4975616	0.869	rs467095	chr5:1336221	T/C	cg07493874	chr5:1342172	CLPTM1L	-0.7	-6.57	-0.6	5.12e-9	Lung cancer;
SKCM	cis	rs9581857	0.685	rs9319371	chr13:28042564	A/G	cg22138327	chr13:27999177	GTF3A	0.92	6.1	0.57	3.78e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs2839186	0.934	rs2839197	chr21:47708133	A/G	cg11766577	chr21:47581405	C21orf56	-0.71	-6.01	-0.56	5.6e-8	Testicular germ cell tumor;
SKCM	cis	rs514406	0.644	rs7530078	chr1:53204861	G/T	cg16325326	chr1:53192061	ZYG11B	-0.86	-9.02	-0.71	9.97e-14	Monocyte count;
SKCM	cis	rs151997	0.671	rs493507	chr5:50219675	G/T	cg06027927	chr5:50259733	NA	-0.65	-6.24	-0.58	2.13e-8	Callous-unemotional behaviour;
SKCM	cis	rs116095464	0.558	rs3213838	chr5:223890	G/C	cg22496380	chr5:211416	CCDC127	-0.96	-5.27	-0.51	1.18e-6	Breast cancer;
SKCM	cis	rs9790314	0.967	rs463928	chr3:161087734	A/T	cg03342759	chr3:160939853	NMD3	-0.72	-7.89	-0.67	1.53e-11	Morning vs. evening chronotype;
SKCM	cis	rs7659604	1.000	rs7659943	chr4:122665560	C/T	cg06713675	chr4:122721982	EXOSC9	-0.65	-5.68	-0.54	2.21e-7	Type 2 diabetes;
SKCM	cis	rs28374715	0.578	rs8036026	chr15:41630499	C/G	cg18705301	chr15:41695430	NDUFAF1	-1.21	-12.61	-0.82	1.61e-20	Ulcerative colitis;
SKCM	trans	rs3780486	0.846	rs10116966	chr9:33122370	T/A	cg20290983	chr6:43655470	MRPS18A	1.03	12.38	0.81	4.3e-20	IgG glycosylation;
SKCM	cis	rs6952808	0.608	rs58120505	chr7:2029867	T/C	cg02951883	chr7:2050386	MAD1L1	-0.82	-7.17	-0.63	3.8e-10	Bipolar disorder and schizophrenia;
SKCM	cis	rs7917772	0.503	rs11191347	chr10:104351617	C/T	cg11453585	chr10:104263688	ACTR1A;SUFU	0.75	5.96	0.56	6.78e-8	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs36093844	0.752	rs75639684	chr11:85571576	A/G	cg25872744	chr11:85566296	CCDC83	-0.85	-4.8	-0.48	7.42e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs2836974	0.897	rs2836923	chr21:40524236	T/C	cg11644478	chr21:40555479	PSMG1	0.98	10.01	0.75	1.22e-15	Cognitive function;
SKCM	cis	rs6570726	1.000	rs405622	chr6:145871897	G/T	cg23711669	chr6:146136114	FBXO30	0.69	6.67	0.6	3.39e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs10256972	0.681	rs6979076	chr7:1116247	C/T	cg09177884	chr7:1199841	ZFAND2A	0.72	5.91	0.56	8.44e-8	Longevity;Endometriosis;
SKCM	cis	rs9815354	0.812	rs17215183	chr3:41812334	T/C	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs9902453	0.740	rs2617884	chr17:28120430	G/C	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.81	-6.26	-0.58	1.93e-8	Coffee consumption (cups per day);
SKCM	cis	rs6912958	0.559	rs6921504	chr6:88058972	A/G	cg08069147	chr6:88032118	GJB7;C6orf162	0.7	6.49	0.59	7.24e-9	Monocyte percentage of white cells;
SKCM	cis	rs2836974	0.644	rs11088472	chr21:40699376	A/C	cg17971929	chr21:40555470	PSMG1	-0.71	-6.2	-0.57	2.5e-8	Cognitive function;
SKCM	cis	rs4888262	0.526	rs4888253	chr16:74583146	C/T	cg01733217	chr16:74700730	RFWD3	0.89	7.31	0.64	1.98e-10	Testicular germ cell tumor;
SKCM	cis	rs7027203	0.717	rs7869328	chr9:96588782	A/G	cg14598338	chr9:96623480	NA	-0.51	-5.04	-0.5	2.96e-6	DNA methylation (variation);
SKCM	cis	rs28595532	0.688	rs116566508	chr4:119619195	G/A	cg11846333	chr4:119757529	SEC24D	1.15	6.24	0.58	2.13e-8	Cannabis dependence symptom count;
SKCM	cis	rs875971	0.964	rs160635	chr7:65528918	T/C	cg18876405	chr7:65276391	NA	0.75	7.32	0.64	1.93e-10	Aortic root size;
SKCM	cis	rs2361718	0.500	rs12451697	chr17:78100690	T/A	cg09238746	chr17:78121135	EIF4A3	-0.87	-6.06	-0.57	4.53e-8	Yeast infection;
SKCM	trans	rs3780486	0.505	rs10758188	chr9:33123386	C/T	cg04842962	chr6:43655489	MRPS18A	-0.87	-8.49	-0.69	1.05e-12	IgG glycosylation;
SKCM	cis	rs35146811	0.735	rs1636975	chr7:99812089	A/G	cg22906224	chr7:99728672	NA	-0.72	-5.76	-0.55	1.61e-7	Coronary artery disease;
SKCM	trans	rs1814175	0.817	rs1794162	chr11:49899506	A/C	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs8103278	1.000	rs36091860	chr19:46312880	G/A	cg11657440	chr19:46296263	DMWD	-0.93	-6.49	-0.59	7.16e-9	Coronary artery disease;
SKCM	cis	rs951366	0.622	rs11580015	chr1:205676088	G/C	cg24503407	chr1:205819492	PM20D1	0.69	5.52	0.53	4.33e-7	Menarche (age at onset);
SKCM	cis	rs6912958	0.703	rs9359748	chr6:88095500	C/T	cg08069147	chr6:88032118	GJB7;C6orf162	0.63	5.24	0.51	1.35e-6	Monocyte percentage of white cells;
SKCM	cis	rs7143963	0.943	rs7147331	chr14:103380208	T/A	cg23020514	chr14:103360112	TRAF3	0.77	6.48	0.59	7.54e-9	Body mass index;
SKCM	cis	rs10504229	1.000	rs67388517	chr8:58176617	C/A	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs4727027	0.933	rs1044358	chr7:148879951	C/A	cg23583168	chr7:148888333	NA	-0.78	-6.4	-0.59	1.06e-8	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs10751667	0.666	rs7943140	chr11:973824	T/C	cg10932868	chr11:921992	NA	0.55	5.1	0.5	2.36e-6	Alzheimer's disease (late onset);
SKCM	trans	rs17685	0.753	rs10952840	chr7:75772878	C/T	cg19862616	chr7:65841803	NCRNA00174	0.92	9.38	0.73	2.02e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs9485372	0.945	rs73781729	chr6:149608635	G/A	cg03072286	chr6:150262044	ULBP2	-0.55	-4.81	-0.48	7.27e-6	Breast cancer;
SKCM	cis	rs2811415	0.597	rs9863134	chr3:127748216	G/T	cg09089421	chr3:127803668	RUVBL1	-0.96	-7.93	-0.67	1.28e-11	Lung function (FEV1/FVC);
SKCM	cis	rs2839186	0.900	rs2839200	chr21:47709095	C/T	cg05896524	chr21:47604654	C21orf56	0.69	5.67	0.54	2.29e-7	Testicular germ cell tumor;
SKCM	cis	rs2204008	0.775	rs11514370	chr12:38305566	G/A	cg26384229	chr12:38710491	ALG10B	0.81	6.61	0.6	4.27e-9	Bladder cancer;
SKCM	cis	rs9443189	0.570	rs72888705	chr6:76403114	A/G	cg01950844	chr6:76311363	SENP6	0.98	6.54	0.59	5.95e-9	Prostate cancer;
SKCM	cis	rs151997	1.000	rs27247	chr5:50232299	T/C	cg06027927	chr5:50259733	NA	-0.67	-5.97	-0.56	6.72e-8	Callous-unemotional behaviour;
SKCM	cis	rs6547741	0.935	rs4666004	chr2:27855052	T/A	cg27432699	chr2:27873401	GPN1	0.73	6.74	0.61	2.43e-9	Oral cavity cancer;
SKCM	cis	rs2120019	0.938	rs8040169	chr15:75370958	C/A	cg17294928	chr15:75287854	SCAMP5	-0.82	-6.77	-0.61	2.13e-9	Blood trace element (Zn levels);
SKCM	cis	rs9814567	0.806	rs4535271	chr3:134321669	T/A	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.65	-5.19	-0.51	1.6e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs6951245	0.554	rs11761322	chr7:1151657	A/G	cg23708337	chr7:1209742	NA	0.71	4.94	0.49	4.35e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs1692580	0.840	rs263526	chr1:2173504	T/C	cg24578937	chr1:2090814	PRKCZ	0.48	5.22	0.51	1.47e-6	Coronary artery disease;
SKCM	cis	rs2243480	0.901	rs12530490	chr7:65691647	G/A	cg18252515	chr7:66147081	NA	1.34	8.18	0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs2481665	0.608	rs2481666	chr1:62596529	A/T	cg18591186	chr1:62594603	INADL	-0.63	-5.1	-0.5	2.37e-6	BMI in non-smokers;BMI (adjusted for smoking behaviour);Body mass index;Body mass index (joint analysis main effects and smoking interaction);
SKCM	cis	rs4727027	0.870	rs62507512	chr7:148799338	C/T	cg23583168	chr7:148888333	NA	-0.82	-6.49	-0.59	7.11e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs9682041	1.000	rs57508070	chr3:170074374	C/A	cg11886554	chr3:170076028	SKIL	0.93	5.5	0.53	4.62e-7	Glomerular filtration rate in non diabetics (creatinine);Glomerular filtration rate (creatinine);
SKCM	cis	rs67311347	0.544	rs1902073	chr3:40333497	C/T	cg13409248	chr3:40428643	ENTPD3	0.57	5.58	0.53	3.37e-7	Renal cell carcinoma;
SKCM	cis	rs6840360	0.571	rs62327274	chr4:152548012	C/T	cg22705602	chr4:152727874	NA	-0.52	-5.69	-0.54	2.15e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs11098499	0.644	rs17517414	chr4:120262101	G/C	cg09307838	chr4:120376055	NA	0.97	8.31	0.69	2.31e-12	Corneal astigmatism;
SKCM	cis	rs9300255	0.510	rs1727322	chr12:123699520	A/G	cg05973401	chr12:123451056	ABCB9	0.79	5.2	0.51	1.59e-6	Neutrophil percentage of white cells;
SKCM	cis	rs2777491	0.874	rs7161772	chr15:41611066	A/T	cg18705301	chr15:41695430	NDUFAF1	-0.98	-9.56	-0.73	9.07e-15	Ulcerative colitis;
SKCM	cis	rs7179456	0.545	rs605928	chr15:59046163	C/G	cg05156742	chr15:59063176	FAM63B	0.81	5.93	0.56	7.76e-8	Asperger disorder;
SKCM	cis	rs57221529	0.766	rs56216231	chr5:581193	G/A	cg09888920	chr5:474111	LOC25845;SLC9A3	0.99	4.79	0.48	7.91e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs992157	1.000	rs736730	chr2:219120255	C/T	cg00012203	chr2:219082015	ARPC2	0.83	6.98	0.62	8.66e-10	Colorectal cancer;
SKCM	cis	rs155076	1.000	rs9509638	chr13:21860193	G/A	cg11317459	chr13:21872234	NA	-1.32	-7.62	-0.65	5.15e-11	White matter hyperintensity burden;
SKCM	cis	rs1691799	0.899	rs903590	chr12:66745777	C/G	cg16791601	chr12:66731901	HELB	-0.59	-5.17	-0.51	1.74e-6	White blood cell count (basophil);
SKCM	cis	rs72781680	0.611	rs4149373	chr2:24300023	C/T	cg20701182	chr2:24300061	SF3B14	0.73	4.94	0.49	4.44e-6	Lymphocyte counts;
SKCM	cis	rs28386778	0.897	rs1062790	chr17:61896455	A/G	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs3820928	0.874	rs10207404	chr2:227794420	T/C	cg11843606	chr2:227700838	RHBDD1	-0.6	-4.81	-0.48	7.34e-6	Pulmonary function;
SKCM	cis	rs7208859	0.623	rs9911490	chr17:29073013	C/T	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs6724607	1.000	rs13006708	chr2:191471428	G/A	cg21644426	chr2:191273491	MFSD6	-0.69	-4.94	-0.49	4.42e-6	Pulse pressure;
SKCM	trans	rs1814175	0.645	rs28445479	chr11:50047999	A/G	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs1538970	0.851	rs61788285	chr1:45919234	A/C	cg05343316	chr1:45956843	TESK2	0.92	4.94	0.49	4.42e-6	Platelet count;
SKCM	cis	rs17685	0.775	rs11761172	chr7:75761547	C/T	cg16684958	chr7:75615977	POR	0.55	5.27	0.51	1.19e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs62238980	0.614	rs117338422	chr22:32399226	C/G	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs7193541	0.684	rs7191665	chr16:74688948	T/G	cg01733217	chr16:74700730	RFWD3	1.02	11.62	0.8	1.08e-18	Multiple myeloma;
SKCM	cis	rs10492096	1.000	rs12422771	chr12:6580273	G/T	cg07142400	chr12:6602447	NCAPD2;MRPL51	-0.75	-4.92	-0.49	4.74e-6	Hip geometry;
SKCM	cis	rs1580019	0.510	rs4723162	chr7:32543804	C/A	cg06627557	chr7:32535165	LSM5;AVL9	0.95	9.08	0.72	7.65e-14	Cognitive ability;
SKCM	cis	rs1153858	1.000	rs2453541	chr15:45645378	G/A	cg10760299	chr15:45669010	GATM	0.63	6.3	0.58	1.6e-8	Homoarginine levels;
SKCM	cis	rs362272	0.505	rs60208975	chr4:3364530	A/G	cg09735869	chr4:3319127	RGS12	0.96	10.77	0.77	4.36e-17	Serum sulfate level;
SKCM	cis	rs2836974	0.863	rs12483216	chr21:40539614	T/C	cg17971929	chr21:40555470	PSMG1	0.87	8.48	0.69	1.1e-12	Cognitive function;
SKCM	cis	rs7666738	0.830	rs9307218	chr4:99024885	T/C	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs8067545	0.518	rs7222987	chr17:20055765	A/G	cg13482628	chr17:19912719	NA	0.65	5.6	0.54	3.06e-7	Schizophrenia;
SKCM	trans	rs3780486	0.846	rs7873903	chr9:33142728	G/A	cg20290983	chr6:43655470	MRPS18A	0.96	11.0	0.78	1.56e-17	IgG glycosylation;
SKCM	cis	rs7666738	0.830	rs6532723	chr4:99052147	A/T	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	trans	rs7618501	1.000	rs2271960	chr3:49878078	A/G	cg21659725	chr3:3221576	CRBN	0.91	8.88	0.71	1.81e-13	Intelligence (multi-trait analysis);
SKCM	cis	rs7100689	0.646	rs1538823	chr10:82088040	C/A	cg00277334	chr10:82204260	NA	-0.57	-5.34	-0.52	8.88e-7	Post bronchodilator FEV1;
SKCM	cis	rs155076	1.000	rs567166	chr13:21837519	T/C	cg14456004	chr13:21872349	NA	-1.23	-6.77	-0.61	2.15e-9	White matter hyperintensity burden;
SKCM	cis	rs8180040	0.767	rs11920853	chr3:47308183	G/A	cg27129171	chr3:47204927	SETD2	-0.79	-5.38	-0.52	7.6e-7	Colorectal cancer;
SKCM	cis	rs6087990	0.966	rs2377667	chr20:31346925	A/G	cg13636640	chr20:31349939	DNMT3B	0.91	7.99	0.67	9.7e-12	Ulcerative colitis;
SKCM	cis	rs1348850	0.526	rs7582179	chr2:178370631	A/G	cg27490568	chr2:178487706	NA	0.9	6.9	0.62	1.22e-9	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs7811142	0.830	rs73401451	chr7:99981895	T/C	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.19	7.5	0.65	8.66e-11	Platelet count;
SKCM	cis	rs769267	0.965	rs12460764	chr19:19431963	G/T	cg26732615	chr19:19648335	CILP2;YJEFN3	-0.65	-6.08	-0.57	4.12e-8	Tonsillectomy;
SKCM	cis	rs1863824	0.625	rs7091192	chr10:88167456	A/G	cg07322936	chr10:88137208	NA	-0.59	-5.02	-0.49	3.24e-6	Schizophrenia;
SKCM	cis	rs1707322	0.964	rs785509	chr1:46527300	G/A	cg03146154	chr1:46216737	IPP	-0.78	-5.79	-0.55	1.38e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs35306767	0.953	rs10904583	chr10:983498	T/C	cg20503657	chr10:835505	NA	0.65	5.2	0.51	1.56e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs62064224	0.791	rs11654833	chr17:30667728	C/T	cg18200150	chr17:30822561	MYO1D	0.76	6.03	0.56	5.16e-8	Schizophrenia;
SKCM	cis	rs4975616	0.869	rs467095	chr5:1336221	T/C	cg06550200	chr5:1325588	CLPTM1L	-0.86	-7.74	-0.66	2.94e-11	Lung cancer;
SKCM	cis	rs875971	0.928	rs2036263	chr7:65800197	C/T	cg18876405	chr7:65276391	NA	-0.64	-6.34	-0.58	1.35e-8	Aortic root size;
SKCM	cis	rs10779751	0.922	rs2746637	chr1:11275588	A/G	cg08854313	chr1:11322531	MTOR	0.87	6.5	0.59	6.88e-9	Body mass index;
SKCM	cis	rs9611565	0.592	rs5996038	chr22:41965300	T/C	cg03806693	chr22:41940476	POLR3H	-1.04	-6.96	-0.62	9.22e-10	Vitiligo;
SKCM	cis	rs7666738	0.830	rs732299	chr4:98995389	C/T	cg17366294	chr4:99064904	C4orf37	0.6	4.98	0.49	3.8e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs634534	0.532	rs12794370	chr11:65770413	G/A	cg26695010	chr11:65641043	EFEMP2	-0.72	-5.48	-0.53	5.15e-7	Sum eosinophil basophil counts;Eosinophil counts;
SKCM	cis	rs7216064	1.000	rs4791212	chr17:65975385	C/T	cg12091567	chr17:66097778	LOC651250	-0.78	-5.35	-0.52	8.66e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs28595532	0.920	rs17323034	chr4:119606518	G/A	cg21605333	chr4:119757512	SEC24D	1.24	7.1	0.63	5.16e-10	Cannabis dependence symptom count;
SKCM	cis	rs28595532	0.844	rs115202072	chr4:119732458	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.43	0.59	9.38e-9	Cannabis dependence symptom count;
SKCM	cis	rs738321	0.757	rs6001020	chr22:38538246	C/G	cg25457927	chr22:38595422	NA	-0.5	-5.74	-0.54	1.74e-7	Breast cancer;
SKCM	cis	rs9902453	0.845	rs3102559	chr17:28029723	T/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.82	5.78	0.55	1.47e-7	Coffee consumption (cups per day);
SKCM	cis	rs867186	1.000	rs8118978	chr20:33574458	A/C	cg04194272	chr20:33683537	NA	-1.22	-6.74	-0.61	2.42e-9	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs4790333	0.845	rs7210932	chr17:2272024	A/G	cg02569219	chr17:2266849	SGSM2	-0.7	-5.93	-0.56	7.91e-8	Proinsulin levels;
SKCM	cis	rs11098499	0.820	rs13128602	chr4:120459366	C/T	cg09307838	chr4:120376055	NA	-0.99	-7.61	-0.65	5.41e-11	Corneal astigmatism;
SKCM	cis	rs2836950	0.520	rs2836966	chr21:40637521	A/G	cg11890956	chr21:40555474	PSMG1	-0.66	-5.24	-0.51	1.32e-6	Menarche (age at onset);
SKCM	cis	rs9300255	0.544	rs1790130	chr12:123701270	A/C	cg00376283	chr12:123451042	ABCB9	0.83	5.49	0.53	4.74e-7	Neutrophil percentage of white cells;
SKCM	cis	rs35306767	0.903	rs1341741	chr10:888073	A/G	cg26597838	chr10:835615	NA	0.77	5.39	0.52	7.26e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs9467773	0.620	rs2504592	chr6:26640951	C/G	cg09904177	chr6:26538194	HMGN4	0.58	5.01	0.49	3.28e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs6598955	0.670	rs12733645	chr1:26540356	G/T	cg00938395	chr1:26633206	UBXN11	0.71	5.0	0.49	3.5e-6	Obesity-related traits;
SKCM	cis	rs13010713	0.806	rs4444479	chr2:182063448	A/G	cg21995919	chr2:182322279	ITGA4	-0.53	-5.11	-0.5	2.2e-6	Celiac disease;
SKCM	cis	rs7811142	0.943	rs10241492	chr7:99994813	A/G	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-1.0	-5.66	-0.54	2.36e-7	Platelet count;
SKCM	cis	rs12474201	0.928	rs35825831	chr2:46932544	T/G	cg06386533	chr2:46925753	SOCS5	1.01	9.13	0.72	5.95e-14	Height;
SKCM	cis	rs2841277	0.802	rs2841269	chr14:105386149	C/G	cg15352829	chr14:105391018	PLD4	-0.59	-4.94	-0.49	4.43e-6	Rheumatoid arthritis;
SKCM	cis	rs9611565	0.659	rs1810461	chr22:41927820	G/A	cg03806693	chr22:41940476	POLR3H	-1.11	-7.56	-0.65	6.67e-11	Vitiligo;
SKCM	cis	rs11122272	0.766	rs2486732	chr1:231531476	A/C	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	-0.64	-5.29	-0.51	1.1e-6	Hemoglobin concentration;
SKCM	cis	rs3785574	0.927	rs2727313	chr17:61961914	A/G	cg23090583	chr17:61904693	PSMC5;FTSJ3	0.66	5.33	0.52	9.1e-7	Height;
SKCM	cis	rs57221529	0.713	rs12522724	chr5:590742	T/C	cg26208419	chr5:473447	SLC9A3;LOC25845	1.01	5.18	0.51	1.7e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs7843479	0.582	rs11135743	chr8:21803008	A/G	cg17168535	chr8:21777572	XPO7	0.81	7.25	0.63	2.64e-10	Mean corpuscular volume;
SKCM	trans	rs62103177	0.810	rs62103194	chr18:77629482	G/A	cg05926928	chr17:57297772	GDPD1	1.29	8.74	0.7	3.44e-13	Opioid sensitivity;
SKCM	cis	rs28530618	0.515	rs6579027	chr20:31239025	G/T	cg25730142	chr20:32031702	SNTA1	0.62	4.8	0.48	7.46e-6	Birth weight;
SKCM	cis	rs478304	0.651	rs7110576	chr11:65512057	T/G	cg27068330	chr11:65405492	SIPA1	-0.89	-8.2	-0.68	3.77e-12	Acne (severe);
SKCM	cis	rs12824058	0.831	rs11609362	chr12:130810526	T/C	cg24838063	chr12:130822603	PIWIL1	0.78	6.91	0.62	1.19e-9	Menopause (age at onset);
SKCM	cis	rs780096	0.506	rs8395	chr2:27715207	T/A	cg05696406	chr2:27599888	SNX17	0.52	5.24	0.51	1.34e-6	Total body bone mineral density;
SKCM	cis	rs875971	0.862	rs17747530	chr7:65994729	G/C	cg11764359	chr7:65958608	NA	0.75	6.8	0.61	1.86e-9	Aortic root size;
SKCM	cis	rs7100689	0.784	rs7089058	chr10:82071263	T/C	cg01528321	chr10:82214614	TSPAN14	0.81	7.3	0.64	2.14e-10	Post bronchodilator FEV1;
SKCM	cis	rs78314980	0.557	rs41265179	chr1:153601828	G/T	cg24884190	chr1:153606480	S100A13;C1orf77	-1.21	-4.88	-0.48	5.61e-6	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs55794721	0.509	rs4649085	chr1:25778832	G/A	cg27572855	chr1:25598939	RHD	0.53	5.06	0.5	2.67e-6	Plateletcrit;Mean corpuscular volume;
SKCM	cis	rs11098499	0.863	rs1480940	chr4:120457682	T/C	cg24375607	chr4:120327624	NA	0.68	5.31	0.52	9.93e-7	Corneal astigmatism;
SKCM	cis	rs782590	0.935	rs6739513	chr2:55749902	G/A	cg18811423	chr2:55921094	PNPT1	0.79	5.93	0.56	7.68e-8	Metabolic syndrome;
SKCM	cis	rs4689592	0.523	rs4256224	chr4:7074583	T/C	cg19539972	chr4:7069911	GRPEL1	1.04	6.64	0.6	3.73e-9	Monocyte percentage of white cells;
SKCM	cis	rs11608355	0.508	rs12822899	chr12:109800978	A/G	cg19025524	chr12:109796872	NA	-0.71	-5.37	-0.52	7.81e-7	Neuroticism;
SKCM	cis	rs1153858	1.000	rs7169587	chr15:45640379	A/G	cg10760299	chr15:45669010	GATM	0.57	5.67	0.54	2.31e-7	Homoarginine levels;
SKCM	cis	rs9815354	0.812	rs59146151	chr3:41949301	T/C	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs9475752	0.793	rs13214255	chr6:56830549	G/T	cg06815302	chr6:57335405	PRIM2	0.59	4.78	0.48	8.1e-6	Menarche (age at onset);
SKCM	cis	rs2120019	1.000	rs12903201	chr15:75370776	A/C	cg09165964	chr15:75287851	SCAMP5	-0.78	-6.63	-0.6	3.95e-9	Blood trace element (Zn levels);
SKCM	cis	rs17685	0.849	rs3815455	chr7:75611756	C/T	cg16684958	chr7:75615977	POR	0.7	6.77	0.61	2.11e-9	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2073499	1.000	rs4141060	chr3:50300117	T/C	cg08207895	chr3:50388901	TUSC4;CYB561D2	0.73	5.36	0.52	8.2e-7	Schizophrenia;
SKCM	cis	rs5750830	0.649	rs5750808	chr22:39790987	G/A	cg11247378	chr22:39784982	NA	-0.51	-6.22	-0.58	2.26e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs7786877	0.723	rs7812123	chr7:100211556	C/A	cg20848291	chr7:100343083	ZAN	-0.68	-5.15	-0.5	1.87e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs951366	0.617	rs823075	chr1:205774897	C/T	cg24503407	chr1:205819492	PM20D1	0.98	10.86	0.78	2.94e-17	Menarche (age at onset);
SKCM	cis	rs713587	0.520	rs493090	chr2:25303772	G/A	cg04586622	chr2:25135609	ADCY3	-0.66	-5.08	-0.5	2.52e-6	Body mass index in non-asthmatics;
SKCM	cis	rs7584330	0.737	rs61212490	chr2:238365230	T/C	cg14458575	chr2:238380390	NA	0.86	6.22	0.58	2.31e-8	Prostate cancer;
SKCM	cis	rs1862618	0.715	rs6866779	chr5:56090000	G/A	cg12311346	chr5:56204834	C5orf35	-0.77	-4.97	-0.49	3.95e-6	Initial pursuit acceleration;
SKCM	cis	rs875971	0.660	rs7807944	chr7:66087195	C/G	cg11764359	chr7:65958608	NA	-0.84	-6.37	-0.59	1.2e-8	Aortic root size;
SKCM	cis	rs2354432	0.556	rs4295925	chr1:146857335	T/C	cg25205988	chr1:146714368	CHD1L	1.11	5.59	0.53	3.21e-7	Mitochondrial DNA levels;
SKCM	cis	rs2836974	0.899	rs2836938	chr21:40574191	C/T	cg11890956	chr21:40555474	PSMG1	1.11	13.57	0.84	3.1e-22	Cognitive function;
SKCM	cis	rs8067545	0.967	rs1034904	chr17:19927699	A/G	cg13482628	chr17:19912719	NA	-0.77	-6.55	-0.6	5.65e-9	Schizophrenia;
SKCM	cis	rs838147	0.815	rs12981072	chr19:49241006	C/G	cg13540341	chr19:49222985	MAMSTR	0.66	5.61	0.54	2.99e-7	Dietary macronutrient intake;
SKCM	cis	rs9303401	0.614	rs3803752	chr17:56540267	C/T	cg02118635	chr17:56770003	RAD51C;TEX14	0.8	5.3	0.51	1.05e-6	Cognitive test performance;
SKCM	cis	rs9902453	0.704	rs2628179	chr17:28071796	G/C	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.85	-5.77	-0.55	1.51e-7	Coffee consumption (cups per day);
SKCM	cis	rs28386778	0.897	rs4968598	chr17:61835579	T/C	cg06873352	chr17:61820015	STRADA	0.76	6.34	0.58	1.38e-8	Prudent dietary pattern;
SKCM	cis	rs995000	0.931	rs6587980	chr1:63090858	C/T	cg06896770	chr1:63153194	DOCK7	0.75	7.1	0.63	5.05e-10	Triglyceride levels;
SKCM	cis	rs12709013	0.686	rs151817	chr16:58737918	T/A	cg02431531	chr16:59244939	NA	-0.49	-5.03	-0.49	3.08e-6	Blood metabolite ratios;
SKCM	cis	rs7828089	0.935	rs896378	chr8:22262321	T/C	cg12081754	chr8:22256438	SLC39A14	0.7	5.49	0.53	4.79e-7	Verbal declarative memory;
SKCM	cis	rs3820068	0.603	rs67349836	chr1:15966176	T/C	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs6580649	0.882	rs7133249	chr12:48456823	C/T	cg05342945	chr12:48394962	COL2A1	0.73	5.2	0.51	1.53e-6	Lung cancer;
SKCM	cis	rs801193	0.967	rs34356500	chr7:66236607	G/T	cg18876405	chr7:65276391	NA	0.82	7.46	0.65	1.05e-10	Aortic root size;
SKCM	cis	rs7666738	0.830	rs62321587	chr4:98997958	T/C	cg17366294	chr4:99064904	C4orf37	0.6	4.98	0.49	3.8e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2243480	1.000	rs313803	chr7:65514731	G/A	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs2303759	0.709	rs8102574	chr19:49828897	A/G	cg05022225	chr19:49866942	DKKL1;TEAD2	0.7	5.05	0.5	2.78e-6	Multiple sclerosis;
SKCM	cis	rs10504229	1.000	rs73609764	chr8:58192971	G/A	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs4253772	0.591	rs73886791	chr22:46687212	A/G	cg03482458	chr22:46692211	CN5H6.4;GTSE1	1.2	5.67	0.54	2.3e-7	LDL cholesterol;Cholesterol, total;
SKCM	cis	rs2832191	0.791	rs2832187	chr21:30485543	T/C	cg08807101	chr21:30365312	RNF160	-0.62	-4.94	-0.49	4.34e-6	Dental caries;
SKCM	cis	rs4665809	0.556	rs6730311	chr2:26419474	C/T	cg26119090	chr2:26468346	HADHA;HADHB	-0.99	-7.2	-0.63	3.22e-10	Gut microbiome composition (summer);
SKCM	cis	rs1577917	1.000	rs12204365	chr6:86700532	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.83	-8.23	-0.68	3.37e-12	Response to antipsychotic treatment;
SKCM	cis	rs2153535	0.601	rs2327059	chr6:8447071	A/G	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs8060686	0.565	rs8044328	chr16:68146859	G/C	cg09117114	chr16:67998030	SLC12A4	-0.81	-5.29	-0.51	1.07e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs9388451	0.839	rs4897157	chr6:126102981	A/T	cg05901451	chr6:126070800	HEY2	-0.77	-6.82	-0.61	1.69e-9	Brugada syndrome;
SKCM	cis	rs6942756	1.000	rs6942756	chr7:128886821	T/G	cg02491457	chr7:128862824	NA	-0.76	-4.89	-0.48	5.29e-6	White matter hyperintensity burden;
SKCM	cis	rs6089584	0.507	rs28545731	chr20:60634102	C/T	cg06108461	chr20:60628389	TAF4	-0.8	-7.72	-0.66	3.25e-11	Body mass index;
SKCM	cis	rs1577917	1.000	rs11758849	chr6:86708262	G/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.66	-5.5	-0.53	4.62e-7	Response to antipsychotic treatment;
SKCM	trans	rs12599106	0.836	rs10438601	chr16:34625895	C/T	cg15383120	chr6:291909	DUSP22	-0.8	-7.52	-0.65	7.98e-11	Menopause (age at onset);
SKCM	cis	rs12142240	0.698	rs17357628	chr1:46808462	A/G	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs11628318	0.660	rs35258120	chr14:103058769	G/A	cg01864069	chr14:103024347	NA	-0.74	-4.78	-0.48	8.18e-6	Platelet count;
SKCM	cis	rs2760061	0.626	rs672977	chr1:228120288	A/C	cg02753203	chr1:228287806	NA	-0.62	-5.03	-0.5	3.03e-6	Diastolic blood pressure;
SKCM	cis	rs6088580	0.634	rs3746455	chr20:32957216	G/A	cg24642439	chr20:33292090	TP53INP2	-0.76	-6.03	-0.56	5.2e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs9911578	0.757	rs8081906	chr17:56631907	A/T	cg05425664	chr17:57184151	TRIM37	0.66	4.84	0.48	6.32e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs17376456	1.000	rs66978370	chr5:93553633	G/A	cg25358565	chr5:93447407	FAM172A	1.27	7.86	0.66	1.78e-11	Diabetic retinopathy;
SKCM	cis	rs2559856	0.935	rs7957666	chr12:102081551	T/C	cg12924262	chr12:102091054	CHPT1	0.7	5.68	0.54	2.19e-7	Blood protein levels;
SKCM	cis	rs6061231	1.000	rs6061231	chr20:60956917	C/A	cg24112000	chr20:60950667	NA	-0.61	-6.02	-0.56	5.47e-8	Colorectal cancer;
SKCM	cis	rs9430161	0.611	rs12081197	chr1:11034239	T/C	cg27631724	chr1:11040367	C1orf127	0.5	4.88	0.48	5.45e-6	Ewing sarcoma;
SKCM	cis	rs7589728	0.514	rs12465706	chr2:88467459	C/A	cg04511125	chr2:88470314	THNSL2	1.07	6.66	0.6	3.43e-9	Plasma clusterin levels;
SKCM	cis	rs1957429	0.901	rs1951491	chr14:65346950	G/A	cg23373153	chr14:65346875	NA	1.07	6.14	0.57	3.19e-8	Pediatric areal bone mineral density (radius);
SKCM	cis	rs709400	0.894	rs61996721	chr14:104061352	G/A	cg26031613	chr14:104095156	KLC1	1.11	12.9	0.83	4.83e-21	Body mass index;
SKCM	trans	rs3780486	0.846	rs913214	chr9:33135085	G/A	cg04842962	chr6:43655489	MRPS18A	1.01	10.58	0.77	9.64e-17	IgG glycosylation;
SKCM	trans	rs17685	0.753	rs11764129	chr7:75761890	T/C	cg19862616	chr7:65841803	NCRNA00174	0.94	9.49	0.73	1.22e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs769267	0.930	rs4808964	chr19:19603692	A/C	cg26732615	chr19:19648335	CILP2;YJEFN3	-0.67	-7.06	-0.62	6e-10	Tonsillectomy;
SKCM	cis	rs933688	0.877	rs1477349	chr5:90707773	G/A	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.96	6.6	0.6	4.58e-9	Smoking behavior;
SKCM	cis	rs1218582	0.772	rs4240874	chr1:154885779	C/T	cg09359103	chr1:154839909	KCNN3	-0.57	-5.3	-0.51	1.05e-6	Prostate cancer;
SKCM	cis	rs6424115	0.708	rs11803575	chr1:24182348	A/T	cg15997130	chr1:24165203	NA	-0.59	-4.8	-0.48	7.41e-6	Immature fraction of reticulocytes;
SKCM	cis	rs1577917	0.518	rs6454482	chr6:86418188	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.62	5.13	0.5	2.08e-6	Response to antipsychotic treatment;
SKCM	cis	rs9858542	0.903	rs35999162	chr3:49597230	C/G	cg03060546	chr3:49711283	APEH	-0.69	-5.11	-0.5	2.24e-6	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs2075371	0.966	rs2544223	chr7:133995787	A/G	cg20476274	chr7:133979776	SLC35B4	1.03	10.69	0.77	5.94e-17	Mean platelet volume;
SKCM	cis	rs28386778	0.897	rs716880	chr17:61902822	C/G	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs7809950	0.731	rs2712196	chr7:107128797	G/T	cg23024343	chr7:107201750	COG5	-0.84	-7.84	-0.66	1.92e-11	Coronary artery disease;
SKCM	trans	rs1814175	0.654	rs7482446	chr11:49779020	A/G	cg03929089	chr4:120376271	NA	-0.91	-8.36	-0.69	1.87e-12	Height;
SKCM	cis	rs314370	0.951	rs17884589	chr7:100493711	G/A	cg10426581	chr7:100472382	SRRT	0.67	5.64	0.54	2.57e-7	Resting heart rate;
SKCM	cis	rs2011503	0.882	rs2060276	chr19:19522491	T/G	cg11584989	chr19:19387371	SF4	0.73	4.78	0.48	8.05e-6	Bipolar disorder;
SKCM	cis	rs34779708	0.742	rs35912711	chr10:35312996	T/C	cg03585969	chr10:35415529	CREM	0.73	6.02	0.56	5.38e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs2842992	0.872	rs1570318	chr6:160111473	C/T	cg11366901	chr6:160182831	ACAT2	0.88	6.82	0.61	1.71e-9	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs17065868	1.000	rs61948004	chr13:45174717	C/G	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs8180040	0.966	rs6800271	chr3:47470787	A/T	cg16586182	chr3:47516702	SCAP	0.73	5.2	0.51	1.55e-6	Colorectal cancer;
SKCM	cis	rs9300255	0.602	rs2682434	chr12:123694724	C/T	cg00376283	chr12:123451042	ABCB9	0.83	5.49	0.53	4.74e-7	Neutrophil percentage of white cells;
SKCM	cis	rs35306767	0.807	rs12768348	chr10:899224	T/G	cg25614935	chr10:1084866	C10orf110	0.81	5.47	0.53	5.26e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs55794721	0.509	rs909834	chr1:25757996	A/G	cg02931644	chr1:25747376	RHCE	0.5	4.77	0.48	8.48e-6	Plateletcrit;Mean corpuscular volume;
SKCM	cis	rs2013441	0.965	rs8071665	chr17:20209943	T/C	cg13482628	chr17:19912719	NA	-0.67	-5.24	-0.51	1.32e-6	Obesity-related traits;
SKCM	cis	rs769267	0.965	rs7254230	chr19:19434350	C/T	cg03709012	chr19:19516395	GATAD2A	-0.84	-6.97	-0.62	9.13e-10	Tonsillectomy;
SKCM	cis	rs17685	0.587	rs1623759	chr7:75724679	A/T	cg16489192	chr7:75678113	MDH2;STYXL1	-0.61	-5.55	-0.53	3.73e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs6952808	0.895	rs12669518	chr7:1921429	G/C	cg02951883	chr7:2050386	MAD1L1	-0.72	-5.9	-0.56	8.76e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs2839186	0.771	rs2280957	chr21:47642272	A/G	cg11766577	chr21:47581405	C21orf56	0.73	6.37	0.58	1.24e-8	Testicular germ cell tumor;
SKCM	cis	rs793571	0.650	rs12899638	chr15:58920275	G/A	cg05156742	chr15:59063176	FAM63B	0.74	5.63	0.54	2.71e-7	Schizophrenia;
SKCM	trans	rs1814175	0.715	rs7479622	chr11:49673340	T/G	cg03929089	chr4:120376271	NA	-0.9	-7.75	-0.66	2.83e-11	Height;
SKCM	cis	rs951366	0.622	rs11580015	chr1:205676088	G/C	cg14893161	chr1:205819251	PM20D1	0.85	7.38	0.64	1.49e-10	Menarche (age at onset);
SKCM	cis	rs28735056	0.596	rs3744879	chr18:77679006	G/C	cg20368463	chr18:77673604	PQLC1	-0.72	-5.45	-0.53	5.59e-7	Schizophrenia;
SKCM	cis	rs9910055	0.762	rs6503489	chr17:42246289	G/A	cg13607699	chr17:42295918	UBTF	0.79	6.25	0.58	2.03e-8	Total body bone mineral density;
SKCM	cis	rs12134245	0.742	rs17501381	chr1:92003919	A/G	cg25838465	chr1:92012736	NA	-0.81	-8.49	-0.69	1.06e-12	Breast cancer;
SKCM	cis	rs7666738	0.830	rs10017557	chr4:98983969	G/A	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7178909	0.831	rs1910587	chr15:90440487	A/C	cg19708238	chr15:90437601	AP3S2	0.72	5.22	0.51	1.43e-6	Common traits (Other);
SKCM	cis	rs6540556	0.859	rs12079960	chr1:209937168	A/C	cg05527609	chr1:210001259	C1orf107	-0.91	-5.14	-0.5	1.97e-6	Red blood cell count;
SKCM	cis	rs1707322	0.789	rs7540578	chr1:46252144	C/T	cg03146154	chr1:46216737	IPP	0.81	5.91	0.56	8.57e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs5769765	0.908	rs9616370	chr22:50306316	A/G	cg22709217	chr22:50311962	ALG12;CRELD2	0.86	5.77	0.55	1.53e-7	Schizophrenia;
SKCM	cis	rs763014	0.838	rs4984670	chr16:641044	A/G	cg00908189	chr16:619842	PIGQ	0.83	7.65	0.65	4.53e-11	Height;
SKCM	cis	rs1401999	0.690	rs3805112	chr3:183645662	C/T	cg01324343	chr3:183735012	ABCC5	0.71	6.74	0.61	2.49e-9	Anterior chamber depth;
SKCM	cis	rs4911259	0.552	rs13037833	chr20:31459562	C/T	cg13636640	chr20:31349939	DNMT3B	-0.74	-6.15	-0.57	3.04e-8	Inflammatory bowel disease;
SKCM	cis	rs875971	0.545	rs6460281	chr7:65681115	A/C	cg18876405	chr7:65276391	NA	0.64	5.29	0.51	1.09e-6	Aortic root size;
SKCM	cis	rs7927771	0.839	rs3817334	chr11:47650993	C/T	cg05585544	chr11:47624801	NA	-0.63	-5.27	-0.51	1.19e-6	Subjective well-being;
SKCM	cis	rs17608059	0.504	rs11656981	chr17:13978777	A/G	cg27005118	chr17:13972210	COX10	-0.53	-6.11	-0.57	3.65e-8	Temperament;
SKCM	cis	rs709400	0.663	rs62007683	chr14:103894071	G/T	cg26031613	chr14:104095156	KLC1	0.69	5.11	0.5	2.23e-6	Body mass index;
SKCM	trans	rs2840044	0.554	rs225267	chr17:33964228	T/C	cg19694781	chr19:47549865	TMEM160	-1.08	-8.36	-0.69	1.88e-12	Response to radiotherapy in cancer (late toxicity);
SKCM	cis	rs769267	0.930	rs7254927	chr19:19404786	C/G	cg03709012	chr19:19516395	GATAD2A	0.82	6.73	0.61	2.6e-9	Tonsillectomy;
SKCM	cis	rs1153858	1.000	rs66939267	chr15:45676902	T/A	cg10760299	chr15:45669010	GATM	0.62	6.35	0.58	1.3e-8	Homoarginine levels;
SKCM	cis	rs12950390	0.776	rs4793646	chr17:45853966	A/C	cg03474202	chr17:45855739	NA	-0.49	-5.58	-0.53	3.34e-7	IgG glycosylation;
SKCM	cis	rs561341	1.000	rs111454793	chr17:30319267	T/C	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs58688157	0.705	rs11539530	chr11:609353	G/A	cg17114584	chr11:613792	IRF7	0.8	5.62	0.54	2.85e-7	Systemic lupus erythematosus;
SKCM	cis	rs826838	1.000	rs11183941	chr12:38851692	G/C	cg26384229	chr12:38710491	ALG10B	1.05	10.1	0.75	8.14e-16	Heart rate;
SKCM	cis	rs801193	0.935	rs3800820	chr7:66147178	C/T	cg18876405	chr7:65276391	NA	-0.8	-7.11	-0.63	4.86e-10	Aortic root size;
SKCM	cis	rs2120019	0.638	rs34492112	chr15:75294917	G/A	cg09165964	chr15:75287851	SCAMP5	0.92	11.19	0.78	6.93e-18	Blood trace element (Zn levels);
SKCM	cis	rs660498	1.000	rs660498	chr10:27740959	C/T	cg15286905	chr10:27530250	ACBD5	-0.55	-5.05	-0.5	2.85e-6	Asthma (childhood onset);
SKCM	cis	rs55728055	0.661	rs56411340	chr22:31984476	G/T	cg01338084	chr22:32026380	PISD	1.5	5.03	0.49	3.11e-6	Age-related hearing impairment;
SKCM	cis	rs35306767	0.953	rs12354639	chr10:963681	G/A	cg26597838	chr10:835615	NA	0.67	5.4	0.52	7e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs28386778	1.000	rs2955241	chr17:61968113	G/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.04	9.34	0.73	2.4e-14	Prudent dietary pattern;
SKCM	cis	rs34779708	0.733	rs12240638	chr10:35542610	G/T	cg03585969	chr10:35415529	CREM	0.74	5.42	0.52	6.41e-7	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs7937682	0.562	rs7938620	chr11:111366844	G/A	cg09085632	chr11:111637200	PPP2R1B	0.78	6.27	0.58	1.85e-8	Primary sclerosing cholangitis;
SKCM	cis	rs3784262	0.669	rs7178598	chr15:58309016	C/A	cg12031962	chr15:58353849	ALDH1A2	-0.41	-4.82	-0.48	6.93e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs11098499	0.663	rs9996501	chr4:120238918	C/A	cg09307838	chr4:120376055	NA	0.98	8.13	0.68	5.33e-12	Corneal astigmatism;
SKCM	cis	rs7666738	0.830	rs62321564	chr4:98976496	C/G	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9303401	0.659	rs12602389	chr17:56779778	G/A	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.35	0.52	8.54e-7	Cognitive test performance;
SKCM	cis	rs909674	0.524	rs5750821	chr22:39825492	A/T	cg24399712	chr22:39784796	NA	-0.59	-5.05	-0.5	2.88e-6	IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis);IgG glycosylation;IgG digalactosylation phenotypes (multivariate analysis);IgG sialylation phenotypes (multivariate analysis);IgG monogalactosylation phenotypes (multivariate analysis);IgG fucosylation phenotypes (multivariate analysis);IgG N-glycosylation phenotypes (multivariate analysis);IgG disialylation phenotypes (multivariate analysis);IgG galactosylation phenotypes (multivariate analysis);Post bronchodilator FEV1;
SKCM	cis	rs4820539	0.966	rs2157709	chr22:23457420	T/C	cg14186256	chr22:23484241	RTDR1	0.83	8.41	0.69	1.52e-12	Bone mineral density;
SKCM	cis	rs7584330	0.740	rs13425580	chr2:238447168	T/C	cg14458575	chr2:238380390	NA	0.79	5.09	0.5	2.38e-6	Prostate cancer;
SKCM	cis	rs8014204	0.901	rs4899536	chr14:75316614	A/G	cg06637938	chr14:75390232	RPS6KL1	-0.82	-6.63	-0.6	3.94e-9	Caffeine consumption;
SKCM	cis	rs28386778	0.897	rs2584601	chr17:61940977	T/C	cg26338869	chr17:61819248	STRADA	0.72	4.83	0.48	6.68e-6	Prudent dietary pattern;
SKCM	cis	rs7811142	0.779	rs111312383	chr7:99905325	C/T	cg00814883	chr7:100076585	TSC22D4	-0.84	-4.78	-0.48	8.01e-6	Platelet count;
SKCM	cis	rs2439831	0.681	rs484846	chr15:43600803	T/C	cg27015174	chr15:43622946	ADAL;LCMT2	0.87	4.81	0.48	7.13e-6	Lung cancer in ever smokers;
SKCM	cis	rs1799949	1.000	rs4793191	chr17:41204377	A/G	cg25918947	chr17:41365094	TMEM106A	-0.62	-5.89	-0.55	9.22e-8	Menopause (age at onset);
SKCM	cis	rs9790314	0.521	rs1450523	chr3:161077270	G/A	cg03342759	chr3:160939853	NMD3	-0.79	-6.94	-0.62	1.01e-9	Morning vs. evening chronotype;
SKCM	cis	rs7937682	0.632	rs4936834	chr11:111764017	T/A	cg09085632	chr11:111637200	PPP2R1B	1.1	10.72	0.77	5.29e-17	Primary sclerosing cholangitis;
SKCM	cis	rs6951245	0.744	rs10265758	chr7:1172518	C/T	cg23708337	chr7:1209742	NA	0.87	5.34	0.52	8.89e-7	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs77216612	0.835	rs10845621	chr12:12887977	C/T	cg04607235	chr12:12878440	APOLD1	-0.92	-6.84	-0.61	1.6e-9	Lymphocyte counts;
SKCM	cis	rs208520	0.690	rs12198297	chr6:66714665	G/A	cg07460842	chr6:66804631	NA	0.9	7.28	0.64	2.28e-10	Exhaled nitric oxide output;
SKCM	cis	rs10504229	1.000	rs111915672	chr8:58191665	T/C	cg22535103	chr8:58192502	C8orf71	-0.75	-5.24	-0.51	1.31e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs9880211	0.752	rs9847427	chr3:136351550	C/A	cg21827317	chr3:136751795	NA	-0.7	-5.26	-0.51	1.25e-6	Body mass index;Height;
SKCM	cis	rs7666738	0.830	rs2114425	chr4:99023967	T/C	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7809950	1.000	rs986994	chr7:107104115	G/T	cg23024343	chr7:107201750	COG5	-0.75	-6.81	-0.61	1.83e-9	Coronary artery disease;
SKCM	cis	rs9910055	0.593	rs58392387	chr17:42297889	A/G	cg10896456	chr17:42255109	ASB16;C17orf65	0.54	4.77	0.48	8.29e-6	Total body bone mineral density;
SKCM	cis	rs3820068	0.581	rs16851876	chr1:15950628	A/T	cg13390004	chr1:15929781	NA	-0.65	-5.16	-0.5	1.84e-6	Systolic blood pressure;
SKCM	cis	rs951366	0.789	rs1775154	chr1:205696615	T/A	cg26354017	chr1:205819088	PM20D1	1.01	8.85	0.71	2.09e-13	Menarche (age at onset);
SKCM	cis	rs10256972	0.528	rs7784607	chr7:1178694	A/G	cg07092213	chr7:1199455	ZFAND2A	-0.67	-5.24	-0.51	1.33e-6	Longevity;Endometriosis;
SKCM	cis	rs35306767	0.807	rs1013505	chr10:953273	C/T	cg20503657	chr10:835505	NA	0.77	5.25	0.51	1.27e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs6977660	0.941	rs10273208	chr7:19816371	T/C	cg05791153	chr7:19748676	TWISTNB	0.78	5.55	0.53	3.83e-7	Thyroid stimulating hormone;
SKCM	cis	rs11105298	0.891	rs10858890	chr12:89907166	A/G	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.9	-5.97	-0.56	6.75e-8	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs12611334	0.928	rs7248546	chr19:40191391	G/A	cg04998674	chr19:40596855	ZNF780A	0.63	4.77	0.47	8.55e-6	Schizophrenia;
SKCM	cis	rs1003719	0.788	rs4817844	chr21:38447064	A/T	cg10648535	chr21:38446584	PIGP;TTC3	-0.63	-5.02	-0.49	3.17e-6	Eye color traits;
SKCM	cis	rs4740619	0.619	rs4741559	chr9:16041982	G/A	cg14451791	chr9:16040625	NA	-0.47	-5.03	-0.49	3.07e-6	Body mass index;
SKCM	cis	rs1348850	0.914	rs7573763	chr2:178249808	C/T	cg02961200	chr2:178257176	LOC100130691;AGPS	0.94	7.09	0.63	5.29e-10	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs4819052	0.851	rs1056099	chr21:46678892	G/A	cg20896738	chr21:46707857	POFUT2;LOC642852	0.64	4.82	0.48	6.85e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs2197308	0.765	rs10880643	chr12:37926452	C/T	cg13010199	chr12:38710504	ALG10B	-0.64	-4.92	-0.49	4.67e-6	Morning vs. evening chronotype;
SKCM	cis	rs854765	0.583	rs7222480	chr17:17818817	G/T	cg04398451	chr17:18023971	MYO15A	-0.79	-5.68	-0.54	2.25e-7	Total body bone mineral density;
SKCM	cis	rs9583531	0.600	rs2119479	chr13:111371181	A/C	cg15841412	chr13:111365552	ING1	0.74	4.86	0.48	5.9e-6	Coronary artery disease;
SKCM	cis	rs6061231	0.724	rs1570027	chr20:60968596	A/G	cg24112000	chr20:60950667	NA	-0.65	-5.93	-0.56	7.94e-8	Colorectal cancer;
SKCM	cis	rs7659604	0.702	rs6826506	chr4:122710865	T/G	cg06713675	chr4:122721982	EXOSC9	-0.76	-7.28	-0.64	2.31e-10	Type 2 diabetes;
SKCM	cis	rs2239908	0.718	rs241776	chr17:26644308	C/T	cg27392559	chr17:27410759	MYO18A	0.55	4.88	0.48	5.57e-6	Blood protein levels;
SKCM	cis	rs11098499	0.779	rs10011097	chr4:120310359	T/G	cg24375607	chr4:120327624	NA	0.65	4.97	0.49	3.87e-6	Corneal astigmatism;
SKCM	cis	rs12824058	0.798	rs7968728	chr12:130804696	T/A	cg24838063	chr12:130822603	PIWIL1	0.78	6.78	0.61	2.04e-9	Menopause (age at onset);
SKCM	cis	rs4332037	0.539	rs11763750	chr7:2080114	G/A	cg23422044	chr7:1970798	MAD1L1	-0.91	-6.18	-0.57	2.67e-8	Bipolar disorder;
SKCM	cis	rs2019137	0.539	rs11123170	chr2:113978940	C/G	cg21550016	chr2:113992930	PAX8;LOC440839;LOC654433	0.64	5.02	0.49	3.19e-6	Lymphocyte counts;
SKCM	cis	rs6942756	1.000	rs10954226	chr7:128953095	T/G	cg02491457	chr7:128862824	NA	-0.82	-5.16	-0.5	1.81e-6	White matter hyperintensity burden;
SKCM	cis	rs9611565	0.659	rs4822035	chr22:41935912	A/G	cg03806693	chr22:41940476	POLR3H	1.09	7.27	0.64	2.4e-10	Vitiligo;
SKCM	cis	rs4619890	0.528	rs28600706	chr4:7876410	T/C	cg08722675	chr4:8412549	ACOX3	0.54	4.94	0.49	4.32e-6	Glaucoma (primary open-angle);
SKCM	cis	rs801193	0.548	rs2659891	chr7:66201114	A/G	cg11764359	chr7:65958608	NA	0.75	6.82	0.61	1.71e-9	Aortic root size;
SKCM	cis	rs684232	0.583	rs2657626	chr17:603052	A/G	cg12384639	chr17:618140	VPS53	0.68	5.33	0.52	9.45e-7	Prostate cancer;
SKCM	cis	rs12682352	0.715	rs332039	chr8:8723651	C/G	cg06636001	chr8:8085503	FLJ10661	0.7	5.94	0.56	7.4e-8	Neuroticism;
SKCM	cis	rs9682041	1.000	rs6773095	chr3:170082181	A/G	cg11886554	chr3:170076028	SKIL	0.93	5.5	0.53	4.62e-7	Glomerular filtration rate in non diabetics (creatinine);Glomerular filtration rate (creatinine);
SKCM	cis	rs3087591	0.960	rs2071009	chr17:29558082	T/C	cg24425628	chr17:29625626	OMG;NF1	-0.64	-5.22	-0.51	1.43e-6	Hip circumference;
SKCM	cis	rs2228479	0.850	rs2238532	chr16:89863672	T/C	cg06558623	chr16:89946397	TCF25	1.1	4.97	0.49	3.82e-6	Skin colour saturation;
SKCM	cis	rs6723226	0.842	rs2754522	chr2:32801257	C/G	cg02381751	chr2:32503542	YIPF4	0.9	6.16	0.57	3.01e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs4150161	0.591	rs3785036	chr16:84219810	T/G	cg10106505	chr16:84220380	TAF1C	-1.35	-5.42	-0.52	6.52e-7	Systolic blood pressure response to hydrochlorothiazide in hypertension;
SKCM	cis	rs9880211	0.613	rs1403763	chr3:135796240	C/G	cg21827317	chr3:136751795	NA	-0.7	-4.93	-0.49	4.45e-6	Body mass index;Height;
SKCM	cis	rs4954585	0.659	rs13018756	chr2:137008235	C/T	cg05194412	chr2:137003533	NA	0.55	4.83	0.48	6.74e-6	Colorectal cancer;
SKCM	cis	rs1348850	0.632	rs4470372	chr2:178505857	G/A	cg02961200	chr2:178257176	LOC100130691;AGPS	0.74	4.97	0.49	3.9e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs10256972	0.567	rs2949185	chr7:1209013	A/G	cg07092213	chr7:1199455	ZFAND2A	-0.67	-5.49	-0.53	4.79e-7	Longevity;Endometriosis;
SKCM	cis	rs9913156	0.789	rs72824951	chr17:4588500	G/C	cg19197139	chr17:4613644	ARRB2	0.8	5.32	0.52	9.73e-7	Lymphocyte counts;
SKCM	cis	rs9394841	0.585	rs9381096	chr6:41821137	C/T	cg08135965	chr6:41755394	TOMM6	0.81	5.14	0.5	2.01e-6	Mean corpuscular hemoglobin;Red cell distribution width;
SKCM	cis	rs55962025	0.883	rs362275	chr4:3224602	C/T	cg11471262	chr4:3318911	RGS12	-0.64	-4.92	-0.49	4.8e-6	Parental longevity (mother's age at death);
SKCM	cis	rs997295	0.570	rs737226	chr15:67840773	T/C	cg24247231	chr15:67904302	MAP2K5	-0.61	-5.01	-0.49	3.36e-6	Motion sickness;
SKCM	cis	rs2842992	0.830	rs1853259	chr6:160147441	A/G	cg19482086	chr6:160211437	TCP1;MRPL18	-0.81	-5.93	-0.56	8e-8	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs13118159	0.550	rs4974617	chr4:1373658	T/C	cg02475777	chr4:1388615	CRIPAK	0.85	5.8	0.55	1.36e-7	Longevity;
SKCM	cis	rs2204008	0.614	rs4578492	chr12:38036350	T/C	cg26384229	chr12:38710491	ALG10B	0.83	6.72	0.61	2.69e-9	Bladder cancer;
SKCM	cis	rs7000551	0.532	rs55726237	chr8:22252985	C/T	cg12081754	chr8:22256438	SLC39A14	1.01	10.54	0.77	1.18e-16	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs362272	0.524	rs881816	chr4:3365366	A/G	cg00764545	chr4:3318001	RGS12	1.01	13.28	0.83	1.02e-21	Serum sulfate level;
SKCM	cis	rs7811142	0.775	rs1059129	chr7:99926522	A/G	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.21	8.05	0.67	7.68e-12	Platelet count;
SKCM	cis	rs7584330	0.910	rs72620830	chr2:238396985	C/T	cg14458575	chr2:238380390	NA	0.97	6.37	0.58	1.23e-8	Prostate cancer;
SKCM	cis	rs2463822	1.000	rs7481995	chr11:62129312	G/C	cg06239285	chr11:62104954	ASRGL1	1.26	5.85	0.55	1.08e-7	Chronic obstructive pulmonary disease-related biomarkers;
SKCM	cis	rs10256972	0.568	rs1133043	chr7:1133305	C/G	cg09177884	chr7:1199841	ZFAND2A	-0.77	-6.36	-0.58	1.28e-8	Longevity;Endometriosis;
SKCM	cis	rs9916302	0.861	rs33933929	chr17:37426441	A/C	cg07936489	chr17:37558343	FBXL20	-0.84	-6.96	-0.62	9.48e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs7666738	0.830	rs34892904	chr4:98938097	T/C	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11892454	0.515	rs10168718	chr2:26053166	G/A	cg17263061	chr2:26915892	KCNK3	0.69	4.98	0.49	3.73e-6	Heschl's gyrus morphology;
SKCM	cis	rs60871478	0.898	rs67785403	chr7:787201	A/G	cg05535760	chr7:792225	HEATR2	1.15	9.71	0.74	4.47e-15	Cerebrospinal P-tau181p levels;
SKCM	cis	rs9611565	0.592	rs28750375	chr22:41990644	A/C	cg03806693	chr22:41940476	POLR3H	-1.1	-7.26	-0.64	2.51e-10	Vitiligo;
SKCM	cis	rs1577917	0.917	rs12202170	chr6:86590386	A/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.67	-5.85	-0.55	1.09e-7	Response to antipsychotic treatment;
SKCM	cis	rs6904897	0.563	rs6569976	chr6:135224753	A/C	cg22676075	chr6:135203613	NA	0.68	6.42	0.59	9.6e-9	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs17376456	0.825	rs36042718	chr5:93180997	C/T	cg21475434	chr5:93447410	FAM172A	0.95	5.31	0.51	1.02e-6	Diabetic retinopathy;
SKCM	cis	rs473651	0.935	rs508483	chr2:239339709	T/C	cg18131467	chr2:239335373	ASB1	1.09	13.23	0.83	1.27e-21	Multiple system atrophy;
SKCM	cis	rs875971	0.540	rs736270	chr7:65428822	T/C	cg00343986	chr7:65444356	GUSB	0.68	5.0	0.49	3.47e-6	Aortic root size;
SKCM	cis	rs7927771	0.832	rs11601603	chr11:47401171	A/C	cg05585544	chr11:47624801	NA	-0.58	-5.19	-0.51	1.61e-6	Subjective well-being;
SKCM	cis	rs2952156	0.652	rs11869286	chr17:37813856	C/G	cg00129232	chr17:37814104	STARD3	-0.78	-6.46	-0.59	8.09e-9	Asthma;
SKCM	cis	rs17345786	0.953	rs78645744	chr3:101327789	T/A	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.71	5.07	0.5	2.61e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9475752	0.947	rs17685185	chr6:56791605	C/G	cg06815302	chr6:57335405	PRIM2	0.64	5.25	0.51	1.29e-6	Menarche (age at onset);
SKCM	cis	rs2811415	0.531	rs9850146	chr3:127744122	G/T	cg09089421	chr3:127803668	RUVBL1	0.99	8.52	0.69	9.09e-13	Lung function (FEV1/FVC);
SKCM	cis	rs7124681	0.584	rs4752792	chr11:47815702	G/A	cg20307385	chr11:47447363	PSMC3	-0.72	-5.81	-0.55	1.31e-7	Body mass index (joint analysis main effects and physical activity interaction);Body mass index;Body mass index in physically active individuals;
SKCM	cis	rs523522	0.962	rs7488320	chr12:120981630	G/T	cg27279351	chr12:120934652	DYNLL1	0.91	8.32	0.69	2.26e-12	High light scatter reticulocyte count;
SKCM	cis	rs4343996	0.902	rs4336505	chr7:3373740	A/C	cg25153887	chr7:2442910	CHST12	-0.69	-4.87	-0.48	5.8e-6	Motion sickness;
SKCM	cis	rs1160297	0.609	rs78310136	chr2:53093171	G/A	cg07782112	chr2:53107842	NA	0.58	6.05	0.56	4.79e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs3780486	0.846	rs12554995	chr9:33132044	A/G	cg13443165	chr9:33130375	B4GALT1	-0.55	-4.99	-0.49	3.65e-6	IgG glycosylation;
SKCM	cis	rs473651	0.935	rs1103770	chr2:239339281	G/C	cg21699342	chr2:239360505	ASB1	0.55	5.29	0.51	1.07e-6	Multiple system atrophy;
SKCM	cis	rs6665290	0.904	rs2297416	chr1:227172935	C/G	cg10327440	chr1:227177885	CDC42BPA	-1.25	-16.25	-0.88	9.48e-27	Myeloid white cell count;
SKCM	cis	rs6840360	0.550	rs4696288	chr4:152621150	A/C	cg22705602	chr4:152727874	NA	-0.51	-5.49	-0.53	4.93e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs9443189	0.526	rs6902898	chr6:76201856	G/A	cg01950844	chr6:76311363	SENP6	0.9	5.32	0.52	9.74e-7	Prostate cancer;
SKCM	cis	rs2404602	0.692	rs35195096	chr15:76938447	C/T	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs7523050	0.643	rs12736534	chr1:109399934	T/C	cg08274380	chr1:109419600	GPSM2	1.13	5.57	0.53	3.54e-7	Fat distribution (HIV);
SKCM	cis	rs2658782	0.951	rs117384439	chr11:93111478	T/G	cg15737290	chr11:93063684	CCDC67	-0.73	-5.15	-0.5	1.94e-6	Pulmonary function decline;
SKCM	cis	rs2188420	0.872	rs77535932	chr7:106500867	G/T	cg23615938	chr7:105753134	SYPL1	-1.08	-5.61	-0.54	2.96e-7	Interferon gamma levels;
SKCM	cis	rs2842992	0.958	rs2758318	chr6:160069637	C/G	cg11366901	chr6:160182831	ACAT2	0.77	5.65	0.54	2.51e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs854765	0.583	rs4925129	chr17:17807186	A/G	cg04398451	chr17:18023971	MYO15A	-0.81	-5.52	-0.53	4.21e-7	Total body bone mineral density;
SKCM	cis	rs55962025	0.686	rs4690073	chr4:3160150	G/A	cg16987761	chr4:3318072	RGS12	-0.58	-4.9	-0.49	5.13e-6	Parental longevity (mother's age at death);
SKCM	cis	rs597205	0.881	rs11102345	chr1:112389307	A/G	cg22162010	chr1:113249994	RHOC	-0.84	-4.82	-0.48	7.04e-6	Gut microbiota (bacterial taxa);
SKCM	cis	rs748404	0.723	rs512431	chr15:43541939	C/G	cg02155558	chr15:43621948	ADAL;LCMT2	-0.68	-5.73	-0.54	1.78e-7	Lung cancer;
SKCM	cis	rs13256369	0.708	rs10903310	chr8:8589687	A/C	cg06636001	chr8:8085503	FLJ10661	-0.75	-5.24	-0.51	1.34e-6	Obesity-related traits;
SKCM	cis	rs2832191	0.655	rs2247110	chr21:30323888	G/A	cg08807101	chr21:30365312	RNF160	-0.76	-6.33	-0.58	1.45e-8	Dental caries;
SKCM	cis	rs116095464	0.558	rs2288457	chr5:231270	C/T	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs4481887	0.927	rs4244184	chr1:248486895	G/T	cg00666640	chr1:248458726	OR2T12	0.62	5.27	0.51	1.2e-6	Common traits (Other);
SKCM	cis	rs3820928	0.605	rs6718767	chr2:227800776	A/G	cg11843606	chr2:227700838	RHBDD1	-0.61	-4.8	-0.48	7.36e-6	Pulmonary function;
SKCM	cis	rs6598955	0.640	rs6667826	chr1:26531408	T/C	cg00938395	chr1:26633206	UBXN11	0.7	4.97	0.49	3.94e-6	Obesity-related traits;
SKCM	cis	rs60871478	0.636	rs4719520	chr7:875216	C/G	cg05535760	chr7:792225	HEATR2	-1.3	-7.8	-0.66	2.27e-11	Cerebrospinal P-tau181p levels;
SKCM	cis	rs7953508	0.711	rs10492321	chr12:93980088	T/A	cg18151635	chr12:93972918	NA	-0.73	-6.41	-0.59	1.02e-8	Pubertal anthropometrics;
SKCM	cis	rs7020830	0.830	rs308499	chr9:37348059	C/G	cg14294708	chr9:37120828	ZCCHC7	0.99	9.38	0.73	1.97e-14	Schizophrenia;
SKCM	cis	rs1865760	0.622	rs10946807	chr6:26079638	T/C	cg16482183	chr6:26056742	HIST1H1C	0.67	5.45	0.53	5.68e-7	Height;
SKCM	cis	rs3892630	0.500	rs6510301	chr19:33359791	A/T	cg22980127	chr19:33182716	NUDT19	0.85	4.89	0.48	5.32e-6	Red blood cell traits;
SKCM	cis	rs9583531	0.600	rs3809344	chr13:111358705	G/A	cg24331049	chr13:111365604	ING1	0.88	6.6	0.6	4.45e-9	Coronary artery disease;
SKCM	cis	rs11785400	0.963	rs4579507	chr8:143733663	C/G	cg20003893	chr8:144489567	NA	-0.55	-4.81	-0.48	7.23e-6	Schizophrenia;
SKCM	cis	rs12142240	0.698	rs56344958	chr1:46814518	G/A	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs9611565	0.512	rs715498	chr22:42148467	G/A	cg03806693	chr22:41940476	POLR3H	1.11	6.13	0.57	3.35e-8	Vitiligo;
SKCM	cis	rs875971	1.000	rs6958484	chr7:65599446	G/A	cg11764359	chr7:65958608	NA	-0.86	-8.23	-0.68	3.44e-12	Aortic root size;
SKCM	cis	rs2811415	0.597	rs9814296	chr3:127732028	G/A	cg09089421	chr3:127803668	RUVBL1	1.0	8.57	0.7	7.53e-13	Lung function (FEV1/FVC);
SKCM	cis	rs12477438	0.520	rs2516830	chr2:99773702	T/G	cg26064155	chr2:99771622	LIPT1;TSGA10	1.03	9.69	0.74	5.05e-15	Chronic sinus infection;
SKCM	cis	rs7940866	0.804	rs3910266	chr11:130814272	A/C	cg12179176	chr11:130786555	SNX19	0.76	6.04	0.56	4.89e-8	Schizophrenia;
SKCM	cis	rs875971	0.638	rs801216	chr7:66011667	T/C	cg11764359	chr7:65958608	NA	-0.86	-6.6	-0.6	4.52e-9	Aortic root size;
SKCM	cis	rs7954584	0.567	rs11043233	chr12:122330733	C/T	cg21171335	chr12:122356390	WDR66	0.46	5.02	0.49	3.24e-6	Mean corpuscular volume;
SKCM	cis	rs763014	0.931	rs56048717	chr16:634867	A/G	cg07343612	chr16:622815	PIGQ	-0.7	-6.0	-0.56	5.84e-8	Height;
SKCM	cis	rs9443189	0.774	rs2647405	chr6:76450023	C/T	cg01950844	chr6:76311363	SENP6	-0.77	-5.31	-0.52	9.96e-7	Prostate cancer;
SKCM	cis	rs13118159	0.509	rs4974554	chr4:1356967	A/C	cg16405210	chr4:1374714	KIAA1530	-0.94	-7.07	-0.62	5.87e-10	Longevity;
SKCM	cis	rs7772486	0.754	rs9399567	chr6:146147295	C/T	cg23711669	chr6:146136114	FBXO30	0.87	9.66	0.74	5.79e-15	Lobe attachment (rater-scored or self-reported);
SKCM	trans	rs312274	0.588	rs4768312	chr12:41236642	T/C	cg13470333	chr7:1908714	MAD1L1	0.65	7.3	0.64	2.07e-10	Metabolite levels  (X-11787);
SKCM	trans	rs1814175	0.588	rs4076322	chr11:49745094	G/A	cg03929089	chr4:120376271	NA	-0.85	-7.61	-0.65	5.27e-11	Height;
SKCM	cis	rs2239547	0.657	rs7638524	chr3:52874861	G/A	cg11645453	chr3:52864694	ITIH4	0.79	7.19	0.63	3.41e-10	Schizophrenia;
SKCM	cis	rs7666738	0.830	rs6829567	chr4:99047340	T/C	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs910316	0.763	rs12588981	chr14:75460561	A/G	cg08847533	chr14:75593920	NEK9	0.82	7.06	0.62	6.19e-10	Height;
SKCM	cis	rs2839186	0.786	rs7409792	chr21:47691729	C/A	cg13126279	chr21:47581558	C21orf56	-0.62	-5.31	-0.52	1.02e-6	Testicular germ cell tumor;
SKCM	cis	rs60871478	0.945	rs4719279	chr7:813618	T/C	cg05535760	chr7:792225	HEATR2	1.03	8.77	0.7	3.02e-13	Cerebrospinal P-tau181p levels;
SKCM	cis	rs12188164	0.543	rs2434694	chr5:462734	C/T	cg26076054	chr5:421317	AHRR	0.62	5.47	0.53	5.27e-7	Cystic fibrosis severity;
SKCM	cis	rs35306767	0.903	rs11253485	chr10:919362	C/T	cg20503657	chr10:835505	NA	0.77	5.32	0.52	9.76e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs28595532	0.841	rs55823625	chr4:119780600	T/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs860295	0.702	rs10796943	chr1:155414729	T/C	cg02153340	chr1:155202674	NA	-0.75	-5.35	-0.52	8.38e-7	Body mass index;
SKCM	cis	rs11690935	0.959	rs7562356	chr2:172626611	C/G	cg13550731	chr2:172543902	DYNC1I2	-0.94	-7.99	-0.67	9.97e-12	Schizophrenia;
SKCM	cis	rs459571	0.839	rs10993895	chr9:136887726	C/T	cg13789015	chr9:136890014	NCRNA00094	-0.76	-6.56	-0.6	5.35e-9	Platelet distribution width;
SKCM	cis	rs6933660	0.760	rs3806982	chr6:151774916	G/A	cg02564969	chr6:151773285	C6orf211;RMND1	0.61	4.88	0.48	5.49e-6	Menarche (age at onset);
SKCM	cis	rs6840360	0.571	rs1822347	chr4:152525319	A/G	cg22705602	chr4:152727874	NA	-0.52	-5.69	-0.54	2.15e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7927771	0.524	rs10838784	chr11:47882341	G/A	cg20307385	chr11:47447363	PSMC3	0.71	5.65	0.54	2.55e-7	Subjective well-being;
SKCM	cis	rs1218582	0.772	rs4845694	chr1:154911651	C/G	cg03351412	chr1:154909251	PMVK	0.76	6.45	0.59	8.5e-9	Prostate cancer;
SKCM	cis	rs72634258	0.945	rs7539255	chr1:8133352	T/C	cg00042356	chr1:8021962	PARK7	1.09	7.62	0.65	5.13e-11	Inflammatory bowel disease;
SKCM	cis	rs7666738	0.830	rs9992391	chr4:98916052	G/A	cg05340658	chr4:99064831	C4orf37	0.6	4.83	0.48	6.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs17685	0.712	rs60232511	chr7:75800082	A/G	cg16684958	chr7:75615977	POR	0.53	5.3	0.51	1.06e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs9457247	0.602	rs9459854	chr6:167465882	C/T	cg13927040	chr6:167453801	FGFR1OP	0.67	4.81	0.48	7.25e-6	Crohn's disease;
SKCM	cis	rs4243830	0.850	rs11122043	chr1:6580429	C/T	cg22792644	chr1:6614718	TAS1R1;NOL9	-1.02	-4.95	-0.49	4.16e-6	Body mass index;
SKCM	cis	rs854765	0.647	rs854809	chr17:18006539	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.83	6.5	0.59	6.85e-9	Total body bone mineral density;
SKCM	cis	rs4481887	1.000	rs6659039	chr1:248465689	C/T	cg00666640	chr1:248458726	OR2T12	0.59	4.98	0.49	3.72e-6	Common traits (Other);
SKCM	cis	rs1348850	0.574	rs11691740	chr2:178445161	A/G	cg05310760	chr2:178500282	PDE11A	0.62	5.1	0.5	2.34e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs5769765	0.773	rs138861	chr22:50202276	A/G	cg22709217	chr22:50311962	ALG12;CRELD2	-0.83	-5.8	-0.55	1.36e-7	Schizophrenia;
SKCM	cis	rs875971	0.862	rs801195	chr7:66026115	A/G	cg18876405	chr7:65276391	NA	-0.61	-6.03	-0.56	5.23e-8	Aortic root size;
SKCM	cis	rs7945705	0.818	rs4929916	chr11:8824996	C/T	cg21881798	chr11:8931708	C11orf17;ST5	0.61	5.65	0.54	2.46e-7	Hemoglobin concentration;
SKCM	cis	rs11122272	0.705	rs2486731	chr1:231532511	C/T	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	0.58	4.79	0.48	7.93e-6	Hemoglobin concentration;
SKCM	cis	rs9549367	0.713	rs3024764	chr13:113824314	A/G	cg18105134	chr13:113819100	PROZ	-0.88	-6.69	-0.6	3e-9	Platelet distribution width;
SKCM	cis	rs4665809	0.590	rs35656275	chr2:26494695	G/C	cg26119090	chr2:26468346	HADHA;HADHB	1.08	8.63	0.7	5.67e-13	Gut microbiome composition (summer);
SKCM	cis	rs4077515	0.874	rs3812560	chr9:139269905	T/C	cg14169450	chr9:139327907	INPP5E	0.48	5.41	0.52	6.71e-7	Ulcerative colitis;IgA nephropathy;Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs1799949	1.000	rs915945	chr17:41179864	C/T	cg05368731	chr17:41323189	NBR1	0.86	7.39	0.64	1.39e-10	Menopause (age at onset);
SKCM	cis	rs7666738	0.830	rs79075162	chr4:98960674	A/T	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs736408	0.812	rs2270197	chr3:52824095	T/G	cg18404041	chr3:52824283	ITIH1	-0.66	-6.05	-0.57	4.71e-8	Bipolar disorder;
SKCM	cis	rs28386778	0.830	rs2597636	chr17:61876010	A/G	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs1707322	0.721	rs10789470	chr1:46158331	T/G	cg03146154	chr1:46216737	IPP	0.84	6.2	0.57	2.51e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs9394841	0.692	rs56215622	chr6:41892457	G/A	cg08135965	chr6:41755394	TOMM6	0.76	4.92	0.49	4.7e-6	Mean corpuscular hemoglobin;Red cell distribution width;
SKCM	trans	rs11722228	0.522	rs73212817	chr4:10064011	T/C	cg26043149	chr18:55253948	FECH	0.91	7.48	0.65	9.63e-11	Gout;Urate levels;Serum uric acid levels;
SKCM	cis	rs875971	0.638	rs801216	chr7:66011667	T/C	cg00343986	chr7:65444356	GUSB	-0.7	-5.14	-0.5	1.98e-6	Aortic root size;
SKCM	cis	rs1062177	1.000	rs62394155	chr5:151248069	G/A	cg00977110	chr5:151150581	G3BP1	0.85	6.44	0.59	9.14e-9	Preschool internalizing problems;
SKCM	cis	rs2153535	0.580	rs6597325	chr6:8461053	A/C	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs11098499	0.779	rs10016060	chr4:120298412	A/G	cg09307838	chr4:120376055	NA	0.97	7.49	0.65	9.08e-11	Corneal astigmatism;
SKCM	cis	rs12474201	0.925	rs17822294	chr2:46960004	G/A	cg06386533	chr2:46925753	SOCS5	1.03	9.82	0.74	2.8e-15	Height;
SKCM	cis	rs6500395	1.000	rs9931123	chr16:48614293	G/T	cg04672837	chr16:48644449	N4BP1	0.69	5.88	0.55	9.68e-8	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs9916302	0.904	rs9898170	chr17:37510092	T/C	cg07936489	chr17:37558343	FBXL20	0.82	7.18	0.63	3.61e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs12497850	0.931	rs7643368	chr3:48992855	T/G	cg07636037	chr3:49044803	WDR6	1.02	11.0	0.78	1.56e-17	Parkinson's disease;
SKCM	cis	rs7666738	0.830	rs6825211	chr4:98807698	A/T	cg17366294	chr4:99064904	C4orf37	0.57	4.86	0.48	6.02e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2180341	0.924	rs6930849	chr6:127630963	A/T	cg27446573	chr6:127587934	RNF146	1.01	8.78	0.7	2.93e-13	Breast cancer;
SKCM	cis	rs2857078	0.732	rs9893756	chr17:42321109	T/C	cg19774624	chr17:42201019	HDAC5	0.75	5.35	0.52	8.65e-7	Red cell distribution width;Reticulocyte count;
SKCM	cis	rs2204008	0.729	rs114133083	chr12:38182923	G/C	cg26384229	chr12:38710491	ALG10B	-0.67	-5.47	-0.53	5.23e-7	Bladder cancer;
SKCM	cis	rs28595532	0.688	rs116580819	chr4:119767362	T/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs7666738	0.830	rs13121558	chr4:99002848	G/A	cg17366294	chr4:99064904	C4orf37	0.61	4.94	0.49	4.41e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2153535	0.580	rs7755284	chr6:8457479	T/C	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs2354432	0.607	rs3820130	chr1:146724003	A/G	cg25205988	chr1:146714368	CHD1L	-1.1	-6.4	-0.59	1.07e-8	Mitochondrial DNA levels;
SKCM	cis	rs861020	0.959	rs658860	chr1:209990549	C/T	cg09163369	chr1:210001066	C1orf107	0.75	4.86	0.48	5.86e-6	Orofacial clefts;
SKCM	cis	rs7843479	1.000	rs727694	chr8:21849962	T/C	cg17168535	chr8:21777572	XPO7	0.72	5.71	0.54	1.99e-7	Mean corpuscular volume;
SKCM	cis	rs4072980	0.545	rs12120737	chr1:38422544	C/T	cg12658694	chr1:38397304	INPP5B	0.62	5.05	0.5	2.87e-6	Coronary artery disease;
SKCM	cis	rs2658782	0.951	rs72972357	chr11:93118840	T/C	cg15737290	chr11:93063684	CCDC67	-0.71	-4.92	-0.49	4.64e-6	Pulmonary function decline;
SKCM	cis	rs3784262	0.739	rs1530293	chr15:58210398	G/A	cg12031962	chr15:58353849	ALDH1A2	-0.45	-4.81	-0.48	7.28e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs2836974	0.897	rs6517513	chr21:40526878	A/G	cg11644478	chr21:40555479	PSMG1	0.97	10.21	0.76	5.08e-16	Cognitive function;
SKCM	cis	rs875971	0.862	rs10950043	chr7:65988610	T/C	cg18876405	chr7:65276391	NA	0.61	6.06	0.57	4.57e-8	Aortic root size;
SKCM	cis	rs3008870	1.000	rs1925411	chr1:67370292	C/T	cg08660285	chr1:67390436	MIER1;WDR78	0.97	6.52	0.59	6.39e-9	Lymphocyte percentage of white cells;
SKCM	cis	rs748404	0.631	rs6493083	chr15:43637985	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	0.82	6.4	0.59	1.07e-8	Lung cancer;
SKCM	cis	rs1707322	1.000	rs11211239	chr1:46451947	A/G	cg03146154	chr1:46216737	IPP	0.79	5.34	0.52	8.73e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs6840360	0.571	rs4696270	chr4:152498289	G/A	cg22705602	chr4:152727874	NA	-0.52	-5.64	-0.54	2.65e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7208859	0.623	rs73269916	chr17:29096326	A/G	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs8180040	0.966	rs13059519	chr3:47539969	C/T	cg16586182	chr3:47516702	SCAP	-0.76	-5.32	-0.52	9.63e-7	Colorectal cancer;
SKCM	cis	rs9611565	0.546	rs2092274	chr22:42123737	A/G	cg03806693	chr22:41940476	POLR3H	1.08	6.67	0.6	3.27e-9	Vitiligo;
SKCM	cis	rs6570726	0.791	rs407887	chr6:145843759	C/T	cg23711669	chr6:146136114	FBXO30	0.81	8.22	0.68	3.49e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs394563	0.775	rs420430	chr6:149785539	T/G	cg03678062	chr6:149772716	ZC3H12D	-0.48	-4.96	-0.49	4.11e-6	Dupuytren's disease;
SKCM	cis	rs7180079	0.620	rs11071815	chr15:65089346	T/G	cg10949862	chr15:64387625	SNX1;FAM96A	0.95	5.0	0.49	3.47e-6	Monocyte count;
SKCM	cis	rs28595532	0.920	rs114639588	chr4:119736176	T/C	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs67311347	1.000	rs4246666	chr3:40407670	C/T	cg00091569	chr3:40428383	ENTPD3	0.61	5.36	0.52	8.37e-7	Renal cell carcinoma;
SKCM	cis	rs1878931	0.535	rs7188903	chr16:3412861	A/G	cg26668626	chr16:3451006	ZNF174;ZNF434	0.76	5.42	0.52	6.37e-7	Body mass index (adult);
SKCM	cis	rs1577917	0.958	rs6454488	chr6:86450842	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.6	-5.1	-0.5	2.3e-6	Response to antipsychotic treatment;
SKCM	cis	rs11098499	0.954	rs13133522	chr4:120324424	A/T	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs1506636	1.000	rs2429617	chr7:123418027	A/G	cg03229431	chr7:123269106	ASB15	0.66	5.29	0.51	1.1e-6	Plateletcrit;Platelet count;
SKCM	cis	rs4560672	0.938	rs1358940	chr6:158526581	C/T	cg10592926	chr6:157876961	ZDHHC14	-0.53	-4.99	-0.49	3.61e-6	Smoking quantity;
SKCM	cis	rs1559088	0.545	rs7257431	chr19:33566924	A/G	cg17764715	chr19:33622953	WDR88	0.92	6.76	0.61	2.24e-9	Bone ultrasound measurement (broadband ultrasound attenuation);
SKCM	cis	rs60871478	0.735	rs4721501	chr7:862166	G/T	cg05535760	chr7:792225	HEATR2	-1.1	-7.28	-0.64	2.27e-10	Cerebrospinal P-tau181p levels;
SKCM	cis	rs7927771	0.864	rs55927797	chr11:47446292	A/T	cg01152729	chr11:47593274	PTPMT1	-0.51	-4.88	-0.48	5.49e-6	Subjective well-being;
SKCM	cis	rs55962025	0.711	rs3856973	chr4:3080173	A/G	cg00764545	chr4:3318001	RGS12	0.58	4.97	0.49	3.88e-6	Parental longevity (mother's age at death);
SKCM	cis	rs34779708	0.897	rs7897827	chr10:35386237	C/T	cg03585969	chr10:35415529	CREM	0.79	6.32	0.58	1.47e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs9911578	1.000	rs2611782	chr17:56717956	T/C	cg12560992	chr17:57184187	TRIM37	0.95	7.69	0.66	3.7e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs7829975	0.511	rs1543238	chr8:8134809	A/G	cg08975724	chr8:8085496	FLJ10661	0.76	6.62	0.6	4.08e-9	Mood instability;
SKCM	cis	rs6547741	1.000	rs11127071	chr2:27838058	C/A	cg27432699	chr2:27873401	GPN1	0.75	6.74	0.61	2.44e-9	Oral cavity cancer;
SKCM	cis	rs873946	0.504	rs4880275	chr10:134576552	C/T	cg27286337	chr10:134555280	INPP5A	1.01	9.07	0.72	7.74e-14	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs7937682	0.575	rs12808601	chr11:111776066	G/A	cg09085632	chr11:111637200	PPP2R1B	1.09	10.45	0.76	1.7e-16	Primary sclerosing cholangitis;
SKCM	cis	rs514406	0.679	rs499239	chr1:53310594	A/G	cg04310824	chr1:53393297	SCP2	-0.61	-4.79	-0.48	7.9e-6	Monocyte count;
SKCM	cis	rs7772486	0.875	rs1331639	chr6:146431869	A/G	cg05347473	chr6:146136440	FBXO30	-0.56	-5.34	-0.52	9.03e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1912528	0.963	rs56172573	chr4:140919381	T/C	cg11128457	chr4:140864437	MAML3	0.58	4.9	0.49	5e-6	Educational attainment (years of education);
SKCM	trans	rs7618501	0.932	rs4855850	chr3:49761571	G/A	cg21659725	chr3:3221576	CRBN	-0.96	-9.61	-0.74	7.08e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs870825	0.616	rs745656	chr4:185637523	C/T	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs3768617	0.528	rs4652778	chr1:183097420	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.69	0.66	3.68e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs7843479	0.601	rs10453141	chr8:21847235	T/C	cg17168535	chr8:21777572	XPO7	0.8	7.43	0.64	1.2e-10	Mean corpuscular volume;
SKCM	cis	rs11122272	0.766	rs1435166	chr1:231502310	T/C	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	-0.63	-5.17	-0.51	1.76e-6	Hemoglobin concentration;
SKCM	cis	rs12711979	0.509	rs10195596	chr2:3824222	T/G	cg17052675	chr2:3827356	NA	-0.82	-8.9	-0.71	1.66e-13	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs7666738	0.830	rs7659593	chr4:98934823	T/C	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6879260	0.963	rs11738924	chr5:179727308	A/G	cg23248424	chr5:179741104	GFPT2	-0.76	-5.94	-0.56	7.42e-8	Height;
SKCM	cis	rs7584330	0.826	rs7604315	chr2:238381729	C/G	cg14458575	chr2:238380390	NA	1.06	6.66	0.6	3.47e-9	Prostate cancer;
SKCM	cis	rs3096299	0.503	rs9940093	chr16:89558705	G/A	cg02187348	chr16:89574699	SPG7	0.65	5.22	0.51	1.44e-6	Multiple myeloma (IgH translocation);
SKCM	cis	rs763121	0.853	rs2281019	chr22:39064378	T/A	cg06022373	chr22:39101656	GTPBP1	0.78	5.63	0.54	2.7e-7	Menopause (age at onset);
SKCM	cis	rs28386778	0.897	rs2044125	chr17:61863184	A/C	cg01411255	chr17:61851458	DDX42;CCDC47	-0.75	-4.83	-0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs9394841	0.692	rs13193235	chr6:41792659	T/C	cg08135965	chr6:41755394	TOMM6	0.74	4.88	0.48	5.45e-6	Mean corpuscular hemoglobin;Red cell distribution width;
SKCM	cis	rs763014	0.865	rs8675	chr16:633843	A/G	cg07343612	chr16:622815	PIGQ	-0.7	-6.0	-0.56	5.84e-8	Height;
SKCM	cis	rs2120019	0.608	rs8042558	chr15:75320433	G/T	cg17294928	chr15:75287854	SCAMP5	-0.88	-8.84	-0.71	2.17e-13	Blood trace element (Zn levels);
SKCM	cis	rs34779708	0.966	rs10508816	chr10:35459976	G/A	cg03585969	chr10:35415529	CREM	0.77	6.05	0.57	4.67e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs11098499	0.615	rs28850368	chr4:120554313	G/A	cg09307838	chr4:120376055	NA	0.94	7.77	0.66	2.64e-11	Corneal astigmatism;
SKCM	cis	rs9902453	0.740	rs1382391	chr17:28111986	G/T	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.78	-5.93	-0.56	7.93e-8	Coffee consumption (cups per day);
SKCM	cis	rs10883723	0.810	rs7090276	chr10:104281239	G/T	cg11453585	chr10:104263688	ACTR1A;SUFU	0.77	6.31	0.58	1.56e-8	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs7666738	0.830	rs10031751	chr4:98939134	G/A	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7617480	0.549	rs9879978	chr3:48846600	T/G	cg07636037	chr3:49044803	WDR6	0.92	6.81	0.61	1.82e-9	Subjective well-being (multi-trait analysis);Menarche (age at onset);
SKCM	cis	rs919433	0.817	rs10931780	chr2:198175297	G/C	cg04278110	chr2:198063759	ANKRD44	-0.7	-5.12	-0.5	2.14e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs72781680	0.898	rs72781639	chr2:24204148	C/G	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	cis	rs6087771	0.926	rs6058431	chr20:30297133	C/T	cg11595048	chr20:30225325	COX4I2	0.54	4.77	0.48	8.4e-6	Subcortical brain region volumes;Putamen volume;
SKCM	cis	rs4888262	0.526	rs7201105	chr16:74590603	A/G	cg01733217	chr16:74700730	RFWD3	0.86	6.88	0.61	1.36e-9	Testicular germ cell tumor;
SKCM	cis	rs9581857	0.579	rs77509251	chr13:27959981	G/A	cg22138327	chr13:27999177	GTF3A	0.93	5.39	0.52	7.18e-7	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs4975616	0.836	rs13178866	chr5:1323212	C/T	cg26373071	chr5:1325741	CLPTM1L	0.74	6.91	0.62	1.18e-9	Lung cancer;
SKCM	cis	rs66573146	0.831	rs67315413	chr4:6987910	T/C	cg00086871	chr4:6988644	TBC1D14	1.29	5.03	0.5	3.04e-6	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs3771570	0.901	rs35496488	chr2:242434316	G/A	cg07612300	chr2:242033426	MTERFD2;SNED1	0.89	4.98	0.49	3.78e-6	Prostate cancer;
SKCM	cis	rs9894429	1.000	rs9747349	chr17:79584297	C/T	cg18240062	chr17:79603768	NPLOC4	0.76	7.43	0.64	1.2e-10	Eye color traits;
SKCM	cis	rs6500395	0.890	rs9936445	chr16:48617754	T/G	cg04672837	chr16:48644449	N4BP1	0.69	5.88	0.55	9.68e-8	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs995000	0.868	rs1168113	chr1:63156098	T/C	cg06896770	chr1:63153194	DOCK7	-0.7	-6.03	-0.56	5.25e-8	Triglyceride levels;
SKCM	cis	rs362272	0.525	rs2857849	chr4:3043638	A/T	cg00764545	chr4:3318001	RGS12	0.57	4.78	0.48	8.22e-6	Serum sulfate level;
SKCM	cis	rs6582630	0.555	rs1906260	chr12:38601013	T/G	cg13010199	chr12:38710504	ALG10B	0.64	4.85	0.48	6.15e-6	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs1348850	0.668	rs2365619	chr2:178497366	A/G	cg27490568	chr2:178487706	NA	-0.9	-6.57	-0.6	5.2e-9	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs801193	1.000	rs11773829	chr7:66141074	G/A	cg18876405	chr7:65276391	NA	-0.8	-7.11	-0.63	4.86e-10	Aortic root size;
SKCM	cis	rs6951245	0.882	rs10256720	chr7:1210825	C/G	cg23708337	chr7:1209742	NA	0.89	4.82	0.48	7.06e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs9926296	0.682	rs467357	chr16:89717397	A/G	cg01097406	chr16:89675127	NA	0.56	5.66	0.54	2.41e-7	Vitiligo;
SKCM	cis	rs10489202	1.000	rs4657727	chr1:167965241	T/C	cg24449463	chr1:168025552	DCAF6	-0.78	-5.84	-0.55	1.15e-7	Schizophrenia;
SKCM	cis	rs2404602	0.684	rs4886816	chr15:76874707	A/C	cg23625390	chr15:77176239	SCAPER	-0.82	-7.93	-0.67	1.26e-11	Blood metabolite levels;
SKCM	cis	rs9467773	0.596	rs3001369	chr6:26670969	C/T	cg15659132	chr6:26577336	NA	0.61	5.35	0.52	8.44e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs2304069	0.954	rs10068537	chr5:149403193	G/A	cg22760475	chr5:149380129	HMGXB3;TIGD6	0.8	5.95	0.56	7.11e-8	HIV-1 control;
SKCM	cis	rs9911578	0.967	rs9894274	chr17:56977919	G/A	cg05425664	chr17:57184151	TRIM37	-0.67	-5.04	-0.5	2.91e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2153535	0.580	rs6929206	chr6:8447961	A/G	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs1957429	0.808	rs4899150	chr14:65344400	A/G	cg23373153	chr14:65346875	NA	1.05	5.87	0.55	1.02e-7	Pediatric areal bone mineral density (radius);
SKCM	cis	rs10504229	0.906	rs59336968	chr8:58176857	T/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs7811142	0.775	rs1636980	chr7:99938864	A/G	cg07160278	chr7:100027354	MEPCE;ZCWPW1	-1.07	-6.78	-0.61	2.04e-9	Platelet count;
SKCM	cis	rs6120849	0.901	rs6088739	chr20:33748724	G/A	cg24642439	chr20:33292090	TP53INP2	0.95	5.17	0.51	1.74e-6	Protein C levels;
SKCM	cis	rs4332037	0.539	rs55790766	chr7:2021248	C/T	cg23422044	chr7:1970798	MAD1L1	-0.9	-5.68	-0.54	2.24e-7	Bipolar disorder;
SKCM	cis	rs11098499	0.575	rs907205	chr4:120238664	G/C	cg09307838	chr4:120376055	NA	0.93	7.56	0.65	6.5500000000000006e-11	Corneal astigmatism;
SKCM	cis	rs684232	0.583	rs2543776	chr17:557149	G/A	cg15660573	chr17:549704	VPS53	-0.71	-5.69	-0.54	2.17e-7	Prostate cancer;
SKCM	cis	rs2842992	0.830	rs1998365	chr6:160179535	A/T	cg16489826	chr6:160211363	TCP1;MRPL18	0.73	5.42	0.52	6.39e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs8014204	0.806	rs11159104	chr14:75293374	A/G	cg06637938	chr14:75390232	RPS6KL1	0.83	6.66	0.6	3.52e-9	Caffeine consumption;
SKCM	cis	rs60871478	0.679	rs62432204	chr7:758283	T/C	cg13798912	chr7:905769	UNC84A	0.74	4.94	0.49	4.39e-6	Cerebrospinal P-tau181p levels;
SKCM	cis	rs12709013	0.792	rs12596434	chr16:58826213	G/C	cg02431531	chr16:59244939	NA	0.48	4.99	0.49	3.62e-6	Blood metabolite ratios;
SKCM	cis	rs8077889	0.871	rs16940243	chr17:41900003	C/G	cg26893861	chr17:41843967	DUSP3	1.2	7.85	0.66	1.82e-11	Triglycerides;
SKCM	cis	rs72772090	0.708	rs17082200	chr5:96048604	T/C	cg17330273	chr5:96107758	CAST;ERAP1	-0.84	-5.06	-0.5	2.77e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs875971	0.798	rs7789615	chr7:65878661	A/G	cg11764359	chr7:65958608	NA	0.74	6.67	0.6	3.3e-9	Aortic root size;
SKCM	trans	rs1814175	0.935	rs7479914	chr11:49661351	T/C	cg15704280	chr7:45808275	SEPT13	-1.0	-9.38	-0.73	1.99e-14	Height;
SKCM	cis	rs72781680	0.848	rs6748727	chr2:24041058	G/A	cg08917208	chr2:24149416	ATAD2B	1.0	4.97	0.49	3.82e-6	Lymphocyte counts;
SKCM	cis	rs1850744	0.702	rs13104360	chr4:9684804	C/A	cg15442990	chr4:9534313	NA	1.1	4.86	0.48	5.98e-6	Economic and political preferences;
SKCM	cis	rs2963155	0.518	rs862489	chr5:142634355	T/C	cg17617527	chr5:142782415	NR3C1	1.13	5.42	0.52	6.46e-7	Breast cancer;
SKCM	cis	rs1419980	0.673	rs12146828	chr12:7739341	C/G	cg10578777	chr12:7781093	NA	-0.68	-4.96	-0.49	4.02e-6	HDL cholesterol levels;
SKCM	cis	rs58688157	0.705	rs12290989	chr11:615010	G/T	cg17114584	chr11:613792	IRF7	0.74	5.0	0.49	3.51e-6	Systemic lupus erythematosus;
SKCM	cis	rs116095464	1.000	rs56235400	chr5:312625	G/A	cg22857025	chr5:266934	NA	-1.64	-6.14	-0.57	3.18e-8	Breast cancer;
SKCM	cis	rs7927771	0.832	rs10838704	chr11:47424717	T/C	cg05585544	chr11:47624801	NA	-0.61	-5.4	-0.52	7.09e-7	Subjective well-being;
SKCM	cis	rs9640161	0.750	rs3735173	chr7:150020526	C/T	cg10018233	chr7:150070692	REPIN1	0.75	6.05	0.56	4.81e-8	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs2952156	0.883	rs907089	chr17:37833600	C/T	cg20243544	chr17:37824526	PNMT	0.69	5.76	0.55	1.57e-7	Asthma;
SKCM	cis	rs1691799	0.867	rs1027401	chr12:66760892	C/G	cg16791601	chr12:66731901	HELB	-0.58	-4.82	-0.48	6.86e-6	White blood cell count (basophil);
SKCM	cis	rs58688157	0.705	rs36060383	chr11:598723	A/C	cg03576123	chr11:487126	PTDSS2	-0.8	-5.19	-0.51	1.61e-6	Systemic lupus erythematosus;
SKCM	cis	rs3785574	0.962	rs35448669	chr17:61938923	G/A	cg06873352	chr17:61820015	STRADA	0.56	4.83	0.48	6.66e-6	Height;
SKCM	cis	rs644799	0.672	rs11021307	chr11:95501407	C/T	cg25622487	chr11:95524042	FAM76B;CEP57	0.75	6.38	0.59	1.16e-8	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs6570726	0.791	rs9403730	chr6:145907233	C/T	cg23711669	chr6:146136114	FBXO30	0.88	8.32	0.69	2.28e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs867186	0.764	rs35291022	chr20:33537157	A/G	cg04194272	chr20:33683537	NA	-1.36	-7.01	-0.62	7.44e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs16854884	0.657	rs4611822	chr3:143735544	C/T	cg06585982	chr3:143692056	C3orf58	0.87	8.11	0.68	5.72e-12	Economic and political preferences (feminism/equality);
SKCM	cis	rs7208859	0.573	rs79505916	chr17:29062326	C/T	cg14067834	chr17:29058358	SUZ12P	1.11	5.62	0.54	2.83e-7	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs2842992	0.709	rs1853257	chr6:160212710	C/G	cg11366901	chr6:160182831	ACAT2	0.91	7.38	0.64	1.46e-10	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs875971	0.660	rs79009421	chr7:66068509	G/C	cg18876405	chr7:65276391	NA	-0.82	-7.48	-0.65	9.41e-11	Aortic root size;
SKCM	cis	rs6570726	0.967	rs373527	chr6:145801861	C/T	cg23711669	chr6:146136114	FBXO30	0.7	6.88	0.61	1.32e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs798766	0.909	rs28521716	chr4:1745751	A/G	cg05874882	chr4:1763078	NA	-0.56	-4.89	-0.48	5.37e-6	Bladder cancer;Urinary bladder cancer;
SKCM	trans	rs9660992	0.710	rs4951184	chr1:205240659	A/T	cg12698750	chr1:193512498	NA	-0.51	-7.67	-0.66	4.15e-11	Mean corpuscular volume;Mean platelet volume;
SKCM	cis	rs9814567	1.000	rs10935120	chr3:134233092	C/T	cg06109529	chr3:134205091	CEP63;ANAPC13	0.61	4.94	0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs12464559	0.649	rs57389554	chr2:152704730	G/A	cg01189475	chr2:152685088	ARL5A	-1.37	-5.53	-0.53	4.18e-7	Response to cognitive-behavioural therapy in anxiety disorder;
SKCM	cis	rs589448	0.933	rs523398	chr12:69752775	C/T	cg20891283	chr12:69753455	YEATS4	0.98	9.89	0.75	2.06e-15	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs737337	0.623	rs4804154	chr19:11334179	C/T	cg00586551	chr19:11347513	LOC55908;DOCK6	0.82	6.02	0.56	5.34e-8	HDL cholesterol;HDL cholesterol levels;
SKCM	cis	rs769267	1.000	rs12985655	chr19:19442434	G/A	cg03709012	chr19:19516395	GATAD2A	-0.84	-7.03	-0.62	7.02e-10	Tonsillectomy;
SKCM	cis	rs72717009	0.825	rs12746613	chr1:161467042	A/G	cg23840854	chr1:161414152	NA	1.13	5.87	0.55	1.02e-7	Rheumatoid arthritis;
SKCM	cis	rs8060686	0.641	rs12445533	chr16:68082527	A/G	cg09117114	chr16:67998030	SLC12A4	-0.78	-5.08	-0.5	2.5e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs17685	0.753	rs10245584	chr7:75745866	C/T	cg01364799	chr7:75623366	TMEM120A	-0.71	-5.72	-0.54	1.85e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7599312	0.534	rs2128321	chr2:213405276	G/T	cg20637307	chr2:213403960	ERBB4	0.76	5.6	0.54	3.12e-7	BMI (adjusted for smoking behaviour);BMI in non-smokers;Body mass index;Body mass index (joint analysis main effects and smoking interaction);
SKCM	cis	rs9581857	0.579	rs79904593	chr13:27996893	G/A	cg22138327	chr13:27999177	GTF3A	0.93	6.04	0.56	4.89e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs7178909	0.797	rs1910586	chr15:90440489	T/G	cg19708238	chr15:90437601	AP3S2	0.72	5.22	0.51	1.43e-6	Common traits (Other);
SKCM	cis	rs55823223	0.564	rs936396	chr17:73846829	C/G	cg08125733	chr17:73851984	WBP2	1.06	6.6	0.6	4.51e-9	Psoriasis;
SKCM	cis	rs34779708	0.966	rs2045917	chr10:35418526	G/A	cg03585969	chr10:35415529	CREM	0.76	6.1	0.57	3.79e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs9880211	0.800	rs35198484	chr3:136492637	G/A	cg21827317	chr3:136751795	NA	-0.74	-5.43	-0.52	6.11e-7	Body mass index;Height;
SKCM	cis	rs9902453	1.000	rs7212497	chr17:28335949	T/G	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.81	-5.78	-0.55	1.45e-7	Coffee consumption (cups per day);
SKCM	cis	rs55962025	0.883	rs363099	chr4:3162056	C/T	cg21096898	chr4:3318625	RGS12	-0.61	-4.9	-0.49	5.06e-6	Parental longevity (mother's age at death);
SKCM	cis	rs2204008	0.818	rs1589389	chr12:38416041	G/A	cg26384229	chr12:38710491	ALG10B	-0.8	-6.31	-0.58	1.56e-8	Bladder cancer;
SKCM	cis	rs9816226	0.590	rs872602	chr3:185826028	A/G	cg00760338	chr3:185826511	ETV5	0.88	6.35	0.58	1.31e-8	Obesity;Body mass index;
SKCM	cis	rs12541335	0.639	rs11135995	chr8:22200148	C/T	cg02788857	chr8:22132959	PIWIL2	-0.54	-4.88	-0.48	5.53e-6	Hypertriglyceridemia;
SKCM	trans	rs1814175	0.586	rs10769603	chr11:49688837	T/C	cg15704280	chr7:45808275	SEPT13	-0.93	-7.85	-0.66	1.85e-11	Height;
SKCM	cis	rs1062177	1.000	rs1062177	chr5:151184701	C/T	cg00977110	chr5:151150581	G3BP1	0.84	6.68	0.6	3.14e-9	Preschool internalizing problems;
SKCM	cis	rs7216064	0.906	rs1976052	chr17:65830578	C/T	cg12091567	chr17:66097778	LOC651250	-0.77	-5.35	-0.52	8.48e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs62238980	0.614	rs117112619	chr22:32508140	G/A	cg00543991	chr22:32367038	NA	1.17	4.81	0.48	7.24e-6	Childhood ear infection;
SKCM	cis	rs4683346	0.712	rs1582882	chr3:42874934	T/C	cg06399164	chr3:42695035	ZBTB47	0.56	4.84	0.48	6.41e-6	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs9814567	1.000	rs6769885	chr3:134286913	G/C	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs1577917	0.958	rs11755864	chr6:86691791	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.63	-5.46	-0.53	5.53e-7	Response to antipsychotic treatment;
SKCM	cis	rs796364	0.951	rs7586320	chr2:201068209	C/G	cg12253985	chr2:200820533	C2orf60;C2orf47	0.95	6.37	0.59	1.21e-8	Schizophrenia;
SKCM	cis	rs62238980	0.614	rs74450300	chr22:32403780	C/G	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs826838	1.000	rs826851	chr12:39112639	A/G	cg13010199	chr12:38710504	ALG10B	-0.79	-5.9	-0.56	8.77e-8	Heart rate;
SKCM	cis	rs4819052	1.000	rs13053002	chr21:46677854	C/T	cg20896738	chr21:46707857	POFUT2;LOC642852	0.76	5.47	0.53	5.23e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs6500395	1.000	rs1224	chr16:48572817	G/A	cg04672837	chr16:48644449	N4BP1	0.69	5.6	0.54	3.1e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs1577917	1.000	rs791856	chr6:86681841	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.61	5.36	0.52	8.26e-7	Response to antipsychotic treatment;
SKCM	cis	rs2839186	0.900	rs59828751	chr21:47708918	A/G	cg13012494	chr21:47604986	C21orf56	0.67	5.71	0.54	1.95e-7	Testicular germ cell tumor;
SKCM	trans	rs8170	0.603	rs1544940	chr19:17414843	A/T	cg07395094	chr5:139554569	C5orf32	-0.88	-7.29	-0.64	2.16e-10	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Ovarian cancer;Breast cancer;Epithelial ovarian cancer;
SKCM	cis	rs4808199	0.947	rs2099333	chr19:19605963	C/T	cg03709012	chr19:19516395	GATAD2A	1.13	8.66	0.7	4.94e-13	Nonalcoholic fatty liver disease;
SKCM	cis	rs651907	0.535	rs13094753	chr3:101525082	A/G	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.78	6.72	0.61	2.65e-9	Colorectal cancer;
SKCM	cis	rs7247513	1.000	rs2042947	chr19:12693103	A/G	cg01871581	chr19:12707946	ZNF490	-0.69	-4.81	-0.48	7.29e-6	Bipolar disorder;
SKCM	cis	rs2153535	0.580	rs1832100	chr6:8446956	G/A	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs1691799	0.867	rs1168297	chr12:66735644	T/C	cg16791601	chr12:66731901	HELB	-0.66	-5.81	-0.55	1.31e-7	White blood cell count (basophil);
SKCM	cis	rs208520	0.874	rs208473	chr6:66917265	G/C	cg07460842	chr6:66804631	NA	-0.9	-6.89	-0.61	1.29e-9	Exhaled nitric oxide output;
SKCM	cis	rs7843479	1.000	rs2054711	chr8:21818060	A/G	cg17168535	chr8:21777572	XPO7	0.72	5.64	0.54	2.65e-7	Mean corpuscular volume;
SKCM	cis	rs854765	0.718	rs7224815	chr17:17845800	A/T	cg04398451	chr17:18023971	MYO15A	-0.71	-4.8	-0.48	7.37e-6	Total body bone mineral density;
SKCM	cis	rs910316	0.967	rs11624893	chr14:75660124	A/G	cg08847533	chr14:75593920	NEK9	-0.99	-9.41	-0.73	1.73e-14	Height;
SKCM	cis	rs3820068	0.603	rs7529759	chr1:15977877	A/G	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs9430161	0.611	rs12081181	chr1:11034165	T/G	cg02454025	chr1:11042201	C1orf127	1.08	10.13	0.75	7.19e-16	Ewing sarcoma;
SKCM	cis	rs2836974	0.831	rs34592564	chr21:40516288	G/C	cg11644478	chr21:40555479	PSMG1	0.99	10.15	0.75	6.65e-16	Cognitive function;
SKCM	cis	rs3768617	0.510	rs2093984	chr1:183094314	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs12971120	0.891	rs11151960	chr18:72177232	G/A	cg26446133	chr18:72167187	CNDP2	-0.68	-5.34	-0.52	8.81e-7	Refractive error;
SKCM	cis	rs2033711	0.936	rs7257999	chr19:58964860	C/G	cg12042659	chr19:58951599	ZNF132	0.7	6.05	0.57	4.75e-8	Uric acid clearance;
SKCM	cis	rs4927850	0.709	rs6783079	chr3:195652708	T/C	cg12923728	chr3:195709715	SDHAP1	-0.91	-5.91	-0.56	8.59e-8	Pancreatic cancer;
SKCM	cis	rs8180040	1.000	rs8180040	chr3:47388947	A/T	cg27129171	chr3:47204927	SETD2	0.87	6.62	0.6	4.15e-9	Colorectal cancer;
SKCM	cis	rs6762	0.748	rs1130663	chr11:837582	G/A	cg16425592	chr11:842748	TSPAN4;POLR2L	-0.8	-5.94	-0.56	7.55e-8	Mean platelet volume;
SKCM	cis	rs9399137	0.507	rs6904897	chr6:135382980	T/G	cg24558204	chr6:135376177	HBS1L	0.64	5.49	0.53	4.93e-7	Glycated hemoglobin levels;Mean corpuscular volume;Hematology traits;HbA2 levels;Mean corpuscular hemoglobin;Hemoglobin levels;F-cell distribution;Platelet count;
SKCM	cis	rs6089584	0.606	rs2296082	chr20:60573983	A/G	cg06108461	chr20:60628389	TAF4	-0.68	-5.62	-0.54	2.85e-7	Body mass index;
SKCM	cis	rs6840360	0.615	rs4696267	chr4:152464500	A/G	cg22705602	chr4:152727874	NA	-0.51	-5.78	-0.55	1.48e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs13118159	0.550	rs1137789	chr4:1381798	A/G	cg20887711	chr4:1340912	KIAA1530	0.95	7.18	0.63	3.54e-10	Longevity;
SKCM	cis	rs9905704	0.647	rs11652713	chr17:57079742	C/T	cg12560992	chr17:57184187	TRIM37	0.74	6.08	0.57	4.13e-8	Testicular germ cell tumor;
SKCM	cis	rs2839186	0.588	rs7280110	chr21:47619039	G/A	cg13126279	chr21:47581558	C21orf56	0.69	6.1	0.57	3.8e-8	Testicular germ cell tumor;
SKCM	cis	rs654950	0.875	rs600109	chr1:41998246	A/G	cg06885757	chr1:42089581	HIVEP3	-0.62	-6.73	-0.61	2.6e-9	Airway imaging phenotypes;
SKCM	cis	rs7843479	1.000	rs7843479	chr8:21820813	G/T	cg17168535	chr8:21777572	XPO7	0.84	7.03	0.62	6.82e-10	Mean corpuscular volume;
SKCM	cis	rs738321	0.790	rs4820317	chr22:38543287	T/C	cg25457927	chr22:38595422	NA	-0.49	-5.41	-0.52	6.79e-7	Breast cancer;
SKCM	cis	rs13010713	0.840	rs7580110	chr2:182057083	G/A	cg21995919	chr2:182322279	ITGA4	-0.53	-5.12	-0.5	2.18e-6	Celiac disease;
SKCM	cis	rs2072499	0.966	rs2253677	chr1:156171296	C/G	cg24450063	chr1:156163899	SLC25A44	-1.07	-10.93	-0.78	2.1e-17	Testicular germ cell tumor;
SKCM	cis	rs7555523	1.000	rs7555523	chr1:165718979	C/A	cg24409356	chr1:165738333	TMCO1	0.93	5.15	0.5	1.93e-6	Intraocular pressure;Glaucoma (high intraocular pressure);
SKCM	cis	rs56235845	0.694	rs11949401	chr5:176765989	A/G	cg16006841	chr5:176797999	RGS14	0.68	6.32	0.58	1.48e-8	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs9300255	0.739	rs1533703	chr12:123742093	T/G	cg05973401	chr12:123451056	ABCB9	0.86	6.11	0.57	3.69e-8	Neutrophil percentage of white cells;
SKCM	cis	rs2832191	0.729	rs2832201	chr21:30499841	A/G	cg24692254	chr21:30365293	RNF160	-0.99	-9.08	-0.72	7.69e-14	Dental caries;
SKCM	cis	rs5758659	0.652	rs133358	chr22:42442539	A/T	cg21144673	chr22:42017783	PPPDE2;XRCC6	-0.63	-4.87	-0.48	5.8e-6	Cognitive function;
SKCM	cis	rs72781680	1.000	rs72796316	chr2:24132272	T/C	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	cis	rs6546550	0.901	rs6754896	chr2:70138170	T/C	cg02498382	chr2:70120550	SNRNP27	-0.45	-4.88	-0.48	5.4e-6	Prevalent atrial fibrillation;
SKCM	cis	rs11098499	0.913	rs10010696	chr4:120164303	T/C	cg09307838	chr4:120376055	NA	0.95	7.75	0.66	2.84e-11	Corneal astigmatism;
SKCM	cis	rs5769765	1.000	rs4824112	chr22:50284345	A/G	cg22709217	chr22:50311962	ALG12;CRELD2	-0.83	-5.74	-0.54	1.73e-7	Schizophrenia;
SKCM	cis	rs62238980	0.522	rs74748244	chr22:32497724	C/T	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs875971	0.660	rs3764903	chr7:66098482	G/A	cg11764359	chr7:65958608	NA	-0.84	-6.37	-0.59	1.2e-8	Aortic root size;
SKCM	cis	rs995000	0.839	rs12403207	chr1:62993620	T/C	cg06896770	chr1:63153194	DOCK7	-0.74	-6.81	-0.61	1.77e-9	Triglyceride levels;
SKCM	cis	rs10751667	0.666	rs4074233	chr11:977685	G/A	cg10932868	chr11:921992	NA	0.55	5.1	0.5	2.36e-6	Alzheimer's disease (late onset);
SKCM	cis	rs7772486	0.875	rs10457796	chr6:146416087	T/G	cg23711669	chr6:146136114	FBXO30	0.86	8.34	0.69	2.1e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs801193	1.000	rs2707856	chr7:66211010	A/T	cg18876405	chr7:65276391	NA	0.8	7.38	0.64	1.51e-10	Aortic root size;
SKCM	cis	rs3785574	0.962	rs2727332	chr17:61878584	T/A	cg06601766	chr17:61851465	DDX42;CCDC47	0.68	5.02	0.49	3.15e-6	Height;
SKCM	cis	rs6570726	0.935	rs906774	chr6:145813770	T/C	cg23711669	chr6:146136114	FBXO30	0.71	6.77	0.61	2.18e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs3768617	0.510	rs2333620	chr1:183100555	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs7829975	0.540	rs2976909	chr8:8346690	C/T	cg15556689	chr8:8085844	FLJ10661	-0.72	-5.81	-0.55	1.28e-7	Mood instability;
SKCM	trans	rs208520	0.526	rs7776413	chr6:66783241	A/G	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-1.12	-11.27	-0.79	4.9e-18	Exhaled nitric oxide output;
SKCM	cis	rs10256972	0.616	rs6957733	chr7:1106327	T/G	cg11360546	chr7:1094263	C7orf50	-0.42	-4.92	-0.49	4.78e-6	Longevity;Endometriosis;
SKCM	cis	rs992157	0.798	rs7587220	chr2:219160864	C/A	cg00012203	chr2:219082015	ARPC2	-0.73	-5.72	-0.54	1.84e-7	Colorectal cancer;
SKCM	cis	rs4910157	1	rs4910157	chr11:8941215	A/G	cg21881798	chr11:8931708	C11orf17;ST5	0.79	7.77	0.66	2.58e-11	Tonsillectomy;
SKCM	cis	rs7599312	0.534	rs2128321	chr2:213405276	G/T	cg16329650	chr2:213403929	ERBB4	0.84	6.04	0.56	4.85e-8	BMI (adjusted for smoking behaviour);BMI in non-smokers;Body mass index;Body mass index (joint analysis main effects and smoking interaction);
SKCM	cis	rs67460515	0.527	rs34221255	chr3:160854123	T/C	cg03342759	chr3:160939853	NMD3	-0.69	-5.84	-0.55	1.13e-7	Parkinson's disease;
SKCM	cis	rs951366	0.789	rs1772148	chr1:205704580	A/T	cg11965913	chr1:205819406	PM20D1	0.99	9.69	0.74	4.88e-15	Menarche (age at onset);
SKCM	cis	rs7980687	0.550	rs1727324	chr12:123698603	A/T	cg00376283	chr12:123451042	ABCB9	0.8	5.29	0.51	1.08e-6	Height;Educational attainment;Head circumference (infant);
SKCM	cis	rs7811142	0.667	rs3873746	chr7:99935097	G/A	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.2	7.98	0.67	1.02e-11	Platelet count;
SKCM	cis	rs7149337	0.805	rs4350491	chr14:51675798	A/G	cg23942311	chr14:51606299	NA	0.61	6.66	0.6	3.42e-9	Cancer;
SKCM	cis	rs846858	0.928	rs865864	chr19:45114009	G/T	cg18042043	chr19:44147545	NA	0.58	4.86	0.48	6e-6	Late-onset Alzheimer's disease;
SKCM	cis	rs2731664	0.792	rs335467	chr5:176890642	A/G	cg23176889	chr5:176863531	GRK6	-0.51	-5.0	-0.49	3.47e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs10871290	0.881	rs7498574	chr16:74472661	A/G	cg01733217	chr16:74700730	RFWD3	-0.72	-5.31	-0.52	1.01e-6	Breast cancer;
SKCM	cis	rs9911578	1.000	rs304270	chr17:56802141	A/G	cg12560992	chr17:57184187	TRIM37	-0.94	-7.55	-0.65	7.01e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs12802200	0.561	rs7937217	chr11:571967	T/C	cg16486109	chr11:613632	IRF7	0.9	5.56	0.53	3.7e-7	Systemic lupus erythematosus;
SKCM	cis	rs933688	1.000	rs1964292	chr5:90743608	T/C	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.94	6.78	0.61	2.1e-9	Smoking behavior;
SKCM	cis	rs4925325	0.915	rs2427246	chr20:60517047	T/C	cg23262073	chr20:60523788	NA	-0.72	-5.34	-0.52	8.92e-7	Obesity-related traits;
SKCM	cis	rs875971	0.619	rs12533585	chr7:65984605	G/C	cg11987759	chr7:65425863	GUSB	-0.69	-5.9	-0.56	8.74e-8	Aortic root size;
SKCM	cis	rs1003719	0.788	rs2835602	chr21:38469069	G/C	cg10648535	chr21:38446584	PIGP;TTC3	0.61	4.79	0.48	7.9e-6	Eye color traits;
SKCM	cis	rs7666738	0.830	rs7691864	chr4:98971376	G/C	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs58688157	0.960	rs702966	chr11:611919	C/G	cg17114584	chr11:613792	IRF7	0.74	5.0	0.49	3.51e-6	Systemic lupus erythematosus;
SKCM	cis	rs473651	0.777	rs550890	chr2:239332555	G/A	cg18131467	chr2:239335373	ASB1	1.01	11.12	0.78	9.51e-18	Multiple system atrophy;
SKCM	cis	rs7584330	0.868	rs58057291	chr2:238395479	T/A	cg14458575	chr2:238380390	NA	1.02	6.39	0.59	1.14e-8	Prostate cancer;
SKCM	cis	rs1005277	0.579	rs1985707	chr10:38434098	C/T	cg25427524	chr10:38739819	LOC399744	-0.71	-6.7	-0.6	2.97e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs11148252	0.532	rs9536190	chr13:53181044	T/C	cg12458913	chr13:53173898	NA	0.65	6.14	0.57	3.25e-8	Lewy body disease;
SKCM	cis	rs7811142	1.000	rs11559117	chr7:100076614	A/G	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.12	6.51	0.59	6.68e-9	Platelet count;
SKCM	cis	rs7659604	1.000	rs6823488	chr4:122664819	A/G	cg06713675	chr4:122721982	EXOSC9	-0.65	-5.78	-0.55	1.48e-7	Type 2 diabetes;
SKCM	cis	rs3820068	0.603	rs16851884	chr1:15961871	A/G	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs2559856	1.000	rs2695285	chr12:102089043	G/A	cg12924262	chr12:102091054	CHPT1	0.7	5.95	0.56	7.09e-8	Blood protein levels;
SKCM	cis	rs362296	0.698	rs3095072	chr4:3263325	G/A	cg24015175	chr4:3319247	RGS12	-0.6	-5.81	-0.55	1.31e-7	Parental longevity (mother's age at death);
SKCM	cis	rs6951245	0.678	rs28600085	chr7:1169636	C/T	cg18402987	chr7:1209562	NA	1.15	7.39	0.64	1.39e-10	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7666738	0.606	rs10006454	chr4:99080361	G/A	cg17366294	chr4:99064904	C4orf37	0.61	5.06	0.5	2.73e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9640161	0.750	rs59211922	chr7:150023790	T/G	cg10018233	chr7:150070692	REPIN1	0.77	6.19	0.57	2.62e-8	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs12464559	0.649	rs73967705	chr2:152702819	C/T	cg01189475	chr2:152685088	ARL5A	-1.37	-5.53	-0.53	4.18e-7	Response to cognitive-behavioural therapy in anxiety disorder;
SKCM	cis	rs6570726	0.764	rs448258	chr6:145869145	C/A	cg05347473	chr6:146136440	FBXO30	0.57	5.14	0.5	1.95e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9660180	0.967	rs6603803	chr1:1812688	A/G	cg13866156	chr1:1669148	SLC35E2	-0.79	-6.59	-0.6	4.77e-9	Body mass index;
SKCM	cis	rs3540	0.533	rs937793	chr15:91053583	A/G	cg22089800	chr15:90895588	ZNF774	-0.75	-5.51	-0.53	4.39e-7	Allergic disease (asthma, hay fever or eczema);Lymphocyte counts;
SKCM	cis	rs748404	0.578	rs507178	chr15:43610135	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	0.82	6.24	0.58	2.08e-8	Lung cancer;
SKCM	cis	rs1552244	0.882	rs28366039	chr3:10028988	C/A	cg02579736	chr3:10068473	FANCD2;CIDECP	0.94	4.84	0.48	6.49e-6	Alzheimer's disease;
SKCM	cis	rs6879260	1.000	rs10903252	chr5:179733934	T/C	cg23221052	chr5:179740743	GFPT2	-0.67	-5.27	-0.51	1.19e-6	Height;
SKCM	cis	rs875971	1.000	rs6460292	chr7:65810075	G/A	cg18876405	chr7:65276391	NA	-0.68	-6.79	-0.61	1.96e-9	Aortic root size;
SKCM	cis	rs651907	0.535	rs11919389	chr3:101424458	T/C	cg12386194	chr3:101231763	SENP7	0.69	5.68	0.54	2.23e-7	Colorectal cancer;
SKCM	cis	rs796364	0.906	rs281766	chr2:200820505	T/G	cg12253985	chr2:200820533	C2orf60;C2orf47	0.92	5.62	0.54	2.83e-7	Schizophrenia;
SKCM	cis	rs9911578	0.934	rs8081967	chr17:57072701	T/C	cg12560992	chr17:57184187	TRIM37	1.09	10.28	0.76	3.75e-16	Intelligence (multi-trait analysis);
SKCM	cis	rs2013441	1.000	rs2703799	chr17:20085768	G/T	cg13482628	chr17:19912719	NA	-0.67	-5.24	-0.51	1.32e-6	Obesity-related traits;
SKCM	cis	rs17376456	0.825	rs13171131	chr5:93223028	C/T	cg25358565	chr5:93447407	FAM172A	1.26	7.82	0.66	2.11e-11	Diabetic retinopathy;
SKCM	cis	rs4803468	0.967	rs67047091	chr19:41938684	C/T	cg14132834	chr19:41945861	ATP5SL	0.77	5.9	0.56	9.04e-8	Height;
SKCM	cis	rs6665290	0.935	rs12403236	chr1:227196502	C/G	cg10327440	chr1:227177885	CDC42BPA	-1.24	-17.42	-0.89	1.29e-28	Myeloid white cell count;
SKCM	cis	rs56235845	0.665	rs4976685	chr5:176766177	C/T	cg16006841	chr5:176797999	RGS14	-0.64	-6.14	-0.57	3.21e-8	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs7786877	0.723	rs73407376	chr7:100215200	C/T	cg20848291	chr7:100343083	ZAN	-0.66	-5.04	-0.5	2.9e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs6430585	0.527	rs62168836	chr2:136463117	G/A	cg07169764	chr2:136633963	MCM6	1.02	7.68	0.66	3.84e-11	Corneal structure;
SKCM	cis	rs870825	0.616	rs7683799	chr4:185632164	T/C	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs9987353	0.589	rs1053036	chr8:9060077	A/G	cg06636001	chr8:8085503	FLJ10661	-0.62	-4.88	-0.48	5.56e-6	Recombination measurement;
SKCM	cis	rs912057	0.965	rs1294409	chr6:6738355	A/G	cg06612196	chr6:6737390	NA	-0.6	-5.19	-0.51	1.63e-6	Waist-to-hip ratio adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);
SKCM	cis	rs28830936	0.510	rs11858843	chr15:42092915	C/A	cg17847044	chr15:42102381	MAPKBP1	-0.44	-5.78	-0.55	1.47e-7	Diastolic blood pressure;
SKCM	cis	rs67311347	1.000	rs17078511	chr3:40396254	A/G	cg00091569	chr3:40428383	ENTPD3	0.65	5.58	0.53	3.36e-7	Renal cell carcinoma;
SKCM	cis	rs919433	0.680	rs788023	chr2:198283305	T/C	cg04278110	chr2:198063759	ANKRD44	0.7	4.79	0.48	7.87e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs9900062	0.628	rs9807030	chr17:62757141	G/C	cg02097616	chr17:62675921	NA	0.73	5.96	0.56	6.77e-8	QT interval;
SKCM	cis	rs16949788	0.826	rs28723485	chr15:66624166	G/T	cg08120210	chr15:66682733	MAP2K1	-0.74	-5.82	-0.55	1.23e-7	Spherical equivalent (joint analysis main effects and education interaction);
SKCM	cis	rs10504229	0.953	rs75545548	chr8:58172816	T/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs3820068	0.581	rs6666373	chr1:15939884	A/T	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs2239547	0.657	rs4687554	chr3:52864135	T/C	cg11645453	chr3:52864694	ITIH4	0.79	7.19	0.63	3.41e-10	Schizophrenia;
SKCM	cis	rs34779708	0.931	rs4934723	chr10:35381763	A/G	cg03585969	chr10:35415529	CREM	0.78	6.31	0.58	1.58e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs55962025	0.686	rs4690073	chr4:3160150	G/A	cg21096898	chr4:3318625	RGS12	-0.58	-5.01	-0.49	3.33e-6	Parental longevity (mother's age at death);
SKCM	cis	rs7659604	0.539	rs11098646	chr4:122729301	T/C	cg19748678	chr4:122722346	EXOSC9	0.68	5.71	0.54	2e-7	Type 2 diabetes;
SKCM	cis	rs6977660	0.714	rs10232870	chr7:19818040	A/G	cg07541023	chr7:19748670	TWISTNB	0.72	4.78	0.48	7.95e-6	Thyroid stimulating hormone;
SKCM	cis	rs1218582	0.772	rs12069356	chr1:154849771	C/T	cg09359103	chr1:154839909	KCNN3	-0.57	-5.42	-0.52	6.37e-7	Prostate cancer;
SKCM	cis	rs11098499	0.863	rs12508173	chr4:120318526	T/C	cg09307838	chr4:120376055	NA	0.97	7.49	0.65	9.08e-11	Corneal astigmatism;
SKCM	cis	rs7666738	0.800	rs7684523	chr4:98983175	G/T	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs66573146	0.831	rs56300156	chr4:6990813	G/C	cg00086871	chr4:6988644	TBC1D14	1.29	5.03	0.5	3.04e-6	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs8180040	0.966	rs9683177	chr3:47490493	G/A	cg16586182	chr3:47516702	SCAP	-0.76	-5.32	-0.52	9.63e-7	Colorectal cancer;
SKCM	trans	rs1814175	0.587	rs847628	chr11:49927064	A/T	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs116095464	0.558	rs7710005	chr5:233572	A/G	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs9399137	0.507	rs4896118	chr6:135276065	A/G	cg24558204	chr6:135376177	HBS1L	-0.69	-6.12	-0.57	3.45e-8	Glycated hemoglobin levels;Mean corpuscular volume;Hematology traits;HbA2 levels;Mean corpuscular hemoglobin;Hemoglobin levels;F-cell distribution;Platelet count;
SKCM	cis	rs793571	0.714	rs972801	chr15:58921198	C/T	cg05156742	chr15:59063176	FAM63B	-0.67	-4.78	-0.48	8.08e-6	Schizophrenia;
SKCM	cis	rs6582630	0.537	rs6582500	chr12:38534206	G/A	cg26384229	chr12:38710491	ALG10B	0.82	6.52	0.59	6.32e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs28386778	0.830	rs6504180	chr17:61813169	T/C	cg01411255	chr17:61851458	DDX42;CCDC47	0.78	5.03	0.49	3.06e-6	Prudent dietary pattern;
SKCM	cis	rs2243480	1.000	rs4718309	chr7:65627764	G/C	cg18252515	chr7:66147081	NA	1.34	8.18	0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs9910055	0.920	rs2855818	chr17:42290015	G/A	cg10896456	chr17:42255109	ASB16;C17orf65	0.53	4.83	0.48	6.69e-6	Total body bone mineral density;
SKCM	cis	rs6430585	0.528	rs309167	chr2:136669264	C/T	cg07169764	chr2:136633963	MCM6	1.32	11.41	0.79	2.72e-18	Corneal structure;
SKCM	cis	rs2749592	0.505	rs7915670	chr10:37870212	T/C	cg00409905	chr10:38381863	ZNF37A	0.6	5.52	0.53	4.31e-7	Age-related hearing impairment (SNP x SNP interaction);
SKCM	cis	rs1153858	1.000	rs1049508	chr15:45653592	A/G	cg21132104	chr15:45694354	SPATA5L1	0.93	7.66	0.66	4.2e-11	Homoarginine levels;
SKCM	cis	rs7208859	0.623	rs9890862	chr17:29125450	C/A	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs3784262	1.000	rs11855259	chr15:58249377	C/G	cg12031962	chr15:58353849	ALDH1A2	-0.5	-6.1	-0.57	3.75e-8	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs748404	0.646	rs2253268	chr15:43800968	A/C	cg02155558	chr15:43621948	ADAL;LCMT2	0.72	5.44	0.52	5.85e-7	Lung cancer;
SKCM	cis	rs11638352	1.000	rs2412853	chr15:44295257	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	-1.25	-4.88	-0.48	5.56e-6	Lipoprotein phospholipase A2 activity in cardiovascular disease;
SKCM	cis	rs4481887	0.830	rs4916126	chr1:248466604	G/A	cg00666640	chr1:248458726	OR2T12	0.6	5.14	0.5	1.98e-6	Common traits (Other);
SKCM	cis	rs1152591	1.000	rs1152591	chr14:64680848	A/G	cg21174375	chr14:64681225	SYNE2	0.49	5.46	0.53	5.37e-7	Atrial fibrillation;
SKCM	cis	rs2072499	0.722	rs61462713	chr1:156161682	C/T	cg24450063	chr1:156163899	SLC25A44	0.88	6.55	0.6	5.55e-9	Testicular germ cell tumor;
SKCM	cis	rs3845702	0.736	rs2367990	chr2:180843126	C/T	cg01881094	chr2:180872142	CWC22	-1.3	-6.15	-0.57	3.07e-8	Schizophrenia;
SKCM	cis	rs644799	0.930	rs2186782	chr11:95649543	G/A	cg03916912	chr11:95522834	CEP57;FAM76B	0.87	6.62	0.6	4.09e-9	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs28386778	0.897	rs8077013	chr17:61850392	C/T	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs10540	1.000	rs10540	chr11:494662	G/A	cg03576123	chr11:487126	PTDSS2	-1.41	-7.85	-0.66	1.82e-11	Body mass index;
SKCM	cis	rs77106637	0.929	rs77464186	chr11:72460398	A/C	cg03713592	chr11:72463424	ARAP1	1.09	5.65	0.54	2.51e-7	Type 2 diabetes;
SKCM	cis	rs7618501	0.633	rs4688757	chr3:50035323	T/C	cg24110177	chr3:50126178	RBM5	-0.6	-5.11	-0.5	2.25e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs60871478	0.853	rs62432222	chr7:787194	T/C	cg04727924	chr7:799746	HEATR2	-0.64	-4.82	-0.48	6.9e-6	Cerebrospinal P-tau181p levels;
SKCM	cis	rs4523957	0.583	rs7212589	chr17:2042393	A/G	cg16513277	chr17:2031491	SMG6	-0.91	-6.21	-0.58	2.38e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs9788682	0.747	rs938682	chr15:78896547	A/G	cg24631222	chr15:78858424	CHRNA5	0.82	6.41	0.59	1.03e-8	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs72781680	0.898	rs2879640	chr2:24043573	T/C	cg08917208	chr2:24149416	ATAD2B	1.0	4.97	0.49	3.82e-6	Lymphocyte counts;
SKCM	cis	rs597539	0.652	rs513359	chr11:68669496	A/T	cg11716795	chr11:68671300	MRPL21;IGHMBP2	-0.8	-5.66	-0.54	2.43e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs2836950	0.545	rs2297256	chr21:40558421	C/T	cg11890956	chr21:40555474	PSMG1	-0.65	-5.06	-0.5	2.75e-6	Menarche (age at onset);
SKCM	cis	rs950776	0.518	rs2869544	chr15:78839400	G/A	cg06917634	chr15:78832804	PSMA4	-1.01	-10.51	-0.77	1.35e-16	Sudden cardiac arrest;
SKCM	cis	rs9814567	1.000	rs11708531	chr3:134224902	T/C	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.66	-5.16	-0.5	1.83e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs9420	0.961	rs71484468	chr11:57632799	G/C	cg19752551	chr11:57585705	CTNND1	-0.71	-7.24	-0.63	2.77e-10	Schizophrenia;
SKCM	cis	rs7119	0.667	rs907393	chr15:77903447	T/C	cg27398640	chr15:77910606	LINGO1	0.51	5.0	0.49	3.48e-6	Type 2 diabetes;
SKCM	cis	rs72615157	0.561	rs113844570	chr7:99873778	A/C	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.05	5.98	0.56	6.25e-8	Lung function (FEV1/FVC);
SKCM	cis	rs8180040	0.620	rs4683322	chr3:47093189	T/C	cg27129171	chr3:47204927	SETD2	0.74	5.37	0.52	7.84e-7	Colorectal cancer;
SKCM	cis	rs4819052	0.851	rs1999335	chr21:46670613	A/G	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.42	0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs57221529	0.825	rs7443550	chr5:578404	G/T	cg10555297	chr5:473380	SLC9A3;LOC25845	1.09	5.49	0.53	4.82e-7	Lung disease severity in cystic fibrosis;
SKCM	trans	rs3780486	0.846	rs10971419	chr9:33124161	T/C	cg04842962	chr6:43655489	MRPS18A	1.02	10.61	0.77	8.7e-17	IgG glycosylation;
SKCM	cis	rs9815354	0.812	rs73071341	chr3:41826211	C/T	cg03022575	chr3:42003672	ULK4	1.0	4.85	0.48	6.1e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs35766269	0.541	rs11256020	chr10:9044677	G/C	cg05671070	chr10:8095960	FLJ45983;GATA3	0.95	4.77	0.48	8.45e-6	Recalcitrant atopic dermatitis;
SKCM	cis	rs2905347	0.726	rs2905320	chr7:22704243	C/A	cg11983867	chr7:22539820	MGC87042	-0.5	-4.78	-0.48	8.14e-6	Major depression and alcohol dependence;
SKCM	cis	rs684232	0.666	rs425961	chr17:573714	G/A	cg12384639	chr17:618140	VPS53	0.79	6.18	0.57	2.74e-8	Prostate cancer;
SKCM	cis	rs2455601	0.882	rs11042116	chr11:8928472	G/C	cg21881798	chr11:8931708	C11orf17;ST5	-0.78	-5.59	-0.53	3.21e-7	Schizophrenia;
SKCM	cis	rs7937682	0.855	rs539553	chr11:111477333	C/T	cg09085632	chr11:111637200	PPP2R1B	-0.98	-10.24	-0.76	4.45e-16	Primary sclerosing cholangitis;
SKCM	cis	rs4481887	0.741	rs6587462	chr1:248539094	C/T	cg00666640	chr1:248458726	OR2T12	-0.49	-5.0	-0.49	3.46e-6	Common traits (Other);
SKCM	cis	rs950027	0.620	rs2461700	chr15:45640627	T/C	cg21132104	chr15:45694354	SPATA5L1	0.76	6.14	0.57	3.2e-8	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs1348850	0.872	rs4893825	chr2:178298687	A/G	cg02961200	chr2:178257176	LOC100130691;AGPS	0.78	5.83	0.55	1.19e-7	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs4975616	0.869	rs465498	chr5:1325803	A/G	cg07493874	chr5:1342172	CLPTM1L	-0.7	-6.57	-0.6	5.12e-9	Lung cancer;
SKCM	cis	rs875971	0.660	rs801217	chr7:66010577	C/T	cg11764359	chr7:65958608	NA	-0.86	-6.6	-0.6	4.52e-9	Aortic root size;
SKCM	cis	rs28595532	1.000	rs28600971	chr4:119712728	G/T	cg14228332	chr4:119757509	SEC24D	1.07	5.49	0.53	4.77e-7	Cannabis dependence symptom count;
SKCM	cis	rs684232	0.602	rs401592	chr17:551316	T/C	cg15660573	chr17:549704	VPS53	-0.76	-6.08	-0.57	4.15e-8	Prostate cancer;
SKCM	cis	rs10504073	0.584	rs72641612	chr8:49947986	C/T	cg00325661	chr8:49890786	NA	0.8	6.81	0.61	1.83e-9	Blood metabolite ratios;
SKCM	cis	rs9911578	0.900	rs717828	chr17:56535932	A/G	cg12560992	chr17:57184187	TRIM37	0.95	7.52	0.65	7.96e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs6500602	0.564	rs3747584	chr16:4516092	A/G	cg08645402	chr16:4508243	NA	0.65	5.03	0.49	3.06e-6	Schizophrenia;
SKCM	cis	rs2836974	0.897	rs68090597	chr21:40535633	A/G	cg11644478	chr21:40555479	PSMG1	0.97	10.21	0.76	5.08e-16	Cognitive function;
SKCM	cis	rs2811415	0.627	rs4602340	chr3:127732942	A/C	cg09089421	chr3:127803668	RUVBL1	1.0	8.57	0.7	7.53e-13	Lung function (FEV1/FVC);
SKCM	cis	rs9916302	0.629	rs9972882	chr17:37807698	A/C	cg00129232	chr17:37814104	STARD3	-0.69	-5.3	-0.51	1.03e-6	Glomerular filtration rate (creatinine);
SKCM	cis	rs6840360	0.571	rs2406976	chr4:152541056	G/C	cg22705602	chr4:152727874	NA	-0.52	-5.69	-0.54	2.15e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs854765	0.604	rs12948749	chr17:17949802	G/A	cg24612305	chr17:17875800	TOM1L2;LRRC48	-0.95	-7.82	-0.66	2.08e-11	Total body bone mineral density;
SKCM	cis	rs514406	0.698	rs11206043	chr1:53402552	C/T	cg16325326	chr1:53192061	ZYG11B	0.65	5.64	0.54	2.61e-7	Monocyte count;
SKCM	cis	rs62238980	0.614	rs79022443	chr22:32456717	T/C	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs801193	0.935	rs2659916	chr7:66151352	C/G	cg11987759	chr7:65425863	GUSB	-0.69	-5.9	-0.56	8.74e-8	Aortic root size;
SKCM	cis	rs3785574	0.962	rs2665799	chr17:61919723	A/G	cg01411255	chr17:61851458	DDX42;CCDC47	1.16	12.75	0.82	9.1e-21	Height;
SKCM	cis	rs870825	0.616	rs1401361	chr4:185643742	G/C	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs12497850	0.931	rs9846123	chr3:49088112	C/T	cg06212747	chr3:49208901	KLHDC8B	-0.68	-4.77	-0.48	8.27e-6	Parkinson's disease;
SKCM	cis	rs561341	1.000	rs521919	chr17:30298039	G/T	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs28595532	0.920	rs116146507	chr4:119749556	A/G	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	trans	rs17685	0.632	rs1859793	chr7:75821283	G/A	cg19862616	chr7:65841803	NCRNA00174	0.89	9.16	0.72	5.27e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs595982	0.527	rs73061659	chr19:49373556	G/A	cg19746536	chr19:49375674	PPP1R15A	1.08	6.03	0.56	5.08e-8	Red cell distribution width;
SKCM	cis	rs9911578	0.967	rs8082544	chr17:57185807	C/T	cg05425664	chr17:57184151	TRIM37	0.83	7.05	0.62	6.36e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs55962025	0.804	rs2071703	chr4:3241413	A/C	cg21096898	chr4:3318625	RGS12	-0.7	-5.42	-0.52	6.53e-7	Parental longevity (mother's age at death);
SKCM	cis	rs13108904	0.710	rs11937232	chr4:1207597	G/C	cg02018176	chr4:1364513	KIAA1530	0.65	5.17	0.51	1.77e-6	Obesity-related traits;
SKCM	cis	rs17345786	1.000	rs73863360	chr3:101316837	G/A	cg12386194	chr3:101231763	SENP7	0.8	6.19	0.57	2.62e-8	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6582630	0.555	rs4601853	chr12:38435569	G/A	cg26384229	chr12:38710491	ALG10B	0.82	6.3	0.58	1.6e-8	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs7666738	0.830	rs1426670	chr4:98923572	A/G	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7208859	0.623	rs9894709	chr17:29078454	G/A	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs769267	0.931	rs15622	chr19:19468734	G/A	cg03709012	chr19:19516395	GATAD2A	-0.86	-7.13	-0.63	4.48e-10	Tonsillectomy;
SKCM	cis	rs6840360	0.615	rs28659854	chr4:152607442	T/C	cg22705602	chr4:152727874	NA	-0.58	-7.78	-0.66	2.55e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs447735	0.507	rs11645271	chr16:89729125	G/T	cg01097406	chr16:89675127	NA	-0.48	-5.04	-0.5	2.89e-6	Hemoglobin concentration;
SKCM	cis	rs9880211	0.563	rs9848926	chr3:135816302	A/G	cg21827317	chr3:136751795	NA	-0.7	-5.12	-0.5	2.13e-6	Body mass index;Height;
SKCM	cis	rs71520386	0.632	rs10279864	chr7:22863824	C/G	cg15401507	chr7:22894281	NA	0.67	4.96	0.49	4.03e-6	Fibrinogen levels;
SKCM	cis	rs798554	0.679	rs2533877	chr7:2882421	G/A	cg19346786	chr7:2764209	NA	-0.66	-6.64	-0.6	3.79e-9	Height;
SKCM	cis	rs4555082	0.645	rs2816605	chr14:105715515	C/T	cg13114125	chr14:105738426	BRF1	-0.7	-5.75	-0.55	1.64e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs17376456	0.877	rs10065056	chr5:93380123	G/T	cg21475434	chr5:93447410	FAM172A	0.95	5.35	0.52	8.56e-7	Diabetic retinopathy;
SKCM	cis	rs11924390	0.800	rs5030059	chr3:186452455	C/G	cg09332604	chr3:186435400	KNG1	-0.55	-5.52	-0.53	4.25e-7	Adiponectin levels;
SKCM	cis	rs10779751	1.000	rs4845856	chr1:11274547	T/C	cg08854313	chr1:11322531	MTOR	1.0	8.97	0.71	1.24e-13	Body mass index;
SKCM	cis	rs6089829	0.925	rs11086152	chr20:61664656	T/C	cg08564027	chr20:61660810	NA	0.63	5.58	0.53	3.4e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs7772486	0.754	rs702306	chr6:145991029	T/C	cg23711669	chr6:146136114	FBXO30	-0.94	-10.42	-0.76	1.95e-16	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs763014	0.931	rs3752567	chr16:628130	A/G	cg00908189	chr16:619842	PIGQ	0.82	7.77	0.66	2.57e-11	Height;
SKCM	cis	rs1218582	0.772	rs906593	chr1:154885255	G/A	cg24250549	chr1:154909240	PMVK	0.87	8.7	0.7	4.13e-13	Prostate cancer;
SKCM	cis	rs7927771	0.800	rs35996350	chr11:47389223	A/G	cg05585544	chr11:47624801	NA	-0.59	-5.24	-0.51	1.33e-6	Subjective well-being;
SKCM	cis	rs1633360	1	rs1633360	chr12:58108052	C/T	cg18357645	chr12:58087776	OS9	0.61	5.23	0.51	1.4e-6	Rheumatoid arthritis;
SKCM	cis	rs933688	1.000	rs10073657	chr5:90689749	G/A	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.05	8.45	0.69	1.26e-12	Smoking behavior;
SKCM	cis	rs9549367	0.713	rs9549682	chr13:113830181	C/T	cg18105134	chr13:113819100	PROZ	-0.91	-6.82	-0.61	1.71e-9	Platelet distribution width;
SKCM	cis	rs12044355	0.827	rs10429978	chr1:231823662	C/T	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	0.82	6.24	0.58	2.14e-8	Alzheimer's disease;
SKCM	cis	rs651907	0.513	rs34963630	chr3:101504817	C/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.78	6.71	0.61	2.75e-9	Colorectal cancer;
SKCM	cis	rs67311347	0.544	rs6804545	chr3:40354040	G/C	cg00656387	chr3:40428638	ENTPD3	0.55	4.77	0.48	8.39e-6	Renal cell carcinoma;
SKCM	cis	rs40363	0.645	rs250630	chr16:3524242	C/T	cg22508957	chr16:3507546	NAT15	0.57	4.87	0.48	5.8e-6	Tuberculosis;
SKCM	cis	rs9902453	0.845	rs2321493	chr17:28230359	T/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.81	5.79	0.55	1.43e-7	Coffee consumption (cups per day);
SKCM	cis	rs1801516	0.950	rs7115351	chr11:108324789	C/T	cg03165700	chr11:108093220	ATM;NPAT	-1.11	-5.06	-0.5	2.68e-6	Melanoma;
SKCM	cis	rs1003719	0.788	rs59637309	chr21:38475398	G/A	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs2404602	0.692	rs35077207	chr15:76935306	A/G	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs453301	0.658	rs6986044	chr8:8874786	G/C	cg06636001	chr8:8085503	FLJ10661	-0.75	-5.62	-0.54	2.83e-7	Joint mobility (Beighton score);
SKCM	cis	rs4919087	0.926	rs7072078	chr10:99026509	G/A	cg25902810	chr10:99078978	FRAT1	0.63	5.12	0.5	2.15e-6	Monocyte count;
SKCM	cis	rs9926296	0.533	rs10852623	chr16:89865242	T/C	cg04287289	chr16:89883240	FANCA	1.04	12.66	0.82	1.33e-20	Vitiligo;
SKCM	cis	rs17685	0.743	rs10277259	chr7:75802674	A/C	cg01364799	chr7:75623366	TMEM120A	-0.7	-5.84	-0.55	1.16e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs875971	0.505	rs6955582	chr7:65431686	A/G	cg18876405	chr7:65276391	NA	0.85	7.86	0.66	1.75e-11	Aortic root size;
SKCM	cis	rs13278732	0.500	rs2290468	chr8:99042226	G/A	cg16297171	chr8:99017690	MATN2	-0.54	-5.13	-0.5	2.07e-6	Eosinophilic esophagitis (pediatric);
SKCM	cis	rs636523	0.561	rs11208008	chr1:63190794	T/G	cg06896770	chr1:63153194	DOCK7	0.8	5.27	0.51	1.17e-6	Lipid traits;
SKCM	cis	rs6815814	0.950	rs5743563	chr4:38806019	A/G	cg02016764	chr4:38805732	TLR1	-0.77	-5.52	-0.53	4.24e-7	Breast cancer;
SKCM	cis	rs7216064	1.000	rs6504543	chr17:65837659	T/C	cg12091567	chr17:66097778	LOC651250	-0.79	-5.72	-0.54	1.9e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs28386778	0.863	rs8076760	chr17:61920497	T/C	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs912057	1.000	rs1294414	chr6:6740366	A/G	cg06612196	chr6:6737390	NA	0.59	4.88	0.48	5.44e-6	Waist-to-hip ratio adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);
SKCM	cis	rs10504229	0.683	rs17802743	chr8:58105897	C/T	cg02725872	chr8:58115012	NA	-0.53	-4.91	-0.49	4.82e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs2333194	0.772	rs8009466	chr14:73832313	C/T	cg08936952	chr14:74026160	HEATR4	0.54	4.89	0.48	5.2e-6	Bipolar disorder with mood-incongruent psychosis;
SKCM	cis	rs929354	1.000	rs1182378	chr7:157048322	T/C	cg17757837	chr7:157058334	UBE3C	-0.89	-6.41	-0.59	1.02e-8	Body mass index;
SKCM	cis	rs28595532	0.920	rs114684527	chr4:119749252	G/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs17854409	1.000	rs6010770	chr20:61494225	G/T	cg06598544	chr20:61472147	COL9A3	-1.12	-5.42	-0.52	6.45e-7	Obesity-related traits;
SKCM	cis	rs28386778	1.000	rs2665851	chr17:61957023	T/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.11	10.96	0.78	1.87e-17	Prudent dietary pattern;
SKCM	cis	rs9660180	0.846	rs10907195	chr1:1713348	C/T	cg13866156	chr1:1669148	SLC35E2	0.73	6.03	0.56	5.1e-8	Body mass index;
SKCM	cis	rs2243480	1.000	rs10950032	chr7:65738591	C/A	cg18252515	chr7:66147081	NA	1.34	8.18	0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs11690935	0.885	rs6727017	chr2:172766847	T/A	cg13550731	chr2:172543902	DYNC1I2	-0.91	-7.45	-0.64	1.1e-10	Schizophrenia;
SKCM	cis	rs7666738	0.861	rs13139309	chr4:99020916	A/G	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1153858	1.000	rs11070457	chr15:45686943	A/C	cg10760299	chr15:45669010	GATM	0.6	5.93	0.56	7.69e-8	Homoarginine levels;
SKCM	cis	rs754466	0.580	rs2579176	chr10:79529350	A/G	cg17075019	chr10:79541650	NA	-0.78	-7.06	-0.62	6.11e-10	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs9300255	0.782	rs12809602	chr12:123768916	T/G	cg05973401	chr12:123451056	ABCB9	-0.82	-5.72	-0.54	1.92e-7	Neutrophil percentage of white cells;
SKCM	cis	rs7772486	0.790	rs2247429	chr6:146217769	T/C	cg05347473	chr6:146136440	FBXO30	0.56	5.28	0.51	1.12e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9790314	0.936	rs336572	chr3:161068014	G/A	cg03342759	chr3:160939853	NMD3	-0.73	-7.8	-0.66	2.27e-11	Morning vs. evening chronotype;
SKCM	cis	rs7208859	0.623	rs9915566	chr17:29132158	G/A	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs4665809	1.000	rs10182857	chr2:26344411	C/T	cg26119090	chr2:26468346	HADHA;HADHB	-0.76	-4.79	-0.48	7.86e-6	Gut microbiome composition (summer);
SKCM	cis	rs823143	0.570	rs823082	chr1:205786935	C/T	cg11965913	chr1:205819406	PM20D1	-0.94	-10.29	-0.76	3.51e-16	Monocyte percentage of white cells;
SKCM	cis	rs561341	1.000	rs72825740	chr17:30338356	A/G	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs7680126	0.633	rs4697745	chr4:10305081	G/A	cg11511795	chr4:10463749	NA	-0.64	-4.81	-0.48	7.27e-6	Urate levels in lean individuals;Urate levels in overweight individuals;Urate levels in obese individuals;
SKCM	cis	rs9325144	0.555	rs7977200	chr12:38713745	C/T	cg26384229	chr12:38710491	ALG10B	0.78	6.71	0.61	2.77e-9	Morning vs. evening chronotype;
SKCM	cis	rs35306767	0.903	rs12769002	chr10:927666	C/G	cg26597838	chr10:835615	NA	-0.86	-5.94	-0.56	7.41e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs2370759	1.000	rs2769241	chr10:32556229	T/C	cg01819863	chr10:32635814	EPC1	-1.05	-5.46	-0.53	5.43e-7	Sexual dysfunction (female);
SKCM	cis	rs9486715	0.867	rs4839828	chr6:96863326	G/A	cg06623918	chr6:96969491	KIAA0776	0.79	7.09	0.63	5.34e-10	Headache;
SKCM	cis	rs2153535	0.541	rs9379207	chr6:8458186	C/T	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs4481887	0.927	rs4405158	chr1:248490647	A/C	cg00666640	chr1:248458726	OR2T12	0.62	5.27	0.51	1.2e-6	Common traits (Other);
SKCM	cis	rs7824557	0.545	rs2736303	chr8:11236850	C/T	cg21775007	chr8:11205619	TDH	-0.59	-5.03	-0.5	3.01e-6	Retinal vascular caliber;
SKCM	cis	rs17685	0.784	rs1613890	chr7:75735037	T/C	cg01364799	chr7:75623366	TMEM120A	-0.79	-6.37	-0.58	1.23e-8	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs4969178	0.895	rs2292640	chr17:76396610	G/A	cg20026190	chr17:76395443	PGS1	0.61	5.29	0.51	1.08e-6	HDL cholesterol levels;
SKCM	cis	rs11098499	0.863	rs1480940	chr4:120457682	T/C	cg09307838	chr4:120376055	NA	0.96	7.56	0.65	6.78e-11	Corneal astigmatism;
SKCM	cis	rs4919694	0.808	rs4918001	chr10:105013147	G/T	cg04362960	chr10:104952993	NT5C2	-0.81	-4.78	-0.48	8.07e-6	Arsenic metabolism;
SKCM	cis	rs2074977	0.550	rs11085020	chr19:3446107	C/T	cg08380311	chr19:3435252	NFIC	-0.83	-6.86	-0.61	1.44e-9	Height;
SKCM	cis	rs7569084	0.687	rs11675538	chr2:65686461	C/T	cg10464312	chr2:66672688	MEIS1	0.45	5.09	0.5	2.39e-6	Sum eosinophil basophil counts;
SKCM	cis	rs13118159	0.550	rs2878607	chr4:1353310	G/C	cg02475777	chr4:1388615	CRIPAK	0.79	5.23	0.51	1.37e-6	Longevity;
SKCM	cis	rs7143963	0.580	rs10148367	chr14:103357310	C/T	cg23020514	chr14:103360112	TRAF3	0.74	7.04	0.62	6.67e-10	Body mass index;
SKCM	cis	rs9581857	0.547	rs9581877	chr13:28104321	T/A	cg22138327	chr13:27999177	GTF3A	0.88	5.84	0.55	1.14e-7	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs2841277	0.708	rs2582533	chr14:105398787	G/C	cg19901468	chr14:105411992	AHNAK2	-1.0	-7.77	-0.66	2.57e-11	Rheumatoid arthritis;
SKCM	cis	rs7618915	0.571	rs6798246	chr3:52599922	G/A	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs2952156	0.684	rs11658786	chr17:37815899	G/A	cg20243544	chr17:37824526	PNMT	0.73	5.61	0.54	2.97e-7	Asthma;
SKCM	cis	rs11155671	0.530	rs9371215	chr6:150194298	C/T	cg05036130	chr6:150231994	NA	0.54	5.74	0.55	1.71e-7	Testicular germ cell tumor;
SKCM	cis	rs9916302	0.904	rs2061342	chr17:37405657	T/G	cg07936489	chr17:37558343	FBXL20	-0.86	-6.98	-0.62	8.74e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs1218582	1.000	rs1218582	chr1:154834183	G/A	cg03351412	chr1:154909251	PMVK	-0.78	-6.56	-0.6	5.29e-9	Prostate cancer;
SKCM	cis	rs9300255	0.739	rs1879380	chr12:123739111	G/A	cg00376283	chr12:123451042	ABCB9	-0.82	-5.73	-0.54	1.83e-7	Neutrophil percentage of white cells;
SKCM	cis	rs72949976	0.606	rs2178756	chr2:214031423	A/G	cg08319019	chr2:214017104	IKZF2	0.82	6.64	0.6	3.8e-9	Lung cancer;Squamous cell lung carcinoma;
SKCM	cis	rs1552244	1.000	rs9827740	chr3:10120531	T/C	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs7659604	1.000	rs7659943	chr4:122665560	C/T	cg19671926	chr4:122722719	EXOSC9	-0.68	-5.04	-0.5	2.93e-6	Type 2 diabetes;
SKCM	cis	rs875971	1.000	rs778699	chr7:65868290	G/A	cg11764359	chr7:65958608	NA	0.87	8.35	0.69	2.01e-12	Aortic root size;
SKCM	cis	rs7666738	0.830	rs3846445	chr4:99032939	T/A	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs13098911	0.540	rs13068572	chr3:46177096	G/A	cg22986271	chr3:45730975	SACM1L	-0.92	-4.83	-0.48	6.63e-6	Celiac disease;
SKCM	cis	rs875971	0.505	rs1167386	chr7:65513096	G/A	cg11764359	chr7:65958608	NA	-0.88	-6.85	-0.61	1.53e-9	Aortic root size;
SKCM	cis	rs6500602	0.929	rs9926114	chr16:4478322	C/G	cg09069446	chr16:4462122	CORO7	-0.46	-4.89	-0.48	5.32e-6	Schizophrenia;
SKCM	cis	rs3789045	0.560	rs3747634	chr1:204411063	C/T	cg17419461	chr1:204415978	PIK3C2B	0.88	6.53	0.59	6.19e-9	Educational attainment (college completion);
SKCM	cis	rs7959452	0.557	rs7980883	chr12:69778914	C/T	cg20891283	chr12:69753455	YEATS4	0.91	9.3	0.73	2.85e-14	Blood protein levels;
SKCM	cis	rs870825	0.932	rs2696059	chr4:185575127	A/T	cg04058563	chr4:185651563	MLF1IP	-1.03	-5.09	-0.5	2.4e-6	Blood protein levels;
SKCM	cis	rs875971	0.965	rs697968	chr7:65535033	G/A	cg18876405	chr7:65276391	NA	-0.71	-7.04	-0.62	6.64e-10	Aortic root size;
SKCM	cis	rs116095464	0.510	rs7723883	chr5:270798	T/C	cg22857025	chr5:266934	NA	-1.47	-8.33	-0.69	2.16e-12	Breast cancer;
SKCM	cis	rs4819052	0.885	rs28576202	chr21:46674684	G/A	cg19498844	chr21:46707878	POFUT2;LOC642852	0.88	7.69	0.66	3.74e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs4819052	0.788	rs9978857	chr21:46705155	T/G	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	6.73	0.61	2.61e-9	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs11148252	0.904	rs7990581	chr13:53019433	A/G	cg00495681	chr13:53174319	NA	0.61	5.19	0.51	1.63e-6	Lewy body disease;
SKCM	cis	rs3793683	0.928	rs10781585	chr10:134553369	C/A	cg27286337	chr10:134555280	INPP5A	-1.0	-10.95	-0.78	1.91e-17	Migraine;
SKCM	trans	rs1814175	0.645	rs1608632	chr11:49967148	C/T	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs208515	0.525	rs1484577	chr6:66688397	A/G	cg07460842	chr6:66804631	NA	0.93	6.34	0.58	1.35e-8	Exhaled nitric oxide levels;
SKCM	cis	rs17065868	1.000	rs61947991	chr13:45128009	G/T	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs7103648	0.669	rs7927445	chr11:47780754	G/T	cg20307385	chr11:47447363	PSMC3	0.91	7.0	0.62	7.82e-10	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs6977660	0.714	rs6976854	chr7:19818311	A/G	cg07541023	chr7:19748670	TWISTNB	0.72	4.78	0.48	7.95e-6	Thyroid stimulating hormone;
SKCM	cis	rs11098499	0.955	rs1551	chr4:120158500	T/G	cg09307838	chr4:120376055	NA	0.93	7.99	0.67	9.9e-12	Corneal astigmatism;
SKCM	cis	rs1577917	0.958	rs2324839	chr6:86536942	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.81	-0.66	2.19e-11	Response to antipsychotic treatment;
SKCM	cis	rs55962025	0.842	rs362272	chr4:3234980	C/T	cg16987761	chr4:3318072	RGS12	-0.72	-5.37	-0.52	7.88e-7	Parental longevity (mother's age at death);
SKCM	cis	rs7143963	0.666	rs66666997	chr14:103345026	G/C	cg23020514	chr14:103360112	TRAF3	0.74	6.99	0.62	8.38e-10	Body mass index;
SKCM	cis	rs28595532	0.920	rs114547492	chr4:119773078	G/C	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs12714314	0.756	rs10181146	chr2:1948645	A/G	cg22350835	chr2:1868857	MYT1L	-0.58	-5.07	-0.5	2.6e-6	Type 2 diabetes (age of onset);
SKCM	cis	rs2032447	0.670	rs198848	chr6:26106325	A/G	cg03517284	chr6:25882590	NA	-0.59	-5.19	-0.51	1.6e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9910055	0.762	rs184478	chr17:42209751	C/G	cg08499158	chr17:42289980	UBTF	0.85	7.48	0.65	9.37e-11	Total body bone mineral density;
SKCM	cis	rs6121246	0.609	rs6089075	chr20:30392884	A/G	cg13852791	chr20:30311386	BCL2L1	0.82	5.64	0.54	2.59e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs2204008	0.640	rs11520199	chr12:38211026	T/C	cg26384229	chr12:38710491	ALG10B	0.82	6.58	0.6	4.87e-9	Bladder cancer;
SKCM	cis	rs2811415	0.597	rs1007232	chr3:127801896	C/A	cg09089421	chr3:127803668	RUVBL1	1.0	8.69	0.7	4.4e-13	Lung function (FEV1/FVC);
SKCM	cis	rs12047808	0.841	rs16854035	chr1:179349559	G/C	cg09822482	chr1:179519214	C1orf125	-0.95	-5.17	-0.51	1.78e-6	Multiple sclerosis (age of onset);
SKCM	cis	rs9660180	0.967	rs12034740	chr1:1728969	C/A	cg17747265	chr1:1875780	NA	-0.53	-4.83	-0.48	6.7e-6	Body mass index;
SKCM	cis	rs250585	0.850	rs152460	chr16:23573833	A/C	cg10006042	chr16:23042421	NA	0.36	4.81	0.48	7.25e-6	Egg allergy;
SKCM	cis	rs870825	0.616	rs4443323	chr4:185629805	C/A	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs6089584	0.586	rs2296087	chr20:60584328	T/A	cg06108461	chr20:60628389	TAF4	-0.64	-5.58	-0.53	3.29e-7	Body mass index;
SKCM	cis	rs11122272	0.668	rs2790874	chr1:231537988	A/G	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	-0.62	-4.91	-0.49	4.84e-6	Hemoglobin concentration;
SKCM	cis	rs2153535	0.560	rs9379214	chr6:8480870	T/C	cg07606381	chr6:8435919	SLC35B3	0.86	6.25	0.58	2.06e-8	Motion sickness;
SKCM	cis	rs9911578	0.935	rs304261	chr17:56813782	A/G	cg05425664	chr17:57184151	TRIM37	-0.69	-5.21	-0.51	1.52e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9815354	0.812	rs73071352	chr3:41828300	A/G	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs12134245	0.776	rs12125947	chr1:91990487	T/C	cg25838465	chr1:92012736	NA	-0.84	-9.34	-0.73	2.32e-14	Breast cancer;
SKCM	cis	rs4746818	1.000	rs1506769	chr10:70959710	T/C	cg11621586	chr10:70884670	VPS26A	0.92	6.82	0.61	1.75e-9	Left atrial antero-posterior diameter;
SKCM	cis	rs595982	0.559	rs17206714	chr19:49362001	T/A	cg15549821	chr19:49342101	PLEKHA4	-0.87	-5.39	-0.52	7.35e-7	Red cell distribution width;
SKCM	cis	rs12971120	0.891	rs2303463	chr18:72168608	G/A	cg26446133	chr18:72167187	CNDP2	-0.67	-5.21	-0.51	1.48e-6	Refractive error;
SKCM	cis	rs6545883	0.894	rs2694649	chr2:61573826	G/A	cg15711740	chr2:61764176	XPO1	0.68	4.82	0.48	6.94e-6	Tuberculosis;
SKCM	cis	rs34172651	0.517	rs36113933	chr16:24838862	A/G	cg06028605	chr16:24865363	SLC5A11	0.56	4.93	0.49	4.61e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9443189	0.526	rs10943250	chr6:76208445	C/G	cg01950844	chr6:76311363	SENP6	0.9	5.32	0.52	9.74e-7	Prostate cancer;
SKCM	cis	rs1635	0.655	rs73742539	chr6:28305471	C/T	cg15743358	chr6:28303923	ZNF323	-1.27	-5.15	-0.5	1.92e-6	Schizophrenia;
SKCM	cis	rs727563	0.552	rs4822045	chr22:41985958	C/A	cg03806693	chr22:41940476	POLR3H	-1.12	-7.23	-0.63	2.84e-10	Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs7666738	0.800	rs12163918	chr4:98835794	T/C	cg17366294	chr4:99064904	C4orf37	0.56	4.87	0.48	5.62e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6570726	0.791	rs414600	chr6:145879606	G/A	cg05347473	chr6:146136440	FBXO30	0.57	5.13	0.5	2.06e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2841277	0.708	rs2582533	chr14:105398787	G/C	cg21017887	chr14:105400489	NA	0.55	4.77	0.48	8.47e-6	Rheumatoid arthritis;
SKCM	cis	rs10504229	0.906	rs112793785	chr8:58190537	T/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs1475911	0.744	rs12481958	chr21:43517269	A/G	cg24372256	chr21:43528868	UMODL1;C21orf128	-0.77	-6.52	-0.59	6.37e-9	IgG glycosylation;
SKCM	cis	rs12142240	0.698	rs17361763	chr1:46810670	T/C	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs1799949	1.000	rs2070834	chr17:41242285	T/G	cg23758822	chr17:41437982	NA	0.95	7.86	0.66	1.79e-11	Menopause (age at onset);
SKCM	cis	rs4561483	0.801	rs33660	chr16:11961858	A/G	cg08843971	chr16:11963173	GSPT1	-0.66	-5.08	-0.5	2.49e-6	Testicular germ cell tumor;
SKCM	cis	rs8067545	0.611	rs11653630	chr17:20189046	C/T	cg13482628	chr17:19912719	NA	-0.68	-5.76	-0.55	1.57e-7	Schizophrenia;
SKCM	cis	rs362296	0.698	rs3129319	chr4:3265381	A/G	cg09735869	chr4:3319127	RGS12	-0.68	-5.76	-0.55	1.58e-7	Parental longevity (mother's age at death);
SKCM	cis	rs13040088	1.000	rs12480870	chr20:61543606	A/C	cg23096297	chr20:61557774	DIDO1	0.79	6.2	0.57	2.55e-8	Menopause (age at onset);
SKCM	cis	rs68190844	1	rs68190844	chr17:4568953	CTA/C	cg19197139	chr17:4613644	ARRB2	-0.79	-5.45	-0.53	5.64e-7	Eosinophil percentage of white cells;
SKCM	cis	rs78269692	0.826	rs16995252	chr19:13243304	A/G	cg19436403	chr19:12780550	MORG1;C19orf56	1.39	5.14	0.5	1.96e-6	Breast cancer;
SKCM	cis	rs8070624	0.543	rs4299203	chr17:17878159	T/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.01	8.61	0.7	6.26e-13	Total body bone mineral density;
SKCM	cis	rs1577917	0.959	rs12201739	chr6:86720739	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.82	-8.08	-0.67	6.61e-12	Response to antipsychotic treatment;
SKCM	cis	rs1552244	0.882	rs35056669	chr3:10014171	C/T	cg02579736	chr3:10068473	FANCD2;CIDECP	0.94	4.84	0.48	6.49e-6	Alzheimer's disease;
SKCM	cis	rs9910055	0.718	rs7212854	chr17:42254417	A/G	cg13607699	chr17:42295918	UBTF	0.79	6.25	0.58	2.03e-8	Total body bone mineral density;
SKCM	cis	rs738321	0.757	rs4820314	chr22:38518538	G/A	cg25457927	chr22:38595422	NA	-0.58	-6.71	-0.61	2.75e-9	Breast cancer;
SKCM	cis	rs7149337	0.869	rs10137445	chr14:51694416	G/A	cg23942311	chr14:51606299	NA	0.61	6.66	0.6	3.42e-9	Cancer;
SKCM	cis	rs1878931	0.624	rs27235	chr16:3439138	G/C	cg26668626	chr16:3451006	ZNF174;ZNF434	-0.82	-6.03	-0.56	5.14e-8	Body mass index (adult);
SKCM	cis	rs6120849	0.754	rs6120812	chr20:33629427	T/C	cg24642439	chr20:33292090	TP53INP2	0.94	4.86	0.48	5.91e-6	Protein C levels;
SKCM	cis	rs654950	0.901	rs607586	chr1:42004379	C/T	cg06885757	chr1:42089581	HIVEP3	-0.63	-6.41	-0.59	1.02e-8	Airway imaging phenotypes;
SKCM	cis	rs747650	0.961	rs7945315	chr11:47110652	A/C	cg03339077	chr11:47165057	C11orf49	-0.61	-5.27	-0.51	1.16e-6	Acne (severe);
SKCM	cis	rs13118159	0.509	rs10023473	chr4:1375285	C/T	cg05025164	chr4:1340916	KIAA1530	0.86	7.1	0.63	5.08e-10	Longevity;
SKCM	cis	rs62244186	0.516	rs11922470	chr3:44777795	C/T	cg15225532	chr3:44803084	KIF15;KIAA1143	0.8	7.36	0.64	1.62e-10	Depressive symptoms;
SKCM	cis	rs7811142	1.000	rs74460138	chr7:100027339	C/G	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.34	0.69	2.1e-12	Platelet count;
SKCM	cis	rs11098499	0.818	rs12498599	chr4:120468503	C/T	cg24375607	chr4:120327624	NA	0.69	5.47	0.53	5.35e-7	Corneal astigmatism;
SKCM	cis	rs12497850	0.931	rs7621015	chr3:49016056	A/G	cg07636037	chr3:49044803	WDR6	1.02	11.0	0.78	1.56e-17	Parkinson's disease;
SKCM	cis	rs17826219	0.706	rs57698184	chr17:29064918	T/C	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Body mass index;
SKCM	cis	rs3784262	0.669	rs4646580	chr15:58329211	A/G	cg12031962	chr15:58353849	ALDH1A2	-0.42	-4.83	-0.48	6.81e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs28595532	0.920	rs55640619	chr4:119761999	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs2980439	0.783	rs2955587	chr8:8098079	A/G	cg06636001	chr8:8085503	FLJ10661	1.0	9.29	0.72	2.9e-14	Neuroticism;
SKCM	cis	rs2836974	0.897	rs14194	chr21:40549466	T/C	cg11644478	chr21:40555479	PSMG1	0.97	10.21	0.76	5.08e-16	Cognitive function;
SKCM	cis	rs1552244	1.000	rs113134644	chr3:10086286	G/A	cg02579736	chr3:10068473	FANCD2;CIDECP	1.25	6.87	0.61	1.36e-9	Alzheimer's disease;
SKCM	cis	rs11122272	0.525	rs2739517	chr1:231537914	C/A	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	-0.62	-4.91	-0.49	4.84e-6	Hemoglobin concentration;
SKCM	cis	rs7824557	0.527	rs2572376	chr8:11237756	C/A	cg21775007	chr8:11205619	TDH	-0.57	-4.8	-0.48	7.47e-6	Retinal vascular caliber;
SKCM	cis	rs941873	0.868	rs12780295	chr10:81115438	G/A	cg09469691	chr10:81107165	PPIF	0.74	7.33	0.64	1.81e-10	Height;
SKCM	cis	rs1218582	0.741	rs2335407	chr1:154843347	A/G	cg16680214	chr1:154839983	KCNN3	0.54	5.01	0.49	3.36e-6	Prostate cancer;
SKCM	cis	rs1005277	0.579	rs1985707	chr10:38434098	C/T	cg00409905	chr10:38381863	ZNF37A	-0.66	-6.18	-0.57	2.71e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs3820928	0.874	rs1917125	chr2:227798981	G/A	cg11843606	chr2:227700838	RHBDD1	-0.6	-4.81	-0.48	7.34e-6	Pulmonary function;
SKCM	cis	rs453301	0.571	rs2929454	chr8:9083854	A/C	cg06636001	chr8:8085503	FLJ10661	-0.76	-6.01	-0.56	5.62e-8	Joint mobility (Beighton score);
SKCM	cis	rs7098414	0.511	rs10466236	chr10:82149717	C/T	cg00277334	chr10:82204260	NA	0.59	6.16	0.57	3e-8	Post bronchodilator FEV1;
SKCM	cis	rs2839186	0.771	rs2280959	chr21:47641996	C/G	cg13126279	chr21:47581558	C21orf56	-0.67	-5.87	-0.55	9.92e-8	Testicular germ cell tumor;
SKCM	cis	rs17826219	0.568	rs9903854	chr17:29153998	C/T	cg13385521	chr17:29058706	SUZ12P	0.9	4.78	0.48	8.1e-6	Body mass index;
SKCM	cis	rs2243480	1.000	rs73142121	chr7:65311206	C/T	cg18252515	chr7:66147081	NA	-1.29	-7.41	-0.64	1.3e-10	Diabetic kidney disease;
SKCM	cis	rs7208859	0.623	rs9899268	chr17:29150255	T/C	cg13385521	chr17:29058706	SUZ12P	1.02	5.45	0.52	5.8e-7	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs595982	0.527	rs12151238	chr19:49368613	T/C	cg19746536	chr19:49375674	PPP1R15A	1.01	5.56	0.53	3.61e-7	Red cell distribution width;
SKCM	cis	rs12824058	0.844	rs7956408	chr12:130807547	A/T	cg24838063	chr12:130822603	PIWIL1	-0.69	-6.52	-0.59	6.44e-9	Menopause (age at onset);
SKCM	cis	rs12478296	1.000	rs56102931	chr2:243039936	A/G	cg06360820	chr2:242988706	NA	-0.92	-5.32	-0.52	9.84e-7	Obesity-related traits;
SKCM	cis	rs7000551	0.556	rs12674913	chr8:22263617	G/C	cg12081754	chr8:22256438	SLC39A14	0.98	9.41	0.73	1.73e-14	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs2228479	0.850	rs117675822	chr16:89919081	C/A	cg06558623	chr16:89946397	TCF25	1.12	5.0	0.49	3.47e-6	Skin colour saturation;
SKCM	cis	rs362296	0.615	rs34030762	chr4:3255736	C/A	cg21096898	chr4:3318625	RGS12	-0.73	-6.54	-0.59	5.92e-9	Parental longevity (mother's age at death);
SKCM	trans	rs3780486	0.846	rs10813950	chr9:33127640	A/G	cg04842962	chr6:43655489	MRPS18A	-1.07	-9.99	-0.75	1.3e-15	IgG glycosylation;
SKCM	cis	rs9916302	0.706	rs28482878	chr17:37497100	A/G	cg07936489	chr17:37558343	FBXL20	0.98	6.84	0.61	1.56e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs1799949	0.965	rs8176323	chr17:41195711	G/C	cg05368731	chr17:41323189	NBR1	0.9	7.94	0.67	1.23e-11	Menopause (age at onset);
SKCM	cis	rs13118159	0.527	rs1250119	chr4:1261336	G/A	cg19318889	chr4:1322082	MAEA	-0.72	-5.41	-0.52	6.72e-7	Longevity;
SKCM	cis	rs3818285	0.679	rs612155	chr10:111630731	C/G	cg00817464	chr10:111662876	XPNPEP1	0.73	8.47	0.69	1.13e-12	Superior crus of antihelix expression;
SKCM	cis	rs1577917	1.000	rs10455455	chr6:86670214	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.85	-8.62	-0.7	5.82e-13	Response to antipsychotic treatment;
SKCM	cis	rs8170	0.603	rs10259	chr19:17430915	G/A	cg07830086	chr19:18107778	KCNN1	-0.8	-5.01	-0.49	3.37e-6	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Ovarian cancer;Breast cancer;Epithelial ovarian cancer;
SKCM	cis	rs7937682	0.889	rs479667	chr11:111484034	C/T	cg19812747	chr11:111475976	SIK2	-0.56	-4.93	-0.49	4.55e-6	Primary sclerosing cholangitis;
SKCM	cis	rs2760061	0.583	rs1636195	chr1:228211589	T/C	cg02753203	chr1:228287806	NA	0.91	8.89	0.71	1.77e-13	Diastolic blood pressure;
SKCM	cis	rs2072510	0.722	rs2247313	chr12:96424447	C/T	cg18817487	chr12:96390143	HAL	0.43	5.68	0.54	2.18e-7	Metabolite levels (small molecules and protein measures);
SKCM	cis	rs760805	0.932	rs1005734	chr1:25262022	C/A	cg22509179	chr1:25234806	RUNX3	-0.74	-6.08	-0.57	4.19e-8	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs933688	0.938	rs6866923	chr5:90669352	A/C	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.05	8.27	0.68	2.79e-12	Smoking behavior;
SKCM	cis	rs2839186	0.504	rs11702278	chr21:47936295	T/G	cg12379764	chr21:47803548	PCNT	0.64	4.96	0.49	3.97e-6	Testicular germ cell tumor;
SKCM	cis	rs7809950	1.000	rs2395883	chr7:107089670	T/C	cg23024343	chr7:107201750	COG5	-0.76	-6.8	-0.61	1.89e-9	Coronary artery disease;
SKCM	cis	rs950776	0.518	rs2292117	chr15:78834689	C/T	cg06917634	chr15:78832804	PSMA4	1.01	10.48	0.76	1.5e-16	Sudden cardiac arrest;
SKCM	cis	rs1348850	0.651	rs1901826	chr2:178225266	G/A	cg02961200	chr2:178257176	LOC100130691;AGPS	0.74	5.28	0.51	1.14e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs34779708	0.801	rs12098720	chr10:35538683	G/A	cg03585969	chr10:35415529	CREM	0.74	5.42	0.52	6.41e-7	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs748404	0.660	rs690472	chr15:43764368	A/C	cg02155558	chr15:43621948	ADAL;LCMT2	0.74	5.54	0.53	3.97e-7	Lung cancer;
SKCM	cis	rs847649	0.694	rs11770319	chr7:102770170	C/G	cg18108683	chr7:102477205	FBXL13	0.8	7.47	0.65	9.92e-11	Morning vs. evening chronotype;
SKCM	cis	rs35146811	0.735	rs11764176	chr7:99786964	G/T	cg22906224	chr7:99728672	NA	0.65	5.19	0.51	1.6e-6	Coronary artery disease;
SKCM	cis	rs801193	1.000	rs2420824	chr7:66131116	G/A	cg00343986	chr7:65444356	GUSB	-0.67	-4.93	-0.49	4.55e-6	Aortic root size;
SKCM	cis	rs362296	0.698	rs3095081	chr4:3263776	C/T	cg05297308	chr4:3317976	RGS12	-0.76	-6.73	-0.61	2.51e-9	Parental longevity (mother's age at death);
SKCM	cis	rs2153535	0.580	rs7755284	chr6:8457479	T/C	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs910316	1.000	rs10138183	chr14:75615227	T/C	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.89e-7	Height;
SKCM	cis	rs2228479	0.702	rs62056100	chr16:89939753	C/T	cg06558623	chr16:89946397	TCF25	1.14	5.17	0.5	1.78e-6	Skin colour saturation;
SKCM	cis	rs28595532	0.920	rs116717907	chr4:119762568	A/G	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs2832191	0.740	rs13048618	chr21:30458684	A/G	cg24692254	chr21:30365293	RNF160	0.99	9.04	0.72	9.07e-14	Dental caries;
SKCM	cis	rs77106637	1.000	rs11605166	chr11:72669777	T/C	cg03713592	chr11:72463424	ARAP1	0.99	4.99	0.49	3.63e-6	Type 2 diabetes;
SKCM	cis	rs7937682	0.632	rs12785809	chr11:111776055	T/A	cg09085632	chr11:111637200	PPP2R1B	1.1	10.72	0.77	5.29e-17	Primary sclerosing cholangitis;
SKCM	cis	rs7143963	0.943	rs7156339	chr14:103366698	C/T	cg23020514	chr14:103360112	TRAF3	0.79	6.88	0.61	1.34e-9	Body mass index;
SKCM	cis	rs1799949	1.000	rs4340367	chr17:41307772	G/A	cg23758822	chr17:41437982	NA	0.92	7.83	0.66	1.97e-11	Menopause (age at onset);
SKCM	cis	rs67311347	0.568	rs57287242	chr3:40335538	T/C	cg13409248	chr3:40428643	ENTPD3	0.58	5.63	0.54	2.68e-7	Renal cell carcinoma;
SKCM	cis	rs9368481	0.645	rs10456350	chr6:26975581	A/C	cg12292205	chr6:26970375	C6orf41	0.72	6.63	0.6	4.02e-9	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs2836974	0.897	rs34035316	chr21:40594023	T/C	cg11644478	chr21:40555479	PSMG1	0.97	10.08	0.75	8.76e-16	Cognitive function;
SKCM	cis	rs9875589	0.509	rs4685058	chr3:14030384	T/C	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.52	5.17	0.51	1.77e-6	Ovarian reserve;
SKCM	cis	rs2760061	0.626	rs596208	chr1:228117982	G/C	cg18477163	chr1:228402036	OBSCN	-0.46	-5.1	-0.5	2.36e-6	Diastolic blood pressure;
SKCM	cis	rs1218582	0.774	rs4845681	chr1:154868055	G/T	cg03351412	chr1:154909251	PMVK	0.7	6.07	0.57	4.27e-8	Prostate cancer;
SKCM	cis	rs2072499	0.966	rs887953	chr1:156191149	T/C	cg24450063	chr1:156163899	SLC25A44	0.95	8.34	0.69	2.04e-12	Testicular germ cell tumor;
SKCM	cis	rs6580649	0.941	rs57054831	chr12:48486892	C/T	cg05342945	chr12:48394962	COL2A1	0.79	5.51	0.53	4.44e-7	Lung cancer;
SKCM	cis	rs4242434	0.819	rs1871902	chr8:22470710	G/A	cg03733263	chr8:22462867	KIAA1967	1.0	8.08	0.67	6.6e-12	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs9325144	0.723	rs11169482	chr12:39164327	A/T	cg13010199	chr12:38710504	ALG10B	0.58	5.02	0.49	3.23e-6	Morning vs. evening chronotype;
SKCM	cis	rs8072100	0.905	rs8077106	chr17:45653291	T/G	cg25173405	chr17:45401733	C17orf57	0.59	5.44	0.52	5.84e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs2050392	0.517	rs603072	chr10:30755778	C/T	cg25182066	chr10:30743637	MAP3K8	0.71	6.22	0.58	2.25e-8	Inflammatory bowel disease;
SKCM	cis	rs754466	0.874	rs55910200	chr10:79665173	T/C	cg17075019	chr10:79541650	NA	-0.71	-5.71	-0.54	1.94e-7	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs9467773	1.000	rs6925895	chr6:26572165	G/T	cg15659132	chr6:26577336	NA	0.61	5.76	0.55	1.6e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs28595532	0.920	rs55671478	chr4:119753811	A/G	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs6430585	0.591	rs12466487	chr2:136407078	C/T	cg07169764	chr2:136633963	MCM6	-1.11	-8.55	-0.7	8.04e-13	Corneal structure;
SKCM	cis	rs1568889	1.000	rs1568889	chr11:28009463	A/G	cg06544937	chr11:28130018	METT5D1;KIF18A	0.8	5.65	0.54	2.47e-7	Bipolar disorder;
SKCM	cis	rs12477438	0.501	rs6708878	chr2:99801564	G/A	cg14399236	chr2:99771627	LIPT1;TSGA10	0.96	8.62	0.7	5.82e-13	Chronic sinus infection;
SKCM	cis	rs826838	0.678	rs11182781	chr12:38610178	C/T	cg13010199	chr12:38710504	ALG10B	0.64	4.85	0.48	6.15e-6	Heart rate;
SKCM	cis	rs67460515	0.892	rs16832082	chr3:161043571	A/G	cg03342759	chr3:160939853	NMD3	-0.81	-7.1	-0.63	5.14e-10	Parkinson's disease;
SKCM	cis	rs71520386	0.632	rs9654968	chr7:22876316	C/T	cg00309339	chr7:22893653	NA	0.67	5.09	0.5	2.45e-6	Fibrinogen levels;
SKCM	cis	rs7215564	0.818	rs4890055	chr17:78587225	A/C	cg16980736	chr17:78789706	RPTOR	-0.89	-4.87	-0.48	5.8e-6	Myopia (pathological);
SKCM	cis	rs6545883	0.931	rs12713438	chr2:61725501	G/A	cg15711740	chr2:61764176	XPO1	-0.73	-5.25	-0.51	1.27e-6	Tuberculosis;
SKCM	cis	rs12044355	0.929	rs1954175	chr1:231855410	T/C	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	0.81	5.92	0.56	8.31e-8	Alzheimer's disease;
SKCM	cis	rs1979654	0.543	rs1552656	chr16:86401425	C/G	cg05448715	chr16:87090352	NA	-0.49	-5.29	-0.51	1.08e-6	Barrett's esophagus  or Esophageal adenocarcinoma;
SKCM	cis	rs8072100	0.967	rs8072644	chr17:45653364	A/T	cg08085267	chr17:45401833	C17orf57	0.6	5.28	0.51	1.15e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	trans	rs1814175	0.645	rs4598671	chr11:50003191	C/A	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs13108904	0.651	rs875475	chr4:1192409	G/A	cg19318889	chr4:1322082	MAEA	0.65	4.79	0.48	7.7e-6	Obesity-related traits;
SKCM	cis	rs9910055	0.718	rs2526022	chr17:42213216	C/T	cg13607699	chr17:42295918	UBTF	0.79	6.21	0.58	2.4e-8	Total body bone mineral density;
SKCM	cis	rs6088580	0.634	rs6141471	chr20:33006730	A/G	cg24642439	chr20:33292090	TP53INP2	-0.76	-6.02	-0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs11098499	0.863	rs6858777	chr4:120475966	A/G	cg09307838	chr4:120376055	NA	1.0	8.27	0.68	2.8e-12	Corneal astigmatism;
SKCM	cis	rs2842992	0.830	rs2758313	chr6:160154099	C/G	cg11366901	chr6:160182831	ACAT2	0.94	7.66	0.66	4.18e-11	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs8070128	0.601	rs8080602	chr17:17954728	G/C	cg04398451	chr17:18023971	MYO15A	0.94	7.53	0.65	7.5e-11	Total body bone mineral density;
SKCM	cis	rs6089584	0.528	rs4925334	chr20:60626769	C/T	cg16423285	chr20:60520624	NA	-0.58	-4.92	-0.49	4.77e-6	Body mass index;
SKCM	cis	rs7100689	0.524	rs7902460	chr10:82199263	T/A	cg00277334	chr10:82204260	NA	-0.67	-6.98	-0.62	8.74e-10	Post bronchodilator FEV1;
SKCM	cis	rs2153535	0.580	rs6927589	chr6:8456632	A/G	cg23788917	chr6:8435910	SLC35B3	-0.69	-5.08	-0.5	2.51e-6	Motion sickness;
SKCM	cis	rs933688	1.000	rs61612071	chr5:90741470	G/A	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.94	6.78	0.61	2.1e-9	Smoking behavior;
SKCM	cis	rs2980439	0.870	rs2945230	chr8:8109936	A/G	cg06636001	chr8:8085503	FLJ10661	1.02	8.92	0.71	1.53e-13	Neuroticism;
SKCM	cis	rs6062496	0.631	rs2297434	chr20:62294015	C/T	cg27236539	chr20:62289627	RTEL1	0.72	4.95	0.49	4.16e-6	Crohn's disease;Inflammatory bowel disease;Ulcerative colitis;
SKCM	cis	rs317689	0.513	rs529268	chr12:69687051	G/A	cg20891283	chr12:69753455	YEATS4	0.64	5.0	0.49	3.47e-6	Response to diuretic therapy;
SKCM	cis	rs7824557	0.628	rs11994376	chr8:11202960	G/A	cg21775007	chr8:11205619	TDH	0.71	6.33	0.58	1.47e-8	Retinal vascular caliber;
SKCM	cis	rs867186	1.000	rs11907438	chr20:33641220	T/A	cg04194272	chr20:33683537	NA	-1.38	-7.2	-0.63	3.29e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs72781680	1.000	rs11125372	chr2:24257582	A/T	cg08917208	chr2:24149416	ATAD2B	-1.1	-5.75	-0.55	1.64e-7	Lymphocyte counts;
SKCM	cis	rs2033711	0.870	rs6510152	chr19:58953319	C/T	cg12042659	chr19:58951599	ZNF132	0.68	5.97	0.56	6.49e-8	Uric acid clearance;
SKCM	cis	rs9640161	0.750	rs3800780	chr7:150027284	C/A	cg27494647	chr7:150038898	RARRES2	0.57	4.96	0.49	3.97e-6	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs6977660	0.660	rs10269891	chr7:19816063	T/C	cg07541023	chr7:19748670	TWISTNB	0.75	4.83	0.48	6.61e-6	Thyroid stimulating hormone;
SKCM	cis	rs2033711	0.870	rs11669741	chr19:58960481	C/T	cg12042659	chr19:58951599	ZNF132	-0.67	-5.92	-0.56	8.02e-8	Uric acid clearance;
SKCM	cis	rs9915657	0.933	rs17246133	chr17:70140485	A/G	cg06234051	chr17:70120541	SOX9	-0.59	-5.07	-0.5	2.57e-6	Thyroid hormone levels;
SKCM	cis	rs933688	1.000	rs7720132	chr5:90745105	T/C	cg12630606	chr5:90679528	LOC100129716;ARRDC3	0.98	7.81	0.66	2.22e-11	Smoking behavior;
SKCM	cis	rs11098499	0.866	rs12513310	chr4:120288039	T/A	cg24375607	chr4:120327624	NA	0.62	4.77	0.48	8.45e-6	Corneal astigmatism;
SKCM	cis	rs7666738	0.830	rs4699598	chr4:99019158	C/T	cg17366294	chr4:99064904	C4orf37	0.59	4.9	0.49	5.04e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2404602	0.692	rs4442773	chr15:77031633	T/C	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs644799	0.965	rs687529	chr11:95545587	T/A	cg25622487	chr11:95524042	FAM76B;CEP57	0.66	5.12	0.5	2.18e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs6952808	1.000	rs6952808	chr7:1886535	C/G	cg04267008	chr7:1944627	MAD1L1	-0.73	-5.55	-0.53	3.85e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs7584330	0.780	rs2292884	chr2:238443226	A/G	cg14458575	chr2:238380390	NA	1.0	7.12	0.63	4.64e-10	Prostate cancer;
SKCM	cis	rs7772486	0.875	rs10872582	chr6:146373061	G/A	cg23711669	chr6:146136114	FBXO30	0.83	7.87	0.67	1.64e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1499614	1.000	rs34250985	chr7:66161062	A/T	cg18252515	chr7:66147081	NA	-1.55	-7.52	-0.65	7.96e-11	Gout;
SKCM	cis	rs1577917	0.958	rs11758508	chr6:86506878	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.61	5.03	0.49	3.08e-6	Response to antipsychotic treatment;
SKCM	cis	rs3820928	0.874	rs4234064	chr2:227857497	G/T	cg11843606	chr2:227700838	RHBDD1	-0.61	-4.98	-0.49	3.73e-6	Pulmonary function;
SKCM	cis	rs8180040	0.966	rs11705957	chr3:47443262	T/G	cg27129171	chr3:47204927	SETD2	-0.79	-5.79	-0.55	1.43e-7	Colorectal cancer;
SKCM	cis	rs6977660	1.000	rs5017193	chr7:19820103	G/A	cg05791153	chr7:19748676	TWISTNB	0.79	5.34	0.52	9.05e-7	Thyroid stimulating hormone;
SKCM	cis	rs9818758	0.607	rs67060340	chr3:48915321	C/T	cg24898236	chr3:49228699	LOC646498	0.65	4.98	0.49	3.66e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs1862618	0.802	rs986049	chr5:56110233	G/A	cg12311346	chr5:56204834	C5orf35	-0.72	-4.92	-0.49	4.63e-6	Initial pursuit acceleration;
SKCM	cis	rs929354	1.000	rs929354	chr7:157045557	C/T	cg17757837	chr7:157058334	UBE3C	-0.89	-6.78	-0.61	2.03e-9	Body mass index;
SKCM	cis	rs3091242	0.935	rs3093632	chr1:25684012	C/T	cg02931644	chr1:25747376	RHCE	0.5	4.97	0.49	3.91e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs3768617	0.510	rs10797835	chr1:183072908	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs875971	0.522	rs4718286	chr7:65292764	A/G	cg11987759	chr7:65425863	GUSB	-0.75	-6.42	-0.59	9.94e-9	Aortic root size;
SKCM	trans	rs561341	1.000	rs554078	chr17:30330109	A/C	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs80033912	0.640	rs6785832	chr3:49224316	C/T	cg07636037	chr3:49044803	WDR6	0.65	5.67	0.54	2.35e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs58688157	0.705	rs936468	chr11:607175	G/A	cg16486109	chr11:613632	IRF7	1.07	7.28	0.64	2.33e-10	Systemic lupus erythematosus;
SKCM	cis	rs4237845	0.636	rs11172371	chr12:58286188	C/T	cg00677455	chr12:58241039	CTDSP2	0.85	7.74	0.66	3.02e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs514406	0.679	rs541852	chr1:53256834	A/G	cg24675658	chr1:53192096	ZYG11B	0.88	8.13	0.68	5.38e-12	Monocyte count;
SKCM	cis	rs28386778	0.933	rs2665804	chr17:61951836	G/T	cg06873352	chr17:61820015	STRADA	0.76	6.56	0.6	5.37e-9	Prudent dietary pattern;
SKCM	cis	rs5769765	0.862	rs138897	chr22:50231067	T/C	cg22709217	chr22:50311962	ALG12;CRELD2	-0.88	-6.04	-0.56	5.03e-8	Schizophrenia;
SKCM	cis	rs4268898	0.560	rs2384007	chr2:24514841	A/G	cg06627628	chr2:24431161	ITSN2	-0.92	-6.76	-0.61	2.26e-9	Asthma;
SKCM	cis	rs2836974	0.932	rs8128734	chr21:40569511	G/A	cg11890956	chr21:40555474	PSMG1	1.11	13.57	0.84	3.1e-22	Cognitive function;
SKCM	cis	rs597539	0.652	rs513615	chr11:68705504	G/T	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.87	5.81	0.55	1.3e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs2455826	1.000	rs2471806	chr3:15674587	A/G	cg21141587	chr3:14755007	C3orf20	-0.58	-4.8	-0.48	7.65e-6	Inflammatory skin disease;
SKCM	cis	rs8038465	0.638	rs12594175	chr15:73973186	C/T	cg15420318	chr15:73925796	NPTN	0.61	4.89	0.48	5.19e-6	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs11155671	0.530	rs2342769	chr6:150216507	T/C	cg05036130	chr6:150231994	NA	0.6	6.54	0.59	5.91e-9	Testicular germ cell tumor;
SKCM	cis	rs6547631	0.622	rs10180451	chr2:85926238	G/T	cg24620635	chr2:85921963	GNLY	0.9	6.65	0.6	3.58e-9	Blood protein levels;
SKCM	cis	rs2733310	0.895	rs1657927	chr15:57139631	C/A	cg01857019	chr15:57210107	LOC145783;TCF12	0.64	4.86	0.48	5.88e-6	Mean platelet volume;
SKCM	cis	rs12142240	0.698	rs67276232	chr1:46825484	T/G	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs62064224	0.703	rs4287613	chr17:30827688	C/T	cg18200150	chr17:30822561	MYO1D	0.7	5.45	0.52	5.76e-7	Schizophrenia;
SKCM	cis	rs1405130	0.869	rs4663466	chr2:235573203	G/C	cg17841421	chr2:235704848	NA	-0.57	-4.95	-0.49	4.14e-6	Coronary artery disease;
SKCM	cis	rs6570726	1.000	rs404229	chr6:145868200	G/A	cg23711669	chr6:146136114	FBXO30	0.69	6.67	0.6	3.39e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4481887	0.741	rs28589987	chr1:248564785	T/C	cg00666640	chr1:248458726	OR2T12	0.51	5.23	0.51	1.37e-6	Common traits (Other);
SKCM	cis	rs7937682	0.889	rs516263	chr11:111484719	A/C	cg19812747	chr11:111475976	SIK2	-0.56	-4.93	-0.49	4.55e-6	Primary sclerosing cholangitis;
SKCM	cis	rs807669	0.903	rs1780637	chr22:19178250	A/G	cg02655711	chr22:19163373	SLC25A1	0.78	7.22	0.63	3.03e-10	Metabolite levels;
SKCM	cis	rs611744	0.647	rs589347	chr8:109253929	T/A	cg18478394	chr8:109455254	TTC35	0.66	5.33	0.52	9.43e-7	Dupuytren's disease;
SKCM	cis	rs4481887	0.676	rs6691314	chr1:248548020	G/A	cg00666640	chr1:248458726	OR2T12	0.47	4.8	0.48	7.51e-6	Common traits (Other);
SKCM	cis	rs4927850	0.521	rs4927679	chr3:195658360	C/T	cg12923728	chr3:195709715	SDHAP1	0.7	5.26	0.51	1.21e-6	Pancreatic cancer;
SKCM	cis	rs62238980	0.521	rs78578916	chr22:32456881	G/A	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs9420	0.961	rs11229148	chr11:57621460	A/T	cg19752551	chr11:57585705	CTNND1	-0.71	-7.24	-0.63	2.77e-10	Schizophrenia;
SKCM	cis	rs7937682	0.921	rs10891280	chr11:111433609	A/T	cg19812747	chr11:111475976	SIK2	0.66	5.32	0.52	9.5e-7	Primary sclerosing cholangitis;
SKCM	cis	rs2952156	0.920	rs11078919	chr17:37835755	T/C	cg00129232	chr17:37814104	STARD3	-0.71	-6.04	-0.56	4.96e-8	Asthma;
SKCM	trans	rs561341	1.000	rs2344312	chr17:30243583	G/T	cg20587970	chr11:113659929	NA	-1.08	-8.21	-0.68	3.61e-12	Hip circumference adjusted for BMI;
SKCM	cis	rs2952156	0.920	rs2952152	chr17:37832735	T/C	cg20243544	chr17:37824526	PNMT	0.75	6.09	0.57	4e-8	Asthma;
SKCM	cis	rs763014	0.898	rs1045277	chr16:633125	T/C	cg00908189	chr16:619842	PIGQ	0.82	7.78	0.66	2.55e-11	Height;
SKCM	cis	rs1153858	0.887	rs28569043	chr15:45730926	A/T	cg21132104	chr15:45694354	SPATA5L1	0.84	5.84	0.55	1.15e-7	Homoarginine levels;
SKCM	cis	rs367615	0.704	rs72802966	chr5:108846754	T/G	cg17395555	chr5:108820864	NA	0.76	6.91	0.62	1.17e-9	Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs151997	1.000	rs373030	chr5:50215836	G/A	cg06027927	chr5:50259733	NA	0.66	5.78	0.55	1.45e-7	Callous-unemotional behaviour;
SKCM	cis	rs8017423	0.935	rs4643251	chr14:90669256	C/T	cg04374321	chr14:90722782	PSMC1	-0.98	-8.8	-0.71	2.63e-13	Mortality in heart failure;
SKCM	cis	rs9905704	0.647	rs11652713	chr17:57079742	C/T	cg05425664	chr17:57184151	TRIM37	-0.58	-4.8	-0.48	7.36e-6	Testicular germ cell tumor;
SKCM	cis	rs13223928	0.651	rs4722435	chr7:3152962	C/T	cg19214707	chr7:3157722	NA	0.51	4.81	0.48	7.27e-6	Eosinophil percentage of white cells;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil counts;
SKCM	cis	rs634534	0.591	rs688862	chr11:65733393	A/G	cg02427764	chr11:65769310	BANF1;EIF1AD	0.64	4.98	0.49	3.75e-6	Sum eosinophil basophil counts;Eosinophil counts;
SKCM	cis	rs4619890	0.510	rs75972227	chr4:7891420	T/G	cg08722675	chr4:8412549	ACOX3	0.52	4.78	0.48	7.99e-6	Glaucoma (primary open-angle);
SKCM	trans	rs1814175	0.616	rs10839342	chr11:49742687	A/C	cg15704280	chr7:45808275	SEPT13	-0.97	-9.35	-0.73	2.25e-14	Height;
SKCM	cis	rs362272	0.524	rs881816	chr4:3365366	A/G	cg03043834	chr4:3319541	RGS12	0.6	4.94	0.49	4.39e-6	Serum sulfate level;
SKCM	cis	rs6835098	0.924	rs7672108	chr4:174165126	A/G	cg08422745	chr4:174089978	GALNT7	0.69	5.18	0.51	1.66e-6	Dementia and core Alzheimer's disease neuropathologic changes;
SKCM	cis	rs17818399	0.547	rs13020299	chr2:46758717	A/G	cg02822958	chr2:46747628	ATP6V1E2	0.68	4.91	0.49	4.99e-6	Height;
SKCM	cis	rs2839186	0.739	rs7282763	chr21:47696800	C/T	cg13012494	chr21:47604986	C21orf56	0.64	5.39	0.52	7.36e-7	Testicular germ cell tumor;
SKCM	cis	rs997295	0.570	rs17241808	chr15:67892792	A/G	cg24247231	chr15:67904302	MAP2K5	-0.59	-4.97	-0.49	3.85e-6	Motion sickness;
SKCM	cis	rs11155671	0.530	rs6557133	chr6:150195384	G/T	cg09699651	chr6:150184138	LRP11	0.63	5.0	0.49	3.44e-6	Testicular germ cell tumor;
SKCM	cis	rs2180341	0.618	rs4502958	chr6:127593113	G/A	cg27446573	chr6:127587934	RNF146	0.68	5.47	0.53	5.22e-7	Breast cancer;
SKCM	cis	rs11764590	0.724	rs62444917	chr7:2107262	A/C	cg23422044	chr7:1970798	MAD1L1	-0.86	-5.96	-0.56	6.86e-8	Neuroticism;
SKCM	cis	rs2204008	0.774	rs11180977	chr12:38263094	G/T	cg26384229	chr12:38710491	ALG10B	0.87	6.83	0.61	1.63e-9	Bladder cancer;
SKCM	cis	rs2180341	1.000	rs2180341	chr6:127600630	C/T	cg27446573	chr6:127587934	RNF146	0.98	7.47	0.65	9.77e-11	Breast cancer;
SKCM	cis	rs2839186	0.739	rs7282763	chr21:47696800	C/T	cg11766577	chr21:47581405	C21orf56	-0.68	-5.67	-0.54	2.35e-7	Testicular germ cell tumor;
SKCM	cis	rs6445797	0.632	rs4681951	chr3:56633402	A/G	cg13616963	chr3:57583610	ARF4	-0.76	-4.89	-0.48	5.37e-6	Gastritis;
SKCM	cis	rs875971	0.540	rs35510581	chr7:65578777	G/A	cg18876405	chr7:65276391	NA	-0.82	-7.34	-0.64	1.76e-10	Aortic root size;
SKCM	cis	rs1865760	0.625	rs9393681	chr6:26008260	A/G	cg16482183	chr6:26056742	HIST1H1C	0.62	4.86	0.48	6.06e-6	Height;
SKCM	cis	rs2228479	0.867	rs11645970	chr16:89958118	G/A	cg00800038	chr16:89945340	TCF25	-0.93	-5.34	-0.52	8.73e-7	Skin colour saturation;
SKCM	cis	rs801193	1.000	rs62466793	chr7:66191517	G/A	cg18876405	chr7:65276391	NA	0.8	7.11	0.63	4.88e-10	Aortic root size;
SKCM	cis	rs7666738	0.791	rs6851549	chr4:99029827	G/A	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4272321	1	rs4272321	chr7:157951835	A/G	cg02538280	chr7:157956927	PTPRN2	0.61	5.75	0.55	1.69e-7	Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes;
SKCM	cis	rs12477438	0.520	rs6756650	chr2:99801800	T/C	cg14399236	chr2:99771627	LIPT1;TSGA10	0.92	7.99	0.67	9.76e-12	Chronic sinus infection;
SKCM	cis	rs72827839	0.654	rs56104550	chr17:45941794	A/T	cg23391107	chr17:45924227	SP6	0.65	5.36	0.52	8.27e-7	Ease of getting up in the morning;
SKCM	cis	rs9611565	0.559	rs132765	chr22:42008068	A/G	cg03806693	chr22:41940476	POLR3H	1.11	7.56	0.65	6.74e-11	Vitiligo;
SKCM	cis	rs9896933	0.830	rs12450046	chr17:80790388	G/A	cg20578329	chr17:80767326	TBCD	-0.94	-6.51	-0.59	6.62e-9	Bone mineral accretion in asthma (oral corticosteroid dose interaction);
SKCM	cis	rs28595532	0.841	rs55744948	chr4:119769243	T/C	cg21605333	chr4:119757512	SEC24D	1.34	7.02	0.62	7.3e-10	Cannabis dependence symptom count;
SKCM	cis	rs3015497	0.527	rs3015473	chr14:51154010	A/G	cg00994032	chr14:50315768	SDCCAG1	-0.61	-4.91	-0.49	4.94e-6	Mean platelet volume;
SKCM	cis	rs2034088	0.897	rs11652657	chr17:439124	A/G	cg06217071	chr17:408420	NA	0.51	5.8	0.55	1.37e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs1799949	1.000	rs4534897	chr17:41431808	A/G	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.2	-0.57	2.51e-8	Menopause (age at onset);
SKCM	cis	rs782590	0.774	rs782629	chr2:55900283	C/T	cg18811423	chr2:55921094	PNPT1	-0.86	-6.88	-0.61	1.33e-9	Metabolic syndrome;
SKCM	cis	rs9435341	0.965	rs61798468	chr1:107569316	T/G	cg09367891	chr1:107599246	PRMT6	0.84	6.83	0.61	1.69e-9	Facial morphology (factor 21, depth of nasal alae);
SKCM	cis	rs873946	0.586	rs12782567	chr10:134576709	C/G	cg26818010	chr10:134567672	INPP5A	0.83	6.54	0.6	5.71e-9	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs9828933	0.577	rs832194	chr3:63857071	G/A	cg16258503	chr3:63850278	ATXN7;THOC7	0.85	5.16	0.5	1.84e-6	Type 2 diabetes;
SKCM	cis	rs7945705	0.902	rs10743095	chr11:8936984	T/C	cg13070366	chr11:9386451	NA	-0.64	-5.51	-0.53	4.48e-7	Hemoglobin concentration;
SKCM	cis	rs4689592	0.503	rs4689064	chr4:7055603	A/G	cg26116260	chr4:7069785	GRPEL1	-1.07	-7.29	-0.64	2.24e-10	Monocyte percentage of white cells;
SKCM	cis	rs2732480	0.577	rs2634680	chr12:48734564	T/C	cg21348975	chr12:48724119	NA	-0.6	-5.35	-0.52	8.64e-7	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs651907	0.763	rs647556	chr3:101590195	G/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.67	5.05	0.5	2.78e-6	Colorectal cancer;
SKCM	trans	rs208520	0.690	rs12204512	chr6:66710486	C/T	cg15611600	chr13:45563400	KIAA1704;NUFIP1	0.92	7.64	0.65	4.69e-11	Exhaled nitric oxide output;
SKCM	cis	rs1044826	0.642	rs295482	chr3:139229264	A/T	cg15131784	chr3:139108705	COPB2	-0.68	-4.96	-0.49	4.03e-6	Obesity-related traits;
SKCM	cis	rs1577917	0.874	rs1838954	chr6:86565478	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.32	-0.52	9.66e-7	Response to antipsychotic treatment;
SKCM	cis	rs763014	0.931	rs11648728	chr16:635525	C/T	cg00908189	chr16:619842	PIGQ	0.82	7.78	0.66	2.55e-11	Height;
SKCM	cis	rs4319547	0.737	rs11058226	chr12:122938958	A/G	cg23029597	chr12:123009494	RSRC2	-0.84	-5.59	-0.53	3.26e-7	Body mass index;
SKCM	cis	rs6840360	0.571	rs11726892	chr4:152555106	A/G	cg22705602	chr4:152727874	NA	-0.52	-5.69	-0.54	2.15e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs910316	0.737	rs28687415	chr14:75495482	T/C	cg08847533	chr14:75593920	NEK9	0.8	6.59	0.6	4.76e-9	Height;
SKCM	cis	rs2777491	1.000	rs7167729	chr15:41721042	G/A	cg18705301	chr15:41695430	NDUFAF1	-0.89	-9.04	-0.72	9.17e-14	Ulcerative colitis;
SKCM	cis	rs10540	0.818	rs12806089	chr11:501468	G/A	cg03352830	chr11:487213	PTDSS2	0.94	4.91	0.49	4.87e-6	Body mass index;
SKCM	cis	rs55823223	0.648	rs936394	chr17:73852008	C/A	cg08125733	chr17:73851984	WBP2	1.06	6.53	0.59	6.17e-9	Psoriasis;
SKCM	cis	rs2013441	0.606	rs12942179	chr17:19999781	G/A	cg13482628	chr17:19912719	NA	0.68	5.16	0.5	1.85e-6	Obesity-related traits;
SKCM	cis	rs7811142	1.000	rs67471932	chr7:100009985	C/G	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.33	0.69	2.11e-12	Platelet count;
SKCM	cis	rs6951245	0.554	rs11761322	chr7:1151657	A/G	cg03188948	chr7:1209495	NA	0.83	5.88	0.55	9.86e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7552404	0.924	rs2153126	chr1:76199345	C/G	cg22875332	chr1:76189707	ACADM	0.69	4.78	0.48	8.13e-6	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs3820068	0.581	rs2861387	chr1:15951296	G/A	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs3785574	0.962	rs62077483	chr17:61806380	C/T	cg01411255	chr17:61851458	DDX42;CCDC47	1.13	12.96	0.83	3.89e-21	Height;
SKCM	cis	rs7618501	0.633	rs9861216	chr3:50059339	A/G	cg24110177	chr3:50126178	RBM5	0.6	5.11	0.5	2.25e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7772486	0.686	rs702314	chr6:146003510	G/A	cg05347473	chr6:146136440	FBXO30	-0.59	-5.24	-0.51	1.34e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2228479	0.850	rs17227263	chr16:89810598	G/A	cg06558623	chr16:89946397	TCF25	1.03	5.59	0.53	3.23e-7	Skin colour saturation;
SKCM	cis	rs4481887	1.000	rs4457616	chr1:248492198	A/G	cg00666640	chr1:248458726	OR2T12	0.59	4.96	0.49	4.04e-6	Common traits (Other);
SKCM	cis	rs826838	0.967	rs1486345	chr12:39131677	G/A	cg26384229	chr12:38710491	ALG10B	-0.92	-8.41	-0.69	1.48e-12	Heart rate;
SKCM	cis	rs6951245	1.000	rs76214082	chr7:1102097	T/A	cg24642844	chr7:1081250	C7orf50	-0.93	-6.22	-0.58	2.28e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7772486	0.875	rs10457794	chr6:146415608	A/G	cg23711669	chr6:146136114	FBXO30	0.85	8.48	0.69	1.09e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1557765	0.527	rs11024272	chr11:17395760	T/C	cg15432903	chr11:17409602	KCNJ11	0.53	5.06	0.5	2.7e-6	Body mass index;Social communication problems;
SKCM	cis	rs2439831	0.850	rs28696802	chr15:44140395	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.3	6.97	0.62	9.12e-10	Lung cancer in ever smokers;
SKCM	cis	rs9611565	0.559	rs12483860	chr22:41961916	C/T	cg03806693	chr22:41940476	POLR3H	-1.04	-6.96	-0.62	9.22e-10	Vitiligo;
SKCM	cis	rs7959452	0.605	rs12819406	chr12:69696400	G/T	cg20891283	chr12:69753455	YEATS4	0.76	6.95	0.62	9.76e-10	Blood protein levels;
SKCM	cis	rs873946	0.648	rs12769533	chr10:134548685	C/T	cg18305652	chr10:134549665	INPP5A	-0.54	-5.53	-0.53	4.08e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs17826219	0.561	rs11655876	chr17:29017150	G/A	cg14067834	chr17:29058358	SUZ12P	1.0	5.4	0.52	7.01e-7	Body mass index;
SKCM	cis	rs4642101	0.535	rs55692304	chr3:12840057	C/T	cg05775895	chr3:12838266	CAND2	0.66	5.58	0.53	3.36e-7	QRS complex (12-leadsum);
SKCM	cis	rs4665809	0.590	rs1049987	chr2:26413817	C/T	cg26119090	chr2:26468346	HADHA;HADHB	1.05	8.09	0.68	6.22e-12	Gut microbiome composition (summer);
SKCM	cis	rs8064299	0.597	rs4789098	chr17:72781292	C/G	cg25054828	chr17:72772726	NAT9;TMEM104	0.92	9.32	0.73	2.57e-14	Monocyte count;
SKCM	cis	rs34779708	0.931	rs7079498	chr10:35375344	C/T	cg03585969	chr10:35415529	CREM	0.78	6.3	0.58	1.6e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	trans	rs7618501	1.000	rs3811696	chr3:49761605	C/T	cg21659725	chr3:3221576	CRBN	-0.96	-9.61	-0.74	7.08e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs7666738	0.830	rs7662199	chr4:99019766	G/A	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7917772	0.539	rs12572775	chr10:104285594	A/T	cg11453585	chr10:104263688	ACTR1A;SUFU	-0.6	-4.93	-0.49	4.53e-6	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs2836974	0.584	rs6517535	chr21:40653352	G/C	cg11890956	chr21:40555474	PSMG1	-0.88	-9.14	-0.72	5.76e-14	Cognitive function;
SKCM	cis	rs1552244	1.000	rs35198334	chr3:10104553	G/C	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs4919087	1.000	rs4919091	chr10:99088682	A/T	cg25902810	chr10:99078978	FRAT1	-0.62	-4.96	-0.49	4.07e-6	Monocyte count;
SKCM	cis	rs1577917	0.958	rs12193904	chr6:86452703	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.67	-5.77	-0.55	1.54e-7	Response to antipsychotic treatment;
SKCM	cis	rs1185460	0.967	rs1786141	chr11:118938315	C/T	cg23280166	chr11:118938394	VPS11	0.57	5.29	0.51	1.08e-6	Coronary artery disease;
SKCM	cis	rs8180040	0.903	rs12487736	chr3:47459679	C/T	cg27129171	chr3:47204927	SETD2	0.74	5.66	0.54	2.37e-7	Colorectal cancer;
SKCM	cis	rs9674544	0.740	rs11870560	chr17:47114033	T/C	cg22947322	chr17:47091978	IGF2BP1	-0.53	-4.86	-0.48	5.98e-6	Primary tooth development (time to first tooth eruption);Primary tooth development (number of teeth);
SKCM	cis	rs2732480	0.577	rs2634693	chr12:48706498	C/T	cg21348975	chr12:48724119	NA	-0.6	-4.97	-0.49	3.88e-6	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs72781680	1.000	rs72796389	chr2:24171761	A/G	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	cis	rs8180040	0.932	rs1038394	chr3:47464122	A/G	cg16586182	chr3:47516702	SCAP	-0.76	-5.32	-0.52	9.63e-7	Colorectal cancer;
SKCM	cis	rs11122272	0.668	rs2749712	chr1:231537751	T/A	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	-0.62	-4.91	-0.49	4.84e-6	Hemoglobin concentration;
SKCM	cis	rs898097	0.528	rs2243523	chr17:80680449	G/T	cg16060761	chr17:80687452	NA	0.7	5.57	0.53	3.55e-7	Breast cancer;
SKCM	cis	rs1799949	0.965	rs799908	chr17:41278916	A/G	cg23758822	chr17:41437982	NA	0.93	7.62	0.65	5.1e-11	Menopause (age at onset);
SKCM	cis	rs7666738	0.830	rs7664169	chr4:99037859	C/T	cg05340658	chr4:99064831	C4orf37	-0.66	-5.11	-0.5	2.25e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2739330	0.791	rs4822458	chr22:24265659	C/T	cg04234412	chr22:24373322	LOC391322	-0.67	-5.74	-0.54	1.73e-7	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs67311347	0.955	rs4973999	chr3:40460383	G/A	cg00091569	chr3:40428383	ENTPD3	0.59	5.03	0.49	3.07e-6	Renal cell carcinoma;
SKCM	cis	rs6461049	0.646	rs3778970	chr7:2143208	C/A	cg02951883	chr7:2050386	MAD1L1	-0.79	-7.4	-0.64	1.37e-10	Schizophrenia;
SKCM	cis	rs933688	1.000	rs35712350	chr5:90679519	C/T	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.12	8.63	0.7	5.55e-13	Smoking behavior;
SKCM	cis	rs694739	0.536	rs11231740	chr11:64046641	C/T	cg02228329	chr11:64053129	BAD;GPR137	-0.89	-6.41	-0.59	1.04e-8	Alopecia areata;Crohn's disease;Psoriasis vulgaris;
SKCM	cis	rs72634258	0.945	rs12727642	chr1:8046672	C/A	cg00042356	chr1:8021962	PARK7	1.09	7.71	0.66	3.35e-11	Inflammatory bowel disease;
SKCM	cis	rs17065868	1.000	rs9533925	chr13:45182917	T/C	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs10504229	0.683	rs7827014	chr8:58132230	G/A	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs72634258	0.945	rs4908724	chr1:8119251	G/T	cg00042356	chr1:8021962	PARK7	1.1	7.79	0.66	2.35e-11	Inflammatory bowel disease;
SKCM	cis	rs1577917	0.710	rs9342041	chr6:86280875	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.74	6.54	0.59	5.95e-9	Response to antipsychotic treatment;
SKCM	cis	rs6500395	1.000	rs11641458	chr16:48670845	C/T	cg04672837	chr16:48644449	N4BP1	0.63	5.29	0.51	1.08e-6	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs9911578	1.000	rs12602346	chr17:56901713	T/C	cg05425664	chr17:57184151	TRIM37	-0.67	-5.04	-0.5	2.91e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1707322	0.686	rs3014242	chr1:46087577	G/A	cg03146154	chr1:46216737	IPP	-0.83	-6.17	-0.57	2.83e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs782590	1.000	rs782594	chr2:55844445	T/C	cg18811423	chr2:55921094	PNPT1	0.9	6.98	0.62	8.78e-10	Metabolic syndrome;
SKCM	cis	rs2070488	0.965	rs35091896	chr3:38443320	G/A	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.98	8.81	0.71	2.51e-13	Electrocardiographic conduction measures;
SKCM	cis	rs9911578	1.000	rs6503866	chr17:56619581	C/T	cg05425664	chr17:57184151	TRIM37	0.69	5.21	0.51	1.52e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs72634258	0.554	rs12745962	chr1:7919825	C/T	cg00042356	chr1:8021962	PARK7	0.81	5.5	0.53	4.56e-7	Inflammatory bowel disease;
SKCM	cis	rs12188164	1.000	rs56104584	chr5:437542	T/C	cg26076054	chr5:421317	AHRR	-0.61	-4.87	-0.48	5.68e-6	Cystic fibrosis severity;
SKCM	cis	rs941408	1.000	rs1736180	chr19:2796021	C/T	cg06609049	chr19:2785107	THOP1	0.87	7.75	0.66	2.87e-11	Total cholesterol levels;
SKCM	cis	rs7772486	0.782	rs7747576	chr6:146277827	C/T	cg23711669	chr6:146136114	FBXO30	-0.79	-7.45	-0.64	1.1e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7772486	0.875	rs2814873	chr6:146308932	T/C	cg23711669	chr6:146136114	FBXO30	0.76	7.08	0.63	5.66e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs17818399	0.645	rs35870739	chr2:46784231	A/C	cg02822958	chr2:46747628	ATP6V1E2	0.69	5.0	0.49	3.4e-6	Height;
SKCM	cis	rs634534	0.622	rs1308733	chr11:65720841	T/C	cg17985854	chr11:65770987	BANF1;EIF1AD	-0.52	-4.95	-0.49	4.21e-6	Sum eosinophil basophil counts;Eosinophil counts;
SKCM	cis	rs72949976	0.646	rs11681232	chr2:214033002	G/A	cg08319019	chr2:214017104	IKZF2	0.82	6.64	0.6	3.8e-9	Lung cancer;Squamous cell lung carcinoma;
SKCM	cis	rs8017423	0.647	rs1958345	chr14:90823770	T/C	cg04374321	chr14:90722782	PSMC1	-0.73	-5.53	-0.53	4.08e-7	Mortality in heart failure;
SKCM	cis	rs6952808	1.000	rs4449693	chr7:1884630	G/C	cg02951883	chr7:2050386	MAD1L1	-0.71	-5.07	-0.5	2.66e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs2153535	0.563	rs6942177	chr6:8534460	A/G	cg07606381	chr6:8435919	SLC35B3	-0.93	-6.84	-0.61	1.58e-9	Motion sickness;
SKCM	cis	rs35306767	0.714	rs17293608	chr10:1056252	C/T	cg26597838	chr10:835615	NA	0.59	4.96	0.49	4.09e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs9443189	0.615	rs602873	chr6:76323818	T/A	cg01950844	chr6:76311363	SENP6	0.99	6.59	0.6	4.64e-9	Prostate cancer;
SKCM	cis	rs2075371	1.000	rs2544218	chr7:133992315	C/A	cg20476274	chr7:133979776	SLC35B4	1.01	10.44	0.76	1.77e-16	Mean platelet volume;
SKCM	cis	rs6089584	0.927	rs2296081	chr20:60572663	G/T	cg23262073	chr20:60523788	NA	-0.55	-5.25	-0.51	1.27e-6	Body mass index;
SKCM	cis	rs9420	0.961	rs11602109	chr11:57435296	G/A	cg19752551	chr11:57585705	CTNND1	-0.7	-6.99	-0.62	8.34e-10	Schizophrenia;
SKCM	cis	rs798554	0.797	rs798487	chr7:2802943	G/A	cg14895029	chr7:2775587	GNA12	-0.68	-4.98	-0.49	3.69e-6	Height;
SKCM	cis	rs701145	0.938	rs2971446	chr3:154073445	G/C	cg17054900	chr3:154042577	DHX36	0.92	5.12	0.5	2.11e-6	Coronary artery disease;
SKCM	cis	rs28595532	0.920	rs116091383	chr4:119635518	A/G	cg14228332	chr4:119757509	SEC24D	0.97	4.92	0.49	4.71e-6	Cannabis dependence symptom count;
SKCM	cis	rs12474201	0.928	rs34186074	chr2:46965010	T/C	cg06386533	chr2:46925753	SOCS5	1.03	9.82	0.74	2.8e-15	Height;
SKCM	cis	rs1003719	0.788	rs2835576	chr21:38457393	C/T	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs910316	1.000	rs175492	chr14:75545220	A/C	cg11812906	chr14:75593930	NEK9	0.67	5.25	0.51	1.25e-6	Height;
SKCM	cis	rs2243480	1.000	rs6460274	chr7:65628484	T/A	cg18252515	chr7:66147081	NA	1.34	8.18	0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs10504229	1.000	rs66870803	chr8:58180022	G/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs826838	1.000	rs6582619	chr12:38729904	A/G	cg26384229	chr12:38710491	ALG10B	1.11	9.91	0.75	1.9e-15	Heart rate;
SKCM	cis	rs10751667	0.643	rs7395613	chr11:933873	C/T	cg06064525	chr11:970664	AP2A2	-0.55	-5.09	-0.5	2.46e-6	Alzheimer's disease (late onset);
SKCM	cis	rs8017423	0.605	rs4904676	chr14:90819220	G/A	cg04374321	chr14:90722782	PSMC1	-0.77	-5.94	-0.56	7.46e-8	Mortality in heart failure;
SKCM	cis	rs2559856	0.967	rs2695297	chr12:102082218	T/C	cg12924262	chr12:102091054	CHPT1	0.71	5.71	0.54	1.97e-7	Blood protein levels;
SKCM	cis	rs12110303	1	rs12110303	chr5:90662839	G/T	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.94	6.39	0.59	1.12e-8	Breast cancer;
SKCM	cis	rs2836950	0.565	rs4816617	chr21:40540690	T/C	cg11644478	chr21:40555479	PSMG1	-0.67	-5.3	-0.51	1.04e-6	Menarche (age at onset);
SKCM	cis	rs2286503	0.780	rs929464	chr7:22874770	T/C	cg15401507	chr7:22894281	NA	-0.58	-5.12	-0.5	2.11e-6	Fibrinogen;
SKCM	cis	rs362272	0.545	rs2748447	chr4:3337831	G/A	cg24015175	chr4:3319247	RGS12	0.83	9.72	0.74	4.46e-15	Serum sulfate level;
SKCM	cis	rs4237845	0.537	rs2002275	chr12:58283385	A/G	cg02175503	chr12:58329896	NA	0.7	5.78	0.55	1.48e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs67311347	0.544	rs4974047	chr3:40339653	G/T	cg02782426	chr3:40428986	ENTPD3	0.52	5.3	0.51	1.06e-6	Renal cell carcinoma;
SKCM	cis	rs13256369	0.951	rs12679360	chr8:8566269	G/T	cg06636001	chr8:8085503	FLJ10661	-0.73	-6.12	-0.57	3.5e-8	Obesity-related traits;
SKCM	cis	rs1048238	0.506	rs7525608	chr1:16141901	A/G	cg21385522	chr1:16154831	NA	0.62	5.07	0.5	2.57e-6	Systolic blood pressure;
SKCM	cis	rs6537837	0.793	rs1434285	chr1:110080809	G/T	cg05049280	chr1:110155535	GNAT2	0.61	5.01	0.49	3.27e-6	Major depressive disorder;
SKCM	cis	rs2777491	0.915	rs7165675	chr15:41614704	T/C	cg18705301	chr15:41695430	NDUFAF1	-0.96	-9.11	-0.72	6.65e-14	Ulcerative colitis;
SKCM	cis	rs4820539	1.000	rs2267003	chr22:23457098	A/G	cg14186256	chr22:23484241	RTDR1	0.83	8.41	0.69	1.52e-12	Bone mineral density;
SKCM	cis	rs2204008	0.811	rs11520277	chr12:38359611	G/A	cg26384229	chr12:38710491	ALG10B	0.81	6.56	0.6	5.29e-9	Bladder cancer;
SKCM	cis	rs826838	0.904	rs10880981	chr12:38763911	G/A	cg26384229	chr12:38710491	ALG10B	1.06	10.14	0.75	6.67e-16	Heart rate;
SKCM	cis	rs79040073	0.530	rs17475228	chr15:49561816	A/G	cg25951582	chr15:49913451	C15orf33;DTWD1	-0.71	-5.17	-0.51	1.74e-6	Lung cancer in ever smokers;
SKCM	cis	rs936229	0.768	rs12442901	chr15:75083912	A/G	cg14664628	chr15:75095509	CSK	-1.15	-9.89	-0.75	2.08e-15	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin);
SKCM	cis	rs9816226	0.618	rs869399	chr3:185826764	C/T	cg00760338	chr3:185826511	ETV5	0.87	6.51	0.59	6.74e-9	Obesity;Body mass index;
SKCM	cis	rs7219014	1	rs7219014	chr17:37624790	A/G	cg07936489	chr17:37558343	FBXL20	-0.87	-7.96	-0.67	1.13e-11	Urinary metabolites;
SKCM	cis	rs2836974	0.897	rs34035316	chr21:40594023	T/C	cg11890956	chr21:40555474	PSMG1	1.09	13.83	0.84	1.08e-22	Cognitive function;
SKCM	cis	rs1552244	0.882	rs3755783	chr3:10029289	A/G	cg02579736	chr3:10068473	FANCD2;CIDECP	0.94	4.84	0.48	6.49e-6	Alzheimer's disease;
SKCM	cis	rs4925386	0.625	rs3810550	chr20:60912117	C/T	cg24112000	chr20:60950667	NA	-0.65	-5.47	-0.53	5.24e-7	Colorectal cancer;Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs7666738	0.830	rs7679961	chr4:99000202	C/T	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2033711	0.936	rs882609	chr19:58991479	G/A	cg00825309	chr19:58991885	ZNF446	-0.66	-5.1	-0.5	2.35e-6	Uric acid clearance;
SKCM	cis	rs995000	0.965	rs11207977	chr1:62977307	C/T	cg06896770	chr1:63153194	DOCK7	0.92	8.25	0.68	3.08e-12	Triglyceride levels;
SKCM	cis	rs762407	0.519	rs4819311	chr21:45189717	G/T	cg01224657	chr21:45787795	TRPM2	0.48	4.9	0.49	5.02e-6	Systolic blood pressure change trajectories;
SKCM	cis	rs2050392	0.517	rs589980	chr10:30756385	T/A	cg25182066	chr10:30743637	MAP3K8	-0.74	-6.66	-0.6	3.42e-9	Inflammatory bowel disease;
SKCM	trans	rs3780486	0.846	rs2209948	chr9:33138247	G/A	cg20290983	chr6:43655470	MRPS18A	1.0	11.51	0.79	1.75e-18	IgG glycosylation;
SKCM	cis	rs9467773	1.000	rs6925703	chr6:26521589	G/A	cg09904177	chr6:26538194	HMGN4	0.54	4.98	0.49	3.78e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7666738	0.715	rs61114099	chr4:98931270	C/T	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6089584	1.000	rs6089583	chr20:60563624	G/A	cg06108461	chr20:60628389	TAF4	-0.81	-7.11	-0.63	4.79e-10	Body mass index;
SKCM	cis	rs9858542	0.903	rs11921590	chr3:49644193	T/C	cg03060546	chr3:49711283	APEH	-0.73	-5.41	-0.52	6.82e-7	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs9325144	0.600	rs7312522	chr12:38730423	A/G	cg26384229	chr12:38710491	ALG10B	0.78	6.82	0.61	1.76e-9	Morning vs. evening chronotype;
SKCM	cis	rs1799949	0.965	rs799910	chr17:41279561	G/C	cg05368731	chr17:41323189	NBR1	0.88	7.51	0.65	8.26e-11	Menopause (age at onset);
SKCM	cis	rs9467773	0.869	rs1796521	chr6:26421392	T/C	cg15659132	chr6:26577336	NA	-0.53	-4.81	-0.48	7.1e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1348850	0.632	rs1358328	chr2:178517532	G/A	cg22681709	chr2:178499509	PDE11A	-0.68	-5.83	-0.55	1.17e-7	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs7786877	0.508	rs11765509	chr7:100310990	T/G	cg20848291	chr7:100343083	ZAN	-0.66	-5.1	-0.5	2.32e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs13118159	0.836	rs2276903	chr4:1343405	A/G	cg20887711	chr4:1340912	KIAA1530	0.7	5.35	0.52	8.57e-7	Longevity;
SKCM	cis	rs6089829	0.851	rs4809460	chr20:61661355	T/C	cg08564027	chr20:61660810	NA	0.62	5.55	0.53	3.75e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs7945705	0.747	rs2568045	chr11:9004060	T/C	cg21881798	chr11:8931708	C11orf17;ST5	-0.84	-9.3	-0.72	2.89e-14	Hemoglobin concentration;
SKCM	cis	rs782590	0.556	rs782579	chr2:55917604	A/G	cg18811423	chr2:55921094	PNPT1	0.99	7.19	0.63	3.39e-10	Metabolic syndrome;
SKCM	cis	rs6500395	0.928	rs4785532	chr16:48695500	G/A	cg04672837	chr16:48644449	N4BP1	-0.65	-5.43	-0.52	6.29e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs1401999	0.966	rs2313212	chr3:183700928	A/G	cg01324343	chr3:183735012	ABCC5	0.86	9.5	0.73	1.18e-14	Anterior chamber depth;
SKCM	cis	rs4243830	0.522	rs10157142	chr1:6618785	A/T	cg22792644	chr1:6614718	TAS1R1;NOL9	-1.23	-4.86	-0.48	5.88e-6	Body mass index;
SKCM	cis	rs9303401	0.659	rs35103007	chr17:56900738	G/A	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.35	0.52	8.54e-7	Cognitive test performance;
SKCM	cis	rs561341	1.000	rs527256	chr17:30321293	C/G	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs4478137	0.824	rs4691905	chr4:164221437	T/C	cg06758707	chr4:164254230	NPY1R	0.96	6.13	0.57	3.34e-8	Subjective well-being (multi-trait analysis);Subjective well-being;
SKCM	cis	rs9467773	1.000	rs6903973	chr6:26499942	C/A	cg15659132	chr6:26577336	NA	0.61	5.82	0.55	1.24e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs12145833	0.596	rs61833913	chr1:243440028	C/G	cg02356786	chr1:243265016	LOC731275	1.28	4.82	0.48	6.99e-6	Obesity (early onset extreme);
SKCM	cis	rs873946	0.586	rs3829130	chr10:134563122	C/T	cg26818010	chr10:134567672	INPP5A	-0.79	-6.06	-0.57	4.54e-8	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs2832191	0.740	rs2832175	chr21:30475606	A/G	cg24692254	chr21:30365293	RNF160	-0.99	-9.05	-0.72	8.59e-14	Dental caries;
SKCM	cis	rs3087591	0.960	rs2269855	chr17:29482878	G/A	cg24425628	chr17:29625626	OMG;NF1	0.64	5.26	0.51	1.21e-6	Hip circumference;
SKCM	cis	rs7666738	0.830	rs4699592	chr4:98974202	A/C	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs55962025	0.842	rs73193303	chr4:3192200	A/G	cg00764545	chr4:3318001	RGS12	-0.66	-5.44	-0.52	5.88e-7	Parental longevity (mother's age at death);
SKCM	cis	rs2404602	0.536	rs11072599	chr15:76774508	T/C	cg23625390	chr15:77176239	SCAPER	0.61	5.24	0.51	1.33e-6	Blood metabolite levels;
SKCM	cis	rs362296	0.698	rs3135168	chr4:3262699	T/C	cg24015175	chr4:3319247	RGS12	-0.62	-5.98	-0.56	6.28e-8	Parental longevity (mother's age at death);
SKCM	trans	rs11083271	0.536	rs62101358	chr18:25858250	C/G	cg00321150	chr11:62623587	SNORD27;SLC3A2;SNHG1;SNORD28;SNORD25;SNORD26	0.8	7.29	0.64	2.17e-10	Non-alcoholic fatty liver disease histology (lobular);
SKCM	cis	rs7829975	0.755	rs3789849	chr8:8687054	G/C	cg15556689	chr8:8085844	FLJ10661	0.65	4.95	0.49	4.27e-6	Mood instability;
SKCM	cis	rs911263	0.961	rs1957570	chr14:68729224	A/C	cg18825221	chr14:68749962	RAD51L1	-0.49	-5.23	-0.51	1.38e-6	Primary biliary cholangitis;
SKCM	cis	rs62344088	0.590	rs55655653	chr5:303446	C/T	cg22857025	chr5:266934	NA	-1.61	-5.97	-0.56	6.6e-8	Asthma (childhood onset);
SKCM	cis	rs12142240	0.698	rs72677592	chr1:46818288	A/G	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs16940212	0.505	rs16940168	chr15:58684154	A/T	cg16767221	chr15:57769667	CGNL1	0.66	5.23	0.51	1.39e-6	HDL cholesterol levels;HDL cholesterol;
SKCM	cis	rs6933660	0.610	rs71549125	chr6:151770796	A/C	cg14262678	chr6:151773367	RMND1;C6orf211	0.75	6.0	0.56	5.81e-8	Menarche (age at onset);
SKCM	cis	rs644799	0.965	rs566877	chr11:95528045	G/A	cg03916912	chr11:95522834	CEP57;FAM76B	0.92	8.04	0.67	8e-12	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs67311347	0.544	rs2278927	chr3:40350447	G/A	cg00656387	chr3:40428638	ENTPD3	0.57	5.06	0.5	2.71e-6	Renal cell carcinoma;
SKCM	cis	rs6087990	0.735	rs2424913	chr20:31374259	C/T	cg13636640	chr20:31349939	DNMT3B	0.87	6.84	0.61	1.61e-9	Ulcerative colitis;
SKCM	cis	rs3780215	0.556	rs1887486	chr9:19581602	A/G	cg13661323	chr9:19657248	SLC24A2	-0.7	-4.88	-0.48	5.43e-6	Body mass index in asthmatics;
SKCM	cis	rs10832963	1.000	rs2084220	chr11:18656932	C/T	cg20219074	chr11:18656078	SPTY2D1	0.85	6.58	0.6	4.85e-9	Breast cancer;
SKCM	cis	rs67460515	0.852	rs2404341	chr3:161092405	T/C	cg03342759	chr3:160939853	NMD3	-0.82	-7.01	-0.62	7.46e-10	Parkinson's disease;
SKCM	cis	rs3820928	0.804	rs4144327	chr2:227790262	C/T	cg11843606	chr2:227700838	RHBDD1	-0.6	-4.81	-0.48	7.17e-6	Pulmonary function;
SKCM	cis	rs4968361	0.892	rs67028302	chr17:57520703	G/A	cg02573089	chr17:57233042	PRR11;SKA2	1.2	5.27	0.51	1.18e-6	Schizophrenia;
SKCM	cis	rs2760061	0.819	rs708111	chr1:228191365	G/A	cg02753203	chr1:228287806	NA	0.69	5.77	0.55	1.51e-7	Diastolic blood pressure;
SKCM	cis	rs28386778	0.897	rs6504184	chr17:61842408	A/T	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs28595532	0.920	rs56117870	chr4:119766583	T/C	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs28386778	0.863	rs2727288	chr17:61901197	T/A	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs10504229	0.683	rs11775568	chr8:58133762	G/A	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs2658782	0.950	rs2446061	chr11:93149277	C/T	cg15737290	chr11:93063684	CCDC67	0.76	5.32	0.52	9.69e-7	Pulmonary function decline;
SKCM	cis	rs12451471	0.559	rs12452263	chr17:78079310	T/C	cg06718696	chr17:78121285	EIF4A3	0.9	6.03	0.56	5.13e-8	Plateletcrit;Mean corpuscular hemoglobin concentration;
SKCM	cis	rs9303401	0.527	rs12946522	chr17:56768103	A/C	cg02118635	chr17:56770003	RAD51C;TEX14	0.77	5.03	0.49	3.06e-6	Cognitive test performance;
SKCM	cis	rs4683346	1.000	rs11129980	chr3:42895982	G/T	cg06399164	chr3:42695035	ZBTB47	0.62	5.8	0.55	1.35e-7	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs2354432	0.607	rs55918563	chr1:146718973	G/C	cg25205988	chr1:146714368	CHD1L	-1.19	-6.56	-0.6	5.34e-9	Mitochondrial DNA levels;
SKCM	cis	rs2274273	0.934	rs10140869	chr14:55795283	G/A	cg26246078	chr14:56151250	KTN1	0.7	4.85	0.48	6.2e-6	Protein biomarker;
SKCM	cis	rs1552244	0.882	rs17050672	chr3:10025463	G/A	cg02579736	chr3:10068473	FANCD2;CIDECP	0.98	4.84	0.48	6.48e-6	Alzheimer's disease;
SKCM	cis	rs7659604	0.605	rs1396080	chr4:122740454	T/G	cg06713675	chr4:122721982	EXOSC9	-0.74	-7.38	-0.64	1.51e-10	Type 2 diabetes;
SKCM	cis	rs8014204	0.720	rs34752362	chr14:75232306	G/A	cg06637938	chr14:75390232	RPS6KL1	0.79	6.03	0.56	5.07e-8	Caffeine consumption;
SKCM	cis	rs11098499	0.774	rs11098505	chr4:120284627	C/T	cg09307838	chr4:120376055	NA	0.98	7.89	0.67	1.52e-11	Corneal astigmatism;
SKCM	cis	rs523522	0.962	rs7136951	chr12:120941927	C/T	cg12219531	chr12:120966889	COQ5	0.91	7.82	0.66	2.11e-11	High light scatter reticulocyte count;
SKCM	cis	rs7937682	0.883	rs1613778	chr11:111456105	G/C	cg09085632	chr11:111637200	PPP2R1B	-1.04	-9.98	-0.75	1.38e-15	Primary sclerosing cholangitis;
SKCM	cis	rs6450176	1.000	rs3776718	chr5:53298714	G/C	ch.5.1024479R	chr5:53302184	ARL15	-0.71	-4.88	-0.48	5.49e-6	HDL cholesterol levels;HDL cholesterol;Adiponectin levels;
SKCM	cis	rs9733	0.650	rs3738485	chr1:150552392	C/G	cg13175981	chr1:150552382	MCL1	0.75	6.6	0.6	4.55e-9	Tonsillectomy;
SKCM	cis	rs600231	0.665	rs2105608	chr11:65228618	T/A	cg24009118	chr11:65545808	DKFZp761E198	0.69	5.1	0.5	2.35e-6	Bone mineral density;
SKCM	cis	rs9902453	0.967	rs4356528	chr17:28489670	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.5	0.53	4.74e-7	Coffee consumption (cups per day);
SKCM	cis	rs2836974	0.644	rs4818017	chr21:40690561	G/T	cg11644478	chr21:40555479	PSMG1	-0.64	-5.33	-0.52	9.27e-7	Cognitive function;
SKCM	trans	rs10506458	0.834	rs55966529	chr12:63384114	A/C	cg03429785	chr15:59498649	MYO1E;LDHAL6B	-1.39	-7.59	-0.65	5.95e-11	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs2228479	0.850	rs117880578	chr16:89910230	C/G	cg00800038	chr16:89945340	TCF25	-1.0	-5.06	-0.5	2.75e-6	Skin colour saturation;
SKCM	cis	rs16854884	0.770	rs7621079	chr3:143814500	G/C	cg06585982	chr3:143692056	C3orf58	0.66	5.02	0.49	3.15e-6	Economic and political preferences (feminism/equality);
SKCM	cis	rs13108904	0.901	rs6826029	chr4:1307689	A/G	cg05665937	chr4:1216051	CTBP1	0.57	5.02	0.49	3.2e-6	Obesity-related traits;
SKCM	cis	rs8180040	0.835	rs6780013	chr3:47452118	G/A	cg27129171	chr3:47204927	SETD2	-0.78	-5.22	-0.51	1.44e-6	Colorectal cancer;
SKCM	cis	rs2658782	0.789	rs2605580	chr11:93147054	C/T	cg15737290	chr11:93063684	CCDC67	0.68	4.81	0.48	7.23e-6	Pulmonary function decline;
SKCM	cis	rs12478296	0.901	rs7603560	chr2:243043256	C/T	cg06360820	chr2:242988706	NA	-1.0	-5.16	-0.5	1.83e-6	Obesity-related traits;
SKCM	cis	rs2288073	0.562	rs112892911	chr2:24590800	G/A	cg06627628	chr2:24431161	ITSN2	-0.9	-6.93	-0.62	1.07e-9	Venous thromboembolism (SNP x SNP interaction);
SKCM	cis	rs873946	0.557	rs34854637	chr10:134582962	A/G	cg18305652	chr10:134549665	INPP5A	0.59	5.83	0.55	1.19e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs7666738	0.830	rs17027225	chr4:99028564	C/T	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2354432	1.000	rs6680778	chr1:146747153	T/C	cg25205988	chr1:146714368	CHD1L	1.22	9.8	0.74	3.02e-15	Mitochondrial DNA levels;
SKCM	cis	rs644799	1.000	rs494829	chr11:95571750	C/A	cg03916912	chr11:95522834	CEP57;FAM76B	0.88	7.53	0.65	7.59e-11	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs57221529	0.825	rs72703051	chr5:582997	G/A	cg17284070	chr5:473007	LOC25845	1.03	4.78	0.48	8.06e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs362296	0.583	rs35658829	chr4:3255738	T/G	cg16987761	chr4:3318072	RGS12	-0.69	-5.79	-0.55	1.41e-7	Parental longevity (mother's age at death);
SKCM	cis	rs10504229	1.000	rs1961778	chr8:58168756	G/A	cg22535103	chr8:58192502	C8orf71	-0.68	-4.82	-0.48	7.06e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs910316	1.000	rs4899544	chr14:75546556	C/T	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.89e-7	Height;
SKCM	cis	rs873946	0.648	rs12769533	chr10:134548685	C/T	cg26818010	chr10:134567672	INPP5A	0.71	5.65	0.54	2.49e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs4927850	0.709	rs6765762	chr3:195652851	G/A	cg01181863	chr3:195395398	SDHAP2	-0.91	-5.92	-0.56	8.09e-8	Pancreatic cancer;
SKCM	cis	rs8180040	0.615	rs13062681	chr3:47021124	A/G	cg27129171	chr3:47204927	SETD2	0.79	6.01	0.56	5.49e-8	Colorectal cancer;
SKCM	cis	rs7666738	0.830	rs11727235	chr4:98946331	T/C	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4774899	1.000	rs12914425	chr15:57476285	C/G	cg01857019	chr15:57210107	LOC145783;TCF12	0.53	4.9	0.49	5.12e-6	Urinary tract infection frequency;
SKCM	cis	rs1348850	0.872	rs4893824	chr2:178298104	G/A	cg02961200	chr2:178257176	LOC100130691;AGPS	0.81	6.11	0.57	3.7e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs861020	0.582	rs630065	chr1:209998662	C/T	cg05527609	chr1:210001259	C1orf107	0.88	6.82	0.61	1.71e-9	Orofacial clefts;
SKCM	cis	rs12477438	0.520	rs13035311	chr2:99717322	C/G	cg26064155	chr2:99771622	LIPT1;TSGA10	1.02	10.07	0.75	9.12e-16	Chronic sinus infection;
SKCM	cis	rs12142240	0.698	rs67941619	chr1:46838219	A/G	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs6450176	0.597	rs1541682	chr5:53304401	C/T	ch.5.1024479R	chr5:53302184	ARL15	-0.89	-4.82	-0.48	6.98e-6	HDL cholesterol levels;HDL cholesterol;Adiponectin levels;
SKCM	cis	rs6580649	0.883	rs4075913	chr12:48537624	A/G	cg05342945	chr12:48394962	COL2A1	-0.79	-5.39	-0.52	7.22e-7	Lung cancer;
SKCM	cis	rs3820068	0.529	rs79570154	chr1:15990912	T/C	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs861020	0.630	rs628445	chr1:210004953	C/T	cg05527609	chr1:210001259	C1orf107	0.86	6.74	0.61	2.43e-9	Orofacial clefts;
SKCM	cis	rs35146811	0.625	rs2906645	chr7:99817859	A/G	cg22906224	chr7:99728672	NA	-0.71	-5.61	-0.54	2.99e-7	Coronary artery disease;
SKCM	cis	rs7082209	0.591	rs61856385	chr10:44818278	G/T	cg17436666	chr10:44806146	NA	0.92	5.26	0.51	1.21e-6	Resistance to Mycobacterium tuberculosis in HIV-positive individuals measured by a negative tuberculin skin test (continuous);
SKCM	cis	rs10089	1.000	rs2054444	chr5:127493206	A/C	cg25462716	chr5:127418816	SLC12A2;FLJ33630	-0.87	-7.85	-0.66	1.83e-11	Ileal carcinoids;
SKCM	cis	rs17345786	0.520	rs1476123	chr3:101313413	C/G	cg12386194	chr3:101231763	SENP7	0.64	5.59	0.53	3.24e-7	Colonoscopy-negative controls vs population controls;
SKCM	trans	rs1814175	0.645	rs847627	chr11:49927177	G/A	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs2204008	0.837	rs4432085	chr12:38181146	C/T	cg13010199	chr12:38710504	ALG10B	0.65	4.84	0.48	6.52e-6	Bladder cancer;
SKCM	cis	rs2120019	0.567	rs8029351	chr15:75177237	A/C	cg09165964	chr15:75287851	SCAMP5	-0.81	-5.8	-0.55	1.34e-7	Blood trace element (Zn levels);
SKCM	cis	rs17376456	0.825	rs10057130	chr5:93282557	C/T	cg21475434	chr5:93447410	FAM172A	1.04	5.19	0.51	1.62e-6	Diabetic retinopathy;
SKCM	cis	rs4332037	0.851	rs1403175	chr7:1964357	A/T	cg02825527	chr7:2087843	MAD1L1	0.73	5.24	0.51	1.31e-6	Bipolar disorder;
SKCM	cis	rs654950	0.875	rs34227270	chr1:41998967	C/T	cg06885757	chr1:42089581	HIVEP3	0.65	7.07	0.62	5.9e-10	Airway imaging phenotypes;
SKCM	cis	rs28386778	0.897	rs2665844	chr17:61874455	A/G	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs7178909	0.835	rs2174292	chr15:90415581	A/C	cg19708238	chr15:90437601	AP3S2	0.72	5.22	0.51	1.43e-6	Common traits (Other);
SKCM	cis	rs2938670	1	rs2938670	chr15:78740688	T/G	cg18825076	chr15:78729989	IREB2	-0.61	-4.85	-0.48	6.1e-6	Post bronchodilator FEV1/FVC ratio;Post bronchodilator FEV1;Post bronchodilator FEV1 in COPD;Post bronchodilator FEV1/FVC ratio in COPD;
SKCM	cis	rs8072100	0.875	rs7208530	chr17:45544107	C/T	cg08085267	chr17:45401833	C17orf57	-0.62	-5.08	-0.5	2.48e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs1878931	0.582	rs27227	chr16:3429778	G/A	cg26668626	chr16:3451006	ZNF174;ZNF434	-0.82	-5.95	-0.56	7.24e-8	Body mass index (adult);
SKCM	cis	rs13256369	0.802	rs13281933	chr8:8562665	C/A	cg06636001	chr8:8085503	FLJ10661	0.8	6.11	0.57	3.65e-8	Obesity-related traits;
SKCM	cis	rs919433	0.680	rs6710530	chr2:198277551	G/A	cg04278110	chr2:198063759	ANKRD44	0.7	4.79	0.48	7.87e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs2731664	0.792	rs2630764	chr5:176880085	C/T	cg23176889	chr5:176863531	GRK6	-0.53	-5.4	-0.52	6.86e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs2842992	0.789	rs10945635	chr6:160214487	C/A	cg16489826	chr6:160211363	TCP1;MRPL18	0.68	4.93	0.49	4.51e-6	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs17065868	1.000	rs61948033	chr13:45204650	A/G	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs2153535	0.601	rs9505473	chr6:8538777	T/C	cg07606381	chr6:8435919	SLC35B3	0.93	6.41	0.59	1e-8	Motion sickness;
SKCM	cis	rs7639513	0.590	rs3729931	chr3:12626516	A/G	cg23032965	chr3:12705835	RAF1	-0.84	-6.94	-0.62	1.04e-9	Itch intensity from mosquito bite;
SKCM	cis	rs7777484	0.534	rs2533888	chr7:2831083	T/C	cg19717773	chr7:2847554	GNA12	-0.49	-5.95	-0.56	7.14e-8	Height;
SKCM	cis	rs950776	0.518	rs12916483	chr15:78832397	G/A	cg06917634	chr15:78832804	PSMA4	1.01	10.49	0.77	1.45e-16	Sudden cardiac arrest;
SKCM	cis	rs12142240	0.698	rs55670684	chr1:46835139	C/T	cg10495392	chr1:46806563	NSUN4	0.75	5.6	0.54	3.1e-7	Menopause (age at onset);
SKCM	cis	rs738321	0.694	rs4821749	chr22:38542074	A/G	cg25457927	chr22:38595422	NA	-0.58	-6.71	-0.61	2.75e-9	Breast cancer;
SKCM	cis	rs11892454	0.515	rs11888036	chr2:26063775	C/T	cg17263061	chr2:26915892	KCNK3	-0.69	-4.98	-0.49	3.73e-6	Heschl's gyrus morphology;
SKCM	cis	rs2952156	0.920	rs2952152	chr17:37832735	T/C	cg00129232	chr17:37814104	STARD3	-0.65	-5.16	-0.5	1.8e-6	Asthma;
SKCM	cis	rs7208859	0.623	rs7219712	chr17:29080570	G/T	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs7937682	0.889	rs479667	chr11:111484034	C/T	cg09085632	chr11:111637200	PPP2R1B	-0.97	-10.08	-0.75	8.74e-16	Primary sclerosing cholangitis;
SKCM	cis	rs453301	0.574	rs10081437	chr8:8948979	T/C	cg06636001	chr8:8085503	FLJ10661	-0.74	-6.2	-0.57	2.5e-8	Joint mobility (Beighton score);
SKCM	cis	rs11690935	0.959	rs7355594	chr2:172639448	G/T	cg13550731	chr2:172543902	DYNC1I2	-0.94	-7.99	-0.67	9.97e-12	Schizophrenia;
SKCM	cis	rs778371	0.630	rs13007579	chr2:233725364	G/A	cg08000102	chr2:233561755	GIGYF2	-0.8	-6.41	-0.59	1.04e-8	Schizophrenia;
SKCM	cis	rs5750830	0.595	rs4821892	chr22:39795683	G/C	cg24399712	chr22:39784796	NA	-0.59	-4.91	-0.49	4.81e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs3785574	0.650	rs2070776	chr17:62007498	A/G	cg11494091	chr17:61959527	GH2	-0.57	-5.6	-0.54	3.1e-7	Height;
SKCM	cis	rs2404602	0.647	rs11072626	chr15:77090826	A/G	cg23625390	chr15:77176239	SCAPER	-0.84	-7.89	-0.67	1.51e-11	Blood metabolite levels;
SKCM	cis	rs854765	0.552	rs11078407	chr17:17841083	T/C	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.0	7.64	0.65	4.64e-11	Total body bone mineral density;
SKCM	trans	rs66573146	0.634	rs55633489	chr4:6988745	C/A	cg07817883	chr1:32538562	TMEM39B	1.94	8.42	0.69	1.47e-12	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs7937682	0.855	rs527078	chr11:111479713	T/C	cg19812747	chr11:111475976	SIK2	-0.56	-4.97	-0.49	3.82e-6	Primary sclerosing cholangitis;
SKCM	cis	rs7103648	0.545	rs6485795	chr11:47929846	G/A	cg20307385	chr11:47447363	PSMC3	0.91	7.12	0.63	4.61e-10	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs3771570	0.901	rs4075818	chr2:242432142	T/C	cg07612300	chr2:242033426	MTERFD2;SNED1	0.89	4.98	0.49	3.78e-6	Prostate cancer;
SKCM	cis	rs2180341	0.961	rs7775493	chr6:127615000	C/A	cg24812749	chr6:127587940	RNF146	0.87	7.33	0.64	1.85e-10	Breast cancer;
SKCM	cis	rs9300255	0.568	rs1790108	chr12:123636841	A/G	cg00376283	chr12:123451042	ABCB9	0.8	5.4	0.52	7.12e-7	Neutrophil percentage of white cells;
SKCM	cis	rs7666738	0.830	rs10031292	chr4:99056877	A/G	cg05340658	chr4:99064831	C4orf37	0.66	4.87	0.48	5.74e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4819052	0.800	rs4819045	chr21:46660138	C/A	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.42	0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs870825	0.616	rs28673855	chr4:185627416	T/G	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs6951245	1.000	rs1881123	chr7:1084706	C/T	cg24642844	chr7:1081250	C7orf50	-0.94	-6.32	-0.58	1.48e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs11718455	0.767	rs11130019	chr3:43989348	C/A	cg21419209	chr3:44054225	NA	-0.59	-4.79	-0.48	7.88e-6	Coronary artery disease;
SKCM	cis	rs7618915	0.571	rs6762457	chr3:52609157	G/A	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs3096299	0.632	rs4399533	chr16:89539382	G/C	cg02187348	chr16:89574699	SPG7	0.56	4.81	0.48	7.17e-6	Multiple myeloma (IgH translocation);
SKCM	cis	rs6977660	1.000	rs2107403	chr7:19819025	G/C	cg07541023	chr7:19748670	TWISTNB	0.7	4.82	0.48	6.98e-6	Thyroid stimulating hormone;
SKCM	cis	rs1577917	1.000	rs12201735	chr6:86656939	C/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.66	-5.74	-0.54	1.76e-7	Response to antipsychotic treatment;
SKCM	cis	rs1165205	0.558	rs531750	chr6:25882642	C/G	cg03517284	chr6:25882590	NA	-0.73	-7.26	-0.64	2.47e-10	Urate levels;
SKCM	cis	rs2075371	1.000	rs378358	chr7:133970628	A/G	cg20476274	chr7:133979776	SLC35B4	1.04	11.39	0.79	2.84e-18	Mean platelet volume;
SKCM	cis	rs28386778	0.797	rs4968664	chr17:61851366	C/G	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs2153535	0.580	rs1577467	chr6:8444241	G/A	cg07606381	chr6:8435919	SLC35B3	0.94	6.94	0.62	1.02e-9	Motion sickness;
SKCM	cis	rs4803468	1.000	rs3816037	chr19:41918009	C/T	cg09537434	chr19:41945824	ATP5SL	-1.1	-13.82	-0.84	1.16e-22	Height;
SKCM	cis	rs453301	0.522	rs1964356	chr8:8853270	G/T	cg06636001	chr8:8085503	FLJ10661	0.69	5.17	0.5	1.79e-6	Joint mobility (Beighton score);
SKCM	cis	rs7216064	0.953	rs10445361	chr17:65962238	G/T	cg12091567	chr17:66097778	LOC651250	0.73	5.21	0.51	1.52e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs7811142	1.000	rs60478351	chr7:100089017	C/T	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.25	0.68	3.05e-12	Platelet count;
SKCM	cis	rs10779751	0.922	rs11121708	chr1:11307253	G/C	cg08854313	chr1:11322531	MTOR	0.93	7.16	0.63	3.9e-10	Body mass index;
SKCM	cis	rs28595532	1.000	rs114682099	chr4:119702004	C/T	cg11846333	chr4:119757529	SEC24D	1.19	6.39	0.59	1.12e-8	Cannabis dependence symptom count;
SKCM	cis	rs694739	0.628	rs11606081	chr11:64137875	T/C	cg02228329	chr11:64053129	BAD;GPR137	0.87	6.15	0.57	3.03e-8	Alopecia areata;Crohn's disease;Psoriasis vulgaris;
SKCM	cis	rs10752881	1.000	rs8179262	chr1:182973186	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.74	6.71	0.6	2.83e-9	Colorectal cancer;
SKCM	cis	rs769267	0.740	rs2965185	chr19:19525792	T/C	cg26732615	chr19:19648335	CILP2;YJEFN3	0.67	5.65	0.54	2.48e-7	Tonsillectomy;
SKCM	cis	rs72781680	0.898	rs55846516	chr2:24158003	T/C	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	cis	rs17376456	0.778	rs72786662	chr5:93137630	C/T	cg25358565	chr5:93447407	FAM172A	1.19	7.78	0.66	2.52e-11	Diabetic retinopathy;
SKCM	cis	rs7020830	0.825	rs66684257	chr9:37199087	G/T	cg14294708	chr9:37120828	ZCCHC7	1.06	10.78	0.77	4.01e-17	Schizophrenia;
SKCM	cis	rs9905704	0.647	rs33922512	chr17:57114148	C/G	cg12560992	chr17:57184187	TRIM37	-0.74	-6.08	-0.57	4.13e-8	Testicular germ cell tumor;
SKCM	cis	rs1147199	0.531	rs1001904	chr9:87271616	C/T	cg13486759	chr9:86751815	NA	-0.63	-4.79	-0.48	7.93e-6	Body mass index;
SKCM	cis	rs12497850	0.931	rs11924597	chr3:48937790	T/C	cg06212747	chr3:49208901	KLHDC8B	0.68	4.9	0.49	5.06e-6	Parkinson's disease;
SKCM	cis	rs10138752	0.643	rs8017092	chr14:69079307	T/G	cg08271153	chr14:69726221	GALNTL1	-0.68	-5.29	-0.51	1.09e-6	Neutrophil count;White blood cell count;Myeloid white cell count;Granulocyte count;Sum neutrophil eosinophil counts;Sum basophil neutrophil counts;
SKCM	cis	rs11690935	0.851	rs10930502	chr2:172890588	A/G	cg13550731	chr2:172543902	DYNC1I2	-0.74	-5.51	-0.53	4.44e-7	Schizophrenia;
SKCM	cis	rs9303401	0.659	rs16943326	chr17:57050365	C/T	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.35	0.52	8.54e-7	Cognitive test performance;
SKCM	cis	rs8014204	0.657	rs2884668	chr14:75281576	T/A	cg06637938	chr14:75390232	RPS6KL1	0.71	5.55	0.53	3.78e-7	Caffeine consumption;
SKCM	cis	rs2228479	0.850	rs62056068	chr16:89909737	C/T	cg06558623	chr16:89946397	TCF25	1.12	5.0	0.49	3.47e-6	Skin colour saturation;
SKCM	cis	rs2777491	0.915	rs8036498	chr15:41603276	A/G	cg18705301	chr15:41695430	NDUFAF1	-0.98	-9.56	-0.73	9.07e-15	Ulcerative colitis;
SKCM	cis	rs826838	0.967	rs4768329	chr12:39129394	T/C	cg26384229	chr12:38710491	ALG10B	-0.91	-8.28	-0.68	2.74e-12	Heart rate;
SKCM	cis	rs9467773	1.000	rs1321479	chr6:26501897	C/T	cg05180451	chr6:27185764	NA	0.51	5.03	0.49	3.08e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7666738	0.830	rs11731478	chr4:99001686	A/G	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs941873	0.868	rs1483733	chr10:81130036	A/G	cg09469691	chr10:81107165	PPIF	0.74	6.95	0.62	9.71e-10	Height;
SKCM	cis	rs3785574	0.650	rs7406102	chr17:62004749	G/A	cg01411255	chr17:61851458	DDX42;CCDC47	-0.76	-5.56	-0.53	3.58e-7	Height;
SKCM	cis	rs6089584	0.816	rs4134440	chr20:60624296	A/G	cg13770153	chr20:60521292	NA	-0.57	-5.06	-0.5	2.68e-6	Body mass index;
SKCM	cis	rs4822044	0.560	rs7284839	chr22:42010902	C/T	cg03806693	chr22:41940476	POLR3H	1.11	7.56	0.65	6.74e-11	Cannabis dependence symptom count;
SKCM	cis	rs796364	1.000	rs281794	chr2:200846666	C/T	cg12253985	chr2:200820533	C2orf60;C2orf47	0.89	5.47	0.53	5.29e-7	Schizophrenia;
SKCM	cis	rs34172651	0.517	rs11642954	chr16:24824248	G/A	cg06028605	chr16:24865363	SLC5A11	0.59	4.95	0.49	4.26e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs3020736	0.500	rs6002605	chr22:42494335	A/G	cg04733989	chr22:42467013	NAGA	-0.72	-5.62	-0.54	2.87e-7	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs1799949	0.930	rs33968979	chr17:41297992	G/T	cg05368731	chr17:41323189	NBR1	0.89	7.91	0.67	1.38e-11	Menopause (age at onset);
SKCM	cis	rs3091242	0.933	rs4649084	chr1:25752617	A/G	cg27572855	chr1:25598939	RHD	0.56	5.49	0.53	4.9e-7	Erythrocyte sedimentation rate;
SKCM	cis	rs3020736	0.500	rs2413669	chr22:42507748	A/C	cg04733989	chr22:42467013	NAGA	-0.72	-5.62	-0.54	2.87e-7	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs7824557	0.547	rs1594967	chr8:11238332	T/G	cg21775007	chr8:11205619	TDH	-0.57	-4.93	-0.49	4.47e-6	Retinal vascular caliber;
SKCM	cis	rs1799949	0.965	rs9646418	chr17:41425901	A/G	cg23758822	chr17:41437982	NA	0.95	8.1	0.68	5.96e-12	Menopause (age at onset);
SKCM	cis	rs4073582	0.595	rs9326370	chr11:65992008	A/G	cg16950941	chr11:66035639	RAB1B	0.89	7.76	0.66	2.73e-11	Gout;
SKCM	cis	rs59918340	0.764	rs2304282	chr8:142229543	A/G	cg23750338	chr8:142222470	SLC45A4	0.61	5.82	0.55	1.24e-7	Immature fraction of reticulocytes;
SKCM	cis	rs897984	0.762	rs8062719	chr16:31002664	A/G	cg00531865	chr16:30841666	NA	0.59	4.92	0.49	4.69e-6	Dementia with Lewy bodies;
SKCM	cis	rs4423214	0.840	rs1792229	chr11:71179395	A/G	cg05163923	chr11:71159392	DHCR7	-0.71	-6.16	-0.57	2.96e-8	Vitamin D levels;
SKCM	trans	rs1814175	0.935	rs11040462	chr11:49683158	G/A	cg03929089	chr4:120376271	NA	-0.87	-7.53	-0.65	7.73e-11	Height;
SKCM	cis	rs1005277	0.579	rs2505237	chr10:38438898	T/G	cg25427524	chr10:38739819	LOC399744	-0.71	-6.71	-0.61	2.75e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs514406	0.607	rs11206000	chr1:53205923	A/C	cg16325326	chr1:53192061	ZYG11B	-0.86	-9.02	-0.71	9.97e-14	Monocyte count;
SKCM	cis	rs943437	0.740	rs626007	chr6:112258027	A/G	cg25325257	chr6:112272685	NA	-0.88	-4.92	-0.49	4.74e-6	Parkinson's disease;
SKCM	cis	rs672059	1.000	rs659307	chr1:183163078	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.65	5.56	0.53	3.7e-7	Hypertriglyceridemia;
SKCM	cis	rs933688	1.000	rs10041402	chr5:90738948	A/T	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.92	6.76	0.61	2.21e-9	Smoking behavior;
SKCM	cis	rs9910055	0.659	rs6503488	chr17:42246158	T/G	cg08499158	chr17:42289980	UBTF	-0.74	-6.46	-0.59	8.29e-9	Total body bone mineral density;
SKCM	cis	rs56235845	0.694	rs36102285	chr5:176774018	C/T	cg06060754	chr5:176797920	RGS14	0.69	6.56	0.6	5.28e-9	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs7598759	0.548	rs1584462	chr2:232369798	A/G	cg19187155	chr2:232395269	NMUR1	0.86	7.47	0.65	9.86e-11	Noise-induced hearing loss;
SKCM	cis	rs1160297	0.643	rs6737483	chr2:53041627	G/A	cg07782112	chr2:53107842	NA	0.51	4.9	0.49	5.08e-6	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs7666738	0.830	rs11097609	chr4:99011707	C/T	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs910316	0.875	rs12588099	chr14:75594462	A/T	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.85e-7	Height;
SKCM	cis	rs992157	0.775	rs7559428	chr2:219150238	A/G	cg20019365	chr2:219134978	PNKD;AAMP	-0.71	-6.08	-0.57	4.22e-8	Colorectal cancer;
SKCM	cis	rs736408	0.570	rs11130327	chr3:52793239	A/G	cg18404041	chr3:52824283	ITIH1	-0.56	-4.94	-0.49	4.32e-6	Bipolar disorder;
SKCM	cis	rs67311347	0.524	rs7649168	chr3:40356158	T/C	cg13409248	chr3:40428643	ENTPD3	0.57	5.32	0.52	9.61e-7	Renal cell carcinoma;
SKCM	cis	rs2153535	0.526	rs7748404	chr6:8472500	A/T	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs1577917	0.771	rs9450319	chr6:86427325	T/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.76	6.73	0.61	2.58e-9	Response to antipsychotic treatment;
SKCM	cis	rs34779708	0.931	rs12768019	chr10:35389843	T/C	cg03585969	chr10:35415529	CREM	0.79	6.35	0.58	1.32e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs17270561	0.541	rs12192932	chr6:25911502	A/G	cg16482183	chr6:26056742	HIST1H1C	0.96	6.47	0.59	7.91e-9	Iron status biomarkers;
SKCM	cis	rs1552244	0.882	rs9757159	chr3:10039166	C/T	cg02579736	chr3:10068473	FANCD2;CIDECP	0.94	4.84	0.48	6.49e-6	Alzheimer's disease;
SKCM	cis	rs875971	0.862	rs10250544	chr7:65766561	A/G	cg11764359	chr7:65958608	NA	-0.75	-6.76	-0.61	2.26e-9	Aortic root size;
SKCM	cis	rs6066825	0.644	rs2092492	chr20:47338650	A/G	cg18078177	chr20:47281410	PREX1	0.63	5.09	0.5	2.44e-6	Colorectal cancer;
SKCM	cis	rs7618915	0.571	rs67539070	chr3:52711974	T/C	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs912057	0.526	rs1294400	chr6:6733421	A/G	cg06612196	chr6:6737390	NA	-0.71	-6.19	-0.57	2.56e-8	Waist-to-hip ratio adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);
SKCM	cis	rs11700980	0.636	rs11702742	chr21:30254022	T/C	cg24692254	chr21:30365293	RNF160	-0.89	-5.17	-0.51	1.73e-6	QRS complex (12-leadsum);
SKCM	cis	rs654950	0.806	rs1535505	chr1:42026152	A/G	cg06885757	chr1:42089581	HIVEP3	0.54	5.25	0.51	1.27e-6	Airway imaging phenotypes;
SKCM	cis	rs11608355	0.521	rs6606707	chr12:109830241	T/G	cg19025524	chr12:109796872	NA	-0.68	-6.2	-0.57	2.49e-8	Neuroticism;
SKCM	cis	rs6545883	0.507	rs6545855	chr2:61532860	G/C	cg15711740	chr2:61764176	XPO1	0.68	5.23	0.51	1.4e-6	Tuberculosis;
SKCM	cis	rs9880211	1.000	rs9841529	chr3:136137283	A/C	cg21827317	chr3:136751795	NA	-0.65	-4.92	-0.49	4.73e-6	Body mass index;Height;
SKCM	cis	rs116095464	0.558	rs10059907	chr5:205360	G/C	cg22857025	chr5:266934	NA	-1.44	-7.74	-0.66	2.94e-11	Breast cancer;
SKCM	cis	rs1577917	0.917	rs1414201	chr6:86500316	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.38	-0.52	7.52e-7	Response to antipsychotic treatment;
SKCM	cis	rs2279817	0.913	rs2270979	chr1:18023290	C/T	cg17142039	chr1:18149651	ACTL8	0.58	4.88	0.48	5.6e-6	Neuroticism;
SKCM	cis	rs4423214	1.000	rs2040323	chr11:71172783	A/C	cg05163923	chr11:71159392	DHCR7	0.83	8.11	0.68	5.77e-12	Vitamin D levels;
SKCM	cis	rs10504229	0.545	rs56394419	chr8:58128982	T/C	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs11098499	0.818	rs7688802	chr4:120451668	G/A	cg24375607	chr4:120327624	NA	0.68	5.27	0.51	1.16e-6	Corneal astigmatism;
SKCM	cis	rs1218582	0.772	rs10908445	chr1:154849590	A/G	cg16680214	chr1:154839983	KCNN3	0.55	5.16	0.5	1.87e-6	Prostate cancer;
SKCM	cis	rs7647973	0.731	rs9831648	chr3:49214303	G/T	cg06212747	chr3:49208901	KLHDC8B	0.91	5.06	0.5	2.68e-6	Menarche (age at onset);
SKCM	cis	rs2727020	0.533	rs10839195	chr11:48973460	C/T	cg14072046	chr11:49124791	NA	-0.51	-4.85	-0.48	6.23e-6	Coronary artery disease;
SKCM	cis	rs780096	0.546	rs12473776	chr2:27636474	A/G	cg05696406	chr2:27599888	SNX17	0.49	5.07	0.5	2.62e-6	Total body bone mineral density;
SKCM	cis	rs4481887	0.676	rs1544177	chr1:248524683	C/G	cg22724847	chr1:248512586	OR14C36	0.59	4.86	0.48	6e-6	Common traits (Other);
SKCM	cis	rs6951245	0.748	rs79658522	chr7:1095877	A/G	cg03188948	chr7:1209495	NA	1.13	6.27	0.58	1.89e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs1799949	1.000	rs1973646	chr17:41310495	T/C	cg05368731	chr17:41323189	NBR1	0.89	7.98	0.67	1.03e-11	Menopause (age at onset);
SKCM	cis	rs2228479	0.850	rs2302162	chr16:89845287	A/G	cg06558623	chr16:89946397	TCF25	1.06	4.84	0.48	6.45e-6	Skin colour saturation;
SKCM	cis	rs2832191	0.720	rs2832200	chr21:30499165	G/A	cg24692254	chr21:30365293	RNF160	-0.9	-8.01	-0.67	9.12e-12	Dental caries;
SKCM	cis	rs2243480	0.708	rs13242216	chr7:65898277	T/C	cg18252515	chr7:66147081	NA	-1.35	-8.04	-0.67	8e-12	Diabetic kidney disease;
SKCM	trans	rs1814175	0.645	rs28634872	chr11:50042175	T/A	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs875971	0.545	rs17138149	chr7:65693180	A/G	cg18876405	chr7:65276391	NA	0.61	5.09	0.5	2.45e-6	Aortic root size;
SKCM	cis	rs875971	0.522	rs56028712	chr7:65466565	C/T	cg11764359	chr7:65958608	NA	0.87	6.6	0.6	4.44e-9	Aortic root size;
SKCM	cis	rs3087591	0.960	rs11870097	chr17:29448097	C/T	cg24425628	chr17:29625626	OMG;NF1	0.65	5.15	0.5	1.89e-6	Hip circumference;
SKCM	cis	rs6952808	1.000	rs4256490	chr7:1890764	G/A	cg02951883	chr7:2050386	MAD1L1	-0.72	-5.56	-0.53	3.67e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs362296	0.698	rs362282	chr4:3259671	G/A	cg16987761	chr4:3318072	RGS12	-0.75	-6.27	-0.58	1.83e-8	Parental longevity (mother's age at death);
SKCM	cis	rs929354	0.742	rs6459734	chr7:156935454	A/G	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs9902453	0.845	rs2628165	chr17:28121166	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.81	5.64	0.54	2.57e-7	Coffee consumption (cups per day);
SKCM	cis	rs644799	0.710	rs564480	chr11:95561741	C/T	cg03916912	chr11:95522834	CEP57;FAM76B	0.77	6.33	0.58	1.46e-8	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs7666738	0.830	rs11944035	chr4:98931618	C/T	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs12950390	0.853	rs28589850	chr17:45855713	A/G	cg03474202	chr17:45855739	NA	-0.49	-5.58	-0.53	3.34e-7	IgG glycosylation;
SKCM	cis	rs870825	0.549	rs28542773	chr4:185617935	A/G	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs13118159	0.509	rs1882098	chr4:1352431	T/C	cg05025164	chr4:1340916	KIAA1530	0.9	7.17	0.63	3.66e-10	Longevity;
SKCM	cis	rs8177179	0.967	rs6782434	chr3:133438834	C/G	cg16262614	chr3:133464971	TF	0.43	5.32	0.52	9.69e-7	Iron status biomarkers (transferrin levels);
SKCM	cis	rs5753618	0.504	rs9609297	chr22:31893731	G/T	cg02404636	chr22:31891804	SFI1	0.66	5.39	0.52	7.32e-7	Colorectal cancer;
SKCM	cis	rs11098499	0.909	rs1546504	chr4:120241179	C/T	cg09307838	chr4:120376055	NA	0.95	7.57	0.65	6.44e-11	Corneal astigmatism;
SKCM	cis	rs4727027	0.933	rs34578816	chr7:148847606	G/A	cg23583168	chr7:148888333	NA	-0.8	-6.66	-0.6	3.52e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs9913156	0.517	rs11868227	chr17:4614539	G/A	cg19197139	chr17:4613644	ARRB2	0.69	5.34	0.52	8.81e-7	Lymphocyte counts;
SKCM	cis	rs950027	0.620	rs1145089	chr15:45652054	G/C	cg21132104	chr15:45694354	SPATA5L1	0.76	5.84	0.55	1.13e-7	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs7772486	0.654	rs6906402	chr6:146089307	C/G	cg23711669	chr6:146136114	FBXO30	-0.9	-10.43	-0.76	1.88e-16	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs995000	0.929	rs636523	chr1:62920008	A/G	cg06896770	chr1:63153194	DOCK7	0.94	9.07	0.72	8e-14	Triglyceride levels;
SKCM	cis	rs9467773	0.967	rs7753565	chr6:26560012	A/G	cg15659132	chr6:26577336	NA	0.6	5.71	0.54	1.99e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7917772	0.505	rs61869211	chr10:104449836	A/G	cg11453585	chr10:104263688	ACTR1A;SUFU	0.72	5.33	0.52	9.25e-7	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs72634258	0.786	rs7524424	chr1:8173369	A/G	cg00042356	chr1:8021962	PARK7	0.8	5.27	0.51	1.2e-6	Inflammatory bowel disease;
SKCM	cis	rs11098499	0.820	rs6829903	chr4:120506884	C/T	cg24375607	chr4:120327624	NA	0.69	5.47	0.53	5.35e-7	Corneal astigmatism;
SKCM	cis	rs1218582	0.741	rs11264283	chr1:154869552	A/G	cg09359103	chr1:154839909	KCNN3	-0.57	-5.3	-0.51	1.05e-6	Prostate cancer;
SKCM	cis	rs4819052	0.851	rs1006779	chr21:46670752	A/G	cg19498844	chr21:46707878	POFUT2;LOC642852	0.8	6.79	0.61	1.96e-9	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7824557	0.628	rs2572387	chr8:11204165	C/T	cg21775007	chr8:11205619	TDH	0.71	6.28	0.58	1.82e-8	Retinal vascular caliber;
SKCM	cis	rs1799949	1.000	rs8074136	chr17:41342313	A/C	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.29	-0.58	1.73e-8	Menopause (age at onset);
SKCM	cis	rs13256369	0.755	rs11776987	chr8:8559401	C/G	cg06636001	chr8:8085503	FLJ10661	0.74	5.5	0.53	4.71e-7	Obesity-related traits;
SKCM	cis	rs1639906	0.895	rs62443039	chr7:2209354	C/T	cg02951883	chr7:2050386	MAD1L1	0.66	5.36	0.52	8.14e-7	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7208859	0.573	rs11654035	chr17:29136426	T/C	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs12188164	0.525	rs2561665	chr5:460135	A/G	cg26076054	chr5:421317	AHRR	0.62	5.47	0.53	5.27e-7	Cystic fibrosis severity;
SKCM	cis	rs10197940	0.638	rs2288193	chr2:152348842	T/A	cg19508488	chr2:152266495	RIF1	0.6	4.86	0.48	5.96e-6	Lung cancer;
SKCM	cis	rs7208859	0.673	rs9915963	chr17:29019643	C/T	cg14067834	chr17:29058358	SUZ12P	1.0	5.43	0.52	6.23e-7	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs1577917	0.761	rs117452258	chr6:86554211	G/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.32	-0.52	9.66e-7	Response to antipsychotic treatment;
SKCM	cis	rs12048904	0.647	rs7528268	chr1:101329295	A/G	cg00063077	chr1:101360652	SLC30A7;EXTL2	0.85	6.73	0.61	2.58e-9	Multiple sclerosis;
SKCM	cis	rs8017423	0.935	rs12880102	chr14:90793526	G/T	cg04374321	chr14:90722782	PSMC1	-1.04	-9.75	-0.74	3.8e-15	Mortality in heart failure;
SKCM	cis	rs56011263	0.687	rs4690186	chr4:703607	G/A	cg17689763	chr4:710664	PCGF3	-0.63	-5.06	-0.5	2.68e-6	White blood cell count;
SKCM	cis	rs752010	0.871	rs2038976	chr1:42094498	A/G	cg06885757	chr1:42089581	HIVEP3	0.6	5.87	0.55	1.01e-7	Lupus nephritis in systemic lupus erythematosus;
SKCM	trans	rs1814175	0.654	rs7482446	chr11:49779020	A/G	cg15704280	chr7:45808275	SEPT13	-1.03	-10.34	-0.76	2.75e-16	Height;
SKCM	cis	rs28386778	0.897	rs894407	chr17:61901641	T/C	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs9911578	0.935	rs2302189	chr17:56584205	A/C	cg12560992	chr17:57184187	TRIM37	-0.93	-7.74	-0.66	2.97e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs9788721	0.836	rs2009746	chr15:78754102	A/G	cg18825076	chr15:78729989	IREB2	-0.62	-4.92	-0.49	4.67e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;Emphysema imaging phenotypes;Emphysema distribution in smoking;Local histogram emphysema pattern;Post bronchodilator FEV1/FVC ratio in COPD;
SKCM	trans	rs561341	0.882	rs504887	chr17:30322881	T/A	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs9880211	0.583	rs9870122	chr3:135820265	T/G	cg21827317	chr3:136751795	NA	-0.65	-4.99	-0.49	3.63e-6	Body mass index;Height;
SKCM	cis	rs28595532	0.844	rs55845920	chr4:119490085	C/T	cg11846333	chr4:119757529	SEC24D	1.15	6.24	0.58	2.13e-8	Cannabis dependence symptom count;
SKCM	cis	rs1912528	0.783	rs10000502	chr4:140864757	G/T	cg11128457	chr4:140864437	MAML3	0.62	5.31	0.52	1e-6	Educational attainment (years of education);
SKCM	cis	rs12477438	0.520	rs12621007	chr2:99791946	G/C	cg14399236	chr2:99771627	LIPT1;TSGA10	0.96	8.57	0.7	7.52e-13	Chronic sinus infection;
SKCM	cis	rs2204008	0.774	rs7305085	chr12:38263511	C/T	cg13010199	chr12:38710504	ALG10B	0.69	4.92	0.49	4.72e-6	Bladder cancer;
SKCM	cis	rs9290877	0.667	rs17615154	chr3:188450757	A/G	cg17392043	chr3:188495102	LPP	-0.65	-5.01	-0.49	3.32e-6	IgE levels;
SKCM	cis	rs2842992	0.789	rs4709370	chr6:160210061	A/G	cg16489826	chr6:160211363	TCP1;MRPL18	0.7	5.07	0.5	2.62e-6	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs28386778	0.897	rs6504187	chr17:61917099	G/A	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs4319547	0.956	rs7397990	chr12:123119472	T/C	cg23029597	chr12:123009494	RSRC2	-0.76	-5.69	-0.54	2.16e-7	Body mass index;
SKCM	cis	rs7666738	0.830	rs1813251	chr4:98921170	A/G	cg17366294	chr4:99064904	C4orf37	0.57	4.85	0.48	6.12e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs35306767	0.904	rs35667562	chr10:950630	G/A	cg20503657	chr10:835505	NA	0.86	6.09	0.57	4.06e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs1692580	0.774	rs10797416	chr1:2182342	T/C	cg21442419	chr1:2182373	SKI	-0.7	-7.15	-0.63	4e-10	Coronary artery disease;
SKCM	cis	rs2153535	0.580	rs2327062	chr6:8453858	G/A	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs2303745	0.544	rs6512181	chr19:17399213	T/G	cg04248312	chr19:17393744	ANKLE1	-1.12	-8.3	-0.69	2.42e-12	Systemic lupus erythematosus;
SKCM	cis	rs7937682	0.883	rs566647	chr11:111466607	A/G	cg09085632	chr11:111637200	PPP2R1B	0.96	8.98	0.71	1.19e-13	Primary sclerosing cholangitis;
SKCM	cis	rs8180040	1.000	rs295442	chr3:47335881	A/C	cg16586182	chr3:47516702	SCAP	-0.71	-4.85	-0.48	6.25e-6	Colorectal cancer;
SKCM	cis	rs8037137	0.915	rs8026714	chr15:91522253	G/A	cg15878949	chr15:91534302	PRC1	0.68	5.23	0.51	1.38e-6	Platelet count;Serous invasive ovarian cancer;High-grade serous ovarian cancer;Invasive epithelial ovarian cancer;
SKCM	cis	rs6834538	0.597	rs9991830	chr4:113485372	T/C	cg05166686	chr4:113558556	LARP7;C4orf21	0.6	5.03	0.49	3.1e-6	Free thyroxine concentration;
SKCM	cis	rs593982	1.000	rs470360	chr11:65500530	T/C	cg08755490	chr11:65554678	OVOL1	1.06	10.75	0.77	4.73e-17	Atopic dermatitis;
SKCM	cis	rs12595025	1	rs12595025	chr15:91520131	C/T	cg15878949	chr15:91534302	PRC1	0.67	5.12	0.5	2.11e-6	Mean platelet volume;
SKCM	cis	rs7659604	0.502	rs13104233	chr4:122672473	T/C	cg19671926	chr4:122722719	EXOSC9	0.76	6.13	0.57	3.42e-8	Type 2 diabetes;
SKCM	cis	rs9467773	0.620	rs4368798	chr6:26593471	A/G	cg09904177	chr6:26538194	HMGN4	0.57	4.87	0.48	5.81e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1577917	0.883	rs9450348	chr6:86598036	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.7	-6.22	-0.58	2.28e-8	Response to antipsychotic treatment;
SKCM	cis	rs875971	1.000	rs778722	chr7:65844828	T/C	cg11764359	chr7:65958608	NA	0.87	8.35	0.69	2.01e-12	Aortic root size;
SKCM	cis	rs4819052	0.851	rs1056100	chr21:46678711	A/C	cg19498844	chr21:46707878	POFUT2;LOC642852	0.87	7.55	0.65	6.99e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs9303401	0.659	rs62081315	chr17:56781468	T/C	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.35	0.52	8.54e-7	Cognitive test performance;
SKCM	cis	rs7824557	0.569	rs7816601	chr8:11205593	T/C	cg21775007	chr8:11205619	TDH	0.72	6.4	0.59	1.09e-8	Retinal vascular caliber;
SKCM	cis	rs9303401	0.659	rs17822908	chr17:56801778	T/C	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.16	0.57	2.91e-8	Cognitive test performance;
SKCM	cis	rs908922	0.584	rs71626721	chr1:152532745	A/G	cg09873164	chr1:152488093	CRCT1	0.69	5.07	0.5	2.67e-6	Hair morphology;
SKCM	cis	rs9911578	0.967	rs2567892	chr17:56668929	T/C	cg12560992	chr17:57184187	TRIM37	0.95	7.67	0.66	4.15e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs1799949	1.000	rs8176220	chr17:41222462	A/G	cg05368731	chr17:41323189	NBR1	0.89	7.87	0.67	1.71e-11	Menopause (age at onset);
SKCM	cis	rs6088580	0.609	rs6059844	chr20:33036482	A/G	cg24642439	chr20:33292090	TP53INP2	0.73	5.84	0.55	1.16e-7	Glomerular filtration rate (creatinine);
SKCM	cis	rs2404602	0.647	rs12440965	chr15:76958591	G/A	cg23625390	chr15:77176239	SCAPER	-0.85	-8.26	-0.68	2.93e-12	Blood metabolite levels;
SKCM	cis	rs11673344	0.764	rs513406	chr19:37439147	G/A	cg07624650	chr19:37064219	ZNF529	-0.8	-5.02	-0.49	3.25e-6	Obesity-related traits;
SKCM	cis	rs3820928	1.000	rs10193316	chr2:227777650	A/G	cg11843606	chr2:227700838	RHBDD1	-0.61	-4.88	-0.48	5.44e-6	Pulmonary function;
SKCM	cis	rs71520386	0.530	rs10256628	chr7:22883259	G/C	cg00309339	chr7:22893653	NA	0.76	5.91	0.56	8.44e-8	Fibrinogen levels;
SKCM	cis	rs11252926	0.550	rs11252134	chr10:442599	G/A	cg18196295	chr10:418757	DIP2C	0.66	5.38	0.52	7.58e-7	Psychosis in Alzheimer's disease;
SKCM	cis	rs6665290	0.835	rs7549586	chr1:227214566	A/G	cg10327440	chr1:227177885	CDC42BPA	-1.18	-15.6	-0.87	1.08e-25	Myeloid white cell count;
SKCM	cis	rs17685	0.712	rs1859792	chr7:75789264	T/C	cg16684958	chr7:75615977	POR	0.53	5.11	0.5	2.23e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs28386778	0.897	rs7207005	chr17:61860355	A/G	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs6066825	0.605	rs4325821	chr20:47224787	T/C	cg18078177	chr20:47281410	PREX1	0.6	4.86	0.48	5.87e-6	Colorectal cancer;
SKCM	cis	rs1949733	1.000	rs6837429	chr4:8502374	A/G	cg11789530	chr4:8429930	ACOX3	0.81	5.8	0.55	1.36e-7	Response to antineoplastic agents;
SKCM	cis	rs1863918	0.616	rs10464077	chr5:178470637	G/A	cg21905437	chr5:178450457	ZNF879	-0.61	-5.33	-0.52	9.14e-7	Depression in response to interferon-based therapy in chronic hepatitis C;
SKCM	cis	rs1577917	0.917	rs2084293	chr6:86566002	A/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.81	-7.82	-0.66	2.07e-11	Response to antipsychotic treatment;
SKCM	cis	rs875971	0.522	rs1617484	chr7:65463095	G/A	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.66	6.14	0.57	3.28e-8	Aortic root size;
SKCM	cis	rs561341	1.000	rs111454793	chr17:30319267	T/C	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs13118159	0.527	rs6599309	chr4:1388115	C/G	cg02018176	chr4:1364513	KIAA1530	0.91	6.98	0.62	8.54e-10	Longevity;
SKCM	cis	rs2439831	0.850	rs7168158	chr15:44050376	G/A	cg02155558	chr15:43621948	ADAL;LCMT2	1.35	7.75	0.66	2.9e-11	Lung cancer in ever smokers;
SKCM	cis	rs995000	0.931	rs6675401	chr1:63073975	C/T	cg06896770	chr1:63153194	DOCK7	0.76	7.17	0.63	3.77e-10	Triglyceride levels;
SKCM	cis	rs7208859	0.623	rs7503542	chr17:29073830	A/C	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs17376456	0.877	rs17083462	chr5:93462401	T/G	cg25358565	chr5:93447407	FAM172A	1.23	7.97	0.67	1.08e-11	Diabetic retinopathy;
SKCM	cis	rs1882538	0.551	rs6974618	chr7:133084031	C/A	cg10665199	chr7:133106180	EXOC4	0.77	5.02	0.49	3.17e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1799949	0.773	rs2137990	chr17:41317896	T/A	cg19454999	chr17:41278357	BRCA1;NBR2	-0.51	-4.84	-0.48	6.42e-6	Menopause (age at onset);
SKCM	cis	rs709400	1.000	rs6593	chr14:104163282	G/A	cg26031613	chr14:104095156	KLC1	1.05	12.89	0.82	5.14e-21	Body mass index;
SKCM	cis	rs2733201	1.000	rs8036541	chr15:44319377	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	-1.25	-4.88	-0.48	5.56e-6	Lipoprotein phospholipase A2 activity in cardiovascular disease;
SKCM	cis	rs11673344	0.704	rs1644710	chr19:37417062	A/G	cg07624650	chr19:37064219	ZNF529	-0.8	-5.24	-0.51	1.31e-6	Obesity-related traits;
SKCM	cis	rs1538970	0.924	rs7528573	chr1:45913860	T/C	cg05343316	chr1:45956843	TESK2	0.92	4.94	0.49	4.42e-6	Platelet count;
SKCM	cis	rs62238980	0.614	rs33954001	chr22:32506050	C/G	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs8014204	0.836	rs7154256	chr14:75252587	A/G	cg06637938	chr14:75390232	RPS6KL1	0.83	6.28	0.58	1.81e-8	Caffeine consumption;
SKCM	cis	rs2032447	0.507	rs199741	chr6:25931577	A/G	cg03264133	chr6:25882463	NA	-0.72	-6.72	-0.61	2.67e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs950776	0.706	rs11636753	chr15:78928946	G/T	cg06917634	chr15:78832804	PSMA4	0.67	4.93	0.49	4.45e-6	Sudden cardiac arrest;
SKCM	cis	rs7666738	0.791	rs4699324	chr4:98967496	G/A	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs875971	0.830	rs809025	chr7:65849819	C/G	cg11764359	chr7:65958608	NA	0.8	7.47	0.65	1.01e-10	Aortic root size;
SKCM	cis	rs1882538	0.503	rs1345938	chr7:133137867	C/T	cg10665199	chr7:133106180	EXOC4	-0.73	-5.14	-0.5	2.01e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2836974	0.932	rs56306759	chr21:40608106	G/A	cg11644478	chr21:40555479	PSMG1	0.97	10.08	0.75	8.76e-16	Cognitive function;
SKCM	cis	rs909674	0.818	rs8137426	chr22:39844350	T/G	cg11247378	chr22:39784982	NA	-0.45	-5.1	-0.5	2.29e-6	IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis);IgG glycosylation;IgG digalactosylation phenotypes (multivariate analysis);IgG sialylation phenotypes (multivariate analysis);IgG monogalactosylation phenotypes (multivariate analysis);IgG fucosylation phenotypes (multivariate analysis);IgG N-glycosylation phenotypes (multivariate analysis);IgG disialylation phenotypes (multivariate analysis);IgG galactosylation phenotypes (multivariate analysis);Post bronchodilator FEV1;
SKCM	cis	rs826838	1.000	rs6582619	chr12:38729904	A/G	cg13010199	chr12:38710504	ALG10B	0.89	6.62	0.6	4.06e-9	Heart rate;
SKCM	cis	rs12142240	0.698	rs17357635	chr1:46808668	G/A	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs10870270	1.000	rs7077744	chr10:133770201	C/T	cg17892150	chr10:133769511	PPP2R2D	-0.66	-4.86	-0.48	5.92e-6	Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals;
SKCM	cis	rs3820928	0.874	rs10169717	chr2:227796911	T/G	cg11843606	chr2:227700838	RHBDD1	-0.6	-4.81	-0.48	7.34e-6	Pulmonary function;
SKCM	cis	rs760805	1.000	rs11249204	chr1:25261740	C/T	cg22509179	chr1:25234806	RUNX3	0.7	5.76	0.55	1.58e-7	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs9911578	1.000	rs2270097	chr17:56572070	G/A	cg12560992	chr17:57184187	TRIM37	-0.92	-7.26	-0.64	2.5e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs116095464	0.681	rs10060016	chr5:241100	T/C	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs28595532	0.920	rs55794497	chr4:119764664	A/G	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs55823223	0.618	rs72860390	chr17:73869914	A/G	cg10935138	chr17:73851978	WBP2	1.2	7.38	0.64	1.45e-10	Psoriasis;
SKCM	cis	rs614226	0.872	rs12307148	chr12:120903179	T/C	cg01236616	chr12:121019343	POP5	-1.34	-8.54	-0.7	8.29e-13	Type 1 diabetes nephropathy;
SKCM	cis	rs10751667	0.666	rs11246357	chr11:963980	A/C	cg10932868	chr11:921992	NA	0.53	4.92	0.49	4.74e-6	Alzheimer's disease (late onset);
SKCM	cis	rs7523273	0.606	rs2724398	chr1:207993699	A/G	cg22525895	chr1:207977042	MIR29B2	-0.83	-6.86	-0.61	1.44e-9	Schizophrenia;
SKCM	cis	rs9951698	0.703	rs28619103	chr18:12993195	A/C	cg12848697	chr18:13133368	NA	0.56	5.37	0.52	7.98e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7818345	0.608	rs6992950	chr8:19272265	T/C	cg03393445	chr8:19249545	SH2D4A	0.6	5.27	0.51	1.17e-6	Language performance in older adults (adjusted for episodic memory);
SKCM	cis	rs453301	0.686	rs10217044	chr8:8894752	A/G	cg15556689	chr8:8085844	FLJ10661	-0.73	-5.77	-0.55	1.52e-7	Joint mobility (Beighton score);
SKCM	cis	rs16989760	1.000	rs3761430	chr22:31538002	C/T	cg01338084	chr22:32026380	PISD	1.17	5.49	0.53	4.94e-7	Age-related hearing impairment;
SKCM	cis	rs4332037	0.539	rs11764780	chr7:2020904	G/C	cg23422044	chr7:1970798	MAD1L1	-0.9	-5.68	-0.54	2.24e-7	Bipolar disorder;
SKCM	cis	rs155076	1.000	rs598754	chr13:21845010	C/A	cg14456004	chr13:21872349	NA	-1.22	-6.76	-0.61	2.24e-9	White matter hyperintensity burden;
SKCM	cis	rs763014	0.898	rs2017567	chr16:637212	T/C	cg07343612	chr16:622815	PIGQ	-0.7	-6.0	-0.56	5.84e-8	Height;
SKCM	cis	rs2836974	0.931	rs12151994	chr21:40690397	A/C	cg11644478	chr21:40555479	PSMG1	0.79	6.95	0.62	9.85e-10	Cognitive function;
SKCM	cis	rs2652834	1.000	rs11637852	chr15:63397151	G/A	cg04194852	chr15:63334506	TPM1	0.76	4.78	0.48	8.15e-6	HDL cholesterol;
SKCM	cis	rs9467773	1.000	rs11756120	chr6:26529808	G/C	cg15659132	chr6:26577336	NA	0.6	5.71	0.54	1.99e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs2243480	1.000	rs2533288	chr7:66056711	C/G	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs17685	0.672	rs55807301	chr7:75807401	C/A	cg01364799	chr7:75623366	TMEM120A	-0.69	-5.81	-0.55	1.28e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1878931	0.501	rs37800	chr16:3423648	T/G	cg26668626	chr16:3451006	ZNF174;ZNF434	-0.88	-7.37	-0.64	1.52e-10	Body mass index (adult);
SKCM	cis	rs7674861	0.508	rs11940101	chr4:151347355	T/C	cg03779973	chr4:151001971	DCLK2	0.55	4.83	0.48	6.59e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6951245	0.872	rs77434655	chr7:1098405	G/A	cg03188948	chr7:1209495	NA	1.13	6.27	0.58	1.89e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7811142	1.000	rs28490152	chr7:100020982	G/A	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.16	7.68	0.66	3.87e-11	Platelet count;
SKCM	cis	rs910316	1.000	rs1047418	chr14:75605792	A/G	cg08847533	chr14:75593920	NEK9	0.95	9.18	0.72	4.88e-14	Height;
SKCM	cis	rs9902453	0.933	rs9908901	chr17:28469713	G/A	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.5	0.53	4.74e-7	Coffee consumption (cups per day);
SKCM	cis	rs9325144	0.647	rs11169222	chr12:39105210	C/T	cg13010199	chr12:38710504	ALG10B	-0.64	-5.44	-0.52	6.02e-7	Morning vs. evening chronotype;
SKCM	cis	rs7829975	0.624	rs7823056	chr8:8382705	A/G	cg06636001	chr8:8085503	FLJ10661	0.86	7.24	0.63	2.76e-10	Mood instability;
SKCM	cis	rs17376456	0.825	rs6874766	chr5:93213807	C/G	cg21475434	chr5:93447410	FAM172A	-1.03	-5.61	-0.54	3e-7	Diabetic retinopathy;
SKCM	cis	rs2479724	0.870	rs6913232	chr6:41915143	C/T	cg17623882	chr6:41773611	USP49	0.73	5.94	0.56	7.65e-8	Menarche (age at onset);
SKCM	cis	rs17685	0.753	rs1637039	chr7:75693009	C/T	cg01364799	chr7:75623366	TMEM120A	-0.75	-6.05	-0.56	4.78e-8	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2836974	0.533	rs4817999	chr21:40554355	C/A	cg11890956	chr21:40555474	PSMG1	-0.88	-9.14	-0.72	5.76e-14	Cognitive function;
SKCM	cis	rs2242194	0.816	rs6671688	chr1:154994265	T/C	cg12436631	chr1:155007014	DCST1;DCST2	0.47	5.62	0.54	2.87e-7	Schizophrenia;
SKCM	cis	rs7937682	0.921	rs34584980	chr11:111441537	G/A	cg22437258	chr11:111473054	SIK2	-0.7	-5.25	-0.51	1.26e-6	Primary sclerosing cholangitis;
SKCM	cis	rs12142240	0.698	rs68112720	chr1:46813888	T/C	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs7811142	1.000	rs4989959	chr7:100032288	T/C	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-0.99	-5.52	-0.53	4.2e-7	Platelet count;
SKCM	cis	rs8077889	0.826	rs60085355	chr17:41847415	T/C	cg26893861	chr17:41843967	DUSP3	1.21	7.19	0.63	3.38e-10	Triglycerides;
SKCM	cis	rs72781680	0.611	rs72783636	chr2:24328706	C/T	cg20701182	chr2:24300061	SF3B14	0.74	5.03	0.49	3.09e-6	Lymphocyte counts;
SKCM	cis	rs992157	0.798	rs10193383	chr2:219157692	C/T	cg00012203	chr2:219082015	ARPC2	0.73	5.76	0.55	1.6e-7	Colorectal cancer;
SKCM	cis	rs10791097	0.690	rs12284487	chr11:130729705	T/C	cg12179176	chr11:130786555	SNX19	0.75	5.99	0.56	6.09e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs3847687	1.000	rs3847687	chr12:131525053	C/T	cg25772418	chr12:131519998	GPR133	-0.51	-5.19	-0.51	1.64e-6	Longevity;
SKCM	cis	rs861020	0.771	rs654470	chr1:210014093	A/T	cg09163369	chr1:210001066	C1orf107	0.74	4.88	0.48	5.5e-6	Orofacial clefts;
SKCM	cis	rs910316	0.967	rs35446981	chr14:75637351	A/T	cg11812906	chr14:75593930	NEK9	-0.71	-5.34	-0.52	9.01e-7	Height;
SKCM	cis	rs2832191	0.692	rs2776240	chr21:30310639	C/T	cg24692254	chr21:30365293	RNF160	0.94	8.76	0.7	3.16e-13	Dental caries;
SKCM	cis	rs7296418	0.961	rs4148863	chr12:123569375	A/G	cg05973401	chr12:123451056	ABCB9	0.84	6.88	0.61	1.34e-9	Platelet count;
SKCM	cis	rs2836974	0.897	rs35064900	chr21:40555492	A/G	cg11890956	chr21:40555474	PSMG1	1.09	13.7	0.84	1.86e-22	Cognitive function;
SKCM	cis	rs8072100	0.748	rs9908016	chr17:45551361	G/A	cg08085267	chr17:45401833	C17orf57	-0.62	-5.08	-0.5	2.48e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs7927771	0.832	rs67116452	chr11:47385194	G/A	cg01152729	chr11:47593274	PTPMT1	-0.51	-4.88	-0.48	5.53e-6	Subjective well-being;
SKCM	cis	rs7959452	0.590	rs6581889	chr12:69757429	T/C	cg20891283	chr12:69753455	YEATS4	0.91	9.31	0.73	2.74e-14	Blood protein levels;
SKCM	cis	rs7647973	0.580	rs2117938	chr3:49263850	A/G	cg07636037	chr3:49044803	WDR6	-0.88	-7.15	-0.63	4.09e-10	Menarche (age at onset);
SKCM	cis	rs9894429	0.682	rs7406360	chr17:79591545	G/A	cg18240062	chr17:79603768	NPLOC4	0.92	10.2	0.76	5.16e-16	Eye color traits;
SKCM	cis	rs8060686	0.621	rs35432211	chr16:68095449	T/C	cg09117114	chr16:67998030	SLC12A4	-0.81	-5.29	-0.51	1.07e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs17685	0.672	rs56343450	chr7:75796235	C/T	cg16684958	chr7:75615977	POR	0.53	5.3	0.51	1.06e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs4888262	0.508	rs7193583	chr16:74649589	C/G	cg01733217	chr16:74700730	RFWD3	0.92	7.53	0.65	7.53e-11	Testicular germ cell tumor;
SKCM	cis	rs9940799	0.577	rs8055015	chr16:5011114	T/C	cg03609003	chr16:4292559	SRL	0.52	4.87	0.48	5.7e-6	Cancer;
SKCM	cis	rs870825	0.860	rs2705886	chr4:185608591	T/C	cg04058563	chr4:185651563	MLF1IP	-1.04	-5.9	-0.56	9.04e-8	Blood protein levels;
SKCM	cis	rs3784262	0.528	rs6493979	chr15:58338052	C/T	cg12031962	chr15:58353849	ALDH1A2	-0.39	-4.91	-0.49	4.86e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs4561483	0.801	rs33649	chr16:11979608	G/C	cg08843971	chr16:11963173	GSPT1	-0.66	-5.08	-0.5	2.49e-6	Testicular germ cell tumor;
SKCM	cis	rs8067545	0.586	rs57837691	chr17:20203073	T/C	cg13482628	chr17:19912719	NA	-0.69	-5.93	-0.56	7.99e-8	Schizophrenia;
SKCM	cis	rs4237845	0.537	rs12426201	chr12:58259752	C/T	cg02175503	chr12:58329896	NA	0.74	5.91	0.56	8.44e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs6951245	1.000	rs78523927	chr7:1089458	T/C	cg03188948	chr7:1209495	NA	1.12	6.25	0.58	2.02e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs9815354	0.812	rs73077359	chr3:41850016	G/A	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs2948294	0.588	rs7011221	chr8:8114246	C/T	cg06636001	chr8:8085503	FLJ10661	0.69	5.33	0.52	9.43e-7	Red cell distribution width;
SKCM	cis	rs6062302	0.545	rs2297430	chr20:62229244	T/C	cg09650180	chr20:62225654	GMEB2	-0.77	-6.11	-0.57	3.64e-8	Glioblastoma;
SKCM	cis	rs1577917	1.000	rs12208493	chr6:86662267	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.66	-5.74	-0.54	1.76e-7	Response to antipsychotic treatment;
SKCM	cis	rs9916302	0.904	rs8081338	chr17:37406139	C/T	cg07936489	chr17:37558343	FBXL20	-0.86	-6.98	-0.62	8.74e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs7192750	0.527	rs30433	chr16:72145404	T/C	cg14768367	chr16:72042858	DHODH	1.03	4.79	0.48	7.77e-6	LDL cholesterol levels;Total cholesterol levels;
SKCM	cis	rs2251381	0.750	rs2776250	chr21:30528094	T/G	cg24692254	chr21:30365293	RNF160	0.78	6.09	0.57	3.93e-8	Selective IgA deficiency;
SKCM	cis	rs6430585	0.583	rs79176913	chr2:136638113	C/A	cg07169764	chr2:136633963	MCM6	1.36	15.01	0.86	1.02e-24	Corneal structure;
SKCM	cis	rs7618501	0.699	rs1062633	chr3:49924940	T/C	cg24110177	chr3:50126178	RBM5	-0.63	-5.16	-0.5	1.86e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9905704	0.647	rs11079367	chr17:57009024	A/G	cg05425664	chr17:57184151	TRIM37	-0.61	-4.86	-0.48	5.91e-6	Testicular germ cell tumor;
SKCM	cis	rs826838	0.967	rs826870	chr12:39120250	G/A	cg13010199	chr12:38710504	ALG10B	-0.78	-6.06	-0.57	4.53e-8	Heart rate;
SKCM	cis	rs9513627	1.000	rs3928271	chr13:100186958	G/A	cg11288260	chr13:100117058	NA	0.79	4.78	0.48	8.1e-6	Obesity-related traits;
SKCM	cis	rs807669	0.807	rs698422	chr22:19205826	A/T	cg02655711	chr22:19163373	SLC25A1	0.59	5.5	0.53	4.74e-7	Metabolite levels;
SKCM	cis	rs3862260	0.509	rs1045827	chr1:120162442	C/T	cg16322792	chr1:120165303	ZNF697	-0.5	-5.32	-0.52	9.47e-7	Systemic lupus erythematosus;
SKCM	cis	rs2839186	0.814	rs2839167	chr21:47661587	A/G	cg13012494	chr21:47604986	C21orf56	0.68	6.02	0.56	5.46e-8	Testicular germ cell tumor;
SKCM	cis	rs9926296	0.605	rs6500453	chr16:89858657	C/G	cg04287289	chr16:89883240	FANCA	1.03	11.97	0.8	2.47e-19	Vitiligo;
SKCM	cis	rs2243480	0.901	rs2900904	chr7:65204264	C/G	cg18252515	chr7:66147081	NA	-1.32	-8.71	-0.7	3.95e-13	Diabetic kidney disease;
SKCM	cis	rs11098499	0.909	rs7659501	chr4:120371552	G/T	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs8014204	0.762	rs12891131	chr14:75240090	A/G	cg06637938	chr14:75390232	RPS6KL1	0.7	5.36	0.52	8.27e-7	Caffeine consumption;
SKCM	cis	rs2032447	0.507	rs478349	chr6:25894057	T/C	cg18357526	chr6:26021779	HIST1H4A	0.75	5.33	0.52	9.32e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs1552244	0.882	rs67895180	chr3:10026079	T/C	cg02579736	chr3:10068473	FANCD2;CIDECP	0.94	4.84	0.48	6.49e-6	Alzheimer's disease;
SKCM	cis	rs11098499	0.722	rs17595727	chr4:120262074	C/T	cg09307838	chr4:120376055	NA	-0.97	-8.31	-0.69	2.31e-12	Corneal astigmatism;
SKCM	cis	rs1395	1.000	rs6717980	chr2:27452784	T/C	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.47	4.77	0.48	8.27e-6	Blood metabolite levels;
SKCM	cis	rs7826238	0.594	rs2948285	chr8:8130538	A/T	cg15556689	chr8:8085844	FLJ10661	0.84	7.51	0.65	8.44e-11	Systolic blood pressure;
SKCM	cis	rs8072100	0.713	rs4968318	chr17:45451894	G/A	cg08085267	chr17:45401833	C17orf57	-0.62	-5.06	-0.5	2.76e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs1018836	0.545	rs7840203	chr8:91701223	A/G	cg16814680	chr8:91681699	NA	-1.03	-11.86	-0.8	3.93e-19	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs6977660	0.660	rs13225400	chr7:19817016	A/G	cg07541023	chr7:19748670	TWISTNB	0.72	4.78	0.48	7.95e-6	Thyroid stimulating hormone;
SKCM	cis	rs3892630	0.824	rs2287882	chr19:33332952	C/T	cg22980127	chr19:33182716	NUDT19	1.21	6.68	0.6	3.17e-9	Red blood cell traits;
SKCM	cis	rs131805	0.794	rs131813	chr22:50961169	A/G	cg09435190	chr22:50968297	TYMP	0.67	4.83	0.48	6.78e-6	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs10256972	0.621	rs2280725	chr7:1087426	G/T	cg07308232	chr7:1071921	C7orf50	-0.56	-4.84	-0.48	6.33e-6	Longevity;Endometriosis;
SKCM	cis	rs28386778	0.897	rs6504187	chr17:61917099	G/A	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs11945232	1.000	rs28630962	chr4:88336386	C/T	cg23841344	chr4:88312519	HSD17B11	-0.66	-4.9	-0.49	5.07e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9543976	1.000	rs73223984	chr13:76181141	G/A	cg01531495	chr13:76123901	UCHL3	-0.9	-4.99	-0.49	3.52e-6	Diabetic retinopathy;
SKCM	cis	rs17065868	0.803	rs9533915	chr13:45147196	C/A	cg10246903	chr13:45222710	NA	0.95	5.38	0.52	7.55e-7	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs7208859	0.623	rs11658022	chr17:29085359	A/T	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs35306767	0.903	rs12254002	chr10:929133	A/G	cg20503657	chr10:835505	NA	-0.71	-4.88	-0.48	5.47e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs314370	0.951	rs12705095	chr7:100484381	T/G	cg10426581	chr7:100472382	SRRT	0.71	5.97	0.56	6.59e-8	Resting heart rate;
SKCM	cis	rs1023500	0.596	rs5758562	chr22:42448238	C/G	cg04733989	chr22:42467013	NAGA	0.77	5.75	0.55	1.68e-7	Schizophrenia;
SKCM	cis	rs1577917	0.958	rs12213331	chr6:86504797	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.86	-8.69	-0.7	4.23e-13	Response to antipsychotic treatment;
SKCM	cis	rs523522	0.923	rs10774553	chr12:120954984	T/C	cg27279351	chr12:120934652	DYNLL1	0.91	8.32	0.69	2.26e-12	High light scatter reticulocyte count;
SKCM	cis	rs2228479	1.000	rs12596492	chr16:89957169	T/G	cg00800038	chr16:89945340	TCF25	-0.96	-5.44	-0.52	5.85e-7	Skin colour saturation;
SKCM	cis	rs151997	1.000	rs152817	chr5:50230879	T/A	cg06027927	chr5:50259733	NA	-0.67	-5.97	-0.56	6.72e-8	Callous-unemotional behaviour;
SKCM	cis	rs1843834	0.505	rs3820763	chr2:225347270	A/G	cg22455342	chr2:225449267	CUL3	-0.71	-5.32	-0.52	9.67e-7	IgE levels in asthmatics (D.p. specific);
SKCM	cis	rs28595532	0.920	rs116612909	chr4:119749823	C/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs3820928	0.874	rs4461255	chr2:227846524	C/T	cg11843606	chr2:227700838	RHBDD1	0.64	5.19	0.51	1.65e-6	Pulmonary function;
SKCM	cis	rs248381	0.590	rs471989	chr5:78404955	C/T	cg17568934	chr5:77892219	LHFPL2	0.55	4.92	0.49	4.65e-6	Toenail selenium levels;
SKCM	cis	rs28386778	0.897	rs2665831	chr17:61912392	C/T	cg22520471	chr17:61851767	DDX42;CCDC47	0.77	5.27	0.51	1.18e-6	Prudent dietary pattern;
SKCM	cis	rs910316	1.000	rs1047418	chr14:75605792	A/G	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.89e-7	Height;
SKCM	cis	rs1401999	0.714	rs1000002	chr3:183635768	A/G	cg01324343	chr3:183735012	ABCC5	-0.62	-5.72	-0.54	1.92e-7	Anterior chamber depth;
SKCM	cis	rs9660180	0.783	rs1107910	chr1:1692321	C/T	cg13866156	chr1:1669148	SLC35E2	-0.68	-5.61	-0.54	3.01e-7	Body mass index;
SKCM	cis	rs798554	0.796	rs2158694	chr7:2863443	T/G	cg19346786	chr7:2764209	NA	-0.64	-6.92	-0.62	1.12e-9	Height;
SKCM	cis	rs875971	0.964	rs55748098	chr7:65763618	T/C	cg11764359	chr7:65958608	NA	-0.88	-8.54	-0.7	8.32e-13	Aortic root size;
SKCM	cis	rs9916302	0.904	rs2338798	chr17:37547269	T/C	cg07936489	chr17:37558343	FBXL20	0.84	7.23	0.63	2.81e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs6087990	0.735	rs6119946	chr20:31329704	A/G	cg13636640	chr20:31349939	DNMT3B	-0.8	-6.52	-0.59	6.36e-9	Ulcerative colitis;
SKCM	cis	rs2839186	0.934	rs2839194	chr21:47699437	T/G	cg13012494	chr21:47604986	C21orf56	0.65	5.44	0.52	6e-7	Testicular germ cell tumor;
SKCM	cis	rs9911578	0.900	rs717828	chr17:56535932	A/G	cg05425664	chr17:57184151	TRIM37	-0.69	-5.11	-0.5	2.2e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7937682	0.556	rs7108048	chr11:111352299	T/C	cg09085632	chr11:111637200	PPP2R1B	0.68	5.3	0.51	1.06e-6	Primary sclerosing cholangitis;
SKCM	cis	rs7772486	0.686	rs1292337	chr6:145967807	A/G	cg05347473	chr6:146136440	FBXO30	-0.6	-5.31	-0.52	1e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs8103278	1.000	rs7256192	chr19:46338492	G/A	cg11657440	chr19:46296263	DMWD	-0.9	-6.05	-0.56	4.8e-8	Coronary artery disease;
SKCM	cis	rs62238980	0.614	rs734092	chr22:32462167	C/G	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs7100689	0.784	rs4934153	chr10:82191255	T/C	cg00277334	chr10:82204260	NA	-0.55	-5.29	-0.51	1.07e-6	Post bronchodilator FEV1;
SKCM	cis	rs870825	0.616	rs28490461	chr4:185651638	C/T	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs7937682	0.575	rs1346180	chr11:111715570	G/C	cg09085632	chr11:111637200	PPP2R1B	1.08	11.04	0.78	1.34e-17	Primary sclerosing cholangitis;
SKCM	cis	rs6500395	0.962	rs11647046	chr16:48623217	T/C	cg04672837	chr16:48644449	N4BP1	0.69	5.88	0.55	9.68e-8	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs17376456	0.877	rs13156865	chr5:93390908	C/A	cg25358565	chr5:93447407	FAM172A	1.19	7.67	0.66	4.06e-11	Diabetic retinopathy;
SKCM	cis	rs12464559	0.522	rs4300824	chr2:152581866	T/C	cg01189475	chr2:152685088	ARL5A	1.03	5.24	0.51	1.32e-6	Response to cognitive-behavioural therapy in anxiety disorder;
SKCM	cis	rs6087990	0.899	rs6087999	chr20:31363774	A/G	cg13636640	chr20:31349939	DNMT3B	0.91	7.97	0.67	1.06e-11	Ulcerative colitis;
SKCM	cis	rs57221529	0.766	rs12519763	chr5:559145	C/T	cg26208419	chr5:473447	SLC9A3;LOC25845	0.96	4.9	0.49	5.03e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs7178909	0.902	rs10459674	chr15:90438295	G/C	cg19708238	chr15:90437601	AP3S2	0.72	5.22	0.51	1.43e-6	Common traits (Other);
SKCM	cis	rs10752881	1.000	rs12035773	chr1:182985716	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.73	6.47	0.59	7.97e-9	Colorectal cancer;
SKCM	cis	rs6430585	0.528	rs6750549	chr2:136707480	A/G	cg07169764	chr2:136633963	MCM6	1.36	12.7	0.82	1.14e-20	Corneal structure;
SKCM	cis	rs992157	0.835	rs13031757	chr2:219151926	T/C	cg00012203	chr2:219082015	ARPC2	-0.72	-5.71	-0.54	1.99e-7	Colorectal cancer;
SKCM	cis	rs807669	0.548	rs885979	chr22:19198375	T/C	cg02655711	chr22:19163373	SLC25A1	0.63	5.51	0.53	4.39e-7	Metabolite levels;
SKCM	cis	rs13108904	0.935	rs6853002	chr4:1295991	C/T	cg05665937	chr4:1216051	CTBP1	0.57	4.99	0.49	3.64e-6	Obesity-related traits;
SKCM	cis	rs17345786	0.954	rs17508319	chr3:101318903	G/A	cg12386194	chr3:101231763	SENP7	0.8	6.19	0.57	2.62e-8	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs614226	1.000	rs616157	chr12:120925795	T/C	cg01236616	chr12:121019343	POP5	-1.39	-7.69	-0.66	3.76e-11	Type 1 diabetes nephropathy;
SKCM	cis	rs684232	0.583	rs4968094	chr17:507120	A/T	cg15660573	chr17:549704	VPS53	-0.75	-5.83	-0.55	1.18e-7	Prostate cancer;
SKCM	cis	rs951366	0.764	rs708725	chr1:205744138	G/T	cg14159672	chr1:205819179	PM20D1	0.96	8.31	0.69	2.4e-12	Menarche (age at onset);
SKCM	cis	rs1344852	0.571	rs13124722	chr4:20140485	C/T	cg03260566	chr4:20256841	SLIT2	-0.56	-4.92	-0.49	4.69e-6	QRS duration;
SKCM	cis	rs875971	0.964	rs1643388	chr7:65844562	T/C	cg18876405	chr7:65276391	NA	0.67	6.65	0.6	3.61e-9	Aortic root size;
SKCM	cis	rs992157	0.710	rs6752254	chr2:219058743	C/T	cg20019365	chr2:219134978	PNKD;AAMP	0.72	6.34	0.58	1.4e-8	Colorectal cancer;
SKCM	cis	rs7020830	0.898	rs506981	chr9:37351348	A/T	cg14294708	chr9:37120828	ZCCHC7	-1.05	-11.05	-0.78	1.28e-17	Schizophrenia;
SKCM	cis	rs6545883	0.965	rs6545872	chr2:61724568	G/A	cg15711740	chr2:61764176	XPO1	-0.75	-5.3	-0.51	1.06e-6	Tuberculosis;
SKCM	cis	rs9916302	0.851	rs6503502	chr17:37501855	A/G	cg07936489	chr17:37558343	FBXL20	0.85	7.28	0.64	2.26e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs2836974	0.899	rs68004583	chr21:40659587	T/C	cg17971929	chr21:40555470	PSMG1	0.86	8.49	0.69	1.04e-12	Cognitive function;
SKCM	cis	rs10779751	1.000	rs2300092	chr1:11266464	T/C	cg08854313	chr1:11322531	MTOR	1.02	9.56	0.73	8.88e-15	Body mass index;
SKCM	cis	rs873946	0.590	rs7071777	chr10:134559976	T/A	cg14275445	chr10:134560047	INPP5A	-0.54	-4.86	-0.48	6e-6	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs2333194	0.772	rs12589739	chr14:73903056	A/G	cg08936952	chr14:74026160	HEATR4	0.55	4.93	0.49	4.6e-6	Bipolar disorder with mood-incongruent psychosis;
SKCM	cis	rs7772486	0.651	rs1292338	chr6:145967471	A/C	cg23711669	chr6:146136114	FBXO30	-0.9	-9.31	-0.73	2.67e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4319547	0.656	rs7975747	chr12:122816995	C/T	cg23029597	chr12:123009494	RSRC2	-0.73	-5.22	-0.51	1.41e-6	Body mass index;
SKCM	cis	rs2739330	0.760	rs1002286	chr22:24257337	A/G	cg04234412	chr22:24373322	LOC391322	0.62	5.23	0.51	1.41e-6	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs514406	0.708	rs514881	chr1:53336737	A/G	cg08859206	chr1:53392774	SCP2	0.64	4.88	0.48	5.57e-6	Monocyte count;
SKCM	cis	rs4555082	0.874	rs3000075	chr14:105713219	C/T	cg13114125	chr14:105738426	BRF1	0.67	5.51	0.53	4.39e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs1348850	0.874	rs12996447	chr2:178283592	C/T	cg02961200	chr2:178257176	LOC100130691;AGPS	0.84	6.5	0.59	6.98e-9	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs8141529	0.732	rs5762784	chr22:29171298	C/T	cg02153584	chr22:29168773	CCDC117	0.66	5.33	0.52	9.26e-7	Lymphocyte counts;
SKCM	cis	rs4481887	1.000	rs10888352	chr1:248451965	G/A	cg00666640	chr1:248458726	OR2T12	0.6	4.9	0.49	5.01e-6	Common traits (Other);
SKCM	cis	rs28386778	0.897	rs2727323	chr17:61921999	G/T	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs208520	0.802	rs208496	chr6:66930786	G/C	cg07460842	chr6:66804631	NA	-0.97	-6.92	-0.62	1.13e-9	Exhaled nitric oxide output;
SKCM	cis	rs9790314	0.934	rs9290074	chr3:160997823	T/C	cg03342759	chr3:160939853	NMD3	-0.72	-7.89	-0.67	1.53e-11	Morning vs. evening chronotype;
SKCM	cis	rs7666738	0.830	rs13106434	chr4:98991651	T/A	cg17366294	chr4:99064904	C4orf37	0.6	4.98	0.49	3.8e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs5769765	0.817	rs8142561	chr22:50291750	T/C	cg22709217	chr22:50311962	ALG12;CRELD2	-0.79	-5.71	-0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs9300255	0.550	rs10772997	chr12:123719880	C/A	cg00376283	chr12:123451042	ABCB9	0.87	7.25	0.63	2.63e-10	Neutrophil percentage of white cells;
SKCM	cis	rs7829975	0.564	rs2921057	chr8:8318667	C/T	cg06636001	chr8:8085503	FLJ10661	0.99	10.28	0.76	3.75e-16	Mood instability;
SKCM	cis	rs9325144	0.555	rs2387843	chr12:38711203	T/C	cg13010199	chr12:38710504	ALG10B	0.63	4.92	0.49	4.64e-6	Morning vs. evening chronotype;
SKCM	cis	rs7647973	0.807	rs4955416	chr3:49108428	T/C	cg07636037	chr3:49044803	WDR6	0.97	7.24	0.63	2.76e-10	Menarche (age at onset);
SKCM	cis	rs8072100	0.905	rs9901869	chr17:45575206	G/A	cg08085267	chr17:45401833	C17orf57	-0.6	-4.98	-0.49	3.66e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs2731664	0.792	rs163199	chr5:176890067	A/G	cg23176889	chr5:176863531	GRK6	-0.55	-5.68	-0.54	2.19e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7561149	0.534	rs12477346	chr2:179737610	A/G	cg03991736	chr2:179345203	MIR548N;PLEKHA3	-0.71	-5.01	-0.49	3.31e-6	QT interval;
SKCM	cis	rs35146811	0.961	rs1880949	chr7:99722266	A/C	cg13334819	chr7:99746414	C7orf59	0.66	4.85	0.48	6.18e-6	Coronary artery disease;
SKCM	cis	rs208520	0.874	rs208514	chr6:66945520	G/A	cg07460842	chr6:66804631	NA	-1.05	-7.28	-0.64	2.34e-10	Exhaled nitric oxide output;
SKCM	cis	rs7954584	0.531	rs10840631	chr12:122373729	C/T	cg21171335	chr12:122356390	WDR66	0.46	4.99	0.49	3.52e-6	Mean corpuscular volume;
SKCM	cis	rs28386778	0.897	rs894408	chr17:61896814	C/T	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs10751667	0.666	rs6597962	chr11:976351	C/T	cg10932868	chr11:921992	NA	0.54	5.03	0.49	3.09e-6	Alzheimer's disease (late onset);
SKCM	cis	rs801193	0.591	rs4506088	chr7:66135457	G/A	cg18876405	chr7:65276391	NA	-0.63	-6.29	-0.58	1.68e-8	Aortic root size;
SKCM	cis	rs2070488	1.000	rs13074025	chr3:38455704	C/A	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.97	9.16	0.72	5.28e-14	Electrocardiographic conduction measures;
SKCM	cis	rs1707322	0.650	rs4553239	chr1:46150486	C/A	cg03146154	chr1:46216737	IPP	0.84	6.16	0.57	2.96e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs1405130	0.781	rs13009798	chr2:235571365	A/G	cg21542780	chr2:234763377	HJURP	-0.64	-4.89	-0.48	5.21e-6	Coronary artery disease;
SKCM	cis	rs651907	0.935	rs2926538	chr3:101587585	A/G	cg12386194	chr3:101231763	SENP7	0.64	4.97	0.49	3.92e-6	Colorectal cancer;
SKCM	cis	rs2243480	1.000	rs316326	chr7:65609453	T/C	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs13010713	0.806	rs4666715	chr2:182061840	G/C	cg21995919	chr2:182322279	ITGA4	-0.53	-5.12	-0.5	2.18e-6	Celiac disease;
SKCM	cis	rs2033711	0.870	rs3764534	chr19:58929136	G/A	cg13877915	chr19:58951672	ZNF132	0.95	10.28	0.76	3.72e-16	Uric acid clearance;
SKCM	cis	rs752010	0.545	rs6600379	chr1:42053497	T/C	cg06885757	chr1:42089581	HIVEP3	0.57	6.25	0.58	2e-8	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs738322	0.753	rs5756968	chr22:38595240	C/T	cg25457927	chr22:38595422	NA	0.58	7.88	0.67	1.59e-11	Cutaneous nevi;
SKCM	cis	rs801193	0.967	rs2420827	chr7:66147101	G/A	cg11764359	chr7:65958608	NA	-0.86	-6.58	-0.6	4.87e-9	Aortic root size;
SKCM	cis	rs1278769	0.786	rs7998551	chr13:113540649	G/T	cg00823993	chr13:113535758	ATP11A	0.61	5.14	0.5	1.95e-6	Interstitial lung disease;
SKCM	cis	rs7959452	0.530	rs12811632	chr12:69755003	G/A	cg14784868	chr12:69753453	YEATS4	0.78	7.39	0.64	1.45e-10	Blood protein levels;
SKCM	cis	rs8180040	0.874	rs11130123	chr3:47285912	A/G	cg16586182	chr3:47516702	SCAP	-0.72	-4.98	-0.49	3.73e-6	Colorectal cancer;
SKCM	cis	rs4332037	0.615	rs62435127	chr7:1884937	A/G	cg23422044	chr7:1970798	MAD1L1	-0.87	-5.57	-0.53	3.53e-7	Bipolar disorder;
SKCM	cis	rs28595532	0.925	rs28627331	chr4:119665345	T/C	cg14228332	chr4:119757509	SEC24D	1.06	5.41	0.52	6.75e-7	Cannabis dependence symptom count;
SKCM	cis	rs10089	0.857	rs7718286	chr5:127459414	G/C	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.91	8.89	0.71	1.79e-13	Ileal carcinoids;
SKCM	cis	rs867186	1.000	rs8117847	chr20:33642480	C/T	cg04194272	chr20:33683537	NA	-1.38	-7.2	-0.63	3.29e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs8103278	1.000	rs8108590	chr19:46301620	A/G	cg11657440	chr19:46296263	DMWD	-0.96	-6.91	-0.62	1.16e-9	Coronary artery disease;
SKCM	cis	rs11098499	0.954	rs12506546	chr4:120301618	T/C	cg24375607	chr4:120327624	NA	0.65	4.97	0.49	3.87e-6	Corneal astigmatism;
SKCM	cis	rs28595532	1.000	rs17258106	chr4:119675406	C/T	cg14228332	chr4:119757509	SEC24D	-1.07	-5.49	-0.53	4.77e-7	Cannabis dependence symptom count;
SKCM	cis	rs910316	0.967	rs11159121	chr14:75666029	A/T	cg08847533	chr14:75593920	NEK9	-0.96	-9.69	-0.74	4.89e-15	Height;
SKCM	cis	rs2243480	1.000	rs13237037	chr7:65997882	T/C	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs4555082	1.000	rs4277291	chr14:105759009	A/G	cg13114125	chr14:105738426	BRF1	-0.67	-5.16	-0.5	1.84e-6	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs35146811	0.657	rs36019559	chr7:99814586	A/G	cg22906224	chr7:99728672	NA	-0.72	-5.76	-0.55	1.61e-7	Coronary artery disease;
SKCM	cis	rs10754283	0.967	rs12058749	chr1:90105604	C/T	cg21401794	chr1:90099060	LRRC8C	0.77	6.96	0.62	9.41e-10	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs10504229	0.683	rs73603877	chr8:58108428	C/T	cg02725872	chr8:58115012	NA	-0.53	-4.91	-0.49	4.82e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs7336332	0.891	rs927578	chr13:28075022	G/T	cg22138327	chr13:27999177	GTF3A	0.86	6.15	0.57	3.13e-8	Weight;
SKCM	cis	rs34779708	0.931	rs11010101	chr10:35411045	T/A	cg03585969	chr10:35415529	CREM	0.79	6.21	0.58	2.4e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs7726839	0.540	rs55929359	chr5:595956	C/G	cg10555297	chr5:473380	SLC9A3;LOC25845	1.02	4.87	0.48	5.72e-6	Obesity-related traits;
SKCM	cis	rs7666738	0.830	rs7678567	chr4:99057346	A/G	cg05340658	chr4:99064831	C4orf37	0.66	4.87	0.48	5.74e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2839186	0.934	rs13046494	chr21:47707430	A/C	cg13126279	chr21:47581558	C21orf56	-0.64	-5.47	-0.53	5.17e-7	Testicular germ cell tumor;
SKCM	cis	rs55962025	0.711	rs2071662	chr4:3223891	T/C	cg00764545	chr4:3318001	RGS12	-0.62	-5.4	-0.52	7.08e-7	Parental longevity (mother's age at death);
SKCM	cis	rs7598759	0.527	rs4973417	chr2:232349636	G/T	cg19187155	chr2:232395269	NMUR1	0.88	7.55	0.65	6.84e-11	Noise-induced hearing loss;
SKCM	cis	rs875971	0.660	rs13224319	chr7:66007363	A/G	cg11987759	chr7:65425863	GUSB	-0.69	-5.9	-0.56	8.74e-8	Aortic root size;
SKCM	trans	rs1814175	0.626	rs1722008	chr11:49897676	A/T	cg15704280	chr7:45808275	SEPT13	-1.03	-10.84	-0.78	3.17e-17	Height;
SKCM	cis	rs57221529	0.713	rs72703072	chr5:590626	A/G	cg09888920	chr5:474111	LOC25845;SLC9A3	0.99	4.79	0.48	7.91e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs2066819	0.901	rs1274490	chr12:56649601	A/G	cg26714650	chr12:56694279	CS	1.64	6.19	0.57	2.62e-8	Psoriasis vulgaris;
SKCM	cis	rs1348850	0.634	rs2293471	chr2:178487729	T/G	cg27490568	chr2:178487706	NA	0.89	6.21	0.57	2.45e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs4927850	0.723	rs7630825	chr3:195753740	T/C	cg01181863	chr3:195395398	SDHAP2	-0.87	-6.96	-0.62	9.23e-10	Pancreatic cancer;
SKCM	cis	rs4891159	0.513	rs35534021	chr18:74130523	G/A	cg24786174	chr18:74118243	ZNF516	0.77	7.76	0.66	2.77e-11	Longevity;
SKCM	cis	rs8017423	0.522	rs12887028	chr14:90819605	A/G	cg04374321	chr14:90722782	PSMC1	-0.77	-5.94	-0.56	7.46e-8	Mortality in heart failure;
SKCM	cis	rs12497850	0.805	rs6446198	chr3:49007638	T/A	cg06212747	chr3:49208901	KLHDC8B	0.68	4.9	0.49	5.06e-6	Parkinson's disease;
SKCM	cis	rs7523273	0.925	rs2745977	chr1:208017360	C/A	cg22525895	chr1:207977042	MIR29B2	-0.76	-5.59	-0.53	3.19e-7	Schizophrenia;
SKCM	cis	rs7103648	0.966	rs1377416	chr11:47416746	C/T	cg20307385	chr11:47447363	PSMC3	1.06	9.25	0.72	3.6e-14	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs28386778	0.897	rs896064	chr17:61860932	C/T	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs13118159	0.509	rs4974556	chr4:1358141	G/C	cg02475777	chr4:1388615	CRIPAK	0.8	5.27	0.51	1.17e-6	Longevity;
SKCM	cis	rs62238980	0.614	rs76037448	chr22:32413653	A/T	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs9916302	0.904	rs801420	chr17:37466103	C/G	cg07936489	chr17:37558343	FBXL20	0.84	6.75	0.61	2.32e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs7937682	0.737	rs682239	chr11:111425105	A/G	cg09085632	chr11:111637200	PPP2R1B	0.83	7.16	0.63	3.94e-10	Primary sclerosing cholangitis;
SKCM	cis	rs12477438	0.501	rs11688004	chr2:99735052	G/T	cg14399236	chr2:99771627	LIPT1;TSGA10	0.93	8.28	0.68	2.67e-12	Chronic sinus infection;
SKCM	cis	rs644799	0.710	rs666398	chr11:95551136	C/T	cg25622487	chr11:95524042	FAM76B;CEP57	0.7	5.67	0.54	2.28e-7	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs9910055	0.530	rs2269905	chr17:42294462	A/G	cg19774624	chr17:42201019	HDAC5	-0.77	-6.27	-0.58	1.84e-8	Total body bone mineral density;
SKCM	cis	rs8060686	0.641	rs55682260	chr16:68057880	G/A	cg09117114	chr16:67998030	SLC12A4	-0.78	-5.06	-0.5	2.72e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs1005277	0.529	rs1780125	chr10:38531376	A/G	cg00409905	chr10:38381863	ZNF37A	-0.62	-5.78	-0.55	1.49e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs4481887	0.927	rs6666903	chr1:248465582	T/A	cg00666640	chr1:248458726	OR2T12	0.62	5.28	0.51	1.14e-6	Common traits (Other);
SKCM	cis	rs4332037	0.510	rs11764040	chr7:1884830	G/C	cg23422044	chr7:1970798	MAD1L1	-0.85	-5.83	-0.55	1.18e-7	Bipolar disorder;
SKCM	cis	rs2839186	0.814	rs2839167	chr21:47661587	A/G	cg11766577	chr21:47581405	C21orf56	-0.69	-5.92	-0.56	8.12e-8	Testicular germ cell tumor;
SKCM	cis	rs763121	0.962	rs6001159	chr22:38966487	A/G	cg06022373	chr22:39101656	GTPBP1	0.77	5.87	0.55	1e-7	Menopause (age at onset);
SKCM	cis	rs2749592	0.550	rs7081464	chr10:37883937	C/T	cg25427524	chr10:38739819	LOC399744	0.59	5.41	0.52	6.76e-7	Age-related hearing impairment (SNP x SNP interaction);
SKCM	cis	rs56011263	0.532	rs4234853	chr4:735150	G/A	cg17689763	chr4:710664	PCGF3	-0.66	-4.79	-0.48	7.67e-6	White blood cell count;
SKCM	cis	rs35146811	0.735	rs1637001	chr7:99808151	G/A	cg22906224	chr7:99728672	NA	-0.72	-5.76	-0.55	1.61e-7	Coronary artery disease;
SKCM	cis	rs317689	0.702	rs544696	chr12:69749939	T/C	cg20891283	chr12:69753455	YEATS4	0.72	5.7	0.54	2.08e-7	Response to diuretic therapy;
SKCM	cis	rs4820539	1.000	rs6003518	chr22:23471533	C/T	cg14186256	chr22:23484241	RTDR1	0.85	8.15	0.68	4.91e-12	Bone mineral density;
SKCM	cis	rs6500395	1.000	rs7197732	chr16:48575878	G/A	cg04672837	chr16:48644449	N4BP1	0.69	5.6	0.54	3.1e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs3789045	0.774	rs12028476	chr1:204476361	G/A	cg17419461	chr1:204415978	PIK3C2B	-0.84	-5.83	-0.55	1.19e-7	Educational attainment (college completion);
SKCM	cis	rs1048238	0.506	rs848209	chr1:16256007	T/C	cg21385522	chr1:16154831	NA	-0.65	-5.53	-0.53	4.04e-7	Systolic blood pressure;
SKCM	cis	rs28595532	0.920	rs115530096	chr4:119760512	T/G	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs1691799	0.899	rs1168308	chr12:66742183	A/G	cg16791601	chr12:66731901	HELB	-0.66	-5.75	-0.55	1.69e-7	White blood cell count (basophil);
SKCM	cis	rs4803468	1.000	rs284656	chr19:41929251	T/C	cg09537434	chr19:41945824	ATP5SL	-1.1	-13.85	-0.84	1.02e-22	Height;
SKCM	cis	rs7659604	0.540	rs10024878	chr4:122665451	C/G	cg19671926	chr4:122722719	EXOSC9	0.74	6.09	0.57	3.92e-8	Type 2 diabetes;
SKCM	cis	rs2806561	0.704	rs664301	chr1:23522522	C/T	cg12483005	chr1:23474871	LUZP1	0.68	5.24	0.51	1.34e-6	Height;
SKCM	cis	rs7772486	0.875	rs9399572	chr6:146362945	T/G	cg05347473	chr6:146136440	FBXO30	0.57	5.12	0.5	2.13e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs5750830	0.649	rs5750818	chr22:39820885	A/G	cg11247378	chr22:39784982	NA	-0.47	-5.43	-0.52	6.23e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs1577917	0.739	rs9450318	chr6:86427177	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.94	9.69	0.74	4.92e-15	Response to antipsychotic treatment;
SKCM	cis	rs362272	0.524	rs3129334	chr4:3368526	T/C	cg16987761	chr4:3318072	RGS12	0.97	11.36	0.79	3.3e-18	Serum sulfate level;
SKCM	cis	rs10870270	0.956	rs10870281	chr10:133762642	G/A	cg17892150	chr10:133769511	PPP2R2D	-0.66	-4.86	-0.48	5.92e-6	Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals;
SKCM	cis	rs8077889	0.619	rs1230399	chr17:41845403	C/T	cg26893861	chr17:41843967	DUSP3	-1.38	-12.1	-0.81	1.42e-19	Triglycerides;
SKCM	cis	rs1801251	1.000	rs283475	chr2:233654381	A/C	cg25237894	chr2:233734115	C2orf82	-0.62	-5.83	-0.55	1.19e-7	Coronary artery disease;
SKCM	cis	rs7584330	0.744	rs72620822	chr2:238379582	C/T	cg14458575	chr2:238380390	NA	1.03	6.61	0.6	4.31e-9	Prostate cancer;
SKCM	cis	rs2153535	0.580	rs9406164	chr6:8470048	C/T	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs7589728	0.514	rs74426843	chr2:88459388	C/T	cg04511125	chr2:88470314	THNSL2	1.07	6.66	0.6	3.43e-9	Plasma clusterin levels;
SKCM	trans	rs1814175	0.645	rs7103554	chr11:50027612	G/A	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs7615952	0.604	rs9837847	chr3:125623919	G/A	cg05084668	chr3:125655381	ALG1L	-1.25	-6.57	-0.6	5.19e-9	Blood pressure (smoking interaction);
SKCM	cis	rs35146811	0.771	rs1060544	chr7:99613476	C/T	cg13334819	chr7:99746414	C7orf59	-0.74	-5.25	-0.51	1.3e-6	Coronary artery disease;
SKCM	cis	rs28595532	0.702	rs116320061	chr4:119384600	C/T	cg21605333	chr4:119757512	SEC24D	1.0	5.15	0.5	1.89e-6	Cannabis dependence symptom count;
SKCM	cis	rs8072100	1.000	rs8065669	chr17:45724996	G/A	cg25173405	chr17:45401733	C17orf57	-0.59	-5.49	-0.53	4.83e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs28386778	0.965	rs2854154	chr17:61981696	C/A	cg06873352	chr17:61820015	STRADA	-0.74	-5.87	-0.55	1e-7	Prudent dietary pattern;
SKCM	cis	rs36093844	0.904	rs1445502	chr11:85589298	T/A	cg25872744	chr11:85566296	CCDC83	-0.66	-5.01	-0.49	3.26e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs1005277	0.579	rs2474599	chr10:38438939	A/G	cg00409905	chr10:38381863	ZNF37A	-0.67	-6.21	-0.58	2.41e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs10492096	0.947	rs10849484	chr12:6637941	C/T	cg13857086	chr12:6580257	VAMP1	0.79	6.0	0.56	5.74e-8	Hip geometry;
SKCM	cis	rs3784262	0.715	rs1994927	chr15:58347949	C/A	cg12031962	chr15:58353849	ALDH1A2	-0.45	-5.37	-0.52	7.81e-7	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs9910055	0.529	rs228766	chr17:42186813	A/G	cg08499158	chr17:42289980	UBTF	0.71	5.59	0.53	3.27e-7	Total body bone mineral density;
SKCM	cis	rs28595532	0.920	rs10025640	chr4:119787451	G/A	cg21605333	chr4:119757512	SEC24D	1.36	8.05	0.67	7.69e-12	Cannabis dependence symptom count;
SKCM	cis	rs62238980	0.614	rs17683704	chr22:32506041	A/G	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs60871478	1.000	rs62432250	chr7:801792	C/G	cg05535760	chr7:792225	HEATR2	1.02	8.66	0.7	4.97e-13	Cerebrospinal P-tau181p levels;
SKCM	cis	rs7666738	0.822	rs11097599	chr4:98959562	T/A	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11098499	0.821	rs3775852	chr4:120454556	A/G	cg09307838	chr4:120376055	NA	0.97	7.66	0.66	4.19e-11	Corneal astigmatism;
SKCM	cis	rs11822910	0.815	rs12422015	chr11:57193653	A/G	cg00522883	chr11:57194120	SLC43A3	0.77	6.66	0.6	3.44e-9	Platelet distribution width;
SKCM	cis	rs1580019	0.587	rs6972365	chr7:32548931	T/A	cg06627557	chr7:32535165	LSM5;AVL9	0.95	9.08	0.72	7.65e-14	Cognitive ability;
SKCM	cis	rs9640161	0.663	rs1916932	chr7:150021644	T/C	cg10018233	chr7:150070692	REPIN1	0.77	6.19	0.57	2.62e-8	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs4771122	0.500	rs1049302	chr13:27998769	T/C	cg22138327	chr13:27999177	GTF3A	-0.92	-7.18	-0.63	3.62e-10	Body mass index;
SKCM	cis	rs875971	0.830	rs6967708	chr7:65657313	A/T	cg11764359	chr7:65958608	NA	-0.8	-7.7	-0.66	3.63e-11	Aortic root size;
SKCM	cis	rs2070488	0.965	rs7642472	chr3:38525567	T/C	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.98	9.25	0.72	3.55e-14	Electrocardiographic conduction measures;
SKCM	cis	rs9300255	0.602	rs11057192	chr12:123693420	T/C	cg00376283	chr12:123451042	ABCB9	0.84	5.56	0.53	3.58e-7	Neutrophil percentage of white cells;
SKCM	cis	rs2991971	0.933	rs12568144	chr1:45965307	G/A	cg24296786	chr1:45957014	TESK2	0.69	5.65	0.54	2.47e-7	High light scatter reticulocyte count;
SKCM	cis	rs5753618	0.555	rs5749286	chr22:31900359	G/T	cg02404636	chr22:31891804	SFI1	0.69	6.34	0.58	1.4e-8	Colorectal cancer;
SKCM	cis	rs453301	0.686	rs1045527	chr8:8890041	A/G	cg15556689	chr8:8085844	FLJ10661	-0.73	-5.77	-0.55	1.52e-7	Joint mobility (Beighton score);
SKCM	cis	rs1153858	1.000	rs12909158	chr15:45621174	A/G	cg21132104	chr15:45694354	SPATA5L1	0.92	7.65	0.65	4.46e-11	Homoarginine levels;
SKCM	cis	rs6840360	0.509	rs62327273	chr4:152547594	A/G	cg22705602	chr4:152727874	NA	-0.52	-5.69	-0.54	2.15e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs4243830	0.677	rs6693922	chr1:6584804	A/T	cg22792644	chr1:6614718	TAS1R1;NOL9	1.07	5.42	0.52	6.57e-7	Body mass index;
SKCM	cis	rs28386778	0.897	rs2584627	chr17:61901439	T/C	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs2836974	0.897	rs13047678	chr21:40708853	C/T	cg11890956	chr21:40555474	PSMG1	1.0	10.51	0.77	1.33e-16	Cognitive function;
SKCM	cis	rs801193	0.660	rs2659897	chr7:66187715	A/G	cg05627663	chr7:65219948	SNORA22;CCT6P1	-0.5	-4.87	-0.48	5.69e-6	Aortic root size;
SKCM	cis	rs4481887	0.854	rs4534423	chr1:248474993	G/C	cg00666640	chr1:248458726	OR2T12	0.63	5.91	0.56	8.65e-8	Common traits (Other);
SKCM	cis	rs7809950	1.000	rs4727684	chr7:107226470	C/T	cg23024343	chr7:107201750	COG5	-0.81	-7.52	-0.65	7.81e-11	Coronary artery disease;
SKCM	cis	rs1552244	1.000	rs6786638	chr3:10118075	G/C	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs823143	0.570	rs1361754	chr1:205801872	C/T	cg24503407	chr1:205819492	PM20D1	-0.93	-9.13	-0.72	6.02e-14	Monocyte percentage of white cells;
SKCM	cis	rs9394841	0.692	rs34073739	chr6:41829970	A/G	cg08135965	chr6:41755394	TOMM6	0.75	4.91	0.49	4.98e-6	Mean corpuscular hemoglobin;Red cell distribution width;
SKCM	cis	rs4481887	1.000	rs4916128	chr1:248466706	G/A	cg00666640	chr1:248458726	OR2T12	0.6	5.14	0.5	1.98e-6	Common traits (Other);
SKCM	cis	rs113601626	1	rs113601626	chr2:24239189	T/TCCTGGC	cg08917208	chr2:24149416	ATAD2B	1.07	5.99	0.56	6.1e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs1577917	0.958	rs36035797	chr6:86562880	G/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.81	-7.82	-0.66	2.07e-11	Response to antipsychotic treatment;
SKCM	cis	rs7666738	0.830	rs10007872	chr4:99001904	T/C	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7772486	0.754	rs9386132	chr6:146140751	T/C	cg05347473	chr6:146136440	FBXO30	0.6	5.62	0.54	2.89e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs950027	0.620	rs1049518	chr15:45653367	G/A	cg21132104	chr15:45694354	SPATA5L1	0.76	5.84	0.55	1.13e-7	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs7666738	0.830	rs11947578	chr4:98930462	T/G	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs55794721	0.611	rs74937936	chr1:25747646	G/A	cg02931644	chr1:25747376	RHCE	0.54	5.51	0.53	4.39e-7	Plateletcrit;Mean corpuscular volume;
SKCM	cis	rs116095464	0.614	rs4371799	chr5:268192	C/A	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs2439831	1.000	rs1814538	chr15:43759774	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	-1.21	-7.96	-0.67	1.1e-11	Lung cancer in ever smokers;
SKCM	cis	rs2439831	1.000	rs2251538	chr15:43767209	G/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.21	7.96	0.67	1.1e-11	Lung cancer in ever smokers;
SKCM	cis	rs4555082	0.874	rs2816620	chr14:105732704	G/T	cg13114125	chr14:105738426	BRF1	-0.72	-5.59	-0.54	3.16e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs711830	1.000	rs1562315	chr2:177045482	T/A	cg13092806	chr2:177043255	NA	0.66	5.91	0.56	8.57e-8	Serous invasive ovarian cancer;Epithelial ovarian cancer;Invasive epithelial ovarian cancer;Mucinous ovarian carcinoma;Low-grade serous and serous borderline ovarian cancer;Serous borderline ovarian cancer;High-grade serous ovarian cancer;
SKCM	cis	rs7659604	1.000	rs7659604	chr4:122665514	A/G	cg19748678	chr4:122722346	EXOSC9	-0.67	-5.42	-0.52	6.51e-7	Type 2 diabetes;
SKCM	cis	rs875971	0.660	rs801217	chr7:66010577	C/T	cg11987759	chr7:65425863	GUSB	0.69	5.9	0.56	8.74e-8	Aortic root size;
SKCM	cis	rs36093844	0.904	rs4631905	chr11:85589418	T/C	cg25872744	chr11:85566296	CCDC83	-0.66	-5.01	-0.49	3.26e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs72615157	0.697	rs2056726	chr7:99780283	G/A	cg07160278	chr7:100027354	MEPCE;ZCWPW1	0.97	5.98	0.56	6.44e-8	Lung function (FEV1/FVC);
SKCM	cis	rs7666738	0.791	rs6840669	chr4:99016020	G/T	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6430585	0.528	rs309172	chr2:136674028	A/G	cg07169764	chr2:136633963	MCM6	1.31	11.98	0.8	2.3e-19	Corneal structure;
SKCM	cis	rs1552244	0.882	rs13074282	chr3:10024699	T/G	cg02579736	chr3:10068473	FANCD2;CIDECP	0.94	4.84	0.48	6.49e-6	Alzheimer's disease;
SKCM	cis	rs778371	0.522	rs10205801	chr2:233597196	G/A	cg08000102	chr2:233561755	GIGYF2	0.76	6.22	0.58	2.35e-8	Schizophrenia;
SKCM	cis	rs3820068	0.603	rs35509554	chr1:15993514	C/T	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs1499614	1.000	rs2707828	chr7:66171377	G/A	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Gout;
SKCM	cis	rs861020	0.604	rs3766612	chr1:210020013	G/T	cg05527609	chr1:210001259	C1orf107	-1.04	-7.77	-0.66	2.57e-11	Orofacial clefts;
SKCM	cis	rs12142240	0.698	rs67276232	chr1:46825484	T/G	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs1799949	1.000	rs8176273	chr17:41211653	A/G	cg05368731	chr17:41323189	NBR1	0.89	7.67	0.66	4.08e-11	Menopause (age at onset);
SKCM	cis	rs12142240	0.698	rs41294476	chr1:46818374	C/A	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs523522	0.962	rs10849759	chr12:120994488	T/A	cg12219531	chr12:120966889	COQ5	0.89	7.53	0.65	7.52e-11	High light scatter reticulocyte count;
SKCM	cis	rs1355223	0.583	rs1549789	chr11:34867947	G/A	cg11058730	chr11:34937778	PDHX;APIP	0.59	4.77	0.47	8.55e-6	Systemic lupus erythematosus and Systemic sclerosis;
SKCM	cis	rs2742234	0.910	rs2503866	chr10:43646261	T/A	cg15022308	chr10:43447071	NA	-0.58	-5.0	-0.49	3.41e-6	Hirschsprung disease;
SKCM	cis	rs17270561	0.779	rs78589800	chr6:25883500	C/G	cg17691542	chr6:26056736	HIST1H1C	0.94	5.76	0.55	1.61e-7	Iron status biomarkers;
SKCM	cis	rs11098499	0.874	rs13139045	chr4:120168588	T/C	cg09307838	chr4:120376055	NA	1.03	8.98	0.71	1.16e-13	Corneal astigmatism;
SKCM	cis	rs6121246	0.697	rs6088864	chr20:30228157	G/A	cg11595048	chr20:30225325	COX4I2	0.65	5.19	0.51	1.62e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs4803468	1.000	rs10417997	chr19:41902361	G/A	cg09537434	chr19:41945824	ATP5SL	-1.08	-13.01	-0.83	3.1e-21	Height;
SKCM	cis	rs7618501	0.699	rs3733135	chr3:49939587	G/A	cg05072774	chr3:49840536	C3orf54	-0.71	-5.24	-0.51	1.31e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9467773	1.000	rs9467782	chr6:26542773	G/A	cg09904177	chr6:26538194	HMGN4	0.54	4.98	0.49	3.78e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs8077889	0.645	rs1230393	chr17:41842592	A/G	cg26893861	chr17:41843967	DUSP3	-1.43	-12.83	-0.82	6.51e-21	Triglycerides;
SKCM	cis	rs10256972	0.552	rs2960831	chr7:1201192	A/T	cg07092213	chr7:1199455	ZFAND2A	-0.65	-5.41	-0.52	6.67e-7	Longevity;Endometriosis;
SKCM	cis	rs1559088	0.625	rs10411739	chr19:33616327	T/C	cg27124370	chr19:33622961	WDR88	0.76	5.55	0.53	3.83e-7	Bone ultrasound measurement (broadband ultrasound attenuation);
SKCM	cis	rs2427308	0.607	rs1741635	chr20:60938197	C/G	cg24112000	chr20:60950667	NA	0.69	6.57	0.6	5.23e-9	Colorectal cancer;
SKCM	cis	rs10927875	0.550	rs12121918	chr1:16183556	C/A	cg21385522	chr1:16154831	NA	-0.99	-8.07	-0.67	6.74e-12	Dilated cardiomyopathy;
SKCM	cis	rs2644899	0.594	rs11668644	chr19:41316746	G/C	cg24958765	chr19:41283667	RAB4B	-0.83	-4.81	-0.48	7.18e-6	Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs912057	0.632	rs1294429	chr6:6744652	G/A	cg06612196	chr6:6737390	NA	0.66	5.47	0.53	5.25e-7	Waist-to-hip ratio adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);
SKCM	cis	rs4237845	0.611	rs6581159	chr12:58323876	C/T	cg02175503	chr12:58329896	NA	-0.65	-5.09	-0.5	2.44e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7811142	0.943	rs67483801	chr7:100031758	G/T	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-0.99	-5.52	-0.53	4.2e-7	Platelet count;
SKCM	cis	rs9814567	1.000	rs9989967	chr3:134238964	A/C	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs651907	0.557	rs13069443	chr3:101373305	C/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.81	7.02	0.62	7.26e-10	Colorectal cancer;
SKCM	cis	rs10504073	0.647	rs11997959	chr8:50014044	C/T	cg00325661	chr8:49890786	NA	0.79	6.79	0.61	1.99e-9	Blood metabolite ratios;
SKCM	cis	rs9916302	0.904	rs1619021	chr17:37739274	G/A	cg00129232	chr17:37814104	STARD3	-0.65	-5.0	-0.49	3.43e-6	Glomerular filtration rate (creatinine);
SKCM	cis	rs12142240	0.698	rs66483119	chr1:46838389	T/C	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs6121246	0.512	rs45443696	chr20:30311396	A/C	cg11595048	chr20:30225325	COX4I2	0.54	4.77	0.48	8.4e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs561341	0.714	rs111760509	chr17:30304320	A/G	cg23018236	chr17:30244563	NA	-0.51	-5.13	-0.5	2.05e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs459571	0.959	rs465724	chr9:136910097	C/T	cg13789015	chr9:136890014	NCRNA00094	0.69	5.39	0.52	7.21e-7	Platelet distribution width;
SKCM	trans	rs561341	1.000	rs501312	chr17:30329066	A/G	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs10089	1.000	rs13356473	chr5:127478250	T/G	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.89	8.95	0.71	1.34e-13	Ileal carcinoids;
SKCM	cis	rs1577917	1.000	rs13217384	chr6:86720000	C/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.67	-5.57	-0.53	3.45e-7	Response to antipsychotic treatment;
SKCM	cis	rs2282032	0.527	rs41309248	chr14:90767386	C/T	cg04374321	chr14:90722782	PSMC1	0.67	5.37	0.52	7.94e-7	Longevity;
SKCM	cis	rs6089584	0.893	rs2281735	chr20:60582540	T/A	cg06108461	chr20:60628389	TAF4	-0.89	-8.5	-0.69	1e-12	Body mass index;
SKCM	cis	rs4642101	0.765	rs6791647	chr3:12826425	C/T	cg05775895	chr3:12838266	CAND2	-0.63	-5.82	-0.55	1.22e-7	QRS complex (12-leadsum);
SKCM	cis	rs62158211	0.955	rs1823125	chr2:114090412	C/T	cg17784749	chr2:114082611	LOC440839	-0.85	-6.19	-0.57	2.61e-8	Sleep duration (oversleepers vs undersleepers);Sleep traits (multi-trait analysis);Sleep duration;
SKCM	trans	rs11722228	0.549	rs3796818	chr4:10097976	C/T	cg26043149	chr18:55253948	FECH	0.93	7.98	0.67	1.02e-11	Gout;Urate levels;Serum uric acid levels;
SKCM	cis	rs7666738	0.830	rs10014986	chr4:99000687	A/C	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs3767633	0.528	rs6671373	chr1:161890796	C/G	cg27519958	chr1:161735129	ATF6	-0.76	-5.79	-0.55	1.4e-7	IgG glycosylation;
SKCM	cis	rs796364	0.901	rs35572201	chr2:201035093	T/C	cg12253985	chr2:200820533	C2orf60;C2orf47	-0.94	-6.25	-0.58	2e-8	Schizophrenia;
SKCM	cis	rs2404602	0.583	rs12438741	chr15:76542114	C/A	cg23625390	chr15:77176239	SCAPER	0.69	6.31	0.58	1.57e-8	Blood metabolite levels;
SKCM	cis	rs9916302	0.514	rs4794817	chr17:37794351	T/A	cg00129232	chr17:37814104	STARD3	-0.7	-5.11	-0.5	2.19e-6	Glomerular filtration rate (creatinine);
SKCM	cis	rs7769051	0.803	rs59740783	chr6:133231711	G/A	cg22852734	chr6:133119734	C6orf192	1.04	5.04	0.5	2.99e-6	Type 2 diabetes nephropathy;
SKCM	cis	rs1799949	0.827	rs74252763	chr17:41402020	C/T	cg25072359	chr17:41440525	NA	0.62	4.83	0.48	6.81e-6	Menopause (age at onset);
SKCM	cis	rs56235845	0.685	rs35630910	chr5:176757841	A/C	cg17509989	chr5:176798049	RGS14	0.85	7.06	0.62	5.99e-10	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs1413885	0.516	rs716592	chr1:65843982	C/T	cg14976592	chr1:65886160	LEPROT;LEPR	-0.59	-5.04	-0.5	2.95e-6	Anticoagulant levels;
SKCM	cis	rs35306767	0.715	rs17293580	chr10:1034895	T/C	cg25614935	chr10:1084866	C10orf110	0.68	4.84	0.48	6.55e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs13256369	0.951	rs10503394	chr8:8565775	A/G	cg06636001	chr8:8085503	FLJ10661	0.8	6.06	0.57	4.62e-8	Obesity-related traits;
SKCM	cis	rs362272	0.545	rs2748447	chr4:3337831	G/A	cg00764545	chr4:3318001	RGS12	1.0	12.97	0.83	3.75e-21	Serum sulfate level;
SKCM	cis	rs1403694	0.695	rs10937266	chr3:186433075	G/A	cg09332604	chr3:186435400	KNG1	-0.49	-4.85	-0.48	6.09e-6	Blood protein levels;
SKCM	cis	rs7829975	0.714	rs4840362	chr8:8670082	C/G	cg06636001	chr8:8085503	FLJ10661	-0.69	-5.91	-0.56	8.4e-8	Mood instability;
SKCM	cis	rs2811415	0.597	rs11714256	chr3:127804368	G/A	cg09089421	chr3:127803668	RUVBL1	1.0	8.69	0.7	4.4e-13	Lung function (FEV1/FVC);
SKCM	cis	rs427394	1.000	rs182135	chr5:6747453	G/A	cg10857441	chr5:6722123	POLS	-0.62	-6.56	-0.6	5.44e-9	Menopause (age at onset);
SKCM	cis	rs778371	0.958	rs2675968	chr2:233736244	A/G	cg08000102	chr2:233561755	GIGYF2	0.78	5.56	0.53	3.68e-7	Schizophrenia;
SKCM	cis	rs8180040	0.966	rs7649234	chr3:47494380	G/C	cg27129171	chr3:47204927	SETD2	0.79	5.79	0.55	1.43e-7	Colorectal cancer;
SKCM	cis	rs17065868	1.000	rs9533901	chr13:45116611	A/T	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs2952156	0.920	rs9675194	chr17:37833805	A/G	cg00129232	chr17:37814104	STARD3	-0.74	-6.33	-0.58	1.41e-8	Asthma;
SKCM	cis	rs55962025	0.842	rs362272	chr4:3234980	C/T	cg24015175	chr4:3319247	RGS12	-0.68	-5.77	-0.55	1.56e-7	Parental longevity (mother's age at death);
SKCM	cis	rs919433	0.783	rs2565165	chr2:198233575	T/G	cg04278110	chr2:198063759	ANKRD44	0.74	5.13	0.5	2.06e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs12474201	0.816	rs35809007	chr2:47019521	G/A	cg06386533	chr2:46925753	SOCS5	0.86	7.1	0.63	5.15e-10	Height;
SKCM	cis	rs6762	0.719	rs1130698	chr11:838542	C/T	cg16425592	chr11:842748	TSPAN4;POLR2L	-0.77	-5.69	-0.54	2.13e-7	Mean platelet volume;
SKCM	cis	rs4803468	0.967	rs11083619	chr19:41913267	A/C	cg09537434	chr19:41945824	ATP5SL	-1.1	-13.82	-0.84	1.16e-22	Height;
SKCM	cis	rs873946	0.564	rs12772704	chr10:134557318	G/A	cg26818010	chr10:134567672	INPP5A	-0.8	-6.13	-0.57	3.38e-8	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs7618915	0.547	rs10865973	chr3:52718154	A/T	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs9475752	1.000	rs71564868	chr6:56798441	C/T	cg06815302	chr6:57335405	PRIM2	0.65	5.25	0.51	1.26e-6	Menarche (age at onset);
SKCM	cis	rs514406	0.548	rs6670871	chr1:53212082	A/C	cg16325326	chr1:53192061	ZYG11B	-0.99	-12.19	-0.81	9.5e-20	Monocyte count;
SKCM	cis	rs9368481	0.761	rs4358615	chr6:26998567	A/G	cg12292205	chr6:26970375	C6orf41	0.72	6.63	0.6	4.02e-9	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs1153858	1.000	rs2467858	chr15:45711492	A/G	cg10760299	chr15:45669010	GATM	0.61	5.9	0.56	8.99e-8	Homoarginine levels;
SKCM	cis	rs116095464	0.558	rs7710005	chr5:233572	A/G	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs910316	1.000	rs10873275	chr14:75531460	A/T	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.85e-7	Height;
SKCM	cis	rs4132509	0.948	rs12048930	chr1:243940076	C/T	cg21452805	chr1:244014465	NA	0.89	5.26	0.51	1.24e-6	RR interval (heart rate);
SKCM	cis	rs10489202	1.000	rs34774552	chr1:168032245	G/A	cg24449463	chr1:168025552	DCAF6	-0.79	-6.18	-0.57	2.73e-8	Schizophrenia;
SKCM	cis	rs67460515	0.500	rs6806015	chr3:160724766	G/A	cg03342759	chr3:160939853	NMD3	-0.65	-4.89	-0.48	5.3e-6	Parkinson's disease;
SKCM	cis	rs4481887	0.927	rs10888344	chr1:248446655	T/C	cg00666640	chr1:248458726	OR2T12	0.58	4.88	0.48	5.46e-6	Common traits (Other);
SKCM	cis	rs4665809	0.590	rs9309474	chr2:26448830	T/A	cg26119090	chr2:26468346	HADHA;HADHB	-1.06	-8.39	-0.69	1.66e-12	Gut microbiome composition (summer);
SKCM	cis	rs6977660	0.943	rs9638765	chr7:19840616	G/A	cg05791153	chr7:19748676	TWISTNB	0.79	5.51	0.53	4.42e-7	Thyroid stimulating hormone;
SKCM	cis	rs9926296	0.605	rs12448860	chr16:89849629	T/A	cg04287289	chr16:89883240	FANCA	1.03	12.03	0.81	1.91e-19	Vitiligo;
SKCM	cis	rs11098499	0.954	rs12508504	chr4:120410607	A/C	cg09307838	chr4:120376055	NA	0.96	7.72	0.66	3.23e-11	Corneal astigmatism;
SKCM	cis	rs1552244	0.872	rs6803517	chr3:10065426	C/T	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs6866344	0.570	rs56236920	chr5:178144617	C/T	cg03877680	chr5:178157825	ZNF354A	0.99	8.25	0.68	3.1e-12	Neutrophil percentage of white cells;
SKCM	cis	rs7666738	0.830	rs13118892	chr4:98968497	T/C	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs142518269	1	rs142518269	chr2:24087095	G/A	cg08917208	chr2:24149416	ATAD2B	1.07	5.67	0.54	2.28e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs1801251	0.778	rs709934	chr2:233733352	A/G	cg25237894	chr2:233734115	C2orf82	-0.6	-6.35	-0.58	1.29e-8	Coronary artery disease;
SKCM	cis	rs35306767	0.903	rs12761424	chr10:967295	C/T	cg20503657	chr10:835505	NA	0.66	5.15	0.5	1.88e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs12928939	0.518	rs12445564	chr16:71943309	C/T	cg03805757	chr16:71968109	PKD1L3	-0.73	-5.23	-0.51	1.38e-6	Post bronchodilator FEV1;
SKCM	cis	rs4819052	0.851	rs2838858	chr21:46681093	T/A	cg02159808	chr21:46707872	POFUT2;LOC642852	0.75	5.99	0.56	6.11e-8	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs1957429	0.808	rs6573581	chr14:65331955	G/A	cg23373153	chr14:65346875	NA	1.15	6.01	0.56	5.48e-8	Pediatric areal bone mineral density (radius);
SKCM	cis	rs67460515	0.892	rs1382429	chr3:161015153	T/C	cg03342759	chr3:160939853	NMD3	-0.81	-7.1	-0.63	5.14e-10	Parkinson's disease;
SKCM	cis	rs6570726	0.791	rs7755253	chr6:145858893	C/G	cg23711669	chr6:146136114	FBXO30	0.85	8.86	0.71	1.97e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs428668	0.523	rs10060607	chr5:150679304	A/C	cg11125805	chr5:150678162	SLC36A3	0.5	6.23	0.58	2.19e-8	Skin aging (microtopography measurement);
SKCM	cis	rs910316	0.875	rs12588099	chr14:75594462	A/T	cg08847533	chr14:75593920	NEK9	0.95	9.18	0.72	4.8e-14	Height;
SKCM	cis	rs9916302	0.904	rs801419	chr17:37466327	A/G	cg07936489	chr17:37558343	FBXL20	0.81	6.65	0.6	3.68e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs3091242	0.804	rs631133	chr1:25724146	T/C	cg27572855	chr1:25598939	RHD	0.56	5.52	0.53	4.35e-7	Erythrocyte sedimentation rate;
SKCM	cis	rs2732480	0.557	rs2634682	chr12:48732943	T/C	cg21348975	chr12:48724119	NA	-0.6	-5.35	-0.52	8.64e-7	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs137761	0.576	rs6006521	chr22:44055944	A/G	cg12729397	chr22:44208276	EFCAB6	0.67	4.79	0.48	7.85e-6	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs208520	0.609	rs208436	chr6:66897470	G/A	cg07460842	chr6:66804631	NA	-0.78	-6.02	-0.56	5.32e-8	Exhaled nitric oxide output;
SKCM	cis	rs67311347	0.544	rs35112505	chr3:40337075	A/G	cg02782426	chr3:40428986	ENTPD3	0.52	5.3	0.51	1.06e-6	Renal cell carcinoma;
SKCM	cis	rs2836950	0.502	rs2150411	chr21:40574552	G/T	cg11644478	chr21:40555479	PSMG1	-0.63	-4.84	-0.48	6.44e-6	Menarche (age at onset);
SKCM	cis	rs4423214	0.840	rs1792233	chr11:71182179	G/A	cg05163923	chr11:71159392	DHCR7	-0.71	-6.07	-0.57	4.35e-8	Vitamin D levels;
SKCM	cis	rs208520	0.874	rs208485	chr6:66925654	T/C	cg07460842	chr6:66804631	NA	-0.9	-6.89	-0.61	1.29e-9	Exhaled nitric oxide output;
SKCM	cis	rs2033711	0.936	rs893185	chr19:58989495	A/C	cg13877915	chr19:58951672	ZNF132	0.88	8.33	0.69	2.16e-12	Uric acid clearance;
SKCM	trans	rs1814175	0.817	rs10769617	chr11:49810421	G/A	cg15704280	chr7:45808275	SEPT13	-1.03	-10.73	-0.77	5.17e-17	Height;
SKCM	cis	rs4930103	0.564	rs1618613	chr11:1969888	G/A	cg23202291	chr11:1979235	NA	-0.64	-6.74	-0.61	2.44e-9	DNA methylation (parent-of-origin);DNA methylation (variation);
SKCM	cis	rs651907	0.557	rs13066768	chr3:101486920	A/T	cg12386194	chr3:101231763	SENP7	-0.68	-5.59	-0.54	3.16e-7	Colorectal cancer;
SKCM	cis	rs9303401	0.659	rs17822837	chr17:56737838	C/T	cg10487724	chr17:56770010	TEX14;RAD51C	0.85	6.13	0.57	3.39e-8	Cognitive test performance;
SKCM	cis	rs4629180	1.000	rs974374	chr2:102105846	C/T	cg20146536	chr2:102096205	NA	-0.56	-4.93	-0.49	4.53e-6	Chronic rhinosinusitis with nasal polyps;
SKCM	cis	rs9814567	1.000	rs17694011	chr3:134213981	T/C	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.67	-5.25	-0.51	1.28e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs13256369	0.802	rs34762800	chr8:8559294	G/A	cg06636001	chr8:8085503	FLJ10661	0.74	5.5	0.53	4.71e-7	Obesity-related traits;
SKCM	cis	rs11098499	0.866	rs9991221	chr4:120292107	G/C	cg24375607	chr4:120327624	NA	0.62	4.77	0.48	8.45e-6	Corneal astigmatism;
SKCM	cis	rs2439831	0.681	rs484029	chr15:43619560	T/C	cg27015174	chr15:43622946	ADAL;LCMT2	0.87	4.81	0.48	7.13e-6	Lung cancer in ever smokers;
SKCM	cis	rs2836974	0.899	rs34176878	chr21:40548855	C/A	cg11890956	chr21:40555474	PSMG1	1.09	12.9	0.83	4.85e-21	Cognitive function;
SKCM	cis	rs9611565	0.559	rs5758428	chr22:42106216	G/A	cg03806693	chr22:41940476	POLR3H	1.11	6.72	0.61	2.72e-9	Vitiligo;
SKCM	cis	rs7315438	0.629	rs4767324	chr12:115920020	A/T	cg04892836	chr12:115174285	NA	0.41	4.98	0.49	3.73e-6	Colorectal cancer;
SKCM	cis	rs7937682	0.562	rs519850	chr11:111376888	A/T	cg09085632	chr11:111637200	PPP2R1B	-0.84	-6.65	-0.6	3.62e-9	Primary sclerosing cholangitis;
SKCM	cis	rs651907	0.535	rs34161138	chr3:101510388	T/C	cg12386194	chr3:101231763	SENP7	0.68	5.74	0.54	1.73e-7	Colorectal cancer;
SKCM	cis	rs6545883	0.929	rs12612982	chr2:61747355	G/A	cg15711740	chr2:61764176	XPO1	-0.73	-5.27	-0.51	1.19e-6	Tuberculosis;
SKCM	cis	rs5750830	0.649	rs6001588	chr22:39819049	G/C	cg24399712	chr22:39784796	NA	-0.6	-5.01	-0.49	3.31e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7635838	0.617	rs347590	chr3:11289561	G/A	cg00170343	chr3:11313890	ATG7	0.77	6.06	0.57	4.59e-8	HDL cholesterol;
SKCM	cis	rs9325144	0.647	rs7487395	chr12:38865660	C/A	cg26384229	chr12:38710491	ALG10B	-0.75	-6.25	-0.58	2.06e-8	Morning vs. evening chronotype;
SKCM	cis	rs2204008	0.774	rs3910796	chr12:38230660	G/T	cg26384229	chr12:38710491	ALG10B	0.82	6.58	0.6	4.87e-9	Bladder cancer;
SKCM	cis	rs57221529	0.766	rs12518859	chr5:587432	C/T	cg10555297	chr5:473380	SLC9A3;LOC25845	1.01	5.03	0.49	3.1e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs155076	1.000	rs484365	chr13:21845944	G/T	cg11317459	chr13:21872234	NA	-1.24	-6.91	-0.62	1.19e-9	White matter hyperintensity burden;
SKCM	cis	rs143829871	1	rs143829871	chr3:47597245	T/C	cg09665691	chr3:47563885	NA	1.54	5.06	0.5	2.77e-6	Stem cell growth factor beta levels;
SKCM	cis	rs2836950	0.545	rs11700813	chr21:40517469	T/G	cg11890956	chr21:40555474	PSMG1	-0.71	-5.42	-0.52	6.45e-7	Menarche (age at onset);
SKCM	cis	rs13256369	0.851	rs13267036	chr8:8566685	G/A	cg06636001	chr8:8085503	FLJ10661	0.77	5.95	0.56	7.26e-8	Obesity-related traits;
SKCM	cis	rs10871290	0.551	rs3863435	chr16:74465396	C/G	cg01733217	chr16:74700730	RFWD3	-0.65	-4.98	-0.49	3.76e-6	Breast cancer;
SKCM	cis	rs778371	0.723	rs2592104	chr2:233645970	G/A	cg08000102	chr2:233561755	GIGYF2	0.82	6.38	0.59	1.14e-8	Schizophrenia;
SKCM	cis	rs2836974	0.863	rs8128026	chr21:40533702	T/C	cg11644478	chr21:40555479	PSMG1	0.97	10.21	0.76	5.08e-16	Cognitive function;
SKCM	cis	rs7618915	0.524	rs2028216	chr3:52680823	C/T	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs35306767	0.903	rs12264711	chr10:929525	T/C	cg20503657	chr10:835505	NA	0.75	5.36	0.52	8.31e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs523522	0.962	rs2233676	chr12:120933607	G/A	cg12219531	chr12:120966889	COQ5	0.91	7.82	0.66	2.11e-11	High light scatter reticulocyte count;
SKCM	cis	rs7618915	0.547	rs11130323	chr3:52770277	T/C	cg18404041	chr3:52824283	ITIH1	-0.56	-4.94	-0.49	4.33e-6	Bipolar disorder;
SKCM	cis	rs12478296	0.901	rs59477854	chr2:243015490	T/C	cg06360820	chr2:242988706	NA	-0.94	-5.68	-0.54	2.21e-7	Obesity-related traits;
SKCM	cis	rs12142240	0.698	rs67200518	chr1:46835777	T/C	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs13118159	0.550	rs4974614	chr4:1373489	A/G	cg05025164	chr4:1340916	KIAA1530	0.89	7.25	0.63	2.67e-10	Longevity;
SKCM	cis	rs6951245	1.000	rs11770909	chr7:1086716	G/A	cg18402987	chr7:1209562	NA	1.14	6.01	0.56	5.68e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs1957429	0.808	rs8009510	chr14:65351338	T/G	cg23373153	chr14:65346875	NA	1.11	6.32	0.58	1.52e-8	Pediatric areal bone mineral density (radius);
SKCM	cis	rs12586317	0.553	rs78124218	chr14:35570606	G/A	cg16230307	chr14:35515116	FAM177A1	0.7	5.12	0.5	2.16e-6	Psoriasis;
SKCM	cis	rs35306767	0.903	rs35370435	chr10:898205	T/C	cg25614935	chr10:1084866	C10orf110	0.81	5.47	0.53	5.26e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs244731	1.000	rs244730	chr5:176539212	A/G	cg06060754	chr5:176797920	RGS14	-0.69	-6.1	-0.57	3.78e-8	Urate levels in lean individuals;
SKCM	cis	rs28386778	0.897	rs2854208	chr17:61946885	C/T	cg01411255	chr17:61851458	DDX42;CCDC47	0.77	4.95	0.49	4.26e-6	Prudent dietary pattern;
SKCM	cis	rs9858542	0.953	rs7623659	chr3:49414791	C/T	cg03060546	chr3:49711283	APEH	-0.69	-5.16	-0.5	1.85e-6	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs17685	0.725	rs4476928	chr7:75642107	C/A	cg16489192	chr7:75678113	MDH2;STYXL1	0.58	5.44	0.52	5.83e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs752010	0.871	rs10789405	chr1:42101962	C/T	cg06885757	chr1:42089581	HIVEP3	0.61	6.19	0.57	2.64e-8	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs2730245	0.527	rs2527205	chr7:158706393	G/T	cg24397884	chr7:158709396	WDR60	-0.98	-5.56	-0.53	3.7e-7	Height;
SKCM	cis	rs523522	0.962	rs11065154	chr12:120971417	T/C	cg27279351	chr12:120934652	DYNLL1	0.91	8.32	0.69	2.26e-12	High light scatter reticulocyte count;
SKCM	cis	rs2842992	0.673	rs6930904	chr6:160217433	T/A	cg11366901	chr6:160182831	ACAT2	0.9	7.3	0.64	2.06e-10	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs7552404	0.883	rs11161493	chr1:76206254	T/A	cg10523679	chr1:76189770	ACADM	0.69	5.07	0.5	2.67e-6	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs7143963	1.000	rs7153002	chr14:103323915	C/T	cg23020514	chr14:103360112	TRAF3	0.9	8.54	0.7	8.45e-13	Body mass index;
SKCM	cis	rs763014	0.966	rs4984903	chr16:680695	A/G	cg00908189	chr16:619842	PIGQ	0.86	7.73	0.66	3.15e-11	Height;
SKCM	cis	rs875971	0.619	rs10278371	chr7:66051540	C/A	cg05627663	chr7:65219948	SNORA22;CCT6P1	-0.56	-4.84	-0.48	6.39e-6	Aortic root size;
SKCM	cis	rs7312774	0.609	rs2374655	chr12:107380162	T/C	cg16260113	chr12:107380972	MTERFD3	1.09	5.05	0.5	2.84e-6	Severe influenza A (H1N1) infection;
SKCM	cis	rs3785574	0.962	rs2727329	chr17:61924566	C/T	cg06601766	chr17:61851465	DDX42;CCDC47	0.72	5.36	0.52	8.34e-7	Height;
SKCM	cis	rs12714314	0.560	rs11694545	chr2:1939208	C/T	cg22350835	chr2:1868857	MYT1L	-0.6	-5.68	-0.54	2.22e-7	Type 2 diabetes (age of onset);
SKCM	cis	rs2842992	0.662	rs2273826	chr6:160211421	A/G	cg16489826	chr6:160211363	TCP1;MRPL18	0.71	5.51	0.53	4.52e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs28374715	0.662	rs28382348	chr15:41487934	G/C	cg18705301	chr15:41695430	NDUFAF1	-0.93	-7.74	-0.66	2.94e-11	Ulcerative colitis;
SKCM	cis	rs2727020	0.729	rs2866328	chr11:49282421	A/G	cg21546286	chr11:48923668	NA	0.54	4.9	0.48	5.15e-6	Coronary artery disease;
SKCM	cis	rs2197308	0.692	rs7488528	chr12:37912971	G/A	cg26384229	chr12:38710491	ALG10B	0.82	6.88	0.61	1.35e-9	Morning vs. evening chronotype;
SKCM	cis	rs9611565	0.592	rs4822047	chr22:41987937	C/A	cg03806693	chr22:41940476	POLR3H	-1.04	-6.74	-0.61	2.44e-9	Vitiligo;
SKCM	cis	rs33794	0.901	rs33776	chr3:45286898	C/T	cg25630594	chr3:44914870	TGM4	0.57	4.97	0.49	3.85e-6	Lung function (forced expiratory volume in 1 second);
SKCM	cis	rs6489882	0.966	rs7980275	chr12:113380529	T/A	cg07232103	chr12:112566177	TRAFD1	0.6	4.8	0.48	7.39e-6	Chronic lymphocytic leukemia;
SKCM	cis	rs637571	0.544	rs56239996	chr11:65730003	A/T	cg02427764	chr11:65769310	BANF1;EIF1AD	0.76	5.82	0.55	1.26e-7	Eosinophil percentage of white cells;
SKCM	cis	rs4774899	0.966	rs12908760	chr15:57505217	G/T	cg01857019	chr15:57210107	LOC145783;TCF12	0.53	4.94	0.49	4.38e-6	Urinary tract infection frequency;
SKCM	cis	rs8060686	0.641	rs118035472	chr16:68242311	A/G	cg09117114	chr16:67998030	SLC12A4	-0.77	-5.03	-0.49	3.12e-6	HDL cholesterol;Metabolic syndrome;
SKCM	trans	rs1814175	0.754	rs10839453	chr11:49955815	A/T	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs2839186	0.771	rs2839155	chr21:47639992	A/G	cg13012494	chr21:47604986	C21orf56	0.67	5.81	0.55	1.29e-7	Testicular germ cell tumor;
SKCM	cis	rs9467773	1.000	rs9467779	chr6:26536687	A/T	cg15659132	chr6:26577336	NA	-0.6	-5.68	-0.54	2.19e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs3768617	0.510	rs12091137	chr1:183075732	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs2811415	0.597	rs9850779	chr3:127744518	G/T	cg09089421	chr3:127803668	RUVBL1	0.99	8.52	0.69	9.09e-13	Lung function (FEV1/FVC);
SKCM	cis	rs28595532	0.920	rs55806110	chr4:119742583	A/G	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs28595532	0.841	rs115233595	chr4:119744214	T/C	cg14228332	chr4:119757509	SEC24D	1.09	5.57	0.53	3.43e-7	Cannabis dependence symptom count;
SKCM	trans	rs3780486	0.522	rs1328898	chr9:33163271	A/G	cg20290983	chr6:43655470	MRPS18A	0.82	8.72	0.7	3.79e-13	IgG glycosylation;
SKCM	cis	rs2832191	0.636	rs8131295	chr21:30516819	A/T	cg24692254	chr21:30365293	RNF160	-0.76	-6.41	-0.59	1.03e-8	Dental caries;
SKCM	cis	rs801193	1.000	rs3857688	chr7:66127806	G/A	cg11987759	chr7:65425863	GUSB	0.67	5.75	0.55	1.68e-7	Aortic root size;
SKCM	cis	rs2070488	0.965	rs3749386	chr3:38496065	C/T	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.99	8.84	0.71	2.18e-13	Electrocardiographic conduction measures;
SKCM	cis	rs875971	0.660	rs10272357	chr7:66063074	G/A	cg11987759	chr7:65425863	GUSB	0.67	5.8	0.55	1.36e-7	Aortic root size;
SKCM	cis	rs28374715	0.681	rs77187862	chr15:41619276	A/T	cg18705301	chr15:41695430	NDUFAF1	-1.05	-9.62	-0.74	6.78e-15	Ulcerative colitis;
SKCM	cis	rs2204008	0.577	rs11520050	chr12:38051839	G/A	cg26384229	chr12:38710491	ALG10B	0.81	6.45	0.59	8.61e-9	Bladder cancer;
SKCM	cis	rs9926296	0.744	rs6860	chr16:89711120	C/T	cg01097406	chr16:89675127	NA	0.56	5.7	0.54	2.07e-7	Vitiligo;
SKCM	cis	rs2120019	0.938	rs13056	chr15:75312187	A/G	cg09165964	chr15:75287851	SCAMP5	-0.85	-8.74	-0.7	3.44e-13	Blood trace element (Zn levels);
SKCM	cis	rs9303401	0.659	rs17741087	chr17:56550300	C/T	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.19	0.57	2.61e-8	Cognitive test performance;
SKCM	cis	rs9388451	0.839	rs10457469	chr6:126083658	G/A	cg05901451	chr6:126070800	HEY2	-0.84	-8.44	-0.69	1.34e-12	Brugada syndrome;
SKCM	cis	rs6893300	0.560	rs1019443	chr5:179207547	A/G	cg08299521	chr5:179344619	NA	-0.43	-4.78	-0.48	8.19e-6	Resting heart rate;
SKCM	cis	rs62238980	0.614	rs117586262	chr22:32406424	G/A	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs1577917	1.000	rs7766645	chr6:86622238	T/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.61	-5.31	-0.52	1.02e-6	Response to antipsychotic treatment;
SKCM	cis	rs9875589	0.509	rs1488379	chr3:14014719	A/G	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.57	5.73	0.54	1.84e-7	Ovarian reserve;
SKCM	cis	rs854765	0.547	rs8069811	chr17:17922280	G/A	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.03	9.04	0.72	8.99e-14	Total body bone mineral density;
SKCM	cis	rs644799	0.930	rs587123	chr11:95560539	T/G	cg03916912	chr11:95522834	CEP57;FAM76B	0.88	7.53	0.65	7.59e-11	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs28386778	0.765	rs2070680	chr17:61986988	A/G	cg23090583	chr17:61904693	PSMC5;FTSJ3	-0.92	-7.67	-0.66	4.04e-11	Prudent dietary pattern;
SKCM	cis	rs11098499	0.954	rs13151285	chr4:120314741	C/A	cg24375607	chr4:120327624	NA	0.65	4.97	0.49	3.87e-6	Corneal astigmatism;
SKCM	cis	rs6570726	0.764	rs9322028	chr6:145895797	G/T	cg05347473	chr6:146136440	FBXO30	0.57	5.08	0.5	2.47e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs12145833	0.538	rs10754798	chr1:243309958	A/G	cg02356786	chr1:243265016	LOC731275	-1.28	-6.57	-0.6	5.1e-9	Obesity (early onset extreme);
SKCM	cis	rs7666738	0.518	rs13133925	chr4:98706398	G/T	cg17366294	chr4:99064904	C4orf37	0.64	5.05	0.5	2.78e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs72634258	0.842	rs6668846	chr1:8152102	C/G	cg00042356	chr1:8021962	PARK7	-0.87	-5.85	-0.55	1.12e-7	Inflammatory bowel disease;
SKCM	cis	rs875971	0.660	rs12698534	chr7:65986845	C/T	cg00343986	chr7:65444356	GUSB	0.7	5.14	0.5	1.98e-6	Aortic root size;
SKCM	cis	rs12497850	0.863	rs4858799	chr3:48728204	G/A	cg00383909	chr3:49044727	WDR6	0.89	5.09	0.5	2.44e-6	Parkinson's disease;
SKCM	cis	rs7937682	0.883	rs568506	chr11:111466429	C/T	cg19812747	chr11:111475976	SIK2	-0.61	-4.94	-0.49	4.41e-6	Primary sclerosing cholangitis;
SKCM	cis	rs79839061	0.610	rs34006051	chr4:847445	C/T	cg07828340	chr4:882639	GAK	1.0	4.86	0.48	5.99e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9300255	0.596	rs1568427	chr12:123738678	A/G	cg05973401	chr12:123451056	ABCB9	0.75	5.83	0.55	1.18e-7	Neutrophil percentage of white cells;
SKCM	cis	rs11585357	0.947	rs6684387	chr1:17611519	T/C	cg08277548	chr1:17600880	PADI3	0.9	6.35	0.58	1.34e-8	Hair shape;
SKCM	cis	rs7523050	0.558	rs34880940	chr1:109487731	T/C	cg08274380	chr1:109419600	GPSM2	1.0	4.81	0.48	7.19e-6	Fat distribution (HIV);
SKCM	cis	rs4481887	1.000	rs4306162	chr1:248468509	C/T	cg00666640	chr1:248458726	OR2T12	0.61	5.6	0.54	3.11e-7	Common traits (Other);
SKCM	cis	rs6087990	0.806	rs4911258	chr20:31369479	G/A	cg13636640	chr20:31349939	DNMT3B	0.93	8.29	0.68	2.61e-12	Ulcerative colitis;
SKCM	cis	rs36093844	0.752	rs7931698	chr11:85549926	A/G	cg25872744	chr11:85566296	CCDC83	-0.85	-4.77	-0.48	8.27e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs1395	0.710	rs11682913	chr2:27473649	G/A	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.5	4.79	0.48	7.88e-6	Blood metabolite levels;
SKCM	cis	rs62238980	0.614	rs17682583	chr22:32401495	G/A	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs933688	1.000	rs933688	chr5:90762748	G/A	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.9	6.28	0.58	1.8e-8	Smoking behavior;
SKCM	cis	rs10193935	1.000	rs4494804	chr2:42395946	A/T	cg27598129	chr2:42591480	NA	-0.92	-6.79	-0.61	1.97e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9875589	0.509	rs56071023	chr3:14075920	A/G	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.5	5.14	0.5	2.01e-6	Ovarian reserve;
SKCM	cis	rs9300255	0.602	rs1716160	chr12:123700225	C/T	cg00376283	chr12:123451042	ABCB9	0.83	5.49	0.53	4.74e-7	Neutrophil percentage of white cells;
SKCM	cis	rs6445797	0.632	rs12636773	chr3:56604536	T/C	cg13616963	chr3:57583610	ARF4	-0.78	-5.17	-0.51	1.76e-6	Gastritis;
SKCM	cis	rs1957429	0.901	rs2884308	chr14:65350406	A/T	cg23373153	chr14:65346875	NA	-1.03	-5.75	-0.55	1.69e-7	Pediatric areal bone mineral density (radius);
SKCM	cis	rs10871290	0.881	rs3863436	chr16:74468038	T/C	cg01733217	chr16:74700730	RFWD3	-0.7	-5.18	-0.51	1.7e-6	Breast cancer;
SKCM	cis	rs6952808	0.500	rs3778996	chr7:2177190	G/A	cg05863683	chr7:1912471	MAD1L1	0.58	4.95	0.49	4.27e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs514406	0.861	rs7526275	chr1:53245849	C/T	cg16325326	chr1:53192061	ZYG11B	-1.01	-11.91	-0.8	3.17e-19	Monocyte count;
SKCM	cis	rs7216064	1.000	rs11079706	chr17:65835470	G/T	cg12091567	chr17:66097778	LOC651250	-0.77	-5.53	-0.53	4.06e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs7618915	0.547	rs11714419	chr3:52628816	A/G	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs4237845	0.780	rs3751331	chr12:58290278	G/A	cg00677455	chr12:58241039	CTDSP2	0.7	5.88	0.55	9.49e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs3784262	0.647	rs2414529	chr15:58317094	G/T	cg12031962	chr15:58353849	ALDH1A2	-0.42	-4.89	-0.48	5.38e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs28386778	0.830	rs6504180	chr17:61813169	T/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.12	11.27	0.79	4.92e-18	Prudent dietary pattern;
SKCM	cis	rs9916302	0.851	rs11870631	chr17:37645129	C/T	cg07936489	chr17:37558343	FBXL20	-0.9	-8.1	-0.68	6.05e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs763121	0.853	rs2413547	chr22:39107338	A/G	cg06022373	chr22:39101656	GTPBP1	0.78	5.59	0.53	3.27e-7	Menopause (age at onset);
SKCM	cis	rs28595532	0.920	rs115860303	chr4:119734526	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.43	0.59	9.38e-9	Cannabis dependence symptom count;
SKCM	cis	rs4819052	0.819	rs34818688	chr21:46672416	C/T	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.36	0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs9910055	0.762	rs2526020	chr17:42216588	G/T	cg09913183	chr17:42254507	C17orf65;ASB16	0.71	6.52	0.59	6.37e-9	Total body bone mineral density;
SKCM	cis	rs2180341	0.920	rs1073932	chr6:127682009	G/T	cg27446573	chr6:127587934	RNF146	0.94	8.11	0.68	5.63e-12	Breast cancer;
SKCM	cis	rs2070488	0.804	rs2276541	chr3:38512779	G/A	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.74	5.96	0.56	6.8e-8	Electrocardiographic conduction measures;
SKCM	cis	rs4481887	0.893	rs11204632	chr1:248479532	G/A	cg00666640	chr1:248458726	OR2T12	0.66	6.0	0.56	5.9e-8	Common traits (Other);
SKCM	cis	rs1153858	1.000	rs1346268	chr15:45673029	T/C	cg10760299	chr15:45669010	GATM	0.62	6.35	0.58	1.3e-8	Homoarginine levels;
SKCM	cis	rs10089	1.000	rs1842006	chr5:127508687	G/A	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.87	7.69	0.66	3.82e-11	Ileal carcinoids;
SKCM	cis	rs1784581	0.851	rs1784591	chr6:162388893	C/G	cg17173639	chr6:162384350	PARK2	-0.62	-5.44	-0.52	5.86e-7	Itch intensity from mosquito bite;
SKCM	cis	rs4819052	0.851	rs8130285	chr21:46671701	G/C	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.36	0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs453301	0.653	rs11784393	chr8:8903134	C/T	cg06636001	chr8:8085503	FLJ10661	0.77	6.09	0.57	4.03e-8	Joint mobility (Beighton score);
SKCM	cis	rs12044355	0.858	rs12031888	chr1:231820012	T/C	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	0.82	6.24	0.58	2.14e-8	Alzheimer's disease;
SKCM	cis	rs548181	0.621	rs2912098	chr11:125528569	C/T	cg03464685	chr11:125439445	EI24	1.25	8.63	0.7	5.54e-13	Schizophrenia;Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);
SKCM	cis	rs16854884	0.584	rs34372603	chr3:143738249	T/C	cg06585982	chr3:143692056	C3orf58	0.87	8.11	0.68	5.72e-12	Economic and political preferences (feminism/equality);
SKCM	cis	rs17685	0.671	rs60303271	chr7:75760008	A/G	cg16684958	chr7:75615977	POR	0.55	5.27	0.51	1.19e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2836950	0.520	rs59916147	chr21:40634702	T/G	cg11890956	chr21:40555474	PSMG1	-0.7	-5.5	-0.53	4.64e-7	Menarche (age at onset);
SKCM	cis	rs9910055	0.659	rs3826412	chr17:42255097	A/G	cg19774624	chr17:42201019	HDAC5	-0.87	-8.15	-0.68	4.72e-12	Total body bone mineral density;
SKCM	cis	rs10504229	0.683	rs7459925	chr8:58111771	G/A	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs7000551	0.581	rs2293145	chr8:22262654	A/T	cg12081754	chr8:22256438	SLC39A14	1.01	10.56	0.77	1.05e-16	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs2268241	0.938	rs2300373	chr21:34788739	A/T	cg14850771	chr21:34775459	IFNGR2	1.08	6.71	0.61	2.73e-9	Obesity-related traits;
SKCM	cis	rs3751667	0.629	rs4984741	chr16:1025464	G/A	cg08750280	chr16:1024642	NA	0.59	5.17	0.51	1.77e-6	Non-glioblastoma glioma;Glioblastoma;Glioma;
SKCM	cis	rs9467773	1.000	rs10484442	chr6:26555879	A/G	cg09904177	chr6:26538194	HMGN4	0.54	4.98	0.49	3.78e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs4900538	0.855	rs1190537	chr14:102887816	C/T	cg18135206	chr14:102964638	TECPR2	-0.72	-5.29	-0.51	1.1e-6	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs6840360	0.593	rs6857073	chr4:152689274	A/G	cg22705602	chr4:152727874	NA	0.61	8.23	0.68	3.35e-12	Intelligence (multi-trait analysis);
SKCM	cis	rs2204008	0.837	rs1842599	chr12:37986081	G/A	cg26384229	chr12:38710491	ALG10B	-0.74	-6.1	-0.57	3.77e-8	Bladder cancer;
SKCM	cis	rs4237845	0.537	rs59401446	chr12:58259564	G/A	cg02175503	chr12:58329896	NA	0.75	6.09	0.57	4.04e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs2180341	0.751	rs9388553	chr6:127574044	A/G	cg24812749	chr6:127587940	RNF146	0.78	6.47	0.59	8.04e-9	Breast cancer;
SKCM	cis	rs9300255	0.537	rs1618679	chr12:123650714	A/G	cg05973401	chr12:123451056	ABCB9	0.8	5.47	0.53	5.23e-7	Neutrophil percentage of white cells;
SKCM	cis	rs1451375	0.617	rs745043	chr7:50543955	T/G	cg18232548	chr7:50535776	DDC	-0.71	-4.77	-0.48	8.5e-6	Malaria;
SKCM	cis	rs4900538	0.855	rs9788420	chr14:102839338	A/G	cg18135206	chr14:102964638	TECPR2	-0.72	-5.21	-0.51	1.5e-6	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs2404602	0.647	rs11631394	chr15:76973209	G/T	cg23625390	chr15:77176239	SCAPER	-0.82	-7.93	-0.67	1.26e-11	Blood metabolite levels;
SKCM	cis	rs2153535	0.580	rs915352	chr6:8442766	G/A	cg23788917	chr6:8435910	SLC35B3	0.69	5.14	0.5	1.99e-6	Motion sickness;
SKCM	cis	rs6977660	0.714	rs10232870	chr7:19818040	A/G	cg05791153	chr7:19748676	TWISTNB	0.77	5.02	0.49	3.23e-6	Thyroid stimulating hormone;
SKCM	cis	rs854765	0.505	rs4506969	chr17:17899839	A/G	cg04398451	chr17:18023971	MYO15A	-0.97	-7.45	-0.64	1.08e-10	Total body bone mineral density;
SKCM	cis	rs1552244	1.000	rs3895942	chr3:10108745	G/C	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs17685	0.712	rs6954569	chr7:75738885	T/A	cg16684958	chr7:75615977	POR	0.57	5.54	0.53	4e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs72781680	0.752	rs12616649	chr2:23890913	G/A	cg08917208	chr2:24149416	ATAD2B	0.98	4.87	0.48	5.69e-6	Lymphocyte counts;
SKCM	cis	rs801193	0.805	rs12532355	chr7:66070584	C/G	cg18876405	chr7:65276391	NA	-0.8	-7.23	-0.63	2.83e-10	Aortic root size;
SKCM	cis	rs2075371	1.000	rs2598288	chr7:133977304	A/T	cg20476274	chr7:133979776	SLC35B4	1.01	10.44	0.76	1.77e-16	Mean platelet volume;
SKCM	cis	rs7666738	0.753	rs11932536	chr4:98930105	A/G	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs17065868	1.000	rs9525981	chr13:45123937	G/A	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs6500602	0.701	rs8053770	chr16:4539030	T/A	cg08645402	chr16:4508243	NA	0.63	4.89	0.48	5.39e-6	Schizophrenia;
SKCM	cis	rs992157	0.560	rs12992937	chr2:219087072	A/T	cg20019365	chr2:219134978	PNKD;AAMP	-0.66	-5.49	-0.53	4.76e-7	Colorectal cancer;
SKCM	cis	rs6951245	1.000	rs11766526	chr7:1101433	G/A	cg18402987	chr7:1209562	NA	1.15	6.09	0.57	3.95e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs2204008	0.744	rs11514358	chr12:38255526	G/A	cg26384229	chr12:38710491	ALG10B	0.87	6.83	0.61	1.63e-9	Bladder cancer;
SKCM	cis	rs899997	1.000	rs12899940	chr15:79001699	A/G	cg04896959	chr15:78267971	NA	-0.65	-6.08	-0.57	4.13e-8	Coronary artery disease or large artery stroke;
SKCM	cis	rs473651	0.740	rs502349	chr2:239318389	C/T	cg21699342	chr2:239360505	ASB1	0.49	4.85	0.48	6.09e-6	Multiple system atrophy;
SKCM	cis	rs7772486	0.623	rs735535	chr6:146036829	C/T	cg05347473	chr6:146136440	FBXO30	-0.56	-4.99	-0.49	3.55e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs11718455	0.883	rs6795366	chr3:44005735	C/T	cg21419209	chr3:44054225	NA	-0.64	-5.19	-0.51	1.6e-6	Coronary artery disease;
SKCM	cis	rs2836950	0.585	rs1029004	chr21:40615343	A/G	cg17971929	chr21:40555470	PSMG1	-0.73	-6.17	-0.57	2.86e-8	Menarche (age at onset);
SKCM	cis	rs10870270	0.957	rs7074604	chr10:133740373	G/C	cg17892150	chr10:133769511	PPP2R2D	-0.66	-4.89	-0.48	5.37e-6	Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals;
SKCM	cis	rs12142240	0.660	rs112560929	chr1:46822297	A/G	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs3857536	0.740	rs9354391	chr6:66890183	C/T	cg07460842	chr6:66804631	NA	0.74	5.03	0.5	3.04e-6	Blood trace element (Cu levels);
SKCM	cis	rs709400	0.633	rs10143247	chr14:103920927	G/A	cg26031613	chr14:104095156	KLC1	0.69	5.13	0.5	2.09e-6	Body mass index;
SKCM	cis	rs9399137	0.507	rs11754021	chr6:135308375	A/G	cg24558204	chr6:135376177	HBS1L	0.7	6.53	0.59	6.11e-9	Glycated hemoglobin levels;Mean corpuscular volume;Hematology traits;HbA2 levels;Mean corpuscular hemoglobin;Hemoglobin levels;F-cell distribution;Platelet count;
SKCM	cis	rs9467773	0.836	rs1624440	chr6:26433329	G/A	cg15659132	chr6:26577336	NA	-0.54	-4.85	-0.48	6.22e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs17376456	0.877	rs2290937	chr5:93356515	A/T	cg21475434	chr5:93447410	FAM172A	0.89	4.89	0.48	5.23e-6	Diabetic retinopathy;
SKCM	cis	rs6500395	1.000	rs7201196	chr16:48674030	C/T	cg04672837	chr16:48644449	N4BP1	0.65	5.4	0.52	7.05e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs3093024	0.595	rs4412174	chr6:167476066	A/G	cg07741184	chr6:167504864	NA	0.58	4.92	0.49	4.76e-6	Rheumatoid arthritis;
SKCM	cis	rs6121246	0.909	rs6060870	chr20:30303299	C/T	cg11595048	chr20:30225325	COX4I2	0.67	5.21	0.51	1.5e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs933688	1.000	rs332531	chr5:90790451	G/C	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.06	8.0	0.67	9.55e-12	Smoking behavior;
SKCM	cis	rs2952156	0.876	rs903504	chr17:37829570	C/G	cg00129232	chr17:37814104	STARD3	-0.64	-5.21	-0.51	1.49e-6	Asthma;
SKCM	cis	rs704795	0.836	rs1647281	chr2:27612938	G/C	cg05696406	chr2:27599888	SNX17	0.49	5.07	0.5	2.62e-6	Menopause (age at onset);
SKCM	cis	rs1577917	1.000	rs12154056	chr6:86634094	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.66	-5.74	-0.54	1.76e-7	Response to antipsychotic treatment;
SKCM	cis	rs6912958	0.514	rs7767449	chr6:87887985	A/C	cg08069147	chr6:88032118	GJB7;C6orf162	-0.65	-5.45	-0.53	5.73e-7	Monocyte percentage of white cells;
SKCM	cis	rs1799949	1.000	rs2298862	chr17:41176688	T/C	cg25072359	chr17:41440525	NA	0.62	4.79	0.48	7.92e-6	Menopause (age at onset);
SKCM	cis	rs2279817	0.675	rs1416853	chr1:18024880	G/C	cg17142039	chr1:18149651	ACTL8	0.58	4.88	0.48	5.6e-6	Neuroticism;
SKCM	cis	rs9549367	0.713	rs576463	chr13:113846614	C/T	cg18105134	chr13:113819100	PROZ	0.87	6.56	0.6	5.34e-9	Platelet distribution width;
SKCM	cis	rs1005277	0.579	rs2474567	chr10:38382492	C/T	cg00409905	chr10:38381863	ZNF37A	-0.64	-5.96	-0.56	6.77e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs1801251	0.963	rs13011298	chr2:233612996	A/G	cg25237894	chr2:233734115	C2orf82	0.56	5.33	0.52	9.23e-7	Coronary artery disease;
SKCM	cis	rs912057	0.560	rs1294416	chr6:6741327	A/G	cg06612196	chr6:6737390	NA	0.73	6.08	0.57	4.12e-8	Waist-to-hip ratio adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);
SKCM	cis	rs2842992	0.513	rs7759086	chr6:160193853	A/G	cg19482086	chr6:160211437	TCP1;MRPL18	0.9	8.21	0.68	3.64e-12	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs250585	0.667	rs466220	chr16:23602499	T/A	cg09934309	chr16:23461721	COG7	-0.83	-5.53	-0.53	4.06e-7	Egg allergy;
SKCM	cis	rs910316	0.967	rs7146523	chr14:75659880	T/C	cg08847533	chr14:75593920	NEK9	-0.98	-9.72	-0.74	4.28e-15	Height;
SKCM	cis	rs17376456	0.877	rs10061080	chr5:93420559	A/G	cg21475434	chr5:93447410	FAM172A	0.95	5.21	0.51	1.52e-6	Diabetic retinopathy;
SKCM	cis	rs12497850	0.931	rs13315711	chr3:48986399	A/T	cg07636037	chr3:49044803	WDR6	1.02	11.0	0.78	1.56e-17	Parkinson's disease;
SKCM	cis	rs12474201	0.862	rs7562173	chr2:46976217	C/G	cg06386533	chr2:46925753	SOCS5	-0.94	-8.79	-0.71	2.79e-13	Height;
SKCM	cis	rs11710229	1.000	rs34796655	chr3:55477935	C/T	cg04915058	chr3:55693741	C3orf51;ERC2	0.9	5.08	0.5	2.53e-6	Response to cytadine analogues (cytosine arabinoside);
SKCM	cis	rs801193	1.000	rs7789184	chr7:66210195	A/T	cg11987759	chr7:65425863	GUSB	-0.69	-5.91	-0.56	8.69e-8	Aortic root size;
SKCM	cis	rs951366	0.617	rs708727	chr1:205767885	G/A	cg17178900	chr1:205818956	PM20D1	0.8	7.91	0.67	1.4e-11	Menarche (age at onset);
SKCM	cis	rs1799949	1.000	rs16941	chr17:41244435	T/C	cg23758822	chr17:41437982	NA	0.9	7.48	0.65	9.38e-11	Menopause (age at onset);
SKCM	cis	rs1577917	1.000	rs2816815	chr6:86691656	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.81	-7.97	-0.67	1.07e-11	Response to antipsychotic treatment;
SKCM	cis	rs8077889	0.703	rs231543	chr17:41940360	G/T	cg26893861	chr17:41843967	DUSP3	-1.05	-5.83	-0.55	1.19e-7	Triglycerides;
SKCM	cis	rs7208859	0.623	rs57486336	chr17:29085731	G/T	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs1348850	0.914	rs1348849	chr2:178358072	C/T	cg02961200	chr2:178257176	LOC100130691;AGPS	0.83	6.14	0.57	3.21e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs4481887	0.927	rs12044126	chr1:248481952	T/C	cg00666640	chr1:248458726	OR2T12	0.66	6.0	0.56	5.9e-8	Common traits (Other);
SKCM	cis	rs2066819	1.000	rs2643626	chr12:56726518	C/T	cg26714650	chr12:56694279	CS	1.98	6.6	0.6	4.52e-9	Psoriasis vulgaris;
SKCM	cis	rs1218582	0.772	rs906593	chr1:154885255	G/A	cg06221963	chr1:154839813	KCNN3	-0.59	-5.97	-0.56	6.76e-8	Prostate cancer;
SKCM	cis	rs823143	0.570	rs1361754	chr1:205801872	C/T	cg07157834	chr1:205819609	PM20D1	-0.86	-8.88	-0.71	1.86e-13	Monocyte percentage of white cells;
SKCM	cis	rs453301	0.624	rs6987558	chr8:8862521	C/G	cg06636001	chr8:8085503	FLJ10661	0.75	5.78	0.55	1.48e-7	Joint mobility (Beighton score);
SKCM	trans	rs66573146	1.000	rs9942188	chr4:6984181	C/T	cg07817883	chr1:32538562	TMEM39B	2.0	8.02	0.67	8.59e-12	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs6138458	1.000	rs7268095	chr20:24972333	C/T	cg26195577	chr20:24973756	C20orf3	1.29	8.85	0.71	2.07e-13	Blood protein levels;
SKCM	cis	rs7927771	0.800	rs55876153	chr11:47416636	G/A	cg05585544	chr11:47624801	NA	-0.6	-5.32	-0.52	9.58e-7	Subjective well-being;
SKCM	cis	rs514406	0.893	rs499195	chr1:53344907	C/T	cg24675658	chr1:53192096	ZYG11B	-0.63	-5.11	-0.5	2.22e-6	Monocyte count;
SKCM	cis	rs57221529	0.766	rs4527146	chr5:555236	A/G	cg10555297	chr5:473380	SLC9A3;LOC25845	1.03	5.12	0.5	2.11e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs763121	0.853	rs1043441	chr22:39130964	C/T	cg06022373	chr22:39101656	GTPBP1	0.79	5.13	0.5	2.05e-6	Menopause (age at onset);
SKCM	cis	rs11105298	0.891	rs10858852	chr12:89833338	T/C	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.88	-6.03	-0.56	5.22e-8	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs6835098	1.000	rs6826412	chr4:174109622	C/T	cg08422745	chr4:174089978	GALNT7	-0.86	-6.84	-0.61	1.61e-9	Dementia and core Alzheimer's disease neuropathologic changes;
SKCM	cis	rs7584330	0.737	rs7595979	chr2:238364492	G/T	cg14458575	chr2:238380390	NA	0.86	6.22	0.58	2.31e-8	Prostate cancer;
SKCM	cis	rs6952808	0.771	rs10265944	chr7:1918337	C/T	cg05863683	chr7:1912471	MAD1L1	0.56	4.98	0.49	3.7e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs7927771	1.000	rs11039426	chr11:47863119	G/A	cg05585544	chr11:47624801	NA	-0.59	-5.09	-0.5	2.43e-6	Subjective well-being;
SKCM	cis	rs7666738	0.830	rs11941961	chr4:99065654	G/T	cg17366294	chr4:99064904	C4orf37	0.61	4.93	0.49	4.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1062177	0.826	rs2915879	chr5:151147442	A/G	cg00977110	chr5:151150581	G3BP1	0.77	5.88	0.55	9.77e-8	Preschool internalizing problems;
SKCM	cis	rs4820539	0.902	rs4822359	chr22:23474972	A/G	cg14186256	chr22:23484241	RTDR1	0.85	8.27	0.68	2.8e-12	Bone mineral density;
SKCM	cis	rs28595532	0.925	rs56200441	chr4:119497440	T/G	cg21605333	chr4:119757512	SEC24D	1.24	7.1	0.63	5.16e-10	Cannabis dependence symptom count;
SKCM	cis	rs5769765	0.862	rs138857	chr22:50199589	C/T	cg22709217	chr22:50311962	ALG12;CRELD2	-0.83	-5.74	-0.55	1.71e-7	Schizophrenia;
SKCM	cis	rs9790314	0.875	rs462514	chr3:161092809	C/T	cg03342759	chr3:160939853	NMD3	-0.73	-8.2	-0.68	3.89e-12	Morning vs. evening chronotype;
SKCM	cis	rs8180040	0.966	rs11130128	chr3:47486632	T/C	cg27129171	chr3:47204927	SETD2	-0.79	-5.79	-0.55	1.43e-7	Colorectal cancer;
SKCM	cis	rs3820928	1.000	rs10197757	chr2:227763244	A/C	cg11843606	chr2:227700838	RHBDD1	-0.64	-5.2	-0.51	1.53e-6	Pulmonary function;
SKCM	cis	rs34375054	0.525	rs7133006	chr12:125606123	G/A	cg25124228	chr12:125621409	AACS	-0.8	-6.56	-0.6	5.45e-9	Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs7666738	0.791	rs13127542	chr4:98949159	C/T	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6088580	0.634	rs13041646	chr20:33082881	T/A	cg24642439	chr20:33292090	TP53INP2	0.75	6.02	0.56	5.32e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs7772486	0.875	rs2224120	chr6:146343280	A/C	cg05347473	chr6:146136440	FBXO30	0.57	5.18	0.51	1.66e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs885518	0.852	rs7866533	chr9:21767404	C/T	cg19481686	chr9:22005288	CDKN2BAS;CDKN2B	-0.8	-4.83	-0.48	6.79e-6	Lung adenocarcinoma;
SKCM	cis	rs1153858	1.000	rs1980288	chr15:45620612	T/C	cg21132104	chr15:45694354	SPATA5L1	0.92	7.65	0.65	4.46e-11	Homoarginine levels;
SKCM	cis	rs55962025	0.855	rs6855981	chr4:3148276	A/G	cg09735869	chr4:3319127	RGS12	0.64	5.2	0.51	1.58e-6	Parental longevity (mother's age at death);
SKCM	cis	rs4819052	0.724	rs9753962	chr21:46661384	G/T	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.42	0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs801193	1.000	rs2707850	chr7:66203870	G/T	cg11987759	chr7:65425863	GUSB	-0.69	-5.91	-0.56	8.69e-8	Aortic root size;
SKCM	cis	rs782590	0.967	rs4290693	chr2:55799991	C/G	cg18811423	chr2:55921094	PNPT1	0.82	6.42	0.59	9.7e-9	Metabolic syndrome;
SKCM	cis	rs1348850	0.645	rs4893963	chr2:178430747	A/G	cg02961200	chr2:178257176	LOC100130691;AGPS	-0.81	-4.9	-0.49	5.08e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs10256972	0.552	rs2949192	chr7:1203841	C/T	cg07092213	chr7:1199455	ZFAND2A	-0.66	-5.52	-0.53	4.21e-7	Longevity;Endometriosis;
SKCM	cis	rs11098499	0.863	rs1480936	chr4:120462861	C/T	cg09307838	chr4:120376055	NA	0.98	7.84	0.66	1.96e-11	Corneal astigmatism;
SKCM	cis	rs28595532	0.841	rs114966236	chr4:119733437	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.43	0.59	9.38e-9	Cannabis dependence symptom count;
SKCM	cis	rs992157	0.835	rs2292550	chr2:219140288	G/C	cg00012203	chr2:219082015	ARPC2	-0.79	-6.25	-0.58	2.02e-8	Colorectal cancer;
SKCM	cis	rs7100689	0.646	rs7077854	chr10:82124070	C/T	cg01528321	chr10:82214614	TSPAN14	0.8	7.0	0.62	7.98e-10	Post bronchodilator FEV1;
SKCM	cis	rs1029738	0.615	rs3757447	chr7:22894735	A/T	cg18884940	chr7:22894078	NA	-0.62	-4.84	-0.48	6.33e-6	Fibrinogen levels;
SKCM	cis	rs2836974	0.897	rs34599551	chr21:40594898	C/A	cg17971929	chr21:40555470	PSMG1	0.9	8.81	0.71	2.52e-13	Cognitive function;
SKCM	cis	rs11690935	0.802	rs34636594	chr2:172911094	A/G	cg13550731	chr2:172543902	DYNC1I2	-0.79	-6.2	-0.57	2.52e-8	Schizophrenia;
SKCM	cis	rs561341	1.000	rs548957	chr17:30302411	G/A	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs6912958	0.559	rs242270	chr6:88062190	C/G	cg08069147	chr6:88032118	GJB7;C6orf162	-0.68	-6.09	-0.57	3.94e-8	Monocyte percentage of white cells;
SKCM	cis	rs9325144	0.723	rs10161183	chr12:39182087	T/C	cg26384229	chr12:38710491	ALG10B	-0.71	-6.25	-0.58	2.02e-8	Morning vs. evening chronotype;
SKCM	cis	rs8017423	0.605	rs8181930	chr14:90811289	A/G	cg04374321	chr14:90722782	PSMC1	-0.76	-5.92	-0.56	8.33e-8	Mortality in heart failure;
SKCM	cis	rs992157	0.798	rs4674284	chr2:219161241	C/T	cg20019365	chr2:219134978	PNKD;AAMP	-0.72	-6.12	-0.57	3.48e-8	Colorectal cancer;
SKCM	cis	rs7659604	0.689	rs59131059	chr4:122666357	C/T	cg19671926	chr4:122722719	EXOSC9	-0.65	-4.79	-0.48	7.93e-6	Type 2 diabetes;
SKCM	cis	rs9467773	1.000	rs9393728	chr6:26509330	C/G	cg15659132	chr6:26577336	NA	0.61	5.82	0.55	1.24e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7647973	0.600	rs12631989	chr3:49273996	C/T	cg06212747	chr3:49208901	KLHDC8B	0.78	5.59	0.54	3.15e-7	Menarche (age at onset);
SKCM	trans	rs10506458	1.000	rs12425932	chr12:63410497	C/A	cg03429785	chr15:59498649	MYO1E;LDHAL6B	-1.38	-7.54	-0.65	7.13e-11	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs875971	1.000	rs1167411	chr7:65539264	C/G	cg11764359	chr7:65958608	NA	-0.89	-8.44	-0.69	1.31e-12	Aortic root size;
SKCM	cis	rs57221529	0.766	rs56278696	chr5:582669	A/G	cg10555297	chr5:473380	SLC9A3;LOC25845	1.01	5.03	0.49	3.1e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs208520	0.690	rs12213575	chr6:66735989	A/G	cg07460842	chr6:66804631	NA	0.92	7.44	0.64	1.12e-10	Exhaled nitric oxide output;
SKCM	cis	rs28386778	0.897	rs2584642	chr17:61942427	T/C	cg01411255	chr17:61851458	DDX42;CCDC47	0.79	5.07	0.5	2.58e-6	Prudent dietary pattern;
SKCM	cis	rs769267	1.000	rs2074090	chr19:19449686	G/T	cg03709012	chr19:19516395	GATAD2A	-0.84	-6.79	-0.61	1.97e-9	Tonsillectomy;
SKCM	cis	rs11098499	0.775	rs10021601	chr4:120282563	G/A	cg09307838	chr4:120376055	NA	0.98	7.89	0.67	1.52e-11	Corneal astigmatism;
SKCM	cis	rs11892454	0.515	rs13413825	chr2:26024450	T/A	cg17263061	chr2:26915892	KCNK3	0.7	5.01	0.49	3.31e-6	Heschl's gyrus morphology;
SKCM	cis	rs8067545	0.750	rs28603224	chr17:19985052	G/A	cg13482628	chr17:19912719	NA	0.73	6.54	0.6	5.78e-9	Schizophrenia;
SKCM	cis	rs860295	0.871	rs11582072	chr1:155477570	T/C	cg02153340	chr1:155202674	NA	0.71	5.48	0.53	5.09e-7	Body mass index;
SKCM	cis	rs2404602	0.647	rs35710279	chr15:77082234	T/A	cg23625390	chr15:77176239	SCAPER	-0.85	-8.26	-0.68	2.93e-12	Blood metabolite levels;
SKCM	cis	rs7193541	0.965	rs8050262	chr16:74661159	T/C	cg01733217	chr16:74700730	RFWD3	0.91	8.81	0.71	2.52e-13	Multiple myeloma;
SKCM	cis	rs12478296	0.581	rs56142391	chr2:242992248	C/T	cg06360820	chr2:242988706	NA	-1.0	-6.31	-0.58	1.57e-8	Obesity-related traits;
SKCM	cis	rs1577917	1.000	rs16876529	chr6:86591202	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.61	-5.27	-0.51	1.18e-6	Response to antipsychotic treatment;
SKCM	cis	rs7772486	0.686	rs9403739	chr6:146015357	A/G	cg23711669	chr6:146136114	FBXO30	-0.89	-9.01	-0.71	1.04e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4808199	1.000	rs4808199	chr19:19545099	C/T	cg03709012	chr19:19516395	GATAD2A	1.13	8.59	0.7	6.84e-13	Nonalcoholic fatty liver disease;
SKCM	cis	rs6545883	0.894	rs2694643	chr2:61604383	A/G	cg15711740	chr2:61764176	XPO1	-0.68	-4.82	-0.48	6.94e-6	Tuberculosis;
SKCM	cis	rs6933660	0.800	rs9383900	chr6:151782816	A/C	cg14262678	chr6:151773367	RMND1;C6orf211	0.62	4.82	0.48	6.95e-6	Menarche (age at onset);
SKCM	cis	rs1005277	0.579	rs176886	chr10:38403974	C/T	cg25427524	chr10:38739819	LOC399744	-0.71	-6.74	-0.61	2.44e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs2153535	0.580	rs6597322	chr6:8449952	T/G	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs16866061	1.000	rs11681451	chr2:225334104	T/C	cg12698349	chr2:225449008	CUL3	1.02	8.77	0.7	3.04e-13	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs2243480	1.000	rs466983	chr7:65520496	T/G	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs7659604	1.000	rs7689722	chr4:122665955	T/C	cg19748678	chr4:122722346	EXOSC9	0.64	5.4	0.52	7.11e-7	Type 2 diabetes;
SKCM	cis	rs7829975	0.514	rs2920983	chr8:8268063	G/C	cg15556689	chr8:8085844	FLJ10661	0.7	5.85	0.55	1.11e-7	Mood instability;
SKCM	cis	rs60871478	0.898	rs4720929	chr7:808009	T/C	cg05535760	chr7:792225	HEATR2	1.02	8.66	0.7	4.97e-13	Cerebrospinal P-tau181p levels;
SKCM	cis	rs1552244	1.000	rs58275763	chr3:10143274	C/T	cg02579736	chr3:10068473	FANCD2;CIDECP	1.23	6.92	0.62	1.13e-9	Alzheimer's disease;
SKCM	cis	rs2404602	0.647	rs10152247	chr15:76942252	T/G	cg23625390	chr15:77176239	SCAPER	-0.82	-7.93	-0.67	1.26e-11	Blood metabolite levels;
SKCM	cis	rs71520386	0.607	rs11767419	chr7:22878983	T/G	cg00309339	chr7:22893653	NA	0.72	5.38	0.52	7.62e-7	Fibrinogen levels;
SKCM	cis	rs7954584	0.635	rs3847694	chr12:122325820	A/G	cg13699009	chr12:122356056	WDR66	0.57	7.07	0.62	5.91e-10	Mean corpuscular volume;
SKCM	cis	rs6502050	0.761	rs12150321	chr17:80061558	T/C	cg13939156	chr17:80058883	NA	0.51	4.77	0.48	8.29e-6	Life satisfaction;
SKCM	cis	rs7539542	0.556	rs2000331	chr1:202857578	G/T	cg19681188	chr1:202830198	LOC148709	0.85	5.82	0.55	1.22e-7	Mean platelet volume;
SKCM	cis	rs17376456	0.825	rs35496867	chr5:93220400	T/C	cg21475434	chr5:93447410	FAM172A	1.05	5.59	0.53	3.21e-7	Diabetic retinopathy;
SKCM	cis	rs875971	0.660	rs2191268	chr7:66110224	C/T	cg11764359	chr7:65958608	NA	0.74	6.38	0.59	1.17e-8	Aortic root size;
SKCM	cis	rs17065868	1.000	rs67898828	chr13:45129347	T/C	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs1395	1.000	rs1275501	chr2:27419282	A/C	cg14242246	chr2:27434262	C2orf28;SLC5A6	-0.49	-4.88	-0.48	5.5e-6	Blood metabolite levels;
SKCM	cis	rs11892454	0.544	rs11894959	chr2:25997821	C/T	cg17263061	chr2:26915892	KCNK3	0.71	5.15	0.5	1.88e-6	Heschl's gyrus morphology;
SKCM	cis	rs28595532	1.000	rs56000725	chr4:119637675	G/A	cg21605333	chr4:119757512	SEC24D	1.24	7.1	0.63	5.16e-10	Cannabis dependence symptom count;
SKCM	cis	rs9517302	0.615	rs2274053	chr13:99098318	C/T	cg22223119	chr13:99095684	FARP1	-0.85	-5.77	-0.55	1.51e-7	Obesity-related traits;
SKCM	cis	rs10256972	0.516	rs12702081	chr7:1141528	T/C	cg09177884	chr7:1199841	ZFAND2A	-0.75	-6.24	-0.58	2.1e-8	Longevity;Endometriosis;
SKCM	cis	rs1218582	1.000	rs1218582	chr1:154834183	G/A	cg24250549	chr1:154909240	PMVK	-0.83	-7.88	-0.67	1.61e-11	Prostate cancer;
SKCM	cis	rs7666738	0.791	rs10013680	chr4:99023030	G/C	cg05340658	chr4:99064831	C4orf37	0.66	5.06	0.5	2.77e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs995000	0.931	rs1168132	chr1:63133468	T/A	cg06896770	chr1:63153194	DOCK7	-0.75	-7.28	-0.64	2.33e-10	Triglyceride levels;
SKCM	cis	rs57221529	0.766	rs4957053	chr5:575927	T/C	cg10555297	chr5:473380	SLC9A3;LOC25845	1.09	5.49	0.53	4.82e-7	Lung disease severity in cystic fibrosis;
SKCM	cis	rs6840360	0.571	rs4696099	chr4:152501951	C/G	cg22705602	chr4:152727874	NA	-0.49	-5.33	-0.52	9.2e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs2243480	0.901	rs778687	chr7:65835819	G/A	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs7927771	0.832	rs11039212	chr11:47393303	A/T	cg05585544	chr11:47624801	NA	0.6	5.33	0.52	9.13e-7	Subjective well-being;
SKCM	cis	rs2404602	0.716	rs2404736	chr15:76875943	T/C	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs8016982	0.630	rs61980900	chr14:81686436	T/C	cg01989461	chr14:81687754	GTF2A1	0.88	7.42	0.64	1.26e-10	Schizophrenia;
SKCM	cis	rs2288073	0.965	rs72789923	chr2:24394504	A/C	cg06627628	chr2:24431161	ITSN2	-0.76	-5.24	-0.51	1.31e-6	Venous thromboembolism (SNP x SNP interaction);
SKCM	cis	rs9815354	0.767	rs73069245	chr3:41951452	G/A	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs420259	0.516	rs11074561	chr16:23495695	C/T	cg10006042	chr16:23042421	NA	-0.37	-4.91	-0.49	4.87e-6	Bipolar disorder;
SKCM	cis	rs7143963	0.636	rs2896460	chr14:103306106	A/T	cg23020514	chr14:103360112	TRAF3	0.73	6.9	0.62	1.23e-9	Body mass index;
SKCM	cis	rs8077889	0.917	rs60335331	chr17:41907509	A/G	cg26893861	chr17:41843967	DUSP3	1.22	8.23	0.68	3.35e-12	Triglycerides;
SKCM	cis	rs9435341	0.731	rs4914939	chr1:107558361	A/T	cg09367891	chr1:107599246	PRMT6	0.8	6.11	0.57	3.6e-8	Facial morphology (factor 21, depth of nasal alae);
SKCM	cis	rs7954584	0.551	rs1169072	chr12:122401501	C/T	cg13699009	chr12:122356056	WDR66	-0.47	-5.53	-0.53	4.05e-7	Mean corpuscular volume;
SKCM	trans	rs208520	0.690	rs12198745	chr6:66722598	T/C	cg15611600	chr13:45563400	KIAA1704;NUFIP1	0.92	7.5	0.65	8.68e-11	Exhaled nitric oxide output;
SKCM	cis	rs7772486	0.754	rs9390358	chr6:146145678	C/T	cg23711669	chr6:146136114	FBXO30	0.88	9.58	0.74	8.31e-15	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4141404	0.737	rs5998058	chr22:32006408	C/T	cg02404636	chr22:31891804	SFI1	0.67	5.34	0.52	8.88e-7	Paclitaxel-induced neuropathy;
SKCM	cis	rs2404602	0.552	rs11636612	chr15:76959530	C/T	cg23625390	chr15:77176239	SCAPER	-0.83	-7.35	-0.64	1.67e-10	Blood metabolite levels;
SKCM	cis	rs694739	0.536	rs671976	chr11:64046029	G/A	cg02228329	chr11:64053129	BAD;GPR137	0.89	6.35	0.58	1.31e-8	Alopecia areata;Crohn's disease;Psoriasis vulgaris;
SKCM	cis	rs7945705	0.875	rs11042059	chr11:8795080	G/A	cg21881798	chr11:8931708	C11orf17;ST5	0.66	6.48	0.59	7.53e-9	Hemoglobin concentration;
SKCM	cis	rs6951245	1.000	rs113066613	chr7:1094128	T/C	cg24642844	chr7:1081250	C7orf50	-0.93	-6.22	-0.58	2.28e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs6912958	0.535	rs1753154	chr6:88032843	G/C	cg08069147	chr6:88032118	GJB7;C6orf162	0.63	5.57	0.53	3.42e-7	Monocyte percentage of white cells;
SKCM	cis	rs11098499	0.909	rs11098530	chr4:120413154	C/T	cg09307838	chr4:120376055	NA	0.99	8.02	0.67	8.7e-12	Corneal astigmatism;
SKCM	cis	rs2836974	0.613	rs2245455	chr21:40548087	A/T	cg11644478	chr21:40555479	PSMG1	-0.67	-5.73	-0.54	1.82e-7	Cognitive function;
SKCM	cis	rs867186	1.000	rs75648520	chr20:33724221	C/T	cg04194272	chr20:33683537	NA	-1.11	-6.01	-0.56	5.61e-8	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs708547	0.836	rs1315005	chr4:57858237	C/G	cg16868167	chr4:57843880	C4orf14;POLR2B	0.96	9.27	0.72	3.19e-14	Response to bleomycin (chromatid breaks);
SKCM	cis	rs7106204	0.668	rs7119362	chr11:24218132	G/T	ch.11.24196551F	chr11:24239977	NA	0.77	6.39	0.59	1.09e-8	Response to Homoharringtonine (cytotoxicity);
SKCM	cis	rs2832191	0.716	rs7284006	chr21:30475186	T/A	cg24692254	chr21:30365293	RNF160	0.99	9.05	0.72	8.59e-14	Dental caries;
SKCM	cis	rs875971	1.000	rs6970030	chr7:65968679	T/C	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	cis	rs7119	0.667	rs1058129	chr15:77905661	A/G	cg27398640	chr15:77910606	LINGO1	0.5	4.82	0.48	7e-6	Type 2 diabetes;
SKCM	cis	rs763121	0.853	rs5995610	chr22:39064681	C/T	cg06022373	chr22:39101656	GTPBP1	0.78	5.63	0.54	2.7e-7	Menopause (age at onset);
SKCM	cis	rs9880211	1.000	rs28634226	chr3:136129882	G/A	cg21827317	chr3:136751795	NA	-0.64	-4.78	-0.48	8.21e-6	Body mass index;Height;
SKCM	cis	rs4819052	0.851	rs4819041	chr21:46659955	C/T	cg19498844	chr21:46707878	POFUT2;LOC642852	0.84	7.1	0.63	5.13e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs651907	0.557	rs13069443	chr3:101373305	C/T	cg12386194	chr3:101231763	SENP7	0.71	5.89	0.55	9.17e-8	Colorectal cancer;
SKCM	cis	rs6546550	0.901	rs12613947	chr2:70161342	A/G	cg02498382	chr2:70120550	SNRNP27	-0.45	-4.88	-0.48	5.4e-6	Prevalent atrial fibrillation;
SKCM	cis	rs514406	0.893	rs512723	chr1:53343880	C/T	cg24675658	chr1:53192096	ZYG11B	0.64	5.21	0.51	1.52e-6	Monocyte count;
SKCM	cis	rs9435341	0.929	rs1730865	chr1:107605611	A/C	cg09367891	chr1:107599246	PRMT6	0.78	6.61	0.6	4.25e-9	Facial morphology (factor 21, depth of nasal alae);
SKCM	cis	rs3820928	0.605	rs6748311	chr2:227792530	T/A	cg11843606	chr2:227700838	RHBDD1	-0.61	-4.8	-0.48	7.41e-6	Pulmonary function;
SKCM	cis	rs801193	0.844	rs7779971	chr7:66161790	T/C	cg11987759	chr7:65425863	GUSB	-0.69	-5.9	-0.56	8.74e-8	Aortic root size;
SKCM	cis	rs929354	0.772	rs1182442	chr7:157026633	G/A	cg17757837	chr7:157058334	UBE3C	-0.81	-5.67	-0.54	2.3e-7	Body mass index;
SKCM	cis	rs11719291	0.833	rs11713694	chr3:48833615	G/T	cg00383909	chr3:49044727	WDR6	0.95	5.43	0.52	6.25e-7	Cognitive function;
SKCM	cis	rs7809950	1.000	rs2253146	chr7:107200319	A/G	cg23024343	chr7:107201750	COG5	-0.77	-6.92	-0.62	1.11e-9	Coronary artery disease;
SKCM	cis	rs7632954	0.588	rs7628272	chr3:8539117	G/T	cg06697448	chr3:8544912	LMCD1	-0.56	-4.96	-0.49	4.09e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs909674	0.524	rs5757670	chr22:39829736	G/A	cg11247378	chr22:39784982	NA	-0.45	-5.27	-0.51	1.19e-6	IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis);IgG glycosylation;IgG digalactosylation phenotypes (multivariate analysis);IgG sialylation phenotypes (multivariate analysis);IgG monogalactosylation phenotypes (multivariate analysis);IgG fucosylation phenotypes (multivariate analysis);IgG N-glycosylation phenotypes (multivariate analysis);IgG disialylation phenotypes (multivariate analysis);IgG galactosylation phenotypes (multivariate analysis);Post bronchodilator FEV1;
SKCM	cis	rs35306767	0.903	rs12260800	chr10:927933	T/C	cg20503657	chr10:835505	NA	0.75	5.36	0.52	8.31e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs28386778	0.830	rs67905415	chr17:61841236	G/A	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs870825	0.616	rs10013562	chr4:185610486	A/G	cg04058563	chr4:185651563	MLF1IP	1.05	7.19	0.63	3.43e-10	Blood protein levels;
SKCM	cis	rs2228479	0.850	rs17232630	chr16:89851179	C/T	cg06558623	chr16:89946397	TCF25	1.06	4.86	0.48	5.99e-6	Skin colour saturation;
SKCM	cis	rs9420	0.807	rs12807357	chr11:57656902	C/T	cg19752551	chr11:57585705	CTNND1	-0.7	-6.74	-0.61	2.45e-9	Schizophrenia;
SKCM	cis	rs6951245	1.000	rs78628466	chr7:1068453	G/C	cg03188948	chr7:1209495	NA	1.12	6.17	0.57	2.88e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	trans	rs1814175	0.935	rs10839317	chr11:49657228	A/C	cg15704280	chr7:45808275	SEPT13	-1.0	-9.43	-0.73	1.61e-14	Height;
SKCM	cis	rs12477438	0.539	rs720228	chr2:99704547	A/G	cg14399236	chr2:99771627	LIPT1;TSGA10	1.03	9.35	0.73	2.24e-14	Chronic sinus infection;
SKCM	cis	rs1799949	1.000	rs8176202	chr17:41230228	G/A	cg05368731	chr17:41323189	NBR1	0.9	7.94	0.67	1.23e-11	Menopause (age at onset);
SKCM	cis	rs1401999	0.932	rs4148557	chr3:183733784	A/G	cg01324343	chr3:183735012	ABCC5	0.88	10.4	0.76	2.13e-16	Anterior chamber depth;
SKCM	cis	rs9902453	0.765	rs2259857	chr17:28097780	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.79	-5.93	-0.56	7.67e-8	Coffee consumption (cups per day);
SKCM	cis	rs634534	0.561	rs14157	chr11:65769780	T/G	cg02427764	chr11:65769310	BANF1;EIF1AD	0.77	5.82	0.55	1.23e-7	Sum eosinophil basophil counts;Eosinophil counts;
SKCM	cis	rs7937682	0.883	rs12804962	chr11:111442683	A/T	cg19812747	chr11:111475976	SIK2	0.57	4.83	0.48	6.76e-6	Primary sclerosing cholangitis;
SKCM	cis	rs870825	0.616	rs28497285	chr4:185629169	G/A	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs909674	0.541	rs5750816	chr22:39810379	A/G	cg24399712	chr22:39784796	NA	0.61	5.22	0.51	1.42e-6	IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis);IgG glycosylation;IgG digalactosylation phenotypes (multivariate analysis);IgG sialylation phenotypes (multivariate analysis);IgG monogalactosylation phenotypes (multivariate analysis);IgG fucosylation phenotypes (multivariate analysis);IgG N-glycosylation phenotypes (multivariate analysis);IgG disialylation phenotypes (multivariate analysis);IgG galactosylation phenotypes (multivariate analysis);Post bronchodilator FEV1;
SKCM	cis	rs7191439	0.858	rs8044367	chr16:88783374	A/G	cg02389323	chr16:88786976	FAM38A	1.58	6.59	0.6	4.66e-9	Plateletcrit;
SKCM	cis	rs6570726	0.791	rs414600	chr6:145879606	G/A	cg23711669	chr6:146136114	FBXO30	0.87	9.14	0.72	5.82e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs477895	0.653	rs11602181	chr11:63896591	C/G	cg07220939	chr11:64358617	SLC22A12	0.74	4.91	0.49	4.86e-6	Mean platelet volume;
SKCM	cis	rs1799949	0.602	rs8176199	chr17:41230524	T/G	cg05368731	chr17:41323189	NBR1	0.79	5.67	0.54	2.28e-7	Menopause (age at onset);
SKCM	cis	rs919433	0.783	rs2565155	chr2:198236425	A/G	cg04278110	chr2:198063759	ANKRD44	0.74	5.13	0.5	2.06e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs2836950	0.545	rs8132424	chr21:40584412	A/T	cg17971929	chr21:40555470	PSMG1	0.7	5.84	0.55	1.14e-7	Menarche (age at onset);
SKCM	cis	rs10504229	0.596	rs6991216	chr8:58115586	T/C	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs11945232	0.624	rs35649088	chr4:88369786	C/T	cg23841344	chr4:88312519	HSD17B11	-0.74	-4.96	-0.49	3.96e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs909341	0.710	rs4809321	chr20:62304299	T/G	cg03999872	chr20:62272968	STMN3	0.54	4.79	0.48	7.9e-6	Atopic dermatitis;
SKCM	cis	rs4689592	0.523	rs3857179	chr4:7070496	T/A	cg19539972	chr4:7069911	GRPEL1	1.01	7.11	0.63	4.81e-10	Monocyte percentage of white cells;
SKCM	cis	rs2439831	0.867	rs4075674	chr15:43650230	A/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.39	9.42	0.73	1.62e-14	Lung cancer in ever smokers;
SKCM	cis	rs737337	1.000	rs3760782	chr19:11346550	C/T	cg00586551	chr19:11347513	LOC55908;DOCK6	0.83	5.21	0.51	1.5e-6	HDL cholesterol;HDL cholesterol levels;
SKCM	cis	rs1799949	0.896	rs8176086	chr17:41274778	G/A	cg23758822	chr17:41437982	NA	0.92	7.8	0.66	2.3e-11	Menopause (age at onset);
SKCM	cis	rs470903	0.773	rs509620	chr18:74717615	A/C	cg05896682	chr18:74964030	GALR1	-0.5	-4.97	-0.49	3.86e-6	Paclitaxel disposition in epithelial ovarian cancer;
SKCM	cis	rs6089829	0.890	rs6062775	chr20:61663650	T/C	cg08564027	chr20:61660810	NA	0.63	5.65	0.54	2.56e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs9790314	1.000	rs6765269	chr3:160948542	T/C	cg03342759	chr3:160939853	NMD3	-0.72	-7.89	-0.67	1.53e-11	Morning vs. evening chronotype;
SKCM	cis	rs4925325	0.741	rs6142886	chr20:60511190	A/G	cg13770153	chr20:60521292	NA	1.03	9.04	0.72	9.03e-14	Obesity-related traits;
SKCM	cis	rs10791097	0.642	rs7107568	chr11:130779668	T/C	cg12179176	chr11:130786555	SNX19	1.09	10.69	0.77	6.13e-17	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs7659604	0.539	rs11098648	chr4:122759872	C/T	cg06713675	chr4:122721982	EXOSC9	-0.75	-7.32	-0.64	1.94e-10	Type 2 diabetes;
SKCM	cis	rs11098499	0.954	rs6847248	chr4:120225955	A/G	cg09307838	chr4:120376055	NA	0.97	7.75	0.66	2.85e-11	Corneal astigmatism;
SKCM	cis	rs9674544	0.757	rs3744085	chr17:47131901	A/G	cg10950924	chr17:47092072	IGF2BP1	-0.59	-5.33	-0.52	9.34e-7	Primary tooth development (time to first tooth eruption);Primary tooth development (number of teeth);
SKCM	trans	rs8073060	0.586	rs225278	chr17:33974170	C/T	cg19694781	chr19:47549865	TMEM160	-1.0	-8.56	-0.7	7.62e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs1552244	0.688	rs7645137	chr3:10020549	A/AT	cg02579736	chr3:10068473	FANCD2;CIDECP	0.98	4.84	0.48	6.48e-6	Alzheimer's disease;
SKCM	cis	rs344364	0.511	rs1742472	chr16:1953040	A/G	cg26897989	chr16:1907736	C16orf73	-0.73	-6.76	-0.61	2.28e-9	Glomerular filtration rate in chronic kidney disease;
SKCM	cis	rs4523957	0.651	rs7214741	chr17:2085598	C/T	cg16513277	chr17:2031491	SMG6	-0.79	-5.86	-0.55	1.07e-7	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs933688	1.000	rs12656350	chr5:90751343	C/T	cg12630606	chr5:90679528	LOC100129716;ARRDC3	0.99	7.75	0.66	2.82e-11	Smoking behavior;
SKCM	cis	rs7959452	0.684	rs11177615	chr12:69754189	G/A	cg14784868	chr12:69753453	YEATS4	0.78	7.39	0.64	1.45e-10	Blood protein levels;
SKCM	cis	rs9611565	0.802	rs9611571	chr22:41784867	G/A	cg03806693	chr22:41940476	POLR3H	-0.93	-5.97	-0.56	6.68e-8	Vitiligo;
SKCM	cis	rs1669338	0.588	rs6788122	chr3:3171897	T/C	cg16797762	chr3:3221439	CRBN	-1.15	-6.73	-0.61	2.58e-9	White matter integrity;
SKCM	cis	rs6545883	0.929	rs9679557	chr2:61709349	C/A	cg15711740	chr2:61764176	XPO1	-0.69	-4.82	-0.48	6.84e-6	Tuberculosis;
SKCM	cis	rs6952808	0.594	rs3778964	chr7:2138109	C/T	cg02951883	chr7:2050386	MAD1L1	-0.79	-7.4	-0.64	1.37e-10	Bipolar disorder and schizophrenia;
SKCM	cis	rs16949788	1.000	rs41315964	chr15:66779698	C/T	cg08120210	chr15:66682733	MAP2K1	-0.69	-5.29	-0.51	1.08e-6	Spherical equivalent (joint analysis main effects and education interaction);
SKCM	cis	rs634534	0.622	rs624273	chr11:65712413	A/G	cg17985854	chr11:65770987	BANF1;EIF1AD	0.49	4.79	0.48	7.71e-6	Sum eosinophil basophil counts;Eosinophil counts;
SKCM	cis	rs9910055	0.530	rs8072954	chr17:42294722	G/A	cg13607699	chr17:42295918	UBTF	0.86	7.36	0.64	1.62e-10	Total body bone mineral density;
SKCM	cis	rs3749237	0.557	rs7631908	chr3:49425707	T/G	cg03060546	chr3:49711283	APEH	0.67	4.86	0.48	5.96e-6	Resting heart rate;
SKCM	cis	rs7618501	0.602	rs2526743	chr3:50115245	G/A	cg24110177	chr3:50126178	RBM5	0.61	5.18	0.51	1.71e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9921222	0.656	rs12719801	chr16:381141	C/T	cg12437481	chr16:420112	MRPL28	-0.64	-5.7	-0.54	2.06e-7	Bone mineral density (spine);Bone mineral density;
SKCM	cis	rs1799949	1.000	rs8176265	chr17:41213996	C/T	cg05368731	chr17:41323189	NBR1	0.9	7.94	0.67	1.23e-11	Menopause (age at onset);
SKCM	cis	rs10540	1.000	rs35068485	chr11:466032	A/T	cg03576123	chr11:487126	PTDSS2	-1.46	-7.68	-0.66	4e-11	Body mass index;
SKCM	cis	rs9611565	0.546	rs132793	chr22:42063681	A/G	cg03806693	chr22:41940476	POLR3H	1.08	7.13	0.63	4.48e-10	Vitiligo;
SKCM	cis	rs2952156	0.876	rs903504	chr17:37829570	C/G	cg20243544	chr17:37824526	PNMT	0.75	6.2	0.57	2.48e-8	Asthma;
SKCM	cis	rs34779708	0.931	rs2384283	chr10:35326789	G/A	cg03585969	chr10:35415529	CREM	0.75	6.23	0.58	2.2e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs1218582	0.741	rs7544528	chr1:154844585	C/T	cg09359103	chr1:154839909	KCNN3	-0.59	-5.93	-0.56	7.77e-8	Prostate cancer;
SKCM	cis	rs9325144	0.624	rs10783333	chr12:39118931	A/T	cg26384229	chr12:38710491	ALG10B	0.73	6.81	0.61	1.84e-9	Morning vs. evening chronotype;
SKCM	cis	rs6570726	0.791	rs13202312	chr6:145913093	T/G	cg23711669	chr6:146136114	FBXO30	0.88	8.37	0.69	1.84e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs60871478	0.685	rs34421533	chr7:816638	A/G	cg05535760	chr7:792225	HEATR2	1.24	9.63	0.74	6.44e-15	Cerebrospinal P-tau181p levels;
SKCM	cis	rs9633740	0.773	rs7080009	chr10:82269461	T/C	cg01528321	chr10:82214614	TSPAN14	0.85	6.76	0.61	2.22e-9	Post bronchodilator FEV1;
SKCM	cis	rs514406	0.505	rs856721	chr1:53162156	C/A	cg16325326	chr1:53192061	ZYG11B	0.89	10.06	0.75	9.7e-16	Monocyte count;
SKCM	cis	rs6582630	0.519	rs7294300	chr12:38277359	C/A	cg13010199	chr12:38710504	ALG10B	0.69	4.92	0.49	4.72e-6	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs2645694	0.533	rs2703125	chr4:77819900	T/C	cg03477792	chr4:77819574	ANKRD56	0.56	6.18	0.57	2.75e-8	Emphysema distribution in smoking;
SKCM	cis	rs116095464	0.558	rs10075018	chr5:239175	G/A	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs4481887	0.861	rs4497248	chr1:248450525	T/C	cg00666640	chr1:248458726	OR2T12	0.6	4.9	0.49	5.01e-6	Common traits (Other);
SKCM	cis	rs7100689	0.556	rs6585971	chr10:82145057	G/C	cg01528321	chr10:82214614	TSPAN14	0.84	7.53	0.65	7.69e-11	Post bronchodilator FEV1;
SKCM	trans	rs17685	0.753	rs8200	chr7:75696606	C/G	cg19862616	chr7:65841803	NCRNA00174	-0.94	-9.39	-0.73	1.88e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs11764590	0.651	rs12673687	chr7:2081873	C/T	cg02825527	chr7:2087843	MAD1L1	-0.64	-4.97	-0.49	3.92e-6	Neuroticism;
SKCM	cis	rs4319547	0.661	rs7398014	chr12:122943980	T/C	cg23029597	chr12:123009494	RSRC2	-0.82	-6.24	-0.58	2.08e-8	Body mass index;
SKCM	cis	rs10911232	0.507	rs10797829	chr1:183033228	C/T	ch.1.3577855R	chr1:183094577	LAMC1	-0.78	-6.63	-0.6	3.88e-9	Hypertriglyceridemia;
SKCM	cis	rs9911578	0.934	rs58092632	chr17:57111101	T/C	cg05425664	chr17:57184151	TRIM37	0.84	6.99	0.62	8.23e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs10193935	0.818	rs2374428	chr2:42667961	T/C	cg27598129	chr2:42591480	NA	0.88	6.71	0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs12142240	0.698	rs66911505	chr1:46823298	A/G	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs7772486	0.875	rs2748497	chr6:146319417	C/T	cg23711669	chr6:146136114	FBXO30	0.74	6.61	0.6	4.26e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs367615	0.660	rs10061221	chr5:108839038	C/T	cg17395555	chr5:108820864	NA	0.73	6.54	0.6	5.85e-9	Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs10754283	1.000	rs10754283	chr1:90112431	G/T	cg21401794	chr1:90099060	LRRC8C	0.73	6.34	0.58	1.35e-8	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs10193935	0.901	rs222469	chr2:42640235	T/C	cg27598129	chr2:42591480	NA	-0.88	-6.71	-0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs950776	0.745	rs36045869	chr15:78929498	C/T	cg06917634	chr15:78832804	PSMA4	0.71	5.12	0.5	2.17e-6	Sudden cardiac arrest;
SKCM	trans	rs1814175	0.616	rs1794131	chr11:49904194	A/G	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs6942756	1.000	rs11979476	chr7:128993756	G/T	cg02491457	chr7:128862824	NA	0.77	4.79	0.48	7.87e-6	White matter hyperintensity burden;
SKCM	cis	rs910316	1.000	rs10149880	chr14:75633008	A/G	cg11812906	chr14:75593930	NEK9	-0.68	-5.27	-0.51	1.2e-6	Height;
SKCM	cis	rs873946	0.586	rs12782567	chr10:134576709	C/G	cg27286337	chr10:134555280	INPP5A	-0.97	-8.69	-0.7	4.36e-13	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs8060686	0.641	rs113258243	chr16:68086656	C/T	cg09117114	chr16:67998030	SLC12A4	-0.81	-5.34	-0.52	8.73e-7	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs7772486	0.846	rs9373482	chr6:146363123	A/C	cg23711669	chr6:146136114	FBXO30	0.77	7.48	0.65	9.65e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9810089	0.527	rs661739	chr3:135953476	C/T	cg21827317	chr3:136751795	NA	0.65	5.32	0.52	9.81e-7	Gestational age at birth (child effect);
SKCM	cis	rs10504073	0.584	rs11778863	chr8:49954893	C/T	cg00325661	chr8:49890786	NA	0.8	6.81	0.61	1.83e-9	Blood metabolite ratios;
SKCM	cis	rs4481887	0.745	rs4540687	chr1:248476099	C/G	cg00666640	chr1:248458726	OR2T12	0.66	6.0	0.56	5.9e-8	Common traits (Other);
SKCM	cis	rs1577917	0.771	rs2484355	chr6:86394403	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.79	-7.52	-0.65	8e-11	Response to antipsychotic treatment;
SKCM	cis	rs12188164	0.897	rs55932239	chr5:423906	G/A	cg26076054	chr5:421317	AHRR	-0.61	-4.8	-0.48	7.47e-6	Cystic fibrosis severity;
SKCM	cis	rs908922	0.676	rs2105117	chr1:152484129	G/A	cg09873164	chr1:152488093	CRCT1	0.76	5.78	0.55	1.47e-7	Hair morphology;
SKCM	cis	rs801193	1.000	rs7785213	chr7:66138978	A/C	cg00343986	chr7:65444356	GUSB	-0.67	-4.93	-0.49	4.55e-6	Aortic root size;
SKCM	cis	rs875971	1.000	rs1167612	chr7:65567976	C/A	cg11764359	chr7:65958608	NA	-0.89	-8.44	-0.69	1.29e-12	Aortic root size;
SKCM	cis	rs6952808	0.595	rs3778983	chr7:2166319	T/G	cg21782813	chr7:2030301	MAD1L1	0.51	5.43	0.52	6.28e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs77106637	1.000	rs77106637	chr11:72478320	G/A	cg03713592	chr11:72463424	ARAP1	1.05	5.39	0.52	7.36e-7	Type 2 diabetes;
SKCM	cis	rs11098499	0.863	rs6835635	chr4:120458867	A/G	cg09307838	chr4:120376055	NA	0.96	7.48	0.65	9.64e-11	Corneal astigmatism;
SKCM	cis	rs7666738	0.830	rs11931166	chr4:99054187	A/T	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs8180040	0.966	rs6765990	chr3:47542894	G/A	cg16586182	chr3:47516702	SCAP	-0.76	-5.32	-0.52	9.63e-7	Colorectal cancer;
SKCM	cis	rs2255932	0.947	rs2686429	chr3:183214054	A/T	cg20852557	chr3:184035519	EIF4G1	-0.65	-5.51	-0.53	4.48e-7	Interleukin-1-beta levels;
SKCM	cis	rs2243480	1.000	rs67728539	chr7:65378124	G/A	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs7618501	0.633	rs6446193	chr3:50059758	T/C	cg05072774	chr3:49840536	C3orf54	0.67	5.06	0.5	2.73e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs854765	0.964	rs854762	chr17:18009102	G/A	cg04398451	chr17:18023971	MYO15A	0.62	4.85	0.48	6.29e-6	Total body bone mineral density;
SKCM	cis	rs1843834	0.539	rs6739735	chr2:225405253	A/G	cg22455342	chr2:225449267	CUL3	-0.74	-5.46	-0.53	5.52e-7	IgE levels in asthmatics (D.p. specific);
SKCM	cis	rs9467773	0.620	rs2451738	chr6:26618459	A/T	cg09904177	chr6:26538194	HMGN4	-0.58	-5.01	-0.49	3.28e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs6429082	0.521	rs291390	chr1:235649678	T/C	cg26050004	chr1:235667680	B3GALNT2	0.93	9.07	0.72	7.91e-14	Adiposity;
SKCM	cis	rs600231	0.665	rs1784858	chr11:65222952	T/C	cg24009118	chr11:65545808	DKFZp761E198	0.69	5.08	0.5	2.5e-6	Bone mineral density;
SKCM	cis	rs28386778	0.897	rs2665797	chr17:61922485	C/G	cg22520471	chr17:61851767	DDX42;CCDC47	-0.78	-5.31	-0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs362296	0.698	rs3095082	chr4:3263617	C/A	cg09735869	chr4:3319127	RGS12	-0.71	-6.3	-0.58	1.65e-8	Parental longevity (mother's age at death);
SKCM	cis	rs929354	1.000	rs8101	chr7:157061474	A/G	cg17757837	chr7:157058334	UBE3C	-0.86	-6.5	-0.59	7.04e-9	Body mass index;
SKCM	cis	rs8042680	0.518	rs8025699	chr15:91533816	A/G	cg15878949	chr15:91534302	PRC1	0.59	4.94	0.49	4.33e-6	Type 2 diabetes;
SKCM	cis	rs854765	0.655	rs4470201	chr17:17844870	G/A	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.0	7.64	0.65	4.64e-11	Total body bone mineral density;
SKCM	cis	rs7666738	0.830	rs13121766	chr4:98935766	A/C	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs362272	0.525	rs910568	chr4:3307373	A/G	cg05297308	chr4:3317976	RGS12	1.0	11.08	0.78	1.11e-17	Serum sulfate level;
SKCM	cis	rs1405130	0.869	rs4663467	chr2:235575051	A/G	cg17841421	chr2:235704848	NA	0.6	4.94	0.49	4.34e-6	Coronary artery disease;
SKCM	cis	rs11098499	0.820	rs13122709	chr4:120555356	T/A	cg09307838	chr4:120376055	NA	0.97	7.73	0.66	3.07e-11	Corneal astigmatism;
SKCM	cis	rs13256369	0.851	rs13258283	chr8:8563630	T/C	cg06636001	chr8:8085503	FLJ10661	0.8	6.11	0.57	3.65e-8	Obesity-related traits;
SKCM	cis	rs2180341	0.814	rs9385424	chr6:127726796	A/G	cg24812749	chr6:127587940	RNF146	0.61	4.97	0.49	3.9e-6	Breast cancer;
SKCM	cis	rs17765925	0.605	rs10486042	chr7:14269202	A/G	cg11279021	chr7:14028690	ETV1	0.51	4.81	0.48	7.17e-6	Verbal declarative memory;
SKCM	cis	rs2463822	0.748	rs2513038	chr11:62081329	A/C	cg06239285	chr11:62104954	ASRGL1	1.27	5.94	0.56	7.44e-8	Chronic obstructive pulmonary disease-related biomarkers;
SKCM	cis	rs2153535	0.580	rs3938660	chr6:8443335	G/A	cg23788917	chr6:8435910	SLC35B3	0.69	5.14	0.5	1.99e-6	Motion sickness;
SKCM	cis	rs2439831	0.850	rs7174208	chr15:44052682	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.35	7.75	0.66	2.9e-11	Lung cancer in ever smokers;
SKCM	cis	rs870825	0.616	rs877276	chr4:185621249	C/T	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs4969178	0.965	rs11077364	chr17:76400337	C/A	cg20026190	chr17:76395443	PGS1	0.59	5.01	0.49	3.3e-6	HDL cholesterol levels;
SKCM	cis	rs6993244	1	rs6993244	chr8:8863059	C/G	cg06636001	chr8:8085503	FLJ10661	0.77	6.11	0.57	3.72e-8	Mean corpuscular hemoglobin;
SKCM	cis	rs17376456	1.000	rs13174700	chr5:93554644	G/A	cg25358565	chr5:93447407	FAM172A	1.27	7.86	0.66	1.78e-11	Diabetic retinopathy;
SKCM	cis	rs10779751	0.690	rs743577	chr1:11119135	G/A	cg08854313	chr1:11322531	MTOR	0.76	5.37	0.52	7.88e-7	Body mass index;
SKCM	cis	rs9300255	0.739	rs2337934	chr12:123745359	A/G	cg05973401	chr12:123451056	ABCB9	0.86	6.11	0.57	3.69e-8	Neutrophil percentage of white cells;
SKCM	cis	rs929354	0.772	rs1182365	chr7:157017255	A/T	cg17757837	chr7:157058334	UBE3C	-0.81	-5.67	-0.54	2.3e-7	Body mass index;
SKCM	cis	rs6066825	0.568	rs6095245	chr20:47320770	G/C	cg18078177	chr20:47281410	PREX1	0.64	5.19	0.51	1.6e-6	Colorectal cancer;
SKCM	cis	rs1218582	0.774	rs12036859	chr1:154859940	A/C	cg03351412	chr1:154909251	PMVK	-0.71	-6.17	-0.57	2.79e-8	Prostate cancer;
SKCM	cis	rs854765	0.663	rs16960744	chr17:17755259	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	-1.03	-7.53	-0.65	7.57e-11	Total body bone mineral density;
SKCM	cis	rs9926296	0.605	rs12709094	chr16:89853017	A/G	cg26513180	chr16:89883248	FANCA	0.96	9.94	0.75	1.65e-15	Vitiligo;
SKCM	cis	rs763014	0.932	rs2269560	chr16:682442	A/C	cg09263875	chr16:632152	PIGQ	0.77	6.52	0.59	6.4e-9	Height;
SKCM	cis	rs3820928	0.605	rs10186145	chr2:227781150	A/G	cg11843606	chr2:227700838	RHBDD1	-0.62	-4.84	-0.48	6.53e-6	Pulmonary function;
SKCM	cis	rs372883	0.506	rs2832301	chr21:30749712	G/A	cg24692254	chr21:30365293	RNF160	0.66	5.14	0.5	1.96e-6	Pancreatic cancer;
SKCM	cis	rs12497850	0.897	rs9850134	chr3:48957147	A/G	cg06212747	chr3:49208901	KLHDC8B	0.68	4.9	0.49	5.06e-6	Parkinson's disease;
SKCM	cis	rs4319547	0.656	rs10161534	chr12:122873864	T/C	cg23029597	chr12:123009494	RSRC2	-0.74	-5.43	-0.52	6.08e-7	Body mass index;
SKCM	cis	rs17065868	1.000	rs9533887	chr13:45093359	T/C	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs597539	0.616	rs473997	chr11:68639481	C/T	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.84	5.61	0.54	3e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs995000	0.931	rs10889343	chr1:63026429	T/G	cg06896770	chr1:63153194	DOCK7	-0.72	-6.46	-0.59	8.17e-9	Triglyceride levels;
SKCM	cis	rs34779708	0.897	rs35784065	chr10:35353574	C/T	cg03585969	chr10:35415529	CREM	0.76	6.28	0.58	1.81e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs6121246	0.511	rs879982	chr20:30398510	A/G	cg11595048	chr20:30225325	COX4I2	0.54	4.77	0.48	8.4e-6	Mean corpuscular hemoglobin;
SKCM	trans	rs1814175	0.817	rs10128730	chr11:50023369	G/T	cg03929089	chr4:120376271	NA	-0.93	-8.77	-0.7	3.08e-13	Height;
SKCM	cis	rs72792276	1.000	rs78529289	chr5:127405378	C/T	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.74	5.01	0.49	3.33e-6	Red cell distribution width;
SKCM	cis	rs72634258	0.786	rs7537362	chr1:8177564	C/T	cg00042356	chr1:8021962	PARK7	0.83	5.47	0.53	5.33e-7	Inflammatory bowel disease;
SKCM	cis	rs3741404	0.620	rs2236648	chr11:63964657	C/T	cg05555928	chr11:63887634	MACROD1	-0.85	-5.36	-0.52	8.11e-7	Platelet count;
SKCM	cis	rs4969178	0.965	rs8075131	chr17:76394595	T/G	cg20026190	chr17:76395443	PGS1	0.61	5.29	0.51	1.08e-6	HDL cholesterol levels;
SKCM	cis	rs9913156	0.841	rs4522461	chr17:4621773	T/G	cg19197139	chr17:4613644	ARRB2	-0.88	-6.06	-0.57	4.49e-8	Lymphocyte counts;
SKCM	cis	rs9916302	0.904	rs2338755	chr17:37419317	C/T	cg07936489	chr17:37558343	FBXL20	0.84	6.96	0.62	9.48e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs9581857	0.547	rs9581870	chr13:28083957	T/G	cg22138327	chr13:27999177	GTF3A	0.84	5.53	0.53	4.15e-7	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs870825	0.616	rs10022818	chr4:185619282	A/G	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs7809950	1.000	rs2237672	chr7:107131563	A/C	cg23024343	chr7:107201750	COG5	-0.74	-6.61	-0.6	4.39e-9	Coronary artery disease;
SKCM	cis	rs13118159	0.509	rs4974556	chr4:1358141	G/C	cg05025164	chr4:1340916	KIAA1530	0.9	7.21	0.63	3.08e-10	Longevity;
SKCM	cis	rs7811142	1.000	rs67163493	chr7:100023838	C/T	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.23	8.03	0.67	8.33e-12	Platelet count;
SKCM	cis	rs6500395	0.926	rs1039342	chr16:48577498	G/A	cg04672837	chr16:48644449	N4BP1	0.7	5.71	0.54	1.92e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs8067545	0.516	rs4925086	chr17:20013459	A/T	cg13482628	chr17:19912719	NA	0.66	5.51	0.53	4.43e-7	Schizophrenia;
SKCM	cis	rs1153858	1.000	rs11070456	chr15:45686835	G/A	cg21132104	chr15:45694354	SPATA5L1	0.89	7.21	0.63	3.12e-10	Homoarginine levels;
SKCM	cis	rs763121	0.853	rs1065201	chr22:39069510	T/C	cg06022373	chr22:39101656	GTPBP1	0.8	5.85	0.55	1.1e-7	Menopause (age at onset);
SKCM	cis	rs4555082	0.874	rs11625098	chr14:105756891	A/G	cg13114125	chr14:105738426	BRF1	-0.75	-5.73	-0.54	1.79e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs7954584	0.505	rs11043278	chr12:122412145	C/T	cg21171335	chr12:122356390	WDR66	0.48	5.03	0.5	3.02e-6	Mean corpuscular volume;
SKCM	cis	rs17376456	0.877	rs9314100	chr5:93447394	T/C	cg21475434	chr5:93447410	FAM172A	0.97	5.42	0.52	6.39e-7	Diabetic retinopathy;
SKCM	cis	rs6570726	0.526	rs4895674	chr6:145735860	T/G	cg23711669	chr6:146136114	FBXO30	-0.68	-6.39	-0.59	1.11e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7772486	0.790	rs2265469	chr6:146219049	T/C	cg05347473	chr6:146136440	FBXO30	0.56	5.18	0.51	1.67e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs12478296	1.000	rs6739247	chr2:243039189	C/A	cg06360820	chr2:242988706	NA	-0.92	-5.32	-0.52	9.84e-7	Obesity-related traits;
SKCM	cis	rs60871478	0.838	rs7789321	chr7:800977	A/G	cg05535760	chr7:792225	HEATR2	1.21	10.42	0.76	1.96e-16	Cerebrospinal P-tau181p levels;
SKCM	cis	rs7843479	1.000	rs13276082	chr8:21823184	A/G	cg17168535	chr8:21777572	XPO7	0.72	5.64	0.54	2.65e-7	Mean corpuscular volume;
SKCM	cis	rs6952808	0.771	rs10265944	chr7:1918337	C/T	cg03354898	chr7:1950403	MAD1L1	-0.52	-5.03	-0.5	3.02e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs951366	0.617	rs9438393	chr1:205782718	A/G	cg11965913	chr1:205819406	PM20D1	1.01	12.76	0.82	8.95e-21	Menarche (age at onset);
SKCM	cis	rs1552244	0.572	rs17032440	chr3:10169819	A/C	cg00149659	chr3:10157352	C3orf10	-1.13	-5.45	-0.53	5.74e-7	Alzheimer's disease;
SKCM	cis	rs28386778	0.897	rs2727326	chr17:61923016	G/A	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs7666738	0.680	rs34267968	chr4:99002574	A/T	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7944584	0.502	rs10769256	chr11:47378396	C/T	cg20307385	chr11:47447363	PSMC3	1.07	9.34	0.73	2.4e-14	Fasting blood glucose;Fasting blood glucose (BMI interaction);
SKCM	cis	rs208515	0.525	rs10944868	chr6:66687508	A/G	cg07460842	chr6:66804631	NA	0.93	6.34	0.58	1.35e-8	Exhaled nitric oxide levels;
SKCM	cis	rs8180040	0.966	rs922957	chr3:47422152	G/C	cg16586182	chr3:47516702	SCAP	0.76	5.32	0.52	9.63e-7	Colorectal cancer;
SKCM	cis	rs9325144	0.600	rs6582630	chr12:38743508	A/G	cg13010199	chr12:38710504	ALG10B	-0.63	-5.15	-0.5	1.87e-6	Morning vs. evening chronotype;
SKCM	cis	rs8014204	0.816	rs11159107	chr14:75341266	C/A	cg06637938	chr14:75390232	RPS6KL1	-0.65	-4.81	-0.48	7.14e-6	Caffeine consumption;
SKCM	cis	rs7208859	0.623	rs3794796	chr17:29130880	G/C	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs6598955	0.670	rs6598942	chr1:26531034	C/T	cg00938395	chr1:26633206	UBXN11	0.71	4.99	0.49	3.6e-6	Obesity-related traits;
SKCM	cis	rs6951245	0.935	rs11766669	chr7:1063593	C/T	cg03188948	chr7:1209495	NA	1.11	6.11	0.57	3.68e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs6951245	0.872	rs57068908	chr7:1060084	A/C	cg21664854	chr7:1097933	C7orf50;GPR146	0.9	4.86	0.48	6.05e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs9911578	1.000	rs2531729	chr17:56539890	C/T	cg05425664	chr17:57184151	TRIM37	-0.69	-5.23	-0.51	1.38e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs4319547	0.695	rs11058034	chr12:122894936	G/T	cg23029597	chr12:123009494	RSRC2	0.74	5.17	0.5	1.79e-6	Body mass index;
SKCM	cis	rs6066825	0.555	rs717709	chr20:47305959	G/A	cg18078177	chr20:47281410	PREX1	0.63	5.14	0.5	2e-6	Colorectal cancer;
SKCM	cis	rs6942756	1.000	rs56026912	chr7:128913937	A/G	cg02491457	chr7:128862824	NA	-0.76	-4.89	-0.48	5.2e-6	White matter hyperintensity burden;
SKCM	cis	rs4819052	0.851	rs875621	chr21:46682295	A/G	cg19498844	chr21:46707878	POFUT2;LOC642852	0.89	7.71	0.66	3.36e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs55962025	0.883	rs362275	chr4:3224602	C/T	cg16987761	chr4:3318072	RGS12	-0.65	-4.81	-0.48	7.21e-6	Parental longevity (mother's age at death);
SKCM	cis	rs3741404	0.791	rs11603192	chr11:63927695	A/G	cg19465662	chr11:63993652	NUDT22;TRPT1	0.8	5.8	0.55	1.37e-7	Platelet count;
SKCM	cis	rs6840360	0.571	rs11736116	chr4:152531816	A/G	cg22705602	chr4:152727874	NA	-0.5	-5.44	-0.52	5.9e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs6951245	1.000	rs113146460	chr7:1105164	C/G	cg24642844	chr7:1081250	C7orf50	-0.93	-6.22	-0.58	2.28e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7296418	0.961	rs4148863	chr12:123569375	A/G	cg00376283	chr12:123451042	ABCB9	0.96	8.66	0.7	5.01e-13	Platelet count;
SKCM	cis	rs9814567	1.000	rs9289478	chr3:134268619	A/G	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs2153535	0.580	rs9505454	chr6:8478532	T/G	cg07606381	chr6:8435919	SLC35B3	0.86	6.25	0.58	2.06e-8	Motion sickness;
SKCM	cis	rs6952808	0.689	rs79950306	chr7:2022063	C/G	cg21782813	chr7:2030301	MAD1L1	0.56	5.84	0.55	1.15e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs7937682	1.000	rs7128353	chr11:111538875	A/G	cg09085632	chr11:111637200	PPP2R1B	-1.01	-11.52	-0.79	1.68e-18	Primary sclerosing cholangitis;
SKCM	cis	rs1957429	0.901	rs7143661	chr14:65378981	G/A	cg23373153	chr14:65346875	NA	1.07	5.71	0.54	1.94e-7	Pediatric areal bone mineral density (radius);
SKCM	cis	rs9394841	0.667	rs71558769	chr6:41782107	T/C	cg08135965	chr6:41755394	TOMM6	0.76	5.12	0.5	2.16e-6	Mean corpuscular hemoglobin;Red cell distribution width;
SKCM	cis	rs2180341	0.889	rs2000909	chr6:127711173	G/A	cg24812749	chr6:127587940	RNF146	0.65	5.3	0.51	1.05e-6	Breast cancer;
SKCM	cis	rs2228479	0.717	rs17226274	chr16:89850170	C/T	cg06558623	chr16:89946397	TCF25	1.18	5.68	0.54	2.23e-7	Skin colour saturation;
SKCM	cis	rs875971	1.000	rs7801282	chr7:65613687	C/T	cg11764359	chr7:65958608	NA	-0.86	-8.23	-0.68	3.44e-12	Aortic root size;
SKCM	cis	rs17685	0.753	rs11972240	chr7:75694079	A/C	cg01364799	chr7:75623366	TMEM120A	-0.75	-6.05	-0.56	4.78e-8	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs478304	0.593	rs2236682	chr11:65480090	G/T	cg27068330	chr11:65405492	SIPA1	-0.85	-7.42	-0.64	1.25e-10	Acne (severe);
SKCM	cis	rs7937682	0.921	rs11213940	chr11:111433927	C/A	cg19812747	chr11:111475976	SIK2	0.66	5.32	0.52	9.5e-7	Primary sclerosing cholangitis;
SKCM	cis	rs875971	1.000	rs1144895	chr7:65541307	C/G	cg18876405	chr7:65276391	NA	-0.71	-7.04	-0.62	6.64e-10	Aortic root size;
SKCM	cis	rs1801251	1.000	rs11555646	chr2:233599904	A/C	cg25237894	chr2:233734115	C2orf82	0.56	5.33	0.52	9.23e-7	Coronary artery disease;
SKCM	cis	rs9513627	0.748	rs61525545	chr13:100118261	T/C	cg11288260	chr13:100117058	NA	-0.75	-4.98	-0.49	3.69e-6	Obesity-related traits;
SKCM	cis	rs12762955	0.561	rs1904671	chr10:1014603	G/A	cg26597838	chr10:835615	NA	-0.7	-5.86	-0.55	1.05e-7	Response to angiotensin II receptor blocker therapy;
SKCM	cis	rs4727027	0.745	rs10952801	chr7:148864757	T/C	cg23583168	chr7:148888333	NA	-0.8	-6.62	-0.6	4.13e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs12047808	0.841	rs10913751	chr1:179393393	T/A	cg09822482	chr1:179519214	C1orf125	-0.95	-5.17	-0.51	1.78e-6	Multiple sclerosis (age of onset);
SKCM	cis	rs561341	0.739	rs6505267	chr17:30225950	A/C	cg00745463	chr17:30367425	LRRC37B	-1.0	-6.43	-0.59	9.36e-9	Hip circumference adjusted for BMI;
SKCM	cis	rs10256972	0.521	rs7811577	chr7:1102829	C/G	cg16145915	chr7:1198662	ZFAND2A	-0.49	-6.3	-0.58	1.63e-8	Longevity;Endometriosis;
SKCM	cis	rs3820068	0.603	rs7536654	chr1:15989141	C/G	cg13390004	chr1:15929781	NA	0.64	5.19	0.51	1.61e-6	Systolic blood pressure;
SKCM	cis	rs8141529	0.687	rs6005867	chr22:29165120	T/C	cg02153584	chr22:29168773	CCDC117	0.69	5.61	0.54	2.99e-7	Lymphocyte counts;
SKCM	cis	rs7809950	1.000	rs10276604	chr7:107216738	C/T	cg23024343	chr7:107201750	COG5	0.67	6.24	0.58	2.12e-8	Coronary artery disease;
SKCM	cis	rs3087591	1.000	rs12600974	chr17:29589360	A/G	cg24425628	chr17:29625626	OMG;NF1	0.63	5.04	0.5	3e-6	Hip circumference;
SKCM	cis	rs2836974	0.932	rs6517523	chr21:40557332	T/C	cg11890956	chr21:40555474	PSMG1	1.11	13.42	0.84	5.75e-22	Cognitive function;
SKCM	cis	rs1790761	0.520	rs7124513	chr11:67395714	C/T	cg14500267	chr11:67383377	NA	-0.52	-5.31	-0.52	1.01e-6	Mean corpuscular volume;
SKCM	cis	rs606458	0.841	rs607389	chr11:64553578	A/T	cg07674570	chr11:65346152	EHBP1L1	0.67	4.84	0.48	6.5e-6	Urate levels;
SKCM	cis	rs910316	0.737	rs175071	chr14:75498177	A/G	cg08847533	chr14:75593920	NEK9	-0.79	-6.64	-0.6	3.77e-9	Height;
SKCM	cis	rs2816062	0.813	rs2816051	chr1:18895460	A/G	cg18795169	chr1:18902165	NA	-0.83	-9.02	-0.71	1.01e-13	Urate levels in lean individuals;
SKCM	cis	rs1801251	1.000	rs6747645	chr2:233571033	C/T	cg25237894	chr2:233734115	C2orf82	-0.54	-5.15	-0.5	1.92e-6	Coronary artery disease;
SKCM	cis	rs28595532	0.920	rs115744897	chr4:119749064	A/G	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs8072100	0.967	rs11079784	chr17:45702280	A/G	cg25173405	chr17:45401733	C17orf57	0.58	5.18	0.51	1.66e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs28595532	0.920	rs56322132	chr4:119742496	T/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs7635838	0.684	rs2606758	chr3:11353064	G/A	cg00170343	chr3:11313890	ATG7	0.72	5.5	0.53	4.68e-7	HDL cholesterol;
SKCM	cis	rs9951698	0.678	rs570505	chr18:13047784	T/G	cg12848697	chr18:13133368	NA	0.53	4.78	0.48	7.97e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs67311347	1.000	rs1466236	chr3:40462162	C/T	cg00091569	chr3:40428383	ENTPD3	0.59	5.03	0.49	3.07e-6	Renal cell carcinoma;
SKCM	cis	rs992157	0.672	rs2382829	chr2:219184617	G/A	cg20019365	chr2:219134978	PNKD;AAMP	0.74	5.94	0.56	7.66e-8	Colorectal cancer;
SKCM	cis	rs798554	0.797	rs798491	chr7:2800521	A/G	cg14895029	chr7:2775587	GNA12	-0.72	-5.21	-0.51	1.47e-6	Height;
SKCM	cis	rs2731664	0.792	rs335434	chr5:176867276	A/G	cg23176889	chr5:176863531	GRK6	-0.51	-4.91	-0.49	4.84e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs6087771	0.821	rs6058444	chr20:30315137	A/G	cg13852791	chr20:30311386	BCL2L1	0.8	5.47	0.53	5.3e-7	Subcortical brain region volumes;Putamen volume;
SKCM	cis	rs10489202	1.000	rs12408205	chr1:167982332	A/G	cg24449463	chr1:168025552	DCAF6	-0.74	-5.9	-0.56	8.97e-8	Schizophrenia;
SKCM	cis	rs2243480	1.000	rs458291	chr7:65520479	C/A	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs823143	0.570	rs1361754	chr1:205801872	C/T	cg23034840	chr1:205782522	SLC41A1	-0.64	-4.84	-0.48	6.53e-6	Monocyte percentage of white cells;
SKCM	cis	rs17685	0.712	rs7794454	chr7:75776010	A/G	cg16684958	chr7:75615977	POR	-0.51	-4.88	-0.48	5.61e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2204008	0.548	rs8189475	chr12:38037115	C/T	cg26384229	chr12:38710491	ALG10B	0.75	6.26	0.58	1.95e-8	Bladder cancer;
SKCM	cis	rs7829975	0.688	rs7826660	chr8:8379107	C/A	cg08975724	chr8:8085496	FLJ10661	0.66	5.2	0.51	1.57e-6	Mood instability;
SKCM	cis	rs10489202	1.000	rs10489202	chr1:167903079	A/C	cg24449463	chr1:168025552	DCAF6	0.77	5.77	0.55	1.53e-7	Schizophrenia;
SKCM	cis	rs798554	1.000	rs798544	chr7:2763102	A/G	cg19346786	chr7:2764209	NA	0.63	6.3	0.58	1.6e-8	Height;
SKCM	cis	rs8103278	0.507	rs2041975	chr19:46238555	T/C	cg11657440	chr19:46296263	DMWD	1.05	9.61	0.74	7e-15	Coronary artery disease;
SKCM	trans	rs2727020	0.636	rs10839275	chr11:49438962	T/A	cg15704280	chr7:45808275	SEPT13	-0.87	-7.93	-0.67	1.31e-11	Coronary artery disease;
SKCM	cis	rs1878931	0.567	rs7196196	chr16:3411855	C/A	cg26668626	chr16:3451006	ZNF174;ZNF434	0.92	8.1	0.68	5.98e-12	Body mass index (adult);
SKCM	cis	rs801193	0.935	rs2286683	chr7:66129843	G/A	cg00343986	chr7:65444356	GUSB	-0.67	-4.93	-0.49	4.55e-6	Aortic root size;
SKCM	cis	rs75229567	0.618	rs11177848	chr12:70180892	A/G	cg10114359	chr12:70132523	RAB3IP	1.2	5.17	0.51	1.74e-6	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes;
SKCM	cis	rs2839186	0.933	rs4818832	chr21:47708634	C/T	cg13012494	chr21:47604986	C21orf56	0.67	5.71	0.54	1.95e-7	Testicular germ cell tumor;
SKCM	cis	rs116095464	0.558	rs2288458	chr5:231260	C/T	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs2180341	0.960	rs9398840	chr6:127669744	G/A	cg27446573	chr6:127587934	RNF146	0.94	8.11	0.68	5.63e-12	Breast cancer;
SKCM	cis	rs72781680	0.898	rs718139	chr2:23975911	G/A	cg08917208	chr2:24149416	ATAD2B	0.96	4.84	0.48	6.44e-6	Lymphocyte counts;
SKCM	cis	rs2760061	0.603	rs697762	chr1:228192410	G/A	cg02753203	chr1:228287806	NA	0.79	7.31	0.64	1.98e-10	Diastolic blood pressure;
SKCM	trans	rs10506458	0.915	rs998505	chr12:63400018	C/T	cg03429785	chr15:59498649	MYO1E;LDHAL6B	-1.38	-7.54	-0.65	7.13e-11	Hemostatic factors and hematological phenotypes;
SKCM	trans	rs17685	0.712	rs4732578	chr7:75721532	A/G	cg19862616	chr7:65841803	NCRNA00174	0.95	9.02	0.71	9.98e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs9300255	0.602	rs1727314	chr12:123640664	C/A	cg00376283	chr12:123451042	ABCB9	0.82	5.61	0.54	3e-7	Neutrophil percentage of white cells;
SKCM	cis	rs16854884	0.632	rs35629416	chr3:143748424	C/T	cg06585982	chr3:143692056	C3orf58	0.83	7.55	0.65	6.97e-11	Economic and political preferences (feminism/equality);
SKCM	cis	rs2836974	0.863	rs8128026	chr21:40533702	T/C	cg17971929	chr21:40555470	PSMG1	0.87	8.48	0.69	1.1e-12	Cognitive function;
SKCM	trans	rs62103177	0.810	rs62103188	chr18:77627661	G/A	cg05926928	chr17:57297772	GDPD1	1.29	8.74	0.7	3.44e-13	Opioid sensitivity;
SKCM	cis	rs910316	1.000	rs175426	chr14:75624134	C/T	cg08847533	chr14:75593920	NEK9	-0.93	-8.64	-0.7	5.4e-13	Height;
SKCM	cis	rs7647973	0.769	rs6446204	chr3:49034879	T/C	cg07636037	chr3:49044803	WDR6	0.92	6.9	0.62	1.24e-9	Menarche (age at onset);
SKCM	cis	rs9902453	0.967	rs61240589	chr17:28449035	G/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.5	0.53	4.74e-7	Coffee consumption (cups per day);
SKCM	cis	rs12477438	0.501	rs6751927	chr2:99740175	T/C	cg14399236	chr2:99771627	LIPT1;TSGA10	1.0	9.4	0.73	1.85e-14	Chronic sinus infection;
SKCM	cis	rs7216064	1.000	rs4318247	chr17:65882172	A/G	cg12091567	chr17:66097778	LOC651250	-0.75	-5.27	-0.51	1.19e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs55962025	0.640	rs2530598	chr4:3230804	A/C	cg09735869	chr4:3319127	RGS12	0.62	4.78	0.48	7.96e-6	Parental longevity (mother's age at death);
SKCM	cis	rs737337	0.623	rs3826815	chr19:11332505	C/T	cg00586551	chr19:11347513	LOC55908;DOCK6	0.81	5.92	0.56	8.3e-8	HDL cholesterol;HDL cholesterol levels;
SKCM	cis	rs13118159	1.000	rs13118159	chr4:1365127	A/G	cg20887711	chr4:1340912	KIAA1530	0.74	5.36	0.52	8.09e-7	Longevity;
SKCM	cis	rs28386778	0.830	rs2597636	chr17:61876010	A/G	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs3091242	0.933	rs34006994	chr1:25780668	C/T	cg27572855	chr1:25598939	RHD	-0.53	-5.06	-0.5	2.67e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs1405130	0.900	rs12692147	chr2:235586898	A/T	cg17841421	chr2:235704848	NA	-0.56	-4.8	-0.48	7.62e-6	Coronary artery disease;
SKCM	cis	rs7552404	0.924	rs1498317	chr1:76171984	A/C	cg03433033	chr1:76189801	ACADM	0.78	5.67	0.54	2.36e-7	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs9911578	0.967	rs7214892	chr17:57065401	G/A	cg12560992	chr17:57184187	TRIM37	0.98	8.0	0.67	9.32e-12	Intelligence (multi-trait analysis);
SKCM	cis	rs2594989	0.779	rs13353407	chr3:11585299	C/T	cg00170343	chr3:11313890	ATG7	-0.97	-5.17	-0.5	1.79e-6	Circulating chemerin levels;
SKCM	cis	rs6547631	0.622	rs11127	chr2:85924729	C/T	cg24620635	chr2:85921963	GNLY	0.9	6.65	0.6	3.58e-9	Blood protein levels;
SKCM	trans	rs561341	1.000	rs8073186	chr17:30244956	T/C	cg20587970	chr11:113659929	NA	-1.1	-9.35	-0.73	2.3e-14	Hip circumference adjusted for BMI;
SKCM	cis	rs72781680	0.898	rs6712175	chr2:24023431	T/G	cg08917208	chr2:24149416	ATAD2B	0.92	4.85	0.48	6.19e-6	Lymphocyte counts;
SKCM	cis	rs875971	0.666	rs13242072	chr7:65765988	A/G	cg00343986	chr7:65444356	GUSB	-0.68	-5.13	-0.5	2.1e-6	Aortic root size;
SKCM	cis	rs4803468	0.934	rs11880674	chr19:41889423	A/T	cg09537434	chr19:41945824	ATP5SL	-1.09	-12.85	-0.82	6e-21	Height;
SKCM	cis	rs17685	0.753	rs9691174	chr7:75790405	T/C	cg16684958	chr7:75615977	POR	0.53	5.3	0.51	1.06e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs763014	0.898	rs4984893	chr16:623082	A/G	cg00908189	chr16:619842	PIGQ	0.81	7.2	0.63	3.3e-10	Height;
SKCM	cis	rs1218582	0.772	rs10908448	chr1:154882544	A/G	cg09359103	chr1:154839909	KCNN3	0.55	5.13	0.5	2.03e-6	Prostate cancer;
SKCM	cis	rs7428	0.527	rs4832164	chr2:85546932	A/C	cg24342717	chr2:85555507	TGOLN2	-0.61	-4.78	-0.48	8.12e-6	Ear protrusion;
SKCM	cis	rs4803468	1.000	rs8105833	chr19:41896145	G/A	cg09537434	chr19:41945824	ATP5SL	-1.08	-13.01	-0.83	3.1e-21	Height;
SKCM	cis	rs3785574	0.962	rs2727324	chr17:61922102	G/C	cg26338869	chr17:61819248	STRADA	0.64	4.83	0.48	6.59e-6	Height;
SKCM	cis	rs2120019	0.938	rs8036573	chr15:75308690	C/T	cg17294928	chr15:75287854	SCAMP5	-0.89	-8.26	-0.68	2.98e-12	Blood trace element (Zn levels);
SKCM	cis	rs875971	0.660	rs12698534	chr7:65986845	C/T	cg11764359	chr7:65958608	NA	0.86	6.6	0.6	4.52e-9	Aortic root size;
SKCM	cis	rs248381	0.967	rs248380	chr5:78331741	T/C	cg17568934	chr5:77892219	LHFPL2	0.51	4.87	0.48	5.83e-6	Toenail selenium levels;
SKCM	trans	rs1814175	0.817	rs28502006	chr11:50049930	T/C	cg03929089	chr4:120376271	NA	-0.93	-8.77	-0.7	3.08e-13	Height;
SKCM	cis	rs4925386	1.000	rs6121990	chr20:60919263	G/A	cg24112000	chr20:60950667	NA	0.63	6.16	0.57	3.02e-8	Colorectal cancer;Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs7213347	1.000	rs7213347	chr17:2153257	G/C	cg18413116	chr17:2293477	MNT	-0.68	-5.38	-0.52	7.7e-7	Total body bone mineral density;
SKCM	cis	rs28595532	0.800	rs67686161	chr4:119336720	C/T	cg21605333	chr4:119757512	SEC24D	0.95	4.91	0.49	4.92e-6	Cannabis dependence symptom count;
SKCM	cis	rs3087591	1.000	rs12939853	chr17:29455021	G/A	cg24425628	chr17:29625626	OMG;NF1	0.66	5.07	0.5	2.59e-6	Hip circumference;
SKCM	cis	rs9910055	0.762	rs11080007	chr17:42265442	A/G	cg09913183	chr17:42254507	C17orf65;ASB16	-0.69	-6.24	-0.58	2.12e-8	Total body bone mineral density;
SKCM	cis	rs4319547	0.626	rs10744210	chr12:122931793	A/G	cg23029597	chr12:123009494	RSRC2	-0.77	-5.53	-0.53	4.13e-7	Body mass index;
SKCM	cis	rs7523050	0.730	rs67312582	chr1:109423976	A/G	cg08274380	chr1:109419600	GPSM2	1.17	6.61	0.6	4.34e-9	Fat distribution (HIV);
SKCM	cis	rs9660180	0.967	rs6603802	chr1:1812521	C/T	cg17747265	chr1:1875780	NA	-0.58	-5.2	-0.51	1.55e-6	Body mass index;
SKCM	cis	rs12478296	0.901	rs56318767	chr2:243046591	T/A	cg06360820	chr2:242988706	NA	-0.91	-5.25	-0.51	1.28e-6	Obesity-related traits;
SKCM	cis	rs826838	0.967	rs826876	chr12:39123843	T/C	cg13010199	chr12:38710504	ALG10B	-0.73	-5.79	-0.55	1.43e-7	Heart rate;
SKCM	cis	rs11105298	0.838	rs10858862	chr12:89842053	T/C	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.88	-6.03	-0.56	5.22e-8	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	trans	rs8073060	0.544	rs225274	chr17:33971221	C/T	cg19694781	chr19:47549865	TMEM160	0.96	8.19	0.68	4.05e-12	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs2204008	0.639	rs7311462	chr12:38278130	G/A	cg26384229	chr12:38710491	ALG10B	0.87	6.83	0.61	1.63e-9	Bladder cancer;
SKCM	cis	rs10256972	0.681	rs12702016	chr7:1129392	C/T	cg07092213	chr7:1199455	ZFAND2A	-0.65	-5.44	-0.52	5.9e-7	Longevity;Endometriosis;
SKCM	cis	rs1419980	0.630	rs2080126	chr12:7774524	A/C	cg10578777	chr12:7781093	NA	0.73	5.17	0.51	1.73e-6	HDL cholesterol levels;
SKCM	cis	rs8180040	0.966	rs60369822	chr3:47479735	A/C	cg27129171	chr3:47204927	SETD2	-0.79	-5.79	-0.55	1.43e-7	Colorectal cancer;
SKCM	trans	rs1814175	0.817	rs1988416	chr11:49932324	G/A	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs2832191	0.632	rs1984011	chr21:30337831	T/A	cg24692254	chr21:30365293	RNF160	-1.0	-9.45	-0.73	1.45e-14	Dental caries;
SKCM	cis	rs34779708	0.897	rs4934529	chr10:35302376	T/A	cg03585969	chr10:35415529	CREM	0.75	6.23	0.58	2.2e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs35146811	0.555	rs1981549	chr7:99541636	A/G	cg22906224	chr7:99728672	NA	0.72	4.96	0.49	4.08e-6	Coronary artery disease;
SKCM	cis	rs7945705	0.875	rs10769947	chr11:8758114	A/G	cg21881798	chr11:8931708	C11orf17;ST5	0.53	4.81	0.48	7.1e-6	Hemoglobin concentration;
SKCM	cis	rs34779708	0.931	rs17583009	chr10:35320915	T/C	cg03585969	chr10:35415529	CREM	0.75	6.23	0.58	2.2e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs933688	1.000	rs60513756	chr5:90727692	A/C	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.02	7.83	0.66	1.97e-11	Smoking behavior;
SKCM	cis	rs6461049	0.519	rs3778992	chr7:2175313	C/G	cg14004847	chr7:1930337	MAD1L1	-0.63	-5.31	-0.52	1.01e-6	Schizophrenia;
SKCM	cis	rs2811415	0.597	rs13094572	chr3:127772785	G/A	cg09089421	chr3:127803668	RUVBL1	1.01	8.79	0.71	2.72e-13	Lung function (FEV1/FVC);
SKCM	cis	rs7809950	0.953	rs3094383	chr7:107143164	G/A	cg23024343	chr7:107201750	COG5	-0.76	-6.83	-0.61	1.64e-9	Coronary artery disease;
SKCM	cis	rs7937682	0.737	rs682239	chr11:111425105	A/G	cg19812747	chr11:111475976	SIK2	0.56	4.86	0.48	5.84e-6	Primary sclerosing cholangitis;
SKCM	cis	rs6982751	0.611	rs56112432	chr8:10814974	G/A	cg01383082	chr8:11323474	FAM167A	0.91	5.11	0.5	2.21e-6	Asthma and hay fever;
SKCM	cis	rs2070488	0.861	rs1858740	chr3:38438372	T/C	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.96	8.93	0.71	1.47e-13	Electrocardiographic conduction measures;
SKCM	cis	rs12928939	0.517	rs12149307	chr16:71968091	A/C	cg03805757	chr16:71968109	PKD1L3	-0.72	-5.13	-0.5	2.02e-6	Post bronchodilator FEV1;
SKCM	cis	rs7824557	0.602	rs7833966	chr8:11206220	C/G	cg21775007	chr8:11205619	TDH	0.72	6.4	0.59	1.09e-8	Retinal vascular caliber;
SKCM	cis	rs523522	0.962	rs3759394	chr12:120933173	C/A	cg12219531	chr12:120966889	COQ5	0.91	7.82	0.66	2.11e-11	High light scatter reticulocyte count;
SKCM	cis	rs6951245	1.000	rs11768761	chr7:1069807	A/G	cg21664854	chr7:1097933	C7orf50;GPR146	0.89	4.79	0.48	7.66e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7613875	0.641	rs2624845	chr3:50062437	C/A	cg24110177	chr3:50126178	RBM5	0.7	5.58	0.53	3.34e-7	Body mass index;
SKCM	cis	rs1948632	0.619	rs1391411	chr16:75985217	T/C	cg01495379	chr16:76669151	NA	0.46	5.32	0.52	9.5e-7	Tuberculosis;
SKCM	cis	rs34779708	0.898	rs4934695	chr10:35280605	C/T	cg03585969	chr10:35415529	CREM	0.72	5.96	0.56	6.77e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs9858038	0.683	rs2270968	chr3:182755209	T/G	cg06384952	chr3:183602746	PARL	0.7	4.86	0.48	5.98e-6	Parkinson's disease;
SKCM	cis	rs1218582	0.772	rs7528532	chr1:154874440	C/T	cg16680214	chr1:154839983	KCNN3	-0.56	-5.01	-0.49	3.29e-6	Prostate cancer;
SKCM	trans	rs17685	0.753	rs1637044	chr7:75703744	T/C	cg19862616	chr7:65841803	NCRNA00174	0.94	9.45	0.73	1.46e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs6952808	1.000	rs12540579	chr7:1882227	C/A	cg04267008	chr7:1944627	MAD1L1	-0.8	-6.1	-0.57	3.78e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs28595532	0.545	rs17516582	chr4:119296763	C/G	cg21605333	chr4:119757512	SEC24D	0.93	4.98	0.49	3.72e-6	Cannabis dependence symptom count;
SKCM	cis	rs55823223	0.752	rs34974290	chr17:73888354	G/A	cg08125733	chr17:73851984	WBP2	1.0	5.36	0.52	8.33e-7	Psoriasis;
SKCM	cis	rs694739	0.894	rs887314	chr11:64053157	T/G	cg02228329	chr11:64053129	BAD;GPR137	0.98	8.5	0.69	9.94e-13	Alopecia areata;Crohn's disease;Psoriasis vulgaris;
SKCM	cis	rs55962025	0.711	rs2298971	chr4:3200079	A/G	cg21096898	chr4:3318625	RGS12	-0.58	-4.79	-0.48	7.73e-6	Parental longevity (mother's age at death);
SKCM	cis	rs17711722	0.640	rs13237956	chr7:65318029	G/A	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.61	5.06	0.5	2.75e-6	Calcium levels;
SKCM	cis	rs6430585	0.528	rs75667274	chr2:136682486	C/T	cg07169764	chr2:136633963	MCM6	1.32	11.41	0.79	2.72e-18	Corneal structure;
SKCM	cis	rs17711722	0.503	rs453835	chr7:65511159	T/A	cg18876405	chr7:65276391	NA	-0.64	-5.05	-0.5	2.79e-6	Calcium levels;
SKCM	trans	rs208520	0.690	rs6929762	chr6:66709277	C/T	cg15611600	chr13:45563400	KIAA1704;NUFIP1	0.92	7.65	0.65	4.38e-11	Exhaled nitric oxide output;
SKCM	cis	rs10751667	0.666	rs7394958	chr11:965944	C/G	cg10932868	chr11:921992	NA	0.55	5.1	0.5	2.36e-6	Alzheimer's disease (late onset);
SKCM	cis	rs9303401	0.659	rs11495824	chr17:56918882	C/A	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.16	0.57	2.91e-8	Cognitive test performance;
SKCM	cis	rs929354	0.566	rs6979947	chr7:157005863	C/T	cg17757837	chr7:157058334	UBE3C	-0.85	-5.72	-0.54	1.88e-7	Body mass index;
SKCM	cis	rs28595532	0.920	rs114168088	chr4:119772666	G/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs7618915	0.501	rs2336146	chr3:52626646	A/G	cg18404041	chr3:52824283	ITIH1	-0.53	-4.77	-0.48	8.42e-6	Bipolar disorder;
SKCM	cis	rs8060686	0.641	rs7201742	chr16:68099821	T/G	cg04539111	chr16:67997858	SLC12A4	-0.85	-4.81	-0.48	7.14e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs854765	0.647	rs2056842	chr17:18009028	C/T	cg04398451	chr17:18023971	MYO15A	-1.0	-9.22	-0.72	4.08e-14	Total body bone mineral density;
SKCM	cis	rs7666738	0.830	rs11721726	chr4:98996314	T/C	cg05340658	chr4:99064831	C4orf37	0.67	5.14	0.5	1.98e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7811142	0.830	rs6955367	chr7:99961194	A/G	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.02	6.28	0.58	1.79e-8	Platelet count;
SKCM	cis	rs2836974	0.602	rs2037925	chr21:40699931	C/T	cg11890956	chr21:40555474	PSMG1	-0.82	-7.64	-0.65	4.75e-11	Cognitive function;
SKCM	cis	rs7523050	0.643	rs12741194	chr1:109400390	T/C	cg08274380	chr1:109419600	GPSM2	1.13	5.57	0.53	3.54e-7	Fat distribution (HIV);
SKCM	cis	rs867186	0.841	rs6060241	chr20:33696495	G/A	cg04194272	chr20:33683537	NA	-1.21	-6.8	-0.61	1.89e-9	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs4822044	0.617	rs13054514	chr22:42130383	A/G	cg03806693	chr22:41940476	POLR3H	0.82	5.03	0.5	3.02e-6	Cannabis dependence symptom count;
SKCM	cis	rs9910055	0.639	rs11656871	chr17:42269141	G/C	cg09913183	chr17:42254507	C17orf65;ASB16	0.67	6.53	0.59	6.13e-9	Total body bone mineral density;
SKCM	cis	rs8180040	0.966	rs11130129	chr3:47489885	G/C	cg16586182	chr3:47516702	SCAP	0.76	5.32	0.52	9.63e-7	Colorectal cancer;
SKCM	cis	rs16940212	0.618	rs16940181	chr15:58687524	A/C	cg16767221	chr15:57769667	CGNL1	-0.62	-5.03	-0.49	3.11e-6	HDL cholesterol levels;HDL cholesterol;
SKCM	cis	rs561341	1.000	rs8073186	chr17:30244956	T/C	cg23018236	chr17:30244563	NA	-0.51	-5.16	-0.5	1.85e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs6723226	0.679	rs116617324	chr2:32622709	C/T	cg02381751	chr2:32503542	YIPF4	-0.66	-4.84	-0.48	6.39e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs523522	0.962	rs1050187	chr12:120902111	A/G	cg12219531	chr12:120966889	COQ5	-0.89	-7.74	-0.66	2.94e-11	High light scatter reticulocyte count;
SKCM	cis	rs1799949	0.965	rs35521261	chr17:41313612	A/G	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.15	-0.57	3.16e-8	Menopause (age at onset);
SKCM	cis	rs17685	0.753	rs1104879	chr7:75685568	C/T	cg16684958	chr7:75615977	POR	0.59	5.63	0.54	2.69e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs651907	0.514	rs12636046	chr3:101434448	T/G	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.81	7.06	0.62	6.11e-10	Colorectal cancer;
SKCM	cis	rs34779708	0.966	rs1213392	chr10:35430285	C/T	cg03585969	chr10:35415529	CREM	0.73	5.93	0.56	7.94e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs3008870	1.000	rs12044278	chr1:67460977	T/C	cg08660285	chr1:67390436	MIER1;WDR78	-0.92	-6.07	-0.57	4.27e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs950776	0.684	rs692780	chr15:78876505	C/G	cg06917634	chr15:78832804	PSMA4	-0.85	-6.83	-0.61	1.68e-9	Sudden cardiac arrest;
SKCM	cis	rs9467773	0.596	rs2451751	chr6:26646714	T/C	cg15659132	chr6:26577336	NA	0.62	5.4	0.52	6.91e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs2658782	0.756	rs3019222	chr11:93079718	C/T	cg15737290	chr11:93063684	CCDC67	0.82	5.74	0.55	1.7e-7	Pulmonary function decline;
SKCM	cis	rs4523957	0.890	rs11655813	chr17:2119101	C/T	cg16513277	chr17:2031491	SMG6	-0.75	-5.31	-0.52	9.93e-7	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs7917772	0.582	rs7899004	chr10:104341435	C/T	cg11453585	chr10:104263688	ACTR1A;SUFU	-0.64	-5.08	-0.5	2.54e-6	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs4237845	0.788	rs6581157	chr12:58288793	C/T	cg00677455	chr12:58241039	CTDSP2	0.7	5.88	0.55	9.49e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs9467773	0.620	rs2504592	chr6:26640951	C/G	cg15659132	chr6:26577336	NA	0.62	5.4	0.52	6.91e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs9814567	1.000	rs9832785	chr3:134213070	A/G	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.64	-5.06	-0.5	2.77e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs453301	0.686	rs6987107	chr8:8893581	A/G	cg06636001	chr8:8085503	FLJ10661	-0.73	-5.55	-0.53	3.74e-7	Joint mobility (Beighton score);
SKCM	cis	rs7811142	0.830	rs6975660	chr7:99975266	A/G	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.07	6.7	0.6	2.88e-9	Platelet count;
SKCM	cis	rs2739330	0.796	rs5760106	chr22:24250645	A/C	cg12419862	chr22:24373484	LOC391322	0.67	6.03	0.56	5.22e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs34172651	0.517	rs200528	chr16:24759131	A/G	cg00339695	chr16:24857497	SLC5A11	-0.8	-6.43	-0.59	9.38e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs1678542	0.651	rs2888334	chr12:57976647	C/G	cg04478727	chr12:58166393	METTL1;FAM119B	-0.68	-5.26	-0.51	1.24e-6	Rheumatoid arthritis;
SKCM	cis	rs2599510	0.840	rs466146	chr2:32539236	A/C	cg02381751	chr2:32503542	YIPF4	0.69	5.54	0.53	3.94e-7	Interleukin-18 levels;
SKCM	cis	rs3793683	0.597	rs2182620	chr10:134590715	C/T	cg00988841	chr10:134556463	INPP5A	0.61	4.78	0.48	8.12e-6	Migraine;
SKCM	cis	rs12497850	0.863	rs4974084	chr3:48939080	G/A	cg07636037	chr3:49044803	WDR6	0.96	8.61	0.7	6.1e-13	Parkinson's disease;
SKCM	cis	rs28386778	0.901	rs2665855	chr17:61965143	A/G	cg11494091	chr17:61959527	GH2	0.59	4.9	0.49	5.04e-6	Prudent dietary pattern;
SKCM	cis	rs2120019	0.938	rs8030089	chr15:75290377	C/T	cg09165964	chr15:75287851	SCAMP5	-0.9	-9.44	-0.73	1.54e-14	Blood trace element (Zn levels);
SKCM	cis	rs2354432	1.000	rs2120003	chr1:146690635	A/G	cg25205988	chr1:146714368	CHD1L	1.39	7.52	0.65	7.85e-11	Mitochondrial DNA levels;
SKCM	cis	rs9640161	0.789	rs34495356	chr7:150057791	A/G	cg10018233	chr7:150070692	REPIN1	0.66	5.14	0.5	2.02e-6	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs7945705	0.747	rs10840158	chr11:9020897	A/C	cg13070366	chr11:9386451	NA	0.62	5.15	0.5	1.93e-6	Hemoglobin concentration;
SKCM	cis	rs7536201	0.738	rs2135754	chr1:25302758	G/A	cg24722749	chr1:24969476	SRRM1	0.62	4.9	0.49	5.06e-6	Psoriasis vulgaris;
SKCM	cis	rs427394	0.659	rs175594	chr5:6729885	T/G	cg10857441	chr5:6722123	POLS	-0.69	-7.38	-0.64	1.51e-10	Menopause (age at onset);
SKCM	cis	rs2228479	0.850	rs11640209	chr16:89807828	C/A	cg06558623	chr16:89946397	TCF25	1.03	5.59	0.53	3.23e-7	Skin colour saturation;
SKCM	cis	rs7103648	0.897	rs35032070	chr11:47408592	G/A	cg20307385	chr11:47447363	PSMC3	0.96	6.93	0.62	1.09e-9	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs561341	1.000	rs113676348	chr17:30244327	A/G	cg00745463	chr17:30367425	LRRC37B	-0.89	-5.9	-0.56	8.83e-8	Hip circumference adjusted for BMI;
SKCM	cis	rs7666738	0.830	rs4392515	chr4:98957431	A/G	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2180341	0.781	rs7742161	chr6:127571676	T/C	cg24812749	chr6:127587940	RNF146	0.79	6.57	0.6	5.17e-9	Breast cancer;
SKCM	cis	rs2836950	0.561	rs34705151	chr21:40553344	G/A	cg17971929	chr21:40555470	PSMG1	-0.76	-6.53	-0.59	6.19e-9	Menarche (age at onset);
SKCM	cis	rs801193	1.000	rs7785213	chr7:66138978	A/C	cg18876405	chr7:65276391	NA	-0.82	-7.53	-0.65	7.59e-11	Aortic root size;
SKCM	cis	rs1707322	0.721	rs4609469	chr1:46117185	C/T	cg03146154	chr1:46216737	IPP	0.82	6.1	0.57	3.89e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs995000	0.931	rs641540	chr1:62908538	A/G	cg06896770	chr1:63153194	DOCK7	0.76	7.24	0.63	2.71e-10	Triglyceride levels;
SKCM	cis	rs12714314	0.602	rs13400823	chr2:1918360	A/G	cg22350835	chr2:1868857	MYT1L	0.53	5.05	0.5	2.89e-6	Type 2 diabetes (age of onset);
SKCM	cis	rs3785574	0.924	rs2584641	chr17:61862889	A/G	cg01411255	chr17:61851458	DDX42;CCDC47	1.15	13.4	0.83	6.26e-22	Height;
SKCM	cis	rs7666738	0.830	rs11932887	chr4:99072965	C/G	cg05340658	chr4:99064831	C4orf37	0.66	4.9	0.49	5.09e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11105298	0.891	rs10858864	chr12:89846230	C/T	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.88	-6.03	-0.56	5.22e-8	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs2153535	0.580	rs9328486	chr6:8528008	T/C	cg23788917	chr6:8435910	SLC35B3	0.68	4.98	0.49	3.66e-6	Motion sickness;
SKCM	cis	rs8077889	1.000	rs113919636	chr17:41877740	A/C	cg26893861	chr17:41843967	DUSP3	1.11	7.49	0.65	9.21e-11	Triglycerides;
SKCM	cis	rs7772486	0.738	rs75288066	chr6:146319386	C/A	cg23711669	chr6:146136114	FBXO30	0.73	6.58	0.6	4.81e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4969178	0.965	rs3817294	chr17:76396963	A/G	cg20026190	chr17:76395443	PGS1	0.61	5.29	0.51	1.08e-6	HDL cholesterol levels;
SKCM	cis	rs4774899	0.966	rs6493901	chr15:57405451	A/G	cg01857019	chr15:57210107	LOC145783;TCF12	0.51	4.83	0.48	6.74e-6	Urinary tract infection frequency;
SKCM	cis	rs11105298	0.891	rs4842654	chr12:89834428	T/A	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.88	-6.03	-0.56	5.22e-8	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs62238980	0.614	rs77489541	chr22:32413863	G/T	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs8072100	0.840	rs56952963	chr17:45493826	T/C	cg08085267	chr17:45401833	C17orf57	-0.62	-5.15	-0.5	1.88e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs684232	0.666	rs838372	chr17:566428	C/T	cg12384639	chr17:618140	VPS53	0.78	6.14	0.57	3.27e-8	Prostate cancer;
SKCM	cis	rs9430161	0.579	rs7542158	chr1:11040193	G/A	cg02454025	chr1:11042201	C1orf127	0.96	8.79	0.71	2.74e-13	Ewing sarcoma;
SKCM	cis	rs9926296	0.548	rs12447465	chr16:89829895	C/T	cg27121462	chr16:89883253	FANCA	0.81	7.28	0.64	2.3e-10	Vitiligo;
SKCM	cis	rs6580649	1.000	rs3825404	chr12:48399931	A/G	cg05342945	chr12:48394962	COL2A1	-0.73	-5.4	-0.52	7.06e-7	Lung cancer;
SKCM	cis	rs9303401	0.527	rs12946522	chr17:56768103	A/C	cg10487724	chr17:56770010	TEX14;RAD51C	0.83	5.82	0.55	1.22e-7	Cognitive test performance;
SKCM	cis	rs10256972	0.577	rs2949179	chr7:1209885	C/G	cg07092213	chr7:1199455	ZFAND2A	-0.74	-6.14	-0.57	3.18e-8	Longevity;Endometriosis;
SKCM	cis	rs2439831	0.867	rs11856184	chr15:43919162	A/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.41	8.33	0.69	2.19e-12	Lung cancer in ever smokers;
SKCM	cis	rs875971	0.660	rs7807930	chr7:66087165	C/T	cg11764359	chr7:65958608	NA	-0.84	-6.37	-0.59	1.2e-8	Aortic root size;
SKCM	cis	rs561341	1.000	rs113115092	chr17:30284164	G/A	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs1256061	0.603	rs1256045	chr14:64729760	A/C	cg21174375	chr14:64681225	SYNE2	0.47	4.95	0.49	4.15e-6	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs1799949	0.965	rs8067269	chr17:41235799	C/T	cg25918947	chr17:41365094	TMEM106A	-0.59	-5.3	-0.51	1.03e-6	Menopause (age at onset);
SKCM	cis	rs9325144	0.647	rs11168819	chr12:39011082	C/A	cg26384229	chr12:38710491	ALG10B	-0.73	-6.62	-0.6	4.04e-9	Morning vs. evening chronotype;
SKCM	cis	rs1577917	1.000	rs884841	chr6:86680300	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.66	-5.69	-0.54	2.11e-7	Response to antipsychotic treatment;
SKCM	cis	rs7829975	0.593	rs2921061	chr8:8317615	A/T	cg06636001	chr8:8085503	FLJ10661	0.96	9.57	0.74	8.34e-15	Mood instability;
SKCM	cis	rs10929159	0.928	rs12053257	chr2:236920174	C/T	cg14226755	chr2:236923322	AGAP1	0.29	4.77	0.48	8.43e-6	Parkinson's disease;
SKCM	cis	rs9815354	0.767	rs73071337	chr3:41822518	G/C	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs9611565	0.504	rs5758452	chr22:42144927	G/A	cg03806693	chr22:41940476	POLR3H	0.81	5.33	0.52	9.33e-7	Vitiligo;
SKCM	cis	rs854765	0.583	rs4925123	chr17:17784374	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	-0.93	-7.56	-0.65	6.65e-11	Total body bone mineral density;
SKCM	cis	rs950776	0.518	rs952216	chr15:78819202	C/T	cg06917634	chr15:78832804	PSMA4	1.01	10.48	0.76	1.5e-16	Sudden cardiac arrest;
SKCM	cis	rs7927771	0.697	rs11039307	chr11:47611152	C/T	cg05585544	chr11:47624801	NA	-0.64	-5.52	-0.53	4.33e-7	Subjective well-being;
SKCM	cis	rs244731	1.000	rs244726	chr5:176536408	G/A	cg06060754	chr5:176797920	RGS14	0.65	5.31	0.52	9.98e-7	Urate levels in lean individuals;
SKCM	cis	rs6545883	0.507	rs2442025	chr2:61571445	G/A	cg15711740	chr2:61764176	XPO1	0.66	5.12	0.5	2.17e-6	Tuberculosis;
SKCM	cis	rs561341	0.843	rs2028067	chr17:30239698	T/C	cg23018236	chr17:30244563	NA	-0.52	-5.3	-0.51	1.05e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs3859192	0.557	rs12602514	chr17:38159745	A/G	cg17467752	chr17:38218738	THRA	-0.74	-6.28	-0.58	1.78e-8	White blood cell count;
SKCM	cis	rs1799949	1.000	rs4793236	chr17:41436440	T/C	cg25918947	chr17:41365094	TMEM106A	-0.71	-6.96	-0.62	9.59e-10	Menopause (age at onset);
SKCM	cis	rs2243480	1.000	rs2961102	chr7:65424658	A/G	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs2832191	0.740	rs6516890	chr21:30476812	T/A	cg24692254	chr21:30365293	RNF160	0.9	8.03	0.67	8.39e-12	Dental caries;
SKCM	cis	rs2836974	0.800	rs12482857	chr21:40514861	T/C	cg17971929	chr21:40555470	PSMG1	0.91	8.58	0.7	7.02e-13	Cognitive function;
SKCM	cis	rs7824557	0.564	rs34964435	chr8:11230206	G/T	cg21775007	chr8:11205619	TDH	-0.61	-5.1	-0.5	2.28e-6	Retinal vascular caliber;
SKCM	cis	rs2905347	0.531	rs2961289	chr7:22677755	C/T	cg11983867	chr7:22539820	MGC87042	-0.47	-4.82	-0.48	7.03e-6	Major depression and alcohol dependence;
SKCM	cis	rs72781680	0.846	rs55770503	chr2:24030126	A/T	cg08917208	chr2:24149416	ATAD2B	0.96	5.18	0.51	1.71e-6	Lymphocyte counts;
SKCM	cis	rs798554	0.797	rs798494	chr7:2798294	C/A	cg14895029	chr7:2775587	GNA12	-0.7	-5.36	-0.52	8.13e-7	Height;
SKCM	cis	rs228769	1.000	rs12937692	chr17:42256430	G/A	cg13607699	chr17:42295918	UBTF	0.87	5.9	0.56	8.82e-8	Bone mineral density (hip);Bone mineral density (spine);
SKCM	cis	rs1403694	0.695	rs1523435	chr3:186436306	G/A	cg09332604	chr3:186435400	KNG1	-0.49	-4.88	-0.48	5.53e-6	Blood protein levels;
SKCM	cis	rs28595532	0.920	rs114724233	chr4:119754918	T/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs7937682	0.632	rs11214037	chr11:111773296	C/T	cg09085632	chr11:111637200	PPP2R1B	1.1	10.72	0.77	5.29e-17	Primary sclerosing cholangitis;
SKCM	cis	rs10504229	0.595	rs77615399	chr8:58117394	C/G	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs875971	0.862	rs6945775	chr7:65968974	G/A	cg18876405	chr7:65276391	NA	0.61	5.94	0.56	7.52e-8	Aortic root size;
SKCM	cis	rs9905704	0.647	rs8077332	chr17:57105223	A/G	cg12560992	chr17:57184187	TRIM37	0.74	6.08	0.57	4.13e-8	Testicular germ cell tumor;
SKCM	cis	rs17818399	0.547	rs4952833	chr2:46762034	T/C	cg02822958	chr2:46747628	ATP6V1E2	0.71	4.93	0.49	4.57e-6	Height;
SKCM	cis	rs2228479	0.681	rs11642428	chr16:89971909	A/T	cg06558623	chr16:89946397	TCF25	1.26	7.26	0.64	2.51e-10	Skin colour saturation;
SKCM	cis	rs3793683	0.597	rs12767469	chr10:134587261	C/G	cg26818010	chr10:134567672	INPP5A	-0.73	-5.16	-0.5	1.82e-6	Migraine;
SKCM	cis	rs9868809	0.505	rs28657585	chr3:48736216	A/T	cg00383909	chr3:49044727	WDR6	0.89	5.09	0.5	2.44e-6	Ulcerative colitis;Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs6998277	0.830	rs12543046	chr8:103603809	A/G	cg10187029	chr8:103597600	NA	-0.67	-5.63	-0.54	2.77e-7	Migraine;
SKCM	cis	rs6570726	0.764	rs448258	chr6:145869145	C/A	cg23711669	chr6:146136114	FBXO30	0.87	9.13	0.72	5.92e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6834538	0.597	rs2087111	chr4:113536080	A/G	cg05166686	chr4:113558556	LARP7;C4orf21	0.63	5.2	0.51	1.56e-6	Free thyroxine concentration;
SKCM	cis	rs2075671	0.903	rs11979818	chr7:100293639	A/G	cg20848291	chr7:100343083	ZAN	0.71	5.38	0.52	7.64e-7	Other erythrocyte phenotypes;
SKCM	cis	rs3862030	0.500	rs11191327	chr10:104303883	T/C	cg11453585	chr10:104263688	ACTR1A;SUFU	0.77	6.27	0.58	1.88e-8	Waist circumference adjusted for BMI (adjusted for smoking behaviour);Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction);Waist circumference adjusted for body mass index;
SKCM	cis	rs8067545	0.611	rs8071274	chr17:20216928	T/C	cg13482628	chr17:19912719	NA	-0.66	-5.33	-0.52	9.27e-7	Schizophrenia;
SKCM	cis	rs12474201	0.889	rs2346878	chr2:46922870	C/T	cg06386533	chr2:46925753	SOCS5	0.98	9.19	0.72	4.68e-14	Height;
SKCM	cis	rs6547631	0.622	rs10180445	chr2:85926218	C/G	cg24620635	chr2:85921963	GNLY	-0.95	-7.38	-0.64	1.45e-10	Blood protein levels;
SKCM	cis	rs6138458	0.961	rs11700073	chr20:24975215	C/G	cg26195577	chr20:24973756	C20orf3	1.29	8.85	0.71	2.07e-13	Blood protein levels;
SKCM	cis	rs7615952	0.673	rs35001498	chr3:125628644	A/G	cg05084668	chr3:125655381	ALG1L	-1.25	-6.57	-0.6	5.19e-9	Blood pressure (smoking interaction);
SKCM	cis	rs7590720	1.000	rs7592663	chr2:216894978	T/C	cg12620499	chr2:216877984	MREG	0.89	8.14	0.68	4.97e-12	Alcohol dependence;
SKCM	cis	rs2153535	0.580	rs9393019	chr6:8462091	G/A	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs10779751	0.690	rs910661	chr1:11130116	C/A	cg08854313	chr1:11322531	MTOR	0.77	5.52	0.53	4.36e-7	Body mass index;
SKCM	cis	rs7632954	0.567	rs2047518	chr3:8537037	T/A	cg06697448	chr3:8544912	LMCD1	-0.62	-5.33	-0.52	9.08e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs9513627	0.573	rs4771336	chr13:100210610	T/G	cg15490075	chr13:100150979	NA	0.8	5.15	0.5	1.94e-6	Obesity-related traits;
SKCM	cis	rs4862750	0.872	rs7679956	chr4:187900229	C/T	cg10295955	chr4:187884368	NA	-1.04	-13.97	-0.85	6.27e-23	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs28386778	0.897	rs1470697	chr17:61799840	T/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.13	11.24	0.79	5.56e-18	Prudent dietary pattern;
SKCM	cis	rs9581857	0.547	rs75085794	chr13:28095944	A/C	cg22138327	chr13:27999177	GTF3A	0.84	5.53	0.53	4.15e-7	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs1461503	0.966	rs10892938	chr11:122841921	A/C	cg27398637	chr11:122830231	C11orf63	-0.63	-4.8	-0.48	7.54e-6	Menarche (age at onset);
SKCM	cis	rs7020830	0.898	rs495863	chr9:37346955	T/C	cg14294708	chr9:37120828	ZCCHC7	1.06	10.76	0.77	4.41e-17	Schizophrenia;
SKCM	cis	rs6840360	0.615	rs2406973	chr4:152608339	G/T	cg22705602	chr4:152727874	NA	0.55	7.18	0.63	3.59e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs9389248	0.708	rs7750574	chr6:135350932	G/C	cg24558204	chr6:135376177	HBS1L	0.68	6.24	0.58	2.14e-8	High light scatter reticulocyte percentage of red cells;
SKCM	cis	rs847649	0.692	rs10271184	chr7:102477176	A/G	cg18108683	chr7:102477205	FBXL13	-0.83	-9.06	-0.72	8.16e-14	Morning vs. evening chronotype;
SKCM	cis	rs4972806	0.814	rs2113560	chr2:177030986	T/C	cg13092806	chr2:177043255	NA	0.58	5.41	0.52	6.71e-7	IgG glycosylation;
SKCM	cis	rs7666738	0.830	rs28618180	chr4:98912184	A/C	cg17366294	chr4:99064904	C4orf37	0.56	4.87	0.48	5.76e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1218582	0.661	rs4845695	chr1:154911798	A/G	cg24250549	chr1:154909240	PMVK	0.82	7.85	0.66	1.8e-11	Prostate cancer;
SKCM	cis	rs769267	0.965	rs2074299	chr19:19380646	T/C	cg26732615	chr19:19648335	CILP2;YJEFN3	0.62	5.67	0.54	2.31e-7	Tonsillectomy;
SKCM	cis	rs7959452	0.901	rs1384	chr12:69747834	C/T	cg20891283	chr12:69753455	YEATS4	0.74	6.28	0.58	1.78e-8	Blood protein levels;
SKCM	cis	rs365132	1.000	rs353467	chr5:176445698	T/C	cg16309518	chr5:176445507	NA	-0.52	-4.98	-0.49	3.76e-6	Menarche and menopause (age at onset);Menopause (age at onset);
SKCM	cis	rs4242434	0.927	rs13271626	chr8:22467760	C/G	cg03733263	chr8:22462867	KIAA1967	1.09	8.99	0.71	1.11e-13	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs6762	0.719	rs4895	chr11:840477	A/G	cg16425592	chr11:842748	TSPAN4;POLR2L	-0.79	-5.8	-0.55	1.33e-7	Mean platelet volume;
SKCM	cis	rs6500395	0.584	rs1420698	chr16:48740708	C/G	cg04672837	chr16:48644449	N4BP1	0.72	5.21	0.51	1.52e-6	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs9910055	0.530	rs2269908	chr17:42294198	G/C	cg10896456	chr17:42255109	ASB16;C17orf65	0.54	4.88	0.48	5.61e-6	Total body bone mineral density;
SKCM	cis	rs40363	0.645	rs250631	chr16:3523215	G/C	cg22508957	chr16:3507546	NAT15	0.56	4.85	0.48	6.19e-6	Tuberculosis;
SKCM	cis	rs2404602	0.647	rs12910820	chr15:77022825	T/C	cg23625390	chr15:77176239	SCAPER	-0.85	-8.26	-0.68	2.93e-12	Blood metabolite levels;
SKCM	cis	rs7659604	1.000	rs28640980	chr4:122664284	T/C	cg19671926	chr4:122722719	EXOSC9	-0.66	-4.98	-0.49	3.71e-6	Type 2 diabetes;
SKCM	cis	rs10540	0.908	rs35608427	chr11:498976	T/C	cg03352830	chr11:487213	PTDSS2	0.94	4.91	0.49	4.87e-6	Body mass index;
SKCM	cis	rs4481887	0.927	rs4558008	chr1:248477641	C/T	cg00666640	chr1:248458726	OR2T12	0.63	5.91	0.56	8.65e-8	Common traits (Other);
SKCM	cis	rs870825	0.929	rs10003354	chr4:185589782	G/A	cg04058563	chr4:185651563	MLF1IP	1.09	5.66	0.54	2.4e-7	Blood protein levels;
SKCM	cis	rs10256972	0.706	rs4285396	chr7:1123738	A/G	cg09177884	chr7:1199841	ZFAND2A	-0.76	-6.44	-0.59	9.06e-9	Longevity;Endometriosis;
SKCM	cis	rs6840360	0.593	rs10016160	chr4:152693998	A/G	cg22705602	chr4:152727874	NA	-0.59	-7.86	-0.66	1.75e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs11098499	0.754	rs2036856	chr4:120249288	G/A	cg09307838	chr4:120376055	NA	0.93	7.56	0.65	6.5500000000000006e-11	Corneal astigmatism;
SKCM	cis	rs4727027	0.704	rs12535115	chr7:148895087	C/T	cg23583168	chr7:148888333	NA	-0.72	-5.67	-0.54	2.27e-7	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs4073582	0.595	rs474005	chr11:66033301	C/T	cg14036092	chr11:66035641	RAB1B	0.75	5.91	0.56	8.39e-8	Gout;
SKCM	cis	rs7917772	0.503	rs7904955	chr10:104367092	C/T	cg11453585	chr10:104263688	ACTR1A;SUFU	0.77	6.1	0.57	3.8e-8	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs1799949	0.896	rs8176086	chr17:41274778	G/A	cg05368731	chr17:41323189	NBR1	0.89	7.91	0.67	1.38e-11	Menopause (age at onset);
SKCM	cis	rs514406	0.861	rs503015	chr1:53254456	T/C	cg16325326	chr1:53192061	ZYG11B	-0.99	-11.71	-0.8	7.39e-19	Monocyte count;
SKCM	cis	rs1218582	0.804	rs4845398	chr1:154859038	G/C	cg24250549	chr1:154909240	PMVK	0.87	8.69	0.7	4.22e-13	Prostate cancer;
SKCM	cis	rs6840360	0.533	rs13119490	chr4:152713412	A/G	cg22705602	chr4:152727874	NA	0.59	7.76	0.66	2.74e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs6580649	0.941	rs72644843	chr12:48465061	A/G	cg05342945	chr12:48394962	COL2A1	0.73	5.2	0.51	1.53e-6	Lung cancer;
SKCM	cis	rs2386661	0.547	rs11259540	chr10:5646706	A/T	cg12223502	chr10:5658492	NA	-0.54	-5.09	-0.5	2.38e-6	Breast cancer;
SKCM	cis	rs6951245	1.000	rs113146460	chr7:1105164	C/G	cg18402987	chr7:1209562	NA	1.15	6.09	0.57	3.95e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs3008870	0.959	rs2815359	chr1:67494374	T/C	cg08660285	chr1:67390436	MIER1;WDR78	0.95	6.51	0.59	6.68e-9	Lymphocyte percentage of white cells;
SKCM	cis	rs651907	0.535	rs34263427	chr3:101507805	A/G	cg12386194	chr3:101231763	SENP7	0.68	5.66	0.54	2.43e-7	Colorectal cancer;
SKCM	cis	rs2228479	0.850	rs1800355	chr16:89813194	C/T	cg00800038	chr16:89945340	TCF25	-0.81	-4.79	-0.48	7.84e-6	Skin colour saturation;
SKCM	cis	rs6450176	0.638	rs11746856	chr5:53291295	A/C	ch.5.1024479R	chr5:53302184	ARL15	-0.95	-5.36	-0.52	8.12e-7	HDL cholesterol levels;HDL cholesterol;Adiponectin levels;
SKCM	cis	rs8077889	0.750	rs76557360	chr17:41936842	G/A	cg26893861	chr17:41843967	DUSP3	1.23	6.83	0.61	1.63e-9	Triglycerides;
SKCM	cis	rs1044826	0.692	rs184155	chr3:139229772	G/A	cg15131784	chr3:139108705	COPB2	-0.68	-4.96	-0.49	4.03e-6	Obesity-related traits;
SKCM	cis	rs1018836	0.923	rs4734266	chr8:91628147	C/T	cg16814680	chr8:91681699	NA	-0.64	-4.85	-0.48	6.29e-6	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs12120353	0.702	rs705689	chr1:4549307	G/T	cg15022359	chr1:4193126	NA	0.59	5.04	0.5	2.94e-6	Anxiety disorder;
SKCM	cis	rs7811142	0.830	rs11761253	chr7:99939321	C/T	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.21	8.05	0.67	7.68e-12	Platelet count;
SKCM	cis	rs1256061	0.603	rs1256037	chr14:64743301	G/A	cg21174375	chr14:64681225	SYNE2	0.47	4.95	0.49	4.15e-6	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs6540556	0.859	rs11119341	chr1:209940675	A/G	cg05527609	chr1:210001259	C1orf107	0.93	5.75	0.55	1.64e-7	Red blood cell count;
SKCM	cis	rs6088580	0.634	rs7271970	chr20:32987666	A/G	cg24642439	chr20:33292090	TP53INP2	-0.76	-6.02	-0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs2153535	0.541	rs9405386	chr6:8458067	C/G	cg07606381	chr6:8435919	SLC35B3	0.93	6.72	0.61	2.63e-9	Motion sickness;
SKCM	cis	rs736408	0.609	rs2268025	chr3:52795224	A/T	cg18404041	chr3:52824283	ITIH1	-0.56	-4.94	-0.49	4.32e-6	Bipolar disorder;
SKCM	cis	rs875971	0.767	rs61348003	chr7:66005934	C/T	cg11764359	chr7:65958608	NA	0.75	6.8	0.61	1.88e-9	Aortic root size;
SKCM	cis	rs7945705	0.791	rs12421789	chr11:8813956	G/A	cg21881798	chr11:8931708	C11orf17;ST5	-0.7	-7.0	-0.62	7.74e-10	Hemoglobin concentration;
SKCM	cis	rs1005277	0.505	rs719569	chr10:38154415	T/G	cg00409905	chr10:38381863	ZNF37A	0.63	5.91	0.56	8.43e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs10504229	0.953	rs67886764	chr8:58187117	T/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs992157	0.866	rs2292554	chr2:219146868	T/C	cg00012203	chr2:219082015	ARPC2	-0.72	-5.71	-0.54	1.99e-7	Colorectal cancer;
SKCM	cis	rs7666738	0.830	rs34916200	chr4:98851593	C/T	cg17366294	chr4:99064904	C4orf37	0.56	4.87	0.48	5.62e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7932354	0.502	rs7118546	chr11:47087128	C/G	cg03339077	chr11:47165057	C11orf49	-0.6	-4.92	-0.49	4.68e-6	Bone mineral density (hip);Bone mineral density;
SKCM	cis	rs7248779	0.532	rs10153475	chr19:2413961	G/C	cg22729335	chr19:2427816	TIMM13	1.07	10.18	0.76	5.66e-16	Cortisol levels (saliva);
SKCM	cis	rs1707322	1.000	rs9429186	chr1:46539687	C/T	cg03146154	chr1:46216737	IPP	-0.83	-5.56	-0.53	3.62e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs11690935	0.959	rs13419987	chr2:172623914	T/C	cg13550731	chr2:172543902	DYNC1I2	-0.95	-8.1	-0.68	6.14e-12	Schizophrenia;
SKCM	cis	rs2739330	0.796	rs1006771	chr22:24314006	G/T	cg12419862	chr22:24373484	LOC391322	-0.58	-5.04	-0.5	3e-6	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs4234284	1.000	rs2358766	chr3:126966294	A/G	cg04889221	chr3:126137216	CCDC37	-0.46	-4.83	-0.48	6.77e-6	Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel);
SKCM	trans	rs877282	0.945	rs12767287	chr10:787310	A/G	cg22713356	chr15:30763199	NA	1.35	7.57	0.65	6.52e-11	Uric acid levels;
SKCM	cis	rs7208859	0.524	rs60114476	chr17:29097667	A/T	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs1568889	1.000	rs12791341	chr11:28335452	T/C	cg06544937	chr11:28130018	METT5D1;KIF18A	0.86	7.03	0.62	6.97e-10	Bipolar disorder;
SKCM	cis	rs8067545	0.611	rs9902032	chr17:20015178	G/C	cg13482628	chr17:19912719	NA	0.7	5.79	0.55	1.41e-7	Schizophrenia;
SKCM	trans	rs10506458	0.915	rs1009540	chr12:63414872	C/A	cg03429785	chr15:59498649	MYO1E;LDHAL6B	-1.38	-7.54	-0.65	7.13e-11	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs12586317	0.547	rs28395170	chr14:35506988	C/T	cg16230307	chr14:35515116	FAM177A1	0.83	6.08	0.57	4.19e-8	Psoriasis;
SKCM	cis	rs2836974	0.966	rs7283420	chr21:40666865	T/C	cg11644478	chr21:40555479	PSMG1	0.83	7.69	0.66	3.66e-11	Cognitive function;
SKCM	cis	rs9435341	0.965	rs1730862	chr1:107614003	G/A	cg09367891	chr1:107599246	PRMT6	-0.79	-6.51	-0.59	6.77e-9	Facial morphology (factor 21, depth of nasal alae);
SKCM	cis	rs6430585	0.583	rs76097170	chr2:136593498	C/T	cg07169764	chr2:136633963	MCM6	1.26	11.77	0.8	5.63e-19	Corneal structure;
SKCM	cis	rs7598759	0.548	rs11686485	chr2:232360697	C/T	cg19187155	chr2:232395269	NMUR1	0.88	7.68	0.66	3.89e-11	Noise-induced hearing loss;
SKCM	cis	rs2760061	0.583	rs708124	chr1:228220771	A/T	cg02753203	chr1:228287806	NA	0.89	8.8	0.71	2.69e-13	Diastolic blood pressure;
SKCM	cis	rs7208859	0.623	rs8079891	chr17:29058863	G/A	cg14067834	chr17:29058358	SUZ12P	1.2	5.77	0.55	1.5e-7	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs6951245	1.000	rs75016635	chr7:1094121	G/A	cg24642844	chr7:1081250	C7orf50	-0.93	-6.22	-0.58	2.28e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs951366	0.789	rs1775154	chr1:205696615	T/A	cg17178900	chr1:205818956	PM20D1	0.73	5.82	0.55	1.25e-7	Menarche (age at onset);
SKCM	cis	rs12142240	0.731	rs12385693	chr1:46818921	A/C	cg10495392	chr1:46806563	NSUN4	0.78	5.58	0.53	3.38e-7	Menopause (age at onset);
SKCM	cis	rs28595532	0.920	rs115084148	chr4:119739290	A/G	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs9815354	0.812	rs73071343	chr3:41826877	G/C	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs8072100	0.811	rs1912483	chr17:45443494	A/G	cg25173405	chr17:45401733	C17orf57	-0.6	-4.91	-0.49	4.99e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs7216064	0.953	rs12601759	chr17:65955284	A/G	cg12091567	chr17:66097778	LOC651250	-0.78	-5.3	-0.51	1.06e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs362296	0.698	rs3095072	chr4:3263325	G/A	cg05297308	chr4:3317976	RGS12	-0.74	-6.57	-0.6	5.2e-9	Parental longevity (mother's age at death);
SKCM	cis	rs6570726	0.935	rs446242	chr6:145843866	A/G	cg23711669	chr6:146136114	FBXO30	0.69	5.99	0.56	6.09e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7666738	0.830	rs11932942	chr4:98998939	T/C	cg17366294	chr4:99064904	C4orf37	0.6	4.98	0.49	3.8e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs873946	0.618	rs12775767	chr10:134545628	C/T	cg27286337	chr10:134555280	INPP5A	0.92	8.33	0.69	2.15e-12	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs76662990	0.908	rs17645885	chr5:73850292	A/G	cg01264639	chr5:73839484	NA	0.85	4.77	0.48	8.39e-6	Residual cognition;
SKCM	cis	rs1862618	0.853	rs832583	chr5:56178217	A/C	cg12311346	chr5:56204834	C5orf35	-0.76	-5.02	-0.49	3.2e-6	Initial pursuit acceleration;
SKCM	cis	rs11098499	0.954	rs13107475	chr4:120393011	A/T	cg09307838	chr4:120376055	NA	0.97	7.65	0.65	4.54e-11	Corneal astigmatism;
SKCM	cis	rs992157	0.710	rs12996912	chr2:219110555	A/G	cg00012203	chr2:219082015	ARPC2	0.84	7.36	0.64	1.6e-10	Colorectal cancer;
SKCM	cis	rs7829975	0.742	rs12547493	chr8:8661534	C/T	cg06636001	chr8:8085503	FLJ10661	-0.81	-7.26	-0.64	2.5e-10	Mood instability;
SKCM	cis	rs769267	0.895	rs2905435	chr19:19495954	G/A	cg03709012	chr19:19516395	GATAD2A	-0.91	-8.6	-0.7	6.53e-13	Tonsillectomy;
SKCM	cis	rs769267	0.930	rs10402451	chr19:19608537	A/G	cg03709012	chr19:19516395	GATAD2A	0.89	8.62	0.7	5.89e-13	Tonsillectomy;
SKCM	cis	rs7122539	0.646	rs9633985	chr11:66520608	A/T	cg12372692	chr11:66233905	PELI3	-0.68	-4.99	-0.49	3.52e-6	HIV-1 susceptibility;
SKCM	cis	rs2180341	0.618	rs12210968	chr6:127596985	A/G	cg27446573	chr6:127587934	RNF146	0.68	5.47	0.53	5.22e-7	Breast cancer;
SKCM	trans	rs17685	0.523	rs10246583	chr7:75746667	C/A	cg19862616	chr7:65841803	NCRNA00174	0.94	9.49	0.73	1.22e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs992157	0.798	rs2382817	chr2:219151218	A/C	cg00012203	chr2:219082015	ARPC2	0.72	5.71	0.54	1.99e-7	Colorectal cancer;
SKCM	cis	rs644799	0.965	rs502521	chr11:95533557	T/A	cg03916912	chr11:95522834	CEP57;FAM76B	0.92	8.04	0.67	8e-12	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs17685	0.712	rs2158867	chr7:75815141	C/A	cg01364799	chr7:75623366	TMEM120A	-0.7	-5.91	-0.56	8.65e-8	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs738322	0.935	rs2413503	chr22:38568944	A/T	cg25457927	chr22:38595422	NA	-0.47	-5.1	-0.5	2.32e-6	Cutaneous nevi;
SKCM	cis	rs2180341	0.961	rs7774468	chr6:127592501	G/C	cg24812749	chr6:127587940	RNF146	0.9	7.35	0.64	1.71e-10	Breast cancer;
SKCM	cis	rs2180341	0.618	rs11154398	chr6:127654281	C/A	cg27446573	chr6:127587934	RNF146	0.69	5.45	0.53	5.72e-7	Breast cancer;
SKCM	cis	rs7539542	0.529	rs3766572	chr1:202860067	C/T	cg19681188	chr1:202830198	LOC148709	0.74	5.49	0.53	4.83e-7	Mean platelet volume;
SKCM	cis	rs9916302	0.706	rs3744349	chr17:37414842	C/T	cg07936489	chr17:37558343	FBXL20	-0.98	-6.58	-0.6	4.83e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs12600856	1	rs12600856	chr17:38163295	T/C	cg17467752	chr17:38218738	THRA	0.68	6.3	0.58	1.61e-8	Sum neutrophil eosinophil counts;Sum basophil neutrophil counts;White blood cell count;Granulocyte count;Neutrophil count;Myeloid white cell count;
SKCM	cis	rs2014572	0.967	rs10412975	chr19:57770554	C/A	cg24459738	chr19:57751996	ZNF805	-0.61	-4.93	-0.49	4.5e-6	Hyperactive-impulsive symptoms;
SKCM	cis	rs634534	0.562	rs1151505	chr11:65734539	C/T	cg02427764	chr11:65769310	BANF1;EIF1AD	0.65	5.17	0.51	1.75e-6	Sum eosinophil basophil counts;Eosinophil counts;
SKCM	cis	rs514406	0.565	rs897732	chr1:53382816	A/C	cg16325326	chr1:53192061	ZYG11B	0.65	5.65	0.54	2.56e-7	Monocyte count;
SKCM	cis	rs10911232	0.507	rs6664995	chr1:183017345	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.65	0.6	3.59e-9	Hypertriglyceridemia;
SKCM	cis	rs362272	0.545	rs3129308	chr4:3309272	C/T	cg05297308	chr4:3317976	RGS12	0.99	12.12	0.81	1.29e-19	Serum sulfate level;
SKCM	cis	rs56235845	0.694	rs11748912	chr5:176765395	G/A	cg06060754	chr5:176797920	RGS14	0.67	6.43	0.59	9.17e-9	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs17376456	1.000	rs13185608	chr5:93509688	T/G	cg25358565	chr5:93447407	FAM172A	1.23	8.18	0.68	4.19e-12	Diabetic retinopathy;
SKCM	cis	rs7772486	0.902	rs1331643	chr6:146398873	T/A	cg23711669	chr6:146136114	FBXO30	0.83	8.17	0.68	4.31e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs11098499	0.743	rs10003567	chr4:120241674	C/T	cg09307838	chr4:120376055	NA	0.93	7.56	0.65	6.5500000000000006e-11	Corneal astigmatism;
SKCM	cis	rs4819052	0.851	rs2838840	chr21:46668494	A/G	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.42	0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs9910055	0.762	rs2526021	chr17:42213347	G/A	cg08499158	chr17:42289980	UBTF	-0.85	-7.6	-0.65	5.61e-11	Total body bone mineral density;
SKCM	cis	rs1707322	0.964	rs1707339	chr1:46513179	A/G	cg03146154	chr1:46216737	IPP	-0.77	-5.36	-0.52	8.35e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs208515	0.525	rs12215007	chr6:66671008	C/T	cg07460842	chr6:66804631	NA	-0.97	-6.52	-0.59	6.32e-9	Exhaled nitric oxide levels;
SKCM	cis	rs79839061	0.610	rs9994159	chr4:891150	C/T	cg07828340	chr4:882639	GAK	1.08	6.12	0.57	3.56e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs6580649	0.941	rs7310579	chr12:48427523	G/A	cg05342945	chr12:48394962	COL2A1	0.69	5.14	0.5	1.96e-6	Lung cancer;
SKCM	cis	rs2721195	0.967	rs748195	chr8:145682514	T/C	cg15857475	chr8:145742913	RECQL4;LRRC14	0.82	7.31	0.64	2.05e-10	Age at first birth;
SKCM	cis	rs6582630	0.537	rs11611326	chr12:38547958	C/A	cg26384229	chr12:38710491	ALG10B	0.82	6.52	0.59	6.37e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs4727027	0.704	rs7787753	chr7:148901779	A/T	cg23583168	chr7:148888333	NA	-0.77	-6.15	-0.57	3.14e-8	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs6500395	1.000	rs6500402	chr16:48687354	C/T	cg04672837	chr16:48644449	N4BP1	0.65	5.42	0.52	6.37e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs9814567	1.000	rs4955555	chr3:134286427	C/T	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	trans	rs8073060	0.586	rs72829923	chr17:34045089	T/A	cg19694781	chr19:47549865	TMEM160	1.08	8.6	0.7	6.4e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs6088590	0.687	rs8115656	chr20:33282780	G/C	cg24642439	chr20:33292090	TP53INP2	0.79	5.66	0.54	2.45e-7	Coronary artery disease;
SKCM	cis	rs1405130	0.869	rs13018244	chr2:235565799	G/A	cg17841421	chr2:235704848	NA	-0.57	-4.95	-0.49	4.14e-6	Coronary artery disease;
SKCM	cis	rs7666738	0.753	rs17483788	chr4:98985623	G/A	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4481887	0.893	rs4529743	chr1:248473683	G/C	cg00666640	chr1:248458726	OR2T12	0.63	5.91	0.56	8.65e-8	Common traits (Other);
SKCM	cis	rs11718455	0.960	rs35869565	chr3:44002394	G/C	cg21419209	chr3:44054225	NA	-0.65	-5.32	-0.52	9.77e-7	Coronary artery disease;
SKCM	cis	rs4724125	0.960	rs10951692	chr7:42707712	T/C	cg09407816	chr7:42972088	MRPL32;PSMA2	0.81	4.89	0.48	5.32e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs55728055	0.661	rs62237814	chr22:31992574	G/C	cg01338084	chr22:32026380	PISD	1.5	5.03	0.49	3.11e-6	Age-related hearing impairment;
SKCM	cis	rs28595532	0.841	rs116521340	chr4:119757415	C/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs4969178	0.965	rs8071889	chr17:76398101	A/G	cg20026190	chr17:76395443	PGS1	0.61	5.29	0.51	1.08e-6	HDL cholesterol levels;
SKCM	cis	rs870825	0.860	rs72703525	chr4:185605154	T/C	cg04058563	chr4:185651563	MLF1IP	1.04	5.96	0.56	7.02e-8	Blood protein levels;
SKCM	cis	rs2153535	0.580	rs1034273	chr6:8468145	A/G	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs66887589	0.777	rs2017058	chr4:120257739	T/C	cg09307838	chr4:120376055	NA	0.7	5.09	0.5	2.46e-6	Diastolic blood pressure;
SKCM	cis	rs35306767	0.903	rs12769002	chr10:927666	C/G	cg20503657	chr10:835505	NA	-0.94	-6.54	-0.6	5.79e-9	Eosinophil percentage of granulocytes;
SKCM	cis	rs7811142	0.943	rs10241492	chr7:99994813	A/G	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.33	0.69	2.11e-12	Platelet count;
SKCM	cis	rs7769051	1.000	rs9493443	chr6:133121349	C/T	cg22852734	chr6:133119734	C6orf192	1.0	5.39	0.52	7.39e-7	Type 2 diabetes nephropathy;
SKCM	cis	rs12497850	0.931	rs9846123	chr3:49088112	C/T	cg07636037	chr3:49044803	WDR6	-1.05	-11.41	-0.79	2.65e-18	Parkinson's disease;
SKCM	cis	rs7647973	0.580	rs12637576	chr3:49237334	C/T	cg06212747	chr3:49208901	KLHDC8B	0.73	5.05	0.5	2.83e-6	Menarche (age at onset);
SKCM	cis	rs2479724	0.868	rs2249703	chr6:41814760	A/G	cg17623882	chr6:41773611	USP49	-0.8	-7.08	-0.63	5.43e-10	Menarche (age at onset);
SKCM	cis	rs2228479	0.541	rs12918575	chr16:89811151	A/G	cg06558623	chr16:89946397	TCF25	1.11	6.06	0.57	4.5e-8	Skin colour saturation;
SKCM	cis	rs11122272	0.677	rs2808615	chr1:231550171	G/A	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	0.66	5.49	0.53	4.82e-7	Hemoglobin concentration;
SKCM	cis	rs798554	0.797	rs798488	chr7:2802522	T/C	cg14895029	chr7:2775587	GNA12	-0.68	-4.89	-0.48	5.36e-6	Height;
SKCM	cis	rs992157	1.000	rs3731859	chr2:219124222	G/A	cg20019365	chr2:219134978	PNKD;AAMP	0.81	7.35	0.64	1.68e-10	Colorectal cancer;
SKCM	cis	rs1218582	0.741	rs6656494	chr1:154839799	A/G	cg03351412	chr1:154909251	PMVK	0.79	6.91	0.62	1.15e-9	Prostate cancer;
SKCM	cis	rs8180040	0.726	rs4682842	chr3:46982773	C/G	cg27129171	chr3:47204927	SETD2	-0.84	-6.46	-0.59	8.31e-9	Colorectal cancer;
SKCM	cis	rs9611565	0.918	rs4820438	chr22:41767135	C/T	cg03806693	chr22:41940476	POLR3H	-0.88	-6.03	-0.56	5.05e-8	Vitiligo;
SKCM	cis	rs4423214	1.000	rs11546509	chr11:71162785	A/G	cg05163923	chr11:71159392	DHCR7	0.83	8.06	0.67	7.35e-12	Vitamin D levels;
SKCM	cis	rs7149337	0.836	rs35345236	chr14:51671817	T/C	cg23942311	chr14:51606299	NA	0.61	6.58	0.6	4.84e-9	Cancer;
SKCM	cis	rs6089584	0.850	rs6089634	chr20:60632566	T/C	cg06108461	chr20:60628389	TAF4	-0.89	-9.05	-0.72	8.53e-14	Body mass index;
SKCM	cis	rs11690935	0.798	rs13018768	chr2:172598592	A/G	cg13550731	chr2:172543902	DYNC1I2	-0.95	-8.21	-0.68	3.64e-12	Schizophrenia;
SKCM	cis	rs28595532	0.920	rs114243409	chr4:119756585	C/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs244731	0.881	rs62397242	chr5:176738538	C/A	cg17509989	chr5:176798049	RGS14	0.98	7.41	0.64	1.32e-10	Urate levels in lean individuals;
SKCM	cis	rs2120019	1.000	rs35736167	chr15:75332002	T/G	cg09165964	chr15:75287851	SCAMP5	-0.82	-7.72	-0.66	3.24e-11	Blood trace element (Zn levels);
SKCM	cis	rs7811142	1.000	rs6979335	chr7:100089860	T/C	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-1.02	-5.76	-0.55	1.59e-7	Platelet count;
SKCM	cis	rs7772486	0.743	rs9390344	chr6:146012755	C/G	cg23711669	chr6:146136114	FBXO30	-0.82	-8.38	-0.69	1.71e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs11098499	0.863	rs11933966	chr4:120476715	G/A	cg24375607	chr4:120327624	NA	0.69	5.47	0.53	5.35e-7	Corneal astigmatism;
SKCM	cis	rs4132509	0.744	rs59953491	chr1:243894953	C/T	cg21452805	chr1:244014465	NA	0.93	5.78	0.55	1.48e-7	RR interval (heart rate);
SKCM	cis	rs1003719	0.788	rs61701101	chr21:38450317	G/A	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs74544699	0.609	rs72855280	chr4:74835131	C/A	cg01470535	chr4:74963112	CXCL2	0.76	4.84	0.48	6.43e-6	Growth-regulated protein alpha levels;
SKCM	cis	rs1005277	0.541	rs2505193	chr10:38394638	G/C	cg25427524	chr10:38739819	LOC399744	-0.71	-6.68	-0.6	3.17e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs28595532	0.702	rs72670256	chr4:119391043	G/A	cg21605333	chr4:119757512	SEC24D	1.02	5.24	0.51	1.34e-6	Cannabis dependence symptom count;
SKCM	cis	rs362272	0.524	rs10937924	chr4:3374898	T/C	cg00764545	chr4:3318001	RGS12	0.96	12.13	0.81	1.21e-19	Serum sulfate level;
SKCM	cis	rs854765	0.547	rs9913277	chr17:17919749	G/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.01	8.92	0.71	1.55e-13	Total body bone mineral density;
SKCM	cis	rs4423214	1.000	rs12792306	chr11:71166992	T/C	cg05163923	chr11:71159392	DHCR7	0.83	8.06	0.67	7.35e-12	Vitamin D levels;
SKCM	cis	rs1475911	0.656	rs9980065	chr21:43528072	G/A	cg19766460	chr21:43528205	UMODL1;C21orf128	0.95	5.19	0.51	1.61e-6	IgG glycosylation;
SKCM	cis	rs2404602	0.669	rs12148877	chr15:76919959	T/G	cg23625390	chr15:77176239	SCAPER	0.61	5.33	0.52	9.13e-7	Blood metabolite levels;
SKCM	cis	rs3749237	0.595	rs4855873	chr3:49459114	A/C	cg02487422	chr3:49467188	NICN1	0.64	4.79	0.48	7.67e-6	Resting heart rate;
SKCM	cis	rs1799949	0.965	rs4239149	chr17:41328095	A/G	cg19454999	chr17:41278357	BRCA1;NBR2	-0.52	-4.82	-0.48	6.91e-6	Menopause (age at onset);
SKCM	cis	rs7772486	0.720	rs1890171	chr6:146072114	T/C	cg05347473	chr6:146136440	FBXO30	-0.6	-5.68	-0.54	2.21e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9902453	0.765	rs1531553	chr17:28066752	T/C	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.79	-5.93	-0.56	7.67e-8	Coffee consumption (cups per day);
SKCM	cis	rs6665290	0.904	rs7541033	chr1:227188371	C/A	cg10327440	chr1:227177885	CDC42BPA	-1.25	-17.46	-0.89	1.15e-28	Myeloid white cell count;
SKCM	cis	rs6120849	0.518	rs11696652	chr20:33637060	T/G	cg24642439	chr20:33292090	TP53INP2	0.94	4.86	0.48	5.91e-6	Protein C levels;
SKCM	cis	rs2841277	0.509	rs11850949	chr14:105408827	A/C	cg19901468	chr14:105411992	AHNAK2	-0.93	-7.11	-0.63	4.76e-10	Rheumatoid arthritis;
SKCM	cis	rs1044826	0.642	rs186103	chr3:139211942	C/A	cg15131784	chr3:139108705	COPB2	0.7	5.19	0.51	1.62e-6	Obesity-related traits;
SKCM	cis	rs10876993	0.784	rs10083154	chr12:58020933	G/A	cg04478727	chr12:58166393	METTL1;FAM119B	0.7	5.38	0.52	7.42e-7	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs62238980	0.614	rs77621610	chr22:32503278	A/G	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs12047808	0.841	rs78940976	chr1:179416051	A/G	cg08037922	chr1:179521085	C1orf125;NPHS2	-1.08	-5.8	-0.55	1.32e-7	Multiple sclerosis (age of onset);
SKCM	cis	rs35306767	0.855	rs61830900	chr10:871481	C/G	cg20503657	chr10:835505	NA	0.79	5.87	0.55	1.02e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs752010	0.967	rs6675999	chr1:42099024	T/G	cg06885757	chr1:42089581	HIVEP3	0.61	6.19	0.57	2.64e-8	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs367615	0.660	rs10477972	chr5:108831951	C/A	cg17395555	chr5:108820864	NA	0.74	6.62	0.6	4.21e-9	Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs7666738	0.822	rs9992360	chr4:98937123	T/C	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4727027	0.704	rs12704070	chr7:148902789	G/A	cg23583168	chr7:148888333	NA	-0.77	-6.15	-0.57	3.14e-8	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs9581857	0.547	rs77005033	chr13:28109793	A/G	cg22138327	chr13:27999177	GTF3A	0.86	5.56	0.53	3.62e-7	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs637571	0.522	rs12792888	chr11:65761446	C/T	cg26695010	chr11:65641043	EFEMP2	-0.68	-5.11	-0.5	2.2e-6	Eosinophil percentage of white cells;
SKCM	cis	rs11098499	0.954	rs1480931	chr4:120395809	G/T	cg24375607	chr4:120327624	NA	0.67	5.41	0.52	6.64e-7	Corneal astigmatism;
SKCM	cis	rs8064299	0.536	rs2290038	chr17:72786611	G/T	cg25054828	chr17:72772726	NAT9;TMEM104	-0.94	-9.1	-0.72	6.96e-14	Monocyte count;
SKCM	cis	rs9517302	0.578	rs2274054	chr13:99098470	C/T	cg22223119	chr13:99095684	FARP1	-0.72	-4.92	-0.49	4.64e-6	Obesity-related traits;
SKCM	cis	rs826838	0.967	rs2892410	chr12:38990282	A/G	cg26384229	chr12:38710491	ALG10B	-1.03	-9.51	-0.73	1.13e-14	Heart rate;
SKCM	cis	rs6570726	0.577	rs441982	chr6:145842848	A/G	cg05347473	chr6:146136440	FBXO30	0.63	5.44	0.52	5.87e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1707322	0.721	rs11211149	chr1:46112218	T/C	cg03146154	chr1:46216737	IPP	0.79	5.42	0.52	6.34e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7666738	0.861	rs28821920	chr4:98962743	T/C	cg05340658	chr4:99064831	C4orf37	0.64	4.91	0.49	4.97e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9911578	0.904	rs7209253	chr17:56908987	C/T	cg12560992	chr17:57184187	TRIM37	0.94	7.55	0.65	7.01e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs875971	0.666	rs13242072	chr7:65765988	A/G	cg11987759	chr7:65425863	GUSB	0.67	5.8	0.55	1.33e-7	Aortic root size;
SKCM	cis	rs5769765	0.908	rs9616388	chr22:50313438	T/C	cg22709217	chr22:50311962	ALG12;CRELD2	-0.94	-5.91	-0.56	8.37e-8	Schizophrenia;
SKCM	cis	rs6547741	0.935	rs4666005	chr2:27855239	A/G	cg27432699	chr2:27873401	GPN1	0.73	6.74	0.61	2.43e-9	Oral cavity cancer;
SKCM	cis	rs7666738	0.723	rs35327100	chr4:98977788	C/A	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4819052	0.851	rs2838858	chr21:46681093	T/A	cg19498844	chr21:46707878	POFUT2;LOC642852	0.9	7.98	0.67	1.04e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs1153858	0.945	rs7182300	chr15:45634928	G/A	cg10760299	chr15:45669010	GATM	0.58	6.04	0.56	4.83e-8	Homoarginine levels;
SKCM	cis	rs2033711	0.818	rs4801595	chr19:58978517	G/A	cg13877915	chr19:58951672	ZNF132	0.9	8.87	0.71	1.93e-13	Uric acid clearance;
SKCM	cis	rs514406	0.679	rs12563825	chr1:53238324	G/T	cg08859206	chr1:53392774	SCP2	0.68	5.34	0.52	8.91e-7	Monocyte count;
SKCM	cis	rs36093844	0.527	rs4944555	chr11:85760616	A/G	cg25872744	chr11:85566296	CCDC83	-0.81	-4.79	-0.48	7.71e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs473651	0.935	rs559579	chr2:239339501	G/C	cg21699342	chr2:239360505	ASB1	0.55	5.29	0.51	1.07e-6	Multiple system atrophy;
SKCM	cis	rs2816062	1.000	rs2816062	chr1:18903902	G/A	cg18795169	chr1:18902165	NA	-0.74	-5.76	-0.55	1.62e-7	Urate levels in lean individuals;
SKCM	cis	rs2072510	0.722	rs2540495	chr12:96406723	G/T	cg18817487	chr12:96390143	HAL	0.43	5.68	0.54	2.25e-7	Metabolite levels (small molecules and protein measures);
SKCM	cis	rs11098499	0.866	rs12499602	chr4:120284387	T/A	cg24375607	chr4:120327624	NA	0.62	4.77	0.48	8.45e-6	Corneal astigmatism;
SKCM	cis	rs35146811	0.586	rs10267212	chr7:99595422	T/C	cg13334819	chr7:99746414	C7orf59	-0.73	-5.04	-0.5	2.9e-6	Coronary artery disease;
SKCM	cis	rs10411262	0.527	rs314672	chr19:47194254	C/T	cg14189808	chr19:47611440	ZC3H4	0.49	4.78	0.48	8.05e-6	Tonsillectomy;
SKCM	cis	rs4727027	0.704	rs12704083	chr7:148909759	G/A	cg23583168	chr7:148888333	NA	-0.77	-6.04	-0.56	4.93e-8	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs9486715	0.838	rs9486275	chr6:96901187	C/T	cg06623918	chr6:96969491	KIAA0776	0.77	6.92	0.62	1.12e-9	Headache;
SKCM	cis	rs6977660	0.714	rs7357319	chr7:19817525	A/G	cg05791153	chr7:19748676	TWISTNB	0.77	5.02	0.49	3.23e-6	Thyroid stimulating hormone;
SKCM	cis	rs6952808	0.501	rs3778999	chr7:2180885	G/A	cg02951883	chr7:2050386	MAD1L1	-0.76	-6.32	-0.58	1.52e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs854765	0.647	rs854814	chr17:18003648	G/A	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.83	6.5	0.59	6.85e-9	Total body bone mineral density;
SKCM	cis	rs2295499	0.673	rs55993221	chr4:2704910	G/T	cg19433769	chr4:2420260	ZFYVE28	0.69	4.77	0.48	8.44e-6	Cognitive ability;Cognitive ability (multi-trait analysis);Intelligence (multi-trait analysis);
SKCM	cis	rs1577917	1.000	rs10944161	chr6:86630376	A/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.66	-5.74	-0.54	1.76e-7	Response to antipsychotic treatment;
SKCM	cis	rs3741404	0.560	rs7938819	chr11:63910116	G/A	cg05555928	chr11:63887634	MACROD1	0.75	4.78	0.48	8.07e-6	Platelet count;
SKCM	cis	rs8017423	0.607	rs12885664	chr14:90845697	T/C	cg04374321	chr14:90722782	PSMC1	-0.66	-5.04	-0.5	2.98e-6	Mortality in heart failure;
SKCM	cis	rs35306767	0.903	rs12244253	chr10:889320	G/T	cg20503657	chr10:835505	NA	0.76	5.17	0.51	1.73e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs11098499	0.954	rs6848389	chr4:120402622	A/G	cg09307838	chr4:120376055	NA	0.95	7.36	0.64	1.64e-10	Corneal astigmatism;
SKCM	cis	rs4888262	0.545	rs7195499	chr16:74693973	C/G	cg01733217	chr16:74700730	RFWD3	0.83	6.36	0.58	1.25e-8	Testicular germ cell tumor;
SKCM	cis	rs362272	0.524	rs2857982	chr4:3358665	G/A	cg11471262	chr4:3318911	RGS12	0.96	11.18	0.78	7.27e-18	Serum sulfate level;
SKCM	cis	rs35096708	0.525	rs34177108	chr16:89893375	C/A	cg26513180	chr16:89883248	FANCA	-0.65	-4.8	-0.48	7.57e-6	Skin aging (microtopography measurement);
SKCM	cis	rs1707322	0.721	rs56255771	chr1:46224319	C/T	cg03146154	chr1:46216737	IPP	0.82	6.12	0.57	3.55e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs8141529	0.732	rs2347447	chr22:29179739	C/A	cg15103426	chr22:29168792	CCDC117	0.61	5.06	0.5	2.7e-6	Lymphocyte counts;
SKCM	cis	rs769267	1.000	rs8103197	chr19:19443466	C/T	cg26732615	chr19:19648335	CILP2;YJEFN3	-0.64	-5.88	-0.55	9.71e-8	Tonsillectomy;
SKCM	cis	rs9486715	0.838	rs9400034	chr6:96954566	C/T	cg06623918	chr6:96969491	KIAA0776	0.8	6.58	0.6	4.94e-9	Headache;
SKCM	cis	rs7772486	0.875	rs6570736	chr6:146388320	C/T	cg05347473	chr6:146136440	FBXO30	0.63	5.7	0.54	2.05e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs780096	0.526	rs3845686	chr2:27655447	T/G	cg05696406	chr2:27599888	SNX17	0.51	5.06	0.5	2.75e-6	Total body bone mineral density;
SKCM	cis	rs644799	1.000	rs505220	chr11:95563228	T/G	cg03916912	chr11:95522834	CEP57;FAM76B	0.88	7.53	0.65	7.59e-11	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs28595532	0.920	rs56212415	chr4:119737731	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs9309711	0.621	rs12993215	chr2:3473727	T/C	cg15506890	chr2:3487001	NA	-0.6	-4.86	-0.48	5.88e-6	Neurofibrillary tangles;
SKCM	cis	rs4727027	0.866	rs2373437	chr7:148779032	T/C	cg23583168	chr7:148888333	NA	-0.82	-6.45	-0.59	8.44e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs7772486	0.875	rs2328712	chr6:146344563	T/C	cg23711669	chr6:146136114	FBXO30	0.77	7.16	0.63	3.9e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1348850	0.958	rs10497501	chr2:178462299	C/G	cg02961200	chr2:178257176	LOC100130691;AGPS	0.84	6.61	0.6	4.29e-9	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs4132509	0.793	rs4478795	chr1:243844576	C/T	cg21452805	chr1:244014465	NA	0.88	4.79	0.48	7.94e-6	RR interval (heart rate);
SKCM	cis	rs1003719	0.762	rs9975361	chr21:38450025	T/C	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs362296	0.615	rs34030762	chr4:3255736	C/A	cg16987761	chr4:3318072	RGS12	-0.69	-5.79	-0.55	1.41e-7	Parental longevity (mother's age at death);
SKCM	cis	rs875971	1.000	rs4718307	chr7:65610988	A/G	cg18876405	chr7:65276391	NA	-0.68	-6.85	-0.61	1.54e-9	Aortic root size;
SKCM	cis	rs11690935	1.000	rs34542126	chr2:172542705	C/T	cg13550731	chr2:172543902	DYNC1I2	0.98	8.89	0.71	1.79e-13	Schizophrenia;
SKCM	cis	rs769267	0.965	rs10419245	chr19:19383755	G/A	cg26732615	chr19:19648335	CILP2;YJEFN3	0.63	5.75	0.55	1.65e-7	Tonsillectomy;
SKCM	cis	rs514406	0.893	rs1242330	chr1:53396842	T/G	cg08859206	chr1:53392774	SCP2	-0.62	-5.01	-0.49	3.28e-6	Monocyte count;
SKCM	cis	rs6547741	1.000	rs4666007	chr2:27856495	T/C	cg27432699	chr2:27873401	GPN1	0.73	6.65	0.6	3.7e-9	Oral cavity cancer;
SKCM	cis	rs7937682	0.961	rs7106104	chr11:111635655	T/C	cg09085632	chr11:111637200	PPP2R1B	1.11	13.76	0.84	1.44e-22	Primary sclerosing cholangitis;
SKCM	cis	rs362272	0.524	rs2749781	chr4:3346617	T/C	cg00764545	chr4:3318001	RGS12	0.99	13.61	0.84	2.68e-22	Serum sulfate level;
SKCM	cis	rs2952156	0.920	rs1018246	chr17:37835240	C/T	cg00129232	chr17:37814104	STARD3	-0.71	-6.04	-0.56	4.96e-8	Asthma;
SKCM	cis	rs2658782	0.654	rs2248531	chr11:93255363	G/T	cg15737290	chr11:93063684	CCDC67	0.8	5.61	0.54	2.98e-7	Pulmonary function decline;
SKCM	cis	rs459571	0.834	rs379417	chr9:136890704	G/A	cg13789015	chr9:136890014	NCRNA00094	0.77	6.63	0.6	3.95e-9	Platelet distribution width;
SKCM	cis	rs3780486	0.846	rs10758192	chr9:33131651	G/A	cg13443165	chr9:33130375	B4GALT1	-0.55	-4.99	-0.49	3.65e-6	IgG glycosylation;
SKCM	cis	rs3771570	0.901	rs4675944	chr2:242430170	C/T	cg07612300	chr2:242033426	MTERFD2;SNED1	0.81	5.01	0.49	3.31e-6	Prostate cancer;
SKCM	cis	rs1707322	0.721	rs7520123	chr1:46235219	C/G	cg03146154	chr1:46216737	IPP	0.82	6.17	0.57	2.79e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7959452	0.535	rs2305641	chr12:69646914	C/T	cg20891283	chr12:69753455	YEATS4	0.75	6.81	0.61	1.77e-9	Blood protein levels;
SKCM	cis	rs9636593	0.649	rs1292750	chr21:16116770	T/C	cg13882606	chr21:17101011	USP25	0.65	5.06	0.5	2.75e-6	Pursuit maintenance gain;
SKCM	cis	rs7523273	0.606	rs2724380	chr1:207949682	C/T	cg22525895	chr1:207977042	MIR29B2	0.81	7.08	0.63	5.47e-10	Schizophrenia;
SKCM	cis	rs514406	0.505	rs437954	chr1:53173321	C/G	cg16325326	chr1:53192061	ZYG11B	0.89	10.06	0.75	9.55e-16	Monocyte count;
SKCM	cis	rs11792861	0.816	rs11790105	chr9:111731785	T/C	cg14432460	chr9:111696404	IKBKAP;C9orf6	0.67	4.82	0.48	6.93e-6	Menarche (age at onset);
SKCM	cis	rs1405130	0.835	rs2892049	chr2:235571903	C/A	cg17841421	chr2:235704848	NA	-0.57	-4.95	-0.49	4.14e-6	Coronary artery disease;
SKCM	cis	rs6430585	0.583	rs59213715	chr2:136646582	A/C	cg07169764	chr2:136633963	MCM6	1.34	11.82	0.8	4.68e-19	Corneal structure;
SKCM	cis	rs933688	1.000	rs10045280	chr5:90717675	T/A	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.1	8.5	0.69	1.01e-12	Smoking behavior;
SKCM	cis	rs870825	0.616	rs7678849	chr4:185648868	T/C	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs1799949	1.000	rs11651341	chr17:41428061	T/C	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.2	-0.57	2.51e-8	Menopause (age at onset);
SKCM	cis	rs4900538	0.927	rs1190547	chr14:102905087	G/C	cg18135206	chr14:102964638	TECPR2	-0.78	-6.37	-0.59	1.2e-8	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs478304	0.654	rs10896029	chr11:65452952	C/T	cg27068330	chr11:65405492	SIPA1	-0.88	-7.54	-0.65	7.28e-11	Acne (severe);
SKCM	cis	rs3785574	0.962	rs2727324	chr17:61922102	G/C	cg06601766	chr17:61851465	DDX42;CCDC47	0.73	5.38	0.52	7.7e-7	Height;
SKCM	cis	rs9790314	0.936	rs466399	chr3:161091194	G/T	cg03342759	chr3:160939853	NMD3	-0.72	-7.89	-0.67	1.53e-11	Morning vs. evening chronotype;
SKCM	cis	rs8103278	0.507	rs10401971	chr19:46261982	C/T	cg11657440	chr19:46296263	DMWD	1.06	10.49	0.77	1.44e-16	Coronary artery disease;
SKCM	cis	rs6952808	0.501	rs4721429	chr7:2171704	T/C	cg21782813	chr7:2030301	MAD1L1	0.52	5.36	0.52	8.21e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs7772486	0.686	rs857879	chr6:145974043	C/A	cg05347473	chr6:146136440	FBXO30	-0.6	-5.31	-0.52	1e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs72634258	0.554	rs17374781	chr1:7919363	A/G	cg26816564	chr1:7831052	VAMP3	-0.68	-5.27	-0.51	1.16e-6	Inflammatory bowel disease;
SKCM	cis	rs2739330	0.760	rs5751761	chr22:24243736	A/G	cg24846343	chr22:24311635	DDTL	-0.62	-5.62	-0.54	2.79e-7	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs763014	0.898	rs4984895	chr16:623238	T/C	cg00908189	chr16:619842	PIGQ	0.81	7.2	0.63	3.3e-10	Height;
SKCM	cis	rs9715521	0.677	rs62301200	chr4:59855179	G/A	cg11281224	chr4:60001000	NA	-0.61	-4.82	-0.48	6.94e-6	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs6951245	1.000	rs74652290	chr7:1090109	G/A	cg24642844	chr7:1081250	C7orf50	-0.94	-6.32	-0.58	1.48e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs951366	0.789	rs823137	chr1:205738302	C/T	cg14893161	chr1:205819251	PM20D1	1.06	10.5	0.77	1.41e-16	Menarche (age at onset);
SKCM	cis	rs1568889	1.000	rs35697240	chr11:28287342	G/C	cg06544937	chr11:28130018	METT5D1;KIF18A	0.86	6.59	0.6	4.73e-9	Bipolar disorder;
SKCM	cis	rs34929064	0.881	rs7802442	chr7:22736446	A/C	cg00394316	chr7:22539822	MGC87042	0.49	4.79	0.48	7.78e-6	Major depression and alcohol dependence;
SKCM	cis	rs17065868	1.000	rs61949807	chr13:45054418	T/G	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs2658782	0.738	rs2605628	chr11:93261560	C/A	cg15737290	chr11:93063684	CCDC67	0.73	4.78	0.48	7.96e-6	Pulmonary function decline;
SKCM	cis	rs10489202	1.000	rs7535138	chr1:167931462	T/G	cg24449463	chr1:168025552	DCAF6	-0.76	-5.87	-0.55	1.02e-7	Schizophrenia;
SKCM	cis	rs9796	0.654	rs2947489	chr15:41459576	T/A	cg18705301	chr15:41695430	NDUFAF1	0.78	5.89	0.55	9.23e-8	Menopause (age at onset);
SKCM	cis	rs11098499	0.779	rs72918579	chr4:120333222	G/C	cg09307838	chr4:120376055	NA	0.97	7.87	0.67	1.7e-11	Corneal astigmatism;
SKCM	cis	rs7618915	1.000	rs7618915	chr3:52279594	G/A	cg18404041	chr3:52824283	ITIH1	-0.6	-5.45	-0.53	5.65e-7	Bipolar disorder;
SKCM	cis	rs1552244	1.000	rs55882090	chr3:10139082	C/T	cg02579736	chr3:10068473	FANCD2;CIDECP	1.23	6.92	0.62	1.13e-9	Alzheimer's disease;
SKCM	cis	rs875971	0.964	rs12668936	chr7:65914404	C/T	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs1348850	0.560	rs13019660	chr2:178498214	C/T	cg27490568	chr2:178487706	NA	0.78	5.74	0.55	1.7e-7	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs34375054	0.672	rs10400509	chr12:125592173	T/C	cg25124228	chr12:125621409	AACS	-0.63	-4.91	-0.49	4.97e-6	Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs12497850	0.931	rs7628719	chr3:48995487	C/T	cg07636037	chr3:49044803	WDR6	1.02	11.0	0.78	1.56e-17	Parkinson's disease;
SKCM	cis	rs61776719	0.806	rs28493395	chr1:38400558	C/T	cg12658694	chr1:38397304	INPP5B	0.71	6.3	0.58	1.6e-8	Coronary artery disease;
SKCM	cis	rs9486715	0.838	rs9386576	chr6:96954717	C/T	cg06623918	chr6:96969491	KIAA0776	0.8	6.58	0.6	4.94e-9	Headache;
SKCM	cis	rs62238980	0.614	rs1475997	chr22:32465025	G/A	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs6977660	1.000	rs10279525	chr7:19822305	C/T	cg07541023	chr7:19748670	TWISTNB	0.7	4.82	0.48	6.98e-6	Thyroid stimulating hormone;
SKCM	cis	rs9399135	0.967	rs6915770	chr6:135369214	G/A	cg24558204	chr6:135376177	HBS1L	0.58	5.05	0.5	2.86e-6	Red blood cell count;
SKCM	cis	rs951366	0.617	rs823080	chr1:205789282	G/A	cg11965913	chr1:205819406	PM20D1	1.04	14.71	0.86	3.29e-24	Menarche (age at onset);
SKCM	cis	rs1552244	1.000	rs7637888	chr3:10080722	T/C	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs875971	0.522	rs1880556	chr7:65432544	T/C	cg11987759	chr7:65425863	GUSB	-0.75	-6.72	-0.61	2.68e-9	Aortic root size;
SKCM	cis	rs55962025	0.711	rs916171	chr4:3216815	C/G	cg09735869	chr4:3319127	RGS12	0.66	5.33	0.52	9.4e-7	Parental longevity (mother's age at death);
SKCM	cis	rs344364	0.511	rs12596510	chr16:1949480	G/A	cg26897989	chr16:1907736	C16orf73	-0.69	-7.13	-0.63	4.45e-10	Glomerular filtration rate in chronic kidney disease;
SKCM	cis	rs933688	0.877	rs1477349	chr5:90707773	G/A	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.02	7.81	0.66	2.22e-11	Smoking behavior;
SKCM	cis	rs7659604	0.540	rs7698889	chr4:122671324	G/T	cg19671926	chr4:122722719	EXOSC9	0.76	6.16	0.57	3.02e-8	Type 2 diabetes;
SKCM	cis	rs17685	0.884	rs6978677	chr7:75636240	C/T	cg16684958	chr7:75615977	POR	0.64	6.24	0.58	2.09e-8	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs3859192	0.561	rs9916158	chr17:38182229	G/T	cg17467752	chr17:38218738	THRA	-0.75	-6.33	-0.58	1.41e-8	White blood cell count;
SKCM	cis	rs1218582	0.772	rs10796935	chr1:154891363	G/T	cg09359103	chr1:154839909	KCNN3	-0.57	-5.3	-0.51	1.05e-6	Prostate cancer;
SKCM	cis	rs2842992	0.662	rs2273825	chr6:160211424	A/C	cg16489826	chr6:160211363	TCP1;MRPL18	0.71	5.51	0.53	4.52e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs2836974	0.602	rs2836987	chr21:40706594	C/T	cg17971929	chr21:40555470	PSMG1	-0.71	-6.15	-0.57	3.14e-8	Cognitive function;
SKCM	cis	rs9359856	0.510	rs74437492	chr6:90338728	A/G	cg13799429	chr6:90582589	CASP8AP2	-0.82	-5.07	-0.5	2.64e-6	Bipolar disorder;
SKCM	cis	rs35306767	0.859	rs11817793	chr10:878895	C/T	cg26597838	chr10:835615	NA	0.77	5.31	0.51	1.02e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs6545883	0.894	rs7572603	chr2:61552145	C/G	cg15711740	chr2:61764176	XPO1	0.68	4.82	0.48	6.94e-6	Tuberculosis;
SKCM	cis	rs67311347	0.824	rs73073561	chr3:40357298	G/T	cg00091569	chr3:40428383	ENTPD3	0.67	5.66	0.54	2.45e-7	Renal cell carcinoma;
SKCM	cis	rs748404	0.650	rs518261	chr15:43573429	A/T	cg02155558	chr15:43621948	ADAL;LCMT2	0.72	6.07	0.57	4.3e-8	Lung cancer;
SKCM	cis	rs9896933	0.775	rs615630	chr17:80730527	T/C	cg20578329	chr17:80767326	TBCD	0.99	6.65	0.6	3.62e-9	Bone mineral accretion in asthma (oral corticosteroid dose interaction);
SKCM	cis	rs1799949	0.965	rs11080034	chr17:41443014	T/C	cg05368731	chr17:41323189	NBR1	0.8	6.42	0.59	9.67e-9	Menopause (age at onset);
SKCM	cis	rs28595532	0.640	rs28649792	chr4:119366463	A/C	cg21605333	chr4:119757512	SEC24D	0.94	4.98	0.49	3.75e-6	Cannabis dependence symptom count;
SKCM	cis	rs1552244	0.882	rs61429272	chr3:10037320	G/C	cg02579736	chr3:10068473	FANCD2;CIDECP	0.94	4.84	0.48	6.49e-6	Alzheimer's disease;
SKCM	cis	rs2980439	0.818	rs2945249	chr8:8094726	G/A	cg08975724	chr8:8085496	FLJ10661	0.8	6.18	0.57	2.68e-8	Neuroticism;
SKCM	cis	rs1003719	0.788	rs2006941	chr21:38467616	C/A	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs478304	0.654	rs7934036	chr11:65451020	G/T	cg17480646	chr11:65405466	SIPA1	-0.66	-4.93	-0.49	4.47e-6	Acne (severe);
SKCM	cis	rs8072100	1.000	rs8065669	chr17:45724996	G/A	cg08085267	chr17:45401833	C17orf57	-0.63	-5.86	-0.55	1.06e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs9325144	0.505	rs10785560	chr12:38636622	C/T	cg26384229	chr12:38710491	ALG10B	0.82	7.07	0.63	5.7e-10	Morning vs. evening chronotype;
SKCM	cis	rs11098499	0.909	rs79704848	chr4:120309351	T/A	cg24375607	chr4:120327624	NA	0.65	4.97	0.49	3.87e-6	Corneal astigmatism;
SKCM	cis	rs9902453	0.817	rs2729435	chr17:28121532	T/C	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.81	-5.64	-0.54	2.57e-7	Coffee consumption (cups per day);
SKCM	cis	rs3087591	0.960	rs9898664	chr17:29567152	T/C	cg24425628	chr17:29625626	OMG;NF1	-0.63	-4.95	-0.49	4.23e-6	Hip circumference;
SKCM	cis	rs6723226	0.698	rs13409142	chr2:32666137	C/T	cg02381751	chr2:32503542	YIPF4	0.81	6.06	0.57	4.46e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs2836974	0.932	rs6517526	chr21:40581530	T/C	cg11644478	chr21:40555479	PSMG1	0.97	10.08	0.75	8.76e-16	Cognitive function;
SKCM	cis	rs9910055	0.614	rs12944572	chr17:42245241	T/C	cg19774624	chr17:42201019	HDAC5	-0.89	-8.19	-0.68	3.96e-12	Total body bone mineral density;
SKCM	cis	rs2153535	0.580	rs9406172	chr6:8515464	T/A	cg07606381	chr6:8435919	SLC35B3	0.87	6.38	0.59	1.17e-8	Motion sickness;
SKCM	cis	rs2228479	1.000	rs2228479	chr16:89985940	G/A	cg06558623	chr16:89946397	TCF25	1.08	5.4	0.52	7.07e-7	Skin colour saturation;
SKCM	cis	rs1348850	0.914	rs2364854	chr2:178378452	T/A	cg02961200	chr2:178257176	LOC100130691;AGPS	0.85	6.54	0.6	5.82e-9	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs10905065	0.866	rs10795547	chr10:5827074	A/G	cg09234995	chr10:5726438	C10orf18	0.67	5.69	0.54	2.13e-7	Menopause (age at onset);
SKCM	trans	rs1814175	0.817	rs12287396	chr11:49819798	G/C	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs7659604	0.689	rs4283687	chr4:122663460	A/G	cg19748678	chr4:122722346	EXOSC9	0.69	5.37	0.52	7.99e-7	Type 2 diabetes;
SKCM	cis	rs1395	0.925	rs1659696	chr2:27407831	G/A	cg14242246	chr2:27434262	C2orf28;SLC5A6	-0.47	-4.77	-0.48	8.27e-6	Blood metabolite levels;
SKCM	cis	rs7772486	0.790	rs9485024	chr6:146142487	A/G	cg23711669	chr6:146136114	FBXO30	-0.83	-7.86	-0.66	1.73e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs919433	0.963	rs10153881	chr2:198171098	T/C	cg04278110	chr2:198063759	ANKRD44	-0.69	-4.8	-0.48	7.58e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs4889855	0.511	rs9908700	chr17:78466594	A/G	cg00066239	chr17:78472159	NA	-0.57	-5.03	-0.5	3.02e-6	Fractional excretion of uric acid;
SKCM	cis	rs899997	0.954	rs11856441	chr15:79030526	T/G	cg04896959	chr15:78267971	NA	0.61	5.2	0.51	1.59e-6	Coronary artery disease or large artery stroke;
SKCM	cis	rs7666738	0.830	rs3846443	chr4:99032666	G/A	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9911578	1.000	rs4793952	chr17:56608465	C/T	cg12560992	chr17:57184187	TRIM37	-0.94	-7.55	-0.65	7.01e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs8072100	0.817	rs9905581	chr17:45547185	C/T	cg25173405	chr17:45401733	C17orf57	-0.58	-4.77	-0.48	8.26e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs6500395	0.962	rs9927888	chr16:48557764	A/T	cg04672837	chr16:48644449	N4BP1	0.66	5.45	0.53	5.72e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs9435341	0.965	rs1730864	chr1:107607810	C/T	cg09367891	chr1:107599246	PRMT6	-0.79	-6.56	-0.6	5.23e-9	Facial morphology (factor 21, depth of nasal alae);
SKCM	cis	rs1801516	1.000	rs12278954	chr11:108328952	C/A	cg03165700	chr11:108093220	ATM;NPAT	-1.18	-5.35	-0.52	8.48e-7	Melanoma;
SKCM	cis	rs854765	0.583	rs4244602	chr17:17841456	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.93	7.3	0.64	2.06e-10	Total body bone mineral density;
SKCM	cis	rs1814175	0.500	rs1825677	chr11:49233099	T/G	cg21546286	chr11:48923668	NA	-0.48	-4.81	-0.48	7.3e-6	Height;
SKCM	cis	rs9543976	1.000	rs7339146	chr13:76173719	G/A	cg16409306	chr13:76195284	LMO7	-0.84	-4.79	-0.48	7.87e-6	Diabetic retinopathy;
SKCM	cis	rs561341	0.739	rs7213369	chr17:30211878	G/A	cg00745463	chr17:30367425	LRRC37B	0.94	5.95	0.56	7.18e-8	Hip circumference adjusted for BMI;
SKCM	cis	rs12477438	0.508	rs2516832	chr2:99771268	G/C	cg26064155	chr2:99771622	LIPT1;TSGA10	1.02	9.73	0.74	4.23e-15	Chronic sinus infection;
SKCM	cis	rs854765	0.647	rs741782	chr17:18019712	T/C	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.88	6.66	0.6	3.51e-9	Total body bone mineral density;
SKCM	cis	rs2354432	0.943	rs6660219	chr1:146691404	A/T	cg25205988	chr1:146714368	CHD1L	1.3	8.06	0.67	7.12e-12	Mitochondrial DNA levels;
SKCM	cis	rs7772486	0.754	rs857881	chr6:145970793	C/A	cg05347473	chr6:146136440	FBXO30	-0.67	-6.11	-0.57	3.68e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6547631	0.622	rs10180547	chr2:85926305	G/A	cg24620635	chr2:85921963	GNLY	0.9	6.65	0.6	3.58e-9	Blood protein levels;
SKCM	cis	rs870825	0.616	rs4444873	chr4:185628406	A/G	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs28386778	0.897	rs4968597	chr17:61805747	G/A	cg06873352	chr17:61820015	STRADA	0.75	6.24	0.58	2.1e-8	Prudent dietary pattern;
SKCM	cis	rs12142240	0.698	rs17357759	chr1:46832534	A/G	cg10495392	chr1:46806563	NSUN4	0.76	5.77	0.55	1.54e-7	Menopause (age at onset);
SKCM	cis	rs9916302	0.904	rs4511574	chr17:37532916	A/G	cg07936489	chr17:37558343	FBXL20	-0.87	-7.02	-0.62	7.09e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs7772486	0.806	rs2265477	chr6:146212338	T/C	cg05347473	chr6:146136440	FBXO30	0.55	5.13	0.5	2.07e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2204008	0.744	rs11514073	chr12:38399553	A/C	cg26384229	chr12:38710491	ALG10B	0.88	6.86	0.61	1.46e-9	Bladder cancer;
SKCM	cis	rs3847687	1.000	rs3847687	chr12:131525053	C/T	cg13586425	chr12:131519906	GPR133	-0.52	-5.82	-0.55	1.23e-7	Longevity;
SKCM	cis	rs860295	0.665	rs12079134	chr1:155466784	C/G	cg02153340	chr1:155202674	NA	-0.81	-5.86	-0.55	1.03e-7	Body mass index;
SKCM	cis	rs9902453	0.765	rs2467334	chr17:28135508	A/C	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.83	-6.37	-0.59	1.2e-8	Coffee consumption (cups per day);
SKCM	cis	rs748404	0.676	rs4401024	chr15:43650335	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	0.84	6.38	0.59	1.17e-8	Lung cancer;
SKCM	cis	rs1348850	0.519	rs1527407	chr2:178525630	T/G	cg22681709	chr2:178499509	PDE11A	-0.61	-5.27	-0.51	1.17e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs7786877	0.723	rs6969697	chr7:100209604	G/A	cg20848291	chr7:100343083	ZAN	-0.66	-4.91	-0.49	4.9e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs951366	0.764	rs708724	chr1:205743663	A/C	cg07157834	chr1:205819609	PM20D1	0.82	7.37	0.64	1.55e-10	Menarche (age at onset);
SKCM	cis	rs873946	0.648	rs1548281	chr10:134552982	C/T	cg18305652	chr10:134549665	INPP5A	0.59	5.93	0.56	7.74e-8	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs7927771	0.690	rs35496532	chr11:47450338	C/T	cg05585544	chr11:47624801	NA	-0.58	-5.19	-0.51	1.61e-6	Subjective well-being;
SKCM	cis	rs2404602	0.692	rs58973160	chr15:77000342	T/C	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.97e-7	Blood metabolite levels;
SKCM	cis	rs2180341	0.618	rs11961994	chr6:127649350	A/G	cg24812749	chr6:127587940	RNF146	-0.6	-4.93	-0.49	4.61e-6	Breast cancer;
SKCM	cis	rs769267	0.929	rs34538000	chr19:19481379	G/T	cg03709012	chr19:19516395	GATAD2A	-0.89	-8.48	-0.69	1.1e-12	Tonsillectomy;
SKCM	cis	rs2836974	0.897	rs13339986	chr21:40605982	T/C	cg11644478	chr21:40555479	PSMG1	0.97	9.95	0.75	1.6e-15	Cognitive function;
SKCM	cis	rs909674	0.514	rs7423	chr22:39781429	C/T	cg24399712	chr22:39784796	NA	-0.62	-5.41	-0.52	6.75e-7	IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis);IgG glycosylation;IgG digalactosylation phenotypes (multivariate analysis);IgG sialylation phenotypes (multivariate analysis);IgG monogalactosylation phenotypes (multivariate analysis);IgG fucosylation phenotypes (multivariate analysis);IgG N-glycosylation phenotypes (multivariate analysis);IgG disialylation phenotypes (multivariate analysis);IgG galactosylation phenotypes (multivariate analysis);Post bronchodilator FEV1;
SKCM	cis	rs7829975	0.840	rs572366	chr8:8578794	A/T	cg15556689	chr8:8085844	FLJ10661	0.75	6.77	0.61	2.12e-9	Mood instability;
SKCM	cis	rs875971	0.522	rs1968127	chr7:66056803	C/T	cg11764359	chr7:65958608	NA	-0.83	-6.29	-0.58	1.71e-8	Aortic root size;
SKCM	cis	rs3741404	1.000	rs3741404	chr11:63999240	G/C	cg19465662	chr11:63993652	NUDT22;TRPT1	0.82	5.76	0.55	1.62e-7	Platelet count;
SKCM	cis	rs12824058	0.831	rs12300308	chr12:130813825	G/A	cg24838063	chr12:130822603	PIWIL1	0.78	6.99	0.62	8.22e-10	Menopause (age at onset);
SKCM	cis	rs873946	0.586	rs12251911	chr10:134570595	A/G	cg18305652	chr10:134549665	INPP5A	0.58	5.57	0.53	3.49e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs8067545	0.611	rs12938355	chr17:20195217	A/G	cg13482628	chr17:19912719	NA	-0.68	-5.77	-0.55	1.51e-7	Schizophrenia;
SKCM	cis	rs7296418	0.663	rs11057276	chr12:123820397	C/T	cg05973401	chr12:123451056	ABCB9	-0.75	-5.74	-0.54	1.74e-7	Platelet count;
SKCM	cis	rs7826238	0.601	rs2979206	chr8:8345581	G/C	cg06636001	chr8:8085503	FLJ10661	0.92	8.4	0.69	1.56e-12	Systolic blood pressure;
SKCM	cis	rs4819052	0.679	rs2255761	chr21:46683622	A/G	cg19498844	chr21:46707878	POFUT2;LOC642852	0.81	6.83	0.61	1.69e-9	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs2228479	0.850	rs11649510	chr16:89851004	A/G	cg06558623	chr16:89946397	TCF25	1.06	4.86	0.48	5.99e-6	Skin colour saturation;
SKCM	cis	rs4724125	0.782	rs12673351	chr7:42702214	T/C	cg09407816	chr7:42972088	MRPL32;PSMA2	0.81	5.13	0.5	2.03e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1635	0.655	rs16893973	chr6:28302113	C/T	cg15743358	chr6:28303923	ZNF323	-1.27	-5.15	-0.5	1.92e-6	Schizophrenia;
SKCM	cis	rs4819052	0.851	rs2838865	chr21:46712299	C/T	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.21	0.51	1.5e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7772486	0.790	rs2253768	chr6:146199922	A/G	cg05347473	chr6:146136440	FBXO30	0.58	5.45	0.53	5.72e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9300255	0.722	rs34997336	chr12:123829116	G/A	cg05973401	chr12:123451056	ABCB9	-0.82	-5.72	-0.54	1.92e-7	Neutrophil percentage of white cells;
SKCM	cis	rs1160297	0.576	rs1376569	chr2:53087260	C/T	cg07782112	chr2:53107842	NA	0.58	6.01	0.56	5.59e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs651907	0.557	rs34181125	chr3:101490278	A/G	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.81	7.03	0.62	6.91e-10	Colorectal cancer;
SKCM	cis	rs2832191	0.765	rs2832162	chr21:30461808	G/A	cg24692254	chr21:30365293	RNF160	1.02	8.89	0.71	1.75e-13	Dental caries;
SKCM	cis	rs12926788	0.689	rs1862450	chr16:24856775	A/G	cg04756594	chr16:24857601	SLC5A11	-0.62	-4.86	-0.48	6.04e-6	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs7208859	0.623	rs9897728	chr17:29108804	A/G	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs3768617	0.528	rs10737242	chr1:183098249	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.79	7.4	0.64	1.37e-10	Fuchs's corneal dystrophy;
SKCM	cis	rs732765	0.657	rs67520590	chr14:75235457	C/T	cg25946216	chr14:74253857	C14orf43	-0.93	-5.16	-0.5	1.86e-6	Non-small cell lung cancer;
SKCM	cis	rs6570726	0.935	rs407721	chr6:145871354	A/C	cg23711669	chr6:146136114	FBXO30	0.71	6.74	0.61	2.47e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9640161	0.789	rs34311995	chr7:150059255	T/C	cg10018233	chr7:150070692	REPIN1	0.76	6.83	0.61	1.64e-9	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs11719291	0.833	rs11709246	chr3:48859498	G/A	cg00383909	chr3:49044727	WDR6	0.95	5.43	0.52	6.25e-7	Cognitive function;
SKCM	cis	rs13010713	0.840	rs4441425	chr2:182058490	C/T	cg21995919	chr2:182322279	ITGA4	-0.53	-5.12	-0.5	2.18e-6	Celiac disease;
SKCM	cis	rs17376456	0.877	rs12153506	chr5:93360953	T/G	cg25358565	chr5:93447407	FAM172A	1.19	7.78	0.66	2.52e-11	Diabetic retinopathy;
SKCM	cis	rs875971	0.522	rs4718285	chr7:65292005	A/G	cg11987759	chr7:65425863	GUSB	-0.75	-6.42	-0.59	9.94e-9	Aortic root size;
SKCM	cis	rs867186	1.000	rs11908100	chr20:33729479	G/A	cg04194272	chr20:33683537	NA	-1.11	-6.01	-0.56	5.7e-8	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs9381040	0.701	rs722442	chr6:41089681	A/G	cg04346459	chr6:41068666	NFYA;LOC221442	-0.72	-5.13	-0.5	2.05e-6	Alzheimer's disease (late onset);
SKCM	cis	rs8077889	0.871	rs72836549	chr17:41904360	G/T	cg26893861	chr17:41843967	DUSP3	1.15	7.34	0.64	1.79e-10	Triglycerides;
SKCM	trans	rs3780486	0.846	rs10124479	chr9:33136233	T/G	cg04842962	chr6:43655489	MRPS18A	1.03	10.87	0.78	2.78e-17	IgG glycosylation;
SKCM	cis	rs12142240	0.698	rs7515284	chr1:46809419	A/G	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs4774899	1.000	rs12916478	chr15:57502856	C/T	cg01857019	chr15:57210107	LOC145783;TCF12	0.54	4.88	0.48	5.51e-6	Urinary tract infection frequency;
SKCM	cis	rs9300255	0.620	rs1716173	chr12:123660721	A/T	cg05973401	chr12:123451056	ABCB9	0.83	5.14	0.5	2.01e-6	Neutrophil percentage of white cells;
SKCM	cis	rs801193	0.805	rs12532355	chr7:66070584	C/G	cg11987759	chr7:65425863	GUSB	0.69	6.01	0.56	5.68e-8	Aortic root size;
SKCM	trans	rs1814175	0.645	rs7115592	chr11:50013243	A/G	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs10927875	0.632	rs4661666	chr1:16162471	C/A	cg21385522	chr1:16154831	NA	-0.99	-12.29	-0.81	6.21e-20	Dilated cardiomyopathy;
SKCM	cis	rs7937682	1.000	rs7937682	chr11:111579939	C/G	cg09085632	chr11:111637200	PPP2R1B	-1.06	-12.99	-0.83	3.33e-21	Primary sclerosing cholangitis;
SKCM	cis	rs2120019	0.938	rs1867150	chr15:75321139	T/C	cg09165964	chr15:75287851	SCAMP5	-0.85	-8.74	-0.7	3.44e-13	Blood trace element (Zn levels);
SKCM	cis	rs7618915	0.547	rs34173654	chr3:52634605	T/C	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs936229	0.861	rs7162232	chr15:75115895	G/A	cg14664628	chr15:75095509	CSK	-1.16	-10.49	-0.77	1.43e-16	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin);
SKCM	cis	rs6495122	0.644	rs11630087	chr15:75261673	G/T	cg17294928	chr15:75287854	SCAMP5	0.7	5.35	0.52	8.66e-7	Caffeine consumption;Diastolic blood pressure;Coffee consumption;
SKCM	cis	rs4891159	0.790	rs689885	chr18:74110563	T/G	cg24786174	chr18:74118243	ZNF516	0.73	7.02	0.62	7.24e-10	Longevity;
SKCM	cis	rs2811415	0.597	rs9813812	chr3:127791936	G/T	cg09089421	chr3:127803668	RUVBL1	1.0	8.69	0.7	4.4e-13	Lung function (FEV1/FVC);
SKCM	cis	rs2811415	0.597	rs6802633	chr3:127774722	A/G	cg09089421	chr3:127803668	RUVBL1	1.02	8.85	0.71	2.14e-13	Lung function (FEV1/FVC);
SKCM	cis	rs875971	0.929	rs12673810	chr7:65923853	T/A	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs898097	0.607	rs2199111	chr17:80823203	A/G	cg15664640	chr17:80829946	TBCD	-0.61	-4.9	-0.48	5.17e-6	Breast cancer;
SKCM	cis	rs2795502	0.882	rs2744095	chr10:43337949	A/T	cg20628663	chr10:43360327	NA	-0.59	-5.26	-0.51	1.21e-6	Blood protein levels;
SKCM	cis	rs28595532	0.920	rs116105567	chr4:119746204	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs4561483	0.831	rs33621	chr16:12008513	G/A	cg08843971	chr16:11963173	GSPT1	-0.65	-4.86	-0.48	5.96e-6	Testicular germ cell tumor;
SKCM	cis	rs6951245	1.000	rs78143408	chr7:1096846	G/A	cg03188948	chr7:1209495	NA	1.13	6.27	0.58	1.89e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs875971	1.000	rs35149210	chr7:65929925	T/C	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs7959452	0.570	rs10878964	chr12:69720691	T/G	cg20891283	chr12:69753455	YEATS4	0.8	7.6	0.65	5.59e-11	Blood protein levels;
SKCM	cis	rs7618501	0.669	rs3774758	chr3:49938227	C/G	cg24110177	chr3:50126178	RBM5	-0.63	-5.16	-0.5	1.86e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2732480	0.577	rs2732481	chr12:48736985	T/G	cg21348975	chr12:48724119	NA	-0.62	-5.32	-0.52	9.82e-7	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs6951245	1.000	rs74887741	chr7:1110658	G/T	cg24642844	chr7:1081250	C7orf50	-0.93	-6.22	-0.58	2.28e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7772486	0.790	rs9376971	chr6:146259505	C/T	cg05347473	chr6:146136440	FBXO30	-0.55	-4.97	-0.49	3.86e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs55962025	0.883	rs3755883	chr4:3223250	A/G	cg21096898	chr4:3318625	RGS12	-0.66	-4.89	-0.48	5.33e-6	Parental longevity (mother's age at death);
SKCM	cis	rs1348850	0.537	rs3770010	chr2:178537796	T/C	cg02961200	chr2:178257176	LOC100130691;AGPS	0.66	4.82	0.48	6.84e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs875971	0.522	rs1880556	chr7:65432544	T/C	cg18876405	chr7:65276391	NA	0.87	8.12	0.68	5.54e-12	Aortic root size;
SKCM	trans	rs10506458	1.000	rs11174759	chr12:63444363	A/T	cg03429785	chr15:59498649	MYO1E;LDHAL6B	-1.38	-7.54	-0.65	7.13e-11	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs6736997	0.903	rs4491680	chr2:235622041	C/T	cg17841421	chr2:235704848	NA	0.59	4.78	0.48	8e-6	Pancreatic cancer;
SKCM	cis	rs7954584	0.635	rs7313252	chr12:122347600	G/A	cg21171335	chr12:122356390	WDR66	0.45	4.95	0.49	4.18e-6	Mean corpuscular volume;
SKCM	cis	rs10503709	0.829	rs1481009	chr8:21447209	A/G	cg23716449	chr8:21608280	GFRA2	0.52	5.32	0.52	9.7e-7	Blood protein levels;
SKCM	cis	rs7598759	0.679	rs6437018	chr2:232327691	A/C	cg19187155	chr2:232395269	NMUR1	0.62	4.98	0.49	3.8e-6	Noise-induced hearing loss;
SKCM	cis	rs6570726	0.791	rs6570693	chr6:145910841	C/T	cg23711669	chr6:146136114	FBXO30	0.88	8.39	0.69	1.67e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs12541335	0.639	rs11779277	chr8:22200683	C/T	cg26039829	chr8:22132926	PIWIL2	0.64	5.64	0.54	2.61e-7	Hypertriglyceridemia;
SKCM	cis	rs208515	0.525	rs12204452	chr6:66680325	C/T	cg07460842	chr6:66804631	NA	0.93	6.34	0.58	1.35e-8	Exhaled nitric oxide levels;
SKCM	cis	rs1044826	0.597	rs6803593	chr3:139193987	T/C	cg15131784	chr3:139108705	COPB2	0.66	4.96	0.49	4.09e-6	Obesity-related traits;
SKCM	cis	rs12711979	0.509	rs1031478	chr2:3827425	G/A	cg17052675	chr2:3827356	NA	-0.85	-9.31	-0.73	2.76e-14	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs10267417	0.544	rs2072185	chr7:19748700	G/A	cg05791153	chr7:19748676	TWISTNB	1.14	7.76	0.66	2.8e-11	Night sleep phenotypes;
SKCM	cis	rs6840360	0.615	rs7669465	chr4:152609289	C/T	cg22705602	chr4:152727874	NA	-0.63	-8.2	-0.68	3.93e-12	Intelligence (multi-trait analysis);
SKCM	cis	rs9611565	0.512	rs5751148	chr22:42139078	A/G	cg03806693	chr22:41940476	POLR3H	1.15	7.18	0.63	3.65e-10	Vitiligo;
SKCM	cis	rs6570726	0.935	rs395948	chr6:145820185	G/A	cg23711669	chr6:146136114	FBXO30	0.7	6.64	0.6	3.72e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs28386778	0.897	rs716880	chr17:61902822	C/G	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs9868809	0.505	rs11706983	chr3:48738678	A/G	cg00383909	chr3:49044727	WDR6	0.89	5.09	0.5	2.44e-6	Ulcerative colitis;Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs9467773	0.935	rs4573	chr6:26546808	A/G	cg09904177	chr6:26538194	HMGN4	0.52	4.9	0.49	5.01e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs941408	1.000	rs4807332	chr19:2793289	T/C	cg06609049	chr19:2785107	THOP1	0.82	6.91	0.62	1.18e-9	Total cholesterol levels;
SKCM	cis	rs6546550	0.901	rs7598283	chr2:70128717	A/G	cg02498382	chr2:70120550	SNRNP27	-0.45	-4.88	-0.48	5.4e-6	Prevalent atrial fibrillation;
SKCM	cis	rs35306767	0.903	rs11812523	chr10:915638	C/T	cg25614935	chr10:1084866	C10orf110	0.78	5.09	0.5	2.42e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs2980439	0.557	rs2921056	chr8:8319182	T/C	cg08975724	chr8:8085496	FLJ10661	0.62	4.85	0.48	6.2e-6	Neuroticism;
SKCM	cis	rs17065868	1.000	rs28405066	chr13:45098388	C/T	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs754466	0.580	rs10824577	chr10:79577408	G/C	cg17075019	chr10:79541650	NA	-0.79	-6.93	-0.62	1.08e-9	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs7666738	0.830	rs2865989	chr4:99067532	G/A	cg05340658	chr4:99064831	C4orf37	0.66	4.87	0.48	5.74e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7927771	0.965	rs11039416	chr11:47846711	G/A	cg05585544	chr11:47624801	NA	-0.59	-5.09	-0.5	2.43e-6	Subjective well-being;
SKCM	cis	rs35306767	0.903	rs11253475	chr10:907262	C/A	cg20503657	chr10:835505	NA	0.77	5.32	0.52	9.76e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs992157	0.932	rs56109829	chr2:219149740	G/A	cg20019365	chr2:219134978	PNKD;AAMP	0.75	6.83	0.61	1.65e-9	Colorectal cancer;
SKCM	cis	rs4073582	0.595	rs801734	chr11:65931216	T/C	cg14036092	chr11:66035641	RAB1B	0.74	5.8	0.55	1.34e-7	Gout;
SKCM	cis	rs11892454	0.515	rs2176181	chr2:26030339	A/G	cg17263061	chr2:26915892	KCNK3	0.7	5.01	0.49	3.31e-6	Heschl's gyrus morphology;
SKCM	cis	rs55962025	0.883	rs2298967	chr4:3185747	T/C	cg11471262	chr4:3318911	RGS12	-0.6	-4.95	-0.49	4.21e-6	Parental longevity (mother's age at death);
SKCM	cis	rs854765	0.583	rs11656840	chr17:17837354	C/T	cg04398451	chr17:18023971	MYO15A	-0.85	-6.05	-0.57	4.75e-8	Total body bone mineral density;
SKCM	cis	rs7937682	0.883	rs549143	chr11:111463779	C/T	cg09085632	chr11:111637200	PPP2R1B	-1.0	-8.74	-0.7	3.47e-13	Primary sclerosing cholangitis;
SKCM	cis	rs2439831	0.850	rs12442297	chr15:44168470	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.25	6.44	0.59	8.86e-9	Lung cancer in ever smokers;
SKCM	cis	rs17376456	0.569	rs10476520	chr5:93058290	A/C	cg21475434	chr5:93447410	FAM172A	0.8	5.02	0.49	3.21e-6	Diabetic retinopathy;
SKCM	cis	rs2032447	1.000	rs2032447	chr6:26044369	A/G	cg18357526	chr6:26021779	HIST1H4A	0.84	7.4	0.64	1.33e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs911555	0.546	rs28798508	chr14:104068970	T/C	cg24130564	chr14:104152367	KLC1	-0.58	-5.11	-0.5	2.27e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs5750830	0.645	rs756640	chr22:39779300	G/A	cg24399712	chr22:39784796	NA	-0.62	-5.41	-0.52	6.75e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs72781680	0.611	rs72797819	chr2:24351141	T/G	cg20701182	chr2:24300061	SF3B14	0.77	5.22	0.51	1.45e-6	Lymphocyte counts;
SKCM	cis	rs11098499	0.863	rs11736416	chr4:120431661	C/T	cg24375607	chr4:120327624	NA	0.7	5.37	0.52	7.82e-7	Corneal astigmatism;
SKCM	cis	rs6952808	1.000	rs10260585	chr7:1889521	G/A	cg02951883	chr7:2050386	MAD1L1	-0.72	-5.56	-0.53	3.67e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs9894429	0.546	rs9906979	chr17:79608765	A/G	cg18240062	chr17:79603768	NPLOC4	0.78	7.57	0.65	6.34e-11	Eye color traits;
SKCM	cis	rs11098499	0.866	rs6847778	chr4:120293582	A/G	cg09307838	chr4:120376055	NA	1.02	8.32	0.69	2.27e-12	Corneal astigmatism;
SKCM	cis	rs6121246	0.908	rs6089094	chr20:30431771	C/T	cg11595048	chr20:30225325	COX4I2	0.65	5.03	0.49	3.1e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs875971	0.895	rs6460278	chr7:65662736	T/C	cg11764359	chr7:65958608	NA	-0.75	-6.89	-0.62	1.26e-9	Aortic root size;
SKCM	cis	rs796364	0.951	rs2881593	chr2:201000347	A/G	cg12253985	chr2:200820533	C2orf60;C2orf47	-0.94	-6.2	-0.57	2.47e-8	Schizophrenia;
SKCM	cis	rs875971	1.000	rs709597	chr7:65825983	A/G	cg18876405	chr7:65276391	NA	-0.65	-6.41	-0.59	1.01e-8	Aortic root size;
SKCM	cis	rs62064224	0.902	rs17732573	chr17:30627664	C/T	cg25809561	chr17:30822961	MYO1D	-0.67	-5.61	-0.54	2.97e-7	Schizophrenia;
SKCM	cis	rs2739330	0.828	rs5760107	chr22:24252597	T/C	cg25703541	chr22:24373054	LOC391322	-0.76	-6.25	-0.58	2e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs208520	0.739	rs1935894	chr6:66891434	A/G	cg07460842	chr6:66804631	NA	-0.91	-7.07	-0.63	5.76e-10	Exhaled nitric oxide output;
SKCM	cis	rs12986445	0.947	rs12713690	chr2:26118096	T/C	cg07291958	chr2:26785531	C2orf70	0.56	5.02	0.49	3.14e-6	Multiple myeloma and monoclonal gammopathy;Multiple myeloma;
SKCM	cis	rs7618501	0.633	rs9866695	chr3:50069452	G/T	cg05072774	chr3:49840536	C3orf54	0.67	5.08	0.5	2.56e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs870825	0.616	rs2696037	chr4:185610940	C/T	cg04058563	chr4:185651563	MLF1IP	-1.07	-7.36	-0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs9911578	1.000	rs7223955	chr17:56917053	C/A	cg12560992	chr17:57184187	TRIM37	0.94	7.55	0.65	7.01e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs28595532	0.925	rs10000445	chr4:119485311	C/T	cg14228332	chr4:119757509	SEC24D	0.97	4.92	0.49	4.71e-6	Cannabis dependence symptom count;
SKCM	cis	rs1552244	0.882	rs13063929	chr3:10010308	T/C	cg02579736	chr3:10068473	FANCD2;CIDECP	0.98	4.84	0.48	6.48e-6	Alzheimer's disease;
SKCM	cis	rs9349203	1	rs9349203	chr6:41893323	G/A	cg17623882	chr6:41773611	USP49	-0.7	-6.01	-0.56	5.67e-8	Menarche (age at onset);
SKCM	cis	rs9790314	1.000	rs4273380	chr3:160950314	A/G	cg03342759	chr3:160939853	NMD3	-0.72	-7.89	-0.67	1.53e-11	Morning vs. evening chronotype;
SKCM	cis	rs1165205	0.500	rs629835	chr6:25879330	T/C	cg12310025	chr6:25882481	NA	-0.67	-6.91	-0.62	1.18e-9	Urate levels;
SKCM	cis	rs12986445	0.688	rs6723069	chr2:26111315	G/T	cg04917511	chr2:26785460	C2orf70	0.53	4.97	0.49	3.88e-6	Multiple myeloma and monoclonal gammopathy;Multiple myeloma;
SKCM	cis	rs875971	0.862	rs1875057	chr7:65731855	A/G	cg18876405	chr7:65276391	NA	-0.65	-6.66	-0.6	3.51e-9	Aortic root size;
SKCM	cis	rs763014	0.898	rs2384978	chr16:625384	T/C	cg09263875	chr16:632152	PIGQ	0.68	5.71	0.54	1.98e-7	Height;
SKCM	cis	rs6570726	0.846	rs441575	chr6:145849205	A/C	cg23711669	chr6:146136114	FBXO30	0.7	6.71	0.61	2.78e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs995000	1.000	rs995000	chr1:63107526	C/T	cg06896770	chr1:63153194	DOCK7	0.99	8.99	0.71	1.12e-13	Triglyceride levels;
SKCM	cis	rs854765	1.000	rs854765	chr17:18012730	T/C	cg04398451	chr17:18023971	MYO15A	0.64	4.88	0.48	5.49e-6	Total body bone mineral density;
SKCM	cis	rs28595532	0.920	rs28837152	chr4:119782868	G/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs8077889	0.917	rs9901676	chr17:41911818	T/C	cg26893861	chr17:41843967	DUSP3	1.22	8.23	0.68	3.35e-12	Triglycerides;
SKCM	cis	rs910316	1.000	rs10146482	chr14:75574087	C/T	cg08847533	chr14:75593920	NEK9	0.95	9.13	0.72	5.96e-14	Height;
SKCM	trans	rs561341	0.739	rs8070554	chr17:30216868	A/T	cg20587970	chr11:113659929	NA	1.03	7.88	0.67	1.58e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs7100689	0.598	rs2342815	chr10:82086532	T/C	cg01528321	chr10:82214614	TSPAN14	0.76	6.26	0.58	1.94e-8	Post bronchodilator FEV1;
SKCM	cis	rs2228479	0.681	rs10153196	chr16:89967397	A/C	cg00800038	chr16:89945340	TCF25	-0.94	-5.55	-0.53	3.77e-7	Skin colour saturation;
SKCM	cis	rs9549367	0.713	rs3024761	chr13:113824090	C/G	cg18105134	chr13:113819100	PROZ	0.83	6.74	0.61	2.5e-9	Platelet distribution width;
SKCM	cis	rs17685	0.753	rs2302435	chr7:75676987	G/A	cg01364799	chr7:75623366	TMEM120A	0.72	5.83	0.55	1.18e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs910316	1.000	rs12889309	chr14:75593902	C/T	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.85e-7	Height;
SKCM	cis	rs9457247	0.602	rs10484530	chr6:167461562	C/T	cg13927040	chr6:167453801	FGFR1OP	0.67	4.81	0.48	7.25e-6	Crohn's disease;
SKCM	cis	rs17376456	0.877	rs17083462	chr5:93462401	T/G	cg21475434	chr5:93447410	FAM172A	0.97	5.42	0.52	6.39e-7	Diabetic retinopathy;
SKCM	cis	rs10504229	0.953	rs116564484	chr8:58172818	T/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs17376456	0.877	rs10059630	chr5:93459807	C/A	cg21475434	chr5:93447410	FAM172A	0.97	5.42	0.52	6.39e-7	Diabetic retinopathy;
SKCM	cis	rs1005277	0.505	rs7917943	chr10:38195811	T/A	cg25427524	chr10:38739819	LOC399744	0.68	6.4	0.59	1.06e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs995000	0.965	rs11207982	chr1:63007182	C/T	cg06896770	chr1:63153194	DOCK7	0.9	7.84	0.66	1.96e-11	Triglyceride levels;
SKCM	cis	rs2153535	0.541	rs6932434	chr6:8467679	G/A	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs28386778	0.897	rs2665831	chr17:61912392	C/T	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.09	11.04	0.78	1.31e-17	Prudent dietary pattern;
SKCM	cis	rs1799949	1.000	rs12516	chr17:41196408	G/A	cg05368731	chr17:41323189	NBR1	0.9	7.94	0.67	1.23e-11	Menopause (age at onset);
SKCM	cis	rs2841277	0.708	rs10083490	chr14:105402418	A/G	cg15352829	chr14:105391018	PLD4	0.57	4.83	0.48	6.55e-6	Rheumatoid arthritis;
SKCM	cis	rs6598955	0.694	rs6659387	chr1:26634307	G/A	cg04990556	chr1:26633338	UBXN11	-0.59	-4.85	-0.48	6.08e-6	Obesity-related traits;
SKCM	cis	rs9905704	0.624	rs4932691	chr17:57094617	T/C	cg12560992	chr17:57184187	TRIM37	-0.74	-6.08	-0.57	4.13e-8	Testicular germ cell tumor;
SKCM	cis	rs362272	0.524	rs6819202	chr4:3368264	G/A	cg16987761	chr4:3318072	RGS12	0.97	11.36	0.79	3.3e-18	Serum sulfate level;
SKCM	cis	rs2204008	0.749	rs4579984	chr12:38166266	A/G	cg13010199	chr12:38710504	ALG10B	0.65	5.11	0.5	2.19e-6	Bladder cancer;
SKCM	cis	rs28595532	1.000	rs114778020	chr4:119662584	C/A	cg11846333	chr4:119757529	SEC24D	1.19	6.39	0.59	1.09e-8	Cannabis dependence symptom count;
SKCM	cis	rs72634258	0.836	rs7545687	chr1:7997183	G/A	cg00042356	chr1:8021962	PARK7	0.97	6.34	0.58	1.37e-8	Inflammatory bowel disease;
SKCM	cis	rs7945705	0.967	rs56316046	chr11:8876598	G/T	cg21881798	chr11:8931708	C11orf17;ST5	0.74	7.09	0.63	5.21e-10	Hemoglobin concentration;
SKCM	cis	rs9325144	0.505	rs7138977	chr12:38642109	G/A	cg26384229	chr12:38710491	ALG10B	0.82	7.04	0.62	6.73e-10	Morning vs. evening chronotype;
SKCM	cis	rs4400599	0.600	rs12095767	chr1:154188028	T/C	cg26808167	chr1:154192205	UBAP2L;C1orf43	-0.54	-4.97	-0.49	3.92e-6	Platelet distribution width;
SKCM	cis	rs4423214	1.000	rs2282620	chr11:71183477	C/T	cg05163923	chr11:71159392	DHCR7	0.81	7.55	0.65	6.83e-11	Vitamin D levels;
SKCM	cis	rs244731	0.959	rs10037110	chr5:176658066	A/T	cg17509989	chr5:176798049	RGS14	-0.88	-6.91	-0.62	1.16e-9	Urate levels in lean individuals;
SKCM	cis	rs651907	0.557	rs3806654	chr3:101396529	G/C	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.81	6.96	0.62	9.48e-10	Colorectal cancer;
SKCM	cis	rs7772486	0.764	rs7762562	chr6:146158994	T/C	cg23711669	chr6:146136114	FBXO30	0.86	9.38	0.73	1.95e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9815354	0.812	rs73081392	chr3:41923009	G/A	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs10256972	0.568	rs1133043	chr7:1133305	C/G	cg07092213	chr7:1199455	ZFAND2A	-0.66	-5.41	-0.52	6.66e-7	Longevity;Endometriosis;
SKCM	cis	rs17376456	0.825	rs17372615	chr5:93124768	C/T	cg21475434	chr5:93447410	FAM172A	0.9	4.99	0.49	3.65e-6	Diabetic retinopathy;
SKCM	cis	rs10504229	0.683	rs10504224	chr8:58143735	A/G	cg02725872	chr8:58115012	NA	-0.54	-5.26	-0.51	1.23e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs4332037	0.624	rs11766944	chr7:1888051	G/A	cg23422044	chr7:1970798	MAD1L1	-0.9	-5.81	-0.55	1.29e-7	Bipolar disorder;
SKCM	cis	rs4927850	0.881	rs7630489	chr3:195753401	T/C	cg12923728	chr3:195709715	SDHAP1	-0.89	-5.76	-0.55	1.57e-7	Pancreatic cancer;
SKCM	trans	rs17685	0.753	rs6953665	chr7:75769049	C/T	cg19862616	chr7:65841803	NCRNA00174	0.94	9.49	0.73	1.22e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs780096	0.546	rs6547626	chr2:27646770	C/T	cg05696406	chr2:27599888	SNX17	0.49	5.07	0.5	2.62e-6	Total body bone mineral density;
SKCM	cis	rs35306767	0.761	rs11253540	chr10:1011958	C/T	cg25614935	chr10:1084866	C10orf110	-0.74	-5.27	-0.51	1.19e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs9322193	0.923	rs9767554	chr6:149937996	T/C	cg07701084	chr6:150067640	NUP43	0.6	4.79	0.48	7.78e-6	Lung cancer;
SKCM	cis	rs2204008	0.782	rs117824012	chr12:38215517	T/C	cg13010199	chr12:38710504	ALG10B	0.65	4.84	0.48	6.52e-6	Bladder cancer;
SKCM	cis	rs910316	1.000	rs7156328	chr14:75532941	T/C	cg08847533	chr14:75593920	NEK9	0.95	9.18	0.72	4.8e-14	Height;
SKCM	cis	rs6570726	0.791	rs1280275	chr6:145892402	C/T	cg23711669	chr6:146136114	FBXO30	0.87	8.94	0.71	1.44e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs17345786	0.911	rs10936707	chr3:101324063	G/A	cg12386194	chr3:101231763	SENP7	0.8	6.19	0.57	2.62e-8	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1577917	1.000	rs1911552	chr6:86638024	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.77	-0.66	2.59e-11	Response to antipsychotic treatment;
SKCM	cis	rs13217239	0.646	rs10946888	chr6:26951678	A/G	cg12292205	chr6:26970375	C6orf41	0.61	5.41	0.52	6.79e-7	Schizophrenia;
SKCM	cis	rs7218675	0.736	rs7501873	chr17:73505172	G/A	cg16555002	chr17:72736021	RAB37	-0.46	-4.8	-0.48	7.52e-6	Lung function (FEV1);
SKCM	cis	rs933688	1.000	rs12654787	chr5:90713259	C/T	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.96	6.6	0.6	4.58e-9	Smoking behavior;
SKCM	cis	rs9902453	0.817	rs55758314	chr17:28173978	T/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.83	5.76	0.55	1.61e-7	Coffee consumption (cups per day);
SKCM	cis	rs17685	0.712	rs10275521	chr7:75770972	T/C	cg16489192	chr7:75678113	MDH2;STYXL1	-0.57	-5.35	-0.52	8.63e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs6879260	1.000	rs7725605	chr5:179732678	T/G	cg02891314	chr5:179741120	GFPT2	-0.68	-5.88	-0.55	9.62e-8	Height;
SKCM	cis	rs561341	1.000	rs68140514	chr17:30335781	T/C	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs6840360	0.571	rs11939356	chr4:152505234	G/C	cg22705602	chr4:152727874	NA	-0.52	-5.55	-0.53	3.82e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs9475752	0.545	rs41267681	chr6:56881883	A/G	cg06815302	chr6:57335405	PRIM2	0.72	4.87	0.48	5.77e-6	Menarche (age at onset);
SKCM	cis	rs35306767	0.715	rs1250891	chr10:1040159	G/C	cg25614935	chr10:1084866	C10orf110	0.65	5.13	0.5	2.03e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs1218582	0.774	rs4845683	chr1:154877407	T/C	cg06221963	chr1:154839813	KCNN3	-0.61	-6.58	-0.6	4.97e-9	Prostate cancer;
SKCM	cis	rs7143963	0.945	rs56330734	chr14:103292150	G/A	cg23020514	chr14:103360112	TRAF3	0.9	8.54	0.7	8.45e-13	Body mass index;
SKCM	cis	rs1707322	0.964	rs6675259	chr1:46502295	G/A	cg03146154	chr1:46216737	IPP	-0.76	-5.14	-0.5	1.98e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs362272	0.545	rs2749783	chr4:3326098	A/C	cg00764545	chr4:3318001	RGS12	1.0	13.23	0.83	1.27e-21	Serum sulfate level;
SKCM	cis	rs2197308	0.692	rs67352173	chr12:37906912	A/T	cg13010199	chr12:38710504	ALG10B	0.63	4.95	0.49	4.18e-6	Morning vs. evening chronotype;
SKCM	cis	rs9914544	1.000	rs28436199	chr17:18751730	C/T	cg26306683	chr17:18585705	ZNF286B	0.71	5.13	0.5	2.06e-6	Educational attainment (years of education);
SKCM	cis	rs28386778	0.799	rs2665836	chr17:61898135	C/A	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs28386778	0.897	rs4968663	chr17:61835603	A/T	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.12	11.27	0.79	4.92e-18	Prudent dietary pattern;
SKCM	cis	rs362272	0.545	rs2239725	chr4:3305739	C/T	cg09735869	chr4:3319127	RGS12	0.97	11.44	0.79	2.34e-18	Serum sulfate level;
SKCM	cis	rs55962025	0.883	rs82332	chr4:3225466	A/G	cg09735869	chr4:3319127	RGS12	-0.73	-5.58	-0.53	3.31e-7	Parental longevity (mother's age at death);
SKCM	cis	rs672059	1.000	rs575474	chr1:183158599	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.63	5.23	0.51	1.38e-6	Hypertriglyceridemia;
SKCM	cis	rs10791097	0.739	rs12279359	chr11:130730544	G/A	cg12179176	chr11:130786555	SNX19	0.75	5.95	0.56	7.12e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs11098499	0.863	rs1383532	chr4:120434404	A/T	cg24375607	chr4:120327624	NA	-0.68	-5.12	-0.5	2.15e-6	Corneal astigmatism;
SKCM	cis	rs801193	1.000	rs2055682	chr7:66260289	A/G	cg18876405	chr7:65276391	NA	0.82	7.53	0.65	7.59e-11	Aortic root size;
SKCM	cis	rs1160297	0.576	rs74181216	chr2:53093194	G/C	cg07782112	chr2:53107842	NA	0.58	6.01	0.56	5.59e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs9914544	0.966	rs1737943	chr17:18841590	A/G	cg26378065	chr17:18585709	ZNF286B	-0.71	-5.12	-0.5	2.16e-6	Educational attainment (years of education);
SKCM	cis	rs35079168	0.923	rs10858276	chr9:137287913	C/T	cg00753924	chr9:137298813	RXRA	-0.75	-5.07	-0.5	2.57e-6	Intelligence;
SKCM	cis	rs7666738	0.830	rs13144771	chr4:99026935	G/C	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6582630	0.502	rs11520278	chr12:38359642	T/A	cg26384229	chr12:38710491	ALG10B	0.87	6.82	0.61	1.73e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs7772486	0.875	rs7766463	chr6:146364453	A/G	cg05347473	chr6:146136440	FBXO30	0.57	5.05	0.5	2.82e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs713587	0.520	rs483428	chr2:25305136	A/G	cg04586622	chr2:25135609	ADCY3	0.63	4.87	0.48	5.78e-6	Body mass index in non-asthmatics;
SKCM	cis	rs1707322	0.752	rs28550303	chr1:46188914	G/T	cg03146154	chr1:46216737	IPP	0.81	5.62	0.54	2.87e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs2921036	0.529	rs2979192	chr8:8338147	C/T	cg15556689	chr8:8085844	FLJ10661	0.66	5.2	0.51	1.59e-6	Neuroticism;
SKCM	cis	rs950027	0.620	rs1346267	chr15:45690989	A/G	cg21132104	chr15:45694354	SPATA5L1	0.72	5.29	0.51	1.09e-6	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs11608355	0.552	rs2304549	chr12:109794875	A/G	cg19025524	chr12:109796872	NA	-0.64	-5.03	-0.49	3.11e-6	Neuroticism;
SKCM	cis	rs8141529	0.644	rs5752795	chr22:29178820	T/C	cg02153584	chr22:29168773	CCDC117	0.68	5.57	0.53	3.52e-7	Lymphocyte counts;
SKCM	cis	rs2594989	0.677	rs7631716	chr3:11576689	T/C	cg00170343	chr3:11313890	ATG7	-0.98	-5.18	-0.51	1.72e-6	Circulating chemerin levels;
SKCM	cis	rs1005277	0.579	rs2474572	chr10:38385316	A/G	cg00409905	chr10:38381863	ZNF37A	-0.64	-6.18	-0.57	2.68e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs7617480	0.558	rs12715430	chr3:48942855	A/C	cg07636037	chr3:49044803	WDR6	0.92	6.9	0.62	1.24e-9	Subjective well-being (multi-trait analysis);Menarche (age at onset);
SKCM	cis	rs2204008	0.720	rs11181343	chr12:38323616	G/T	cg26384229	chr12:38710491	ALG10B	0.81	6.67	0.6	3.28e-9	Bladder cancer;
SKCM	cis	rs2948294	0.588	rs4840913	chr8:8116906	A/C	cg08975724	chr8:8085496	FLJ10661	0.66	5.16	0.5	1.86e-6	Red cell distribution width;
SKCM	cis	rs2439831	0.867	rs2242068	chr15:43699304	C/G	cg27015174	chr15:43622946	ADAL;LCMT2	0.97	5.0	0.49	3.42e-6	Lung cancer in ever smokers;
SKCM	cis	rs16854884	0.586	rs4527375	chr3:143735515	A/T	cg06585982	chr3:143692056	C3orf58	-0.87	-8.17	-0.68	4.41e-12	Economic and political preferences (feminism/equality);
SKCM	cis	rs477895	0.838	rs7111278	chr11:64016284	G/A	cg07220939	chr11:64358617	SLC22A12	0.75	4.88	0.48	5.57e-6	Mean platelet volume;
SKCM	cis	rs1577917	0.958	rs12202712	chr6:86578541	T/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.39	-0.52	7.24e-7	Response to antipsychotic treatment;
SKCM	cis	rs35306767	0.953	rs12259801	chr10:959306	C/G	cg20503657	chr10:835505	NA	0.65	4.94	0.49	4.37e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs12048904	0.512	rs932798	chr1:101249355	G/C	cg16556008	chr1:101360663	SLC30A7;EXTL2	-0.83	-5.84	-0.55	1.14e-7	Multiple sclerosis;
SKCM	cis	rs12048904	0.505	rs6577209	chr1:101255080	A/C	cg16556008	chr1:101360663	SLC30A7;EXTL2	0.79	5.64	0.54	2.57e-7	Multiple sclerosis;
SKCM	cis	rs17685	0.925	rs1057868	chr7:75615006	C/T	cg16489192	chr7:75678113	MDH2;STYXL1	-0.64	-5.74	-0.54	1.76e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2439831	0.850	rs8023458	chr15:44080939	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.35	7.75	0.66	2.9e-11	Lung cancer in ever smokers;
SKCM	cis	rs7809950	0.817	rs2701679	chr7:107283908	A/G	cg23024343	chr7:107201750	COG5	0.8	7.23	0.63	2.87e-10	Coronary artery disease;
SKCM	cis	rs9818758	0.607	rs67060340	chr3:48915321	C/T	cg00383909	chr3:49044727	WDR6	0.95	5.43	0.52	6.25e-7	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs9911578	0.967	rs6416932	chr17:57148991	G/A	cg12560992	chr17:57184187	TRIM37	1.08	10.19	0.76	5.38e-16	Intelligence (multi-trait analysis);
SKCM	cis	rs8072100	0.748	rs9912592	chr17:45556945	G/A	cg08085267	chr17:45401833	C17orf57	-0.62	-5.08	-0.5	2.48e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs7786877	0.723	rs6969584	chr7:100209747	A/C	cg20848291	chr7:100343083	ZAN	-0.66	-4.91	-0.49	4.9e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs6120849	0.754	rs6120819	chr20:33653038	T/C	cg24642439	chr20:33292090	TP53INP2	0.94	4.86	0.48	5.91e-6	Protein C levels;
SKCM	cis	rs10489202	1.000	rs718885	chr1:167954659	A/G	cg24449463	chr1:168025552	DCAF6	-0.76	-5.87	-0.55	1.02e-7	Schizophrenia;
SKCM	cis	rs2842992	0.915	rs2842980	chr6:160100116	A/T	cg11366901	chr6:160182831	ACAT2	0.9	6.37	0.59	1.19e-8	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs55823223	0.838	rs61510938	chr17:73882692	T/A	cg10935138	chr17:73851978	WBP2	1.13	6.37	0.59	1.19e-8	Psoriasis;
SKCM	cis	rs7666738	0.830	rs6817645	chr4:99016054	T/C	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1577917	0.652	rs75593931	chr6:86719539	A/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.63	-5.4	-0.52	7.05e-7	Response to antipsychotic treatment;
SKCM	cis	rs2239547	0.522	rs2581797	chr3:52972468	C/T	cg11645453	chr3:52864694	ITIH4	-0.58	-4.96	-0.49	3.98e-6	Schizophrenia;
SKCM	cis	rs6933660	0.666	rs9371516	chr6:151739642	G/A	cg10883421	chr6:151773342	RMND1;C6orf211	0.84	7.4	0.64	1.36e-10	Menarche (age at onset);
SKCM	cis	rs2413583	0.591	rs12484030	chr22:39712936	G/A	cg17798944	chr22:39715225	SNORD43;RPL3	0.92	5.12	0.5	2.12e-6	Ulcerative colitis;Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs11608355	0.538	rs12228876	chr12:109796799	C/A	cg19025524	chr12:109796872	NA	-0.71	-6.33	-0.58	1.47e-8	Neuroticism;
SKCM	cis	rs2836633	0.965	rs2836621	chr21:40054149	C/T	cg05519781	chr21:40033154	ERG	0.69	6.2	0.57	2.51e-8	Coronary artery disease;
SKCM	trans	rs1814175	0.817	rs7927373	chr11:49957640	A/C	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs28386778	0.865	rs2727276	chr17:61929709	G/A	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.36	0.52	8.06e-7	Prudent dietary pattern;
SKCM	cis	rs919433	0.750	rs788012	chr2:198229856	A/T	cg04278110	chr2:198063759	ANKRD44	0.76	5.34	0.52	8.86e-7	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs28595532	0.920	rs56150431	chr4:119764786	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs2204008	0.837	rs11495722	chr12:38337245	G/A	cg26384229	chr12:38710491	ALG10B	0.88	7.02	0.62	7.15e-10	Bladder cancer;
SKCM	cis	rs873946	0.564	rs35831787	chr10:134546346	T/C	cg27286337	chr10:134555280	INPP5A	0.94	8.91	0.71	1.63e-13	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs12142240	0.698	rs17361887	chr1:46834775	A/G	cg10495392	chr1:46806563	NSUN4	0.75	5.6	0.54	3.1e-7	Menopause (age at onset);
SKCM	cis	rs1707322	0.662	rs11211160	chr1:46146229	T/A	cg03146154	chr1:46216737	IPP	0.8	5.47	0.53	5.23e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs2032447	0.798	rs807212	chr6:26065621	A/G	cg18357526	chr6:26021779	HIST1H4A	0.86	7.35	0.64	1.66e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs28595532	0.920	rs114057512	chr4:119750179	G/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs11098499	0.908	rs2017057	chr4:120257711	A/G	cg09307838	chr4:120376055	NA	0.96	7.45	0.64	1.06e-10	Corneal astigmatism;
SKCM	cis	rs854765	0.547	rs9897761	chr17:17912011	A/T	cg04398451	chr17:18023971	MYO15A	-0.87	-6.78	-0.61	2.05e-9	Total body bone mineral density;
SKCM	cis	rs28386778	0.897	rs2584635	chr17:61865934	A/G	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs2642660	0.539	rs157293	chr5:156017161	A/G	cg15611624	chr5:156886970	NIPAL4	0.5	4.91	0.49	4.94e-6	Airway responsiveness in chronic obstructive pulmonary disease;
SKCM	cis	rs55823223	0.648	rs936393	chr17:73847613	A/G	cg08125733	chr17:73851984	WBP2	1.06	6.53	0.59	6.17e-9	Psoriasis;
SKCM	cis	rs1405130	0.869	rs13016360	chr2:235572104	A/G	cg17841421	chr2:235704848	NA	-0.57	-4.95	-0.49	4.14e-6	Coronary artery disease;
SKCM	cis	rs686320	1.000	rs1787666	chr11:65249089	A/C	cg13521124	chr11:66064082	TMEM151A	0.79	4.93	0.49	4.52e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs875971	0.862	rs6952182	chr7:65683317	T/G	cg18876405	chr7:65276391	NA	-0.65	-6.74	-0.61	2.46e-9	Aortic root size;
SKCM	cis	rs7635838	0.826	rs9867963	chr3:11469126	C/T	cg00170343	chr3:11313890	ATG7	0.76	5.26	0.51	1.21e-6	HDL cholesterol;
SKCM	cis	rs3749237	0.595	rs7621003	chr3:49411404	T/C	cg03060546	chr3:49711283	APEH	0.67	4.86	0.48	5.96e-6	Resting heart rate;
SKCM	cis	rs9796	0.553	rs7171437	chr15:41315168	G/A	cg18705301	chr15:41695430	NDUFAF1	-0.72	-5.83	-0.55	1.2e-7	Menopause (age at onset);
SKCM	cis	rs28595532	1.000	rs28595532	chr4:119716950	A/C	cg11846333	chr4:119757529	SEC24D	1.19	6.39	0.59	1.12e-8	Cannabis dependence symptom count;
SKCM	cis	rs1953600	0.729	rs2819872	chr10:81906269	A/G	cg04850286	chr10:81895943	PLAC9	0.54	5.58	0.53	3.4e-7	Sarcoidosis;
SKCM	cis	rs3820928	0.874	rs7605032	chr2:227847630	T/G	cg11843606	chr2:227700838	RHBDD1	-0.61	-4.9	-0.49	5.12e-6	Pulmonary function;
SKCM	cis	rs12134245	0.747	rs11164929	chr1:92012836	G/C	cg25838465	chr1:92012736	NA	-0.8	-8.13	-0.68	5.18e-12	Breast cancer;
SKCM	cis	rs1577917	1.000	rs12209127	chr6:86724427	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.63	-5.38	-0.52	7.46e-7	Response to antipsychotic treatment;
SKCM	cis	rs933688	0.938	rs7705465	chr5:90680949	G/A	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.12	8.45	0.69	1.25e-12	Smoking behavior;
SKCM	cis	rs7523273	0.606	rs2488253	chr1:207938709	C/A	cg22525895	chr1:207977042	MIR29B2	0.81	7.08	0.63	5.47e-10	Schizophrenia;
SKCM	cis	rs1912528	0.745	rs6852749	chr4:140864455	C/T	cg11128457	chr4:140864437	MAML3	0.62	5.31	0.52	1e-6	Educational attainment (years of education);
SKCM	cis	rs870825	0.616	rs7667409	chr4:185650941	C/T	cg04058563	chr4:185651563	MLF1IP	-1.07	-7.36	-0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs8067545	0.611	rs77449863	chr17:20191860	C/G	cg13482628	chr17:19912719	NA	-0.68	-5.76	-0.55	1.57e-7	Schizophrenia;
SKCM	cis	rs7511006	1.000	rs5771109	chr22:50678571	T/C	cg16473166	chr22:50639996	SELO	0.62	5.0	0.49	3.4e-6	Obesity-related traits;
SKCM	cis	rs763014	0.865	rs62030874	chr16:632233	T/C	cg09263875	chr16:632152	PIGQ	0.66	5.66	0.54	2.43e-7	Height;
SKCM	cis	rs929354	0.772	rs6954050	chr7:156978554	A/G	cg17757837	chr7:157058334	UBE3C	0.82	5.72	0.54	1.87e-7	Body mass index;
SKCM	cis	rs1538970	0.924	rs1007858	chr1:45912005	C/T	cg05343316	chr1:45956843	TESK2	0.92	4.94	0.49	4.42e-6	Platelet count;
SKCM	cis	rs10089	0.953	rs6595807	chr5:127531603	G/T	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.92	8.12	0.68	5.4e-12	Ileal carcinoids;
SKCM	cis	rs9467773	0.620	rs2504571	chr6:26643435	C/T	cg15659132	chr6:26577336	NA	0.62	5.4	0.52	6.91e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs4975616	0.869	rs31484	chr5:1337906	A/T	cg06550200	chr5:1325588	CLPTM1L	-0.85	-7.61	-0.65	5.44e-11	Lung cancer;
SKCM	cis	rs875971	0.767	rs12668005	chr7:65909021	T/C	cg11764359	chr7:65958608	NA	0.75	6.79	0.61	1.95e-9	Aortic root size;
SKCM	cis	rs28595532	0.920	rs115006522	chr4:119732499	A/G	cg11846333	chr4:119757529	SEC24D	1.2	6.43	0.59	9.38e-9	Cannabis dependence symptom count;
SKCM	cis	rs793571	0.544	rs1427282	chr15:58914326	C/T	cg05156742	chr15:59063176	FAM63B	0.75	5.98	0.56	6.4e-8	Schizophrenia;
SKCM	cis	rs3768617	0.510	rs6691755	chr1:183099821	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs8064299	0.967	rs3744208	chr17:72767565	A/G	cg25054828	chr17:72772726	NAT9;TMEM104	0.76	6.67	0.6	3.34e-9	Monocyte count;
SKCM	cis	rs910316	1.000	rs3742778	chr14:75538217	A/C	cg11812906	chr14:75593930	NEK9	-0.68	-5.2	-0.51	1.55e-6	Height;
SKCM	cis	rs28386778	0.897	rs1062788	chr17:61896127	C/G	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	trans	rs208520	0.690	rs864314	chr6:66814830	G/A	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-1.08	-11.82	-0.8	4.59e-19	Exhaled nitric oxide output;
SKCM	cis	rs7940866	0.845	rs10894294	chr11:130830748	G/T	cg12179176	chr11:130786555	SNX19	0.79	6.3	0.58	1.63e-8	Schizophrenia;
SKCM	cis	rs9443189	0.570	rs6931578	chr6:76272310	C/T	cg01950844	chr6:76311363	SENP6	0.99	6.28	0.58	1.77e-8	Prostate cancer;
SKCM	cis	rs995000	0.965	rs1570694	chr1:63103217	A/G	cg06896770	chr1:63153194	DOCK7	0.97	9.15	0.72	5.54e-14	Triglyceride levels;
SKCM	cis	rs875971	0.522	rs2949690	chr7:65483242	C/T	cg11987759	chr7:65425863	GUSB	0.76	6.75	0.61	2.31e-9	Aortic root size;
SKCM	cis	rs2404602	0.583	rs11072580	chr15:76540231	G/A	cg22467129	chr15:76604101	ETFA	-0.65	-5.35	-0.52	8.68e-7	Blood metabolite levels;
SKCM	cis	rs11690935	0.959	rs7586207	chr2:172671094	A/G	cg13550731	chr2:172543902	DYNC1I2	-0.93	-7.9	-0.67	1.48e-11	Schizophrenia;
SKCM	cis	rs780096	0.565	rs10169261	chr2:27727314	C/T	cg05696406	chr2:27599888	SNX17	0.53	5.3	0.51	1.04e-6	Total body bone mineral density;
SKCM	cis	rs9788682	0.948	rs59133824	chr15:78833450	C/A	cg24631222	chr15:78858424	CHRNA5	0.96	6.69	0.6	3.03e-9	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs9916302	0.904	rs12600751	chr17:37553651	G/C	cg07936489	chr17:37558343	FBXL20	0.82	6.79	0.61	1.95e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs9467773	0.620	rs3800303	chr6:26598188	A/G	cg09904177	chr6:26538194	HMGN4	0.57	4.89	0.48	5.24e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs867186	1.000	rs6060246	chr20:33701107	A/G	cg04194272	chr20:33683537	NA	-1.14	-6.37	-0.58	1.22e-8	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs10779751	0.922	rs2295080	chr1:11322628	G/T	cg08854313	chr1:11322531	MTOR	1.05	10.32	0.76	3.09e-16	Body mass index;
SKCM	cis	rs2153535	0.580	rs1932283	chr6:8477661	C/T	cg23788917	chr6:8435910	SLC35B3	0.67	4.78	0.48	8.23e-6	Motion sickness;
SKCM	cis	rs34779708	0.931	rs3740083	chr10:35320383	C/T	cg03585969	chr10:35415529	CREM	0.76	6.24	0.58	2.1e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs7296418	0.885	rs1716184	chr12:123637509	G/C	cg00376283	chr12:123451042	ABCB9	0.95	8.2	0.68	3.89e-12	Platelet count;
SKCM	cis	rs6545883	0.965	rs12713439	chr2:61752154	G/A	cg15711740	chr2:61764176	XPO1	-0.75	-5.3	-0.51	1.06e-6	Tuberculosis;
SKCM	cis	rs9611565	0.559	rs5758397	chr22:42019251	C/T	cg03806693	chr22:41940476	POLR3H	1.11	7.56	0.65	6.74e-11	Vitiligo;
SKCM	cis	rs908922	0.676	rs12132469	chr1:152491856	G/T	cg09873164	chr1:152488093	CRCT1	0.76	5.94	0.56	7.4e-8	Hair morphology;
SKCM	cis	rs644799	0.525	rs3016206	chr11:95536724	T/C	cg25622487	chr11:95524042	FAM76B;CEP57	0.7	5.67	0.54	2.28e-7	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs2302777	0.507	rs9889711	chr17:38108292	A/T	cg17467752	chr17:38218738	THRA	0.65	5.15	0.5	1.91e-6	Multiple myeloma (hyperdiploidy);
SKCM	cis	rs1577917	0.771	rs6454486	chr6:86433587	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.75	6.43	0.59	9.49e-9	Response to antipsychotic treatment;
SKCM	cis	rs992157	0.735	rs13430006	chr2:219113089	A/C	cg00012203	chr2:219082015	ARPC2	-0.83	-7.18	-0.63	3.5e-10	Colorectal cancer;
SKCM	cis	rs763121	0.853	rs7289855	chr22:39042221	G/T	cg06022373	chr22:39101656	GTPBP1	0.75	5.2	0.51	1.59e-6	Menopause (age at onset);
SKCM	cis	rs9902453	0.808	rs62068617	chr17:28144728	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.8	5.4	0.52	6.96e-7	Coffee consumption (cups per day);
SKCM	cis	rs9902453	0.967	rs9900911	chr17:28330280	T/G	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.81	-5.78	-0.55	1.45e-7	Coffee consumption (cups per day);
SKCM	cis	rs2455601	0.786	rs3763913	chr11:8951230	C/T	cg21881798	chr11:8931708	C11orf17;ST5	-0.74	-5.29	-0.51	1.07e-6	Schizophrenia;
SKCM	cis	rs7666738	0.830	rs28417716	chr4:98864859	C/T	cg17366294	chr4:99064904	C4orf37	0.56	4.87	0.48	5.62e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1850744	0.702	rs4974812	chr4:9614598	A/C	cg15442990	chr4:9534313	NA	-1.55	-5.83	-0.55	1.18e-7	Economic and political preferences;
SKCM	cis	rs801193	0.901	rs4273746	chr7:66301111	C/T	cg11987759	chr7:65425863	GUSB	0.69	5.91	0.56	8.62e-8	Aortic root size;
SKCM	trans	rs1814175	0.791	rs10839395	chr11:49846274	G/T	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs7809950	0.798	rs10281535	chr7:107229618	T/G	cg23024343	chr7:107201750	COG5	0.84	7.73	0.66	3.1e-11	Coronary artery disease;
SKCM	cis	rs7646501	0.765	rs1397881	chr3:24063290	A/G	cg22892432	chr3:24537792	THRB	0.57	4.87	0.48	5.64e-6	Cognitive ability;Intelligence;
SKCM	cis	rs55962025	0.686	rs362331	chr4:3215835	T/C	cg21096898	chr4:3318625	RGS12	-0.6	-5.08	-0.5	2.47e-6	Parental longevity (mother's age at death);
SKCM	cis	rs10808739	0.702	rs11992694	chr8:65655454	A/C	cg05711235	chr8:65498612	NA	-0.81	-5.4	-0.52	7.01e-7	HIV-1 susceptibility;
SKCM	cis	rs1005277	0.579	rs1740737	chr10:38499365	G/T	cg25427524	chr10:38739819	LOC399744	-0.72	-6.54	-0.6	5.74e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs28595532	0.920	rs115683389	chr4:119735557	T/G	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs1461503	0.966	rs10892939	chr11:122841959	T/C	cg27398637	chr11:122830231	C11orf63	-0.63	-4.8	-0.48	7.54e-6	Menarche (age at onset);
SKCM	cis	rs6570726	0.791	rs6914203	chr6:145899975	C/A	cg23711669	chr6:146136114	FBXO30	0.85	8.68	0.7	4.45e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9611565	0.694	rs202613	chr22:41821993	C/A	cg03806693	chr22:41940476	POLR3H	1.13	7.36	0.64	1.63e-10	Vitiligo;
SKCM	cis	rs62238980	0.614	rs2413064	chr22:32458536	G/T	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs6840360	0.571	rs11723395	chr4:152524191	G/A	cg22705602	chr4:152727874	NA	-0.52	-5.7	-0.54	2.03e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs28386778	0.897	rs894407	chr17:61901641	T/C	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	trans	rs17685	0.753	rs2286830	chr7:75693963	C/T	cg19862616	chr7:65841803	NCRNA00174	-0.93	-8.82	-0.71	2.37e-13	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7772486	0.686	rs2179323	chr6:145982786	T/G	cg23711669	chr6:146136114	FBXO30	-0.9	-9.43	-0.73	1.62e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs17376456	0.597	rs6869110	chr5:93355531	G/A	cg25358565	chr5:93447407	FAM172A	-0.79	-5.11	-0.5	2.27e-6	Diabetic retinopathy;
SKCM	cis	rs1218582	0.774	rs4845683	chr1:154877407	T/C	cg09359103	chr1:154839909	KCNN3	-0.59	-5.81	-0.55	1.31e-7	Prostate cancer;
SKCM	cis	rs1005277	0.579	rs1548255	chr10:38417193	T/C	cg00409905	chr10:38381863	ZNF37A	-0.66	-6.16	-0.57	3e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs7937682	0.564	rs11600652	chr11:111754368	A/T	cg09085632	chr11:111637200	PPP2R1B	1.09	10.84	0.78	3.11e-17	Primary sclerosing cholangitis;
SKCM	cis	rs9788721	0.836	rs17483929	chr15:78742376	C/T	cg18825076	chr15:78729989	IREB2	-0.63	-5.02	-0.49	3.21e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;Emphysema imaging phenotypes;Emphysema distribution in smoking;Local histogram emphysema pattern;Post bronchodilator FEV1/FVC ratio in COPD;
SKCM	cis	rs6580649	0.882	rs59766465	chr12:48470169	G/A	cg05342945	chr12:48394962	COL2A1	0.81	5.59	0.54	3.16e-7	Lung cancer;
SKCM	cis	rs10504229	0.683	rs11786074	chr8:58133532	A/G	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs9303401	0.527	rs34835800	chr17:56764990	G/A	cg02118635	chr17:56770003	RAD51C;TEX14	0.77	5.03	0.49	3.06e-6	Cognitive test performance;
SKCM	cis	rs2153535	0.580	rs9505467	chr6:8520219	G/A	cg07606381	chr6:8435919	SLC35B3	0.87	6.38	0.59	1.17e-8	Motion sickness;
SKCM	cis	rs929354	0.772	rs3802126	chr7:156970281	G/A	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs1707322	1.000	rs785498	chr1:46592414	C/T	cg03146154	chr1:46216737	IPP	-0.79	-5.88	-0.55	9.5e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs244731	0.959	rs3105419	chr5:176551396	G/C	cg17509989	chr5:176798049	RGS14	0.89	5.98	0.56	6.31e-8	Urate levels in lean individuals;
SKCM	cis	rs2439831	0.850	rs16977798	chr15:44151948	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.23	6.42	0.59	9.61e-9	Lung cancer in ever smokers;
SKCM	cis	rs13118159	0.550	rs28522910	chr4:1374774	C/T	cg02475777	chr4:1388615	CRIPAK	0.83	5.8	0.55	1.33e-7	Longevity;
SKCM	cis	rs9581857	0.512	rs9581866	chr13:28063176	G/A	cg22138327	chr13:27999177	GTF3A	0.89	5.91	0.56	8.55e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs453301	0.658	rs6986044	chr8:8874786	G/C	cg15556689	chr8:8085844	FLJ10661	-0.76	-5.93	-0.56	7.98e-8	Joint mobility (Beighton score);
SKCM	cis	rs8180040	0.620	rs7373821	chr3:47080127	A/C	cg27129171	chr3:47204927	SETD2	0.74	5.37	0.52	7.84e-7	Colorectal cancer;
SKCM	cis	rs1707322	0.963	rs11211229	chr1:46400517	A/C	cg03146154	chr1:46216737	IPP	0.77	5.36	0.52	8.35e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs28386778	0.863	rs894414	chr17:61916384	T/C	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs8070624	0.549	rs60073596	chr17:17870974	G/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.86	6.01	0.56	5.51e-8	Total body bone mineral density;
SKCM	cis	rs4237845	0.680	rs10877033	chr12:58283731	T/C	cg02175503	chr12:58329896	NA	0.8	7.28	0.64	2.32e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs1046896	0.553	rs8073413	chr17:80836005	G/A	cg22027946	chr17:80790580	TBCD;ZNF750	0.65	4.77	0.48	8.45e-6	Glycated hemoglobin levels;
SKCM	cis	rs7647973	0.600	rs11920267	chr3:49275964	G/A	cg06212747	chr3:49208901	KLHDC8B	0.78	5.59	0.54	3.15e-7	Menarche (age at onset);
SKCM	cis	rs9814567	0.806	rs7626557	chr3:134318213	A/G	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.62	-5.16	-0.5	1.86e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs561341	0.882	rs2428337	chr17:30299467	C/T	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs208520	0.661	rs7747492	chr6:66857788	A/T	cg07460842	chr6:66804631	NA	-1.08	-8.03	-0.67	8.38e-12	Exhaled nitric oxide output;
SKCM	trans	rs17685	0.587	rs1623759	chr7:75724679	A/T	cg19862616	chr7:65841803	NCRNA00174	0.95	9.02	0.71	9.98e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs8064299	1.000	rs8064299	chr17:72762646	C/A	cg25054828	chr17:72772726	NAT9;TMEM104	0.77	6.9	0.62	1.22e-9	Monocyte count;
SKCM	cis	rs12971120	0.947	rs7241558	chr18:72169267	A/T	cg25817165	chr18:72167213	CNDP2	-0.65	-5.21	-0.51	1.51e-6	Refractive error;
SKCM	cis	rs62238980	0.522	rs117304447	chr22:32422267	C/T	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs12048904	0.505	rs11166508	chr1:101233511	A/G	cg16556008	chr1:101360663	SLC30A7;EXTL2	-0.81	-5.55	-0.53	3.84e-7	Multiple sclerosis;
SKCM	cis	rs2839186	0.558	rs2968	chr21:47608580	C/T	cg13012494	chr21:47604986	C21orf56	-0.71	-6.21	-0.58	2.41e-8	Testicular germ cell tumor;
SKCM	cis	rs12497850	0.829	rs12636030	chr3:49182237	A/G	cg06212747	chr3:49208901	KLHDC8B	0.75	5.0	0.49	3.47e-6	Parkinson's disease;
SKCM	cis	rs35146811	0.883	rs4134903	chr7:99711040	G/A	cg13334819	chr7:99746414	C7orf59	-0.76	-5.45	-0.53	5.72e-7	Coronary artery disease;
SKCM	cis	rs62158211	1.000	rs62158211	chr2:114106139	G/T	cg17784749	chr2:114082611	LOC440839	0.81	5.65	0.54	2.53e-7	Sleep duration (oversleepers vs undersleepers);Sleep traits (multi-trait analysis);Sleep duration;
SKCM	cis	rs8014204	1.000	rs4553560	chr14:75334199	T/C	cg06637938	chr14:75390232	RPS6KL1	-0.78	-5.83	-0.55	1.18e-7	Caffeine consumption;
SKCM	cis	rs2479724	0.905	rs2149274	chr6:41839092	T/C	cg17623882	chr6:41773611	USP49	-0.79	-6.75	-0.61	2.37e-9	Menarche (age at onset);
SKCM	cis	rs1577917	0.839	rs1596990	chr6:86550692	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.69	-6.15	-0.57	3.1e-8	Response to antipsychotic treatment;
SKCM	cis	rs9430161	0.611	rs35033941	chr1:11034382	C/T	cg02454025	chr1:11042201	C1orf127	1.08	10.13	0.75	7.19e-16	Ewing sarcoma;
SKCM	cis	rs1153858	0.725	rs74572151	chr15:45647526	T/G	cg21132104	chr15:45694354	SPATA5L1	0.92	7.81	0.66	2.22e-11	Homoarginine levels;
SKCM	cis	rs9910055	0.762	rs2631299	chr17:42219773	G/T	cg09913183	chr17:42254507	C17orf65;ASB16	0.71	6.5	0.59	7.01e-9	Total body bone mineral density;
SKCM	cis	rs3809863	0.602	rs7225700	chr17:45391804	T/C	cg08085267	chr17:45401833	C17orf57	-0.86	-6.68	-0.6	3.22e-9	Glaucoma (primary open-angle);
SKCM	cis	rs875971	0.638	rs10278816	chr7:66036987	T/C	cg00343986	chr7:65444356	GUSB	-0.7	-5.14	-0.5	1.98e-6	Aortic root size;
SKCM	cis	rs1577917	1.000	rs7756203	chr6:86627707	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.66	-5.74	-0.54	1.76e-7	Response to antipsychotic treatment;
SKCM	cis	rs2204008	0.659	rs4002655	chr12:38169881	T/G	cg26384229	chr12:38710491	ALG10B	0.82	6.58	0.6	4.87e-9	Bladder cancer;
SKCM	cis	rs7523050	0.730	rs7519107	chr1:109399367	A/C	cg08274380	chr1:109419600	GPSM2	1.12	5.52	0.53	4.24e-7	Fat distribution (HIV);
SKCM	cis	rs10779751	1.000	rs11121698	chr1:11267283	C/T	cg08854313	chr1:11322531	MTOR	1.0	8.91	0.71	1.64e-13	Body mass index;
SKCM	cis	rs523522	0.847	rs11065132	chr12:120908459	C/T	cg12219531	chr12:120966889	COQ5	0.91	7.6	0.65	5.66e-11	High light scatter reticulocyte count;
SKCM	cis	rs67311347	1.000	rs9842564	chr3:40405810	A/G	cg00091569	chr3:40428383	ENTPD3	-0.56	-4.77	-0.48	8.36e-6	Renal cell carcinoma;
SKCM	cis	rs8180040	0.676	rs7636252	chr3:47013542	T/G	cg27129171	chr3:47204927	SETD2	0.79	6.01	0.56	5.49e-8	Colorectal cancer;
SKCM	cis	rs11098499	0.754	rs1511017	chr4:120250805	G/A	cg09307838	chr4:120376055	NA	0.91	7.36	0.64	1.63e-10	Corneal astigmatism;
SKCM	cis	rs12986445	0.744	rs2138390	chr2:26112833	A/G	cg04917511	chr2:26785460	C2orf70	0.53	4.97	0.49	3.88e-6	Multiple myeloma and monoclonal gammopathy;Multiple myeloma;
SKCM	cis	rs694739	0.857	rs574835	chr11:64110668	G/A	cg02228329	chr11:64053129	BAD;GPR137	0.98	8.33	0.69	2.12e-12	Alopecia areata;Crohn's disease;Psoriasis vulgaris;
SKCM	trans	rs620875	1.000	rs646236	chr11:126851452	A/G	cg21659431	chr15:98837004	NA	-0.87	-7.62	-0.65	5e-11	Response to antipsychotic treatment;
SKCM	cis	rs2239547	0.657	rs6445539	chr3:52874296	G/A	cg11645453	chr3:52864694	ITIH4	0.79	7.19	0.63	3.41e-10	Schizophrenia;
SKCM	cis	rs9486715	0.867	rs11152924	chr6:96877383	A/G	cg06623918	chr6:96969491	KIAA0776	0.79	7.09	0.63	5.34e-10	Headache;
SKCM	cis	rs7216064	1.000	rs7214758	chr17:65880538	T/C	cg12091567	chr17:66097778	LOC651250	-0.75	-5.27	-0.51	1.19e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs2153535	0.580	rs5001130	chr6:8442298	G/A	cg07606381	chr6:8435919	SLC35B3	0.94	6.94	0.62	1.02e-9	Motion sickness;
SKCM	cis	rs6582630	0.555	rs34145279	chr12:38405588	T/C	cg26384229	chr12:38710491	ALG10B	0.88	6.86	0.61	1.46e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs8017423	1.000	rs11622075	chr14:90669894	G/T	cg04374321	chr14:90722782	PSMC1	0.94	8.33	0.69	2.19e-12	Mortality in heart failure;
SKCM	cis	rs7666738	0.830	rs62321569	chr4:98984250	T/A	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs71520386	0.632	rs2286509	chr7:22854451	T/C	cg00309339	chr7:22893653	NA	0.66	4.92	0.49	4.76e-6	Fibrinogen levels;
SKCM	cis	rs7178909	0.835	rs7169019	chr15:90400364	T/G	cg19708238	chr15:90437601	AP3S2	0.69	4.86	0.48	6.01e-6	Common traits (Other);
SKCM	cis	rs10193935	0.901	rs13384885	chr2:42536646	G/C	cg27598129	chr2:42591480	NA	-0.88	-6.71	-0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2836974	0.897	rs8132419	chr21:40527827	C/T	cg17971929	chr21:40555470	PSMG1	0.87	8.48	0.69	1.1e-12	Cognitive function;
SKCM	cis	rs10791097	0.694	rs4264159	chr11:130755784	G/T	cg12179176	chr11:130786555	SNX19	0.91	8.08	0.67	6.69e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs7659604	0.537	rs6823818	chr4:122731699	G/C	cg19748678	chr4:122722346	EXOSC9	0.65	5.4	0.52	7.02e-7	Type 2 diabetes;
SKCM	trans	rs6481128	0.708	rs1733752	chr10:56702753	C/T	cg04272632	chr1:34629400	CSMD2	0.67	7.3	0.64	2.08e-10	Extraversion;
SKCM	cis	rs4803468	0.967	rs3213860	chr19:41920211	T/C	cg09537434	chr19:41945824	ATP5SL	-1.1	-13.82	-0.84	1.16e-22	Height;
SKCM	cis	rs7666738	0.715	rs61114099	chr4:98931270	C/T	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7208859	0.623	rs55638872	chr17:29149552	G/C	cg13385521	chr17:29058706	SUZ12P	1.02	5.45	0.52	5.8e-7	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs867186	1.000	rs7263253	chr20:33649376	T/C	cg04194272	chr20:33683537	NA	-1.38	-7.2	-0.63	3.29e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs7216064	1.000	rs56148300	chr17:65892752	T/C	cg12091567	chr17:66097778	LOC651250	-0.78	-5.27	-0.51	1.19e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs4555082	1.000	rs4555082	chr14:105758964	C/T	cg13114125	chr14:105738426	BRF1	-0.67	-5.16	-0.5	1.84e-6	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs10504073	0.647	rs10808744	chr8:49988984	A/G	cg00325661	chr8:49890786	NA	0.79	6.82	0.61	1.73e-9	Blood metabolite ratios;
SKCM	cis	rs3749237	0.595	rs1464566	chr3:49459376	T/C	cg03060546	chr3:49711283	APEH	0.67	4.95	0.49	4.23e-6	Resting heart rate;
SKCM	cis	rs995000	0.931	rs10889350	chr1:63085266	C/T	cg06896770	chr1:63153194	DOCK7	0.76	7.17	0.63	3.77e-10	Triglyceride levels;
SKCM	cis	rs6089829	0.962	rs6062777	chr20:61663748	G/A	cg08564027	chr20:61660810	NA	0.63	5.65	0.54	2.56e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs10905065	0.931	rs10795510	chr10:5758827	G/A	cg09234995	chr10:5726438	C10orf18	-0.67	-5.72	-0.54	1.88e-7	Menopause (age at onset);
SKCM	cis	rs1153858	1.000	rs12437887	chr15:45669094	G/A	cg21132104	chr15:45694354	SPATA5L1	0.93	7.94	0.67	1.22e-11	Homoarginine levels;
SKCM	cis	rs4906332	0.782	rs7161305	chr14:104002234	G/A	cg04998671	chr14:104000505	TRMT61A	-0.72	-4.89	-0.48	5.39e-6	Coronary artery disease;
SKCM	cis	rs2243480	0.803	rs34004500	chr7:65312178	A/T	cg18252515	chr7:66147081	NA	-1.29	-7.41	-0.64	1.3e-10	Diabetic kidney disease;
SKCM	cis	rs11083475	0.686	rs73040728	chr19:39257601	C/G	cg07403899	chr19:39283540	NA	-0.56	-5.06	-0.5	2.75e-6	Heart rate;
SKCM	cis	rs7666738	0.753	rs13111199	chr4:98953705	A/G	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs826838	1.000	rs1719830	chr12:39096992	T/G	cg26384229	chr12:38710491	ALG10B	-0.94	-8.17	-0.68	4.46e-12	Heart rate;
SKCM	cis	rs12926788	0.640	rs73551577	chr16:24845143	G/A	cg06028605	chr16:24865363	SLC5A11	0.56	4.97	0.49	3.88e-6	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs514406	0.644	rs6661196	chr1:53203664	A/G	cg16325326	chr1:53192061	ZYG11B	-0.86	-9.02	-0.71	9.97e-14	Monocyte count;
SKCM	cis	rs7666738	0.830	rs13138051	chr4:99050367	C/T	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9911578	1.000	rs172565	chr17:56808996	A/T	cg12560992	chr17:57184187	TRIM37	0.95	7.69	0.66	3.7e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs10503709	0.861	rs1383578	chr8:21448635	T/C	cg23716449	chr8:21608280	GFRA2	0.49	4.95	0.49	4.11e-6	Blood protein levels;
SKCM	cis	rs8081692	1	rs8081692	chr17:38154595	A/G	cg17467752	chr17:38218738	THRA	0.67	6.13	0.57	3.38e-8	Neutrophil count;
SKCM	cis	rs9911578	0.967	rs8075786	chr17:56819216	T/C	cg12560992	chr17:57184187	TRIM37	0.95	7.69	0.66	3.7e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs6951245	1.000	rs1881123	chr7:1084706	C/T	cg03188948	chr7:1209495	NA	1.12	6.25	0.58	2.02e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs420259	0.516	rs120961	chr16:23590302	C/T	cg10006042	chr16:23042421	NA	0.36	4.85	0.48	6.15e-6	Bipolar disorder;
SKCM	cis	rs67311347	0.544	rs6769627	chr3:40327845	G/A	cg02782426	chr3:40428986	ENTPD3	0.5	5.02	0.49	3.14e-6	Renal cell carcinoma;
SKCM	cis	rs7959452	0.640	rs4761233	chr12:69722880	T/C	cg14784868	chr12:69753453	YEATS4	0.66	5.94	0.56	7.56e-8	Blood protein levels;
SKCM	cis	rs9300255	0.722	rs28458312	chr12:123863265	G/T	cg00376283	chr12:123451042	ABCB9	-0.78	-5.26	-0.51	1.24e-6	Neutrophil percentage of white cells;
SKCM	cis	rs7523273	0.606	rs2488252	chr1:207938228	C/T	cg22525895	chr1:207977042	MIR29B2	0.81	7.08	0.63	5.47e-10	Schizophrenia;
SKCM	cis	rs910316	0.737	rs175080	chr14:75513828	G/A	cg08847533	chr14:75593920	NEK9	-0.82	-6.75	-0.61	2.3e-9	Height;
SKCM	cis	rs28595532	0.920	rs114678295	chr4:119756281	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs34779708	0.931	rs7923172	chr10:35309367	G/A	cg03585969	chr10:35415529	CREM	0.76	6.23	0.58	2.17e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs12214131	0.965	rs12203376	chr6:106227347	C/T	cg22231056	chr6:106958645	AIM1	0.56	4.77	0.48	8.32e-6	Male-pattern baldness;
SKCM	cis	rs2204008	0.837	rs2387317	chr12:38235319	T/C	cg26384229	chr12:38710491	ALG10B	0.87	6.9	0.62	1.21e-9	Bladder cancer;
SKCM	cis	rs9880211	0.800	rs35100027	chr3:136467561	T/A	cg21827317	chr3:136751795	NA	-0.69	-5.28	-0.51	1.13e-6	Body mass index;Height;
SKCM	cis	rs4790333	0.562	rs2429904	chr17:2260362	T/C	cg02569219	chr17:2266849	SGSM2	0.68	5.74	0.54	1.75e-7	Proinsulin levels;
SKCM	cis	rs7683537	0.887	rs7678412	chr4:185648611	T/C	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Systemic lupus erythematosus;
SKCM	cis	rs4930103	0.508	rs217205	chr11:1973205	T/C	cg23202291	chr11:1979235	NA	-0.64	-6.74	-0.61	2.44e-9	DNA methylation (parent-of-origin);DNA methylation (variation);
SKCM	cis	rs10089	1.000	rs4836370	chr5:127499224	A/G	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.86	7.85	0.66	1.85e-11	Ileal carcinoids;
SKCM	cis	rs769267	0.965	rs12977937	chr19:19429975	C/G	cg26732615	chr19:19648335	CILP2;YJEFN3	0.65	6.08	0.57	4.12e-8	Tonsillectomy;
SKCM	cis	rs4819052	1.000	rs733739	chr21:46666210	A/G	cg02159808	chr21:46707872	POFUT2;LOC642852	0.79	5.87	0.55	1.01e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs67460515	0.563	rs11922957	chr3:160828865	A/C	cg03342759	chr3:160939853	NMD3	-0.73	-6.3	-0.58	1.62e-8	Parkinson's disease;
SKCM	cis	rs7408868	0.908	rs2074619	chr19:15276919	G/A	cg14696996	chr19:15285081	NOTCH3	0.82	4.92	0.49	4.7e-6	Pulse pressure;
SKCM	cis	rs2279817	0.820	rs11203440	chr1:18026352	A/G	cg17142039	chr1:18149651	ACTL8	0.6	5.1	0.5	2.32e-6	Neuroticism;
SKCM	cis	rs1577917	0.958	rs34622605	chr6:86456519	G/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.87	-8.7	-0.7	4.17e-13	Response to antipsychotic treatment;
SKCM	trans	rs17685	0.736	rs4732594	chr7:75753273	T/C	cg19862616	chr7:65841803	NCRNA00174	0.94	9.49	0.73	1.22e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1124769	0.871	rs17646461	chr15:51158110	C/T	cg21246271	chr15:51200259	AP4E1	-0.79	-5.0	-0.49	3.48e-6	Cognitive performance;
SKCM	cis	rs2836950	0.545	rs2836956	chr21:40623018	C/G	cg11890956	chr21:40555474	PSMG1	0.71	5.56	0.53	3.68e-7	Menarche (age at onset);
SKCM	cis	rs754466	0.651	rs11815015	chr10:79625482	C/T	cg17075019	chr10:79541650	NA	-0.73	-6.45	-0.59	8.46e-9	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs28374715	0.532	rs28897479	chr15:41690851	T/G	cg18705301	chr15:41695430	NDUFAF1	-1.19	-11.85	-0.8	4.1e-19	Ulcerative colitis;
SKCM	cis	rs7044106	0.791	rs2900177	chr9:123497645	C/T	cg09419670	chr9:123605666	PSMD5;LOC253039	0.53	4.89	0.48	5.22e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs4132509	1.000	rs10927050	chr1:243805907	A/G	cg21452805	chr1:244014465	NA	0.79	5.1	0.5	2.32e-6	RR interval (heart rate);
SKCM	cis	rs12478296	1.000	rs7603984	chr2:243047294	A/G	cg06360820	chr2:242988706	NA	-1.0	-5.02	-0.49	3.14e-6	Obesity-related traits;
SKCM	cis	rs7811142	0.943	rs10241492	chr7:99994813	A/G	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.16	7.68	0.66	3.87e-11	Platelet count;
SKCM	cis	rs1862618	0.802	rs7733041	chr5:56107377	A/C	cg03609598	chr5:56110824	MAP3K1	-0.86	-5.08	-0.5	2.49e-6	Initial pursuit acceleration;
SKCM	cis	rs4242434	0.757	rs4872531	chr8:22529695	A/G	cg03733263	chr8:22462867	KIAA1967	-0.84	-6.56	-0.6	5.3e-9	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs7829975	0.714	rs60315134	chr8:8670599	A/G	cg15556689	chr8:8085844	FLJ10661	0.67	5.9	0.56	8.87e-8	Mood instability;
SKCM	cis	rs9913156	0.793	rs8074545	chr17:4567337	C/G	cg19197139	chr17:4613644	ARRB2	-0.79	-5.3	-0.51	1.04e-6	Lymphocyte counts;
SKCM	cis	rs2180341	1.000	rs3798850	chr6:127613966	C/T	cg24812749	chr6:127587940	RNF146	0.87	7.33	0.64	1.85e-10	Breast cancer;
SKCM	cis	rs6061231	0.631	rs927133	chr20:60972109	C/T	cg24112000	chr20:60950667	NA	-0.59	-6.07	-0.57	4.3e-8	Colorectal cancer;
SKCM	cis	rs523522	0.962	rs670568	chr12:121021206	C/T	cg12219531	chr12:120966889	COQ5	0.9	7.63	0.65	4.83e-11	High light scatter reticulocyte count;
SKCM	cis	rs897984	0.762	rs4889604	chr16:30985994	G/T	cg00531865	chr16:30841666	NA	0.59	4.98	0.49	3.69e-6	Dementia with Lewy bodies;
SKCM	cis	rs10504229	1.000	rs61998259	chr8:58192290	T/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs6500395	1.000	rs7187513	chr16:48591638	T/C	cg04672837	chr16:48644449	N4BP1	0.69	5.73	0.54	1.8e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs11098499	0.863	rs1010740	chr4:120463409	C/T	cg09307838	chr4:120376055	NA	-0.97	-7.5	-0.65	8.64e-11	Corneal astigmatism;
SKCM	cis	rs28595532	0.920	rs17325129	chr4:119778284	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs67460515	0.892	rs10513564	chr3:161059762	A/G	cg03342759	chr3:160939853	NMD3	-0.8	-7.25	-0.63	2.6e-10	Parkinson's disease;
SKCM	cis	rs6545883	0.929	rs7563678	chr2:61741811	C/T	cg15711740	chr2:61764176	XPO1	0.75	5.32	0.52	9.7e-7	Tuberculosis;
SKCM	cis	rs2836974	0.931	rs2989330	chr21:40716209	A/G	cg11644478	chr21:40555479	PSMG1	0.76	6.4	0.59	1.05e-8	Cognitive function;
SKCM	cis	rs875971	0.798	rs12698522	chr7:65967341	T/C	cg11764359	chr7:65958608	NA	0.75	6.79	0.61	1.95e-9	Aortic root size;
SKCM	cis	rs6840360	0.550	rs6836343	chr4:152497564	A/G	cg22705602	chr4:152727874	NA	-0.52	-5.56	-0.53	3.71e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7811142	1.000	rs11763511	chr7:100081944	G/A	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-1.02	-5.76	-0.55	1.59e-7	Platelet count;
SKCM	cis	rs2070488	0.662	rs7375040	chr3:38469116	A/G	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.78	5.89	0.55	9.38e-8	Electrocardiographic conduction measures;
SKCM	cis	rs10504073	0.647	rs55920380	chr8:50026353	G/A	cg00325661	chr8:49890786	NA	0.79	6.76	0.61	2.29e-9	Blood metabolite ratios;
SKCM	cis	rs35146811	0.735	rs1727133	chr7:99812870	C/T	cg22906224	chr7:99728672	NA	-0.72	-5.76	-0.55	1.61e-7	Coronary artery disease;
SKCM	cis	rs748404	0.578	rs576557	chr15:43597737	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	0.8	5.92	0.56	8.14e-8	Lung cancer;
SKCM	cis	rs7829975	0.688	rs13270194	chr8:8378102	T/C	cg06636001	chr8:8085503	FLJ10661	0.85	7.36	0.64	1.62e-10	Mood instability;
SKCM	cis	rs7618501	0.633	rs2856234	chr3:50139142	A/G	cg24110177	chr3:50126178	RBM5	0.61	5.29	0.51	1.09e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs28595532	0.920	rs116821181	chr4:119734892	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs2404602	1.000	rs12594212	chr15:76802014	T/A	cg23625390	chr15:77176239	SCAPER	0.75	7.27	0.64	2.44e-10	Blood metabolite levels;
SKCM	cis	rs11673344	0.764	rs16971873	chr19:37469423	C/T	cg07624650	chr19:37064219	ZNF529	-0.78	-4.85	-0.48	6.09e-6	Obesity-related traits;
SKCM	cis	rs5769765	0.773	rs9616751	chr22:50222236	T/G	cg22709217	chr22:50311962	ALG12;CRELD2	-0.84	-5.3	-0.51	1.07e-6	Schizophrenia;
SKCM	cis	rs7666738	0.715	rs3857216	chr4:99032129	G/T	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2836950	0.520	rs8130240	chr21:40538108	G/A	cg17971929	chr21:40555470	PSMG1	-0.76	-6.53	-0.59	6.19e-9	Menarche (age at onset);
SKCM	cis	rs2836974	0.565	rs34304022	chr21:40579619	G/A	cg11890956	chr21:40555474	PSMG1	0.96	6.73	0.61	2.51e-9	Cognitive function;
SKCM	cis	rs950776	0.684	rs11637635	chr15:78877150	A/G	cg06917634	chr15:78832804	PSMA4	-0.85	-6.83	-0.61	1.68e-9	Sudden cardiac arrest;
SKCM	cis	rs1348850	0.632	rs13008833	chr2:178514439	G/C	cg02961200	chr2:178257176	LOC100130691;AGPS	0.72	4.8	0.48	7.54e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs7216064	1.000	rs62084214	chr17:65843325	C/G	cg12091567	chr17:66097778	LOC651250	-0.77	-5.53	-0.53	4.06e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs6753739	0.871	rs6436109	chr2:219980481	A/T	cg09617556	chr2:219924408	IHH	0.48	5.08	0.5	2.5e-6	Height;
SKCM	cis	rs8072100	0.967	rs9894905	chr17:45485982	C/T	cg08085267	chr17:45401833	C17orf57	-0.66	-5.95	-0.56	7.35e-8	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs1401999	1.000	rs6443924	chr3:183679532	A/G	cg01324343	chr3:183735012	ABCC5	0.93	10.78	0.77	4.03e-17	Anterior chamber depth;
SKCM	cis	rs1044826	0.642	rs2118981	chr3:139178853	A/G	cg15131784	chr3:139108705	COPB2	0.65	4.77	0.48	8.43e-6	Obesity-related traits;
SKCM	cis	rs1912528	1.000	rs1912528	chr4:140945966	C/T	cg11128457	chr4:140864437	MAML3	0.59	4.96	0.49	4.02e-6	Educational attainment (years of education);
SKCM	cis	rs75920871	0.588	rs1940626	chr11:116828121	T/C	cg01368799	chr11:117014884	PAFAH1B2	-0.69	-5.51	-0.53	4.46e-7	Subjective well-being;
SKCM	cis	rs2188420	0.872	rs17153616	chr7:106568489	T/G	cg23615938	chr7:105753134	SYPL1	-0.95	-5.14	-0.5	1.96e-6	Interferon gamma levels;
SKCM	cis	rs514406	0.861	rs35517489	chr1:53304062	G/C	cg16325326	chr1:53192061	ZYG11B	1.0	11.05	0.78	1.25e-17	Monocyte count;
SKCM	cis	rs861020	1.000	rs622832	chr1:209974232	A/C	cg09163369	chr1:210001066	C1orf107	0.8	5.15	0.5	1.9e-6	Orofacial clefts;
SKCM	cis	rs208520	0.526	rs2881644	chr6:66803535	A/C	cg07460842	chr6:66804631	NA	1.16	13.18	0.83	1.52e-21	Exhaled nitric oxide output;
SKCM	cis	rs28386778	0.769	rs6504179	chr17:61812995	T/G	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.34	0.52	9.08e-7	Prudent dietary pattern;
SKCM	cis	rs9733	0.680	rs3738484	chr1:150552330	G/T	cg13175981	chr1:150552382	MCL1	0.75	6.6	0.6	4.55e-9	Tonsillectomy;
SKCM	cis	rs798554	0.679	rs1636253	chr7:2885123	A/G	cg19346786	chr7:2764209	NA	-0.65	-6.79	-0.61	1.96e-9	Height;
SKCM	cis	rs362296	0.698	rs362266	chr4:3259632	C/G	cg24015175	chr4:3319247	RGS12	-0.59	-5.43	-0.52	6.27e-7	Parental longevity (mother's age at death);
SKCM	cis	rs478304	0.654	rs10896035	chr11:65461160	G/A	cg27068330	chr11:65405492	SIPA1	-0.89	-7.49	-0.65	9.25e-11	Acne (severe);
SKCM	cis	rs8017423	0.935	rs12884698	chr14:90750566	G/A	cg04374321	chr14:90722782	PSMC1	-0.95	-8.73	-0.7	3.68e-13	Mortality in heart failure;
SKCM	trans	rs1814175	0.645	rs1721997	chr11:49916653	T/C	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs7633770	0.841	rs11709936	chr3:46680483	C/G	cg11219411	chr3:46661640	NA	0.7	6.93	0.62	1.05e-9	Coronary artery disease;
SKCM	cis	rs3135063	0.847	rs1138690	chr4:3291401	G/T	cg11471262	chr4:3318911	RGS12	0.56	4.88	0.48	5.48e-6	Blood protein levels;
SKCM	cis	rs1577917	1.000	rs6933377	chr6:86705255	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.8	8.21	0.68	3.65e-12	Response to antipsychotic treatment;
SKCM	cis	rs875971	0.965	rs10267430	chr7:65743023	G/T	cg18876405	chr7:65276391	NA	-0.68	-6.79	-0.61	1.94e-9	Aortic root size;
SKCM	cis	rs11249608	0.548	rs34881171	chr5:178451932	C/T	cg21905437	chr5:178450457	ZNF879	0.76	6.46	0.59	8.29e-9	Pubertal anthropometrics;
SKCM	cis	rs644799	0.635	rs10831428	chr11:95508404	C/A	cg25622487	chr11:95524042	FAM76B;CEP57	0.76	6.47	0.59	7.89e-9	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs7659604	0.540	rs67150579	chr4:122704331	T/A	cg19671926	chr4:122722719	EXOSC9	0.76	6.97	0.62	9.04e-10	Type 2 diabetes;
SKCM	cis	rs9896933	0.561	rs2264375	chr17:80692709	T/A	cg20578329	chr17:80767326	TBCD	-0.91	-6.7	-0.6	2.89e-9	Bone mineral accretion in asthma (oral corticosteroid dose interaction);
SKCM	cis	rs1577917	1.000	rs10944163	chr6:86658693	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.66	-5.74	-0.54	1.76e-7	Response to antipsychotic treatment;
SKCM	cis	rs910316	0.523	rs4026175	chr14:75502240	C/A	cg08847533	chr14:75593920	NEK9	0.82	7.14	0.63	4.24e-10	Height;
SKCM	cis	rs2153535	0.504	rs5001323	chr6:8451605	C/T	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs1185460	0.967	rs3825061	chr11:118944675	C/T	cg23280166	chr11:118938394	VPS11	0.59	5.31	0.51	1.02e-6	Coronary artery disease;
SKCM	cis	rs951366	0.528	rs1172198	chr1:205662718	C/T	cg11965913	chr1:205819406	PM20D1	0.8	6.78	0.61	2.03e-9	Menarche (age at onset);
SKCM	cis	rs2033711	0.755	rs4801587	chr19:58936679	C/A	cg12042659	chr19:58951599	ZNF132	0.68	5.87	0.55	1.01e-7	Uric acid clearance;
SKCM	trans	rs1814175	0.817	rs7109440	chr11:49966296	C/T	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs8017423	0.904	rs12433417	chr14:90804028	A/G	cg04374321	chr14:90722782	PSMC1	-1.03	-9.68	-0.74	5.19e-15	Mortality in heart failure;
SKCM	cis	rs2836974	0.644	rs719230	chr21:40676307	C/T	cg17971929	chr21:40555470	PSMG1	-0.74	-7.06	-0.62	5.99e-10	Cognitive function;
SKCM	cis	rs362272	0.545	rs3135146	chr4:3307638	C/G	cg00764545	chr4:3318001	RGS12	-0.94	-11.98	-0.8	2.31e-19	Serum sulfate level;
SKCM	cis	rs1153858	1.000	rs56806728	chr15:45637814	A/G	cg10760299	chr15:45669010	GATM	0.58	6.04	0.56	4.83e-8	Homoarginine levels;
SKCM	cis	rs12824058	0.831	rs7979497	chr12:130804706	C/T	cg24838063	chr12:130822603	PIWIL1	0.78	6.78	0.61	2.04e-9	Menopause (age at onset);
SKCM	cis	rs2153535	0.541	rs1414347	chr6:8471831	T/C	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs4423214	0.550	rs4944885	chr11:71114075	C/T	cg05163923	chr11:71159392	DHCR7	0.59	5.23	0.51	1.38e-6	Vitamin D levels;
SKCM	cis	rs7809950	0.593	rs62482503	chr7:106987988	A/G	cg23024343	chr7:107201750	COG5	-0.82	-7.0	-0.62	7.72e-10	Coronary artery disease;
SKCM	cis	rs2836950	0.565	rs2836942	chr21:40591381	A/G	cg11644478	chr21:40555479	PSMG1	-0.64	-5.02	-0.49	3.17e-6	Menarche (age at onset);
SKCM	cis	rs7772486	0.743	rs1292339	chr6:145967086	C/T	cg05347473	chr6:146136440	FBXO30	-0.56	-5.21	-0.51	1.49e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2180341	1.000	rs9321073	chr6:127609691	C/T	cg24812749	chr6:127587940	RNF146	0.87	7.33	0.64	1.85e-10	Breast cancer;
SKCM	cis	rs2180341	0.781	rs7760652	chr6:127572096	A/G	cg24812749	chr6:127587940	RNF146	0.79	6.57	0.6	5.17e-9	Breast cancer;
SKCM	cis	rs1218582	0.772	rs6669791	chr1:154845484	G/T	cg03351412	chr1:154909251	PMVK	0.8	6.96	0.62	9.42e-10	Prostate cancer;
SKCM	cis	rs9640161	0.750	rs3800780	chr7:150027284	C/A	cg10018233	chr7:150070692	REPIN1	0.68	5.27	0.51	1.19e-6	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs12971120	0.891	rs2278159	chr18:72178161	T/C	cg25817165	chr18:72167213	CNDP2	-0.65	-4.87	-0.48	5.69e-6	Refractive error;
SKCM	cis	rs875971	0.862	rs6460307	chr7:66060871	A/G	cg11764359	chr7:65958608	NA	0.72	6.65	0.6	3.65e-9	Aortic root size;
SKCM	cis	rs1395	0.744	rs3739092	chr2:27462076	C/T	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.51	5.14	0.5	1.96e-6	Blood metabolite levels;
SKCM	cis	rs10193935	1.000	rs10180528	chr2:42436723	T/A	cg27598129	chr2:42591480	NA	-0.88	-6.71	-0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10489202	1.000	rs7520232	chr1:168011995	T/C	cg24449463	chr1:168025552	DCAF6	-0.8	-6.19	-0.57	2.63e-8	Schizophrenia;
SKCM	cis	rs72615157	0.645	rs76281814	chr7:99846414	T/C	cg07160278	chr7:100027354	MEPCE;ZCWPW1	0.97	5.63	0.54	2.73e-7	Lung function (FEV1/FVC);
SKCM	cis	rs1691799	0.867	rs1168309	chr12:66726439	A/G	cg16791601	chr12:66731901	HELB	0.62	5.53	0.53	4.17e-7	White blood cell count (basophil);
SKCM	cis	rs8072100	0.905	rs8078686	chr17:45735706	T/C	cg08085267	chr17:45401833	C17orf57	0.59	5.43	0.52	6.22e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs875971	1.000	rs1183245	chr7:65541185	C/T	cg11764359	chr7:65958608	NA	-0.89	-8.44	-0.69	1.29e-12	Aortic root size;
SKCM	cis	rs28595532	0.920	rs17324821	chr4:119770716	A/G	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs7954584	0.545	rs12824593	chr12:122374108	G/A	cg22618164	chr12:122356400	WDR66	0.54	5.44	0.52	6.02e-7	Mean corpuscular volume;
SKCM	cis	rs3793683	0.545	rs12784446	chr10:134589094	T/G	cg18305652	chr10:134549665	INPP5A	0.61	6.16	0.57	2.94e-8	Migraine;
SKCM	cis	rs7811142	0.830	rs73401451	chr7:99981895	T/C	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.07	6.7	0.6	2.88e-9	Platelet count;
SKCM	cis	rs826838	1.000	rs55828987	chr12:39056421	A/C	cg13010199	chr12:38710504	ALG10B	0.75	6.01	0.56	5.7e-8	Heart rate;
SKCM	cis	rs9926296	0.585	rs1800337	chr16:89845194	A/G	cg04287289	chr16:89883240	FANCA	1.04	12.56	0.82	2.03e-20	Vitiligo;
SKCM	cis	rs12586317	0.547	rs4982234	chr14:35460106	T/A	cg16230307	chr14:35515116	FAM177A1	0.81	5.88	0.55	9.47e-8	Psoriasis;
SKCM	cis	rs2404602	1.000	rs12148786	chr15:76800362	A/G	cg23625390	chr15:77176239	SCAPER	0.75	7.27	0.64	2.44e-10	Blood metabolite levels;
SKCM	cis	rs909674	0.818	rs7364148	chr22:39842165	T/C	cg11247378	chr22:39784982	NA	-0.45	-5.04	-0.5	2.9e-6	IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis);IgG glycosylation;IgG digalactosylation phenotypes (multivariate analysis);IgG sialylation phenotypes (multivariate analysis);IgG monogalactosylation phenotypes (multivariate analysis);IgG fucosylation phenotypes (multivariate analysis);IgG N-glycosylation phenotypes (multivariate analysis);IgG disialylation phenotypes (multivariate analysis);IgG galactosylation phenotypes (multivariate analysis);Post bronchodilator FEV1;
SKCM	cis	rs10751667	0.666	rs6597957	chr11:982294	T/A	cg10932868	chr11:921992	NA	0.56	5.47	0.53	5.29e-7	Alzheimer's disease (late onset);
SKCM	cis	rs79839061	0.518	rs3755960	chr4:895060	G/T	cg07828340	chr4:882639	GAK	1.03	5.84	0.55	1.14e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs9308433	0.553	rs9308435	chr1:214500166	C/T	cg06198575	chr1:214491504	SMYD2	0.81	5.09	0.5	2.41e-6	IgG glycosylation;
SKCM	cis	rs9790314	0.846	rs4560315	chr3:160982132	G/T	cg03342759	chr3:160939853	NMD3	-0.72	-8.12	-0.68	5.59e-12	Morning vs. evening chronotype;
SKCM	cis	rs56104184	0.830	rs45589039	chr19:49355385	C/T	cg15549821	chr19:49342101	PLEKHA4	-1.27	-7.95	-0.67	1.17e-11	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs7438704	0.532	rs192832	chr4:48338344	A/C	cg15299388	chr4:48491941	ZAR1	0.42	4.83	0.48	6.66e-6	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs732528	0.501	rs6508039	chr18:48361252	G/A	cg03255741	chr18:48556964	SMAD4	-0.68	-4.95	-0.49	4.23e-6	Entorhinal cortical thickness;
SKCM	cis	rs6912958	0.703	rs9353483	chr6:88097180	G/A	cg08069147	chr6:88032118	GJB7;C6orf162	0.63	5.29	0.51	1.09e-6	Monocyte percentage of white cells;
SKCM	cis	rs7647973	0.621	rs3774800	chr3:49334768	A/G	cg06212747	chr3:49208901	KLHDC8B	-0.75	-5.34	-0.52	8.99e-7	Menarche (age at onset);
SKCM	cis	rs2361718	0.568	rs1042397	chr17:78092063	G/A	cg09238746	chr17:78121135	EIF4A3	-0.75	-4.83	-0.48	6.77e-6	Yeast infection;
SKCM	cis	rs9910055	0.747	rs2905981	chr17:42238625	C/T	cg10896456	chr17:42255109	ASB16;C17orf65	0.66	6.43	0.59	9.35e-9	Total body bone mineral density;
SKCM	cis	rs72781680	1.000	rs7594510	chr2:24173377	A/G	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	cis	rs4927850	0.829	rs6768483	chr3:195745963	C/G	cg01181863	chr3:195395398	SDHAP2	-0.97	-6.52	-0.59	6.36e-9	Pancreatic cancer;
SKCM	cis	rs28386778	0.863	rs2727288	chr17:61901197	T/A	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs1580019	0.885	rs4580942	chr7:32496435	A/G	cg06627557	chr7:32535165	LSM5;AVL9	0.76	5.85	0.55	1.09e-7	Cognitive ability;
SKCM	cis	rs7959452	0.868	rs12812860	chr12:69746671	T/C	cg20891283	chr12:69753455	YEATS4	0.74	6.28	0.58	1.78e-8	Blood protein levels;
SKCM	cis	rs9300255	0.679	rs4759420	chr12:123794871	G/C	cg05973401	chr12:123451056	ABCB9	0.82	5.72	0.54	1.92e-7	Neutrophil percentage of white cells;
SKCM	cis	rs875971	0.619	rs12533585	chr7:65984605	G/C	cg18876405	chr7:65276391	NA	0.8	7.11	0.63	4.86e-10	Aortic root size;
SKCM	cis	rs8070128	0.568	rs3935505	chr17:17882020	T/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.84	6.13	0.57	3.32e-8	Total body bone mineral density;
SKCM	cis	rs2204008	0.687	rs2320523	chr12:38251397	T/C	cg13010199	chr12:38710504	ALG10B	0.66	4.8	0.48	7.64e-6	Bladder cancer;
SKCM	cis	rs2721195	0.719	rs4925811	chr8:145802447	G/T	cg15320075	chr8:145703422	NA	-0.81	-6.7	-0.6	2.96e-9	Age at first birth;
SKCM	cis	rs9815354	0.680	rs73071354	chr3:41829186	C/A	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs701145	0.585	rs242577	chr3:153941208	G/A	cg17054900	chr3:154042577	DHX36	1.19	5.1	0.5	2.37e-6	Coronary artery disease;
SKCM	cis	rs1799949	0.683	rs55737636	chr17:41264739	C/T	cg25918947	chr17:41365094	TMEM106A	-0.6	-5.54	-0.53	3.89e-7	Menopause (age at onset);
SKCM	cis	rs2204008	0.657	rs8186888	chr12:38334260	T/G	cg26384229	chr12:38710491	ALG10B	0.73	5.8	0.55	1.33e-7	Bladder cancer;
SKCM	cis	rs2439831	0.850	rs12702	chr15:44093927	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	-0.95	-6.05	-0.57	4.7e-8	Lung cancer in ever smokers;
SKCM	cis	rs9911578	0.757	rs4793954	chr17:56629527	G/T	cg05425664	chr17:57184151	TRIM37	0.67	4.85	0.48	6.12e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2204008	0.694	rs1672436	chr12:38132547	G/T	cg26384229	chr12:38710491	ALG10B	-0.67	-5.47	-0.53	5.23e-7	Bladder cancer;
SKCM	cis	rs944289	0.708	rs1958622	chr14:36596495	G/A	cg20710709	chr14:37135671	PAX9	0.42	4.82	0.48	6.96e-6	Thyroid cancer;
SKCM	cis	rs2439831	1.000	rs2245054	chr15:43751909	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.19	7.61	0.65	5.35e-11	Lung cancer in ever smokers;
SKCM	cis	rs7772486	0.764	rs2265468	chr6:146218346	A/C	cg23711669	chr6:146136114	FBXO30	0.76	7.66	0.66	4.34e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs362272	0.524	rs7435601	chr4:3369645	A/G	cg21096898	chr4:3318625	RGS12	1.0	12.13	0.81	1.22e-19	Serum sulfate level;
SKCM	cis	rs861020	0.959	rs658860	chr1:209990549	C/T	cg05527609	chr1:210001259	C1orf107	1.02	7.29	0.64	2.25e-10	Orofacial clefts;
SKCM	cis	rs7100689	0.646	rs1934692	chr10:82125734	C/A	cg01528321	chr10:82214614	TSPAN14	0.8	7.0	0.62	7.98e-10	Post bronchodilator FEV1;
SKCM	cis	rs1348850	0.872	rs12991272	chr2:178457339	T/C	cg02961200	chr2:178257176	LOC100130691;AGPS	0.75	5.84	0.55	1.14e-7	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs7772486	0.558	rs702316	chr6:146004677	C/A	cg05347473	chr6:146136440	FBXO30	-0.66	-5.21	-0.51	1.51e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs10779751	0.960	rs11121712	chr1:11320329	G/C	cg08854313	chr1:11322531	MTOR	1.02	9.43	0.73	1.61e-14	Body mass index;
SKCM	cis	rs55962025	0.669	rs28403215	chr4:3172439	C/T	cg21096898	chr4:3318625	RGS12	-0.58	-4.95	-0.49	4.21e-6	Parental longevity (mother's age at death);
SKCM	cis	rs10937913	0.534	rs12511418	chr4:2734859	C/A	cg19433769	chr4:2420260	ZFYVE28	0.73	5.01	0.49	3.36e-6	Extrinsic epigenetic age acceleration;
SKCM	cis	rs644799	1.000	rs11021319	chr11:95523123	C/G	cg25622487	chr11:95524042	FAM76B;CEP57	0.66	5.12	0.5	2.18e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs873946	0.557	rs34854637	chr10:134582962	A/G	cg26818010	chr10:134567672	INPP5A	-0.82	-6.48	-0.59	7.43e-9	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs736408	0.716	rs2239550	chr3:52822509	G/C	cg18404041	chr3:52824283	ITIH1	-0.54	-4.92	-0.49	4.79e-6	Bipolar disorder;
SKCM	cis	rs6570726	0.791	rs400329	chr6:145879442	A/T	cg23711669	chr6:146136114	FBXO30	0.87	9.14	0.72	5.82e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1005277	0.579	rs2504143	chr10:38383706	C/T	cg00409905	chr10:38381863	ZNF37A	-0.64	-5.96	-0.56	6.77e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs2832191	0.755	rs55671430	chr21:30492421	G/C	cg24692254	chr21:30365293	RNF160	-0.9	-8.03	-0.67	8.39e-12	Dental caries;
SKCM	cis	rs2479724	0.551	rs9529	chr6:41903007	T/C	cg17623882	chr6:41773611	USP49	-0.7	-5.01	-0.49	3.27e-6	Menarche (age at onset);
SKCM	cis	rs1577917	0.917	rs4098044	chr6:86462066	T/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.6	-5.1	-0.5	2.3e-6	Response to antipsychotic treatment;
SKCM	cis	rs7208859	0.623	rs7208088	chr17:29143667	C/T	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs763014	0.932	rs35067229	chr16:649638	T/C	cg07343612	chr16:622815	PIGQ	-0.67	-5.78	-0.55	1.47e-7	Height;
SKCM	cis	rs668210	0.739	rs1151511	chr11:65756283	A/G	cg20909159	chr11:65625947	CFL1	-0.73	-4.87	-0.48	5.78e-6	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs7811142	1.000	rs7783550	chr7:99987805	A/G	cg18515655	chr7:100026757	MEPCE;ZCWPW1	1.06	6.02	0.56	5.36e-8	Platelet count;
SKCM	cis	rs72634258	0.519	rs35267144	chr1:7934258	G/A	cg00042356	chr1:8021962	PARK7	0.82	5.65	0.54	2.55e-7	Inflammatory bowel disease;
SKCM	cis	rs1218582	0.651	rs4845396	chr1:154828409	A/G	cg24250549	chr1:154909240	PMVK	-0.65	-5.56	-0.53	3.65e-7	Prostate cancer;
SKCM	cis	rs6951245	0.554	rs2070118	chr7:1132505	G/A	cg03188948	chr7:1209495	NA	0.84	5.88	0.55	9.81e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs1912528	0.963	rs17373621	chr4:140934146	G/A	cg11128457	chr4:140864437	MAML3	0.58	4.82	0.48	6.87e-6	Educational attainment (years of education);
SKCM	cis	rs7666738	0.830	rs10516426	chr4:99035827	A/G	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs826838	1.000	rs10880785	chr12:38655405	T/G	cg13010199	chr12:38710504	ALG10B	0.72	5.27	0.51	1.19e-6	Heart rate;
SKCM	cis	rs17685	0.632	rs1859793	chr7:75821283	G/A	cg16489192	chr7:75678113	MDH2;STYXL1	-0.51	-4.77	-0.47	8.54e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1552244	1.000	rs1552244	chr3:10135577	A/G	cg02579736	chr3:10068473	FANCD2;CIDECP	1.23	6.92	0.62	1.13e-9	Alzheimer's disease;
SKCM	cis	rs634534	0.622	rs624273	chr11:65712413	A/G	cg02427764	chr11:65769310	BANF1;EIF1AD	0.64	5.0	0.49	3.49e-6	Sum eosinophil basophil counts;Eosinophil counts;
SKCM	cis	rs9475752	1.000	rs17752459	chr6:56798755	A/G	cg06815302	chr6:57335405	PRIM2	0.65	5.25	0.51	1.26e-6	Menarche (age at onset);
SKCM	cis	rs6063399	0.502	rs3091737	chr20:47993307	C/T	cg05303999	chr20:47988955	KCNB1	-0.79	-6.81	-0.61	1.79e-9	Obesity-related traits;
SKCM	cis	rs7945705	0.869	rs4909952	chr11:8963946	A/G	cg21881798	chr11:8931708	C11orf17;ST5	0.78	7.76	0.66	2.77e-11	Hemoglobin concentration;
SKCM	cis	rs2354432	0.607	rs68080346	chr1:146708484	T/C	cg25205988	chr1:146714368	CHD1L	-1.19	-6.54	-0.59	5.94e-9	Mitochondrial DNA levels;
SKCM	cis	rs7809950	1.000	rs10251808	chr7:107120453	G/A	cg23024343	chr7:107201750	COG5	-0.74	-6.62	-0.6	4.19e-9	Coronary artery disease;
SKCM	cis	rs9325144	0.555	rs61929925	chr12:38698828	C/A	cg26384229	chr12:38710491	ALG10B	-0.75	-6.43	-0.59	9.47e-9	Morning vs. evening chronotype;
SKCM	cis	rs2463822	1.000	rs2513076	chr11:62103711	A/G	cg06239285	chr11:62104954	ASRGL1	1.28	6.09	0.57	3.93e-8	Chronic obstructive pulmonary disease-related biomarkers;
SKCM	cis	rs1801516	0.950	rs11212633	chr11:108307433	A/T	cg03165700	chr11:108093220	ATM;NPAT	-1.11	-5.06	-0.5	2.68e-6	Melanoma;
SKCM	cis	rs763014	0.898	rs1045277	chr16:633125	T/C	cg07343612	chr16:622815	PIGQ	-0.7	-6.0	-0.56	5.84e-8	Height;
SKCM	cis	rs2404602	1.000	rs12594541	chr15:76834368	G/A	cg23625390	chr15:77176239	SCAPER	0.75	7.27	0.64	2.44e-10	Blood metabolite levels;
SKCM	cis	rs7618915	0.547	rs6768697	chr3:52703615	C/T	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs11585357	0.895	rs877552	chr1:17631236	C/T	cg08277548	chr1:17600880	PADI3	-0.89	-6.31	-0.58	1.53e-8	Hair shape;
SKCM	cis	rs2816062	0.775	rs2745315	chr1:18897118	G/A	cg18795169	chr1:18902165	NA	-0.83	-8.91	-0.71	1.59e-13	Urate levels in lean individuals;
SKCM	cis	rs7584330	0.744	rs58223447	chr2:238378644	G/C	cg14458575	chr2:238380390	NA	1.02	6.6	0.6	4.55e-9	Prostate cancer;
SKCM	cis	rs3847687	1.000	rs34853396	chr12:131519265	G/T	cg13586425	chr12:131519906	GPR133	-0.48	-5.4	-0.52	6.94e-7	Longevity;
SKCM	cis	rs7937682	0.883	rs659529	chr11:111436896	T/A	cg22437258	chr11:111473054	SIK2	0.64	4.85	0.48	6.21e-6	Primary sclerosing cholangitis;
SKCM	cis	rs12142240	0.583	rs5013330	chr1:46815154	G/A	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs873946	0.564	rs12242672	chr10:134555609	A/T	cg26818010	chr10:134567672	INPP5A	-0.72	-5.66	-0.54	2.41e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs9910055	0.571	rs28897216	chr17:42240824	A/G	cg08499158	chr17:42289980	UBTF	-0.75	-6.5	-0.59	6.98e-9	Total body bone mineral density;
SKCM	cis	rs3135063	0.884	rs3129317	chr4:3287655	A/G	cg09735869	chr4:3319127	RGS12	0.59	4.96	0.49	3.96e-6	Blood protein levels;
SKCM	cis	rs2836974	0.931	rs2989330	chr21:40716209	A/G	cg17971929	chr21:40555470	PSMG1	0.84	7.78	0.66	2.54e-11	Cognitive function;
SKCM	cis	rs1552244	1.000	rs17032276	chr3:10076975	A/C	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs6977660	1.000	rs34367208	chr7:19818811	T/G	cg05791153	chr7:19748676	TWISTNB	0.79	5.34	0.52	9.05e-7	Thyroid stimulating hormone;
SKCM	cis	rs8180040	1.000	rs4858888	chr3:47405305	C/T	cg27129171	chr3:47204927	SETD2	-0.85	-6.29	-0.58	1.71e-8	Colorectal cancer;
SKCM	cis	rs7296418	0.885	rs1727305	chr12:123633382	T/C	cg06742321	chr12:123595122	PITPNM2	0.66	5.38	0.52	7.49e-7	Platelet count;
SKCM	cis	rs10504229	1.000	rs59843034	chr8:58195756	T/G	cg22535103	chr8:58192502	C8orf71	-0.75	-4.99	-0.49	3.6e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs798554	0.836	rs798526	chr7:2775542	G/C	cg14895029	chr7:2775587	GNA12	-0.72	-5.67	-0.54	2.3e-7	Height;
SKCM	cis	rs1348850	0.567	rs3770009	chr2:178536544	C/T	cg22681709	chr2:178499509	PDE11A	-0.68	-6.38	-0.59	1.18e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs2841277	0.802	rs2841269	chr14:105386149	C/G	cg19901468	chr14:105411992	AHNAK2	-0.97	-7.55	-0.65	6.94e-11	Rheumatoid arthritis;
SKCM	cis	rs780096	0.565	rs11681351	chr2:27743423	G/A	cg05696406	chr2:27599888	SNX17	0.55	5.51	0.53	4.4e-7	Total body bone mineral density;
SKCM	cis	rs10089	0.909	rs7732599	chr5:127370421	T/C	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.91	8.09	0.68	6.28e-12	Ileal carcinoids;
SKCM	cis	rs10540	0.818	rs12806089	chr11:501468	G/A	cg03576123	chr11:487126	PTDSS2	-1.43	-8.14	-0.68	5.08e-12	Body mass index;
SKCM	cis	rs9910055	0.529	rs228757	chr17:42164885	G/C	cg09913183	chr17:42254507	C17orf65;ASB16	-0.59	-4.82	-0.48	6.82e-6	Total body bone mineral density;
SKCM	cis	rs8103278	0.507	rs522769	chr19:46284520	G/A	cg12641515	chr19:46296257	DMWD	0.8	6.4	0.59	1.08e-8	Coronary artery disease;
SKCM	cis	rs6138458	1.000	rs227616	chr20:24908811	T/C	cg26195577	chr20:24973756	C20orf3	1.29	8.69	0.7	4.32e-13	Blood protein levels;
SKCM	cis	rs11112613	0.713	rs11112588	chr12:105943801	A/C	cg03607813	chr12:105948248	NA	0.86	5.58	0.53	3.31e-7	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;
SKCM	cis	rs5753618	0.583	rs2899164	chr22:31790289	G/A	cg02404636	chr22:31891804	SFI1	0.58	4.97	0.49	3.86e-6	Colorectal cancer;
SKCM	cis	rs61935443	0.720	rs11107776	chr12:95294283	T/G	cg21533806	chr12:95267307	NA	0.92	5.15	0.5	1.91e-6	Schizophrenia;
SKCM	cis	rs634534	0.622	rs593525	chr11:65727799	T/C	cg02427764	chr11:65769310	BANF1;EIF1AD	0.68	5.34	0.52	8.74e-7	Sum eosinophil basophil counts;Eosinophil counts;
SKCM	cis	rs2153535	0.580	rs1119691	chr6:8460452	C/T	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs9300255	0.722	rs10846515	chr12:123801672	T/G	cg00376283	chr12:123451042	ABCB9	0.78	5.26	0.51	1.24e-6	Neutrophil percentage of white cells;
SKCM	cis	rs12986445	0.681	rs6734496	chr2:26119708	G/T	cg04917511	chr2:26785460	C2orf70	0.51	4.92	0.49	4.79e-6	Multiple myeloma and monoclonal gammopathy;Multiple myeloma;
SKCM	cis	rs634534	0.622	rs531612	chr11:65705432	C/T	cg26695010	chr11:65641043	EFEMP2	0.65	4.99	0.49	3.59e-6	Sum eosinophil basophil counts;Eosinophil counts;
SKCM	cis	rs2439831	0.850	rs9944216	chr15:44160773	C/G	cg02155558	chr15:43621948	ADAL;LCMT2	-1.3	-6.97	-0.62	9.12e-10	Lung cancer in ever smokers;
SKCM	cis	rs9926296	0.546	rs7187436	chr16:89845110	A/T	cg27121462	chr16:89883253	FANCA	0.86	7.99	0.67	9.65e-12	Vitiligo;
SKCM	cis	rs17376456	0.825	rs10476590	chr5:93244884	A/T	cg25358565	chr5:93447407	FAM172A	1.3	7.53	0.65	7.57e-11	Diabetic retinopathy;
SKCM	cis	rs514406	0.823	rs501006	chr1:53368292	T/A	cg08859206	chr1:53392774	SCP2	-0.6	-4.82	-0.48	7.02e-6	Monocyte count;
SKCM	cis	rs4132509	1.000	rs1458024	chr1:243937445	G/C	cg21452805	chr1:244014465	NA	0.88	5.15	0.5	1.92e-6	RR interval (heart rate);
SKCM	cis	rs1707322	0.827	rs6694302	chr1:46245645	A/T	cg03146154	chr1:46216737	IPP	0.81	5.92	0.56	8.2e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7143963	0.697	rs2273393	chr14:103357603	G/T	cg23020514	chr14:103360112	TRAF3	0.77	7.24	0.63	2.69e-10	Body mass index;
SKCM	cis	rs9814567	0.896	rs1357764	chr3:134344928	T/G	cg06109529	chr3:134205091	CEP63;ANAPC13	0.63	5.1	0.5	2.35e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs9303401	0.659	rs12150536	chr17:56640834	C/T	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.61	0.54	2.94e-7	Cognitive test performance;
SKCM	cis	rs67311347	1.000	rs9332450	chr3:40458041	C/T	cg00091569	chr3:40428383	ENTPD3	-0.62	-5.1	-0.5	2.35e-6	Renal cell carcinoma;
SKCM	cis	rs8180040	0.764	rs12630534	chr3:47001043	T/C	cg27129171	chr3:47204927	SETD2	0.79	6.01	0.56	5.49e-8	Colorectal cancer;
SKCM	cis	rs12188164	0.561	rs2251843	chr5:457955	C/T	cg26076054	chr5:421317	AHRR	-0.58	-4.95	-0.49	4.18e-6	Cystic fibrosis severity;
SKCM	cis	rs763014	0.932	rs2384972	chr16:674424	G/A	cg00908189	chr16:619842	PIGQ	0.82	7.62	0.65	5.2e-11	Height;
SKCM	cis	rs7020830	0.931	rs9775431	chr9:37130433	G/A	cg14294708	chr9:37120828	ZCCHC7	1.08	10.36	0.76	2.56e-16	Schizophrenia;
SKCM	cis	rs16854884	1.000	rs7649614	chr3:143789028	G/A	cg06585982	chr3:143692056	C3orf58	0.74	5.69	0.54	2.17e-7	Economic and political preferences (feminism/equality);
SKCM	cis	rs3008870	1.000	rs912797	chr1:67413478	A/G	cg08660285	chr1:67390436	MIER1;WDR78	0.92	6.05	0.57	4.69e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs1577917	1.000	rs955196	chr6:86729951	G/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.76	6.71	0.6	2.84e-9	Response to antipsychotic treatment;
SKCM	cis	rs7959452	0.558	rs1478464	chr12:69779789	G/C	cg14784868	chr12:69753453	YEATS4	0.78	7.4	0.64	1.33e-10	Blood protein levels;
SKCM	cis	rs2255932	0.945	rs2686427	chr3:183211327	A/G	cg20852557	chr3:184035519	EIF4G1	0.65	5.51	0.53	4.48e-7	Interleukin-1-beta levels;
SKCM	cis	rs1552244	0.938	rs66915020	chr3:10110174	A/G	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs694739	0.894	rs11601860	chr11:64110422	A/T	cg23796481	chr11:64053134	BAD;GPR137	0.74	5.51	0.53	4.54e-7	Alopecia areata;Crohn's disease;Psoriasis vulgaris;
SKCM	cis	rs1218582	0.741	rs10908447	chr1:154869742	C/T	cg09359103	chr1:154839909	KCNN3	-0.59	-5.81	-0.55	1.31e-7	Prostate cancer;
SKCM	cis	rs7811142	1.000	rs74460138	chr7:100027339	C/G	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.12	6.51	0.59	6.68e-9	Platelet count;
SKCM	cis	rs1005277	0.505	rs13503	chr10:38239843	C/A	cg25427524	chr10:38739819	LOC399744	0.68	6.6	0.6	4.53e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs8141529	0.764	rs5752812	chr22:29225603	T/A	cg15103426	chr22:29168792	CCDC117	0.61	5.13	0.5	2.06e-6	Lymphocyte counts;
SKCM	cis	rs4924935	0.887	rs2428380	chr17:18843089	C/A	cg26378065	chr17:18585709	ZNF286B	-0.79	-5.28	-0.51	1.13e-6	Pancreatic cancer;
SKCM	cis	rs1912528	0.783	rs769658	chr4:140872682	C/T	cg11128457	chr4:140864437	MAML3	0.62	5.33	0.52	9.22e-7	Educational attainment (years of education);
SKCM	cis	rs7772486	0.566	rs735536	chr6:146036832	A/C	cg23711669	chr6:146136114	FBXO30	-0.82	-8.12	-0.68	5.44e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7945705	0.818	rs2742552	chr11:8876852	C/T	cg21881798	chr11:8931708	C11orf17;ST5	-0.79	-8.13	-0.68	5.28e-12	Hemoglobin concentration;
SKCM	cis	rs1387259	0.723	rs2732488	chr12:48771444	G/A	cg21466736	chr12:48725269	NA	-0.6	-4.77	-0.48	8.28e-6	Obstructive sleep apnea trait (apnea hypopnea index);
SKCM	cis	rs1401999	1.000	rs869417	chr3:183689138	T/C	cg01324343	chr3:183735012	ABCC5	0.93	10.93	0.78	2.14e-17	Anterior chamber depth;
SKCM	cis	rs1153858	1.000	rs2453541	chr15:45645378	G/A	cg21132104	chr15:45694354	SPATA5L1	0.92	7.54	0.65	7.3e-11	Homoarginine levels;
SKCM	cis	rs870825	0.860	rs2705895	chr4:185598404	C/T	cg04058563	chr4:185651563	MLF1IP	-1.09	-6.2	-0.57	2.53e-8	Blood protein levels;
SKCM	cis	rs1799949	1.000	rs8176234	chr17:41219780	T/C	cg25918947	chr17:41365094	TMEM106A	-0.61	-5.91	-0.56	8.59e-8	Menopause (age at onset);
SKCM	cis	rs10504229	0.679	rs16921688	chr8:58054659	T/C	cg02725872	chr8:58115012	NA	-0.54	-5.04	-0.5	2.97e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs7811142	0.943	rs66958101	chr7:100074020	G/A	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.12	6.51	0.59	6.68e-9	Platelet count;
SKCM	cis	rs2188420	0.872	rs59813697	chr7:106529975	A/C	cg23615938	chr7:105753134	SYPL1	-0.89	-5.06	-0.5	2.73e-6	Interferon gamma levels;
SKCM	cis	rs6582630	0.531	rs3850000	chr12:38483752	T/C	cg26384229	chr12:38710491	ALG10B	0.81	6.22	0.58	2.31e-8	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs2228479	0.681	rs7196840	chr16:89959647	A/G	cg06558623	chr16:89946397	TCF25	1.25	7.18	0.63	3.53e-10	Skin colour saturation;
SKCM	cis	rs9926296	0.527	rs1800335	chr16:89846195	A/G	cg27121462	chr16:89883253	FANCA	0.83	7.7	0.66	3.5e-11	Vitiligo;
SKCM	trans	rs1814175	0.616	rs1794139	chr11:49910855	C/T	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs4073582	0.595	rs801736	chr11:65928430	A/T	cg14036092	chr11:66035641	RAB1B	0.74	5.8	0.55	1.34e-7	Gout;
SKCM	cis	rs1577917	0.629	rs6927475	chr6:86206773	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.65	5.46	0.53	5.56e-7	Response to antipsychotic treatment;
SKCM	cis	rs151997	0.671	rs152099	chr5:50210091	A/G	cg06027927	chr5:50259733	NA	0.65	6.24	0.58	2.13e-8	Callous-unemotional behaviour;
SKCM	cis	rs10779751	0.734	rs2486920	chr1:11125050	T/C	cg08854313	chr1:11322531	MTOR	0.77	5.52	0.53	4.36e-7	Body mass index;
SKCM	cis	rs7811142	0.562	rs7786844	chr7:99934008	T/G	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.21	7.77	0.66	2.57e-11	Platelet count;
SKCM	cis	rs1799949	0.931	rs34474989	chr17:41445410	A/T	cg23758822	chr17:41437982	NA	1.0	7.79	0.66	2.42e-11	Menopause (age at onset);
SKCM	cis	rs1153858	0.832	rs1145078	chr15:45682277	C/T	cg10760299	chr15:45669010	GATM	0.63	6.32	0.58	1.49e-8	Homoarginine levels;
SKCM	cis	rs35306767	0.903	rs7074642	chr10:878359	A/G	cg25614935	chr10:1084866	C10orf110	0.78	5.14	0.5	2e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs2836974	0.831	rs2836921	chr21:40516070	C/T	cg17971929	chr21:40555470	PSMG1	0.88	8.07	0.67	6.75e-12	Cognitive function;
SKCM	cis	rs8103278	0.793	rs59093775	chr19:46374037	G/A	cg11657440	chr19:46296263	DMWD	-0.78	-4.83	-0.48	6.73e-6	Coronary artery disease;
SKCM	cis	rs507080	0.961	rs34413584	chr11:118545782	G/T	cg18045108	chr11:118530628	TREH	-0.47	-4.89	-0.48	5.32e-6	Serum metabolite levels;
SKCM	cis	rs5753618	0.583	rs5753631	chr22:31863022	A/C	cg02404636	chr22:31891804	SFI1	0.6	5.13	0.5	2.03e-6	Colorectal cancer;
SKCM	cis	rs870825	0.616	rs57086463	chr4:185639525	G/A	cg04058563	chr4:185651563	MLF1IP	1.08	7.26	0.64	2.51e-10	Blood protein levels;
SKCM	cis	rs28386778	0.687	rs59596917	chr17:61806264	T/A	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.36	0.52	8.08e-7	Prudent dietary pattern;
SKCM	cis	rs9325144	0.647	rs61930266	chr12:38922048	A/G	cg26384229	chr12:38710491	ALG10B	-0.74	-6.4	-0.59	1.06e-8	Morning vs. evening chronotype;
SKCM	cis	rs4819052	1.000	rs4819052	chr21:46699777	A/G	cg20896738	chr21:46707857	POFUT2;LOC642852	0.74	5.11	0.5	2.25e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs6815814	0.950	rs56289835	chr4:38811845	G/C	cg02016764	chr4:38805732	TLR1	-0.77	-5.49	-0.53	4.78e-7	Breast cancer;
SKCM	cis	rs9467773	0.967	rs9467775	chr6:26513435	G/A	cg15659132	chr6:26577336	NA	0.6	5.71	0.54	1.99e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs28595532	0.623	rs10016452	chr4:119277490	A/G	cg11846333	chr4:119757529	SEC24D	1.06	6.0	0.56	5.8e-8	Cannabis dependence symptom count;
SKCM	cis	rs873946	0.648	rs3793673	chr10:134547732	A/C	cg18305652	chr10:134549665	INPP5A	0.54	5.32	0.52	9.83e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs4665809	0.590	rs4665313	chr2:26415897	A/G	cg26119090	chr2:26468346	HADHA;HADHB	-1.02	-7.92	-0.67	1.35e-11	Gut microbiome composition (summer);
SKCM	cis	rs801193	0.761	rs2659888	chr7:66230171	T/G	cg18876405	chr7:65276391	NA	0.82	7.46	0.65	1.03e-10	Aortic root size;
SKCM	cis	rs6570726	0.791	rs12208019	chr6:145935572	T/C	cg23711669	chr6:146136114	FBXO30	0.86	8.04	0.67	7.98e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2286503	0.901	rs10950922	chr7:22854006	C/T	cg00309339	chr7:22893653	NA	-0.51	-4.85	-0.48	6.17e-6	Fibrinogen;
SKCM	cis	rs4927850	1.000	rs4927850	chr3:195751630	C/T	cg12923728	chr3:195709715	SDHAP1	0.93	6.29	0.58	1.73e-8	Pancreatic cancer;
SKCM	cis	rs1707322	0.721	rs6665808	chr1:46162283	C/T	cg03146154	chr1:46216737	IPP	0.81	6.0	0.56	5.79e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7666738	0.830	rs6532715	chr4:99016792	G/A	cg17366294	chr4:99064904	C4orf37	0.6	4.98	0.49	3.66e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9916302	0.904	rs8079560	chr17:37497661	C/T	cg07936489	chr17:37558343	FBXL20	0.85	7.28	0.64	2.26e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs362272	0.524	rs13150241	chr4:3367281	A/G	cg00764545	chr4:3318001	RGS12	1.01	13.55	0.84	3.44e-22	Serum sulfate level;
SKCM	cis	rs7100689	0.753	rs2185426	chr10:82120887	G/A	cg01528321	chr10:82214614	TSPAN14	0.82	7.43	0.64	1.2e-10	Post bronchodilator FEV1;
SKCM	cis	rs6430585	0.591	rs72970243	chr2:136484232	G/A	cg07169764	chr2:136633963	MCM6	0.79	5.31	0.51	1.02e-6	Corneal structure;
SKCM	cis	rs17376456	0.877	rs35075119	chr5:93385457	T/C	cg25358565	chr5:93447407	FAM172A	1.19	7.67	0.66	4.06e-11	Diabetic retinopathy;
SKCM	cis	rs4253772	0.530	rs9627387	chr22:46684678	A/G	cg03482458	chr22:46692211	CN5H6.4;GTSE1	1.2	5.67	0.54	2.3e-7	LDL cholesterol;Cholesterol, total;
SKCM	cis	rs13031619	0.950	rs7589966	chr2:3696636	A/G	cg16540950	chr2:3696648	NA	0.68	4.82	0.48	6.81e-6	Response to inhaled corticosteroid treatment in asthma (change in FEV1);
SKCM	cis	rs11098499	0.909	rs11723757	chr4:120299669	C/T	cg09307838	chr4:120376055	NA	0.97	7.49	0.65	9.08e-11	Corneal astigmatism;
SKCM	cis	rs55962025	0.804	rs362268	chr4:3242148	C/G	cg16987761	chr4:3318072	RGS12	-0.7	-5.32	-0.52	9.54e-7	Parental longevity (mother's age at death);
SKCM	cis	rs11098499	0.697	rs4373140	chr4:120307698	A/G	cg09307838	chr4:120376055	NA	0.97	7.49	0.65	9.08e-11	Corneal astigmatism;
SKCM	cis	rs10504229	0.639	rs66667899	chr8:58117065	C/T	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs1707322	0.716	rs6699444	chr1:46135120	G/C	cg03146154	chr1:46216737	IPP	0.79	5.42	0.52	6.34e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs10752881	0.901	rs10911201	chr1:183001622	G/T	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.64	0.6	3.83e-9	Colorectal cancer;
SKCM	cis	rs1325195	0.537	rs4651014	chr1:179073039	C/G	cg10806749	chr1:179558114	NA	-0.58	-5.06	-0.5	2.73e-6	IgE grass sensitization;
SKCM	cis	rs867186	1.000	rs6579210	chr20:33605802	C/T	cg04194272	chr20:33683537	NA	-1.38	-7.2	-0.63	3.29e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs950776	0.616	rs3743077	chr15:78894896	C/T	cg06917634	chr15:78832804	PSMA4	0.91	8.04	0.67	7.84e-12	Sudden cardiac arrest;
SKCM	cis	rs8180040	0.966	rs3816779	chr3:47543389	C/T	cg27129171	chr3:47204927	SETD2	0.79	5.79	0.55	1.43e-7	Colorectal cancer;
SKCM	cis	rs4423214	0.650	rs2186777	chr11:71219803	C/A	cg05163923	chr11:71159392	DHCR7	0.78	6.03	0.56	5.2e-8	Vitamin D levels;
SKCM	cis	rs10937913	0.840	rs10937911	chr4:2747862	C/A	cg19433769	chr4:2420260	ZFYVE28	0.64	4.88	0.48	5.41e-6	Extrinsic epigenetic age acceleration;
SKCM	cis	rs950776	0.720	rs11633223	chr15:78935476	T/C	cg06917634	chr15:78832804	PSMA4	0.72	5.22	0.51	1.45e-6	Sudden cardiac arrest;
SKCM	cis	rs7216064	0.648	rs61676547	chr17:65892507	G/C	cg12091567	chr17:66097778	LOC651250	-0.77	-5.3	-0.51	1.03e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs6582630	0.502	rs11181230	chr12:38300085	A/G	cg26384229	chr12:38710491	ALG10B	0.81	6.57	0.6	5.18e-9	Drug-induced liver injury (flucloxacillin);
SKCM	trans	rs208520	0.507	rs3903670	chr6:66812183	T/C	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-1.08	-11.82	-0.8	4.59e-19	Exhaled nitric oxide output;
SKCM	cis	rs2952156	0.920	rs2934956	chr17:37830447	T/A	cg00129232	chr17:37814104	STARD3	-0.64	-5.21	-0.51	1.49e-6	Asthma;
SKCM	cis	rs10504229	0.636	rs72649133	chr8:58054681	G/A	cg02725872	chr8:58115012	NA	-0.54	-5.04	-0.5	2.97e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs17376456	0.597	rs7733142	chr5:93322795	C/A	cg25358565	chr5:93447407	FAM172A	-0.75	-4.78	-0.48	8.16e-6	Diabetic retinopathy;
SKCM	cis	rs6942756	0.758	rs13226649	chr7:128977598	C/T	cg02491457	chr7:128862824	NA	-0.76	-4.96	-0.49	4.07e-6	White matter hyperintensity burden;
SKCM	cis	rs9911578	0.933	rs11868348	chr17:57179238	C/T	cg05425664	chr17:57184151	TRIM37	-0.83	-7.07	-0.62	5.91e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs1707322	1.000	rs7547189	chr1:46319514	C/A	cg03146154	chr1:46216737	IPP	0.75	5.15	0.5	1.94e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7772486	0.754	rs9497419	chr6:146142609	T/C	cg23711669	chr6:146136114	FBXO30	0.88	9.58	0.74	8.31e-15	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4819052	0.851	rs13052344	chr21:46676101	C/T	cg02159808	chr21:46707872	POFUT2;LOC642852	0.73	5.71	0.54	1.93e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs55962025	0.846	rs16843836	chr4:3113337	G/A	cg00764545	chr4:3318001	RGS12	-0.67	-5.38	-0.52	7.66e-7	Parental longevity (mother's age at death);
SKCM	cis	rs7659604	0.539	rs1507995	chr4:122748308	G/A	cg19748678	chr4:122722346	EXOSC9	0.65	5.4	0.52	7.02e-7	Type 2 diabetes;
SKCM	cis	rs992157	0.932	rs10194082	chr2:219188577	C/T	cg00012203	chr2:219082015	ARPC2	0.8	6.09	0.57	4.06e-8	Colorectal cancer;
SKCM	cis	rs2228479	0.867	rs12919804	chr16:89945369	G/A	cg06558623	chr16:89946397	TCF25	1.26	6.97	0.62	9.17e-10	Skin colour saturation;
SKCM	cis	rs6582630	0.555	rs7965311	chr12:38513307	G/A	cg26384229	chr12:38710491	ALG10B	-0.79	-6.42	-0.59	9.91e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs1218582	0.741	rs11264291	chr1:154914797	C/T	cg06221963	chr1:154839813	KCNN3	-0.53	-5.11	-0.5	2.22e-6	Prostate cancer;
SKCM	cis	rs1403694	0.515	rs1656925	chr3:186449123	T/C	cg09332604	chr3:186435400	KNG1	-0.56	-5.67	-0.54	2.31e-7	Blood protein levels;
SKCM	cis	rs1865760	0.566	rs9366634	chr6:26072396	C/G	cg16482183	chr6:26056742	HIST1H1C	0.58	4.77	0.48	8.43e-6	Height;
SKCM	cis	rs875971	0.862	rs11773628	chr7:65982631	G/T	cg11764359	chr7:65958608	NA	-0.8	-7.56	-0.65	6.67e-11	Aortic root size;
SKCM	cis	rs2354432	0.607	rs72692962	chr1:146802674	C/A	cg25205988	chr1:146714368	CHD1L	-1.19	-6.56	-0.6	5.24e-9	Mitochondrial DNA levels;
SKCM	cis	rs644799	0.965	rs2950522	chr11:95524719	C/T	cg25622487	chr11:95524042	FAM76B;CEP57	0.66	5.12	0.5	2.18e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs2286503	0.780	rs12113458	chr7:22855628	G/T	cg15401507	chr7:22894281	NA	-0.55	-5.07	-0.5	2.58e-6	Fibrinogen;
SKCM	cis	rs2066819	0.901	rs773665	chr12:56717466	C/T	cg26714650	chr12:56694279	CS	1.71	6.71	0.61	2.74e-9	Psoriasis vulgaris;
SKCM	cis	rs1577917	0.958	rs10944137	chr6:86454314	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.67	-5.77	-0.55	1.54e-7	Response to antipsychotic treatment;
SKCM	cis	rs55823223	0.648	rs9894383	chr17:73865657	T/G	cg08125733	chr17:73851984	WBP2	1.06	5.97	0.56	6.62e-8	Psoriasis;
SKCM	cis	rs6120849	0.754	rs1885116	chr20:33600560	A/G	cg24642439	chr20:33292090	TP53INP2	0.94	4.86	0.48	5.91e-6	Protein C levels;
SKCM	cis	rs1348850	0.915	rs10930798	chr2:178446141	G/A	cg02961200	chr2:178257176	LOC100130691;AGPS	0.78	6.01	0.56	5.57e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs9911578	0.967	rs12944948	chr17:56951474	A/G	cg05425664	chr17:57184151	TRIM37	-0.67	-5.04	-0.5	2.91e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1568889	0.877	rs57202579	chr11:28221677	T/C	cg06544937	chr11:28130018	METT5D1;KIF18A	0.86	6.38	0.59	1.18e-8	Bipolar disorder;
SKCM	cis	rs72781680	0.611	rs2303287	chr2:24302246	A/G	cg20701182	chr2:24300061	SF3B14	-0.76	-5.17	-0.51	1.73e-6	Lymphocyte counts;
SKCM	cis	rs17685	0.753	rs3757593	chr7:75678735	G/A	cg16684958	chr7:75615977	POR	-0.57	-5.6	-0.54	3.07e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs870825	0.860	rs72689277	chr4:185593699	G/A	cg04058563	chr4:185651563	MLF1IP	0.99	6.16	0.57	2.95e-8	Blood protein levels;
SKCM	cis	rs4888262	0.526	rs6564142	chr16:74590047	T/C	cg01733217	chr16:74700730	RFWD3	0.86	6.88	0.61	1.36e-9	Testicular germ cell tumor;
SKCM	cis	rs58688157	0.960	rs1051390	chr11:613165	G/C	cg03576123	chr11:487126	PTDSS2	-0.84	-5.45	-0.53	5.64e-7	Systemic lupus erythematosus;
SKCM	cis	rs8180040	0.966	rs3736177	chr3:47451411	C/T	cg27129171	chr3:47204927	SETD2	-0.79	-5.79	-0.55	1.43e-7	Colorectal cancer;
SKCM	cis	rs514406	0.621	rs928452	chr1:53195926	G/C	cg16325326	chr1:53192061	ZYG11B	-1.0	-12.3	-0.81	6.1e-20	Monocyte count;
SKCM	cis	rs1405130	0.867	rs2053476	chr2:235588230	A/G	cg17841421	chr2:235704848	NA	0.58	4.84	0.48	6.46e-6	Coronary artery disease;
SKCM	cis	rs2153535	0.580	rs9406163	chr6:8466642	C/T	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs7208859	0.673	rs9895815	chr17:29138033	A/G	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs7618915	0.547	rs13064064	chr3:52657002	T/C	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs9435341	0.762	rs72697623	chr1:107554269	G/A	cg09367891	chr1:107599246	PRMT6	0.79	6.06	0.57	4.58e-8	Facial morphology (factor 21, depth of nasal alae);
SKCM	cis	rs17685	0.736	rs4732594	chr7:75753273	T/C	cg16684958	chr7:75615977	POR	0.55	5.27	0.51	1.19e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs757110	0.745	rs10734252	chr11:17404839	G/A	cg15432903	chr11:17409602	KCNJ11	0.53	5.05	0.5	2.8e-6	Type 2 diabetes;
SKCM	cis	rs2243480	0.901	rs13237344	chr7:66022256	T/A	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs908922	0.651	rs4240886	chr1:152530396	A/T	cg09873164	chr1:152488093	CRCT1	-0.76	-5.93	-0.56	7.7e-8	Hair morphology;
SKCM	cis	rs1799949	0.894	rs36062488	chr17:41337472	C/T	cg05368731	chr17:41323189	NBR1	-0.87	-7.35	-0.64	1.67e-10	Menopause (age at onset);
SKCM	cis	rs798554	0.644	rs7783400	chr7:2894434	A/C	cg04166393	chr7:2884313	GNA12	-0.71	-4.93	-0.49	4.47e-6	Height;
SKCM	cis	rs7937682	0.855	rs571462	chr11:111487106	C/G	cg19812747	chr11:111475976	SIK2	-0.56	-4.93	-0.49	4.55e-6	Primary sclerosing cholangitis;
SKCM	cis	rs112158604	1	rs112158604	chr1:150696792	TCTTCTGCAG/T	cg13175981	chr1:150552382	MCL1	0.64	4.86	0.48	5.85e-6	Lymphocyte counts;
SKCM	cis	rs35306767	0.714	rs66797613	chr10:1090469	C/T	cg25614935	chr10:1084866	C10orf110	0.71	5.46	0.53	5.39e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs2980439	0.783	rs2955587	chr8:8098079	A/G	cg15556689	chr8:8085844	FLJ10661	0.86	7.29	0.64	2.17e-10	Neuroticism;
SKCM	cis	rs425277	0.606	rs3128295	chr1:2068480	C/T	cg03732007	chr1:2071316	PRKCZ	-0.5	-4.81	-0.48	7.33e-6	Height;
SKCM	cis	rs208515	0.525	rs12204706	chr6:66669930	A/G	cg07460842	chr6:66804631	NA	-0.96	-5.96	-0.56	6.84e-8	Exhaled nitric oxide levels;
SKCM	cis	rs3820068	0.581	rs72645871	chr1:15926142	G/A	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs7772486	0.790	rs9376968	chr6:146180364	T/C	cg05347473	chr6:146136440	FBXO30	0.54	5.03	0.49	3.12e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7666738	0.830	rs17484966	chr4:99014432	T/C	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4481887	0.927	rs4472779	chr1:248474603	G/A	cg00666640	chr1:248458726	OR2T12	0.63	5.91	0.56	8.65e-8	Common traits (Other);
SKCM	cis	rs1577917	0.958	rs3900313	chr6:86537154	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.33	-0.52	9.19e-7	Response to antipsychotic treatment;
SKCM	cis	rs2153535	0.580	rs962590	chr6:8450899	A/G	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs2721195	1.000	rs750472	chr8:145701453	A/C	cg11211951	chr8:145729740	GPT	-0.63	-5.81	-0.55	1.3e-7	Age at first birth;
SKCM	cis	rs10256972	0.626	rs62433138	chr7:1050877	T/C	cg02733842	chr7:1102375	C7orf50	-0.46	-4.8	-0.48	7.4e-6	Longevity;Endometriosis;
SKCM	cis	rs28386778	0.897	rs2665796	chr17:61923716	G/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs9303401	0.659	rs62081314	chr17:56778328	A/G	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.35	0.52	8.54e-7	Cognitive test performance;
SKCM	cis	rs6547741	1.000	rs4665381	chr2:27757150	A/C	cg27432699	chr2:27873401	GPN1	0.74	6.55	0.6	5.55e-9	Oral cavity cancer;
SKCM	cis	rs2999052	0.526	rs10934838	chr3:127730319	C/A	cg09089421	chr3:127803668	RUVBL1	-0.55	-4.87	-0.48	5.73e-6	Hypospadias;
SKCM	cis	rs2836974	0.897	rs34599551	chr21:40594898	C/A	cg11644478	chr21:40555479	PSMG1	0.97	10.08	0.75	8.76e-16	Cognitive function;
SKCM	cis	rs2921036	0.545	rs4840975	chr8:8363258	C/T	cg06636001	chr8:8085503	FLJ10661	-0.69	-5.47	-0.53	5.15e-7	Neuroticism;
SKCM	cis	rs28386778	1.000	rs2665849	chr17:61953670	T/C	cg26338869	chr17:61819248	STRADA	0.7	4.79	0.48	7.67e-6	Prudent dietary pattern;
SKCM	cis	rs1799949	0.965	rs8071278	chr17:41193910	A/T	cg19454999	chr17:41278357	BRCA1;NBR2	0.52	4.82	0.48	6.98e-6	Menopause (age at onset);
SKCM	cis	rs7659604	0.539	rs7660548	chr4:122730821	G/C	cg20573242	chr4:122745356	CCNA2	0.74	6.25	0.58	2e-8	Type 2 diabetes;
SKCM	cis	rs7296418	0.961	rs949143	chr12:123595163	G/A	cg05973401	chr12:123451056	ABCB9	0.84	6.97	0.62	9.07e-10	Platelet count;
SKCM	cis	rs763121	0.889	rs4820335	chr22:38935927	C/G	cg06022373	chr22:39101656	GTPBP1	-0.77	-5.9	-0.56	9e-8	Menopause (age at onset);
SKCM	cis	rs62238980	0.614	rs76161060	chr22:32383153	G/A	cg00543991	chr22:32367038	NA	1.15	4.87	0.48	5.76e-6	Childhood ear infection;
SKCM	cis	rs7659604	1.000	rs73844281	chr4:122664688	A/G	cg06713675	chr4:122721982	EXOSC9	-0.65	-5.78	-0.55	1.48e-7	Type 2 diabetes;
SKCM	cis	rs4237845	0.804	rs11172372	chr12:58286273	T/C	cg00677455	chr12:58241039	CTDSP2	0.67	5.54	0.53	3.95e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs1218582	0.688	rs2135219	chr1:154857217	G/A	cg16680214	chr1:154839983	KCNN3	-0.57	-5.11	-0.5	2.19e-6	Prostate cancer;
SKCM	cis	rs67460515	0.926	rs66508859	chr3:160946351	C/T	cg03342759	chr3:160939853	NMD3	-0.81	-7.1	-0.63	5.14e-10	Parkinson's disease;
SKCM	cis	rs12478296	0.818	rs57194240	chr2:243011545	A/G	cg06360820	chr2:242988706	NA	-1.01	-5.87	-0.55	1e-7	Obesity-related traits;
SKCM	cis	rs34779708	0.931	rs11010083	chr10:35351531	C/G	cg03585969	chr10:35415529	CREM	0.76	6.24	0.58	2.11e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs55794721	0.509	rs873308	chr1:25758655	A/G	cg27572855	chr1:25598939	RHD	-0.54	-5.19	-0.51	1.6e-6	Plateletcrit;Mean corpuscular volume;
SKCM	cis	rs7666738	0.830	rs9994346	chr4:99037986	A/G	cg17366294	chr4:99064904	C4orf37	0.64	5.12	0.5	2.15e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs12188164	0.582	rs72700694	chr5:483267	T/C	cg26076054	chr5:421317	AHRR	-0.64	-4.79	-0.48	7.79e-6	Cystic fibrosis severity;
SKCM	cis	rs7666738	0.535	rs6850010	chr4:98971601	A/T	cg17366294	chr4:99064904	C4orf37	0.59	4.83	0.48	6.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4733789	0.605	rs28617188	chr8:128830054	C/G	cg24514600	chr8:128805414	PVT1	-0.56	-4.9	-0.49	5.12e-6	Height;
SKCM	cis	rs5769765	0.778	rs8137331	chr22:50313358	G/C	cg22709217	chr22:50311962	ALG12;CRELD2	-0.98	-6.19	-0.57	2.57e-8	Schizophrenia;
SKCM	cis	rs7811142	1.000	rs4989959	chr7:100032288	T/C	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.23	7.89	0.67	1.53e-11	Platelet count;
SKCM	cis	rs58688157	0.705	rs2396545	chr11:601785	T/C	cg17114584	chr11:613792	IRF7	0.8	5.62	0.54	2.88e-7	Systemic lupus erythematosus;
SKCM	cis	rs2153535	0.562	rs6901765	chr6:8455436	A/T	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs9581857	0.685	rs9319372	chr13:28042796	C/T	cg22138327	chr13:27999177	GTF3A	-0.9	-6.21	-0.58	2.42e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs6570726	0.935	rs409121	chr6:145839793	G/A	cg23711669	chr6:146136114	FBXO30	0.7	6.64	0.6	3.72e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6089829	0.926	rs1060491	chr20:61665817	C/A	cg08564027	chr20:61660810	NA	-0.63	-5.65	-0.54	2.56e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs1160297	0.609	rs12713232	chr2:53108308	A/T	cg07782112	chr2:53107842	NA	-0.62	-6.56	-0.6	5.25e-9	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs4343996	0.870	rs4722708	chr7:3382563	A/T	cg25153887	chr7:2442910	CHST12	-0.69	-4.78	-0.48	8.22e-6	Motion sickness;
SKCM	cis	rs7666738	0.830	rs6834014	chr4:98951431	G/A	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4665809	0.590	rs6730310	chr2:26419470	C/G	cg26119090	chr2:26468346	HADHA;HADHB	-1.02	-7.57	-0.65	6.4e-11	Gut microbiome composition (summer);
SKCM	cis	rs2153535	0.542	rs915354	chr6:8440357	T/C	cg07606381	chr6:8435919	SLC35B3	0.94	6.94	0.62	1.02e-9	Motion sickness;
SKCM	trans	rs1814175	0.616	rs1722001	chr11:49894427	A/G	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs7959452	0.535	rs7308481	chr12:69659299	A/G	cg20891283	chr12:69753455	YEATS4	0.73	6.51	0.59	6.69e-9	Blood protein levels;
SKCM	cis	rs941408	1.000	rs1640274	chr19:2807375	G/A	cg06609049	chr19:2785107	THOP1	0.84	7.28	0.64	2.34e-10	Total cholesterol levels;
SKCM	cis	rs7829975	0.840	rs555617	chr8:8592845	C/G	cg06636001	chr8:8085503	FLJ10661	-0.78	-7.22	-0.63	3.02e-10	Mood instability;
SKCM	cis	rs9640161	0.789	rs10282458	chr7:150045302	C/T	cg10018233	chr7:150070692	REPIN1	0.75	5.79	0.55	1.4e-7	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs34779708	0.931	rs35136660	chr10:35385973	C/A	cg03585969	chr10:35415529	CREM	0.79	6.34	0.58	1.4e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs7829975	0.606	rs11776838	chr8:8794801	C/T	cg06636001	chr8:8085503	FLJ10661	-0.68	-4.92	-0.49	4.65e-6	Mood instability;
SKCM	cis	rs854765	0.583	rs8065416	chr17:17851162	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.01	7.49	0.65	9.28e-11	Total body bone mineral density;
SKCM	cis	rs801193	0.875	rs13227951	chr7:66213108	C/T	cg11764359	chr7:65958608	NA	-0.85	-6.52	-0.59	6.39e-9	Aortic root size;
SKCM	cis	rs1577917	1.000	rs12207610	chr6:86688016	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.64	-5.54	-0.53	3.92e-7	Response to antipsychotic treatment;
SKCM	cis	rs1707322	0.964	rs785496	chr1:46588006	T/C	cg03146154	chr1:46216737	IPP	-0.8	-5.28	-0.51	1.15e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs798766	1.000	rs4865467	chr4:1745500	G/T	cg24239225	chr4:1659016	FAM53A	0.72	4.87	0.48	5.66e-6	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs2243480	1.000	rs422164	chr7:65586605	C/G	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs6743226	0.870	rs10933547	chr2:242230443	C/G	cg10021735	chr2:242295487	FARP2	-0.55	-4.85	-0.48	6.17e-6	Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction);Waist circumference adjusted for BMI (adjusted for smoking behaviour);Waist circumference adjusted for BMI in non-smokers;
SKCM	cis	rs2295499	0.646	rs2341303	chr4:2747475	G/A	cg19433769	chr4:2420260	ZFYVE28	0.64	4.88	0.48	5.41e-6	Cognitive ability;Cognitive ability (multi-trait analysis);Intelligence (multi-trait analysis);
SKCM	cis	rs12048904	0.595	rs2295280	chr1:101342497	T/C	cg00063077	chr1:101360652	SLC30A7;EXTL2	0.74	6.25	0.58	2.02e-8	Multiple sclerosis;
SKCM	cis	rs9583531	0.600	rs3809344	chr13:111358705	G/A	cg15841412	chr13:111365552	ING1	0.73	4.88	0.48	5.56e-6	Coronary artery disease;
SKCM	cis	rs7833790	0.963	rs7836040	chr8:82698328	G/A	cg17211192	chr8:82754475	SNX16	-0.86	-5.01	-0.49	3.29e-6	Diastolic blood pressure;
SKCM	cis	rs7666738	0.830	rs62318471	chr4:98925848	G/A	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1707322	1.000	rs10890350	chr1:46262378	G/A	cg03146154	chr1:46216737	IPP	0.75	5.15	0.5	1.94e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs3785574	0.927	rs2854160	chr17:61977248	C/T	cg01411255	chr17:61851458	DDX42;CCDC47	1.03	9.42	0.73	1.68e-14	Height;
SKCM	cis	rs9858542	0.953	rs6809216	chr3:49412559	G/A	cg03060546	chr3:49711283	APEH	-0.69	-5.16	-0.5	1.85e-6	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs9911578	1.000	rs3744108	chr17:56585872	G/C	cg05425664	chr17:57184151	TRIM37	0.7	5.31	0.51	1.02e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2404602	0.647	rs36114653	chr15:77025393	G/A	cg23625390	chr15:77176239	SCAPER	-0.85	-8.26	-0.68	2.93e-12	Blood metabolite levels;
SKCM	cis	rs883565	0.684	rs811971	chr3:39168283	C/T	cg20743662	chr3:38589496	NA	0.49	5.01	0.49	3.37e-6	Handedness;
SKCM	cis	rs2559856	1.000	rs2559858	chr12:102089300	A/G	cg12924262	chr12:102091054	CHPT1	0.69	5.92	0.56	8.34e-8	Blood protein levels;
SKCM	cis	rs1577917	0.727	rs2758840	chr6:86304625	A/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.98	-11.08	-0.78	1.13e-17	Response to antipsychotic treatment;
SKCM	cis	rs9457247	0.602	rs6456152	chr6:167472062	A/G	cg07741184	chr6:167504864	NA	0.58	4.92	0.49	4.76e-6	Crohn's disease;
SKCM	cis	rs2072499	0.750	rs2241109	chr1:156173082	C/T	cg24450063	chr1:156163899	SLC25A44	0.91	6.89	0.61	1.3e-9	Testicular germ cell tumor;
SKCM	cis	rs875971	0.862	rs10278014	chr7:66051264	C/T	cg11764359	chr7:65958608	NA	-0.74	-6.67	-0.6	3.37e-9	Aortic root size;
SKCM	cis	rs1707322	1.000	rs6677777	chr1:46475836	A/G	cg03146154	chr1:46216737	IPP	0.79	5.32	0.52	9.47e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs1832007	0.529	rs4880716	chr10:5238196	C/T	cg02449762	chr10:5661741	NA	0.69	4.83	0.48	6.61e-6	Triglycerides;Triglyceride levels;
SKCM	cis	rs6570726	0.791	rs6900040	chr6:145893134	C/T	cg05347473	chr6:146136440	FBXO30	0.57	5.08	0.5	2.47e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs947211	0.950	rs1775145	chr1:205756143	C/A	cg07157834	chr1:205819609	PM20D1	0.62	4.78	0.48	7.96e-6	Parkinson's disease;
SKCM	cis	rs12682352	0.602	rs635594	chr8:8613387	C/T	cg15556689	chr8:8085844	FLJ10661	-0.64	-5.69	-0.54	2.09e-7	Neuroticism;
SKCM	cis	rs7666738	0.819	rs13120307	chr4:99036100	A/C	cg05340658	chr4:99064831	C4orf37	0.66	5.01	0.49	3.35e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs5760092	0.755	rs11090298	chr22:24262061	G/A	cg25703541	chr22:24373054	LOC391322	0.73	5.13	0.5	2.09e-6	Urinary 1,3-butadiene metabolite levels in smokers;
SKCM	cis	rs7143963	1.000	rs8022110	chr14:103328158	C/T	cg23020514	chr14:103360112	TRAF3	0.9	8.54	0.7	8.45e-13	Body mass index;
SKCM	cis	rs17818399	0.547	rs7607633	chr2:46759427	T/C	cg02822958	chr2:46747628	ATP6V1E2	0.68	4.91	0.49	4.99e-6	Height;
SKCM	cis	rs6998277	1.000	rs35155104	chr8:103646559	G/T	cg10187029	chr8:103597600	NA	0.7	5.15	0.5	1.88e-6	Migraine;
SKCM	cis	rs12824058	0.831	rs7310433	chr12:130809289	C/T	cg26677194	chr12:130822605	PIWIL1	0.71	5.83	0.55	1.17e-7	Menopause (age at onset);
SKCM	cis	rs9467773	0.620	rs2494692	chr6:26615223	G/A	cg15659132	chr6:26577336	NA	0.62	5.4	0.52	6.91e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7772486	0.654	rs4896829	chr6:145953675	T/A	cg05347473	chr6:146136440	FBXO30	0.55	5.08	0.5	2.5e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs875971	0.862	rs10224872	chr7:65759773	T/A	cg18876405	chr7:65276391	NA	-0.64	-6.38	-0.59	1.18e-8	Aortic root size;
SKCM	cis	rs6138458	1.000	rs227658	chr20:24932028	A/G	cg26195577	chr20:24973756	C20orf3	1.29	8.85	0.71	2.07e-13	Blood protein levels;
SKCM	cis	rs561341	0.783	rs512698	chr17:30292507	G/T	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs2228479	0.850	rs11076623	chr16:89844120	G/T	cg06558623	chr16:89946397	TCF25	1.05	4.81	0.48	7.23e-6	Skin colour saturation;
SKCM	cis	rs72781680	0.561	rs72783615	chr2:24296397	C/A	cg20701182	chr2:24300061	SF3B14	0.74	5.01	0.49	3.33e-6	Lymphocyte counts;
SKCM	cis	rs1577917	0.839	rs9450333	chr6:86519755	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.73	-6.49	-0.59	7.18e-9	Response to antipsychotic treatment;
SKCM	cis	rs6430585	0.528	rs309133	chr2:136751842	A/C	cg07169764	chr2:136633963	MCM6	1.22	9.51	0.73	1.1e-14	Corneal structure;
SKCM	cis	rs746265	0.527	rs16968739	chr15:39604140	A/G	cg18175690	chr15:40580770	PLCB2	-0.8	-4.92	-0.49	4.8e-6	PR interval;
SKCM	cis	rs9911578	0.967	rs11079354	chr17:56594460	G/A	cg05425664	chr17:57184151	TRIM37	0.69	5.21	0.51	1.52e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs523522	0.962	rs4767912	chr12:120981202	A/G	cg12219531	chr12:120966889	COQ5	0.91	7.82	0.66	2.11e-11	High light scatter reticulocyte count;
SKCM	cis	rs752010	0.967	rs10890153	chr1:42102060	C/A	cg06885757	chr1:42089581	HIVEP3	0.61	6.19	0.57	2.64e-8	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs1799949	0.930	rs8176194	chr17:41231221	A/C	cg23758822	chr17:41437982	NA	0.93	7.82	0.66	2.1e-11	Menopause (age at onset);
SKCM	cis	rs1784581	1.000	rs1784582	chr6:162400712	A/G	cg17173639	chr6:162384350	PARK2	-0.6	-5.16	-0.5	1.8e-6	Itch intensity from mosquito bite;
SKCM	cis	rs9300255	0.602	rs2510885	chr12:123614813	G/C	cg05973401	chr12:123451056	ABCB9	0.81	5.57	0.53	3.51e-7	Neutrophil percentage of white cells;
SKCM	cis	rs6840360	0.615	rs1561917	chr4:152479233	G/A	cg22705602	chr4:152727874	NA	-0.51	-5.78	-0.55	1.45e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs9916302	0.904	rs4357971	chr17:37717280	C/T	cg07936489	chr17:37558343	FBXL20	-0.9	-8.15	-0.68	4.86e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs11098499	0.909	rs28571712	chr4:120375980	G/A	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs7100689	0.577	rs756208	chr10:82041751	A/G	cg01528321	chr10:82214614	TSPAN14	0.79	7.79	0.66	2.36e-11	Post bronchodilator FEV1;
SKCM	cis	rs4766646	0.619	rs10850883	chr12:110292513	G/A	cg08114617	chr12:110271441	TRPV4	0.51	4.85	0.48	6.08e-6	Metabolite levels (MHPG);
SKCM	cis	rs854765	0.547	rs8075189	chr17:17901946	C/G	cg04398451	chr17:18023971	MYO15A	-0.87	-6.78	-0.61	2.05e-9	Total body bone mineral density;
SKCM	cis	rs6547741	0.935	rs12714204	chr2:27787540	T/C	cg27432699	chr2:27873401	GPN1	0.73	6.55	0.6	5.7e-9	Oral cavity cancer;
SKCM	cis	rs28595532	0.764	rs78161283	chr4:119792345	C/T	cg21605333	chr4:119757512	SEC24D	1.47	5.64	0.54	2.62e-7	Cannabis dependence symptom count;
SKCM	cis	rs9583531	0.527	rs12875067	chr13:111365104	A/G	cg24331049	chr13:111365604	ING1	0.88	6.6	0.6	4.45e-9	Coronary artery disease;
SKCM	cis	rs854765	0.587	rs4077828	chr17:17833644	A/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.0	7.64	0.65	4.64e-11	Total body bone mineral density;
SKCM	cis	rs801193	0.527	rs2707837	chr7:66181073	G/C	cg11764359	chr7:65958608	NA	0.75	6.79	0.61	1.95e-9	Aortic root size;
SKCM	cis	rs6580649	0.941	rs1793931	chr12:48396505	G/T	cg05342945	chr12:48394962	COL2A1	-0.75	-5.04	-0.5	2.94e-6	Lung cancer;
SKCM	cis	rs62238980	0.614	rs4821002	chr22:32362687	C/T	cg00543991	chr22:32367038	NA	1.28	5.18	0.51	1.68e-6	Childhood ear infection;
SKCM	cis	rs2033711	0.755	rs4801587	chr19:58936679	C/A	cg00825309	chr19:58991885	ZNF446	-0.69	-5.6	-0.54	3.13e-7	Uric acid clearance;
SKCM	cis	rs780096	0.587	rs6743819	chr2:27567407	G/T	cg05696406	chr2:27599888	SNX17	0.49	5.12	0.5	2.17e-6	Total body bone mineral density;
SKCM	cis	rs4862750	0.872	rs6811569	chr4:187897988	A/G	cg10295955	chr4:187884368	NA	1.04	14.12	0.85	3.41e-23	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2842992	0.789	rs7758895	chr6:160193465	T/C	cg11366901	chr6:160182831	ACAT2	0.94	7.85	0.66	1.81e-11	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs8180040	0.726	rs1869869	chr3:47027833	G/A	cg27129171	chr3:47204927	SETD2	0.83	6.19	0.57	2.6e-8	Colorectal cancer;
SKCM	cis	rs34779708	0.931	rs79749947	chr10:35277081	A/T	cg03585969	chr10:35415529	CREM	0.72	5.96	0.56	6.77e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs9911578	0.935	rs420878	chr17:56709077	A/G	cg05425664	chr17:57184151	TRIM37	-0.69	-5.21	-0.51	1.52e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7647973	0.848	rs4955411	chr3:49145304	A/G	cg07636037	chr3:49044803	WDR6	0.89	5.48	0.53	5e-7	Menarche (age at onset);
SKCM	cis	rs13108904	0.901	rs7673398	chr4:1300077	G/A	cg05665937	chr4:1216051	CTBP1	0.57	4.97	0.49	3.83e-6	Obesity-related traits;
SKCM	cis	rs875971	0.862	rs35378740	chr7:65987712	C/A	cg11764359	chr7:65958608	NA	0.75	6.8	0.61	1.86e-9	Aortic root size;
SKCM	cis	rs62103177	0.564	rs7228971	chr18:77738025	C/T	cg27393146	chr18:77495563	CTDP1	0.92	5.83	0.55	1.21e-7	Opioid sensitivity;
SKCM	cis	rs2980439	0.557	rs2921056	chr8:8319182	T/C	cg15556689	chr8:8085844	FLJ10661	0.71	5.91	0.56	8.51e-8	Neuroticism;
SKCM	cis	rs9660180	0.967	rs61422524	chr1:1767565	C/A	cg23982607	chr1:1823379	GNB1	-0.67	-5.61	-0.54	3.02e-7	Body mass index;
SKCM	cis	rs10876993	0.821	rs1629032	chr12:58038686	C/T	cg18357645	chr12:58087776	OS9	0.61	5.62	0.54	2.84e-7	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs7618501	0.521	rs11130222	chr3:49901060	A/T	cg24110177	chr3:50126178	RBM5	-0.71	-5.36	-0.52	8.33e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs9733	0.594	rs12116492	chr1:150534368	T/C	cg13175981	chr1:150552382	MCL1	0.71	6.39	0.59	1.13e-8	Tonsillectomy;
SKCM	cis	rs28386778	0.897	rs894408	chr17:61896814	C/T	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs992157	0.698	rs6746089	chr2:219170377	A/G	cg20019365	chr2:219134978	PNKD;AAMP	0.72	6.12	0.57	3.48e-8	Colorectal cancer;
SKCM	cis	rs6088580	0.602	rs6058064	chr20:33086622	A/G	cg24642439	chr20:33292090	TP53INP2	0.73	5.76	0.55	1.62e-7	Glomerular filtration rate (creatinine);
SKCM	cis	rs67478160	0.575	rs8014294	chr14:104322983	A/G	cg01117925	chr14:105267060	ZBTB42	-0.64	-4.91	-0.49	4.94e-6	Schizophrenia;
SKCM	cis	rs73201462	1.000	rs2955091	chr3:127971361	C/T	cg09089421	chr3:127803668	RUVBL1	-1.0	-5.11	-0.5	2.22e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs7772486	0.754	rs4360151	chr6:146255079	A/C	cg05347473	chr6:146136440	FBXO30	-0.55	-4.9	-0.49	5.11e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs198426	0.506	rs7949187	chr11:61418046	G/C	cg19838087	chr11:61442541	NA	0.44	5.05	0.5	2.84e-6	Plasma omega-3 polyunsaturated fatty acid levels (docosapentaenoic acid);
SKCM	cis	rs3087591	0.919	rs9913470	chr17:29566575	A/G	cg24425628	chr17:29625626	OMG;NF1	-0.63	-4.95	-0.49	4.23e-6	Hip circumference;
SKCM	cis	rs7618915	0.533	rs35107891	chr3:52613656	G/C	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs6570726	0.557	rs403956	chr6:145829956	T/C	cg23711669	chr6:146136114	FBXO30	0.8	7.12	0.63	4.74e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7584330	0.822	rs13390494	chr2:238388792	G/A	cg14458575	chr2:238380390	NA	0.98	6.49	0.59	7.27e-9	Prostate cancer;
SKCM	cis	rs4674676	1	rs4674676	chr2:223529112	A/G	cg25565276	chr2:223520875	FARSB	1.23	6.64	0.6	3.74e-9	Chin dimples;
SKCM	cis	rs7937682	0.793	rs7130440	chr11:111417779	A/G	cg09085632	chr11:111637200	PPP2R1B	0.71	5.68	0.54	2.23e-7	Primary sclerosing cholangitis;
SKCM	cis	rs1506636	0.927	rs11983604	chr7:123329754	T/G	cg03229431	chr7:123269106	ASB15	-0.62	-5.06	-0.5	2.75e-6	Plateletcrit;Platelet count;
SKCM	cis	rs3785574	0.962	rs2727331	chr17:61926990	G/T	cg06601766	chr17:61851465	DDX42;CCDC47	0.72	5.36	0.52	8.34e-7	Height;
SKCM	cis	rs9902453	0.904	rs4528633	chr17:28356136	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.82	-6.4	-0.59	1.06e-8	Coffee consumption (cups per day);
SKCM	cis	rs763121	0.626	rs5750643	chr22:39009017	A/G	cg06022373	chr22:39101656	GTPBP1	0.82	5.57	0.53	3.55e-7	Menopause (age at onset);
SKCM	cis	rs1153858	1.000	rs2467863	chr15:45641880	G/A	cg21132104	chr15:45694354	SPATA5L1	0.89	7.48	0.65	9.43e-11	Homoarginine levels;
SKCM	cis	rs6598955	0.756	rs10902723	chr1:26568542	T/C	cg00938395	chr1:26633206	UBXN11	0.7	4.95	0.49	4.18e-6	Obesity-related traits;
SKCM	cis	rs6489882	0.867	rs4766663	chr12:113362974	C/T	cg07232103	chr12:112566177	TRAFD1	-0.6	-4.83	-0.48	6.6e-6	Chronic lymphocytic leukemia;
SKCM	cis	rs7584330	0.910	rs6737914	chr2:238393434	A/G	cg14458575	chr2:238380390	NA	0.98	6.47	0.59	7.93e-9	Prostate cancer;
SKCM	cis	rs1799949	1.000	rs36036395	chr17:41181297	T/C	cg25918947	chr17:41365094	TMEM106A	-0.61	-5.87	-0.55	1e-7	Menopause (age at onset);
SKCM	trans	rs1814175	0.541	rs12287397	chr11:49819799	G/A	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs28595532	0.545	rs17516512	chr4:119258491	T/C	cg21605333	chr4:119757512	SEC24D	0.96	5.21	0.51	1.47e-6	Cannabis dependence symptom count;
SKCM	cis	rs4481887	0.962	rs4244177	chr1:248468279	C/T	cg00666640	chr1:248458726	OR2T12	0.61	5.6	0.54	3.11e-7	Common traits (Other);
SKCM	cis	rs60871478	1.000	rs9195	chr7:825786	C/T	cg04727924	chr7:799746	HEATR2	0.61	4.96	0.49	3.99e-6	Cerebrospinal P-tau181p levels;
SKCM	cis	rs7178909	0.902	rs8038480	chr15:90441597	T/C	cg19708238	chr15:90437601	AP3S2	0.72	5.22	0.51	1.43e-6	Common traits (Other);
SKCM	cis	rs9902453	0.967	rs4473252	chr17:28454423	G/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.5	0.53	4.74e-7	Coffee consumption (cups per day);
SKCM	cis	rs1799949	0.930	rs1554063	chr17:41287145	T/C	cg19454999	chr17:41278357	BRCA1;NBR2	0.51	4.8	0.48	7.53e-6	Menopause (age at onset);
SKCM	cis	rs736408	0.609	rs13095332	chr3:52787242	C/T	cg18404041	chr3:52824283	ITIH1	-0.56	-4.94	-0.49	4.32e-6	Bipolar disorder;
SKCM	cis	rs6088580	0.634	rs6058070	chr20:33103521	G/C	cg24642439	chr20:33292090	TP53INP2	0.75	6.02	0.56	5.32e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs11252926	0.624	rs7085214	chr10:468133	A/G	cg18196295	chr10:418757	DIP2C	0.65	5.31	0.52	1.02e-6	Psychosis in Alzheimer's disease;
SKCM	cis	rs2721195	0.845	rs67392224	chr8:145707044	T/C	cg15857475	chr8:145742913	RECQL4;LRRC14	-0.94	-9.51	-0.73	1.11e-14	Age at first birth;
SKCM	cis	rs742614	0.533	rs6120395	chr20:32451693	A/G	cg06304546	chr20:32448765	NA	-0.7	-5.58	-0.53	3.32e-7	Stearic acid (18:0) levels;
SKCM	cis	rs2243480	0.522	rs12698511	chr7:65474919	G/T	cg18252515	chr7:66147081	NA	-1.39	-7.61	-0.65	5.44e-11	Diabetic kidney disease;
SKCM	cis	rs995000	0.839	rs12090886	chr1:62981440	G/A	cg06896770	chr1:63153194	DOCK7	-0.62	-5.59	-0.54	3.15e-7	Triglyceride levels;
SKCM	cis	rs9815354	0.812	rs59476821	chr3:41946481	A/G	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs875971	0.706	rs1643374	chr7:65872682	T/A	cg00343986	chr7:65444356	GUSB	0.68	5.1	0.5	2.35e-6	Aortic root size;
SKCM	cis	rs514406	0.823	rs501006	chr1:53368292	T/A	cg24675658	chr1:53192096	ZYG11B	-0.61	-4.93	-0.49	4.54e-6	Monocyte count;
SKCM	cis	rs11098499	0.909	rs17046118	chr4:120387496	T/G	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs798766	1.000	rs1374469	chr4:1724799	C/T	cg24239225	chr4:1659016	FAM53A	-0.69	-4.87	-0.48	5.8e-6	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs875971	0.660	rs3857686	chr7:66036191	C/T	cg11764359	chr7:65958608	NA	-0.86	-6.6	-0.6	4.52e-9	Aortic root size;
SKCM	cis	rs7666738	0.830	rs1534318	chr4:98965058	C/T	cg17366294	chr4:99064904	C4orf37	0.59	4.89	0.48	5.36e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7937682	0.889	rs521155	chr11:111492563	G/A	cg19812747	chr11:111475976	SIK2	-0.56	-4.93	-0.49	4.55e-6	Primary sclerosing cholangitis;
SKCM	cis	rs4555082	0.957	rs2975216	chr14:105713134	T/C	cg13114125	chr14:105738426	BRF1	-0.7	-5.65	-0.54	2.51e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs10883723	0.738	rs715438	chr10:104258303	C/T	cg11453585	chr10:104263688	ACTR1A;SUFU	0.75	5.75	0.55	1.66e-7	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs2124969	0.562	rs4665164	chr2:161070078	T/G	cg03641300	chr2:160917029	PLA2R1	-0.61	-4.97	-0.49	3.81e-6	Waist circumference adjusted for body mass index;
SKCM	cis	rs7727544	0.735	rs272894	chr5:131662460	C/T	cg24060327	chr5:131705240	SLC22A5	-0.67	-4.89	-0.48	5.37e-6	Blood metabolite levels;
SKCM	cis	rs7666738	0.830	rs13149346	chr4:99009933	C/T	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7615952	0.551	rs58274173	chr3:125800700	G/A	cg05084668	chr3:125655381	ALG1L	-1.27	-6.22	-0.58	2.33e-8	Blood pressure (smoking interaction);
SKCM	cis	rs13108904	0.775	rs2279282	chr4:1216033	G/C	cg02018176	chr4:1364513	KIAA1530	0.65	5.13	0.5	2.07e-6	Obesity-related traits;
SKCM	cis	rs4803468	1.000	rs2241709	chr19:41912250	C/T	cg14132834	chr19:41945861	ATP5SL	-0.77	-6.08	-0.57	4.18e-8	Height;
SKCM	cis	rs1461503	0.966	rs10892937	chr11:122841904	T/C	cg27398637	chr11:122830231	C11orf63	-0.63	-4.8	-0.48	7.54e-6	Menarche (age at onset);
SKCM	cis	rs8072100	0.935	rs12150231	chr17:45717091	G/A	cg08085267	chr17:45401833	C17orf57	0.63	5.86	0.55	1.06e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs992157	0.798	rs7587220	chr2:219160864	C/A	cg20019365	chr2:219134978	PNKD;AAMP	-0.72	-6.12	-0.57	3.48e-8	Colorectal cancer;
SKCM	cis	rs11155671	0.530	rs6935829	chr6:150217811	C/T	cg05036130	chr6:150231994	NA	0.59	6.26	0.58	1.9e-8	Testicular germ cell tumor;
SKCM	cis	rs910316	0.737	rs175424	chr14:75626257	T/C	cg08847533	chr14:75593920	NEK9	-0.83	-6.78	-0.61	2.02e-9	Height;
SKCM	cis	rs4642101	0.512	rs12629892	chr3:12818920	A/G	cg05775895	chr3:12838266	CAND2	0.67	5.61	0.54	2.95e-7	QRS complex (12-leadsum);
SKCM	cis	rs2777491	0.507	rs34040639	chr15:41760807	A/G	cg18705301	chr15:41695430	NDUFAF1	-1.17	-12.33	-0.81	5.22e-20	Ulcerative colitis;
SKCM	cis	rs1707322	1.000	rs10890370	chr1:46389217	C/T	cg03146154	chr1:46216737	IPP	0.76	5.21	0.51	1.53e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs951366	0.589	rs823099	chr1:205669322	C/A	cg07167872	chr1:205819463	PM20D1	0.8	6.47	0.59	7.94e-9	Menarche (age at onset);
SKCM	cis	rs1577917	0.727	rs9344539	chr6:86353621	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.74	-6.62	-0.6	4.1e-9	Response to antipsychotic treatment;
SKCM	cis	rs8180040	0.934	rs4858811	chr3:47480524	G/C	cg27129171	chr3:47204927	SETD2	-0.79	-5.79	-0.55	1.43e-7	Colorectal cancer;
SKCM	cis	rs67311347	0.668	rs73071710	chr3:40288587	A/G	cg00091569	chr3:40428383	ENTPD3	0.61	5.06	0.5	2.69e-6	Renal cell carcinoma;
SKCM	cis	rs9581857	0.579	rs3759434	chr13:27997700	A/C	cg22138327	chr13:27999177	GTF3A	0.84	5.95	0.56	7.05e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs12477438	0.520	rs11677247	chr2:99756358	A/G	cg14399236	chr2:99771627	LIPT1;TSGA10	0.97	8.9	0.71	1.72e-13	Chronic sinus infection;
SKCM	cis	rs798554	1.000	rs798560	chr7:2758309	A/G	cg19346786	chr7:2764209	NA	-0.66	-6.63	-0.6	3.89e-9	Height;
SKCM	cis	rs1707322	1.000	rs7519181	chr1:46387829	G/C	cg03146154	chr1:46216737	IPP	0.74	5.06	0.5	2.76e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs6952808	0.771	rs10269191	chr7:1915731	A/G	cg03354898	chr7:1950403	MAD1L1	-0.54	-5.4	-0.52	6.92e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs1850744	0.510	rs3975528	chr4:9584444	T/C	cg15442990	chr4:9534313	NA	-1.43	-5.75	-0.55	1.68e-7	Economic and political preferences;
SKCM	cis	rs6570726	0.791	rs1935612	chr6:145906090	T/A	cg23711669	chr6:146136114	FBXO30	0.86	7.97	0.67	1.06e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2204008	0.743	rs2132212	chr12:38039405	G/A	cg13010199	chr12:38710504	ALG10B	0.62	4.84	0.48	6.53e-6	Bladder cancer;
SKCM	cis	rs6952808	0.595	rs3778983	chr7:2166319	T/G	cg02951883	chr7:2050386	MAD1L1	-0.79	-7.5	-0.65	8.73e-11	Bipolar disorder and schizophrenia;
SKCM	cis	rs7829975	0.502	rs7820738	chr8:8702607	C/G	cg15556689	chr8:8085844	FLJ10661	-0.63	-5.03	-0.5	3.02e-6	Mood instability;
SKCM	cis	rs10911251	0.508	rs944970	chr1:183112566	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.76	7.28	0.64	2.26e-10	Colorectal cancer;
SKCM	cis	rs1577917	0.740	rs7771612	chr6:86264374	T/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.74	6.42	0.59	9.66e-9	Response to antipsychotic treatment;
SKCM	cis	rs10504073	0.647	rs10105794	chr8:50012793	G/C	cg00325661	chr8:49890786	NA	0.82	7.02	0.62	7.13e-10	Blood metabolite ratios;
SKCM	cis	rs826838	0.967	rs7136593	chr12:39128265	C/T	cg13010199	chr12:38710504	ALG10B	-0.72	-5.73	-0.54	1.83e-7	Heart rate;
SKCM	cis	rs7216064	0.953	rs9890629	chr17:65871559	G/A	cg12091567	chr17:66097778	LOC651250	-0.75	-5.27	-0.51	1.19e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs867186	1.000	rs17401737	chr20:33552642	C/A	cg04194272	chr20:33683537	NA	-1.37	-6.77	-0.61	2.18e-9	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs4740619	0.619	rs2026661	chr9:16045125	C/G	cg14451791	chr9:16040625	NA	0.46	5.19	0.51	1.63e-6	Body mass index;
SKCM	cis	rs4665809	0.590	rs3806515	chr2:26466975	C/T	cg26119090	chr2:26468346	HADHA;HADHB	1.06	8.39	0.69	1.66e-12	Gut microbiome composition (summer);
SKCM	cis	rs7726839	0.540	rs72703092	chr5:599269	G/A	cg10555297	chr5:473380	SLC9A3;LOC25845	1.03	4.96	0.49	4e-6	Obesity-related traits;
SKCM	cis	rs28595532	0.920	rs115683389	chr4:119735557	T/G	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs28595532	0.920	rs115744897	chr4:119749064	A/G	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs7927771	0.832	rs10838697	chr11:47384484	T/A	cg05585544	chr11:47624801	NA	-0.59	-5.24	-0.51	1.33e-6	Subjective well-being;
SKCM	cis	rs8103278	0.507	rs7246377	chr19:46292259	G/A	cg14061069	chr19:46274453	DMPK	0.51	5.1	0.5	2.32e-6	Coronary artery disease;
SKCM	cis	rs7772486	0.790	rs1854900	chr6:146331382	G/A	cg23711669	chr6:146136114	FBXO30	0.76	7.15	0.63	4.1e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs35306767	0.714	rs17293608	chr10:1056252	C/T	cg25614935	chr10:1084866	C10orf110	0.67	5.42	0.52	6.43e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs7824557	0.547	rs2736287	chr8:11228006	G/A	cg21775007	chr8:11205619	TDH	-0.65	-5.97	-0.56	6.74e-8	Retinal vascular caliber;
SKCM	cis	rs12134245	0.776	rs625525	chr1:91997593	C/T	cg02896835	chr1:92012615	NA	-0.58	-5.48	-0.53	4.95e-7	Breast cancer;
SKCM	cis	rs2730245	0.618	rs859781	chr7:158661758	G/A	cg24397884	chr7:158709396	WDR60	0.66	5.1	0.5	2.35e-6	Height;
SKCM	cis	rs12477438	0.520	rs11689265	chr2:99799267	A/G	cg26064155	chr2:99771622	LIPT1;TSGA10	1.0	9.17	0.72	5.12e-14	Chronic sinus infection;
SKCM	cis	rs870825	0.616	rs28444118	chr4:185621692	T/C	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs1403694	0.669	rs10440056	chr3:186433822	C/T	cg09332604	chr3:186435400	KNG1	-0.5	-5.07	-0.5	2.57e-6	Blood protein levels;
SKCM	cis	rs7216064	0.636	rs62084696	chr17:66038181	C/G	cg12091567	chr17:66097778	LOC651250	0.89	6.71	0.6	2.8e-9	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs16854884	0.710	rs1867607	chr3:143809274	T/C	cg06585982	chr3:143692056	C3orf58	0.63	5.08	0.5	2.47e-6	Economic and political preferences (feminism/equality);
SKCM	cis	rs7296418	0.663	rs11057276	chr12:123820397	C/T	cg00376283	chr12:123451042	ABCB9	-0.84	-6.66	-0.6	3.47e-9	Platelet count;
SKCM	cis	rs854765	0.583	rs8065416	chr17:17851162	C/T	cg04398451	chr17:18023971	MYO15A	-0.86	-5.91	-0.56	8.41e-8	Total body bone mineral density;
SKCM	cis	rs4727027	0.870	rs11525060	chr7:148801091	G/A	cg23583168	chr7:148888333	NA	-0.85	-6.83	-0.61	1.67e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs11112613	0.713	rs73184081	chr12:105951745	C/T	cg03607813	chr12:105948248	NA	0.86	5.51	0.53	4.38e-7	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;
SKCM	cis	rs7666738	0.830	rs7674095	chr4:99048158	T/A	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	trans	rs17685	0.735	rs11763339	chr7:75761541	T/C	cg19862616	chr7:65841803	NCRNA00174	0.94	9.49	0.73	1.22e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs936229	0.861	rs11634474	chr15:75116184	C/G	cg14664628	chr15:75095509	CSK	-1.16	-10.49	-0.77	1.43e-16	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin);
SKCM	cis	rs941873	0.838	rs2233713	chr10:81107135	A/C	cg09469691	chr10:81107165	PPIF	0.71	6.88	0.61	1.3e-9	Height;
SKCM	cis	rs709400	0.627	rs55859054	chr14:103953666	T/A	cg26031613	chr14:104095156	KLC1	0.76	5.45	0.53	5.72e-7	Body mass index;
SKCM	cis	rs7216064	0.953	rs58141639	chr17:65864902	C/T	cg12091567	chr17:66097778	LOC651250	-0.75	-5.27	-0.51	1.19e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs7954584	0.583	rs10770186	chr12:122361412	A/G	cg13699009	chr12:122356056	WDR66	0.49	5.55	0.53	3.72e-7	Mean corpuscular volume;
SKCM	cis	rs2952156	0.920	rs907090	chr17:37833632	T/C	cg20243544	chr17:37824526	PNMT	0.71	5.74	0.54	1.74e-7	Asthma;
SKCM	cis	rs8064299	0.597	rs6501737	chr17:72780830	C/T	cg25054828	chr17:72772726	NAT9;TMEM104	-0.92	-9.46	-0.73	1.41e-14	Monocyte count;
SKCM	cis	rs2721195	1.000	rs11784118	chr8:145684978	G/A	cg15320075	chr8:145703422	NA	-0.84	-7.02	-0.62	7.08e-10	Age at first birth;
SKCM	cis	rs10504073	0.647	rs28685207	chr8:50003484	A/G	cg00325661	chr8:49890786	NA	0.82	7.02	0.62	7.13e-10	Blood metabolite ratios;
SKCM	cis	rs17376456	0.757	rs10066431	chr5:93198204	A/G	cg25358565	chr5:93447407	FAM172A	1.18	7.56	0.65	6.77e-11	Diabetic retinopathy;
SKCM	cis	rs5750830	0.649	rs5757663	chr22:39821319	T/C	cg11247378	chr22:39784982	NA	-0.47	-5.43	-0.52	6.23e-7	Intelligence (multi-trait analysis);
SKCM	trans	rs7618501	0.669	rs7634084	chr3:49949834	A/T	cg21659725	chr3:3221576	CRBN	0.87	7.3	0.64	2.12e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs4891159	0.790	rs1056714	chr18:74149526	A/G	cg24786174	chr18:74118243	ZNF516	-0.74	-7.05	-0.62	6.2e-10	Longevity;
SKCM	cis	rs9911578	0.967	rs6503893	chr17:57149695	G/A	cg12560992	chr17:57184187	TRIM37	1.08	10.19	0.76	5.38e-16	Intelligence (multi-trait analysis);
SKCM	cis	rs7666738	0.830	rs34164616	chr4:99015251	G/A	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1707322	0.717	rs3014237	chr1:46090252	A/G	cg03146154	chr1:46216737	IPP	-0.78	-5.07	-0.5	2.57e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7523273	0.526	rs2745975	chr1:208013620	C/T	cg22525895	chr1:207977042	MIR29B2	-0.78	-6.7	-0.6	2.91e-9	Schizophrenia;
SKCM	cis	rs12477438	0.520	rs1044575	chr2:99812070	G/A	cg26064155	chr2:99771622	LIPT1;TSGA10	0.97	8.85	0.71	2.11e-13	Chronic sinus infection;
SKCM	cis	rs6665290	0.901	rs61834004	chr1:227202782	G/A	cg10327440	chr1:227177885	CDC42BPA	-1.21	-16.02	-0.88	2.21e-26	Myeloid white cell count;
SKCM	cis	rs11690935	0.655	rs12052995	chr2:172537212	A/G	cg13550731	chr2:172543902	DYNC1I2	0.63	5.5	0.53	4.74e-7	Schizophrenia;
SKCM	cis	rs7177699	0.526	rs7165733	chr15:79123505	G/A	cg04896959	chr15:78267971	NA	-0.54	-4.84	-0.48	6.39e-6	Post bronchodilator FEV1/FVC ratio;Post bronchodilator FEV1;
SKCM	cis	rs2153535	0.580	rs6902001	chr6:8477055	T/G	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs1218582	0.710	rs7553195	chr1:154837796	T/C	cg03351412	chr1:154909251	PMVK	0.75	6.65	0.6	3.64e-9	Prostate cancer;
SKCM	cis	rs17685	0.753	rs11972240	chr7:75694079	A/C	cg16684958	chr7:75615977	POR	0.59	5.63	0.54	2.69e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2228479	0.764	rs35518096	chr16:89961140	C/A	cg00800038	chr16:89945340	TCF25	-0.94	-5.51	-0.53	4.53e-7	Skin colour saturation;
SKCM	cis	rs6570726	0.791	rs383841	chr6:145888329	G/T	cg23711669	chr6:146136114	FBXO30	-0.9	-9.11	-0.72	6.54e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs754466	0.580	rs2579177	chr10:79529245	C/T	cg17075019	chr10:79541650	NA	-0.74	-6.63	-0.6	3.87e-9	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs1405130	0.835	rs2892049	chr2:235571903	C/A	cg21542780	chr2:234763377	HJURP	-0.64	-4.89	-0.48	5.21e-6	Coronary artery disease;
SKCM	cis	rs801193	1.000	rs7782320	chr7:66177098	C/T	cg18876405	chr7:65276391	NA	0.8	7.11	0.63	4.88e-10	Aortic root size;
SKCM	cis	rs1405130	1.000	rs13031727	chr2:235564046	A/G	cg21542780	chr2:234763377	HJURP	-0.65	-4.79	-0.48	7.73e-6	Coronary artery disease;
SKCM	cis	rs6545883	0.929	rs2264100	chr2:61670829	G/A	cg15711740	chr2:61764176	XPO1	-0.7	-4.93	-0.49	4.5e-6	Tuberculosis;
SKCM	cis	rs1707322	0.686	rs3014239	chr1:46089801	G/A	cg03146154	chr1:46216737	IPP	-0.83	-6.17	-0.57	2.83e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs2811415	0.597	rs9857492	chr3:127763522	A/G	cg09089421	chr3:127803668	RUVBL1	0.99	8.52	0.69	9.09e-13	Lung function (FEV1/FVC);
SKCM	cis	rs7208859	0.623	rs56378576	chr17:29010120	C/T	cg14067834	chr17:29058358	SUZ12P	1.05	5.55	0.53	3.71e-7	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs7208859	0.623	rs11657990	chr17:29124200	C/T	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs137603	0.644	rs137621	chr22:39710244	G/A	cg17798944	chr22:39715225	SNORD43;RPL3	-0.62	-5.26	-0.51	1.24e-6	Primary biliary cholangitis;
SKCM	cis	rs12451471	0.620	rs11150846	chr17:78098520	C/T	cg06718696	chr17:78121285	EIF4A3	0.93	6.57	0.6	5.13e-9	Plateletcrit;Mean corpuscular hemoglobin concentration;
SKCM	cis	rs9682041	0.877	rs10804841	chr3:170072031	T/A	cg11886554	chr3:170076028	SKIL	0.84	5.1	0.5	2.36e-6	Glomerular filtration rate in non diabetics (creatinine);Glomerular filtration rate (creatinine);
SKCM	cis	rs1691799	0.899	rs1168304	chr12:66738667	A/C	cg16791601	chr12:66731901	HELB	-0.66	-5.81	-0.55	1.31e-7	White blood cell count (basophil);
SKCM	cis	rs919433	0.890	rs979020	chr2:198169749	T/C	cg04278110	chr2:198063759	ANKRD44	-0.7	-5.12	-0.5	2.14e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs9399135	0.935	rs4273704	chr6:135297520	G/T	cg24558204	chr6:135376177	HBS1L	0.55	4.98	0.49	3.73e-6	Red blood cell count;
SKCM	cis	rs7666738	0.830	rs13118945	chr4:98968586	T/G	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs17065868	1.000	rs55684354	chr13:45067534	G/A	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs2354432	0.660	rs10751415	chr1:146830785	T/A	cg25205988	chr1:146714368	CHD1L	1.13	6.24	0.58	2.08e-8	Mitochondrial DNA levels;
SKCM	cis	rs7769051	1.000	rs7761365	chr6:133101561	T/A	cg22852734	chr6:133119734	C6orf192	0.99	4.99	0.49	3.53e-6	Type 2 diabetes nephropathy;
SKCM	cis	rs28386778	0.787	rs2665827	chr17:61961350	G/C	cg01411255	chr17:61851458	DDX42;CCDC47	0.76	4.85	0.48	6.15e-6	Prudent dietary pattern;
SKCM	cis	rs2404602	0.655	rs12438362	chr15:77243990	G/C	cg23625390	chr15:77176239	SCAPER	0.6	5.41	0.52	6.72e-7	Blood metabolite levels;
SKCM	cis	rs798554	0.679	rs2533870	chr7:2885274	C/G	cg04166393	chr7:2884313	GNA12	-0.78	-5.68	-0.54	2.23e-7	Height;
SKCM	cis	rs2404602	0.647	rs7178250	chr15:77099107	T/C	cg23625390	chr15:77176239	SCAPER	-0.82	-7.93	-0.67	1.26e-11	Blood metabolite levels;
SKCM	cis	rs7632954	0.547	rs9847309	chr3:8536560	T/C	cg06697448	chr3:8544912	LMCD1	-0.61	-5.25	-0.51	1.28e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs9910055	0.529	rs228757	chr17:42164885	G/C	cg19774624	chr17:42201019	HDAC5	0.83	6.53	0.59	6.08e-9	Total body bone mineral density;
SKCM	cis	rs736408	0.505	rs2083180	chr3:52668119	G/T	cg18404041	chr3:52824283	ITIH1	-0.53	-4.77	-0.48	8.43e-6	Bipolar disorder;
SKCM	cis	rs6580649	0.883	rs7967762	chr12:48420214	C/T	cg05342945	chr12:48394962	COL2A1	0.67	5.0	0.49	3.39e-6	Lung cancer;
SKCM	cis	rs344364	0.511	rs62040569	chr16:1948137	C/T	cg26897989	chr16:1907736	C16orf73	-0.69	-7.13	-0.63	4.45e-10	Glomerular filtration rate in chronic kidney disease;
SKCM	cis	rs6951245	0.554	rs4724294	chr7:1139695	G/A	cg23708337	chr7:1209742	NA	0.71	4.9	0.49	5.02e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs992157	0.710	rs13026485	chr2:219057984	C/T	cg00012203	chr2:219082015	ARPC2	-0.85	-7.47	-0.65	9.82e-11	Colorectal cancer;
SKCM	cis	rs2842992	0.789	rs7758895	chr6:160193465	T/C	cg16489826	chr6:160211363	TCP1;MRPL18	0.73	5.42	0.52	6.39e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs6089829	0.925	rs6062396	chr20:61667949	T/C	cg08564027	chr20:61660810	NA	0.63	5.65	0.54	2.46e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs6424115	1.000	rs6697805	chr1:24151996	C/A	cg15997130	chr1:24165203	NA	-0.62	-5.42	-0.52	6.33e-7	Immature fraction of reticulocytes;
SKCM	cis	rs6445797	0.632	rs1045926	chr3:56654600	C/G	cg13616963	chr3:57583610	ARF4	-0.76	-4.92	-0.49	4.78e-6	Gastritis;
SKCM	cis	rs10256972	0.732	rs1574108	chr7:1105805	T/C	cg16145915	chr7:1198662	ZFAND2A	-0.47	-5.89	-0.56	9.16e-8	Longevity;Endometriosis;
SKCM	cis	rs7917772	0.502	rs10748827	chr10:104368336	G/T	cg11453585	chr10:104263688	ACTR1A;SUFU	0.77	6.1	0.57	3.8e-8	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs62238980	0.522	rs2413065	chr22:32458608	C/A	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs1850744	0.826	rs76738832	chr4:9597809	C/A	cg15442990	chr4:9534313	NA	-1.38	-5.09	-0.5	2.44e-6	Economic and political preferences;
SKCM	cis	rs4774899	0.934	rs12904561	chr15:57510974	G/A	cg01857019	chr15:57210107	LOC145783;TCF12	0.54	4.86	0.48	5.93e-6	Urinary tract infection frequency;
SKCM	cis	rs2842992	0.750	rs2758354	chr6:160125854	A/G	cg19482086	chr6:160211437	TCP1;MRPL18	0.8	5.89	0.56	9.15e-8	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs2075371	0.863	rs1646635	chr7:134006728	T/C	cg20476274	chr7:133979776	SLC35B4	1.02	10.68	0.77	6.2e-17	Mean platelet volume;
SKCM	cis	rs453301	0.686	rs10217044	chr8:8894752	A/G	cg06636001	chr8:8085503	FLJ10661	-0.73	-5.55	-0.53	3.74e-7	Joint mobility (Beighton score);
SKCM	cis	rs8060686	0.516	rs7194894	chr16:68145062	C/T	cg04539111	chr16:67997858	SLC12A4	-0.85	-4.81	-0.48	7.14e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs7100689	0.753	rs1572816	chr10:82137600	A/G	cg00277334	chr10:82204260	NA	-0.52	-4.97	-0.49	3.95e-6	Post bronchodilator FEV1;
SKCM	cis	rs7633770	1.000	rs7633770	chr3:46688562	G/A	cg11219411	chr3:46661640	NA	0.68	6.14	0.57	3.26e-8	Coronary artery disease;
SKCM	cis	rs7772486	0.875	rs12194437	chr6:146411440	A/G	cg23711669	chr6:146136114	FBXO30	0.85	8.48	0.69	1.09e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6121246	0.779	rs6060763	chr20:30282223	A/G	cg11595048	chr20:30225325	COX4I2	0.67	5.21	0.51	1.5e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs28595532	0.920	rs115437723	chr4:119741828	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs17826219	0.706	rs9893922	chr17:29068425	T/C	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Body mass index;
SKCM	cis	rs4563143	0.704	rs16961809	chr19:29226299	C/T	cg04546413	chr19:29218101	NA	0.82	5.49	0.53	4.84e-7	Methadone dose in opioid dependence;
SKCM	cis	rs2204008	0.614	rs4578492	chr12:38036350	T/C	cg13010199	chr12:38710504	ALG10B	0.66	4.96	0.49	3.96e-6	Bladder cancer;
SKCM	trans	rs11722228	0.508	rs3822246	chr4:10094698	G/A	cg26043149	chr18:55253948	FECH	0.93	7.98	0.67	1.02e-11	Gout;Urate levels;Serum uric acid levels;
SKCM	cis	rs6138458	1.000	rs227624	chr20:24911562	T/C	cg26195577	chr20:24973756	C20orf3	1.29	8.69	0.7	4.32e-13	Blood protein levels;
SKCM	cis	rs1577917	0.876	rs66986937	chr6:86532191	A/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.68	-5.91	-0.56	8.36e-8	Response to antipsychotic treatment;
SKCM	cis	rs2836974	0.897	rs11911112	chr21:40528346	A/C	cg17971929	chr21:40555470	PSMG1	0.87	8.48	0.69	1.1e-12	Cognitive function;
SKCM	cis	rs1790761	0.658	rs666328	chr11:67335538	G/A	cg00290607	chr11:67383545	NA	0.51	5.38	0.52	7.43e-7	Mean corpuscular volume;
SKCM	cis	rs7100689	0.622	rs1340383	chr10:82095968	T/G	cg00277334	chr10:82204260	NA	-0.57	-5.11	-0.5	2.22e-6	Post bronchodilator FEV1;
SKCM	cis	rs7772486	0.521	rs9485017	chr6:146023326	C/T	cg05347473	chr6:146136440	FBXO30	0.65	5.6	0.54	3.15e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2479724	0.901	rs6458244	chr6:41790455	C/T	cg17623882	chr6:41773611	USP49	0.8	7.08	0.63	5.43e-10	Menarche (age at onset);
SKCM	cis	rs6424115	0.830	rs2501424	chr1:24199182	T/C	cg15997130	chr1:24165203	NA	0.6	4.94	0.49	4.37e-6	Immature fraction of reticulocytes;
SKCM	cis	rs10911232	0.507	rs3935384	chr1:183028970	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.76	6.67	0.6	3.25e-9	Hypertriglyceridemia;
SKCM	cis	rs11719291	0.833	rs11715835	chr3:48770732	C/T	cg00383909	chr3:49044727	WDR6	1.08	5.86	0.55	1.06e-7	Cognitive function;
SKCM	cis	rs2739330	0.760	rs5751761	chr22:24243736	A/G	cg25703541	chr22:24373054	LOC391322	0.77	6.07	0.57	4.42e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs7829975	0.688	rs6995407	chr8:8384647	C/G	cg06636001	chr8:8085503	FLJ10661	0.87	7.16	0.63	3.92e-10	Mood instability;
SKCM	cis	rs611744	0.538	rs13257548	chr8:109273185	G/A	cg18478394	chr8:109455254	TTC35	0.64	5.45	0.53	5.7e-7	Dupuytren's disease;
SKCM	cis	rs644799	0.965	rs3016295	chr11:95554311	A/G	cg25622487	chr11:95524042	FAM76B;CEP57	0.66	5.12	0.5	2.18e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs875971	0.767	rs1695815	chr7:65831344	A/G	cg18876405	chr7:65276391	NA	0.68	6.79	0.61	2.01e-9	Aortic root size;
SKCM	cis	rs245880	0.666	rs245894	chr7:29192686	G/C	cg17163760	chr7:29186267	CPVL	-0.4	-5.37	-0.52	7.95e-7	Warfarin maintenance dose;
SKCM	cis	rs763121	0.853	rs9622833	chr22:39000397	G/A	cg06022373	chr22:39101656	GTPBP1	0.72	4.96	0.49	4.08e-6	Menopause (age at onset);
SKCM	cis	rs561341	0.882	rs28649357	chr17:30367190	A/G	cg00745463	chr17:30367425	LRRC37B	-1.06	-7.23	-0.63	2.87e-10	Hip circumference adjusted for BMI;
SKCM	cis	rs12142240	0.698	rs72677589	chr1:46817770	T/C	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs2839186	0.786	rs7409792	chr21:47691729	C/A	cg11766577	chr21:47581405	C21orf56	-0.68	-5.79	-0.55	1.38e-7	Testicular germ cell tumor;
SKCM	cis	rs11677370	0.561	rs10191326	chr2:3827524	G/C	cg17052675	chr2:3827356	NA	-0.62	-5.11	-0.5	2.24e-6	Type 2 diabetes;
SKCM	cis	rs10832963	1.000	rs4757676	chr11:18640477	C/T	cg09201001	chr11:18656081	SPTY2D1	1.03	11.04	0.78	1.31e-17	Breast cancer;
SKCM	cis	rs10504073	0.584	rs4873300	chr8:49902201	C/G	cg00325661	chr8:49890786	NA	0.79	7.15	0.63	3.99e-10	Blood metabolite ratios;
SKCM	cis	rs6570726	0.791	rs392612	chr6:145881586	C/G	cg05347473	chr6:146136440	FBXO30	-0.57	-5.05	-0.5	2.81e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9814567	1.000	rs6772896	chr3:134203347	C/T	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.67	-5.26	-0.51	1.21e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs4072980	0.527	rs11210825	chr1:38446986	G/A	cg12658694	chr1:38397304	INPP5B	0.58	4.93	0.49	4.54e-6	Coronary artery disease;
SKCM	cis	rs763014	0.865	rs8909	chr16:633851	T/C	cg00908189	chr16:619842	PIGQ	0.82	7.78	0.66	2.55e-11	Height;
SKCM	cis	rs1005277	0.522	rs1208684	chr10:38093936	G/A	cg00409905	chr10:38381863	ZNF37A	-0.6	-5.68	-0.54	2.17e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs4780401	0.539	rs62040604	chr16:11803641	G/A	cg01061890	chr16:11836724	TXNDC11	-0.8	-6.08	-0.57	4.16e-8	Rheumatoid arthritis;
SKCM	cis	rs798554	0.757	rs1182187	chr7:2870454	T/G	cg19346786	chr7:2764209	NA	-0.65	-6.97	-0.62	8.82e-10	Height;
SKCM	cis	rs17270561	0.525	rs10484432	chr6:26008876	G/A	cg17691542	chr6:26056736	HIST1H1C	1.24	9.84	0.74	2.54e-15	Iron status biomarkers;
SKCM	cis	rs9916302	0.904	rs3744348	chr17:37417575	C/G	cg07936489	chr17:37558343	FBXL20	-0.84	-6.96	-0.62	9.48e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs1957429	1.000	rs1957431	chr14:65353187	A/G	cg23373153	chr14:65346875	NA	1.03	6.23	0.58	2.18e-8	Pediatric areal bone mineral density (radius);
SKCM	cis	rs644799	0.540	rs10831422	chr11:95478968	T/C	cg03916912	chr11:95522834	CEP57;FAM76B	0.67	5.03	0.49	3.11e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs951366	0.617	rs823074	chr1:205774839	T/C	cg17178900	chr1:205818956	PM20D1	0.83	8.3	0.68	2.44e-12	Menarche (age at onset);
SKCM	cis	rs854765	0.616	rs8076747	chr17:17853595	C/T	cg04398451	chr17:18023971	MYO15A	-0.9	-6.24	-0.58	2.12e-8	Total body bone mineral density;
SKCM	cis	rs870825	0.616	rs7659101	chr4:185632158	C/T	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs4073582	0.595	rs2508657	chr11:66043898	G/A	cg14036092	chr11:66035641	RAB1B	0.75	5.91	0.56	8.39e-8	Gout;
SKCM	cis	rs3091242	0.781	rs71652378	chr1:25721457	G/C	cg02931644	chr1:25747376	RHCE	0.53	5.48	0.53	5.13e-7	Erythrocyte sedimentation rate;
SKCM	cis	rs2404602	0.608	rs17361504	chr15:76601871	A/G	cg22467129	chr15:76604101	ETFA	-0.65	-5.35	-0.52	8.68e-7	Blood metabolite levels;
SKCM	trans	rs62103177	0.810	rs62103178	chr18:77624555	C/G	cg05926928	chr17:57297772	GDPD1	1.29	8.74	0.7	3.44e-13	Opioid sensitivity;
SKCM	cis	rs7666738	0.830	rs6852015	chr4:99054373	C/A	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10254284	1.000	rs10254284	chr7:28167391	A/T	cg15170557	chr7:28214983	JAZF1	-0.61	-5.25	-0.51	1.3e-6	Lymphocyte percentage of white cells;Systemic lupus erythematosus;
SKCM	cis	rs898097	1.000	rs898097	chr17:80904310	C/T	cg15369054	chr17:80825471	TBCD	-0.56	-5.2	-0.51	1.58e-6	Breast cancer;
SKCM	cis	rs11098499	0.954	rs66506550	chr4:120371445	T/A	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs867186	0.920	rs2145558	chr20:33650069	A/G	cg04194272	chr20:33683537	NA	-1.38	-7.2	-0.63	3.29e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs12474201	0.928	rs17822019	chr2:46934505	T/C	cg06386533	chr2:46925753	SOCS5	1.01	9.13	0.72	5.95e-14	Height;
SKCM	cis	rs853679	0.599	rs149943	chr6:28002388	G/A	cg06761719	chr6:27280190	POM121L2	0.89	4.99	0.49	3.55e-6	Depression;
SKCM	cis	rs1707322	0.963	rs11211202	chr1:46292382	C/T	cg03146154	chr1:46216737	IPP	0.75	5.15	0.5	1.94e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs992157	0.965	rs13419763	chr2:219134950	C/T	cg00012203	chr2:219082015	ARPC2	0.82	6.96	0.62	9.29e-10	Colorectal cancer;
SKCM	cis	rs3087591	0.919	rs11080148	chr17:29609922	T/C	cg24425628	chr17:29625626	OMG;NF1	-0.63	-4.79	-0.48	7.9e-6	Hip circumference;
SKCM	cis	rs13010713	0.840	rs7355751	chr2:182090633	T/C	cg21995919	chr2:182322279	ITGA4	-0.56	-4.83	-0.48	6.77e-6	Celiac disease;
SKCM	cis	rs2599510	0.811	rs62136345	chr2:32807223	G/T	cg02381751	chr2:32503542	YIPF4	0.74	5.76	0.55	1.63e-7	Interleukin-18 levels;
SKCM	cis	rs7208859	0.623	rs73267858	chr17:29059737	A/G	cg14067834	chr17:29058358	SUZ12P	1.2	5.77	0.55	1.5e-7	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs8077889	0.917	rs4793037	chr17:41914826	C/T	cg26893861	chr17:41843967	DUSP3	1.15	7.34	0.64	1.79e-10	Triglycerides;
SKCM	cis	rs9911578	0.967	rs6503890	chr17:57064167	A/G	cg05425664	chr17:57184151	TRIM37	-0.72	-5.39	-0.52	7.35e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs17376456	0.877	rs7702521	chr5:93484579	G/T	cg25358565	chr5:93447407	FAM172A	1.23	7.97	0.67	1.08e-11	Diabetic retinopathy;
SKCM	cis	rs6120849	0.802	rs6087681	chr20:33752896	G/C	cg24642439	chr20:33292090	TP53INP2	0.95	5.17	0.51	1.74e-6	Protein C levels;
SKCM	cis	rs3820928	0.874	rs13393894	chr2:227880543	A/G	cg11843606	chr2:227700838	RHBDD1	-0.62	-5.12	-0.5	2.19e-6	Pulmonary function;
SKCM	cis	rs10883723	0.810	rs7069356	chr10:104254359	G/C	cg11453585	chr10:104263688	ACTR1A;SUFU	0.75	5.7	0.54	2.03e-7	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs28386778	0.863	rs2665834	chr17:61904724	T/C	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs7666738	0.830	rs28802909	chr4:99039410	G/A	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs875971	0.540	rs35510581	chr7:65578777	G/A	cg11764359	chr7:65958608	NA	-0.93	-7.31	-0.64	2.01e-10	Aortic root size;
SKCM	cis	rs875971	1.000	rs3981131	chr7:65951677	A/G	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	cis	rs8014204	0.967	rs4903266	chr14:75344941	C/G	cg06637938	chr14:75390232	RPS6KL1	-0.77	-5.82	-0.55	1.22e-7	Caffeine consumption;
SKCM	cis	rs4481887	0.927	rs6587445	chr1:248440915	A/G	cg00666640	chr1:248458726	OR2T12	0.61	5.46	0.53	5.47e-7	Common traits (Other);
SKCM	cis	rs6089829	0.851	rs6122346	chr20:61661822	C/G	cg08564027	chr20:61660810	NA	0.63	5.65	0.54	2.56e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs2836974	0.897	rs12481860	chr21:40537836	T/A	cg17971929	chr21:40555470	PSMG1	0.87	8.48	0.69	1.1e-12	Cognitive function;
SKCM	cis	rs910316	1.000	rs2098297	chr14:75619118	G/T	cg08847533	chr14:75593920	NEK9	-0.93	-9.15	-0.72	5.51e-14	Height;
SKCM	cis	rs7208859	0.623	rs73269945	chr17:29108759	G/A	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs7100689	0.622	rs1340373	chr10:82129250	G/A	cg01528321	chr10:82214614	TSPAN14	0.8	7.0	0.62	7.98e-10	Post bronchodilator FEV1;
SKCM	cis	rs7811142	1.000	rs7783550	chr7:99987805	A/G	cg13153964	chr7:100026424	MEPCE;ZCWPW1	-1.25	-8.0	-0.67	9.51e-12	Platelet count;
SKCM	cis	rs3091242	0.866	rs11249249	chr1:25758134	A/G	cg27572855	chr1:25598939	RHD	0.53	5.06	0.5	2.73e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs367615	0.552	rs2115511	chr5:108725403	A/T	cg17395555	chr5:108820864	NA	-0.65	-5.34	-0.52	8.86e-7	Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs2952156	0.684	rs1877031	chr17:37814080	G/A	cg20243544	chr17:37824526	PNMT	0.73	5.61	0.54	2.97e-7	Asthma;
SKCM	cis	rs7954584	0.505	rs11043278	chr12:122412145	C/T	cg01765077	chr12:122356316	WDR66	0.47	5.06	0.5	2.68e-6	Mean corpuscular volume;
SKCM	cis	rs634534	0.561	rs655744	chr11:65776585	G/T	cg26695010	chr11:65641043	EFEMP2	0.69	5.1	0.5	2.35e-6	Sum eosinophil basophil counts;Eosinophil counts;
SKCM	trans	rs5756813	0.635	rs12160750	chr22:38199054	A/G	cg19894588	chr14:64061835	NA	-0.88	-7.39	-0.64	1.44e-10	Optic cup area;Vertical cup-disc ratio;
SKCM	cis	rs6105452	0.524	rs8123014	chr20:15681440	C/G	cg04678219	chr20:16554259	KIF16B	-0.82	-5.23	-0.51	1.39e-6	Epstein-Barr virus copy number in lymphoblastoid cell lines;
SKCM	cis	rs7772486	0.754	rs4566902	chr6:146244128	A/G	cg23711669	chr6:146136114	FBXO30	-0.77	-7.3	-0.64	2.15e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7829975	0.714	rs12544992	chr8:8661681	C/G	cg15556689	chr8:8085844	FLJ10661	0.7	6.12	0.57	3.57e-8	Mood instability;
SKCM	cis	rs7786877	0.723	rs11764045	chr7:100212754	C/T	cg16850897	chr7:100343110	ZAN	-0.65	-4.93	-0.49	4.54e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs634534	0.622	rs1192168	chr11:65730945	T/G	cg02427764	chr11:65769310	BANF1;EIF1AD	0.65	5.17	0.51	1.75e-6	Sum eosinophil basophil counts;Eosinophil counts;
SKCM	cis	rs1801251	1.000	rs283476	chr2:233650168	A/G	cg25237894	chr2:233734115	C2orf82	0.62	5.66	0.54	2.44e-7	Coronary artery disease;
SKCM	cis	rs7216064	0.684	rs8182243	chr17:66018505	T/C	cg12091567	chr17:66097778	LOC651250	0.89	6.71	0.6	2.8e-9	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs4803468	1.000	rs2241708	chr19:41912270	C/T	cg09537434	chr19:41945824	ATP5SL	-1.1	-13.82	-0.84	1.16e-22	Height;
SKCM	trans	rs3780486	0.846	rs3780487	chr9:33139237	T/C	cg04842962	chr6:43655489	MRPS18A	1.03	10.87	0.78	2.78e-17	IgG glycosylation;
SKCM	cis	rs589448	0.902	rs642786	chr12:69758462	T/C	cg14784868	chr12:69753453	YEATS4	0.84	7.65	0.65	4.54e-11	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs61776719	0.905	rs28570969	chr1:38407146	A/G	cg17077180	chr1:38461687	NA	0.5	4.92	0.49	4.63e-6	Coronary artery disease;
SKCM	cis	rs8180040	0.932	rs12490058	chr3:47529063	T/C	cg27129171	chr3:47204927	SETD2	0.79	5.79	0.55	1.43e-7	Colorectal cancer;
SKCM	cis	rs17345786	0.861	rs11707689	chr3:101086475	A/G	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.66	4.85	0.48	6.24e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7927771	1.000	rs12418852	chr11:47868853	C/G	cg05585544	chr11:47624801	NA	-0.6	-5.22	-0.51	1.45e-6	Subjective well-being;
SKCM	cis	rs28595532	0.841	rs115851302	chr4:119776504	C/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	trans	rs1814175	0.817	rs7481230	chr11:49772235	G/A	cg15704280	chr7:45808275	SEPT13	-1.03	-10.73	-0.77	5.17e-17	Height;
SKCM	cis	rs2439831	0.681	rs7176849	chr15:43681427	T/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.21	7.84	0.66	1.9e-11	Lung cancer in ever smokers;
SKCM	cis	rs6088580	0.608	rs1205342	chr20:32921842	C/T	cg24642439	chr20:33292090	TP53INP2	-0.72	-5.7	-0.54	2.06e-7	Glomerular filtration rate (creatinine);
SKCM	cis	rs6121246	0.559	rs6087782	chr20:30391580	C/T	cg11595048	chr20:30225325	COX4I2	0.54	4.77	0.48	8.4e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs9858542	1.000	rs9858542	chr3:49701983	A/G	cg03060546	chr3:49711283	APEH	0.7	5.26	0.51	1.24e-6	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs7100689	0.646	rs10736348	chr10:82139244	C/A	cg00277334	chr10:82204260	NA	-0.52	-4.78	-0.48	8.05e-6	Post bronchodilator FEV1;
SKCM	cis	rs1577917	0.959	rs34258068	chr6:86679449	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.65	-5.59	-0.54	3.16e-7	Response to antipsychotic treatment;
SKCM	cis	rs1577917	0.798	rs7772384	chr6:86639680	G/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.66	-5.74	-0.54	1.76e-7	Response to antipsychotic treatment;
SKCM	cis	rs1348850	0.914	rs8941	chr2:178406481	C/T	cg02961200	chr2:178257176	LOC100130691;AGPS	0.83	6.14	0.57	3.21e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs7633770	0.805	rs11130098	chr3:46661926	A/G	cg11219411	chr3:46661640	NA	-0.75	-7.65	-0.65	4.53e-11	Coronary artery disease;
SKCM	cis	rs703842	1.000	rs10877019	chr12:58172929	A/G	cg04478727	chr12:58166393	METTL1;FAM119B	-0.71	-5.48	-0.53	4.95e-7	Multiple sclerosis;
SKCM	cis	rs5760092	0.627	rs6519489	chr22:24261846	G/A	cg24846343	chr22:24311635	DDTL	-0.62	-4.99	-0.49	3.6e-6	Urinary 1,3-butadiene metabolite levels in smokers;
SKCM	cis	rs8042680	0.554	rs6496746	chr15:91532869	C/A	cg15878949	chr15:91534302	PRC1	0.59	4.94	0.49	4.33e-6	Type 2 diabetes;
SKCM	cis	rs12497850	0.931	rs11920534	chr3:48937761	G/T	cg07636037	chr3:49044803	WDR6	1.02	11.0	0.78	1.56e-17	Parkinson's disease;
SKCM	cis	rs6977660	1.000	rs6959591	chr7:19821824	A/G	cg05791153	chr7:19748676	TWISTNB	0.79	5.34	0.52	9.05e-7	Thyroid stimulating hormone;
SKCM	cis	rs28386778	0.897	rs2665844	chr17:61874455	A/G	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs28595532	0.920	rs115046587	chr4:119779604	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs941408	0.515	rs1640262	chr19:2779134	C/T	cg06609049	chr19:2785107	THOP1	-1.09	-10.57	-0.77	1.02e-16	Total cholesterol levels;
SKCM	cis	rs6982751	0.673	rs73196859	chr8:10813944	C/G	cg01383082	chr8:11323474	FAM167A	0.91	5.11	0.5	2.21e-6	Asthma and hay fever;
SKCM	cis	rs2952156	0.920	rs2247862	chr17:37829129	A/G	cg20243544	chr17:37824526	PNMT	0.68	5.68	0.54	2.25e-7	Asthma;
SKCM	cis	rs16940212	0.505	rs12185071	chr15:58683227	C/T	cg16767221	chr15:57769667	CGNL1	-0.67	-5.27	-0.51	1.17e-6	HDL cholesterol levels;HDL cholesterol;
SKCM	cis	rs941873	0.869	rs7917610	chr10:81117237	T/C	cg09469691	chr10:81107165	PPIF	0.71	6.8	0.61	1.89e-9	Height;
SKCM	cis	rs1707322	0.721	rs4660314	chr1:46229885	T/C	cg03146154	chr1:46216737	IPP	0.84	6.26	0.58	1.97e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs362272	0.524	rs7435601	chr4:3369645	A/G	cg09735869	chr4:3319127	RGS12	0.99	10.87	0.78	2.78e-17	Serum sulfate level;
SKCM	cis	rs1707322	0.717	rs1135850	chr1:46093692	G/A	cg03146154	chr1:46216737	IPP	0.79	5.42	0.52	6.34e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs28386778	0.787	rs2665827	chr17:61961350	G/C	cg06873352	chr17:61820015	STRADA	0.77	6.54	0.6	5.71e-9	Prudent dietary pattern;
SKCM	cis	rs933688	1.000	rs1035476	chr5:90745976	C/T	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.0	7.62	0.65	5.2e-11	Smoking behavior;
SKCM	cis	rs8072100	0.934	rs6504872	chr17:45438952	C/T	cg25173405	chr17:45401733	C17orf57	-0.63	-5.57	-0.53	3.52e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs2228479	0.557	rs11648881	chr16:89862434	T/C	cg06558623	chr16:89946397	TCF25	1.1	4.97	0.49	3.82e-6	Skin colour saturation;
SKCM	cis	rs2204008	0.522	rs117743143	chr12:38030824	C/T	cg26384229	chr12:38710491	ALG10B	0.75	6.26	0.58	1.95e-8	Bladder cancer;
SKCM	cis	rs8141529	0.719	rs5762825	chr22:29223642	A/G	cg15103426	chr22:29168792	CCDC117	0.62	5.2	0.51	1.57e-6	Lymphocyte counts;
SKCM	cis	rs951366	0.844	rs823096	chr1:205679887	G/T	cg07157834	chr1:205819609	PM20D1	0.77	6.53	0.59	6.03e-9	Menarche (age at onset);
SKCM	cis	rs861020	1.000	rs680923	chr1:209986672	T/C	cg05527609	chr1:210001259	C1orf107	1.04	7.42	0.64	1.27e-10	Orofacial clefts;
SKCM	cis	rs17376456	0.877	rs10050465	chr5:93349963	C/A	cg25358565	chr5:93447407	FAM172A	1.19	7.78	0.66	2.52e-11	Diabetic retinopathy;
SKCM	cis	rs9303401	0.614	rs34941454	chr17:57102742	T/G	cg10487724	chr17:56770010	TEX14;RAD51C	0.79	4.97	0.49	3.86e-6	Cognitive test performance;
SKCM	cis	rs4481887	0.639	rs10749644	chr1:248414587	A/C	cg00666640	chr1:248458726	OR2T12	0.66	5.41	0.52	6.65e-7	Common traits (Other);
SKCM	cis	rs79839061	0.610	rs62297062	chr4:869698	C/T	cg07828340	chr4:882639	GAK	1.02	4.95	0.49	4.16e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs6933660	0.720	rs6936936	chr6:151753395	A/G	cg10883421	chr6:151773342	RMND1;C6orf211	0.82	6.83	0.61	1.69e-9	Menarche (age at onset);
SKCM	cis	rs9325144	0.600	rs12424410	chr12:38758035	A/T	cg26384229	chr12:38710491	ALG10B	-0.75	-6.52	-0.59	6.23e-9	Morning vs. evening chronotype;
SKCM	cis	rs992157	0.732	rs10932771	chr2:219170236	A/T	cg00012203	chr2:219082015	ARPC2	0.73	5.72	0.54	1.84e-7	Colorectal cancer;
SKCM	cis	rs7772486	0.875	rs10872583	chr6:146396699	G/T	cg05347473	chr6:146136440	FBXO30	-0.65	-5.69	-0.54	2.13e-7	Lobe attachment (rater-scored or self-reported);
SKCM	trans	rs1198430	0.925	rs1207124	chr1:23760408	A/G	cg09691861	chr4:77870047	SEPT11	-1.02	-7.41	-0.64	1.3100000000000001e-10	Total cholesterol levels;
SKCM	cis	rs2120019	0.935	rs34835684	chr15:75331805	T/G	cg17294928	chr15:75287854	SCAMP5	-0.91	-8.76	-0.7	3.17e-13	Blood trace element (Zn levels);
SKCM	cis	rs8180040	1.000	rs807931	chr3:47389317	C/T	cg16586182	chr3:47516702	SCAP	-0.71	-4.85	-0.48	6.25e-6	Colorectal cancer;
SKCM	cis	rs11640734	0.619	rs2293586	chr16:89962394	A/G	cg06558623	chr16:89946397	TCF25	1.25	7.18	0.63	3.53e-10	Interleukin-17 levels;
SKCM	cis	rs9611565	0.512	rs964898	chr22:42142306	C/T	cg03806693	chr22:41940476	POLR3H	-1.15	-7.27	-0.64	2.37e-10	Vitiligo;
SKCM	cis	rs9815354	0.812	rs73071344	chr3:41827062	C/T	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs6500395	1.000	rs12934126	chr16:48705951	C/G	cg04672837	chr16:48644449	N4BP1	-0.63	-5.37	-0.52	8.01e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs55823223	0.648	rs9894383	chr17:73865657	T/G	cg10935138	chr17:73851978	WBP2	1.19	7.17	0.63	3.81e-10	Psoriasis;
SKCM	cis	rs13118159	0.550	rs2878607	chr4:1353310	G/C	cg20887711	chr4:1340912	KIAA1530	0.98	7.45	0.64	1.09e-10	Longevity;
SKCM	cis	rs25645	0.502	rs7209742	chr17:38108708	A/G	cg17467752	chr17:38218738	THRA	0.65	5.15	0.5	1.91e-6	Myeloid white cell count;
SKCM	trans	rs561341	0.843	rs4795666	chr17:30241409	A/G	cg20587970	chr11:113659929	NA	-1.03	-8.22	-0.68	3.56e-12	Hip circumference adjusted for BMI;
SKCM	cis	rs2115536	0.967	rs934137	chr15:80211768	T/C	cg00225070	chr15:80189496	MTHFS	0.75	4.9	0.48	5.15e-6	Eosinophil counts;Eosinophil percentage of white cells;Sum eosinophil basophil counts;Eosinophil percentage of granulocytes;Neutrophil percentage of granulocytes;
SKCM	cis	rs17065868	1.000	rs9525971	chr13:45095344	A/G	cg10246903	chr13:45222710	NA	-0.92	-5.05	-0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs1577917	0.958	rs12195776	chr6:86488599	C/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.83	-8.21	-0.68	3.76e-12	Response to antipsychotic treatment;
SKCM	cis	rs9325144	0.624	rs10783333	chr12:39118931	A/T	cg13010199	chr12:38710504	ALG10B	0.63	5.58	0.53	3.4e-7	Morning vs. evening chronotype;
SKCM	cis	rs4555082	0.957	rs2816608	chr14:105718407	A/G	cg13114125	chr14:105738426	BRF1	0.73	5.52	0.53	4.29e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs875971	0.965	rs9969301	chr7:65781655	G/A	cg18876405	chr7:65276391	NA	-0.68	-6.79	-0.61	1.96e-9	Aortic root size;
SKCM	cis	rs1014246	0.848	rs11197799	chr10:118457650	C/T	cg14919929	chr10:118506882	NA	0.8	6.03	0.56	5.24e-8	Age at smoking initiation in chronic obstructive pulmonary disease;
SKCM	cis	rs2228479	0.850	rs11641147	chr16:89813589	C/T	cg00800038	chr16:89945340	TCF25	-0.81	-4.79	-0.48	7.84e-6	Skin colour saturation;
SKCM	cis	rs933688	1.000	rs12188467	chr5:90765632	A/T	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.9	6.33	0.58	1.46e-8	Smoking behavior;
SKCM	cis	rs9485372	1.000	rs60115501	chr6:149607540	C/T	cg03072286	chr6:150262044	ULBP2	-0.55	-4.89	-0.48	5.3e-6	Breast cancer;
SKCM	trans	rs1814175	0.817	rs3974439	chr11:50022607	G/A	cg03929089	chr4:120376271	NA	-0.93	-8.77	-0.7	3.08e-13	Height;
SKCM	cis	rs2439831	0.681	rs540388	chr15:43606494	G/A	cg27015174	chr15:43622946	ADAL;LCMT2	0.87	4.81	0.48	7.13e-6	Lung cancer in ever smokers;
SKCM	cis	rs3087591	0.960	rs6505232	chr17:29611411	T/C	cg24425628	chr17:29625626	OMG;NF1	-0.64	-5.08	-0.5	2.48e-6	Hip circumference;
SKCM	cis	rs8067545	0.750	rs9915758	chr17:19964775	A/G	cg13482628	chr17:19912719	NA	0.73	6.54	0.6	5.78e-9	Schizophrenia;
SKCM	cis	rs2841277	0.646	rs3742935	chr14:105405599	G/C	cg21017887	chr14:105400489	NA	0.59	5.31	0.52	1e-6	Rheumatoid arthritis;
SKCM	cis	rs2070488	1.000	rs13058903	chr3:38513365	C/T	cg01465620	chr3:38496096	LOC100128640;ACVR2B	-0.98	-9.35	-0.73	2.29e-14	Electrocardiographic conduction measures;
SKCM	cis	rs10254284	0.885	rs10276070	chr7:28150689	T/C	cg15170557	chr7:28214983	JAZF1	-0.6	-5.09	-0.5	2.45e-6	Lymphocyte percentage of white cells;Systemic lupus erythematosus;
SKCM	trans	rs1814175	0.791	rs9787917	chr11:49937281	C/T	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs4727027	0.705	rs10952803	chr7:148890091	T/G	cg23583168	chr7:148888333	NA	-0.76	-5.89	-0.55	9.45e-8	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs7124681	0.505	rs7126378	chr11:47585348	G/T	cg20307385	chr11:47447363	PSMC3	0.72	5.24	0.51	1.34e-6	Body mass index (joint analysis main effects and physical activity interaction);Body mass index;Body mass index in physically active individuals;
SKCM	cis	rs7945705	0.869	rs7925728	chr11:9013002	A/G	cg13070366	chr11:9386451	NA	0.6	5.15	0.5	1.87e-6	Hemoglobin concentration;
SKCM	cis	rs9911578	0.874	rs302874	chr17:56767996	A/G	cg05425664	chr17:57184151	TRIM37	-0.64	-4.92	-0.49	4.69e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1799949	1.000	rs8176103	chr17:41267050	G/A	cg05368731	chr17:41323189	NBR1	0.9	7.76	0.66	2.73e-11	Menopause (age at onset);
SKCM	cis	rs61776719	0.875	rs28435150	chr1:38407014	C/T	cg17077180	chr1:38461687	NA	0.5	4.92	0.49	4.63e-6	Coronary artery disease;
SKCM	trans	rs1814175	0.645	rs4411280	chr11:49962750	A/G	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs911555	0.504	rs8006526	chr14:104075015	T/C	cg24130564	chr14:104152367	KLC1	-0.58	-5.11	-0.5	2.27e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2836950	0.565	rs3171465	chr21:40552307	A/G	cg17971929	chr21:40555470	PSMG1	-0.76	-6.53	-0.59	6.19e-9	Menarche (age at onset);
SKCM	trans	rs561341	0.739	rs9906455	chr17:30215669	G/A	cg20587970	chr11:113659929	NA	1.03	7.88	0.67	1.58e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs11098499	0.909	rs7681978	chr4:120383775	T/C	cg09307838	chr4:120376055	NA	0.96	7.73	0.66	3.08e-11	Corneal astigmatism;
SKCM	cis	rs875971	0.862	rs1083554	chr7:65852341	T/C	cg18876405	chr7:65276391	NA	0.63	6.34	0.58	1.39e-8	Aortic root size;
SKCM	cis	rs7959452	0.535	rs11177577	chr12:69671791	C/T	cg20891283	chr12:69753455	YEATS4	0.75	6.81	0.61	1.77e-9	Blood protein levels;
SKCM	cis	rs7333181	0.649	rs2027428	chr13:112228836	G/A	cg26646207	chr13:112610299	NA	-0.67	-4.85	-0.48	6.09e-6	Menopause (age at onset);
SKCM	cis	rs6500395	0.962	rs9941336	chr16:48652769	G/A	cg04672837	chr16:48644449	N4BP1	0.68	5.6	0.54	3.07e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs1862618	0.573	rs2034245	chr5:56243685	T/C	cg12311346	chr5:56204834	C5orf35	0.74	5.36	0.52	8.18e-7	Initial pursuit acceleration;
SKCM	cis	rs8180040	0.966	rs11719877	chr3:47425473	C/T	cg27129171	chr3:47204927	SETD2	0.79	5.79	0.55	1.43e-7	Colorectal cancer;
SKCM	cis	rs2075371	1.000	rs2544213	chr7:133982867	G/C	cg20476274	chr7:133979776	SLC35B4	1.01	10.44	0.76	1.77e-16	Mean platelet volume;
SKCM	cis	rs614226	1.000	rs563920	chr12:121017439	A/G	cg01236616	chr12:121019343	POP5	1.37	8.37	0.69	1.79e-12	Type 1 diabetes nephropathy;
SKCM	cis	rs9902453	0.709	rs6505162	chr17:28444183	A/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.76	5.53	0.53	4.17e-7	Coffee consumption (cups per day);
SKCM	cis	rs6087990	0.735	rs6058892	chr20:31388461	C/T	cg13636640	chr20:31349939	DNMT3B	0.83	6.25	0.58	2.06e-8	Ulcerative colitis;
SKCM	cis	rs929354	0.772	rs2301916	chr7:156974127	G/T	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs9875589	0.509	rs7636901	chr3:14030958	G/A	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.51	5.17	0.51	1.73e-6	Ovarian reserve;
SKCM	cis	rs7523273	0.606	rs7144	chr1:207967719	A/G	cg22525895	chr1:207977042	MIR29B2	-0.76	-6.55	-0.6	5.64e-9	Schizophrenia;
SKCM	cis	rs3780486	0.846	rs73484568	chr9:33132492	G/A	cg13443165	chr9:33130375	B4GALT1	-0.55	-4.99	-0.49	3.65e-6	IgG glycosylation;
SKCM	cis	rs782590	0.967	rs2627759	chr2:55853341	T/C	cg18811423	chr2:55921094	PNPT1	0.9	6.98	0.62	8.78e-10	Metabolic syndrome;
SKCM	cis	rs875971	1.000	rs6979382	chr7:65886375	C/T	cg18876405	chr7:65276391	NA	0.67	6.65	0.6	3.61e-9	Aortic root size;
SKCM	cis	rs1348850	0.914	rs4893957	chr2:178380409	A/G	cg02961200	chr2:178257176	LOC100130691;AGPS	0.85	6.45	0.59	8.7e-9	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs28386778	0.897	rs8067102	chr17:61848779	C/G	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs4555082	0.915	rs2816632	chr14:105741355	C/T	cg13114125	chr14:105738426	BRF1	0.75	5.86	0.55	1.03e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs6580649	0.883	rs879242	chr12:48503301	T/C	cg05342945	chr12:48394962	COL2A1	0.79	5.36	0.52	8.37e-7	Lung cancer;
SKCM	cis	rs748404	0.697	rs493444	chr15:43566470	G/C	cg02155558	chr15:43621948	ADAL;LCMT2	0.7	5.68	0.54	2.19e-7	Lung cancer;
SKCM	cis	rs365132	0.934	rs251844	chr5:176476605	T/A	cg16309518	chr5:176445507	NA	-0.49	-4.77	-0.48	8.4e-6	Menarche and menopause (age at onset);Menopause (age at onset);
SKCM	cis	rs6430585	0.527	rs12465544	chr2:136451676	C/T	cg07169764	chr2:136633963	MCM6	1.02	7.68	0.66	3.84e-11	Corneal structure;
SKCM	cis	rs796364	1.000	rs1704186	chr2:200769539	A/C	cg12253985	chr2:200820533	C2orf60;C2orf47	0.9	5.65	0.54	2.47e-7	Schizophrenia;
SKCM	cis	rs6121246	0.559	rs6060962	chr20:30397847	A/G	cg11595048	chr20:30225325	COX4I2	0.54	4.77	0.48	8.4e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs7917772	0.560	rs729023	chr10:104341887	A/G	cg11453585	chr10:104263688	ACTR1A;SUFU	-0.64	-5.2	-0.51	1.59e-6	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs2721195	0.967	rs748195	chr8:145682514	T/C	cg11211951	chr8:145729740	GPT	0.65	6.19	0.57	2.65e-8	Age at first birth;
SKCM	cis	rs6129767	1	rs6129767	chr20:39822332	T/G	cg06424997	chr20:39929561	ZHX3	0.71	5.69	0.54	2.14e-7	Coronary artery disease;
SKCM	cis	rs1707322	0.721	rs28817701	chr1:46186050	C/T	cg03146154	chr1:46216737	IPP	0.84	6.2	0.57	2.51e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs1669338	0.588	rs55959448	chr3:3204000	C/T	cg16797762	chr3:3221439	CRBN	-1.01	-6.1	-0.57	3.89e-8	White matter integrity;
SKCM	cis	rs35306767	0.903	rs12260800	chr10:927933	T/C	cg26597838	chr10:835615	NA	0.75	5.51	0.53	4.53e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs2836974	0.604	rs2854727	chr21:40713787	A/G	cg11644478	chr21:40555479	PSMG1	0.64	4.88	0.48	5.48e-6	Cognitive function;
SKCM	cis	rs951366	0.789	rs823110	chr1:205701078	G/C	cg24503407	chr1:205819492	PM20D1	0.88	7.38	0.64	1.5e-10	Menarche (age at onset);
SKCM	cis	rs2404602	0.692	rs1116535	chr15:77009514	C/G	cg23625390	chr15:77176239	SCAPER	-0.59	-5.24	-0.51	1.35e-6	Blood metabolite levels;
SKCM	cis	rs9951698	0.703	rs9783903	chr18:13000210	A/G	cg12848697	chr18:13133368	NA	0.53	4.9	0.48	5.18e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs8017423	0.967	rs17188605	chr14:90722579	C/T	cg04374321	chr14:90722782	PSMC1	1.03	9.44	0.73	1.55e-14	Mortality in heart failure;
SKCM	cis	rs3820068	0.581	rs72645879	chr1:15928199	A/G	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs4423214	0.879	rs4945008	chr11:71221248	A/G	cg05163923	chr11:71159392	DHCR7	0.82	7.8	0.66	2.26e-11	Vitamin D levels;
SKCM	cis	rs208520	0.754	rs1100989	chr6:66880532	G/A	cg07460842	chr6:66804631	NA	-0.91	-7.07	-0.63	5.76e-10	Exhaled nitric oxide output;
SKCM	cis	rs873946	0.564	rs35831787	chr10:134546346	T/C	cg26818010	chr10:134567672	INPP5A	-0.65	-5.0	-0.49	3.51e-6	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs7927771	0.524	rs10769299	chr11:47865160	G/T	cg20307385	chr11:47447363	PSMC3	0.72	5.81	0.55	1.31e-7	Subjective well-being;
SKCM	cis	rs13040088	1.000	rs6090155	chr20:61527378	G/A	cg23096297	chr20:61557774	DIDO1	0.7	5.71	0.54	1.98e-7	Menopause (age at onset);
SKCM	cis	rs1577917	0.958	rs12198061	chr6:86550985	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.81	-7.82	-0.66	2.07e-11	Response to antipsychotic treatment;
SKCM	cis	rs9303401	0.659	rs12952325	chr17:56899371	G/A	cg02118635	chr17:56770003	RAD51C;TEX14	0.84	5.55	0.53	3.8e-7	Cognitive test performance;
SKCM	cis	rs4400599	0.572	rs7516809	chr1:154205501	T/C	cg26808167	chr1:154192205	UBAP2L;C1orf43	-0.54	-4.9	-0.49	5.01e-6	Platelet distribution width;
SKCM	cis	rs860295	0.702	rs34124416	chr1:155578049	C/G	cg02153340	chr1:155202674	NA	-0.74	-5.43	-0.52	6.23e-7	Body mass index;
SKCM	cis	rs12134245	0.747	rs17501512	chr1:92012481	C/G	cg02896835	chr1:92012615	NA	0.64	5.69	0.54	2.09e-7	Breast cancer;
SKCM	cis	rs4774899	1.000	rs1462156	chr15:57503423	A/G	cg01857019	chr15:57210107	LOC145783;TCF12	0.54	4.88	0.48	5.51e-6	Urinary tract infection frequency;
SKCM	cis	rs6500395	1.000	rs9937610	chr16:48671274	C/G	cg04672837	chr16:48644449	N4BP1	0.65	5.31	0.51	1.02e-6	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs9420	0.809	rs11600169	chr11:57464945	T/A	cg19752551	chr11:57585705	CTNND1	-0.71	-7.03	-0.62	6.89e-10	Schizophrenia;
SKCM	cis	rs763014	0.931	rs2071980	chr16:626346	A/C	cg07343612	chr16:622815	PIGQ	-0.7	-6.0	-0.56	5.84e-8	Height;
SKCM	cis	rs6088580	0.634	rs1205336	chr20:32926336	G/A	cg24642439	chr20:33292090	TP53INP2	-0.7	-5.34	-0.52	9.07e-7	Glomerular filtration rate (creatinine);
SKCM	cis	rs17376456	0.877	rs12716456	chr5:93397557	A/G	cg21475434	chr5:93447410	FAM172A	0.95	5.35	0.52	8.56e-7	Diabetic retinopathy;
SKCM	cis	rs6815814	0.950	rs5743560	chr4:38806200	G/T	cg02016764	chr4:38805732	TLR1	-0.76	-5.4	-0.52	6.95e-7	Breast cancer;
SKCM	cis	rs79839061	0.610	rs11733713	chr4:869169	A/G	cg07828340	chr4:882639	GAK	1.06	5.32	0.52	9.74e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs6088580	0.634	rs6088475	chr20:32964987	T/C	cg24642439	chr20:33292090	TP53INP2	-0.76	-6.02	-0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs72634258	0.945	rs34157438	chr1:8023586	C/T	cg00042356	chr1:8021962	PARK7	1.04	6.7	0.6	2.88e-9	Inflammatory bowel disease;
SKCM	cis	rs2739330	0.760	rs5760095	chr22:24247293	A/G	cg25703541	chr22:24373054	LOC391322	-0.83	-6.8	-0.61	1.91e-9	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs8077889	0.871	rs11079838	chr17:41898971	G/A	cg26893861	chr17:41843967	DUSP3	1.2	7.85	0.66	1.82e-11	Triglycerides;
SKCM	cis	rs17685	0.712	rs6464994	chr7:75784668	C/T	cg16489192	chr7:75678113	MDH2;STYXL1	-0.52	-4.78	-0.48	8.22e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs12142240	0.698	rs72679807	chr1:46846490	G/A	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs314370	0.951	rs6706	chr7:100471044	C/T	cg10426581	chr7:100472382	SRRT	0.73	6.19	0.57	2.59e-8	Resting heart rate;
SKCM	trans	rs8073060	0.586	rs117573546	chr17:33909588	G/A	cg19694781	chr19:47549865	TMEM160	1.08	8.69	0.7	4.26e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs2836974	0.605	rs2836971	chr21:40652040	A/C	cg11644478	chr21:40555479	PSMG1	-0.8	-7.6	-0.65	5.6e-11	Cognitive function;
SKCM	cis	rs4481887	0.741	rs6587458	chr1:248532290	T/A	cg22724847	chr1:248512586	OR14C36	0.59	5.07	0.5	2.63e-6	Common traits (Other);
SKCM	cis	rs10911232	0.507	rs10797822	chr1:183017769	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.65	0.6	3.59e-9	Hypertriglyceridemia;
SKCM	cis	rs6089829	0.925	rs4809270	chr20:61676709	C/A	cg08564027	chr20:61660810	NA	0.64	5.85	0.55	1.11e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs57221529	0.766	rs4957053	chr5:575927	T/C	cg26208419	chr5:473447	SLC9A3;LOC25845	1.05	5.37	0.52	7.95e-7	Lung disease severity in cystic fibrosis;
SKCM	cis	rs7666738	0.830	rs36047842	chr4:99004902	C/A	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs951366	0.764	rs708724	chr1:205743663	A/C	cg14159672	chr1:205819179	PM20D1	0.97	8.21	0.68	3.64e-12	Menarche (age at onset);
SKCM	cis	rs4423214	0.592	rs79634040	chr11:71230169	G/C	cg05163923	chr11:71159392	DHCR7	-0.67	-4.82	-0.48	6.99e-6	Vitamin D levels;
SKCM	cis	rs2268241	0.877	rs17885509	chr21:34779630	C/T	cg14850771	chr21:34775459	IFNGR2	1.09	6.8	0.61	1.9e-9	Obesity-related traits;
SKCM	cis	rs9325144	0.723	rs1586373	chr12:39181582	G/A	cg13010199	chr12:38710504	ALG10B	-0.58	-5.0	-0.49	3.5e-6	Morning vs. evening chronotype;
SKCM	cis	rs2836974	0.568	rs414850	chr21:40543337	A/C	cg11644478	chr21:40555479	PSMG1	0.8	7.6	0.65	5.6e-11	Cognitive function;
SKCM	cis	rs4423214	1.000	rs1981412	chr11:71138710	T/C	cg05163923	chr11:71159392	DHCR7	0.77	7.48	0.65	9.67e-11	Vitamin D levels;
SKCM	cis	rs801193	0.660	rs2659914	chr7:66156914	C/T	cg18876405	chr7:65276391	NA	0.66	6.49	0.59	7.13e-9	Aortic root size;
SKCM	trans	rs1814175	0.817	rs10769613	chr11:49769692	G/A	cg03929089	chr4:120376271	NA	-0.9	-8.5	-0.69	9.91e-13	Height;
SKCM	cis	rs9815354	0.812	rs73077373	chr3:41852887	C/T	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs1023500	0.573	rs8135801	chr22:42475568	A/G	cg04733989	chr22:42467013	NAGA	-0.72	-5.72	-0.54	1.9e-7	Schizophrenia;
SKCM	cis	rs4242434	0.854	rs11782130	chr8:22452357	G/T	cg03733263	chr8:22462867	KIAA1967	1.07	9.5	0.73	1.16e-14	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs9325144	0.510	rs6582599	chr12:38715965	T/G	cg26384229	chr12:38710491	ALG10B	0.78	6.67	0.6	3.39e-9	Morning vs. evening chronotype;
SKCM	cis	rs597539	0.616	rs10896386	chr11:68722694	C/T	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.79	5.2	0.51	1.54e-6	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs28595532	0.623	rs17516540	chr4:119278443	A/G	cg11846333	chr4:119757529	SEC24D	1.06	6.0	0.56	5.8e-8	Cannabis dependence symptom count;
SKCM	cis	rs35306767	0.903	rs11253492	chr10:936873	T/C	cg20503657	chr10:835505	NA	0.83	5.37	0.52	7.86e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs10088262	0.629	rs6990565	chr8:124785645	C/A	cg02993010	chr8:124780839	FAM91A1	-0.68	-4.88	-0.48	5.41e-6	Pancreatic cancer;
SKCM	cis	rs801193	0.935	rs2286683	chr7:66129843	G/A	cg05627663	chr7:65219948	SNORA22;CCT6P1	-0.56	-4.84	-0.48	6.39e-6	Aortic root size;
SKCM	cis	rs4237845	0.844	rs4630335	chr12:58302258	A/G	cg02175503	chr12:58329896	NA	0.74	6.76	0.61	2.26e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs10754283	0.967	rs1934044	chr1:90107501	C/T	cg21401794	chr1:90099060	LRRC8C	-0.74	-6.67	-0.6	3.35e-9	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs854765	0.583	rs8075965	chr17:17853180	A/T	cg04398451	chr17:18023971	MYO15A	-0.86	-5.91	-0.56	8.41e-8	Total body bone mineral density;
SKCM	cis	rs36093844	0.800	rs11826218	chr11:85568522	T/G	cg25872744	chr11:85566296	CCDC83	-0.85	-4.77	-0.48	8.27e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs9674544	0.757	rs11871214	chr17:47124902	G/T	cg22947322	chr17:47091978	IGF2BP1	-0.55	-4.89	-0.48	5.32e-6	Primary tooth development (time to first tooth eruption);Primary tooth development (number of teeth);
SKCM	cis	rs2228479	0.850	rs74251568	chr16:89903416	A/C	cg00800038	chr16:89945340	TCF25	-0.96	-4.88	-0.48	5.51e-6	Skin colour saturation;
SKCM	cis	rs4561483	0.801	rs8061189	chr16:11951749	C/G	cg08843971	chr16:11963173	GSPT1	0.7	5.39	0.52	7.27e-7	Testicular germ cell tumor;
SKCM	cis	rs2839186	0.814	rs2839167	chr21:47661587	A/G	cg13126279	chr21:47581558	C21orf56	-0.62	-5.37	-0.52	7.8e-7	Testicular germ cell tumor;
SKCM	cis	rs854765	0.624	rs7501812	chr17:17750907	G/A	cg04398451	chr17:18023971	MYO15A	0.79	5.51	0.53	4.46e-7	Total body bone mineral density;
SKCM	cis	rs875971	0.862	rs1643375	chr7:65872677	T/C	cg11764359	chr7:65958608	NA	0.8	7.47	0.65	1.01e-10	Aortic root size;
SKCM	cis	rs826838	0.967	rs11169142	chr12:39085773	A/T	cg13010199	chr12:38710504	ALG10B	-0.82	-6.22	-0.58	2.26e-8	Heart rate;
SKCM	cis	rs1707322	0.721	rs10789468	chr1:46124558	A/G	cg03146154	chr1:46216737	IPP	0.82	6.1	0.57	3.89e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7149337	0.773	rs3007067	chr14:51596420	G/A	cg23942311	chr14:51606299	NA	0.65	7.52	0.65	7.89e-11	Cancer;
SKCM	cis	rs228769	0.653	rs2523162	chr17:42179281	A/G	cg19774624	chr17:42201019	HDAC5	0.77	5.17	0.51	1.76e-6	Bone mineral density (hip);Bone mineral density (spine);
SKCM	cis	rs1005277	0.579	rs2103938	chr10:38493998	T/G	cg25427524	chr10:38739819	LOC399744	-0.74	-7.46	-0.65	1.02e-10	Extrinsic epigenetic age acceleration;
SKCM	cis	rs11945232	1.000	rs4314250	chr4:88340969	A/G	cg23841344	chr4:88312519	HSD17B11	0.68	5.02	0.49	3.2e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1801251	1.000	rs2674839	chr2:233669040	G/C	cg25237894	chr2:233734115	C2orf82	0.61	5.9	0.56	8.76e-8	Coronary artery disease;
SKCM	cis	rs2413583	0.591	rs76449672	chr22:39696482	G/A	cg17798944	chr22:39715225	SNORD43;RPL3	0.92	5.12	0.5	2.12e-6	Ulcerative colitis;Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs3784262	0.669	rs6493981	chr15:58352923	T/C	cg12031962	chr15:58353849	ALDH1A2	-0.41	-4.82	-0.48	6.93e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs459571	0.920	rs2520094	chr9:136919985	A/T	cg13789015	chr9:136890014	NCRNA00094	0.75	6.46	0.59	8.06e-9	Platelet distribution width;
SKCM	cis	rs8072100	1.000	rs8065437	chr17:45721653	C/T	cg25173405	chr17:45401733	C17orf57	-0.59	-5.49	-0.53	4.83e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs908922	0.676	rs491077	chr1:152519570	C/A	cg09873164	chr1:152488093	CRCT1	0.77	6.04	0.56	5.01e-8	Hair morphology;
SKCM	cis	rs7940866	0.838	rs1991898	chr11:130801786	C/G	cg12179176	chr11:130786555	SNX19	-0.78	-6.78	-0.61	2.08e-9	Schizophrenia;
SKCM	cis	rs2153535	0.601	rs9502719	chr6:8541032	A/G	cg07606381	chr6:8435919	SLC35B3	0.91	6.31	0.58	1.56e-8	Motion sickness;
SKCM	cis	rs7927771	0.793	rs12803525	chr11:47413475	G/A	cg01152729	chr11:47593274	PTPMT1	-0.51	-4.92	-0.49	4.64e-6	Subjective well-being;
SKCM	cis	rs1707322	1.000	rs10890360	chr1:46338444	C/T	cg03146154	chr1:46216737	IPP	0.75	5.15	0.5	1.94e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs829883	0.738	rs249846	chr12:98868739	T/C	cg25150519	chr12:98850993	NA	0.54	5.41	0.52	6.78e-7	Colorectal adenoma (advanced);
SKCM	cis	rs12477438	0.520	rs10865029	chr2:99718298	C/T	cg26064155	chr2:99771622	LIPT1;TSGA10	1.02	10.07	0.75	9.12e-16	Chronic sinus infection;
SKCM	cis	rs9324022	0.584	rs72698722	chr14:101181881	C/T	cg18089426	chr14:101175970	NA	0.68	5.21	0.51	1.48e-6	Plateletcrit;
SKCM	cis	rs12478296	0.901	rs7423119	chr2:243005488	T/A	cg06360820	chr2:242988706	NA	-1.01	-5.86	-0.55	1.03e-7	Obesity-related traits;
SKCM	cis	rs9905704	0.671	rs4337355	chr17:56950920	C/T	cg12560992	chr17:57184187	TRIM37	0.76	6.04	0.56	4.92e-8	Testicular germ cell tumor;
SKCM	cis	rs7940866	0.838	rs10750455	chr11:130800330	C/T	cg12179176	chr11:130786555	SNX19	0.76	6.08	0.57	4.13e-8	Schizophrenia;
SKCM	cis	rs1801251	0.963	rs66549961	chr2:233602293	A/G	cg25237894	chr2:233734115	C2orf82	0.56	5.33	0.52	9.23e-7	Coronary artery disease;
SKCM	cis	rs2072499	0.865	rs2758603	chr1:156198994	T/C	cg25208724	chr1:156163844	SLC25A44	0.9	7.92	0.67	1.36e-11	Testicular germ cell tumor;
SKCM	cis	rs778371	0.624	rs6733495	chr2:233616709	A/G	cg08000102	chr2:233561755	GIGYF2	0.9	7.58	0.65	6.01e-11	Schizophrenia;
SKCM	cis	rs362272	0.524	rs6819202	chr4:3368264	G/A	cg05297308	chr4:3317976	RGS12	1.02	12.39	0.81	4.11e-20	Serum sulfate level;
SKCM	cis	rs155076	0.666	rs4770128	chr13:21881922	A/G	cg14456004	chr13:21872349	NA	1.3	7.55	0.65	6.84e-11	White matter hyperintensity burden;
SKCM	cis	rs151997	0.853	rs3846498	chr5:50253625	A/C	cg01829002	chr5:50259133	NA	-0.51	-4.81	-0.48	7.3e-6	Callous-unemotional behaviour;
SKCM	cis	rs11924390	0.749	rs822364	chr3:186452716	A/G	cg09332604	chr3:186435400	KNG1	-0.55	-5.52	-0.53	4.25e-7	Adiponectin levels;
SKCM	cis	rs2836974	0.590	rs9974757	chr21:40617244	T/C	cg11644478	chr21:40555479	PSMG1	-0.8	-7.6	-0.65	5.6e-11	Cognitive function;
SKCM	cis	rs10489202	0.632	rs6659713	chr1:168072249	G/T	cg24449463	chr1:168025552	DCAF6	0.76	7.74	0.66	3.05e-11	Schizophrenia;
SKCM	cis	rs6952808	0.534	rs1113736	chr7:1992992	T/C	cg02951883	chr7:2050386	MAD1L1	-0.85	-7.46	-0.65	1.05e-10	Bipolar disorder and schizophrenia;
SKCM	cis	rs6952808	0.630	rs10239050	chr7:2158390	A/G	cg02951883	chr7:2050386	MAD1L1	-0.81	-7.86	-0.66	1.79e-11	Bipolar disorder and schizophrenia;
SKCM	cis	rs1405130	0.869	rs11681332	chr2:235566260	C/A	cg17841421	chr2:235704848	NA	-0.57	-4.95	-0.49	4.14e-6	Coronary artery disease;
SKCM	cis	rs12142240	0.621	rs66828173	chr1:46818166	G/A	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs733592	0.507	rs3825403	chr12:48457159	G/A	cg24011408	chr12:48396354	COL2A1	-0.66	-4.91	-0.49	4.98e-6	Plateletcrit;
SKCM	cis	rs6088580	0.601	rs6120668	chr20:33099793	A/G	cg24642439	chr20:33292090	TP53INP2	0.76	6.02	0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs7937682	0.847	rs583032	chr11:111432757	C/T	cg09085632	chr11:111637200	PPP2R1B	-1.0	-9.96	-0.75	1.52e-15	Primary sclerosing cholangitis;
SKCM	cis	rs10504073	0.647	rs4348510	chr8:50016027	C/A	cg00325661	chr8:49890786	NA	0.82	7.02	0.62	7.13e-10	Blood metabolite ratios;
SKCM	cis	rs533581	0.866	rs2968474	chr16:88970566	A/G	cg16701003	chr16:89028210	CBFA2T3	-0.61	-5.31	-0.52	1.01e-6	Social autistic-like traits;
SKCM	cis	rs801193	1.000	rs10234018	chr7:66146284	A/T	cg00343986	chr7:65444356	GUSB	-0.69	-4.98	-0.49	3.78e-6	Aortic root size;
SKCM	cis	rs9910055	0.762	rs4239142	chr17:42205876	A/G	cg13607699	chr17:42295918	UBTF	-0.78	-6.13	-0.57	3.38e-8	Total body bone mineral density;
SKCM	cis	rs3820068	0.581	rs59684759	chr1:15919893	A/G	cg24675056	chr1:15929824	NA	0.77	5.54	0.53	4.01e-7	Systolic blood pressure;
SKCM	cis	rs12458462	0.665	rs2035085	chr18:77485280	C/T	cg11879182	chr18:77439856	CTDP1	0.88	7.07	0.63	5.69e-10	Monocyte count;
SKCM	cis	rs6570726	0.791	rs11155435	chr6:145938545	T/C	cg23711669	chr6:146136114	FBXO30	0.86	8.04	0.67	7.98e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1062177	0.855	rs1346489	chr5:151266534	C/T	cg00977110	chr5:151150581	G3BP1	0.71	5.97	0.56	6.52e-8	Preschool internalizing problems;
SKCM	cis	rs7143963	0.666	rs66970053	chr14:103307655	G/C	cg23020514	chr14:103360112	TRAF3	0.77	7.14	0.63	4.31e-10	Body mass index;
SKCM	cis	rs10905065	1.000	rs10737013	chr10:5746772	C/G	cg09234995	chr10:5726438	C10orf18	-0.59	-4.97	-0.49	3.87e-6	Menopause (age at onset);
SKCM	cis	rs478304	0.651	rs11532071	chr11:65500198	C/A	cg17480646	chr11:65405466	SIPA1	-0.71	-5.64	-0.54	2.62e-7	Acne (severe);
SKCM	cis	rs3820068	0.603	rs3795763	chr1:15959977	C/T	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs7772486	0.790	rs3924499	chr6:146232978	A/T	cg23711669	chr6:146136114	FBXO30	-0.82	-8.0	-0.67	9.2e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs427394	0.582	rs274667	chr5:6710771	A/G	cg10857441	chr5:6722123	POLS	0.67	7.29	0.64	2.2e-10	Menopause (age at onset);
SKCM	cis	rs9814567	0.964	rs6772406	chr3:134210183	A/G	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.67	-5.36	-0.52	8.3e-7	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs2180341	0.960	rs1543432	chr6:127698018	T/C	cg27446573	chr6:127587934	RNF146	0.93	8.09	0.68	6.27e-12	Breast cancer;
SKCM	cis	rs2075371	1.000	rs1421485	chr7:133985181	C/T	cg20476274	chr7:133979776	SLC35B4	1.01	10.44	0.76	1.77e-16	Mean platelet volume;
SKCM	cis	rs7590720	1.000	rs7590720	chr2:216898658	A/G	cg12620499	chr2:216877984	MREG	-0.92	-8.34	-0.69	2.05e-12	Alcohol dependence;
SKCM	cis	rs10193935	0.901	rs10174872	chr2:42459807	T/G	cg27598129	chr2:42591480	NA	-0.88	-6.71	-0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1348850	0.831	rs1345139	chr2:178449791	G/T	cg02961200	chr2:178257176	LOC100130691;AGPS	0.7	5.3	0.51	1.03e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs1799949	0.929	rs799906	chr17:41278116	T/C	cg05368731	chr17:41323189	NBR1	0.88	7.51	0.65	8.26e-11	Menopause (age at onset);
SKCM	cis	rs151997	0.671	rs152926	chr5:50201787	G/A	cg06027927	chr5:50259733	NA	-0.65	-6.16	-0.57	3.01e-8	Callous-unemotional behaviour;
SKCM	cis	rs1639906	0.895	rs78469080	chr7:2200729	G/A	cg21782813	chr7:2030301	MAD1L1	-0.53	-5.38	-0.52	7.45e-7	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1005277	0.579	rs176880	chr10:38401417	C/G	cg00409905	chr10:38381863	ZNF37A	0.66	6.36	0.58	1.27e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs796364	1.000	rs281771	chr2:200812202	A/C	cg12253985	chr2:200820533	C2orf60;C2orf47	-0.85	-5.39	-0.52	7.18e-7	Schizophrenia;
SKCM	cis	rs11760633	0.526	rs10230862	chr7:1825321	T/G	cg02825527	chr7:2087843	MAD1L1	-0.62	-4.93	-0.49	4.6e-6	Coronary artery disease;
SKCM	cis	rs875971	0.508	rs6947808	chr7:66045082	A/G	cg18876405	chr7:65276391	NA	-0.8	-7.24	-0.63	2.75e-10	Aortic root size;
SKCM	cis	rs116095464	0.558	rs6962	chr5:256509	G/A	cg22857025	chr5:266934	NA	-1.49	-7.16	-0.63	3.91e-10	Breast cancer;
SKCM	cis	rs28386778	0.897	rs2584615	chr17:61927774	T/C	cg06873352	chr17:61820015	STRADA	0.76	6.34	0.58	1.38e-8	Prudent dietary pattern;
SKCM	cis	rs9303401	0.580	rs12603808	chr17:56578508	T/G	cg02118635	chr17:56770003	RAD51C;TEX14	0.8	5.3	0.51	1.05e-6	Cognitive test performance;
SKCM	cis	rs9902453	0.838	rs9646438	chr17:28209091	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.81	5.78	0.55	1.44e-7	Coffee consumption (cups per day);
SKCM	cis	rs7523050	0.643	rs35907086	chr1:109406625	A/G	cg08274380	chr1:109419600	GPSM2	1.18	6.44	0.59	9.12e-9	Fat distribution (HIV);
SKCM	cis	rs9790314	0.670	rs9864752	chr3:160937591	A/C	cg03342759	chr3:160939853	NMD3	-0.72	-7.72	-0.66	3.28e-11	Morning vs. evening chronotype;
SKCM	cis	rs17065868	0.892	rs35665055	chr13:45094501	T/C	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs1799949	0.965	rs8176198	chr17:41230537	A/T	cg05368731	chr17:41323189	NBR1	0.8	6.08	0.57	4.1e-8	Menopause (age at onset);
SKCM	cis	rs4642101	0.662	rs4034942	chr3:12836792	C/T	cg05775895	chr3:12838266	CAND2	0.66	5.82	0.55	1.26e-7	QRS complex (12-leadsum);
SKCM	cis	rs9303401	0.659	rs36093395	chr17:56957357	C/T	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.35	0.52	8.54e-7	Cognitive test performance;
SKCM	cis	rs4555082	0.834	rs2975217	chr14:105710238	A/C	cg13114125	chr14:105738426	BRF1	-0.66	-5.49	-0.53	4.84e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs11602339	1	rs11602339	chr11:47761471	C/T	cg05585544	chr11:47624801	NA	-0.6	-5.22	-0.51	1.45e-6	Body mass index;
SKCM	cis	rs17685	0.753	rs13240967	chr7:75658197	C/T	cg01364799	chr7:75623366	TMEM120A	0.72	5.83	0.55	1.18e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs6570726	0.935	rs366621	chr6:145861275	A/G	cg23711669	chr6:146136114	FBXO30	0.69	6.66	0.6	3.51e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2404602	0.647	rs11632765	chr15:76974261	A/T	cg23625390	chr15:77176239	SCAPER	0.82	7.93	0.67	1.26e-11	Blood metabolite levels;
SKCM	cis	rs12497850	0.864	rs4521268	chr3:49137904	G/T	cg06212747	chr3:49208901	KLHDC8B	0.75	4.82	0.48	6.85e-6	Parkinson's disease;
SKCM	cis	rs7959452	0.590	rs6581889	chr12:69757429	T/C	cg14784868	chr12:69753453	YEATS4	0.8	7.57	0.65	6.41e-11	Blood protein levels;
SKCM	cis	rs8103278	1.000	rs1548029	chr19:46309203	A/C	cg11657440	chr19:46296263	DMWD	-0.94	-6.46	-0.59	8.24e-9	Coronary artery disease;
SKCM	cis	rs2559856	1.000	rs2695288	chr12:102088112	T/C	cg12924262	chr12:102091054	CHPT1	0.7	5.95	0.56	7.09e-8	Blood protein levels;
SKCM	cis	rs13118159	0.550	rs4974612	chr4:1364543	A/G	cg20887711	chr4:1340912	KIAA1530	0.99	7.59	0.65	5.89e-11	Longevity;
SKCM	cis	rs11098499	0.779	rs7674500	chr4:120303593	C/T	cg24375607	chr4:120327624	NA	0.65	4.97	0.49	3.87e-6	Corneal astigmatism;
SKCM	cis	rs12047808	0.841	rs79370571	chr1:179404718	A/G	cg09822482	chr1:179519214	C1orf125	-0.95	-5.17	-0.51	1.78e-6	Multiple sclerosis (age of onset);
SKCM	cis	rs9325144	0.554	rs1906264	chr12:38739490	A/G	cg13010199	chr12:38710504	ALG10B	0.64	5.12	0.5	2.17e-6	Morning vs. evening chronotype;
SKCM	cis	rs11098499	0.754	rs4443261	chr4:120249301	T/C	cg09307838	chr4:120376055	NA	0.93	7.56	0.65	6.5500000000000006e-11	Corneal astigmatism;
SKCM	cis	rs3784262	0.740	rs1441829	chr15:58289739	T/C	cg12031962	chr15:58353849	ALDH1A2	-0.45	-5.37	-0.52	7.83e-7	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs1799949	1.000	rs8070085	chr17:41341984	C/T	cg25918947	chr17:41365094	TMEM106A	0.6	5.56	0.53	3.68e-7	Menopause (age at onset);
SKCM	cis	rs2479724	0.901	rs10947987	chr6:41754370	C/T	cg17623882	chr6:41773611	USP49	0.72	6.11	0.57	3.71e-8	Menarche (age at onset);
SKCM	cis	rs12044355	0.927	rs17748239	chr1:231834901	A/G	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	-0.84	-6.57	-0.6	5.07e-9	Alzheimer's disease;
SKCM	cis	rs933688	0.941	rs2887007	chr5:90740531	A/T	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.01	8.43	0.69	1.41e-12	Smoking behavior;
SKCM	cis	rs10155981	0.510	rs10255241	chr7:22593806	C/T	cg05062323	chr7:22590069	NA	-1.04	-5.94	-0.56	7.37e-8	Bilirubin levels;
SKCM	cis	rs847851	0.701	rs2258604	chr6:34997606	T/A	cg07306190	chr6:34760872	UHRF1BP1	0.53	4.94	0.49	4.34e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2302190	0.882	rs11650710	chr17:56583547	C/T	cg25885038	chr17:56607967	SEPT4	-0.72	-4.81	-0.48	7.23e-6	Vitamin D levels;
SKCM	cis	rs752010	0.905	rs2038977	chr1:42094659	A/G	cg06885757	chr1:42089581	HIVEP3	0.62	6.12	0.57	3.49e-8	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs684232	0.563	rs12939528	chr17:524391	C/T	cg15660573	chr17:549704	VPS53	-0.75	-5.83	-0.55	1.18e-7	Prostate cancer;
SKCM	cis	rs1692580	0.840	rs696094	chr1:2169215	G/A	cg24578937	chr1:2090814	PRKCZ	0.48	5.26	0.51	1.24e-6	Coronary artery disease;
SKCM	cis	rs6089584	0.507	rs6061989	chr20:60627893	C/T	cg16423285	chr20:60520624	NA	-0.58	-4.92	-0.49	4.77e-6	Body mass index;
SKCM	cis	rs10492096	0.898	rs12426815	chr12:6580314	A/G	cg07142400	chr12:6602447	NCAPD2;MRPL51	-0.75	-4.96	-0.49	4.05e-6	Hip geometry;
SKCM	cis	rs514406	0.505	rs440871	chr1:53173052	C/T	cg16325326	chr1:53192061	ZYG11B	0.89	10.06	0.75	9.55e-16	Monocyte count;
SKCM	cis	rs760805	1.000	rs3845302	chr1:25259884	C/G	cg22509179	chr1:25234806	RUNX3	-0.76	-6.35	-0.58	1.29e-8	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs2354432	0.607	rs7516430	chr1:146767062	A/G	cg25205988	chr1:146714368	CHD1L	-1.16	-8.19	-0.68	3.97e-12	Mitochondrial DNA levels;
SKCM	cis	rs9814567	0.806	rs9841371	chr3:134320765	A/G	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.65	-5.19	-0.51	1.6e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs910316	1.000	rs4903281	chr14:75554361	G/C	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.89e-7	Height;
SKCM	cis	rs6879260	1.000	rs7706951	chr5:179733407	C/T	cg23248424	chr5:179741104	GFPT2	-0.75	-5.92	-0.56	8.17e-8	Height;
SKCM	cis	rs6977660	0.660	rs12531296	chr7:19816450	A/C	cg07541023	chr7:19748670	TWISTNB	0.72	4.78	0.48	7.95e-6	Thyroid stimulating hormone;
SKCM	cis	rs394563	0.726	rs6922130	chr6:149672375	C/G	cg03678062	chr6:149772716	ZC3H12D	0.52	5.99	0.56	6.12e-8	Dupuytren's disease;
SKCM	cis	rs208520	0.909	rs60604603	chr6:67022955	T/C	cg07460842	chr6:66804631	NA	0.82	5.43	0.52	6.08e-7	Exhaled nitric oxide output;
SKCM	cis	rs936229	0.690	rs2445618	chr15:75035256	T/C	cg14664628	chr15:75095509	CSK	-1.13	-9.33	-0.73	2.51e-14	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin);
SKCM	cis	rs1153858	1.000	rs66714503	chr15:45648038	G/C	cg10760299	chr15:45669010	GATM	0.62	6.33	0.58	1.42e-8	Homoarginine levels;
SKCM	cis	rs7786877	0.723	rs62482239	chr7:100217810	C/T	cg20848291	chr7:100343083	ZAN	-0.66	-5.01	-0.49	3.34e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs2153535	0.580	rs9392224	chr6:8472614	G/A	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs4803468	1.000	rs2241711	chr19:41911980	T/C	cg14132834	chr19:41945861	ATP5SL	-0.77	-6.08	-0.57	4.18e-8	Height;
SKCM	cis	rs66573146	1.000	rs7686186	chr4:6986094	C/T	cg00086871	chr4:6988644	TBC1D14	1.43	5.33	0.52	9.25e-7	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs10823500	0.748	rs7072230	chr10:71978144	A/G	cg04118878	chr10:71993077	PPA1	0.65	4.88	0.48	5.45e-6	Blood protein levels;
SKCM	cis	rs2120019	1.000	rs12898259	chr15:75369780	G/A	cg17294928	chr15:75287854	SCAMP5	-0.82	-6.77	-0.61	2.13e-9	Blood trace element (Zn levels);
SKCM	cis	rs875971	1.000	rs778706	chr7:65860424	A/G	cg18876405	chr7:65276391	NA	0.67	6.65	0.6	3.61e-9	Aortic root size;
SKCM	cis	rs6570726	1.000	rs951143	chr6:145932576	C/T	cg23711669	chr6:146136114	FBXO30	0.69	6.15	0.57	3.05e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs17685	0.753	rs10233282	chr7:75790081	C/T	cg01364799	chr7:75623366	TMEM120A	-0.7	-5.84	-0.55	1.16e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs362272	0.524	rs3129334	chr4:3368526	T/C	cg11471262	chr4:3318911	RGS12	0.93	10.72	0.77	5.35e-17	Serum sulfate level;
SKCM	cis	rs651907	0.557	rs11720745	chr3:101441690	G/A	cg12386194	chr3:101231763	SENP7	0.68	5.59	0.54	3.16e-7	Colorectal cancer;
SKCM	cis	rs6430585	0.591	rs75223002	chr2:136525309	G/T	cg07169764	chr2:136633963	MCM6	1.31	13.14	0.83	1.86e-21	Corneal structure;
SKCM	cis	rs4481887	0.861	rs10888345	chr1:248447533	A/G	cg00666640	chr1:248458726	OR2T12	0.58	4.88	0.48	5.46e-6	Common traits (Other);
SKCM	cis	rs28595532	0.702	rs72670238	chr4:119322751	C/T	cg11846333	chr4:119757529	SEC24D	1.13	6.5	0.59	6.82e-9	Cannabis dependence symptom count;
SKCM	cis	rs867186	1.000	rs8117100	chr20:33692261	T/C	cg04194272	chr20:33683537	NA	-1.21	-6.8	-0.61	1.89e-9	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs11098499	0.691	rs9995716	chr4:120264996	T/C	cg09307838	chr4:120376055	NA	0.98	8.58	0.7	6.96e-13	Corneal astigmatism;
SKCM	cis	rs67311347	0.544	rs9864664	chr3:40336226	T/C	cg00656387	chr3:40428638	ENTPD3	0.57	5.05	0.5	2.81e-6	Renal cell carcinoma;
SKCM	cis	rs7555523	0.887	rs4657476	chr1:165732661	A/G	cg24409356	chr1:165738333	TMCO1	-0.93	-5.15	-0.5	1.93e-6	Intraocular pressure;Glaucoma (high intraocular pressure);
SKCM	cis	rs13336428	0.730	rs3946124	chr16:1525779	A/G	cg07835181	chr16:1525278	CLCN7	-0.83	-7.42	-0.64	1.23e-10	Bone mineral density;
SKCM	cis	rs1577917	0.958	rs2121594	chr6:86576854	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.68	-6.02	-0.56	5.48e-8	Response to antipsychotic treatment;
SKCM	cis	rs7945705	0.846	rs2742540	chr11:8899528	A/G	cg13070366	chr11:9386451	NA	-0.54	-4.8	-0.48	7.4e-6	Hemoglobin concentration;
SKCM	cis	rs7659604	0.540	rs10007956	chr4:122700669	A/T	cg06713675	chr4:122721982	EXOSC9	0.51	4.82	0.48	6.89e-6	Type 2 diabetes;
SKCM	cis	rs7666738	0.830	rs6834014	chr4:98951431	G/A	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs5769765	0.728	rs6520064	chr22:50294469	A/G	cg22709217	chr22:50311962	ALG12;CRELD2	-0.79	-5.71	-0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs7954584	0.567	rs11612028	chr12:122387872	C/G	cg22618164	chr12:122356400	WDR66	0.53	5.39	0.52	7.24e-7	Mean corpuscular volume;
SKCM	cis	rs7666738	0.606	rs4699611	chr4:99097492	T/G	cg17366294	chr4:99064904	C4orf37	0.63	5.34	0.52	8.85e-7	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11105298	0.891	rs6538189	chr12:89885923	C/A	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.89	-6.03	-0.56	5.25e-8	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs1577917	0.958	rs3857480	chr6:86535149	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.81	-0.66	2.19e-11	Response to antipsychotic treatment;
SKCM	cis	rs9894429	0.646	rs58398000	chr17:79576923	G/A	cg18240062	chr17:79603768	NPLOC4	-0.68	-5.9	-0.56	8.85e-8	Eye color traits;
SKCM	cis	rs4774899	0.934	rs4774250	chr15:57487863	C/T	cg01857019	chr15:57210107	LOC145783;TCF12	0.52	4.79	0.48	7.67e-6	Urinary tract infection frequency;
SKCM	cis	rs992157	0.764	rs2891077	chr2:219184430	A/C	cg20019365	chr2:219134978	PNKD;AAMP	0.74	5.82	0.55	1.22e-7	Colorectal cancer;
SKCM	cis	rs847649	0.621	rs2222539	chr7:102674786	G/A	cg18108683	chr7:102477205	FBXL13	0.8	7.54	0.65	7.18e-11	Morning vs. evening chronotype;
SKCM	cis	rs3784262	1.000	rs4646593	chr15:58302467	A/G	cg12031962	chr15:58353849	ALDH1A2	-0.5	-6.27	-0.58	1.85e-8	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs1577917	0.958	rs2660576	chr6:86651603	T/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.77	-0.66	2.59e-11	Response to antipsychotic treatment;
SKCM	cis	rs589448	0.902	rs528974	chr12:69765918	A/T	cg14784868	chr12:69753453	YEATS4	0.84	7.65	0.65	4.54e-11	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs8060686	0.641	rs73612690	chr16:68153200	G/A	cg09117114	chr16:67998030	SLC12A4	-0.81	-5.29	-0.51	1.07e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs2204008	0.837	rs4312131	chr12:38181087	G/T	cg26384229	chr12:38710491	ALG10B	0.82	6.58	0.6	4.87e-9	Bladder cancer;
SKCM	cis	rs28595532	0.668	rs58467651	chr4:119349011	T/G	cg14228332	chr4:119757509	SEC24D	1.0	4.98	0.49	3.69e-6	Cannabis dependence symptom count;
SKCM	cis	rs854765	0.547	rs7223696	chr17:17915791	G/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.03	9.04	0.72	8.99e-14	Total body bone mineral density;
SKCM	cis	rs440932	1.000	rs365309	chr8:9026940	C/T	cg06636001	chr8:8085503	FLJ10661	-0.68	-4.96	-0.49	4.09e-6	High light scatter reticulocyte percentage of red cells;
SKCM	cis	rs798554	0.757	rs2533878	chr7:2878707	A/G	cg19346786	chr7:2764209	NA	0.62	6.93	0.62	1.09e-9	Height;
SKCM	cis	rs3780486	0.846	rs6476399	chr9:33123013	A/G	cg13443165	chr9:33130375	B4GALT1	-0.57	-5.29	-0.51	1.07e-6	IgG glycosylation;
SKCM	cis	rs9790314	0.663	rs1599379	chr3:160860665	A/G	cg03342759	chr3:160939853	NMD3	-0.67	-6.81	-0.61	1.8e-9	Morning vs. evening chronotype;
SKCM	cis	rs6952808	0.531	rs3779002	chr7:2183219	C/T	cg02951883	chr7:2050386	MAD1L1	-0.77	-6.09	-0.57	4.05e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs6951245	0.608	rs10252234	chr7:1114381	C/T	cg03188948	chr7:1209495	NA	0.73	4.85	0.48	6.12e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs6545883	0.862	rs11691734	chr2:61702466	C/T	cg15711740	chr2:61764176	XPO1	-0.68	-4.87	-0.48	5.76e-6	Tuberculosis;
SKCM	cis	rs4555082	0.718	rs75139030	chr14:105710853	A/AG	cg13114125	chr14:105738426	BRF1	-0.69	-5.7	-0.54	2.07e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs1153858	1.000	rs7171577	chr15:45627979	G/A	cg10760299	chr15:45669010	GATM	0.53	5.01	0.49	3.33e-6	Homoarginine levels;
SKCM	cis	rs7772486	0.817	rs12198065	chr6:146385286	G/C	cg05347473	chr6:146136440	FBXO30	0.63	5.8	0.55	1.34e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs793571	0.543	rs4775087	chr15:58974904	T/C	cg05156742	chr15:59063176	FAM63B	0.73	5.26	0.51	1.23e-6	Schizophrenia;
SKCM	cis	rs2072510	1.000	rs2660897	chr12:96425432	G/A	cg18817487	chr12:96390143	HAL	0.43	5.66	0.54	2.42e-7	Metabolite levels (small molecules and protein measures);
SKCM	cis	rs17376456	0.825	rs10079708	chr5:93261796	G/C	cg25358565	chr5:93447407	FAM172A	1.3	7.53	0.65	7.57e-11	Diabetic retinopathy;
SKCM	cis	rs10504229	0.645	rs56670121	chr8:58138872	C/T	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs6738485	0.507	rs66569888	chr2:106886967	G/A	cg15412446	chr2:106886593	NA	-0.69	-4.8	-0.48	7.63e-6	Pursuit maintenance gain;Pursuit maintenance gain in psychotic disorders;
SKCM	cis	rs829883	1.000	rs829883	chr12:98879606	G/A	cg25150519	chr12:98850993	NA	0.5	5.27	0.51	1.17e-6	Colorectal adenoma (advanced);
SKCM	cis	rs6840360	0.571	rs62327268	chr4:152522326	T/A	cg22705602	chr4:152727874	NA	-0.52	-5.7	-0.54	2.03e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs5769765	0.955	rs5770750	chr22:50276828	A/G	cg22709217	chr22:50311962	ALG12;CRELD2	0.79	5.71	0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs9443189	0.570	rs6903448	chr6:76173832	C/T	cg01950844	chr6:76311363	SENP6	0.9	5.8	0.55	1.33e-7	Prostate cancer;
SKCM	cis	rs9916302	0.706	rs903507	chr17:37726423	A/G	cg07936489	chr17:37558343	FBXL20	-1.0	-7.78	-0.66	2.48e-11	Glomerular filtration rate (creatinine);
SKCM	cis	rs909341	0.710	rs6089953	chr20:62291008	C/T	cg03999872	chr20:62272968	STMN3	-0.56	-5.02	-0.49	3.21e-6	Atopic dermatitis;
SKCM	cis	rs17685	0.712	rs56088021	chr7:75852480	C/T	cg16684958	chr7:75615977	POR	0.51	4.84	0.48	6.5e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs6866344	0.570	rs1132336	chr5:178140090	C/T	cg03877680	chr5:178157825	ZNF354A	0.91	7.37	0.64	1.54e-10	Neutrophil percentage of white cells;
SKCM	cis	rs860295	0.702	rs11264381	chr1:155522572	C/T	cg02153340	chr1:155202674	NA	0.73	5.31	0.52	9.99e-7	Body mass index;
SKCM	cis	rs11098499	0.874	rs13123591	chr4:120105990	T/G	cg09307838	chr4:120376055	NA	0.86	6.08	0.57	4.13e-8	Corneal astigmatism;
SKCM	trans	rs11083271	0.614	rs72889929	chr18:25858979	T/C	cg00321150	chr11:62623587	SNORD27;SLC3A2;SNHG1;SNORD28;SNORD25;SNORD26	0.8	7.29	0.64	2.17e-10	Non-alcoholic fatty liver disease histology (lobular);
SKCM	cis	rs11098499	0.743	rs11098501	chr4:120252017	T/G	cg09307838	chr4:120376055	NA	0.91	7.36	0.64	1.63e-10	Corneal astigmatism;
SKCM	cis	rs362296	0.698	rs362266	chr4:3259632	C/G	cg16987761	chr4:3318072	RGS12	-0.72	-6.17	-0.57	2.85e-8	Parental longevity (mother's age at death);
SKCM	cis	rs10256972	0.552	rs6953538	chr7:1196974	A/G	cg07092213	chr7:1199455	ZFAND2A	-0.62	-4.97	-0.49	3.94e-6	Longevity;Endometriosis;
SKCM	cis	rs1799949	1.000	rs11654731	chr17:41326940	G/A	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.25	-0.58	2.03e-8	Menopause (age at onset);
SKCM	cis	rs28595532	0.640	rs28649792	chr4:119366463	A/C	cg11846333	chr4:119757529	SEC24D	1.05	5.77	0.55	1.54e-7	Cannabis dependence symptom count;
SKCM	cis	rs28595532	0.920	rs115506655	chr4:119757667	A/G	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs2439831	0.867	rs76542740	chr15:43891512	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.41	8.33	0.69	2.19e-12	Lung cancer in ever smokers;
SKCM	cis	rs7100689	0.646	rs10736356	chr10:82148325	A/G	cg01528321	chr10:82214614	TSPAN14	0.82	7.12	0.63	4.62e-10	Post bronchodilator FEV1;
SKCM	cis	rs606458	0.920	rs477549	chr11:64527080	T/C	cg07674570	chr11:65346152	EHBP1L1	0.69	4.95	0.49	4.13e-6	Urate levels;
SKCM	cis	rs7618501	0.633	rs2353579	chr3:50027774	C/T	cg05072774	chr3:49840536	C3orf54	-0.67	-5.06	-0.5	2.73e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs11718455	0.767	rs6771202	chr3:43990087	A/T	cg21419209	chr3:44054225	NA	-0.62	-5.06	-0.5	2.75e-6	Coronary artery disease;
SKCM	cis	rs3820928	1.000	rs12615988	chr2:227769000	A/G	cg11843606	chr2:227700838	RHBDD1	-0.64	-5.2	-0.51	1.53e-6	Pulmonary function;
SKCM	cis	rs362296	0.698	rs362283	chr4:3259558	T/C	cg11471262	chr4:3318911	RGS12	-0.77	-6.77	-0.61	2.14e-9	Parental longevity (mother's age at death);
SKCM	cis	rs17826219	0.562	rs719600	chr17:28731262	G/A	cg14067834	chr17:29058358	SUZ12P	-0.85	-4.83	-0.48	6.61e-6	Body mass index;
SKCM	cis	rs6724607	1.000	rs6724607	chr2:191466532	C/T	cg27211696	chr2:191398769	TMEM194B	0.78	6.48	0.59	7.56e-9	Pulse pressure;
SKCM	cis	rs6582630	0.502	rs10880450	chr12:38440294	G/C	cg26384229	chr12:38710491	ALG10B	0.81	6.22	0.58	2.33e-8	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs10504073	0.584	rs56074306	chr8:49940282	C/T	cg00325661	chr8:49890786	NA	0.81	6.83	0.61	1.64e-9	Blood metabolite ratios;
SKCM	cis	rs929354	1.000	rs1182381	chr7:157043473	G/A	cg17757837	chr7:157058334	UBE3C	-0.88	-6.64	-0.6	3.79e-9	Body mass index;
SKCM	cis	rs362272	0.505	rs13104157	chr4:3366950	T/C	cg00764545	chr4:3318001	RGS12	0.98	13.59	0.84	2.93e-22	Serum sulfate level;
SKCM	cis	rs6424115	0.830	rs3003335	chr1:24200052	A/G	cg15997130	chr1:24165203	NA	0.6	4.94	0.49	4.37e-6	Immature fraction of reticulocytes;
SKCM	cis	rs58688157	0.960	rs1055382	chr11:612182	T/C	cg16486109	chr11:613632	IRF7	1.07	7.29	0.64	2.17e-10	Systemic lupus erythematosus;
SKCM	cis	rs2439831	0.850	rs11856795	chr15:44160582	G/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.3	6.97	0.62	9.12e-10	Lung cancer in ever smokers;
SKCM	cis	rs28595532	0.920	rs115484560	chr4:119756781	T/G	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs4332037	0.722	rs4719332	chr7:1914681	G/A	cg23422044	chr7:1970798	MAD1L1	-0.95	-6.54	-0.6	5.79e-9	Bipolar disorder;
SKCM	cis	rs72634258	0.679	rs7523227	chr1:8180097	G/A	cg00042356	chr1:8021962	PARK7	0.77	5.09	0.5	2.4e-6	Inflammatory bowel disease;
SKCM	cis	rs6951245	0.744	rs10265736	chr7:1172465	C/T	cg18402987	chr7:1209562	NA	1.15	7.39	0.64	1.39e-10	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs6486730	0.508	rs7133440	chr12:129269244	A/C	cg09035930	chr12:129282057	SLC15A4	-0.72	-6.57	-0.6	5.22e-9	Systemic lupus erythematosus;
SKCM	cis	rs2075671	0.808	rs75949939	chr7:100256671	A/C	cg20848291	chr7:100343083	ZAN	-0.72	-5.43	-0.52	6.25e-7	Other erythrocyte phenotypes;
SKCM	cis	rs250677	0.687	rs171636	chr5:148434545	G/A	cg18129178	chr5:148520854	ABLIM3	-0.8	-4.79	-0.48	7.9e-6	Breast cancer;
SKCM	cis	rs1692580	0.807	rs60635488	chr1:2202572	C/T	cg21442419	chr1:2182373	SKI	-0.69	-6.97	-0.62	9.02e-10	Coronary artery disease;
SKCM	cis	rs7811142	0.830	rs11769057	chr7:99964661	A/G	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.19	7.5	0.65	8.66e-11	Platelet count;
SKCM	trans	rs208520	0.690	rs2126120	chr6:66742754	A/G	cg15611600	chr13:45563400	KIAA1704;NUFIP1	0.92	7.47	0.65	9.89e-11	Exhaled nitric oxide output;
SKCM	cis	rs1801251	1.000	rs7606090	chr2:233606740	T/C	cg08000102	chr2:233561755	GIGYF2	0.87	7.05	0.62	6.23e-10	Coronary artery disease;
SKCM	cis	rs4820539	1.000	rs5751589	chr22:23475762	A/G	cg14186256	chr22:23484241	RTDR1	-0.89	-8.25	-0.68	3.13e-12	Bone mineral density;
SKCM	cis	rs60871478	0.783	rs28545348	chr7:782757	G/A	cg05535760	chr7:792225	HEATR2	1.06	8.78	0.7	2.92e-13	Cerebrospinal P-tau181p levels;
SKCM	cis	rs208520	0.690	rs2126120	chr6:66742754	A/G	cg07460842	chr6:66804631	NA	0.9	7.2	0.63	3.26e-10	Exhaled nitric oxide output;
SKCM	cis	rs1568889	0.838	rs10835283	chr11:28214985	G/A	cg06544937	chr11:28130018	METT5D1;KIF18A	0.87	7.5	0.65	8.78e-11	Bipolar disorder;
SKCM	cis	rs3892630	0.588	rs2287881	chr19:33333155	A/G	cg22980127	chr19:33182716	NUDT19	-1.15	-6.38	-0.59	1.14e-8	Red blood cell traits;
SKCM	cis	rs1707322	0.686	rs2152078	chr1:46055600	C/T	cg03146154	chr1:46216737	IPP	-0.73	-4.85	-0.48	6.27e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs6951245	1.000	rs79617366	chr7:1111958	G/C	cg24642844	chr7:1081250	C7orf50	-0.93	-6.22	-0.58	2.28e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs867186	0.841	rs56400038	chr20:33537671	G/A	cg04194272	chr20:33683537	NA	-1.36	-7.01	-0.62	7.44e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs17685	0.671	rs10274404	chr7:75706634	G/A	cg16489192	chr7:75678113	MDH2;STYXL1	-0.58	-5.46	-0.53	5.43e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs561341	0.556	rs542244	chr17:30307242	T/C	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs1046896	0.553	rs3744160	chr17:80828303	G/A	cg02711726	chr17:80685570	FN3KRP	-0.79	-5.95	-0.56	7.17e-8	Glycated hemoglobin levels;
SKCM	cis	rs7959452	0.535	rs4761228	chr12:69682327	G/A	cg20891283	chr12:69753455	YEATS4	0.69	6.03	0.56	5.14e-8	Blood protein levels;
SKCM	cis	rs13217239	0.646	rs35691005	chr6:26972070	A/G	cg12292205	chr6:26970375	C6orf41	0.63	5.64	0.54	2.58e-7	Schizophrenia;
SKCM	cis	rs72615157	0.612	rs7786505	chr7:99817585	G/T	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.08	6.51	0.59	6.7e-9	Lung function (FEV1/FVC);
SKCM	cis	rs28595532	0.623	rs56324414	chr4:119274655	A/C	cg21605333	chr4:119757512	SEC24D	0.93	5.03	0.49	3.12e-6	Cannabis dependence symptom count;
SKCM	cis	rs6743226	0.934	rs6705421	chr2:242212672	A/G	cg10021735	chr2:242295487	FARP2	0.55	4.78	0.48	8.22e-6	Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction);Waist circumference adjusted for BMI (adjusted for smoking behaviour);Waist circumference adjusted for BMI in non-smokers;
SKCM	cis	rs780096	0.526	rs1260341	chr2:27663215	T/A	cg05696406	chr2:27599888	SNX17	0.51	5.22	0.51	1.46e-6	Total body bone mineral density;
SKCM	cis	rs9818758	0.607	rs34326553	chr3:49134429	A/G	cg00383909	chr3:49044727	WDR6	1.05	5.85	0.55	1.11e-7	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs56104184	0.887	rs4801778	chr19:49370609	G/T	cg19746536	chr19:49375674	PPP1R15A	1.08	6.83	0.61	1.68e-9	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs514406	0.893	rs1242326	chr1:53399104	C/A	cg24675658	chr1:53192096	ZYG11B	-0.67	-5.57	-0.53	3.46e-7	Monocyte count;
SKCM	cis	rs2050392	0.517	rs160017	chr10:30772894	A/G	cg25182066	chr10:30743637	MAP3K8	-0.65	-5.47	-0.53	5.26e-7	Inflammatory bowel disease;
SKCM	cis	rs11098499	0.908	rs11729050	chr4:120300066	T/C	cg09307838	chr4:120376055	NA	0.97	7.49	0.65	9.08e-11	Corneal astigmatism;
SKCM	cis	rs2224391	0.911	rs9504368	chr6:5261460	A/C	cg09085698	chr6:5261316	LYRM4;FARS2	-0.77	-5.73	-0.54	1.79e-7	Height;
SKCM	cis	rs10540	1.000	rs61876332	chr11:487101	C/T	cg03576123	chr11:487126	PTDSS2	-1.4	-7.12	-0.63	4.72e-10	Body mass index;
SKCM	cis	rs1843834	0.838	rs6436506	chr2:225558242	T/C	cg22455342	chr2:225449267	CUL3	0.61	4.79	0.48	7.83e-6	IgE levels in asthmatics (D.p. specific);
SKCM	cis	rs875971	0.862	rs4718330	chr7:65715243	G/A	cg18876405	chr7:65276391	NA	-0.65	-6.58	-0.6	4.89e-9	Aortic root size;
SKCM	cis	rs67460515	0.892	rs11711413	chr3:160998910	C/G	cg03342759	chr3:160939853	NMD3	-0.81	-7.1	-0.63	5.14e-10	Parkinson's disease;
SKCM	cis	rs4689592	0.503	rs11937667	chr4:7057037	C/G	cg19539972	chr4:7069911	GRPEL1	-0.97	-6.37	-0.58	1.24e-8	Monocyte percentage of white cells;
SKCM	cis	rs4969178	0.965	rs2292643	chr17:76395421	G/A	cg20026190	chr17:76395443	PGS1	0.61	5.29	0.51	1.08e-6	HDL cholesterol levels;
SKCM	cis	rs7786877	1.000	rs7786877	chr7:100214015	A/G	cg20848291	chr7:100343083	ZAN	-0.66	-5.32	-0.52	9.75e-7	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs634534	0.562	rs661335	chr11:65754061	G/A	cg02427764	chr11:65769310	BANF1;EIF1AD	0.77	5.79	0.55	1.4e-7	Sum eosinophil basophil counts;Eosinophil counts;
SKCM	cis	rs362296	0.615	rs34030762	chr4:3255736	C/A	cg00764545	chr4:3318001	RGS12	-0.72	-6.59	-0.6	4.63e-9	Parental longevity (mother's age at death);
SKCM	cis	rs7945705	0.783	rs11042125	chr11:8938049	A/T	cg21881798	chr11:8931708	C11orf17;ST5	-0.76	-7.72	-0.66	3.29e-11	Hemoglobin concentration;
SKCM	cis	rs860295	0.614	rs639398	chr1:155890238	T/A	cg02153340	chr1:155202674	NA	0.68	4.99	0.49	3.64e-6	Body mass index;
SKCM	cis	rs35306767	0.807	rs12768348	chr10:899224	T/G	cg26597838	chr10:835615	NA	0.79	5.7	0.54	2.01e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs10911232	0.507	rs4369195	chr1:182996291	G/C	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.64	0.6	3.83e-9	Hypertriglyceridemia;
SKCM	cis	rs28595532	0.641	rs72670220	chr4:119300053	A/G	cg11846333	chr4:119757529	SEC24D	1.11	6.34	0.58	1.38e-8	Cannabis dependence symptom count;
SKCM	cis	rs7666738	0.830	rs1426664	chr4:98988264	A/C	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10752881	0.967	rs6695746	chr1:182991355	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.64	0.6	3.83e-9	Colorectal cancer;
SKCM	cis	rs9858542	0.953	rs7648841	chr3:49416825	G/A	cg03060546	chr3:49711283	APEH	-0.69	-5.16	-0.5	1.85e-6	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs10751667	0.666	rs7396509	chr11:956761	G/A	cg10932868	chr11:921992	NA	0.54	4.84	0.48	6.38e-6	Alzheimer's disease (late onset);
SKCM	cis	rs7829975	0.533	rs13274028	chr8:8729193	A/C	cg06636001	chr8:8085503	FLJ10661	0.78	6.47	0.59	7.94e-9	Mood instability;
SKCM	cis	rs2841277	0.645	rs28380382	chr14:105410827	C/T	cg19901468	chr14:105411992	AHNAK2	-0.98	-7.74	-0.66	2.93e-11	Rheumatoid arthritis;
SKCM	cis	rs2370759	1.000	rs11599044	chr10:32615445	A/G	cg01819863	chr10:32635814	EPC1	1.05	5.8	0.55	1.33e-7	Sexual dysfunction (female);
SKCM	cis	rs4975616	0.869	rs421284	chr5:1325590	T/C	cg26373071	chr5:1325741	CLPTM1L	0.74	6.91	0.62	1.18e-9	Lung cancer;
SKCM	cis	rs2120019	0.608	rs8042558	chr15:75320433	G/T	cg09165964	chr15:75287851	SCAMP5	-0.92	-10.73	-0.77	5.02e-17	Blood trace element (Zn levels);
SKCM	cis	rs28386778	0.799	rs2727322	chr17:61921706	G/A	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs1395	1.000	rs3769143	chr2:27450724	A/G	cg14242246	chr2:27434262	C2orf28;SLC5A6	-0.47	-4.77	-0.48	8.27e-6	Blood metabolite levels;
SKCM	cis	rs7937682	0.883	rs1789351	chr11:111456436	T/A	cg19812747	chr11:111475976	SIK2	-0.59	-4.87	-0.48	5.69e-6	Primary sclerosing cholangitis;
SKCM	trans	rs208520	0.661	rs704519	chr6:66801136	T/C	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-1.01	-7.5	-0.65	8.58e-11	Exhaled nitric oxide output;
SKCM	cis	rs4237845	0.591	rs10747788	chr12:58315338	C/T	cg23860436	chr12:58378763	NA	0.45	4.89	0.48	5.32e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs6461049	0.765	rs4719432	chr7:2140330	A/G	cg21782813	chr7:2030301	MAD1L1	0.49	5.23	0.51	1.4e-6	Schizophrenia;
SKCM	cis	rs2204008	0.683	rs11522927	chr12:38137537	C/T	cg13010199	chr12:38710504	ALG10B	0.65	4.84	0.48	6.52e-6	Bladder cancer;
SKCM	cis	rs12134245	0.776	rs12122066	chr1:92005140	C/T	cg02896835	chr1:92012615	NA	-0.65	-5.99	-0.56	6.15e-8	Breast cancer;
SKCM	cis	rs28595532	0.920	rs116106661	chr4:119749794	A/G	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs8180040	0.764	rs13061071	chr3:47138708	G/A	cg27129171	chr3:47204927	SETD2	0.79	6.11	0.57	3.69e-8	Colorectal cancer;
SKCM	cis	rs1707322	1.000	rs12124291	chr1:46432132	G/A	cg03146154	chr1:46216737	IPP	0.8	5.44	0.52	5.87e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs9910055	0.614	rs12944572	chr17:42245241	T/C	cg13607699	chr17:42295918	UBTF	0.72	5.7	0.54	2.05e-7	Total body bone mineral density;
SKCM	cis	rs6952808	0.717	rs6967442	chr7:1926090	A/G	cg03354898	chr7:1950403	MAD1L1	-0.51	-4.94	-0.49	4.4e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs17376456	0.877	rs2085960	chr5:93399934	A/G	cg21475434	chr5:93447410	FAM172A	0.95	5.35	0.52	8.56e-7	Diabetic retinopathy;
SKCM	cis	rs7824557	0.564	rs2572404	chr8:11199584	A/G	cg21775007	chr8:11205619	TDH	0.69	6.1	0.57	3.76e-8	Retinal vascular caliber;
SKCM	cis	rs1218582	0.774	rs4845683	chr1:154877407	T/C	cg16680214	chr1:154839983	KCNN3	-0.55	-5.08	-0.5	2.54e-6	Prostate cancer;
SKCM	cis	rs826838	0.967	rs11183577	chr12:38781887	A/G	cg13010199	chr12:38710504	ALG10B	0.86	6.84	0.61	1.61e-9	Heart rate;
SKCM	cis	rs6500395	1.000	rs8052073	chr16:48682696	T/C	cg04672837	chr16:48644449	N4BP1	0.65	5.43	0.52	6.28e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs12824058	0.831	rs7485200	chr12:130811641	C/T	cg24838063	chr12:130822603	PIWIL1	0.79	7.02	0.62	7.36e-10	Menopause (age at onset);
SKCM	cis	rs6840360	0.533	rs13147021	chr4:152722688	A/C	cg22705602	chr4:152727874	NA	0.59	7.76	0.66	2.74e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs2836974	0.605	rs2836988	chr21:40707975	A/G	cg11890956	chr21:40555474	PSMG1	-0.82	-7.61	-0.65	5.41e-11	Cognitive function;
SKCM	cis	rs2811415	0.597	rs9820563	chr3:127780871	A/G	cg09089421	chr3:127803668	RUVBL1	1.01	8.78	0.71	2.82e-13	Lung function (FEV1/FVC);
SKCM	cis	rs7666738	0.830	rs13119995	chr4:99026790	T/C	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs12540874	0.698	rs3823674	chr7:50571996	C/T	cg18232548	chr7:50535776	DDC	-0.87	-5.97	-0.56	6.57e-8	Systemic sclerosis;
SKCM	cis	rs35306767	0.716	rs34487581	chr10:897201	G/A	cg25614935	chr10:1084866	C10orf110	0.81	5.47	0.53	5.26e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs7824557	0.606	rs1435277	chr8:11196970	C/T	cg21775007	chr8:11205619	TDH	0.65	5.81	0.55	1.28e-7	Retinal vascular caliber;
SKCM	cis	rs6762	0.748	rs28735718	chr11:839629	A/G	cg16425592	chr11:842748	TSPAN4;POLR2L	-0.79	-5.82	-0.55	1.25e-7	Mean platelet volume;
SKCM	cis	rs4746818	1.000	rs7899844	chr10:70949694	A/G	cg11621586	chr10:70884670	VPS26A	0.93	7.37	0.64	1.52e-10	Left atrial antero-posterior diameter;
SKCM	cis	rs763121	0.819	rs5750658	chr22:39060917	C/T	cg06022373	chr22:39101656	GTPBP1	0.74	5.24	0.51	1.35e-6	Menopause (age at onset);
SKCM	cis	rs6668108	1	rs6668108	chr1:165691320	A/G	cg24409356	chr1:165738333	TMCO1	0.93	5.15	0.5	1.93e-6	Intraocular pressure;
SKCM	cis	rs9902453	0.933	rs7221154	chr17:28505024	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.77	-5.5	-0.53	4.74e-7	Coffee consumption (cups per day);
SKCM	cis	rs7020830	0.931	rs13295115	chr9:37157964	T/G	cg14294708	chr9:37120828	ZCCHC7	1.09	10.39	0.76	2.29e-16	Schizophrenia;
SKCM	cis	rs13108904	0.846	rs9631805	chr4:1283035	T/C	cg05665937	chr4:1216051	CTBP1	-0.56	-4.77	-0.48	8.44e-6	Obesity-related traits;
SKCM	cis	rs8070624	0.543	rs8068175	chr17:17874486	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.01	8.61	0.7	6.26e-13	Total body bone mineral density;
SKCM	cis	rs2075371	0.611	rs35428392	chr7:134019645	G/A	cg20476274	chr7:133979776	SLC35B4	0.87	8.18	0.68	4.3e-12	Mean platelet volume;
SKCM	cis	rs34779708	0.931	rs11010082	chr10:35351155	A/G	cg03585969	chr10:35415529	CREM	0.74	6.12	0.57	3.47e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs9388451	0.839	rs9321054	chr6:126079968	A/G	cg05901451	chr6:126070800	HEY2	0.81	8.04	0.67	7.91e-12	Brugada syndrome;
SKCM	cis	rs11139399	0.689	rs11139387	chr9:84348608	T/G	cg13729285	chr9:84764156	NA	0.48	5.13	0.5	2.1e-6	Hippocampal atrophy;
SKCM	cis	rs9916302	0.605	rs12938099	chr17:37612910	T/G	cg07936489	chr17:37558343	FBXL20	-1.03	-7.61	-0.65	5.23e-11	Glomerular filtration rate (creatinine);
SKCM	cis	rs1256061	0.624	rs1152577	chr14:64697485	T/G	cg21174375	chr14:64681225	SYNE2	0.47	4.83	0.48	6.66e-6	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs2011503	0.882	rs4808933	chr19:19363812	T/A	cg11584989	chr19:19387371	SF4	0.78	5.16	0.5	1.85e-6	Bipolar disorder;
SKCM	cis	rs9430161	0.644	rs6685766	chr1:11037051	T/C	cg02454025	chr1:11042201	C1orf127	1.02	9.27	0.72	3.19e-14	Ewing sarcoma;
SKCM	cis	rs2760061	0.545	rs1636196	chr1:228204030	A/G	cg02753203	chr1:228287806	NA	0.89	8.28	0.68	2.65e-12	Diastolic blood pressure;
SKCM	cis	rs873946	0.586	rs61862838	chr10:134572282	C/T	cg27286337	chr10:134555280	INPP5A	0.99	8.98	0.71	1.2e-13	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs7666738	0.830	rs1813642	chr4:98852225	G/A	cg17366294	chr4:99064904	C4orf37	0.56	4.87	0.48	5.62e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4803468	1.000	rs2304242	chr19:41944616	G/T	cg09537434	chr19:41945824	ATP5SL	1.1	13.21	0.83	1.39e-21	Height;
SKCM	cis	rs7618501	0.602	rs34831713	chr3:50118748	T/C	cg05072774	chr3:49840536	C3orf54	0.71	5.48	0.53	5e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs28386778	0.897	rs3744293	chr17:61841788	T/A	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs11098499	0.863	rs3775844	chr4:120428033	G/A	cg24375607	chr4:120327624	NA	0.7	5.38	0.52	7.69e-7	Corneal astigmatism;
SKCM	cis	rs1568889	0.887	rs2062269	chr11:28116537	C/T	cg06544937	chr11:28130018	METT5D1;KIF18A	0.89	8.44	0.69	1.31e-12	Bipolar disorder;
SKCM	cis	rs11764590	0.724	rs55789728	chr7:2107649	A/G	cg23422044	chr7:1970798	MAD1L1	-0.86	-5.96	-0.56	6.86e-8	Neuroticism;
SKCM	cis	rs611744	0.647	rs2848620	chr8:109249551	G/T	cg18478394	chr8:109455254	TTC35	0.66	5.33	0.52	9.43e-7	Dupuytren's disease;
SKCM	cis	rs10905065	1.000	rs10905065	chr10:5769827	C/T	cg11519256	chr10:5708881	ASB13	0.59	5.16	0.5	1.8e-6	Menopause (age at onset);
SKCM	cis	rs7666738	0.830	rs4441757	chr4:98927059	T/C	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2839186	0.967	rs9637172	chr21:47685787	T/C	cg13126279	chr21:47581558	C21orf56	-0.63	-5.42	-0.52	6.37e-7	Testicular germ cell tumor;
SKCM	cis	rs11690935	0.885	rs7602037	chr2:172817794	G/A	cg13550731	chr2:172543902	DYNC1I2	-0.92	-7.66	-0.66	4.32e-11	Schizophrenia;
SKCM	cis	rs8060686	0.545	rs76836953	chr16:68061763	G/C	cg09117114	chr16:67998030	SLC12A4	-0.78	-5.06	-0.5	2.72e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs8170	0.603	rs3810204	chr19:17448660	T/C	cg07830086	chr19:18107778	KCNN1	-0.8	-5.01	-0.49	3.37e-6	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Ovarian cancer;Breast cancer;Epithelial ovarian cancer;
SKCM	cis	rs1395	0.778	rs34618115	chr2:27418289	G/A	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.51	5.14	0.5	1.96e-6	Blood metabolite levels;
SKCM	cis	rs2197308	0.715	rs11181816	chr12:37911626	A/G	cg26384229	chr12:38710491	ALG10B	-0.76	-6.24	-0.58	2.08e-8	Morning vs. evening chronotype;
SKCM	cis	rs3096299	0.658	rs3934737	chr16:89560209	G/A	cg02187348	chr16:89574699	SPG7	0.63	5.16	0.5	1.86e-6	Multiple myeloma (IgH translocation);
SKCM	cis	rs10779751	0.734	rs1211575	chr1:11118390	G/A	cg08854313	chr1:11322531	MTOR	0.74	5.1	0.5	2.31e-6	Body mass index;
SKCM	cis	rs12500482	0.935	rs2239736	chr4:2438929	T/C	cg26605046	chr4:2439731	NA	-0.63	-5.69	-0.54	2.11e-7	Cognitive function;
SKCM	cis	rs61776719	0.817	rs17531077	chr1:38415507	A/G	cg12658694	chr1:38397304	INPP5B	0.68	5.79	0.55	1.43e-7	Coronary artery disease;
SKCM	cis	rs6545883	0.929	rs13413337	chr2:61747123	A/G	cg15711740	chr2:61764176	XPO1	-0.73	-5.27	-0.51	1.19e-6	Tuberculosis;
SKCM	cis	rs12611334	0.964	rs11670568	chr19:40184320	G/A	cg04998674	chr19:40596855	ZNF780A	0.63	4.77	0.47	8.55e-6	Schizophrenia;
SKCM	cis	rs701145	0.640	rs357506	chr3:153932403	A/C	cg17054900	chr3:154042577	DHX36	1.19	5.1	0.5	2.37e-6	Coronary artery disease;
SKCM	cis	rs2839186	0.807	rs2032226	chr21:47680352	G/A	cg13012494	chr21:47604986	C21orf56	0.68	6.0	0.56	5.83e-8	Testicular germ cell tumor;
SKCM	cis	rs4423214	1.000	rs12791871	chr11:71164544	A/C	cg05163923	chr11:71159392	DHCR7	0.83	8.06	0.67	7.35e-12	Vitamin D levels;
SKCM	cis	rs5750830	0.645	rs4821890	chr22:39777523	G/A	cg11247378	chr22:39784982	NA	-0.47	-5.61	-0.54	2.93e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs2075371	0.897	rs1643033	chr7:134004662	T/C	cg20476274	chr7:133979776	SLC35B4	1.06	11.34	0.79	3.65e-18	Mean platelet volume;
SKCM	cis	rs17376456	0.877	rs12153788	chr5:93405437	A/G	cg21475434	chr5:93447410	FAM172A	0.97	5.41	0.52	6.8e-7	Diabetic retinopathy;
SKCM	cis	rs7811142	0.830	rs11771936	chr7:99943283	A/G	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.21	8.05	0.67	7.68e-12	Platelet count;
SKCM	cis	rs7552404	0.924	rs1146580	chr1:76209935	T/C	cg10523679	chr1:76189770	ACADM	0.68	5.0	0.49	3.44e-6	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs9300255	0.568	rs1790102	chr12:123704890	G/A	cg05973401	chr12:123451056	ABCB9	0.81	5.37	0.52	7.77e-7	Neutrophil percentage of white cells;
SKCM	cis	rs7828089	0.819	rs4872488	chr8:22257012	G/A	cg12081754	chr8:22256438	SLC39A14	0.72	6.2	0.57	2.53e-8	Verbal declarative memory;
SKCM	cis	rs72781680	1.000	rs7578969	chr2:24168620	T/C	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	cis	rs12762955	0.528	rs10903358	chr10:1102386	G/A	cg25614935	chr10:1084866	C10orf110	0.69	5.23	0.51	1.41e-6	Response to angiotensin II receptor blocker therapy;
SKCM	cis	rs514406	0.505	rs269289	chr1:53167151	A/C	cg16325326	chr1:53192061	ZYG11B	0.91	10.29	0.76	3.51e-16	Monocyte count;
SKCM	cis	rs763121	1.000	rs138457	chr22:38898051	T/C	cg06022373	chr22:39101656	GTPBP1	-0.82	-5.88	-0.55	9.85e-8	Menopause (age at onset);
SKCM	cis	rs782590	0.837	rs782573	chr2:55912961	T/C	cg18811423	chr2:55921094	PNPT1	0.95	8.0	0.67	9.22e-12	Metabolic syndrome;
SKCM	cis	rs10883723	0.773	rs7917402	chr10:104246690	C/T	cg11453585	chr10:104263688	ACTR1A;SUFU	0.73	5.41	0.52	6.74e-7	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs2180341	1.000	rs4895822	chr6:127642703	T/C	cg27446573	chr6:127587934	RNF146	0.94	8.08	0.68	6.49e-12	Breast cancer;
SKCM	cis	rs4561483	0.801	rs40311	chr16:11963190	C/G	cg08843971	chr16:11963173	GSPT1	0.66	5.08	0.5	2.49e-6	Testicular germ cell tumor;
SKCM	cis	rs7659604	0.689	rs59131059	chr4:122666357	C/T	cg19748678	chr4:122722346	EXOSC9	0.67	5.45	0.52	5.79e-7	Type 2 diabetes;
SKCM	cis	rs4819052	0.851	rs7276103	chr21:46666078	G/A	cg02159808	chr21:46707872	POFUT2;LOC642852	0.69	5.27	0.51	1.16e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs28595532	0.623	rs34284204	chr4:119227672	C/T	cg11846333	chr4:119757529	SEC24D	0.96	5.37	0.52	7.87e-7	Cannabis dependence symptom count;
SKCM	cis	rs1059312	0.669	rs11059917	chr12:129287925	T/A	cg09035930	chr12:129282057	SLC15A4	0.78	7.57	0.65	6.49e-11	Systemic lupus erythematosus;
SKCM	cis	rs7937682	0.737	rs663763	chr11:111422217	C/T	cg19812747	chr11:111475976	SIK2	-0.56	-4.88	-0.48	5.57e-6	Primary sclerosing cholangitis;
SKCM	cis	rs9486715	0.867	rs9373833	chr6:96904998	A/G	cg06623918	chr6:96969491	KIAA0776	-0.77	-6.83	-0.61	1.66e-9	Headache;
SKCM	cis	rs7937682	0.883	rs11213941	chr11:111434094	T/C	cg22437258	chr11:111473054	SIK2	-0.64	-4.85	-0.48	6.21e-6	Primary sclerosing cholangitis;
SKCM	cis	rs3820928	1.000	rs7561378	chr2:227772248	T/C	cg11843606	chr2:227700838	RHBDD1	-0.64	-5.2	-0.51	1.53e-6	Pulmonary function;
SKCM	cis	rs9913156	0.748	rs55959711	chr17:4562581	C/A	cg19197139	chr17:4613644	ARRB2	0.79	5.28	0.51	1.14e-6	Lymphocyte counts;
SKCM	cis	rs1799949	0.965	rs6503726	chr17:41284742	T/C	cg23758822	chr17:41437982	NA	0.94	7.42	0.64	1.24e-10	Menopause (age at onset);
SKCM	cis	rs611744	0.647	rs615126	chr8:109247619	C/T	cg18478394	chr8:109455254	TTC35	0.66	5.33	0.52	9.43e-7	Dupuytren's disease;
SKCM	cis	rs929354	1.000	rs1182414	chr7:157058363	G/A	cg17757837	chr7:157058334	UBE3C	-0.93	-7.21	-0.63	3.17e-10	Body mass index;
SKCM	cis	rs867743	0.853	rs6982265	chr8:60529722	C/T	cg17885579	chr8:59572218	NSMAF	0.62	4.78	0.48	8.03e-6	Schizophrenia;
SKCM	cis	rs2032447	0.714	rs2051540	chr6:25947197	T/C	cg18357526	chr6:26021779	HIST1H4A	0.72	5.5	0.53	4.65e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7247513	0.701	rs8107642	chr19:12766370	C/T	cg04657146	chr19:12876947	HOOK2	0.66	5.07	0.5	2.66e-6	Bipolar disorder;
SKCM	cis	rs2645694	0.626	rs2703126	chr4:77819842	T/C	cg06046430	chr4:77819534	ANKRD56	0.54	5.83	0.55	1.18e-7	Emphysema distribution in smoking;
SKCM	cis	rs10504229	1.000	rs17217082	chr8:58180918	G/A	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs4968361	0.892	rs11653976	chr17:57516994	A/C	cg02573089	chr17:57233042	PRR11;SKA2	-1.18	-5.16	-0.5	1.81e-6	Schizophrenia;
SKCM	cis	rs7772486	0.754	rs6932863	chr6:146021255	A/T	cg23711669	chr6:146136114	FBXO30	-0.89	-9.58	-0.74	8.28e-15	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6087990	0.769	rs17123658	chr20:31390840	C/A	cg13636640	chr20:31349939	DNMT3B	0.93	8.12	0.68	5.5e-12	Ulcerative colitis;
SKCM	cis	rs7659604	0.702	rs6826506	chr4:122710865	T/G	cg19671926	chr4:122722719	EXOSC9	-0.65	-4.78	-0.48	8.05e-6	Type 2 diabetes;
SKCM	cis	rs2836950	0.545	rs2836959	chr21:40623668	T/G	cg17971929	chr21:40555470	PSMG1	-0.73	-6.16	-0.57	2.97e-8	Menarche (age at onset);
SKCM	cis	rs2999052	0.526	rs35546672	chr3:127740453	C/G	cg09089421	chr3:127803668	RUVBL1	-0.59	-5.59	-0.54	3.16e-7	Hypospadias;
SKCM	cis	rs67460515	0.528	rs11915989	chr3:160902259	A/G	cg03342759	chr3:160939853	NMD3	-0.73	-6.17	-0.57	2.79e-8	Parkinson's disease;
SKCM	cis	rs13118159	0.550	rs13123016	chr4:1340889	T/C	cg16405210	chr4:1374714	KIAA1530	-0.94	-7.1	-0.63	5.02e-10	Longevity;
SKCM	cis	rs10256972	0.641	rs12702017	chr7:1129413	C/T	cg07092213	chr7:1199455	ZFAND2A	-0.65	-5.44	-0.52	5.9e-7	Longevity;Endometriosis;
SKCM	cis	rs2404602	0.647	rs11072620	chr15:77048770	T/A	cg23625390	chr15:77176239	SCAPER	-0.82	-7.93	-0.67	1.26e-11	Blood metabolite levels;
SKCM	cis	rs8067545	0.586	rs11657161	chr17:20180715	A/G	cg13482628	chr17:19912719	NA	-0.65	-5.43	-0.52	6.15e-7	Schizophrenia;
SKCM	cis	rs9393692	0.537	rs9358926	chr6:26323132	C/G	cg00631329	chr6:26305371	NA	-0.63	-4.88	-0.48	5.44e-6	Educational attainment;
SKCM	cis	rs6545883	0.965	rs7421663	chr2:61753786	C/T	cg15711740	chr2:61764176	XPO1	-0.73	-5.27	-0.51	1.19e-6	Tuberculosis;
SKCM	cis	rs801193	1.000	rs1553610	chr7:66197233	T/C	cg11764359	chr7:65958608	NA	0.86	6.55	0.6	5.68e-9	Aortic root size;
SKCM	cis	rs2180341	1.000	rs6937287	chr6:127645719	T/A	cg24812749	chr6:127587940	RNF146	0.85	7.3	0.64	2.08e-10	Breast cancer;
SKCM	cis	rs7149337	0.837	rs4296182	chr14:51662167	A/C	cg23942311	chr14:51606299	NA	0.65	7.58	0.65	6.02e-11	Cancer;
SKCM	cis	rs611744	0.647	rs689275	chr8:109241822	T/C	cg18478394	chr8:109455254	TTC35	0.66	5.33	0.52	9.43e-7	Dupuytren's disease;
SKCM	cis	rs523522	0.926	rs10774555	chr12:120971978	G/A	cg12219531	chr12:120966889	COQ5	0.91	7.82	0.66	2.11e-11	High light scatter reticulocyte count;
SKCM	cis	rs7666738	0.791	rs10005118	chr4:99038196	A/C	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs28595532	0.545	rs17516582	chr4:119296763	C/G	cg11846333	chr4:119757529	SEC24D	1.09	6.21	0.58	2.41e-8	Cannabis dependence symptom count;
SKCM	cis	rs1577917	0.958	rs4707223	chr6:86509802	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.79	-0.66	2.4e-11	Response to antipsychotic treatment;
SKCM	cis	rs28595532	1.000	rs114778020	chr4:119662584	C/A	cg21605333	chr4:119757512	SEC24D	1.34	7.8	0.66	2.27e-11	Cannabis dependence symptom count;
SKCM	cis	rs2204008	0.606	rs1581358	chr12:38391582	G/T	cg26384229	chr12:38710491	ALG10B	0.88	6.86	0.61	1.46e-9	Bladder cancer;
SKCM	cis	rs875971	0.895	rs6460300	chr7:65952924	A/G	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	cis	rs2073499	0.872	rs2282751	chr3:50291785	A/G	cg08207895	chr3:50388901	TUSC4;CYB561D2	-0.73	-4.79	-0.48	7.79e-6	Schizophrenia;
SKCM	cis	rs1147199	0.585	rs1147197	chr9:87274148	G/A	cg13486759	chr9:86751815	NA	-0.64	-4.81	-0.48	7.23e-6	Body mass index;
SKCM	cis	rs12148488	0.763	rs2304902	chr15:75340727	G/T	cg17294928	chr15:75287854	SCAMP5	0.66	4.88	0.48	5.47e-6	Caffeine consumption;
SKCM	cis	rs17683430	0.764	rs117001013	chr22:32348841	C/T	cg00543991	chr22:32367038	NA	1.41	5.48	0.53	5.05e-7	GIP levels in response to oral glucose tolerance test (120 minutes);
SKCM	cis	rs6951245	0.678	rs4724725	chr7:1214751	G/A	cg23708337	chr7:1209742	NA	0.89	5.21	0.51	1.5e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs1552244	1.000	rs9845756	chr3:10067548	G/C	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs10504229	0.683	rs7817188	chr8:58129549	C/T	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs1218582	0.628	rs12130132	chr1:154880386	C/T	cg09359103	chr1:154839909	KCNN3	-0.58	-5.38	-0.52	7.47e-7	Prostate cancer;
SKCM	cis	rs875971	1.000	rs2087647	chr7:65593188	C/A	cg11764359	chr7:65958608	NA	-0.86	-8.23	-0.68	3.44e-12	Aortic root size;
SKCM	cis	rs10911251	0.546	rs2027081	chr1:183074576	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.81	7.75	0.66	2.85e-11	Colorectal cancer;
SKCM	cis	rs28386778	0.897	rs9906247	chr17:61857314	T/C	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs826838	0.809	rs11169666	chr12:39211300	T/C	cg26384229	chr12:38710491	ALG10B	0.9	7.85	0.66	1.84e-11	Heart rate;
SKCM	cis	rs7772486	0.597	rs9285508	chr6:146262697	G/T	cg05347473	chr6:146136440	FBXO30	-0.68	-5.42	-0.52	6.49e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs514406	0.893	rs6661115	chr1:53426148	G/A	cg24675658	chr1:53192096	ZYG11B	0.73	6.02	0.56	5.32e-8	Monocyte count;
SKCM	cis	rs6879260	1.000	rs729568	chr5:179732350	C/T	cg13944838	chr5:179740914	GFPT2	0.69	5.77	0.55	1.52e-7	Height;
SKCM	cis	rs2549003	1.000	rs2549009	chr5:131826765	T/C	cg21138405	chr5:131827807	IRF1	-0.42	-4.95	-0.49	4.25e-6	Asthma (sex interaction);
SKCM	cis	rs12142240	0.698	rs45449893	chr1:46859024	A/G	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs4862750	0.872	rs13101408	chr4:187894777	G/A	cg10295955	chr4:187884368	NA	-1.04	-13.91	-0.84	7.95e-23	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1348850	0.526	rs6723063	chr2:178491398	C/T	cg27490568	chr2:178487706	NA	1.16	7.85	0.66	1.8e-11	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs2153535	0.580	rs7341383	chr6:8470634	A/C	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs362296	0.550	rs3135064	chr4:3285389	T/C	cg21096898	chr4:3318625	RGS12	0.81	7.89	0.67	1.52e-11	Parental longevity (mother's age at death);
SKCM	cis	rs7635838	0.587	rs347591	chr3:11290122	G/T	cg00170343	chr3:11313890	ATG7	0.77	6.06	0.57	4.59e-8	HDL cholesterol;
SKCM	cis	rs116095464	0.558	rs9688136	chr5:229348	T/C	cg22496380	chr5:211416	CCDC127	-0.95	-5.22	-0.51	1.42e-6	Breast cancer;
SKCM	cis	rs362272	0.524	rs2857982	chr4:3358665	G/A	cg21096898	chr4:3318625	RGS12	1.01	12.88	0.82	5.24e-21	Serum sulfate level;
SKCM	cis	rs875971	0.895	rs778700	chr7:65866450	C/T	cg11764359	chr7:65958608	NA	0.87	8.35	0.69	2.01e-12	Aortic root size;
SKCM	cis	rs875971	0.651	rs313829	chr7:65552497	A/G	cg18876405	chr7:65276391	NA	-0.65	-5.12	-0.5	2.13e-6	Aortic root size;
SKCM	cis	rs10883723	0.847	rs3808934	chr10:104264280	C/T	cg11453585	chr10:104263688	ACTR1A;SUFU	0.75	5.7	0.54	2.03e-7	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs875971	0.505	rs2462573	chr7:65507392	C/T	cg11764359	chr7:65958608	NA	-0.88	-6.85	-0.61	1.53e-9	Aortic root size;
SKCM	cis	rs798554	0.757	rs1182188	chr7:2869985	T/C	cg19346786	chr7:2764209	NA	-0.63	-6.95	-0.62	9.84e-10	Height;
SKCM	cis	rs2842992	0.714	rs2475564	chr6:160123673	A/G	cg19482086	chr6:160211437	TCP1;MRPL18	0.79	5.84	0.55	1.13e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs1005277	0.579	rs2472173	chr10:38374638	G/A	cg00409905	chr10:38381863	ZNF37A	-0.64	-5.96	-0.56	6.77e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs769267	0.930	rs1054284	chr19:19616953	T/G	cg26732615	chr19:19648335	CILP2;YJEFN3	0.67	7.06	0.62	6e-10	Tonsillectomy;
SKCM	cis	rs28386778	0.742	rs3020617	chr17:61947303	A/G	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.12	10.64	0.77	7.49e-17	Prudent dietary pattern;
SKCM	cis	rs2839186	0.708	rs6518285	chr21:47644667	T/C	cg05896524	chr21:47604654	C21orf56	0.68	5.63	0.54	2.78e-7	Testicular germ cell tumor;
SKCM	cis	rs34779708	0.931	rs67976880	chr10:35372261	G/C	cg03585969	chr10:35415529	CREM	0.78	6.31	0.58	1.58e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs7666738	0.830	rs7682991	chr4:98982595	C/A	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs644799	1.000	rs514170	chr11:95556696	C/T	cg03916912	chr11:95522834	CEP57;FAM76B	0.88	7.53	0.65	7.59e-11	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs10138752	0.555	rs11848320	chr14:69105359	G/A	cg08271153	chr14:69726221	GALNTL1	-0.69	-5.37	-0.52	7.75e-7	Neutrophil count;White blood cell count;Myeloid white cell count;Granulocyte count;Sum neutrophil eosinophil counts;Sum basophil neutrophil counts;
SKCM	cis	rs2836950	0.565	rs7279497	chr21:40531306	A/G	cg11890956	chr21:40555474	PSMG1	0.71	5.66	0.54	2.38e-7	Menarche (age at onset);
SKCM	cis	rs6570726	0.791	rs6913727	chr6:145899826	A/G	cg23711669	chr6:146136114	FBXO30	0.88	9.09	0.72	7.08e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2839186	0.558	rs2968	chr21:47608580	C/T	cg13126279	chr21:47581558	C21orf56	0.71	6.3	0.58	1.61e-8	Testicular germ cell tumor;
SKCM	cis	rs6570726	0.791	rs427128	chr6:145865917	T/C	cg23711669	chr6:146136114	FBXO30	0.87	9.13	0.72	5.92e-14	Lobe attachment (rater-scored or self-reported);
SKCM	trans	rs1814175	0.715	rs7479622	chr11:49673340	T/G	cg15704280	chr7:45808275	SEPT13	-1.04	-9.75	-0.74	3.81e-15	Height;
SKCM	cis	rs6866344	0.697	rs6873150	chr5:178125704	G/A	cg10224037	chr5:178157518	ZNF354A	0.74	4.92	0.49	4.8e-6	Neutrophil percentage of white cells;
SKCM	cis	rs798554	0.679	rs7784066	chr7:2819727	T/A	cg04166393	chr7:2884313	GNA12	0.79	5.82	0.55	1.22e-7	Height;
SKCM	cis	rs1707322	0.721	rs10430123	chr1:46221440	T/C	cg03146154	chr1:46216737	IPP	0.84	6.2	0.57	2.51e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs2153535	0.601	rs969420	chr6:8451966	T/A	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs1185460	1.000	rs1614264	chr11:118942638	A/C	cg23280166	chr11:118938394	VPS11	0.59	5.26	0.51	1.23e-6	Coronary artery disease;
SKCM	cis	rs6087990	0.899	rs1883729	chr20:31363193	G/A	cg13636640	chr20:31349939	DNMT3B	0.91	7.97	0.67	1.06e-11	Ulcerative colitis;
SKCM	cis	rs4481887	1.000	rs7517319	chr1:248466408	C/A	cg00666640	chr1:248458726	OR2T12	0.6	5.14	0.5	1.98e-6	Common traits (Other);
SKCM	cis	rs3820068	0.581	rs6669417	chr1:15922371	G/T	cg13390004	chr1:15929781	NA	0.65	5.01	0.49	3.31e-6	Systolic blood pressure;
SKCM	cis	rs13118159	0.550	rs4974611	chr4:1358449	T/C	cg05025164	chr4:1340916	KIAA1530	0.9	7.21	0.63	3.08e-10	Longevity;
SKCM	cis	rs7829975	0.593	rs2979241	chr8:8303353	G/C	cg15556689	chr8:8085844	FLJ10661	0.62	5.12	0.5	2.12e-6	Mood instability;
SKCM	cis	rs2760061	0.583	rs1774757	chr1:228211135	C/G	cg02753203	chr1:228287806	NA	0.9	8.47	0.69	1.17e-12	Diastolic blood pressure;
SKCM	cis	rs1005277	0.505	rs200935	chr10:38132810	T/A	cg00409905	chr10:38381863	ZNF37A	-0.62	-5.81	-0.55	1.29e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs13256369	0.851	rs13271698	chr8:8567539	C/A	cg06636001	chr8:8085503	FLJ10661	0.77	5.93	0.56	7.8e-8	Obesity-related traits;
SKCM	cis	rs2836974	0.666	rs1888487	chr21:40683259	A/G	cg11644478	chr21:40555479	PSMG1	-0.68	-5.96	-0.56	6.94e-8	Cognitive function;
SKCM	cis	rs12142240	0.698	rs66972124	chr1:46807445	A/G	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs2228479	0.702	rs2074903	chr16:89811663	T/C	cg00800038	chr16:89945340	TCF25	-0.81	-4.79	-0.48	7.84e-6	Skin colour saturation;
SKCM	cis	rs736408	0.609	rs62255396	chr3:52782839	C/T	cg18404041	chr3:52824283	ITIH1	-0.56	-4.94	-0.49	4.32e-6	Bipolar disorder;
SKCM	cis	rs9910055	0.639	rs227583	chr17:42231698	C/G	cg10896456	chr17:42255109	ASB16;C17orf65	0.69	7.22	0.63	3e-10	Total body bone mineral density;
SKCM	cis	rs12928939	0.517	rs8049508	chr16:71978313	C/T	cg03805757	chr16:71968109	PKD1L3	-0.72	-5.17	-0.51	1.78e-6	Post bronchodilator FEV1;
SKCM	cis	rs796364	1.000	rs10178177	chr2:200829993	G/A	cg12253985	chr2:200820533	C2orf60;C2orf47	0.92	5.62	0.54	2.83e-7	Schizophrenia;
SKCM	cis	rs7017252	0.964	rs13264707	chr8:129950004	T/C	cg08633665	chr8:128972829	MIR1205;PVT1	-0.44	-5.15	-0.5	1.87e-6	Nonsyndromic cleft lip with cleft palate;
SKCM	cis	rs12950390	0.853	rs12450733	chr17:45855404	A/G	cg03474202	chr17:45855739	NA	-0.49	-5.58	-0.53	3.34e-7	IgG glycosylation;
SKCM	cis	rs7772486	0.790	rs9497427	chr6:146238302	T/A	cg05347473	chr6:146136440	FBXO30	-0.56	-5.19	-0.51	1.6e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs801193	1.000	rs2420824	chr7:66131116	G/A	cg05627663	chr7:65219948	SNORA22;CCT6P1	-0.56	-4.84	-0.48	6.39e-6	Aortic root size;
SKCM	cis	rs9581857	0.579	rs9581836	chr13:27963824	T/G	cg22138327	chr13:27999177	GTF3A	0.93	5.39	0.52	7.18e-7	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs216303	0.841	rs2239161	chr12:6162661	C/T	cg22867714	chr12:6169044	VWF	-0.86	-4.86	-0.48	5.93e-6	Low vWF levels;
SKCM	cis	rs8017423	0.967	rs2401875	chr14:90688451	A/G	cg04374321	chr14:90722782	PSMC1	0.97	8.67	0.7	4.78e-13	Mortality in heart failure;
SKCM	cis	rs9303401	0.659	rs35828828	chr17:56718205	C/T	cg10487724	chr17:56770010	TEX14;RAD51C	0.84	5.99	0.56	6.18e-8	Cognitive test performance;
SKCM	cis	rs873946	0.590	rs12259699	chr10:134549692	A/G	cg18305652	chr10:134549665	INPP5A	0.57	5.65	0.54	2.49e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs1003719	0.667	rs2298683	chr21:38445069	T/C	cg10648535	chr21:38446584	PIGP;TTC3	0.64	4.98	0.49	3.72e-6	Eye color traits;
SKCM	cis	rs6866344	0.570	rs1071882	chr5:178136040	C/T	cg10224037	chr5:178157518	ZNF354A	0.84	6.3	0.58	1.65e-8	Neutrophil percentage of white cells;
SKCM	cis	rs6952808	1.000	rs6978048	chr7:1886872	T/G	cg02951883	chr7:2050386	MAD1L1	-0.71	-5.35	-0.52	8.61e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs1801251	0.896	rs4973561	chr2:233687337	C/G	cg25237894	chr2:233734115	C2orf82	-0.53	-5.18	-0.51	1.68e-6	Coronary artery disease;
SKCM	cis	rs2013441	0.670	rs35317166	chr17:19959820	T/A	cg13482628	chr17:19912719	NA	0.67	4.8	0.48	7.46e-6	Obesity-related traits;
SKCM	cis	rs748404	0.578	rs2012467	chr15:43690565	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	0.79	5.95	0.56	7.09e-8	Lung cancer;
SKCM	cis	rs7666738	0.791	rs6828752	chr4:99063382	C/T	cg17366294	chr4:99064904	C4orf37	0.61	4.93	0.49	4.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2455601	0.766	rs1109304	chr11:8955455	A/G	cg21881798	chr11:8931708	C11orf17;ST5	-0.74	-5.29	-0.51	1.07e-6	Schizophrenia;
SKCM	cis	rs9926296	0.605	rs7205053	chr16:89856763	G/C	cg26513180	chr16:89883248	FANCA	0.97	10.72	0.77	5.25e-17	Vitiligo;
SKCM	cis	rs742731	0.963	rs6045681	chr20:18888667	G/A	cg04272256	chr20:17949548	C20orf72;SNX5	0.71	5.1	0.5	2.29e-6	Fasting insulin (dietary factor interaction);Homeostasis model assessment of insulin resistance (dietary factor interaction);
SKCM	cis	rs7191439	0.858	rs2290902	chr16:88782676	A/G	cg02389323	chr16:88786976	FAM38A	1.5	6.31	0.58	1.57e-8	Plateletcrit;
SKCM	cis	rs62238980	0.614	rs79807615	chr22:32415867	G/A	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs9581857	0.546	rs9579082	chr13:27965763	C/T	cg22138327	chr13:27999177	GTF3A	0.93	5.39	0.52	7.18e-7	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs28595532	0.920	rs116739193	chr4:119771024	G/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs2836974	0.965	rs6517538	chr21:40656242	C/T	cg17971929	chr21:40555470	PSMG1	0.9	8.81	0.71	2.52e-13	Cognitive function;
SKCM	cis	rs763014	0.898	rs4984893	chr16:623082	A/G	cg09263875	chr16:632152	PIGQ	0.68	5.71	0.54	1.98e-7	Height;
SKCM	cis	rs2033711	0.840	rs4801590	chr19:58961813	G/C	cg26874164	chr19:58962979	ZNF324B	0.62	5.11	0.5	2.28e-6	Uric acid clearance;
SKCM	cis	rs16854884	0.586	rs7611326	chr3:143736374	C/T	cg06585982	chr3:143692056	C3orf58	0.87	8.34	0.69	2.04e-12	Economic and political preferences (feminism/equality);
SKCM	cis	rs2228479	0.717	rs17233678	chr16:89809962	T/C	cg00800038	chr16:89945340	TCF25	-0.81	-4.79	-0.48	7.84e-6	Skin colour saturation;
SKCM	cis	rs2404602	0.532	rs12591100	chr15:76700801	C/A	cg23625390	chr15:77176239	SCAPER	-0.64	-5.64	-0.54	2.59e-7	Blood metabolite levels;
SKCM	cis	rs875971	0.660	rs801211	chr7:66015689	T/G	cg00343986	chr7:65444356	GUSB	-0.7	-5.14	-0.5	1.98e-6	Aortic root size;
SKCM	cis	rs4819052	0.851	rs4819043	chr21:46660078	G/A	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.35	0.64	1.68e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7666738	0.791	rs11730069	chr4:98945772	A/G	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs17826219	0.706	rs8075357	chr17:29057197	A/C	cg14067834	chr17:29058358	SUZ12P	1.2	5.77	0.55	1.5e-7	Body mass index;
SKCM	cis	rs6582630	0.572	rs1969363	chr12:38514872	A/G	cg13010199	chr12:38710504	ALG10B	0.59	4.92	0.49	4.7e-6	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs1348850	0.554	rs11679519	chr2:178432110	C/T	cg02961200	chr2:178257176	LOC100130691;AGPS	0.83	4.83	0.48	6.6e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs12714314	0.560	rs2116652	chr2:1941825	A/G	cg22350835	chr2:1868857	MYT1L	0.59	5.61	0.54	2.94e-7	Type 2 diabetes (age of onset);
SKCM	cis	rs1003719	0.788	rs7276917	chr21:38451334	T/C	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs2153535	0.601	rs2327091	chr6:8540369	G/A	cg07606381	chr6:8435919	SLC35B3	0.91	6.31	0.58	1.56e-8	Motion sickness;
SKCM	cis	rs6087990	0.965	rs6058869	chr20:31348750	C/T	cg13636640	chr20:31349939	DNMT3B	0.9	7.79	0.66	2.36e-11	Ulcerative colitis;
SKCM	cis	rs9399137	0.507	rs13064	chr6:135287533	A/G	cg24558204	chr6:135376177	HBS1L	0.69	6.37	0.59	1.19e-8	Glycated hemoglobin levels;Mean corpuscular volume;Hematology traits;HbA2 levels;Mean corpuscular hemoglobin;Hemoglobin levels;F-cell distribution;Platelet count;
SKCM	cis	rs1801251	1.000	rs6747645	chr2:233571033	C/T	cg08000102	chr2:233561755	GIGYF2	-0.83	-6.73	-0.61	2.59e-9	Coronary artery disease;
SKCM	cis	rs7937682	0.921	rs4616071	chr11:111440865	C/G	cg09085632	chr11:111637200	PPP2R1B	0.97	8.62	0.7	5.94e-13	Primary sclerosing cholangitis;
SKCM	cis	rs17376456	0.877	rs10057814	chr5:93399092	C/G	cg25358565	chr5:93447407	FAM172A	1.18	7.56	0.65	6.77e-11	Diabetic retinopathy;
SKCM	cis	rs9916302	0.800	rs11869259	chr17:37518141	C/A	cg07936489	chr17:37558343	FBXL20	0.85	7.28	0.64	2.26e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs9420	0.961	rs11604333	chr11:57467035	C/G	cg19752551	chr11:57585705	CTNND1	-0.7	-6.97	-0.62	9.17e-10	Schizophrenia;
SKCM	cis	rs9581857	0.579	rs79653667	chr13:27961109	G/A	cg22138327	chr13:27999177	GTF3A	0.93	5.39	0.52	7.18e-7	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs4919087	0.748	rs1147600	chr10:98981643	T/C	cg25902810	chr10:99078978	FRAT1	-0.65	-4.97	-0.49	3.86e-6	Monocyte count;
SKCM	cis	rs35306767	0.903	rs35637113	chr10:874149	G/C	cg20503657	chr10:835505	NA	0.75	5.43	0.52	6.09e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs854765	0.583	rs4341796	chr17:17839024	C/A	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.93	7.3	0.64	2.06e-10	Total body bone mineral density;
SKCM	cis	rs9818758	0.556	rs9872660	chr3:49378832	G/T	cg05072774	chr3:49840536	C3orf54	0.75	4.78	0.48	8.15e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs6753739	0.745	rs1378640	chr2:219917632	C/T	cg09617556	chr2:219924408	IHH	0.48	5.12	0.5	2.13e-6	Height;
SKCM	cis	rs7659604	0.676	rs4077102	chr4:122699830	A/G	cg20573242	chr4:122745356	CCNA2	0.75	6.23	0.58	2.18e-8	Type 2 diabetes;
SKCM	cis	rs10911251	0.546	rs1547714	chr1:183114119	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.76	7.28	0.64	2.26e-10	Colorectal cancer;
SKCM	cis	rs4243830	0.850	rs4434862	chr1:6602241	C/A	cg22792644	chr1:6614718	TAS1R1;NOL9	-1.06	-5.63	-0.54	2.69e-7	Body mass index;
SKCM	cis	rs9921222	0.521	rs757460	chr16:367174	G/C	cg00101154	chr16:420108	MRPL28	-0.67	-5.53	-0.53	4.15e-7	Bone mineral density (spine);Bone mineral density;
SKCM	cis	rs4237845	0.537	rs59401446	chr12:58259564	G/A	cg00677455	chr12:58241039	CTDSP2	0.92	8.21	0.68	3.66e-12	Intelligence (multi-trait analysis);
SKCM	cis	rs1325195	0.537	rs61821690	chr1:179188006	C/T	cg10806749	chr1:179558114	NA	0.55	4.84	0.48	6.32e-6	IgE grass sensitization;
SKCM	cis	rs9322193	0.847	rs4870054	chr6:150169538	C/T	cg13206674	chr6:150067644	NUP43	0.63	4.92	0.49	4.63e-6	Lung cancer;
SKCM	cis	rs155076	1.000	rs566364	chr13:21837583	T/C	cg14456004	chr13:21872349	NA	-1.23	-6.77	-0.61	2.15e-9	White matter hyperintensity burden;
SKCM	cis	rs3768617	0.510	rs10911249	chr1:183080690	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs992157	0.560	rs1514132	chr2:219084082	C/T	cg20019365	chr2:219134978	PNKD;AAMP	-0.66	-5.52	-0.53	4.37e-7	Colorectal cancer;
SKCM	cis	rs736408	0.774	rs4687551	chr3:52823448	C/T	cg18404041	chr3:52824283	ITIH1	0.66	6.05	0.57	4.71e-8	Bipolar disorder;
SKCM	cis	rs4150161	0.656	rs2230131	chr16:84212779	G/A	cg10106505	chr16:84220380	TAF1C	-1.29	-5.35	-0.52	8.52e-7	Systolic blood pressure response to hydrochlorothiazide in hypertension;
SKCM	cis	rs2153535	0.526	rs1796689	chr6:8536433	A/C	cg23788917	chr6:8435910	SLC35B3	0.64	4.79	0.48	7.7e-6	Motion sickness;
SKCM	cis	rs7666738	0.830	rs2167892	chr4:99048503	G/C	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9894429	1.000	rs7209180	chr17:79581519	C/A	cg18240062	chr17:79603768	NPLOC4	0.76	7.43	0.64	1.2e-10	Eye color traits;
SKCM	cis	rs344364	0.597	rs1065656	chr16:1838836	C/G	cg01729862	chr16:1824041	EME2;MRPS34	0.59	4.77	0.48	8.49e-6	Glomerular filtration rate in chronic kidney disease;
SKCM	cis	rs9399135	0.967	rs9389258	chr6:135361140	T/C	cg24558204	chr6:135376177	HBS1L	0.57	5.01	0.49	3.34e-6	Red blood cell count;
SKCM	cis	rs6952808	0.771	rs4719336	chr7:1916397	T/C	cg21782813	chr7:2030301	MAD1L1	0.5	5.13	0.5	2.05e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs1218582	0.772	rs6656435	chr1:154876869	G/A	cg06221963	chr1:154839813	KCNN3	-0.59	-5.97	-0.56	6.76e-8	Prostate cancer;
SKCM	cis	rs9916302	0.904	rs1966916	chr17:37425238	T/G	cg07936489	chr17:37558343	FBXL20	-0.84	-6.96	-0.62	9.48e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs2075371	0.830	rs2077671	chr7:133951204	C/T	cg20476274	chr7:133979776	SLC35B4	1.03	10.88	0.78	2.61e-17	Mean platelet volume;
SKCM	cis	rs1153858	1.000	rs1346266	chr15:45694516	G/T	cg21132104	chr15:45694354	SPATA5L1	0.89	6.95	0.62	9.91e-10	Homoarginine levels;
SKCM	cis	rs72634258	0.786	rs7514098	chr1:8177632	G/A	cg00042356	chr1:8021962	PARK7	0.77	5.09	0.5	2.4e-6	Inflammatory bowel disease;
SKCM	cis	rs11690935	0.632	rs2292816	chr2:172586714	G/C	cg13550731	chr2:172543902	DYNC1I2	0.63	5.5	0.53	4.74e-7	Schizophrenia;
SKCM	cis	rs1799949	1.000	rs1824889	chr17:41421876	C/G	cg05368731	chr17:41323189	NBR1	0.85	7.32	0.64	1.89e-10	Menopause (age at onset);
SKCM	cis	rs1577917	1.000	rs36096931	chr6:86693134	T/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.64	-5.54	-0.53	3.92e-7	Response to antipsychotic treatment;
SKCM	cis	rs35306767	0.953	rs11253517	chr10:970524	A/G	cg20503657	chr10:835505	NA	-0.64	-4.98	-0.49	3.78e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs9611565	0.659	rs9607812	chr22:41941243	G/A	cg03806693	chr22:41940476	POLR3H	-1.13	-7.48	-0.65	9.6e-11	Vitiligo;
SKCM	cis	rs6951245	1.000	rs77868187	chr7:1093968	A/C	cg24642844	chr7:1081250	C7orf50	-0.93	-6.22	-0.58	2.28e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs1403694	0.655	rs3806688	chr3:186434819	T/C	cg09332604	chr3:186435400	KNG1	-0.5	-5.07	-0.5	2.57e-6	Blood protein levels;
SKCM	cis	rs7937682	0.824	rs510866	chr11:111484113	A/C	cg09085632	chr11:111637200	PPP2R1B	-0.97	-10.08	-0.75	8.74e-16	Primary sclerosing cholangitis;
SKCM	cis	rs1371924	0.520	rs6440178	chr3:143267140	T/C	cg19399326	chr3:142720039	SR140	-0.6	-4.81	-0.48	7.16e-6	Tonometry;
SKCM	cis	rs2153535	0.584	rs9502721	chr6:8541379	G/A	cg23788917	chr6:8435910	SLC35B3	0.69	4.87	0.48	5.62e-6	Motion sickness;
SKCM	cis	rs8177179	1.000	rs8177179	chr3:133463457	G/A	cg16262614	chr3:133464971	TF	0.44	5.37	0.52	7.82e-7	Iron status biomarkers (transferrin levels);
SKCM	cis	rs2836974	0.602	rs2037925	chr21:40699931	C/T	cg17971929	chr21:40555470	PSMG1	-0.71	-6.2	-0.57	2.5e-8	Cognitive function;
SKCM	cis	rs8068544	0.818	rs7209012	chr17:40161323	C/T	cg18442075	chr17:40169520	DNAJC7;NKIRAS2	-1.38	-7.28	-0.64	2.26e-10	Reticulocyte fraction of red cells;Reticulocyte count;
SKCM	cis	rs12705054	1.000	rs17161617	chr7:98793418	G/A	cg11543304	chr7:98729543	SMURF1	1.06	4.77	0.48	8.44e-6	Facial emotion recognition (sad faces);
SKCM	cis	rs394563	0.591	rs237028	chr6:149718650	C/T	cg16235748	chr6:149772707	ZC3H12D	-0.43	-4.89	-0.48	5.21e-6	Dupuytren's disease;
SKCM	cis	rs1401999	0.668	rs6806313	chr3:183642152	G/C	cg01324343	chr3:183735012	ABCC5	0.69	6.53	0.59	6.04e-9	Anterior chamber depth;
SKCM	cis	rs1882538	0.538	rs7783217	chr7:133104117	C/G	cg10665199	chr7:133106180	EXOC4	-0.75	-5.2	-0.51	1.59e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs362272	0.525	rs910568	chr4:3307373	A/G	cg03043834	chr4:3319541	RGS12	0.64	5.42	0.52	6.45e-7	Serum sulfate level;
SKCM	trans	rs1814175	0.746	rs10839429	chr11:49906845	G/A	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs2980439	0.818	rs2948294	chr8:8094961	A/G	cg08975724	chr8:8085496	FLJ10661	0.83	6.82	0.61	1.76e-9	Neuroticism;
SKCM	cis	rs9309711	0.961	rs11675119	chr2:3476422	C/A	cg10845886	chr2:3471009	TTC15	-0.84	-6.61	-0.6	4.32e-9	Neurofibrillary tangles;
SKCM	cis	rs798554	0.797	rs798487	chr7:2802943	G/A	cg19346786	chr7:2764209	NA	-0.7	-7.55	-0.65	6.89e-11	Height;
SKCM	cis	rs4927850	0.794	rs4927849	chr3:195738482	A/G	cg12923728	chr3:195709715	SDHAP1	-0.96	-6.26	-0.58	1.93e-8	Pancreatic cancer;
SKCM	cis	rs9910055	0.659	rs7207464	chr17:42245033	C/T	cg09913183	chr17:42254507	C17orf65;ASB16	0.67	6.36	0.58	1.27e-8	Total body bone mineral density;
SKCM	cis	rs6061231	1.000	rs13043313	chr20:60958269	A/G	cg24112000	chr20:60950667	NA	-0.59	-5.75	-0.55	1.66e-7	Colorectal cancer;
SKCM	cis	rs2477686	0.526	rs12042427	chr1:2398107	C/T	cg12929805	chr1:2399054	NA	-0.55	-5.59	-0.53	3.27e-7	Non-obstructive azoospermia;
SKCM	cis	rs6088590	0.561	rs6059934	chr20:33178324	G/T	cg24642439	chr20:33292090	TP53INP2	0.76	5.84	0.55	1.13e-7	Coronary artery disease;
SKCM	trans	rs62103177	0.810	rs3902996	chr18:77630571	A/G	cg05926928	chr17:57297772	GDPD1	1.29	8.74	0.7	3.44e-13	Opioid sensitivity;
SKCM	cis	rs116095464	0.558	rs13357299	chr5:242211	T/C	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs17065868	0.881	rs17068853	chr13:45050742	G/A	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs11764590	0.694	rs10276536	chr7:2086960	C/T	cg02825527	chr7:2087843	MAD1L1	-0.62	-4.97	-0.49	3.84e-6	Neuroticism;
SKCM	cis	rs34779708	0.931	rs35317849	chr10:35285721	C/A	cg03585969	chr10:35415529	CREM	0.72	5.96	0.56	6.77e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	trans	rs17685	0.753	rs10251863	chr7:75790192	T/C	cg19862616	chr7:65841803	NCRNA00174	0.97	10.73	0.77	5.13e-17	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs6120849	0.615	rs11167248	chr20:33538721	G/T	cg24642439	chr20:33292090	TP53INP2	0.99	5.46	0.53	5.54e-7	Protein C levels;
SKCM	cis	rs8078723	1.000	rs2227336	chr17:38174855	T/G	cg17467752	chr17:38218738	THRA	0.69	6.29	0.58	1.67e-8	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs2153535	0.601	rs9505472	chr6:8538765	T/C	cg07606381	chr6:8435919	SLC35B3	0.93	6.41	0.59	1e-8	Motion sickness;
SKCM	cis	rs4819052	0.765	rs2838827	chr21:46656146	C/T	cg02159808	chr21:46707872	POFUT2;LOC642852	0.69	5.28	0.51	1.13e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7772486	0.686	rs857877	chr6:145976230	A/C	cg05347473	chr6:146136440	FBXO30	-0.61	-5.46	-0.53	5.55e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs35306767	0.903	rs11253488	chr10:922482	G/C	cg26597838	chr10:835615	NA	0.74	5.42	0.52	6.5e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs2842992	0.830	rs2842974	chr6:160159034	C/T	cg19482086	chr6:160211437	TCP1;MRPL18	0.82	6.43	0.59	9.54e-9	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs4819052	0.851	rs10470258	chr21:46658989	C/T	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.36	0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs3091242	0.933	rs10903130	chr1:25769221	A/T	cg02931644	chr1:25747376	RHCE	0.5	4.9	0.48	5.17e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs17376456	0.825	rs55724660	chr5:93276636	A/G	cg25358565	chr5:93447407	FAM172A	1.3	7.53	0.65	7.57e-11	Diabetic retinopathy;
SKCM	cis	rs16854884	0.741	rs55909524	chr3:143794734	T/C	cg06585982	chr3:143692056	C3orf58	0.72	5.63	0.54	2.78e-7	Economic and political preferences (feminism/equality);
SKCM	cis	rs10779751	0.922	rs2746638	chr1:11278125	T/C	cg08854313	chr1:11322531	MTOR	0.87	6.48	0.59	7.43e-9	Body mass index;
SKCM	cis	rs35306767	0.953	rs1106064	chr10:957211	G/A	cg20503657	chr10:835505	NA	0.65	4.94	0.49	4.37e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs2731664	0.756	rs4976695	chr5:176862963	T/A	cg23176889	chr5:176863531	GRK6	-0.52	-5.37	-0.52	7.79e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7772486	0.597	rs6570732	chr6:146245151	G/A	cg05347473	chr6:146136440	FBXO30	-0.65	-5.26	-0.51	1.22e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7208859	0.510	rs216402	chr17:28917126	A/T	cg14067834	chr17:29058358	SUZ12P	1.06	4.82	0.48	7.05e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs8180040	0.966	rs11710322	chr3:47331136	C/T	cg16586182	chr3:47516702	SCAP	0.7	4.94	0.49	4.38e-6	Colorectal cancer;
SKCM	cis	rs867186	1.000	rs111641740	chr20:33707177	C/T	cg04194272	chr20:33683537	NA	-1.11	-6.05	-0.57	4.7e-8	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs17826219	0.500	rs2449749	chr17:29078298	C/T	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Body mass index;
SKCM	cis	rs6456156	0.586	rs12528323	chr6:167461645	A/G	cg13927040	chr6:167453801	FGFR1OP	0.66	4.85	0.48	6.24e-6	Primary biliary cholangitis;
SKCM	cis	rs155076	0.711	rs4770131	chr13:21897468	A/G	cg14456004	chr13:21872349	NA	1.37	8.17	0.68	4.35e-12	White matter hyperintensity burden;
SKCM	cis	rs7090367	0.555	rs705161	chr10:125249060	G/A	cg16197717	chr10:125650957	CPXM2	-0.47	-4.82	-0.48	6.9e-6	Body mass index;
SKCM	cis	rs4740619	0.619	rs1359957	chr9:16044182	G/A	cg14451791	chr9:16040625	NA	-0.47	-4.98	-0.49	3.68e-6	Body mass index;
SKCM	cis	rs2730245	0.527	rs2657362	chr7:158685095	A/G	cg24397884	chr7:158709396	WDR60	0.98	5.56	0.53	3.7e-7	Height;
SKCM	cis	rs1160297	0.609	rs10164868	chr2:53095923	G/T	cg07782112	chr2:53107842	NA	0.59	6.3	0.58	1.63e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs951366	0.789	rs823094	chr1:205689807	G/T	cg26354017	chr1:205819088	PM20D1	-0.81	-6.71	-0.6	2.83e-9	Menarche (age at onset);
SKCM	cis	rs6951245	0.678	rs4724725	chr7:1214751	G/A	cg03188948	chr7:1209495	NA	1.11	6.93	0.62	1.06e-9	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs870825	0.616	rs6810600	chr4:185616814	T/C	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs2295499	0.649	rs55679022	chr4:2707325	T/G	cg19433769	chr4:2420260	ZFYVE28	0.69	4.77	0.48	8.44e-6	Cognitive ability;Cognitive ability (multi-trait analysis);Intelligence (multi-trait analysis);
SKCM	cis	rs11628318	0.951	rs10134794	chr14:103034195	C/A	cg01864069	chr14:103024347	NA	-0.7	-5.02	-0.49	3.25e-6	Platelet count;
SKCM	cis	rs2072499	0.898	rs2758609	chr1:156202868	G/A	cg25208724	chr1:156163844	SLC25A44	0.91	7.9	0.67	1.46e-11	Testicular germ cell tumor;
SKCM	cis	rs634534	0.561	rs14157	chr11:65769780	T/G	cg26695010	chr11:65641043	EFEMP2	-0.72	-5.48	-0.53	5.15e-7	Sum eosinophil basophil counts;Eosinophil counts;
SKCM	cis	rs208520	0.633	rs7738469	chr6:66807446	T/C	cg07460842	chr6:66804631	NA	-1.02	-7.51	-0.65	8.37e-11	Exhaled nitric oxide output;
SKCM	trans	rs3780486	0.505	rs10813958	chr9:33165985	A/G	cg20290983	chr6:43655470	MRPS18A	0.84	8.92	0.71	1.51e-13	IgG glycosylation;
SKCM	cis	rs1153858	1.000	rs2114501	chr15:45670316	G/A	cg21132104	chr15:45694354	SPATA5L1	0.93	7.94	0.67	1.22e-11	Homoarginine levels;
SKCM	cis	rs137761	0.576	rs5763978	chr22:44126306	C/T	cg12729397	chr22:44208276	EFCAB6	0.69	5.1	0.5	2.35e-6	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs13256369	1.000	rs13282915	chr8:8570891	T/G	cg06636001	chr8:8085503	FLJ10661	0.74	5.69	0.54	2.15e-7	Obesity-related traits;
SKCM	cis	rs17685	0.712	rs10275521	chr7:75770972	T/C	cg01364799	chr7:75623366	TMEM120A	-0.7	-5.69	-0.54	2.09e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs67311347	0.544	rs4974040	chr3:40331059	G/A	cg13409248	chr3:40428643	ENTPD3	0.57	5.58	0.53	3.37e-7	Renal cell carcinoma;
SKCM	cis	rs9325144	0.560	rs2387923	chr12:38662677	G/A	cg26384229	chr12:38710491	ALG10B	-0.61	-4.93	-0.49	4.57e-6	Morning vs. evening chronotype;
SKCM	cis	rs7953508	0.506	rs1316740	chr12:93968288	C/A	cg18151635	chr12:93972918	NA	-0.65	-5.83	-0.55	1.2e-7	Pubertal anthropometrics;
SKCM	cis	rs67311347	0.544	rs4974047	chr3:40339653	G/T	cg00656387	chr3:40428638	ENTPD3	0.56	4.98	0.49	3.71e-6	Renal cell carcinoma;
SKCM	cis	rs1218582	0.772	rs2335408	chr1:154915977	G/A	cg06221963	chr1:154839813	KCNN3	-0.53	-5.11	-0.5	2.22e-6	Prostate cancer;
SKCM	cis	rs763014	0.898	rs8060921	chr16:635988	C/A	cg09263875	chr16:632152	PIGQ	0.67	5.82	0.55	1.24e-7	Height;
SKCM	cis	rs1577917	1.000	rs1962716	chr6:86648436	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.81	-8.0	-0.67	9.4e-12	Response to antipsychotic treatment;
SKCM	cis	rs9926296	0.712	rs2434872	chr16:89716915	C/G	cg01097406	chr16:89675127	NA	0.56	5.66	0.54	2.41e-7	Vitiligo;
SKCM	cis	rs4665809	0.590	rs4665837	chr2:26434022	C/A	cg26119090	chr2:26468346	HADHA;HADHB	-1.05	-8.25	-0.68	3.13e-12	Gut microbiome composition (summer);
SKCM	cis	rs11122272	0.735	rs2749714	chr1:231538634	G/C	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	-0.64	-5.18	-0.51	1.66e-6	Hemoglobin concentration;
SKCM	cis	rs2404602	0.735	rs11072598	chr15:76764788	T/C	cg23625390	chr15:77176239	SCAPER	-0.83	-8.16	-0.68	4.7e-12	Blood metabolite levels;
SKCM	cis	rs2721195	1.000	rs6599530	chr8:145677418	C/G	cg15320075	chr8:145703422	NA	-0.86	-7.3	-0.64	2.1e-10	Age at first birth;
SKCM	cis	rs10803016	0.564	rs1898153	chr1:242292794	C/T	ch.1.4829111R	chr1:242658279	PLD5	-0.58	-4.95	-0.49	4.12e-6	Coronary artery calcification;
SKCM	cis	rs2153535	0.541	rs6908504	chr6:8456778	A/G	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs801193	0.569	rs2659908	chr7:66160822	G/A	cg18876405	chr7:65276391	NA	0.61	6.01	0.56	5.49e-8	Aortic root size;
SKCM	cis	rs2073499	1.000	rs1989839	chr3:50378946	A/G	cg08207895	chr3:50388901	TUSC4;CYB561D2	0.73	4.9	0.49	5e-6	Schizophrenia;
SKCM	cis	rs3845702	0.736	rs115569960	chr2:180848214	C/T	cg01881094	chr2:180872142	CWC22	1.3	6.15	0.57	3.07e-8	Schizophrenia;
SKCM	cis	rs6952808	1.000	rs10233560	chr7:1885415	T/C	cg04267008	chr7:1944627	MAD1L1	-0.8	-6.1	-0.57	3.78e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs6424115	0.546	rs35993651	chr1:24180613	C/G	cg15997130	chr1:24165203	NA	-0.57	-4.77	-0.48	8.43e-6	Immature fraction of reticulocytes;
SKCM	cis	rs72634258	0.945	rs441597	chr1:8080895	A/G	cg00042356	chr1:8021962	PARK7	0.91	6.19	0.57	2.58e-8	Inflammatory bowel disease;
SKCM	cis	rs2857078	0.772	rs2079008	chr17:42322132	C/A	cg08499158	chr17:42289980	UBTF	0.82	6.35	0.58	1.32e-8	Red cell distribution width;Reticulocyte count;
SKCM	cis	rs2839186	0.934	rs17182538	chr21:47705673	C/A	cg13126279	chr21:47581558	C21orf56	-0.62	-5.17	-0.5	1.79e-6	Testicular germ cell tumor;
SKCM	cis	rs9486715	0.867	rs9384585	chr6:96875664	C/T	cg06623918	chr6:96969491	KIAA0776	0.79	7.09	0.63	5.34e-10	Headache;
SKCM	cis	rs58688157	0.705	rs12795572	chr11:590999	G/A	cg17114584	chr11:613792	IRF7	0.78	5.1	0.5	2.36e-6	Systemic lupus erythematosus;
SKCM	cis	rs28530618	0.603	rs6119924	chr20:31250465	T/C	cg25730142	chr20:32031702	SNTA1	0.62	4.94	0.49	4.42e-6	Birth weight;
SKCM	cis	rs11098499	0.954	rs67265404	chr4:120359270	C/T	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs995000	0.931	rs659656	chr1:62912120	C/G	cg06896770	chr1:63153194	DOCK7	0.76	7.24	0.63	2.71e-10	Triglyceride levels;
SKCM	cis	rs10503709	0.895	rs11774383	chr8:21439705	A/G	cg23716449	chr8:21608280	GFRA2	-0.47	-4.78	-0.48	7.98e-6	Blood protein levels;
SKCM	cis	rs782590	0.967	rs1084522	chr2:55843294	A/G	cg18811423	chr2:55921094	PNPT1	0.9	6.98	0.62	8.78e-10	Metabolic syndrome;
SKCM	cis	rs7082209	0.583	rs72790834	chr10:44839136	G/A	cg17436666	chr10:44806146	NA	0.94	5.02	0.49	3.22e-6	Resistance to Mycobacterium tuberculosis in HIV-positive individuals measured by a negative tuberculin skin test (continuous);
SKCM	cis	rs9815354	0.857	rs9852020	chr3:41830206	G/A	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs854765	0.624	rs11657130	chr17:17733826	T/C	cg24612305	chr17:17875800	TOM1L2;LRRC48	-0.95	-7.11	-0.63	4.78e-10	Total body bone mineral density;
SKCM	cis	rs6754311	0.731	rs309134	chr2:136755684	A/G	cg07169764	chr2:136633963	MCM6	-0.7	-4.91	-0.49	4.95e-6	Mosquito bite size;
SKCM	cis	rs17376456	0.877	rs10055741	chr5:93297187	C/T	cg21475434	chr5:93447410	FAM172A	1.03	5.57	0.53	3.48e-7	Diabetic retinopathy;
SKCM	cis	rs3087591	0.960	rs9807077	chr17:29634457	A/G	cg24425628	chr17:29625626	OMG;NF1	-0.64	-4.97	-0.49	3.84e-6	Hip circumference;
SKCM	cis	rs8017423	1.000	rs1959001	chr14:90667739	G/A	cg04374321	chr14:90722782	PSMC1	0.94	8.42	0.69	1.42e-12	Mortality in heart failure;
SKCM	cis	rs365132	1.000	rs35977534	chr5:176335231	T/C	cg16309518	chr5:176445507	NA	-0.52	-5.12	-0.5	2.11e-6	Menarche and menopause (age at onset);Menopause (age at onset);
SKCM	trans	rs2727020	0.595	rs10466496	chr11:49501514	C/T	cg15704280	chr7:45808275	SEPT13	-0.98	-9.22	-0.72	3.98e-14	Coronary artery disease;
SKCM	cis	rs2479106	0.791	rs2058432	chr9:126703738	T/C	cg16191174	chr9:126692580	DENND1A	0.7	5.62	0.54	2.79e-7	Polycystic ovary syndrome;
SKCM	cis	rs2108225	0.872	rs7792139	chr7:107445433	G/A	cg18560240	chr7:107437656	SLC26A3	-0.66	-5.28	-0.51	1.12e-6	Ulcerative colitis;
SKCM	cis	rs1707322	1.000	rs7526369	chr1:46390560	G/C	cg03146154	chr1:46216737	IPP	0.74	5.06	0.5	2.76e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs738321	0.711	rs5995541	chr22:38553411	C/T	cg25457927	chr22:38595422	NA	-0.6	-7.01	-0.62	7.5e-10	Breast cancer;
SKCM	cis	rs155076	0.938	rs261375	chr13:21871882	A/G	cg11317459	chr13:21872234	NA	1.15	7.14	0.63	4.34e-10	White matter hyperintensity burden;
SKCM	cis	rs651907	0.557	rs11917682	chr3:101355427	G/A	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.79	6.55	0.6	5.65e-9	Colorectal cancer;
SKCM	cis	rs7940866	0.834	rs1594821	chr11:130835883	C/T	cg12179176	chr11:130786555	SNX19	0.74	5.81	0.55	1.3e-7	Schizophrenia;
SKCM	cis	rs28386778	0.933	rs2665804	chr17:61951836	G/T	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.32	0.52	9.5e-7	Prudent dietary pattern;
SKCM	cis	rs6665290	0.836	rs12593	chr1:227172290	A/G	cg10327440	chr1:227177885	CDC42BPA	1.22	16.53	0.88	3.31e-27	Myeloid white cell count;
SKCM	cis	rs1046896	0.553	rs56775875	chr17:80831291	G/T	cg02711726	chr17:80685570	FN3KRP	-0.79	-6.01	-0.56	5.55e-8	Glycated hemoglobin levels;
SKCM	cis	rs870825	0.616	rs6818447	chr4:185650154	G/A	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs748404	0.560	rs570933	chr15:43824030	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	0.68	5.14	0.5	1.98e-6	Lung cancer;
SKCM	cis	rs7590368	0.961	rs13431852	chr2:10960410	T/C	cg15705551	chr2:10952987	PDIA6	0.76	4.88	0.48	5.52e-6	Educational attainment (years of education);
SKCM	cis	rs1577917	0.655	rs9450311	chr6:86376586	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.78	6.96	0.62	9.21e-10	Response to antipsychotic treatment;
SKCM	cis	rs995000	0.931	rs10889344	chr1:63033941	T/C	cg06896770	chr1:63153194	DOCK7	-0.72	-6.46	-0.59	8.17e-9	Triglyceride levels;
SKCM	cis	rs854765	0.551	rs6502626	chr17:17849450	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.99	7.46	0.65	1.04e-10	Total body bone mineral density;
SKCM	cis	rs35306767	0.715	rs1871622	chr10:1049309	T/G	cg25614935	chr10:1084866	C10orf110	0.72	5.67	0.54	2.31e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs7937682	0.921	rs10891280	chr11:111433609	A/T	cg09085632	chr11:111637200	PPP2R1B	0.98	8.12	0.68	5.52e-12	Primary sclerosing cholangitis;
SKCM	cis	rs71335811	1	rs71335811	chr19:49130070	TC/T	cg06530960	chr19:49140787	SEC1;DBP	-0.78	-5.62	-0.54	2.89e-7	Myeloid white cell count;
SKCM	cis	rs6500395	1.000	rs2355297	chr16:48685338	T/C	cg04672837	chr16:48644449	N4BP1	-0.65	-5.43	-0.52	6.28e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs12142240	0.698	rs28578741	chr1:46825176	T/C	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs4727027	0.631	rs62507511	chr7:148796080	C/A	cg23583168	chr7:148888333	NA	-0.82	-6.49	-0.59	7.11e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs1707322	0.721	rs11211181	chr1:46236800	C/T	cg03146154	chr1:46216737	IPP	0.82	6.17	0.57	2.85e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs4237845	0.773	rs6650218	chr12:58289078	T/A	cg02175503	chr12:58329896	NA	0.79	7.22	0.63	3e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs1218582	0.844	rs6699080	chr1:154834911	G/A	cg09359103	chr1:154839909	KCNN3	-0.57	-5.66	-0.54	2.44e-7	Prostate cancer;
SKCM	cis	rs2034088	0.930	rs9907540	chr17:448042	A/G	cg06217071	chr17:408420	NA	0.49	5.34	0.52	8.97e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs9790314	1.000	rs460508	chr3:161091089	C/G	cg03342759	chr3:160939853	NMD3	0.66	6.54	0.6	5.84e-9	Morning vs. evening chronotype;
SKCM	cis	rs595982	0.527	rs73061656	chr19:49372355	G/A	cg15549821	chr19:49342101	PLEKHA4	-0.85	-5.02	-0.49	3.18e-6	Red cell distribution width;
SKCM	cis	rs798554	0.759	rs798495	chr7:2797267	T/C	cg14895029	chr7:2775587	GNA12	-0.7	-5.36	-0.52	8.13e-7	Height;
SKCM	cis	rs2739330	0.828	rs2877178	chr22:24251517	C/T	cg24846343	chr22:24311635	DDTL	0.64	6.08	0.57	4.13e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs7683537	0.673	rs1401363	chr4:185643862	A/G	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Systemic lupus erythematosus;
SKCM	cis	rs1552244	1.000	rs6781811	chr3:10121922	A/G	cg02579736	chr3:10068473	FANCD2;CIDECP	-1.31	-7.19	-0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs8017423	0.647	rs12590712	chr14:90822481	T/C	cg04374321	chr14:90722782	PSMC1	-0.73	-5.53	-0.53	4.08e-7	Mortality in heart failure;
SKCM	cis	rs846858	0.894	rs2695801	chr19:45113651	C/T	cg18042043	chr19:44147545	NA	0.59	4.84	0.48	6.49e-6	Late-onset Alzheimer's disease;
SKCM	cis	rs7296418	0.961	rs4148862	chr12:123568619	A/C	cg06742321	chr12:123595122	PITPNM2	0.65	5.45	0.52	5.77e-7	Platelet count;
SKCM	cis	rs35306767	0.903	rs12240651	chr10:943656	A/G	cg26597838	chr10:835615	NA	0.77	5.39	0.52	7.26e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs72781680	0.898	rs7569424	chr2:24036222	A/G	cg08917208	chr2:24149416	ATAD2B	0.96	5.18	0.51	1.71e-6	Lymphocyte counts;
SKCM	cis	rs28386778	0.769	rs6504179	chr17:61812995	T/G	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.02	9.33	0.73	2.46e-14	Prudent dietary pattern;
SKCM	cis	rs2070488	0.736	rs2070988	chr3:38437835	C/T	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.92	8.12	0.68	5.42e-12	Electrocardiographic conduction measures;
SKCM	cis	rs17376456	0.877	rs10055741	chr5:93297187	C/T	cg25358565	chr5:93447407	FAM172A	1.25	7.61	0.65	5.29e-11	Diabetic retinopathy;
SKCM	cis	rs10905065	0.965	rs10737019	chr10:5783733	G/A	cg11519256	chr10:5708881	ASB13	0.59	5.32	0.52	9.75e-7	Menopause (age at onset);
SKCM	cis	rs9910055	0.659	rs7212573	chr17:42254281	A/G	cg08499158	chr17:42289980	UBTF	-0.74	-6.4	-0.59	1.05e-8	Total body bone mineral density;
SKCM	cis	rs11098499	0.775	rs10029303	chr4:120286755	T/A	cg09307838	chr4:120376055	NA	0.98	7.89	0.67	1.52e-11	Corneal astigmatism;
SKCM	trans	rs1814175	0.817	rs28594987	chr11:50045181	C/T	cg15704280	chr7:45808275	SEPT13	-1.05	-11.07	-0.78	1.14e-17	Height;
SKCM	cis	rs4780401	0.587	rs9931332	chr16:11807517	G/C	cg01061890	chr16:11836724	TXNDC11	-0.8	-6.08	-0.57	4.16e-8	Rheumatoid arthritis;
SKCM	cis	rs62064224	0.791	rs72811096	chr17:30647302	A/T	cg25809561	chr17:30822961	MYO1D	0.65	4.99	0.49	3.53e-6	Schizophrenia;
SKCM	cis	rs951366	0.668	rs823154	chr1:205762406	C/T	cg24503407	chr1:205819492	PM20D1	0.92	9.1	0.72	7.05e-14	Menarche (age at onset);
SKCM	cis	rs1577917	0.655	rs1059307	chr6:86387888	G/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.71	5.66	0.54	2.41e-7	Response to antipsychotic treatment;
SKCM	cis	rs34779708	0.931	rs11593858	chr10:35381373	G/A	cg03585969	chr10:35415529	CREM	0.78	6.31	0.58	1.58e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs28386778	0.897	rs2597634	chr17:61878144	G/A	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs6120849	0.802	rs6087682	chr20:33752897	A/T	cg24642439	chr20:33292090	TP53INP2	0.95	5.17	0.51	1.74e-6	Protein C levels;
SKCM	cis	rs6547741	0.935	rs6547738	chr2:27852637	A/G	cg27432699	chr2:27873401	GPN1	0.76	6.84	0.61	1.57e-9	Oral cavity cancer;
SKCM	cis	rs4808199	0.947	rs7250658	chr19:19571100	A/G	cg03709012	chr19:19516395	GATAD2A	1.12	8.53	0.69	8.93e-13	Nonalcoholic fatty liver disease;
SKCM	cis	rs6456156	0.586	rs12528689	chr6:167461746	A/G	cg13927040	chr6:167453801	FGFR1OP	0.66	4.85	0.48	6.24e-6	Primary biliary cholangitis;
SKCM	cis	rs2013441	0.931	rs4925089	chr17:20064784	A/T	cg13482628	chr17:19912719	NA	0.67	5.24	0.51	1.32e-6	Obesity-related traits;
SKCM	cis	rs673604	1.000	rs7520747	chr1:35678139	G/T	cg12633102	chr1:35676489	NA	-0.68	-5.35	-0.52	8.54e-7	Endometrial cancer;
SKCM	cis	rs4911259	0.552	rs13042651	chr20:31467423	C/T	cg13636640	chr20:31349939	DNMT3B	-0.74	-6.15	-0.57	3.04e-8	Inflammatory bowel disease;
SKCM	cis	rs6500395	0.962	rs9924483	chr16:48646258	C/T	cg04672837	chr16:48644449	N4BP1	0.69	5.68	0.54	2.26e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs2197308	0.765	rs68029712	chr12:37906585	T/G	cg13010199	chr12:38710504	ALG10B	0.65	4.93	0.49	4.48e-6	Morning vs. evening chronotype;
SKCM	cis	rs10504229	1.000	rs73609760	chr8:58192170	A/G	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs6062496	0.631	rs6062482	chr20:62296214	G/C	cg27236539	chr20:62289627	RTEL1	0.72	4.95	0.49	4.16e-6	Crohn's disease;Inflammatory bowel disease;Ulcerative colitis;
SKCM	cis	rs11098499	0.866	rs6847778	chr4:120293582	A/G	cg24375607	chr4:120327624	NA	0.67	5.13	0.5	2.07e-6	Corneal astigmatism;
SKCM	cis	rs17345786	0.861	rs11711808	chr3:101235101	T/C	cg11279151	chr3:101281821	RG9MTD1	-0.69	-5.23	-0.51	1.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs28595532	0.920	rs56303276	chr4:119723514	C/T	cg14228332	chr4:119757509	SEC24D	1.07	5.49	0.53	4.77e-7	Cannabis dependence symptom count;
SKCM	cis	rs738322	0.554	rs6001033	chr22:38557513	T/A	cg25457927	chr22:38595422	NA	-0.53	-6.14	-0.57	3.24e-8	Cutaneous nevi;
SKCM	cis	rs2739330	0.685	rs4822453	chr22:24254862	G/T	cg12419862	chr22:24373484	LOC391322	-0.73	-6.73	-0.61	2.52e-9	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs2404602	0.716	rs4886817	chr15:76877702	C/T	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs4740619	0.617	rs7873925	chr9:16027483	C/T	cg14451791	chr9:16040625	NA	-0.47	-4.99	-0.49	3.56e-6	Body mass index;
SKCM	cis	rs72634258	0.732	rs6577464	chr1:8171302	T/C	cg00042356	chr1:8021962	PARK7	-0.84	-5.53	-0.53	4.17e-7	Inflammatory bowel disease;
SKCM	cis	rs1218582	0.741	rs2335407	chr1:154843347	A/G	cg09359103	chr1:154839909	KCNN3	0.59	5.93	0.56	7.77e-8	Prostate cancer;
SKCM	cis	rs8078723	1.000	rs8078723	chr17:38166879	A/G	cg17467752	chr17:38218738	THRA	0.68	6.3	0.58	1.6e-8	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs4820539	0.966	rs2267005	chr22:23461723	A/G	cg14186256	chr22:23484241	RTDR1	0.86	8.57	0.7	7.44e-13	Bone mineral density;
SKCM	cis	rs10504229	0.683	rs16921843	chr8:58113338	T/C	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs910316	0.935	rs3742771	chr14:75599647	A/G	cg08847533	chr14:75593920	NEK9	0.95	9.18	0.72	4.88e-14	Height;
SKCM	cis	rs2180341	0.597	rs3798859	chr6:127663116	C/T	cg24812749	chr6:127587940	RNF146	0.64	5.34	0.52	8.87e-7	Breast cancer;
SKCM	cis	rs4905558	1.000	rs58514314	chr14:97338825	A/C	cg11863609	chr14:97355128	NA	0.55	4.99	0.49	3.58e-6	Neutrophil count;
SKCM	cis	rs17376456	0.877	rs7736620	chr5:93305762	C/T	cg25358565	chr5:93447407	FAM172A	1.23	7.26	0.63	2.53e-10	Diabetic retinopathy;
SKCM	cis	rs4237845	0.611	rs7978588	chr12:58304783	G/C	cg02175503	chr12:58329896	NA	0.96	9.51	0.73	1.09e-14	Intelligence (multi-trait analysis);
SKCM	cis	rs1570989	0.543	rs6458035	chr6:12015296	A/G	cg17804551	chr6:12015979	HIVEP1	0.56	5.75	0.55	1.67e-7	Alcohol and nicotine co-dependence;
SKCM	cis	rs7216064	1.000	rs7223813	chr17:65945840	A/G	cg12091567	chr17:66097778	LOC651250	-0.78	-5.3	-0.51	1.06e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs7917772	0.502	rs2296584	chr10:104244323	T/A	cg11453585	chr10:104263688	ACTR1A;SUFU	0.73	5.41	0.52	6.74e-7	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs9303401	0.659	rs17222691	chr17:56771096	C/T	cg10487724	chr17:56770010	TEX14;RAD51C	0.85	6.03	0.56	5.18e-8	Cognitive test performance;
SKCM	cis	rs28595532	0.920	rs55869953	chr4:119751893	T/C	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs7959452	0.649	rs4761239	chr12:69776886	T/A	cg20891283	chr12:69753455	YEATS4	0.9	9.18	0.72	4.74e-14	Blood protein levels;
SKCM	cis	rs3020736	0.500	rs6002604	chr22:42493081	A/T	cg04733989	chr22:42467013	NAGA	-0.72	-5.62	-0.54	2.87e-7	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs11098499	0.954	rs2389802	chr4:120325732	C/A	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs17376456	0.877	rs10476601	chr5:93402522	G/A	cg25358565	chr5:93447407	FAM172A	1.22	7.9	0.67	1.49e-11	Diabetic retinopathy;
SKCM	cis	rs6546550	0.901	rs6750488	chr2:70146125	C/T	cg02498382	chr2:70120550	SNRNP27	-0.45	-4.88	-0.48	5.4e-6	Prevalent atrial fibrillation;
SKCM	cis	rs1413885	0.502	rs7545397	chr1:65856282	C/A	cg14976592	chr1:65886160	LEPROT;LEPR	0.59	4.79	0.48	7.85e-6	Anticoagulant levels;
SKCM	cis	rs3789045	0.774	rs11801299	chr1:204529084	G/A	cg17419461	chr1:204415978	PIK3C2B	-0.86	-6.04	-0.56	5.01e-8	Educational attainment (college completion);
SKCM	cis	rs6665290	0.904	rs10916075	chr1:227184074	G/A	cg10327440	chr1:227177885	CDC42BPA	-1.25	-17.46	-0.89	1.15e-28	Myeloid white cell count;
SKCM	cis	rs10905065	0.965	rs2797488	chr10:5784509	C/T	cg09234995	chr10:5726438	C10orf18	-0.69	-5.77	-0.55	1.53e-7	Menopause (age at onset);
SKCM	cis	rs1577917	0.958	rs28442244	chr6:86701236	G/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.81	7.31	0.64	2.02e-10	Response to antipsychotic treatment;
SKCM	cis	rs1799949	1.000	rs72829113	chr17:41181835	C/T	cg25072359	chr17:41440525	NA	0.63	4.88	0.48	5.43e-6	Menopause (age at onset);
SKCM	cis	rs17376456	1.000	rs17376456	chr5:93557702	C/T	cg21475434	chr5:93447410	FAM172A	-0.98	-5.61	-0.54	3e-7	Diabetic retinopathy;
SKCM	cis	rs2050392	0.894	rs2480277	chr10:30703513	G/T	cg25182066	chr10:30743637	MAP3K8	0.64	5.55	0.53	3.79e-7	Inflammatory bowel disease;
SKCM	cis	rs6840360	0.555	rs4554052	chr4:152726610	T/C	cg22705602	chr4:152727874	NA	0.59	7.76	0.66	2.74e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs523522	1.000	rs1563333	chr12:120934407	C/T	cg12219531	chr12:120966889	COQ5	0.91	7.82	0.66	2.11e-11	High light scatter reticulocyte count;
SKCM	cis	rs2153535	0.580	rs4451187	chr6:8473910	C/T	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs7826238	0.566	rs2945886	chr8:8148270	C/G	cg15556689	chr8:8085844	FLJ10661	0.68	5.6	0.54	3.02e-7	Systolic blood pressure;
SKCM	cis	rs8060686	0.565	rs36046686	chr16:68122269	T/C	cg04539111	chr16:67997858	SLC12A4	-0.85	-4.81	-0.48	7.14e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs67311347	1.000	rs7612015	chr3:40399974	A/C	cg00091569	chr3:40428383	ENTPD3	0.61	5.36	0.52	8.37e-7	Renal cell carcinoma;
SKCM	cis	rs10504229	0.817	rs55891651	chr8:58167600	C/T	cg22535103	chr8:58192502	C8orf71	-0.68	-4.82	-0.48	7.06e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs8103278	0.507	rs16939	chr19:46276056	C/A	cg12641515	chr19:46296257	DMWD	0.78	6.25	0.58	2.05e-8	Coronary artery disease;
SKCM	cis	rs10254284	0.917	rs1109484	chr7:28144801	A/C	cg15170557	chr7:28214983	JAZF1	0.57	5.1	0.5	2.32e-6	Lymphocyte percentage of white cells;Systemic lupus erythematosus;
SKCM	cis	rs59574136	1	rs59574136	chr7:2036460	T/C	cg02951883	chr7:2050386	MAD1L1	-0.88	-8.14	-0.68	5.12e-12	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs453301	0.571	rs2929452	chr8:9084465	G/A	cg06636001	chr8:8085503	FLJ10661	-0.74	-5.72	-0.54	1.9e-7	Joint mobility (Beighton score);
SKCM	cis	rs1005277	0.579	rs176880	chr10:38401417	C/G	cg25427524	chr10:38739819	LOC399744	0.69	6.76	0.61	2.25e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs514406	0.607	rs6696940	chr1:53203427	C/T	cg16325326	chr1:53192061	ZYG11B	-1.0	-12.19	-0.81	9.61e-20	Monocyte count;
SKCM	cis	rs1165205	0.500	rs629835	chr6:25879330	T/C	cg03517284	chr6:25882590	NA	-0.69	-6.73	-0.61	2.61e-9	Urate levels;
SKCM	cis	rs1218582	0.772	rs4240874	chr1:154885779	C/T	cg06221963	chr1:154839813	KCNN3	-0.59	-5.97	-0.56	6.76e-8	Prostate cancer;
SKCM	cis	rs875971	1.000	rs1182882	chr7:65562063	C/T	cg18876405	chr7:65276391	NA	-0.71	-7.04	-0.62	6.64e-10	Aortic root size;
SKCM	cis	rs2839186	1.000	rs2839186	chr21:47690068	C/T	cg11766577	chr21:47581405	C21orf56	-0.7	-6.02	-0.56	5.28e-8	Testicular germ cell tumor;
SKCM	cis	rs9910055	0.550	rs113844752	chr17:42297631	C/A	cg10896456	chr17:42255109	ASB16;C17orf65	0.54	4.77	0.48	8.29e-6	Total body bone mineral density;
SKCM	cis	rs2645694	0.626	rs2703118	chr4:77823672	A/G	cg03477792	chr4:77819574	ANKRD56	0.57	6.37	0.58	1.22e-8	Emphysema distribution in smoking;
SKCM	cis	rs3087591	0.960	rs12942479	chr17:29461912	T/A	cg24425628	chr17:29625626	OMG;NF1	0.65	5.15	0.5	1.94e-6	Hip circumference;
SKCM	cis	rs10754283	0.967	rs7523518	chr1:90110010	G/A	cg21401794	chr1:90099060	LRRC8C	0.73	6.34	0.58	1.35e-8	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs1707322	1.000	rs1707303	chr1:46598273	A/C	cg03146154	chr1:46216737	IPP	-0.81	-5.43	-0.52	6.11e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7829975	0.514	rs2976929	chr8:8258712	T/C	cg08975724	chr8:8085496	FLJ10661	0.61	5.0	0.49	3.47e-6	Mood instability;
SKCM	cis	rs7666738	0.830	rs28867388	chr4:98962794	A/T	cg17366294	chr4:99064904	C4orf37	0.59	4.89	0.48	5.36e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6121246	0.909	rs2376992	chr20:30263418	T/C	cg11595048	chr20:30225325	COX4I2	0.67	5.21	0.51	1.5e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs514406	0.584	rs7548832	chr1:53193576	A/T	cg16325326	chr1:53192061	ZYG11B	1.01	12.74	0.82	9.51e-21	Monocyte count;
SKCM	cis	rs28386778	0.897	rs10221279	chr17:61806138	A/G	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.36	0.52	8.08e-7	Prudent dietary pattern;
SKCM	cis	rs3857536	0.740	rs6455080	chr6:66887413	T/A	cg07460842	chr6:66804631	NA	-0.7	-5.07	-0.5	2.64e-6	Blood trace element (Cu levels);
SKCM	cis	rs10089	1.000	rs11957052	chr5:127524055	T/C	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.87	7.69	0.66	3.82e-11	Ileal carcinoids;
SKCM	cis	rs7659604	0.521	rs13114801	chr4:122670855	C/A	cg19671926	chr4:122722719	EXOSC9	0.76	6.16	0.57	3.02e-8	Type 2 diabetes;
SKCM	cis	rs7666738	0.830	rs10022331	chr4:98960392	C/A	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9475752	1.000	rs1599280	chr6:56792576	A/G	cg06815302	chr6:57335405	PRIM2	0.65	5.25	0.51	1.26e-6	Menarche (age at onset);
SKCM	cis	rs7927771	0.524	rs10838782	chr11:47877800	A/G	cg20307385	chr11:47447363	PSMC3	0.72	5.81	0.55	1.31e-7	Subjective well-being;
SKCM	cis	rs4819052	0.851	rs28622522	chr21:46676599	G/T	cg19498844	chr21:46707878	POFUT2;LOC642852	0.88	7.69	0.66	3.74e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs8072100	1.000	rs11650372	chr17:45721795	G/A	cg25173405	chr17:45401733	C17orf57	-0.59	-5.49	-0.53	4.83e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs2836950	0.561	rs34705151	chr21:40553344	G/A	cg11644478	chr21:40555479	PSMG1	-0.67	-5.3	-0.51	1.04e-6	Menarche (age at onset);
SKCM	cis	rs9467773	0.935	rs1056668	chr6:26510605	C/T	cg09904177	chr6:26538194	HMGN4	0.54	4.96	0.49	4.11e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs362272	0.545	rs3129308	chr4:3309272	C/T	cg21096898	chr4:3318625	RGS12	0.95	11.91	0.8	3.07e-19	Serum sulfate level;
SKCM	cis	rs801193	1.000	rs2659906	chr7:66165310	T/C	cg18876405	chr7:65276391	NA	0.8	7.11	0.63	4.86e-10	Aortic root size;
SKCM	cis	rs17376456	0.597	rs10064158	chr5:93095186	C/T	cg25358565	chr5:93447407	FAM172A	0.86	5.45	0.53	5.59e-7	Diabetic retinopathy;
SKCM	cis	rs709400	1.000	rs3783404	chr14:104118498	A/G	cg26031613	chr14:104095156	KLC1	1.05	12.89	0.82	5.14e-21	Body mass index;
SKCM	cis	rs7811142	0.830	rs11768967	chr7:99967644	G/A	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.05	5.92	0.56	8.02e-8	Platelet count;
SKCM	cis	rs6089584	0.606	rs2296082	chr20:60573983	A/G	cg16423285	chr20:60520624	NA	-0.58	-4.78	-0.48	8.12e-6	Body mass index;
SKCM	cis	rs137761	0.576	rs8136283	chr22:44101141	T/C	cg12729397	chr22:44208276	EFCAB6	0.7	4.94	0.49	4.27e-6	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs2228479	0.850	rs62056063	chr16:89903680	C/T	cg00800038	chr16:89945340	TCF25	-0.96	-4.88	-0.48	5.51e-6	Skin colour saturation;
SKCM	cis	rs561341	1.000	rs4795669	chr17:30244701	C/T	cg23018236	chr17:30244563	NA	-0.48	-4.99	-0.49	3.64e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs654950	0.841	rs2810549	chr1:41991761	C/T	cg06885757	chr1:42089581	HIVEP3	-0.64	-7.17	-0.63	3.67e-10	Airway imaging phenotypes;
SKCM	cis	rs3820068	0.603	rs1980607	chr1:15975237	A/G	cg13390004	chr1:15929781	NA	0.64	5.19	0.51	1.61e-6	Systolic blood pressure;
SKCM	cis	rs4853012	0.838	rs12619982	chr2:74356022	G/A	cg01017244	chr2:74357527	NA	0.71	4.79	0.48	7.66e-6	Gestational age at birth (maternal effect);
SKCM	cis	rs9790314	0.540	rs35462273	chr3:160991877	C/T	cg03342759	chr3:160939853	NMD3	-0.81	-7.1	-0.63	5.14e-10	Morning vs. evening chronotype;
SKCM	cis	rs763014	0.966	rs4984677	chr16:671682	A/G	cg09263875	chr16:632152	PIGQ	0.71	6.26	0.58	1.98e-8	Height;
SKCM	cis	rs9987353	0.519	rs2929465	chr8:9064002	C/G	cg06868095	chr8:8084610	FLJ10661	0.44	4.78	0.48	8.14e-6	Recombination measurement;
SKCM	cis	rs2370759	1.000	rs75984055	chr10:32591276	T/C	cg01819863	chr10:32635814	EPC1	0.99	5.62	0.54	2.88e-7	Sexual dysfunction (female);
SKCM	cis	rs10803016	0.638	rs2252441	chr1:242292340	A/G	ch.1.4829111R	chr1:242658279	PLD5	-0.57	-4.8	-0.48	7.37e-6	Coronary artery calcification;
SKCM	cis	rs12477438	0.520	rs13010904	chr2:99754289	G/A	cg26064155	chr2:99771622	LIPT1;TSGA10	1.05	10.1	0.75	7.95e-16	Chronic sinus infection;
SKCM	cis	rs11098499	0.909	rs35165976	chr4:120325630	G/A	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs7772486	0.655	rs2142981	chr6:146071695	G/C	cg23711669	chr6:146136114	FBXO30	-0.89	-10.12	-0.75	7.58e-16	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6570726	0.791	rs12205752	chr6:145896118	A/G	cg23711669	chr6:146136114	FBXO30	0.87	8.94	0.71	1.44e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7143963	1.000	rs12588749	chr14:103330873	C/T	cg23020514	chr14:103360112	TRAF3	0.91	8.51	0.69	9.68e-13	Body mass index;
SKCM	cis	rs6088590	0.561	rs6087600	chr20:33157217	T/C	cg24642439	chr20:33292090	TP53INP2	0.76	5.84	0.55	1.13e-7	Coronary artery disease;
SKCM	cis	rs3862030	0.503	rs6584505	chr10:104254412	C/A	cg11453585	chr10:104263688	ACTR1A;SUFU	0.75	5.75	0.55	1.66e-7	Waist circumference adjusted for BMI (adjusted for smoking behaviour);Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction);Waist circumference adjusted for body mass index;
SKCM	cis	rs3768617	0.510	rs7414273	chr1:183075017	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs7208859	0.524	rs8069400	chr17:29075967	G/T	cg13385521	chr17:29058706	SUZ12P	1.08	5.11	0.5	2.22e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs116095464	0.558	rs9312956	chr5:201812	T/C	cg22857025	chr5:266934	NA	-1.44	-7.74	-0.66	2.94e-11	Breast cancer;
SKCM	cis	rs79040073	0.530	rs2078024	chr15:49621610	A/G	cg25951582	chr15:49913451	C15orf33;DTWD1	-0.72	-5.22	-0.51	1.44e-6	Lung cancer in ever smokers;
SKCM	cis	rs4523957	0.522	rs8081921	chr17:2021490	C/A	cg16513277	chr17:2031491	SMG6	-0.81	-5.98	-0.56	6.24e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs1799949	0.930	rs33968979	chr17:41297992	G/T	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.11	-0.57	3.67e-8	Menopause (age at onset);
SKCM	cis	rs10883723	0.810	rs7072351	chr10:104265047	C/T	cg11453585	chr10:104263688	ACTR1A;SUFU	0.75	5.75	0.55	1.66e-7	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs55962025	0.842	rs2269477	chr4:3184464	G/T	cg21096898	chr4:3318625	RGS12	-0.6	-4.85	-0.48	6.25e-6	Parental longevity (mother's age at death);
SKCM	cis	rs9549367	0.789	rs2287253	chr13:113891075	G/A	cg18105134	chr13:113819100	PROZ	0.67	4.83	0.48	6.6e-6	Platelet distribution width;
SKCM	cis	rs2243480	1.000	rs316322	chr7:65611233	G/C	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs35264875	0.851	rs72930631	chr11:68867835	T/C	cg02660097	chr11:68866761	NA	0.54	5.14	0.5	1.96e-6	Blond vs. brown hair color;
SKCM	cis	rs798766	1.000	rs798766	chr4:1734239	C/T	cg24239225	chr4:1659016	FAM53A	0.72	4.95	0.49	4.18e-6	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs9910055	0.529	rs190144	chr17:42164584	A/G	cg08499158	chr17:42289980	UBTF	0.71	5.52	0.53	4.35e-7	Total body bone mineral density;
SKCM	cis	rs2072499	0.931	rs1052053	chr1:156202173	A/G	cg24450063	chr1:156163899	SLC25A44	0.85	7.33	0.64	1.86e-10	Testicular germ cell tumor;
SKCM	cis	rs507080	0.922	rs471227	chr11:118564601	T/C	cg18045108	chr11:118530628	TREH	-0.47	-4.81	-0.48	7.17e-6	Serum metabolite levels;
SKCM	cis	rs4900538	0.963	rs8017980	chr14:102961341	C/G	cg18135206	chr14:102964638	TECPR2	0.79	6.53	0.59	6.09e-9	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs8180040	0.966	rs7628631	chr3:47560863	C/T	cg27129171	chr3:47204927	SETD2	-0.8	-5.68	-0.54	2.22e-7	Colorectal cancer;
SKCM	cis	rs17685	0.587	rs1623759	chr7:75724679	A/T	cg16684958	chr7:75615977	POR	0.56	5.13	0.5	2.03e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2836950	0.565	rs2836931	chr21:40546569	T/G	cg11644478	chr21:40555479	PSMG1	-0.67	-5.3	-0.51	1.04e-6	Menarche (age at onset);
SKCM	cis	rs2243480	0.901	rs2949697	chr7:65464236	A/G	cg18252515	chr7:66147081	NA	-1.34	-8.12	-0.68	5.55e-12	Diabetic kidney disease;
SKCM	cis	rs6430585	0.528	rs12464050	chr2:136663110	G/T	cg07169764	chr2:136633963	MCM6	1.32	11.41	0.79	2.72e-18	Corneal structure;
SKCM	cis	rs9549367	0.577	rs3024713	chr13:113813321	G/A	cg18105134	chr13:113819100	PROZ	-0.81	-5.92	-0.56	8.19e-8	Platelet distribution width;
SKCM	cis	rs4466137	0.553	rs16898	chr5:82986149	T/C	cg16102102	chr5:83017553	HAPLN1	-0.46	-5.55	-0.53	3.86e-7	Prostate cancer;
SKCM	cis	rs2479106	0.553	rs3739827	chr9:126690157	A/G	cg16191174	chr9:126692580	DENND1A	-0.75	-6.07	-0.57	4.34e-8	Polycystic ovary syndrome;
SKCM	cis	rs9300255	0.602	rs1716177	chr12:123655457	C/T	cg00376283	chr12:123451042	ABCB9	0.83	5.48	0.53	5.03e-7	Neutrophil percentage of white cells;
SKCM	cis	rs6430585	0.528	rs7573555	chr2:136694905	C/T	cg07169764	chr2:136633963	MCM6	-1.36	-12.98	-0.83	3.49e-21	Corneal structure;
SKCM	cis	rs13118159	0.509	rs7681872	chr4:1376735	G/A	cg05025164	chr4:1340916	KIAA1530	0.88	7.21	0.63	3.13e-10	Longevity;
SKCM	cis	rs11585357	0.843	rs12095095	chr1:17625832	C/G	cg08277548	chr1:17600880	PADI3	-0.89	-6.31	-0.58	1.53e-8	Hair shape;
SKCM	cis	rs2243480	1.000	rs313831	chr7:65551226	C/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs801193	1.000	rs2707854	chr7:66212597	G/A	cg18876405	chr7:65276391	NA	0.8	7.11	0.63	4.88e-10	Aortic root size;
SKCM	cis	rs7618915	0.501	rs55678971	chr3:52717229	T/A	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs854765	0.583	rs7503334	chr17:17779458	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	-0.99	-8.26	-0.68	2.96e-12	Total body bone mineral density;
SKCM	cis	rs2839186	0.749	rs62226488	chr21:47710517	C/T	cg13012494	chr21:47604986	C21orf56	0.67	5.71	0.54	1.95e-7	Testicular germ cell tumor;
SKCM	cis	rs7829975	0.777	rs6989926	chr8:8547313	A/C	cg15556689	chr8:8085844	FLJ10661	-0.65	-5.37	-0.52	7.75e-7	Mood instability;
SKCM	cis	rs9640161	0.750	rs11538922	chr7:150035183	C/T	cg27494647	chr7:150038898	RARRES2	0.61	5.33	0.52	9.39e-7	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs7447593	0.626	rs3812036	chr5:176813404	C/T	cg06060754	chr5:176797920	RGS14	0.71	6.91	0.62	1.18e-9	Urinary electrolytes (magnesium/calcium ratio);
SKCM	cis	rs10752881	1.000	rs6673559	chr1:182983197	G/C	ch.1.3577855R	chr1:183094577	LAMC1	0.73	6.47	0.59	7.97e-9	Colorectal cancer;
SKCM	cis	rs7927771	0.507	rs12366244	chr11:47882130	C/A	cg20307385	chr11:47447363	PSMC3	0.71	5.65	0.54	2.55e-7	Subjective well-being;
SKCM	trans	rs17685	0.753	rs6951943	chr7:75772452	A/G	cg19862616	chr7:65841803	NCRNA00174	0.94	9.63	0.74	6.45e-15	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs6815814	0.950	rs5743593	chr4:38802913	A/G	cg02016764	chr4:38805732	TLR1	-0.77	-5.49	-0.53	4.78e-7	Breast cancer;
SKCM	cis	rs10504229	0.683	rs35889486	chr8:58117749	T/A	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs1348850	0.526	rs4893829	chr2:178399810	A/G	cg27490568	chr2:178487706	NA	-0.89	-7.02	-0.62	7.08e-10	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs860295	0.812	rs12131079	chr1:155319668	C/T	cg02153340	chr1:155202674	NA	0.73	5.73	0.54	1.81e-7	Body mass index;
SKCM	cis	rs35306767	0.953	rs11253521	chr10:976416	G/C	cg26597838	chr10:835615	NA	0.62	4.96	0.49	3.97e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs4523957	0.713	rs9906500	chr17:2129210	C/A	cg16513277	chr17:2031491	SMG6	-0.73	-5.1	-0.5	2.33e-6	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs7945705	0.967	rs10769970	chr11:8917937	A/G	cg21881798	chr11:8931708	C11orf17;ST5	0.8	7.95	0.67	1.18e-11	Hemoglobin concentration;
SKCM	cis	rs4900538	0.963	rs1998422	chr14:102980993	G/C	cg18135206	chr14:102964638	TECPR2	0.75	6.15	0.57	3.1e-8	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs2228479	0.850	rs11648689	chr16:89806732	G/A	cg06558623	chr16:89946397	TCF25	1.03	5.59	0.53	3.23e-7	Skin colour saturation;
SKCM	cis	rs2836950	0.565	rs2836930	chr21:40545656	A/G	cg17971929	chr21:40555470	PSMG1	-0.76	-6.53	-0.59	6.19e-9	Menarche (age at onset);
SKCM	cis	rs950776	0.518	rs8025429	chr15:78836362	G/A	cg06917634	chr15:78832804	PSMA4	-1.01	-10.48	-0.76	1.5e-16	Sudden cardiac arrest;
SKCM	cis	rs926938	0.520	rs6663115	chr1:115272254	G/A	cg12756093	chr1:115239321	AMPD1	-0.72	-5.41	-0.52	6.68e-7	Autism;
SKCM	cis	rs7824557	0.628	rs7820301	chr8:11228672	G/A	cg21775007	chr8:11205619	TDH	0.65	5.97	0.56	6.72e-8	Retinal vascular caliber;
SKCM	cis	rs7772486	0.875	rs2748485	chr6:146332421	T/C	cg23711669	chr6:146136114	FBXO30	0.76	7.15	0.63	4.1e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs10927875	0.501	rs9660676	chr1:16279041	C/T	cg21385522	chr1:16154831	NA	-1.01	-8.32	-0.69	2.23e-12	Dilated cardiomyopathy;
SKCM	cis	rs651907	0.557	rs3094296	chr3:101400167	A/G	cg12386194	chr3:101231763	SENP7	0.6	4.96	0.49	4.02e-6	Colorectal cancer;
SKCM	cis	rs10504073	0.669	rs341809	chr8:50042557	C/T	cg00325661	chr8:49890786	NA	0.8	6.9	0.62	1.22e-9	Blood metabolite ratios;
SKCM	cis	rs7772486	0.738	rs2246334	chr6:146183635	G/A	cg05347473	chr6:146136440	FBXO30	0.58	5.56	0.53	3.57e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1707322	0.721	rs7519900	chr1:46234947	C/T	cg03146154	chr1:46216737	IPP	0.84	6.26	0.58	1.97e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs1559088	0.600	rs7256470	chr19:33558085	C/A	cg17764715	chr19:33622953	WDR88	0.92	6.76	0.61	2.24e-9	Bone ultrasound measurement (broadband ultrasound attenuation);
SKCM	cis	rs3008870	1.000	rs2985825	chr1:67412822	T/G	cg08660285	chr1:67390436	MIER1;WDR78	0.92	6.05	0.57	4.69e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs763014	0.932	rs7204439	chr16:661335	T/C	cg07343612	chr16:622815	PIGQ	-0.72	-6.16	-0.57	2.93e-8	Height;
SKCM	cis	rs11098499	0.532	rs4504231	chr4:120586891	G/A	cg09307838	chr4:120376055	NA	0.97	8.28	0.68	2.65e-12	Corneal astigmatism;
SKCM	cis	rs2806561	0.704	rs663942	chr1:23522476	G/A	cg12483005	chr1:23474871	LUZP1	0.68	5.24	0.51	1.34e-6	Height;
SKCM	cis	rs875971	0.558	rs4433015	chr7:65639723	A/C	cg00343986	chr7:65444356	GUSB	-0.7	-5.16	-0.5	1.86e-6	Aortic root size;
SKCM	cis	rs12044355	0.964	rs12045144	chr1:231844248	T/C	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	0.76	5.49	0.53	4.81e-7	Alzheimer's disease;
SKCM	cis	rs2204008	0.740	rs1283308	chr12:38154565	C/T	cg26384229	chr12:38710491	ALG10B	-0.68	-5.4	-0.52	6.95e-7	Bladder cancer;
SKCM	cis	rs1799949	0.536	rs4793227	chr17:41412250	A/C	cg23758822	chr17:41437982	NA	0.93	7.9	0.67	1.48e-11	Menopause (age at onset);
SKCM	cis	rs26868	0.690	rs26835	chr16:2237549	C/T	cg27608139	chr16:2294856	DCI	0.74	6.21	0.58	2.42e-8	Height;
SKCM	cis	rs951366	0.559	rs823101	chr1:205667006	T/C	cg07167872	chr1:205819463	PM20D1	0.7	5.12	0.5	2.16e-6	Menarche (age at onset);
SKCM	cis	rs6500602	0.964	rs2896893	chr16:4478559	T/A	cg09069446	chr16:4462122	CORO7	-0.46	-4.89	-0.48	5.32e-6	Schizophrenia;
SKCM	cis	rs2180341	0.574	rs13192350	chr6:127677762	G/T	cg24812749	chr6:127587940	RNF146	0.62	5.25	0.51	1.29e-6	Breast cancer;
SKCM	cis	rs1405130	0.869	rs11688577	chr2:235567050	A/G	cg21542780	chr2:234763377	HJURP	-0.64	-4.89	-0.48	5.21e-6	Coronary artery disease;
SKCM	cis	rs933688	0.941	rs6452954	chr5:90735692	G/A	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.01	8.43	0.69	1.41e-12	Smoking behavior;
SKCM	cis	rs1046896	1.000	rs1046875	chr17:80685426	A/G	cg02711726	chr17:80685570	FN3KRP	0.7	6.06	0.57	4.54e-8	Glycated hemoglobin levels;
SKCM	cis	rs55823223	0.564	rs936391	chr17:73847799	A/G	cg08125733	chr17:73851984	WBP2	-0.92	-5.67	-0.54	2.27e-7	Psoriasis;
SKCM	cis	rs514406	0.679	rs61768344	chr1:53229274	G/A	cg16325326	chr1:53192061	ZYG11B	-0.63	-5.01	-0.49	3.29e-6	Monocyte count;
SKCM	cis	rs12709013	0.792	rs257626	chr16:58793478	T/C	cg02431531	chr16:59244939	NA	0.49	5.13	0.5	2.07e-6	Blood metabolite ratios;
SKCM	cis	rs7959452	0.640	rs1598543	chr12:69688757	G/T	cg14784868	chr12:69753453	YEATS4	0.66	5.85	0.55	1.12e-7	Blood protein levels;
SKCM	cis	rs4319547	0.915	rs7316734	chr12:123117425	A/G	cg23029597	chr12:123009494	RSRC2	-0.76	-5.69	-0.54	2.16e-7	Body mass index;
SKCM	cis	rs8180040	0.620	rs56217494	chr3:47048452	T/G	cg27129171	chr3:47204927	SETD2	-0.74	-5.37	-0.52	7.84e-7	Colorectal cancer;
SKCM	cis	rs1325195	0.537	rs2793804	chr1:179201000	C/T	cg24632843	chr1:179557954	NA	0.62	5.07	0.5	2.62e-6	IgE grass sensitization;
SKCM	cis	rs11098499	0.863	rs3775849	chr4:120450908	G/C	cg24375607	chr4:120327624	NA	0.68	5.27	0.51	1.16e-6	Corneal astigmatism;
SKCM	cis	rs4595586	0.525	rs17464772	chr12:39247777	G/A	cg26384229	chr12:38710491	ALG10B	0.68	5.11	0.5	2.27e-6	Morning vs. evening chronotype;
SKCM	cis	rs245880	0.740	rs245886	chr7:29189336	G/T	cg17163760	chr7:29186267	CPVL	-0.4	-5.37	-0.52	7.91e-7	Warfarin maintenance dose;
SKCM	cis	rs5769765	1.000	rs5769760	chr22:50259696	A/G	cg22709217	chr22:50311962	ALG12;CRELD2	0.79	5.71	0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs1949733	1.000	rs868105	chr4:8501030	G/T	cg11789530	chr4:8429930	ACOX3	-0.81	-5.73	-0.54	1.83e-7	Response to antineoplastic agents;
SKCM	cis	rs7811142	1.000	rs6975729	chr7:100028187	C/T	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.12	6.51	0.59	6.68e-9	Platelet count;
SKCM	trans	rs2727020	0.658	rs1851992	chr11:49438110	C/T	cg15704280	chr7:45808275	SEPT13	-0.87	-7.93	-0.67	1.31e-11	Coronary artery disease;
SKCM	trans	rs3780486	0.757	rs10813949	chr9:33123464	G/A	cg04842962	chr6:43655489	MRPS18A	1.03	11.27	0.79	4.92e-18	IgG glycosylation;
SKCM	cis	rs11139399	0.506	rs56351396	chr9:84347967	T/C	cg13729285	chr9:84764156	NA	0.49	5.15	0.5	1.9e-6	Hippocampal atrophy;
SKCM	cis	rs28386778	0.897	rs2727330	chr17:61925498	A/G	cg23090583	chr17:61904693	PSMC5;FTSJ3	-1.11	-11.37	-0.79	3.21e-18	Prudent dietary pattern;
SKCM	cis	rs2842992	0.692	rs1128661	chr6:160211554	T/G	cg16489826	chr6:160211363	TCP1;MRPL18	0.71	5.51	0.53	4.52e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs7659604	0.539	rs11731917	chr4:122783233	G/A	cg19748678	chr4:122722346	EXOSC9	0.65	5.34	0.52	8.74e-7	Type 2 diabetes;
SKCM	cis	rs11122272	0.735	rs2790882	chr1:231532783	A/G	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	0.63	4.86	0.48	5.93e-6	Hemoglobin concentration;
SKCM	trans	rs3749237	0.964	rs13084243	chr3:49821878	G/C	cg21659725	chr3:3221576	CRBN	0.99	7.4	0.64	1.35e-10	Resting heart rate;
SKCM	cis	rs7772486	0.875	rs9376975	chr6:146355581	T/G	cg23711669	chr6:146136114	FBXO30	0.77	7.48	0.65	9.65e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1160297	0.609	rs10167421	chr2:53096163	G/C	cg07782112	chr2:53107842	NA	0.59	6.3	0.58	1.63e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs6500395	1.000	rs6500398	chr16:48650332	C/T	cg04672837	chr16:48644449	N4BP1	0.68	5.66	0.54	2.36e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs9325144	0.647	rs1875609	chr12:39018259	C/T	cg13010199	chr12:38710504	ALG10B	-0.64	-5.53	-0.53	4.12e-7	Morning vs. evening chronotype;
SKCM	cis	rs12971120	0.783	rs7229256	chr18:72169129	T/A	cg26446133	chr18:72167187	CNDP2	-0.67	-5.65	-0.54	2.54e-7	Refractive error;
SKCM	cis	rs9443189	0.527	rs775059	chr6:76370130	G/T	cg01950844	chr6:76311363	SENP6	1.02	6.34	0.58	1.39e-8	Prostate cancer;
SKCM	cis	rs477895	0.652	rs72920332	chr11:63947071	G/T	cg07220939	chr11:64358617	SLC22A12	0.74	4.99	0.49	3.58e-6	Mean platelet volume;
SKCM	cis	rs12477438	0.520	rs4340581	chr2:99725025	C/T	cg26064155	chr2:99771622	LIPT1;TSGA10	1.05	10.46	0.76	1.63e-16	Chronic sinus infection;
SKCM	cis	rs138491296	1	rs138491296	chr17:27961561	GATTATT/G	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.84	-6.26	-0.58	1.95e-8	White blood cell count;
SKCM	cis	rs738321	0.671	rs3761446	chr22:38595483	G/A	cg25457927	chr22:38595422	NA	-0.68	-7.11	-0.63	4.76e-10	Breast cancer;
SKCM	cis	rs908922	0.676	rs11205032	chr1:152527690	A/G	cg09873164	chr1:152488093	CRCT1	0.72	5.62	0.54	2.85e-7	Hair morphology;
SKCM	cis	rs6089584	0.627	rs13045575	chr20:60565596	G/A	cg06108461	chr20:60628389	TAF4	-0.66	-5.48	-0.53	5.08e-7	Body mass index;
SKCM	cis	rs694739	0.861	rs479552	chr11:64110683	G/C	cg02228329	chr11:64053129	BAD;GPR137	0.98	8.28	0.68	2.69e-12	Alopecia areata;Crohn's disease;Psoriasis vulgaris;
SKCM	cis	rs651907	0.535	rs34063583	chr3:101509948	C/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.78	6.72	0.61	2.65e-9	Colorectal cancer;
SKCM	cis	rs2836974	0.739	rs12482181	chr21:40548852	A/G	cg17971929	chr21:40555470	PSMG1	0.87	8.48	0.69	1.1e-12	Cognitive function;
SKCM	cis	rs1577917	0.958	rs12193904	chr6:86452703	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.87	-8.7	-0.7	4.17e-13	Response to antipsychotic treatment;
SKCM	cis	rs4969178	0.896	rs11077361	chr17:76397128	A/G	cg20026190	chr17:76395443	PGS1	0.61	5.29	0.51	1.08e-6	HDL cholesterol levels;
SKCM	cis	rs12497850	0.805	rs11130176	chr3:48844077	A/G	cg06212747	chr3:49208901	KLHDC8B	0.66	4.81	0.48	7.08e-6	Parkinson's disease;
SKCM	cis	rs6121246	0.559	rs6121243	chr20:30415094	C/G	cg13852791	chr20:30311386	BCL2L1	0.82	5.69	0.54	2.09e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs7772486	0.790	rs2249147	chr6:146184999	T/C	cg23711669	chr6:146136114	FBXO30	0.85	9.32	0.73	2.57e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6977660	0.714	rs12536561	chr7:19816659	G/A	cg05791153	chr7:19748676	TWISTNB	0.77	5.02	0.49	3.23e-6	Thyroid stimulating hormone;
SKCM	cis	rs7727544	0.735	rs272879	chr5:131670546	C/G	cg24060327	chr5:131705240	SLC22A5	-0.7	-5.13	-0.5	2.07e-6	Blood metabolite levels;
SKCM	cis	rs9300255	0.722	rs12304248	chr12:123810425	C/T	cg00376283	chr12:123451042	ABCB9	-0.78	-5.26	-0.51	1.24e-6	Neutrophil percentage of white cells;
SKCM	cis	rs2019137	0.560	rs7578633	chr2:113978650	C/T	cg11763394	chr2:113992921	PAX8;LOC440839;LOC654433	0.63	5.03	0.49	3.11e-6	Lymphocyte counts;
SKCM	cis	rs1799949	1.000	rs11652332	chr17:41295489	G/A	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.11	-0.57	3.67e-8	Menopause (age at onset);
SKCM	cis	rs6933660	0.800	rs2046371	chr6:151754744	G/A	cg10883421	chr6:151773342	RMND1;C6orf211	0.84	6.6	0.6	4.51e-9	Menarche (age at onset);
SKCM	cis	rs7666738	0.830	rs35213297	chr4:98984049	T/C	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4665809	0.590	rs4665319	chr2:26424583	A/C	cg04944784	chr2:26401820	FAM59B	-0.74	-4.79	-0.48	7.65e-6	Gut microbiome composition (summer);
SKCM	cis	rs873946	0.564	rs2803991	chr10:134557068	A/G	cg18305652	chr10:134549665	INPP5A	0.59	5.97	0.56	6.66e-8	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs8067545	0.750	rs4267380	chr17:19971564	A/G	cg13482628	chr17:19912719	NA	0.73	6.54	0.6	5.78e-9	Schizophrenia;
SKCM	cis	rs7811142	0.830	rs10085549	chr7:99983135	C/T	cg00814883	chr7:100076585	TSC22D4	-0.84	-4.8	-0.48	7.62e-6	Platelet count;
SKCM	cis	rs362296	0.698	rs3095083	chr4:3263499	G/A	cg21096898	chr4:3318625	RGS12	-0.76	-7.35	-0.64	1.68e-10	Parental longevity (mother's age at death);
SKCM	cis	rs2073499	1.000	rs6776145	chr3:50316119	C/T	cg08207895	chr3:50388901	TUSC4;CYB561D2	-0.72	-5.37	-0.52	8.04e-7	Schizophrenia;
SKCM	cis	rs2836950	0.545	rs2297256	chr21:40558421	C/T	cg17971929	chr21:40555470	PSMG1	-0.71	-5.89	-0.55	9.3e-8	Menarche (age at onset);
SKCM	cis	rs738321	0.762	rs5995543	chr22:38579026	G/A	cg25457927	chr22:38595422	NA	-0.63	-7.49	-0.65	8.97e-11	Breast cancer;
SKCM	cis	rs2645694	0.626	rs2703140	chr4:77830057	C/G	cg06046430	chr4:77819534	ANKRD56	0.54	5.94	0.56	7.49e-8	Emphysema distribution in smoking;
SKCM	cis	rs10256972	0.616	rs4585652	chr7:1145396	A/G	cg09177884	chr7:1199841	ZFAND2A	-0.77	-6.14	-0.57	3.27e-8	Longevity;Endometriosis;
SKCM	cis	rs4523957	0.620	rs1565764	chr17:2074303	G/A	cg16513277	chr17:2031491	SMG6	-0.89	-6.12	-0.57	3.49e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	trans	rs1814175	0.645	rs28478790	chr11:50054322	C/A	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs2033711	0.870	rs1465789	chr19:58946056	C/T	cg12042659	chr19:58951599	ZNF132	0.67	5.63	0.54	2.71e-7	Uric acid clearance;
SKCM	cis	rs7666738	0.830	rs6532720	chr4:99043781	C/T	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs60871478	0.898	rs67785403	chr7:787201	A/G	cg04727924	chr7:799746	HEATR2	-0.64	-4.82	-0.48	6.9e-6	Cerebrospinal P-tau181p levels;
SKCM	cis	rs992157	0.835	rs2292550	chr2:219140288	G/C	cg20019365	chr2:219134978	PNKD;AAMP	-0.74	-6.22	-0.58	2.28e-8	Colorectal cancer;
SKCM	cis	rs1801251	0.893	rs6733151	chr2:233592341	A/C	cg08000102	chr2:233561755	GIGYF2	0.89	6.92	0.62	1.11e-9	Coronary artery disease;
SKCM	cis	rs1577917	0.681	rs4348284	chr6:86350394	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.27	-0.51	1.18e-6	Response to antipsychotic treatment;
SKCM	cis	rs4242434	0.892	rs4872527	chr8:22496048	G/A	cg03733263	chr8:22462867	KIAA1967	1.06	8.62	0.7	5.8e-13	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs7927771	0.965	rs1064608	chr11:47640429	G/C	cg05585544	chr11:47624801	NA	-0.63	-5.5	-0.53	4.73e-7	Subjective well-being;
SKCM	cis	rs7666738	0.753	rs2865957	chr4:99040725	G/A	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1799949	1.000	rs35070007	chr17:41316747	C/G	cg23758822	chr17:41437982	NA	-0.95	-7.81	-0.66	2.17e-11	Menopause (age at onset);
SKCM	cis	rs11098499	0.865	rs28753180	chr4:120405367	A/T	cg09307838	chr4:120376055	NA	0.97	7.65	0.65	4.54e-11	Corneal astigmatism;
SKCM	cis	rs9858542	0.953	rs1873625	chr3:49666964	C/A	cg03060546	chr3:49711283	APEH	-0.71	-5.29	-0.51	1.07e-6	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs8067545	0.750	rs4925081	chr17:19991993	A/G	cg13482628	chr17:19912719	NA	-0.73	-6.47	-0.59	8.05e-9	Schizophrenia;
SKCM	cis	rs12926788	0.546	rs200531	chr16:24756172	G/A	cg06028605	chr16:24865363	SLC5A11	-0.59	-4.98	-0.49	3.66e-6	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs748404	0.560	rs2255663	chr15:43829008	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	-0.72	-5.04	-0.5	2.94e-6	Lung cancer;
SKCM	cis	rs798554	0.679	rs2644300	chr7:2883071	G/A	cg04166393	chr7:2884313	GNA12	0.8	5.35	0.52	8.45e-7	Height;
SKCM	cis	rs28595532	0.920	rs115500312	chr4:119752551	G/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs9788682	1.000	rs34138960	chr15:78831668	A/G	cg24631222	chr15:78858424	CHRNA5	0.96	6.69	0.6	3.03e-9	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs9682041	0.877	rs9682908	chr3:170072010	C/T	cg11886554	chr3:170076028	SKIL	0.84	5.1	0.5	2.36e-6	Glomerular filtration rate in non diabetics (creatinine);Glomerular filtration rate (creatinine);
SKCM	cis	rs2732480	1.000	rs2732480	chr12:48736303	A/C	cg21348975	chr12:48724119	NA	0.55	4.85	0.48	6.3e-6	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs847649	0.692	rs7800548	chr7:102481842	C/T	cg18108683	chr7:102477205	FBXL13	0.82	9.06	0.72	8.17e-14	Morning vs. evening chronotype;
SKCM	cis	rs12477438	0.520	rs2516829	chr2:99773201	T/G	cg14399236	chr2:99771627	LIPT1;TSGA10	0.97	8.9	0.71	1.72e-13	Chronic sinus infection;
SKCM	cis	rs1005277	0.579	rs2474571	chr10:38384639	T/G	cg25427524	chr10:38739819	LOC399744	-0.69	-6.41	-0.59	1.02e-8	Extrinsic epigenetic age acceleration;
SKCM	trans	rs8073060	0.586	rs72829933	chr17:34056406	C/T	cg19694781	chr19:47549865	TMEM160	1.07	7.96	0.67	1.14e-11	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs2836974	0.544	rs8128919	chr21:40711862	C/T	cg11644478	chr21:40555479	PSMG1	0.67	5.14	0.5	1.96e-6	Cognitive function;
SKCM	cis	rs427394	0.659	rs274725	chr5:6717408	C/G	cg10857441	chr5:6722123	POLS	-0.7	-7.5	-0.65	8.59e-11	Menopause (age at onset);
SKCM	cis	rs12477438	0.501	rs1133977	chr2:99741984	G/T	cg26064155	chr2:99771622	LIPT1;TSGA10	-1.03	-9.38	-0.73	1.98e-14	Chronic sinus infection;
SKCM	cis	rs17376456	0.825	rs17374166	chr5:93238655	T/C	cg21475434	chr5:93447410	FAM172A	1.02	5.17	0.51	1.74e-6	Diabetic retinopathy;
SKCM	cis	rs28595532	0.920	rs115154776	chr4:119774803	A/G	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs908922	0.542	rs4845785	chr1:152510143	C/T	cg09873164	chr1:152488093	CRCT1	0.76	5.93	0.56	7.7e-8	Hair morphology;
SKCM	cis	rs765787	0.505	rs1648302	chr15:45494238	A/G	cg24006582	chr15:45444508	DUOX1	-0.68	-5.01	-0.49	3.27e-6	Uric acid levels;
SKCM	cis	rs16866061	0.962	rs72972361	chr2:225341550	G/A	cg12698349	chr2:225449008	CUL3	1.02	8.77	0.7	3.04e-13	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs2811415	0.627	rs1984451	chr3:127768462	C/G	cg09089421	chr3:127803668	RUVBL1	1.01	8.79	0.71	2.72e-13	Lung function (FEV1/FVC);
SKCM	cis	rs589448	0.902	rs315124	chr12:69771727	G/A	cg22834771	chr12:69754056	YEATS4	-0.71	-5.81	-0.55	1.3e-7	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs2279817	0.955	rs2270977	chr1:18023509	T/C	cg17142039	chr1:18149651	ACTL8	0.58	4.88	0.48	5.6e-6	Neuroticism;
SKCM	cis	rs3020736	0.500	rs7364293	chr22:42506370	C/T	cg04733989	chr22:42467013	NAGA	-0.72	-5.62	-0.54	2.87e-7	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs748404	0.516	rs523156	chr15:43811843	C/G	cg02155558	chr15:43621948	ADAL;LCMT2	-0.73	-5.17	-0.5	1.79e-6	Lung cancer;
SKCM	cis	rs8037137	0.571	rs3743445	chr15:91561182	C/T	cg15878949	chr15:91534302	PRC1	0.68	5.14	0.5	1.98e-6	Platelet count;Serous invasive ovarian cancer;High-grade serous ovarian cancer;Invasive epithelial ovarian cancer;
SKCM	cis	rs116095464	0.558	rs6555055	chr5:226160	A/C	cg22496380	chr5:211416	CCDC127	-0.96	-5.27	-0.51	1.18e-6	Breast cancer;
SKCM	cis	rs7824557	0.628	rs58283816	chr8:11192551	G/C	cg21775007	chr8:11205619	TDH	0.72	6.73	0.61	2.51e-9	Retinal vascular caliber;
SKCM	cis	rs9300255	0.739	rs1533703	chr12:123742093	T/G	cg00376283	chr12:123451042	ABCB9	0.84	5.91	0.56	8.5e-8	Neutrophil percentage of white cells;
SKCM	cis	rs6424115	1.000	rs12031592	chr1:24127864	A/C	cg15997130	chr1:24165203	NA	0.63	5.38	0.52	7.59e-7	Immature fraction of reticulocytes;
SKCM	cis	rs6138458	1.000	rs227651	chr20:24929834	A/G	cg26195577	chr20:24973756	C20orf3	1.29	8.85	0.71	2.07e-13	Blood protein levels;
SKCM	cis	rs17376456	0.825	rs10054903	chr5:93281491	C/A	cg21475434	chr5:93447410	FAM172A	1.04	5.19	0.51	1.62e-6	Diabetic retinopathy;
SKCM	trans	rs208520	0.507	rs7755710	chr6:66783355	G/A	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-1.12	-11.27	-0.79	4.9e-18	Exhaled nitric oxide output;
SKCM	cis	rs2842992	0.724	rs1128670	chr6:160211636	G/A	cg11366901	chr6:160182831	ACAT2	0.84	7.09	0.63	5.2e-10	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs8060686	0.641	rs12599880	chr16:68152035	A/G	cg09117114	chr16:67998030	SLC12A4	-0.81	-5.29	-0.51	1.07e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs754466	0.580	rs1344966	chr10:79534527	T/C	cg17075019	chr10:79541650	NA	-0.78	-7.13	-0.63	4.48e-10	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs801193	1.000	rs6975195	chr7:66124774	T/A	cg00343986	chr7:65444356	GUSB	-0.67	-4.93	-0.49	4.55e-6	Aortic root size;
SKCM	cis	rs9905704	0.647	rs11650809	chr17:56972741	A/G	cg05425664	chr17:57184151	TRIM37	-0.61	-4.86	-0.48	5.91e-6	Testicular germ cell tumor;
SKCM	cis	rs514406	0.668	rs12037492	chr1:53440816	G/T	cg16325326	chr1:53192061	ZYG11B	-0.64	-5.44	-0.52	5.92e-7	Monocyte count;
SKCM	cis	rs35306767	0.903	rs7914758	chr10:891702	T/C	cg26597838	chr10:835615	NA	0.79	5.77	0.55	1.54e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs644799	0.965	rs499076	chr11:95546341	A/G	cg03916912	chr11:95522834	CEP57;FAM76B	0.92	8.04	0.67	8e-12	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs514406	0.698	rs1775540	chr1:53407893	C/A	cg04310824	chr1:53393297	SCP2	-0.6	-4.9	-0.49	5.01e-6	Monocyte count;
SKCM	cis	rs9910055	0.762	rs2526020	chr17:42216588	G/T	cg13607699	chr17:42295918	UBTF	0.79	6.21	0.58	2.4e-8	Total body bone mineral density;
SKCM	cis	rs28386778	0.830	rs2665798	chr17:61921397	C/T	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs1046896	0.594	rs4075209	chr17:80800027	G/T	cg22027946	chr17:80790580	TBCD;ZNF750	0.7	5.29	0.51	1.09e-6	Glycated hemoglobin levels;
SKCM	cis	rs67460515	0.892	rs2100238	chr3:161058055	T/A	cg03342759	chr3:160939853	NMD3	-0.81	-7.1	-0.63	5.14e-10	Parkinson's disease;
SKCM	cis	rs826838	0.967	rs10875979	chr12:39095149	G/A	cg13010199	chr12:38710504	ALG10B	0.76	5.67	0.54	2.29e-7	Heart rate;
SKCM	cis	rs1801251	1.000	rs1867778	chr2:233679644	C/T	cg25237894	chr2:233734115	C2orf82	-0.59	-5.67	-0.54	2.34e-7	Coronary artery disease;
SKCM	cis	rs6951245	1.000	rs113575110	chr7:1084394	G/A	cg03188948	chr7:1209495	NA	1.12	6.25	0.58	2.02e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs2243480	1.000	rs4548056	chr7:65298873	A/G	cg18252515	chr7:66147081	NA	-1.29	-7.41	-0.64	1.3e-10	Diabetic kidney disease;
SKCM	cis	rs6120849	0.754	rs6087666	chr20:33640242	G/A	cg24642439	chr20:33292090	TP53INP2	0.94	4.86	0.48	5.91e-6	Protein C levels;
SKCM	cis	rs8017423	0.967	rs55667096	chr14:90714798	C/T	cg04374321	chr14:90722782	PSMC1	0.97	8.97	0.71	1.25e-13	Mortality in heart failure;
SKCM	cis	rs208520	0.802	rs4710314	chr6:66883656	G/A	cg07460842	chr6:66804631	NA	-0.91	-7.07	-0.63	5.76e-10	Exhaled nitric oxide output;
SKCM	cis	rs2836974	0.568	rs414850	chr21:40543337	A/C	cg11890956	chr21:40555474	PSMG1	0.88	9.14	0.72	5.76e-14	Cognitive function;
SKCM	cis	rs9325144	0.581	rs2730929	chr12:38942739	T/C	cg26384229	chr12:38710491	ALG10B	-0.86	-7.75	-0.66	2.9100000000000002e-11	Morning vs. evening chronotype;
SKCM	cis	rs4808199	0.948	rs11085261	chr19:19462606	G/A	cg03709012	chr19:19516395	GATAD2A	1.08	7.53	0.65	7.65e-11	Nonalcoholic fatty liver disease;
SKCM	cis	rs2439831	1.000	rs689826	chr15:43749916	G/A	cg02155558	chr15:43621948	ADAL;LCMT2	1.2	7.6	0.65	5.52e-11	Lung cancer in ever smokers;
SKCM	cis	rs7772486	0.764	rs9399569	chr6:146242942	C/T	cg23711669	chr6:146136114	FBXO30	-0.78	-7.74	-0.66	3.05e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6951245	0.580	rs77101766	chr7:1122438	A/G	cg18402987	chr7:1209562	NA	0.82	5.36	0.52	8.37e-7	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs34779708	0.931	rs35848945	chr10:35287561	G/T	cg03585969	chr10:35415529	CREM	0.73	6.03	0.56	5.13e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs4820539	1.000	rs13054985	chr22:23458577	G/A	cg14186256	chr22:23484241	RTDR1	0.81	7.88	0.67	1.61e-11	Bone mineral density;
SKCM	cis	rs838147	0.733	rs8106205	chr19:49250197	T/C	cg13540341	chr19:49222985	MAMSTR	0.56	4.86	0.48	5.91e-6	Dietary macronutrient intake;
SKCM	cis	rs9583531	0.527	rs2391866	chr13:111363294	A/T	cg24331049	chr13:111365604	ING1	0.87	6.47	0.59	7.91e-9	Coronary artery disease;
SKCM	cis	rs10504229	0.639	rs11781834	chr8:58133422	C/T	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs9911578	1.000	rs7342903	chr17:56914588	C/G	cg12560992	chr17:57184187	TRIM37	0.94	7.55	0.65	7.01e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs2404602	0.583	rs12438741	chr15:76542114	C/A	cg22467129	chr15:76604101	ETFA	-0.65	-5.35	-0.52	8.68e-7	Blood metabolite levels;
SKCM	cis	rs1395	0.778	rs56364136	chr2:27451429	T/C	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.47	4.77	0.48	8.27e-6	Blood metabolite levels;
SKCM	cis	rs12130219	0.500	rs4845743	chr1:152184149	A/G	cg13447818	chr1:152298884	FLG	-0.53	-4.93	-0.49	4.46e-6	Inflammatory skin disease;
SKCM	cis	rs738322	1.000	rs738322	chr22:38569006	A/G	cg25457927	chr22:38595422	NA	-0.5	-5.56	-0.53	3.61e-7	Cutaneous nevi;
SKCM	cis	rs4819052	1.000	rs2838847	chr21:46670958	G/C	cg02159808	chr21:46707872	POFUT2;LOC642852	0.79	5.87	0.55	1.01e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs2811415	0.597	rs10934845	chr3:127763859	C/T	cg09089421	chr3:127803668	RUVBL1	0.99	8.52	0.69	9.09e-13	Lung function (FEV1/FVC);
SKCM	cis	rs4237845	0.514	rs4760339	chr12:58268149	G/T	cg00677455	chr12:58241039	CTDSP2	0.9	8.16	0.68	4.55e-12	Intelligence (multi-trait analysis);
SKCM	cis	rs9325144	0.647	rs34311455	chr12:39060889	C/T	cg26384229	chr12:38710491	ALG10B	-0.71	-6.38	-0.59	1.17e-8	Morning vs. evening chronotype;
SKCM	cis	rs28386778	0.897	rs894413	chr17:61916347	A/G	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs2153535	0.580	rs9406169	chr6:8509470	A/T	cg23788917	chr6:8435910	SLC35B3	0.63	4.86	0.48	6.01e-6	Motion sickness;
SKCM	cis	rs6752107	1.000	rs2241878	chr2:234183718	T/C	cg07618928	chr2:234183455	ATG16L1;SCARNA5	0.56	4.77	0.48	8.37e-6	Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs634534	0.622	rs552130	chr11:65732800	T/C	cg26695010	chr11:65641043	EFEMP2	-0.65	-5.32	-0.52	9.77e-7	Sum eosinophil basophil counts;Eosinophil counts;
SKCM	cis	rs12762955	0.519	rs10795306	chr10:1019138	A/T	cg25614935	chr10:1084866	C10orf110	-0.66	-4.85	-0.48	6.19e-6	Response to angiotensin II receptor blocker therapy;
SKCM	cis	rs9902453	0.967	rs12450441	chr17:28495021	G/A	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.5	0.53	4.74e-7	Coffee consumption (cups per day);
SKCM	cis	rs2228479	0.850	rs2190808	chr16:89840856	C/T	cg06558623	chr16:89946397	TCF25	1.06	4.84	0.48	6.45e-6	Skin colour saturation;
SKCM	cis	rs1160297	0.575	rs6715857	chr2:53097395	T/G	cg07782112	chr2:53107842	NA	0.59	6.3	0.58	1.63e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs6951245	0.554	rs58210047	chr7:1149381	G/A	cg18402987	chr7:1209562	NA	0.82	5.43	0.52	6.18e-7	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7811142	0.830	rs41280971	chr7:99954457	G/T	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.19	7.5	0.65	8.66e-11	Platelet count;
SKCM	cis	rs763014	0.966	rs4984677	chr16:671682	A/G	cg00908189	chr16:619842	PIGQ	0.8	7.31	0.64	1.98e-10	Height;
SKCM	cis	rs7666738	0.830	rs6848404	chr4:98946750	A/G	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs36093844	0.904	rs7101889	chr11:85595579	C/G	cg02149136	chr11:85995039	NA	0.68	5.04	0.5	2.97e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs1005277	0.540	rs11011351	chr10:38030525	A/G	cg00409905	chr10:38381863	ZNF37A	-0.63	-6.05	-0.57	4.71e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs4819052	1.000	rs3746980	chr21:46711580	C/T	cg19498844	chr21:46707878	POFUT2;LOC642852	0.92	7.05	0.62	6.22e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs10256972	0.567	rs2949185	chr7:1209013	A/G	cg16145915	chr7:1198662	ZFAND2A	-0.59	-8.25	-0.68	3.07e-12	Longevity;Endometriosis;
SKCM	cis	rs17376456	0.877	rs7734897	chr5:93305402	G/A	cg25358565	chr5:93447407	FAM172A	1.23	7.26	0.63	2.53e-10	Diabetic retinopathy;
SKCM	cis	rs1790761	0.520	rs12805884	chr11:67387977	G/A	cg00864171	chr11:67383662	NA	-0.62	-5.18	-0.51	1.66e-6	Mean corpuscular volume;
SKCM	cis	rs7666738	0.822	rs13110418	chr4:99046963	G/A	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2072499	0.833	rs2758605	chr1:156200445	G/C	cg24450063	chr1:156163899	SLC25A44	0.79	6.76	0.61	2.21e-9	Testicular germ cell tumor;
SKCM	trans	rs9329221	0.905	rs10283145	chr8:10241411	C/T	cg06636001	chr8:8085503	FLJ10661	-0.9	-8.12	-0.68	5.59e-12	Neuroticism;
SKCM	cis	rs13118159	0.550	rs13123016	chr4:1340889	T/C	cg02018176	chr4:1364513	KIAA1530	0.92	7.64	0.65	4.7e-11	Longevity;
SKCM	cis	rs7666738	0.830	rs10009206	chr4:99056900	A/C	cg17366294	chr4:99064904	C4orf37	-0.62	-5.07	-0.5	2.57e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7208859	0.623	rs11657662	chr17:29076347	A/G	cg13385521	chr17:29058706	SUZ12P	-1.02	-5.22	-0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs9611565	0.512	rs9607841	chr22:42186838	G/A	cg03806693	chr22:41940476	POLR3H	-1.06	-6.84	-0.61	1.61e-9	Vitiligo;
SKCM	cis	rs1153858	0.943	rs12439575	chr15:45684816	T/G	cg10760299	chr15:45669010	GATM	0.62	6.35	0.58	1.3e-8	Homoarginine levels;
SKCM	cis	rs13118159	0.550	rs4974614	chr4:1373489	A/G	cg02018176	chr4:1364513	KIAA1530	0.89	7.24	0.63	2.72e-10	Longevity;
SKCM	cis	rs11098499	0.775	rs10029303	chr4:120286755	T/A	cg24375607	chr4:120327624	NA	0.62	4.77	0.48	8.45e-6	Corneal astigmatism;
SKCM	cis	rs6089829	0.962	rs4809462	chr20:61661560	A/G	cg08564027	chr20:61660810	NA	0.63	5.65	0.54	2.56e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs709400	0.663	rs3783402	chr14:103967929	C/G	cg26031613	chr14:104095156	KLC1	0.76	5.78	0.55	1.47e-7	Body mass index;
SKCM	cis	rs17345786	0.798	rs9817043	chr3:101281852	A/G	cg12386194	chr3:101231763	SENP7	0.72	5.53	0.53	4.12e-7	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs933688	1.000	rs12655973	chr5:90736537	A/G	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.92	6.76	0.61	2.21e-9	Smoking behavior;
SKCM	cis	rs4481887	1.000	rs7511706	chr1:248467360	G/A	cg00666640	chr1:248458726	OR2T12	0.61	5.6	0.54	3.11e-7	Common traits (Other);
SKCM	cis	rs362272	0.545	rs2749782	chr4:3339761	A/G	cg09735869	chr4:3319127	RGS12	0.97	11.46	0.79	2.17e-18	Serum sulfate level;
SKCM	cis	rs8072100	0.967	rs4338849	chr17:45512483	A/G	cg08085267	chr17:45401833	C17orf57	-0.66	-5.95	-0.56	7.35e-8	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs875971	0.660	rs10263935	chr7:66096028	A/G	cg18876405	chr7:65276391	NA	0.63	5.35	0.52	8.39e-7	Aortic root size;
SKCM	cis	rs7937682	0.924	rs499750	chr11:111513645	T/G	cg09085632	chr11:111637200	PPP2R1B	-1.07	-11.3	-0.79	4.28e-18	Primary sclerosing cholangitis;
SKCM	cis	rs35146811	0.844	rs34031156	chr7:99677917	T/A	cg13334819	chr7:99746414	C7orf59	-0.75	-5.35	-0.52	8.5e-7	Coronary artery disease;
SKCM	cis	rs62238980	0.614	rs976915	chr22:32428445	A/G	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs6866344	0.697	rs17184344	chr5:178129281	A/G	cg03877680	chr5:178157825	ZNF354A	0.79	5.7	0.54	2.05e-7	Neutrophil percentage of white cells;
SKCM	cis	rs753778	0.667	rs10103731	chr8:142206068	C/T	cg18755752	chr8:142205143	DENND3	-0.67	-5.81	-0.55	1.3e-7	Reticulocyte fraction of red cells;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs769267	0.930	rs6909	chr19:19619542	A/G	cg03709012	chr19:19516395	GATAD2A	0.89	8.62	0.7	5.89e-13	Tonsillectomy;
SKCM	cis	rs17376456	0.569	rs1026279	chr5:93209581	C/A	cg25358565	chr5:93447407	FAM172A	-0.88	-5.29	-0.51	1.07e-6	Diabetic retinopathy;
SKCM	cis	rs2228479	0.850	rs11640336	chr16:89941153	T/C	cg06558623	chr16:89946397	TCF25	1.13	5.67	0.54	2.28e-7	Skin colour saturation;
SKCM	cis	rs826838	1.000	rs4768328	chr12:39129315	C/T	cg13010199	chr12:38710504	ALG10B	-0.72	-5.73	-0.54	1.83e-7	Heart rate;
SKCM	cis	rs2839186	0.647	rs9976233	chr21:47616913	G/A	cg13126279	chr21:47581558	C21orf56	0.69	6.1	0.57	3.8e-8	Testicular germ cell tumor;
SKCM	cis	rs4790333	0.562	rs2447104	chr17:2257532	C/T	cg02569219	chr17:2266849	SGSM2	0.67	5.76	0.55	1.57e-7	Proinsulin levels;
SKCM	cis	rs950776	0.518	rs12906951	chr15:78825562	C/T	cg06917634	chr15:78832804	PSMA4	1.01	10.47	0.76	1.56e-16	Sudden cardiac arrest;
SKCM	cis	rs17345786	1.000	rs11715368	chr3:101336380	G/A	cg12386194	chr3:101231763	SENP7	0.8	6.19	0.57	2.56e-8	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1218582	0.772	rs6656435	chr1:154876869	G/A	cg16680214	chr1:154839983	KCNN3	-0.56	-5.01	-0.49	3.29e-6	Prostate cancer;
SKCM	cis	rs17685	0.753	rs869804	chr7:75688954	A/G	cg16684958	chr7:75615977	POR	0.59	5.63	0.54	2.69e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs654950	0.875	rs632166	chr1:41995681	T/C	cg06885757	chr1:42089581	HIVEP3	-0.64	-7.03	-0.62	6.98e-10	Airway imaging phenotypes;
SKCM	cis	rs709400	1.000	rs58133129	chr14:104104759	A/G	cg26031613	chr14:104095156	KLC1	1.05	11.37	0.79	3.17e-18	Body mass index;
SKCM	cis	rs6545883	0.791	rs4672445	chr2:61655008	T/C	cg15711740	chr2:61764176	XPO1	0.7	4.93	0.49	4.5e-6	Tuberculosis;
SKCM	cis	rs8072100	0.967	rs9894905	chr17:45485982	C/T	cg25173405	chr17:45401733	C17orf57	-0.6	-5.39	-0.52	7.18e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs11690935	0.959	rs6738445	chr2:172599615	T/C	cg13550731	chr2:172543902	DYNC1I2	0.96	8.33	0.69	2.12e-12	Schizophrenia;
SKCM	cis	rs9926296	0.528	rs4785721	chr16:89839997	G/A	cg04287289	chr16:89883240	FANCA	1.0	11.06	0.78	1.22e-17	Vitiligo;
SKCM	cis	rs79040073	0.530	rs17396612	chr15:49549943	A/G	cg25951582	chr15:49913451	C15orf33;DTWD1	-0.72	-5.22	-0.51	1.44e-6	Lung cancer in ever smokers;
SKCM	cis	rs992157	1.000	rs13429408	chr2:219142860	C/A	cg20019365	chr2:219134978	PNKD;AAMP	0.75	6.99	0.62	8.08e-10	Colorectal cancer;
SKCM	cis	rs11638352	1.000	rs7176955	chr15:44308905	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	-1.25	-4.88	-0.48	5.56e-6	Lipoprotein phospholipase A2 activity in cardiovascular disease;
SKCM	cis	rs1692580	0.807	rs260508	chr1:2187085	T/G	cg21442419	chr1:2182373	SKI	-0.69	-7.27	-0.64	2.42e-10	Coronary artery disease;
SKCM	cis	rs1153858	1.000	rs1613559	chr15:45622116	A/G	cg21132104	chr15:45694354	SPATA5L1	0.89	7.18	0.63	3.58e-10	Homoarginine levels;
SKCM	cis	rs11764590	0.694	rs60626033	chr7:2099719	A/G	cg02825527	chr7:2087843	MAD1L1	-0.62	-4.92	-0.49	4.67e-6	Neuroticism;
SKCM	cis	rs875971	0.862	rs2420173	chr7:65645399	A/T	cg18876405	chr7:65276391	NA	-0.65	-6.63	-0.6	3.96e-9	Aortic root size;
SKCM	cis	rs9910055	0.960	rs9911991	chr17:42278916	G/C	cg09913183	chr17:42254507	C17orf65;ASB16	0.67	5.83	0.55	1.2e-7	Total body bone mineral density;
SKCM	cis	rs6545883	0.524	rs2694619	chr2:61536901	C/T	cg15711740	chr2:61764176	XPO1	0.68	5.23	0.51	1.4e-6	Tuberculosis;
SKCM	cis	rs73201462	1.000	rs6765233	chr3:128002850	T/C	cg09089421	chr3:127803668	RUVBL1	-1.0	-5.11	-0.5	2.22e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs10504073	0.565	rs35282337	chr8:49920994	G/A	cg00325661	chr8:49890786	NA	0.79	7.15	0.63	3.99e-10	Blood metabolite ratios;
SKCM	cis	rs7954584	0.567	rs7132055	chr12:122346034	A/G	cg13699009	chr12:122356056	WDR66	-0.59	-7.43	-0.64	1.2e-10	Mean corpuscular volume;
SKCM	cis	rs2739330	0.828	rs2186366	chr22:24254113	A/G	cg04234412	chr22:24373322	LOC391322	0.59	4.84	0.48	6.51e-6	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs4523957	0.928	rs394752	chr17:2199749	C/A	cg16513277	chr17:2031491	SMG6	0.68	4.78	0.48	8.02e-6	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs1005277	0.579	rs2474584	chr10:38416389	C/T	cg25427524	chr10:38739819	LOC399744	-0.71	-6.74	-0.61	2.44e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs1577917	0.958	rs12665542	chr6:86544443	G/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.68	-5.91	-0.56	8.36e-8	Response to antipsychotic treatment;
SKCM	cis	rs10927875	0.632	rs4661667	chr1:16162731	C/T	cg21385522	chr1:16154831	NA	-0.99	-12.29	-0.81	6.21e-20	Dilated cardiomyopathy;
SKCM	cis	rs2228479	0.717	rs34027607	chr16:89808939	T/C	cg06558623	chr16:89946397	TCF25	1.11	6.06	0.57	4.5e-8	Skin colour saturation;
SKCM	cis	rs10791097	0.694	rs11222370	chr11:130744767	T/G	cg12179176	chr11:130786555	SNX19	0.93	8.16	0.68	4.64e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs4332037	0.539	rs62444881	chr7:2052318	C/T	cg23422044	chr7:1970798	MAD1L1	-0.92	-5.87	-0.55	1.02e-7	Bipolar disorder;
SKCM	cis	rs453301	0.658	rs9650616	chr8:8869199	T/G	cg06636001	chr8:8085503	FLJ10661	-0.75	-5.62	-0.54	2.83e-7	Joint mobility (Beighton score);
SKCM	cis	rs6977660	0.714	rs6945297	chr7:19814029	A/C	cg05791153	chr7:19748676	TWISTNB	0.8	5.01	0.49	3.37e-6	Thyroid stimulating hormone;
SKCM	cis	rs2948294	0.524	rs13270062	chr8:8112650	C/A	cg08975724	chr8:8085496	FLJ10661	0.64	4.81	0.48	7.18e-6	Red cell distribution width;
SKCM	cis	rs6762	0.748	rs28551040	chr11:840740	G/A	cg16425592	chr11:842748	TSPAN4;POLR2L	-0.79	-5.8	-0.55	1.33e-7	Mean platelet volume;
SKCM	cis	rs8067545	0.611	rs2526466	chr17:20165251	C/T	cg13482628	chr17:19912719	NA	-0.67	-5.58	-0.53	3.39e-7	Schizophrenia;
SKCM	cis	rs6138458	0.620	rs2151462	chr20:24911823	T/C	cg26195577	chr20:24973756	C20orf3	1.29	8.69	0.7	4.32e-13	Blood protein levels;
SKCM	cis	rs9660180	0.967	rs11260623	chr1:1781456	G/T	cg17747265	chr1:1875780	NA	-0.55	-5.08	-0.5	2.54e-6	Body mass index;
SKCM	cis	rs28386778	0.897	rs2236737	chr17:61938100	C/T	cg01411255	chr17:61851458	DDX42;CCDC47	0.79	5.07	0.5	2.58e-6	Prudent dietary pattern;
SKCM	cis	rs308403	0.509	rs309372	chr4:123682639	C/T	cg01449224	chr4:123073775	NA	-0.6	-4.85	-0.48	6.22e-6	Blood protein levels;
SKCM	cis	rs9486715	0.867	rs9373907	chr6:96981189	G/A	cg06623918	chr6:96969491	KIAA0776	0.82	7.29	0.64	2.2e-10	Headache;
SKCM	cis	rs8072100	0.840	rs12452796	chr17:45479733	G/T	cg08085267	chr17:45401833	C17orf57	0.62	5.28	0.51	1.12e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs4242434	0.854	rs3735893	chr8:22452704	A/G	cg03733263	chr8:22462867	KIAA1967	1.01	8.44	0.69	1.32e-12	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs9325144	0.560	rs61929893	chr12:38653366	G/A	cg26384229	chr12:38710491	ALG10B	-0.69	-5.66	-0.54	2.36e-7	Morning vs. evening chronotype;
SKCM	cis	rs1005277	0.579	rs1740742	chr10:38518860	C/T	cg25427524	chr10:38739819	LOC399744	-0.69	-6.79	-0.61	1.96e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs12701220	0.857	rs1057558	chr7:1062366	A/G	cg02733842	chr7:1102375	C7orf50	-0.58	-4.99	-0.49	3.52e-6	Bronchopulmonary dysplasia;
SKCM	cis	rs12048904	0.533	rs1590580	chr1:101292668	A/G	cg16556008	chr1:101360663	SLC30A7;EXTL2	0.92	6.84	0.61	1.59e-9	Multiple sclerosis;
SKCM	cis	rs7824557	0.583	rs2263511	chr8:11233318	A/C	cg21775007	chr8:11205619	TDH	-0.6	-5.03	-0.49	3.1e-6	Retinal vascular caliber;
SKCM	cis	rs1799949	0.965	rs34633610	chr17:41419385	A/G	cg23758822	chr17:41437982	NA	0.93	7.88	0.67	1.62e-11	Menopause (age at onset);
SKCM	cis	rs11628318	1.000	rs11628318	chr14:103040087	T/A	cg01864069	chr14:103024347	NA	-0.7	-5.02	-0.49	3.25e-6	Platelet count;
SKCM	cis	rs6840360	0.550	rs6535806	chr4:152483906	G/A	cg22705602	chr4:152727874	NA	-0.5	-5.38	-0.52	7.49e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs2075371	0.796	rs10954440	chr7:134005657	C/T	cg20476274	chr7:133979776	SLC35B4	1.01	10.1	0.75	8.14e-16	Mean platelet volume;
SKCM	cis	rs867186	1.000	rs8118005	chr20:33636219	G/C	cg04194272	chr20:33683537	NA	-1.38	-7.2	-0.63	3.29e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs35306767	0.715	rs11253550	chr10:1028288	C/G	cg25614935	chr10:1084866	C10orf110	0.68	4.84	0.48	6.55e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs13256369	0.851	rs13254997	chr8:8563753	G/C	cg06636001	chr8:8085503	FLJ10661	0.8	6.15	0.57	3.12e-8	Obesity-related traits;
SKCM	cis	rs7811142	0.887	rs111972532	chr7:100069088	T/C	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.09	6.32	0.58	1.49e-8	Platelet count;
SKCM	cis	rs9325144	0.647	rs61930266	chr12:38922048	A/G	cg13010199	chr12:38710504	ALG10B	-0.66	-5.45	-0.53	5.73e-7	Morning vs. evening chronotype;
SKCM	cis	rs6424115	0.830	rs2229585	chr1:24200921	T/C	cg15997130	chr1:24165203	NA	0.6	4.94	0.49	4.37e-6	Immature fraction of reticulocytes;
SKCM	cis	rs6547631	0.622	rs2118402	chr2:85931078	A/G	cg24620635	chr2:85921963	GNLY	0.91	6.68	0.6	3.21e-9	Blood protein levels;
SKCM	cis	rs6570726	0.791	rs401331	chr6:145831408	A/G	cg05347473	chr6:146136440	FBXO30	0.53	4.78	0.48	8.07e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2439831	0.850	rs8042868	chr15:43939642	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.28	7.01	0.62	7.43e-10	Lung cancer in ever smokers;
SKCM	cis	rs7666738	0.830	rs13130923	chr4:99046281	T/C	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2836950	0.565	rs4816617	chr21:40540690	T/C	cg11890956	chr21:40555474	PSMG1	-0.7	-5.62	-0.54	2.84e-7	Menarche (age at onset);
SKCM	cis	rs13108904	0.935	rs2199956	chr4:1248919	A/G	cg05025164	chr4:1340916	KIAA1530	0.59	4.98	0.49	3.71e-6	Obesity-related traits;
SKCM	cis	rs4819052	0.851	rs2838850	chr21:46671445	G/C	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.36	0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs2841277	0.708	rs4465542	chr14:105407798	A/G	cg15352829	chr14:105391018	PLD4	-0.61	-5.12	-0.5	2.13e-6	Rheumatoid arthritis;
SKCM	cis	rs4862750	0.872	rs1991254	chr4:187875375	T/G	cg10295955	chr4:187884368	NA	-1.04	-13.63	-0.84	2.47e-22	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs637571	0.512	rs660118	chr11:65735174	G/C	cg26695010	chr11:65641043	EFEMP2	-0.69	-5.27	-0.51	1.17e-6	Eosinophil percentage of white cells;
SKCM	cis	rs67460515	0.500	rs9832109	chr3:160723364	T/C	cg03342759	chr3:160939853	NMD3	-0.65	-4.89	-0.48	5.3e-6	Parkinson's disease;
SKCM	cis	rs28595532	0.920	rs115084148	chr4:119739290	A/G	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs1577917	0.655	rs9444352	chr6:86257535	G/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.57	4.84	0.48	6.46e-6	Response to antipsychotic treatment;
SKCM	cis	rs362272	0.545	rs2239725	chr4:3305739	C/T	cg11471262	chr4:3318911	RGS12	0.93	11.0	0.78	1.55e-17	Serum sulfate level;
SKCM	cis	rs1801251	0.963	rs7591176	chr2:233581803	C/A	cg25237894	chr2:233734115	C2orf82	0.61	5.66	0.54	2.39e-7	Coronary artery disease;
SKCM	cis	rs28785552	0.589	rs7257371	chr19:53243910	A/G	cg10871876	chr19:53194124	ZNF83	0.95	6.82	0.61	1.72e-9	Response to paliperidone in schizophrenia (PANSS score);
SKCM	cis	rs1577917	1.000	rs117907570	chr6:86601283	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.61	-5.31	-0.52	9.96e-7	Response to antipsychotic treatment;
SKCM	cis	rs77216612	0.877	rs66561220	chr12:12878765	T/C	cg09462578	chr12:12878428	APOLD1	-0.85	-5.59	-0.54	3.17e-7	Lymphocyte counts;
SKCM	cis	rs1044826	0.642	rs4607068	chr3:139162994	A/G	cg15131784	chr3:139108705	COPB2	0.7	5.18	0.51	1.67e-6	Obesity-related traits;
SKCM	cis	rs478304	0.651	rs78412025	chr11:65495696	T/C	cg27068330	chr11:65405492	SIPA1	-0.89	-8.21	-0.68	3.71e-12	Acne (severe);
SKCM	cis	rs9894429	0.738	rs8077038	chr17:79577127	T/G	cg18240062	chr17:79603768	NPLOC4	-0.91	-10.36	-0.76	2.55e-16	Eye color traits;
SKCM	trans	rs561341	1.000	rs693116	chr17:30246124	C/T	cg20587970	chr11:113659929	NA	-1.19	-10.36	-0.76	2.61e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs8067545	0.611	rs7212500	chr17:20045658	A/G	cg13482628	chr17:19912719	NA	0.66	5.61	0.54	2.98e-7	Schizophrenia;
SKCM	cis	rs870825	0.929	rs55880126	chr4:185591237	T/G	cg04058563	chr4:185651563	MLF1IP	1.09	5.66	0.54	2.4e-7	Blood protein levels;
SKCM	cis	rs875971	0.798	rs57739047	chr7:65972566	A/T	cg11764359	chr7:65958608	NA	0.81	7.61	0.65	5.25e-11	Aortic root size;
SKCM	cis	rs55823223	0.648	rs66584478	chr17:73870203	G/A	cg08125733	chr17:73851984	WBP2	1.05	5.94	0.56	7.42e-8	Psoriasis;
SKCM	cis	rs2535633	0.642	rs6798941	chr3:52893465	C/T	cg11645453	chr3:52864694	ITIH4	0.56	4.79	0.48	7.86e-6	Body mass index;
SKCM	cis	rs4619890	0.510	rs28562959	chr4:7873174	T/C	cg08722675	chr4:8412549	ACOX3	0.54	4.95	0.49	4.16e-6	Glaucoma (primary open-angle);
SKCM	cis	rs58688157	0.705	rs936468	chr11:607175	G/A	cg03576123	chr11:487126	PTDSS2	-0.8	-5.15	-0.5	1.88e-6	Systemic lupus erythematosus;
SKCM	cis	rs1218582	0.596	rs906595	chr1:154822907	C/T	cg24250549	chr1:154909240	PMVK	0.65	5.78	0.55	1.46e-7	Prostate cancer;
SKCM	cis	rs7772486	0.738	rs9485039	chr6:146319387	C/T	cg23711669	chr6:146136114	FBXO30	0.73	6.58	0.6	4.81e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs8180040	0.620	rs2278963	chr3:47054869	G/T	cg27129171	chr3:47204927	SETD2	-0.74	-5.37	-0.52	7.84e-7	Colorectal cancer;
SKCM	cis	rs3768617	0.510	rs2296294	chr1:183095596	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs9611565	0.694	rs7285041	chr22:41829149	G/T	cg03806693	chr22:41940476	POLR3H	1.13	7.36	0.64	1.63e-10	Vitiligo;
SKCM	cis	rs4819052	0.851	rs2838857	chr21:46681000	A/G	cg20896738	chr21:46707857	POFUT2;LOC642852	0.65	4.89	0.48	5.35e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7824557	0.767	rs2164273	chr8:11168499	A/G	cg21775007	chr8:11205619	TDH	0.72	6.08	0.57	4.18e-8	Retinal vascular caliber;
SKCM	cis	rs9902453	0.967	rs12450956	chr17:28529025	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.78	5.31	0.52	1.01e-6	Coffee consumption (cups per day);
SKCM	cis	rs7772486	0.790	rs6570723	chr6:146151230	A/T	cg23711669	chr6:146136114	FBXO30	0.86	9.38	0.73	1.95e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4820539	1.000	rs916585	chr22:23469438	G/A	cg14186256	chr22:23484241	RTDR1	0.85	8.15	0.68	4.91e-12	Bone mineral density;
SKCM	cis	rs8114671	0.562	rs2425005	chr20:33407715	C/G	cg22976979	chr20:33146263	MAP1LC3A	-0.72	-4.84	-0.48	6.52e-6	Height;
SKCM	cis	rs12611334	0.929	rs2286757	chr19:40194866	C/T	cg04998674	chr19:40596855	ZNF780A	0.63	4.77	0.47	8.55e-6	Schizophrenia;
SKCM	cis	rs936229	0.813	rs2168519	chr15:75080872	T/C	cg14664628	chr15:75095509	CSK	-1.15	-9.89	-0.75	2.08e-15	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin);
SKCM	cis	rs1799949	1.000	rs12942277	chr17:41187974	G/C	cg23758822	chr17:41437982	NA	0.91	7.51	0.65	8.13e-11	Menopause (age at onset);
SKCM	cis	rs1153858	1.000	rs1288775	chr15:45661678	T/A	cg10760299	chr15:45669010	GATM	0.63	6.32	0.58	1.49e-8	Homoarginine levels;
SKCM	cis	rs1405130	0.869	rs13010653	chr2:235575273	G/A	cg17841421	chr2:235704848	NA	-0.6	-4.94	-0.49	4.34e-6	Coronary artery disease;
SKCM	cis	rs2204008	0.811	rs8189445	chr12:38276295	T/C	cg26384229	chr12:38710491	ALG10B	0.87	6.83	0.61	1.63e-9	Bladder cancer;
SKCM	cis	rs35306767	0.716	rs34487581	chr10:897201	G/A	cg20503657	chr10:835505	NA	0.78	5.53	0.53	4.14e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs873946	0.590	rs7071777	chr10:134559976	T/A	cg27286337	chr10:134555280	INPP5A	0.96	8.98	0.71	1.16e-13	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs3785574	0.962	rs2727329	chr17:61924566	C/T	cg01411255	chr17:61851458	DDX42;CCDC47	1.15	12.64	0.82	1.42e-20	Height;
SKCM	cis	rs6879260	1.000	rs729568	chr5:179732350	C/T	cg23248424	chr5:179741104	GFPT2	0.73	6.36	0.58	1.26e-8	Height;
SKCM	trans	rs208520	0.565	rs1385222	chr6:66753013	C/T	cg15611600	chr13:45563400	KIAA1704;NUFIP1	1.02	11.12	0.78	9.51e-18	Exhaled nitric oxide output;
SKCM	cis	rs1005277	0.502	rs2800484	chr10:38542415	C/T	cg00409905	chr10:38381863	ZNF37A	-0.62	-5.78	-0.55	1.49e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs28595532	0.920	rs56331118	chr4:119767054	G/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs28595532	0.800	rs114321375	chr4:119341663	G/A	cg21605333	chr4:119757512	SEC24D	0.95	4.91	0.49	4.92e-6	Cannabis dependence symptom count;
SKCM	cis	rs6120849	0.754	rs6088678	chr20:33607551	A/G	cg24642439	chr20:33292090	TP53INP2	-0.94	-4.86	-0.48	5.91e-6	Protein C levels;
SKCM	cis	rs6456156	0.586	rs720325	chr6:167467349	G/T	cg07741184	chr6:167504864	NA	0.55	4.81	0.48	7.33e-6	Primary biliary cholangitis;
SKCM	cis	rs72717009	0.825	rs9427398	chr1:161476205	A/G	cg23840854	chr1:161414152	NA	-0.99	-5.66	-0.54	2.44e-7	Rheumatoid arthritis;
SKCM	cis	rs344364	0.511	rs2917519	chr16:1950479	C/A	cg26897989	chr16:1907736	C16orf73	-0.69	-7.13	-0.63	4.45e-10	Glomerular filtration rate in chronic kidney disease;
SKCM	cis	rs9815354	0.767	rs79323474	chr3:42000973	C/T	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs4862750	0.914	rs11945845	chr4:187874136	T/C	cg10295955	chr4:187884368	NA	-1.03	-12.64	-0.82	1.46e-20	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7666738	0.830	rs7662389	chr4:99019892	G/A	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1577917	1.000	rs1857964	chr6:86635994	A/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.66	-5.74	-0.54	1.76e-7	Response to antipsychotic treatment;
SKCM	cis	rs365132	1.000	rs601923	chr5:176417386	C/G	cg16309518	chr5:176445507	NA	-0.53	-5.22	-0.51	1.44e-6	Menarche and menopause (age at onset);Menopause (age at onset);
SKCM	cis	rs908922	0.651	rs4240885	chr1:152529850	G/C	cg09873164	chr1:152488093	CRCT1	0.72	5.62	0.54	2.85e-7	Hair morphology;
SKCM	cis	rs9611565	0.500	rs2011053	chr22:42121278	G/A	cg03806693	chr22:41940476	POLR3H	0.79	5.05	0.5	2.87e-6	Vitiligo;
SKCM	cis	rs4319547	1.000	rs7295397	chr12:123116209	C/T	cg23029597	chr12:123009494	RSRC2	-0.82	-5.97	-0.56	6.64e-8	Body mass index;
SKCM	cis	rs17376456	0.569	rs17083377	chr5:93164870	C/G	cg25358565	chr5:93447407	FAM172A	0.91	5.81	0.55	1.29e-7	Diabetic retinopathy;
SKCM	cis	rs6753739	0.745	rs6751990	chr2:219912295	T/C	cg09617556	chr2:219924408	IHH	0.47	4.94	0.49	4.44e-6	Height;
SKCM	cis	rs2652834	0.898	rs10162675	chr15:63370358	T/C	cg04194852	chr15:63334506	TPM1	-0.73	-4.93	-0.49	4.61e-6	HDL cholesterol;
SKCM	cis	rs8177253	0.828	rs8177259	chr3:133480388	T/C	cg16414030	chr3:133502952	NA	-0.69	-5.84	-0.55	1.12e-7	Iron status biomarkers;
SKCM	cis	rs12497850	0.931	rs9311430	chr3:48845251	C/T	cg07636037	chr3:49044803	WDR6	0.97	10.25	0.76	4.16e-16	Parkinson's disease;
SKCM	cis	rs9902453	0.726	rs3115088	chr17:28031275	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.79	5.93	0.56	7.67e-8	Coffee consumption (cups per day);
SKCM	cis	rs7618915	0.501	rs34754793	chr3:52629177	A/T	cg18404041	chr3:52824283	ITIH1	-0.53	-4.77	-0.48	8.42e-6	Bipolar disorder;
SKCM	cis	rs6582630	0.519	rs11519914	chr12:38287014	A/G	cg26384229	chr12:38710491	ALG10B	0.78	6.56	0.6	5.26e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs1850744	0.702	rs6837106	chr4:9626304	T/C	cg15442990	chr4:9534313	NA	1.55	5.8	0.55	1.34e-7	Economic and political preferences;
SKCM	cis	rs9393692	0.905	rs9366649	chr6:26329103	A/T	cg00631329	chr6:26305371	NA	0.67	4.79	0.48	7.79e-6	Educational attainment;
SKCM	cis	rs56235845	0.694	rs6860069	chr5:176755841	C/T	cg17509989	chr5:176798049	RGS14	0.76	6.09	0.57	4.04e-8	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs4819052	0.788	rs9978857	chr21:46705155	T/G	cg20896738	chr21:46707857	POFUT2;LOC642852	0.69	4.9	0.49	5.07e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7954584	0.567	rs7132055	chr12:122346034	A/G	cg22168489	chr12:122356033	WDR66	-0.49	-5.02	-0.49	3.19e-6	Mean corpuscular volume;
SKCM	cis	rs6952808	0.723	rs1107592	chr7:2041432	C/T	cg02951883	chr7:2050386	MAD1L1	0.83	7.53	0.65	7.48e-11	Bipolar disorder and schizophrenia;
SKCM	cis	rs4683346	0.636	rs4682867	chr3:42905465	C/T	cg06399164	chr3:42695035	ZBTB47	0.57	5.0	0.49	3.47e-6	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs7020830	0.931	rs7851239	chr9:37138672	A/G	cg14294708	chr9:37120828	ZCCHC7	-1.18	-10.43	-0.76	1.93e-16	Schizophrenia;
SKCM	cis	rs2836950	0.545	rs2836922	chr21:40516308	C/T	cg11644478	chr21:40555479	PSMG1	-0.72	-5.47	-0.53	5.3e-7	Menarche (age at onset);
SKCM	cis	rs9325144	0.560	rs7971313	chr12:38653413	A/G	cg26384229	chr12:38710491	ALG10B	-0.61	-4.93	-0.49	4.57e-6	Morning vs. evening chronotype;
SKCM	cis	rs7666738	0.830	rs6819177	chr4:99040907	T/C	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1801251	1.000	rs7558609	chr2:233700379	C/T	cg08000102	chr2:233561755	GIGYF2	0.83	6.73	0.61	2.54e-9	Coronary artery disease;
SKCM	cis	rs4481887	0.927	rs4376768	chr1:248476088	A/G	cg00666640	chr1:248458726	OR2T12	-0.64	-6.18	-0.57	2.74e-8	Common traits (Other);
SKCM	cis	rs55962025	0.842	rs73193303	chr4:3192200	A/G	cg24015175	chr4:3319247	RGS12	-0.57	-4.93	-0.49	4.45e-6	Parental longevity (mother's age at death);
SKCM	cis	rs3820928	0.874	rs13383070	chr2:227904939	C/T	cg11843606	chr2:227700838	RHBDD1	-0.6	-4.95	-0.49	4.18e-6	Pulmonary function;
SKCM	cis	rs838147	0.760	rs412712	chr19:49234299	A/T	cg13540341	chr19:49222985	MAMSTR	0.63	5.73	0.54	1.78e-7	Dietary macronutrient intake;
SKCM	cis	rs7809950	0.678	rs79902674	chr7:106866498	A/C	cg23024343	chr7:107201750	COG5	-0.77	-6.61	-0.6	4.37e-9	Coronary artery disease;
SKCM	trans	rs1814175	0.935	rs10839329	chr11:49694206	G/A	cg03929089	chr4:120376271	NA	-0.88	-7.69	-0.66	3.73e-11	Height;
SKCM	cis	rs826838	1.000	rs1095575	chr12:39110284	C/G	cg26384229	chr12:38710491	ALG10B	-0.92	-8.26	-0.68	2.89e-12	Heart rate;
SKCM	cis	rs427394	0.593	rs880993	chr5:6732120	C/G	cg10857441	chr5:6722123	POLS	-0.69	-7.38	-0.64	1.51e-10	Menopause (age at onset);
SKCM	cis	rs2832191	0.791	rs4817270	chr21:30480368	G/A	cg24692254	chr21:30365293	RNF160	-0.9	-8.03	-0.67	8.39e-12	Dental caries;
SKCM	cis	rs7020830	0.867	rs1339553	chr9:37266123	C/G	cg14294708	chr9:37120828	ZCCHC7	1.01	9.61	0.74	7.19e-15	Schizophrenia;
SKCM	cis	rs1707322	1.000	rs4454479	chr1:46423555	G/A	cg03146154	chr1:46216737	IPP	0.8	5.44	0.52	5.87e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs826838	0.935	rs3886109	chr12:39189243	C/T	cg13010199	chr12:38710504	ALG10B	0.67	5.06	0.5	2.68e-6	Heart rate;
SKCM	cis	rs72781680	0.898	rs72786298	chr2:24083011	C/T	cg08917208	chr2:24149416	ATAD2B	1.07	5.67	0.54	2.28e-7	Lymphocyte counts;
SKCM	cis	rs875971	0.830	rs6976714	chr7:65891461	G/A	cg11764359	chr7:65958608	NA	0.81	7.61	0.65	5.25e-11	Aortic root size;
SKCM	trans	rs1814175	0.647	rs10839394	chr11:49844747	T/C	cg15704280	chr7:45808275	SEPT13	-1.02	-10.65	-0.77	7.08e-17	Height;
SKCM	cis	rs6450176	0.638	rs56220547	chr5:53287952	A/G	ch.5.1024479R	chr5:53302184	ARL15	-0.89	-4.97	-0.49	3.94e-6	HDL cholesterol levels;HDL cholesterol;Adiponectin levels;
SKCM	cis	rs1577917	0.665	rs4304137	chr6:86217448	G/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.79	7.26	0.64	2.46e-10	Response to antipsychotic treatment;
SKCM	cis	rs6088580	0.561	rs3761147	chr20:32996689	G/T	cg24642439	chr20:33292090	TP53INP2	-0.76	-6.02	-0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs8180040	0.966	rs13079098	chr3:47442863	A/G	cg27129171	chr3:47204927	SETD2	0.79	5.79	0.55	1.43e-7	Colorectal cancer;
SKCM	cis	rs4481887	0.927	rs4916087	chr1:248493833	T/C	cg00666640	chr1:248458726	OR2T12	0.61	5.25	0.51	1.28e-6	Common traits (Other);
SKCM	cis	rs2386661	0.516	rs61832676	chr10:5646337	G/A	cg12223502	chr10:5658492	NA	-0.53	-4.87	-0.48	5.76e-6	Breast cancer;
SKCM	cis	rs2974760	0.606	rs2858918	chr16:201183	T/C	cg08400316	chr16:204221	HBZ	0.96	7.52	0.65	8.03e-11	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs35306767	0.761	rs11253537	chr10:1010735	G/A	cg26597838	chr10:835615	NA	0.76	6.32	0.58	1.52e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs951366	0.646	rs1772159	chr1:205759195	G/A	cg07167872	chr1:205819463	PM20D1	0.98	9.58	0.74	8.17e-15	Menarche (age at onset);
SKCM	cis	rs763121	0.853	rs138702	chr22:39132601	A/T	cg06022373	chr22:39101656	GTPBP1	-0.8	-5.07	-0.5	2.63e-6	Menopause (age at onset);
SKCM	cis	rs7940866	0.903	rs7942900	chr11:130839244	G/A	cg12179176	chr11:130786555	SNX19	0.78	5.91	0.56	8.48e-8	Schizophrenia;
SKCM	cis	rs2180341	0.920	rs6916990	chr6:127698759	G/A	cg27446573	chr6:127587934	RNF146	0.93	8.09	0.68	6.27e-12	Breast cancer;
SKCM	cis	rs7829975	0.564	rs2921057	chr8:8318667	C/T	cg08975724	chr8:8085496	FLJ10661	0.78	6.73	0.61	2.58e-9	Mood instability;
SKCM	cis	rs769267	0.965	rs2965191	chr19:19453521	T/G	cg03709012	chr19:19516395	GATAD2A	-0.84	-6.79	-0.61	1.97e-9	Tonsillectomy;
SKCM	cis	rs10737909	1.000	rs10803369	chr1:15550525	G/T	cg21012057	chr1:15538911	TMEM51	-0.51	-5.11	-0.5	2.28e-6	Migraine;
SKCM	cis	rs324014	0.845	rs2122692	chr12:57510511	C/G	cg17311469	chr12:58022410	B4GALNT1	-0.38	-5.0	-0.49	3.44e-6	Itch intensity from mosquito bite adjusted by bite size;Itch intensity from mosquito bite;
SKCM	cis	rs2439831	0.850	rs28513374	chr15:44125495	G/A	cg02155558	chr15:43621948	ADAL;LCMT2	1.35	7.76	0.66	2.77e-11	Lung cancer in ever smokers;
SKCM	cis	rs12477438	0.520	rs2309581	chr2:99784292	A/G	cg26064155	chr2:99771622	LIPT1;TSGA10	-0.87	-6.59	-0.6	4.77e-9	Chronic sinus infection;
SKCM	cis	rs1799949	1.000	rs8176083	chr17:41275151	G/C	cg05368731	chr17:41323189	NBR1	0.89	7.58	0.65	6.06e-11	Menopause (age at onset);
SKCM	cis	rs6951245	1.000	rs2363286	chr7:1091625	A/G	cg03188948	chr7:1209495	NA	1.01	5.8	0.55	1.32e-7	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs16854884	1.000	rs35887108	chr3:143780632	C/T	cg06585982	chr3:143692056	C3orf58	0.74	5.69	0.54	2.17e-7	Economic and political preferences (feminism/equality);
SKCM	cis	rs9814567	0.806	rs55835132	chr3:134325256	T/G	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.65	-5.19	-0.51	1.6e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs11734570	0.581	rs73811716	chr4:38590773	C/T	cg18361445	chr4:38666374	KLF3;FLJ13197	0.86	5.85	0.55	1.08e-7	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs10911232	0.507	rs10797816	chr1:182998486	A/T	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.64	0.6	3.83e-9	Hypertriglyceridemia;
SKCM	cis	rs2072510	0.966	rs2660896	chr12:96423782	A/G	cg18817487	chr12:96390143	HAL	0.42	5.62	0.54	2.83e-7	Metabolite levels (small molecules and protein measures);
SKCM	cis	rs6138458	1.000	rs227630	chr20:24913584	A/G	cg26195577	chr20:24973756	C20orf3	1.29	8.69	0.7	4.32e-13	Blood protein levels;
SKCM	cis	rs6977660	0.714	rs6959039	chr7:19818182	T/C	cg05791153	chr7:19748676	TWISTNB	0.77	5.02	0.49	3.23e-6	Thyroid stimulating hormone;
SKCM	cis	rs1348850	0.793	rs13000048	chr2:178337089	C/A	cg02961200	chr2:178257176	LOC100130691;AGPS	0.82	6.18	0.57	2.78e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs7659604	0.539	rs72680779	chr4:122797263	C/T	cg06713675	chr4:122721982	EXOSC9	-0.74	-6.99	-0.62	8.23e-10	Type 2 diabetes;
SKCM	cis	rs9913156	0.793	rs11568061	chr17:4546445	G/A	cg19197139	chr17:4613644	ARRB2	0.79	4.92	0.49	4.67e-6	Lymphocyte counts;
SKCM	cis	rs9796	0.689	rs561301	chr15:41444723	C/T	cg18705301	chr15:41695430	NDUFAF1	-0.74	-5.35	-0.52	8.47e-7	Menopause (age at onset);
SKCM	cis	rs1577917	1.000	rs12196037	chr6:86694631	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.64	-5.54	-0.53	3.92e-7	Response to antipsychotic treatment;
SKCM	cis	rs1568889	1.000	rs7951681	chr11:28273894	G/C	cg06544937	chr11:28130018	METT5D1;KIF18A	0.86	6.4	0.59	1.07e-8	Bipolar disorder;
SKCM	cis	rs34172651	0.517	rs2287783	chr16:24831727	C/T	cg04756594	chr16:24857601	SLC5A11	0.71	5.04	0.5	2.92e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2075371	0.933	rs2544182	chr7:133949793	C/T	cg20476274	chr7:133979776	SLC35B4	1.05	10.88	0.78	2.69e-17	Mean platelet volume;
SKCM	cis	rs7193541	0.684	rs4887783	chr16:74700743	G/C	cg01733217	chr16:74700730	RFWD3	1.05	12.02	0.81	1.97e-19	Multiple myeloma;
SKCM	cis	rs6942756	0.876	rs7789697	chr7:129060386	T/A	cg02491457	chr7:128862824	NA	-0.78	-4.89	-0.48	5.27e-6	White matter hyperintensity burden;
SKCM	cis	rs9543976	0.925	rs2876706	chr13:76186305	T/G	cg16409306	chr13:76195284	LMO7	0.84	4.79	0.48	7.87e-6	Diabetic retinopathy;
SKCM	cis	rs4665809	0.525	rs4665324	chr2:26447147	A/C	cg26119090	chr2:26468346	HADHA;HADHB	-1.06	-8.39	-0.69	1.66e-12	Gut microbiome composition (summer);
SKCM	cis	rs72615157	0.664	rs6953580	chr7:99825275	A/G	cg23667466	chr7:100026434	MEPCE;ZCWPW1	0.91	4.87	0.48	5.74e-6	Lung function (FEV1/FVC);
SKCM	cis	rs1577917	1.000	rs12204015	chr6:86598334	C/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.61	-5.31	-0.52	1.02e-6	Response to antipsychotic treatment;
SKCM	cis	rs7809950	1.000	rs2237673	chr7:107131580	T/C	cg23024343	chr7:107201750	COG5	-0.74	-6.61	-0.6	4.39e-9	Coronary artery disease;
SKCM	cis	rs12802200	0.561	rs7940600	chr11:572105	A/G	cg16486109	chr11:613632	IRF7	0.89	5.45	0.53	5.7e-7	Systemic lupus erythematosus;
SKCM	cis	rs6088580	0.634	rs1205345	chr20:32914699	A/G	cg24642439	chr20:33292090	TP53INP2	-0.73	-5.65	-0.54	2.55e-7	Glomerular filtration rate (creatinine);
SKCM	cis	rs507080	0.922	rs644498	chr11:118567486	T/C	cg18045108	chr11:118530628	TREH	-0.47	-5.11	-0.5	2.22e-6	Serum metabolite levels;
SKCM	cis	rs875971	0.862	rs6964437	chr7:65686444	A/G	cg18876405	chr7:65276391	NA	-0.65	-6.74	-0.61	2.46e-9	Aortic root size;
SKCM	cis	rs2404602	0.692	rs35395069	chr15:76986334	C/T	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs62244186	0.545	rs7640654	chr3:44763037	A/C	cg15225532	chr3:44803084	KIF15;KIAA1143	0.63	4.86	0.48	5.88e-6	Depressive symptoms;
SKCM	cis	rs910316	1.000	rs175512	chr14:75523382	T/C	cg08847533	chr14:75593920	NEK9	-0.96	-8.88	-0.71	1.83e-13	Height;
SKCM	cis	rs561341	1.000	rs550264	chr17:30317540	G/T	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs55823223	0.564	rs4572466	chr17:73846314	A/C	cg08125733	chr17:73851984	WBP2	1.06	6.62	0.6	4.16e-9	Psoriasis;
SKCM	cis	rs28595532	0.841	rs116582665	chr4:119487248	G/C	cg11846333	chr4:119757529	SEC24D	1.15	6.24	0.58	2.13e-8	Cannabis dependence symptom count;
SKCM	cis	rs189798	0.807	rs12785	chr8:8994936	A/T	cg06636001	chr8:8085503	FLJ10661	0.82	5.9	0.56	9.02e-8	Myopia (pathological);
SKCM	cis	rs9399135	0.967	rs7750300	chr6:135350950	C/G	cg24558204	chr6:135376177	HBS1L	0.61	5.34	0.52	8.82e-7	Red blood cell count;
SKCM	cis	rs910316	0.967	rs2268619	chr14:75640354	C/G	cg08847533	chr14:75593920	NEK9	-0.96	-8.31	-0.69	2.41e-12	Height;
SKCM	trans	rs11722228	0.522	rs12504600	chr4:10067138	C/A	cg26043149	chr18:55253948	FECH	0.91	7.48	0.65	9.63e-11	Gout;Urate levels;Serum uric acid levels;
SKCM	cis	rs870825	0.616	rs6552810	chr4:185644143	G/A	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs28595532	0.920	rs10018977	chr4:119785229	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	trans	rs10506458	0.915	rs12426308	chr12:63405778	C/T	cg03429785	chr15:59498649	MYO1E;LDHAL6B	-1.38	-7.54	-0.65	7.13e-11	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs28386778	0.897	rs11079510	chr17:61820902	T/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.12	11.27	0.79	4.92e-18	Prudent dietary pattern;
SKCM	cis	rs514406	0.861	rs1749907	chr1:53259658	C/T	cg16325326	chr1:53192061	ZYG11B	-0.99	-11.71	-0.8	7.39e-19	Monocyte count;
SKCM	cis	rs116095464	0.558	rs10036253	chr5:238519	A/C	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	trans	rs2727020	0.615	rs35423199	chr11:49514914	T/C	cg15704280	chr7:45808275	SEPT13	-0.97	-9.13	-0.72	6.1e-14	Coronary artery disease;
SKCM	cis	rs6570726	0.902	rs396681	chr6:145853603	T/C	cg23711669	chr6:146136114	FBXO30	0.72	6.84	0.61	1.58e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7618501	0.633	rs6446189	chr3:50008566	A/G	cg05072774	chr3:49840536	C3orf54	-0.67	-5.06	-0.5	2.73e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs28595532	0.841	rs116582665	chr4:119487248	G/C	cg14228332	chr4:119757509	SEC24D	0.97	4.92	0.49	4.71e-6	Cannabis dependence symptom count;
SKCM	cis	rs11229030	0.893	rs2584859	chr11:57207447	A/G	cg00522883	chr11:57194120	SLC43A3	0.73	5.9	0.56	8.82e-8	Crohn's disease;
SKCM	cis	rs7216064	1.000	rs8079754	chr17:65887896	A/G	cg12091567	chr17:66097778	LOC651250	-0.76	-5.38	-0.52	7.44e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs6545883	0.542	rs10177225	chr2:61594498	C/T	cg15711740	chr2:61764176	XPO1	0.66	5.12	0.5	2.17e-6	Tuberculosis;
SKCM	cis	rs28386778	0.897	rs7212196	chr17:61834981	T/C	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.36	0.52	8.36e-7	Prudent dietary pattern;
SKCM	cis	rs2404602	0.692	rs67010831	chr15:76965308	T/G	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs28595532	0.920	rs115354352	chr4:119750358	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs2354432	0.607	rs2353999	chr1:146830686	T/C	cg25205988	chr1:146714368	CHD1L	-1.13	-6.24	-0.58	2.08e-8	Mitochondrial DNA levels;
SKCM	cis	rs35306767	0.859	rs11817793	chr10:878895	C/T	cg20503657	chr10:835505	NA	0.78	5.21	0.51	1.52e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs1005277	0.579	rs2474586	chr10:38418882	T/C	cg25427524	chr10:38739819	LOC399744	-0.71	-6.74	-0.61	2.44e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs208520	0.690	rs1776365	chr6:66834474	G/T	cg07460842	chr6:66804631	NA	-1.09	-8.46	-0.69	1.22e-12	Exhaled nitric oxide output;
SKCM	cis	rs4975616	0.750	rs4404721	chr5:1306165	T/C	cg06550200	chr5:1325588	CLPTM1L	0.69	5.08	0.5	2.56e-6	Lung cancer;
SKCM	cis	rs2455601	0.882	rs11042118	chr11:8928791	T/A	cg21881798	chr11:8931708	C11orf17;ST5	-0.78	-5.59	-0.53	3.21e-7	Schizophrenia;
SKCM	cis	rs2013441	1.000	rs4924810	chr17:20071819	T/C	cg13482628	chr17:19912719	NA	0.67	5.24	0.51	1.32e-6	Obesity-related traits;
SKCM	cis	rs3820928	0.967	rs4675118	chr2:227773157	C/A	cg11843606	chr2:227700838	RHBDD1	-0.64	-5.2	-0.51	1.53e-6	Pulmonary function;
SKCM	cis	rs2439831	1.000	rs2467739	chr15:43740196	G/A	cg02155558	chr15:43621948	ADAL;LCMT2	1.12	8.05	0.67	7.58e-12	Lung cancer in ever smokers;
SKCM	cis	rs10028773	0.515	rs9994488	chr4:120587781	C/T	cg09307838	chr4:120376055	NA	0.91	7.58	0.65	6.11e-11	Educational attainment;
SKCM	cis	rs738321	0.658	rs5756916	chr22:38507047	G/A	cg25457927	chr22:38595422	NA	-0.67	-7.99	-0.67	9.95e-12	Breast cancer;
SKCM	cis	rs28386778	0.799	rs2727322	chr17:61921706	G/A	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs3768617	0.510	rs10752899	chr1:183081241	T/G	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs748404	0.560	rs572837	chr15:43823813	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	0.67	5.08	0.5	2.53e-6	Lung cancer;
SKCM	cis	rs1799949	1.000	rs8176202	chr17:41230228	G/A	cg23758822	chr17:41437982	NA	0.94	7.87	0.67	1.68e-11	Menopause (age at onset);
SKCM	cis	rs17685	0.753	rs6953665	chr7:75769049	C/T	cg16684958	chr7:75615977	POR	0.55	5.27	0.51	1.19e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs4819052	0.959	rs9976074	chr21:46655638	G/T	cg02159808	chr21:46707872	POFUT2;LOC642852	0.8	5.8	0.55	1.37e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs28595532	0.920	rs115464801	chr4:119730673	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.43	0.59	9.38e-9	Cannabis dependence symptom count;
SKCM	cis	rs7100689	0.784	rs7082102	chr10:82104890	A/C	cg00277334	chr10:82204260	NA	-0.59	-5.67	-0.54	2.33e-7	Post bronchodilator FEV1;
SKCM	cis	rs9303401	0.659	rs62083368	chr17:56878062	G/A	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.35	0.52	8.54e-7	Cognitive test performance;
SKCM	cis	rs7666738	0.830	rs1593570	chr4:99017058	T/C	cg17366294	chr4:99064904	C4orf37	0.6	4.98	0.49	3.66e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1691799	0.899	rs1168329	chr12:66731864	C/A	cg16791601	chr12:66731901	HELB	-0.66	-5.81	-0.55	1.31e-7	White blood cell count (basophil);
SKCM	cis	rs782590	0.967	rs11125581	chr2:55796527	C/G	cg18811423	chr2:55921094	PNPT1	0.9	6.98	0.62	8.78e-10	Metabolic syndrome;
SKCM	cis	rs514406	0.893	rs6682024	chr1:53439525	T/C	cg16325326	chr1:53192061	ZYG11B	-0.91	-9.81	-0.74	2.87e-15	Monocyte count;
SKCM	cis	rs9443189	0.813	rs2133191	chr6:76440761	C/T	cg01950844	chr6:76311363	SENP6	-0.75	-5.29	-0.51	1.1e-6	Prostate cancer;
SKCM	cis	rs769267	0.831	rs2872878	chr19:19480521	G/C	cg03709012	chr19:19516395	GATAD2A	-0.9	-8.22	-0.68	3.5e-12	Tonsillectomy;
SKCM	cis	rs807669	0.903	rs2800974	chr22:19168087	C/T	cg02655711	chr22:19163373	SLC25A1	0.78	6.99	0.62	8.17e-10	Metabolite levels;
SKCM	cis	rs12142240	0.698	rs6703374	chr1:46862332	C/G	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs55962025	0.711	rs4690072	chr4:3122507	T/G	cg00764545	chr4:3318001	RGS12	-0.59	-5.12	-0.5	2.15e-6	Parental longevity (mother's age at death);
SKCM	cis	rs7552404	0.924	rs12136754	chr1:76230232	C/A	cg03433033	chr1:76189801	ACADM	0.76	5.36	0.52	8.17e-7	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs7613875	0.641	rs6446194	chr3:50067298	T/A	cg24110177	chr3:50126178	RBM5	0.69	5.49	0.53	4.88e-7	Body mass index;
SKCM	cis	rs4727027	0.870	rs62507509	chr7:148795522	C/T	cg23583168	chr7:148888333	NA	-0.82	-6.49	-0.59	7.11e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs860295	0.836	rs6684889	chr1:155427062	T/A	cg02153340	chr1:155202674	NA	0.7	5.46	0.53	5.46e-7	Body mass index;
SKCM	cis	rs10791097	0.547	rs1050078	chr11:130746146	T/C	cg12179176	chr11:130786555	SNX19	0.94	8.11	0.68	5.86e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs4073582	0.595	rs801739	chr11:65922589	A/G	cg16950941	chr11:66035639	RAB1B	0.86	7.28	0.64	2.28e-10	Gout;
SKCM	cis	rs7666738	0.830	rs17027090	chr4:98897923	G/T	cg17366294	chr4:99064904	C4orf37	0.57	4.85	0.48	6.12e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs34375054	0.525	rs7133614	chr12:125605957	C/T	cg25124228	chr12:125621409	AACS	-0.8	-6.54	-0.6	5.73e-9	Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs9368481	0.729	rs9379948	chr6:26944783	T/G	cg12292205	chr6:26970375	C6orf41	0.67	6.14	0.57	3.26e-8	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs4969178	0.965	rs12450528	chr17:76395753	G/A	cg20026190	chr17:76395443	PGS1	0.61	5.29	0.51	1.08e-6	HDL cholesterol levels;
SKCM	cis	rs6696846	0.765	rs2836	chr1:205111761	G/T	cg03948781	chr1:205179583	DSTYK	-0.51	-4.85	-0.48	6.24e-6	Red blood cell count;
SKCM	cis	rs606458	0.920	rs680273	chr11:64539635	C/G	cg07674570	chr11:65346152	EHBP1L1	0.68	5.05	0.5	2.85e-6	Urate levels;
SKCM	cis	rs17065868	1.000	rs9533919	chr13:45156951	C/T	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs9486715	0.830	rs2255552	chr6:96999643	A/G	cg06623918	chr6:96969491	KIAA0776	-0.83	-7.3	-0.64	2.1e-10	Headache;
SKCM	cis	rs1218582	0.682	rs12144978	chr1:154850445	G/A	cg16680214	chr1:154839983	KCNN3	-0.54	-4.81	-0.48	7.22e-6	Prostate cancer;
SKCM	cis	rs7829975	0.688	rs6601703	chr8:8380224	A/G	cg08975724	chr8:8085496	FLJ10661	0.66	5.2	0.51	1.57e-6	Mood instability;
SKCM	cis	rs12497850	1.000	rs1352420	chr3:48757291	A/G	cg07636037	chr3:49044803	WDR6	0.9	9.08	0.72	7.39e-14	Parkinson's disease;
SKCM	cis	rs208520	0.690	rs1580430	chr6:66715162	T/A	cg07460842	chr6:66804631	NA	0.9	7.28	0.64	2.28e-10	Exhaled nitric oxide output;
SKCM	cis	rs2120019	1.000	rs12903201	chr15:75370776	A/C	cg17294928	chr15:75287854	SCAMP5	-0.82	-6.77	-0.61	2.13e-9	Blood trace element (Zn levels);
SKCM	cis	rs7829975	0.714	rs60315134	chr8:8670599	A/G	cg06636001	chr8:8085503	FLJ10661	0.72	6.26	0.58	1.97e-8	Mood instability;
SKCM	cis	rs4237845	0.804	rs10877034	chr12:58286444	T/C	cg00677455	chr12:58241039	CTDSP2	0.67	5.54	0.53	3.95e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs9858542	1.000	rs11709525	chr3:49690496	C/T	cg03060546	chr3:49711283	APEH	-0.77	-5.69	-0.54	2.15e-7	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs9467773	1.000	rs9393729	chr6:26514166	C/T	cg15659132	chr6:26577336	NA	0.6	5.71	0.54	1.99e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs9393692	0.557	rs9379845	chr6:26291601	C/T	cg00631329	chr6:26305371	NA	-0.68	-5.19	-0.51	1.6e-6	Educational attainment;
SKCM	cis	rs34779708	0.931	rs34087268	chr10:35346724	T/G	cg03585969	chr10:35415529	CREM	0.76	6.26	0.58	1.91e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs34172651	0.517	rs11862923	chr16:24767303	G/T	cg06028605	chr16:24865363	SLC5A11	0.59	4.98	0.49	3.66e-6	Intelligence (multi-trait analysis);
SKCM	trans	rs561341	1.000	rs537166	chr17:30326827	C/T	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs4272321	1	rs4272321	chr7:157951835	A/G	cg05195085	chr7:157951403	PTPRN2	0.49	6.23	0.58	2.2e-8	Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes;
SKCM	cis	rs2197308	0.740	rs10880619	chr12:37922720	T/C	cg13010199	chr12:38710504	ALG10B	0.65	4.93	0.49	4.48e-6	Morning vs. evening chronotype;
SKCM	cis	rs2952156	0.883	rs2517960	chr17:37846521	T/C	cg00129232	chr17:37814104	STARD3	-0.66	-5.38	-0.52	7.54e-7	Asthma;
SKCM	cis	rs8180040	0.620	rs11715121	chr3:47072621	T/A	cg27129171	chr3:47204927	SETD2	-0.74	-5.37	-0.52	7.84e-7	Colorectal cancer;
SKCM	cis	rs10752881	1.000	rs10752883	chr1:182980963	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.74	6.71	0.6	2.81e-9	Colorectal cancer;
SKCM	cis	rs12142240	0.698	rs17361936	chr1:46862893	C/T	cg10495392	chr1:46806563	NSUN4	0.75	5.56	0.53	3.58e-7	Menopause (age at onset);
SKCM	cis	rs17376456	0.825	rs10078941	chr5:93279029	C/T	cg25358565	chr5:93447407	FAM172A	1.31	7.46	0.65	1.04e-10	Diabetic retinopathy;
SKCM	cis	rs9399135	0.660	rs9376072	chr6:135280519	G/C	cg24558204	chr6:135376177	HBS1L	0.65	5.97	0.56	6.49e-8	Red blood cell count;
SKCM	cis	rs4332037	0.522	rs4721098	chr7:1881527	G/C	cg23422044	chr7:1970798	MAD1L1	0.9	5.84	0.55	1.16e-7	Bipolar disorder;
SKCM	cis	rs4808199	0.649	rs12983940	chr19:19516431	G/A	cg03709012	chr19:19516395	GATAD2A	1.12	8.37	0.69	1.84e-12	Nonalcoholic fatty liver disease;
SKCM	cis	rs67460515	0.892	rs35100811	chr3:161084046	A/C	cg03342759	chr3:160939853	NMD3	-0.81	-6.99	-0.62	8.35e-10	Parkinson's disease;
SKCM	cis	rs2836950	0.565	rs8131132	chr21:40538256	T/C	cg11890956	chr21:40555474	PSMG1	-0.7	-5.62	-0.54	2.84e-7	Menarche (age at onset);
SKCM	cis	rs9549367	0.713	rs4907599	chr13:113861441	C/T	cg18105134	chr13:113819100	PROZ	0.84	6.5	0.59	7.01e-9	Platelet distribution width;
SKCM	cis	rs6120849	0.754	rs1885117	chr20:33600740	C/T	cg24642439	chr20:33292090	TP53INP2	0.94	4.86	0.48	5.91e-6	Protein C levels;
SKCM	cis	rs7659604	1.000	rs35249024	chr4:122664538	C/A	cg19748678	chr4:122722346	EXOSC9	0.68	5.59	0.53	3.23e-7	Type 2 diabetes;
SKCM	cis	rs1218582	0.510	rs2878411	chr1:154823545	C/T	cg03351412	chr1:154909251	PMVK	0.6	4.79	0.48	7.79e-6	Prostate cancer;
SKCM	cis	rs2011503	0.882	rs72999030	chr19:19364240	A/T	cg11584989	chr19:19387371	SF4	0.78	5.16	0.5	1.85e-6	Bipolar disorder;
SKCM	cis	rs7666738	0.830	rs13125537	chr4:98978428	A/G	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs34779708	0.966	rs34776628	chr10:35426324	G/A	cg03585969	chr10:35415529	CREM	0.74	6.04	0.56	4.96e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs8180040	0.620	rs6768722	chr3:47079112	G/A	cg27129171	chr3:47204927	SETD2	0.74	5.37	0.52	7.84e-7	Colorectal cancer;
SKCM	cis	rs28595532	0.920	rs114792862	chr4:119759938	G/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs7954584	0.531	rs11043271	chr12:122394921	A/C	cg01765077	chr12:122356316	WDR66	0.44	4.91	0.49	4.96e-6	Mean corpuscular volume;
SKCM	cis	rs9796	0.621	rs2928142	chr15:41470449	T/C	cg18705301	chr15:41695430	NDUFAF1	0.7	5.18	0.51	1.67e-6	Menopause (age at onset);
SKCM	cis	rs13336428	0.696	rs17808854	chr16:1528387	T/C	cg08008072	chr16:1524255	CLCN7	-0.55	-6.44	-0.59	8.89e-9	Bone mineral density;
SKCM	cis	rs8180040	0.903	rs13094438	chr3:47277885	G/A	cg27129171	chr3:47204927	SETD2	0.85	6.39	0.59	1.11e-8	Colorectal cancer;
SKCM	cis	rs1395	0.744	rs1122227	chr2:27544285	C/T	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.54	4.88	0.48	5.4e-6	Blood metabolite levels;
SKCM	cis	rs2839186	0.872	rs13046834	chr21:47701485	T/C	cg13012494	chr21:47604986	C21orf56	0.65	5.44	0.52	6e-7	Testicular germ cell tumor;
SKCM	cis	rs1577917	0.958	rs36053156	chr6:86575509	T/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.68	-6.02	-0.56	5.48e-8	Response to antipsychotic treatment;
SKCM	cis	rs7772486	0.754	rs6570718	chr6:146088443	T/G	cg05347473	chr6:146136440	FBXO30	-0.61	-5.81	-0.55	1.31e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1552244	1.000	rs56270432	chr3:10087517	G/C	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs2455826	0.917	rs2471809	chr3:15680525	G/A	cg21141587	chr3:14755007	C3orf20	-0.58	-4.8	-0.48	7.65e-6	Inflammatory skin disease;
SKCM	cis	rs8068544	0.818	rs78333491	chr17:40163138	A/G	cg18442075	chr17:40169520	DNAJC7;NKIRAS2	-1.38	-7.28	-0.64	2.26e-10	Reticulocyte fraction of red cells;Reticulocyte count;
SKCM	cis	rs1218582	0.772	rs1109815	chr1:154909268	A/G	cg16680214	chr1:154839983	KCNN3	-0.56	-5.01	-0.49	3.29e-6	Prostate cancer;
SKCM	cis	rs873946	0.586	rs12767391	chr10:134573844	A/G	cg18305652	chr10:134549665	INPP5A	-0.56	-5.79	-0.55	1.43e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs7824557	0.767	rs7003241	chr8:11169075	A/G	cg21775007	chr8:11205619	TDH	0.72	6.03	0.56	5.2100000000000003e-08	Retinal vascular caliber;
SKCM	cis	rs7945705	0.935	rs2653593	chr11:8877317	G/A	cg21881798	chr11:8931708	C11orf17;ST5	-0.77	-7.96	-0.67	1.14e-11	Hemoglobin concentration;
SKCM	cis	rs4400599	0.642	rs4072431	chr1:154167116	A/G	cg26808167	chr1:154192205	UBAP2L;C1orf43	-0.53	-4.83	-0.48	6.8e-6	Platelet distribution width;
SKCM	cis	rs10256972	0.504	rs2949178	chr7:1209925	T/C	cg18765753	chr7:1198926	ZFAND2A	-0.52	-5.74	-0.54	1.73e-7	Longevity;Endometriosis;
SKCM	cis	rs9611565	0.512	rs139571	chr22:42214238	G/A	cg03806693	chr22:41940476	POLR3H	-1.12	-6.49	-0.59	7.19e-9	Vitiligo;
SKCM	cis	rs362272	0.524	rs2749781	chr4:3346617	T/C	cg05297308	chr4:3317976	RGS12	1.05	13.75	0.84	1.54e-22	Serum sulfate level;
SKCM	cis	rs7106204	0.748	rs4636667	chr11:24238615	T/C	ch.11.24196551F	chr11:24239977	NA	0.76	6.03	0.56	5.06e-8	Response to Homoharringtonine (cytotoxicity);
SKCM	cis	rs7937682	0.710	rs674230	chr11:111437887	A/G	cg19812747	chr11:111475976	SIK2	-0.58	-4.86	-0.48	5.88e-6	Primary sclerosing cholangitis;
SKCM	cis	rs7666738	0.791	rs13111960	chr4:98976851	C/T	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2439831	0.681	rs825739	chr15:43592428	T/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.19	8.52	0.69	9.21e-13	Lung cancer in ever smokers;
SKCM	cis	rs12474201	0.589	rs76089707	chr2:47013899	G/A	cg06386533	chr2:46925753	SOCS5	0.85	7.1	0.63	5.07e-10	Height;
SKCM	cis	rs4077515	0.934	rs10781507	chr9:139272058	A/G	cg14169450	chr9:139327907	INPP5E	0.46	5.29	0.51	1.1e-6	Ulcerative colitis;IgA nephropathy;Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs10503709	0.895	rs10096718	chr8:21441655	C/A	cg23716449	chr8:21608280	GFRA2	0.52	5.24	0.51	1.36e-6	Blood protein levels;
SKCM	cis	rs4237845	0.788	rs1962047	chr12:58292707	G/A	cg00677455	chr12:58241039	CTDSP2	0.74	6.18	0.57	2.72e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs651907	0.557	rs2318090	chr3:101474933	A/G	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.81	7.11	0.63	4.78e-10	Colorectal cancer;
SKCM	cis	rs4319547	0.688	rs10847415	chr12:123144293	T/C	cg23029597	chr12:123009494	RSRC2	-0.72	-4.99	-0.49	3.57e-6	Body mass index;
SKCM	cis	rs875971	0.862	rs6460293	chr7:65810192	C/A	cg11764359	chr7:65958608	NA	-0.74	-6.75	-0.61	2.36e-9	Aortic root size;
SKCM	cis	rs1801251	1.000	rs4973054	chr2:233710713	G/C	cg08000102	chr2:233561755	GIGYF2	-0.89	-7.22	-0.63	3.02e-10	Coronary artery disease;
SKCM	cis	rs6665290	0.904	rs1045285	chr1:227179054	G/A	cg10327440	chr1:227177885	CDC42BPA	-1.23	-16.54	-0.88	3.22e-27	Myeloid white cell count;
SKCM	cis	rs116095464	0.558	rs10057626	chr5:239720	T/G	cg22857025	chr5:266934	NA	-1.36	-8.21	-0.68	3.65e-12	Breast cancer;
SKCM	cis	rs3784262	0.740	rs1372369	chr15:58294381	T/G	cg12031962	chr15:58353849	ALDH1A2	-0.45	-5.45	-0.53	5.67e-7	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs2282032	1.000	rs76139392	chr14:90746462	G/T	cg04374321	chr14:90722782	PSMC1	0.71	4.93	0.49	4.54e-6	Longevity;
SKCM	cis	rs8078723	1.000	rs3213762	chr17:38178627	A/G	cg17467752	chr17:38218738	THRA	0.68	6.11	0.57	3.73e-8	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs10489202	0.908	rs6692861	chr1:168079553	G/C	cg24449463	chr1:168025552	DCAF6	-0.85	-6.28	-0.58	1.76e-8	Schizophrenia;
SKCM	cis	rs2033711	0.870	rs11669741	chr19:58960481	C/T	cg03735888	chr19:58951602	ZNF132	-0.71	-6.38	-0.59	1.15e-8	Uric acid clearance;
SKCM	cis	rs1799949	0.896	rs35908185	chr17:41255111	A/T	cg05368731	chr17:41323189	NBR1	0.87	7.55	0.65	6.95e-11	Menopause (age at onset);
SKCM	cis	rs1577917	0.916	rs12203358	chr6:86603224	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.67	-5.89	-0.55	9.22e-8	Response to antipsychotic treatment;
SKCM	cis	rs9926296	0.605	rs886952	chr16:89836781	G/A	cg26513180	chr16:89883248	FANCA	0.94	9.97	0.75	1.44e-15	Vitiligo;
SKCM	cis	rs12458462	0.859	rs35493271	chr18:77448793	G/T	cg11879182	chr18:77439856	CTDP1	0.89	7.56	0.65	6.69e-11	Monocyte count;
SKCM	cis	rs4073582	0.595	rs801739	chr11:65922589	A/G	cg14036092	chr11:66035641	RAB1B	0.71	5.4	0.52	6.99e-7	Gout;
SKCM	cis	rs12971120	0.947	rs8083001	chr18:72165058	A/G	cg25817165	chr18:72167213	CNDP2	-0.63	-5.03	-0.5	3.01e-6	Refractive error;
SKCM	cis	rs854765	0.655	rs4470201	chr17:17844870	G/A	cg04398451	chr17:18023971	MYO15A	-0.85	-6.05	-0.57	4.75e-8	Total body bone mineral density;
SKCM	cis	rs11098499	0.644	rs7693919	chr4:120540571	G/A	cg09307838	chr4:120376055	NA	0.94	7.77	0.66	2.64e-11	Corneal astigmatism;
SKCM	cis	rs4819052	0.851	rs4818768	chr21:46659818	T/A	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.36	0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs1799949	1.000	rs8176145	chr17:41249094	A/G	cg25918947	chr17:41365094	TMEM106A	-0.62	-5.85	-0.55	1.1e-7	Menopause (age at onset);
SKCM	cis	rs4523957	0.579	rs2270478	chr17:2089848	G/A	cg16513277	chr17:2031491	SMG6	-0.71	-5.08	-0.5	2.47e-6	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs7208859	0.623	rs2035494	chr17:29130393	T/G	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs6570726	0.693	rs450921	chr6:145864260	C/T	cg05347473	chr6:146136440	FBXO30	0.55	4.97	0.49	3.81e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7617480	0.585	rs7373072	chr3:48960017	T/A	cg07636037	chr3:49044803	WDR6	0.92	6.9	0.62	1.24e-9	Subjective well-being (multi-trait analysis);Menarche (age at onset);
SKCM	cis	rs514406	0.698	rs11206043	chr1:53402552	C/T	cg04310824	chr1:53393297	SCP2	-0.6	-4.9	-0.49	5.01e-6	Monocyte count;
SKCM	cis	rs3845702	0.736	rs3845701	chr2:180826781	A/G	cg01881094	chr2:180872142	CWC22	-1.3	-6.15	-0.57	3.07e-8	Schizophrenia;
SKCM	cis	rs2836974	0.590	rs11911822	chr21:40607843	C/T	cg17971929	chr21:40555470	PSMG1	-0.76	-7.16	-0.63	3.94e-10	Cognitive function;
SKCM	cis	rs7772486	0.686	rs857882	chr6:145969716	T/G	cg23711669	chr6:146136114	FBXO30	-0.9	-9.54	-0.73	9.76e-15	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7666738	0.791	rs62318907	chr4:99037120	C/T	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1580019	0.961	rs958217	chr7:32493417	A/G	cg06627557	chr7:32535165	LSM5;AVL9	0.71	5.36	0.52	8.21e-7	Cognitive ability;
SKCM	cis	rs2404602	0.716	rs12440815	chr15:76627328	C/A	cg23625390	chr15:77176239	SCAPER	0.68	5.95	0.56	7.24e-8	Blood metabolite levels;
SKCM	cis	rs1552244	1.000	rs6782602	chr3:10116541	G/T	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs2832191	0.740	rs2832177	chr21:30478353	G/A	cg24692254	chr21:30365293	RNF160	-0.99	-9.05	-0.72	8.59e-14	Dental caries;
SKCM	cis	rs854765	0.647	rs854808	chr17:18006634	C/T	cg04398451	chr17:18023971	MYO15A	-1.0	-9.22	-0.72	4.08e-14	Total body bone mineral density;
SKCM	cis	rs11098499	0.909	rs10002083	chr4:120311152	C/T	cg09307838	chr4:120376055	NA	0.97	7.49	0.65	9.08e-11	Corneal astigmatism;
SKCM	trans	rs8073060	0.586	rs225296	chr17:33924847	C/G	cg19694781	chr19:47549865	TMEM160	-1.08	-8.69	-0.7	4.26e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs34779708	0.931	rs34304999	chr10:35365705	C/T	cg03585969	chr10:35415529	CREM	0.78	6.3	0.58	1.67e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs35306767	0.903	rs11813210	chr10:919796	G/A	cg20503657	chr10:835505	NA	0.75	5.36	0.52	8.31e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs4925386	0.921	rs11204472	chr20:60920887	G/A	cg24112000	chr20:60950667	NA	0.63	6.16	0.57	3.02e-8	Colorectal cancer;Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs12711979	0.584	rs11694096	chr2:3868113	G/A	cg17052675	chr2:3827356	NA	-0.83	-8.95	-0.71	1.37e-13	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs7618501	0.521	rs2883059	chr3:49902160	C/T	cg24110177	chr3:50126178	RBM5	0.69	5.08	0.5	2.48e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs28595532	0.841	rs116452272	chr4:119770802	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs67311347	0.911	rs58282210	chr3:40417943	C/T	cg00091569	chr3:40428383	ENTPD3	0.63	5.37	0.52	7.84e-7	Renal cell carcinoma;
SKCM	cis	rs644799	1.000	rs568668	chr11:95528209	G/A	cg25622487	chr11:95524042	FAM76B;CEP57	0.66	5.12	0.5	2.18e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs1799949	1.000	rs4793190	chr17:41200109	T/C	cg05368731	chr17:41323189	NBR1	0.89	7.67	0.66	4.08e-11	Menopause (age at onset);
SKCM	cis	rs7584330	0.737	rs7584314	chr2:238361089	C/T	cg14458575	chr2:238380390	NA	0.88	6.21	0.57	2.43e-8	Prostate cancer;
SKCM	cis	rs7598759	0.548	rs1823328	chr2:232355184	G/A	cg19187155	chr2:232395269	NMUR1	0.88	7.56	0.65	6.64e-11	Noise-induced hearing loss;
SKCM	cis	rs12142240	0.698	rs72886907	chr1:46814265	C/T	cg10495392	chr1:46806563	NSUN4	0.77	5.74	0.54	1.74e-7	Menopause (age at onset);
SKCM	cis	rs7811142	0.830	rs118119933	chr7:99939050	C/T	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.27	6.91	0.62	1.19e-9	Platelet count;
SKCM	cis	rs7799006	0.527	rs6967286	chr7:2212758	C/A	cg02951883	chr7:2050386	MAD1L1	-0.6	-4.86	-0.48	5.85e-6	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);
SKCM	cis	rs8014204	0.836	rs12588415	chr14:75278211	G/A	cg06637938	chr14:75390232	RPS6KL1	0.83	6.65	0.6	3.64e-9	Caffeine consumption;
SKCM	cis	rs6665290	0.901	rs3795453	chr1:227205331	A/G	cg10327440	chr1:227177885	CDC42BPA	-1.18	-15.29	-0.87	3.58e-25	Myeloid white cell count;
SKCM	cis	rs875971	1.000	rs10257427	chr7:65743208	T/C	cg11764359	chr7:65958608	NA	-0.88	-8.54	-0.7	8.32e-13	Aortic root size;
SKCM	cis	rs9916302	0.904	rs600010	chr17:37433517	T/C	cg07936489	chr17:37558343	FBXL20	-0.82	-6.73	-0.61	2.6e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs67460515	0.859	rs7610800	chr3:161002582	C/T	cg03342759	chr3:160939853	NMD3	-0.81	-7.1	-0.63	5.14e-10	Parkinson's disease;
SKCM	cis	rs9611565	0.694	rs202641	chr22:41833116	C/T	cg03806693	chr22:41940476	POLR3H	1.07	6.74	0.61	2.44e-9	Vitiligo;
SKCM	cis	rs28595532	0.920	rs114420700	chr4:119751297	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs3020736	0.500	rs5996110	chr22:42493767	A/G	cg04733989	chr22:42467013	NAGA	-0.72	-5.62	-0.54	2.87e-7	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs798554	0.679	rs1636250	chr7:2884433	T/C	cg19346786	chr7:2764209	NA	-0.64	-6.44	-0.59	9.14e-9	Height;
SKCM	cis	rs4727027	0.933	rs6955564	chr7:148866173	A/G	cg23583168	chr7:148888333	NA	-0.79	-6.64	-0.6	3.84e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs4727443	0.866	rs12531809	chr7:99620473	G/T	cg07913999	chr7:99613796	ZKSCAN1	0.66	5.09	0.5	2.43e-6	Interstitial lung disease;
SKCM	cis	rs4423214	1.000	rs12790558	chr11:71170905	T/C	cg05163923	chr11:71159392	DHCR7	0.83	8.11	0.68	5.77e-12	Vitamin D levels;
SKCM	cis	rs769267	0.965	rs2074296	chr19:19373689	A/G	cg03709012	chr19:19516395	GATAD2A	0.81	6.49	0.59	7.18e-9	Tonsillectomy;
SKCM	cis	rs769267	0.930	rs6511038	chr19:19607564	A/C	cg03709012	chr19:19516395	GATAD2A	0.89	8.62	0.7	5.89e-13	Tonsillectomy;
SKCM	cis	rs362296	0.698	rs362289	chr4:3256378	G/A	cg16987761	chr4:3318072	RGS12	-0.83	-7.05	-0.62	6.41e-10	Parental longevity (mother's age at death);
SKCM	cis	rs875971	0.540	rs1723268	chr7:65473080	A/C	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.63	5.5	0.53	4.73e-7	Aortic root size;
SKCM	cis	rs1403694	0.695	rs5029969	chr3:186434405	G/T	cg09332604	chr3:186435400	KNG1	-0.5	-5.07	-0.5	2.57e-6	Blood protein levels;
SKCM	cis	rs3793683	0.597	rs12767469	chr10:134587261	C/G	cg18305652	chr10:134549665	INPP5A	0.61	5.83	0.55	1.19e-7	Migraine;
SKCM	cis	rs8016982	0.633	rs4363794	chr14:81674327	C/A	cg01989461	chr14:81687754	GTF2A1	0.87	6.91	0.62	1.19e-9	Schizophrenia;
SKCM	cis	rs10927875	0.619	rs2013019	chr1:16129320	T/C	cg21385522	chr1:16154831	NA	-0.75	-7.13	-0.63	4.51e-10	Dilated cardiomyopathy;
SKCM	cis	rs7100689	0.784	rs3802638	chr10:82179689	T/C	cg01528321	chr10:82214614	TSPAN14	0.98	10.11	0.75	7.91e-16	Post bronchodilator FEV1;
SKCM	cis	rs7666738	0.830	rs6823718	chr4:99063202	C/T	cg17366294	chr4:99064904	C4orf37	0.61	4.93	0.49	4.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs28386778	0.897	rs3744293	chr17:61841788	T/A	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs1790761	0.692	rs674783	chr11:67339076	C/T	cg00290607	chr11:67383545	NA	0.51	5.38	0.52	7.43e-7	Mean corpuscular volume;
SKCM	cis	rs7772486	0.686	rs1011596	chr6:146076433	A/G	cg05347473	chr6:146136440	FBXO30	0.54	4.96	0.49	3.97e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs875971	0.577	rs35072105	chr7:65609817	A/G	cg00343986	chr7:65444356	GUSB	-0.69	-5.05	-0.5	2.83e-6	Aortic root size;
SKCM	cis	rs11608355	0.597	rs9943699	chr12:109840876	G/C	cg19025524	chr12:109796872	NA	-0.67	-5.95	-0.56	7.18e-8	Neuroticism;
SKCM	cis	rs58688157	0.960	rs11246213	chr11:612967	A/G	cg16486109	chr11:613632	IRF7	1.07	7.29	0.64	2.17e-10	Systemic lupus erythematosus;
SKCM	cis	rs17376456	0.825	rs28534784	chr5:93063332	C/A	cg25358565	chr5:93447407	FAM172A	1.17	8.0	0.67	9.26e-12	Diabetic retinopathy;
SKCM	cis	rs453301	0.571	rs2929453	chr8:9084341	A/G	cg15556689	chr8:8085844	FLJ10661	-0.65	-4.93	-0.49	4.51e-6	Joint mobility (Beighton score);
SKCM	cis	rs1799949	1.000	rs35956818	chr17:41422985	T/C	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.18	-0.57	2.68e-8	Menopause (age at onset);
SKCM	cis	rs28595532	0.920	rs17324821	chr4:119770716	A/G	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs6809651	0.524	rs12638263	chr3:185795855	A/C	cg00760338	chr3:185826511	ETV5	-0.92	-5.65	-0.54	2.53e-7	Body mass index in physically active individuals;Glomerular filtration rate (creatinine);Body mass index (joint analysis main effects and physical activity interaction);Body mass index;Body mass index in physically inactive individuals;
SKCM	cis	rs3857536	0.566	rs208463	chr6:66913962	T/A	cg07460842	chr6:66804631	NA	-0.76	-5.8	-0.55	1.37e-7	Blood trace element (Cu levels);
SKCM	cis	rs2075371	0.933	rs2544191	chr7:133954248	A/G	cg20476274	chr7:133979776	SLC35B4	1.03	10.88	0.78	2.61e-17	Mean platelet volume;
SKCM	cis	rs28374715	0.681	rs11629979	chr15:41626579	A/G	cg18705301	chr15:41695430	NDUFAF1	-1.07	-10.54	-0.77	1.16e-16	Ulcerative colitis;
SKCM	cis	rs9311474	0.659	rs1133415	chr3:52575831	G/A	cg18404041	chr3:52824283	ITIH1	-0.53	-4.79	-0.48	7.87e-6	Electroencephalogram traits;
SKCM	cis	rs1559088	0.600	rs10421769	chr19:33605312	T/C	cg17764715	chr19:33622953	WDR88	0.93	6.71	0.61	2.74e-9	Bone ultrasound measurement (broadband ultrasound attenuation);
SKCM	cis	rs11608355	0.618	rs7958220	chr12:109830980	T/C	cg19025524	chr12:109796872	NA	-0.66	-5.75	-0.55	1.69e-7	Neuroticism;
SKCM	cis	rs9325144	0.534	rs4882350	chr12:38686979	A/G	cg26384229	chr12:38710491	ALG10B	0.78	6.74	0.61	2.48e-9	Morning vs. evening chronotype;
SKCM	cis	rs875971	0.545	rs10950036	chr7:65818228	G/T	cg18876405	chr7:65276391	NA	0.62	4.95	0.49	4.11e-6	Aortic root size;
SKCM	cis	rs62064224	0.652	rs116325033	chr17:30715229	T/C	cg25809561	chr17:30822961	MYO1D	0.65	5.0	0.49	3.48e-6	Schizophrenia;
SKCM	cis	rs651907	0.535	rs2290859	chr3:101525625	C/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.78	6.72	0.61	2.65e-9	Colorectal cancer;
SKCM	cis	rs2228479	0.867	rs11645970	chr16:89958118	G/A	cg06558623	chr16:89946397	TCF25	1.26	6.97	0.62	9.17e-10	Skin colour saturation;
SKCM	cis	rs10256972	0.567	rs2960850	chr7:1211649	A/G	cg16145915	chr7:1198662	ZFAND2A	-0.56	-7.48	-0.65	9.48e-11	Longevity;Endometriosis;
SKCM	cis	rs62103177	0.810	rs62103175	chr18:77622467	C/T	cg27393146	chr18:77495563	CTDP1	-0.92	-5.36	-0.52	8.37e-7	Opioid sensitivity;
SKCM	cis	rs6416877	0.885	rs8072859	chr17:1371123	T/C	cg04196298	chr17:1480710	SLC43A2	0.65	4.79	0.48	7.83e-6	Myeloid white cell count;
SKCM	cis	rs1005277	0.579	rs9418322	chr10:38377296	G/T	cg00409905	chr10:38381863	ZNF37A	-0.64	-5.96	-0.56	6.77e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs12044355	0.927	rs11577035	chr1:231835941	C/A	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	0.84	6.57	0.6	5.07e-9	Alzheimer's disease;
SKCM	cis	rs245880	0.740	rs245892	chr7:29191273	T/C	cg17163760	chr7:29186267	CPVL	-0.4	-5.37	-0.52	7.91e-7	Warfarin maintenance dose;
SKCM	cis	rs1153858	1.000	rs61365925	chr15:45650311	T/C	cg10760299	chr15:45669010	GATM	0.62	6.35	0.58	1.3e-8	Homoarginine levels;
SKCM	cis	rs12497850	0.931	rs13316620	chr3:49045355	T/C	cg07636037	chr3:49044803	WDR6	1.03	11.13	0.78	8.79e-18	Parkinson's disease;
SKCM	cis	rs7666738	0.830	rs62321587	chr4:98997958	T/C	cg05340658	chr4:99064831	C4orf37	0.67	5.14	0.5	1.98e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1005277	0.579	rs2504143	chr10:38383706	C/T	cg25427524	chr10:38739819	LOC399744	-0.69	-6.45	-0.59	8.73e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs936229	1.000	rs4886615	chr15:75131661	A/G	cg14664628	chr15:75095509	CSK	-1.05	-8.24	-0.68	3.25e-12	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin);
SKCM	cis	rs67460515	0.563	rs11922959	chr3:160828871	A/G	cg03342759	chr3:160939853	NMD3	-0.73	-6.3	-0.58	1.62e-8	Parkinson's disease;
SKCM	cis	rs561341	1.000	rs535151	chr17:30317405	C/T	cg23018236	chr17:30244563	NA	-0.54	-5.47	-0.53	5.29e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs875971	0.545	rs73142265	chr7:65699497	G/A	cg18876405	chr7:65276391	NA	0.65	5.3	0.51	1.05e-6	Aortic root size;
SKCM	cis	rs55823223	0.503	rs9906971	chr17:73848477	A/G	cg10935138	chr17:73851978	WBP2	1.13	7.39	0.64	1.43e-10	Psoriasis;
SKCM	cis	rs4969178	0.965	rs16971107	chr17:76394042	C/T	cg20026190	chr17:76395443	PGS1	0.61	5.29	0.51	1.08e-6	HDL cholesterol levels;
SKCM	cis	rs12586317	0.547	rs10142667	chr14:35445090	A/G	cg16230307	chr14:35515116	FAM177A1	0.77	5.47	0.53	5.21e-7	Psoriasis;
SKCM	cis	rs951366	0.668	rs823154	chr1:205762406	C/T	cg26354017	chr1:205819088	PM20D1	0.98	9.76	0.74	3.66e-15	Menarche (age at onset);
SKCM	cis	rs28386778	0.765	rs2070680	chr17:61986988	A/G	cg06873352	chr17:61820015	STRADA	-0.64	-5.12	-0.5	2.18e-6	Prudent dietary pattern;
SKCM	cis	rs6570726	0.791	rs425999	chr6:145819370	C/A	cg05347473	chr6:146136440	FBXO30	0.53	4.78	0.48	8.07e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9467773	1.000	rs3736781	chr6:26505362	G/A	cg15659132	chr6:26577336	NA	0.61	5.82	0.55	1.24e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs2731664	0.819	rs449351	chr5:176872591	T/C	cg23176889	chr5:176863531	GRK6	-0.53	-5.49	-0.53	4.83e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs4925386	0.759	rs2427293	chr20:60925859	A/G	cg24112000	chr20:60950667	NA	0.76	6.88	0.61	1.36e-9	Colorectal cancer;Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs2439831	0.850	rs3759790	chr15:44121030	G/A	cg02155558	chr15:43621948	ADAL;LCMT2	1.36	7.78	0.66	2.56e-11	Lung cancer in ever smokers;
SKCM	cis	rs2836974	0.549	rs34160989	chr21:40554118	C/G	cg11890956	chr21:40555474	PSMG1	0.96	6.67	0.6	3.38e-9	Cognitive function;
SKCM	cis	rs2019137	0.560	rs11123172	chr2:113984303	C/T	cg12889195	chr2:113992843	PAX8;LOC440839;LOC654433	-0.74	-5.43	-0.52	6.12e-7	Lymphocyte counts;
SKCM	cis	rs704	0.523	rs11080054	chr17:26645991	G/A	cg27392559	chr17:27410759	MYO18A	-0.55	-4.88	-0.48	5.57e-6	Osteoprotegerin levels;
SKCM	cis	rs11992186	0.597	rs77717027	chr8:8591632	T/C	cg06636001	chr8:8085503	FLJ10661	-0.64	-4.96	-0.49	4.03e-6	Neuroticism;
SKCM	cis	rs11098499	0.954	rs7436506	chr4:120393769	T/C	cg24375607	chr4:120327624	NA	0.66	5.09	0.5	2.44e-6	Corneal astigmatism;
SKCM	cis	rs11098499	0.863	rs1383532	chr4:120434404	A/T	cg09307838	chr4:120376055	NA	-0.99	-7.61	-0.65	5.41e-11	Corneal astigmatism;
SKCM	cis	rs2075371	0.863	rs12707139	chr7:133954153	A/G	cg20476274	chr7:133979776	SLC35B4	0.96	9.42	0.73	1.63e-14	Mean platelet volume;
SKCM	cis	rs8067545	0.611	rs757494	chr17:20150340	C/T	cg13482628	chr17:19912719	NA	-0.65	-5.44	-0.52	5.84e-7	Schizophrenia;
SKCM	cis	rs2439831	0.681	rs2278859	chr15:43632960	A/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.17	8.32	0.69	2.25e-12	Lung cancer in ever smokers;
SKCM	cis	rs11249608	0.548	rs7707587	chr5:178462590	G/C	cg21905437	chr5:178450457	ZNF879	0.71	5.45	0.53	5.65e-7	Pubertal anthropometrics;
SKCM	cis	rs11105298	0.891	rs11105299	chr12:89877943	A/G	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.89	-6.03	-0.56	5.25e-8	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs778371	0.647	rs974321	chr2:233638351	G/A	cg08000102	chr2:233561755	GIGYF2	0.82	6.38	0.59	1.14e-8	Schizophrenia;
SKCM	cis	rs6547741	1.000	rs4666009	chr2:27857992	T/A	cg27432699	chr2:27873401	GPN1	0.73	6.65	0.6	3.7e-9	Oral cavity cancer;
SKCM	cis	rs6952808	0.929	rs12532128	chr7:1925454	T/C	cg21782813	chr7:2030301	MAD1L1	0.54	5.45	0.53	5.61e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs4888262	0.526	rs7193423	chr16:74626340	A/C	cg01733217	chr16:74700730	RFWD3	0.99	7.43	0.64	1.2e-10	Testicular germ cell tumor;
SKCM	cis	rs9916302	0.904	rs4794814	chr17:37696852	G/A	cg07936489	chr17:37558343	FBXL20	-0.9	-8.11	-0.68	5.65e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs3784262	0.669	rs4646554	chr15:58355437	A/G	cg12031962	chr15:58353849	ALDH1A2	-0.42	-4.89	-0.48	5.38e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs6500602	0.561	rs62039231	chr16:4519548	A/G	cg08645402	chr16:4508243	NA	0.54	4.99	0.49	3.55e-6	Schizophrenia;
SKCM	cis	rs6461049	0.638	rs3778994	chr7:2175855	G/T	cg02951883	chr7:2050386	MAD1L1	-0.7	-6.1	-0.57	3.78e-8	Schizophrenia;
SKCM	cis	rs763121	0.853	rs1569716	chr22:38998519	C/A	cg06022373	chr22:39101656	GTPBP1	0.82	5.62	0.54	2.79e-7	Menopause (age at onset);
SKCM	cis	rs12986445	0.625	rs6732186	chr2:26136252	C/T	cg07291958	chr2:26785531	C2orf70	0.54	4.82	0.48	7.04e-6	Multiple myeloma and monoclonal gammopathy;Multiple myeloma;
SKCM	cis	rs245880	0.740	rs245890	chr7:29190720	T/C	cg17163760	chr7:29186267	CPVL	-0.4	-5.37	-0.52	7.91e-7	Warfarin maintenance dose;
SKCM	cis	rs4481887	0.927	rs10749646	chr1:248429719	A/G	cg00666640	chr1:248458726	OR2T12	-0.6	-5.49	-0.53	4.92e-7	Common traits (Other);
SKCM	cis	rs6840360	0.530	rs12645029	chr4:152650032	T/C	cg22705602	chr4:152727874	NA	-0.53	-5.61	-0.54	2.91e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs473651	0.935	rs558924	chr2:239339511	A/G	cg18131467	chr2:239335373	ASB1	1.06	10.89	0.78	2.56e-17	Multiple system atrophy;
SKCM	cis	rs7408868	1.000	rs4809029	chr19:15273248	A/C	cg14696996	chr19:15285081	NOTCH3	0.82	4.92	0.49	4.7e-6	Pulse pressure;
SKCM	cis	rs10489202	0.632	rs12410730	chr1:168069477	T/C	cg24449463	chr1:168025552	DCAF6	-0.77	-7.41	-0.64	1.29e-10	Schizophrenia;
SKCM	cis	rs9325144	0.555	rs2387843	chr12:38711203	T/C	cg26384229	chr12:38710491	ALG10B	0.78	6.71	0.61	2.77e-9	Morning vs. evening chronotype;
SKCM	cis	rs951366	0.646	rs1772159	chr1:205759195	G/A	cg17178900	chr1:205818956	PM20D1	0.78	7.28	0.64	2.34e-10	Menarche (age at onset);
SKCM	cis	rs1348850	0.561	rs57986285	chr2:178468663	C/T	cg27490568	chr2:178487706	NA	0.94	6.38	0.59	1.18e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs1801251	1.000	rs7587309	chr2:233705702	G/T	cg08000102	chr2:233561755	GIGYF2	-0.85	-7.04	-0.62	6.74e-10	Coronary artery disease;
SKCM	cis	rs4619890	0.510	rs7680747	chr4:7871623	G/A	cg08722675	chr4:8412549	ACOX3	0.54	4.95	0.49	4.24e-6	Glaucoma (primary open-angle);
SKCM	cis	rs4954585	0.593	rs12691881	chr2:137029668	A/G	cg05194412	chr2:137003533	NA	0.57	5.05	0.5	2.8e-6	Colorectal cancer;
SKCM	cis	rs780096	0.587	rs10205219	chr2:27568565	T/C	cg05696406	chr2:27599888	SNX17	0.49	5.12	0.5	2.17e-6	Total body bone mineral density;
SKCM	cis	rs2836974	0.644	rs2836981	chr21:40688365	C/T	cg17971929	chr21:40555470	PSMG1	-0.7	-6.28	-0.58	1.81e-8	Cognitive function;
SKCM	cis	rs10256972	0.521	rs7811577	chr7:1102829	C/G	cg11360546	chr7:1094263	C7orf50	-0.42	-4.92	-0.49	4.78e-6	Longevity;Endometriosis;
SKCM	cis	rs66573146	0.808	rs73202120	chr4:7005588	A/G	cg00086871	chr4:6988644	TBC1D14	1.31	5.09	0.5	2.39e-6	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs2180341	0.960	rs6900074	chr6:127685893	A/G	cg24812749	chr6:127587940	RNF146	0.83	7.18	0.63	3.63e-10	Breast cancer;
SKCM	cis	rs7811142	1.000	rs4472444	chr7:100070758	T/C	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.34	0.69	2.1e-12	Platelet count;
SKCM	cis	rs912057	0.833	rs1024245	chr6:6743319	A/G	cg06612196	chr6:6737390	NA	0.58	4.91	0.49	4.81e-6	Waist-to-hip ratio adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);
SKCM	cis	rs189798	1.000	rs189798	chr8:8990577	A/G	cg06636001	chr8:8085503	FLJ10661	-0.64	-4.81	-0.48	7.12e-6	Myopia (pathological);
SKCM	cis	rs651907	0.557	rs34624546	chr3:101374226	T/G	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.81	7.02	0.62	7.26e-10	Colorectal cancer;
SKCM	cis	rs17685	0.558	rs60787921	chr7:75792844	C/A	cg16489192	chr7:75678113	MDH2;STYXL1	-0.57	-5.49	-0.53	4.89e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs897984	0.806	rs1458202	chr16:30953202	A/G	cg00531865	chr16:30841666	NA	-0.56	-4.8	-0.48	7.53e-6	Dementia with Lewy bodies;
SKCM	cis	rs7937682	0.575	rs34695265	chr11:111719128	T/C	cg09085632	chr11:111637200	PPP2R1B	1.08	11.04	0.78	1.34e-17	Primary sclerosing cholangitis;
SKCM	cis	rs17376456	0.877	rs17315943	chr5:93442830	T/C	cg25358565	chr5:93447407	FAM172A	1.23	7.97	0.67	1.08e-11	Diabetic retinopathy;
SKCM	cis	rs1005277	0.579	rs2472174	chr10:38375382	A/G	cg00409905	chr10:38381863	ZNF37A	-0.64	-5.96	-0.56	6.77e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs72634258	0.519	rs2071984	chr1:7928656	C/T	cg00042356	chr1:8021962	PARK7	0.7	4.92	0.49	4.77e-6	Inflammatory bowel disease;
SKCM	cis	rs2832191	0.935	rs11910316	chr21:30519729	G/A	cg24692254	chr21:30365293	RNF160	-0.76	-6.81	-0.61	1.79e-9	Dental caries;
SKCM	cis	rs3820068	0.532	rs72647105	chr1:15935238	C/G	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs7769051	0.711	rs7770081	chr6:133089569	G/T	cg22852734	chr6:133119734	C6orf192	0.93	5.03	0.5	3.03e-6	Type 2 diabetes nephropathy;
SKCM	cis	rs28386778	0.897	rs2236737	chr17:61938100	C/T	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.13	11.24	0.79	5.64e-18	Prudent dietary pattern;
SKCM	cis	rs58688157	0.705	rs12419618	chr11:611531	G/A	cg17114584	chr11:613792	IRF7	0.81	5.49	0.53	4.8e-7	Systemic lupus erythematosus;
SKCM	cis	rs7666738	0.830	rs2865990	chr4:99067399	C/A	cg17366294	chr4:99064904	C4orf37	0.61	4.93	0.49	4.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2839186	0.771	rs2280957	chr21:47642272	A/G	cg13126279	chr21:47581558	C21orf56	0.67	5.87	0.55	9.92e-8	Testicular germ cell tumor;
SKCM	cis	rs2243480	1.000	rs316307	chr7:65570171	C/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs2479724	0.818	rs9357369	chr6:41818202	A/C	cg17623882	chr6:41773611	USP49	-0.8	-7.08	-0.63	5.43e-10	Menarche (age at onset);
SKCM	cis	rs2836974	0.533	rs418298	chr21:40536654	A/T	cg11644478	chr21:40555479	PSMG1	0.83	8.06	0.67	7.33e-12	Cognitive function;
SKCM	cis	rs4862750	0.872	rs4862747	chr4:187877236	A/T	cg10295955	chr4:187884368	NA	1.05	14.48	0.85	8.36e-24	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs11249608	0.548	rs6894076	chr5:178449813	T/C	cg21905437	chr5:178450457	ZNF879	0.75	6.31	0.58	1.55e-8	Pubertal anthropometrics;
SKCM	cis	rs6495367	0.803	rs2870111	chr15:79403585	C/T	cg10259521	chr15:79428573	NA	-0.49	-5.05	-0.5	2.85e-6	Spherical equivalent (joint analysis main effects and education interaction);
SKCM	cis	rs752010	0.715	rs11807117	chr1:42101206	C/T	cg06885757	chr1:42089581	HIVEP3	0.67	7.02	0.62	7.25e-10	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs2836974	0.563	rs997147	chr21:40695325	A/G	cg17971929	chr21:40555470	PSMG1	-0.71	-6.2	-0.57	2.5e-8	Cognitive function;
SKCM	cis	rs7111031	0.932	rs7110440	chr11:113349374	C/A	cg04642306	chr11:112834466	NCAM1	-0.45	-5.03	-0.5	3.03e-6	Subjective well-being (multi-trait analysis);Depressive symptoms (multi-trait analysis);Neuroticism;
SKCM	cis	rs2839186	0.588	rs2839140	chr21:47616080	G/A	cg13126279	chr21:47581558	C21orf56	0.69	6.1	0.57	3.8e-8	Testicular germ cell tumor;
SKCM	cis	rs8180040	0.522	rs749512	chr3:47035900	C/T	cg27129171	chr3:47204927	SETD2	-0.75	-5.45	-0.53	5.61e-7	Colorectal cancer;
SKCM	cis	rs2243480	0.708	rs35310401	chr7:65390359	A/G	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs12134245	0.776	rs12137878	chr1:91973210	G/T	cg25838465	chr1:92012736	NA	-0.82	-9.14	-0.72	5.7e-14	Breast cancer;
SKCM	cis	rs7772486	0.686	rs1415744	chr6:146022531	C/T	cg23711669	chr6:146136114	FBXO30	0.83	8.52	0.69	9.25e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7811142	1.000	rs7811142	chr7:100065443	A/T	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.34	0.69	2.1e-12	Platelet count;
SKCM	cis	rs644799	0.930	rs3802764	chr11:95514599	T/A	cg03916912	chr11:95522834	CEP57;FAM76B	0.94	8.46	0.69	1.18e-12	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs1577917	0.771	rs2842609	chr6:86296788	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.98	-10.99	-0.78	1.66e-17	Response to antipsychotic treatment;
SKCM	cis	rs2075371	1.000	rs2241336	chr7:133979578	A/G	cg20476274	chr7:133979776	SLC35B4	1.02	10.84	0.78	3.18e-17	Mean platelet volume;
SKCM	cis	rs16854884	0.837	rs13083068	chr3:143801642	G/T	cg06585982	chr3:143692056	C3orf58	0.73	5.43	0.52	6.24e-7	Economic and political preferences (feminism/equality);
SKCM	cis	rs11785400	1.000	rs4518642	chr8:143737396	T/C	cg20003893	chr8:144489567	NA	-0.55	-4.79	-0.48	7.95e-6	Schizophrenia;
SKCM	cis	rs7539542	0.556	rs6427979	chr1:202869503	T/C	cg19681188	chr1:202830198	LOC148709	0.79	5.54	0.53	3.93e-7	Mean platelet volume;
SKCM	cis	rs4911259	0.533	rs6058931	chr20:31471012	C/T	cg13636640	chr20:31349939	DNMT3B	-0.74	-6.15	-0.57	3.04e-8	Inflammatory bowel disease;
SKCM	cis	rs9513627	0.512	rs9517759	chr13:100180108	T/G	cg25919922	chr13:100150906	NA	0.85	5.45	0.53	5.67e-7	Obesity-related traits;
SKCM	cis	rs951366	0.789	rs1772148	chr1:205704580	A/T	cg07167872	chr1:205819463	PM20D1	0.96	8.0	0.67	9.33e-12	Menarche (age at onset);
SKCM	cis	rs28386778	0.897	rs9912557	chr17:61784963	C/A	cg01411255	chr17:61851458	DDX42;CCDC47	0.79	5.1	0.5	2.35e-6	Prudent dietary pattern;
SKCM	cis	rs28386778	0.901	rs2665855	chr17:61965143	A/G	cg06873352	chr17:61820015	STRADA	0.74	6.13	0.57	3.31e-8	Prudent dietary pattern;
SKCM	cis	rs1005277	0.579	rs1780122	chr10:38529509	C/A	cg25427524	chr10:38739819	LOC399744	-0.76	-6.92	-0.62	1.13e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs2404602	0.692	rs34478400	chr15:76923510	C/T	cg23625390	chr15:77176239	SCAPER	0.61	5.33	0.52	9.13e-7	Blood metabolite levels;
SKCM	cis	rs6840360	0.554	rs4643789	chr4:152726691	C/T	cg22705602	chr4:152727874	NA	-0.55	-7.26	-0.64	2.51e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs6089584	0.850	rs6142938	chr20:60627723	A/C	cg06108461	chr20:60628389	TAF4	-0.89	-9.05	-0.72	8.53e-14	Body mass index;
SKCM	cis	rs6570726	0.791	rs10457788	chr6:145921136	T/A	cg23711669	chr6:146136114	FBXO30	0.87	8.2	0.68	3.85e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1218582	0.772	rs2061690	chr1:154919080	C/T	cg03351412	chr1:154909251	PMVK	0.75	6.28	0.58	1.79e-8	Prostate cancer;
SKCM	cis	rs7100689	0.577	rs10749560	chr10:82092801	G/T	cg01528321	chr10:82214614	TSPAN14	0.76	6.21	0.58	2.39e-8	Post bronchodilator FEV1;
SKCM	cis	rs7666738	0.830	rs10017201	chr4:98983561	G/A	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4555082	0.874	rs2816613	chr14:105726367	C/T	cg13114125	chr14:105738426	BRF1	-0.69	-5.47	-0.53	5.33e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs873946	0.648	rs12767283	chr10:134557094	C/G	cg18305652	chr10:134549665	INPP5A	0.59	5.72	0.54	1.88e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs748404	0.578	rs478028	chr15:43610772	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	0.82	6.24	0.58	2.08e-8	Lung cancer;
SKCM	cis	rs8077889	0.956	rs4793025	chr17:41841621	T/C	cg26893861	chr17:41843967	DUSP3	1.25	7.55	0.65	6.85e-11	Triglycerides;
SKCM	cis	rs4481887	0.927	rs4244187	chr1:248493511	T/C	cg00666640	chr1:248458726	OR2T12	0.63	5.22	0.51	1.46e-6	Common traits (Other);
SKCM	cis	rs1707322	0.752	rs3811436	chr1:46125880	T/C	cg03146154	chr1:46216737	IPP	0.8	5.57	0.53	3.52e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs28595532	0.920	rs112016126	chr4:119726528	C/T	cg14228332	chr4:119757509	SEC24D	1.07	5.49	0.53	4.77e-7	Cannabis dependence symptom count;
SKCM	cis	rs7811142	1.000	rs11766752	chr7:100073292	A/G	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.17	7.71	0.66	3.44e-11	Platelet count;
SKCM	cis	rs2644899	1.000	rs2644899	chr19:41302949	G/T	cg24958765	chr19:41283667	RAB4B	-0.71	-4.78	-0.48	7.98e-6	Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs709400	0.567	rs28496120	chr14:103897899	C/T	cg26031613	chr14:104095156	KLC1	0.72	5.3	0.51	1.04e-6	Body mass index;
SKCM	cis	rs250585	0.667	rs530564	chr16:23603434	G/A	cg09934309	chr16:23461721	COG7	-0.83	-5.53	-0.53	4.06e-7	Egg allergy;
SKCM	cis	rs7809950	0.784	rs7803102	chr7:107248929	T/G	cg23024343	chr7:107201750	COG5	0.83	7.64	0.65	4.65e-11	Coronary artery disease;
SKCM	cis	rs28386778	0.933	rs2665801	chr17:61952100	C/T	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.32	0.52	9.5e-7	Prudent dietary pattern;
SKCM	cis	rs7408868	1.000	rs757472	chr19:15273221	T/C	cg14696996	chr19:15285081	NOTCH3	0.82	4.92	0.49	4.7e-6	Pulse pressure;
SKCM	cis	rs514406	0.929	rs564273	chr1:53332445	G/C	cg16325326	chr1:53192061	ZYG11B	0.96	10.06	0.75	9.52e-16	Monocyte count;
SKCM	cis	rs992157	1.000	rs13429408	chr2:219142860	C/A	cg00012203	chr2:219082015	ARPC2	0.77	6.53	0.59	6.11e-9	Colorectal cancer;
SKCM	cis	rs3892630	0.588	rs12610342	chr19:33250690	C/T	cg22980127	chr19:33182716	NUDT19	1.45	8.49	0.69	1.07e-12	Red blood cell traits;
SKCM	cis	rs7659604	0.605	rs1507994	chr4:122749541	C/T	cg06713675	chr4:122721982	EXOSC9	-0.73	-7.34	-0.64	1.78e-10	Type 2 diabetes;
SKCM	cis	rs867186	0.925	rs1033797	chr20:33719687	T/C	cg04194272	chr20:33683537	NA	-1.0	-5.89	-0.56	9.12e-8	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs10751667	0.666	rs11246358	chr11:967349	G/A	cg10932868	chr11:921992	NA	0.54	5.22	0.51	1.43e-6	Alzheimer's disease (late onset);
SKCM	cis	rs4665809	0.590	rs6749046	chr2:26429451	C/G	cg26119090	chr2:26468346	HADHA;HADHB	1.02	8.05	0.67	7.59e-12	Gut microbiome composition (summer);
SKCM	cis	rs854765	0.964	rs12943202	chr17:17994332	T/A	cg04398451	chr17:18023971	MYO15A	0.67	4.89	0.48	5.25e-6	Total body bone mineral density;
SKCM	cis	rs2439831	0.867	rs12324572	chr15:43636200	G/A	cg02155558	chr15:43621948	ADAL;LCMT2	1.39	9.42	0.73	1.62e-14	Lung cancer in ever smokers;
SKCM	cis	rs8060686	0.641	rs2285910	chr16:68104422	T/C	cg09117114	chr16:67998030	SLC12A4	-0.81	-5.29	-0.51	1.07e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs3892630	0.817	rs12609866	chr19:33184412	C/T	cg22980127	chr19:33182716	NUDT19	1.39	8.08	0.67	6.68e-12	Red blood cell traits;
SKCM	cis	rs7666738	0.830	rs13112131	chr4:98976784	G/A	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs35146811	0.589	rs1727142	chr7:99816179	T/C	cg22906224	chr7:99728672	NA	-0.73	-5.27	-0.51	1.18e-6	Coronary artery disease;
SKCM	cis	rs12148488	0.763	rs2304902	chr15:75340727	G/T	cg09165964	chr15:75287851	SCAMP5	0.67	5.22	0.51	1.43e-6	Caffeine consumption;
SKCM	cis	rs7584330	0.740	rs13404177	chr2:238441412	T/C	cg14458575	chr2:238380390	NA	0.81	5.12	0.5	2.14e-6	Prostate cancer;
SKCM	cis	rs6495122	0.618	rs4886413	chr15:75262310	G/C	cg17294928	chr15:75287854	SCAMP5	0.7	5.35	0.52	8.66e-7	Caffeine consumption;Diastolic blood pressure;Coffee consumption;
SKCM	cis	rs514406	0.893	rs522287	chr1:53365493	C/T	cg16325326	chr1:53192061	ZYG11B	0.91	9.81	0.74	2.88e-15	Monocyte count;
SKCM	cis	rs8067545	0.586	rs3850779	chr17:20171872	C/T	cg13482628	chr17:19912719	NA	-0.65	-5.44	-0.52	5.84e-7	Schizophrenia;
SKCM	cis	rs9300255	0.722	rs12304248	chr12:123810425	C/T	cg05973401	chr12:123451056	ABCB9	-0.82	-5.72	-0.54	1.92e-7	Neutrophil percentage of white cells;
SKCM	cis	rs2836950	0.565	rs2836931	chr21:40546569	T/G	cg17971929	chr21:40555470	PSMG1	-0.76	-6.53	-0.59	6.19e-9	Menarche (age at onset);
SKCM	cis	rs9513627	1.000	rs2390279	chr13:100208705	A/G	cg11288260	chr13:100117058	NA	-0.79	-4.78	-0.48	8.1e-6	Obesity-related traits;
SKCM	cis	rs2204008	0.684	rs11514164	chr12:38036494	C/T	cg26384229	chr12:38710491	ALG10B	0.81	6.83	0.61	1.69e-9	Bladder cancer;
SKCM	cis	rs875971	0.862	rs6947339	chr7:65888470	T/C	cg18876405	chr7:65276391	NA	0.63	6.34	0.58	1.39e-8	Aortic root size;
SKCM	cis	rs8180040	0.701	rs7625067	chr3:47095305	T/C	cg27129171	chr3:47204927	SETD2	0.82	6.49	0.59	7.26e-9	Colorectal cancer;
SKCM	cis	rs1949733	1.000	rs2688223	chr4:8471398	T/C	cg11789530	chr4:8429930	ACOX3	0.87	6.41	0.59	1.02e-8	Response to antineoplastic agents;
SKCM	cis	rs727563	0.580	rs202626	chr22:41847190	C/A	cg03806693	chr22:41940476	POLR3H	1.07	6.74	0.61	2.44e-9	Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs611744	0.647	rs4735053	chr8:109260776	A/G	cg18478394	chr8:109455254	TTC35	0.66	5.33	0.52	9.43e-7	Dupuytren's disease;
SKCM	cis	rs12142240	0.698	rs4372193	chr1:46853233	G/T	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs1957429	0.808	rs11158564	chr14:65335082	G/A	cg23373153	chr14:65346875	NA	1.22	6.35	0.58	1.3e-8	Pediatric areal bone mineral density (radius);
SKCM	trans	rs11083271	0.608	rs7237216	chr18:25848482	T/C	cg00321150	chr11:62623587	SNORD27;SLC3A2;SNHG1;SNORD28;SNORD25;SNORD26	0.79	7.29	0.64	2.17e-10	Non-alcoholic fatty liver disease histology (lobular);
SKCM	cis	rs4819852	1.000	rs2073743	chr22:19989612	C/G	cg07821417	chr22:19972146	ARVCF	0.53	6.7	0.6	2.9e-9	Pulse pressure;
SKCM	cis	rs72615157	0.634	rs74742883	chr7:99785765	T/G	cg23667466	chr7:100026434	MEPCE;ZCWPW1	0.89	4.84	0.48	6.53e-6	Lung function (FEV1/FVC);
SKCM	cis	rs2281727	0.500	rs2169356	chr17:2138016	A/T	cg16513277	chr17:2031491	SMG6	-0.71	-4.78	-0.48	7.99e-6	Coronary artery disease;Body mass index;
SKCM	cis	rs28595532	0.841	rs114385163	chr4:119737058	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs7590720	0.531	rs6435932	chr2:216906030	T/C	cg12620499	chr2:216877984	MREG	0.66	5.09	0.5	2.43e-6	Alcohol dependence;
SKCM	trans	rs11083271	0.608	rs12326078	chr18:25856527	G/T	cg00321150	chr11:62623587	SNORD27;SLC3A2;SNHG1;SNORD28;SNORD25;SNORD26	0.8	7.63	0.65	4.88e-11	Non-alcoholic fatty liver disease histology (lobular);
SKCM	cis	rs2739330	0.761	rs5760176	chr22:24402321	A/G	cg25703541	chr22:24373054	LOC391322	0.94	8.68	0.7	4.57e-13	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs7193541	0.695	rs7199490	chr16:74716026	G/A	cg01733217	chr16:74700730	RFWD3	0.79	6.78	0.61	2.06e-9	Multiple myeloma;
SKCM	cis	rs523522	0.962	rs4767902	chr12:120910004	C/T	cg12219531	chr12:120966889	COQ5	0.91	7.6	0.65	5.66e-11	High light scatter reticulocyte count;
SKCM	cis	rs12711979	0.509	rs10181286	chr2:3824567	G/A	cg17052675	chr2:3827356	NA	-0.82	-8.9	-0.71	1.66e-13	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs7809950	1.000	rs2894475	chr7:107262558	A/T	cg23024343	chr7:107201750	COG5	-0.84	-7.72	-0.66	3.23e-11	Coronary artery disease;
SKCM	cis	rs9911578	0.933	rs2531726	chr17:56522533	C/T	cg05425664	chr17:57184151	TRIM37	0.68	4.96	0.49	4.02e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1005277	0.522	rs1208681	chr10:38092975	C/T	cg00409905	chr10:38381863	ZNF37A	-0.59	-5.6	-0.54	3.08e-7	Extrinsic epigenetic age acceleration;
SKCM	trans	rs62103177	0.810	rs62103175	chr18:77622467	C/T	cg05926928	chr17:57297772	GDPD1	1.29	8.74	0.7	3.44e-13	Opioid sensitivity;
SKCM	cis	rs362296	0.698	rs3095080	chr4:3264418	C/T	cg05297308	chr4:3317976	RGS12	-0.63	-4.77	-0.48	8.36e-6	Parental longevity (mother's age at death);
SKCM	cis	rs7666738	0.791	rs7684521	chr4:99071219	A/G	cg17366294	chr4:99064904	C4orf37	0.61	4.93	0.49	4.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1577917	1.000	rs12213740	chr6:86656733	A/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.85	-8.62	-0.7	5.82e-13	Response to antipsychotic treatment;
SKCM	cis	rs2816062	0.786	rs742486	chr1:18900829	G/A	cg18795169	chr1:18902165	NA	-0.85	-8.22	-0.68	3.46e-12	Urate levels in lean individuals;
SKCM	cis	rs10504229	0.906	rs7003285	chr8:58173108	A/G	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs16866061	0.962	rs16825685	chr2:225434256	C/G	cg12698349	chr2:225449008	CUL3	1.01	8.51	0.69	9.75e-13	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs7659604	0.539	rs11098645	chr4:122729251	G/A	cg20573242	chr4:122745356	CCNA2	0.74	6.25	0.58	2e-8	Type 2 diabetes;
SKCM	cis	rs8177253	0.930	rs12595	chr3:133496553	T/C	cg16414030	chr3:133502952	NA	-0.7	-5.93	-0.56	7.88e-8	Iron status biomarkers;
SKCM	cis	rs798554	0.959	rs798556	chr7:2759002	C/A	cg14895029	chr7:2775587	GNA12	-0.69	-5.04	-0.5	2.95e-6	Height;
SKCM	cis	rs1160297	0.609	rs1828338	chr2:53096951	T/C	cg07782112	chr2:53107842	NA	0.59	6.3	0.58	1.63e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs10504229	0.954	rs114134184	chr8:58181969	G/A	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs2404602	0.646	rs3764245	chr15:77223176	G/C	cg23625390	chr15:77176239	SCAPER	0.81	7.58	0.65	6.2e-11	Blood metabolite levels;
SKCM	cis	rs4727027	0.680	rs6464941	chr7:148826352	A/G	cg23583168	chr7:148888333	NA	-0.81	-5.58	-0.53	3.41e-7	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs8180040	0.627	rs6442059	chr3:47187075	C/G	cg27129171	chr3:47204927	SETD2	0.74	5.3	0.51	1.05e-6	Colorectal cancer;
SKCM	cis	rs992157	0.735	rs12990082	chr2:219102332	C/T	cg20019365	chr2:219134978	PNKD;AAMP	0.72	6.4	0.59	1.07e-8	Colorectal cancer;
SKCM	cis	rs420259	0.516	rs1135045	chr16:23489711	C/G	cg10006042	chr16:23042421	NA	-0.37	-4.91	-0.49	4.87e-6	Bipolar disorder;
SKCM	cis	rs9916302	0.904	rs8077104	chr17:37530510	A/G	cg07936489	chr17:37558343	FBXL20	0.85	7.3	0.64	2.13e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs854765	0.547	rs4925135	chr17:17952868	T/C	cg24612305	chr17:17875800	TOM1L2;LRRC48	-1.05	-9.29	-0.72	2.92e-14	Total body bone mineral density;
SKCM	cis	rs4077515	0.874	rs4498662	chr9:139290251	C/G	cg14169450	chr9:139327907	INPP5E	0.48	5.2	0.51	1.55e-6	Ulcerative colitis;IgA nephropathy;Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs909674	0.524	rs5757670	chr22:39829736	G/A	cg24399712	chr22:39784796	NA	-0.58	-4.85	-0.48	6.07e-6	IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis);IgG glycosylation;IgG digalactosylation phenotypes (multivariate analysis);IgG sialylation phenotypes (multivariate analysis);IgG monogalactosylation phenotypes (multivariate analysis);IgG fucosylation phenotypes (multivariate analysis);IgG N-glycosylation phenotypes (multivariate analysis);IgG disialylation phenotypes (multivariate analysis);IgG galactosylation phenotypes (multivariate analysis);Post bronchodilator FEV1;
SKCM	cis	rs4689592	0.503	rs59640165	chr4:7051661	G/A	cg26116260	chr4:7069785	GRPEL1	-1.08	-7.34	-0.64	1.76e-10	Monocyte percentage of white cells;
SKCM	cis	rs2153535	0.580	rs6918391	chr6:8461178	A/C	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs1577917	1.000	rs12215903	chr6:86675028	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.86	-8.61	-0.7	6.29e-13	Response to antipsychotic treatment;
SKCM	cis	rs7772486	0.776	rs2265467	chr6:146218339	T/A	cg05347473	chr6:146136440	FBXO30	0.55	5.13	0.5	2.07e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2188420	0.872	rs2230460	chr7:106524689	C/T	cg23615938	chr7:105753134	SYPL1	-0.89	-5.08	-0.5	2.49e-6	Interferon gamma levels;
SKCM	cis	rs3784262	0.669	rs2414530	chr15:58356362	T/C	cg12031962	chr15:58353849	ALDH1A2	-0.43	-5.02	-0.49	3.23e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs9300255	0.739	rs11057210	chr12:123733799	A/G	cg00376283	chr12:123451042	ABCB9	0.84	5.91	0.56	8.5e-8	Neutrophil percentage of white cells;
SKCM	cis	rs6570726	0.689	rs411785	chr6:145888398	G/A	cg23711669	chr6:146136114	FBXO30	0.89	9.46	0.73	1.37e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs763014	0.898	rs8060585	chr16:635794	C/G	cg00908189	chr16:619842	PIGQ	0.82	7.78	0.66	2.55e-11	Height;
SKCM	trans	rs1814175	0.935	rs7482690	chr11:49648814	C/T	cg15704280	chr7:45808275	SEPT13	-0.97	-8.6	-0.7	6.57e-13	Height;
SKCM	cis	rs995000	0.931	rs1168097	chr1:63120371	C/T	cg06896770	chr1:63153194	DOCK7	-0.76	-7.5	-0.65	8.71e-11	Triglyceride levels;
SKCM	cis	rs7666738	0.822	rs6815312	chr4:99058220	T/C	cg05340658	chr4:99064831	C4orf37	0.66	4.87	0.48	5.74e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2011503	0.882	rs10423874	chr19:19359500	C/G	cg11584989	chr19:19387371	SF4	0.77	5.09	0.5	2.41e-6	Bipolar disorder;
SKCM	cis	rs854765	0.551	rs56886154	chr17:17831473	C/A	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.93	7.3	0.64	2.06e-10	Total body bone mineral density;
SKCM	cis	rs3768617	0.510	rs12061219	chr1:183101471	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs4478037	0.822	rs9868526	chr3:33124269	A/G	cg19404215	chr3:33155277	CRTAP	-1.02	-4.78	-0.48	8.13e-6	Major depressive disorder;
SKCM	cis	rs3091242	0.933	rs35403885	chr1:25784551	G/A	cg27572855	chr1:25598939	RHD	-0.53	-5.06	-0.5	2.67e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs4771122	0.728	rs7992289	chr13:28036430	G/A	cg22138327	chr13:27999177	GTF3A	-0.89	-6.57	-0.6	5.21e-9	Body mass index;
SKCM	cis	rs12971120	0.838	rs2241510	chr18:72180739	G/A	cg25817165	chr18:72167213	CNDP2	-0.65	-4.87	-0.48	5.69e-6	Refractive error;
SKCM	cis	rs12142240	0.698	rs66972124	chr1:46807445	A/G	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs826838	0.904	rs11612004	chr12:39204282	G/A	cg13010199	chr12:38710504	ALG10B	0.67	5.06	0.5	2.68e-6	Heart rate;
SKCM	cis	rs9325144	0.534	rs1843866	chr12:38703160	G/T	cg13010199	chr12:38710504	ALG10B	0.63	4.92	0.49	4.64e-6	Morning vs. evening chronotype;
SKCM	cis	rs6547631	0.507	rs7355681	chr2:85911339	G/A	cg24620635	chr2:85921963	GNLY	0.8	7.04	0.62	6.63e-10	Blood protein levels;
SKCM	cis	rs11112613	0.713	rs871220	chr12:105938558	G/A	cg03607813	chr12:105948248	NA	0.89	5.71	0.54	1.94e-7	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;
SKCM	cis	rs3793683	0.597	rs2182620	chr10:134590715	C/T	cg18305652	chr10:134549665	INPP5A	0.6	6.16	0.57	2.97e-8	Migraine;
SKCM	cis	rs7589728	0.563	rs2292868	chr2:88475047	A/G	cg04511125	chr2:88470314	THNSL2	-1.07	-6.66	-0.6	3.43e-9	Plasma clusterin levels;
SKCM	cis	rs1799949	0.965	rs4793230	chr17:41427403	A/C	cg05368731	chr17:41323189	NBR1	0.84	7.18	0.63	3.56e-10	Menopause (age at onset);
SKCM	cis	rs9910055	0.659	rs3826412	chr17:42255097	A/G	cg08499158	chr17:42289980	UBTF	-0.73	-6.45	-0.59	8.6e-9	Total body bone mineral density;
SKCM	cis	rs10504229	0.683	rs10504225	chr8:58145121	A/T	cg02725872	chr8:58115012	NA	-0.54	-5.26	-0.51	1.23e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs62238980	0.614	rs116941748	chr22:32404361	C/T	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs796364	0.951	rs281776	chr2:200834282	T/G	cg12253985	chr2:200820533	C2orf60;C2orf47	0.92	5.62	0.54	2.83e-7	Schizophrenia;
SKCM	cis	rs11098499	0.731	rs6846966	chr4:120293208	A/G	cg24375607	chr4:120327624	NA	0.67	5.13	0.5	2.07e-6	Corneal astigmatism;
SKCM	cis	rs3818717	0.538	rs12945601	chr17:17653411	C/T	cg15994159	chr17:17584505	RAI1	-0.52	-4.97	-0.49	3.92e-6	Lymphocyte counts;
SKCM	cis	rs2354432	0.607	rs10900350	chr1:146828017	T/G	cg25205988	chr1:146714368	CHD1L	1.13	6.24	0.58	2.08e-8	Mitochondrial DNA levels;
SKCM	cis	rs6933660	0.745	rs3778608	chr6:151738131	A/G	cg10883421	chr6:151773342	RMND1;C6orf211	0.83	7.04	0.62	6.61e-10	Menarche (age at onset);
SKCM	cis	rs854765	0.552	rs6502624	chr17:17847936	G/A	cg04398451	chr17:18023971	MYO15A	-0.85	-6.05	-0.57	4.75e-8	Total body bone mineral density;
SKCM	cis	rs8016982	0.674	rs1957549	chr14:81706179	G/A	cg01989461	chr14:81687754	GTF2A1	0.87	7.17	0.63	3.66e-10	Schizophrenia;
SKCM	cis	rs589448	0.934	rs554591	chr12:69753847	T/C	cg20891283	chr12:69753455	YEATS4	0.98	9.89	0.75	2.06e-15	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs12477438	0.520	rs6542863	chr2:99725138	C/T	cg14399236	chr2:99771627	LIPT1;TSGA10	0.95	8.78	0.71	2.89e-13	Chronic sinus infection;
SKCM	cis	rs6938	0.534	rs11636892	chr15:75266049	G/C	cg17294928	chr15:75287854	SCAMP5	0.69	5.26	0.51	1.23e-6	Breast cancer;
SKCM	cis	rs7829975	0.591	rs12677543	chr8:8644274	G/C	cg06636001	chr8:8085503	FLJ10661	0.81	7.16	0.63	3.97e-10	Mood instability;
SKCM	cis	rs1401999	0.899	rs2313211	chr3:183738626	T/A	cg01324343	chr3:183735012	ABCC5	0.88	10.48	0.76	1.5e-16	Anterior chamber depth;
SKCM	cis	rs6977660	0.943	rs10240816	chr7:19819620	A/C	cg05791153	chr7:19748676	TWISTNB	0.79	5.34	0.52	9.05e-7	Thyroid stimulating hormone;
SKCM	cis	rs12142240	0.698	rs17357635	chr1:46808668	G/A	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs6088590	0.930	rs6087618	chr20:33288407	C/T	cg24642439	chr20:33292090	TP53INP2	0.99	7.53	0.65	7.63e-11	Coronary artery disease;
SKCM	cis	rs7811142	0.943	rs3900792	chr7:100004577	C/G	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.23	8.03	0.67	8.33e-12	Platelet count;
SKCM	cis	rs7809950	0.954	rs2520242	chr7:107136320	G/T	cg23024343	chr7:107201750	COG5	0.76	6.75	0.61	2.37e-9	Coronary artery disease;
SKCM	cis	rs2228479	0.850	rs62056065	chr16:89905115	C/G	cg00800038	chr16:89945340	TCF25	-0.96	-4.88	-0.48	5.51e-6	Skin colour saturation;
SKCM	cis	rs7143963	0.943	rs34503276	chr14:103266077	C/T	cg23020514	chr14:103360112	TRAF3	0.84	7.73	0.66	3.2e-11	Body mass index;
SKCM	cis	rs854765	0.619	rs4561528	chr17:17979099	C/T	cg04398451	chr17:18023971	MYO15A	-1.03	-9.3	-0.73	2.8e-14	Total body bone mineral density;
SKCM	cis	rs2777491	0.872	rs7163649	chr15:41586798	A/G	cg18705301	chr15:41695430	NDUFAF1	-0.93	-8.72	-0.7	3.71e-13	Ulcerative colitis;
SKCM	cis	rs9943753	0.508	rs11066422	chr12:109807153	A/G	cg19025524	chr12:109796872	NA	-0.63	-5.83	-0.55	1.21e-7	HDL cholesterol;
SKCM	cis	rs7408868	1.000	rs10407320	chr19:15275716	G/C	cg14696996	chr19:15285081	NOTCH3	0.82	4.92	0.49	4.7e-6	Pulse pressure;
SKCM	cis	rs9457247	0.534	rs4710154	chr6:167394634	A/T	cg23791538	chr6:167370224	RNASET2	0.55	4.98	0.49	3.74e-6	Crohn's disease;
SKCM	cis	rs77216612	0.877	rs7956514	chr12:12879254	T/G	cg09462578	chr12:12878428	APOLD1	-0.85	-5.59	-0.54	3.17e-7	Lymphocyte counts;
SKCM	cis	rs854765	0.583	rs4414547	chr17:17859052	G/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.01	7.49	0.65	9.28e-11	Total body bone mineral density;
SKCM	cis	rs62238980	0.614	rs80148383	chr22:32513717	A/C	cg00543991	chr22:32367038	NA	1.17	4.81	0.48	7.24e-6	Childhood ear infection;
SKCM	cis	rs4819052	0.851	rs9979545	chr21:46679805	G/A	cg02159808	chr21:46707872	POFUT2;LOC642852	0.75	5.99	0.56	6.11e-8	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs2739330	0.760	rs5751760	chr22:24243573	G/A	cg12419862	chr22:24373484	LOC391322	-0.78	-7.26	-0.64	2.46e-10	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs3785574	0.962	rs56295011	chr17:61850359	A/G	cg01411255	chr17:61851458	DDX42;CCDC47	1.11	12.47	0.82	2.97e-20	Height;
SKCM	cis	rs9325144	0.647	rs12830095	chr12:38864199	C/T	cg13010199	chr12:38710504	ALG10B	-0.66	-5.27	-0.51	1.2e-6	Morning vs. evening chronotype;
SKCM	cis	rs854765	0.547	rs12150369	chr17:17911014	G/A	cg04398451	chr17:18023971	MYO15A	-0.87	-6.78	-0.61	2.05e-9	Total body bone mineral density;
SKCM	cis	rs7523050	0.643	rs17621922	chr1:109404454	C/T	cg08274380	chr1:109419600	GPSM2	1.13	6.45	0.59	8.46e-9	Fat distribution (HIV);
SKCM	cis	rs11112613	0.713	rs55646142	chr12:105949557	G/A	cg03607813	chr12:105948248	NA	0.83	5.77	0.55	1.55e-7	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;
SKCM	cis	rs2204008	0.776	rs8186824	chr12:38316537	A/C	cg26384229	chr12:38710491	ALG10B	0.78	6.48	0.59	7.59e-9	Bladder cancer;
SKCM	cis	rs875971	0.895	rs7788984	chr7:65915616	A/G	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	cis	rs6500602	0.701	rs11643057	chr16:4544505	C/T	cg08645402	chr16:4508243	NA	0.61	4.77	0.48	8.3e-6	Schizophrenia;
SKCM	cis	rs2204008	0.811	rs2139752	chr12:38370398	C/T	cg26384229	chr12:38710491	ALG10B	0.81	6.56	0.6	5.29e-9	Bladder cancer;
SKCM	cis	rs28386778	0.703	rs2286565	chr17:62010232	G/T	cg23090583	chr17:61904693	PSMC5;FTSJ3	-0.78	-6.42	-0.59	9.98e-9	Prudent dietary pattern;
SKCM	cis	rs2120019	1.000	rs12910644	chr15:75358388	A/G	cg17294928	chr15:75287854	SCAMP5	-0.83	-7.08	-0.63	5.44e-10	Blood trace element (Zn levels);
SKCM	cis	rs17376456	0.825	rs55947981	chr5:93278104	G/T	cg25358565	chr5:93447407	FAM172A	1.31	7.46	0.65	1.04e-10	Diabetic retinopathy;
SKCM	cis	rs7179456	0.513	rs640704	chr15:59049021	A/G	cg05156742	chr15:59063176	FAM63B	0.83	6.27	0.58	1.83e-8	Asperger disorder;
SKCM	cis	rs2204008	0.583	rs12820907	chr12:37990931	T/C	cg26384229	chr12:38710491	ALG10B	0.79	6.58	0.6	4.85e-9	Bladder cancer;
SKCM	cis	rs2295499	0.615	rs57978437	chr4:2711162	C/T	cg19433769	chr4:2420260	ZFYVE28	0.69	4.77	0.48	8.44e-6	Cognitive ability;Cognitive ability (multi-trait analysis);Intelligence (multi-trait analysis);
SKCM	cis	rs8141529	0.778	rs7287806	chr22:29213011	G/A	cg02153584	chr22:29168773	CCDC117	0.66	5.35	0.52	8.64e-7	Lymphocyte counts;
SKCM	cis	rs72634258	0.838	rs10489450	chr1:8079301	C/T	cg00042356	chr1:8021962	PARK7	1.09	7.71	0.66	3.35e-11	Inflammatory bowel disease;
SKCM	cis	rs2836974	0.605	rs2836971	chr21:40652040	A/C	cg17971929	chr21:40555470	PSMG1	-0.76	-7.16	-0.63	3.94e-10	Cognitive function;
SKCM	cis	rs7523273	0.606	rs2724391	chr1:207953244	T/C	cg22525895	chr1:207977042	MIR29B2	0.8	6.94	0.62	1.01e-9	Schizophrenia;
SKCM	cis	rs35306767	0.715	rs12777801	chr10:1036285	T/A	cg20503657	chr10:835505	NA	0.69	5.47	0.53	5.29e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs7824557	0.592	rs920044	chr8:11224313	C/T	cg21775007	chr8:11205619	TDH	0.63	5.94	0.56	7.63e-8	Retinal vascular caliber;
SKCM	cis	rs116095464	0.764	rs10069197	chr5:230822	G/C	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs2153535	0.541	rs6932434	chr6:8467679	G/A	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs2153535	0.563	rs1796688	chr6:8536423	A/T	cg23788917	chr6:8435910	SLC35B3	0.65	4.88	0.48	5.49e-6	Motion sickness;
SKCM	cis	rs3741151	0.892	rs76854106	chr11:73027110	G/A	cg17517138	chr11:73019481	ARHGEF17	1.36	5.51	0.53	4.55e-7	GIP levels in response to oral glucose tolerance test (120 minutes);
SKCM	cis	rs12602901	0.500	rs28846454	chr17:4825387	T/A	cg25236894	chr17:5323110	RPAIN;NUP88	0.81	5.83	0.55	1.2e-7	Blood metabolite levels;
SKCM	cis	rs9902453	0.900	rs9910970	chr17:28478329	C/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.79	6.03	0.56	5.24e-8	Coffee consumption (cups per day);
SKCM	cis	rs5769765	0.874	rs4624	chr22:50281917	A/G	cg22709217	chr22:50311962	ALG12;CRELD2	0.79	5.71	0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs589448	0.902	rs315134	chr12:69762713	G/A	cg22834771	chr12:69754056	YEATS4	-0.71	-5.79	-0.55	1.39e-7	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs344364	0.511	rs1657144	chr16:1963989	C/A	cg26897989	chr16:1907736	C16orf73	-0.75	-7.23	-0.63	2.86e-10	Glomerular filtration rate in chronic kidney disease;
SKCM	cis	rs798554	1.000	rs798550	chr7:2760609	A/G	cg19346786	chr7:2764209	NA	-0.68	-7.11	-0.63	4.94e-10	Height;
SKCM	cis	rs3091242	0.900	rs669063	chr1:25721154	A/G	cg27572855	chr1:25598939	RHD	0.56	5.52	0.53	4.35e-7	Erythrocyte sedimentation rate;
SKCM	cis	rs7959452	0.640	rs10878957	chr12:69699638	G/C	cg20891283	chr12:69753455	YEATS4	0.76	6.89	0.62	1.26e-9	Blood protein levels;
SKCM	cis	rs9611565	0.625	rs9611606	chr22:41931074	A/G	cg03806693	chr22:41940476	POLR3H	-1.11	-7.56	-0.65	6.67e-11	Vitiligo;
SKCM	cis	rs3087591	0.960	rs2952976	chr17:29486152	G/A	cg24425628	chr17:29625626	OMG;NF1	0.64	5.26	0.51	1.21e-6	Hip circumference;
SKCM	cis	rs6598955	0.543	rs17163720	chr1:26549399	A/G	cg04990556	chr1:26633338	UBXN11	-0.7	-5.36	-0.52	8.12e-7	Obesity-related traits;
SKCM	cis	rs10089	1.000	rs4836369	chr5:127486462	A/G	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.9	8.98	0.71	1.17e-13	Ileal carcinoids;
SKCM	cis	rs28595532	0.920	rs56046676	chr4:119766733	A/G	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs362272	0.505	rs13104157	chr4:3366950	T/C	cg09735869	chr4:3319127	RGS12	0.97	11.28	0.79	4.61e-18	Serum sulfate level;
SKCM	cis	rs1005277	0.579	rs1621040	chr10:38497232	T/C	cg25427524	chr10:38739819	LOC399744	-0.71	-7.19	-0.63	3.35e-10	Extrinsic epigenetic age acceleration;
SKCM	cis	rs9399135	0.684	rs1135205	chr6:135281795	C/T	cg24558204	chr6:135376177	HBS1L	0.65	5.97	0.56	6.49e-8	Red blood cell count;
SKCM	trans	rs17685	0.753	rs10245584	chr7:75745866	C/T	cg19862616	chr7:65841803	NCRNA00174	0.94	9.48	0.73	1.26e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs16866061	1.000	rs4674916	chr2:225365635	C/A	cg12698349	chr2:225449008	CUL3	1.03	8.8	0.71	2.7e-13	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs2404602	0.692	rs34287706	chr15:76942402	A/C	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs561341	0.943	rs508566	chr17:30289861	G/C	cg23018236	chr17:30244563	NA	-0.52	-5.26	-0.51	1.21e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs9815354	0.767	rs73073342	chr3:41839455	A/C	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs654950	1.000	rs621680	chr1:41984584	C/T	cg06885757	chr1:42089581	HIVEP3	-0.67	-7.08	-0.63	5.56e-10	Airway imaging phenotypes;
SKCM	cis	rs9902453	0.808	rs8069669	chr17:28239502	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.8	6.3	0.58	1.61e-8	Coffee consumption (cups per day);
SKCM	cis	rs2153535	0.601	rs7775274	chr6:8530303	A/G	cg23788917	chr6:8435910	SLC35B3	0.68	4.98	0.49	3.66e-6	Motion sickness;
SKCM	cis	rs9300255	0.698	rs4759416	chr12:123746357	C/G	cg00376283	chr12:123451042	ABCB9	0.84	5.91	0.56	8.5e-8	Neutrophil percentage of white cells;
SKCM	cis	rs362272	0.545	rs3129308	chr4:3309272	C/T	cg24015175	chr4:3319247	RGS12	0.8	9.7	0.74	4.81e-15	Serum sulfate level;
SKCM	cis	rs909674	0.818	rs8136980	chr22:39844574	G/A	cg11247378	chr22:39784982	NA	-0.45	-5.14	-0.5	1.99e-6	IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis);IgG glycosylation;IgG digalactosylation phenotypes (multivariate analysis);IgG sialylation phenotypes (multivariate analysis);IgG monogalactosylation phenotypes (multivariate analysis);IgG fucosylation phenotypes (multivariate analysis);IgG N-glycosylation phenotypes (multivariate analysis);IgG disialylation phenotypes (multivariate analysis);IgG galactosylation phenotypes (multivariate analysis);Post bronchodilator FEV1;
SKCM	cis	rs617791	0.508	rs10791837	chr11:65774596	C/T	cg27068330	chr11:65405492	SIPA1	-0.68	-4.9	-0.49	5.11e-6	Breast cancer;
SKCM	cis	rs6087771	0.890	rs6089056	chr20:30325773	A/G	cg13852791	chr20:30311386	BCL2L1	0.82	5.69	0.54	2.09e-7	Subcortical brain region volumes;Putamen volume;
SKCM	trans	rs1814175	0.817	rs1319547	chr11:49916705	C/T	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	trans	rs9929218	0.529	rs11640736	chr16:68738324	G/T	cg04657470	chr2:198365150	HSPE1;HSPD1	0.94	8.83	0.71	2.28e-13	Colorectal cancer;
SKCM	cis	rs11098499	0.731	rs6846966	chr4:120293208	A/G	cg09307838	chr4:120376055	NA	1.02	8.32	0.69	2.27e-12	Corneal astigmatism;
SKCM	cis	rs7932354	0.528	rs4319472	chr11:47109514	G/C	cg03339077	chr11:47165057	C11orf49	0.61	5.27	0.51	1.16e-6	Bone mineral density (hip);Bone mineral density;
SKCM	cis	rs155076	1.000	rs261423	chr13:21852331	A/C	cg11317459	chr13:21872234	NA	-1.24	-6.91	-0.62	1.19e-9	White matter hyperintensity burden;
SKCM	cis	rs7666738	0.830	rs1124253	chr4:98949682	C/T	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11252926	0.550	rs10904148	chr10:454551	G/T	cg18196295	chr10:418757	DIP2C	0.65	5.26	0.51	1.23e-6	Psychosis in Alzheimer's disease;
SKCM	cis	rs992157	0.560	rs1514132	chr2:219084082	C/T	cg00012203	chr2:219082015	ARPC2	-0.77	-6.29	-0.58	1.73e-8	Colorectal cancer;
SKCM	cis	rs6951245	1.000	rs76833820	chr7:1070278	A/T	cg24642844	chr7:1081250	C7orf50	-0.95	-6.4	-0.59	1.06e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs2072499	0.750	rs7534339	chr1:156156219	A/G	cg25208724	chr1:156163844	SLC25A44	0.92	6.63	0.6	3.98e-9	Testicular germ cell tumor;
SKCM	cis	rs4927850	0.723	rs7630825	chr3:195753740	T/C	cg12923728	chr3:195709715	SDHAP1	-0.83	-6.48	-0.59	7.53e-9	Pancreatic cancer;
SKCM	cis	rs3845702	0.668	rs3856415	chr2:180807367	G/A	cg01881094	chr2:180872142	CWC22	-1.3	-6.15	-0.57	3.07e-8	Schizophrenia;
SKCM	cis	rs1707322	1.000	rs12077546	chr1:46431806	C/T	cg03146154	chr1:46216737	IPP	0.8	5.44	0.52	5.87e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs1669338	0.507	rs4685607	chr3:3179400	C/T	cg16797762	chr3:3221439	CRBN	0.91	5.45	0.53	5.68e-7	White matter integrity;
SKCM	cis	rs79839061	0.518	rs3755961	chr4:895059	A/G	cg07828340	chr4:882639	GAK	1.03	5.84	0.55	1.14e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs17711722	0.701	rs55773927	chr7:65337902	T/C	cg18876405	chr7:65276391	NA	0.86	7.56	0.65	6.53e-11	Calcium levels;
SKCM	cis	rs7336332	0.598	rs9581850	chr13:28012265	A/G	cg22138327	chr13:27999177	GTF3A	0.9	6.4	0.59	1.07e-8	Weight;
SKCM	cis	rs2072499	0.966	rs2842857	chr1:156168736	T/C	cg24450063	chr1:156163899	SLC25A44	1.13	11.43	0.79	2.4e-18	Testicular germ cell tumor;
SKCM	cis	rs2836974	0.899	rs35774464	chr21:40580169	G/A	cg11890956	chr21:40555474	PSMG1	1.09	13.83	0.84	1.08e-22	Cognitive function;
SKCM	cis	rs854765	0.583	rs8078583	chr17:17811465	C/T	cg09796270	chr17:17721594	SREBF1	0.65	4.87	0.48	5.79e-6	Total body bone mineral density;
SKCM	cis	rs995000	0.868	rs880694	chr1:63173284	C/T	cg06896770	chr1:63153194	DOCK7	-0.75	-6.63	-0.6	3.99e-9	Triglyceride levels;
SKCM	cis	rs2033711	0.840	rs10423138	chr19:58928302	T/C	cg00825309	chr19:58991885	ZNF446	-0.69	-5.59	-0.53	3.19e-7	Uric acid clearance;
SKCM	cis	rs748404	0.578	rs2244746	chr15:43695083	T/A	cg02155558	chr15:43621948	ADAL;LCMT2	0.79	5.95	0.56	7.09e-8	Lung cancer;
SKCM	cis	rs554111	0.656	rs17450586	chr1:21254593	T/G	cg01072550	chr1:21505969	NA	0.62	4.87	0.48	5.62e-6	Facial morphology (factor 17, height of vermillion upper lip);
SKCM	cis	rs1325195	0.537	rs2793805	chr1:179195777	A/G	cg24632843	chr1:179557954	NA	0.62	5.07	0.5	2.62e-6	IgE grass sensitization;
SKCM	cis	rs854765	0.583	rs8070128	chr17:17804725	C/T	cg04398451	chr17:18023971	MYO15A	0.79	5.69	0.54	2.13e-7	Total body bone mineral density;
SKCM	cis	rs4268898	0.662	rs59996104	chr2:24404064	C/T	cg06627628	chr2:24431161	ITSN2	-0.89	-6.69	-0.6	2.98e-9	Asthma;
SKCM	cis	rs12497850	0.864	rs4521268	chr3:49137904	G/T	cg07636037	chr3:49044803	WDR6	1.02	8.65	0.7	5.08e-13	Parkinson's disease;
SKCM	cis	rs7659604	0.539	rs7699776	chr4:122753885	A/G	cg19748678	chr4:122722346	EXOSC9	0.66	5.4	0.52	7.12e-7	Type 2 diabetes;
SKCM	cis	rs7666738	0.830	rs10034330	chr4:99064849	G/A	cg05340658	chr4:99064831	C4orf37	0.66	4.87	0.48	5.74e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9399135	0.967	rs9389261	chr6:135371148	C/G	cg24558204	chr6:135376177	HBS1L	0.58	5.05	0.5	2.86e-6	Red blood cell count;
SKCM	cis	rs6977660	0.598	rs72591445	chr7:19773035	G/A	cg05791153	chr7:19748676	TWISTNB	0.93	4.92	0.49	4.79e-6	Thyroid stimulating hormone;
SKCM	cis	rs11700980	0.636	rs61735765	chr21:30255347	C/A	cg24692254	chr21:30365293	RNF160	-0.89	-5.17	-0.51	1.73e-6	QRS complex (12-leadsum);
SKCM	cis	rs875971	0.862	rs7803416	chr7:65954199	A/G	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs9325144	0.577	rs12314639	chr12:39119869	T/C	cg13010199	chr12:38710504	ALG10B	-0.63	-5.51	-0.53	4.42e-7	Morning vs. evening chronotype;
SKCM	cis	rs9905704	0.624	rs11652761	chr17:56986095	C/T	cg12560992	chr17:57184187	TRIM37	0.76	6.03	0.56	5.1e-8	Testicular germ cell tumor;
SKCM	cis	rs4319547	0.698	rs10744217	chr12:122942070	A/G	cg23029597	chr12:123009494	RSRC2	-0.79	-6.0	-0.56	5.95e-8	Body mass index;
SKCM	cis	rs2120019	1.000	rs1867146	chr15:75354971	C/G	cg09165964	chr15:75287851	SCAMP5	-0.75	-6.28	-0.58	1.78e-8	Blood trace element (Zn levels);
SKCM	cis	rs1451375	0.617	rs2060763	chr7:50542359	G/A	cg18232548	chr7:50535776	DDC	-0.74	-5.03	-0.49	3.09e-6	Malaria;
SKCM	cis	rs9435341	0.860	rs12406721	chr1:107563243	G/T	cg09367891	chr1:107599246	PRMT6	0.82	6.58	0.6	4.8e-9	Facial morphology (factor 21, depth of nasal alae);
SKCM	cis	rs12458462	0.509	rs3786241	chr18:77494328	A/C	cg11879182	chr18:77439856	CTDP1	0.69	5.31	0.52	9.96e-7	Monocyte count;
SKCM	cis	rs561341	0.941	rs112569713	chr17:30271738	C/T	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs10207060	0.500	rs7600350	chr2:240716225	T/C	cg07506560	chr2:240697449	NA	0.75	6.1	0.57	3.8e-8	Obesity-related traits;
SKCM	cis	rs9902453	0.934	rs4343336	chr17:28488236	A/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.5	0.53	4.74e-7	Coffee consumption (cups per day);
SKCM	cis	rs11690935	0.959	rs3770451	chr2:172668715	T/G	cg13550731	chr2:172543902	DYNC1I2	-0.95	-8.29	-0.68	2.61e-12	Schizophrenia;
SKCM	cis	rs55962025	0.711	rs363092	chr4:3196029	A/C	cg09735869	chr4:3319127	RGS12	0.61	4.96	0.49	4.03e-6	Parental longevity (mother's age at death);
SKCM	cis	rs9951698	0.678	rs478006	chr18:13054103	A/G	cg12848697	chr18:13133368	NA	0.53	4.96	0.49	4.04e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs992157	0.932	rs4672884	chr2:219182481	G/A	cg00012203	chr2:219082015	ARPC2	-0.77	-5.83	-0.55	1.21e-7	Colorectal cancer;
SKCM	cis	rs11098499	0.738	rs34965784	chr4:120361586	G/C	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs10911232	0.542	rs12128323	chr1:183050087	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.78	6.87	0.61	1.42e-9	Hypertriglyceridemia;
SKCM	cis	rs477692	0.905	rs489966	chr10:131422115	C/G	cg11019008	chr10:131425282	MGMT	-0.51	-4.93	-0.49	4.51e-6	Response to temozolomide;
SKCM	cis	rs826838	1.000	rs11168505	chr12:38939057	A/T	cg13010199	chr12:38710504	ALG10B	-0.86	-6.53	-0.59	6.05e-9	Heart rate;
SKCM	cis	rs2075371	1.000	rs2505	chr7:133979552	C/T	cg20476274	chr7:133979776	SLC35B4	1.01	10.44	0.76	1.77e-16	Mean platelet volume;
SKCM	cis	rs28595532	0.920	rs116834347	chr4:119774155	C/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs10028773	0.506	rs12374346	chr4:120281705	G/A	cg09307838	chr4:120376055	NA	0.98	7.89	0.67	1.52e-11	Educational attainment;
SKCM	cis	rs1506636	0.962	rs17623873	chr7:123417100	C/A	cg03229431	chr7:123269106	ASB15	0.64	5.22	0.51	1.43e-6	Plateletcrit;Platelet count;
SKCM	cis	rs6089584	0.888	rs2892060	chr20:60617955	G/T	cg06108461	chr20:60628389	TAF4	-0.89	-8.72	-0.7	3.75e-13	Body mass index;
SKCM	cis	rs1850744	0.826	rs11933525	chr4:9630504	G/A	cg15442990	chr4:9534313	NA	1.4	5.3	0.51	1.04e-6	Economic and political preferences;
SKCM	cis	rs2255932	0.945	rs2662768	chr3:183211127	G/A	cg20852557	chr3:184035519	EIF4G1	-0.65	-5.51	-0.53	4.48e-7	Interleukin-1-beta levels;
SKCM	cis	rs919433	0.680	rs67580728	chr2:198431258	C/T	cg04278110	chr2:198063759	ANKRD44	0.74	4.94	0.49	4.42e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs561341	1.000	rs521919	chr17:30298039	G/T	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs2032447	0.670	rs198852	chr6:26104448	A/G	cg12310025	chr6:25882481	NA	0.54	4.77	0.48	8.41e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1405130	0.781	rs13009798	chr2:235571365	A/G	cg17841421	chr2:235704848	NA	-0.57	-4.95	-0.49	4.14e-6	Coronary artery disease;
SKCM	cis	rs933688	1.000	rs12656350	chr5:90751343	C/T	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.06	8.11	0.68	5.81e-12	Smoking behavior;
SKCM	cis	rs28386778	0.933	rs2665804	chr17:61951836	G/T	cg01411255	chr17:61851458	DDX42;CCDC47	0.76	4.89	0.48	5.22e-6	Prudent dietary pattern;
SKCM	cis	rs2952156	0.834	rs903503	chr17:37829571	C/A	cg00129232	chr17:37814104	STARD3	-0.64	-5.21	-0.51	1.49e-6	Asthma;
SKCM	cis	rs826838	0.684	rs12367400	chr12:38618673	G/T	cg26384229	chr12:38710491	ALG10B	0.82	6.85	0.61	1.49e-9	Heart rate;
SKCM	cis	rs7959452	0.536	rs4761237	chr12:69776461	C/G	cg14784868	chr12:69753453	YEATS4	0.8	7.56	0.65	6.53e-11	Blood protein levels;
SKCM	trans	rs208520	0.690	rs3846808	chr6:66818604	A/G	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-0.91	-7.45	-0.64	1.06e-10	Exhaled nitric oxide output;
SKCM	cis	rs7208859	0.623	rs73271842	chr17:29137155	T/C	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs4523957	0.820	rs7212249	chr17:2135980	A/T	cg16513277	chr17:2031491	SMG6	-0.71	-4.78	-0.48	7.99e-6	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs79839061	0.610	rs3775130	chr4:875144	G/A	cg07828340	chr4:882639	GAK	1.02	4.99	0.49	3.6e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2836974	0.931	rs2735306	chr21:40713134	A/G	cg11644478	chr21:40555479	PSMG1	-0.75	-6.38	-0.59	1.14e-8	Cognitive function;
SKCM	cis	rs1580019	0.520	rs6945238	chr7:32646096	C/T	cg06627557	chr7:32535165	LSM5;AVL9	-0.92	-8.03	-0.67	8.25e-12	Cognitive ability;
SKCM	cis	rs17685	0.753	rs2302435	chr7:75676987	G/A	cg16684958	chr7:75615977	POR	-0.57	-5.6	-0.54	3.07e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs9583531	0.600	rs6492303	chr13:111356800	G/A	cg15841412	chr13:111365552	ING1	0.73	4.87	0.48	5.76e-6	Coronary artery disease;
SKCM	cis	rs4724125	0.920	rs7778217	chr7:42700532	T/C	cg09407816	chr7:42972088	MRPL32;PSMA2	0.81	5.09	0.5	2.38e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs35306767	0.855	rs11253468	chr10:903261	G/A	cg20503657	chr10:835505	NA	0.76	5.11	0.5	2.21e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs1451375	0.617	rs896307	chr7:50569060	T/C	cg18232548	chr7:50535776	DDC	-0.77	-4.99	-0.49	3.59e-6	Malaria;
SKCM	cis	rs3818285	0.679	rs552419	chr10:111630883	G/T	cg00817464	chr10:111662876	XPNPEP1	0.73	8.39	0.69	1.62e-12	Superior crus of antihelix expression;
SKCM	cis	rs801193	0.548	rs6975044	chr7:66227482	C/T	cg11764359	chr7:65958608	NA	0.75	6.82	0.61	1.71e-9	Aortic root size;
SKCM	cis	rs10492096	0.947	rs12371184	chr12:6632925	A/G	cg13857086	chr12:6580257	VAMP1	0.76	5.82	0.55	1.24e-7	Hip geometry;
SKCM	cis	rs3091242	0.809	rs660129	chr1:25727438	C/T	cg02931644	chr1:25747376	RHCE	0.5	5.01	0.49	3.36e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs801193	0.569	rs11761542	chr7:66218196	G/A	cg11764359	chr7:65958608	NA	0.75	6.82	0.61	1.71e-9	Aortic root size;
SKCM	cis	rs9322193	0.923	rs9404048	chr6:149937324	C/T	cg07701084	chr6:150067640	NUP43	0.6	4.79	0.48	7.78e-6	Lung cancer;
SKCM	cis	rs6860806	0.507	rs272872	chr5:131675864	C/T	cg24060327	chr5:131705240	SLC22A5	0.84	5.64	0.54	2.59e-7	Breast cancer;
SKCM	cis	rs6570726	0.818	rs9399555	chr6:145877554	T/C	cg05347473	chr6:146136440	FBXO30	0.52	4.81	0.48	7.12e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs10504229	1.000	rs67105789	chr8:58192002	G/T	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs6754311	0.517	rs60453613	chr2:136527120	G/C	cg07169764	chr2:136633963	MCM6	0.91	7.21	0.63	3.09e-10	Mosquito bite size;
SKCM	cis	rs654950	0.806	rs7550496	chr1:42043834	G/A	cg06885757	chr1:42089581	HIVEP3	0.63	6.43	0.59	9.51e-9	Airway imaging phenotypes;
SKCM	cis	rs13217239	0.585	rs114919438	chr6:26963792	T/C	cg12292205	chr6:26970375	C6orf41	-0.62	-5.58	-0.53	3.31e-7	Schizophrenia;
SKCM	cis	rs1014246	0.848	rs758362	chr10:118457905	G/A	cg14919929	chr10:118506882	NA	0.8	6.03	0.56	5.24e-8	Age at smoking initiation in chronic obstructive pulmonary disease;
SKCM	cis	rs2033711	0.840	rs4801590	chr19:58961813	G/C	cg13877915	chr19:58951672	ZNF132	0.94	10.42	0.76	2e-16	Uric acid clearance;
SKCM	trans	rs1814175	0.817	rs6486046	chr11:49997017	T/C	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs62238980	0.522	rs79367011	chr22:32450245	G/T	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs6088590	1.000	rs6119524	chr20:33373813	C/T	cg24642439	chr20:33292090	TP53INP2	1.01	7.2	0.63	3.23e-10	Coronary artery disease;
SKCM	cis	rs10883723	0.810	rs10786669	chr10:104256094	C/G	cg11453585	chr10:104263688	ACTR1A;SUFU	0.75	5.7	0.54	2.03e-7	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs523522	0.962	rs1050187	chr12:120902111	A/G	cg27279351	chr12:120934652	DYNLL1	-0.88	-7.96	-0.67	1.11e-11	High light scatter reticulocyte count;
SKCM	cis	rs9467773	0.523	rs2498399	chr6:26706544	T/C	cg15659132	chr6:26577336	NA	0.65	5.48	0.53	4.97e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs10267417	0.544	rs2072185	chr7:19748700	G/A	cg07541023	chr7:19748670	TWISTNB	1.03	6.93	0.62	1.09e-9	Night sleep phenotypes;
SKCM	cis	rs10504229	0.683	rs7838958	chr8:58136968	T/C	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs10751667	0.643	rs10902237	chr11:944801	C/A	cg06064525	chr11:970664	AP2A2	-0.55	-4.85	-0.48	6.12e-6	Alzheimer's disease (late onset);
SKCM	cis	rs910316	1.000	rs12897094	chr14:75579416	C/T	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.85e-7	Height;
SKCM	cis	rs2739330	0.791	rs4822458	chr22:24265659	C/T	cg24846343	chr22:24311635	DDTL	0.59	5.37	0.52	7.86e-7	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs4478137	0.899	rs10857354	chr4:164239841	A/G	cg06758707	chr4:164254230	NPY1R	0.93	6.18	0.57	2.75e-8	Subjective well-being (multi-trait analysis);Subjective well-being;
SKCM	cis	rs28386778	0.897	rs4968662	chr17:61834537	A/G	cg06873352	chr17:61820015	STRADA	0.76	6.34	0.58	1.38e-8	Prudent dietary pattern;
SKCM	cis	rs644799	0.965	rs534488	chr11:95562327	G/A	cg03916912	chr11:95522834	CEP57;FAM76B	0.88	7.53	0.65	7.59e-11	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs6424115	0.830	rs3123554	chr1:24196401	C/T	cg15997130	chr1:24165203	NA	-0.64	-5.49	-0.53	4.86e-7	Immature fraction of reticulocytes;
SKCM	cis	rs9910055	0.607	rs13726	chr17:42239561	C/T	cg13607699	chr17:42295918	UBTF	0.72	5.58	0.53	3.41e-7	Total body bone mineral density;
SKCM	cis	rs9902453	0.935	rs9898424	chr17:28392946	G/A	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.81	-5.78	-0.55	1.45e-7	Coffee consumption (cups per day);
SKCM	cis	rs1153858	1.000	rs1346266	chr15:45694516	G/T	cg10760299	chr15:45669010	GATM	0.61	5.9	0.56	8.99e-8	Homoarginine levels;
SKCM	cis	rs6089584	0.546	rs6061980	chr20:60618877	G/A	cg06108461	chr20:60628389	TAF4	-0.74	-6.9	-0.62	1.2e-9	Body mass index;
SKCM	cis	rs2980439	0.870	rs2945230	chr8:8109936	A/G	cg15556689	chr8:8085844	FLJ10661	0.86	6.88	0.61	1.32e-9	Neuroticism;
SKCM	cis	rs2153535	0.580	rs969422	chr6:8451780	A/T	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs453301	0.653	rs2956244	chr8:8885166	A/G	cg06636001	chr8:8085503	FLJ10661	0.75	6.32	0.58	1.52e-8	Joint mobility (Beighton score);
SKCM	cis	rs7811142	0.830	rs77861211	chr7:99962096	T/C	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.05	5.92	0.56	8.02e-8	Platelet count;
SKCM	cis	rs3892630	0.588	rs8106748	chr19:33282797	G/A	cg22980127	chr19:33182716	NUDT19	1.25	7.07	0.63	5.73e-10	Red blood cell traits;
SKCM	cis	rs9300255	0.739	rs10846491	chr12:123753492	C/G	cg00376283	chr12:123451042	ABCB9	0.82	5.64	0.54	2.61e-7	Neutrophil percentage of white cells;
SKCM	cis	rs1801251	0.929	rs10933409	chr2:233629386	A/G	cg25237894	chr2:233734115	C2orf82	0.59	5.66	0.54	2.45e-7	Coronary artery disease;
SKCM	cis	rs151997	1.000	rs42415	chr5:50207442	T/A	cg06027927	chr5:50259733	NA	0.66	5.78	0.55	1.45e-7	Callous-unemotional behaviour;
SKCM	cis	rs5769765	0.908	rs56351880	chr22:50316597	A/G	cg22709217	chr22:50311962	ALG12;CRELD2	-1.01	-6.03	-0.56	5.11e-8	Schizophrenia;
SKCM	cis	rs875971	0.660	rs7807930	chr7:66087165	C/T	cg00343986	chr7:65444356	GUSB	-0.68	-4.99	-0.49	3.65e-6	Aortic root size;
SKCM	cis	rs12142240	0.698	rs6683192	chr1:46830257	C/T	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs9902453	0.967	rs61014003	chr17:28485233	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.5	0.53	4.74e-7	Coffee consumption (cups per day);
SKCM	cis	rs10751667	0.643	rs7394524	chr11:933865	T/C	cg06064525	chr11:970664	AP2A2	-0.55	-5.09	-0.5	2.46e-6	Alzheimer's disease (late onset);
SKCM	cis	rs63406760	1	rs63406760	chr12:123742692	TG/T	cg05973401	chr12:123451056	ABCB9	0.86	6.11	0.57	3.69e-8	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs7523050	0.643	rs35520362	chr1:109419841	C/T	cg08274380	chr1:109419600	GPSM2	1.17	6.61	0.6	4.34e-9	Fat distribution (HIV);
SKCM	cis	rs6723226	0.750	rs1033751	chr2:32695759	T/C	cg02381751	chr2:32503542	YIPF4	0.69	4.97	0.49	3.91e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2075371	0.965	rs2544216	chr7:133987902	G/A	cg20476274	chr7:133979776	SLC35B4	1.01	10.44	0.76	1.77e-16	Mean platelet volume;
SKCM	cis	rs3768617	0.510	rs2296300	chr1:183099701	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs9902453	0.817	rs67206808	chr17:28190096	A/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.93	6.51	0.59	6.63e-9	Coffee consumption (cups per day);
SKCM	cis	rs736408	0.648	rs3774355	chr3:52817778	G/A	cg18404041	chr3:52824283	ITIH1	-0.55	-4.82	-0.48	6.98e-6	Bipolar disorder;
SKCM	cis	rs40363	0.645	rs1690449	chr16:3520893	C/G	cg27500918	chr16:2933308	FLYWCH2	0.71	4.9	0.49	5.13e-6	Tuberculosis;
SKCM	cis	rs28386778	0.863	rs8076760	chr17:61920497	T/C	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs854765	0.583	rs11650890	chr17:17790882	C/T	cg04398451	chr17:18023971	MYO15A	0.79	5.69	0.54	2.13e-7	Total body bone mineral density;
SKCM	cis	rs17826219	0.706	rs8075107	chr17:29106649	C/A	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Body mass index;
SKCM	cis	rs2404602	0.647	rs12913024	chr15:77145216	C/T	cg23625390	chr15:77176239	SCAPER	-0.85	-8.26	-0.68	2.93e-12	Blood metabolite levels;
SKCM	cis	rs10489202	0.634	rs6427119	chr1:168074145	A/G	cg24449463	chr1:168025552	DCAF6	0.8	7.21	0.63	3.13e-10	Schizophrenia;
SKCM	cis	rs7523050	0.558	rs35926243	chr1:109407712	T/A	cg08274380	chr1:109419600	GPSM2	1.18	6.44	0.59	9.12e-9	Fat distribution (HIV);
SKCM	cis	rs826838	1.000	rs10875717	chr12:38911174	T/C	cg26384229	chr12:38710491	ALG10B	1.04	9.75	0.74	3.88e-15	Heart rate;
SKCM	cis	rs1691799	0.867	rs1168338	chr12:66759369	T/C	cg16791601	chr12:66731901	HELB	-0.63	-5.72	-0.54	1.89e-7	White blood cell count (basophil);
SKCM	cis	rs950776	0.518	rs3813572	chr15:78832588	T/C	cg06917634	chr15:78832804	PSMA4	1.01	10.47	0.76	1.56e-16	Sudden cardiac arrest;
SKCM	cis	rs4619890	0.528	rs28622214	chr4:7879440	C/T	cg08722675	chr4:8412549	ACOX3	0.54	4.94	0.49	4.32e-6	Glaucoma (primary open-angle);
SKCM	cis	rs798554	0.679	rs1636254	chr7:2885724	T/C	cg04166393	chr7:2884313	GNA12	0.79	5.54	0.53	3.9e-7	Height;
SKCM	trans	rs66573146	0.831	rs6832482	chr4:7023433	A/T	cg07817883	chr1:32538562	TMEM39B	1.98	8.65	0.7	5.13e-13	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs3741151	1.000	rs75912489	chr11:73073846	G/A	cg17517138	chr11:73019481	ARHGEF17	1.27	4.87	0.48	5.81e-6	GIP levels in response to oral glucose tolerance test (120 minutes);
SKCM	cis	rs7937682	0.562	rs955744	chr11:111374334	C/T	cg09085632	chr11:111637200	PPP2R1B	0.79	6.45	0.59	8.61e-9	Primary sclerosing cholangitis;
SKCM	cis	rs9814567	1.000	rs3846055	chr3:134203973	T/A	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.69	-5.48	-0.53	4.97e-7	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs8064299	0.967	rs878905	chr17:72769411	G/A	cg25054828	chr17:72772726	NAT9;TMEM104	0.76	6.58	0.6	4.84e-9	Monocyte count;
SKCM	cis	rs748404	0.660	rs2467742	chr15:43750237	C/A	cg02155558	chr15:43621948	ADAL;LCMT2	0.71	5.4	0.52	7.05e-7	Lung cancer;
SKCM	cis	rs10540	0.915	rs12419209	chr11:494510	T/C	cg03576123	chr11:487126	PTDSS2	-1.41	-7.87	-0.67	1.68e-11	Body mass index;
SKCM	cis	rs763014	0.966	rs15564	chr16:677854	G/T	cg00908189	chr16:619842	PIGQ	0.81	7.31	0.64	1.98e-10	Height;
SKCM	cis	rs1405130	0.967	rs11688510	chr2:235566952	A/G	cg21542780	chr2:234763377	HJURP	-0.65	-4.92	-0.49	4.75e-6	Coronary artery disease;
SKCM	cis	rs11098499	0.691	rs28396837	chr4:120271541	G/A	cg09307838	chr4:120376055	NA	0.94	7.73	0.66	3.07e-11	Corneal astigmatism;
SKCM	cis	rs6951245	1.000	rs80212261	chr7:1114012	C/T	cg18402987	chr7:1209562	NA	1.16	6.13	0.57	3.42e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs561341	0.681	rs56064462	chr17:30235116	G/A	cg00745463	chr17:30367425	LRRC37B	-0.99	-6.33	-0.58	1.46e-8	Hip circumference adjusted for BMI;
SKCM	cis	rs4819052	1.000	rs13053002	chr21:46677854	C/T	cg19498844	chr21:46707878	POFUT2;LOC642852	0.91	7.16	0.63	3.86e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs2153535	0.580	rs6910742	chr6:8448328	G/A	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs9303401	0.659	rs61291849	chr17:56909867	T/C	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.16	0.57	2.91e-8	Cognitive test performance;
SKCM	cis	rs875971	0.660	rs79009421	chr7:66068509	G/C	cg11764359	chr7:65958608	NA	-0.84	-6.37	-0.59	1.2e-8	Aortic root size;
SKCM	cis	rs9937943	0.721	rs8059315	chr16:74506447	C/G	cg01733217	chr16:74700730	RFWD3	0.84	5.24	0.51	1.32e-6	Neutrophil percentage of white cells;
SKCM	cis	rs2153535	0.623	rs6597338	chr6:8533508	A/C	cg23788917	chr6:8435910	SLC35B3	0.68	4.98	0.49	3.66e-6	Motion sickness;
SKCM	cis	rs7523050	0.643	rs12741359	chr1:109400489	T/C	cg08274380	chr1:109419600	GPSM2	1.13	5.57	0.53	3.54e-7	Fat distribution (HIV);
SKCM	cis	rs10751667	0.600	rs10751672	chr11:948712	T/C	cg10932868	chr11:921992	NA	0.54	5.22	0.51	1.43e-6	Alzheimer's disease (late onset);
SKCM	cis	rs6933660	0.646	rs3736176	chr6:151773320	T/A	cg14262678	chr6:151773367	RMND1;C6orf211	0.73	5.86	0.55	1.07e-7	Menarche (age at onset);
SKCM	cis	rs2721195	0.967	rs11777703	chr8:145703508	G/A	cg15320075	chr8:145703422	NA	-0.97	-9.16	-0.72	5.37e-14	Age at first birth;
SKCM	cis	rs637571	0.522	rs493899	chr11:65747952	A/C	cg02427764	chr11:65769310	BANF1;EIF1AD	0.77	5.89	0.55	9.2e-8	Eosinophil percentage of white cells;
SKCM	cis	rs801193	0.967	rs3800823	chr7:66147110	C/A	cg11764359	chr7:65958608	NA	-0.86	-6.58	-0.6	4.91e-9	Aortic root size;
SKCM	cis	rs9926296	0.568	rs417323	chr16:89746277	T/G	cg01097406	chr16:89675127	NA	0.55	5.5	0.53	4.69e-7	Vitiligo;
SKCM	cis	rs826838	1.000	rs11169031	chr12:39056738	T/C	cg26384229	chr12:38710491	ALG10B	0.97	9.33	0.73	2.52e-14	Heart rate;
SKCM	cis	rs12477438	0.501	rs11683107	chr2:99759235	T/A	cg14399236	chr2:99771627	LIPT1;TSGA10	0.95	8.41	0.69	1.48e-12	Chronic sinus infection;
SKCM	cis	rs1801251	1.000	rs4973055	chr2:233720283	G/T	cg25237894	chr2:233734115	C2orf82	-0.53	-5.03	-0.5	3.01e-6	Coronary artery disease;
SKCM	cis	rs763121	0.853	rs5757213	chr22:39053888	C/T	cg06022373	chr22:39101656	GTPBP1	0.72	4.96	0.49	4.08e-6	Menopause (age at onset);
SKCM	cis	rs1153858	0.943	rs67045941	chr15:45677011	A/G	cg21132104	chr15:45694354	SPATA5L1	0.93	7.94	0.67	1.22e-11	Homoarginine levels;
SKCM	cis	rs2839186	0.721	rs13051200	chr21:47701693	A/T	cg13012494	chr21:47604986	C21orf56	0.65	5.44	0.52	6e-7	Testicular germ cell tumor;
SKCM	cis	rs208520	0.690	rs3846808	chr6:66818604	A/G	cg07460842	chr6:66804631	NA	-0.91	-7.46	-0.65	1.05e-10	Exhaled nitric oxide output;
SKCM	cis	rs10489202	0.608	rs7556350	chr1:168077797	C/T	cg24449463	chr1:168025552	DCAF6	-0.8	-7.21	-0.63	3.13e-10	Schizophrenia;
SKCM	cis	rs3862260	0.509	rs10754416	chr1:120163531	A/G	cg16322792	chr1:120165303	ZNF697	0.48	5.01	0.49	3.25e-6	Systemic lupus erythematosus;
SKCM	cis	rs2599510	0.783	rs13399071	chr2:32793783	C/T	cg02381751	chr2:32503542	YIPF4	0.73	5.62	0.54	2.79e-7	Interleukin-18 levels;
SKCM	cis	rs12926788	0.542	rs11862971	chr16:24767574	C/A	cg00339695	chr16:24857497	SLC5A11	0.8	6.43	0.59	9.38e-9	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs11690935	0.632	rs17581284	chr2:172659376	C/T	cg13550731	chr2:172543902	DYNC1I2	0.62	5.3	0.51	1.06e-6	Schizophrenia;
SKCM	cis	rs4689592	0.554	rs66925245	chr4:7071999	C/T	cg26116260	chr4:7069785	GRPEL1	-1.0	-6.58	-0.6	4.99e-9	Monocyte percentage of white cells;
SKCM	cis	rs4665809	0.590	rs1122972	chr2:26418788	A/C	cg26119090	chr2:26468346	HADHA;HADHB	-1.02	-8.05	-0.67	7.59e-12	Gut microbiome composition (summer);
SKCM	cis	rs6089584	0.606	rs2273989	chr20:60579138	G/A	cg16423285	chr20:60520624	NA	-0.6	-5.15	-0.5	1.91e-6	Body mass index;
SKCM	cis	rs1552244	0.882	rs17081288	chr3:10042113	A/G	cg02579736	chr3:10068473	FANCD2;CIDECP	0.98	4.84	0.48	6.48e-6	Alzheimer's disease;
SKCM	cis	rs595982	0.527	rs73061658	chr19:49372376	G/C	cg15549821	chr19:49342101	PLEKHA4	-0.85	-5.02	-0.49	3.18e-6	Red cell distribution width;
SKCM	cis	rs2204008	0.743	rs11495614	chr12:38156358	C/T	cg13010199	chr12:38710504	ALG10B	0.69	4.82	0.48	6.84e-6	Bladder cancer;
SKCM	cis	rs9581857	0.547	rs9579096	chr13:28084069	T/C	cg22138327	chr13:27999177	GTF3A	0.84	5.53	0.53	4.15e-7	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs6977660	0.943	rs10270447	chr7:19849823	C/G	cg07541023	chr7:19748670	TWISTNB	-0.7	-4.92	-0.49	4.79e-6	Thyroid stimulating hormone;
SKCM	cis	rs873946	0.517	rs7071784	chr10:134559980	T/C	cg18305652	chr10:134549665	INPP5A	0.6	6.34	0.58	1.35e-8	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs28386778	0.897	rs6504176	chr17:61811920	T/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.13	11.24	0.79	5.56e-18	Prudent dietary pattern;
SKCM	cis	rs6088590	1.000	rs2236270	chr20:33523155	G/T	cg24642439	chr20:33292090	TP53INP2	0.99	7.04	0.62	6.66e-10	Coronary artery disease;
SKCM	cis	rs10911232	0.507	rs4072709	chr1:183028855	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.77	6.89	0.62	1.27e-9	Hypertriglyceridemia;
SKCM	cis	rs763014	0.898	rs1981484	chr16:630710	A/G	cg00908189	chr16:619842	PIGQ	0.82	7.78	0.66	2.55e-11	Height;
SKCM	cis	rs10824796	0.794	rs61844328	chr10:54538421	C/T	cg27418851	chr10:54531653	MBL2	-0.75	-4.97	-0.49	3.89e-6	Blood protein levels;
SKCM	cis	rs3820068	0.603	rs6668726	chr1:15962614	G/A	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs7106204	0.925	rs3924745	chr11:24223001	G/A	ch.11.24196551F	chr11:24239977	NA	0.77	6.34	0.58	1.36e-8	Response to Homoharringtonine (cytotoxicity);
SKCM	cis	rs875971	0.862	rs6955837	chr7:66043142	C/T	cg11764359	chr7:65958608	NA	-0.74	-6.67	-0.6	3.37e-9	Aortic root size;
SKCM	cis	rs9788721	0.630	rs77681598	chr15:78906103	C/A	cg06917634	chr15:78832804	PSMA4	-0.9	-7.95	-0.67	1.16e-11	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;Emphysema imaging phenotypes;Emphysema distribution in smoking;Local histogram emphysema pattern;Post bronchodilator FEV1/FVC ratio in COPD;
SKCM	cis	rs4523957	0.579	rs57130712	chr17:2089035	A/G	cg16513277	chr17:2031491	SMG6	-0.71	-5.08	-0.5	2.47e-6	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs7569084	0.687	rs7562559	chr2:65679853	G/A	cg14775296	chr2:66672841	MEIS1	0.51	4.81	0.48	7.15e-6	Sum eosinophil basophil counts;
SKCM	cis	rs4665809	1.000	rs17040322	chr2:26351274	G/C	cg26119090	chr2:26468346	HADHA;HADHB	-0.76	-4.79	-0.48	7.86e-6	Gut microbiome composition (summer);
SKCM	cis	rs9902453	0.765	rs2628191	chr17:28051140	T/G	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.79	-5.93	-0.56	7.67e-8	Coffee consumption (cups per day);
SKCM	cis	rs3820928	0.874	rs13419455	chr2:227850465	C/G	cg11843606	chr2:227700838	RHBDD1	-0.61	-4.89	-0.48	5.28e-6	Pulmonary function;
SKCM	cis	rs1160297	0.576	rs10206560	chr2:53089060	G/C	cg07782112	chr2:53107842	NA	0.58	6.01	0.56	5.59e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs875971	0.964	rs6978429	chr7:65959876	T/G	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs9325144	0.624	rs7979541	chr12:39129679	T/C	cg26384229	chr12:38710491	ALG10B	-0.74	-6.94	-0.62	1.02e-9	Morning vs. evening chronotype;
SKCM	cis	rs2777491	0.915	rs7180418	chr15:41629502	A/C	cg18705301	chr15:41695430	NDUFAF1	-0.96	-9.11	-0.72	6.65e-14	Ulcerative colitis;
SKCM	cis	rs16854884	0.657	rs16854819	chr3:143736126	C/T	cg06585982	chr3:143692056	C3orf58	-0.87	-7.96	-0.67	1.12e-11	Economic and political preferences (feminism/equality);
SKCM	cis	rs2228479	0.850	rs62054257	chr16:89900195	G/A	cg06558623	chr16:89946397	TCF25	1.1	4.95	0.49	4.17e-6	Skin colour saturation;
SKCM	cis	rs1005277	0.579	rs11011461	chr10:38431427	G/A	cg00409905	chr10:38381863	ZNF37A	-0.66	-6.16	-0.57	3e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs651907	0.557	rs59596156	chr3:101394217	C/T	cg12386194	chr3:101231763	SENP7	0.71	5.94	0.56	7.61e-8	Colorectal cancer;
SKCM	cis	rs62244186	0.545	rs9284880	chr3:44759389	C/T	cg02073558	chr3:44770973	ZNF501	0.87	7.72	0.66	3.28e-11	Depressive symptoms;
SKCM	cis	rs9910055	0.530	rs2269905	chr17:42294462	A/G	cg09913183	chr17:42254507	C17orf65;ASB16	0.6	5.25	0.51	1.3e-6	Total body bone mineral density;
SKCM	cis	rs2180341	0.618	rs12529077	chr6:127634244	G/T	cg24812749	chr6:127587940	RNF146	0.64	5.29	0.51	1.11e-6	Breast cancer;
SKCM	cis	rs11249608	0.548	rs6875473	chr5:178451387	C/A	cg21905437	chr5:178450457	ZNF879	0.76	6.46	0.59	8.29e-9	Pubertal anthropometrics;
SKCM	cis	rs2836974	0.666	rs1888487	chr21:40683259	A/G	cg11890956	chr21:40555474	PSMG1	-0.82	-8.04	-0.67	7.71e-12	Cognitive function;
SKCM	cis	rs7618915	0.547	rs6762813	chr3:52726695	C/T	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs1003719	0.788	rs7275582	chr21:38451130	C/T	cg10648535	chr21:38446584	PIGP;TTC3	0.66	5.27	0.51	1.16e-6	Eye color traits;
SKCM	cis	rs8017423	0.935	rs11628952	chr14:90734953	T/C	cg04374321	chr14:90722782	PSMC1	-0.95	-8.73	-0.7	3.68e-13	Mortality in heart failure;
SKCM	cis	rs7208859	0.623	rs55961983	chr17:29119286	G/A	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs6696846	0.716	rs6593921	chr1:205062861	A/G	cg00857998	chr1:205179979	DSTYK	0.59	4.83	0.48	6.79e-6	Red blood cell count;
SKCM	cis	rs919433	0.756	rs7575389	chr2:198198489	A/G	cg04278110	chr2:198063759	ANKRD44	-0.7	-4.91	-0.49	4.86e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs2204008	0.837	rs11168387	chr12:37962818	G/A	cg13010199	chr12:38710504	ALG10B	-0.63	-4.89	-0.48	5.2e-6	Bladder cancer;
SKCM	cis	rs7927771	0.864	rs11604680	chr11:47457539	A/G	cg05585544	chr11:47624801	NA	-0.6	-5.26	-0.51	1.23e-6	Subjective well-being;
SKCM	cis	rs6570726	0.791	rs418701	chr6:145889992	C/T	cg05347473	chr6:146136440	FBXO30	0.57	5.08	0.5	2.47e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs28595532	0.841	rs112953035	chr4:119752450	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs9790314	0.846	rs6768818	chr3:160951648	A/G	cg03342759	chr3:160939853	NMD3	-0.72	-8.12	-0.68	5.59e-12	Morning vs. evening chronotype;
SKCM	cis	rs34779708	0.931	rs10437420	chr10:35335044	A/C	cg03585969	chr10:35415529	CREM	-0.74	-5.92	-0.56	8.28e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs873946	0.586	rs2001426	chr10:134563871	G/A	cg27286337	chr10:134555280	INPP5A	0.98	8.81	0.71	2.49e-13	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs362272	0.505	rs60208975	chr4:3364530	A/G	cg00764545	chr4:3318001	RGS12	0.98	12.66	0.82	1.33e-20	Serum sulfate level;
SKCM	cis	rs12142240	0.698	rs1057533	chr1:46815836	C/T	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs13256369	0.901	rs12679831	chr8:8566411	T/G	cg06636001	chr8:8085503	FLJ10661	0.78	6.01	0.56	5.67e-8	Obesity-related traits;
SKCM	cis	rs11098499	0.954	rs7654587	chr4:120388406	C/T	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	trans	rs8073060	0.614	rs72829932	chr17:34055935	A/G	cg19694781	chr19:47549865	TMEM160	1.08	8.6	0.7	6.4e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs11601602	0.531	rs35031414	chr11:28545563	T/C	cg06544937	chr11:28130018	METT5D1;KIF18A	0.95	5.3	0.51	1.04e-6	Obesity-related traits;
SKCM	cis	rs1577917	0.958	rs2875456	chr6:86602284	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.86	-8.63	-0.7	5.66e-13	Response to antipsychotic treatment;
SKCM	cis	rs10504229	1.000	rs73607871	chr8:58173007	T/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs875971	1.000	rs778699	chr7:65868290	G/A	cg18876405	chr7:65276391	NA	0.67	6.65	0.6	3.61e-9	Aortic root size;
SKCM	cis	rs514406	0.861	rs4926932	chr1:53247495	C/T	cg16325326	chr1:53192061	ZYG11B	-1.01	-11.91	-0.8	3.17e-19	Monocyte count;
SKCM	cis	rs561341	1.000	rs113676348	chr17:30244327	A/G	cg23018236	chr17:30244563	NA	-0.48	-4.99	-0.49	3.64e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs7666738	0.830	rs4699588	chr4:98973789	A/G	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6570726	0.791	rs440477	chr6:145854188	C/T	cg23711669	chr6:146136114	FBXO30	0.85	8.86	0.71	1.97e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7659604	0.521	rs4833234	chr4:122694799	T/C	cg19671926	chr4:122722719	EXOSC9	0.76	6.84	0.61	1.57e-9	Type 2 diabetes;
SKCM	cis	rs155076	1.000	rs566364	chr13:21837583	T/C	cg11317459	chr13:21872234	NA	-1.25	-6.82	-0.61	1.71e-9	White matter hyperintensity burden;
SKCM	cis	rs10905065	0.861	rs10752069	chr10:5752403	A/G	cg11519256	chr10:5708881	ASB13	0.58	5.41	0.52	6.77e-7	Menopause (age at onset);
SKCM	cis	rs950776	0.593	rs481134	chr15:78877563	C/T	cg06917634	chr15:78832804	PSMA4	0.9	7.99	0.67	9.7e-12	Sudden cardiac arrest;
SKCM	cis	rs7772486	0.817	rs9322047	chr6:146400394	G/A	cg23711669	chr6:146136114	FBXO30	0.86	8.52	0.69	9.13e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs11112613	0.713	rs17041546	chr12:105950801	G/T	cg03607813	chr12:105948248	NA	-0.8	-5.47	-0.53	5.27e-7	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;
SKCM	cis	rs2811415	0.597	rs10934837	chr3:127726173	A/G	cg09089421	chr3:127803668	RUVBL1	0.97	8.25	0.68	3.07e-12	Lung function (FEV1/FVC);
SKCM	cis	rs941408	1.000	rs1736183	chr19:2809672	A/G	cg17333051	chr19:2783644	SGTA	0.41	4.89	0.48	5.22e-6	Total cholesterol levels;
SKCM	cis	rs6951245	0.935	rs78573577	chr7:1089087	C/A	cg18402987	chr7:1209562	NA	1.14	6.01	0.56	5.68e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs9368481	0.761	rs9357030	chr6:26985026	G/T	cg12292205	chr6:26970375	C6orf41	-0.72	-6.6	-0.6	4.58e-9	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs208520	0.770	rs2224422	chr6:66883993	G/A	cg07460842	chr6:66804631	NA	-0.91	-7.07	-0.63	5.76e-10	Exhaled nitric oxide output;
SKCM	cis	rs7811142	0.830	rs11768967	chr7:99967644	G/A	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.19	7.5	0.65	8.66e-11	Platelet count;
SKCM	cis	rs367615	0.704	rs4320313	chr5:108828687	A/G	cg17395555	chr5:108820864	NA	0.75	6.79	0.61	1.95e-9	Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs910316	0.726	rs12882664	chr14:75446778	C/T	cg08847533	chr14:75593920	NEK9	0.79	6.65	0.6	3.64e-9	Height;
SKCM	cis	rs6545883	0.894	rs6760075	chr2:61612881	C/A	cg15711740	chr2:61764176	XPO1	0.7	4.93	0.49	4.5e-6	Tuberculosis;
SKCM	cis	rs780096	0.587	rs6760828	chr2:27579231	T/C	cg05696406	chr2:27599888	SNX17	0.49	5.12	0.5	2.17e-6	Total body bone mineral density;
SKCM	cis	rs873946	0.590	rs12783478	chr10:134550700	A/G	cg27286337	chr10:134555280	INPP5A	0.94	8.43	0.69	1.36e-12	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs1801251	1.000	rs283486	chr2:233644223	A/G	cg25237894	chr2:233734115	C2orf82	0.6	5.8	0.55	1.36e-7	Coronary artery disease;
SKCM	cis	rs9682041	0.696	rs9872796	chr3:170099393	T/G	cg11886554	chr3:170076028	SKIL	0.93	5.5	0.53	4.62e-7	Glomerular filtration rate in non diabetics (creatinine);Glomerular filtration rate (creatinine);
SKCM	cis	rs6834538	0.597	rs6822451	chr4:113463265	G/A	cg05166686	chr4:113558556	LARP7;C4orf21	0.63	5.21	0.51	1.48e-6	Free thyroxine concentration;
SKCM	cis	rs7635838	0.619	rs347616	chr3:11277927	G/A	cg00170343	chr3:11313890	ATG7	0.77	5.36	0.52	8.2e-7	HDL cholesterol;
SKCM	cis	rs2952156	0.920	rs732084	chr17:37834357	A/C	cg00129232	chr17:37814104	STARD3	-0.74	-6.39	-0.59	1.11e-8	Asthma;
SKCM	cis	rs6840360	0.550	rs12651635	chr4:152557786	C/T	cg22705602	chr4:152727874	NA	-0.52	-5.69	-0.54	2.15e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs2739330	0.828	rs5760108	chr22:24252668	G/T	cg25703541	chr22:24373054	LOC391322	-0.78	-6.52	-0.59	6.42e-9	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs17683430	0.702	rs5994483	chr22:32574215	T/A	cg00543991	chr22:32367038	NA	1.1	4.8	0.48	7.44e-6	GIP levels in response to oral glucose tolerance test (120 minutes);
SKCM	cis	rs28595532	0.920	rs10001115	chr4:119781867	A/C	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs55962025	0.765	rs3905238	chr4:3078937	A/G	cg00764545	chr4:3318001	RGS12	-0.57	-4.84	-0.48	6.43e-6	Parental longevity (mother's age at death);
SKCM	cis	rs870825	0.616	rs4615214	chr4:185624129	G/C	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs9911578	1.000	rs2531734	chr17:56550804	T/C	cg05425664	chr17:57184151	TRIM37	0.69	5.23	0.51	1.38e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs8062405	0.558	rs151228	chr16:28563026	A/G	cg09445799	chr16:28968168	NFATC2IP	-0.51	-4.92	-0.49	4.65e-6	Cognitive ability (multi-trait analysis);Cognitive ability;
SKCM	cis	rs67460515	0.500	rs9812507	chr3:160723393	G/A	cg03342759	chr3:160939853	NMD3	-0.65	-4.89	-0.48	5.3e-6	Parkinson's disease;
SKCM	cis	rs1218582	0.688	rs58629129	chr1:154910930	T/C	cg06221963	chr1:154839813	KCNN3	-0.6	-6.02	-0.56	5.3e-8	Prostate cancer;
SKCM	cis	rs2354432	0.505	rs72691009	chr1:146708397	C/T	cg25205988	chr1:146714368	CHD1L	-1.19	-6.54	-0.59	5.94e-9	Mitochondrial DNA levels;
SKCM	cis	rs7811142	0.830	rs11771936	chr7:99943283	A/G	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.06	6.05	0.56	4.82e-8	Platelet count;
SKCM	cis	rs2832191	0.791	rs2832178	chr21:30479858	T/G	cg08807101	chr21:30365312	RNF160	-0.62	-4.94	-0.49	4.34e-6	Dental caries;
SKCM	cis	rs9894429	0.546	rs55917554	chr17:79608776	T/C	cg18240062	chr17:79603768	NPLOC4	0.78	7.53	0.65	7.5e-11	Eye color traits;
SKCM	cis	rs9303401	0.659	rs34913878	chr17:56897094	A/G	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.35	0.52	8.54e-7	Cognitive test performance;
SKCM	trans	rs1814175	0.935	rs11040463	chr11:49685574	C/T	cg03929089	chr4:120376271	NA	-0.87	-7.53	-0.65	7.73e-11	Height;
SKCM	cis	rs763014	0.966	rs4247097	chr16:654224	G/A	cg07343612	chr16:622815	PIGQ	-0.67	-5.78	-0.55	1.47e-7	Height;
SKCM	cis	rs910316	1.000	rs12589815	chr14:75544101	C/T	cg08847533	chr14:75593920	NEK9	0.95	9.18	0.72	4.8e-14	Height;
SKCM	cis	rs7772486	0.875	rs6570738	chr6:146412695	G/A	cg05347473	chr6:146136440	FBXO30	0.64	5.83	0.55	1.19e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs11098499	0.954	rs17005535	chr4:120411562	C/T	cg24375607	chr4:120327624	NA	0.65	5.01	0.49	3.32e-6	Corneal astigmatism;
SKCM	cis	rs8141529	0.753	rs5752813	chr22:29226570	T/G	cg15103426	chr22:29168792	CCDC117	0.61	5.13	0.5	2.06e-6	Lymphocyte counts;
SKCM	cis	rs951366	0.585	rs72750964	chr1:205675240	C/T	cg07157834	chr1:205819609	PM20D1	0.64	5.58	0.53	3.32e-7	Menarche (age at onset);
SKCM	cis	rs1348850	0.668	rs6705405	chr2:178493713	A/G	cg27490568	chr2:178487706	NA	0.79	5.95	0.56	7.25e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs801193	1.000	rs2003301	chr7:66147656	G/C	cg00343986	chr7:65444356	GUSB	-0.7	-5.14	-0.5	1.98e-6	Aortic root size;
SKCM	cis	rs6121246	0.609	rs6060843	chr20:30297047	G/C	cg13852791	chr20:30311386	BCL2L1	0.82	5.64	0.54	2.59e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs17213078	0.510	rs17032713	chr2:106886839	T/C	cg16099169	chr2:106886729	NA	-0.68	-5.58	-0.53	3.3e-7	Facial morphology (factor 23);
SKCM	cis	rs6951245	0.554	rs76243429	chr7:1152543	C/T	cg18402987	chr7:1209562	NA	0.83	5.53	0.53	4.06e-7	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs838147	0.844	rs12982115	chr19:49248640	A/G	cg13540341	chr19:49222985	MAMSTR	0.56	5.06	0.5	2.77e-6	Dietary macronutrient intake;
SKCM	cis	rs2839186	0.709	rs2839176	chr21:47678173	A/G	cg05896524	chr21:47604654	C21orf56	0.65	5.69	0.54	2.17e-7	Testicular germ cell tumor;
SKCM	cis	rs9486715	0.867	rs4240553	chr6:96965324	T/C	cg06623918	chr6:96969491	KIAA0776	0.79	6.49	0.59	7.35e-9	Headache;
SKCM	cis	rs9926296	0.682	rs645019	chr16:89716883	C/T	cg01097406	chr16:89675127	NA	0.56	5.66	0.54	2.41e-7	Vitiligo;
SKCM	cis	rs2282032	1.000	rs3742671	chr14:90756760	A/T	cg04374321	chr14:90722782	PSMC1	0.7	4.85	0.48	6.26e-6	Longevity;
SKCM	cis	rs1799949	1.000	rs3092994	chr17:41215825	C/T	cg25918947	chr17:41365094	TMEM106A	-0.61	-5.91	-0.56	8.59e-8	Menopause (age at onset);
SKCM	cis	rs9303401	0.527	rs7224468	chr17:56749943	C/T	cg02118635	chr17:56770003	RAD51C;TEX14	0.77	5.03	0.49	3.06e-6	Cognitive test performance;
SKCM	cis	rs10769945	0.730	rs217208	chr11:1974892	C/G	cg23202291	chr11:1979235	NA	-0.63	-6.04	-0.56	4.86e-8	DNA methylation (variation);
SKCM	cis	rs1799949	1.000	rs16942	chr17:41244000	T/C	cg05368731	chr17:41323189	NBR1	0.89	7.49	0.65	9.23e-11	Menopause (age at onset);
SKCM	cis	rs6138458	1.000	rs6114980	chr20:24974288	A/G	cg26195577	chr20:24973756	C20orf3	1.29	8.85	0.71	2.07e-13	Blood protein levels;
SKCM	cis	rs1577917	0.958	rs12196230	chr6:86519960	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.81	-0.66	2.19e-11	Response to antipsychotic treatment;
SKCM	cis	rs3771570	0.901	rs62190410	chr2:242410621	C/T	cg07612300	chr2:242033426	MTERFD2;SNED1	0.88	4.9	0.48	5.13e-6	Prostate cancer;
SKCM	cis	rs1395	0.710	rs58965570	chr2:27481460	C/T	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.5	4.79	0.48	7.88e-6	Blood metabolite levels;
SKCM	cis	rs6088580	0.634	rs6059850	chr20:33044784	C/G	cg24642439	chr20:33292090	TP53INP2	0.76	6.02	0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs362296	0.597	rs3129320	chr4:3265130	G/C	cg16987761	chr4:3318072	RGS12	-0.59	-4.88	-0.48	5.59e-6	Parental longevity (mother's age at death);
SKCM	cis	rs62103177	0.810	rs62103195	chr18:77629693	T/C	cg27393146	chr18:77495563	CTDP1	-0.92	-5.36	-0.52	8.37e-7	Opioid sensitivity;
SKCM	cis	rs1568889	0.838	rs7131379	chr11:28085789	C/T	cg06544937	chr11:28130018	METT5D1;KIF18A	0.89	8.44	0.69	1.31e-12	Bipolar disorder;
SKCM	cis	rs1003719	0.788	rs9975168	chr21:38450557	A/G	cg10648535	chr21:38446584	PIGP;TTC3	-0.63	-5.02	-0.49	3.17e-6	Eye color traits;
SKCM	cis	rs4595586	0.563	rs11169769	chr12:39233134	C/G	cg26384229	chr12:38710491	ALG10B	0.68	5.11	0.5	2.27e-6	Morning vs. evening chronotype;
SKCM	cis	rs6942756	1.000	rs7778277	chr7:128978805	C/T	cg02491457	chr7:128862824	NA	-0.86	-5.48	-0.53	5.11e-7	White matter hyperintensity burden;
SKCM	cis	rs864745	0.967	rs1513272	chr7:28200097	C/T	cg15170557	chr7:28214983	JAZF1	-0.72	-7.29	-0.64	2.17e-10	Crohn's disease;Type 2 diabetes;
SKCM	cis	rs11892454	0.573	rs7564262	chr2:25968196	G/C	cg17263061	chr2:26915892	KCNK3	0.71	5.07	0.5	2.6e-6	Heschl's gyrus morphology;
SKCM	cis	rs9300255	0.739	rs2337934	chr12:123745359	A/G	cg00376283	chr12:123451042	ABCB9	0.84	5.91	0.56	8.5e-8	Neutrophil percentage of white cells;
SKCM	cis	rs1046896	0.553	rs56775875	chr17:80831291	G/T	cg22027946	chr17:80790580	TBCD;ZNF750	0.65	4.77	0.48	8.45e-6	Glycated hemoglobin levels;
SKCM	cis	rs7772486	0.686	rs9376956	chr6:145949844	T/C	cg23711669	chr6:146136114	FBXO30	0.9	10.02	0.75	1.16e-15	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs875971	0.929	rs4122249	chr7:65920936	T/C	cg11764359	chr7:65958608	NA	0.89	8.7	0.7	4.13e-13	Aortic root size;
SKCM	cis	rs7826238	0.623	rs2976893	chr8:8338219	G/T	cg15556689	chr8:8085844	FLJ10661	-0.83	-7.26	-0.64	2.46e-10	Systolic blood pressure;
SKCM	cis	rs9790314	0.838	rs4414866	chr3:160928709	C/T	cg03342759	chr3:160939853	NMD3	-0.67	-6.64	-0.6	3.82e-9	Morning vs. evening chronotype;
SKCM	cis	rs55794721	0.509	rs12027110	chr1:25775682	A/T	cg02931644	chr1:25747376	RHCE	0.51	4.94	0.49	4.39e-6	Plateletcrit;Mean corpuscular volume;
SKCM	cis	rs4243830	0.737	rs925744	chr1:6615695	C/T	cg22792644	chr1:6614718	TAS1R1;NOL9	-1.23	-4.81	-0.48	7.15e-6	Body mass index;
SKCM	cis	rs3771570	0.892	rs59715783	chr2:242366262	C/T	cg07612300	chr2:242033426	MTERFD2;SNED1	0.87	4.77	0.47	8.54e-6	Prostate cancer;
SKCM	cis	rs875971	0.545	rs73148639	chr7:65855329	A/T	cg18876405	chr7:65276391	NA	0.61	4.84	0.48	6.44e-6	Aortic root size;
SKCM	cis	rs4819052	0.851	rs2236446	chr21:46678985	T/C	cg20896738	chr21:46707857	POFUT2;LOC642852	0.64	4.82	0.48	6.85e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs1577917	0.771	rs2758847	chr6:86349103	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-1.01	-11.43	-0.79	2.49e-18	Response to antipsychotic treatment;
SKCM	cis	rs72781680	0.848	rs56371415	chr2:23932603	C/G	cg08917208	chr2:24149416	ATAD2B	0.95	4.78	0.48	8.1e-6	Lymphocyte counts;
SKCM	trans	rs8073060	0.544	rs2626626	chr17:34026717	A/G	cg19694781	chr19:47549865	TMEM160	-1.08	-8.6	-0.7	6.4e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	trans	rs561341	1.000	rs530715	chr17:30320544	T/G	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs2228479	0.850	rs62056102	chr16:89941438	T/C	cg06558623	chr16:89946397	TCF25	1.12	5.64	0.54	2.58e-7	Skin colour saturation;
SKCM	cis	rs7824557	0.628	rs6601580	chr8:11193736	T/G	cg21775007	chr8:11205619	TDH	0.72	6.73	0.61	2.51e-9	Retinal vascular caliber;
SKCM	cis	rs7824557	0.606	rs2736273	chr8:11199938	C/A	cg21775007	chr8:11205619	TDH	0.65	5.81	0.55	1.28e-7	Retinal vascular caliber;
SKCM	cis	rs2832191	0.633	rs2832166	chr21:30462395	G/C	cg08807101	chr21:30365312	RNF160	0.68	5.1	0.5	2.32e-6	Dental caries;
SKCM	cis	rs2228479	0.850	rs17233567	chr16:89813821	G/A	cg06558623	chr16:89946397	TCF25	1.03	5.59	0.53	3.23e-7	Skin colour saturation;
SKCM	cis	rs919433	0.963	rs12469546	chr2:198178826	T/C	cg04278110	chr2:198063759	ANKRD44	-0.69	-4.8	-0.48	7.58e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs929354	0.742	rs7801905	chr7:156940111	T/C	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs4073582	0.595	rs801741	chr11:65917084	A/G	cg14036092	chr11:66035641	RAB1B	0.74	5.8	0.55	1.34e-7	Gout;
SKCM	cis	rs62238980	0.614	rs17744899	chr22:32406766	G/C	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs826838	1.000	rs11183196	chr12:38685915	G/T	cg26384229	chr12:38710491	ALG10B	1.08	9.62	0.74	6.73e-15	Heart rate;
SKCM	cis	rs4481887	0.830	rs6686474	chr1:248477116	A/C	cg00666640	chr1:248458726	OR2T12	0.66	6.0	0.56	5.9e-8	Common traits (Other);
SKCM	cis	rs34779708	0.931	rs34375045	chr10:35362356	A/C	cg03585969	chr10:35415529	CREM	0.79	6.34	0.58	1.37e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs2999052	0.526	rs1030656	chr3:127773627	C/G	cg09089421	chr3:127803668	RUVBL1	0.55	5.11	0.5	2.25e-6	Hypospadias;
SKCM	cis	rs9916302	0.904	rs7501488	chr17:37576417	T/G	cg07936489	chr17:37558343	FBXL20	-0.85	-7.35	-0.64	1.71e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs9393692	0.645	rs4145910	chr6:26313305	T/C	cg00631329	chr6:26305371	NA	-0.7	-4.84	-0.48	6.33e-6	Educational attainment;
SKCM	cis	rs9790314	1.000	rs336590	chr3:161079583	G/A	cg03342759	chr3:160939853	NMD3	-0.72	-7.89	-0.67	1.53e-11	Morning vs. evening chronotype;
SKCM	cis	rs28595532	0.920	rs116607127	chr4:119731072	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.52	0.53	4.28e-7	Cannabis dependence symptom count;
SKCM	cis	rs6952808	0.798	rs28970524	chr7:1927484	C/T	cg21782813	chr7:2030301	MAD1L1	0.54	5.45	0.53	5.61e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs514406	0.505	rs427319	chr1:53178807	T/G	cg16325326	chr1:53192061	ZYG11B	0.89	10.06	0.75	9.55e-16	Monocyte count;
SKCM	cis	rs7953249	0.502	rs1169294	chr12:121426594	G/A	cg02403541	chr12:121454288	C12orf43	0.69	5.63	0.54	2.68e-7	Invasive epithelial ovarian cancer;High-grade serous ovarian cancer;Chronic obstructive pulmonary disease-related biomarkers;N-glycan levels;Serous invasive ovarian cancer;Epithelial ovarian cancer;
SKCM	cis	rs7789940	0.904	rs6953281	chr7:75946943	C/T	cg10167463	chr7:75959203	YWHAG	-0.68	-4.81	-0.48	7.15e-6	Multiple sclerosis;
SKCM	cis	rs28595532	1.000	rs11938970	chr4:119660152	A/G	cg21605333	chr4:119757512	SEC24D	1.21	6.77	0.61	2.18e-9	Cannabis dependence symptom count;
SKCM	cis	rs28595532	0.920	rs114223775	chr4:119775091	C/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs35306767	0.715	rs17221463	chr10:1038040	T/C	cg20503657	chr10:835505	NA	0.6	4.9	0.48	5.16e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs1005277	0.579	rs2472178	chr10:38384750	T/C	cg00409905	chr10:38381863	ZNF37A	-0.64	-6.18	-0.57	2.68e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs7208859	0.623	rs11658945	chr17:29122509	T/C	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs7829975	0.593	rs2979241	chr8:8303353	G/C	cg06636001	chr8:8085503	FLJ10661	0.68	5.62	0.54	2.8e-7	Mood instability;
SKCM	cis	rs875971	1.000	rs778696	chr7:65870813	C/G	cg11764359	chr7:65958608	NA	0.87	8.35	0.69	2.01e-12	Aortic root size;
SKCM	cis	rs951366	0.844	rs823096	chr1:205679887	G/T	cg26354017	chr1:205819088	PM20D1	0.91	7.36	0.64	1.62e-10	Menarche (age at onset);
SKCM	cis	rs7408868	1.000	rs7245814	chr19:15274503	A/G	cg14696996	chr19:15285081	NOTCH3	0.82	4.92	0.49	4.7e-6	Pulse pressure;
SKCM	cis	rs9910055	0.659	rs227578	chr17:42210189	C/A	cg19774624	chr17:42201019	HDAC5	0.93	8.83	0.71	2.36e-13	Total body bone mineral density;
SKCM	cis	rs12142240	0.659	rs1984491	chr1:46858607	T/G	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs801193	0.591	rs721717	chr7:66130292	G/T	cg11764359	chr7:65958608	NA	-0.74	-6.66	-0.6	3.49e-9	Aortic root size;
SKCM	cis	rs17685	0.712	rs869805	chr7:75688596	C/T	cg16684958	chr7:75615977	POR	0.59	5.63	0.54	2.69e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs9916302	0.718	rs7219909	chr17:37706243	C/T	cg07936489	chr17:37558343	FBXL20	-0.9	-8.15	-0.68	4.86e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs951366	0.617	rs708727	chr1:205767885	G/A	cg26354017	chr1:205819088	PM20D1	1.0	10.78	0.77	4.13e-17	Menarche (age at onset);
SKCM	cis	rs4862750	0.914	rs1346126	chr4:187876404	T/C	cg10295955	chr4:187884368	NA	-1.06	-14.08	-0.85	3.96e-23	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7811142	1.000	rs66632384	chr7:100018904	G/A	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.11	6.45	0.59	8.66e-9	Platelet count;
SKCM	cis	rs9790314	0.690	rs7617204	chr3:160821969	A/G	cg03342759	chr3:160939853	NMD3	-0.67	-6.68	-0.6	3.16e-9	Morning vs. evening chronotype;
SKCM	cis	rs1784581	0.855	rs1790002	chr6:162384397	G/T	cg17173639	chr6:162384350	PARK2	-0.61	-5.37	-0.52	7.99e-7	Itch intensity from mosquito bite;
SKCM	cis	rs8072100	0.576	rs7216112	chr17:45406345	C/T	cg08085267	chr17:45401833	C17orf57	0.88	7.1	0.63	4.98e-10	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs12950390	0.893	rs4239165	chr17:45847272	A/T	cg03474202	chr17:45855739	NA	-0.49	-5.58	-0.53	3.34e-7	IgG glycosylation;
SKCM	cis	rs908922	0.676	rs11205014	chr1:152483634	C/T	cg09873164	chr1:152488093	CRCT1	0.76	5.84	0.55	1.14e-7	Hair morphology;
SKCM	cis	rs7811142	0.830	rs7792525	chr7:99972122	A/G	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.07	6.7	0.6	2.88e-9	Platelet count;
SKCM	cis	rs4654899	0.758	rs6690574	chr1:21504279	G/A	cg01072550	chr1:21505969	NA	-0.62	-4.79	-0.48	7.86e-6	Superior frontal gyrus grey matter volume;
SKCM	cis	rs1153858	1.000	rs12439274	chr15:45636667	A/G	cg21132104	chr15:45694354	SPATA5L1	0.92	7.87	0.67	1.69e-11	Homoarginine levels;
SKCM	cis	rs4924935	1.000	rs11658555	chr17:18817486	C/T	cg26378065	chr17:18585709	ZNF286B	-0.77	-5.58	-0.53	3.37e-7	Pancreatic cancer;
SKCM	cis	rs9300255	0.664	rs28636834	chr12:123871070	A/C	cg00376283	chr12:123451042	ABCB9	-0.78	-5.23	-0.51	1.39e-6	Neutrophil percentage of white cells;
SKCM	cis	rs2180341	0.924	rs9285459	chr6:127631113	T/C	cg27446573	chr6:127587934	RNF146	1.01	8.78	0.7	2.93e-13	Breast cancer;
SKCM	cis	rs8103278	1.000	rs7250497	chr19:46358425	A/G	cg11657440	chr19:46296263	DMWD	-0.86	-5.69	-0.54	2.1e-7	Coronary artery disease;
SKCM	cis	rs4862750	0.832	rs6836426	chr4:187897837	T/G	cg10295955	chr4:187884368	NA	-1.04	-14.07	-0.85	4.23e-23	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs208520	0.909	rs9453672	chr6:66991431	A/G	cg07460842	chr6:66804631	NA	0.87	5.96	0.56	6.95e-8	Exhaled nitric oxide output;
SKCM	cis	rs7786877	0.545	rs73156234	chr7:100234744	C/T	cg20848291	chr7:100343083	ZAN	-0.68	-5.07	-0.5	2.59e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs2153535	0.580	rs5001322	chr6:8451608	A/G	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs4900538	0.819	rs72698591	chr14:102838896	G/A	cg18135206	chr14:102964638	TECPR2	-0.72	-5.27	-0.51	1.19e-6	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs10503709	0.568	rs13272708	chr8:21457312	C/T	cg24196612	chr8:21608193	GFRA2	-0.51	-4.99	-0.49	3.64e-6	Blood protein levels;
SKCM	cis	rs854765	0.619	rs4561528	chr17:17979099	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.85	6.55	0.6	5.58e-9	Total body bone mineral density;
SKCM	cis	rs11718455	0.960	rs11921995	chr3:44017301	C/A	cg21419209	chr3:44054225	NA	-0.66	-5.22	-0.51	1.46e-6	Coronary artery disease;
SKCM	trans	rs8073060	0.586	rs4796100	chr17:33997657	G/T	cg19694781	chr19:47549865	TMEM160	1.04	8.53	0.69	8.9e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs228769	0.517	rs2526011	chr17:42288128	T/G	cg08499158	chr17:42289980	UBTF	-0.97	-5.09	-0.5	2.37e-6	Bone mineral density (hip);Bone mineral density (spine);
SKCM	cis	rs2836974	0.666	rs12626405	chr21:40663121	G/T	cg11644478	chr21:40555479	PSMG1	-0.69	-6.11	-0.57	3.59e-8	Cognitive function;
SKCM	cis	rs9399137	0.529	rs7739722	chr6:135282225	T/C	cg24558204	chr6:135376177	HBS1L	0.69	6.37	0.59	1.21e-8	Glycated hemoglobin levels;Mean corpuscular volume;Hematology traits;HbA2 levels;Mean corpuscular hemoglobin;Hemoglobin levels;F-cell distribution;Platelet count;
SKCM	cis	rs6582630	0.555	rs56228141	chr12:38518652	T/G	cg26384229	chr12:38710491	ALG10B	0.82	6.67	0.6	3.25e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs28595532	0.920	rs116634064	chr4:119736514	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs9300255	0.544	rs1790100	chr12:123656725	G/T	cg05973401	chr12:123451056	ABCB9	0.81	5.37	0.52	7.77e-7	Neutrophil percentage of white cells;
SKCM	cis	rs9467773	1.000	rs2224380	chr6:26553943	G/A	cg15659132	chr6:26577336	NA	0.6	5.71	0.54	1.99e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs703842	1.000	rs10877012	chr12:58162085	G/T	cg04478727	chr12:58166393	METTL1;FAM119B	0.72	5.66	0.54	2.37e-7	Multiple sclerosis;
SKCM	cis	rs2439831	0.764	rs2447193	chr15:43929733	A/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.31	7.38	0.64	1.49e-10	Lung cancer in ever smokers;
SKCM	cis	rs8017423	0.935	rs11621820	chr14:90727154	C/T	cg04374321	chr14:90722782	PSMC1	1.03	9.44	0.73	1.55e-14	Mortality in heart failure;
SKCM	cis	rs561341	0.941	rs2428338	chr17:30299629	T/C	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs10751667	0.666	rs6597966	chr11:950750	T/C	cg10932868	chr11:921992	NA	0.55	5.1	0.5	2.36e-6	Alzheimer's disease (late onset);
SKCM	cis	rs9868809	0.505	rs28567949	chr3:48744560	G/A	cg00383909	chr3:49044727	WDR6	0.89	5.09	0.5	2.44e-6	Ulcerative colitis;Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs10905065	0.965	rs7078711	chr10:5744985	C/G	cg09234995	chr10:5726438	C10orf18	-0.66	-5.73	-0.54	1.84e-7	Menopause (age at onset);
SKCM	cis	rs7090367	1.000	rs10794618	chr10:125234633	A/G	cg16197717	chr10:125650957	CPXM2	-0.5	-5.03	-0.49	3.09e-6	Body mass index;
SKCM	cis	rs9420	0.961	rs1647405	chr11:57477889	C/T	cg19752551	chr11:57585705	CTNND1	-0.7	-6.97	-0.62	9.17e-10	Schizophrenia;
SKCM	cis	rs6430585	0.583	rs2839740	chr2:136648883	G/T	cg07169764	chr2:136633963	MCM6	1.34	11.82	0.8	4.68e-19	Corneal structure;
SKCM	cis	rs7811142	0.830	rs6979910	chr7:99940630	A/C	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.08	6.85	0.61	1.49e-9	Platelet count;
SKCM	cis	rs2404602	0.716	rs4079681	chr15:76695230	G/A	cg23625390	chr15:77176239	SCAPER	0.59	5.31	0.52	9.85e-7	Blood metabolite levels;
SKCM	cis	rs7639513	0.520	rs4684111	chr3:12729485	T/G	cg23032965	chr3:12705835	RAF1	0.81	6.85	0.61	1.51e-9	Itch intensity from mosquito bite;
SKCM	cis	rs1577917	0.958	rs13213551	chr6:86608701	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.85	-8.62	-0.7	5.82e-13	Response to antipsychotic treatment;
SKCM	cis	rs1790761	0.667	rs598811	chr11:67311676	C/T	cg00290607	chr11:67383545	NA	0.5	5.23	0.51	1.36e-6	Mean corpuscular volume;
SKCM	cis	rs1005277	0.579	rs1780146	chr10:38517874	C/A	cg25427524	chr10:38739819	LOC399744	-0.73	-6.68	-0.6	3.19e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs11690935	0.632	rs9789538	chr2:172618474	G/C	cg13550731	chr2:172543902	DYNC1I2	0.64	5.49	0.53	4.81e-7	Schizophrenia;
SKCM	cis	rs1707322	0.752	rs61784798	chr1:46173481	C/T	cg03146154	chr1:46216737	IPP	0.81	5.62	0.54	2.87e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs1858740	0.526	rs196372	chr3:38432083	G/A	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.83	7.08	0.63	5.53e-10	Schizophrenia;
SKCM	cis	rs1799949	0.965	rs4793234	chr17:41436183	A/G	cg23758822	chr17:41437982	NA	0.97	7.84	0.66	1.96e-11	Menopause (age at onset);
SKCM	cis	rs941408	0.515	rs1640265	chr19:2784405	C/T	cg06609049	chr19:2785107	THOP1	1.11	9.7	0.74	4.69e-15	Total cholesterol levels;
SKCM	cis	rs6951245	1.000	rs113146460	chr7:1105164	C/G	cg03188948	chr7:1209495	NA	1.13	6.27	0.58	1.89e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs13256369	0.851	rs13266562	chr8:8564065	T/C	cg15556689	chr8:8085844	FLJ10661	0.65	4.77	0.48	8.39e-6	Obesity-related traits;
SKCM	cis	rs2502731	0.504	rs10115537	chr9:130957091	G/A	cg13642260	chr9:130955380	CIZ1	-0.82	-7.59	-0.65	5.75e-11	Attention deficit hyperactivity disorder;
SKCM	cis	rs1707322	0.721	rs61784800	chr1:46178112	A/G	cg03146154	chr1:46216737	IPP	-0.81	-6.0	-0.56	5.79e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs12477438	0.520	rs4402818	chr2:99717608	A/G	cg26064155	chr2:99771622	LIPT1;TSGA10	1.02	10.07	0.75	9.12e-16	Chronic sinus infection;
SKCM	cis	rs3845702	0.668	rs12693215	chr2:180826007	A/C	cg01881094	chr2:180872142	CWC22	-1.3	-6.15	-0.57	3.07e-8	Schizophrenia;
SKCM	cis	rs854765	0.654	rs9911281	chr17:17762457	G/C	cg24612305	chr17:17875800	TOM1L2;LRRC48	-1.05	-8.25	-0.68	3.1e-12	Total body bone mineral density;
SKCM	cis	rs2180341	0.513	rs12196828	chr6:127696864	C/T	cg24812749	chr6:127587940	RNF146	0.65	5.48	0.53	5.03e-7	Breast cancer;
SKCM	cis	rs7927771	0.507	rs7119517	chr11:47675316	T/C	cg20307385	chr11:47447363	PSMC3	0.72	5.81	0.55	1.31e-7	Subjective well-being;
SKCM	cis	rs6952808	1.000	rs4721121	chr7:1892565	A/G	cg02951883	chr7:2050386	MAD1L1	-0.73	-5.52	-0.53	4.3e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs9290877	0.667	rs62291298	chr3:188460544	A/G	cg17392043	chr3:188495102	LPP	-0.64	-4.93	-0.49	4.6e-6	IgE levels;
SKCM	cis	rs12709013	0.792	rs8049572	chr16:58843576	A/C	cg02431531	chr16:59244939	NA	0.48	4.99	0.49	3.62e-6	Blood metabolite ratios;
SKCM	cis	rs1577917	0.696	rs2842603	chr6:86336337	G/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.75	-6.67	-0.6	3.25e-9	Response to antipsychotic treatment;
SKCM	cis	rs4819052	0.851	rs13048789	chr21:46660714	A/G	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.36	0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7639513	0.545	rs55977822	chr3:12704438	C/A	cg23032965	chr3:12705835	RAF1	0.82	7.03	0.62	7.05e-10	Itch intensity from mosquito bite;
SKCM	cis	rs10751667	0.643	rs7395613	chr11:933873	C/T	cg10932868	chr11:921992	NA	0.55	5.13	0.5	2.09e-6	Alzheimer's disease (late onset);
SKCM	cis	rs9611565	0.512	rs45500192	chr22:42177899	A/G	cg03806693	chr22:41940476	POLR3H	-1.2	-7.59	-0.65	5.96e-11	Vitiligo;
SKCM	cis	rs1218582	0.772	rs10796934	chr1:154849479	C/G	cg16680214	chr1:154839983	KCNN3	-0.55	-4.94	-0.49	4.37e-6	Prostate cancer;
SKCM	cis	rs155076	0.938	rs485361	chr13:21845826	G/T	cg11317459	chr13:21872234	NA	-1.24	-6.91	-0.62	1.19e-9	White matter hyperintensity burden;
SKCM	cis	rs9381040	0.655	rs879491	chr6:41026953	A/G	cg04346459	chr6:41068666	NFYA;LOC221442	-0.69	-4.8	-0.48	7.61e-6	Alzheimer's disease (late onset);
SKCM	cis	rs6461049	0.519	rs3778992	chr7:2175313	C/G	cg21782813	chr7:2030301	MAD1L1	0.49	5.49	0.53	4.83e-7	Schizophrenia;
SKCM	cis	rs3741404	0.825	rs2515241	chr11:63975331	C/T	cg19465662	chr11:63993652	NUDT22;TRPT1	0.81	6.02	0.56	5.35e-8	Platelet count;
SKCM	cis	rs735396	0.694	rs2264750	chr12:121450165	C/T	cg02403541	chr12:121454288	C12orf43	0.74	6.15	0.57	3.04e-8	N-glycan levels;
SKCM	cis	rs9303401	0.592	rs12936771	chr17:56725052	T/C	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.16	0.57	2.91e-8	Cognitive test performance;
SKCM	cis	rs2239547	0.522	rs2581815	chr3:52982159	C/G	cg11645453	chr3:52864694	ITIH4	0.58	4.96	0.49	3.98e-6	Schizophrenia;
SKCM	cis	rs7937682	0.632	rs10789850	chr11:111750829	C/T	cg09085632	chr11:111637200	PPP2R1B	1.07	9.99	0.75	1.34e-15	Primary sclerosing cholangitis;
SKCM	cis	rs3820068	0.603	rs7529759	chr1:15977877	A/G	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs7666738	0.830	rs28456179	chr4:98991439	A/G	cg05340658	chr4:99064831	C4orf37	0.67	5.14	0.5	1.98e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs80033912	0.713	rs7629936	chr3:49836707	G/A	cg07636037	chr3:49044803	WDR6	0.71	5.11	0.5	2.2e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs4819052	0.807	rs4819047	chr21:46665139	C/T	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.42	0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs912057	0.526	rs746453	chr6:6734221	C/A	cg06612196	chr6:6737390	NA	0.74	6.48	0.59	7.63e-9	Waist-to-hip ratio adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);
SKCM	cis	rs748404	0.690	rs2467737	chr15:43737188	G/A	cg02155558	chr15:43621948	ADAL;LCMT2	0.77	6.08	0.57	4.2e-8	Lung cancer;
SKCM	cis	rs4808199	0.948	rs2301671	chr19:19466269	C/T	cg03709012	chr19:19516395	GATAD2A	1.08	7.53	0.65	7.65e-11	Nonalcoholic fatty liver disease;
SKCM	cis	rs7937682	0.921	rs11213940	chr11:111433927	C/A	cg09085632	chr11:111637200	PPP2R1B	0.98	8.12	0.68	5.52e-12	Primary sclerosing cholangitis;
SKCM	cis	rs548181	0.577	rs569766	chr11:125532369	G/A	cg03464685	chr11:125439445	EI24	1.26	8.71	0.7	3.93e-13	Schizophrenia;Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);
SKCM	cis	rs3784262	1.000	rs10851631	chr15:58242193	C/T	cg12031962	chr15:58353849	ALDH1A2	-0.5	-6.24	-0.58	2.15e-8	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs912057	0.526	rs201061	chr6:6730512	C/T	cg06612196	chr6:6737390	NA	-0.71	-6.19	-0.57	2.61e-8	Waist-to-hip ratio adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);
SKCM	cis	rs7208859	0.623	rs12103508	chr17:29086781	T/G	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs7811142	0.945	rs6955362	chr7:100056166	C/T	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.12	6.51	0.59	6.68e-9	Platelet count;
SKCM	cis	rs28386778	0.897	rs2584642	chr17:61942427	T/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.13	11.24	0.79	5.64e-18	Prudent dietary pattern;
SKCM	cis	rs6570726	0.791	rs10872577	chr6:145900560	G/T	cg05347473	chr6:146136440	FBXO30	0.58	5.16	0.5	1.82e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2243480	1.000	rs1796220	chr7:66062100	C/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs4925325	0.955	rs1776262	chr20:60516023	G/T	cg06108461	chr20:60628389	TAF4	0.8	5.03	0.49	3.07e-6	Obesity-related traits;
SKCM	cis	rs13118159	0.550	rs4974612	chr4:1364543	A/G	cg16405210	chr4:1374714	KIAA1530	-0.96	-7.25	-0.63	2.61e-10	Longevity;
SKCM	cis	rs4782151	0.692	rs17652566	chr16:9351466	G/C	cg05568466	chr16:8431529	NA	0.39	4.94	0.49	4.32e-6	Cervical cancer;
SKCM	cis	rs13256369	0.802	rs13280101	chr8:8562773	G/A	cg06636001	chr8:8085503	FLJ10661	0.8	6.04	0.56	5.01e-8	Obesity-related traits;
SKCM	cis	rs2777491	0.957	rs16971798	chr15:41657144	A/T	cg18705301	chr15:41695430	NDUFAF1	0.89	9.03	0.71	9.52e-14	Ulcerative colitis;
SKCM	cis	rs832540	0.669	rs832538	chr5:56200016	C/T	cg03609598	chr5:56110824	MAP3K1	-0.92	-5.85	-0.55	1.11e-7	Coronary artery disease;
SKCM	cis	rs2836950	0.565	rs8131132	chr21:40538256	T/C	cg17971929	chr21:40555470	PSMG1	-0.76	-6.53	-0.59	6.19e-9	Menarche (age at onset);
SKCM	cis	rs867186	1.000	rs7273734	chr20:33599403	C/G	cg04194272	chr20:33683537	NA	-1.38	-7.2	-0.63	3.29e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs26868	0.766	rs30995	chr16:2248017	C/T	cg27608139	chr16:2294856	DCI	-0.62	-5.25	-0.51	1.28e-6	Height;
SKCM	cis	rs35306767	0.855	rs61830931	chr10:932497	T/C	cg26597838	chr10:835615	NA	0.83	5.78	0.55	1.47e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs17345786	0.906	rs72940399	chr3:101122575	A/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.66	4.85	0.48	6.24e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2204008	0.837	rs2892296	chr12:37969785	C/T	cg26384229	chr12:38710491	ALG10B	-0.74	-6.1	-0.57	3.77e-8	Bladder cancer;
SKCM	cis	rs7100689	0.784	rs4934139	chr10:82177023	C/A	cg01528321	chr10:82214614	TSPAN14	0.98	10.35	0.76	2.69e-16	Post bronchodilator FEV1;
SKCM	cis	rs732765	0.618	rs57404741	chr14:75245368	C/T	cg25946216	chr14:74253857	C14orf43	-0.94	-5.23	-0.51	1.36e-6	Non-small cell lung cancer;
SKCM	cis	rs71520386	0.632	rs10224244	chr7:22870074	C/A	cg00309339	chr7:22893653	NA	0.66	4.94	0.49	4.33e-6	Fibrinogen levels;
SKCM	cis	rs5769765	0.908	rs9616390	chr22:50314289	G/C	cg22709217	chr22:50311962	ALG12;CRELD2	-0.94	-6.02	-0.56	5.3e-8	Schizophrenia;
SKCM	cis	rs8072100	0.875	rs12451409	chr17:45544856	A/G	cg08085267	chr17:45401833	C17orf57	-0.62	-5.08	-0.5	2.48e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs4905558	1.000	rs1951311	chr14:97312642	G/A	cg11863609	chr14:97355128	NA	-0.54	-4.88	-0.48	5.52e-6	Neutrophil count;
SKCM	cis	rs2841277	0.708	rs4465542	chr14:105407798	A/G	cg21017887	chr14:105400489	NA	0.59	5.34	0.52	8.83e-7	Rheumatoid arthritis;
SKCM	cis	rs554111	0.613	rs6699704	chr1:21241432	G/C	cg01072550	chr1:21505969	NA	0.62	4.88	0.48	5.41e-6	Facial morphology (factor 17, height of vermillion upper lip);
SKCM	cis	rs4972806	0.814	rs966801	chr2:177037827	G/A	cg14324370	chr2:177042789	NA	0.58	5.31	0.52	1.01e-6	IgG glycosylation;
SKCM	cis	rs7523273	0.606	rs2796268	chr1:207925192	G/A	cg22525895	chr1:207977042	MIR29B2	0.8	6.99	0.62	8.1e-10	Schizophrenia;
SKCM	cis	rs8060686	0.565	rs75286242	chr16:68145798	C/T	cg04539111	chr16:67997858	SLC12A4	-0.85	-4.81	-0.48	7.14e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs7555523	0.887	rs4656461	chr1:165687205	G/A	cg24409356	chr1:165738333	TMCO1	0.93	5.15	0.5	1.93e-6	Intraocular pressure;Glaucoma (high intraocular pressure);
SKCM	cis	rs9911578	1.000	rs9907499	chr17:56949044	A/G	cg12560992	chr17:57184187	TRIM37	0.94	7.55	0.65	7.01e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs3820928	0.709	rs10178202	chr2:227914561	C/T	cg11843606	chr2:227700838	RHBDD1	-0.63	-4.84	-0.48	6.52e-6	Pulmonary function;
SKCM	cis	rs7917772	0.503	rs7896841	chr10:104294665	C/T	cg11453585	chr10:104263688	ACTR1A;SUFU	0.78	6.33	0.58	1.47e-8	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs9660180	0.967	rs9660106	chr1:1797947	A/G	cg17747265	chr1:1875780	NA	-0.58	-5.19	-0.51	1.63e-6	Body mass index;
SKCM	cis	rs910316	1.000	rs4903289	chr14:75623988	C/T	cg11812906	chr14:75593930	NEK9	-0.67	-5.23	-0.51	1.37e-6	Height;
SKCM	cis	rs2180341	0.618	rs6683	chr6:127610021	G/A	cg24812749	chr6:127587940	RNF146	0.63	5.18	0.51	1.7e-6	Breast cancer;
SKCM	cis	rs9896933	0.732	rs590886	chr17:80767350	A/G	cg20578329	chr17:80767326	TBCD	0.98	6.96	0.62	9.35e-10	Bone mineral accretion in asthma (oral corticosteroid dose interaction);
SKCM	cis	rs1799949	1.000	rs12951869	chr17:41187567	T/G	cg25072359	chr17:41440525	NA	0.63	4.88	0.48	5.43e-6	Menopause (age at onset);
SKCM	cis	rs9902453	0.933	rs4470197	chr17:28464474	T/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.5	0.53	4.74e-7	Coffee consumption (cups per day);
SKCM	cis	rs708547	0.836	rs1718882	chr4:57859533	C/G	cg00922110	chr4:57842668	C4orf14	-0.57	-4.78	-0.48	7.95e-6	Response to bleomycin (chromatid breaks);
SKCM	cis	rs2841233	0.791	rs2028415	chr14:105349220	T/G	cg16576083	chr14:105354267	KIAA0284	0.67	5.69	0.54	2.13e-7	IgG glycosylation;
SKCM	cis	rs4523957	0.584	rs7219557	chr17:2086200	G/A	cg16513277	chr17:2031491	SMG6	-0.78	-5.25	-0.51	1.3e-6	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs3796619	1.000	rs11939380	chr4:1086871	C/T	cg27284194	chr4:1044797	NA	-0.67	-4.8	-0.48	7.53e-6	Recombination rate (males);
SKCM	cis	rs1707322	0.785	rs10890348	chr1:46242423	G/T	cg03146154	chr1:46216737	IPP	0.74	4.92	0.49	4.67e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7111031	1.000	rs7948028	chr11:113328681	A/C	cg04642306	chr11:112834466	NCAM1	-0.45	-4.79	-0.48	7.89e-6	Subjective well-being (multi-trait analysis);Depressive symptoms (multi-trait analysis);Neuroticism;
SKCM	cis	rs28595532	0.920	rs56389935	chr4:119683571	G/A	cg11846333	chr4:119757529	SEC24D	1.19	6.39	0.59	1.12e-8	Cannabis dependence symptom count;
SKCM	cis	rs929354	0.772	rs1182441	chr7:157026650	A/G	cg17757837	chr7:157058334	UBE3C	-0.81	-5.67	-0.54	2.3e-7	Body mass index;
SKCM	cis	rs992157	0.764	rs4423579	chr2:219185033	G/T	cg00012203	chr2:219082015	ARPC2	0.75	5.54	0.53	3.92e-7	Colorectal cancer;
SKCM	cis	rs3768617	0.510	rs7518957	chr1:183093028	A/T	ch.1.3577855R	chr1:183094577	LAMC1	-0.78	-7.36	-0.64	1.63e-10	Fuchs's corneal dystrophy;
SKCM	cis	rs898097	0.812	rs56405605	chr17:80843663	T/C	cg15369054	chr17:80825471	TBCD	0.66	6.18	0.57	2.69e-8	Breast cancer;
SKCM	cis	rs847649	0.842	rs869332	chr7:102632247	A/G	cg18108683	chr7:102477205	FBXL13	-0.82	-7.9	-0.67	1.48e-11	Morning vs. evening chronotype;
SKCM	cis	rs7940866	0.801	rs2113928	chr11:130835975	A/G	cg12179176	chr11:130786555	SNX19	0.84	6.58	0.6	4.91e-9	Schizophrenia;
SKCM	cis	rs67311347	0.544	rs6787516	chr3:40355616	C/T	cg00091569	chr3:40428383	ENTPD3	0.64	5.64	0.54	2.66e-7	Renal cell carcinoma;
SKCM	cis	rs7666738	0.830	rs36028444	chr4:98968635	G/T	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7786877	0.723	rs7812235	chr7:100211486	G/C	cg20848291	chr7:100343083	ZAN	-0.68	-5.15	-0.5	1.87e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs9911578	1.000	rs11870671	chr17:56605360	A/G	cg05425664	chr17:57184151	TRIM37	0.69	5.2	0.51	1.56e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs561341	1.000	rs8069199	chr17:30281845	A/G	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs7945705	0.967	rs7943377	chr11:8848700	C/T	cg21881798	chr11:8931708	C11orf17;ST5	0.66	6.3	0.58	1.63e-8	Hemoglobin concentration;
SKCM	cis	rs1348850	0.554	rs1374438	chr2:178376684	A/G	cg27490568	chr2:178487706	NA	0.9	6.86	0.61	1.42e-9	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs801193	0.875	rs13227951	chr7:66213108	C/T	cg18876405	chr7:65276391	NA	-0.77	-6.71	-0.61	2.78e-9	Aortic root size;
SKCM	cis	rs10754283	0.967	rs7552896	chr1:90103194	A/G	cg21401794	chr1:90099060	LRRC8C	0.78	7.17	0.63	3.72e-10	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs28386778	0.863	rs58269663	chr17:61843130	G/A	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs854765	0.927	rs4925138	chr17:17992793	T/G	cg04398451	chr17:18023971	MYO15A	0.67	4.89	0.48	5.25e-6	Total body bone mineral density;
SKCM	cis	rs3820928	1.000	rs1346618	chr2:227771988	C/T	cg11843606	chr2:227700838	RHBDD1	0.61	5.01	0.49	3.35e-6	Pulmonary function;
SKCM	cis	rs9303401	0.659	rs34818467	chr17:56643109	C/T	cg02118635	chr17:56770003	RAD51C;TEX14	-0.68	-5.02	-0.49	3.15e-6	Cognitive test performance;
SKCM	cis	rs2075371	0.611	rs13235296	chr7:134019192	A/G	cg20476274	chr7:133979776	SLC35B4	-0.9	-8.75	-0.7	3.37e-13	Mean platelet volume;
SKCM	cis	rs41313321	0.526	rs2240960	chr9:131039250	A/C	cg14626490	chr9:131710514	NUP188;DOLK	-0.89	-4.88	-0.48	5.56e-6	Coenzyme Q10 levels;
SKCM	cis	rs11718455	0.960	rs34179760	chr3:44002303	A/G	cg21419209	chr3:44054225	NA	-0.65	-5.32	-0.52	9.77e-7	Coronary artery disease;
SKCM	cis	rs208520	0.690	rs207119	chr6:66786408	C/T	cg07460842	chr6:66804631	NA	-1.03	-7.65	-0.65	4.49e-11	Exhaled nitric oxide output;
SKCM	cis	rs6089584	0.627	rs35560719	chr20:60561917	A/C	cg06108461	chr20:60628389	TAF4	-0.66	-5.48	-0.53	5.08e-7	Body mass index;
SKCM	cis	rs6450176	1.000	rs67473746	chr5:53296730	G/C	ch.5.1024479R	chr5:53302184	ARL15	-0.7	-5.0	-0.49	3.47e-6	HDL cholesterol levels;HDL cholesterol;Adiponectin levels;
SKCM	cis	rs10089	1.000	rs9968597	chr5:127455383	C/G	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.91	8.89	0.71	1.79e-13	Ileal carcinoids;
SKCM	cis	rs66573146	1.000	rs55672215	chr4:6970529	T/C	cg00086871	chr4:6988644	TBC1D14	1.29	5.03	0.5	3.04e-6	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs950027	0.549	rs11636114	chr15:45601412	C/G	cg21132104	chr15:45694354	SPATA5L1	0.8	5.26	0.51	1.25e-6	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs6753739	0.826	rs6732562	chr2:219966862	T/C	cg09617556	chr2:219924408	IHH	0.46	4.8	0.48	7.37e-6	Height;
SKCM	cis	rs34779708	0.966	rs4934730	chr10:35415555	A/G	cg03585969	chr10:35415529	CREM	0.78	6.2	0.57	2.53e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs6723226	0.806	rs2249109	chr2:32750879	G/A	cg02381751	chr2:32503542	YIPF4	0.8	5.47	0.53	5.27e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs2404602	0.716	rs1125932	chr15:76820540	C/T	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs870825	0.549	rs10015956	chr4:185614705	T/C	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs28595532	0.920	rs116401323	chr4:119721727	C/T	cg21605333	chr4:119757512	SEC24D	1.35	7.92	0.67	1.37e-11	Cannabis dependence symptom count;
SKCM	cis	rs9916302	0.821	rs412430	chr17:37737094	C/G	cg07936489	chr17:37558343	FBXL20	-0.91	-7.9	-0.67	1.46e-11	Glomerular filtration rate (creatinine);
SKCM	cis	rs910316	0.967	rs1071989	chr14:75564659	G/T	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.89e-7	Height;
SKCM	cis	rs875971	0.895	rs3857684	chr7:65938158	G/C	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs4970988	0.556	rs6695123	chr1:150563483	T/C	cg17724175	chr1:150552817	MCL1	-0.65	-5.29	-0.51	1.09e-6	Urate levels;
SKCM	cis	rs2980439	0.557	rs2976876	chr8:8318850	T/C	cg08975724	chr8:8085496	FLJ10661	0.62	4.85	0.48	6.2e-6	Neuroticism;
SKCM	cis	rs2204008	0.777	rs8189597	chr12:38307739	G/C	cg26384229	chr12:38710491	ALG10B	-0.86	-6.78	-0.61	2.07e-9	Bladder cancer;
SKCM	cis	rs4319547	0.741	rs4758644	chr12:122943915	A/C	cg23029597	chr12:123009494	RSRC2	-0.79	-6.04	-0.56	4.9e-8	Body mass index;
SKCM	cis	rs9475752	0.644	rs35336675	chr6:56851757	T/C	cg06815302	chr6:57335405	PRIM2	0.59	4.78	0.48	8.1e-6	Menarche (age at onset);
SKCM	cis	rs1799949	0.965	rs1842147	chr17:41435192	C/T	cg05368731	chr17:41323189	NBR1	0.87	7.43	0.64	1.18e-10	Menopause (age at onset);
SKCM	cis	rs6952808	0.792	rs2056481	chr7:1955435	A/G	cg21782813	chr7:2030301	MAD1L1	0.58	6.05	0.57	4.71e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs6835098	1.000	rs6835098	chr4:174089238	T/C	cg08422745	chr4:174089978	GALNT7	-0.87	-6.8	-0.61	1.91e-9	Dementia and core Alzheimer's disease neuropathologic changes;
SKCM	cis	rs9880211	0.706	rs67382287	chr3:136380459	C/T	cg21827317	chr3:136751795	NA	-0.7	-5.26	-0.51	1.25e-6	Body mass index;Height;
SKCM	cis	rs4927850	1.000	rs7630875	chr3:195753766	A/G	cg12923728	chr3:195709715	SDHAP1	-0.88	-5.69	-0.54	2.09e-7	Pancreatic cancer;
SKCM	cis	rs16854884	0.770	rs6784938	chr3:143817528	C/T	cg06585982	chr3:143692056	C3orf58	0.68	5.34	0.52	8.99e-7	Economic and political preferences (feminism/equality);
SKCM	cis	rs501120	1.000	rs671765	chr10:44752976	A/G	cg09554077	chr10:44749378	NA	0.42	5.12	0.5	2.11e-6	Coronary artery disease;Coronary heart disease;
SKCM	cis	rs4727027	0.769	rs10952797	chr7:148816722	A/T	cg23583168	chr7:148888333	NA	-0.83	-6.73	-0.61	2.6e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs72634258	0.554	rs10462018	chr1:7879627	C/T	cg26816564	chr1:7831052	VAMP3	0.76	5.62	0.54	2.83e-7	Inflammatory bowel disease;
SKCM	cis	rs7726839	0.540	rs58599998	chr5:596087	A/G	cg10555297	chr5:473380	SLC9A3;LOC25845	1.02	4.87	0.48	5.72e-6	Obesity-related traits;
SKCM	cis	rs7945705	0.902	rs7930026	chr11:9013639	T/C	cg21881798	chr11:8931708	C11orf17;ST5	0.82	8.0	0.67	9.52e-12	Hemoglobin concentration;
SKCM	cis	rs1957429	0.901	rs1467569	chr14:65347986	T/C	cg23373153	chr14:65346875	NA	1.11	6.32	0.58	1.52e-8	Pediatric areal bone mineral density (radius);
SKCM	cis	rs9325144	0.600	rs1817648	chr12:38733424	C/T	cg26384229	chr12:38710491	ALG10B	-0.78	-6.57	-0.6	5.05e-9	Morning vs. evening chronotype;
SKCM	cis	rs4803468	1.000	rs11670668	chr19:41920454	G/C	cg14132834	chr19:41945861	ATP5SL	-0.77	-6.08	-0.57	4.18e-8	Height;
SKCM	cis	rs1005277	0.579	rs1740745	chr10:38520056	T/C	cg00409905	chr10:38381863	ZNF37A	-0.62	-5.82	-0.55	1.24e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs12497850	0.931	rs4072859	chr3:49032205	G/C	cg07636037	chr3:49044803	WDR6	1.03	11.23	0.79	5.76e-18	Parkinson's disease;
SKCM	cis	rs12701220	0.901	rs12701708	chr7:1090333	C/T	cg02733842	chr7:1102375	C7orf50	-0.58	-4.99	-0.49	3.52e-6	Bronchopulmonary dysplasia;
SKCM	cis	rs151997	0.853	rs6882235	chr5:50260139	T/C	cg01829002	chr5:50259133	NA	0.53	5.14	0.5	2e-6	Callous-unemotional behaviour;
SKCM	cis	rs9911578	1.000	rs9901181	chr17:56964271	C/T	cg05425664	chr17:57184151	TRIM37	-0.67	-5.04	-0.5	2.91e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9325144	0.554	rs7960616	chr12:39096664	T/A	cg13010199	chr12:38710504	ALG10B	-0.62	-5.34	-0.52	8.94e-7	Morning vs. evening chronotype;
SKCM	cis	rs453301	0.686	rs7814328	chr8:8876229	T/C	cg15556689	chr8:8085844	FLJ10661	-0.76	-5.93	-0.56	7.98e-8	Joint mobility (Beighton score);
SKCM	cis	rs875971	0.862	rs778680	chr7:65840414	G/A	cg11764359	chr7:65958608	NA	0.81	7.63	0.65	4.91e-11	Aortic root size;
SKCM	cis	rs7659604	0.540	rs13140070	chr4:122713899	C/T	cg19671926	chr4:122722719	EXOSC9	0.76	6.97	0.62	9.04e-10	Type 2 diabetes;
SKCM	cis	rs10779751	0.922	rs4845985	chr1:11288618	G/A	cg08854313	chr1:11322531	MTOR	0.96	7.85	0.66	1.87e-11	Body mass index;
SKCM	cis	rs1790761	0.501	rs4930210	chr11:67404726	G/T	cg24690094	chr11:67383802	NA	-0.49	-5.16	-0.5	1.81e-6	Mean corpuscular volume;
SKCM	cis	rs6089829	0.962	rs6122347	chr20:61661866	C/T	cg08564027	chr20:61660810	NA	0.63	5.65	0.54	2.56e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs4332037	0.510	rs58673065	chr7:1885600	A/G	cg02825527	chr7:2087843	MAD1L1	-0.68	-4.94	-0.49	4.33e-6	Bipolar disorder;
SKCM	cis	rs28595532	0.920	rs56212415	chr4:119737731	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs9399135	0.933	rs9389262	chr6:135376409	G/T	cg24558204	chr6:135376177	HBS1L	0.58	5.05	0.5	2.86e-6	Red blood cell count;
SKCM	cis	rs929354	0.772	rs1182448	chr7:157021415	G/A	cg17757837	chr7:157058334	UBE3C	-0.81	-5.67	-0.54	2.3e-7	Body mass index;
SKCM	cis	rs9910055	0.762	rs1135215	chr17:42253519	T/C	cg10896456	chr17:42255109	ASB16;C17orf65	0.66	6.43	0.59	9.35e-9	Total body bone mineral density;
SKCM	cis	rs9911578	0.967	rs2429369	chr17:56501420	A/G	cg05425664	chr17:57184151	TRIM37	-0.65	-4.88	-0.48	5.52e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7100689	0.646	rs7919380	chr10:82133380	C/T	cg01528321	chr10:82214614	TSPAN14	0.8	7.0	0.62	7.98e-10	Post bronchodilator FEV1;
SKCM	cis	rs910316	1.000	rs7147118	chr14:75610170	G/C	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.89e-7	Height;
SKCM	cis	rs908922	0.676	rs11205033	chr1:152527966	C/A	cg09873164	chr1:152488093	CRCT1	0.72	5.62	0.54	2.85e-7	Hair morphology;
SKCM	cis	rs9611565	0.512	rs9607842	chr22:42192722	G/A	cg03806693	chr22:41940476	POLR3H	-1.06	-6.84	-0.61	1.61e-9	Vitiligo;
SKCM	cis	rs10504229	0.683	rs6984765	chr8:58127124	T/C	cg02725872	chr8:58115012	NA	-0.52	-4.97	-0.49	3.92e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs898097	0.812	rs8065641	chr17:80820259	A/G	cg15369054	chr17:80825471	TBCD	0.66	6.22	0.58	2.3e-8	Breast cancer;
SKCM	cis	rs59918340	0.728	rs10112337	chr8:142233573	A/G	cg23750338	chr8:142222470	SLC45A4	-0.62	-5.93	-0.56	7.69e-8	Immature fraction of reticulocytes;
SKCM	cis	rs6087990	0.806	rs6141814	chr20:31368960	C/A	cg13636640	chr20:31349939	DNMT3B	0.93	8.29	0.68	2.61e-12	Ulcerative colitis;
SKCM	cis	rs13108904	0.811	rs12508446	chr4:1198957	C/T	cg04997045	chr4:1240068	CTBP1	-0.49	-4.78	-0.48	8.03e-6	Obesity-related traits;
SKCM	cis	rs2859741	0.967	rs575939	chr1:37513854	T/C	cg09363841	chr1:37513479	NA	-0.53	-4.88	-0.48	5.5e-6	Forced expiratory volume in 1 second (environmental tobacco smoke interaction);
SKCM	cis	rs951366	0.617	rs823074	chr1:205774839	T/C	cg11965913	chr1:205819406	PM20D1	1.01	12.76	0.82	8.95e-21	Menarche (age at onset);
SKCM	cis	rs55962025	0.686	rs362314	chr4:3235241	A/G	cg09735869	chr4:3319127	RGS12	-0.65	-5.31	-0.51	1.02e-6	Parental longevity (mother's age at death);
SKCM	cis	rs6582630	0.502	rs7311700	chr12:38463232	T/A	cg26384229	chr12:38710491	ALG10B	0.87	6.82	0.61	1.76e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs55823223	0.680	rs3744017	chr17:73871467	G/A	cg08125733	chr17:73851984	WBP2	1.0	5.3	0.51	1.03e-6	Psoriasis;
SKCM	cis	rs611744	0.647	rs1609472	chr8:109269232	T/G	cg18478394	chr8:109455254	TTC35	0.66	5.27	0.51	1.16e-6	Dupuytren's disease;
SKCM	cis	rs12824058	0.831	rs1390849	chr12:130811547	A/G	cg24838063	chr12:130822603	PIWIL1	0.78	6.91	0.62	1.19e-9	Menopause (age at onset);
SKCM	cis	rs28386778	0.863	rs894414	chr17:61916384	T/C	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs6866344	0.697	rs11748497	chr5:178130012	C/G	cg03877680	chr5:178157825	ZNF354A	0.8	5.82	0.55	1.22e-7	Neutrophil percentage of white cells;
SKCM	cis	rs17685	0.753	rs8200	chr7:75696606	C/G	cg01364799	chr7:75623366	TMEM120A	0.72	5.83	0.55	1.18e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs873946	0.504	rs4880275	chr10:134576552	C/T	cg18305652	chr10:134549665	INPP5A	0.61	5.85	0.55	1.1e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs7954584	0.604	rs34159444	chr12:122416667	A/G	cg01765077	chr12:122356316	WDR66	0.44	4.88	0.48	5.44e-6	Mean corpuscular volume;
SKCM	cis	rs208520	0.560	rs2351880	chr6:66863707	G/A	cg07460842	chr6:66804631	NA	-1.05	-7.75	-0.66	2.8e-11	Exhaled nitric oxide output;
SKCM	cis	rs644799	0.710	rs523153	chr11:95570961	G/A	cg25622487	chr11:95524042	FAM76B;CEP57	0.65	5.15	0.5	1.91e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs1801251	0.963	rs35395584	chr2:233573698	G/C	cg08000102	chr2:233561755	GIGYF2	0.89	6.91	0.62	1.15e-9	Coronary artery disease;
SKCM	cis	rs6120849	0.851	rs13040631	chr20:33747714	T/C	cg24642439	chr20:33292090	TP53INP2	0.95	5.17	0.51	1.74e-6	Protein C levels;
SKCM	cis	rs6938	0.534	rs4886636	chr15:75196176	G/A	cg09165964	chr15:75287851	SCAMP5	0.62	4.78	0.48	8.04e-6	Breast cancer;
SKCM	cis	rs6951245	1.000	rs6951245	chr7:1058193	G/A	cg18402987	chr7:1209562	NA	1.14	5.99	0.56	6.11e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs9660180	0.934	rs34849348	chr1:1762757	C/T	cg13866156	chr1:1669148	SLC35E2	-0.71	-5.83	-0.55	1.19e-7	Body mass index;
SKCM	cis	rs4478137	0.690	rs12501657	chr4:164189254	A/T	cg06758707	chr4:164254230	NPY1R	0.89	5.95	0.56	7.06e-8	Subjective well-being (multi-trait analysis);Subjective well-being;
SKCM	cis	rs763014	0.898	rs916414	chr16:632073	C/T	cg00908189	chr16:619842	PIGQ	0.82	7.78	0.66	2.55e-11	Height;
SKCM	cis	rs7666738	0.830	rs6832568	chr4:98994061	G/A	cg05340658	chr4:99064831	C4orf37	0.67	5.14	0.5	1.98e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs28386778	0.799	rs2955234	chr17:61983601	A/C	cg11494091	chr17:61959527	GH2	-0.6	-5.01	-0.49	3.29e-6	Prudent dietary pattern;
SKCM	cis	rs561341	1.000	rs4795668	chr17:30244554	G/A	cg00745463	chr17:30367425	LRRC37B	-0.89	-5.9	-0.56	8.83e-8	Hip circumference adjusted for BMI;
SKCM	cis	rs4975616	0.804	rs31489	chr5:1342714	C/A	cg26373071	chr5:1325741	CLPTM1L	0.68	5.71	0.54	1.96e-7	Lung cancer;
SKCM	cis	rs8141529	0.719	rs2097461	chr22:29191879	T/C	cg15103426	chr22:29168792	CCDC117	0.62	5.23	0.51	1.37e-6	Lymphocyte counts;
SKCM	cis	rs72781680	1.000	rs6751655	chr2:24155478	A/G	cg08917208	chr2:24149416	ATAD2B	1.02	5.84	0.55	1.16e-7	Lymphocyte counts;
SKCM	cis	rs2404602	0.583	rs2139190	chr15:76555539	G/C	cg22467129	chr15:76604101	ETFA	-0.65	-5.35	-0.52	8.68e-7	Blood metabolite levels;
SKCM	cis	rs9902453	0.967	rs17825877	chr17:28515188	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.75	5.19	0.51	1.65e-6	Coffee consumption (cups per day);
SKCM	cis	rs72949976	0.646	rs4673731	chr2:214028544	C/T	cg08319019	chr2:214017104	IKZF2	0.85	6.8	0.61	1.87e-9	Lung cancer;Squamous cell lung carcinoma;
SKCM	cis	rs10754283	0.901	rs6663526	chr1:90110862	T/C	cg21401794	chr1:90099060	LRRC8C	0.73	6.34	0.58	1.35e-8	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs7666738	0.830	rs1405767	chr4:98965295	T/C	cg17366294	chr4:99064904	C4orf37	0.59	4.89	0.48	5.36e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1046896	0.561	rs8076476	chr17:80861017	A/C	cg02711726	chr17:80685570	FN3KRP	-0.78	-5.98	-0.56	6.32e-8	Glycated hemoglobin levels;
SKCM	cis	rs6062302	0.522	rs3761126	chr20:62252044	C/T	cg09650180	chr20:62225654	GMEB2	-0.79	-6.3	-0.58	1.62e-8	Glioblastoma;
SKCM	cis	rs12048904	0.619	rs12239082	chr1:101330077	G/T	cg16556008	chr1:101360663	SLC30A7;EXTL2	-0.98	-8.5	-0.69	1.02e-12	Multiple sclerosis;
SKCM	cis	rs7666738	0.830	rs28515641	chr4:98726419	G/A	cg17366294	chr4:99064904	C4orf37	0.59	5.11	0.5	2.25e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9467773	0.967	rs9358954	chr6:26531178	A/G	cg15659132	chr6:26577336	NA	0.6	5.71	0.54	1.99e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7216064	1.000	rs8071463	chr17:65938655	C/T	cg12091567	chr17:66097778	LOC651250	0.76	5.15	0.5	1.87e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs2243480	1.000	rs316312	chr7:65596491	T/G	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs6545883	0.894	rs10496092	chr2:61524679	C/T	cg15711740	chr2:61764176	XPO1	0.68	4.82	0.48	6.94e-6	Tuberculosis;
SKCM	cis	rs9913156	0.789	rs72824977	chr17:4612975	C/G	cg00122941	chr17:4613640	ARRB2	0.78	4.87	0.48	5.64e-6	Lymphocyte counts;
SKCM	cis	rs2075371	0.796	rs1646644	chr7:134011817	A/T	cg11752832	chr7:134001865	SLC35B4	0.56	4.79	0.48	7.76e-6	Mean platelet volume;
SKCM	cis	rs62238980	0.614	rs76473853	chr22:32365685	G/C	cg00543991	chr22:32367038	NA	1.28	5.18	0.51	1.68e-6	Childhood ear infection;
SKCM	cis	rs736408	0.812	rs6778329	chr3:52824610	G/A	cg18404041	chr3:52824283	ITIH1	-0.66	-6.05	-0.57	4.71e-8	Bipolar disorder;
SKCM	cis	rs4319547	0.585	rs7953007	chr12:122816977	A/C	cg23029597	chr12:123009494	RSRC2	-0.73	-5.22	-0.51	1.41e-6	Body mass index;
SKCM	cis	rs12477438	0.520	rs11685759	chr2:99766217	T/C	cg14399236	chr2:99771627	LIPT1;TSGA10	1.01	9.53	0.73	1.01e-14	Chronic sinus infection;
SKCM	cis	rs7584330	0.780	rs10176842	chr2:238428256	T/C	cg14458575	chr2:238380390	NA	0.79	5.3	0.51	1.03e-6	Prostate cancer;
SKCM	cis	rs6933660	0.646	rs9397051	chr6:151778325	C/T	cg14416726	chr6:151773293	C6orf211;RMND1	-0.67	-5.42	-0.52	6.38e-7	Menarche (age at onset);
SKCM	cis	rs2120019	0.938	rs13056	chr15:75312187	A/G	cg17294928	chr15:75287854	SCAMP5	-0.89	-8.91	-0.71	1.6e-13	Blood trace element (Zn levels);
SKCM	cis	rs2658782	0.547	rs3020052	chr11:93055184	C/G	cg15737290	chr11:93063684	CCDC67	0.95	8.21	0.68	3.67e-12	Pulmonary function decline;
SKCM	cis	rs35306767	0.715	rs1250891	chr10:1040159	G/C	cg26597838	chr10:835615	NA	0.63	5.29	0.51	1.11e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs362296	0.661	rs3095077	chr4:3265710	A/G	cg09735869	chr4:3319127	RGS12	0.65	5.47	0.53	5.2e-7	Parental longevity (mother's age at death);
SKCM	cis	rs55962025	0.711	rs363063	chr4:3141488	G/A	cg16987761	chr4:3318072	RGS12	-0.63	-5.19	-0.51	1.65e-6	Parental longevity (mother's age at death);
SKCM	cis	rs672059	1.000	rs549844	chr1:183158143	A/G	ch.1.3577855R	chr1:183094577	LAMC1	-0.68	-5.86	-0.55	1.04e-7	Hypertriglyceridemia;
SKCM	cis	rs780096	0.546	rs1060525	chr2:27635582	A/G	cg05696406	chr2:27599888	SNX17	0.51	5.24	0.51	1.34e-6	Total body bone mineral density;
SKCM	cis	rs910316	0.967	rs10246	chr14:75544470	T/A	cg08847533	chr14:75593920	NEK9	0.95	9.18	0.72	4.8e-14	Height;
SKCM	cis	rs9443189	0.570	rs6903124	chr6:76290079	A/C	cg01950844	chr6:76311363	SENP6	0.99	6.07	0.57	4.36e-8	Prostate cancer;
SKCM	cis	rs6461049	0.766	rs10256077	chr7:2171450	C/T	cg02951883	chr7:2050386	MAD1L1	0.73	6.66	0.6	3.52e-9	Schizophrenia;
SKCM	cis	rs72615157	0.628	rs7801070	chr7:99847147	T/G	cg07160278	chr7:100027354	MEPCE;ZCWPW1	0.96	5.55	0.53	3.78e-7	Lung function (FEV1/FVC);
SKCM	cis	rs6474412	0.581	rs11995030	chr8:42626418	A/G	cg11207534	chr8:41686438	ANK1	-0.78	-4.94	-0.49	4.43e-6	Smoking behavior;
SKCM	cis	rs7666738	0.830	rs4345191	chr4:98945408	A/G	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs12497850	0.931	rs7643368	chr3:48992855	T/G	cg06212747	chr3:49208901	KLHDC8B	0.68	4.9	0.49	5.06e-6	Parkinson's disease;
SKCM	cis	rs9611565	0.659	rs9611603	chr22:41912750	A/G	cg03806693	chr22:41940476	POLR3H	-1.11	-7.56	-0.65	6.67e-11	Vitiligo;
SKCM	trans	rs561341	1.000	rs7214017	chr17:30332220	T/C	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs7727544	0.735	rs273913	chr5:131661156	A/G	cg24060327	chr5:131705240	SLC22A5	-0.69	-4.84	-0.48	6.42e-6	Blood metabolite levels;
SKCM	cis	rs35306767	0.903	rs12264711	chr10:929525	T/C	cg26597838	chr10:835615	NA	0.75	5.51	0.53	4.53e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs9916302	0.851	rs4794810	chr17:37603774	T/C	cg07936489	chr17:37558343	FBXL20	-0.86	-7.39	-0.64	1.42e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs34172651	0.517	rs3803716	chr16:24802325	C/T	cg06028605	chr16:24865363	SLC5A11	0.59	4.98	0.49	3.66e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs4727027	0.933	rs2158633	chr7:148832652	C/T	cg23583168	chr7:148888333	NA	-0.82	-6.56	-0.6	5.29e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs1799949	1.000	rs8176273	chr17:41211653	A/G	cg23758822	chr17:41437982	NA	0.94	7.82	0.66	2.13e-11	Menopause (age at onset);
SKCM	cis	rs6598955	0.670	rs7520517	chr1:26556385	A/C	cg00938395	chr1:26633206	UBXN11	0.69	4.85	0.48	6.29e-6	Obesity-related traits;
SKCM	cis	rs4523957	0.614	rs1563966	chr17:2095954	A/G	cg16513277	chr17:2031491	SMG6	0.74	4.99	0.49	3.62e-6	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs28386778	0.897	rs2137144	chr17:61805607	G/A	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.23	0.51	1.37e-6	Prudent dietary pattern;
SKCM	cis	rs1348850	0.632	rs13008857	chr2:178514468	G/A	cg02961200	chr2:178257176	LOC100130691;AGPS	0.72	4.8	0.48	7.54e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs2727020	0.729	rs1164685	chr11:49293660	G/A	cg21546286	chr11:48923668	NA	0.53	4.77	0.48	8.31e-6	Coronary artery disease;
SKCM	cis	rs17685	0.753	rs9691174	chr7:75790405	T/C	cg16489192	chr7:75678113	MDH2;STYXL1	-0.57	-5.49	-0.53	4.89e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs873917	0.577	rs784599	chr1:40138507	A/G	cg21785781	chr1:39339218	MYCBP	-0.74	-5.01	-0.49	3.27e-6	Amyotrophic lateral sclerosis;
SKCM	cis	rs7666738	0.791	rs1830231	chr4:99026185	A/C	cg17366294	chr4:99064904	C4orf37	0.61	5.18	0.51	1.69e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11098499	0.954	rs12502423	chr4:120424172	A/C	cg24375607	chr4:120327624	NA	0.68	5.33	0.52	9.12e-7	Corneal astigmatism;
SKCM	cis	rs651907	0.535	rs11711903	chr3:101500748	C/G	cg12386194	chr3:101231763	SENP7	0.64	5.3	0.51	1.05e-6	Colorectal cancer;
SKCM	cis	rs9814567	1.000	rs9834755	chr3:134206845	G/A	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.67	-5.26	-0.51	1.21e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs4642101	0.611	rs6442331	chr3:12820636	T/G	cg05775895	chr3:12838266	CAND2	0.61	5.49	0.53	4.8e-7	QRS complex (12-leadsum);
SKCM	cis	rs473651	0.901	rs563282	chr2:239329736	T/C	cg18131467	chr2:239335373	ASB1	1.05	10.99	0.78	1.67e-17	Multiple system atrophy;
SKCM	cis	rs6840360	0.615	rs4696097	chr4:152479765	C/T	cg22705602	chr4:152727874	NA	0.48	5.4	0.52	7.03e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs4423214	0.840	rs1540127	chr11:71179038	G/A	cg05163923	chr11:71159392	DHCR7	-0.74	-6.65	-0.6	3.61e-9	Vitamin D levels;
SKCM	cis	rs17376456	1.000	rs13154249	chr5:93550508	C/T	cg21475434	chr5:93447410	FAM172A	0.98	5.23	0.51	1.4e-6	Diabetic retinopathy;
SKCM	cis	rs796364	1.000	rs35220450	chr2:200780737	T/C	cg12253985	chr2:200820533	C2orf60;C2orf47	-0.96	-5.67	-0.54	2.3e-7	Schizophrenia;
SKCM	cis	rs854765	0.647	rs7212447	chr17:17987067	G/A	cg04398451	chr17:18023971	MYO15A	-1.02	-8.72	-0.7	3.81e-13	Total body bone mineral density;
SKCM	cis	rs2304069	0.954	rs4705408	chr5:149412545	A/G	cg22760475	chr5:149380129	HMGXB3;TIGD6	-0.78	-5.86	-0.55	1.04e-7	HIV-1 control;
SKCM	cis	rs875971	1.000	rs2420168	chr7:65630631	C/G	cg18876405	chr7:65276391	NA	-0.68	-6.85	-0.61	1.54e-9	Aortic root size;
SKCM	cis	rs9788682	1.000	rs35212593	chr15:78831826	G/A	cg06917634	chr15:78832804	PSMA4	-0.82	-4.96	-0.49	3.97e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs651907	0.535	rs34743741	chr3:101532448	C/T	cg12386194	chr3:101231763	SENP7	0.68	5.74	0.54	1.73e-7	Colorectal cancer;
SKCM	cis	rs10193935	0.901	rs6544533	chr2:42516372	G/C	cg27598129	chr2:42591480	NA	-0.95	-6.75	-0.61	2.38e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9611565	0.649	rs5758442	chr22:42133060	T/C	cg03806693	chr22:41940476	POLR3H	0.84	5.47	0.53	5.32e-7	Vitiligo;
SKCM	cis	rs8180040	0.654	rs4682831	chr3:47027138	A/G	cg27129171	chr3:47204927	SETD2	-0.83	-6.19	-0.57	2.6e-8	Colorectal cancer;
SKCM	cis	rs7917772	0.503	rs11191321	chr10:104293412	C/T	cg11453585	chr10:104263688	ACTR1A;SUFU	0.78	6.33	0.58	1.47e-8	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs12709013	0.792	rs12928733	chr16:58841120	A/C	cg02431531	chr16:59244939	NA	0.48	4.99	0.49	3.62e-6	Blood metabolite ratios;
SKCM	cis	rs72615157	0.612	rs7786505	chr7:99817585	G/T	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.21	8.07	0.67	7e-12	Lung function (FEV1/FVC);
SKCM	cis	rs4481887	0.893	rs10888355	chr1:248457180	G/A	cg00666640	chr1:248458726	OR2T12	0.58	4.83	0.48	6.68e-6	Common traits (Other);
SKCM	cis	rs7811142	0.830	rs11761253	chr7:99939321	C/T	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.21	7.77	0.66	2.57e-11	Platelet count;
SKCM	cis	rs2832191	0.791	rs2832198	chr21:30498240	C/T	cg08807101	chr21:30365312	RNF160	0.61	4.78	0.48	8.17e-6	Dental caries;
SKCM	cis	rs4984778	0.750	rs7198064	chr16:1272472	C/T	cg07748719	chr16:1272498	TPSG1	0.64	6.22	0.58	2.34e-8	Blood protein levels;
SKCM	cis	rs8042680	0.554	rs7179428	chr15:91532565	C/A	cg15878949	chr15:91534302	PRC1	0.59	4.94	0.49	4.33e-6	Type 2 diabetes;
SKCM	cis	rs2836950	0.545	rs2836959	chr21:40623668	T/G	cg11890956	chr21:40555474	PSMG1	-0.66	-5.24	-0.51	1.32e-6	Menarche (age at onset);
SKCM	cis	rs3784262	1.000	rs4646638	chr15:58248783	C/T	cg12031962	chr15:58353849	ALDH1A2	0.5	6.1	0.57	3.75e-8	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs854765	0.583	rs12452254	chr17:17829434	G/A	cg04398451	chr17:18023971	MYO15A	-0.74	-5.35	-0.52	8.43e-7	Total body bone mineral density;
SKCM	cis	rs244731	0.881	rs62397242	chr5:176738538	C/A	cg06060754	chr5:176797920	RGS14	0.9	7.85	0.66	1.86e-11	Urate levels in lean individuals;
SKCM	cis	rs7824557	0.628	rs34237267	chr8:11197301	G/C	cg21775007	chr8:11205619	TDH	0.73	6.79	0.61	1.99e-9	Retinal vascular caliber;
SKCM	cis	rs2842992	0.513	rs7759086	chr6:160193853	A/G	cg11366901	chr6:160182831	ACAT2	0.85	7.49	0.65	8.93e-11	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs7215564	0.730	rs76584516	chr17:78549237	A/G	cg16980736	chr17:78789706	RPTOR	-0.89	-4.89	-0.48	5.38e-6	Myopia (pathological);
SKCM	cis	rs1577917	1.000	rs4706254	chr6:86602813	G/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.61	-5.31	-0.52	1.02e-6	Response to antipsychotic treatment;
SKCM	cis	rs1461503	0.966	rs7113725	chr11:122843511	G/T	cg27398637	chr11:122830231	C11orf63	-0.63	-4.8	-0.48	7.54e-6	Menarche (age at onset);
SKCM	cis	rs6087990	0.899	rs4911107	chr20:31374991	G/A	cg13636640	chr20:31349939	DNMT3B	0.96	8.64	0.7	5.29e-13	Ulcerative colitis;
SKCM	cis	rs1577917	0.916	rs4706252	chr6:86555180	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.81	-7.82	-0.66	2.07e-11	Response to antipsychotic treatment;
SKCM	cis	rs854765	0.604	rs12948749	chr17:17949802	G/A	cg04398451	chr17:18023971	MYO15A	0.82	6.25	0.58	2.06e-8	Total body bone mineral density;
SKCM	cis	rs62367758	0.687	rs316396	chr5:43038959	C/A	cg24150528	chr5:43125550	ZNF131	-0.78	-5.03	-0.49	3.05e-6	Facial morphology (factor 8, orbital inclination due to vertical and horizontal position of exocanthion);
SKCM	cis	rs9790314	0.521	rs13084731	chr3:161086020	G/A	cg03342759	chr3:160939853	NMD3	-0.79	-6.79	-0.61	1.97e-9	Morning vs. evening chronotype;
SKCM	cis	rs16854884	0.632	rs59287916	chr3:143638337	G/A	cg06585982	chr3:143692056	C3orf58	0.84	7.62	0.65	5.11e-11	Economic and political preferences (feminism/equality);
SKCM	cis	rs2243480	1.000	rs73142162	chr7:65374296	A/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs28386778	0.897	rs11654841	chr17:61838259	C/T	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs7937682	0.564	rs1944116	chr11:111366792	A/C	cg09085632	chr11:111637200	PPP2R1B	0.66	4.88	0.48	5.55e-6	Primary sclerosing cholangitis;
SKCM	cis	rs7179456	0.547	rs6494035	chr15:59015888	C/G	cg05156742	chr15:59063176	FAM63B	0.74	5.28	0.51	1.13e-6	Asperger disorder;
SKCM	cis	rs1218582	0.682	rs12046459	chr1:154912017	A/C	cg24250549	chr1:154909240	PMVK	0.87	8.96	0.71	1.3e-13	Prostate cancer;
SKCM	cis	rs7954584	0.523	rs11043280	chr12:122426643	T/C	cg22168489	chr12:122356033	WDR66	0.49	4.95	0.49	4.18e-6	Mean corpuscular volume;
SKCM	cis	rs10911251	0.546	rs20560	chr1:183105534	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.76	7.47	0.65	1e-10	Colorectal cancer;
SKCM	cis	rs6500395	0.962	rs1872652	chr16:48642928	C/A	cg04672837	chr16:48644449	N4BP1	0.69	5.68	0.54	2.26e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs9910055	0.659	rs7214540	chr17:42256604	A/G	cg08499158	chr17:42289980	UBTF	-0.73	-6.45	-0.59	8.6e-9	Total body bone mineral density;
SKCM	cis	rs55962025	0.846	rs363064	chr4:3141410	C/T	cg21096898	chr4:3318625	RGS12	-0.77	-5.84	-0.55	1.12e-7	Parental longevity (mother's age at death);
SKCM	cis	rs17685	0.753	rs1104878	chr7:75685593	G/T	cg16489192	chr7:75678113	MDH2;STYXL1	-0.6	-5.51	-0.53	4.43e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs4689592	0.587	rs3822269	chr4:7069901	T/C	cg26116260	chr4:7069785	GRPEL1	1.16	8.84	0.71	2.2e-13	Monocyte percentage of white cells;
SKCM	cis	rs7523273	1.000	rs7541230	chr1:207957555	T/C	cg22525895	chr1:207977042	MIR29B2	-0.8	-5.92	-0.56	8.31e-8	Schizophrenia;
SKCM	cis	rs4423214	0.840	rs1123007	chr11:71185357	G/A	cg05163923	chr11:71159392	DHCR7	-0.71	-6.07	-0.57	4.35e-8	Vitamin D levels;
SKCM	cis	rs6547741	0.904	rs2384628	chr2:27774702	T/G	cg27432699	chr2:27873401	GPN1	0.73	6.54	0.6	5.81e-9	Oral cavity cancer;
SKCM	cis	rs9475752	1.000	rs34812189	chr6:56806727	C/G	cg06815302	chr6:57335405	PRIM2	0.63	4.84	0.48	6.4e-6	Menarche (age at onset);
SKCM	cis	rs7539542	0.577	rs6662398	chr1:202888456	T/G	cg19681188	chr1:202830198	LOC148709	0.7	5.12	0.5	2.12e-6	Mean platelet volume;
SKCM	cis	rs1552244	1.000	rs67134728	chr3:10151431	G/C	cg02579736	chr3:10068473	FANCD2;CIDECP	1.23	6.92	0.62	1.13e-9	Alzheimer's disease;
SKCM	cis	rs4727027	0.835	rs11767810	chr7:148774433	T/A	cg23583168	chr7:148888333	NA	-0.81	-6.31	-0.58	1.57e-8	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs873946	0.586	rs12776770	chr10:134564831	T/C	cg27286337	chr10:134555280	INPP5A	0.97	8.71	0.7	3.94e-13	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs769267	0.965	rs4808938	chr19:19401218	G/A	cg26732615	chr19:19648335	CILP2;YJEFN3	0.64	5.94	0.56	7.41e-8	Tonsillectomy;
SKCM	cis	rs4972806	0.814	rs1446575	chr2:177047801	A/C	cg14324370	chr2:177042789	NA	0.58	5.31	0.52	1.01e-6	IgG glycosylation;
SKCM	cis	rs7124681	0.584	rs10769285	chr11:47709212	C/T	cg20307385	chr11:47447363	PSMC3	0.71	5.63	0.54	2.67e-7	Body mass index (joint analysis main effects and physical activity interaction);Body mass index;Body mass index in physically active individuals;
SKCM	trans	rs561341	0.883	rs886224	chr17:30229902	T/C	cg20587970	chr11:113659929	NA	-1.11	-8.92	-0.71	1.53e-13	Hip circumference adjusted for BMI;
SKCM	cis	rs1160297	0.609	rs1828336	chr2:53096937	G/T	cg07782112	chr2:53107842	NA	0.59	6.3	0.58	1.63e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs1912483	0.545	rs35161461	chr17:45401757	A/G	cg08085267	chr17:45401833	C17orf57	-0.91	-6.85	-0.61	1.53e-9	Coronary artery disease;
SKCM	cis	rs1348850	0.958	rs4893965	chr2:178463852	G/T	cg02961200	chr2:178257176	LOC100130691;AGPS	0.84	6.61	0.6	4.29e-9	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs4819052	0.851	rs8127834	chr21:46696109	G/A	cg19498844	chr21:46707878	POFUT2;LOC642852	0.91	7.84	0.66	1.92e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs8016982	0.674	rs759939	chr14:81663453	G/C	cg01989461	chr14:81687754	GTF2A1	0.88	7.42	0.64	1.26e-10	Schizophrenia;
SKCM	cis	rs763121	0.819	rs8137829	chr22:39061030	G/A	cg06022373	chr22:39101656	GTPBP1	0.74	5.24	0.51	1.35e-6	Menopause (age at onset);
SKCM	cis	rs1348850	0.567	rs2222711	chr2:178534110	G/T	cg02961200	chr2:178257176	LOC100130691;AGPS	0.7	4.87	0.48	5.73e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs6977660	1.000	rs13231036	chr7:19806141	G/A	cg05791153	chr7:19748676	TWISTNB	0.79	5.53	0.53	4.14e-7	Thyroid stimulating hormone;
SKCM	cis	rs2404602	0.716	rs12917430	chr15:76674360	T/C	cg23625390	chr15:77176239	SCAPER	0.59	5.35	0.52	8.52e-7	Blood metabolite levels;
SKCM	cis	rs1153858	1.000	rs4774578	chr15:45646051	G/A	cg10760299	chr15:45669010	GATM	0.62	6.33	0.58	1.42e-8	Homoarginine levels;
SKCM	cis	rs854765	0.624	rs12946746	chr17:17741669	T/C	cg24612305	chr17:17875800	TOM1L2;LRRC48	-0.95	-7.06	-0.62	5.98e-10	Total body bone mineral density;
SKCM	cis	rs1577917	1.000	rs1577917	chr6:86691940	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.64	-5.54	-0.53	3.92e-7	Response to antipsychotic treatment;
SKCM	cis	rs1801251	0.711	rs778368	chr2:233745333	G/C	cg25237894	chr2:233734115	C2orf82	-0.57	-5.27	-0.51	1.2e-6	Coronary artery disease;
SKCM	cis	rs910316	1.000	rs175512	chr14:75523382	T/C	cg11812906	chr14:75593930	NEK9	-0.72	-5.45	-0.53	5.7e-7	Height;
SKCM	cis	rs2463822	1.000	rs2463825	chr11:62094493	G/A	cg06239285	chr11:62104954	ASRGL1	1.27	6.04	0.56	4.98e-8	Chronic obstructive pulmonary disease-related biomarkers;
SKCM	cis	rs899997	0.773	rs1114829	chr15:78989821	G/A	cg04896959	chr15:78267971	NA	-0.59	-5.09	-0.5	2.4e-6	Coronary artery disease or large artery stroke;
SKCM	cis	rs208520	0.802	rs208499	chr6:66932146	C/T	cg07460842	chr6:66804631	NA	-0.97	-6.92	-0.62	1.13e-9	Exhaled nitric oxide output;
SKCM	cis	rs763121	0.853	rs5757226	chr22:39070550	T/C	cg06022373	chr22:39101656	GTPBP1	0.8	5.85	0.55	1.1e-7	Menopause (age at onset);
SKCM	cis	rs6840360	0.571	rs11099823	chr4:152510565	T/G	cg22705602	chr4:152727874	NA	-0.52	-5.69	-0.54	2.15e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7945705	0.967	rs10840147	chr11:8920704	A/G	cg21881798	chr11:8931708	C11orf17;ST5	0.81	8.08	0.68	6.57e-12	Hemoglobin concentration;
SKCM	cis	rs58688157	0.960	rs1131665	chr11:613208	T/C	cg16486109	chr11:613632	IRF7	1.07	7.29	0.64	2.17e-10	Systemic lupus erythematosus;
SKCM	cis	rs870825	0.929	rs72689278	chr4:185593718	C/T	cg04058563	chr4:185651563	MLF1IP	0.99	6.16	0.57	2.95e-8	Blood protein levels;
SKCM	cis	rs7666738	0.830	rs6818045	chr4:99049374	G/A	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7811142	0.830	rs7792525	chr7:99972122	A/G	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.05	5.92	0.56	8.02e-8	Platelet count;
SKCM	cis	rs8070128	0.583	rs7406982	chr17:17942613	C/T	cg04398451	chr17:18023971	MYO15A	-0.94	-7.53	-0.65	7.5e-11	Total body bone mineral density;
SKCM	cis	rs9611565	0.592	rs4822038	chr22:41958495	G/A	cg03806693	chr22:41940476	POLR3H	-1.07	-6.9	-0.62	1.24e-9	Vitiligo;
SKCM	cis	rs1577917	1.000	rs34852683	chr6:86702330	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.83	-8.23	-0.68	3.37e-12	Response to antipsychotic treatment;
SKCM	cis	rs501120	1.000	rs559580	chr10:44752078	C/T	cg09554077	chr10:44749378	NA	-0.41	-5.05	-0.5	2.87e-6	Coronary artery disease;Coronary heart disease;
SKCM	cis	rs2549003	1.000	rs13170412	chr5:131823519	A/G	cg21138405	chr5:131827807	IRF1	0.42	4.99	0.49	3.52e-6	Asthma (sex interaction);
SKCM	cis	rs2243480	1.000	rs778679	chr7:65840911	A/G	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs17711722	0.640	rs13237956	chr7:65318029	G/A	cg18876405	chr7:65276391	NA	0.86	7.56	0.65	6.53e-11	Calcium levels;
SKCM	cis	rs9308433	0.505	rs958304	chr1:214474241	C/T	cg06198575	chr1:214491504	SMYD2	0.82	5.15	0.5	1.87e-6	IgG glycosylation;
SKCM	trans	rs1814175	0.935	rs28586931	chr11:49693872	G/A	cg15704280	chr7:45808275	SEPT13	-1.01	-9.52	-0.73	1.08e-14	Height;
SKCM	cis	rs9660180	0.967	rs2272908	chr1:1721479	A/G	cg13866156	chr1:1669148	SLC35E2	0.69	5.9	0.56	8.76e-8	Body mass index;
SKCM	cis	rs6121246	0.559	rs6060919	chr20:30331922	A/T	cg11595048	chr20:30225325	COX4I2	0.54	4.77	0.48	8.4e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs9486715	0.867	rs7451950	chr6:96879974	T/C	cg06623918	chr6:96969491	KIAA0776	0.79	7.09	0.63	5.34e-10	Headache;
SKCM	cis	rs7954584	0.604	rs34159444	chr12:122416667	A/G	cg22618164	chr12:122356400	WDR66	0.53	5.4	0.52	7.02e-7	Mean corpuscular volume;
SKCM	cis	rs4819052	0.851	rs8127834	chr21:46696109	G/A	cg02159808	chr21:46707872	POFUT2;LOC642852	0.74	5.68	0.54	2.22e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs9399137	0.507	rs4520025	chr6:135278619	G/T	cg24558204	chr6:135376177	HBS1L	0.69	6.37	0.59	1.21e-8	Glycated hemoglobin levels;Mean corpuscular volume;Hematology traits;HbA2 levels;Mean corpuscular hemoglobin;Hemoglobin levels;F-cell distribution;Platelet count;
SKCM	cis	rs5821446	1	rs5821446	chr17:65962538	A/AT	cg12091567	chr17:66097778	LOC651250	0.81	5.74	0.54	1.77e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs9368481	0.761	rs12661756	chr6:27003483	A/G	cg12292205	chr6:26970375	C6orf41	0.72	6.6	0.6	4.58e-9	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs7666738	0.830	rs28795113	chr4:98951331	A/G	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11718455	0.920	rs13084408	chr3:44008967	G/A	cg21419209	chr3:44054225	NA	-0.65	-5.32	-0.52	9.77e-7	Coronary artery disease;
SKCM	cis	rs13108904	0.935	rs922698	chr4:1282722	C/T	cg05025164	chr4:1340916	KIAA1530	-0.6	-4.82	-0.48	6.9e-6	Obesity-related traits;
SKCM	cis	rs899997	0.773	rs11072784	chr15:78966058	T/C	cg04896959	chr15:78267971	NA	0.6	5.1	0.5	2.35e-6	Coronary artery disease or large artery stroke;
SKCM	cis	rs250585	0.588	rs432508	chr16:23593919	T/C	cg09934309	chr16:23461721	COG7	-0.94	-6.18	-0.57	2.76e-8	Egg allergy;
SKCM	cis	rs7954584	0.504	rs10840633	chr12:122377511	A/T	cg22618164	chr12:122356400	WDR66	0.54	5.37	0.52	7.88e-7	Mean corpuscular volume;
SKCM	cis	rs2033711	0.728	rs4801586	chr19:58934528	A/G	cg13877915	chr19:58951672	ZNF132	0.95	10.28	0.76	3.72e-16	Uric acid clearance;
SKCM	cis	rs72781680	1.000	rs72796328	chr2:24141343	A/G	cg08917208	chr2:24149416	ATAD2B	1.02	5.84	0.55	1.16e-7	Lymphocyte counts;
SKCM	cis	rs854765	0.693	rs9907287	chr17:17774118	C/T	cg04398451	chr17:18023971	MYO15A	0.92	6.79	0.61	1.97e-9	Total body bone mineral density;
SKCM	cis	rs9790314	0.586	rs73021449	chr3:161128941	G/A	cg03342759	chr3:160939853	NMD3	-0.74	-6.62	-0.6	4.08e-9	Morning vs. evening chronotype;
SKCM	cis	rs6424115	0.733	rs2502996	chr1:24199041	T/C	cg15997130	chr1:24165203	NA	0.6	4.94	0.49	4.37e-6	Immature fraction of reticulocytes;
SKCM	cis	rs10503709	0.556	rs13263772	chr8:21479481	G/A	cg15997512	chr8:21608254	GFRA2	-0.51	-4.83	-0.48	6.58e-6	Blood protein levels;
SKCM	cis	rs1878931	0.501	rs42329	chr16:3425524	G/A	cg26668626	chr16:3451006	ZNF174;ZNF434	-0.87	-6.71	-0.6	2.82e-9	Body mass index (adult);
SKCM	cis	rs17818399	0.547	rs35178974	chr2:46763898	T/C	cg02822958	chr2:46747628	ATP6V1E2	0.77	5.32	0.52	9.79e-7	Height;
SKCM	cis	rs2243480	0.706	rs6460257	chr7:65196780	C/T	cg18252515	chr7:66147081	NA	-1.22	-8.1	-0.68	6.13e-12	Diabetic kidney disease;
SKCM	cis	rs9300255	0.602	rs2682434	chr12:123694724	C/T	cg05973401	chr12:123451056	ABCB9	0.81	5.37	0.52	7.77e-7	Neutrophil percentage of white cells;
SKCM	cis	rs2404602	0.647	rs11634266	chr15:77093461	A/G	cg23625390	chr15:77176239	SCAPER	-0.82	-7.93	-0.67	1.26e-11	Blood metabolite levels;
SKCM	cis	rs9905704	0.671	rs4337355	chr17:56950920	C/T	cg05425664	chr17:57184151	TRIM37	-0.61	-4.83	-0.48	6.6e-6	Testicular germ cell tumor;
SKCM	cis	rs2013441	1.000	rs9897328	chr17:20174852	G/A	cg13482628	chr17:19912719	NA	-0.64	-5.04	-0.5	2.94e-6	Obesity-related traits;
SKCM	cis	rs10504229	0.683	rs55807014	chr8:58131801	T/C	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs13118159	0.550	rs28733902	chr4:1374789	A/G	cg19318889	chr4:1322082	MAEA	0.79	5.72	0.54	1.9e-7	Longevity;
SKCM	cis	rs73201462	1.000	rs11706455	chr3:127891991	G/A	cg09089421	chr3:127803668	RUVBL1	1.0	5.11	0.5	2.22e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs7599312	0.534	rs7607363	chr2:213402705	A/G	cg20637307	chr2:213403960	ERBB4	0.76	5.6	0.54	3.12e-7	BMI (adjusted for smoking behaviour);BMI in non-smokers;Body mass index;Body mass index (joint analysis main effects and smoking interaction);
SKCM	cis	rs7666738	0.830	rs17027198	chr4:98991085	G/C	cg17366294	chr4:99064904	C4orf37	0.6	4.98	0.49	3.8e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1799949	1.000	rs33920795	chr17:41329010	A/G	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.25	-0.58	2.03e-8	Menopause (age at onset);
SKCM	cis	rs2032447	0.670	rs198848	chr6:26106325	A/G	cg18357526	chr6:26021779	HIST1H4A	0.76	6.27	0.58	1.85e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs35306767	0.855	rs35825568	chr10:950760	C/T	cg25614935	chr10:1084866	C10orf110	0.82	5.33	0.52	9.4e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs7618501	0.602	rs2240327	chr3:50113034	C/T	cg24110177	chr3:50126178	RBM5	-0.62	-5.25	-0.51	1.3e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7927771	0.832	rs11601173	chr11:47401058	A/G	cg05585544	chr11:47624801	NA	-0.58	-5.19	-0.51	1.61e-6	Subjective well-being;
SKCM	cis	rs12497850	0.897	rs6795025	chr3:49081247	T/C	cg07636037	chr3:49044803	WDR6	1.06	11.78	0.8	5.51e-19	Parkinson's disease;
SKCM	cis	rs10751667	0.666	rs6597960	chr11:977036	C/T	cg10932868	chr11:921992	NA	0.55	5.1	0.5	2.36e-6	Alzheimer's disease (late onset);
SKCM	cis	rs394563	0.591	rs805026	chr6:149728254	G/C	cg03678062	chr6:149772716	ZC3H12D	-0.49	-5.41	-0.52	6.66e-7	Dupuytren's disease;
SKCM	cis	rs951366	0.589	rs823099	chr1:205669322	C/A	cg11965913	chr1:205819406	PM20D1	0.83	7.61	0.65	5.29e-11	Menarche (age at onset);
SKCM	cis	rs2204008	0.623	rs1315348	chr12:38163044	G/A	cg26384229	chr12:38710491	ALG10B	-0.67	-5.47	-0.53	5.23e-7	Bladder cancer;
SKCM	cis	rs2396545	0.634	rs35788385	chr11:570094	G/A	cg03576123	chr11:487126	PTDSS2	-0.86	-5.08	-0.5	2.55e-6	Systemic lupus erythematosus and Systemic sclerosis;
SKCM	cis	rs1218582	0.596	rs906595	chr1:154822907	C/T	cg06221963	chr1:154839813	KCNN3	-0.5	-4.94	-0.49	4.34e-6	Prostate cancer;
SKCM	cis	rs2239547	0.657	rs3755803	chr3:52866157	C/G	cg11645453	chr3:52864694	ITIH4	0.79	7.19	0.63	3.41e-10	Schizophrenia;
SKCM	cis	rs7264396	0.790	rs6060582	chr20:34313297	A/G	cg23207816	chr20:34252616	CPNE1;RBM12	-0.8	-4.85	-0.48	6.13e-6	Total cholesterol levels;
SKCM	cis	rs2274273	0.901	rs68046603	chr14:55762803	T/A	cg26246078	chr14:56151250	KTN1	0.69	4.81	0.48	7.12e-6	Protein biomarker;
SKCM	cis	rs8038465	0.516	rs8037836	chr15:73859855	G/A	cg24184689	chr15:74723271	SEMA7A	0.42	4.77	0.48	8.33e-6	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs9921192	1.000	rs2892165	chr16:4324293	A/T	cg00021532	chr16:4324280	TFAP4	0.91	8.67	0.7	4.71e-13	Prostate-specific antigen levels;
SKCM	cis	rs2066819	1.000	rs2695782	chr12:56722830	C/T	cg26714650	chr12:56694279	CS	1.64	6.34	0.58	1.36e-8	Psoriasis vulgaris;
SKCM	cis	rs9911578	0.900	rs4793593	chr17:56892699	C/G	cg12560992	chr17:57184187	TRIM37	-0.95	-7.69	-0.66	3.7e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs12497850	0.897	rs6781790	chr3:49044767	C/T	cg06212747	chr3:49208901	KLHDC8B	0.68	4.82	0.48	6.97e-6	Parkinson's disease;
SKCM	cis	rs861020	0.630	rs592694	chr1:210009533	G/T	cg05527609	chr1:210001259	C1orf107	0.86	6.74	0.61	2.43e-9	Orofacial clefts;
SKCM	cis	rs67311347	1.000	rs11716675	chr3:40485280	G/T	cg00091569	chr3:40428383	ENTPD3	0.62	5.09	0.5	2.4e-6	Renal cell carcinoma;
SKCM	cis	rs36093844	0.527	rs111955441	chr11:85759652	G/A	cg25872744	chr11:85566296	CCDC83	-0.81	-4.79	-0.48	7.71e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs17376456	0.877	rs10476597	chr5:93367172	C/T	cg25358565	chr5:93447407	FAM172A	-1.26	-7.82	-0.66	2.11e-11	Diabetic retinopathy;
SKCM	cis	rs2243480	1.000	rs35432774	chr7:65393019	G/C	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs6951245	0.872	rs11768895	chr7:1063691	T/C	cg03188948	chr7:1209495	NA	0.82	4.79	0.48	7.94e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs17376456	0.877	rs55832164	chr5:93436579	C/T	cg25358565	chr5:93447407	FAM172A	1.23	7.97	0.67	1.08e-11	Diabetic retinopathy;
SKCM	cis	rs9325144	0.505	rs1906262	chr12:38653605	A/G	cg13010199	chr12:38710504	ALG10B	0.68	5.39	0.52	7.24e-7	Morning vs. evening chronotype;
SKCM	cis	rs9303401	0.527	rs12939313	chr17:56755616	A/T	cg10487724	chr17:56770010	TEX14;RAD51C	0.82	5.73	0.54	1.83e-7	Cognitive test performance;
SKCM	cis	rs35146811	0.961	rs1880949	chr7:99722266	A/C	cg22906224	chr7:99728672	NA	-0.8	-6.51	-0.59	6.56e-9	Coronary artery disease;
SKCM	cis	rs8070128	0.568	rs3935506	chr17:17882059	G/A	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.83	6.02	0.56	5.29e-8	Total body bone mineral density;
SKCM	cis	rs4774899	0.966	rs12898844	chr15:57358508	A/T	cg01857019	chr15:57210107	LOC145783;TCF12	0.53	4.97	0.49	3.86e-6	Urinary tract infection frequency;
SKCM	cis	rs7772486	0.846	rs7755440	chr6:146375906	T/C	cg05347473	chr6:146136440	FBXO30	0.63	5.8	0.55	1.34e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs929354	0.772	rs3802120	chr7:156977794	C/T	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs668210	0.793	rs1786172	chr11:65770658	A/G	cg20909159	chr11:65625947	CFL1	-0.72	-4.82	-0.48	6.89e-6	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs769267	0.930	rs4808965	chr19:19631655	A/G	cg03709012	chr19:19516395	GATAD2A	0.89	8.62	0.7	5.89e-13	Tonsillectomy;
SKCM	cis	rs4819052	0.959	rs9976074	chr21:46655638	G/T	cg20896738	chr21:46707857	POFUT2;LOC642852	0.74	5.23	0.51	1.38e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs597539	0.652	rs1249474	chr11:68654774	C/T	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.72	5.08	0.5	2.47e-6	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs1577917	0.958	rs11752180	chr6:86573165	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.81	-7.82	-0.66	2.07e-11	Response to antipsychotic treatment;
SKCM	cis	rs2658782	1.000	rs2608216	chr11:93149172	G/A	cg15737290	chr11:93063684	CCDC67	0.76	5.32	0.52	9.69e-7	Pulmonary function decline;
SKCM	cis	rs6951245	0.706	rs28522260	chr7:1183964	C/A	cg03188948	chr7:1209495	NA	1.07	6.74	0.61	2.44e-9	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs947211	0.948	rs1775143	chr1:205755550	C/T	cg07157834	chr1:205819609	PM20D1	0.67	5.03	0.49	3.09e-6	Parkinson's disease;
SKCM	cis	rs9834970	0.588	rs9985296	chr3:36889621	C/T	cg25202636	chr3:37035158	MLH1;EPM2AIP1	-0.69	-5.19	-0.51	1.64e-6	Bipolar disorder with mood-incongruent psychosis;Subjective response to lithium treatment;Bipolar disorder;Schizophrenia or bipolar disorder;Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);
SKCM	cis	rs7777484	0.500	rs2533885	chr7:2835655	C/T	cg19717773	chr7:2847554	GNA12	-0.47	-5.52	-0.53	4.29e-7	Height;
SKCM	cis	rs7772486	0.764	rs2265471	chr6:146220250	G/A	cg23711669	chr6:146136114	FBXO30	0.78	7.7	0.66	3.53e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs875971	0.792	rs6971752	chr7:65737986	G/A	cg18876405	chr7:65276391	NA	-0.65	-6.57	-0.6	5.03e-9	Aortic root size;
SKCM	cis	rs28595532	0.920	rs114414928	chr4:119728188	T/C	cg21605333	chr4:119757512	SEC24D	1.36	8.05	0.67	7.69e-12	Cannabis dependence symptom count;
SKCM	cis	rs873946	0.586	rs12767391	chr10:134573844	A/G	cg14275445	chr10:134560047	INPP5A	0.53	4.79	0.48	7.93e-6	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs798554	0.679	rs2533877	chr7:2882421	G/A	cg04166393	chr7:2884313	GNA12	0.8	5.35	0.52	8.45e-7	Height;
SKCM	cis	rs28595532	0.920	rs17324884	chr4:119771477	C/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs2075371	0.901	rs2544220	chr7:133993004	T/C	cg20476274	chr7:133979776	SLC35B4	0.9	8.03	0.67	8.08e-12	Mean platelet volume;
SKCM	cis	rs8078723	1.000	rs1042658	chr17:38173902	C/T	cg17467752	chr17:38218738	THRA	0.69	6.33	0.58	1.46e-8	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs4724125	0.722	rs13230133	chr7:42669837	T/C	cg09407816	chr7:42972088	MRPL32;PSMA2	0.8	5.21	0.51	1.48e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs478304	0.651	rs12225620	chr11:65505448	T/C	cg27068330	chr11:65405492	SIPA1	-0.89	-8.21	-0.68	3.71e-12	Acne (severe);
SKCM	cis	rs6430585	0.583	rs3769008	chr2:136586183	C/T	cg07169764	chr2:136633963	MCM6	1.31	13.22	0.83	1.29e-21	Corneal structure;
SKCM	cis	rs1707322	1.000	rs6671754	chr1:46433990	A/G	cg03146154	chr1:46216737	IPP	0.79	5.34	0.52	8.73e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs3091242	0.933	rs9438904	chr1:25756860	T/C	cg02931644	chr1:25747376	RHCE	0.53	5.24	0.51	1.31e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs10911232	0.507	rs10797821	chr1:183012559	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.64	0.6	3.83e-9	Hypertriglyceridemia;
SKCM	cis	rs10752881	1.000	rs10797800	chr1:182969828	C/A	ch.1.3577855R	chr1:183094577	LAMC1	0.73	6.62	0.6	4.17e-9	Colorectal cancer;
SKCM	cis	rs1577917	0.771	rs4351223	chr6:86237797	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.98	10.89	0.78	2.49e-17	Response to antipsychotic treatment;
SKCM	cis	rs1552244	0.935	rs66493421	chr3:10092569	G/A	cg02579736	chr3:10068473	FANCD2;CIDECP	1.34	7.21	0.63	3.15e-10	Alzheimer's disease;
SKCM	cis	rs2013441	0.932	rs3850785	chr17:20185248	A/G	cg13482628	chr17:19912719	NA	-0.66	-5.12	-0.5	2.18e-6	Obesity-related traits;
SKCM	cis	rs3820928	0.874	rs10178731	chr2:227874232	C/T	cg11843606	chr2:227700838	RHBDD1	-0.61	-4.9	-0.49	5.12e-6	Pulmonary function;
SKCM	cis	rs6066825	0.554	rs4809711	chr20:47235811	T/C	cg18078177	chr20:47281410	PREX1	0.65	5.32	0.52	9.78e-7	Colorectal cancer;
SKCM	cis	rs4423214	1.000	rs12419334	chr11:71139472	T/C	cg05163923	chr11:71159392	DHCR7	0.77	7.48	0.65	9.67e-11	Vitamin D levels;
SKCM	cis	rs7772486	0.720	rs7752286	chr6:146072662	C/T	cg05347473	chr6:146136440	FBXO30	-0.6	-5.68	-0.54	2.21e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9381040	0.655	rs2268190	chr6:41030226	C/T	cg04346459	chr6:41068666	NFYA;LOC221442	-0.72	-5.06	-0.5	2.71e-6	Alzheimer's disease (late onset);
SKCM	cis	rs12142240	0.698	rs67487250	chr1:46811333	T/C	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs7523050	0.643	rs35924015	chr1:109404626	T/C	cg08274380	chr1:109419600	GPSM2	1.18	6.49	0.59	7.3e-9	Fat distribution (HIV);
SKCM	cis	rs2841233	0.692	rs78118267	chr14:105344111	G/A	cg16576083	chr14:105354267	KIAA0284	0.6	4.78	0.48	7.96e-6	IgG glycosylation;
SKCM	cis	rs7811142	1.000	rs113738841	chr7:100081306	C/T	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.24	7.92	0.67	1.36e-11	Platelet count;
SKCM	cis	rs7980687	0.628	rs2851443	chr12:123694250	C/T	cg05973401	chr12:123451056	ABCB9	0.72	5.07	0.5	2.61e-6	Height;Educational attainment;Head circumference (infant);
SKCM	cis	rs72781680	1.000	rs72798411	chr2:24184343	A/G	cg08917208	chr2:24149416	ATAD2B	1.02	5.84	0.55	1.16e-7	Lymphocyte counts;
SKCM	cis	rs7772486	0.754	rs6915718	chr6:146100676	A/G	cg23711669	chr6:146136114	FBXO30	-0.9	-10.43	-0.76	1.88e-16	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs13126513	0.708	rs883028	chr4:100451375	A/G	cg05468953	chr4:100565104	NA	0.48	4.98	0.49	3.74e-6	Metabolite levels (MHPG);
SKCM	cis	rs709400	0.628	rs7146506	chr14:103924477	A/G	cg26031613	chr14:104095156	KLC1	0.73	5.62	0.54	2.87e-7	Body mass index;
SKCM	cis	rs7772486	0.790	rs1062067	chr6:146207563	A/G	cg23711669	chr6:146136114	FBXO30	0.76	7.55	0.65	7.1e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7937682	0.824	rs539524	chr11:111477325	A/G	cg09085632	chr11:111637200	PPP2R1B	-0.97	-10.1	-0.75	8.28e-16	Primary sclerosing cholangitis;
SKCM	cis	rs2108225	0.934	rs2283045	chr7:107440714	G/A	cg18560240	chr7:107437656	SLC26A3	-0.59	-4.93	-0.49	4.58e-6	Ulcerative colitis;
SKCM	cis	rs12044355	0.516	rs2356383	chr1:231742973	G/C	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	-0.58	-4.9	-0.48	5.19e-6	Alzheimer's disease;
SKCM	cis	rs951366	0.789	rs823097	chr1:205681370	G/A	cg24503407	chr1:205819492	PM20D1	0.74	6.02	0.56	5.4e-8	Menarche (age at onset);
SKCM	cis	rs507080	0.922	rs7114458	chr11:118566175	G/A	cg18045108	chr11:118530628	TREH	-0.47	-5.07	-0.5	2.57e-6	Serum metabolite levels;
SKCM	cis	rs3020736	0.500	rs2839708	chr22:42500745	A/G	cg04733989	chr22:42467013	NAGA	-0.72	-5.62	-0.54	2.87e-7	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs72772090	0.539	rs11747896	chr5:96113397	A/G	cg17330273	chr5:96107758	CAST;ERAP1	0.79	4.79	0.48	7.84e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs4631830	0.720	rs11004422	chr10:51498336	A/G	cg16070123	chr10:51489643	NA	0.53	4.96	0.49	3.99e-6	Prostate-specific antigen levels;
SKCM	cis	rs1577917	1.000	rs884841	chr6:86680300	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.85	-8.48	-0.69	1.12e-12	Response to antipsychotic treatment;
SKCM	cis	rs1691799	0.899	rs1168292	chr12:66732660	C/T	cg16791601	chr12:66731901	HELB	-0.66	-5.75	-0.55	1.69e-7	White blood cell count (basophil);
SKCM	cis	rs4819052	0.851	rs7281263	chr21:46695606	T/C	cg19498844	chr21:46707878	POFUT2;LOC642852	0.91	7.84	0.66	1.92e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs2153535	0.580	rs2327061	chr6:8447231	G/C	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs2404602	0.647	rs12903331	chr15:77168268	C/G	cg23625390	chr15:77176239	SCAPER	-0.81	-7.67	-0.66	4.06e-11	Blood metabolite levels;
SKCM	cis	rs9910055	0.762	rs2631299	chr17:42219773	G/T	cg08499158	chr17:42289980	UBTF	-0.84	-7.44	-0.64	1.14e-10	Total body bone mineral density;
SKCM	cis	rs796364	0.789	rs176008	chr2:200814720	A/T	cg12253985	chr2:200820533	C2orf60;C2orf47	0.85	5.39	0.52	7.18e-7	Schizophrenia;
SKCM	cis	rs1635	0.826	rs78270345	chr6:28179560	T/G	cg15743358	chr6:28303923	ZNF323	-1.36	-5.26	-0.51	1.22e-6	Schizophrenia;
SKCM	cis	rs9910055	0.531	rs6503490	chr17:42246656	A/G	cg08499158	chr17:42289980	UBTF	-0.74	-6.46	-0.59	8.29e-9	Total body bone mineral density;
SKCM	cis	rs742614	0.533	rs2103804	chr20:32425403	A/G	cg06304546	chr20:32448765	NA	0.73	5.91	0.56	8.51e-8	Stearic acid (18:0) levels;
SKCM	cis	rs854765	0.624	rs4925116	chr17:17731200	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	-0.9	-6.78	-0.61	2.04e-9	Total body bone mineral density;
SKCM	cis	rs1639906	0.895	rs6972752	chr7:2196551	G/A	cg21782813	chr7:2030301	MAD1L1	-0.53	-5.38	-0.52	7.45e-7	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs763014	0.931	rs7192508	chr16:630367	C/T	cg00908189	chr16:619842	PIGQ	0.82	7.78	0.66	2.55e-11	Height;
SKCM	cis	rs11098499	0.566	rs7664440	chr4:120578540	A/G	cg09307838	chr4:120376055	NA	1.01	8.35	0.69	2.01e-12	Corneal astigmatism;
SKCM	cis	rs1669338	0.588	rs3864049	chr3:3186719	T/G	cg16797762	chr3:3221439	CRBN	-1.1	-6.31	-0.58	1.55e-8	White matter integrity;
SKCM	cis	rs11249608	0.548	rs11951738	chr5:178491228	G/A	cg21905437	chr5:178450457	ZNF879	0.68	5.18	0.51	1.72e-6	Pubertal anthropometrics;
SKCM	cis	rs644799	0.763	rs2950521	chr11:95536870	G/A	cg25622487	chr11:95524042	FAM76B;CEP57	0.66	5.12	0.5	2.18e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs4481887	0.927	rs10788779	chr1:248481661	C/G	cg00666640	chr1:248458726	OR2T12	0.63	5.91	0.56	8.65e-8	Common traits (Other);
SKCM	cis	rs875971	0.964	rs2161065	chr7:65932905	A/G	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs2180341	1.000	rs9285460	chr6:127640190	A/G	cg27446573	chr6:127587934	RNF146	0.94	8.08	0.68	6.49e-12	Breast cancer;
SKCM	cis	rs910316	0.967	rs175498	chr14:75536369	G/A	cg08847533	chr14:75593920	NEK9	-0.96	-8.88	-0.71	1.87e-13	Height;
SKCM	cis	rs7843479	0.601	rs2306645	chr8:21845428	C/T	cg17168535	chr8:21777572	XPO7	-0.8	-6.94	-0.62	1.03e-9	Mean corpuscular volume;
SKCM	cis	rs2769264	0.505	rs4246526	chr1:151403916	G/T	cg18801370	chr1:151430492	POGZ	0.87	6.05	0.57	4.77e-8	Blood trace element (Cu levels);
SKCM	cis	rs2404602	0.692	rs4886829	chr15:77091182	G/T	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs684232	0.800	rs371318	chr17:555816	A/G	cg20012309	chr17:1538416	SCARF1	0.49	5.02	0.49	3.18e-6	Prostate cancer;
SKCM	cis	rs6591182	0.967	rs11227229	chr11:65354150	C/T	cg27068330	chr11:65405492	SIPA1	-0.7	-5.06	-0.5	2.71e-6	Non-alcoholic fatty liver disease histology (lobular);
SKCM	cis	rs2153535	0.580	rs2327067	chr6:8518482	C/G	cg07606381	chr6:8435919	SLC35B3	0.87	6.38	0.59	1.17e-8	Motion sickness;
SKCM	cis	rs9682041	0.736	rs34237232	chr3:170063753	C/T	cg11886554	chr3:170076028	SKIL	-0.88	-5.0	-0.49	3.47e-6	Glomerular filtration rate in non diabetics (creatinine);Glomerular filtration rate (creatinine);
SKCM	trans	rs1814175	0.817	rs11040651	chr11:49938395	G/A	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs2014572	0.967	rs10418480	chr19:57755055	C/T	cg24459738	chr19:57751996	ZNF805	-0.64	-5.29	-0.51	1.1e-6	Hyperactive-impulsive symptoms;
SKCM	cis	rs17270561	0.525	rs12201678	chr6:25978993	C/T	cg17691542	chr6:26056736	HIST1H1C	1.24	9.77	0.74	3.43e-15	Iron status biomarkers;
SKCM	cis	rs13256369	0.851	rs13249700	chr8:8563637	C/T	cg06636001	chr8:8085503	FLJ10661	0.8	6.11	0.57	3.65e-8	Obesity-related traits;
SKCM	cis	rs4803468	1.000	rs1473248	chr19:41923314	C/T	cg09537434	chr19:41945824	ATP5SL	1.11	13.76	0.84	1.44e-22	Height;
SKCM	cis	rs997295	0.570	rs28730805	chr15:67879418	G/A	cg24247231	chr15:67904302	MAP2K5	-0.6	-4.98	-0.49	3.74e-6	Motion sickness;
SKCM	cis	rs9910055	0.639	rs11656871	chr17:42269141	G/C	cg10896456	chr17:42255109	ASB16;C17orf65	0.68	7.28	0.64	2.25e-10	Total body bone mineral density;
SKCM	cis	rs6547631	0.594	rs7585576	chr2:85937785	G/A	cg24620635	chr2:85921963	GNLY	0.86	6.29	0.58	1.68e-8	Blood protein levels;
SKCM	cis	rs4819052	0.765	rs2838852	chr21:46677037	C/A	cg02159808	chr21:46707872	POFUT2;LOC642852	0.73	5.71	0.54	1.93e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs2204008	0.502	rs2387275	chr12:38142836	G/A	cg26384229	chr12:38710491	ALG10B	0.86	6.85	0.61	1.53e-9	Bladder cancer;
SKCM	cis	rs9911578	1.000	rs9904879	chr17:56864422	G/A	cg12560992	chr17:57184187	TRIM37	0.95	7.69	0.66	3.7e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs875971	0.545	rs1796222	chr7:66057154	T/C	cg18876405	chr7:65276391	NA	-0.61	-4.91	-0.49	4.98e-6	Aortic root size;
SKCM	cis	rs1568889	1.000	rs12794100	chr11:28332785	A/T	cg06544937	chr11:28130018	METT5D1;KIF18A	0.86	7.03	0.62	6.97e-10	Bipolar disorder;
SKCM	cis	rs992157	0.764	rs10932774	chr2:219191569	A/G	cg20019365	chr2:219134978	PNKD;AAMP	0.76	6.14	0.57	3.24e-8	Colorectal cancer;
SKCM	cis	rs2857078	0.720	rs9906669	chr17:42305706	A/G	cg08499158	chr17:42289980	UBTF	-0.79	-6.91	-0.62	1.15e-9	Red cell distribution width;Reticulocyte count;
SKCM	trans	rs9929218	0.551	rs2296406	chr16:68721340	G/A	cg04657470	chr2:198365150	HSPE1;HSPD1	1.01	11.2	0.79	6.66e-18	Colorectal cancer;
SKCM	cis	rs2836974	0.583	rs9636957	chr21:40705847	G/A	cg11644478	chr21:40555479	PSMG1	-0.66	-5.44	-0.52	5.98e-7	Cognitive function;
SKCM	cis	rs116095464	0.558	rs10057674	chr5:266813	C/T	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs6541297	1.000	rs2352723	chr1:230291868	C/T	cg05784532	chr1:230284198	GALNT2	-0.57	-5.1	-0.5	2.34e-6	Coronary artery disease;
SKCM	cis	rs3091242	0.935	rs3093632	chr1:25684012	C/T	cg27572855	chr1:25598939	RHD	0.54	5.28	0.51	1.13e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs58688157	0.705	rs7928902	chr11:609068	G/A	cg16486109	chr11:613632	IRF7	1.06	7.19	0.63	3.44e-10	Systemic lupus erythematosus;
SKCM	cis	rs7666738	0.830	rs2903152	chr4:99067992	A/G	cg17366294	chr4:99064904	C4orf37	0.61	4.93	0.49	4.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs736408	0.609	rs2230534	chr3:52802402	A/C	cg18404041	chr3:52824283	ITIH1	-0.56	-4.94	-0.49	4.32e-6	Bipolar disorder;
SKCM	cis	rs644799	0.687	rs11021318	chr11:95522996	T/C	cg03916912	chr11:95522834	CEP57;FAM76B	0.81	6.83	0.61	1.67e-9	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs8060686	0.641	rs7188085	chr16:68113873	A/G	cg04539111	chr16:67997858	SLC12A4	-0.87	-4.89	-0.48	5.33e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs9910055	0.639	rs7217858	chr17:42254527	T/G	cg08499158	chr17:42289980	UBTF	-0.73	-6.45	-0.59	8.6e-9	Total body bone mineral density;
SKCM	cis	rs66887589	0.934	rs56843000	chr4:120516597	T/C	cg09307838	chr4:120376055	NA	-0.65	-4.87	-0.48	5.72e-6	Diastolic blood pressure;
SKCM	cis	rs7772486	0.790	rs80050589	chr6:146230454	T/C	cg05347473	chr6:146136440	FBXO30	-0.56	-5.28	-0.51	1.12e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7666738	0.830	rs6854994	chr4:98977624	C/G	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs875971	0.862	rs7782704	chr7:65805366	G/A	cg18876405	chr7:65276391	NA	-0.64	-6.34	-0.58	1.35e-8	Aortic root size;
SKCM	cis	rs2832191	0.545	rs2251381	chr21:30530692	T/G	cg24692254	chr21:30365293	RNF160	0.62	5.08	0.5	2.53e-6	Dental caries;
SKCM	cis	rs4803468	0.967	rs1077856	chr19:41885221	T/C	cg09537434	chr19:41945824	ATP5SL	-1.08	-13.01	-0.83	3.1e-21	Height;
SKCM	cis	rs9910055	0.762	rs2631299	chr17:42219773	G/T	cg10896456	chr17:42255109	ASB16;C17orf65	0.66	6.42	0.59	9.68e-9	Total body bone mineral density;
SKCM	cis	rs6121246	0.909	rs6119729	chr20:30413163	A/G	cg11595048	chr20:30225325	COX4I2	-0.67	-5.21	-0.51	1.5e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs7811142	1.000	rs113738841	chr7:100081306	C/T	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.19	7.92	0.67	1.33e-11	Platelet count;
SKCM	cis	rs2075371	0.966	rs1646676	chr7:133999267	G/A	cg20476274	chr7:133979776	SLC35B4	1.05	10.74	0.77	4.81e-17	Mean platelet volume;
SKCM	cis	rs12047808	0.730	rs73035925	chr1:179532121	G/A	cg09822482	chr1:179519214	C1orf125	-0.96	-4.77	-0.48	8.48e-6	Multiple sclerosis (age of onset);
SKCM	cis	rs2413583	0.591	rs115038091	chr22:39728575	C/A	cg17798944	chr22:39715225	SNORD43;RPL3	0.93	5.29	0.51	1.11e-6	Ulcerative colitis;Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs1878931	0.624	rs27241	chr16:3447282	C/G	cg26668626	chr16:3451006	ZNF174;ZNF434	-0.78	-5.63	-0.54	2.75e-7	Body mass index (adult);
SKCM	cis	rs9430161	0.579	rs79323519	chr1:11036050	T/C	cg02454025	chr1:11042201	C1orf127	1.13	9.81	0.74	2.9e-15	Ewing sarcoma;
SKCM	cis	rs873946	0.504	rs3793681	chr10:134564451	T/C	cg14275445	chr10:134560047	INPP5A	-0.55	-4.85	-0.48	6.27e-6	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs7666738	0.716	rs1426660	chr4:98876792	T/A	cg17366294	chr4:99064904	C4orf37	0.56	4.87	0.48	5.62e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs17685	0.753	rs11982200	chr7:75714883	T/C	cg16489192	chr7:75678113	MDH2;STYXL1	-0.58	-5.46	-0.53	5.43e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs870825	0.860	rs56180712	chr4:185600223	A/G	cg04058563	chr4:185651563	MLF1IP	1.04	5.96	0.56	7.02e-8	Blood protein levels;
SKCM	cis	rs7772486	0.754	rs1415746	chr6:146077107	A/G	cg05347473	chr6:146136440	FBXO30	-0.62	-5.8	-0.55	1.37e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs8180040	0.676	rs11130114	chr3:47154651	T/G	cg27129171	chr3:47204927	SETD2	0.82	6.49	0.59	7.26e-9	Colorectal cancer;
SKCM	trans	rs3749237	0.929	rs62260715	chr3:49829326	G/A	cg21659725	chr3:3221576	CRBN	0.99	7.35	0.64	1.71e-10	Resting heart rate;
SKCM	cis	rs4665809	0.652	rs10779956	chr2:26405985	A/G	cg26119090	chr2:26468346	HADHA;HADHB	-1.0	-6.87	-0.61	1.37e-9	Gut microbiome composition (summer);
SKCM	cis	rs7666738	0.800	rs28427190	chr4:98989106	A/G	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs514406	0.560	rs1889033	chr1:53211887	A/G	cg16325326	chr1:53192061	ZYG11B	-0.99	-12.19	-0.81	9.5e-20	Monocyte count;
SKCM	cis	rs9902453	0.791	rs2628166	chr17:28113123	T/C	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.78	-5.29	-0.51	1.07e-6	Coffee consumption (cups per day);
SKCM	cis	rs873946	0.586	rs12259688	chr10:134549628	A/G	cg27286337	chr10:134555280	INPP5A	0.93	7.9	0.67	1.44e-11	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs763121	0.853	rs9607566	chr22:39075434	C/G	cg06022373	chr22:39101656	GTPBP1	0.78	5.59	0.53	3.27e-7	Menopause (age at onset);
SKCM	cis	rs4319547	0.955	rs6489159	chr12:123112806	G/A	cg23029597	chr12:123009494	RSRC2	-0.8	-5.72	-0.54	1.9e-7	Body mass index;
SKCM	cis	rs933688	1.000	rs6865495	chr5:90746424	G/A	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.07	8.69	0.7	4.41e-13	Smoking behavior;
SKCM	cis	rs7843479	0.965	rs17581910	chr8:21799626	A/G	cg17168535	chr8:21777572	XPO7	0.78	6.42	0.59	9.79e-9	Mean corpuscular volume;
SKCM	cis	rs28735056	0.563	rs12968139	chr18:77685520	A/G	cg20368463	chr18:77673604	PQLC1	-0.74	-5.83	-0.55	1.19e-7	Schizophrenia;
SKCM	cis	rs2842992	0.789	rs4276525	chr6:160193612	G/A	cg16489826	chr6:160211363	TCP1;MRPL18	0.73	5.42	0.52	6.39e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs3784262	0.839	rs1579744	chr15:58229523	G/A	cg12031962	chr15:58353849	ALDH1A2	0.44	5.03	0.49	3.08e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs4073582	0.516	rs1151539	chr11:66031660	C/T	cg16950941	chr11:66035639	RAB1B	0.82	7.01	0.62	7.59e-10	Gout;
SKCM	cis	rs12142240	0.698	rs3991877	chr1:46853749	C/A	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs2033711	0.837	rs3764535	chr19:58929052	G/A	cg03735888	chr19:58951602	ZNF132	0.7	6.08	0.57	4.25e-8	Uric acid clearance;
SKCM	cis	rs732765	0.734	rs2270424	chr14:75159007	G/A	cg25946216	chr14:74253857	C14orf43	-0.79	-4.97	-0.49	3.83e-6	Non-small cell lung cancer;
SKCM	cis	rs7552404	0.961	rs1767458	chr1:76219155	A/G	cg10523679	chr1:76189770	ACADM	0.69	4.93	0.49	4.45e-6	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs7639513	0.767	rs7617041	chr3:12709167	A/G	cg23032965	chr3:12705835	RAF1	0.81	7.08	0.63	5.53e-10	Itch intensity from mosquito bite;
SKCM	cis	rs1577917	0.958	rs3857480	chr6:86535149	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.33	-0.52	9.19e-7	Response to antipsychotic treatment;
SKCM	cis	rs9926296	0.744	rs164747	chr16:89708680	T/G	cg08949735	chr16:89699720	DPEP1	-0.54	-4.92	-0.49	4.8e-6	Vitiligo;
SKCM	cis	rs6120849	0.901	rs6088737	chr20:33745938	A/G	cg24642439	chr20:33292090	TP53INP2	0.94	5.15	0.5	1.89e-6	Protein C levels;
SKCM	cis	rs17376456	0.877	rs9314101	chr5:93461593	A/T	cg25358565	chr5:93447407	FAM172A	1.23	7.97	0.67	1.08e-11	Diabetic retinopathy;
SKCM	cis	rs7811142	0.830	rs11771936	chr7:99943283	A/G	cg00814883	chr7:100076585	TSC22D4	-0.84	-4.78	-0.48	8.01e-6	Platelet count;
SKCM	cis	rs9300255	0.602	rs2695479	chr12:123689386	T/C	cg05973401	chr12:123451056	ABCB9	0.79	5.2	0.51	1.59e-6	Neutrophil percentage of white cells;
SKCM	cis	rs736408	0.561	rs2276815	chr3:52853747	C/G	cg11645453	chr3:52864694	ITIH4	0.74	6.69	0.6	3.05e-9	Bipolar disorder;
SKCM	cis	rs17685	0.753	rs6464999	chr7:75787315	T/C	cg16684958	chr7:75615977	POR	0.52	5.03	0.49	3.11e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs116095464	0.558	rs59113266	chr5:279965	T/C	cg22857025	chr5:266934	NA	-1.47	-8.33	-0.69	2.16e-12	Breast cancer;
SKCM	cis	rs929354	0.651	rs6951298	chr7:156949149	T/C	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs7100689	0.784	rs7081903	chr10:82162509	T/C	cg01528321	chr10:82214614	TSPAN14	0.94	9.27	0.72	3.2e-14	Post bronchodilator FEV1;
SKCM	cis	rs28386778	0.897	rs2665823	chr17:61885917	G/A	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs13424612	0.930	rs4149545	chr2:240942818	G/T	cg01812947	chr2:240904978	NDUFA10	0.66	5.09	0.5	2.39e-6	Odorant perception (isobutyraldehyde);
SKCM	cis	rs10751667	0.580	rs11246363	chr11:971667	T/C	cg10932868	chr11:921992	NA	0.55	5.1	0.5	2.36e-6	Alzheimer's disease (late onset);
SKCM	cis	rs992157	0.835	rs10932769	chr2:219147245	T/G	cg00012203	chr2:219082015	ARPC2	-0.72	-5.71	-0.54	1.99e-7	Colorectal cancer;
SKCM	cis	rs9467773	0.620	rs2494692	chr6:26615223	G/A	cg09904177	chr6:26538194	HMGN4	0.58	5.01	0.49	3.28e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs13256369	0.802	rs11249888	chr8:8564934	T/C	cg06636001	chr8:8085503	FLJ10661	0.8	6.11	0.57	3.65e-8	Obesity-related traits;
SKCM	cis	rs8077889	0.719	rs4793033	chr17:41879627	C/T	cg26893861	chr17:41843967	DUSP3	1.28	11.63	0.8	1.02e-18	Triglycerides;
SKCM	cis	rs763014	0.865	rs2071979	chr16:624114	A/G	cg00908189	chr16:619842	PIGQ	0.81	7.2	0.63	3.3e-10	Height;
SKCM	cis	rs8180040	0.647	rs57756484	chr3:47239333	A/G	cg27129171	chr3:47204927	SETD2	-0.73	-5.25	-0.51	1.3e-6	Colorectal cancer;
SKCM	cis	rs992157	0.730	rs2382828	chr2:219184492	A/G	cg20019365	chr2:219134978	PNKD;AAMP	0.74	5.94	0.56	7.66e-8	Colorectal cancer;
SKCM	cis	rs1577917	0.958	rs11755864	chr6:86691791	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.83	-8.11	-0.68	5.64e-12	Response to antipsychotic treatment;
SKCM	cis	rs8063761	0.589	rs4238833	chr16:90050689	G/T	cg08547343	chr16:90038815	CENPBD1;AFG3L1	0.79	7.12	0.63	4.64e-10	Squamous cell carcinoma;
SKCM	cis	rs478304	0.654	rs11601509	chr11:65456864	T/C	cg27068330	chr11:65405492	SIPA1	-0.91	-7.66	-0.66	4.2e-11	Acne (severe);
SKCM	cis	rs34779708	0.966	rs17591857	chr10:35499043	A/G	cg03585969	chr10:35415529	CREM	-0.77	-6.3	-0.58	1.66e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs1005277	0.579	rs2983343	chr10:38383332	A/G	cg25427524	chr10:38739819	LOC399744	-0.69	-6.45	-0.59	8.73e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs1863918	0.659	rs75649946	chr5:178493656	A/C	cg21905437	chr5:178450457	ZNF879	-0.63	-5.53	-0.53	4.12e-7	Depression in response to interferon-based therapy in chronic hepatitis C;
SKCM	cis	rs7027203	0.790	rs10123836	chr9:96584109	G/T	cg14396892	chr9:96623032	NA	-0.45	-4.86	-0.48	5.99e-6	DNA methylation (variation);
SKCM	cis	rs7666738	0.753	rs10004827	chr4:99037953	A/C	cg05340658	chr4:99064831	C4orf37	0.67	5.16	0.5	1.85e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs3785574	0.962	rs2665799	chr17:61919723	A/G	cg06873352	chr17:61820015	STRADA	0.56	4.82	0.48	6.86e-6	Height;
SKCM	cis	rs11098499	0.599	rs3864142	chr4:120266191	A/T	cg09307838	chr4:120376055	NA	0.96	8.24	0.68	3.19e-12	Corneal astigmatism;
SKCM	cis	rs3540	0.576	rs12907587	chr15:91045851	G/C	cg22089800	chr15:90895588	ZNF774	-0.68	-4.92	-0.49	4.72e-6	Allergic disease (asthma, hay fever or eczema);Lymphocyte counts;
SKCM	cis	rs875971	0.825	rs1860472	chr7:66082723	T/C	cg11764359	chr7:65958608	NA	-0.74	-6.63	-0.6	3.89e-9	Aortic root size;
SKCM	cis	rs950776	0.518	rs12910978	chr15:78810017	A/G	cg06917634	chr15:78832804	PSMA4	1.01	10.48	0.76	1.5e-16	Sudden cardiac arrest;
SKCM	cis	rs8016982	0.651	rs9806027	chr14:81668707	G/C	cg01989461	chr14:81687754	GTF2A1	0.87	6.91	0.62	1.19e-9	Schizophrenia;
SKCM	cis	rs8067545	0.667	rs7222403	chr17:19879164	T/C	cg13482628	chr17:19912719	NA	0.65	4.77	0.48	8.36e-6	Schizophrenia;
SKCM	cis	rs950027	0.620	rs1426932	chr15:45687256	T/C	cg21132104	chr15:45694354	SPATA5L1	0.74	5.41	0.52	6.68e-7	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs1552244	0.765	rs17050675	chr3:10027686	A/G	cg02579736	chr3:10068473	FANCD2;CIDECP	0.95	4.84	0.48	6.45e-6	Alzheimer's disease;
SKCM	cis	rs9796	0.689	rs6492983	chr15:41436049	T/G	cg18705301	chr15:41695430	NDUFAF1	-0.76	-5.34	-0.52	8.78e-7	Menopause (age at onset);
SKCM	cis	rs7772486	0.875	rs9322048	chr6:146400439	A/G	cg05347473	chr6:146136440	FBXO30	0.64	5.65	0.54	2.52e-7	Lobe attachment (rater-scored or self-reported);
SKCM	trans	rs1814175	0.619	rs847644	chr11:49918418	G/A	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	trans	rs1814175	0.791	rs10839468	chr11:49986288	A/G	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs6580649	1.000	rs7132668	chr12:48405860	C/T	cg05342945	chr12:48394962	COL2A1	-0.77	-5.42	-0.52	6.52e-7	Lung cancer;
SKCM	cis	rs2463822	1.000	rs2463820	chr11:62112290	A/T	cg06239285	chr11:62104954	ASRGL1	1.25	5.93	0.56	7.79e-8	Chronic obstructive pulmonary disease-related biomarkers;
SKCM	cis	rs208520	1.000	rs208520	chr6:66952828	G/T	cg07460842	chr6:66804631	NA	-0.84	-5.89	-0.55	9.44e-8	Exhaled nitric oxide output;
SKCM	cis	rs644799	0.582	rs1727149	chr11:95497171	C/T	cg03916912	chr11:95522834	CEP57;FAM76B	-0.74	-6.12	-0.57	3.47e-8	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs637571	0.522	rs542332	chr11:65744421	C/T	cg02427764	chr11:65769310	BANF1;EIF1AD	0.77	5.84	0.55	1.15e-7	Eosinophil percentage of white cells;
SKCM	cis	rs9303401	0.659	rs34351230	chr17:56782555	C/A	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.35	0.52	8.54e-7	Cognitive test performance;
SKCM	cis	rs875971	0.830	rs28714531	chr7:65968237	G/A	cg18876405	chr7:65276391	NA	0.61	6.04	0.56	5.03e-8	Aortic root size;
SKCM	cis	rs1552244	0.882	rs6443279	chr3:10053599	C/A	cg02579736	chr3:10068473	FANCD2;CIDECP	0.98	4.84	0.48	6.48e-6	Alzheimer's disease;
SKCM	cis	rs6723226	0.803	rs176415	chr2:32649778	G/A	cg02381751	chr2:32503542	YIPF4	-0.96	-7.38	-0.64	1.45e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs11626933	0.959	rs17799226	chr14:90754538	C/T	cg14092571	chr14:90743983	NA	-0.92	-8.33	-0.69	2.11e-12	Gut microbiota (bacterial taxa);
SKCM	cis	rs1153858	1.000	rs10519022	chr15:45663684	C/T	cg21132104	chr15:45694354	SPATA5L1	-0.91	-7.45	-0.65	1.06e-10	Homoarginine levels;
SKCM	cis	rs7177699	0.526	rs7165042	chr15:79123338	C/G	cg04896959	chr15:78267971	NA	-0.54	-4.84	-0.48	6.39e-6	Post bronchodilator FEV1/FVC ratio;Post bronchodilator FEV1;
SKCM	cis	rs6582630	0.555	rs11181657	chr12:38381858	T/C	cg26384229	chr12:38710491	ALG10B	-0.81	-6.6	-0.6	4.58e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs7811142	1.000	rs60844404	chr7:100080474	A/T	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-1.02	-5.76	-0.55	1.59e-7	Platelet count;
SKCM	cis	rs6430585	0.528	rs586964	chr2:136652491	G/A	cg07169764	chr2:136633963	MCM6	1.33	11.27	0.79	4.81e-18	Corneal structure;
SKCM	cis	rs9796	0.689	rs72737758	chr15:41449778	C/T	cg18705301	chr15:41695430	NDUFAF1	-0.73	-5.27	-0.51	1.18e-6	Menopause (age at onset);
SKCM	cis	rs4563143	0.663	rs10406794	chr19:29228056	C/T	cg04546413	chr19:29218101	NA	0.78	5.71	0.54	1.96e-7	Methadone dose in opioid dependence;
SKCM	cis	rs11252926	0.527	rs10904093	chr10:436848	A/G	cg18196295	chr10:418757	DIP2C	-0.58	-5.0	-0.49	3.48e-6	Psychosis in Alzheimer's disease;
SKCM	cis	rs2836974	0.831	rs34592564	chr21:40516288	G/C	cg17971929	chr21:40555470	PSMG1	0.89	8.48	0.69	1.11e-12	Cognitive function;
SKCM	cis	rs116095464	0.558	rs57335027	chr5:262907	A/G	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs995000	0.899	rs1168030	chr1:62968491	C/T	cg06896770	chr1:63153194	DOCK7	-0.62	-5.59	-0.54	3.15e-7	Triglyceride levels;
SKCM	cis	rs7647973	0.769	rs4974081	chr3:49070499	A/G	cg07636037	chr3:49044803	WDR6	-0.97	-7.24	-0.63	2.76e-10	Menarche (age at onset);
SKCM	cis	rs11690935	0.959	rs6754817	chr2:172663394	C/T	cg13550731	chr2:172543902	DYNC1I2	-0.92	-7.75	-0.66	2.89e-11	Schizophrenia;
SKCM	cis	rs782590	0.643	rs5012561	chr2:55742032	G/C	cg18811423	chr2:55921094	PNPT1	-0.68	-5.01	-0.49	3.25e-6	Metabolic syndrome;
SKCM	cis	rs57221529	0.766	rs72703065	chr5:588123	C/A	cg26208419	chr5:473447	SLC9A3;LOC25845	1.01	5.18	0.51	1.7e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs561341	0.882	rs504887	chr17:30322881	T/A	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs4819052	1.000	rs2838847	chr21:46670958	G/C	cg20896738	chr21:46707857	POFUT2;LOC642852	0.74	5.35	0.52	8.71e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs1005277	0.502	rs2800484	chr10:38542415	C/T	cg25427524	chr10:38739819	LOC399744	-0.72	-6.99	-0.62	8.31e-10	Extrinsic epigenetic age acceleration;
SKCM	cis	rs8064299	0.574	rs1879455	chr17:72774738	C/G	cg25054828	chr17:72772726	NAT9;TMEM104	0.88	8.46	0.69	1.19e-12	Monocyte count;
SKCM	cis	rs7666738	0.649	rs28865589	chr4:98954279	C/A	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11718455	0.960	rs13060222	chr3:44005046	A/T	cg21419209	chr3:44054225	NA	-0.65	-5.32	-0.52	9.77e-7	Coronary artery disease;
SKCM	cis	rs798554	0.797	rs798497	chr7:2795957	A/G	cg19346786	chr7:2764209	NA	-0.64	-6.81	-0.61	1.79e-9	Height;
SKCM	cis	rs6088580	0.634	rs4277599	chr20:33008905	A/G	cg24642439	chr20:33292090	TP53INP2	-0.73	-5.76	-0.55	1.61e-7	Glomerular filtration rate (creatinine);
SKCM	cis	rs754466	0.580	rs1054608	chr10:79543308	T/G	cg17075019	chr10:79541650	NA	-0.77	-6.91	-0.62	1.18e-9	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs2645694	0.626	rs2703143	chr4:77830441	A/G	cg03477792	chr4:77819574	ANKRD56	0.57	6.42	0.59	9.57e-9	Emphysema distribution in smoking;
SKCM	cis	rs10489202	0.632	rs202259	chr1:167962072	G/A	cg24449463	chr1:168025552	DCAF6	-0.8	-7.62	-0.65	5.14e-11	Schizophrenia;
SKCM	cis	rs7635838	0.617	rs346084	chr3:11281159	C/T	cg00170343	chr3:11313890	ATG7	0.77	5.81	0.55	1.32e-7	HDL cholesterol;
SKCM	cis	rs8067545	0.611	rs12936443	chr17:20033446	T/G	cg13482628	chr17:19912719	NA	0.66	5.61	0.54	2.98e-7	Schizophrenia;
SKCM	cis	rs9325144	0.647	rs11169189	chr12:39097078	A/T	cg13010199	chr12:38710504	ALG10B	-0.62	-5.34	-0.52	8.94e-7	Morning vs. evening chronotype;
SKCM	cis	rs16854884	0.526	rs7643341	chr3:143726980	C/T	cg06585982	chr3:143692056	C3orf58	0.74	6.92	0.62	1.12e-9	Economic and political preferences (feminism/equality);
SKCM	cis	rs11718455	0.881	rs17076257	chr3:44006787	C/T	cg21419209	chr3:44054225	NA	-0.66	-5.41	-0.52	6.81e-7	Coronary artery disease;
SKCM	cis	rs62238980	0.520	rs77155221	chr22:32514092	G/A	cg00543991	chr22:32367038	NA	1.17	4.81	0.48	7.24e-6	Childhood ear infection;
SKCM	cis	rs6835098	1.000	rs10011724	chr4:174088865	A/G	cg08422745	chr4:174089978	GALNT7	-0.87	-6.8	-0.61	1.91e-9	Dementia and core Alzheimer's disease neuropathologic changes;
SKCM	cis	rs10504229	1.000	rs73607875	chr8:58173522	T/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs637571	0.522	rs649000	chr11:65742933	T/C	cg02427764	chr11:65769310	BANF1;EIF1AD	0.76	5.72	0.54	1.87e-7	Eosinophil percentage of white cells;
SKCM	cis	rs875971	0.638	rs35986979	chr7:66088990	G/A	cg11987759	chr7:65425863	GUSB	0.67	5.8	0.55	1.36e-7	Aortic root size;
SKCM	cis	rs35306767	0.903	rs7074642	chr10:878359	A/G	cg26597838	chr10:835615	NA	0.76	5.44	0.52	5.82e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs8067545	0.611	rs10491107	chr17:20188174	C/T	cg13482628	chr17:19912719	NA	0.68	5.76	0.55	1.57e-7	Schizophrenia;
SKCM	cis	rs28386778	0.897	rs2584627	chr17:61901439	T/C	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs9790314	0.747	rs7619011	chr3:160855676	A/G	cg03342759	chr3:160939853	NMD3	-0.64	-6.6	-0.6	4.57e-9	Morning vs. evening chronotype;
SKCM	cis	rs875971	0.862	rs7783779	chr7:65796626	A/G	cg11764359	chr7:65958608	NA	-0.74	-6.75	-0.61	2.36e-9	Aortic root size;
SKCM	cis	rs62238980	0.614	rs4821016	chr22:32402598	T/C	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs11098499	0.820	rs6534140	chr4:120455311	C/T	cg24375607	chr4:120327624	NA	0.68	5.27	0.51	1.16e-6	Corneal astigmatism;
SKCM	cis	rs860295	0.702	rs2175391	chr1:155625602	G/T	cg02153340	chr1:155202674	NA	0.71	5.31	0.52	9.95e-7	Body mass index;
SKCM	cis	rs1218582	0.772	rs6686873	chr1:154913404	C/G	cg06221963	chr1:154839813	KCNN3	-0.54	-5.29	-0.51	1.09e-6	Prostate cancer;
SKCM	cis	rs861020	0.771	rs1962735	chr1:210012102	A/G	cg05527609	chr1:210001259	C1orf107	1.05	8.02	0.67	8.48e-12	Orofacial clefts;
SKCM	cis	rs362296	0.530	rs3129316	chr4:3287906	A/G	cg05297308	chr4:3317976	RGS12	0.86	8.7	0.7	4.13e-13	Parental longevity (mother's age at death);
SKCM	cis	rs4642101	0.561	rs7638333	chr3:12806142	T/C	cg05775895	chr3:12838266	CAND2	0.58	4.82	0.48	6.83e-6	QRS complex (12-leadsum);
SKCM	cis	rs116095464	1.000	rs6555159	chr5:311562	G/A	cg22857025	chr5:266934	NA	-1.64	-6.14	-0.57	3.18e-8	Breast cancer;
SKCM	cis	rs9388451	0.626	rs9385383	chr6:126086290	G/T	cg05901451	chr6:126070800	HEY2	-0.57	-4.83	-0.48	6.74e-6	Brugada syndrome;
SKCM	cis	rs9814567	1.000	rs9829092	chr3:134229866	C/G	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.59	-4.77	-0.48	8.36e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs13118159	0.714	rs6843025	chr4:1334418	C/G	cg20887711	chr4:1340912	KIAA1530	0.71	5.35	0.52	8.56e-7	Longevity;
SKCM	cis	rs16854884	0.837	rs7644767	chr3:143803092	C/G	cg06585982	chr3:143692056	C3orf58	0.72	5.63	0.54	2.78e-7	Economic and political preferences (feminism/equality);
SKCM	cis	rs875971	0.862	rs2420174	chr7:65645361	C/T	cg18876405	chr7:65276391	NA	-0.65	-6.63	-0.6	3.96e-9	Aortic root size;
SKCM	cis	rs16854884	0.586	rs7642551	chr3:143732167	C/T	cg06585982	chr3:143692056	C3orf58	0.87	8.34	0.69	2.04e-12	Economic and political preferences (feminism/equality);
SKCM	cis	rs7809950	0.678	rs17154040	chr7:107005246	C/T	cg23024343	chr7:107201750	COG5	0.78	6.68	0.6	3.19e-9	Coronary artery disease;
SKCM	cis	rs12477438	0.501	rs12992218	chr2:99753834	G/A	cg26064155	chr2:99771622	LIPT1;TSGA10	1.02	9.73	0.74	4.23e-15	Chronic sinus infection;
SKCM	cis	rs17376456	0.542	rs1453003	chr5:93151611	T/C	cg25358565	chr5:93447407	FAM172A	-0.9	-5.8	-0.55	1.37e-7	Diabetic retinopathy;
SKCM	cis	rs2239547	0.523	rs6803486	chr3:53098209	T/A	cg11645453	chr3:52864694	ITIH4	0.62	5.0	0.49	3.5e-6	Schizophrenia;
SKCM	cis	rs11098499	0.698	rs4422403	chr4:120258194	C/T	cg09307838	chr4:120376055	NA	0.96	7.58	0.65	6.04e-11	Corneal astigmatism;
SKCM	cis	rs10504073	0.584	rs4873092	chr8:49974053	T/C	cg00325661	chr8:49890786	NA	0.8	6.81	0.61	1.83e-9	Blood metabolite ratios;
SKCM	cis	rs57221529	0.766	rs72703064	chr5:587825	T/C	cg09888920	chr5:474111	LOC25845;SLC9A3	0.99	4.79	0.48	7.91e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs12477438	0.520	rs2964969	chr2:99782811	G/A	cg14399236	chr2:99771627	LIPT1;TSGA10	0.97	8.9	0.71	1.72e-13	Chronic sinus infection;
SKCM	cis	rs732765	0.608	rs3813555	chr14:75244950	A/G	cg25946216	chr14:74253857	C14orf43	-0.94	-5.23	-0.51	1.36e-6	Non-small cell lung cancer;
SKCM	cis	rs7208859	0.573	rs73267872	chr17:29067207	T/C	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs6977660	1.000	rs10275322	chr7:19821220	C/T	cg05791153	chr7:19748676	TWISTNB	0.79	5.34	0.52	9.05e-7	Thyroid stimulating hormone;
SKCM	cis	rs4132509	1.000	rs6660534	chr1:243791642	A/C	cg21452805	chr1:244014465	NA	0.78	4.99	0.49	3.59e-6	RR interval (heart rate);
SKCM	cis	rs6424115	0.679	rs2076345	chr1:24083494	C/T	cg15997130	chr1:24165203	NA	-0.62	-4.93	-0.49	4.5e-6	Immature fraction of reticulocytes;
SKCM	cis	rs9916302	0.706	rs12950186	chr17:37393395	A/C	cg07936489	chr17:37558343	FBXL20	-0.99	-7.57	-0.65	6.41e-11	Glomerular filtration rate (creatinine);
SKCM	cis	rs9858542	0.953	rs9821311	chr3:49543656	C/T	cg03060546	chr3:49711283	APEH	-0.75	-5.53	-0.53	4.17e-7	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs72781680	0.752	rs72780185	chr2:24003967	G/A	cg08917208	chr2:24149416	ATAD2B	0.92	4.85	0.48	6.19e-6	Lymphocyte counts;
SKCM	cis	rs1707322	1.000	rs11211237	chr1:46447329	G/C	cg03146154	chr1:46216737	IPP	0.79	5.34	0.52	8.73e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs838147	0.873	rs28400014	chr19:49250657	C/G	cg13540341	chr19:49222985	MAMSTR	0.56	4.86	0.48	5.91e-6	Dietary macronutrient intake;
SKCM	cis	rs2204008	0.837	rs7301679	chr12:37989629	T/C	cg13010199	chr12:38710504	ALG10B	-0.62	-4.84	-0.48	6.53e-6	Bladder cancer;
SKCM	cis	rs826838	1.000	rs826891	chr12:39100824	A/G	cg13010199	chr12:38710504	ALG10B	-0.82	-6.28	-0.58	1.77e-8	Heart rate;
SKCM	cis	rs2033711	0.783	rs11671113	chr19:58958087	C/T	cg00825309	chr19:58991885	ZNF446	-0.71	-5.93	-0.56	7.69e-8	Uric acid clearance;
SKCM	cis	rs2288073	1.000	rs6708328	chr2:24412413	A/G	cg06627628	chr2:24431161	ITSN2	-0.83	-5.83	-0.55	1.2e-7	Venous thromboembolism (SNP x SNP interaction);
SKCM	cis	rs1577917	0.958	rs884842	chr6:86680397	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.65	-5.59	-0.54	3.16e-7	Response to antipsychotic treatment;
SKCM	cis	rs362296	0.698	rs3129319	chr4:3265381	A/G	cg21096898	chr4:3318625	RGS12	-0.71	-6.46	-0.59	8.22e-9	Parental longevity (mother's age at death);
SKCM	cis	rs7666738	0.606	rs6839946	chr4:99076132	A/C	cg05340658	chr4:99064831	C4orf37	0.64	4.84	0.48	6.38e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs875971	0.545	rs1267814	chr7:66044409	G/A	cg18876405	chr7:65276391	NA	-0.61	-4.83	-0.48	6.57e-6	Aortic root size;
SKCM	cis	rs9611565	0.659	rs73178641	chr22:41952075	A/T	cg03806693	chr22:41940476	POLR3H	-1.13	-7.48	-0.65	9.6e-11	Vitiligo;
SKCM	cis	rs995000	0.868	rs9787156	chr1:63179212	G/A	cg06896770	chr1:63153194	DOCK7	-0.79	-7.0	-0.62	8.05e-10	Triglyceride levels;
SKCM	cis	rs9549367	0.707	rs9549353	chr13:113843427	G/A	cg18105134	chr13:113819100	PROZ	-0.91	-6.82	-0.61	1.71e-9	Platelet distribution width;
SKCM	cis	rs875971	0.522	rs7784623	chr7:65395034	T/G	cg18876405	chr7:65276391	NA	0.85	7.51	0.65	8.46e-11	Aortic root size;
SKCM	cis	rs1046896	0.514	rs9894705	chr17:80823758	A/C	cg02711726	chr17:80685570	FN3KRP	0.79	5.88	0.55	9.85e-8	Glycated hemoglobin levels;
SKCM	cis	rs9926296	0.605	rs1800287	chr16:89858525	C/G	cg26513180	chr16:89883248	FANCA	0.96	10.61	0.77	8.78e-17	Vitiligo;
SKCM	cis	rs11690935	0.959	rs10206062	chr2:172577276	A/T	cg13550731	chr2:172543902	DYNC1I2	-0.95	-8.21	-0.68	3.64e-12	Schizophrenia;
SKCM	cis	rs7824557	0.527	rs57629785	chr8:11235150	C/A	cg21775007	chr8:11205619	TDH	-0.59	-5.04	-0.5	3e-6	Retinal vascular caliber;
SKCM	cis	rs9611565	0.918	rs9538	chr22:41755857	G/T	cg03806693	chr22:41940476	POLR3H	-0.83	-5.57	-0.53	3.46e-7	Vitiligo;
SKCM	cis	rs2066819	1.000	rs1274493	chr12:56682371	C/T	cg26714650	chr12:56694279	CS	1.71	6.71	0.61	2.74e-9	Psoriasis vulgaris;
SKCM	cis	rs2645694	0.626	rs2703115	chr4:77824442	C/T	cg03477792	chr4:77819574	ANKRD56	0.56	6.25	0.58	2.02e-8	Emphysema distribution in smoking;
SKCM	cis	rs12477438	0.501	rs13008171	chr2:99743419	G/A	cg14399236	chr2:99771627	LIPT1;TSGA10	0.95	8.41	0.69	1.48e-12	Chronic sinus infection;
SKCM	cis	rs12142240	0.621	rs13374968	chr1:46843908	T/G	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs13217239	0.646	rs4583981	chr6:26992023	G/T	cg12292205	chr6:26970375	C6orf41	0.63	5.64	0.54	2.58e-7	Schizophrenia;
SKCM	cis	rs12145833	0.538	rs9803701	chr1:243391634	T/C	cg02356786	chr1:243265016	LOC731275	-1.3	-5.27	-0.51	1.19e-6	Obesity (early onset extreme);
SKCM	cis	rs933688	0.938	rs7705465	chr5:90680949	G/A	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.01	7.62	0.65	5.01e-11	Smoking behavior;
SKCM	cis	rs11892454	0.515	rs10198667	chr2:26020876	T/G	cg17263061	chr2:26915892	KCNK3	0.71	5.13	0.5	2.1e-6	Heschl's gyrus morphology;
SKCM	cis	rs9902453	0.808	rs78154346	chr17:28169493	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.8	5.4	0.52	6.96e-7	Coffee consumption (cups per day);
SKCM	cis	rs11858159	0.528	rs6576332	chr15:24794490	G/C	cg24138476	chr15:25312939	SNORD116-5;SNORD116-7	0.56	4.81	0.48	7.29e-6	Platelet thrombus formation;
SKCM	cis	rs2204008	0.604	rs11172718	chr12:38069819	T/C	cg13010199	chr12:38710504	ALG10B	0.65	5.04	0.5	2.98e-6	Bladder cancer;
SKCM	cis	rs732528	0.501	rs7240170	chr18:48361675	G/A	cg03255741	chr18:48556964	SMAD4	-0.68	-4.95	-0.49	4.23e-6	Entorhinal cortical thickness;
SKCM	cis	rs6138458	0.701	rs6138474	chr20:25012427	T/A	cg26195577	chr20:24973756	C20orf3	0.9	5.92	0.56	8.07e-8	Blood protein levels;
SKCM	cis	rs2404602	0.692	rs57178708	chr15:76904069	T/C	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs7953508	0.506	rs768775	chr12:93968197	T/C	cg18151635	chr12:93972918	NA	-0.65	-5.83	-0.55	1.2e-7	Pubertal anthropometrics;
SKCM	cis	rs2180341	1.000	rs3798852	chr6:127636733	A/G	cg24812749	chr6:127587940	RNF146	0.84	7.25	0.63	2.6e-10	Breast cancer;
SKCM	cis	rs12477438	0.520	rs6708576	chr2:99801308	G/A	cg14399236	chr2:99771627	LIPT1;TSGA10	0.92	7.99	0.67	9.76e-12	Chronic sinus infection;
SKCM	cis	rs10504229	1.000	rs67344620	chr8:58187537	C/A	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs35146811	0.586	rs6946168	chr7:99598286	C/T	cg22906224	chr7:99728672	NA	0.85	6.07	0.57	4.42e-8	Coronary artery disease;
SKCM	cis	rs9325144	0.513	rs12313652	chr12:38665412	G/A	cg26384229	chr12:38710491	ALG10B	-0.69	-5.66	-0.54	2.36e-7	Morning vs. evening chronotype;
SKCM	cis	rs9300255	0.602	rs1727316	chr12:123618603	C/T	cg05973401	chr12:123451056	ABCB9	0.8	5.47	0.53	5.23e-7	Neutrophil percentage of white cells;
SKCM	cis	rs9818758	0.607	rs9837237	chr3:49215583	G/T	cg00383909	chr3:49044727	WDR6	0.94	5.35	0.52	8.49e-7	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs362296	0.698	rs3095072	chr4:3263325	G/A	cg16987761	chr4:3318072	RGS12	-0.7	-6.23	-0.58	2.23e-8	Parental longevity (mother's age at death);
SKCM	cis	rs4423214	0.840	rs1792315	chr11:71165547	C/T	cg05163923	chr11:71159392	DHCR7	-0.74	-6.55	-0.6	5.61e-9	Vitamin D levels;
SKCM	cis	rs1863824	0.625	rs2018507	chr10:88163251	A/G	cg07322936	chr10:88137208	NA	0.59	5.15	0.5	1.91e-6	Schizophrenia;
SKCM	cis	rs1552244	1.000	rs7652935	chr3:10151138	T/C	cg02579736	chr3:10068473	FANCD2;CIDECP	1.23	6.92	0.62	1.13e-9	Alzheimer's disease;
SKCM	cis	rs6502050	0.626	rs11868521	chr17:80100195	T/G	cg13939156	chr17:80058883	NA	0.54	5.07	0.5	2.6e-6	Life satisfaction;
SKCM	cis	rs6547741	0.563	rs10196039	chr2:27971195	C/T	cg27432699	chr2:27873401	GPN1	-0.8	-6.69	-0.6	2.99e-9	Oral cavity cancer;
SKCM	cis	rs11792861	0.926	rs72607170	chr9:111836941	G/A	cg14432460	chr9:111696404	IKBKAP;C9orf6	0.66	4.81	0.48	7.17e-6	Menarche (age at onset);
SKCM	cis	rs2841277	0.616	rs1048257	chr14:105404384	T/C	cg21017887	chr14:105400489	NA	0.59	5.31	0.52	1e-6	Rheumatoid arthritis;
SKCM	cis	rs9611565	0.765	rs132921	chr22:41812044	G/A	cg03806693	chr22:41940476	POLR3H	1.02	6.92	0.62	1.13e-9	Vitiligo;
SKCM	cis	rs1799949	1.000	rs915945	chr17:41179864	C/T	cg25072359	chr17:41440525	NA	0.63	4.88	0.48	5.43e-6	Menopause (age at onset);
SKCM	cis	rs9682041	0.867	rs6444925	chr3:170123358	G/T	cg11886554	chr3:170076028	SKIL	1.01	5.81	0.55	1.29e-7	Glomerular filtration rate in non diabetics (creatinine);Glomerular filtration rate (creatinine);
SKCM	cis	rs2033711	0.870	rs7408188	chr19:58939389	T/G	cg13877915	chr19:58951672	ZNF132	0.95	10.28	0.76	3.6e-16	Uric acid clearance;
SKCM	cis	rs12142240	0.698	rs7548675	chr1:46809321	C/G	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs2075371	0.829	rs35897242	chr7:134004041	G/A	cg20476274	chr7:133979776	SLC35B4	1.01	10.1	0.75	8.14e-16	Mean platelet volume;
SKCM	cis	rs9910055	0.659	rs227578	chr17:42210189	C/A	cg09913183	chr17:42254507	C17orf65;ASB16	-0.68	-6.44	-0.59	8.86e-9	Total body bone mineral density;
SKCM	cis	rs1559088	0.576	rs4805852	chr19:33609441	C/T	cg17764715	chr19:33622953	WDR88	0.94	7.44	0.64	1.11e-10	Bone ultrasound measurement (broadband ultrasound attenuation);
SKCM	cis	rs9399135	0.967	rs13199205	chr6:135286505	T/C	cg24558204	chr6:135376177	HBS1L	0.56	5.07	0.5	2.64e-6	Red blood cell count;
SKCM	cis	rs7191439	0.858	rs4238685	chr16:88775220	T/C	cg02389323	chr16:88786976	FAM38A	1.34	6.31	0.58	1.56e-8	Plateletcrit;
SKCM	cis	rs2404602	0.735	rs437131	chr15:76781051	C/T	cg23625390	chr15:77176239	SCAPER	0.83	8.18	0.68	4.26e-12	Blood metabolite levels;
SKCM	cis	rs2153535	0.580	rs7341381	chr6:8470537	A/G	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs6089584	0.888	rs6061982	chr20:60620673	C/T	cg06108461	chr20:60628389	TAF4	-0.89	-8.72	-0.7	3.75e-13	Body mass index;
SKCM	cis	rs35146811	0.844	rs13232115	chr7:99670932	T/C	cg22906224	chr7:99728672	NA	0.82	6.34	0.58	1.37e-8	Coronary artery disease;
SKCM	cis	rs9300255	0.722	rs67624109	chr12:123824635	C/T	cg05973401	chr12:123451056	ABCB9	-0.82	-5.72	-0.54	1.92e-7	Neutrophil percentage of white cells;
SKCM	cis	rs6840360	0.593	rs10033405	chr4:152474489	A/G	cg22705602	chr4:152727874	NA	-0.51	-5.78	-0.55	1.48e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs8072100	0.967	rs11871606	chr17:45732774	G/T	cg25173405	chr17:45401733	C17orf57	0.57	5.13	0.5	2.07e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs507080	0.845	rs481903	chr11:118567733	T/C	cg18045108	chr11:118530628	TREH	-0.45	-4.92	-0.49	4.68e-6	Serum metabolite levels;
SKCM	cis	rs2963155	0.518	rs6196	chr5:142661490	A/G	cg17617527	chr5:142782415	NR3C1	1.05	4.88	0.48	5.42e-6	Breast cancer;
SKCM	cis	rs754466	0.580	rs12354903	chr10:79536465	T/C	cg17075019	chr10:79541650	NA	-0.78	-6.94	-0.62	1e-9	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs752010	0.619	rs1123483	chr1:42114198	C/T	cg06885757	chr1:42089581	HIVEP3	-0.57	-6.42	-0.59	9.79e-9	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs73001065	0.551	rs79954596	chr19:19548643	T/G	cg03709012	chr19:19516395	GATAD2A	1.14	5.41	0.52	6.76e-7	LDL cholesterol;
SKCM	cis	rs3784262	0.692	rs4646581	chr15:58307898	C/A	cg12031962	chr15:58353849	ALDH1A2	-0.42	-4.89	-0.48	5.38e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs6570726	0.791	rs414297	chr6:145887556	C/T	cg23711669	chr6:146136114	FBXO30	0.86	9.05	0.72	8.81e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs860295	0.702	rs5005770	chr1:155345043	C/T	cg02153340	chr1:155202674	NA	0.77	5.48	0.53	4.96e-7	Body mass index;
SKCM	cis	rs9902453	0.791	rs6505141	chr17:27998187	T/A	cg26525008	chr17:28256777	EFCAB5;SSH2	0.79	5.94	0.56	7.41e-8	Coffee consumption (cups per day);
SKCM	cis	rs4819052	1.000	rs2297284	chr21:46705345	G/A	cg20896738	chr21:46707857	POFUT2;LOC642852	0.77	5.53	0.53	4.05e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7216064	1.000	rs6504549	chr17:65888784	A/G	cg12091567	chr17:66097778	LOC651250	-0.76	-5.42	-0.52	6.34e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs9325144	0.560	rs11182930	chr12:38633693	A/T	cg26384229	chr12:38710491	ALG10B	-0.68	-5.43	-0.52	6.19e-7	Morning vs. evening chronotype;
SKCM	cis	rs1552244	1.000	rs35993975	chr3:10067794	A/G	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs5753618	0.504	rs5753671	chr22:31910734	T/C	cg02404636	chr22:31891804	SFI1	0.68	6.03	0.56	5.13e-8	Colorectal cancer;
SKCM	cis	rs62244186	0.535	rs59726036	chr3:44850074	G/T	cg18165381	chr3:44552316	NA	-0.62	-4.77	-0.47	8.51e-6	Depressive symptoms;
SKCM	cis	rs250585	0.667	rs449499	chr16:23599013	G/A	cg09934309	chr16:23461721	COG7	-0.94	-6.18	-0.57	2.76e-8	Egg allergy;
SKCM	cis	rs4891159	0.548	rs654754	chr18:74143695	T/C	cg24786174	chr18:74118243	ZNF516	0.78	7.91	0.67	1.44e-11	Longevity;
SKCM	cis	rs5753618	0.583	rs2273251	chr22:31843567	G/C	cg02404636	chr22:31891804	SFI1	0.59	5.05	0.5	2.79e-6	Colorectal cancer;
SKCM	cis	rs7945705	0.870	rs4929922	chr11:8975776	A/G	cg21881798	chr11:8931708	C11orf17;ST5	-0.73	-7.05	-0.62	6.41e-10	Hemoglobin concentration;
SKCM	cis	rs41369048	0.502	rs75336590	chr1:221069847	A/G	cg03536711	chr1:221509067	LOC400804	0.54	5.0	0.49	3.43e-6	Sum eosinophil basophil counts;Eosinophil counts;
SKCM	cis	rs1801251	0.963	rs283481	chr2:233648091	A/G	cg25237894	chr2:233734115	C2orf82	0.65	5.82	0.55	1.22e-7	Coronary artery disease;
SKCM	cis	rs6088580	0.634	rs6058073	chr20:33116483	T/C	cg24642439	chr20:33292090	TP53INP2	0.76	6.02	0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs10871290	0.650	rs3760055	chr16:74490529	G/A	cg01733217	chr16:74700730	RFWD3	0.91	6.7	0.6	2.95e-9	Breast cancer;
SKCM	cis	rs28374715	0.635	rs28557159	chr15:41657353	T/C	cg18705301	chr15:41695430	NDUFAF1	-1.05	-10.64	-0.77	7.53e-17	Ulcerative colitis;
SKCM	cis	rs1568889	0.592	rs7110074	chr11:28469325	G/T	cg06544937	chr11:28130018	METT5D1;KIF18A	0.9	5.47	0.53	5.18e-7	Bipolar disorder;
SKCM	cis	rs12142240	0.698	rs10158130	chr1:46822600	T/C	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs28386778	0.897	rs8079818	chr17:61824667	C/G	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.36	0.52	8.06e-7	Prudent dietary pattern;
SKCM	cis	rs7772486	0.790	rs2814880	chr6:146208937	T/G	cg23711669	chr6:146136114	FBXO30	0.76	7.55	0.65	7.1e-11	Lobe attachment (rater-scored or self-reported);
SKCM	trans	rs7618501	0.735	rs9876508	chr3:49780844	G/A	cg21659725	chr3:3221576	CRBN	-0.96	-9.61	-0.74	7.08e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs1799949	0.965	rs4793204	chr17:41279298	A/G	cg05368731	chr17:41323189	NBR1	0.89	7.91	0.67	1.38e-11	Menopause (age at onset);
SKCM	cis	rs7824557	0.602	rs7817658	chr8:11206543	A/G	cg21775007	chr8:11205619	TDH	0.72	6.4	0.59	1.09e-8	Retinal vascular caliber;
SKCM	cis	rs1401999	0.864	rs4148563	chr3:183725999	T/C	cg01324343	chr3:183735012	ABCC5	0.88	10.48	0.76	1.5e-16	Anterior chamber depth;
SKCM	cis	rs1801251	1.000	rs1022330	chr2:233577330	G/A	cg25237894	chr2:233734115	C2orf82	0.61	5.66	0.54	2.39e-7	Coronary artery disease;
SKCM	cis	rs7552404	0.920	rs1612097	chr1:76218875	C/T	cg03433033	chr1:76189801	ACADM	0.76	5.41	0.52	6.62e-7	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs2836950	0.545	rs8132143	chr21:40584258	A/T	cg11644478	chr21:40555479	PSMG1	-0.64	-5.02	-0.49	3.17e-6	Menarche (age at onset);
SKCM	cis	rs1865760	0.534	rs2032444	chr6:26046744	T/G	cg16482183	chr6:26056742	HIST1H1C	0.67	5.45	0.53	5.68e-7	Height;
SKCM	cis	rs4727027	0.901	rs1534198	chr7:148772323	T/C	cg23583168	chr7:148888333	NA	-0.81	-6.31	-0.58	1.57e-8	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs34779708	0.900	rs73262807	chr10:35496386	C/T	cg03585969	chr10:35415529	CREM	0.78	6.27	0.58	1.87e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs4268898	0.610	rs72791170	chr2:24449776	C/T	cg06627628	chr2:24431161	ITSN2	-0.94	-7.34	-0.64	1.73e-10	Asthma;
SKCM	cis	rs1577917	0.740	rs6926049	chr6:86266133	G/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.98	10.89	0.78	2.49e-17	Response to antipsychotic treatment;
SKCM	cis	rs6580649	0.941	rs7957764	chr12:48429701	C/T	cg05342945	chr12:48394962	COL2A1	0.7	5.24	0.51	1.33e-6	Lung cancer;
SKCM	cis	rs58688157	0.549	rs11246192	chr11:572473	T/C	cg16486109	chr11:613632	IRF7	0.9	5.56	0.53	3.7e-7	Systemic lupus erythematosus;
SKCM	cis	rs11098499	0.866	rs6824111	chr4:120285968	T/A	cg09307838	chr4:120376055	NA	0.98	7.89	0.67	1.52e-11	Corneal astigmatism;
SKCM	cis	rs7824557	0.628	rs7005469	chr8:11194457	G/A	cg21775007	chr8:11205619	TDH	0.72	6.73	0.61	2.51e-9	Retinal vascular caliber;
SKCM	cis	rs362272	0.524	rs13150241	chr4:3367281	A/G	cg16987761	chr4:3318072	RGS12	1.01	11.83	0.8	4.37e-19	Serum sulfate level;
SKCM	cis	rs4346635	0.554	rs2055177	chr4:81844526	A/G	cg07982899	chr4:81307586	C4orf22	-0.65	-4.88	-0.48	5.48e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs453301	0.624	rs7014430	chr8:8827737	T/G	cg06636001	chr8:8085503	FLJ10661	0.77	5.55	0.53	3.86e-7	Joint mobility (Beighton score);
SKCM	cis	rs8042680	0.554	rs8031684	chr15:91527451	T/A	cg15878949	chr15:91534302	PRC1	0.58	4.87	0.48	5.82e-6	Type 2 diabetes;
SKCM	cis	rs754466	0.580	rs10430529	chr10:79582623	C/A	cg17075019	chr10:79541650	NA	-0.81	-7.17	-0.63	3.73e-10	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs3096299	0.874	rs3102342	chr16:89451575	T/C	cg02187348	chr16:89574699	SPG7	0.63	5.0	0.49	3.41e-6	Multiple myeloma (IgH translocation);
SKCM	trans	rs12599106	0.707	rs2163977	chr16:34916134	A/G	cg15383120	chr6:291909	DUSP22	-0.75	-7.36	-0.64	1.6e-10	Menopause (age at onset);
SKCM	cis	rs7772486	0.754	rs9386134	chr6:146145508	G/A	cg23711669	chr6:146136114	FBXO30	0.87	9.66	0.74	5.79e-15	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1799949	1.000	rs8077486	chr17:41212805	C/T	cg25072359	chr17:41440525	NA	0.63	4.84	0.48	6.44e-6	Menopause (age at onset);
SKCM	cis	rs2836974	0.965	rs7354783	chr21:40652992	G/A	cg17971929	chr21:40555470	PSMG1	0.9	8.87	0.71	1.93e-13	Cognitive function;
SKCM	cis	rs362272	0.505	rs60208975	chr4:3364530	A/G	cg16987761	chr4:3318072	RGS12	0.95	10.68	0.77	6.3e-17	Serum sulfate level;
SKCM	cis	rs7216064	0.906	rs8074644	chr17:65878217	G/C	cg12091567	chr17:66097778	LOC651250	-0.75	-5.27	-0.51	1.19e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs6840360	0.615	rs2120098	chr4:152457180	T/A	cg22705602	chr4:152727874	NA	-0.51	-5.78	-0.55	1.45e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs9926296	0.585	rs6500441	chr16:89828669	C/G	cg26513180	chr16:89883248	FANCA	0.97	11.69	0.8	8.03e-19	Vitiligo;
SKCM	cis	rs4919087	1.000	rs10882898	chr10:99087330	G/A	cg25902810	chr10:99078978	FRAT1	-0.62	-4.96	-0.49	4.06e-6	Monocyte count;
SKCM	cis	rs1799949	0.930	rs3765640	chr17:41276247	A/G	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.11	-0.57	3.67e-8	Menopause (age at onset);
SKCM	cis	rs10540	1.000	rs61876333	chr11:487136	G/A	cg03352830	chr11:487213	PTDSS2	1.05	4.95	0.49	4.23e-6	Body mass index;
SKCM	cis	rs6834538	0.597	rs9307383	chr4:113529834	C/T	cg05166686	chr4:113558556	LARP7;C4orf21	0.63	5.2	0.51	1.56e-6	Free thyroxine concentration;
SKCM	cis	rs9393692	0.645	rs766406	chr6:26319588	G/T	cg00631329	chr6:26305371	NA	-0.7	-4.84	-0.48	6.33e-6	Educational attainment;
SKCM	cis	rs4665809	0.590	rs6730317	chr2:26419482	C/T	cg04944784	chr2:26401820	FAM59B	-0.78	-5.02	-0.49	3.24e-6	Gut microbiome composition (summer);
SKCM	cis	rs11122272	0.733	rs2749700	chr1:231522734	A/G	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	-0.64	-5.31	-0.52	9.86e-7	Hemoglobin concentration;
SKCM	cis	rs9611565	0.592	rs5758427	chr22:42099688	A/G	cg03806693	chr22:41940476	POLR3H	1.08	6.67	0.6	3.27e-9	Vitiligo;
SKCM	cis	rs2841277	0.741	rs9672139	chr14:105408182	T/G	cg14403583	chr14:105418241	AHNAK2	-0.89	-6.84	-0.61	1.57e-9	Rheumatoid arthritis;
SKCM	cis	rs9814567	1.000	rs7645295	chr3:134307734	T/G	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.6	-4.79	-0.48	7.68e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs57221529	0.766	rs72703075	chr5:592819	C/T	cg09888920	chr5:474111	LOC25845;SLC9A3	1.03	4.83	0.48	6.65e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs34375054	0.660	rs12305181	chr12:125594156	C/A	cg25124228	chr12:125621409	AACS	-0.68	-4.98	-0.49	3.66e-6	Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs1348850	0.846	rs4893962	chr2:178421106	A/G	cg02961200	chr2:178257176	LOC100130691;AGPS	0.78	5.98	0.56	6.25e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs1355223	0.583	rs2116085	chr11:34884001	C/A	cg11058730	chr11:34937778	PDHX;APIP	0.63	5.08	0.5	2.5e-6	Systemic lupus erythematosus and Systemic sclerosis;
SKCM	cis	rs8072100	0.738	rs9900123	chr17:45549055	T/C	cg08085267	chr17:45401833	C17orf57	-0.64	-5.2	-0.51	1.54e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs763121	0.853	rs3788545	chr22:39065172	A/G	cg06022373	chr22:39101656	GTPBP1	0.78	5.38	0.52	7.72e-7	Menopause (age at onset);
SKCM	cis	rs2072510	0.683	rs2246972	chr12:96427889	C/T	cg18817487	chr12:96390143	HAL	0.4	5.21	0.51	1.51e-6	Metabolite levels (small molecules and protein measures);
SKCM	cis	rs6088580	0.634	rs6142153	chr20:32968747	C/G	cg24642439	chr20:33292090	TP53INP2	-0.76	-6.02	-0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs7811142	0.943	rs67483801	chr7:100031758	G/T	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.34	0.69	2.1e-12	Platelet count;
SKCM	cis	rs593982	1.000	rs56257941	chr11:65505641	C/T	cg08755490	chr11:65554678	OVOL1	-0.95	-7.42	-0.64	1.22e-10	Atopic dermatitis;
SKCM	cis	rs6430585	0.583	rs3769012	chr2:136556480	C/T	cg07169764	chr2:136633963	MCM6	1.25	11.45	0.79	2.26e-18	Corneal structure;
SKCM	cis	rs4891159	0.790	rs8085133	chr18:74144083	A/C	cg24786174	chr18:74118243	ZNF516	-0.73	-7.08	-0.63	5.49e-10	Longevity;
SKCM	cis	rs9943753	0.525	rs7952909	chr12:109808573	A/T	cg19025524	chr12:109796872	NA	0.61	5.64	0.54	2.57e-7	HDL cholesterol;
SKCM	cis	rs155076	1.000	rs12870992	chr13:21846019	A/G	cg11317459	chr13:21872234	NA	1.24	6.91	0.62	1.19e-9	White matter hyperintensity burden;
SKCM	cis	rs7666738	0.830	rs7661264	chr4:98961574	G/A	cg17366294	chr4:99064904	C4orf37	0.59	4.89	0.48	5.36e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9733	0.791	rs11204693	chr1:150647987	C/T	cg13175981	chr1:150552382	MCL1	0.64	4.95	0.49	4.17e-6	Tonsillectomy;
SKCM	cis	rs11098499	0.754	rs7672594	chr4:120248543	A/C	cg09307838	chr4:120376055	NA	0.93	7.56	0.65	6.5500000000000006e-11	Corneal astigmatism;
SKCM	cis	rs4683346	0.963	rs10865924	chr3:42894427	C/G	cg06399164	chr3:42695035	ZBTB47	0.62	5.8	0.55	1.35e-7	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs2370759	0.945	rs10508773	chr10:32575444	C/T	cg01819863	chr10:32635814	EPC1	1.05	5.81	0.55	1.27e-7	Sexual dysfunction (female);
SKCM	cis	rs7824557	0.592	rs2572371	chr8:11223793	G/T	cg21775007	chr8:11205619	TDH	0.63	5.94	0.56	7.63e-8	Retinal vascular caliber;
SKCM	cis	rs801193	0.569	rs13226966	chr7:66233623	A/G	cg18876405	chr7:65276391	NA	0.61	6.04	0.56	4.98e-8	Aortic root size;
SKCM	cis	rs6580649	0.598	rs1793913	chr12:48387025	T/A	cg05342945	chr12:48394962	COL2A1	-0.7	-4.92	-0.49	4.65e-6	Lung cancer;
SKCM	cis	rs2188420	0.872	rs75576923	chr7:106558358	C/T	cg23615938	chr7:105753134	SYPL1	-0.95	-5.14	-0.5	1.96e-6	Interferon gamma levels;
SKCM	trans	rs3780486	0.505	rs10813959	chr9:33166234	C/T	cg20290983	chr6:43655470	MRPS18A	-0.91	-9.86	-0.74	2.35e-15	IgG glycosylation;
SKCM	cis	rs801193	1.000	rs2707854	chr7:66212597	G/A	cg11764359	chr7:65958608	NA	0.86	6.55	0.6	5.68e-9	Aortic root size;
SKCM	cis	rs1403694	0.515	rs1648700	chr3:186449916	C/T	cg09332604	chr3:186435400	KNG1	0.53	5.16	0.5	1.85e-6	Blood protein levels;
SKCM	cis	rs910316	0.967	rs35446981	chr14:75637351	A/T	cg08847533	chr14:75593920	NEK9	-0.95	-8.8	-0.71	2.64e-13	Height;
SKCM	cis	rs798554	0.683	rs1636264	chr7:2864586	G/T	cg04166393	chr7:2884313	GNA12	0.76	5.23	0.51	1.39e-6	Height;
SKCM	cis	rs1639906	0.708	rs3779013	chr7:2210844	A/G	cg21782813	chr7:2030301	MAD1L1	0.52	4.95	0.49	4.13e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs13118159	0.934	rs2878608	chr4:1354286	C/G	cg02018176	chr4:1364513	KIAA1530	0.62	4.79	0.48	7.81e-6	Longevity;
SKCM	cis	rs11690935	1.000	rs312925	chr2:172563922	G/A	cg13550731	chr2:172543902	DYNC1I2	-0.95	-8.21	-0.68	3.64e-12	Schizophrenia;
SKCM	cis	rs4724125	0.920	rs10499630	chr7:42723953	T/A	cg09407816	chr7:42972088	MRPL32;PSMA2	0.79	4.94	0.49	4.34e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs78456975	0.739	rs72776248	chr2:1521314	A/G	cg01028140	chr2:1542097	TPO	-0.56	-5.02	-0.49	3.16e-6	Placebo response in major depressive disorder (% change in symptom score);
SKCM	cis	rs7615952	0.736	rs9862893	chr3:125686974	A/G	cg05084668	chr3:125655381	ALG1L	-1.33	-6.97	-0.62	9.12e-10	Blood pressure (smoking interaction);
SKCM	cis	rs6582630	0.555	rs7301250	chr12:38596244	G/T	cg26384229	chr12:38710491	ALG10B	0.78	6.45	0.59	8.67e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs548181	0.668	rs540555	chr11:125486848	T/C	cg03464685	chr11:125439445	EI24	1.41	8.27	0.68	2.84e-12	Schizophrenia;Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);
SKCM	cis	rs561341	1.000	rs506766	chr17:30289659	T/C	cg00745463	chr17:30367425	LRRC37B	-1.09	-7.35	-0.64	1.67e-10	Hip circumference adjusted for BMI;
SKCM	cis	rs2153535	0.601	rs6906170	chr6:8543128	T/A	cg07606381	chr6:8435919	SLC35B3	0.9	6.17	0.57	2.82e-8	Motion sickness;
SKCM	cis	rs2204008	0.606	rs1581358	chr12:38391582	G/T	cg13010199	chr12:38710504	ALG10B	0.69	4.89	0.48	5.2e-6	Bladder cancer;
SKCM	cis	rs703842	1.000	rs3825079	chr12:58203354	C/T	cg04478727	chr12:58166393	METTL1;FAM119B	0.72	5.78	0.55	1.48e-7	Multiple sclerosis;
SKCM	cis	rs651907	0.557	rs62284198	chr3:101474699	G/A	cg12386194	chr3:101231763	SENP7	0.66	5.4	0.52	6.96e-7	Colorectal cancer;
SKCM	cis	rs2413583	0.591	rs17000981	chr22:39708017	C/T	cg17798944	chr22:39715225	SNORD43;RPL3	0.92	5.12	0.5	2.12e-6	Ulcerative colitis;Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs116095464	0.558	rs2162870	chr5:228129	G/A	cg22496380	chr5:211416	CCDC127	-0.95	-5.22	-0.51	1.42e-6	Breast cancer;
SKCM	cis	rs1784581	0.894	rs1626020	chr6:162383379	G/A	cg17173639	chr6:162384350	PARK2	-0.61	-5.37	-0.52	7.81e-7	Itch intensity from mosquito bite;
SKCM	cis	rs9910055	0.762	rs227579	chr17:42223134	A/T	cg09913183	chr17:42254507	C17orf65;ASB16	-0.69	-6.31	-0.58	1.55e-8	Total body bone mineral density;
SKCM	cis	rs908922	0.676	rs4845782	chr1:152492225	A/G	cg09873164	chr1:152488093	CRCT1	0.76	5.94	0.56	7.4e-8	Hair morphology;
SKCM	cis	rs9913156	0.517	rs2326118	chr17:4611851	C/T	cg19197139	chr17:4613644	ARRB2	0.62	4.79	0.48	7.88e-6	Lymphocyte counts;
SKCM	cis	rs1799949	0.965	rs33961729	chr17:41287924	C/A	cg05368731	chr17:41323189	NBR1	0.89	7.91	0.67	1.38e-11	Menopause (age at onset);
SKCM	cis	rs7633770	0.769	rs2385858	chr3:46660436	T/C	cg11219411	chr3:46661640	NA	0.72	6.95	0.62	9.76e-10	Coronary artery disease;
SKCM	cis	rs12142240	0.731	rs6681857	chr1:46850124	T/C	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs10197940	0.967	rs4664423	chr2:152266311	T/C	cg06191203	chr2:152266755	RIF1	-0.64	-4.85	-0.48	6.28e-6	Lung cancer;
SKCM	cis	rs12780845	1.000	rs7921162	chr10:17229004	A/G	cg07990022	chr10:16570110	NA	-0.62	-4.89	-0.48	5.28e-6	Homocysteine levels;
SKCM	cis	rs2032447	0.507	rs199748	chr6:25909045	C/G	cg12310025	chr6:25882481	NA	-0.69	-6.23	-0.58	2.23e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs244731	0.959	rs11740250	chr5:176721272	G/C	cg16006841	chr5:176797999	RGS14	0.79	6.27	0.58	1.87e-8	Urate levels in lean individuals;
SKCM	cis	rs10832963	1.000	rs10832956	chr11:18645668	A/G	cg20219074	chr11:18656078	SPTY2D1	0.8	6.7	0.6	2.86e-9	Breast cancer;
SKCM	cis	rs2439831	1.000	rs2439841	chr15:43734749	G/A	cg02155558	chr15:43621948	ADAL;LCMT2	1.12	8.05	0.67	7.58e-12	Lung cancer in ever smokers;
SKCM	cis	rs875971	0.638	rs6460305	chr7:66060408	G/A	cg11987759	chr7:65425863	GUSB	0.67	5.8	0.55	1.36e-7	Aortic root size;
SKCM	cis	rs4780401	0.527	rs4780402	chr16:11839809	C/T	cg01061890	chr16:11836724	TXNDC11	-0.67	-4.89	-0.48	5.35e-6	Rheumatoid arthritis;
SKCM	cis	rs11098499	0.690	rs7674713	chr4:120322257	T/C	cg24375607	chr4:120327624	NA	0.64	4.94	0.49	4.33e-6	Corneal astigmatism;
SKCM	cis	rs362296	0.511	rs2051558	chr4:3324886	G/A	cg24015175	chr4:3319247	RGS12	0.74	8.67	0.7	4.69e-13	Parental longevity (mother's age at death);
SKCM	cis	rs6570726	0.791	rs6902404	chr6:145905254	G/A	cg23711669	chr6:146136114	FBXO30	0.8	7.56	0.65	6.66e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs13108904	0.604	rs11946375	chr4:1313488	T/C	cg02018176	chr4:1364513	KIAA1530	0.63	4.84	0.48	6.31e-6	Obesity-related traits;
SKCM	cis	rs1153858	1.000	rs9788780	chr15:45685487	T/A	cg21132104	chr15:45694354	SPATA5L1	0.89	7.21	0.63	3.12e-10	Homoarginine levels;
SKCM	cis	rs2153535	0.580	rs1414346	chr6:8471574	A/G	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs4925386	0.840	rs6143036	chr20:60921721	C/A	cg24112000	chr20:60950667	NA	-0.74	-7.01	-0.62	7.4e-10	Colorectal cancer;Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs28386778	0.704	rs1051688	chr17:62006433	G/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	-0.78	-6.42	-0.59	9.64e-9	Prudent dietary pattern;
SKCM	cis	rs711830	1.000	rs1051929	chr2:177036754	T/C	cg13092806	chr2:177043255	NA	0.67	6.15	0.57	3.04e-8	Serous invasive ovarian cancer;Epithelial ovarian cancer;Invasive epithelial ovarian cancer;Mucinous ovarian carcinoma;Low-grade serous and serous borderline ovarian cancer;Serous borderline ovarian cancer;High-grade serous ovarian cancer;
SKCM	cis	rs7523050	0.730	rs11102650	chr1:109464228	C/G	cg08274380	chr1:109419600	GPSM2	1.06	6.5	0.59	6.89e-9	Fat distribution (HIV);
SKCM	cis	rs2204008	0.775	rs3900361	chr12:38238936	A/G	cg26384229	chr12:38710491	ALG10B	-0.86	-7.18	-0.63	3.58e-10	Bladder cancer;
SKCM	cis	rs9583531	0.574	rs7319459	chr13:111352408	T/C	cg24331049	chr13:111365604	ING1	-0.82	-5.52	-0.53	4.29e-7	Coronary artery disease;
SKCM	cis	rs10752881	1.000	rs12028740	chr1:182985581	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.73	6.47	0.59	7.97e-9	Colorectal cancer;
SKCM	cis	rs2204008	0.701	rs3898237	chr12:38219714	A/G	cg13010199	chr12:38710504	ALG10B	0.65	4.84	0.48	6.52e-6	Bladder cancer;
SKCM	cis	rs769267	0.930	rs4808965	chr19:19631655	A/G	cg26732615	chr19:19648335	CILP2;YJEFN3	0.67	7.06	0.62	6e-10	Tonsillectomy;
SKCM	cis	rs910316	1.000	rs10873275	chr14:75531460	A/T	cg08847533	chr14:75593920	NEK9	0.95	9.18	0.72	4.8e-14	Height;
SKCM	cis	rs10754283	0.967	rs10737706	chr1:90112579	G/T	cg21401794	chr1:90099060	LRRC8C	0.73	6.31	0.58	1.57e-8	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs9325144	0.647	rs7316392	chr12:39064381	T/G	cg26384229	chr12:38710491	ALG10B	-0.7	-6.07	-0.57	4.27e-8	Morning vs. evening chronotype;
SKCM	cis	rs1801251	1.000	rs6437074	chr2:233712296	C/T	cg25237894	chr2:233734115	C2orf82	-0.56	-5.33	-0.52	9.23e-7	Coronary artery disease;
SKCM	cis	rs7659604	0.521	rs13130789	chr4:122690166	G/A	cg19671926	chr4:122722719	EXOSC9	0.76	6.84	0.61	1.57e-9	Type 2 diabetes;
SKCM	cis	rs870825	0.616	rs6552807	chr4:185640531	A/G	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs3087591	0.960	rs11080146	chr17:29578724	C/T	cg24425628	chr17:29625626	OMG;NF1	-0.63	-5.04	-0.5	3e-6	Hip circumference;
SKCM	trans	rs10506458	1.000	rs10506458	chr12:63445092	G/A	cg03429785	chr15:59498649	MYO1E;LDHAL6B	-1.38	-7.54	-0.65	7.13e-11	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs2658782	0.654	rs2605620	chr11:93247646	C/T	cg15737290	chr11:93063684	CCDC67	0.73	4.87	0.48	5.77e-6	Pulmonary function decline;
SKCM	cis	rs28386778	0.897	rs2665797	chr17:61922485	C/G	cg23090583	chr17:61904693	PSMC5;FTSJ3	-1.1	-11.09	-0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs9581857	0.725	rs117947621	chr13:28022267	T/C	cg22138327	chr13:27999177	GTF3A	0.93	6.24	0.58	2.1e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs6545883	0.894	rs7566035	chr2:61520815	C/T	cg15711740	chr2:61764176	XPO1	0.68	4.82	0.48	6.94e-6	Tuberculosis;
SKCM	cis	rs801193	0.967	rs2707849	chr7:66152712	T/C	cg11764359	chr7:65958608	NA	0.86	6.6	0.6	4.52e-9	Aortic root size;
SKCM	cis	rs6815814	0.950	rs11727978	chr4:38811051	T/A	cg02016764	chr4:38805732	TLR1	-0.77	-5.49	-0.53	4.78e-7	Breast cancer;
SKCM	cis	rs10504229	0.683	rs61241336	chr8:58106585	A/G	cg02725872	chr8:58115012	NA	-0.53	-4.91	-0.49	4.82e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs1577917	1.000	rs12212733	chr6:86726013	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.83	-8.07	-0.67	6.96e-12	Response to antipsychotic treatment;
SKCM	cis	rs1256061	0.624	rs1256046	chr14:64729356	A/C	cg21174375	chr14:64681225	SYNE2	0.47	4.95	0.49	4.15e-6	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs2235573	0.625	rs1883471	chr22:38417510	T/C	cg03683946	chr22:38051826	SH3BP1	-0.48	-4.83	-0.48	6.79e-6	Glioblastoma;Glioma;
SKCM	cis	rs939658	0.683	rs8041222	chr15:79465549	A/G	cg10259521	chr15:79428573	NA	0.49	5.07	0.5	2.6e-6	Refractive error;
SKCM	cis	rs875971	0.929	rs4122249	chr7:65920936	T/C	cg12463550	chr7:65579703	CRCP	0.58	4.87	0.48	5.67e-6	Aortic root size;
SKCM	cis	rs7772486	0.566	rs735536	chr6:146036832	A/C	cg05347473	chr6:146136440	FBXO30	-0.56	-4.99	-0.49	3.55e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs77106637	1.000	rs79430446	chr11:72474004	G/T	cg03713592	chr11:72463424	ARAP1	1.09	5.58	0.53	3.41e-7	Type 2 diabetes;
SKCM	cis	rs6977660	1.000	rs13237667	chr7:19820288	G/C	cg05791153	chr7:19748676	TWISTNB	0.79	5.34	0.52	9.05e-7	Thyroid stimulating hormone;
SKCM	cis	rs2033711	0.755	rs4801587	chr19:58936679	C/A	cg13877915	chr19:58951672	ZNF132	0.95	10.28	0.76	3.74e-16	Uric acid clearance;
SKCM	cis	rs12478296	0.792	rs57482298	chr2:243011148	C/A	cg06360820	chr2:242988706	NA	-1.12	-5.57	-0.53	3.55e-7	Obesity-related traits;
SKCM	cis	rs4481887	1.000	rs7513161	chr1:248453422	A/T	cg00666640	chr1:248458726	OR2T12	0.58	4.83	0.48	6.68e-6	Common traits (Other);
SKCM	cis	rs7215564	0.818	rs4890054	chr17:78587195	C/T	cg16980736	chr17:78789706	RPTOR	-0.89	-4.87	-0.48	5.8e-6	Myopia (pathological);
SKCM	cis	rs7208859	0.524	rs59913838	chr17:29101563	A/T	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs2832191	0.791	rs9983651	chr21:30491227	T/A	cg24692254	chr21:30365293	RNF160	-0.9	-8.03	-0.67	8.39e-12	Dental caries;
SKCM	cis	rs33794	0.901	rs28213	chr3:45290708	A/G	cg25630594	chr3:44914870	TGM4	0.58	5.06	0.5	2.7e-6	Lung function (forced expiratory volume in 1 second);
SKCM	cis	rs4332037	0.624	rs11764337	chr7:1892309	A/G	cg23422044	chr7:1970798	MAD1L1	0.85	5.72	0.54	1.91e-7	Bipolar disorder;
SKCM	cis	rs7843479	0.601	rs3824338	chr8:21864540	A/C	cg17168535	chr8:21777572	XPO7	0.79	7.46	0.65	1.06e-10	Mean corpuscular volume;
SKCM	cis	rs875971	0.508	rs10950045	chr7:66066373	T/C	cg11764359	chr7:65958608	NA	-0.79	-5.88	-0.55	9.67e-8	Aortic root size;
SKCM	cis	rs13118159	0.509	rs10023473	chr4:1375285	C/T	cg20887711	chr4:1340912	KIAA1530	0.89	6.72	0.61	2.69e-9	Longevity;
SKCM	cis	rs9325144	0.647	rs12822023	chr12:39097964	T/C	cg13010199	chr12:38710504	ALG10B	-0.64	-5.44	-0.52	6.02e-7	Morning vs. evening chronotype;
SKCM	trans	rs1814175	0.781	rs1851872	chr11:50009770	A/G	cg15704280	chr7:45808275	SEPT13	-1.05	-11.07	-0.78	1.14e-17	Height;
SKCM	cis	rs3008870	0.958	rs34367328	chr1:67445321	T/C	cg08660285	chr1:67390436	MIER1;WDR78	-0.92	-6.07	-0.57	4.27e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs7666738	0.830	rs2903152	chr4:99067992	A/G	cg05340658	chr4:99064831	C4orf37	0.66	4.87	0.48	5.74e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4919694	1.000	rs12257941	chr10:104833161	C/T	cg04362960	chr10:104952993	NT5C2	0.76	4.92	0.49	4.65e-6	Arsenic metabolism;
SKCM	cis	rs867186	1.000	rs7261312	chr20:33684909	A/T	cg04194272	chr20:33683537	NA	-1.21	-6.8	-0.61	1.89e-9	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs2228479	0.681	rs7199685	chr16:89959805	G/C	cg06558623	chr16:89946397	TCF25	1.25	7.18	0.63	3.53e-10	Skin colour saturation;
SKCM	cis	rs6840360	0.615	rs12647465	chr4:152607318	C/A	cg22705602	chr4:152727874	NA	-0.58	-7.78	-0.66	2.55e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs28386778	0.897	rs1062791	chr17:61896487	C/T	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.54	0.53	3.91e-7	Prudent dietary pattern;
SKCM	cis	rs7659604	0.539	rs7660548	chr4:122730821	G/C	cg06713675	chr4:122721982	EXOSC9	-0.75	-7.31	-0.64	2.01e-10	Type 2 diabetes;
SKCM	cis	rs1062177	0.756	rs2915815	chr5:151115883	G/C	cg00977110	chr5:151150581	G3BP1	-0.83	-6.76	-0.61	2.23e-9	Preschool internalizing problems;
SKCM	cis	rs861020	0.771	rs661849	chr1:210001233	C/T	cg05527609	chr1:210001259	C1orf107	1.05	8.02	0.67	8.48e-12	Orofacial clefts;
SKCM	cis	rs4332037	0.552	rs11773627	chr7:2002733	A/G	cg02825527	chr7:2087843	MAD1L1	-0.72	-5.0	-0.49	3.38e-6	Bipolar disorder;
SKCM	cis	rs2645694	0.533	rs2645681	chr4:77820949	G/A	cg06046430	chr4:77819534	ANKRD56	0.54	5.83	0.55	1.18e-7	Emphysema distribution in smoking;
SKCM	cis	rs11734570	0.581	rs73811714	chr4:38588327	T/G	cg18361445	chr4:38666374	KLF3;FLJ13197	0.88	5.98	0.56	6.46e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs55962025	0.842	rs362272	chr4:3234980	C/T	cg00764545	chr4:3318001	RGS12	-0.76	-6.14	-0.57	3.26e-8	Parental longevity (mother's age at death);
SKCM	cis	rs478304	0.651	rs4930312	chr11:65499719	G/A	cg27068330	chr11:65405492	SIPA1	-0.89	-8.21	-0.68	3.71e-12	Acne (severe);
SKCM	cis	rs1707322	0.656	rs9429172	chr1:46092476	C/G	cg03146154	chr1:46216737	IPP	-0.79	-5.42	-0.52	6.34e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs1552244	0.816	rs17050701	chr3:10041554	A/G	cg02579736	chr3:10068473	FANCD2;CIDECP	0.94	4.84	0.48	6.49e-6	Alzheimer's disease;
SKCM	cis	rs826838	1.000	rs1963562	chr12:38662896	C/T	cg13010199	chr12:38710504	ALG10B	0.72	5.27	0.51	1.19e-6	Heart rate;
SKCM	cis	rs3796619	1.000	rs1453605	chr4:1075771	C/T	cg27284194	chr4:1044797	NA	0.67	4.8	0.48	7.53e-6	Recombination rate (males);
SKCM	cis	rs66573146	0.803	rs60228659	chr4:7031704	G/A	cg00086871	chr4:6988644	TBC1D14	1.45	5.42	0.52	6.38e-7	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs2836633	0.895	rs2212606	chr21:40044940	A/C	cg05519781	chr21:40033154	ERG	0.68	6.22	0.58	2.33e-8	Coronary artery disease;
SKCM	cis	rs6570726	0.905	rs430248	chr6:145874104	A/G	cg23711669	chr6:146136114	FBXO30	0.73	6.9	0.62	1.21e-9	Lobe attachment (rater-scored or self-reported);
SKCM	trans	rs66573146	1.000	rs55913461	chr4:7017509	C/T	cg07817883	chr1:32538562	TMEM39B	2.01	8.09	0.68	6.3e-12	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs12586317	0.514	rs61100068	chr14:35400232	A/T	cg16230307	chr14:35515116	FAM177A1	0.77	5.43	0.52	6.21e-7	Psoriasis;
SKCM	cis	rs9894429	1.000	rs11652797	chr17:79574124	A/G	cg18240062	chr17:79603768	NPLOC4	0.76	7.5	0.65	8.69e-11	Eye color traits;
SKCM	cis	rs2836950	0.545	rs2836922	chr21:40516308	C/T	cg11890956	chr21:40555474	PSMG1	-0.73	-5.55	-0.53	3.78e-7	Menarche (age at onset);
SKCM	cis	rs7100689	0.646	rs7098045	chr10:82123856	G/C	cg01528321	chr10:82214614	TSPAN14	0.8	7.0	0.62	7.98e-10	Post bronchodilator FEV1;
SKCM	cis	rs13118159	0.573	rs7664763	chr4:1352305	A/G	cg19318889	chr4:1322082	MAEA	0.77	5.44	0.52	5.84e-7	Longevity;
SKCM	cis	rs66573146	1.000	rs67405518	chr4:6965930	C/T	cg00086871	chr4:6988644	TBC1D14	1.43	5.33	0.52	9.25e-7	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs28595532	0.920	rs17324968	chr4:119772316	A/G	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs2841277	0.708	rs10083496	chr14:105402786	G/A	cg15352829	chr14:105391018	PLD4	-0.58	-4.81	-0.48	7.35e-6	Rheumatoid arthritis;
SKCM	cis	rs10088262	0.629	rs7828192	chr8:124804669	C/T	cg20713898	chr8:124780851	FAM91A1	-0.7	-5.08	-0.5	2.55e-6	Pancreatic cancer;
SKCM	cis	rs71636778	0.543	rs17162333	chr1:27236757	C/G	cg01689405	chr1:26370407	SLC30A2	-0.53	-4.86	-0.48	5.9e-6	Monocyte percentage of white cells;Granulocyte percentage of myeloid white cells;
SKCM	cis	rs6952808	0.771	rs10950415	chr7:1914477	A/G	cg21782813	chr7:2030301	MAD1L1	0.5	5.13	0.5	2.05e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs11112613	0.653	rs59504344	chr12:105950837	C/T	cg03607813	chr12:105948248	NA	0.85	5.62	0.54	2.86e-7	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;
SKCM	cis	rs701145	0.585	rs436852	chr3:153913403	G/A	cg17054900	chr3:154042577	DHX36	1.25	5.36	0.52	8.3e-7	Coronary artery disease;
SKCM	cis	rs6430585	0.527	rs961360	chr2:136393658	A/G	cg07169764	chr2:136633963	MCM6	1.04	7.93	0.67	1.26e-11	Corneal structure;
SKCM	cis	rs748404	0.631	rs11070399	chr15:43646347	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	0.84	6.38	0.59	1.17e-8	Lung cancer;
SKCM	cis	rs11098499	0.863	rs1480939	chr4:120456927	T/C	cg24375607	chr4:120327624	NA	0.68	5.27	0.51	1.16e-6	Corneal astigmatism;
SKCM	cis	rs1348850	0.567	rs12994392	chr2:178536640	A/G	cg02961200	chr2:178257176	LOC100130691;AGPS	0.66	4.82	0.48	6.84e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs35264875	0.808	rs2305498	chr11:68866914	G/A	cg02660097	chr11:68866761	NA	0.54	5.14	0.5	1.96e-6	Blond vs. brown hair color;
SKCM	cis	rs28595532	0.702	rs72670252	chr4:119337546	A/C	cg21605333	chr4:119757512	SEC24D	0.95	4.91	0.49	4.92e-6	Cannabis dependence symptom count;
SKCM	cis	rs362296	0.671	rs3095074	chr4:3261152	G/A	cg21096898	chr4:3318625	RGS12	-0.83	-7.9	-0.67	1.46e-11	Parental longevity (mother's age at death);
SKCM	cis	rs7811142	0.830	rs73401443	chr7:99977582	T/G	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.2	7.87	0.67	1.7e-11	Platelet count;
SKCM	cis	rs9911578	1.000	rs4482353	chr17:56896834	A/G	cg05425664	chr17:57184151	TRIM37	-0.69	-5.21	-0.51	1.52e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs11608355	0.521	rs6606709	chr12:109846714	A/C	cg19025524	chr12:109796872	NA	-0.68	-6.26	-0.58	1.9e-8	Neuroticism;
SKCM	cis	rs7002619	0.517	rs435815	chr8:16043667	C/T	cg16243756	chr8:15397637	TUSC3	0.61	4.77	0.47	8.55e-6	Schizophrenia;
SKCM	cis	rs7408868	1.000	rs7254269	chr19:15277429	A/T	cg14696996	chr19:15285081	NOTCH3	-0.82	-4.92	-0.49	4.7e-6	Pulse pressure;
SKCM	cis	rs2836974	0.602	rs2836987	chr21:40706594	C/T	cg11890956	chr21:40555474	PSMG1	-0.82	-7.57	-0.65	6.49e-11	Cognitive function;
SKCM	cis	rs10504229	0.683	rs2101864	chr8:58113226	C/T	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs17345786	1.000	rs55641278	chr3:101290577	G/A	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.73	5.27	0.51	1.18e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4836694	0.574	rs3824542	chr9:132936132	C/T	cg13414629	chr9:132935646	FREQ	0.83	5.26	0.51	1.24e-6	Alzheimer's disease (cognitive decline);
SKCM	cis	rs2153535	0.580	rs4639392	chr6:8446547	A/G	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs11671005	0.695	rs8106061	chr19:58917990	G/C	cg00825309	chr19:58991885	ZNF446	-0.94	-8.9	-0.71	1.71e-13	Mean platelet volume;
SKCM	cis	rs11626933	1.000	rs11621007	chr14:90743967	G/A	cg14092571	chr14:90743983	NA	-0.92	-8.33	-0.69	2.11e-12	Gut microbiota (bacterial taxa);
SKCM	cis	rs17065868	1.000	rs9595144	chr13:45107333	C/G	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs644799	0.965	rs687529	chr11:95545587	T/A	cg03916912	chr11:95522834	CEP57;FAM76B	0.92	8.04	0.67	8e-12	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs6089829	0.962	rs7267951	chr20:61665979	A/G	cg03213289	chr20:61660250	NA	0.49	4.81	0.48	7.29e-6	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs9316337	0.500	rs7336072	chr13:21942702	A/G	cg05830425	chr13:21654356	NA	0.52	4.95	0.49	4.13e-6	Schizophrenia;
SKCM	cis	rs875971	1.000	rs55962648	chr7:65625751	C/G	cg11764359	chr7:65958608	NA	-0.86	-8.23	-0.68	3.44e-12	Aortic root size;
SKCM	cis	rs28595532	0.920	rs114544767	chr4:119728364	T/C	cg21605333	chr4:119757512	SEC24D	1.36	8.05	0.67	7.69e-12	Cannabis dependence symptom count;
SKCM	cis	rs2836974	0.897	rs2836933	chr21:40564202	C/G	cg11644478	chr21:40555479	PSMG1	0.97	10.08	0.75	8.76e-16	Cognitive function;
SKCM	cis	rs780096	0.526	rs2911713	chr2:27640980	G/A	cg05696406	chr2:27599888	SNX17	0.49	5.07	0.5	2.62e-6	Total body bone mineral density;
SKCM	cis	rs9894429	0.646	rs7406828	chr17:79619226	A/G	cg18240062	chr17:79603768	NPLOC4	-0.68	-5.89	-0.55	9.19e-8	Eye color traits;
SKCM	cis	rs7666738	0.830	rs1834645	chr4:98979593	T/A	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs56104184	0.830	rs28556985	chr19:49351149	C/T	cg15549821	chr19:49342101	PLEKHA4	-1.27	-7.95	-0.67	1.17e-11	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs7666738	0.830	rs2865949	chr4:99039967	A/G	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	trans	rs208520	0.690	rs12201156	chr6:66720874	G/T	cg15611600	chr13:45563400	KIAA1704;NUFIP1	0.92	7.5	0.65	8.69e-11	Exhaled nitric oxide output;
SKCM	cis	rs2204008	0.840	rs7136347	chr12:38453531	G/A	cg26384229	chr12:38710491	ALG10B	0.87	6.82	0.61	1.76e-9	Bladder cancer;
SKCM	cis	rs2439831	0.681	rs526450	chr15:43599325	A/G	cg27015174	chr15:43622946	ADAL;LCMT2	0.84	4.92	0.49	4.8e-6	Lung cancer in ever smokers;
SKCM	cis	rs6951245	1.000	rs79422648	chr7:1080241	T/C	cg18402987	chr7:1209562	NA	1.14	6.01	0.56	5.68e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs1577917	0.560	rs9450288	chr6:86221586	A/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.65	5.09	0.5	2.4e-6	Response to antipsychotic treatment;
SKCM	cis	rs9325144	0.534	rs1973293	chr12:38679575	C/T	cg26384229	chr12:38710491	ALG10B	0.69	5.8	0.55	1.36e-7	Morning vs. evening chronotype;
SKCM	cis	rs2075371	0.547	rs12666682	chr7:134021784	C/A	cg20476274	chr7:133979776	SLC35B4	0.87	8.33	0.69	2.19e-12	Mean platelet volume;
SKCM	cis	rs1160297	0.576	rs1376570	chr2:53087099	G/A	cg07782112	chr2:53107842	NA	0.56	5.94	0.56	7.61e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs6582630	0.519	rs11181294	chr12:38312787	C/T	cg26384229	chr12:38710491	ALG10B	0.81	6.57	0.6	5.18e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs4683346	0.731	rs760193	chr3:42918297	A/G	cg06399164	chr3:42695035	ZBTB47	-0.53	-4.91	-0.49	4.94e-6	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs9325144	0.647	rs12830095	chr12:38864199	C/T	cg26384229	chr12:38710491	ALG10B	-0.75	-6.25	-0.58	2.06e-8	Morning vs. evening chronotype;
SKCM	cis	rs8072100	0.713	rs2136750	chr17:45456100	A/G	cg08085267	chr17:45401833	C17orf57	-0.62	-5.03	-0.49	3.05e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs9467773	0.967	rs1535276	chr6:26520941	T/C	cg15659132	chr6:26577336	NA	0.6	5.71	0.54	1.99e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs4319547	0.956	rs10744275	chr12:123048618	A/G	cg23029597	chr12:123009494	RSRC2	-0.8	-5.58	-0.53	3.39e-7	Body mass index;
SKCM	cis	rs9311474	0.508	rs11720243	chr3:52618018	T/C	cg18404041	chr3:52824283	ITIH1	-0.53	-4.77	-0.48	8.42e-6	Electroencephalogram traits;
SKCM	cis	rs854765	0.603	rs4506967	chr17:17990474	A/C	cg04398451	chr17:18023971	MYO15A	-1.02	-8.72	-0.7	3.81e-13	Total body bone mineral density;
SKCM	cis	rs362296	0.661	rs3095077	chr4:3265710	A/G	cg16987761	chr4:3318072	RGS12	0.63	5.28	0.51	1.14e-6	Parental longevity (mother's age at death);
SKCM	cis	rs12497850	0.931	rs12493289	chr3:48905161	G/A	cg07636037	chr3:49044803	WDR6	1.01	10.82	0.77	3.36e-17	Parkinson's disease;
SKCM	cis	rs28386778	0.863	rs6504178	chr17:61812733	A/G	cg23090583	chr17:61904693	PSMC5;FTSJ3	-1.1	-11.09	-0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs7940866	0.801	rs10894288	chr11:130808679	T/C	cg12179176	chr11:130786555	SNX19	0.75	5.93	0.56	7.83e-8	Schizophrenia;
SKCM	cis	rs7617480	0.648	rs6796790	chr3:48780317	G/A	cg07636037	chr3:49044803	WDR6	0.9	6.65	0.6	3.64e-9	Subjective well-being (multi-trait analysis);Menarche (age at onset);
SKCM	cis	rs427394	0.582	rs274665	chr5:6707981	C/T	cg10857441	chr5:6722123	POLS	-0.69	-7.42	-0.64	1.24e-10	Menopause (age at onset);
SKCM	cis	rs4332037	0.707	rs73046323	chr7:1882795	G/A	cg23422044	chr7:1970798	MAD1L1	-0.9	-5.81	-0.55	1.29e-7	Bipolar disorder;
SKCM	cis	rs2816062	0.747	rs2816049	chr1:18893768	A/G	cg18795169	chr1:18902165	NA	-0.83	-9.02	-0.71	1.01e-13	Urate levels in lean individuals;
SKCM	cis	rs11098499	0.863	rs6534139	chr4:120449456	A/G	cg09307838	chr4:120376055	NA	-0.94	-6.95	-0.62	9.97e-10	Corneal astigmatism;
SKCM	cis	rs9300255	0.544	rs1716157	chr12:123670473	T/C	cg05973401	chr12:123451056	ABCB9	0.83	5.14	0.5	2.01e-6	Neutrophil percentage of white cells;
SKCM	cis	rs476633	0.691	rs28735224	chr15:41537539	C/T	cg18705301	chr15:41695430	NDUFAF1	-0.65	-4.86	-0.48	6.01e-6	Glomerular filtration rate (creatinine);
SKCM	trans	rs561341	1.000	rs484175	chr17:30309041	G/A	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs672059	1.000	rs522372	chr1:183157449	C/G	ch.1.3577855R	chr1:183094577	LAMC1	-0.64	-5.24	-0.51	1.35e-6	Hypertriglyceridemia;
SKCM	cis	rs4319547	0.695	rs4758643	chr12:122924819	A/T	cg23029597	chr12:123009494	RSRC2	-0.78	-5.86	-0.55	1.06e-7	Body mass index;
SKCM	cis	rs6424115	0.830	rs6672157	chr1:24198840	C/G	cg15997130	chr1:24165203	NA	0.6	4.94	0.49	4.37e-6	Immature fraction of reticulocytes;
SKCM	cis	rs7666738	0.830	rs17548431	chr4:98923768	C/G	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs28510890	0.658	rs12442454	chr15:93158992	C/T	cg23043611	chr15:93139145	NA	-0.69	-4.95	-0.49	4.14e-6	Lung cancer in ever smokers;
SKCM	cis	rs1018836	0.923	rs12680211	chr8:91633434	C/T	cg16814680	chr8:91681699	NA	-0.64	-4.94	-0.49	4.38e-6	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs17854409	0.803	rs3210314	chr20:61472117	C/A	cg06598544	chr20:61472147	COL9A3	-1.14	-5.6	-0.54	3.08e-7	Obesity-related traits;
SKCM	cis	rs1348850	0.526	rs7588049	chr2:178390778	C/T	cg27490568	chr2:178487706	NA	-0.9	-6.35	-0.58	1.29e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs2243480	1.000	rs464895	chr7:65527106	A/G	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs7666738	0.830	rs17027058	chr4:98864671	G/A	cg17366294	chr4:99064904	C4orf37	0.56	4.87	0.48	5.62e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7666738	0.830	rs6831925	chr4:98947401	T/C	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7666738	0.830	rs35685312	chr4:98858521	G/A	cg17366294	chr4:99064904	C4orf37	0.56	4.87	0.48	5.62e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs780096	0.545	rs6716894	chr2:27583273	A/G	cg05696406	chr2:27599888	SNX17	0.5	5.14	0.5	2e-6	Total body bone mineral density;
SKCM	cis	rs7940866	0.801	rs10894300	chr11:130845943	A/G	cg12179176	chr11:130786555	SNX19	0.79	6.17	0.57	2.88e-8	Schizophrenia;
SKCM	cis	rs8014204	0.773	rs2241275	chr14:75251440	C/T	cg06637938	chr14:75390232	RPS6KL1	-0.84	-6.73	-0.61	2.58e-9	Caffeine consumption;
SKCM	cis	rs4891159	0.527	rs690593	chr18:74160408	C/G	cg24786174	chr18:74118243	ZNF516	0.77	7.94	0.67	1.23e-11	Longevity;
SKCM	cis	rs17102884	0.506	rs4899541	chr14:75403437	T/G	cg08847533	chr14:75593920	NEK9	-0.68	-5.4	-0.52	7.09e-7	Neuroticism;
SKCM	cis	rs1669338	0.588	rs3749360	chr3:3213775	G/A	cg16797762	chr3:3221439	CRBN	-1.12	-6.4	-0.59	1.06e-8	White matter integrity;
SKCM	cis	rs4319547	0.774	rs7295105	chr12:123124225	G/A	cg23029597	chr12:123009494	RSRC2	-0.73	-5.5	-0.53	4.6e-7	Body mass index;
SKCM	cis	rs2153535	0.601	rs2015281	chr6:8539673	G/A	cg23788917	chr6:8435910	SLC35B3	0.69	4.92	0.49	4.79e-6	Motion sickness;
SKCM	cis	rs1005277	0.522	rs1208767	chr10:38042295	G/T	cg25427524	chr10:38739819	LOC399744	-0.64	-6.06	-0.57	4.44e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs13217239	0.646	rs12527111	chr6:27006475	C/T	cg12292205	chr6:26970375	C6orf41	0.61	5.37	0.52	7.89e-7	Schizophrenia;
SKCM	cis	rs6724607	1.000	rs10165399	chr2:191441595	A/G	cg21644426	chr2:191273491	MFSD6	0.69	4.94	0.49	4.42e-6	Pulse pressure;
SKCM	cis	rs995000	0.899	rs1183260	chr1:62945418	A/G	cg06896770	chr1:63153194	DOCK7	-0.76	-7.3	-0.64	2.08e-10	Triglyceride levels;
SKCM	cis	rs10754283	0.870	rs2390764	chr1:90112827	T/G	cg21401794	chr1:90099060	LRRC8C	0.73	6.34	0.58	1.35e-8	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs9911578	1.000	rs6503887	chr17:56993320	T/C	cg12560992	chr17:57184187	TRIM37	0.94	7.55	0.65	7.01e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs2730245	0.527	rs924910	chr7:158672272	C/T	cg24397884	chr7:158709396	WDR60	0.98	5.56	0.53	3.7e-7	Height;
SKCM	cis	rs507080	0.922	rs508640	chr11:118564413	A/G	cg18045108	chr11:118530628	TREH	-0.47	-4.81	-0.48	7.17e-6	Serum metabolite levels;
SKCM	cis	rs2346177	0.542	rs1900591	chr2:46697968	C/T	cg02822958	chr2:46747628	ATP6V1E2	0.71	5.3	0.51	1.03e-6	HDL cholesterol;
SKCM	cis	rs9297145	0.958	rs11975761	chr7:98766688	G/A	cg05967295	chr7:98741636	SMURF1	-1.08	-8.44	-0.69	1.31e-12	Crohn's disease;Inflammatory bowel disease;Ulcerative colitis;
SKCM	cis	rs72615157	0.612	rs7786505	chr7:99817585	G/T	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.04	6.43	0.59	9.47e-9	Lung function (FEV1/FVC);
SKCM	cis	rs600231	0.665	rs1616810	chr11:65220105	A/G	cg24009118	chr11:65545808	DKFZp761E198	0.69	4.97	0.49	3.87e-6	Bone mineral density;
SKCM	cis	rs7829975	0.714	rs12544992	chr8:8661681	C/G	cg06636001	chr8:8085503	FLJ10661	0.78	6.92	0.62	1.13e-9	Mood instability;
SKCM	cis	rs854765	0.647	rs2974998	chr17:17995619	A/G	cg04398451	chr17:18023971	MYO15A	-1.02	-8.72	-0.7	3.81e-13	Total body bone mineral density;
SKCM	cis	rs875971	0.660	rs10281080	chr7:66042441	T/C	cg05627663	chr7:65219948	SNORA22;CCT6P1	-0.56	-4.84	-0.48	6.39e-6	Aortic root size;
SKCM	cis	rs4911259	0.552	rs6058926	chr20:31465450	T/C	cg13636640	chr20:31349939	DNMT3B	-0.74	-6.15	-0.57	3.04e-8	Inflammatory bowel disease;
SKCM	cis	rs548181	0.611	rs2849225	chr11:125415936	A/G	cg03464685	chr11:125439445	EI24	1.48	9.54	0.73	9.7e-15	Schizophrenia;Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);
SKCM	cis	rs11249608	0.600	rs6859767	chr5:178451107	T/C	cg21905437	chr5:178450457	ZNF879	0.76	6.46	0.59	8.29e-9	Pubertal anthropometrics;
SKCM	cis	rs2153535	0.563	rs1796688	chr6:8536423	A/T	cg07606381	chr6:8435919	SLC35B3	0.86	6.32	0.58	1.52e-8	Motion sickness;
SKCM	cis	rs7618501	0.573	rs2624824	chr3:50088266	T/C	cg24110177	chr3:50126178	RBM5	0.62	5.24	0.51	1.32e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs867186	1.000	rs75537616	chr20:33592588	C/T	cg04194272	chr20:33683537	NA	-1.36	-7.01	-0.62	7.44e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs67460515	0.892	rs35310734	chr3:160943209	T/G	cg03342759	chr3:160939853	NMD3	-0.81	-7.1	-0.63	5.14e-10	Parkinson's disease;
SKCM	cis	rs933688	1.000	rs6867219	chr5:90718008	T/G	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.96	6.6	0.6	4.58e-9	Smoking behavior;
SKCM	cis	rs854765	0.623	rs9893690	chr17:17753846	A/T	cg04398451	chr17:18023971	MYO15A	0.87	5.86	0.55	1.04e-7	Total body bone mineral density;
SKCM	cis	rs11608355	0.521	rs10850131	chr12:109837052	A/G	cg19025524	chr12:109796872	NA	0.69	6.5	0.59	6.92e-9	Neuroticism;
SKCM	cis	rs13424612	1.000	rs1465880	chr2:240932326	G/A	cg01812947	chr2:240904978	NDUFA10	0.65	5.11	0.5	2.26e-6	Odorant perception (isobutyraldehyde);
SKCM	cis	rs875971	0.798	rs6460304	chr7:65964728	G/A	cg18876405	chr7:65276391	NA	0.61	5.94	0.56	7.52e-8	Aortic root size;
SKCM	cis	rs1153858	1.000	rs67461176	chr15:45676819	C/T	cg10760299	chr15:45669010	GATM	0.62	6.35	0.58	1.3e-8	Homoarginine levels;
SKCM	cis	rs1799949	1.000	rs11658754	chr17:41292739	G/A	cg05368731	chr17:41323189	NBR1	0.89	7.91	0.67	1.38e-11	Menopause (age at onset);
SKCM	cis	rs801193	0.591	rs2707839	chr7:66193084	A/G	cg18876405	chr7:65276391	NA	0.68	6.67	0.6	3.25e-9	Aortic root size;
SKCM	cis	rs1850744	0.536	rs6843869	chr4:9634451	T/C	cg15442990	chr4:9534313	NA	1.1	4.86	0.48	5.98e-6	Economic and political preferences;
SKCM	cis	rs2760061	0.819	rs708112	chr1:228192452	G/A	cg18477163	chr1:228402036	OBSCN	0.48	5.69	0.54	2.16e-7	Diastolic blood pressure;
SKCM	cis	rs9399135	0.904	rs4895438	chr6:135317665	G/T	cg24558204	chr6:135376177	HBS1L	0.59	5.23	0.51	1.41e-6	Red blood cell count;
SKCM	cis	rs3818285	0.556	rs2084607	chr10:111681411	C/T	cg00817464	chr10:111662876	XPNPEP1	0.72	7.3	0.64	2.07e-10	Superior crus of antihelix expression;
SKCM	cis	rs1878931	0.624	rs1149492	chr16:3445239	A/G	cg26668626	chr16:3451006	ZNF174;ZNF434	-0.82	-5.99	-0.56	6.05e-8	Body mass index (adult);
SKCM	cis	rs873946	0.517	rs2803990	chr10:134560340	A/G	cg18305652	chr10:134549665	INPP5A	0.59	6.28	0.58	1.76e-8	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs6547741	1.000	rs2384654	chr2:27847364	C/T	cg27432699	chr2:27873401	GPN1	0.75	6.74	0.61	2.45e-9	Oral cavity cancer;
SKCM	cis	rs2479724	0.846	rs1536702	chr6:41869950	T/A	cg17623882	chr6:41773611	USP49	-0.74	-6.28	-0.58	1.8e-8	Menarche (age at onset);
SKCM	cis	rs9894429	0.690	rs12949956	chr17:79542813	C/T	cg18240062	chr17:79603768	NPLOC4	-0.91	-10.36	-0.76	2.55e-16	Eye color traits;
SKCM	cis	rs10504229	0.683	rs79284841	chr8:58107611	T/A	cg02725872	chr8:58115012	NA	-0.53	-4.91	-0.49	4.82e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs6840360	0.615	rs3828546	chr4:152679816	A/G	cg22705602	chr4:152727874	NA	-0.59	-7.95	-0.67	1.19e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs4481887	1.000	rs10888358	chr1:248471467	C/A	cg00666640	chr1:248458726	OR2T12	0.64	5.69	0.54	2.13e-7	Common traits (Other);
SKCM	cis	rs4891159	0.790	rs59762437	chr18:74153146	G/A	cg24786174	chr18:74118243	ZNF516	-0.74	-7.09	-0.63	5.28e-10	Longevity;
SKCM	cis	rs3768617	0.528	rs6672093	chr1:183079853	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs28595532	0.920	rs55726697	chr4:119742863	G/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs2842992	0.789	rs2146163	chr6:160224346	T/C	cg11366901	chr6:160182831	ACAT2	0.9	7.3	0.64	2.06e-10	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs2153535	0.580	rs4451187	chr6:8473910	C/T	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs7605378	0.528	rs1704191	chr2:200816393	C/A	cg23649088	chr2:200775458	C2orf69	0.71	5.45	0.53	5.68e-7	Osteoporosis;
SKCM	cis	rs11122272	0.735	rs2808604	chr1:231538916	T/C	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	-0.64	-5.18	-0.51	1.66e-6	Hemoglobin concentration;
SKCM	cis	rs2836974	0.565	rs34304022	chr21:40579619	G/A	cg11644478	chr21:40555479	PSMG1	0.84	5.56	0.53	3.71e-7	Cognitive function;
SKCM	cis	rs17376456	0.877	rs13165147	chr5:93422214	G/A	cg25358565	chr5:93447407	FAM172A	1.23	7.97	0.67	1.08e-11	Diabetic retinopathy;
SKCM	cis	rs17376456	0.877	rs12374488	chr5:93481407	A/G	cg25358565	chr5:93447407	FAM172A	1.23	7.97	0.67	1.08e-11	Diabetic retinopathy;
SKCM	trans	rs208520	0.526	rs6455072	chr6:66797215	A/G	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-1.12	-11.79	-0.8	5.24e-19	Exhaled nitric oxide output;
SKCM	cis	rs7215564	0.908	rs115148337	chr17:78688545	G/T	cg16980736	chr17:78789706	RPTOR	-0.88	-4.83	-0.48	6.66e-6	Myopia (pathological);
SKCM	cis	rs801193	1.000	rs4279493	chr7:66226620	C/T	cg00343986	chr7:65444356	GUSB	0.67	4.95	0.49	4.27e-6	Aortic root size;
SKCM	cis	rs1325195	0.506	rs2636266	chr1:179199652	A/G	cg10806749	chr1:179558114	NA	0.59	5.44	0.52	5.84e-7	IgE grass sensitization;
SKCM	cis	rs7811142	1.000	rs11763511	chr7:100081944	G/A	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.19	7.92	0.67	1.33e-11	Platelet count;
SKCM	cis	rs600231	0.708	rs682845	chr11:65254201	A/G	cg24009118	chr11:65545808	DKFZp761E198	0.66	4.89	0.48	5.24e-6	Bone mineral density;
SKCM	trans	rs1814175	0.645	rs1851853	chr11:49953434	C/T	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs2032447	0.677	rs199737	chr6:25933538	A/T	cg03517284	chr6:25882590	NA	-0.67	-5.48	-0.53	4.99e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs9611565	0.659	rs9607815	chr22:41950671	A/T	cg03806693	chr22:41940476	POLR3H	-1.13	-7.48	-0.65	9.6e-11	Vitiligo;
SKCM	cis	rs4819052	0.851	rs35064782	chr21:46674360	G/A	cg20896738	chr21:46707857	POFUT2;LOC642852	0.64	4.82	0.48	6.85e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7772486	0.727	rs4896843	chr6:146063451	T/C	cg23711669	chr6:146136114	FBXO30	-0.88	-9.55	-0.73	9.22e-15	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7618501	0.602	rs2013208	chr3:50129399	C/T	cg05072774	chr3:49840536	C3orf54	0.71	5.48	0.53	5e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs2274273	0.934	rs17740741	chr14:55762712	G/C	cg26246078	chr14:56151250	KTN1	0.69	4.81	0.48	7.12e-6	Protein biomarker;
SKCM	cis	rs79057730	0.599	rs78347394	chr7:831817	G/A	cg06242242	chr7:766104	PRKAR1B;HEATR2	1.13	5.07	0.5	2.63e-6	Initial pursuit acceleration;
SKCM	cis	rs17376456	1.000	rs17323433	chr5:93551028	G/A	cg25358565	chr5:93447407	FAM172A	1.27	7.86	0.66	1.78e-11	Diabetic retinopathy;
SKCM	cis	rs4332037	0.802	rs73048106	chr7:1929019	G/T	cg23422044	chr7:1970798	MAD1L1	-0.98	-6.65	-0.6	3.61e-9	Bipolar disorder;
SKCM	cis	rs614226	0.748	rs78714658	chr12:121009944	G/A	cg01236616	chr12:121019343	POP5	-1.34	-7.67	-0.66	4.14e-11	Type 1 diabetes nephropathy;
SKCM	cis	rs1799949	0.965	rs8070179	chr17:41202688	G/A	cg23758822	chr17:41437982	NA	0.93	7.48	0.65	9.37e-11	Menopause (age at onset);
SKCM	cis	rs875971	0.862	rs2420173	chr7:65645399	A/T	cg11764359	chr7:65958608	NA	-0.8	-7.66	-0.66	4.2e-11	Aortic root size;
SKCM	cis	rs909674	0.818	rs5750833	chr22:39843091	C/A	cg24399712	chr22:39784796	NA	-0.57	-4.83	-0.48	6.78e-6	IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis);IgG glycosylation;IgG digalactosylation phenotypes (multivariate analysis);IgG sialylation phenotypes (multivariate analysis);IgG monogalactosylation phenotypes (multivariate analysis);IgG fucosylation phenotypes (multivariate analysis);IgG N-glycosylation phenotypes (multivariate analysis);IgG disialylation phenotypes (multivariate analysis);IgG galactosylation phenotypes (multivariate analysis);Post bronchodilator FEV1;
SKCM	cis	rs28595532	0.920	rs116791817	chr4:119763303	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs1153858	0.887	rs7171163	chr15:45636395	A/C	cg21132104	chr15:45694354	SPATA5L1	0.92	8.33	0.69	2.14e-12	Homoarginine levels;
SKCM	cis	rs2180341	0.920	rs7756880	chr6:127683999	A/T	cg24812749	chr6:127587940	RNF146	0.83	7.24	0.63	2.76e-10	Breast cancer;
SKCM	cis	rs9916302	0.904	rs10852933	chr17:37698194	G/T	cg07936489	chr17:37558343	FBXL20	-0.9	-8.11	-0.68	5.65e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs7932354	0.528	rs7947878	chr11:47028531	C/T	cg03339077	chr11:47165057	C11orf49	-0.61	-4.99	-0.49	3.57e-6	Bone mineral density (hip);Bone mineral density;
SKCM	cis	rs362272	0.545	rs2748447	chr4:3337831	G/A	cg09735869	chr4:3319127	RGS12	0.99	11.19	0.78	6.93e-18	Serum sulfate level;
SKCM	cis	rs796364	0.901	rs13030683	chr2:201061535	C/T	cg12253985	chr2:200820533	C2orf60;C2orf47	0.94	6.15	0.57	3.08e-8	Schizophrenia;
SKCM	cis	rs561341	0.882	rs2521594	chr17:30302087	C/T	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs875971	0.545	rs66594357	chr7:65792784	G/A	cg18876405	chr7:65276391	NA	0.63	5.03	0.49	3.07e-6	Aortic root size;
SKCM	cis	rs17711722	0.585	rs6942660	chr7:65302406	C/T	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.61	5.06	0.5	2.75e-6	Calcium levels;
SKCM	cis	rs7772486	0.641	rs67882056	chr6:146416301	T/C	cg23711669	chr6:146136114	FBXO30	0.85	6.96	0.62	9.38e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs72634258	0.945	rs2050198	chr1:8111839	T/G	cg00042356	chr1:8021962	PARK7	1.08	7.51	0.65	8.25e-11	Inflammatory bowel disease;
SKCM	cis	rs11098499	0.775	rs67281037	chr4:120281157	G/C	cg24375607	chr4:120327624	NA	0.62	4.77	0.48	8.45e-6	Corneal astigmatism;
SKCM	cis	rs5769765	0.817	rs11912619	chr22:50317401	G/A	cg22709217	chr22:50311962	ALG12;CRELD2	-0.97	-5.83	-0.55	1.18e-7	Schizophrenia;
SKCM	cis	rs933688	1.000	rs985434	chr5:90744509	A/G	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.07	8.52	0.69	9.25e-13	Smoking behavior;
SKCM	cis	rs6835098	1.000	rs2332654	chr4:174088399	C/T	cg08422745	chr4:174089978	GALNT7	-0.88	-6.87	-0.61	1.38e-9	Dementia and core Alzheimer's disease neuropathologic changes;
SKCM	cis	rs7100689	0.646	rs7089003	chr10:82124155	T/C	cg01528321	chr10:82214614	TSPAN14	0.8	7.0	0.62	7.98e-10	Post bronchodilator FEV1;
SKCM	cis	rs9818758	0.607	rs5030795	chr3:49141116	C/T	cg00383909	chr3:49044727	WDR6	1.06	5.9	0.56	9.03e-8	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs933688	1.000	rs35712350	chr5:90679519	C/T	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.05	8.26	0.68	2.89e-12	Smoking behavior;
SKCM	cis	rs9916302	0.706	rs4795385	chr17:37733148	A/G	cg07936489	chr17:37558343	FBXL20	1.04	7.96	0.67	1.12e-11	Glomerular filtration rate (creatinine);
SKCM	cis	rs6582630	0.634	rs10748443	chr12:38734062	G/T	cg26384229	chr12:38710491	ALG10B	0.78	6.82	0.61	1.76e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs6570726	0.764	rs9386125	chr6:145911677	C/T	cg23711669	chr6:146136114	FBXO30	0.88	8.39	0.69	1.67e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9303401	0.573	rs34097494	chr17:57171917	C/T	cg10487724	chr17:56770010	TEX14;RAD51C	0.79	4.97	0.49	3.86e-6	Cognitive test performance;
SKCM	trans	rs12599106	0.680	rs34728702	chr16:34896584	A/G	cg03395511	chr6:291903	DUSP22	-0.72	-7.64	-0.65	4.57e-11	Menopause (age at onset);
SKCM	cis	rs7829975	0.902	rs777707	chr8:8584344	A/G	cg15556689	chr8:8085844	FLJ10661	0.74	6.77	0.61	2.17e-9	Mood instability;
SKCM	cis	rs2033711	0.870	rs6510152	chr19:58953319	C/T	cg00825309	chr19:58991885	ZNF446	-0.71	-5.93	-0.56	7.76e-8	Uric acid clearance;
SKCM	cis	rs13118159	0.573	rs7657357	chr4:1372939	C/T	cg02475777	chr4:1388615	CRIPAK	0.9	6.75	0.61	2.32e-9	Longevity;
SKCM	cis	rs9926296	0.605	rs7205053	chr16:89856763	G/C	cg27121462	chr16:89883253	FANCA	0.81	7.32	0.64	1.92e-10	Vitiligo;
SKCM	cis	rs1577917	0.958	rs12205492	chr6:86475976	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.9	-8.97	-0.71	1.22e-13	Response to antipsychotic treatment;
SKCM	cis	rs2439831	1.000	rs689754	chr15:43775895	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.4	8.78	0.7	2.94e-13	Lung cancer in ever smokers;
SKCM	cis	rs55823223	0.680	rs57287238	chr17:73850940	T/C	cg10935138	chr17:73851978	WBP2	1.15	7.57	0.65	6.31e-11	Psoriasis;
SKCM	cis	rs9790314	1.000	rs4370045	chr3:160943865	A/G	cg03342759	chr3:160939853	NMD3	-0.71	-7.65	-0.65	4.52e-11	Morning vs. evening chronotype;
SKCM	cis	rs2760061	0.819	rs708115	chr1:228198046	C/T	cg18477163	chr1:228402036	OBSCN	0.49	5.77	0.55	1.52e-7	Diastolic blood pressure;
SKCM	cis	rs62238980	0.614	rs4821013	chr22:32388224	A/C	cg00543991	chr22:32367038	NA	1.15	4.87	0.48	5.76e-6	Childhood ear infection;
SKCM	cis	rs8103278	0.507	rs1865116	chr19:46294510	G/A	cg12641515	chr19:46296257	DMWD	0.78	6.06	0.57	4.46e-8	Coronary artery disease;
SKCM	cis	rs701145	0.938	rs1086106	chr3:154084032	C/T	cg17054900	chr3:154042577	DHX36	0.89	4.98	0.49	3.78e-6	Coronary artery disease;
SKCM	cis	rs9910055	0.639	rs7217858	chr17:42254527	T/G	cg10896456	chr17:42255109	ASB16;C17orf65	0.68	7.28	0.64	2.25e-10	Total body bone mineral density;
SKCM	cis	rs55962025	0.883	rs82334	chr4:3225371	A/C	cg16987761	chr4:3318072	RGS12	-0.65	-4.81	-0.48	7.21e-6	Parental longevity (mother's age at death);
SKCM	cis	rs362296	0.511	rs2857861	chr4:3323767	C/T	cg21096898	chr4:3318625	RGS12	0.88	10.47	0.76	1.61e-16	Parental longevity (mother's age at death);
SKCM	cis	rs36093844	0.642	rs7934759	chr11:85613869	C/G	cg02149136	chr11:85995039	NA	-0.64	-5.13	-0.5	2.03e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs9902453	0.933	rs1532042	chr17:28504389	G/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.5	0.53	4.74e-7	Coffee consumption (cups per day);
SKCM	cis	rs7940866	0.803	rs10894307	chr11:130876350	G/A	cg12179176	chr11:130786555	SNX19	0.72	5.38	0.52	7.67e-7	Schizophrenia;
SKCM	cis	rs11718455	0.653	rs28533958	chr3:43974179	C/A	cg21419209	chr3:44054225	NA	-0.62	-5.06	-0.5	2.75e-6	Coronary artery disease;
SKCM	cis	rs4242434	0.927	rs2291231	chr8:22463912	C/T	cg03733263	chr8:22462867	KIAA1967	1.07	9.15	0.72	5.54e-14	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs875971	0.737	rs7803424	chr7:65880605	T/C	cg11764359	chr7:65958608	NA	0.87	8.35	0.69	2.01e-12	Aortic root size;
SKCM	cis	rs4819052	1.000	rs4818769	chr21:46667451	C/T	cg20896738	chr21:46707857	POFUT2;LOC642852	0.74	5.35	0.52	8.71e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs9796	0.717	rs476633	chr15:41392134	C/G	cg18705301	chr15:41695430	NDUFAF1	-0.78	-5.56	-0.53	3.68e-7	Menopause (age at onset);
SKCM	cis	rs7666738	0.822	rs17484018	chr4:98988960	G/A	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs28595532	0.748	rs67928655	chr4:119336525	C/A	cg21605333	chr4:119757512	SEC24D	0.95	4.91	0.49	4.92e-6	Cannabis dependence symptom count;
SKCM	cis	rs6089829	1.000	rs6089828	chr20:61668998	C/T	cg08564027	chr20:61660810	NA	0.62	5.63	0.54	2.69e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs7584330	0.744	rs10929234	chr2:238380034	C/G	cg14458575	chr2:238380390	NA	-1.03	-6.61	-0.6	4.31e-9	Prostate cancer;
SKCM	cis	rs72781680	1.000	rs72788286	chr2:24098321	A/C	cg08917208	chr2:24149416	ATAD2B	0.99	5.24	0.51	1.31e-6	Lymphocyte counts;
SKCM	cis	rs4911259	0.552	rs13041458	chr20:31467376	G/T	cg13636640	chr20:31349939	DNMT3B	-0.74	-6.15	-0.57	3.04e-8	Inflammatory bowel disease;
SKCM	cis	rs908922	0.887	rs4845783	chr1:152492559	G/A	cg09873164	chr1:152488093	CRCT1	0.84	5.03	0.49	3.11e-6	Hair morphology;
SKCM	cis	rs2386661	0.826	rs7073741	chr10:5671213	G/A	cg12223502	chr10:5658492	NA	-0.57	-4.9	-0.49	5.01e-6	Breast cancer;
SKCM	cis	rs1865760	0.623	rs12216125	chr6:25997458	C/T	cg17691542	chr6:26056736	HIST1H1C	0.72	5.51	0.53	4.4e-7	Height;
SKCM	cis	rs7917772	0.503	rs7093285	chr10:104374815	G/C	cg11453585	chr10:104263688	ACTR1A;SUFU	0.77	6.1	0.57	3.8e-8	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs8070128	0.637	rs4925133	chr17:17884801	A/G	cg04398451	chr17:18023971	MYO15A	-0.82	-5.71	-0.54	1.97e-7	Total body bone mineral density;
SKCM	cis	rs1577917	0.771	rs9294337	chr6:86248460	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.98	10.89	0.78	2.49e-17	Response to antipsychotic treatment;
SKCM	cis	rs10927875	0.832	rs4661342	chr1:16160773	C/G	cg21385522	chr1:16154831	NA	-1.03	-8.46	-0.69	1.22e-12	Dilated cardiomyopathy;
SKCM	cis	rs4925386	1.000	rs4925386	chr20:60921044	C/T	cg24112000	chr20:60950667	NA	-0.62	-5.9	-0.56	8.73e-8	Colorectal cancer;Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs13118159	0.527	rs9328733	chr4:1388583	A/G	cg20887711	chr4:1340912	KIAA1530	0.95	6.67	0.6	3.29e-9	Longevity;
SKCM	cis	rs875971	0.756	rs4718328	chr7:65693337	A/G	cg11764359	chr7:65958608	NA	-0.81	-7.73	-0.66	3.08e-11	Aortic root size;
SKCM	cis	rs116095464	0.867	rs7726582	chr5:215349	C/G	cg22496380	chr5:211416	CCDC127	-0.96	-5.27	-0.51	1.18e-6	Breast cancer;
SKCM	cis	rs11252926	0.537	rs4554800	chr10:458477	G/T	cg18196295	chr10:418757	DIP2C	-0.65	-5.54	-0.53	3.94e-7	Psychosis in Alzheimer's disease;
SKCM	cis	rs7809950	1.000	rs2520268	chr7:107191161	T/A	cg23024343	chr7:107201750	COG5	-0.77	-6.92	-0.62	1.11e-9	Coronary artery disease;
SKCM	trans	rs1814175	0.619	rs10769623	chr11:49865926	C/T	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	trans	rs1814175	0.645	rs28839231	chr11:50044292	G/T	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs826838	0.872	rs826878	chr12:39088837	A/T	cg26384229	chr12:38710491	ALG10B	-0.78	-6.37	-0.58	1.23e-8	Heart rate;
SKCM	cis	rs1878931	0.559	rs2106863	chr16:3391330	T/C	cg26668626	chr16:3451006	ZNF174;ZNF434	0.83	6.35	0.58	1.33e-8	Body mass index (adult);
SKCM	cis	rs4268898	0.662	rs2891380	chr2:24525830	G/A	cg06627628	chr2:24431161	ITSN2	-0.96	-7.33	-0.64	1.83e-10	Asthma;
SKCM	cis	rs367615	0.704	rs7726991	chr5:108847434	C/T	cg17395555	chr5:108820864	NA	0.76	6.91	0.62	1.17e-9	Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs2836974	0.666	rs4818015	chr21:40675493	A/C	cg17971929	chr21:40555470	PSMG1	0.76	7.24	0.63	2.7e-10	Cognitive function;
SKCM	cis	rs6545883	0.929	rs6545873	chr2:61733012	T/C	cg15711740	chr2:61764176	XPO1	-0.73	-5.27	-0.51	1.19e-6	Tuberculosis;
SKCM	cis	rs10779751	0.734	rs2791647	chr1:11132801	G/A	cg08854313	chr1:11322531	MTOR	0.77	5.52	0.53	4.36e-7	Body mass index;
SKCM	cis	rs8064299	0.560	rs11077763	chr17:72786029	T/C	cg25054828	chr17:72772726	NAT9;TMEM104	0.93	9.65	0.74	6.03e-15	Monocyte count;
SKCM	cis	rs2404602	0.684	rs8029283	chr15:76837140	A/G	cg23625390	chr15:77176239	SCAPER	-0.82	-7.93	-0.67	1.26e-11	Blood metabolite levels;
SKCM	cis	rs9297145	1.000	rs10953280	chr7:98763405	A/G	cg05967295	chr7:98741636	SMURF1	-1.08	-8.44	-0.69	1.31e-12	Crohn's disease;Inflammatory bowel disease;Ulcerative colitis;
SKCM	cis	rs3820928	0.874	rs7582251	chr2:227791703	G/T	cg11843606	chr2:227700838	RHBDD1	-0.6	-4.81	-0.48	7.17e-6	Pulmonary function;
SKCM	cis	rs826838	0.967	rs11168985	chr12:39045983	A/C	cg26384229	chr12:38710491	ALG10B	-0.94	-8.4	-0.69	1.59e-12	Heart rate;
SKCM	cis	rs12950390	0.853	rs8071192	chr17:45856141	A/G	cg03474202	chr17:45855739	NA	-0.49	-5.58	-0.53	3.34e-7	IgG glycosylation;
SKCM	cis	rs2730245	0.615	rs2527207	chr7:158743078	A/G	cg24397884	chr7:158709396	WDR60	-0.96	-5.25	-0.51	1.28e-6	Height;
SKCM	cis	rs9951698	0.703	rs6505776	chr18:12984144	C/A	cg12848697	chr18:13133368	NA	0.53	4.96	0.49	4.04e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs801193	0.569	rs2659893	chr7:66199993	G/A	cg11764359	chr7:65958608	NA	0.75	6.82	0.61	1.71e-9	Aortic root size;
SKCM	cis	rs8180040	0.966	rs11707895	chr3:47574937	G/A	cg27129171	chr3:47204927	SETD2	-0.81	-5.66	-0.54	2.44e-7	Colorectal cancer;
SKCM	cis	rs769267	0.895	rs2965183	chr19:19545696	G/A	cg26732615	chr19:19648335	CILP2;YJEFN3	0.67	6.92	0.62	1.13e-9	Tonsillectomy;
SKCM	cis	rs709400	0.604	rs7158144	chr14:103887615	A/G	cg26031613	chr14:104095156	KLC1	0.69	5.03	0.49	3.05e-6	Body mass index;
SKCM	cis	rs4319547	0.656	rs10773088	chr12:122828069	A/T	cg23029597	chr12:123009494	RSRC2	-0.73	-5.22	-0.51	1.41e-6	Body mass index;
SKCM	cis	rs28595532	0.920	rs114653217	chr4:119769216	G/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs2243480	1.000	rs4145008	chr7:65647511	T/G	cg18252515	chr7:66147081	NA	1.36	8.16	0.68	4.6e-12	Diabetic kidney disease;
SKCM	cis	rs2228479	0.541	rs62052173	chr16:89950739	T/C	cg00800038	chr16:89945340	TCF25	-0.94	-5.67	-0.54	2.3e-7	Skin colour saturation;
SKCM	trans	rs208520	0.661	rs207079	chr6:66770462	C/T	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-1.04	-7.86	-0.66	1.76e-11	Exhaled nitric oxide output;
SKCM	cis	rs7208859	0.573	rs73267872	chr17:29067207	T/C	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs7618915	0.570	rs2336145	chr3:52629750	A/C	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs10870270	0.913	rs4550	chr10:133781798	C/T	cg17892150	chr10:133769511	PPP2R2D	-0.66	-4.86	-0.48	5.92e-6	Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals;
SKCM	cis	rs62238980	0.614	rs75142210	chr22:32398992	G/A	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs732528	0.501	rs6508036	chr18:48359730	A/G	cg03255741	chr18:48556964	SMAD4	0.67	4.98	0.49	3.69e-6	Entorhinal cortical thickness;
SKCM	cis	rs67311347	0.544	rs12054197	chr3:40337562	C/T	cg13409248	chr3:40428643	ENTPD3	0.57	5.57	0.53	3.48e-7	Renal cell carcinoma;
SKCM	cis	rs11098499	0.690	rs7674713	chr4:120322257	T/C	cg09307838	chr4:120376055	NA	0.93	7.3	0.64	2.09e-10	Corneal astigmatism;
SKCM	cis	rs3789045	0.826	rs55979051	chr1:204567041	A/G	cg17419461	chr1:204415978	PIK3C2B	-0.72	-4.85	-0.48	6.14e-6	Educational attainment (college completion);
SKCM	cis	rs6120849	0.754	rs6087667	chr20:33651887	A/G	cg24642439	chr20:33292090	TP53INP2	0.94	4.86	0.48	5.91e-6	Protein C levels;
SKCM	cis	rs60871478	0.947	rs7790823	chr7:788923	T/G	cg04727924	chr7:799746	HEATR2	-0.6	-4.8	-0.48	7.39e-6	Cerebrospinal P-tau181p levels;
SKCM	cis	rs7618501	0.669	rs7634084	chr3:49949834	A/T	cg05072774	chr3:49840536	C3orf54	-0.64	-4.81	-0.48	7.15e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2816062	0.965	rs2816061	chr1:18903819	A/G	cg18795169	chr1:18902165	NA	0.74	5.71	0.54	1.95e-7	Urate levels in lean individuals;
SKCM	cis	rs453301	0.653	rs7853	chr8:8890814	A/G	cg06636001	chr8:8085503	FLJ10661	0.79	6.29	0.58	1.73e-8	Joint mobility (Beighton score);
SKCM	cis	rs7829975	0.502	rs11785183	chr8:8565957	G/A	cg06636001	chr8:8085503	FLJ10661	-0.72	-5.27	-0.51	1.2e-6	Mood instability;
SKCM	cis	rs8064024	0.590	rs7186142	chr16:4900987	A/G	cg09549813	chr16:4587862	C16orf5	0.59	4.95	0.49	4.12e-6	Cancer;
SKCM	cis	rs875971	0.862	rs7786892	chr7:65628876	G/A	cg11764359	chr7:65958608	NA	-0.8	-7.66	-0.66	4.2e-11	Aortic root size;
SKCM	cis	rs2224391	0.955	rs2773322	chr6:5263065	C/T	cg09085698	chr6:5261316	LYRM4;FARS2	-0.77	-5.73	-0.54	1.79e-7	Height;
SKCM	cis	rs637571	0.544	rs55704213	chr11:65730002	C/A	cg02427764	chr11:65769310	BANF1;EIF1AD	0.76	5.82	0.55	1.26e-7	Eosinophil percentage of white cells;
SKCM	cis	rs1153858	0.943	rs8038342	chr15:45651537	T/C	cg10760299	chr15:45669010	GATM	0.62	6.35	0.58	1.3e-8	Homoarginine levels;
SKCM	cis	rs9790314	1.000	rs1993891	chr3:161047467	A/G	cg03342759	chr3:160939853	NMD3	-0.72	-7.87	-0.67	1.65e-11	Morning vs. evening chronotype;
SKCM	cis	rs9513627	1.000	rs9513627	chr13:100196952	G/A	cg11288260	chr13:100117058	NA	0.79	4.78	0.48	8.1e-6	Obesity-related traits;
SKCM	cis	rs9467773	0.583	rs1021373	chr6:26632457	G/A	cg09904177	chr6:26538194	HMGN4	0.58	5.01	0.49	3.28e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs17065868	1.000	rs9533890	chr13:45098674	C/G	cg10246903	chr13:45222710	NA	-0.99	-4.95	-0.49	4.11e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs67311347	0.544	rs60329764	chr3:40334621	C/T	cg13409248	chr3:40428643	ENTPD3	-0.56	-5.23	-0.51	1.39e-6	Renal cell carcinoma;
SKCM	cis	rs17376456	0.877	rs12153501	chr5:93360866	T/G	cg21475434	chr5:93447410	FAM172A	0.95	5.36	0.52	8.36e-7	Diabetic retinopathy;
SKCM	cis	rs12200782	0.530	rs6929908	chr6:26555289	C/A	cg11502198	chr6:26597334	ABT1	0.77	4.92	0.49	4.73e-6	Small cell lung carcinoma;
SKCM	cis	rs1577917	0.560	rs12193777	chr6:86246709	C/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.76	6.82	0.61	1.72e-9	Response to antipsychotic treatment;
SKCM	cis	rs8072100	0.967	rs8075411	chr17:45676760	C/T	cg08085267	chr17:45401833	C17orf57	0.62	5.49	0.53	4.77e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs6951245	0.554	rs75075857	chr7:1140298	C/T	cg23708337	chr7:1209742	NA	0.71	4.94	0.49	4.35e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs17685	0.753	rs1639617	chr7:75701728	A/G	cg01364799	chr7:75623366	TMEM120A	-0.72	-5.81	-0.55	1.31e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs3087591	1.000	rs6505234	chr17:29688299	G/A	cg24425628	chr17:29625626	OMG;NF1	-0.62	-4.8	-0.48	7.51e-6	Hip circumference;
SKCM	cis	rs34779708	0.931	rs35388511	chr10:35296616	A/G	cg03585969	chr10:35415529	CREM	0.73	6.02	0.56	5.38e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs7959452	0.590	rs11177619	chr12:69758871	G/A	cg14784868	chr12:69753453	YEATS4	0.8	7.57	0.65	6.41e-11	Blood protein levels;
SKCM	cis	rs9581857	0.547	rs78273785	chr13:28052884	T/C	cg22138327	chr13:27999177	GTF3A	0.93	6.24	0.58	2.11e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs4665809	0.590	rs13016300	chr2:26468365	G/C	cg26119090	chr2:26468346	HADHA;HADHB	1.06	8.39	0.69	1.66e-12	Gut microbiome composition (summer);
SKCM	trans	rs17685	0.725	rs2302436	chr7:75676988	A/T	cg19862616	chr7:65841803	NCRNA00174	-0.94	-9.39	-0.73	1.88e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs3741151	1.000	rs79038783	chr11:73038746	C/G	cg17517138	chr11:73019481	ARHGEF17	1.25	4.84	0.48	6.43e-6	GIP levels in response to oral glucose tolerance test (120 minutes);
SKCM	cis	rs12142240	0.698	rs56909107	chr1:46808224	A/C	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs2073499	0.935	rs57838764	chr3:50374568	T/C	cg08207895	chr3:50388901	TUSC4;CYB561D2	0.73	4.9	0.49	5e-6	Schizophrenia;
SKCM	cis	rs62238980	0.614	rs117441849	chr22:32489297	T/A	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs4319547	0.656	rs10846664	chr12:122823777	C/T	cg23029597	chr12:123009494	RSRC2	0.75	5.48	0.53	5.05e-7	Body mass index;
SKCM	cis	rs2732480	0.577	rs2634684	chr12:48730875	C/T	cg21348975	chr12:48724119	NA	0.6	5.25	0.51	1.26e-6	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs644799	0.965	rs2950522	chr11:95524719	C/T	cg03916912	chr11:95522834	CEP57;FAM76B	0.92	8.04	0.67	8e-12	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs7937682	0.924	rs10891284	chr11:111527737	T/C	cg09085632	chr11:111637200	PPP2R1B	-1.05	-12.29	-0.81	6.25e-20	Primary sclerosing cholangitis;
SKCM	cis	rs7618915	0.571	rs11130307	chr3:52607682	G/A	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs2228479	0.850	rs11641552	chr16:89838700	C/A	cg06558623	chr16:89946397	TCF25	1.11	5.26	0.51	1.23e-6	Skin colour saturation;
SKCM	cis	rs6696846	0.749	rs7553876	chr1:205079915	A/G	cg00857998	chr1:205179979	DSTYK	0.59	4.83	0.48	6.79e-6	Red blood cell count;
SKCM	cis	rs7100689	0.577	rs10788545	chr10:82034675	A/G	cg01528321	chr10:82214614	TSPAN14	0.81	7.44	0.64	1.12e-10	Post bronchodilator FEV1;
SKCM	cis	rs9815354	0.812	rs73071212	chr3:41981856	C/A	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs910316	0.967	rs175432	chr14:75615246	C/G	cg08847533	chr14:75593920	NEK9	-0.94	-8.78	-0.7	2.95e-13	Height;
SKCM	cis	rs72717009	0.825	rs10494360	chr1:161475750	G/A	cg23840854	chr1:161414152	NA	-0.99	-5.66	-0.54	2.44e-7	Rheumatoid arthritis;
SKCM	cis	rs1160297	0.539	rs12469781	chr2:53136539	C/T	cg07782112	chr2:53107842	NA	-0.61	-5.95	-0.56	7.12e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs995000	0.826	rs12023489	chr1:62923858	G/A	cg06896770	chr1:63153194	DOCK7	0.74	7.18	0.63	3.62e-10	Triglyceride levels;
SKCM	cis	rs16854884	0.770	rs1530478	chr3:143819553	C/T	cg06585982	chr3:143692056	C3orf58	0.63	5.0	0.49	3.44e-6	Economic and political preferences (feminism/equality);
SKCM	cis	rs1799949	0.965	rs12950779	chr17:41306523	C/T	cg05368731	chr17:41323189	NBR1	0.89	7.98	0.67	1.03e-11	Menopause (age at onset);
SKCM	cis	rs11673344	0.764	rs10403679	chr19:37471712	G/C	cg07624650	chr19:37064219	ZNF529	-0.78	-4.82	-0.48	7.05e-6	Obesity-related traits;
SKCM	cis	rs9303401	0.592	rs66583824	chr17:56639853	C/T	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.61	0.54	2.94e-7	Cognitive test performance;
SKCM	cis	rs17376456	0.757	rs10476591	chr5:93333723	G/C	cg21475434	chr5:93447410	FAM172A	0.97	5.32	0.52	9.66e-7	Diabetic retinopathy;
SKCM	cis	rs478304	0.651	rs11604451	chr11:65551710	C/T	cg27068330	chr11:65405492	SIPA1	-0.92	-8.24	-0.68	3.29e-12	Acne (severe);
SKCM	cis	rs7666738	0.544	rs35160902	chr4:98974690	A/T	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9894429	1.000	rs9674872	chr17:79581931	T/A	cg18240062	chr17:79603768	NPLOC4	0.76	7.43	0.64	1.2e-10	Eye color traits;
SKCM	cis	rs6456156	0.565	rs12529238	chr6:167465576	G/A	cg13927040	chr6:167453801	FGFR1OP	0.66	4.85	0.48	6.24e-6	Primary biliary cholangitis;
SKCM	cis	rs2404602	0.647	rs12904149	chr15:77043652	A/C	cg23625390	chr15:77176239	SCAPER	-0.85	-8.26	-0.68	2.93e-12	Blood metabolite levels;
SKCM	cis	rs6546550	0.935	rs13017134	chr2:70090579	C/G	cg02498382	chr2:70120550	SNRNP27	-0.47	-5.25	-0.51	1.3e-6	Prevalent atrial fibrillation;
SKCM	cis	rs1005277	0.522	rs289647	chr10:37968278	A/G	cg25427524	chr10:38739819	LOC399744	-0.62	-6.06	-0.57	4.56e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs9911578	1.000	rs12936058	chr17:57017420	T/C	cg12560992	chr17:57184187	TRIM37	0.94	7.55	0.65	7.01e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs1568889	1.000	rs7949057	chr11:28255053	A/C	cg06544937	chr11:28130018	METT5D1;KIF18A	0.84	6.6	0.6	4.46e-9	Bipolar disorder;
SKCM	cis	rs7208859	0.673	rs9898858	chr17:29156211	A/T	cg13385521	chr17:29058706	SUZ12P	0.9	4.78	0.48	8.1e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs12458462	0.892	rs35928863	chr18:77438956	A/G	cg11879182	chr18:77439856	CTDP1	0.91	7.93	0.67	1.26e-11	Monocyte count;
SKCM	cis	rs7659604	0.840	rs6821305	chr4:122713863	A/C	cg06713675	chr4:122721982	EXOSC9	-0.7	-6.72	-0.61	2.68e-9	Type 2 diabetes;
SKCM	cis	rs34172651	0.517	rs2303084	chr16:24834581	G/C	cg04756594	chr16:24857601	SLC5A11	0.7	4.89	0.48	5.34e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs875971	1.000	rs6970030	chr7:65968679	T/C	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs9583531	0.600	rs754599	chr13:111354788	C/A	cg15841412	chr13:111365552	ING1	0.73	4.8	0.48	7.53e-6	Coronary artery disease;
SKCM	cis	rs910316	0.967	rs2024653	chr14:75595154	G/A	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.85e-7	Height;
SKCM	cis	rs7959452	0.590	rs28778648	chr12:69771911	C/A	cg20891283	chr12:69753455	YEATS4	0.9	9.17	0.72	4.95e-14	Blood protein levels;
SKCM	trans	rs9503598	0.542	rs746933	chr6:3444617	C/T	cg06892006	chr12:131568441	GPR133	0.55	7.31	0.64	2.06e-10	Cognitive ability (multi-trait analysis);Cognitive ability;Intelligence (multi-trait analysis);
SKCM	cis	rs6921919	0.583	rs6922374	chr6:28381272	T/C	cg14547644	chr6:28411285	ZSCAN23	-0.58	-4.8	-0.48	7.46e-6	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs4237845	0.537	rs2002275	chr12:58283385	A/G	cg00677455	chr12:58241039	CTDSP2	0.84	7.64	0.65	4.62e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs8017423	0.569	rs10141476	chr14:90823351	C/T	cg04374321	chr14:90722782	PSMC1	-0.73	-5.53	-0.53	4.08e-7	Mortality in heart failure;
SKCM	cis	rs8177179	0.967	rs9869311	chr3:133451613	C/T	cg16262614	chr3:133464971	TF	0.43	5.38	0.52	7.59e-7	Iron status biomarkers (transferrin levels);
SKCM	cis	rs116095464	0.619	rs2303741	chr5:218356	T/C	cg22496380	chr5:211416	CCDC127	-0.96	-5.27	-0.51	1.18e-6	Breast cancer;
SKCM	cis	rs11098499	0.909	rs28632018	chr4:120386730	T/C	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs2075371	0.932	rs2598290	chr7:133987736	C/G	cg20476274	chr7:133979776	SLC35B4	1.01	10.44	0.76	1.77e-16	Mean platelet volume;
SKCM	cis	rs7666738	0.791	rs28579101	chr4:98843203	T/C	cg05340658	chr4:99064831	C4orf37	0.6	4.81	0.48	7.19e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs28386778	0.897	rs2584615	chr17:61927774	T/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.12	11.27	0.79	4.92e-18	Prudent dietary pattern;
SKCM	cis	rs9399135	0.935	rs6908681	chr6:135337733	A/G	cg24558204	chr6:135376177	HBS1L	0.59	5.22	0.51	1.42e-6	Red blood cell count;
SKCM	cis	rs992157	0.775	rs1877714	chr2:219134928	A/G	cg00012203	chr2:219082015	ARPC2	-0.79	-6.25	-0.58	2.02e-8	Colorectal cancer;
SKCM	cis	rs6545883	0.507	rs34668697	chr2:61568349	T/A	cg15711740	chr2:61764176	XPO1	0.66	5.12	0.5	2.17e-6	Tuberculosis;
SKCM	cis	rs470903	0.891	rs2974261	chr18:74712382	G/T	cg05896682	chr18:74964030	GALR1	0.58	5.84	0.55	1.14e-7	Paclitaxel disposition in epithelial ovarian cancer;
SKCM	cis	rs7777484	0.534	rs2533886	chr7:2834869	C/T	cg09658497	chr7:2847517	GNA12	-0.38	-4.83	-0.48	6.58e-6	Height;
SKCM	trans	rs8073060	0.561	rs225260	chr17:33958422	T/C	cg19694781	chr19:47549865	TMEM160	-1.08	-8.41	-0.69	1.53e-12	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs2739330	0.760	rs5751761	chr22:24243736	A/G	cg12419862	chr22:24373484	LOC391322	0.74	6.68	0.6	3.11e-9	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs7666738	0.830	rs11938686	chr4:98964470	A/G	cg17366294	chr4:99064904	C4orf37	0.59	4.89	0.48	5.36e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6951245	1.000	rs77702926	chr7:1088838	G/A	cg18402987	chr7:1209562	NA	1.14	6.01	0.56	5.68e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs2836974	0.897	rs2836925	chr21:40532353	T/C	cg11644478	chr21:40555479	PSMG1	0.97	10.21	0.76	5.08e-16	Cognitive function;
SKCM	cis	rs9325144	0.752	rs12300353	chr12:39154492	G/C	cg26384229	chr12:38710491	ALG10B	-0.7	-6.26	-0.58	1.93e-8	Morning vs. evening chronotype;
SKCM	cis	rs28386778	0.897	rs2727320	chr17:61865325	T/C	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs2243480	0.901	rs34807232	chr7:65965133	G/A	cg18252515	chr7:66147081	NA	-1.35	-8.04	-0.67	8e-12	Diabetic kidney disease;
SKCM	cis	rs8060686	0.565	rs8044328	chr16:68146859	G/C	cg04539111	chr16:67997858	SLC12A4	-0.85	-4.81	-0.48	7.14e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs6951245	0.580	rs78894484	chr7:1138721	T/G	cg23708337	chr7:1209742	NA	0.71	4.9	0.49	5.02e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs12044355	0.858	rs28434312	chr1:231819913	C/G	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	0.82	6.24	0.58	2.14e-8	Alzheimer's disease;
SKCM	cis	rs10751667	0.643	rs7942693	chr11:957832	G/A	cg10932868	chr11:921992	NA	0.55	5.1	0.5	2.36e-6	Alzheimer's disease (late onset);
SKCM	cis	rs6840360	0.615	rs72728179	chr4:152477877	A/G	cg22705602	chr4:152727874	NA	-0.51	-5.78	-0.55	1.45e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7020830	0.894	rs28766572	chr9:37093872	G/T	cg14294708	chr9:37120828	ZCCHC7	1.06	9.71	0.74	4.56e-15	Schizophrenia;
SKCM	cis	rs6486730	1.000	rs6486730	chr12:129275027	C/T	cg09035930	chr12:129282057	SLC15A4	0.69	6.42	0.59	9.97e-9	Systemic lupus erythematosus;
SKCM	cis	rs2841277	0.616	rs1048257	chr14:105404384	T/C	cg15352829	chr14:105391018	PLD4	-0.58	-4.81	-0.48	7.35e-6	Rheumatoid arthritis;
SKCM	cis	rs10504229	1.000	rs72650892	chr8:58179714	A/G	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs9790314	1.000	rs163328	chr3:161073599	A/G	cg03342759	chr3:160939853	NMD3	-0.72	-7.89	-0.67	1.51e-11	Morning vs. evening chronotype;
SKCM	cis	rs2282032	1.000	rs2282032	chr14:90758891	G/T	cg04374321	chr14:90722782	PSMC1	0.7	4.88	0.48	5.48e-6	Longevity;
SKCM	cis	rs6430585	0.583	rs2304371	chr2:136561557	A/G	cg07169764	chr2:136633963	MCM6	1.04	8.25	0.68	3.12e-12	Corneal structure;
SKCM	trans	rs8073060	0.586	rs226090	chr17:34034059	C/T	cg19694781	chr19:47549865	TMEM160	-1.08	-8.6	-0.7	6.4e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs3008870	1.000	rs2815348	chr1:67472165	G/C	cg08660285	chr1:67390436	MIER1;WDR78	0.91	5.96	0.56	6.81e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs72949976	0.646	rs1441171	chr2:214033637	G/T	cg08319019	chr2:214017104	IKZF2	0.82	6.64	0.6	3.8e-9	Lung cancer;Squamous cell lung carcinoma;
SKCM	cis	rs1003719	0.788	rs11911508	chr21:38470504	T/C	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs7954584	0.567	rs10840632	chr12:122375460	C/T	cg22168489	chr12:122356033	WDR66	0.46	4.78	0.48	8.01e-6	Mean corpuscular volume;
SKCM	cis	rs9309711	0.666	rs6723101	chr2:3484443	T/C	cg15506890	chr2:3487001	NA	-0.62	-5.03	-0.5	3.02e-6	Neurofibrillary tangles;
SKCM	cis	rs1577917	1.000	rs12199516	chr6:86726221	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.63	-5.38	-0.52	7.46e-7	Response to antipsychotic treatment;
SKCM	cis	rs17213078	0.602	rs4851113	chr2:106747009	G/C	cg16099169	chr2:106886729	NA	0.54	4.77	0.48	8.46e-6	Facial morphology (factor 23);
SKCM	cis	rs651907	0.535	rs13059470	chr3:101424800	A/G	cg12386194	chr3:101231763	SENP7	-0.69	-5.68	-0.54	2.23e-7	Colorectal cancer;
SKCM	cis	rs910316	1.000	rs10140851	chr14:75512612	G/A	cg08847533	chr14:75593920	NEK9	0.95	9.18	0.72	4.92e-14	Height;
SKCM	cis	rs8072100	0.967	rs2317826	chr17:45730899	C/T	cg08085267	chr17:45401833	C17orf57	-0.63	-5.86	-0.55	1.06e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs208520	0.690	rs1318604	chr6:66825278	A/C	cg07460842	chr6:66804631	NA	-1.09	-8.46	-0.69	1.22e-12	Exhaled nitric oxide output;
SKCM	cis	rs854765	0.583	rs9912895	chr17:17826020	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	-1.0	-7.4	-0.64	1.35e-10	Total body bone mineral density;
SKCM	cis	rs362272	0.524	rs881816	chr4:3365366	A/G	cg09735869	chr4:3319127	RGS12	1.0	11.3	0.79	4.32e-18	Serum sulfate level;
SKCM	cis	rs875971	0.540	rs736270	chr7:65428822	T/C	cg18876405	chr7:65276391	NA	0.85	7.91	0.67	1.39e-11	Aortic root size;
SKCM	cis	rs6570726	0.846	rs411468	chr6:145832792	A/G	cg23711669	chr6:146136114	FBXO30	0.7	6.64	0.6	3.72e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9790314	0.704	rs4618258	chr3:160869129	G/C	cg03342759	chr3:160939853	NMD3	-0.69	-6.59	-0.6	4.79e-9	Morning vs. evening chronotype;
SKCM	cis	rs12478296	1.000	rs4973685	chr2:243019089	A/C	cg06360820	chr2:242988706	NA	-1.0	-5.16	-0.5	1.83e-6	Obesity-related traits;
SKCM	cis	rs4740619	0.587	rs2382551	chr9:16033443	C/T	cg14451791	chr9:16040625	NA	-0.47	-4.81	-0.48	7.13e-6	Body mass index;
SKCM	trans	rs1814175	0.817	rs2866863	chr11:49953242	C/T	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs7937682	0.814	rs1784788	chr11:111486136	T/G	cg19812747	chr11:111475976	SIK2	-0.56	-4.99	-0.49	3.61e-6	Primary sclerosing cholangitis;
SKCM	cis	rs11098499	0.690	rs34818745	chr4:120257055	T/C	cg09307838	chr4:120376055	NA	0.97	7.3	0.64	2.14e-10	Corneal astigmatism;
SKCM	cis	rs7666738	0.830	rs1426668	chr4:98945585	T/A	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2075371	0.501	rs1643051	chr7:134025372	A/G	cg20476274	chr7:133979776	SLC35B4	-0.83	-7.07	-0.62	5.84e-10	Mean platelet volume;
SKCM	cis	rs9394841	0.667	rs3747749	chr6:41770604	G/A	cg08135965	chr6:41755394	TOMM6	0.75	4.96	0.49	3.96e-6	Mean corpuscular hemoglobin;Red cell distribution width;
SKCM	cis	rs34779708	0.966	rs4934732	chr10:35431684	T/C	cg03585969	chr10:35415529	CREM	0.73	6.02	0.56	5.28e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs2153535	0.580	rs969422	chr6:8451780	A/T	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs9815354	0.812	rs17217536	chr3:41923300	A/C	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs7666738	0.830	rs6839277	chr4:99015563	C/T	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10504229	0.683	rs16921817	chr8:58107563	A/T	cg02725872	chr8:58115012	NA	-0.53	-4.91	-0.49	4.82e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs116095464	0.558	rs12173244	chr5:269524	G/A	cg22857025	chr5:266934	NA	-1.47	-7.89	-0.67	1.54e-11	Breast cancer;
SKCM	cis	rs1577917	0.958	rs72907388	chr6:86440207	C/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.75	-6.52	-0.59	6.3e-9	Response to antipsychotic treatment;
SKCM	cis	rs6570726	0.791	rs378937	chr6:145834745	C/T	cg23711669	chr6:146136114	FBXO30	0.79	8.32	0.69	2.28e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs17376456	0.825	rs10036024	chr5:93074804	C/A	cg21475434	chr5:93447410	FAM172A	0.94	5.16	0.5	1.8e-6	Diabetic retinopathy;
SKCM	cis	rs8180040	0.966	rs13064843	chr3:47415467	C/T	cg16586182	chr3:47516702	SCAP	-0.76	-5.32	-0.52	9.63e-7	Colorectal cancer;
SKCM	cis	rs873946	0.504	rs12254034	chr10:134571007	T/C	cg14275445	chr10:134560047	INPP5A	-0.54	-4.77	-0.48	8.51e-6	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs2032447	0.869	rs2230655	chr6:26033506	A/G	cg18357526	chr6:26021779	HIST1H4A	-0.84	-7.17	-0.63	3.78e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs10927875	0.632	rs4481843	chr1:16128205	G/A	cg21385522	chr1:16154831	NA	-0.98	-11.21	-0.79	6.28e-18	Dilated cardiomyopathy;
SKCM	cis	rs9875589	0.509	rs7614591	chr3:14061118	A/T	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.52	5.24	0.51	1.34e-6	Ovarian reserve;
SKCM	cis	rs2204008	0.652	rs11520002	chr12:38022179	G/T	cg26384229	chr12:38710491	ALG10B	0.83	6.72	0.61	2.69e-9	Bladder cancer;
SKCM	cis	rs875971	0.508	rs10258739	chr7:66062935	A/T	cg11987759	chr7:65425863	GUSB	0.68	5.86	0.55	1.04e-7	Aortic root size;
SKCM	cis	rs1635	0.655	rs60698636	chr6:28316045	A/G	cg15743358	chr6:28303923	ZNF323	-1.27	-5.15	-0.5	1.92e-6	Schizophrenia;
SKCM	cis	rs867186	0.841	rs76110461	chr20:33552305	C/T	cg04194272	chr20:33683537	NA	-1.37	-6.77	-0.61	2.18e-9	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs12762955	0.561	rs1904671	chr10:1014603	G/A	cg25614935	chr10:1084866	C10orf110	-0.65	-4.83	-0.48	6.77e-6	Response to angiotensin II receptor blocker therapy;
SKCM	cis	rs9467773	1.000	rs9461259	chr6:26504835	C/A	cg15659132	chr6:26577336	NA	0.61	5.82	0.55	1.24e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7584330	0.652	rs7607231	chr2:238372896	T/C	cg14458575	chr2:238380390	NA	0.89	6.2	0.57	2.45e-8	Prostate cancer;
SKCM	cis	rs6120849	0.707	rs3746448	chr20:33572979	C/T	cg24642439	chr20:33292090	TP53INP2	0.98	5.01	0.49	3.28e-6	Protein C levels;
SKCM	cis	rs2991971	0.716	rs7532573	chr1:45915892	A/T	cg24296786	chr1:45957014	TESK2	-0.65	-5.24	-0.51	1.31e-6	High light scatter reticulocyte count;
SKCM	cis	rs7666738	0.830	rs35235971	chr4:98999833	G/T	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1577917	1.000	rs7771342	chr6:86631936	C/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.85	-8.62	-0.7	5.82e-13	Response to antipsychotic treatment;
SKCM	cis	rs17345786	0.906	rs56171035	chr3:101111108	G/C	cg11279151	chr3:101281821	RG9MTD1	-0.62	-5.03	-0.5	3.01e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11098499	0.754	rs12506487	chr4:120271361	T/G	cg09307838	chr4:120376055	NA	0.94	7.73	0.66	3.07e-11	Corneal astigmatism;
SKCM	cis	rs7940866	0.834	rs7939417	chr11:130853832	T/A	cg12179176	chr11:130786555	SNX19	0.79	6.04	0.56	4.84e-8	Schizophrenia;
SKCM	cis	rs7980687	0.628	rs1609520	chr12:123735937	A/G	cg05973401	chr12:123451056	ABCB9	-0.75	-5.83	-0.55	1.18e-7	Height;Educational attainment;Head circumference (infant);
SKCM	cis	rs1707322	1.000	rs4660318	chr1:46334876	A/G	cg03146154	chr1:46216737	IPP	0.75	5.15	0.5	1.94e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs933688	1.000	rs7715402	chr5:90679504	T/A	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.05	8.26	0.68	2.89e-12	Smoking behavior;
SKCM	cis	rs950027	0.596	rs2467853	chr15:45698793	T/G	cg21132104	chr15:45694354	SPATA5L1	0.74	5.41	0.52	6.68e-7	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs16949788	1.000	rs78288367	chr15:66772721	C/T	cg08120210	chr15:66682733	MAP2K1	-0.74	-5.69	-0.54	2.1e-7	Spherical equivalent (joint analysis main effects and education interaction);
SKCM	cis	rs9905704	0.647	rs9898048	chr17:57108543	C/T	cg05425664	chr17:57184151	TRIM37	-0.61	-5.03	-0.5	3.02e-6	Testicular germ cell tumor;
SKCM	cis	rs9902453	0.740	rs2244247	chr17:28110174	G/A	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.78	-5.89	-0.56	9.1e-8	Coffee consumption (cups per day);
SKCM	cis	rs2739330	0.828	rs5760098	chr22:24248314	A/G	cg04234412	chr22:24373322	LOC391322	-0.63	-5.08	-0.5	2.52e-6	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs9399135	0.967	rs2150681	chr6:135375232	A/G	cg24558204	chr6:135376177	HBS1L	-0.59	-5.12	-0.5	2.17e-6	Red blood cell count;
SKCM	cis	rs12047808	0.841	rs73050574	chr1:179379019	A/T	cg09822482	chr1:179519214	C1orf125	-0.95	-5.17	-0.51	1.78e-6	Multiple sclerosis (age of onset);
SKCM	cis	rs1865760	0.534	rs2032444	chr6:26046744	T/G	cg17691542	chr6:26056736	HIST1H1C	0.76	5.85	0.55	1.1e-7	Height;
SKCM	cis	rs684232	0.602	rs445268	chr17:563338	G/A	cg15660573	chr17:549704	VPS53	-0.77	-6.1	-0.57	3.77e-8	Prostate cancer;
SKCM	cis	rs11764590	0.694	rs3996323	chr7:2079428	G/T	cg02825527	chr7:2087843	MAD1L1	-0.62	-4.97	-0.49	3.84e-6	Neuroticism;
SKCM	cis	rs9926664	0.591	rs1519978	chr16:85935211	A/T	cg16682899	chr16:85508110	NA	-0.56	-5.64	-0.54	2.61e-7	Sum basophil neutrophil counts;Neutrophil count;
SKCM	cis	rs17345786	0.628	rs11718446	chr3:101552553	C/T	cg12386194	chr3:101231763	SENP7	0.67	4.8	0.48	7.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2243480	1.000	rs56291018	chr7:65390339	G/A	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs1153858	1.000	rs12594857	chr15:45667178	A/G	cg10760299	chr15:45669010	GATM	0.62	6.35	0.58	1.3e-8	Homoarginine levels;
SKCM	cis	rs8072100	0.676	rs9905308	chr17:45409386	T/A	cg25173405	chr17:45401733	C17orf57	-0.73	-5.94	-0.56	7.45e-8	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs2816062	0.786	rs2745320	chr1:18893592	G/A	cg18795169	chr1:18902165	NA	-0.83	-9.02	-0.71	1.01e-13	Urate levels in lean individuals;
SKCM	cis	rs6866344	0.697	rs72812613	chr5:178135257	G/A	cg03877680	chr5:178157825	ZNF354A	0.88	6.61	0.6	4.35e-9	Neutrophil percentage of white cells;
SKCM	cis	rs7659604	0.582	rs3217780	chr4:122737278	T/C	cg06713675	chr4:122721982	EXOSC9	-0.75	-7.26	-0.64	2.47e-10	Type 2 diabetes;
SKCM	cis	rs11098499	0.865	rs28753180	chr4:120405367	A/T	cg24375607	chr4:120327624	NA	0.66	5.09	0.5	2.44e-6	Corneal astigmatism;
SKCM	cis	rs34172651	0.517	rs11639856	chr16:24788645	A/T	cg06028605	chr16:24865363	SLC5A11	-0.59	-4.98	-0.49	3.66e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs11690935	0.959	rs6724337	chr2:172735329	C/T	cg13550731	chr2:172543902	DYNC1I2	-0.95	-8.21	-0.68	3.64e-12	Schizophrenia;
SKCM	cis	rs6089829	0.888	rs4809467	chr20:61671688	A/G	cg03213289	chr20:61660250	NA	0.51	5.07	0.5	2.58e-6	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs36093844	0.752	rs17744606	chr11:85565450	C/T	cg25872744	chr11:85566296	CCDC83	-0.85	-4.77	-0.48	8.27e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs9894429	0.809	rs9889642	chr17:79591762	T/C	cg18240062	chr17:79603768	NPLOC4	0.77	7.44	0.64	1.15e-10	Eye color traits;
SKCM	cis	rs1568889	1.000	rs7937778	chr11:28104605	C/T	cg06544937	chr11:28130018	METT5D1;KIF18A	0.86	7.03	0.62	6.97e-10	Bipolar disorder;
SKCM	trans	rs17685	0.753	rs10476	chr7:75696420	C/T	cg19862616	chr7:65841803	NCRNA00174	-0.97	-9.49	-0.73	1.19e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs62238980	0.614	rs74658500	chr22:32410101	C/A	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs1707322	1.000	rs4660328	chr1:46444831	G/T	cg03146154	chr1:46216737	IPP	0.79	5.34	0.52	8.73e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs2836974	0.644	rs7281853	chr21:40693490	A/G	cg11644478	chr21:40555479	PSMG1	-0.64	-5.14	-0.5	1.95e-6	Cognitive function;
SKCM	cis	rs13256369	1.000	rs7004438	chr8:8574379	C/T	cg06636001	chr8:8085503	FLJ10661	0.72	5.39	0.52	7.26e-7	Obesity-related traits;
SKCM	cis	rs2033711	0.870	rs1051500	chr19:58944402	A/G	cg12042659	chr19:58951599	ZNF132	0.68	5.87	0.55	1e-7	Uric acid clearance;
SKCM	cis	rs9911578	1.000	rs999431	chr17:56854441	A/G	cg12560992	chr17:57184187	TRIM37	0.95	7.54	0.65	7.14e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs9467773	0.935	rs11752946	chr6:26560364	C/A	cg15659132	chr6:26577336	NA	0.62	6.05	0.56	4.81e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs1153858	1.000	rs1145091	chr15:45649996	A/G	cg21132104	chr15:45694354	SPATA5L1	0.93	7.66	0.66	4.2e-11	Homoarginine levels;
SKCM	cis	rs634534	0.561	rs613924	chr11:65769295	C/T	cg26695010	chr11:65641043	EFEMP2	-0.72	-5.48	-0.53	5.15e-7	Sum eosinophil basophil counts;Eosinophil counts;
SKCM	cis	rs1912528	0.887	rs6846081	chr4:140928557	C/A	cg11128457	chr4:140864437	MAML3	0.58	4.84	0.48	6.41e-6	Educational attainment (years of education);
SKCM	cis	rs28386778	0.863	rs6919	chr17:61909485	A/T	cg22520471	chr17:61851767	DDX42;CCDC47	-0.79	-5.33	-0.52	9.35e-7	Prudent dietary pattern;
SKCM	trans	rs1814175	0.765	rs1794141	chr11:49914135	G/C	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs8082590	1	rs8082590	chr17:17958402	G/A	cg24612305	chr17:17875800	TOM1L2;LRRC48	-1.02	-9.54	-0.73	9.55e-15	Schizophrenia;
SKCM	cis	rs2836974	0.897	rs34394827	chr21:40528087	T/C	cg11644478	chr21:40555479	PSMG1	0.97	10.21	0.76	5.08e-16	Cognitive function;
SKCM	cis	rs1800469	0.598	rs8103493	chr19:41874339	T/G	cg09537434	chr19:41945824	ATP5SL	-0.72	-4.84	-0.48	6.54e-6	Colorectal cancer;
SKCM	cis	rs2033711	0.902	rs4801589	chr19:58953398	C/G	cg03735888	chr19:58951602	ZNF132	0.72	6.51	0.59	6.66e-9	Uric acid clearance;
SKCM	cis	rs67311347	0.544	rs35112505	chr3:40337075	A/G	cg00656387	chr3:40428638	ENTPD3	0.56	4.98	0.49	3.71e-6	Renal cell carcinoma;
SKCM	cis	rs933688	1.000	rs1035477	chr5:90743325	T/C	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.94	6.78	0.61	2.1e-9	Smoking behavior;
SKCM	trans	rs9929218	0.529	rs8060790	chr16:68729112	A/G	cg04657470	chr2:198365150	HSPE1;HSPD1	1.0	10.33	0.76	2.98e-16	Colorectal cancer;
SKCM	cis	rs1799949	1.000	rs4793191	chr17:41204377	A/G	cg23758822	chr17:41437982	NA	0.94	7.82	0.66	2.13e-11	Menopause (age at onset);
SKCM	cis	rs12042938	0.507	rs1655301	chr1:231731730	T/C	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	-0.55	-4.8	-0.48	7.57e-6	Neuranatomic and neurocognitive phenotypes;
SKCM	cis	rs4423214	0.802	rs4402322	chr11:71184015	C/G	cg05163923	chr11:71159392	DHCR7	-0.71	-6.07	-0.57	4.35e-8	Vitamin D levels;
SKCM	cis	rs6570726	0.935	rs391820	chr6:145821284	C/T	cg23711669	chr6:146136114	FBXO30	0.71	6.9	0.62	1.21e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs3820928	1.000	rs3731593	chr2:227773924	A/G	cg11843606	chr2:227700838	RHBDD1	-0.64	-5.2	-0.51	1.53e-6	Pulmonary function;
SKCM	cis	rs1799949	1.000	rs35330014	chr17:41212547	C/T	cg25918947	chr17:41365094	TMEM106A	-0.61	-5.91	-0.56	8.59e-8	Menopause (age at onset);
SKCM	cis	rs941873	0.772	rs7920127	chr10:81122914	T/C	cg09469691	chr10:81107165	PPIF	0.7	6.65	0.6	3.6e-9	Height;
SKCM	cis	rs1580019	0.562	rs4720064	chr7:32559638	G/A	cg06627557	chr7:32535165	LSM5;AVL9	0.94	9.12	0.72	6.39e-14	Cognitive ability;
SKCM	cis	rs9815354	0.812	rs61661916	chr3:41921915	T/C	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs72615157	0.645	rs76281814	chr7:99846414	T/C	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.18	7.4	0.64	1.33e-10	Lung function (FEV1/FVC);
SKCM	cis	rs12142240	0.698	rs17413701	chr1:46818452	A/G	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs2731664	0.792	rs466256	chr5:176875956	C/A	cg23176889	chr5:176863531	GRK6	-0.52	-5.27	-0.51	1.16e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2153535	0.580	rs1414348	chr6:8471940	A/G	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs9325144	0.647	rs11169258	chr12:39113040	C/T	cg26384229	chr12:38710491	ALG10B	-0.73	-6.23	-0.58	2.21e-8	Morning vs. evening chronotype;
SKCM	cis	rs8067354	0.645	rs2645487	chr17:57886125	T/G	cg02344993	chr17:57696989	CLTC	0.67	4.79	0.48	7.85e-6	Hemoglobin concentration;
SKCM	cis	rs35306767	0.855	rs11253459	chr10:886402	C/T	cg26597838	chr10:835615	NA	0.77	5.39	0.52	7.26e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs2204008	0.837	rs12366727	chr12:38365748	A/C	cg13010199	chr12:38710504	ALG10B	0.68	4.85	0.48	6.3e-6	Bladder cancer;
SKCM	cis	rs4631830	0.683	rs10763193	chr10:51504938	G/A	cg16070123	chr10:51489643	NA	0.51	4.84	0.48	6.5e-6	Prostate-specific antigen levels;
SKCM	cis	rs6570726	0.967	rs9403707	chr6:145800010	A/G	cg23711669	chr6:146136114	FBXO30	0.7	6.88	0.61	1.32e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs12478296	0.892	rs60545379	chr2:243034390	A/T	cg06360820	chr2:242988706	NA	-0.91	-5.31	-0.52	1.01e-6	Obesity-related traits;
SKCM	cis	rs9858542	1.000	rs34762726	chr3:49689210	G/A	cg03060546	chr3:49711283	APEH	-0.76	-5.67	-0.54	2.31e-7	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs3789045	0.819	rs16854023	chr1:204551830	A/G	cg17419461	chr1:204415978	PIK3C2B	-0.74	-5.35	-0.52	8.65e-7	Educational attainment (college completion);
SKCM	cis	rs7811142	0.830	rs7792959	chr7:99972403	C/T	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.19	7.5	0.65	8.66e-11	Platelet count;
SKCM	cis	rs826838	0.967	rs11183622	chr12:38792849	T/C	cg26384229	chr12:38710491	ALG10B	1.06	10.14	0.75	6.67e-16	Heart rate;
SKCM	cis	rs2153535	0.580	rs9328488	chr6:8529411	G/C	cg23788917	chr6:8435910	SLC35B3	0.68	4.98	0.49	3.66e-6	Motion sickness;
SKCM	cis	rs6066825	0.644	rs6019393	chr20:47334435	G/C	cg18078177	chr20:47281410	PREX1	0.63	4.96	0.49	4.07e-6	Colorectal cancer;
SKCM	cis	rs8014204	0.836	rs7153700	chr14:75268544	C/T	cg06637938	chr14:75390232	RPS6KL1	0.83	6.65	0.6	3.64e-9	Caffeine consumption;
SKCM	cis	rs7122539	0.646	rs608248	chr11:66562248	C/T	cg24851651	chr11:66362959	CCS	-0.67	-5.06	-0.5	2.69e-6	HIV-1 susceptibility;
SKCM	cis	rs7659604	1.000	rs35224452	chr4:122664677	C/T	cg06713675	chr4:122721982	EXOSC9	-0.65	-5.78	-0.55	1.48e-7	Type 2 diabetes;
SKCM	cis	rs1682361	1	rs1682361	chr3:136734014	G/C	cg21827317	chr3:136751795	NA	0.71	5.88	0.55	9.78e-8	Schizophrenia;
SKCM	cis	rs736408	0.812	rs4687654	chr3:52827566	G/A	cg11645453	chr3:52864694	ITIH4	0.61	4.89	0.48	5.4e-6	Bipolar disorder;
SKCM	cis	rs116095464	0.558	rs28418643	chr5:240859	A/G	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs4891159	0.790	rs4891018	chr18:74127082	A/T	cg24786174	chr18:74118243	ZNF516	-0.74	-7.03	-0.62	7.04e-10	Longevity;
SKCM	cis	rs2439831	0.702	rs16977724	chr15:44151299	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.3	6.97	0.62	9.12e-10	Lung cancer in ever smokers;
SKCM	cis	rs708547	0.578	rs781665	chr4:57831461	G/A	cg16868167	chr4:57843880	C4orf14;POLR2B	0.73	5.45	0.52	5.77e-7	Response to bleomycin (chromatid breaks);
SKCM	cis	rs514406	0.929	rs562178	chr1:53319562	T/C	cg16325326	chr1:53192061	ZYG11B	0.92	9.93	0.75	1.75e-15	Monocyte count;
SKCM	trans	rs1814175	0.817	rs1996982	chr11:49972619	G/T	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs6840360	0.593	rs11723227	chr4:152689717	G/A	cg22705602	chr4:152727874	NA	-0.59	-7.93	-0.67	1.3e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs4819052	0.819	rs8134084	chr21:46693295	G/A	cg19498844	chr21:46707878	POFUT2;LOC642852	0.91	7.84	0.66	1.92e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs9303401	0.614	rs12950028	chr17:56510140	A/G	cg10487724	chr17:56770010	TEX14;RAD51C	0.82	5.86	0.55	1.03e-7	Cognitive test performance;
SKCM	cis	rs2228479	0.717	rs11644967	chr16:89806614	T/A	cg06558623	chr16:89946397	TCF25	1.09	5.81	0.55	1.28e-7	Skin colour saturation;
SKCM	cis	rs28595532	0.841	rs114155681	chr4:119736427	A/G	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs763014	0.932	rs2384974	chr16:651279	C/G	cg09263875	chr16:632152	PIGQ	0.69	6.05	0.57	4.7e-8	Height;
SKCM	cis	rs7666738	0.830	rs35951881	chr4:98999474	A/C	cg17366294	chr4:99064904	C4orf37	0.6	4.98	0.49	3.8e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4853012	0.793	rs6707619	chr2:74344656	G/A	cg01017244	chr2:74357527	NA	0.7	4.78	0.48	8.1e-6	Gestational age at birth (maternal effect);
SKCM	cis	rs2836974	0.897	rs8132419	chr21:40527827	C/T	cg11890956	chr21:40555474	PSMG1	1.07	13.19	0.83	1.48e-21	Cognitive function;
SKCM	cis	rs9910055	0.540	rs609292	chr17:42180436	G/A	cg08499158	chr17:42289980	UBTF	0.72	5.62	0.54	2.9e-7	Total body bone mineral density;
SKCM	cis	rs3820068	0.581	rs61056912	chr1:15926296	A/G	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs427394	0.582	rs4701751	chr5:6704137	C/T	cg10857441	chr5:6722123	POLS	-0.66	-7.02	-0.62	7.19e-10	Menopause (age at onset);
SKCM	cis	rs12142240	0.698	rs41293285	chr1:46808426	C/T	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs6430585	0.528	rs114760827	chr2:136661110	G/A	cg07169764	chr2:136633963	MCM6	1.32	11.41	0.79	2.72e-18	Corneal structure;
SKCM	cis	rs9399137	0.507	rs12663447	chr6:135317026	A/C	cg24558204	chr6:135376177	HBS1L	0.7	6.53	0.59	6.11e-9	Glycated hemoglobin levels;Mean corpuscular volume;Hematology traits;HbA2 levels;Mean corpuscular hemoglobin;Hemoglobin levels;F-cell distribution;Platelet count;
SKCM	cis	rs2204008	0.626	rs11520260	chr12:38330092	C/T	cg26384229	chr12:38710491	ALG10B	0.81	6.67	0.6	3.38e-9	Bladder cancer;
SKCM	cis	rs72634258	0.786	rs9434991	chr1:8178708	G/C	cg00042356	chr1:8021962	PARK7	0.77	5.09	0.5	2.4e-6	Inflammatory bowel disease;
SKCM	cis	rs478304	0.593	rs4645933	chr11:65485120	C/T	cg27068330	chr11:65405492	SIPA1	-0.88	-7.36	-0.64	1.63e-10	Acne (severe);
SKCM	cis	rs8180040	0.966	rs59586735	chr3:47518325	C/T	cg27129171	chr3:47204927	SETD2	-0.79	-5.79	-0.55	1.43e-7	Colorectal cancer;
SKCM	cis	rs73001065	0.551	rs10424702	chr19:19508013	A/G	cg03709012	chr19:19516395	GATAD2A	1.15	5.47	0.53	5.22e-7	LDL cholesterol;
SKCM	cis	rs1475911	0.708	rs8129075	chr21:43523430	G/T	cg24372256	chr21:43528868	UMODL1;C21orf128	-0.74	-5.43	-0.52	6.07e-7	IgG glycosylation;
SKCM	cis	rs7824557	0.628	rs3779891	chr8:11183505	G/A	cg21775007	chr8:11205619	TDH	0.72	6.73	0.61	2.61e-9	Retinal vascular caliber;
SKCM	cis	rs4803468	0.967	rs4802116	chr19:41905540	C/T	cg09537434	chr19:41945824	ATP5SL	-1.08	-13.01	-0.83	3.1e-21	Height;
SKCM	cis	rs6545883	0.895	rs6545871	chr2:61692203	G/T	cg15711740	chr2:61764176	XPO1	-0.71	-4.99	-0.49	3.56e-6	Tuberculosis;
SKCM	cis	rs7523050	0.643	rs35662800	chr1:109400816	C/A	cg08274380	chr1:109419600	GPSM2	1.13	5.57	0.53	3.54e-7	Fat distribution (HIV);
SKCM	cis	rs12188164	0.543	rs2672757	chr5:454732	A/G	cg26076054	chr5:421317	AHRR	0.62	5.47	0.53	5.27e-7	Cystic fibrosis severity;
SKCM	cis	rs1799949	0.965	rs11656945	chr17:41330265	A/G	cg23758822	chr17:41437982	NA	0.93	7.84	0.66	1.91e-11	Menopause (age at onset);
SKCM	cis	rs28595532	0.920	rs115738062	chr4:119725490	C/T	cg14228332	chr4:119757509	SEC24D	1.05	4.84	0.48	6.52e-6	Cannabis dependence symptom count;
SKCM	cis	rs3820068	0.581	rs78175477	chr1:15948091	C/G	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs7811142	1.000	rs6975514	chr7:100056220	T/C	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.17	7.71	0.66	3.44e-11	Platelet count;
SKCM	cis	rs60871478	0.636	rs7792072	chr7:886239	C/T	cg05535760	chr7:792225	HEATR2	-1.3	-7.8	-0.66	2.27e-11	Cerebrospinal P-tau181p levels;
SKCM	cis	rs875971	0.545	rs12671152	chr7:65776127	G/T	cg18876405	chr7:65276391	NA	0.61	4.89	0.48	5.22e-6	Aortic root size;
SKCM	cis	rs1707322	1.000	rs11211219	chr1:46359478	G/C	cg03146154	chr1:46216737	IPP	0.74	5.06	0.5	2.76e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs3785574	0.962	rs16947051	chr17:61790917	G/C	cg01411255	chr17:61851458	DDX42;CCDC47	1.13	12.96	0.83	3.89e-21	Height;
SKCM	cis	rs2075371	0.897	rs1646743	chr7:134003451	C/A	cg20476274	chr7:133979776	SLC35B4	1.06	11.34	0.79	3.65e-18	Mean platelet volume;
SKCM	cis	rs9911578	0.813	rs12452313	chr17:57129882	C/A	cg12560992	chr17:57184187	TRIM37	-1.02	-8.72	-0.7	3.84e-13	Intelligence (multi-trait analysis);
SKCM	cis	rs7772486	0.719	rs702317	chr6:146005010	C/T	cg23711669	chr6:146136114	FBXO30	-0.94	-10.38	-0.76	2.33e-16	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs8078723	1.000	rs7214085	chr17:38169095	T/C	cg17467752	chr17:38218738	THRA	0.68	6.3	0.58	1.61e-8	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs4555082	0.834	rs28846738	chr14:105745781	A/G	cg13114125	chr14:105738426	BRF1	-0.7	-5.49	-0.53	4.77e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs12541335	0.615	rs4872464	chr8:22153381	G/A	cg09517075	chr8:22133004	PIWIL2	0.59	5.41	0.52	6.77e-7	Hypertriglyceridemia;
SKCM	cis	rs854765	0.654	rs9911281	chr17:17762457	G/C	cg04398451	chr17:18023971	MYO15A	0.92	6.67	0.6	3.3e-9	Total body bone mineral density;
SKCM	cis	rs2120019	1.000	rs35577967	chr15:75354621	G/A	cg17294928	chr15:75287854	SCAMP5	-0.83	-7.08	-0.63	5.44e-10	Blood trace element (Zn levels);
SKCM	cis	rs4819052	0.724	rs9753987	chr21:46661389	C/T	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.42	0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7103648	0.695	rs12223593	chr11:47789082	T/G	cg20307385	chr11:47447363	PSMC3	0.91	7.0	0.62	7.82e-10	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs67311347	0.544	rs2278927	chr3:40350447	G/A	cg18306943	chr3:40428807	ENTPD3	0.56	4.85	0.48	6.09e-6	Renal cell carcinoma;
SKCM	cis	rs11098499	0.754	rs2036860	chr4:120248934	A/G	cg09307838	chr4:120376055	NA	0.93	7.56	0.65	6.5500000000000006e-11	Corneal astigmatism;
SKCM	cis	rs2153535	0.580	rs7748455	chr6:8453625	C/T	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs9894429	0.572	rs112417725	chr17:79578219	A/G	cg18240062	chr17:79603768	NPLOC4	-0.68	-5.9	-0.56	8.85e-8	Eye color traits;
SKCM	cis	rs8072100	0.840	rs4968319	chr17:45464967	A/G	cg08085267	chr17:45401833	C17orf57	-0.61	-5.11	-0.5	2.19e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs854765	0.547	rs9896837	chr17:17924868	A/G	cg04398451	chr17:18023971	MYO15A	-0.94	-7.4	-0.64	1.34e-10	Total body bone mineral density;
SKCM	cis	rs873946	0.586	rs12770021	chr10:134562021	G/A	cg18305652	chr10:134549665	INPP5A	0.59	6.04	0.56	4.89e-8	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs6570726	0.791	rs9390336	chr6:145896823	A/T	cg23711669	chr6:146136114	FBXO30	0.88	9.09	0.72	7.08e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1348850	0.632	rs12471621	chr2:178502353	T/C	cg02961200	chr2:178257176	LOC100130691;AGPS	0.74	4.97	0.49	3.9e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs4746818	0.711	rs2491024	chr10:70847084	T/C	cg11621586	chr10:70884670	VPS26A	1.04	7.06	0.62	6.13e-10	Left atrial antero-posterior diameter;
SKCM	cis	rs6121246	0.559	rs6060933	chr20:30351903	C/T	cg11595048	chr20:30225325	COX4I2	0.54	4.77	0.48	8.4e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs2204008	0.658	rs11495742	chr12:38395688	C/A	cg26384229	chr12:38710491	ALG10B	0.88	6.86	0.61	1.46e-9	Bladder cancer;
SKCM	cis	rs754466	1.000	rs2278218	chr10:79680399	G/A	cg17075019	chr10:79541650	NA	-0.7	-5.72	-0.54	1.92e-7	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs10028773	0.600	rs4001390	chr4:120265783	G/C	cg09307838	chr4:120376055	NA	0.96	8.24	0.68	3.19e-12	Educational attainment;
SKCM	cis	rs7666738	0.830	rs6853266	chr4:99047528	G/T	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs367615	0.552	rs2416210	chr5:108741137	C/T	cg17395555	chr5:108820864	NA	-0.65	-5.34	-0.52	8.86e-7	Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs2243480	1.000	rs462853	chr7:65558167	G/C	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs7590368	0.924	rs72779464	chr2:10963159	T/C	cg15705551	chr2:10952987	PDIA6	0.76	4.88	0.48	5.52e-6	Educational attainment (years of education);
SKCM	cis	rs9926296	0.546	rs6500442	chr16:89828862	T/C	cg04287289	chr16:89883240	FANCA	1.02	13.21	0.83	1.34e-21	Vitiligo;
SKCM	cis	rs514406	0.683	rs6588440	chr1:53209587	C/T	cg16325326	chr1:53192061	ZYG11B	-1.0	-12.19	-0.81	9.61e-20	Monocyte count;
SKCM	cis	rs11112613	0.713	rs11112591	chr12:105951620	C/T	cg03607813	chr12:105948248	NA	0.84	5.44	0.52	5.84e-7	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;
SKCM	cis	rs7552404	0.924	rs1251075	chr1:76190569	C/G	cg03433033	chr1:76189801	ACADM	0.79	5.72	0.54	1.9e-7	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs8060686	0.641	rs75297764	chr16:68212820	C/T	cg09117114	chr16:67998030	SLC12A4	-0.77	-5.03	-0.49	3.12e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs9910055	0.530	rs8072954	chr17:42294722	G/A	cg19774624	chr17:42201019	HDAC5	-0.77	-6.27	-0.58	1.84e-8	Total body bone mineral density;
SKCM	cis	rs17065868	1.000	rs9533893	chr13:45099865	A/C	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs9916302	0.706	rs9646419	chr17:37597185	A/G	cg07936489	chr17:37558343	FBXL20	-1.0	-6.99	-0.62	8.29e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs769267	0.931	rs2965193	chr19:19454828	G/A	cg03709012	chr19:19516395	GATAD2A	-0.84	-6.79	-0.61	1.97e-9	Tonsillectomy;
SKCM	cis	rs10089	0.953	rs6875982	chr5:127529197	A/C	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.87	7.99	0.67	9.95e-12	Ileal carcinoids;
SKCM	cis	rs12497850	0.864	rs6779394	chr3:49157771	G/A	cg06212747	chr3:49208901	KLHDC8B	0.75	4.97	0.49	3.91e-6	Parkinson's disease;
SKCM	cis	rs1059312	0.522	rs3825181	chr12:129279264	G/A	cg09035930	chr12:129282057	SLC15A4	-0.86	-7.02	-0.62	7.07e-10	Systemic lupus erythematosus;
SKCM	cis	rs2832191	0.716	rs8132085	chr21:30501389	G/T	cg24692254	chr21:30365293	RNF160	-0.87	-7.43	-0.64	1.17e-10	Dental caries;
SKCM	cis	rs883565	0.771	rs3736573	chr3:39129742	A/C	cg20743662	chr3:38589496	NA	0.46	4.77	0.48	8.36e-6	Handedness;
SKCM	cis	rs17818399	0.716	rs62134741	chr2:46782189	G/A	cg02822958	chr2:46747628	ATP6V1E2	0.7	5.0	0.49	3.46e-6	Height;
SKCM	cis	rs2739330	0.789	rs5760109	chr22:24252938	C/G	cg04234412	chr22:24373322	LOC391322	-0.58	-4.81	-0.48	7.25e-6	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs9467773	1.000	rs6456733	chr6:26566804	C/T	cg15659132	chr6:26577336	NA	0.61	5.76	0.55	1.6e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs854765	0.551	rs12600546	chr17:17867614	A/G	cg04398451	chr17:18023971	MYO15A	-0.86	-5.91	-0.56	8.41e-8	Total body bone mineral density;
SKCM	cis	rs9443189	0.615	rs6453829	chr6:76268509	C/T	cg01950844	chr6:76311363	SENP6	0.89	5.07	0.5	2.58e-6	Prostate cancer;
SKCM	cis	rs34779708	0.931	rs67261877	chr10:35386340	T/A	cg03585969	chr10:35415529	CREM	0.79	6.35	0.58	1.32e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs11098499	0.954	rs9685777	chr4:120365965	C/A	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs8180040	0.768	rs11915074	chr3:47309757	A/T	cg27129171	chr3:47204927	SETD2	-0.8	-5.37	-0.52	8.01e-7	Colorectal cancer;
SKCM	cis	rs4819052	0.851	rs7275468	chr21:46656499	C/A	cg19498844	chr21:46707878	POFUT2;LOC642852	0.84	7.1	0.63	5.13e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs6933660	0.610	rs71549125	chr6:151770796	A/C	cg02564969	chr6:151773285	C6orf211;RMND1	0.66	5.45	0.53	5.62e-7	Menarche (age at onset);
SKCM	cis	rs2836974	0.568	rs442972	chr21:40534757	C/T	cg11890956	chr21:40555474	PSMG1	-0.88	-9.14	-0.72	5.76e-14	Cognitive function;
SKCM	cis	rs854765	0.547	rs2955353	chr17:17948979	T/C	cg24612305	chr17:17875800	TOM1L2;LRRC48	-1.05	-9.29	-0.72	2.92e-14	Total body bone mineral density;
SKCM	cis	rs929354	0.772	rs3802125	chr7:156970563	A/C	cg17757837	chr7:157058334	UBE3C	0.83	5.82	0.55	1.27e-7	Body mass index;
SKCM	cis	rs9303401	0.614	rs34550282	chr17:57092788	G/A	cg10487724	chr17:56770010	TEX14;RAD51C	0.79	4.97	0.49	3.86e-6	Cognitive test performance;
SKCM	cis	rs9300255	0.602	rs1569068	chr12:123632276	A/G	cg05973401	chr12:123451056	ABCB9	-0.76	-4.95	-0.49	4.22e-6	Neutrophil percentage of white cells;
SKCM	cis	rs2836950	0.565	rs2836934	chr21:40564885	A/C	cg11890956	chr21:40555474	PSMG1	-0.66	-5.26	-0.51	1.22e-6	Menarche (age at onset);
SKCM	cis	rs6570726	0.738	rs6917199	chr6:145918320	G/A	cg23711669	chr6:146136114	FBXO30	0.88	8.37	0.69	1.84e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7932354	0.528	rs11039097	chr11:47131881	C/T	cg03339077	chr11:47165057	C11orf49	-0.6	-5.21	-0.51	1.49e-6	Bone mineral density (hip);Bone mineral density;
SKCM	cis	rs2070488	0.804	rs13092164	chr3:38458533	G/A	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.75	6.16	0.57	2.93e-8	Electrocardiographic conduction measures;
SKCM	cis	rs3087591	1.000	rs9902427	chr17:29625430	G/A	cg24425628	chr17:29625626	OMG;NF1	-0.64	-4.97	-0.49	3.84e-6	Hip circumference;
SKCM	cis	rs4237845	0.742	rs6650219	chr12:58289100	T/C	cg02175503	chr12:58329896	NA	0.79	7.22	0.63	3e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs7772486	0.754	rs13214277	chr6:146136125	G/T	cg23711669	chr6:146136114	FBXO30	0.89	9.94	0.75	1.63e-15	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1799949	0.628	rs4474733	chr17:41433660	G/T	cg25918947	chr17:41365094	TMEM106A	-0.56	-5.03	-0.5	3.01e-6	Menopause (age at onset);
SKCM	cis	rs6500395	0.962	rs1564980	chr16:48651377	A/T	cg04672837	chr16:48644449	N4BP1	0.62	4.9	0.49	5.09e-6	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs2033711	0.840	rs3764533	chr19:58929194	A/G	cg13877915	chr19:58951672	ZNF132	0.95	10.27	0.76	3.76e-16	Uric acid clearance;
SKCM	cis	rs13118159	0.509	rs4974554	chr4:1356967	A/C	cg05025164	chr4:1340916	KIAA1530	0.9	7.21	0.63	3.08e-10	Longevity;
SKCM	cis	rs1348850	0.537	rs3770010	chr2:178537796	T/C	cg22681709	chr2:178499509	PDE11A	-0.57	-5.15	-0.5	1.87e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs28386778	0.799	rs2584612	chr17:61932204	A/G	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.36	0.52	8.06e-7	Prudent dietary pattern;
SKCM	cis	rs1005277	0.579	rs2505197	chr10:38393310	T/C	cg25427524	chr10:38739819	LOC399744	-0.69	-6.45	-0.59	8.73e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs6952808	0.743	rs10266703	chr7:1918941	C/A	cg02951883	chr7:2050386	MAD1L1	-0.63	-5.07	-0.5	2.62e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs7927771	0.524	rs10838777	chr11:47860954	A/C	cg20307385	chr11:47447363	PSMC3	0.71	5.63	0.54	2.67e-7	Subjective well-being;
SKCM	cis	rs1799949	0.930	rs4445938	chr17:41337900	A/C	cg05368731	chr17:41323189	NBR1	0.87	7.74	0.66	3.01e-11	Menopause (age at onset);
SKCM	cis	rs11626933	0.885	rs28517514	chr14:90788709	G/A	cg14092571	chr14:90743983	NA	-0.78	-7.73	-0.66	3.12e-11	Gut microbiota (bacterial taxa);
SKCM	cis	rs9467773	0.620	rs2504599	chr6:26641060	C/T	cg15659132	chr6:26577336	NA	0.62	5.4	0.52	6.91e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs6952808	0.630	rs1860832	chr7:2161849	G/A	cg02951883	chr7:2050386	MAD1L1	-0.76	-6.97	-0.62	9.08e-10	Bipolar disorder and schizophrenia;
SKCM	cis	rs11098499	0.908	rs7696649	chr4:120322177	G/A	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs7666738	0.791	rs1527516	chr4:98967937	A/C	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs13108904	0.557	rs1250086	chr4:1248051	G/A	cg02018176	chr4:1364513	KIAA1530	-0.68	-5.44	-0.52	5.82e-7	Obesity-related traits;
SKCM	cis	rs763014	0.898	rs35666389	chr16:629458	A/G	cg09263875	chr16:632152	PIGQ	0.67	5.82	0.55	1.23e-7	Height;
SKCM	cis	rs6977660	1.000	rs6959591	chr7:19821824	A/G	cg07541023	chr7:19748670	TWISTNB	0.7	4.82	0.48	6.98e-6	Thyroid stimulating hormone;
SKCM	cis	rs28386778	0.897	rs2727320	chr17:61865325	T/C	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs6089829	0.926	rs7273917	chr20:61665975	G/A	cg08564027	chr20:61660810	NA	0.63	5.63	0.54	2.74e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs2839186	0.647	rs9976233	chr21:47616913	G/A	cg13012494	chr21:47604986	C21orf56	-0.71	-6.18	-0.57	2.77e-8	Testicular germ cell tumor;
SKCM	cis	rs2439831	0.717	rs2447198	chr15:43895118	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.41	8.33	0.69	2.19e-12	Lung cancer in ever smokers;
SKCM	cis	rs28595532	0.920	rs115446044	chr4:119754635	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs4332037	0.707	rs56070303	chr7:1891015	C/T	cg23422044	chr7:1970798	MAD1L1	-0.89	-5.68	-0.54	2.19e-7	Bipolar disorder;
SKCM	cis	rs1865760	1.000	rs3830057	chr6:25918510	G/T	cg08401836	chr6:26032486	HIST1H3B	-0.6	-4.78	-0.48	8.09e-6	Height;
SKCM	cis	rs1707322	0.928	rs925524	chr1:46496709	A/G	cg03146154	chr1:46216737	IPP	-0.78	-5.32	-0.52	9.84e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs6582630	0.555	rs10880611	chr12:38509316	C/G	cg26384229	chr12:38710491	ALG10B	0.79	6.11	0.57	3.66e-8	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs709400	0.633	rs1136165	chr14:103988180	G/T	cg26031613	chr14:104095156	KLC1	-0.68	-5.46	-0.53	5.36e-7	Body mass index;
SKCM	cis	rs2832191	0.716	rs1984012	chr21:30392472	T/C	cg24692254	chr21:30365293	RNF160	1.0	9.45	0.73	1.45e-14	Dental caries;
SKCM	cis	rs2050392	1.000	rs2183176	chr10:30698544	C/T	cg25182066	chr10:30743637	MAP3K8	0.66	5.69	0.54	2.11e-7	Inflammatory bowel disease;
SKCM	cis	rs709400	0.663	rs11624367	chr14:103892818	T/A	cg26031613	chr14:104095156	KLC1	0.69	5.11	0.5	2.23e-6	Body mass index;
SKCM	cis	rs9300255	0.722	rs12298826	chr12:123829028	A/G	cg00376283	chr12:123451042	ABCB9	-0.78	-5.26	-0.51	1.24e-6	Neutrophil percentage of white cells;
SKCM	cis	rs11105298	0.891	rs10858865	chr12:89846476	G/A	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.88	-6.03	-0.56	5.22e-8	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs11764590	0.724	rs1533829	chr7:2082841	A/G	cg23422044	chr7:1970798	MAD1L1	-0.82	-6.18	-0.57	2.74e-8	Neuroticism;
SKCM	cis	rs2153535	0.580	rs2225765	chr6:8481785	A/G	cg07606381	chr6:8435919	SLC35B3	0.86	6.25	0.58	2.06e-8	Motion sickness;
SKCM	cis	rs7100689	0.646	rs1934696	chr10:82124966	T/C	cg01528321	chr10:82214614	TSPAN14	0.8	7.0	0.62	7.98e-10	Post bronchodilator FEV1;
SKCM	cis	rs9303401	0.659	rs35797125	chr17:56736547	G/A	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.16	0.57	2.91e-8	Cognitive test performance;
SKCM	cis	rs11249608	0.789	rs7704963	chr5:178436854	A/G	cg21905437	chr5:178450457	ZNF879	0.69	5.4	0.52	7.04e-7	Pubertal anthropometrics;
SKCM	cis	rs9399135	0.660	rs4267967	chr6:135272477	T/G	cg24558204	chr6:135376177	HBS1L	0.67	6.16	0.57	2.91e-8	Red blood cell count;
SKCM	cis	rs8014204	0.570	rs7147721	chr14:75186010	A/G	cg06637938	chr14:75390232	RPS6KL1	0.83	6.52	0.59	6.37e-9	Caffeine consumption;
SKCM	cis	rs4925386	0.681	rs2427296	chr20:60927475	G/A	cg24112000	chr20:60950667	NA	-0.7	-6.79	-0.61	1.99e-9	Colorectal cancer;Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs9911578	0.967	rs8072712	chr17:57162464	A/T	cg12560992	chr17:57184187	TRIM37	1.06	10.05	0.75	1.01e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs763014	0.898	rs12917944	chr16:622565	A/G	cg07343612	chr16:622815	PIGQ	-0.69	-5.73	-0.54	1.79e-7	Height;
SKCM	cis	rs7666738	0.830	rs13101352	chr4:98957544	C/T	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9611565	0.546	rs5758426	chr22:42098763	T/G	cg03806693	chr22:41940476	POLR3H	0.98	6.13	0.57	3.38e-8	Vitiligo;
SKCM	cis	rs826838	1.000	rs10880826	chr12:38672787	G/C	cg26384229	chr12:38710491	ALG10B	0.94	7.63	0.65	4.85e-11	Heart rate;
SKCM	cis	rs4919087	1.000	rs4919089	chr10:99087905	G/A	cg25902810	chr10:99078978	FRAT1	-0.62	-4.96	-0.49	4.06e-6	Monocyte count;
SKCM	cis	rs2455601	0.882	rs11042105	chr11:8894510	G/C	cg21881798	chr11:8931708	C11orf17;ST5	-0.77	-5.55	-0.53	3.79e-7	Schizophrenia;
SKCM	cis	rs875971	1.000	rs1144894	chr7:65542894	A/G	cg18876405	chr7:65276391	NA	-0.71	-7.04	-0.62	6.64e-10	Aortic root size;
SKCM	cis	rs2439831	0.867	rs2245715	chr15:43818052	G/A	cg02155558	chr15:43621948	ADAL;LCMT2	1.18	7.32	0.64	1.95e-10	Lung cancer in ever smokers;
SKCM	cis	rs6952808	0.692	rs12666575	chr7:2004421	C/T	cg02951883	chr7:2050386	MAD1L1	-0.79	-6.9	-0.62	1.23e-9	Bipolar disorder and schizophrenia;
SKCM	cis	rs9880211	1.000	rs13092193	chr3:136240366	T/C	cg21827317	chr3:136751795	NA	-0.65	-4.92	-0.49	4.73e-6	Body mass index;Height;
SKCM	cis	rs1669338	0.588	rs3864050	chr3:3186769	T/C	cg16797762	chr3:3221439	CRBN	-1.1	-6.31	-0.58	1.55e-8	White matter integrity;
SKCM	cis	rs736408	0.609	rs13087772	chr3:52782274	T/G	cg18404041	chr3:52824283	ITIH1	-0.56	-4.94	-0.49	4.32e-6	Bipolar disorder;
SKCM	cis	rs28386778	0.901	rs2854194	chr17:61952110	T/G	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.32	0.52	9.5e-7	Prudent dietary pattern;
SKCM	cis	rs6835098	0.962	rs10014010	chr4:174083230	C/T	cg08422745	chr4:174089978	GALNT7	-0.81	-6.26	-0.58	1.96e-8	Dementia and core Alzheimer's disease neuropathologic changes;
SKCM	cis	rs10504073	0.584	rs7823690	chr8:49943831	G/A	cg00325661	chr8:49890786	NA	0.8	6.81	0.61	1.83e-9	Blood metabolite ratios;
SKCM	cis	rs3008870	0.920	rs12132532	chr1:67457015	G/T	cg08660285	chr1:67390436	MIER1;WDR78	-0.92	-6.07	-0.57	4.27e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs1062177	1.000	rs12654573	chr5:151207473	T/G	cg00977110	chr5:151150581	G3BP1	0.8	6.41	0.59	1e-8	Preschool internalizing problems;
SKCM	trans	rs1814175	0.745	rs7483456	chr11:49774613	C/T	cg15704280	chr7:45808275	SEPT13	-1.03	-10.73	-0.77	5.17e-17	Height;
SKCM	cis	rs11601602	0.576	rs12576396	chr11:28555952	C/T	cg06544937	chr11:28130018	METT5D1;KIF18A	0.84	5.64	0.54	2.62e-7	Obesity-related traits;
SKCM	cis	rs2120019	0.567	rs8025170	chr15:75170983	A/G	cg17294928	chr15:75287854	SCAMP5	0.84	5.91	0.56	8.61e-8	Blood trace element (Zn levels);
SKCM	cis	rs2404602	0.684	rs57682236	chr15:76868478	G/A	cg23625390	chr15:77176239	SCAPER	-0.85	-8.26	-0.68	2.93e-12	Blood metabolite levels;
SKCM	cis	rs10504229	1.000	rs112284078	chr8:58191640	A/G	cg22535103	chr8:58192502	C8orf71	-0.75	-5.24	-0.51	1.31e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs6570726	0.791	rs447992	chr6:145817184	C/T	cg05347473	chr6:146136440	FBXO30	0.53	4.78	0.48	8.07e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2346177	0.519	rs1597040	chr2:46673903	C/T	cg02822958	chr2:46747628	ATP6V1E2	0.64	4.8	0.48	7.49e-6	HDL cholesterol;
SKCM	cis	rs651907	0.514	rs55654108	chr3:101425703	A/G	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.81	7.06	0.62	6.11e-10	Colorectal cancer;
SKCM	cis	rs875971	0.522	rs781144	chr7:65440344	C/G	cg11987759	chr7:65425863	GUSB	-0.75	-6.72	-0.61	2.68e-9	Aortic root size;
SKCM	cis	rs28595532	0.920	rs116146507	chr4:119749556	A/G	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs933688	1.000	rs10073657	chr5:90689749	G/A	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.94	6.58	0.6	4.82e-9	Smoking behavior;
SKCM	cis	rs1801251	1.000	rs13008942	chr2:233594875	G/A	cg08000102	chr2:233561755	GIGYF2	0.88	6.76	0.61	2.28e-9	Coronary artery disease;
SKCM	cis	rs7666738	0.830	rs4699574	chr4:98725544	C/T	cg17366294	chr4:99064904	C4orf37	0.59	5.11	0.5	2.25e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs769267	0.896	rs7253807	chr19:19631444	A/T	cg03709012	chr19:19516395	GATAD2A	0.89	8.62	0.7	5.89e-13	Tonsillectomy;
SKCM	cis	rs9905704	0.647	rs6503888	chr17:57028126	T/C	cg12560992	chr17:57184187	TRIM37	0.75	5.99	0.56	6.06e-8	Testicular germ cell tumor;
SKCM	cis	rs875971	0.862	rs6960446	chr7:65733259	A/G	cg11764359	chr7:65958608	NA	-0.76	-7.0	-0.62	8.03e-10	Aortic root size;
SKCM	trans	rs7618501	1.000	rs7618501	chr3:49772647	A/G	cg21659725	chr3:3221576	CRBN	-0.96	-9.61	-0.74	7.08e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs477895	0.713	rs882146	chr11:63976699	G/A	cg07220939	chr11:64358617	SLC22A12	0.74	4.99	0.49	3.58e-6	Mean platelet volume;
SKCM	cis	rs4727443	0.866	rs6963345	chr7:99618606	G/A	cg07913999	chr7:99613796	ZKSCAN1	0.66	5.09	0.5	2.43e-6	Interstitial lung disease;
SKCM	cis	rs1451375	0.617	rs11772714	chr7:50542843	G/A	cg18232548	chr7:50535776	DDC	-0.72	-4.86	-0.48	5.91e-6	Malaria;
SKCM	cis	rs3809863	0.602	rs11650072	chr17:45393665	A/G	cg08085267	chr17:45401833	C17orf57	-0.87	-6.8	-0.61	1.91e-9	Glaucoma (primary open-angle);
SKCM	cis	rs10540	1.000	rs67912009	chr11:495057	G/T	cg03352830	chr11:487213	PTDSS2	0.93	4.86	0.48	5.92e-6	Body mass index;
SKCM	cis	rs9916302	0.861	rs11078912	chr17:37671490	A/G	cg07936489	chr17:37558343	FBXL20	-0.9	-8.11	-0.68	5.65e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs1405130	1.000	rs6721496	chr2:235564633	T/C	cg17841421	chr2:235704848	NA	-0.58	-4.85	-0.48	6.07e-6	Coronary artery disease;
SKCM	cis	rs1799949	1.000	rs11649954	chr17:41420035	A/G	cg23758822	chr17:41437982	NA	0.93	7.88	0.67	1.62e-11	Menopause (age at onset);
SKCM	cis	rs9325144	0.513	rs7977596	chr12:38649067	C/A	cg26384229	chr12:38710491	ALG10B	-0.69	-5.66	-0.54	2.36e-7	Morning vs. evening chronotype;
SKCM	cis	rs1153858	1.000	rs2467864	chr15:45641098	C/T	cg21132104	chr15:45694354	SPATA5L1	-0.9	-7.57	-0.65	6.46e-11	Homoarginine levels;
SKCM	cis	rs864745	1.000	rs864745	chr7:28180556	C/T	cg15170557	chr7:28214983	JAZF1	0.67	6.83	0.61	1.68e-9	Crohn's disease;Type 2 diabetes;
SKCM	cis	rs7944584	0.545	rs7118178	chr11:47659135	G/A	cg20307385	chr11:47447363	PSMC3	0.86	5.81	0.55	1.28e-7	Fasting blood glucose;Fasting blood glucose (BMI interaction);
SKCM	cis	rs4561483	0.734	rs33655	chr16:11970381	C/T	cg08843971	chr16:11963173	GSPT1	-0.66	-5.08	-0.5	2.49e-6	Testicular germ cell tumor;
SKCM	cis	rs826838	0.904	rs11612004	chr12:39204282	G/A	cg26384229	chr12:38710491	ALG10B	0.9	7.85	0.66	1.84e-11	Heart rate;
SKCM	cis	rs992157	0.560	rs12987130	chr2:219104990	T/C	cg20019365	chr2:219134978	PNKD;AAMP	-0.66	-5.49	-0.53	4.76e-7	Colorectal cancer;
SKCM	cis	rs7590720	0.959	rs2372684	chr2:216884764	C/A	cg12620499	chr2:216877984	MREG	0.88	7.76	0.66	2.68e-11	Alcohol dependence;
SKCM	trans	rs1814175	0.588	rs10466497	chr11:49864381	A/T	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs7635838	0.619	rs347614	chr3:11276399	T/C	cg00170343	chr3:11313890	ATG7	0.75	5.19	0.51	1.65e-6	HDL cholesterol;
SKCM	cis	rs9814567	1.000	rs6766897	chr3:134191303	C/A	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.62	-5.05	-0.5	2.87e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs8017423	0.967	rs7150093	chr14:90724661	C/T	cg04374321	chr14:90722782	PSMC1	-0.95	-8.2	-0.68	3.86e-12	Mortality in heart failure;
SKCM	cis	rs11719291	0.833	rs13074318	chr3:48816725	C/T	cg00383909	chr3:49044727	WDR6	1.15	5.54	0.53	3.96e-7	Cognitive function;
SKCM	cis	rs9790314	0.750	rs6765270	chr3:160899974	A/G	cg03342759	chr3:160939853	NMD3	-0.63	-6.47	-0.59	7.84e-9	Morning vs. evening chronotype;
SKCM	cis	rs1003719	0.751	rs2835585	chr21:38460488	T/A	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs6570726	0.791	rs405206	chr6:145836873	C/A	cg23711669	chr6:146136114	FBXO30	0.79	7.93	0.67	1.26e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6087990	0.731	rs2424897	chr20:31338098	A/T	cg13636640	chr20:31349939	DNMT3B	0.9	7.15	0.63	4e-10	Ulcerative colitis;
SKCM	cis	rs12824058	0.831	rs12310049	chr12:130811260	C/G	cg26677194	chr12:130822605	PIWIL1	0.71	5.83	0.55	1.17e-7	Menopause (age at onset);
SKCM	cis	rs514406	0.698	rs576891	chr1:53364976	A/G	cg08859206	chr1:53392774	SCP2	-0.62	-5.01	-0.49	3.34e-6	Monocyte count;
SKCM	cis	rs2204008	0.806	rs7305409	chr12:38349133	G/A	cg13010199	chr12:38710504	ALG10B	0.68	4.85	0.48	6.3e-6	Bladder cancer;
SKCM	cis	rs9581857	0.547	rs9579086	chr13:28058537	T/A	cg22138327	chr13:27999177	GTF3A	0.91	6.05	0.57	4.64e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs2286503	0.780	rs2286506	chr7:22854815	T/C	cg15401507	chr7:22894281	NA	-0.55	-5.07	-0.5	2.58e-6	Fibrinogen;
SKCM	cis	rs1692580	0.870	rs263532	chr1:2164116	T/C	cg21442419	chr1:2182373	SKI	-0.48	-4.83	-0.48	6.64e-6	Coronary artery disease;
SKCM	cis	rs9325144	0.555	rs7955128	chr12:38684121	A/T	cg26384229	chr12:38710491	ALG10B	0.7	5.78	0.55	1.48e-7	Morning vs. evening chronotype;
SKCM	cis	rs8141529	0.764	rs5752807	chr22:29223169	A/G	cg02153584	chr22:29168773	CCDC117	0.66	5.35	0.52	8.64e-7	Lymphocyte counts;
SKCM	cis	rs807669	0.903	rs2854643	chr22:19189706	T/C	cg02655711	chr22:19163373	SLC25A1	0.82	7.36	0.64	1.62e-10	Metabolite levels;
SKCM	cis	rs36093844	0.851	rs1445499	chr11:85537188	G/C	cg02149136	chr11:85995039	NA	-0.67	-4.88	-0.48	5.41e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs909674	0.541	rs5750812	chr22:39793079	G/A	cg24399712	chr22:39784796	NA	-0.57	-4.83	-0.48	6.73e-6	IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis);IgG glycosylation;IgG digalactosylation phenotypes (multivariate analysis);IgG sialylation phenotypes (multivariate analysis);IgG monogalactosylation phenotypes (multivariate analysis);IgG fucosylation phenotypes (multivariate analysis);IgG N-glycosylation phenotypes (multivariate analysis);IgG disialylation phenotypes (multivariate analysis);IgG galactosylation phenotypes (multivariate analysis);Post bronchodilator FEV1;
SKCM	cis	rs8077889	0.750	rs8081396	chr17:41929874	A/G	cg26893861	chr17:41843967	DUSP3	1.31	7.65	0.65	4.46e-11	Triglycerides;
SKCM	cis	rs4665809	0.590	rs11552518	chr2:26455127	G/A	cg26119090	chr2:26468346	HADHA;HADHB	1.06	8.39	0.69	1.66e-12	Gut microbiome composition (summer);
SKCM	cis	rs902774	0.554	rs4919749	chr12:53358034	C/T	cg05393297	chr12:53359155	NA	-0.67	-6.94	-0.62	1.04e-9	Prostate cancer;
SKCM	cis	rs473651	0.904	rs62196716	chr2:239356977	C/G	cg21699342	chr2:239360505	ASB1	0.53	5.3	0.51	1.03e-6	Multiple system atrophy;
SKCM	cis	rs875971	0.545	rs2420456	chr7:65745606	T/G	cg18876405	chr7:65276391	NA	0.65	5.32	0.52	9.65e-7	Aortic root size;
SKCM	cis	rs12701220	0.901	rs12701710	chr7:1090396	A/G	cg02733842	chr7:1102375	C7orf50	0.58	4.99	0.49	3.52e-6	Bronchopulmonary dysplasia;
SKCM	cis	rs2075371	0.965	rs1862049	chr7:133978344	A/T	cg20476274	chr7:133979776	SLC35B4	1.01	10.44	0.76	1.77e-16	Mean platelet volume;
SKCM	cis	rs6942756	0.806	rs6467240	chr7:128984018	T/C	cg02491457	chr7:128862824	NA	-0.77	-5.07	-0.5	2.6e-6	White matter hyperintensity burden;
SKCM	cis	rs7917772	0.503	rs56219824	chr10:104302337	C/T	cg11453585	chr10:104263688	ACTR1A;SUFU	0.78	6.33	0.58	1.47e-8	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs7772486	0.875	rs1412080	chr6:146417304	T/C	cg23711669	chr6:146136114	FBXO30	0.86	8.52	0.69	9.39e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs763014	0.865	rs710924	chr16:633353	T/C	cg09263875	chr16:632152	PIGQ	0.67	5.82	0.55	1.24e-7	Height;
SKCM	cis	rs763014	0.898	rs4984669	chr16:624713	C/T	cg09263875	chr16:632152	PIGQ	0.68	5.71	0.54	1.98e-7	Height;
SKCM	cis	rs12142240	0.845	rs4313342	chr1:46801904	T/C	cg10495392	chr1:46806563	NSUN4	0.67	4.91	0.49	4.88e-6	Menopause (age at onset);
SKCM	cis	rs6840360	0.615	rs12647462	chr4:152607278	C/T	cg22705602	chr4:152727874	NA	-0.58	-7.78	-0.66	2.55e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs826838	1.000	rs1843881	chr12:38733706	A/G	cg26384229	chr12:38710491	ALG10B	-1.09	-10.34	-0.76	2.82e-16	Heart rate;
SKCM	cis	rs208520	0.690	rs851459	chr6:66813989	A/G	cg07460842	chr6:66804631	NA	-0.98	-7.7	-0.66	3.58e-11	Exhaled nitric oxide output;
SKCM	cis	rs6500602	0.727	rs6500607	chr16:4503631	C/T	cg08645402	chr16:4508243	NA	0.6	5.22	0.51	1.42e-6	Schizophrenia;
SKCM	cis	rs28595532	0.920	rs115690307	chr4:119768289	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs9790314	0.747	rs1599378	chr3:160874511	A/C	cg03342759	chr3:160939853	NMD3	-0.65	-6.65	-0.6	3.67e-9	Morning vs. evening chronotype;
SKCM	cis	rs9325144	0.600	rs10748442	chr12:38732939	A/T	cg26384229	chr12:38710491	ALG10B	0.78	6.82	0.61	1.76e-9	Morning vs. evening chronotype;
SKCM	cis	rs1799949	1.000	rs1973646	chr17:41310495	T/C	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.15	-0.57	3.16e-8	Menopause (age at onset);
SKCM	cis	rs4911259	0.552	rs11697394	chr20:31460076	G/A	cg13636640	chr20:31349939	DNMT3B	-0.74	-6.15	-0.57	3.04e-8	Inflammatory bowel disease;
SKCM	cis	rs798554	0.718	rs1636247	chr7:2881917	A/G	cg19346786	chr7:2764209	NA	-0.66	-6.8	-0.61	1.9e-9	Height;
SKCM	cis	rs8067545	0.636	rs11204300	chr17:20195438	C/T	cg13482628	chr17:19912719	NA	-0.68	-5.77	-0.55	1.51e-7	Schizophrenia;
SKCM	cis	rs2228479	0.717	rs34027607	chr16:89808939	T/C	cg00800038	chr16:89945340	TCF25	-0.85	-4.99	-0.49	3.65e-6	Skin colour saturation;
SKCM	cis	rs57221529	0.766	rs12522303	chr5:555564	A/C	cg10555297	chr5:473380	SLC9A3;LOC25845	1.05	5.35	0.52	8.71e-7	Lung disease severity in cystic fibrosis;
SKCM	cis	rs1577917	0.740	rs7775864	chr6:86247759	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.74	6.42	0.59	9.66e-9	Response to antipsychotic treatment;
SKCM	cis	rs28595532	0.920	rs114037572	chr4:119735609	T/G	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs7811142	1.000	rs7809801	chr7:100072031	T/C	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.34	0.69	2.1e-12	Platelet count;
SKCM	cis	rs244731	0.959	rs918459	chr5:176669030	C/T	cg16006841	chr5:176797999	RGS14	-0.72	-6.42	-0.59	9.96e-9	Urate levels in lean individuals;
SKCM	cis	rs9303401	0.659	rs12948133	chr17:56673602	T/C	cg02118635	chr17:56770003	RAD51C;TEX14	0.82	5.45	0.53	5.64e-7	Cognitive test performance;
SKCM	cis	rs7666738	0.830	rs13148913	chr4:99009732	C/T	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7666738	0.830	rs7667796	chr4:99071415	G/T	cg17366294	chr4:99064904	C4orf37	-0.6	-4.92	-0.49	4.8e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs523522	0.962	rs10744752	chr12:120900554	T/G	cg27279351	chr12:120934652	DYNLL1	0.89	7.7	0.66	3.57e-11	High light scatter reticulocyte count;
SKCM	cis	rs854765	0.522	rs63721860	chr17:17829576	T/C	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.0	7.64	0.65	4.64e-11	Total body bone mineral density;
SKCM	cis	rs35306767	0.903	rs12250936	chr10:870109	C/T	cg26597838	chr10:835615	NA	0.76	5.66	0.54	2.4e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs2404602	0.716	rs12441247	chr15:76812316	T/C	cg23625390	chr15:77176239	SCAPER	0.59	5.38	0.52	7.54e-7	Blood metabolite levels;
SKCM	cis	rs7937682	0.632	rs10891297	chr11:111770150	C/T	cg09085632	chr11:111637200	PPP2R1B	1.1	10.72	0.77	5.29e-17	Primary sclerosing cholangitis;
SKCM	cis	rs2901656	0.640	rs4916258	chr1:172413526	T/G	cg03748243	chr1:172413542	C1orf105;PIGC	0.49	4.78	0.48	8.23e-6	Red cell distribution width;Platelet distribution width;
SKCM	cis	rs12950390	0.853	rs67441169	chr17:45854462	T/G	cg03474202	chr17:45855739	NA	-0.49	-5.58	-0.53	3.34e-7	IgG glycosylation;
SKCM	cis	rs2180341	1.000	rs2144742	chr6:127595786	C/A	cg27446573	chr6:127587934	RNF146	0.99	8.51	0.69	9.46e-13	Breast cancer;
SKCM	cis	rs6087771	0.662	rs6058298	chr20:30247916	C/T	cg13852791	chr20:30311386	BCL2L1	0.78	5.4	0.52	6.98e-7	Subcortical brain region volumes;Putamen volume;
SKCM	cis	rs7208859	0.623	rs35916850	chr17:29011173	G/A	cg14067834	chr17:29058358	SUZ12P	1.05	5.55	0.53	3.71e-7	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs1850744	0.510	rs12646317	chr4:9565838	A/G	cg15442990	chr4:9534313	NA	1.42	5.75	0.55	1.64e-7	Economic and political preferences;
SKCM	cis	rs6500395	0.775	rs1968903	chr16:48664014	C/T	cg04672837	chr16:48644449	N4BP1	0.6	4.88	0.48	5.59e-6	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs1552244	0.832	rs73024575	chr3:10198200	C/G	cg02579736	chr3:10068473	FANCD2;CIDECP	1.23	6.74	0.61	2.48e-9	Alzheimer's disease;
SKCM	cis	rs6952808	0.636	rs6964522	chr7:1953523	C/T	cg03354898	chr7:1950403	MAD1L1	-0.55	-5.65	-0.54	2.56e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs11892454	0.544	rs10490569	chr2:26001427	T/C	cg17263061	chr2:26915892	KCNK3	0.71	5.15	0.5	1.88e-6	Heschl's gyrus morphology;
SKCM	cis	rs12474201	0.783	rs34606703	chr2:47014522	G/A	cg06386533	chr2:46925753	SOCS5	0.86	7.1	0.63	5.15e-10	Height;
SKCM	cis	rs2836974	0.568	rs371625	chr21:40535271	A/G	cg11644478	chr21:40555479	PSMG1	-0.8	-7.6	-0.65	5.6e-11	Cognitive function;
SKCM	cis	rs17376456	0.877	rs12716457	chr5:93397627	T/C	cg25358565	chr5:93447407	FAM172A	1.19	7.67	0.66	4.06e-11	Diabetic retinopathy;
SKCM	cis	rs4073582	1.000	rs524859	chr11:66041079	G/A	cg16950941	chr11:66035639	RAB1B	0.76	5.32	0.52	9.7e-7	Gout;
SKCM	cis	rs1865760	0.827	rs9461227	chr6:25960815	C/T	cg08401836	chr6:26032486	HIST1H3B	-0.61	-4.84	-0.48	6.47e-6	Height;
SKCM	cis	rs362296	0.661	rs3121420	chr4:3264210	T/C	cg09735869	chr4:3319127	RGS12	-0.67	-5.68	-0.54	2.23e-7	Parental longevity (mother's age at death);
SKCM	cis	rs55962025	0.686	rs6844859	chr4:3190486	T/C	cg00764545	chr4:3318001	RGS12	-0.55	-4.92	-0.49	4.72e-6	Parental longevity (mother's age at death);
SKCM	cis	rs9324022	0.626	rs10873520	chr14:101175967	G/A	cg18089426	chr14:101175970	NA	0.68	5.05	0.5	2.89e-6	Plateletcrit;
SKCM	cis	rs9467773	1.000	rs9467783	chr6:26542894	C/T	cg09904177	chr6:26538194	HMGN4	0.54	4.98	0.49	3.78e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs611744	0.647	rs2298603	chr8:109271426	C/T	cg18478394	chr8:109455254	TTC35	0.59	4.87	0.48	5.74e-6	Dupuytren's disease;
SKCM	cis	rs7647973	0.580	rs4955432	chr3:49266772	C/T	cg06212747	chr3:49208901	KLHDC8B	0.78	5.59	0.54	3.15e-7	Menarche (age at onset);
SKCM	cis	rs651907	0.557	rs13099674	chr3:101489629	G/A	cg12386194	chr3:101231763	SENP7	0.66	5.4	0.52	6.96e-7	Colorectal cancer;
SKCM	cis	rs2836974	0.623	rs34240248	chr21:40685239	A/G	cg17971929	chr21:40555470	PSMG1	-0.74	-6.92	-0.62	1.14e-9	Cognitive function;
SKCM	cis	rs3744028	0.570	rs60059537	chr17:73880612	T/C	cg09249101	chr17:74520697	NA	-0.56	-4.82	-0.48	6.86e-6	White matter hyperintensity burden;
SKCM	cis	rs595982	0.559	rs117227130	chr19:49367959	A/G	cg19746536	chr19:49375674	PPP1R15A	1.01	5.56	0.53	3.61e-7	Red cell distribution width;
SKCM	trans	rs17685	0.725	rs4728548	chr7:75654632	A/T	cg19862616	chr7:65841803	NCRNA00174	-0.88	-8.05	-0.67	7.54e-12	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7829975	0.660	rs10093926	chr8:8549020	A/C	cg06636001	chr8:8085503	FLJ10661	-0.74	-6.14	-0.57	3.21e-8	Mood instability;
SKCM	cis	rs6089584	0.546	rs4925337	chr20:60637637	T/C	cg16423285	chr20:60520624	NA	-0.58	-4.94	-0.49	4.38e-6	Body mass index;
SKCM	cis	rs950027	0.620	rs1719245	chr15:45623782	T/C	cg21132104	chr15:45694354	SPATA5L1	0.76	5.75	0.55	1.68e-7	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs1707322	1.000	rs11211228	chr1:46399840	G/A	cg03146154	chr1:46216737	IPP	0.77	5.36	0.52	8.35e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs17065868	0.730	rs11619670	chr13:45209913	C/T	cg10246903	chr13:45222710	NA	0.95	5.35	0.52	8.5e-7	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs7927771	0.832	rs11607981	chr11:47401060	T/G	cg01152729	chr11:47593274	PTPMT1	-0.51	-4.88	-0.48	5.49e-6	Subjective well-being;
SKCM	cis	rs651907	0.535	rs4342086	chr3:101503765	G/A	cg12386194	chr3:101231763	SENP7	0.64	5.3	0.51	1.05e-6	Colorectal cancer;
SKCM	cis	rs2836974	0.623	rs7280326	chr21:40700408	A/G	cg17971929	chr21:40555470	PSMG1	-0.71	-6.2	-0.57	2.5e-8	Cognitive function;
SKCM	cis	rs936229	0.626	rs3765066	chr15:75140854	G/A	cg14664628	chr15:75095509	CSK	-0.93	-6.83	-0.61	1.68e-9	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin);
SKCM	cis	rs2070488	1.000	rs13079757	chr3:38491444	C/T	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.97	8.85	0.71	2.08e-13	Electrocardiographic conduction measures;
SKCM	cis	rs634534	0.622	rs1308733	chr11:65720841	T/C	cg26695010	chr11:65641043	EFEMP2	0.7	5.52	0.53	4.27e-7	Sum eosinophil basophil counts;Eosinophil counts;
SKCM	cis	rs8017423	0.904	rs11159963	chr14:90805358	C/T	cg04374321	chr14:90722782	PSMC1	-1.02	-9.17	-0.72	4.97e-14	Mortality in heart failure;
SKCM	cis	rs6547631	0.502	rs77067405	chr2:85927739	G/T	cg24620635	chr2:85921963	GNLY	0.93	6.88	0.61	1.34e-9	Blood protein levels;
SKCM	cis	rs654950	0.875	rs2810550	chr1:41995339	T/C	cg06885757	chr1:42089581	HIVEP3	-0.64	-7.03	-0.62	6.98e-10	Airway imaging phenotypes;
SKCM	cis	rs9815354	0.812	rs56728371	chr3:41999381	T/A	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs1005277	0.579	rs2472176	chr10:38382921	T/C	cg25427524	chr10:38739819	LOC399744	-0.69	-6.45	-0.59	8.73e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs2243480	0.803	rs160649	chr7:65543199	C/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs4819052	0.851	rs35871601	chr21:46675214	C/T	cg19498844	chr21:46707878	POFUT2;LOC642852	0.88	7.69	0.66	3.74e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs116095464	0.558	rs6881920	chr5:222411	T/C	cg22496380	chr5:211416	CCDC127	-0.96	-5.27	-0.51	1.18e-6	Breast cancer;
SKCM	cis	rs7666738	0.830	rs28465658	chr4:99035866	T/C	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs950776	0.593	rs601079	chr15:78869579	T/A	cg06917634	chr15:78832804	PSMA4	-0.9	-7.99	-0.67	9.7e-12	Sudden cardiac arrest;
SKCM	cis	rs926938	0.583	rs12401670	chr1:115244337	C/T	cg12756093	chr1:115239321	AMPD1	-0.71	-5.39	-0.52	7.3e-7	Autism;
SKCM	cis	rs7618501	0.572	rs4688756	chr3:50040194	T/A	cg05072774	chr3:49840536	C3orf54	-0.67	-5.06	-0.5	2.73e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs6500602	0.789	rs2404546	chr16:4479734	C/G	cg09069446	chr16:4462122	CORO7	-0.46	-4.89	-0.48	5.32e-6	Schizophrenia;
SKCM	cis	rs6952407	1	rs6952407	chr7:66045512	A/G	cg00343986	chr7:65444356	GUSB	-0.67	-4.93	-0.49	4.55e-6	Cotinine glucuronidation;
SKCM	cis	rs6840360	0.571	rs10007653	chr4:152524055	A/G	cg22705602	chr4:152727874	NA	-0.53	-6.01	-0.56	5.69e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs8180040	0.903	rs11710013	chr3:47296921	T/C	cg16586182	chr3:47516702	SCAP	-0.72	-4.98	-0.49	3.73e-6	Colorectal cancer;
SKCM	trans	rs1814175	0.817	rs80244685	chr11:49763292	C/A	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs798766	0.830	rs8389	chr4:1746844	A/T	cg05874882	chr4:1763078	NA	-0.56	-4.89	-0.48	5.37e-6	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs6835098	0.646	rs10012395	chr4:174078772	A/G	cg08422745	chr4:174089978	GALNT7	-0.85	-6.97	-0.62	8.92e-10	Dementia and core Alzheimer's disease neuropathologic changes;
SKCM	trans	rs3749237	1.000	rs11920900	chr3:49823024	G/C	cg21659725	chr3:3221576	CRBN	0.99	7.4	0.64	1.35e-10	Resting heart rate;
SKCM	cis	rs7613875	0.620	rs17657688	chr3:50033228	C/T	cg24110177	chr3:50126178	RBM5	0.7	5.58	0.53	3.34e-7	Body mass index;
SKCM	cis	rs16949788	0.793	rs12439705	chr15:66668003	C/A	cg08120210	chr15:66682733	MAP2K1	-0.74	-5.82	-0.55	1.23e-7	Spherical equivalent (joint analysis main effects and education interaction);
SKCM	cis	rs7772486	0.875	rs6934467	chr6:146410529	G/T	cg23711669	chr6:146136114	FBXO30	0.85	8.48	0.69	1.09e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4268898	0.662	rs2303291	chr2:24431184	C/T	cg06627628	chr2:24431161	ITSN2	-0.94	-7.0	-0.62	7.72e-10	Asthma;
SKCM	cis	rs2404602	0.647	rs12440511	chr15:76993135	A/G	cg23625390	chr15:77176239	SCAPER	-0.85	-8.26	-0.68	2.93e-12	Blood metabolite levels;
SKCM	cis	rs4423214	0.650	rs4245442	chr11:71220909	T/C	cg05163923	chr11:71159392	DHCR7	0.78	6.03	0.56	5.2e-8	Vitamin D levels;
SKCM	trans	rs17685	0.753	rs1574107	chr7:75685047	A/C	cg19862616	chr7:65841803	NCRNA00174	0.97	9.64	0.74	6.12e-15	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs798554	0.683	rs1636264	chr7:2864586	G/T	cg19346786	chr7:2764209	NA	-0.64	-6.57	-0.6	5.07e-9	Height;
SKCM	cis	rs9790314	0.669	rs7630768	chr3:160864879	T/A	cg03342759	chr3:160939853	NMD3	-0.66	-6.72	-0.61	2.68e-9	Morning vs. evening chronotype;
SKCM	cis	rs6449957	0.966	rs73126520	chr5:67475425	C/T	cg09038926	chr5:67483109	NA	-0.69	-5.69	-0.54	2.14e-7	Cleft lip with or without cleft palate;
SKCM	cis	rs561341	0.883	rs886224	chr17:30229902	T/C	cg00745463	chr17:30367425	LRRC37B	-1.04	-6.76	-0.61	2.28e-9	Hip circumference adjusted for BMI;
SKCM	cis	rs13118159	0.527	rs1250119	chr4:1261336	G/A	cg16405210	chr4:1374714	KIAA1530	0.84	6.32	0.58	1.48e-8	Longevity;
SKCM	cis	rs7296418	0.961	rs7957096	chr12:123544878	A/G	cg06742321	chr12:123595122	PITPNM2	0.65	5.45	0.52	5.77e-7	Platelet count;
SKCM	cis	rs6952808	0.771	rs10244946	chr7:1921068	A/G	cg03354898	chr7:1950403	MAD1L1	0.51	5.03	0.5	3.03e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs951366	0.622	rs11580015	chr1:205676088	G/C	cg14159672	chr1:205819179	PM20D1	0.75	5.82	0.55	1.23e-7	Menarche (age at onset);
SKCM	cis	rs6951245	0.935	rs11766669	chr7:1063593	C/T	cg24642844	chr7:1081250	C7orf50	-0.95	-6.39	-0.59	1.13e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs997295	0.570	rs72747462	chr15:67818538	G/A	cg24247231	chr15:67904302	MAP2K5	-0.61	-5.03	-0.49	3.06e-6	Motion sickness;
SKCM	cis	rs6724607	1.000	rs11680758	chr2:191446268	T/G	cg21644426	chr2:191273491	MFSD6	0.69	4.94	0.49	4.42e-6	Pulse pressure;
SKCM	cis	rs7666738	0.830	rs6848404	chr4:98946750	A/G	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10744422	1.000	rs7294991	chr12:123286780	C/T	cg25930673	chr12:123319894	HIP1R	-1.02	-4.88	-0.48	5.53e-6	Schizophrenia;
SKCM	cis	rs1760803	0.754	rs2340473	chr1:154225344	C/T	cg26808167	chr1:154192205	UBAP2L;C1orf43	0.56	4.93	0.49	4.62e-6	Nicotine dependence;
SKCM	cis	rs13064447	0.806	rs2030151	chr3:12749130	A/G	cg05775895	chr3:12838266	CAND2	0.66	5.15	0.5	1.93e-6	Major depression and alcohol dependence;
SKCM	cis	rs4665809	0.590	rs2891496	chr2:26452605	G/A	cg26119090	chr2:26468346	HADHA;HADHB	1.06	8.39	0.69	1.66e-12	Gut microbiome composition (summer);
SKCM	cis	rs10870270	0.917	rs11146417	chr10:133791034	C/G	cg17892150	chr10:133769511	PPP2R2D	-0.75	-5.14	-0.5	1.97e-6	Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals;
SKCM	cis	rs933688	0.938	rs10942634	chr5:90658392	A/T	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.96	6.63	0.6	3.9e-9	Smoking behavior;
SKCM	cis	rs7811142	0.945	rs6974282	chr7:100098295	C/T	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.19	7.85	0.66	1.82e-11	Platelet count;
SKCM	cis	rs782590	0.967	rs17798852	chr2:55805172	A/C	cg18811423	chr2:55921094	PNPT1	0.88	6.98	0.62	8.55e-10	Metabolic syndrome;
SKCM	cis	rs7927771	0.524	rs2290851	chr11:47753370	C/T	cg20307385	chr11:47447363	PSMC3	-0.72	-5.81	-0.55	1.31e-7	Subjective well-being;
SKCM	cis	rs793571	0.544	rs11638244	chr15:58907151	A/T	cg05156742	chr15:59063176	FAM63B	0.77	5.83	0.55	1.21e-7	Schizophrenia;
SKCM	cis	rs9937943	0.512	rs13335886	chr16:74577161	C/G	cg01733217	chr16:74700730	RFWD3	-0.83	-5.03	-0.49	3.1e-6	Neutrophil percentage of white cells;
SKCM	cis	rs2836974	0.897	rs35123057	chr21:40711689	C/T	cg11890956	chr21:40555474	PSMG1	0.98	10.34	0.76	2.82e-16	Cognitive function;
SKCM	cis	rs10489202	0.686	rs11585936	chr1:167847069	G/T	cg24449463	chr1:168025552	DCAF6	-0.81	-4.96	-0.49	4.02e-6	Schizophrenia;
SKCM	cis	rs2153535	0.580	rs9505457	chr6:8479142	C/T	cg07606381	chr6:8435919	SLC35B3	0.86	6.25	0.58	2.06e-8	Motion sickness;
SKCM	cis	rs780096	0.526	rs11682621	chr2:27749669	G/A	cg05696406	chr2:27599888	SNX17	0.55	5.69	0.54	2.14e-7	Total body bone mineral density;
SKCM	cis	rs4819052	0.851	rs8131143	chr21:46671646	C/G	cg02159808	chr21:46707872	POFUT2;LOC642852	-0.7	-5.42	-0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs9880211	1.000	rs6767889	chr3:136365455	T/A	cg21827317	chr3:136751795	NA	-0.65	-4.92	-0.49	4.73e-6	Body mass index;Height;
SKCM	cis	rs6570726	0.818	rs9399555	chr6:145877554	T/C	cg23711669	chr6:146136114	FBXO30	0.8	8.36	0.69	1.89e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs11098499	0.754	rs9999724	chr4:120239944	C/T	cg09307838	chr4:120376055	NA	0.93	7.56	0.65	6.5500000000000006e-11	Corneal astigmatism;
SKCM	cis	rs9818758	0.607	rs9311439	chr3:49310408	A/G	cg00383909	chr3:49044727	WDR6	0.95	4.95	0.49	4.17e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs514406	0.668	rs520281	chr1:53365235	G/C	cg16325326	chr1:53192061	ZYG11B	0.65	5.65	0.54	2.56e-7	Monocyte count;
SKCM	cis	rs427394	0.659	rs419128	chr5:6739791	G/A	cg10857441	chr5:6722123	POLS	-0.7	-7.55	-0.65	7.03e-11	Menopause (age at onset);
SKCM	cis	rs4975616	0.869	rs380286	chr5:1320247	G/A	cg07493874	chr5:1342172	CLPTM1L	-0.7	-6.56	-0.6	5.26e-9	Lung cancer;
SKCM	cis	rs9926296	0.548	rs6500439	chr16:89808275	A/C	cg26513180	chr16:89883248	FANCA	0.96	11.79	0.8	5.26e-19	Vitiligo;
SKCM	cis	rs9858542	0.953	rs35169793	chr3:49423274	A/G	cg03060546	chr3:49711283	APEH	-0.69	-5.16	-0.5	1.85e-6	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs17345786	0.861	rs17402964	chr3:101067945	C/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.66	4.78	0.48	8.24e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2180341	0.814	rs7768435	chr6:127737038	A/C	cg24812749	chr6:127587940	RNF146	0.61	4.97	0.49	3.9e-6	Breast cancer;
SKCM	cis	rs7772486	0.754	rs6921073	chr6:146144377	G/A	cg23711669	chr6:146136114	FBXO30	0.88	9.58	0.74	8.31e-15	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4746818	1.000	rs906217	chr10:70954661	T/C	cg11621586	chr10:70884670	VPS26A	0.86	5.43	0.52	6.29e-7	Left atrial antero-posterior diameter;
SKCM	cis	rs9399137	0.507	rs56164974	chr6:135288716	C/T	cg24558204	chr6:135376177	HBS1L	0.69	6.37	0.59	1.19e-8	Glycated hemoglobin levels;Mean corpuscular volume;Hematology traits;HbA2 levels;Mean corpuscular hemoglobin;Hemoglobin levels;F-cell distribution;Platelet count;
SKCM	cis	rs367615	0.679	rs4259216	chr5:108841817	A/G	cg17395555	chr5:108820864	NA	0.75	6.87	0.61	1.39e-9	Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs3892630	0.588	rs7245709	chr19:33242755	C/T	cg22980127	chr19:33182716	NUDT19	1.47	8.62	0.7	5.94e-13	Red blood cell traits;
SKCM	cis	rs6951245	0.872	rs75280240	chr7:1058511	C/T	cg21664854	chr7:1097933	C7orf50;GPR146	0.9	4.86	0.48	6.05e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs12464559	0.522	rs7424335	chr2:152593741	C/T	cg01189475	chr2:152685088	ARL5A	1.03	5.24	0.51	1.32e-6	Response to cognitive-behavioural therapy in anxiety disorder;
SKCM	cis	rs875971	0.522	rs1617484	chr7:65463095	G/A	cg11987759	chr7:65425863	GUSB	-0.74	-6.87	-0.61	1.4e-9	Aortic root size;
SKCM	cis	rs9902453	0.765	rs3115087	chr17:28030267	G/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.82	5.78	0.55	1.47e-7	Coffee consumption (cups per day);
SKCM	cis	rs13118159	0.509	rs1882098	chr4:1352431	T/C	cg20887711	chr4:1340912	KIAA1530	0.98	7.45	0.64	1.09e-10	Longevity;
SKCM	cis	rs1878931	0.624	rs39728	chr16:3453076	A/T	cg26668626	chr16:3451006	ZNF174;ZNF434	0.83	6.08	0.57	4.19e-8	Body mass index (adult);
SKCM	cis	rs9325144	0.647	rs7957185	chr12:38909710	G/A	cg13010199	chr12:38710504	ALG10B	-0.62	-5.04	-0.5	2.92e-6	Morning vs. evening chronotype;
SKCM	cis	rs909674	0.865	rs5757682	chr22:39848259	T/G	cg11247378	chr22:39784982	NA	-0.46	-5.1	-0.5	2.28e-6	IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis);IgG glycosylation;IgG digalactosylation phenotypes (multivariate analysis);IgG sialylation phenotypes (multivariate analysis);IgG monogalactosylation phenotypes (multivariate analysis);IgG fucosylation phenotypes (multivariate analysis);IgG N-glycosylation phenotypes (multivariate analysis);IgG disialylation phenotypes (multivariate analysis);IgG galactosylation phenotypes (multivariate analysis);Post bronchodilator FEV1;
SKCM	cis	rs910316	1.000	rs3742780	chr14:75505008	G/C	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.89e-7	Height;
SKCM	cis	rs12477438	0.559	rs6733285	chr2:99725575	T/C	cg26064155	chr2:99771622	LIPT1;TSGA10	1.01	9.65	0.74	5.91e-15	Chronic sinus infection;
SKCM	cis	rs60780116	1	rs60780116	chr4:185708807	T/C	cg04058563	chr4:185651563	MLF1IP	0.85	6.03	0.56	5.13e-8	Type 2 diabetes;
SKCM	cis	rs10911232	0.507	rs10797819	chr1:183006911	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.64	0.6	3.83e-9	Hypertriglyceridemia;
SKCM	cis	rs9640161	0.711	rs3800781	chr7:150027324	T/A	cg10018233	chr7:150070692	REPIN1	0.68	5.27	0.51	1.19e-6	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs7659604	1.000	rs73844281	chr4:122664688	A/G	cg19748678	chr4:122722346	EXOSC9	0.66	5.44	0.52	5.83e-7	Type 2 diabetes;
SKCM	cis	rs28386778	0.799	rs2584612	chr17:61932204	A/G	cg01411255	chr17:61851458	DDX42;CCDC47	0.78	5.03	0.49	3.06e-6	Prudent dietary pattern;
SKCM	cis	rs1707322	0.681	rs12048866	chr1:46117492	T/G	cg03146154	chr1:46216737	IPP	0.79	5.42	0.52	6.34e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs796364	0.762	rs13030712	chr2:200973569	G/A	cg23649088	chr2:200775458	C2orf69	0.79	5.73	0.54	1.81e-7	Schizophrenia;
SKCM	cis	rs875971	1.000	rs778710	chr7:65854834	T/C	cg11764359	chr7:65958608	NA	0.87	8.35	0.69	2.01e-12	Aortic root size;
SKCM	cis	rs6952808	0.771	rs10950415	chr7:1914477	A/G	cg05863683	chr7:1912471	MAD1L1	0.58	5.25	0.51	1.28e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs9581857	0.547	rs9581878	chr13:28104552	T/A	cg22138327	chr13:27999177	GTF3A	0.88	5.84	0.55	1.14e-7	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs62238980	0.614	rs74611447	chr22:32417612	T/A	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs6540556	0.954	rs10489342	chr1:209935778	A/G	cg05527609	chr1:210001259	C1orf107	-0.86	-4.8	-0.48	7.39e-6	Red blood cell count;
SKCM	cis	rs7666738	0.753	rs11932536	chr4:98930105	A/G	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10504229	0.683	rs56196593	chr8:58141898	G/A	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs9910055	0.529	rs425038	chr17:42182028	T/C	cg09913183	chr17:42254507	C17orf65;ASB16	-0.59	-4.78	-0.48	8.16e-6	Total body bone mineral density;
SKCM	cis	rs12142240	0.698	rs1057534	chr1:46815880	A/C	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs62064224	0.791	rs2344977	chr17:30720573	C/G	cg18200150	chr17:30822561	MYO1D	0.72	5.71	0.54	1.97e-7	Schizophrenia;
SKCM	cis	rs116095464	0.558	rs10462755	chr5:246748	T/C	cg22857025	chr5:266934	NA	-1.37	-8.31	-0.69	2.38e-12	Breast cancer;
SKCM	cis	rs9916302	0.861	rs12150493	chr17:37586154	T/C	cg07936489	chr17:37558343	FBXL20	-0.85	-7.35	-0.64	1.71e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs7666738	0.791	rs28579101	chr4:98843203	T/C	cg17366294	chr4:99064904	C4orf37	0.56	4.89	0.48	5.25e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1801251	1.000	rs6714245	chr2:233580505	T/C	cg08000102	chr2:233561755	GIGYF2	0.89	6.91	0.62	1.15e-9	Coronary artery disease;
SKCM	cis	rs1419980	0.586	rs10845548	chr12:7777657	T/A	cg10578777	chr12:7781093	NA	-0.72	-5.12	-0.5	2.12e-6	HDL cholesterol levels;
SKCM	cis	rs9303401	0.580	rs34076823	chr17:57114497	C/G	cg10487724	chr17:56770010	TEX14;RAD51C	0.79	4.97	0.49	3.86e-6	Cognitive test performance;
SKCM	cis	rs10751667	0.643	rs7395592	chr11:934094	C/G	cg10932868	chr11:921992	NA	0.55	4.93	0.49	4.54e-6	Alzheimer's disease (late onset);
SKCM	cis	rs523522	0.962	rs2233676	chr12:120933607	G/A	cg27279351	chr12:120934652	DYNLL1	0.91	8.32	0.69	2.26e-12	High light scatter reticulocyte count;
SKCM	trans	rs8073060	0.586	rs2428464	chr17:34021994	C/G	cg19694781	chr19:47549865	TMEM160	-1.04	-8.53	-0.69	8.9e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs2836974	0.897	rs2836925	chr21:40532353	T/C	cg11890956	chr21:40555474	PSMG1	1.07	13.19	0.83	1.48e-21	Cognitive function;
SKCM	trans	rs5756813	0.635	rs6000899	chr22:38203796	C/T	cg19894588	chr14:64061835	NA	-0.89	-7.5	-0.65	8.56e-11	Optic cup area;Vertical cup-disc ratio;
SKCM	cis	rs9790314	0.586	rs1839491	chr3:161126429	C/A	cg03342759	chr3:160939853	NMD3	-0.74	-6.62	-0.6	4.08e-9	Morning vs. evening chronotype;
SKCM	cis	rs3087591	0.922	rs9892839	chr17:29618990	A/G	cg24425628	chr17:29625626	OMG;NF1	-0.64	-5.08	-0.5	2.48e-6	Hip circumference;
SKCM	cis	rs3857536	0.740	rs7769722	chr6:66891363	C/T	cg07460842	chr6:66804631	NA	-0.7	-5.08	-0.5	2.51e-6	Blood trace element (Cu levels);
SKCM	cis	rs3091242	0.933	rs10903129	chr1:25768937	A/G	cg27572855	chr1:25598939	RHD	0.52	4.92	0.49	4.67e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs9911578	1.000	rs12449365	chr17:56600660	C/G	cg05425664	chr17:57184151	TRIM37	0.69	5.21	0.51	1.52e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs748404	0.697	rs473016	chr15:43558823	A/C	cg02155558	chr15:43621948	ADAL;LCMT2	0.7	5.74	0.54	1.74e-7	Lung cancer;
SKCM	cis	rs473651	0.935	rs10170056	chr2:239339291	G/C	cg21699342	chr2:239360505	ASB1	0.55	5.29	0.51	1.07e-6	Multiple system atrophy;
SKCM	trans	rs561341	1.000	rs483301	chr17:30293398	G/T	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs208520	1.000	rs12190773	chr6:66968194	T/C	cg07460842	chr6:66804631	NA	0.84	5.89	0.55	9.44e-8	Exhaled nitric oxide output;
SKCM	cis	rs11098499	1.000	rs6849889	chr4:120186348	A/C	cg09307838	chr4:120376055	NA	0.95	7.75	0.66	2.84e-11	Corneal astigmatism;
SKCM	cis	rs208520	1.000	rs12199876	chr6:66989469	A/G	cg07460842	chr6:66804631	NA	0.87	5.96	0.56	6.95e-8	Exhaled nitric oxide output;
SKCM	cis	rs12477438	0.520	rs11695751	chr2:99708247	A/C	cg26064155	chr2:99771622	LIPT1;TSGA10	1.07	9.99	0.75	1.32e-15	Chronic sinus infection;
SKCM	cis	rs7937682	0.961	rs491937	chr11:111494947	A/T	cg09085632	chr11:111637200	PPP2R1B	-0.96	-9.87	-0.75	2.29e-15	Primary sclerosing cholangitis;
SKCM	cis	rs9910055	0.762	rs7213436	chr17:42252163	A/G	cg19774624	chr17:42201019	HDAC5	0.89	7.83	0.66	1.97e-11	Total body bone mineral density;
SKCM	cis	rs2180341	1.000	rs4895822	chr6:127642703	T/C	cg24812749	chr6:127587940	RNF146	0.85	7.3	0.64	2.08e-10	Breast cancer;
SKCM	cis	rs9486715	1.000	rs6902835	chr6:97063005	C/G	cg06623918	chr6:96969491	KIAA0776	-0.69	-6.1	-0.57	3.8e-8	Headache;
SKCM	cis	rs7659604	0.518	rs17452156	chr4:122733623	T/C	cg06713675	chr4:122721982	EXOSC9	-0.75	-7.26	-0.64	2.47e-10	Type 2 diabetes;
SKCM	cis	rs2404602	0.655	rs8028294	chr15:77084877	T/C	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs6121246	0.559	rs6060915	chr20:30330306	A/G	cg13852791	chr20:30311386	BCL2L1	0.82	5.69	0.54	2.09e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs6582630	0.502	rs4559747	chr12:38436235	G/A	cg26384229	chr12:38710491	ALG10B	0.82	6.3	0.58	1.6e-8	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs2730245	1.000	rs2730241	chr7:158723014	T/C	cg24397884	chr7:158709396	WDR60	-1.01	-9.51	-0.73	1.12e-14	Height;
SKCM	cis	rs4683346	0.731	rs7623543	chr3:42921627	C/A	cg06399164	chr3:42695035	ZBTB47	0.55	5.11	0.5	2.25e-6	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs427394	0.632	rs377137	chr5:6740468	T/G	cg10857441	chr5:6722123	POLS	-0.68	-7.35	-0.64	1.69e-10	Menopause (age at onset);
SKCM	cis	rs2594989	0.733	rs6779007	chr3:11583254	C/T	cg00170343	chr3:11313890	ATG7	-0.97	-5.17	-0.5	1.79e-6	Circulating chemerin levels;
SKCM	cis	rs7811142	0.943	rs111493473	chr7:100049742	A/G	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.23	7.89	0.67	1.53e-11	Platelet count;
SKCM	cis	rs826838	0.933	rs1906263	chr12:38653362	T/C	cg13010199	chr12:38710504	ALG10B	0.72	5.27	0.51	1.19e-6	Heart rate;
SKCM	cis	rs12142240	0.698	rs12385697	chr1:46818898	T/C	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs651907	0.557	rs62284199	chr3:101478531	T/G	cg12386194	chr3:101231763	SENP7	0.65	5.26	0.51	1.21e-6	Colorectal cancer;
SKCM	cis	rs2204008	0.806	rs7305409	chr12:38349133	G/A	cg26384229	chr12:38710491	ALG10B	0.87	6.82	0.61	1.73e-9	Bladder cancer;
SKCM	cis	rs9300255	0.722	rs10846515	chr12:123801672	T/G	cg05973401	chr12:123451056	ABCB9	0.82	5.72	0.54	1.92e-7	Neutrophil percentage of white cells;
SKCM	cis	rs9910055	0.509	rs9916444	chr17:42313512	C/G	cg10896456	chr17:42255109	ASB16;C17orf65	0.54	4.88	0.48	5.61e-6	Total body bone mineral density;
SKCM	cis	rs6993244	1	rs6993244	chr8:8863059	C/G	cg15556689	chr8:8085844	FLJ10661	0.7	5.6	0.54	3.02e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs561341	0.505	rs28708703	chr17:30386845	C/G	cg00745463	chr17:30367425	LRRC37B	-1.06	-7.34	-0.64	1.8e-10	Hip circumference adjusted for BMI;
SKCM	cis	rs826838	0.967	rs4768330	chr12:39129399	T/C	cg26384229	chr12:38710491	ALG10B	-0.91	-8.28	-0.68	2.74e-12	Heart rate;
SKCM	cis	rs597539	0.652	rs592697	chr11:68650064	G/A	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.82	5.44	0.52	5.87e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs6088580	0.660	rs6087592	chr20:33114503	A/G	cg24642439	chr20:33292090	TP53INP2	0.76	6.03	0.56	5.23e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs1799949	1.000	rs67060599	chr17:41255102	A/G	cg25918947	chr17:41365094	TMEM106A	-0.62	-5.98	-0.56	6.24e-8	Menopause (age at onset);
SKCM	cis	rs2153535	0.601	rs7741024	chr6:8530313	T/C	cg07606381	chr6:8435919	SLC35B3	0.93	6.8	0.61	1.92e-9	Motion sickness;
SKCM	cis	rs2731664	0.792	rs385981	chr5:176886539	C/T	cg23176889	chr5:176863531	GRK6	-0.54	-5.66	-0.54	2.41e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs4148883	0.675	rs34511427	chr4:100105405	G/T	cg12011299	chr4:100065546	ADH4	0.48	4.78	0.48	8.14e-6	Alcohol dependence;
SKCM	cis	rs1865760	0.892	rs6456705	chr6:25936056	G/A	cg08401836	chr6:26032486	HIST1H3B	-0.62	-5.03	-0.5	3.01e-6	Height;
SKCM	cis	rs72781680	1.000	rs72798418	chr2:24188922	A/G	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	cis	rs55823223	0.590	rs11870142	chr17:73859002	A/G	cg08125733	chr17:73851984	WBP2	1.06	6.07	0.57	4.35e-8	Psoriasis;
SKCM	cis	rs73201462	1.000	rs2811511	chr3:127912988	G/A	cg09089421	chr3:127803668	RUVBL1	1.0	5.11	0.5	2.22e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs3793683	0.520	rs4880426	chr10:134590610	G/A	cg18305652	chr10:134549665	INPP5A	0.6	6.16	0.57	2.97e-8	Migraine;
SKCM	cis	rs1218582	0.772	rs4845694	chr1:154911651	C/G	cg24250549	chr1:154909240	PMVK	0.87	8.96	0.71	1.3e-13	Prostate cancer;
SKCM	cis	rs7811142	1.000	rs4463351	chr7:100078226	G/A	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-0.99	-5.52	-0.53	4.2e-7	Platelet count;
SKCM	cis	rs8064024	0.649	rs9934930	chr16:4902038	A/G	cg09549813	chr16:4587862	C16orf5	0.59	4.95	0.49	4.12e-6	Cancer;
SKCM	cis	rs8078723	0.738	rs8066582	chr17:38146929	A/G	cg17467752	chr17:38218738	THRA	-0.57	-5.15	-0.5	1.9e-6	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs826838	0.967	rs1486345	chr12:39131677	G/A	cg13010199	chr12:38710504	ALG10B	-0.73	-5.81	-0.55	1.27e-7	Heart rate;
SKCM	cis	rs3087591	0.959	rs9893872	chr17:29571195	G/A	cg24425628	chr17:29625626	OMG;NF1	-0.63	-4.95	-0.49	4.23e-6	Hip circumference;
SKCM	cis	rs10791097	0.694	rs4459316	chr11:130756176	T/C	cg12179176	chr11:130786555	SNX19	0.91	8.08	0.67	6.64e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs514406	0.644	rs6662414	chr1:53198893	A/G	cg24675658	chr1:53192096	ZYG11B	0.66	5.52	0.53	4.33e-7	Monocyte count;
SKCM	cis	rs6570726	0.967	rs450973	chr6:145863065	C/A	cg23711669	chr6:146136114	FBXO30	0.68	6.6	0.6	4.54e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6866344	0.570	rs1071881	chr5:178135917	C/T	cg03877680	chr5:178157825	ZNF354A	0.92	7.46	0.65	1.04e-10	Neutrophil percentage of white cells;
SKCM	cis	rs664172	1	rs664172	chr15:78862762	G/A	cg24631222	chr15:78858424	CHRNA5	0.87	6.62	0.6	4.19e-9	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs58688157	0.705	rs12272434	chr11:615011	A/T	cg17114584	chr11:613792	IRF7	0.74	5.0	0.49	3.51e-6	Systemic lupus erythematosus;
SKCM	cis	rs8072100	0.817	rs12449647	chr17:45548958	C/A	cg08085267	chr17:45401833	C17orf57	-0.62	-5.08	-0.5	2.48e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs763014	0.931	rs3752567	chr16:628130	A/G	cg07343612	chr16:622815	PIGQ	-0.7	-6.0	-0.56	5.93e-8	Height;
SKCM	cis	rs2239547	0.522	rs2710345	chr3:52976075	T/C	cg11645453	chr3:52864694	ITIH4	-0.58	-4.96	-0.49	3.98e-6	Schizophrenia;
SKCM	cis	rs3812762	0.783	rs34524863	chr11:8777408	T/C	cg21881798	chr11:8931708	C11orf17;ST5	-0.54	-4.96	-0.49	4.01e-6	Hypospadias;
SKCM	cis	rs12477438	0.520	rs11123766	chr2:99780915	C/T	cg14399236	chr2:99771627	LIPT1;TSGA10	0.97	8.9	0.71	1.72e-13	Chronic sinus infection;
SKCM	cis	rs951366	0.789	rs7536483	chr1:205718858	A/T	cg14159672	chr1:205819179	PM20D1	0.95	7.7	0.66	3.56e-11	Menarche (age at onset);
SKCM	cis	rs801193	0.569	rs6951302	chr7:66132512	T/C	cg18876405	chr7:65276391	NA	-0.63	-6.29	-0.58	1.68e-8	Aortic root size;
SKCM	cis	rs6598955	0.694	rs4659416	chr1:26580937	T/G	cg04990556	chr1:26633338	UBXN11	-0.6	-4.82	-0.48	6.93e-6	Obesity-related traits;
SKCM	cis	rs116095464	0.558	rs10058428	chr5:235608	A/G	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs2404602	0.672	rs35374222	chr15:77071394	G/T	cg23625390	chr15:77176239	SCAPER	-0.85	-8.26	-0.68	2.93e-12	Blood metabolite levels;
SKCM	cis	rs13256369	0.851	rs13256611	chr8:8564341	G/A	cg15556689	chr8:8085844	FLJ10661	0.65	4.77	0.48	8.39e-6	Obesity-related traits;
SKCM	cis	rs3087591	0.922	rs11867284	chr17:29597464	G/A	cg24425628	chr17:29625626	OMG;NF1	0.64	5.08	0.5	2.48e-6	Hip circumference;
SKCM	cis	rs10872587	0.657	rs11155459	chr6:146578751	A/G	cg23711669	chr6:146136114	FBXO30	-0.75	-5.57	-0.53	3.51e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs801193	0.844	rs7779971	chr7:66161790	T/C	cg18876405	chr7:65276391	NA	0.8	7.11	0.63	4.86e-10	Aortic root size;
SKCM	trans	rs6481128	0.743	rs962472	chr10:56700597	T/C	cg04272632	chr1:34629400	CSMD2	0.69	7.66	0.66	4.26e-11	Extraversion;
SKCM	cis	rs1218582	0.772	rs1976559	chr1:154879788	A/T	cg06221963	chr1:154839813	KCNN3	-0.59	-5.97	-0.56	6.76e-8	Prostate cancer;
SKCM	cis	rs3820068	0.581	rs16851848	chr1:15927698	G/A	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs28735056	0.565	rs2012687	chr18:77711127	G/T	cg20368463	chr18:77673604	PQLC1	-0.64	-4.77	-0.48	8.35e-6	Schizophrenia;
SKCM	cis	rs2836974	0.796	rs77153312	chr21:40695499	G/A	cg17971929	chr21:40555470	PSMG1	0.82	7.5	0.65	8.73e-11	Cognitive function;
SKCM	cis	rs28386778	0.897	rs6504184	chr17:61842408	A/T	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs11098499	0.738	rs28687057	chr4:120280812	A/G	cg09307838	chr4:120376055	NA	0.98	7.89	0.67	1.52e-11	Corneal astigmatism;
SKCM	cis	rs7296418	0.961	rs11608811	chr12:123529056	A/G	cg06742321	chr12:123595122	PITPNM2	0.66	5.7	0.54	2.07e-7	Platelet count;
SKCM	cis	rs3820928	0.904	rs4439949	chr2:227764954	T/G	cg11843606	chr2:227700838	RHBDD1	-0.64	-5.25	-0.51	1.26e-6	Pulmonary function;
SKCM	cis	rs7666738	0.830	rs13110903	chr4:98946373	A/G	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9913156	0.517	rs9893958	chr17:4611388	A/G	cg19197139	chr17:4613644	ARRB2	0.62	4.79	0.48	7.88e-6	Lymphocyte counts;
SKCM	cis	rs8180040	0.620	rs6442055	chr3:47110722	A/G	cg27129171	chr3:47204927	SETD2	0.74	5.37	0.52	7.84e-7	Colorectal cancer;
SKCM	cis	rs11585357	0.895	rs2501795	chr1:17633499	A/G	cg08277548	chr1:17600880	PADI3	-0.92	-6.66	-0.6	3.5e-9	Hair shape;
SKCM	cis	rs10504229	1.000	rs59275611	chr8:58195191	G/A	cg22535103	chr8:58192502	C8orf71	-0.76	-5.07	-0.5	2.66e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs10911251	0.508	rs729672	chr1:183109236	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.76	7.28	0.64	2.26e-10	Colorectal cancer;
SKCM	cis	rs6951245	0.832	rs10266519	chr7:1142977	C/T	cg18402987	chr7:1209562	NA	1.15	7.08	0.63	5.47e-10	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs1577917	0.958	rs12215265	chr6:86443969	C/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.79	-7.73	-0.66	3.07e-11	Response to antipsychotic treatment;
SKCM	cis	rs929354	0.742	rs10274687	chr7:156933181	T/G	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs793571	0.614	rs347117	chr15:59000957	C/T	cg05156742	chr15:59063176	FAM63B	0.69	4.93	0.49	4.45e-6	Schizophrenia;
SKCM	cis	rs9926296	1.000	rs9926296	chr16:89818089	A/G	cg26513180	chr16:89883248	FANCA	0.76	7.07	0.63	5.74e-10	Vitiligo;
SKCM	cis	rs4481887	0.927	rs6587444	chr1:248438452	C/T	cg00666640	chr1:248458726	OR2T12	-0.64	-5.56	-0.53	3.68e-7	Common traits (Other);
SKCM	cis	rs9467773	0.836	rs1977198	chr6:26466225	A/C	cg15659132	chr6:26577336	NA	0.57	5.07	0.5	2.58e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs6580649	0.783	rs7969749	chr12:48550755	C/T	cg05342945	chr12:48394962	COL2A1	-0.79	-5.39	-0.52	7.22e-7	Lung cancer;
SKCM	cis	rs2354432	0.556	rs2275249	chr1:146759320	C/G	cg25205988	chr1:146714368	CHD1L	1.16	6.74	0.61	2.44e-9	Mitochondrial DNA levels;
SKCM	cis	rs17376456	0.877	rs12153788	chr5:93405437	A/G	cg25358565	chr5:93447407	FAM172A	1.22	7.9	0.67	1.49e-11	Diabetic retinopathy;
SKCM	cis	rs950027	0.620	rs1617984	chr15:45622662	A/G	cg21132104	chr15:45694354	SPATA5L1	0.78	5.83	0.55	1.2e-7	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs6840360	0.571	rs11729136	chr4:152529227	C/A	cg22705602	chr4:152727874	NA	-0.52	-5.7	-0.54	2.03e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs13098911	0.540	rs17282238	chr3:46174605	A/G	cg22986271	chr3:45730975	SACM1L	-0.9	-4.91	-0.49	4.83e-6	Celiac disease;
SKCM	cis	rs9640161	0.789	rs1464751	chr7:150021282	C/T	cg10018233	chr7:150070692	REPIN1	0.77	6.19	0.57	2.62e-8	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs6088590	1.000	rs6087623	chr20:33317662	C/G	cg24642439	chr20:33292090	TP53INP2	1.02	7.56	0.65	6.73e-11	Coronary artery disease;
SKCM	cis	rs2816062	0.710	rs2816052	chr1:18895536	T/C	cg18795169	chr1:18902165	NA	-0.83	-9.02	-0.71	1.01e-13	Urate levels in lean individuals;
SKCM	cis	rs72827839	0.793	rs72823513	chr17:46048920	A/G	cg23391107	chr17:45924227	SP6	0.66	5.32	0.52	9.84e-7	Ease of getting up in the morning;
SKCM	cis	rs7953508	0.506	rs2200160	chr12:93963873	C/T	cg18151635	chr12:93972918	NA	-0.63	-5.67	-0.54	2.28e-7	Pubertal anthropometrics;
SKCM	cis	rs28386778	0.897	rs8066754	chr17:61816590	T/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.12	11.27	0.79	4.92e-18	Prudent dietary pattern;
SKCM	cis	rs7100689	0.646	rs10788562	chr10:82072310	C/T	cg01528321	chr10:82214614	TSPAN14	-0.75	-6.55	-0.6	5.47e-9	Post bronchodilator FEV1;
SKCM	cis	rs2050392	0.590	rs2065723	chr10:30720462	A/T	cg25182066	chr10:30743637	MAP3K8	-0.65	-5.3	-0.51	1.05e-6	Inflammatory bowel disease;
SKCM	cis	rs735396	0.770	rs1169301	chr12:121431300	C/T	cg02403541	chr12:121454288	C12orf43	0.77	6.72	0.61	2.65e-9	N-glycan levels;
SKCM	cis	rs1799949	1.000	rs4793231	chr17:41427469	A/G	cg05368731	chr17:41323189	NBR1	0.85	7.42	0.64	1.23e-10	Menopause (age at onset);
SKCM	cis	rs17376456	0.877	rs34184666	chr5:93444584	T/C	cg21475434	chr5:93447410	FAM172A	0.97	5.42	0.52	6.39e-7	Diabetic retinopathy;
SKCM	cis	rs10256972	0.694	rs7784701	chr7:1003041	A/G	cg07930192	chr7:1003750	NA	0.54	5.41	0.52	6.73e-7	Longevity;Endometriosis;
SKCM	cis	rs875971	1.000	rs1981798	chr7:65954903	G/T	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	cis	rs8180040	0.764	rs12629262	chr3:47196580	C/T	cg27129171	chr3:47204927	SETD2	0.82	6.44	0.59	9.04e-9	Colorectal cancer;
SKCM	cis	rs11098499	0.863	rs11723090	chr4:120490592	T/C	cg09307838	chr4:120376055	NA	1.0	8.27	0.68	2.8e-12	Corneal astigmatism;
SKCM	cis	rs1801251	1.000	rs2674839	chr2:233669040	G/C	cg08000102	chr2:233561755	GIGYF2	0.89	7.22	0.63	3.02e-10	Coronary artery disease;
SKCM	cis	rs7666738	0.830	rs10012271	chr4:99065154	A/C	cg05340658	chr4:99064831	C4orf37	0.66	4.87	0.48	5.74e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2243480	1.000	rs316325	chr7:65609518	G/A	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs17270561	0.578	rs76182885	chr6:25904085	G/C	cg16482183	chr6:26056742	HIST1H1C	0.96	6.47	0.59	7.91e-9	Iron status biomarkers;
SKCM	cis	rs801193	1.000	rs17566701	chr7:66193183	T/C	cg11764359	chr7:65958608	NA	0.86	6.56	0.6	5.31e-9	Aortic root size;
SKCM	cis	rs12477438	0.520	rs11123764	chr2:99750677	T/C	cg14399236	chr2:99771627	LIPT1;TSGA10	0.97	8.9	0.71	1.72e-13	Chronic sinus infection;
SKCM	cis	rs10155981	0.510	rs4722157	chr7:22583941	G/A	cg05062323	chr7:22590069	NA	-0.99	-6.04	-0.56	4.91e-8	Bilirubin levels;
SKCM	cis	rs763014	0.966	rs4144003	chr16:645968	C/T	cg00908189	chr16:619842	PIGQ	0.82	7.77	0.66	2.58e-11	Height;
SKCM	cis	rs16854884	0.683	rs6766544	chr3:143736659	G/T	cg06585982	chr3:143692056	C3orf58	0.87	8.11	0.68	5.72e-12	Economic and political preferences (feminism/equality);
SKCM	cis	rs2153535	0.580	rs1932284	chr6:8477694	A/T	cg07606381	chr6:8435919	SLC35B3	0.95	6.78	0.61	2.09e-9	Motion sickness;
SKCM	cis	rs1395	0.778	rs4665960	chr2:27467598	C/T	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.51	5.14	0.5	1.96e-6	Blood metabolite levels;
SKCM	cis	rs244731	1.000	rs244731	chr5:176539679	C/T	cg06060754	chr5:176797920	RGS14	0.78	5.8	0.55	1.36e-7	Urate levels in lean individuals;
SKCM	cis	rs8014204	0.839	rs6574197	chr14:75331487	A/G	cg06637938	chr14:75390232	RPS6KL1	-0.78	-5.83	-0.55	1.18e-7	Caffeine consumption;
SKCM	cis	rs3540	0.533	rs2352601	chr15:91053125	G/A	cg22089800	chr15:90895588	ZNF774	-0.68	-4.91	-0.49	4.92e-6	Allergic disease (asthma, hay fever or eczema);Lymphocyte counts;
SKCM	cis	rs7124681	0.546	rs7941399	chr11:47890421	A/T	cg20307385	chr11:47447363	PSMC3	0.71	5.65	0.54	2.55e-7	Body mass index (joint analysis main effects and physical activity interaction);Body mass index;Body mass index in physically active individuals;
SKCM	cis	rs1552244	1.000	rs6772315	chr3:10113644	G/A	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs4727027	0.933	rs1468369	chr7:148839840	G/C	cg23583168	chr7:148888333	NA	-0.82	-6.85	-0.61	1.54e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs9300255	0.602	rs1727306	chr12:123665695	A/G	cg00376283	chr12:123451042	ABCB9	0.86	5.28	0.51	1.12e-6	Neutrophil percentage of white cells;
SKCM	cis	rs7666738	0.830	rs34135615	chr4:99001325	C/T	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs427394	0.664	rs274701	chr5:6728707	C/A	cg10857441	chr5:6722123	POLS	-0.66	-6.72	-0.61	2.68e-9	Menopause (age at onset);
SKCM	cis	rs2204008	0.715	rs11514342	chr12:38236710	T/A	cg13010199	chr12:38710504	ALG10B	0.69	4.99	0.49	3.57e-6	Bladder cancer;
SKCM	cis	rs7829975	0.577	rs940032	chr8:8546343	C/T	cg15556689	chr8:8085844	FLJ10661	-0.69	-5.37	-0.52	8.03e-7	Mood instability;
SKCM	cis	rs561341	0.941	rs2470236	chr17:30304940	G/C	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs9910055	0.762	rs4239142	chr17:42205876	A/G	cg19774624	chr17:42201019	HDAC5	0.93	8.25	0.68	3.08e-12	Total body bone mineral density;
SKCM	cis	rs2836974	0.897	rs36113648	chr21:40555497	G/A	cg11644478	chr21:40555479	PSMG1	0.97	10.17	0.75	5.99e-16	Cognitive function;
SKCM	cis	rs6879260	0.928	rs11739624	chr5:179727290	T/C	cg02891314	chr5:179741120	GFPT2	-0.74	-5.71	-0.54	1.94e-7	Height;
SKCM	cis	rs35306767	0.951	rs61833265	chr10:990143	C/T	cg26597838	chr10:835615	NA	0.75	6.3	0.58	1.66e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs7584330	0.617	rs28725355	chr2:238372824	T/G	cg14458575	chr2:238380390	NA	0.99	6.57	0.6	5.03e-9	Prostate cancer;
SKCM	cis	rs4654899	0.785	rs9426736	chr1:21505931	T/G	cg01072550	chr1:21505969	NA	-0.62	-4.79	-0.48	7.86e-6	Superior frontal gyrus grey matter volume;
SKCM	cis	rs9388451	0.903	rs7758115	chr6:126061502	C/T	cg05901451	chr6:126070800	HEY2	-0.77	-7.54	-0.65	7.32e-11	Brugada syndrome;
SKCM	cis	rs875971	1.000	rs10257427	chr7:65743208	T/C	cg18876405	chr7:65276391	NA	-0.68	-6.79	-0.61	1.94e-9	Aortic root size;
SKCM	cis	rs151997	0.671	rs27907	chr5:50193797	C/G	cg06027927	chr5:50259733	NA	0.65	6.24	0.58	2.13e-8	Callous-unemotional behaviour;
SKCM	cis	rs4906332	0.754	rs34235720	chr14:104004968	C/T	cg04998671	chr14:104000505	TRMT61A	-0.72	-4.92	-0.49	4.72e-6	Coronary artery disease;
SKCM	cis	rs6500395	1.000	rs12599028	chr16:48713082	C/A	cg04672837	chr16:48644449	N4BP1	-0.63	-5.37	-0.52	8.01e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs860295	0.871	rs6688636	chr1:155478897	T/C	cg02153340	chr1:155202674	NA	0.73	5.64	0.54	2.59e-7	Body mass index;
SKCM	cis	rs9325144	0.555	rs1973292	chr12:38679626	T/C	cg13010199	chr12:38710504	ALG10B	0.63	5.01	0.49	3.31e-6	Morning vs. evening chronotype;
SKCM	cis	rs6977660	0.943	rs10270447	chr7:19849823	C/G	cg05791153	chr7:19748676	TWISTNB	-0.79	-5.51	-0.53	4.42e-7	Thyroid stimulating hormone;
SKCM	cis	rs7772486	0.686	rs857880	chr6:145971115	T/C	cg23711669	chr6:146136114	FBXO30	-0.9	-9.54	-0.73	9.76e-15	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs651907	0.535	rs12631513	chr3:101517476	A/C	cg12386194	chr3:101231763	SENP7	0.68	5.74	0.54	1.73e-7	Colorectal cancer;
SKCM	cis	rs34779708	0.931	rs11597483	chr10:35285117	A/G	cg03585969	chr10:35415529	CREM	0.72	5.96	0.56	6.77e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs7829975	0.633	rs2979181	chr8:8323088	A/T	cg08975724	chr8:8085496	FLJ10661	0.74	6.07	0.57	4.35e-8	Mood instability;
SKCM	cis	rs11098499	0.863	rs6835635	chr4:120458867	A/G	cg24375607	chr4:120327624	NA	0.68	5.24	0.51	1.34e-6	Corneal astigmatism;
SKCM	cis	rs4975616	0.836	rs13178866	chr5:1323212	C/T	cg06550200	chr5:1325588	CLPTM1L	-0.86	-7.74	-0.66	2.94e-11	Lung cancer;
SKCM	cis	rs11098499	0.618	rs6858383	chr4:120296772	T/C	cg24375607	chr4:120327624	NA	0.65	4.97	0.49	3.87e-6	Corneal astigmatism;
SKCM	cis	rs6083	0.571	rs56010348	chr15:58848120	T/G	cg05156742	chr15:59063176	FAM63B	-0.75	-5.12	-0.5	2.12e-6	Schizophrenia;
SKCM	cis	rs7954584	0.567	rs1169071	chr12:122390084	G/T	cg13699009	chr12:122356056	WDR66	0.58	7.26	0.64	2.5e-10	Mean corpuscular volume;
SKCM	cis	rs2404602	0.622	rs9635380	chr15:77103479	A/G	cg23625390	chr15:77176239	SCAPER	-0.83	-7.53	-0.65	7.64e-11	Blood metabolite levels;
SKCM	cis	rs7208859	0.524	rs8065744	chr17:29099449	C/T	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs7927771	1.000	rs11039390	chr11:47796295	C/G	cg05585544	chr11:47624801	NA	-0.6	-5.22	-0.51	1.45e-6	Subjective well-being;
SKCM	cis	rs4073582	0.964	rs801742	chr11:65914766	C/A	cg16950941	chr11:66035639	RAB1B	0.75	5.28	0.51	1.14e-6	Gout;
SKCM	cis	rs7635838	0.785	rs2594972	chr3:11397417	A/G	cg00170343	chr3:11313890	ATG7	0.66	4.92	0.49	4.69e-6	HDL cholesterol;
SKCM	cis	rs116095464	0.558	rs62344300	chr5:246336	A/G	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs4803468	1.000	rs13344563	chr19:41945904	G/C	cg09537434	chr19:41945824	ATP5SL	1.1	13.21	0.83	1.39e-21	Height;
SKCM	cis	rs9911578	0.967	rs2643124	chr17:56741672	T/C	cg05425664	chr17:57184151	TRIM37	-0.69	-5.21	-0.51	1.52e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs4423214	0.625	rs78685409	chr11:71137383	T/C	cg05163923	chr11:71159392	DHCR7	-0.67	-6.0	-0.56	5.84e-8	Vitamin D levels;
SKCM	cis	rs4242434	0.927	rs7843828	chr8:22463623	C/T	cg03733263	chr8:22462867	KIAA1967	1.09	8.99	0.71	1.11e-13	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs56104184	0.725	rs1466896	chr19:49385253	C/G	cg19746536	chr19:49375674	PPP1R15A	1.13	5.5	0.53	4.69e-7	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs2153535	0.580	rs1577468	chr6:8444266	C/A	cg23788917	chr6:8435910	SLC35B3	0.69	5.14	0.5	1.99e-6	Motion sickness;
SKCM	cis	rs344364	0.578	rs344352	chr16:1846476	G/C	cg00490583	chr16:1843685	IGFALS	0.52	4.98	0.49	3.74e-6	Glomerular filtration rate in chronic kidney disease;
SKCM	cis	rs4242434	0.819	rs6558173	chr8:22492103	A/C	cg03733263	chr8:22462867	KIAA1967	-1.0	-8.62	-0.7	5.85e-13	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs6430585	0.527	rs62168833	chr2:136449254	G/A	cg07169764	chr2:136633963	MCM6	1.02	7.68	0.66	3.84e-11	Corneal structure;
SKCM	cis	rs801193	1.000	rs10274773	chr7:66133578	G/A	cg11987759	chr7:65425863	GUSB	0.67	5.75	0.55	1.68e-7	Aortic root size;
SKCM	cis	rs4687718	0.929	rs62255996	chr3:53279868	A/G	cg07507251	chr3:52567010	NT5DC2	0.87	5.58	0.53	3.38e-7	QRS duration;
SKCM	cis	rs7829975	0.777	rs560544	chr8:8637429	G/A	cg06636001	chr8:8085503	FLJ10661	-0.86	-7.81	-0.66	2.23e-11	Mood instability;
SKCM	cis	rs16854884	0.710	rs1530479	chr3:143819653	C/T	cg06585982	chr3:143692056	C3orf58	0.63	5.09	0.5	2.4e-6	Economic and political preferences (feminism/equality);
SKCM	cis	rs703842	1.000	rs11172333	chr12:58170335	A/G	cg04478727	chr12:58166393	METTL1;FAM119B	0.73	5.84	0.55	1.15e-7	Multiple sclerosis;
SKCM	cis	rs6066825	0.644	rs2869669	chr20:47321449	T/C	cg18078177	chr20:47281410	PREX1	0.64	5.19	0.51	1.6e-6	Colorectal cancer;
SKCM	cis	rs2072510	1.000	rs1978331	chr12:96409201	A/G	cg18817487	chr12:96390143	HAL	0.42	5.61	0.54	3.01e-7	Metabolite levels (small molecules and protein measures);
SKCM	cis	rs854765	0.583	rs2350977	chr17:17802779	A/G	cg20995835	chr17:18528589	CCDC144B	-0.73	-4.84	-0.48	6.31e-6	Total body bone mineral density;
SKCM	cis	rs4862307	0.514	rs7696176	chr4:185014390	A/G	cg06737308	chr4:185021514	ENPP6	0.47	5.29	0.51	1.07e-6	Serum dimethylarginine levels (asymmetric/symetric ratio);
SKCM	cis	rs11122272	0.525	rs61835222	chr1:231537917	C/A	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	-0.62	-4.91	-0.49	4.84e-6	Hemoglobin concentration;
SKCM	cis	rs4332037	0.950	rs10267593	chr7:1937261	G/A	cg23422044	chr7:1970798	MAD1L1	-1.01	-6.85	-0.61	1.55e-9	Bipolar disorder;
SKCM	cis	rs9581857	0.512	rs9507886	chr13:27957286	G/A	cg22138327	chr13:27999177	GTF3A	0.97	6.01	0.56	5.57e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs2439831	0.867	rs3213990	chr15:43670226	C/A	cg02155558	chr15:43621948	ADAL;LCMT2	1.22	8.33	0.69	2.19e-12	Lung cancer in ever smokers;
SKCM	cis	rs1029738	0.659	rs1608553	chr7:22896231	G/C	cg04907244	chr7:22894795	SNORD93	-0.58	-5.14	-0.5	1.98e-6	Fibrinogen levels;
SKCM	cis	rs1949733	0.543	rs62287446	chr4:8535988	G/A	cg11789530	chr4:8429930	ACOX3	-0.8	-5.17	-0.5	1.79e-6	Response to antineoplastic agents;
SKCM	cis	rs62064224	0.905	rs9891969	chr17:30627085	C/T	cg25809561	chr17:30822961	MYO1D	0.67	5.61	0.54	2.9e-7	Schizophrenia;
SKCM	cis	rs7772486	0.875	rs9322045	chr6:146384950	C/G	cg05347473	chr6:146136440	FBXO30	0.63	5.7	0.54	2.05e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9911578	1.000	rs4636974	chr17:56965373	C/G	cg05425664	chr17:57184151	TRIM37	-0.67	-5.04	-0.5	2.91e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9303401	0.614	rs12948536	chr17:56580413	G/T	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.16	0.57	2.93e-8	Cognitive test performance;
SKCM	cis	rs561341	0.941	rs72825736	chr17:30330286	G/A	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs854765	0.583	rs11869536	chr17:17826528	T/A	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.0	7.64	0.65	4.64e-11	Total body bone mineral density;
SKCM	cis	rs2839186	0.770	rs2330353	chr21:47669648	T/A	cg05896524	chr21:47604654	C21orf56	0.71	5.66	0.54	2.44e-7	Testicular germ cell tumor;
SKCM	cis	rs9911578	1.000	rs302859	chr17:56693132	C/T	cg05425664	chr17:57184151	TRIM37	-0.69	-5.21	-0.51	1.52e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs10808739	1.000	rs10808739	chr8:65640260	A/G	cg05711235	chr8:65498612	NA	0.79	5.29	0.51	1.11e-6	HIV-1 susceptibility;
SKCM	cis	rs2224391	0.822	rs2773321	chr6:5262220	C/G	cg09085698	chr6:5261316	LYRM4;FARS2	-0.78	-5.8	-0.55	1.34e-7	Height;
SKCM	cis	rs11105298	0.891	rs4842664	chr12:89938030	G/A	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.84	-5.19	-0.51	1.63e-6	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs597539	0.652	rs546382	chr11:68704264	C/T	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.85	5.67	0.54	2.32e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs1348850	0.526	rs6718769	chr2:178450909	T/C	cg27490568	chr2:178487706	NA	0.73	5.18	0.51	1.72e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs2404602	0.716	rs8039545	chr15:76707247	A/G	cg23625390	chr15:77176239	SCAPER	0.59	5.31	0.52	9.85e-7	Blood metabolite levels;
SKCM	cis	rs4972806	0.849	rs2071581	chr2:177026148	G/T	cg13092806	chr2:177043255	NA	0.59	5.39	0.52	7.15e-7	IgG glycosylation;
SKCM	cis	rs1639906	0.893	rs13233298	chr7:2227707	C/T	cg21782813	chr7:2030301	MAD1L1	0.49	5.17	0.5	1.78e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs362296	0.511	rs2051558	chr4:3324886	G/A	cg00764545	chr4:3318001	RGS12	0.8	8.92	0.71	1.55e-13	Parental longevity (mother's age at death);
SKCM	cis	rs910316	0.575	rs12889133	chr14:75465089	C/T	cg08847533	chr14:75593920	NEK9	0.82	7.14	0.63	4.24e-10	Height;
SKCM	cis	rs611744	0.647	rs587340	chr8:109246032	C/A	cg18478394	chr8:109455254	TTC35	0.66	5.33	0.52	9.43e-7	Dupuytren's disease;
SKCM	cis	rs9467773	0.620	rs2504600	chr6:26648334	C/A	cg09904177	chr6:26538194	HMGN4	0.58	5.01	0.49	3.28e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs611744	0.647	rs615233	chr8:109254262	C/T	cg18478394	chr8:109455254	TTC35	0.66	5.33	0.52	9.43e-7	Dupuytren's disease;
SKCM	cis	rs7216064	0.734	rs12942774	chr17:65967562	A/G	cg12091567	chr17:66097778	LOC651250	0.67	5.04	0.5	2.98e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs28386778	0.863	rs9207	chr17:61823899	C/T	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.12	11.27	0.79	4.92e-18	Prudent dietary pattern;
SKCM	cis	rs1153858	0.943	rs8038342	chr15:45651537	T/C	cg21132104	chr15:45694354	SPATA5L1	0.93	7.94	0.67	1.22e-11	Homoarginine levels;
SKCM	cis	rs875971	1.000	rs6945843	chr7:65734783	G/A	cg18876405	chr7:65276391	NA	-0.68	-6.79	-0.61	1.94e-9	Aortic root size;
SKCM	cis	rs1790761	0.520	rs4930461	chr11:67394895	A/G	cg24690094	chr11:67383802	NA	0.57	5.96	0.56	6.91e-8	Mean corpuscular volume;
SKCM	cis	rs17685	0.712	rs10275521	chr7:75770972	T/C	cg16684958	chr7:75615977	POR	0.55	5.27	0.51	1.19e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2404602	0.692	rs8024476	chr15:76983954	T/C	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs1348850	0.632	rs4470372	chr2:178505857	G/A	cg22681709	chr2:178499509	PDE11A	-0.69	-5.98	-0.56	6.36e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs6489882	0.763	rs1859329	chr12:113376452	C/T	cg07232103	chr12:112566177	TRAFD1	0.59	4.78	0.48	8.01e-6	Chronic lymphocytic leukemia;
SKCM	cis	rs4481887	1.000	rs7553333	chr1:248493956	C/G	cg00666640	chr1:248458726	OR2T12	0.59	4.96	0.49	4.04e-6	Common traits (Other);
SKCM	cis	rs11098499	0.863	rs13140391	chr4:120503437	A/G	cg24375607	chr4:120327624	NA	0.69	5.47	0.53	5.35e-7	Corneal astigmatism;
SKCM	cis	rs7143963	0.609	rs11846158	chr14:103292959	A/G	cg23020514	chr14:103360112	TRAF3	0.67	5.93	0.56	7.96e-8	Body mass index;
SKCM	cis	rs2841277	0.802	rs2841269	chr14:105386149	C/G	cg14403583	chr14:105418241	AHNAK2	-0.8	-5.27	-0.51	1.2e-6	Rheumatoid arthritis;
SKCM	cis	rs1395	0.925	rs2580754	chr2:27398196	A/T	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.48	4.93	0.49	4.56e-6	Blood metabolite levels;
SKCM	cis	rs9926296	0.605	rs12599180	chr16:89839306	C/T	cg26513180	chr16:89883248	FANCA	-0.96	-10.08	-0.75	8.75e-16	Vitiligo;
SKCM	cis	rs9581857	0.579	rs76657892	chr13:27997604	A/G	cg22138327	chr13:27999177	GTF3A	0.95	6.38	0.59	1.14e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs4423214	0.840	rs1792231	chr11:71182681	G/A	cg05163923	chr11:71159392	DHCR7	-0.71	-6.07	-0.57	4.35e-8	Vitamin D levels;
SKCM	cis	rs4242434	0.699	rs878051	chr8:22483836	T/C	cg03733263	chr8:22462867	KIAA1967	0.79	5.56	0.53	3.67e-7	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs4523957	0.855	rs9896535	chr17:2133205	C/T	cg16513277	chr17:2031491	SMG6	-0.72	-5.03	-0.49	3.08e-6	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs1005277	0.505	rs7069702	chr10:38247359	G/T	cg00409905	chr10:38381863	ZNF37A	0.6	5.57	0.53	3.44e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs35306767	0.903	rs12763396	chr10:927357	C/A	cg26597838	chr10:835615	NA	0.75	5.51	0.53	4.53e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs10905065	0.895	rs9423930	chr10:5731707	T/G	cg09234995	chr10:5726438	C10orf18	-0.62	-5.37	-0.52	7.75e-7	Menopause (age at onset);
SKCM	cis	rs10905065	0.804	rs2380203	chr10:5810897	A/G	cg11519256	chr10:5708881	ASB13	0.59	5.26	0.51	1.23e-6	Menopause (age at onset);
SKCM	cis	rs67311347	0.544	rs6804545	chr3:40354040	G/C	cg00091569	chr3:40428383	ENTPD3	0.64	5.64	0.54	2.66e-7	Renal cell carcinoma;
SKCM	cis	rs17711722	0.701	rs4467826	chr7:65368708	A/G	cg18876405	chr7:65276391	NA	0.86	7.56	0.65	6.53e-11	Calcium levels;
SKCM	cis	rs13064447	0.967	rs7644528	chr3:12767194	T/C	cg05775895	chr3:12838266	CAND2	0.66	5.38	0.52	7.47e-7	Major depression and alcohol dependence;
SKCM	cis	rs651907	0.557	rs7629753	chr3:101371922	C/T	cg12386194	chr3:101231763	SENP7	-0.68	-5.68	-0.54	2.25e-7	Colorectal cancer;
SKCM	cis	rs11637445	0.626	rs1878699	chr15:67900883	C/T	cg24247231	chr15:67904302	MAP2K5	-0.67	-5.59	-0.53	3.22e-7	Posterior cortical atrophy and Alzheimer's disease;
SKCM	cis	rs4478137	0.657	rs12510104	chr4:164253021	A/T	cg06758707	chr4:164254230	NPY1R	0.96	7.59	0.65	5.92e-11	Subjective well-being (multi-trait analysis);Subjective well-being;
SKCM	cis	rs208520	0.690	rs1233103	chr6:66855943	T/G	cg07460842	chr6:66804631	NA	-1.08	-8.03	-0.67	8.38e-12	Exhaled nitric oxide output;
SKCM	cis	rs7659604	0.676	rs6534323	chr4:122695888	G/A	cg19748678	chr4:122722346	EXOSC9	0.71	5.69	0.54	2.12e-7	Type 2 diabetes;
SKCM	cis	rs763121	0.925	rs9835	chr22:39130971	A/G	cg06022373	chr22:39101656	GTPBP1	0.76	5.32	0.52	9.82e-7	Menopause (age at onset);
SKCM	cis	rs6582630	0.537	rs11520294	chr12:38402705	C/A	cg13010199	chr12:38710504	ALG10B	0.69	4.89	0.48	5.2e-6	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs6598955	0.543	rs3795687	chr1:26560745	G/A	cg04990556	chr1:26633338	UBXN11	0.64	4.92	0.49	4.78e-6	Obesity-related traits;
SKCM	cis	rs12142240	0.698	rs6690075	chr1:46819848	G/A	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs7980687	0.657	rs10744151	chr12:123723735	G/C	cg05973401	chr12:123451056	ABCB9	0.77	5.98	0.56	6.22e-8	Height;Educational attainment;Head circumference (infant);
SKCM	cis	rs208520	0.661	rs7766144	chr6:66827795	C/T	cg07460842	chr6:66804631	NA	-1.09	-8.46	-0.69	1.22e-12	Exhaled nitric oxide output;
SKCM	cis	rs2075671	0.855	rs62483567	chr7:100286435	G/A	cg20848291	chr7:100343083	ZAN	-0.73	-5.56	-0.53	3.6e-7	Other erythrocyte phenotypes;
SKCM	cis	rs2070488	0.775	rs6599208	chr3:38558104	A/C	cg01465620	chr3:38496096	LOC100128640;ACVR2B	-0.74	-5.88	-0.55	9.48e-8	Electrocardiographic conduction measures;
SKCM	cis	rs12134245	1.000	rs12134245	chr1:92021464	C/T	cg25838465	chr1:92012736	NA	-0.79	-7.79	-0.66	2.37e-11	Breast cancer;
SKCM	cis	rs1799949	1.000	rs8176242	chr17:41217874	C/T	cg05368731	chr17:41323189	NBR1	0.89	7.87	0.67	1.71e-11	Menopause (age at onset);
SKCM	cis	rs28595532	0.920	rs114966881	chr4:119761078	C/G	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs1348850	0.526	rs2178017	chr2:178374788	G/T	cg27490568	chr2:178487706	NA	0.9	6.52	0.59	6.42e-9	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs151997	0.925	rs27287	chr5:50195567	C/A	cg06027927	chr5:50259733	NA	0.64	5.57	0.53	3.49e-7	Callous-unemotional behaviour;
SKCM	cis	rs2180341	0.843	rs4895821	chr6:127572761	T/A	cg24812749	chr6:127587940	RNF146	0.91	8.05	0.67	7.38e-12	Breast cancer;
SKCM	cis	rs1552244	1.000	rs35741213	chr3:10087661	A/G	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs1461503	0.934	rs7113330	chr11:122843358	C/T	cg27398637	chr11:122830231	C11orf63	-0.66	-5.1	-0.5	2.28e-6	Menarche (age at onset);
SKCM	cis	rs10751667	0.643	rs7396407	chr11:929374	A/T	cg10932868	chr11:921992	NA	0.55	5.13	0.5	2.09e-6	Alzheimer's disease (late onset);
SKCM	cis	rs12142240	0.698	rs68112720	chr1:46813888	T/C	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs738322	0.935	rs133014	chr22:38571087	T/G	cg25457927	chr22:38595422	NA	-0.54	-6.14	-0.57	3.27e-8	Cutaneous nevi;
SKCM	cis	rs6570726	0.935	rs385185	chr6:145814992	A/G	cg23711669	chr6:146136114	FBXO30	0.71	6.77	0.61	2.18e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs3784262	0.765	rs11631127	chr15:58270009	G/C	cg12031962	chr15:58353849	ALDH1A2	-0.46	-5.73	-0.54	1.78e-7	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs9300255	0.739	rs4759371	chr12:123742563	T/C	cg05973401	chr12:123451056	ABCB9	0.86	6.11	0.57	3.69e-8	Neutrophil percentage of white cells;
SKCM	cis	rs9300255	0.602	rs1716168	chr12:123651966	C/G	cg00376283	chr12:123451042	ABCB9	-0.84	-5.87	-0.55	1e-7	Neutrophil percentage of white cells;
SKCM	cis	rs28386778	0.897	rs2727320	chr17:61865325	T/C	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs1577917	0.958	rs13219504	chr6:86556917	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.87	-8.71	-0.7	3.92e-13	Response to antipsychotic treatment;
SKCM	cis	rs28595532	0.920	rs115860482	chr4:119759546	A/G	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs9611565	0.659	rs17367849	chr22:41923644	G/A	cg03806693	chr22:41940476	POLR3H	-1.11	-7.56	-0.65	6.67e-11	Vitiligo;
SKCM	cis	rs3789045	0.560	rs1002779	chr1:204405098	T/A	cg17419461	chr1:204415978	PIK3C2B	-0.83	-6.15	-0.57	3.13e-8	Educational attainment (college completion);
SKCM	cis	rs248381	0.905	rs248378	chr5:78333155	C/T	cg17568934	chr5:77892219	LHFPL2	0.56	5.0	0.49	3.47e-6	Toenail selenium levels;
SKCM	cis	rs7666738	0.830	rs13139078	chr4:99020774	C/T	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4724125	0.722	rs2222550	chr7:42666669	T/C	cg09407816	chr7:42972088	MRPL32;PSMA2	0.77	5.04	0.5	2.92e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2952156	0.920	rs2517953	chr17:37841211	G/C	cg00129232	chr17:37814104	STARD3	-0.66	-5.38	-0.52	7.54e-7	Asthma;
SKCM	cis	rs3845702	1.000	rs3768839	chr2:180835992	G/A	cg01881094	chr2:180872142	CWC22	-1.02	-5.29	-0.51	1.07e-6	Schizophrenia;
SKCM	cis	rs9815354	0.597	rs17283481	chr3:41924015	T/C	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs13118159	0.934	rs4974553	chr4:1356911	G/A	cg02018176	chr4:1364513	KIAA1530	0.61	4.82	0.48	6.85e-6	Longevity;
SKCM	cis	rs2841277	0.616	rs1048257	chr14:105404384	T/C	cg19901468	chr14:105411992	AHNAK2	-0.98	-7.76	-0.66	2.7e-11	Rheumatoid arthritis;
SKCM	cis	rs8067545	0.604	rs55705283	chr17:20027138	G/A	cg13482628	chr17:19912719	NA	0.65	5.6	0.54	3.06e-7	Schizophrenia;
SKCM	cis	rs7811142	1.000	rs76913697	chr7:100002772	A/G	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.19	7.91	0.67	1.4e-11	Platelet count;
SKCM	cis	rs3892630	0.620	rs10413279	chr19:33182746	A/G	cg22980127	chr19:33182716	NUDT19	1.28	8.73	0.7	3.67e-13	Red blood cell traits;
SKCM	cis	rs9399135	0.967	rs6569990	chr6:135365818	C/T	cg24558204	chr6:135376177	HBS1L	0.57	5.01	0.49	3.34e-6	Red blood cell count;
SKCM	cis	rs9875589	0.509	rs6775534	chr3:14051001	C/T	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.5	5.15	0.5	1.9e-6	Ovarian reserve;
SKCM	cis	rs478304	0.654	rs7934036	chr11:65451020	G/T	cg27068330	chr11:65405492	SIPA1	-0.87	-7.53	-0.65	7.76e-11	Acne (severe);
SKCM	cis	rs873946	0.586	rs12783078	chr10:134569706	C/T	cg18305652	chr10:134549665	INPP5A	0.58	5.64	0.54	2.62e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs6570726	0.755	rs2103633	chr6:145894021	C/T	cg23711669	chr6:146136114	FBXO30	0.87	8.94	0.71	1.44e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs28595532	0.920	rs116550416	chr4:119753467	A/C	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs2070488	0.965	rs2051215	chr3:38560345	A/G	cg01465620	chr3:38496096	LOC100128640;ACVR2B	-1.04	-9.4	-0.73	1.85e-14	Electrocardiographic conduction measures;
SKCM	cis	rs2228479	0.702	rs62053701	chr16:89860584	G/A	cg00800038	chr16:89945340	TCF25	-0.93	-4.9	-0.48	5.16e-6	Skin colour saturation;
SKCM	cis	rs2842992	0.789	rs4709376	chr6:160226337	A/G	cg19482086	chr6:160211437	TCP1;MRPL18	0.77	5.73	0.54	1.84e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs4819052	0.851	rs2838833	chr21:46665160	C/T	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.44	0.64	1.11e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs1577917	0.958	rs2324817	chr6:86462654	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.6	-5.1	-0.5	2.3e-6	Response to antipsychotic treatment;
SKCM	cis	rs898097	0.812	rs56274787	chr17:80862682	C/T	cg15369054	chr17:80825471	TBCD	0.66	6.18	0.57	2.69e-8	Breast cancer;
SKCM	cis	rs72634258	0.842	rs6577463	chr1:8169485	T/G	cg00042356	chr1:8021962	PARK7	-0.84	-5.53	-0.53	4.17e-7	Inflammatory bowel disease;
SKCM	cis	rs2180341	0.960	rs7773484	chr6:127670779	T/C	cg24812749	chr6:127587940	RNF146	0.83	7.24	0.63	2.76e-10	Breast cancer;
SKCM	cis	rs7178909	0.835	rs12437459	chr15:90420773	A/C	cg19708238	chr15:90437601	AP3S2	0.72	5.22	0.51	1.43e-6	Common traits (Other);
SKCM	cis	rs2832191	0.716	rs1888439	chr21:30454457	A/G	cg24692254	chr21:30365293	RNF160	0.96	8.96	0.71	1.32e-13	Dental caries;
SKCM	cis	rs7122539	0.646	rs627330	chr11:66602099	C/T	cg12372692	chr11:66233905	PELI3	-0.72	-5.42	-0.52	6.5e-7	HIV-1 susceptibility;
SKCM	cis	rs2228479	0.717	rs17233678	chr16:89809962	T/C	cg06558623	chr16:89946397	TCF25	1.03	5.59	0.53	3.23e-7	Skin colour saturation;
SKCM	cis	rs12142240	0.698	rs6703374	chr1:46862332	C/G	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs2268241	0.938	rs17879003	chr21:34778527	C/T	cg14850771	chr21:34775459	IFNGR2	1.09	6.8	0.61	1.9e-9	Obesity-related traits;
SKCM	cis	rs514406	0.823	rs501006	chr1:53368292	T/A	cg16325326	chr1:53192061	ZYG11B	0.91	9.81	0.74	2.88e-15	Monocyte count;
SKCM	cis	rs875971	0.895	rs778700	chr7:65866450	C/T	cg18876405	chr7:65276391	NA	0.67	6.65	0.6	3.61e-9	Aortic root size;
SKCM	cis	rs997295	0.535	rs11630854	chr15:67858116	A/T	cg24247231	chr15:67904302	MAP2K5	-0.61	-4.97	-0.49	3.95e-6	Motion sickness;
SKCM	cis	rs6089584	0.816	rs6061411	chr20:60634716	C/A	cg13770153	chr20:60521292	NA	-0.56	-5.01	-0.49	3.35e-6	Body mass index;
SKCM	cis	rs8072100	0.871	rs7206971	chr17:45425115	A/G	cg08085267	chr17:45401833	C17orf57	0.69	6.18	0.57	2.77e-8	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs11673344	0.704	rs1726719	chr19:37418032	T/C	cg07624650	chr19:37064219	ZNF529	-0.8	-5.24	-0.51	1.31e-6	Obesity-related traits;
SKCM	cis	rs2836974	0.830	rs2735309	chr21:40715313	C/T	cg11890956	chr21:40555474	PSMG1	0.94	9.67	0.74	5.57e-15	Cognitive function;
SKCM	cis	rs17065868	1.000	rs56208811	chr13:45067786	C/T	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs7666738	0.830	rs6831588	chr4:98977356	T/G	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs5750830	0.645	rs4821890	chr22:39777523	G/A	cg24399712	chr22:39784796	NA	-0.58	-5.02	-0.49	3.24e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs12142240	0.659	rs72677602	chr1:46837487	G/A	cg10495392	chr1:46806563	NSUN4	0.74	5.5	0.53	4.57e-7	Menopause (age at onset);
SKCM	cis	rs208520	1.000	rs9453671	chr6:66991208	A/G	cg07460842	chr6:66804631	NA	0.87	5.96	0.56	6.95e-8	Exhaled nitric oxide output;
SKCM	cis	rs116095464	0.542	rs28650039	chr5:273954	C/A	cg22857025	chr5:266934	NA	-1.47	-8.33	-0.69	2.16e-12	Breast cancer;
SKCM	cis	rs9512730	0.906	rs4771136	chr13:28070769	C/G	cg22138327	chr13:27999177	GTF3A	0.86	5.87	0.55	1.01e-7	Schizophrenia;
SKCM	cis	rs344364	0.511	rs56077812	chr16:1948870	T/G	cg26897989	chr16:1907736	C16orf73	-0.69	-7.13	-0.63	4.45e-10	Glomerular filtration rate in chronic kidney disease;
SKCM	cis	rs2033711	0.783	rs11671113	chr19:58958087	C/T	cg13877915	chr19:58951672	ZNF132	0.95	10.39	0.76	2.26e-16	Uric acid clearance;
SKCM	cis	rs11098499	0.954	rs10031483	chr4:120422636	T/C	cg09307838	chr4:120376055	NA	0.99	8.1	0.68	6.11e-12	Corneal astigmatism;
SKCM	cis	rs7809950	1.000	rs2712189	chr7:107195747	G/A	cg23024343	chr7:107201750	COG5	-0.77	-6.92	-0.62	1.11e-9	Coronary artery disease;
SKCM	cis	rs9910055	0.529	rs228757	chr17:42164885	G/C	cg08499158	chr17:42289980	UBTF	0.72	5.61	0.54	2.95e-7	Total body bone mineral density;
SKCM	cis	rs11098499	0.697	rs4373140	chr4:120307698	A/G	cg24375607	chr4:120327624	NA	0.65	4.97	0.49	3.87e-6	Corneal astigmatism;
SKCM	cis	rs9300255	0.722	rs28458312	chr12:123863265	G/T	cg05973401	chr12:123451056	ABCB9	-0.82	-5.72	-0.54	1.92e-7	Neutrophil percentage of white cells;
SKCM	cis	rs1419980	0.673	rs12366473	chr12:7728270	G/C	cg10578777	chr12:7781093	NA	0.74	5.28	0.51	1.14e-6	HDL cholesterol levels;
SKCM	cis	rs35306767	0.855	rs55708963	chr10:925712	C/A	cg26597838	chr10:835615	NA	0.8	6.02	0.56	5.37e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs9790314	0.846	rs6791213	chr3:161033721	A/G	cg03342759	chr3:160939853	NMD3	-0.72	-8.12	-0.68	5.59e-12	Morning vs. evening chronotype;
SKCM	cis	rs1218582	0.772	rs10796934	chr1:154849479	C/G	cg03351412	chr1:154909251	PMVK	0.79	6.91	0.62	1.15e-9	Prostate cancer;
SKCM	cis	rs10751667	0.643	rs10902245	chr11:953014	C/T	cg10932868	chr11:921992	NA	-0.54	-5.16	-0.5	1.86e-6	Alzheimer's disease (late onset);
SKCM	cis	rs12478296	1.000	rs55758933	chr2:243040289	T/C	cg06360820	chr2:242988706	NA	-0.92	-5.32	-0.52	9.84e-7	Obesity-related traits;
SKCM	cis	rs10504073	0.647	rs6997703	chr8:49998364	T/C	cg00325661	chr8:49890786	NA	0.81	6.93	0.62	1.07e-9	Blood metabolite ratios;
SKCM	cis	rs2836974	0.897	rs2836924	chr21:40525639	C/T	cg11644478	chr21:40555479	PSMG1	0.97	10.21	0.76	5.08e-16	Cognitive function;
SKCM	cis	rs6121246	0.647	rs6088855	chr20:30225792	C/T	cg11595048	chr20:30225325	COX4I2	0.63	4.94	0.49	4.31e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs67460515	0.892	rs4856757	chr3:160999418	A/T	cg03342759	chr3:160939853	NMD3	-0.81	-7.1	-0.63	5.14e-10	Parkinson's disease;
SKCM	cis	rs8180040	0.966	rs62260711	chr3:47564491	G/C	cg27129171	chr3:47204927	SETD2	-0.82	-5.92	-0.56	8.29e-8	Colorectal cancer;
SKCM	cis	rs6121246	0.560	rs6088854	chr20:30225357	G/A	cg11595048	chr20:30225325	COX4I2	0.62	4.82	0.48	6.82e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs12451471	0.637	rs12452616	chr17:78090081	A/G	cg06718696	chr17:78121285	EIF4A3	-0.9	-6.15	-0.57	3.1e-8	Plateletcrit;Mean corpuscular hemoglobin concentration;
SKCM	cis	rs4927850	1.000	rs4927848	chr3:195738406	A/G	cg12923728	chr3:195709715	SDHAP1	-0.98	-6.88	-0.61	1.36e-9	Pancreatic cancer;
SKCM	cis	rs1580019	0.587	rs7806941	chr7:32553319	G/T	cg06627557	chr7:32535165	LSM5;AVL9	0.94	9.12	0.72	6.39e-14	Cognitive ability;
SKCM	cis	rs12586317	0.620	rs8021414	chr14:35581480	T/A	cg16230307	chr14:35515116	FAM177A1	0.7	5.18	0.51	1.67e-6	Psoriasis;
SKCM	cis	rs1044826	0.642	rs7624321	chr3:139220159	C/A	cg15131784	chr3:139108705	COPB2	0.68	4.97	0.49	3.85e-6	Obesity-related traits;
SKCM	cis	rs2075371	0.863	rs1646638	chr7:134008706	T/C	cg20476274	chr7:133979776	SLC35B4	1.06	11.34	0.79	3.65e-18	Mean platelet volume;
SKCM	cis	rs875971	0.862	rs4236208	chr7:65749078	C/T	cg11764359	chr7:65958608	NA	-0.81	-7.63	-0.65	4.79e-11	Aortic root size;
SKCM	cis	rs9611565	0.649	rs5751108	chr22:41858035	T/C	cg03806693	chr22:41940476	POLR3H	1.13	7.36	0.64	1.63e-10	Vitiligo;
SKCM	cis	rs151997	0.962	rs27936	chr5:50181418	T/A	cg06027927	chr5:50259733	NA	0.63	5.35	0.52	8.43e-7	Callous-unemotional behaviour;
SKCM	cis	rs2072499	0.966	rs2853643	chr1:156184831	G/A	cg24450063	chr1:156163899	SLC25A44	0.95	8.34	0.69	2.04e-12	Testicular germ cell tumor;
SKCM	cis	rs6500395	0.775	rs1968902	chr16:48663974	A/G	cg04672837	chr16:48644449	N4BP1	0.59	4.86	0.48	6.03e-6	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs2952156	0.920	rs2517951	chr17:37853097	C/T	cg20243544	chr17:37824526	PNMT	0.67	5.36	0.52	8.19e-7	Asthma;
SKCM	trans	rs1814175	0.562	rs1794130	chr11:49903764	T/A	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs28595532	0.920	rs17325129	chr4:119778284	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs860295	0.580	rs2297480	chr1:155279482	T/G	cg02153340	chr1:155202674	NA	-0.78	-5.42	-0.52	6.37e-7	Body mass index;
SKCM	cis	rs941873	0.868	rs2145998	chr10:81121696	T/A	cg09469691	chr10:81107165	PPIF	0.74	7.33	0.64	1.81e-10	Height;
SKCM	cis	rs28386778	0.863	rs3760252	chr17:61852186	G/C	cg06873352	chr17:61820015	STRADA	0.76	6.51	0.59	6.72e-9	Prudent dietary pattern;
SKCM	cis	rs7296418	0.961	rs1790094	chr12:123586688	T/C	cg05973401	chr12:123451056	ABCB9	0.83	6.86	0.61	1.48e-9	Platelet count;
SKCM	cis	rs2228479	0.850	rs11648433	chr16:89965055	G/A	cg06558623	chr16:89946397	TCF25	1.12	5.64	0.54	2.58e-7	Skin colour saturation;
SKCM	cis	rs7937682	0.847	rs11213948	chr11:111464401	G/A	cg09085632	chr11:111637200	PPP2R1B	-1.0	-8.74	-0.7	3.47e-13	Primary sclerosing cholangitis;
SKCM	cis	rs7659604	0.676	rs6855269	chr4:122697418	T/G	cg19748678	chr4:122722346	EXOSC9	0.69	5.59	0.54	3.17e-7	Type 2 diabetes;
SKCM	cis	rs72634258	0.554	rs35307738	chr1:7919839	C/G	cg00042356	chr1:8021962	PARK7	0.81	5.5	0.53	4.56e-7	Inflammatory bowel disease;
SKCM	cis	rs2286503	0.839	rs2270105	chr7:22862467	G/A	cg15401507	chr7:22894281	NA	-0.57	-5.61	-0.54	2.99e-7	Fibrinogen;
SKCM	cis	rs875971	1.000	rs9986696	chr7:65704576	C/A	cg12463550	chr7:65579703	CRCP	-0.59	-4.89	-0.48	5.33e-6	Aortic root size;
SKCM	cis	rs11112613	0.762	rs17037312	chr12:105950085	C/T	cg03607813	chr12:105948248	NA	0.85	5.62	0.54	2.86e-7	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;
SKCM	cis	rs12971120	0.891	rs11151961	chr18:72177340	C/T	cg26446133	chr18:72167187	CNDP2	-0.68	-5.34	-0.52	8.81e-7	Refractive error;
SKCM	cis	rs3820068	0.603	rs72645900	chr1:15931980	A/T	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs4237845	0.773	rs6650217	chr12:58289072	T/G	cg02175503	chr12:58329896	NA	0.79	7.22	0.63	3e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs10870270	0.956	rs7894	chr10:133769482	G/C	cg17892150	chr10:133769511	PPP2R2D	-0.66	-4.86	-0.48	5.92e-6	Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals;
SKCM	cis	rs2228479	1.000	rs62052213	chr16:89991963	C/T	cg06558623	chr16:89946397	TCF25	1.08	5.4	0.52	7.07e-7	Skin colour saturation;
SKCM	cis	rs12709013	0.792	rs11646756	chr16:58807502	T/A	cg02431531	chr16:59244939	NA	0.48	5.01	0.49	3.26e-6	Blood metabolite ratios;
SKCM	cis	rs9910055	0.614	rs12944572	chr17:42245241	T/C	cg09913183	chr17:42254507	C17orf65;ASB16	0.67	6.43	0.59	9.39e-9	Total body bone mineral density;
SKCM	cis	rs3738772	0.633	rs2483789	chr1:110053945	G/T	cg06948763	chr1:110763078	KCNC4	-0.54	-5.43	-0.52	6.18e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs2439831	1.000	rs7173487	chr15:43750239	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.46	9.0	0.71	1.09e-13	Lung cancer in ever smokers;
SKCM	cis	rs1799949	0.965	rs9646418	chr17:41425901	A/G	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.11	-0.57	3.66e-8	Menopause (age at onset);
SKCM	cis	rs1577917	0.696	rs2842617	chr6:86309698	C/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.75	-6.74	-0.61	2.43e-9	Response to antipsychotic treatment;
SKCM	cis	rs875971	0.964	rs11765965	chr7:65842221	A/G	cg18876405	chr7:65276391	NA	0.68	6.79	0.61	2.01e-9	Aortic root size;
SKCM	cis	rs929354	0.772	rs6459739	chr7:156998863	A/T	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs9513627	0.920	rs73556201	chr13:100128753	C/G	cg11288260	chr13:100117058	NA	-0.8	-4.77	-0.48	8.48e-6	Obesity-related traits;
SKCM	cis	rs28595532	0.920	rs55869953	chr4:119751893	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs2153535	0.580	rs9379216	chr6:8481235	G/A	cg07606381	chr6:8435919	SLC35B3	0.86	6.25	0.58	2.06e-8	Motion sickness;
SKCM	cis	rs959260	0.502	rs11658023	chr17:73308722	C/T	cg14668889	chr17:73230827	NUP85	-0.77	-6.37	-0.58	1.21e-8	Systemic lupus erythematosus;
SKCM	cis	rs227584	0.663	rs3180912	chr17:42259463	A/G	cg19774624	chr17:42201019	HDAC5	-0.74	-6.28	-0.58	1.75e-8	Bone mineral density (hip);Bone mineral density;
SKCM	cis	rs1707322	1.000	rs6687301	chr1:46382852	T/C	cg03146154	chr1:46216737	IPP	0.74	5.06	0.5	2.76e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs9420	0.961	rs499188	chr11:57434122	C/A	cg19752551	chr11:57585705	CTNND1	-0.7	-6.99	-0.62	8.34e-10	Schizophrenia;
SKCM	cis	rs11764590	0.694	rs6972969	chr7:2099331	A/G	cg23422044	chr7:1970798	MAD1L1	-0.81	-6.16	-0.57	2.98e-8	Neuroticism;
SKCM	cis	rs1461503	0.932	rs10892944	chr11:122843895	T/C	cg27398637	chr11:122830231	C11orf63	-0.63	-4.8	-0.48	7.54e-6	Menarche (age at onset);
SKCM	cis	rs854765	0.822	rs1889014	chr17:17767165	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	-0.87	-6.54	-0.59	5.93e-9	Total body bone mineral density;
SKCM	cis	rs6450176	1.000	rs3776716	chr5:53298923	A/G	ch.5.1024479R	chr5:53302184	ARL15	-0.71	-4.88	-0.48	5.49e-6	HDL cholesterol levels;HDL cholesterol;Adiponectin levels;
SKCM	trans	rs11722228	0.522	rs77691548	chr4:10136115	T/G	cg26043149	chr18:55253948	FECH	0.96	8.72	0.7	3.84e-13	Gout;Urate levels;Serum uric acid levels;
SKCM	cis	rs875971	0.545	rs6969224	chr7:65834998	T/G	cg18876405	chr7:65276391	NA	0.63	5.0	0.49	3.41e-6	Aortic root size;
SKCM	cis	rs362272	0.505	rs10155132	chr4:3369500	A/G	cg11471262	chr4:3318911	RGS12	0.96	11.18	0.78	7.27e-18	Serum sulfate level;
SKCM	cis	rs12986445	0.652	rs62127754	chr2:26144517	A/G	cg07291958	chr2:26785531	C2orf70	0.53	4.77	0.48	8.27e-6	Multiple myeloma and monoclonal gammopathy;Multiple myeloma;
SKCM	cis	rs5753618	0.583	rs5749279	chr22:31854209	A/G	cg02404636	chr22:31891804	SFI1	0.53	4.96	0.49	3.96e-6	Colorectal cancer;
SKCM	cis	rs9309711	0.623	rs4641971	chr2:3481857	A/C	cg15506890	chr2:3487001	NA	0.61	5.05	0.5	2.88e-6	Neurofibrillary tangles;
SKCM	cis	rs6582630	0.555	rs34145279	chr12:38405588	T/C	cg13010199	chr12:38710504	ALG10B	0.69	4.89	0.48	5.2e-6	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs4819052	0.851	rs9974628	chr21:46672647	C/T	cg20896738	chr21:46707857	POFUT2;LOC642852	0.64	4.82	0.48	6.85e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs2832191	0.716	rs1543652	chr21:30448000	G/C	cg24692254	chr21:30365293	RNF160	0.99	9.05	0.72	8.59e-14	Dental caries;
SKCM	cis	rs2095921	1	rs2095921	chr1:11033322	C/G	cg02454025	chr1:11042201	C1orf127	1.08	10.13	0.75	7.19e-16	Male-pattern baldness;
SKCM	cis	rs2288073	0.965	rs6545335	chr2:24422011	G/A	cg06627628	chr2:24431161	ITSN2	-0.85	-5.84	-0.55	1.14e-7	Venous thromboembolism (SNP x SNP interaction);
SKCM	cis	rs7524258	0.868	rs10779678	chr1:7300573	A/G	cg07173049	chr1:7289937	CAMTA1	0.42	4.87	0.48	5.79e-6	Tourette's syndrome or obsessive-compulsive disorder;
SKCM	trans	rs208520	0.690	rs207091	chr6:66799847	G/T	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-1.01	-7.5	-0.65	8.58e-11	Exhaled nitric oxide output;
SKCM	cis	rs7828089	0.792	rs12544610	chr8:22239813	C/T	cg12081754	chr8:22256438	SLC39A14	0.7	5.23	0.51	1.4e-6	Verbal declarative memory;
SKCM	cis	rs60871478	1.000	rs62432251	chr7:801855	T/G	cg05535760	chr7:792225	HEATR2	1.02	8.66	0.7	4.97e-13	Cerebrospinal P-tau181p levels;
SKCM	cis	rs12928939	0.517	rs8050058	chr16:71981374	T/G	cg03805757	chr16:71968109	PKD1L3	-0.72	-5.17	-0.51	1.78e-6	Post bronchodilator FEV1;
SKCM	cis	rs11098499	0.874	rs7661020	chr4:120106982	T/C	cg09307838	chr4:120376055	NA	0.86	6.08	0.57	4.13e-8	Corneal astigmatism;
SKCM	cis	rs2842992	0.747	rs9365095	chr6:160192928	T/G	cg19482086	chr6:160211437	TCP1;MRPL18	0.86	6.82	0.61	1.71e-9	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs2404602	0.692	rs34181263	chr15:77065388	C/T	cg23625390	chr15:77176239	SCAPER	0.59	5.19	0.51	1.62e-6	Blood metabolite levels;
SKCM	cis	rs8077889	0.763	rs4792913	chr17:41854497	T/C	cg26893861	chr17:41843967	DUSP3	1.37	12.61	0.82	1.65e-20	Triglycerides;
SKCM	cis	rs782590	0.522	rs12329050	chr2:55894428	G/A	cg18811423	chr2:55921094	PNPT1	-0.69	-4.88	-0.48	5.51e-6	Metabolic syndrome;
SKCM	cis	rs7828089	0.792	rs4871995	chr8:22233726	A/C	cg12081754	chr8:22256438	SLC39A14	0.71	5.27	0.51	1.17e-6	Verbal declarative memory;
SKCM	cis	rs7100689	0.784	rs11202699	chr10:82131453	A/G	cg00277334	chr10:82204260	NA	-0.52	-4.89	-0.48	5.24e-6	Post bronchodilator FEV1;
SKCM	cis	rs873946	0.586	rs12259688	chr10:134549628	A/G	cg18305652	chr10:134549665	INPP5A	0.56	5.43	0.52	6.27e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs2948294	0.588	rs12544596	chr8:8116346	A/T	cg06636001	chr8:8085503	FLJ10661	0.68	5.23	0.51	1.37e-6	Red cell distribution width;
SKCM	cis	rs514406	0.861	rs562182	chr1:53270010	C/T	cg16325326	chr1:53192061	ZYG11B	1.01	11.95	0.8	2.6e-19	Monocyte count;
SKCM	cis	rs1979654	0.543	rs1552656	chr16:86401425	C/G	cg03720195	chr16:87119252	NA	-0.5	-5.03	-0.49	3.06e-6	Barrett's esophagus  or Esophageal adenocarcinoma;
SKCM	cis	rs9311474	0.581	rs13621	chr3:52558133	T/C	cg18404041	chr3:52824283	ITIH1	-0.55	-4.98	-0.49	3.8e-6	Electroencephalogram traits;
SKCM	cis	rs2404602	0.735	rs3765115	chr15:76673716	T/C	cg23625390	chr15:77176239	SCAPER	-0.82	-8.05	-0.67	7.68e-12	Blood metabolite levels;
SKCM	cis	rs7635838	0.819	rs4684072	chr3:11514860	A/G	cg00170343	chr3:11313890	ATG7	0.69	5.26	0.51	1.22e-6	HDL cholesterol;
SKCM	cis	rs1799949	0.930	rs4445938	chr17:41337900	A/C	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.29	-0.58	1.73e-8	Menopause (age at onset);
SKCM	cis	rs1799949	0.965	rs9646413	chr17:41426157	A/G	cg23758822	chr17:41437982	NA	0.92	7.68	0.66	3.96e-11	Menopause (age at onset);
SKCM	cis	rs17376456	0.569	rs10067754	chr5:93093110	T/A	cg25358565	chr5:93447407	FAM172A	0.86	5.45	0.53	5.59e-7	Diabetic retinopathy;
SKCM	cis	rs1160297	0.576	rs12475542	chr2:53111504	A/G	cg07782112	chr2:53107842	NA	-0.57	-5.88	-0.55	9.57e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs11098499	0.865	rs2389809	chr4:120377399	T/C	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs1153858	0.887	rs7164139	chr15:45670851	G/A	cg10760299	chr15:45669010	GATM	0.62	6.35	0.58	1.3e-8	Homoarginine levels;
SKCM	cis	rs4481887	0.741	rs6587471	chr1:248560741	C/T	cg00666640	chr1:248458726	OR2T12	0.5	5.21	0.51	1.5e-6	Common traits (Other);
SKCM	cis	rs72781680	0.898	rs2339851	chr2:23938883	G/A	cg08917208	chr2:24149416	ATAD2B	0.95	4.78	0.48	8.1e-6	Lymphocyte counts;
SKCM	cis	rs4319547	0.915	rs7966094	chr12:123115771	A/G	cg23029597	chr12:123009494	RSRC2	-0.79	-5.68	-0.54	2.26e-7	Body mass index;
SKCM	cis	rs875971	0.502	rs2946580	chr7:65531842	G/A	cg18876405	chr7:65276391	NA	-0.67	-5.32	-0.52	9.82e-7	Aortic root size;
SKCM	cis	rs1580019	0.844	rs1037322	chr7:32501857	C/T	cg06627557	chr7:32535165	LSM5;AVL9	0.77	5.86	0.55	1.03e-7	Cognitive ability;
SKCM	trans	rs561341	1.000	rs8077092	chr17:30281992	T/C	cg20587970	chr11:113659929	NA	-1.16	-9.91	-0.75	1.84e-15	Hip circumference adjusted for BMI;
SKCM	cis	rs9435341	0.762	rs2878349	chr1:107549245	G/A	cg09367891	chr1:107599246	PRMT6	0.8	6.12	0.57	3.51e-8	Facial morphology (factor 21, depth of nasal alae);
SKCM	cis	rs11098499	0.615	rs59867181	chr4:120556467	C/T	cg09307838	chr4:120376055	NA	-0.97	-8.11	-0.68	5.87e-12	Corneal astigmatism;
SKCM	cis	rs823143	0.570	rs823082	chr1:205786935	C/T	cg14893161	chr1:205819251	PM20D1	-1.01	-11.14	-0.78	8.42e-18	Monocyte percentage of white cells;
SKCM	cis	rs58688157	0.705	rs12272434	chr11:615011	A/T	cg16486109	chr11:613632	IRF7	1.07	7.29	0.64	2.17e-10	Systemic lupus erythematosus;
SKCM	cis	rs7589728	0.563	rs75606549	chr2:88466069	T/C	cg04511125	chr2:88470314	THNSL2	1.07	6.66	0.6	3.43e-9	Plasma clusterin levels;
SKCM	cis	rs6952808	0.723	rs11766575	chr7:2005747	T/C	cg21782813	chr7:2030301	MAD1L1	0.56	5.83	0.55	1.18e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs4642101	0.561	rs9831765	chr3:12805934	A/T	cg05775895	chr3:12838266	CAND2	0.58	4.82	0.48	6.83e-6	QRS complex (12-leadsum);
SKCM	cis	rs7932354	0.528	rs12796744	chr11:47132724	A/T	cg03339077	chr11:47165057	C11orf49	0.6	4.9	0.49	5.08e-6	Bone mineral density (hip);Bone mineral density;
SKCM	cis	rs4888262	0.604	rs12935075	chr16:74676033	A/T	cg01733217	chr16:74700730	RFWD3	0.89	7.85	0.66	1.82e-11	Testicular germ cell tumor;
SKCM	cis	rs131777	0.563	rs5770927	chr22:51028945	C/T	cg25309564	chr22:51001381	C22orf41	0.82	5.71	0.54	1.99e-7	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs4523957	0.553	rs9909515	chr17:2039733	T/C	cg16513277	chr17:2031491	SMG6	-0.91	-6.21	-0.58	2.38e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs6570726	0.791	rs9373463	chr6:145894762	C/T	cg23711669	chr6:146136114	FBXO30	0.87	8.94	0.71	1.44e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs116095464	0.867	rs10074958	chr5:230828	C/T	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs11098499	0.954	rs7687843	chr4:120421211	C/T	cg24375607	chr4:120327624	NA	0.66	5.13	0.5	2.07e-6	Corneal astigmatism;
SKCM	cis	rs12497850	0.866	rs6791234	chr3:48996137	A/G	cg06212747	chr3:49208901	KLHDC8B	0.68	4.9	0.49	5.06e-6	Parkinson's disease;
SKCM	cis	rs703842	1.000	rs11172349	chr12:58212528	G/A	cg04478727	chr12:58166393	METTL1;FAM119B	0.72	5.78	0.55	1.48e-7	Multiple sclerosis;
SKCM	cis	rs9443189	0.570	rs529383	chr6:76297847	T/G	cg01950844	chr6:76311363	SENP6	0.99	5.76	0.55	1.57e-7	Prostate cancer;
SKCM	cis	rs6089584	0.507	rs6061999	chr20:60637429	G/A	cg16423285	chr20:60520624	NA	-0.62	-5.39	-0.52	7.38e-7	Body mass index;
SKCM	cis	rs7523273	0.606	rs2724387	chr1:207932617	T/G	cg22525895	chr1:207977042	MIR29B2	0.81	7.08	0.63	5.47e-10	Schizophrenia;
SKCM	cis	rs4555082	0.957	rs2735818	chr14:105714751	A/G	cg13114125	chr14:105738426	BRF1	-0.71	-5.72	-0.54	1.87e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs3820068	0.603	rs6429769	chr1:15968610	C/G	cg24675056	chr1:15929824	NA	0.78	5.45	0.52	5.77e-7	Systolic blood pressure;
SKCM	cis	rs1325195	0.537	rs2793807	chr1:179171713	C/T	cg25467746	chr1:179556597	NA	0.64	5.8	0.55	1.36e-7	IgE grass sensitization;
SKCM	cis	rs9913156	0.748	rs56124631	chr17:4561378	A/G	cg19197139	chr17:4613644	ARRB2	0.79	5.28	0.51	1.14e-6	Lymphocyte counts;
SKCM	cis	rs9325144	0.555	rs28738714	chr12:38706912	G/A	cg26384229	chr12:38710491	ALG10B	-0.76	-6.4	-0.59	1.05e-8	Morning vs. evening chronotype;
SKCM	cis	rs2404602	0.716	rs7164060	chr15:76707694	T/C	cg23625390	chr15:77176239	SCAPER	0.59	5.31	0.52	9.85e-7	Blood metabolite levels;
SKCM	cis	rs2153535	0.580	rs9406165	chr6:8488837	C/T	cg07606381	chr6:8435919	SLC35B3	0.86	6.25	0.58	2.06e-8	Motion sickness;
SKCM	cis	rs9300255	0.596	rs1727331	chr12:123718879	C/G	cg00376283	chr12:123451042	ABCB9	-0.93	-7.47	-0.65	9.96e-11	Neutrophil percentage of white cells;
SKCM	cis	rs748404	0.588	rs506120	chr15:43802024	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	0.72	5.44	0.52	5.85e-7	Lung cancer;
SKCM	cis	rs2033711	0.840	rs10423138	chr19:58928302	T/C	cg03735888	chr19:58951602	ZNF132	0.7	6.07	0.57	4.34e-8	Uric acid clearance;
SKCM	cis	rs9640161	0.830	rs1051760	chr7:150070630	A/G	cg10018233	chr7:150070692	REPIN1	0.81	9.18	0.72	4.91e-14	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs9457247	0.544	rs6920858	chr6:167464630	G/A	cg07741184	chr6:167504864	NA	0.59	4.97	0.49	3.88e-6	Crohn's disease;
SKCM	cis	rs4803468	1.000	rs10422956	chr19:41901261	C/T	cg14132834	chr19:41945861	ATP5SL	-0.74	-5.71	-0.54	1.99e-7	Height;
SKCM	cis	rs7618501	0.602	rs10049087	chr3:50123417	A/G	cg24110177	chr3:50126178	RBM5	0.61	5.18	0.51	1.71e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs34891900	0.507	rs738133	chr22:18205557	C/T	cg19898043	chr22:18121309	BCL2L13	0.7	5.54	0.53	4.03e-7	Sum neutrophil eosinophil counts;
SKCM	cis	rs7772486	0.686	rs9390357	chr6:146129347	A/G	cg23711669	chr6:146136114	FBXO30	0.9	10.05	0.75	1.02e-15	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs908922	0.676	rs1572533	chr1:152509742	T/C	cg09873164	chr1:152488093	CRCT1	0.76	5.93	0.56	7.7e-8	Hair morphology;
SKCM	cis	rs9300255	0.537	rs1716182	chr12:123686127	A/C	cg05973401	chr12:123451056	ABCB9	0.81	5.37	0.52	7.77e-7	Neutrophil percentage of white cells;
SKCM	cis	rs1185460	0.967	rs2509121	chr11:118928253	C/T	cg23280166	chr11:118938394	VPS11	0.57	5.02	0.49	3.25e-6	Coronary artery disease;
SKCM	cis	rs2404602	0.684	rs157759	chr15:76846990	T/A	cg23625390	chr15:77176239	SCAPER	0.85	8.26	0.68	2.93e-12	Blood metabolite levels;
SKCM	cis	rs2839186	0.770	rs2330353	chr21:47669648	T/A	cg13012494	chr21:47604986	C21orf56	0.7	5.81	0.55	1.28e-7	Testicular germ cell tumor;
SKCM	cis	rs7086627	0.515	rs11202963	chr10:82210392	A/G	cg00277334	chr10:82204260	NA	-0.74	-8.47	-0.69	1.14e-12	Post bronchodilator FEV1;
SKCM	cis	rs1850744	0.536	rs13131004	chr4:9612911	C/A	cg15442990	chr4:9534313	NA	1.25	4.81	0.48	7.21e-6	Economic and political preferences;
SKCM	cis	rs2070488	1.000	rs2070488	chr3:38442490	A/G	cg01465620	chr3:38496096	LOC100128640;ACVR2B	-0.97	-8.92	-0.71	1.5700000000000001e-13	Electrocardiographic conduction measures;
SKCM	cis	rs7769051	1.000	rs9493446	chr6:133125643	C/T	cg22852734	chr6:133119734	C6orf192	1.0	5.39	0.52	7.39e-7	Type 2 diabetes nephropathy;
SKCM	cis	rs2832077	0.689	rs2832055	chr21:30132382	C/G	cg24692254	chr21:30365293	RNF160	0.73	4.96	0.49	4e-6	Cognitive test performance;
SKCM	cis	rs1005277	0.541	rs2505193	chr10:38394638	G/C	cg00409905	chr10:38381863	ZNF37A	-0.66	-6.12	-0.57	3.52e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs6445797	0.632	rs7626378	chr3:56602885	A/T	cg13616963	chr3:57583610	ARF4	-0.79	-5.1	-0.5	2.35e-6	Gastritis;
SKCM	cis	rs9905704	0.671	rs28709536	chr17:57008912	C/A	cg05425664	chr17:57184151	TRIM37	-0.61	-4.86	-0.48	5.91e-6	Testicular germ cell tumor;
SKCM	cis	rs9517302	0.615	rs4772081	chr13:99100262	T/C	cg22223119	chr13:99095684	FARP1	-0.84	-5.57	-0.53	3.53e-7	Obesity-related traits;
SKCM	cis	rs62064224	0.818	rs11080180	chr17:30682998	G/A	cg18200150	chr17:30822561	MYO1D	0.78	6.26	0.58	1.94e-8	Schizophrenia;
SKCM	cis	rs9388451	0.868	rs10457467	chr6:126045148	T/A	cg05901451	chr6:126070800	HEY2	-0.79	-7.95	-0.67	1.19e-11	Brugada syndrome;
SKCM	cis	rs4523957	0.579	rs2307143	chr17:2089754	G/A	cg16513277	chr17:2031491	SMG6	-0.71	-5.08	-0.5	2.47e-6	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs7772486	0.875	rs6930975	chr6:146387111	C/T	cg05347473	chr6:146136440	FBXO30	0.63	5.7	0.54	2.05e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2066819	1.000	rs2371494	chr12:56728000	G/A	cg26714650	chr12:56694279	CS	-1.71	-6.71	-0.61	2.74e-9	Psoriasis vulgaris;
SKCM	cis	rs3008870	1.000	rs12137403	chr1:67437043	C/T	cg08660285	chr1:67390436	MIER1;WDR78	-0.95	-6.5	-0.59	6.96e-9	Lymphocyte percentage of white cells;
SKCM	cis	rs798554	0.679	rs2527677	chr7:2882621	A/G	cg04166393	chr7:2884313	GNA12	0.8	5.35	0.52	8.45e-7	Height;
SKCM	cis	rs2832191	0.720	rs4643617	chr21:30485278	T/C	cg24692254	chr21:30365293	RNF160	-0.9	-8.03	-0.67	8.39e-12	Dental caries;
SKCM	cis	rs7843479	0.544	rs4872110	chr8:21784989	A/G	cg17168535	chr8:21777572	XPO7	0.73	6.49	0.59	7.3e-9	Mean corpuscular volume;
SKCM	cis	rs703842	0.964	rs10431552	chr12:58178148	G/A	cg04478727	chr12:58166393	METTL1;FAM119B	0.73	5.84	0.55	1.15e-7	Multiple sclerosis;
SKCM	cis	rs9300255	0.664	rs12316131	chr12:123817796	T/C	cg00376283	chr12:123451042	ABCB9	-0.78	-5.26	-0.51	1.24e-6	Neutrophil percentage of white cells;
SKCM	cis	rs2811415	0.597	rs11709484	chr3:127745068	C/T	cg09089421	chr3:127803668	RUVBL1	0.99	8.52	0.69	9.09e-13	Lung function (FEV1/FVC);
SKCM	cis	rs1862618	0.671	rs2591965	chr5:56236176	T/C	cg03609598	chr5:56110824	MAP3K1	0.68	4.79	0.48	7.77e-6	Initial pursuit acceleration;
SKCM	cis	rs9443189	0.526	rs775060	chr6:76373567	G/A	cg01950844	chr6:76311363	SENP6	-1.02	-6.34	-0.58	1.39e-8	Prostate cancer;
SKCM	cis	rs9926296	0.585	rs4785595	chr16:89835521	C/T	cg26513180	chr16:89883248	FANCA	-0.98	-11.17	-0.78	7.39e-18	Vitiligo;
SKCM	cis	rs651907	0.535	rs34063583	chr3:101509948	C/T	cg12386194	chr3:101231763	SENP7	0.68	5.74	0.54	1.73e-7	Colorectal cancer;
SKCM	cis	rs763014	0.865	rs2018789	chr16:632051	T/C	cg00908189	chr16:619842	PIGQ	0.82	7.78	0.66	2.55e-11	Height;
SKCM	cis	rs362296	0.597	rs3129320	chr4:3265130	G/C	cg00764545	chr4:3318001	RGS12	-0.59	-5.09	-0.5	2.38e-6	Parental longevity (mother's age at death);
SKCM	cis	rs7829975	0.742	rs1533059	chr8:8684953	A/G	cg06636001	chr8:8085503	FLJ10661	-0.75	-6.17	-0.57	2.84e-8	Mood instability;
SKCM	cis	rs9914266	1	rs9914266	chr17:2133250	T/C	cg16513277	chr17:2031491	SMG6	-0.72	-5.03	-0.49	3.08e-6	Myocardial infarction;
SKCM	cis	rs11764590	0.950	rs62444919	chr7:2109499	C/T	cg23422044	chr7:1970798	MAD1L1	-0.89	-5.97	-0.56	6.66e-8	Neuroticism;
SKCM	cis	rs35306767	0.903	rs35968821	chr10:910225	A/G	cg26597838	chr10:835615	NA	0.75	5.51	0.53	4.53e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs1577917	0.655	rs6454472	chr6:86224053	T/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.76	6.83	0.61	1.63e-9	Response to antipsychotic treatment;
SKCM	cis	rs10754283	0.557	rs1215511	chr1:90087543	C/A	cg21401794	chr1:90099060	LRRC8C	0.67	5.15	0.5	1.9e-6	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs932287	0.666	rs10840161	chr11:9053824	G/A	cg21881798	chr11:8931708	C11orf17;ST5	0.57	5.21	0.51	1.53e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2952156	0.959	rs2941503	chr17:37828745	A/G	cg20243544	chr17:37824526	PNMT	0.73	5.79	0.55	1.43e-7	Asthma;
SKCM	cis	rs9300255	0.568	rs1627724	chr12:123638580	T/A	cg05973401	chr12:123451056	ABCB9	0.79	5.37	0.52	8.03e-7	Neutrophil percentage of white cells;
SKCM	cis	rs7824557	0.583	rs6601585	chr8:11233659	A/G	cg21775007	chr8:11205619	TDH	-0.6	-5.03	-0.49	3.1e-6	Retinal vascular caliber;
SKCM	cis	rs1153858	1.000	rs4775895	chr15:45617957	T/A	cg21132104	chr15:45694354	SPATA5L1	0.91	7.52	0.65	7.96e-11	Homoarginine levels;
SKCM	cis	rs7659604	0.540	rs9995322	chr4:122675642	G/A	cg19671926	chr4:122722719	EXOSC9	0.77	6.27	0.58	1.89e-8	Type 2 diabetes;
SKCM	cis	rs6570726	0.846	rs439035	chr6:145887990	G/C	cg23711669	chr6:146136114	FBXO30	0.81	8.51	0.69	9.71e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs12145833	0.538	rs61833885	chr1:243397188	C/A	cg02356786	chr1:243265016	LOC731275	1.46	5.77	0.55	1.54e-7	Obesity (early onset extreme);
SKCM	cis	rs826838	1.000	rs11183160	chr12:38676702	T/C	cg13010199	chr12:38710504	ALG10B	0.73	5.28	0.51	1.12e-6	Heart rate;
SKCM	cis	rs7765828	0.611	rs742067	chr6:16205060	A/G	cg25457331	chr6:16238547	GMPR	0.66	4.86	0.48	5.94e-6	QT interval;
SKCM	cis	rs875971	0.862	rs4149461	chr7:65744732	T/C	cg18876405	chr7:65276391	NA	-0.65	-6.57	-0.6	5.03e-9	Aortic root size;
SKCM	cis	rs10754283	0.967	rs7519971	chr1:90108743	G/A	cg21401794	chr1:90099060	LRRC8C	0.73	6.34	0.58	1.35e-8	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs9300255	0.596	rs10734900	chr12:123743445	G/A	cg00376283	chr12:123451042	ABCB9	0.87	7.25	0.63	2.63e-10	Neutrophil percentage of white cells;
SKCM	cis	rs362296	0.624	rs362287	chr4:3257593	C/T	cg21096898	chr4:3318625	RGS12	-0.82	-7.4	-0.64	1.38e-10	Parental longevity (mother's age at death);
SKCM	cis	rs2180341	0.924	rs877661	chr6:127587915	T/G	cg24812749	chr6:127587940	RNF146	0.94	7.97	0.67	1.09e-11	Breast cancer;
SKCM	cis	rs7666738	0.830	rs35938349	chr4:98974998	T/C	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7613875	0.620	rs11721204	chr3:49982765	C/T	cg24110177	chr3:50126178	RBM5	-0.68	-5.42	-0.52	6.36e-7	Body mass index;
SKCM	cis	rs189798	0.592	rs10111263	chr8:8969433	C/G	cg06636001	chr8:8085503	FLJ10661	-0.8	-5.67	-0.54	2.31e-7	Myopia (pathological);
SKCM	cis	rs992157	0.932	rs56109829	chr2:219149740	G/A	cg00012203	chr2:219082015	ARPC2	0.75	6.28	0.58	1.76e-8	Colorectal cancer;
SKCM	cis	rs7824557	0.603	rs6995404	chr8:11182148	C/G	cg21775007	chr8:11205619	TDH	0.71	6.42	0.59	9.75e-9	Retinal vascular caliber;
SKCM	cis	rs9467773	0.595	rs12525810	chr6:26623511	T/A	cg09904177	chr6:26538194	HMGN4	0.58	4.85	0.48	6.2e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs908922	0.676	rs6674451	chr1:152531054	C/T	cg09873164	chr1:152488093	CRCT1	0.72	5.62	0.54	2.85e-7	Hair morphology;
SKCM	cis	rs2050392	0.517	rs656600	chr10:30765654	G/A	cg25182066	chr10:30743637	MAP3K8	-0.69	-6.11	-0.57	3.68e-8	Inflammatory bowel disease;
SKCM	cis	rs6120849	0.707	rs752075	chr20:33591591	C/A	cg24642439	chr20:33292090	TP53INP2	0.94	4.86	0.48	5.91e-6	Protein C levels;
SKCM	cis	rs4132509	0.948	rs1458023	chr1:243886673	A/G	cg21452805	chr1:244014465	NA	0.91	6.3	0.58	1.65e-8	RR interval (heart rate);
SKCM	cis	rs6430585	0.583	rs60253740	chr2:136571852	G/T	cg07169764	chr2:136633963	MCM6	1.31	13.14	0.83	1.86e-21	Corneal structure;
SKCM	cis	rs7143963	0.580	rs3783385	chr14:103367667	G/A	cg23020514	chr14:103360112	TRAF3	0.64	5.51	0.53	4.39e-7	Body mass index;
SKCM	cis	rs12142240	0.698	rs1053627	chr1:46827728	A/C	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs478304	0.654	rs7115734	chr11:65458964	G/A	cg27068330	chr11:65405492	SIPA1	-0.89	-7.62	-0.65	5.13e-11	Acne (severe);
SKCM	cis	rs12824058	0.798	rs7968728	chr12:130804696	T/A	cg26677194	chr12:130822605	PIWIL1	0.71	5.67	0.54	2.29e-7	Menopause (age at onset);
SKCM	cis	rs62244186	0.520	rs9311361	chr3:44796132	T/G	cg15225532	chr3:44803084	KIF15;KIAA1143	0.64	5.07	0.5	2.62e-6	Depressive symptoms;
SKCM	cis	rs8060686	0.641	rs76501820	chr16:68114582	G/A	cg09117114	chr16:67998030	SLC12A4	-0.81	-5.24	-0.51	1.31e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs1003719	0.788	rs1155787	chr21:38448069	G/A	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	trans	rs62103177	0.810	rs62103195	chr18:77629693	T/C	cg05926928	chr17:57297772	GDPD1	1.29	8.74	0.7	3.44e-13	Opioid sensitivity;
SKCM	cis	rs8067545	0.750	rs918228	chr17:20002012	C/T	cg13482628	chr17:19912719	NA	0.72	6.01	0.56	5.48e-8	Schizophrenia;
SKCM	cis	rs6598955	0.950	rs6700455	chr1:26545864	T/C	cg04990556	chr1:26633338	UBXN11	0.65	5.5	0.53	4.59e-7	Obesity-related traits;
SKCM	cis	rs875971	0.638	rs7793569	chr7:66116633	T/G	cg11987759	chr7:65425863	GUSB	0.67	5.8	0.55	1.36e-7	Aortic root size;
SKCM	cis	rs12497850	0.764	rs6784111	chr3:49178846	T/C	cg07636037	chr3:49044803	WDR6	1.0	8.69	0.7	4.39e-13	Parkinson's disease;
SKCM	cis	rs62064224	0.791	rs17806082	chr17:30705346	G/C	cg18200150	chr17:30822561	MYO1D	0.78	6.26	0.58	1.9e-8	Schizophrenia;
SKCM	cis	rs4785763	0.513	rs4408545	chr16:90044028	C/T	cg08547343	chr16:90038815	CENPBD1;AFG3L1	0.71	5.64	0.54	2.58e-7	Melanoma;
SKCM	cis	rs7811142	1.000	rs112317829	chr7:100043173	A/G	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.34	0.69	2.1e-12	Platelet count;
SKCM	cis	rs2404602	0.692	rs59088060	chr15:76859974	T/C	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs4819052	0.851	rs4819044	chr21:46660118	G/A	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.35	0.64	1.68e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7100689	0.754	rs10736339	chr10:82059970	G/C	cg00277334	chr10:82204260	NA	-0.59	-5.81	-0.55	1.31e-7	Post bronchodilator FEV1;
SKCM	cis	rs4721295	0.573	rs3779000	chr7:2181628	G/A	cg02951883	chr7:2050386	MAD1L1	-0.77	-6.09	-0.57	4.05e-8	Schizophrenia, schizoaffective disorder or bipolar disorder;
SKCM	cis	rs28595532	0.920	rs115103359	chr4:119739608	A/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs28595532	1.000	rs55634130	chr4:119655093	C/T	cg21605333	chr4:119757512	SEC24D	1.24	7.1	0.63	5.16e-10	Cannabis dependence symptom count;
SKCM	cis	rs55962025	0.588	rs362312	chr4:3237644	T/C	cg16987761	chr4:3318072	RGS12	-0.56	-4.81	-0.48	7.2e-6	Parental longevity (mother's age at death);
SKCM	trans	rs17685	0.849	rs3815455	chr7:75611756	C/T	cg19862616	chr7:65841803	NCRNA00174	0.89	7.47	0.65	1e-10	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2841277	0.770	rs10149193	chr14:105403474	C/T	cg15352829	chr14:105391018	PLD4	-0.58	-4.81	-0.48	7.35e-6	Rheumatoid arthritis;
SKCM	cis	rs7220401	0.512	rs71371126	chr17:28002642	G/A	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.72	-5.1	-0.5	2.31e-6	Coronary artery disease;
SKCM	cis	rs611744	0.647	rs7015513	chr8:109262570	A/C	cg18478394	chr8:109455254	TTC35	0.66	5.32	0.52	9.59e-7	Dupuytren's disease;
SKCM	cis	rs6951245	1.000	rs76833820	chr7:1070278	A/T	cg21664854	chr7:1097933	C7orf50;GPR146	0.89	4.79	0.48	7.66e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs12477438	0.501	rs6727749	chr2:99793590	C/T	cg26064155	chr2:99771622	LIPT1;TSGA10	1.03	9.76	0.74	3.61e-15	Chronic sinus infection;
SKCM	cis	rs7215564	0.730	rs9901550	chr17:78584464	T/C	cg16980736	chr17:78789706	RPTOR	-0.89	-4.87	-0.48	5.8e-6	Myopia (pathological);
SKCM	cis	rs1005277	0.602	rs1740743	chr10:38519222	C/T	cg25427524	chr10:38739819	LOC399744	-0.69	-6.79	-0.61	1.96e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs752010	0.644	rs7541348	chr1:42113215	T/G	cg06885757	chr1:42089581	HIVEP3	0.5	5.53	0.53	4.05e-7	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs854765	0.647	rs4365346	chr17:17989373	G/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.88	6.64	0.6	3.8e-9	Total body bone mineral density;
SKCM	cis	rs2073499	1.000	rs12629572	chr3:50324672	T/G	cg05260129	chr3:50388622	TUSC4;CYB561D2	0.88	5.25	0.51	1.27e-6	Schizophrenia;
SKCM	cis	rs854765	0.583	rs12603148	chr17:17865257	C/T	cg04398451	chr17:18023971	MYO15A	-0.86	-5.91	-0.56	8.41e-8	Total body bone mineral density;
SKCM	cis	rs1005277	0.579	rs1780130	chr10:38485378	T/A	cg00409905	chr10:38381863	ZNF37A	-0.65	-5.92	-0.56	8.1e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs208520	0.690	rs10944872	chr6:66708239	T/G	cg07460842	chr6:66804631	NA	0.91	7.48	0.65	9.57e-11	Exhaled nitric oxide output;
SKCM	cis	rs2075371	0.501	rs1646652	chr7:134024515	A/T	cg20476274	chr7:133979776	SLC35B4	0.89	7.35	0.64	1.7e-10	Mean platelet volume;
SKCM	cis	rs1692580	0.807	rs12040414	chr1:2192948	T/C	cg24578937	chr1:2090814	PRKCZ	0.47	5.16	0.5	1.81e-6	Coronary artery disease;
SKCM	cis	rs1577917	0.771	rs9362237	chr6:86409064	G/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.85	7.86	0.66	1.75e-11	Response to antipsychotic treatment;
SKCM	cis	rs2760061	0.626	rs672907	chr1:228120345	G/A	cg18477163	chr1:228402036	OBSCN	-0.43	-4.87	-0.48	5.62e-6	Diastolic blood pressure;
SKCM	cis	rs507080	0.922	rs644867	chr11:118567545	A/G	cg18045108	chr11:118530628	TREH	-0.47	-5.11	-0.5	2.22e-6	Serum metabolite levels;
SKCM	cis	rs2836974	0.932	rs8129416	chr21:40617145	C/T	cg17971929	chr21:40555470	PSMG1	0.9	8.81	0.71	2.52e-13	Cognitive function;
SKCM	cis	rs9902453	0.845	rs12452201	chr17:28214173	G/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.84	6.07	0.57	4.28e-8	Coffee consumption (cups per day);
SKCM	cis	rs2153535	0.580	rs1414342	chr6:8462552	A/G	cg07606381	chr6:8435919	SLC35B3	0.92	6.66	0.6	3.44e-9	Motion sickness;
SKCM	cis	rs6430585	0.583	rs3769013	chr2:136556182	C/T	cg07169764	chr2:136633963	MCM6	1.26	13.27	0.83	1.08e-21	Corneal structure;
SKCM	cis	rs7528419	0.895	rs1277930	chr1:109822143	G/A	cg00908766	chr1:109817496	CELSR2	0.45	4.99	0.49	3.65e-6	Coronary artery disease (myocardial infartum, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease);Myocardial infarction;Lipoprotein-associated phospholipase A2 activity and mass;Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease;Cholesterol, total;Coronary artery disease;
SKCM	cis	rs4919694	1.000	rs75691516	chr10:104652045	C/T	cg04362960	chr10:104952993	NT5C2	0.76	4.85	0.48	6.19e-6	Arsenic metabolism;
SKCM	cis	rs6540556	0.768	rs6692012	chr1:209935490	A/G	cg05527609	chr1:210001259	C1orf107	-0.86	-4.8	-0.48	7.39e-6	Red blood cell count;
SKCM	cis	rs2235573	0.657	rs5756890	chr22:38445400	C/A	cg03683946	chr22:38051826	SH3BP1	-0.48	-4.83	-0.48	6.64e-6	Glioblastoma;Glioma;
SKCM	cis	rs1882538	0.538	rs7803848	chr7:133108547	C/T	cg10665199	chr7:133106180	EXOC4	0.83	5.17	0.51	1.76e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2836974	0.899	rs2836957	chr21:40623134	T/C	cg11890956	chr21:40555474	PSMG1	1.09	13.83	0.84	1.08e-22	Cognitive function;
SKCM	cis	rs1799949	1.000	rs1545764	chr17:41424565	G/A	cg05368731	chr17:41323189	NBR1	0.85	7.32	0.64	1.89e-10	Menopause (age at onset);
SKCM	cis	rs9640161	0.789	rs10248490	chr7:150051418	C/G	cg10018233	chr7:150070692	REPIN1	0.67	5.15	0.5	1.94e-6	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs28595532	0.920	rs55985953	chr4:119764971	T/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs7824557	0.707	rs3808519	chr8:11142970	C/G	cg21775007	chr8:11205619	TDH	0.7	5.79	0.55	1.43e-7	Retinal vascular caliber;
SKCM	cis	rs7811142	1.000	rs73161762	chr7:100014846	C/T	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.2	7.76	0.66	2.78e-11	Platelet count;
SKCM	cis	rs7296418	0.961	rs1790106	chr12:123591596	G/T	cg06742321	chr12:123595122	PITPNM2	0.65	5.45	0.52	5.77e-7	Platelet count;
SKCM	cis	rs2070488	0.775	rs1073505	chr3:38566722	T/C	cg01465620	chr3:38496096	LOC100128640;ACVR2B	-0.74	-5.79	-0.55	1.38e-7	Electrocardiographic conduction measures;
SKCM	cis	rs2180341	0.889	rs9321074	chr6:127618019	G/A	cg27446573	chr6:127587934	RNF146	1.0	8.68	0.7	4.48e-13	Breast cancer;
SKCM	cis	rs8177253	0.761	rs35332919	chr3:133519002	T/A	cg01448562	chr3:133502909	NA	-0.55	-4.8	-0.48	7.52e-6	Iron status biomarkers;
SKCM	cis	rs1218582	0.772	rs4240875	chr1:154885782	G/A	cg06221963	chr1:154839813	KCNN3	-0.59	-5.97	-0.56	6.76e-8	Prostate cancer;
SKCM	cis	rs10256972	0.630	rs13235747	chr7:1129123	T/C	cg07092213	chr7:1199455	ZFAND2A	-0.65	-5.44	-0.52	5.9e-7	Longevity;Endometriosis;
SKCM	cis	rs763121	0.853	rs5757166	chr22:38995385	G/T	cg06022373	chr22:39101656	GTPBP1	0.82	5.62	0.54	2.79e-7	Menopause (age at onset);
SKCM	cis	rs28386778	0.830	rs2584625	chr17:61903445	G/C	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs875971	0.929	rs12535036	chr7:65964063	G/T	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs9902453	1.000	rs4074170	chr17:28381141	C/G	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.81	-5.78	-0.55	1.45e-7	Coffee consumption (cups per day);
SKCM	cis	rs9467773	1.000	rs1884946	chr6:26545308	C/G	cg15659132	chr6:26577336	NA	0.6	5.78	0.55	1.47e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs4819052	0.851	rs28616694	chr21:46674786	G/C	cg02159808	chr21:46707872	POFUT2;LOC642852	0.74	5.82	0.55	1.22e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs2033711	0.902	rs4801589	chr19:58953398	C/G	cg00825309	chr19:58991885	ZNF446	-0.71	-5.93	-0.56	7.76e-8	Uric acid clearance;
SKCM	cis	rs3768617	0.510	rs3768621	chr1:183090057	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs16870629	0.541	rs2334955	chr5:1062444	A/G	cg00278107	chr5:1061253	SLC12A7	-1.04	-11.12	-0.78	9.13e-18	QT interval;
SKCM	cis	rs7666738	0.830	rs34212748	chr4:99068708	G/A	cg05340658	chr4:99064831	C4orf37	0.66	4.87	0.48	5.74e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs588177	0.919	rs2244625	chr11:64026144	G/A	cg02228329	chr11:64053129	BAD;GPR137	0.81	5.22	0.51	1.42e-6	High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs35306767	0.903	rs12762228	chr10:880854	G/A	cg25614935	chr10:1084866	C10orf110	0.8	5.41	0.52	6.69e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs1218582	0.804	rs869506	chr1:154859581	A/C	cg24250549	chr1:154909240	PMVK	0.87	8.69	0.7	4.22e-13	Prostate cancer;
SKCM	cis	rs9790314	0.846	rs899275	chr3:161042104	T/C	cg03342759	chr3:160939853	NMD3	-0.72	-8.12	-0.68	5.59e-12	Morning vs. evening chronotype;
SKCM	cis	rs7829975	0.688	rs7827182	chr8:8380471	C/G	cg06636001	chr8:8085503	FLJ10661	0.84	7.25	0.63	2.6200000000000003e-10	Mood instability;
SKCM	cis	rs9611565	0.729	rs9611570	chr22:41782721	G/T	cg03806693	chr22:41940476	POLR3H	-0.99	-6.37	-0.58	1.23e-8	Vitiligo;
SKCM	cis	rs4665809	0.590	rs962217	chr2:26438276	T/C	cg26119090	chr2:26468346	HADHA;HADHB	-1.05	-8.25	-0.68	3.13e-12	Gut microbiome composition (summer);
SKCM	cis	rs2404602	0.619	rs7342603	chr15:76982625	C/T	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs597539	0.652	rs564849	chr11:68621440	C/T	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.78	5.33	0.52	9.36e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs7208859	0.673	rs9895815	chr17:29138033	A/G	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs7811142	1.000	rs28490152	chr7:100020982	G/A	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-1.0	-5.66	-0.54	2.36e-7	Platelet count;
SKCM	cis	rs514406	0.861	rs551435	chr1:53260537	G/T	cg16325326	chr1:53192061	ZYG11B	-0.99	-11.71	-0.8	7.39e-19	Monocyte count;
SKCM	cis	rs846858	0.963	rs846856	chr19:45126900	T/C	cg18042043	chr19:44147545	NA	0.61	4.95	0.49	4.19e-6	Late-onset Alzheimer's disease;
SKCM	cis	rs738321	0.757	rs12329956	chr22:38535946	G/A	cg25457927	chr22:38595422	NA	-0.49	-5.42	-0.52	6.43e-7	Breast cancer;
SKCM	cis	rs2836974	0.584	rs7276774	chr21:40628725	T/G	cg11890956	chr21:40555474	PSMG1	-0.88	-9.14	-0.72	5.76e-14	Cognitive function;
SKCM	cis	rs7539542	0.516	rs10920530	chr1:202902754	A/G	cg19681188	chr1:202830198	LOC148709	0.7	5.31	0.52	9.93e-7	Mean platelet volume;
SKCM	cis	rs10791097	0.694	rs7106973	chr11:130758113	G/A	cg12179176	chr11:130786555	SNX19	0.93	8.37	0.69	1.82e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs4819052	0.851	rs7279182	chr21:46656112	G/A	cg19498844	chr21:46707878	POFUT2;LOC642852	0.84	7.19	0.63	3.46e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs6424115	0.790	rs72874118	chr1:24177800	A/G	cg15997130	chr1:24165203	NA	-0.57	-4.77	-0.48	8.44e-6	Immature fraction of reticulocytes;
SKCM	cis	rs6952808	0.771	rs10275045	chr7:1920826	C/T	cg21782813	chr7:2030301	MAD1L1	0.5	5.21	0.51	1.52e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs7824557	0.564	rs13268126	chr8:11230574	G/A	cg21775007	chr8:11205619	TDH	-0.6	-4.94	-0.49	4.33e-6	Retinal vascular caliber;
SKCM	cis	rs8141529	0.687	rs6005867	chr22:29165120	T/C	cg15103426	chr22:29168792	CCDC117	0.61	5.01	0.49	3.32e-6	Lymphocyte counts;
SKCM	cis	rs250677	0.798	rs11168080	chr5:148409821	C/T	cg18129178	chr5:148520854	ABLIM3	-0.78	-4.84	-0.48	6.41e-6	Breast cancer;
SKCM	cis	rs644799	0.648	rs1255176	chr11:95471465	A/T	cg03916912	chr11:95522834	CEP57;FAM76B	0.62	5.01	0.49	3.31e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs992157	0.732	rs10932771	chr2:219170236	A/T	cg20019365	chr2:219134978	PNKD;AAMP	0.72	6.12	0.57	3.48e-8	Colorectal cancer;
SKCM	cis	rs870825	0.616	rs7700216	chr4:185648510	G/T	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs1568889	0.877	rs34351528	chr11:28304293	T/C	cg06544937	chr11:28130018	METT5D1;KIF18A	0.86	7.03	0.62	6.97e-10	Bipolar disorder;
SKCM	cis	rs9911578	0.967	rs8072712	chr17:57162464	A/T	cg05425664	chr17:57184151	TRIM37	-0.83	-7.07	-0.62	5.91e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs3820068	0.603	rs6429769	chr1:15968610	C/G	cg13390004	chr1:15929781	NA	0.67	5.11	0.5	2.26e-6	Systolic blood pressure;
SKCM	cis	rs61776719	0.875	rs10890238	chr1:38445654	A/T	cg17077180	chr1:38461687	NA	0.48	4.87	0.48	5.78e-6	Coronary artery disease;
SKCM	cis	rs2404602	0.647	rs3812909	chr15:77176200	A/T	cg23625390	chr15:77176239	SCAPER	-0.82	-7.93	-0.67	1.26e-11	Blood metabolite levels;
SKCM	cis	rs2841277	0.834	rs2841281	chr14:105394669	C/T	cg21017887	chr14:105400489	NA	-0.59	-5.18	-0.51	1.67e-6	Rheumatoid arthritis;
SKCM	cis	rs12714314	0.602	rs10199754	chr2:1938028	G/A	cg22350835	chr2:1868857	MYT1L	0.6	5.78	0.55	1.49e-7	Type 2 diabetes (age of onset);
SKCM	cis	rs16854884	0.586	rs4613453	chr3:143735600	C/G	cg06585982	chr3:143692056	C3orf58	0.86	7.79	0.66	2.36e-11	Economic and political preferences (feminism/equality);
SKCM	cis	rs738322	0.804	rs4821742	chr22:38514839	T/C	cg25457927	chr22:38595422	NA	-0.46	-5.01	-0.49	3.33e-6	Cutaneous nevi;
SKCM	cis	rs12706411	1.000	rs12706410	chr7:122058470	A/C	cg17986181	chr7:121955208	NA	0.68	5.06	0.5	2.69e-6	Alzheimer disease and age of onset;
SKCM	cis	rs16866061	1.000	rs72974219	chr2:225423784	G/C	cg12698349	chr2:225449008	CUL3	1.01	8.51	0.69	9.75e-13	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs7937682	0.855	rs490897	chr11:111487914	A/G	cg09085632	chr11:111637200	PPP2R1B	-0.97	-10.08	-0.75	8.74e-16	Primary sclerosing cholangitis;
SKCM	cis	rs3780486	0.846	rs7873903	chr9:33142728	G/A	cg13443165	chr9:33130375	B4GALT1	-0.54	-4.95	-0.49	4.17e-6	IgG glycosylation;
SKCM	cis	rs6061231	0.837	rs6121558	chr20:60961365	A/G	cg24112000	chr20:60950667	NA	-0.65	-6.02	-0.56	5.29e-8	Colorectal cancer;
SKCM	cis	rs10927875	0.691	rs2017583	chr1:16350028	A/G	cg21385522	chr1:16154831	NA	0.67	4.9	0.48	5.15e-6	Dilated cardiomyopathy;
SKCM	cis	rs10504229	0.683	rs7827881	chr8:58132137	C/T	cg02725872	chr8:58115012	NA	-0.54	-5.17	-0.51	1.73e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs9910055	0.659	rs8079310	chr17:42270291	A/G	cg09913183	chr17:42254507	C17orf65;ASB16	0.66	6.21	0.57	2.45e-8	Total body bone mineral density;
SKCM	cis	rs28595532	1.000	rs11098451	chr4:119717673	C/T	cg11846333	chr4:119757529	SEC24D	1.19	6.39	0.59	1.12e-8	Cannabis dependence symptom count;
SKCM	cis	rs853679	0.599	rs149943	chr6:28002388	G/A	cg09551472	chr6:27280195	POM121L2	0.87	4.79	0.48	7.68e-6	Depression;
SKCM	cis	rs951366	0.528	rs1172198	chr1:205662718	C/T	cg24503407	chr1:205819492	PM20D1	0.71	5.55	0.53	3.86e-7	Menarche (age at onset);
SKCM	cis	rs12142240	0.698	rs17361763	chr1:46810670	T/C	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs9611565	0.694	rs202622	chr22:41825342	T/G	cg03806693	chr22:41940476	POLR3H	1.13	7.36	0.64	1.63e-10	Vitiligo;
SKCM	cis	rs12477438	0.520	rs2309581	chr2:99784292	A/G	cg14399236	chr2:99771627	LIPT1;TSGA10	-0.9	-6.95	-0.62	9.99e-10	Chronic sinus infection;
SKCM	cis	rs7577851	0.627	rs112826171	chr2:69672871	A/G	cg10773587	chr2:69614142	GFPT1	0.81	4.77	0.47	8.53e-6	Parkinson's disease (age of onset);
SKCM	cis	rs919433	0.963	rs12693815	chr2:198168403	T/C	cg04278110	chr2:198063759	ANKRD44	-0.69	-4.8	-0.48	7.58e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	trans	rs3749237	1.000	rs4768	chr3:49758764	A/G	cg21659725	chr3:3221576	CRBN	0.99	7.4	0.64	1.35e-10	Resting heart rate;
SKCM	cis	rs7020830	0.931	rs7027473	chr9:37132462	A/G	cg14294708	chr9:37120828	ZCCHC7	1.1	10.41	0.76	2.09e-16	Schizophrenia;
SKCM	cis	rs9325144	0.647	rs34311455	chr12:39060889	C/T	cg13010199	chr12:38710504	ALG10B	-0.6	-5.09	-0.5	2.4e-6	Morning vs. evening chronotype;
SKCM	cis	rs12142240	0.730	rs56030283	chr1:46823093	C/G	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs78905543	0.772	rs11135694	chr8:22925515	A/G	cg02190353	chr8:23405296	SLC25A37	-0.57	-4.91	-0.49	4.87e-6	Mean corpuscular volume;
SKCM	cis	rs8030485	0.536	rs4778918	chr15:79434040	T/C	cg10259521	chr15:79428573	NA	-0.49	-5.12	-0.5	2.12e-6	Left ventricle wall thickness;
SKCM	cis	rs116095464	0.558	rs55838121	chr5:266890	G/A	cg22857025	chr5:266934	NA	-1.35	-8.11	-0.68	5.73e-12	Breast cancer;
SKCM	cis	rs8180040	0.903	rs6791842	chr3:47279810	T/C	cg27129171	chr3:47204927	SETD2	0.85	6.39	0.59	1.11e-8	Colorectal cancer;
SKCM	cis	rs2197308	0.765	rs117216293	chr12:37882982	T/C	cg26384229	chr12:38710491	ALG10B	-0.77	-6.29	-0.58	1.72e-8	Morning vs. evening chronotype;
SKCM	cis	rs763121	0.814	rs5757212	chr22:39053757	G/C	cg06022373	chr22:39101656	GTPBP1	0.82	5.62	0.54	2.8e-7	Menopause (age at onset);
SKCM	cis	rs4888262	0.545	rs8050624	chr16:74686690	A/G	cg01733217	chr16:74700730	RFWD3	-0.89	-7.75	-0.66	2.87e-11	Testicular germ cell tumor;
SKCM	cis	rs6565180	1.000	rs11863150	chr16:30385503	C/T	cg17640201	chr16:30407289	ZNF48	0.93	7.56	0.65	6.64e-11	Tonsillectomy;
SKCM	cis	rs754466	0.914	rs4595491	chr10:79685833	G/A	cg17075019	chr10:79541650	NA	-0.64	-5.1	-0.5	2.35e-6	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs11700980	0.636	rs114711857	chr21:30260199	T/C	cg24692254	chr21:30365293	RNF160	-0.89	-5.17	-0.51	1.73e-6	QRS complex (12-leadsum);
SKCM	cis	rs2243480	1.000	rs7787230	chr7:65629099	G/A	cg18252515	chr7:66147081	NA	1.34	8.18	0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs80282103	0.618	rs2387299	chr10:1163427	A/G	cg19207066	chr10:1251074	ADARB2	-0.76	-4.94	-0.49	4.41e-6	Glomerular filtration rate (creatinine);
SKCM	cis	rs7769051	0.708	rs9483514	chr6:133228716	G/A	cg22852734	chr6:133119734	C6orf192	0.9	4.77	0.48	8.46e-6	Type 2 diabetes nephropathy;
SKCM	cis	rs6539267	0.741	rs2279759	chr12:106694988	T/C	cg00173435	chr12:106696525	TCP11L2	0.85	6.21	0.58	2.39e-8	Tourette syndrome;
SKCM	cis	rs4888262	0.526	rs7205258	chr16:74642539	C/T	cg01733217	chr16:74700730	RFWD3	0.92	7.53	0.65	7.53e-11	Testicular germ cell tumor;
SKCM	cis	rs116095464	0.558	rs9688045	chr5:254035	T/C	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs2204008	0.557	rs11520191	chr12:38197057	T/A	cg26384229	chr12:38710491	ALG10B	0.82	6.58	0.6	4.87e-9	Bladder cancer;
SKCM	cis	rs11098499	0.866	rs7677068	chr4:120291704	C/T	cg09307838	chr4:120376055	NA	0.98	7.89	0.67	1.52e-11	Corneal astigmatism;
SKCM	cis	rs763014	0.593	rs28455838	chr16:681966	T/C	cg07343612	chr16:622815	PIGQ	-0.67	-5.2	-0.51	1.57e-6	Height;
SKCM	cis	rs13256369	0.901	rs12681298	chr8:8566235	A/G	cg17143192	chr8:8559678	CLDN23	-0.66	-4.77	-0.48	8.44e-6	Obesity-related traits;
SKCM	cis	rs4523957	0.583	rs903159	chr17:2055109	C/T	cg16513277	chr17:2031491	SMG6	-0.88	-5.81	-0.55	1.28e-7	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs7208859	0.623	rs9906957	chr17:29157755	C/T	cg13385521	chr17:29058706	SUZ12P	0.9	4.78	0.48	8.1e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs7666738	0.830	rs13148324	chr4:98833616	G/A	cg17366294	chr4:99064904	C4orf37	0.56	4.87	0.48	5.62e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs769267	0.965	rs10419245	chr19:19383755	G/A	cg03709012	chr19:19516395	GATAD2A	0.8	6.36	0.58	1.27e-8	Tonsillectomy;
SKCM	cis	rs7666738	0.830	rs4699593	chr4:98980628	A/G	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7945705	0.875	rs4929914	chr11:8824388	C/T	cg21881798	chr11:8931708	C11orf17;ST5	-0.7	-7.09	-0.63	5.4e-10	Hemoglobin concentration;
SKCM	cis	rs709400	0.526	rs11622835	chr14:103967504	G/A	cg25964908	chr14:103967516	MARK3	-0.76	-5.32	-0.52	9.57e-7	Body mass index;
SKCM	cis	rs2463822	1.000	rs115395195	chr11:62100353	G/A	cg06239285	chr11:62104954	ASRGL1	-1.27	-6.04	-0.56	4.98e-8	Chronic obstructive pulmonary disease-related biomarkers;
SKCM	cis	rs763014	0.966	rs4247097	chr16:654224	G/A	cg00908189	chr16:619842	PIGQ	0.79	7.44	0.64	1.12e-10	Height;
SKCM	trans	rs9929218	0.581	rs7203337	chr16:68774800	C/G	cg04657470	chr2:198365150	HSPE1;HSPD1	0.83	7.5	0.65	8.65e-11	Colorectal cancer;
SKCM	cis	rs6461049	0.608	rs3800923	chr7:2184673	A/G	cg05863683	chr7:1912471	MAD1L1	0.55	4.83	0.48	6.56e-6	Schizophrenia;
SKCM	cis	rs67311347	0.524	rs7649168	chr3:40356158	T/C	cg02782426	chr3:40428986	ENTPD3	0.5	4.99	0.49	3.64e-6	Renal cell carcinoma;
SKCM	cis	rs2658782	0.724	rs2248020	chr11:93259965	A/C	cg15737290	chr11:93063684	CCDC67	0.83	5.74	0.54	1.74e-7	Pulmonary function decline;
SKCM	cis	rs72781680	0.898	rs72796154	chr2:23933839	G/A	cg08917208	chr2:24149416	ATAD2B	0.95	4.78	0.48	8.1e-6	Lymphocyte counts;
SKCM	cis	rs3784262	0.669	rs4646635	chr15:58252277	T/C	cg12031962	chr15:58353849	ALDH1A2	-0.41	-4.97	-0.49	3.86e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs28595532	0.920	rs116108618	chr4:119763585	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs7100689	0.784	rs10749578	chr10:82139115	A/G	cg00277334	chr10:82204260	NA	0.52	5.11	0.5	2.2e-6	Post bronchodilator FEV1;
SKCM	cis	rs644799	0.710	rs522536	chr11:95528714	C/T	cg03916912	chr11:95522834	CEP57;FAM76B	0.8	6.71	0.6	2.8e-9	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs34779708	0.966	rs4934737	chr10:35512799	T/C	cg03585969	chr10:35415529	CREM	0.78	6.28	0.58	1.75e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs17711722	0.653	rs2460421	chr7:65491123	A/T	cg11987759	chr7:65425863	GUSB	0.72	6.71	0.6	2.79e-9	Calcium levels;
SKCM	cis	rs2836950	0.527	rs2836948	chr21:40599677	T/C	cg17971929	chr21:40555470	PSMG1	-0.73	-6.17	-0.57	2.86e-8	Menarche (age at onset);
SKCM	cis	rs10504229	0.683	rs7000349	chr8:58114569	C/A	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs1669338	0.507	rs4685606	chr3:3177973	T/G	cg16797762	chr3:3221439	CRBN	-1.14	-6.5	-0.59	6.86e-9	White matter integrity;
SKCM	cis	rs250585	0.516	rs367983	chr16:23603125	A/G	cg09934309	chr16:23461721	COG7	-0.79	-5.18	-0.51	1.7e-6	Egg allergy;
SKCM	cis	rs909341	0.678	rs2738778	chr20:62291830	C/T	cg09650180	chr20:62225654	GMEB2	-0.65	-5.02	-0.49	3.16e-6	Atopic dermatitis;
SKCM	cis	rs12474201	0.569	rs13411633	chr2:46932666	A/G	cg06386533	chr2:46925753	SOCS5	0.82	6.93	0.62	1.08e-9	Height;
SKCM	cis	rs3820068	0.603	rs72645887	chr1:15929905	G/C	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs1707322	0.963	rs4508055	chr1:46257731	A/T	cg03146154	chr1:46216737	IPP	0.74	5.0	0.49	3.39e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs35146811	0.735	rs1727138	chr7:99815247	A/G	cg22906224	chr7:99728672	NA	-0.69	-5.69	-0.54	2.12e-7	Coronary artery disease;
SKCM	cis	rs7917772	0.507	rs2778036	chr10:104485725	G/A	cg11453585	chr10:104263688	ACTR1A;SUFU	0.74	4.92	0.49	4.78e-6	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs722599	0.501	rs2286914	chr14:75387012	T/C	cg08847533	chr14:75593920	NEK9	-0.6	-4.83	-0.48	6.64e-6	IgG glycosylation;
SKCM	cis	rs780096	0.546	rs4665976	chr2:27640325	A/G	cg05696406	chr2:27599888	SNX17	0.49	5.07	0.5	2.62e-6	Total body bone mineral density;
SKCM	cis	rs8017423	0.605	rs11624565	chr14:90810274	A/T	cg04374321	chr14:90722782	PSMC1	-0.76	-5.8	-0.55	1.36e-7	Mortality in heart failure;
SKCM	cis	rs867186	1.000	rs117616040	chr20:33565528	G/C	cg04194272	chr20:33683537	NA	-1.37	-6.77	-0.61	2.18e-9	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs3008870	1.000	rs11208979	chr1:67442275	C/T	cg08660285	chr1:67390436	MIER1;WDR78	-0.92	-6.07	-0.57	4.27e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs6500395	0.889	rs2080507	chr16:48688634	T/A	cg04672837	chr16:48644449	N4BP1	-0.65	-5.43	-0.52	6.28e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs9905704	0.647	rs2108435	chr17:57102133	T/C	cg12560992	chr17:57184187	TRIM37	-0.74	-6.04	-0.56	4.86e-8	Testicular germ cell tumor;
SKCM	cis	rs1405130	0.839	rs4663156	chr2:235581361	C/T	cg21542780	chr2:234763377	HJURP	-0.66	-4.93	-0.49	4.45e-6	Coronary artery disease;
SKCM	cis	rs2180341	0.814	rs6940933	chr6:127732740	C/G	cg24812749	chr6:127587940	RNF146	0.61	4.97	0.49	3.9e-6	Breast cancer;
SKCM	cis	rs9788682	1.000	rs12441426	chr15:78812329	T/C	cg24631222	chr15:78858424	CHRNA5	0.94	6.59	0.6	4.67e-9	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs11105298	0.891	rs1008764	chr12:89887649	T/C	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.89	-6.03	-0.56	5.25e-8	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs17345786	1.000	rs3804775	chr3:101306507	C/T	cg12386194	chr3:101231763	SENP7	0.8	6.37	0.58	1.23e-8	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4803468	1.000	rs3810174	chr19:41904165	C/T	cg14132834	chr19:41945861	ATP5SL	-0.74	-5.71	-0.54	1.99e-7	Height;
SKCM	cis	rs875971	0.545	rs7783889	chr7:65748353	T/A	cg18876405	chr7:65276391	NA	0.64	5.17	0.51	1.77e-6	Aortic root size;
SKCM	cis	rs2839186	0.771	rs2839155	chr21:47639992	A/G	cg05896524	chr21:47604654	C21orf56	0.68	5.63	0.54	2.78e-7	Testicular germ cell tumor;
SKCM	cis	rs17685	0.712	rs1859792	chr7:75789264	T/C	cg16489192	chr7:75678113	MDH2;STYXL1	-0.53	-4.88	-0.48	5.55e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs62238980	0.614	rs116888565	chr22:32419164	C/A	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs17376456	0.877	rs2085960	chr5:93399934	A/G	cg25358565	chr5:93447407	FAM172A	1.19	7.67	0.66	4.06e-11	Diabetic retinopathy;
SKCM	cis	rs1538970	0.924	rs11211118	chr1:45930270	A/C	cg05343316	chr1:45956843	TESK2	0.99	5.13	0.5	2.07e-6	Platelet count;
SKCM	cis	rs10503709	0.965	rs10107425	chr8:21479725	C/T	cg23716449	chr8:21608280	GFRA2	0.49	4.96	0.49	4.01e-6	Blood protein levels;
SKCM	cis	rs10751667	0.643	rs10751671	chr11:944479	T/G	cg10932868	chr11:921992	NA	0.54	5.05	0.5	2.81e-6	Alzheimer's disease (late onset);
SKCM	trans	rs5756813	0.661	rs2285177	chr22:38205894	A/G	cg19894588	chr14:64061835	NA	-0.86	-7.31	-0.64	2e-10	Optic cup area;Vertical cup-disc ratio;
SKCM	cis	rs7945705	0.967	rs34842234	chr11:8891894	G/A	cg13070366	chr11:9386451	NA	-0.59	-5.1	-0.5	2.36e-6	Hemoglobin concentration;
SKCM	cis	rs2239547	0.603	rs2276825	chr3:52886605	T/C	cg11645453	chr3:52864694	ITIH4	0.77	6.95	0.62	9.68e-10	Schizophrenia;
SKCM	cis	rs6545883	0.929	rs10193666	chr2:61629408	C/T	cg15711740	chr2:61764176	XPO1	0.71	5.03	0.49	3.1e-6	Tuberculosis;
SKCM	trans	rs66573146	0.831	rs56300156	chr4:6990813	G/C	cg07817883	chr1:32538562	TMEM39B	1.94	8.42	0.69	1.47e-12	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs7666738	0.830	rs2098934	chr4:98992403	A/G	cg17366294	chr4:99064904	C4orf37	0.6	4.98	0.49	3.8e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs67311347	0.544	rs6787516	chr3:40355616	C/T	cg02782426	chr3:40428986	ENTPD3	0.5	4.99	0.49	3.64e-6	Renal cell carcinoma;
SKCM	cis	rs7119	0.700	rs57471224	chr15:77888169	A/G	cg27398640	chr15:77910606	LINGO1	0.51	5.1	0.5	2.32e-6	Type 2 diabetes;
SKCM	cis	rs9880211	0.800	rs34324561	chr3:136101242	T/G	cg21827317	chr3:136751795	NA	-0.65	-4.92	-0.49	4.73e-6	Body mass index;Height;
SKCM	cis	rs6952808	0.689	rs79950306	chr7:2022063	C/G	cg02951883	chr7:2050386	MAD1L1	-0.79	-6.96	-0.62	9.3e-10	Bipolar disorder and schizophrenia;
SKCM	cis	rs4975616	0.869	rs466502	chr5:1325767	C/T	cg26373071	chr5:1325741	CLPTM1L	-0.75	-6.83	-0.61	1.68e-9	Lung cancer;
SKCM	cis	rs3785574	0.621	rs1051684	chr17:62006497	A/G	cg01411255	chr17:61851458	DDX42;CCDC47	-0.72	-5.39	-0.52	7.36e-7	Height;
SKCM	cis	rs1801251	0.963	rs13011298	chr2:233612996	A/G	cg08000102	chr2:233561755	GIGYF2	0.87	7.05	0.62	6.23e-10	Coronary artery disease;
SKCM	cis	rs2070488	0.965	rs6805386	chr3:38557921	T/C	cg01465620	chr3:38496096	LOC100128640;ACVR2B	-1.02	-9.28	-0.72	3.06e-14	Electrocardiographic conduction measures;
SKCM	cis	rs9905704	0.647	rs7221274	chr17:57008128	A/G	cg05425664	chr17:57184151	TRIM37	-0.61	-4.86	-0.48	5.91e-6	Testicular germ cell tumor;
SKCM	cis	rs763014	0.931	rs7192508	chr16:630367	C/T	cg09263875	chr16:632152	PIGQ	0.67	5.82	0.55	1.24e-7	Height;
SKCM	cis	rs561341	0.700	rs8079471	chr17:30218317	A/G	cg00745463	chr17:30367425	LRRC37B	-0.78	-5.05	-0.5	2.81e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs4243830	0.850	rs57203351	chr1:6601319	T/C	cg22792644	chr1:6614718	TAS1R1;NOL9	1.08	5.78	0.55	1.45e-7	Body mass index;
SKCM	cis	rs2153535	0.580	rs1335641	chr6:8487860	G/T	cg07606381	chr6:8435919	SLC35B3	0.86	6.25	0.58	2.06e-8	Motion sickness;
SKCM	cis	rs4555082	0.789	rs2816649	chr14:105708326	A/G	cg13114125	chr14:105738426	BRF1	-0.7	-5.65	-0.54	2.51e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs4803468	0.967	rs4605279	chr19:41888131	C/G	cg14132834	chr19:41945861	ATP5SL	-0.74	-5.71	-0.54	1.99e-7	Height;
SKCM	cis	rs6500395	1.000	rs1909765	chr16:48597358	A/G	cg04672837	chr16:48644449	N4BP1	0.69	5.73	0.54	1.8e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs9535495	0.930	rs7989991	chr13:51383943	A/G	cg13204699	chr13:50703841	NA	-0.43	-4.92	-0.49	4.67e-6	Reticulocyte count;Reticulocyte fraction of red cells;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs769267	0.896	rs10410664	chr19:19556651	G/A	cg26732615	chr19:19648335	CILP2;YJEFN3	0.67	7.06	0.62	6e-10	Tonsillectomy;
SKCM	cis	rs6951245	0.872	rs74360401	chr7:1067403	G/A	cg18402987	chr7:1209562	NA	1.15	6.02	0.56	5.38e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs2070488	0.965	rs2366119	chr3:38484453	C/T	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.97	8.85	0.71	2.08e-13	Electrocardiographic conduction measures;
SKCM	cis	rs6835098	1.000	rs1054497	chr4:174089048	A/T	cg08422745	chr4:174089978	GALNT7	0.87	6.8	0.61	1.91e-9	Dementia and core Alzheimer's disease neuropathologic changes;
SKCM	cis	rs9788721	0.806	rs4887056	chr15:78734585	A/G	cg18825076	chr15:78729989	IREB2	-0.61	-4.85	-0.48	6.1e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;Emphysema imaging phenotypes;Emphysema distribution in smoking;Local histogram emphysema pattern;Post bronchodilator FEV1/FVC ratio in COPD;
SKCM	cis	rs208520	1.000	rs12193164	chr6:66978962	C/T	cg07460842	chr6:66804631	NA	0.87	6.25	0.58	2.01e-8	Exhaled nitric oxide output;
SKCM	cis	rs763014	0.931	rs11643039	chr16:634260	G/A	cg00908189	chr16:619842	PIGQ	0.82	7.78	0.66	2.55e-11	Height;
SKCM	cis	rs2841233	0.692	rs2304756	chr14:105344533	C/T	cg16576083	chr14:105354267	KIAA0284	0.6	4.77	0.48	8.29e-6	IgG glycosylation;
SKCM	cis	rs116095464	0.614	rs62344292	chr5:244630	G/A	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs11098499	0.954	rs17009122	chr4:120362403	G/A	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs17065868	0.881	rs61949804	chr13:45049965	T/C	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs116095464	0.558	rs7356561	chr5:284381	G/C	cg22857025	chr5:266934	NA	-1.47	-8.33	-0.69	2.16e-12	Breast cancer;
SKCM	cis	rs10489202	0.632	rs12401555	chr1:168069473	G/C	cg24449463	chr1:168025552	DCAF6	-0.76	-6.99	-0.62	8.31e-10	Schizophrenia;
SKCM	cis	rs12142240	0.698	rs68191463	chr1:46808695	T/C	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs28595532	1.000	rs114912871	chr4:119697004	G/C	cg11846333	chr4:119757529	SEC24D	1.19	6.39	0.59	1.12e-8	Cannabis dependence symptom count;
SKCM	cis	rs2243480	1.000	rs10247526	chr7:65780696	T/G	cg18252515	chr7:66147081	NA	1.34	8.18	0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs1153858	1.000	rs1346268	chr15:45673029	T/C	cg21132104	chr15:45694354	SPATA5L1	0.93	7.94	0.67	1.22e-11	Homoarginine levels;
SKCM	cis	rs17685	0.753	rs2302438	chr7:75677065	C/A	cg01364799	chr7:75623366	TMEM120A	-0.72	-5.83	-0.55	1.18e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs4975616	0.804	rs459961	chr5:1337106	T/A	cg07493874	chr5:1342172	CLPTM1L	-0.7	-6.57	-0.6	5.12e-9	Lung cancer;
SKCM	cis	rs17065868	1.000	rs55889128	chr13:45108341	G/A	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs5750830	0.620	rs1007337	chr22:39781585	C/T	cg24399712	chr22:39784796	NA	-0.61	-5.3	-0.51	1.03e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs17376456	0.877	rs17083460	chr5:93462354	A/G	cg25358565	chr5:93447407	FAM172A	1.23	7.97	0.67	1.08e-11	Diabetic retinopathy;
SKCM	cis	rs9910055	0.762	rs11080007	chr17:42265442	A/G	cg13607699	chr17:42295918	UBTF	-0.79	-6.11	-0.57	3.7e-8	Total body bone mineral density;
SKCM	cis	rs9399137	0.507	rs11759062	chr6:135381248	A/C	cg24558204	chr6:135376177	HBS1L	0.64	5.49	0.53	4.93e-7	Glycated hemoglobin levels;Mean corpuscular volume;Hematology traits;HbA2 levels;Mean corpuscular hemoglobin;Hemoglobin levels;F-cell distribution;Platelet count;
SKCM	cis	rs11685299	1	rs11685299	chr2:225391296	C/A	cg02879423	chr2:224806760	WDFY1	0.67	4.81	0.48	7.16e-6	Schizophrenia;
SKCM	cis	rs62079673	0.527	rs9788998	chr17:80605644	A/G	cg10281770	chr17:80606947	WDR45L	0.62	6.27	0.58	1.88e-8	Breast cancer;
SKCM	cis	rs7937682	0.924	rs489783	chr11:111520522	A/G	cg09085632	chr11:111637200	PPP2R1B	-1.07	-11.3	-0.79	4.28e-18	Primary sclerosing cholangitis;
SKCM	cis	rs7208859	0.623	rs60890550	chr17:29030861	A/G	cg14067834	chr17:29058358	SUZ12P	1.18	5.86	0.55	1.07e-7	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs1865760	1.000	rs3752421	chr6:25918688	G/A	cg08401836	chr6:26032486	HIST1H3B	-0.6	-4.78	-0.48	8.09e-6	Height;
SKCM	cis	rs7447593	0.518	rs4074995	chr5:176797343	C/T	cg16006841	chr5:176797999	RGS14	0.84	9.25	0.72	3.52e-14	Urinary electrolytes (magnesium/calcium ratio);
SKCM	cis	rs778371	0.871	rs2675954	chr2:233750627	C/G	cg08000102	chr2:233561755	GIGYF2	-0.88	-6.43	-0.59	9.32e-9	Schizophrenia;
SKCM	cis	rs7215564	0.908	rs35128297	chr17:78652909	A/C	cg16980736	chr17:78789706	RPTOR	-0.91	-4.92	-0.49	4.67e-6	Myopia (pathological);
SKCM	cis	rs1799949	1.000	rs4793197	chr17:41231902	C/T	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.01	-0.56	5.5e-8	Menopause (age at onset);
SKCM	cis	rs8067354	0.645	rs2173120	chr17:57892640	A/T	cg02344993	chr17:57696989	CLTC	0.67	4.79	0.48	7.85e-6	Hemoglobin concentration;
SKCM	cis	rs367615	0.552	rs7720036	chr5:108710699	A/G	cg17395555	chr5:108820864	NA	-0.68	-5.58	-0.53	3.42e-7	Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs763121	0.853	rs2072794	chr22:39150543	G/T	cg06022373	chr22:39101656	GTPBP1	0.8	4.95	0.49	4.19e-6	Menopause (age at onset);
SKCM	cis	rs1577917	0.740	rs2758845	chr6:86334848	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.88	-8.71	-0.7	3.98e-13	Response to antipsychotic treatment;
SKCM	cis	rs6474412	0.503	rs7825907	chr8:42604281	G/A	cg11207534	chr8:41686438	ANK1	-0.87	-5.07	-0.5	2.65e-6	Smoking behavior;
SKCM	cis	rs933688	1.000	rs10058025	chr5:90689052	A/G	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.1	8.33	0.69	2.14e-12	Smoking behavior;
SKCM	cis	rs943437	0.877	rs633640	chr6:112272805	C/G	cg25325257	chr6:112272685	NA	-0.85	-4.89	-0.48	5.28e-6	Parkinson's disease;
SKCM	cis	rs12451471	0.559	rs34746710	chr17:78079224	G/A	cg06718696	chr17:78121285	EIF4A3	0.9	6.03	0.56	5.13e-8	Plateletcrit;Mean corpuscular hemoglobin concentration;
SKCM	cis	rs7772486	0.597	rs6570732	chr6:146245151	G/A	cg23711669	chr6:146136114	FBXO30	-0.78	-6.3	-0.58	1.65e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7937682	0.632	rs11823089	chr11:111673539	A/G	cg09085632	chr11:111637200	PPP2R1B	1.09	10.48	0.76	1.52e-16	Primary sclerosing cholangitis;
SKCM	cis	rs7811142	1.000	rs66632384	chr7:100018904	G/A	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.33	0.69	2.11e-12	Platelet count;
SKCM	cis	rs10752881	1.000	rs10737235	chr1:182971816	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.71	6.46	0.59	8.07e-9	Colorectal cancer;
SKCM	cis	rs10089	1.000	rs72794396	chr5:127501386	G/A	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.87	7.27	0.64	2.44e-10	Ileal carcinoids;
SKCM	cis	rs10540	1.000	rs61876340	chr11:495699	A/C	cg03576123	chr11:487126	PTDSS2	-1.42	-7.96	-0.67	1.12e-11	Body mass index;
SKCM	cis	rs1580019	0.922	rs1466147	chr7:32486262	C/T	cg06627557	chr7:32535165	LSM5;AVL9	0.74	5.21	0.51	1.49e-6	Cognitive ability;
SKCM	cis	rs7100689	0.784	rs6585986	chr10:82171559	T/C	cg01528321	chr10:82214614	TSPAN14	0.92	9.06	0.72	8.17e-14	Post bronchodilator FEV1;
SKCM	cis	rs28595532	0.920	rs116094766	chr4:119729291	T/C	cg21605333	chr4:119757512	SEC24D	1.36	8.05	0.67	7.69e-12	Cannabis dependence symptom count;
SKCM	cis	rs7618501	0.635	rs34080578	chr3:50026029	A/C	cg05072774	chr3:49840536	C3orf54	-0.67	-5.06	-0.5	2.73e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs17854409	0.881	rs12625401	chr20:61472939	A/T	cg06598544	chr20:61472147	COL9A3	-1.13	-5.47	-0.53	5.33e-7	Obesity-related traits;
SKCM	trans	rs1814175	0.587	rs7948538	chr11:50021353	A/C	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs72772090	0.908	rs11750510	chr5:96042095	T/C	cg17330273	chr5:96107758	CAST;ERAP1	-0.82	-5.0	-0.49	3.47e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs9303401	0.659	rs2072316	chr17:56604813	G/T	cg10487724	chr17:56770010	TEX14;RAD51C	0.83	6.12	0.57	3.56e-8	Cognitive test performance;
SKCM	cis	rs7666738	0.753	rs4699604	chr4:99056353	T/C	cg17366294	chr4:99064904	C4orf37	0.6	4.88	0.48	5.45e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9303401	0.615	rs35288118	chr17:56600748	A/C	cg10487724	chr17:56770010	TEX14;RAD51C	0.83	6.03	0.56	5.2e-8	Cognitive test performance;
SKCM	cis	rs4148883	0.675	rs11724783	chr4:100099688	C/A	cg12011299	chr4:100065546	ADH4	0.48	4.78	0.48	8.14e-6	Alcohol dependence;
SKCM	cis	rs7647973	0.769	rs7434187	chr3:49032967	C/T	cg07636037	chr3:49044803	WDR6	0.92	6.9	0.62	1.24e-9	Menarche (age at onset);
SKCM	cis	rs8180040	0.587	rs1466741	chr3:47247214	C/T	cg27129171	chr3:47204927	SETD2	-0.73	-5.32	-0.52	9.51e-7	Colorectal cancer;
SKCM	cis	rs3892630	0.818	rs80137870	chr19:33182750	C/T	cg22980127	chr19:33182716	NUDT19	1.39	8.08	0.67	6.68e-12	Red blood cell traits;
SKCM	cis	rs6121246	0.559	rs6060857	chr20:30300222	A/G	cg13852791	chr20:30311386	BCL2L1	0.82	5.69	0.54	2.09e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs1801516	0.950	rs11212650	chr11:108327218	A/G	cg03165700	chr11:108093220	ATM;NPAT	-1.18	-5.35	-0.52	8.63e-7	Melanoma;
SKCM	cis	rs17711722	0.727	rs781151	chr7:65479878	T/C	cg00343986	chr7:65444356	GUSB	0.67	4.81	0.48	7.3e-6	Calcium levels;
SKCM	cis	rs711830	1.000	rs2249131	chr2:177032095	C/T	cg13092806	chr2:177043255	NA	0.65	5.81	0.55	1.31e-7	Serous invasive ovarian cancer;Epithelial ovarian cancer;Invasive epithelial ovarian cancer;Mucinous ovarian carcinoma;Low-grade serous and serous borderline ovarian cancer;Serous borderline ovarian cancer;High-grade serous ovarian cancer;
SKCM	cis	rs7027203	0.828	rs3996239	chr9:96611290	T/A	cg14598338	chr9:96623480	NA	-0.5	-5.11	-0.5	2.25e-6	DNA methylation (variation);
SKCM	cis	rs10193935	1.000	rs10173107	chr2:42420302	A/T	cg27598129	chr2:42591480	NA	-0.88	-6.71	-0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs941408	0.963	rs2537855	chr19:2806574	A/G	cg06609049	chr19:2785107	THOP1	0.83	7.17	0.63	3.7e-10	Total cholesterol levels;
SKCM	cis	rs8180040	0.966	rs11716763	chr3:47518266	C/T	cg16586182	chr3:47516702	SCAP	0.76	5.32	0.52	9.63e-7	Colorectal cancer;
SKCM	cis	rs7945705	0.782	rs3763918	chr11:8819683	T/A	cg21881798	chr11:8931708	C11orf17;ST5	0.72	7.41	0.64	1.3e-10	Hemoglobin concentration;
SKCM	cis	rs7666738	0.830	rs921522	chr4:98841608	C/T	cg05340658	chr4:99064831	C4orf37	0.6	4.87	0.48	5.67e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10779751	1.000	rs12032364	chr1:11286872	G/T	cg08854313	chr1:11322531	MTOR	0.92	6.99	0.62	8.23e-10	Body mass index;
SKCM	cis	rs4319547	0.876	rs10846978	chr12:122964708	T/C	cg23029597	chr12:123009494	RSRC2	-0.82	-6.33	-0.58	1.46e-8	Body mass index;
SKCM	cis	rs1707322	1.000	rs785517	chr1:46567535	A/T	cg03146154	chr1:46216737	IPP	-0.8	-5.28	-0.51	1.15e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs2303745	0.589	rs8103523	chr19:17398269	A/G	cg04248312	chr19:17393744	ANKLE1	-1.11	-8.18	-0.68	4.15e-12	Systemic lupus erythematosus;
SKCM	cis	rs11098499	0.954	rs11098525	chr4:120390152	G/A	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs798554	0.757	rs1183085	chr7:2875570	G/A	cg19346786	chr7:2764209	NA	-0.62	-6.93	-0.62	1.09e-9	Height;
SKCM	cis	rs2836974	0.932	rs11910151	chr21:40560262	T/C	cg11644478	chr21:40555479	PSMG1	0.99	9.91	0.75	1.88e-15	Cognitive function;
SKCM	cis	rs2072499	0.750	rs55675376	chr1:156165881	C/T	cg24450063	chr1:156163899	SLC25A44	0.89	6.63	0.6	3.93e-9	Testicular germ cell tumor;
SKCM	cis	rs2836974	0.897	rs35123057	chr21:40711689	C/T	cg17971929	chr21:40555470	PSMG1	0.83	7.71	0.66	3.43e-11	Cognitive function;
SKCM	cis	rs769267	0.825	rs1469713	chr19:19528806	A/G	cg03709012	chr19:19516395	GATAD2A	0.91	8.6	0.7	6.53e-13	Tonsillectomy;
SKCM	cis	rs12928939	0.517	rs12445641	chr16:71967783	C/T	cg03805757	chr16:71968109	PKD1L3	-0.72	-5.17	-0.51	1.78e-6	Post bronchodilator FEV1;
SKCM	cis	rs1348850	0.645	rs10164417	chr2:178444130	A/G	cg02961200	chr2:178257176	LOC100130691;AGPS	0.85	5.46	0.53	5.36e-7	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs17376456	1.000	rs10514382	chr5:93566534	G/A	cg21475434	chr5:93447410	FAM172A	1.18	6.26	0.58	1.91e-8	Diabetic retinopathy;
SKCM	cis	rs4819052	0.851	rs1056100	chr21:46678711	A/C	cg02159808	chr21:46707872	POFUT2;LOC642852	0.75	5.86	0.55	1.05e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	trans	rs561341	0.740	rs11080174	chr17:30208521	C/A	cg20587970	chr11:113659929	NA	1.03	7.94	0.67	1.24e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs4665809	0.590	rs7260	chr2:26413917	C/T	cg26119090	chr2:26468346	HADHA;HADHB	-0.99	-7.43	-0.64	1.19e-10	Gut microbiome composition (summer);
SKCM	cis	rs11122272	0.766	rs2790870	chr1:231543823	A/G	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	-0.66	-5.34	-0.52	9.04e-7	Hemoglobin concentration;
SKCM	cis	rs5753618	0.583	rs9606839	chr22:31802710	A/C	cg02404636	chr22:31891804	SFI1	0.58	4.97	0.49	3.86e-6	Colorectal cancer;
SKCM	cis	rs1395	0.778	rs6749393	chr2:27451000	C/T	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.51	5.14	0.5	1.96e-6	Blood metabolite levels;
SKCM	cis	rs763014	0.966	rs7198877	chr16:661439	A/G	cg00908189	chr16:619842	PIGQ	0.84	7.87	0.67	1.67e-11	Height;
SKCM	cis	rs3087591	0.960	rs2905872	chr17:29525027	C/A	cg24425628	chr17:29625626	OMG;NF1	0.61	4.87	0.48	5.75e-6	Hip circumference;
SKCM	cis	rs12478296	1.000	rs6732595	chr2:243035338	T/C	cg06360820	chr2:242988706	NA	-0.91	-5.31	-0.52	1.01e-6	Obesity-related traits;
SKCM	cis	rs7811142	0.830	rs11761253	chr7:99939321	C/T	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.08	6.85	0.61	1.49e-9	Platelet count;
SKCM	cis	rs11098499	0.697	rs4560394	chr4:120313435	T/G	cg24375607	chr4:120327624	NA	0.64	4.89	0.48	5.28e-6	Corneal astigmatism;
SKCM	cis	rs763014	0.898	rs4984894	chr16:623103	T/C	cg09263875	chr16:632152	PIGQ	0.68	5.71	0.54	1.98e-7	Height;
SKCM	cis	rs3845702	0.736	rs56401468	chr2:180857757	C/T	cg01881094	chr2:180872142	CWC22	1.26	6.25	0.58	2.01e-8	Schizophrenia;
SKCM	cis	rs3741404	0.791	rs7112960	chr11:63907079	A/G	cg19465662	chr11:63993652	NUDT22;TRPT1	0.79	5.27	0.51	1.19e-6	Platelet count;
SKCM	cis	rs28595532	0.920	rs56291421	chr4:119732294	G/A	cg21605333	chr4:119757512	SEC24D	1.36	8.05	0.67	7.69e-12	Cannabis dependence symptom count;
SKCM	cis	rs2013441	0.901	rs2526474	chr17:20137134	C/T	cg13482628	chr17:19912719	NA	-0.64	-5.04	-0.5	2.94e-6	Obesity-related traits;
SKCM	cis	rs1005277	0.579	rs1780122	chr10:38529509	C/A	cg00409905	chr10:38381863	ZNF37A	-0.62	-5.23	-0.51	1.39e-6	Extrinsic epigenetic age acceleration;
SKCM	cis	rs875971	0.638	rs6460305	chr7:66060408	G/A	cg18876405	chr7:65276391	NA	-0.82	-7.48	-0.65	9.41e-11	Aortic root size;
SKCM	cis	rs17376456	0.877	rs10078194	chr5:93364310	A/C	cg25358565	chr5:93447407	FAM172A	1.19	7.78	0.66	2.52e-11	Diabetic retinopathy;
SKCM	cis	rs597539	0.690	rs7129960	chr11:68622456	A/G	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.81	5.33	0.52	9.43e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs801193	1.000	rs2707854	chr7:66212597	G/A	cg11987759	chr7:65425863	GUSB	-0.69	-5.91	-0.56	8.69e-8	Aortic root size;
SKCM	cis	rs7216064	1.000	rs60432293	chr17:65860407	T/C	cg12091567	chr17:66097778	LOC651250	-0.75	-5.27	-0.51	1.19e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs28595532	0.841	rs10019311	chr4:119785458	G/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs732765	0.734	rs4899530	chr14:75165825	A/G	cg25946216	chr14:74253857	C14orf43	-0.86	-5.52	-0.53	4.35e-7	Non-small cell lung cancer;
SKCM	cis	rs6840360	0.571	rs6833814	chr4:152539679	A/G	cg22705602	chr4:152727874	NA	-0.52	-5.7	-0.54	2.03e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs72781680	1.000	rs17763442	chr2:24255991	C/T	cg08917208	chr2:24149416	ATAD2B	1.1	5.75	0.55	1.64e-7	Lymphocyte counts;
SKCM	cis	rs10752881	1.000	rs10752881	chr1:182973491	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.81	0.61	1.81e-9	Colorectal cancer;
SKCM	cis	rs933688	1.000	rs4382199	chr5:90744228	A/G	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.94	6.78	0.61	2.1e-9	Smoking behavior;
SKCM	cis	rs9796	0.621	rs7170049	chr15:41484287	C/A	cg18705301	chr15:41695430	NDUFAF1	-0.68	-4.84	-0.48	6.48e-6	Menopause (age at onset);
SKCM	cis	rs2153535	0.580	rs6597335	chr6:8527714	T/C	cg23788917	chr6:8435910	SLC35B3	0.68	4.98	0.49	3.66e-6	Motion sickness;
SKCM	cis	rs28386778	0.897	rs2854208	chr17:61946885	C/T	cg06873352	chr17:61820015	STRADA	0.75	6.25	0.58	2.06e-8	Prudent dietary pattern;
SKCM	cis	rs9381040	0.655	rs4140578	chr6:41041829	A/G	cg04346459	chr6:41068666	NFYA;LOC221442	-0.71	-5.0	-0.49	3.5e-6	Alzheimer's disease (late onset);
SKCM	cis	rs1405130	0.967	rs12989429	chr2:235571553	C/T	cg21542780	chr2:234763377	HJURP	-0.65	-4.92	-0.49	4.75e-6	Coronary artery disease;
SKCM	cis	rs9640161	0.658	rs60467296	chr7:150015471	G/A	cg10018233	chr7:150070692	REPIN1	0.7	5.72	0.54	1.88e-7	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs2836950	0.520	rs8133927	chr21:40689961	G/T	cg17971929	chr21:40555470	PSMG1	-0.64	-5.1	-0.5	2.31e-6	Menarche (age at onset);
SKCM	cis	rs9467773	0.595	rs2451736	chr6:26620544	G/A	cg09904177	chr6:26538194	HMGN4	0.58	5.01	0.49	3.28e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2839186	0.867	rs13050387	chr21:47701423	C/T	cg13012494	chr21:47604986	C21orf56	0.65	5.44	0.52	6e-7	Testicular germ cell tumor;
SKCM	cis	rs7772486	0.875	rs2748485	chr6:146332421	T/C	cg05347473	chr6:146136440	FBXO30	0.57	5.18	0.51	1.66e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1790761	0.520	rs12800028	chr11:67403285	A/G	cg23188684	chr11:67383651	NA	-0.66	-5.09	-0.5	2.43e-6	Mean corpuscular volume;
SKCM	cis	rs8072100	0.840	rs11079774	chr17:45479706	C/G	cg08085267	chr17:45401833	C17orf57	-0.61	-5.1	-0.5	2.3e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs1403694	0.695	rs1851665	chr3:186436398	A/G	cg09332604	chr3:186435400	KNG1	-0.49	-4.88	-0.48	5.53e-6	Blood protein levels;
SKCM	cis	rs9815354	0.767	rs61283393	chr3:41854135	T/G	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs77106637	0.860	rs75896506	chr11:72429579	G/A	cg03713592	chr11:72463424	ARAP1	1.14	6.16	0.57	3.01e-8	Type 2 diabetes;
SKCM	cis	rs929354	0.739	rs12533082	chr7:157014172	T/A	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	trans	rs561341	1.000	rs55643307	chr17:30263074	T/C	cg20587970	chr11:113659929	NA	-1.18	-9.98	-0.75	1.38e-15	Hip circumference adjusted for BMI;
SKCM	cis	rs801193	0.904	rs4718403	chr7:66242729	C/G	cg18876405	chr7:65276391	NA	0.82	7.48	0.65	9.4e-11	Aortic root size;
SKCM	cis	rs7552404	0.765	rs1251078	chr1:76189488	C/G	cg22875332	chr1:76189707	ACADM	-0.75	-5.27	-0.51	1.16e-6	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs644799	1.000	rs500054	chr11:95593806	G/A	cg03916912	chr11:95522834	CEP57;FAM76B	0.89	7.3	0.64	2.1e-10	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs13118159	0.550	rs28614045	chr4:1374695	C/A	cg16405210	chr4:1374714	KIAA1530	-0.95	-7.27	-0.64	2.43e-10	Longevity;
SKCM	cis	rs7789940	1.000	rs758944	chr7:75953297	G/T	cg10167463	chr7:75959203	YWHAG	-0.64	-4.92	-0.49	4.71e-6	Multiple sclerosis;
SKCM	cis	rs732765	0.657	rs8016513	chr14:75238261	C/T	cg25946216	chr14:74253857	C14orf43	1.02	5.8	0.55	1.33e-7	Non-small cell lung cancer;
SKCM	cis	rs7666738	0.753	rs13122897	chr4:98936185	C/A	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9604529	0.532	rs41291213	chr13:114774991	C/T	cg04826882	chr13:114838756	RASA3	-0.98	-4.8	-0.48	7.38e-6	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs875971	0.964	rs2277911	chr7:65958625	T/G	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs796364	0.951	rs10931888	chr2:201022952	T/G	cg12253985	chr2:200820533	C2orf60;C2orf47	-0.99	-6.24	-0.58	2.11e-8	Schizophrenia;
SKCM	trans	rs1814175	0.817	rs7924619	chr11:49620632	G/A	cg15704280	chr7:45808275	SEPT13	-1.03	-10.38	-0.76	2.38e-16	Height;
SKCM	cis	rs56196003	1	rs56196003	chr7:102783527	C/A	cg18108683	chr7:102477205	FBXL13	-0.74	-5.39	-0.52	7.13e-7	Breast cancer;
SKCM	cis	rs8016982	0.593	rs7160569	chr14:81713686	C/T	cg01989461	chr14:81687754	GTF2A1	0.84	7.04	0.62	6.52e-10	Schizophrenia;
SKCM	cis	rs4665809	0.590	rs2033317	chr2:26477650	G/A	cg26119090	chr2:26468346	HADHA;HADHB	1.03	7.99	0.67	9.69e-12	Gut microbiome composition (summer);
SKCM	cis	rs7208859	0.623	rs9916725	chr17:29107471	A/C	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs9790314	0.690	rs6799130	chr3:160847801	C/G	cg03342759	chr3:160939853	NMD3	-0.69	-6.89	-0.62	1.26e-9	Morning vs. evening chronotype;
SKCM	cis	rs9300255	0.602	rs1716167	chr12:123651162	C/T	cg05973401	chr12:123451056	ABCB9	-0.79	-5.37	-0.52	8.03e-7	Neutrophil percentage of white cells;
SKCM	cis	rs738322	0.805	rs2235344	chr22:38518083	G/A	cg25457927	chr22:38595422	NA	-0.52	-5.75	-0.55	1.63e-7	Cutaneous nevi;
SKCM	cis	rs13118159	0.872	rs1882105	chr4:1345956	T/C	cg02018176	chr4:1364513	KIAA1530	0.7	5.75	0.55	1.64e-7	Longevity;
SKCM	cis	rs763121	0.853	rs5757141	chr22:38957483	G/A	cg06022373	chr22:39101656	GTPBP1	0.78	5.85	0.55	1.08e-7	Menopause (age at onset);
SKCM	cis	rs28386778	0.897	rs9913323	chr17:61851485	C/A	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs9815354	0.680	rs57525756	chr3:41843591	A/C	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs7772486	0.790	rs4435956	chr6:146232403	G/C	cg23711669	chr6:146136114	FBXO30	-0.78	-7.74	-0.66	3.05e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2282032	0.527	rs8020828	chr14:90768183	C/T	cg04374321	chr14:90722782	PSMC1	0.67	5.37	0.52	7.94e-7	Longevity;
SKCM	cis	rs17376456	0.825	rs10072232	chr5:93398890	G/A	cg21475434	chr5:93447410	FAM172A	0.95	5.35	0.52	8.56e-7	Diabetic retinopathy;
SKCM	cis	rs11122272	0.766	rs2808608	chr1:231543175	A/G	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	-0.66	-5.34	-0.52	9.04e-7	Hemoglobin concentration;
SKCM	cis	rs7811142	1.000	rs7787620	chr7:100089234	A/G	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.25	0.68	3.05e-12	Platelet count;
SKCM	cis	rs55962025	0.723	rs2269478	chr4:3234828	G/T	cg05297308	chr4:3317976	RGS12	-0.62	-4.88	-0.48	5.52e-6	Parental longevity (mother's age at death);
SKCM	cis	rs8072100	0.575	rs1221385	chr17:45527574	T/G	cg08085267	chr17:45401833	C17orf57	-0.62	-4.98	-0.49	3.67e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs2839186	0.504	rs4347941	chr21:47938239	T/C	cg12379764	chr21:47803548	PCNT	0.64	4.96	0.49	3.97e-6	Testicular germ cell tumor;
SKCM	cis	rs2439831	0.867	rs7170489	chr15:43636651	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.39	9.42	0.73	1.62e-14	Lung cancer in ever smokers;
SKCM	cis	rs2455601	1.000	rs2455601	chr11:8899400	C/T	cg21881798	chr11:8931708	C11orf17;ST5	-0.81	-5.07	-0.5	2.64e-6	Schizophrenia;
SKCM	cis	rs6582630	0.537	rs1949611	chr12:38373092	C/T	cg26384229	chr12:38710491	ALG10B	-0.79	-6.56	-0.6	5.34e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs6545883	0.501	rs935860	chr2:61406561	G/C	cg15711740	chr2:61764176	XPO1	-0.67	-4.97	-0.49	3.83e-6	Tuberculosis;
SKCM	cis	rs28595532	1.000	rs28595532	chr4:119716950	A/C	cg21605333	chr4:119757512	SEC24D	1.35	7.92	0.67	1.37e-11	Cannabis dependence symptom count;
SKCM	cis	rs6474412	0.581	rs10109864	chr8:42613516	G/T	cg11207534	chr8:41686438	ANK1	-0.83	-4.85	-0.48	6.29e-6	Smoking behavior;
SKCM	cis	rs763014	0.833	rs916415	chr16:632115	G/A	cg09263875	chr16:632152	PIGQ	0.67	5.82	0.55	1.24e-7	Height;
SKCM	cis	rs7666738	0.830	rs7661264	chr4:98961574	G/A	cg05340658	chr4:99064831	C4orf37	0.64	4.91	0.49	4.97e-6	Colonoscopy-negative controls vs population controls;
SKCM	trans	rs1814175	0.559	rs1818892	chr11:49863084	C/A	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs4819052	0.590	rs414743	chr21:46512075	G/A	cg19498844	chr21:46707878	POFUT2;LOC642852	0.72	4.82	0.48	6.88e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs763014	0.865	rs62030874	chr16:632233	T/C	cg00908189	chr16:619842	PIGQ	0.81	7.62	0.65	5.04e-11	Height;
SKCM	cis	rs6066825	0.532	rs6012506	chr20:47285637	A/G	cg18078177	chr20:47281410	PREX1	0.68	5.76	0.55	1.57e-7	Colorectal cancer;
SKCM	cis	rs1707322	1.000	rs785468	chr1:46521517	G/A	cg03146154	chr1:46216737	IPP	-0.77	-5.36	-0.52	8.35e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs17376456	0.877	rs9314093	chr5:93333347	G/A	cg21475434	chr5:93447410	FAM172A	0.95	5.35	0.52	8.56e-7	Diabetic retinopathy;
SKCM	cis	rs7100689	0.646	rs1290317	chr10:82062531	C/A	cg00277334	chr10:82204260	NA	-0.57	-5.35	-0.52	8.66e-7	Post bronchodilator FEV1;
SKCM	cis	rs2072499	0.966	rs1137703	chr1:156184458	T/C	cg25208724	chr1:156163844	SLC25A44	1.08	9.87	0.75	2.22e-15	Testicular germ cell tumor;
SKCM	cis	rs2836974	0.605	rs2836971	chr21:40652040	A/C	cg11890956	chr21:40555474	PSMG1	-0.88	-9.14	-0.72	5.76e-14	Cognitive function;
SKCM	cis	rs2836974	0.897	rs2776308	chr21:40715175	A/G	cg11890956	chr21:40555474	PSMG1	0.94	9.67	0.74	5.57e-15	Cognitive function;
SKCM	cis	rs3771570	0.901	rs73008106	chr2:242422446	C/T	cg07612300	chr2:242033426	MTERFD2;SNED1	0.88	4.9	0.48	5.13e-6	Prostate cancer;
SKCM	cis	rs7772486	0.790	rs9497431	chr6:146248177	T/C	cg23711669	chr6:146136114	FBXO30	-0.75	-7.24	-0.63	2.71e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs826838	0.967	rs4768330	chr12:39129399	T/C	cg13010199	chr12:38710504	ALG10B	-0.72	-5.73	-0.54	1.83e-7	Heart rate;
SKCM	cis	rs6570726	0.791	rs441290	chr6:145883183	A/G	cg05347473	chr6:146136440	FBXO30	0.52	4.81	0.48	7.12e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs11098499	0.954	rs4577559	chr4:120404043	T/G	cg24375607	chr4:120327624	NA	0.66	5.09	0.5	2.44e-6	Corneal astigmatism;
SKCM	cis	rs1801251	1.000	rs283477	chr2:233649427	A/G	cg08000102	chr2:233561755	GIGYF2	0.95	7.09	0.63	5.26e-10	Coronary artery disease;
SKCM	cis	rs7811142	0.943	rs11769886	chr7:99998607	G/A	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.33	0.69	2.11e-12	Platelet count;
SKCM	cis	rs1580019	0.539	rs11769109	chr7:32571352	A/G	cg06627557	chr7:32535165	LSM5;AVL9	0.94	9.12	0.72	6.39e-14	Cognitive ability;
SKCM	cis	rs55962025	0.846	rs363066	chr4:3135953	G/T	cg16987761	chr4:3318072	RGS12	0.76	5.77	0.55	1.52e-7	Parental longevity (mother's age at death);
SKCM	cis	rs950776	0.518	rs56007453	chr15:78826239	T/C	cg06917634	chr15:78832804	PSMA4	1.01	10.49	0.77	1.45e-16	Sudden cardiac arrest;
SKCM	cis	rs514406	0.584	rs11205997	chr1:53195271	G/C	cg16325326	chr1:53192061	ZYG11B	-1.0	-12.3	-0.81	6.1e-20	Monocyte count;
SKCM	cis	rs1801251	1.000	rs2592105	chr2:233645968	C/G	cg25237894	chr2:233734115	C2orf82	0.6	5.8	0.55	1.36e-7	Coronary artery disease;
SKCM	cis	rs35146811	0.883	rs4134903	chr7:99711040	G/A	cg22906224	chr7:99728672	NA	0.8	5.94	0.56	7.41e-8	Coronary artery disease;
SKCM	cis	rs801193	0.935	rs2286683	chr7:66129843	G/A	cg18876405	chr7:65276391	NA	-0.82	-7.53	-0.65	7.59e-11	Aortic root size;
SKCM	cis	rs1218582	0.741	rs10908447	chr1:154869742	C/T	cg06221963	chr1:154839813	KCNN3	-0.61	-6.58	-0.6	4.97e-9	Prostate cancer;
SKCM	cis	rs3820068	0.581	rs6692461	chr1:15928449	A/G	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs7618501	0.633	rs6772095	chr3:49978069	C/T	cg05072774	chr3:49840536	C3orf54	-0.66	-5.03	-0.49	3.12e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7216064	0.954	rs12602556	chr17:65826861	A/G	cg12091567	chr17:66097778	LOC651250	-0.75	-5.28	-0.51	1.11e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs6474412	0.581	rs4737069	chr8:42626560	A/G	cg11207534	chr8:41686438	ANK1	-0.81	-4.96	-0.49	4.01e-6	Smoking behavior;
SKCM	cis	rs6951245	1.000	rs80094748	chr7:1103958	G/A	cg03188948	chr7:1209495	NA	1.14	6.34	0.58	1.39e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs1218582	0.772	rs11264290	chr1:154912300	C/T	cg06221963	chr1:154839813	KCNN3	-0.54	-5.29	-0.51	1.09e-6	Prostate cancer;
SKCM	cis	rs1707322	0.752	rs7529699	chr1:46134634	C/T	cg03146154	chr1:46216737	IPP	0.8	5.57	0.53	3.52e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs801193	1.000	rs10234018	chr7:66146284	A/T	cg18876405	chr7:65276391	NA	-0.79	-6.79	-0.61	1.98e-9	Aortic root size;
SKCM	cis	rs2439831	0.571	rs689883	chr15:43812596	G/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.18	7.32	0.64	1.95e-10	Lung cancer in ever smokers;
SKCM	cis	rs1801251	0.963	rs13021246	chr2:233623111	T/C	cg08000102	chr2:233561755	GIGYF2	0.88	7.07	0.63	5.69e-10	Coronary artery disease;
SKCM	cis	rs1799949	0.930	rs56729776	chr17:41422131	C/T	cg23758822	chr17:41437982	NA	0.93	7.88	0.67	1.62e-11	Menopause (age at onset);
SKCM	cis	rs2013441	0.813	rs4925088	chr17:20049344	A/G	cg13482628	chr17:19912719	NA	0.64	5.0	0.49	3.44e-6	Obesity-related traits;
SKCM	cis	rs754466	0.651	rs10824584	chr10:79625947	G/A	cg17075019	chr10:79541650	NA	-0.73	-6.45	-0.59	8.46e-9	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs17608059	0.518	rs4792436	chr17:13972307	T/A	cg27005118	chr17:13972210	COX10	0.54	6.59	0.6	4.6e-9	Temperament;
SKCM	cis	rs2153535	0.580	rs4960412	chr6:8438261	G/C	cg07606381	chr6:8435919	SLC35B3	0.93	6.77	0.61	2.18e-9	Motion sickness;
SKCM	cis	rs910316	1.000	rs12879542	chr14:75507525	C/T	cg08847533	chr14:75593920	NEK9	0.95	9.18	0.72	4.92e-14	Height;
SKCM	cis	rs875971	0.660	rs3764903	chr7:66098482	G/A	cg11987759	chr7:65425863	GUSB	0.67	5.8	0.55	1.36e-7	Aortic root size;
SKCM	cis	rs1707322	0.648	rs4439382	chr1:46150805	C/T	cg03146154	chr1:46216737	IPP	0.81	5.61	0.54	2.94e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs854765	0.547	rs9894138	chr17:17964345	G/A	cg04398451	chr17:18023971	MYO15A	0.84	6.78	0.61	2.05e-9	Total body bone mineral density;
SKCM	cis	rs9486715	1.000	rs6899647	chr6:97065661	A/G	cg06623918	chr6:96969491	KIAA0776	-0.74	-6.6	-0.6	4.58e-9	Headache;
SKCM	cis	rs2153535	0.580	rs9505448	chr6:8459804	A/G	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs1348850	0.519	rs4144275	chr2:178523368	C/T	cg22681709	chr2:178499509	PDE11A	-0.61	-5.27	-0.51	1.17e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs6570726	0.905	rs419575	chr6:145840174	A/G	cg23711669	chr6:146136114	FBXO30	0.7	6.64	0.6	3.72e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9674544	0.757	rs11871214	chr17:47124902	G/T	cg10950924	chr17:47092072	IGF2BP1	-0.58	-5.17	-0.5	1.8e-6	Primary tooth development (time to first tooth eruption);Primary tooth development (number of teeth);
SKCM	cis	rs34779708	0.931	rs4934700	chr10:35310842	A/G	cg03585969	chr10:35415529	CREM	0.75	6.23	0.58	2.2e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs8103278	0.507	rs4802275	chr19:46260375	C/T	cg14061069	chr19:46274453	DMPK	0.52	5.4	0.52	7.04e-7	Coronary artery disease;
SKCM	cis	rs10791097	0.694	rs11222369	chr11:130744670	A/G	cg12179176	chr11:130786555	SNX19	0.93	8.16	0.68	4.64e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs2502731	0.504	rs10115537	chr9:130957091	G/A	cg09976142	chr9:130955436	CIZ1	-0.78	-8.14	-0.68	4.95e-12	Attention deficit hyperactivity disorder;
SKCM	cis	rs2070488	0.766	rs6808093	chr3:38498160	T/C	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.74	5.96	0.56	6.8e-8	Electrocardiographic conduction measures;
SKCM	cis	rs13118159	0.801	rs7664474	chr4:1329116	T/A	cg20887711	chr4:1340912	KIAA1530	0.71	5.35	0.52	8.44e-7	Longevity;
SKCM	cis	rs34375054	0.525	rs7136220	chr12:125602684	T/C	cg25124228	chr12:125621409	AACS	-0.81	-6.57	-0.6	5.21e-9	Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs79839061	0.656	rs3775126	chr4:886345	C/T	cg07828340	chr4:882639	GAK	1.06	5.86	0.55	1.06e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs248381	1.000	rs705418	chr5:78331434	T/C	cg17568934	chr5:77892219	LHFPL2	-0.53	-5.14	-0.5	1.99e-6	Toenail selenium levels;
SKCM	cis	rs9303401	0.614	rs3087762	chr17:56568680	C/T	cg02118635	chr17:56770003	RAD51C;TEX14	0.8	5.33	0.52	9.25e-7	Cognitive test performance;
SKCM	cis	rs2228479	0.681	rs62052184	chr16:89967217	T/C	cg06558623	chr16:89946397	TCF25	1.25	7.05	0.62	6.25e-10	Skin colour saturation;
SKCM	cis	rs11098499	0.739	rs9884728	chr4:120127079	C/T	cg09307838	chr4:120376055	NA	-0.78	-5.85	-0.55	1.1e-7	Corneal astigmatism;
SKCM	cis	rs6754311	0.773	rs4988183	chr2:136622046	T/C	cg07169764	chr2:136633963	MCM6	0.84	6.08	0.57	4.11e-8	Mosquito bite size;
SKCM	cis	rs12611334	0.964	rs3826923	chr19:40188968	C/A	cg04998674	chr19:40596855	ZNF780A	0.63	4.77	0.47	8.55e-6	Schizophrenia;
SKCM	cis	rs7221595	0.696	rs2727065	chr17:3941244	G/A	cg23770271	chr17:3704471	ITGAE	-0.47	-4.77	-0.48	8.39e-6	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia;
SKCM	cis	rs6545883	0.507	rs12478192	chr2:61591175	A/G	cg15711740	chr2:61764176	XPO1	0.66	5.12	0.5	2.17e-6	Tuberculosis;
SKCM	cis	rs4481887	0.927	rs4578248	chr1:248434069	G/A	cg00666640	chr1:248458726	OR2T12	0.66	5.61	0.54	2.95e-7	Common traits (Other);
SKCM	cis	rs652889	0.512	rs2700179	chr3:61819856	A/G	cg02121773	chr3:61669786	PTPRG	-0.59	-4.78	-0.48	8.09e-6	QT interval;
SKCM	cis	rs28595532	0.516	rs28552458	chr4:119288363	T/C	cg11846333	chr4:119757529	SEC24D	1.09	6.21	0.58	2.41e-8	Cannabis dependence symptom count;
SKCM	cis	rs2836950	0.501	rs62223052	chr21:40708702	A/C	cg11890956	chr21:40555474	PSMG1	-0.66	-4.88	-0.48	5.42e-6	Menarche (age at onset);
SKCM	cis	rs637571	0.584	rs594689	chr11:65635559	G/A	cg00576331	chr11:65640516	EFEMP2	0.59	4.91	0.49	4.97e-6	Eosinophil percentage of white cells;
SKCM	cis	rs11892454	0.504	rs55737015	chr2:26010303	G/A	cg17263061	chr2:26915892	KCNK3	0.71	5.13	0.5	2.1e-6	Heschl's gyrus morphology;
SKCM	cis	rs4819052	1.000	rs2297285	chr21:46705621	A/G	cg02159808	chr21:46707872	POFUT2;LOC642852	-0.86	-6.58	-0.6	4.93e-9	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs6938	0.534	rs11854704	chr15:75221015	C/T	cg09165964	chr15:75287851	SCAMP5	0.65	5.11	0.5	2.28e-6	Breast cancer;
SKCM	cis	rs13118159	0.550	rs4974611	chr4:1358449	T/C	cg16405210	chr4:1374714	KIAA1530	-0.94	-7.07	-0.62	5.87e-10	Longevity;
SKCM	cis	rs62238980	0.614	rs116862462	chr22:32470463	C/T	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs6546550	0.868	rs12713682	chr2:70154134	G/A	cg02498382	chr2:70120550	SNRNP27	-0.45	-4.88	-0.48	5.4e-6	Prevalent atrial fibrillation;
SKCM	cis	rs9399135	0.967	rs17638970	chr6:135320063	A/G	cg24558204	chr6:135376177	HBS1L	0.59	5.23	0.51	1.41e-6	Red blood cell count;
SKCM	cis	rs951366	0.764	rs708724	chr1:205743663	A/C	cg14893161	chr1:205819251	PM20D1	1.06	10.63	0.77	8.03e-17	Menarche (age at onset);
SKCM	cis	rs2836974	0.653	rs8130556	chr21:40516872	C/T	cg11890956	chr21:40555474	PSMG1	1.1	13.26	0.83	1.1e-21	Cognitive function;
SKCM	cis	rs2204008	0.782	rs11514339	chr12:38236670	G/A	cg26384229	chr12:38710491	ALG10B	0.87	6.9	0.62	1.21e-9	Bladder cancer;
SKCM	cis	rs9814567	1.000	rs4309773	chr3:134277301	G/A	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs651907	0.535	rs36060163	chr3:101360963	C/T	cg12386194	chr3:101231763	SENP7	0.72	5.97	0.56	6.65e-8	Colorectal cancer;
SKCM	cis	rs7666738	0.830	rs11947578	chr4:98930462	T/G	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs870825	0.616	rs7692367	chr4:185651056	T/C	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs12047808	0.841	rs78488371	chr1:179379197	T/A	cg08037922	chr1:179521085	C1orf125;NPHS2	-1.08	-5.8	-0.55	1.32e-7	Multiple sclerosis (age of onset);
SKCM	cis	rs514406	0.800	rs4926930	chr1:53217335	A/G	cg16325326	chr1:53192061	ZYG11B	-1.01	-11.9	-0.8	3.23e-19	Monocyte count;
SKCM	cis	rs6912958	0.712	rs6454638	chr6:88329427	C/T	cg08069147	chr6:88032118	GJB7;C6orf162	0.6	4.83	0.48	6.67e-6	Monocyte percentage of white cells;
SKCM	cis	rs1348850	0.632	rs13008833	chr2:178514439	G/C	cg22681709	chr2:178499509	PDE11A	-0.68	-5.83	-0.55	1.17e-7	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs2033711	0.936	rs7257999	chr19:58964860	C/G	cg26874164	chr19:58962979	ZNF324B	0.64	5.16	0.5	1.87e-6	Uric acid clearance;
SKCM	cis	rs9467773	1.000	rs6940053	chr6:26562122	C/T	cg15659132	chr6:26577336	NA	0.6	5.71	0.54	1.99e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs12477438	0.520	rs2171359	chr2:99795360	T/C	cg26064155	chr2:99771622	LIPT1;TSGA10	0.97	8.85	0.71	2.11e-13	Chronic sinus infection;
SKCM	cis	rs1639906	0.895	rs3800926	chr7:2205956	G/A	cg02951883	chr7:2050386	MAD1L1	0.65	5.24	0.51	1.31e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9926296	0.568	rs886950	chr16:89836872	T/C	cg26513180	chr16:89883248	FANCA	0.94	10.14	0.75	6.69e-16	Vitiligo;
SKCM	cis	rs11249608	0.789	rs7700958	chr5:178436617	G/A	cg21905437	chr5:178450457	ZNF879	0.71	5.57	0.53	3.44e-7	Pubertal anthropometrics;
SKCM	cis	rs12044355	0.827	rs11586191	chr1:231831781	G/C	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	0.84	6.27	0.58	1.87e-8	Alzheimer's disease;
SKCM	cis	rs394563	0.602	rs409111	chr6:149766860	A/G	cg03678062	chr6:149772716	ZC3H12D	-0.49	-5.46	-0.53	5.38e-7	Dupuytren's disease;
SKCM	cis	rs4774899	0.966	rs7161965	chr15:57485620	G/A	cg01857019	chr15:57210107	LOC145783;TCF12	0.53	4.94	0.49	4.38e-6	Urinary tract infection frequency;
SKCM	cis	rs1707322	0.963	rs10789484	chr1:46406978	G/C	cg03146154	chr1:46216737	IPP	0.77	5.36	0.52	8.35e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7954584	0.523	rs11043280	chr12:122426643	T/C	cg13699009	chr12:122356056	WDR66	0.58	7.22	0.63	3.04e-10	Mean corpuscular volume;
SKCM	cis	rs7666738	0.791	rs2865953	chr4:99040319	C/T	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs5750830	0.546	rs4821891	chr22:39785381	C/T	cg24399712	chr22:39784796	NA	-0.57	-4.86	-0.48	5.88e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs12986445	0.846	rs2176182	chr2:26109402	A/T	cg04917511	chr2:26785460	C2orf70	0.52	4.85	0.48	6.17e-6	Multiple myeloma and monoclonal gammopathy;Multiple myeloma;
SKCM	cis	rs4150161	0.656	rs3785032	chr16:84216257	A/G	cg10106505	chr16:84220380	TAF1C	-1.29	-5.36	-0.52	8.36e-7	Systolic blood pressure response to hydrochlorothiazide in hypertension;
SKCM	cis	rs208520	0.690	rs12201156	chr6:66720874	G/T	cg07460842	chr6:66804631	NA	0.91	7.35	0.64	1.66e-10	Exhaled nitric oxide output;
SKCM	cis	rs7646501	0.765	rs3856622	chr3:24054013	G/A	cg22892432	chr3:24537792	THRB	0.57	4.83	0.48	6.64e-6	Cognitive ability;Intelligence;
SKCM	cis	rs951366	0.617	rs9438393	chr1:205782718	A/G	cg07167872	chr1:205819463	PM20D1	1.01	10.8	0.77	3.79e-17	Menarche (age at onset);
SKCM	cis	rs6570726	0.791	rs12205752	chr6:145896118	A/G	cg05347473	chr6:146136440	FBXO30	0.57	5.08	0.5	2.47e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1218582	0.772	rs1109815	chr1:154909268	A/G	cg09359103	chr1:154839909	KCNN3	-0.57	-5.3	-0.51	1.05e-6	Prostate cancer;
SKCM	cis	rs4968361	1.000	rs4968361	chr17:57502828	A/G	cg02573089	chr17:57233042	PRR11;SKA2	1.12	5.19	0.51	1.62e-6	Schizophrenia;
SKCM	cis	rs4888262	0.526	rs6564145	chr16:74621129	G/A	cg01733217	chr16:74700730	RFWD3	0.87	6.93	0.62	1.08e-9	Testicular germ cell tumor;
SKCM	cis	rs8060686	0.641	rs76984161	chr16:68139423	C/A	cg09117114	chr16:67998030	SLC12A4	-0.81	-5.29	-0.51	1.07e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs7937682	0.883	rs659529	chr11:111436896	T/A	cg19812747	chr11:111475976	SIK2	-0.58	-4.86	-0.48	5.88e-6	Primary sclerosing cholangitis;
SKCM	cis	rs1865760	0.663	rs9348704	chr6:26000393	A/C	cg17691542	chr6:26056736	HIST1H1C	0.67	4.9	0.48	5.15e-6	Height;
SKCM	cis	rs55962025	0.883	rs362273	chr4:3227419	A/G	cg21096898	chr4:3318625	RGS12	-0.65	-4.98	-0.49	3.75e-6	Parental longevity (mother's age at death);
SKCM	cis	rs860295	0.676	rs10908466	chr1:155429725	A/C	cg02153340	chr1:155202674	NA	-0.8	-5.77	-0.55	1.52e-7	Body mass index;
SKCM	cis	rs6450176	1.000	rs59061738	chr5:53296557	A/G	ch.5.1024479R	chr5:53302184	ARL15	-0.7	-5.0	-0.49	3.47e-6	HDL cholesterol levels;HDL cholesterol;Adiponectin levels;
SKCM	cis	rs9300255	0.602	rs2695476	chr12:123694206	T/C	cg05973401	chr12:123451056	ABCB9	0.79	5.2	0.51	1.59e-6	Neutrophil percentage of white cells;
SKCM	cis	rs8072100	0.935	rs4793978	chr17:45698175	G/A	cg08085267	chr17:45401833	C17orf57	0.61	5.49	0.53	4.77e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs55962025	0.883	rs82332	chr4:3225466	A/G	cg21096898	chr4:3318625	RGS12	-0.65	-4.98	-0.49	3.75e-6	Parental longevity (mother's age at death);
SKCM	cis	rs2204008	0.774	rs4534658	chr12:38246783	G/A	cg26384229	chr12:38710491	ALG10B	0.86	6.76	0.61	2.25e-9	Bladder cancer;
SKCM	cis	rs6121246	0.559	rs10439607	chr20:30258541	G/A	cg13852791	chr20:30311386	BCL2L1	0.83	5.71	0.54	2e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs9910055	0.593	rs2905983	chr17:42212429	T/G	cg08499158	chr17:42289980	UBTF	0.74	6.4	0.59	1.07e-8	Total body bone mineral density;
SKCM	cis	rs9902453	0.874	rs11653805	chr17:28378276	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.82	-6.4	-0.59	1.06e-8	Coffee consumption (cups per day);
SKCM	cis	rs6089584	0.546	rs6061978	chr20:60615604	C/T	cg06108461	chr20:60628389	TAF4	-0.7	-6.35	-0.58	1.34e-8	Body mass index;
SKCM	cis	rs9420	0.884	rs644883	chr11:57663522	C/G	cg19752551	chr11:57585705	CTNND1	0.72	7.45	0.64	1.11e-10	Schizophrenia;
SKCM	cis	rs782590	0.967	rs35504023	chr2:55806503	C/T	cg18811423	chr2:55921094	PNPT1	-0.8	-6.31	-0.58	1.59e-8	Metabolic syndrome;
SKCM	cis	rs2204008	0.744	rs66474616	chr12:38461564	G/A	cg26384229	chr12:38710491	ALG10B	0.87	6.82	0.61	1.76e-9	Bladder cancer;
SKCM	cis	rs4073582	0.894	rs801733	chr11:65934549	A/C	cg16950941	chr11:66035639	RAB1B	0.75	5.28	0.51	1.14e-6	Gout;
SKCM	cis	rs6582630	0.555	rs1969362	chr12:38514843	C/T	cg13010199	chr12:38710504	ALG10B	0.64	4.84	0.48	6.4e-6	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs9875589	0.509	rs7648345	chr3:14039901	G/A	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.51	5.1	0.5	2.28e-6	Ovarian reserve;
SKCM	cis	rs801193	0.569	rs2013908	chr7:66121069	A/T	cg11764359	chr7:65958608	NA	-0.74	-6.63	-0.6	3.89e-9	Aortic root size;
SKCM	cis	rs10906466	0.869	rs11258585	chr10:13802212	G/A	cg19695507	chr10:13526193	BEND7	-0.56	-4.91	-0.49	4.86e-6	Migraine;
SKCM	cis	rs2075671	0.812	rs2231172	chr7:100252918	A/G	cg20848291	chr7:100343083	ZAN	-0.71	-5.37	-0.52	7.88e-7	Other erythrocyte phenotypes;
SKCM	cis	rs875971	1.000	rs1363055	chr7:65943275	A/G	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	cis	rs60871478	0.592	rs4275123	chr7:857352	A/G	cg05535760	chr7:792225	HEATR2	-0.8	-5.95	-0.56	7.28e-8	Cerebrospinal P-tau181p levels;
SKCM	cis	rs875971	0.862	rs10261398	chr7:65750164	A/G	cg11764359	chr7:65958608	NA	-0.81	-7.63	-0.65	4.79e-11	Aortic root size;
SKCM	cis	rs12047808	0.841	rs55637213	chr1:179373680	T/A	cg09822482	chr1:179519214	C1orf125	-0.95	-5.17	-0.51	1.78e-6	Multiple sclerosis (age of onset);
SKCM	cis	rs10504229	1.000	rs34616626	chr8:58184650	C/T	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs9899728	0.520	rs12936866	chr17:73052050	A/G	cg27626185	chr17:73056755	KCTD2	-1.22	-7.67	-0.66	4.17e-11	Alzheimer's disease or small vessel stroke;
SKCM	cis	rs4423214	0.840	rs2017686	chr11:71187061	C/G	cg05163923	chr11:71159392	DHCR7	-0.71	-6.07	-0.57	4.35e-8	Vitamin D levels;
SKCM	cis	rs1953600	0.818	rs2152546	chr10:81906384	G/T	cg04850286	chr10:81895943	PLAC9	-0.49	-4.93	-0.49	4.6e-6	Sarcoidosis;
SKCM	cis	rs4332037	0.722	rs7788921	chr7:1915282	C/A	cg23422044	chr7:1970798	MAD1L1	-0.95	-6.54	-0.6	5.79e-9	Bipolar disorder;
SKCM	cis	rs12477438	0.520	rs34252185	chr2:99737646	A/G	cg26064155	chr2:99771622	LIPT1;TSGA10	1.05	10.46	0.76	1.63e-16	Chronic sinus infection;
SKCM	cis	rs585510	1	rs585510	chr12:121000133	A/G	cg27279351	chr12:120934652	DYNLL1	0.9	8.2	0.68	3.93e-12	Reticulocyte fraction of red cells;
SKCM	cis	rs9303401	0.659	rs34170300	chr17:56789905	G/C	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.35	0.52	8.54e-7	Cognitive test performance;
SKCM	cis	rs873946	0.586	rs3793682	chr10:134564563	C/T	cg14275445	chr10:134560047	INPP5A	-0.55	-4.8	-0.48	7.38e-6	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs2594989	0.779	rs2443701	chr3:11588773	C/T	cg00170343	chr3:11313890	ATG7	-0.97	-5.42	-0.52	6.41e-7	Circulating chemerin levels;
SKCM	cis	rs10927875	0.691	rs1048302	chr1:16340879	T/G	cg21385522	chr1:16154831	NA	0.66	4.77	0.48	8.39e-6	Dilated cardiomyopathy;
SKCM	cis	rs2070488	0.745	rs7649153	chr3:38467753	T/A	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.78	5.89	0.55	9.38e-8	Electrocardiographic conduction measures;
SKCM	cis	rs9475752	0.793	rs71564872	chr6:56838484	A/G	cg06815302	chr6:57335405	PRIM2	0.59	4.78	0.48	8.1e-6	Menarche (age at onset);
SKCM	cis	rs651907	0.557	rs34181125	chr3:101490278	A/G	cg11279151	chr3:101281821	RG9MTD1	-0.57	-4.79	-0.48	7.72e-6	Colorectal cancer;
SKCM	cis	rs28595532	0.841	rs115907265	chr4:119730593	G/A	cg11846333	chr4:119757529	SEC24D	1.2	6.43	0.59	9.38e-9	Cannabis dependence symptom count;
SKCM	cis	rs34172651	0.517	rs2303083	chr16:24835168	G/A	cg06028605	chr16:24865363	SLC5A11	0.6	4.9	0.49	5.13e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs17572109	0.666	rs11696005	chr2:219229641	T/C	cg00012203	chr2:219082015	ARPC2	-0.76	-4.92	-0.49	4.66e-6	Platelet count;Platelet distribution width;Mean platelet volume;
SKCM	cis	rs16866061	1.000	rs12470077	chr2:225334971	T/C	cg02879423	chr2:224806760	WDFY1	0.69	5.03	0.5	3.03e-6	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs7809950	0.678	rs2237661	chr7:106863123	T/C	cg23024343	chr7:107201750	COG5	-0.77	-6.61	-0.6	4.37e-9	Coronary artery disease;
SKCM	trans	rs1814175	0.588	rs7481648	chr11:49754910	A/G	cg03929089	chr4:120376271	NA	-0.89	-8.07	-0.67	7.01e-12	Height;
SKCM	cis	rs9818758	0.556	rs9835439	chr3:49220330	G/C	cg00383909	chr3:49044727	WDR6	0.94	5.35	0.52	8.49e-7	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs6582630	0.519	rs8186881	chr12:38310285	A/G	cg26384229	chr12:38710491	ALG10B	0.8	6.55	0.6	5.47e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs701145	0.537	rs446144	chr3:153922154	T/C	cg17054900	chr3:154042577	DHX36	1.24	5.27	0.51	1.16e-6	Coronary artery disease;
SKCM	cis	rs4237845	0.537	rs1599931	chr12:58258850	A/G	cg02175503	chr12:58329896	NA	0.75	6.05	0.57	4.65e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs2721195	0.967	rs748193	chr8:145682115	C/T	cg11211951	chr8:145729740	GPT	0.65	6.19	0.57	2.63e-8	Age at first birth;
SKCM	cis	rs910316	1.000	rs11159117	chr14:75584867	C/T	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.85e-7	Height;
SKCM	cis	rs137603	0.502	rs137627	chr22:39716341	G/A	cg17798944	chr22:39715225	SNORD43;RPL3	-0.64	-5.54	-0.53	3.91e-7	Primary biliary cholangitis;
SKCM	cis	rs2072499	0.750	rs72708291	chr1:156177285	A/T	cg25208724	chr1:156163844	SLC25A44	0.9	6.56	0.6	5.42e-9	Testicular germ cell tumor;
SKCM	cis	rs2836974	0.931	rs8132285	chr21:40655752	T/C	cg11890956	chr21:40555474	PSMG1	1.09	13.83	0.84	1.08e-22	Cognitive function;
SKCM	cis	rs6087990	0.806	rs992472	chr20:31385269	G/T	cg13636640	chr20:31349939	DNMT3B	0.88	7.46	0.65	1.05e-10	Ulcerative colitis;
SKCM	cis	rs12709013	0.755	rs1628029	chr16:58797750	A/G	cg02431531	chr16:59244939	NA	0.49	5.13	0.5	2.07e-6	Blood metabolite ratios;
SKCM	cis	rs12477438	0.520	rs8179690	chr2:99795300	A/T	cg26064155	chr2:99771622	LIPT1;TSGA10	-0.97	-8.85	-0.71	2.11e-13	Chronic sinus infection;
SKCM	cis	rs644799	0.710	rs10831427	chr11:95508383	G/T	cg03916912	chr11:95522834	CEP57;FAM76B	0.83	7.18	0.63	3.57e-10	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs7826238	0.601	rs2976907	chr8:8345168	C/T	cg08975724	chr8:8085496	FLJ10661	0.67	5.18	0.51	1.68e-6	Systolic blood pressure;
SKCM	cis	rs10489202	1.000	rs34058770	chr1:168057399	C/A	cg24449463	chr1:168025552	DCAF6	-0.78	-6.08	-0.57	4.23e-8	Schizophrenia;
SKCM	cis	rs17784882	0.521	rs11713693	chr3:47074906	T/C	cg27129171	chr3:47204927	SETD2	-0.75	-5.45	-0.53	5.61e-7	QT interval;
SKCM	cis	rs2404602	0.692	rs12437733	chr15:77155562	A/G	cg23625390	chr15:77176239	SCAPER	0.61	5.45	0.53	5.63e-7	Blood metabolite levels;
SKCM	cis	rs7215564	0.818	rs1531946	chr17:78630807	G/A	cg16980736	chr17:78789706	RPTOR	-0.87	-4.83	-0.48	6.64e-6	Myopia (pathological);
SKCM	cis	rs6582630	0.519	rs11495700	chr12:38288240	A/G	cg26384229	chr12:38710491	ALG10B	0.86	6.78	0.61	2.07e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs28595532	0.920	rs114162429	chr4:119741078	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs28386778	0.863	rs6504178	chr17:61812733	A/G	cg01411255	chr17:61851458	DDX42;CCDC47	-0.75	-4.83	-0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs72781680	0.611	rs55983206	chr2:24333995	A/C	cg20701182	chr2:24300061	SF3B14	0.74	5.03	0.49	3.09e-6	Lymphocyte counts;
SKCM	cis	rs7937682	0.883	rs12804962	chr11:111442683	A/T	cg09085632	chr11:111637200	PPP2R1B	1.02	10.33	0.76	2.93e-16	Primary sclerosing cholangitis;
SKCM	cis	rs3785574	0.962	rs8079161	chr17:61808561	C/G	cg06601766	chr17:61851465	DDX42;CCDC47	0.66	4.98	0.49	3.74e-6	Height;
SKCM	cis	rs9303401	0.659	rs11079358	chr17:56920949	G/T	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.35	0.52	8.54e-7	Cognitive test performance;
SKCM	cis	rs11204677	1	rs11204677	chr1:150574695	C/G	cg13175981	chr1:150552382	MCL1	0.72	6.31	0.58	1.57e-8	Monocyte percentage of white cells;Granulocyte percentage of myeloid white cells;
SKCM	cis	rs10504229	1.000	rs67594249	chr8:58180521	T/A	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs1850744	0.536	rs6448846	chr4:9580937	G/C	cg15442990	chr4:9534313	NA	1.18	4.96	0.49	4e-6	Economic and political preferences;
SKCM	cis	rs28595532	0.920	rs115226628	chr4:119639818	A/G	cg14228332	chr4:119757509	SEC24D	0.97	4.92	0.49	4.71e-6	Cannabis dependence symptom count;
SKCM	cis	rs10155981	0.510	rs4719706	chr7:22592796	G/A	cg05062323	chr7:22590069	NA	-1.05	-6.05	-0.57	4.69e-8	Bilirubin levels;
SKCM	cis	rs694739	0.892	rs647152	chr11:64109118	T/G	cg02228329	chr11:64053129	BAD;GPR137	1.01	9.21	0.72	4.17e-14	Alopecia areata;Crohn's disease;Psoriasis vulgaris;
SKCM	cis	rs10256972	0.641	rs12702017	chr7:1129413	C/T	cg16145915	chr7:1198662	ZFAND2A	-0.56	-7.9	-0.67	1.47e-11	Longevity;Endometriosis;
SKCM	cis	rs1790761	0.520	rs12805884	chr11:67387977	G/A	cg00290607	chr11:67383545	NA	-0.66	-6.89	-0.62	1.27e-9	Mean corpuscular volume;
SKCM	cis	rs2645694	0.603	rs2703123	chr4:77821154	C/T	cg03477792	chr4:77819574	ANKRD56	0.57	6.38	0.59	1.18e-8	Emphysema distribution in smoking;
SKCM	cis	rs1797081	0.967	rs780632	chr10:16861400	A/G	cg23933602	chr10:16859644	RSU1	-1.02	-15.48	-0.87	1.73e-25	Platelet distribution width;
SKCM	cis	rs11105298	0.891	rs11105318	chr12:89926658	C/T	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.86	-5.46	-0.53	5.48e-7	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs4819052	0.851	rs2236445	chr21:46678453	T/C	cg19498844	chr21:46707878	POFUT2;LOC642852	0.88	7.74	0.66	3.03e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs244731	1.000	rs244726	chr5:176536408	G/A	cg16006841	chr5:176797999	RGS14	0.63	4.82	0.48	6.98e-6	Urate levels in lean individuals;
SKCM	trans	rs1814175	0.817	rs1794162	chr11:49899506	A/C	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs561341	1.000	rs484175	chr17:30309041	G/A	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs1005277	0.563	rs2800550	chr10:38482929	T/C	cg00409905	chr10:38381863	ZNF37A	-0.66	-5.91	-0.56	8.45e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs477895	0.713	rs11607165	chr11:63963947	T/G	cg07220939	chr11:64358617	SLC22A12	0.74	4.99	0.49	3.58e-6	Mean platelet volume;
SKCM	cis	rs394563	0.619	rs4895787	chr6:149646500	G/A	cg16235748	chr6:149772707	ZC3H12D	0.46	5.26	0.51	1.22e-6	Dupuytren's disease;
SKCM	cis	rs9581857	0.615	rs61622854	chr13:28023194	T/A	cg22138327	chr13:27999177	GTF3A	0.72	5.05	0.5	2.88e-6	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs116095464	0.558	rs73029475	chr5:206969	T/C	cg22857025	chr5:266934	NA	-1.44	-7.74	-0.66	2.94e-11	Breast cancer;
SKCM	cis	rs8014204	0.819	rs2003490	chr14:75377555	C/A	cg06637938	chr14:75390232	RPS6KL1	0.82	5.95	0.56	7.18e-8	Caffeine consumption;
SKCM	cis	rs4819052	0.851	rs875621	chr21:46682295	A/G	cg02159808	chr21:46707872	POFUT2;LOC642852	0.73	5.65	0.54	2.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs8067545	0.586	rs8080649	chr17:20069677	G/C	cg13482628	chr17:19912719	NA	0.66	5.57	0.53	3.54e-7	Schizophrenia;
SKCM	trans	rs561341	0.714	rs7218466	chr17:30263314	A/G	cg20587970	chr11:113659929	NA	-1.07	-8.84	-0.71	2.25e-13	Hip circumference adjusted for BMI;
SKCM	cis	rs9910055	0.571	rs10208	chr17:42300278	C/T	cg13607699	chr17:42295918	UBTF	0.87	7.56	0.65	6.75e-11	Total body bone mineral density;
SKCM	cis	rs2075371	0.796	rs12154724	chr7:133943443	G/A	cg20476274	chr7:133979776	SLC35B4	0.94	8.63	0.7	5.6e-13	Mean platelet volume;
SKCM	trans	rs1814175	0.616	rs847641	chr11:49919261	T/C	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs6088580	0.634	rs6087579	chr20:32985155	A/G	cg24642439	chr20:33292090	TP53INP2	-0.76	-6.02	-0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs7666738	0.830	rs7680909	chr4:98934604	A/G	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7789940	0.951	rs7787526	chr7:75947553	C/T	cg10167463	chr7:75959203	YWHAG	-0.68	-4.81	-0.48	7.15e-6	Multiple sclerosis;
SKCM	cis	rs7829975	0.517	rs12542733	chr8:8824858	G/T	cg06636001	chr8:8085503	FLJ10661	-0.79	-6.0	-0.56	5.94e-8	Mood instability;
SKCM	cis	rs6461049	0.800	rs2398706	chr7:2156338	A/T	cg21782813	chr7:2030301	MAD1L1	0.48	5.09	0.5	2.42e-6	Schizophrenia;
SKCM	cis	rs6942756	0.876	rs822038	chr7:129065477	A/G	cg02491457	chr7:128862824	NA	-0.78	-4.89	-0.48	5.27e-6	White matter hyperintensity burden;
SKCM	cis	rs208520	0.690	rs6929762	chr6:66709277	C/T	cg07460842	chr6:66804631	NA	0.91	7.48	0.65	9.57e-11	Exhaled nitric oxide output;
SKCM	cis	rs2070488	0.662	rs6599203	chr3:38487802	G/A	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.75	5.63	0.54	2.73e-7	Electrocardiographic conduction measures;
SKCM	cis	rs9814567	1.000	rs4974483	chr3:134219001	A/G	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.66	-5.15	-0.5	1.88e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	trans	rs1814175	0.676	rs1721999	chr11:49917372	A/G	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs7618501	0.669	rs3774758	chr3:49938227	C/G	cg05072774	chr3:49840536	C3orf54	-0.71	-5.24	-0.51	1.31e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs651907	0.557	rs11710533	chr3:101351472	G/A	cg12386194	chr3:101231763	SENP7	0.75	6.3	0.58	1.64e-8	Colorectal cancer;
SKCM	cis	rs4237845	0.591	rs10747788	chr12:58315338	C/T	cg02175503	chr12:58329896	NA	0.93	9.44	0.73	1.51e-14	Intelligence (multi-trait analysis);
SKCM	cis	rs1048238	0.506	rs698889	chr1:16267040	A/C	cg21385522	chr1:16154831	NA	-0.64	-5.56	-0.53	3.64e-7	Systolic blood pressure;
SKCM	cis	rs2952156	0.920	rs9675194	chr17:37833805	A/G	cg20243544	chr17:37824526	PNMT	0.72	5.8	0.55	1.34e-7	Asthma;
SKCM	cis	rs1401999	1.000	rs6443926	chr3:183706630	A/C	cg01324343	chr3:183735012	ABCC5	0.84	9.29	0.72	2.91e-14	Anterior chamber depth;
SKCM	cis	rs6570726	0.967	rs1396648	chr6:145785248	C/A	cg23711669	chr6:146136114	FBXO30	-0.68	-6.55	-0.6	5.51e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs10876993	0.855	rs1689585	chr12:58080140	A/G	cg18357645	chr12:58087776	OS9	-0.65	-5.97	-0.56	6.61e-8	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs55962025	0.737	rs7685686	chr4:3207142	A/G	cg09735869	chr4:3319127	RGS12	-0.65	-5.47	-0.53	5.15e-7	Parental longevity (mother's age at death);
SKCM	cis	rs6088590	0.707	rs67159833	chr20:33488079	T/C	cg24642439	chr20:33292090	TP53INP2	0.92	6.21	0.58	2.37e-8	Coronary artery disease;
SKCM	cis	rs28386778	0.830	rs2854210	chr17:61946338	C/A	cg01411255	chr17:61851458	DDX42;CCDC47	0.77	4.95	0.49	4.26e-6	Prudent dietary pattern;
SKCM	cis	rs6570726	0.764	rs9399553	chr6:145873664	A/T	cg05347473	chr6:146136440	FBXO30	0.57	5.12	0.5	2.14e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs651907	0.557	rs3094295	chr3:101401995	T/C	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.81	7.06	0.62	6.11e-10	Colorectal cancer;
SKCM	cis	rs362296	0.583	rs35658829	chr4:3255738	T/G	cg21096898	chr4:3318625	RGS12	-0.73	-6.54	-0.59	5.92e-9	Parental longevity (mother's age at death);
SKCM	cis	rs4905558	1.000	rs10145383	chr14:97283495	C/T	cg11863609	chr14:97355128	NA	-0.55	-4.79	-0.48	7.83e-6	Neutrophil count;
SKCM	cis	rs769267	0.965	rs735273	chr19:19385411	T/C	cg03709012	chr19:19516395	GATAD2A	0.81	6.49	0.59	7.18e-9	Tonsillectomy;
SKCM	cis	rs6495122	0.644	rs11630087	chr15:75261673	G/T	cg09165964	chr15:75287851	SCAMP5	0.68	5.38	0.52	7.65e-7	Caffeine consumption;Diastolic blood pressure;Coffee consumption;
SKCM	cis	rs1577917	0.518	rs2475787	chr6:86415236	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.62	5.13	0.5	2.08e-6	Response to antipsychotic treatment;
SKCM	cis	rs9457247	0.534	rs2345568	chr6:167381804	A/G	cg23791538	chr6:167370224	RNASET2	0.56	4.89	0.48	5.38e-6	Crohn's disease;
SKCM	cis	rs6952808	0.501	rs3778999	chr7:2180885	G/A	cg21782813	chr7:2030301	MAD1L1	0.52	5.13	0.5	2.09e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs9814567	0.896	rs6794258	chr3:134344505	G/A	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.65	-5.25	-0.51	1.26e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs854765	0.505	rs2955358	chr17:17946623	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	-1.03	-9.61	-0.74	7.01e-15	Total body bone mineral density;
SKCM	cis	rs4332037	0.538	rs4721164	chr7:1932629	C/G	cg23422044	chr7:1970798	MAD1L1	-0.92	-6.52	-0.59	6.39e-9	Bipolar disorder;
SKCM	cis	rs67311347	0.822	rs11709089	chr3:40351484	C/T	cg00091569	chr3:40428383	ENTPD3	0.67	5.66	0.54	2.45e-7	Renal cell carcinoma;
SKCM	cis	rs4332037	0.851	rs73050128	chr7:1961882	C/A	cg23422044	chr7:1970798	MAD1L1	-1.05	-7.23	-0.63	2.89e-10	Bipolar disorder;
SKCM	cis	rs9388451	0.839	rs11154331	chr6:126111429	A/T	cg05901451	chr6:126070800	HEY2	-0.74	-6.7	-0.6	2.98e-9	Brugada syndrome;
SKCM	cis	rs4132509	1.000	rs6659180	chr1:243995348	C/T	cg21452805	chr1:244014465	NA	0.9	5.5	0.53	4.65e-7	RR interval (heart rate);
SKCM	cis	rs7940866	0.903	rs1433980	chr11:130870956	A/G	cg12179176	chr11:130786555	SNX19	0.78	6.34	0.58	1.35e-8	Schizophrenia;
SKCM	cis	rs17685	0.712	rs1639620	chr7:75704090	A/G	cg16489192	chr7:75678113	MDH2;STYXL1	-0.58	-5.46	-0.53	5.43e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7143963	0.636	rs1131877	chr14:103342049	T/C	cg23020514	chr14:103360112	TRAF3	0.74	7.04	0.62	6.58e-10	Body mass index;
SKCM	cis	rs2404602	0.647	rs10851892	chr15:77176491	T/C	cg23625390	chr15:77176239	SCAPER	-0.85	-8.26	-0.68	2.93e-12	Blood metabolite levels;
SKCM	cis	rs2400749	0.685	rs2400744	chr14:100026717	A/C	cg03498048	chr14:99733089	BCL11B	0.8	5.64	0.54	2.6e-7	Alzheimer's disease (survival time);
SKCM	cis	rs36093844	0.799	rs7124956	chr11:85588819	A/G	cg25872744	chr11:85566296	CCDC83	-0.66	-5.01	-0.49	3.26e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs710865	1.000	rs710866	chr1:19568722	G/C	cg13387374	chr1:19411106	UBR4	0.64	4.83	0.48	6.75e-6	Brain structure;
SKCM	cis	rs7208859	0.623	rs7219712	chr17:29080570	G/T	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs6570726	0.846	rs453834	chr6:145886261	T/C	cg23711669	chr6:146136114	FBXO30	0.81	8.47	0.69	1.13e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9303280	0.691	rs7221814	chr17:38089717	A/G	cg17467752	chr17:38218738	THRA	0.61	4.93	0.49	4.57e-6	Self-reported allergy;
SKCM	cis	rs7552404	0.824	rs1251077	chr1:76189745	C/G	cg10523679	chr1:76189770	ACADM	-0.84	-6.62	-0.6	4.17e-9	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs62238980	0.614	rs117161237	chr22:32501630	C/T	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs9611565	0.625	rs9607819	chr22:41958862	C/G	cg03806693	chr22:41940476	POLR3H	-1.02	-6.66	-0.6	3.44e-9	Vitiligo;
SKCM	cis	rs2836950	0.565	rs2836926	chr21:40536790	G/A	cg17971929	chr21:40555470	PSMG1	-0.76	-6.53	-0.59	6.19e-9	Menarche (age at onset);
SKCM	cis	rs77106637	0.858	rs117819392	chr11:72514503	C/T	cg03713592	chr11:72463424	ARAP1	1.09	5.6	0.54	3.11e-7	Type 2 diabetes;
SKCM	cis	rs6546550	0.867	rs7592647	chr2:70139134	C/T	cg02498382	chr2:70120550	SNRNP27	-0.45	-4.88	-0.48	5.4e-6	Prevalent atrial fibrillation;
SKCM	cis	rs10906466	0.869	rs4750409	chr10:13805502	C/T	cg19695507	chr10:13526193	BEND7	-0.53	-4.79	-0.48	7.76e-6	Migraine;
SKCM	cis	rs7618501	0.521	rs11712056	chr3:49914397	T/C	cg24110177	chr3:50126178	RBM5	-0.73	-5.57	-0.53	3.52e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7666738	0.830	rs35276471	chr4:99068691	A/T	cg05340658	chr4:99064831	C4orf37	0.66	4.87	0.48	5.74e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10492096	1.000	rs10849462	chr12:6575992	C/T	cg13857086	chr12:6580257	VAMP1	0.98	7.5	0.65	8.6e-11	Hip geometry;
SKCM	cis	rs1707322	1.000	rs10890365	chr1:46359348	C/T	cg03146154	chr1:46216737	IPP	0.71	4.82	0.48	7.07e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs8014204	0.816	rs10083386	chr14:75347585	C/A	cg06637938	chr14:75390232	RPS6KL1	-0.64	-4.78	-0.48	8.26e-6	Caffeine consumption;
SKCM	cis	rs7828089	0.875	rs6998575	chr8:22254499	C/T	cg12081754	chr8:22256438	SLC39A14	0.7	5.9	0.56	8.84e-8	Verbal declarative memory;
SKCM	cis	rs1403694	0.695	rs3806689	chr3:186435077	A/G	cg09332604	chr3:186435400	KNG1	-0.5	-5.07	-0.5	2.57e-6	Blood protein levels;
SKCM	cis	rs7772486	0.817	rs12198065	chr6:146385286	G/C	cg23711669	chr6:146136114	FBXO30	0.85	8.45	0.69	1.28e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2033711	0.870	rs11669741	chr19:58960481	C/T	cg13877915	chr19:58951672	ZNF132	-0.94	-10.42	-0.76	2e-16	Uric acid clearance;
SKCM	cis	rs1707322	0.752	rs7541962	chr1:46235117	G/A	cg03146154	chr1:46216737	IPP	0.8	5.47	0.53	5.19e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs769267	0.930	rs10419912	chr19:19597055	A/G	cg03709012	chr19:19516395	GATAD2A	-0.89	-8.62	-0.7	5.89e-13	Tonsillectomy;
SKCM	cis	rs7618915	0.501	rs34157897	chr3:52716937	T/C	cg18404041	chr3:52824283	ITIH1	-0.53	-4.77	-0.48	8.42e-6	Bipolar disorder;
SKCM	cis	rs752010	0.631	rs4660549	chr1:42088102	A/G	cg06885757	chr1:42089581	HIVEP3	0.65	6.81	0.61	1.78e-9	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs2095921	1	rs2095921	chr1:11033322	C/G	cg27631724	chr1:11040367	C1orf127	0.5	4.88	0.48	5.45e-6	Male-pattern baldness;
SKCM	cis	rs7216064	0.953	rs11868959	chr17:65840810	T/C	cg12091567	chr17:66097778	LOC651250	-0.77	-5.53	-0.53	4.06e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs992157	0.764	rs2891076	chr2:219184398	C/T	cg20019365	chr2:219134978	PNKD;AAMP	0.74	5.95	0.56	7.08e-8	Colorectal cancer;
SKCM	cis	rs10751667	0.666	rs10902248	chr11:957742	A/G	cg10932868	chr11:921992	NA	0.55	5.1	0.5	2.36e-6	Alzheimer's disease (late onset);
SKCM	cis	rs10421328	0.784	rs28635562	chr19:19769690	C/T	cg26732615	chr19:19648335	CILP2;YJEFN3	0.59	4.78	0.48	8.22e-6	Parental longevity (combined parental age at death);
SKCM	cis	rs6547741	0.967	rs4665996	chr2:27814343	T/C	cg27432699	chr2:27873401	GPN1	0.73	6.64	0.6	3.76e-9	Oral cavity cancer;
SKCM	cis	rs892961	0.931	rs2411110	chr17:75400143	A/C	cg24757533	chr17:74494286	RHBDF2	0.55	5.01	0.49	3.31e-6	Airflow obstruction;
SKCM	cis	rs13118159	0.836	rs2276903	chr4:1343405	A/G	cg02018176	chr4:1364513	KIAA1530	0.69	5.81	0.55	1.31e-7	Longevity;
SKCM	cis	rs4740619	0.619	rs1410454	chr9:16042193	C/A	cg14451791	chr9:16040625	NA	-0.47	-5.03	-0.49	3.07e-6	Body mass index;
SKCM	cis	rs6138458	0.828	rs6138466	chr20:24997137	A/G	cg26195577	chr20:24973756	C20orf3	0.94	5.62	0.54	2.86e-7	Blood protein levels;
SKCM	cis	rs10751667	0.643	rs7396951	chr11:927355	G/A	cg10932868	chr11:921992	NA	0.55	5.13	0.5	2.09e-6	Alzheimer's disease (late onset);
SKCM	cis	rs8180040	0.966	rs7651762	chr3:47470484	G/A	cg16586182	chr3:47516702	SCAP	0.76	5.32	0.52	9.63e-7	Colorectal cancer;
SKCM	cis	rs17376456	0.542	rs2084916	chr5:93194961	A/T	cg25358565	chr5:93447407	FAM172A	-0.88	-5.63	-0.54	2.71e-7	Diabetic retinopathy;
SKCM	cis	rs7659604	0.628	rs6838153	chr4:122720999	A/G	cg20573242	chr4:122745356	CCNA2	0.76	6.61	0.6	4.4e-9	Type 2 diabetes;
SKCM	cis	rs28386778	0.897	rs894407	chr17:61901641	T/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs9325144	0.624	rs7309400	chr12:39150369	G/C	cg13010199	chr12:38710504	ALG10B	-0.6	-5.14	-0.5	2.01e-6	Morning vs. evening chronotype;
SKCM	cis	rs2197308	0.728	rs7304305	chr12:37932990	T/C	cg26384229	chr12:38710491	ALG10B	-0.76	-6.51	-0.59	6.66e-9	Morning vs. evening chronotype;
SKCM	cis	rs7811142	0.830	rs77861211	chr7:99962096	T/C	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.07	6.7	0.6	2.88e-9	Platelet count;
SKCM	cis	rs55962025	0.846	rs363064	chr4:3141410	C/T	cg00764545	chr4:3318001	RGS12	-0.83	-6.73	-0.61	2.52e-9	Parental longevity (mother's age at death);
SKCM	cis	rs4727027	0.865	rs62505077	chr7:148849656	T/A	cg23583168	chr7:148888333	NA	-0.8	-6.66	-0.6	3.52e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs7584330	0.744	rs10929235	chr2:238380272	A/G	cg14458575	chr2:238380390	NA	1.03	6.61	0.6	4.31e-9	Prostate cancer;
SKCM	trans	rs17685	0.884	rs6978677	chr7:75636240	C/T	cg19862616	chr7:65841803	NCRNA00174	0.9	8.24	0.68	3.21e-12	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs5758659	0.652	rs133347	chr22:42423645	A/T	cg21144673	chr22:42017783	PPPDE2;XRCC6	-0.65	-4.94	-0.49	4.42e-6	Cognitive function;
SKCM	cis	rs9910055	0.530	rs2269905	chr17:42294462	A/G	cg08499158	chr17:42289980	UBTF	-0.79	-6.91	-0.62	1.15e-9	Total body bone mineral density;
SKCM	cis	rs747650	0.859	rs4567413	chr11:47232184	A/G	cg03339077	chr11:47165057	C11orf49	-0.58	-4.96	-0.49	4.02e-6	Acne (severe);
SKCM	cis	rs11662586	0.517	rs11663082	chr18:77713494	C/T	cg20368463	chr18:77673604	PQLC1	0.69	5.92	0.56	8.28e-8	Exploratory eye movement dysfunction in schizophrenia (responsive search score);
SKCM	cis	rs2404602	0.692	rs35498563	chr15:76958868	C/T	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs28386778	0.897	rs2584639	chr17:61863732	C/T	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs8180040	0.932	rs12489046	chr3:47527683	T/G	cg16586182	chr3:47516702	SCAP	-0.76	-5.32	-0.52	9.63e-7	Colorectal cancer;
SKCM	cis	rs9399135	0.967	rs7766189	chr6:135353851	A/C	cg24558204	chr6:135376177	HBS1L	0.6	5.36	0.52	8.17e-7	Red blood cell count;
SKCM	cis	rs1707322	1.000	rs11211222	chr1:46367757	T/C	cg03146154	chr1:46216737	IPP	0.74	5.06	0.5	2.76e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs208520	1.000	rs12191403	chr6:66978137	C/T	cg07460842	chr6:66804631	NA	0.87	6.25	0.58	2.01e-8	Exhaled nitric oxide output;
SKCM	cis	rs6582630	0.502	rs2387603	chr12:38353389	A/C	cg26384229	chr12:38710491	ALG10B	0.81	6.56	0.6	5.29e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs72949976	0.606	rs11898263	chr2:214030649	A/G	cg08319019	chr2:214017104	IKZF2	0.82	6.64	0.6	3.8e-9	Lung cancer;Squamous cell lung carcinoma;
SKCM	cis	rs7937682	0.824	rs577044	chr11:111490420	G/T	cg19812747	chr11:111475976	SIK2	-0.56	-4.97	-0.49	3.82e-6	Primary sclerosing cholangitis;
SKCM	cis	rs72634258	0.519	rs4908713	chr1:7946831	G/A	cg00042356	chr1:8021962	PARK7	0.83	5.14	0.5	1.96e-6	Inflammatory bowel disease;
SKCM	cis	rs2839186	0.967	rs4819222	chr21:47707778	G/A	cg13126279	chr21:47581558	C21orf56	-0.64	-5.47	-0.53	5.17e-7	Testicular germ cell tumor;
SKCM	cis	rs2439831	0.681	rs28594657	chr15:43588888	C/A	cg02155558	chr15:43621948	ADAL;LCMT2	1.31	7.69	0.66	3.78e-11	Lung cancer in ever smokers;
SKCM	cis	rs3784262	0.934	rs4646611	chr15:58265083	T/C	cg12031962	chr15:58353849	ALDH1A2	-0.51	-6.58	-0.6	4.94e-9	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs17270561	0.579	rs10456326	chr6:25919662	G/A	cg17691542	chr6:26056736	HIST1H1C	1.25	9.21	0.72	4.29e-14	Iron status biomarkers;
SKCM	cis	rs6951245	1.000	rs79765398	chr7:1073764	A/G	cg24642844	chr7:1081250	C7orf50	-0.95	-6.4	-0.59	1.06e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs55962025	0.842	rs362271	chr4:3235518	C/T	cg09735869	chr4:3319127	RGS12	-0.74	-5.57	-0.53	3.54e-7	Parental longevity (mother's age at death);
SKCM	trans	rs4765913	0.552	rs7295089	chr12:2440464	C/T	cg25850808	chr6:74405048	CD109	0.81	8.16	0.68	4.54e-12	Bipolar disorder;
SKCM	cis	rs2153535	0.580	rs2327056	chr6:8443305	C/T	cg07606381	chr6:8435919	SLC35B3	0.94	6.94	0.62	1.02e-9	Motion sickness;
SKCM	cis	rs9911578	0.730	rs55759249	chr17:57027135	A/G	cg12560992	chr17:57184187	TRIM37	-0.83	-5.98	-0.56	6.24e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs28386778	0.863	rs3760256	chr17:61821161	A/G	cg06873352	chr17:61820015	STRADA	0.76	6.34	0.58	1.38e-8	Prudent dietary pattern;
SKCM	cis	rs910316	0.935	rs175076	chr14:75505486	A/G	cg11812906	chr14:75593930	NEK9	-0.72	-5.5	-0.53	4.57e-7	Height;
SKCM	cis	rs11249608	0.636	rs13359549	chr5:178449178	T/A	cg21905437	chr5:178450457	ZNF879	0.71	6.0	0.56	5.9e-8	Pubertal anthropometrics;
SKCM	cis	rs12540874	0.698	rs10899736	chr7:50546925	C/T	cg18232548	chr7:50535776	DDC	-0.83	-6.28	-0.58	1.8e-8	Systemic sclerosis;
SKCM	cis	rs2075371	0.501	rs1646654	chr7:134027547	G/C	cg20476274	chr7:133979776	SLC35B4	0.81	6.84	0.61	1.61e-9	Mean platelet volume;
SKCM	cis	rs208520	0.690	rs74707865	chr6:66717352	A/G	cg07460842	chr6:66804631	NA	0.9	7.28	0.64	2.28e-10	Exhaled nitric oxide output;
SKCM	cis	rs651907	0.817	rs650567	chr3:101594402	G/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.67	5.05	0.5	2.78e-6	Colorectal cancer;
SKCM	cis	rs4724125	0.782	rs12673352	chr7:42702223	T/C	cg09407816	chr7:42972088	MRPL32;PSMA2	0.81	5.13	0.5	2.03e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs10751667	0.666	rs10794347	chr11:939863	G/A	cg10932868	chr11:921992	NA	0.54	5.05	0.5	2.81e-6	Alzheimer's disease (late onset);
SKCM	cis	rs427394	0.802	rs274694	chr5:6734079	A/G	cg10857441	chr5:6722123	POLS	-0.71	-7.33	-0.64	1.82e-10	Menopause (age at onset);
SKCM	cis	rs12142240	0.698	rs13374893	chr1:46843800	A/G	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs2075671	0.582	rs3891039	chr7:100346654	T/C	cg20848291	chr7:100343083	ZAN	-0.64	-4.87	-0.48	5.73e-6	Other erythrocyte phenotypes;
SKCM	cis	rs867186	1.000	rs11906318	chr20:33729442	A/C	cg04194272	chr20:33683537	NA	-1.11	-6.01	-0.56	5.7e-8	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs3862260	0.509	rs3795663	chr1:120165187	G/A	cg16322792	chr1:120165303	ZNF697	0.5	5.32	0.52	9.47e-7	Systemic lupus erythematosus;
SKCM	cis	rs4820539	1.000	rs916583	chr22:23469267	C/T	cg14186256	chr22:23484241	RTDR1	0.85	7.96	0.67	1.12e-11	Bone mineral density;
SKCM	cis	rs7937682	0.921	rs4534611	chr11:111440425	C/G	cg19812747	chr11:111475976	SIK2	-0.58	-4.83	-0.48	6.6e-6	Primary sclerosing cholangitis;
SKCM	trans	rs1814175	0.616	rs28417656	chr11:50040152	C/T	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs7666738	0.753	rs28390295	chr4:99028497	C/A	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs362296	0.661	rs3121420	chr4:3264210	T/C	cg24015175	chr4:3319247	RGS12	-0.55	-5.03	-0.5	3.01e-6	Parental longevity (mother's age at death);
SKCM	cis	rs9485372	1.000	rs9485370	chr6:149606801	G/T	cg03072286	chr6:150262044	ULBP2	-0.55	-4.89	-0.48	5.3e-6	Breast cancer;
SKCM	cis	rs875971	0.522	rs2008188	chr7:65429013	G/C	cg18876405	chr7:65276391	NA	0.84	7.62	0.65	5.02e-11	Aortic root size;
SKCM	cis	rs2228479	0.557	rs34420680	chr16:89809171	C/T	cg06558623	chr16:89946397	TCF25	1.05	5.66	0.54	2.44e-7	Skin colour saturation;
SKCM	cis	rs8072100	0.967	rs8074149	chr17:45583375	A/C	cg08085267	chr17:45401833	C17orf57	0.61	5.08	0.5	2.49e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs7666738	0.830	rs4443293	chr4:99063120	G/A	cg05340658	chr4:99064831	C4orf37	0.66	4.87	0.48	5.74e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6120849	0.754	rs11167253	chr20:33614449	T/C	cg24642439	chr20:33292090	TP53INP2	0.94	4.86	0.48	5.91e-6	Protein C levels;
SKCM	cis	rs10504229	0.683	rs55660024	chr8:58128943	G/A	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs7296418	0.754	rs1619283	chr12:123717362	A/G	cg06742321	chr12:123595122	PITPNM2	0.62	4.95	0.49	4.2e-6	Platelet count;
SKCM	cis	rs6912958	0.559	rs446851	chr6:88043640	G/A	cg08069147	chr6:88032118	GJB7;C6orf162	0.64	5.66	0.54	2.4e-7	Monocyte percentage of white cells;
SKCM	trans	rs3780486	0.846	rs7036812	chr9:33143822	T/C	cg20290983	chr6:43655470	MRPS18A	0.96	11.17	0.78	7.53e-18	IgG glycosylation;
SKCM	cis	rs2836974	0.897	rs1571709	chr21:40553980	T/C	cg17971929	chr21:40555470	PSMG1	0.89	8.73	0.7	3.6e-13	Cognitive function;
SKCM	cis	rs453301	0.686	rs6748	chr8:8890802	C/T	cg15556689	chr8:8085844	FLJ10661	-0.73	-5.77	-0.55	1.52e-7	Joint mobility (Beighton score);
SKCM	cis	rs7932354	0.528	rs7108902	chr11:47091571	C/T	cg03339077	chr11:47165057	C11orf49	-0.59	-4.79	-0.48	7.68e-6	Bone mineral density (hip);Bone mineral density;
SKCM	cis	rs8017423	0.934	rs2401874	chr14:90682467	C/T	cg04374321	chr14:90722782	PSMC1	0.95	8.38	0.69	1.69e-12	Mortality in heart failure;
SKCM	cis	rs709400	0.663	rs28444993	chr14:103930564	T/C	cg26031613	chr14:104095156	KLC1	0.73	5.62	0.54	2.87e-7	Body mass index;
SKCM	cis	rs514406	0.825	rs6588441	chr1:53223494	G/A	cg16325326	chr1:53192061	ZYG11B	-1.01	-11.9	-0.8	3.23e-19	Monocyte count;
SKCM	cis	rs919433	0.963	rs1896857	chr2:198164530	A/G	cg04278110	chr2:198063759	ANKRD44	-0.69	-4.8	-0.48	7.58e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs738322	0.967	rs132985	chr22:38563471	C/T	cg25457927	chr22:38595422	NA	-0.52	-5.96	-0.56	6.94e-8	Cutaneous nevi;
SKCM	cis	rs9303401	0.659	rs12602389	chr17:56779778	G/A	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.16	0.57	2.91e-8	Cognitive test performance;
SKCM	cis	rs9300255	0.544	rs1716174	chr12:123660717	T/C	cg00376283	chr12:123451042	ABCB9	0.84	5.1	0.5	2.35e-6	Neutrophil percentage of white cells;
SKCM	cis	rs838147	0.844	rs12975033	chr19:49249443	A/T	cg13540341	chr19:49222985	MAMSTR	0.55	5.08	0.5	2.49e-6	Dietary macronutrient intake;
SKCM	cis	rs28595532	0.920	rs17259284	chr4:119779298	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs2243480	1.000	rs3885839	chr7:65290403	G/T	cg18252515	chr7:66147081	NA	-1.29	-7.41	-0.64	1.3e-10	Diabetic kidney disease;
SKCM	cis	rs1044826	0.642	rs295470	chr3:139213903	A/G	cg15131784	chr3:139108705	COPB2	0.7	5.18	0.51	1.67e-6	Obesity-related traits;
SKCM	cis	rs2836974	0.583	rs2410124	chr21:40704760	C/G	cg17971929	chr21:40555470	PSMG1	-0.71	-6.15	-0.57	3.14e-8	Cognitive function;
SKCM	cis	rs17685	0.736	rs4732594	chr7:75753273	T/C	cg16489192	chr7:75678113	MDH2;STYXL1	-0.57	-5.35	-0.52	8.63e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs875971	0.862	rs801206	chr7:66021966	C/G	cg11764359	chr7:65958608	NA	-0.75	-6.8	-0.61	1.88e-9	Aortic root size;
SKCM	cis	rs8017423	0.967	rs28424204	chr14:90705669	G/C	cg04374321	chr14:90722782	PSMC1	0.97	8.87	0.71	1.91e-13	Mortality in heart failure;
SKCM	cis	rs6951245	1.000	rs74652290	chr7:1090109	G/A	cg03188948	chr7:1209495	NA	1.12	6.25	0.58	2.02e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs847649	0.765	rs10953383	chr7:102774076	C/T	cg18108683	chr7:102477205	FBXL13	0.8	6.93	0.62	1.09e-9	Morning vs. evening chronotype;
SKCM	cis	rs2075371	1.000	rs2598291	chr7:133988313	C/G	cg20476274	chr7:133979776	SLC35B4	1.03	10.51	0.77	1.36e-16	Mean platelet volume;
SKCM	cis	rs611744	0.647	rs12675265	chr8:109268805	C/T	cg18478394	chr8:109455254	TTC35	0.66	5.27	0.51	1.16e-6	Dupuytren's disease;
SKCM	cis	rs6545883	0.894	rs2600672	chr2:61536740	A/G	cg15711740	chr2:61764176	XPO1	-0.74	-5.05	-0.5	2.79e-6	Tuberculosis;
SKCM	cis	rs514406	0.825	rs1242328	chr1:53396869	A/G	cg24675658	chr1:53192096	ZYG11B	-0.67	-5.57	-0.53	3.46e-7	Monocyte count;
SKCM	cis	rs10779751	1.000	rs10779751	chr1:11284336	A/G	cg08854313	chr1:11322531	MTOR	0.87	6.48	0.59	7.43e-9	Body mass index;
SKCM	cis	rs9902453	0.845	rs7501472	chr17:28010628	T/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.82	5.78	0.55	1.47e-7	Coffee consumption (cups per day);
SKCM	cis	rs9467773	1.000	rs4871	chr6:26545632	G/A	cg09904177	chr6:26538194	HMGN4	0.54	4.98	0.49	3.78e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs10489202	0.583	rs201539	chr1:167995407	A/G	cg24449463	chr1:168025552	DCAF6	-0.8	-7.83	-0.66	2e-11	Schizophrenia;
SKCM	cis	rs606458	0.920	rs523200	chr11:64532579	C/A	cg07674570	chr11:65346152	EHBP1L1	-0.68	-5.05	-0.5	2.85e-6	Urate levels;
SKCM	cis	rs7618915	0.508	rs7628578	chr3:52628321	A/T	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs13118159	0.550	rs13123016	chr4:1340889	T/C	cg20887711	chr4:1340912	KIAA1530	0.98	7.55	0.65	6.97e-11	Longevity;
SKCM	cis	rs4975616	0.804	rs381949	chr5:1322468	G/A	cg06550200	chr5:1325588	CLPTM1L	-0.83	-6.78	-0.61	2.07e-9	Lung cancer;
SKCM	cis	rs7772486	0.754	rs702319	chr6:146006117	T/C	cg23711669	chr6:146136114	FBXO30	-0.96	-10.3	-0.76	3.36e-16	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2019137	0.539	rs4849177	chr2:113982584	T/C	cg11763394	chr2:113992921	PAX8;LOC440839;LOC654433	0.62	4.93	0.49	4.53e-6	Lymphocyte counts;
SKCM	cis	rs1801251	1.000	rs778166	chr2:233664097	A/T	cg08000102	chr2:233561755	GIGYF2	0.85	7.04	0.62	6.74e-10	Coronary artery disease;
SKCM	cis	rs595982	0.702	rs626974	chr19:49375900	T/C	cg19746536	chr19:49375674	PPP1R15A	1.24	15.63	0.87	9.72e-26	Red cell distribution width;
SKCM	cis	rs2072499	0.750	rs10159384	chr1:156160822	C/T	cg25208724	chr1:156163844	SLC25A44	0.89	6.31	0.58	1.55e-8	Testicular germ cell tumor;
SKCM	cis	rs62064224	0.720	rs8078837	chr17:30763537	A/G	cg18200150	chr17:30822561	MYO1D	0.81	6.93	0.62	1.09e-9	Schizophrenia;
SKCM	cis	rs7769051	0.808	rs1467404	chr6:133090141	A/G	cg22852734	chr6:133119734	C6orf192	-0.84	-4.8	-0.48	7.61e-6	Type 2 diabetes nephropathy;
SKCM	cis	rs13118159	0.556	rs4974615	chr4:1373551	A/G	cg02018176	chr4:1364513	KIAA1530	-0.87	-7.23	-0.63	2.83e-10	Longevity;
SKCM	cis	rs10752881	0.839	rs6692207	chr1:183085304	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Colorectal cancer;
SKCM	cis	rs1799949	0.965	rs8176140	chr17:41251646	T/A	cg25918947	chr17:41365094	TMEM106A	-0.62	-5.85	-0.55	1.1e-7	Menopause (age at onset);
SKCM	cis	rs9394841	0.667	rs9471653	chr6:41755410	C/G	cg08135965	chr6:41755394	TOMM6	0.75	4.96	0.49	3.96e-6	Mean corpuscular hemoglobin;Red cell distribution width;
SKCM	cis	rs6665290	0.935	rs6704144	chr1:227201030	C/G	cg10327440	chr1:227177885	CDC42BPA	-1.16	-14.67	-0.86	3.89e-24	Myeloid white cell count;
SKCM	cis	rs2836974	0.666	rs4818015	chr21:40675493	A/C	cg11890956	chr21:40555474	PSMG1	0.84	8.33	0.69	2.14e-12	Cognitive function;
SKCM	cis	rs1577917	1.000	rs12215903	chr6:86675028	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.66	-5.72	-0.54	1.88e-7	Response to antipsychotic treatment;
SKCM	cis	rs9325144	0.532	rs1352121	chr12:39130696	A/G	cg26384229	chr12:38710491	ALG10B	-0.74	-6.94	-0.62	1.02e-9	Morning vs. evening chronotype;
SKCM	cis	rs2839186	0.770	rs2839171	chr21:47673247	C/T	cg05896524	chr21:47604654	C21orf56	-0.71	-5.78	-0.55	1.49e-7	Testicular germ cell tumor;
SKCM	cis	rs1799949	1.000	rs1960605	chr17:41305397	C/T	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.15	-0.57	3.16e-8	Menopause (age at onset);
SKCM	cis	rs2836974	0.932	rs2836955	chr21:40619887	G/A	cg11890956	chr21:40555474	PSMG1	1.09	13.83	0.84	1.08e-22	Cognitive function;
SKCM	cis	rs589448	0.933	rs523398	chr12:69752775	C/T	cg14784868	chr12:69753453	YEATS4	0.84	7.65	0.65	4.54e-11	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs9611565	0.512	rs139560	chr22:42194962	A/G	cg03806693	chr22:41940476	POLR3H	-1.06	-6.84	-0.61	1.61e-9	Vitiligo;
SKCM	cis	rs7954584	0.531	rs10840631	chr12:122373729	C/T	cg22618164	chr12:122356400	WDR66	0.54	5.44	0.52	6.02e-7	Mean corpuscular volume;
SKCM	cis	rs7666738	0.830	rs13121766	chr4:98935766	A/C	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2832191	0.626	rs2254796	chr21:30341891	A/G	cg08807101	chr21:30365312	RNF160	-0.71	-5.83	-0.55	1.18e-7	Dental caries;
SKCM	cis	rs2072499	0.750	rs72708291	chr1:156177285	A/T	cg24450063	chr1:156163899	SLC25A44	0.88	6.63	0.6	4.03e-9	Testicular germ cell tumor;
SKCM	cis	rs28386778	0.863	rs3826341	chr17:61819222	C/A	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.36	0.52	8.06e-7	Prudent dietary pattern;
SKCM	cis	rs208520	0.802	rs1342959	chr6:66883329	A/G	cg07460842	chr6:66804631	NA	-0.91	-7.07	-0.63	5.76e-10	Exhaled nitric oxide output;
SKCM	cis	rs362272	0.545	rs2236052	chr4:3318413	C/T	cg05297308	chr4:3317976	RGS12	-1.03	-13.63	-0.84	2.47e-22	Serum sulfate level;
SKCM	cis	rs801193	1.000	rs4717319	chr7:66242593	A/G	cg00343986	chr7:65444356	GUSB	0.68	5.04	0.5	2.99e-6	Aortic root size;
SKCM	cis	rs453301	0.682	rs2929451	chr8:9085295	A/T	cg15556689	chr8:8085844	FLJ10661	0.67	5.24	0.51	1.35e-6	Joint mobility (Beighton score);
SKCM	cis	rs4819052	0.851	rs4819042	chr21:46660072	A/G	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.42	0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs6951245	0.935	rs61910751	chr7:1097895	A/G	cg18402987	chr7:1209562	NA	1.15	6.09	0.57	3.95e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs13118159	0.573	rs7664763	chr4:1352305	A/G	cg02018176	chr4:1364513	KIAA1530	0.94	7.82	0.66	2.07e-11	Longevity;
SKCM	trans	rs10506458	0.915	rs17763441	chr12:63418335	T/C	cg03429785	chr15:59498649	MYO1E;LDHAL6B	-1.38	-7.54	-0.65	7.13e-11	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs12714314	0.756	rs1469646	chr2:1950180	T/C	cg22350835	chr2:1868857	MYT1L	0.66	5.2	0.51	1.54e-6	Type 2 diabetes (age of onset);
SKCM	cis	rs4740619	0.630	rs2794645	chr9:15893770	A/G	cg14451791	chr9:16040625	NA	0.43	5.16	0.5	1.85e-6	Body mass index;
SKCM	cis	rs2439831	1.000	rs2467736	chr15:43784917	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.22	7.98	0.67	1.01e-11	Lung cancer in ever smokers;
SKCM	cis	rs9894429	0.816	rs7406040	chr17:79597583	A/C	cg18240062	chr17:79603768	NPLOC4	0.91	10.35	0.76	2.68e-16	Eye color traits;
SKCM	cis	rs854765	0.547	rs2955384	chr17:17939573	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.03	9.1	0.72	6.96e-14	Total body bone mineral density;
SKCM	cis	rs12188164	0.543	rs2434695	chr5:464177	C/G	cg26076054	chr5:421317	AHRR	0.61	5.14	0.5	1.95e-6	Cystic fibrosis severity;
SKCM	cis	rs4803468	1.000	rs6508977	chr19:41909346	A/G	cg14132834	chr19:41945861	ATP5SL	-0.77	-6.08	-0.57	4.18e-8	Height;
SKCM	cis	rs17685	0.884	rs6978677	chr7:75636240	C/T	cg01364799	chr7:75623366	TMEM120A	-0.73	-5.65	-0.54	2.53e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs867186	1.000	rs11907594	chr20:33673843	C/T	cg04194272	chr20:33683537	NA	-1.38	-7.2	-0.63	3.29e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs4665809	1.000	rs2289022	chr2:26350136	G/T	cg26119090	chr2:26468346	HADHA;HADHB	-0.76	-4.79	-0.48	7.86e-6	Gut microbiome composition (summer);
SKCM	trans	rs3749237	1.000	rs2307021	chr3:49765483	C/G	cg21659725	chr3:3221576	CRBN	0.99	7.4	0.64	1.35e-10	Resting heart rate;
SKCM	cis	rs1182196	0.502	rs757786	chr7:2836019	C/T	cg19717773	chr7:2847554	GNA12	-0.47	-5.6	-0.54	3.07e-7	Plateletcrit;
SKCM	cis	rs4889855	0.545	rs61171555	chr17:78465975	T/G	cg16591659	chr17:78472290	NA	-0.56	-5.72	-0.54	1.87e-7	Fractional excretion of uric acid;
SKCM	cis	rs11673344	0.734	rs1644638	chr19:37461415	C/A	cg07624650	chr19:37064219	ZNF529	-0.78	-4.82	-0.48	7.05e-6	Obesity-related traits;
SKCM	cis	rs1218582	0.774	rs4845680	chr1:154863195	A/G	cg24250549	chr1:154909240	PMVK	0.87	8.69	0.7	4.22e-13	Prostate cancer;
SKCM	trans	rs1814175	0.647	rs61306292	chr11:49856040	G/C	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs73072330	1.000	rs17729010	chr3:47912703	A/G	cg09665691	chr3:47563885	NA	-1.38	-5.84	-0.55	1.16e-7	Stem cell growth factor beta levels;
SKCM	cis	rs860295	0.580	rs10908463	chr1:155286258	C/T	cg02153340	chr1:155202674	NA	-0.78	-5.57	-0.53	3.5e-7	Body mass index;
SKCM	cis	rs6061231	0.583	rs2427313	chr20:60970675	G/A	cg24112000	chr20:60950667	NA	-0.62	-6.04	-0.56	4.89e-8	Colorectal cancer;
SKCM	cis	rs769267	1.000	rs7246748	chr19:19433105	C/T	cg26732615	chr19:19648335	CILP2;YJEFN3	-0.65	-6.0	-0.56	5.88e-8	Tonsillectomy;
SKCM	cis	rs763014	0.931	rs11648728	chr16:635525	C/T	cg07343612	chr16:622815	PIGQ	-0.7	-6.0	-0.56	5.84e-8	Height;
SKCM	cis	rs10504073	0.584	rs56134839	chr8:49918899	C/T	cg00325661	chr8:49890786	NA	0.79	7.15	0.63	3.99e-10	Blood metabolite ratios;
SKCM	cis	rs10256972	0.591	rs6968988	chr7:1169619	A/G	cg07092213	chr7:1199455	ZFAND2A	-0.66	-4.96	-0.49	4.07e-6	Longevity;Endometriosis;
SKCM	cis	rs11679564	0.714	rs4670638	chr2:37164911	C/G	cg14987922	chr2:37194071	STRN	0.87	7.09	0.63	5.3e-10	Immature fraction of reticulocytes;
SKCM	cis	rs2204008	0.660	rs2874343	chr12:38239096	C/T	cg26384229	chr12:38710491	ALG10B	0.87	6.9	0.62	1.21e-9	Bladder cancer;
SKCM	cis	rs600231	0.708	rs1784860	chr11:65240712	C/A	cg24009118	chr11:65545808	DKFZp761E198	0.66	4.94	0.49	4.36e-6	Bone mineral density;
SKCM	cis	rs9583531	0.600	rs754599	chr13:111354788	C/A	cg24331049	chr13:111365604	ING1	0.87	6.42	0.59	9.84e-9	Coronary artery disease;
SKCM	cis	rs854765	0.583	rs67253360	chr17:17828973	T/C	cg04398451	chr17:18023971	MYO15A	-0.85	-6.05	-0.57	4.75e-8	Total body bone mineral density;
SKCM	cis	rs28374715	0.662	rs16971558	chr15:41458619	G/A	cg18705301	chr15:41695430	NDUFAF1	-0.96	-8.43	-0.69	1.37e-12	Ulcerative colitis;
SKCM	cis	rs7945705	0.967	rs10840141	chr11:8902218	T/C	cg13070366	chr11:9386451	NA	-0.61	-5.37	-0.52	7.75e-7	Hemoglobin concentration;
SKCM	cis	rs3857536	0.740	rs7751095	chr6:66891318	A/G	cg07460842	chr6:66804631	NA	-0.7	-5.08	-0.5	2.51e-6	Blood trace element (Cu levels);
SKCM	cis	rs763014	0.865	rs62030874	chr16:632233	T/C	cg07343612	chr16:622815	PIGQ	-0.69	-5.92	-0.56	8.2e-8	Height;
SKCM	cis	rs7786877	0.723	rs73407376	chr7:100215200	C/T	cg16850897	chr7:100343110	ZAN	-0.64	-4.84	-0.48	6.46e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs2204008	0.748	rs11180579	chr12:38237830	A/G	cg13010199	chr12:38710504	ALG10B	0.69	4.99	0.49	3.57e-6	Bladder cancer;
SKCM	cis	rs67311347	0.544	rs9833640	chr3:40354941	T/A	cg00656387	chr3:40428638	ENTPD3	0.55	4.77	0.48	8.39e-6	Renal cell carcinoma;
SKCM	cis	rs654950	0.934	rs665223	chr1:42000654	A/T	cg06885757	chr1:42089581	HIVEP3	-0.66	-6.78	-0.61	2.06e-9	Airway imaging phenotypes;
SKCM	cis	rs17376456	0.877	rs10476598	chr5:93367281	C/T	cg25358565	chr5:93447407	FAM172A	-1.2	-8.07	-0.67	6.79e-12	Diabetic retinopathy;
SKCM	cis	rs1799949	0.930	rs1554063	chr17:41287145	T/C	cg25918947	chr17:41365094	TMEM106A	-0.62	-5.9	-0.56	8.91e-8	Menopause (age at onset);
SKCM	cis	rs2739330	0.731	rs4822450	chr22:24242887	C/T	cg04234412	chr22:24373322	LOC391322	-0.7	-6.04	-0.56	5.03e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs8017423	0.967	rs11159958	chr14:90716051	T/C	cg04374321	chr14:90722782	PSMC1	0.97	8.91	0.71	1.61e-13	Mortality in heart failure;
SKCM	cis	rs4242434	0.927	rs2291232	chr8:22464064	A/G	cg03733263	chr8:22462867	KIAA1967	1.03	8.84	0.71	2.25e-13	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs2228479	0.850	rs11647174	chr16:89958538	G/A	cg06558623	chr16:89946397	TCF25	1.12	5.64	0.54	2.58e-7	Skin colour saturation;
SKCM	cis	rs769267	0.895	rs2965182	chr19:19548246	A/G	cg26732615	chr19:19648335	CILP2;YJEFN3	0.67	6.92	0.62	1.13e-9	Tonsillectomy;
SKCM	cis	rs2197308	0.765	rs12230545	chr12:37927114	C/T	cg26384229	chr12:38710491	ALG10B	-0.76	-6.24	-0.58	2.08e-8	Morning vs. evening chronotype;
SKCM	cis	rs10779751	0.686	rs2791656	chr1:11128329	A/G	cg08854313	chr1:11322531	MTOR	0.76	4.88	0.48	5.6e-6	Body mass index;
SKCM	cis	rs4481887	0.790	rs4382760	chr1:248422343	A/C	cg00666640	chr1:248458726	OR2T12	-0.65	-5.99	-0.56	6.02e-8	Common traits (Other);
SKCM	cis	rs365132	0.934	rs6861925	chr5:176324729	C/G	cg16309518	chr5:176445507	NA	-0.5	-5.04	-0.5	2.99e-6	Menarche and menopause (age at onset);Menopause (age at onset);
SKCM	cis	rs7824557	0.628	rs7815802	chr8:11190647	G/C	cg21775007	chr8:11205619	TDH	0.72	6.73	0.61	2.51e-9	Retinal vascular caliber;
SKCM	cis	rs12477438	0.834	rs6757019	chr2:99676936	T/A	cg26064155	chr2:99771622	LIPT1;TSGA10	-0.72	-4.86	-0.48	6e-6	Chronic sinus infection;
SKCM	cis	rs9611565	0.649	rs738422	chr22:42123399	C/T	cg03806693	chr22:41940476	POLR3H	0.79	5.05	0.5	2.87e-6	Vitiligo;
SKCM	cis	rs7336332	0.662	rs9581862	chr13:28039993	T/G	cg22138327	chr13:27999177	GTF3A	0.71	5.36	0.52	8.12e-7	Weight;
SKCM	cis	rs62238980	0.614	rs55695217	chr22:32463135	C/G	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs9911578	1.000	rs9892062	chr17:56976981	G/A	cg12560992	chr17:57184187	TRIM37	0.94	7.55	0.65	7.01e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs3767633	0.502	rs2499845	chr1:161933066	G/C	cg27519958	chr1:161735129	ATF6	-0.84	-6.48	-0.59	7.42e-9	IgG glycosylation;
SKCM	cis	rs2032447	0.714	rs199734	chr6:25940393	G/C	cg03517284	chr6:25882590	NA	-0.65	-5.31	-0.52	9.99e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs4481887	0.790	rs10888364	chr1:248488387	T/G	cg00666640	chr1:248458726	OR2T12	0.59	5.19	0.51	1.64e-6	Common traits (Other);
SKCM	cis	rs8060686	0.641	rs79375669	chr16:68099262	A/T	cg09117114	chr16:67998030	SLC12A4	-0.81	-5.29	-0.51	1.07e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs1153858	1.000	rs8042786	chr15:45703539	T/C	cg10760299	chr15:45669010	GATM	0.6	5.93	0.56	7.69e-8	Homoarginine levels;
SKCM	cis	rs9910055	0.530	rs2269908	chr17:42294198	G/C	cg08499158	chr17:42289980	UBTF	-0.79	-6.91	-0.62	1.15e-9	Total body bone mineral density;
SKCM	cis	rs8060686	0.641	rs73612222	chr16:68216072	A/G	cg09117114	chr16:67998030	SLC12A4	-0.77	-5.03	-0.49	3.12e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs2204008	0.683	rs12370288	chr12:38127740	G/A	cg13010199	chr12:38710504	ALG10B	0.65	4.84	0.48	6.52e-6	Bladder cancer;
SKCM	cis	rs1799949	0.929	rs799906	chr17:41278116	T/C	cg19454999	chr17:41278357	BRCA1;NBR2	0.51	4.8	0.48	7.53e-6	Menopause (age at onset);
SKCM	cis	rs7811142	0.830	rs118119933	chr7:99939050	C/T	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.28	7.13	0.63	4.46e-10	Platelet count;
SKCM	cis	rs2832191	0.740	rs2012645	chr21:30445961	G/A	cg24692254	chr21:30365293	RNF160	0.99	9.05	0.72	8.59e-14	Dental caries;
SKCM	cis	rs644799	0.760	rs7114555	chr11:95648242	T/C	cg03916912	chr11:95522834	CEP57;FAM76B	0.62	4.96	0.49	4.06e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs2033711	0.936	rs882609	chr19:58991479	G/A	cg12042659	chr19:58951599	ZNF132	0.73	6.3	0.58	1.63e-8	Uric acid clearance;
SKCM	cis	rs2760061	0.598	rs632832	chr1:228121838	G/T	cg02753203	chr1:228287806	NA	-0.61	-5.04	-0.5	2.96e-6	Diastolic blood pressure;
SKCM	cis	rs4332037	0.851	rs28728306	chr7:1961814	C/A	cg02825527	chr7:2087843	MAD1L1	-0.74	-5.06	-0.5	2.68e-6	Bipolar disorder;
SKCM	cis	rs17818399	0.547	rs12997164	chr2:46758746	A/C	cg02822958	chr2:46747628	ATP6V1E2	0.66	4.98	0.49	3.68e-6	Height;
SKCM	cis	rs2644899	0.859	rs2545755	chr19:41293162	T/G	cg24958765	chr19:41283667	RAB4B	-0.84	-5.36	-0.52	8.17e-7	Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs7618501	0.538	rs9856572	chr3:50109073	A/T	cg24110177	chr3:50126178	RBM5	0.62	5.24	0.51	1.32e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs6500395	0.962	rs9921741	chr16:48589896	G/A	cg04672837	chr16:48644449	N4BP1	0.69	5.73	0.54	1.8e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs2228479	0.618	rs34689166	chr16:89860697	C/T	cg06558623	chr16:89946397	TCF25	1.04	4.82	0.48	6.97e-6	Skin colour saturation;
SKCM	cis	rs7937682	0.593	rs1944117	chr11:111351184	T/C	cg09085632	chr11:111637200	PPP2R1B	0.68	5.33	0.52	9.34e-7	Primary sclerosing cholangitis;
SKCM	cis	rs910316	0.763	rs13712	chr14:75483812	T/C	cg08847533	chr14:75593920	NEK9	0.83	7.06	0.62	6e-10	Height;
SKCM	cis	rs2282335	0.507	rs2498421	chr9:71855357	A/G	cg14075627	chr9:71863002	TJP2	0.69	5.45	0.53	5.6e-7	Renal sinus fat;
SKCM	cis	rs826838	0.806	rs826873	chr12:39121305	G/A	cg26384229	chr12:38710491	ALG10B	-0.94	-8.05	-0.67	7.57e-12	Heart rate;
SKCM	cis	rs6582630	0.502	rs11181214	chr12:38298313	C/A	cg26384229	chr12:38710491	ALG10B	0.8	6.55	0.6	5.47e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs6752107	0.782	rs12692254	chr2:234161211	A/T	cg23050873	chr2:234184376	ATG16L1;SCARNA5	0.62	4.83	0.48	6.71e-6	Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs4746818	0.688	rs951718	chr10:70928044	A/G	cg11621586	chr10:70884670	VPS26A	0.99	7.62	0.65	5.08e-11	Left atrial antero-posterior diameter;
SKCM	cis	rs1799949	1.000	rs8176318	chr17:41197274	G/T	cg23758822	chr17:41437982	NA	0.94	7.87	0.67	1.68e-11	Menopause (age at onset);
SKCM	cis	rs12464559	0.649	rs16830418	chr2:152707614	A/G	cg01189475	chr2:152685088	ARL5A	1.37	5.53	0.53	4.18e-7	Response to cognitive-behavioural therapy in anxiety disorder;
SKCM	cis	rs910316	1.000	rs11623413	chr14:75588824	C/T	cg08847533	chr14:75593920	NEK9	-0.97	-8.96	-0.71	1.29e-13	Height;
SKCM	cis	rs7216064	1.000	rs62084246	chr17:65867911	G/C	cg12091567	chr17:66097778	LOC651250	-0.75	-5.27	-0.51	1.19e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	trans	rs1814175	0.645	rs10444311	chr11:49986906	A/G	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs35079168	0.923	rs11103473	chr9:137287629	A/T	cg00753924	chr9:137298813	RXRA	0.75	5.07	0.5	2.57e-6	Intelligence;
SKCM	cis	rs2841233	0.718	rs2304758	chr14:105344318	G/A	cg16576083	chr14:105354267	KIAA0284	0.6	4.77	0.48	8.29e-6	IgG glycosylation;
SKCM	cis	rs9880211	0.718	rs35320690	chr3:135932494	C/T	cg21827317	chr3:136751795	NA	0.64	4.83	0.48	6.75e-6	Body mass index;Height;
SKCM	cis	rs727563	0.636	rs2187795	chr22:42092225	C/A	cg03806693	chr22:41940476	POLR3H	1.13	6.92	0.62	1.13e-9	Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs7666738	0.753	rs10004827	chr4:99037953	A/C	cg17366294	chr4:99064904	C4orf37	0.6	4.98	0.49	3.66e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7684253	0.565	rs13130605	chr4:57810071	G/A	cg25313468	chr4:57773308	REST	0.4	4.89	0.48	5.24e-6	Migraine;
SKCM	cis	rs10832963	0.924	rs10832950	chr11:18635815	A/G	cg09201001	chr11:18656081	SPTY2D1	1.03	11.04	0.78	1.31e-17	Breast cancer;
SKCM	cis	rs8177253	1.000	rs8177240	chr3:133477701	T/G	cg16414030	chr3:133502952	NA	-0.71	-5.95	-0.56	7.12e-8	Iron status biomarkers;
SKCM	cis	rs2645694	0.626	rs2703124	chr4:77820626	G/T	cg06046430	chr4:77819534	ANKRD56	0.54	5.83	0.55	1.18e-7	Emphysema distribution in smoking;
SKCM	cis	rs7843479	0.965	rs4872104	chr8:21780744	A/G	cg17168535	chr8:21777572	XPO7	0.7	5.3	0.51	1.04e-6	Mean corpuscular volume;
SKCM	trans	rs1814175	0.669	rs10839315	chr11:49654406	G/A	cg15704280	chr7:45808275	SEPT13	-0.79	-7.36	-0.64	1.62e-10	Height;
SKCM	cis	rs7772486	0.790	rs2247206	chr6:146216184	C/T	cg05347473	chr6:146136440	FBXO30	0.56	5.18	0.51	1.67e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs8078723	0.714	rs2241244	chr17:38153554	G/C	cg17467752	chr17:38218738	THRA	-0.63	-5.73	-0.54	1.8e-7	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs7811142	1.000	rs6975514	chr7:100056220	T/C	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.12	6.51	0.59	6.68e-9	Platelet count;
SKCM	cis	rs6089829	0.962	rs4809456	chr20:61660849	C/A	cg08564027	chr20:61660810	NA	0.62	5.55	0.53	3.75e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs1799949	1.000	rs2292595	chr17:41290674	G/C	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.11	-0.57	3.67e-8	Menopause (age at onset);
SKCM	cis	rs16940212	0.580	rs493987	chr15:58687906	T/C	cg16767221	chr15:57769667	CGNL1	0.58	4.78	0.48	8.22e-6	HDL cholesterol levels;HDL cholesterol;
SKCM	cis	rs10752881	0.743	rs10737244	chr1:183098417	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Colorectal cancer;
SKCM	cis	rs7772486	0.686	rs1045820	chr6:145947080	C/T	cg05347473	chr6:146136440	FBXO30	0.57	5.19	0.51	1.61e-6	Lobe attachment (rater-scored or self-reported);
SKCM	trans	rs17685	0.712	rs7794454	chr7:75776010	A/G	cg19862616	chr7:65841803	NCRNA00174	-0.86	-8.24	-0.68	3.26e-12	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2836974	0.897	rs2836973	chr21:40654928	A/G	cg17971929	chr21:40555470	PSMG1	0.9	8.81	0.71	2.52e-13	Cognitive function;
SKCM	cis	rs9926296	0.585	rs8045232	chr16:89857548	A/G	cg27121462	chr16:89883253	FANCA	0.81	7.32	0.64	1.92e-10	Vitiligo;
SKCM	cis	rs116095464	0.558	rs10076655	chr5:239464	G/C	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs8078723	0.677	rs11658328	chr17:38149236	T/C	cg17467752	chr17:38218738	THRA	-0.61	-5.49	-0.53	4.75e-7	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs875971	0.862	rs35378740	chr7:65987712	C/A	cg18876405	chr7:65276391	NA	0.61	6.06	0.57	4.57e-8	Aortic root size;
SKCM	cis	rs6066825	0.590	rs6063307	chr20:47304045	A/G	cg18078177	chr20:47281410	PREX1	0.63	5.19	0.51	1.62e-6	Colorectal cancer;
SKCM	cis	rs6912958	0.559	rs499373	chr6:88042062	A/T	cg08069147	chr6:88032118	GJB7;C6orf162	0.64	5.61	0.54	2.97e-7	Monocyte percentage of white cells;
SKCM	cis	rs4642101	0.669	rs1467026	chr3:12830775	G/A	cg05775895	chr3:12838266	CAND2	0.59	5.11	0.5	2.24e-6	QRS complex (12-leadsum);
SKCM	cis	rs6424115	0.830	rs2501369	chr1:24206032	G/A	cg15997130	chr1:24165203	NA	0.58	4.77	0.48	8.43e-6	Immature fraction of reticulocytes;
SKCM	cis	rs2999052	0.526	rs981446	chr3:127753730	G/A	cg09089421	chr3:127803668	RUVBL1	-0.54	-4.84	-0.48	6.5e-6	Hypospadias;
SKCM	cis	rs17376456	0.877	rs10072592	chr5:93405989	C/G	cg25358565	chr5:93447407	FAM172A	1.22	7.9	0.67	1.49e-11	Diabetic retinopathy;
SKCM	cis	rs919433	0.927	rs7592748	chr2:198170688	G/A	cg04278110	chr2:198063759	ANKRD44	-0.69	-4.8	-0.48	7.58e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs873946	0.590	rs7071777	chr10:134559976	T/A	cg18305652	chr10:134549665	INPP5A	0.59	6.04	0.56	4.89e-8	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs6753739	0.826	rs7599778	chr2:219961660	G/C	cg09297636	chr2:219923910	IHH	0.46	4.79	0.48	7.89e-6	Height;
SKCM	cis	rs1395	0.710	rs72817533	chr2:27482612	A/G	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.5	4.79	0.48	7.88e-6	Blood metabolite levels;
SKCM	cis	rs6089829	0.888	rs4809467	chr20:61671688	A/G	cg08564027	chr20:61660810	NA	0.64	5.85	0.55	1.11e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs1799949	0.930	rs1554063	chr17:41287145	T/C	cg23758822	chr17:41437982	NA	0.93	7.62	0.65	5.1e-11	Menopause (age at onset);
SKCM	cis	rs2204008	0.837	rs12370891	chr12:37984531	A/G	cg26384229	chr12:38710491	ALG10B	0.8	6.2	0.57	2.47e-8	Bladder cancer;
SKCM	cis	rs6582630	0.502	rs4309219	chr12:38293584	A/G	cg26384229	chr12:38710491	ALG10B	0.78	6.56	0.6	5.26e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs847649	0.731	rs2298854	chr7:102729631	T/G	cg18108683	chr7:102477205	FBXL13	0.8	7.3	0.64	2.1e-10	Morning vs. evening chronotype;
SKCM	cis	rs769267	0.930	rs2288852	chr19:19605348	T/C	cg26732615	chr19:19648335	CILP2;YJEFN3	0.67	7.06	0.62	6e-10	Tonsillectomy;
SKCM	cis	rs28374715	0.532	rs28535540	chr15:41659277	G/A	cg18705301	chr15:41695430	NDUFAF1	-1.18	-12.81	-0.82	7.04e-21	Ulcerative colitis;
SKCM	cis	rs6952808	0.964	rs10950400	chr7:1882470	C/T	cg04267008	chr7:1944627	MAD1L1	-0.8	-6.1	-0.57	3.78e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs1029738	0.615	rs717624	chr7:22894487	T/C	cg18884940	chr7:22894078	NA	-0.62	-4.84	-0.48	6.33e-6	Fibrinogen levels;
SKCM	cis	rs6951245	1.000	rs78158942	chr7:1090440	G/T	cg24642844	chr7:1081250	C7orf50	-0.94	-6.32	-0.58	1.48e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7959452	0.532	rs2291005	chr12:69764388	A/G	cg14784868	chr12:69753453	YEATS4	0.8	7.57	0.65	6.41e-11	Blood protein levels;
SKCM	cis	rs1218582	0.772	rs4845682	chr1:154877105	T/C	cg16680214	chr1:154839983	KCNN3	-0.56	-5.01	-0.49	3.29e-6	Prostate cancer;
SKCM	cis	rs7659604	0.840	rs6821305	chr4:122713863	A/C	cg19748678	chr4:122722346	EXOSC9	0.68	5.78	0.55	1.44e-7	Type 2 diabetes;
SKCM	cis	rs9611565	0.659	rs73178626	chr22:41928371	T/G	cg03806693	chr22:41940476	POLR3H	-1.11	-7.56	-0.65	6.67e-11	Vitiligo;
SKCM	cis	rs7809950	0.678	rs3801966	chr7:106824580	G/A	cg23024343	chr7:107201750	COG5	-0.8	-6.48	-0.59	7.58e-9	Coronary artery disease;
SKCM	cis	rs6120849	0.901	rs6060273	chr20:33744323	G/C	cg24642439	chr20:33292090	TP53INP2	0.91	5.05	0.5	2.83e-6	Protein C levels;
SKCM	cis	rs875971	0.862	rs7786892	chr7:65628876	G/A	cg18876405	chr7:65276391	NA	-0.65	-6.63	-0.6	3.96e-9	Aortic root size;
SKCM	cis	rs7772486	0.875	rs2814876	chr6:146304030	C/T	cg23711669	chr6:146136114	FBXO30	0.75	6.79	0.61	1.99e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2739330	0.796	rs5760097	chr22:24247794	G/C	cg24846343	chr22:24311635	DDTL	0.7	6.75	0.61	2.4e-9	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs4724125	0.960	rs2330629	chr7:42699121	T/C	cg09407816	chr7:42972088	MRPL32;PSMA2	0.81	4.94	0.49	4.31e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9457247	0.624	rs2239826	chr6:167504880	T/C	cg07741184	chr6:167504864	NA	0.58	5.35	0.52	8.55e-7	Crohn's disease;
SKCM	cis	rs7811142	1.000	rs67040465	chr7:100083078	G/A	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-1.02	-5.76	-0.55	1.59e-7	Platelet count;
SKCM	cis	rs9485372	0.945	rs57671746	chr6:149607774	G/A	cg03072286	chr6:150262044	ULBP2	-0.55	-4.89	-0.48	5.3e-6	Breast cancer;
SKCM	cis	rs951366	0.789	rs823094	chr1:205689807	G/T	cg24503407	chr1:205819492	PM20D1	-0.63	-4.96	-0.49	3.98e-6	Menarche (age at onset);
SKCM	cis	rs2963155	0.518	rs853179	chr5:142634773	G/T	cg17617527	chr5:142782415	NR3C1	1.13	5.42	0.52	6.46e-7	Breast cancer;
SKCM	cis	rs151997	0.777	rs6870880	chr5:50256207	G/A	cg06027927	chr5:50259733	NA	0.7	6.53	0.59	6.14e-9	Callous-unemotional behaviour;
SKCM	cis	rs1044826	0.642	rs295479	chr3:139223865	C/T	cg15131784	chr3:139108705	COPB2	0.68	4.97	0.49	3.85e-6	Obesity-related traits;
SKCM	cis	rs1005277	0.589	rs2749624	chr10:38529865	A/G	cg00409905	chr10:38381863	ZNF37A	-0.65	-5.96	-0.56	6.88e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs2204008	0.905	rs8189449	chr12:38437377	C/A	cg26384229	chr12:38710491	ALG10B	0.81	6.22	0.58	2.33e-8	Bladder cancer;
SKCM	cis	rs453301	0.624	rs2288671	chr8:8860894	T/C	cg15556689	chr8:8085844	FLJ10661	0.66	5.2	0.51	1.55e-6	Joint mobility (Beighton score);
SKCM	cis	rs3096299	0.685	rs4785676	chr16:89553624	T/C	cg02187348	chr16:89574699	SPG7	0.6	4.84	0.48	6.38e-6	Multiple myeloma (IgH translocation);
SKCM	cis	rs1218582	0.772	rs6699043	chr1:154913021	T/C	cg06221963	chr1:154839813	KCNN3	-0.54	-5.29	-0.51	1.09e-6	Prostate cancer;
SKCM	cis	rs116095464	0.558	rs73024831	chr5:257192	A/G	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs2180341	0.814	rs9321085	chr6:127735361	T/C	cg27446573	chr6:127587934	RNF146	0.69	5.49	0.53	4.79e-7	Breast cancer;
SKCM	cis	rs561341	1.000	rs576985	chr17:30323323	C/T	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs9818758	0.607	rs13087930	chr3:48961726	A/G	cg00383909	chr3:49044727	WDR6	0.95	5.43	0.52	6.25e-7	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs6933660	0.646	rs9397410	chr6:151770503	C/T	cg02564969	chr6:151773285	C6orf211;RMND1	0.66	5.54	0.53	3.87e-7	Menarche (age at onset);
SKCM	cis	rs28386778	0.897	rs2727295	chr17:61887693	C/T	cg01411255	chr17:61851458	DDX42;CCDC47	0.78	5.16	0.5	1.85e-6	Prudent dietary pattern;
SKCM	cis	rs7027203	0.828	rs3957506	chr9:96588133	C/T	cg14598338	chr9:96623480	NA	-0.51	-5.04	-0.5	2.96e-6	DNA methylation (variation);
SKCM	cis	rs9910055	0.529	rs425038	chr17:42182028	T/C	cg08499158	chr17:42289980	UBTF	0.73	5.64	0.54	2.64e-7	Total body bone mineral density;
SKCM	trans	rs66573146	1.000	rs56074877	chr4:6990374	C/T	cg07817883	chr1:32538562	TMEM39B	1.94	8.42	0.69	1.47e-12	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs875971	0.862	rs12537823	chr7:65720884	C/T	cg18876405	chr7:65276391	NA	0.63	6.38	0.59	1.18e-8	Aortic root size;
SKCM	cis	rs6445797	0.632	rs2317133	chr3:56648292	G/A	cg13616963	chr3:57583610	ARF4	-0.76	-4.92	-0.49	4.78e-6	Gastritis;
SKCM	cis	rs4733789	0.647	rs4733778	chr8:128828680	C/T	cg24514600	chr8:128805414	PVT1	-0.55	-4.85	-0.48	6.16e-6	Height;
SKCM	cis	rs17065868	1.000	rs9533894	chr13:45102865	T/C	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs6089584	0.508	rs6061988	chr20:60626300	C/T	cg06108461	chr20:60628389	TAF4	-0.83	-7.92	-0.67	1.33e-11	Body mass index;
SKCM	cis	rs35306767	0.903	rs35370435	chr10:898205	T/C	cg20503657	chr10:835505	NA	0.78	5.53	0.53	4.14e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs7666738	0.830	rs28769113	chr4:98950371	T/G	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs514406	0.505	rs425520	chr1:53179805	C/G	cg16325326	chr1:53192061	ZYG11B	0.89	10.18	0.76	5.81e-16	Monocyte count;
SKCM	cis	rs72781680	0.898	rs10490751	chr2:24001356	A/G	cg08917208	chr2:24149416	ATAD2B	0.92	4.85	0.48	6.19e-6	Lymphocyte counts;
SKCM	cis	rs28595532	0.920	rs116146507	chr4:119749556	A/G	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs55823223	0.564	rs12103594	chr17:73855279	C/T	cg10935138	chr17:73851978	WBP2	1.18	7.17	0.63	3.66e-10	Psoriasis;
SKCM	trans	rs1814175	0.645	rs847635	chr11:49923323	G/A	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs1707322	0.721	rs28641748	chr1:46212836	A/G	cg03146154	chr1:46216737	IPP	0.84	6.2	0.57	2.51e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs10911232	0.507	rs4651138	chr1:183001312	C/A	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.64	0.6	3.83e-9	Hypertriglyceridemia;
SKCM	cis	rs807669	0.903	rs807666	chr22:19160549	C/T	cg02655711	chr22:19163373	SLC25A1	0.78	7.4	0.64	1.34e-10	Metabolite levels;
SKCM	cis	rs4808199	1.000	rs12972397	chr19:19562349	G/A	cg03709012	chr19:19516395	GATAD2A	1.13	8.66	0.7	4.94e-13	Nonalcoholic fatty liver disease;
SKCM	cis	rs2153535	0.580	rs7775909	chr6:8477778	A/G	cg23788917	chr6:8435910	SLC35B3	0.67	4.78	0.48	8.23e-6	Motion sickness;
SKCM	cis	rs875971	1.000	rs6956179	chr7:65806659	C/T	cg11764359	chr7:65958608	NA	-0.88	-8.54	-0.7	8.36e-13	Aortic root size;
SKCM	cis	rs7659604	1.000	rs6846232	chr4:122664805	A/G	cg19671926	chr4:122722719	EXOSC9	-0.64	-4.78	-0.48	8.04e-6	Type 2 diabetes;
SKCM	cis	rs11892454	0.544	rs7560314	chr2:26007959	G/T	cg17263061	chr2:26915892	KCNK3	0.68	4.98	0.49	3.67e-6	Heschl's gyrus morphology;
SKCM	cis	rs8072100	0.676	rs9905308	chr17:45409386	T/A	cg08085267	chr17:45401833	C17orf57	-0.85	-7.16	-0.63	3.97e-10	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs597539	0.652	rs482172	chr11:68668437	C/A	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.83	5.52	0.53	4.36e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs2836633	0.895	rs62217513	chr21:40024416	A/T	cg05519781	chr21:40033154	ERG	0.82	7.09	0.63	5.29e-10	Coronary artery disease;
SKCM	trans	rs1814175	0.715	rs11040586	chr11:49858432	T/A	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	trans	rs8073060	0.559	rs10438814	chr17:34007065	A/G	cg19694781	chr19:47549865	TMEM160	-1.04	-8.28	-0.68	2.65e-12	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs10823500	0.777	rs10999196	chr10:71982305	T/C	cg04118878	chr10:71993077	PPA1	0.65	4.88	0.48	5.45e-6	Blood protein levels;
SKCM	cis	rs7809950	0.678	rs62483641	chr7:106901741	T/C	cg23024343	chr7:107201750	COG5	-0.79	-6.77	-0.61	2.16e-9	Coronary artery disease;
SKCM	cis	rs801193	1.000	rs13239306	chr7:66136017	T/G	cg11764359	chr7:65958608	NA	-0.71	-5.22	-0.51	1.43e-6	Aortic root size;
SKCM	cis	rs2013441	1.000	rs2034109	chr17:20196633	C/T	cg13482628	chr17:19912719	NA	-0.65	-5.07	-0.5	2.67e-6	Obesity-related traits;
SKCM	trans	rs17685	0.753	rs2302438	chr7:75677065	C/A	cg19862616	chr7:65841803	NCRNA00174	0.94	9.39	0.73	1.88e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs11098499	0.697	rs11941899	chr4:120382758	C/A	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs17345786	1.000	rs3762729	chr3:101308874	C/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.69	4.91	0.49	4.87e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1799949	0.965	rs11658499	chr17:41334749	C/T	cg23758822	chr17:41437982	NA	0.93	7.84	0.66	1.91e-11	Menopause (age at onset);
SKCM	cis	rs60871478	1.000	rs60871478	chr7:827325	A/G	cg05535760	chr7:792225	HEATR2	1.02	8.66	0.7	4.97e-13	Cerebrospinal P-tau181p levels;
SKCM	cis	rs362272	0.524	rs7435601	chr4:3369645	A/G	cg24015175	chr4:3319247	RGS12	0.83	9.48	0.73	1.28e-14	Serum sulfate level;
SKCM	cis	rs12586317	0.547	rs2038254	chr14:35462134	C/T	cg16230307	chr14:35515116	FAM177A1	0.81	5.88	0.55	9.47e-8	Psoriasis;
SKCM	cis	rs7786877	0.587	rs56328569	chr7:100202219	C/G	cg20848291	chr7:100343083	ZAN	-0.68	-5.02	-0.49	3.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs7584330	0.666	rs60671275	chr2:238374318	C/A	cg14458575	chr2:238380390	NA	1.08	7.27	0.64	2.35e-10	Prostate cancer;
SKCM	cis	rs28595532	0.920	rs114564223	chr4:119729953	A/G	cg11846333	chr4:119757529	SEC24D	1.2	6.43	0.59	9.38e-9	Cannabis dependence symptom count;
SKCM	cis	rs6840360	0.571	rs28454076	chr4:152520083	G/T	cg22705602	chr4:152727874	NA	-0.52	-5.69	-0.54	2.15e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs6088580	0.634	rs4911419	chr20:32995873	G/A	cg24642439	chr20:33292090	TP53INP2	-0.76	-6.02	-0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs1707322	1.000	rs1768800	chr1:46549188	A/G	cg03146154	chr1:46216737	IPP	-0.81	-5.43	-0.52	6.11e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs2120019	1.000	rs8033837	chr15:75353975	A/C	cg09165964	chr15:75287851	SCAMP5	-0.75	-6.7	-0.6	2.88e-9	Blood trace element (Zn levels);
SKCM	cis	rs6912958	0.703	rs12207825	chr6:88098292	C/T	cg08069147	chr6:88032118	GJB7;C6orf162	0.63	5.28	0.51	1.14e-6	Monocyte percentage of white cells;
SKCM	trans	rs1814175	0.645	rs847639	chr11:49919603	C/T	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs1799949	0.930	rs66499067	chr17:41248484	G/C	cg05368731	chr17:41323189	NBR1	0.89	7.49	0.65	9.23e-11	Menopause (age at onset);
SKCM	cis	rs2159324	1.000	rs10421129	chr19:45695836	G/A	cg17904997	chr19:44952572	ZNF229	-0.59	-4.91	-0.49	4.83e-6	Quantitative traits;
SKCM	cis	rs6753739	0.745	rs6736620	chr2:219912103	C/T	cg09617556	chr2:219924408	IHH	0.47	4.94	0.49	4.44e-6	Height;
SKCM	cis	rs35306767	0.807	rs34527494	chr10:935192	T/C	cg26597838	chr10:835615	NA	0.83	5.78	0.55	1.47e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs614226	1.000	rs7174	chr12:121017171	A/G	cg01236616	chr12:121019343	POP5	1.37	8.37	0.69	1.79e-12	Type 1 diabetes nephropathy;
SKCM	cis	rs1153858	1.000	rs7402650	chr15:45701895	C/T	cg10760299	chr15:45669010	GATM	0.6	5.93	0.56	7.69e-8	Homoarginine levels;
SKCM	cis	rs7020830	0.931	rs7034554	chr9:37081301	A/G	cg14294708	chr9:37120828	ZCCHC7	1.08	9.8	0.74	3.1e-15	Schizophrenia;
SKCM	cis	rs7666738	0.830	rs1534318	chr4:98965058	C/T	cg05340658	chr4:99064831	C4orf37	0.64	4.91	0.49	4.97e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2404602	0.647	rs11072628	chr15:77107761	C/A	cg23625390	chr15:77176239	SCAPER	-0.85	-8.26	-0.68	2.93e-12	Blood metabolite levels;
SKCM	cis	rs929354	1.000	rs1182385	chr7:157040583	C/T	cg17757837	chr7:157058334	UBE3C	-0.86	-6.5	-0.59	6.99e-9	Body mass index;
SKCM	cis	rs4148883	0.651	rs10020052	chr4:100086331	C/G	cg12011299	chr4:100065546	ADH4	0.48	4.78	0.48	8.14e-6	Alcohol dependence;
SKCM	cis	rs4237845	0.537	rs1599931	chr12:58258850	A/G	cg00677455	chr12:58241039	CTDSP2	0.91	8.12	0.68	5.57e-12	Intelligence (multi-trait analysis);
SKCM	cis	rs11690935	0.632	rs34242651	chr2:172553999	G/A	cg13550731	chr2:172543902	DYNC1I2	0.63	5.53	0.53	4.04e-7	Schizophrenia;
SKCM	cis	rs737337	0.623	rs3810308	chr19:11333596	T/C	cg00586551	chr19:11347513	LOC55908;DOCK6	0.81	5.92	0.56	8.3e-8	HDL cholesterol;HDL cholesterol levels;
SKCM	cis	rs9858542	0.953	rs34363169	chr3:49537712	G/A	cg03060546	chr3:49711283	APEH	-0.75	-5.53	-0.53	4.17e-7	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs7618501	0.633	rs11130228	chr3:50003246	C/T	cg05072774	chr3:49840536	C3orf54	-0.67	-5.06	-0.5	2.73e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1552244	1.000	rs9834980	chr3:10065528	G/A	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs2153535	0.580	rs6597327	chr6:8482157	G/A	cg07606381	chr6:8435919	SLC35B3	0.86	6.25	0.58	2.06e-8	Motion sickness;
SKCM	cis	rs28386778	0.897	rs2044125	chr17:61863184	A/C	cg06873352	chr17:61820015	STRADA	-0.76	-6.49	-0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs9894429	0.966	rs6565601	chr17:79580173	C/T	cg18240062	chr17:79603768	NPLOC4	0.76	7.43	0.64	1.2e-10	Eye color traits;
SKCM	cis	rs7843479	0.601	rs10101881	chr8:21830158	A/G	cg17168535	chr8:21777572	XPO7	0.86	7.56	0.65	6.76e-11	Mean corpuscular volume;
SKCM	cis	rs2842992	0.747	rs1547093	chr6:160205991	C/A	cg19482086	chr6:160211437	TCP1;MRPL18	0.86	6.82	0.61	1.71e-9	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs2120019	0.938	rs8028632	chr15:75321262	T/C	cg09165964	chr15:75287851	SCAMP5	-0.85	-8.74	-0.7	3.44e-13	Blood trace element (Zn levels);
SKCM	cis	rs11658309	1	rs11658309	chr17:17762247	T/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	-1.05	-8.25	-0.68	3.1e-12	Strep throat;
SKCM	cis	rs1878931	0.696	rs35984213	chr16:3451030	G/A	cg26668626	chr16:3451006	ZNF174;ZNF434	1.1	10.72	0.77	5.21e-17	Body mass index (adult);
SKCM	cis	rs67311347	1.000	rs4974017	chr3:40473519	C/T	cg00091569	chr3:40428383	ENTPD3	0.6	5.02	0.49	3.22e-6	Renal cell carcinoma;
SKCM	cis	rs6840360	0.615	rs12503677	chr4:152610543	A/G	cg22705602	chr4:152727874	NA	-0.6	-7.96	-0.67	1.12e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs35146811	0.695	rs858509	chr7:99821470	A/G	cg22906224	chr7:99728672	NA	-0.71	-5.61	-0.54	2.99e-7	Coronary artery disease;
SKCM	cis	rs3796619	1.000	rs1466214	chr4:1073760	C/T	cg27284194	chr4:1044797	NA	0.67	4.8	0.48	7.53e-6	Recombination rate (males);
SKCM	cis	rs1552244	1.000	rs4260416	chr3:10125283	C/T	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs9916302	0.904	rs1619021	chr17:37739274	G/A	cg07936489	chr17:37558343	FBXL20	-0.91	-7.39	-0.64	1.39e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs3766606	0.505	rs67002863	chr1:7923478	G/A	cg00042356	chr1:8021962	PARK7	0.83	5.67	0.54	2.29e-7	Ulcerative colitis;Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs898097	0.812	rs7406011	chr17:80829980	C/T	cg15369054	chr17:80825471	TBCD	0.66	6.18	0.57	2.69e-8	Breast cancer;
SKCM	cis	rs17685	0.535	rs41299460	chr7:75600951	G/A	cg16684958	chr7:75615977	POR	0.62	5.17	0.51	1.75e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2303759	0.874	rs10411630	chr19:49891314	C/A	cg05022225	chr19:49866942	DKKL1;TEAD2	0.68	4.86	0.48	5.94e-6	Multiple sclerosis;
SKCM	cis	rs995000	0.931	rs1168018	chr1:63001120	A/C	cg06896770	chr1:63153194	DOCK7	-0.75	-6.89	-0.61	1.29e-9	Triglyceride levels;
SKCM	cis	rs28386778	0.897	rs2727327	chr17:61923422	G/A	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs12477438	0.798	rs1993230	chr2:99686079	T/C	cg26064155	chr2:99771622	LIPT1;TSGA10	-0.72	-4.86	-0.48	6e-6	Chronic sinus infection;
SKCM	cis	rs9818758	0.607	rs11552724	chr3:49156473	C/G	cg00383909	chr3:49044727	WDR6	1.05	5.85	0.55	1.11e-7	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs9880211	0.563	rs6793835	chr3:135819934	A/G	cg21827317	chr3:136751795	NA	0.68	5.06	0.5	2.77e-6	Body mass index;Height;
SKCM	cis	rs2228479	0.557	rs11641726	chr16:89891619	G/A	cg06558623	chr16:89946397	TCF25	1.1	4.95	0.49	4.17e-6	Skin colour saturation;
SKCM	cis	rs6120849	0.707	rs6088703	chr20:33676049	T/A	cg24642439	chr20:33292090	TP53INP2	0.95	4.84	0.48	6.43e-6	Protein C levels;
SKCM	cis	rs2836974	0.674	rs1011413	chr21:40638241	A/G	cg17971929	chr21:40555470	PSMG1	-0.76	-7.17	-0.63	3.67e-10	Cognitive function;
SKCM	cis	rs3008870	1.000	rs4655663	chr1:67430103	C/T	cg08660285	chr1:67390436	MIER1;WDR78	0.94	6.41	0.59	1.04e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs9300255	0.596	rs4460848	chr12:123677810	A/G	cg00376283	chr12:123451042	ABCB9	0.86	6.55	0.6	5.68e-9	Neutrophil percentage of white cells;
SKCM	cis	rs2404602	0.622	rs1567671	chr15:77209200	C/G	cg23625390	chr15:77176239	SCAPER	-0.83	-8.01	-0.67	9.15e-12	Blood metabolite levels;
SKCM	cis	rs11700980	0.636	rs73190119	chr21:30303685	C/A	cg24692254	chr21:30365293	RNF160	-0.88	-5.04	-0.5	2.93e-6	QRS complex (12-leadsum);
SKCM	cis	rs7659604	1.000	rs72678650	chr4:122666000	A/G	cg19748678	chr4:122722346	EXOSC9	0.64	5.4	0.52	7.11e-7	Type 2 diabetes;
SKCM	cis	rs908922	0.676	rs7530609	chr1:152526812	C/A	cg09873164	chr1:152488093	CRCT1	0.72	5.62	0.54	2.85e-7	Hair morphology;
SKCM	cis	rs2832077	0.527	rs9980449	chr21:30224889	G/C	cg24692254	chr21:30365293	RNF160	-0.75	-5.62	-0.54	2.79e-7	Cognitive test performance;
SKCM	cis	rs12497850	0.931	rs4974087	chr3:48919232	A/G	cg07636037	chr3:49044803	WDR6	1.02	11.0	0.78	1.56e-17	Parkinson's disease;
SKCM	cis	rs35146811	0.695	rs1618851	chr7:99810643	T/G	cg22906224	chr7:99728672	NA	-0.72	-5.76	-0.55	1.61e-7	Coronary artery disease;
SKCM	cis	rs644799	0.965	rs11021317	chr11:95517576	C/T	cg25622487	chr11:95524042	FAM76B;CEP57	0.73	5.9	0.56	8.71e-8	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs7666738	0.830	rs10031190	chr4:98908683	C/A	cg05340658	chr4:99064831	C4orf37	0.6	4.83	0.48	6.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs911555	0.504	rs4444269	chr14:104072724	G/C	cg24130564	chr14:104152367	KLC1	-0.58	-5.11	-0.5	2.27e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs875971	0.862	rs6978028	chr7:65886300	G/C	cg11764359	chr7:65958608	NA	0.74	6.67	0.6	3.3e-9	Aortic root size;
SKCM	cis	rs7666738	0.830	rs9998682	chr4:98939009	T/C	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7772486	0.686	rs9497396	chr6:146014963	C/A	cg05347473	chr6:146136440	FBXO30	-0.58	-5.15	-0.5	1.92e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7829975	0.714	rs59046059	chr8:8670736	C/A	cg06636001	chr8:8085503	FLJ10661	0.72	6.31	0.58	1.57e-8	Mood instability;
SKCM	cis	rs35306767	0.761	rs12771539	chr10:1050653	A/G	cg20503657	chr10:835505	NA	0.62	4.87	0.48	5.77e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs4642101	0.618	rs9877079	chr3:12821287	A/G	cg05775895	chr3:12838266	CAND2	0.68	6.16	0.57	2.99e-8	QRS complex (12-leadsum);
SKCM	cis	rs936229	0.813	rs7085	chr15:75095483	T/C	cg14664628	chr15:75095509	CSK	-1.19	-10.7	-0.77	5.75e-17	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin);
SKCM	cis	rs801193	1.000	rs7783924	chr7:66209057	A/C	cg00343986	chr7:65444356	GUSB	0.7	5.19	0.51	1.63e-6	Aortic root size;
SKCM	cis	rs9916302	0.605	rs2879258	chr17:37399379	G/T	cg07936489	chr17:37558343	FBXL20	-1.02	-7.36	-0.64	1.61e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs523522	0.962	rs655530	chr12:121022275	T/C	cg27279351	chr12:120934652	DYNLL1	0.91	8.36	0.69	1.88e-12	High light scatter reticulocyte count;
SKCM	cis	rs9303401	0.659	rs7223708	chr17:56896398	A/G	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.35	0.52	8.54e-7	Cognitive test performance;
SKCM	cis	rs4888262	0.545	rs12716768	chr16:74556486	A/G	cg01733217	chr16:74700730	RFWD3	-0.9	-6.13	-0.57	3.32e-8	Testicular germ cell tumor;
SKCM	cis	rs35306767	0.953	rs35174953	chr10:961191	C/A	cg25614935	chr10:1084866	C10orf110	0.67	4.85	0.48	6.07e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs244731	1.000	rs244730	chr5:176539212	A/G	cg17509989	chr5:176798049	RGS14	-0.79	-6.24	-0.58	2.09e-8	Urate levels in lean individuals;
SKCM	cis	rs875971	0.895	rs3857684	chr7:65938158	G/C	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	cis	rs826838	0.709	rs4882355	chr12:38721462	A/T	cg26384229	chr12:38710491	ALG10B	0.78	6.71	0.61	2.77e-9	Heart rate;
SKCM	cis	rs8067545	0.611	rs2703776	chr17:20137709	C/A	cg13482628	chr17:19912719	NA	-0.65	-5.44	-0.52	5.84e-7	Schizophrenia;
SKCM	cis	rs2836974	0.563	rs6517522	chr21:40553845	T/C	cg17971929	chr21:40555470	PSMG1	0.83	7.3	0.64	2.14e-10	Cognitive function;
SKCM	trans	rs17685	0.753	rs1104878	chr7:75685593	G/T	cg19862616	chr7:65841803	NCRNA00174	0.95	9.34	0.73	2.39e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs12586317	0.547	rs74243586	chr14:35477325	C/T	cg16230307	chr14:35515116	FAM177A1	0.81	5.88	0.55	9.47e-8	Psoriasis;
SKCM	cis	rs1577917	1.000	rs10498958	chr6:86649705	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.58	4.92	0.49	4.78e-6	Response to antipsychotic treatment;
SKCM	cis	rs6582630	0.537	rs11520294	chr12:38402705	C/A	cg26384229	chr12:38710491	ALG10B	0.88	6.86	0.61	1.46e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs1577917	0.682	rs1173419	chr6:86402163	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.75	-6.91	-0.62	1.16e-9	Response to antipsychotic treatment;
SKCM	cis	rs7613875	0.620	rs13079006	chr3:49996924	G/T	cg24110177	chr3:50126178	RBM5	-0.71	-5.68	-0.54	2.18e-7	Body mass index;
SKCM	cis	rs10256972	0.527	rs28671326	chr7:1174973	G/A	cg07092213	chr7:1199455	ZFAND2A	-0.66	-5.2	-0.51	1.55e-6	Longevity;Endometriosis;
SKCM	cis	rs11098499	0.863	rs3733525	chr4:120447048	A/G	cg09307838	chr4:120376055	NA	0.97	7.66	0.66	4.19e-11	Corneal astigmatism;
SKCM	cis	rs1577917	0.771	rs6454486	chr6:86433587	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.94	9.23	0.72	3.94e-14	Response to antipsychotic treatment;
SKCM	cis	rs2033711	0.840	rs4801590	chr19:58961813	G/C	cg00825309	chr19:58991885	ZNF446	-0.69	-5.8	-0.55	1.35e-7	Uric acid clearance;
SKCM	trans	rs1814175	0.817	rs10769618	chr11:49822336	A/G	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs6582630	0.537	rs1851124	chr12:38516404	G/A	cg26384229	chr12:38710491	ALG10B	0.78	6.39	0.59	1.12e-8	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs7191439	0.858	rs11076702	chr16:88774569	A/C	cg02389323	chr16:88786976	FAM38A	1.39	6.54	0.59	5.93e-9	Plateletcrit;
SKCM	cis	rs362296	0.698	rs362282	chr4:3259671	G/A	cg00764545	chr4:3318001	RGS12	-0.74	-6.48	-0.59	7.39e-9	Parental longevity (mother's age at death);
SKCM	cis	rs6456156	0.586	rs12213683	chr6:167460718	G/A	cg13927040	chr6:167453801	FGFR1OP	0.66	4.85	0.48	6.24e-6	Primary biliary cholangitis;
SKCM	cis	rs9815354	0.767	rs17281609	chr3:41833432	G/A	cg03022575	chr3:42003672	ULK4	1.01	5.01	0.49	3.35e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs1552244	0.572	rs58223482	chr3:10169746	G/C	cg00149659	chr3:10157352	C3orf10	1.13	5.45	0.53	5.74e-7	Alzheimer's disease;
SKCM	cis	rs17685	0.753	rs12531559	chr7:75631697	C/T	cg01364799	chr7:75623366	TMEM120A	0.73	5.61	0.54	2.94e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs875971	1.000	rs9986696	chr7:65704576	C/A	cg18876405	chr7:65276391	NA	-0.69	-6.78	-0.61	2.05e-9	Aortic root size;
SKCM	cis	rs9300255	0.539	rs1969355	chr12:123742061	G/A	cg00376283	chr12:123451042	ABCB9	0.87	7.25	0.63	2.63e-10	Neutrophil percentage of white cells;
SKCM	cis	rs1153858	1.000	rs12440038	chr15:45706739	A/G	cg10760299	chr15:45669010	GATM	0.61	5.94	0.56	7.67e-8	Homoarginine levels;
SKCM	cis	rs7824557	0.767	rs2164272	chr8:11162496	A/C	cg21775007	chr8:11205619	TDH	0.72	6.0	0.56	5.73e-8	Retinal vascular caliber;
SKCM	cis	rs11098499	0.954	rs2389803	chr4:120393511	A/G	cg09307838	chr4:120376055	NA	-0.98	-7.75	-0.66	2.89e-11	Corneal astigmatism;
SKCM	cis	rs10752881	0.839	rs2093983	chr1:183094210	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Colorectal cancer;
SKCM	cis	rs28386778	0.797	rs4968664	chr17:61851366	C/G	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs1801251	1.000	rs283479	chr2:233648754	A/G	cg25237894	chr2:233734115	C2orf82	0.65	5.82	0.55	1.22e-7	Coronary artery disease;
SKCM	cis	rs10540	1.000	rs12786555	chr11:506229	C/T	cg03576123	chr11:487126	PTDSS2	-1.43	-8.14	-0.68	5.08e-12	Body mass index;
SKCM	cis	rs644799	1.000	rs525404	chr11:95566520	A/G	cg03916912	chr11:95522834	CEP57;FAM76B	0.88	7.53	0.65	7.59e-11	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs2153535	0.580	rs1119688	chr6:8460850	T/C	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs798554	0.836	rs798502	chr7:2789880	G/T	cg19346786	chr7:2764209	NA	0.56	5.47	0.53	5.29e-7	Height;
SKCM	cis	rs5769765	0.773	rs7290751	chr22:50318312	T/C	cg22709217	chr22:50311962	ALG12;CRELD2	-0.99	-6.09	-0.57	4.04e-8	Schizophrenia;
SKCM	cis	rs10193935	0.901	rs72800020	chr2:42655615	A/G	cg27598129	chr2:42591480	NA	-0.88	-6.71	-0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7216064	1.000	rs2046323	chr17:65849927	T/G	cg12091567	chr17:66097778	LOC651250	-0.75	-5.27	-0.51	1.19e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs854765	0.603	rs4506967	chr17:17990474	A/C	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.88	6.64	0.6	3.8e-9	Total body bone mineral density;
SKCM	cis	rs910316	1.000	rs4322591	chr14:75600697	C/T	cg08847533	chr14:75593920	NEK9	0.95	9.18	0.72	4.8e-14	Height;
SKCM	cis	rs9916302	0.904	rs9944411	chr17:37483599	T/C	cg07936489	chr17:37558343	FBXL20	0.81	6.65	0.6	3.68e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs7828089	0.522	rs4872484	chr8:22255859	C/T	cg12081754	chr8:22256438	SLC39A14	0.86	7.88	0.67	1.6e-11	Verbal declarative memory;
SKCM	cis	rs2072499	0.966	rs2842882	chr1:156165342	T/G	cg25208724	chr1:156163844	SLC25A44	1.1	9.96	0.75	1.48e-15	Testicular germ cell tumor;
SKCM	cis	rs875971	0.545	rs73136346	chr7:65566082	A/G	cg18876405	chr7:65276391	NA	-0.67	-5.32	-0.52	9.82e-7	Aortic root size;
SKCM	trans	rs561341	1.000	rs542132	chr17:30307193	A/T	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs7811142	1.000	rs74460138	chr7:100027339	C/G	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.23	7.89	0.67	1.53e-11	Platelet count;
SKCM	cis	rs2286503	1.000	rs2286498	chr7:22857504	C/T	cg00309339	chr7:22893653	NA	0.49	4.82	0.48	7.03e-6	Fibrinogen;
SKCM	cis	rs17685	0.753	rs1639609	chr7:75683581	T/C	cg01364799	chr7:75623366	TMEM120A	-0.75	-6.05	-0.56	4.78e-8	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs9815354	0.812	rs4547673	chr3:41952303	A/C	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs9815354	0.812	rs59138513	chr3:41908611	T/G	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs8037137	0.915	rs2290202	chr15:91512267	G/T	cg15878949	chr15:91534302	PRC1	0.67	5.19	0.51	1.61e-6	Platelet count;Serous invasive ovarian cancer;High-grade serous ovarian cancer;Invasive epithelial ovarian cancer;
SKCM	cis	rs6753739	0.745	rs1378640	chr2:219917632	C/T	cg09297636	chr2:219923910	IHH	0.45	4.82	0.48	6.87e-6	Height;
SKCM	cis	rs6665290	0.669	rs34267809	chr1:227176162	C/G	cg10327440	chr1:227177885	CDC42BPA	-1.08	-9.89	-0.75	2.02e-15	Myeloid white cell count;
SKCM	cis	rs7584330	0.554	rs6760913	chr2:238400702	C/T	cg08992911	chr2:238395768	MLPH	1.01	4.91	0.49	4.93e-6	Prostate cancer;
SKCM	cis	rs7811142	0.720	rs7795656	chr7:99950297	A/T	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.2	7.87	0.67	1.7e-11	Platelet count;
SKCM	cis	rs2153535	0.580	rs9378554	chr6:8488468	C/T	cg07606381	chr6:8435919	SLC35B3	0.86	6.25	0.58	2.06e-8	Motion sickness;
SKCM	cis	rs910316	0.763	rs175016	chr14:75459633	C/T	cg08847533	chr14:75593920	NEK9	-0.83	-7.11	-0.63	4.81e-10	Height;
SKCM	cis	rs11950121	0.563	rs7701838	chr5:53163215	G/A	cg06476337	chr5:52856530	NDUFS4	-0.68	-4.8	-0.48	7.59e-6	Alcoholic chronic pancreatitis;
SKCM	cis	rs1005277	0.579	rs2800485	chr10:38542588	G/A	cg25427524	chr10:38739819	LOC399744	-0.72	-6.99	-0.62	8.31e-10	Extrinsic epigenetic age acceleration;
SKCM	cis	rs55823223	0.564	rs936391	chr17:73847799	A/G	cg10935138	chr17:73851978	WBP2	-1.04	-6.89	-0.62	1.27e-9	Psoriasis;
SKCM	cis	rs801193	0.569	rs2659908	chr7:66160822	G/A	cg11764359	chr7:65958608	NA	0.75	6.79	0.61	1.95e-9	Aortic root size;
SKCM	cis	rs1559088	0.600	rs6510344	chr19:33583942	C/A	cg17764715	chr19:33622953	WDR88	0.93	6.74	0.61	2.44e-9	Bone ultrasound measurement (broadband ultrasound attenuation);
SKCM	cis	rs9926296	0.568	rs886950	chr16:89836872	T/C	cg04287289	chr16:89883240	FANCA	1.03	11.93	0.8	2.87e-19	Vitiligo;
SKCM	cis	rs7590720	0.704	rs7603645	chr2:216876949	C/G	cg12620499	chr2:216877984	MREG	0.95	10.1	0.75	7.95e-16	Alcohol dependence;
SKCM	cis	rs950027	0.620	rs872192	chr15:45614502	A/G	cg10760299	chr15:45669010	GATM	0.51	4.8	0.48	7.54e-6	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs6121246	0.559	rs6087771	chr20:30306724	A/G	cg13852791	chr20:30311386	BCL2L1	0.82	5.69	0.54	2.09e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs12541335	0.639	rs68063696	chr8:22153236	A/G	cg09517075	chr8:22133004	PIWIL2	0.58	5.22	0.51	1.42e-6	Hypertriglyceridemia;
SKCM	cis	rs9399137	0.507	rs4580893	chr6:135297662	G/A	cg24558204	chr6:135376177	HBS1L	0.7	6.53	0.59	6.11e-9	Glycated hemoglobin levels;Mean corpuscular volume;Hematology traits;HbA2 levels;Mean corpuscular hemoglobin;Hemoglobin levels;F-cell distribution;Platelet count;
SKCM	cis	rs754466	1.000	rs12220328	chr10:79681482	G/C	cg17075019	chr10:79541650	NA	-0.7	-5.72	-0.54	1.92e-7	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs17345786	0.861	rs11711808	chr3:101235101	T/C	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.71	4.8	0.48	7.47e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs56235845	0.964	rs11741640	chr5:176792743	G/A	cg16006841	chr5:176797999	RGS14	0.88	7.62	0.65	5.16e-11	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs2760061	0.583	rs708121	chr1:228208257	A/G	cg02753203	chr1:228287806	NA	0.9	8.47	0.69	1.17e-12	Diastolic blood pressure;
SKCM	cis	rs3008870	0.583	rs11208985	chr1:67464666	G/A	cg08660285	chr1:67390436	MIER1;WDR78	-0.94	-6.07	-0.57	4.4e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs10089	0.953	rs17164427	chr5:127361736	C/G	cg25462716	chr5:127418816	SLC12A2;FLJ33630	-0.92	-8.44	-0.69	1.34e-12	Ileal carcinoids;
SKCM	cis	rs929354	0.713	rs3802129	chr7:156965297	G/A	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs7927771	0.524	rs7114813	chr11:47801101	A/G	cg20307385	chr11:47447363	PSMC3	0.71	5.63	0.54	2.67e-7	Subjective well-being;
SKCM	cis	rs736408	0.608	rs2239547	chr3:52855229	T/C	cg11645453	chr3:52864694	ITIH4	0.74	6.69	0.6	3.05e-9	Bipolar disorder;
SKCM	cis	rs6500395	0.928	rs12934788	chr16:48706343	C/A	cg04672837	chr16:48644449	N4BP1	-0.63	-5.37	-0.52	8.01e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs9911578	0.839	rs7214098	chr17:57204632	C/T	cg12560992	chr17:57184187	TRIM37	0.99	8.46	0.69	1.22e-12	Intelligence (multi-trait analysis);
SKCM	cis	rs7177699	0.550	rs7182103	chr15:79123946	G/T	cg04896959	chr15:78267971	NA	-0.54	-4.84	-0.48	6.39e-6	Post bronchodilator FEV1/FVC ratio;Post bronchodilator FEV1;
SKCM	cis	rs4434138	0.683	rs13063160	chr3:52602274	T/C	cg18404041	chr3:52824283	ITIH1	-0.53	-4.77	-0.48	8.42e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7772486	0.727	rs10447449	chr6:146138707	A/G	cg23711669	chr6:146136114	FBXO30	0.89	9.86	0.74	2.39e-15	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs28595532	0.920	rs115853212	chr4:119765354	C/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs2153535	0.580	rs9405391	chr6:8466548	C/T	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs28595532	0.688	rs116053430	chr4:119731375	G/A	cg14228332	chr4:119757509	SEC24D	1.08	5.52	0.53	4.28e-7	Cannabis dependence symptom count;
SKCM	cis	rs593982	0.858	rs663797	chr11:65552740	A/G	cg08755490	chr11:65554678	OVOL1	1.04	9.73	0.74	4.15e-15	Atopic dermatitis;
SKCM	cis	rs1577917	0.876	rs11752223	chr6:86573394	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.32	-0.52	9.66e-7	Response to antipsychotic treatment;
SKCM	cis	rs936229	0.668	rs67411922	chr15:75187612	A/G	cg14664628	chr15:75095509	CSK	-0.97	-7.02	-0.62	7.35e-10	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin);
SKCM	cis	rs597539	0.731	rs664229	chr11:68624483	C/G	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.81	5.33	0.52	9.43e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs7811142	0.779	rs111312383	chr7:99905325	C/T	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.06	6.05	0.56	4.82e-8	Platelet count;
SKCM	cis	rs35306767	0.903	rs11253460	chr10:887382	C/G	cg20503657	chr10:835505	NA	0.76	5.17	0.51	1.73e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs936229	0.813	rs72730503	chr15:75086386	G/A	cg14664628	chr15:75095509	CSK	-1.15	-9.89	-0.75	2.08e-15	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin);
SKCM	cis	rs6952808	0.771	rs10265944	chr7:1918337	C/T	cg21782813	chr7:2030301	MAD1L1	0.52	5.42	0.52	6.48e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs929354	0.772	rs1182360	chr7:157020550	C/G	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs116095464	0.558	rs7715108	chr5:264661	A/G	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs8077889	0.750	rs4793040	chr17:41930569	A/G	cg26893861	chr17:41843967	DUSP3	1.31	7.65	0.65	4.46e-11	Triglycerides;
SKCM	cis	rs13010713	0.840	rs7561880	chr2:182076748	G/A	cg21995919	chr2:182322279	ITGA4	-0.55	-4.87	-0.48	5.65e-6	Celiac disease;
SKCM	cis	rs10256972	0.721	rs10435145	chr7:1065988	C/T	cg11360546	chr7:1094263	C7orf50	-0.41	-4.86	-0.48	6.02e-6	Longevity;Endometriosis;
SKCM	cis	rs644799	0.664	rs603625	chr11:95554283	G/A	cg25622487	chr11:95524042	FAM76B;CEP57	0.7	5.67	0.54	2.28e-7	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs6495122	0.594	rs11072507	chr15:75054866	G/C	cg14664628	chr15:75095509	CSK	-0.92	-6.45	-0.59	8.69e-9	Caffeine consumption;Diastolic blood pressure;Coffee consumption;
SKCM	cis	rs5753618	0.539	rs695438	chr22:31811876	G/C	cg02404636	chr22:31891804	SFI1	0.52	4.84	0.48	6.47e-6	Colorectal cancer;
SKCM	cis	rs10911251	0.509	rs4652780	chr1:183105923	G/C	ch.1.3577855R	chr1:183094577	LAMC1	0.76	7.47	0.65	1e-10	Colorectal cancer;
SKCM	cis	rs6088580	0.634	rs6059860	chr20:33063830	A/C	cg24642439	chr20:33292090	TP53INP2	0.76	6.02	0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs10751667	0.621	rs10794353	chr11:948740	A/G	cg10932868	chr11:921992	NA	0.54	5.22	0.51	1.43e-6	Alzheimer's disease (late onset);
SKCM	cis	rs55962025	0.883	rs3755883	chr4:3223250	A/G	cg24015175	chr4:3319247	RGS12	-0.64	-5.32	-0.52	9.51e-7	Parental longevity (mother's age at death);
SKCM	cis	rs35146811	1.000	rs35146811	chr7:99720994	A/C	cg13334819	chr7:99746414	C7orf59	-0.68	-4.98	-0.49	3.76e-6	Coronary artery disease;
SKCM	cis	rs2204008	0.688	rs12824232	chr12:38175901	G/A	cg26384229	chr12:38710491	ALG10B	0.82	6.58	0.6	4.87e-9	Bladder cancer;
SKCM	cis	rs6570726	0.764	rs9403726	chr6:145901686	G/T	cg23711669	chr6:146136114	FBXO30	0.86	7.97	0.67	1.06e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4819052	1.000	rs2838830	chr21:46664227	T/G	cg19498844	chr21:46707878	POFUT2;LOC642852	0.87	6.8	0.61	1.88e-9	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs10504229	0.906	rs73607869	chr8:58172665	G/T	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs9549367	0.713	rs4907598	chr13:113861385	C/T	cg18105134	chr13:113819100	PROZ	0.81	6.53	0.59	6.2e-9	Platelet distribution width;
SKCM	cis	rs763121	0.853	rs5750668	chr22:39079964	T/C	cg06022373	chr22:39101656	GTPBP1	0.77	5.49	0.53	4.87e-7	Menopause (age at onset);
SKCM	cis	rs3780486	0.813	rs3780488	chr9:33133812	T/C	cg13443165	chr9:33130375	B4GALT1	-0.55	-4.99	-0.49	3.65e-6	IgG glycosylation;
SKCM	cis	rs1401999	1.000	rs939338	chr3:183704068	A/G	cg01324343	chr3:183735012	ABCC5	-0.84	-9.4	-0.73	1.78e-14	Anterior chamber depth;
SKCM	cis	rs7811142	0.945	rs34989573	chr7:100097895	C/T	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.11	6.3	0.58	1.66e-8	Platelet count;
SKCM	cis	rs7666738	0.830	rs4323111	chr4:98952276	A/G	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs3785574	0.962	rs2584614	chr17:61929445	C/T	cg26338869	chr17:61819248	STRADA	0.63	4.81	0.48	7.11e-6	Height;
SKCM	cis	rs1799949	0.965	rs8176161	chr17:41241390	C/A	cg05368731	chr17:41323189	NBR1	0.88	7.75	0.66	2.84e-11	Menopause (age at onset);
SKCM	cis	rs9485372	0.945	rs9498288	chr6:149607690	C/G	cg03072286	chr6:150262044	ULBP2	-0.55	-4.89	-0.48	5.3e-6	Breast cancer;
SKCM	cis	rs28386778	0.897	rs2597634	chr17:61878144	G/A	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs208520	0.837	rs208498	chr6:66931560	G/A	cg07460842	chr6:66804631	NA	-0.97	-6.92	-0.62	1.13e-9	Exhaled nitric oxide output;
SKCM	cis	rs589448	1.000	rs589448	chr12:69752200	A/G	cg20891283	chr12:69753455	YEATS4	0.98	9.89	0.75	2.06e-15	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs7772486	0.623	rs9485021	chr6:146068797	A/G	cg05347473	chr6:146136440	FBXO30	-0.54	-4.96	-0.49	3.97e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs8060686	0.545	rs9922165	chr16:68181177	C/A	cg09117114	chr16:67998030	SLC12A4	-0.76	-4.98	-0.49	3.79e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs2836974	0.831	rs2836964	chr21:40631006	T/C	cg17971929	chr21:40555470	PSMG1	0.9	8.87	0.71	1.93e-13	Cognitive function;
SKCM	cis	rs1218582	0.772	rs4845689	chr1:154885524	A/G	cg06221963	chr1:154839813	KCNN3	-0.59	-5.97	-0.56	6.76e-8	Prostate cancer;
SKCM	cis	rs606458	0.920	rs2959652	chr11:64520942	G/T	cg07674570	chr11:65346152	EHBP1L1	-0.67	-4.84	-0.48	6.5e-6	Urate levels;
SKCM	cis	rs2836974	0.568	rs442972	chr21:40534757	C/T	cg17971929	chr21:40555470	PSMG1	-0.76	-7.16	-0.63	3.94e-10	Cognitive function;
SKCM	cis	rs11098499	0.575	rs907204	chr4:120238654	G/A	cg09307838	chr4:120376055	NA	0.93	7.56	0.65	6.5500000000000006e-11	Corneal astigmatism;
SKCM	cis	rs9303401	0.614	rs34683543	chr17:56520036	C/A	cg10487724	chr17:56770010	TEX14;RAD51C	0.85	6.13	0.57	3.4e-8	Cognitive test performance;
SKCM	cis	rs1032355	0.558	rs7698547	chr4:100529085	C/T	cg25391692	chr4:100495869	MTTP	-0.82	-4.97	-0.49	3.9e-6	Celiac disease;
SKCM	cis	rs6089829	0.962	rs2277768	chr20:61666823	T/C	cg08564027	chr20:61660810	NA	0.63	5.65	0.54	2.46e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs9815354	0.812	rs73071222	chr3:41986896	C/T	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs651907	0.557	rs7612283	chr3:101434919	C/T	cg12386194	chr3:101231763	SENP7	0.69	5.68	0.54	2.23e-7	Colorectal cancer;
SKCM	cis	rs875971	0.862	rs1981799	chr7:65955559	T/C	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	cis	rs2180341	0.814	rs6940933	chr6:127732740	C/G	cg27446573	chr6:127587934	RNF146	0.69	5.49	0.53	4.79e-7	Breast cancer;
SKCM	cis	rs992157	0.835	rs2292555	chr2:219146882	G/C	cg20019365	chr2:219134978	PNKD;AAMP	-0.71	-6.08	-0.57	4.22e-8	Colorectal cancer;
SKCM	cis	rs7618501	0.633	rs55751738	chr3:49972101	A/G	cg24110177	chr3:50126178	RBM5	-0.6	-5.1	-0.5	2.36e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs8103278	0.507	rs4802275	chr19:46260375	C/T	cg11657440	chr19:46296263	DMWD	1.06	10.47	0.76	1.56e-16	Coronary artery disease;
SKCM	cis	rs2842992	0.709	rs1853257	chr6:160212710	C/G	cg19482086	chr6:160211437	TCP1;MRPL18	0.82	6.24	0.58	2.11e-8	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs6840360	0.571	rs4696271	chr4:152509118	G/A	cg22705602	chr4:152727874	NA	-0.52	-5.7	-0.54	2.03e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs4073582	0.595	rs528842	chr11:66032390	G/A	cg14036092	chr11:66035641	RAB1B	0.75	5.91	0.56	8.39e-8	Gout;
SKCM	cis	rs8017423	0.900	rs11625870	chr14:90693396	C/T	cg04374321	chr14:90722782	PSMC1	-0.99	-8.89	-0.71	1.74e-13	Mortality in heart failure;
SKCM	cis	rs2455601	0.786	rs56680262	chr11:8971555	C/T	cg21881798	chr11:8931708	C11orf17;ST5	-0.85	-5.94	-0.56	7.4e-8	Schizophrenia;
SKCM	trans	rs8073060	0.586	rs8077826	chr17:34001139	G/A	cg19694781	chr19:47549865	TMEM160	-1.04	-8.28	-0.68	2.65e-12	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs4319547	0.695	rs6488939	chr12:122858250	T/C	cg23029597	chr12:123009494	RSRC2	-0.72	-5.31	-0.52	1.01e-6	Body mass index;
SKCM	cis	rs1405130	0.933	rs11677087	chr2:235569892	A/G	cg21542780	chr2:234763377	HJURP	-0.65	-4.92	-0.49	4.75e-6	Coronary artery disease;
SKCM	cis	rs60871478	0.898	rs62432225	chr7:789433	G/A	cg04727924	chr7:799746	HEATR2	-0.64	-4.82	-0.48	6.9e-6	Cerebrospinal P-tau181p levels;
SKCM	cis	rs694739	0.628	rs617051	chr11:64133638	C/A	cg02228329	chr11:64053129	BAD;GPR137	0.86	6.0	0.56	5.79e-8	Alopecia areata;Crohn's disease;Psoriasis vulgaris;
SKCM	cis	rs9818758	0.607	rs9862483	chr3:49195441	G/A	cg24110177	chr3:50126178	RBM5	0.87	4.86	0.48	6e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs2251381	0.565	rs2832279	chr21:30613466	G/T	cg24692254	chr21:30365293	RNF160	0.73	5.14	0.5	1.99e-6	Selective IgA deficiency;
SKCM	cis	rs6121246	0.909	rs6058463	chr20:30385192	C/T	cg11595048	chr20:30225325	COX4I2	0.67	5.21	0.51	1.5e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs473651	1.000	rs473651	chr2:239335401	A/C	cg21699342	chr2:239360505	ASB1	0.49	4.79	0.48	7.71e-6	Multiple system atrophy;
SKCM	trans	rs3780486	0.846	rs10116966	chr9:33122370	T/A	cg04842962	chr6:43655489	MRPS18A	1.05	11.36	0.79	3.28e-18	IgG glycosylation;
SKCM	cis	rs1153858	0.943	rs12439575	chr15:45684816	T/G	cg21132104	chr15:45694354	SPATA5L1	0.93	7.94	0.67	1.22e-11	Homoarginine levels;
SKCM	cis	rs7002619	0.570	rs117118392	chr8:16046785	A/T	cg16243756	chr8:15397637	TUSC3	0.71	4.91	0.49	4.89e-6	Schizophrenia;
SKCM	cis	rs9611565	0.659	rs12484228	chr22:41939739	A/G	cg03806693	chr22:41940476	POLR3H	-1.11	-7.56	-0.65	6.67e-11	Vitiligo;
SKCM	cis	rs13126513	0.768	rs6822162	chr4:100472583	A/G	cg05468953	chr4:100565104	NA	0.46	4.78	0.48	8.22e-6	Metabolite levels (MHPG);
SKCM	cis	rs12188164	0.561	rs2721010	chr5:456915	A/G	cg26076054	chr5:421317	AHRR	0.61	5.42	0.52	6.52e-7	Cystic fibrosis severity;
SKCM	cis	rs10911232	0.524	rs10737238	chr1:183025303	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.77	6.89	0.62	1.26e-9	Hypertriglyceridemia;
SKCM	cis	rs16854884	0.632	rs4535221	chr3:143658607	A/G	cg06585982	chr3:143692056	C3orf58	0.81	7.63	0.65	4.89e-11	Economic and political preferences (feminism/equality);
SKCM	cis	rs17376456	0.542	rs10061069	chr5:93071630	G/C	cg25358565	chr5:93447407	FAM172A	0.74	5.01	0.49	3.27e-6	Diabetic retinopathy;
SKCM	cis	rs9913156	0.793	rs11655166	chr17:4559302	T/A	cg19197139	chr17:4613644	ARRB2	-0.79	-5.28	-0.51	1.14e-6	Lymphocyte counts;
SKCM	cis	rs7811142	1.000	rs76913697	chr7:100002772	A/G	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.13	6.53	0.59	5.99e-9	Platelet count;
SKCM	cis	rs62064224	0.533	rs11657826	chr17:30790386	T/A	cg18200150	chr17:30822561	MYO1D	0.75	6.58	0.6	4.97e-9	Schizophrenia;
SKCM	cis	rs769267	0.930	rs3752151	chr19:19616026	T/C	cg26732615	chr19:19648335	CILP2;YJEFN3	0.67	7.06	0.62	6e-10	Tonsillectomy;
SKCM	cis	rs2836974	0.831	rs6517521	chr21:40551588	A/G	cg11890956	chr21:40555474	PSMG1	1.07	13.19	0.83	1.48e-21	Cognitive function;
SKCM	cis	rs11148252	0.574	rs9536247	chr13:53279542	T/C	cg00495681	chr13:53174319	NA	0.66	5.47	0.53	5.29e-7	Lewy body disease;
SKCM	cis	rs6591182	0.935	rs11606601	chr11:65354439	C/G	cg27068330	chr11:65405492	SIPA1	-0.69	-5.07	-0.5	2.62e-6	Non-alcoholic fatty liver disease histology (lobular);
SKCM	cis	rs4423214	0.879	rs1792282	chr11:71135166	G/A	cg05163923	chr11:71159392	DHCR7	-0.65	-5.76	-0.55	1.61e-7	Vitamin D levels;
SKCM	cis	rs13256369	1.000	rs7820159	chr8:8576215	T/C	cg06636001	chr8:8085503	FLJ10661	0.72	5.25	0.51	1.27e-6	Obesity-related traits;
SKCM	cis	rs17065868	1.000	rs61947995	chr13:45160499	T/C	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs6570726	1.000	rs444564	chr6:145859795	G/C	cg23711669	chr6:146136114	FBXO30	0.68	6.57	0.6	5.07e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7193541	0.508	rs7188581	chr16:74672901	T/A	cg01733217	chr16:74700730	RFWD3	1.01	11.94	0.8	2.74e-19	Multiple myeloma;
SKCM	cis	rs9911578	0.933	rs2632508	chr17:56533235	G/A	cg05425664	chr17:57184151	TRIM37	-0.69	-5.11	-0.5	2.2e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs12477438	0.520	rs2632283	chr2:99776000	C/G	cg14399236	chr2:99771627	LIPT1;TSGA10	0.97	8.66	0.7	4.83e-13	Chronic sinus infection;
SKCM	cis	rs826838	0.834	rs826874	chr12:39122599	C/A	cg13010199	chr12:38710504	ALG10B	-0.61	-4.92	-0.49	4.66e-6	Heart rate;
SKCM	cis	rs7937682	0.883	rs1784776	chr11:111472392	C/T	cg09085632	chr11:111637200	PPP2R1B	-1.02	-10.03	-0.75	1.11e-15	Primary sclerosing cholangitis;
SKCM	cis	rs116095464	0.558	rs56043030	chr5:220917	A/G	cg22496380	chr5:211416	CCDC127	-0.96	-5.27	-0.51	1.18e-6	Breast cancer;
SKCM	cis	rs3768617	0.510	rs1413388	chr1:183096694	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs875971	0.505	rs1723275	chr7:65504633	G/C	cg11764359	chr7:65958608	NA	-0.87	-6.61	-0.6	4.37e-9	Aortic root size;
SKCM	cis	rs9325144	0.505	rs7138977	chr12:38642109	G/A	cg13010199	chr12:38710504	ALG10B	0.66	5.21	0.51	1.52e-6	Morning vs. evening chronotype;
SKCM	cis	rs798766	0.953	rs798751	chr4:1719572	A/G	cg24239225	chr4:1659016	FAM53A	-0.68	-4.82	-0.48	6.98e-6	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs12477438	0.520	rs13010904	chr2:99754289	G/A	cg14399236	chr2:99771627	LIPT1;TSGA10	1.01	9.53	0.73	1.01e-14	Chronic sinus infection;
SKCM	cis	rs7666738	0.861	rs5014702	chr4:99052102	C/A	cg05340658	chr4:99064831	C4orf37	0.66	4.99	0.49	3.54e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4642101	0.662	rs1969154	chr3:12829156	A/G	cg05775895	chr3:12838266	CAND2	0.62	5.45	0.53	5.72e-7	QRS complex (12-leadsum);
SKCM	cis	rs861020	0.710	rs7516902	chr1:210022179	A/G	cg09163369	chr1:210001066	C1orf107	0.71	4.77	0.48	8.3e-6	Orofacial clefts;
SKCM	cis	rs7666738	0.830	rs6840766	chr4:99016260	C/G	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs911263	0.961	rs7148882	chr14:68740924	A/G	cg18825221	chr14:68749962	RAD51L1	-0.48	-5.2	-0.51	1.55e-6	Primary biliary cholangitis;
SKCM	cis	rs16854884	0.632	rs4446205	chr3:143682607	A/G	cg06585982	chr3:143692056	C3orf58	0.81	7.63	0.65	4.89e-11	Economic and political preferences (feminism/equality);
SKCM	cis	rs1580019	0.961	rs4460271	chr7:32496503	T/C	cg06627557	chr7:32535165	LSM5;AVL9	0.74	5.64	0.54	2.59e-7	Cognitive ability;
SKCM	cis	rs561341	0.941	rs4525554	chr17:30312819	T/C	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs9640161	0.742	rs11983355	chr7:150016697	A/C	cg10018233	chr7:150070692	REPIN1	0.7	5.79	0.55	1.39e-7	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs362296	0.698	rs362289	chr4:3256378	G/A	cg24015175	chr4:3319247	RGS12	-0.72	-6.64	-0.6	3.7e-9	Parental longevity (mother's age at death);
SKCM	cis	rs6951245	0.786	rs77943789	chr7:1140158	C/T	cg18402987	chr7:1209562	NA	1.15	7.08	0.63	5.57e-10	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	trans	rs8073060	0.586	rs225250	chr17:33941963	A/G	cg19694781	chr19:47549865	TMEM160	-1.08	-8.69	-0.7	4.26e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs72627123	1.000	rs17094021	chr14:74394295	C/T	cg19860245	chr14:74300557	NA	0.78	4.99	0.49	3.55e-6	Morning vs. evening chronotype;
SKCM	cis	rs7103648	0.864	rs12801188	chr11:47388214	G/A	cg03711944	chr11:47377212	SPI1	-0.57	-5.06	-0.5	2.73e-6	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs826838	1.000	rs10880826	chr12:38672787	G/C	cg13010199	chr12:38710504	ALG10B	0.72	5.21	0.51	1.5e-6	Heart rate;
SKCM	cis	rs9858542	0.953	rs11719996	chr3:49525958	T/C	cg03060546	chr3:49711283	APEH	-0.75	-5.53	-0.53	4.17e-7	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs10504229	0.906	rs116341227	chr8:58190532	G/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs1018836	0.923	rs62526886	chr8:91627676	G/A	cg16814680	chr8:91681699	NA	-0.64	-4.85	-0.48	6.29e-6	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs9393692	1.000	rs9393692	chr6:26276650	A/G	cg00631329	chr6:26305371	NA	-0.67	-4.98	-0.49	3.66e-6	Educational attainment;
SKCM	cis	rs4319547	0.698	rs10773178	chr12:122944752	T/C	cg23029597	chr12:123009494	RSRC2	-0.8	-6.08	-0.57	4.24e-8	Body mass index;
SKCM	cis	rs10504229	1.000	rs57378064	chr8:58169844	C/G	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs7772486	0.720	rs6901888	chr6:146023144	A/G	cg05347473	chr6:146136440	FBXO30	-0.62	-5.62	-0.54	2.8e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9896933	0.830	rs607544	chr17:80768760	C/G	cg20578329	chr17:80767326	TBCD	-0.93	-6.61	-0.6	4.39e-9	Bone mineral accretion in asthma (oral corticosteroid dose interaction);
SKCM	cis	rs7191700	0.644	rs918738	chr16:11439679	C/G	cg00044050	chr16:11439710	C16orf75	-0.74	-5.48	-0.53	5e-7	Multiple sclerosis;
SKCM	cis	rs17685	0.753	rs2286830	chr7:75693963	C/T	cg16489192	chr7:75678113	MDH2;STYXL1	0.6	5.59	0.53	3.25e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs10492096	0.947	rs10849482	chr12:6635274	G/A	cg13857086	chr12:6580257	VAMP1	0.77	5.87	0.55	1.02e-7	Hip geometry;
SKCM	cis	rs6951245	1.000	rs77702926	chr7:1088838	G/A	cg03188948	chr7:1209495	NA	1.12	6.25	0.58	2.02e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs1218582	0.772	rs6683557	chr1:154852307	C/G	cg24250549	chr1:154909240	PMVK	0.87	8.68	0.7	4.54e-13	Prostate cancer;
SKCM	cis	rs12611334	0.929	rs12610398	chr19:40193350	T/A	cg04998674	chr19:40596855	ZNF780A	0.63	4.77	0.47	8.55e-6	Schizophrenia;
SKCM	cis	rs2739330	0.828	rs5760099	chr22:24248414	G/A	cg12419862	chr22:24373484	LOC391322	-0.69	-5.94	-0.56	7.43e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs1552244	1.000	rs7631678	chr3:10078816	T/G	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs12458462	0.892	rs2242174	chr18:77458037	T/C	cg11879182	chr18:77439856	CTDP1	0.87	7.43	0.64	1.17e-10	Monocyte count;
SKCM	cis	rs1568889	0.838	rs11030230	chr11:28174631	A/G	cg06544937	chr11:28130018	METT5D1;KIF18A	0.89	8.3	0.68	2.43e-12	Bipolar disorder;
SKCM	cis	rs910316	0.967	rs4903292	chr14:75656245	A/G	cg11812906	chr14:75593930	NEK9	0.74	5.19	0.51	1.63e-6	Height;
SKCM	cis	rs1538970	0.739	rs4660863	chr1:45955868	T/C	cg05343316	chr1:45956843	TESK2	0.94	4.82	0.48	7.07e-6	Platelet count;
SKCM	cis	rs11098499	0.954	rs10031483	chr4:120422636	T/C	cg24375607	chr4:120327624	NA	0.66	5.13	0.5	2.07e-6	Corneal astigmatism;
SKCM	cis	rs137603	0.623	rs137657	chr22:39733242	G/T	cg17798944	chr22:39715225	SNORD43;RPL3	-0.63	-5.36	-0.52	8.08e-7	Primary biliary cholangitis;
SKCM	trans	rs208520	0.690	rs9345764	chr6:66820597	C/T	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-1.02	-8.21	-0.68	3.75e-12	Exhaled nitric oxide output;
SKCM	cis	rs6921919	0.583	rs6899603	chr6:28381305	A/G	cg14547644	chr6:28411285	ZSCAN23	-0.58	-4.8	-0.48	7.46e-6	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs9640161	0.659	rs7781827	chr7:150008858	T/C	cg10018233	chr7:150070692	REPIN1	0.7	5.68	0.54	2.21e-7	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs1506636	0.962	rs629474	chr7:123399684	C/T	cg03229431	chr7:123269106	ASB15	0.64	5.21	0.51	1.5e-6	Plateletcrit;Platelet count;
SKCM	cis	rs4819052	0.808	rs2838825	chr21:46655651	C/T	cg19498844	chr21:46707878	POFUT2;LOC642852	0.89	7.22	0.63	3.01e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs1570989	0.571	rs6916066	chr6:12016009	G/C	cg17804551	chr6:12015979	HIVEP1	0.56	5.84	0.55	1.14e-7	Alcohol and nicotine co-dependence;
SKCM	cis	rs7772486	0.701	rs697056	chr6:146003897	C/T	cg23711669	chr6:146136114	FBXO30	-0.96	-10.7	-0.77	5.81e-17	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs11681884	0.581	rs75396415	chr2:113681242	A/C	cg09250933	chr2:114035619	PAX8;LOC440839	-0.75	-4.78	-0.48	8.11e-6	Stroke;
SKCM	cis	rs10089	0.552	rs55902659	chr5:127545505	C/G	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.68	5.5	0.53	4.58e-7	Ileal carcinoids;
SKCM	cis	rs362296	0.698	rs3095081	chr4:3263776	C/T	cg21096898	chr4:3318625	RGS12	-0.78	-7.42	-0.64	1.26e-10	Parental longevity (mother's age at death);
SKCM	cis	rs10751667	0.621	rs10794351	chr11:946228	C/T	cg10932868	chr11:921992	NA	0.55	5.1	0.5	2.36e-6	Alzheimer's disease (late onset);
SKCM	cis	rs3540	0.597	rs7498113	chr15:91051192	C/G	cg22089800	chr15:90895588	ZNF774	-0.68	-4.91	-0.49	4.92e-6	Allergic disease (asthma, hay fever or eczema);Lymphocyte counts;
SKCM	cis	rs7613875	0.600	rs2856238	chr3:50158191	C/T	cg24110177	chr3:50126178	RBM5	-0.74	-6.09	-0.57	4.05e-8	Body mass index;
SKCM	cis	rs870825	0.929	rs871254	chr4:185589226	G/C	cg04058563	chr4:185651563	MLF1IP	1.09	5.66	0.54	2.4e-7	Blood protein levels;
SKCM	cis	rs7617480	0.610	rs10865954	chr3:49211989	T/C	cg07636037	chr3:49044803	WDR6	0.72	5.37	0.52	7.98e-7	Subjective well-being (multi-trait analysis);Menarche (age at onset);
SKCM	cis	rs4481887	0.927	rs4427440	chr1:248480337	T/A	cg00666640	chr1:248458726	OR2T12	0.66	6.0	0.56	5.9e-8	Common traits (Other);
SKCM	cis	rs6951245	0.706	rs28483034	chr7:1170171	C/A	cg18402987	chr7:1209562	NA	1.15	7.39	0.64	1.39e-10	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7811142	1.000	rs2897358	chr7:100088640	C/G	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.25	0.68	3.05e-12	Platelet count;
SKCM	cis	rs35146811	0.735	rs1727139	chr7:99815367	C/T	cg22906224	chr7:99728672	NA	-0.72	-5.77	-0.55	1.52e-7	Coronary artery disease;
SKCM	cis	rs9300255	0.602	rs1716160	chr12:123700225	C/T	cg05973401	chr12:123451056	ABCB9	0.81	5.37	0.52	7.77e-7	Neutrophil percentage of white cells;
SKCM	cis	rs6951245	0.935	rs118132455	chr7:1068232	C/A	cg21664854	chr7:1097933	C7orf50;GPR146	0.89	4.79	0.48	7.66e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs9322193	0.961	rs2064520	chr6:149924786	A/T	cg07701084	chr6:150067640	NUP43	0.62	5.07	0.5	2.59e-6	Lung cancer;
SKCM	cis	rs1799949	0.501	rs35399157	chr17:41411602	G/C	cg23758822	chr17:41437982	NA	0.93	7.88	0.67	1.62e-11	Menopause (age at onset);
SKCM	cis	rs782590	0.935	rs782649	chr2:55860308	T/C	cg18811423	chr2:55921094	PNPT1	0.89	6.96	0.62	9.4e-10	Metabolic syndrome;
SKCM	cis	rs2811415	0.597	rs1044843	chr3:127783698	A/T	cg09089421	chr3:127803668	RUVBL1	1.01	8.78	0.71	2.82e-13	Lung function (FEV1/FVC);
SKCM	cis	rs875971	0.862	rs6460302	chr7:65960257	C/G	cg18876405	chr7:65276391	NA	0.61	5.81	0.55	1.3e-7	Aortic root size;
SKCM	cis	rs9926296	0.509	rs2159113	chr16:89832083	C/T	cg27121462	chr16:89883253	FANCA	0.73	5.11	0.5	2.21e-6	Vitiligo;
SKCM	cis	rs1153858	1.000	rs2668747	chr15:45617216	T/C	cg21132104	chr15:45694354	SPATA5L1	0.91	7.64	0.65	4.71e-11	Homoarginine levels;
SKCM	cis	rs55962025	0.883	rs82334	chr4:3225371	A/C	cg24015175	chr4:3319247	RGS12	-0.63	-5.42	-0.52	6.54e-7	Parental longevity (mother's age at death);
SKCM	cis	rs2404602	0.684	rs28895952	chr15:76856776	A/G	cg23625390	chr15:77176239	SCAPER	-0.85	-8.26	-0.68	2.93e-12	Blood metabolite levels;
SKCM	cis	rs2839186	0.770	rs2839984	chr21:47671690	A/G	cg11766577	chr21:47581405	C21orf56	-0.76	-6.51	-0.59	6.55e-9	Testicular germ cell tumor;
SKCM	cis	rs78269692	0.826	rs79105431	chr19:13233820	G/T	cg19436403	chr19:12780550	MORG1;C19orf56	1.39	5.14	0.5	1.96e-6	Breast cancer;
SKCM	cis	rs28595532	0.920	rs115472708	chr4:119773407	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs11098499	0.866	rs12513310	chr4:120288039	T/A	cg09307838	chr4:120376055	NA	0.98	7.89	0.67	1.52e-11	Corneal astigmatism;
SKCM	cis	rs9815354	0.812	rs73069240	chr3:41950973	A/T	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	trans	rs1814175	0.754	rs28593359	chr11:50042357	C/T	cg03929089	chr4:120376271	NA	-0.93	-8.77	-0.7	3.08e-13	Height;
SKCM	cis	rs9910055	0.659	rs227578	chr17:42210189	C/A	cg13607699	chr17:42295918	UBTF	-0.71	-5.52	-0.53	4.23e-7	Total body bone mineral density;
SKCM	trans	rs17685	0.753	rs12531559	chr7:75631697	C/T	cg19862616	chr7:65841803	NCRNA00174	-0.96	-9.14	-0.72	5.89e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs798554	0.757	rs1182171	chr7:2878510	A/G	cg19346786	chr7:2764209	NA	-0.62	-6.89	-0.62	1.26e-9	Height;
SKCM	cis	rs2836974	0.644	rs2410123	chr21:40700093	C/T	cg11644478	chr21:40555479	PSMG1	-0.67	-5.63	-0.54	2.71e-7	Cognitive function;
SKCM	cis	rs7095944	0.614	rs7099316	chr10:126469005	G/A	cg08799069	chr10:126477246	METTL10	-0.56	-4.77	-0.48	8.48e-6	Asthma;
SKCM	cis	rs67460515	0.892	rs73026976	chr3:160964271	G/A	cg03342759	chr3:160939853	NMD3	-0.81	-7.1	-0.63	5.14e-10	Parkinson's disease;
SKCM	cis	rs8180040	0.903	rs7636423	chr3:47309134	C/G	cg27129171	chr3:47204927	SETD2	0.85	6.39	0.59	1.11e-8	Colorectal cancer;
SKCM	cis	rs778371	0.723	rs13001052	chr2:233683984	C/T	cg08000102	chr2:233561755	GIGYF2	-0.76	-5.94	-0.56	7.47e-8	Schizophrenia;
SKCM	cis	rs11719291	0.504	rs34571182	chr3:49209057	T/A	cg24898236	chr3:49228699	LOC646498	0.65	4.98	0.49	3.66e-6	Cognitive function;
SKCM	cis	rs941408	1.000	rs759068	chr19:2792566	G/A	cg06609049	chr19:2785107	THOP1	0.83	6.74	0.61	2.46e-9	Total cholesterol levels;
SKCM	cis	rs60871478	1.000	rs4721124	chr7:823761	T/C	cg05535760	chr7:792225	HEATR2	1.02	8.66	0.7	4.97e-13	Cerebrospinal P-tau181p levels;
SKCM	cis	rs807669	0.903	rs1780640	chr22:19174597	C/T	cg02655711	chr22:19163373	SLC25A1	0.78	7.22	0.63	3.03e-10	Metabolite levels;
SKCM	cis	rs1799949	1.000	rs1399323	chr17:41332330	T/C	cg05368731	chr17:41323189	NBR1	0.87	7.74	0.66	3.01e-11	Menopause (age at onset);
SKCM	cis	rs7666738	0.830	rs4699594	chr4:98980775	T/C	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs801193	1.000	rs2659889	chr7:66217112	A/G	cg18876405	chr7:65276391	NA	0.82	7.53	0.65	7.55e-11	Aortic root size;
SKCM	cis	rs2243480	1.000	rs34974928	chr7:65364006	T/C	cg18252515	chr7:66147081	NA	-1.29	-7.41	-0.64	1.3e-10	Diabetic kidney disease;
SKCM	trans	rs1814175	0.645	rs1851844	chr11:50021773	T/C	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs1005277	0.505	rs200910	chr10:38108176	C/T	cg00409905	chr10:38381863	ZNF37A	-0.62	-5.81	-0.55	1.29e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs7659604	0.539	rs2221628	chr4:122795361	G/A	cg20573242	chr4:122745356	CCNA2	0.76	6.54	0.59	5.89e-9	Type 2 diabetes;
SKCM	cis	rs7666738	0.830	rs1365458	chr4:98950961	C/T	cg05340658	chr4:99064831	C4orf37	0.64	4.9	0.49	5.05e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs28595532	0.920	rs114581578	chr4:119756404	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs7829975	0.502	rs7820738	chr8:8702607	C/G	cg06636001	chr8:8085503	FLJ10661	-0.74	-6.07	-0.57	4.27e-8	Mood instability;
SKCM	cis	rs7296418	0.961	rs1790122	chr12:123606739	G/A	cg06742321	chr12:123595122	PITPNM2	0.66	5.48	0.53	4.99e-7	Platelet count;
SKCM	cis	rs34779708	0.966	rs11010122	chr10:35493518	A/C	cg03585969	chr10:35415529	CREM	0.78	6.15	0.57	3.11e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs8180040	0.620	rs9845728	chr3:47103376	C/T	cg27129171	chr3:47204927	SETD2	0.74	5.37	0.52	7.84e-7	Colorectal cancer;
SKCM	cis	rs769267	0.895	rs2916069	chr19:19520358	A/G	cg26732615	chr19:19648335	CILP2;YJEFN3	0.69	7.02	0.62	7.14e-10	Tonsillectomy;
SKCM	cis	rs910316	0.783	rs11850751	chr14:75590113	A/T	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.89e-7	Height;
SKCM	cis	rs561341	0.943	rs508566	chr17:30289861	G/C	cg00745463	chr17:30367425	LRRC37B	-1.08	-7.46	-0.65	1.04e-10	Hip circumference adjusted for BMI;
SKCM	cis	rs1912528	0.963	rs1510719	chr4:140938116	T/C	cg11128457	chr4:140864437	MAML3	0.58	4.82	0.48	6.87e-6	Educational attainment (years of education);
SKCM	cis	rs3820068	0.581	rs78175477	chr1:15948091	C/G	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs6754311	0.551	rs10928545	chr2:136501840	A/G	cg07169764	chr2:136633963	MCM6	-0.85	-6.11	-0.57	3.66e-8	Mosquito bite size;
SKCM	cis	rs9814567	1.000	rs1357762	chr3:134264859	A/C	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs6088590	0.965	rs6088620	chr20:33412022	A/G	cg24642439	chr20:33292090	TP53INP2	1.01	7.37	0.64	1.54e-10	Coronary artery disease;
SKCM	cis	rs1799949	1.000	rs2271573	chr17:41327621	A/G	cg25918947	chr17:41365094	TMEM106A	-0.62	-5.97	-0.56	6.53e-8	Menopause (age at onset);
SKCM	cis	rs1568889	0.838	rs7952717	chr11:28261658	C/T	cg06544937	chr11:28130018	METT5D1;KIF18A	0.87	8.02	0.67	8.66e-12	Bipolar disorder;
SKCM	cis	rs2404602	0.647	rs11072631	chr15:77132909	T/C	cg23625390	chr15:77176239	SCAPER	-0.85	-8.26	-0.68	2.93e-12	Blood metabolite levels;
SKCM	cis	rs13392177	0.684	rs11682371	chr2:219079513	G/A	cg00012203	chr2:219082015	ARPC2	-0.64	-4.89	-0.48	5.39e-6	Pyoderma gangrenosum in inflammatory bowel disease;
SKCM	cis	rs995000	0.965	rs10889333	chr1:62957030	G/A	cg06896770	chr1:63153194	DOCK7	0.89	8.84	0.71	2.18e-13	Triglyceride levels;
SKCM	cis	rs826838	1.000	rs11183160	chr12:38676702	T/C	cg26384229	chr12:38710491	ALG10B	0.95	7.87	0.67	1.67e-11	Heart rate;
SKCM	cis	rs8180040	0.966	rs7651762	chr3:47470484	G/A	cg27129171	chr3:47204927	SETD2	-0.79	-5.79	-0.55	1.43e-7	Colorectal cancer;
SKCM	cis	rs867186	1.000	rs79438986	chr20:33702280	T/G	cg04194272	chr20:33683537	NA	-1.14	-6.37	-0.58	1.22e-8	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs12477438	0.501	rs34272114	chr2:99737443	A/C	cg26064155	chr2:99771622	LIPT1;TSGA10	1.01	9.65	0.74	5.91e-15	Chronic sinus infection;
SKCM	cis	rs6545883	0.772	rs1186709	chr2:61689380	G/A	cg15711740	chr2:61764176	XPO1	-0.71	-4.99	-0.49	3.56e-6	Tuberculosis;
SKCM	cis	rs8180040	0.966	rs56351005	chr3:47430186	G/T	cg16586182	chr3:47516702	SCAP	0.76	5.32	0.52	9.63e-7	Colorectal cancer;
SKCM	cis	rs9430161	0.645	rs12081186	chr1:11034195	T/C	cg27631724	chr1:11040367	C1orf127	0.5	4.88	0.48	5.45e-6	Ewing sarcoma;
SKCM	cis	rs478304	0.654	rs1074155	chr11:65458197	C/T	cg27068330	chr11:65405492	SIPA1	0.9	7.3	0.64	2.13e-10	Acne (severe);
SKCM	cis	rs9790314	1.000	rs336543	chr3:161061080	C/T	cg03342759	chr3:160939853	NMD3	0.72	7.89	0.67	1.53e-11	Morning vs. evening chronotype;
SKCM	cis	rs12044355	0.892	rs1538974	chr1:231828596	A/C	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	-0.89	-6.86	-0.61	1.43e-9	Alzheimer's disease;
SKCM	cis	rs997295	0.570	rs7170299	chr15:67872718	A/G	cg24247231	chr15:67904302	MAP2K5	-0.6	-4.98	-0.49	3.74e-6	Motion sickness;
SKCM	cis	rs9916302	0.784	rs4795361	chr17:37573446	G/A	cg07936489	chr17:37558343	FBXL20	-0.85	-7.35	-0.64	1.71e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs2404602	0.692	rs3110382	chr15:77148688	G/A	cg23625390	chr15:77176239	SCAPER	-0.61	-5.33	-0.52	9.13e-7	Blood metabolite levels;
SKCM	cis	rs3820928	1.000	rs6752707	chr2:227766822	C/G	cg11843606	chr2:227700838	RHBDD1	-0.6	-4.8	-0.48	7.53e-6	Pulmonary function;
SKCM	cis	rs4132509	0.793	rs74379351	chr1:243779604	T/C	cg21452805	chr1:244014465	NA	0.84	4.95	0.49	4.24e-6	RR interval (heart rate);
SKCM	cis	rs9910055	0.530	rs2269905	chr17:42294462	A/G	cg10896456	chr17:42255109	ASB16;C17orf65	0.54	4.88	0.48	5.61e-6	Total body bone mineral density;
SKCM	cis	rs7659604	0.539	rs2221628	chr4:122795361	G/A	cg19748678	chr4:122722346	EXOSC9	0.65	5.34	0.52	8.74e-7	Type 2 diabetes;
SKCM	cis	rs2032447	0.831	rs9467664	chr6:26021813	A/T	cg18357526	chr6:26021779	HIST1H4A	0.84	7.13	0.63	4.37e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs6570726	0.935	rs425731	chr6:145834151	A/G	cg23711669	chr6:146136114	FBXO30	0.7	6.64	0.6	3.72e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1957429	0.634	rs7143541	chr14:65419777	G/T	cg23373153	chr14:65346875	NA	-1.24	-6.27	-0.58	1.86e-8	Pediatric areal bone mineral density (radius);
SKCM	cis	rs9467773	0.620	rs6925087	chr6:26592853	T/A	cg09904177	chr6:26538194	HMGN4	0.57	4.87	0.48	5.81e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs4132509	0.744	rs10803146	chr1:243709454	T/G	cg21452805	chr1:244014465	NA	0.87	5.27	0.51	1.2e-6	RR interval (heart rate);
SKCM	cis	rs6952808	0.964	rs10950400	chr7:1882470	C/T	cg02951883	chr7:2050386	MAD1L1	-0.71	-5.35	-0.52	8.61e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs4268898	0.662	rs2288074	chr2:24413595	C/T	cg06627628	chr2:24431161	ITSN2	-0.96	-7.31	-0.64	2e-10	Asthma;
SKCM	cis	rs13424612	0.930	rs12478169	chr2:240951603	C/T	cg01812947	chr2:240904978	NDUFA10	0.64	4.91	0.49	4.85e-6	Odorant perception (isobutyraldehyde);
SKCM	cis	rs614226	1.000	rs1167726	chr12:120967364	A/C	cg01236616	chr12:121019343	POP5	-1.34	-8.54	-0.7	8.29e-13	Type 1 diabetes nephropathy;
SKCM	trans	rs1814175	0.817	rs11040700	chr11:50023832	C/T	cg15704280	chr7:45808275	SEPT13	-1.05	-11.07	-0.78	1.14e-17	Height;
SKCM	cis	rs1577917	1.000	rs1577919	chr6:86757296	C/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.83	-8.14	-0.68	5.09e-12	Response to antipsychotic treatment;
SKCM	cis	rs35306767	0.714	rs28512382	chr10:1092195	G/C	cg25614935	chr10:1084866	C10orf110	0.69	5.22	0.51	1.45e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs9611565	0.532	rs202627	chr22:41847367	A/T	cg03806693	chr22:41940476	POLR3H	1.07	6.74	0.61	2.44e-9	Vitiligo;
SKCM	cis	rs3793683	0.545	rs12784407	chr10:134589631	A/G	cg26818010	chr10:134567672	INPP5A	-0.72	-5.42	-0.52	6.55e-7	Migraine;
SKCM	cis	rs34779708	0.966	rs12762493	chr10:35471873	G/A	cg03585969	chr10:35415529	CREM	0.77	6.39	0.59	1.09e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs34779708	0.733	rs7070778	chr10:35541688	T/C	cg03585969	chr10:35415529	CREM	0.74	5.42	0.52	6.41e-7	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs77216612	0.877	rs72656645	chr12:12881055	A/G	cg04607235	chr12:12878440	APOLD1	-0.99	-7.1	-0.63	5.02e-10	Lymphocyte counts;
SKCM	cis	rs9318086	0.712	rs66683041	chr13:24442090	T/A	cg25267304	chr13:24462978	PCOTH;MIPEP	0.88	6.59	0.6	4.68e-9	Myopia (pathological);
SKCM	cis	rs55962025	0.686	rs362331	chr4:3215835	T/C	cg16987761	chr4:3318072	RGS12	-0.59	-4.84	-0.48	6.42e-6	Parental longevity (mother's age at death);
SKCM	cis	rs6977660	1.000	rs10249989	chr7:19822296	A/G	cg05791153	chr7:19748676	TWISTNB	0.79	5.34	0.52	9.05e-7	Thyroid stimulating hormone;
SKCM	cis	rs244731	1.000	rs244731	chr5:176539679	C/T	cg16006841	chr5:176797999	RGS14	0.74	5.19	0.51	1.6e-6	Urate levels in lean individuals;
SKCM	cis	rs2836974	1.000	rs12710454	chr21:40656919	A/G	cg17971929	chr21:40555470	PSMG1	0.86	8.49	0.69	1.04e-12	Cognitive function;
SKCM	cis	rs7100689	0.725	rs2487074	chr10:82064104	A/G	cg00277334	chr10:82204260	NA	-0.58	-5.69	-0.54	2.16e-7	Post bronchodilator FEV1;
SKCM	cis	rs10489202	0.954	rs11586522	chr1:168091031	G/T	cg24449463	chr1:168025552	DCAF6	-0.9	-6.3	-0.58	1.65e-8	Schizophrenia;
SKCM	cis	rs10871290	0.650	rs2288054	chr16:74491733	A/G	cg01733217	chr16:74700730	RFWD3	0.9	6.58	0.6	4.91e-9	Breast cancer;
SKCM	cis	rs651907	0.557	rs7651404	chr3:101393294	C/A	cg12386194	chr3:101231763	SENP7	0.71	5.94	0.56	7.61e-8	Colorectal cancer;
SKCM	cis	rs9910055	0.920	rs2855818	chr17:42290015	G/A	cg13607699	chr17:42295918	UBTF	0.8	6.49	0.59	7.32e-9	Total body bone mineral density;
SKCM	cis	rs7100689	0.784	rs1972370	chr10:82127180	A/G	cg00277334	chr10:82204260	NA	-0.52	-4.89	-0.48	5.24e-6	Post bronchodilator FEV1;
SKCM	cis	rs34779708	0.897	rs16935880	chr10:35415468	C/G	cg03585969	chr10:35415529	CREM	0.78	6.2	0.57	2.53e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs992157	0.730	rs4280446	chr2:219184721	T/C	cg00012203	chr2:219082015	ARPC2	0.75	5.54	0.53	3.92e-7	Colorectal cancer;
SKCM	trans	rs8073060	0.586	rs3859284	chr17:34012792	C/T	cg19694781	chr19:47549865	TMEM160	-1.04	-8.28	-0.68	2.65e-12	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs593982	0.920	rs76925283	chr11:65548108	C/T	cg08755490	chr11:65554678	OVOL1	-0.92	-7.02	-0.62	7.2e-10	Atopic dermatitis;
SKCM	cis	rs9457247	0.534	rs2757053	chr6:167380338	A/C	cg23791538	chr6:167370224	RNASET2	0.55	4.87	0.48	5.78e-6	Crohn's disease;
SKCM	cis	rs6580649	0.941	rs4589362	chr12:48478664	T/C	cg05342945	chr12:48394962	COL2A1	0.81	5.59	0.54	3.16e-7	Lung cancer;
SKCM	cis	rs79839061	0.520	rs6842808	chr4:906903	C/T	cg07828340	chr4:882639	GAK	1.05	5.99	0.56	5.99e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs2404602	0.647	rs2404604	chr15:76991105	A/G	cg23625390	chr15:77176239	SCAPER	-0.84	-8.23	-0.68	3.3e-12	Blood metabolite levels;
SKCM	cis	rs3785574	0.962	rs2584623	chr17:61906679	G/A	cg06873352	chr17:61820015	STRADA	0.56	4.82	0.48	6.86e-6	Height;
SKCM	cis	rs9640161	0.659	rs77354576	chr7:150013300	A/C	cg10018233	chr7:150070692	REPIN1	0.69	5.72	0.54	1.86e-7	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs9815354	0.812	rs17283243	chr3:41914792	C/T	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs2153535	0.580	rs969421	chr6:8451949	A/C	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs2836974	0.897	rs13052882	chr21:40555351	G/C	cg17971929	chr21:40555470	PSMG1	0.89	8.73	0.7	3.6e-13	Cognitive function;
SKCM	cis	rs7811142	0.562	rs7786844	chr7:99934008	T/G	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.06	6.05	0.56	4.82e-8	Platelet count;
SKCM	cis	rs7618915	0.547	rs11720432	chr3:52672742	T/C	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs4727027	0.933	rs12704063	chr7:148827909	T/C	cg23583168	chr7:148888333	NA	-0.82	-6.56	-0.6	5.29e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs9788721	0.836	rs7181486	chr15:78741618	C/T	cg18825076	chr15:78729989	IREB2	0.61	4.85	0.48	6.1e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;Emphysema imaging phenotypes;Emphysema distribution in smoking;Local histogram emphysema pattern;Post bronchodilator FEV1/FVC ratio in COPD;
SKCM	cis	rs2836974	0.831	rs2836921	chr21:40516070	C/T	cg11644478	chr21:40555479	PSMG1	0.97	9.49	0.73	1.22e-14	Cognitive function;
SKCM	cis	rs10193935	1.000	rs13421289	chr2:42412808	T/C	cg27598129	chr2:42591480	NA	-0.91	-6.64	-0.6	3.8e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs28386778	0.897	rs7501614	chr17:61802612	T/C	cg06873352	chr17:61820015	STRADA	0.75	6.24	0.58	2.1e-8	Prudent dietary pattern;
SKCM	cis	rs1707322	1.000	rs10890380	chr1:46449469	A/G	cg03146154	chr1:46216737	IPP	0.78	5.2	0.51	1.57e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs6696846	0.749	rs7553876	chr1:205079915	A/G	cg03948781	chr1:205179583	DSTYK	0.56	5.28	0.51	1.14e-6	Red blood cell count;
SKCM	cis	rs12709013	0.792	rs35684307	chr16:58835555	A/G	cg02431531	chr16:59244939	NA	0.48	4.99	0.49	3.62e-6	Blood metabolite ratios;
SKCM	cis	rs1707322	1.000	rs4073847	chr1:46463012	A/C	cg03146154	chr1:46216737	IPP	-0.73	-4.88	-0.48	5.45e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs1707322	1.000	rs7539800	chr1:46262129	C/G	cg03146154	chr1:46216737	IPP	-0.76	-5.21	-0.51	1.53e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs66569888	0.789	rs66826026	chr2:106732879	C/T	cg15412446	chr2:106886593	NA	-0.72	-5.04	-0.5	2.93e-6	Facial morphology (factor 23);
SKCM	cis	rs7438704	0.552	rs4599384	chr4:48318390	G/A	cg15299388	chr4:48491941	ZAR1	-0.45	-5.21	-0.51	1.49e-6	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs2836974	0.965	rs34578707	chr21:40675167	G/A	cg11890956	chr21:40555474	PSMG1	0.99	11.14	0.78	8.38e-18	Cognitive function;
SKCM	cis	rs8180040	0.966	rs13075233	chr3:47420627	T/C	cg27129171	chr3:47204927	SETD2	0.79	5.79	0.55	1.43e-7	Colorectal cancer;
SKCM	cis	rs763121	0.853	rs2267393	chr22:39101619	G/C	cg06022373	chr22:39101656	GTPBP1	0.86	6.35	0.58	1.32e-8	Menopause (age at onset);
SKCM	cis	rs514406	0.755	rs11206015	chr1:53242187	T/C	cg24675658	chr1:53192096	ZYG11B	0.61	4.78	0.48	8.25e-6	Monocyte count;
SKCM	cis	rs2929278	0.561	rs3099045	chr15:43923955	A/C	cg02155558	chr15:43621948	ADAL;LCMT2	0.76	5.52	0.53	4.3e-7	Schizophrenia;
SKCM	cis	rs9926296	0.605	rs12599180	chr16:89839306	C/T	cg27121462	chr16:89883253	FANCA	-0.81	-6.99	-0.62	8.41e-10	Vitiligo;
SKCM	cis	rs875971	0.830	rs427973	chr7:65526648	C/A	cg11987759	chr7:65425863	GUSB	-0.56	-4.94	-0.49	4.34e-6	Aortic root size;
SKCM	cis	rs909674	0.818	rs7364148	chr22:39842165	T/C	cg24399712	chr22:39784796	NA	-0.58	-4.77	-0.48	8.35e-6	IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis);IgG glycosylation;IgG digalactosylation phenotypes (multivariate analysis);IgG sialylation phenotypes (multivariate analysis);IgG monogalactosylation phenotypes (multivariate analysis);IgG fucosylation phenotypes (multivariate analysis);IgG N-glycosylation phenotypes (multivariate analysis);IgG disialylation phenotypes (multivariate analysis);IgG galactosylation phenotypes (multivariate analysis);Post bronchodilator FEV1;
SKCM	cis	rs1790761	0.692	rs10896179	chr11:67316928	C/A	cg00290607	chr11:67383545	NA	0.52	5.48	0.53	4.97e-7	Mean corpuscular volume;
SKCM	cis	rs2439831	0.850	rs3742982	chr15:44176681	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.3	6.97	0.62	9.12e-10	Lung cancer in ever smokers;
SKCM	cis	rs870825	0.616	rs28666955	chr4:185631338	A/G	cg04058563	chr4:185651563	MLF1IP	1.08	7.26	0.64	2.51e-10	Blood protein levels;
SKCM	cis	rs36051895	0.659	rs10974935	chr9:5050307	C/T	cg02405213	chr9:5042618	JAK2	-0.65	-5.23	-0.51	1.41e-6	Pediatric autoimmune diseases;
SKCM	cis	rs2204008	0.714	rs11520135	chr12:38114863	C/T	cg13010199	chr12:38710504	ALG10B	0.69	5.0	0.49	3.48e-6	Bladder cancer;
SKCM	cis	rs2739330	0.685	rs4822453	chr22:24254862	G/T	cg25703541	chr22:24373054	LOC391322	-0.82	-6.92	-0.62	1.11e-9	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs8017423	0.967	rs8015510	chr14:90729984	C/T	cg04374321	chr14:90722782	PSMC1	1.0	9.0	0.71	1.09e-13	Mortality in heart failure;
SKCM	cis	rs9309711	0.666	rs11127429	chr2:3485224	T/G	cg15506890	chr2:3487001	NA	-0.68	-5.36	-0.52	8.33e-7	Neurofibrillary tangles;
SKCM	cis	rs2721195	0.845	rs4244611	chr8:145739924	G/A	cg11211951	chr8:145729740	GPT	0.53	4.83	0.48	6.62e-6	Age at first birth;
SKCM	cis	rs2980439	0.525	rs2980508	chr8:8171732	C/T	cg06636001	chr8:8085503	FLJ10661	0.75	6.62	0.6	4.18e-9	Neuroticism;
SKCM	cis	rs548181	0.536	rs503287	chr11:125461788	C/T	cg03464685	chr11:125439445	EI24	1.33	8.61	0.7	6.29e-13	Schizophrenia;Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);
SKCM	cis	rs3087591	0.920	rs7225014	chr17:29572973	A/G	cg24425628	chr17:29625626	OMG;NF1	-0.63	-4.95	-0.49	4.23e-6	Hip circumference;
SKCM	cis	rs10256972	0.706	rs12701969	chr7:1121849	A/G	cg07092213	chr7:1199455	ZFAND2A	-0.65	-5.45	-0.53	5.73e-7	Longevity;Endometriosis;
SKCM	cis	rs644799	1.000	rs544119	chr11:95538624	G/A	cg25622487	chr11:95524042	FAM76B;CEP57	0.66	5.12	0.5	2.18e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs4740619	0.630	rs2794646	chr9:15893580	A/G	cg14451791	chr9:16040625	NA	0.43	5.18	0.51	1.68e-6	Body mass index;
SKCM	cis	rs514406	0.570	rs1332776	chr1:53189816	C/T	cg16325326	chr1:53192061	ZYG11B	0.91	10.42	0.76	2.01e-16	Monocyte count;
SKCM	cis	rs6461049	0.765	rs1476887	chr7:2151633	T/C	cg21782813	chr7:2030301	MAD1L1	0.48	5.1	0.5	2.32e-6	Schizophrenia;
SKCM	cis	rs1059312	0.932	rs4760592	chr12:129287149	G/C	cg09035930	chr12:129282057	SLC15A4	0.8	8.73	0.7	3.65e-13	Systemic lupus erythematosus;
SKCM	cis	rs2885056	0.830	rs2018810	chr19:10669172	A/G	cg04833646	chr19:10679720	CDKN2D	1.09	9.67	0.74	5.4e-15	Red cell distribution width;
SKCM	cis	rs1799949	0.965	rs8176087	chr17:41270666	C/A	cg25072359	chr17:41440525	NA	0.63	4.79	0.48	7.88e-6	Menopause (age at onset);
SKCM	cis	rs9803723	0.648	rs4560984	chr1:25449410	C/T	cg20685674	chr1:26233538	STMN1	0.53	5.44	0.52	5.9e-7	Male-pattern baldness;
SKCM	cis	rs4481887	1.000	rs4244176	chr1:248468231	G/A	cg00666640	chr1:248458726	OR2T12	0.61	5.6	0.54	3.11e-7	Common traits (Other);
SKCM	cis	rs2120019	0.567	rs28844983	chr15:75178088	T/A	cg17294928	chr15:75287854	SCAMP5	-0.85	-5.9	-0.56	8.72e-8	Blood trace element (Zn levels);
SKCM	cis	rs7666738	0.830	rs2865979	chr4:99027137	T/C	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs12714314	0.756	rs7355512	chr2:1948166	A/T	cg22350835	chr2:1868857	MYT1L	0.66	5.2	0.51	1.54e-6	Type 2 diabetes (age of onset);
SKCM	cis	rs6582630	0.502	rs1115515	chr12:38279830	C/T	cg26384229	chr12:38710491	ALG10B	0.87	6.83	0.61	1.63e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs7647973	0.848	rs4292260	chr3:49148890	T/C	cg07636037	chr3:49044803	WDR6	0.89	5.48	0.53	5e-7	Menarche (age at onset);
SKCM	cis	rs8141529	0.732	rs3788409	chr22:29198151	T/G	cg15103426	chr22:29168792	CCDC117	0.62	5.23	0.51	1.37e-6	Lymphocyte counts;
SKCM	cis	rs2153535	0.601	rs1737581	chr6:8539138	A/G	cg07606381	chr6:8435919	SLC35B3	0.93	6.41	0.59	1e-8	Motion sickness;
SKCM	cis	rs2839186	0.739	rs2280958	chr21:47642016	C/T	cg05896524	chr21:47604654	C21orf56	0.68	5.63	0.54	2.78e-7	Testicular germ cell tumor;
SKCM	cis	rs6570726	0.846	rs870491	chr6:145933390	T/G	cg23711669	chr6:146136114	FBXO30	0.78	7.37	0.64	1.56e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2204008	0.806	rs3922574	chr12:38329069	C/T	cg26384229	chr12:38710491	ALG10B	0.81	6.67	0.6	3.38e-9	Bladder cancer;
SKCM	cis	rs7666738	0.830	rs1834645	chr4:98979593	T/A	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs8067545	0.750	rs9896411	chr17:19987610	A/T	cg13482628	chr17:19912719	NA	0.73	6.54	0.6	5.78e-9	Schizophrenia;
SKCM	cis	rs7086627	0.515	rs7077373	chr10:82211615	C/T	cg00277334	chr10:82204260	NA	-0.75	-8.99	-0.71	1.12e-13	Post bronchodilator FEV1;
SKCM	cis	rs8067545	0.750	rs35003563	chr17:19989218	G/A	cg13482628	chr17:19912719	NA	0.73	6.54	0.6	5.78e-9	Schizophrenia;
SKCM	cis	rs754466	0.580	rs1058198	chr10:79566632	G/A	cg17075019	chr10:79541650	NA	-0.81	-7.33	-0.64	1.81e-10	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs7843479	0.601	rs1031882	chr8:21788934	T/G	cg17168535	chr8:21777572	XPO7	0.83	8.27	0.68	2.81e-12	Mean corpuscular volume;
SKCM	cis	rs807669	0.548	rs5748028	chr22:19172281	G/A	cg02655711	chr22:19163373	SLC25A1	0.64	5.61	0.54	2.93e-7	Metabolite levels;
SKCM	cis	rs1218582	0.710	rs7553195	chr1:154837796	T/C	cg09359103	chr1:154839909	KCNN3	-0.59	-5.93	-0.56	7.77e-8	Prostate cancer;
SKCM	cis	rs2841277	0.708	rs9671643	chr14:105408030	A/G	cg15352829	chr14:105391018	PLD4	-0.58	-4.81	-0.48	7.35e-6	Rheumatoid arthritis;
SKCM	cis	rs1577917	1.000	rs1962716	chr6:86648436	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.61	-5.27	-0.51	1.2e-6	Response to antipsychotic treatment;
SKCM	cis	rs9818758	0.556	rs116432667	chr3:48947589	C/T	cg00383909	chr3:49044727	WDR6	0.95	5.43	0.52	6.25e-7	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs6951245	1.000	rs11763793	chr7:1094342	A/G	cg03188948	chr7:1209495	NA	1.13	6.27	0.58	1.89e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs2070488	0.775	rs2051214	chr3:38560303	C/A	cg01465620	chr3:38496096	LOC100128640;ACVR2B	-0.7	-5.43	-0.52	6.3e-7	Electrocardiographic conduction measures;
SKCM	cis	rs6665290	0.935	rs17528667	chr1:227201770	C/T	cg10327440	chr1:227177885	CDC42BPA	-1.21	-16.02	-0.88	2.21e-26	Myeloid white cell count;
SKCM	cis	rs7940866	0.834	rs10894302	chr11:130861994	C/T	cg12179176	chr11:130786555	SNX19	0.75	5.77	0.55	1.54e-7	Schizophrenia;
SKCM	cis	rs523522	0.962	rs9040	chr12:120900274	C/T	cg27279351	chr12:120934652	DYNLL1	0.93	8.36	0.69	1.89e-12	High light scatter reticulocyte count;
SKCM	cis	rs7315438	0.719	rs4767323	chr12:115916868	T/A	cg04892836	chr12:115174285	NA	0.4	4.82	0.48	7.01e-6	Colorectal cancer;
SKCM	cis	rs6088590	0.748	rs6142206	chr20:33212055	G/A	cg24642439	chr20:33292090	TP53INP2	0.83	6.22	0.58	2.32e-8	Coronary artery disease;
SKCM	cis	rs11098499	0.863	rs3775847	chr4:120447642	A/C	cg24375607	chr4:120327624	NA	0.68	5.27	0.51	1.16e-6	Corneal astigmatism;
SKCM	cis	rs12500482	1.000	rs12500482	chr4:2430235	A/G	cg26605046	chr4:2439731	NA	-0.6	-5.25	-0.51	1.28e-6	Cognitive function;
SKCM	cis	rs10504229	0.953	rs66676208	chr8:58173866	C/T	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs4803468	1.000	rs284650	chr19:41927129	A/G	cg14132834	chr19:41945861	ATP5SL	-0.77	-6.04	-0.56	4.87e-8	Height;
SKCM	cis	rs8177253	0.761	rs13079426	chr3:133522334	A/G	cg01448562	chr3:133502909	NA	-0.55	-4.77	-0.48	8.44e-6	Iron status biomarkers;
SKCM	cis	rs2814982	0.605	rs114032116	chr6:34468333	C/T	cg17674042	chr6:34482479	PACSIN1	-1.0	-5.42	-0.52	6.4e-7	Cholesterol, total;Total cholesterol levels;
SKCM	cis	rs151997	0.925	rs26089	chr5:50172251	A/G	cg06027927	chr5:50259733	NA	-0.66	-5.68	-0.54	2.22e-7	Callous-unemotional behaviour;
SKCM	cis	rs11252926	0.673	rs816620	chr10:645916	A/G	cg18196295	chr10:418757	DIP2C	-0.65	-4.98	-0.49	3.77e-6	Psychosis in Alzheimer's disease;
SKCM	cis	rs1707322	0.691	rs11211174	chr1:46220816	C/G	cg03146154	chr1:46216737	IPP	0.84	6.2	0.57	2.51e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs5417	0.751	rs1634381	chr17:7180007	C/T	cg25256661	chr17:7137939	DVL2	-0.82	-6.29	-0.58	1.71e-8	Diastolic blood pressure;
SKCM	cis	rs11098499	1.000	rs3749591	chr4:120214030	T/G	cg09307838	chr4:120376055	NA	0.95	7.75	0.66	2.89e-11	Corneal astigmatism;
SKCM	cis	rs7647973	0.560	rs7638154	chr3:49299375	C/A	cg07636037	chr3:49044803	WDR6	0.83	6.82	0.61	1.76e-9	Menarche (age at onset);
SKCM	cis	rs1218582	0.596	rs4845676	chr1:154827861	C/G	cg06221963	chr1:154839813	KCNN3	-0.49	-4.83	-0.48	6.57e-6	Prostate cancer;
SKCM	cis	rs7954584	0.531	rs1154514	chr12:122374888	C/T	cg21171335	chr12:122356390	WDR66	0.46	4.99	0.49	3.52e-6	Mean corpuscular volume;
SKCM	cis	rs75229567	0.618	rs11177849	chr12:70182473	C/T	cg10114359	chr12:70132523	RAB3IP	-1.2	-5.17	-0.51	1.74e-6	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes;
SKCM	cis	rs57221529	0.713	rs72703072	chr5:590626	A/G	cg10555297	chr5:473380	SLC9A3;LOC25845	1.01	5.03	0.49	3.1e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs10504073	0.506	rs7007271	chr8:49941897	T/C	cg00325661	chr8:49890786	NA	0.81	6.83	0.61	1.64e-9	Blood metabolite ratios;
SKCM	cis	rs1552244	0.935	rs35586456	chr3:10116938	A/G	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs2032447	0.832	rs6922788	chr6:26052291	C/T	cg18357526	chr6:26021779	HIST1H4A	0.85	7.36	0.64	1.6e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs2204008	0.837	rs2127955	chr12:37969194	A/G	cg26384229	chr12:38710491	ALG10B	0.75	6.29	0.58	1.74e-8	Bladder cancer;
SKCM	cis	rs2120019	0.938	rs59094290	chr15:75308561	G/T	cg17294928	chr15:75287854	SCAMP5	-0.89	-8.26	-0.68	2.98e-12	Blood trace element (Zn levels);
SKCM	cis	rs6089584	0.546	rs6061978	chr20:60615604	C/T	cg16423285	chr20:60520624	NA	-0.63	-5.63	-0.54	2.68e-7	Body mass index;
SKCM	cis	rs7296418	0.738	rs1568428	chr12:123738876	A/G	cg05973401	chr12:123451056	ABCB9	-0.73	-5.63	-0.54	2.75e-7	Platelet count;
SKCM	cis	rs6424115	1.000	rs4649115	chr1:24155731	A/G	cg15997130	chr1:24165203	NA	-0.62	-5.42	-0.52	6.33e-7	Immature fraction of reticulocytes;
SKCM	cis	rs208515	0.525	rs10944859	chr6:66665197	A/G	cg07460842	chr6:66804631	NA	0.94	5.82	0.55	1.22e-7	Exhaled nitric oxide levels;
SKCM	cis	rs1568889	0.838	rs10835304	chr11:28296529	A/G	cg06544937	chr11:28130018	METT5D1;KIF18A	0.89	8.2	0.68	3.84e-12	Bipolar disorder;
SKCM	cis	rs6580649	0.941	rs1968071	chr12:48489357	A/G	cg05342945	chr12:48394962	COL2A1	0.82	5.71	0.54	1.94e-7	Lung cancer;
SKCM	cis	rs7927771	0.832	rs10838698	chr11:47385923	G/A	cg05585544	chr11:47624801	NA	0.56	4.84	0.48	6.52e-6	Subjective well-being;
SKCM	cis	rs9303401	0.659	rs34351230	chr17:56782555	C/A	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.16	0.57	2.91e-8	Cognitive test performance;
SKCM	cis	rs28595532	0.920	rs115437723	chr4:119741828	C/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	trans	rs3780486	0.505	rs10117038	chr9:33122626	T/C	cg04842962	chr6:43655489	MRPS18A	0.89	8.31	0.69	2.38e-12	IgG glycosylation;
SKCM	cis	rs2739330	0.892	rs4822455	chr22:24255296	C/T	cg04234412	chr22:24373322	LOC391322	-0.58	-4.82	-0.48	7.06e-6	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs798554	0.680	rs1713912	chr7:2895784	C/A	cg19346786	chr7:2764209	NA	-0.63	-6.2	-0.57	2.46e-8	Height;
SKCM	cis	rs2836974	0.897	rs13052882	chr21:40555351	G/C	cg11644478	chr21:40555479	PSMG1	0.97	10.17	0.75	5.99e-16	Cognitive function;
SKCM	cis	rs2302777	0.507	rs9889716	chr17:38108298	A/G	cg17467752	chr17:38218738	THRA	0.65	5.15	0.5	1.91e-6	Multiple myeloma (hyperdiploidy);
SKCM	cis	rs6951245	0.872	rs57068908	chr7:1060084	A/C	cg18402987	chr7:1209562	NA	1.14	5.99	0.56	6.11e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs995000	0.965	rs12116574	chr1:63037837	C/T	cg06896770	chr1:63153194	DOCK7	0.89	7.69	0.66	3.79e-11	Triglyceride levels;
SKCM	trans	rs561341	0.883	rs7219239	chr17:30212016	A/G	cg20587970	chr11:113659929	NA	1.07	8.37	0.69	1.77e-12	Hip circumference adjusted for BMI;
SKCM	cis	rs28386778	0.724	rs35092235	chr17:61944621	T/C	cg06873352	chr17:61820015	STRADA	0.74	6.15	0.57	3.13e-8	Prudent dietary pattern;
SKCM	cis	rs66573146	1.000	rs7686168	chr4:6986057	C/A	cg00086871	chr4:6988644	TBC1D14	1.43	5.33	0.52	9.25e-7	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs7666738	0.830	rs11727653	chr4:99001774	T/C	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4148883	0.645	rs2851287	chr4:100014548	G/A	cg12011299	chr4:100065546	ADH4	0.48	4.78	0.48	8.24e-6	Alcohol dependence;
SKCM	cis	rs2885056	0.783	rs73007347	chr19:10650649	C/T	cg04833646	chr19:10679720	CDKN2D	1.01	7.95	0.67	1.17e-11	Red cell distribution width;
SKCM	cis	rs826838	0.904	rs10876086	chr12:39188208	C/A	cg26384229	chr12:38710491	ALG10B	0.9	7.85	0.66	1.84e-11	Heart rate;
SKCM	cis	rs908922	0.676	rs493133	chr1:152493875	G/C	cg09873164	chr1:152488093	CRCT1	0.76	5.94	0.56	7.4e-8	Hair morphology;
SKCM	cis	rs2228479	0.764	rs7186976	chr16:89961593	A/G	cg00800038	chr16:89945340	TCF25	-0.94	-5.51	-0.53	4.53e-7	Skin colour saturation;
SKCM	cis	rs28595532	0.764	rs55704595	chr4:119780607	G/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs12142240	0.698	rs72677599	chr1:46834251	G/A	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs155076	0.938	rs9509633	chr13:21844482	G/C	cg11317459	chr13:21872234	NA	-1.24	-6.91	-0.62	1.19e-9	White matter hyperintensity burden;
SKCM	cis	rs1218582	0.772	rs10796934	chr1:154849479	C/G	cg24250549	chr1:154909240	PMVK	0.89	9.39	0.73	1.86e-14	Prostate cancer;
SKCM	cis	rs8141529	0.764	rs5762824	chr22:29222930	C/T	cg15103426	chr22:29168792	CCDC117	0.62	5.2	0.51	1.57e-6	Lymphocyte counts;
SKCM	cis	rs4555082	0.834	rs2735825	chr14:105710900	G/A	cg13114125	chr14:105738426	BRF1	-0.69	-5.7	-0.54	2.07e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs8078723	0.802	rs9303283	chr17:38192633	A/G	cg17467752	chr17:38218738	THRA	0.8	7.66	0.66	4.35e-11	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs1568889	0.877	rs17310076	chr11:28147590	C/T	cg06544937	chr11:28130018	METT5D1;KIF18A	0.9	6.37	0.58	1.22e-8	Bipolar disorder;
SKCM	cis	rs10193935	0.901	rs10189710	chr2:42573102	C/G	cg27598129	chr2:42591480	NA	-0.88	-6.71	-0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1577917	1.000	rs1857965	chr6:86630776	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.66	-5.74	-0.54	1.76e-7	Response to antipsychotic treatment;
SKCM	cis	rs7618501	0.633	rs9814664	chr3:50078541	C/T	cg05072774	chr3:49840536	C3orf54	0.67	5.06	0.5	2.7e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9467773	1.000	rs1321480	chr6:26532742	A/G	cg15659132	chr6:26577336	NA	0.6	5.71	0.54	1.99e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs72827839	0.516	rs72833458	chr17:45938051	A/G	cg23391107	chr17:45924227	SP6	0.66	5.61	0.54	2.96e-7	Ease of getting up in the morning;
SKCM	cis	rs9790314	0.846	rs7636941	chr3:160993928	A/G	cg03342759	chr3:160939853	NMD3	-0.72	-8.12	-0.68	5.59e-12	Morning vs. evening chronotype;
SKCM	cis	rs11098499	0.955	rs6815725	chr4:120158410	C/A	cg09307838	chr4:120376055	NA	0.93	7.99	0.67	9.9e-12	Corneal astigmatism;
SKCM	cis	rs2282032	0.527	rs57011283	chr14:90767165	G/T	cg04374321	chr14:90722782	PSMC1	0.67	5.43	0.52	6.07e-7	Longevity;
SKCM	cis	rs514406	0.763	rs9988539	chr1:53213884	T/C	cg16325326	chr1:53192061	ZYG11B	-1.01	-11.9	-0.8	3.23e-19	Monocyte count;
SKCM	cis	rs1799949	1.000	rs8176289	chr17:41206056	T/C	cg23758822	chr17:41437982	NA	0.94	7.82	0.66	2.13e-11	Menopause (age at onset);
SKCM	cis	rs9325144	0.554	rs1906264	chr12:38739490	A/G	cg26384229	chr12:38710491	ALG10B	0.78	6.83	0.61	1.68e-9	Morning vs. evening chronotype;
SKCM	cis	rs1395	0.634	rs62130713	chr2:27525661	A/G	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.55	5.16	0.5	1.8e-6	Blood metabolite levels;
SKCM	cis	rs9880211	1.000	rs9818056	chr3:136210074	C/T	cg21827317	chr3:136751795	NA	-0.64	-4.78	-0.48	8.21e-6	Body mass index;Height;
SKCM	cis	rs17376456	0.597	rs11135401	chr5:93365716	G/A	cg25358565	chr5:93447407	FAM172A	-0.87	-5.6	-0.54	3.04e-7	Diabetic retinopathy;
SKCM	cis	rs7646501	0.734	rs954734	chr3:24055654	A/C	cg22892432	chr3:24537792	THRB	0.57	4.83	0.48	6.64e-6	Cognitive ability;Intelligence;
SKCM	cis	rs1005277	0.589	rs2749624	chr10:38529865	A/G	cg25427524	chr10:38739819	LOC399744	-0.71	-6.71	-0.6	2.79e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs1790761	0.505	rs7106423	chr11:67314144	A/G	cg00290607	chr11:67383545	NA	-0.51	-4.82	-0.48	6.84e-6	Mean corpuscular volume;
SKCM	cis	rs17065868	1.000	rs73174032	chr13:45205137	T/A	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs453301	0.506	rs686189	chr8:8623637	A/G	cg06636001	chr8:8085503	FLJ10661	-0.68	-6.25	-0.58	2.05e-8	Joint mobility (Beighton score);
SKCM	cis	rs3768617	0.510	rs10797838	chr1:183077020	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.79	7.82	0.66	2.09e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs3812565	0.530	rs10781538	chr9:139320929	C/G	cg14169450	chr9:139327907	INPP5E	-0.49	-5.36	-0.52	8.12e-7	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs2836974	0.897	rs2026265	chr21:40595517	G/A	cg11890956	chr21:40555474	PSMG1	1.09	13.83	0.84	1.08e-22	Cognitive function;
SKCM	cis	rs3820928	1.000	rs9288617	chr2:227762815	G/C	cg11843606	chr2:227700838	RHBDD1	-0.62	-4.99	-0.49	3.52e-6	Pulmonary function;
SKCM	cis	rs1005277	0.579	rs1780121	chr10:38529437	C/A	cg00409905	chr10:38381863	ZNF37A	-0.62	-5.23	-0.51	1.39e-6	Extrinsic epigenetic age acceleration;
SKCM	cis	rs1577917	0.727	rs9351065	chr6:86360428	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.82	-7.6	-0.65	5.57e-11	Response to antipsychotic treatment;
SKCM	cis	rs7666738	0.830	rs3907020	chr4:99038583	T/C	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1218582	0.745	rs1580943	chr1:154865125	G/A	cg09359103	chr1:154839909	KCNN3	-0.57	-5.25	-0.51	1.26e-6	Prostate cancer;
SKCM	cis	rs9640161	0.711	rs3735170	chr7:150034184	T/C	cg10018233	chr7:150070692	REPIN1	0.71	5.54	0.53	3.98e-7	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs854765	0.618	rs8066982	chr17:17851377	T/C	cg04398451	chr17:18023971	MYO15A	-0.86	-5.91	-0.56	8.41e-8	Total body bone mineral density;
SKCM	cis	rs1218582	0.710	rs4845685	chr1:154878300	C/A	cg09359103	chr1:154839909	KCNN3	-0.57	-5.3	-0.51	1.05e-6	Prostate cancer;
SKCM	cis	rs9900062	0.844	rs9908143	chr17:62754586	T/C	cg02097616	chr17:62675921	NA	0.71	5.49	0.53	4.88e-7	QT interval;
SKCM	cis	rs344364	0.511	rs2982452	chr16:1949511	G/A	cg26897989	chr16:1907736	C16orf73	-0.69	-7.13	-0.63	4.45e-10	Glomerular filtration rate in chronic kidney disease;
SKCM	cis	rs66887589	0.934	rs12648182	chr4:120503891	T/A	cg09307838	chr4:120376055	NA	-0.65	-4.87	-0.48	5.72e-6	Diastolic blood pressure;
SKCM	cis	rs1538970	0.924	rs4660858	chr1:45936351	G/A	cg05343316	chr1:45956843	TESK2	0.96	5.05	0.5	2.81e-6	Platelet count;
SKCM	cis	rs10504229	0.683	rs7464038	chr8:58111908	T/C	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs941873	0.805	rs10762860	chr10:81117794	C/G	cg09469691	chr10:81107165	PPIF	0.7	6.65	0.6	3.6e-9	Height;
SKCM	cis	rs17376456	0.877	rs10076052	chr5:93317762	C/T	cg21475434	chr5:93447410	FAM172A	1.04	5.55	0.53	3.82e-7	Diabetic retinopathy;
SKCM	cis	rs1348850	0.793	rs13027299	chr2:178455501	T/G	cg02961200	chr2:178257176	LOC100130691;AGPS	0.75	5.84	0.55	1.14e-7	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs1005277	0.579	rs2983343	chr10:38383332	A/G	cg00409905	chr10:38381863	ZNF37A	-0.64	-5.96	-0.56	6.77e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs9581857	0.547	rs7336332	chr13:28058404	A/G	cg22138327	chr13:27999177	GTF3A	0.93	6.45	0.59	8.5e-9	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs9733	0.650	rs1971378	chr1:150597261	C/T	cg13175981	chr1:150552382	MCL1	0.69	5.85	0.55	1.11e-7	Tonsillectomy;
SKCM	cis	rs2204008	0.715	rs11514282	chr12:38169056	G/T	cg26384229	chr12:38710491	ALG10B	0.82	6.58	0.6	4.87e-9	Bladder cancer;
SKCM	cis	rs7408868	1.000	rs2074618	chr19:15276143	C/T	cg14696996	chr19:15285081	NOTCH3	0.82	4.92	0.49	4.7e-6	Pulse pressure;
SKCM	cis	rs769267	0.896	rs10405625	chr19:19579046	T/G	cg03709012	chr19:19516395	GATAD2A	0.89	8.62	0.7	5.89e-13	Tonsillectomy;
SKCM	cis	rs12142240	0.621	rs66828173	chr1:46818166	G/A	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs55962025	0.711	rs363092	chr4:3196029	A/C	cg21096898	chr4:3318625	RGS12	0.58	4.79	0.48	7.73e-6	Parental longevity (mother's age at death);
SKCM	cis	rs13424612	0.930	rs6748327	chr2:240902511	G/A	cg01812947	chr2:240904978	NDUFA10	0.63	4.8	0.48	7.43e-6	Odorant perception (isobutyraldehyde);
SKCM	cis	rs2153535	0.580	rs2327064	chr6:8454052	C/T	cg07606381	chr6:8435919	SLC35B3	0.85	6.17	0.57	2.85e-8	Motion sickness;
SKCM	cis	rs829883	0.763	rs249843	chr12:98870987	G/A	cg25150519	chr12:98850993	NA	0.53	5.28	0.51	1.16e-6	Colorectal adenoma (advanced);
SKCM	cis	rs10754283	0.840	rs1215500	chr1:90097254	G/C	cg21401794	chr1:90099060	LRRC8C	0.74	5.88	0.55	9.5e-8	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs7149242	0.697	rs12882815	chr14:101183142	C/G	cg18089426	chr14:101175970	NA	-0.54	-5.0	-0.49	3.41e-6	Platelet count;
SKCM	cis	rs7584330	1.000	rs7584330	chr2:238387228	A/G	cg14458575	chr2:238380390	NA	0.99	6.47	0.59	7.76e-9	Prostate cancer;
SKCM	cis	rs12477438	0.520	rs11123763	chr2:99750673	A/G	cg26064155	chr2:99771622	LIPT1;TSGA10	1.02	9.73	0.74	4.23e-15	Chronic sinus infection;
SKCM	cis	rs951366	0.789	rs1775154	chr1:205696615	T/A	cg07157834	chr1:205819609	PM20D1	0.82	7.17	0.63	3.74e-10	Menarche (age at onset);
SKCM	cis	rs7552404	0.824	rs1251077	chr1:76189745	C/G	cg03433033	chr1:76189801	ACADM	-0.86	-6.72	-0.61	2.63e-9	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs734999	0.549	rs6667564	chr1:2520302	T/C	cg18163442	chr1:2779061	NA	-0.43	-4.8	-0.48	7.59e-6	Ulcerative colitis;
SKCM	cis	rs2439831	0.557	rs13329084	chr15:44151063	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	-1.24	-6.74	-0.61	2.47e-9	Lung cancer in ever smokers;
SKCM	cis	rs17685	0.849	rs3815455	chr7:75611756	C/T	cg01364799	chr7:75623366	TMEM120A	-0.79	-6.0	-0.56	5.91e-8	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs908922	0.651	rs7529157	chr1:152531365	C/A	cg09873164	chr1:152488093	CRCT1	0.72	5.62	0.54	2.85e-7	Hair morphology;
SKCM	cis	rs7666738	0.606	rs4637413	chr4:99088151	A/G	cg17366294	chr4:99064904	C4orf37	0.61	5.06	0.5	2.73e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs898097	0.578	rs9906163	chr17:80908174	T/C	cg15369054	chr17:80825471	TBCD	-0.58	-5.64	-0.54	2.6e-7	Breast cancer;
SKCM	cis	rs514406	0.893	rs4584343	chr1:53434539	A/C	cg16325326	chr1:53192061	ZYG11B	-0.91	-9.82	-0.74	2.77e-15	Monocyte count;
SKCM	cis	rs769267	0.965	rs1010207	chr19:19416045	T/C	cg03709012	chr19:19516395	GATAD2A	0.83	6.87	0.61	1.38e-9	Tonsillectomy;
SKCM	cis	rs11098499	0.663	rs28369503	chr4:120238925	G/A	cg09307838	chr4:120376055	NA	0.98	8.13	0.68	5.33e-12	Corneal astigmatism;
SKCM	cis	rs55962025	0.669	rs28403215	chr4:3172439	C/T	cg09735869	chr4:3319127	RGS12	-0.6	-5.04	-0.5	2.94e-6	Parental longevity (mother's age at death);
SKCM	cis	rs1799949	0.602	rs8176235	chr17:41219560	C/T	cg25918947	chr17:41365094	TMEM106A	-0.55	-4.93	-0.49	4.6e-6	Menopause (age at onset);
SKCM	cis	rs6951245	1.000	rs74369356	chr7:1071711	T/C	cg21664854	chr7:1097933	C7orf50;GPR146	0.89	4.79	0.48	7.66e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs34172651	0.517	rs189919	chr16:24737741	G/A	cg00339695	chr16:24857497	SLC5A11	-0.81	-6.52	-0.59	6.26e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs56104184	0.775	rs117016425	chr19:49400216	C/T	cg19746536	chr19:49375674	PPP1R15A	1.16	5.93	0.56	7.67e-8	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	trans	rs7819412	0.775	rs11773990	chr8:10935082	T/C	cg06636001	chr8:8085503	FLJ10661	-0.88	-7.51	-0.65	8.19e-11	Triglycerides;
SKCM	cis	rs8017423	0.935	rs11159959	chr14:90733656	C/T	cg04374321	chr14:90722782	PSMC1	-0.95	-8.73	-0.7	3.68e-13	Mortality in heart failure;
SKCM	cis	rs7646501	0.715	rs11129132	chr3:24067144	T/G	cg22892432	chr3:24537792	THRB	0.57	4.87	0.48	5.64e-6	Cognitive ability;Intelligence;
SKCM	cis	rs11249608	0.548	rs13161528	chr5:178452958	C/G	cg21905437	chr5:178450457	ZNF879	0.73	5.93	0.56	7.89e-8	Pubertal anthropometrics;
SKCM	cis	rs9910055	1.000	rs2071167	chr17:42287519	A/G	cg19774624	chr17:42201019	HDAC5	0.79	6.69	0.6	3e-9	Total body bone mineral density;
SKCM	cis	rs995000	0.965	rs10789113	chr1:63015199	A/T	cg06896770	chr1:63153194	DOCK7	0.89	7.69	0.66	3.79e-11	Triglyceride levels;
SKCM	cis	rs11098499	0.913	rs35271032	chr4:120156659	C/T	cg09307838	chr4:120376055	NA	0.91	7.22	0.63	2.98e-10	Corneal astigmatism;
SKCM	cis	rs826838	0.967	rs7299170	chr12:38789536	G/A	cg13010199	chr12:38710504	ALG10B	0.86	6.84	0.61	1.61e-9	Heart rate;
SKCM	cis	rs7359257	0.576	rs9652480	chr15:67847317	G/A	cg24247231	chr15:67904302	MAP2K5	-0.7	-5.84	-0.55	1.14e-7	Menarche (age at onset);
SKCM	cis	rs2072499	0.966	rs2853641	chr1:156181770	A/G	cg24450063	chr1:156163899	SLC25A44	0.96	10.43	0.76	1.86e-16	Testicular germ cell tumor;
SKCM	cis	rs7811142	0.945	rs6974282	chr7:100098295	C/T	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.21	7.59	0.65	5.9e-11	Platelet count;
SKCM	cis	rs11098499	0.754	rs66900435	chr4:120249425	C/A	cg09307838	chr4:120376055	NA	0.93	7.56	0.65	6.5500000000000006e-11	Corneal astigmatism;
SKCM	trans	rs561341	0.843	rs2028067	chr17:30239698	T/C	cg20587970	chr11:113659929	NA	-1.03	-8.22	-0.68	3.56e-12	Hip circumference adjusted for BMI;
SKCM	cis	rs9388451	0.505	rs9372828	chr6:126175185	A/T	cg05901451	chr6:126070800	HEY2	-0.66	-4.79	-0.48	7.68e-6	Brugada syndrome;
SKCM	cis	rs8180040	0.701	rs34103310	chr3:47073266	C/T	cg27129171	chr3:47204927	SETD2	0.82	6.49	0.59	7.26e-9	Colorectal cancer;
SKCM	cis	rs9911578	0.935	rs6503878	chr17:56884581	T/G	cg12560992	chr17:57184187	TRIM37	0.95	7.69	0.66	3.7e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs912057	0.601	rs1294405	chr6:6737591	A/G	cg06612196	chr6:6737390	NA	0.74	6.48	0.59	7.63e-9	Waist-to-hip ratio adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);
SKCM	cis	rs11098499	0.954	rs34858317	chr4:120387110	A/C	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs9902453	0.808	rs76515799	chr17:28169491	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.8	5.4	0.52	6.96e-7	Coffee consumption (cups per day);
SKCM	cis	rs6456156	0.586	rs12529876	chr6:167461501	G/A	cg13927040	chr6:167453801	FGFR1OP	0.66	4.85	0.48	6.24e-6	Primary biliary cholangitis;
SKCM	cis	rs7191439	0.858	rs7205626	chr16:88780472	T/C	cg02389323	chr16:88786976	FAM38A	1.47	6.49	0.59	7.17e-9	Plateletcrit;
SKCM	cis	rs4332037	0.586	rs62442944	chr7:2015047	T/G	cg02825527	chr7:2087843	MAD1L1	-0.73	-5.05	-0.5	2.85e-6	Bipolar disorder;
SKCM	cis	rs17345786	0.628	rs11718446	chr3:101552553	C/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.74	5.31	0.52	1.01e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11209185	0.563	rs4655763	chr1:68438400	G/A	cg17031739	chr1:67600172	NA	0.5	4.84	0.48	6.45e-6	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs17376456	0.877	rs35075119	chr5:93385457	T/C	cg21475434	chr5:93447410	FAM172A	0.95	5.35	0.52	8.56e-7	Diabetic retinopathy;
SKCM	cis	rs611744	0.647	rs2597658	chr8:109256014	C/T	cg18478394	chr8:109455254	TTC35	0.71	5.65	0.54	2.47e-7	Dupuytren's disease;
SKCM	cis	rs1801251	1.000	rs1446311	chr2:233705071	G/A	cg08000102	chr2:233561755	GIGYF2	-0.89	-7.22	-0.63	3.02e-10	Coronary artery disease;
SKCM	cis	rs7927771	0.524	rs7932703	chr11:47769936	A/C	cg20307385	chr11:47447363	PSMC3	0.71	5.63	0.54	2.67e-7	Subjective well-being;
SKCM	cis	rs1865760	0.892	rs2328903	chr6:25935765	T/C	cg08401836	chr6:26032486	HIST1H3B	-0.62	-5.03	-0.5	3.01e-6	Height;
SKCM	cis	rs1348850	0.958	rs10930801	chr2:178459861	G/A	cg02961200	chr2:178257176	LOC100130691;AGPS	0.78	5.92	0.56	8.16e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs4900538	0.927	rs8005804	chr14:102957803	A/G	cg18135206	chr14:102964638	TECPR2	0.79	6.53	0.59	6.09e-9	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs951366	0.668	rs823154	chr1:205762406	C/T	cg24739457	chr1:205821442	NA	0.54	4.9	0.49	5.04e-6	Menarche (age at onset);
SKCM	cis	rs1850744	0.536	rs1825043	chr4:9573740	G/A	cg15442990	chr4:9534313	NA	1.2	5.09	0.5	2.41e-6	Economic and political preferences;
SKCM	cis	rs4727027	0.865	rs13236754	chr7:148845773	G/A	cg23583168	chr7:148888333	NA	-0.8	-6.66	-0.6	3.52e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs523522	0.962	rs10849758	chr12:120971149	C/T	cg27279351	chr12:120934652	DYNLL1	0.91	8.32	0.69	2.26e-12	High light scatter reticulocyte count;
SKCM	cis	rs12986445	0.947	rs2072695	chr2:26151643	A/T	cg07291958	chr2:26785531	C2orf70	0.55	4.96	0.49	4.01e-6	Multiple myeloma and monoclonal gammopathy;Multiple myeloma;
SKCM	cis	rs7824557	0.568	rs35747588	chr8:11206627	C/G	cg21775007	chr8:11205619	TDH	0.72	6.4	0.59	1.09e-8	Retinal vascular caliber;
SKCM	cis	rs995000	0.931	rs2366636	chr1:63056670	G/A	cg06896770	chr1:63153194	DOCK7	0.97	9.01	0.71	1.02e-13	Triglyceride levels;
SKCM	cis	rs66573146	0.831	rs6851488	chr4:6987412	C/T	cg00086871	chr4:6988644	TBC1D14	1.29	5.03	0.5	3.04e-6	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs1577917	0.570	rs114854865	chr6:86554236	A/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.81	-7.82	-0.66	2.07e-11	Response to antipsychotic treatment;
SKCM	cis	rs9513627	1.000	rs9585075	chr13:100128634	G/A	cg11288260	chr13:100117058	NA	-0.8	-4.77	-0.48	8.48e-6	Obesity-related traits;
SKCM	cis	rs10927875	0.929	rs10927879	chr1:16320028	G/A	cg21385522	chr1:16154831	NA	-0.89	-7.18	-0.63	3.57e-10	Dilated cardiomyopathy;
SKCM	cis	rs1005277	0.579	rs2474595	chr10:38426782	C/G	cg25427524	chr10:38739819	LOC399744	0.69	6.63	0.6	4.02e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs12762955	0.608	rs7922760	chr10:1156815	G/C	cg18964960	chr10:1102726	WDR37	-0.66	-4.95	-0.49	4.24e-6	Response to angiotensin II receptor blocker therapy;
SKCM	cis	rs3096299	0.967	rs16965692	chr16:89471482	C/T	cg02187348	chr16:89574699	SPG7	0.64	5.17	0.51	1.73e-6	Multiple myeloma (IgH translocation);
SKCM	cis	rs801193	0.761	rs2659888	chr7:66230171	T/G	cg11987759	chr7:65425863	GUSB	-0.67	-5.81	-0.55	1.29e-7	Aortic root size;
SKCM	cis	rs7615952	0.611	rs72979452	chr3:125756178	C/T	cg05084668	chr3:125655381	ALG1L	-1.29	-6.33	-0.58	1.42e-8	Blood pressure (smoking interaction);
SKCM	cis	rs9951698	0.687	rs10221384	chr18:13035831	G/A	cg12848697	chr18:13133368	NA	0.55	4.9	0.48	5.17e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1577917	0.771	rs2842601	chr6:86330133	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-1.02	-11.61	-0.8	1.14e-18	Response to antipsychotic treatment;
SKCM	trans	rs17685	0.753	rs11972240	chr7:75694079	A/C	cg19862616	chr7:65841803	NCRNA00174	0.95	9.34	0.73	2.39e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs9486715	1.000	rs2273621	chr6:97058553	A/G	cg06623918	chr6:96969491	KIAA0776	-0.76	-6.38	-0.59	1.15e-8	Headache;
SKCM	cis	rs362296	0.698	rs362283	chr4:3259558	T/C	cg09735869	chr4:3319127	RGS12	-0.79	-6.74	-0.61	2.47e-9	Parental longevity (mother's age at death);
SKCM	cis	rs2811415	0.597	rs2276867	chr3:127786675	T/G	cg09089421	chr3:127803668	RUVBL1	1.0	8.69	0.7	4.4e-13	Lung function (FEV1/FVC);
SKCM	cis	rs7193541	0.684	rs8062783	chr16:74691264	C/T	cg01733217	chr16:74700730	RFWD3	-1.04	-11.33	-0.79	3.77e-18	Multiple myeloma;
SKCM	cis	rs2386661	0.547	rs72781996	chr10:5646485	C/G	cg12223502	chr10:5658492	NA	-0.55	-5.05	-0.5	2.78e-6	Breast cancer;
SKCM	cis	rs62238980	0.614	rs73391051	chr22:32475878	G/C	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs7215564	0.908	rs8070102	chr17:78683982	C/T	cg16980736	chr17:78789706	RPTOR	-0.88	-4.83	-0.48	6.66e-6	Myopia (pathological);
SKCM	cis	rs228769	0.543	rs170634	chr17:42175821	C/A	cg08499158	chr17:42289980	UBTF	0.73	5.64	0.54	2.64e-7	Bone mineral density (hip);Bone mineral density (spine);
SKCM	cis	rs875971	0.862	rs1167408	chr7:65556108	G/A	cg18876405	chr7:65276391	NA	-0.67	-6.79	-0.61	2.01e-9	Aortic root size;
SKCM	cis	rs60871478	0.735	rs4721306	chr7:839098	C/T	cg05535760	chr7:792225	HEATR2	-1.25	-7.91	-0.67	1.39e-11	Cerebrospinal P-tau181p levels;
SKCM	cis	rs11098499	0.954	rs71614438	chr4:120371252	G/A	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs274567	0.550	rs272885	chr5:131667736	A/G	cg24060327	chr5:131705240	SLC22A5	-0.76	-4.94	-0.49	4.42e-6	Blood metabolite levels;
SKCM	cis	rs9906944	0.545	rs2088140	chr17:47094599	T/C	cg10950924	chr17:47092072	IGF2BP1	-0.61	-5.23	-0.51	1.41e-6	Intelligence (multi-trait analysis);Body fat percentage;
SKCM	cis	rs12142240	0.698	rs72886911	chr1:46814352	G/A	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs362296	0.698	rs3135171	chr4:3261127	A/G	cg09735869	chr4:3319127	RGS12	-0.8	-7.1	-0.63	5.13e-10	Parental longevity (mother's age at death);
SKCM	cis	rs17854409	1.000	rs6011427	chr20:61496680	C/T	cg06598544	chr20:61472147	COL9A3	-1.02	-5.55	-0.53	3.82e-7	Obesity-related traits;
SKCM	cis	rs2439831	0.850	rs12442129	chr15:44055856	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.35	7.75	0.66	2.9e-11	Lung cancer in ever smokers;
SKCM	cis	rs2439831	1.000	rs565007	chr15:43716641	A/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.15	7.17	0.63	3.73e-10	Lung cancer in ever smokers;
SKCM	cis	rs947211	0.846	rs708726	chr1:205762139	G/T	cg11965913	chr1:205819406	PM20D1	-0.62	-4.77	-0.48	8.32e-6	Parkinson's disease;
SKCM	cis	rs9875589	0.509	rs11128679	chr3:14075245	C/T	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.5	5.15	0.5	1.9e-6	Ovarian reserve;
SKCM	cis	rs7927771	1.000	rs10838748	chr11:47716381	T/G	cg05585544	chr11:47624801	NA	-0.6	-5.24	-0.51	1.31e-6	Subjective well-being;
SKCM	cis	rs2197308	0.623	rs1672426	chr12:38118671	C/T	cg26384229	chr12:38710491	ALG10B	-0.67	-5.47	-0.53	5.23e-7	Morning vs. evening chronotype;
SKCM	cis	rs9611565	0.694	rs5758365	chr22:41858657	A/G	cg03806693	chr22:41940476	POLR3H	1.13	7.36	0.64	1.63e-10	Vitiligo;
SKCM	cis	rs738322	0.839	rs133015	chr22:38572526	C/G	cg25457927	chr22:38595422	NA	-0.62	-7.64	-0.65	4.72e-11	Cutaneous nevi;
SKCM	cis	rs56104184	0.775	rs56349331	chr19:49403009	T/A	cg19746536	chr19:49375674	PPP1R15A	1.16	5.93	0.56	7.67e-8	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs2019137	0.539	rs4849181	chr2:113991970	A/G	cg21550016	chr2:113992930	PAX8;LOC440839;LOC654433	0.68	5.29	0.51	1.07e-6	Lymphocyte counts;
SKCM	cis	rs1577917	1.000	rs1337844	chr6:86677273	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.86	-8.65	-0.7	5.1e-13	Response to antipsychotic treatment;
SKCM	cis	rs3780486	0.846	rs3824458	chr9:33144809	C/T	cg13443165	chr9:33130375	B4GALT1	-0.53	-4.98	-0.49	3.77e-6	IgG glycosylation;
SKCM	cis	rs16866061	0.926	rs17479770	chr2:225335814	A/G	cg12698349	chr2:225449008	CUL3	0.91	7.52	0.65	8e-11	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs9911578	1.000	rs2567905	chr17:56782297	T/C	cg12560992	chr17:57184187	TRIM37	0.95	7.6	0.65	5.56e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs7811142	0.830	rs11771936	chr7:99943283	A/G	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.08	6.85	0.61	1.49e-9	Platelet count;
SKCM	cis	rs1538970	0.816	rs3790583	chr1:45956828	C/G	cg05343316	chr1:45956843	TESK2	0.94	4.82	0.48	7.07e-6	Platelet count;
SKCM	cis	rs3785574	0.962	rs2665835	chr17:61903258	C/T	cg01411255	chr17:61851458	DDX42;CCDC47	1.16	12.75	0.82	9.1e-21	Height;
SKCM	cis	rs1348850	0.632	rs12616288	chr2:178503813	G/T	cg02961200	chr2:178257176	LOC100130691;AGPS	0.74	4.97	0.49	3.9e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs7772486	0.790	rs4435956	chr6:146232403	G/C	cg05347473	chr6:146136440	FBXO30	-0.56	-5.19	-0.51	1.6e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7772486	0.875	rs9322046	chr6:146393625	A/G	cg23711669	chr6:146136114	FBXO30	0.86	8.52	0.69	9.13e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7143963	0.636	rs11160706	chr14:103361736	A/G	cg23020514	chr14:103360112	TRAF3	-0.68	-6.56	-0.6	5.42e-9	Body mass index;
SKCM	cis	rs992157	0.697	rs13384682	chr2:219069137	G/A	cg20019365	chr2:219134978	PNKD;AAMP	0.72	6.4	0.59	1.07e-8	Colorectal cancer;
SKCM	cis	rs2204008	0.702	rs8175764	chr12:38363690	T/C	cg26384229	chr12:38710491	ALG10B	0.81	6.56	0.6	5.29e-9	Bladder cancer;
SKCM	cis	rs798766	1.000	rs7682402	chr4:1743343	G/A	cg05874882	chr4:1763078	NA	-0.56	-4.89	-0.48	5.37e-6	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs2739330	0.828	rs5760098	chr22:24248314	A/G	cg12419862	chr22:24373484	LOC391322	-0.66	-5.54	-0.53	3.87e-7	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs35306767	0.903	rs11253485	chr10:919362	C/T	cg25614935	chr10:1084866	C10orf110	0.78	5.09	0.5	2.42e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs9911578	0.757	rs117987711	chr17:57111269	A/C	cg05425664	chr17:57184151	TRIM37	0.83	6.54	0.59	5.93e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs7095944	0.585	rs7080838	chr10:126419841	A/G	cg08799069	chr10:126477246	METTL10	0.54	4.77	0.47	8.52e-6	Asthma;
SKCM	cis	rs7208859	0.623	rs73271842	chr17:29137155	T/C	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs875971	0.660	rs3857686	chr7:66036191	C/T	cg00343986	chr7:65444356	GUSB	-0.7	-5.14	-0.5	1.98e-6	Aortic root size;
SKCM	cis	rs9486715	0.867	rs9386500	chr6:96889845	A/C	cg06623918	chr6:96969491	KIAA0776	0.8	7.22	0.63	2.98e-10	Headache;
SKCM	trans	rs6481128	0.836	rs1733758	chr10:56699752	C/A	cg04272632	chr1:34629400	CSMD2	0.69	7.49	0.65	9.04e-11	Extraversion;
SKCM	cis	rs2479724	0.636	rs2265139	chr6:41819407	C/G	cg17623882	chr6:41773611	USP49	-0.73	-6.04	-0.56	4.97e-8	Menarche (age at onset);
SKCM	cis	rs7659604	0.540	rs10004284	chr4:122699222	A/T	cg19671926	chr4:122722719	EXOSC9	0.76	6.97	0.62	9.04e-10	Type 2 diabetes;
SKCM	cis	rs2120019	0.938	rs8040169	chr15:75370958	C/A	cg09165964	chr15:75287851	SCAMP5	-0.78	-6.63	-0.6	3.95e-9	Blood trace element (Zn levels);
SKCM	cis	rs514406	0.679	rs12563825	chr1:53238324	G/T	cg16325326	chr1:53192061	ZYG11B	-0.63	-5.01	-0.49	3.29e-6	Monocyte count;
SKCM	cis	rs7666738	0.830	rs13136930	chr4:98937933	A/T	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9815354	0.812	rs73073323	chr3:41834051	C/T	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs7569084	0.687	rs1344891	chr2:65686024	A/T	cg10464312	chr2:66672688	MEIS1	0.43	4.86	0.48	5.91e-6	Sum eosinophil basophil counts;
SKCM	cis	rs8180040	0.593	rs10433549	chr3:47031433	C/T	cg27129171	chr3:47204927	SETD2	-0.74	-5.37	-0.52	7.84e-7	Colorectal cancer;
SKCM	cis	rs2239547	0.522	rs6445550	chr3:52983434	G/A	cg11645453	chr3:52864694	ITIH4	0.58	4.96	0.49	3.98e-6	Schizophrenia;
SKCM	cis	rs8072100	0.967	rs7221548	chr17:45582952	T/C	cg08085267	chr17:45401833	C17orf57	0.57	4.85	0.48	6.1e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs9368481	0.761	rs4713062	chr6:26948195	A/G	cg12292205	chr6:26970375	C6orf41	-0.71	-6.43	-0.59	9.17e-9	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs10155981	0.510	rs78815495	chr7:22584529	C/T	cg05062323	chr7:22590069	NA	-0.99	-6.04	-0.56	4.91e-8	Bilirubin levels;
SKCM	cis	rs732765	0.734	rs12323899	chr14:75117513	T/C	cg25946216	chr14:74253857	C14orf43	-0.87	-5.45	-0.53	5.68e-7	Non-small cell lung cancer;
SKCM	cis	rs870825	0.860	rs34985821	chr4:185599489	G/A	cg04058563	chr4:185651563	MLF1IP	1.04	5.96	0.56	7.02e-8	Blood protein levels;
SKCM	cis	rs2228479	0.850	rs11641147	chr16:89813589	C/T	cg06558623	chr16:89946397	TCF25	1.03	5.59	0.53	3.23e-7	Skin colour saturation;
SKCM	cis	rs3820068	0.581	rs16851819	chr1:15918739	C/T	cg24675056	chr1:15929824	NA	-0.77	-5.51	-0.53	4.52e-7	Systolic blood pressure;
SKCM	cis	rs2404602	0.692	rs35999717	chr15:77193367	G/C	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs28386778	0.897	rs968719	chr17:61908271	C/T	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.11	10.72	0.77	5.31e-17	Prudent dietary pattern;
SKCM	cis	rs9399137	0.507	rs12664898	chr6:135288663	T/C	cg24558204	chr6:135376177	HBS1L	0.69	6.37	0.59	1.19e-8	Glycated hemoglobin levels;Mean corpuscular volume;Hematology traits;HbA2 levels;Mean corpuscular hemoglobin;Hemoglobin levels;F-cell distribution;Platelet count;
SKCM	cis	rs875971	0.862	rs12698526	chr7:65969105	T/C	cg11764359	chr7:65958608	NA	0.75	6.79	0.61	1.95e-9	Aortic root size;
SKCM	cis	rs28530618	0.603	rs11697988	chr20:31248176	C/G	cg25730142	chr20:32031702	SNTA1	0.61	4.93	0.49	4.58e-6	Birth weight;
SKCM	cis	rs1348850	0.574	rs11691740	chr2:178445161	A/G	cg27490568	chr2:178487706	NA	-0.71	-5.23	-0.51	1.41e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs9914544	0.544	rs4244595	chr17:18677329	C/T	cg26306683	chr17:18585705	ZNF286B	0.62	4.96	0.49	4.03e-6	Educational attainment (years of education);
SKCM	cis	rs1552244	1.000	rs113153120	chr3:10156398	G/A	cg02579736	chr3:10068473	FANCD2;CIDECP	1.23	6.8	0.61	1.9e-9	Alzheimer's disease;
SKCM	cis	rs644799	0.965	rs598876	chr11:95560853	A/G	cg03916912	chr11:95522834	CEP57;FAM76B	0.88	7.53	0.65	7.59e-11	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs793571	0.544	rs383902	chr15:59034174	C/T	cg05156742	chr15:59063176	FAM63B	0.79	5.78	0.55	1.48e-7	Schizophrenia;
SKCM	cis	rs12477438	0.501	rs13033012	chr2:99795149	T/C	cg26064155	chr2:99771622	LIPT1;TSGA10	1.03	9.76	0.74	3.61e-15	Chronic sinus infection;
SKCM	cis	rs7584330	0.910	rs880932	chr2:238396963	A/G	cg14458575	chr2:238380390	NA	0.93	6.43	0.59	9.19e-9	Prostate cancer;
SKCM	cis	rs7959452	0.536	rs4761237	chr12:69776461	C/G	cg20891283	chr12:69753455	YEATS4	0.91	9.3	0.73	2.78e-14	Blood protein levels;
SKCM	cis	rs13118159	0.550	rs4974617	chr4:1373658	T/C	cg20887711	chr4:1340912	KIAA1530	0.93	6.95	0.62	9.67e-10	Longevity;
SKCM	cis	rs561341	0.882	rs111484028	chr17:30287701	G/A	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs7829975	0.564	rs2976855	chr8:8301794	G/A	cg08975724	chr8:8085496	FLJ10661	0.68	5.37	0.52	7.74e-7	Mood instability;
SKCM	cis	rs12586317	0.511	rs11540758	chr14:35498485	C/T	cg16230307	chr14:35515116	FAM177A1	0.81	5.88	0.55	9.47e-8	Psoriasis;
SKCM	cis	rs703842	1.000	rs11172343	chr12:58188157	T/C	cg04478727	chr12:58166393	METTL1;FAM119B	0.73	5.84	0.55	1.15e-7	Multiple sclerosis;
SKCM	cis	rs9549367	0.713	rs2476319	chr13:113836519	C/T	cg18105134	chr13:113819100	PROZ	0.87	6.56	0.6	5.34e-9	Platelet distribution width;
SKCM	trans	rs1814175	0.616	rs4881723	chr11:49788566	G/T	cg15704280	chr7:45808275	SEPT13	-0.93	-8.6	-0.7	6.36e-13	Height;
SKCM	cis	rs2836633	0.929	rs62217518	chr21:40033189	T/G	cg05519781	chr21:40033154	ERG	0.81	7.07	0.62	5.77e-10	Coronary artery disease;
SKCM	cis	rs67311347	0.524	rs7649168	chr3:40356158	T/C	cg00656387	chr3:40428638	ENTPD3	0.55	4.77	0.48	8.39e-6	Renal cell carcinoma;
SKCM	cis	rs2836974	0.568	rs428602	chr21:40547004	A/G	cg17971929	chr21:40555470	PSMG1	0.76	7.16	0.63	3.94e-10	Cognitive function;
SKCM	cis	rs6519955	0.860	rs8136098	chr22:46425646	A/G	cg05468064	chr22:46423449	NA	0.44	5.14	0.5	1.97e-6	Dupuytren's disease;
SKCM	cis	rs8060686	0.641	rs12447931	chr16:68179195	C/T	cg09117114	chr16:67998030	SLC12A4	-0.76	-4.93	-0.49	4.58e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs7666738	0.830	rs34070283	chr4:98893027	A/T	cg17366294	chr4:99064904	C4orf37	0.57	4.86	0.48	6.02e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs8017423	0.904	rs11848894	chr14:90723660	C/A	cg04374321	chr14:90722782	PSMC1	1.03	9.44	0.73	1.55e-14	Mortality in heart failure;
SKCM	cis	rs2228479	0.717	rs12917681	chr16:89810941	C/A	cg04287289	chr16:89883240	FANCA	0.89	4.92	0.49	4.64e-6	Skin colour saturation;
SKCM	cis	rs7618501	0.573	rs7634917	chr3:50049299	T/G	cg05072774	chr3:49840536	C3orf54	0.67	5.06	0.5	2.73e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9814567	0.896	rs6790338	chr3:134208167	G/C	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.65	-5.1	-0.5	2.33e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs9300255	0.739	rs4759417	chr12:123746510	C/T	cg00376283	chr12:123451042	ABCB9	0.84	5.91	0.56	8.5e-8	Neutrophil percentage of white cells;
SKCM	cis	rs10927875	0.757	rs4661679	chr1:16321010	C/T	cg21385522	chr1:16154831	NA	0.82	6.95	0.62	1e-9	Dilated cardiomyopathy;
SKCM	cis	rs7666738	0.753	rs35146453	chr4:98902278	A/G	cg17366294	chr4:99064904	C4orf37	0.57	4.85	0.48	6.12e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2404602	0.716	rs7164813	chr15:76708066	T/C	cg23625390	chr15:77176239	SCAPER	0.59	5.31	0.52	9.85e-7	Blood metabolite levels;
SKCM	cis	rs11098499	0.863	rs7669520	chr4:120515278	T/C	cg09307838	chr4:120376055	NA	1.0	8.27	0.68	2.8e-12	Corneal astigmatism;
SKCM	cis	rs8060686	0.641	rs12447640	chr16:68150527	A/G	cg09117114	chr16:67998030	SLC12A4	-0.81	-5.29	-0.51	1.07e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs55962025	0.686	rs2237007	chr4:3235450	T/C	cg16987761	chr4:3318072	RGS12	-0.6	-4.83	-0.48	6.61e-6	Parental longevity (mother's age at death);
SKCM	cis	rs55962025	0.883	rs82332	chr4:3225466	A/G	cg00764545	chr4:3318001	RGS12	-0.71	-5.79	-0.55	1.39e-7	Parental longevity (mother's age at death);
SKCM	cis	rs995000	0.899	rs1748201	chr1:63045506	A/C	cg06896770	chr1:63153194	DOCK7	-0.76	-7.44	-0.64	1.13e-10	Triglyceride levels;
SKCM	cis	rs4561483	0.801	rs33619	chr16:12008941	T/G	cg08843971	chr16:11963173	GSPT1	-0.66	-5.08	-0.5	2.49e-6	Testicular germ cell tumor;
SKCM	cis	rs4836694	0.689	rs4837479	chr9:132940007	C/T	cg05251000	chr9:132935664	FREQ	0.65	4.78	0.48	7.98e-6	Alzheimer's disease (cognitive decline);
SKCM	cis	rs1878931	0.580	rs7194596	chr16:3404408	T/A	cg26668626	chr16:3451006	ZNF174;ZNF434	1.01	8.17	0.68	4.5e-12	Body mass index (adult);
SKCM	cis	rs752010	0.806	rs4641303	chr1:42091310	A/G	cg06885757	chr1:42089581	HIVEP3	0.5	4.87	0.48	5.65e-6	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs8060686	0.641	rs73612690	chr16:68153200	G/A	cg04539111	chr16:67997858	SLC12A4	-0.85	-4.81	-0.48	7.14e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs3091242	0.933	rs7541095	chr1:25761291	T/C	cg27572855	chr1:25598939	RHD	0.53	5.06	0.5	2.73e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs7772486	0.686	rs4896828	chr6:145953339	A/C	cg05347473	chr6:146136440	FBXO30	0.58	5.3	0.51	1.05e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs992157	1.000	rs6736362	chr2:219115108	C/T	cg00012203	chr2:219082015	ARPC2	0.81	6.62	0.6	4.17e-9	Colorectal cancer;
SKCM	cis	rs634534	0.561	rs613924	chr11:65769295	C/T	cg02427764	chr11:65769310	BANF1;EIF1AD	0.77	5.82	0.55	1.23e-7	Sum eosinophil basophil counts;Eosinophil counts;
SKCM	cis	rs6138458	0.828	rs6132785	chr20:24993414	T/C	cg26195577	chr20:24973756	C20orf3	0.94	5.62	0.54	2.86e-7	Blood protein levels;
SKCM	cis	rs2839186	0.616	rs4819213	chr21:47619300	G/A	cg05896524	chr21:47604654	C21orf56	-0.73	-6.14	-0.57	3.26e-8	Testicular germ cell tumor;
SKCM	cis	rs2777491	1.000	rs2730057	chr15:41736275	C/A	cg18705301	chr15:41695430	NDUFAF1	-0.89	-9.04	-0.72	9.17e-14	Ulcerative colitis;
SKCM	cis	rs1799949	1.000	rs67060599	chr17:41255102	A/G	cg05368731	chr17:41323189	NBR1	0.87	7.55	0.65	6.95e-11	Menopause (age at onset);
SKCM	cis	rs9809213	1.000	rs12495398	chr3:72350579	G/A	cg09429735	chr3:71752026	EIF4E3	-0.58	-5.68	-0.54	2.25e-7	Cognitive ability;Cognitive ability (multi-trait analysis);
SKCM	cis	rs951366	0.622	rs11580015	chr1:205676088	G/C	cg26354017	chr1:205819088	PM20D1	0.82	6.82	0.61	1.71e-9	Menarche (age at onset);
SKCM	cis	rs4665809	0.590	rs13022190	chr2:26515055	C/T	cg26119090	chr2:26468346	HADHA;HADHB	1.08	8.63	0.7	5.67e-13	Gut microbiome composition (summer);
SKCM	cis	rs2404602	0.740	rs34924128	chr15:76965169	T/G	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs12586317	0.586	rs74243591	chr14:35520917	C/T	cg16230307	chr14:35515116	FAM177A1	0.83	6.08	0.57	4.19e-8	Psoriasis;
SKCM	cis	rs9399135	0.967	rs6902954	chr6:135313994	C/A	cg24558204	chr6:135376177	HBS1L	0.59	5.23	0.51	1.41e-6	Red blood cell count;
SKCM	cis	rs10504229	0.953	rs6991035	chr8:58183374	C/T	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs28595532	0.920	rs115838006	chr4:119754356	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs17065868	1.000	rs9525987	chr13:45171831	A/G	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs1850744	0.536	rs2037313	chr4:9724711	T/C	cg15442990	chr4:9534313	NA	1.43	5.56	0.53	3.71e-7	Economic and political preferences;
SKCM	cis	rs2354432	0.599	rs4950423	chr1:146854539	T/C	cg25205988	chr1:146714368	CHD1L	1.11	5.59	0.53	3.21e-7	Mitochondrial DNA levels;
SKCM	cis	rs6933660	0.745	rs9397405	chr6:151736084	G/T	cg10883421	chr6:151773342	RMND1;C6orf211	0.83	7.04	0.62	6.61e-10	Menarche (age at onset);
SKCM	cis	rs6835098	0.961	rs2078475	chr4:174098226	A/C	cg08422745	chr4:174089978	GALNT7	0.85	6.55	0.6	5.69e-9	Dementia and core Alzheimer's disease neuropathologic changes;
SKCM	cis	rs11098499	1.000	rs7659194	chr4:120207147	T/G	cg09307838	chr4:120376055	NA	0.95	7.75	0.66	2.84e-11	Corneal astigmatism;
SKCM	cis	rs34779708	0.931	rs11596502	chr10:35387187	A/C	cg03585969	chr10:35415529	CREM	0.77	6.27	0.58	1.84e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs6489882	0.966	rs6489880	chr12:113380271	C/T	cg07232103	chr12:112566177	TRAFD1	0.6	4.8	0.48	7.39e-6	Chronic lymphocytic leukemia;
SKCM	cis	rs860295	0.702	rs10796945	chr1:155427688	G/A	cg02153340	chr1:155202674	NA	-0.77	-5.58	-0.53	3.3e-7	Body mass index;
SKCM	cis	rs3924048	0.574	rs11121928	chr1:12615888	C/G	cg00291366	chr1:12616550	NA	0.35	5.17	0.51	1.75e-6	Optic cup area;
SKCM	cis	rs2730245	0.527	rs842702	chr7:158696814	C/T	cg24397884	chr7:158709396	WDR60	0.98	5.55	0.53	3.73e-7	Height;
SKCM	cis	rs4268898	0.662	rs58971404	chr2:24403753	G/A	cg06627628	chr2:24431161	ITSN2	-0.89	-6.69	-0.6	2.98e-9	Asthma;
SKCM	cis	rs7811142	1.000	rs68116612	chr7:100006493	G/A	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.11	6.45	0.59	8.66e-9	Platelet count;
SKCM	cis	rs6088580	0.634	rs6059897	chr20:33113224	A/G	cg24642439	chr20:33292090	TP53INP2	0.76	6.02	0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs2072499	0.932	rs2736613	chr1:156196016	T/C	cg25208724	chr1:156163844	SLC25A44	0.97	7.94	0.67	1.23e-11	Testicular germ cell tumor;
SKCM	cis	rs1218582	0.772	rs4845690	chr1:154886817	C/T	cg24250549	chr1:154909240	PMVK	-0.87	-8.7	-0.7	4.13e-13	Prostate cancer;
SKCM	cis	rs2180341	0.782	rs6912750	chr6:127723081	A/T	cg24812749	chr6:127587940	RNF146	0.6	4.8	0.48	7.4e-6	Breast cancer;
SKCM	cis	rs6951245	1.000	rs79683221	chr7:1096139	A/G	cg18402987	chr7:1209562	NA	1.15	6.09	0.57	3.95e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs3780486	0.846	rs10971420	chr9:33125000	T/C	cg13443165	chr9:33130375	B4GALT1	-0.54	-4.84	-0.48	6.46e-6	IgG glycosylation;
SKCM	cis	rs9393692	0.557	rs61534839	chr6:26305623	C/T	cg13736514	chr6:26305472	NA	-0.67	-5.02	-0.49	3.24e-6	Educational attainment;
SKCM	cis	rs10838687	0.673	rs11039035	chr11:46967415	G/T	cg05584439	chr11:47213196	NA	-0.8	-4.84	-0.48	6.53e-6	Proinsulin levels;
SKCM	cis	rs11763147	1	rs11763147	chr7:65326821	C/T	cg05627663	chr7:65219948	SNORA22;CCT6P1	-0.61	-5.07	-0.5	2.66e-6	Corneal structure;
SKCM	cis	rs7666738	0.830	rs6532724	chr4:99060993	C/T	cg17366294	chr4:99064904	C4orf37	0.61	4.93	0.49	4.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11892454	0.515	rs3731638	chr2:26046845	T/C	cg17263061	chr2:26915892	KCNK3	0.69	4.98	0.49	3.73e-6	Heschl's gyrus morphology;
SKCM	cis	rs17376456	0.825	rs10214278	chr5:93237679	C/T	cg21475434	chr5:93447410	FAM172A	-1.01	-5.37	-0.52	7.9e-7	Diabetic retinopathy;
SKCM	cis	rs8180040	0.764	rs13062022	chr3:47169375	G/A	cg27129171	chr3:47204927	SETD2	0.82	6.49	0.59	7.26e-9	Colorectal cancer;
SKCM	cis	rs2404602	0.716	rs7174953	chr15:76906847	A/C	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs4268898	0.717	rs2543662	chr2:24443271	G/T	cg06627628	chr2:24431161	ITSN2	0.84	6.91	0.62	1.18e-9	Asthma;
SKCM	cis	rs7811142	0.830	rs7792959	chr7:99972403	C/T	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.2	7.87	0.67	1.7e-11	Platelet count;
SKCM	cis	rs4243830	0.850	rs2412309	chr1:6603151	A/G	cg22792644	chr1:6614718	TAS1R1;NOL9	-1.06	-5.63	-0.54	2.69e-7	Body mass index;
SKCM	cis	rs28374715	0.532	rs1899	chr15:41689232	C/T	cg18705301	chr15:41695430	NDUFAF1	-1.2	-12.87	-0.82	5.46e-21	Ulcerative colitis;
SKCM	cis	rs1475911	0.708	rs56185023	chr21:43521538	T/C	cg24372256	chr21:43528868	UMODL1;C21orf128	-0.73	-5.3	-0.51	1.03e-6	IgG glycosylation;
SKCM	cis	rs1405130	0.967	rs13009617	chr2:235571317	A/G	cg21542780	chr2:234763377	HJURP	-0.65	-4.92	-0.49	4.75e-6	Coronary artery disease;
SKCM	cis	rs8072100	0.676	rs9908049	chr17:45502096	G/C	cg08085267	chr17:45401833	C17orf57	-0.62	-5.06	-0.5	2.76e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs1799949	1.000	rs2070834	chr17:41242285	T/G	cg25918947	chr17:41365094	TMEM106A	-0.62	-5.88	-0.55	9.82e-8	Menopause (age at onset);
SKCM	cis	rs798554	1.000	rs798545	chr7:2762386	C/T	cg19346786	chr7:2764209	NA	-0.64	-6.49	-0.59	7.25e-9	Height;
SKCM	cis	rs28386778	0.897	rs7210443	chr17:61785374	A/G	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.11	11.13	0.78	9.01e-18	Prudent dietary pattern;
SKCM	cis	rs11098499	0.954	rs34858317	chr4:120387110	A/C	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs6089584	0.566	rs2181589	chr20:60622817	C/T	cg06108461	chr20:60628389	TAF4	0.73	6.66	0.6	3.43e-9	Body mass index;
SKCM	cis	rs9790314	0.580	rs10936227	chr3:161043869	A/C	cg03342759	chr3:160939853	NMD3	-0.68	-5.77	-0.55	1.5e-7	Morning vs. evening chronotype;
SKCM	cis	rs55962025	0.711	rs82333	chr4:3225389	C/T	cg24015175	chr4:3319247	RGS12	0.53	4.81	0.48	7.17e-6	Parental longevity (mother's age at death);
SKCM	cis	rs8180040	1.000	rs295449	chr3:47375955	G/A	cg27129171	chr3:47204927	SETD2	0.87	6.62	0.6	4.2e-9	Colorectal cancer;
SKCM	cis	rs2839186	0.872	rs13052233	chr21:47707284	G/T	cg13126279	chr21:47581558	C21orf56	-0.64	-5.47	-0.53	5.17e-7	Testicular germ cell tumor;
SKCM	cis	rs7020830	0.571	rs3780335	chr9:37376587	A/G	cg14294708	chr9:37120828	ZCCHC7	-0.94	-5.88	-0.55	9.66e-8	Schizophrenia;
SKCM	cis	rs7647973	0.560	rs7638154	chr3:49299375	C/A	cg06212747	chr3:49208901	KLHDC8B	0.78	5.59	0.54	3.15e-7	Menarche (age at onset);
SKCM	cis	rs453301	0.686	rs11785634	chr8:8892597	G/T	cg06636001	chr8:8085503	FLJ10661	-0.73	-5.55	-0.53	3.74e-7	Joint mobility (Beighton score);
SKCM	cis	rs2839186	0.967	rs4819222	chr21:47707778	G/A	cg11766577	chr21:47581405	C21orf56	-0.71	-6.01	-0.56	5.6e-8	Testicular germ cell tumor;
SKCM	cis	rs8072100	0.817	rs9892497	chr17:45545919	G/A	cg08085267	chr17:45401833	C17orf57	-0.62	-5.08	-0.5	2.48e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs8180040	0.966	rs9683033	chr3:47489820	C/T	cg27129171	chr3:47204927	SETD2	0.79	5.79	0.55	1.43e-7	Colorectal cancer;
SKCM	cis	rs6570726	0.755	rs2092297	chr6:145893765	A/G	cg23711669	chr6:146136114	FBXO30	0.87	8.94	0.71	1.44e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2197308	0.765	rs12230545	chr12:37927114	C/T	cg13010199	chr12:38710504	ALG10B	-0.64	-4.92	-0.49	4.67e-6	Morning vs. evening chronotype;
SKCM	cis	rs28386778	0.863	rs2597633	chr17:61872871	T/C	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs8017423	0.967	rs12896540	chr14:90729392	T/C	cg04374321	chr14:90722782	PSMC1	-1.02	-9.46	-0.73	1.4e-14	Mortality in heart failure;
SKCM	cis	rs4481887	0.708	rs6696691	chr1:248539720	T/C	cg22724847	chr1:248512586	OR14C36	0.58	4.87	0.48	5.64e-6	Common traits (Other);
SKCM	cis	rs7103648	0.603	rs3740688	chr11:47380340	G/T	cg05585544	chr11:47624801	NA	0.59	4.79	0.48	7.92e-6	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs7618915	0.501	rs7622694	chr3:52663882	G/A	cg18404041	chr3:52824283	ITIH1	-0.53	-4.77	-0.48	8.43e-6	Bipolar disorder;
SKCM	cis	rs875971	1.000	rs2420168	chr7:65630631	C/G	cg11764359	chr7:65958608	NA	-0.86	-8.23	-0.68	3.44e-12	Aortic root size;
SKCM	cis	rs1801251	0.778	rs809639	chr2:233731244	C/G	cg25237894	chr2:233734115	C2orf82	0.56	5.9	0.56	8.79e-8	Coronary artery disease;
SKCM	cis	rs4900538	0.928	rs1190551	chr14:102911508	A/G	cg18135206	chr14:102964638	TECPR2	-0.78	-6.37	-0.59	1.2e-8	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs523522	0.571	rs11065120	chr12:120875456	C/T	cg27279351	chr12:120934652	DYNLL1	0.89	6.9	0.62	1.23e-9	High light scatter reticulocyte count;
SKCM	cis	rs17685	0.558	rs60787921	chr7:75792844	C/A	cg01364799	chr7:75623366	TMEM120A	-0.7	-5.84	-0.55	1.16e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs9290877	0.667	rs9820669	chr3:188462854	T/C	cg17392043	chr3:188495102	LPP	-0.66	-5.23	-0.51	1.37e-6	IgE levels;
SKCM	cis	rs9420	0.961	rs7938083	chr11:57493622	C/A	cg19752551	chr11:57585705	CTNND1	-0.7	-6.78	-0.61	2.07e-9	Schizophrenia;
SKCM	cis	rs28595532	0.920	rs116405053	chr4:119739352	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs9300255	0.602	rs1727294	chr12:123616514	A/G	cg05973401	chr12:123451056	ABCB9	0.8	5.47	0.53	5.23e-7	Neutrophil percentage of white cells;
SKCM	cis	rs28830936	0.510	rs12440605	chr15:42102285	A/G	cg17847044	chr15:42102381	MAPKBP1	0.4	5.07	0.5	2.64e-6	Diastolic blood pressure;
SKCM	cis	rs11098499	0.820	rs13128602	chr4:120459366	C/T	cg24375607	chr4:120327624	NA	-0.68	-5.12	-0.5	2.15e-6	Corneal astigmatism;
SKCM	cis	rs854765	0.618	rs9908017	chr17:17774422	C/T	cg04398451	chr17:18023971	MYO15A	0.89	6.71	0.61	2.75e-9	Total body bone mineral density;
SKCM	cis	rs9611565	0.512	rs5758465	chr22:42175314	T/C	cg03806693	chr22:41940476	POLR3H	1.2	7.59	0.65	5.96e-11	Vitiligo;
SKCM	cis	rs1577917	0.655	rs7742691	chr6:86278691	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.88	8.76	0.7	3.13e-13	Response to antipsychotic treatment;
SKCM	cis	rs56235845	0.694	rs4976643	chr5:176760227	A/C	cg16006841	chr5:176797999	RGS14	0.69	6.42	0.59	9.83e-9	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs12188164	0.610	rs57433159	chr5:418725	C/T	cg26076054	chr5:421317	AHRR	-0.59	-4.84	-0.48	6.35e-6	Cystic fibrosis severity;
SKCM	cis	rs2836974	0.931	rs2776307	chr21:40713833	C/G	cg11644478	chr21:40555479	PSMG1	-0.75	-6.38	-0.59	1.14e-8	Cognitive function;
SKCM	cis	rs780096	0.526	rs809058	chr2:27616790	T/C	cg05696406	chr2:27599888	SNX17	0.47	4.92	0.49	4.75e-6	Total body bone mineral density;
SKCM	cis	rs1153858	1.000	rs4395020	chr15:45652889	A/C	cg21132104	chr15:45694354	SPATA5L1	0.91	7.45	0.65	1.06e-10	Homoarginine levels;
SKCM	cis	rs9399135	0.967	rs13191501	chr6:135366880	T/C	cg24558204	chr6:135376177	HBS1L	0.57	5.01	0.49	3.34e-6	Red blood cell count;
SKCM	cis	rs548181	0.536	rs503288	chr11:125461787	C/T	cg03464685	chr11:125439445	EI24	-1.24	-8.22	-0.68	3.58e-12	Schizophrenia;Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);
SKCM	cis	rs7937682	0.883	rs542831	chr11:111471392	T/A	cg19812747	chr11:111475976	SIK2	-0.6	-5.15	-0.5	1.89e-6	Primary sclerosing cholangitis;
SKCM	cis	rs2013441	0.613	rs11204422	chr17:19996429	A/T	cg13482628	chr17:19912719	NA	-0.64	-5.21	-0.51	1.52e-6	Obesity-related traits;
SKCM	cis	rs6952808	0.564	rs55865401	chr7:2145720	G/C	cg02951883	chr7:2050386	MAD1L1	-0.82	-8.09	-0.68	6.26e-12	Bipolar disorder and schizophrenia;
SKCM	cis	rs28595532	0.546	rs36058627	chr4:119233201	G/T	cg11846333	chr4:119757529	SEC24D	0.96	5.37	0.52	7.87e-7	Cannabis dependence symptom count;
SKCM	cis	rs4819852	1.000	rs7285377	chr22:19987202	G/T	cg07821417	chr22:19972146	ARVCF	0.51	6.28	0.58	1.79e-8	Pulse pressure;
SKCM	cis	rs7954584	0.567	rs11043233	chr12:122330733	C/T	cg13699009	chr12:122356056	WDR66	0.58	7.26	0.64	2.5e-10	Mean corpuscular volume;
SKCM	cis	rs7927771	0.832	rs11607981	chr11:47401060	T/G	cg05585544	chr11:47624801	NA	-0.58	-5.19	-0.51	1.61e-6	Subjective well-being;
SKCM	cis	rs3820928	0.874	rs6707265	chr2:227849255	T/A	cg11843606	chr2:227700838	RHBDD1	-0.61	-4.97	-0.49	3.83e-6	Pulmonary function;
SKCM	cis	rs1912528	0.963	rs13143388	chr4:140917009	T/C	cg11128457	chr4:140864437	MAML3	0.58	4.89	0.48	5.21e-6	Educational attainment (years of education);
SKCM	cis	rs1552244	1.000	rs13319597	chr3:10126312	A/C	cg02579736	chr3:10068473	FANCD2;CIDECP	-1.31	-7.19	-0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs7216064	1.000	rs12451707	chr17:65871598	G/A	cg12091567	chr17:66097778	LOC651250	-0.75	-5.27	-0.51	1.19e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs9300255	0.596	rs11057202	chr12:123720775	G/T	cg05973401	chr12:123451056	ABCB9	0.8	6.21	0.57	2.44e-8	Neutrophil percentage of white cells;
SKCM	cis	rs7216064	1.000	rs7210027	chr17:65977053	C/T	cg12091567	chr17:66097778	LOC651250	0.82	5.78	0.55	1.46e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs2811415	0.597	rs9882664	chr3:127766058	A/C	cg09089421	chr3:127803668	RUVBL1	-1.01	-8.77	-0.7	2.97e-13	Lung function (FEV1/FVC);
SKCM	cis	rs6951245	1.000	rs77868187	chr7:1093968	A/C	cg18402987	chr7:1209562	NA	1.15	6.09	0.57	3.95e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs2013441	1.000	rs9896709	chr17:20180550	G/A	cg13482628	chr17:19912719	NA	-0.66	-5.12	-0.5	2.18e-6	Obesity-related traits;
SKCM	cis	rs10752881	1.000	rs4420053	chr1:182976133	A/C	ch.1.3577855R	chr1:183094577	LAMC1	0.74	6.71	0.6	2.83e-9	Colorectal cancer;
SKCM	cis	rs78456975	1.000	rs13431491	chr2:1553808	T/A	cg01028140	chr2:1542097	TPO	-0.6	-5.14	-0.5	2.02e-6	Placebo response in major depressive disorder (% change in symptom score);
SKCM	cis	rs17361889	0.727	rs1527208	chr7:16280843	C/A	cg09714114	chr7:16439993	ISPD	0.51	5.25	0.51	1.27e-6	Pediatric bone mineral content (hip);
SKCM	cis	rs1405130	0.869	rs11687171	chr2:235566512	A/G	cg21542780	chr2:234763377	HJURP	-0.64	-4.89	-0.48	5.21e-6	Coronary artery disease;
SKCM	cis	rs3793683	0.520	rs4880426	chr10:134590610	G/A	cg26818010	chr10:134567672	INPP5A	-0.72	-5.42	-0.52	6.55e-7	Migraine;
SKCM	cis	rs1568889	1.000	rs66857704	chr11:28212346	A/G	cg06544937	chr11:28130018	METT5D1;KIF18A	0.86	6.87	0.61	1.4e-9	Bipolar disorder;
SKCM	cis	rs7811142	0.779	rs28680963	chr7:99905475	C/G	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.08	6.85	0.61	1.49e-9	Platelet count;
SKCM	cis	rs796364	0.951	rs11897245	chr2:201063644	A/G	cg12253985	chr2:200820533	C2orf60;C2orf47	0.95	6.37	0.59	1.21e-8	Schizophrenia;
SKCM	cis	rs8042680	0.518	rs6496745	chr15:91532630	C/T	cg15878949	chr15:91534302	PRC1	0.59	4.94	0.49	4.33e-6	Type 2 diabetes;
SKCM	cis	rs75229567	0.717	rs17107156	chr12:70234066	A/G	cg10114359	chr12:70132523	RAB3IP	-1.33	-5.67	-0.54	2.34e-7	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes;
SKCM	cis	rs2404602	0.692	rs7163397	chr15:76940315	A/G	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs854765	0.583	rs7222480	chr17:17818817	G/T	cg09796270	chr17:17721594	SREBF1	0.65	4.87	0.48	5.79e-6	Total body bone mineral density;
SKCM	cis	rs2204008	0.846	rs2030416	chr12:38465118	A/G	cg26384229	chr12:38710491	ALG10B	-0.8	-6.31	-0.58	1.56e-8	Bladder cancer;
SKCM	cis	rs4072980	0.545	rs7528185	chr1:38452059	C/T	cg12658694	chr1:38397304	INPP5B	-0.69	-5.3	-0.51	1.04e-6	Coronary artery disease;
SKCM	cis	rs1577917	0.917	rs13213603	chr6:86534758	T/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.33	-0.52	9.19e-7	Response to antipsychotic treatment;
SKCM	cis	rs6952808	0.782	rs4236271	chr7:1881369	C/T	cg04267008	chr7:1944627	MAD1L1	-0.75	-5.75	-0.55	1.63e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs9467773	0.967	rs1056347	chr6:26527524	G/C	cg15659132	chr6:26577336	NA	0.6	5.71	0.54	1.99e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs951366	0.789	rs823095	chr1:205679239	G/A	cg14159672	chr1:205819179	PM20D1	0.83	6.43	0.59	9.42e-9	Menarche (age at onset);
SKCM	cis	rs7632954	0.609	rs3755789	chr3:8542278	G/A	cg06697448	chr3:8544912	LMCD1	-0.62	-5.25	-0.51	1.28e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7666738	0.716	rs6817529	chr4:99023213	T/C	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs34375054	0.687	rs12303572	chr12:125611271	G/T	cg25124228	chr12:125621409	AACS	-0.68	-5.07	-0.5	2.58e-6	Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs12986445	0.744	rs10209951	chr2:26144986	C/G	cg07291958	chr2:26785531	C2orf70	0.53	4.92	0.49	4.79e-6	Multiple myeloma and monoclonal gammopathy;Multiple myeloma;
SKCM	cis	rs427394	0.802	rs274698	chr5:6730957	T/G	cg10857441	chr5:6722123	POLS	-0.71	-7.33	-0.64	1.82e-10	Menopause (age at onset);
SKCM	cis	rs10540	1.000	rs12421457	chr11:505780	T/C	cg03352830	chr11:487213	PTDSS2	0.94	4.91	0.49	4.87e-6	Body mass index;
SKCM	cis	rs9902453	0.584	rs3809790	chr17:27955540	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.9	-6.41	-0.59	1.02e-8	Coffee consumption (cups per day);
SKCM	cis	rs10504229	0.953	rs59265461	chr8:58189701	A/T	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs2404602	0.716	rs12441550	chr15:76863682	A/T	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs4975616	0.804	rs457130	chr5:1336178	A/T	cg07493874	chr5:1342172	CLPTM1L	-0.66	-5.76	-0.55	1.6e-7	Lung cancer;
SKCM	cis	rs7772486	0.686	rs6570701	chr6:145954090	A/G	cg05347473	chr6:146136440	FBXO30	0.58	5.3	0.51	1.05e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4665809	0.590	rs1560865	chr2:26452197	C/A	cg26119090	chr2:26468346	HADHA;HADHB	-1.03	-7.99	-0.67	9.69e-12	Gut microbiome composition (summer);
SKCM	trans	rs1814175	0.588	rs1794144	chr11:49918233	A/G	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs67311347	1.000	rs1119179	chr3:40424929	A/C	cg00091569	chr3:40428383	ENTPD3	-0.63	-5.34	-0.52	8.92e-7	Renal cell carcinoma;
SKCM	cis	rs16866061	0.816	rs115900205	chr2:225467840	G/C	cg12698349	chr2:225449008	CUL3	0.92	6.98	0.62	8.52e-10	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs2295499	0.673	rs55641756	chr4:2704621	C/T	cg19433769	chr4:2420260	ZFYVE28	0.69	4.77	0.48	8.44e-6	Cognitive ability;Cognitive ability (multi-trait analysis);Intelligence (multi-trait analysis);
SKCM	cis	rs7552404	0.924	rs2275378	chr1:76198436	T/C	cg10523679	chr1:76189770	ACADM	0.7	5.19	0.51	1.64e-6	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs9300255	0.602	rs4372492	chr12:123697357	T/C	cg05973401	chr12:123451056	ABCB9	0.81	5.37	0.52	7.77e-7	Neutrophil percentage of white cells;
SKCM	cis	rs4740619	0.619	rs10756741	chr9:16041911	A/G	cg14451791	chr9:16040625	NA	-0.47	-5.03	-0.49	3.07e-6	Body mass index;
SKCM	cis	rs875971	0.522	rs2949690	chr7:65483242	C/T	cg05627663	chr7:65219948	SNORA22;CCT6P1	-0.63	-5.5	-0.53	4.73e-7	Aortic root size;
SKCM	cis	rs6500395	0.962	rs17826468	chr16:48568271	A/G	cg04672837	chr16:48644449	N4BP1	0.72	6.04	0.56	4.96e-8	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs4808199	0.843	rs10402308	chr19:19657500	G/A	cg03709012	chr19:19516395	GATAD2A	1.03	7.41	0.64	1.32e-10	Nonalcoholic fatty liver disease;
SKCM	trans	rs17685	0.753	rs4732595	chr7:75755139	A/G	cg19862616	chr7:65841803	NCRNA00174	0.94	9.49	0.73	1.22e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs909674	0.541	rs5757655	chr22:39797178	C/G	cg24399712	chr22:39784796	NA	0.6	5.07	0.5	2.64e-6	IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis);IgG glycosylation;IgG digalactosylation phenotypes (multivariate analysis);IgG sialylation phenotypes (multivariate analysis);IgG monogalactosylation phenotypes (multivariate analysis);IgG fucosylation phenotypes (multivariate analysis);IgG N-glycosylation phenotypes (multivariate analysis);IgG disialylation phenotypes (multivariate analysis);IgG galactosylation phenotypes (multivariate analysis);Post bronchodilator FEV1;
SKCM	cis	rs9910055	0.573	rs113184718	chr17:42206543	A/T	cg08499158	chr17:42289980	UBTF	0.71	5.9	0.56	9.02e-8	Total body bone mineral density;
SKCM	cis	rs2439831	0.850	rs28718261	chr15:44043793	C/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.35	7.72	0.66	3.27e-11	Lung cancer in ever smokers;
SKCM	cis	rs9467773	1.000	rs12526680	chr6:26550954	A/G	cg09904177	chr6:26538194	HMGN4	0.54	5.02	0.49	3.24e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1218582	0.804	rs4845398	chr1:154859038	G/C	cg09359103	chr1:154839909	KCNN3	-0.57	-5.25	-0.51	1.26e-6	Prostate cancer;
SKCM	cis	rs34779708	0.649	rs34421369	chr10:35550275	G/C	cg03585969	chr10:35415529	CREM	0.74	5.3	0.51	1.03e-6	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs7447593	0.666	rs10866705	chr5:176801131	G/T	cg17509989	chr5:176798049	RGS14	-0.71	-6.9	-0.62	1.21e-9	Urinary electrolytes (magnesium/calcium ratio);
SKCM	cis	rs11098499	0.775	rs10021601	chr4:120282563	G/A	cg24375607	chr4:120327624	NA	0.62	4.77	0.48	8.45e-6	Corneal astigmatism;
SKCM	cis	rs6952808	0.693	rs10950413	chr7:1912988	A/G	cg05863683	chr7:1912471	MAD1L1	0.6	5.41	0.52	6.71e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs58688157	0.924	rs35865896	chr11:584591	A/G	cg16486109	chr11:613632	IRF7	1.12	7.11	0.63	4.92e-10	Systemic lupus erythematosus;
SKCM	cis	rs58688157	0.705	rs12800061	chr11:587425	C/A	cg16486109	chr11:613632	IRF7	1.09	6.84	0.61	1.6e-9	Systemic lupus erythematosus;
SKCM	cis	rs16866061	0.962	rs3845840	chr2:225359100	G/A	cg12698349	chr2:225449008	CUL3	1.03	8.81	0.71	2.51e-13	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs472402	0.540	rs2288445	chr5:6620092	C/T	cg10789808	chr5:6633262	NSUN2;SRD5A1	-0.76	-4.97	-0.49	3.92e-6	Response to amphetamines;
SKCM	cis	rs67311347	0.910	rs7617361	chr3:40373259	G/T	cg00091569	chr3:40428383	ENTPD3	0.61	5.36	0.52	8.37e-7	Renal cell carcinoma;
SKCM	cis	rs344364	0.518	rs1657129	chr16:1945826	G/A	cg26897989	chr16:1907736	C16orf73	-0.69	-7.13	-0.63	4.45e-10	Glomerular filtration rate in chronic kidney disease;
SKCM	cis	rs4619890	0.528	rs62289336	chr4:7877661	T/C	cg08722675	chr4:8412549	ACOX3	0.54	5.06	0.5	2.68e-6	Glaucoma (primary open-angle);
SKCM	cis	rs6547741	0.967	rs4665999	chr2:27834444	T/C	cg27432699	chr2:27873401	GPN1	0.75	6.74	0.61	2.44e-9	Oral cavity cancer;
SKCM	cis	rs1023500	0.596	rs133352	chr22:42434022	C/A	cg04733989	chr22:42467013	NAGA	0.77	5.84	0.55	1.13e-7	Schizophrenia;
SKCM	cis	rs6089584	1.000	rs3787424	chr20:60559219	G/A	cg06108461	chr20:60628389	TAF4	-0.81	-7.11	-0.63	4.79e-10	Body mass index;
SKCM	cis	rs7772486	0.875	rs2492855	chr6:146296926	A/G	cg05347473	chr6:146136440	FBXO30	0.56	4.79	0.48	7.7e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7811142	0.830	rs11761426	chr7:99956893	A/T	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.19	7.5	0.65	8.66e-11	Platelet count;
SKCM	cis	rs769267	0.895	rs1858999	chr19:19497669	C/G	cg26732615	chr19:19648335	CILP2;YJEFN3	-0.64	-6.45	-0.59	8.44e-9	Tonsillectomy;
SKCM	cis	rs10504229	0.639	rs72650811	chr8:58115661	G/A	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs4237845	0.844	rs4630335	chr12:58302258	A/G	cg00677455	chr12:58241039	CTDSP2	0.7	6.02	0.56	5.33e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs28595532	0.764	rs115877991	chr4:119728298	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.52	0.53	4.28e-7	Cannabis dependence symptom count;
SKCM	cis	rs2404602	0.735	rs4886805	chr15:76739384	A/G	cg23625390	chr15:77176239	SCAPER	0.83	8.16	0.68	4.7e-12	Blood metabolite levels;
SKCM	cis	rs472402	0.540	rs3776431	chr5:6618756	T/C	cg10789808	chr5:6633262	NSUN2;SRD5A1	-0.74	-4.79	-0.48	7.7e-6	Response to amphetamines;
SKCM	cis	rs826838	1.000	rs1719848	chr12:39085586	A/G	cg13010199	chr12:38710504	ALG10B	-0.82	-6.22	-0.58	2.26e-8	Heart rate;
SKCM	cis	rs9910055	0.615	rs189049	chr17:42197213	A/C	cg10896456	chr17:42255109	ASB16;C17orf65	-0.68	-6.97	-0.62	9.16e-10	Total body bone mineral density;
SKCM	cis	rs216303	0.841	rs2283333	chr12:6162852	T/C	cg22867714	chr12:6169044	VWF	-0.98	-5.51	-0.53	4.52e-7	Low vWF levels;
SKCM	cis	rs919433	0.680	rs699319	chr2:198281776	C/A	cg04278110	chr2:198063759	ANKRD44	0.7	4.79	0.48	7.87e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs3768617	0.565	rs10752897	chr1:183071024	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.76	6.82	0.61	1.73e-9	Fuchs's corneal dystrophy;
SKCM	cis	rs2842992	0.724	rs2273823	chr6:160211485	T/C	cg19482086	chr6:160211437	TCP1;MRPL18	0.87	7.46	0.65	1.04e-10	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs514406	0.893	rs1242317	chr1:53414766	T/C	cg08859206	chr1:53392774	SCP2	-0.62	-5.02	-0.49	3.22e-6	Monocyte count;
SKCM	cis	rs950027	0.549	rs1719250	chr15:45609773	A/G	cg21132104	chr15:45694354	SPATA5L1	0.77	5.25	0.51	1.27e-6	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs1577917	0.958	rs66807489	chr6:86440702	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.44	-0.52	5.96e-7	Response to antipsychotic treatment;
SKCM	cis	rs769267	0.930	rs1865034	chr19:19605763	C/T	cg03709012	chr19:19516395	GATAD2A	0.89	8.62	0.7	5.89e-13	Tonsillectomy;
SKCM	cis	rs28595532	0.920	rs114207133	chr4:119755140	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs62238980	0.614	rs1475996	chr22:32464980	T/C	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs2228479	0.702	rs12599561	chr16:89894358	C/G	cg06558623	chr16:89946397	TCF25	1.1	4.95	0.49	4.17e-6	Skin colour saturation;
SKCM	cis	rs6912958	0.559	rs183599	chr6:88061024	C/T	cg08069147	chr6:88032118	GJB7;C6orf162	0.72	6.77	0.61	2.19e-9	Monocyte percentage of white cells;
SKCM	cis	rs6066825	0.644	rs6019386	chr20:47326440	T/G	cg18078177	chr20:47281410	PREX1	0.64	5.19	0.51	1.6e-6	Colorectal cancer;
SKCM	cis	rs9916302	0.861	rs7503514	chr17:37669884	G/C	cg07936489	chr17:37558343	FBXL20	-0.91	-8.19	-0.68	4e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs2816062	0.721	rs2816047	chr1:18893728	A/C	cg18795169	chr1:18902165	NA	-0.83	-9.02	-0.71	1.01e-13	Urate levels in lean individuals;
SKCM	cis	rs12477438	0.539	rs720228	chr2:99704547	A/G	cg26064155	chr2:99771622	LIPT1;TSGA10	1.07	9.99	0.75	1.32e-15	Chronic sinus infection;
SKCM	cis	rs28386778	0.897	rs2044125	chr17:61863184	A/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	-1.1	-11.09	-0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs2032447	0.639	rs198810	chr6:26128618	A/G	cg03517284	chr6:25882590	NA	0.58	4.91	0.49	4.95e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs870825	0.616	rs2003994	chr4:185636568	G/T	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs7618501	0.521	rs952594	chr3:49908023	G/A	cg24110177	chr3:50126178	RBM5	-0.71	-5.36	-0.52	8.33e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs72634258	0.519	rs4908708	chr1:7938113	G/C	cg00042356	chr1:8021962	PARK7	0.81	5.52	0.53	4.26e-7	Inflammatory bowel disease;
SKCM	cis	rs10791097	0.592	rs4936122	chr11:130734264	A/C	cg12179176	chr11:130786555	SNX19	0.94	8.13	0.68	5.18e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs1005277	0.577	rs4934906	chr10:38015028	C/T	cg00409905	chr10:38381863	ZNF37A	-0.63	-6.05	-0.57	4.71e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs7937682	0.889	rs542424	chr11:111477698	T/C	cg09085632	chr11:111637200	PPP2R1B	-0.97	-10.1	-0.75	8.28e-16	Primary sclerosing cholangitis;
SKCM	cis	rs3135063	0.884	rs3129317	chr4:3287655	A/G	cg24015175	chr4:3319247	RGS12	0.51	4.79	0.48	7.87e-6	Blood protein levels;
SKCM	cis	rs2228479	0.541	rs12918575	chr16:89811151	A/G	cg00800038	chr16:89945340	TCF25	-0.85	-4.99	-0.49	3.65e-6	Skin colour saturation;
SKCM	cis	rs12142240	0.698	rs68083747	chr1:46807416	T/G	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs6089584	0.850	rs6142939	chr20:60627729	A/G	cg06108461	chr20:60628389	TAF4	-0.89	-9.05	-0.72	8.53e-14	Body mass index;
SKCM	cis	rs4740619	0.619	rs10738426	chr9:16041615	T/C	cg14451791	chr9:16040625	NA	-0.47	-5.03	-0.49	3.07e-6	Body mass index;
SKCM	trans	rs1814175	0.615	rs11040654	chr11:49939485	T/G	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs2066819	0.818	rs703830	chr12:56701872	T/C	cg26714650	chr12:56694279	CS	1.71	6.71	0.61	2.74e-9	Psoriasis vulgaris;
SKCM	cis	rs875971	0.893	rs62465470	chr7:65601218	T/C	cg11764359	chr7:65958608	NA	-0.8	-7.66	-0.66	4.2e-11	Aortic root size;
SKCM	cis	rs910316	0.737	rs175072	chr14:75502827	T/C	cg08847533	chr14:75593920	NEK9	-0.8	-6.62	-0.6	4.21e-9	Height;
SKCM	cis	rs4481887	1.000	rs4360553	chr1:248467092	A/G	cg00666640	chr1:248458726	OR2T12	0.56	4.82	0.48	6.92e-6	Common traits (Other);
SKCM	cis	rs7811142	1.000	rs73405353	chr7:100091215	G/A	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.24	7.92	0.67	1.36e-11	Platelet count;
SKCM	cis	rs7809950	0.817	rs17154091	chr7:107084790	T/C	cg23024343	chr7:107201750	COG5	-0.88	-8.2	-0.68	3.87e-12	Coronary artery disease;
SKCM	cis	rs1005277	0.540	rs2224248	chr10:38451886	A/G	cg25427524	chr10:38739819	LOC399744	-0.71	-6.71	-0.61	2.75e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs7927771	0.800	rs35996350	chr11:47389223	A/G	cg01152729	chr11:47593274	PTPMT1	-0.51	-4.88	-0.48	5.53e-6	Subjective well-being;
SKCM	cis	rs2842992	0.709	rs1853257	chr6:160212710	C/G	cg16489826	chr6:160211363	TCP1;MRPL18	0.68	4.93	0.49	4.51e-6	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs2204008	0.720	rs10880697	chr12:38594529	G/C	cg26384229	chr12:38710491	ALG10B	0.87	7.11	0.63	4.92e-10	Bladder cancer;
SKCM	cis	rs55962025	0.883	rs362275	chr4:3224602	C/T	cg21096898	chr4:3318625	RGS12	-0.65	-4.98	-0.49	3.75e-6	Parental longevity (mother's age at death);
SKCM	cis	rs6952808	0.608	rs6461049	chr7:2017445	C/T	cg21782813	chr7:2030301	MAD1L1	-0.59	-6.1	-0.57	3.8e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs801193	1.000	rs2659912	chr7:66157999	G/C	cg11987759	chr7:65425863	GUSB	-0.69	-5.9	-0.56	8.74e-8	Aortic root size;
SKCM	cis	rs2357013	0.725	rs13426096	chr2:53206582	A/G	cg07782112	chr2:53107842	NA	0.54	5.38	0.52	7.54e-7	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs2839186	0.770	rs2330353	chr21:47669648	T/A	cg11766577	chr21:47581405	C21orf56	-0.77	-6.5	-0.59	7.03e-9	Testicular germ cell tumor;
SKCM	cis	rs28595532	0.920	rs116559327	chr4:119754526	T/G	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs6815814	0.950	rs5743566	chr4:38805942	G/C	cg02016764	chr4:38805732	TLR1	-0.77	-5.52	-0.53	4.24e-7	Breast cancer;
SKCM	cis	rs35766269	0.541	rs1912584	chr10:9041158	C/T	cg05671070	chr10:8095960	FLJ45983;GATA3	0.95	4.77	0.48	8.45e-6	Recalcitrant atopic dermatitis;
SKCM	cis	rs9902453	0.817	rs9909128	chr17:28161482	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.8	6.02	0.56	5.28e-8	Coffee consumption (cups per day);
SKCM	cis	rs2842992	0.692	rs9347342	chr6:160193129	T/C	cg19482086	chr6:160211437	TCP1;MRPL18	0.9	8.1	0.68	5.89e-12	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs1401999	1.000	rs6767013	chr3:183680102	G/A	cg01324343	chr3:183735012	ABCC5	0.93	10.78	0.77	4.03e-17	Anterior chamber depth;
SKCM	cis	rs2153535	0.580	rs6929206	chr6:8447961	A/G	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	trans	rs208520	0.874	rs208518	chr6:66948501	C/G	cg15611600	chr13:45563400	KIAA1704;NUFIP1	1.04	7.4	0.64	1.37e-10	Exhaled nitric oxide output;
SKCM	cis	rs1577917	1.000	rs1577919	chr6:86757296	C/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.64	-5.48	-0.53	5.09e-7	Response to antipsychotic treatment;
SKCM	cis	rs6430585	0.528	rs309123	chr2:136761175	C/G	cg07169764	chr2:136633963	MCM6	1.29	11.91	0.8	3.13e-19	Corneal structure;
SKCM	cis	rs55962025	0.723	rs2269478	chr4:3234828	G/T	cg21096898	chr4:3318625	RGS12	-0.61	-5.04	-0.5	2.89e-6	Parental longevity (mother's age at death);
SKCM	cis	rs10751667	0.666	rs7105477	chr11:964271	C/G	cg10932868	chr11:921992	NA	0.6	5.63	0.54	2.72e-7	Alzheimer's disease (late onset);
SKCM	cis	rs2014572	0.901	rs35658377	chr19:57755627	T/G	cg24459738	chr19:57751996	ZNF805	-0.64	-5.29	-0.51	1.1e-6	Hyperactive-impulsive symptoms;
SKCM	cis	rs61867294	0.501	rs7092080	chr10:106830537	A/G	cg05291666	chr10:106073406	ITPRIP	-0.74	-5.0	-0.49	3.38e-6	Schizophrenia;
SKCM	cis	rs763121	0.853	rs4821798	chr22:39021165	T/C	cg06022373	chr22:39101656	GTPBP1	0.82	5.62	0.54	2.79e-7	Menopause (age at onset);
SKCM	cis	rs7618501	0.633	rs2526748	chr3:50080439	A/G	cg24110177	chr3:50126178	RBM5	0.63	5.38	0.52	7.62e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs2479106	0.727	rs2159793	chr9:126701763	T/C	cg16191174	chr9:126692580	DENND1A	0.76	6.44	0.59	8.81e-9	Polycystic ovary syndrome;
SKCM	cis	rs9430161	0.645	rs12081186	chr1:11034195	T/C	cg02454025	chr1:11042201	C1orf127	1.08	10.13	0.75	7.19e-16	Ewing sarcoma;
SKCM	cis	rs875971	0.522	rs1880556	chr7:65432544	T/C	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.63	5.48	0.53	5.11e-7	Aortic root size;
SKCM	cis	rs933688	1.000	rs12651840	chr5:90729592	T/C	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.93	6.49	0.59	7.31e-9	Smoking behavior;
SKCM	cis	rs7613875	0.543	rs34034116	chr3:49959156	C/A	cg24110177	chr3:50126178	RBM5	-0.71	-5.71	-0.54	1.95e-7	Body mass index;
SKCM	cis	rs7635838	0.654	rs164101	chr3:11281082	G/A	cg00170343	chr3:11313890	ATG7	0.79	5.5	0.53	4.71e-7	HDL cholesterol;
SKCM	cis	rs7959452	0.535	rs1350166	chr12:69636314	G/T	cg14784868	chr12:69753453	YEATS4	0.6	5.07	0.5	2.61e-6	Blood protein levels;
SKCM	cis	rs9796	0.775	rs57393155	chr15:41426251	A/G	cg18705301	chr15:41695430	NDUFAF1	-0.72	-5.31	-0.52	9.93e-7	Menopause (age at onset);
SKCM	cis	rs7843479	0.932	rs68023663	chr8:21794379	T/C	cg17168535	chr8:21777572	XPO7	0.74	6.13	0.57	3.41e-8	Mean corpuscular volume;
SKCM	cis	rs2070488	0.775	rs1073506	chr3:38566235	G/T	cg01465620	chr3:38496096	LOC100128640;ACVR2B	-0.73	-5.6	-0.54	3.13e-7	Electrocardiographic conduction measures;
SKCM	cis	rs1577917	0.958	rs7382798	chr6:86559834	C/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.81	-7.82	-0.66	2.07e-11	Response to antipsychotic treatment;
SKCM	cis	rs10416265	0.527	rs6510337	chr19:33545701	C/T	cg17764715	chr19:33622953	WDR88	0.9	6.27	0.58	1.9e-8	Bone properties (heel);
SKCM	cis	rs11098499	0.863	rs11933966	chr4:120476715	G/A	cg09307838	chr4:120376055	NA	1.0	8.27	0.68	2.8e-12	Corneal astigmatism;
SKCM	cis	rs4975616	0.804	rs457130	chr5:1336178	A/T	cg06550200	chr5:1325588	CLPTM1L	-0.83	-6.78	-0.61	2.02e-9	Lung cancer;
SKCM	cis	rs2153535	0.580	rs1889715	chr6:8443475	G/A	cg07606381	chr6:8435919	SLC35B3	0.94	6.94	0.62	1.02e-9	Motion sickness;
SKCM	cis	rs9910055	0.762	rs1135215	chr17:42253519	T/C	cg08499158	chr17:42289980	UBTF	-0.85	-7.66	-0.66	4.36e-11	Total body bone mineral density;
SKCM	cis	rs1799949	1.000	rs8176133	chr17:41257458	A/C	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.01	-0.56	5.5e-8	Menopause (age at onset);
SKCM	trans	rs1814175	0.645	rs2140602	chr11:50022800	G/C	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	trans	rs208520	0.690	rs10455595	chr6:66738034	T/C	cg15611600	chr13:45563400	KIAA1704;NUFIP1	0.92	7.47	0.65	9.89e-11	Exhaled nitric oxide output;
SKCM	cis	rs9900062	0.586	rs6504249	chr17:62676149	A/G	cg02097616	chr17:62675921	NA	0.75	6.15	0.57	3.11e-8	QT interval;
SKCM	cis	rs6121246	0.559	rs6058468	chr20:30406448	C/A	cg11595048	chr20:30225325	COX4I2	0.54	4.77	0.48	8.4e-6	Mean corpuscular hemoglobin;
SKCM	trans	rs1814175	0.645	rs28478790	chr11:50054322	C/A	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs12950390	0.814	rs11659069	chr17:45834275	G/T	cg03474202	chr17:45855739	NA	-0.49	-5.58	-0.53	3.34e-7	IgG glycosylation;
SKCM	cis	rs589448	0.902	rs315113	chr12:69786543	G/T	cg22834771	chr12:69754056	YEATS4	0.7	5.72	0.54	1.91e-7	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs57221529	0.545	rs55955015	chr5:575182	A/G	cg10555297	chr5:473380	SLC9A3;LOC25845	1.09	5.49	0.53	4.82e-7	Lung disease severity in cystic fibrosis;
SKCM	cis	rs3820068	0.603	rs72645887	chr1:15929905	G/C	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs4727027	0.704	rs12704073	chr7:148905067	G/A	cg23583168	chr7:148888333	NA	-0.78	-6.05	-0.57	4.63e-8	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs11626933	1.000	rs11626016	chr14:90747979	C/T	cg14092571	chr14:90743983	NA	-0.92	-8.33	-0.69	2.11e-12	Gut microbiota (bacterial taxa);
SKCM	cis	rs2251381	0.808	rs7364112	chr21:30548968	C/A	cg24692254	chr21:30365293	RNF160	0.78	6.33	0.58	1.46e-8	Selective IgA deficiency;
SKCM	cis	rs3820928	1.000	rs4675120	chr2:227774888	C/T	cg11843606	chr2:227700838	RHBDD1	-0.61	-4.88	-0.48	5.44e-6	Pulmonary function;
SKCM	cis	rs116095464	0.558	rs6555052	chr5:224268	G/A	cg22857025	chr5:266934	NA	-1.36	-8.0	-0.67	9.23e-12	Breast cancer;
SKCM	cis	rs2243480	1.000	rs13247184	chr7:65358928	A/G	cg07424592	chr7:64974309	NA	0.99	4.9	0.49	5.08e-6	Diabetic kidney disease;
SKCM	cis	rs12478296	0.901	rs6731775	chr2:242999443	T/C	cg06360820	chr2:242988706	NA	-0.98	-5.56	-0.53	3.6e-7	Obesity-related traits;
SKCM	cis	rs873946	0.648	rs12771651	chr10:134554482	C/A	cg26818010	chr10:134567672	INPP5A	-0.79	-6.43	-0.59	9.19e-9	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs9300255	0.679	rs58809476	chr12:123724880	C/T	cg05973401	chr12:123451056	ABCB9	-0.86	-6.1	-0.57	3.87e-8	Neutrophil percentage of white cells;
SKCM	cis	rs9325144	0.671	rs7485963	chr12:38768254	C/G	cg13010199	chr12:38710504	ALG10B	-0.66	-5.44	-0.52	5.88e-7	Morning vs. evening chronotype;
SKCM	cis	rs6840360	0.571	rs62327275	chr4:152548238	G/T	cg22705602	chr4:152727874	NA	-0.52	-5.69	-0.54	2.15e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs9443189	0.762	rs2748955	chr6:76464302	C/G	cg01950844	chr6:76311363	SENP6	-0.82	-5.55	-0.53	3.76e-7	Prostate cancer;
SKCM	cis	rs3096299	0.967	rs7205785	chr16:89458984	A/G	cg02187348	chr16:89574699	SPG7	0.63	5.04	0.5	2.93e-6	Multiple myeloma (IgH translocation);
SKCM	cis	rs6598955	0.543	rs3795689	chr1:26560366	C/G	cg04990556	chr1:26633338	UBXN11	0.64	4.92	0.49	4.78e-6	Obesity-related traits;
SKCM	cis	rs28386778	0.897	rs2665831	chr17:61912392	C/T	cg06873352	chr17:61820015	STRADA	0.74	6.39	0.59	1.13e-8	Prudent dietary pattern;
SKCM	cis	rs10779751	1.000	rs11121706	chr1:11302065	C/T	cg08854313	chr1:11322531	MTOR	0.91	7.14	0.63	4.17e-10	Body mass index;
SKCM	cis	rs56011263	0.512	rs12502944	chr4:736054	G/A	cg17689763	chr4:710664	PCGF3	-0.66	-4.79	-0.48	7.67e-6	White blood cell count;
SKCM	cis	rs6430585	0.583	rs12475516	chr2:136560761	C/G	cg07169764	chr2:136633963	MCM6	1.04	8.25	0.68	3.12e-12	Corneal structure;
SKCM	cis	rs6500395	0.962	rs9972682	chr16:48686644	T/G	cg04672837	chr16:48644449	N4BP1	0.65	5.36	0.52	8.23e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs6921919	0.525	rs6929825	chr6:28378959	A/G	cg14547644	chr6:28411285	ZSCAN23	-0.58	-4.8	-0.48	7.46e-6	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs9880211	0.800	rs35880395	chr3:136507090	C/T	cg21827317	chr3:136751795	NA	-0.7	-5.38	-0.52	7.54e-7	Body mass index;Height;
SKCM	cis	rs1707322	0.963	rs10890371	chr1:46390897	T/G	cg03146154	chr1:46216737	IPP	0.74	5.06	0.5	2.76e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs4972806	0.814	rs6710370	chr2:177045969	T/C	cg13092806	chr2:177043255	NA	0.57	5.37	0.52	7.9e-7	IgG glycosylation;
SKCM	cis	rs9902453	0.845	rs7222842	chr17:28246943	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.79	5.67	0.54	2.35e-7	Coffee consumption (cups per day);
SKCM	cis	rs997295	0.570	rs11632574	chr15:67852405	A/C	cg24247231	chr15:67904302	MAP2K5	-0.61	-5.0	-0.49	3.4e-6	Motion sickness;
SKCM	cis	rs7208859	0.623	rs8068645	chr17:29104342	T/A	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs35306767	0.903	rs13377166	chr10:886259	G/A	cg25614935	chr10:1084866	C10orf110	0.82	5.39	0.52	7.4e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs10028773	0.700	rs7671797	chr4:120248157	A/G	cg09307838	chr4:120376055	NA	0.93	7.56	0.65	6.5500000000000006e-11	Educational attainment;
SKCM	cis	rs12477438	0.520	rs11123762	chr2:99727789	T/C	cg14399236	chr2:99771627	LIPT1;TSGA10	0.95	8.78	0.71	2.89e-13	Chronic sinus infection;
SKCM	cis	rs28595532	0.920	rs115259971	chr4:119762654	T/C	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs3008870	1.000	rs12132068	chr1:67451924	G/T	cg08660285	chr1:67390436	MIER1;WDR78	-0.92	-6.1	-0.57	3.82e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs34779708	0.931	rs2384275	chr10:35297142	A/G	cg03585969	chr10:35415529	CREM	0.73	6.02	0.56	5.27e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs1218582	0.772	rs4240874	chr1:154885779	C/T	cg16680214	chr1:154839983	KCNN3	-0.56	-5.01	-0.49	3.29e-6	Prostate cancer;
SKCM	cis	rs40363	0.645	rs1690449	chr16:3520893	C/G	cg22508957	chr16:3507546	NAT15	0.58	5.01	0.49	3.33e-6	Tuberculosis;
SKCM	cis	rs9916302	0.861	rs4795377	chr17:37669056	C/T	cg07936489	chr17:37558343	FBXL20	-0.9	-8.11	-0.68	5.65e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs9896933	0.775	rs79299098	chr17:80830944	G/A	cg20578329	chr17:80767326	TBCD	-0.98	-6.54	-0.59	5.94e-9	Bone mineral accretion in asthma (oral corticosteroid dose interaction);
SKCM	cis	rs13118159	0.527	rs1250119	chr4:1261336	G/A	cg05025164	chr4:1340916	KIAA1530	-0.83	-6.91	-0.62	1.17e-9	Longevity;
SKCM	cis	rs12142240	0.698	rs6679898	chr1:46820589	A/C	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs2204008	0.660	rs2320745	chr12:38239101	T/C	cg26384229	chr12:38710491	ALG10B	0.86	7.18	0.63	3.58e-10	Bladder cancer;
SKCM	cis	rs1506636	0.962	rs2456551	chr7:123394610	C/G	cg03229431	chr7:123269106	ASB15	0.64	5.19	0.51	1.63e-6	Plateletcrit;Platelet count;
SKCM	cis	rs66573146	0.831	rs68111914	chr4:6986677	C/T	cg00086871	chr4:6988644	TBC1D14	1.29	5.03	0.5	3.04e-6	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs1577917	0.740	rs2475792	chr6:86392102	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.76	7.31	0.64	2.06e-10	Response to antipsychotic treatment;
SKCM	cis	rs1799949	1.000	rs8176109	chr17:41265776	A/G	cg05368731	chr17:41323189	NBR1	0.88	7.75	0.66	2.84e-11	Menopause (age at onset);
SKCM	cis	rs6582630	0.555	rs10880624	chr12:38526316	C/T	cg26384229	chr12:38710491	ALG10B	0.82	6.64	0.6	3.86e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs13278732	0.500	rs2279120	chr8:99046040	C/T	cg16297171	chr8:99017690	MATN2	-0.54	-5.13	-0.5	2.07e-6	Eosinophilic esophagitis (pediatric);
SKCM	cis	rs6952808	0.636	rs6964522	chr7:1953523	C/T	cg02951883	chr7:2050386	MAD1L1	-0.66	-5.58	-0.53	3.29e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs738321	0.756	rs11089863	chr22:38512402	G/A	cg25457927	chr22:38595422	NA	-0.51	-5.73	-0.54	1.83e-7	Breast cancer;
SKCM	cis	rs995000	0.931	rs2131925	chr1:63025942	G/T	cg06896770	chr1:63153194	DOCK7	-0.72	-6.46	-0.59	8.17e-9	Triglyceride levels;
SKCM	cis	rs7937682	0.889	rs1940529	chr11:111498523	G/C	cg09085632	chr11:111637200	PPP2R1B	-1.07	-11.23	-0.79	5.72e-18	Primary sclerosing cholangitis;
SKCM	cis	rs2204008	0.837	rs11180549	chr12:38236950	A/G	cg13010199	chr12:38710504	ALG10B	0.69	4.99	0.49	3.57e-6	Bladder cancer;
SKCM	cis	rs2941509	1.000	rs3859186	chr17:38076329	G/A	cg12655416	chr17:38077870	ORMDL3	-0.48	-5.27	-0.51	1.17e-6	Systemic lupus erythematosus;
SKCM	cis	rs6547741	0.935	rs4665384	chr2:27848397	A/G	cg27432699	chr2:27873401	GPN1	0.76	6.84	0.61	1.57e-9	Oral cavity cancer;
SKCM	trans	rs17685	0.784	rs1637043	chr7:75699099	G/A	cg19862616	chr7:65841803	NCRNA00174	0.94	9.39	0.73	1.88e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs11155671	0.530	rs4870080	chr6:150202644	T/C	cg09699651	chr6:150184138	LRP11	0.63	5.35	0.52	8.46e-7	Testicular germ cell tumor;
SKCM	cis	rs55962025	0.737	rs2237006	chr4:3228492	A/G	cg21096898	chr4:3318625	RGS12	-0.61	-5.04	-0.5	2.99e-6	Parental longevity (mother's age at death);
SKCM	cis	rs11105298	0.891	rs4842653	chr12:89834113	C/T	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.88	-6.03	-0.56	5.22e-8	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs2404602	1.000	rs2896954	chr15:76851692	C/A	cg23625390	chr15:77176239	SCAPER	0.75	7.48	0.65	9.66e-11	Blood metabolite levels;
SKCM	cis	rs9457247	0.561	rs916331	chr6:167470559	T/G	cg07741184	chr6:167504864	NA	0.58	4.92	0.49	4.76e-6	Crohn's disease;
SKCM	cis	rs9788682	0.894	rs4461039	chr15:78817447	A/T	cg24631222	chr15:78858424	CHRNA5	-0.94	-6.59	-0.6	4.67e-9	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs2814982	0.543	rs75776386	chr6:34465215	G/A	cg17674042	chr6:34482479	PACSIN1	-1.0	-5.42	-0.52	6.4e-7	Cholesterol, total;Total cholesterol levels;
SKCM	cis	rs2811415	0.597	rs67763343	chr3:127803163	C/T	cg09089421	chr3:127803668	RUVBL1	1.0	8.69	0.7	4.4e-13	Lung function (FEV1/FVC);
SKCM	cis	rs2072499	1.000	rs2540173	chr1:156188214	A/G	cg25208724	chr1:156163844	SLC25A44	1.08	9.87	0.75	2.22e-15	Testicular germ cell tumor;
SKCM	cis	rs9611565	0.649	rs202625	chr22:41827082	G/A	cg03806693	chr22:41940476	POLR3H	1.13	7.36	0.64	1.63e-10	Vitiligo;
SKCM	cis	rs1707322	0.682	rs12041197	chr1:46104464	T/C	cg03146154	chr1:46216737	IPP	0.79	5.42	0.52	6.34e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs2204008	0.837	rs11519926	chr12:38348992	G/A	cg13010199	chr12:38710504	ALG10B	0.68	4.85	0.48	6.3e-6	Bladder cancer;
SKCM	cis	rs17376456	0.877	rs17374627	chr5:93296306	C/T	cg25358565	chr5:93447407	FAM172A	1.17	7.05	0.62	6.32e-10	Diabetic retinopathy;
SKCM	cis	rs875971	0.862	rs11765791	chr7:65936574	A/G	cg18876405	chr7:65276391	NA	0.61	6.04	0.56	5.03e-8	Aortic root size;
SKCM	cis	rs7811142	1.000	rs112317829	chr7:100043173	A/G	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.17	7.71	0.66	3.44e-11	Platelet count;
SKCM	cis	rs9911578	1.000	rs6503887	chr17:56993320	T/C	cg05425664	chr17:57184151	TRIM37	-0.67	-5.04	-0.5	2.91e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs829883	0.966	rs249815	chr12:98893709	A/G	cg25150519	chr12:98850993	NA	0.5	5.3	0.51	1.07e-6	Colorectal adenoma (advanced);
SKCM	cis	rs9916302	0.904	rs11078910	chr17:37671269	G/T	cg07936489	chr17:37558343	FBXL20	-0.9	-8.11	-0.68	5.65e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs7666738	0.830	rs6854902	chr4:99033416	T/G	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs5769765	0.862	rs9616385	chr22:50313124	C/T	cg22709217	chr22:50311962	ALG12;CRELD2	-0.94	-5.91	-0.56	8.37e-8	Schizophrenia;
SKCM	cis	rs798554	0.757	rs2533882	chr7:2846894	G/T	cg19346786	chr7:2764209	NA	-0.65	-7.11	-0.63	4.86e-10	Height;
SKCM	cis	rs7959452	0.562	rs11177630	chr12:69767963	G/C	cg14784868	chr12:69753453	YEATS4	0.8	7.57	0.65	6.41e-11	Blood protein levels;
SKCM	cis	rs62238980	0.614	rs75840726	chr22:32425834	A/G	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs116095464	0.558	rs28558836	chr5:285748	C/G	cg22857025	chr5:266934	NA	-1.47	-8.33	-0.69	2.16e-12	Breast cancer;
SKCM	cis	rs873946	0.586	rs3793686	chr10:134569559	A/G	cg27286337	chr10:134555280	INPP5A	0.99	8.87	0.71	1.93e-13	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs28386778	1.000	rs2665849	chr17:61953670	T/C	cg06873352	chr17:61820015	STRADA	0.76	6.56	0.6	5.37e-9	Prudent dietary pattern;
SKCM	cis	rs12477438	0.520	rs13022329	chr2:99731189	A/T	cg26064155	chr2:99771622	LIPT1;TSGA10	1.02	10.07	0.75	9.12e-16	Chronic sinus infection;
SKCM	cis	rs8180040	1.000	rs11714294	chr3:47339723	G/A	cg27129171	chr3:47204927	SETD2	-0.87	-6.62	-0.6	4.15e-9	Colorectal cancer;
SKCM	cis	rs57221529	0.766	rs72704799	chr5:551457	C/G	cg10555297	chr5:473380	SLC9A3;LOC25845	1.14	5.52	0.53	4.25e-7	Lung disease severity in cystic fibrosis;
SKCM	cis	rs4891159	0.790	rs7234653	chr18:74111988	C/T	cg24786174	chr18:74118243	ZNF516	-0.75	-7.23	-0.63	2.84e-10	Longevity;
SKCM	cis	rs9911578	1.000	rs12940681	chr17:56933622	T/C	cg05425664	chr17:57184151	TRIM37	-0.67	-5.04	-0.5	2.91e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs6952808	0.636	rs6964522	chr7:1953523	C/T	cg04267008	chr7:1944627	MAD1L1	-0.6	-4.81	-0.48	7.27e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs875971	0.508	rs10242423	chr7:66059175	A/G	cg11987759	chr7:65425863	GUSB	0.69	6.02	0.56	5.47e-8	Aortic root size;
SKCM	cis	rs1799949	0.965	rs9897425	chr17:41430179	C/G	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.07	-0.57	4.29e-8	Menopause (age at onset);
SKCM	cis	rs8103278	0.507	rs522769	chr19:46284520	G/A	cg14061069	chr19:46274453	DMPK	0.51	5.1	0.5	2.28e-6	Coronary artery disease;
SKCM	cis	rs6951245	1.000	rs78628466	chr7:1068453	G/C	cg18402987	chr7:1209562	NA	1.15	6.02	0.56	5.38e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs9814567	0.929	rs9838834	chr3:134207077	G/A	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.69	-5.47	-0.53	5.15e-7	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs4423214	1.000	rs11233746	chr11:71171440	A/G	cg05163923	chr11:71159392	DHCR7	0.83	8.11	0.68	5.77e-12	Vitamin D levels;
SKCM	cis	rs798554	0.757	rs1182181	chr7:2873247	C/G	cg19346786	chr7:2764209	NA	-0.64	-7.24	-0.63	2.69e-10	Height;
SKCM	cis	rs2836974	0.526	rs418359	chr21:40536734	T/C	cg11644478	chr21:40555479	PSMG1	-0.8	-7.6	-0.65	5.6e-11	Cognitive function;
SKCM	cis	rs9430161	0.579	rs77578010	chr1:11035758	G/A	cg02454025	chr1:11042201	C1orf127	1.13	9.81	0.74	2.9e-15	Ewing sarcoma;
SKCM	cis	rs3087591	0.919	rs2952993	chr17:29539998	G/A	cg24425628	chr17:29625626	OMG;NF1	0.63	4.93	0.49	4.47e-6	Hip circumference;
SKCM	cis	rs595982	0.702	rs638050	chr19:49375676	A/G	cg19746536	chr19:49375674	PPP1R15A	1.27	15.49	0.87	1.65e-25	Red cell distribution width;
SKCM	cis	rs2836974	0.830	rs2735309	chr21:40715313	C/T	cg17971929	chr21:40555470	PSMG1	0.82	7.62	0.65	5.11e-11	Cognitive function;
SKCM	cis	rs9926296	0.533	rs12102290	chr16:89812617	C/T	cg03388025	chr16:89894329	SPIRE2	0.49	4.95	0.49	4.24e-6	Vitiligo;
SKCM	cis	rs6952808	0.594	rs3778969	chr7:2139990	A/G	cg21782813	chr7:2030301	MAD1L1	-0.52	-5.55	-0.53	3.75e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs2836974	0.932	rs2836953	chr21:40617483	G/A	cg17971929	chr21:40555470	PSMG1	0.9	8.81	0.71	2.52e-13	Cognitive function;
SKCM	cis	rs6951245	0.872	rs75493422	chr7:1072890	C/T	cg24642844	chr7:1081250	C7orf50	-0.95	-6.4	-0.59	1.06e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs514406	0.644	rs928451	chr1:53195800	A/G	cg24675658	chr1:53192096	ZYG11B	0.62	4.98	0.49	3.72e-6	Monocyte count;
SKCM	cis	rs1707322	1.000	rs12124847	chr1:46380850	T/A	cg03146154	chr1:46216737	IPP	0.73	4.91	0.49	4.98e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs826838	0.804	rs6580755	chr12:39159190	C/T	cg13010199	chr12:38710504	ALG10B	0.7	5.41	0.52	6.65e-7	Heart rate;
SKCM	cis	rs548181	0.736	rs556884	chr11:125550049	G/A	cg03464685	chr11:125439445	EI24	1.25	8.68	0.7	4.48e-13	Schizophrenia;Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);
SKCM	cis	rs7590368	1.000	rs2884289	chr2:10959724	G/A	cg15705551	chr2:10952987	PDIA6	0.76	4.88	0.48	5.52e-6	Educational attainment (years of education);
SKCM	cis	rs248381	0.684	rs651852	chr5:78409060	C/T	cg17568934	chr5:77892219	LHFPL2	0.54	4.83	0.48	6.79e-6	Toenail selenium levels;
SKCM	cis	rs34779708	0.966	rs4294520	chr10:35422506	C/T	cg03585969	chr10:35415529	CREM	0.76	6.1	0.57	3.82e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs4888262	0.508	rs4888258	chr16:74634198	G/T	cg01733217	chr16:74700730	RFWD3	0.91	7.31	0.64	2.02e-10	Testicular germ cell tumor;
SKCM	cis	rs3135063	0.847	rs1138690	chr4:3291401	G/T	cg21096898	chr4:3318625	RGS12	0.68	6.27	0.58	1.84e-8	Blood protein levels;
SKCM	cis	rs28595532	0.920	rs10025640	chr4:119787451	G/A	cg11846333	chr4:119757529	SEC24D	1.2	6.43	0.59	9.38e-9	Cannabis dependence symptom count;
SKCM	cis	rs919433	0.783	rs805497	chr2:198222548	A/T	cg04278110	chr2:198063759	ANKRD44	0.73	5.0	0.49	3.51e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs10911251	0.528	rs10911266	chr1:183115097	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.76	7.21	0.63	3.18e-10	Colorectal cancer;
SKCM	cis	rs651907	0.557	rs34457525	chr3:101435225	C/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.81	7.06	0.62	6.11e-10	Colorectal cancer;
SKCM	cis	rs4819052	0.851	rs4819038	chr21:46659393	C/T	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.42	0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs6723226	0.739	rs2069213	chr2:32743084	C/T	cg02381751	chr2:32503542	YIPF4	0.7	5.14	0.5	2.01e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1799949	1.000	rs4793192	chr17:41204390	T/C	cg25918947	chr17:41365094	TMEM106A	-0.62	-5.89	-0.55	9.22e-8	Menopause (age at onset);
SKCM	cis	rs1707322	0.686	rs2275085	chr1:46085852	C/T	cg03146154	chr1:46216737	IPP	-0.83	-6.17	-0.57	2.83e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs1799949	1.000	rs11653069	chr17:41283377	C/T	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.11	-0.57	3.67e-8	Menopause (age at onset);
SKCM	cis	rs8180040	0.966	rs4858868	chr3:47455086	G/A	cg16586182	chr3:47516702	SCAP	-0.76	-5.32	-0.52	9.63e-7	Colorectal cancer;
SKCM	cis	rs17376456	0.877	rs10057605	chr5:93443950	T/G	cg25358565	chr5:93447407	FAM172A	1.23	7.97	0.67	1.08e-11	Diabetic retinopathy;
SKCM	cis	rs7772486	0.764	rs2247211	chr6:146216379	G/A	cg05347473	chr6:146136440	FBXO30	0.56	5.18	0.51	1.67e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs826838	0.935	rs7301104	chr12:39182821	C/T	cg13010199	chr12:38710504	ALG10B	0.67	5.06	0.5	2.68e-6	Heart rate;
SKCM	cis	rs4819052	0.851	rs2330011	chr21:46658498	G/A	cg02159808	chr21:46707872	POFUT2;LOC642852	0.68	5.17	0.5	1.78e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs12824058	0.831	rs12300308	chr12:130813825	G/A	cg26677194	chr12:130822605	PIWIL1	0.71	5.91	0.56	8.57e-8	Menopause (age at onset);
SKCM	cis	rs8180040	1.000	rs7613282	chr3:47389409	C/T	cg27129171	chr3:47204927	SETD2	-0.87	-6.62	-0.6	4.15e-9	Colorectal cancer;
SKCM	cis	rs864745	0.782	rs10274928	chr7:28142088	C/T	cg15170557	chr7:28214983	JAZF1	0.67	7.1	0.63	5.14e-10	Crohn's disease;Type 2 diabetes;
SKCM	cis	rs2295499	0.515	rs3733222	chr4:2745734	A/G	cg19433769	chr4:2420260	ZFYVE28	-0.68	-4.77	-0.47	8.53e-6	Cognitive ability;Cognitive ability (multi-trait analysis);Intelligence (multi-trait analysis);
SKCM	cis	rs2153535	0.580	rs7341382	chr6:8470549	A/G	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs9902453	0.967	rs62070344	chr17:28476997	C/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.5	0.53	4.74e-7	Coffee consumption (cups per day);
SKCM	cis	rs7646501	0.765	rs1949121	chr3:24055298	C/T	cg22892432	chr3:24537792	THRB	0.57	4.83	0.48	6.64e-6	Cognitive ability;Intelligence;
SKCM	cis	rs362272	0.545	rs2749785	chr4:3325179	G/C	cg21096898	chr4:3318625	RGS12	1.0	12.15	0.81	1.11e-19	Serum sulfate level;
SKCM	cis	rs1862618	0.853	rs866222	chr5:56184444	T/C	cg12311346	chr5:56204834	C5orf35	-0.76	-5.02	-0.49	3.2e-6	Initial pursuit acceleration;
SKCM	cis	rs823143	0.570	rs823082	chr1:205786935	C/T	cg24739457	chr1:205821442	NA	-0.58	-5.53	-0.53	4.19e-7	Monocyte percentage of white cells;
SKCM	cis	rs11098499	0.863	rs11723090	chr4:120490592	T/C	cg24375607	chr4:120327624	NA	0.69	5.47	0.53	5.35e-7	Corneal astigmatism;
SKCM	cis	rs9640161	0.830	rs6722	chr7:150068933	T/C	cg10018233	chr7:150070692	REPIN1	0.81	9.03	0.71	9.35e-14	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs6088590	0.965	rs6087639	chr20:33443866	G/A	cg24642439	chr20:33292090	TP53INP2	1.0	7.11	0.63	4.79e-10	Coronary artery disease;
SKCM	cis	rs12477438	0.520	rs13009147	chr2:99803998	T/G	cg14399236	chr2:99771627	LIPT1;TSGA10	0.92	7.99	0.67	9.76e-12	Chronic sinus infection;
SKCM	cis	rs478304	0.530	rs11568300	chr11:65425167	C/G	cg27068330	chr11:65405492	SIPA1	-0.87	-7.23	-0.63	2.89e-10	Acne (severe);
SKCM	cis	rs6570726	0.791	rs6913727	chr6:145899826	A/G	cg05347473	chr6:146136440	FBXO30	0.58	5.16	0.5	1.82e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1506636	0.886	rs6945841	chr7:123266094	G/A	cg03229431	chr7:123269106	ASB15	-0.63	-4.88	-0.48	5.47e-6	Plateletcrit;Platelet count;
SKCM	cis	rs9325144	0.555	rs4882359	chr12:38726679	T/C	cg26384229	chr12:38710491	ALG10B	0.78	6.82	0.61	1.76e-9	Morning vs. evening chronotype;
SKCM	cis	rs908922	0.676	rs10888492	chr1:152499908	G/C	cg09873164	chr1:152488093	CRCT1	0.76	5.93	0.56	7.7e-8	Hair morphology;
SKCM	cis	rs7937682	0.921	rs1944119	chr11:111436387	A/G	cg22437258	chr11:111473054	SIK2	-0.74	-5.61	-0.54	3.02e-7	Primary sclerosing cholangitis;
SKCM	cis	rs951366	0.617	rs823075	chr1:205774897	C/T	cg14893161	chr1:205819251	PM20D1	1.07	13.37	0.83	7.13e-22	Menarche (age at onset);
SKCM	cis	rs10256972	0.591	rs11766651	chr7:1161646	A/G	cg09177884	chr7:1199841	ZFAND2A	-0.77	-6.25	-0.58	2.05e-8	Longevity;Endometriosis;
SKCM	cis	rs826838	0.933	rs980573	chr12:39127811	T/C	cg26384229	chr12:38710491	ALG10B	-0.91	-8.28	-0.68	2.74e-12	Heart rate;
SKCM	cis	rs10870270	1.000	rs7199	chr10:133769848	C/G	cg17892150	chr10:133769511	PPP2R2D	-0.66	-4.86	-0.48	5.92e-6	Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals;
SKCM	cis	rs561341	1.000	rs501312	chr17:30329066	A/G	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs10193935	0.901	rs6713242	chr2:42470794	C/T	cg27598129	chr2:42591480	NA	-0.91	-6.37	-0.59	1.2e-8	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs514406	0.793	rs12402415	chr1:53218539	G/T	cg24675658	chr1:53192096	ZYG11B	0.61	4.79	0.48	7.76e-6	Monocyte count;
SKCM	cis	rs6500395	1.000	rs36077931	chr16:48594221	A/G	cg04672837	chr16:48644449	N4BP1	0.69	5.73	0.54	1.8e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs2839186	0.843	rs17182671	chr21:47696238	T/C	cg13012494	chr21:47604986	C21orf56	0.64	5.39	0.52	7.36e-7	Testicular germ cell tumor;
SKCM	cis	rs2072499	0.966	rs2853641	chr1:156181770	A/G	cg25208724	chr1:156163844	SLC25A44	0.98	10.13	0.75	7.23e-16	Testicular germ cell tumor;
SKCM	cis	rs4803468	0.967	rs2304243	chr19:41942708	C/G	cg09537434	chr19:41945824	ATP5SL	1.1	13.21	0.83	1.39e-21	Height;
SKCM	cis	rs854765	0.583	rs8065970	chr17:17858771	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.01	7.49	0.65	9.28e-11	Total body bone mineral density;
SKCM	cis	rs10876993	0.928	rs1678540	chr12:58065002	A/G	cg18357645	chr12:58087776	OS9	0.66	6.05	0.56	4.8e-8	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs523522	1.000	rs523522	chr12:121020250	A/T	cg12219531	chr12:120966889	COQ5	0.9	7.63	0.65	4.83e-11	High light scatter reticulocyte count;
SKCM	cis	rs861020	0.771	rs126280	chr1:210019824	A/G	cg09163369	chr1:210001066	C1orf107	0.71	4.77	0.48	8.3e-6	Orofacial clefts;
SKCM	cis	rs7666738	0.830	rs3911282	chr4:99037602	T/A	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9902453	0.817	rs59420007	chr17:28196114	T/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.83	5.76	0.55	1.61e-7	Coffee consumption (cups per day);
SKCM	cis	rs4746818	1.000	rs10762263	chr10:70970178	A/G	cg11621586	chr10:70884670	VPS26A	1.02	7.55	0.65	7.03e-11	Left atrial antero-posterior diameter;
SKCM	cis	rs4740619	0.692	rs1328288	chr9:15918706	A/T	cg14451791	chr9:16040625	NA	0.44	5.3	0.51	1.06e-6	Body mass index;
SKCM	cis	rs8180040	0.729	rs11720439	chr3:47347003	T/G	cg27129171	chr3:47204927	SETD2	-0.82	-5.65	-0.54	2.53e-7	Colorectal cancer;
SKCM	cis	rs9790314	0.718	rs1599383	chr3:160829820	T/C	cg03342759	chr3:160939853	NMD3	-0.64	-6.59	-0.6	4.63e-9	Morning vs. evening chronotype;
SKCM	cis	rs6570726	0.764	rs376257	chr6:145862949	G/A	cg23711669	chr6:146136114	FBXO30	0.84	8.8	0.71	2.65e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2836974	0.568	rs4816620	chr21:40613786	A/G	cg11890956	chr21:40555474	PSMG1	-0.88	-9.14	-0.72	5.76e-14	Cognitive function;
SKCM	cis	rs6088590	0.561	rs6088527	chr20:33155841	C/T	cg24642439	chr20:33292090	TP53INP2	0.76	5.84	0.55	1.13e-7	Coronary artery disease;
SKCM	cis	rs950776	0.518	rs12907169	chr15:78825498	G/C	cg06917634	chr15:78832804	PSMA4	1.01	10.47	0.76	1.56e-16	Sudden cardiac arrest;
SKCM	cis	rs4481887	1.000	rs4244183	chr1:248471222	G/A	cg00666640	chr1:248458726	OR2T12	0.61	5.6	0.54	3.11e-7	Common traits (Other);
SKCM	cis	rs748404	0.604	rs2278857	chr15:43632549	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	0.82	6.68	0.6	3.24e-9	Lung cancer;
SKCM	cis	rs9300255	0.596	rs1568427	chr12:123738678	A/G	cg00376283	chr12:123451042	ABCB9	0.87	7.25	0.63	2.63e-10	Neutrophil percentage of white cells;
SKCM	cis	rs9815354	0.812	rs59873855	chr3:41929538	T/C	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs2404602	0.716	rs56216512	chr15:76686936	T/C	cg23625390	chr15:77176239	SCAPER	0.59	5.31	0.52	9.87e-7	Blood metabolite levels;
SKCM	cis	rs35306767	0.855	rs11253468	chr10:903261	G/A	cg25614935	chr10:1084866	C10orf110	0.84	5.56	0.53	3.68e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs738321	0.757	rs4821748	chr22:38541936	G/A	cg25457927	chr22:38595422	NA	-0.58	-6.71	-0.61	2.75e-9	Breast cancer;
SKCM	cis	rs7829975	0.688	rs13270194	chr8:8378102	T/C	cg15556689	chr8:8085844	FLJ10661	0.85	7.66	0.66	4.35e-11	Mood instability;
SKCM	cis	rs10791097	0.694	rs2236717	chr11:130739887	G/T	cg12179176	chr11:130786555	SNX19	0.93	8.2	0.68	3.79e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs875971	1.000	rs4718344	chr7:65874381	C/A	cg18876405	chr7:65276391	NA	0.67	6.65	0.6	3.61e-9	Aortic root size;
SKCM	cis	rs7666738	0.830	rs6833822	chr4:98951354	G/A	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6121246	0.909	rs6119651	chr20:30259246	G/T	cg11595048	chr20:30225325	COX4I2	0.67	5.21	0.51	1.5e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs476633	0.691	rs11858115	chr15:41542591	G/A	cg18705301	chr15:41695430	NDUFAF1	-0.65	-4.86	-0.48	6.01e-6	Glomerular filtration rate (creatinine);
SKCM	cis	rs1878931	0.582	rs27231	chr16:3434966	C/T	cg26668626	chr16:3451006	ZNF174;ZNF434	0.82	5.95	0.56	7.24e-8	Body mass index (adult);
SKCM	cis	rs951366	0.789	rs823121	chr1:205724302	A/G	cg11965913	chr1:205819406	PM20D1	-1.0	-10.0	-0.75	1.26e-15	Menarche (age at onset);
SKCM	cis	rs910316	1.000	rs12590452	chr14:75548756	T/C	cg08847533	chr14:75593920	NEK9	0.95	9.18	0.72	4.88e-14	Height;
SKCM	cis	rs992157	0.767	rs2382822	chr2:219173327	T/C	cg00012203	chr2:219082015	ARPC2	-0.73	-5.86	-0.55	1.04e-7	Colorectal cancer;
SKCM	cis	rs7772486	0.521	rs9485017	chr6:146023326	C/T	cg23711669	chr6:146136114	FBXO30	0.74	6.1	0.57	3.77e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs11098499	0.954	rs28685688	chr4:120420334	T/C	cg09307838	chr4:120376055	NA	0.99	8.1	0.68	6.11e-12	Corneal astigmatism;
SKCM	cis	rs933688	1.000	rs6865495	chr5:90746424	G/A	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.92	6.76	0.61	2.21e-9	Smoking behavior;
SKCM	cis	rs3008870	1.000	rs3008874	chr1:67431365	A/T	cg08660285	chr1:67390436	MIER1;WDR78	0.92	6.07	0.57	4.27e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs769267	0.965	rs8101938	chr19:19390497	G/A	cg26732615	chr19:19648335	CILP2;YJEFN3	0.62	5.67	0.54	2.31e-7	Tonsillectomy;
SKCM	trans	rs1814175	0.817	rs11518158	chr11:49985633	G/T	cg03929089	chr4:120376271	NA	-0.9	-8.53	-0.69	8.76e-13	Height;
SKCM	cis	rs10540	0.730	rs61876338	chr11:493730	A/G	cg03576123	chr11:487126	PTDSS2	-1.41	-7.85	-0.66	1.82e-11	Body mass index;
SKCM	cis	rs34779708	0.931	rs72789687	chr10:35372489	G/A	cg03585969	chr10:35415529	CREM	0.78	6.31	0.58	1.58e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs2153535	0.580	rs1119689	chr6:8460754	C/G	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs1850744	0.702	rs55813730	chr4:9595618	G/A	cg15442990	chr4:9534313	NA	-1.3	-4.84	-0.48	6.55e-6	Economic and political preferences;
SKCM	cis	rs12188164	0.965	rs55948934	chr5:423671	C/T	cg26076054	chr5:421317	AHRR	-0.61	-4.8	-0.48	7.47e-6	Cystic fibrosis severity;
SKCM	cis	rs6500395	1.000	rs904818	chr16:48622582	T/C	cg04672837	chr16:48644449	N4BP1	0.7	6.0	0.56	5.93e-8	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs763014	0.931	rs1981483	chr16:630665	G/A	cg09263875	chr16:632152	PIGQ	0.67	5.82	0.55	1.24e-7	Height;
SKCM	trans	rs8073060	0.586	rs6505485	chr17:33996102	C/T	cg19694781	chr19:47549865	TMEM160	-1.06	-8.35	-0.69	2e-12	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs1062177	0.756	rs2964592	chr5:151115688	A/G	cg00977110	chr5:151150581	G3BP1	-0.83	-6.73	-0.61	2.57e-9	Preschool internalizing problems;
SKCM	cis	rs826838	0.935	rs4583043	chr12:38645147	T/G	cg13010199	chr12:38710504	ALG10B	0.71	4.98	0.49	3.66e-6	Heart rate;
SKCM	cis	rs2769264	0.546	rs12047617	chr1:151392597	G/A	cg18801370	chr1:151430492	POGZ	0.87	6.04	0.56	4.89e-8	Blood trace element (Cu levels);
SKCM	cis	rs7937682	0.921	rs4534611	chr11:111440425	C/G	cg09085632	chr11:111637200	PPP2R1B	-0.95	-8.57	-0.7	7.49e-13	Primary sclerosing cholangitis;
SKCM	cis	rs2153535	0.580	rs7742794	chr6:8459723	C/A	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs9916302	0.904	rs13341996	chr17:37536862	C/T	cg07936489	chr17:37558343	FBXL20	0.84	7.23	0.63	2.81e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs4642101	0.640	rs9877049	chr3:12821231	A/G	cg05775895	chr3:12838266	CAND2	0.68	6.16	0.57	2.99e-8	QRS complex (12-leadsum);
SKCM	cis	rs35306767	0.951	rs11253530	chr10:993729	T/C	cg26597838	chr10:835615	NA	0.75	6.3	0.58	1.66e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs1218582	0.772	rs2174507	chr1:154887949	C/T	cg03351412	chr1:154909251	PMVK	0.77	6.52	0.59	6.43e-9	Prostate cancer;
SKCM	cis	rs9803723	0.682	rs4649065	chr1:25431725	C/T	cg20685674	chr1:26233538	STMN1	0.53	4.98	0.49	3.8e-6	Male-pattern baldness;
SKCM	cis	rs7666738	0.535	rs6850010	chr4:98971601	A/T	cg05340658	chr4:99064831	C4orf37	0.64	4.84	0.48	6.35e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2204008	0.683	rs7305703	chr12:38138381	T/C	cg26384229	chr12:38710491	ALG10B	0.81	6.95	0.62	9.67e-10	Bladder cancer;
SKCM	cis	rs523522	0.962	rs4766966	chr12:120942911	G/C	cg27279351	chr12:120934652	DYNLL1	0.91	8.32	0.69	2.26e-12	High light scatter reticulocyte count;
SKCM	cis	rs4774899	1.000	rs12914410	chr15:57429837	T/C	cg01857019	chr15:57210107	LOC145783;TCF12	0.53	4.89	0.48	5.3e-6	Urinary tract infection frequency;
SKCM	cis	rs2832191	0.791	rs2832202	chr21:30501342	G/A	cg08807101	chr21:30365312	RNF160	-0.61	-4.78	-0.48	8.17e-6	Dental caries;
SKCM	cis	rs1799949	1.000	rs2298862	chr17:41176688	T/C	cg05368731	chr17:41323189	NBR1	0.85	7.18	0.63	3.55e-10	Menopause (age at onset);
SKCM	cis	rs2559856	1.000	rs10860771	chr12:102087242	A/G	cg12924262	chr12:102091054	CHPT1	0.71	5.96	0.56	6.99e-8	Blood protein levels;
SKCM	cis	rs362296	0.698	rs3095072	chr4:3263325	G/A	cg11471262	chr4:3318911	RGS12	-0.73	-6.85	-0.61	1.51e-9	Parental longevity (mother's age at death);
SKCM	cis	rs644799	0.965	rs3789960	chr11:95509037	C/G	cg25622487	chr11:95524042	FAM76B;CEP57	0.74	5.91	0.56	8.37e-8	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs2602836	0.600	rs6858148	chr4:100065917	T/C	cg12011299	chr4:100065546	ADH4	-0.48	-4.79	-0.48	7.93e-6	HDL cholesterol;HDL cholesterol levels;
SKCM	cis	rs10823500	0.777	rs10762348	chr10:71952322	C/A	cg04118878	chr10:71993077	PPA1	0.65	4.88	0.48	5.45e-6	Blood protein levels;
SKCM	cis	rs2836974	0.932	rs8128734	chr21:40569511	G/A	cg11644478	chr21:40555479	PSMG1	0.98	9.83	0.74	2.68e-15	Cognitive function;
SKCM	cis	rs7100689	0.784	rs4934139	chr10:82177023	C/A	cg00277334	chr10:82204260	NA	-0.53	-4.96	-0.49	4.1e-6	Post bronchodilator FEV1;
SKCM	cis	rs2760061	0.626	rs2796057	chr1:228124414	G/C	cg18477163	chr1:228402036	OBSCN	-0.42	-4.83	-0.48	6.63e-6	Diastolic blood pressure;
SKCM	cis	rs394563	0.690	rs372205	chr6:149775267	T/C	cg03678062	chr6:149772716	ZC3H12D	-0.5	-5.48	-0.53	5.09e-7	Dupuytren's disease;
SKCM	cis	rs826838	0.967	rs826879	chr12:39088999	A/C	cg13010199	chr12:38710504	ALG10B	-0.82	-6.13	-0.57	3.42e-8	Heart rate;
SKCM	cis	rs1153858	1.000	rs12593370	chr15:45617417	C/T	cg10760299	chr15:45669010	GATM	0.55	5.38	0.52	7.45e-7	Homoarginine levels;
SKCM	cis	rs10752881	0.875	rs10752894	chr1:183050610	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.78	6.87	0.61	1.42e-9	Colorectal cancer;
SKCM	cis	rs9902453	0.904	rs7212292	chr17:28409264	T/C	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.86	-6.4	-0.59	1.04e-8	Coffee consumption (cups per day);
SKCM	cis	rs1882538	0.538	rs9649587	chr7:133104569	A/C	cg10665199	chr7:133106180	EXOC4	0.77	5.14	0.5	2.01e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2072510	0.683	rs2246973	chr12:96427875	A/C	cg18817487	chr12:96390143	HAL	0.4	5.28	0.51	1.14e-6	Metabolite levels (small molecules and protein measures);
SKCM	cis	rs34891900	0.507	rs2535707	chr22:18181869	C/T	cg19898043	chr22:18121309	BCL2L13	-0.73	-5.72	-0.54	1.86e-7	Sum neutrophil eosinophil counts;
SKCM	cis	rs875971	0.508	rs6947808	chr7:66045082	A/G	cg11987759	chr7:65425863	GUSB	0.68	5.97	0.56	6.52e-8	Aortic root size;
SKCM	cis	rs1559088	0.576	rs10407255	chr19:33581150	A/G	cg17764715	chr19:33622953	WDR88	-0.96	-7.72	-0.66	3.22e-11	Bone ultrasound measurement (broadband ultrasound attenuation);
SKCM	cis	rs611744	0.604	rs6469170	chr8:109305277	T/C	cg18478394	chr8:109455254	TTC35	0.64	5.03	0.5	3.03e-6	Dupuytren's disease;
SKCM	cis	rs951366	0.668	rs823154	chr1:205762406	C/T	cg14159672	chr1:205819179	PM20D1	0.98	9.55	0.73	9.4e-15	Menarche (age at onset);
SKCM	cis	rs4727027	0.736	rs12704084	chr7:148915050	C/G	cg23583168	chr7:148888333	NA	-0.66	-5.44	-0.52	5.93e-7	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs561341	0.843	rs879944	chr17:30242803	A/G	cg00745463	chr17:30367425	LRRC37B	-0.99	-6.61	-0.6	4.22e-9	Hip circumference adjusted for BMI;
SKCM	cis	rs9875589	0.509	rs2731305	chr3:14081342	T/C	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.5	5.15	0.5	1.92e-6	Ovarian reserve;
SKCM	cis	rs763014	0.898	rs1981484	chr16:630710	A/G	cg07343612	chr16:622815	PIGQ	-0.7	-6.0	-0.56	5.84e-8	Height;
SKCM	cis	rs9916302	0.707	rs11078903	chr17:37631924	G/A	cg07936489	chr17:37558343	FBXL20	-0.9	-8.1	-0.68	6.05e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs501916	0.833	rs10519143	chr15:48055567	T/G	cg16110827	chr15:48056943	SEMA6D	-0.64	-5.25	-0.51	1.26e-6	Inflammatory bowel disease;Ulcerative colitis;
SKCM	cis	rs7584330	0.740	rs7586312	chr2:238439389	G/A	cg14458575	chr2:238380390	NA	0.83	5.31	0.52	9.87e-7	Prostate cancer;
SKCM	cis	rs2153535	0.580	rs7741456	chr6:8452424	G/A	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs8067545	0.750	rs62067555	chr17:20001502	T/C	cg13482628	chr17:19912719	NA	0.72	6.01	0.56	5.48e-8	Schizophrenia;
SKCM	cis	rs9926296	0.529	rs7195906	chr16:89806347	A/T	cg04287289	chr16:89883240	FANCA	1.01	13.13	0.83	1.87e-21	Vitiligo;
SKCM	cis	rs507080	0.922	rs582630	chr11:118562799	C/A	cg18045108	chr11:118530628	TREH	-0.47	-4.81	-0.48	7.17e-6	Serum metabolite levels;
SKCM	cis	rs12824058	0.831	rs4759657	chr12:130815818	G/A	cg26677194	chr12:130822605	PIWIL1	0.71	5.91	0.56	8.57e-8	Menopause (age at onset);
SKCM	cis	rs7208859	0.623	rs1061343	chr17:29114276	G/A	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs2108225	0.872	rs4618632	chr7:107440952	T/G	cg18560240	chr7:107437656	SLC26A3	-0.63	-5.19	-0.51	1.6e-6	Ulcerative colitis;
SKCM	cis	rs28386778	0.897	rs2665797	chr17:61922485	C/G	cg06873352	chr17:61820015	STRADA	-0.76	-6.49	-0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs9325144	0.600	rs7965877	chr12:38743697	G/T	cg26384229	chr12:38710491	ALG10B	0.78	6.83	0.61	1.68e-9	Morning vs. evening chronotype;
SKCM	cis	rs3820928	0.934	rs16822890	chr2:227761477	G/A	cg11843606	chr2:227700838	RHBDD1	-0.62	-4.99	-0.49	3.52e-6	Pulmonary function;
SKCM	cis	rs2836974	0.899	rs35774464	chr21:40580169	G/A	cg17971929	chr21:40555470	PSMG1	0.9	8.81	0.71	2.52e-13	Cognitive function;
SKCM	cis	rs2599510	0.807	rs176416	chr2:32652223	A/G	cg02381751	chr2:32503542	YIPF4	-0.64	-5.07	-0.5	2.61e-6	Interleukin-18 levels;
SKCM	trans	rs3780486	0.846	rs2209948	chr9:33138247	G/A	cg04842962	chr6:43655489	MRPS18A	1.03	10.87	0.78	2.78e-17	IgG glycosylation;
SKCM	trans	rs3780486	0.846	rs10738905	chr9:33123627	A/G	cg20290983	chr6:43655470	MRPS18A	1.01	12.01	0.81	2.05e-19	IgG glycosylation;
SKCM	cis	rs4925386	1.000	rs1889201	chr20:60923075	C/T	cg24112000	chr20:60950667	NA	0.64	5.9	0.56	8.85e-8	Colorectal cancer;Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs2816062	0.775	rs2816048	chr1:18893763	T/C	cg18795169	chr1:18902165	NA	-0.83	-9.01	-0.71	1.03e-13	Urate levels in lean individuals;
SKCM	cis	rs514406	0.679	rs499239	chr1:53310594	A/G	cg08859206	chr1:53392774	SCP2	-0.66	-5.42	-0.52	6.57e-7	Monocyte count;
SKCM	cis	rs55962025	0.842	rs2269477	chr4:3184464	G/T	cg00764545	chr4:3318001	RGS12	-0.63	-5.32	-0.52	9.69e-7	Parental longevity (mother's age at death);
SKCM	cis	rs10911251	0.546	rs7473	chr1:183114634	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.76	7.28	0.64	2.3e-10	Colorectal cancer;
SKCM	cis	rs72772090	0.908	rs76539796	chr5:96038675	G/A	cg17330273	chr5:96107758	CAST;ERAP1	-0.8	-4.79	-0.48	7.69e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs7809950	1.000	rs2520271	chr7:107194949	C/T	cg23024343	chr7:107201750	COG5	-0.77	-6.92	-0.62	1.11e-9	Coronary artery disease;
SKCM	cis	rs4819052	0.851	rs9977178	chr21:46664531	G/T	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.36	0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs1153858	1.000	rs12595087	chr15:45655232	A/G	cg21132104	chr15:45694354	SPATA5L1	0.93	7.94	0.67	1.22e-11	Homoarginine levels;
SKCM	cis	rs1538970	0.816	rs11211123	chr1:45957609	G/A	cg05343316	chr1:45956843	TESK2	0.94	4.82	0.48	7.07e-6	Platelet count;
SKCM	cis	rs11155671	0.530	rs4869763	chr6:150211684	T/C	cg05036130	chr6:150231994	NA	0.61	6.58	0.6	4.87e-9	Testicular germ cell tumor;
SKCM	cis	rs58688157	0.705	rs7941547	chr11:611503	G/A	cg03576123	chr11:487126	PTDSS2	-0.84	-5.46	-0.53	5.55e-7	Systemic lupus erythematosus;
SKCM	cis	rs7569084	0.640	rs11126039	chr2:65685087	A/G	cg14775296	chr2:66672841	MEIS1	0.51	4.8	0.48	7.49e-6	Sum eosinophil basophil counts;
SKCM	cis	rs3820928	0.904	rs2217359	chr2:227759892	C/T	cg11843606	chr2:227700838	RHBDD1	-0.62	-5.04	-0.5	2.95e-6	Pulmonary function;
SKCM	cis	rs7772486	0.597	rs9285508	chr6:146262697	G/T	cg23711669	chr6:146136114	FBXO30	-0.85	-6.86	-0.61	1.47e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2239547	0.618	rs2071041	chr3:52864693	T/G	cg11645453	chr3:52864694	ITIH4	0.79	7.19	0.63	3.41e-10	Schizophrenia;
SKCM	cis	rs7809950	0.773	rs9791733	chr7:107041730	T/C	cg23024343	chr7:107201750	COG5	-0.88	-8.04	-0.67	7.89e-12	Coronary artery disease;
SKCM	cis	rs10781543	0.839	rs6560632	chr9:139371786	A/C	cg14169450	chr9:139327907	INPP5E	0.52	5.62	0.54	2.81e-7	Monocyte percentage of white cells;
SKCM	cis	rs9583531	0.600	rs7984468	chr13:111362093	C/A	cg24331049	chr13:111365604	ING1	0.88	6.6	0.6	4.45e-9	Coronary artery disease;
SKCM	cis	rs9910055	0.659	rs6503488	chr17:42246158	T/G	cg13607699	chr17:42295918	UBTF	0.71	5.65	0.54	2.53e-7	Total body bone mineral density;
SKCM	cis	rs9611565	0.659	rs12484175	chr22:41953739	A/C	cg03806693	chr22:41940476	POLR3H	-1.09	-7.42	-0.64	1.24e-10	Vitiligo;
SKCM	cis	rs1062177	0.756	rs2964591	chr5:151117397	A/G	cg00977110	chr5:151150581	G3BP1	-0.82	-6.51	-0.59	6.64e-9	Preschool internalizing problems;
SKCM	cis	rs910316	0.763	rs4556	chr14:75476071	G/C	cg08847533	chr14:75593920	NEK9	0.82	7.06	0.62	6.19e-10	Height;
SKCM	cis	rs2243480	1.000	rs4718317	chr7:65648901	A/G	cg18252515	chr7:66147081	NA	1.35	8.09	0.68	6.24e-12	Diabetic kidney disease;
SKCM	cis	rs2013441	1.000	rs2013441	chr17:20023099	G/A	cg13482628	chr17:19912719	NA	0.64	4.83	0.48	6.78e-6	Obesity-related traits;
SKCM	cis	rs9325144	0.647	rs11169258	chr12:39113040	C/T	cg13010199	chr12:38710504	ALG10B	-0.64	-5.18	-0.51	1.66e-6	Morning vs. evening chronotype;
SKCM	cis	rs9951698	0.703	rs12605638	chr18:12993543	A/G	cg12848697	chr18:13133368	NA	0.53	4.9	0.48	5.18e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs6138458	0.887	rs227622	chr20:24910597	T/C	cg26195577	chr20:24973756	C20orf3	1.29	8.69	0.7	4.32e-13	Blood protein levels;
SKCM	cis	rs7945705	0.869	rs11042154	chr11:9029700	A/G	cg21881798	chr11:8931708	C11orf17;ST5	-0.67	-6.64	-0.6	3.74e-9	Hemoglobin concentration;
SKCM	cis	rs12541335	0.639	rs7834182	chr8:22163112	G/A	cg26039829	chr8:22132926	PIWIL2	0.64	5.59	0.53	3.28e-7	Hypertriglyceridemia;
SKCM	cis	rs11155671	0.530	rs9383940	chr6:150226059	T/G	cg05036130	chr6:150231994	NA	0.62	6.05	0.56	4.79e-8	Testicular germ cell tumor;
SKCM	cis	rs12824058	0.831	rs12320318	chr12:130812335	T/C	cg26677194	chr12:130822605	PIWIL1	0.71	5.83	0.55	1.17e-7	Menopause (age at onset);
SKCM	cis	rs875971	0.862	rs1643375	chr7:65872677	T/C	cg18876405	chr7:65276391	NA	0.63	6.25	0.58	2.06e-8	Aortic root size;
SKCM	cis	rs10779751	0.770	rs6674994	chr1:11239515	T/C	cg08854313	chr1:11322531	MTOR	0.92	7.13	0.63	4.38e-10	Body mass index;
SKCM	cis	rs2019137	0.560	rs6707386	chr2:113981022	G/A	cg11763394	chr2:113992921	PAX8;LOC440839;LOC654433	0.63	5.03	0.49	3.11e-6	Lymphocyte counts;
SKCM	cis	rs6424115	0.965	rs2502986	chr1:24135292	G/T	cg15997130	chr1:24165203	NA	0.63	5.51	0.53	4.53e-7	Immature fraction of reticulocytes;
SKCM	cis	rs8180040	0.966	rs4858868	chr3:47455086	G/A	cg27129171	chr3:47204927	SETD2	0.79	5.79	0.55	1.43e-7	Colorectal cancer;
SKCM	cis	rs6088590	0.523	rs6088536	chr20:33189106	T/C	cg24642439	chr20:33292090	TP53INP2	0.76	5.84	0.55	1.13e-7	Coronary artery disease;
SKCM	cis	rs11098499	0.954	rs6848389	chr4:120402622	A/G	cg24375607	chr4:120327624	NA	0.67	5.18	0.51	1.67e-6	Corneal astigmatism;
SKCM	cis	rs2153535	0.580	rs6921964	chr6:8446395	A/G	cg07606381	chr6:8435919	SLC35B3	0.94	6.9	0.62	1.24e-9	Motion sickness;
SKCM	cis	rs2070488	1.000	rs17733640	chr3:38446742	G/A	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.97	9.16	0.72	5.28e-14	Electrocardiographic conduction measures;
SKCM	cis	rs873946	0.648	rs12783354	chr10:134557235	T/A	cg26818010	chr10:134567672	INPP5A	-0.8	-6.13	-0.57	3.38e-8	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs2070488	1.000	rs7373805	chr3:38455439	C/T	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.97	9.16	0.72	5.28e-14	Electrocardiographic conduction measures;
SKCM	cis	rs12134245	0.776	rs13447526	chr1:91983174	A/G	cg02896835	chr1:92012615	NA	0.61	5.97	0.56	6.75e-8	Breast cancer;
SKCM	cis	rs7959452	0.558	rs1478464	chr12:69779789	G/C	cg20891283	chr12:69753455	YEATS4	0.92	9.53	0.73	1.03e-14	Blood protein levels;
SKCM	cis	rs854765	0.647	rs2056842	chr17:18009028	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.83	6.5	0.59	6.85e-9	Total body bone mineral density;
SKCM	cis	rs143536437	1	rs143536437	chr15:30898332	C/T	cg14298792	chr15:30685198	CHRFAM7A	-0.93	-7.57	-0.65	6.33e-11	Epilepsy (remission after treatment);
SKCM	trans	rs8073060	0.586	rs188959	chr17:34021307	C/A	cg19694781	chr19:47549865	TMEM160	-1.04	-8.53	-0.69	8.9e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs12540874	0.698	rs3807566	chr7:50564204	G/T	cg18232548	chr7:50535776	DDC	-0.88	-6.09	-0.57	4.06e-8	Systemic sclerosis;
SKCM	cis	rs13223928	0.592	rs4722439	chr7:3155858	C/T	cg19214707	chr7:3157722	NA	0.51	4.78	0.48	7.99e-6	Eosinophil percentage of white cells;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil counts;
SKCM	cis	rs17270561	0.525	rs12201678	chr6:25978993	C/T	cg16482183	chr6:26056742	HIST1H1C	0.98	7.13	0.63	4.45e-10	Iron status biomarkers;
SKCM	cis	rs9815354	0.812	rs76966288	chr3:41825055	G/A	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs4924590	0.513	rs4244586	chr15:42238759	T/G	cg17847044	chr15:42102381	MAPKBP1	0.45	5.22	0.51	1.42e-6	Lymphocyte percentage of white cells;Sum basophil neutrophil counts;Granulocyte count;
SKCM	cis	rs644799	0.965	rs607039	chr11:95547086	G/A	cg03916912	chr11:95522834	CEP57;FAM76B	0.92	8.04	0.67	8e-12	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs35264875	0.950	rs7931790	chr11:68824910	G/A	cg02660097	chr11:68866761	NA	0.53	4.9	0.48	5.14e-6	Blond vs. brown hair color;
SKCM	cis	rs7843479	0.544	rs11135735	chr8:21791557	C/T	cg17168535	chr8:21777572	XPO7	0.78	7.57	0.65	6.32e-11	Mean corpuscular volume;
SKCM	cis	rs2032447	0.677	rs199737	chr6:25933538	A/T	cg12310025	chr6:25882481	NA	-0.61	-5.13	-0.5	2.1e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs12824058	0.831	rs55726136	chr12:130810312	G/A	cg24838063	chr12:130822603	PIWIL1	0.78	6.91	0.62	1.19e-9	Menopause (age at onset);
SKCM	cis	rs1153858	0.943	rs11070454	chr15:45680252	C/T	cg10760299	chr15:45669010	GATM	0.62	6.35	0.58	1.3e-8	Homoarginine levels;
SKCM	cis	rs2011503	0.882	rs1064395	chr19:19361735	C/T	cg11584989	chr19:19387371	SF4	0.77	5.07	0.5	2.6e-6	Bipolar disorder;
SKCM	cis	rs7208859	0.673	rs8077116	chr17:29140162	A/G	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs2777491	0.872	rs7176588	chr15:41588872	C/T	cg18705301	chr15:41695430	NDUFAF1	-0.94	-8.67	-0.7	4.68e-13	Ulcerative colitis;
SKCM	cis	rs2739330	0.828	rs2330635	chr22:24251344	T/C	cg25703541	chr22:24373054	LOC391322	-0.76	-6.09	-0.57	4.05e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs34779708	0.931	rs4934702	chr10:35323074	T/C	cg03585969	chr10:35415529	CREM	0.74	6.1	0.57	3.77e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs1801251	1.000	rs7606090	chr2:233606740	T/C	cg25237894	chr2:233734115	C2orf82	0.56	5.33	0.52	9.23e-7	Coronary artery disease;
SKCM	cis	rs4919087	0.892	rs2065861	chr10:99004608	C/T	cg25902810	chr10:99078978	FRAT1	0.63	5.12	0.5	2.13e-6	Monocyte count;
SKCM	trans	rs1814175	0.904	rs1846289	chr11:49620253	G/A	cg15704280	chr7:45808275	SEPT13	-1.0	-9.43	-0.73	1.61e-14	Height;
SKCM	cis	rs17376456	1.000	rs12188453	chr5:93560807	G/T	cg25358565	chr5:93447407	FAM172A	-1.3	-8.21	-0.68	3.63e-12	Diabetic retinopathy;
SKCM	cis	rs28595532	0.920	rs116607127	chr4:119731072	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.43	0.59	9.38e-9	Cannabis dependence symptom count;
SKCM	cis	rs6750795	0.569	rs1667308	chr2:232406344	T/C	cg19187155	chr2:232395269	NMUR1	0.87	7.61	0.65	5.4e-11	Height;
SKCM	cis	rs875971	0.617	rs810400	chr7:66022889	G/C	cg18876405	chr7:65276391	NA	-0.8	-7.11	-0.63	4.86e-10	Aortic root size;
SKCM	cis	rs9858542	0.953	rs35261698	chr3:49537839	C/G	cg03060546	chr3:49711283	APEH	-0.75	-5.53	-0.53	4.17e-7	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs6834538	0.597	rs4833414	chr4:113469913	T/C	cg05166686	chr4:113558556	LARP7;C4orf21	0.63	5.21	0.51	1.48e-6	Free thyroxine concentration;
SKCM	trans	rs208520	0.690	rs1776365	chr6:66834474	G/T	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-1.09	-8.61	-0.7	6.3e-13	Exhaled nitric oxide output;
SKCM	cis	rs992157	0.764	rs62183964	chr2:219186592	G/A	cg20019365	chr2:219134978	PNKD;AAMP	0.74	5.94	0.56	7.66e-8	Colorectal cancer;
SKCM	cis	rs9880211	0.563	rs6792630	chr3:135824901	C/A	cg21827317	chr3:136751795	NA	-0.68	-5.08	-0.5	2.56e-6	Body mass index;Height;
SKCM	cis	rs1403694	0.695	rs3774292	chr3:186433574	A/T	cg09332604	chr3:186435400	KNG1	-0.5	-5.07	-0.5	2.57e-6	Blood protein levels;
SKCM	cis	rs28595532	0.920	rs115878132	chr4:119756239	T/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs867186	1.000	rs75888794	chr20:33702998	G/C	cg04194272	chr20:33683537	NA	-1.14	-6.37	-0.58	1.22e-8	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs7666738	0.712	rs34043080	chr4:99008748	G/C	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs854765	0.583	rs2350977	chr17:17802779	A/G	cg04398451	chr17:18023971	MYO15A	-0.87	-6.01	-0.56	5.56e-8	Total body bone mineral density;
SKCM	cis	rs4782151	0.608	rs4780910	chr16:9364583	A/G	cg05568466	chr16:8431529	NA	-0.39	-4.96	-0.49	4.05e-6	Cervical cancer;
SKCM	cis	rs2929278	0.617	rs2955969	chr15:44114527	G/A	cg02155558	chr15:43621948	ADAL;LCMT2	-0.75	-5.21	-0.51	1.52e-6	Schizophrenia;
SKCM	cis	rs17685	0.712	rs28506984	chr7:75763484	A/G	cg16684958	chr7:75615977	POR	0.55	5.27	0.51	1.19e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs12824058	0.831	rs11608407	chr12:130805869	G/A	cg26677194	chr12:130822605	PIWIL1	0.7	5.64	0.54	2.66e-7	Menopause (age at onset);
SKCM	cis	rs1005277	0.565	rs2474565	chr10:38380828	A/G	cg00409905	chr10:38381863	ZNF37A	-0.64	-5.96	-0.56	6.77e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs4481887	0.893	rs6587450	chr1:248480496	T/A	cg00666640	chr1:248458726	OR2T12	0.66	6.0	0.56	5.9e-8	Common traits (Other);
SKCM	cis	rs6951245	1.000	rs1881123	chr7:1084706	C/T	cg18402987	chr7:1209562	NA	1.14	6.01	0.56	5.68e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs2180341	0.782	rs6924274	chr6:127721556	T/A	cg27446573	chr6:127587934	RNF146	0.68	5.19	0.51	1.63e-6	Breast cancer;
SKCM	cis	rs80130819	0.515	rs7315258	chr12:48572670	T/C	cg05342945	chr12:48394962	COL2A1	-0.79	-4.77	-0.48	8.38e-6	Prostate cancer;
SKCM	cis	rs6982751	0.673	rs55905112	chr8:10813014	T/C	cg01383082	chr8:11323474	FAM167A	0.91	5.11	0.5	2.21e-6	Asthma and hay fever;
SKCM	cis	rs8077889	1.000	rs2342310	chr17:41866199	T/C	cg26893861	chr17:41843967	DUSP3	1.24	7.74	0.66	3.04e-11	Triglycerides;
SKCM	cis	rs1862618	0.754	rs252899	chr5:56188569	G/C	cg12311346	chr5:56204834	C5orf35	-0.76	-5.02	-0.49	3.2e-6	Initial pursuit acceleration;
SKCM	cis	rs6952808	0.792	rs13224989	chr7:1953766	C/G	cg04267008	chr7:1944627	MAD1L1	-0.63	-5.01	-0.49	3.34e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs7635838	0.722	rs6773963	chr3:11511975	G/A	cg00170343	chr3:11313890	ATG7	0.69	5.16	0.5	1.8e-6	HDL cholesterol;
SKCM	cis	rs244731	0.959	rs3105419	chr5:176551396	G/C	cg16006841	chr5:176797999	RGS14	0.8	5.75	0.55	1.68e-7	Urate levels in lean individuals;
SKCM	cis	rs704795	0.836	rs1083865	chr2:27620827	A/G	cg05696406	chr2:27599888	SNX17	0.47	4.92	0.49	4.75e-6	Menopause (age at onset);
SKCM	cis	rs8016982	0.617	rs2241621	chr14:81737076	G/T	cg01989461	chr14:81687754	GTF2A1	-0.62	-4.83	-0.48	6.79e-6	Schizophrenia;
SKCM	cis	rs4481887	0.741	rs4360554	chr1:248553206	C/T	cg22724847	chr1:248512586	OR14C36	0.58	4.88	0.48	5.48e-6	Common traits (Other);
SKCM	cis	rs3008870	0.917	rs12044492	chr1:67461667	T/C	cg08660285	chr1:67390436	MIER1;WDR78	-0.92	-6.07	-0.57	4.27e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs10752881	1.000	rs10752886	chr1:182987248	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.73	6.47	0.59	7.97e-9	Colorectal cancer;
SKCM	trans	rs8073060	0.586	rs225264	chr17:33961335	A/G	cg19694781	chr19:47549865	TMEM160	-1.08	-8.36	-0.69	1.88e-12	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs4820539	0.611	rs28451783	chr22:23488569	G/T	cg14186256	chr22:23484241	RTDR1	0.98	9.05	0.72	8.71e-14	Bone mineral density;
SKCM	cis	rs709400	1.000	rs861539	chr14:104165753	G/A	cg26031613	chr14:104095156	KLC1	1.05	12.89	0.82	5.14e-21	Body mass index;
SKCM	cis	rs8063761	0.720	rs9939542	chr16:90053048	A/C	cg08547343	chr16:90038815	CENPBD1;AFG3L1	-1.14	-10.99	-0.78	1.62e-17	Squamous cell carcinoma;
SKCM	cis	rs2153535	0.504	rs4493781	chr6:8473941	G/C	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs7809950	0.678	rs2237660	chr7:106862963	T/A	cg23024343	chr7:107201750	COG5	-0.76	-6.46	-0.59	8.25e-9	Coronary artery disease;
SKCM	cis	rs1005277	0.579	rs2505257	chr10:38372664	A/G	cg00409905	chr10:38381863	ZNF37A	-0.64	-5.96	-0.56	6.77e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs11760633	0.502	rs1106396	chr7:1821635	T/C	cg23422044	chr7:1970798	MAD1L1	-0.69	-4.8	-0.48	7.59e-6	Coronary artery disease;
SKCM	cis	rs2439831	0.867	rs6493082	chr15:43634808	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.39	9.42	0.73	1.62e-14	Lung cancer in ever smokers;
SKCM	cis	rs9914544	0.708	rs113103355	chr17:18663414	A/G	cg26306683	chr17:18585705	ZNF286B	0.87	6.5	0.59	6.99e-9	Educational attainment (years of education);
SKCM	cis	rs77106637	0.858	rs7109575	chr11:72463435	G/A	cg03713592	chr11:72463424	ARAP1	1.09	5.65	0.54	2.51e-7	Type 2 diabetes;
SKCM	cis	rs7193541	0.684	rs4888265	chr16:74683737	T/C	cg01733217	chr16:74700730	RFWD3	0.98	10.79	0.77	3.92e-17	Multiple myeloma;
SKCM	cis	rs55962025	0.842	rs363088	chr4:3210330	A/T	cg21096898	chr4:3318625	RGS12	-0.66	-5.04	-0.5	2.9e-6	Parental longevity (mother's age at death);
SKCM	cis	rs6879260	1.000	rs729568	chr5:179732350	C/T	cg23221052	chr5:179740743	GFPT2	0.68	5.81	0.55	1.29e-7	Height;
SKCM	cis	rs7438704	0.552	rs309878	chr4:48322573	G/T	cg15299388	chr4:48491941	ZAR1	0.45	5.21	0.51	1.47e-6	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs561341	0.883	rs4450460	chr17:30201309	C/T	cg00745463	chr17:30367425	LRRC37B	0.99	6.38	0.59	1.18e-8	Hip circumference adjusted for BMI;
SKCM	cis	rs9815354	0.767	rs6805140	chr3:41995791	A/G	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs56235845	0.796	rs13153019	chr5:176782218	T/C	cg16006841	chr5:176797999	RGS14	0.88	7.41	0.64	1.3100000000000001e-10	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs7296418	0.961	rs1727307	chr12:123575742	A/G	cg06742321	chr12:123595122	PITPNM2	0.65	5.45	0.52	5.77e-7	Platelet count;
SKCM	cis	rs6750795	0.502	rs11685196	chr2:232381298	A/G	cg19187155	chr2:232395269	NMUR1	0.68	4.94	0.49	4.29e-6	Height;
SKCM	cis	rs1971762	0.563	rs7975862	chr12:54078427	A/C	cg16917193	chr12:54089295	NA	-0.59	-4.86	-0.48	5.87e-6	Height;
SKCM	cis	rs6495122	0.618	rs4886413	chr15:75262310	G/C	cg09165964	chr15:75287851	SCAMP5	0.68	5.38	0.52	7.65e-7	Caffeine consumption;Diastolic blood pressure;Coffee consumption;
SKCM	cis	rs244731	0.920	rs72813185	chr5:176739110	C/A	cg06060754	chr5:176797920	RGS14	0.89	7.12	0.63	4.65e-10	Urate levels in lean individuals;
SKCM	cis	rs4819052	0.959	rs9976074	chr21:46655638	G/T	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	6.34	0.58	1.36e-8	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs1153858	1.000	rs12437887	chr15:45669094	G/A	cg10760299	chr15:45669010	GATM	0.62	6.35	0.58	1.3e-8	Homoarginine levels;
SKCM	cis	rs2463822	0.858	rs2463836	chr11:62126494	A/G	cg06239285	chr11:62104954	ASRGL1	1.26	5.85	0.55	1.08e-7	Chronic obstructive pulmonary disease-related biomarkers;
SKCM	cis	rs9814567	1.000	rs7611611	chr3:134307877	A/G	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs2033711	0.783	rs11671113	chr19:58958087	C/T	cg03735888	chr19:58951602	ZNF132	0.72	6.51	0.59	6.62e-9	Uric acid clearance;
SKCM	cis	rs72615157	0.613	rs56089143	chr7:99819844	G/A	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.04	6.43	0.59	9.47e-9	Lung function (FEV1/FVC);
SKCM	cis	rs8180040	0.966	rs34634681	chr3:47579102	G/A	cg27129171	chr3:47204927	SETD2	-0.81	-5.66	-0.54	2.44e-7	Colorectal cancer;
SKCM	cis	rs4072980	0.524	rs16824514	chr1:38395947	A/T	cg12658694	chr1:38397304	INPP5B	0.64	4.97	0.49	3.9e-6	Coronary artery disease;
SKCM	cis	rs7143963	1.000	rs76327888	chr14:103380403	G/T	cg23020514	chr14:103360112	TRAF3	0.76	6.31	0.58	1.55e-8	Body mass index;
SKCM	cis	rs7659604	0.967	rs28529384	chr4:122664215	T/C	cg06713675	chr4:122721982	EXOSC9	-0.65	-5.83	-0.55	1.21e-7	Type 2 diabetes;
SKCM	cis	rs3796619	1.000	rs12647929	chr4:1092019	G/T	cg27284194	chr4:1044797	NA	0.67	4.8	0.48	7.53e-6	Recombination rate (males);
SKCM	cis	rs864745	1.000	rs849142	chr7:28185891	T/C	cg15170557	chr7:28214983	JAZF1	-0.7	-7.26	-0.64	2.48e-10	Crohn's disease;Type 2 diabetes;
SKCM	cis	rs11892454	0.515	rs4063544	chr2:26042515	A/C	cg17263061	chr2:26915892	KCNK3	0.69	4.98	0.49	3.73e-6	Heschl's gyrus morphology;
SKCM	cis	rs2832191	0.671	rs2832213	chr21:30512914	A/G	cg24692254	chr21:30365293	RNF160	-0.76	-6.41	-0.59	1.03e-8	Dental caries;
SKCM	cis	rs7666738	0.830	rs7679961	chr4:99000202	C/T	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7666738	0.830	rs10009943	chr4:99021475	G/A	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7811142	1.000	rs11763511	chr7:100081944	G/A	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.24	7.92	0.67	1.36e-11	Platelet count;
SKCM	cis	rs2013441	1.000	rs2243732	chr17:20088589	C/G	cg13482628	chr17:19912719	NA	-0.65	-5.21	-0.51	1.48e-6	Obesity-related traits;
SKCM	cis	rs919433	0.889	rs12472355	chr2:198205840	C/A	cg04278110	chr2:198063759	ANKRD44	-0.72	-5.02	-0.49	3.21e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs8180040	0.966	rs2291298	chr3:47555142	C/A	cg16586182	chr3:47516702	SCAP	-0.73	-4.95	-0.49	4.12e-6	Colorectal cancer;
SKCM	cis	rs748404	0.587	rs690276	chr15:43704558	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	0.8	5.96	0.56	7.02e-8	Lung cancer;
SKCM	cis	rs3793683	0.520	rs12769959	chr10:134579026	A/C	cg18305652	chr10:134549665	INPP5A	0.6	6.15	0.57	3.03e-8	Migraine;
SKCM	cis	rs2204008	0.744	rs11181635	chr12:38378420	C/T	cg26384229	chr12:38710491	ALG10B	0.87	6.82	0.61	1.73e-9	Bladder cancer;
SKCM	cis	rs7666738	0.830	rs7672901	chr4:98938781	C/T	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1865760	0.964	rs1324084	chr6:25915134	C/T	cg08401836	chr6:26032486	HIST1H3B	-0.6	-4.78	-0.48	8.09e-6	Height;
SKCM	cis	rs34172651	0.517	rs200528	chr16:24759131	A/G	cg04756594	chr16:24857601	SLC5A11	-0.72	-5.19	-0.51	1.65e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs4930103	0.534	rs2063550	chr11:1979223	G/C	cg23202291	chr11:1979235	NA	0.73	7.55	0.65	6.96e-11	DNA methylation (parent-of-origin);DNA methylation (variation);
SKCM	cis	rs10504229	0.683	rs66893068	chr8:58144238	A/G	cg02725872	chr8:58115012	NA	-0.54	-5.26	-0.51	1.23e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs12474201	0.775	rs7584870	chr2:46973400	A/T	cg06386533	chr2:46925753	SOCS5	0.93	8.67	0.7	4.78e-13	Height;
SKCM	cis	rs9674544	0.646	rs6504594	chr17:47142697	C/A	cg10950924	chr17:47092072	IGF2BP1	-0.57	-4.78	-0.48	8.23e-6	Primary tooth development (time to first tooth eruption);Primary tooth development (number of teeth);
SKCM	cis	rs11209185	0.602	rs6662249	chr1:68447214	C/A	cg17031739	chr1:67600172	NA	-0.5	-4.85	-0.48	6.17e-6	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs1801251	0.778	rs709934	chr2:233733352	A/G	cg08000102	chr2:233561755	GIGYF2	-0.62	-4.78	-0.48	7.99e-6	Coronary artery disease;
SKCM	cis	rs6570726	0.791	rs11759979	chr6:145918881	C/T	cg23711669	chr6:146136114	FBXO30	0.88	8.37	0.69	1.84e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4819852	1.000	rs1034565	chr22:19984211	A/G	cg07821417	chr22:19972146	ARVCF	-0.49	-6.44	-0.59	8.83e-9	Pulse pressure;
SKCM	cis	rs6754311	0.517	rs1469996	chr2:136542560	A/G	cg07169764	chr2:136633963	MCM6	0.89	7.01	0.62	7.67e-10	Mosquito bite size;
SKCM	cis	rs1878931	0.582	rs27232	chr16:3436782	G/A	cg26668626	chr16:3451006	ZNF174;ZNF434	-0.78	-5.55	-0.53	3.73e-7	Body mass index (adult);
SKCM	cis	rs12142240	0.698	rs72677593	chr1:46824363	T/C	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs12464559	0.649	rs6743968	chr2:152715055	A/C	cg01189475	chr2:152685088	ARL5A	-1.39	-5.58	-0.53	3.4e-7	Response to cognitive-behavioural therapy in anxiety disorder;
SKCM	cis	rs4665809	0.549	rs13001722	chr2:26521530	T/C	cg26119090	chr2:26468346	HADHA;HADHB	0.98	7.24	0.63	2.71e-10	Gut microbiome composition (summer);
SKCM	cis	rs10876993	0.715	rs2169987	chr12:58012111	G/A	cg04478727	chr12:58166393	METTL1;FAM119B	0.65	4.79	0.48	7.93e-6	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs9399137	0.561	rs11753985	chr6:135280438	C/T	cg24558204	chr6:135376177	HBS1L	0.69	6.37	0.59	1.21e-8	Glycated hemoglobin levels;Mean corpuscular volume;Hematology traits;HbA2 levels;Mean corpuscular hemoglobin;Hemoglobin levels;F-cell distribution;Platelet count;
SKCM	cis	rs7613875	0.600	rs2624848	chr3:50165101	T/C	cg24110177	chr3:50126178	RBM5	0.72	5.75	0.55	1.67e-7	Body mass index;
SKCM	cis	rs28595532	1.000	rs116030177	chr4:119650768	T/C	cg14228332	chr4:119757509	SEC24D	0.97	4.92	0.49	4.71e-6	Cannabis dependence symptom count;
SKCM	cis	rs477692	0.905	rs509041	chr10:131424948	A/G	cg11019008	chr10:131425282	MGMT	0.49	4.81	0.48	7.09e-6	Response to temozolomide;
SKCM	cis	rs2842992	0.830	rs2758313	chr6:160154099	C/G	cg19482086	chr6:160211437	TCP1;MRPL18	0.82	6.07	0.57	4.42e-8	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs2013441	1.000	rs4588033	chr17:20029901	C/G	cg13482628	chr17:19912719	NA	-0.7	-5.44	-0.52	5.87e-7	Obesity-related traits;
SKCM	cis	rs1568889	0.730	rs6484350	chr11:28113658	G/A	cg06544937	chr11:28130018	METT5D1;KIF18A	-0.89	-8.44	-0.69	1.31e-12	Bipolar disorder;
SKCM	cis	rs6089829	0.888	rs4809465	chr20:61671156	G/C	cg08564027	chr20:61660810	NA	0.64	5.85	0.55	1.11e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs17376456	0.877	rs13169675	chr5:93331284	A/G	cg21475434	chr5:93447410	FAM172A	0.95	5.35	0.52	8.56e-7	Diabetic retinopathy;
SKCM	cis	rs116095464	0.558	rs9312978	chr5:221930	C/G	cg22496380	chr5:211416	CCDC127	-1.0	-5.11	-0.5	2.25e-6	Breast cancer;
SKCM	cis	rs4148883	0.675	rs10000357	chr4:100099942	G/C	cg12011299	chr4:100065546	ADH4	0.48	4.78	0.48	8.14e-6	Alcohol dependence;
SKCM	cis	rs1552244	0.515	rs111560858	chr3:10166845	G/A	cg00149659	chr3:10157352	C3orf10	1.13	5.45	0.53	5.74e-7	Alzheimer's disease;
SKCM	cis	rs9674544	0.646	rs8069452	chr17:47140999	A/G	cg10950924	chr17:47092072	IGF2BP1	0.58	4.9	0.49	5.04e-6	Primary tooth development (time to first tooth eruption);Primary tooth development (number of teeth);
SKCM	cis	rs9660180	0.967	rs12044597	chr1:1708801	A/G	cg13866156	chr1:1669148	SLC35E2	-0.72	-6.07	-0.57	4.39e-8	Body mass index;
SKCM	cis	rs897984	0.721	rs2305884	chr16:30970741	G/A	cg00531865	chr16:30841666	NA	0.59	4.98	0.49	3.7e-6	Dementia with Lewy bodies;
SKCM	cis	rs6120849	0.754	rs3818253	chr20:33596876	C/T	cg24642439	chr20:33292090	TP53INP2	0.94	4.86	0.48	5.91e-6	Protein C levels;
SKCM	cis	rs3785574	0.962	rs2665842	chr17:61878535	G/A	cg06601766	chr17:61851465	DDX42;CCDC47	0.68	5.02	0.49	3.15e-6	Height;
SKCM	cis	rs7937682	0.889	rs541198	chr11:111475340	A/G	cg19812747	chr11:111475976	SIK2	-0.56	-4.97	-0.49	3.89e-6	Primary sclerosing cholangitis;
SKCM	cis	rs9287719	0.967	rs6432113	chr2:10744889	C/T	cg01299579	chr2:10830716	NOL10	0.51	4.82	0.48	6.89e-6	Prostate cancer;
SKCM	cis	rs10771431	0.817	rs10843149	chr12:9362067	G/A	cg08997352	chr12:9597637	DDX12	-0.68	-4.86	-0.48	6.01e-6	Breast size;
SKCM	cis	rs1552244	1.000	rs17032295	chr3:10086680	C/T	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs7940866	0.803	rs1865296	chr11:130882944	C/T	cg12179176	chr11:130786555	SNX19	-0.76	-5.94	-0.56	7.47e-8	Schizophrenia;
SKCM	cis	rs651907	0.535	rs1460097	chr3:101497569	C/T	cg12386194	chr3:101231763	SENP7	0.64	5.3	0.51	1.05e-6	Colorectal cancer;
SKCM	cis	rs1029738	0.615	rs717624	chr7:22894487	T/C	cg00309339	chr7:22893653	NA	-0.67	-6.3	-0.58	1.67e-8	Fibrinogen levels;
SKCM	cis	rs2777491	0.915	rs28526381	chr15:41621842	A/C	cg18705301	chr15:41695430	NDUFAF1	-0.96	-9.11	-0.72	6.65e-14	Ulcerative colitis;
SKCM	cis	rs1799949	1.000	rs12952790	chr17:41299607	A/G	cg23758822	chr17:41437982	NA	0.92	7.8	0.66	2.3e-11	Menopause (age at onset);
SKCM	cis	rs3892630	0.824	rs12976069	chr19:33280084	G/A	cg22980127	chr19:33182716	NUDT19	1.28	7.08	0.63	5.56e-10	Red blood cell traits;
SKCM	trans	rs1814175	0.645	rs28436748	chr11:50046422	G/A	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs2842992	0.789	rs4235925	chr6:160202860	C/T	cg19482086	chr6:160211437	TCP1;MRPL18	0.86	6.71	0.61	2.75e-9	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs4561483	0.832	rs171656	chr16:11953167	C/T	cg08843971	chr16:11963173	GSPT1	-0.7	-5.39	-0.52	7.27e-7	Testicular germ cell tumor;
SKCM	cis	rs2404602	0.583	rs4381566	chr15:76589262	A/G	cg23625390	chr15:77176239	SCAPER	0.69	6.31	0.58	1.57e-8	Blood metabolite levels;
SKCM	cis	rs12477438	0.520	rs6542869	chr2:99783403	G/A	cg14399236	chr2:99771627	LIPT1;TSGA10	0.92	8.02	0.67	8.58e-12	Chronic sinus infection;
SKCM	cis	rs72634258	0.517	rs35982383	chr1:7949148	A/G	cg00042356	chr1:8021962	PARK7	0.83	5.14	0.5	1.96e-6	Inflammatory bowel disease;
SKCM	cis	rs910316	0.967	rs175502	chr14:75533679	A/G	cg11812906	chr14:75593930	NEK9	-0.72	-5.45	-0.53	5.7e-7	Height;
SKCM	cis	rs9910055	0.502	rs1684662	chr17:42180822	T/A	cg08499158	chr17:42289980	UBTF	0.71	5.59	0.53	3.27e-7	Total body bone mineral density;
SKCM	cis	rs7772486	0.875	rs6909827	chr6:146365738	A/G	cg23711669	chr6:146136114	FBXO30	0.78	7.48	0.65	9.35e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4819052	0.851	rs28676615	chr21:46676576	G/C	cg20896738	chr21:46707857	POFUT2;LOC642852	0.64	4.82	0.48	6.85e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs9910055	0.762	rs1135215	chr17:42253519	T/C	cg19774624	chr17:42201019	HDAC5	-0.89	-7.83	-0.66	1.97e-11	Total body bone mineral density;
SKCM	cis	rs1256061	0.603	rs1152579	chr14:64695087	A/G	cg21174375	chr14:64681225	SYNE2	0.47	4.83	0.48	6.66e-6	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs4332037	1.000	rs4332037	chr7:1950809	C/T	cg02825527	chr7:2087843	MAD1L1	-0.71	-4.95	-0.49	4.19e-6	Bipolar disorder;
SKCM	cis	rs28386778	1.000	rs2665849	chr17:61953670	T/C	cg01411255	chr17:61851458	DDX42;CCDC47	0.76	4.89	0.48	5.22e-6	Prudent dietary pattern;
SKCM	cis	rs7811142	1.000	rs11771241	chr7:99994785	G/A	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.11	6.45	0.59	8.66e-9	Platelet count;
SKCM	cis	rs7811142	1.000	rs4989959	chr7:100032288	T/C	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.12	6.51	0.59	6.68e-9	Platelet count;
SKCM	cis	rs1707322	0.650	rs4660879	chr1:46105401	C/A	cg03146154	chr1:46216737	IPP	0.82	6.1	0.57	3.89e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs16854884	0.545	rs7650459	chr3:143658934	C/G	cg06585982	chr3:143692056	C3orf58	0.77	7.26	0.64	2.46e-10	Economic and political preferences (feminism/equality);
SKCM	cis	rs17376456	0.877	rs10476597	chr5:93367172	C/T	cg21475434	chr5:93447410	FAM172A	-1.03	-5.61	-0.54	3e-7	Diabetic retinopathy;
SKCM	cis	rs1878931	0.507	rs8054222	chr16:3413477	C/T	cg26668626	chr16:3451006	ZNF174;ZNF434	-0.81	-5.57	-0.53	3.44e-7	Body mass index (adult);
SKCM	cis	rs7811142	0.830	rs41280971	chr7:99954457	G/T	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.07	6.7	0.6	2.88e-9	Platelet count;
SKCM	cis	rs28595532	0.920	rs56162974	chr4:119742333	T/C	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs3789045	0.729	rs61817460	chr1:204543579	G/A	cg17419461	chr1:204415978	PIK3C2B	-0.86	-6.04	-0.56	5.01e-8	Educational attainment (college completion);
SKCM	cis	rs372883	0.600	rs2832293	chr21:30738872	C/G	cg24692254	chr21:30365293	RNF160	0.65	5.28	0.51	1.14e-6	Pancreatic cancer;
SKCM	cis	rs801193	0.967	rs1110414	chr7:66205582	A/G	cg11764359	chr7:65958608	NA	0.86	6.55	0.6	5.68e-9	Aortic root size;
SKCM	cis	rs8072100	1.000	rs11870935	chr17:45732605	G/A	cg25173405	chr17:45401733	C17orf57	0.59	5.49	0.53	4.83e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs9902453	1.000	rs7222308	chr17:28277041	T/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.79	5.67	0.54	2.35e-7	Coffee consumption (cups per day);
SKCM	cis	rs55962025	0.883	rs2298967	chr4:3185747	T/C	cg21096898	chr4:3318625	RGS12	-0.59	-4.89	-0.48	5.22e-6	Parental longevity (mother's age at death);
SKCM	cis	rs9858542	0.953	rs1987628	chr3:49399259	G/A	cg03060546	chr3:49711283	APEH	-0.69	-5.16	-0.5	1.85e-6	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs6582630	0.519	rs11181526	chr12:38360230	A/G	cg26384229	chr12:38710491	ALG10B	0.81	6.56	0.6	5.29e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs6429082	0.668	rs291395	chr1:235652049	A/C	cg26050004	chr1:235667680	B3GALNT2	-0.79	-7.02	-0.62	7.21e-10	Adiposity;
SKCM	cis	rs7666738	0.830	rs28615340	chr4:98896922	T/C	cg17366294	chr4:99064904	C4orf37	0.57	4.85	0.48	6.12e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6424115	0.867	rs11588187	chr1:24145047	T/A	cg15997130	chr1:24165203	NA	0.61	5.29	0.51	1.1e-6	Immature fraction of reticulocytes;
SKCM	cis	rs12928939	0.517	rs10852507	chr16:71971900	G/A	cg03805757	chr16:71968109	PKD1L3	-0.72	-5.13	-0.5	2.02e-6	Post bronchodilator FEV1;
SKCM	cis	rs672059	0.934	rs641057	chr1:183156859	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.63	5.23	0.51	1.38e-6	Hypertriglyceridemia;
SKCM	cis	rs78314980	0.557	rs41265179	chr1:153601828	G/T	cg21169096	chr1:153628983	NA	-1.21	-5.23	-0.51	1.37e-6	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs9475752	0.793	rs28360536	chr6:56831647	C/T	cg06815302	chr6:57335405	PRIM2	0.59	4.78	0.48	8.1e-6	Menarche (age at onset);
SKCM	cis	rs34172651	0.502	rs12930727	chr16:24838497	G/T	cg00339695	chr16:24857497	SLC5A11	-0.69	-6.06	-0.57	4.58e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs4665809	0.590	rs7588328	chr2:26469788	G/A	cg26119090	chr2:26468346	HADHA;HADHB	1.06	8.39	0.69	1.66e-12	Gut microbiome composition (summer);
SKCM	cis	rs6570726	0.935	rs447818	chr6:145868996	C/T	cg23711669	chr6:146136114	FBXO30	0.7	6.76	0.61	2.25e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1401999	1.000	rs3805108	chr3:183691650	T/C	cg01324343	chr3:183735012	ABCC5	0.93	10.78	0.77	4.03e-17	Anterior chamber depth;
SKCM	cis	rs1799949	1.000	rs11653460	chr17:41331306	C/T	cg23758822	chr17:41437982	NA	0.93	7.84	0.66	1.91e-11	Menopause (age at onset);
SKCM	cis	rs7772486	0.790	rs6917135	chr6:146152426	T/C	cg23711669	chr6:146136114	FBXO30	0.86	9.38	0.73	1.95e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7359257	0.576	rs17241403	chr15:67875762	A/G	cg24247231	chr15:67904302	MAP2K5	-0.69	-5.78	-0.55	1.49e-7	Menarche (age at onset);
SKCM	cis	rs769267	0.965	rs2017964	chr19:19387149	T/C	cg26732615	chr19:19648335	CILP2;YJEFN3	0.62	5.67	0.54	2.31e-7	Tonsillectomy;
SKCM	cis	rs1957429	0.901	rs8008745	chr14:65351593	C/G	cg23373153	chr14:65346875	NA	1.11	6.32	0.58	1.52e-8	Pediatric areal bone mineral density (radius);
SKCM	cis	rs11764590	0.694	rs56072378	chr7:2104364	A/G	cg02825527	chr7:2087843	MAD1L1	-0.65	-4.78	-0.48	8.09e-6	Neuroticism;
SKCM	cis	rs5753618	1.000	rs5753618	chr22:31838518	C/T	cg02404636	chr22:31891804	SFI1	0.63	5.18	0.51	1.69e-6	Colorectal cancer;
SKCM	cis	rs1568889	0.548	rs34906813	chr11:28508819	A/G	cg06544937	chr11:28130018	METT5D1;KIF18A	0.93	5.36	0.52	8.12e-7	Bipolar disorder;
SKCM	cis	rs9381040	0.631	rs13216201	chr6:41162060	G/T	cg25110423	chr6:41068646	NFYA;LOC221442	-0.72	-4.92	-0.49	4.8e-6	Alzheimer's disease (late onset);
SKCM	cis	rs854765	0.547	rs2955356	chr17:17964717	G/A	cg24612305	chr17:17875800	TOM1L2;LRRC48	-1.02	-9.54	-0.73	9.55e-15	Total body bone mineral density;
SKCM	cis	rs10504229	0.683	rs55986917	chr8:58137210	C/T	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs9322193	0.886	rs9322198	chr6:149944908	T/C	cg07701084	chr6:150067640	NUP43	0.61	4.84	0.48	6.48e-6	Lung cancer;
SKCM	cis	rs3091242	1.000	rs3091242	chr1:25674785	C/T	cg27572855	chr1:25598939	RHD	0.55	5.34	0.52	8.86e-7	Erythrocyte sedimentation rate;
SKCM	cis	rs778371	0.723	rs283470	chr2:233656918	G/A	cg08000102	chr2:233561755	GIGYF2	0.83	6.76	0.61	2.28e-9	Schizophrenia;
SKCM	cis	rs28595532	0.920	rs115090549	chr4:119753554	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs8180040	0.966	rs11925823	chr3:47443065	C/G	cg27129171	chr3:47204927	SETD2	0.79	5.79	0.55	1.43e-7	Colorectal cancer;
SKCM	cis	rs2243480	0.901	rs313808	chr7:65499873	T/G	cg18252515	chr7:66147081	NA	-1.33	-8.1	-0.68	6.08e-12	Diabetic kidney disease;
SKCM	cis	rs36051895	0.695	rs12352214	chr9:5018041	G/A	cg02405213	chr9:5042618	JAK2	-0.63	-4.8	-0.48	7.62e-6	Pediatric autoimmune diseases;
SKCM	cis	rs5769765	0.954	rs910799	chr22:50278568	A/G	cg22709217	chr22:50311962	ALG12;CRELD2	0.82	5.73	0.54	1.8e-7	Schizophrenia;
SKCM	cis	rs2243480	1.000	rs4718315	chr7:65648541	T/C	cg18252515	chr7:66147081	NA	1.36	8.16	0.68	4.6e-12	Diabetic kidney disease;
SKCM	cis	rs6121246	0.609	rs6060652	chr20:30266845	A/G	cg13852791	chr20:30311386	BCL2L1	0.82	5.64	0.54	2.59e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs7824557	0.701	rs4568582	chr8:11160495	A/T	cg21775007	chr8:11205619	TDH	0.72	6.07	0.57	4.36e-8	Retinal vascular caliber;
SKCM	cis	rs35306767	0.903	rs7067865	chr10:908387	C/T	cg20503657	chr10:835505	NA	0.75	5.36	0.52	8.31e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs28595532	0.748	rs113336496	chr4:119336957	C/T	cg21605333	chr4:119757512	SEC24D	0.95	4.91	0.49	4.92e-6	Cannabis dependence symptom count;
SKCM	cis	rs7639513	0.545	rs13061104	chr3:12717321	G/T	cg23032965	chr3:12705835	RAF1	0.81	7.0	0.62	7.95e-10	Itch intensity from mosquito bite;
SKCM	trans	rs5756813	0.530	rs5756822	chr22:38196474	C/T	cg19894588	chr14:64061835	NA	1.07	10.53	0.77	1.24e-16	Optic cup area;Vertical cup-disc ratio;
SKCM	cis	rs910316	0.664	rs2098252	chr14:75492732	T/C	cg08847533	chr14:75593920	NEK9	0.8	6.59	0.6	4.76e-9	Height;
SKCM	cis	rs362296	0.698	rs3095073	chr4:3263138	C/T	cg11471262	chr4:3318911	RGS12	-0.74	-7.18	-0.63	3.6e-10	Parental longevity (mother's age at death);
SKCM	cis	rs1865760	1.000	rs2071299	chr6:25914801	G/A	cg08401836	chr6:26032486	HIST1H3B	-0.6	-4.78	-0.48	8.09e-6	Height;
SKCM	cis	rs2858942	0.602	rs1211375	chr16:240280	G/T	cg03788090	chr16:233062	NA	0.6	5.08	0.5	2.47e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs9814567	0.964	rs3856729	chr3:134200925	A/G	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.68	-5.33	-0.52	9.31e-7	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs875971	0.660	rs10950044	chr7:66042976	A/G	cg11764359	chr7:65958608	NA	-0.83	-6.29	-0.58	1.71e-8	Aortic root size;
SKCM	cis	rs826838	0.684	rs12367400	chr12:38618673	G/T	cg13010199	chr12:38710504	ALG10B	0.64	4.91	0.49	4.85e-6	Heart rate;
SKCM	cis	rs10489202	1.000	rs275157	chr1:168064178	T/C	cg24449463	chr1:168025552	DCAF6	-0.77	-5.95	-0.56	7.18e-8	Schizophrenia;
SKCM	cis	rs933688	1.000	rs10073935	chr5:90742188	A/G	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.07	8.69	0.7	4.41e-13	Smoking behavior;
SKCM	cis	rs11098499	0.908	rs11098527	chr4:120399906	A/G	cg09307838	chr4:120376055	NA	0.97	7.65	0.65	4.54e-11	Corneal astigmatism;
SKCM	cis	rs11098499	0.866	rs3756156	chr4:120524841	G/A	cg09307838	chr4:120376055	NA	0.99	8.0	0.67	9.34e-12	Corneal astigmatism;
SKCM	cis	rs7772486	0.727	rs11155442	chr6:146140725	T/C	cg05347473	chr6:146136440	FBXO30	0.59	5.45	0.53	5.71e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2479724	0.875	rs2253961	chr6:41827011	A/G	cg17623882	chr6:41773611	USP49	-0.77	-6.56	-0.6	5.36e-9	Menarche (age at onset);
SKCM	cis	rs8077889	0.917	rs58283314	chr17:41905963	T/G	cg26893861	chr17:41843967	DUSP3	1.15	7.34	0.64	1.79e-10	Triglycerides;
SKCM	cis	rs2243480	1.000	rs35391607	chr7:65360829	G/A	cg18252515	chr7:66147081	NA	-1.29	-7.41	-0.64	1.3e-10	Diabetic kidney disease;
SKCM	cis	rs71335811	1	rs71335811	chr19:49130070	TC/T	cg06677660	chr19:49140777	SEC1;DBP	-0.87	-6.34	-0.58	1.35e-8	Myeloid white cell count;
SKCM	cis	rs4073582	0.595	rs1151540	chr11:66041807	A/C	cg16950941	chr11:66035639	RAB1B	0.82	7.01	0.62	7.59e-10	Gout;
SKCM	cis	rs6570726	0.720	rs412623	chr6:145883257	C/A	cg05347473	chr6:146136440	FBXO30	0.52	4.79	0.48	7.88e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs873946	0.648	rs12771651	chr10:134554482	C/A	cg18305652	chr10:134549665	INPP5A	0.57	5.83	0.55	1.17e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs28595532	0.841	rs114768988	chr4:119744451	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs6570726	0.791	rs6900040	chr6:145893134	C/T	cg23711669	chr6:146136114	FBXO30	0.87	8.94	0.71	1.44e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4891159	0.790	rs11872411	chr18:74132051	C/T	cg24786174	chr18:74118243	ZNF516	-0.74	-7.05	-0.62	6.2e-10	Longevity;
SKCM	cis	rs2120019	0.938	rs59094290	chr15:75308561	G/T	cg09165964	chr15:75287851	SCAMP5	-0.83	-7.83	-0.66	2e-11	Blood trace element (Zn levels);
SKCM	cis	rs7954584	0.567	rs10840632	chr12:122375460	C/T	cg22618164	chr12:122356400	WDR66	0.52	5.36	0.52	8.35e-7	Mean corpuscular volume;
SKCM	cis	rs6860806	0.507	rs272878	chr5:131671769	C/T	cg24060327	chr5:131705240	SLC22A5	0.78	5.1	0.5	2.33e-6	Breast cancer;
SKCM	cis	rs4689592	0.503	rs56099074	chr4:7071259	A/G	cg26116260	chr4:7069785	GRPEL1	-1.06	-7.14	-0.63	4.22e-10	Monocyte percentage of white cells;
SKCM	cis	rs6424115	0.830	rs2501423	chr1:24199026	A/C	cg15997130	chr1:24165203	NA	0.6	4.94	0.49	4.37e-6	Immature fraction of reticulocytes;
SKCM	cis	rs9300255	0.602	rs1727296	chr12:123647725	G/C	cg05973401	chr12:123451056	ABCB9	0.8	5.47	0.53	5.23e-7	Neutrophil percentage of white cells;
SKCM	cis	rs9611565	0.559	rs13056262	chr22:42081921	A/G	cg03806693	chr22:41940476	POLR3H	1.12	7.53	0.65	7.69e-11	Vitiligo;
SKCM	cis	rs4924544	1	rs4924544	chr15:41693455	G/T	cg18705301	chr15:41695430	NDUFAF1	-0.69	-5.25	-0.51	1.26e-6	Eosinophil percentage of white cells;
SKCM	cis	rs2304069	0.913	rs7734382	chr5:149383241	A/T	cg22760475	chr5:149380129	HMGXB3;TIGD6	0.91	6.09	0.57	3.98e-8	HIV-1 control;
SKCM	cis	rs362272	0.524	rs13150241	chr4:3367281	A/G	cg24015175	chr4:3319247	RGS12	0.83	9.8	0.74	3.03e-15	Serum sulfate level;
SKCM	cis	rs2559856	0.935	rs7970952	chr12:102081577	C/T	cg12924262	chr12:102091054	CHPT1	0.7	5.68	0.54	2.19e-7	Blood protein levels;
SKCM	cis	rs2739330	0.703	rs5760112	chr22:24259772	C/G	cg25703541	chr22:24373054	LOC391322	-0.81	-7.02	-0.62	7.17e-10	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs9322193	0.884	rs10782312	chr6:149943805	G/T	cg07701084	chr6:150067640	NUP43	0.61	4.84	0.48	6.48e-6	Lung cancer;
SKCM	cis	rs4332037	0.851	rs1403175	chr7:1964357	A/T	cg23422044	chr7:1970798	MAD1L1	1.04	7.56	0.65	6.69e-11	Bipolar disorder;
SKCM	cis	rs5417	0.689	rs55868524	chr17:7170665	G/A	cg25256661	chr17:7137939	DVL2	-0.86	-6.58	-0.6	4.95e-9	Diastolic blood pressure;
SKCM	cis	rs2739330	0.753	rs4822452	chr22:24254363	C/T	cg25703541	chr22:24373054	LOC391322	-0.78	-6.52	-0.59	6.42e-9	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs17826219	0.568	rs2626985	chr17:29077437	A/G	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Body mass index;
SKCM	cis	rs7666738	0.830	rs13138920	chr4:99020786	A/G	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs28595532	0.920	rs56227053	chr4:119772460	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs6977660	0.652	rs10274428	chr7:19850592	C/T	cg05791153	chr7:19748676	TWISTNB	0.8	5.03	0.49	3.12e-6	Thyroid stimulating hormone;
SKCM	cis	rs10754283	0.967	rs10922679	chr1:90100925	T/C	cg21401794	chr1:90099060	LRRC8C	0.78	7.17	0.63	3.72e-10	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs62238980	0.614	rs80321137	chr22:32460767	C/T	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs9911578	0.967	rs4132925	chr17:56938016	C/G	cg05425664	chr17:57184151	TRIM37	0.68	5.09	0.5	2.46e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7296418	0.699	rs1109559	chr12:123757861	C/T	cg05973401	chr12:123451056	ABCB9	0.77	6.05	0.57	4.7e-8	Platelet count;
SKCM	cis	rs2153535	0.580	rs1577466	chr6:8444192	T/C	cg07606381	chr6:8435919	SLC35B3	0.94	6.94	0.62	1.02e-9	Motion sickness;
SKCM	cis	rs6724607	0.875	rs9630991	chr2:191432139	G/A	cg21644426	chr2:191273491	MFSD6	0.72	4.99	0.49	3.62e-6	Pulse pressure;
SKCM	cis	rs34779708	0.966	rs4934734	chr10:35434373	T/C	cg03585969	chr10:35415529	CREM	0.73	6.0	0.56	5.85e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs10779751	0.770	rs2791643	chr1:11207269	C/T	cg08854313	chr1:11322531	MTOR	0.78	4.94	0.49	4.43e-6	Body mass index;
SKCM	cis	rs611744	0.608	rs667742	chr8:109254003	T/C	cg18478394	chr8:109455254	TTC35	0.66	5.33	0.52	9.43e-7	Dupuytren's disease;
SKCM	cis	rs6598955	0.724	rs3924934	chr1:26644079	A/G	cg04990556	chr1:26633338	UBXN11	-0.59	-4.85	-0.48	6.08e-6	Obesity-related traits;
SKCM	cis	rs7523050	0.643	rs35665867	chr1:109395436	G/A	cg08274380	chr1:109419600	GPSM2	1.15	5.69	0.54	2.15e-7	Fat distribution (HIV);
SKCM	cis	rs1218582	0.772	rs12069356	chr1:154849771	C/T	cg06221963	chr1:154839813	KCNN3	-0.59	-5.99	-0.56	6.03e-8	Prostate cancer;
SKCM	cis	rs3785574	0.962	rs2584628	chr17:61894578	T/C	cg01411255	chr17:61851458	DDX42;CCDC47	1.16	12.75	0.82	9.1e-21	Height;
SKCM	cis	rs7618915	0.570	rs13068293	chr3:52672167	C/A	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs6138458	1.000	rs227632	chr20:24913729	G/A	cg26195577	chr20:24973756	C20orf3	1.29	8.69	0.7	4.32e-13	Blood protein levels;
SKCM	cis	rs250585	0.646	rs66569010	chr16:23486952	C/T	cg10006042	chr16:23042421	NA	-0.37	-4.91	-0.49	4.87e-6	Egg allergy;
SKCM	cis	rs4481887	0.800	rs4514268	chr1:248444600	T/G	cg00666640	chr1:248458726	OR2T12	0.66	5.88	0.55	9.73e-8	Common traits (Other);
SKCM	cis	rs7215564	0.908	rs35646299	chr17:78653506	T/G	cg16980736	chr17:78789706	RPTOR	-0.91	-4.92	-0.49	4.67e-6	Myopia (pathological);
SKCM	cis	rs4077515	0.577	rs10870165	chr9:139316601	C/T	cg14169450	chr9:139327907	INPP5E	0.45	4.79	0.48	7.84e-6	Ulcerative colitis;IgA nephropathy;Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs7937682	0.883	rs529529	chr11:111461128	C/T	cg19812747	chr11:111475976	SIK2	-0.62	-4.96	-0.49	4.06e-6	Primary sclerosing cholangitis;
SKCM	cis	rs10504229	0.679	rs11786328	chr8:58039269	A/G	cg02725872	chr8:58115012	NA	-0.52	-4.85	-0.48	6.18e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs10754283	0.967	rs1317864	chr1:90105448	A/G	cg21401794	chr1:90099060	LRRC8C	0.78	7.17	0.63	3.72e-10	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs7191439	0.674	rs4782430	chr16:88792047	A/G	cg27087555	chr16:88793112	FAM38A	-1.34	-6.79	-0.61	2e-9	Plateletcrit;
SKCM	cis	rs1153858	1.000	rs1890565	chr15:45663299	T/C	cg21132104	chr15:45694354	SPATA5L1	0.93	7.94	0.67	1.22e-11	Homoarginine levels;
SKCM	cis	rs28386778	0.897	rs2584617	chr17:61925298	C/T	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	trans	rs3780486	0.846	rs10113903	chr9:33122645	C/G	cg04842962	chr6:43655489	MRPS18A	-1.03	-10.48	-0.76	1.51e-16	IgG glycosylation;
SKCM	cis	rs1014246	0.848	rs2420330	chr10:118457481	C/T	cg14919929	chr10:118506882	NA	0.88	6.23	0.58	2.16e-8	Age at smoking initiation in chronic obstructive pulmonary disease;
SKCM	cis	rs1506636	1.000	rs7357252	chr7:123369856	C/T	cg03229431	chr7:123269106	ASB15	-0.6	-4.83	-0.48	6.69e-6	Plateletcrit;Platelet count;
SKCM	cis	rs6547741	0.717	rs2178197	chr2:27860551	C/T	cg27432699	chr2:27873401	GPN1	0.84	7.21	0.63	3.15e-10	Oral cavity cancer;
SKCM	cis	rs778371	0.723	rs12993791	chr2:233690082	C/T	cg08000102	chr2:233561755	GIGYF2	-0.8	-6.41	-0.59	1.04e-8	Schizophrenia;
SKCM	cis	rs1799949	0.965	rs8067269	chr17:41235799	C/T	cg05368731	chr17:41323189	NBR1	0.88	7.1	0.63	5.14e-10	Menopause (age at onset);
SKCM	cis	rs2811415	0.597	rs11715883	chr3:127726465	C/T	cg09089421	chr3:127803668	RUVBL1	0.97	8.25	0.68	3.07e-12	Lung function (FEV1/FVC);
SKCM	cis	rs2354432	0.505	rs4424556	chr1:146863973	G/C	cg25205988	chr1:146714368	CHD1L	1.09	5.49	0.53	4.81e-7	Mitochondrial DNA levels;
SKCM	cis	rs4481887	0.861	rs10788778	chr1:248481551	T/C	cg00666640	chr1:248458726	OR2T12	0.64	5.69	0.54	2.13e-7	Common traits (Other);
SKCM	cis	rs12047808	0.841	rs78233610	chr1:179369617	G/A	cg09822482	chr1:179519214	C1orf125	-0.95	-5.17	-0.51	1.78e-6	Multiple sclerosis (age of onset);
SKCM	cis	rs2120019	1.000	rs35577967	chr15:75354621	G/A	cg09165964	chr15:75287851	SCAMP5	-0.75	-6.28	-0.58	1.78e-8	Blood trace element (Zn levels);
SKCM	cis	rs6089829	0.962	rs6062778	chr20:61663959	A/G	cg08564027	chr20:61660810	NA	0.63	5.65	0.54	2.56e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs2153535	1.000	rs11243251	chr6:8368207	G/A	cg07606381	chr6:8435919	SLC35B3	-0.65	-4.93	-0.49	4.47e-6	Motion sickness;
SKCM	cis	rs1790761	0.520	rs12800028	chr11:67403285	A/G	cg00864171	chr11:67383662	NA	-0.78	-6.19	-0.57	2.65e-8	Mean corpuscular volume;
SKCM	cis	rs6570726	0.791	rs385729	chr6:145855465	T/C	cg05347473	chr6:146136440	FBXO30	0.56	5.08	0.5	2.49e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1348850	0.668	rs12618542	chr2:178494520	A/G	cg27490568	chr2:178487706	NA	0.9	6.57	0.6	5.2e-9	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs2013441	1.000	rs2386429	chr17:20210809	G/A	cg13482628	chr17:19912719	NA	-0.66	-5.19	-0.51	1.65e-6	Obesity-related traits;
SKCM	cis	rs13118159	0.573	rs4974618	chr4:1373663	C/T	cg02018176	chr4:1364513	KIAA1530	0.86	7.11	0.63	4.81e-10	Longevity;
SKCM	cis	rs1580019	0.547	rs56981934	chr7:32535202	C/G	cg06627557	chr7:32535165	LSM5;AVL9	0.99	9.77	0.74	3.53e-15	Cognitive ability;
SKCM	cis	rs2243480	1.000	rs781156	chr7:65479141	C/A	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs7208859	0.623	rs73269916	chr17:29096326	A/G	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs6951245	0.745	rs79788515	chr7:1101079	C/T	cg24642844	chr7:1081250	C7orf50	-0.95	-6.82	-0.61	1.76e-9	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs28386778	0.805	rs9911714	chr17:61828952	G/A	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.36	0.52	8.06e-7	Prudent dietary pattern;
SKCM	cis	rs1801251	1.000	rs2100053	chr2:233719516	G/T	cg25237894	chr2:233734115	C2orf82	-0.6	-5.71	-0.54	1.96e-7	Coronary artery disease;
SKCM	cis	rs7829975	0.711	rs4841051	chr8:8685646	C/T	cg15556689	chr8:8085844	FLJ10661	-0.66	-6.0	-0.56	5.82e-8	Mood instability;
SKCM	trans	rs1814175	0.817	rs28679516	chr11:50055998	G/A	cg03929089	chr4:120376271	NA	-0.93	-8.8	-0.71	2.63e-13	Height;
SKCM	cis	rs2992632	0.583	rs3006925	chr1:243609927	T/C	cg12636785	chr1:242684042	PLD5	-0.44	-4.83	-0.48	6.7e-6	Educational attainment (years of education);
SKCM	cis	rs4560672	0.938	rs977794	chr6:158538222	G/C	cg10592926	chr6:157876961	ZDHHC14	-0.53	-5.21	-0.51	1.49e-6	Smoking quantity;
SKCM	cis	rs4819052	0.788	rs13049700	chr21:46701909	G/C	cg02159808	chr21:46707872	POFUT2;LOC642852	0.75	5.38	0.52	7.42e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs2644899	0.715	rs2607415	chr19:41262687	C/G	cg24958765	chr19:41283667	RAB4B	-0.84	-5.34	-0.52	8.92e-7	Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs7666738	0.830	rs28729647	chr4:99059552	T/C	cg05340658	chr4:99064831	C4orf37	0.66	4.87	0.48	5.74e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs8017423	0.935	rs17260827	chr14:90732703	G/A	cg04374321	chr14:90722782	PSMC1	-1.03	-9.53	-0.73	1.01e-14	Mortality in heart failure;
SKCM	cis	rs155076	0.625	rs4769159	chr13:21881978	A/C	cg14456004	chr13:21872349	NA	1.3	7.55	0.65	6.84e-11	White matter hyperintensity burden;
SKCM	trans	rs66573146	0.831	rs68111914	chr4:6986677	C/T	cg07817883	chr1:32538562	TMEM39B	1.94	8.42	0.69	1.47e-12	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs860295	0.651	rs12239114	chr1:155322142	G/A	cg02153340	chr1:155202674	NA	-0.78	-5.64	-0.54	2.61e-7	Body mass index;
SKCM	cis	rs7208859	0.623	rs7214570	chr17:29147164	A/G	cg13385521	chr17:29058706	SUZ12P	1.02	5.41	0.52	6.68e-7	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs75920871	0.588	rs7101763	chr11:116941985	G/T	cg01368799	chr11:117014884	PAFAH1B2	-0.64	-4.86	-0.48	5.89e-6	Subjective well-being;
SKCM	cis	rs6951245	1.000	rs28379681	chr7:1070539	C/T	cg24642844	chr7:1081250	C7orf50	-0.95	-6.4	-0.59	1.06e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs72781680	1.000	rs72796327	chr2:24140372	T/C	cg08917208	chr2:24149416	ATAD2B	1.02	5.84	0.55	1.16e-7	Lymphocyte counts;
SKCM	cis	rs7666738	0.830	rs7662218	chr4:98983126	T/G	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1799949	1.000	rs12936816	chr17:41301709	C/T	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.11	-0.57	3.67e-8	Menopause (age at onset);
SKCM	cis	rs28595532	0.920	rs10001115	chr4:119781867	A/C	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs6461049	0.765	rs10224497	chr7:2149967	A/G	cg21782813	chr7:2030301	MAD1L1	0.47	5.03	0.5	3.02e-6	Schizophrenia;
SKCM	trans	rs1814175	0.817	rs4084376	chr11:49831160	T/C	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs478304	0.627	rs11227254	chr11:65454000	A/G	cg17480646	chr11:65405466	SIPA1	-0.67	-4.99	-0.49	3.64e-6	Acne (severe);
SKCM	cis	rs2180341	0.883	rs9388568	chr6:127690694	C/A	cg27446573	chr6:127587934	RNF146	0.93	8.09	0.68	6.27e-12	Breast cancer;
SKCM	cis	rs875971	0.638	rs6960778	chr7:66071597	C/T	cg18876405	chr7:65276391	NA	-0.83	-7.62	-0.65	5.18e-11	Aortic root size;
SKCM	trans	rs1814175	0.817	rs10769641	chr11:49960141	A/G	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs9660180	0.967	rs10907191	chr1:1774820	A/T	cg17747265	chr1:1875780	NA	-0.56	-5.15	-0.5	1.91e-6	Body mass index;
SKCM	cis	rs6500395	1.000	rs9933314	chr16:48676608	T/C	cg04672837	chr16:48644449	N4BP1	0.65	5.43	0.52	6.28e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs10883723	0.810	rs2296582	chr10:104244139	G/T	ch.10.2196322F	chr10:104248062	ACTR1A	0.66	4.77	0.48	8.36e-6	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs9788682	1.000	rs35212593	chr15:78831826	G/A	cg24631222	chr15:78858424	CHRNA5	0.96	6.69	0.6	3.03e-9	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs9926296	0.605	rs7205053	chr16:89856763	G/C	cg04287289	chr16:89883240	FANCA	1.03	12.09	0.81	1.44e-19	Vitiligo;
SKCM	cis	rs28595532	0.920	rs116145969	chr4:119770908	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs11792861	0.816	rs7021366	chr9:111727670	C/G	cg14432460	chr9:111696404	IKBKAP;C9orf6	0.69	4.88	0.48	5.46e-6	Menarche (age at onset);
SKCM	cis	rs2777491	0.707	rs8024774	chr15:41792560	A/G	cg18705301	chr15:41695430	NDUFAF1	-1.02	-10.17	-0.75	6.03e-16	Ulcerative colitis;
SKCM	cis	rs929354	0.713	rs7798816	chr7:156940574	A/G	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs77216612	0.874	rs11055034	chr12:12890626	C/A	cg09462578	chr12:12878428	APOLD1	-0.78	-5.17	-0.51	1.73e-6	Lymphocyte counts;
SKCM	cis	rs2832077	0.527	rs59730679	chr21:30226244	T/C	cg24692254	chr21:30365293	RNF160	-0.75	-5.62	-0.54	2.79e-7	Cognitive test performance;
SKCM	cis	rs7772486	0.817	rs9322047	chr6:146400394	G/A	cg05347473	chr6:146136440	FBXO30	0.63	5.7	0.54	2.05e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6500395	1.000	rs2883475	chr16:48560315	C/T	cg04672837	chr16:48644449	N4BP1	0.68	5.7	0.54	2.02e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs10751667	0.666	rs7395402	chr11:950293	A/G	cg10932868	chr11:921992	NA	-0.57	-5.32	-0.52	9.5e-7	Alzheimer's disease (late onset);
SKCM	cis	rs28595532	0.920	rs17325017	chr4:119774607	A/G	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs7772486	0.686	rs1292337	chr6:145967807	A/G	cg23711669	chr6:146136114	FBXO30	-0.9	-9.43	-0.73	1.62e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs17213078	0.602	rs4851926	chr2:106742660	A/G	cg16099169	chr2:106886729	NA	0.56	4.88	0.48	5.55e-6	Facial morphology (factor 23);
SKCM	cis	rs644799	1.000	rs627568	chr11:95569253	A/C	cg03916912	chr11:95522834	CEP57;FAM76B	0.87	7.33	0.64	1.88e-10	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs9611565	0.503	rs5751156	chr22:42170025	A/G	cg03806693	chr22:41940476	POLR3H	1.16	6.38	0.59	1.16e-8	Vitiligo;
SKCM	cis	rs10504229	1.000	rs60231757	chr8:58169937	T/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs2204008	0.635	rs1283298	chr12:38147630	G/A	cg26384229	chr12:38710491	ALG10B	-0.7	-5.58	-0.53	3.32e-7	Bladder cancer;
SKCM	cis	rs7666738	0.830	rs7657982	chr4:99044015	G/A	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs16866061	1.000	rs4674916	chr2:225365635	C/A	cg02879423	chr2:224806760	WDFY1	0.67	4.8	0.48	7.61e-6	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs16870629	0.567	rs35661060	chr5:1060379	G/A	cg00278107	chr5:1061253	SLC12A7	1.06	11.17	0.78	7.5e-18	QT interval;
SKCM	trans	rs1814175	0.935	rs11040465	chr11:49689323	C/T	cg03929089	chr4:120376271	NA	-0.91	-7.73	-0.66	3.15e-11	Height;
SKCM	cis	rs1707322	1.000	rs7527079	chr1:46413450	C/G	cg03146154	chr1:46216737	IPP	0.8	5.44	0.52	5.87e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs2439831	0.681	rs3742969	chr15:43621947	A/G	cg27015174	chr15:43622946	ADAL;LCMT2	0.87	4.81	0.48	7.13e-6	Lung cancer in ever smokers;
SKCM	cis	rs1153858	1.000	rs12439274	chr15:45636667	A/G	cg10760299	chr15:45669010	GATM	0.61	6.2	0.57	2.46e-8	Homoarginine levels;
SKCM	cis	rs13118159	0.509	rs4974556	chr4:1358141	G/C	cg02018176	chr4:1364513	KIAA1530	0.93	7.8	0.66	2.31e-11	Longevity;
SKCM	cis	rs6942756	0.774	rs2402944	chr7:128951402	G/T	cg02491457	chr7:128862824	NA	-0.76	-4.92	-0.49	4.75e-6	White matter hyperintensity burden;
SKCM	cis	rs9910055	0.659	rs227584	chr17:42225547	A/C	cg08499158	chr17:42289980	UBTF	-0.74	-6.46	-0.59	8.29e-9	Total body bone mineral density;
SKCM	cis	rs7772486	0.790	rs2254257	chr6:146203724	C/T	cg05347473	chr6:146136440	FBXO30	0.55	5.16	0.5	1.86e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs908922	0.651	rs4845444	chr1:152530125	G/A	cg09873164	chr1:152488093	CRCT1	0.72	5.62	0.54	2.85e-7	Hair morphology;
SKCM	cis	rs208520	0.565	rs1385222	chr6:66753013	C/T	cg07460842	chr6:66804631	NA	1.03	11.35	0.79	3.47e-18	Exhaled nitric oxide output;
SKCM	cis	rs1395	0.744	rs1975384	chr2:27542041	C/T	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.56	5.2	0.51	1.56e-6	Blood metabolite levels;
SKCM	cis	rs1018836	0.923	rs9643308	chr8:91625399	A/C	cg16814680	chr8:91681699	NA	-0.62	-4.83	-0.48	6.67e-6	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs644799	0.965	rs1944080	chr11:95503636	T/C	cg25622487	chr11:95524042	FAM76B;CEP57	0.74	5.91	0.56	8.37e-8	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs1419980	0.673	rs10772553	chr12:7768089	G/A	cg10578777	chr12:7781093	NA	-0.68	-4.96	-0.49	4.02e-6	HDL cholesterol levels;
SKCM	cis	rs116095464	0.558	rs6878087	chr5:223117	C/T	cg22857025	chr5:266934	NA	1.15	6.37	0.59	1.21e-8	Breast cancer;
SKCM	cis	rs28595532	1.000	rs41455648	chr4:119718030	A/G	cg21605333	chr4:119757512	SEC24D	1.35	7.92	0.67	1.37e-11	Cannabis dependence symptom count;
SKCM	cis	rs12709013	0.792	rs11649387	chr16:58837080	C/T	cg02431531	chr16:59244939	NA	0.48	4.99	0.49	3.62e-6	Blood metabolite ratios;
SKCM	cis	rs2075371	0.933	rs2544201	chr7:133963561	C/G	cg20476274	chr7:133979776	SLC35B4	1.03	10.89	0.78	2.52e-17	Mean platelet volume;
SKCM	cis	rs801193	1.000	rs4717310	chr7:66161007	C/T	cg18876405	chr7:65276391	NA	0.8	7.11	0.63	4.86e-10	Aortic root size;
SKCM	cis	rs4927850	1.000	rs7625570	chr3:195747398	A/G	cg12923728	chr3:195709715	SDHAP1	-0.92	-6.36	-0.58	1.27e-8	Pancreatic cancer;
SKCM	cis	rs595982	0.726	rs607356	chr19:49371241	T/C	cg19746536	chr19:49375674	PPP1R15A	1.24	12.58	0.82	1.86e-20	Red cell distribution width;
SKCM	cis	rs9914544	1.000	rs9916245	chr17:18766825	C/G	cg26378065	chr17:18585709	ZNF286B	0.71	4.8	0.48	7.54e-6	Educational attainment (years of education);
SKCM	cis	rs2239547	0.563	rs4687560	chr3:52898121	T/G	cg11645453	chr3:52864694	ITIH4	0.77	6.99	0.62	8.13e-10	Schizophrenia;
SKCM	cis	rs1707322	1.000	rs4660334	chr1:46462126	A/C	cg03146154	chr1:46216737	IPP	0.75	5.15	0.5	1.94e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs72634258	0.945	rs2294889	chr1:8075934	A/G	cg00042356	chr1:8021962	PARK7	1.05	7.31	0.64	1.98e-10	Inflammatory bowel disease;
SKCM	cis	rs9916302	0.904	rs11654018	chr17:37703740	C/T	cg07936489	chr17:37558343	FBXL20	0.9	7.8	0.66	2.32e-11	Glomerular filtration rate (creatinine);
SKCM	cis	rs2980439	0.557	rs2976876	chr8:8318850	T/C	cg06636001	chr8:8085503	FLJ10661	0.81	6.96	0.62	9.54e-10	Neuroticism;
SKCM	cis	rs908922	0.676	rs568661	chr1:152519787	C/A	cg09873164	chr1:152488093	CRCT1	0.77	6.04	0.56	5.01e-8	Hair morphology;
SKCM	cis	rs644799	0.965	rs11021310	chr11:95502106	A/C	cg25622487	chr11:95524042	FAM76B;CEP57	0.73	5.9	0.56	9e-8	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs17685	0.753	rs10233282	chr7:75790081	C/T	cg16684958	chr7:75615977	POR	0.53	5.3	0.51	1.06e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs13256369	0.951	rs13259955	chr8:8565885	C/G	cg06636001	chr8:8085503	FLJ10661	0.8	6.06	0.57	4.62e-8	Obesity-related traits;
SKCM	cis	rs58688157	0.705	rs36060383	chr11:598723	A/C	cg17114584	chr11:613792	IRF7	0.79	5.56	0.53	3.64e-7	Systemic lupus erythematosus;
SKCM	cis	rs9910055	0.659	rs3826412	chr17:42255097	A/G	cg13607699	chr17:42295918	UBTF	0.71	5.74	0.55	1.72e-7	Total body bone mineral density;
SKCM	trans	rs11083271	0.608	rs10153350	chr18:25841883	A/G	cg00321150	chr11:62623587	SNORD27;SLC3A2;SNHG1;SNORD28;SNORD25;SNORD26	0.86	8.3	0.68	2.51e-12	Non-alcoholic fatty liver disease histology (lobular);
SKCM	cis	rs6547741	1.000	rs76784350	chr2:27764278	A/G	cg27432699	chr2:27873401	GPN1	0.73	6.43	0.59	9.41e-9	Oral cavity cancer;
SKCM	cis	rs5769765	1.000	rs910800	chr22:50278642	C/T	cg22709217	chr22:50311962	ALG12;CRELD2	0.79	5.71	0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs9796	0.870	rs2927061	chr15:41302219	A/G	cg00616447	chr15:41694635	NDUFAF1	0.71	4.97	0.49	3.83e-6	Menopause (age at onset);
SKCM	cis	rs9814567	0.806	rs6806810	chr3:134323522	G/A	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.65	-5.19	-0.51	1.6e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs9916302	0.706	rs7208487	chr17:37543449	T/G	cg07936489	chr17:37558343	FBXL20	0.96	6.76	0.61	2.28e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs7091957	1.000	rs7091957	chr10:134439478	C/T	cg27286337	chr10:134555280	INPP5A	0.62	5.18	0.51	1.67e-6	Gait speed in old age;
SKCM	cis	rs7945705	0.967	rs7123861	chr11:8892323	G/A	cg21881798	chr11:8931708	C11orf17;ST5	0.76	7.65	0.65	4.47e-11	Hemoglobin concentration;
SKCM	cis	rs9815354	0.638	rs73071259	chr3:42001847	G/A	cg03022575	chr3:42003672	ULK4	1.0	5.0	0.49	3.43e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs1051424	0.651	rs1292063	chr17:57907768	T/A	cg02344993	chr17:57696989	CLTC	-0.67	-4.79	-0.48	7.85e-6	Obesity-related traits;
SKCM	cis	rs4523957	0.855	rs143499	chr17:2132324	T/C	cg16513277	chr17:2031491	SMG6	0.72	4.85	0.48	6.14e-6	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs910316	1.000	rs12889309	chr14:75593902	C/T	cg08847533	chr14:75593920	NEK9	0.95	9.18	0.72	4.8e-14	Height;
SKCM	cis	rs6545883	0.931	rs11125885	chr2:61755728	G/C	cg15711740	chr2:61764176	XPO1	-0.74	-5.26	-0.51	1.23e-6	Tuberculosis;
SKCM	cis	rs2153535	0.580	rs5001324	chr6:8451604	A/T	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs2999052	0.526	rs2075402	chr3:127784262	C/T	cg09089421	chr3:127803668	RUVBL1	-0.55	-4.96	-0.49	3.97e-6	Hypospadias;
SKCM	cis	rs6500395	0.802	rs13330784	chr16:48661530	A/C	cg04672837	chr16:48644449	N4BP1	0.59	4.89	0.48	5.37e-6	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs1401999	0.836	rs34571027	chr3:183726644	T/C	cg01324343	chr3:183735012	ABCC5	0.88	10.48	0.76	1.5e-16	Anterior chamber depth;
SKCM	cis	rs7584330	0.784	rs1463795	chr2:238412392	C/G	cg14458575	chr2:238380390	NA	-0.96	-5.94	-0.56	7.52e-8	Prostate cancer;
SKCM	cis	rs7122539	0.734	rs2513658	chr11:66628249	G/A	cg24851651	chr11:66362959	CCS	-0.75	-5.42	-0.52	6.55e-7	HIV-1 susceptibility;
SKCM	cis	rs12477438	0.501	rs12995473	chr2:99764884	G/T	cg14399236	chr2:99771627	LIPT1;TSGA10	0.97	8.9	0.71	1.72e-13	Chronic sinus infection;
SKCM	cis	rs11098499	0.774	rs11098505	chr4:120284627	C/T	cg24375607	chr4:120327624	NA	0.62	4.77	0.48	8.45e-6	Corneal astigmatism;
SKCM	cis	rs8141529	0.732	rs6005872	chr22:29172898	T/G	cg02153584	chr22:29168773	CCDC117	0.69	5.61	0.54	2.99e-7	Lymphocyte counts;
SKCM	cis	rs2070488	0.775	rs1132064	chr3:38566519	T/C	cg01465620	chr3:38496096	LOC100128640;ACVR2B	-0.74	-5.79	-0.55	1.38e-7	Electrocardiographic conduction measures;
SKCM	cis	rs10504229	0.683	rs11786527	chr8:58131344	G/C	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs12477438	0.501	rs13008171	chr2:99743419	G/A	cg26064155	chr2:99771622	LIPT1;TSGA10	1.01	9.39	0.73	1.86e-14	Chronic sinus infection;
SKCM	cis	rs4253772	0.550	rs6007761	chr22:46670394	C/T	cg03482458	chr22:46692211	CN5H6.4;GTSE1	-1.02	-4.77	-0.48	8.48e-6	LDL cholesterol;Cholesterol, total;
SKCM	cis	rs853679	0.599	rs149990	chr6:27998258	G/A	cg06761719	chr6:27280190	POM121L2	0.89	4.99	0.49	3.55e-6	Depression;
SKCM	cis	rs7811142	0.830	rs78256546	chr7:99952970	A/G	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.05	5.92	0.56	8.02e-8	Platelet count;
SKCM	cis	rs28595532	0.920	rs115154776	chr4:119774803	A/G	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs17065868	1.000	rs17065859	chr13:45049498	T/A	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs11249608	0.548	rs13156530	chr5:178475017	C/T	cg21905437	chr5:178450457	ZNF879	0.7	5.31	0.52	1e-6	Pubertal anthropometrics;
SKCM	cis	rs10504229	0.683	rs56058640	chr8:58128862	C/T	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs10089	0.953	rs1036171	chr5:127402798	C/T	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.92	8.51	0.69	9.76e-13	Ileal carcinoids;
SKCM	cis	rs6665290	0.839	rs6699400	chr1:227190497	A/G	cg10327440	chr1:227177885	CDC42BPA	-1.24	-16.57	-0.88	2.83e-27	Myeloid white cell count;
SKCM	cis	rs7927771	0.864	rs755555	chr11:47431966	C/T	cg05585544	chr11:47624801	NA	-0.6	-5.32	-0.52	9.64e-7	Subjective well-being;
SKCM	cis	rs870825	0.518	rs12512933	chr4:185665055	C/T	cg04058563	chr4:185651563	MLF1IP	0.99	6.86	0.61	1.47e-9	Blood protein levels;
SKCM	cis	rs372883	0.600	rs1312254	chr21:30695401	A/G	cg24692254	chr21:30365293	RNF160	-0.7	-5.65	-0.54	2.49e-7	Pancreatic cancer;
SKCM	cis	rs1401999	1.000	rs6443927	chr3:183718864	A/G	cg01324343	chr3:183735012	ABCC5	0.85	9.82	0.74	2.76e-15	Anterior chamber depth;
SKCM	cis	rs1707322	0.721	rs11211178	chr1:46227566	G/T	cg03146154	chr1:46216737	IPP	0.84	6.26	0.58	1.97e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs875971	0.862	rs778720	chr7:65846275	A/C	cg18876405	chr7:65276391	NA	-0.63	-6.27	-0.58	1.89e-8	Aortic root size;
SKCM	cis	rs798554	0.757	rs1182181	chr7:2873247	C/G	cg04166393	chr7:2884313	GNA12	0.71	5.2	0.51	1.58e-6	Height;
SKCM	cis	rs3793683	0.520	rs12769959	chr10:134579026	A/C	cg26818010	chr10:134567672	INPP5A	-0.72	-5.55	-0.53	3.72e-7	Migraine;
SKCM	cis	rs9535495	0.965	rs9568476	chr13:51390842	A/C	cg13204699	chr13:50703841	NA	-0.42	-4.87	-0.48	5.77e-6	Reticulocyte count;Reticulocyte fraction of red cells;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs477895	0.713	rs67546972	chr11:63962162	G/A	cg07220939	chr11:64358617	SLC22A12	0.74	4.99	0.49	3.58e-6	Mean platelet volume;
SKCM	cis	rs9814567	1.000	rs9869981	chr3:134248801	C/T	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs995000	0.868	rs9787151	chr1:63179138	C/T	cg06896770	chr1:63153194	DOCK7	-0.79	-7.0	-0.62	8.05e-10	Triglyceride levels;
SKCM	cis	rs10254284	0.959	rs881850	chr7:28152675	C/T	cg15170557	chr7:28214983	JAZF1	-0.6	-5.09	-0.5	2.45e-6	Lymphocyte percentage of white cells;Systemic lupus erythematosus;
SKCM	cis	rs9583531	0.600	rs2119479	chr13:111371181	A/C	cg24331049	chr13:111365604	ING1	0.88	6.49	0.59	7.29e-9	Coronary artery disease;
SKCM	cis	rs55962025	0.711	rs916171	chr4:3216815	C/G	cg21096898	chr4:3318625	RGS12	0.61	4.98	0.49	3.72e-6	Parental longevity (mother's age at death);
SKCM	cis	rs4555082	0.750	rs2816650	chr14:105708343	C/T	cg13114125	chr14:105738426	BRF1	-0.69	-5.7	-0.54	2.07e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs17065868	1.000	rs9525985	chr13:45167390	C/G	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs875971	0.862	rs1860469	chr7:66106875	A/G	cg11764359	chr7:65958608	NA	-0.74	-6.63	-0.6	3.89e-9	Aortic root size;
SKCM	cis	rs9543976	1.000	rs55927305	chr13:76135349	A/G	cg01531495	chr13:76123901	UCHL3	-0.94	-5.2	-0.51	1.54e-6	Diabetic retinopathy;
SKCM	cis	rs708547	0.723	rs35982175	chr4:57841365	C/T	cg16868167	chr4:57843880	C4orf14;POLR2B	0.85	6.9	0.62	1.22e-9	Response to bleomycin (chromatid breaks);
SKCM	cis	rs34779708	0.966	rs34605125	chr10:35411246	A/G	cg03585969	chr10:35415529	CREM	0.79	6.25	0.58	2e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs17826219	0.636	rs79565452	chr17:29142841	T/C	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Body mass index;
SKCM	cis	rs2404602	0.684	rs8037847	chr15:76856551	C/T	cg23625390	chr15:77176239	SCAPER	-0.84	-8.2	-0.68	3.85e-12	Blood metabolite levels;
SKCM	cis	rs35306767	0.807	rs34982663	chr10:852521	C/G	cg20503657	chr10:835505	NA	0.79	5.81	0.55	1.3e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs8017423	0.647	rs12895269	chr14:90822430	T/C	cg04374321	chr14:90722782	PSMC1	-0.73	-5.53	-0.53	4.08e-7	Mortality in heart failure;
SKCM	cis	rs6582630	0.537	rs1829579	chr12:38420555	A/G	cg26384229	chr12:38710491	ALG10B	0.82	6.3	0.58	1.6e-8	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs12497850	1.000	rs10865952	chr3:48744484	A/G	cg07636037	chr3:49044803	WDR6	0.9	9.1	0.72	6.77e-14	Parkinson's disease;
SKCM	cis	rs7666738	0.830	rs6851253	chr4:99029980	A/G	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs3008870	1.000	rs2755240	chr1:67477339	T/G	cg08660285	chr1:67390436	MIER1;WDR78	0.91	5.96	0.56	6.81e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs8042680	0.554	rs8026781	chr15:91530675	G/A	cg15878949	chr15:91534302	PRC1	0.59	4.94	0.49	4.33e-6	Type 2 diabetes;
SKCM	cis	rs7666738	0.830	rs17483521	chr4:98974058	A/T	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs28595532	0.545	rs13132957	chr4:119250841	G/C	cg11846333	chr4:119757529	SEC24D	1.04	5.83	0.55	1.2e-7	Cannabis dependence symptom count;
SKCM	cis	rs1799949	0.965	rs7212284	chr17:41205941	A/G	cg23758822	chr17:41437982	NA	0.93	7.48	0.65	9.37e-11	Menopause (age at onset);
SKCM	cis	rs9910055	0.607	rs13726	chr17:42239561	C/T	cg19774624	chr17:42201019	HDAC5	-0.9	-8.07	-0.67	7.01e-12	Total body bone mineral density;
SKCM	trans	rs208520	0.661	rs207111	chr6:66792513	C/T	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-1.02	-7.49	-0.65	9.2e-11	Exhaled nitric oxide output;
SKCM	cis	rs4819052	1.000	rs28628220	chr21:46663741	G/C	cg19498844	chr21:46707878	POFUT2;LOC642852	0.87	6.8	0.61	1.88e-9	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs2204008	0.805	rs11169513	chr12:37988640	G/A	cg26384229	chr12:38710491	ALG10B	0.8	6.2	0.57	2.47e-8	Bladder cancer;
SKCM	cis	rs362296	0.671	rs1006798	chr4:3258373	A/G	cg21096898	chr4:3318625	RGS12	-0.81	-7.35	-0.64	1.69e-10	Parental longevity (mother's age at death);
SKCM	cis	rs10504229	0.517	rs75486476	chr8:58056079	G/T	cg21724239	chr8:58056113	NA	0.68	4.96	0.49	4.1e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs873946	0.504	rs3793681	chr10:134564451	T/C	cg26818010	chr10:134567672	INPP5A	-0.7	-5.22	-0.51	1.46e-6	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs62064224	0.791	rs11656289	chr17:30761160	T/C	cg18200150	chr17:30822561	MYO1D	0.81	6.45	0.59	8.71e-9	Schizophrenia;
SKCM	cis	rs16854884	0.802	rs6783329	chr3:143798454	T/G	cg06585982	chr3:143692056	C3orf58	0.72	5.63	0.54	2.78e-7	Economic and political preferences (feminism/equality);
SKCM	cis	rs2180341	1.000	rs9385419	chr6:127597591	A/G	cg27446573	chr6:127587934	RNF146	0.99	8.51	0.69	9.46e-13	Breast cancer;
SKCM	cis	rs7932354	0.528	rs4752962	chr11:47141670	C/G	cg03339077	chr11:47165057	C11orf49	0.61	5.28	0.51	1.14e-6	Bone mineral density (hip);Bone mineral density;
SKCM	cis	rs2857078	0.745	rs4793085	chr17:42320732	A/C	cg10896456	chr17:42255109	ASB16;C17orf65	-0.58	-5.25	-0.51	1.28e-6	Red cell distribution width;Reticulocyte count;
SKCM	cis	rs908922	0.676	rs11584191	chr1:152500428	A/T	cg09873164	chr1:152488093	CRCT1	-0.74	-5.54	-0.53	3.95e-7	Hair morphology;
SKCM	cis	rs801193	0.548	rs2109297	chr7:66122384	G/A	cg18876405	chr7:65276391	NA	-0.63	-6.29	-0.58	1.68e-8	Aortic root size;
SKCM	cis	rs4423214	1.000	rs28364617	chr11:71159764	T/G	cg05163923	chr11:71159392	DHCR7	0.83	8.01	0.67	8.87e-12	Vitamin D levels;
SKCM	cis	rs9611565	0.765	rs132907	chr22:41801268	A/C	cg03806693	chr22:41940476	POLR3H	1.02	6.92	0.62	1.13e-9	Vitiligo;
SKCM	cis	rs2153535	0.601	rs9502719	chr6:8541032	A/G	cg23788917	chr6:8435910	SLC35B3	0.69	4.92	0.49	4.79e-6	Motion sickness;
SKCM	cis	rs2153535	0.580	rs2184585	chr6:8474168	G/A	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs801193	1.000	rs2286684	chr7:66129830	G/T	cg00343986	chr7:65444356	GUSB	-0.67	-4.93	-0.49	4.55e-6	Aortic root size;
SKCM	cis	rs847649	0.699	rs7794668	chr7:102510416	C/T	cg18108683	chr7:102477205	FBXL13	0.79	8.1	0.68	6.11e-12	Morning vs. evening chronotype;
SKCM	cis	rs10779751	0.734	rs1194820	chr1:11129259	A/C	cg08854313	chr1:11322531	MTOR	0.81	6.33	0.58	1.42e-8	Body mass index;
SKCM	cis	rs2032447	0.714	rs175319	chr6:25956172	A/G	cg03517284	chr6:25882590	NA	-0.61	-5.0	-0.49	3.47e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs875971	0.862	rs801203	chr7:66023012	A/G	cg18876405	chr7:65276391	NA	-0.61	-6.03	-0.56	5.23e-8	Aortic root size;
SKCM	cis	rs2404602	0.735	rs4886800	chr15:76678692	A/G	cg23625390	chr15:77176239	SCAPER	-0.74	-6.61	-0.6	4.28e-9	Blood metabolite levels;
SKCM	cis	rs7613875	0.578	rs2526749	chr3:50076734	A/G	cg24110177	chr3:50126178	RBM5	0.74	5.95	0.56	7.25e-8	Body mass index;
SKCM	cis	rs3820928	0.904	rs4129884	chr2:227820943	G/A	cg11843606	chr2:227700838	RHBDD1	-0.6	-4.77	-0.48	8.46e-6	Pulmonary function;
SKCM	cis	rs7809950	0.678	rs12672451	chr7:106853817	C/G	cg23024343	chr7:107201750	COG5	-0.76	-6.54	-0.6	5.71e-9	Coronary artery disease;
SKCM	cis	rs116095464	0.558	rs10068203	chr5:206618	C/T	cg22857025	chr5:266934	NA	-1.44	-7.74	-0.66	2.94e-11	Breast cancer;
SKCM	cis	rs11764590	0.694	rs6977161	chr7:2099361	T/C	cg02825527	chr7:2087843	MAD1L1	-0.62	-4.92	-0.49	4.67e-6	Neuroticism;
SKCM	cis	rs11249608	0.636	rs6888539	chr5:178449010	T/A	cg21905437	chr5:178450457	ZNF879	0.71	6.0	0.56	5.81e-8	Pubertal anthropometrics;
SKCM	cis	rs875971	1.000	rs10244498	chr7:66116056	A/G	cg11764359	chr7:65958608	NA	0.78	7.09	0.63	5.3e-10	Aortic root size;
SKCM	cis	rs28595532	0.841	rs114175487	chr4:119733580	C/G	cg11846333	chr4:119757529	SEC24D	1.2	6.43	0.59	9.38e-9	Cannabis dependence symptom count;
SKCM	cis	rs34779708	0.931	rs11597392	chr10:35288575	T/C	cg03585969	chr10:35415529	CREM	0.76	6.23	0.58	2.2e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs875971	0.660	rs6460308	chr7:66084740	T/C	cg18876405	chr7:65276391	NA	-0.82	-7.48	-0.65	9.41e-11	Aortic root size;
SKCM	cis	rs2731664	0.792	rs652242	chr5:176873010	C/G	cg23176889	chr5:176863531	GRK6	-0.53	-5.49	-0.53	4.83e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs992157	0.710	rs7569907	chr2:219070551	C/T	cg20019365	chr2:219134978	PNKD;AAMP	0.72	6.4	0.59	1.07e-8	Colorectal cancer;
SKCM	cis	rs13118159	0.651	rs4974599	chr4:1314430	A/C	cg20887711	chr4:1340912	KIAA1530	0.7	5.24	0.51	1.32e-6	Longevity;
SKCM	cis	rs933688	1.000	rs6862125	chr5:90724598	T/C	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.1	8.55	0.7	8.18e-13	Smoking behavior;
SKCM	cis	rs11764590	0.694	rs10241537	chr7:2083358	A/G	cg02825527	chr7:2087843	MAD1L1	-0.62	-4.97	-0.49	3.84e-6	Neuroticism;
SKCM	cis	rs1200821	0.535	rs1208783	chr10:37767467	A/G	cg25427524	chr10:38739819	LOC399744	-0.53	-5.4	-0.52	7.06e-7	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs7659604	0.840	rs6821305	chr4:122713863	A/C	cg19671926	chr4:122722719	EXOSC9	-0.66	-5.05	-0.5	2.81e-6	Type 2 diabetes;
SKCM	cis	rs9818758	0.607	rs34566463	chr3:49245077	T/C	cg00383909	chr3:49044727	WDR6	0.91	5.14	0.5	1.96e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs7824557	0.569	rs35418978	chr8:11186453	T/C	cg21775007	chr8:11205619	TDH	0.65	5.6	0.54	3.02e-7	Retinal vascular caliber;
SKCM	cis	rs6866344	0.697	rs11748495	chr5:178130000	A/G	cg10224037	chr5:178157518	ZNF354A	-0.78	-5.46	-0.53	5.43e-7	Neutrophil percentage of white cells;
SKCM	cis	rs514406	0.708	rs546334	chr1:53326210	T/C	cg24675658	chr1:53192096	ZYG11B	-0.87	-8.01	-0.67	9.12e-12	Monocyte count;
SKCM	cis	rs12497850	0.931	rs1134591	chr3:48972892	C/T	cg07636037	chr3:49044803	WDR6	1.01	11.34	0.79	3.63e-18	Parkinson's disease;
SKCM	cis	rs1218582	0.772	rs6686873	chr1:154913404	C/G	cg24250549	chr1:154909240	PMVK	0.87	8.96	0.71	1.3e-13	Prostate cancer;
SKCM	trans	rs62103177	0.810	rs62096745	chr18:77619135	A/G	cg05926928	chr17:57297772	GDPD1	1.29	8.74	0.7	3.44e-13	Opioid sensitivity;
SKCM	cis	rs9790314	0.905	rs1154701	chr3:161008025	T/A	cg03342759	chr3:160939853	NMD3	-0.73	-8.2	-0.68	3.89e-12	Morning vs. evening chronotype;
SKCM	cis	rs4481887	0.927	rs4244185	chr1:248486913	A/G	cg00666640	chr1:248458726	OR2T12	0.59	5.19	0.51	1.64e-6	Common traits (Other);
SKCM	cis	rs9790314	0.502	rs34972965	chr3:160984296	G/A	cg03342759	chr3:160939853	NMD3	-0.81	-7.1	-0.63	5.14e-10	Morning vs. evening chronotype;
SKCM	cis	rs2228479	0.717	rs12917681	chr16:89810941	C/A	cg06558623	chr16:89946397	TCF25	1.11	6.06	0.57	4.5e-8	Skin colour saturation;
SKCM	cis	rs8017423	0.935	rs7144070	chr14:90753047	T/C	cg04374321	chr14:90722782	PSMC1	0.93	8.33	0.69	2.15e-12	Mortality in heart failure;
SKCM	cis	rs9308433	0.529	rs6660335	chr1:214501855	C/T	cg06198575	chr1:214491504	SMYD2	0.82	5.16	0.5	1.8e-6	IgG glycosylation;
SKCM	cis	rs6840360	0.571	rs4696276	chr4:152532682	G/A	cg22705602	chr4:152727874	NA	-0.52	-5.7	-0.54	2.03e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs3784262	0.740	rs2044071	chr15:58270804	A/G	cg12031962	chr15:58353849	ALDH1A2	-0.46	-5.73	-0.54	1.81e-7	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs7408868	1.000	rs7254735	chr19:15263385	A/G	cg14696996	chr19:15285081	NOTCH3	0.82	4.92	0.49	4.7e-6	Pulse pressure;
SKCM	cis	rs9399135	0.967	rs1041480	chr6:135373076	G/T	cg24558204	chr6:135376177	HBS1L	0.58	5.05	0.5	2.86e-6	Red blood cell count;
SKCM	cis	rs5769765	0.955	rs2295406	chr22:50260169	G/A	cg22709217	chr22:50311962	ALG12;CRELD2	0.79	5.71	0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs6570726	0.791	rs6570694	chr6:145911204	C/G	cg23711669	chr6:146136114	FBXO30	0.88	8.39	0.69	1.67e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9902453	0.808	rs4595850	chr17:28206326	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.84	6.07	0.57	4.27e-8	Coffee consumption (cups per day);
SKCM	cis	rs2033711	0.870	rs4801583	chr19:58918405	A/G	cg12042659	chr19:58951599	ZNF132	0.66	5.6	0.54	3.07e-7	Uric acid clearance;
SKCM	cis	rs2404602	0.709	rs11072591	chr15:76649562	A/G	cg23625390	chr15:77176239	SCAPER	0.8	7.9	0.67	1.46e-11	Blood metabolite levels;
SKCM	cis	rs1218582	0.772	rs11264290	chr1:154912300	C/T	cg03351412	chr1:154909251	PMVK	0.76	6.45	0.59	8.5e-9	Prostate cancer;
SKCM	cis	rs28595532	0.800	rs111626798	chr4:119352517	C/T	cg21605333	chr4:119757512	SEC24D	1.01	5.23	0.51	1.39e-6	Cannabis dependence symptom count;
SKCM	cis	rs2404602	0.716	rs67888330	chr15:76752483	A/G	cg23625390	chr15:77176239	SCAPER	0.57	5.23	0.51	1.39e-6	Blood metabolite levels;
SKCM	cis	rs8177179	1.000	rs8177179	chr3:133463457	G/A	cg24879335	chr3:133465180	TF	0.38	4.84	0.48	6.5e-6	Iron status biomarkers (transferrin levels);
SKCM	cis	rs62238980	0.614	rs77034034	chr22:32466661	G/A	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs6088580	0.634	rs6120650	chr20:33039973	G/A	cg24642439	chr20:33292090	TP53INP2	0.76	6.02	0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs9303401	0.659	rs17222691	chr17:56771096	C/T	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.31	0.51	1.02e-6	Cognitive test performance;
SKCM	cis	rs8077889	1.000	rs17675122	chr17:41886190	A/G	cg26893861	chr17:41843967	DUSP3	1.13	7.37	0.64	1.58e-10	Triglycerides;
SKCM	cis	rs16854884	0.657	rs1867609	chr3:143752916	A/G	cg06585982	chr3:143692056	C3orf58	0.87	8.11	0.68	5.72e-12	Economic and political preferences (feminism/equality);
SKCM	cis	rs801193	1.000	rs1553610	chr7:66197233	T/C	cg18876405	chr7:65276391	NA	0.8	7.11	0.63	4.88e-10	Aortic root size;
SKCM	cis	rs73157695	0.676	rs4819169	chr21:47340971	G/A	cg10605724	chr21:47966967	DIP2A	-0.7	-5.17	-0.51	1.75e-6	Myopia;
SKCM	cis	rs6598955	0.502	rs6683157	chr1:26545865	G/A	cg04990556	chr1:26633338	UBXN11	0.68	5.08	0.5	2.55e-6	Obesity-related traits;
SKCM	cis	rs7818345	0.608	rs10481427	chr8:19279220	C/T	cg03393445	chr8:19249545	SH2D4A	0.62	5.66	0.54	2.43e-7	Language performance in older adults (adjusted for episodic memory);
SKCM	cis	rs9913156	0.748	rs72835619	chr17:4557285	G/A	cg19197139	chr17:4613644	ARRB2	0.79	5.28	0.51	1.14e-6	Lymphocyte counts;
SKCM	cis	rs9916302	0.904	rs10491128	chr17:37551988	G/A	cg07936489	chr17:37558343	FBXL20	0.82	7.23	0.63	2.84e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs13118159	0.527	rs6599308	chr4:1387780	A/G	cg16405210	chr4:1374714	KIAA1530	-0.97	-6.97	-0.62	9.15e-10	Longevity;
SKCM	cis	rs9303401	0.659	rs66514313	chr17:56714057	C/T	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.35	0.52	8.54e-7	Cognitive test performance;
SKCM	cis	rs6580649	0.941	rs11613485	chr12:48462455	T/C	cg05342945	chr12:48394962	COL2A1	0.73	5.2	0.51	1.53e-6	Lung cancer;
SKCM	cis	rs9325144	0.555	rs7977200	chr12:38713745	C/T	cg13010199	chr12:38710504	ALG10B	0.63	4.92	0.49	4.64e-6	Morning vs. evening chronotype;
SKCM	cis	rs7953508	0.750	rs11107119	chr12:93983132	T/A	cg18151635	chr12:93972918	NA	-0.73	-6.41	-0.59	1.02e-8	Pubertal anthropometrics;
SKCM	cis	rs2857078	0.886	rs2072081	chr17:42327493	G/T	cg08499158	chr17:42289980	UBTF	-0.75	-5.06	-0.5	2.67e-6	Red cell distribution width;Reticulocyte count;
SKCM	cis	rs7666738	0.830	rs34870112	chr4:99045815	T/G	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs826838	1.000	rs11169031	chr12:39056738	T/C	cg13010199	chr12:38710504	ALG10B	0.75	6.01	0.56	5.7e-8	Heart rate;
SKCM	cis	rs28386778	0.897	rs2584601	chr17:61940977	T/C	cg01411255	chr17:61851458	DDX42;CCDC47	0.8	5.04	0.5	2.92e-6	Prudent dietary pattern;
SKCM	cis	rs57221529	0.766	rs72703064	chr5:587825	T/C	cg26208419	chr5:473447	SLC9A3;LOC25845	1.01	5.18	0.51	1.7e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs992157	0.661	rs17653757	chr2:219109364	G/C	cg20019365	chr2:219134978	PNKD;AAMP	0.72	6.4	0.59	1.07e-8	Colorectal cancer;
SKCM	cis	rs11249608	0.548	rs2132671	chr5:178457434	A/G	cg21905437	chr5:178450457	ZNF879	-0.72	-5.74	-0.54	1.75e-7	Pubertal anthropometrics;
SKCM	cis	rs6570726	0.599	rs9376951	chr6:145898911	C/T	cg23711669	chr6:146136114	FBXO30	0.82	7.15	0.63	4.16e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1005277	0.579	rs2749616	chr10:38510993	A/T	cg25427524	chr10:38739819	LOC399744	-0.73	-6.68	-0.6	3.19e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs3862260	0.509	rs10923879	chr1:120163831	A/G	cg16322792	chr1:120165303	ZNF697	0.49	5.12	0.5	2.15e-6	Systemic lupus erythematosus;
SKCM	cis	rs10504229	0.906	rs7842482	chr8:58167720	A/T	cg22535103	chr8:58192502	C8orf71	-0.68	-4.82	-0.48	7.06e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs4820539	1.000	rs4822357	chr22:23473231	A/G	cg14186256	chr22:23484241	RTDR1	0.86	8.04	0.67	7.84e-12	Bone mineral density;
SKCM	cis	rs951366	0.617	rs823075	chr1:205774897	C/T	cg26354017	chr1:205819088	PM20D1	1.03	11.41	0.79	2.66e-18	Menarche (age at onset);
SKCM	cis	rs8180040	0.966	rs1872164	chr3:47415100	G/A	cg16586182	chr3:47516702	SCAP	0.76	5.32	0.52	9.63e-7	Colorectal cancer;
SKCM	cis	rs7659604	0.540	rs116452657	chr4:122674147	A/G	cg19671926	chr4:122722719	EXOSC9	0.77	6.27	0.58	1.89e-8	Type 2 diabetes;
SKCM	cis	rs7020830	0.931	rs3802422	chr9:37097172	G/A	cg14294708	chr9:37120828	ZCCHC7	1.08	9.76	0.74	3.58e-15	Schizophrenia;
SKCM	cis	rs11792861	0.591	rs10979632	chr9:111732140	G/C	cg14432460	chr9:111696404	IKBKAP;C9orf6	0.77	6.43	0.59	9.27e-9	Menarche (age at onset);
SKCM	cis	rs10876993	0.821	rs1678522	chr12:58049923	G/A	cg18357645	chr12:58087776	OS9	0.61	5.65	0.54	2.52e-7	Celiac disease or Rheumatoid arthritis;
SKCM	trans	rs1814175	0.645	rs1851850	chr11:50012168	G/A	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs875971	0.543	rs801191	chr7:66032955	G/A	cg11987759	chr7:65425863	GUSB	0.7	6.12	0.57	3.47e-8	Aortic root size;
SKCM	cis	rs1577917	0.518	rs2475787	chr6:86415236	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.76	6.81	0.61	1.8e-9	Response to antipsychotic treatment;
SKCM	cis	rs9894429	0.671	rs6565616	chr17:79612161	C/T	cg18240062	chr17:79603768	NPLOC4	0.68	6.07	0.57	4.41e-8	Eye color traits;
SKCM	cis	rs66887589	0.934	rs2389873	chr4:120554714	A/G	cg09307838	chr4:120376055	NA	-0.65	-4.82	-0.48	6.89e-6	Diastolic blood pressure;
SKCM	cis	rs7772486	0.754	rs702319	chr6:146006117	T/C	cg05347473	chr6:146136440	FBXO30	-0.68	-6.17	-0.57	2.79e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs8180040	0.726	rs6785790	chr3:47146932	C/T	cg27129171	chr3:47204927	SETD2	0.82	6.49	0.59	7.26e-9	Colorectal cancer;
SKCM	cis	rs9467773	1.000	rs6932156	chr6:26571506	T/G	cg09904177	chr6:26538194	HMGN4	0.54	4.91	0.49	4.97e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs62238980	0.522	rs117129307	chr22:32519810	A/C	cg00543991	chr22:32367038	NA	1.17	4.81	0.48	7.24e-6	Childhood ear infection;
SKCM	cis	rs875971	1.000	rs1981798	chr7:65954903	G/T	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs826838	0.967	rs11169169	chr12:39093153	A/C	cg26384229	chr12:38710491	ALG10B	1.0	8.84	0.71	2.21e-13	Heart rate;
SKCM	cis	rs11098499	0.954	rs3733523	chr4:120423719	C/T	cg09307838	chr4:120376055	NA	0.99	8.1	0.68	6.11e-12	Corneal astigmatism;
SKCM	cis	rs155076	1.000	rs261423	chr13:21852331	A/C	cg14456004	chr13:21872349	NA	-1.22	-6.76	-0.61	2.24e-9	White matter hyperintensity burden;
SKCM	cis	rs11673344	0.704	rs826262	chr19:37419442	G/A	cg07624650	chr19:37064219	ZNF529	-0.8	-5.24	-0.51	1.31e-6	Obesity-related traits;
SKCM	cis	rs11608355	0.521	rs9888353	chr12:109843594	G/A	cg19025524	chr12:109796872	NA	-0.68	-6.27	-0.58	1.88e-8	Neuroticism;
SKCM	cis	rs7666738	0.791	rs12233867	chr4:98950233	A/G	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9325144	0.555	rs12424003	chr12:38688140	C/T	cg13010199	chr12:38710504	ALG10B	-0.65	-5.26	-0.51	1.22e-6	Morning vs. evening chronotype;
SKCM	cis	rs7666738	0.830	rs59751489	chr4:98933802	A/G	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11098499	0.909	rs9994810	chr4:120381590	A/G	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs4319547	0.695	rs4758645	chr12:122946487	G/A	cg23029597	chr12:123009494	RSRC2	-0.82	-6.23	-0.58	2.18e-8	Body mass index;
SKCM	cis	rs7143963	0.636	rs58638472	chr14:103303311	A/T	cg23020514	chr14:103360112	TRAF3	0.73	6.9	0.62	1.23e-9	Body mass index;
SKCM	cis	rs8072100	0.651	rs1912484	chr17:45443664	C/G	cg25173405	chr17:45401733	C17orf57	-0.61	-4.81	-0.48	7.08e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs6570726	0.846	rs9376954	chr6:145943737	T/A	cg23711669	chr6:146136114	FBXO30	0.89	9.89	0.75	2.07e-15	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs997295	0.570	rs7172298	chr15:67872983	T/C	cg24247231	chr15:67904302	MAP2K5	-0.6	-4.98	-0.49	3.74e-6	Motion sickness;
SKCM	cis	rs826838	0.586	rs1843903	chr12:38627524	C/T	cg26384229	chr12:38710491	ALG10B	0.66	5.62	0.54	2.79e-7	Heart rate;
SKCM	cis	rs1878931	0.507	rs35214904	chr16:3410017	C/A	cg26668626	chr16:3451006	ZNF174;ZNF434	-0.82	-5.78	-0.55	1.44e-7	Body mass index (adult);
SKCM	cis	rs9300255	0.602	rs2695476	chr12:123694206	T/C	cg00376283	chr12:123451042	ABCB9	0.8	5.29	0.51	1.08e-6	Neutrophil percentage of white cells;
SKCM	cis	rs9868809	0.772	rs9821797	chr3:48718253	T/A	cg00383909	chr3:49044727	WDR6	0.89	4.92	0.49	4.79e-6	Ulcerative colitis;Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs1799949	0.965	rs11657883	chr17:41330024	T/C	cg05368731	chr17:41323189	NBR1	0.87	7.74	0.66	3.01e-11	Menopause (age at onset);
SKCM	cis	rs208520	0.526	rs1385219	chr6:66754476	C/T	cg07460842	chr6:66804631	NA	1.03	11.25	0.79	5.32e-18	Exhaled nitric oxide output;
SKCM	cis	rs1577917	0.740	rs7771612	chr6:86264374	T/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.88	8.56	0.7	7.74e-13	Response to antipsychotic treatment;
SKCM	cis	rs12682352	0.652	rs408459	chr8:8706332	A/C	cg15556689	chr8:8085844	FLJ10661	0.63	5.53	0.53	4.04e-7	Neuroticism;
SKCM	cis	rs9549367	0.713	rs1323315	chr13:113859658	T/C	cg18105134	chr13:113819100	PROZ	0.88	6.6	0.6	4.59e-9	Platelet distribution width;
SKCM	cis	rs9300255	0.510	rs1790109	chr12:123637752	C/G	cg00376283	chr12:123451042	ABCB9	0.8	5.4	0.52	7.12e-7	Neutrophil percentage of white cells;
SKCM	cis	rs17376456	0.877	rs10076052	chr5:93317762	C/T	cg25358565	chr5:93447407	FAM172A	1.23	7.26	0.63	2.53e-10	Diabetic retinopathy;
SKCM	cis	rs6951245	0.554	rs79367977	chr7:1152657	G/A	cg03188948	chr7:1209495	NA	0.85	6.02	0.56	5.43e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs1577917	0.958	rs11754330	chr6:86455070	G/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.87	-8.7	-0.7	4.17e-13	Response to antipsychotic treatment;
SKCM	cis	rs9916302	0.706	rs439537	chr17:37734482	T/C	cg07936489	chr17:37558343	FBXL20	-1.04	-7.96	-0.67	1.12e-11	Glomerular filtration rate (creatinine);
SKCM	cis	rs6977660	0.943	rs10254261	chr7:19846001	A/G	cg07541023	chr7:19748670	TWISTNB	-0.7	-4.92	-0.49	4.79e-6	Thyroid stimulating hormone;
SKCM	cis	rs651907	0.935	rs2929922	chr3:101587934	A/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.74	5.96	0.56	7.05e-8	Colorectal cancer;
SKCM	cis	rs9815354	0.812	rs73830516	chr3:41876056	A/G	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs8060686	0.641	rs7204192	chr16:68039309	A/G	cg09117114	chr16:67998030	SLC12A4	-0.71	-4.91	-0.49	4.89e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs738322	1.000	rs4381	chr22:38570791	T/C	cg25457927	chr22:38595422	NA	-0.54	-6.14	-0.57	3.27e-8	Cutaneous nevi;
SKCM	cis	rs7666738	0.927	rs4699328	chr4:99055890	C/T	cg17366294	chr4:99064904	C4orf37	0.65	5.41	0.52	6.63e-7	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7666738	0.830	rs13122456	chr4:98936011	A/G	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9308433	0.529	rs11800749	chr1:214499754	A/G	cg06198575	chr1:214491504	SMYD2	-0.82	-5.31	-0.52	9.9e-7	IgG glycosylation;
SKCM	cis	rs62158211	1.000	rs4618068	chr2:114109355	C/T	cg17784749	chr2:114082611	LOC440839	0.82	5.78	0.55	1.49e-7	Sleep duration (oversleepers vs undersleepers);Sleep traits (multi-trait analysis);Sleep duration;
SKCM	cis	rs9926296	0.512	rs11076626	chr16:89865103	T/A	cg26513180	chr16:89883248	FANCA	0.98	11.26	0.79	5.13e-18	Vitiligo;
SKCM	cis	rs17685	0.884	rs8565	chr7:75630274	T/C	cg16684958	chr7:75615977	POR	-0.67	-6.56	-0.6	5.3300000000000004e-09	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7635838	0.751	rs9811658	chr3:11395833	A/G	cg00170343	chr3:11313890	ATG7	0.69	5.18	0.51	1.66e-6	HDL cholesterol;
SKCM	cis	rs28595532	0.920	rs115485705	chr4:119733286	G/C	cg11846333	chr4:119757529	SEC24D	1.2	6.43	0.59	9.38e-9	Cannabis dependence symptom count;
SKCM	cis	rs10751667	0.580	rs10751664	chr11:927077	T/G	cg06064525	chr11:970664	AP2A2	-0.55	-5.09	-0.5	2.46e-6	Alzheimer's disease (late onset);
SKCM	cis	rs12986445	0.711	rs12713701	chr2:26136031	T/A	cg04917511	chr2:26785460	C2orf70	0.5	4.87	0.48	5.74e-6	Multiple myeloma and monoclonal gammopathy;Multiple myeloma;
SKCM	cis	rs66569888	0.507	rs11673736	chr2:106886935	T/C	cg15412446	chr2:106886593	NA	-0.88	-7.8	-0.66	2.27e-11	Facial morphology (factor 23);
SKCM	cis	rs7659604	0.605	rs1507994	chr4:122749541	C/T	cg20573242	chr4:122745356	CCNA2	0.71	6.15	0.57	3.07e-8	Type 2 diabetes;
SKCM	cis	rs35306767	0.903	rs12249828	chr10:894838	C/T	cg26597838	chr10:835615	NA	0.76	5.17	0.51	1.73e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs9660180	0.967	rs61422524	chr1:1767565	C/A	cg17747265	chr1:1875780	NA	-0.56	-5.15	-0.5	1.91e-6	Body mass index;
SKCM	trans	rs877282	0.945	rs11253390	chr10:788678	A/G	cg22713356	chr15:30763199	NA	1.35	7.57	0.65	6.52e-11	Uric acid levels;
SKCM	trans	rs1814175	0.817	rs7481230	chr11:49772235	G/A	cg03929089	chr4:120376271	NA	-0.9	-8.5	-0.69	9.91e-13	Height;
SKCM	cis	rs2180341	0.814	rs6569488	chr6:127726256	C/T	cg24812749	chr6:127587940	RNF146	0.61	4.97	0.49	3.9e-6	Breast cancer;
SKCM	cis	rs3091242	0.902	rs36003018	chr1:25784318	A/G	cg27572855	chr1:25598939	RHD	-0.53	-5.06	-0.5	2.67e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs9814567	0.793	rs55940445	chr3:134306064	G/T	cg06109529	chr3:134205091	CEP63;ANAPC13	0.61	4.81	0.48	7.36e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs2228479	0.850	rs62052660	chr16:89847420	T/A	cg00800038	chr16:89945340	TCF25	-0.93	-4.8	-0.48	7.41e-6	Skin colour saturation;
SKCM	cis	rs2204008	0.837	rs2387317	chr12:38235319	T/C	cg13010199	chr12:38710504	ALG10B	0.69	4.99	0.49	3.57e-6	Bladder cancer;
SKCM	cis	rs10752881	1.000	rs6424880	chr1:182986679	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.73	6.47	0.59	7.97e-9	Colorectal cancer;
SKCM	cis	rs7809950	0.817	rs34325395	chr7:107113808	C/G	cg23024343	chr7:107201750	COG5	-0.84	-7.84	-0.66	1.92e-11	Coronary artery disease;
SKCM	cis	rs6840360	0.593	rs10013612	chr4:152693622	A/G	cg22705602	chr4:152727874	NA	-0.59	-7.86	-0.66	1.79e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs846858	1.000	rs12975854	chr19:45120592	C/T	cg18042043	chr19:44147545	NA	0.59	4.9	0.48	5.19e-6	Late-onset Alzheimer's disease;
SKCM	cis	rs4833079	0.562	rs11944291	chr4:38631620	T/G	cg18361445	chr4:38666374	KLF3;FLJ13197	0.62	4.99	0.49	3.53e-6	Body mass index;
SKCM	cis	rs12047808	0.722	rs13306729	chr1:179316687	A/G	cg09822482	chr1:179519214	C1orf125	-0.77	-4.81	-0.48	7.17e-6	Multiple sclerosis (age of onset);
SKCM	cis	rs1218582	0.774	rs12036859	chr1:154859940	A/C	cg09359103	chr1:154839909	KCNN3	0.6	6.07	0.57	4.39e-8	Prostate cancer;
SKCM	cis	rs9911578	1.000	rs304292	chr17:56824123	G/A	cg05425664	chr17:57184151	TRIM37	-0.69	-5.21	-0.51	1.52e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs4975616	0.869	rs380286	chr5:1320247	G/A	cg26373071	chr5:1325741	CLPTM1L	0.74	6.91	0.62	1.18e-9	Lung cancer;
SKCM	cis	rs548181	0.545	rs4486648	chr11:125610589	T/A	cg03464685	chr11:125439445	EI24	-1.26	-6.58	-0.6	4.85e-9	Schizophrenia;Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);
SKCM	cis	rs2013441	0.670	rs12937327	chr17:19978984	C/T	cg13482628	chr17:19912719	NA	0.67	4.8	0.48	7.46e-6	Obesity-related traits;
SKCM	cis	rs875971	0.642	rs35526611	chr7:66094008	C/T	cg05627663	chr7:65219948	SNORA22;CCT6P1	-0.56	-4.81	-0.48	7.26e-6	Aortic root size;
SKCM	cis	rs9300255	0.508	rs1716176	chr12:123655467	T/G	cg00376283	chr12:123451042	ABCB9	0.83	5.48	0.53	5.03e-7	Neutrophil percentage of white cells;
SKCM	cis	rs10911251	0.546	rs12034436	chr1:183114797	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.76	7.28	0.64	2.3e-10	Colorectal cancer;
SKCM	cis	rs910316	0.870	rs7147712	chr14:75670707	C/G	cg11812906	chr14:75593930	NEK9	-0.68	-5.0	-0.49	3.43e-6	Height;
SKCM	cis	rs28386778	0.897	rs3785572	chr17:61829989	C/T	cg01411255	chr17:61851458	DDX42;CCDC47	0.78	5.03	0.49	3.06e-6	Prudent dietary pattern;
SKCM	cis	rs58688157	0.960	rs1061502	chr11:614318	T/C	cg17114584	chr11:613792	IRF7	0.74	5.0	0.49	3.51e-6	Systemic lupus erythematosus;
SKCM	cis	rs7438704	0.532	rs309874	chr4:48335343	G/A	cg15299388	chr4:48491941	ZAR1	0.42	4.82	0.48	6.88e-6	Inflammatory bowel disease;Crohn's disease;
SKCM	trans	rs8073060	0.586	rs17638867	chr17:34052513	C/T	cg19694781	chr19:47549865	TMEM160	1.07	8.52	0.69	9.3e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs561341	1.000	rs757009	chr17:30243937	A/G	cg23018236	chr17:30244563	NA	-0.51	-5.17	-0.51	1.75e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs208520	0.690	rs1738970	chr6:66809491	T/G	cg07460842	chr6:66804631	NA	-0.96	-7.6	-0.65	5.61e-11	Exhaled nitric oxide output;
SKCM	cis	rs1559088	0.600	rs6510344	chr19:33583942	C/A	cg27124370	chr19:33622961	WDR88	0.82	5.72	0.54	1.88e-7	Bone ultrasound measurement (broadband ultrasound attenuation);
SKCM	cis	rs1878931	0.580	rs7204571	chr16:3402444	T/C	cg26668626	chr16:3451006	ZNF174;ZNF434	0.95	8.12	0.68	5.4e-12	Body mass index (adult);
SKCM	cis	rs6500395	0.963	rs4785528	chr16:48687908	A/C	cg04672837	chr16:48644449	N4BP1	-0.65	-5.43	-0.52	6.28e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs28374715	0.662	rs111522288	chr15:41480169	C/T	cg18705301	chr15:41695430	NDUFAF1	-0.93	-7.74	-0.66	2.94e-11	Ulcerative colitis;
SKCM	cis	rs3780486	0.801	rs56687083	chr9:33132134	A/G	cg13443165	chr9:33130375	B4GALT1	-0.55	-4.99	-0.49	3.65e-6	IgG glycosylation;
SKCM	cis	rs2153535	0.580	rs1319169	chr6:8464456	G/A	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs7618501	0.633	rs6446189	chr3:50008566	A/G	cg24110177	chr3:50126178	RBM5	-0.6	-5.11	-0.5	2.25e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs4132509	1.000	rs10927076	chr1:243958293	A/G	cg21452805	chr1:244014465	NA	0.87	5.16	0.5	1.81e-6	RR interval (heart rate);
SKCM	cis	rs9902453	0.753	rs7226121	chr17:28208125	C/A	cg26525008	chr17:28256777	EFCAB5;SSH2	0.82	6.42	0.59	9.9e-9	Coffee consumption (cups per day);
SKCM	cis	rs6087990	0.735	rs1855350	chr20:31387525	C/T	cg13636640	chr20:31349939	DNMT3B	0.83	6.25	0.58	2.06e-8	Ulcerative colitis;
SKCM	cis	rs28386778	0.897	rs894406	chr17:61901657	A/G	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs7618501	0.699	rs2681781	chr3:49898273	A/G	cg05072774	chr3:49840536	C3orf54	-0.7	-5.25	-0.51	1.3e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs6951245	0.706	rs28685743	chr7:1197736	C/T	cg03188948	chr7:1209495	NA	1.04	6.04	0.56	4.89e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs1577917	0.785	rs1885607	chr6:86394905	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.83	8.18	0.68	4.16e-12	Response to antipsychotic treatment;
SKCM	cis	rs6545883	0.801	rs778142	chr2:61681428	G/T	cg15711740	chr2:61764176	XPO1	-0.7	-4.93	-0.49	4.5e-6	Tuberculosis;
SKCM	cis	rs2929278	0.588	rs688009	chr15:44156302	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	0.72	5.11	0.5	2.24e-6	Schizophrenia;
SKCM	cis	rs2842992	0.830	rs1535475	chr6:160148935	T/C	cg11366901	chr6:160182831	ACAT2	0.94	7.56	0.65	6.66e-11	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs17685	0.753	rs7788763	chr7:75651665	T/C	cg16489192	chr7:75678113	MDH2;STYXL1	0.58	5.26	0.51	1.22e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs561341	0.663	rs72821936	chr17:30224068	C/G	cg00745463	chr17:30367425	LRRC37B	-0.8	-5.15	-0.5	1.87e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs10256972	0.504	rs2949178	chr7:1209925	T/C	cg09177884	chr7:1199841	ZFAND2A	-0.84	-6.98	-0.62	8.44e-10	Longevity;Endometriosis;
SKCM	cis	rs2404602	0.647	rs11072619	chr15:77043242	A/C	cg23625390	chr15:77176239	SCAPER	-0.82	-7.93	-0.67	1.26e-11	Blood metabolite levels;
SKCM	cis	rs735396	0.770	rs2464196	chr12:121435427	G/A	cg02403541	chr12:121454288	C12orf43	0.76	6.57	0.6	5.04e-9	N-glycan levels;
SKCM	cis	rs7617480	0.648	rs4974083	chr3:49000626	A/G	cg07636037	chr3:49044803	WDR6	0.92	6.9	0.62	1.24e-9	Subjective well-being (multi-trait analysis);Menarche (age at onset);
SKCM	cis	rs1577917	1.000	rs35385043	chr6:86648546	T/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.77	-0.66	2.59e-11	Response to antipsychotic treatment;
SKCM	cis	rs4319547	0.774	rs7954006	chr12:123131824	A/C	cg23029597	chr12:123009494	RSRC2	0.71	5.02	0.49	3.15e-6	Body mass index;
SKCM	cis	rs7824557	0.564	rs2736293	chr8:11234613	T/A	cg21775007	chr8:11205619	TDH	-0.59	-5.04	-0.5	2.96e-6	Retinal vascular caliber;
SKCM	cis	rs11098499	0.863	rs12498539	chr4:120468370	C/T	cg09307838	chr4:120376055	NA	1.0	8.27	0.68	2.8e-12	Corneal astigmatism;
SKCM	cis	rs79839061	0.610	rs12651271	chr4:854071	C/T	cg07828340	chr4:882639	GAK	1.06	5.32	0.52	9.74e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs12477438	0.798	rs1453561	chr2:99613924	C/T	cg26064155	chr2:99771622	LIPT1;TSGA10	-0.72	-4.86	-0.48	6e-6	Chronic sinus infection;
SKCM	cis	rs9911578	1.000	rs4372750	chr17:57013803	A/C	cg12560992	chr17:57184187	TRIM37	-0.88	-7.24	-0.63	2.69e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs6089584	0.830	rs6089309	chr20:60585687	T/C	cg06108461	chr20:60628389	TAF4	-0.88	-7.93	-0.67	1.27e-11	Body mass index;
SKCM	cis	rs2072499	0.966	rs2984615	chr1:156165317	G/C	cg25208724	chr1:156163844	SLC25A44	1.1	9.96	0.75	1.48e-15	Testicular germ cell tumor;
SKCM	cis	rs782590	0.774	rs782632	chr2:55898290	C/G	cg18811423	chr2:55921094	PNPT1	0.91	7.45	0.64	1.08e-10	Metabolic syndrome;
SKCM	cis	rs9910055	0.571	rs10208	chr17:42300278	C/T	cg08499158	chr17:42289980	UBTF	-0.84	-7.7	-0.66	3.58e-11	Total body bone mineral density;
SKCM	cis	rs798554	1.000	rs798548	chr7:2760935	A/G	cg19346786	chr7:2764209	NA	-0.69	-7.34	-0.64	1.73e-10	Height;
SKCM	cis	rs17685	0.753	rs12531559	chr7:75631697	C/T	cg16684958	chr7:75615977	POR	-0.6	-5.66	-0.54	2.37e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7727544	0.735	rs272875	chr5:131674888	T/C	cg24060327	chr5:131705240	SLC22A5	-0.7	-5.13	-0.5	2.07e-6	Blood metabolite levels;
SKCM	cis	rs6582630	0.555	rs11182202	chr12:38476451	C/G	cg26384229	chr12:38710491	ALG10B	0.81	6.22	0.58	2.31e-8	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs9381040	0.655	rs4140578	chr6:41041829	A/G	cg03644281	chr6:41068752	NFYA;LOC221442	-0.72	-4.81	-0.48	7.24e-6	Alzheimer's disease (late onset);
SKCM	cis	rs28595532	0.920	rs17324807	chr4:119770638	G/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs3857536	0.642	rs7755840	chr6:66891913	A/G	cg07460842	chr6:66804631	NA	-0.7	-5.08	-0.5	2.51e-6	Blood trace element (Cu levels);
SKCM	cis	rs4727027	0.625	rs75129390	chr7:148846775	T/A	cg23583168	chr7:148888333	NA	-0.79	-6.36	-0.58	1.28e-8	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	trans	rs1814175	0.616	rs10769644	chr11:49987676	C/A	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs2180341	1.000	rs2144742	chr6:127595786	C/A	cg24812749	chr6:127587940	RNF146	0.86	7.32	0.64	1.92e-10	Breast cancer;
SKCM	cis	rs2032447	0.507	rs478349	chr6:25894057	T/C	cg03264133	chr6:25882463	NA	-0.62	-5.37	-0.52	7.83e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs367615	0.512	rs414724	chr5:108670421	A/G	cg17395555	chr5:108820864	NA	0.7	5.67	0.54	2.32e-7	Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs2739330	0.828	rs2154593	chr22:24252085	A/G	cg25703541	chr22:24373054	LOC391322	-0.77	-6.31	-0.58	1.55e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs10256972	0.706	rs12701970	chr7:1121958	T/C	cg09177884	chr7:1199841	ZFAND2A	-0.76	-6.45	-0.59	8.73e-9	Longevity;Endometriosis;
SKCM	cis	rs854765	0.686	rs8065497	chr17:17782649	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	-0.87	-6.31	-0.58	1.59e-8	Total body bone mineral density;
SKCM	cis	rs1577917	0.665	rs4304137	chr6:86217448	G/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.97	10.74	0.77	4.95e-17	Response to antipsychotic treatment;
SKCM	cis	rs28595532	0.920	rs116062544	chr4:119735548	G/C	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs2858942	0.575	rs2858011	chr16:247938	C/T	cg03788090	chr16:233062	NA	-0.57	-4.88	-0.48	5.51e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs644799	0.544	rs56298021	chr11:95545113	T/G	cg03916912	chr11:95522834	CEP57;FAM76B	0.61	4.87	0.48	5.73e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs6089584	0.888	rs6061983	chr20:60621202	T/C	cg06108461	chr20:60628389	TAF4	-0.89	-8.72	-0.7	3.75e-13	Body mass index;
SKCM	cis	rs1218582	0.774	rs12036859	chr1:154859940	A/C	cg16680214	chr1:154839983	KCNN3	0.57	5.41	0.52	6.58e-7	Prostate cancer;
SKCM	cis	rs959260	0.623	rs2164244	chr17:73325244	C/T	cg14668889	chr17:73230827	NUP85	-0.75	-6.29	-0.58	1.72e-8	Systemic lupus erythematosus;
SKCM	cis	rs9303401	0.659	rs1864754	chr17:56688789	G/T	cg02118635	chr17:56770003	RAD51C;TEX14	-0.81	-5.35	-0.52	8.54e-7	Cognitive test performance;
SKCM	trans	rs12599106	0.624	rs2173885	chr16:34992749	G/A	cg03395511	chr6:291903	DUSP22	-0.69	-7.61	-0.65	5.41e-11	Menopause (age at onset);
SKCM	cis	rs6120849	0.901	rs6058194	chr20:33739831	G/A	cg24642439	chr20:33292090	TP53INP2	0.91	5.05	0.5	2.83e-6	Protein C levels;
SKCM	cis	rs4268898	0.662	rs35624938	chr2:24576651	T/C	cg06627628	chr2:24431161	ITSN2	-0.9	-6.93	-0.62	1.07e-9	Asthma;
SKCM	cis	rs6424115	0.679	rs2294495	chr1:24075876	C/T	cg15997130	chr1:24165203	NA	-0.63	-5.02	-0.49	3.24e-6	Immature fraction of reticulocytes;
SKCM	cis	rs1577917	0.883	rs12214536	chr6:86790310	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.63	-5.36	-0.52	8.17e-7	Response to antipsychotic treatment;
SKCM	cis	rs67311347	0.544	rs4974040	chr3:40331059	G/A	cg02782426	chr3:40428986	ENTPD3	0.51	5.2	0.51	1.57e-6	Renal cell carcinoma;
SKCM	cis	rs9790314	0.543	rs1349352	chr3:161118486	C/T	cg03342759	chr3:160939853	NMD3	-0.74	-6.62	-0.6	4.08e-9	Morning vs. evening chronotype;
SKCM	cis	rs8078723	1.000	rs4794824	chr17:38179290	G/A	cg17467752	chr17:38218738	THRA	0.69	6.3	0.58	1.63e-8	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs11098499	0.863	rs3775843	chr4:120427844	T/C	cg24375607	chr4:120327624	NA	0.7	5.38	0.52	7.69e-7	Corneal astigmatism;
SKCM	cis	rs9858542	0.953	rs9811982	chr3:49624377	A/C	cg03060546	chr3:49711283	APEH	-0.69	-5.08	-0.5	2.49e-6	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs4740619	0.617	rs1328275	chr9:16027029	T/C	cg14451791	chr9:16040625	NA	-0.47	-4.99	-0.49	3.56e-6	Body mass index;
SKCM	cis	rs11098499	0.954	rs7437420	chr4:120312903	A/G	cg09307838	chr4:120376055	NA	0.97	7.49	0.65	9.08e-11	Corneal astigmatism;
SKCM	cis	rs651907	0.557	rs34624546	chr3:101374226	T/G	cg12386194	chr3:101231763	SENP7	0.71	5.89	0.55	9.17e-8	Colorectal cancer;
SKCM	cis	rs7216064	0.953	rs8073510	chr17:65839210	A/G	cg12091567	chr17:66097778	LOC651250	-0.77	-5.53	-0.53	4.06e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs561341	1.000	rs560132	chr17:30320019	C/T	cg23018236	chr17:30244563	NA	-0.55	-5.65	-0.54	2.46e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs7584330	0.554	rs880931	chr2:238396741	G/A	cg08992911	chr2:238395768	MLPH	0.95	5.1	0.5	2.3e-6	Prostate cancer;
SKCM	cis	rs651907	0.557	rs13066768	chr3:101486920	A/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	-0.82	-7.06	-0.62	6.06e-10	Colorectal cancer;
SKCM	cis	rs36093844	0.706	rs11828105	chr11:85550384	C/T	cg25872744	chr11:85566296	CCDC83	-0.85	-4.77	-0.48	8.27e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs12706411	0.764	rs11984390	chr7:122074148	T/C	cg17986181	chr7:121955208	NA	-0.65	-5.01	-0.49	3.36e-6	Alzheimer disease and age of onset;
SKCM	cis	rs9388451	0.839	rs3799709	chr6:126078361	A/G	cg05901451	chr6:126070800	HEY2	-0.81	-8.01	-0.67	9.05e-12	Brugada syndrome;
SKCM	cis	rs7824557	0.767	rs28507159	chr8:11166076	C/T	cg21775007	chr8:11205619	TDH	0.72	6.0	0.56	5.73e-8	Retinal vascular caliber;
SKCM	cis	rs2721195	0.816	rs4251689	chr8:145741130	C/T	cg15320075	chr8:145703422	NA	0.8	7.02	0.62	7.09e-10	Age at first birth;
SKCM	cis	rs9858542	0.951	rs1800668	chr3:49395757	G/A	cg03060546	chr3:49711283	APEH	-0.69	-5.16	-0.5	1.85e-6	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs6665290	0.870	rs1045289	chr1:227178713	C/T	cg10327440	chr1:227177885	CDC42BPA	-1.22	-17.17	-0.89	3.2e-28	Myeloid white cell count;
SKCM	cis	rs514406	0.760	rs1242198	chr1:53352016	G/A	cg16325326	chr1:53192061	ZYG11B	0.83	7.75	0.66	2.86e-11	Monocyte count;
SKCM	cis	rs10489202	1.000	rs67600256	chr1:167972357	T/C	cg24449463	chr1:168025552	DCAF6	-0.78	-5.84	-0.55	1.15e-7	Schizophrenia;
SKCM	cis	rs28595532	0.920	rs116047800	chr4:119773569	G/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs8072100	0.713	rs11651643	chr17:45483229	A/G	cg08085267	chr17:45401833	C17orf57	-0.62	-5.06	-0.5	2.76e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs13217239	0.646	rs6456767	chr6:27070543	C/T	cg12292205	chr6:26970375	C6orf41	-0.59	-5.15	-0.5	1.94e-6	Schizophrenia;
SKCM	cis	rs823143	0.570	rs1361754	chr1:205801872	C/T	cg26354017	chr1:205819088	PM20D1	-1.02	-10.65	-0.77	7.37e-17	Monocyte percentage of white cells;
SKCM	cis	rs1799949	0.965	rs11658499	chr17:41334749	C/T	cg05368731	chr17:41323189	NBR1	0.87	7.74	0.66	3.01e-11	Menopause (age at onset);
SKCM	cis	rs6728642	1.000	rs7580504	chr2:97605597	C/G	cg00438775	chr2:97175311	NEURL3	1.05	4.85	0.48	6.22e-6	Bipolar disorder lithium response (continuous) or schizophrenia;
SKCM	cis	rs7772486	0.713	rs2328704	chr6:146020494	T/C	cg23711669	chr6:146136114	FBXO30	-0.82	-8.38	-0.69	1.71e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs17685	0.672	rs6465011	chr7:75811297	T/C	cg01364799	chr7:75623366	TMEM120A	-0.69	-5.81	-0.55	1.28e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs72615157	0.634	rs7789890	chr7:99800559	G/T	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.23	8.38	0.69	1.71e-12	Lung function (FEV1/FVC);
SKCM	cis	rs11098499	0.754	rs1511025	chr4:120240238	T/C	cg09307838	chr4:120376055	NA	0.93	7.56	0.65	6.5500000000000006e-11	Corneal astigmatism;
SKCM	cis	rs11112613	0.713	rs11112587	chr12:105941285	G/A	cg03607813	chr12:105948248	NA	0.85	5.51	0.53	4.41e-7	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;
SKCM	cis	rs2303759	0.670	rs45549132	chr19:49794028	G/T	cg05022225	chr19:49866942	DKKL1;TEAD2	0.68	4.82	0.48	7.05e-6	Multiple sclerosis;
SKCM	cis	rs6089829	0.962	rs1116450	chr20:61658210	T/C	cg08564027	chr20:61660810	NA	0.65	5.71	0.54	1.95e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs763014	1.000	rs763014	chr16:675680	T/C	cg09263875	chr16:632152	PIGQ	0.71	6.32	0.58	1.52e-8	Height;
SKCM	cis	rs769267	0.825	rs1469713	chr19:19528806	A/G	cg26732615	chr19:19648335	CILP2;YJEFN3	0.69	7.02	0.62	7.14e-10	Tonsillectomy;
SKCM	cis	rs8103278	0.507	rs3745802	chr19:46271177	G/T	cg12641515	chr19:46296257	DMWD	0.78	6.25	0.58	2.05e-8	Coronary artery disease;
SKCM	cis	rs28595532	0.623	rs17516540	chr4:119278443	A/G	cg21605333	chr4:119757512	SEC24D	0.93	5.03	0.49	3.12e-6	Cannabis dependence symptom count;
SKCM	cis	rs4268898	0.662	rs714531	chr2:24399877	G/A	cg06627628	chr2:24431161	ITSN2	-0.89	-6.69	-0.6	2.98e-9	Asthma;
SKCM	cis	rs7618915	1.000	rs59565798	chr3:52307169	G/A	cg18404041	chr3:52824283	ITIH1	-0.6	-5.45	-0.53	5.65e-7	Bipolar disorder;
SKCM	cis	rs3820068	0.581	rs16851855	chr1:15930869	G/A	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs3749237	0.595	rs12489092	chr3:49550914	G/C	cg03060546	chr3:49711283	APEH	0.67	4.82	0.48	7.06e-6	Resting heart rate;
SKCM	cis	rs1577917	0.917	rs13213603	chr6:86534758	T/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.81	-0.66	2.19e-11	Response to antipsychotic treatment;
SKCM	cis	rs6500395	1.000	rs9931737	chr16:48623539	C/T	cg04672837	chr16:48644449	N4BP1	0.69	5.88	0.55	9.68e-8	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs28595532	0.920	rs114410095	chr4:119731110	G/A	cg11846333	chr4:119757529	SEC24D	1.2	6.43	0.59	9.38e-9	Cannabis dependence symptom count;
SKCM	cis	rs4523957	0.690	rs7213715	chr17:2093511	A/T	cg16513277	chr17:2031491	SMG6	-0.89	-6.19	-0.57	2.61e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	trans	rs561341	1.000	rs473356	chr17:30321762	G/C	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs1635	0.655	rs60568488	chr6:28309511	T/C	cg15743358	chr6:28303923	ZNF323	-1.27	-5.15	-0.5	1.92e-6	Schizophrenia;
SKCM	cis	rs28374715	0.662	rs10851403	chr15:41466087	T/G	cg18705301	chr15:41695430	NDUFAF1	-0.93	-7.74	-0.66	2.94e-11	Ulcerative colitis;
SKCM	cis	rs13424612	1.000	rs10193610	chr2:240940618	A/G	cg01812947	chr2:240904978	NDUFA10	0.7	5.42	0.52	6.38e-7	Odorant perception (isobutyraldehyde);
SKCM	cis	rs7772486	0.875	rs10457792	chr6:146412415	T/C	cg05347473	chr6:146136440	FBXO30	0.64	5.83	0.55	1.19e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs362296	0.698	rs3129319	chr4:3265381	A/G	cg11471262	chr4:3318911	RGS12	-0.69	-6.15	-0.57	3.12e-8	Parental longevity (mother's age at death);
SKCM	cis	rs1577917	1.000	rs7747824	chr6:86647106	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.77	-0.66	2.59e-11	Response to antipsychotic treatment;
SKCM	cis	rs6933660	0.721	rs2128945	chr6:151767907	A/G	cg10883421	chr6:151773342	RMND1;C6orf211	0.82	6.99	0.62	8.08e-10	Menarche (age at onset);
SKCM	cis	rs9325144	0.647	rs61937754	chr12:39060543	T/C	cg26384229	chr12:38710491	ALG10B	-0.71	-6.38	-0.59	1.17e-8	Morning vs. evening chronotype;
SKCM	cis	rs644799	0.672	rs11021347	chr11:95653494	T/C	cg03916912	chr11:95522834	CEP57;FAM76B	0.77	6.11	0.57	3.67e-8	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs7826238	0.564	rs2921053	chr8:8319963	G/C	cg15556689	chr8:8085844	FLJ10661	0.7	5.66	0.54	2.42e-7	Systolic blood pressure;
SKCM	cis	rs7296418	0.922	rs1790134	chr12:123697898	T/C	cg00376283	chr12:123451042	ABCB9	0.89	7.23	0.63	2.92e-10	Platelet count;
SKCM	cis	rs6121246	0.512	rs6060941	chr20:30367383	C/T	cg11595048	chr20:30225325	COX4I2	0.54	4.77	0.48	8.4e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs208520	1.000	rs72882086	chr6:66976671	G/A	cg07460842	chr6:66804631	NA	0.85	6.05	0.56	4.8e-8	Exhaled nitric oxide output;
SKCM	cis	rs9322193	0.923	rs9322197	chr6:149943713	C/A	cg07701084	chr6:150067640	NUP43	0.61	4.84	0.48	6.48e-6	Lung cancer;
SKCM	cis	rs367615	0.506	rs2963021	chr5:108800365	C/T	cg17395555	chr5:108820864	NA	0.83	7.41	0.64	1.28e-10	Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs28386778	0.897	rs2665796	chr17:61923716	G/C	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs1878931	0.582	rs4785933	chr16:3419741	T/A	cg26668626	chr16:3451006	ZNF174;ZNF434	0.82	5.95	0.56	7.24e-8	Body mass index (adult);
SKCM	cis	rs244731	0.920	rs67008484	chr5:176735383	T/C	cg06060754	chr5:176797920	RGS14	0.85	7.31	0.64	1.99e-10	Urate levels in lean individuals;
SKCM	cis	rs12971120	0.685	rs34780792	chr18:72173278	G/A	cg26446133	chr18:72167187	CNDP2	-0.68	-5.25	-0.51	1.3e-6	Refractive error;
SKCM	trans	rs9929218	0.529	rs17715450	chr16:68729785	C/A	cg04657470	chr2:198365150	HSPE1;HSPD1	0.94	8.84	0.71	2.19e-13	Colorectal cancer;
SKCM	cis	rs28595532	0.702	rs56217716	chr4:119338490	T/G	cg21605333	chr4:119757512	SEC24D	0.95	4.91	0.49	4.92e-6	Cannabis dependence symptom count;
SKCM	cis	rs11626933	0.589	rs10140761	chr14:90740588	G/C	cg14092571	chr14:90743983	NA	0.6	5.38	0.52	7.5e-7	Gut microbiota (bacterial taxa);
SKCM	cis	rs8141529	0.732	rs5762788	chr22:29174770	G/T	cg15103426	chr22:29168792	CCDC117	0.63	5.22	0.51	1.44e-6	Lymphocyte counts;
SKCM	cis	rs6933660	0.646	rs3816778	chr6:151773353	G/C	cg02564969	chr6:151773285	C6orf211;RMND1	0.66	5.59	0.54	3.17e-7	Menarche (age at onset);
SKCM	cis	rs875971	0.660	rs3857686	chr7:66036191	C/T	cg11987759	chr7:65425863	GUSB	0.69	5.9	0.56	8.74e-8	Aortic root size;
SKCM	trans	rs1814175	0.781	rs11040681	chr11:49981654	G/T	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs2832191	0.791	rs2832202	chr21:30501342	G/A	cg24692254	chr21:30365293	RNF160	-0.9	-8.01	-0.67	9.12e-12	Dental caries;
SKCM	cis	rs4642101	0.680	rs6442330	chr3:12820501	A/G	cg05775895	chr3:12838266	CAND2	0.61	5.49	0.53	4.8e-7	QRS complex (12-leadsum);
SKCM	cis	rs4900538	0.855	rs1209151	chr14:102893756	C/T	cg18135206	chr14:102964638	TECPR2	-0.7	-5.08	-0.5	2.49e-6	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs7811142	0.943	rs28578163	chr7:100044754	A/G	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-0.99	-5.52	-0.53	4.2e-7	Platelet count;
SKCM	cis	rs2180341	1.000	rs6569477	chr6:127589302	T/A	cg27446573	chr6:127587934	RNF146	1.02	8.27	0.68	2.88e-12	Breast cancer;
SKCM	cis	rs654950	1.000	rs654950	chr1:41987868	G/C	cg06885757	chr1:42089581	HIVEP3	-0.63	-6.83	-0.61	1.69e-9	Airway imaging phenotypes;
SKCM	cis	rs4727027	0.933	rs6464940	chr7:148826309	G/T	cg23583168	chr7:148888333	NA	-0.82	-6.56	-0.6	5.29e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs968451	0.526	rs5757617	chr22:39722714	G/C	cg17798944	chr22:39715225	SNORD43;RPL3	1.1	11.32	0.79	3.99e-18	Primary biliary cholangitis;
SKCM	cis	rs2836974	0.932	rs6517527	chr21:40581751	G/A	cg11644478	chr21:40555479	PSMG1	0.97	10.08	0.75	8.76e-16	Cognitive function;
SKCM	cis	rs8141529	0.732	rs2239815	chr22:29192670	C/T	cg02153584	chr22:29168773	CCDC117	-0.65	-5.44	-0.52	5.92e-7	Lymphocyte counts;
SKCM	cis	rs12541335	0.639	rs13257108	chr8:22165043	T/C	cg02463440	chr8:22132932	PIWIL2	0.62	5.39	0.52	7.41e-7	Hypertriglyceridemia;
SKCM	cis	rs933688	1.000	rs1363839	chr5:90671274	A/T	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.96	6.57	0.6	5.08e-9	Smoking behavior;
SKCM	cis	rs6430585	0.591	rs12477421	chr2:136433740	A/G	cg07169764	chr2:136633963	MCM6	1.15	8.6	0.7	6.42e-13	Corneal structure;
SKCM	cis	rs9300255	0.510	rs1727323	chr12:123698790	T/C	cg05973401	chr12:123451056	ABCB9	0.81	5.37	0.52	7.77e-7	Neutrophil percentage of white cells;
SKCM	cis	rs6951245	0.678	rs4724725	chr7:1214751	G/A	cg18402987	chr7:1209562	NA	1.2	7.34	0.64	1.75e-10	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs6753739	0.826	rs10164493	chr2:219948092	A/G	cg09617556	chr2:219924408	IHH	0.47	4.91	0.49	4.97e-6	Height;
SKCM	cis	rs2072499	0.833	rs2758605	chr1:156200445	G/C	cg25208724	chr1:156163844	SLC25A44	0.9	7.92	0.67	1.36e-11	Testicular germ cell tumor;
SKCM	cis	rs7523050	0.730	rs41279678	chr1:109440215	G/A	cg08274380	chr1:109419600	GPSM2	1.15	6.57	0.6	5.22e-9	Fat distribution (HIV);
SKCM	cis	rs514406	0.679	rs11585495	chr1:53244331	T/C	cg24675658	chr1:53192096	ZYG11B	0.89	7.95	0.67	1.16e-11	Monocyte count;
SKCM	cis	rs614226	1.000	rs614226	chr12:120974510	C/T	cg01236616	chr12:121019343	POP5	-1.34	-8.54	-0.7	8.29e-13	Type 1 diabetes nephropathy;
SKCM	cis	rs9902453	0.904	rs7218379	chr17:28402737	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.82	-6.4	-0.59	1.06e-8	Coffee consumption (cups per day);
SKCM	cis	rs523522	0.962	rs10849753	chr12:120910813	C/T	cg27279351	chr12:120934652	DYNLL1	0.9	7.85	0.66	1.8e-11	High light scatter reticulocyte count;
SKCM	cis	rs8180040	0.966	rs9683033	chr3:47489820	C/T	cg16586182	chr3:47516702	SCAP	-0.76	-5.32	-0.52	9.63e-7	Colorectal cancer;
SKCM	cis	rs55962025	0.883	rs2298967	chr4:3185747	T/C	cg09735869	chr4:3319127	RGS12	-0.64	-5.25	-0.51	1.3e-6	Parental longevity (mother's age at death);
SKCM	cis	rs12134245	0.776	rs61548854	chr1:92001536	C/T	cg02896835	chr1:92012615	NA	-0.65	-5.99	-0.56	6.15e-8	Breast cancer;
SKCM	cis	rs2404602	0.598	rs11634019	chr15:76634680	A/G	cg23625390	chr15:77176239	SCAPER	-0.78	-6.93	-0.62	1.06e-9	Blood metabolite levels;
SKCM	cis	rs514406	0.929	rs557920	chr1:53338757	C/A	cg16325326	chr1:53192061	ZYG11B	0.97	10.09	0.75	8.55e-16	Monocyte count;
SKCM	cis	rs17376456	0.569	rs6895356	chr5:93060781	A/G	cg25358565	chr5:93447407	FAM172A	0.91	6.1	0.57	3.85e-8	Diabetic retinopathy;
SKCM	cis	rs2811415	0.597	rs6808774	chr3:127759090	G/A	cg09089421	chr3:127803668	RUVBL1	0.99	8.52	0.69	9.09e-13	Lung function (FEV1/FVC);
SKCM	cis	rs6062302	0.522	rs914558	chr20:62216976	A/G	cg09650180	chr20:62225654	GMEB2	-0.81	-6.61	-0.6	4.23e-9	Glioblastoma;
SKCM	cis	rs7826238	0.509	rs2948288	chr8:8115304	A/G	cg15556689	chr8:8085844	FLJ10661	0.82	6.93	0.62	1.08e-9	Systolic blood pressure;
SKCM	cis	rs13256369	0.802	rs12541520	chr8:8564146	G/T	cg06636001	chr8:8085503	FLJ10661	0.83	6.37	0.59	1.2e-8	Obesity-related traits;
SKCM	cis	rs11673344	0.704	rs1726724	chr19:37416792	A/G	cg07624650	chr19:37064219	ZNF529	-0.8	-5.24	-0.51	1.31e-6	Obesity-related traits;
SKCM	cis	rs10504229	0.683	rs17194792	chr8:58107195	A/C	cg02725872	chr8:58115012	NA	-0.53	-4.91	-0.49	4.82e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs28595532	0.925	rs56200441	chr4:119497440	T/G	cg11846333	chr4:119757529	SEC24D	1.15	6.24	0.58	2.13e-8	Cannabis dependence symptom count;
SKCM	cis	rs1912528	0.778	rs769656	chr4:140878643	T/C	cg11128457	chr4:140864437	MAML3	0.57	4.89	0.48	5.36e-6	Educational attainment (years of education);
SKCM	cis	rs1707322	0.682	rs3014241	chr1:46087879	A/G	cg03146154	chr1:46216737	IPP	-0.78	-5.08	-0.5	2.51e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs1862618	0.853	rs6885541	chr5:56110857	G/C	cg12311346	chr5:56204834	C5orf35	-0.71	-4.79	-0.48	7.79e-6	Initial pursuit acceleration;
SKCM	cis	rs7811142	1.000	rs1000215	chr7:100004543	A/G	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-1.04	-5.98	-0.56	6.44e-8	Platelet count;
SKCM	cis	rs2153535	0.601	rs1855768	chr6:8472969	T/G	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs7927771	0.832	rs55677087	chr11:47397714	C/G	cg01152729	chr11:47593274	PTPMT1	-0.51	-4.88	-0.48	5.49e-6	Subjective well-being;
SKCM	cis	rs9543976	1.000	rs2328964	chr13:76138830	G/T	cg01531495	chr13:76123901	UCHL3	0.93	5.16	0.5	1.83e-6	Diabetic retinopathy;
SKCM	cis	rs1568889	1.000	rs11603799	chr11:28196488	T/A	cg06544937	chr11:28130018	METT5D1;KIF18A	0.86	6.87	0.61	1.4e-9	Bipolar disorder;
SKCM	trans	rs1814175	0.616	rs10769644	chr11:49987676	C/A	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs250567	0.581	rs461494	chr16:23608449	C/A	cg09934309	chr16:23461721	COG7	-0.79	-5.22	-0.51	1.44e-6	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes;
SKCM	cis	rs1801251	1.000	rs7592717	chr2:233577038	G/A	cg08000102	chr2:233561755	GIGYF2	0.89	6.91	0.62	1.15e-9	Coronary artery disease;
SKCM	cis	rs6088590	0.965	rs910869	chr20:33292777	C/T	cg24642439	chr20:33292090	TP53INP2	0.99	7.53	0.65	7.63e-11	Coronary artery disease;
SKCM	cis	rs2439831	1.000	rs471229	chr15:43733994	G/A	cg02155558	chr15:43621948	ADAL;LCMT2	1.1	7.54	0.65	7.34e-11	Lung cancer in ever smokers;
SKCM	trans	rs1814175	0.754	rs28663627	chr11:50048829	C/T	cg15704280	chr7:45808275	SEPT13	-1.05	-11.07	-0.78	1.14e-17	Height;
SKCM	cis	rs5760092	0.755	rs6003959	chr22:24264395	C/T	cg04234412	chr22:24373322	LOC391322	0.73	5.61	0.54	2.92e-7	Urinary 1,3-butadiene metabolite levels in smokers;
SKCM	cis	rs10883723	0.810	rs1884929	chr10:104275418	C/T	cg11453585	chr10:104263688	ACTR1A;SUFU	0.79	6.45	0.59	8.77e-9	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs62244186	0.545	rs725866	chr3:44765533	A/G	cg15225532	chr3:44803084	KIF15;KIAA1143	0.64	5.08	0.5	2.5e-6	Depressive symptoms;
SKCM	cis	rs2204008	0.805	rs11179579	chr12:38213957	A/C	cg26384229	chr12:38710491	ALG10B	0.82	6.58	0.6	4.87e-9	Bladder cancer;
SKCM	cis	rs6952808	0.600	rs2895202	chr7:2131829	T/C	cg02951883	chr7:2050386	MAD1L1	-0.77	-7.06	-0.62	5.96e-10	Bipolar disorder and schizophrenia;
SKCM	trans	rs1814175	0.546	rs1614397	chr11:49913384	G/C	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs6087990	0.806	rs910085	chr20:31383353	T/G	cg13636640	chr20:31349939	DNMT3B	0.92	8.06	0.67	7.3e-12	Ulcerative colitis;
SKCM	cis	rs908922	0.676	rs945788	chr1:152512762	A/G	cg09873164	chr1:152488093	CRCT1	0.75	5.95	0.56	7.3e-8	Hair morphology;
SKCM	cis	rs4665809	0.549	rs62130460	chr2:26472718	T/C	cg26119090	chr2:26468346	HADHA;HADHB	0.99	7.35	0.64	1.67e-10	Gut microbiome composition (summer);
SKCM	cis	rs2013441	1.000	rs2526464	chr17:20075052	A/G	cg13482628	chr17:19912719	NA	-0.67	-5.24	-0.51	1.32e-6	Obesity-related traits;
SKCM	cis	rs6570726	0.846	rs446031	chr6:145885592	C/T	cg05347473	chr6:146136440	FBXO30	0.55	4.99	0.49	3.62e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs992157	0.798	rs10206064	chr2:219157959	T/C	cg20019365	chr2:219134978	PNKD;AAMP	0.71	6.11	0.57	3.64e-8	Colorectal cancer;
SKCM	cis	rs4975616	0.869	rs455433	chr5:1336243	A/G	cg06550200	chr5:1325588	CLPTM1L	-0.86	-7.74	-0.66	2.94e-11	Lung cancer;
SKCM	cis	rs2404602	0.692	rs4886503	chr15:77108874	C/T	cg23625390	chr15:77176239	SCAPER	-0.61	-5.44	-0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs7937682	0.632	rs11214028	chr11:111761149	T/C	cg09085632	chr11:111637200	PPP2R1B	1.1	10.72	0.77	5.29e-17	Primary sclerosing cholangitis;
SKCM	cis	rs873946	0.586	rs3793684	chr10:134568645	G/A	cg18305652	chr10:134549665	INPP5A	0.58	5.64	0.54	2.62e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs1218582	0.774	rs2335409	chr1:154916106	G/A	cg24250549	chr1:154909240	PMVK	0.84	8.58	0.7	7.06e-13	Prostate cancer;
SKCM	cis	rs16854884	0.609	rs9872126	chr3:143683851	G/A	cg06585982	chr3:143692056	C3orf58	0.77	7.6	0.65	5.68e-11	Economic and political preferences (feminism/equality);
SKCM	cis	rs732765	0.734	rs11844127	chr14:75139936	C/G	cg25946216	chr14:74253857	C14orf43	-0.92	-6.0	-0.56	5.93e-8	Non-small cell lung cancer;
SKCM	cis	rs8014204	0.804	rs34956813	chr14:75254167	G/A	cg06637938	chr14:75390232	RPS6KL1	0.84	6.66	0.6	3.53e-9	Caffeine consumption;
SKCM	cis	rs6121246	0.909	rs6058460	chr20:30363071	G/A	cg11595048	chr20:30225325	COX4I2	0.67	5.21	0.51	1.5e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs5750830	0.649	rs5750820	chr22:39825322	T/G	cg11247378	chr22:39784982	NA	-0.46	-5.25	-0.51	1.26e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7552404	0.924	rs2153126	chr1:76199345	C/G	cg03433033	chr1:76189801	ACADM	0.76	5.58	0.53	3.34e-7	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs875971	0.522	rs34973832	chr7:65396204	A/G	cg11987759	chr7:65425863	GUSB	-0.74	-6.36	-0.58	1.26e-8	Aortic root size;
SKCM	cis	rs6547631	0.836	rs4832004	chr2:85912870	C/T	cg24620635	chr2:85921963	GNLY	0.74	6.04	0.56	4.84e-8	Blood protein levels;
SKCM	cis	rs10504229	1.000	rs58382845	chr8:58169851	A/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs6547631	0.622	rs4832185	chr2:85928814	T/A	cg24620635	chr2:85921963	GNLY	0.9	6.65	0.6	3.58e-9	Blood protein levels;
SKCM	cis	rs6951245	0.935	rs79143504	chr7:1110212	A/G	cg18402987	chr7:1209562	NA	1.15	6.09	0.57	3.95e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs6430585	0.941	rs10496737	chr2:136540083	A/G	cg07169764	chr2:136633963	MCM6	0.89	7.01	0.62	7.69e-10	Corneal structure;
SKCM	cis	rs4073582	0.595	rs801731	chr11:65938446	G/C	cg16950941	chr11:66035639	RAB1B	0.81	6.87	0.61	1.41e-9	Gout;
SKCM	cis	rs763121	0.853	rs2205802	chr22:39046327	T/C	cg06022373	chr22:39101656	GTPBP1	0.72	4.96	0.49	4.08e-6	Menopause (age at onset);
SKCM	cis	rs12824058	0.737	rs11060829	chr12:130814996	G/T	cg26677194	chr12:130822605	PIWIL1	0.71	5.91	0.56	8.57e-8	Menopause (age at onset);
SKCM	cis	rs9467773	1.000	rs9393729	chr6:26514166	C/T	cg09904177	chr6:26538194	HMGN4	0.54	4.98	0.49	3.78e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1348850	0.872	rs2084233	chr2:178331206	G/A	cg02961200	chr2:178257176	LOC100130691;AGPS	0.83	6.14	0.57	3.21e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs28595532	0.920	rs115673173	chr4:119755321	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs9443189	0.570	rs567903	chr6:76327851	C/T	cg01950844	chr6:76311363	SENP6	0.97	7.04	0.62	6.57e-10	Prostate cancer;
SKCM	cis	rs2153535	0.580	rs2184583	chr6:8447808	A/G	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs9611565	0.729	rs2413646	chr22:41906325	C/T	cg03806693	chr22:41940476	POLR3H	-1.11	-7.39	-0.64	1.4e-10	Vitiligo;
SKCM	cis	rs28595532	0.920	rs115841156	chr4:119740073	C/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs25645	0.792	rs8077456	chr17:38128765	C/G	cg17467752	chr17:38218738	THRA	-0.8	-6.72	-0.61	2.63e-9	Myeloid white cell count;
SKCM	cis	rs4555082	0.874	rs2142190	chr14:105719306	G/A	cg13114125	chr14:105738426	BRF1	-0.72	-5.49	-0.53	4.81e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs644799	1.000	rs518919	chr11:95623313	G/C	cg03916912	chr11:95522834	CEP57;FAM76B	0.87	7.03	0.62	6.92e-10	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs2404602	0.647	rs11633869	chr15:77133322	G/T	cg23625390	chr15:77176239	SCAPER	0.82	7.93	0.67	1.26e-11	Blood metabolite levels;
SKCM	cis	rs5769765	0.954	rs1569954	chr22:50244071	C/T	cg22709217	chr22:50311962	ALG12;CRELD2	0.77	5.57	0.53	3.47e-7	Schizophrenia;
SKCM	cis	rs7100689	0.622	rs10749569	chr10:82129892	G/A	cg01528321	chr10:82214614	TSPAN14	0.8	7.0	0.62	7.98e-10	Post bronchodilator FEV1;
SKCM	cis	rs7954584	0.626	rs10840637	chr12:122427310	A/G	cg13699009	chr12:122356056	WDR66	0.58	7.22	0.63	3.04e-10	Mean corpuscular volume;
SKCM	cis	rs9910055	0.718	rs7212854	chr17:42254417	A/G	cg19774624	chr17:42201019	HDAC5	-0.89	-7.83	-0.66	1.97e-11	Total body bone mineral density;
SKCM	cis	rs7552404	0.924	rs1694419	chr1:76219801	C/T	cg03433033	chr1:76189801	ACADM	0.69	4.99	0.49	3.56e-6	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs36093844	0.752	rs56202113	chr11:85553558	G/A	cg25872744	chr11:85566296	CCDC83	-0.85	-4.77	-0.48	8.27e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs6500602	0.701	rs4785968	chr16:4535307	T/A	cg08645402	chr16:4508243	NA	0.63	4.89	0.48	5.39e-6	Schizophrenia;
SKCM	cis	rs651907	0.557	rs1056579	chr3:101397877	T/G	cg12386194	chr3:101231763	SENP7	0.69	5.68	0.54	2.23e-7	Colorectal cancer;
SKCM	cis	rs9910055	0.821	rs4473241	chr17:42281282	G/T	cg13607699	chr17:42295918	UBTF	0.77	5.99	0.56	6.06e-8	Total body bone mineral density;
SKCM	cis	rs2836974	0.583	rs2776306	chr21:40713754	A/G	cg11890956	chr21:40555474	PSMG1	0.72	5.76	0.55	1.56e-7	Cognitive function;
SKCM	cis	rs6951245	0.554	rs11761322	chr7:1151657	A/G	cg18402987	chr7:1209562	NA	0.82	5.43	0.52	6.18e-7	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs10751667	0.666	rs7394992	chr11:980690	G/C	cg10932868	chr11:921992	NA	0.58	5.37	0.52	7.7300000000000005e-07	Alzheimer's disease (late onset);
SKCM	cis	rs13108904	0.846	rs9631804	chr4:1283032	A/T	cg05665937	chr4:1216051	CTBP1	-0.56	-4.77	-0.48	8.44e-6	Obesity-related traits;
SKCM	cis	rs12586317	0.547	rs10145723	chr14:35460954	G/A	cg16230307	chr14:35515116	FAM177A1	0.81	5.88	0.55	9.47e-8	Psoriasis;
SKCM	cis	rs7395662	0.534	rs12418219	chr11:48988091	G/T	cg14072046	chr11:49124791	NA	-0.51	-4.87	-0.48	5.72e-6	HDL cholesterol;
SKCM	cis	rs3091242	0.933	rs34933589	chr1:25788198	T/C	cg02931644	chr1:25747376	RHCE	-0.51	-4.92	-0.49	4.65e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs9430161	0.579	rs11121669	chr1:11039567	T/C	cg02454025	chr1:11042201	C1orf127	0.96	8.79	0.71	2.74e-13	Ewing sarcoma;
SKCM	cis	rs28386778	0.897	rs1470697	chr17:61799840	T/C	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.36	0.52	8.08e-7	Prudent dietary pattern;
SKCM	cis	rs561341	1.000	rs550923	chr17:30327013	G/C	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	trans	rs6481128	0.778	rs962471	chr10:56700494	C/G	cg04272632	chr1:34629400	CSMD2	0.69	7.66	0.66	4.26e-11	Extraversion;
SKCM	cis	rs1850744	0.510	rs9995183	chr4:9625793	C/A	cg15442990	chr4:9534313	NA	1.55	5.8	0.55	1.34e-7	Economic and political preferences;
SKCM	cis	rs6088590	1.000	rs6120747	chr20:33449769	T/C	cg24642439	chr20:33292090	TP53INP2	0.98	6.92	0.62	1.11e-9	Coronary artery disease;
SKCM	cis	rs11690935	0.632	rs34531723	chr2:172564094	A/C	cg13550731	chr2:172543902	DYNC1I2	0.63	5.53	0.53	4.04e-7	Schizophrenia;
SKCM	cis	rs4481887	0.861	rs4486480	chr1:248449714	C/T	cg00666640	chr1:248458726	OR2T12	0.63	5.23	0.51	1.41e-6	Common traits (Other);
SKCM	cis	rs951366	0.789	rs823097	chr1:205681370	G/A	cg07157834	chr1:205819609	PM20D1	0.73	6.4	0.59	1.07e-8	Menarche (age at onset);
SKCM	cis	rs34779708	0.702	rs35969476	chr10:35544318	G/A	cg03585969	chr10:35415529	CREM	0.74	5.42	0.52	6.41e-7	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs763121	0.962	rs909564	chr22:39126508	A/G	cg06022373	chr22:39101656	GTPBP1	0.77	5.36	0.52	8.35e-7	Menopause (age at onset);
SKCM	cis	rs7937682	0.883	rs510388	chr11:111451869	G/T	cg09085632	chr11:111637200	PPP2R1B	1.03	9.99	0.75	1.33e-15	Primary sclerosing cholangitis;
SKCM	cis	rs4803468	1.000	rs17318666	chr19:41940342	T/G	cg09537434	chr19:41945824	ATP5SL	1.1	13.21	0.83	1.39e-21	Height;
SKCM	cis	rs7143963	0.943	rs72704737	chr14:103373434	C/G	cg23020514	chr14:103360112	TRAF3	0.79	6.88	0.61	1.34e-9	Body mass index;
SKCM	cis	rs651907	0.557	rs7651721	chr3:101393583	C/A	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.81	6.96	0.62	9.48e-10	Colorectal cancer;
SKCM	cis	rs752010	0.806	rs1109255	chr1:42091708	C/T	cg06885757	chr1:42089581	HIVEP3	0.5	4.87	0.48	5.65e-6	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs2404602	0.735	rs4886495	chr15:76738959	C/T	cg23625390	chr15:77176239	SCAPER	0.8	7.82	0.66	2.1e-11	Blood metabolite levels;
SKCM	cis	rs7937682	0.632	rs7128862	chr11:111755435	C/T	cg09085632	chr11:111637200	PPP2R1B	1.07	9.99	0.75	1.34e-15	Primary sclerosing cholangitis;
SKCM	cis	rs9910055	0.530	rs2269907	chr17:42294215	G/A	cg09913183	chr17:42254507	C17orf65;ASB16	0.6	5.25	0.51	1.3e-6	Total body bone mineral density;
SKCM	cis	rs1005277	0.522	rs7072977	chr10:37940440	C/A	cg25427524	chr10:38739819	LOC399744	-0.61	-5.68	-0.54	2.21e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs6087990	0.701	rs1997797	chr20:31387954	C/G	cg13636640	chr20:31349939	DNMT3B	0.83	6.25	0.58	2.06e-8	Ulcerative colitis;
SKCM	cis	rs10193935	0.901	rs10175378	chr2:42456267	A/C	cg27598129	chr2:42591480	NA	-0.88	-6.71	-0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7772486	0.686	rs9386131	chr6:146121608	G/A	cg05347473	chr6:146136440	FBXO30	0.55	5.07	0.5	2.6e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2153535	0.580	rs7341201	chr6:8470270	T/C	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs3820068	0.581	rs1122386	chr1:15946877	C/T	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs245880	0.740	rs245883	chr7:29187946	G/A	cg17163760	chr7:29186267	CPVL	-0.38	-4.81	-0.48	7.12e-6	Warfarin maintenance dose;
SKCM	cis	rs7666738	0.791	rs6532725	chr4:99061479	T/C	cg05340658	chr4:99064831	C4orf37	0.66	4.87	0.48	5.74e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2839186	0.588	rs7280110	chr21:47619039	G/A	cg05896524	chr21:47604654	C21orf56	-0.73	-6.14	-0.57	3.26e-8	Testicular germ cell tumor;
SKCM	cis	rs7179456	0.610	rs650366	chr15:59061142	A/G	cg05156742	chr15:59063176	FAM63B	0.78	5.72	0.54	1.85e-7	Asperger disorder;
SKCM	cis	rs910316	0.967	rs12890371	chr14:75593839	T/C	cg08847533	chr14:75593920	NEK9	0.95	9.18	0.72	4.8e-14	Height;
SKCM	cis	rs62238980	0.614	rs115866486	chr22:32510228	A/T	cg00543991	chr22:32367038	NA	1.17	4.81	0.48	7.24e-6	Childhood ear infection;
SKCM	cis	rs2243480	1.000	rs316318	chr7:65612904	A/G	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs7618501	0.635	rs7635002	chr3:49989155	T/G	cg05072774	chr3:49840536	C3orf54	-0.66	-5.03	-0.49	3.12e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2731664	0.792	rs335466	chr5:176889530	C/A	cg23176889	chr5:176863531	GRK6	-0.55	-5.72	-0.54	1.88e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs13118159	0.742	rs34947293	chr4:1335034	T/C	cg02018176	chr4:1364513	KIAA1530	0.66	5.38	0.52	7.42e-7	Longevity;
SKCM	cis	rs6430585	1.000	rs73958618	chr2:136500475	A/G	cg07169764	chr2:136633963	MCM6	0.97	7.55	0.65	6.94e-11	Corneal structure;
SKCM	cis	rs7666738	0.830	rs13113899	chr4:99050422	T/C	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs950027	0.620	rs1153862	chr15:45631868	A/G	cg21132104	chr15:45694354	SPATA5L1	0.74	5.42	0.52	6.44e-7	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs1865760	0.622	rs10946807	chr6:26079638	T/C	cg17691542	chr6:26056736	HIST1H1C	0.76	5.85	0.55	1.1e-7	Height;
SKCM	cis	rs9640161	0.711	rs10259796	chr7:150050427	T/C	cg10018233	chr7:150070692	REPIN1	0.68	5.25	0.51	1.27e-6	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs2228479	0.850	rs74251570	chr16:89910068	C/A	cg00800038	chr16:89945340	TCF25	-1.0	-5.06	-0.5	2.75e-6	Skin colour saturation;
SKCM	cis	rs4803468	0.967	rs4803461	chr19:41908871	G/A	cg14132834	chr19:41945861	ATP5SL	-0.74	-5.68	-0.54	2.23e-7	Height;
SKCM	cis	rs17685	0.725	rs4728548	chr7:75654632	A/T	cg16489192	chr7:75678113	MDH2;STYXL1	0.62	5.82	0.55	1.23e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs763121	0.962	rs6001193	chr22:39074737	A/G	cg06022373	chr22:39101656	GTPBP1	0.84	6.53	0.59	6.05e-9	Menopause (age at onset);
SKCM	trans	rs11722228	0.522	rs881641	chr4:10133747	G/A	cg26043149	chr18:55253948	FECH	0.94	8.42	0.69	1.43e-12	Gout;Urate levels;Serum uric acid levels;
SKCM	cis	rs4819052	0.808	rs2838825	chr21:46655651	C/T	cg20896738	chr21:46707857	POFUT2;LOC642852	0.7	4.98	0.49	3.66e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs11155671	0.530	rs7763849	chr6:150206380	C/T	cg09699651	chr6:150184138	LRP11	0.6	5.36	0.52	8.11e-7	Testicular germ cell tumor;
SKCM	cis	rs12451471	0.559	rs1042396	chr17:78084769	G/A	cg06718696	chr17:78121285	EIF4A3	0.92	6.26	0.58	1.96e-8	Plateletcrit;Mean corpuscular hemoglobin concentration;
SKCM	cis	rs4523957	0.651	rs9908373	chr17:2086534	G/A	cg16513277	chr17:2031491	SMG6	-0.83	-5.97	-0.56	6.59e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs6545883	0.929	rs10173974	chr2:61748900	C/G	cg15711740	chr2:61764176	XPO1	-0.73	-5.27	-0.51	1.19e-6	Tuberculosis;
SKCM	cis	rs2255932	1.000	rs2255932	chr3:183210854	A/G	cg20852557	chr3:184035519	EIF4G1	-0.65	-5.51	-0.53	4.48e-7	Interleukin-1-beta levels;
SKCM	cis	rs5750830	0.649	rs2413590	chr22:39790191	G/C	cg11247378	chr22:39784982	NA	-0.51	-6.22	-0.58	2.26e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs3784262	1.000	rs4646586	chr15:58305344	C/A	cg12031962	chr15:58353849	ALDH1A2	-0.5	-6.27	-0.58	1.85e-8	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs995000	0.931	rs6690733	chr1:63060311	A/C	cg06896770	chr1:63153194	DOCK7	0.76	7.17	0.63	3.77e-10	Triglyceride levels;
SKCM	cis	rs507080	0.663	rs7926970	chr11:118559881	T/G	cg18045108	chr11:118530628	TREH	-0.47	-4.82	-0.48	6.89e-6	Serum metabolite levels;
SKCM	cis	rs7927771	0.864	rs755553	chr11:47432303	G/A	cg05585544	chr11:47624801	NA	0.57	4.92	0.49	4.76e-6	Subjective well-being;
SKCM	cis	rs2228479	0.850	rs1800339	chr16:89839637	C/A	cg06558623	chr16:89946397	TCF25	1.11	5.26	0.51	1.23e-6	Skin colour saturation;
SKCM	cis	rs7954584	0.531	rs11043271	chr12:122394921	A/C	cg13699009	chr12:122356056	WDR66	0.58	7.26	0.64	2.5e-10	Mean corpuscular volume;
SKCM	cis	rs4969178	0.965	rs12451715	chr17:76397334	A/C	cg20026190	chr17:76395443	PGS1	0.61	5.29	0.51	1.08e-6	HDL cholesterol levels;
SKCM	cis	rs9435341	0.826	rs17496332	chr1:107546375	C/T	cg09367891	chr1:107599246	PRMT6	-0.8	-6.17	-0.57	2.85e-8	Facial morphology (factor 21, depth of nasal alae);
SKCM	cis	rs9875589	0.509	rs2607757	chr3:14081948	A/G	cg14375111	chr3:14165186	TMEM43;CHCHD4	-0.56	-5.77	-0.55	1.52e-7	Ovarian reserve;
SKCM	cis	rs11690935	1.000	rs11678984	chr2:172535848	T/G	cg13550731	chr2:172543902	DYNC1I2	0.98	8.89	0.71	1.79e-13	Schizophrenia;
SKCM	cis	rs4974559	0.790	rs10012582	chr4:1324481	G/A	cg02980000	chr4:1222292	CTBP1	0.88	5.25	0.51	1.29e-6	Systolic blood pressure;
SKCM	cis	rs793571	0.502	rs395601	chr15:59063196	G/C	cg05156742	chr15:59063176	FAM63B	0.79	6.47	0.59	7.74e-9	Schizophrenia;
SKCM	cis	rs9583531	0.600	rs4773240	chr13:111360585	G/A	cg15841412	chr13:111365552	ING1	0.73	4.88	0.48	5.56e-6	Coronary artery disease;
SKCM	cis	rs9905704	0.647	rs11659035	chr17:56966052	C/T	cg12560992	chr17:57184187	TRIM37	0.76	6.03	0.56	5.1e-8	Testicular germ cell tumor;
SKCM	cis	rs9911578	1.000	rs4793950	chr17:56593111	T/C	cg12560992	chr17:57184187	TRIM37	-0.95	-7.69	-0.66	3.7e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs6430585	0.640	rs3816155	chr2:136552526	A/C	cg07169764	chr2:136633963	MCM6	-1.32	-13.34	-0.83	7.99e-22	Corneal structure;
SKCM	cis	rs17376456	0.877	rs114256265	chr5:93473130	T/A	cg25358565	chr5:93447407	FAM172A	1.23	7.97	0.67	1.08e-11	Diabetic retinopathy;
SKCM	cis	rs736408	0.716	rs2239549	chr3:52823126	C/T	cg18404041	chr3:52824283	ITIH1	-0.55	-5.02	-0.49	3.16e-6	Bipolar disorder;
SKCM	cis	rs9815354	0.812	rs17218103	chr3:41943724	A/G	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs7772486	0.754	rs4566902	chr6:146244128	A/G	cg05347473	chr6:146136440	FBXO30	-0.55	-4.88	-0.48	5.48e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7296418	0.885	rs1727305	chr12:123633382	T/C	cg00376283	chr12:123451042	ABCB9	0.95	8.2	0.68	3.89e-12	Platelet count;
SKCM	cis	rs35306767	0.903	rs7077278	chr10:911291	A/G	cg25614935	chr10:1084866	C10orf110	-0.75	-4.83	-0.48	6.68e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs10751667	0.621	rs7394862	chr11:927500	T/C	cg06064525	chr11:970664	AP2A2	-0.55	-5.09	-0.5	2.46e-6	Alzheimer's disease (late onset);
SKCM	cis	rs1348850	0.567	rs12994392	chr2:178536640	A/G	cg22681709	chr2:178499509	PDE11A	-0.57	-5.15	-0.5	1.87e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs28595532	0.920	rs115240535	chr4:119745395	G/C	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs1003719	0.762	rs3787787	chr21:38463452	T/C	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs62560775	0.688	rs3217986	chr9:22005330	G/T	cg19481686	chr9:22005288	CDKN2BAS;CDKN2B	0.92	5.43	0.52	6.18e-7	Lung adenocarcinoma;Lung cancer;
SKCM	cis	rs2839186	0.934	rs13046494	chr21:47707430	A/C	cg13012494	chr21:47604986	C21orf56	0.67	5.71	0.54	1.95e-7	Testicular germ cell tumor;
SKCM	cis	rs7523273	0.606	rs2761433	chr1:207917361	G/A	cg22525895	chr1:207977042	MIR29B2	0.78	6.6	0.6	4.57e-9	Schizophrenia;
SKCM	cis	rs12824058	0.831	rs12314111	chr12:130813663	G/T	cg24838063	chr12:130822603	PIWIL1	0.76	6.7	0.6	2.91e-9	Menopause (age at onset);
SKCM	cis	rs4555082	0.834	rs2816652	chr14:105712493	C/T	cg13114125	chr14:105738426	BRF1	-0.69	-5.7	-0.54	2.07e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs4820539	0.966	rs5759600	chr22:23483769	C/A	cg14186256	chr22:23484241	RTDR1	0.87	8.8	0.71	2.6e-13	Bone mineral density;
SKCM	cis	rs12541335	0.639	rs4565458	chr8:22154133	T/C	cg02463440	chr8:22132932	PIWIL2	0.6	5.05	0.5	2.84e-6	Hypertriglyceridemia;
SKCM	cis	rs1799949	0.501	rs9675035	chr17:41415016	A/T	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.18	-0.57	2.68e-8	Menopause (age at onset);
SKCM	cis	rs17345786	0.861	rs11707689	chr3:101086475	A/G	cg11279151	chr3:101281821	RG9MTD1	-0.62	-5.03	-0.5	3.01e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9303401	0.592	rs12936771	chr17:56725052	T/C	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.35	0.52	8.54e-7	Cognitive test performance;
SKCM	cis	rs4073582	0.595	rs801741	chr11:65917084	A/G	cg16950941	chr11:66035639	RAB1B	0.81	6.87	0.61	1.41e-9	Gout;
SKCM	cis	rs9910055	0.659	rs7212573	chr17:42254281	A/G	cg19774624	chr17:42201019	HDAC5	-0.88	-8.01	-0.67	8.97e-12	Total body bone mineral density;
SKCM	cis	rs8180040	0.966	rs13059519	chr3:47539969	C/T	cg27129171	chr3:47204927	SETD2	0.79	5.79	0.55	1.43e-7	Colorectal cancer;
SKCM	cis	rs870825	0.616	rs4437295	chr4:185643336	C/T	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs7937682	0.855	rs10891285	chr11:111527775	T/C	cg09085632	chr11:111637200	PPP2R1B	-1.05	-12.29	-0.81	6.25e-20	Primary sclerosing cholangitis;
SKCM	cis	rs7828089	0.792	rs4872478	chr8:22231427	A/G	cg12081754	chr8:22256438	SLC39A14	0.71	5.27	0.51	1.17e-6	Verbal declarative memory;
SKCM	cis	rs12477438	0.520	rs2632277	chr2:99778985	A/G	cg14399236	chr2:99771627	LIPT1;TSGA10	1.04	9.67	0.74	5.37e-15	Chronic sinus infection;
SKCM	cis	rs7523273	0.927	rs1891423	chr1:207931913	G/A	cg22525895	chr1:207977042	MIR29B2	0.77	6.01	0.56	5.58e-8	Schizophrenia;
SKCM	cis	rs8017423	0.967	rs2282030	chr14:90730265	G/A	cg04374321	chr14:90722782	PSMC1	1.0	9.0	0.71	1.09e-13	Mortality in heart failure;
SKCM	cis	rs853679	0.599	rs188015	chr6:27877446	T/A	cg06761719	chr6:27280190	POM121L2	0.88	4.88	0.48	5.57e-6	Depression;
SKCM	cis	rs4332037	0.539	rs34809719	chr7:2028968	G/T	cg23422044	chr7:1970798	MAD1L1	-0.92	-5.87	-0.55	1.02e-7	Bipolar disorder;
SKCM	cis	rs9814567	0.896	rs10935123	chr3:134345327	C/G	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.65	-5.25	-0.51	1.26e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs17711722	0.690	rs116823227	chr7:65331001	A/G	cg11764359	chr7:65958608	NA	0.91	6.64	0.6	3.72e-9	Calcium levels;
SKCM	cis	rs7829975	0.871	rs572307	chr8:8578811	T/C	cg15556689	chr8:8085844	FLJ10661	-0.71	-6.36	-0.58	1.24e-8	Mood instability;
SKCM	cis	rs6503525	0.628	rs4065985	chr17:38101932	G/C	cg17467752	chr17:38218738	THRA	0.65	5.34	0.52	9.06e-7	Asthma;
SKCM	cis	rs28595532	1.000	rs11098451	chr4:119717673	C/T	cg14228332	chr4:119757509	SEC24D	1.07	5.49	0.53	4.77e-7	Cannabis dependence symptom count;
SKCM	cis	rs2072510	1.000	rs2540492	chr12:96417659	C/T	cg18817487	chr12:96390143	HAL	0.41	5.37	0.52	7.95e-7	Metabolite levels (small molecules and protein measures);
SKCM	trans	rs7618501	0.933	rs1128535	chr3:49866392	C/T	cg21659725	chr3:3221576	CRBN	0.96	9.43	0.73	1.59e-14	Intelligence (multi-trait analysis);
SKCM	cis	rs10256972	0.521	rs10280960	chr7:1103697	A/G	cg09177884	chr7:1199841	ZFAND2A	-0.62	-4.78	-0.48	8.22e-6	Longevity;Endometriosis;
SKCM	cis	rs873946	0.586	rs12770021	chr10:134562021	G/A	cg27286337	chr10:134555280	INPP5A	0.96	8.98	0.71	1.16e-13	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs6570726	0.791	rs9376945	chr6:145828080	T/A	cg23711669	chr6:146136114	FBXO30	0.79	7.93	0.67	1.26e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4400599	0.618	rs1194600	chr1:154236009	G/C	cg26808167	chr1:154192205	UBAP2L;C1orf43	-0.58	-5.17	-0.51	1.75e-6	Platelet distribution width;
SKCM	cis	rs2439831	0.850	rs68079546	chr15:44136957	G/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.3	6.97	0.62	9.12e-10	Lung cancer in ever smokers;
SKCM	cis	rs1707322	1.000	rs12060274	chr1:46291062	G/T	cg03146154	chr1:46216737	IPP	0.75	5.15	0.5	1.94e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs28386778	0.669	rs12603821	chr17:62006432	G/A	cg23090583	chr17:61904693	PSMC5;FTSJ3	-0.78	-6.42	-0.59	9.64e-9	Prudent dietary pattern;
SKCM	cis	rs7090367	0.555	rs6599699	chr10:125245215	T/C	cg16197717	chr10:125650957	CPXM2	-0.47	-4.94	-0.49	4.41e-6	Body mass index;
SKCM	cis	rs763014	0.898	rs916416	chr16:632198	T/A	cg07343612	chr16:622815	PIGQ	-0.7	-6.0	-0.56	5.84e-8	Height;
SKCM	cis	rs1153858	1.000	rs7179743	chr15:45638331	G/C	cg10760299	chr15:45669010	GATM	0.58	6.04	0.56	4.83e-8	Homoarginine levels;
SKCM	cis	rs9300255	0.722	rs34997336	chr12:123829116	G/A	cg00376283	chr12:123451042	ABCB9	-0.78	-5.26	-0.51	1.24e-6	Neutrophil percentage of white cells;
SKCM	cis	rs950776	0.506	rs12915366	chr15:78831753	G/A	cg06917634	chr15:78832804	PSMA4	1.01	10.44	0.76	1.84e-16	Sudden cardiac arrest;
SKCM	cis	rs7937682	0.889	rs1789355	chr11:111499718	T/C	cg09085632	chr11:111637200	PPP2R1B	-1.07	-11.23	-0.79	5.72e-18	Primary sclerosing cholangitis;
SKCM	cis	rs28386778	0.897	rs9913323	chr17:61851485	C/A	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs870825	0.587	rs7682995	chr4:185640684	G/A	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs2228479	0.850	rs62056065	chr16:89905115	C/G	cg06558623	chr16:89946397	TCF25	1.1	4.97	0.49	3.93e-6	Skin colour saturation;
SKCM	cis	rs2180341	0.695	rs6569487	chr6:127726196	C/T	cg27446573	chr6:127587934	RNF146	-0.6	-4.82	-0.48	6.88e-6	Breast cancer;
SKCM	cis	rs208520	0.802	rs851600	chr6:66893754	T/C	cg07460842	chr6:66804631	NA	-0.91	-7.07	-0.63	5.76e-10	Exhaled nitric oxide output;
SKCM	cis	rs2739330	0.796	rs1006771	chr22:24314006	G/T	cg25703541	chr22:24373054	LOC391322	-0.7	-5.68	-0.54	2.23e-7	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs7666738	0.830	rs1365458	chr4:98950961	C/T	cg17366294	chr4:99064904	C4orf37	0.58	4.85	0.48	6.26e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2346177	0.554	rs36006825	chr2:46708945	G/T	cg02822958	chr2:46747628	ATP6V1E2	0.76	5.58	0.53	3.38e-7	HDL cholesterol;
SKCM	cis	rs875971	0.862	rs6958294	chr7:65794796	C/A	cg11764359	chr7:65958608	NA	-0.74	-6.75	-0.61	2.36e-9	Aortic root size;
SKCM	cis	rs7666738	0.830	rs7696568	chr4:99005333	A/T	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6933660	0.683	rs8180642	chr6:151756612	A/G	cg10883421	chr6:151773342	RMND1;C6orf211	0.84	6.65	0.6	3.66e-9	Menarche (age at onset);
SKCM	cis	rs2952156	0.920	rs903502	chr17:37829604	C/T	cg00129232	chr17:37814104	STARD3	-0.64	-5.21	-0.51	1.49e-6	Asthma;
SKCM	cis	rs7216064	1.000	rs11870068	chr17:65944515	A/C	cg12091567	chr17:66097778	LOC651250	-0.78	-5.3	-0.51	1.06e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs8060686	0.641	rs78537727	chr16:68120606	A/G	cg09117114	chr16:67998030	SLC12A4	-0.81	-5.29	-0.51	1.07e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs6546550	0.935	rs1056482	chr2:70108256	A/T	cg02498382	chr2:70120550	SNRNP27	-0.48	-5.33	-0.52	9.18e-7	Prevalent atrial fibrillation;
SKCM	cis	rs12497850	0.931	rs9311434	chr3:48884147	T/C	cg07636037	chr3:49044803	WDR6	1.01	10.82	0.77	3.36e-17	Parkinson's disease;
SKCM	cis	rs28386778	0.863	rs3760254	chr17:61851751	T/G	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs992157	0.835	rs4674282	chr2:219144230	A/T	cg20019365	chr2:219134978	PNKD;AAMP	-0.71	-6.11	-0.57	3.64e-8	Colorectal cancer;
SKCM	cis	rs1790761	0.520	rs12800028	chr11:67403285	A/G	cg00290607	chr11:67383545	NA	-0.7	-6.48	-0.59	7.42e-9	Mean corpuscular volume;
SKCM	cis	rs933688	1.000	rs6452951	chr5:90653868	T/G	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.11	8.47	0.69	1.14e-12	Smoking behavior;
SKCM	cis	rs992157	1.000	rs4674280	chr2:219141458	C/G	cg00012203	chr2:219082015	ARPC2	-0.81	-6.87	-0.61	1.41e-9	Colorectal cancer;
SKCM	cis	rs9814567	0.896	rs58491661	chr3:134355189	G/T	cg06109529	chr3:134205091	CEP63;ANAPC13	0.63	5.1	0.5	2.35e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs7296418	0.922	rs12425009	chr12:123502044	C/T	cg00376283	chr12:123451042	ABCB9	0.92	8.07	0.67	6.77e-12	Platelet count;
SKCM	cis	rs514406	0.667	rs10788942	chr1:53210521	A/T	cg24675658	chr1:53192096	ZYG11B	0.64	5.3	0.51	1.04e-6	Monocyte count;
SKCM	cis	rs12044355	0.827	rs12034296	chr1:231820077	G/A	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	0.82	6.24	0.58	2.14e-8	Alzheimer's disease;
SKCM	cis	rs13040088	1.000	rs12480117	chr20:61558274	G/A	cg23096297	chr20:61557774	DIDO1	0.79	5.8	0.55	1.36e-7	Menopause (age at onset);
SKCM	cis	rs2033711	0.936	rs7257999	chr19:58964860	C/G	cg03735888	chr19:58951602	ZNF132	0.74	6.53	0.59	5.99e-9	Uric acid clearance;
SKCM	cis	rs2760061	0.626	rs672977	chr1:228120288	A/C	cg18477163	chr1:228402036	OBSCN	-0.43	-4.87	-0.48	5.62e-6	Diastolic blood pressure;
SKCM	cis	rs11098499	0.954	rs3733520	chr4:120423480	C/G	cg09307838	chr4:120376055	NA	0.99	8.1	0.68	6.11e-12	Corneal astigmatism;
SKCM	cis	rs1799949	1.000	rs8176103	chr17:41267050	G/A	cg25072359	chr17:41440525	NA	0.64	4.95	0.49	4.25e-6	Menopause (age at onset);
SKCM	cis	rs9300255	0.602	rs1617434	chr12:123649486	A/G	cg00376283	chr12:123451042	ABCB9	0.8	5.4	0.52	6.99e-7	Neutrophil percentage of white cells;
SKCM	cis	rs6558174	0.714	rs12541601	chr8:22524141	G/A	cg03733263	chr8:22462867	KIAA1967	-0.76	-4.78	-0.48	7.99e-6	Breast cancer;
SKCM	cis	rs17685	0.523	rs10246583	chr7:75746667	C/A	cg16489192	chr7:75678113	MDH2;STYXL1	-0.57	-5.35	-0.52	8.63e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs8180040	0.690	rs7640397	chr3:46989828	C/T	cg27129171	chr3:47204927	SETD2	0.82	6.18	0.57	2.7e-8	Colorectal cancer;
SKCM	cis	rs8017423	0.647	rs12883844	chr14:90820519	T/C	cg04374321	chr14:90722782	PSMC1	-0.77	-5.94	-0.56	7.46e-8	Mortality in heart failure;
SKCM	cis	rs6430585	0.583	rs58509842	chr2:136586027	G/A	cg07169764	chr2:136633963	MCM6	1.31	13.22	0.83	1.29e-21	Corneal structure;
SKCM	cis	rs2188420	0.808	rs78011512	chr7:106516296	G/A	cg23615938	chr7:105753134	SYPL1	-0.89	-5.08	-0.5	2.49e-6	Interferon gamma levels;
SKCM	cis	rs9815354	0.767	rs12185934	chr3:41836558	A/C	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs9902453	0.817	rs55974138	chr17:28215546	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.84	6.07	0.57	4.28e-8	Coffee consumption (cups per day);
SKCM	cis	rs1799949	1.000	rs12944430	chr17:41330820	C/G	cg05368731	chr17:41323189	NBR1	0.87	7.74	0.66	3.01e-11	Menopause (age at onset);
SKCM	cis	rs11638352	1.000	rs11638352	chr15:44293137	C/A	cg02155558	chr15:43621948	ADAL;LCMT2	-1.25	-4.88	-0.48	5.56e-6	Lipoprotein phospholipase A2 activity in cardiovascular disease;
SKCM	cis	rs35306767	0.903	rs12240651	chr10:943656	A/G	cg20503657	chr10:835505	NA	0.76	5.17	0.51	1.73e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs561341	1.000	rs510264	chr17:30323414	A/G	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs1577917	0.958	rs10944147	chr6:86550786	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.68	-5.91	-0.56	8.36e-8	Response to antipsychotic treatment;
SKCM	cis	rs9940799	0.577	rs4283249	chr16:5011755	G/C	cg03609003	chr16:4292559	SRL	0.52	4.87	0.48	5.7e-6	Cancer;
SKCM	cis	rs2204008	0.550	rs11495600	chr12:38126654	C/T	cg26384229	chr12:38710491	ALG10B	0.82	6.58	0.6	4.87e-9	Bladder cancer;
SKCM	cis	rs709400	0.930	rs28513222	chr14:104028069	A/T	cg26031613	chr14:104095156	KLC1	1.06	11.49	0.79	1.88e-18	Body mass index;
SKCM	cis	rs116095464	0.558	rs6882584	chr5:223411	A/C	cg22496380	chr5:211416	CCDC127	-0.96	-5.27	-0.51	1.18e-6	Breast cancer;
SKCM	cis	rs4077515	0.806	rs3812564	chr9:139271190	A/G	cg14169450	chr9:139327907	INPP5E	0.48	5.31	0.52	9.96e-7	Ulcerative colitis;IgA nephropathy;Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs929354	0.772	rs2051876	chr7:157009037	A/G	cg17757837	chr7:157058334	UBE3C	-0.79	-5.5	-0.53	4.71e-7	Body mass index;
SKCM	cis	rs2739330	0.828	rs2186366	chr22:24254113	A/G	cg24846343	chr22:24311635	DDTL	-0.63	-6.01	-0.56	5.6e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs8103278	0.507	rs10401971	chr19:46261982	C/T	cg14061069	chr19:46274453	DMPK	0.52	5.4	0.52	7.08e-7	Coronary artery disease;
SKCM	cis	rs7523273	0.853	rs7537216	chr1:208006429	A/T	cg22525895	chr1:207977042	MIR29B2	-0.78	-5.76	-0.55	1.57e-7	Schizophrenia;
SKCM	cis	rs7937682	0.889	rs567859	chr11:111486738	A/G	cg09085632	chr11:111637200	PPP2R1B	-0.97	-10.08	-0.75	8.74e-16	Primary sclerosing cholangitis;
SKCM	cis	rs17685	0.753	rs3757593	chr7:75678735	G/A	cg01364799	chr7:75623366	TMEM120A	0.72	5.83	0.55	1.18e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs453301	0.682	rs2929451	chr8:9085295	A/T	cg06636001	chr8:8085503	FLJ10661	0.76	6.0	0.56	5.85e-8	Joint mobility (Beighton score);
SKCM	cis	rs28595532	0.920	rs116145969	chr4:119770908	T/C	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs28595532	0.920	rs115850161	chr4:119732447	T/C	cg21605333	chr4:119757512	SEC24D	1.36	8.05	0.67	7.69e-12	Cannabis dependence symptom count;
SKCM	cis	rs34779708	0.931	rs7908573	chr10:35309513	T/C	cg03585969	chr10:35415529	CREM	0.75	6.23	0.58	2.2e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs2235573	0.657	rs4821731	chr22:38445214	C/A	cg03683946	chr22:38051826	SH3BP1	-0.48	-4.88	-0.48	5.53e-6	Glioblastoma;Glioma;
SKCM	cis	rs7216064	0.700	rs4791295	chr17:65997317	G/A	cg12091567	chr17:66097778	LOC651250	-0.87	-6.06	-0.57	4.45e-8	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs7027203	0.828	rs10761288	chr9:96609363	C/T	cg14396892	chr9:96623032	NA	-0.42	-4.77	-0.48	8.28e-6	DNA methylation (variation);
SKCM	cis	rs7122539	0.646	rs569818	chr11:66570749	G/A	cg24851651	chr11:66362959	CCS	0.7	5.19	0.51	1.6e-6	HIV-1 susceptibility;
SKCM	cis	rs7149242	0.849	rs10146962	chr14:101170540	A/G	cg18089426	chr14:101175970	NA	0.56	4.99	0.49	3.62e-6	Platelet count;
SKCM	cis	rs2836950	0.565	rs2836945	chr21:40596757	C/T	cg11890956	chr21:40555474	PSMG1	-0.66	-5.26	-0.51	1.22e-6	Menarche (age at onset);
SKCM	cis	rs595982	0.559	rs73061632	chr19:49361663	G/A	cg15549821	chr19:49342101	PLEKHA4	-0.87	-5.39	-0.52	7.35e-7	Red cell distribution width;
SKCM	cis	rs10256972	0.721	rs2030959	chr7:1075906	T/C	cg07308232	chr7:1071921	C7orf50	-0.62	-5.42	-0.52	6.51e-7	Longevity;Endometriosis;
SKCM	cis	rs12142240	0.660	rs72886903	chr1:46813860	C/T	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs2153535	0.541	rs6905934	chr6:8440043	C/A	cg23788917	chr6:8435910	SLC35B3	0.69	5.14	0.5	1.99e-6	Motion sickness;
SKCM	cis	rs12477438	0.520	rs4850897	chr2:99768419	A/G	cg14399236	chr2:99771627	LIPT1;TSGA10	0.95	8.41	0.69	1.48e-12	Chronic sinus infection;
SKCM	cis	rs1059312	0.808	rs10847694	chr12:129292457	C/A	cg09035930	chr12:129282057	SLC15A4	0.77	8.03	0.67	8.18e-12	Systemic lupus erythematosus;
SKCM	cis	rs1799949	1.000	rs2271574	chr17:41327648	T/C	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.25	-0.58	2.03e-8	Menopause (age at onset);
SKCM	cis	rs1552244	0.882	rs34779351	chr3:10021801	A/G	cg02579736	chr3:10068473	FANCD2;CIDECP	0.94	4.84	0.48	6.49e-6	Alzheimer's disease;
SKCM	cis	rs8180040	0.966	rs11925823	chr3:47443065	C/G	cg16586182	chr3:47516702	SCAP	-0.76	-5.32	-0.52	9.63e-7	Colorectal cancer;
SKCM	cis	rs875971	0.862	rs801209	chr7:66019390	G/T	cg18876405	chr7:65276391	NA	-0.61	-6.03	-0.56	5.23e-8	Aortic root size;
SKCM	cis	rs2235573	0.653	rs3026670	chr22:38426774	T/C	cg03683946	chr22:38051826	SH3BP1	-0.48	-4.86	-0.48	6.01e-6	Glioblastoma;Glioma;
SKCM	cis	rs933688	1.000	rs985434	chr5:90744509	A/G	cg12630606	chr5:90679528	LOC100129716;ARRDC3	0.98	7.81	0.66	2.22e-11	Smoking behavior;
SKCM	cis	rs12541335	0.639	rs35068739	chr8:22201719	T/C	cg09517075	chr8:22133004	PIWIL2	0.6	5.51	0.53	4.49e-7	Hypertriglyceridemia;
SKCM	cis	rs752010	0.695	rs10890156	chr1:42108090	T/C	cg06885757	chr1:42089581	HIVEP3	0.51	6.04	0.56	4.83e-8	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs12142240	0.698	rs41294456	chr1:46809782	T/C	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs7552404	0.824	rs1251077	chr1:76189745	C/G	cg22875332	chr1:76189707	ACADM	-0.75	-5.24	-0.51	1.31e-6	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs899997	1.000	rs9888691	chr15:79010046	T/C	cg04896959	chr15:78267971	NA	0.62	5.66	0.54	2.38e-7	Coronary artery disease or large artery stroke;
SKCM	cis	rs2224391	1.000	rs2753248	chr6:5262154	G/T	cg09085698	chr6:5261316	LYRM4;FARS2	-0.77	-5.73	-0.54	1.79e-7	Height;
SKCM	cis	rs36093844	0.660	rs12274717	chr11:85577714	A/C	cg25872744	chr11:85566296	CCDC83	-0.86	-4.88	-0.48	5.6e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs9912468	0.933	rs17633401	chr17:64301363	C/T	cg19474267	chr17:64306194	PRKCA	0.63	5.48	0.53	4.96e-7	QRS duration;QRS complex (12-leadsum);QRS complex (Sokolow-Lyon);
SKCM	cis	rs8017423	0.967	rs2277514	chr14:90723059	T/C	cg04374321	chr14:90722782	PSMC1	1.03	9.44	0.73	1.55e-14	Mortality in heart failure;
SKCM	cis	rs992157	0.835	rs6707559	chr2:219142773	C/T	cg20019365	chr2:219134978	PNKD;AAMP	0.72	6.22	0.58	2.33e-8	Colorectal cancer;
SKCM	cis	rs35146811	0.586	rs1076237	chr7:99585441	A/C	cg22906224	chr7:99728672	NA	0.76	5.48	0.53	5.14e-7	Coronary artery disease;
SKCM	cis	rs752010	0.695	rs11210508	chr1:42106935	A/G	cg06885757	chr1:42089581	HIVEP3	0.51	6.04	0.56	4.83e-8	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs950027	0.787	rs1547487	chr15:45723983	A/G	cg10760299	chr15:45669010	GATM	0.54	4.95	0.49	4.12e-6	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs941873	0.772	rs1316312	chr10:81110417	G/C	cg09469691	chr10:81107165	PPIF	0.7	6.59	0.6	4.65e-9	Height;
SKCM	cis	rs763121	0.853	rs8138996	chr22:39047435	G/T	cg06022373	chr22:39101656	GTPBP1	0.72	4.96	0.49	4.08e-6	Menopause (age at onset);
SKCM	cis	rs7927771	0.524	rs10838760	chr11:47786414	A/G	cg20307385	chr11:47447363	PSMC3	0.71	5.63	0.54	2.67e-7	Subjective well-being;
SKCM	cis	rs11719291	0.831	rs11715177	chr3:48763894	G/A	cg00383909	chr3:49044727	WDR6	0.91	5.36	0.52	8.08e-7	Cognitive function;
SKCM	cis	rs28595532	0.925	rs115651057	chr4:119486708	A/G	cg14228332	chr4:119757509	SEC24D	0.97	4.92	0.49	4.71e-6	Cannabis dependence symptom count;
SKCM	cis	rs17376456	0.825	rs28645862	chr5:93233128	G/C	cg21475434	chr5:93447410	FAM172A	1.03	5.61	0.54	3e-7	Diabetic retinopathy;
SKCM	cis	rs4905558	0.962	rs4905547	chr14:97290290	T/C	cg11863609	chr14:97355128	NA	-0.56	-4.87	-0.48	5.81e-6	Neutrophil count;
SKCM	cis	rs208520	0.690	rs10455594	chr6:66737894	C/G	cg07460842	chr6:66804631	NA	0.9	7.2	0.63	3.26e-10	Exhaled nitric oxide output;
SKCM	cis	rs910316	0.789	rs4899552	chr14:75667921	C/A	cg08847533	chr14:75593920	NEK9	-0.86	-7.0	-0.62	7.89e-10	Height;
SKCM	cis	rs7666738	0.830	rs13119995	chr4:99026790	T/C	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4808199	0.793	rs12459676	chr19:19425141	A/T	cg03709012	chr19:19516395	GATAD2A	1.1	6.89	0.61	1.3e-9	Nonalcoholic fatty liver disease;
SKCM	cis	rs6121246	0.909	rs1994249	chr20:30287593	C/T	cg11595048	chr20:30225325	COX4I2	0.67	5.21	0.51	1.5e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs6424115	0.830	rs2502992	chr1:24201919	T/C	cg15997130	chr1:24165203	NA	0.6	4.94	0.49	4.37e-6	Immature fraction of reticulocytes;
SKCM	cis	rs2439831	1.000	rs689596	chr15:43761717	A/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.22	8.04	0.67	7.73e-12	Lung cancer in ever smokers;
SKCM	cis	rs959260	0.588	rs12938183	chr17:73320433	G/C	cg14668889	chr17:73230827	NUP85	-0.75	-6.29	-0.58	1.72e-8	Systemic lupus erythematosus;
SKCM	cis	rs2075371	1.000	rs1862051	chr7:133981021	G/A	cg20476274	chr7:133979776	SLC35B4	1.01	10.44	0.76	1.77e-16	Mean platelet volume;
SKCM	trans	rs7618501	0.966	rs2352974	chr3:49890613	C/T	cg21659725	chr3:3221576	CRBN	0.94	9.05	0.72	8.71e-14	Intelligence (multi-trait analysis);
SKCM	cis	rs2075371	0.933	rs1833475	chr7:133958263	C/T	cg20476274	chr7:133979776	SLC35B4	1.03	10.88	0.78	2.61e-17	Mean platelet volume;
SKCM	cis	rs7811142	0.830	rs77861211	chr7:99962096	T/C	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.19	7.5	0.65	8.66e-11	Platelet count;
SKCM	cis	rs6463523	0.933	rs79984239	chr7:766220	A/G	cg06242242	chr7:766104	PRKAR1B;HEATR2	1.09	9.66	0.74	5.76e-15	Subjective well-being;
SKCM	cis	rs7296418	0.883	rs1727312	chr12:123642220	G/T	cg05973401	chr12:123451056	ABCB9	0.81	6.39	0.59	1.1e-8	Platelet count;
SKCM	cis	rs1878931	0.501	rs4785934	chr16:3419934	G/T	cg26668626	chr16:3451006	ZNF174;ZNF434	0.88	7.36	0.64	1.59e-10	Body mass index (adult);
SKCM	cis	rs763121	0.853	rs6519124	chr22:39045099	T/C	cg06022373	chr22:39101656	GTPBP1	0.82	5.62	0.54	2.8e-7	Menopause (age at onset);
SKCM	cis	rs2243480	1.000	rs35820085	chr7:65442758	C/T	cg18252515	chr7:66147081	NA	-1.34	-8.12	-0.68	5.55e-12	Diabetic kidney disease;
SKCM	cis	rs116095464	0.558	rs9312979	chr5:222057	A/C	cg22496380	chr5:211416	CCDC127	-1.0	-5.11	-0.5	2.25e-6	Breast cancer;
SKCM	cis	rs9457247	0.602	rs13204839	chr6:167471119	G/A	cg07741184	chr6:167504864	NA	0.58	4.92	0.49	4.76e-6	Crohn's disease;
SKCM	cis	rs1256061	0.533	rs2357479	chr14:64792764	G/T	cg21174375	chr14:64681225	SYNE2	0.46	4.84	0.48	6.49e-6	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs763121	0.813	rs2179143	chr22:39037984	A/G	cg06022373	chr22:39101656	GTPBP1	0.8	5.93	0.56	7.77e-8	Menopause (age at onset);
SKCM	cis	rs6977660	0.943	rs10227692	chr7:19850199	T/C	cg07541023	chr7:19748670	TWISTNB	0.72	5.14	0.5	2.02e-6	Thyroid stimulating hormone;
SKCM	cis	rs7100689	0.646	rs1890889	chr10:82090827	G/T	cg00277334	chr10:82204260	NA	-0.53	-4.8	-0.48	7.56e-6	Post bronchodilator FEV1;
SKCM	cis	rs72717009	0.825	rs9427397	chr1:161476204	C/T	cg23840854	chr1:161414152	NA	-0.99	-5.66	-0.54	2.44e-7	Rheumatoid arthritis;
SKCM	cis	rs12477438	0.501	rs6708878	chr2:99801564	G/A	cg26064155	chr2:99771622	LIPT1;TSGA10	1.03	9.76	0.74	3.61e-15	Chronic sinus infection;
SKCM	cis	rs60871478	0.735	rs62432241	chr7:795360	G/A	cg05535760	chr7:792225	HEATR2	1.24	7.57	0.65	6.48e-11	Cerebrospinal P-tau181p levels;
SKCM	cis	rs10193935	0.901	rs1439231	chr2:42542884	G/A	cg27598129	chr2:42591480	NA	-0.89	-6.82	-0.61	1.74e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7523050	0.643	rs36052234	chr1:109402943	C/T	cg08274380	chr1:109419600	GPSM2	1.13	5.57	0.53	3.54e-7	Fat distribution (HIV);
SKCM	cis	rs2033711	0.936	rs893185	chr19:58989495	A/C	cg03735888	chr19:58951602	ZNF132	0.72	6.12	0.57	3.54e-8	Uric acid clearance;
SKCM	cis	rs13004237	1	rs13004237	chr2:172833139	A/G	cg13550731	chr2:172543902	DYNC1I2	-0.79	-5.87	-0.55	1.02e-7	Schizophrenia;
SKCM	cis	rs2354432	0.505	rs7551766	chr1:146858964	A/G	cg25205988	chr1:146714368	CHD1L	-1.11	-5.59	-0.53	3.21e-7	Mitochondrial DNA levels;
SKCM	cis	rs12142240	0.660	rs7520497	chr1:46824919	C/A	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs79839061	0.656	rs28662837	chr4:879776	G/A	cg07828340	chr4:882639	GAK	1.04	5.72	0.54	1.88e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs477895	0.838	rs1058735	chr11:64000410	C/G	cg07220939	chr11:64358617	SLC22A12	0.72	4.77	0.48	8.37e-6	Mean platelet volume;
SKCM	cis	rs9640161	0.750	rs73170185	chr7:150030191	C/A	cg27494647	chr7:150038898	RARRES2	0.6	5.25	0.51	1.3e-6	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs9814567	1.000	rs2370578	chr3:134199612	G/A	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.68	-5.33	-0.52	9.31e-7	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs2072510	0.900	rs2110762	chr12:96402534	T/C	cg18817487	chr12:96390143	HAL	0.42	5.45	0.53	5.67e-7	Metabolite levels (small molecules and protein measures);
SKCM	cis	rs62244186	0.516	rs11922470	chr3:44777795	C/T	cg02073558	chr3:44770973	ZNF501	0.95	10.39	0.76	2.24e-16	Depressive symptoms;
SKCM	cis	rs17826219	0.568	rs11658027	chr17:29094882	A/G	cg13385521	chr17:29058706	SUZ12P	-1.06	-5.76	-0.55	1.56e-7	Body mass index;
SKCM	trans	rs7618501	1.000	rs6802890	chr3:49832261	A/G	cg21659725	chr3:3221576	CRBN	0.96	9.44	0.73	1.52e-14	Intelligence (multi-trait analysis);
SKCM	cis	rs6570726	0.764	rs76635693	chr6:145834070	T/C	cg23711669	chr6:146136114	FBXO30	0.79	7.93	0.67	1.26e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1552244	0.882	rs56332224	chr3:10037321	G/A	cg02579736	chr3:10068473	FANCD2;CIDECP	0.98	4.84	0.48	6.48e-6	Alzheimer's disease;
SKCM	cis	rs1348850	0.567	rs1405714	chr2:178538584	A/G	cg22681709	chr2:178499509	PDE11A	0.66	5.99	0.56	5.96e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs7927771	0.524	rs11039402	chr11:47826090	A/C	cg20307385	chr11:47447363	PSMC3	0.71	5.63	0.54	2.67e-7	Subjective well-being;
SKCM	cis	rs933688	0.941	rs11948056	chr5:90680468	A/C	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.12	8.63	0.7	5.55e-13	Smoking behavior;
SKCM	cis	rs875971	0.830	rs4718358	chr7:65973668	T/C	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs7666738	0.830	rs28417577	chr4:99053007	T/C	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7092929	0.941	rs835325	chr10:3571175	A/G	cg14308648	chr10:3568949	NA	0.75	5.11	0.5	2.27e-6	Coronary artery calcification;
SKCM	cis	rs7618501	0.521	rs2352984	chr3:49948728	T/C	cg24110177	chr3:50126178	RBM5	-0.7	-5.74	-0.55	1.72e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs933688	0.938	rs7708782	chr5:90718517	T/C	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.02	7.81	0.66	2.22e-11	Smoking behavior;
SKCM	cis	rs7666738	0.753	rs7698541	chr4:98986351	T/A	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs362296	0.661	rs3095078	chr4:3265479	C/T	cg16987761	chr4:3318072	RGS12	-0.65	-5.51	-0.53	4.47e-7	Parental longevity (mother's age at death);
SKCM	cis	rs1577917	0.771	rs2758847	chr6:86349103	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.83	-7.64	-0.65	4.74e-11	Response to antipsychotic treatment;
SKCM	cis	rs35306767	1.000	rs35306767	chr10:989437	A/T	cg20503657	chr10:835505	NA	0.74	6.1	0.57	3.89e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs6582630	0.634	rs10748443	chr12:38734062	G/T	cg13010199	chr12:38710504	ALG10B	0.64	5.11	0.5	2.28e-6	Drug-induced liver injury (flucloxacillin);
SKCM	trans	rs9329221	0.967	rs7005363	chr8:10283748	C/T	cg06636001	chr8:8085503	FLJ10661	-0.91	-8.38	-0.69	1.74e-12	Neuroticism;
SKCM	cis	rs2832191	0.755	rs2832193	chr21:30493589	T/C	cg08807101	chr21:30365312	RNF160	-0.62	-4.94	-0.49	4.34e-6	Dental caries;
SKCM	cis	rs10421328	0.784	rs11667828	chr19:19768474	G/T	cg26732615	chr19:19648335	CILP2;YJEFN3	-0.58	-4.89	-0.48	5.39e-6	Parental longevity (combined parental age at death);
SKCM	cis	rs1218582	0.710	rs4845685	chr1:154878300	C/A	cg16680214	chr1:154839983	KCNN3	-0.56	-5.01	-0.49	3.29e-6	Prostate cancer;
SKCM	cis	rs7296418	0.961	rs12425850	chr12:123501972	T/C	cg06742321	chr12:123595122	PITPNM2	0.66	5.51	0.53	4.52e-7	Platelet count;
SKCM	cis	rs8103278	1.000	rs8108864	chr19:46301671	G/A	cg11657440	chr19:46296263	DMWD	-0.96	-6.91	-0.62	1.16e-9	Coronary artery disease;
SKCM	cis	rs2075371	0.933	rs1421481	chr7:133964380	A/C	cg20476274	chr7:133979776	SLC35B4	1.03	10.89	0.78	2.52e-17	Mean platelet volume;
SKCM	cis	rs8060686	0.641	rs1125333	chr16:68227566	C/A	cg09117114	chr16:67998030	SLC12A4	-0.77	-5.03	-0.49	3.12e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs644799	0.622	rs1255167	chr11:95500213	C/T	cg03916912	chr11:95522834	CEP57;FAM76B	0.7	5.59	0.53	3.22e-7	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs28595532	0.920	rs115226628	chr4:119639818	A/G	cg21605333	chr4:119757512	SEC24D	1.24	7.1	0.63	5.16e-10	Cannabis dependence symptom count;
SKCM	cis	rs593982	0.688	rs3897552	chr11:65560880	C/T	cg08755490	chr11:65554678	OVOL1	-0.96	-7.41	-0.64	1.28e-10	Atopic dermatitis;
SKCM	cis	rs10751667	0.643	rs10902257	chr11:973577	T/C	cg10932868	chr11:921992	NA	0.55	5.1	0.5	2.36e-6	Alzheimer's disease (late onset);
SKCM	cis	rs748404	0.578	rs510108	chr15:43605439	T/G	cg02155558	chr15:43621948	ADAL;LCMT2	0.82	6.24	0.58	2.08e-8	Lung cancer;
SKCM	cis	rs11098499	0.754	rs938056	chr4:120237453	C/T	cg09307838	chr4:120376055	NA	0.93	7.56	0.65	6.5500000000000006e-11	Corneal astigmatism;
SKCM	cis	rs9914544	1.000	rs9916245	chr17:18766825	C/G	cg26306683	chr17:18585705	ZNF286B	0.71	5.13	0.5	2.06e-6	Educational attainment (years of education);
SKCM	cis	rs9911578	1.000	rs304292	chr17:56824123	G/A	cg12560992	chr17:57184187	TRIM37	0.95	7.69	0.66	3.7e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs9910055	0.639	rs11656871	chr17:42269141	G/C	cg19774624	chr17:42201019	HDAC5	-0.87	-8.15	-0.68	4.72e-12	Total body bone mineral density;
SKCM	cis	rs3741404	0.895	rs2429455	chr11:63995302	C/G	cg19465662	chr11:63993652	NUDT22;TRPT1	0.81	5.84	0.55	1.12e-7	Platelet count;
SKCM	cis	rs6952808	0.575	rs2056479	chr7:1954273	G/A	cg03354898	chr7:1950403	MAD1L1	-0.53	-5.4	-0.52	7.05e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs4268898	0.662	rs72793967	chr2:24422902	C/T	cg06627628	chr2:24431161	ITSN2	-0.98	-7.62	-0.65	5.05e-11	Asthma;
SKCM	cis	rs2737618	0.674	rs2260033	chr1:200086074	G/A	cg21825944	chr1:200113062	NR5A2	-0.59	-4.93	-0.49	4.55e-6	Uric acid levels;
SKCM	cis	rs250585	0.588	rs550099	chr16:23597174	C/T	cg09934309	chr16:23461721	COG7	-0.94	-6.18	-0.57	2.76e-8	Egg allergy;
SKCM	cis	rs1784581	0.855	rs1893101	chr6:162384371	G/C	cg17173639	chr6:162384350	PARK2	-0.61	-5.37	-0.52	7.99e-7	Itch intensity from mosquito bite;
SKCM	cis	rs2836950	0.509	rs11088466	chr21:40580017	T/A	cg11644478	chr21:40555479	PSMG1	-0.64	-5.02	-0.49	3.17e-6	Menarche (age at onset);
SKCM	cis	rs7811142	0.943	rs73403312	chr7:100024153	T/C	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.23	8.03	0.67	8.33e-12	Platelet count;
SKCM	cis	rs7212938	0.509	rs3893044	chr17:38103016	C/T	cg17467752	chr17:38218738	THRA	-0.65	-5.34	-0.52	9.06e-7	Asthma and hay fever;
SKCM	cis	rs933688	0.941	rs11948056	chr5:90680468	A/C	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.05	8.26	0.68	2.89e-12	Smoking behavior;
SKCM	cis	rs9910055	1.000	rs9910055	chr17:42283037	C/T	cg13607699	chr17:42295918	UBTF	0.82	6.33	0.58	1.46e-8	Total body bone mineral density;
SKCM	cis	rs9818758	0.556	rs9813813	chr3:49207093	T/A	cg00383909	chr3:49044727	WDR6	1.15	5.54	0.53	3.96e-7	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs72634258	0.786	rs4268374	chr1:8174083	G/T	cg00042356	chr1:8021962	PARK7	-0.81	-5.27	-0.51	1.16e-6	Inflammatory bowel disease;
SKCM	cis	rs17345786	0.906	rs56171035	chr3:101111108	G/C	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.66	4.85	0.48	6.24e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2842992	0.724	rs4709368	chr6:160204127	C/T	cg19482086	chr6:160211437	TCP1;MRPL18	-0.85	-7.56	-0.65	6.57e-11	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs1801251	1.000	rs10933412	chr2:233707226	G/C	cg08000102	chr2:233561755	GIGYF2	-0.89	-7.22	-0.63	3.02e-10	Coronary artery disease;
SKCM	cis	rs7811142	0.943	rs111757992	chr7:100016354	A/C	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.11	6.45	0.59	8.66e-9	Platelet count;
SKCM	cis	rs1568889	1.000	rs11826837	chr11:28322566	C/G	cg06544937	chr11:28130018	METT5D1;KIF18A	-0.87	-7.04	-0.62	6.66e-10	Bipolar disorder;
SKCM	cis	rs2760061	0.598	rs673726	chr1:228120173	T/C	cg02753203	chr1:228287806	NA	-0.62	-5.03	-0.5	3.03e-6	Diastolic blood pressure;
SKCM	cis	rs4819052	0.851	rs9974891	chr21:46680767	T/A	cg19498844	chr21:46707878	POFUT2;LOC642852	0.9	7.98	0.67	1.04e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs9900062	0.586	rs35018407	chr17:62690181	A/C	cg02097616	chr17:62675921	NA	0.76	6.4	0.59	1.08e-8	QT interval;
SKCM	cis	rs9611565	0.694	rs5758368	chr22:41862288	C/T	cg03806693	chr22:41940476	POLR3H	-1.07	-6.74	-0.61	2.44e-9	Vitiligo;
SKCM	cis	rs8077889	0.956	rs4793026	chr17:41850508	A/G	cg26893861	chr17:41843967	DUSP3	1.25	7.71	0.66	3.36e-11	Triglycerides;
SKCM	cis	rs7937682	1.000	rs9734135	chr11:111536190	G/A	cg09085632	chr11:111637200	PPP2R1B	-1.03	-11.65	-0.8	9.4e-19	Primary sclerosing cholangitis;
SKCM	cis	rs7618915	0.547	rs13065019	chr3:52685244	T/C	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs2153535	0.580	rs7767756	chr6:8453428	A/C	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs1801251	0.963	rs283481	chr2:233648091	A/G	cg08000102	chr2:233561755	GIGYF2	0.95	7.13	0.63	4.4e-10	Coronary artery disease;
SKCM	cis	rs13256369	0.851	rs13255061	chr8:8563834	G/A	cg06636001	chr8:8085503	FLJ10661	0.8	6.11	0.57	3.65e-8	Obesity-related traits;
SKCM	cis	rs1799949	0.930	rs4584865	chr17:41424919	C/G	cg23758822	chr17:41437982	NA	0.93	7.88	0.67	1.62e-11	Menopause (age at onset);
SKCM	cis	rs4073582	0.595	rs801734	chr11:65931216	T/C	cg16950941	chr11:66035639	RAB1B	0.81	6.87	0.61	1.41e-9	Gout;
SKCM	cis	rs9303401	0.614	rs68100606	chr17:56500898	G/A	cg10487724	chr17:56770010	TEX14;RAD51C	0.85	6.13	0.57	3.4e-8	Cognitive test performance;
SKCM	cis	rs1577917	1.000	rs791856	chr6:86681841	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.79	7.7	0.66	3.6e-11	Response to antipsychotic treatment;
SKCM	cis	rs28595532	0.920	rs114916728	chr4:119776886	G/A	cg11846333	chr4:119757529	SEC24D	1.17	6.09	0.57	4.03e-8	Cannabis dependence symptom count;
SKCM	cis	rs6500395	1.000	rs1558815	chr16:48704869	C/A	cg04672837	chr16:48644449	N4BP1	-0.63	-5.37	-0.52	8.01e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs870825	0.929	rs72689256	chr4:185590174	C/T	cg04058563	chr4:185651563	MLF1IP	1.09	5.66	0.54	2.4e-7	Blood protein levels;
SKCM	cis	rs2721195	1.000	rs11784118	chr8:145684978	G/A	cg11211951	chr8:145729740	GPT	-0.65	-6.17	-0.57	2.87e-8	Age at first birth;
SKCM	cis	rs523522	0.962	rs9040	chr12:120900274	C/T	cg12219531	chr12:120966889	COQ5	0.92	7.73	0.66	3.06e-11	High light scatter reticulocyte count;
SKCM	cis	rs8180040	0.966	rs11130137	chr3:47578838	C/T	cg27129171	chr3:47204927	SETD2	0.81	5.88	0.55	9.74e-8	Colorectal cancer;
SKCM	cis	rs3785574	0.621	rs1051684	chr17:62006497	A/G	cg11494091	chr17:61959527	GH2	-0.57	-5.55	-0.53	3.76e-7	Height;
SKCM	cis	rs12709013	0.792	rs12926512	chr16:58802221	G/C	cg02431531	chr16:59244939	NA	0.49	5.13	0.5	2.07e-6	Blood metabolite ratios;
SKCM	cis	rs12478296	0.685	rs35577962	chr2:242993575	A/G	cg06360820	chr2:242988706	NA	-1.08	-6.51	-0.59	6.76e-9	Obesity-related traits;
SKCM	cis	rs7552404	0.765	rs1251078	chr1:76189488	C/G	cg03433033	chr1:76189801	ACADM	-0.87	-6.67	-0.6	3.36e-9	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs6546550	0.901	rs10205487	chr2:70151471	C/T	cg02498382	chr2:70120550	SNRNP27	0.44	4.82	0.48	6.84e-6	Prevalent atrial fibrillation;
SKCM	cis	rs6545883	0.862	rs778141	chr2:61682178	A/G	cg15711740	chr2:61764176	XPO1	-0.7	-4.93	-0.49	4.5e-6	Tuberculosis;
SKCM	cis	rs1799949	1.000	rs11658754	chr17:41292739	G/A	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.11	-0.57	3.67e-8	Menopause (age at onset);
SKCM	cis	rs1577917	0.958	rs12192033	chr6:86472559	T/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.6	-5.1	-0.5	2.3e-6	Response to antipsychotic treatment;
SKCM	cis	rs11122272	0.667	rs2244992	chr1:231537220	T/C	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	-0.6	-4.8	-0.48	7.45e-6	Hemoglobin concentration;
SKCM	cis	rs362272	0.505	rs60208975	chr4:3364530	A/G	cg05297308	chr4:3317976	RGS12	1.04	12.71	0.82	1.07e-20	Serum sulfate level;
SKCM	cis	rs8077889	0.672	rs1230400	chr17:41845451	G/A	cg26893861	chr17:41843967	DUSP3	-1.38	-12.1	-0.81	1.42e-19	Triglycerides;
SKCM	cis	rs10504229	0.679	rs16920056	chr8:58106218	C/A	cg02725872	chr8:58115012	NA	-0.53	-4.91	-0.49	4.82e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs910316	0.763	rs175014	chr14:75456927	A/G	cg08847533	chr14:75593920	NEK9	-0.8	-6.62	-0.6	4.04e-9	Height;
SKCM	cis	rs651907	0.535	rs58658478	chr3:101511667	G/A	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.78	6.72	0.61	2.67e-9	Colorectal cancer;
SKCM	cis	rs1003719	0.762	rs11088381	chr21:38478429	G/A	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs7769051	1.000	rs9493454	chr6:133144629	G/T	cg22852734	chr6:133119734	C6orf192	-0.95	-5.64	-0.54	2.65e-7	Type 2 diabetes nephropathy;
SKCM	cis	rs12478296	0.792	rs3924263	chr2:243005167	A/C	cg06360820	chr2:242988706	NA	-1.02	-5.87	-0.55	1.03e-7	Obesity-related traits;
SKCM	cis	rs6500395	1.000	rs9933237	chr16:48676562	T/C	cg04672837	chr16:48644449	N4BP1	0.65	5.43	0.52	6.28e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs7408868	1.000	rs10416389	chr19:15278674	G/C	cg14696996	chr19:15285081	NOTCH3	0.82	4.92	0.49	4.7e-6	Pulse pressure;
SKCM	cis	rs4665809	0.590	rs7586047	chr2:26447335	A/G	cg26119090	chr2:26468346	HADHA;HADHB	-1.06	-8.39	-0.69	1.66e-12	Gut microbiome composition (summer);
SKCM	cis	rs473651	0.935	rs477041	chr2:239355995	C/G	cg21699342	chr2:239360505	ASB1	-0.54	-5.41	-0.52	6.67e-7	Multiple system atrophy;
SKCM	cis	rs7523273	1.000	rs7523273	chr1:207977083	A/G	cg22525895	chr1:207977042	MIR29B2	-0.74	-5.36	-0.52	8.33e-7	Schizophrenia;
SKCM	cis	rs561341	0.882	rs563539	chr17:30307958	A/G	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs801193	0.660	rs974239	chr7:66213491	G/A	cg18876405	chr7:65276391	NA	0.66	6.5	0.59	7.03e-9	Aortic root size;
SKCM	cis	rs9900062	0.519	rs2676293	chr17:62710461	T/C	cg02097616	chr17:62675921	NA	0.75	6.4	0.59	1.08e-8	QT interval;
SKCM	cis	rs801193	1.000	rs2707836	chr7:66160435	A/C	cg18876405	chr7:65276391	NA	0.8	7.11	0.63	4.86e-10	Aortic root size;
SKCM	cis	rs7927771	0.524	rs3758655	chr11:47703943	T/C	cg20307385	chr11:47447363	PSMC3	0.71	5.63	0.54	2.67e-7	Subjective well-being;
SKCM	cis	rs62103177	0.810	rs62103178	chr18:77624555	C/G	cg27393146	chr18:77495563	CTDP1	-0.92	-5.36	-0.52	8.37e-7	Opioid sensitivity;
SKCM	cis	rs6723226	0.699	rs376914	chr2:32508393	G/C	cg02381751	chr2:32503542	YIPF4	0.92	6.85	0.61	1.5e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs10193935	0.901	rs12622153	chr2:42598386	C/A	cg27598129	chr2:42591480	NA	-0.88	-6.71	-0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4689592	0.587	rs3822269	chr4:7069901	T/C	cg19539972	chr4:7069911	GRPEL1	0.98	6.73	0.61	2.57e-9	Monocyte percentage of white cells;
SKCM	cis	rs10256972	0.567	rs2960835	chr7:1202963	A/G	cg09177884	chr7:1199841	ZFAND2A	-0.76	-6.32	-0.58	1.5e-8	Longevity;Endometriosis;
SKCM	cis	rs7615952	0.800	rs35390120	chr3:125599809	G/A	cg05084668	chr3:125655381	ALG1L	-1.26	-7.1	-0.63	5.08e-10	Blood pressure (smoking interaction);
SKCM	cis	rs514406	0.861	rs72637996	chr1:53249618	A/T	cg16325326	chr1:53192061	ZYG11B	-0.85	-8.71	-0.7	3.95e-13	Monocyte count;
SKCM	cis	rs4819052	0.851	rs1056099	chr21:46678892	G/A	cg02159808	chr21:46707872	POFUT2;LOC642852	0.73	5.71	0.54	1.93e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs2180341	1.000	rs9388561	chr6:127634921	C/T	cg24812749	chr6:127587940	RNF146	0.84	7.25	0.63	2.6e-10	Breast cancer;
SKCM	cis	rs208520	0.706	rs851601	chr6:66893853	G/A	cg07460842	chr6:66804631	NA	-0.91	-7.07	-0.63	5.76e-10	Exhaled nitric oxide output;
SKCM	cis	rs8177179	0.967	rs4078166	chr3:133435979	C/A	cg16262614	chr3:133464971	TF	0.42	5.26	0.51	1.21e-6	Iron status biomarkers (transferrin levels);
SKCM	cis	rs9926296	0.568	rs1230	chr16:89804855	A/G	cg04287289	chr16:89883240	FANCA	-1.07	-12.8	-0.82	7.39e-21	Vitiligo;
SKCM	cis	rs116095464	0.558	rs13354585	chr5:242263	G/C	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs55728055	0.661	rs16989334	chr22:32016092	A/G	cg01338084	chr22:32026380	PISD	1.5	5.03	0.49	3.11e-6	Age-related hearing impairment;
SKCM	cis	rs1395	0.571	rs114507490	chr2:27527246	T/A	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.55	4.98	0.49	3.69e-6	Blood metabolite levels;
SKCM	cis	rs2841277	0.708	rs28454709	chr14:105405942	G/A	cg21017887	chr14:105400489	NA	0.59	5.31	0.52	1e-6	Rheumatoid arthritis;
SKCM	cis	rs10193935	1.000	rs72796507	chr2:42409840	A/G	cg27598129	chr2:42591480	NA	-0.89	-6.39	-0.59	1.09e-8	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs28595532	0.545	rs13144171	chr4:119257458	G/A	cg21605333	chr4:119757512	SEC24D	0.96	5.21	0.51	1.47e-6	Cannabis dependence symptom count;
SKCM	cis	rs1707322	0.964	rs785483	chr1:46559171	T/C	cg03146154	chr1:46216737	IPP	-0.81	-5.43	-0.52	6.11e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs600231	0.708	rs3132767	chr11:65234860	C/T	cg24009118	chr11:65545808	DKFZp761E198	0.68	5.02	0.49	3.14e-6	Bone mineral density;
SKCM	cis	rs11673344	0.764	rs569371	chr19:37453997	A/G	cg07624650	chr19:37064219	ZNF529	-0.78	-4.82	-0.48	7.05e-6	Obesity-related traits;
SKCM	cis	rs7666738	0.830	rs11940273	chr4:98979965	T/A	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.22e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4523957	0.788	rs2169357	chr17:2096441	C/T	cg16513277	chr17:2031491	SMG6	-0.77	-5.46	-0.53	5.38e-7	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs732765	0.734	rs6574189	chr14:75166493	C/T	cg25946216	chr14:74253857	C14orf43	0.78	5.04	0.5	2.9e-6	Non-small cell lung cancer;
SKCM	cis	rs1577917	0.629	rs9450285	chr6:86208096	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.75	6.68	0.6	3.15e-9	Response to antipsychotic treatment;
SKCM	cis	rs7940866	0.804	rs10894289	chr11:130808685	C/T	cg12179176	chr11:130786555	SNX19	0.75	5.93	0.56	7.83e-8	Schizophrenia;
SKCM	cis	rs7927771	0.832	rs56030824	chr11:47397353	G/A	cg01152729	chr11:47593274	PTPMT1	-0.52	-4.84	-0.48	6.52e-6	Subjective well-being;
SKCM	cis	rs9300255	0.679	rs4759409	chr12:123719585	G/C	cg05973401	chr12:123451056	ABCB9	0.86	6.11	0.57	3.69e-8	Neutrophil percentage of white cells;
SKCM	cis	rs3859192	0.539	rs2305481	chr17:38138624	G/A	cg17467752	chr17:38218738	THRA	-0.72	-6.0	-0.56	5.73e-8	White blood cell count;
SKCM	cis	rs2180341	1.000	rs9398837	chr6:127635217	G/A	cg27446573	chr6:127587934	RNF146	0.94	8.06	0.67	7.08e-12	Breast cancer;
SKCM	cis	rs28595532	0.920	rs56303276	chr4:119723514	C/T	cg11846333	chr4:119757529	SEC24D	1.19	6.39	0.59	1.12e-8	Cannabis dependence symptom count;
SKCM	cis	rs2439831	0.717	rs28495368	chr15:43895642	G/A	cg02155558	chr15:43621948	ADAL;LCMT2	1.41	8.33	0.69	2.19e-12	Lung cancer in ever smokers;
SKCM	cis	rs4819052	0.724	rs1304487	chr21:46657283	C/G	cg19498844	chr21:46707878	POFUT2;LOC642852	-0.84	-7.13	-0.63	4.39e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs3784262	0.904	rs4646616	chr15:58261349	G/A	cg12031962	chr15:58353849	ALDH1A2	-0.49	-6.48	-0.59	7.67e-9	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs17826219	0.706	rs2322197	chr17:29105805	T/C	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Body mass index;
SKCM	cis	rs16866061	1.000	rs72974205	chr2:225408468	C/T	cg12698349	chr2:225449008	CUL3	1.01	8.51	0.69	9.75e-13	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs748404	0.660	rs690512	chr15:43717678	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	0.73	5.42	0.52	6.48e-7	Lung cancer;
SKCM	cis	rs2070488	0.662	rs7373930	chr3:38454931	A/G	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.78	6.02	0.56	5.37e-8	Electrocardiographic conduction measures;
SKCM	cis	rs870825	0.655	rs1527870	chr4:185616631	T/C	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs7659604	0.791	rs57316471	chr4:122663939	A/G	cg20573242	chr4:122745356	CCNA2	0.72	5.72	0.54	1.84e-7	Type 2 diabetes;
SKCM	cis	rs2153535	0.601	rs1855765	chr6:8444325	C/T	cg07606381	chr6:8435919	SLC35B3	0.94	6.94	0.62	1.02e-9	Motion sickness;
SKCM	cis	rs4268898	0.662	rs72793208	chr2:24510284	C/T	cg06627628	chr2:24431161	ITSN2	-0.96	-7.33	-0.64	1.83e-10	Asthma;
SKCM	cis	rs11792861	0.816	rs28361186	chr9:111704064	G/A	cg14432460	chr9:111696404	IKBKAP;C9orf6	0.69	4.86	0.48	5.86e-6	Menarche (age at onset);
SKCM	cis	rs3091242	0.967	rs3091240	chr1:25676935	G/T	cg02931644	chr1:25747376	RHCE	0.51	5.06	0.5	2.72e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs1348850	0.874	rs952746	chr2:178306584	A/G	cg02961200	chr2:178257176	LOC100130691;AGPS	0.82	6.21	0.58	2.42e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs875971	0.558	rs4433015	chr7:65639723	A/C	cg18876405	chr7:65276391	NA	-0.83	-7.6	-0.65	5.67e-11	Aortic root size;
SKCM	cis	rs2739330	0.828	rs4822451	chr22:24248166	T/G	cg24846343	chr22:24311635	DDTL	0.71	6.83	0.61	1.64e-9	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs13108904	0.557	rs1250086	chr4:1248051	G/A	cg16405210	chr4:1374714	KIAA1530	0.67	4.88	0.48	5.55e-6	Obesity-related traits;
SKCM	cis	rs3820928	0.874	rs4234066	chr2:227882180	G/A	cg11843606	chr2:227700838	RHBDD1	-0.62	-5.12	-0.5	2.19e-6	Pulmonary function;
SKCM	cis	rs2075371	1.000	rs2598286	chr7:133976029	G/A	cg20476274	chr7:133979776	SLC35B4	1.03	10.5	0.77	1.4e-16	Mean platelet volume;
SKCM	cis	rs9287719	0.614	rs6432105	chr2:10697599	G/A	cg01299579	chr2:10830716	NOL10	-0.52	-4.93	-0.49	4.53e-6	Prostate cancer;
SKCM	cis	rs6951245	0.748	rs79658522	chr7:1095877	A/G	cg24642844	chr7:1081250	C7orf50	-0.93	-6.22	-0.58	2.28e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs801193	1.000	rs4717319	chr7:66242593	A/G	cg18876405	chr7:65276391	NA	0.82	7.48	0.65	9.4e-11	Aortic root size;
SKCM	cis	rs709400	0.633	rs3783395	chr14:103895020	T/C	cg26031613	chr14:104095156	KLC1	0.69	5.11	0.5	2.23e-6	Body mass index;
SKCM	cis	rs7584330	0.657	rs10211024	chr2:238353776	A/T	cg14458575	chr2:238380390	NA	0.99	6.72	0.61	2.65e-9	Prostate cancer;
SKCM	cis	rs10911251	0.546	rs1547715	chr1:183113952	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.76	7.28	0.64	2.26e-10	Colorectal cancer;
SKCM	cis	rs7208859	0.623	rs80355557	chr17:29154421	C/T	cg13385521	chr17:29058706	SUZ12P	0.9	4.78	0.48	8.1e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs8063761	0.576	rs4238832	chr16:90050261	C/T	cg26513180	chr16:89883248	FANCA	0.69	5.2	0.51	1.57e-6	Squamous cell carcinoma;
SKCM	cis	rs2204008	0.777	rs2387813	chr12:38382091	A/C	cg26384229	chr12:38710491	ALG10B	0.81	6.6	0.6	4.58e-9	Bladder cancer;
SKCM	cis	rs9549367	0.577	rs513479	chr13:113815200	C/T	cg18105134	chr13:113819100	PROZ	-0.85	-6.21	-0.58	2.4e-8	Platelet distribution width;
SKCM	cis	rs709400	0.663	rs11623869	chr14:103883633	G/T	cg26031613	chr14:104095156	KLC1	0.69	5.03	0.49	3.05e-6	Body mass index;
SKCM	cis	rs9911578	0.900	rs7214335	chr17:57158840	G/A	cg05425664	chr17:57184151	TRIM37	-0.77	-6.04	-0.56	5.01e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs35146811	0.586	rs10267231	chr7:99595480	T/C	cg13334819	chr7:99746414	C7orf59	-0.72	-4.8	-0.48	7.46e-6	Coronary artery disease;
SKCM	cis	rs2153535	0.601	rs9393030	chr6:8516489	C/G	cg07606381	chr6:8435919	SLC35B3	0.87	6.38	0.59	1.17e-8	Motion sickness;
SKCM	cis	rs576982	1	rs576982	chr15:78870803	C/T	cg24631222	chr15:78858424	CHRNA5	0.87	6.62	0.6	4.19e-9	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs2811415	0.627	rs1042911	chr3:127789594	T/G	cg09089421	chr3:127803668	RUVBL1	1.0	8.69	0.7	4.4e-13	Lung function (FEV1/FVC);
SKCM	cis	rs7953508	0.711	rs3825198	chr12:93977465	T/A	cg18151635	chr12:93972918	NA	-0.71	-6.11	-0.57	3.67e-8	Pubertal anthropometrics;
SKCM	cis	rs514406	0.698	rs511599	chr1:53362818	T/C	cg24675658	chr1:53192096	ZYG11B	-0.82	-7.84	-0.66	1.89e-11	Monocyte count;
SKCM	cis	rs9467773	0.620	rs2504565	chr6:26656890	G/A	cg09904177	chr6:26538194	HMGN4	0.58	5.01	0.49	3.28e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs8180040	0.903	rs2276853	chr3:47282303	G/A	cg27129171	chr3:47204927	SETD2	0.85	6.39	0.59	1.11e-8	Colorectal cancer;
SKCM	cis	rs453301	0.686	rs11785819	chr8:8870378	T/G	cg15556689	chr8:8085844	FLJ10661	-0.77	-6.1	-0.57	3.89e-8	Joint mobility (Beighton score);
SKCM	cis	rs3820928	0.874	rs13430941	chr2:227904447	G/A	cg11843606	chr2:227700838	RHBDD1	-0.61	-4.88	-0.48	5.48e-6	Pulmonary function;
SKCM	cis	rs9911578	0.900	rs4793593	chr17:56892699	C/G	cg05425664	chr17:57184151	TRIM37	0.69	5.21	0.51	1.52e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1577917	0.959	rs16876540	chr6:86612519	G/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.66	-5.74	-0.54	1.76e-7	Response to antipsychotic treatment;
SKCM	trans	rs1814175	0.817	rs10769648	chr11:50013992	T/C	cg15704280	chr7:45808275	SEPT13	-1.05	-11.07	-0.78	1.14e-17	Height;
SKCM	cis	rs11690935	1.000	rs312924	chr2:172564021	A/T	cg13550731	chr2:172543902	DYNC1I2	0.95	8.14	0.68	5.11e-12	Schizophrenia;
SKCM	cis	rs79040073	0.530	rs73392262	chr15:49521710	C/G	cg25951582	chr15:49913451	C15orf33;DTWD1	-0.72	-5.22	-0.51	1.44e-6	Lung cancer in ever smokers;
SKCM	cis	rs28595532	0.920	rs114796605	chr4:119744472	C/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs35306767	0.903	rs11816064	chr10:931176	A/C	cg20503657	chr10:835505	NA	0.75	5.36	0.52	8.31e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs908922	0.676	rs11581947	chr1:152482587	G/A	cg09873164	chr1:152488093	CRCT1	0.76	5.84	0.55	1.14e-7	Hair morphology;
SKCM	cis	rs6546550	0.901	rs3732266	chr2:70057448	T/G	cg02498382	chr2:70120550	SNRNP27	-0.47	-5.2	-0.51	1.54e-6	Prevalent atrial fibrillation;
SKCM	cis	rs6582630	0.555	rs7969922	chr12:38529491	C/T	cg26384229	chr12:38710491	ALG10B	0.81	6.58	0.6	4.89e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs10504229	0.639	rs2291764	chr8:58142943	A/C	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs7772486	0.686	rs7744014	chr6:146123818	G/A	cg23711669	chr6:146136114	FBXO30	0.85	9.32	0.73	2.62e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs561341	1.000	rs564714	chr17:30318404	C/T	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs6088580	0.634	rs6120666	chr20:33090718	A/G	cg24642439	chr20:33292090	TP53INP2	0.76	6.02	0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs870825	0.932	rs10034861	chr4:185577450	C/T	cg04058563	chr4:185651563	MLF1IP	1.03	5.09	0.5	2.4e-6	Blood protein levels;
SKCM	cis	rs12477438	0.520	rs6542866	chr2:99764592	T/C	cg26064155	chr2:99771622	LIPT1;TSGA10	1.01	9.39	0.73	1.86e-14	Chronic sinus infection;
SKCM	cis	rs17376456	0.825	rs74825443	chr5:93254973	T/C	cg25358565	chr5:93447407	FAM172A	1.3	7.53	0.65	7.57e-11	Diabetic retinopathy;
SKCM	cis	rs1218582	0.844	rs6699080	chr1:154834911	G/A	cg06221963	chr1:154839813	KCNN3	-0.57	-6.21	-0.58	2.4e-8	Prostate cancer;
SKCM	cis	rs651907	0.817	rs675779	chr3:101599019	T/C	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.7	5.39	0.52	7.24e-7	Colorectal cancer;
SKCM	cis	rs1044826	0.647	rs4683463	chr3:139196946	T/G	cg15131784	chr3:139108705	COPB2	0.66	4.96	0.49	4.09e-6	Obesity-related traits;
SKCM	cis	rs1552244	0.882	rs56224841	chr3:10044014	A/C	cg02579736	chr3:10068473	FANCD2;CIDECP	0.94	4.84	0.48	6.49e-6	Alzheimer's disease;
SKCM	trans	rs208520	0.690	rs207118	chr6:66788948	T/A	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-1.02	-7.49	-0.65	9.2e-11	Exhaled nitric oxide output;
SKCM	cis	rs116095464	0.558	rs10057299	chr5:242135	C/T	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs1568889	0.938	rs11601602	chr11:28233768	A/G	cg06544937	chr11:28130018	METT5D1;KIF18A	0.86	6.87	0.61	1.4e-9	Bipolar disorder;
SKCM	cis	rs2070488	0.775	rs4371464	chr3:38548021	T/C	cg01465620	chr3:38496096	LOC100128640;ACVR2B	-0.74	-5.88	-0.55	9.48e-8	Electrocardiographic conduction measures;
SKCM	cis	rs4629710	0.568	rs9492880	chr6:131565962	G/T	cg12606694	chr6:131520996	AKAP7	0.51	4.83	0.48	6.65e-6	Multiple myeloma (IgH translocation);
SKCM	cis	rs7666738	0.830	rs13124689	chr4:98961182	A/T	cg17366294	chr4:99064904	C4orf37	0.59	4.89	0.48	5.36e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs826838	0.868	rs12322306	chr12:39130021	A/G	cg26384229	chr12:38710491	ALG10B	-0.91	-8.28	-0.68	2.74e-12	Heart rate;
SKCM	cis	rs2739330	0.828	rs5760099	chr22:24248414	G/A	cg24846343	chr22:24311635	DDTL	0.71	6.83	0.61	1.64e-9	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs35306767	0.761	rs11253538	chr10:1011166	C/T	cg20503657	chr10:835505	NA	0.76	6.08	0.57	4.18e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs12971120	1.000	rs2278161	chr18:72176083	T/C	cg26446133	chr18:72167187	CNDP2	-0.67	-5.62	-0.54	2.8e-7	Refractive error;
SKCM	cis	rs11098499	0.866	rs11098506	chr4:120284971	A/G	cg09307838	chr4:120376055	NA	0.95	7.25	0.63	2.63e-10	Corneal astigmatism;
SKCM	cis	rs595982	0.559	rs17272680	chr19:49364511	A/G	cg19746536	chr19:49375674	PPP1R15A	-0.96	-5.37	-0.52	7.85e-7	Red cell distribution width;
SKCM	cis	rs17376456	0.877	rs34184666	chr5:93444584	T/C	cg25358565	chr5:93447407	FAM172A	1.23	7.97	0.67	1.08e-11	Diabetic retinopathy;
SKCM	cis	rs941408	0.515	rs2110118	chr19:2775144	T/C	cg06609049	chr19:2785107	THOP1	1.09	10.19	0.76	5.37e-16	Total cholesterol levels;
SKCM	cis	rs6942756	1.000	rs13235749	chr7:128879678	C/G	cg02491457	chr7:128862824	NA	-0.76	-4.84	-0.48	6.51e-6	White matter hyperintensity burden;
SKCM	cis	rs9399135	0.967	rs1854865	chr6:135360300	C/G	cg24558204	chr6:135376177	HBS1L	0.59	5.13	0.5	2.06e-6	Red blood cell count;
SKCM	cis	rs7659604	0.540	rs11098643	chr4:122701507	C/A	cg19671926	chr4:122722719	EXOSC9	0.76	6.97	0.62	9.04e-10	Type 2 diabetes;
SKCM	cis	rs2836950	0.565	rs2836934	chr21:40564885	A/C	cg11644478	chr21:40555479	PSMG1	-0.64	-5.02	-0.49	3.17e-6	Menarche (age at onset);
SKCM	cis	rs12762955	0.529	rs2387213	chr10:1051420	C/T	cg20503657	chr10:835505	NA	0.56	4.83	0.48	6.62e-6	Response to angiotensin II receptor blocker therapy;
SKCM	cis	rs11098499	0.730	rs78971550	chr4:120281041	C/T	cg09307838	chr4:120376055	NA	0.98	7.89	0.67	1.52e-11	Corneal astigmatism;
SKCM	cis	rs56235845	0.694	rs11949401	chr5:176765989	A/G	cg17509989	chr5:176798049	RGS14	0.69	5.7	0.54	2.06e-7	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs9926296	0.605	rs886951	chr16:89836865	A/G	cg04287289	chr16:89883240	FANCA	1.02	11.72	0.8	6.92e-19	Vitiligo;
SKCM	cis	rs17685	0.784	rs1637043	chr7:75699099	G/A	cg01364799	chr7:75623366	TMEM120A	-0.72	-5.83	-0.55	1.18e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs3820928	0.874	rs10195072	chr2:227794452	G/A	cg11843606	chr2:227700838	RHBDD1	-0.6	-4.81	-0.48	7.34e-6	Pulmonary function;
SKCM	cis	rs62064224	0.703	rs4287613	chr17:30827688	C/T	cg25809561	chr17:30822961	MYO1D	0.74	6.06	0.57	4.52e-8	Schizophrenia;
SKCM	cis	rs644799	0.710	rs522536	chr11:95528714	C/T	cg25622487	chr11:95524042	FAM76B;CEP57	0.7	5.67	0.54	2.28e-7	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs9790314	0.690	rs1599389	chr3:160836006	G/A	cg03342759	chr3:160939853	NMD3	-0.69	-6.89	-0.62	1.26e-9	Morning vs. evening chronotype;
SKCM	cis	rs12477438	1.000	rs11897712	chr2:99735697	G/A	cg26064155	chr2:99771622	LIPT1;TSGA10	-0.82	-5.33	-0.52	9.09e-7	Chronic sinus infection;
SKCM	cis	rs8067545	0.750	rs7208365	chr17:19998017	T/G	cg13482628	chr17:19912719	NA	0.71	6.15	0.57	3.07e-8	Schizophrenia;
SKCM	cis	rs4891159	0.824	rs17059362	chr18:74144307	G/A	cg24786174	chr18:74118243	ZNF516	-0.75	-6.95	-0.62	9.71e-10	Longevity;
SKCM	cis	rs2243480	1.000	rs709607	chr7:65449541	C/G	cg18252515	chr7:66147081	NA	1.33	7.67	0.66	4.18e-11	Diabetic kidney disease;
SKCM	cis	rs8180040	0.966	rs11705957	chr3:47443262	T/G	cg16586182	chr3:47516702	SCAP	0.76	5.32	0.52	9.63e-7	Colorectal cancer;
SKCM	cis	rs7100689	0.622	rs7897994	chr10:82133304	T/G	cg01528321	chr10:82214614	TSPAN14	0.8	7.0	0.62	7.98e-10	Post bronchodilator FEV1;
SKCM	cis	rs4319547	0.956	rs10847179	chr12:123040985	T/C	cg23029597	chr12:123009494	RSRC2	-0.81	-5.95	-0.56	7.21e-8	Body mass index;
SKCM	cis	rs992157	0.835	rs11677953	chr2:219121663	G/A	cg20019365	chr2:219134978	PNKD;AAMP	-0.77	-6.49	-0.59	7.27e-9	Colorectal cancer;
SKCM	cis	rs35766269	0.541	rs2120794	chr10:9048518	A/G	cg05671070	chr10:8095960	FLJ45983;GATA3	0.95	4.77	0.48	8.45e-6	Recalcitrant atopic dermatitis;
SKCM	cis	rs17376456	0.877	rs12716460	chr5:93416733	A/G	cg25358565	chr5:93447407	FAM172A	1.22	7.9	0.67	1.49e-11	Diabetic retinopathy;
SKCM	cis	rs7100689	0.646	rs1538819	chr10:82122523	A/G	cg01528321	chr10:82214614	TSPAN14	0.8	7.0	0.62	7.98e-10	Post bronchodilator FEV1;
SKCM	cis	rs470903	1.000	rs523243	chr18:74714585	C/T	cg05896682	chr18:74964030	GALR1	-0.55	-5.4	-0.52	6.89e-7	Paclitaxel disposition in epithelial ovarian cancer;
SKCM	cis	rs2439831	0.850	rs7163245	chr15:43671294	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.22	8.33	0.69	2.19e-12	Lung cancer in ever smokers;
SKCM	cis	rs4481887	1.000	rs11204626	chr1:248458974	T/A	cg00666640	chr1:248458726	OR2T12	0.6	4.9	0.49	5.01e-6	Common traits (Other);
SKCM	cis	rs1577917	0.958	rs3900313	chr6:86537154	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.81	-0.66	2.19e-11	Response to antipsychotic treatment;
SKCM	cis	rs3820068	0.603	rs56032936	chr1:15970953	T/C	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs2180341	1.000	rs9375499	chr6:127618072	T/C	cg27446573	chr6:127587934	RNF146	1.0	8.68	0.7	4.48e-13	Breast cancer;
SKCM	cis	rs11764590	0.694	rs60626033	chr7:2099719	A/G	cg23422044	chr7:1970798	MAD1L1	-0.81	-6.16	-0.57	2.98e-8	Neuroticism;
SKCM	cis	rs7824557	0.628	rs11782706	chr8:11186215	A/C	cg21775007	chr8:11205619	TDH	0.72	6.73	0.61	2.61e-9	Retinal vascular caliber;
SKCM	cis	rs36051895	0.659	rs7046077	chr9:5045328	C/G	cg02405213	chr9:5042618	JAK2	-0.65	-5.2	-0.51	1.57e-6	Pediatric autoimmune diseases;
SKCM	cis	rs2721195	0.549	rs2620666	chr8:145703413	T/C	cg15320075	chr8:145703422	NA	0.98	8.92	0.71	1.56e-13	Age at first birth;
SKCM	cis	rs7666738	0.791	rs7660866	chr4:98961335	G/A	cg17366294	chr4:99064904	C4orf37	0.59	4.89	0.48	5.36e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs3087591	0.960	rs2905878	chr17:29511199	T/C	cg24425628	chr17:29625626	OMG;NF1	0.61	4.87	0.48	5.75e-6	Hip circumference;
SKCM	cis	rs4654899	0.758	rs10218584	chr1:21474480	C/G	cg01072550	chr1:21505969	NA	0.63	4.96	0.49	4.02e-6	Superior frontal gyrus grey matter volume;
SKCM	cis	rs11098499	0.754	rs7689729	chr4:120256192	A/G	cg09307838	chr4:120376055	NA	0.93	7.53	0.65	7.72e-11	Corneal astigmatism;
SKCM	cis	rs8180040	1.000	rs1076394	chr3:47322781	G/A	cg16586182	chr3:47516702	SCAP	0.71	4.85	0.48	6.25e-6	Colorectal cancer;
SKCM	cis	rs4975616	0.836	rs421629	chr5:1320136	G/A	cg07493874	chr5:1342172	CLPTM1L	-0.69	-6.41	-0.59	1.04e-8	Lung cancer;
SKCM	cis	rs250585	0.588	rs484226	chr16:23608991	G/A	cg09934309	chr16:23461721	COG7	-0.83	-5.56	-0.53	3.6e-7	Egg allergy;
SKCM	cis	rs9916302	0.904	rs9892055	chr17:37510402	C/T	cg07936489	chr17:37558343	FBXL20	0.85	7.28	0.64	2.26e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs1005277	0.557	rs2983338	chr10:38550734	C/T	cg25427524	chr10:38739819	LOC399744	-0.72	-6.81	-0.61	1.84e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs10256972	0.552	rs7805591	chr7:1210745	A/G	cg09177884	chr7:1199841	ZFAND2A	-0.74	-5.98	-0.56	6.43e-8	Longevity;Endometriosis;
SKCM	cis	rs2839186	0.934	rs13049797	chr21:47707582	T/C	cg13012494	chr21:47604986	C21orf56	0.67	5.71	0.54	1.95e-7	Testicular germ cell tumor;
SKCM	cis	rs7829975	0.846	rs11779061	chr8:8549432	G/A	cg15556689	chr8:8085844	FLJ10661	-0.76	-6.31	-0.58	1.54e-8	Mood instability;
SKCM	cis	rs514406	0.708	rs514881	chr1:53336737	A/G	cg16325326	chr1:53192061	ZYG11B	-0.72	-6.02	-0.56	5.36e-8	Monocyte count;
SKCM	cis	rs6598955	0.724	rs12732295	chr1:26602251	C/T	cg00938395	chr1:26633206	UBXN11	0.67	4.83	0.48	6.71e-6	Obesity-related traits;
SKCM	cis	rs6547741	0.874	rs58737572	chr2:27852118	A/C	cg27432699	chr2:27873401	GPN1	0.75	6.86	0.61	1.48e-9	Oral cavity cancer;
SKCM	cis	rs1707322	1.000	rs11211223	chr1:46380605	C/T	cg03146154	chr1:46216737	IPP	0.73	4.91	0.49	4.98e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs72781680	0.898	rs56303870	chr2:24086944	G/A	cg08917208	chr2:24149416	ATAD2B	0.99	5.24	0.51	1.31e-6	Lymphocyte counts;
SKCM	cis	rs7954584	0.531	rs11043271	chr12:122394921	A/C	cg22618164	chr12:122356400	WDR66	0.53	5.39	0.52	7.24e-7	Mean corpuscular volume;
SKCM	cis	rs9430161	0.611	rs12081197	chr1:11034239	T/C	cg02454025	chr1:11042201	C1orf127	1.08	10.13	0.75	7.19e-16	Ewing sarcoma;
SKCM	cis	rs10155981	0.510	rs28661240	chr7:22594075	G/A	cg05062323	chr7:22590069	NA	-1.04	-5.94	-0.56	7.37e-8	Bilirubin levels;
SKCM	cis	rs8063761	0.568	rs4350572	chr16:90043840	A/G	cg08547343	chr16:90038815	CENPBD1;AFG3L1	0.82	7.12	0.63	4.58e-10	Squamous cell carcinoma;
SKCM	cis	rs35306767	0.714	rs67205460	chr10:1090366	C/T	cg25614935	chr10:1084866	C10orf110	0.71	5.46	0.53	5.39e-7	Eosinophil percentage of granulocytes;
SKCM	trans	rs10506458	1.000	rs1009539	chr12:63414655	A/G	cg03429785	chr15:59498649	MYO1E;LDHAL6B	1.38	7.54	0.65	7.13e-11	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs6580649	0.941	rs3742074	chr12:48457385	C/T	cg05342945	chr12:48394962	COL2A1	0.73	5.2	0.51	1.53e-6	Lung cancer;
SKCM	cis	rs7659604	1.000	rs28532673	chr4:122664323	A/G	cg19748678	chr4:122722346	EXOSC9	-0.68	-5.58	-0.53	3.39e-7	Type 2 diabetes;
SKCM	cis	rs10256972	0.591	rs10229680	chr7:1158565	C/T	cg16145915	chr7:1198662	ZFAND2A	-0.59	-8.09	-0.68	6.4e-12	Longevity;Endometriosis;
SKCM	cis	rs10504073	0.584	rs56078938	chr8:49940342	A/C	cg00325661	chr8:49890786	NA	0.81	6.83	0.61	1.64e-9	Blood metabolite ratios;
SKCM	cis	rs4555082	0.830	rs2816648	chr14:105708289	C/T	cg13114125	chr14:105738426	BRF1	-0.67	-5.59	-0.53	3.25e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs1046896	0.514	rs9894705	chr17:80823758	A/C	cg22027946	chr17:80790580	TBCD;ZNF750	-0.67	-4.93	-0.49	4.57e-6	Glycated hemoglobin levels;
SKCM	cis	rs7666738	0.830	rs17550630	chr4:99008332	G/T	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs3857536	0.706	rs7755994	chr6:66891747	T/C	cg07460842	chr6:66804631	NA	-0.7	-5.08	-0.5	2.51e-6	Blood trace element (Cu levels);
SKCM	cis	rs2180341	0.596	rs12215298	chr6:127676833	C/T	cg27446573	chr6:127587934	RNF146	0.73	6.28	0.58	1.75e-8	Breast cancer;
SKCM	cis	rs2841277	0.708	rs11623422	chr14:105407031	A/G	cg15352829	chr14:105391018	PLD4	-0.58	-4.81	-0.48	7.35e-6	Rheumatoid arthritis;
SKCM	cis	rs9457247	0.582	rs9459855	chr6:167466150	G/T	cg07741184	chr6:167504864	NA	0.59	4.97	0.49	3.88e-6	Crohn's disease;
SKCM	cis	rs245880	0.765	rs245893	chr7:29191507	G/C	cg17163760	chr7:29186267	CPVL	-0.4	-5.37	-0.52	7.91e-7	Warfarin maintenance dose;
SKCM	cis	rs28386778	0.897	rs5020097	chr17:61814198	G/C	cg06873352	chr17:61820015	STRADA	0.79	6.37	0.59	1.19e-8	Prudent dietary pattern;
SKCM	cis	rs1403694	0.695	rs1851664	chr3:186436503	T/A	cg09332604	chr3:186435400	KNG1	-0.49	-4.88	-0.48	5.53e-6	Blood protein levels;
SKCM	cis	rs7772486	0.754	rs6570703	chr6:145957052	C/T	cg05347473	chr6:146136440	FBXO30	0.57	5.19	0.51	1.61e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs10207060	0.771	rs4852124	chr2:240680022	C/T	cg07506560	chr2:240697449	NA	0.52	4.83	0.48	6.72e-6	Obesity-related traits;
SKCM	cis	rs4523957	0.552	rs923862	chr17:2031382	A/C	cg16513277	chr17:2031491	SMG6	-0.91	-6.21	-0.58	2.38e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	trans	rs62103177	0.810	rs62103192	chr18:77629050	A/T	cg05926928	chr17:57297772	GDPD1	1.29	8.74	0.7	3.44e-13	Opioid sensitivity;
SKCM	cis	rs12142240	0.698	rs56358525	chr1:46849520	C/T	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs7618915	0.547	rs34215106	chr3:52659124	T/C	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs9916302	0.653	rs11657058	chr17:37699378	T/G	cg07936489	chr17:37558343	FBXL20	-1.01	-8.17	-0.68	4.34e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs870825	0.616	rs28582728	chr4:185646920	C/T	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs823143	0.570	rs1361754	chr1:205801872	C/T	cg11965913	chr1:205819406	PM20D1	-0.98	-10.97	-0.78	1.81e-17	Monocyte percentage of white cells;
SKCM	cis	rs17376456	0.877	rs10476596	chr5:93367074	C/T	cg25358565	chr5:93447407	FAM172A	-1.17	-8.0	-0.67	9.26e-12	Diabetic retinopathy;
SKCM	cis	rs28595532	0.920	rs114611353	chr4:119736607	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs798554	0.680	rs2533889	chr7:2900309	G/C	cg19346786	chr7:2764209	NA	-0.63	-6.2	-0.57	2.48e-8	Height;
SKCM	cis	rs34779708	0.733	rs12777960	chr10:35541026	C/A	cg03585969	chr10:35415529	CREM	0.74	5.42	0.52	6.41e-7	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs908922	0.676	rs2282296	chr1:152487979	C/T	cg09873164	chr1:152488093	CRCT1	0.76	5.94	0.56	7.4e-8	Hair morphology;
SKCM	cis	rs1577917	0.682	rs6909767	chr6:86228109	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.88	8.74	0.7	3.41e-13	Response to antipsychotic treatment;
SKCM	cis	rs9399135	0.967	rs12526055	chr6:135325918	C/T	cg24558204	chr6:135376177	HBS1L	0.55	4.84	0.48	6.5e-6	Red blood cell count;
SKCM	cis	rs514406	0.679	rs960570	chr1:53237763	A/G	cg16325326	chr1:53192061	ZYG11B	-0.63	-5.01	-0.49	3.29e-6	Monocyte count;
SKCM	cis	rs72772090	1.000	rs72772092	chr5:96046912	A/G	cg17330273	chr5:96107758	CAST;ERAP1	-0.83	-5.06	-0.5	2.73e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs910316	0.712	rs76488064	chr14:75446171	A/C	cg08847533	chr14:75593920	NEK9	-0.78	-6.04	-0.56	4.86e-8	Height;
SKCM	cis	rs1799949	1.000	rs33918839	chr17:41329172	T/C	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.25	-0.58	2.03e-8	Menopause (age at onset);
SKCM	cis	rs4727443	0.866	rs13243708	chr7:99616291	T/C	cg07913999	chr7:99613796	ZKSCAN1	0.66	5.09	0.5	2.43e-6	Interstitial lung disease;
SKCM	cis	rs12477438	0.520	rs6741772	chr2:99738961	A/G	cg26064155	chr2:99771622	LIPT1;TSGA10	1.02	10.07	0.75	9.12e-16	Chronic sinus infection;
SKCM	cis	rs7666738	0.830	rs6818045	chr4:99049374	G/A	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4819052	0.885	rs28576202	chr21:46674684	G/A	cg20896738	chr21:46707857	POFUT2;LOC642852	0.64	4.82	0.48	6.85e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7647973	0.580	rs35218722	chr3:49275805	A/G	cg06212747	chr3:49208901	KLHDC8B	0.78	5.59	0.54	3.15e-7	Menarche (age at onset);
SKCM	cis	rs6461049	0.765	rs1476887	chr7:2151633	T/C	cg02951883	chr7:2050386	MAD1L1	-0.75	-6.95	-0.62	9.76e-10	Schizophrenia;
SKCM	cis	rs9911578	1.000	rs2611782	chr17:56717956	T/C	cg05425664	chr17:57184151	TRIM37	-0.69	-5.21	-0.51	1.52e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2836950	0.520	rs11911087	chr21:40665192	G/A	cg11644478	chr21:40555479	PSMG1	-0.64	-5.02	-0.49	3.17e-6	Menarche (age at onset);
SKCM	cis	rs12464559	0.522	rs1916301	chr2:152640498	G/A	cg01189475	chr2:152685088	ARL5A	1.01	5.25	0.51	1.3e-6	Response to cognitive-behavioural therapy in anxiety disorder;
SKCM	cis	rs10256972	0.516	rs12702081	chr7:1141528	T/C	cg16145915	chr7:1198662	ZFAND2A	-0.56	-7.74	-0.66	2.97e-11	Longevity;Endometriosis;
SKCM	cis	rs208520	0.690	rs3899423	chr6:66835285	A/G	cg07460842	chr6:66804631	NA	-0.93	-6.96	-0.62	9.37e-10	Exhaled nitric oxide output;
SKCM	cis	rs2033711	0.905	rs893186	chr19:58969179	C/A	cg26874164	chr19:58962979	ZNF324B	0.61	5.0	0.49	3.43e-6	Uric acid clearance;
SKCM	cis	rs523522	0.923	rs2235217	chr12:120884328	C/T	cg27279351	chr12:120934652	DYNLL1	0.9	7.79	0.66	2.42e-11	High light scatter reticulocyte count;
SKCM	cis	rs362296	0.698	rs362283	chr4:3259558	T/C	cg21096898	chr4:3318625	RGS12	-0.81	-7.35	-0.64	1.69e-10	Parental longevity (mother's age at death);
SKCM	cis	rs208520	1.000	rs72882100	chr6:66981495	G/C	cg07460842	chr6:66804631	NA	0.87	5.96	0.56	6.95e-8	Exhaled nitric oxide output;
SKCM	cis	rs10751667	0.621	rs7396107	chr11:970029	C/T	cg10932868	chr11:921992	NA	0.55	5.1	0.5	2.36e-6	Alzheimer's disease (late onset);
SKCM	cis	rs9581857	0.556	rs1885990	chr13:28040502	C/T	cg22138327	chr13:27999177	GTF3A	0.71	5.23	0.51	1.36e-6	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs1577917	0.958	rs1447160	chr6:86546123	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.81	-7.82	-0.66	2.07e-11	Response to antipsychotic treatment;
SKCM	cis	rs59918340	0.728	rs2304279	chr8:142229891	A/G	cg23750338	chr8:142222470	SLC45A4	0.61	5.82	0.55	1.24e-7	Immature fraction of reticulocytes;
SKCM	cis	rs3741151	1.000	rs74776668	chr11:73065909	G/A	cg17517138	chr11:73019481	ARHGEF17	1.27	4.87	0.48	5.81e-6	GIP levels in response to oral glucose tolerance test (120 minutes);
SKCM	cis	rs2180341	1.000	rs9401950	chr6:127655485	C/T	cg24812749	chr6:127587940	RNF146	0.85	7.3	0.64	2.08e-10	Breast cancer;
SKCM	cis	rs11718455	0.767	rs11708363	chr3:43966585	G/A	cg21419209	chr3:44054225	NA	-0.62	-5.06	-0.5	2.75e-6	Coronary artery disease;
SKCM	cis	rs12971120	0.891	rs71359051	chr18:72169723	G/A	cg26446133	chr18:72167187	CNDP2	-0.67	-5.21	-0.51	1.48e-6	Refractive error;
SKCM	cis	rs908922	0.676	rs1538082	chr1:152517304	A/G	cg09873164	chr1:152488093	CRCT1	0.78	6.09	0.57	4.03e-8	Hair morphology;
SKCM	cis	rs6430585	0.583	rs730005	chr2:136582694	T/C	cg07169764	chr2:136633963	MCM6	1.31	13.14	0.83	1.86e-21	Corneal structure;
SKCM	cis	rs10503709	0.895	rs4739259	chr8:21442617	C/T	cg23716449	chr8:21608280	GFRA2	0.52	5.24	0.51	1.36e-6	Blood protein levels;
SKCM	cis	rs7954584	0.531	rs1154514	chr12:122374888	C/T	cg22618164	chr12:122356400	WDR66	0.54	5.44	0.52	6.02e-7	Mean corpuscular volume;
SKCM	cis	rs10504073	0.584	rs62507182	chr8:49942500	C/A	cg00325661	chr8:49890786	NA	0.8	6.81	0.61	1.83e-9	Blood metabolite ratios;
SKCM	cis	rs7002619	0.536	rs12176618	chr8:16067292	C/T	cg16243756	chr8:15397637	TUSC3	-0.58	-5.0	-0.49	3.51e-6	Schizophrenia;
SKCM	cis	rs28595532	0.748	rs67928655	chr4:119336525	C/A	cg11846333	chr4:119757529	SEC24D	1.19	6.71	0.6	2.81e-9	Cannabis dependence symptom count;
SKCM	cis	rs7666738	0.791	rs1426661	chr4:98874303	C/G	cg17366294	chr4:99064904	C4orf37	0.56	4.87	0.48	5.62e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2153535	0.580	rs6421948	chr6:8531020	T/C	cg23788917	chr6:8435910	SLC35B3	0.68	4.98	0.49	3.66e-6	Motion sickness;
SKCM	cis	rs4969178	0.965	rs2292642	chr17:76395430	C/T	cg20026190	chr17:76395443	PGS1	0.61	5.29	0.51	1.08e-6	HDL cholesterol levels;
SKCM	cis	rs1790761	0.520	rs4930461	chr11:67394895	A/G	cg14500267	chr11:67383377	NA	0.52	5.31	0.52	1.01e-6	Mean corpuscular volume;
SKCM	cis	rs116095464	0.558	rs3213838	chr5:223890	G/C	cg22857025	chr5:266934	NA	-1.36	-8.0	-0.67	9.23e-12	Breast cancer;
SKCM	cis	rs2439831	0.850	rs524417	chr15:43772374	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.05	6.6	0.6	4.56e-9	Lung cancer in ever smokers;
SKCM	cis	rs208520	0.690	rs12204512	chr6:66710486	C/T	cg07460842	chr6:66804631	NA	0.91	7.48	0.65	9.46e-11	Exhaled nitric oxide output;
SKCM	cis	rs6088590	0.561	rs2295444	chr20:33173883	C/T	cg24642439	chr20:33292090	TP53INP2	0.76	5.84	0.55	1.13e-7	Coronary artery disease;
SKCM	cis	rs3793683	0.571	rs12781152	chr10:134590257	G/C	cg27286337	chr10:134555280	INPP5A	1.0	9.01	0.71	1.05e-13	Migraine;
SKCM	cis	rs6977660	0.714	rs6943204	chr7:19818671	A/G	cg05791153	chr7:19748676	TWISTNB	0.79	4.82	0.48	6.91e-6	Thyroid stimulating hormone;
SKCM	cis	rs7666738	0.830	rs13116691	chr4:98929771	A/C	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs867186	0.920	rs78704804	chr20:33665831	A/C	cg04194272	chr20:33683537	NA	-1.38	-7.2	-0.63	3.29e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs6120849	0.707	rs6120798	chr20:33610822	T/G	cg24642439	chr20:33292090	TP53INP2	0.94	4.86	0.48	5.91e-6	Protein C levels;
SKCM	cis	rs2842992	0.915	rs2758321	chr6:160071611	C/G	cg19482086	chr6:160211437	TCP1;MRPL18	0.67	4.93	0.49	4.47e-6	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs9790314	0.846	rs4856738	chr3:160986637	C/G	cg03342759	chr3:160939853	NMD3	-0.72	-7.96	-0.67	1.13e-11	Morning vs. evening chronotype;
SKCM	cis	rs12497850	0.931	rs9755490	chr3:48871664	A/C	cg07636037	chr3:49044803	WDR6	1.01	10.82	0.77	3.36e-17	Parkinson's disease;
SKCM	cis	rs17685	0.515	rs111240556	chr7:75600863	T/C	cg16684958	chr7:75615977	POR	0.62	5.17	0.51	1.75e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs9926296	0.605	rs1800287	chr16:89858525	C/G	cg04287289	chr16:89883240	FANCA	1.03	11.97	0.8	2.47e-19	Vitiligo;
SKCM	cis	rs829883	0.664	rs865509	chr12:98854444	T/A	cg25150519	chr12:98850993	NA	0.51	5.06	0.5	2.7e-6	Colorectal adenoma (advanced);
SKCM	cis	rs13118159	0.550	rs11941200	chr4:1369093	C/G	cg02475777	chr4:1388615	CRIPAK	0.84	5.66	0.54	2.37e-7	Longevity;
SKCM	cis	rs9910055	0.659	rs2251165	chr17:42234748	T/C	cg13607699	chr17:42295918	UBTF	0.72	5.72	0.54	1.9e-7	Total body bone mineral density;
SKCM	cis	rs73110464	0.609	rs727266	chr12:53356411	C/T	cg05393297	chr12:53359155	NA	-0.65	-5.98	-0.56	6.35e-8	Cancer (pleiotropy);
SKCM	cis	rs473651	0.967	rs483042	chr2:239335320	A/G	cg18131467	chr2:239335373	ASB1	1.08	13.18	0.83	1.55e-21	Multiple system atrophy;
SKCM	cis	rs6951245	0.554	rs78999139	chr7:1138525	G/A	cg23708337	chr7:1209742	NA	0.71	4.9	0.49	5.02e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs6580649	0.941	rs72644841	chr12:48411987	A/G	cg05342945	chr12:48394962	COL2A1	0.76	5.18	0.51	1.71e-6	Lung cancer;
SKCM	cis	rs2180341	0.782	rs6569490	chr6:127729615	C/T	cg27446573	chr6:127587934	RNF146	0.69	5.49	0.53	4.79e-7	Breast cancer;
SKCM	cis	rs7772486	0.558	rs9376965	chr6:146130055	G/A	cg05347473	chr6:146136440	FBXO30	0.68	6.23	0.58	2.21e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2032447	0.765	rs1935235	chr6:26067782	C/G	cg03517284	chr6:25882590	NA	-0.57	-4.78	-0.48	8.24e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9926296	0.509	rs2159113	chr16:89832083	C/T	cg04287289	chr16:89883240	FANCA	0.97	7.73	0.66	3.11e-11	Vitiligo;
SKCM	cis	rs8180040	0.783	rs11710121	chr3:47351501	T/G	cg27129171	chr3:47204927	SETD2	-0.82	-5.65	-0.54	2.53e-7	Colorectal cancer;
SKCM	cis	rs11112613	0.775	rs12305225	chr12:105963266	G/C	cg03607813	chr12:105948248	NA	0.88	6.01	0.56	5.5e-8	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;
SKCM	cis	rs1552244	0.572	rs41464050	chr3:10158393	A/G	cg00149659	chr3:10157352	C3orf10	1.21	6.12	0.57	3.45e-8	Alzheimer's disease;
SKCM	cis	rs5769765	0.955	rs1321	chr22:50297435	A/G	cg22709217	chr22:50311962	ALG12;CRELD2	-0.83	-5.85	-0.55	1.1e-7	Schizophrenia;
SKCM	cis	rs362296	0.615	rs34030762	chr4:3255736	C/A	cg24015175	chr4:3319247	RGS12	-0.61	-5.68	-0.54	2.2e-7	Parental longevity (mother's age at death);
SKCM	cis	rs28595532	0.920	rs114420700	chr4:119751297	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs17376456	0.809	rs10476602	chr5:93445255	T/C	cg25358565	chr5:93447407	FAM172A	1.23	7.97	0.67	1.08e-11	Diabetic retinopathy;
SKCM	cis	rs9916302	0.752	rs12150047	chr17:37601755	A/G	cg07936489	chr17:37558343	FBXL20	-0.99	-6.94	-0.62	1e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs34779708	0.966	rs2505639	chr10:35474421	A/G	cg03585969	chr10:35415529	CREM	-0.75	-6.5	-0.59	7.06e-9	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs7726839	0.540	rs72703087	chr5:598029	C/T	cg10555297	chr5:473380	SLC9A3;LOC25845	1.02	4.87	0.48	5.72e-6	Obesity-related traits;
SKCM	cis	rs801193	1.000	rs6975195	chr7:66124774	T/A	cg11987759	chr7:65425863	GUSB	0.67	5.75	0.55	1.68e-7	Aortic root size;
SKCM	trans	rs1814175	0.669	rs12416837	chr11:49669761	G/T	cg15704280	chr7:45808275	SEPT13	-0.79	-7.34	-0.64	1.73e-10	Height;
SKCM	cis	rs1153858	1.000	rs4775906	chr15:45638294	C/T	cg10760299	chr15:45669010	GATM	0.58	6.04	0.56	4.83e-8	Homoarginine levels;
SKCM	cis	rs9951698	0.678	rs527839	chr18:13087815	G/A	cg12848697	chr18:13133368	NA	0.55	5.19	0.51	1.62e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2404602	0.967	rs2083762	chr15:76907376	T/C	cg23625390	chr15:77176239	SCAPER	0.75	7.27	0.64	2.44e-10	Blood metabolite levels;
SKCM	cis	rs55962025	0.883	rs362273	chr4:3227419	A/G	cg00764545	chr4:3318001	RGS12	-0.71	-5.79	-0.55	1.39e-7	Parental longevity (mother's age at death);
SKCM	cis	rs6570726	1.000	rs455109	chr6:145872665	C/T	cg23711669	chr6:146136114	FBXO30	0.69	6.67	0.6	3.39e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7666738	0.830	rs7687958	chr4:99014495	T/C	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11098499	0.754	rs1546503	chr4:120241167	T/C	cg09307838	chr4:120376055	NA	0.93	7.56	0.65	6.5500000000000006e-11	Corneal astigmatism;
SKCM	cis	rs3857536	0.740	rs7745163	chr6:66889936	A/G	cg07460842	chr6:66804631	NA	-0.7	-5.07	-0.5	2.64e-6	Blood trace element (Cu levels);
SKCM	cis	rs912057	0.582	rs1294412	chr6:6739854	A/G	cg06612196	chr6:6737390	NA	0.73	6.24	0.58	2.11e-8	Waist-to-hip ratio adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);
SKCM	cis	rs854765	0.547	rs7209003	chr17:17907393	T/A	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.04	9.2	0.72	4.44e-14	Total body bone mineral density;
SKCM	cis	rs1153858	1.000	rs4775909	chr15:45643042	T/C	cg21132104	chr15:45694354	SPATA5L1	0.89	7.07	0.63	5.75e-10	Homoarginine levels;
SKCM	cis	rs780096	0.546	rs7563162	chr2:27631191	C/T	cg05696406	chr2:27599888	SNX17	0.48	4.83	0.48	6.76e-6	Total body bone mineral density;
SKCM	cis	rs2243480	1.000	rs1723269	chr7:65472786	C/G	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs12188164	0.900	rs72717425	chr5:438809	C/T	cg26076054	chr5:421317	AHRR	-0.61	-5.04	-0.5	2.92e-6	Cystic fibrosis severity;
SKCM	cis	rs7927771	1.000	rs10838747	chr11:47716324	G/C	cg05585544	chr11:47624801	NA	-0.6	-5.24	-0.51	1.31e-6	Subjective well-being;
SKCM	cis	rs9470366	0.545	rs2395655	chr6:36645696	C/T	cg08179530	chr6:36648295	CDKN1A	-1.0	-8.09	-0.68	6.17e-12	QRS duration;
SKCM	cis	rs769267	0.965	rs2074303	chr19:19381755	C/T	cg03709012	chr19:19516395	GATAD2A	0.81	6.49	0.59	7.18e-9	Tonsillectomy;
SKCM	cis	rs2304069	0.955	rs4288106	chr5:149394872	A/G	cg22760475	chr5:149380129	HMGXB3;TIGD6	0.83	6.02	0.56	5.45e-8	HIV-1 control;
SKCM	cis	rs760805	1.000	rs61774728	chr1:25258867	G/C	cg22509179	chr1:25234806	RUNX3	-0.75	-6.22	-0.58	2.26e-8	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs1577917	0.958	rs7747897	chr6:86647349	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.85	-8.62	-0.7	5.82e-13	Response to antipsychotic treatment;
SKCM	cis	rs7100689	0.784	rs7082102	chr10:82104890	A/C	cg01528321	chr10:82214614	TSPAN14	0.85	7.74	0.66	3.01e-11	Post bronchodilator FEV1;
SKCM	cis	rs995000	0.931	rs638305	chr1:62906537	G/T	cg06896770	chr1:63153194	DOCK7	0.76	7.24	0.63	2.71e-10	Triglyceride levels;
SKCM	cis	rs28595532	0.920	rs28797314	chr4:119783044	A/G	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs6815814	0.950	rs113465719	chr4:38808045	A/T	cg02016764	chr4:38805732	TLR1	-0.76	-5.4	-0.52	6.95e-7	Breast cancer;
SKCM	cis	rs477692	0.935	rs554458	chr10:131427372	A/G	cg11019008	chr10:131425282	MGMT	0.5	5.08	0.5	2.56e-6	Response to temozolomide;
SKCM	cis	rs4972806	0.849	rs1542180	chr2:177028767	C/T	cg13092806	chr2:177043255	NA	0.55	4.94	0.49	4.41e-6	IgG glycosylation;
SKCM	cis	rs2180341	0.920	rs9401951	chr6:127671632	A/C	cg24812749	chr6:127587940	RNF146	0.8	6.89	0.62	1.27e-9	Breast cancer;
SKCM	cis	rs9303401	0.659	rs34275691	chr17:56736640	A/T	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.16	0.57	2.91e-8	Cognitive test performance;
SKCM	cis	rs9426691	1	rs9426691	chr1:23484904	A/G	cg12483005	chr1:23474871	LUZP1	0.65	5.04	0.5	2.99e-6	Coenzyme Q10 levels;
SKCM	cis	rs1032355	0.558	rs76819189	chr4:100528381	C/T	cg25391692	chr4:100495869	MTTP	-0.82	-4.97	-0.49	3.9e-6	Celiac disease;
SKCM	cis	rs6951245	0.706	rs1133116	chr7:1195215	A/C	cg03188948	chr7:1209495	NA	1.07	6.74	0.61	2.47e-9	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs116095464	0.558	rs6882584	chr5:223411	A/C	cg22857025	chr5:266934	NA	-1.36	-8.0	-0.67	9.23e-12	Breast cancer;
SKCM	trans	rs561341	1.000	rs560132	chr17:30320019	C/T	cg20587970	chr11:113659929	NA	-1.17	-10.23	-0.76	4.52e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs7772486	0.790	rs2249386	chr6:146186611	G/A	cg05347473	chr6:146136440	FBXO30	0.58	5.56	0.53	3.57e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs10416265	0.527	rs7246814	chr19:33538414	G/T	cg27124370	chr19:33622961	WDR88	0.66	4.82	0.48	6.94e-6	Bone properties (heel);
SKCM	cis	rs13040088	1.000	rs2273412	chr20:61553802	G/A	cg23096297	chr20:61557774	DIDO1	0.78	5.93	0.56	7.69e-8	Menopause (age at onset);
SKCM	cis	rs951366	0.903	rs823116	chr1:205720483	G/A	cg11965913	chr1:205819406	PM20D1	0.72	5.54	0.53	3.98e-7	Menarche (age at onset);
SKCM	cis	rs1018836	0.923	rs4735268	chr8:91629715	C/T	cg16814680	chr8:91681699	NA	-0.64	-4.85	-0.48	6.29e-6	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs28386778	0.830	rs2665841	chr17:61861219	A/T	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs12526480	0.509	rs301395	chr6:25486626	C/A	cg15326795	chr6:26217500	HIST1H2BG;HIST1H2AE	0.51	4.8	0.48	7.59e-6	Mean platelet volume;Plateletcrit;
SKCM	cis	rs11098499	0.774	rs73842616	chr4:120290683	G/A	cg24375607	chr4:120327624	NA	0.62	4.77	0.48	8.45e-6	Corneal astigmatism;
SKCM	cis	rs7666738	0.800	rs13106995	chr4:99028790	A/T	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6424115	0.743	rs2229580	chr1:24201109	C/T	cg15997130	chr1:24165203	NA	0.6	4.94	0.49	4.37e-6	Immature fraction of reticulocytes;
SKCM	cis	rs35306767	0.903	rs7077278	chr10:911291	A/G	cg26597838	chr10:835615	NA	-0.72	-5.03	-0.49	3.05e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs798766	0.723	rs3134865	chr4:1723279	T/C	cg24239225	chr4:1659016	FAM53A	-0.69	-4.87	-0.48	5.8e-6	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs7809950	0.768	rs2701678	chr7:107283711	A/G	cg23024343	chr7:107201750	COG5	0.8	7.23	0.63	2.87e-10	Coronary artery disease;
SKCM	cis	rs4727027	0.870	rs11524138	chr7:148799125	G/A	cg23583168	chr7:148888333	NA	-0.81	-6.35	-0.58	1.3e-8	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs1014246	0.813	rs11197797	chr10:118454499	C/T	cg14919929	chr10:118506882	NA	0.75	5.68	0.54	2.18e-7	Age at smoking initiation in chronic obstructive pulmonary disease;
SKCM	cis	rs7772486	0.754	rs702323	chr6:146008274	A/G	cg23711669	chr6:146136114	FBXO30	-0.9	-9.03	-0.71	9.5e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs10754283	0.901	rs10047070	chr1:90098715	G/C	cg21401794	chr1:90099060	LRRC8C	0.78	7.17	0.63	3.72e-10	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs1707322	0.963	rs12145287	chr1:46325002	C/G	cg03146154	chr1:46216737	IPP	0.74	5.0	0.49	3.39e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7100689	0.784	rs10749578	chr10:82139115	A/G	cg01528321	chr10:82214614	TSPAN14	-0.84	-8.26	-0.68	3.01e-12	Post bronchodilator FEV1;
SKCM	cis	rs6570726	0.791	rs379040	chr6:145889035	T/C	cg05347473	chr6:146136440	FBXO30	0.57	5.18	0.51	1.67e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs644799	1.000	rs543530	chr11:95545170	A/G	cg25622487	chr11:95524042	FAM76B;CEP57	0.66	5.12	0.5	2.18e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs362272	0.545	rs2749782	chr4:3339761	A/G	cg24015175	chr4:3319247	RGS12	0.85	10.87	0.78	2.81e-17	Serum sulfate level;
SKCM	cis	rs16854884	0.586	rs7639366	chr3:143752034	T/G	cg06585982	chr3:143692056	C3orf58	0.87	8.34	0.69	2.04e-12	Economic and political preferences (feminism/equality);
SKCM	cis	rs6952808	1.000	rs4721122	chr7:1893311	C/G	cg02951883	chr7:2050386	MAD1L1	-0.73	-5.52	-0.53	4.3e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs10540	1.000	rs61876341	chr11:495892	C/G	cg03352830	chr11:487213	PTDSS2	0.94	4.91	0.49	4.87e-6	Body mass index;
SKCM	cis	rs9916302	0.904	rs35285898	chr17:37555872	A/C	cg07936489	chr17:37558343	FBXL20	0.85	7.35	0.64	1.71e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs875971	0.862	rs1167408	chr7:65556108	G/A	cg11764359	chr7:65958608	NA	-0.83	-7.86	-0.66	1.78e-11	Aortic root size;
SKCM	cis	rs875971	0.862	rs937494	chr7:65764678	T/A	cg11764359	chr7:65958608	NA	-0.81	-7.63	-0.65	4.79e-11	Aortic root size;
SKCM	cis	rs11112613	0.595	rs871219	chr12:105938519	C/A	cg03607813	chr12:105948248	NA	0.9	5.82	0.55	1.23e-7	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;
SKCM	cis	rs4975616	0.807	rs28379291	chr5:1313701	A/G	cg07493874	chr5:1342172	CLPTM1L	0.61	5.06	0.5	2.71e-6	Lung cancer;
SKCM	cis	rs9916302	0.706	rs9893735	chr17:37469858	A/C	cg07936489	chr17:37558343	FBXL20	1.0	7.19	0.63	3.42e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs75920871	0.588	rs7119185	chr11:116886096	C/T	cg01368799	chr11:117014884	PAFAH1B2	-0.63	-4.83	-0.48	6.58e-6	Subjective well-being;
SKCM	cis	rs61935443	0.720	rs10859784	chr12:95288926	G/A	cg21533806	chr12:95267307	NA	0.92	5.33	0.52	9.24e-7	Schizophrenia;
SKCM	cis	rs2439831	0.702	rs9989313	chr15:44152817	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.3	6.97	0.62	9.12e-10	Lung cancer in ever smokers;
SKCM	cis	rs10791097	0.739	rs11222358	chr11:130730497	G/A	cg12179176	chr11:130786555	SNX19	0.75	5.95	0.56	7.12e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs763014	0.931	rs7191939	chr16:630089	C/T	cg09263875	chr16:632152	PIGQ	0.67	5.82	0.55	1.24e-7	Height;
SKCM	cis	rs7408868	0.831	rs1548555	chr19:15278057	A/G	cg14696996	chr19:15285081	NOTCH3	0.82	4.92	0.49	4.7e-6	Pulse pressure;
SKCM	cis	rs6570726	0.935	rs12663204	chr6:145818373	G/A	cg23711669	chr6:146136114	FBXO30	0.7	6.64	0.6	3.72e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9300255	0.664	rs7306755	chr12:123767929	G/A	cg05973401	chr12:123451056	ABCB9	-0.82	-5.72	-0.54	1.92e-7	Neutrophil percentage of white cells;
SKCM	cis	rs67311347	1.000	rs28434528	chr3:40484893	A/G	cg00091569	chr3:40428383	ENTPD3	0.62	5.09	0.5	2.4e-6	Renal cell carcinoma;
SKCM	cis	rs931234	1.000	rs931234	chr3:65153148	G/A	cg06271087	chr3:65342546	MAGI1	-0.54	-5.51	-0.53	4.53e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6912958	0.967	rs6914299	chr6:88149176	T/G	cg08069147	chr6:88032118	GJB7;C6orf162	-0.78	-6.78	-0.61	2.05e-9	Monocyte percentage of white cells;
SKCM	cis	rs7937682	0.924	rs513425	chr11:111504861	C/T	cg09085632	chr11:111637200	PPP2R1B	-1.07	-11.3	-0.79	4.28e-18	Primary sclerosing cholangitis;
SKCM	cis	rs589448	0.902	rs2603089	chr12:69776800	C/T	cg22834771	chr12:69754056	YEATS4	0.69	5.52	0.53	4.25e-7	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs826838	0.804	rs6580755	chr12:39159190	C/T	cg26384229	chr12:38710491	ALG10B	0.95	8.77	0.7	2.98e-13	Heart rate;
SKCM	cis	rs860295	0.665	rs11264393	chr1:155574471	C/A	cg02153340	chr1:155202674	NA	-0.74	-5.43	-0.52	6.23e-7	Body mass index;
SKCM	cis	rs7828089	0.819	rs12548353	chr8:22243491	T/C	cg12081754	chr8:22256438	SLC39A14	0.69	5.1	0.5	2.36e-6	Verbal declarative memory;
SKCM	cis	rs4819052	1.000	rs2297286	chr21:46707897	C/G	cg19498844	chr21:46707878	POFUT2;LOC642852	0.95	7.26	0.64	2.48e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs2839186	0.872	rs2250213	chr21:47674275	G/A	cg13126279	chr21:47581558	C21orf56	-0.62	-5.25	-0.51	1.26e-6	Testicular germ cell tumor;
SKCM	cis	rs2239547	0.562	rs35380116	chr3:52979178	A/G	cg11645453	chr3:52864694	ITIH4	-0.58	-4.96	-0.49	3.98e-6	Schizophrenia;
SKCM	trans	rs1814175	0.791	rs11040472	chr11:49703116	C/T	cg03929089	chr4:120376271	NA	-0.9	-8.54	-0.7	8.58e-13	Height;
SKCM	cis	rs8014204	0.762	rs973879	chr14:75297727	T/C	cg06637938	chr14:75390232	RPS6KL1	0.71	5.55	0.53	3.82e-7	Caffeine consumption;
SKCM	cis	rs7296418	0.599	rs2277343	chr12:123794450	A/T	cg05973401	chr12:123451056	ABCB9	0.72	5.48	0.53	5.12e-7	Platelet count;
SKCM	cis	rs651907	0.817	rs654102	chr3:101608155	A/G	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.73	5.7	0.54	2.04e-7	Colorectal cancer;
SKCM	cis	rs3784262	0.692	rs4646590	chr15:58303137	C/T	cg12031962	chr15:58353849	ALDH1A2	-0.42	-4.89	-0.48	5.38e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs365132	1.000	rs353493	chr5:176432585	T/C	cg16309518	chr5:176445507	NA	-0.52	-4.99	-0.49	3.54e-6	Menarche and menopause (age at onset);Menopause (age at onset);
SKCM	cis	rs9894429	0.789	rs7219915	chr17:79591813	C/T	cg18240062	chr17:79603768	NPLOC4	0.91	10.36	0.76	2.55e-16	Eye color traits;
SKCM	cis	rs6545883	0.560	rs11677776	chr2:61503113	T/C	cg15711740	chr2:61764176	XPO1	0.66	5.12	0.5	2.17e-6	Tuberculosis;
SKCM	cis	rs9902453	0.791	rs9904051	chr17:28244122	T/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.8	6.3	0.58	1.61e-8	Coffee consumption (cups per day);
SKCM	cis	rs2811415	0.597	rs13097739	chr3:127739076	T/C	cg09089421	chr3:127803668	RUVBL1	1.0	8.57	0.7	7.53e-13	Lung function (FEV1/FVC);
SKCM	cis	rs55823223	0.564	rs12103594	chr17:73855279	C/T	cg08125733	chr17:73851984	WBP2	1.06	6.07	0.57	4.35e-8	Psoriasis;
SKCM	cis	rs9796	0.774	rs28866311	chr15:41442195	T/G	cg18705301	chr15:41695430	NDUFAF1	-0.72	-5.33	-0.52	9.26e-7	Menopause (age at onset);
SKCM	cis	rs55962025	0.883	rs61792530	chr4:3145866	T/C	cg05297308	chr4:3317976	RGS12	-0.65	-4.88	-0.48	5.58e-6	Parental longevity (mother's age at death);
SKCM	cis	rs7786877	0.511	rs11770534	chr7:100245876	T/C	cg16850897	chr7:100343110	ZAN	-0.68	-4.89	-0.48	5.26e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs28595532	0.748	rs17594978	chr4:119336398	T/C	cg11846333	chr4:119757529	SEC24D	1.19	6.71	0.6	2.81e-9	Cannabis dependence symptom count;
SKCM	cis	rs28386778	0.897	rs4968662	chr17:61834537	A/G	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.12	11.27	0.79	4.92e-18	Prudent dietary pattern;
SKCM	cis	rs6545883	0.524	rs4599092	chr2:61498968	T/G	cg15711740	chr2:61764176	XPO1	0.66	5.12	0.5	2.17e-6	Tuberculosis;
SKCM	cis	rs71520386	0.632	rs10254365	chr7:22864754	A/T	cg00309339	chr7:22893653	NA	0.66	4.94	0.49	4.33e-6	Fibrinogen levels;
SKCM	cis	rs9818758	0.607	rs9855123	chr3:49229457	C/T	cg24110177	chr3:50126178	RBM5	0.86	5.12	0.5	2.15e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs17685	0.753	rs1859791	chr7:75786043	T/C	cg16489192	chr7:75678113	MDH2;STYXL1	-0.56	-5.23	-0.51	1.36e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs875971	0.660	rs10215132	chr7:66054406	C/A	cg00343986	chr7:65444356	GUSB	-0.67	-4.93	-0.49	4.55e-6	Aortic root size;
SKCM	cis	rs9902453	0.967	rs34323226	chr17:28517454	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.75	5.19	0.51	1.65e-6	Coffee consumption (cups per day);
SKCM	trans	rs1814175	0.817	rs1851858	chr11:49855638	G/A	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs9640161	0.636	rs3735171	chr7:150033882	A/G	cg10018233	chr7:150070692	REPIN1	0.71	5.59	0.53	3.28e-7	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs17711722	0.510	rs73142128	chr7:65331109	A/C	cg18876405	chr7:65276391	NA	0.63	4.88	0.48	5.61e-6	Calcium levels;
SKCM	cis	rs2370759	1.000	rs16933177	chr10:32565705	G/A	cg01819863	chr10:32635814	EPC1	1.0	5.08	0.5	2.48e-6	Sexual dysfunction (female);
SKCM	cis	rs1003719	0.788	rs9977602	chr21:38450650	G/T	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs514406	0.893	rs1242326	chr1:53399104	C/A	cg16325326	chr1:53192061	ZYG11B	0.89	9.33	0.73	2.51e-14	Monocyte count;
SKCM	cis	rs847649	1.000	rs28856331	chr7:102543763	T/G	cg18108683	chr7:102477205	FBXL13	-0.81	-8.31	-0.69	2.36e-12	Morning vs. evening chronotype;
SKCM	cis	rs9300255	0.602	rs1790126	chr12:123683563	C/T	cg00376283	chr12:123451042	ABCB9	0.83	5.49	0.53	4.74e-7	Neutrophil percentage of white cells;
SKCM	cis	rs2243480	0.711	rs2420172	chr7:65635341	T/C	cg18252515	chr7:66147081	NA	1.34	8.18	0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs10905065	0.931	rs6602240	chr10:5816751	C/A	cg09234995	chr10:5726438	C10orf18	0.66	5.72	0.54	1.86e-7	Menopause (age at onset);
SKCM	cis	rs9467773	0.873	rs9295698	chr6:26566099	T/A	cg09904177	chr6:26538194	HMGN4	0.54	4.98	0.49	3.78e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs11690935	0.632	rs35854151	chr2:172657439	G/A	cg13550731	chr2:172543902	DYNC1I2	0.6	5.19	0.51	1.62e-6	Schizophrenia;
SKCM	cis	rs597539	0.617	rs598353	chr11:68635770	C/A	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.84	5.61	0.54	3e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs4969178	0.932	rs3744219	chr17:76400236	G/A	cg20026190	chr17:76395443	PGS1	0.59	5.01	0.49	3.3e-6	HDL cholesterol levels;
SKCM	cis	rs514406	0.505	rs436363	chr1:53172163	T/C	cg16325326	chr1:53192061	ZYG11B	0.89	10.06	0.75	9.55e-16	Monocyte count;
SKCM	cis	rs11105298	0.891	rs10858872	chr12:89872932	C/T	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.91	-6.01	-0.56	5.69e-8	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs58688157	0.705	rs7941547	chr11:611503	G/A	cg17114584	chr11:613792	IRF7	0.75	5.05	0.5	2.85e-6	Systemic lupus erythematosus;
SKCM	cis	rs16949788	1.000	rs79097157	chr15:66764814	C/A	cg08120210	chr15:66682733	MAP2K1	-0.74	-5.69	-0.54	2.1e-7	Spherical equivalent (joint analysis main effects and education interaction);
SKCM	cis	rs523522	0.923	rs2235217	chr12:120884328	C/T	cg12219531	chr12:120966889	COQ5	0.88	7.17	0.63	3.67e-10	High light scatter reticulocyte count;
SKCM	cis	rs3784262	0.669	rs12594082	chr15:58267779	G/A	cg12031962	chr15:58353849	ALDH1A2	-0.43	-5.15	-0.5	1.87e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs7772486	0.727	rs12190966	chr6:146146820	T/G	cg23711669	chr6:146136114	FBXO30	0.88	9.58	0.74	8.31e-15	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2072499	0.722	rs61462713	chr1:156161682	C/T	cg25208724	chr1:156163844	SLC25A44	0.89	6.31	0.58	1.55e-8	Testicular germ cell tumor;
SKCM	cis	rs28595532	0.841	rs115852209	chr4:119753465	A/G	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs17685	0.753	rs1637044	chr7:75703744	T/C	cg01364799	chr7:75623366	TMEM120A	-0.72	-5.81	-0.55	1.31e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2760061	0.598	rs1774755	chr1:228115282	T/G	cg02753203	chr1:228287806	NA	-0.63	-4.96	-0.49	3.99e-6	Diastolic blood pressure;
SKCM	cis	rs11718455	1.000	rs9858826	chr3:44031412	C/T	cg21419209	chr3:44054225	NA	0.66	5.24	0.51	1.34e-6	Coronary artery disease;
SKCM	cis	rs9916302	0.706	rs582176	chr17:37453999	T/C	cg07936489	chr17:37558343	FBXL20	1.0	7.19	0.63	3.42e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs1005277	0.579	rs2505248	chr10:38459097	A/G	cg00409905	chr10:38381863	ZNF37A	-0.61	-5.8	-0.55	1.38e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs4819052	0.851	rs10470247	chr21:46659018	T/C	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.35	0.64	1.68e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs875971	1.000	rs2420820	chr7:66091907	T/C	cg11764359	chr7:65958608	NA	-0.82	-7.48	-0.65	9.59e-11	Aortic root size;
SKCM	cis	rs7555523	0.887	rs10800155	chr1:165723770	A/G	cg24409356	chr1:165738333	TMCO1	0.93	5.15	0.5	1.93e-6	Intraocular pressure;Glaucoma (high intraocular pressure);
SKCM	cis	rs9640161	0.789	rs2098053	chr7:150043205	G/A	cg27494647	chr7:150038898	RARRES2	0.56	4.87	0.48	5.64e-6	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs9467773	0.967	rs9467775	chr6:26513435	G/A	cg09904177	chr6:26538194	HMGN4	0.54	4.98	0.49	3.78e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs3008870	0.959	rs2985816	chr1:67387750	G/T	cg08660285	chr1:67390436	MIER1;WDR78	0.98	6.56	0.6	5.45e-9	Lymphocyte percentage of white cells;
SKCM	cis	rs1707322	0.963	rs4630155	chr1:46257110	G/C	cg03146154	chr1:46216737	IPP	0.74	5.0	0.49	3.39e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs617791	0.530	rs7952056	chr11:65744597	C/T	cg27068330	chr11:65405492	SIPA1	-0.68	-4.9	-0.49	5.12e-6	Breast cancer;
SKCM	cis	rs1062177	1.000	rs6890099	chr5:151151962	A/G	cg00977110	chr5:151150581	G3BP1	0.79	6.51	0.59	6.71e-9	Preschool internalizing problems;
SKCM	cis	rs875971	0.540	rs781152	chr7:65479572	T/A	cg11987759	chr7:65425863	GUSB	-0.77	-6.93	-0.62	1.09e-9	Aortic root size;
SKCM	cis	rs2732480	0.557	rs923397	chr12:48720392	G/A	cg21348975	chr12:48724119	NA	-0.58	-4.88	-0.48	5.47e-6	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs7666738	0.830	rs7657490	chr4:99043973	C/T	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs860295	0.702	rs10908471	chr1:155542942	A/G	cg02153340	chr1:155202674	NA	-0.78	-5.91	-0.56	8.65e-8	Body mass index;
SKCM	cis	rs7811142	1.000	rs11763414	chr7:100016844	C/G	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.33	0.69	2.11e-12	Platelet count;
SKCM	cis	rs17826219	0.714	rs11650821	chr17:28968150	T/C	cg14067834	chr17:29058358	SUZ12P	1.07	4.92	0.49	4.65e-6	Body mass index;
SKCM	cis	rs826838	0.868	rs864324	chr12:39122853	A/G	cg26384229	chr12:38710491	ALG10B	0.73	5.97	0.56	6.69e-8	Heart rate;
SKCM	cis	rs9300255	0.722	rs1060105	chr12:123806219	C/T	cg05973401	chr12:123451056	ABCB9	-0.82	-5.72	-0.54	1.92e-7	Neutrophil percentage of white cells;
SKCM	cis	rs7772486	0.754	rs697055	chr6:146003790	C/G	cg05347473	chr6:146136440	FBXO30	0.62	5.46	0.53	5.55e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs801193	0.613	rs2659900	chr7:66184443	G/C	cg18876405	chr7:65276391	NA	0.66	6.49	0.59	7.13e-9	Aortic root size;
SKCM	cis	rs9788682	1.000	rs7181245	chr15:78814389	C/T	cg24631222	chr15:78858424	CHRNA5	0.94	6.59	0.6	4.67e-9	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs8077889	0.750	rs80053172	chr17:41936843	C/T	cg26893861	chr17:41843967	DUSP3	1.23	6.83	0.61	1.63e-9	Triglycerides;
SKCM	cis	rs7666738	0.830	rs13111977	chr4:98953813	G/A	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9581857	0.579	rs9581843	chr13:27980507	T/G	cg22138327	chr13:27999177	GTF3A	0.95	6.38	0.59	1.14e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs11792861	0.591	rs2275641	chr9:111696389	G/C	cg14432460	chr9:111696404	IKBKAP;C9orf6	0.79	6.7	0.6	2.93e-9	Menarche (age at onset);
SKCM	cis	rs9992101	0.744	rs2870238	chr4:77373079	C/T	cg10131286	chr4:76554724	CDKL2	0.51	4.88	0.48	5.55e-6	Creatinine levels;
SKCM	cis	rs6921919	0.583	rs4642462	chr6:28389251	G/C	cg14547644	chr6:28411285	ZSCAN23	-0.58	-4.8	-0.48	7.46e-6	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs6952808	0.689	rs12668156	chr7:2019875	G/A	cg21782813	chr7:2030301	MAD1L1	0.54	5.45	0.53	5.67e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs12971120	0.891	rs12968731	chr18:72169708	G/T	cg26446133	chr18:72167187	CNDP2	-0.67	-5.21	-0.51	1.48e-6	Refractive error;
SKCM	cis	rs2268241	0.938	rs8133431	chr21:34796556	C/T	cg14850771	chr21:34775459	IFNGR2	1.09	6.23	0.58	2.18e-8	Obesity-related traits;
SKCM	cis	rs1577917	1.000	rs12216328	chr6:86703418	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.64	-5.54	-0.53	3.92e-7	Response to antipsychotic treatment;
SKCM	cis	rs9880211	1.000	rs17200216	chr3:136067232	C/A	cg21827317	chr3:136751795	NA	-0.64	-4.78	-0.48	8.21e-6	Body mass index;Height;
SKCM	cis	rs12047808	0.841	rs78488371	chr1:179379197	T/A	cg09822482	chr1:179519214	C1orf125	-0.95	-5.17	-0.51	1.78e-6	Multiple sclerosis (age of onset);
SKCM	cis	rs10752881	0.905	rs12132262	chr1:182989949	T/A	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.65	0.6	3.65e-9	Colorectal cancer;
SKCM	cis	rs826838	1.000	rs2129627	chr12:38653036	C/T	cg26384229	chr12:38710491	ALG10B	0.95	7.92	0.67	1.32e-11	Heart rate;
SKCM	cis	rs7772486	0.776	rs2265467	chr6:146218339	T/A	cg23711669	chr6:146136114	FBXO30	0.74	7.31	0.64	2.05e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7618915	0.547	rs12496476	chr3:52708737	A/G	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs6570726	0.791	rs383841	chr6:145888329	G/T	cg05347473	chr6:146136440	FBXO30	-0.6	-5.16	-0.5	1.82e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs10779751	1.000	rs4845854	chr1:11261929	T/C	cg08854313	chr1:11322531	MTOR	0.98	7.99	0.67	9.92e-12	Body mass index;
SKCM	cis	rs61935443	0.832	rs11107771	chr12:95276844	A/G	cg21533806	chr12:95267307	NA	0.92	5.32	0.52	9.53e-7	Schizophrenia;
SKCM	cis	rs684232	0.583	rs17677436	chr17:520314	T/C	cg15660573	chr17:549704	VPS53	-0.75	-5.83	-0.55	1.18e-7	Prostate cancer;
SKCM	cis	rs9911578	0.817	rs304264	chr17:56749628	A/G	cg12560992	chr17:57184187	TRIM37	0.91	7.58	0.65	6.07e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs9814567	1.000	rs2056604	chr3:134312648	G/A	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs13217239	0.646	rs12201393	chr6:26975690	C/A	cg12292205	chr6:26970375	C6orf41	0.63	5.64	0.54	2.58e-7	Schizophrenia;
SKCM	cis	rs7020830	0.898	rs7857936	chr9:37078491	T/C	cg14294708	chr9:37120828	ZCCHC7	1.09	9.86	0.74	2.36e-15	Schizophrenia;
SKCM	cis	rs7824557	0.602	rs11781375	chr8:11204532	A/G	cg21775007	chr8:11205619	TDH	0.71	6.31	0.58	1.57e-8	Retinal vascular caliber;
SKCM	cis	rs12188164	1.000	rs55842567	chr5:437586	G/A	cg26076054	chr5:421317	AHRR	-0.61	-4.87	-0.48	5.68e-6	Cystic fibrosis severity;
SKCM	cis	rs763014	0.966	rs7185390	chr16:666382	A/G	cg00908189	chr16:619842	PIGQ	0.82	7.61	0.65	5.42e-11	Height;
SKCM	cis	rs10751667	0.666	rs12295141	chr11:947065	G/A	cg10932868	chr11:921992	NA	0.55	5.1	0.5	2.36e-6	Alzheimer's disease (late onset);
SKCM	cis	rs17685	0.625	rs1639630	chr7:75730499	T/C	cg16489192	chr7:75678113	MDH2;STYXL1	-0.61	-5.55	-0.53	3.73e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs11764590	0.694	rs11773643	chr7:2104063	A/G	cg23422044	chr7:1970798	MAD1L1	-0.87	-6.13	-0.57	3.36e-8	Neuroticism;
SKCM	cis	rs7829975	0.688	rs7827182	chr8:8380471	C/G	cg08975724	chr8:8085496	FLJ10661	0.64	4.96	0.49	4.05e-6	Mood instability;
SKCM	cis	rs2760061	0.624	rs10442629	chr1:228191070	T/A	cg02753203	chr1:228287806	NA	0.79	7.23	0.63	2.83e-10	Diastolic blood pressure;
SKCM	cis	rs11105298	0.891	rs11105312	chr12:89920733	C/T	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.91	-5.65	-0.54	2.56e-7	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs3768617	0.510	rs3765521	chr1:183077615	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs1218582	0.803	rs7531728	chr1:154840516	C/A	cg24250549	chr1:154909240	PMVK	0.84	8.9	0.71	1.69e-13	Prostate cancer;
SKCM	cis	rs9815354	0.812	rs12108049	chr3:41958161	A/G	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs362272	0.505	rs60208975	chr4:3364530	A/G	cg21096898	chr4:3318625	RGS12	0.99	12.39	0.81	4.16e-20	Serum sulfate level;
SKCM	cis	rs6541297	0.941	rs6693579	chr1:230282707	T/C	cg05784532	chr1:230284198	GALNT2	0.65	4.98	0.49	3.69e-6	Coronary artery disease;
SKCM	cis	rs11249608	0.548	rs7709054	chr5:178462757	C/T	cg21905437	chr5:178450457	ZNF879	0.71	5.45	0.53	5.65e-7	Pubertal anthropometrics;
SKCM	trans	rs1814175	0.645	rs1851845	chr11:49982396	C/T	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs754466	0.606	rs12356375	chr10:79594514	C/A	cg17075019	chr10:79541650	NA	-0.78	-7.04	-0.62	6.57e-10	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs11690935	0.632	rs12998411	chr2:172530707	G/C	cg13550731	chr2:172543902	DYNC1I2	0.64	5.67	0.54	2.33e-7	Schizophrenia;
SKCM	cis	rs763014	1.000	rs2269558	chr16:682250	C/T	cg09263875	chr16:632152	PIGQ	0.78	6.69	0.6	3.07e-9	Height;
SKCM	cis	rs34779708	0.733	rs4298846	chr10:35547380	A/G	cg03585969	chr10:35415529	CREM	0.71	5.25	0.51	1.27e-6	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs13256369	0.755	rs12550057	chr8:8562268	G/A	cg06636001	chr8:8085503	FLJ10661	0.8	6.11	0.57	3.65e-8	Obesity-related traits;
SKCM	cis	rs8077889	0.917	rs28694735	chr17:41912144	A/G	cg26893861	chr17:41843967	DUSP3	1.15	7.34	0.64	1.79e-10	Triglycerides;
SKCM	cis	rs7937682	0.855	rs571462	chr11:111487106	C/G	cg09085632	chr11:111637200	PPP2R1B	-0.97	-10.08	-0.75	8.74e-16	Primary sclerosing cholangitis;
SKCM	cis	rs514406	0.679	rs12563825	chr1:53238324	G/T	cg27535305	chr1:53392650	SCP2	0.55	5.0	0.49	3.41e-6	Monocyte count;
SKCM	cis	rs7618915	0.547	rs62253733	chr3:52653414	A/G	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs2760061	0.583	rs708123	chr1:228220495	A/G	cg02753203	chr1:228287806	NA	0.91	8.88	0.71	1.88e-13	Diastolic blood pressure;
SKCM	cis	rs9467773	0.596	rs2451751	chr6:26646714	T/C	cg09904177	chr6:26538194	HMGN4	0.58	5.01	0.49	3.28e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7639513	0.767	rs9878151	chr3:12703714	G/C	cg23032965	chr3:12705835	RAF1	0.81	7.01	0.62	7.4e-10	Itch intensity from mosquito bite;
SKCM	cis	rs6570726	0.967	rs441364	chr6:145853662	G/C	cg23711669	chr6:146136114	FBXO30	0.7	6.85	0.61	1.53e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9583531	0.600	rs4773241	chr13:111363021	A/G	cg24331049	chr13:111365604	ING1	0.88	6.6	0.6	4.45e-9	Coronary artery disease;
SKCM	cis	rs10876993	0.890	rs12302350	chr12:58062589	T/G	cg18357645	chr12:58087776	OS9	0.61	5.62	0.54	2.9e-7	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs2243480	1.000	rs1039664	chr7:65449716	T/G	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs4132509	0.744	rs12031994	chr1:243917309	T/C	cg21452805	chr1:244014465	NA	0.93	6.05	0.57	4.77e-8	RR interval (heart rate);
SKCM	cis	rs8072100	1.000	rs8065437	chr17:45721653	C/T	cg08085267	chr17:45401833	C17orf57	-0.63	-5.86	-0.55	1.06e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs7659604	0.539	rs56159666	chr4:122782879	G/A	cg06713675	chr4:122721982	EXOSC9	-0.75	-7.38	-0.64	1.48e-10	Type 2 diabetes;
SKCM	cis	rs10193935	0.786	rs13416119	chr2:42462930	A/G	cg27598129	chr2:42591480	NA	-1.03	-6.5	-0.59	6.94e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1395	1.000	rs4665958	chr2:27443196	A/G	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.47	4.77	0.48	8.27e-6	Blood metabolite levels;
SKCM	cis	rs919433	0.963	rs6738836	chr2:198182432	A/G	cg04278110	chr2:198063759	ANKRD44	-0.69	-4.8	-0.48	7.58e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs7666738	0.830	rs6848397	chr4:98946738	A/G	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4481887	1.000	rs4554750	chr1:248496530	C/G	cg00666640	chr1:248458726	OR2T12	0.59	4.94	0.49	4.38e-6	Common traits (Other);
SKCM	cis	rs6840360	0.571	rs4696274	chr4:152528478	C/A	cg22705602	chr4:152727874	NA	-0.52	-5.7	-0.54	2.03e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs11719291	0.504	rs34571182	chr3:49209057	T/A	cg00383909	chr3:49044727	WDR6	0.95	5.43	0.52	6.25e-7	Cognitive function;
SKCM	cis	rs9393692	0.645	rs9467703	chr6:26318903	A/G	cg00631329	chr6:26305371	NA	-0.68	-4.81	-0.48	7.25e-6	Educational attainment;
SKCM	cis	rs6545883	0.894	rs778144	chr2:61583128	A/C	cg15711740	chr2:61764176	XPO1	0.68	4.83	0.48	6.8e-6	Tuberculosis;
SKCM	cis	rs72781680	0.898	rs12620558	chr2:23936022	G/A	cg08917208	chr2:24149416	ATAD2B	0.95	4.78	0.48	8.1e-6	Lymphocyte counts;
SKCM	cis	rs7917772	0.536	rs12357172	chr10:104388549	C/T	cg11453585	chr10:104263688	ACTR1A;SUFU	0.75	5.83	0.55	1.21e-7	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs709400	0.628	rs1989565	chr14:103862193	G/A	cg26031613	chr14:104095156	KLC1	-0.75	-5.74	-0.54	1.75e-7	Body mass index;
SKCM	cis	rs875971	0.862	rs7809814	chr7:65615397	G/A	cg18876405	chr7:65276391	NA	-0.65	-6.63	-0.6	3.96e-9	Aortic root size;
SKCM	cis	rs2404602	1.000	rs2404602	chr15:77030792	A/G	cg23625390	chr15:77176239	SCAPER	0.74	7.23	0.63	2.86e-10	Blood metabolite levels;
SKCM	cis	rs7666738	0.830	rs1426663	chr4:98990092	T/G	cg17366294	chr4:99064904	C4orf37	0.59	4.93	0.49	4.49e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9894429	0.646	rs7220310	chr17:79606056	C/A	cg18240062	chr17:79603768	NPLOC4	0.68	6.0	0.56	5.88e-8	Eye color traits;
SKCM	cis	rs9814567	1.000	rs7611828	chr3:134250325	C/T	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs597539	0.652	rs488363	chr11:68658298	C/G	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.82	5.44	0.52	5.87e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs9325144	0.560	rs11182979	chr12:38642562	C/A	cg26384229	chr12:38710491	ALG10B	-0.68	-5.47	-0.53	5.17e-7	Morning vs. evening chronotype;
SKCM	cis	rs9815354	0.638	rs73069277	chr3:41967521	C/T	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs9399137	0.507	rs13214669	chr6:135299959	T/C	cg24558204	chr6:135376177	HBS1L	0.7	6.53	0.59	6.11e-9	Glycated hemoglobin levels;Mean corpuscular volume;Hematology traits;HbA2 levels;Mean corpuscular hemoglobin;Hemoglobin levels;F-cell distribution;Platelet count;
SKCM	cis	rs2739330	0.828	rs4822454	chr22:24255208	G/A	cg24846343	chr22:24311635	DDTL	0.61	5.75	0.55	1.68e-7	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs9420	0.961	rs11604325	chr11:57497011	C/A	cg19752551	chr11:57585705	CTNND1	-0.7	-6.84	-0.61	1.6e-9	Schizophrenia;
SKCM	cis	rs9303401	0.614	rs34058624	chr17:57118121	T/C	cg10487724	chr17:56770010	TEX14;RAD51C	0.79	4.97	0.49	3.86e-6	Cognitive test performance;
SKCM	cis	rs1568889	1.000	rs12797712	chr11:28290890	G/A	cg06544937	chr11:28130018	METT5D1;KIF18A	0.86	6.08	0.57	4.19e-8	Bipolar disorder;
SKCM	cis	rs4919087	0.962	rs3740522	chr10:99019144	C/T	cg25902810	chr10:99078978	FRAT1	0.63	5.14	0.5	2.01e-6	Monocyte count;
SKCM	cis	rs477895	0.653	rs11603212	chr11:63927810	C/T	cg07220939	chr11:64358617	SLC22A12	-0.74	-4.96	-0.49	4.1e-6	Mean platelet volume;
SKCM	cis	rs875971	0.651	rs313829	chr7:65552497	A/G	cg11764359	chr7:65958608	NA	-0.73	-5.05	-0.5	2.8e-6	Aortic root size;
SKCM	cis	rs7772486	0.875	rs2777476	chr6:146345024	A/G	cg23711669	chr6:146136114	FBXO30	0.76	7.15	0.63	4.1e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs208520	0.837	rs208488	chr6:66926902	C/T	cg07460842	chr6:66804631	NA	-0.98	-6.96	-0.62	9.58e-10	Exhaled nitric oxide output;
SKCM	cis	rs9902453	0.899	rs8067580	chr17:28471248	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.5	0.53	4.74e-7	Coffee consumption (cups per day);
SKCM	cis	rs34779708	0.931	rs13377158	chr10:35370465	A/C	cg03585969	chr10:35415529	CREM	-0.75	-6.06	-0.57	4.57e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs9549367	0.713	rs56002882	chr13:113830694	T/C	cg18105134	chr13:113819100	PROZ	-0.91	-6.82	-0.61	1.71e-9	Platelet distribution width;
SKCM	cis	rs28595532	0.702	rs72670250	chr4:119337134	T/C	cg21605333	chr4:119757512	SEC24D	0.95	4.91	0.49	4.92e-6	Cannabis dependence symptom count;
SKCM	cis	rs6461049	0.734	rs1558465	chr7:2151398	G/C	cg21782813	chr7:2030301	MAD1L1	0.48	5.1	0.5	2.32e-6	Schizophrenia;
SKCM	cis	rs873946	0.590	rs12783478	chr10:134550700	A/G	cg26818010	chr10:134567672	INPP5A	-0.73	-5.61	-0.54	3.01e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs9911578	1.000	rs9901181	chr17:56964271	C/T	cg12560992	chr17:57184187	TRIM37	0.94	7.55	0.65	7.01e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs72949976	0.646	rs1441170	chr2:214033563	A/G	cg08319019	chr2:214017104	IKZF2	-0.79	-6.05	-0.57	4.71e-8	Lung cancer;Squamous cell lung carcinoma;
SKCM	cis	rs826838	0.654	rs7977738	chr12:38722460	G/A	cg13010199	chr12:38710504	ALG10B	0.63	4.92	0.49	4.64e-6	Heart rate;
SKCM	cis	rs116095464	0.558	rs10077076	chr5:231940	C/T	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs7945705	0.714	rs2653570	chr11:8987823	A/G	cg21881798	chr11:8931708	C11orf17;ST5	-0.82	-8.76	-0.7	3.2e-13	Hemoglobin concentration;
SKCM	cis	rs7106204	0.748	rs36092013	chr11:24211987	C/T	ch.11.24196551F	chr11:24239977	NA	0.77	5.97	0.56	6.6e-8	Response to Homoharringtonine (cytotoxicity);
SKCM	cis	rs4975616	0.836	rs421629	chr5:1320136	G/A	cg06550200	chr5:1325588	CLPTM1L	-0.84	-7.31	-0.64	1.98e-10	Lung cancer;
SKCM	cis	rs826838	0.935	rs10875816	chr12:38955014	C/A	cg13010199	chr12:38710504	ALG10B	0.85	6.38	0.59	1.14e-8	Heart rate;
SKCM	cis	rs6598955	0.640	rs6667826	chr1:26531408	T/C	cg04990556	chr1:26633338	UBXN11	-0.6	-4.78	-0.48	8.15e-6	Obesity-related traits;
SKCM	cis	rs1799949	1.000	rs12952790	chr17:41299607	A/G	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.11	-0.57	3.67e-8	Menopause (age at onset);
SKCM	cis	rs2901656	0.677	rs2269615	chr1:172415451	C/T	cg03748243	chr1:172413542	C1orf105;PIGC	0.5	4.92	0.49	4.75e-6	Red cell distribution width;Platelet distribution width;
SKCM	cis	rs1577917	1.000	rs12207305	chr6:86723502	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.83	-8.07	-0.67	6.96e-12	Response to antipsychotic treatment;
SKCM	cis	rs2839186	0.900	rs56840278	chr21:47708933	T/G	cg13126279	chr21:47581558	C21orf56	-0.64	-5.47	-0.53	5.17e-7	Testicular germ cell tumor;
SKCM	cis	rs2836974	0.899	rs34978594	chr21:40580003	C/T	cg11890956	chr21:40555474	PSMG1	1.09	13.83	0.84	1.08e-22	Cognitive function;
SKCM	cis	rs78269692	0.826	rs74569397	chr19:13239298	C/T	cg19436403	chr19:12780550	MORG1;C19orf56	1.39	5.14	0.5	1.96e-6	Breast cancer;
SKCM	cis	rs7772486	0.651	rs1292338	chr6:145967471	A/C	cg05347473	chr6:146136440	FBXO30	-0.6	-5.26	-0.51	1.22e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs3820928	0.874	rs10189579	chr2:227864876	A/G	cg11843606	chr2:227700838	RHBDD1	-0.61	-4.89	-0.48	5.28e-6	Pulmonary function;
SKCM	cis	rs62238980	0.614	rs17683011	chr22:32445946	A/G	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs909341	0.710	rs3848669	chr20:62300811	G/T	cg03999872	chr20:62272968	STMN3	0.55	4.85	0.48	6.23e-6	Atopic dermatitis;
SKCM	cis	rs7666738	0.830	rs9996098	chr4:98867740	T/C	cg17366294	chr4:99064904	C4orf37	0.56	4.87	0.48	5.62e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2841277	0.708	rs10083496	chr14:105402786	G/A	cg21017887	chr14:105400489	NA	0.59	5.31	0.52	1e-6	Rheumatoid arthritis;
SKCM	cis	rs4481887	0.741	rs11485458	chr1:248569050	A/G	cg00666640	chr1:248458726	OR2T12	0.5	5.11	0.5	2.24e-6	Common traits (Other);
SKCM	cis	rs1707322	0.717	rs3014245	chr1:46086913	C/T	cg03146154	chr1:46216737	IPP	-0.76	-5.07	-0.5	2.64e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs1153858	1.000	rs66939267	chr15:45676902	T/A	cg21132104	chr15:45694354	SPATA5L1	0.93	7.94	0.67	1.22e-11	Homoarginine levels;
SKCM	cis	rs7106204	0.748	rs28552633	chr11:24207518	A/C	ch.11.24196551F	chr11:24239977	NA	0.81	6.47	0.59	7.99e-9	Response to Homoharringtonine (cytotoxicity);
SKCM	cis	rs9325144	0.647	rs34963631	chr12:38912260	T/A	cg13010199	chr12:38710504	ALG10B	-0.63	-5.11	-0.5	2.26e-6	Morning vs. evening chronotype;
SKCM	cis	rs634534	0.622	rs593525	chr11:65727799	T/C	cg26695010	chr11:65641043	EFEMP2	-0.68	-5.48	-0.53	4.96e-7	Sum eosinophil basophil counts;Eosinophil counts;
SKCM	cis	rs8180040	0.593	rs4018905	chr3:47138170	A/G	cg27129171	chr3:47204927	SETD2	0.74	5.37	0.52	7.84e-7	Colorectal cancer;
SKCM	cis	rs854765	0.647	rs854814	chr17:18003648	G/A	cg04398451	chr17:18023971	MYO15A	-1.0	-9.22	-0.72	4.08e-14	Total body bone mineral density;
SKCM	cis	rs2239547	0.562	rs2581810	chr3:52960859	C/T	cg11645453	chr3:52864694	ITIH4	-0.58	-4.96	-0.49	3.98e-6	Schizophrenia;
SKCM	cis	rs2832191	0.692	rs2254872	chr21:30414724	C/T	cg24692254	chr21:30365293	RNF160	1.0	9.45	0.73	1.45e-14	Dental caries;
SKCM	cis	rs7666738	0.830	rs13147768	chr4:98833675	A/T	cg17366294	chr4:99064904	C4orf37	0.56	4.87	0.48	5.62e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs67311347	0.866	rs11712426	chr3:40330322	G/A	cg00091569	chr3:40428383	ENTPD3	0.64	5.38	0.52	7.57e-7	Renal cell carcinoma;
SKCM	cis	rs6570726	0.791	rs7765687	chr6:145915100	A/C	cg23711669	chr6:146136114	FBXO30	0.85	7.97	0.67	1.05e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs3784262	0.631	rs12903724	chr15:58310387	G/C	cg12031962	chr15:58353849	ALDH1A2	-0.41	-4.82	-0.48	6.93e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs4819052	0.851	rs2838842	chr21:46669217	C/T	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.41	0.52	6.6e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs6570726	0.557	rs403956	chr6:145829956	T/C	cg05347473	chr6:146136440	FBXO30	0.62	5.34	0.52	8.97e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1552244	0.572	rs12107622	chr3:10171898	T/A	cg00149659	chr3:10157352	C3orf10	1.13	5.45	0.53	5.74e-7	Alzheimer's disease;
SKCM	cis	rs2952156	0.684	rs881844	chr17:37810218	C/G	cg00129232	chr17:37814104	STARD3	-0.77	-6.32	-0.58	1.52e-8	Asthma;
SKCM	cis	rs8016982	0.674	rs1951615	chr14:81671762	G/A	cg01989461	chr14:81687754	GTF2A1	0.88	7.42	0.64	1.26e-10	Schizophrenia;
SKCM	cis	rs7590368	1.000	rs55771723	chr2:10961902	T/C	cg15705551	chr2:10952987	PDIA6	0.76	4.88	0.48	5.52e-6	Educational attainment (years of education);
SKCM	cis	rs12682352	0.652	rs408459	chr8:8706332	A/C	cg06636001	chr8:8085503	FLJ10661	0.68	5.94	0.56	7.57e-8	Neuroticism;
SKCM	cis	rs9399135	0.967	rs6929661	chr6:135328792	G/A	cg24558204	chr6:135376177	HBS1L	0.59	5.23	0.51	1.41e-6	Red blood cell count;
SKCM	cis	rs116095464	0.558	rs10057299	chr5:242135	C/T	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs6665290	0.904	rs10495273	chr1:227183359	T/G	cg10327440	chr1:227177885	CDC42BPA	-1.22	-17.11	-0.89	4.01e-28	Myeloid white cell count;
SKCM	cis	rs7086627	0.515	rs10887900	chr10:82210265	A/G	cg01528321	chr10:82214614	TSPAN14	0.65	5.24	0.51	1.35e-6	Post bronchodilator FEV1;
SKCM	cis	rs28595532	0.920	rs115484560	chr4:119756781	T/G	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs7666738	0.830	rs28729647	chr4:99059552	T/C	cg17366294	chr4:99064904	C4orf37	0.61	4.93	0.49	4.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1878931	0.507	rs1218762	chr16:3405986	G/A	cg26668626	chr16:3451006	ZNF174;ZNF434	-0.82	-5.78	-0.55	1.44e-7	Body mass index (adult);
SKCM	cis	rs6977660	1.000	rs5017191	chr7:19820158	C/A	cg05791153	chr7:19748676	TWISTNB	0.79	5.34	0.52	9.05e-7	Thyroid stimulating hormone;
SKCM	cis	rs2952156	0.920	rs8078228	chr17:37834998	C/T	cg00129232	chr17:37814104	STARD3	-0.74	-6.39	-0.59	1.11e-8	Asthma;
SKCM	cis	rs7980687	0.596	rs1727319	chr12:123701353	T/C	cg00376283	chr12:123451042	ABCB9	0.86	6.55	0.6	5.68e-9	Height;Educational attainment;Head circumference (infant);
SKCM	cis	rs2120019	0.567	rs12385940	chr15:75168162	C/T	cg09165964	chr15:75287851	SCAMP5	-0.78	-5.76	-0.55	1.6e-7	Blood trace element (Zn levels);
SKCM	cis	rs1577917	0.655	rs6454472	chr6:86224053	T/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.64	5.44	0.52	5.98e-7	Response to antipsychotic treatment;
SKCM	cis	rs17685	0.753	rs9691174	chr7:75790405	T/C	cg01364799	chr7:75623366	TMEM120A	-0.7	-5.84	-0.55	1.16e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs6088590	1.000	rs6119512	chr20:33306904	T/C	cg24642439	chr20:33292090	TP53INP2	1.01	7.39	0.64	1.39e-10	Coronary artery disease;
SKCM	cis	rs1790761	0.505	rs4320958	chr11:67310334	G/A	cg00290607	chr11:67383545	NA	-0.51	-4.82	-0.48	6.84e-6	Mean corpuscular volume;
SKCM	cis	rs2836974	0.653	rs8130556	chr21:40516872	C/T	cg11644478	chr21:40555479	PSMG1	0.99	10.15	0.75	6.65e-16	Cognitive function;
SKCM	cis	rs7666738	0.830	rs34870112	chr4:99045815	T/G	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs17065868	1.000	rs9533895	chr13:45103407	T/C	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs17376456	1.000	rs34068652	chr5:93563319	G/A	cg21475434	chr5:93447410	FAM172A	1.08	5.94	0.56	7.64e-8	Diabetic retinopathy;
SKCM	cis	rs5753618	0.529	rs5749298	chr22:31941032	C/T	cg02404636	chr22:31891804	SFI1	0.69	6.09	0.57	3.96e-8	Colorectal cancer;
SKCM	cis	rs36093844	0.800	rs79349553	chr11:85567836	G/T	cg25872744	chr11:85566296	CCDC83	-0.85	-4.77	-0.48	8.27e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs2739330	0.796	rs5760106	chr22:24250645	A/C	cg25703541	chr22:24373054	LOC391322	0.78	6.5	0.59	6.85e-9	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs2019137	0.560	rs4849179	chr2:113985170	C/T	cg21550016	chr2:113992930	PAX8;LOC440839;LOC654433	0.62	4.86	0.48	6.01e-6	Lymphocyte counts;
SKCM	trans	rs1814175	0.616	rs28417656	chr11:50040152	C/T	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs2980439	0.607	rs2980419	chr8:8114141	A/T	cg06636001	chr8:8085503	FLJ10661	1.0	8.75	0.7	3.28e-13	Neuroticism;
SKCM	cis	rs9640161	0.789	rs28432021	chr7:150046235	G/C	cg10018233	chr7:150070692	REPIN1	0.71	5.69	0.54	2.09e-7	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs3784262	0.904	rs3784260	chr15:58253269	T/G	cg12031962	chr15:58353849	ALDH1A2	-0.48	-6.21	-0.58	2.4e-8	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs6582630	0.555	rs10785454	chr12:38476260	C/T	cg26384229	chr12:38710491	ALG10B	0.81	6.22	0.58	2.31e-8	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs10256972	0.516	rs12702081	chr7:1141528	T/C	cg07092213	chr7:1199455	ZFAND2A	-0.66	-5.45	-0.53	5.62e-7	Longevity;Endometriosis;
SKCM	cis	rs875971	0.660	rs10215132	chr7:66054406	C/A	cg11987759	chr7:65425863	GUSB	0.67	5.75	0.55	1.68e-7	Aortic root size;
SKCM	cis	rs6570726	0.902	rs373321	chr6:145854150	T/A	cg23711669	chr6:146136114	FBXO30	0.7	6.71	0.61	2.76e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs798554	1.000	rs798554	chr7:2759795	C/T	cg14895029	chr7:2775587	GNA12	-0.69	-5.04	-0.5	2.95e-6	Height;
SKCM	cis	rs703842	0.560	rs11533604	chr12:58047713	G/A	cg04478727	chr12:58166393	METTL1;FAM119B	0.69	4.95	0.49	4.15e-6	Multiple sclerosis;
SKCM	cis	rs3743104	1.000	rs17816260	chr15:33023685	A/C	cg07179000	chr15:33023586	GREM1	-0.62	-6.86	-0.61	1.47e-9	Hypospadias;
SKCM	cis	rs651907	0.535	rs11717638	chr3:101505468	A/G	cg12386194	chr3:101231763	SENP7	0.66	5.47	0.53	5.27e-7	Colorectal cancer;
SKCM	cis	rs11098499	0.604	rs2389887	chr4:120570644	T/C	cg24375607	chr4:120327624	NA	0.63	4.83	0.48	6.74e-6	Corneal astigmatism;
SKCM	cis	rs9303401	0.659	rs34913878	chr17:56897094	A/G	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.16	0.57	2.91e-8	Cognitive test performance;
SKCM	cis	rs9581857	0.579	rs9581838	chr13:27966127	G/A	cg22138327	chr13:27999177	GTF3A	0.93	5.39	0.52	7.18e-7	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs72781680	0.752	rs72796114	chr2:23906133	C/G	cg08917208	chr2:24149416	ATAD2B	0.98	5.0	0.49	3.41e-6	Lymphocyte counts;
SKCM	cis	rs2760061	0.598	rs658238	chr1:228121291	A/G	cg02753203	chr1:228287806	NA	-0.62	-5.03	-0.5	3.03e-6	Diastolic blood pressure;
SKCM	cis	rs4927850	1.000	rs6799572	chr3:195740408	C/T	cg12923728	chr3:195709715	SDHAP1	-0.99	-6.8	-0.61	1.87e-9	Pancreatic cancer;
SKCM	cis	rs35306767	0.807	rs1013505	chr10:953273	C/T	cg26597838	chr10:835615	NA	0.79	5.51	0.53	4.5e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs9858542	0.953	rs9859556	chr3:49455986	G/T	cg03060546	chr3:49711283	APEH	-0.75	-5.53	-0.53	4.17e-7	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs12477438	0.520	rs2632283	chr2:99776000	C/G	cg26064155	chr2:99771622	LIPT1;TSGA10	1.03	9.69	0.74	5.05e-15	Chronic sinus infection;
SKCM	cis	rs3741404	0.825	rs11603538	chr11:63986713	C/A	cg19465662	chr11:63993652	NUDT22;TRPT1	0.82	5.97	0.56	6.64e-8	Platelet count;
SKCM	cis	rs9868809	0.505	rs9811027	chr3:48725014	G/C	cg00383909	chr3:49044727	WDR6	0.89	5.48	0.53	5.12e-7	Ulcerative colitis;Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs7598759	0.679	rs6437019	chr2:232327707	T/C	cg19187155	chr2:232395269	NMUR1	0.62	4.98	0.49	3.8e-6	Noise-induced hearing loss;
SKCM	cis	rs2841233	0.692	rs41317300	chr14:105344761	C/T	cg16576083	chr14:105354267	KIAA0284	0.6	4.77	0.48	8.29e-6	IgG glycosylation;
SKCM	cis	rs1949733	1.000	rs1357481	chr4:8496221	A/T	cg11789530	chr4:8429930	ACOX3	0.81	5.73	0.54	1.83e-7	Response to antineoplastic agents;
SKCM	cis	rs11690935	1.000	rs12053003	chr2:172537350	A/C	cg13550731	chr2:172543902	DYNC1I2	0.95	8.21	0.68	3.64e-12	Schizophrenia;
SKCM	cis	rs13256369	0.851	rs12541477	chr8:8563895	G/A	cg06636001	chr8:8085503	FLJ10661	0.8	6.11	0.57	3.65e-8	Obesity-related traits;
SKCM	cis	rs7296418	0.630	rs11608305	chr12:123791165	C/G	cg05973401	chr12:123451056	ABCB9	0.72	5.48	0.53	5.12e-7	Platelet count;
SKCM	cis	rs9311474	0.508	rs11714565	chr3:52606292	C/T	cg18404041	chr3:52824283	ITIH1	-0.56	-4.92	-0.49	4.79e-6	Electroencephalogram traits;
SKCM	cis	rs7584330	0.657	rs10190310	chr2:238352282	C/T	cg14458575	chr2:238380390	NA	1.01	6.75	0.61	2.34e-9	Prostate cancer;
SKCM	cis	rs28595532	0.920	rs115320476	chr4:119759680	G/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs8180040	1.000	rs295428	chr3:47359262	G/T	cg16586182	chr3:47516702	SCAP	-0.71	-4.85	-0.48	6.25e-6	Colorectal cancer;
SKCM	cis	rs9300255	0.602	rs1626899	chr12:123708063	A/G	cg05973401	chr12:123451056	ABCB9	0.81	5.37	0.52	7.77e-7	Neutrophil percentage of white cells;
SKCM	cis	rs1211375	0.606	rs1203977	chr16:256278	A/C	cg00126636	chr16:237282	NA	0.54	4.8	0.48	7.45e-6	Hematology traits;Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs7618501	0.699	rs9821675	chr3:49902544	A/G	cg05072774	chr3:49840536	C3orf54	-0.69	-5.24	-0.51	1.34e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1790761	0.554	rs3758938	chr11:67402362	T/G	cg24690094	chr11:67383802	NA	-0.64	-6.61	-0.6	4.22e-9	Mean corpuscular volume;
SKCM	cis	rs6547741	1.000	rs1919126	chr2:27801418	C/A	cg27432699	chr2:27873401	GPN1	0.73	6.64	0.6	3.76e-9	Oral cavity cancer;
SKCM	cis	rs16854884	0.657	rs35309714	chr3:143735011	T/A	cg06585982	chr3:143692056	C3orf58	0.87	8.11	0.68	5.72e-12	Economic and political preferences (feminism/equality);
SKCM	cis	rs2777491	0.915	rs28578057	chr15:41621921	G/A	cg18705301	chr15:41695430	NDUFAF1	-0.96	-9.11	-0.72	6.65e-14	Ulcerative colitis;
SKCM	cis	rs67311347	1.000	rs6795475	chr3:40489281	A/G	cg00091569	chr3:40428383	ENTPD3	0.62	5.09	0.5	2.4e-6	Renal cell carcinoma;
SKCM	cis	rs2180341	1.000	rs2057223	chr6:127637374	T/C	cg24812749	chr6:127587940	RNF146	0.85	7.3	0.64	2.08e-10	Breast cancer;
SKCM	cis	rs11083475	0.686	rs73040728	chr19:39257601	C/G	cg22014579	chr19:38795051	C19orf33;YIF1B	0.64	4.8	0.48	7.64e-6	Heart rate;
SKCM	cis	rs796364	0.906	rs281784	chr2:200749749	T/A	cg12253985	chr2:200820533	C2orf60;C2orf47	0.85	5.39	0.52	7.18e-7	Schizophrenia;
SKCM	cis	rs826838	1.000	rs10880785	chr12:38655405	T/G	cg26384229	chr12:38710491	ALG10B	0.95	7.92	0.67	1.32e-11	Heart rate;
SKCM	cis	rs7772486	0.558	rs2142978	chr6:146012061	T/C	cg05347473	chr6:146136440	FBXO30	-0.69	-6.04	-0.56	4.85e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs3857536	0.740	rs4710571	chr6:66890250	T/C	cg07460842	chr6:66804631	NA	-0.7	-5.08	-0.5	2.51e-6	Blood trace element (Cu levels);
SKCM	cis	rs9467773	0.596	rs2451750	chr6:26646579	A/T	cg15659132	chr6:26577336	NA	0.62	5.4	0.52	6.91e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs12477438	0.520	rs36071868	chr2:99737120	G/A	cg14399236	chr2:99771627	LIPT1;TSGA10	1.0	9.4	0.73	1.85e-14	Chronic sinus infection;
SKCM	cis	rs9583531	0.527	rs3818496	chr13:111358488	G/A	cg15841412	chr13:111365552	ING1	0.7	4.82	0.48	7.07e-6	Coronary artery disease;
SKCM	cis	rs1153858	1.000	rs4395020	chr15:45652889	A/C	cg10760299	chr15:45669010	GATM	0.61	6.08	0.57	4.11e-8	Homoarginine levels;
SKCM	trans	rs1814175	0.935	rs7479914	chr11:49661351	T/C	cg03929089	chr4:120376271	NA	-0.87	-7.53	-0.65	7.73e-11	Height;
SKCM	cis	rs62064224	0.818	rs35677406	chr17:30665005	T/C	cg18200150	chr17:30822561	MYO1D	0.77	5.92	0.56	8.27e-8	Schizophrenia;
SKCM	cis	rs11608355	0.508	rs2075434	chr12:109797051	G/A	cg19025524	chr12:109796872	NA	-0.73	-5.51	-0.53	4.51e-7	Neuroticism;
SKCM	cis	rs2228479	0.850	rs62054224	chr16:89892071	C/T	cg06558623	chr16:89946397	TCF25	1.1	4.95	0.49	4.17e-6	Skin colour saturation;
SKCM	cis	rs7959452	0.640	rs10878957	chr12:69699638	G/C	cg14784868	chr12:69753453	YEATS4	0.65	5.65	0.54	2.56e-7	Blood protein levels;
SKCM	cis	rs2075371	0.933	rs2244548	chr7:133986234	A/G	cg20476274	chr7:133979776	SLC35B4	1.01	10.44	0.76	1.77e-16	Mean platelet volume;
SKCM	cis	rs3785574	0.745	rs2854162	chr17:61975610	T/C	cg01411255	chr17:61851458	DDX42;CCDC47	-0.99	-9.19	-0.72	4.65e-14	Height;
SKCM	cis	rs28595532	0.920	rs115484560	chr4:119756781	T/G	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs8017423	0.605	rs3742673	chr14:90735707	C/T	cg04374321	chr14:90722782	PSMC1	0.86	6.79	0.61	1.98e-9	Mortality in heart failure;
SKCM	cis	rs1707322	0.752	rs6678444	chr1:46229847	A/G	cg03146154	chr1:46216737	IPP	0.8	5.47	0.53	5.19e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs2120019	0.567	rs12385940	chr15:75168162	C/T	cg17294928	chr15:75287854	SCAMP5	-0.83	-6.05	-0.57	4.74e-8	Blood trace element (Zn levels);
SKCM	cis	rs1153858	1.000	rs12593370	chr15:45617417	C/T	cg21132104	chr15:45694354	SPATA5L1	0.91	7.64	0.65	4.71e-11	Homoarginine levels;
SKCM	cis	rs12220238	0.822	rs10824160	chr10:76132267	G/A	cg19889307	chr10:75911429	ADK;AP3M1	0.88	4.84	0.48	6.36e-6	Soluble interleukin-2 receptor subunit alpha;
SKCM	cis	rs4481887	0.893	rs4275482	chr1:248473506	T/C	cg00666640	chr1:248458726	OR2T12	0.65	5.76	0.55	1.62e-7	Common traits (Other);
SKCM	cis	rs34779708	0.931	rs17591135	chr10:35465190	T/A	cg03585969	chr10:35415529	CREM	0.75	6.26	0.58	1.9e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs17270561	0.562	rs12199626	chr6:26013604	G/A	cg17691542	chr6:26056736	HIST1H1C	1.23	9.73	0.74	4.09e-15	Iron status biomarkers;
SKCM	cis	rs12142240	0.698	rs1984490	chr1:46858734	C/T	cg14993813	chr1:46806288	NSUN4	0.69	4.96	0.49	4.09e-6	Menopause (age at onset);
SKCM	cis	rs2295499	0.515	rs2269495	chr4:2744087	C/T	cg19433769	chr4:2420260	ZFYVE28	0.71	4.98	0.49	3.71e-6	Cognitive ability;Cognitive ability (multi-trait analysis);Intelligence (multi-trait analysis);
SKCM	cis	rs4973517	0.654	rs3100620	chr2:232853047	G/A	cg13952656	chr2:232260762	B3GNT7	0.49	4.88	0.48	5.45e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs1395	0.744	rs62130714	chr2:27532870	A/G	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.56	5.2	0.51	1.56e-6	Blood metabolite levels;
SKCM	cis	rs2730245	0.527	rs712197	chr7:158660846	C/G	cg24397884	chr7:158709396	WDR60	0.98	5.56	0.53	3.7e-7	Height;
SKCM	cis	rs7659604	0.539	rs11731917	chr4:122783233	G/A	cg20573242	chr4:122745356	CCNA2	0.76	6.54	0.59	5.89e-9	Type 2 diabetes;
SKCM	cis	rs17376456	0.877	rs114256265	chr5:93473130	T/A	cg21475434	chr5:93447410	FAM172A	0.97	5.42	0.52	6.39e-7	Diabetic retinopathy;
SKCM	cis	rs3087591	0.887	rs2905875	chr17:29541339	A/T	cg24425628	chr17:29625626	OMG;NF1	0.64	5.22	0.51	1.43e-6	Hip circumference;
SKCM	cis	rs1278329	0.537	rs7912887	chr10:127827431	T/A	cg01368217	chr10:127836603	ADAM12	-0.48	-4.83	-0.48	6.71e-6	Metabolite levels (5-HIAA/ MHPG Ratio);
SKCM	cis	rs16854884	0.657	rs7610378	chr3:143711298	G/A	cg06585982	chr3:143692056	C3orf58	0.85	7.82	0.66	2.1e-11	Economic and political preferences (feminism/equality);
SKCM	cis	rs1218582	0.741	rs11264283	chr1:154869552	A/G	cg16680214	chr1:154839983	KCNN3	-0.56	-5.01	-0.49	3.29e-6	Prostate cancer;
SKCM	cis	rs1256061	0.624	rs944047	chr14:64700292	C/T	cg21174375	chr14:64681225	SYNE2	0.47	4.87	0.48	5.65e-6	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs6977660	0.714	rs12334001	chr7:19814399	T/C	cg05791153	chr7:19748676	TWISTNB	0.8	5.01	0.49	3.37e-6	Thyroid stimulating hormone;
SKCM	cis	rs1568889	0.838	rs10767708	chr11:28294847	A/G	cg06544937	chr11:28130018	METT5D1;KIF18A	0.89	8.2	0.68	3.84e-12	Bipolar disorder;
SKCM	trans	rs12599106	0.770	rs12445057	chr16:34970274	C/G	cg03395511	chr6:291903	DUSP22	-0.71	-7.39	-0.64	1.4e-10	Menopause (age at onset);
SKCM	cis	rs8072100	0.934	rs6504872	chr17:45438952	C/T	cg08085267	chr17:45401833	C17orf57	-0.71	-6.41	-0.59	1.01e-8	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs7666738	0.791	rs10005118	chr4:99038196	A/C	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs595982	0.501	rs112370206	chr19:49396623	C/T	cg19746536	chr19:49375674	PPP1R15A	1.14	8.39	0.69	1.67e-12	Red cell distribution width;
SKCM	cis	rs589448	0.967	rs2617834	chr12:69753365	T/C	cg22834771	chr12:69754056	YEATS4	-0.71	-5.79	-0.55	1.39e-7	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs1153858	0.945	rs1974981	chr15:45729123	C/T	cg10760299	chr15:45669010	GATM	-0.55	-5.0	-0.49	3.41e-6	Homoarginine levels;
SKCM	cis	rs9911578	1.000	rs2079703	chr17:56603978	G/A	cg12560992	chr17:57184187	TRIM37	-0.96	-7.74	-0.66	2.95e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs8103278	0.507	rs16939	chr19:46276056	C/A	cg11657440	chr19:46296263	DMWD	1.06	10.49	0.76	1.48e-16	Coronary artery disease;
SKCM	cis	rs2839186	0.900	rs59828751	chr21:47708918	A/G	cg11766577	chr21:47581405	C21orf56	-0.71	-6.01	-0.56	5.6e-8	Testicular germ cell tumor;
SKCM	cis	rs7683537	0.692	rs56317358	chr4:185659470	G/A	cg04058563	chr4:185651563	MLF1IP	1.02	6.01	0.56	5.54e-8	Systemic lupus erythematosus;
SKCM	cis	rs1790761	0.667	rs591434	chr11:67337814	C/T	cg00290607	chr11:67383545	NA	0.51	5.38	0.52	7.43e-7	Mean corpuscular volume;
SKCM	cis	rs362296	0.698	rs3095072	chr4:3263325	G/A	cg21096898	chr4:3318625	RGS12	-0.76	-7.35	-0.64	1.68e-10	Parental longevity (mother's age at death);
SKCM	cis	rs1395	0.710	rs1992291	chr2:27504312	A/G	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.53	5.07	0.5	2.59e-6	Blood metabolite levels;
SKCM	cis	rs7552404	0.924	rs12136754	chr1:76230232	C/A	cg10523679	chr1:76189770	ACADM	0.7	4.98	0.49	3.71e-6	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs763121	0.853	rs5757187	chr22:39021522	A/G	cg06022373	chr22:39101656	GTPBP1	-0.76	-5.12	-0.5	2.14e-6	Menopause (age at onset);
SKCM	cis	rs1577917	1.000	rs11758849	chr6:86708262	G/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.88	-8.33	-0.69	2.19e-12	Response to antipsychotic treatment;
SKCM	cis	rs9796	0.689	rs692153	chr15:41452681	C/T	cg00616447	chr15:41694635	NDUFAF1	0.8	5.6	0.54	3.1e-7	Menopause (age at onset);
SKCM	cis	rs2816062	0.813	rs2816040	chr1:18889536	C/T	cg18795169	chr1:18902165	NA	0.82	8.17	0.68	4.46e-12	Urate levels in lean individuals;
SKCM	cis	rs116095464	0.558	rs73031482	chr5:227594	G/A	cg22496380	chr5:211416	CCDC127	-0.95	-5.22	-0.51	1.42e-6	Breast cancer;
SKCM	cis	rs933688	1.000	rs10474353	chr5:90732285	A/C	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.1	8.55	0.7	8.18e-13	Smoking behavior;
SKCM	cis	rs514406	0.679	rs541852	chr1:53256834	A/G	cg27535305	chr1:53392650	SCP2	0.54	5.05	0.5	2.78e-6	Monocyte count;
SKCM	cis	rs28386778	0.863	rs4968661	chr17:61796306	A/G	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.11	10.85	0.78	2.98e-17	Prudent dietary pattern;
SKCM	cis	rs1577917	0.916	rs4706252	chr6:86555180	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.32	-0.52	9.66e-7	Response to antipsychotic treatment;
SKCM	cis	rs738322	0.511	rs2267371	chr22:38577119	T/G	cg25457927	chr22:38595422	NA	-0.61	-6.83	-0.61	1.68e-9	Cutaneous nevi;
SKCM	cis	rs2075371	0.966	rs2544225	chr7:133995838	A/C	cg20476274	chr7:133979776	SLC35B4	1.03	10.69	0.77	5.94e-17	Mean platelet volume;
SKCM	cis	rs6500395	1.000	rs3817029	chr16:48584942	C/T	cg04672837	chr16:48644449	N4BP1	0.7	5.69	0.54	2.16e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs12477438	0.501	rs7608938	chr2:99782226	C/T	cg26064155	chr2:99771622	LIPT1;TSGA10	1.03	9.69	0.74	5.05e-15	Chronic sinus infection;
SKCM	cis	rs9911578	0.839	rs11654986	chr17:57206124	A/G	cg05425664	chr17:57184151	TRIM37	-0.77	-6.13	-0.57	3.37e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs28595532	0.920	rs28837152	chr4:119782868	G/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs11098499	0.954	rs6849561	chr4:120409694	C/G	cg09307838	chr4:120376055	NA	-0.97	-6.96	-0.62	9.35e-10	Corneal astigmatism;
SKCM	cis	rs9790314	0.521	rs1376122	chr3:161087857	A/G	cg03342759	chr3:160939853	NMD3	-0.79	-6.79	-0.61	1.97e-9	Morning vs. evening chronotype;
SKCM	cis	rs9818758	0.607	rs61729488	chr3:49067904	T/C	cg00383909	chr3:49044727	WDR6	1.13	5.42	0.52	6.49e-7	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs11083475	0.681	rs62121377	chr19:39257296	G/A	cg07403899	chr19:39283540	NA	-0.5	-4.83	-0.48	6.73e-6	Heart rate;
SKCM	cis	rs67311347	0.544	rs2278930	chr3:40351092	C/T	cg02782426	chr3:40428986	ENTPD3	0.5	4.99	0.49	3.64e-6	Renal cell carcinoma;
SKCM	cis	rs7091068	0.615	rs11187609	chr10:95467031	A/C	cg20715218	chr10:95462985	C10orf4	0.68	4.98	0.49	3.8e-6	Urinary tract infection frequency;
SKCM	cis	rs362296	0.698	rs3095081	chr4:3263776	C/T	cg16987761	chr4:3318072	RGS12	-0.71	-6.18	-0.57	2.72e-8	Parental longevity (mother's age at death);
SKCM	cis	rs28595532	0.844	rs115411027	chr4:119490685	T/C	cg14228332	chr4:119757509	SEC24D	0.97	4.92	0.49	4.71e-6	Cannabis dependence symptom count;
SKCM	cis	rs9818758	0.545	rs11717978	chr3:48969036	T/A	cg00383909	chr3:49044727	WDR6	0.95	5.43	0.52	6.25e-7	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs7666738	0.830	rs13122456	chr4:98936011	A/G	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1467026	0.606	rs9814180	chr3:12818386	A/G	cg05775895	chr3:12838266	CAND2	0.67	5.61	0.54	2.95e-7	P wave duration;
SKCM	cis	rs1405130	0.869	rs4663460	chr2:235567861	G/A	cg21542780	chr2:234763377	HJURP	-0.65	-4.92	-0.49	4.75e-6	Coronary artery disease;
SKCM	cis	rs12971120	1.000	rs2278161	chr18:72176083	T/C	cg25817165	chr18:72167213	CNDP2	-0.61	-4.8	-0.48	7.57e-6	Refractive error;
SKCM	cis	rs6546550	0.901	rs6736408	chr2:70137774	C/T	cg02498382	chr2:70120550	SNRNP27	-0.45	-4.88	-0.48	5.4e-6	Prevalent atrial fibrillation;
SKCM	cis	rs1577917	0.958	rs2100109	chr6:86544926	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.32	-0.52	9.66e-7	Response to antipsychotic treatment;
SKCM	cis	rs2033711	0.840	rs3764533	chr19:58929194	A/G	cg12042659	chr19:58951599	ZNF132	0.68	5.87	0.55	1.01e-7	Uric acid clearance;
SKCM	cis	rs875971	0.895	rs1974769	chr7:65950614	G/A	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs6489882	0.966	rs4238033	chr12:113378081	T/A	cg07232103	chr12:112566177	TRAFD1	0.6	4.78	0.48	8.16e-6	Chronic lymphocytic leukemia;
SKCM	cis	rs2153535	0.580	rs9392224	chr6:8472614	G/A	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs7191439	0.789	rs4433802	chr16:88784964	A/G	cg02389323	chr16:88786976	FAM38A	1.58	6.59	0.6	4.66e-9	Plateletcrit;
SKCM	cis	rs9916302	0.904	rs4795355	chr17:37427382	C/T	cg07936489	chr17:37558343	FBXL20	-0.84	-6.96	-0.62	9.48e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs2019137	0.560	rs6707386	chr2:113981022	G/A	cg23156509	chr2:114033830	PAX8;LOC440839	-0.56	-4.81	-0.48	7.3e-6	Lymphocyte counts;
SKCM	cis	rs7666738	0.830	rs3846444	chr4:99032888	T/C	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs28595532	0.920	rs116246794	chr4:119732491	C/T	cg21605333	chr4:119757512	SEC24D	1.36	8.05	0.67	7.69e-12	Cannabis dependence symptom count;
SKCM	cis	rs9926296	0.585	rs8058009	chr16:89856439	G/A	cg27121462	chr16:89883253	FANCA	0.8	4.97	0.49	3.94e-6	Vitiligo;
SKCM	cis	rs7772486	0.790	rs9390365	chr6:146235626	A/G	cg23711669	chr6:146136114	FBXO30	-0.77	-7.69	-0.66	3.71e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs35264875	0.808	rs921675	chr11:68869034	A/G	cg02660097	chr11:68866761	NA	-0.56	-5.3	-0.51	1.03e-6	Blond vs. brown hair color;
SKCM	cis	rs798554	0.836	rs13243214	chr7:2817455	G/T	cg14895029	chr7:2775587	GNA12	-0.63	-4.78	-0.48	8.22e-6	Height;
SKCM	cis	rs854765	0.663	rs3744115	chr17:17749822	G/A	cg04398451	chr17:18023971	MYO15A	0.76	4.97	0.49	3.84e-6	Total body bone mineral density;
SKCM	cis	rs4481887	0.927	rs4916121	chr1:248432003	C/T	cg00666640	chr1:248458726	OR2T12	0.61	5.28	0.51	1.14e-6	Common traits (Other);
SKCM	cis	rs7829975	0.522	rs6601689	chr8:8172283	C/T	cg06636001	chr8:8085503	FLJ10661	0.7	5.97	0.56	6.58e-8	Mood instability;
SKCM	cis	rs9303401	0.659	rs17741087	chr17:56550300	C/T	cg02118635	chr17:56770003	RAD51C;TEX14	0.8	5.33	0.52	9.25e-7	Cognitive test performance;
SKCM	cis	rs7772486	0.632	rs9386128	chr6:146049053	G/A	cg23711669	chr6:146136114	FBXO30	-0.82	-8.01	-0.67	9.12e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs875971	0.660	rs10281080	chr7:66042441	T/C	cg18876405	chr7:65276391	NA	-0.82	-7.53	-0.65	7.59e-11	Aortic root size;
SKCM	cis	rs55962025	0.804	rs2269499	chr4:3239702	C/T	cg00764545	chr4:3318001	RGS12	-0.67	-5.52	-0.53	4.26e-7	Parental longevity (mother's age at death);
SKCM	cis	rs10504229	0.683	rs7835498	chr8:58129780	A/C	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs554111	0.685	rs113664832	chr1:21058655	G/A	cg01072550	chr1:21505969	NA	0.59	4.95	0.49	4.24e-6	Facial morphology (factor 17, height of vermillion upper lip);
SKCM	cis	rs3859192	0.561	rs34453912	chr17:38180352	T/A	cg17467752	chr17:38218738	THRA	-0.76	-6.37	-0.58	1.22e-8	White blood cell count;
SKCM	cis	rs12541335	0.639	rs35068739	chr8:22201719	T/C	cg02463440	chr8:22132932	PIWIL2	0.64	5.61	0.54	3e-7	Hypertriglyceridemia;
SKCM	cis	rs4891159	0.548	rs690082	chr18:74116668	C/T	cg24786174	chr18:74118243	ZNF516	0.81	8.75	0.7	3.24e-13	Longevity;
SKCM	cis	rs684232	0.602	rs448465	chr17:559888	A/T	cg15660573	chr17:549704	VPS53	-0.74	-5.8	-0.55	1.36e-7	Prostate cancer;
SKCM	cis	rs1552244	1.000	rs6768102	chr3:10149380	A/G	cg02579736	chr3:10068473	FANCD2;CIDECP	1.24	7.05	0.62	6.45e-10	Alzheimer's disease;
SKCM	cis	rs6582630	0.519	rs8189599	chr12:38280748	A/G	cg26384229	chr12:38710491	ALG10B	0.86	6.78	0.61	2.07e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs1577917	1.000	rs1911553	chr6:86630892	T/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.66	-5.74	-0.54	1.76e-7	Response to antipsychotic treatment;
SKCM	trans	rs1814175	0.817	rs10839351	chr11:49758153	C/T	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs116095464	0.558	rs56298907	chr5:283280	C/A	cg22857025	chr5:266934	NA	-1.58	-8.14	-0.68	4.99e-12	Breast cancer;
SKCM	cis	rs1577917	0.771	rs4419647	chr6:86225739	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.78	7.21	0.63	3.17e-10	Response to antipsychotic treatment;
SKCM	cis	rs1475911	1.000	rs1475911	chr21:43513480	A/C	cg24372256	chr21:43528868	UMODL1;C21orf128	-0.69	-4.83	-0.48	6.81e-6	IgG glycosylation;
SKCM	trans	rs12599106	0.709	rs1501462	chr16:34964515	A/T	cg15383120	chr6:291909	DUSP22	-0.75	-7.5	-0.65	8.82e-11	Menopause (age at onset);
SKCM	cis	rs9880211	1.000	rs28718456	chr3:136204006	A/G	cg21827317	chr3:136751795	NA	-0.65	-4.92	-0.49	4.73e-6	Body mass index;Height;
SKCM	cis	rs9399137	0.507	rs7754722	chr6:135260303	T/C	cg24558204	chr6:135376177	HBS1L	-0.67	-6.12	-0.57	3.51e-8	Glycated hemoglobin levels;Mean corpuscular volume;Hematology traits;HbA2 levels;Mean corpuscular hemoglobin;Hemoglobin levels;F-cell distribution;Platelet count;
SKCM	trans	rs877282	0.945	rs11253391	chr10:788752	G/A	cg22713356	chr15:30763199	NA	1.35	7.57	0.65	6.52e-11	Uric acid levels;
SKCM	cis	rs6087990	0.899	rs6058893	chr20:31392777	C/T	cg13636640	chr20:31349939	DNMT3B	0.9	7.99	0.67	9.91e-12	Ulcerative colitis;
SKCM	cis	rs561341	0.941	rs736678	chr17:30347423	G/T	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs9674544	0.740	rs11870560	chr17:47114033	T/C	cg20966754	chr17:47091339	IGF2BP1	-0.49	-4.84	-0.48	6.42e-6	Primary tooth development (time to first tooth eruption);Primary tooth development (number of teeth);
SKCM	cis	rs801193	0.636	rs2659895	chr7:66196471	C/A	cg11764359	chr7:65958608	NA	0.83	7.67	0.66	4.11e-11	Aortic root size;
SKCM	cis	rs9880211	0.800	rs1872239	chr3:136503911	C/T	cg21827317	chr3:136751795	NA	-0.7	-5.43	-0.52	6.12e-7	Body mass index;Height;
SKCM	cis	rs55962025	0.883	rs61792530	chr4:3145866	T/C	cg21096898	chr4:3318625	RGS12	-0.66	-5.2	-0.51	1.57e-6	Parental longevity (mother's age at death);
SKCM	cis	rs9902453	0.868	rs12944395	chr17:28323499	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.83	-6.38	-0.59	1.15e-8	Coffee consumption (cups per day);
SKCM	cis	rs28386778	0.897	rs896064	chr17:61860932	C/T	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs72634258	0.786	rs9434992	chr1:8179392	G/T	cg00042356	chr1:8021962	PARK7	0.77	5.09	0.5	2.4e-6	Inflammatory bowel disease;
SKCM	cis	rs1218582	0.772	rs12095061	chr1:154912968	A/T	cg06221963	chr1:154839813	KCNN3	-0.54	-5.29	-0.51	1.09e-6	Prostate cancer;
SKCM	cis	rs317689	0.581	rs160829	chr12:69769538	G/C	cg20891283	chr12:69753455	YEATS4	0.74	5.67	0.54	2.32e-7	Response to diuretic therapy;
SKCM	cis	rs35306767	0.761	rs11253560	chr10:1047226	T/G	cg20503657	chr10:835505	NA	0.62	4.87	0.48	5.77e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs941408	1.000	rs941407	chr19:2812153	A/G	cg17333051	chr19:2783644	SGTA	0.42	5.21	0.51	1.48e-6	Total cholesterol levels;
SKCM	cis	rs9911578	0.935	rs2567912	chr17:56731270	T/C	cg05425664	chr17:57184151	TRIM37	-0.69	-5.19	-0.51	1.65e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2737618	0.651	rs2248967	chr1:200084893	A/G	cg21825944	chr1:200113062	NR5A2	0.61	4.99	0.49	3.57e-6	Uric acid levels;
SKCM	cis	rs854765	0.583	rs4534911	chr17:17852330	A/G	cg04398451	chr17:18023971	MYO15A	-0.79	-5.68	-0.54	2.25e-7	Total body bone mineral density;
SKCM	cis	rs6500395	0.832	rs8052733	chr16:48691978	C/T	cg04672837	chr16:48644449	N4BP1	-0.65	-5.43	-0.52	6.29e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs4481887	1.000	rs7527822	chr1:248467301	A/G	cg00666640	chr1:248458726	OR2T12	0.63	5.81	0.55	1.28e-7	Common traits (Other);
SKCM	cis	rs1405130	0.869	rs55905532	chr2:235568903	A/C	cg21542780	chr2:234763377	HJURP	-0.65	-4.92	-0.49	4.75e-6	Coronary artery disease;
SKCM	cis	rs931127	0.502	rs1466462	chr11:65419364	C/G	cg27068330	chr11:65405492	SIPA1	0.77	6.34	0.58	1.38e-8	Systemic lupus erythematosus;
SKCM	cis	rs7215564	0.908	rs36100789	chr17:78701117	C/T	cg16980736	chr17:78789706	RPTOR	-0.88	-4.83	-0.48	6.66e-6	Myopia (pathological);
SKCM	cis	rs67311347	0.544	rs6762121	chr3:40355313	G/A	cg13409248	chr3:40428643	ENTPD3	0.57	5.32	0.52	9.61e-7	Renal cell carcinoma;
SKCM	cis	rs8072100	1.000	rs4794048	chr17:45763073	A/C	cg08085267	chr17:45401833	C17orf57	-0.63	-5.71	-0.54	1.92e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs55823223	0.648	rs56901103	chr17:73865667	C/A	cg10935138	chr17:73851978	WBP2	1.19	7.17	0.63	3.81e-10	Psoriasis;
SKCM	cis	rs736408	0.812	rs1076425	chr3:52825462	A/G	cg18404041	chr3:52824283	ITIH1	-0.64	-5.73	-0.54	1.84e-7	Bipolar disorder;
SKCM	cis	rs1218582	0.804	rs4845678	chr1:154853295	A/G	cg06221963	chr1:154839813	KCNN3	-0.58	-5.84	-0.55	1.13e-7	Prostate cancer;
SKCM	cis	rs2439831	0.867	rs8041132	chr15:43635136	G/A	cg02155558	chr15:43621948	ADAL;LCMT2	1.39	9.42	0.73	1.62e-14	Lung cancer in ever smokers;
SKCM	cis	rs7772486	0.686	rs2092263	chr6:146029687	G/A	cg05347473	chr6:146136440	FBXO30	-0.55	-4.85	-0.48	6.14e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs909674	0.541	rs5750812	chr22:39793079	G/A	cg11247378	chr22:39784982	NA	-0.48	-5.83	-0.55	1.18e-7	IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis);IgG glycosylation;IgG digalactosylation phenotypes (multivariate analysis);IgG sialylation phenotypes (multivariate analysis);IgG monogalactosylation phenotypes (multivariate analysis);IgG fucosylation phenotypes (multivariate analysis);IgG N-glycosylation phenotypes (multivariate analysis);IgG disialylation phenotypes (multivariate analysis);IgG galactosylation phenotypes (multivariate analysis);Post bronchodilator FEV1;
SKCM	cis	rs7927771	0.524	rs7116346	chr11:47883880	G/A	cg20307385	chr11:47447363	PSMC3	-0.72	-5.82	-0.55	1.26e-7	Subjective well-being;
SKCM	cis	rs589448	0.967	rs2617835	chr12:69753420	C/A	cg20891283	chr12:69753455	YEATS4	0.98	9.89	0.75	2.06e-15	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs9818758	0.607	rs66991555	chr3:49228643	A/G	cg24110177	chr3:50126178	RBM5	0.86	5.12	0.5	2.15e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs854765	0.547	rs4584886	chr17:17896205	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.01	8.49	0.69	1.03e-12	Total body bone mineral density;
SKCM	cis	rs8177179	0.967	rs6439434	chr3:133450371	T/G	cg16262614	chr3:133464971	TF	0.43	5.38	0.52	7.57e-7	Iron status biomarkers (transferrin levels);
SKCM	cis	rs875971	0.545	rs2707851	chr7:66089165	C/T	cg18876405	chr7:65276391	NA	-0.61	-4.87	-0.48	5.74e-6	Aortic root size;
SKCM	cis	rs11098499	0.863	rs10009626	chr4:120470005	T/C	cg24375607	chr4:120327624	NA	0.69	5.47	0.53	5.35e-7	Corneal astigmatism;
SKCM	cis	rs2732480	0.557	rs2732454	chr12:48719677	T/C	cg21348975	chr12:48724119	NA	-0.58	-4.88	-0.48	5.47e-6	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs2439831	0.850	rs56909447	chr15:44137618	G/A	cg02155558	chr15:43621948	ADAL;LCMT2	1.3	6.97	0.62	9.12e-10	Lung cancer in ever smokers;
SKCM	cis	rs12986445	0.711	rs6709946	chr2:26111305	A/G	cg04917511	chr2:26785460	C2orf70	0.53	4.97	0.49	3.88e-6	Multiple myeloma and monoclonal gammopathy;Multiple myeloma;
SKCM	cis	rs1577917	1.000	rs11759855	chr6:86610841	T/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.85	-8.62	-0.7	5.82e-13	Response to antipsychotic treatment;
SKCM	cis	rs860295	0.702	rs12081067	chr1:155358982	A/G	cg02153340	chr1:155202674	NA	-0.77	-5.47	-0.53	5.24e-7	Body mass index;
SKCM	cis	rs9660180	0.934	rs34849348	chr1:1762757	C/T	cg23982607	chr1:1823379	GNB1	-0.67	-5.61	-0.54	3.02e-7	Body mass index;
SKCM	cis	rs9640161	0.659	rs11974980	chr7:150009838	C/T	cg10018233	chr7:150070692	REPIN1	0.7	5.68	0.54	2.21e-7	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs2836974	0.897	rs12481860	chr21:40537836	T/A	cg11644478	chr21:40555479	PSMG1	0.97	10.21	0.76	5.08e-16	Cognitive function;
SKCM	cis	rs6570726	0.902	rs973855	chr6:145781850	C/T	cg23711669	chr6:146136114	FBXO30	-0.72	-6.84	-0.61	1.59e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs16866061	0.962	rs72972361	chr2:225341550	G/A	cg02879423	chr2:224806760	WDFY1	0.69	5.03	0.5	3.03e-6	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs7539542	0.516	rs10920517	chr1:202856469	A/T	cg19681188	chr1:202830198	LOC148709	0.75	4.96	0.49	4.06e-6	Mean platelet volume;
SKCM	cis	rs597539	0.652	rs544370	chr11:68653232	C/T	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.82	5.44	0.52	5.87e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs950027	0.620	rs1145077	chr15:45683795	A/C	cg21132104	chr15:45694354	SPATA5L1	-0.73	-5.42	-0.52	6.32e-7	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs12142240	0.698	rs17361915	chr1:46847321	C/T	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs3845702	0.866	rs3914458	chr2:180862606	A/G	cg01881094	chr2:180872142	CWC22	-1.06	-5.68	-0.54	2.19e-7	Schizophrenia;
SKCM	cis	rs7020830	1.000	rs7020830	chr9:37085184	A/T	cg14294708	chr9:37120828	ZCCHC7	1.04	9.32	0.73	2.57e-14	Schizophrenia;
SKCM	cis	rs62238980	0.614	rs79497892	chr22:32434359	C/A	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs10751667	0.643	rs7396767	chr11:938808	G/A	cg10932868	chr11:921992	NA	0.55	5.13	0.5	2.09e-6	Alzheimer's disease (late onset);
SKCM	cis	rs28595532	0.920	rs17325129	chr4:119778284	T/C	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs10504229	0.683	rs11786845	chr8:58133642	T/C	cg02725872	chr8:58115012	NA	-0.54	-5.22	-0.51	1.44e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs951366	0.789	rs823095	chr1:205679239	G/A	cg07167872	chr1:205819463	PM20D1	0.86	6.88	0.61	1.35e-9	Menarche (age at onset);
SKCM	cis	rs7829975	0.539	rs4841012	chr8:8551710	C/A	cg15556689	chr8:8085844	FLJ10661	-0.68	-5.12	-0.5	2.18e-6	Mood instability;
SKCM	cis	rs6546550	0.900	rs897122	chr2:70140271	C/T	cg02498382	chr2:70120550	SNRNP27	-0.45	-4.88	-0.48	5.4e-6	Prevalent atrial fibrillation;
SKCM	cis	rs7953508	0.506	rs3782415	chr12:93967755	T/C	cg18151635	chr12:93972918	NA	-0.65	-5.83	-0.55	1.2e-7	Pubertal anthropometrics;
SKCM	cis	rs7599312	0.534	rs10182996	chr2:213404834	T/C	cg20637307	chr2:213403960	ERBB4	0.76	5.6	0.54	3.12e-7	BMI (adjusted for smoking behaviour);BMI in non-smokers;Body mass index;Body mass index (joint analysis main effects and smoking interaction);
SKCM	cis	rs7666738	0.830	rs7663661	chr4:99014761	A/G	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs28595532	0.920	rs114696063	chr4:119760624	T/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs8180040	1.000	rs295428	chr3:47359262	G/T	cg27129171	chr3:47204927	SETD2	0.87	6.62	0.6	4.15e-9	Colorectal cancer;
SKCM	cis	rs7659604	0.540	rs9998385	chr4:122676673	C/T	cg19671926	chr4:122722719	EXOSC9	0.77	6.27	0.58	1.89e-8	Type 2 diabetes;
SKCM	cis	rs55962025	0.846	rs363066	chr4:3135953	G/T	cg24015175	chr4:3319247	RGS12	0.69	5.9	0.56	8.84e-8	Parental longevity (mother's age at death);
SKCM	trans	rs1814175	0.646	rs61904497	chr11:49883449	A/T	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs1799949	1.000	rs8176077	chr17:41276348	T/C	cg23758822	chr17:41437982	NA	0.92	7.8	0.66	2.3e-11	Menopause (age at onset);
SKCM	cis	rs1044826	0.597	rs1017468	chr3:139145778	A/G	cg15131784	chr3:139108705	COPB2	0.68	5.03	0.49	3.1e-6	Obesity-related traits;
SKCM	cis	rs709400	0.930	rs61996717	chr14:104048571	T/C	cg26031613	chr14:104095156	KLC1	1.09	12.05	0.81	1.74e-19	Body mass index;
SKCM	cis	rs9640161	0.742	rs2108851	chr7:150019634	T/C	cg10018233	chr7:150070692	REPIN1	0.75	6.05	0.56	4.81e-8	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs28386778	0.897	rs2665795	chr17:61925272	A/G	cg01411255	chr17:61851458	DDX42;CCDC47	-0.75	-4.83	-0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs7193541	0.684	rs4888262	chr16:74670458	C/T	cg01733217	chr16:74700730	RFWD3	1.03	11.79	0.8	5.19e-19	Multiple myeloma;
SKCM	cis	rs7937682	0.924	rs495460	chr11:111504777	G/A	cg09085632	chr11:111637200	PPP2R1B	-1.07	-11.3	-0.79	4.28e-18	Primary sclerosing cholangitis;
SKCM	cis	rs7666738	0.830	rs10516426	chr4:99035827	A/G	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1218582	0.772	rs10908448	chr1:154882544	A/G	cg06221963	chr1:154839813	KCNN3	0.57	5.91	0.56	8.42e-8	Prostate cancer;
SKCM	cis	rs861020	1.000	rs861020	chr1:209977111	A/G	cg09163369	chr1:210001066	C1orf107	0.8	5.15	0.5	1.9e-6	Orofacial clefts;
SKCM	cis	rs12705054	1.000	rs73401390	chr7:98795229	A/G	cg11543304	chr7:98729543	SMURF1	1.06	4.77	0.48	8.44e-6	Facial emotion recognition (sad faces);
SKCM	cis	rs13090388	1	rs13090388	chr3:49391082	C/T	cg03060546	chr3:49711283	APEH	-0.68	-5.15	-0.5	1.91e-6	Intelligence (multi-trait analysis);Educational attainment (years of education);
SKCM	cis	rs1707322	0.717	rs28752166	chr1:46213309	G/A	cg03146154	chr1:46216737	IPP	0.81	5.62	0.54	2.87e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs951366	0.789	rs823130	chr1:205714372	C/T	cg26354017	chr1:205819088	PM20D1	1.01	8.85	0.71	2.06e-13	Menarche (age at onset);
SKCM	cis	rs11098499	0.863	rs28718422	chr4:120466304	C/A	cg09307838	chr4:120376055	NA	1.0	8.27	0.68	2.8e-12	Corneal astigmatism;
SKCM	cis	rs2594714	0.789	rs62122067	chr19:13955506	G/A	cg13326686	chr19:13030096	SYCE2	0.81	4.85	0.48	6.3e-6	Breast cancer;
SKCM	cis	rs875971	0.862	rs778724	chr7:65829291	T/C	cg18876405	chr7:65276391	NA	0.64	6.36	0.58	1.26e-8	Aortic root size;
SKCM	cis	rs71520386	0.530	rs10256628	chr7:22883259	G/C	cg15401507	chr7:22894281	NA	0.72	5.52	0.53	4.31e-7	Fibrinogen levels;
SKCM	cis	rs155076	1.000	rs195570	chr13:21867580	T/G	cg11317459	chr13:21872234	NA	-1.33	-7.9	-0.67	1.49e-11	White matter hyperintensity burden;
SKCM	cis	rs28595532	0.920	rs56042726	chr4:119751777	T/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs57221529	0.709	rs72703034	chr5:577101	C/T	cg10555297	chr5:473380	SLC9A3;LOC25845	1.09	5.49	0.53	4.82e-7	Lung disease severity in cystic fibrosis;
SKCM	cis	rs7208859	0.623	rs1061346	chr17:29114229	G/A	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs151997	0.962	rs27272	chr5:50181865	A/G	cg06027927	chr5:50259733	NA	0.63	5.35	0.52	8.43e-7	Callous-unemotional behaviour;
SKCM	cis	rs875971	0.862	rs778724	chr7:65829291	T/C	cg11764359	chr7:65958608	NA	0.81	7.63	0.65	4.91e-11	Aortic root size;
SKCM	cis	rs1707322	0.721	rs11211151	chr1:46112752	T/C	cg03146154	chr1:46216737	IPP	0.82	6.1	0.57	3.89e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs6500395	0.788	rs12446280	chr16:48651171	G/T	cg04672837	chr16:48644449	N4BP1	0.68	5.6	0.54	3.07e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs6835098	0.961	rs1574314	chr4:174106663	C/T	cg08422745	chr4:174089978	GALNT7	-0.86	-6.84	-0.61	1.61e-9	Dementia and core Alzheimer's disease neuropathologic changes;
SKCM	cis	rs801193	0.548	rs7805152	chr7:66209253	C/T	cg11764359	chr7:65958608	NA	0.75	6.82	0.61	1.71e-9	Aortic root size;
SKCM	trans	rs561341	1.000	rs72825740	chr17:30338356	A/G	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs8103278	0.740	rs2341097	chr19:46268902	C/T	cg11657440	chr19:46296263	DMWD	-0.91	-6.76	-0.61	2.22e-9	Coronary artery disease;
SKCM	cis	rs62244186	0.566	rs2135531	chr3:44881158	C/G	cg02073558	chr3:44770973	ZNF501	0.8	6.89	0.61	1.29e-9	Depressive symptoms;
SKCM	cis	rs6500395	0.926	rs9929569	chr16:48677584	C/T	cg04672837	chr16:48644449	N4BP1	0.65	5.36	0.52	8.23e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs1395	0.885	rs7575245	chr2:27527321	G/A	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.5	4.83	0.48	6.55e-6	Blood metabolite levels;
SKCM	cis	rs651907	0.535	rs13059470	chr3:101424800	A/G	cg03837452	chr3:101395095	ZBTB11;LOC100009676	-0.81	-7.06	-0.62	6.11e-10	Colorectal cancer;
SKCM	cis	rs67517081	1	rs67517081	chr16:30987380	GT/G	cg00531865	chr16:30841666	NA	0.58	4.9	0.49	5.12e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs10754283	0.967	rs7546410	chr1:90109815	C/T	cg21401794	chr1:90099060	LRRC8C	0.73	6.34	0.58	1.35e-8	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs7789940	0.810	rs12533978	chr7:75943352	T/C	cg10167463	chr7:75959203	YWHAG	-0.68	-4.81	-0.48	7.15e-6	Multiple sclerosis;
SKCM	cis	rs7927771	0.542	rs7108479	chr11:47781460	G/T	cg20307385	chr11:47447363	PSMC3	0.71	5.63	0.54	2.67e-7	Subjective well-being;
SKCM	cis	rs2842992	0.830	rs2025189	chr6:160137518	C/T	cg11366901	chr6:160182831	ACAT2	0.89	7.03	0.62	6.78e-10	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs7772486	0.686	rs7744014	chr6:146123818	G/A	cg05347473	chr6:146136440	FBXO30	0.55	5.07	0.5	2.6e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9880211	0.752	rs9838884	chr3:136455704	C/T	cg21827317	chr3:136751795	NA	-0.68	-5.07	-0.5	2.64e-6	Body mass index;Height;
SKCM	trans	rs1814175	0.645	rs7928714	chr11:49887622	G/A	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs1691799	0.867	rs1168347	chr12:66757303	T/C	cg16791601	chr12:66731901	HELB	-0.57	-4.83	-0.48	6.76e-6	White blood cell count (basophil);
SKCM	cis	rs1691799	0.867	rs1168332	chr12:66761548	C/T	cg16791601	chr12:66731901	HELB	-0.58	-4.82	-0.48	6.86e-6	White blood cell count (basophil);
SKCM	cis	rs9911578	1.000	rs2643119	chr17:56827760	G/T	cg12560992	chr17:57184187	TRIM37	0.95	7.69	0.66	3.7e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs2204008	0.837	rs34381557	chr12:38181983	T/C	cg13010199	chr12:38710504	ALG10B	0.65	4.84	0.48	6.52e-6	Bladder cancer;
SKCM	cis	rs1552244	0.882	rs112621205	chr3:10017916	G/A	cg02579736	chr3:10068473	FANCD2;CIDECP	0.94	4.84	0.48	6.49e-6	Alzheimer's disease;
SKCM	cis	rs1160297	0.609	rs12713231	chr2:53105695	C/G	cg07782112	chr2:53107842	NA	0.57	6.06	0.57	4.44e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs67311347	0.544	rs2278927	chr3:40350447	G/A	cg13409248	chr3:40428643	ENTPD3	0.59	5.67	0.54	2.32e-7	Renal cell carcinoma;
SKCM	cis	rs910316	1.000	rs175436	chr14:75608683	C/G	cg08847533	chr14:75593920	NEK9	-0.96	-8.08	-0.68	6.54e-12	Height;
SKCM	cis	rs6942756	0.774	rs891545	chr7:128866616	A/C	cg02491457	chr7:128862824	NA	0.7	4.79	0.48	7.71e-6	White matter hyperintensity burden;
SKCM	cis	rs951366	0.789	rs823095	chr1:205679239	G/A	cg14893161	chr1:205819251	PM20D1	0.93	8.18	0.68	4.28e-12	Menarche (age at onset);
SKCM	cis	rs12586317	0.620	rs12437439	chr14:35585669	C/A	cg16230307	chr14:35515116	FAM177A1	0.69	5.04	0.5	2.92e-6	Psoriasis;
SKCM	cis	rs7666738	0.791	rs4440223	chr4:99044796	G/A	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2645694	0.626	rs2703126	chr4:77819842	T/C	cg03477792	chr4:77819574	ANKRD56	0.57	6.38	0.59	1.18e-8	Emphysema distribution in smoking;
SKCM	cis	rs10752881	1.000	rs10797813	chr1:182989366	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.65	0.6	3.65e-9	Colorectal cancer;
SKCM	cis	rs1635	0.655	rs2159275	chr6:28308446	G/A	cg15743358	chr6:28303923	ZNF323	-1.27	-5.15	-0.5	1.92e-6	Schizophrenia;
SKCM	cis	rs951366	0.789	rs823152	chr1:205736285	G/A	cg07167872	chr1:205819463	PM20D1	0.96	8.35	0.69	2e-12	Menarche (age at onset);
SKCM	cis	rs8060686	0.641	rs12599880	chr16:68152035	A/G	cg04539111	chr16:67997858	SLC12A4	-0.85	-4.81	-0.48	7.14e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs7091068	0.507	rs913046	chr10:95408484	A/C	cg20715218	chr10:95462985	C10orf4	0.68	5.93	0.56	7.95e-8	Urinary tract infection frequency;
SKCM	cis	rs28785552	0.897	rs10424736	chr19:53239176	G/A	cg10871876	chr19:53194124	ZNF83	0.81	5.91	0.56	8.68e-8	Response to paliperidone in schizophrenia (PANSS score);
SKCM	cis	rs1426153	0.606	rs1365196	chr11:125158049	A/G	cg05302441	chr11:125157402	PKNOX2	-0.73	-4.78	-0.48	8.14e-6	Alcohol and nicotine co-dependence;
SKCM	trans	rs1814175	0.803	rs11040451	chr11:49650639	C/T	cg03929089	chr4:120376271	NA	-0.87	-7.53	-0.65	7.64e-11	Height;
SKCM	cis	rs1801251	1.000	rs13004406	chr2:233584557	A/T	cg08000102	chr2:233561755	GIGYF2	-0.89	-6.91	-0.62	1.15e-9	Coronary artery disease;
SKCM	cis	rs3768617	0.510	rs7542640	chr1:183063738	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs7772486	0.840	rs11155451	chr6:146422524	A/G	cg23711669	chr6:146136114	FBXO30	0.85	8.48	0.69	1.09e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6546550	0.901	rs12232914	chr2:70117176	C/T	cg02498382	chr2:70120550	SNRNP27	-0.45	-4.9	-0.49	5e-6	Prevalent atrial fibrillation;
SKCM	cis	rs1348850	0.914	rs6710575	chr2:178377311	C/T	cg02961200	chr2:178257176	LOC100130691;AGPS	0.85	6.45	0.59	8.7e-9	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs11098499	0.866	rs9995136	chr4:120286845	A/G	cg09307838	chr4:120376055	NA	0.98	7.89	0.67	1.52e-11	Corneal astigmatism;
SKCM	cis	rs8177253	0.761	rs1830084	chr3:133508464	A/T	cg16414030	chr3:133502952	NA	0.7	5.66	0.54	2.36e-7	Iron status biomarkers;
SKCM	cis	rs12497850	0.931	rs4974085	chr3:48924900	C/T	cg07636037	chr3:49044803	WDR6	1.08	11.96	0.8	2.49e-19	Parkinson's disease;
SKCM	cis	rs17345786	1.000	rs997739	chr3:101313940	A/G	cg12386194	chr3:101231763	SENP7	0.8	6.19	0.57	2.62e-8	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs3784262	0.542	rs2899611	chr15:58327347	A/C	cg12031962	chr15:58353849	ALDH1A2	-0.39	-5.03	-0.5	3.05e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs7954584	0.626	rs10840637	chr12:122427310	A/G	cg22618164	chr12:122356400	WDR66	0.54	5.43	0.52	6.17e-7	Mean corpuscular volume;
SKCM	cis	rs9300255	0.510	rs1790109	chr12:123637752	C/G	cg05973401	chr12:123451056	ABCB9	0.79	5.37	0.52	8.03e-7	Neutrophil percentage of white cells;
SKCM	cis	rs870825	0.929	rs72689260	chr4:185590656	G/T	cg04058563	chr4:185651563	MLF1IP	1.08	5.57	0.53	3.53e-7	Blood protein levels;
SKCM	cis	rs28595532	0.844	rs115411027	chr4:119490685	T/C	cg21605333	chr4:119757512	SEC24D	1.24	7.1	0.63	5.16e-10	Cannabis dependence symptom count;
SKCM	cis	rs1218582	0.772	rs4845688	chr1:154884142	T/C	cg24250549	chr1:154909240	PMVK	0.87	8.7	0.7	4.13e-13	Prostate cancer;
SKCM	cis	rs1218582	0.804	rs4845678	chr1:154853295	A/G	cg03351412	chr1:154909251	PMVK	0.78	6.55	0.6	5.5e-9	Prostate cancer;
SKCM	cis	rs34779708	0.931	rs12776390	chr10:35391535	T/G	cg03585969	chr10:35415529	CREM	0.79	6.37	0.59	1.2e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs12497850	0.931	rs7626445	chr3:49114544	C/T	cg07636037	chr3:49044803	WDR6	1.06	11.78	0.8	5.51e-19	Parkinson's disease;
SKCM	cis	rs9513627	1.000	rs3928270	chr13:100184268	A/G	cg11288260	chr13:100117058	NA	0.79	4.78	0.48	8.1e-6	Obesity-related traits;
SKCM	cis	rs3087591	0.922	rs2905879	chr17:29545431	T/A	cg24425628	chr17:29625626	OMG;NF1	0.64	5.22	0.51	1.43e-6	Hip circumference;
SKCM	cis	rs7666738	0.791	rs11097601	chr4:98960103	C/T	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7843479	1.000	rs66824050	chr8:21815425	T/G	cg17168535	chr8:21777572	XPO7	0.75	6.18	0.57	2.75e-8	Mean corpuscular volume;
SKCM	cis	rs6598955	0.614	rs1134584	chr1:26608828	G/A	cg00938395	chr1:26633206	UBXN11	0.67	4.84	0.48	6.43e-6	Obesity-related traits;
SKCM	trans	rs1814175	0.534	rs1983448	chr11:49933856	C/A	cg15704280	chr7:45808275	SEPT13	-0.93	-8.46	-0.69	1.18e-12	Height;
SKCM	cis	rs13256369	0.951	rs13270852	chr8:8566853	A/G	cg06636001	chr8:8085503	FLJ10661	0.77	5.89	0.55	9.31e-8	Obesity-related traits;
SKCM	cis	rs2836974	0.545	rs8128901	chr21:40710419	G/A	cg11644478	chr21:40555479	PSMG1	0.67	5.14	0.5	1.96e-6	Cognitive function;
SKCM	cis	rs1218582	0.772	rs12095061	chr1:154912968	A/T	cg24250549	chr1:154909240	PMVK	0.87	8.96	0.71	1.3e-13	Prostate cancer;
SKCM	cis	rs4132509	1.000	rs9782883	chr1:243892532	A/G	cg21452805	chr1:244014465	NA	0.88	5.37	0.52	7.83e-7	RR interval (heart rate);
SKCM	cis	rs11249608	0.548	rs10479519	chr5:178450693	T/C	cg21905437	chr5:178450457	ZNF879	0.76	6.46	0.59	8.29e-9	Pubertal anthropometrics;
SKCM	cis	rs17685	0.671	rs60303271	chr7:75760008	A/G	cg16489192	chr7:75678113	MDH2;STYXL1	-0.57	-5.35	-0.52	8.63e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs867186	1.000	rs8123978	chr20:33598789	C/T	cg04194272	chr20:33683537	NA	-1.39	-7.22	-0.63	3e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs7927771	0.524	rs7107922	chr11:47669289	C/A	cg20307385	chr11:47447363	PSMC3	0.71	5.63	0.54	2.67e-7	Subjective well-being;
SKCM	trans	rs17685	0.672	rs6465011	chr7:75811297	T/C	cg19862616	chr7:65841803	NCRNA00174	0.94	10.42	0.76	1.95e-16	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7772486	0.790	rs2265472	chr6:146220758	G/C	cg05347473	chr6:146136440	FBXO30	0.56	5.18	0.51	1.67e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6951245	1.000	rs11768761	chr7:1069807	A/G	cg18402987	chr7:1209562	NA	1.15	6.02	0.56	5.38e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs6087990	0.806	rs4911108	chr20:31375311	A/G	cg13636640	chr20:31349939	DNMT3B	0.93	8.29	0.68	2.61e-12	Ulcerative colitis;
SKCM	cis	rs11098499	0.739	rs10013032	chr4:120149419	C/T	cg09307838	chr4:120376055	NA	-0.78	-5.85	-0.55	1.1e-7	Corneal astigmatism;
SKCM	cis	rs6951245	0.554	rs10270249	chr7:1151886	G/T	cg23708337	chr7:1209742	NA	0.73	5.05	0.5	2.78e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs12497850	0.644	rs11928552	chr3:48739883	T/C	cg07636037	chr3:49044803	WDR6	0.9	9.18	0.72	4.85e-14	Parkinson's disease;
SKCM	cis	rs6724607	1.000	rs4321393	chr2:191452899	G/T	cg27211696	chr2:191398769	TMEM194B	0.8	6.53	0.59	5.99e-9	Pulse pressure;
SKCM	cis	rs12762955	0.561	rs4880744	chr10:1012026	A/G	cg26597838	chr10:835615	NA	-0.7	-5.86	-0.55	1.05e-7	Response to angiotensin II receptor blocker therapy;
SKCM	cis	rs7937682	0.921	rs12806479	chr11:111443192	G/C	cg19812747	chr11:111475976	SIK2	0.64	5.42	0.52	6.47e-7	Primary sclerosing cholangitis;
SKCM	cis	rs2354432	0.607	rs3766524	chr1:146729093	A/G	cg25205988	chr1:146714368	CHD1L	-1.19	-6.56	-0.6	5.24e-9	Mitochondrial DNA levels;
SKCM	cis	rs4555082	0.834	rs2816624	chr14:105733909	A/G	cg13114125	chr14:105738426	BRF1	-0.69	-5.47	-0.53	5.33e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs514406	0.584	rs12095247	chr1:53193796	A/C	cg24675658	chr1:53192096	ZYG11B	0.63	5.17	0.51	1.77e-6	Monocyte count;
SKCM	cis	rs6951245	1.000	rs11767527	chr7:1097394	T/C	cg03188948	chr7:1209495	NA	1.13	6.27	0.58	1.89e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs597539	0.652	rs11603827	chr11:68719221	C/T	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.79	5.25	0.51	1.27e-6	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs2836974	0.897	rs11911112	chr21:40528346	A/C	cg11644478	chr21:40555479	PSMG1	0.97	10.21	0.76	5.08e-16	Cognitive function;
SKCM	cis	rs17685	0.712	rs11770149	chr7:75791644	G/A	cg01364799	chr7:75623366	TMEM120A	-0.66	-5.29	-0.51	1.07e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs10911251	0.546	rs2027084	chr1:183110801	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.76	7.28	0.64	2.26e-10	Colorectal cancer;
SKCM	cis	rs1005277	0.522	rs1208684	chr10:38093936	G/A	cg25427524	chr10:38739819	LOC399744	-0.66	-6.44	-0.59	9.09e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs17685	0.753	rs4728586	chr7:75802869	T/C	cg01364799	chr7:75623366	TMEM120A	-0.7	-5.84	-0.55	1.16e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs12047808	0.572	rs56145419	chr1:179379405	G/A	cg09822482	chr1:179519214	C1orf125	-0.95	-5.17	-0.51	1.78e-6	Multiple sclerosis (age of onset);
SKCM	cis	rs244731	0.959	rs10037110	chr5:176658066	A/T	cg16006841	chr5:176797999	RGS14	-0.8	-6.68	-0.6	3.24e-9	Urate levels in lean individuals;
SKCM	cis	rs6545883	0.831	rs1186704	chr2:61672991	A/G	cg15711740	chr2:61764176	XPO1	-0.7	-4.93	-0.49	4.5e-6	Tuberculosis;
SKCM	cis	rs709400	0.628	rs11623470	chr14:104004810	T/A	cg26031613	chr14:104095156	KLC1	0.74	5.64	0.54	2.61e-7	Body mass index;
SKCM	cis	rs3091242	0.867	rs602052	chr1:25722206	T/C	cg02931644	chr1:25747376	RHCE	0.53	5.48	0.53	5.13e-7	Erythrocyte sedimentation rate;
SKCM	cis	rs1799949	1.000	rs12951869	chr17:41187567	T/G	cg05368731	chr17:41323189	NBR1	0.86	7.39	0.64	1.39e-10	Menopause (age at onset);
SKCM	cis	rs4906332	0.811	rs2296487	chr14:103996205	T/C	cg04998671	chr14:104000505	TRMT61A	-0.72	-4.87	-0.48	5.65e-6	Coronary artery disease;
SKCM	cis	rs1878931	0.520	rs12447807	chr16:3413896	A/G	cg26668626	chr16:3451006	ZNF174;ZNF434	0.95	8.31	0.69	2.37e-12	Body mass index (adult);
SKCM	cis	rs4481887	0.741	rs28589987	chr1:248564785	T/C	cg22724847	chr1:248512586	OR14C36	0.59	4.97	0.49	3.82e-6	Common traits (Other);
SKCM	cis	rs7666738	0.830	rs2098934	chr4:98992403	A/G	cg05340658	chr4:99064831	C4orf37	0.67	5.14	0.5	1.98e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs28386778	0.966	rs2854206	chr17:61947203	G/A	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.13	11.22	0.79	5.99e-18	Prudent dietary pattern;
SKCM	cis	rs12477438	0.520	rs6542863	chr2:99725138	C/T	cg26064155	chr2:99771622	LIPT1;TSGA10	1.02	10.07	0.75	9.12e-16	Chronic sinus infection;
SKCM	cis	rs6430585	0.527	rs6753232	chr2:136436317	C/T	cg07169764	chr2:136633963	MCM6	-0.99	-7.5	-0.65	8.61e-11	Corneal structure;
SKCM	cis	rs1790761	0.632	rs625978	chr11:67344664	C/T	cg00290607	chr11:67383545	NA	0.51	5.38	0.52	7.43e-7	Mean corpuscular volume;
SKCM	cis	rs10752881	1.000	rs6697739	chr1:182983333	A/C	ch.1.3577855R	chr1:183094577	LAMC1	0.73	6.47	0.59	7.97e-9	Colorectal cancer;
SKCM	cis	rs4523957	0.855	rs9893573	chr17:2126003	A/G	cg16513277	chr17:2031491	SMG6	-0.73	-4.95	-0.49	4.13e-6	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs13256369	1.000	rs13271966	chr8:8575472	T/C	cg06636001	chr8:8085503	FLJ10661	0.72	5.39	0.52	7.26e-7	Obesity-related traits;
SKCM	cis	rs2404602	0.735	rs2957614	chr15:76696635	C/T	cg23625390	chr15:77176239	SCAPER	0.83	8.16	0.68	4.7e-12	Blood metabolite levels;
SKCM	cis	rs2239547	0.522	rs4519686	chr3:52997871	C/T	cg11645453	chr3:52864694	ITIH4	0.6	5.19	0.51	1.61e-6	Schizophrenia;
SKCM	cis	rs72781680	0.611	rs36052574	chr2:24306587	A/C	cg20701182	chr2:24300061	SF3B14	0.74	5.03	0.49	3.09e-6	Lymphocyte counts;
SKCM	cis	rs16866061	1.000	rs34345163	chr2:225459080	A/G	cg12698349	chr2:225449008	CUL3	1.01	8.51	0.69	9.75e-13	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs6087990	0.748	rs4911255	chr20:31357580	A/T	cg13636640	chr20:31349939	DNMT3B	0.91	7.97	0.67	1.06e-11	Ulcerative colitis;
SKCM	cis	rs4727027	0.933	rs13225884	chr7:148857795	A/G	cg23583168	chr7:148888333	NA	-0.83	-6.89	-0.62	1.26e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs4523957	0.583	rs2641443	chr17:2036162	G/A	cg16513277	chr17:2031491	SMG6	-0.91	-6.21	-0.58	2.38e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs2370759	1.000	rs79806114	chr10:32618022	T/C	cg01819863	chr10:32635814	EPC1	1.0	5.7	0.54	2.02e-7	Sexual dysfunction (female);
SKCM	cis	rs7811142	0.830	rs11765869	chr7:99964789	T/G	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.2	7.87	0.67	1.7e-11	Platelet count;
SKCM	cis	rs1799949	0.550	rs2343818	chr17:41409774	G/A	cg23758822	chr17:41437982	NA	0.93	7.88	0.67	1.62e-11	Menopause (age at onset);
SKCM	cis	rs17376456	0.597	rs7708175	chr5:93381182	A/G	cg25358565	chr5:93447407	FAM172A	-0.87	-5.53	-0.53	4.15e-7	Diabetic retinopathy;
SKCM	cis	rs870825	0.929	rs72689255	chr4:185590141	T/C	cg04058563	chr4:185651563	MLF1IP	1.09	5.66	0.54	2.4e-7	Blood protein levels;
SKCM	cis	rs4242434	0.927	rs13264187	chr8:22506098	C/T	cg03733263	chr8:22462867	KIAA1967	1.13	10.22	0.76	4.75e-16	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs8072100	0.748	rs9912592	chr17:45556945	G/A	cg25173405	chr17:45401733	C17orf57	-0.58	-4.77	-0.48	8.26e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs11585357	0.843	rs72633805	chr1:17617471	A/T	cg08277548	chr1:17600880	PADI3	-0.89	-6.31	-0.58	1.53e-8	Hair shape;
SKCM	cis	rs778371	0.748	rs2675953	chr2:233749565	G/C	cg08000102	chr2:233561755	GIGYF2	-0.84	-6.11	-0.57	3.7e-8	Schizophrenia;
SKCM	cis	rs7666738	0.830	rs11727612	chr4:99001662	T/C	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs72781680	0.611	rs7602797	chr2:24318148	C/T	cg20701182	chr2:24300061	SF3B14	0.74	5.03	0.49	3.09e-6	Lymphocyte counts;
SKCM	cis	rs9902453	0.817	rs17226179	chr17:28168573	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.75	5.15	0.5	1.93e-6	Coffee consumption (cups per day);
SKCM	cis	rs854765	0.619	rs6502636	chr17:17983817	A/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.88	6.64	0.6	3.8e-9	Total body bone mineral density;
SKCM	cis	rs17376456	0.569	rs35878747	chr5:93094070	C/A	cg25358565	chr5:93447407	FAM172A	0.86	5.45	0.53	5.59e-7	Diabetic retinopathy;
SKCM	cis	rs10911232	0.507	rs7515822	chr1:183037803	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.78	6.87	0.61	1.42e-9	Hypertriglyceridemia;
SKCM	cis	rs3820068	0.553	rs7545782	chr1:15955227	G/C	cg24675056	chr1:15929824	NA	0.73	5.44	0.52	6.03e-7	Systolic blood pressure;
SKCM	cis	rs4889855	0.511	rs9908700	chr17:78466594	A/G	cg16591659	chr17:78472290	NA	-0.56	-5.72	-0.54	1.87e-7	Fractional excretion of uric acid;
SKCM	cis	rs6546550	0.933	rs6546555	chr2:70135760	A/G	cg02498382	chr2:70120550	SNRNP27	-0.45	-4.88	-0.48	5.4e-6	Prevalent atrial fibrillation;
SKCM	cis	rs6547741	0.874	rs28381983	chr2:27804432	T/C	cg27432699	chr2:27873401	GPN1	0.75	6.66	0.6	3.49e-9	Oral cavity cancer;
SKCM	cis	rs1799949	0.965	rs11657883	chr17:41330024	T/C	cg23758822	chr17:41437982	NA	0.93	7.84	0.66	1.91e-11	Menopause (age at onset);
SKCM	cis	rs8014204	0.753	rs6574199	chr14:75356103	T/C	cg06637938	chr14:75390232	RPS6KL1	-0.8	-6.28	-0.58	1.8e-8	Caffeine consumption;
SKCM	cis	rs56011263	0.532	rs4690192	chr4:743670	A/G	cg17689763	chr4:710664	PCGF3	-0.65	-4.84	-0.48	6.44e-6	White blood cell count;
SKCM	cis	rs1005277	0.579	rs1740735	chr10:38497777	A/C	cg25427524	chr10:38739819	LOC399744	-0.69	-6.91	-0.62	1.17e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs8017423	0.647	rs10132599	chr14:90815342	C/T	cg04374321	chr14:90722782	PSMC1	-0.72	-5.24	-0.51	1.34e-6	Mortality in heart failure;
SKCM	cis	rs1005277	0.579	rs2474569	chr10:38383491	C/G	cg00409905	chr10:38381863	ZNF37A	-0.64	-5.96	-0.56	6.77e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs9308433	0.529	rs3767842	chr1:214498306	C/T	cg06198575	chr1:214491504	SMYD2	0.81	5.09	0.5	2.41e-6	IgG glycosylation;
SKCM	cis	rs2153535	0.623	rs6597338	chr6:8533508	A/C	cg07606381	chr6:8435919	SLC35B3	0.93	6.8	0.61	1.92e-9	Motion sickness;
SKCM	cis	rs2072510	0.722	rs2247323	chr12:96424256	A/G	cg18817487	chr12:96390143	HAL	0.43	5.68	0.54	2.18e-7	Metabolite levels (small molecules and protein measures);
SKCM	cis	rs9900062	1.000	rs11871616	chr17:62737602	C/T	cg02097616	chr17:62675921	NA	0.69	5.59	0.53	3.23e-7	QT interval;
SKCM	cis	rs9858542	0.953	rs6803222	chr3:49665976	T/G	cg03060546	chr3:49711283	APEH	-0.71	-5.29	-0.51	1.07e-6	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs7824557	0.603	rs7016671	chr8:11182455	A/G	cg21775007	chr8:11205619	TDH	0.72	6.85	0.61	1.54e-9	Retinal vascular caliber;
SKCM	cis	rs1577917	1.000	rs35419329	chr6:86702291	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.83	-8.23	-0.68	3.37e-12	Response to antipsychotic treatment;
SKCM	cis	rs11098499	0.908	rs1002152	chr4:120273387	C/A	cg09307838	chr4:120376055	NA	0.94	7.2	0.63	3.23e-10	Corneal astigmatism;
SKCM	trans	rs8073060	0.586	rs226089	chr17:34016935	C/T	cg19694781	chr19:47549865	TMEM160	-1.04	-8.28	-0.68	2.65e-12	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs2836974	0.584	rs6517535	chr21:40653352	G/C	cg17971929	chr21:40555470	PSMG1	-0.76	-7.16	-0.63	3.94e-10	Cognitive function;
SKCM	cis	rs1577917	0.958	rs11754330	chr6:86455070	G/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.67	-5.77	-0.55	1.54e-7	Response to antipsychotic treatment;
SKCM	cis	rs3789045	0.560	rs1107339	chr1:204411942	C/T	cg17419461	chr1:204415978	PIK3C2B	-0.84	-6.38	-0.59	1.17e-8	Educational attainment (college completion);
SKCM	cis	rs9875589	0.509	rs4684174	chr3:14048375	C/T	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.52	5.24	0.51	1.34e-6	Ovarian reserve;
SKCM	cis	rs28595532	0.841	rs55823625	chr4:119780600	T/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs9875589	0.509	rs1601870	chr3:14024162	T/C	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.52	5.19	0.51	1.65e-6	Ovarian reserve;
SKCM	cis	rs854765	0.551	rs56886154	chr17:17831473	C/A	cg09796270	chr17:17721594	SREBF1	0.65	4.87	0.48	5.79e-6	Total body bone mineral density;
SKCM	cis	rs12477438	0.520	rs36071868	chr2:99737120	G/A	cg26064155	chr2:99771622	LIPT1;TSGA10	1.05	10.46	0.76	1.63e-16	Chronic sinus infection;
SKCM	cis	rs1005277	0.579	rs2505240	chr10:38442419	G/T	cg00409905	chr10:38381863	ZNF37A	-0.67	-6.21	-0.58	2.41e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs28386778	0.897	rs896064	chr17:61860932	C/T	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs1577917	0.837	rs10944157	chr6:86577199	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.39	-0.52	7.24e-7	Response to antipsychotic treatment;
SKCM	cis	rs933688	1.000	rs1035476	chr5:90745976	C/T	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.1	8.43	0.69	1.4e-12	Smoking behavior;
SKCM	cis	rs55962025	0.711	rs4690010	chr4:3159719	G/T	cg09735869	chr4:3319127	RGS12	-0.59	-5.01	-0.49	3.37e-6	Parental longevity (mother's age at death);
SKCM	cis	rs2832191	0.671	rs68101501	chr21:30513229	G/T	cg24692254	chr21:30365293	RNF160	-0.76	-6.41	-0.59	1.03e-8	Dental caries;
SKCM	cis	rs3768617	0.510	rs10911243	chr1:183075415	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs35096708	1.000	rs35096708	chr16:89887249	G/A	cg08547343	chr16:90038815	CENPBD1;AFG3L1	-0.87	-6.51	-0.59	6.51e-9	Skin aging (microtopography measurement);
SKCM	cis	rs17065868	0.803	rs9595164	chr13:45205257	A/C	cg10246903	chr13:45222710	NA	0.95	5.35	0.52	8.5e-7	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs875971	0.825	rs10281499	chr7:66048966	A/G	cg18876405	chr7:65276391	NA	-0.63	-6.31	-0.58	1.6e-8	Aortic root size;
SKCM	cis	rs986417	0.901	rs8020084	chr14:61001495	C/T	cg27398547	chr14:60952738	C14orf39	1.15	5.07	0.5	2.59e-6	Gut microbiota (bacterial taxa);
SKCM	cis	rs3091242	0.933	rs909833	chr1:25754140	C/G	cg27572855	chr1:25598939	RHD	0.56	5.49	0.53	4.9e-7	Erythrocyte sedimentation rate;
SKCM	cis	rs2836950	0.520	rs2836966	chr21:40637521	A/G	cg17971929	chr21:40555470	PSMG1	-0.73	-6.16	-0.57	2.97e-8	Menarche (age at onset);
SKCM	cis	rs7954584	0.611	rs3887885	chr12:122336486	C/T	cg22618164	chr12:122356400	WDR66	0.5	5.01	0.49	3.31e-6	Mean corpuscular volume;
SKCM	cis	rs1218582	0.772	rs10908445	chr1:154849590	A/G	cg24250549	chr1:154909240	PMVK	-0.89	-9.88	-0.75	2.18e-15	Prostate cancer;
SKCM	cis	rs7777484	0.571	rs2527686	chr7:2834413	G/A	cg19717773	chr7:2847554	GNA12	-0.49	-5.95	-0.56	7.09e-8	Height;
SKCM	cis	rs2204008	0.807	rs4123933	chr12:37973539	G/A	cg26384229	chr12:38710491	ALG10B	0.8	6.2	0.57	2.47e-8	Bladder cancer;
SKCM	cis	rs752010	0.619	rs6703992	chr1:42115888	G/A	cg06885757	chr1:42089581	HIVEP3	0.57	6.21	0.58	2.4e-8	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs6951245	0.938	rs11764937	chr7:1092074	C/T	cg18402987	chr7:1209562	NA	1.08	5.53	0.53	4.12e-7	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs1395	0.778	rs17005956	chr2:27451099	C/T	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.5	5.06	0.5	2.67e-6	Blood metabolite levels;
SKCM	cis	rs8060686	0.641	rs3743735	chr16:68119555	G/A	cg04539111	chr16:67997858	SLC12A4	-0.85	-4.81	-0.48	7.14e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs2952156	0.959	rs2952151	chr17:37828496	T/C	cg20243544	chr17:37824526	PNMT	0.73	5.79	0.55	1.43e-7	Asthma;
SKCM	cis	rs1218582	0.600	rs72702224	chr1:154911689	G/A	cg03351412	chr1:154909251	PMVK	0.67	5.39	0.52	7.2e-7	Prostate cancer;
SKCM	cis	rs9910055	0.529	rs400460	chr17:42182770	A/G	cg19774624	chr17:42201019	HDAC5	0.81	6.25	0.58	2e-8	Total body bone mineral density;
SKCM	cis	rs8078723	0.966	rs2227322	chr17:38171668	C/G	cg17467752	chr17:38218738	THRA	0.69	6.33	0.58	1.46e-8	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs6089584	0.861	rs2180302	chr20:60576369	A/G	cg06108461	chr20:60628389	TAF4	-0.83	-7.31	-0.64	1.98e-10	Body mass index;
SKCM	cis	rs1799949	0.827	rs74252763	chr17:41402020	C/T	cg05368731	chr17:41323189	NBR1	0.87	7.6	0.65	5.5e-11	Menopause (age at onset);
SKCM	cis	rs7772486	0.597	rs1970306	chr6:146154543	A/G	cg05347473	chr6:146136440	FBXO30	0.68	6.08	0.57	4.16e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6570726	0.935	rs385134	chr6:145851005	C/T	cg23711669	chr6:146136114	FBXO30	0.7	6.71	0.61	2.78e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7555523	0.887	rs4657471	chr1:165686873	T/C	cg24409356	chr1:165738333	TMCO1	0.93	5.15	0.5	1.93e-6	Intraocular pressure;Glaucoma (high intraocular pressure);
SKCM	cis	rs10751667	0.666	rs10902255	chr11:967268	T/C	cg10932868	chr11:921992	NA	0.55	5.1	0.5	2.36e-6	Alzheimer's disease (late onset);
SKCM	cis	rs72792276	1.000	rs72792279	chr5:127374404	G/A	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.74	5.01	0.49	3.33e-6	Red cell distribution width;
SKCM	cis	rs7811142	0.830	rs6948685	chr7:99970188	C/T	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.07	6.7	0.6	2.88e-9	Platelet count;
SKCM	cis	rs28386778	0.897	rs2727333	chr17:61876023	G/A	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs208520	0.690	rs2797693	chr6:66868985	T/C	cg07460842	chr6:66804631	NA	-0.95	-6.8	-0.61	1.85e-9	Exhaled nitric oxide output;
SKCM	cis	rs61776719	0.500	rs11210866	chr1:38449565	T/C	cg12658694	chr1:38397304	INPP5B	0.58	4.93	0.49	4.54e-6	Coronary artery disease;
SKCM	cis	rs10883723	0.773	rs715439	chr10:104257809	A/C	cg11453585	chr10:104263688	ACTR1A;SUFU	0.75	5.7	0.54	2.03e-7	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs5750830	0.595	rs4821892	chr22:39795683	G/C	cg11247378	chr22:39784982	NA	-0.47	-5.43	-0.52	6.26e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7954584	0.567	rs11043233	chr12:122330733	C/T	cg22618164	chr12:122356400	WDR66	0.53	5.39	0.52	7.24e-7	Mean corpuscular volume;
SKCM	cis	rs10916772	1.000	rs10916774	chr1:20683434	A/G	cg05356564	chr1:21044770	KIF17	-0.62	-5.15	-0.5	1.88e-6	Psychosis proneness (perceptual aberration scale);
SKCM	cis	rs4268898	0.662	rs9917355	chr2:24433400	C/T	cg06627628	chr2:24431161	ITSN2	-0.92	-7.12	-0.63	4.73e-10	Asthma;
SKCM	cis	rs12142240	0.698	rs17361812	chr1:46814008	C/T	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs7811142	1.000	rs6962151	chr7:100028484	T/C	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-0.99	-5.52	-0.53	4.2e-7	Platelet count;
SKCM	cis	rs9926296	0.585	rs4785595	chr16:89835521	C/T	cg04287289	chr16:89883240	FANCA	-1.02	-11.94	-0.8	2.8e-19	Vitiligo;
SKCM	cis	rs2073499	1.000	rs6776145	chr3:50316119	C/T	cg05260129	chr3:50388622	TUSC4;CYB561D2	-0.82	-5.24	-0.51	1.31e-6	Schizophrenia;
SKCM	cis	rs7811142	1.000	rs1073	chr7:100031612	G/A	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.23	7.89	0.67	1.53e-11	Platelet count;
SKCM	cis	rs3096299	0.967	rs28689480	chr16:89460093	T/C	cg02187348	chr16:89574699	SPG7	0.63	5.04	0.5	2.93e-6	Multiple myeloma (IgH translocation);
SKCM	cis	rs7336332	0.598	rs10220056	chr13:28003781	T/G	cg22138327	chr13:27999177	GTF3A	0.91	6.51	0.59	6.52e-9	Weight;
SKCM	cis	rs2894969	0.664	rs11252703	chr10:4795125	A/T	cg09807945	chr10:4066442	NA	0.77	6.43	0.59	9.21e-9	Major depressive disorder;
SKCM	cis	rs60871478	0.787	rs4720928	chr7:808002	T/C	cg05535760	chr7:792225	HEATR2	1.02	8.66	0.7	4.97e-13	Cerebrospinal P-tau181p levels;
SKCM	cis	rs2842992	0.724	rs15982	chr6:160199687	T/C	cg11366901	chr6:160182831	ACAT2	0.85	7.49	0.65	8.93e-11	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs2645694	0.651	rs2703144	chr4:77830505	C/G	cg06046430	chr4:77819534	ANKRD56	0.54	5.94	0.56	7.49e-8	Emphysema distribution in smoking;
SKCM	cis	rs651907	0.514	rs55654108	chr3:101425703	A/G	cg12386194	chr3:101231763	SENP7	0.69	5.68	0.54	2.23e-7	Colorectal cancer;
SKCM	cis	rs34779708	0.966	rs12775799	chr10:35488264	C/T	cg03585969	chr10:35415529	CREM	0.78	6.15	0.57	3.11e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs8072100	0.967	rs3760370	chr17:45695832	C/T	cg25173405	chr17:45401733	C17orf57	0.58	5.23	0.51	1.37e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs7659604	0.539	rs7686084	chr4:122764725	A/C	cg19748678	chr4:122722346	EXOSC9	0.65	5.34	0.52	8.74e-7	Type 2 diabetes;
SKCM	cis	rs4819052	0.851	rs2877019	chr21:46658647	G/A	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.42	0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs854765	0.693	rs8080061	chr17:17776389	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	-1.02	-8.27	-0.68	2.82e-12	Total body bone mineral density;
SKCM	cis	rs10876993	0.890	rs1678539	chr12:58060359	A/G	cg18357645	chr12:58087776	OS9	0.61	5.65	0.54	2.52e-7	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs2921073	0.509	rs2976931	chr8:8257317	C/A	cg06636001	chr8:8085503	FLJ10661	0.74	6.51	0.59	6.59e-9	Parkinson's disease;
SKCM	trans	rs5756813	0.584	rs12484820	chr22:38207556	A/G	cg19894588	chr14:64061835	NA	-0.91	-7.73	-0.66	3.07e-11	Optic cup area;Vertical cup-disc ratio;
SKCM	cis	rs7666738	0.830	rs34671152	chr4:98978177	C/T	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs17376456	0.825	rs6877030	chr5:93201841	C/A	cg25358565	chr5:93447407	FAM172A	1.18	7.56	0.65	6.77e-11	Diabetic retinopathy;
SKCM	cis	rs1707322	0.721	rs28442079	chr1:46172001	A/G	cg03146154	chr1:46216737	IPP	0.84	6.2	0.57	2.51e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7666738	0.571	rs7683769	chr4:99091742	T/C	cg17366294	chr4:99064904	C4orf37	0.62	5.03	0.49	3.06e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6951245	0.745	rs79788515	chr7:1101079	C/T	cg03188948	chr7:1209495	NA	1.05	5.97	0.56	6.65e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs12497850	0.931	rs7626445	chr3:49114544	C/T	cg06212747	chr3:49208901	KLHDC8B	0.7	4.94	0.49	4.32e-6	Parkinson's disease;
SKCM	trans	rs17685	0.753	rs55812043	chr7:75747241	T/C	cg19862616	chr7:65841803	NCRNA00174	0.94	9.49	0.73	1.22e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1799949	1.000	rs11653460	chr17:41331306	C/T	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.29	-0.58	1.73e-8	Menopause (age at onset);
SKCM	cis	rs7208859	0.623	rs383436	chr17:28959179	A/G	cg14067834	chr17:29058358	SUZ12P	1.07	4.92	0.49	4.65e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs798766	0.909	rs28521716	chr4:1745751	A/G	cg24239225	chr4:1659016	FAM53A	-0.72	-4.87	-0.48	5.66e-6	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs60871478	0.636	rs55663559	chr7:884057	G/A	cg05535760	chr7:792225	HEATR2	-1.3	-7.8	-0.66	2.27e-11	Cerebrospinal P-tau181p levels;
SKCM	cis	rs514406	0.893	rs1242317	chr1:53414766	T/C	cg16325326	chr1:53192061	ZYG11B	0.89	9.33	0.73	2.49e-14	Monocyte count;
SKCM	cis	rs1023500	0.551	rs2854837	chr22:42458481	G/A	cg04733989	chr22:42467013	NAGA	0.74	5.93	0.56	7.84e-8	Schizophrenia;
SKCM	cis	rs2842992	0.789	rs2842969	chr6:160145364	C/T	cg11366901	chr6:160182831	ACAT2	0.9	6.99	0.62	8.17e-10	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs11098499	0.863	rs9884402	chr4:120489982	A/G	cg09307838	chr4:120376055	NA	1.0	8.27	0.68	2.8e-12	Corneal astigmatism;
SKCM	cis	rs4975616	0.869	rs31490	chr5:1344458	G/A	cg07493874	chr5:1342172	CLPTM1L	-0.69	-6.53	-0.59	6.16e-9	Lung cancer;
SKCM	cis	rs10751667	0.643	rs10751666	chr11:941933	C/T	cg10932868	chr11:921992	NA	0.54	5.05	0.5	2.81e-6	Alzheimer's disease (late onset);
SKCM	cis	rs34779708	0.931	rs1926556	chr10:35344907	T/C	cg03585969	chr10:35415529	CREM	0.76	6.26	0.58	1.91e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs9790314	0.521	rs60625846	chr3:161084525	G/T	cg03342759	chr3:160939853	NMD3	-0.79	-6.79	-0.61	1.97e-9	Morning vs. evening chronotype;
SKCM	cis	rs1005277	0.579	rs2505240	chr10:38442419	G/T	cg25427524	chr10:38739819	LOC399744	-0.71	-6.71	-0.61	2.75e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs8180040	0.966	rs3816779	chr3:47543389	C/T	cg16586182	chr3:47516702	SCAP	-0.76	-5.32	-0.52	9.63e-7	Colorectal cancer;
SKCM	cis	rs28595532	0.920	rs73842253	chr4:119721856	G/A	cg11846333	chr4:119757529	SEC24D	1.13	5.32	0.52	9.79e-7	Cannabis dependence symptom count;
SKCM	cis	rs2204008	0.506	rs11495470	chr12:38026904	C/T	cg26384229	chr12:38710491	ALG10B	0.81	6.83	0.61	1.69e-9	Bladder cancer;
SKCM	cis	rs9467773	0.967	rs9295694	chr6:26512994	A/T	cg09904177	chr6:26538194	HMGN4	0.54	4.98	0.49	3.78e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2075371	0.579	rs11766422	chr7:134018160	T/C	cg11752832	chr7:134001865	SLC35B4	0.56	4.82	0.48	7.07e-6	Mean platelet volume;
SKCM	cis	rs2204008	0.597	rs4002591	chr12:38133841	A/G	cg26384229	chr12:38710491	ALG10B	0.82	6.58	0.6	4.87e-9	Bladder cancer;
SKCM	cis	rs1707322	0.752	rs4660313	chr1:46110841	A/G	cg03146154	chr1:46216737	IPP	-0.77	-5.26	-0.51	1.22e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs6840360	0.615	rs1561916	chr4:152479234	C/T	cg22705602	chr4:152727874	NA	-0.51	-5.78	-0.55	1.45e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs2439831	0.681	rs7175434	chr15:43628542	A/C	cg27015174	chr15:43622946	ADAL;LCMT2	0.84	4.8	0.48	7.64e-6	Lung cancer in ever smokers;
SKCM	cis	rs2032447	0.507	rs199741	chr6:25931577	A/G	cg03517284	chr6:25882590	NA	-0.8	-6.94	-0.62	1.01e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs7100689	0.784	rs7078075	chr10:82162768	A/G	cg01528321	chr10:82214614	TSPAN14	0.94	9.27	0.72	3.2e-14	Post bronchodilator FEV1;
SKCM	cis	rs7940866	0.845	rs2324314	chr11:130834589	A/C	cg12179176	chr11:130786555	SNX19	0.78	5.88	0.55	9.57e-8	Schizophrenia;
SKCM	cis	rs854765	0.693	rs4924823	chr17:17764502	A/G	cg04398451	chr17:18023971	MYO15A	0.92	6.67	0.6	3.3e-9	Total body bone mineral density;
SKCM	cis	rs17376456	0.778	rs10476604	chr5:93461838	C/T	cg25358565	chr5:93447407	FAM172A	0.8	5.08	0.5	2.52e-6	Diabetic retinopathy;
SKCM	cis	rs929354	0.685	rs7807856	chr7:156934498	T/C	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs2739330	0.761	rs5760176	chr22:24402321	A/G	cg12419862	chr22:24373484	LOC391322	0.9	9.78	0.74	3.34e-15	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs7772486	0.686	rs9399565	chr6:146081906	G/T	cg23711669	chr6:146136114	FBXO30	-0.85	-9.32	-0.73	2.62e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6951245	1.000	rs11770909	chr7:1086716	G/A	cg03188948	chr7:1209495	NA	1.12	6.25	0.58	2.02e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs2204008	0.744	rs67889662	chr12:38327042	T/A	cg13010199	chr12:38710504	ALG10B	0.69	4.92	0.49	4.75e-6	Bladder cancer;
SKCM	cis	rs6570726	0.791	rs436156	chr6:145874873	A/G	cg23711669	chr6:146136114	FBXO30	0.87	9.14	0.72	5.82e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1577917	0.958	rs28442244	chr6:86701236	G/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.61	4.92	0.49	4.77e-6	Response to antipsychotic treatment;
SKCM	cis	rs7666738	0.830	rs28522896	chr4:99008243	C/T	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9303401	0.659	rs62083410	chr17:56964386	T/C	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.35	0.52	8.54e-7	Cognitive test performance;
SKCM	cis	rs12142240	0.698	rs9661240	chr1:46827050	G/A	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs4332037	0.950	rs11767515	chr7:1941051	C/T	cg02825527	chr7:2087843	MAD1L1	-0.73	-5.11	-0.5	2.22e-6	Bipolar disorder;
SKCM	cis	rs2739330	0.828	rs2186366	chr22:24254113	A/G	cg12419862	chr22:24373484	LOC391322	0.65	5.68	0.54	2.26e-7	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs694739	1.000	rs11231757	chr11:64106317	C/T	cg02228329	chr11:64053129	BAD;GPR137	1.0	9.0	0.71	1.08e-13	Alopecia areata;Crohn's disease;Psoriasis vulgaris;
SKCM	cis	rs10193935	0.901	rs13375	chr2:42559288	A/G	cg27598129	chr2:42591480	NA	-0.88	-6.71	-0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1799949	1.000	rs8176120	chr17:41261233	C/T	cg23758822	chr17:41437982	NA	0.92	7.68	0.66	3.96e-11	Menopause (age at onset);
SKCM	cis	rs6723226	0.750	rs762019	chr2:32688601	A/C	cg02381751	chr2:32503542	YIPF4	0.69	4.93	0.49	4.53e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2836974	0.644	rs9978775	chr21:40694526	A/G	cg17971929	chr21:40555470	PSMG1	-0.73	-6.44	-0.59	9.11e-9	Cognitive function;
SKCM	cis	rs13336428	0.730	rs28653458	chr16:1525850	T/C	cg07835181	chr16:1525278	CLCN7	0.81	6.83	0.61	1.69e-9	Bone mineral density;
SKCM	cis	rs17376456	0.877	rs10057814	chr5:93399092	C/G	cg21475434	chr5:93447410	FAM172A	0.95	5.31	0.51	1.02e-6	Diabetic retinopathy;
SKCM	cis	rs10089	0.953	rs10463839	chr5:127519675	T/A	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.87	7.69	0.66	3.82e-11	Ileal carcinoids;
SKCM	cis	rs4132509	1.000	rs73128287	chr1:243952150	T/G	cg21452805	chr1:244014465	NA	0.88	5.37	0.52	7.83e-7	RR interval (heart rate);
SKCM	cis	rs7502499	0.961	rs12944684	chr17:47509486	C/G	cg04650899	chr17:48194835	SAMD14	0.58	4.79	0.48	7.94e-6	Coronary artery disease;Cancer;
SKCM	cis	rs7584330	0.554	rs2325838	chr2:238386515	C/A	cg08992911	chr2:238395768	MLPH	0.95	5.1	0.5	2.3e-6	Prostate cancer;
SKCM	cis	rs7959452	0.503	rs7300266	chr12:69654187	A/G	cg14784868	chr12:69753453	YEATS4	0.63	5.53	0.53	4.18e-7	Blood protein levels;
SKCM	cis	rs6430585	0.583	rs111837148	chr2:136612036	G/A	cg07169764	chr2:136633963	MCM6	1.31	13.05	0.83	2.59e-21	Corneal structure;
SKCM	cis	rs597539	0.690	rs635529	chr11:68626294	C/T	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.82	5.51	0.53	4.49e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs7666738	0.830	rs1426664	chr4:98988264	A/C	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs939658	0.683	rs1434459	chr15:79465210	T/C	cg10259521	chr15:79428573	NA	0.49	5.07	0.5	2.6e-6	Refractive error;
SKCM	cis	rs7811142	1.000	rs11769700	chr7:100090049	T/C	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.14	6.58	0.6	4.83e-9	Platelet count;
SKCM	cis	rs1218582	0.744	rs6674853	chr1:154892753	G/C	cg06221963	chr1:154839813	KCNN3	-0.61	-6.47	-0.59	7.88e-9	Prostate cancer;
SKCM	cis	rs208520	0.661	rs1100950	chr6:66827285	A/C	cg07460842	chr6:66804631	NA	-1.09	-8.46	-0.69	1.22e-12	Exhaled nitric oxide output;
SKCM	cis	rs34375054	0.553	rs12580221	chr12:125621066	T/C	cg25124228	chr12:125621409	AACS	-0.76	-5.5	-0.53	4.72e-7	Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs9311474	0.508	rs12637627	chr3:52619962	G/T	cg18404041	chr3:52824283	ITIH1	-0.53	-4.77	-0.48	8.42e-6	Electroencephalogram traits;
SKCM	cis	rs933688	0.938	rs10942634	chr5:90658392	A/T	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.11	8.47	0.69	1.14e-12	Smoking behavior;
SKCM	cis	rs164748	0.565	rs12924572	chr16:89748736	G/A	cg01097406	chr16:89675127	NA	-0.49	-5.22	-0.51	1.46e-6	Glomerular filtration rate;Glomerular filtration rate in non diabetics (creatinine);
SKCM	cis	rs873946	0.557	rs34854637	chr10:134582962	A/G	cg27286337	chr10:134555280	INPP5A	0.97	8.63	0.7	5.57e-13	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs13424612	1.000	rs4149556	chr2:240915307	C/T	cg01812947	chr2:240904978	NDUFA10	0.65	4.79	0.48	7.7e-6	Odorant perception (isobutyraldehyde);
SKCM	cis	rs10256972	0.552	rs6978842	chr7:1204599	A/C	cg16145915	chr7:1198662	ZFAND2A	-0.64	-10.31	-0.76	3.28e-16	Longevity;Endometriosis;
SKCM	cis	rs2120019	0.935	rs8042409	chr15:75350433	G/A	cg09165964	chr15:75287851	SCAMP5	-0.75	-6.7	-0.6	2.88e-9	Blood trace element (Zn levels);
SKCM	cis	rs6866344	0.570	rs11740283	chr5:178136440	T/C	cg03877680	chr5:178157825	ZNF354A	0.92	7.46	0.65	1.04e-10	Neutrophil percentage of white cells;
SKCM	cis	rs7945705	0.902	rs10743095	chr11:8936984	T/C	cg21881798	chr11:8931708	C11orf17;ST5	0.78	7.65	0.65	4.41e-11	Hemoglobin concentration;
SKCM	cis	rs7100689	0.646	rs1953971	chr10:82145647	G/C	cg00277334	chr10:82204260	NA	-0.53	-4.96	-0.49	4.02e-6	Post bronchodilator FEV1;
SKCM	cis	rs9467773	1.000	rs9467797	chr6:26568473	A/T	cg15659132	chr6:26577336	NA	0.61	5.76	0.55	1.6e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs995000	0.965	rs1979722	chr1:62940097	G/A	cg06896770	chr1:63153194	DOCK7	0.91	8.61	0.7	6.24e-13	Triglyceride levels;
SKCM	cis	rs6951245	1.000	rs79617366	chr7:1111958	G/C	cg03188948	chr7:1209495	NA	1.13	6.27	0.58	1.89e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7829975	0.623	rs7010753	chr8:8373956	A/G	cg06636001	chr8:8085503	FLJ10661	0.67	4.92	0.49	4.67e-6	Mood instability;
SKCM	cis	rs28595532	0.920	rs56364904	chr4:119742504	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs1160297	0.634	rs10179810	chr2:53096145	T/A	cg07782112	chr2:53107842	NA	0.59	6.3	0.58	1.63e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs9911578	0.935	rs302873	chr17:56769481	C/G	cg05425664	chr17:57184151	TRIM37	-0.65	-4.77	-0.48	8.38e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9443189	0.526	rs10943255	chr6:76225928	T/A	cg01950844	chr6:76311363	SENP6	0.9	5.32	0.52	9.74e-7	Prostate cancer;
SKCM	cis	rs4728302	0.559	rs7779409	chr7:133158475	A/G	cg10665199	chr7:133106180	EXOC4	0.84	5.27	0.51	1.2e-6	Intelligence;Intelligence (multi-trait analysis);
SKCM	cis	rs7666738	0.830	rs10049985	chr4:99023517	C/T	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6951245	0.872	rs113119264	chr7:1080564	G/A	cg18402987	chr7:1209562	NA	1.14	6.01	0.56	5.68e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs4819052	0.851	rs2838840	chr21:46668494	A/G	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.36	0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs3820928	0.904	rs1835159	chr2:227764057	A/G	cg11843606	chr2:227700838	RHBDD1	-0.62	-5.05	-0.5	2.8e-6	Pulmonary function;
SKCM	cis	rs9583531	0.600	rs6492303	chr13:111356800	G/A	cg24331049	chr13:111365604	ING1	0.87	6.47	0.59	7.9e-9	Coronary artery disease;
SKCM	cis	rs7523273	0.606	rs2796271	chr1:207941927	A/G	cg22525895	chr1:207977042	MIR29B2	0.81	7.08	0.63	5.47e-10	Schizophrenia;
SKCM	cis	rs769267	1.000	rs769267	chr19:19446936	A/G	cg03709012	chr19:19516395	GATAD2A	0.94	7.86	0.66	1.79e-11	Tonsillectomy;
SKCM	cis	rs9300255	0.639	rs941306	chr12:123715113	C/T	cg05973401	chr12:123451056	ABCB9	0.82	5.31	0.51	1.02e-6	Neutrophil percentage of white cells;
SKCM	cis	rs1580019	0.587	rs1597555	chr7:32546118	T/G	cg06627557	chr7:32535165	LSM5;AVL9	0.95	9.08	0.72	7.65e-14	Cognitive ability;
SKCM	cis	rs801193	0.935	rs2286683	chr7:66129843	G/A	cg11764359	chr7:65958608	NA	-0.83	-6.29	-0.58	1.71e-8	Aortic root size;
SKCM	cis	rs801193	0.660	rs1016265	chr7:66214567	C/T	cg11764359	chr7:65958608	NA	0.83	7.69	0.66	3.75e-11	Aortic root size;
SKCM	cis	rs7945705	0.870	rs10840142	chr11:8906078	A/G	cg21881798	chr11:8931708	C11orf17;ST5	0.76	7.8	0.66	2.29e-11	Hemoglobin concentration;
SKCM	cis	rs9467773	0.595	rs2172007	chr6:26639777	A/C	cg15659132	chr6:26577336	NA	0.66	5.82	0.55	1.22e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs951366	0.764	rs708724	chr1:205743663	A/C	cg26354017	chr1:205819088	PM20D1	1.03	9.58	0.74	7.95e-15	Menarche (age at onset);
SKCM	cis	rs9902453	0.817	rs7217961	chr17:28403112	T/C	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.82	-6.4	-0.59	1.06e-8	Coffee consumption (cups per day);
SKCM	cis	rs2180341	0.960	rs9401953	chr6:127687574	G/A	cg27446573	chr6:127587934	RNF146	0.93	8.09	0.68	6.27e-12	Breast cancer;
SKCM	cis	rs9790314	0.686	rs2306061	chr3:160787502	C/T	cg03342759	chr3:160939853	NMD3	-0.6	-5.78	-0.55	1.46e-7	Morning vs. evening chronotype;
SKCM	cis	rs13256369	0.802	rs11249887	chr8:8562184	T/C	cg15556689	chr8:8085844	FLJ10661	0.65	4.77	0.48	8.39e-6	Obesity-related traits;
SKCM	cis	rs10489202	0.657	rs3767478	chr1:168069626	G/A	cg24449463	chr1:168025552	DCAF6	-0.76	-6.99	-0.62	8.31e-10	Schizophrenia;
SKCM	cis	rs9486715	0.867	rs1855533	chr6:97050265	T/C	cg06623918	chr6:96969491	KIAA0776	-0.86	-7.66	-0.66	4.3e-11	Headache;
SKCM	cis	rs34779708	0.931	rs1926554	chr10:35344969	C/T	cg03585969	chr10:35415529	CREM	0.76	6.26	0.58	1.91e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs12971120	0.891	rs3794953	chr18:72180519	C/T	cg25817165	chr18:72167213	CNDP2	-0.65	-4.87	-0.48	5.69e-6	Refractive error;
SKCM	cis	rs11690935	0.885	rs10202823	chr2:172780132	T/C	cg13550731	chr2:172543902	DYNC1I2	-0.92	-7.64	-0.65	4.73e-11	Schizophrenia;
SKCM	cis	rs875971	0.522	rs1917563	chr7:65415647	C/T	cg00343986	chr7:65444356	GUSB	-0.66	-4.77	-0.47	8.52e-6	Aortic root size;
SKCM	cis	rs11155671	0.530	rs3823021	chr6:150210999	G/C	cg05036130	chr6:150231994	NA	0.61	6.58	0.6	4.87e-9	Testicular germ cell tumor;
SKCM	cis	rs6435862	0.517	rs6757091	chr2:215672793	G/C	cg04004882	chr2:215674386	BARD1	-0.83	-6.36	-0.58	1.26e-8	Neuroblastoma (high-risk);
SKCM	cis	rs7296418	0.630	rs7974099	chr12:123771475	A/G	cg00376283	chr12:123451042	ABCB9	0.82	6.54	0.6	5.78e-9	Platelet count;
SKCM	cis	rs2153535	0.580	rs6912374	chr6:8456423	T/C	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs6546550	0.901	rs1979214	chr2:70137498	G/C	cg02498382	chr2:70120550	SNRNP27	-0.45	-4.88	-0.48	5.4e-6	Prevalent atrial fibrillation;
SKCM	cis	rs2645694	0.626	rs2645705	chr4:77830434	G/A	cg03477792	chr4:77819574	ANKRD56	0.57	6.42	0.59	9.57e-9	Emphysema distribution in smoking;
SKCM	cis	rs76167968	1	rs76167968	chr1:35681738	T/C	cg12633102	chr1:35676489	NA	-0.68	-5.4	-0.52	7.09e-7	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs17685	0.753	rs4573217	chr7:75733946	G/A	cg16489192	chr7:75678113	MDH2;STYXL1	-0.61	-5.55	-0.53	3.73e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs8067545	0.559	rs3874846	chr17:20297545	T/G	cg13482628	chr17:19912719	NA	0.73	5.74	0.54	1.74e-7	Schizophrenia;
SKCM	cis	rs28595532	0.841	rs116329146	chr4:119733438	G/A	cg11846333	chr4:119757529	SEC24D	1.2	6.43	0.59	9.38e-9	Cannabis dependence symptom count;
SKCM	cis	rs523522	0.847	rs11065132	chr12:120908459	C/T	cg27279351	chr12:120934652	DYNLL1	0.9	7.85	0.66	1.8e-11	High light scatter reticulocyte count;
SKCM	cis	rs35306767	0.903	rs11253467	chr10:901244	A/G	cg25614935	chr10:1084866	C10orf110	0.83	5.45	0.53	5.64e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs1843834	0.539	rs1494109	chr2:225441833	G/A	cg22455342	chr2:225449267	CUL3	0.76	5.56	0.53	3.62e-7	IgE levels in asthmatics (D.p. specific);
SKCM	cis	rs1218582	0.772	rs12095061	chr1:154912968	A/T	cg03351412	chr1:154909251	PMVK	0.76	6.45	0.59	8.5e-9	Prostate cancer;
SKCM	cis	rs7666738	0.830	rs7689495	chr4:98920152	T/C	cg17366294	chr4:99064904	C4orf37	0.57	4.85	0.48	6.12e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs12047808	0.841	rs16854064	chr1:179363275	A/C	cg08037922	chr1:179521085	C1orf125;NPHS2	1.08	5.8	0.55	1.32e-7	Multiple sclerosis (age of onset);
SKCM	cis	rs1799949	1.000	rs11649954	chr17:41420035	A/G	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.18	-0.57	2.68e-8	Menopause (age at onset);
SKCM	cis	rs4974559	0.594	rs59544360	chr4:1313575	G/T	cg02980000	chr4:1222292	CTBP1	0.89	5.16	0.5	1.85e-6	Systolic blood pressure;
SKCM	cis	rs7959452	1.000	rs7959452	chr12:69735492	A/G	cg20891283	chr12:69753455	YEATS4	0.71	6.13	0.57	3.44e-8	Blood protein levels;
SKCM	cis	rs3784262	0.967	rs12910752	chr15:58314679	G/A	cg12031962	chr15:58353849	ALDH1A2	-0.5	-6.27	-0.58	1.85e-8	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs5750830	0.649	rs5757657	chr22:39798429	G/T	cg24399712	chr22:39784796	NA	-0.61	-5.24	-0.51	1.32e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1865760	0.516	rs9295684	chr6:26069669	T/C	cg16482183	chr6:26056742	HIST1H1C	0.61	4.85	0.48	6.08e-6	Height;
SKCM	cis	rs9913156	0.748	rs7217849	chr17:4562165	G/C	cg19197139	chr17:4613644	ARRB2	0.79	5.28	0.51	1.14e-6	Lymphocyte counts;
SKCM	cis	rs2197308	0.619	rs4002730	chr12:37876400	T/C	cg13010199	chr12:38710504	ALG10B	0.65	4.93	0.49	4.48e-6	Morning vs. evening chronotype;
SKCM	cis	rs2836950	0.565	rs3171465	chr21:40552307	A/G	cg11644478	chr21:40555479	PSMG1	-0.67	-5.3	-0.51	1.04e-6	Menarche (age at onset);
SKCM	cis	rs734999	0.545	rs6684865	chr1:2546229	A/G	cg18854424	chr1:2615690	NA	-0.44	-4.88	-0.48	5.49e-6	Ulcerative colitis;
SKCM	cis	rs477895	0.838	rs35090903	chr11:64000598	C/T	cg07220939	chr11:64358617	SLC22A12	0.72	4.77	0.48	8.37e-6	Mean platelet volume;
SKCM	cis	rs10779751	0.960	rs4845857	chr1:11285680	T/C	cg08854313	chr1:11322531	MTOR	0.91	6.95	0.62	9.63e-10	Body mass index;
SKCM	cis	rs561341	1.000	rs501957	chr17:30314504	C/T	cg23018236	chr17:30244563	NA	-0.54	-5.66	-0.54	2.42e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs1568889	1.000	rs12287732	chr11:28120845	A/G	cg06544937	chr11:28130018	METT5D1;KIF18A	0.86	7.03	0.62	6.97e-10	Bipolar disorder;
SKCM	cis	rs17376456	0.877	rs10060160	chr5:93387879	G/A	cg25358565	chr5:93447407	FAM172A	1.19	7.67	0.66	4.06e-11	Diabetic retinopathy;
SKCM	cis	rs9300255	0.537	rs1619561	chr12:123620268	G/C	cg00376283	chr12:123451042	ABCB9	0.82	5.61	0.54	3e-7	Neutrophil percentage of white cells;
SKCM	cis	rs1048238	0.506	rs10927866	chr1:16175317	C/T	cg21385522	chr1:16154831	NA	0.65	5.56	0.53	3.61e-7	Systolic blood pressure;
SKCM	cis	rs11155671	0.530	rs9397398	chr6:150193603	G/A	cg05036130	chr6:150231994	NA	0.54	5.73	0.54	1.82e-7	Testicular germ cell tumor;
SKCM	cis	rs7809950	1.000	rs3801954	chr7:107117048	C/T	cg23024343	chr7:107201750	COG5	-0.74	-6.62	-0.6	4.19e-9	Coronary artery disease;
SKCM	cis	rs1405130	0.869	rs13020275	chr2:235566099	C/T	cg21542780	chr2:234763377	HJURP	-0.64	-4.89	-0.48	5.21e-6	Coronary artery disease;
SKCM	trans	rs208520	0.690	rs207112	chr6:66792092	C/T	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-1.02	-7.49	-0.65	9.2e-11	Exhaled nitric oxide output;
SKCM	cis	rs5753618	0.583	rs5753615	chr22:31828027	T/C	cg02404636	chr22:31891804	SFI1	0.6	5.15	0.5	1.91e-6	Colorectal cancer;
SKCM	cis	rs2013441	1.000	rs2165897	chr17:20209721	T/C	cg13482628	chr17:19912719	NA	-0.67	-5.24	-0.51	1.32e-6	Obesity-related traits;
SKCM	cis	rs28595532	0.920	rs115860303	chr4:119734526	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.52	0.53	4.28e-7	Cannabis dependence symptom count;
SKCM	cis	rs6430585	0.527	rs1446586	chr2:136407445	C/T	cg07169764	chr2:136633963	MCM6	-1.0	-7.65	-0.65	4.43e-11	Corneal structure;
SKCM	cis	rs1862618	0.802	rs7733041	chr5:56107377	A/C	cg12311346	chr5:56204834	C5orf35	-0.79	-5.38	-0.52	7.56e-7	Initial pursuit acceleration;
SKCM	cis	rs754466	0.606	rs7084705	chr10:79596675	A/G	cg17075019	chr10:79541650	NA	-0.8	-7.39	-0.64	1.4e-10	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs801193	0.660	rs1016265	chr7:66214567	C/T	cg18876405	chr7:65276391	NA	0.66	6.5	0.59	7.03e-9	Aortic root size;
SKCM	cis	rs10089	0.953	rs10223203	chr5:127527646	A/T	cg25462716	chr5:127418816	SLC12A2;FLJ33630	-0.82	-7.02	-0.62	7.18e-10	Ileal carcinoids;
SKCM	cis	rs7103648	0.669	rs11039332	chr11:47695840	G/A	cg20307385	chr11:47447363	PSMC3	0.91	7.0	0.62	7.82e-10	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs2857078	0.720	rs9901595	chr17:42305699	G/A	cg10896456	chr17:42255109	ASB16;C17orf65	0.54	4.88	0.48	5.61e-6	Red cell distribution width;Reticulocyte count;
SKCM	cis	rs7666738	0.830	rs11938686	chr4:98964470	A/G	cg05340658	chr4:99064831	C4orf37	0.64	4.91	0.49	4.97e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6424115	0.867	rs34902309	chr1:24192200	A/G	cg15997130	chr1:24165203	NA	-0.63	-5.37	-0.52	7.91e-7	Immature fraction of reticulocytes;
SKCM	trans	rs1814175	0.791	rs10219223	chr11:49791468	A/T	cg15704280	chr7:45808275	SEPT13	-1.03	-10.73	-0.77	5.17e-17	Height;
SKCM	cis	rs11098499	0.863	rs3736115	chr4:120488703	A/G	cg24375607	chr4:120327624	NA	-0.69	-5.32	-0.52	9.64e-7	Corneal astigmatism;
SKCM	cis	rs2032447	0.517	rs7767546	chr6:25904067	T/C	cg12310025	chr6:25882481	NA	-0.69	-6.23	-0.58	2.23e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs2180341	0.597	rs11154397	chr6:127646649	G/C	cg24812749	chr6:127587940	RNF146	0.64	5.31	0.51	1.02e-6	Breast cancer;
SKCM	cis	rs9633740	1.000	rs10748526	chr10:82273079	T/C	cg01528321	chr10:82214614	TSPAN14	0.76	5.4	0.52	6.94e-7	Post bronchodilator FEV1;
SKCM	cis	rs9902453	0.780	rs62068621	chr17:28170382	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.8	5.41	0.52	6.72e-7	Coffee consumption (cups per day);
SKCM	cis	rs6866344	0.697	rs56159071	chr5:178127246	T/A	cg10224037	chr5:178157518	ZNF354A	0.75	4.92	0.49	4.75e-6	Neutrophil percentage of white cells;
SKCM	cis	rs7954584	0.616	rs10743185	chr12:122356435	G/A	cg13699009	chr12:122356056	WDR66	0.49	5.55	0.53	3.72e-7	Mean corpuscular volume;
SKCM	cis	rs854765	0.647	rs7406744	chr17:17981938	C/G	cg04398451	chr17:18023971	MYO15A	-1.02	-8.79	-0.71	2.79e-13	Total body bone mineral density;
SKCM	cis	rs6545883	1.000	rs778763	chr2:61785639	C/G	cg15711740	chr2:61764176	XPO1	-0.74	-5.26	-0.51	1.23e-6	Tuberculosis;
SKCM	cis	rs2839186	0.868	rs2839199	chr21:47708269	T/C	cg11766577	chr21:47581405	C21orf56	-0.71	-6.01	-0.56	5.6e-8	Testicular germ cell tumor;
SKCM	cis	rs7954584	0.626	rs12809676	chr12:122442381	C/A	cg21171335	chr12:122356390	WDR66	0.45	4.84	0.48	6.47e-6	Mean corpuscular volume;
SKCM	cis	rs7666738	0.791	rs13128640	chr4:99003918	A/C	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs763014	0.898	rs4984897	chr16:632180	G/C	cg07343612	chr16:622815	PIGQ	-0.7	-6.0	-0.56	5.84e-8	Height;
SKCM	cis	rs6952808	1.000	rs6957894	chr7:1887362	G/A	cg04267008	chr7:1944627	MAD1L1	-0.8	-6.1	-0.57	3.78e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs1552244	0.882	rs13066757	chr3:10045030	C/A	cg02579736	chr3:10068473	FANCD2;CIDECP	0.98	4.84	0.48	6.48e-6	Alzheimer's disease;
SKCM	cis	rs17345786	0.953	rs78645744	chr3:101327789	T/A	cg12386194	chr3:101231763	SENP7	0.8	6.19	0.57	2.62e-8	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs17826219	0.706	rs57698184	chr17:29064918	T/C	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Body mass index;
SKCM	cis	rs13118159	0.899	rs3796613	chr4:1353321	A/T	cg02018176	chr4:1364513	KIAA1530	0.67	5.54	0.53	4.01e-7	Longevity;
SKCM	cis	rs12142240	0.660	rs7520497	chr1:46824919	C/A	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs13256369	1.000	rs883648	chr8:8569521	A/G	cg06636001	chr8:8085503	FLJ10661	0.77	5.93	0.56	7.8e-8	Obesity-related traits;
SKCM	cis	rs9303401	0.659	rs62081315	chr17:56781468	T/C	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.16	0.57	2.91e-8	Cognitive test performance;
SKCM	cis	rs4319547	0.656	rs2173582	chr12:122824694	A/G	cg23029597	chr12:123009494	RSRC2	-0.73	-5.22	-0.51	1.41e-6	Body mass index;
SKCM	cis	rs1577917	1.000	rs955197	chr6:86729675	G/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.63	-5.38	-0.52	7.46e-7	Response to antipsychotic treatment;
SKCM	cis	rs28595532	0.920	rs115994240	chr4:119744622	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs11718455	0.582	rs6763436	chr3:43913653	A/G	cg21419209	chr3:44054225	NA	0.66	5.42	0.52	6.5e-7	Coronary artery disease;
SKCM	cis	rs9910055	0.529	rs228749	chr17:42174570	A/G	cg08499158	chr17:42289980	UBTF	0.72	5.61	0.54	2.95e-7	Total body bone mineral density;
SKCM	cis	rs2832191	0.740	rs2832168	chr21:30463695	G/A	cg08807101	chr21:30365312	RNF160	0.74	6.09	0.57	4.06e-8	Dental caries;
SKCM	cis	rs394563	0.559	rs7752555	chr6:149671116	A/G	cg03678062	chr6:149772716	ZC3H12D	0.51	6.1	0.57	3.87e-8	Dupuytren's disease;
SKCM	cis	rs6951245	0.938	rs113642700	chr7:1105654	C/T	cg18402987	chr7:1209562	NA	1.15	6.09	0.57	3.95e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs17685	0.535	rs41296542	chr7:75600008	A/G	cg16684958	chr7:75615977	POR	0.62	5.17	0.51	1.75e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1949733	0.848	rs2255501	chr4:8475014	G/A	cg11789530	chr4:8429930	ACOX3	-0.72	-5.23	-0.51	1.36e-6	Response to antineoplastic agents;
SKCM	cis	rs28595532	0.920	rs115994609	chr4:119777273	G/A	cg21605333	chr4:119757512	SEC24D	1.41	8.39	0.69	1.68e-12	Cannabis dependence symptom count;
SKCM	cis	rs798554	0.759	rs2644291	chr7:2890456	T/C	cg04166393	chr7:2884313	GNA12	0.73	4.93	0.49	4.54e-6	Height;
SKCM	cis	rs4888262	0.526	rs4887777	chr16:74637821	A/G	cg01733217	chr16:74700730	RFWD3	0.87	7.04	0.62	6.72e-10	Testicular germ cell tumor;
SKCM	cis	rs56235845	0.964	rs11741640	chr5:176792743	G/A	cg06060754	chr5:176797920	RGS14	0.83	7.34	0.64	1.79e-10	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs9875589	0.509	rs6770928	chr3:14077189	G/C	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.52	5.24	0.51	1.34e-6	Ovarian reserve;
SKCM	cis	rs11764590	0.666	rs7787359	chr7:2090849	A/G	cg02825527	chr7:2087843	MAD1L1	-0.62	-4.97	-0.49	3.84e-6	Neuroticism;
SKCM	cis	rs1160297	0.609	rs6545310	chr2:53103542	T/C	cg07782112	chr2:53107842	NA	0.58	6.08	0.57	4.18e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs12458462	0.892	rs2242175	chr18:77464406	G/A	cg11879182	chr18:77439856	CTDP1	0.9	7.74	0.66	3.06e-11	Monocyte count;
SKCM	cis	rs8060686	0.641	rs9923710	chr16:68224018	C/T	cg09117114	chr16:67998030	SLC12A4	-0.78	-5.08	-0.5	2.56e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs1692580	0.840	rs262679	chr1:2169792	C/T	cg24578937	chr1:2090814	PRKCZ	0.48	5.27	0.51	1.16e-6	Coronary artery disease;
SKCM	cis	rs4332037	0.754	rs62436669	chr7:1926636	G/A	cg23422044	chr7:1970798	MAD1L1	-0.95	-6.71	-0.6	2.82e-9	Bipolar disorder;
SKCM	cis	rs12438659	1	rs12438659	chr15:78824924	G/A	cg06917634	chr15:78832804	PSMA4	-0.83	-5.02	-0.49	3.13e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs1707322	0.896	rs785518	chr1:46568422	A/T	cg03146154	chr1:46216737	IPP	-0.81	-5.43	-0.52	6.11e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs10504229	0.683	rs11786043	chr8:58133174	T/C	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs8067545	0.532	rs17759041	chr17:19959966	A/G	cg13482628	chr17:19912719	NA	0.67	4.8	0.48	7.46e-6	Schizophrenia;
SKCM	cis	rs72634258	0.786	rs7523335	chr1:8180210	G/A	cg00042356	chr1:8021962	PARK7	0.77	5.09	0.5	2.4e-6	Inflammatory bowel disease;
SKCM	cis	rs13161895	0.591	rs12655422	chr5:179480825	C/A	cg02702477	chr5:179499311	RNF130	0.98	5.06	0.5	2.76e-6	LDL cholesterol;
SKCM	cis	rs6840360	0.615	rs6535816	chr4:152614264	T/C	cg22705602	chr4:152727874	NA	-0.61	-8.1	-0.68	6.04e-12	Intelligence (multi-trait analysis);
SKCM	trans	rs2727020	0.514	rs4980444	chr11:49550764	T/A	cg15704280	chr7:45808275	SEPT13	-0.96	-8.57	-0.7	7.28e-13	Coronary artery disease;
SKCM	cis	rs6977660	1.000	rs10240227	chr7:19823188	T/C	cg05791153	chr7:19748676	TWISTNB	0.79	5.34	0.52	9.05e-7	Thyroid stimulating hormone;
SKCM	cis	rs9815354	0.812	rs73083333	chr3:41927505	G/A	cg03022575	chr3:42003672	ULK4	1.0	5.07	0.5	2.66e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs7769051	1.000	rs7769051	chr6:133146796	G/T	cg22852734	chr6:133119734	C6orf192	1.2	5.31	0.52	9.93e-7	Type 2 diabetes nephropathy;
SKCM	cis	rs7953249	0.656	rs2243616	chr12:121406370	G/T	cg02403541	chr12:121454288	C12orf43	-0.65	-4.95	-0.49	4.11e-6	Invasive epithelial ovarian cancer;High-grade serous ovarian cancer;Chronic obstructive pulmonary disease-related biomarkers;N-glycan levels;Serous invasive ovarian cancer;Epithelial ovarian cancer;
SKCM	cis	rs2180341	0.640	rs11154395	chr6:127629138	T/C	cg27446573	chr6:127587934	RNF146	0.72	5.67	0.54	2.29e-7	Breast cancer;
SKCM	cis	rs208520	0.526	rs7775830	chr6:66755249	A/G	cg07460842	chr6:66804631	NA	1.02	11.11	0.78	9.58e-18	Exhaled nitric oxide output;
SKCM	cis	rs1865760	1.000	rs2071298	chr6:25914901	G/A	cg08401836	chr6:26032486	HIST1H3B	-0.6	-4.78	-0.48	8.09e-6	Height;
SKCM	cis	rs763014	0.833	rs916415	chr16:632115	G/A	cg07343612	chr16:622815	PIGQ	-0.7	-6.0	-0.56	5.84e-8	Height;
SKCM	cis	rs478304	0.651	rs11537193	chr11:65500003	A/C	cg17480646	chr11:65405466	SIPA1	-0.71	-5.64	-0.54	2.62e-7	Acne (severe);
SKCM	cis	rs2952156	0.920	rs1565920	chr17:37831613	G/A	cg00129232	chr17:37814104	STARD3	-0.65	-5.29	-0.51	1.09e-6	Asthma;
SKCM	cis	rs1799949	1.000	rs9646412	chr17:41425893	A/T	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.23	-0.58	2.22e-8	Menopause (age at onset);
SKCM	cis	rs7523273	0.606	rs2761430	chr1:207912408	G/A	cg22525895	chr1:207977042	MIR29B2	0.77	6.46	0.59	8.11e-9	Schizophrenia;
SKCM	cis	rs8067545	0.750	rs4925080	chr17:19991838	T/A	cg13482628	chr17:19912719	NA	0.74	6.47	0.59	7.76e-9	Schizophrenia;
SKCM	cis	rs12142240	0.698	rs72677594	chr1:46824371	A/C	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs992157	0.764	rs1870123	chr2:219187698	G/A	cg00012203	chr2:219082015	ARPC2	0.75	5.54	0.53	3.92e-7	Colorectal cancer;
SKCM	cis	rs12048904	0.619	rs10783153	chr1:101328230	T/C	cg16556008	chr1:101360663	SLC30A7;EXTL2	0.95	7.84	0.66	1.93e-11	Multiple sclerosis;
SKCM	cis	rs208520	1.000	rs12190187	chr6:66973207	T/G	cg07460842	chr6:66804631	NA	0.86	6.07	0.57	4.28e-8	Exhaled nitric oxide output;
SKCM	cis	rs6088590	0.561	rs11167239	chr20:33140472	G/A	cg24642439	chr20:33292090	TP53INP2	0.76	5.84	0.55	1.15e-7	Coronary artery disease;
SKCM	cis	rs651907	0.557	rs17347644	chr3:101547733	C/T	cg12386194	chr3:101231763	SENP7	0.68	5.69	0.54	2.11e-7	Colorectal cancer;
SKCM	cis	rs2033711	0.870	rs7408188	chr19:58939389	T/G	cg12042659	chr19:58951599	ZNF132	0.68	5.87	0.55	1e-7	Uric acid clearance;
SKCM	cis	rs8014204	1.000	rs8014204	chr14:75322794	A/G	cg06637938	chr14:75390232	RPS6KL1	0.8	6.21	0.58	2.39e-8	Caffeine consumption;
SKCM	cis	rs7809950	0.817	rs11535285	chr7:107143866	A/G	cg23024343	chr7:107201750	COG5	-0.84	-7.75	-0.66	2.85e-11	Coronary artery disease;
SKCM	cis	rs1552244	0.572	rs2054478	chr3:10172211	C/T	cg00149659	chr3:10157352	C3orf10	1.23	5.46	0.53	5.43e-7	Alzheimer's disease;
SKCM	cis	rs28386778	0.897	rs2854213	chr17:61945631	T/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.12	11.2	0.79	6.65e-18	Prudent dietary pattern;
SKCM	cis	rs7829975	0.536	rs2980439	chr8:8094870	G/A	cg15556689	chr8:8085844	FLJ10661	0.94	8.47	0.69	1.16e-12	Mood instability;
SKCM	cis	rs28595532	0.841	rs115233595	chr4:119744214	T/C	cg21605333	chr4:119757512	SEC24D	1.39	8.4	0.69	1.59e-12	Cannabis dependence symptom count;
SKCM	cis	rs7793919	0.652	rs10228886	chr7:4783224	C/T	cg09789173	chr7:4769017	FOXK1	-0.86	-7.02	-0.62	7.13e-10	Mosquito bite size;
SKCM	cis	rs6089584	0.586	rs4925216	chr20:60599923	G/A	cg06108461	chr20:60628389	TAF4	-0.72	-6.3	-0.58	1.64e-8	Body mass index;
SKCM	cis	rs17826219	0.500	rs28452421	chr17:29083980	G/A	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Body mass index;
SKCM	cis	rs28374715	0.532	rs28477406	chr15:41642036	C/G	cg18705301	chr15:41695430	NDUFAF1	-1.21	-12.61	-0.82	1.61e-20	Ulcerative colitis;
SKCM	cis	rs1005277	0.602	rs1780141	chr10:38504299	T/C	cg00409905	chr10:38381863	ZNF37A	-0.62	-5.82	-0.55	1.24e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs10870270	0.956	rs6557	chr10:133781449	C/T	cg17892150	chr10:133769511	PPP2R2D	-0.66	-4.86	-0.48	5.92e-6	Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals;
SKCM	cis	rs7659604	0.539	rs3217773	chr4:122739121	A/G	cg19748678	chr4:122722346	EXOSC9	0.65	5.4	0.52	7.02e-7	Type 2 diabetes;
SKCM	cis	rs10256972	0.758	rs7789093	chr7:1002981	T/C	cg07930192	chr7:1003750	NA	0.54	5.41	0.52	6.73e-7	Longevity;Endometriosis;
SKCM	cis	rs6977660	0.507	rs4721822	chr7:19771693	T/C	cg05791153	chr7:19748676	TWISTNB	0.93	4.92	0.49	4.79e-6	Thyroid stimulating hormone;
SKCM	cis	rs16949788	1.000	rs7183477	chr15:66748212	T/A	cg08120210	chr15:66682733	MAP2K1	-0.74	-5.69	-0.54	2.1e-7	Spherical equivalent (joint analysis main effects and education interaction);
SKCM	cis	rs34779708	0.931	rs2384289	chr10:35343525	G/A	cg03585969	chr10:35415529	CREM	0.74	6.12	0.57	3.47e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs8180040	0.966	rs6790763	chr3:47572585	C/A	cg27129171	chr3:47204927	SETD2	0.82	5.92	0.56	8.29e-8	Colorectal cancer;
SKCM	cis	rs2836974	0.899	rs2836957	chr21:40623134	T/C	cg11644478	chr21:40555479	PSMG1	0.97	10.08	0.75	8.76e-16	Cognitive function;
SKCM	cis	rs61332075	0.504	rs7596847	chr2:239321118	T/A	cg18131467	chr2:239335373	ASB1	-0.96	-5.06	-0.5	2.74e-6	Lung function (FEV1/FVC);
SKCM	cis	rs875971	0.522	rs781144	chr7:65440344	C/G	cg11764359	chr7:65958608	NA	0.87	6.65	0.6	3.58e-9	Aortic root size;
SKCM	cis	rs11098499	0.604	rs10022185	chr4:120571765	C/G	cg24375607	chr4:120327624	NA	0.63	4.83	0.48	6.74e-6	Corneal astigmatism;
SKCM	cis	rs1046896	1.000	rs28485881	chr17:80690014	G/A	cg02711726	chr17:80685570	FN3KRP	-0.69	-5.93	-0.56	7.8e-8	Glycated hemoglobin levels;
SKCM	cis	rs6724607	1.000	rs6434402	chr2:191469322	C/T	cg21644426	chr2:191273491	MFSD6	-0.69	-4.94	-0.49	4.42e-6	Pulse pressure;
SKCM	cis	rs933688	1.000	rs2367526	chr5:90740525	A/G	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.07	8.52	0.69	9.25e-13	Smoking behavior;
SKCM	cis	rs1799949	1.000	rs2175957	chr17:41286822	T/G	cg05368731	chr17:41323189	NBR1	0.89	7.91	0.67	1.38e-11	Menopause (age at onset);
SKCM	cis	rs2204008	0.591	rs11495396	chr12:38380182	C/T	cg26384229	chr12:38710491	ALG10B	0.81	6.6	0.6	4.58e-9	Bladder cancer;
SKCM	cis	rs7769051	0.614	rs6912936	chr6:133102664	A/G	cg22852734	chr6:133119734	C6orf192	0.99	4.99	0.49	3.53e-6	Type 2 diabetes nephropathy;
SKCM	cis	rs6952808	0.929	rs11768206	chr7:1932151	T/G	cg05863683	chr7:1912471	MAD1L1	0.65	5.76	0.55	1.58e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs9951698	0.703	rs7243660	chr18:13002196	C/T	cg12848697	chr18:13133368	NA	0.53	4.9	0.48	5.18e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs3825199	0.515	rs2072593	chr12:93970026	T/C	cg18151635	chr12:93972918	NA	-0.65	-5.83	-0.55	1.2e-7	Height;
SKCM	trans	rs1814175	0.727	rs2140597	chr11:49873946	G/A	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs4911259	0.552	rs2014837	chr20:31461082	C/T	cg13636640	chr20:31349939	DNMT3B	0.74	6.15	0.57	3.04e-8	Inflammatory bowel disease;
SKCM	cis	rs4423214	0.840	rs1629220	chr11:71174553	C/T	cg05163923	chr11:71159392	DHCR7	-0.74	-6.65	-0.6	3.61e-9	Vitamin D levels;
SKCM	cis	rs5769765	0.954	rs5769762	chr22:50264042	G/A	cg22709217	chr22:50311962	ALG12;CRELD2	0.79	5.71	0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs9300255	0.544	rs1790100	chr12:123656725	G/T	cg00376283	chr12:123451042	ABCB9	0.83	5.49	0.53	4.74e-7	Neutrophil percentage of white cells;
SKCM	cis	rs2404602	1.000	rs6495206	chr15:76870963	C/T	cg23625390	chr15:77176239	SCAPER	0.76	7.48	0.65	9.68e-11	Blood metabolite levels;
SKCM	cis	rs28386778	0.897	rs1062787	chr17:61896004	T/C	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs4969178	0.931	rs6501208	chr17:76395038	A/T	cg20026190	chr17:76395443	PGS1	0.61	5.29	0.51	1.08e-6	HDL cholesterol levels;
SKCM	cis	rs10754283	0.967	rs10801757	chr1:90103080	A/G	cg21401794	chr1:90099060	LRRC8C	0.78	7.19	0.63	3.41e-10	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs9911578	1.000	rs2009948	chr17:56611920	A/C	cg05425664	chr17:57184151	TRIM37	0.69	5.2	0.51	1.56e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1018836	0.770	rs12543806	chr8:91664011	C/T	cg16814680	chr8:91681699	NA	-0.87	-7.38	-0.64	1.45e-10	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs12142240	0.698	rs67142569	chr1:46828460	C/T	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs9435341	0.929	rs3108681	chr1:107556493	C/A	cg09367891	chr1:107599246	PRMT6	-0.8	-6.08	-0.57	4.12e-8	Facial morphology (factor 21, depth of nasal alae);
SKCM	cis	rs11098499	0.708	rs10005237	chr4:120237897	T/C	cg09307838	chr4:120376055	NA	0.93	7.56	0.65	6.5500000000000006e-11	Corneal astigmatism;
SKCM	cis	rs1348850	0.874	rs2166558	chr2:178373652	G/T	cg02961200	chr2:178257176	LOC100130691;AGPS	0.85	6.27	0.58	1.85e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs4727027	0.866	rs1358062	chr7:148783743	T/C	cg23583168	chr7:148888333	NA	-0.8	-6.3	-0.58	1.66e-8	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	trans	rs1814175	0.935	rs6485999	chr11:49658986	G/C	cg03929089	chr4:120376271	NA	-0.87	-7.53	-0.65	7.64e-11	Height;
SKCM	cis	rs782590	0.818	rs2627782	chr2:55825352	A/G	cg18811423	chr2:55921094	PNPT1	0.94	6.83	0.61	1.63e-9	Metabolic syndrome;
SKCM	cis	rs6952808	0.771	rs10265944	chr7:1918337	C/T	cg04267008	chr7:1944627	MAD1L1	-0.63	-5.02	-0.49	3.13e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs4888262	0.526	rs4887776	chr16:74635632	A/G	cg01733217	chr16:74700730	RFWD3	0.87	6.84	0.61	1.62e-9	Testicular germ cell tumor;
SKCM	cis	rs7447593	0.666	rs10866705	chr5:176801131	G/T	cg16006841	chr5:176797999	RGS14	-0.68	-7.42	-0.64	1.21e-10	Urinary electrolytes (magnesium/calcium ratio);
SKCM	cis	rs4790333	0.677	rs2447099	chr17:2268139	G/C	cg02569219	chr17:2266849	SGSM2	0.7	5.98	0.56	6.45e-8	Proinsulin levels;
SKCM	trans	rs1814175	0.645	rs28627251	chr11:50048125	G/T	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs1799949	1.000	rs3950989	chr17:41237953	G/A	cg25918947	chr17:41365094	TMEM106A	-0.62	-5.88	-0.55	9.82e-8	Menopause (age at onset);
SKCM	cis	rs7772486	0.790	rs2253764	chr6:146199881	T/A	cg23711669	chr6:146136114	FBXO30	0.85	9.32	0.73	2.57e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs769267	0.896	rs2074298	chr19:19377716	C/G	cg26732615	chr19:19648335	CILP2;YJEFN3	0.62	5.67	0.54	2.31e-7	Tonsillectomy;
SKCM	cis	rs4234284	0.965	rs11915186	chr3:126959331	A/G	cg04889221	chr3:126137216	CCDC37	-0.46	-4.88	-0.48	5.52e-6	Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel);
SKCM	cis	rs72781680	0.898	rs6712524	chr2:24083925	T/C	cg08917208	chr2:24149416	ATAD2B	0.99	5.24	0.51	1.31e-6	Lymphocyte counts;
SKCM	cis	rs7666738	0.830	rs62321565	chr4:98976571	G/A	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2197308	0.703	rs10880251	chr12:37903297	G/A	cg13010199	chr12:38710504	ALG10B	0.65	4.93	0.49	4.48e-6	Morning vs. evening chronotype;
SKCM	cis	rs780096	0.526	rs12476704	chr2:27613031	C/A	cg05696406	chr2:27599888	SNX17	0.49	4.91	0.49	4.9e-6	Total body bone mineral density;
SKCM	cis	rs8067545	0.532	rs35915823	chr17:19973397	A/G	cg13482628	chr17:19912719	NA	0.67	4.8	0.48	7.46e-6	Schizophrenia;
SKCM	cis	rs6088580	0.634	rs4142007	chr20:32990050	G/T	cg24642439	chr20:33292090	TP53INP2	-0.76	-6.02	-0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs10870270	1.000	rs6560694	chr10:133773448	G/A	cg17892150	chr10:133769511	PPP2R2D	-0.66	-4.86	-0.48	5.92e-6	Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals;
SKCM	cis	rs28386778	0.897	rs7501614	chr17:61802612	T/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.13	11.24	0.79	5.56e-18	Prudent dietary pattern;
SKCM	cis	rs35995292	0.500	rs1019065	chr7:38939775	C/T	cg19327137	chr7:38886074	VPS41	0.53	5.05	0.5	2.89e-6	Subjective well-being (multi-trait analysis);
SKCM	cis	rs9910055	0.552	rs4793084	chr17:42317371	G/T	cg08499158	chr17:42289980	UBTF	0.87	7.1	0.63	5.1e-10	Total body bone mineral density;
SKCM	cis	rs9911578	0.967	rs405684	chr17:56777148	T/C	cg12560992	chr17:57184187	TRIM37	0.95	7.69	0.66	3.7e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs9640161	0.673	rs34489187	chr7:150044379	G/A	cg10018233	chr7:150070692	REPIN1	0.71	5.74	0.55	1.7e-7	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs1639906	0.895	rs6972752	chr7:2196551	G/A	cg02951883	chr7:2050386	MAD1L1	0.65	5.23	0.51	1.4e-6	Colonoscopy-negative controls vs population controls;
SKCM	trans	rs1814175	0.529	rs1988417	chr11:49932430	A/G	cg15704280	chr7:45808275	SEPT13	-0.88	-7.52	-0.65	8.06e-11	Height;
SKCM	cis	rs8017423	0.967	rs4900030	chr14:90689813	T/A	cg04374321	chr14:90722782	PSMC1	0.97	8.67	0.7	4.78e-13	Mortality in heart failure;
SKCM	cis	rs2032447	0.772	rs199754	chr6:25992309	A/G	cg18357526	chr6:26021779	HIST1H4A	0.75	5.72	0.54	1.9e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs910316	0.737	rs175065	chr14:75494983	T/C	cg08847533	chr14:75593920	NEK9	-0.8	-6.59	-0.6	4.76e-9	Height;
SKCM	cis	rs1801251	1.000	rs13008942	chr2:233594875	G/A	cg25237894	chr2:233734115	C2orf82	0.58	5.23	0.51	1.36e-6	Coronary artery disease;
SKCM	cis	rs7811142	0.720	rs112622797	chr7:99917416	G/A	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.21	8.05	0.67	7.68e-12	Platelet count;
SKCM	cis	rs11098499	0.954	rs28685688	chr4:120420334	T/C	cg24375607	chr4:120327624	NA	0.66	5.13	0.5	2.07e-6	Corneal astigmatism;
SKCM	cis	rs9325144	0.647	rs12822023	chr12:39097964	T/C	cg26384229	chr12:38710491	ALG10B	-0.72	-6.39	-0.59	1.12e-8	Morning vs. evening chronotype;
SKCM	cis	rs9486715	0.867	rs3849199	chr6:97049191	T/C	cg06623918	chr6:96969491	KIAA0776	-0.86	-7.66	-0.66	4.3e-11	Headache;
SKCM	cis	rs6952808	0.792	rs2056480	chr7:1954301	A/G	cg05863683	chr7:1912471	MAD1L1	-0.55	-4.99	-0.49	3.55e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs798766	1.000	rs3099555	chr4:1725651	T/C	cg24239225	chr4:1659016	FAM53A	-0.69	-4.87	-0.48	5.8e-6	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs35146811	0.771	rs1060544	chr7:99613476	C/T	cg22906224	chr7:99728672	NA	0.79	5.8	0.55	1.36e-7	Coronary artery disease;
SKCM	cis	rs6424115	0.830	rs6663474	chr1:24199642	G/A	cg15997130	chr1:24165203	NA	0.6	4.94	0.49	4.37e-6	Immature fraction of reticulocytes;
SKCM	cis	rs752010	0.630	rs12134174	chr1:42105942	C/T	cg06885757	chr1:42089581	HIVEP3	0.46	4.99	0.49	3.55e-6	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs870825	0.616	rs28445002	chr4:185648977	C/T	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs13010713	0.806	rs4439920	chr2:182059382	A/G	cg21995919	chr2:182322279	ITGA4	-0.53	-5.12	-0.5	2.18e-6	Celiac disease;
SKCM	cis	rs854765	0.552	rs6502624	chr17:17847936	G/A	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.0	7.64	0.65	4.64e-11	Total body bone mineral density;
SKCM	cis	rs6912958	0.500	rs4707352	chr6:87929705	G/A	cg08069147	chr6:88032118	GJB7;C6orf162	-0.64	-5.33	-0.52	9.1e-7	Monocyte percentage of white cells;
SKCM	cis	rs7666738	0.830	rs28769113	chr4:98950371	T/G	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs873946	0.529	rs12258248	chr10:134573767	A/G	cg27286337	chr10:134555280	INPP5A	1.01	9.67	0.74	5.42e-15	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	trans	rs1814175	0.588	rs34449937	chr11:49756013	G/A	cg03929089	chr4:120376271	NA	-0.89	-8.07	-0.67	7.01e-12	Height;
SKCM	cis	rs6500395	1.000	rs2354578	chr16:48593298	T/C	cg04672837	chr16:48644449	N4BP1	0.69	5.73	0.54	1.8e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs2439831	0.702	rs2467402	chr15:44024490	A/C	cg02155558	chr15:43621948	ADAL;LCMT2	-1.22	-7.17	-0.63	3.75e-10	Lung cancer in ever smokers;
SKCM	cis	rs3087591	0.801	rs2012535	chr17:29561391	A/T	cg24425628	chr17:29625626	OMG;NF1	-0.64	-5.22	-0.51	1.43e-6	Hip circumference;
SKCM	cis	rs9911578	0.967	rs302843	chr17:56727986	C/T	cg12560992	chr17:57184187	TRIM37	0.95	7.69	0.66	3.7e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs748404	0.697	rs530683	chr15:43568999	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	-0.7	-5.68	-0.54	2.19e-7	Lung cancer;
SKCM	cis	rs6545883	0.931	rs9807965	chr2:61732159	T/C	cg15711740	chr2:61764176	XPO1	-0.73	-5.27	-0.51	1.19e-6	Tuberculosis;
SKCM	cis	rs2197308	0.765	rs2387436	chr12:37935337	C/T	cg13010199	chr12:38710504	ALG10B	-0.64	-5.16	-0.5	1.81e-6	Morning vs. evening chronotype;
SKCM	cis	rs7927771	0.542	rs3886262	chr11:47817010	T/G	cg20307385	chr11:47447363	PSMC3	0.71	5.63	0.54	2.67e-7	Subjective well-being;
SKCM	cis	rs7208859	0.673	rs11653955	chr17:29033292	C/A	cg14067834	chr17:29058358	SUZ12P	1.18	5.86	0.55	1.07e-7	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs7927771	0.524	rs11039392	chr11:47798753	A/G	cg20307385	chr11:47447363	PSMC3	0.72	5.81	0.55	1.31e-7	Subjective well-being;
SKCM	cis	rs12497850	0.931	rs13315711	chr3:48986399	A/T	cg06212747	chr3:49208901	KLHDC8B	0.68	4.9	0.49	5.06e-6	Parkinson's disease;
SKCM	cis	rs6952808	0.531	rs1107351	chr7:2177093	G/A	cg02951883	chr7:2050386	MAD1L1	-0.77	-6.09	-0.57	4.05e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs116095464	0.614	rs62344339	chr5:252995	T/G	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs6582630	0.502	rs11181475	chr12:38348922	G/A	cg26384229	chr12:38710491	ALG10B	0.81	6.56	0.6	5.29e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs1348850	0.526	rs10930802	chr2:178460095	A/G	cg27490568	chr2:178487706	NA	0.89	6.14	0.57	3.17e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs2842992	0.789	rs2277072	chr6:160182845	A/G	cg11366901	chr6:160182831	ACAT2	0.92	7.61	0.65	5.33e-11	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs55962025	0.883	rs363099	chr4:3162056	C/T	cg16987761	chr4:3318072	RGS12	-0.61	-4.83	-0.48	6.62e-6	Parental longevity (mother's age at death);
SKCM	cis	rs2841277	0.836	rs2841268	chr14:105386039	T/C	cg14403583	chr14:105418241	AHNAK2	0.91	6.83	0.61	1.68e-9	Rheumatoid arthritis;
SKCM	cis	rs116095464	0.558	rs6875291	chr5:264192	T/C	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs1799949	1.000	rs35668327	chr17:41273095	G/A	cg23758822	chr17:41437982	NA	0.92	7.68	0.66	3.96e-11	Menopause (age at onset);
SKCM	cis	rs1799949	0.965	rs799910	chr17:41279561	G/C	cg19454999	chr17:41278357	BRCA1;NBR2	0.51	4.8	0.48	7.53e-6	Menopause (age at onset);
SKCM	cis	rs4819052	0.851	rs28442024	chr21:46674475	C/A	cg19498844	chr21:46707878	POFUT2;LOC642852	0.88	7.69	0.66	3.74e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs1801251	0.964	rs13007783	chr2:233566679	G/A	cg25237894	chr2:233734115	C2orf82	0.61	5.59	0.53	3.22e-7	Coronary artery disease;
SKCM	cis	rs10504229	1.000	rs76944716	chr8:58191643	T/C	cg22535103	chr8:58192502	C8orf71	-0.75	-5.24	-0.51	1.31e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs12142240	0.698	rs68083747	chr1:46807416	T/G	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs2303759	0.918	rs9749416	chr19:49885005	G/A	cg05022225	chr19:49866942	DKKL1;TEAD2	0.7	5.04	0.5	2.94e-6	Multiple sclerosis;
SKCM	cis	rs1801251	1.000	rs3816334	chr2:233708806	A/G	cg25237894	chr2:233734115	C2orf82	-0.61	-5.9	-0.56	8.76e-8	Coronary artery disease;
SKCM	cis	rs12497850	0.931	rs9835307	chr3:48857805	T/C	cg06212747	chr3:49208901	KLHDC8B	0.68	4.89	0.48	5.28e-6	Parkinson's disease;
SKCM	cis	rs12971120	0.891	rs11151961	chr18:72177340	C/T	cg25817165	chr18:72167213	CNDP2	-0.65	-4.87	-0.48	5.69e-6	Refractive error;
SKCM	cis	rs908922	0.676	rs4112786	chr1:152532872	T/A	cg09873164	chr1:152488093	CRCT1	0.72	5.62	0.54	2.85e-7	Hair morphology;
SKCM	cis	rs6912958	0.525	rs242262	chr6:88018057	A/C	cg08069147	chr6:88032118	GJB7;C6orf162	0.65	5.86	0.55	1.05e-7	Monocyte percentage of white cells;
SKCM	cis	rs9300255	0.596	rs11057202	chr12:123720775	G/T	cg00376283	chr12:123451042	ABCB9	0.9	7.4	0.64	1.33e-10	Neutrophil percentage of white cells;
SKCM	cis	rs1801251	1.000	rs12987513	chr2:233622066	A/G	cg08000102	chr2:233561755	GIGYF2	0.88	7.07	0.63	5.69e-10	Coronary artery disease;
SKCM	cis	rs995000	0.899	rs6696502	chr1:63039533	C/T	cg06896770	chr1:63153194	DOCK7	-0.72	-6.46	-0.59	8.17e-9	Triglyceride levels;
SKCM	cis	rs28595532	0.920	rs114789346	chr4:119748652	G/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs78456975	0.527	rs11901028	chr2:1557972	A/G	cg01028140	chr2:1542097	TPO	-0.49	-4.88	-0.48	5.52e-6	Placebo response in major depressive disorder (% change in symptom score);
SKCM	cis	rs9910055	1.000	rs9895423	chr17:42285740	T/C	cg19774624	chr17:42201019	HDAC5	-0.89	-7.43	-0.64	1.16e-10	Total body bone mineral density;
SKCM	cis	rs116095464	0.558	rs2288459	chr5:231143	T/C	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs2836950	0.509	rs4816618	chr21:40599529	G/A	cg11890956	chr21:40555474	PSMG1	-0.66	-5.26	-0.51	1.22e-6	Menarche (age at onset);
SKCM	cis	rs9399135	0.967	rs9376075	chr6:135296963	A/G	cg24558204	chr6:135376177	HBS1L	0.55	4.98	0.49	3.73e-6	Red blood cell count;
SKCM	cis	rs9911578	0.935	rs7218105	chr17:57041119	A/G	cg05425664	chr17:57184151	TRIM37	-0.67	-5.04	-0.5	2.91e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs473651	0.935	rs578510	chr2:239343140	C/T	cg21699342	chr2:239360505	ASB1	0.51	4.97	0.49	3.87e-6	Multiple system atrophy;
SKCM	cis	rs6580649	0.783	rs1635526	chr12:48396785	C/T	cg05342945	chr12:48394962	COL2A1	-0.75	-5.04	-0.5	2.94e-6	Lung cancer;
SKCM	cis	rs838147	0.844	rs8111208	chr19:49248022	A/C	cg13540341	chr19:49222985	MAMSTR	0.56	5.06	0.5	2.77e-6	Dietary macronutrient intake;
SKCM	cis	rs4481887	0.893	rs1339990	chr1:248509495	C/T	cg22724847	chr1:248512586	OR14C36	-0.64	-4.77	-0.48	8.43e-6	Common traits (Other);
SKCM	cis	rs28386778	0.897	rs894407	chr17:61901641	T/C	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs611744	0.647	rs1448150	chr8:109276161	T/C	cg18478394	chr8:109455254	TTC35	0.66	5.31	0.52	1.02e-6	Dupuytren's disease;
SKCM	cis	rs17826219	0.568	rs2626985	chr17:29077437	A/G	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Body mass index;
SKCM	cis	rs1799949	1.000	rs1973646	chr17:41310495	T/C	cg23758822	chr17:41437982	NA	0.92	7.83	0.66	1.97e-11	Menopause (age at onset);
SKCM	cis	rs6840360	0.571	rs28608620	chr4:152504791	C/T	cg22705602	chr4:152727874	NA	-0.51	-5.54	-0.53	3.87e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs35766269	0.541	rs4116671	chr10:9040836	T/C	cg05671070	chr10:8095960	FLJ45983;GATA3	0.95	4.77	0.48	8.45e-6	Recalcitrant atopic dermatitis;
SKCM	cis	rs1552244	0.882	rs7633769	chr3:10020622	C/T	cg02579736	chr3:10068473	FANCD2;CIDECP	0.94	4.84	0.48	6.49e-6	Alzheimer's disease;
SKCM	cis	rs1552244	0.882	rs55840655	chr3:10042690	C/T	cg02579736	chr3:10068473	FANCD2;CIDECP	0.94	4.84	0.48	6.49e-6	Alzheimer's disease;
SKCM	cis	rs1577917	0.566	rs2842611	chr6:86302034	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.73	-6.45	-0.59	8.51e-9	Response to antipsychotic treatment;
SKCM	cis	rs875971	0.964	rs6945032	chr7:65922486	C/T	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs867186	0.925	rs6120843	chr20:33718993	C/G	cg04194272	chr20:33683537	NA	-1.0	-5.89	-0.56	9.12e-8	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs1577917	0.958	rs2324840	chr6:86557620	T/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.81	-7.82	-0.66	2.07e-11	Response to antipsychotic treatment;
SKCM	cis	rs28386778	0.830	rs2597637	chr17:61875066	T/G	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs2929278	0.617	rs12908467	chr15:44047430	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	-0.75	-5.32	-0.52	9.47e-7	Schizophrenia;
SKCM	cis	rs9303401	0.615	rs7502342	chr17:56922629	C/A	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.35	0.52	8.54e-7	Cognitive test performance;
SKCM	cis	rs6138458	1.000	rs7269416	chr20:24976196	T/G	cg26195577	chr20:24973756	C20orf3	1.29	8.85	0.71	2.07e-13	Blood protein levels;
SKCM	cis	rs10791097	0.694	rs7107595	chr11:130758556	C/T	cg12179176	chr11:130786555	SNX19	0.93	8.37	0.69	1.82e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs6879260	0.963	rs1035412	chr5:179729328	C/T	cg23221052	chr5:179740743	GFPT2	-0.69	-5.86	-0.55	1.05e-7	Height;
SKCM	cis	rs1799949	1.000	rs2298862	chr17:41176688	T/C	cg25918947	chr17:41365094	TMEM106A	-0.61	-5.78	-0.55	1.49e-7	Menopause (age at onset);
SKCM	cis	rs6500395	0.928	rs2080509	chr16:48690915	T/C	cg04672837	chr16:48644449	N4BP1	-0.65	-5.43	-0.52	6.29e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs5750830	0.594	rs6001568	chr22:39775786	G/A	cg11247378	chr22:39784982	NA	-0.49	-5.77	-0.55	1.5e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs826838	0.967	rs1719856	chr12:39127201	C/T	cg13010199	chr12:38710504	ALG10B	-0.77	-6.19	-0.57	2.59e-8	Heart rate;
SKCM	cis	rs7523050	0.730	rs34182354	chr1:109416340	C/T	cg08274380	chr1:109419600	GPSM2	1.17	6.61	0.6	4.34e-9	Fat distribution (HIV);
SKCM	cis	rs763121	0.889	rs9610971	chr22:38910810	C/T	cg06022373	chr22:39101656	GTPBP1	0.77	5.52	0.53	4.3e-7	Menopause (age at onset);
SKCM	cis	rs7937682	0.593	rs1944118	chr11:111352032	A/G	cg09085632	chr11:111637200	PPP2R1B	-0.66	-5.18	-0.51	1.71e-6	Primary sclerosing cholangitis;
SKCM	cis	rs999943	0.774	rs10947421	chr6:33611278	G/T	cg14003231	chr6:33640908	ITPR3	0.67	6.11	0.57	3.64e-8	Obesity (extreme);
SKCM	cis	rs2228479	0.717	rs2074904	chr16:89811546	A/G	cg00800038	chr16:89945340	TCF25	-0.81	-4.79	-0.48	7.84e-6	Skin colour saturation;
SKCM	cis	rs763121	0.853	rs5750652	chr22:39048316	A/G	cg06022373	chr22:39101656	GTPBP1	0.82	5.62	0.54	2.8e-7	Menopause (age at onset);
SKCM	cis	rs2836974	0.897	rs2836929	chr21:40543811	T/C	cg11890956	chr21:40555474	PSMG1	1.07	13.19	0.83	1.48e-21	Cognitive function;
SKCM	cis	rs16854884	0.586	rs6440212	chr3:143748526	T/C	cg06585982	chr3:143692056	C3orf58	0.87	8.34	0.69	2.04e-12	Economic and political preferences (feminism/equality);
SKCM	cis	rs950776	0.518	rs1504545	chr15:78818471	C/G	cg06917634	chr15:78832804	PSMA4	-1.03	-10.55	-0.77	1.1e-16	Sudden cardiac arrest;
SKCM	cis	rs569214	0.648	rs519238	chr8:27513271	A/G	cg04264299	chr8:27491209	SCARA3	-0.65	-5.15	-0.5	1.92e-6	Alzheimer's disease;
SKCM	cis	rs2180341	1.000	rs6910763	chr6:127630925	T/C	cg27446573	chr6:127587934	RNF146	1.01	8.78	0.7	2.93e-13	Breast cancer;
SKCM	cis	rs2842992	0.714	rs2495278	chr6:160123674	G/A	cg11366901	chr6:160182831	ACAT2	0.86	6.69	0.6	3.06e-9	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs10905065	0.610	rs61832743	chr10:5741462	T/G	cg09234995	chr10:5726438	C10orf18	0.63	5.37	0.52	7.78e-7	Menopause (age at onset);
SKCM	cis	rs9902453	0.904	rs9900974	chr17:28364456	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.82	-6.4	-0.59	1.06e-8	Coffee consumption (cups per day);
SKCM	cis	rs2072499	0.966	rs6427304	chr1:156156789	A/G	cg24450063	chr1:156163899	SLC25A44	1.02	9.81	0.74	2.97e-15	Testicular germ cell tumor;
SKCM	cis	rs116095464	0.614	rs62344339	chr5:252995	T/G	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs11098499	0.954	rs11098524	chr4:120390032	A/G	cg09307838	chr4:120376055	NA	0.95	7.66	0.66	4.22e-11	Corneal astigmatism;
SKCM	cis	rs2153535	0.541	rs945304	chr6:8442892	A/G	cg07606381	chr6:8435919	SLC35B3	0.94	6.94	0.62	1.02e-9	Motion sickness;
SKCM	cis	rs10411262	0.901	rs10425955	chr19:47216015	G/A	cg14189808	chr19:47611440	ZC3H4	0.46	4.8	0.48	7.51e-6	Tonsillectomy;
SKCM	cis	rs35146811	0.735	rs1043915	chr7:99799845	T/A	cg22906224	chr7:99728672	NA	0.65	5.19	0.51	1.6e-6	Coronary artery disease;
SKCM	cis	rs34779708	0.931	rs2148482	chr10:35348910	A/G	cg03585969	chr10:35415529	CREM	0.77	6.33	0.58	1.42e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs72781680	0.948	rs113530757	chr2:24142500	G/A	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	cis	rs4819052	0.851	rs2330012	chr21:46658592	G/A	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.36	0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs2153535	0.542	rs6912740	chr6:8439959	A/G	cg23788917	chr6:8435910	SLC35B3	0.69	5.14	0.5	1.99e-6	Motion sickness;
SKCM	cis	rs7772486	0.536	rs9373467	chr6:145955605	C/T	cg23711669	chr6:146136114	FBXO30	0.83	7.61	0.65	5.34e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs561341	0.941	rs72825736	chr17:30330286	G/A	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs6570726	0.846	rs439035	chr6:145887990	G/C	cg05347473	chr6:146136440	FBXO30	0.53	4.89	0.48	5.28e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6951245	0.872	rs74360401	chr7:1067403	G/A	cg21664854	chr7:1097933	C7orf50;GPR146	0.89	4.79	0.48	7.66e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs1003719	0.788	rs13050757	chr21:38465345	C/T	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs523522	0.962	rs10849753	chr12:120910813	C/T	cg12219531	chr12:120966889	COQ5	0.91	7.6	0.65	5.66e-11	High light scatter reticulocyte count;
SKCM	cis	rs1707322	1.000	rs10890355	chr1:46317348	G/A	cg03146154	chr1:46216737	IPP	0.75	5.15	0.5	1.94e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7772486	0.701	rs11155438	chr6:145950112	C/G	cg05347473	chr6:146136440	FBXO30	0.64	5.91	0.56	8.66e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs3768617	0.510	rs7525917	chr1:183065406	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs807669	0.802	rs762528	chr22:19166680	A/G	cg02655711	chr22:19163373	SLC25A1	0.79	7.62	0.65	5.09e-11	Metabolite levels;
SKCM	cis	rs10883723	0.810	rs2296582	chr10:104244139	G/T	cg11453585	chr10:104263688	ACTR1A;SUFU	0.8	6.22	0.58	2.35e-8	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs7555523	0.779	rs2790049	chr1:165743523	A/G	cg24409356	chr1:165738333	TMCO1	0.94	5.13	0.5	2.09e-6	Intraocular pressure;Glaucoma (high intraocular pressure);
SKCM	cis	rs7811142	1.000	rs6953107	chr7:100095664	C/T	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-1.02	-5.76	-0.55	1.59e-7	Platelet count;
SKCM	cis	rs7811142	1.000	rs74460138	chr7:100027339	C/G	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.17	7.71	0.66	3.44e-11	Platelet count;
SKCM	cis	rs3793683	0.545	rs12784407	chr10:134589631	A/G	cg00988841	chr10:134556463	INPP5A	0.61	4.78	0.48	8.12e-6	Migraine;
SKCM	cis	rs2836950	0.565	rs3171465	chr21:40552307	A/G	cg11890956	chr21:40555474	PSMG1	-0.7	-5.62	-0.54	2.84e-7	Menarche (age at onset);
SKCM	cis	rs12950390	0.893	rs12325760	chr17:45840886	C/T	cg03474202	chr17:45855739	NA	-0.49	-5.6	-0.54	3.04e-7	IgG glycosylation;
SKCM	cis	rs3793683	0.597	rs12767469	chr10:134587261	C/G	cg27286337	chr10:134555280	INPP5A	0.97	8.24	0.68	3.25e-12	Migraine;
SKCM	cis	rs854765	0.520	rs7219324	chr17:17909775	C/T	cg04398451	chr17:18023971	MYO15A	1.01	7.42	0.64	1.25e-10	Total body bone mineral density;
SKCM	cis	rs1620921	0.505	rs4708886	chr6:161206350	G/T	cg01280913	chr6:161186852	NA	0.57	5.27	0.51	1.19e-6	Lipoprotein (a) - cholesterol levels;
SKCM	cis	rs1799949	1.000	rs12944458	chr17:41180772	C/T	cg05368731	chr17:41323189	NBR1	0.86	7.39	0.64	1.39e-10	Menopause (age at onset);
SKCM	cis	rs8177179	0.967	rs4994581	chr3:133437563	T/C	cg16262614	chr3:133464971	TF	0.43	5.28	0.51	1.13e-6	Iron status biomarkers (transferrin levels);
SKCM	trans	rs1814175	0.702	rs7481418	chr11:49759932	C/T	cg03929089	chr4:120376271	NA	-0.9	-7.92	-0.67	1.32e-11	Height;
SKCM	cis	rs4478137	0.931	rs3967762	chr4:164244976	T/C	cg06758707	chr4:164254230	NPY1R	0.94	6.24	0.58	2.08e-8	Subjective well-being (multi-trait analysis);Subjective well-being;
SKCM	cis	rs67460515	0.892	rs13073147	chr3:161045237	T/C	cg03342759	chr3:160939853	NMD3	-0.79	-6.79	-0.61	2e-9	Parkinson's disease;
SKCM	cis	rs7143963	1.000	rs12590238	chr14:103350197	C/G	cg23020514	chr14:103360112	TRAF3	0.91	8.6	0.7	6.42e-13	Body mass index;
SKCM	cis	rs17376456	0.877	rs7701974	chr5:93311417	C/T	cg25358565	chr5:93447407	FAM172A	1.23	7.26	0.63	2.53e-10	Diabetic retinopathy;
SKCM	cis	rs17826219	0.568	rs9898097	chr17:29072672	T/G	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Body mass index;
SKCM	cis	rs72387598	1	rs72387598	chr1:45922977	CAT/C	cg05343316	chr1:45956843	TESK2	0.92	4.94	0.49	4.42e-6	Platelet distribution width;
SKCM	cis	rs875971	0.522	rs10807697	chr7:65416170	A/G	cg11764359	chr7:65958608	NA	0.9	6.95	0.62	1e-9	Aortic root size;
SKCM	cis	rs72781680	0.611	rs72783619	chr2:24311607	G/A	cg20701182	chr2:24300061	SF3B14	0.74	5.03	0.49	3.09e-6	Lymphocyte counts;
SKCM	cis	rs6736997	0.545	rs7574685	chr2:235611521	T/C	cg17841421	chr2:235704848	NA	0.61	5.16	0.5	1.85e-6	Pancreatic cancer;
SKCM	cis	rs362272	0.545	rs2749783	chr4:3326098	A/C	cg11471262	chr4:3318911	RGS12	0.96	11.06	0.78	1.23e-17	Serum sulfate level;
SKCM	cis	rs9303401	0.659	rs34468504	chr17:56648277	C/T	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.13	0.57	3.42e-8	Cognitive test performance;
SKCM	cis	rs4237845	0.837	rs7971877	chr12:58287630	T/G	cg02175503	chr12:58329896	NA	0.77	6.98	0.62	8.52e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs6570726	0.818	rs437147	chr6:145875423	A/T	cg05347473	chr6:146136440	FBXO30	0.57	5.13	0.5	2.06e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs13118159	0.509	rs7681872	chr4:1376735	G/A	cg16405210	chr4:1374714	KIAA1530	-0.83	-6.0	-0.56	5.96e-8	Longevity;
SKCM	cis	rs7618501	0.633	rs2526748	chr3:50080439	A/G	cg05072774	chr3:49840536	C3orf54	0.67	5.06	0.5	2.7e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs17376456	0.877	rs13170509	chr5:93378564	T/C	cg21475434	chr5:93447410	FAM172A	0.95	5.35	0.52	8.56e-7	Diabetic retinopathy;
SKCM	cis	rs28595532	0.920	rs115372254	chr4:119771735	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs1707322	0.752	rs11488313	chr1:46224780	G/C	cg03146154	chr1:46216737	IPP	0.8	5.47	0.53	5.19e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs4925325	0.956	rs1776263	chr20:60515820	A/G	cg06108461	chr20:60628389	TAF4	-0.81	-5.14	-0.5	2.01e-6	Obesity-related traits;
SKCM	cis	rs6450176	1.000	rs7736354	chr5:53297591	C/T	ch.5.1024479R	chr5:53302184	ARL15	-0.73	-5.04	-0.5	2.91e-6	HDL cholesterol levels;HDL cholesterol;Adiponectin levels;
SKCM	cis	rs2204008	0.754	rs11181643	chr12:38380553	G/A	cg26384229	chr12:38710491	ALG10B	0.81	6.6	0.6	4.58e-9	Bladder cancer;
SKCM	cis	rs28595532	0.920	rs114057512	chr4:119750179	G/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs10489202	0.632	rs275143	chr1:168056724	A/G	cg24449463	chr1:168025552	DCAF6	-0.79	-7.65	-0.65	4.5e-11	Schizophrenia;
SKCM	cis	rs2839186	0.588	rs2839140	chr21:47616080	G/A	cg13012494	chr21:47604986	C21orf56	-0.71	-6.18	-0.57	2.77e-8	Testicular germ cell tumor;
SKCM	cis	rs873946	0.586	rs36084869	chr10:134566069	G/A	cg18305652	chr10:134549665	INPP5A	0.58	5.64	0.54	2.62e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs754466	1.000	rs56256440	chr10:79698207	A/G	cg17075019	chr10:79541650	NA	-0.64	-4.83	-0.48	6.56e-6	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs1577917	0.740	rs2758845	chr6:86334848	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.74	-6.58	-0.6	4.95e-9	Response to antipsychotic treatment;
SKCM	cis	rs13256369	0.802	rs35382339	chr8:8559255	G/A	cg06636001	chr8:8085503	FLJ10661	0.74	5.5	0.53	4.71e-7	Obesity-related traits;
SKCM	cis	rs2382817	0.580	rs6756265	chr2:219095554	G/A	cg00012203	chr2:219082015	ARPC2	-0.78	-6.52	-0.59	6.36e-9	Ulcerative colitis;Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs6120849	0.754	rs3746436	chr20:33586193	C/T	cg24642439	chr20:33292090	TP53INP2	0.94	4.86	0.48	5.91e-6	Protein C levels;
SKCM	cis	rs1005277	0.579	rs2474587	chr10:38420666	C/T	cg00409905	chr10:38381863	ZNF37A	-0.66	-6.16	-0.57	3e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs5750830	0.649	rs5750808	chr22:39790987	G/A	cg24399712	chr22:39784796	NA	-0.57	-4.79	-0.48	7.68e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2153535	0.580	rs1335643	chr6:8488021	T/G	cg07606381	chr6:8435919	SLC35B3	0.86	6.25	0.58	2.06e-8	Motion sickness;
SKCM	cis	rs860295	0.702	rs11264366	chr1:155335411	A/T	cg02153340	chr1:155202674	NA	-0.75	-5.35	-0.52	8.38e-7	Body mass index;
SKCM	cis	rs992157	0.798	rs4674284	chr2:219161241	C/T	cg00012203	chr2:219082015	ARPC2	-0.73	-5.72	-0.54	1.84e-7	Colorectal cancer;
SKCM	cis	rs17376456	0.877	rs12374463	chr5:93483569	C/G	cg21475434	chr5:93447410	FAM172A	0.97	5.42	0.52	6.39e-7	Diabetic retinopathy;
SKCM	cis	rs780096	0.526	rs704795	chr2:27716494	G/A	cg05696406	chr2:27599888	SNX17	0.51	5.22	0.51	1.46e-6	Total body bone mineral density;
SKCM	cis	rs801193	0.761	rs2659888	chr7:66230171	T/G	cg11764359	chr7:65958608	NA	0.83	6.31	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs28595532	0.920	rs114683212	chr4:119760209	A/G	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs7772486	0.682	rs1337840	chr6:146042558	T/C	cg23711669	chr6:146136114	FBXO30	-0.77	-7.51	-0.65	8.49e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2439831	0.867	rs16957632	chr15:43642897	G/A	cg02155558	chr15:43621948	ADAL;LCMT2	1.39	9.42	0.73	1.62e-14	Lung cancer in ever smokers;
SKCM	cis	rs873946	0.517	rs2803990	chr10:134560340	A/G	cg26818010	chr10:134567672	INPP5A	-0.71	-5.61	-0.54	2.97e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs17345786	0.602	rs11923273	chr3:101337863	T/C	cg12386194	chr3:101231763	SENP7	0.8	6.81	0.61	1.78e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4481887	0.927	rs4409694	chr1:248485498	C/T	cg00666640	chr1:248458726	OR2T12	0.59	5.19	0.51	1.64e-6	Common traits (Other);
SKCM	cis	rs1218582	0.774	rs4845681	chr1:154868055	G/T	cg09359103	chr1:154839909	KCNN3	-0.59	-5.96	-0.56	7.03e-8	Prostate cancer;
SKCM	cis	rs8067545	0.603	rs10083830	chr17:19965883	G/A	cg13482628	chr17:19912719	NA	0.75	6.02	0.56	5.38e-8	Schizophrenia;
SKCM	cis	rs2228479	0.850	rs11649510	chr16:89851004	A/G	cg00800038	chr16:89945340	TCF25	-0.93	-4.8	-0.48	7.41e-6	Skin colour saturation;
SKCM	cis	rs6121246	0.909	rs6119720	chr20:30347568	T/G	cg11595048	chr20:30225325	COX4I2	0.67	5.21	0.51	1.5e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs4819052	0.918	rs2330013	chr21:46658662	G/T	cg19498844	chr21:46707878	POFUT2;LOC642852	0.87	6.8	0.61	1.88e-9	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs2836974	0.800	rs12482857	chr21:40514861	T/C	cg11644478	chr21:40555479	PSMG1	1.02	10.57	0.77	1.01e-16	Cognitive function;
SKCM	cis	rs4077515	0.839	rs3812563	chr9:139271106	A/G	cg14169450	chr9:139327907	INPP5E	0.48	5.41	0.52	6.71e-7	Ulcerative colitis;IgA nephropathy;Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs7980687	0.638	rs7299943	chr12:123593485	A/T	cg00376283	chr12:123451042	ABCB9	0.83	5.65	0.54	2.47e-7	Height;Educational attainment;Head circumference (infant);
SKCM	cis	rs672059	1.000	rs672059	chr1:183162539	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.65	5.56	0.53	3.7e-7	Hypertriglyceridemia;
SKCM	cis	rs116095464	0.558	rs6869925	chr5:264036	A/G	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs514406	0.798	rs575138	chr1:53328394	C/G	cg08859206	chr1:53392774	SCP2	-0.64	-4.91	-0.49	4.97e-6	Monocyte count;
SKCM	cis	rs2479106	0.727	rs10986139	chr9:126689150	C/G	cg16191174	chr9:126692580	DENND1A	0.71	5.2	0.51	1.58e-6	Polycystic ovary syndrome;
SKCM	cis	rs7618501	0.633	rs11130228	chr3:50003246	C/T	cg24110177	chr3:50126178	RBM5	-0.6	-5.11	-0.5	2.25e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs208520	0.754	rs12204635	chr6:66740779	C/A	cg07460842	chr6:66804631	NA	0.9	7.2	0.63	3.26e-10	Exhaled nitric oxide output;
SKCM	cis	rs13256369	0.760	rs7839473	chr8:8575836	C/T	cg06636001	chr8:8085503	FLJ10661	0.72	5.28	0.51	1.15e-6	Obesity-related traits;
SKCM	cis	rs1395	0.744	rs11679220	chr2:27476378	G/A	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.5	4.79	0.48	7.88e-6	Blood metabolite levels;
SKCM	cis	rs4724125	0.814	rs1546357	chr7:42687837	A/T	cg09407816	chr7:42972088	MRPL32;PSMA2	0.81	5.2	0.51	1.58e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7937682	0.889	rs541198	chr11:111475340	A/G	cg09085632	chr11:111637200	PPP2R1B	-0.97	-10.1	-0.75	8.28e-16	Primary sclerosing cholangitis;
SKCM	cis	rs57024841	0.562	rs2071006	chr9:139839904	G/T	cg18798099	chr9:140189618	NA	0.56	4.78	0.48	8.24e-6	Beta-trace protein levels;
SKCM	cis	rs1153858	1.000	rs1153849	chr15:45695695	G/A	cg21132104	chr15:45694354	SPATA5L1	0.89	6.95	0.62	9.91e-10	Homoarginine levels;
SKCM	cis	rs8060686	0.641	rs79323429	chr16:68084594	A/G	cg09117114	chr16:67998030	SLC12A4	-0.81	-5.34	-0.52	8.73e-7	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs4132509	0.739	rs79367267	chr1:243689543	C/A	cg21452805	chr1:244014465	NA	0.87	5.39	0.52	7.36e-7	RR interval (heart rate);
SKCM	cis	rs5750830	0.649	rs7949	chr22:39827553	G/A	cg24399712	chr22:39784796	NA	-0.59	-5.05	-0.5	2.88e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs875971	0.964	rs697969	chr7:65558478	C/A	cg18876405	chr7:65276391	NA	-0.71	-7.04	-0.62	6.64e-10	Aortic root size;
SKCM	cis	rs9303401	0.625	rs34963822	chr17:56988424	C/A	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.35	0.52	8.54e-7	Cognitive test performance;
SKCM	cis	rs4888262	0.526	rs7205992	chr16:74590578	T/A	cg01733217	chr16:74700730	RFWD3	0.86	6.88	0.61	1.36e-9	Testicular germ cell tumor;
SKCM	cis	rs17685	0.712	rs1637049	chr7:75729975	C/G	cg16489192	chr7:75678113	MDH2;STYXL1	-0.62	-5.7	-0.54	2.08e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7100689	0.784	rs4934083	chr10:82116501	G/C	cg00277334	chr10:82204260	NA	-0.55	-5.22	-0.51	1.42e-6	Post bronchodilator FEV1;
SKCM	cis	rs514406	0.584	rs7524702	chr1:53197830	G/A	cg24675658	chr1:53192096	ZYG11B	0.62	4.98	0.49	3.72e-6	Monocyte count;
SKCM	cis	rs10504229	0.600	rs6987243	chr8:58115406	T/C	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs453301	0.658	rs3855900	chr8:8901921	A/G	cg15556689	chr8:8085844	FLJ10661	-0.77	-5.82	-0.55	1.24e-7	Joint mobility (Beighton score);
SKCM	cis	rs2842992	0.724	rs9365097	chr6:160211259	G/A	cg11366901	chr6:160182831	ACAT2	0.84	7.09	0.63	5.2e-10	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs9815354	0.767	rs17281182	chr3:41817263	C/T	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs6952808	0.501	rs4721429	chr7:2171704	T/C	cg02951883	chr7:2050386	MAD1L1	-0.75	-6.55	-0.6	5.51e-9	Bipolar disorder and schizophrenia;
SKCM	cis	rs10905065	0.648	rs4237365	chr10:5821484	T/G	cg09234995	chr10:5726438	C10orf18	0.64	5.45	0.53	5.73e-7	Menopause (age at onset);
SKCM	cis	rs807669	0.903	rs1018764	chr22:19172006	T/C	cg02655711	chr22:19163373	SLC25A1	0.78	7.22	0.63	3.03e-10	Metabolite levels;
SKCM	cis	rs58688157	0.705	rs12419720	chr11:598205	C/G	cg16486109	chr11:613632	IRF7	1.08	7.48	0.65	9.51e-11	Systemic lupus erythematosus;
SKCM	cis	rs1459148	1.000	rs1459148	chr14:98840443	A/G	cg19450111	chr14:99728984	BCL11B	0.74	5.0	0.49	3.43e-6	Response to antipsychotic therapy (extrapyramidal side effects);
SKCM	trans	rs1814175	0.817	rs4881623	chr11:49804991	C/T	cg15704280	chr7:45808275	SEPT13	-1.03	-10.73	-0.77	5.17e-17	Height;
SKCM	cis	rs453301	0.624	rs2979256	chr8:8871710	C/T	cg06636001	chr8:8085503	FLJ10661	0.81	6.06	0.57	4.48e-8	Joint mobility (Beighton score);
SKCM	cis	rs7666738	0.791	rs1896155	chr4:99020948	C/A	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9880211	0.848	rs71336069	chr3:136351866	G/C	cg21827317	chr3:136751795	NA	-0.64	-4.78	-0.48	8.21e-6	Body mass index;Height;
SKCM	cis	rs2836950	0.509	rs4816618	chr21:40599529	G/A	cg11644478	chr21:40555479	PSMG1	-0.64	-5.02	-0.49	3.17e-6	Menarche (age at onset);
SKCM	cis	rs6121246	0.954	rs73241710	chr20:30424956	G/A	cg11595048	chr20:30225325	COX4I2	0.65	5.03	0.49	3.1e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs6062302	0.522	rs6090476	chr20:62248001	G/A	cg09650180	chr20:62225654	GMEB2	-0.78	-6.22	-0.58	2.28e-8	Glioblastoma;
SKCM	cis	rs35306767	0.761	rs11253558	chr10:1043983	T/C	cg26597838	chr10:835615	NA	0.64	5.14	0.5	2.02e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs2404602	0.583	rs3759853	chr15:76587777	C/T	cg23625390	chr15:77176239	SCAPER	0.69	6.31	0.58	1.57e-8	Blood metabolite levels;
SKCM	cis	rs9796	0.621	rs2578655	chr15:41462809	T/G	cg18705301	chr15:41695430	NDUFAF1	-0.74	-5.63	-0.54	2.74e-7	Menopause (age at onset);
SKCM	cis	rs3789045	0.774	rs12041243	chr1:204490470	A/G	cg17419461	chr1:204415978	PIK3C2B	-0.84	-5.83	-0.55	1.19e-7	Educational attainment (college completion);
SKCM	cis	rs7633770	0.965	rs6804112	chr3:46686248	C/T	cg11219411	chr3:46661640	NA	0.66	6.02	0.56	5.45e-8	Coronary artery disease;
SKCM	cis	rs10504229	0.683	rs10504223	chr8:58140944	G/A	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs9435341	0.965	rs6669831	chr1:107608607	G/A	cg09367891	chr1:107599246	PRMT6	-0.78	-6.46	-0.59	8.29e-9	Facial morphology (factor 21, depth of nasal alae);
SKCM	cis	rs13118159	0.509	rs9683830	chr4:1377873	A/G	cg16405210	chr4:1374714	KIAA1530	-0.94	-7.09	-0.63	5.32e-10	Longevity;
SKCM	cis	rs9325144	0.560	rs10876005	chr12:39126149	C/G	cg26384229	chr12:38710491	ALG10B	-0.81	-7.77	-0.66	2.6e-11	Morning vs. evening chronotype;
SKCM	cis	rs2204008	0.748	rs11180579	chr12:38237830	A/G	cg26384229	chr12:38710491	ALG10B	0.87	6.9	0.62	1.21e-9	Bladder cancer;
SKCM	cis	rs933688	1.000	rs10059163	chr5:90742444	C/T	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.01	8.43	0.69	1.41e-12	Smoking behavior;
SKCM	cis	rs10197940	0.753	rs2290368	chr2:152266473	T/C	cg06191203	chr2:152266755	RIF1	-0.62	-4.78	-0.48	8.02e-6	Lung cancer;
SKCM	cis	rs10193935	0.901	rs222463	chr2:42644080	A/G	cg27598129	chr2:42591480	NA	-0.96	-6.71	-0.61	2.74e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs35306767	0.903	rs11253460	chr10:887382	C/G	cg25614935	chr10:1084866	C10orf110	0.82	5.39	0.52	7.4e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs7584330	0.737	rs10445707	chr2:238368751	A/G	cg14458575	chr2:238380390	NA	0.88	6.21	0.57	2.43e-8	Prostate cancer;
SKCM	cis	rs7659604	0.540	rs7676867	chr4:122671315	T/C	cg19671926	chr4:122722719	EXOSC9	0.76	6.16	0.57	3.02e-8	Type 2 diabetes;
SKCM	cis	rs2836974	0.932	rs11910151	chr21:40560262	T/C	cg17971929	chr21:40555470	PSMG1	0.9	8.42	0.69	1.45e-12	Cognitive function;
SKCM	cis	rs7772486	0.875	rs6913797	chr6:146413758	A/G	cg23711669	chr6:146136114	FBXO30	0.86	8.52	0.69	9.39e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2073499	1.000	rs2233474	chr3:50388607	C/A	cg08207895	chr3:50388901	TUSC4;CYB561D2	0.73	5.1	0.5	2.36e-6	Schizophrenia;
SKCM	cis	rs992157	0.560	rs4674274	chr2:219089131	A/T	cg00012203	chr2:219082015	ARPC2	-0.78	-6.52	-0.59	6.36e-9	Colorectal cancer;
SKCM	cis	rs10540	1.000	rs71487296	chr11:500282	G/A	cg03352830	chr11:487213	PTDSS2	0.94	4.91	0.49	4.87e-6	Body mass index;
SKCM	cis	rs1707322	1.000	rs11211190	chr1:46266255	C/T	cg03146154	chr1:46216737	IPP	0.74	5.0	0.49	3.39e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs453301	0.538	rs7830804	chr8:8970762	G/T	cg06636001	chr8:8085503	FLJ10661	-0.82	-5.85	-0.55	1.09e-7	Joint mobility (Beighton score);
SKCM	cis	rs28595532	0.920	rs10004184	chr4:119486801	G/T	cg21605333	chr4:119757512	SEC24D	1.24	7.1	0.63	5.16e-10	Cannabis dependence symptom count;
SKCM	cis	rs2032447	0.798	rs807212	chr6:26065621	A/G	cg03517284	chr6:25882590	NA	-0.57	-4.78	-0.48	8.24e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs4243830	0.522	rs10864614	chr1:6596008	G/A	cg22792644	chr1:6614718	TAS1R1;NOL9	-1.06	-5.63	-0.54	2.69e-7	Body mass index;
SKCM	cis	rs6582630	0.555	rs11613249	chr12:38519339	T/C	cg26384229	chr12:38710491	ALG10B	0.82	6.67	0.6	3.25e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs11148252	0.574	rs3742297	chr13:53278067	T/C	cg00495681	chr13:53174319	NA	0.66	5.47	0.53	5.29e-7	Lewy body disease;
SKCM	cis	rs34779708	0.966	rs35814343	chr10:35427714	G/T	cg03585969	chr10:35415529	CREM	0.73	6.03	0.56	5.12e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs561341	1.000	rs8070262	chr17:30262467	A/G	cg23018236	chr17:30244563	NA	-0.53	-5.54	-0.53	3.96e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs2243480	1.000	rs316330	chr7:65605372	C/A	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs8017423	1.000	rs2184281	chr14:90685923	A/G	cg04374321	chr14:90722782	PSMC1	-0.97	-8.64	-0.7	5.3e-13	Mortality in heart failure;
SKCM	cis	rs28386778	0.734	rs7210724	chr17:61799198	T/C	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.36	0.52	8.08e-7	Prudent dietary pattern;
SKCM	cis	rs453301	0.598	rs10104303	chr8:8834528	A/T	cg15556689	chr8:8085844	FLJ10661	0.74	5.53	0.53	4.09e-7	Joint mobility (Beighton score);
SKCM	cis	rs2836974	0.932	rs2234543	chr21:40572072	G/A	cg17971929	chr21:40555470	PSMG1	0.9	8.51	0.69	9.85e-13	Cognitive function;
SKCM	cis	rs60871478	0.898	rs34766380	chr7:786862	G/A	cg05535760	chr7:792225	HEATR2	1.01	8.42	0.69	1.45e-12	Cerebrospinal P-tau181p levels;
SKCM	cis	rs6933660	0.745	rs9371517	chr6:151739810	G/T	cg10883421	chr6:151773342	RMND1;C6orf211	0.86	7.67	0.66	4.15e-11	Menarche (age at onset);
SKCM	cis	rs2836950	0.565	rs2836945	chr21:40596757	C/T	cg11644478	chr21:40555479	PSMG1	-0.64	-5.02	-0.49	3.17e-6	Menarche (age at onset);
SKCM	cis	rs6582630	0.537	rs10785436	chr12:38461040	G/C	cg26384229	chr12:38710491	ALG10B	0.81	6.22	0.58	2.31e-8	Drug-induced liver injury (flucloxacillin);
SKCM	trans	rs9329221	0.905	rs17709397	chr8:10249861	G/A	cg06636001	chr8:8085503	FLJ10661	-0.83	-7.37	-0.64	1.53e-10	Neuroticism;
SKCM	cis	rs12497850	0.931	rs9867373	chr3:48960938	A/T	cg07636037	chr3:49044803	WDR6	1.02	11.0	0.78	1.56e-17	Parkinson's disease;
SKCM	cis	rs4819052	0.851	rs2838856	chr21:46680766	T/G	cg02159808	chr21:46707872	POFUT2;LOC642852	0.75	5.99	0.56	6.11e-8	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs6089584	0.528	rs4925335	chr20:60627034	G/A	cg06108461	chr20:60628389	TAF4	-0.79	-7.45	-0.64	1.08e-10	Body mass index;
SKCM	cis	rs8067545	0.611	rs2703807	chr17:20109189	C/T	cg13482628	chr17:19912719	NA	-0.66	-5.5	-0.53	4.68e-7	Schizophrenia;
SKCM	cis	rs875971	0.895	rs1833495	chr7:65921595	T/C	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	cis	rs4975616	0.804	rs459961	chr5:1337106	T/A	cg26373071	chr5:1325741	CLPTM1L	0.74	6.91	0.62	1.18e-9	Lung cancer;
SKCM	cis	rs6545883	0.929	rs2121660	chr2:61653058	T/C	cg15711740	chr2:61764176	XPO1	0.7	4.93	0.49	4.5e-6	Tuberculosis;
SKCM	cis	rs898097	0.841	rs8074284	chr17:80909967	G/A	cg15369054	chr17:80825471	TBCD	-0.66	-6.15	-0.57	3.07e-8	Breast cancer;
SKCM	cis	rs11628318	1.000	rs11160693	chr14:103031831	C/A	cg01864069	chr14:103024347	NA	-0.7	-5.03	-0.49	3.06e-6	Platelet count;
SKCM	cis	rs9815354	0.556	rs56201224	chr3:42004427	A/C	cg03022575	chr3:42003672	ULK4	1.0	5.0	0.49	3.43e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs12188164	0.582	rs80273890	chr5:483057	C/T	cg26076054	chr5:421317	AHRR	-0.64	-4.79	-0.48	7.79e-6	Cystic fibrosis severity;
SKCM	cis	rs2303759	0.918	rs8107548	chr19:49870643	T/C	cg05022225	chr19:49866942	DKKL1;TEAD2	0.68	5.1	0.5	2.31e-6	Multiple sclerosis;
SKCM	cis	rs1577917	0.771	rs7742201	chr6:86432930	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.99	-11.07	-0.78	1.16e-17	Response to antipsychotic treatment;
SKCM	cis	rs7772486	0.754	rs697053	chr6:145989807	T/C	cg23711669	chr6:146136114	FBXO30	-0.94	-10.41	-0.76	2.04e-16	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2836974	0.568	rs371625	chr21:40535271	A/G	cg11890956	chr21:40555474	PSMG1	-0.88	-9.14	-0.72	5.76e-14	Cognitive function;
SKCM	cis	rs875971	0.830	rs778715	chr7:65849209	C/T	cg18876405	chr7:65276391	NA	0.63	6.25	0.58	2.06e-8	Aortic root size;
SKCM	cis	rs2404602	0.622	rs2003344	chr15:76632301	T/C	cg23625390	chr15:77176239	SCAPER	-0.81	-6.99	-0.62	8.37e-10	Blood metabolite levels;
SKCM	cis	rs2153535	0.580	rs6905237	chr6:8471790	A/T	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs854765	0.547	rs9913277	chr17:17919749	G/T	cg04398451	chr17:18023971	MYO15A	-0.88	-7.1	-0.63	4.98e-10	Total body bone mineral density;
SKCM	cis	rs644799	0.664	rs603625	chr11:95554283	G/A	cg03916912	chr11:95522834	CEP57;FAM76B	0.8	6.71	0.6	2.8e-9	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs1044826	0.642	rs1580642	chr3:139132203	A/C	cg15131784	chr3:139108705	COPB2	-0.65	-4.92	-0.49	4.63e-6	Obesity-related traits;
SKCM	cis	rs2404602	0.575	rs11633309	chr15:76962349	C/A	cg23625390	chr15:77176239	SCAPER	-0.86	-8.0	-0.67	9.21e-12	Blood metabolite levels;
SKCM	cis	rs7772486	0.875	rs6934467	chr6:146410529	G/T	cg05347473	chr6:146136440	FBXO30	0.65	5.96	0.56	6.79e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs8180040	0.932	rs1531875	chr3:47452786	G/A	cg27129171	chr3:47204927	SETD2	0.79	5.79	0.55	1.43e-7	Colorectal cancer;
SKCM	cis	rs11112613	0.818	rs73184099	chr12:106018143	A/G	cg03607813	chr12:105948248	NA	0.98	4.81	0.48	7.32e-6	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;
SKCM	cis	rs8070128	0.534	rs2955350	chr17:17953548	G/A	cg24612305	chr17:17875800	TOM1L2;LRRC48	-1.05	-9.29	-0.72	2.92e-14	Total body bone mineral density;
SKCM	cis	rs2242194	0.844	rs11264295	chr1:154987526	C/T	cg12436631	chr1:155007014	DCST1;DCST2	0.49	5.81	0.55	1.28e-7	Schizophrenia;
SKCM	cis	rs933688	1.000	rs1363839	chr5:90671274	A/T	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.05	8.27	0.68	2.79e-12	Smoking behavior;
SKCM	cis	rs12824058	0.831	rs11616174	chr12:130814503	A/G	cg26677194	chr12:130822605	PIWIL1	0.71	5.91	0.56	8.57e-8	Menopause (age at onset);
SKCM	cis	rs8072100	0.935	rs12150231	chr17:45717091	G/A	cg25173405	chr17:45401733	C17orf57	0.59	5.49	0.53	4.83e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs6933660	0.676	rs3757316	chr6:151774339	A/G	cg02564969	chr6:151773285	C6orf211;RMND1	-0.67	-5.08	-0.5	2.51e-6	Menarche (age at onset);
SKCM	cis	rs362296	0.698	rs3095073	chr4:3263138	C/T	cg05297308	chr4:3317976	RGS12	-0.73	-6.53	-0.59	5.98e-9	Parental longevity (mother's age at death);
SKCM	cis	rs6951245	1.000	rs11764748	chr7:1094508	T/C	cg18402987	chr7:1209562	NA	1.15	6.09	0.57	3.95e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7618501	0.521	rs868891	chr3:49949071	A/G	cg24110177	chr3:50126178	RBM5	-0.7	-5.74	-0.55	1.72e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs6546550	0.935	rs1377995	chr2:70064155	C/G	cg02498382	chr2:70120550	SNRNP27	-0.46	-5.17	-0.51	1.75e-6	Prevalent atrial fibrillation;
SKCM	cis	rs9467773	0.620	rs2504565	chr6:26656890	G/A	cg15659132	chr6:26577336	NA	0.62	5.4	0.52	6.91e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7618915	0.547	rs62255362	chr3:52699741	C/G	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs2839186	0.770	rs2330353	chr21:47669648	T/A	cg13126279	chr21:47581558	C21orf56	-0.69	-5.81	-0.55	1.27e-7	Testicular germ cell tumor;
SKCM	cis	rs344364	0.511	rs1657133	chr16:1950300	A/G	cg26897989	chr16:1907736	C16orf73	-0.69	-7.13	-0.63	4.45e-10	Glomerular filtration rate in chronic kidney disease;
SKCM	cis	rs4891159	0.790	rs72975929	chr18:74144630	G/C	cg24786174	chr18:74118243	ZNF516	-0.75	-6.95	-0.62	9.71e-10	Longevity;
SKCM	cis	rs503341	0.756	rs10897450	chr11:63593219	G/C	cg04362095	chr11:63592001	C11orf84	-0.84	-9.74	-0.74	3.97e-15	Pulse pressure;
SKCM	cis	rs7829975	0.742	rs7832968	chr8:8652889	G/A	cg06636001	chr8:8085503	FLJ10661	0.77	6.79	0.61	1.97e-9	Mood instability;
SKCM	cis	rs28595532	1.000	rs11931194	chr4:119631160	C/T	cg11846333	chr4:119757529	SEC24D	1.15	6.24	0.58	2.13e-8	Cannabis dependence symptom count;
SKCM	cis	rs9398764	0.700	rs6923037	chr6:125039548	A/G	cg02285725	chr6:125121219	NKAIN2	-0.38	-4.79	-0.48	7.78e-6	Political ideology;
SKCM	cis	rs1005277	0.579	rs1740742	chr10:38518860	C/T	cg00409905	chr10:38381863	ZNF37A	-0.62	-5.82	-0.55	1.24e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs7843479	0.526	rs34802507	chr8:21773853	C/T	cg17168535	chr8:21777572	XPO7	0.6	4.88	0.48	5.58e-6	Mean corpuscular volume;
SKCM	trans	rs1814175	0.626	rs1722008	chr11:49897676	A/T	cg03929089	chr4:120376271	NA	-0.9	-8.64	-0.7	5.49e-13	Height;
SKCM	cis	rs2941509	1.000	rs113657930	chr17:38065485	C/G	cg12655416	chr17:38077870	ORMDL3	-0.48	-5.25	-0.51	1.26e-6	Systemic lupus erythematosus;
SKCM	cis	rs17065868	1.000	rs17065995	chr13:45222314	C/T	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs1348850	0.567	rs3770012	chr2:178538023	A/G	cg22681709	chr2:178499509	PDE11A	0.68	6.38	0.59	1.18e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs9420	0.922	rs35808061	chr11:57547000	T/C	cg19752551	chr11:57585705	CTNND1	-0.7	-7.21	-0.63	3.18e-10	Schizophrenia;
SKCM	cis	rs929354	0.772	rs3802123	chr7:156970641	G/A	cg17757837	chr7:157058334	UBE3C	0.8	5.46	0.53	5.55e-7	Body mass index;
SKCM	cis	rs1506636	1.000	rs2259457	chr7:123424350	A/G	cg03229431	chr7:123269106	ASB15	0.66	5.29	0.51	1.1e-6	Plateletcrit;Platelet count;
SKCM	cis	rs10779751	1.000	rs11121711	chr1:11317661	A/T	cg08854313	chr1:11322531	MTOR	0.94	7.36	0.64	1.6e-10	Body mass index;
SKCM	cis	rs9611565	0.605	rs202638	chr22:41855458	A/G	cg03806693	chr22:41940476	POLR3H	0.78	4.94	0.49	4.4e-6	Vitiligo;
SKCM	cis	rs6570726	0.967	rs365515	chr6:145802833	C/T	cg23711669	chr6:146136114	FBXO30	-0.68	-6.88	-0.61	1.33e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs801193	0.839	rs12534943	chr7:66070520	A/G	cg18876405	chr7:65276391	NA	-0.8	-7.23	-0.63	2.83e-10	Aortic root size;
SKCM	cis	rs28595532	0.920	rs56252481	chr4:119754023	C/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs1018836	0.884	rs7008765	chr8:91632589	C/T	cg16814680	chr8:91681699	NA	-0.64	-4.85	-0.48	6.29e-6	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs870825	0.616	rs6844146	chr4:185636396	G/A	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs9910055	0.531	rs6503490	chr17:42246656	A/G	cg09913183	chr17:42254507	C17orf65;ASB16	0.67	6.36	0.58	1.27e-8	Total body bone mineral density;
SKCM	cis	rs11252926	0.599	rs11252213	chr10:454694	C/T	cg18196295	chr10:418757	DIP2C	0.65	5.26	0.51	1.23e-6	Psychosis in Alzheimer's disease;
SKCM	cis	rs155076	1.000	rs58519241	chr13:21845006	C/A	cg11317459	chr13:21872234	NA	-1.24	-6.91	-0.62	1.19e-9	White matter hyperintensity burden;
SKCM	cis	rs2811415	0.597	rs9861755	chr3:127739721	A/G	cg09089421	chr3:127803668	RUVBL1	1.0	8.57	0.7	7.53e-13	Lung function (FEV1/FVC);
SKCM	cis	rs7659604	1.000	rs35901586	chr4:122664757	T/A	cg06713675	chr4:122721982	EXOSC9	-0.65	-5.78	-0.55	1.48e-7	Type 2 diabetes;
SKCM	cis	rs1348850	0.958	rs1405713	chr2:178461560	G/C	cg02961200	chr2:178257176	LOC100130691;AGPS	0.84	6.61	0.6	4.29e-9	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs6087990	0.835	rs4911106	chr20:31331330	A/G	cg13636640	chr20:31349939	DNMT3B	0.9	7.15	0.63	4.07e-10	Ulcerative colitis;
SKCM	cis	rs4803468	0.967	rs4803462	chr19:41908936	T/A	cg09537434	chr19:41945824	ATP5SL	-1.09	-13.02	-0.83	3.05e-21	Height;
SKCM	cis	rs7772486	0.806	rs2253648	chr6:146199296	G/A	cg05347473	chr6:146136440	FBXO30	0.56	5.38	0.52	7.57e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2072510	0.778	rs2540494	chr12:96412338	A/C	cg18817487	chr12:96390143	HAL	0.45	5.84	0.55	1.15e-7	Metabolite levels (small molecules and protein measures);
SKCM	cis	rs2188420	0.872	rs115150350	chr7:106515822	T/C	cg23615938	chr7:105753134	SYPL1	-0.89	-5.08	-0.5	2.49e-6	Interferon gamma levels;
SKCM	cis	rs854765	0.583	rs62064156	chr17:17822480	C/T	cg04398451	chr17:18023971	MYO15A	-0.79	-5.68	-0.54	2.25e-7	Total body bone mineral density;
SKCM	cis	rs9611565	0.918	rs73176685	chr22:41781094	C/G	cg03806693	chr22:41940476	POLR3H	-0.82	-5.57	-0.53	3.5e-7	Vitiligo;
SKCM	cis	rs1949733	1.000	rs1949733	chr4:8503359	C/T	cg11789530	chr4:8429930	ACOX3	-0.81	-5.79	-0.55	1.38e-7	Response to antineoplastic agents;
SKCM	cis	rs9611565	0.559	rs6002408	chr22:41967870	C/T	cg03806693	chr22:41940476	POLR3H	-1.04	-6.61	-0.6	4.38e-9	Vitiligo;
SKCM	cis	rs875971	0.862	rs3926380	chr7:66080645	G/T	cg18876405	chr7:65276391	NA	-0.63	-6.32	-0.58	1.5e-8	Aortic root size;
SKCM	cis	rs72781680	0.898	rs6545127	chr2:24060670	C/T	cg08917208	chr2:24149416	ATAD2B	1.0	5.14	0.5	1.98e-6	Lymphocyte counts;
SKCM	cis	rs9910055	0.664	rs433610	chr17:42197281	A/G	cg13607699	chr17:42295918	UBTF	-0.78	-6.1	-0.57	3.9e-8	Total body bone mineral density;
SKCM	cis	rs6951245	1.000	rs884977	chr7:1066410	T/C	cg03188948	chr7:1209495	NA	1.05	5.65	0.54	2.48e-7	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7772486	0.875	rs13198450	chr6:146370524	C/A	cg05347473	chr6:146136440	FBXO30	0.57	5.24	0.51	1.31e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6951245	1.000	rs77305932	chr7:1100861	T/A	cg03188948	chr7:1209495	NA	1.13	6.27	0.58	1.89e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs4862750	0.794	rs1030382	chr4:187903782	T/G	cg10295955	chr4:187884368	NA	-1.03	-12.6	-0.82	1.73e-20	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs875971	1.000	rs4718357	chr7:65960878	A/G	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs8060686	0.641	rs75796305	chr16:68208791	A/G	cg09117114	chr16:67998030	SLC12A4	-0.77	-5.03	-0.49	3.12e-6	HDL cholesterol;Metabolic syndrome;
SKCM	trans	rs9929218	0.551	rs2274239	chr16:68725783	G/A	cg04657470	chr2:198365150	HSPE1;HSPD1	0.98	10.11	0.75	7.75e-16	Colorectal cancer;
SKCM	cis	rs1790761	0.501	rs4930210	chr11:67404726	G/T	cg00864171	chr11:67383662	NA	-0.58	-5.07	-0.5	2.62e-6	Mean corpuscular volume;
SKCM	cis	rs9611565	0.512	rs6002474	chr22:42168181	A/G	cg03806693	chr22:41940476	POLR3H	1.17	6.46	0.59	8.4e-9	Vitiligo;
SKCM	cis	rs67460515	0.567	rs34691229	chr3:160876897	G/T	cg03342759	chr3:160939853	NMD3	-0.71	-5.95	-0.56	7.28e-8	Parkinson's disease;
SKCM	cis	rs4900538	0.855	rs12586378	chr14:102853150	T/C	cg18135206	chr14:102964638	TECPR2	-0.71	-5.36	-0.52	8.09e-7	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs67311347	0.866	rs56331709	chr3:40356558	A/C	cg00091569	chr3:40428383	ENTPD3	0.67	5.66	0.54	2.45e-7	Renal cell carcinoma;
SKCM	cis	rs875971	0.862	rs778684	chr7:65836403	A/T	cg18876405	chr7:65276391	NA	0.64	6.36	0.58	1.26e-8	Aortic root size;
SKCM	cis	rs798766	1.000	rs798741	chr4:1712413	A/G	cg05874882	chr4:1763078	NA	-0.58	-4.98	-0.49	3.73e-6	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs606458	0.920	rs3741398	chr11:64546106	C/T	cg07674570	chr11:65346152	EHBP1L1	0.68	4.89	0.48	5.2e-6	Urate levels;
SKCM	cis	rs10256972	0.567	rs2960835	chr7:1202963	A/G	cg16145915	chr7:1198662	ZFAND2A	-0.58	-8.26	-0.68	2.94e-12	Longevity;Endometriosis;
SKCM	cis	rs1499614	0.522	rs13247442	chr7:66188858	T/C	cg18252515	chr7:66147081	NA	-1.42	-7.62	-0.65	5.04e-11	Gout;
SKCM	cis	rs644799	0.710	rs10831429	chr11:95508524	C/A	cg25622487	chr11:95524042	FAM76B;CEP57	0.76	6.47	0.59	7.89e-9	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs597539	0.652	rs674654	chr11:68698762	G/T	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.82	5.41	0.52	6.82e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs2836950	0.585	rs1029004	chr21:40615343	A/G	cg11644478	chr21:40555479	PSMG1	-0.64	-5.02	-0.49	3.17e-6	Menarche (age at onset);
SKCM	cis	rs151997	0.962	rs27612	chr5:50179120	G/A	cg06027927	chr5:50259733	NA	0.63	5.35	0.52	8.43e-7	Callous-unemotional behaviour;
SKCM	cis	rs2894969	0.664	rs11252716	chr10:4800140	A/G	cg10503599	chr10:4193868	NA	0.65	5.26	0.51	1.25e-6	Major depressive disorder;
SKCM	cis	rs11098499	0.954	rs9993199	chr4:120392873	A/G	cg24375607	chr4:120327624	NA	-0.63	-4.81	-0.48	7.11e-6	Corneal astigmatism;
SKCM	cis	rs9815354	0.904	rs73081347	chr3:41903582	T/C	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs3820068	0.581	rs58425551	chr1:15922518	A/G	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs801193	1.000	rs10274773	chr7:66133578	G/A	cg18876405	chr7:65276391	NA	-0.82	-7.53	-0.65	7.59e-11	Aortic root size;
SKCM	cis	rs1559088	0.600	rs10423965	chr19:33600319	T/G	cg17764715	chr19:33622953	WDR88	0.93	6.71	0.61	2.74e-9	Bone ultrasound measurement (broadband ultrasound attenuation);
SKCM	cis	rs2204008	0.569	rs11495449	chr12:37995753	C/T	cg26384229	chr12:38710491	ALG10B	0.8	6.2	0.57	2.47e-8	Bladder cancer;
SKCM	cis	rs9906944	0.545	rs12939375	chr17:47089717	C/G	cg10950924	chr17:47092072	IGF2BP1	-0.54	-4.94	-0.49	4.31e-6	Intelligence (multi-trait analysis);Body fat percentage;
SKCM	cis	rs4243830	0.522	rs11122086	chr1:6601246	T/G	cg22792644	chr1:6614718	TAS1R1;NOL9	-1.05	-5.61	-0.54	3.01e-7	Body mass index;
SKCM	cis	rs2836974	0.931	rs8132285	chr21:40655752	T/C	cg11644478	chr21:40555479	PSMG1	0.97	10.08	0.75	8.76e-16	Cognitive function;
SKCM	trans	rs561341	0.883	rs1034626	chr17:30219500	C/G	cg20587970	chr11:113659929	NA	1.03	7.85	0.66	1.81e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs10416265	0.502	rs7245411	chr19:33543029	A/T	cg17764715	chr19:33622953	WDR88	0.88	6.07	0.57	4.38e-8	Bone properties (heel);
SKCM	cis	rs7809950	1.000	rs3801948	chr7:107238447	A/T	cg23024343	chr7:107201750	COG5	-0.86	-7.69	-0.66	3.71e-11	Coronary artery disease;
SKCM	cis	rs11112613	0.713	rs12307351	chr12:105955634	T/A	cg03607813	chr12:105948248	NA	0.88	6.01	0.56	5.5e-8	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;
SKCM	cis	rs58688157	0.960	rs1051390	chr11:613165	G/C	cg16486109	chr11:613632	IRF7	1.07	7.29	0.64	2.17e-10	Systemic lupus erythematosus;
SKCM	cis	rs4687718	0.929	rs73840299	chr3:53277063	C/T	cg07507251	chr3:52567010	NT5DC2	0.87	5.73	0.54	1.79e-7	QRS duration;
SKCM	cis	rs951366	0.789	rs7536483	chr1:205718858	A/T	cg17178900	chr1:205818956	PM20D1	0.73	5.91	0.56	8.63e-8	Menarche (age at onset);
SKCM	cis	rs847649	0.842	rs1608651	chr7:102624192	C/T	cg18108683	chr7:102477205	FBXL13	0.86	8.53	0.69	8.74e-13	Morning vs. evening chronotype;
SKCM	cis	rs6545883	0.894	rs1186703	chr2:61672965	A/C	cg15711740	chr2:61764176	XPO1	-0.68	-4.92	-0.49	4.76e-6	Tuberculosis;
SKCM	cis	rs208520	0.874	rs208512	chr6:66943869	C/G	cg07460842	chr6:66804631	NA	-1.07	-7.41	-0.64	1.32e-10	Exhaled nitric oxide output;
SKCM	cis	rs3820068	0.581	rs72645888	chr1:15929922	C/A	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs12824058	0.831	rs12322456	chr12:130813594	A/G	cg26677194	chr12:130822605	PIWIL1	0.72	5.94	0.56	7.6e-8	Menopause (age at onset);
SKCM	cis	rs3845702	0.736	rs6733426	chr2:180830958	A/G	cg01881094	chr2:180872142	CWC22	-1.3	-6.15	-0.57	3.07e-8	Schizophrenia;
SKCM	cis	rs6942756	1.000	rs7803052	chr7:128959427	A/G	cg02491457	chr7:128862824	NA	-0.86	-5.48	-0.53	5.11e-7	White matter hyperintensity burden;
SKCM	cis	rs7959452	1.000	rs2168029	chr12:69734641	A/C	cg20891283	chr12:69753455	YEATS4	0.71	6.13	0.57	3.44e-8	Blood protein levels;
SKCM	cis	rs7937682	0.737	rs542275	chr11:111431614	C/T	cg09085632	chr11:111637200	PPP2R1B	-0.82	-7.06	-0.62	5.95e-10	Primary sclerosing cholangitis;
SKCM	cis	rs4975616	0.869	rs401681	chr5:1322087	C/T	cg26373071	chr5:1325741	CLPTM1L	0.73	6.65	0.6	3.69e-9	Lung cancer;
SKCM	cis	rs17770015	0.602	rs4917653	chr10:115198443	C/T	cg14665389	chr10:114710815	TCF7L2	0.65	4.81	0.48	7.28e-6	Migraine without aura;
SKCM	cis	rs7772486	0.790	rs9403755	chr6:146231470	C/A	cg05347473	chr6:146136440	FBXO30	-0.56	-5.19	-0.51	1.6e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs35146811	0.844	rs4424195	chr7:99642745	A/G	cg22906224	chr7:99728672	NA	0.8	6.04	0.56	4.91e-8	Coronary artery disease;
SKCM	cis	rs58688157	0.880	rs12272314	chr11:590648	A/G	cg03576123	chr11:487126	PTDSS2	-0.83	-5.11	-0.5	2.2e-6	Systemic lupus erythematosus;
SKCM	cis	rs10751667	0.600	rs10751672	chr11:948712	T/C	cg06064525	chr11:970664	AP2A2	-0.54	-5.12	-0.5	2.13e-6	Alzheimer's disease (late onset);
SKCM	cis	rs2658782	0.951	rs2608214	chr11:93148665	C/T	cg15737290	chr11:93063684	CCDC67	0.71	5.25	0.51	1.26e-6	Pulmonary function decline;
SKCM	cis	rs1298637	0.655	rs41443646	chr1:53921571	C/T	cg09586583	chr1:54755153	SSBP3	-0.6	-5.21	-0.51	1.49e-6	Nicotine use;
SKCM	cis	rs17376456	0.877	rs10062711	chr5:93348659	G/A	cg21475434	chr5:93447410	FAM172A	0.95	5.36	0.52	8.36e-7	Diabetic retinopathy;
SKCM	cis	rs8103278	0.507	rs7260651	chr19:46260245	G/A	cg12641515	chr19:46296257	DMWD	0.78	6.24	0.58	2.1e-8	Coronary artery disease;
SKCM	cis	rs6087990	0.842	rs4911253	chr20:31352585	A/G	cg13636640	chr20:31349939	DNMT3B	0.9	7.17	0.63	3.66e-10	Ulcerative colitis;
SKCM	cis	rs6724607	1.000	rs10165399	chr2:191441595	A/G	cg27211696	chr2:191398769	TMEM194B	0.8	6.53	0.59	6.07e-9	Pulse pressure;
SKCM	cis	rs28386778	0.897	rs2665796	chr17:61923716	G/C	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs11098499	0.863	rs1010740	chr4:120463409	C/T	cg24375607	chr4:120327624	NA	-0.68	-5.21	-0.51	1.48e-6	Corneal astigmatism;
SKCM	cis	rs7666738	0.753	rs28390295	chr4:99028497	C/A	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7100689	0.646	rs7899791	chr10:82091950	A/T	cg00277334	chr10:82204260	NA	-0.57	-5.34	-0.52	9.02e-7	Post bronchodilator FEV1;
SKCM	cis	rs7193541	0.646	rs7188880	chr16:74664810	A/T	cg01733217	chr16:74700730	RFWD3	1.01	11.93	0.8	2.82e-19	Multiple myeloma;
SKCM	cis	rs11685299	1	rs11685299	chr2:225391296	C/A	cg12698349	chr2:225449008	CUL3	1.03	8.73	0.7	3.68e-13	Schizophrenia;
SKCM	cis	rs875971	0.862	rs778702	chr7:65864835	G/A	cg11764359	chr7:65958608	NA	0.8	7.47	0.65	1.01e-10	Aortic root size;
SKCM	cis	rs1218582	0.772	rs3738026	chr1:154919565	A/G	cg09359103	chr1:154839909	KCNN3	-0.54	-4.91	-0.49	4.92e-6	Prostate cancer;
SKCM	cis	rs1348850	0.958	rs4893941	chr2:178269531	A/T	cg02961200	chr2:178257176	LOC100130691;AGPS	0.85	6.45	0.59	8.7e-9	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs7208859	0.524	rs77498725	chr17:29063986	C/T	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs651907	0.557	rs3806654	chr3:101396529	G/C	cg12386194	chr3:101231763	SENP7	0.71	5.94	0.56	7.61e-8	Colorectal cancer;
SKCM	cis	rs4319547	0.774	rs7307233	chr12:123124301	C/G	cg23029597	chr12:123009494	RSRC2	-0.73	-5.5	-0.53	4.6e-7	Body mass index;
SKCM	cis	rs9311474	0.508	rs17052259	chr3:52593138	A/G	cg18404041	chr3:52824283	ITIH1	-0.53	-4.77	-0.48	8.42e-6	Electroencephalogram traits;
SKCM	cis	rs35306767	0.855	rs34251037	chr10:867884	C/T	cg26597838	chr10:835615	NA	0.79	6.08	0.57	4.12e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs2952156	0.920	rs2517953	chr17:37841211	G/C	cg20243544	chr17:37824526	PNMT	0.66	5.18	0.51	1.68e-6	Asthma;
SKCM	cis	rs12986445	0.711	rs12713701	chr2:26136031	T/A	cg07291958	chr2:26785531	C2orf70	0.53	4.92	0.49	4.79e-6	Multiple myeloma and monoclonal gammopathy;Multiple myeloma;
SKCM	cis	rs244731	1.000	rs244730	chr5:176539212	A/G	cg16006841	chr5:176797999	RGS14	-0.71	-6.01	-0.56	5.56e-8	Urate levels in lean individuals;
SKCM	cis	rs6952808	0.693	rs10950413	chr7:1912988	A/G	cg21782813	chr7:2030301	MAD1L1	0.5	5.1	0.5	2.3e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs1023500	0.573	rs133374	chr22:42465941	G/A	cg04733989	chr22:42467013	NAGA	0.72	5.72	0.54	1.9e-7	Schizophrenia;
SKCM	cis	rs9394841	0.692	rs3218108	chr6:41902655	C/T	cg08135965	chr6:41755394	TOMM6	0.78	5.07	0.5	2.6e-6	Mean corpuscular hemoglobin;Red cell distribution width;
SKCM	cis	rs2303759	0.918	rs2288480	chr19:49867016	C/G	cg05022225	chr19:49866942	DKKL1;TEAD2	0.69	5.26	0.51	1.23e-6	Multiple sclerosis;
SKCM	cis	rs72781680	0.752	rs55859418	chr2:23904231	C/A	cg08917208	chr2:24149416	ATAD2B	0.98	5.0	0.49	3.41e-6	Lymphocyte counts;
SKCM	cis	rs5769765	1.000	rs764813	chr22:50286172	T/C	cg22709217	chr22:50311962	ALG12;CRELD2	-0.79	-5.71	-0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs2439831	1.000	rs2253708	chr15:43797273	G/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.22	7.98	0.67	1.01e-11	Lung cancer in ever smokers;
SKCM	cis	rs561341	0.609	rs2051810	chr17:30195841	C/T	cg00745463	chr17:30367425	LRRC37B	0.88	5.18	0.51	1.66e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs9467773	1.000	rs9467787	chr6:26556769	G/T	cg15659132	chr6:26577336	NA	0.6	5.65	0.54	2.49e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7552404	0.924	rs1858536	chr1:76161595	G/T	cg10523679	chr1:76189770	ACADM	0.7	5.05	0.5	2.83e-6	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs7584330	0.780	rs937395	chr2:238378749	T/C	cg14458575	chr2:238380390	NA	0.87	5.98	0.56	6.42e-8	Prostate cancer;
SKCM	cis	rs4481887	0.617	rs7511986	chr1:248527810	G/A	cg22724847	chr1:248512586	OR14C36	0.62	5.32	0.52	9.49e-7	Common traits (Other);
SKCM	cis	rs6977660	0.660	rs10239332	chr7:19824465	A/G	cg07541023	chr7:19748670	TWISTNB	0.72	4.78	0.48	7.95e-6	Thyroid stimulating hormone;
SKCM	cis	rs10779751	0.610	rs2486921	chr1:11124943	G/A	cg08854313	chr1:11322531	MTOR	0.77	5.52	0.53	4.36e-7	Body mass index;
SKCM	cis	rs3785574	0.962	rs35448669	chr17:61938923	G/A	cg26338869	chr17:61819248	STRADA	0.63	4.81	0.48	7.11e-6	Height;
SKCM	cis	rs6840360	0.550	rs7689266	chr4:152561048	T/C	cg22705602	chr4:152727874	NA	-0.52	-5.69	-0.54	2.15e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs1799949	1.000	rs8176126	chr17:41259049	A/G	cg25918947	chr17:41365094	TMEM106A	0.59	5.72	0.54	1.9e-7	Menopause (age at onset);
SKCM	cis	rs3785574	0.927	rs2727313	chr17:61961914	A/G	cg06873352	chr17:61820015	STRADA	0.57	5.02	0.49	3.24e-6	Height;
SKCM	cis	rs7917772	0.503	rs11191342	chr10:104344450	G/A	cg11453585	chr10:104263688	ACTR1A;SUFU	0.75	5.96	0.56	6.78e-8	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs1577917	0.916	rs4142546	chr6:86505311	G/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.37	-0.52	7.87e-7	Response to antipsychotic treatment;
SKCM	cis	rs6547741	1.000	rs6737921	chr2:27839107	T/C	cg27432699	chr2:27873401	GPN1	0.75	6.74	0.61	2.45e-9	Oral cavity cancer;
SKCM	cis	rs28437878	1	rs28437878	chr15:78807872	C/T	cg24631222	chr15:78858424	CHRNA5	0.93	6.3	0.58	1.66e-8	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs1577917	0.958	rs10944168	chr6:86680156	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.84	-8.35	-0.69	1.97e-12	Response to antipsychotic treatment;
SKCM	cis	rs561341	0.883	rs6505274	chr17:30344581	G/T	cg00745463	chr17:30367425	LRRC37B	-0.97	-6.75	-0.61	2.32e-9	Hip circumference adjusted for BMI;
SKCM	cis	rs17685	0.712	rs56965035	chr7:75795670	G/A	cg01364799	chr7:75623366	TMEM120A	-0.7	-5.84	-0.55	1.16e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs9640161	0.742	rs11983355	chr7:150016697	A/C	cg27494647	chr7:150038898	RARRES2	0.54	4.77	0.48	8.3e-6	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs7635838	0.785	rs7427412	chr3:11535020	G/A	cg00170343	chr3:11313890	ATG7	0.68	4.89	0.48	5.22e-6	HDL cholesterol;
SKCM	cis	rs6121246	0.559	rs6060932	chr20:30350545	A/G	cg13852791	chr20:30311386	BCL2L1	0.82	5.69	0.54	2.09e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs4803468	1.000	rs284655	chr19:41928765	C/T	cg09537434	chr19:41945824	ATP5SL	-1.1	-13.85	-0.84	1.02e-22	Height;
SKCM	cis	rs9910055	0.683	rs7220138	chr17:42254011	C/G	cg13607699	chr17:42295918	UBTF	0.71	5.74	0.55	1.72e-7	Total body bone mineral density;
SKCM	cis	rs2737618	0.651	rs2249172	chr1:200082955	A/G	cg21825944	chr1:200113062	NR5A2	0.6	5.08	0.5	2.53e-6	Uric acid levels;
SKCM	cis	rs12971120	0.891	rs2278158	chr18:72178300	G/T	cg25817165	chr18:72167213	CNDP2	-0.65	-4.87	-0.48	5.69e-6	Refractive error;
SKCM	cis	rs9911578	0.967	rs12938821	chr17:56959422	T/C	cg05425664	chr17:57184151	TRIM37	-0.67	-5.04	-0.5	2.91e-6	Intelligence (multi-trait analysis);
SKCM	trans	rs1814175	0.791	rs10769625	chr11:49869887	G/A	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs7945705	0.936	rs978636	chr11:8836596	C/T	cg21881798	chr11:8931708	C11orf17;ST5	0.69	6.96	0.62	9.38e-10	Hemoglobin concentration;
SKCM	cis	rs644799	0.648	rs1016031	chr11:95473365	C/T	cg03916912	chr11:95522834	CEP57;FAM76B	-0.68	-5.61	-0.54	2.92e-7	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs9399135	0.967	rs4451151	chr6:135310546	C/T	cg24558204	chr6:135376177	HBS1L	0.58	5.05	0.5	2.8e-6	Red blood cell count;
SKCM	cis	rs16866061	1.000	rs72974203	chr2:225408430	G/A	cg12698349	chr2:225449008	CUL3	1.01	8.51	0.69	9.75e-13	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs9896933	0.623	rs77166830	chr17:80833525	T/C	cg20578329	chr17:80767326	TBCD	-0.95	-6.32	-0.58	1.52e-8	Bone mineral accretion in asthma (oral corticosteroid dose interaction);
SKCM	cis	rs6430585	0.528	rs16832417	chr2:136744678	C/T	cg07169764	chr2:136633963	MCM6	1.32	11.74	0.8	6.6e-19	Corneal structure;
SKCM	cis	rs1559088	0.576	rs10407255	chr19:33581150	A/G	cg27124370	chr19:33622961	WDR88	-0.78	-5.76	-0.55	1.57e-7	Bone ultrasound measurement (broadband ultrasound attenuation);
SKCM	cis	rs1568889	0.838	rs1483858	chr11:28189639	A/G	cg06544937	chr11:28130018	METT5D1;KIF18A	0.89	8.3	0.68	2.43e-12	Bipolar disorder;
SKCM	cis	rs3892630	0.878	rs114224536	chr19:33211232	A/G	cg22980127	chr19:33182716	NUDT19	1.39	7.88	0.67	1.6e-11	Red blood cell traits;
SKCM	cis	rs34779708	0.733	rs12243593	chr10:35549045	C/T	cg03585969	chr10:35415529	CREM	0.71	5.25	0.51	1.27e-6	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs9325144	0.555	rs1813392	chr12:38692203	C/T	cg13010199	chr12:38710504	ALG10B	-0.63	-5.06	-0.5	2.76e-6	Morning vs. evening chronotype;
SKCM	cis	rs1552244	1.000	rs61052895	chr3:10147516	G/A	cg02579736	chr3:10068473	FANCD2;CIDECP	1.23	6.92	0.62	1.13e-9	Alzheimer's disease;
SKCM	cis	rs8180040	0.934	rs12630641	chr3:47534836	G/T	cg16586182	chr3:47516702	SCAP	-0.76	-5.32	-0.52	9.63e-7	Colorectal cancer;
SKCM	cis	rs3008870	1.000	rs1925412	chr1:67405057	G/A	cg08660285	chr1:67390436	MIER1;WDR78	0.92	6.05	0.57	4.69e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs394563	0.717	rs548848	chr6:149782009	A/G	cg03678062	chr6:149772716	ZC3H12D	-0.48	-4.96	-0.49	4.11e-6	Dupuytren's disease;
SKCM	cis	rs2153535	0.580	rs4960422	chr6:8459309	T/C	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs1799949	1.000	rs2175957	chr17:41286822	T/G	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.11	-0.57	3.67e-8	Menopause (age at onset);
SKCM	cis	rs55962025	0.842	rs363088	chr4:3210330	A/T	cg00764545	chr4:3318001	RGS12	-0.73	-5.89	-0.56	9.11e-8	Parental longevity (mother's age at death);
SKCM	cis	rs12497850	0.765	rs12487580	chr3:49182932	G/A	cg06212747	chr3:49208901	KLHDC8B	0.75	5.0	0.49	3.47e-6	Parkinson's disease;
SKCM	cis	rs7666738	0.830	rs1426672	chr4:98923984	T/C	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1878931	0.624	rs28089	chr16:3446937	G/A	cg26668626	chr16:3451006	ZNF174;ZNF434	-0.87	-6.07	-0.57	4.29e-8	Body mass index (adult);
SKCM	cis	rs2836950	0.565	rs2836931	chr21:40546569	T/G	cg11890956	chr21:40555474	PSMG1	-0.7	-5.62	-0.54	2.84e-7	Menarche (age at onset);
SKCM	cis	rs9902453	0.868	rs9890075	chr17:28470464	C/A	cg26525008	chr17:28256777	EFCAB5;SSH2	0.79	6.03	0.56	5.24e-8	Coffee consumption (cups per day);
SKCM	cis	rs1799949	0.965	rs799916	chr17:41243190	G/T	cg05368731	chr17:41323189	NBR1	-0.86	-7.3	-0.64	2.15e-10	Menopause (age at onset);
SKCM	cis	rs995000	0.931	rs10159255	chr1:63020816	C/A	cg06896770	chr1:63153194	DOCK7	0.89	7.69	0.66	3.79e-11	Triglyceride levels;
SKCM	cis	rs875971	1.000	rs778710	chr7:65854834	T/C	cg18876405	chr7:65276391	NA	0.67	6.65	0.6	3.61e-9	Aortic root size;
SKCM	cis	rs11155671	0.530	rs9968871	chr6:150209196	G/A	cg05036130	chr6:150231994	NA	0.61	6.58	0.6	4.87e-9	Testicular germ cell tumor;
SKCM	cis	rs6942756	0.955	rs55638303	chr7:128885770	C/T	cg02491457	chr7:128862824	NA	-0.77	-4.97	-0.49	3.83e-6	White matter hyperintensity burden;
SKCM	cis	rs1799949	1.000	rs8176273	chr17:41211653	A/G	cg25918947	chr17:41365094	TMEM106A	-0.62	-5.89	-0.55	9.22e-8	Menopause (age at onset);
SKCM	cis	rs1348850	0.757	rs4893954	chr2:178340520	T/G	cg02961200	chr2:178257176	LOC100130691;AGPS	0.8	5.94	0.56	7.56e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs72634258	0.553	rs112697022	chr1:7949253	G/A	cg00042356	chr1:8021962	PARK7	0.83	5.14	0.5	1.96e-6	Inflammatory bowel disease;
SKCM	cis	rs12541335	0.639	rs6993855	chr8:22163797	A/G	cg02463440	chr8:22132932	PIWIL2	0.61	5.32	0.52	9.83e-7	Hypertriglyceridemia;
SKCM	cis	rs473651	0.935	rs541013	chr2:239336492	G/A	cg18131467	chr2:239335373	ASB1	1.08	13.29	0.83	9.89e-22	Multiple system atrophy;
SKCM	cis	rs6921919	0.583	rs4254981	chr6:28371402	A/C	cg14547644	chr6:28411285	ZSCAN23	-0.58	-4.8	-0.48	7.46e-6	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs4969178	1.000	rs4969178	chr17:76388202	C/T	cg20026190	chr17:76395443	PGS1	-0.6	-4.84	-0.48	6.51e-6	HDL cholesterol levels;
SKCM	cis	rs9325144	0.647	rs10875953	chr12:39050536	G/C	cg13010199	chr12:38710504	ALG10B	-0.62	-5.28	-0.51	1.14e-6	Morning vs. evening chronotype;
SKCM	cis	rs514406	0.825	rs1242328	chr1:53396869	A/G	cg08859206	chr1:53392774	SCP2	-0.62	-5.01	-0.49	3.28e-6	Monocyte count;
SKCM	cis	rs12134245	0.776	rs6688261	chr1:91987034	C/T	cg25838465	chr1:92012736	NA	-0.8	-8.58	-0.7	7.11e-13	Breast cancer;
SKCM	cis	rs2204008	0.837	rs11180549	chr12:38236950	A/G	cg26384229	chr12:38710491	ALG10B	0.87	6.9	0.62	1.21e-9	Bladder cancer;
SKCM	cis	rs2153535	0.542	rs1120393	chr6:8486890	G/A	cg07606381	chr6:8435919	SLC35B3	0.86	6.25	0.58	2.06e-8	Motion sickness;
SKCM	cis	rs2952156	0.920	rs903502	chr17:37829604	C/T	cg20243544	chr17:37824526	PNMT	0.75	6.2	0.57	2.48e-8	Asthma;
SKCM	cis	rs6866344	0.697	rs17184302	chr5:178127676	C/T	cg03877680	chr5:178157825	ZNF354A	0.82	5.7	0.54	2.03e-7	Neutrophil percentage of white cells;
SKCM	cis	rs561341	0.505	rs548298	chr17:30297494	C/A	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs2842992	1.000	rs2758322	chr6:160075188	G/T	cg11366901	chr6:160182831	ACAT2	0.78	5.75	0.55	1.66e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs7937682	0.564	rs10891277	chr11:111373103	A/G	cg09085632	chr11:111637200	PPP2R1B	0.69	5.05	0.5	2.81e-6	Primary sclerosing cholangitis;
SKCM	cis	rs523522	0.962	rs7471	chr12:120941215	T/C	cg12219531	chr12:120966889	COQ5	0.91	7.82	0.66	2.11e-11	High light scatter reticulocyte count;
SKCM	cis	rs2439831	0.850	rs28590651	chr15:44113016	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.35	7.75	0.66	2.9e-11	Lung cancer in ever smokers;
SKCM	cis	rs9858542	1.000	rs11718165	chr3:49696797	A/G	cg03060546	chr3:49711283	APEH	-0.79	-5.68	-0.54	2.18e-7	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs9300255	0.722	rs12322888	chr12:123825559	A/G	cg05973401	chr12:123451056	ABCB9	0.83	5.83	0.55	1.19e-7	Neutrophil percentage of white cells;
SKCM	cis	rs13343954	0.518	rs2216594	chr19:33533258	G/A	cg17764715	chr19:33622953	WDR88	0.73	5.13	0.5	2.1e-6	Colorectal cancer;
SKCM	cis	rs2243480	1.000	rs419603	chr7:65597341	C/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs1552244	1.000	rs7619340	chr3:10108178	C/T	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs860295	0.702	rs11264380	chr1:155520144	T/C	cg02153340	chr1:155202674	NA	-0.78	-5.52	-0.53	4.25e-7	Body mass index;
SKCM	cis	rs738322	0.600	rs7286105	chr22:38557821	A/G	cg25457927	chr22:38595422	NA	-0.53	-6.14	-0.57	3.24e-8	Cutaneous nevi;
SKCM	cis	rs478304	0.637	rs11227255	chr11:65454044	C/T	cg27068330	chr11:65405492	SIPA1	-0.88	-7.54	-0.65	7.28e-11	Acne (severe);
SKCM	cis	rs447735	0.587	rs258336	chr16:89720831	A/C	cg01097406	chr16:89675127	NA	0.45	5.11	0.5	2.25e-6	Hemoglobin concentration;
SKCM	cis	rs899997	1.000	rs11634628	chr15:79005579	G/A	cg04896959	chr15:78267971	NA	0.65	6.05	0.57	4.73e-8	Coronary artery disease or large artery stroke;
SKCM	cis	rs10752881	1.000	rs12028732	chr1:182985525	G/C	ch.1.3577855R	chr1:183094577	LAMC1	0.73	6.47	0.59	7.97e-9	Colorectal cancer;
SKCM	cis	rs4319547	0.697	rs7974262	chr12:122896385	C/T	cg23029597	chr12:123009494	RSRC2	0.73	5.37	0.52	7.93e-7	Body mass index;
SKCM	cis	rs1160297	0.609	rs10203699	chr2:53105568	A/G	cg07782112	chr2:53107842	NA	0.59	6.13	0.57	3.31e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs8077889	0.750	rs231539	chr17:41942109	T/C	cg26893861	chr17:41843967	DUSP3	-1.24	-6.69	-0.6	3.02e-9	Triglycerides;
SKCM	cis	rs8063761	0.640	rs4785760	chr16:90051438	G/A	cg08547343	chr16:90038815	CENPBD1;AFG3L1	0.81	7.32	0.64	1.94e-10	Squamous cell carcinoma;
SKCM	cis	rs1850744	0.702	rs9799502	chr4:9595942	G/A	cg15442990	chr4:9534313	NA	-1.3	-4.84	-0.48	6.55e-6	Economic and political preferences;
SKCM	cis	rs12477438	0.501	rs2632284	chr2:99775865	C/G	cg26064155	chr2:99771622	LIPT1;TSGA10	1.05	10.1	0.75	7.95e-16	Chronic sinus infection;
SKCM	cis	rs367615	0.506	rs2914684	chr5:108775110	C/T	cg17395555	chr5:108820864	NA	-0.75	-6.46	-0.59	8.27e-9	Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs9467773	0.620	rs3800303	chr6:26598188	A/G	cg15659132	chr6:26577336	NA	0.63	5.52	0.53	4.22e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs28595532	0.920	rs56302493	chr4:119772382	A/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs10504229	0.773	rs60466370	chr8:58171248	A/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs7954584	0.531	rs6486781	chr12:122318985	A/C	cg13699009	chr12:122356056	WDR66	0.48	5.63	0.54	2.72e-7	Mean corpuscular volume;
SKCM	cis	rs17685	0.712	rs59659102	chr7:75710114	G/A	cg01364799	chr7:75623366	TMEM120A	-0.72	-5.81	-0.55	1.31e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2999052	0.526	rs981447	chr3:127753688	G/A	cg09089421	chr3:127803668	RUVBL1	-0.54	-4.84	-0.48	6.5e-6	Hypospadias;
SKCM	cis	rs3784262	0.669	rs7180059	chr15:58288172	C/T	cg12031962	chr15:58353849	ALDH1A2	-0.41	-4.82	-0.48	6.93e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs10751667	0.666	rs7123912	chr11:963936	T/C	cg10932868	chr11:921992	NA	0.55	5.1	0.5	2.36e-6	Alzheimer's disease (late onset);
SKCM	cis	rs8180040	0.654	rs6773521	chr3:47234419	A/G	cg27129171	chr3:47204927	SETD2	-0.73	-5.25	-0.51	1.3e-6	Colorectal cancer;
SKCM	cis	rs7666738	0.791	rs7657399	chr4:98851861	T/C	cg17366294	chr4:99064904	C4orf37	0.56	4.87	0.48	5.62e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs941873	0.868	rs4980063	chr10:81105844	A/T	cg09469691	chr10:81107165	PPIF	0.74	7.44	0.64	1.13e-10	Height;
SKCM	cis	rs4642101	0.686	rs9822382	chr3:12828828	T/G	cg05775895	chr3:12838266	CAND2	0.69	6.24	0.58	2.07e-8	QRS complex (12-leadsum);
SKCM	cis	rs9916302	0.808	rs12943928	chr17:37611330	G/A	cg07936489	chr17:37558343	FBXL20	-0.86	-7.39	-0.64	1.42e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs4523957	0.651	rs7212342	chr17:2084305	A/G	cg16513277	chr17:2031491	SMG6	-0.79	-5.86	-0.55	1.07e-7	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs314370	0.951	rs3757868	chr7:100482720	G/A	cg10426581	chr7:100472382	SRRT	0.73	6.19	0.57	2.59e-8	Resting heart rate;
SKCM	cis	rs9325144	0.534	rs4882350	chr12:38686979	A/G	cg13010199	chr12:38710504	ALG10B	0.63	5.01	0.49	3.31e-6	Morning vs. evening chronotype;
SKCM	cis	rs12986445	0.688	rs6723069	chr2:26111315	G/T	cg07291958	chr2:26785531	C2orf70	0.55	4.92	0.49	4.8e-6	Multiple myeloma and monoclonal gammopathy;Multiple myeloma;
SKCM	cis	rs2370759	1.000	rs78959390	chr10:32616346	C/T	cg01819863	chr10:32635814	EPC1	0.98	5.43	0.52	6.26e-7	Sexual dysfunction (female);
SKCM	cis	rs6565180	0.926	rs4787643	chr16:30393660	G/A	cg17640201	chr16:30407289	ZNF48	0.94	7.06	0.62	6.08e-10	Tonsillectomy;
SKCM	cis	rs28386778	0.897	rs4968598	chr17:61835579	T/C	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.36	0.52	8.06e-7	Prudent dietary pattern;
SKCM	cis	rs1801251	1.000	rs283471	chr2:233656627	G/A	cg25237894	chr2:233734115	C2orf82	0.68	6.05	0.57	4.63e-8	Coronary artery disease;
SKCM	cis	rs1005277	0.579	rs116912400	chr10:38479207	G/T	cg25427524	chr10:38739819	LOC399744	-0.78	-7.75	-0.66	2.83e-11	Extrinsic epigenetic age acceleration;
SKCM	cis	rs7954584	0.583	rs6486782	chr12:122359172	T/C	cg13699009	chr12:122356056	WDR66	0.49	5.55	0.53	3.72e-7	Mean corpuscular volume;
SKCM	cis	rs13010713	0.840	rs4667135	chr2:182062281	C/T	cg21995919	chr2:182322279	ITGA4	-0.53	-5.11	-0.5	2.2e-6	Celiac disease;
SKCM	cis	rs898097	0.578	rs8069697	chr17:80908110	T/C	cg15369054	chr17:80825471	TBCD	-0.58	-5.64	-0.54	2.6e-7	Breast cancer;
SKCM	cis	rs6879260	0.714	rs888926	chr5:179738101	A/G	cg23248424	chr5:179741104	GFPT2	-0.69	-4.83	-0.48	6.61e-6	Height;
SKCM	cis	rs7811142	0.943	rs28578163	chr7:100044754	A/G	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.23	7.89	0.67	1.53e-11	Platelet count;
SKCM	cis	rs651907	0.535	rs34161138	chr3:101510388	T/C	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.78	6.72	0.61	2.65e-9	Colorectal cancer;
SKCM	cis	rs838147	0.873	rs11667321	chr19:49250538	A/G	cg13540341	chr19:49222985	MAMSTR	0.56	4.86	0.48	5.91e-6	Dietary macronutrient intake;
SKCM	cis	rs4237845	1.000	rs4237845	chr12:58302436	A/G	cg00677455	chr12:58241039	CTDSP2	-0.64	-5.32	-0.52	9.52e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs12477438	0.520	rs13035311	chr2:99717322	C/G	cg14399236	chr2:99771627	LIPT1;TSGA10	0.95	8.78	0.71	2.89e-13	Chronic sinus infection;
SKCM	cis	rs10179986	0.930	rs10199707	chr2:134870080	A/G	cg14579516	chr2:135677120	CCNT2	0.72	4.77	0.48	8.36e-6	Glucose homeostasis traits;
SKCM	trans	rs17685	0.753	rs1859791	chr7:75786043	T/C	cg19862616	chr7:65841803	NCRNA00174	0.92	9.38	0.73	2.02e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs9640161	0.742	rs2108852	chr7:150019628	T/C	cg10018233	chr7:150070692	REPIN1	0.75	6.05	0.56	4.81e-8	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs12497850	0.931	rs7623023	chr3:48914238	G/A	cg07636037	chr3:49044803	WDR6	1.01	10.82	0.77	3.36e-17	Parkinson's disease;
SKCM	cis	rs12986445	0.744	rs62127753	chr2:26143069	C/T	cg07291958	chr2:26785531	C2orf70	0.53	4.91	0.49	4.95e-6	Multiple myeloma and monoclonal gammopathy;Multiple myeloma;
SKCM	cis	rs644799	0.710	rs3017756	chr11:95537358	G/A	cg03916912	chr11:95522834	CEP57;FAM76B	0.8	6.71	0.6	2.8e-9	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs7635838	0.590	rs2256773	chr3:11386329	C/G	cg00170343	chr3:11313890	ATG7	0.71	5.6	0.54	3.13e-7	HDL cholesterol;
SKCM	cis	rs919433	0.889	rs787995	chr2:198216853	T/G	cg04278110	chr2:198063759	ANKRD44	0.73	5.0	0.49	3.51e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs873946	0.648	rs12782123	chr10:134554662	G/A	cg27286337	chr10:134555280	INPP5A	0.92	8.15	0.68	4.83e-12	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs10752881	0.905	rs10797830	chr1:183036274	A/T	ch.1.3577855R	chr1:183094577	LAMC1	0.78	6.87	0.61	1.42e-9	Colorectal cancer;
SKCM	cis	rs3820068	0.603	rs6429768	chr1:15963531	G/A	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs2239547	0.657	rs13072536	chr3:52861211	A/T	cg11645453	chr3:52864694	ITIH4	0.79	7.19	0.63	3.41e-10	Schizophrenia;
SKCM	cis	rs8016982	0.698	rs8011097	chr14:81702736	T/C	cg01989461	chr14:81687754	GTF2A1	0.88	6.89	0.62	1.26e-9	Schizophrenia;
SKCM	cis	rs3096299	0.933	rs28608022	chr16:89454292	C/T	cg02187348	chr16:89574699	SPG7	0.63	4.99	0.49	3.61e-6	Multiple myeloma (IgH translocation);
SKCM	cis	rs10779751	0.734	rs2791658	chr1:11127871	A/G	cg08854313	chr1:11322531	MTOR	0.77	5.52	0.53	4.36e-7	Body mass index;
SKCM	cis	rs6089829	0.925	rs4809270	chr20:61676709	C/A	cg03213289	chr20:61660250	NA	0.51	5.07	0.5	2.58e-6	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs2413583	0.642	rs932329	chr22:39673421	G/A	cg17798944	chr22:39715225	SNORD43;RPL3	0.84	4.86	0.48	5.86e-6	Ulcerative colitis;Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs950027	0.596	rs2467865	chr15:45638307	T/C	cg10760299	chr15:45669010	GATM	0.53	5.42	0.52	6.45e-7	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs7208859	0.623	rs8081299	chr17:29104296	G/A	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs6866344	0.697	rs17184302	chr5:178127676	C/T	cg10224037	chr5:178157518	ZNF354A	0.75	4.92	0.49	4.75e-6	Neutrophil percentage of white cells;
SKCM	cis	rs2075371	0.897	rs1646733	chr7:134002228	C/A	cg20476274	chr7:133979776	SLC35B4	1.07	11.43	0.79	2.45e-18	Mean platelet volume;
SKCM	cis	rs9916302	0.653	rs4239223	chr17:37717004	T/C	cg07936489	chr17:37558343	FBXL20	-1.01	-8.17	-0.68	4.34e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs10751667	0.643	rs7396623	chr11:934104	G/A	cg10932868	chr11:921992	NA	0.54	5.05	0.5	2.81e-6	Alzheimer's disease (late onset);
SKCM	cis	rs9549367	0.713	rs4907598	chr13:113861385	C/T	cg24722198	chr13:113567732	NA	-0.5	-5.18	-0.51	1.72e-6	Platelet distribution width;
SKCM	cis	rs1153858	1.000	rs12595087	chr15:45655232	A/G	cg10760299	chr15:45669010	GATM	0.62	6.35	0.58	1.3e-8	Homoarginine levels;
SKCM	cis	rs35955747	0.714	rs4820048	chr22:31854370	A/G	cg22777020	chr22:31556080	RNF185	-0.69	-5.12	-0.5	2.16e-6	Neutrophil count;Sum basophil neutrophil counts;
SKCM	cis	rs11122272	0.735	rs2066140	chr1:231504311	C/G	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	-0.58	-4.79	-0.48	7.93e-6	Hemoglobin concentration;
SKCM	cis	rs1577917	0.958	rs11752180	chr6:86573165	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.32	-0.52	9.66e-7	Response to antipsychotic treatment;
SKCM	cis	rs6879260	1.000	rs7706951	chr5:179733407	C/T	cg13944838	chr5:179740914	GFPT2	-0.7	-5.33	-0.52	9.41e-7	Height;
SKCM	cis	rs1635	0.655	rs58019071	chr6:28304016	T/C	cg15743358	chr6:28303923	ZNF323	-1.27	-5.15	-0.5	1.92e-6	Schizophrenia;
SKCM	cis	rs3784262	0.631	rs4646625	chr15:58256296	C/T	cg12031962	chr15:58353849	ALDH1A2	-0.42	-5.23	-0.51	1.37e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs8180040	0.726	rs11130110	chr3:47000606	T/C	cg27129171	chr3:47204927	SETD2	0.79	6.01	0.56	5.49e-8	Colorectal cancer;
SKCM	cis	rs9633740	1.000	rs9633740	chr10:82265271	A/G	cg01528321	chr10:82214614	TSPAN14	0.85	6.53	0.59	6.14e-9	Post bronchodilator FEV1;
SKCM	cis	rs11098499	0.739	rs6534130	chr4:120131339	A/T	cg09307838	chr4:120376055	NA	-0.76	-5.46	-0.53	5.45e-7	Corneal astigmatism;
SKCM	cis	rs55962025	0.804	rs3775061	chr4:3238754	A/G	cg11471262	chr4:3318911	RGS12	-0.65	-5.01	-0.49	3.37e-6	Parental longevity (mother's age at death);
SKCM	cis	rs8072100	1.000	rs4794048	chr17:45763073	A/C	cg25173405	chr17:45401733	C17orf57	-0.6	-5.41	-0.52	6.59e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs28595532	0.920	rs28797314	chr4:119783044	A/G	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs1325195	0.537	rs931441	chr1:179189845	C/G	cg25467746	chr1:179556597	NA	0.63	5.28	0.51	1.13e-6	IgE grass sensitization;
SKCM	cis	rs67460515	0.563	rs6441362	chr3:160877613	G/A	cg03342759	chr3:160939853	NMD3	-0.71	-5.95	-0.56	7.28e-8	Parkinson's disease;
SKCM	cis	rs17685	0.753	rs6951943	chr7:75772452	A/G	cg01364799	chr7:75623366	TMEM120A	-0.69	-5.59	-0.53	3.2e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs9290877	0.667	rs9864167	chr3:188456896	T/C	cg17392043	chr3:188495102	LPP	-0.64	-4.93	-0.49	4.6e-6	IgE levels;
SKCM	cis	rs8078723	0.966	rs57065891	chr17:38168227	C/T	cg17467752	chr17:38218738	THRA	0.68	6.3	0.58	1.61e-8	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs35306767	0.761	rs11253540	chr10:1011958	C/T	cg20503657	chr10:835505	NA	-0.77	-5.99	-0.56	6.1e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs854765	0.505	rs4924832	chr17:17897739	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.11	9.92	0.75	1.82e-15	Total body bone mineral density;
SKCM	cis	rs823143	0.570	rs1361754	chr1:205801872	C/T	cg17178900	chr1:205818956	PM20D1	-0.82	-7.95	-0.67	1.17e-11	Monocyte percentage of white cells;
SKCM	cis	rs7208859	0.573	rs8078656	chr17:29080971	A/T	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs9325144	0.600	rs10748442	chr12:38732939	A/T	cg13010199	chr12:38710504	ALG10B	0.64	5.11	0.5	2.28e-6	Morning vs. evening chronotype;
SKCM	cis	rs6756590	0.818	rs1033084	chr2:217209289	T/G	cg05686990	chr2:216964242	TMEM169	0.61	4.98	0.49	3.76e-6	Migraine;Cancer;
SKCM	cis	rs7666738	0.830	rs7662596	chr4:99019962	G/T	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7599312	0.534	rs10180824	chr2:213407975	G/A	cg20637307	chr2:213403960	ERBB4	0.76	5.6	0.54	3.12e-7	BMI (adjusted for smoking behaviour);BMI in non-smokers;Body mass index;Body mass index (joint analysis main effects and smoking interaction);
SKCM	cis	rs12541335	0.639	rs11135995	chr8:22200148	C/T	cg09517075	chr8:22133004	PIWIL2	-0.57	-5.26	-0.51	1.22e-6	Hypertriglyceridemia;
SKCM	cis	rs11690935	0.959	rs10174525	chr2:172635697	T/C	cg13550731	chr2:172543902	DYNC1I2	-0.94	-7.99	-0.67	9.97e-12	Schizophrenia;
SKCM	trans	rs2727020	0.615	rs4980435	chr11:49591576	G/A	cg03929089	chr4:120376271	NA	-0.84	-7.33	-0.64	1.8e-10	Coronary artery disease;
SKCM	cis	rs2180341	0.842	rs9375492	chr6:127545492	C/T	cg24812749	chr6:127587940	RNF146	-0.95	-7.05	-0.62	6.21e-10	Breast cancer;
SKCM	cis	rs9790314	1.000	rs7647327	chr3:161016421	T/C	cg03342759	chr3:160939853	NMD3	-0.72	-7.87	-0.67	1.65e-11	Morning vs. evening chronotype;
SKCM	cis	rs2033711	0.870	rs7259841	chr19:58951123	T/C	cg13877915	chr19:58951672	ZNF132	0.97	11.08	0.78	1.13e-17	Uric acid clearance;
SKCM	cis	rs6942756	0.840	rs963465	chr7:128875612	C/G	cg02491457	chr7:128862824	NA	0.7	4.79	0.48	7.71e-6	White matter hyperintensity burden;
SKCM	cis	rs2153535	0.623	rs2327055	chr6:8443145	A/G	cg23788917	chr6:8435910	SLC35B3	0.69	5.14	0.5	1.99e-6	Motion sickness;
SKCM	cis	rs9916302	0.904	rs34363096	chr17:37594294	G/A	cg07936489	chr17:37558343	FBXL20	-0.85	-7.35	-0.64	1.71e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs6570726	0.875	rs416243	chr6:145868081	A/T	cg23711669	chr6:146136114	FBXO30	0.72	6.88	0.61	1.35e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9902453	0.904	rs4567782	chr17:28268800	A/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.8	6.3	0.58	1.61e-8	Coffee consumption (cups per day);
SKCM	cis	rs62238980	0.614	rs117338064	chr22:32447147	A/C	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs1153858	1.000	rs1145091	chr15:45649996	A/G	cg10760299	chr15:45669010	GATM	0.63	6.32	0.58	1.49e-8	Homoarginine levels;
SKCM	cis	rs7809950	1.000	rs7786801	chr7:107085889	C/T	cg23024343	chr7:107201750	COG5	-0.76	-6.8	-0.61	1.89e-9	Coronary artery disease;
SKCM	cis	rs933688	1.000	rs2059207	chr5:90731931	C/A	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.1	8.62	0.7	5.93e-13	Smoking behavior;
SKCM	cis	rs7618915	0.547	rs2878726	chr3:52748271	C/G	cg18404041	chr3:52824283	ITIH1	-0.56	-4.94	-0.49	4.33e-6	Bipolar disorder;
SKCM	cis	rs9467773	0.595	rs12525810	chr6:26623511	T/A	cg15659132	chr6:26577336	NA	0.66	5.8	0.55	1.35e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs1348850	0.519	rs13034781	chr2:178523550	C/A	cg22681709	chr2:178499509	PDE11A	-0.61	-5.27	-0.51	1.17e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs10256972	0.630	rs10282584	chr7:1081442	C/T	cg02733842	chr7:1102375	C7orf50	-0.48	-5.31	-0.52	9.97e-7	Longevity;Endometriosis;
SKCM	cis	rs8077889	0.917	rs58080788	chr17:41902909	A/G	cg26893861	chr17:41843967	DUSP3	1.15	7.34	0.64	1.79e-10	Triglycerides;
SKCM	cis	rs28386778	0.897	rs4968599	chr17:61835992	T/C	cg01411255	chr17:61851458	DDX42;CCDC47	0.78	5.03	0.49	3.06e-6	Prudent dietary pattern;
SKCM	cis	rs9325144	0.650	rs6582624	chr12:38733475	A/T	cg26384229	chr12:38710491	ALG10B	-0.74	-6.39	-0.59	1.12e-8	Morning vs. evening chronotype;
SKCM	cis	rs7954584	1.000	rs7954584	chr12:122461566	G/A	cg13699009	chr12:122356056	WDR66	0.48	5.67	0.54	2.3e-7	Mean corpuscular volume;
SKCM	cis	rs7772486	0.875	rs1125461	chr6:146417653	C/T	cg05347473	chr6:146136440	FBXO30	0.64	5.77	0.55	1.51e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1451375	0.572	rs896309	chr7:50545022	A/G	cg18232548	chr7:50535776	DDC	-0.71	-4.77	-0.48	8.5e-6	Malaria;
SKCM	cis	rs35146811	0.844	rs34031156	chr7:99677917	T/A	cg22906224	chr7:99728672	NA	0.79	5.82	0.55	1.26e-7	Coronary artery disease;
SKCM	cis	rs7829975	0.871	rs777709	chr8:8583872	T/C	cg06636001	chr8:8085503	FLJ10661	-0.8	-7.62	-0.65	5.16e-11	Mood instability;
SKCM	cis	rs2153535	0.580	rs9378552	chr6:8463748	G/A	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs3785574	0.962	rs2584614	chr17:61929445	C/T	cg01411255	chr17:61851458	DDX42;CCDC47	1.15	12.64	0.82	1.42e-20	Height;
SKCM	trans	rs17685	0.697	rs2302437	chr7:75677016	G/A	cg19862616	chr7:65841803	NCRNA00174	-0.94	-9.39	-0.73	1.88e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs4924935	1.000	rs9905565	chr17:18758641	C/T	cg26378065	chr17:18585709	ZNF286B	0.74	5.37	0.52	7.92e-7	Pancreatic cancer;
SKCM	cis	rs708547	0.830	rs1713994	chr4:57868367	G/A	cg16868167	chr4:57843880	C4orf14;POLR2B	0.96	9.27	0.72	3.19e-14	Response to bleomycin (chromatid breaks);
SKCM	cis	rs12477438	0.520	rs11695379	chr2:99742161	A/G	cg14399236	chr2:99771627	LIPT1;TSGA10	0.97	8.87	0.71	1.96e-13	Chronic sinus infection;
SKCM	cis	rs7671266	0.578	rs73089942	chr4:10178235	G/T	cg09374173	chr4:9383942	NA	0.83	5.18	0.51	1.7e-6	Cardiovascular disease risk factors;
SKCM	cis	rs2832191	0.791	rs2065270	chr21:30485420	T/C	cg08807101	chr21:30365312	RNF160	-0.62	-4.94	-0.49	4.34e-6	Dental caries;
SKCM	cis	rs7215564	0.908	rs79961397	chr17:78687146	T/A	cg16980736	chr17:78789706	RPTOR	-0.88	-4.83	-0.48	6.66e-6	Myopia (pathological);
SKCM	cis	rs11734570	0.581	rs4401459	chr4:38585268	G/T	cg18361445	chr4:38666374	KLF3;FLJ13197	-0.84	-5.71	-0.54	1.98e-7	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs9303401	0.614	rs34900851	chr17:56566399	G/A	cg02118635	chr17:56770003	RAD51C;TEX14	0.8	5.33	0.52	9.25e-7	Cognitive test performance;
SKCM	cis	rs561341	1.000	rs68140514	chr17:30335781	T/C	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs732765	0.580	rs113868141	chr14:75233463	A/T	cg25946216	chr14:74253857	C14orf43	-0.93	-5.16	-0.5	1.82e-6	Non-small cell lung cancer;
SKCM	cis	rs78456975	0.628	rs13426896	chr2:1554768	C/T	cg01028140	chr2:1542097	TPO	-0.58	-5.24	-0.51	1.34e-6	Placebo response in major depressive disorder (% change in symptom score);
SKCM	cis	rs709400	0.628	rs6575983	chr14:103869849	C/G	cg26031613	chr14:104095156	KLC1	0.65	4.83	0.48	6.58e-6	Body mass index;
SKCM	cis	rs1014246	0.848	rs10787718	chr10:118467648	A/G	cg14919929	chr10:118506882	NA	-0.81	-6.06	-0.57	4.45e-8	Age at smoking initiation in chronic obstructive pulmonary disease;
SKCM	cis	rs6570726	0.791	rs6915094	chr6:145883540	C/G	cg23711669	chr6:146136114	FBXO30	0.87	9.14	0.72	5.82e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7927771	0.757	rs1057233	chr11:47376448	G/A	cg05585544	chr11:47624801	NA	0.57	4.86	0.48	6.06e-6	Subjective well-being;
SKCM	cis	rs2839186	0.558	rs2968	chr21:47608580	C/T	cg05896524	chr21:47604654	C21orf56	-0.73	-6.17	-0.57	2.85e-8	Testicular germ cell tumor;
SKCM	cis	rs6952808	0.965	rs4719318	chr7:1887930	G/A	cg04267008	chr7:1944627	MAD1L1	-0.8	-6.1	-0.57	3.78e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs10751667	0.643	rs11246362	chr11:969818	C/T	cg10932868	chr11:921992	NA	0.55	5.1	0.5	2.36e-6	Alzheimer's disease (late onset);
SKCM	cis	rs7772486	0.681	rs9390343	chr6:146010527	A/T	cg05347473	chr6:146136440	FBXO30	-0.56	-4.99	-0.49	3.65e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7666738	0.830	rs7673385	chr4:99024922	T/G	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs28386778	0.897	rs4968599	chr17:61835992	T/C	cg06873352	chr17:61820015	STRADA	0.76	6.34	0.58	1.38e-8	Prudent dietary pattern;
SKCM	cis	rs1707322	1.000	rs11211248	chr1:46476844	A/G	cg03146154	chr1:46216737	IPP	0.77	5.36	0.52	8.35e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7103648	0.618	rs11039284	chr11:47564785	A/G	cg20307385	chr11:47447363	PSMC3	0.86	5.81	0.55	1.28e-7	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs7208859	0.623	rs8075341	chr17:29136565	A/G	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs8060686	0.641	rs111227007	chr16:68093138	T/A	cg09117114	chr16:67998030	SLC12A4	-0.81	-5.29	-0.51	1.07e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs7659604	1.000	rs6816071	chr4:122665185	G/A	cg19671926	chr4:122722719	EXOSC9	-0.64	-4.78	-0.48	8.04e-6	Type 2 diabetes;
SKCM	cis	rs2228479	0.681	rs4287569	chr16:89957815	A/G	cg06558623	chr16:89946397	TCF25	1.25	7.18	0.63	3.53e-10	Skin colour saturation;
SKCM	cis	rs6570726	0.967	rs374728	chr6:145854598	T/A	cg23711669	chr6:146136114	FBXO30	0.7	6.71	0.61	2.76e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs748404	0.723	rs565658	chr15:43556307	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	0.7	5.77	0.55	1.53e-7	Lung cancer;
SKCM	cis	rs3820068	0.603	rs932602	chr1:15986087	A/G	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs3768617	0.565	rs2027080	chr1:183074415	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs10256972	0.552	rs2960837	chr7:1203957	A/G	cg09177884	chr7:1199841	ZFAND2A	-0.76	-6.39	-0.59	1.12e-8	Longevity;Endometriosis;
SKCM	cis	rs397020	0.904	rs203547	chr20:1195245	T/A	cg23117778	chr20:1206693	RAD21L1	0.8	7.83	0.66	2.01e-11	Multiple sclerosis;
SKCM	cis	rs17685	0.712	rs4732578	chr7:75721532	A/G	cg01364799	chr7:75623366	TMEM120A	-0.79	-6.37	-0.58	1.23e-8	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1878931	0.520	rs2015640	chr16:3465018	G/C	cg26668626	chr16:3451006	ZNF174;ZNF434	-0.86	-5.71	-0.54	1.92e-7	Body mass index (adult);
SKCM	cis	rs2811415	0.597	rs9812487	chr3:127807835	G/C	cg09089421	chr3:127803668	RUVBL1	1.0	8.69	0.7	4.4e-13	Lung function (FEV1/FVC);
SKCM	cis	rs9543976	0.858	rs8192763	chr13:76179170	A/T	cg01531495	chr13:76123901	UCHL3	0.9	4.99	0.49	3.52e-6	Diabetic retinopathy;
SKCM	cis	rs673604	1.000	rs11264119	chr1:35676580	C/G	cg12633102	chr1:35676489	NA	-0.68	-5.35	-0.52	8.54e-7	Endometrial cancer;
SKCM	cis	rs1577917	1.000	rs35761942	chr6:86629504	C/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.66	-5.74	-0.54	1.76e-7	Response to antipsychotic treatment;
SKCM	cis	rs35306767	0.761	rs12771539	chr10:1050653	A/G	cg25614935	chr10:1084866	C10orf110	0.72	5.67	0.54	2.31e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs472402	0.560	rs2288444	chr5:6619923	A/G	cg10789808	chr5:6633262	NSUN2;SRD5A1	-0.73	-4.77	-0.48	8.37e-6	Response to amphetamines;
SKCM	cis	rs10911251	0.508	rs2245784	chr1:183107665	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.76	7.28	0.64	2.26e-10	Colorectal cancer;
SKCM	cis	rs12586317	0.547	rs3759548	chr14:35450333	C/T	cg16230307	chr14:35515116	FAM177A1	0.76	5.22	0.51	1.43e-6	Psoriasis;
SKCM	cis	rs1153858	1.000	rs1719247	chr15:45620985	C/T	cg21132104	chr15:45694354	SPATA5L1	0.88	7.15	0.63	3.99e-10	Homoarginine levels;
SKCM	cis	rs7959452	0.535	rs7135092	chr12:69658330	T/C	cg20891283	chr12:69753455	YEATS4	0.73	6.51	0.59	6.69e-9	Blood protein levels;
SKCM	cis	rs2011503	0.882	rs8108777	chr19:19359058	C/A	cg11584989	chr19:19387371	SF4	0.77	5.09	0.5	2.41e-6	Bipolar disorder;
SKCM	cis	rs1185460	0.967	rs1784461	chr11:118937985	G/A	cg23280166	chr11:118938394	VPS11	0.59	5.41	0.52	6.78e-7	Coronary artery disease;
SKCM	cis	rs9913156	0.841	rs34230287	chr17:4613630	C/T	cg19197139	chr17:4613644	ARRB2	0.91	6.31	0.58	1.57e-8	Lymphocyte counts;
SKCM	cis	rs17376456	1.000	rs56046246	chr5:93531545	T/G	cg21475434	chr5:93447410	FAM172A	0.99	5.65	0.54	2.49e-7	Diabetic retinopathy;
SKCM	cis	rs2072499	0.838	rs2758619	chr1:156162559	A/G	cg24450063	chr1:156163899	SLC25A44	1.11	10.97	0.78	1.78e-17	Testicular germ cell tumor;
SKCM	cis	rs12148488	0.763	rs4886648	chr15:75308837	G/A	cg17294928	chr15:75287854	SCAMP5	0.68	4.98	0.49	3.72e-6	Caffeine consumption;
SKCM	trans	rs66573146	0.831	rs1048009	chr4:6988677	G/A	cg07817883	chr1:32538562	TMEM39B	1.91	8.25	0.68	3.05e-12	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs17376456	0.569	rs10050364	chr5:93064127	T/C	cg21475434	chr5:93447410	FAM172A	0.8	5.02	0.49	3.21e-6	Diabetic retinopathy;
SKCM	cis	rs28386778	0.897	rs8081454	chr17:61842646	A/G	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs2115536	1.000	rs2115536	chr15:80194247	C/T	cg00225070	chr15:80189496	MTHFS	0.76	5.1	0.5	2.31e-6	Eosinophil counts;Eosinophil percentage of white cells;Sum eosinophil basophil counts;Eosinophil percentage of granulocytes;Neutrophil percentage of granulocytes;
SKCM	cis	rs6500395	1.000	rs871903	chr16:48593643	A/C	cg04672837	chr16:48644449	N4BP1	0.69	5.73	0.54	1.8e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs9911578	1.000	rs302854	chr17:56683612	G/A	cg12560992	chr17:57184187	TRIM37	0.95	7.69	0.66	3.7e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs801193	1.000	rs2286684	chr7:66129830	G/T	cg11764359	chr7:65958608	NA	-0.83	-6.29	-0.58	1.71e-8	Aortic root size;
SKCM	cis	rs6951245	1.000	rs1997243	chr7:1083777	A/G	cg18402987	chr7:1209562	NA	1.14	6.01	0.56	5.68e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7618915	0.547	rs11130313	chr3:52676190	A/C	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs9733	0.818	rs4970926	chr1:150673684	T/C	cg13175981	chr1:150552382	MCL1	0.64	4.86	0.48	5.85e-6	Tonsillectomy;
SKCM	cis	rs6546550	0.713	rs6718517	chr2:70018462	T/C	cg02498382	chr2:70120550	SNRNP27	-0.47	-4.93	-0.49	4.53e-6	Prevalent atrial fibrillation;
SKCM	cis	rs28386778	0.966	rs2854206	chr17:61947203	G/A	cg26338869	chr17:61819248	STRADA	0.72	4.81	0.48	7.14e-6	Prudent dietary pattern;
SKCM	cis	rs4808199	0.895	rs7252888	chr19:19628037	C/T	cg03709012	chr19:19516395	GATAD2A	1.12	8.59	0.7	6.77e-13	Nonalcoholic fatty liver disease;
SKCM	cis	rs11098499	0.645	rs78422072	chr4:120281042	C/T	cg24375607	chr4:120327624	NA	0.62	4.77	0.48	8.45e-6	Corneal astigmatism;
SKCM	cis	rs9858542	0.953	rs3811697	chr3:49590770	C/T	cg03060546	chr3:49711283	APEH	-0.69	-5.11	-0.5	2.24e-6	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs826838	1.000	rs1684395	chr12:39083161	T/G	cg13010199	chr12:38710504	ALG10B	-0.76	-5.9	-0.56	8.97e-8	Heart rate;
SKCM	cis	rs12134245	0.874	rs35115044	chr1:92021650	A/G	cg02896835	chr1:92012615	NA	-0.58	-5.11	-0.5	2.26e-6	Breast cancer;
SKCM	cis	rs11105298	0.891	rs3825330	chr12:89933710	C/T	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.83	-5.18	-0.51	1.66e-6	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs7315438	0.719	rs4766766	chr12:115913665	G/C	cg04892836	chr12:115174285	NA	0.4	4.82	0.48	7.01e-6	Colorectal cancer;
SKCM	cis	rs6463523	0.898	rs66892628	chr7:759374	T/A	cg05729249	chr7:766119	PRKAR1B;HEATR2	0.91	7.19	0.63	3.45e-10	Subjective well-being;
SKCM	cis	rs28595532	0.764	rs55704595	chr4:119780607	G/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs58688157	0.880	rs12272314	chr11:590648	A/G	cg16486109	chr11:613632	IRF7	1.09	7.04	0.62	6.58e-10	Systemic lupus erythematosus;
SKCM	cis	rs7618915	0.501	rs10865974	chr3:52718280	A/C	cg18404041	chr3:52824283	ITIH1	0.53	4.77	0.48	8.42e-6	Bipolar disorder;
SKCM	cis	rs9611565	0.592	rs6519270	chr22:42078666	A/G	cg03806693	chr22:41940476	POLR3H	1.01	6.99	0.62	8.38e-10	Vitiligo;
SKCM	cis	rs2439831	0.681	rs1095386	chr15:43609509	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.29	9.4	0.73	1.78e-14	Lung cancer in ever smokers;
SKCM	cis	rs6921919	0.609	rs67211468	chr6:28391987	T/C	cg14547644	chr6:28411285	ZSCAN23	-0.58	-4.8	-0.48	7.46e-6	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs6545883	0.929	rs7606167	chr2:61742654	C/G	cg15711740	chr2:61764176	XPO1	-0.75	-5.3	-0.51	1.06e-6	Tuberculosis;
SKCM	cis	rs769267	1.000	rs2074090	chr19:19449686	G/T	cg26732615	chr19:19648335	CILP2;YJEFN3	-0.65	-5.91	-0.56	8.42e-8	Tonsillectomy;
SKCM	cis	rs6430585	0.697	rs6724569	chr2:136516970	G/A	cg07169764	chr2:136633963	MCM6	1.31	13.14	0.83	1.86e-21	Corneal structure;
SKCM	cis	rs6570726	0.791	rs6570695	chr6:145911286	C/A	cg23711669	chr6:146136114	FBXO30	0.88	8.39	0.69	1.67e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs12971120	0.891	rs4891557	chr18:72170299	C/T	cg26446133	chr18:72167187	CNDP2	-0.67	-5.21	-0.51	1.49e-6	Refractive error;
SKCM	cis	rs9814567	0.806	rs11927539	chr3:134319448	C/G	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.65	-5.19	-0.51	1.6e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs769267	0.930	rs7254927	chr19:19404786	C/G	cg26732615	chr19:19648335	CILP2;YJEFN3	0.64	5.94	0.56	7.41e-8	Tonsillectomy;
SKCM	cis	rs4132509	0.696	rs12023642	chr1:243767826	T/G	cg21452805	chr1:244014465	NA	0.89	5.5	0.53	4.66e-7	RR interval (heart rate);
SKCM	cis	rs248381	0.743	rs2461248	chr5:78400431	A/T	cg17568934	chr5:77892219	LHFPL2	0.51	4.77	0.47	8.55e-6	Toenail selenium levels;
SKCM	cis	rs2929278	0.617	rs575082	chr15:44110142	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	-0.75	-5.21	-0.51	1.52e-6	Schizophrenia;
SKCM	cis	rs477895	0.713	rs7952318	chr11:63961242	G/A	cg07220939	chr11:64358617	SLC22A12	0.68	4.84	0.48	6.31e-6	Mean platelet volume;
SKCM	cis	rs6866344	0.570	rs1079487	chr5:178136005	G/A	cg10224037	chr5:178157518	ZNF354A	0.84	6.3	0.58	1.65e-8	Neutrophil percentage of white cells;
SKCM	cis	rs10905065	0.965	rs2244755	chr10:5754611	G/A	cg09234995	chr10:5726438	C10orf18	-0.64	-5.44	-0.52	6.01e-7	Menopause (age at onset);
SKCM	cis	rs1577917	0.876	rs66986937	chr6:86532191	A/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.87	-8.71	-0.7	3.92e-13	Response to antipsychotic treatment;
SKCM	cis	rs10479542	0.549	rs4376229	chr5:179042971	A/G	cg19723775	chr5:179050963	HNRNPH1	0.72	5.85	0.55	1.08e-7	Lung cancer;
SKCM	cis	rs7179456	0.547	rs6494036	chr15:59015961	A/T	cg05156742	chr15:59063176	FAM63B	0.74	5.09	0.5	2.41e-6	Asperger disorder;
SKCM	cis	rs4589502	0.512	rs4395023	chr15:67097208	G/A	cg12317470	chr15:67143691	NA	0.83	4.95	0.49	4.26e-6	Lung cancer (smoking interaction);
SKCM	cis	rs9916302	0.904	rs8079355	chr17:37473018	G/A	cg07936489	chr17:37558343	FBXL20	0.84	6.75	0.61	2.32e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs2180341	0.722	rs9388555	chr6:127576363	G/A	cg24812749	chr6:127587940	RNF146	0.78	6.47	0.59	8.04e-9	Breast cancer;
SKCM	cis	rs7618915	0.547	rs11177	chr3:52721305	G/A	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs12451471	0.637	rs12950757	chr17:78096800	T/G	cg06718696	chr17:78121285	EIF4A3	0.9	6.15	0.57	3.1e-8	Plateletcrit;Mean corpuscular hemoglobin concentration;
SKCM	cis	rs12986445	1.000	rs12986445	chr2:26112518	T/A	cg07291958	chr2:26785531	C2orf70	0.54	4.92	0.49	4.77e-6	Multiple myeloma and monoclonal gammopathy;Multiple myeloma;
SKCM	trans	rs17685	0.775	rs11761172	chr7:75761547	C/T	cg19862616	chr7:65841803	NCRNA00174	0.94	9.49	0.73	1.22e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1577917	1.000	rs34106666	chr6:86676258	G/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.66	-5.72	-0.54	1.88e-7	Response to antipsychotic treatment;
SKCM	cis	rs4774899	0.966	rs1814585	chr15:57509058	A/G	cg01857019	chr15:57210107	LOC145783;TCF12	0.53	4.94	0.49	4.38e-6	Urinary tract infection frequency;
SKCM	cis	rs1865760	0.663	rs9467656	chr6:25993559	G/A	cg17691542	chr6:26056736	HIST1H1C	0.66	4.84	0.48	6.37e-6	Height;
SKCM	cis	rs9303401	0.659	rs34170300	chr17:56789905	G/C	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.16	0.57	2.91e-8	Cognitive test performance;
SKCM	cis	rs13256369	0.951	rs13260947	chr8:8565883	A/G	cg06636001	chr8:8085503	FLJ10661	0.8	6.06	0.57	4.62e-8	Obesity-related traits;
SKCM	cis	rs453301	0.686	rs4840389	chr8:8884503	G/C	cg06636001	chr8:8085503	FLJ10661	-0.74	-5.9	-0.56	8.9e-8	Joint mobility (Beighton score);
SKCM	cis	rs11608355	0.521	rs6606704	chr12:109814036	T/C	cg19025524	chr12:109796872	NA	-0.68	-6.16	-0.57	2.91e-8	Neuroticism;
SKCM	cis	rs4481887	1.000	rs10736378	chr1:248455769	T/G	cg00666640	chr1:248458726	OR2T12	0.58	4.83	0.48	6.68e-6	Common traits (Other);
SKCM	cis	rs5753618	0.504	rs8142121	chr22:31882785	G/A	cg02404636	chr22:31891804	SFI1	0.64	5.57	0.53	3.51e-7	Colorectal cancer;
SKCM	cis	rs10808739	0.702	rs28873972	chr8:65645038	T/C	cg05711235	chr8:65498612	NA	-0.81	-5.4	-0.52	7.01e-7	HIV-1 susceptibility;
SKCM	cis	rs7809950	0.817	rs2712195	chr7:107127496	C/T	cg23024343	chr7:107201750	COG5	-0.84	-7.84	-0.66	1.92e-11	Coronary artery disease;
SKCM	cis	rs7635838	0.557	rs347615	chr3:11277284	T/A	cg00170343	chr3:11313890	ATG7	0.78	5.86	0.55	1.07e-7	HDL cholesterol;
SKCM	cis	rs1843834	0.539	rs12694643	chr2:225446603	A/G	cg22455342	chr2:225449267	CUL3	0.76	5.56	0.53	3.62e-7	IgE levels in asthmatics (D.p. specific);
SKCM	cis	rs4523957	0.583	rs6503302	chr17:2052704	C/T	cg16513277	chr17:2031491	SMG6	-0.88	-5.81	-0.55	1.28e-7	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs9916302	0.752	rs11078895	chr17:37401051	A/G	cg07936489	chr17:37558343	FBXL20	-0.97	-7.47	-0.65	1.01e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs62238980	0.614	rs4821023	chr22:32414413	G/C	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs28595532	0.920	rs114168088	chr4:119772666	G/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs4927850	0.957	rs4927851	chr3:195751853	A/G	cg12923728	chr3:195709715	SDHAP1	-0.92	-6.11	-0.57	3.61e-8	Pancreatic cancer;
SKCM	cis	rs919433	0.963	rs13033821	chr2:198173536	T/G	cg04278110	chr2:198063759	ANKRD44	-0.69	-4.8	-0.48	7.58e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs9485372	1.000	rs9498287	chr6:149607644	A/C	cg03072286	chr6:150262044	ULBP2	-0.55	-4.89	-0.48	5.3e-6	Breast cancer;
SKCM	cis	rs7811142	1.000	rs1073	chr7:100031612	G/A	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.12	6.51	0.59	6.68e-9	Platelet count;
SKCM	cis	rs11671005	0.695	rs8106061	chr19:58917990	G/C	cg12042659	chr19:58951599	ZNF132	0.74	6.25	0.58	2.01e-8	Mean platelet volume;
SKCM	cis	rs6809651	0.524	rs79262908	chr3:185803594	C/T	cg00760338	chr3:185826511	ETV5	-0.9	-5.81	-0.55	1.32e-7	Body mass index in physically active individuals;Glomerular filtration rate (creatinine);Body mass index (joint analysis main effects and physical activity interaction);Body mass index;Body mass index in physically inactive individuals;
SKCM	cis	rs116095464	0.558	rs6555056	chr5:226222	T/C	cg22496380	chr5:211416	CCDC127	-0.96	-5.27	-0.51	1.18e-6	Breast cancer;
SKCM	cis	rs875971	0.929	rs4122249	chr7:65920936	T/C	cg18876405	chr7:65276391	NA	0.66	6.36	0.58	1.25e-8	Aortic root size;
SKCM	cis	rs67311347	0.869	rs6790495	chr3:40366770	C/T	cg00091569	chr3:40428383	ENTPD3	0.65	5.5	0.53	4.64e-7	Renal cell carcinoma;
SKCM	cis	rs763014	0.966	rs7198877	chr16:661439	A/G	cg09263875	chr16:632152	PIGQ	0.74	6.73	0.61	2.6e-9	Height;
SKCM	cis	rs8072100	1.000	rs8072100	chr17:45674687	A/T	cg08085267	chr17:45401833	C17orf57	0.64	5.91	0.56	8.45e-8	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	trans	rs11722228	0.549	rs2241488	chr4:10101131	T/C	cg26043149	chr18:55253948	FECH	0.94	8.04	0.67	7.81e-12	Gout;Urate levels;Serum uric acid levels;
SKCM	cis	rs4400599	0.618	rs9803862	chr1:154192143	A/G	cg26808167	chr1:154192205	UBAP2L;C1orf43	0.52	4.83	0.48	6.7e-6	Platelet distribution width;
SKCM	cis	rs2070488	0.804	rs13085153	chr3:38461279	A/G	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.73	5.86	0.55	1.04e-7	Electrocardiographic conduction measures;
SKCM	cis	rs7666738	0.830	rs4443295	chr4:99044935	G/A	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs62238980	0.614	rs2899174	chr22:32458789	T/C	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs763014	0.898	rs2017567	chr16:637212	T/C	cg09263875	chr16:632152	PIGQ	0.67	5.82	0.55	1.24e-7	Height;
SKCM	cis	rs826838	0.651	rs1843896	chr12:38612913	G/C	cg26384229	chr12:38710491	ALG10B	0.69	5.89	0.55	9.3e-8	Heart rate;
SKCM	cis	rs2180341	0.618	rs11154396	chr6:127638911	C/T	cg27446573	chr6:127587934	RNF146	0.69	5.46	0.53	5.54e-7	Breast cancer;
SKCM	cis	rs7618501	0.602	rs2624853	chr3:50128893	A/G	cg24110177	chr3:50126178	RBM5	0.61	5.18	0.51	1.71e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs11122272	0.732	rs2808605	chr1:231540187	A/C	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	-0.64	-5.18	-0.51	1.66e-6	Hemoglobin concentration;
SKCM	cis	rs17376456	0.825	rs10214278	chr5:93237679	C/T	cg25358565	chr5:93447407	FAM172A	-1.24	-7.48	-0.65	9.71e-11	Diabetic retinopathy;
SKCM	cis	rs1395	0.922	rs4665376	chr2:27509032	T/C	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.5	4.83	0.48	6.55e-6	Blood metabolite levels;
SKCM	cis	rs2120019	1.000	rs7162900	chr15:75368017	T/C	cg17294928	chr15:75287854	SCAMP5	-0.82	-6.77	-0.61	2.13e-9	Blood trace element (Zn levels);
SKCM	cis	rs7772486	0.701	rs11155438	chr6:145950112	C/G	cg23711669	chr6:146136114	FBXO30	0.93	10.47	0.76	1.56e-16	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs950776	0.518	rs12591557	chr15:78811732	A/G	cg06917634	chr15:78832804	PSMA4	1.01	10.48	0.76	1.5e-16	Sudden cardiac arrest;
SKCM	cis	rs854765	0.583	rs4925123	chr17:17784374	A/G	cg04398451	chr17:18023971	MYO15A	0.78	5.78	0.55	1.48e-7	Total body bone mineral density;
SKCM	cis	rs9467773	0.534	rs34453863	chr6:26628005	T/C	cg15659132	chr6:26577336	NA	0.66	5.87	0.55	9.9e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs2153535	0.580	rs9393021	chr6:8466123	A/G	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs7666738	0.546	rs10461174	chr4:98698293	G/A	cg17366294	chr4:99064904	C4orf37	0.64	5.05	0.5	2.78e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7618501	0.699	rs9862795	chr3:49915506	A/T	cg24110177	chr3:50126178	RBM5	-0.62	-5.37	-0.52	7.93e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs13118159	0.550	rs9685761	chr4:1377942	C/G	cg19318889	chr4:1322082	MAEA	0.82	6.35	0.58	1.33e-8	Longevity;
SKCM	cis	rs2180341	1.000	rs7776136	chr6:127638348	A/T	cg27446573	chr6:127587934	RNF146	0.96	8.65	0.7	5.19e-13	Breast cancer;
SKCM	cis	rs2243480	1.000	rs431318	chr7:65511597	G/A	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs62238980	0.522	rs76599991	chr22:32495779	G/A	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs6762	0.748	rs28677123	chr11:840604	C/G	cg16425592	chr11:842748	TSPAN4;POLR2L	-0.79	-5.8	-0.55	1.33e-7	Mean platelet volume;
SKCM	cis	rs778371	0.723	rs6710294	chr2:233579634	T/C	cg08000102	chr2:233561755	GIGYF2	0.89	7.35	0.64	1.65e-10	Schizophrenia;
SKCM	cis	rs2894969	0.664	rs11252703	chr10:4795125	A/T	cg08452525	chr10:5727808	C10orf18	-0.58	-4.85	-0.48	6.15e-6	Major depressive disorder;
SKCM	cis	rs9611565	0.765	rs28604950	chr22:41785812	A/G	cg03806693	chr22:41940476	POLR3H	-0.93	-5.97	-0.56	6.68e-8	Vitiligo;
SKCM	cis	rs2839186	0.903	rs61182475	chr21:47707050	T/A	cg05896524	chr21:47604654	C21orf56	0.69	5.67	0.54	2.29e-7	Testicular germ cell tumor;
SKCM	cis	rs7945705	0.967	rs10840148	chr11:8923528	C/T	cg13070366	chr11:9386451	NA	-0.65	-5.57	-0.53	3.47e-7	Hemoglobin concentration;
SKCM	cis	rs7829975	0.514	rs2976926	chr8:8261624	T/C	cg08975724	chr8:8085496	FLJ10661	0.61	4.95	0.49	4.18e-6	Mood instability;
SKCM	cis	rs10540	1.000	rs79808876	chr11:465763	C/A	cg03576123	chr11:487126	PTDSS2	-1.46	-7.68	-0.66	4e-11	Body mass index;
SKCM	cis	rs55823223	0.752	rs3744027	chr17:73888743	G/A	cg08125733	chr17:73851984	WBP2	1.0	5.36	0.52	8.33e-7	Psoriasis;
SKCM	cis	rs910316	0.967	rs4899551	chr14:75660246	C/G	cg11812906	chr14:75593930	NEK9	-0.74	-5.75	-0.55	1.69e-7	Height;
SKCM	cis	rs9581857	0.547	rs9581869	chr13:28082498	G/A	cg22138327	chr13:27999177	GTF3A	0.84	5.53	0.53	4.15e-7	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs62012628	0.527	rs12437868	chr15:79088460	T/C	cg04896959	chr15:78267971	NA	-0.69	-6.05	-0.56	4.81e-8	Diastolic blood pressure;
SKCM	cis	rs2120019	1.000	rs12901243	chr15:75374233	C/T	cg09165964	chr15:75287851	SCAMP5	-0.78	-6.63	-0.6	3.95e-9	Blood trace element (Zn levels);
SKCM	cis	rs12824058	0.831	rs11060826	chr12:130809931	G/C	cg26677194	chr12:130822605	PIWIL1	0.71	5.83	0.55	1.17e-7	Menopause (age at onset);
SKCM	cis	rs763121	0.853	rs138713	chr22:39142615	T/C	cg06022373	chr22:39101656	GTPBP1	0.78	4.83	0.48	6.58e-6	Menopause (age at onset);
SKCM	cis	rs7666738	0.606	rs10006414	chr4:99101401	T/C	cg05340658	chr4:99064831	C4orf37	0.62	4.77	0.47	8.51e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2739330	0.734	rs2000467	chr22:24241533	C/T	cg24846343	chr22:24311635	DDTL	-0.58	-5.35	-0.52	8.66e-7	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs875971	1.000	rs1968225	chr7:65874773	T/C	cg18876405	chr7:65276391	NA	0.67	6.65	0.6	3.61e-9	Aortic root size;
SKCM	cis	rs7829975	0.539	rs883647	chr8:8569724	G/A	cg06636001	chr8:8085503	FLJ10661	-0.71	-5.23	-0.51	1.39e-6	Mood instability;
SKCM	cis	rs10876993	0.928	rs1689594	chr12:58057156	T/C	cg18357645	chr12:58087776	OS9	0.61	5.65	0.54	2.52e-7	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs7659604	0.539	rs56159666	chr4:122782879	G/A	cg19748678	chr4:122722346	EXOSC9	0.65	5.34	0.52	8.74e-7	Type 2 diabetes;
SKCM	cis	rs870825	0.616	rs28500698	chr4:185627746	A/C	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs2268241	0.938	rs9808753	chr21:34787312	A/G	cg14850771	chr21:34775459	IFNGR2	1.1	6.95	0.62	9.78e-10	Obesity-related traits;
SKCM	cis	rs9910055	0.718	rs7212854	chr17:42254417	A/G	cg08499158	chr17:42289980	UBTF	-0.85	-7.66	-0.66	4.36e-11	Total body bone mineral density;
SKCM	cis	rs870825	0.655	rs72703561	chr4:185630890	T/C	cg04058563	chr4:185651563	MLF1IP	1.08	7.26	0.64	2.51e-10	Blood protein levels;
SKCM	cis	rs10883723	0.810	rs6584504	chr10:104253507	T/C	cg11453585	chr10:104263688	ACTR1A;SUFU	0.75	5.7	0.54	2.03e-7	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs362296	0.698	rs3135172	chr4:3258735	A/G	cg05297308	chr4:3317976	RGS12	-0.75	-6.12	-0.57	3.58e-8	Parental longevity (mother's age at death);
SKCM	cis	rs4423214	0.840	rs1790328	chr11:71148038	G/A	cg05163923	chr11:71159392	DHCR7	-0.7	-6.35	-0.58	1.35e-8	Vitamin D levels;
SKCM	cis	rs1577917	0.958	rs12202712	chr6:86578541	T/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.81	-7.92	-0.67	1.35e-11	Response to antipsychotic treatment;
SKCM	cis	rs1005277	0.683	rs7923868	chr10:37989766	T/C	cg00409905	chr10:38381863	ZNF37A	-0.56	-4.92	-0.49	4.79e-6	Extrinsic epigenetic age acceleration;
SKCM	cis	rs6545883	0.894	rs778143	chr2:61581890	A/C	cg15711740	chr2:61764176	XPO1	-0.68	-4.82	-0.48	6.94e-6	Tuberculosis;
SKCM	cis	rs6580649	0.941	rs12580764	chr12:48453882	G/A	cg05342945	chr12:48394962	COL2A1	0.73	5.2	0.51	1.53e-6	Lung cancer;
SKCM	cis	rs1669338	0.588	rs6784329	chr3:3200013	C/T	cg16797762	chr3:3221439	CRBN	-0.96	-5.49	-0.53	4.78e-7	White matter integrity;
SKCM	cis	rs4642101	0.793	rs6763619	chr3:12822147	T/G	cg05775895	chr3:12838266	CAND2	0.63	5.82	0.55	1.22e-7	QRS complex (12-leadsum);
SKCM	cis	rs7208859	0.673	rs11652370	chr17:29097223	G/A	cg14067834	chr17:29058358	SUZ12P	0.99	5.11	0.5	2.22e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs1506636	1.000	rs652497	chr7:123423671	G/T	cg03229431	chr7:123269106	ASB15	0.66	5.29	0.51	1.1e-6	Plateletcrit;Platelet count;
SKCM	cis	rs1801251	1.000	rs4973053	chr2:233670099	G/A	cg25237894	chr2:233734115	C2orf82	-0.58	-5.74	-0.54	1.75e-7	Coronary artery disease;
SKCM	cis	rs2153535	0.562	rs10458225	chr6:8386004	G/A	cg07606381	chr6:8435919	SLC35B3	-0.88	-7.21	-0.63	3.16e-10	Motion sickness;
SKCM	cis	rs11098499	0.697	rs6832410	chr4:120296800	A/G	cg24375607	chr4:120327624	NA	0.65	4.97	0.49	3.87e-6	Corneal astigmatism;
SKCM	cis	rs4803468	0.967	rs3826713	chr19:41892269	C/T	cg09537434	chr19:41945824	ATP5SL	-1.08	-13.01	-0.83	3.1e-21	Height;
SKCM	cis	rs1577917	1.000	rs12203924	chr6:86776412	A/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.83	-8.15	-0.68	4.73e-12	Response to antipsychotic treatment;
SKCM	cis	rs4808199	0.901	rs12973258	chr19:19488718	T/C	cg03709012	chr19:19516395	GATAD2A	1.14	8.76	0.7	3.13e-13	Nonalcoholic fatty liver disease;
SKCM	cis	rs6951245	1.000	rs77760339	chr7:1083927	G/T	cg24642844	chr7:1081250	C7orf50	-0.94	-6.32	-0.58	1.48e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs873946	0.586	rs3793686	chr10:134569559	A/G	cg26818010	chr10:134567672	INPP5A	-0.79	-6.03	-0.56	5.11e-8	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs13294100	0.929	rs8181077	chr9:17580616	A/T	cg11213383	chr9:17579734	SH3GL2	-0.51	-4.97	-0.49	3.95e-6	Parkinson's disease;
SKCM	cis	rs9815354	0.812	rs73069213	chr3:41940590	G/A	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs3087591	0.922	rs2905788	chr17:29480295	C/T	cg24425628	chr17:29625626	OMG;NF1	0.64	5.26	0.51	1.21e-6	Hip circumference;
SKCM	cis	rs7811142	0.830	rs11761426	chr7:99956893	A/T	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.07	6.7	0.6	2.88e-9	Platelet count;
SKCM	cis	rs823143	0.570	rs823084	chr1:205798313	G/T	cg24503407	chr1:205819492	PM20D1	0.93	9.13	0.72	6.02e-14	Monocyte percentage of white cells;
SKCM	cis	rs9640161	0.617	rs56019796	chr7:150009226	T/C	cg10018233	chr7:150070692	REPIN1	0.7	5.68	0.54	2.21e-7	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs854765	0.587	rs4077828	chr17:17833644	A/T	cg04398451	chr17:18023971	MYO15A	-0.85	-6.05	-0.57	4.75e-8	Total body bone mineral density;
SKCM	cis	rs2832191	0.692	rs2245517	chr21:30357968	C/T	cg08807101	chr21:30365312	RNF160	0.76	6.34	0.58	1.38e-8	Dental caries;
SKCM	cis	rs9611565	0.722	rs202635	chr22:41809637	C/T	cg03806693	chr22:41940476	POLR3H	1.02	6.92	0.62	1.13e-9	Vitiligo;
SKCM	cis	rs9926296	0.533	rs9938865	chr16:89867797	A/G	cg26513180	chr16:89883248	FANCA	0.98	11.26	0.79	5.13e-18	Vitiligo;
SKCM	cis	rs9803723	0.682	rs61774796	chr1:25448466	C/T	cg20685674	chr1:26233538	STMN1	0.49	4.8	0.48	7.4e-6	Male-pattern baldness;
SKCM	cis	rs2204008	0.837	rs11183232	chr12:37941053	A/G	cg13010199	chr12:38710504	ALG10B	0.63	5.02	0.49	3.24e-6	Bladder cancer;
SKCM	cis	rs72949976	0.606	rs1922797	chr2:214027642	G/A	cg08319019	chr2:214017104	IKZF2	0.85	6.8	0.61	1.87e-9	Lung cancer;Squamous cell lung carcinoma;
SKCM	cis	rs7208859	0.623	rs7223209	chr17:29107220	C/A	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs898097	0.756	rs56249965	chr17:80806603	C/G	cg15369054	chr17:80825471	TBCD	0.64	5.61	0.54	2.98e-7	Breast cancer;
SKCM	cis	rs8180040	0.764	rs4683324	chr3:47251284	T/C	cg27129171	chr3:47204927	SETD2	0.8	6.46	0.59	8.31e-9	Colorectal cancer;
SKCM	cis	rs6570726	0.764	rs9399553	chr6:145873664	A/T	cg23711669	chr6:146136114	FBXO30	0.87	9.1	0.72	6.9e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6580649	0.843	rs3803184	chr12:48398002	G/C	cg05342945	chr12:48394962	COL2A1	-0.76	-5.48	-0.53	5.05e-7	Lung cancer;
SKCM	cis	rs2224391	1.000	rs2753246	chr6:5261845	A/G	cg09085698	chr6:5261316	LYRM4;FARS2	-0.77	-5.73	-0.54	1.79e-7	Height;
SKCM	cis	rs2980439	0.846	rs2980437	chr8:8094763	C/T	cg15556689	chr8:8085844	FLJ10661	-0.85	-6.8	-0.61	1.85e-9	Neuroticism;
SKCM	cis	rs12477438	0.520	rs2969379	chr2:99776686	G/A	cg26064155	chr2:99771622	LIPT1;TSGA10	1.05	10.1	0.75	7.95e-16	Chronic sinus infection;
SKCM	cis	rs7100689	0.753	rs4934125	chr10:82147466	T/C	cg01528321	chr10:82214614	TSPAN14	0.85	7.98	0.67	1.04e-11	Post bronchodilator FEV1;
SKCM	cis	rs2777491	0.574	rs2730056	chr15:41735785	A/G	cg18705301	chr15:41695430	NDUFAF1	-1.19	-13.25	-0.83	1.15e-21	Ulcerative colitis;
SKCM	cis	rs5753618	0.583	rs34545960	chr22:31812462	G/A	cg02404636	chr22:31891804	SFI1	0.58	4.97	0.49	3.86e-6	Colorectal cancer;
SKCM	cis	rs2386661	0.704	rs2386650	chr10:5678058	G/A	cg12223502	chr10:5658492	NA	-0.56	-4.79	-0.48	7.72e-6	Breast cancer;
SKCM	cis	rs61776719	0.747	rs28428561	chr1:38434306	G/A	cg12658694	chr1:38397304	INPP5B	-0.72	-6.62	-0.6	4.07e-9	Coronary artery disease;
SKCM	cis	rs9581857	0.547	rs9581881	chr13:28106637	A/G	cg22138327	chr13:27999177	GTF3A	0.84	5.73	0.54	1.79e-7	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs28595532	0.920	rs114410095	chr4:119731110	G/A	cg21605333	chr4:119757512	SEC24D	1.36	8.05	0.67	7.69e-12	Cannabis dependence symptom count;
SKCM	cis	rs8067545	0.611	rs2703814	chr17:20117151	T/C	cg13482628	chr17:19912719	NA	-0.66	-5.59	-0.53	3.23e-7	Schizophrenia;
SKCM	cis	rs919433	0.963	rs4850429	chr2:198178409	A/G	cg04278110	chr2:198063759	ANKRD44	0.69	4.8	0.48	7.58e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs933688	1.000	rs12651840	chr5:90729592	T/C	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.05	8.46	0.69	1.19e-12	Smoking behavior;
SKCM	cis	rs8072100	0.967	rs11079784	chr17:45702280	A/G	cg08085267	chr17:45401833	C17orf57	0.6	5.27	0.51	1.18e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs561341	1.000	rs2470267	chr17:30274132	G/A	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs1707322	0.721	rs61784796	chr1:46163256	A/G	cg03146154	chr1:46216737	IPP	0.84	6.2	0.57	2.51e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs9902453	1.000	rs56280226	chr17:28429575	T/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.5	0.53	4.67e-7	Coffee consumption (cups per day);
SKCM	cis	rs11098499	0.604	rs17051352	chr4:120581427	G/A	cg09307838	chr4:120376055	NA	1.03	8.62	0.7	6.02e-13	Corneal astigmatism;
SKCM	cis	rs4523957	0.690	rs11078855	chr17:2091308	A/G	cg16513277	chr17:2031491	SMG6	0.76	5.08	0.5	2.48e-6	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs7666738	0.570	rs1921415	chr4:99093804	C/T	cg17366294	chr4:99064904	C4orf37	0.62	5.03	0.49	3.06e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2404602	0.608	rs12911035	chr15:76606591	T/C	cg22467129	chr15:76604101	ETFA	-0.64	-5.19	-0.51	1.65e-6	Blood metabolite levels;
SKCM	cis	rs2153535	0.580	rs2327058	chr6:8447018	C/T	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs2180341	0.960	rs9398839	chr6:127665863	G/A	cg24812749	chr6:127587940	RNF146	0.85	7.37	0.64	1.56e-10	Breast cancer;
SKCM	cis	rs12142240	0.667	rs41293287	chr1:46808852	C/T	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs2153535	0.541	rs7774752	chr6:8468978	C/T	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs1218582	0.772	rs4845682	chr1:154877105	T/C	cg24250549	chr1:154909240	PMVK	0.87	8.7	0.7	4.13e-13	Prostate cancer;
SKCM	cis	rs6982751	0.611	rs56166963	chr8:10809045	G/A	cg01383082	chr8:11323474	FAM167A	0.86	4.98	0.49	3.74e-6	Asthma and hay fever;
SKCM	cis	rs4919694	1.000	rs4917382	chr10:104838510	G/A	cg04362960	chr10:104952993	NT5C2	0.76	4.92	0.49	4.65e-6	Arsenic metabolism;
SKCM	cis	rs9916302	0.731	rs11868030	chr17:37650332	A/G	cg07936489	chr17:37558343	FBXL20	-0.9	-8.1	-0.68	6.05e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs7216064	0.953	rs4790905	chr17:65863350	C/A	cg12091567	chr17:66097778	LOC651250	-0.75	-5.27	-0.51	1.19e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs2070488	0.965	rs13097628	chr3:38521156	T/C	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.98	9.25	0.72	3.55e-14	Electrocardiographic conduction measures;
SKCM	cis	rs11098499	0.954	rs17046116	chr4:120387259	G/A	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs7666738	0.830	rs11931166	chr4:99054187	A/T	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs3768617	0.528	rs3736888	chr1:183084607	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs67311347	0.544	rs2123998	chr3:40359005	C/G	cg00656387	chr3:40428638	ENTPD3	-0.57	-5.13	-0.5	2.05e-6	Renal cell carcinoma;
SKCM	cis	rs1957429	0.808	rs1951492	chr14:65346895	G/A	cg23373153	chr14:65346875	NA	1.07	6.14	0.57	3.19e-8	Pediatric areal bone mineral density (radius);
SKCM	cis	rs9916302	0.645	rs1053651	chr17:37822311	A/C	cg00129232	chr17:37814104	STARD3	-0.7	-5.92	-0.56	8.07e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs951366	0.789	rs1775154	chr1:205696615	T/A	cg24503407	chr1:205819492	PM20D1	0.89	7.38	0.64	1.48e-10	Menarche (age at onset);
SKCM	cis	rs1256061	0.603	rs1256039	chr14:64738979	G/C	cg21174375	chr14:64681225	SYNE2	0.47	4.95	0.49	4.15e-6	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs208520	0.661	rs4710566	chr6:66848538	G/A	cg07460842	chr6:66804631	NA	-1.11	-8.46	-0.69	1.21e-12	Exhaled nitric oxide output;
SKCM	cis	rs2836974	0.831	rs6517521	chr21:40551588	A/G	cg11644478	chr21:40555479	PSMG1	0.97	10.21	0.76	5.08e-16	Cognitive function;
SKCM	trans	rs561341	1.000	rs564714	chr17:30318404	C/T	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs9815354	0.812	rs17218504	chr3:41987278	A/G	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs72781680	0.898	rs12614616	chr2:23996501	T/G	cg08917208	chr2:24149416	ATAD2B	0.92	4.85	0.48	6.19e-6	Lymphocyte counts;
SKCM	cis	rs1577917	0.958	rs36035797	chr6:86562880	G/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.32	-0.52	9.66e-7	Response to antipsychotic treatment;
SKCM	cis	rs6546550	0.901	rs7573442	chr2:70154037	G/A	cg02498382	chr2:70120550	SNRNP27	-0.45	-4.88	-0.48	5.4e-6	Prevalent atrial fibrillation;
SKCM	cis	rs7927771	0.524	rs7107792	chr11:47669249	A/C	cg20307385	chr11:47447363	PSMC3	0.72	5.81	0.55	1.31e-7	Subjective well-being;
SKCM	cis	rs12540874	0.529	rs732215	chr7:50544063	A/C	cg18232548	chr7:50535776	DDC	-0.83	-6.28	-0.58	1.8e-8	Systemic sclerosis;
SKCM	cis	rs9325144	0.600	rs12424410	chr12:38758035	A/T	cg13010199	chr12:38710504	ALG10B	-0.66	-5.44	-0.52	5.88e-7	Morning vs. evening chronotype;
SKCM	cis	rs1059312	0.772	rs11609637	chr12:129300202	T/G	cg09035930	chr12:129282057	SLC15A4	0.77	8.06	0.67	7.15e-12	Systemic lupus erythematosus;
SKCM	trans	rs5756813	0.661	rs2071910	chr22:38204259	C/T	cg19894588	chr14:64061835	NA	-0.89	-7.5	-0.65	8.56e-11	Optic cup area;Vertical cup-disc ratio;
SKCM	cis	rs11170631	0.507	rs12307701	chr12:54090724	A/C	cg16917193	chr12:54089295	NA	0.61	5.13	0.5	2.06e-6	Height;
SKCM	cis	rs1577917	0.816	rs12664099	chr6:86648572	A/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.62	-5.24	-0.51	1.33e-6	Response to antipsychotic treatment;
SKCM	cis	rs992157	1.000	rs2292553	chr2:219146803	G/A	cg00012203	chr2:219082015	ARPC2	0.75	6.25	0.58	2.02e-8	Colorectal cancer;
SKCM	cis	rs12142240	0.698	rs57267378	chr1:46816644	A/G	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs7666738	0.830	rs1426669	chr4:98945534	C/T	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs910316	1.000	rs10140851	chr14:75512612	G/A	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.89e-7	Height;
SKCM	cis	rs72781680	1.000	rs56104215	chr2:24133590	T/C	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	cis	rs1799949	1.000	rs12516	chr17:41196408	G/A	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.06	-0.57	4.62e-8	Menopause (age at onset);
SKCM	cis	rs2811415	0.597	rs2878507	chr3:127793923	G/A	cg09089421	chr3:127803668	RUVBL1	1.0	8.69	0.7	4.4e-13	Lung function (FEV1/FVC);
SKCM	cis	rs9900062	0.885	rs4790966	chr17:62759092	G/A	cg02097616	chr17:62675921	NA	-0.71	-5.52	-0.53	4.33e-7	QT interval;
SKCM	cis	rs1218582	0.600	rs72702224	chr1:154911689	G/A	cg24250549	chr1:154909240	PMVK	0.82	7.85	0.66	1.8e-11	Prostate cancer;
SKCM	cis	rs6001027	0.540	rs1005529	chr22:38541266	T/C	cg25457927	chr22:38595422	NA	-0.44	-5.39	-0.52	7.38e-7	Melanoma;
SKCM	cis	rs1325195	0.520	rs3122378	chr1:179234045	A/C	cg10806749	chr1:179558114	NA	0.54	5.12	0.5	2.16e-6	IgE grass sensitization;
SKCM	cis	rs4819052	0.851	rs2838848	chr21:46671017	A/G	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.42	0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs2836974	0.897	rs2836932	chr21:40546717	G/A	cg17971929	chr21:40555470	PSMG1	0.87	8.48	0.69	1.1e-12	Cognitive function;
SKCM	trans	rs1814175	0.645	rs28538913	chr11:50040718	C/T	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs2180341	0.960	rs7756884	chr6:127684018	A/G	cg27446573	chr6:127587934	RNF146	0.94	8.11	0.68	5.63e-12	Breast cancer;
SKCM	cis	rs2479724	0.591	rs2479723	chr6:41890835	G/A	cg17623882	chr6:41773611	USP49	-0.67	-4.84	-0.48	6.45e-6	Menarche (age at onset);
SKCM	cis	rs1799949	0.602	rs4600503	chr17:41414324	C/G	cg05368731	chr17:41323189	NBR1	0.85	7.32	0.64	1.89e-10	Menopause (age at onset);
SKCM	cis	rs1046896	0.553	rs1044661	chr17:80901020	G/A	cg02711726	chr17:80685570	FN3KRP	-0.63	-4.93	-0.49	4.5e-6	Glycated hemoglobin levels;
SKCM	cis	rs6500395	0.925	rs6500396	chr16:48625458	A/T	cg04672837	chr16:48644449	N4BP1	0.69	5.88	0.55	9.68e-8	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs394563	0.591	rs237029	chr6:149717425	A/G	cg16235748	chr6:149772707	ZC3H12D	-0.45	-5.09	-0.5	2.44e-6	Dupuytren's disease;
SKCM	cis	rs9910055	0.659	rs7214540	chr17:42256604	A/G	cg10896456	chr17:42255109	ASB16;C17orf65	0.68	7.28	0.64	2.25e-10	Total body bone mineral density;
SKCM	cis	rs8067545	0.611	rs9893832	chr17:20038273	A/G	cg13482628	chr17:19912719	NA	0.66	5.61	0.54	2.98e-7	Schizophrenia;
SKCM	cis	rs6430585	0.527	rs62168830	chr2:136443900	A/T	cg07169764	chr2:136633963	MCM6	1.02	7.68	0.66	3.84e-11	Corneal structure;
SKCM	cis	rs28386778	0.897	rs2584608	chr17:61936710	A/G	cg06873352	chr17:61820015	STRADA	0.75	6.24	0.58	2.1e-8	Prudent dietary pattern;
SKCM	cis	rs769267	0.899	rs67720221	chr19:19440864	C/T	cg03709012	chr19:19516395	GATAD2A	-0.86	-7.15	-0.63	4.06e-10	Tonsillectomy;
SKCM	cis	rs9790314	1.000	rs1382428	chr3:161032386	A/C	cg03342759	chr3:160939853	NMD3	-0.72	-7.87	-0.67	1.65e-11	Morning vs. evening chronotype;
SKCM	cis	rs453301	0.686	rs3989373	chr8:8911308	G/T	cg06636001	chr8:8085503	FLJ10661	-0.66	-4.82	-0.48	6.97e-6	Joint mobility (Beighton score);
SKCM	cis	rs362296	0.698	rs3095081	chr4:3263776	C/T	cg11471262	chr4:3318911	RGS12	-0.73	-6.73	-0.61	2.53e-9	Parental longevity (mother's age at death);
SKCM	cis	rs28595532	0.920	rs114547492	chr4:119773078	G/C	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	trans	rs10506458	0.915	rs1463821	chr12:63402875	C/G	cg03429785	chr15:59498649	MYO1E;LDHAL6B	1.38	7.54	0.65	7.13e-11	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs6930083	0.713	rs1321308	chr6:36638691	A/C	cg08179530	chr6:36648295	CDKN1A	-0.7	-5.44	-0.52	6.04e-7	Coronary artery disease;
SKCM	cis	rs4972806	0.849	rs2857535	chr2:177036211	G/A	cg03152288	chr2:177042942	NA	0.57	4.99	0.49	3.52e-6	IgG glycosylation;
SKCM	cis	rs7659604	0.539	rs7699776	chr4:122753885	A/G	cg06713675	chr4:122721982	EXOSC9	-0.75	-7.32	-0.64	1.94e-10	Type 2 diabetes;
SKCM	cis	rs28386778	0.897	rs1062791	chr17:61896487	C/T	cg06873352	chr17:61820015	STRADA	0.76	6.46	0.59	8.18e-9	Prudent dietary pattern;
SKCM	cis	rs1577917	1.000	rs13194429	chr6:86646705	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.85	-8.62	-0.7	5.82e-13	Response to antipsychotic treatment;
SKCM	cis	rs7632954	0.567	rs9849204	chr3:8537944	A/G	cg06697448	chr3:8544912	LMCD1	-0.61	-5.25	-0.51	1.28e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs796364	0.951	rs971232	chr2:200792881	C/T	cg12253985	chr2:200820533	C2orf60;C2orf47	0.85	5.39	0.52	7.18e-7	Schizophrenia;
SKCM	cis	rs28595532	0.920	rs116023902	chr4:119725131	A/G	cg14228332	chr4:119757509	SEC24D	1.07	5.49	0.53	4.77e-7	Cannabis dependence symptom count;
SKCM	cis	rs6951245	1.000	rs28528096	chr7:1070912	G/C	cg03188948	chr7:1209495	NA	1.12	6.17	0.57	2.88e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs870825	0.860	rs2696044	chr4:185595988	C/G	cg04058563	chr4:185651563	MLF1IP	0.88	5.8	0.55	1.33e-7	Blood protein levels;
SKCM	cis	rs9303401	0.659	rs62083368	chr17:56878062	G/A	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.16	0.57	2.91e-8	Cognitive test performance;
SKCM	cis	rs7772486	0.727	rs2235481	chr6:146056848	T/C	cg05347473	chr6:146136440	FBXO30	-0.7	-6.1	-0.57	3.81e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4319547	0.695	rs11057797	chr12:122860732	G/A	cg23029597	chr12:123009494	RSRC2	0.72	5.31	0.52	1.01e-6	Body mass index;
SKCM	cis	rs2033711	0.902	rs4801589	chr19:58953398	C/G	cg11952622	chr19:58962976	ZNF324B	0.63	4.8	0.48	7.52e-6	Uric acid clearance;
SKCM	cis	rs7552404	0.924	rs7546641	chr1:76158035	T/C	cg10523679	chr1:76189770	ACADM	0.7	5.05	0.5	2.83e-6	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs1348850	0.958	rs11684320	chr2:178456346	T/C	cg02961200	chr2:178257176	LOC100130691;AGPS	0.83	6.69	0.6	3.08e-9	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs2836950	0.565	rs8134214	chr21:40542367	A/C	cg11644478	chr21:40555479	PSMG1	-0.67	-5.3	-0.51	1.04e-6	Menarche (age at onset);
SKCM	cis	rs7927771	0.542	rs7122217	chr11:47777920	G/C	cg20307385	chr11:47447363	PSMC3	-0.72	-5.81	-0.55	1.31e-7	Subjective well-being;
SKCM	cis	rs9790314	0.521	rs1450522	chr3:161077630	A/G	cg03342759	chr3:160939853	NMD3	-0.81	-7.15	-0.63	4e-10	Morning vs. evening chronotype;
SKCM	cis	rs909674	0.541	rs5757655	chr22:39797178	C/G	cg11247378	chr22:39784982	NA	0.45	5.26	0.51	1.23e-6	IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis);IgG glycosylation;IgG digalactosylation phenotypes (multivariate analysis);IgG sialylation phenotypes (multivariate analysis);IgG monogalactosylation phenotypes (multivariate analysis);IgG fucosylation phenotypes (multivariate analysis);IgG N-glycosylation phenotypes (multivariate analysis);IgG disialylation phenotypes (multivariate analysis);IgG galactosylation phenotypes (multivariate analysis);Post bronchodilator FEV1;
SKCM	cis	rs6952808	1.000	rs6953693	chr7:1886388	C/G	cg02951883	chr7:2050386	MAD1L1	-0.71	-5.35	-0.52	8.61e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs116095464	0.558	rs1812843	chr5:267658	A/G	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs5758659	0.652	rs133303	chr22:42395242	C/G	cg21144673	chr22:42017783	PPPDE2;XRCC6	-0.61	-4.8	-0.48	7.45e-6	Cognitive function;
SKCM	cis	rs7937682	0.601	rs2187388	chr11:111387116	C/T	cg09085632	chr11:111637200	PPP2R1B	0.72	5.49	0.53	4.76e-7	Primary sclerosing cholangitis;
SKCM	cis	rs10504229	0.683	rs6982990	chr8:58115275	C/T	cg02725872	chr8:58115012	NA	0.53	5.19	0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs2839186	1.000	rs2839181	chr21:47685939	A/G	cg13012494	chr21:47604986	C21orf56	0.67	5.78	0.55	1.44e-7	Testicular germ cell tumor;
SKCM	cis	rs1062177	0.756	rs2915826	chr5:151119963	G/A	cg00977110	chr5:151150581	G3BP1	-0.77	-5.42	-0.52	6.37e-7	Preschool internalizing problems;
SKCM	cis	rs55962025	0.855	rs6855981	chr4:3148276	A/G	cg11471262	chr4:3318911	RGS12	0.58	4.8	0.48	7.54e-6	Parental longevity (mother's age at death);
SKCM	cis	rs1577917	0.771	rs9362230	chr6:86305013	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.79	-7.4	-0.64	1.34e-10	Response to antipsychotic treatment;
SKCM	cis	rs6952808	0.595	rs3778982	chr7:2166233	T/C	cg21782813	chr7:2030301	MAD1L1	0.53	5.64	0.54	2.58e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs3008870	1.000	rs12039172	chr1:67447450	A/G	cg08660285	chr1:67390436	MIER1;WDR78	-0.92	-6.07	-0.57	4.27e-8	Lymphocyte percentage of white cells;
SKCM	trans	rs7618501	1.000	rs4855862	chr3:49748833	C/T	cg21659725	chr3:3221576	CRBN	-0.97	-9.69	-0.74	4.96e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs1348850	0.645	rs11887886	chr2:178425730	C/T	cg02961200	chr2:178257176	LOC100130691;AGPS	0.83	4.83	0.48	6.6e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs875971	0.545	rs6460276	chr7:65647277	G/A	cg18876405	chr7:65276391	NA	0.64	5.29	0.51	1.09e-6	Aortic root size;
SKCM	cis	rs7811142	1.000	rs2897358	chr7:100088640	C/G	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.14	6.58	0.6	4.83e-9	Platelet count;
SKCM	cis	rs4819052	0.851	rs9979545	chr21:46679805	G/A	cg20896738	chr21:46707857	POFUT2;LOC642852	0.65	4.89	0.48	5.35e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7296418	0.599	rs2277343	chr12:123794450	A/T	cg00376283	chr12:123451042	ABCB9	0.82	6.54	0.6	5.78e-9	Platelet count;
SKCM	cis	rs12586317	0.513	rs11156871	chr14:35481196	G/A	cg16230307	chr14:35515116	FAM177A1	0.81	5.88	0.55	9.47e-8	Psoriasis;
SKCM	cis	rs1692580	0.840	rs263526	chr1:2173504	T/C	cg21442419	chr1:2182373	SKI	-0.69	-6.94	-0.62	1.01e-9	Coronary artery disease;
SKCM	cis	rs936229	1.000	rs936229	chr15:75132319	A/G	cg14664628	chr15:75095509	CSK	-1.05	-8.24	-0.68	3.25e-12	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin);
SKCM	cis	rs11608355	0.521	rs11066503	chr12:109842434	A/G	cg19025524	chr12:109796872	NA	-0.68	-6.27	-0.58	1.88e-8	Neuroticism;
SKCM	cis	rs854765	0.647	rs854770	chr17:18019048	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.88	6.66	0.6	3.51e-9	Total body bone mineral density;
SKCM	cis	rs12047808	0.841	rs58340590	chr1:179416568	G/A	cg09822482	chr1:179519214	C1orf125	-0.95	-5.17	-0.51	1.78e-6	Multiple sclerosis (age of onset);
SKCM	cis	rs782590	0.935	rs2627776	chr2:55873301	T/A	cg18811423	chr2:55921094	PNPT1	0.92	7.48	0.65	9.53e-11	Metabolic syndrome;
SKCM	cis	rs798554	0.683	rs1182155	chr7:2902890	C/G	cg19346786	chr7:2764209	NA	-0.62	-6.02	-0.56	5.32e-8	Height;
SKCM	cis	rs561341	0.830	rs2301765	chr17:30202056	T/A	cg00745463	chr17:30367425	LRRC37B	0.99	6.38	0.59	1.18e-8	Hip circumference adjusted for BMI;
SKCM	cis	rs933688	1.000	rs9293568	chr5:90737845	C/T	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.07	8.52	0.69	9.25e-13	Smoking behavior;
SKCM	cis	rs7829975	1.000	rs7829975	chr8:8548117	T/A	cg06636001	chr8:8085503	FLJ10661	-0.91	-8.57	-0.7	7.36e-13	Mood instability;
SKCM	cis	rs7666738	0.830	rs13129479	chr4:98987860	T/C	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11098499	0.863	rs6858592	chr4:120458692	G/A	cg24375607	chr4:120327624	NA	0.68	5.27	0.51	1.16e-6	Corneal astigmatism;
SKCM	cis	rs4077515	0.874	rs3812575	chr9:139293259	T/C	cg14169450	chr9:139327907	INPP5E	0.5	5.39	0.52	7.14e-7	Ulcerative colitis;IgA nephropathy;Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs1568889	0.838	rs6484347	chr11:28040969	G/T	cg06544937	chr11:28130018	METT5D1;KIF18A	-0.87	-7.79	-0.66	2.43e-11	Bipolar disorder;
SKCM	cis	rs116095464	0.558	rs62346506	chr5:201594	T/C	cg22857025	chr5:266934	NA	-1.44	-7.74	-0.66	2.94e-11	Breast cancer;
SKCM	cis	rs7666738	0.830	rs2865981	chr4:99031493	G/A	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7208859	0.573	rs55661352	chr17:29045628	A/G	cg14067834	chr17:29058358	SUZ12P	1.18	5.86	0.55	1.07e-7	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs9790314	1.000	rs62279921	chr3:161065441	T/C	cg03342759	chr3:160939853	NMD3	-0.72	-7.89	-0.67	1.53e-11	Morning vs. evening chronotype;
SKCM	cis	rs3091242	0.900	rs4649086	chr1:25778967	T/A	cg02931644	chr1:25747376	RHCE	0.5	4.9	0.48	5.17e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs4900538	0.821	rs2009575	chr14:102820787	C/T	cg18135206	chr14:102964638	TECPR2	-0.75	-5.86	-0.55	1.07e-7	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs748404	0.660	rs2444251	chr15:43788595	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	0.72	5.5	0.53	4.7e-7	Lung cancer;
SKCM	cis	rs7811142	0.945	rs34989573	chr7:100097895	C/T	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-1.08	-6.17	-0.57	2.88e-8	Platelet count;
SKCM	trans	rs7819412	0.745	rs2898260	chr8:10939490	G/T	cg06636001	chr8:8085503	FLJ10661	-0.9	-8.05	-0.67	7.62e-12	Triglycerides;
SKCM	cis	rs2836974	0.897	rs35391055	chr21:40525516	G/A	cg17971929	chr21:40555470	PSMG1	0.87	8.48	0.69	1.1e-12	Cognitive function;
SKCM	cis	rs4927850	0.958	rs2044599	chr3:195736740	G/A	cg12923728	chr3:195709715	SDHAP1	-0.98	-6.86	-0.61	1.44e-9	Pancreatic cancer;
SKCM	cis	rs28595532	0.623	rs34958556	chr4:119222074	C/T	cg21605333	chr4:119757512	SEC24D	1.18	7.13	0.63	4.48e-10	Cannabis dependence symptom count;
SKCM	cis	rs10779751	0.770	rs7553827	chr1:11222393	C/T	cg08854313	chr1:11322531	MTOR	0.78	4.94	0.49	4.43e-6	Body mass index;
SKCM	cis	rs1577917	1.000	rs12190604	chr6:86716215	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.63	-5.45	-0.53	5.64e-7	Response to antipsychotic treatment;
SKCM	cis	rs1878931	0.501	rs17136359	chr16:3420814	C/T	cg26668626	chr16:3451006	ZNF174;ZNF434	-0.89	-7.25	-0.63	2.66e-10	Body mass index (adult);
SKCM	cis	rs1506636	0.924	rs2402668	chr7:123296605	T/A	cg03229431	chr7:123269106	ASB15	-0.64	-5.18	-0.51	1.7e-6	Plateletcrit;Platelet count;
SKCM	cis	rs6977660	0.943	rs10227692	chr7:19850199	T/C	cg05791153	chr7:19748676	TWISTNB	0.8	5.68	0.54	2.22e-7	Thyroid stimulating hormone;
SKCM	cis	rs8180040	0.966	rs2101247	chr3:47494303	G/A	cg16586182	chr3:47516702	SCAP	0.76	5.32	0.52	9.63e-7	Colorectal cancer;
SKCM	cis	rs10504073	0.584	rs1511368	chr8:49949523	A/T	cg00325661	chr8:49890786	NA	0.8	6.81	0.61	1.83e-9	Blood metabolite ratios;
SKCM	cis	rs10752881	1.000	rs4304541	chr1:182970238	G/T	ch.1.3577855R	chr1:183094577	LAMC1	0.73	6.62	0.6	4.17e-9	Colorectal cancer;
SKCM	cis	rs1218582	0.710	rs4845687	chr1:154878911	A/G	cg09359103	chr1:154839909	KCNN3	-0.56	-5.0	-0.49	3.48e-6	Prostate cancer;
SKCM	cis	rs62238980	0.614	rs79061246	chr22:32468866	G/C	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs12453682	0.568	rs3794712	chr17:37791487	A/C	cg20243544	chr17:37824526	PNMT	0.75	5.41	0.52	6.79e-7	Mean corpuscular hemoglobin;Red blood cell count;
SKCM	cis	rs9902453	0.791	rs3115090	chr17:28035014	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.79	5.93	0.56	7.67e-8	Coffee consumption (cups per day);
SKCM	cis	rs208520	0.633	rs79679034	chr6:66701724	A/C	cg07460842	chr6:66804631	NA	0.97	7.88	0.67	1.61e-11	Exhaled nitric oxide output;
SKCM	cis	rs854765	0.547	rs4365348	chr17:17912548	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.04	9.2	0.72	4.44e-14	Total body bone mineral density;
SKCM	cis	rs2841277	0.708	rs28454709	chr14:105405942	G/A	cg19901468	chr14:105411992	AHNAK2	-0.98	-7.76	-0.66	2.7e-11	Rheumatoid arthritis;
SKCM	cis	rs514406	0.861	rs12038438	chr1:53230581	A/T	cg16325326	chr1:53192061	ZYG11B	-1.01	-11.84	-0.8	4.17e-19	Monocyte count;
SKCM	cis	rs2180341	1.000	rs2326567	chr6:127606160	G/A	cg27446573	chr6:127587934	RNF146	1.0	8.68	0.7	4.48e-13	Breast cancer;
SKCM	cis	rs2836950	0.545	rs2836959	chr21:40623668	T/G	cg11644478	chr21:40555479	PSMG1	-0.64	-5.04	-0.5	2.95e-6	Menarche (age at onset);
SKCM	cis	rs9660180	0.967	rs2272908	chr1:1721479	A/G	cg23982607	chr1:1823379	GNB1	0.71	6.44	0.59	9.1e-9	Body mass index;
SKCM	cis	rs995000	0.931	rs1168015	chr1:62996046	C/G	cg06896770	chr1:63153194	DOCK7	-0.75	-6.89	-0.61	1.29e-9	Triglyceride levels;
SKCM	cis	rs870825	0.616	rs6844588	chr4:185644517	T/G	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs854765	0.583	rs9904163	chr17:17830553	C/T	cg04398451	chr17:18023971	MYO15A	-0.85	-6.05	-0.57	4.75e-8	Total body bone mineral density;
SKCM	cis	rs12449000	1	rs12449000	chr16:89872970	T/C	cg04287289	chr16:89883240	FANCA	0.98	10.6	0.77	8.95e-17	Schizophrenia;
SKCM	cis	rs11098499	0.562	rs2389879	chr4:120557684	G/A	cg09307838	chr4:120376055	NA	-0.97	-8.11	-0.68	5.87e-12	Corneal astigmatism;
SKCM	cis	rs2479724	0.846	rs2488338	chr6:41808351	A/G	cg17623882	chr6:41773611	USP49	-0.76	-6.61	-0.6	4.32e-9	Menarche (age at onset);
SKCM	cis	rs34779708	0.897	rs11010131	chr10:35513316	A/C	cg03585969	chr10:35415529	CREM	0.75	5.98	0.56	6.41e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs10779751	0.770	rs12041740	chr1:11236524	G/A	cg08854313	chr1:11322531	MTOR	0.95	7.68	0.66	3.89e-11	Body mass index;
SKCM	cis	rs523522	0.571	rs11065120	chr12:120875456	C/T	cg12219531	chr12:120966889	COQ5	0.89	6.49	0.59	7.3e-9	High light scatter reticulocyte count;
SKCM	cis	rs7811142	1.000	rs7803454	chr7:99991548	C/T	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-1.0	-5.66	-0.54	2.36e-7	Platelet count;
SKCM	cis	rs7017252	1.000	rs1372449	chr8:129950390	G/A	cg08633665	chr8:128972829	MIR1205;PVT1	-0.44	-5.12	-0.5	2.18e-6	Nonsyndromic cleft lip with cleft palate;
SKCM	cis	rs701145	0.938	rs1086056	chr3:154088411	T/G	cg17054900	chr3:154042577	DHX36	0.89	4.98	0.49	3.78e-6	Coronary artery disease;
SKCM	cis	rs7408868	0.908	rs10416865	chr19:15277601	T/C	cg14696996	chr19:15285081	NOTCH3	0.82	4.92	0.49	4.7e-6	Pulse pressure;
SKCM	cis	rs9911578	0.967	rs2643124	chr17:56741672	T/C	cg12560992	chr17:57184187	TRIM37	0.95	7.69	0.66	3.7e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs12497850	0.931	rs6442130	chr3:48778027	A/G	cg07636037	chr3:49044803	WDR6	1.0	9.93	0.75	1.73e-15	Parkinson's disease;
SKCM	cis	rs11098499	0.865	rs28845498	chr4:120405186	G/A	cg24375607	chr4:120327624	NA	0.66	5.09	0.5	2.44e-6	Corneal astigmatism;
SKCM	cis	rs4973517	0.677	rs12988095	chr2:232838728	G/A	cg13952656	chr2:232260762	B3GNT7	-0.51	-5.11	-0.5	2.21e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs600231	0.571	rs10896000	chr11:65218018	A/G	cg24009118	chr11:65545808	DKFZp761E198	0.77	5.5	0.53	4.71e-7	Bone mineral density;
SKCM	cis	rs2180341	1.000	rs6569482	chr6:127631371	C/T	cg24812749	chr6:127587940	RNF146	0.88	7.44	0.64	1.12e-10	Breast cancer;
SKCM	cis	rs12188164	1.000	rs56042615	chr5:437667	G/A	cg26076054	chr5:421317	AHRR	-0.61	-4.87	-0.48	5.68e-6	Cystic fibrosis severity;
SKCM	cis	rs910316	0.810	rs77939209	chr14:75670070	A/G	cg11812906	chr14:75593930	NEK9	-0.73	-5.37	-0.52	7.8e-7	Height;
SKCM	cis	rs55823223	0.648	rs11867560	chr17:73857206	A/G	cg08125733	chr17:73851984	WBP2	1.06	5.97	0.56	6.62e-8	Psoriasis;
SKCM	cis	rs736408	0.924	rs2535629	chr3:52833219	C/T	cg11645453	chr3:52864694	ITIH4	0.65	5.48	0.53	5e-7	Bipolar disorder;
SKCM	cis	rs6570726	0.935	rs386344	chr6:145855622	A/G	cg23711669	chr6:146136114	FBXO30	0.67	6.4	0.59	1.07e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs514406	0.798	rs4351588	chr1:53263826	A/T	cg16325326	chr1:53192061	ZYG11B	-0.72	-6.75	-0.61	2.39e-9	Monocyte count;
SKCM	cis	rs12477438	0.520	rs4851188	chr2:99745898	G/A	cg26064155	chr2:99771622	LIPT1;TSGA10	1.01	9.39	0.73	1.86e-14	Chronic sinus infection;
SKCM	cis	rs8180040	0.966	rs11719877	chr3:47425473	C/T	cg16586182	chr3:47516702	SCAP	-0.76	-5.32	-0.52	9.63e-7	Colorectal cancer;
SKCM	cis	rs12497850	0.829	rs12636030	chr3:49182237	A/G	cg07636037	chr3:49044803	WDR6	1.0	8.69	0.7	4.39e-13	Parkinson's disease;
SKCM	cis	rs11718455	0.960	rs11920021	chr3:44000856	T/C	cg21419209	chr3:44054225	NA	-0.65	-5.38	-0.52	7.61e-7	Coronary artery disease;
SKCM	cis	rs1348850	0.513	rs6730406	chr2:178492722	C/T	cg27490568	chr2:178487706	NA	0.69	5.01	0.49	3.3e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs7618501	0.669	rs2230590	chr3:49936102	T/C	cg24110177	chr3:50126178	RBM5	-0.63	-5.16	-0.5	1.86e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs561341	1.000	rs530209	chr17:30315287	A/G	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs7296418	0.885	rs1716184	chr12:123637509	G/C	cg05973401	chr12:123451056	ABCB9	0.81	6.39	0.59	1.1e-8	Platelet count;
SKCM	cis	rs6952808	0.575	rs2056479	chr7:1954273	G/A	cg21782813	chr7:2030301	MAD1L1	0.5	5.36	0.52	8.23e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs7208859	0.623	rs55638872	chr17:29149552	G/C	cg14067834	chr17:29058358	SUZ12P	1.0	5.15	0.5	1.88e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs778371	1.000	rs778370	chr2:233743363	C/T	cg08000102	chr2:233561755	GIGYF2	-0.84	-6.11	-0.57	3.7e-8	Schizophrenia;
SKCM	cis	rs2836974	0.865	rs7282624	chr21:40667040	C/T	cg11644478	chr21:40555479	PSMG1	0.83	7.69	0.66	3.66e-11	Cognitive function;
SKCM	cis	rs992157	0.932	rs10203039	chr2:219187367	T/C	cg00012203	chr2:219082015	ARPC2	0.78	5.95	0.56	7.19e-8	Colorectal cancer;
SKCM	cis	rs875971	0.862	rs6960446	chr7:65733259	A/G	cg18876405	chr7:65276391	NA	-0.65	-6.66	-0.6	3.51e-9	Aortic root size;
SKCM	cis	rs116095464	0.510	rs73016876	chr5:244475	T/C	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs1153858	1.000	rs1288775	chr15:45661678	T/A	cg21132104	chr15:45694354	SPATA5L1	0.93	7.66	0.66	4.2e-11	Homoarginine levels;
SKCM	cis	rs2153535	0.580	rs3938660	chr6:8443335	G/A	cg07606381	chr6:8435919	SLC35B3	0.94	6.94	0.62	1.02e-9	Motion sickness;
SKCM	cis	rs9290877	0.667	rs6774775	chr3:188455874	A/G	cg17392043	chr3:188495102	LPP	-0.64	-4.93	-0.49	4.6e-6	IgE levels;
SKCM	cis	rs28595532	0.920	rs6818519	chr4:119787820	G/T	cg14228332	chr4:119757509	SEC24D	1.08	5.52	0.53	4.28e-7	Cannabis dependence symptom count;
SKCM	cis	rs2180341	0.814	rs6914131	chr6:127737489	T/C	cg27446573	chr6:127587934	RNF146	0.69	5.49	0.53	4.79e-7	Breast cancer;
SKCM	cis	rs4243830	0.850	rs932112	chr1:6591937	A/G	cg22792644	chr1:6614718	TAS1R1;NOL9	-1.05	-5.58	-0.53	3.28e-7	Body mass index;
SKCM	cis	rs3784262	0.739	rs1550574	chr15:58213368	G/T	cg12031962	chr15:58353849	ALDH1A2	-0.46	-5.18	-0.51	1.71e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs2404602	0.716	rs17460201	chr15:76673627	C/T	cg23625390	chr15:77176239	SCAPER	-0.59	-5.35	-0.52	8.52e-7	Blood metabolite levels;
SKCM	cis	rs8180040	1.000	rs295442	chr3:47335881	A/C	cg27129171	chr3:47204927	SETD2	0.87	6.62	0.6	4.15e-9	Colorectal cancer;
SKCM	cis	rs3087591	0.960	rs2953009	chr17:29498387	A/C	cg24425628	chr17:29625626	OMG;NF1	0.64	5.31	0.52	9.85e-7	Hip circumference;
SKCM	cis	rs17376456	0.757	rs6859757	chr5:93206042	C/T	cg25358565	chr5:93447407	FAM172A	1.18	7.56	0.65	6.77e-11	Diabetic retinopathy;
SKCM	cis	rs8067545	0.562	rs2526481	chr17:20127018	T/C	cg13482628	chr17:19912719	NA	-0.66	-5.51	-0.53	4.53e-7	Schizophrenia;
SKCM	trans	rs9929218	0.559	rs12923775	chr16:68756450	C/T	cg04657470	chr2:198365150	HSPE1;HSPD1	0.89	8.05	0.67	7.66e-12	Colorectal cancer;
SKCM	cis	rs9549367	0.636	rs486407	chr13:113833499	G/A	cg18105134	chr13:113819100	PROZ	0.87	6.56	0.6	5.34e-9	Platelet distribution width;
SKCM	cis	rs826838	1.000	rs826888	chr12:39104719	C/G	cg26384229	chr12:38710491	ALG10B	-0.97	-7.97	-0.67	1.05e-11	Heart rate;
SKCM	cis	rs6087990	0.863	rs1569686	chr20:31367079	G/T	cg13636640	chr20:31349939	DNMT3B	0.91	7.97	0.67	1.06e-11	Ulcerative colitis;
SKCM	cis	rs12477438	0.520	rs2516830	chr2:99773702	T/G	cg14399236	chr2:99771627	LIPT1;TSGA10	0.97	8.66	0.7	4.83e-13	Chronic sinus infection;
SKCM	cis	rs1218582	0.740	rs1977879	chr1:154879743	G/A	cg06221963	chr1:154839813	KCNN3	-0.59	-5.97	-0.56	6.76e-8	Prostate cancer;
SKCM	cis	rs4820539	0.966	rs5751587	chr22:23470090	G/A	cg14186256	chr22:23484241	RTDR1	0.85	8.15	0.68	4.91e-12	Bone mineral density;
SKCM	cis	rs6087990	1.000	rs2424900	chr20:31344342	G/C	cg13636640	chr20:31349939	DNMT3B	0.91	7.99	0.67	9.7e-12	Ulcerative colitis;
SKCM	cis	rs7208859	0.623	rs9897728	chr17:29108804	A/G	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs7811142	0.943	rs67196635	chr7:100025564	T/C	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-0.99	-5.52	-0.53	4.2e-7	Platelet count;
SKCM	cis	rs2153535	0.601	rs7741024	chr6:8530313	T/C	cg23788917	chr6:8435910	SLC35B3	0.68	4.98	0.49	3.66e-6	Motion sickness;
SKCM	cis	rs11098499	0.954	rs13145352	chr4:120409963	C/T	cg24375607	chr4:120327624	NA	-0.66	-5.04	-0.5	2.96e-6	Corneal astigmatism;
SKCM	cis	rs861020	0.771	rs629150	chr1:209998467	C/T	cg05527609	chr1:210001259	C1orf107	1.04	7.96	0.67	1.11e-11	Orofacial clefts;
SKCM	cis	rs6952808	0.608	rs58120505	chr7:2029867	T/C	cg21782813	chr7:2030301	MAD1L1	0.57	5.82	0.55	1.25e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs60871478	0.685	rs113591626	chr7:846680	C/T	cg05535760	chr7:792225	HEATR2	-0.84	-5.85	-0.55	1.12e-7	Cerebrospinal P-tau181p levels;
SKCM	cis	rs11105298	0.891	rs10858899	chr12:89923811	G/C	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.9	-5.92	-0.56	8.11e-8	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs3789045	0.774	rs4252733	chr1:204516918	C/T	cg17419461	chr1:204415978	PIK3C2B	-0.87	-5.99	-0.56	6.02e-8	Educational attainment (college completion);
SKCM	cis	rs6942756	1.000	rs66538149	chr7:128974061	G/A	cg02491457	chr7:128862824	NA	-0.86	-5.48	-0.53	5.11e-7	White matter hyperintensity burden;
SKCM	cis	rs9549367	0.713	rs9549356	chr13:113851633	A/G	cg18105134	chr13:113819100	PROZ	-0.91	-6.86	-0.61	1.45e-9	Platelet distribution width;
SKCM	cis	rs7208859	0.623	rs28627615	chr17:29145817	G/C	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs7811142	1.000	rs112317829	chr7:100043173	A/G	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.23	7.89	0.67	1.53e-11	Platelet count;
SKCM	cis	rs11098499	0.821	rs10032151	chr4:120391628	C/T	cg24375607	chr4:120327624	NA	0.65	4.97	0.49	3.87e-6	Corneal astigmatism;
SKCM	cis	rs6582630	0.502	rs4379906	chr12:38295673	G/A	cg26384229	chr12:38710491	ALG10B	0.78	6.57	0.6	5.13e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs1843834	0.898	rs2014887	chr2:225520082	A/G	cg22455342	chr2:225449267	CUL3	0.61	4.8	0.48	7.53e-6	IgE levels in asthmatics (D.p. specific);
SKCM	cis	rs17608059	0.545	rs9944522	chr17:13918783	C/T	cg11395062	chr17:14139857	CDRT15	0.69	5.88	0.55	9.72e-8	Temperament;
SKCM	cis	rs870825	0.616	rs36022027	chr4:185639192	C/T	cg04058563	chr4:185651563	MLF1IP	1.08	7.26	0.64	2.51e-10	Blood protein levels;
SKCM	trans	rs2727020	0.595	rs7924311	chr11:49507573	G/A	cg15704280	chr7:45808275	SEPT13	-0.98	-9.29	-0.72	2.93e-14	Coronary artery disease;
SKCM	cis	rs2404602	0.684	rs2047504	chr15:76883516	A/T	cg23625390	chr15:77176239	SCAPER	-0.85	-8.26	-0.68	2.93e-12	Blood metabolite levels;
SKCM	cis	rs4819052	0.632	rs4819050	chr21:46692943	C/A	cg02159808	chr21:46707872	POFUT2;LOC642852	0.67	5.07	0.5	2.63e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs3820928	0.934	rs60141402	chr2:227761445	A/C	cg11843606	chr2:227700838	RHBDD1	-0.62	-4.99	-0.49	3.52e-6	Pulmonary function;
SKCM	cis	rs7584330	0.697	rs7574337	chr2:238439503	A/G	cg14458575	chr2:238380390	NA	0.81	5.12	0.5	2.14e-6	Prostate cancer;
SKCM	cis	rs992157	0.764	rs4672886	chr2:219185545	C/T	cg00012203	chr2:219082015	ARPC2	-0.76	-5.59	-0.54	3.17e-7	Colorectal cancer;
SKCM	trans	rs3780486	0.846	rs3780490	chr9:33129839	A/G	cg04842962	chr6:43655489	MRPS18A	1.03	10.85	0.78	2.95e-17	IgG glycosylation;
SKCM	cis	rs1044826	0.642	rs295473	chr3:139215585	T/C	cg15131784	chr3:139108705	COPB2	0.68	4.97	0.49	3.85e-6	Obesity-related traits;
SKCM	cis	rs9823696	1	rs9823696	chr3:183783353	A/G	cg26321066	chr3:183769987	HTR3C	-0.56	-5.27	-0.51	1.17e-6	Esophageal adenocarcinoma;
SKCM	cis	rs826838	0.967	rs1719853	chr12:39128515	A/G	cg13010199	chr12:38710504	ALG10B	-0.72	-5.73	-0.54	1.83e-7	Heart rate;
SKCM	cis	rs1801251	1.000	rs1446308	chr2:233639309	T/C	cg08000102	chr2:233561755	GIGYF2	0.89	7.15	0.63	4.05e-10	Coronary artery disease;
SKCM	cis	rs3820068	0.581	rs72645861	chr1:15920314	A/G	cg13390004	chr1:15929781	NA	0.67	5.29	0.51	1.11e-6	Systolic blood pressure;
SKCM	cis	rs13256369	1.000	rs10095733	chr8:8574646	A/G	cg06636001	chr8:8085503	FLJ10661	0.72	5.39	0.52	7.26e-7	Obesity-related traits;
SKCM	cis	rs10876993	0.928	rs2640631	chr12:58067532	A/T	cg18357645	chr12:58087776	OS9	0.65	5.72	0.54	1.86e-7	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs2842992	0.872	rs2758330	chr6:160104844	G/T	cg19482086	chr6:160211437	TCP1;MRPL18	0.77	5.55	0.53	3.77e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs3087591	0.960	rs2952995	chr17:29541061	T/C	cg24425628	chr17:29625626	OMG;NF1	0.64	5.22	0.51	1.43e-6	Hip circumference;
SKCM	cis	rs950776	0.518	rs62008194	chr15:78813805	G/T	cg06917634	chr15:78832804	PSMA4	1.01	10.48	0.76	1.5e-16	Sudden cardiac arrest;
SKCM	cis	rs12044355	0.927	rs16854809	chr1:231839247	A/G	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	0.77	5.58	0.53	3.28e-7	Alzheimer's disease;
SKCM	cis	rs2839186	0.708	rs17183123	chr21:47671961	G/C	cg11766577	chr21:47581405	C21orf56	-0.78	-6.58	-0.6	4.86e-9	Testicular germ cell tumor;
SKCM	cis	rs6138458	0.701	rs6050255	chr20:25007089	A/G	cg26195577	chr20:24973756	C20orf3	0.89	5.91	0.56	8.62e-8	Blood protein levels;
SKCM	cis	rs2836974	0.584	rs34436313	chr21:40685246	A/G	cg17971929	chr21:40555470	PSMG1	-0.74	-6.92	-0.62	1.14e-9	Cognitive function;
SKCM	cis	rs7927771	0.524	rs7122182	chr11:47843133	A/C	cg20307385	chr11:47447363	PSMC3	-0.72	-5.81	-0.55	1.31e-7	Subjective well-being;
SKCM	cis	rs9896933	0.832	rs79103992	chr17:80855483	G/A	cg20578329	chr17:80767326	TBCD	-0.97	-6.6	-0.6	4.44e-9	Bone mineral accretion in asthma (oral corticosteroid dose interaction);
SKCM	cis	rs875971	0.522	rs4718285	chr7:65292005	A/G	cg18876405	chr7:65276391	NA	0.86	7.56	0.65	6.53e-11	Aortic root size;
SKCM	cis	rs1552244	0.572	rs3894323	chr3:10168967	G/A	cg00149659	chr3:10157352	C3orf10	1.13	5.45	0.53	5.74e-7	Alzheimer's disease;
SKCM	cis	rs116095464	0.558	rs6866632	chr5:264429	C/G	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs875971	0.767	rs1643394	chr7:65836094	A/G	cg11764359	chr7:65958608	NA	0.81	7.65	0.65	4.38e-11	Aortic root size;
SKCM	cis	rs1707322	0.717	rs1972410	chr1:46080947	G/T	cg03146154	chr1:46216737	IPP	0.79	5.42	0.52	6.34e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs2153535	0.580	rs6912193	chr6:8456306	T/G	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs12497850	1.000	rs12493578	chr3:48730116	C/T	cg07636037	chr3:49044803	WDR6	-0.97	-9.57	-0.73	8.56e-15	Parkinson's disease;
SKCM	cis	rs6724607	0.905	rs7603849	chr2:191438741	A/C	cg27211696	chr2:191398769	TMEM194B	0.75	5.87	0.55	1.02e-7	Pulse pressure;
SKCM	cis	rs9611565	0.802	rs73176692	chr22:41785735	G/A	cg03806693	chr22:41940476	POLR3H	-0.93	-5.97	-0.56	6.68e-8	Vitiligo;
SKCM	cis	rs2839186	0.869	rs17176513	chr21:47682428	A/G	cg05896524	chr21:47604654	C21orf56	0.73	5.88	0.55	9.48e-8	Testicular germ cell tumor;
SKCM	cis	rs7917772	0.503	rs7096072	chr10:104299976	C/T	cg11453585	chr10:104263688	ACTR1A;SUFU	0.78	6.33	0.58	1.47e-8	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs4242434	0.927	rs3735894	chr8:22454826	A/G	cg03733263	chr8:22462867	KIAA1967	1.05	9.06	0.72	8.22e-14	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs9796	0.621	rs2918462	chr15:41481254	A/G	cg18705301	chr15:41695430	NDUFAF1	0.7	5.17	0.5	1.79e-6	Menopause (age at onset);
SKCM	cis	rs861020	1.000	rs674433	chr1:209964875	A/C	cg05527609	chr1:210001259	C1orf107	-1.09	-8.33	-0.69	2.18e-12	Orofacial clefts;
SKCM	cis	rs11950121	0.597	rs6866140	chr5:53156777	G/A	cg06476337	chr5:52856530	NDUFS4	-0.68	-4.8	-0.48	7.59e-6	Alcoholic chronic pancreatitis;
SKCM	cis	rs1577917	0.917	rs12665464	chr6:86574133	C/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.39	-0.52	7.24e-7	Response to antipsychotic treatment;
SKCM	cis	rs4629180	1.000	rs13031791	chr2:102108790	T/C	cg20146536	chr2:102096205	NA	-0.58	-4.89	-0.48	5.28e-6	Chronic rhinosinusitis with nasal polyps;
SKCM	cis	rs7666738	0.753	rs13111199	chr4:98953705	A/G	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1568889	0.938	rs1464898	chr11:28034748	A/G	cg06544937	chr11:28130018	METT5D1;KIF18A	0.83	6.32	0.58	1.5e-8	Bipolar disorder;
SKCM	cis	rs7666738	0.753	rs11097607	chr4:99011640	C/T	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs8180040	0.900	rs10865946	chr3:47425060	T/G	cg16586182	chr3:47516702	SCAP	-0.76	-5.32	-0.52	9.63e-7	Colorectal cancer;
SKCM	cis	rs1059312	1.000	rs9738216	chr12:129281788	C/T	cg09035930	chr12:129282057	SLC15A4	0.81	9.03	0.71	9.52e-14	Systemic lupus erythematosus;
SKCM	cis	rs2836974	0.932	rs56306759	chr21:40608106	G/A	cg17971929	chr21:40555470	PSMG1	0.9	8.81	0.71	2.52e-13	Cognitive function;
SKCM	cis	rs9916302	0.706	rs4332770	chr17:37704712	T/C	cg07936489	chr17:37558343	FBXL20	-1.01	-8.17	-0.68	4.34e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs10206020	0.921	rs4072986	chr2:1547734	C/G	cg01028140	chr2:1542097	TPO	-0.53	-5.06	-0.5	2.74e-6	IgG glycosylation;
SKCM	cis	rs11098499	0.754	rs10006259	chr4:120242145	C/T	cg09307838	chr4:120376055	NA	0.93	7.56	0.65	6.5500000000000006e-11	Corneal astigmatism;
SKCM	cis	rs10870270	1.000	rs7078692	chr10:133775370	T/A	cg17892150	chr10:133769511	PPP2R2D	-0.66	-4.86	-0.48	5.92e-6	Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals;
SKCM	cis	rs5750830	0.645	rs756640	chr22:39779300	G/A	cg11247378	chr22:39784982	NA	-0.48	-5.77	-0.55	1.51e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs798554	0.679	rs1639066	chr7:2892972	A/G	cg04166393	chr7:2884313	GNA12	0.8	5.62	0.54	2.86e-7	Height;
SKCM	cis	rs7772486	0.790	rs9399571	chr6:146282061	A/G	cg23711669	chr6:146136114	FBXO30	-0.79	-7.45	-0.64	1.1e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs17376456	0.542	rs1982439	chr5:93160560	C/G	cg25358565	chr5:93447407	FAM172A	-0.9	-5.8	-0.55	1.37e-7	Diabetic retinopathy;
SKCM	cis	rs732765	0.734	rs7152804	chr14:75164008	T/C	cg25946216	chr14:74253857	C14orf43	-0.84	-5.34	-0.52	8.93e-7	Non-small cell lung cancer;
SKCM	cis	rs870825	0.616	rs28524599	chr4:185647414	A/G	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs4665809	0.816	rs2384359	chr2:26371364	T/C	cg26119090	chr2:26468346	HADHA;HADHB	-0.79	-4.84	-0.48	6.5e-6	Gut microbiome composition (summer);
SKCM	cis	rs7772486	0.658	rs4895683	chr6:146113654	T/A	cg23711669	chr6:146136114	FBXO30	-0.85	-9.35	-0.73	2.22e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs807669	0.835	rs698423	chr22:19197896	T/C	cg02655711	chr22:19163373	SLC25A1	0.81	7.3	0.64	2.07e-10	Metabolite levels;
SKCM	cis	rs10751667	0.643	rs7396951	chr11:927355	G/A	cg06064525	chr11:970664	AP2A2	-0.55	-5.09	-0.5	2.46e-6	Alzheimer's disease (late onset);
SKCM	cis	rs748404	0.660	rs2467741	chr15:43742626	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	0.71	5.65	0.54	2.54e-7	Lung cancer;
SKCM	cis	rs738322	0.555	rs731821	chr22:38559448	C/A	cg25457927	chr22:38595422	NA	-0.58	-7.15	-0.63	4.09e-10	Cutaneous nevi;
SKCM	cis	rs709400	0.663	rs62007719	chr14:103943130	G/T	cg26031613	chr14:104095156	KLC1	0.77	5.96	0.56	6.87e-8	Body mass index;
SKCM	cis	rs1862618	0.641	rs252893	chr5:56224714	T/C	cg03609598	chr5:56110824	MAP3K1	-0.71	-5.08	-0.5	2.5e-6	Initial pursuit acceleration;
SKCM	cis	rs4589502	0.512	rs7183242	chr15:67096658	A/G	cg12317470	chr15:67143691	NA	0.87	5.39	0.52	7.39e-7	Lung cancer (smoking interaction);
SKCM	cis	rs2197308	0.765	rs12370231	chr12:37917881	T/C	cg13010199	chr12:38710504	ALG10B	0.66	4.89	0.48	5.28e-6	Morning vs. evening chronotype;
SKCM	cis	rs8017423	0.935	rs3783838	chr14:90733012	A/G	cg04374321	chr14:90722782	PSMC1	-0.95	-8.51	-0.69	9.52e-13	Mortality in heart failure;
SKCM	cis	rs7726839	0.540	rs11739847	chr5:609661	G/A	cg10555297	chr5:473380	SLC9A3;LOC25845	1.0	4.81	0.48	7.1e-6	Obesity-related traits;
SKCM	cis	rs2463822	0.687	rs118012228	chr11:62155914	G/A	cg06239285	chr11:62104954	ASRGL1	-1.26	-5.85	-0.55	1.08e-7	Chronic obstructive pulmonary disease-related biomarkers;
SKCM	cis	rs6547741	0.752	rs7562863	chr2:27892694	T/A	cg27432699	chr2:27873401	GPN1	-0.87	-7.21	-0.63	3.19e-10	Oral cavity cancer;
SKCM	cis	rs7511006	0.893	rs2038049	chr22:50654888	G/C	cg16473166	chr22:50639996	SELO	0.69	5.93	0.56	7.85e-8	Obesity-related traits;
SKCM	cis	rs1957429	0.808	rs9783609	chr14:65352282	A/G	cg23373153	chr14:65346875	NA	1.11	6.32	0.58	1.52e-8	Pediatric areal bone mineral density (radius);
SKCM	cis	rs12142240	0.698	rs72890727	chr1:46860237	G/A	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs2180341	1.000	rs6569486	chr6:127708424	A/C	cg24812749	chr6:127587940	RNF146	0.82	7.12	0.63	4.57e-10	Breast cancer;
SKCM	cis	rs11252926	0.797	rs61837235	chr10:489363	G/A	cg18196295	chr10:418757	DIP2C	-0.7	-5.0	-0.49	3.46e-6	Psychosis in Alzheimer's disease;
SKCM	cis	rs7103648	0.569	rs11039266	chr11:47532395	T/G	cg20307385	chr11:47447363	PSMC3	0.86	5.81	0.55	1.28e-7	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs597539	0.690	rs615644	chr11:68621806	G/C	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.81	5.33	0.52	9.43e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs2842992	0.789	rs7765490	chr6:160204326	C/T	cg19482086	chr6:160211437	TCP1;MRPL18	0.84	6.33	0.58	1.46e-8	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs11098499	0.542	rs10440343	chr4:120309787	G/C	cg09307838	chr4:120376055	NA	0.97	7.49	0.65	9.08e-11	Corneal astigmatism;
SKCM	cis	rs912057	1.000	rs912057	chr6:6736931	C/T	cg06612196	chr6:6737390	NA	-0.57	-5.07	-0.5	2.63e-6	Waist-to-hip ratio adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);
SKCM	cis	rs2072510	0.966	rs1990611	chr12:96413984	G/A	cg18817487	chr12:96390143	HAL	0.42	5.63	0.54	2.78e-7	Metabolite levels (small molecules and protein measures);
SKCM	cis	rs7219021	0.798	rs11652858	chr17:46844996	C/T	cg25699343	chr17:46534766	NA	-0.71	-5.24	-0.51	1.31e-6	Schizophrenia or bipolar disorder;
SKCM	cis	rs62238980	0.614	rs2006867	chr22:32384307	C/T	cg00543991	chr22:32367038	NA	1.15	4.87	0.48	5.76e-6	Childhood ear infection;
SKCM	cis	rs6570726	0.935	rs421268	chr6:145845558	A/T	cg23711669	chr6:146136114	FBXO30	0.7	6.71	0.61	2.78e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4319547	0.910	rs6416298	chr12:123002143	C/T	cg23029597	chr12:123009494	RSRC2	-0.84	-6.24	-0.58	2.14e-8	Body mass index;
SKCM	cis	rs2075371	0.637	rs13245165	chr7:133951492	A/T	cg20476274	chr7:133979776	SLC35B4	0.95	8.78	0.7	2.91e-13	Mean platelet volume;
SKCM	cis	rs3818285	0.504	rs4917547	chr10:111652285	T/C	cg00817464	chr10:111662876	XPNPEP1	-0.7	-6.21	-0.58	2.36e-8	Superior crus of antihelix expression;
SKCM	cis	rs12666575	0.504	rs10226475	chr7:2226162	A/G	cg02951883	chr7:2050386	MAD1L1	-0.61	-4.94	-0.49	4.38e-6	Schizophrenia;
SKCM	cis	rs9916302	0.706	rs2338799	chr17:37513941	G/A	cg07936489	chr17:37558343	FBXL20	0.98	6.84	0.61	1.56e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs651907	0.535	rs2290859	chr3:101525625	C/T	cg12386194	chr3:101231763	SENP7	0.68	5.74	0.54	1.73e-7	Colorectal cancer;
SKCM	cis	rs4972806	0.849	rs2113561	chr2:177030925	G/A	cg03152288	chr2:177042942	NA	0.57	4.99	0.49	3.52e-6	IgG glycosylation;
SKCM	cis	rs9420	0.961	rs17455520	chr11:57540458	C/A	cg19752551	chr11:57585705	CTNND1	-0.7	-7.21	-0.63	3.18e-10	Schizophrenia;
SKCM	cis	rs1153858	1.000	rs1049503	chr15:45653707	T/C	cg10760299	chr15:45669010	GATM	0.62	6.35	0.58	1.3e-8	Homoarginine levels;
SKCM	cis	rs7618915	0.547	rs2289250	chr3:52682946	A/C	cg18404041	chr3:52824283	ITIH1	0.56	5.05	0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs826838	0.967	rs7970069	chr12:38810631	T/C	cg26384229	chr12:38710491	ALG10B	1.06	10.14	0.75	6.67e-16	Heart rate;
SKCM	cis	rs514406	0.825	rs6695819	chr1:53223366	T/C	cg16325326	chr1:53192061	ZYG11B	-1.01	-11.9	-0.8	3.23e-19	Monocyte count;
SKCM	cis	rs847649	0.599	rs13232194	chr7:102742554	T/A	cg18108683	chr7:102477205	FBXL13	0.81	7.52	0.65	8.05e-11	Morning vs. evening chronotype;
SKCM	cis	rs9311474	0.581	rs4687626	chr3:52569098	G/A	cg18404041	chr3:52824283	ITIH1	-0.55	-4.98	-0.49	3.8e-6	Electroencephalogram traits;
SKCM	cis	rs3091242	0.933	rs11249251	chr1:25770188	C/G	cg27572855	chr1:25598939	RHD	0.53	5.06	0.5	2.67e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs473651	0.935	rs540636	chr2:239358341	T/C	cg18131467	chr2:239335373	ASB1	1.09	13.55	0.84	3.36e-22	Multiple system atrophy;
SKCM	cis	rs2841233	0.692	rs34009344	chr14:105344419	A/G	cg16576083	chr14:105354267	KIAA0284	0.6	4.77	0.48	8.29e-6	IgG glycosylation;
SKCM	cis	rs9513627	0.920	rs7984052	chr13:100177225	G/A	cg11288260	chr13:100117058	NA	0.83	4.97	0.49	3.8e-6	Obesity-related traits;
SKCM	cis	rs17685	0.784	rs1613890	chr7:75735037	T/C	cg16489192	chr7:75678113	MDH2;STYXL1	-0.61	-5.55	-0.53	3.73e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs473651	0.935	rs482775	chr2:239335403	G/C	cg18131467	chr2:239335373	ASB1	1.08	13.18	0.83	1.55e-21	Multiple system atrophy;
SKCM	cis	rs2204008	0.774	rs7305085	chr12:38263511	C/T	cg26384229	chr12:38710491	ALG10B	0.87	6.83	0.61	1.63e-9	Bladder cancer;
SKCM	cis	rs1059312	0.932	rs4760589	chr12:129284382	T/C	cg09035930	chr12:129282057	SLC15A4	0.81	8.93	0.71	1.45e-13	Systemic lupus erythematosus;
SKCM	cis	rs2836974	0.931	rs13625	chr21:40669083	G/T	cg11644478	chr21:40555479	PSMG1	0.83	7.69	0.66	3.66e-11	Cognitive function;
SKCM	cis	rs7811142	0.666	rs28401739	chr7:99905684	A/G	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.06	6.05	0.56	4.82e-8	Platelet count;
SKCM	cis	rs13064447	0.874	rs13058951	chr3:12752381	C/T	cg05775895	chr3:12838266	CAND2	-0.66	-4.79	-0.48	7.79e-6	Major depression and alcohol dependence;
SKCM	cis	rs861020	0.630	rs655713	chr1:210006438	C/T	cg05527609	chr1:210001259	C1orf107	0.86	6.74	0.61	2.43e-9	Orofacial clefts;
SKCM	cis	rs7959452	0.719	rs57954211	chr12:69748397	C/A	cg20891283	chr12:69753455	YEATS4	0.91	9.36	0.73	2.14e-14	Blood protein levels;
SKCM	cis	rs7959452	0.640	rs12370042	chr12:69692420	C/G	cg14784868	chr12:69753453	YEATS4	0.66	5.86	0.55	1.03e-7	Blood protein levels;
SKCM	cis	rs7584330	0.666	rs72620819	chr2:238354982	C/T	cg14458575	chr2:238380390	NA	1.13	7.27	0.64	2.4e-10	Prostate cancer;
SKCM	cis	rs637571	0.584	rs594689	chr11:65635559	G/A	cg26695010	chr11:65641043	EFEMP2	0.71	5.83	0.55	1.18e-7	Eosinophil percentage of white cells;
SKCM	cis	rs7208859	0.623	rs7220289	chr17:29103762	G/T	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs9611565	0.802	rs2234058	chr22:41777883	G/A	cg03806693	chr22:41940476	POLR3H	-0.86	-5.89	-0.55	9.19e-8	Vitiligo;
SKCM	cis	rs9910055	0.509	rs9916444	chr17:42313512	C/G	cg19774624	chr17:42201019	HDAC5	-0.77	-6.27	-0.58	1.84e-8	Total body bone mineral density;
SKCM	cis	rs8180040	0.903	rs2276854	chr3:47276968	C/T	cg16586182	chr3:47516702	SCAP	-0.72	-4.98	-0.49	3.73e-6	Colorectal cancer;
SKCM	cis	rs10540	1.000	rs61876341	chr11:495892	C/G	cg03576123	chr11:487126	PTDSS2	-1.43	-8.14	-0.68	5.08e-12	Body mass index;
SKCM	cis	rs7786877	0.723	rs10487157	chr7:100214487	C/G	cg16850897	chr7:100343110	ZAN	-0.64	-4.86	-0.48	5.98e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs703842	0.616	rs10783850	chr12:58229377	T/C	cg00677455	chr12:58241039	CTDSP2	0.74	5.83	0.55	1.18e-7	Multiple sclerosis;
SKCM	cis	rs9902453	0.817	rs2617881	chr17:28063275	A/T	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.82	-5.78	-0.55	1.47e-7	Coffee consumption (cups per day);
SKCM	cis	rs6951245	0.872	rs75493422	chr7:1072890	C/T	cg03188948	chr7:1209495	NA	1.12	6.17	0.57	2.88e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs9916302	0.904	rs2303316	chr17:37704217	A/G	cg07936489	chr17:37558343	FBXL20	-0.88	-7.34	-0.64	1.78e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs514406	0.767	rs551591	chr1:53301876	A/G	cg16325326	chr1:53192061	ZYG11B	0.81	7.43	0.64	1.19e-10	Monocyte count;
SKCM	cis	rs9303401	0.659	rs3809724	chr17:57061238	G/A	cg10487724	chr17:56770010	TEX14;RAD51C	0.85	6.03	0.56	5.18e-8	Cognitive test performance;
SKCM	cis	rs3820928	0.874	rs1114562	chr2:227788592	T/C	cg11843606	chr2:227700838	RHBDD1	-0.6	-4.81	-0.48	7.17e-6	Pulmonary function;
SKCM	cis	rs28595532	0.841	rs112953035	chr4:119752450	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs3729931	0.507	rs79945102	chr3:12711975	A/C	cg23032965	chr3:12705835	RAF1	0.78	6.49	0.59	7.27e-9	Cardiac hypertrophy;
SKCM	cis	rs7208859	0.623	rs9911173	chr17:29154750	C/T	cg13385521	chr17:29058706	SUZ12P	0.9	4.78	0.48	8.1e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs1878931	0.535	rs10852706	chr16:3412582	G/C	cg26668626	chr16:3451006	ZNF174;ZNF434	0.76	5.42	0.52	6.37e-7	Body mass index (adult);
SKCM	cis	rs317689	0.513	rs317678	chr12:69692166	C/G	cg20891283	chr12:69753455	YEATS4	0.62	4.87	0.48	5.65e-6	Response to diuretic therapy;
SKCM	cis	rs7954584	0.567	rs1720033	chr12:122384344	C/T	cg21171335	chr12:122356390	WDR66	-0.45	-4.87	-0.48	5.8e-6	Mean corpuscular volume;
SKCM	cis	rs992157	0.866	rs2292554	chr2:219146868	T/C	cg20019365	chr2:219134978	PNKD;AAMP	-0.71	-6.08	-0.57	4.22e-8	Colorectal cancer;
SKCM	cis	rs2952156	0.959	rs2941504	chr17:37830900	A/G	cg20243544	chr17:37824526	PNMT	0.76	5.99	0.56	6.06e-8	Asthma;
SKCM	cis	rs6951245	1.000	rs78896566	chr7:1080182	C/G	cg18402987	chr7:1209562	NA	1.14	6.01	0.56	5.68e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs873946	0.590	rs7071777	chr10:134559976	T/A	cg26818010	chr10:134567672	INPP5A	-0.78	-6.22	-0.58	2.3e-8	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs3903072	0.528	rs11227306	chr11:65578672	C/A	cg00576331	chr11:65640516	EFEMP2	-0.73	-5.26	-0.51	1.24e-6	Breast cancer;
SKCM	cis	rs2228479	0.867	rs62052187	chr16:89973071	G/A	cg00800038	chr16:89945340	TCF25	-0.94	-5.51	-0.53	4.53e-7	Skin colour saturation;
SKCM	cis	rs10504229	0.645	rs6995814	chr8:58114159	C/T	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs1401999	0.606	rs7644687	chr3:183753353	A/G	cg01324343	chr3:183735012	ABCC5	0.79	8.16	0.68	4.65e-12	Anterior chamber depth;
SKCM	cis	rs2836633	1.000	rs2836633	chr21:40067445	C/T	cg05519781	chr21:40033154	ERG	-0.69	-6.04	-0.56	4.93e-8	Coronary artery disease;
SKCM	cis	rs9910055	0.659	rs186603	chr17:42207884	C/T	cg08499158	chr17:42289980	UBTF	0.74	6.32	0.58	1.52e-8	Total body bone mineral density;
SKCM	cis	rs4819052	0.788	rs4819051	chr21:46693128	C/T	cg02159808	chr21:46707872	POFUT2;LOC642852	0.74	5.68	0.54	2.22e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs55962025	0.711	rs916171	chr4:3216815	C/G	cg05297308	chr4:3317976	RGS12	0.62	4.89	0.48	5.23e-6	Parental longevity (mother's age at death);
SKCM	cis	rs798766	1.000	rs798762	chr4:1731150	T/C	cg05874882	chr4:1763078	NA	-0.56	-4.89	-0.48	5.37e-6	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs9399135	0.967	rs11754783	chr6:135347661	T/A	cg24558204	chr6:135376177	HBS1L	0.6	5.36	0.52	8.17e-7	Red blood cell count;
SKCM	cis	rs8016982	0.674	rs6574631	chr14:81675772	C/T	cg01989461	chr14:81687754	GTF2A1	0.86	7.12	0.63	4.67e-10	Schizophrenia;
SKCM	cis	rs12477438	0.501	rs6542868	chr2:99782848	A/C	cg26064155	chr2:99771622	LIPT1;TSGA10	1.03	9.69	0.74	5.05e-15	Chronic sinus infection;
SKCM	cis	rs8141529	0.732	rs5762784	chr22:29171298	C/T	cg15103426	chr22:29168792	CCDC117	0.61	5.02	0.49	3.16e-6	Lymphocyte counts;
SKCM	cis	rs7208859	0.623	rs9895785	chr17:29107708	C/T	cg14067834	chr17:29058358	SUZ12P	-1.06	-4.99	-0.49	3.64e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs2963155	0.518	rs853177	chr5:142635460	A/G	cg17617527	chr5:142782415	NR3C1	1.13	5.42	0.52	6.46e-7	Breast cancer;
SKCM	cis	rs9467773	1.000	rs4713008	chr6:26538268	T/C	cg09904177	chr6:26538194	HMGN4	0.54	4.98	0.49	3.78e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7552404	0.924	rs1146588	chr1:76229787	C/G	cg10523679	chr1:76189770	ACADM	0.7	4.98	0.49	3.71e-6	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs4819052	0.704	rs2297283	chr21:46683590	G/A	cg02159808	chr21:46707872	POFUT2;LOC642852	0.73	5.3	0.51	1.06e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs3087591	1.000	rs9904169	chr17:29572518	C/T	cg24425628	chr17:29625626	OMG;NF1	-0.63	-4.95	-0.49	4.23e-6	Hip circumference;
SKCM	cis	rs10504229	0.562	rs2014516	chr8:58128288	C/A	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	trans	rs208520	0.526	rs4710310	chr6:66802808	T/C	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-1.11	-11.6	-0.8	1.16e-18	Exhaled nitric oxide output;
SKCM	cis	rs951366	0.764	rs823143	chr1:205743425	A/C	cg11965913	chr1:205819406	PM20D1	1.0	10.32	0.76	3.06e-16	Menarche (age at onset);
SKCM	cis	rs5753618	0.539	rs5753596	chr22:31787472	C/T	cg02404636	chr22:31891804	SFI1	-0.52	-4.84	-0.48	6.47e-6	Colorectal cancer;
SKCM	cis	rs2153535	0.623	rs2327055	chr6:8443145	A/G	cg07606381	chr6:8435919	SLC35B3	0.94	6.94	0.62	1.02e-9	Motion sickness;
SKCM	cis	rs6952808	0.500	rs3800902	chr7:2144378	C/T	cg02951883	chr7:2050386	MAD1L1	-0.79	-7.4	-0.64	1.37e-10	Bipolar disorder and schizophrenia;
SKCM	cis	rs2732480	0.577	rs2732479	chr12:48736260	A/C	cg21348975	chr12:48724119	NA	-0.62	-5.41	-0.52	6.74e-7	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs595982	0.517	rs10404905	chr19:49406175	A/T	cg19746536	chr19:49375674	PPP1R15A	-1.05	-8.21	-0.68	3.77e-12	Red cell distribution width;
SKCM	cis	rs5758511	0.689	rs56906457	chr22:42628335	A/G	cg26793846	chr22:42538988	CYP2D7P1	-0.72	-4.82	-0.48	6.88e-6	Birth weight;
SKCM	cis	rs1153858	0.945	rs1974981	chr15:45729123	C/T	cg21132104	chr15:45694354	SPATA5L1	-0.82	-6.0	-0.56	5.83e-8	Homoarginine levels;
SKCM	cis	rs4727027	0.840	rs12670633	chr7:148796707	G/A	cg23583168	chr7:148888333	NA	-0.82	-6.49	-0.59	7.11e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs875971	1.000	rs937495	chr7:65779798	A/G	cg18876405	chr7:65276391	NA	-0.68	-6.79	-0.61	1.96e-9	Aortic root size;
SKCM	cis	rs870825	0.549	rs28579266	chr4:185627262	T/C	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs6545883	0.895	rs2442029	chr2:61679552	G/T	cg15711740	chr2:61764176	XPO1	-0.7	-4.93	-0.49	4.5e-6	Tuberculosis;
SKCM	cis	rs2439831	1.000	rs28666488	chr15:43741090	G/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.12	8.05	0.67	7.58e-12	Lung cancer in ever smokers;
SKCM	cis	rs9325144	0.600	rs34138871	chr12:38735261	A/G	cg26384229	chr12:38710491	ALG10B	0.78	6.82	0.61	1.76e-9	Morning vs. evening chronotype;
SKCM	cis	rs910316	1.000	rs8017642	chr14:75590822	G/A	cg08847533	chr14:75593920	NEK9	0.95	9.18	0.72	4.88e-14	Height;
SKCM	cis	rs362296	0.698	rs3095082	chr4:3263617	C/A	cg16987761	chr4:3318072	RGS12	-0.7	-6.23	-0.58	2.23e-8	Parental longevity (mother's age at death);
SKCM	cis	rs67311347	0.544	rs7644643	chr3:40350209	C/T	cg18306943	chr3:40428807	ENTPD3	-0.58	-5.14	-0.5	1.97e-6	Renal cell carcinoma;
SKCM	cis	rs8177253	0.931	rs8177256	chr3:133480276	G/T	cg16414030	chr3:133502952	NA	-0.69	-5.78	-0.55	1.49e-7	Iron status biomarkers;
SKCM	cis	rs9325144	0.723	rs11169519	chr12:39177441	G/A	cg13010199	chr12:38710504	ALG10B	-0.58	-4.98	-0.49	3.76e-6	Morning vs. evening chronotype;
SKCM	cis	rs3784262	1.000	rs12915901	chr15:58279432	G/A	cg12031962	chr15:58353849	ALDH1A2	-0.52	-6.5	-0.59	6.83e-9	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs798554	0.523	rs1182197	chr7:2863289	A/C	cg19346786	chr7:2764209	NA	-0.6	-6.34	-0.58	1.36e-8	Height;
SKCM	cis	rs478304	0.651	rs11227299	chr11:65549570	C/G	cg27068330	chr11:65405492	SIPA1	-0.92	-8.24	-0.68	3.29e-12	Acne (severe);
SKCM	cis	rs732528	0.501	rs6508037	chr18:48360516	C/G	cg03255741	chr18:48556964	SMAD4	-0.68	-4.95	-0.49	4.15e-6	Entorhinal cortical thickness;
SKCM	cis	rs362272	0.545	rs3129308	chr4:3309272	C/T	cg00764545	chr4:3318001	RGS12	0.92	11.75	0.8	6.2800000000000005e-19	Serum sulfate level;
SKCM	cis	rs10254284	0.959	rs757729	chr7:28146305	G/C	cg15170557	chr7:28214983	JAZF1	-0.61	-5.26	-0.51	1.24e-6	Lymphocyte percentage of white cells;Systemic lupus erythematosus;
SKCM	cis	rs4819052	0.851	rs4819039	chr21:46659458	G/A	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.36	0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7777754	0.512	rs4470989	chr7:50562698	T/A	cg18232548	chr7:50535776	DDC	-0.85	-6.21	-0.57	2.44e-8	Response to zileuton treatment in asthma (FEV1 change interaction);
SKCM	cis	rs826838	0.834	rs2387842	chr12:38736442	T/C	cg13010199	chr12:38710504	ALG10B	0.88	6.56	0.6	5.42e-9	Heart rate;
SKCM	cis	rs3768617	0.510	rs2296293	chr1:183095477	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs4523957	0.614	rs7219693	chr17:2061101	C/A	cg16513277	chr17:2031491	SMG6	-0.79	-5.63	-0.54	2.7e-7	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs6121246	0.697	rs6088857	chr20:30226764	G/C	cg11595048	chr20:30225325	COX4I2	0.65	5.19	0.51	1.62e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs62238980	0.614	rs79592563	chr22:32425982	T/C	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs2204008	0.687	rs2320523	chr12:38251397	T/C	cg26384229	chr12:38710491	ALG10B	0.85	6.78	0.61	2.05e-9	Bladder cancer;
SKCM	cis	rs1506636	1.000	rs2215553	chr7:123318478	G/T	cg03229431	chr7:123269106	ASB15	-0.62	-5.06	-0.5	2.75e-6	Plateletcrit;Platelet count;
SKCM	cis	rs9788682	0.948	rs34664138	chr15:78831624	T/G	cg24631222	chr15:78858424	CHRNA5	0.96	6.69	0.6	3.03e-9	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs7811142	1.000	rs11559117	chr7:100076614	A/G	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.34	0.69	2.1e-12	Platelet count;
SKCM	cis	rs9790314	1.000	rs9872514	chr3:161042833	T/C	cg03342759	chr3:160939853	NMD3	-0.72	-8.07	-0.67	6.91e-12	Morning vs. evening chronotype;
SKCM	cis	rs2404602	0.716	rs12437627	chr15:76845050	T/C	cg23625390	chr15:77176239	SCAPER	0.59	5.38	0.52	7.54e-7	Blood metabolite levels;
SKCM	cis	rs2228479	0.850	rs1108063	chr16:89893983	A/G	cg06558623	chr16:89946397	TCF25	1.1	4.95	0.49	4.17e-6	Skin colour saturation;
SKCM	cis	rs514406	0.689	rs7548389	chr1:53404211	C/T	cg24675658	chr1:53192096	ZYG11B	-0.8	-7.04	-0.62	6.64e-10	Monocyte count;
SKCM	cis	rs644799	1.000	rs527899	chr11:95529242	T/G	cg03916912	chr11:95522834	CEP57;FAM76B	0.92	8.04	0.67	8e-12	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs28595532	0.841	rs56046449	chr4:119769302	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs10929159	0.928	rs7557693	chr2:236920713	G/A	cg14226755	chr2:236923322	AGAP1	0.29	4.77	0.48	8.43e-6	Parkinson's disease;
SKCM	cis	rs36093844	0.904	rs7113656	chr11:85594739	T/C	cg25872744	chr11:85566296	CCDC83	-0.66	-5.01	-0.49	3.26e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs589448	0.900	rs588493	chr12:69751986	G/A	cg20891283	chr12:69753455	YEATS4	0.98	9.89	0.75	2.06e-15	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs1577917	1.000	rs35760725	chr6:86648985	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.77	-0.66	2.59e-11	Response to antipsychotic treatment;
SKCM	trans	rs17685	0.558	rs60787921	chr7:75792844	C/A	cg19862616	chr7:65841803	NCRNA00174	0.97	10.73	0.77	5.13e-17	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs208520	1.000	rs12194996	chr6:66973366	G/C	cg07460842	chr6:66804631	NA	0.86	5.69	0.54	2.16e-7	Exhaled nitric oxide output;
SKCM	cis	rs6545883	0.929	rs1186707	chr2:61673520	C/A	cg15711740	chr2:61764176	XPO1	-0.68	-4.92	-0.49	4.76e-6	Tuberculosis;
SKCM	cis	rs17685	0.664	rs9801113	chr7:75792031	C/T	cg16684958	chr7:75615977	POR	0.53	5.3	0.51	1.06e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs995000	0.899	rs1167998	chr1:62931632	C/A	cg06896770	chr1:63153194	DOCK7	-0.64	-6.05	-0.57	4.72e-8	Triglyceride levels;
SKCM	cis	rs875971	0.964	rs60193905	chr7:65971260	A/G	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	cis	rs7191439	0.858	rs4390574	chr16:88776297	T/C	cg02389323	chr16:88786976	FAM38A	1.33	6.24	0.58	2.1e-8	Plateletcrit;
SKCM	cis	rs7666738	0.830	rs34244876	chr4:99031336	G/A	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs12497850	0.931	rs7430501	chr3:48890119	C/T	cg06212747	chr3:49208901	KLHDC8B	0.68	4.89	0.48	5.28e-6	Parkinson's disease;
SKCM	cis	rs2153535	0.601	rs1928183	chr6:8530018	A/G	cg23788917	chr6:8435910	SLC35B3	0.68	4.98	0.49	3.66e-6	Motion sickness;
SKCM	cis	rs6840360	0.571	rs4696278	chr4:152558978	A/G	cg22705602	chr4:152727874	NA	-0.52	-5.69	-0.54	2.15e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7829975	0.517	rs12542733	chr8:8824858	G/T	cg15556689	chr8:8085844	FLJ10661	-0.7	-5.28	-0.51	1.12e-6	Mood instability;
SKCM	cis	rs644799	1.000	rs568668	chr11:95528209	G/A	cg03916912	chr11:95522834	CEP57;FAM76B	0.92	8.04	0.67	8e-12	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs7917772	0.503	rs7893155	chr10:104294228	C/A	cg11453585	chr10:104263688	ACTR1A;SUFU	0.78	6.33	0.58	1.47e-8	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs861020	1.000	rs680923	chr1:209986672	T/C	cg09163369	chr1:210001066	C1orf107	0.77	5.01	0.49	3.31e-6	Orofacial clefts;
SKCM	cis	rs2153535	0.542	rs6905925	chr6:8440030	C/T	cg07606381	chr6:8435919	SLC35B3	0.94	6.94	0.62	1.02e-9	Motion sickness;
SKCM	cis	rs2120019	1.000	rs12185102	chr15:75352201	G/A	cg17294928	chr15:75287854	SCAMP5	-0.82	-7.36	-0.64	1.58e-10	Blood trace element (Zn levels);
SKCM	cis	rs34065801	0.526	rs9574926	chr13:36498356	A/G	cg09605634	chr13:36521538	DCLK1	-0.71	-4.77	-0.48	8.41e-6	Breast size;
SKCM	cis	rs16866061	1.000	rs12470077	chr2:225334971	T/C	cg12698349	chr2:225449008	CUL3	1.02	8.77	0.7	3.04e-13	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs2197308	0.605	rs2387437	chr12:37919367	T/C	cg13010199	chr12:38710504	ALG10B	0.63	4.95	0.49	4.18e-6	Morning vs. evening chronotype;
SKCM	cis	rs2204008	0.540	rs1283306	chr12:38153778	C/A	cg26384229	chr12:38710491	ALG10B	-0.67	-5.47	-0.53	5.23e-7	Bladder cancer;
SKCM	cis	rs668210	0.793	rs677350	chr11:65761967	G/A	cg20909159	chr11:65625947	CFL1	-0.72	-4.84	-0.48	6.5e-6	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs7809950	0.953	rs1468336	chr7:107208250	T/C	cg23024343	chr7:107201750	COG5	0.72	6.52	0.59	6.29e-9	Coronary artery disease;
SKCM	cis	rs7020830	0.861	rs13289001	chr9:37311592	A/G	cg14294708	chr9:37120828	ZCCHC7	1.06	10.67	0.77	6.51e-17	Schizophrenia;
SKCM	cis	rs116095464	0.558	rs6874745	chr5:264527	A/G	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs13064447	0.870	rs7631468	chr3:12754997	A/G	cg05775895	chr3:12838266	CAND2	-0.66	-4.79	-0.48	7.79e-6	Major depression and alcohol dependence;
SKCM	cis	rs2439831	0.681	rs7168940	chr15:43633334	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.17	8.32	0.69	2.25e-12	Lung cancer in ever smokers;
SKCM	cis	rs875971	0.965	rs10267430	chr7:65743023	G/T	cg11764359	chr7:65958608	NA	-0.88	-8.54	-0.7	8.32e-13	Aortic root size;
SKCM	cis	rs9916302	0.904	rs612194	chr17:37442707	T/A	cg07936489	chr17:37558343	FBXL20	0.84	6.75	0.61	2.32e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs28386778	0.897	rs7210443	chr17:61785374	A/G	cg01411255	chr17:61851458	DDX42;CCDC47	0.79	5.19	0.51	1.63e-6	Prudent dietary pattern;
SKCM	cis	rs7666738	0.830	rs114722517	chr4:99042061	G/A	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4665809	0.590	rs66477033	chr2:26472497	T/C	cg26119090	chr2:26468346	HADHA;HADHB	1.06	8.39	0.69	1.66e-12	Gut microbiome composition (summer);
SKCM	cis	rs2652834	0.904	rs34786874	chr15:63397504	A/G	cg04194852	chr15:63334506	TPM1	0.76	4.78	0.48	8.15e-6	HDL cholesterol;
SKCM	cis	rs2599510	0.729	rs1135484	chr2:32749060	G/A	cg02381751	chr2:32503542	YIPF4	0.66	5.06	0.5	2.71e-6	Interleukin-18 levels;
SKCM	cis	rs6570726	0.935	rs451349	chr6:145820894	A/G	cg23711669	chr6:146136114	FBXO30	0.7	6.64	0.6	3.72e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs523522	0.962	rs2168319	chr12:120933217	C/T	cg12219531	chr12:120966889	COQ5	0.91	7.82	0.66	2.11e-11	High light scatter reticulocyte count;
SKCM	cis	rs838147	0.844	rs11083948	chr19:49248120	A/G	cg13540341	chr19:49222985	MAMSTR	0.56	5.06	0.5	2.77e-6	Dietary macronutrient intake;
SKCM	cis	rs1580019	0.587	rs7804457	chr7:32557981	A/G	cg06627557	chr7:32535165	LSM5;AVL9	0.94	9.12	0.72	6.39e-14	Cognitive ability;
SKCM	cis	rs56235845	0.964	rs11746443	chr5:176798306	G/A	cg17509989	chr5:176798049	RGS14	0.93	8.98	0.71	1.2e-13	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs6088590	0.930	rs6120723	chr20:33364655	C/T	cg24642439	chr20:33292090	TP53INP2	1.01	7.2	0.63	3.23e-10	Coronary artery disease;
SKCM	cis	rs7666738	0.800	rs13107147	chr4:99028753	C/T	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs769267	0.930	rs3794990	chr19:19610030	A/G	cg26732615	chr19:19648335	CILP2;YJEFN3	0.67	7.06	0.62	6e-10	Tonsillectomy;
SKCM	cis	rs6430585	0.583	rs4988201	chr2:136618507	A/G	cg07169764	chr2:136633963	MCM6	1.31	13.05	0.83	2.59e-21	Corneal structure;
SKCM	cis	rs7937682	0.663	rs7116280	chr11:111659111	T/C	cg09085632	chr11:111637200	PPP2R1B	1.05	10.36	0.76	2.62e-16	Primary sclerosing cholangitis;
SKCM	cis	rs116095464	1.000	rs1567956	chr5:315616	C/A	cg22857025	chr5:266934	NA	-1.63	-6.12	-0.57	3.5e-8	Breast cancer;
SKCM	cis	rs6489882	0.902	rs7966314	chr12:113372539	C/T	cg07232103	chr12:112566177	TRAFD1	-0.62	-5.03	-0.5	3.04e-6	Chronic lymphocytic leukemia;
SKCM	cis	rs17065868	1.000	rs58838977	chr13:45222235	A/G	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs4233949	0.601	rs4439997	chr2:54632995	C/A	cg14634210	chr2:54682758	SPTBN1	0.59	4.97	0.49	3.9e-6	Bone mineral density;
SKCM	cis	rs1552244	0.882	rs55962400	chr3:10044457	C/T	cg02579736	chr3:10068473	FANCD2;CIDECP	0.98	4.84	0.48	6.48e-6	Alzheimer's disease;
SKCM	cis	rs2905347	0.560	rs2961291	chr7:22681504	C/T	cg11983867	chr7:22539820	MGC87042	-0.48	-4.86	-0.48	5.88e-6	Major depression and alcohol dependence;
SKCM	cis	rs16940212	0.580	rs74019425	chr15:58687465	G/T	cg16767221	chr15:57769667	CGNL1	-0.59	-4.81	-0.48	7.24e-6	HDL cholesterol levels;HDL cholesterol;
SKCM	cis	rs5769765	0.955	rs9616367	chr22:50303515	A/C	cg22709217	chr22:50311962	ALG12;CRELD2	-0.93	-5.88	-0.55	9.84e-8	Schizophrenia;
SKCM	cis	rs651907	0.535	rs13084113	chr3:101534039	C/G	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.78	6.72	0.61	2.65e-9	Colorectal cancer;
SKCM	cis	rs116095464	0.558	rs62346526	chr5:220614	T/C	cg22496380	chr5:211416	CCDC127	-0.96	-5.27	-0.51	1.18e-6	Breast cancer;
SKCM	cis	rs4891159	0.505	rs680253	chr18:74167427	A/C	cg24786174	chr18:74118243	ZNF516	-0.74	-7.23	-0.63	2.87e-10	Longevity;
SKCM	cis	rs6500602	0.627	rs9934267	chr16:4534366	G/C	cg08645402	chr16:4508243	NA	0.64	4.95	0.49	4.26e-6	Schizophrenia;
SKCM	cis	rs11673344	0.765	rs826296	chr19:37438286	A/G	cg07624650	chr19:37064219	ZNF529	-0.81	-5.12	-0.5	2.15e-6	Obesity-related traits;
SKCM	cis	rs13256369	0.802	rs11249888	chr8:8564934	T/C	cg15556689	chr8:8085844	FLJ10661	0.65	4.77	0.48	8.39e-6	Obesity-related traits;
SKCM	cis	rs7959452	0.590	rs7968629	chr12:69782857	G/A	cg20891283	chr12:69753455	YEATS4	0.92	9.53	0.73	1.03e-14	Blood protein levels;
SKCM	cis	rs847649	0.699	rs10271157	chr7:102527591	A/G	cg18108683	chr7:102477205	FBXL13	-0.81	-8.51	-0.69	9.78e-13	Morning vs. evening chronotype;
SKCM	cis	rs875971	0.651	rs2420596	chr7:65915983	T/C	cg11764359	chr7:65958608	NA	0.81	7.61	0.65	5.25e-11	Aortic root size;
SKCM	cis	rs17213078	0.505	rs2167531	chr2:106738625	A/G	cg15412446	chr2:106886593	NA	-0.58	-4.88	-0.48	5.58e-6	Facial morphology (factor 23);
SKCM	cis	rs4481887	0.741	rs6682953	chr1:248535626	T/C	cg00666640	chr1:248458726	OR2T12	0.5	5.3	0.51	1.04e-6	Common traits (Other);
SKCM	cis	rs909674	0.865	rs5757683	chr22:39850174	G/A	cg11247378	chr22:39784982	NA	-0.44	-5.0	-0.49	3.47e-6	IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis);IgG glycosylation;IgG digalactosylation phenotypes (multivariate analysis);IgG sialylation phenotypes (multivariate analysis);IgG monogalactosylation phenotypes (multivariate analysis);IgG fucosylation phenotypes (multivariate analysis);IgG N-glycosylation phenotypes (multivariate analysis);IgG disialylation phenotypes (multivariate analysis);IgG galactosylation phenotypes (multivariate analysis);Post bronchodilator FEV1;
SKCM	cis	rs2404602	0.583	rs12907668	chr15:76589767	A/T	cg22467129	chr15:76604101	ETFA	-0.65	-5.35	-0.52	8.68e-7	Blood metabolite levels;
SKCM	cis	rs3820928	0.845	rs1917126	chr2:227840923	G/T	cg11843606	chr2:227700838	RHBDD1	-0.61	-4.9	-0.49	5.12e-6	Pulmonary function;
SKCM	cis	rs6952808	0.689	rs871924	chr7:2047845	A/G	cg02951883	chr7:2050386	MAD1L1	-0.85	-8.01	-0.67	8.95e-12	Bipolar disorder and schizophrenia;
SKCM	cis	rs6063399	0.538	rs3091458	chr20:47999008	A/G	cg05303999	chr20:47988955	KCNB1	-0.74	-6.57	-0.6	5.19e-9	Obesity-related traits;
SKCM	cis	rs9790314	1.000	rs9790314	chr3:161019558	T/C	cg03342759	chr3:160939853	NMD3	-0.72	-8.07	-0.67	6.91e-12	Morning vs. evening chronotype;
SKCM	trans	rs7618501	1.000	rs11130221	chr3:49819102	C/G	cg21659725	chr3:3221576	CRBN	0.96	9.61	0.74	7.08e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs6445797	0.662	rs9862490	chr3:56633874	T/C	cg13616963	chr3:57583610	ARF4	-0.75	-4.91	-0.49	4.92e-6	Gastritis;
SKCM	cis	rs875971	1.000	rs778726	chr7:65828731	C/T	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	7.89e-13	Aortic root size;
SKCM	cis	rs8014204	0.736	rs2111705	chr14:75261641	G/A	cg06637938	chr14:75390232	RPS6KL1	0.73	5.62	0.54	2.82e-7	Caffeine consumption;
SKCM	cis	rs10911232	0.507	rs12037585	chr1:183000041	G/T	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.64	0.6	3.83e-9	Hypertriglyceridemia;
SKCM	cis	rs4523957	0.583	rs8077597	chr17:2043818	C/T	cg16513277	chr17:2031491	SMG6	-0.91	-6.21	-0.58	2.38e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs826838	1.000	rs11183214	chr12:38692938	C/T	cg26384229	chr12:38710491	ALG10B	1.06	10.14	0.75	6.67e-16	Heart rate;
SKCM	cis	rs7772486	0.754	rs9373475	chr6:146126419	C/T	cg23711669	chr6:146136114	FBXO30	0.9	10.38	0.76	2.38e-16	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs28386778	0.897	rs2727323	chr17:61921999	G/T	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs4819052	0.851	rs9974628	chr21:46672647	C/T	cg19498844	chr21:46707878	POFUT2;LOC642852	0.88	7.69	0.66	3.74e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs67311347	0.544	rs6762121	chr3:40355313	G/A	cg02782426	chr3:40428986	ENTPD3	0.5	4.99	0.49	3.64e-6	Renal cell carcinoma;
SKCM	cis	rs7769051	1.000	rs10484629	chr6:133117870	A/C	cg22852734	chr6:133119734	C6orf192	1.01	5.42	0.52	6.37e-7	Type 2 diabetes nephropathy;
SKCM	cis	rs6582630	0.537	rs1949610	chr12:38387838	C/T	cg26384229	chr12:38710491	ALG10B	0.81	6.6	0.6	4.58e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs28374715	0.578	rs17730888	chr15:41637547	A/G	cg18705301	chr15:41695430	NDUFAF1	-1.2	-12.9	-0.83	4.81e-21	Ulcerative colitis;
SKCM	cis	rs7809950	1.000	rs2520265	chr7:107181231	A/G	cg23024343	chr7:107201750	COG5	-0.77	-6.95	-0.62	9.61e-10	Coronary artery disease;
SKCM	cis	rs62064224	0.714	rs4794915	chr17:30634363	A/G	cg18200150	chr17:30822561	MYO1D	-0.62	-4.84	-0.48	6.38e-6	Schizophrenia;
SKCM	cis	rs6089584	0.853	rs1740367	chr20:60574834	C/T	cg06108461	chr20:60628389	TAF4	-0.85	-6.7	-0.6	2.89e-9	Body mass index;
SKCM	cis	rs2204008	0.668	rs1619009	chr12:38120485	G/A	cg26384229	chr12:38710491	ALG10B	-0.67	-5.47	-0.53	5.23e-7	Bladder cancer;
SKCM	cis	rs57221529	0.766	rs72703070	chr5:590458	T/C	cg26208419	chr5:473447	SLC9A3;LOC25845	1.01	5.18	0.51	1.7e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs769267	0.965	rs2023882	chr19:19405405	T/C	cg03709012	chr19:19516395	GATAD2A	0.82	6.73	0.61	2.6e-9	Tonsillectomy;
SKCM	cis	rs9818758	0.607	rs35673421	chr3:49139406	G/A	cg24110177	chr3:50126178	RBM5	0.87	4.86	0.48	6e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs7208859	0.524	rs8065744	chr17:29099449	C/T	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs1957429	0.808	rs11628910	chr14:65332392	A/G	cg23373153	chr14:65346875	NA	1.22	6.35	0.58	1.3e-8	Pediatric areal bone mineral density (radius);
SKCM	cis	rs8078723	0.668	rs4239225	chr17:38127112	G/A	cg17467752	chr17:38218738	THRA	0.64	5.62	0.54	2.86e-7	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs2842992	0.789	rs7765490	chr6:160204326	C/T	cg11366901	chr6:160182831	ACAT2	0.85	6.48	0.59	7.51e-9	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs10504229	0.683	rs56741275	chr8:58136108	C/G	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs17376456	0.825	rs34592268	chr5:93232751	G/C	cg21475434	chr5:93447410	FAM172A	1.03	5.61	0.54	3e-7	Diabetic retinopathy;
SKCM	cis	rs4820539	1.000	rs4822358	chr22:23474795	A/G	cg14186256	chr22:23484241	RTDR1	0.85	8.27	0.68	2.8e-12	Bone mineral density;
SKCM	cis	rs870825	0.616	rs7692104	chr4:185650895	T/G	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs796364	1.000	rs796364	chr2:200716119	C/A	cg12253985	chr2:200820533	C2orf60;C2orf47	0.96	5.89	0.55	9.17e-8	Schizophrenia;
SKCM	cis	rs2386661	0.826	rs4427479	chr10:5682855	T/C	cg12223502	chr10:5658492	NA	0.56	5.04	0.5	2.96e-6	Breast cancer;
SKCM	cis	rs10256972	0.552	rs6953538	chr7:1196974	A/G	cg09177884	chr7:1199841	ZFAND2A	-0.78	-6.45	-0.59	8.77e-9	Longevity;Endometriosis;
SKCM	cis	rs7811142	1.000	rs67040465	chr7:100083078	G/A	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.19	7.92	0.67	1.33e-11	Platelet count;
SKCM	cis	rs4619890	0.528	rs28437157	chr4:7874435	C/A	cg08722675	chr4:8412549	ACOX3	0.54	4.96	0.49	4.03e-6	Glaucoma (primary open-angle);
SKCM	cis	rs4819052	0.851	rs1056099	chr21:46678892	G/A	cg19498844	chr21:46707878	POFUT2;LOC642852	0.88	7.69	0.66	3.74e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs67311347	0.911	rs9849224	chr3:40392562	T/C	cg00091569	chr3:40428383	ENTPD3	0.61	5.36	0.52	8.37e-7	Renal cell carcinoma;
SKCM	cis	rs2439831	0.850	rs16963953	chr15:44081719	A/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.35	7.75	0.66	2.9e-11	Lung cancer in ever smokers;
SKCM	cis	rs9300255	0.679	rs12829456	chr12:123725395	C/T	cg05973401	chr12:123451056	ABCB9	-0.86	-6.1	-0.57	3.87e-8	Neutrophil percentage of white cells;
SKCM	cis	rs11098499	0.874	rs9995277	chr4:120108603	G/A	cg09307838	chr4:120376055	NA	0.86	6.08	0.57	4.13e-8	Corneal astigmatism;
SKCM	cis	rs7666738	1.000	rs13116475	chr4:99054843	C/T	cg05340658	chr4:99064831	C4orf37	-0.68	-4.77	-0.48	8.48e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs561341	0.505	rs28708703	chr17:30386845	C/G	cg23018236	chr17:30244563	NA	-0.54	-5.6	-0.54	3.12e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs35766269	0.541	rs4749831	chr10:9041722	C/T	cg05671070	chr10:8095960	FLJ45983;GATA3	0.95	4.77	0.48	8.45e-6	Recalcitrant atopic dermatitis;
SKCM	cis	rs514406	0.755	rs10888754	chr1:53228751	C/G	cg16325326	chr1:53192061	ZYG11B	-0.88	-8.89	-0.71	1.75e-13	Monocyte count;
SKCM	cis	rs9910055	0.530	rs2269906	chr17:42294337	G/T	cg09913183	chr17:42254507	C17orf65;ASB16	-0.6	-5.29	-0.51	1.1e-6	Total body bone mineral density;
SKCM	cis	rs875971	0.825	rs801202	chr7:66023929	C/T	cg11764359	chr7:65958608	NA	-0.75	-6.8	-0.61	1.88e-9	Aortic root size;
SKCM	cis	rs2721195	1.000	rs11542372	chr8:145677089	G/A	cg11211951	chr8:145729740	GPT	-0.63	-5.98	-0.56	6.27e-8	Age at first birth;
SKCM	cis	rs72781680	0.898	rs112985192	chr2:24102797	G/A	cg08917208	chr2:24149416	ATAD2B	1.01	5.46	0.53	5.37e-7	Lymphocyte counts;
SKCM	cis	rs67460515	0.563	rs6772723	chr3:160895074	C/G	cg03342759	chr3:160939853	NMD3	-0.72	-5.9	-0.56	8.71e-8	Parkinson's disease;
SKCM	cis	rs7843479	1.000	rs11775444	chr8:21813018	A/G	cg17168535	chr8:21777572	XPO7	0.72	5.64	0.54	2.65e-7	Mean corpuscular volume;
SKCM	cis	rs3087591	0.960	rs2018634	chr17:29560678	A/C	cg24425628	chr17:29625626	OMG;NF1	-0.63	-5.07	-0.5	2.57e-6	Hip circumference;
SKCM	cis	rs11764590	0.651	rs12673687	chr7:2081873	C/T	cg23422044	chr7:1970798	MAD1L1	-0.85	-6.36	-0.58	1.27e-8	Neuroticism;
SKCM	cis	rs362272	0.524	rs881816	chr4:3365366	A/G	cg24015175	chr4:3319247	RGS12	0.83	9.67	0.74	5.46e-15	Serum sulfate level;
SKCM	cis	rs1046896	0.520	rs8074086	chr17:80818460	A/C	cg02711726	chr17:80685570	FN3KRP	-0.78	-5.85	-0.55	1.08e-7	Glycated hemoglobin levels;
SKCM	cis	rs11105298	0.891	rs3741898	chr12:89933763	G/C	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.83	-5.18	-0.51	1.66e-6	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs651907	0.557	rs12629658	chr3:101356535	A/G	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.79	6.55	0.6	5.65e-9	Colorectal cancer;
SKCM	cis	rs2072499	0.778	rs2842868	chr1:156196407	A/C	cg25208724	chr1:156163844	SLC25A44	0.77	5.89	0.56	9.11e-8	Testicular germ cell tumor;
SKCM	cis	rs2032447	0.670	rs198820	chr6:26124243	G/A	cg18357526	chr6:26021779	HIST1H4A	-0.8	-6.51	-0.59	6.54e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs7927771	0.524	rs7101597	chr11:47797917	A/T	cg20307385	chr11:47447363	PSMC3	0.72	5.81	0.55	1.31e-7	Subjective well-being;
SKCM	cis	rs10503709	0.581	rs13258281	chr8:21473286	C/T	cg15997512	chr8:21608254	GFRA2	-0.5	-4.79	-0.48	7.83e-6	Blood protein levels;
SKCM	cis	rs854765	0.547	rs2955359	chr17:17946730	T/C	cg04398451	chr17:18023971	MYO15A	0.94	7.53	0.65	7.5e-11	Total body bone mineral density;
SKCM	cis	rs12497850	0.931	rs11924597	chr3:48937790	T/C	cg07636037	chr3:49044803	WDR6	1.02	11.0	0.78	1.56e-17	Parkinson's disease;
SKCM	cis	rs7647973	0.580	rs2117938	chr3:49263850	A/G	cg06212747	chr3:49208901	KLHDC8B	-0.81	-5.64	-0.54	2.62e-7	Menarche (age at onset);
SKCM	cis	rs36051895	0.695	rs10974916	chr9:5017350	G/A	cg02405213	chr9:5042618	JAK2	-0.63	-4.8	-0.48	7.62e-6	Pediatric autoimmune diseases;
SKCM	cis	rs9467773	0.584	rs1021372	chr6:26632444	T/C	cg09904177	chr6:26538194	HMGN4	0.58	5.01	0.49	3.28e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1843834	0.539	rs2047135	chr2:225427302	G/C	cg12698349	chr2:225449008	CUL3	0.86	6.98	0.62	8.42e-10	IgE levels in asthmatics (D.p. specific);
SKCM	cis	rs155076	1.000	rs155076	chr13:21870114	A/G	cg11317459	chr13:21872234	NA	-1.33	-7.9	-0.67	1.49e-11	White matter hyperintensity burden;
SKCM	cis	rs1692580	0.807	rs60635488	chr1:2202572	C/T	cg24578937	chr1:2090814	PRKCZ	0.47	5.09	0.5	2.42e-6	Coronary artery disease;
SKCM	cis	rs8072100	0.713	rs8074451	chr17:45477573	C/T	cg08085267	chr17:45401833	C17orf57	-0.61	-4.86	-0.48	6.01e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs2832191	0.692	rs8134627	chr21:30349069	C/T	cg24692254	chr21:30365293	RNF160	-1.0	-9.45	-0.73	1.45e-14	Dental caries;
SKCM	cis	rs9581857	0.579	rs75872792	chr13:27996064	G/T	cg22138327	chr13:27999177	GTF3A	0.95	6.38	0.59	1.14e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs763121	0.853	rs5750677	chr22:39147715	C/T	cg06022373	chr22:39101656	GTPBP1	0.82	5.06	0.5	2.74e-6	Menopause (age at onset);
SKCM	cis	rs936229	0.954	rs936230	chr15:75145098	C/T	cg14664628	chr15:75095509	CSK	1.06	8.2	0.68	3.77e-12	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin);
SKCM	cis	rs6912958	0.516	rs242278	chr6:88047059	C/T	cg08069147	chr6:88032118	GJB7;C6orf162	0.65	5.83	0.55	1.21e-7	Monocyte percentage of white cells;
SKCM	cis	rs244731	0.959	rs7721671	chr5:176630984	A/G	cg06060754	chr5:176797920	RGS14	-0.81	-7.16	-0.63	3.9e-10	Urate levels in lean individuals;
SKCM	cis	rs34779708	0.897	rs4934527	chr10:35281118	T/A	cg03585969	chr10:35415529	CREM	0.74	6.02	0.56	5.31e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs9902453	0.967	rs4533341	chr17:28495672	T/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.5	0.53	4.74e-7	Coffee consumption (cups per day);
SKCM	cis	rs6120849	0.754	rs36003887	chr20:33589107	G/A	cg24642439	chr20:33292090	TP53INP2	0.94	4.86	0.48	5.91e-6	Protein C levels;
SKCM	trans	rs561341	1.000	rs550264	chr17:30317540	G/T	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs9913156	0.793	rs72835642	chr17:4573407	T/C	cg19197139	chr17:4613644	ARRB2	0.79	5.45	0.53	5.64e-7	Lymphocyte counts;
SKCM	cis	rs4819052	0.851	rs3673	chr21:46681775	C/T	cg02159808	chr21:46707872	POFUT2;LOC642852	0.73	5.65	0.54	2.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs6546550	0.901	rs6546559	chr2:70145833	G/A	cg02498382	chr2:70120550	SNRNP27	-0.45	-4.88	-0.48	5.4e-6	Prevalent atrial fibrillation;
SKCM	cis	rs3820068	0.581	rs56128111	chr1:15928948	T/G	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs12477438	0.501	rs12619780	chr2:99707307	C/T	cg14399236	chr2:99771627	LIPT1;TSGA10	0.96	8.25	0.68	3.07e-12	Chronic sinus infection;
SKCM	cis	rs9914544	0.628	rs67053020	chr17:18680061	G/C	cg26306683	chr17:18585705	ZNF286B	0.64	4.88	0.48	5.59e-6	Educational attainment (years of education);
SKCM	cis	rs801193	1.000	rs7785213	chr7:66138978	A/C	cg11764359	chr7:65958608	NA	-0.83	-6.29	-0.58	1.71e-8	Aortic root size;
SKCM	cis	rs10791097	0.694	rs4370948	chr11:130755700	A/C	cg12179176	chr11:130786555	SNX19	0.91	8.24	0.68	3.24e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs28386778	0.897	rs2665833	chr17:61906846	T/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs1799949	0.965	rs1842147	chr17:41435192	C/T	cg23758822	chr17:41437982	NA	0.95	7.99	0.67	9.76e-12	Menopause (age at onset);
SKCM	cis	rs1005277	0.540	rs1987431	chr10:37988887	T/C	cg25427524	chr10:38739819	LOC399744	-0.63	-6.2	-0.57	2.49e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs1005277	0.565	rs2474565	chr10:38380828	A/G	cg25427524	chr10:38739819	LOC399744	-0.69	-6.45	-0.59	8.73e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs9467773	0.549	rs9467805	chr6:26583366	C/T	cg15659132	chr6:26577336	NA	0.64	5.65	0.54	2.48e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs10504073	0.669	rs4493917	chr8:50015846	C/T	cg00325661	chr8:49890786	NA	0.79	6.79	0.61	1.99e-9	Blood metabolite ratios;
SKCM	cis	rs9815354	0.761	rs73079307	chr3:41862273	A/C	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs4862750	0.872	rs7664463	chr4:187876686	A/C	cg10295955	chr4:187884368	NA	-1.07	-14.16	-0.85	2.94e-23	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs644799	1.000	rs611020	chr11:95567905	C/T	cg03916912	chr11:95522834	CEP57;FAM76B	0.88	7.53	0.65	7.59e-11	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs854765	0.547	rs6502632	chr17:17913057	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.06	9.36	0.73	2.2e-14	Total body bone mineral density;
SKCM	cis	rs476633	0.691	rs28409265	chr15:41539404	G/A	cg18705301	chr15:41695430	NDUFAF1	-0.65	-4.86	-0.48	6.01e-6	Glomerular filtration rate (creatinine);
SKCM	cis	rs6977660	0.714	rs28371050	chr7:19816882	C/T	cg05791153	chr7:19748676	TWISTNB	0.76	4.89	0.48	5.28e-6	Thyroid stimulating hormone;
SKCM	cis	rs28595532	0.920	rs116634064	chr4:119736514	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs10540	1.000	rs79440439	chr11:478147	A/C	cg03352830	chr11:487213	PTDSS2	1.09	5.25	0.51	1.27e-6	Body mass index;
SKCM	trans	rs1814175	0.645	rs7119101	chr11:49955665	G/A	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs7772486	0.875	rs2207785	chr6:146332784	T/G	cg05347473	chr6:146136440	FBXO30	0.57	5.18	0.51	1.66e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1552244	1.000	rs7622966	chr3:10139833	C/T	cg02579736	chr3:10068473	FANCD2;CIDECP	1.23	6.92	0.62	1.13e-9	Alzheimer's disease;
SKCM	cis	rs10911232	0.507	rs10732271	chr1:183025898	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.77	6.89	0.62	1.27e-9	Hypertriglyceridemia;
SKCM	cis	rs62064224	0.703	rs62065493	chr17:30822620	C/G	cg18200150	chr17:30822561	MYO1D	0.71	6.16	0.57	3e-8	Schizophrenia;
SKCM	cis	rs62064224	0.560	rs12162135	chr17:30805795	A/C	cg18200150	chr17:30822561	MYO1D	0.68	5.84	0.55	1.12e-7	Schizophrenia;
SKCM	cis	rs1805008	0.584	rs1800341	chr16:89836899	T/C	cg08547343	chr16:90038815	CENPBD1;AFG3L1	-1.14	-5.21	-0.51	1.51e-6	Skin colour saturation;
SKCM	cis	rs8017423	0.935	rs3737035	chr14:90745422	T/C	cg04374321	chr14:90722782	PSMC1	-0.95	-8.73	-0.7	3.68e-13	Mortality in heart failure;
SKCM	cis	rs12458462	0.892	rs3786228	chr18:77464170	C/T	cg11879182	chr18:77439856	CTDP1	-0.88	-7.49	-0.65	9.26e-11	Monocyte count;
SKCM	cis	rs35146811	0.735	rs2272344	chr7:99786819	C/T	cg22906224	chr7:99728672	NA	0.65	5.19	0.51	1.6e-6	Coronary artery disease;
SKCM	cis	rs72945132	0.598	rs61887432	chr11:70239065	A/C	cg14191688	chr11:70257035	CTTN	0.83	4.77	0.48	8.32e-6	Coronary artery disease;
SKCM	cis	rs10911232	0.507	rs10797817	chr1:182999136	G/T	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.64	0.6	3.83e-9	Hypertriglyceridemia;
SKCM	cis	rs7940866	0.903	rs10791112	chr11:130870215	A/C	cg12179176	chr11:130786555	SNX19	-0.77	-6.08	-0.57	4.09e-8	Schizophrenia;
SKCM	cis	rs911263	1.000	rs911263	chr14:68753593	C/T	cg18825221	chr14:68749962	RAD51L1	0.5	5.46	0.53	5.46e-7	Primary biliary cholangitis;
SKCM	cis	rs1878931	0.559	rs1968055	chr16:3392053	A/G	cg26668626	chr16:3451006	ZNF174;ZNF434	0.84	6.56	0.6	5.39e-9	Body mass index (adult);
SKCM	cis	rs1801251	0.963	rs7562712	chr2:233606580	A/G	cg08000102	chr2:233561755	GIGYF2	0.87	7.05	0.62	6.23e-10	Coronary artery disease;
SKCM	cis	rs6570726	0.818	rs398812	chr6:145817271	T/C	cg23711669	chr6:146136114	FBXO30	0.68	6.32	0.58	1.47e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs919433	0.648	rs3097384	chr2:198278834	T/A	cg04278110	chr2:198063759	ANKRD44	0.7	4.79	0.48	7.87e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs2762353	0.603	rs9393670	chr6:25789061	A/G	cg16906712	chr6:26217615	HIST1H2BG;HIST1H2AE	-0.52	-4.96	-0.49	4.07e-6	Blood metabolite levels;
SKCM	cis	rs9916302	0.904	rs9898773	chr17:37532507	C/G	cg07936489	chr17:37558343	FBXL20	0.83	6.87	0.61	1.37e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs1003719	0.788	rs2835597	chr21:38466539	C/T	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs6500602	0.727	rs1477123	chr16:4560627	T/A	cg08645402	chr16:4508243	NA	0.63	5.04	0.5	3e-6	Schizophrenia;
SKCM	cis	rs6570726	0.935	rs366308	chr6:145814532	T/A	cg23711669	chr6:146136114	FBXO30	0.71	6.77	0.61	2.18e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7569084	0.663	rs1437461	chr2:65679712	C/T	cg10464312	chr2:66672688	MEIS1	0.45	5.11	0.5	2.25e-6	Sum eosinophil basophil counts;
SKCM	cis	rs4746818	1.000	rs1506770	chr10:70964357	G/A	cg11621586	chr10:70884670	VPS26A	0.93	7.37	0.64	1.52e-10	Left atrial antero-posterior diameter;
SKCM	cis	rs9911578	1.000	rs437732	chr17:56675861	A/C	cg12560992	chr17:57184187	TRIM37	0.95	7.69	0.66	3.7e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs1267303	0.675	rs1267312	chr1:46986748	C/G	cg25110126	chr1:46999211	NA	-0.69	-5.03	-0.49	3.08e-6	Monobrow;
SKCM	cis	rs67460515	0.563	rs35914913	chr3:160826561	A/G	cg03342759	chr3:160939853	NMD3	-0.73	-6.33	-0.58	1.42e-8	Parkinson's disease;
SKCM	cis	rs1707322	0.717	rs2253862	chr1:46081960	C/T	cg03146154	chr1:46216737	IPP	-0.8	-5.59	-0.53	3.22e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7772486	0.875	rs932522	chr6:146374026	A/G	cg05347473	chr6:146136440	FBXO30	-0.62	-5.65	-0.54	2.52e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2404602	0.716	rs17363713	chr15:76746128	G/C	cg23625390	chr15:77176239	SCAPER	0.57	5.23	0.51	1.39e-6	Blood metabolite levels;
SKCM	cis	rs4891159	0.570	rs690132	chr18:74117261	T/C	cg24786174	chr18:74118243	ZNF516	0.81	8.75	0.7	3.24e-13	Longevity;
SKCM	cis	rs55720021	1	rs55720021	chr19:49144241	G/T	cg06677660	chr19:49140777	SEC1;DBP	0.88	6.15	0.57	3.09e-8	Lymphocyte percentage of white cells;Neutrophil percentage of white cells;
SKCM	cis	rs2991971	0.967	rs2356551	chr1:46009318	C/T	cg24296786	chr1:45957014	TESK2	0.65	5.16	0.5	1.81e-6	High light scatter reticulocyte count;
SKCM	cis	rs1577917	0.958	rs10806337	chr6:86474249	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.87	-8.66	-0.7	5.01e-13	Response to antipsychotic treatment;
SKCM	cis	rs202629	1	rs202629	chr22:41849975	C/T	cg03806693	chr22:41940476	POLR3H	1.07	6.74	0.61	2.44e-9	Cannabis dependence symptom count;
SKCM	cis	rs1707322	0.827	rs12125508	chr1:46246010	A/G	cg03146154	chr1:46216737	IPP	0.81	5.92	0.56	8.2e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs2070488	0.804	rs1870914	chr3:38494220	T/C	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.71	5.57	0.53	3.49e-7	Electrocardiographic conduction measures;
SKCM	cis	rs1979654	0.543	rs4843933	chr16:86401190	A/G	cg03720195	chr16:87119252	NA	0.52	5.52	0.53	4.3e-7	Barrett's esophagus  or Esophageal adenocarcinoma;
SKCM	cis	rs2731664	0.792	rs179809	chr5:176865329	T/G	cg23176889	chr5:176863531	GRK6	-0.5	-5.17	-0.51	1.74e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9910055	0.708	rs2631298	chr17:42219832	T/C	cg08499158	chr17:42289980	UBTF	-0.74	-6.4	-0.59	1.07e-8	Total body bone mineral density;
SKCM	cis	rs4727027	0.704	rs2888600	chr7:148908562	C/T	cg23583168	chr7:148888333	NA	-0.77	-6.04	-0.56	4.93e-8	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs708547	0.836	rs1713997	chr4:57843863	G/C	cg00922110	chr4:57842668	C4orf14	-0.58	-4.82	-0.48	6.98e-6	Response to bleomycin (chromatid breaks);
SKCM	cis	rs711830	1.000	rs711830	chr2:177037311	C/T	cg13092806	chr2:177043255	NA	-0.68	-6.21	-0.58	2.41e-8	Serous invasive ovarian cancer;Epithelial ovarian cancer;Invasive epithelial ovarian cancer;Mucinous ovarian carcinoma;Low-grade serous and serous borderline ovarian cancer;Serous borderline ovarian cancer;High-grade serous ovarian cancer;
SKCM	cis	rs870825	0.616	rs4263438	chr4:185624238	C/T	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs6089584	0.927	rs6089593	chr20:60572312	G/A	cg06108461	chr20:60628389	TAF4	-0.84	-7.12	-0.63	4.61e-10	Body mass index;
SKCM	cis	rs3785574	0.650	rs7406102	chr17:62004749	G/A	cg11494091	chr17:61959527	GH2	-0.6	-5.76	-0.55	1.6e-7	Height;
SKCM	cis	rs12142240	0.667	rs45524035	chr1:46862780	C/T	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs7937682	0.924	rs10891288	chr11:111552053	G/T	cg09085632	chr11:111637200	PPP2R1B	1.05	12.37	0.81	4.56e-20	Primary sclerosing cholangitis;
SKCM	cis	rs2013441	1.000	rs2703794	chr17:20073338	T/C	cg13482628	chr17:19912719	NA	0.67	5.24	0.51	1.32e-6	Obesity-related traits;
SKCM	cis	rs6952808	0.609	rs4721190	chr7:1954732	A/G	cg21782813	chr7:2030301	MAD1L1	-0.5	-5.41	-0.52	6.71e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs1799949	0.930	rs56729776	chr17:41422131	C/T	cg05368731	chr17:41323189	NBR1	0.85	7.32	0.64	1.89e-10	Menopause (age at onset);
SKCM	cis	rs875971	0.522	rs1968127	chr7:66056803	C/T	cg11987759	chr7:65425863	GUSB	0.67	5.75	0.55	1.68e-7	Aortic root size;
SKCM	cis	rs9902453	0.765	rs2628167	chr17:28064498	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.79	-5.93	-0.56	7.67e-8	Coffee consumption (cups per day);
SKCM	cis	rs34779708	0.931	rs4934693	chr10:35271844	G/A	cg03585969	chr10:35415529	CREM	0.72	5.96	0.56	6.77e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	trans	rs561341	0.883	rs72821942	chr17:30234460	C/T	cg20587970	chr11:113659929	NA	-1.11	-8.92	-0.71	1.53e-13	Hip circumference adjusted for BMI;
SKCM	cis	rs67311347	0.544	rs12633295	chr3:40335292	G/T	cg13409248	chr3:40428643	ENTPD3	-0.56	-5.23	-0.51	1.39e-6	Renal cell carcinoma;
SKCM	cis	rs6547631	0.622	rs1437745	chr2:85928283	A/G	cg24620635	chr2:85921963	GNLY	0.9	6.65	0.6	3.58e-9	Blood protein levels;
SKCM	cis	rs4332037	0.713	rs56093134	chr7:1973970	C/T	cg23422044	chr7:1970798	MAD1L1	-1.08	-7.36	-0.64	1.64e-10	Bipolar disorder;
SKCM	cis	rs28386778	0.805	rs9911714	chr17:61828952	G/A	cg06873352	chr17:61820015	STRADA	0.76	6.34	0.58	1.38e-8	Prudent dietary pattern;
SKCM	cis	rs11719291	0.915	rs9834996	chr3:48754877	G/T	cg00383909	chr3:49044727	WDR6	0.93	5.5	0.53	4.69e-7	Cognitive function;
SKCM	cis	rs55962025	0.628	rs67950027	chr4:3152786	A/C	cg00764545	chr4:3318001	RGS12	-0.65	-5.49	-0.53	4.78e-7	Parental longevity (mother's age at death);
SKCM	cis	rs28595532	0.920	rs115320476	chr4:119759680	G/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs875971	0.660	rs801193	chr7:66030612	A/C	cg05627663	chr7:65219948	SNORA22;CCT6P1	-0.56	-4.8	-0.48	7.45e-6	Aortic root size;
SKCM	cis	rs1218582	0.772	rs4845400	chr1:154872523	C/T	cg24250549	chr1:154909240	PMVK	0.87	8.7	0.7	4.13e-13	Prostate cancer;
SKCM	cis	rs861020	0.563	rs61820640	chr1:210041297	G/T	cg05527609	chr1:210001259	C1orf107	-0.92	-6.29	-0.58	1.73e-8	Orofacial clefts;
SKCM	cis	rs875971	0.825	rs4587224	chr7:65736182	G/A	cg11764359	chr7:65958608	NA	-0.82	-7.87	-0.67	1.68e-11	Aortic root size;
SKCM	cis	rs873946	0.648	rs12766050	chr10:134549108	G/A	cg18305652	chr10:134549665	INPP5A	0.54	5.32	0.52	9.83e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs1707322	1.000	rs4660335	chr1:46474718	C/T	cg03146154	chr1:46216737	IPP	0.76	5.21	0.51	1.53e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs561341	1.000	rs4795668	chr17:30244554	G/A	cg12193833	chr17:30244370	NA	-0.47	-4.79	-0.48	7.65e-6	Hip circumference adjusted for BMI;
SKCM	trans	rs208520	0.690	rs851467	chr6:66802721	A/G	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-1.01	-7.5	-0.65	8.58e-11	Exhaled nitric oxide output;
SKCM	cis	rs9467773	0.901	rs1407045	chr6:26476155	A/G	cg15659132	chr6:26577336	NA	0.58	5.4	0.52	7.09e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs1639906	0.895	rs62443039	chr7:2209354	C/T	cg21782813	chr7:2030301	MAD1L1	-0.52	-5.38	-0.52	7.71e-7	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1801251	1.000	rs778166	chr2:233664097	A/T	cg25237894	chr2:233734115	C2orf82	0.58	5.74	0.54	1.75e-7	Coronary artery disease;
SKCM	cis	rs2839186	0.872	rs13046834	chr21:47701485	T/C	cg05896524	chr21:47604654	C21orf56	0.67	5.49	0.53	4.77e-7	Testicular germ cell tumor;
SKCM	cis	rs2243480	1.000	rs35421653	chr7:65363429	C/A	cg07424592	chr7:64974309	NA	0.99	4.9	0.49	5.08e-6	Diabetic kidney disease;
SKCM	cis	rs801193	1.000	rs3857688	chr7:66127806	G/A	cg11764359	chr7:65958608	NA	-0.83	-6.29	-0.58	1.71e-8	Aortic root size;
SKCM	cis	rs763121	0.853	rs9610993	chr22:39042818	C/A	cg06022373	chr22:39101656	GTPBP1	0.72	4.96	0.49	4.08e-6	Menopause (age at onset);
SKCM	cis	rs2732480	0.538	rs2468943	chr12:48747249	G/T	cg21348975	chr12:48724119	NA	0.59	4.99	0.49	3.63e-6	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs7296418	0.518	rs28825193	chr12:123878262	T/C	cg05973401	chr12:123451056	ABCB9	0.72	5.18	0.51	1.66e-6	Platelet count;
SKCM	cis	rs1059312	0.808	rs4760533	chr12:129297651	A/G	cg09035930	chr12:129282057	SLC15A4	-0.76	-7.88	-0.67	1.6e-11	Systemic lupus erythematosus;
SKCM	cis	rs6570726	0.846	rs426874	chr6:145880630	A/C	cg05347473	chr6:146136440	FBXO30	0.53	4.9	0.48	5.19e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs748404	0.631	rs7163288	chr15:43671355	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	0.79	5.99	0.56	6e-8	Lung cancer;
SKCM	cis	rs6582630	0.537	rs3942440	chr12:38459672	A/G	cg26384229	chr12:38710491	ALG10B	0.81	6.22	0.58	2.31e-8	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs2730245	0.527	rs842700	chr7:158697565	G/A	cg24397884	chr7:158709396	WDR60	0.98	5.56	0.53	3.7e-7	Height;
SKCM	cis	rs2033711	0.870	rs4801583	chr19:58918405	A/G	cg03735888	chr19:58951602	ZNF132	0.69	5.86	0.55	1.05e-7	Uric acid clearance;
SKCM	cis	rs709400	0.663	rs55723020	chr14:103991401	G/A	cg26031613	chr14:104095156	KLC1	0.69	5.28	0.51	1.13e-6	Body mass index;
SKCM	cis	rs6541297	0.887	rs4846906	chr1:230284257	C/A	cg05784532	chr1:230284198	GALNT2	0.57	4.77	0.48	8.4e-6	Coronary artery disease;
SKCM	cis	rs9583531	0.628	rs9521914	chr13:111382231	C/A	cg24331049	chr13:111365604	ING1	0.79	6.02	0.56	5.32e-8	Coronary artery disease;
SKCM	cis	rs9921222	0.500	rs11648673	chr16:377794	G/A	cg00101154	chr16:420108	MRPL28	-0.63	-5.15	-0.5	1.9e-6	Bone mineral density (spine);Bone mineral density;
SKCM	cis	rs992157	0.710	rs10167446	chr2:219056866	A/G	cg00012203	chr2:219082015	ARPC2	0.85	7.47	0.65	9.82e-11	Colorectal cancer;
SKCM	cis	rs2839186	0.934	rs17182538	chr21:47705673	C/A	cg11766577	chr21:47581405	C21orf56	-0.69	-5.67	-0.54	2.33e-7	Testicular germ cell tumor;
SKCM	cis	rs1799949	0.930	rs56729776	chr17:41422131	C/T	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.18	-0.57	2.68e-8	Menopause (age at onset);
SKCM	cis	rs1912528	0.814	rs12505942	chr4:140906390	T/C	cg11128457	chr4:140864437	MAML3	0.58	4.91	0.49	4.83e-6	Educational attainment (years of education);
SKCM	cis	rs10504229	1.000	rs60651159	chr8:58174074	T/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs3820928	0.874	rs2228557	chr2:227872182	G/A	cg11843606	chr2:227700838	RHBDD1	-0.59	-4.81	-0.48	7.13e-6	Pulmonary function;
SKCM	cis	rs6582630	0.519	rs4405392	chr12:38293661	A/C	cg26384229	chr12:38710491	ALG10B	0.8	6.55	0.6	5.47e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs6977660	1.000	rs13230910	chr7:19806003	A/G	cg07541023	chr7:19748670	TWISTNB	-0.72	-5.03	-0.5	3.01e-6	Thyroid stimulating hormone;
SKCM	cis	rs6570726	0.935	rs409725	chr6:145840340	G/A	cg23711669	chr6:146136114	FBXO30	0.7	6.64	0.6	3.72e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9325144	0.600	rs1817648	chr12:38733424	C/T	cg13010199	chr12:38710504	ALG10B	-0.64	-5.03	-0.49	3.08e-6	Morning vs. evening chronotype;
SKCM	cis	rs57221529	0.709	rs72703090	chr5:598314	C/T	cg10555297	chr5:473380	SLC9A3;LOC25845	1.03	4.96	0.49	4e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs8067545	0.750	rs4925079	chr17:19986861	T/A	cg13482628	chr17:19912719	NA	0.73	6.54	0.6	5.78e-9	Schizophrenia;
SKCM	cis	rs10088262	0.634	rs7815695	chr8:124783978	C/G	cg20713898	chr8:124780851	FAM91A1	-0.71	-4.9	-0.49	5.03e-6	Pancreatic cancer;
SKCM	cis	rs9715521	0.868	rs12650159	chr4:59818550	C/T	cg11281224	chr4:60001000	NA	-0.63	-4.93	-0.49	4.56e-6	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs6750795	0.746	rs2916579	chr2:232421159	A/G	cg19187155	chr2:232395269	NMUR1	1.09	11.46	0.79	2.12e-18	Height;
SKCM	cis	rs10193935	0.901	rs1390609	chr2:42666230	G/T	cg27598129	chr2:42591480	NA	0.88	6.71	0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9790314	0.586	rs11710916	chr3:161130070	A/G	cg03342759	chr3:160939853	NMD3	-0.74	-6.62	-0.6	4.08e-9	Morning vs. evening chronotype;
SKCM	trans	rs1814175	0.715	rs10839409	chr11:49884647	G/T	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs11122272	0.735	rs2808603	chr1:231537738	T/C	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	-0.62	-4.91	-0.49	4.84e-6	Hemoglobin concentration;
SKCM	cis	rs6089584	0.528	rs881994	chr20:60623931	G/A	cg16423285	chr20:60520624	NA	-0.58	-4.96	-0.49	4.1e-6	Body mass index;
SKCM	cis	rs1577917	0.916	rs12661611	chr6:86553835	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.69	-6.15	-0.57	3.1e-8	Response to antipsychotic treatment;
SKCM	cis	rs9915657	0.870	rs12941066	chr17:70141226	C/T	cg06234051	chr17:70120541	SOX9	-0.62	-5.33	-0.52	9.26e-7	Thyroid hormone levels;
SKCM	cis	rs28595532	0.748	rs115651241	chr4:119363509	C/T	cg11846333	chr4:119757529	SEC24D	1.16	6.33	0.58	1.42e-8	Cannabis dependence symptom count;
SKCM	cis	rs763121	0.853	rs5757203	chr22:39044152	G/C	cg06022373	chr22:39101656	GTPBP1	0.72	4.96	0.49	4.08e-6	Menopause (age at onset);
SKCM	cis	rs561341	0.941	rs4625780	chr17:30249214	A/C	cg23018236	chr17:30244563	NA	-0.53	-5.38	-0.52	7.72e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs6461049	0.800	rs3800909	chr7:2159594	C/G	cg02951883	chr7:2050386	MAD1L1	-0.72	-6.54	-0.6	5.79e-9	Schizophrenia;
SKCM	cis	rs10504073	0.584	rs12546490	chr8:49932841	C/T	cg00325661	chr8:49890786	NA	0.77	6.3	0.58	1.64e-8	Blood metabolite ratios;
SKCM	cis	rs11690935	0.851	rs9808259	chr2:172648974	C/T	cg13550731	chr2:172543902	DYNC1I2	-0.91	-7.69	-0.66	3.69e-11	Schizophrenia;
SKCM	cis	rs9297145	0.678	rs62473051	chr7:98781955	C/T	cg05967295	chr7:98741636	SMURF1	1.08	7.69	0.66	3.66e-11	Crohn's disease;Inflammatory bowel disease;Ulcerative colitis;
SKCM	cis	rs4819052	0.851	rs12626188	chr21:46669258	A/G	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.42	0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs10504073	0.647	rs11785310	chr8:50025035	G/A	cg00325661	chr8:49890786	NA	0.79	6.79	0.61	1.99e-9	Blood metabolite ratios;
SKCM	cis	rs6952808	1.000	rs4721121	chr7:1892565	A/G	cg04267008	chr7:1944627	MAD1L1	-0.77	-5.86	-0.55	1.06e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs2836974	0.931	rs12151994	chr21:40690397	A/C	cg11890956	chr21:40555474	PSMG1	0.97	10.18	0.76	5.63e-16	Cognitive function;
SKCM	cis	rs9486715	0.838	rs7452350	chr6:96883326	C/A	cg06623918	chr6:96969491	KIAA0776	0.79	7.09	0.63	5.34e-10	Headache;
SKCM	cis	rs2841277	0.676	rs10438247	chr14:105411781	G/A	cg19901468	chr14:105411992	AHNAK2	-0.89	-6.75	-0.61	2.31e-9	Rheumatoid arthritis;
SKCM	cis	rs4665809	0.590	rs3792007	chr2:26497541	C/T	cg26119090	chr2:26468346	HADHA;HADHB	1.08	8.63	0.7	5.67e-13	Gut microbiome composition (summer);
SKCM	cis	rs1577917	0.740	rs9344542	chr6:86393905	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.92	9.45	0.73	1.43e-14	Response to antipsychotic treatment;
SKCM	cis	rs7539542	0.536	rs12091234	chr1:202855508	C/T	cg19681188	chr1:202830198	LOC148709	0.82	5.69	0.54	2.14e-7	Mean platelet volume;
SKCM	cis	rs7659604	0.846	rs35986491	chr4:122664528	A/T	cg06713675	chr4:122721982	EXOSC9	-0.65	-5.83	-0.55	1.21e-7	Type 2 diabetes;
SKCM	cis	rs9467773	1.000	rs1078679	chr6:26568741	C/T	cg15659132	chr6:26577336	NA	0.61	5.76	0.55	1.6e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs4478137	0.931	rs11100488	chr4:164237660	C/A	cg06758707	chr4:164254230	NPY1R	0.93	6.88	0.61	1.35e-9	Subjective well-being (multi-trait analysis);Subjective well-being;
SKCM	cis	rs7811142	0.562	rs7786844	chr7:99934008	T/G	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.21	8.05	0.67	7.68e-12	Platelet count;
SKCM	cis	rs2204008	0.837	rs11168387	chr12:37962818	G/A	cg26384229	chr12:38710491	ALG10B	-0.75	-6.15	-0.57	3.14e-8	Bladder cancer;
SKCM	cis	rs7100689	0.577	rs2282367	chr10:82040346	A/G	cg01528321	chr10:82214614	TSPAN14	0.8	7.83	0.66	1.96e-11	Post bronchodilator FEV1;
SKCM	cis	rs6951245	1.000	rs113858334	chr7:1073476	A/G	cg18402987	chr7:1209562	NA	1.15	6.02	0.56	5.38e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs1552244	1.000	rs66797209	chr3:10078526	G/A	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs4865169	0.783	rs7668814	chr4:57825190	A/G	cg16868167	chr4:57843880	C4orf14;POLR2B	0.63	5.22	0.51	1.44e-6	Breast cancer;
SKCM	cis	rs2228479	0.867	rs17784386	chr16:89947457	A/G	cg06558623	chr16:89946397	TCF25	1.26	6.97	0.62	9.17e-10	Skin colour saturation;
SKCM	cis	rs6089584	0.526	rs6089316	chr20:60627552	C/T	cg06108461	chr20:60628389	TAF4	-0.79	-7.45	-0.64	1.08e-10	Body mass index;
SKCM	cis	rs9470366	0.527	rs733590	chr6:36645203	A/G	cg08179530	chr6:36648295	CDKN1A	0.69	4.77	0.48	8.34e-6	QRS duration;
SKCM	cis	rs62244186	0.545	rs9284880	chr3:44759389	C/T	cg15225532	chr3:44803084	KIF15;KIAA1143	0.64	4.93	0.49	4.47e-6	Depressive symptoms;
SKCM	cis	rs10870270	0.956	rs10870293	chr10:133771413	G/A	cg17892150	chr10:133769511	PPP2R2D	-0.66	-4.86	-0.48	5.92e-6	Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals;
SKCM	cis	rs6121246	0.559	rs6060933	chr20:30351903	C/T	cg13852791	chr20:30311386	BCL2L1	0.82	5.69	0.54	2.09e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs459571	0.635	rs379471	chr9:136890649	G/A	cg13789015	chr9:136890014	NCRNA00094	0.81	6.95	0.62	9.82e-10	Platelet distribution width;
SKCM	cis	rs4561483	0.771	rs12924398	chr16:11972948	T/A	cg08843971	chr16:11963173	GSPT1	-0.64	-4.81	-0.48	7.35e-6	Testicular germ cell tumor;
SKCM	cis	rs7684253	0.565	rs13108570	chr4:57807083	G/C	cg25313468	chr4:57773308	REST	0.4	4.89	0.48	5.24e-6	Migraine;
SKCM	cis	rs9910055	0.676	rs11079983	chr17:42198170	C/T	cg19774624	chr17:42201019	HDAC5	-0.93	-8.25	-0.68	3.08e-12	Total body bone mineral density;
SKCM	cis	rs62238980	0.614	rs116866390	chr22:32533595	G/A	cg00543991	chr22:32367038	NA	1.16	4.77	0.47	8.55e-6	Childhood ear infection;
SKCM	cis	rs2072499	0.865	rs2758603	chr1:156198994	T/C	cg24450063	chr1:156163899	SLC25A44	0.79	6.76	0.61	2.21e-9	Testicular germ cell tumor;
SKCM	cis	rs7937682	0.961	rs552387	chr11:111490047	T/G	cg19812747	chr11:111475976	SIK2	-0.56	-4.97	-0.49	3.82e-6	Primary sclerosing cholangitis;
SKCM	cis	rs6545883	0.894	rs35292974	chr2:61522047	T/C	cg15711740	chr2:61764176	XPO1	0.68	4.82	0.48	6.94e-6	Tuberculosis;
SKCM	cis	rs9916302	0.861	rs593480	chr17:37453780	A/C	cg07936489	chr17:37558343	FBXL20	0.85	6.83	0.61	1.66e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs10503709	0.543	rs10093520	chr8:21465469	C/T	cg23716449	chr8:21608280	GFRA2	-0.49	-4.8	-0.48	7.38e-6	Blood protein levels;
SKCM	cis	rs55728055	0.661	rs62237857	chr22:32039311	G/A	cg01338084	chr22:32026380	PISD	1.62	5.14	0.5	1.99e-6	Age-related hearing impairment;
SKCM	cis	rs13118159	0.556	rs4974615	chr4:1373551	A/G	cg05025164	chr4:1340916	KIAA1530	-0.88	-7.31	-0.64	2.05e-10	Longevity;
SKCM	cis	rs12706411	0.764	rs13241783	chr7:122093760	A/G	cg17986181	chr7:121955208	NA	-0.65	-5.01	-0.49	3.36e-6	Alzheimer disease and age of onset;
SKCM	cis	rs9300255	0.663	rs7953929	chr12:123758235	C/G	cg05973401	chr12:123451056	ABCB9	0.84	5.94	0.56	7.59e-8	Neutrophil percentage of white cells;
SKCM	cis	rs28386778	0.863	rs3760254	chr17:61851751	T/G	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs9300255	0.602	rs2851450	chr12:123703501	C/T	cg05973401	chr12:123451056	ABCB9	0.81	5.37	0.52	7.77e-7	Neutrophil percentage of white cells;
SKCM	cis	rs12048904	0.533	rs12026932	chr1:101212881	T/A	cg16556008	chr1:101360663	SLC30A7;EXTL2	0.75	5.11	0.5	2.21e-6	Multiple sclerosis;
SKCM	cis	rs6951245	0.872	rs75280240	chr7:1058511	C/T	cg03188948	chr7:1209495	NA	1.11	6.11	0.57	3.68e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs362272	0.524	rs2857982	chr4:3358665	G/A	cg09735869	chr4:3319127	RGS12	1.0	11.49	0.79	1.86e-18	Serum sulfate level;
SKCM	cis	rs6061231	0.631	rs2427318	chr20:60975727	G/T	cg24112000	chr20:60950667	NA	-0.59	-6.07	-0.57	4.3e-8	Colorectal cancer;
SKCM	cis	rs798554	0.757	rs2644312	chr7:2841164	G/A	cg19346786	chr7:2764209	NA	-0.65	-7.08	-0.63	5.46e-10	Height;
SKCM	cis	rs28785552	0.769	rs11669363	chr19:53232321	C/A	cg10871876	chr19:53194124	ZNF83	0.66	4.79	0.48	7.82e-6	Response to paliperidone in schizophrenia (PANSS score);
SKCM	cis	rs116095464	0.558	rs9687898	chr5:253952	A/G	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs1413885	0.516	rs10158872	chr1:65836230	T/C	cg14976592	chr1:65886160	LEPROT;LEPR	0.62	5.25	0.51	1.28e-6	Anticoagulant levels;
SKCM	cis	rs1005277	0.541	rs2472177	chr10:38384015	T/G	cg00409905	chr10:38381863	ZNF37A	-0.64	-6.18	-0.57	2.68e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs7584330	0.737	rs11886117	chr2:238361650	A/T	cg14458575	chr2:238380390	NA	0.88	6.21	0.57	2.43e-8	Prostate cancer;
SKCM	cis	rs6933660	0.665	rs6921042	chr6:151732385	T/C	cg10883421	chr6:151773342	RMND1;C6orf211	0.83	7.04	0.62	6.61e-10	Menarche (age at onset);
SKCM	cis	rs875971	0.862	rs6952182	chr7:65683317	T/G	cg11764359	chr7:65958608	NA	-0.75	-6.89	-0.62	1.26e-9	Aortic root size;
SKCM	cis	rs28595532	0.546	rs17516389	chr4:119239267	T/C	cg11846333	chr4:119757529	SEC24D	0.97	5.32	0.52	9.68e-7	Cannabis dependence symptom count;
SKCM	cis	rs10028773	0.568	rs6838457	chr4:120267367	A/G	cg09307838	chr4:120376055	NA	0.96	8.24	0.68	3.19e-12	Educational attainment;
SKCM	cis	rs644799	0.710	rs11021311	chr11:95505227	G/A	cg25622487	chr11:95524042	FAM76B;CEP57	0.76	6.47	0.59	7.89e-9	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs35306767	0.953	rs7908138	chr10:962978	C/T	cg26597838	chr10:835615	NA	0.67	5.22	0.51	1.44e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs35306767	0.903	rs11812523	chr10:915638	C/T	cg20503657	chr10:835505	NA	0.77	5.32	0.52	9.76e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs7953508	0.506	rs10777530	chr12:93961110	C/T	cg18151635	chr12:93972918	NA	-0.7	-6.81	-0.61	1.8e-9	Pubertal anthropometrics;
SKCM	cis	rs13118159	0.550	rs10016557	chr4:1363628	C/T	cg02018176	chr4:1364513	KIAA1530	-0.96	-8.67	-0.7	4.75e-13	Longevity;
SKCM	cis	rs10208940	0.502	rs10203846	chr2:68670921	G/A	cg12452813	chr2:68675892	NA	-0.88	-5.22	-0.51	1.46e-6	Urate levels in lean individuals;
SKCM	cis	rs6121246	0.697	rs6120970	chr20:30232452	C/T	cg11595048	chr20:30225325	COX4I2	0.65	5.19	0.51	1.62e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs11112613	0.775	rs61200462	chr12:105969271	G/A	cg03607813	chr12:105948248	NA	0.87	6.2	0.57	2.55e-8	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;
SKCM	cis	rs997295	0.592	rs7162320	chr15:67766038	C/G	cg24247231	chr15:67904302	MAP2K5	-0.6	-5.1	-0.5	2.3e-6	Motion sickness;
SKCM	cis	rs28386778	0.897	rs2727326	chr17:61923016	G/A	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs1032355	0.558	rs79194015	chr4:100518483	A/T	cg25391692	chr4:100495869	MTTP	-0.82	-4.97	-0.49	3.9e-6	Celiac disease;
SKCM	cis	rs2836633	0.895	rs61085980	chr21:40032140	C/T	cg05519781	chr21:40033154	ERG	0.75	6.8	0.61	1.86e-9	Coronary artery disease;
SKCM	cis	rs870825	0.616	rs72703531	chr4:185611092	C/T	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs9943753	0.508	rs7958071	chr12:109836089	G/A	cg19025524	chr12:109796872	NA	-0.62	-5.83	-0.55	1.19e-7	HDL cholesterol;
SKCM	cis	rs6977660	1.000	rs34367208	chr7:19818811	T/G	cg07541023	chr7:19748670	TWISTNB	0.7	4.82	0.48	6.98e-6	Thyroid stimulating hormone;
SKCM	cis	rs7666738	0.791	rs1593571	chr4:98963763	T/C	cg17366294	chr4:99064904	C4orf37	0.59	4.89	0.48	5.36e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10905065	1.000	rs7913067	chr10:5787305	C/T	cg09234995	chr10:5726438	C10orf18	-0.62	-5.21	-0.51	1.5e-6	Menopause (age at onset);
SKCM	cis	rs854765	0.583	rs9912895	chr17:17826020	C/T	cg04398451	chr17:18023971	MYO15A	0.88	6.11	0.57	3.66e-8	Total body bone mineral density;
SKCM	cis	rs7208859	0.623	rs9890862	chr17:29125450	C/A	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs738322	0.511	rs2267370	chr22:38576826	G/A	cg25457927	chr22:38595422	NA	-0.58	-6.4	-0.59	1.05e-8	Cutaneous nevi;
SKCM	cis	rs778371	0.723	rs737027	chr2:233641083	G/C	cg08000102	chr2:233561755	GIGYF2	0.88	7.39	0.64	1.41e-10	Schizophrenia;
SKCM	cis	rs10504229	0.815	rs75577263	chr8:58188434	A/G	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs13118159	0.550	rs4974611	chr4:1358449	T/C	cg02018176	chr4:1364513	KIAA1530	0.93	7.8	0.66	2.31e-11	Longevity;
SKCM	cis	rs4862750	0.832	rs4862744	chr4:187877074	T/A	cg03452623	chr4:187889614	NA	-0.44	-5.4	-0.52	6.91e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs951366	0.622	rs11580015	chr1:205676088	G/C	cg07167872	chr1:205819463	PM20D1	0.77	6.16	0.57	2.96e-8	Menarche (age at onset);
SKCM	cis	rs6545883	0.929	rs3821222	chr2:61713526	C/G	cg15711740	chr2:61764176	XPO1	-0.7	-4.96	-0.49	4.1e-6	Tuberculosis;
SKCM	trans	rs1814175	0.669	rs12364577	chr11:49707361	A/C	cg15704280	chr7:45808275	SEPT13	-0.82	-7.86	-0.66	1.78e-11	Height;
SKCM	cis	rs7027203	0.797	rs4744294	chr9:96612114	C/G	cg14598338	chr9:96623480	NA	-0.5	-5.11	-0.5	2.25e-6	DNA methylation (variation);
SKCM	cis	rs867186	1.000	rs74543591	chr20:33658658	T/C	cg04194272	chr20:33683537	NA	-1.38	-7.2	-0.63	3.29e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs3793683	0.520	rs4880426	chr10:134590610	G/A	cg00988841	chr10:134556463	INPP5A	0.61	4.78	0.48	8.12e-6	Migraine;
SKCM	cis	rs13118159	0.509	rs7688922	chr4:1361011	T/C	cg02475777	chr4:1388615	CRIPAK	0.8	5.27	0.51	1.17e-6	Longevity;
SKCM	cis	rs11098499	0.697	rs28655325	chr4:120372999	A/G	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs1568889	1.000	rs61889026	chr11:28274803	G/A	cg06544937	chr11:28130018	METT5D1;KIF18A	0.86	6.4	0.59	1.07e-8	Bipolar disorder;
SKCM	cis	rs1032355	0.908	rs17029173	chr4:100509321	G/T	cg25391692	chr4:100495869	MTTP	0.73	5.45	0.53	5.73e-7	Celiac disease;
SKCM	cis	rs754466	0.606	rs10824581	chr10:79599501	A/G	cg17075019	chr10:79541650	NA	-0.78	-7.01	-0.62	7.47e-10	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs62064224	0.818	rs11080181	chr17:30701210	C/T	cg18200150	chr17:30822561	MYO1D	0.78	6.23	0.58	2.2e-8	Schizophrenia;
SKCM	cis	rs4237845	0.514	rs4760339	chr12:58268149	G/T	cg02175503	chr12:58329896	NA	0.73	5.88	0.55	9.8e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs2032447	0.714	rs199739	chr6:25960509	A/C	cg18357526	chr6:26021779	HIST1H4A	0.66	4.81	0.48	7.23e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7666738	0.791	rs13127542	chr4:98949159	C/T	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9788682	1.000	rs12441354	chr15:78821016	G/A	cg06917634	chr15:78832804	PSMA4	-0.85	-5.3	-0.51	1.05e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs3087591	0.960	rs1124918	chr17:29492423	A/G	cg24425628	chr17:29625626	OMG;NF1	-0.64	-5.43	-0.52	6.23e-7	Hip circumference;
SKCM	cis	rs11148252	0.574	rs61958118	chr13:53170226	C/T	cg00495681	chr13:53174319	NA	0.63	5.29	0.51	1.08e-6	Lewy body disease;
SKCM	cis	rs2075671	0.903	rs11760602	chr7:100264128	G/C	cg16850897	chr7:100343110	ZAN	-0.65	-4.78	-0.48	8.2e-6	Other erythrocyte phenotypes;
SKCM	cis	rs1799949	0.965	rs7223952	chr17:41194885	T/C	cg23758822	chr17:41437982	NA	0.94	7.62	0.65	5e-11	Menopause (age at onset);
SKCM	cis	rs28595532	0.920	rs114940990	chr4:119758568	A/G	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs9911578	0.967	rs686425	chr17:56776730	A/G	cg12560992	chr17:57184187	TRIM37	0.95	7.69	0.66	3.7e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs71520386	0.632	rs12535331	chr7:22878104	G/T	cg00309339	chr7:22893653	NA	-0.69	-5.28	-0.51	1.13e-6	Fibrinogen levels;
SKCM	cis	rs6500395	1.000	rs9939103	chr16:48592376	G/C	cg04672837	chr16:48644449	N4BP1	0.69	5.73	0.54	1.8e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs9611565	0.681	rs6002372	chr22:41801299	A/T	cg03806693	chr22:41940476	POLR3H	1.02	6.92	0.62	1.13e-9	Vitiligo;
SKCM	cis	rs875971	1.000	rs778726	chr7:65828731	C/T	cg18876405	chr7:65276391	NA	0.68	6.79	0.61	2.01e-9	Aortic root size;
SKCM	cis	rs60871478	0.592	rs55704002	chr7:851797	C/A	cg05535760	chr7:792225	HEATR2	-0.81	-5.97	-0.56	6.63e-8	Cerebrospinal P-tau181p levels;
SKCM	cis	rs4819052	0.851	rs4819044	chr21:46660118	G/A	cg02159808	chr21:46707872	POFUT2;LOC642852	0.69	5.36	0.52	8.31e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7666738	0.830	rs62318470	chr4:98925846	A/C	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10503709	0.606	rs34832098	chr8:21464687	G/A	cg23716449	chr8:21608280	GFRA2	-0.49	-4.8	-0.48	7.63e-6	Blood protein levels;
SKCM	cis	rs477895	0.713	rs1059440	chr11:63991801	C/T	cg07220939	chr11:64358617	SLC22A12	-0.74	-4.91	-0.49	4.86e-6	Mean platelet volume;
SKCM	cis	rs826838	1.000	rs7315028	chr12:38710523	G/A	cg26384229	chr12:38710491	ALG10B	1.09	10.33	0.76	2.97e-16	Heart rate;
SKCM	cis	rs10504229	0.906	rs113745779	chr8:58191301	C/G	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs6087990	0.806	rs4911257	chr20:31359574	T/C	cg13636640	chr20:31349939	DNMT3B	0.97	9.05	0.72	8.63e-14	Ulcerative colitis;
SKCM	cis	rs6088580	0.634	rs6088508	chr20:33060081	A/G	cg24642439	chr20:33292090	TP53INP2	0.76	6.02	0.56	5.26e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs9814567	1.000	rs6801596	chr3:134252114	C/T	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs6665290	0.904	rs1045290	chr1:227178700	A/G	cg10327440	chr1:227177885	CDC42BPA	-1.22	-17.17	-0.89	3.2e-28	Myeloid white cell count;
SKCM	cis	rs1005277	0.579	rs2472174	chr10:38375382	A/G	cg25427524	chr10:38739819	LOC399744	-0.69	-6.45	-0.59	8.73e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs992157	0.710	rs6719789	chr2:219057810	G/T	cg00012203	chr2:219082015	ARPC2	-0.86	-7.63	-0.65	4.81e-11	Colorectal cancer;
SKCM	cis	rs140364877	1	rs140364877	chr7:1885178	C/T	cg02951883	chr7:2050386	MAD1L1	-0.74	-5.41	-0.52	6.74e-7	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs16866061	1.000	rs11681451	chr2:225334104	T/C	cg02879423	chr2:224806760	WDFY1	0.69	5.03	0.5	3.03e-6	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs5769765	0.954	rs5770707	chr22:50244533	G/A	cg22709217	chr22:50311962	ALG12;CRELD2	0.77	5.57	0.53	3.47e-7	Schizophrenia;
SKCM	cis	rs912057	0.797	rs1294430	chr6:6744698	A/G	cg06612196	chr6:6737390	NA	0.58	4.91	0.49	4.81e-6	Waist-to-hip ratio adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);
SKCM	cis	rs12477438	0.520	rs11678456	chr2:99708237	G/A	cg14399236	chr2:99771627	LIPT1;TSGA10	0.98	8.71	0.7	3.93e-13	Chronic sinus infection;
SKCM	cis	rs66887589	0.777	rs1814815	chr4:120258091	C/T	cg09307838	chr4:120376055	NA	0.7	5.09	0.5	2.46e-6	Diastolic blood pressure;
SKCM	cis	rs9796	0.689	rs7180494	chr15:41451841	T/C	cg18705301	chr15:41695430	NDUFAF1	-0.74	-5.44	-0.52	6.06e-7	Menopause (age at onset);
SKCM	cis	rs7811142	1.000	rs66632384	chr7:100018904	G/A	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-1.0	-5.66	-0.54	2.36e-7	Platelet count;
SKCM	cis	rs11098499	0.909	rs73842633	chr4:120375464	G/A	cg24375607	chr4:120327624	NA	0.68	5.45	0.53	5.66e-7	Corneal astigmatism;
SKCM	cis	rs17685	0.753	rs869806	chr7:75688623	C/T	cg01364799	chr7:75623366	TMEM120A	-0.75	-6.05	-0.56	4.78e-8	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs6545883	0.931	rs12713437	chr2:61722904	C/T	cg15711740	chr2:61764176	XPO1	-0.75	-5.3	-0.51	1.06e-6	Tuberculosis;
SKCM	cis	rs7208859	0.573	rs11654035	chr17:29136426	T/C	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs798766	1.000	rs3752749	chr4:1737262	T/C	cg24239225	chr4:1659016	FAM53A	-0.72	-4.87	-0.48	5.66e-6	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs6952808	0.689	rs12668156	chr7:2019875	G/A	cg02951883	chr7:2050386	MAD1L1	-0.79	-6.86	-0.61	1.46e-9	Bipolar disorder and schizophrenia;
SKCM	cis	rs17826219	0.500	rs2874724	chr17:29072433	T/C	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Body mass index;
SKCM	cis	rs7659604	0.539	rs7686084	chr4:122764725	A/C	cg20573242	chr4:122745356	CCNA2	0.76	6.54	0.59	5.89e-9	Type 2 diabetes;
SKCM	cis	rs12477438	0.520	rs6708576	chr2:99801308	G/A	cg26064155	chr2:99771622	LIPT1;TSGA10	0.97	8.85	0.71	2.11e-13	Chronic sinus infection;
SKCM	cis	rs4481887	0.741	rs6587467	chr1:248550976	T/G	cg22724847	chr1:248512586	OR14C36	0.58	4.88	0.48	5.48e-6	Common traits (Other);
SKCM	cis	rs9611565	0.838	rs4239894	chr22:41745548	C/G	cg03806693	chr22:41940476	POLR3H	-0.81	-5.23	-0.51	1.39e-6	Vitiligo;
SKCM	cis	rs4466137	1.000	rs1154888	chr5:82977410	C/A	cg16102102	chr5:83017553	HAPLN1	-0.54	-5.73	-0.54	1.79e-7	Prostate cancer;
SKCM	cis	rs1348850	0.914	rs4341974	chr2:178324879	A/C	cg02961200	chr2:178257176	LOC100130691;AGPS	0.82	6.21	0.58	2.42e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs2075371	1.000	rs447266	chr7:133989543	A/G	cg20476274	chr7:133979776	SLC35B4	1.04	11.01	0.78	1.5e-17	Mean platelet volume;
SKCM	cis	rs7100689	0.646	rs4468295	chr10:82119276	C/G	cg00277334	chr10:82204260	NA	-0.53	-4.89	-0.48	5.28e-6	Post bronchodilator FEV1;
SKCM	cis	rs72949976	0.564	rs4673730	chr2:214024836	G/T	cg08319019	chr2:214017104	IKZF2	0.84	6.86	0.61	1.44e-9	Lung cancer;Squamous cell lung carcinoma;
SKCM	cis	rs9796	0.689	rs576336	chr15:41452771	C/T	cg18705301	chr15:41695430	NDUFAF1	-0.73	-5.72	-0.54	1.86e-7	Menopause (age at onset);
SKCM	cis	rs34779708	0.931	rs7897457	chr10:35386040	A/G	cg03585969	chr10:35415529	CREM	0.79	6.32	0.58	1.47e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs2811415	0.597	rs9814461	chr3:127792309	G/A	cg09089421	chr3:127803668	RUVBL1	1.0	8.69	0.7	4.4e-13	Lung function (FEV1/FVC);
SKCM	cis	rs6547741	0.844	rs7586655	chr2:27915659	A/G	cg27432699	chr2:27873401	GPN1	-0.84	-7.14	-0.63	4.26e-10	Oral cavity cancer;
SKCM	cis	rs7216064	0.954	rs4790974	chr17:65951107	A/T	cg12091567	chr17:66097778	LOC651250	0.8	5.5	0.53	4.69e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs9916302	0.706	rs9891892	chr17:37479856	A/C	cg07936489	chr17:37558343	FBXL20	1.0	7.19	0.63	3.42e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs6951245	1.000	rs78158942	chr7:1090440	G/T	cg03188948	chr7:1209495	NA	1.12	6.25	0.58	2.02e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs910316	0.967	rs175505	chr14:75529619	C/T	cg11812906	chr14:75593930	NEK9	-0.7	-5.23	-0.51	1.4e-6	Height;
SKCM	cis	rs9880211	0.613	rs67109185	chr3:135827392	G/A	cg21827317	chr3:136751795	NA	-0.65	-4.96	-0.49	4.1e-6	Body mass index;Height;
SKCM	cis	rs7511006	0.893	rs5771104	chr22:50651839	C/T	cg16473166	chr22:50639996	SELO	0.66	5.53	0.53	4.15e-7	Obesity-related traits;
SKCM	cis	rs1799949	0.930	rs2298861	chr17:41176831	G/A	cg25918947	chr17:41365094	TMEM106A	-0.61	-5.78	-0.55	1.49e-7	Menopause (age at onset);
SKCM	cis	rs12142240	0.698	rs72677593	chr1:46824363	T/C	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs17685	0.816	rs11763076	chr7:75765963	C/T	cg16684958	chr7:75615977	POR	0.55	5.27	0.51	1.19e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs35146811	0.735	rs858512	chr7:99824453	A/G	cg22906224	chr7:99728672	NA	-0.71	-5.61	-0.54	2.99e-7	Coronary artery disease;
SKCM	cis	rs995000	0.931	rs10157265	chr1:63093617	C/T	cg06896770	chr1:63153194	DOCK7	0.77	7.31	0.64	2.05e-10	Triglyceride levels;
SKCM	cis	rs7829975	0.533	rs13274028	chr8:8729193	A/C	cg15556689	chr8:8085844	FLJ10661	0.73	6.1	0.57	3.84e-8	Mood instability;
SKCM	cis	rs7772486	0.875	rs56181683	chr6:146286620	A/G	cg23711669	chr6:146136114	FBXO30	-0.79	-7.28	-0.64	2.29e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2749592	0.550	rs10764135	chr10:37866845	C/T	cg00409905	chr10:38381863	ZNF37A	0.6	5.52	0.53	4.31e-7	Age-related hearing impairment (SNP x SNP interaction);
SKCM	cis	rs523522	0.923	rs3916065	chr12:120934624	A/C	cg27279351	chr12:120934652	DYNLL1	0.91	8.32	0.69	2.26e-12	High light scatter reticulocyte count;
SKCM	cis	rs10937913	0.534	rs4690032	chr4:2723531	C/T	cg19433769	chr4:2420260	ZFYVE28	-0.69	-4.79	-0.48	7.84e-6	Extrinsic epigenetic age acceleration;
SKCM	cis	rs12802200	0.561	rs746707	chr11:571984	C/T	cg16486109	chr11:613632	IRF7	0.9	5.56	0.53	3.7e-7	Systemic lupus erythematosus;
SKCM	cis	rs13217239	0.646	rs10456351	chr6:26986792	C/T	cg12292205	chr6:26970375	C6orf41	0.63	5.64	0.54	2.58e-7	Schizophrenia;
SKCM	cis	rs2153535	0.580	rs9393033	chr6:8521446	G/A	cg07606381	chr6:8435919	SLC35B3	0.87	6.38	0.59	1.17e-8	Motion sickness;
SKCM	cis	rs1707322	0.717	rs10890345	chr1:46213927	C/T	cg03146154	chr1:46216737	IPP	0.8	5.47	0.53	5.19e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs885518	0.852	rs7866533	chr9:21767404	C/T	cg08390209	chr9:22005563	CDKN2BAS;CDKN2B	-0.85	-5.33	-0.52	9.22e-7	Lung adenocarcinoma;
SKCM	cis	rs17376456	0.569	rs10050364	chr5:93064127	T/C	cg25358565	chr5:93447407	FAM172A	0.91	6.1	0.57	3.85e-8	Diabetic retinopathy;
SKCM	cis	rs1577917	1.000	rs34281561	chr6:86701872	T/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.83	-8.23	-0.68	3.37e-12	Response to antipsychotic treatment;
SKCM	cis	rs9815354	0.767	rs73087378	chr3:41936827	G/A	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs12142240	0.698	rs6697123	chr1:46811310	A/C	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs116095464	0.510	rs7714944	chr5:231765	C/T	cg22496380	chr5:211416	CCDC127	-0.98	-5.11	-0.5	2.21e-6	Breast cancer;
SKCM	cis	rs6426558	0.681	rs10495274	chr1:227175253	C/T	cg10327440	chr1:227177885	CDC42BPA	-0.83	-6.06	-0.57	4.59e-8	Neutrophil percentage of white cells;
SKCM	cis	rs1850744	0.826	rs6858644	chr4:9741681	T/G	cg15442990	chr4:9534313	NA	1.33	5.1	0.5	2.33e-6	Economic and political preferences;
SKCM	cis	rs12706411	0.764	rs28492775	chr7:122096555	T/C	cg17986181	chr7:121955208	NA	-0.65	-5.01	-0.49	3.36e-6	Alzheimer disease and age of onset;
SKCM	cis	rs778371	0.671	rs13008436	chr2:233719948	C/T	cg08000102	chr2:233561755	GIGYF2	-0.8	-6.28	-0.58	1.75e-8	Schizophrenia;
SKCM	cis	rs10256972	0.552	rs2949195	chr7:1202705	G/A	cg09177884	chr7:1199841	ZFAND2A	-0.76	-6.39	-0.59	1.12e-8	Longevity;Endometriosis;
SKCM	cis	rs9611565	0.512	rs5758436	chr22:42124265	C/T	cg03806693	chr22:41940476	POLR3H	1.11	6.72	0.61	2.72e-9	Vitiligo;
SKCM	cis	rs1707322	0.752	rs11211169	chr1:46166709	A/G	cg03146154	chr1:46216737	IPP	0.81	5.62	0.54	2.87e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs10504229	0.683	rs7820559	chr8:58142662	C/T	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs1801251	1.000	rs11679079	chr2:233612656	C/T	cg08000102	chr2:233561755	GIGYF2	0.87	7.05	0.62	6.23e-10	Coronary artery disease;
SKCM	cis	rs1153858	1.000	rs61365925	chr15:45650311	T/C	cg21132104	chr15:45694354	SPATA5L1	0.93	7.94	0.67	1.22e-11	Homoarginine levels;
SKCM	cis	rs8072100	1.000	rs4794016	chr17:45725931	T/A	cg08085267	chr17:45401833	C17orf57	0.63	5.86	0.55	1.06e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs7666738	0.678	rs7670805	chr4:99008763	A/G	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6545883	0.859	rs35760550	chr2:61603865	T/A	cg15711740	chr2:61764176	XPO1	0.68	4.82	0.48	6.94e-6	Tuberculosis;
SKCM	cis	rs1801251	1.000	rs2675974	chr2:233727071	A/G	cg25237894	chr2:233734115	C2orf82	0.58	5.52	0.53	4.28e-7	Coronary artery disease;
SKCM	cis	rs2032447	0.714	rs175319	chr6:25956172	A/G	cg18357526	chr6:26021779	HIST1H4A	0.66	4.78	0.48	7.97e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs28595532	0.545	rs13101451	chr4:119253427	A/G	cg11846333	chr4:119757529	SEC24D	1.04	5.83	0.55	1.2e-7	Cannabis dependence symptom count;
SKCM	cis	rs17376456	0.877	rs7701974	chr5:93311417	C/T	cg21475434	chr5:93447410	FAM172A	1.04	5.55	0.53	3.82e-7	Diabetic retinopathy;
SKCM	cis	rs10489202	0.686	rs6427113	chr1:167845787	C/T	cg24449463	chr1:168025552	DCAF6	0.71	4.87	0.48	5.74e-6	Schizophrenia;
SKCM	cis	rs9815354	0.812	rs73073326	chr3:41834195	G/T	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs13256369	0.802	rs13256404	chr8:8562974	T/C	cg06636001	chr8:8085503	FLJ10661	0.8	6.11	0.57	3.65e-8	Obesity-related traits;
SKCM	cis	rs57221529	0.766	rs72706606	chr5:558609	T/C	cg26208419	chr5:473447	SLC9A3;LOC25845	0.96	4.9	0.49	5.03e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs58904263	1	rs58904263	chr20:30401406	A/AG	cg11595048	chr20:30225325	COX4I2	0.68	5.23	0.51	1.4e-6	Monocyte count;
SKCM	cis	rs875971	0.862	rs880166	chr7:65670762	T/C	cg18876405	chr7:65276391	NA	-0.65	-6.64	-0.6	3.71e-9	Aortic root size;
SKCM	cis	rs8180040	1.000	rs1024037	chr3:47318449	C/A	cg27129171	chr3:47204927	SETD2	-0.87	-6.58	-0.6	4.92e-9	Colorectal cancer;
SKCM	cis	rs13118159	0.550	rs11941200	chr4:1369093	C/G	cg16405210	chr4:1374714	KIAA1530	-0.96	-7.37	-0.64	1.53e-10	Longevity;
SKCM	cis	rs9611565	0.592	rs4822046	chr22:41987543	G/A	cg03806693	chr22:41940476	POLR3H	-1.12	-7.23	-0.63	2.84e-10	Vitiligo;
SKCM	trans	rs208520	0.526	rs9354366	chr6:66788559	C/T	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-1.12	-11.47	-0.79	2.01e-18	Exhaled nitric oxide output;
SKCM	cis	rs8068544	0.748	rs75881902	chr17:40156612	C/A	cg18442075	chr17:40169520	DNAJC7;NKIRAS2	-1.38	-7.28	-0.64	2.26e-10	Reticulocyte fraction of red cells;Reticulocyte count;
SKCM	cis	rs13278732	0.500	rs2290467	chr8:99040154	G/T	cg16297171	chr8:99017690	MATN2	0.54	5.1	0.5	2.33e-6	Eosinophilic esophagitis (pediatric);
SKCM	cis	rs912057	0.841	rs1294423	chr6:6743795	C/T	cg06612196	chr6:6737390	NA	0.58	4.91	0.49	4.81e-6	Waist-to-hip ratio adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);
SKCM	cis	rs12532878	0.652	rs11768465	chr7:100198386	C/T	cg20848291	chr7:100343083	ZAN	-0.74	-5.56	-0.53	3.62e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs2159324	1.000	rs2159324	chr19:45695738	A/G	cg17904997	chr19:44952572	ZNF229	-0.59	-4.93	-0.49	4.54e-6	Quantitative traits;
SKCM	cis	rs9902453	0.765	rs9890747	chr17:28007442	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.79	5.93	0.56	7.67e-8	Coffee consumption (cups per day);
SKCM	cis	rs7296418	0.961	rs1727307	chr12:123575742	A/G	cg05973401	chr12:123451056	ABCB9	0.84	6.88	0.61	1.34e-9	Platelet count;
SKCM	cis	rs12586317	0.620	rs12588810	chr14:35554484	C/T	cg16230307	chr14:35515116	FAM177A1	0.79	5.71	0.54	1.98e-7	Psoriasis;
SKCM	cis	rs7143963	0.666	rs8008502	chr14:103359492	G/A	cg23020514	chr14:103360112	TRAF3	0.77	7.24	0.63	2.69e-10	Body mass index;
SKCM	cis	rs701145	0.537	rs1713847	chr3:153791107	C/A	cg17054900	chr3:154042577	DHX36	1.18	5.21	0.51	1.51e-6	Coronary artery disease;
SKCM	cis	rs782590	0.935	rs10460508	chr2:55882565	A/C	cg18811423	chr2:55921094	PNPT1	0.87	7.18	0.63	3.52e-10	Metabolic syndrome;
SKCM	cis	rs7618501	0.633	rs12496973	chr3:50002245	T/C	cg24110177	chr3:50126178	RBM5	-0.6	-5.11	-0.5	2.25e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs28595532	0.920	rs116428408	chr4:119758514	G/C	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs3845702	0.935	rs3845695	chr2:180796989	A/G	cg01881094	chr2:180872142	CWC22	-0.98	-5.12	-0.5	2.14e-6	Schizophrenia;
SKCM	cis	rs1580019	0.523	rs13236410	chr7:32690663	G/A	cg06627557	chr7:32535165	LSM5;AVL9	0.96	9.42	0.73	1.67e-14	Cognitive ability;
SKCM	trans	rs17685	0.712	rs10275521	chr7:75770972	T/C	cg19862616	chr7:65841803	NCRNA00174	0.94	9.49	0.73	1.22e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs6977660	1.000	rs10279601	chr7:19822171	G/A	cg05791153	chr7:19748676	TWISTNB	0.79	5.34	0.52	9.05e-7	Thyroid stimulating hormone;
SKCM	cis	rs7772486	0.875	rs2748490	chr6:146329681	G/T	cg05347473	chr6:146136440	FBXO30	0.55	4.81	0.48	7.3e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs11098499	0.874	rs28452522	chr4:120110784	A/G	cg09307838	chr4:120376055	NA	0.9	6.66	0.6	3.43e-9	Corneal astigmatism;
SKCM	cis	rs7772486	0.686	rs857880	chr6:145971115	T/C	cg05347473	chr6:146136440	FBXO30	-0.61	-5.46	-0.53	5.55e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2645694	0.626	rs2645709	chr4:77824474	G/A	cg03477792	chr4:77819574	ANKRD56	0.57	6.42	0.59	9.57e-9	Emphysema distribution in smoking;
SKCM	cis	rs9910055	1.000	rs9910055	chr17:42283037	C/T	cg19774624	chr17:42201019	HDAC5	-0.89	-7.43	-0.64	1.16e-10	Total body bone mineral density;
SKCM	cis	rs7811142	1.000	rs4989959	chr7:100032288	T/C	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.17	7.71	0.66	3.44e-11	Platelet count;
SKCM	cis	rs9910055	1.000	rs9895423	chr17:42285740	T/C	cg09913183	chr17:42254507	C17orf65;ASB16	0.69	6.02	0.56	5.3e-8	Total body bone mineral density;
SKCM	cis	rs9921222	0.597	rs7193109	chr16:413523	T/G	cg12437481	chr16:420112	MRPL28	-0.66	-6.06	-0.57	4.53e-8	Bone mineral density (spine);Bone mineral density;
SKCM	cis	rs9916302	0.904	rs1077715	chr17:37683548	A/T	cg07936489	chr17:37558343	FBXL20	-0.9	-8.11	-0.68	5.65e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs2404602	0.647	rs12898416	chr15:77042292	C/G	cg23625390	chr15:77176239	SCAPER	-0.85	-8.26	-0.68	2.93e-12	Blood metabolite levels;
SKCM	cis	rs2404602	0.967	rs7167613	chr15:77041192	C/A	cg23625390	chr15:77176239	SCAPER	0.75	7.27	0.64	2.44e-10	Blood metabolite levels;
SKCM	cis	rs908922	0.676	rs10888494	chr1:152514709	T/C	cg09873164	chr1:152488093	CRCT1	0.76	5.93	0.56	7.7e-8	Hair morphology;
SKCM	cis	rs8180040	0.966	rs56351005	chr3:47430186	G/T	cg27129171	chr3:47204927	SETD2	-0.79	-5.79	-0.55	1.43e-7	Colorectal cancer;
SKCM	cis	rs992157	0.932	rs1473901	chr2:219188838	C/T	cg20019365	chr2:219134978	PNKD;AAMP	0.81	6.8	0.61	1.88e-9	Colorectal cancer;
SKCM	cis	rs1799949	0.965	rs9897425	chr17:41430179	C/G	cg05368731	chr17:41323189	NBR1	0.84	7.18	0.63	3.56e-10	Menopause (age at onset);
SKCM	cis	rs4319547	1.000	rs7307735	chr12:123087442	A/G	cg23029597	chr12:123009494	RSRC2	-0.75	-5.69	-0.54	2.09e-7	Body mass index;
SKCM	cis	rs5750830	0.569	rs5750809	chr22:39791491	T/G	cg11247378	chr22:39784982	NA	-0.51	-6.23	-0.58	2.24e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs870825	0.860	rs55974219	chr4:185600733	G/A	cg04058563	chr4:185651563	MLF1IP	1.04	5.96	0.56	7.02e-8	Blood protein levels;
SKCM	cis	rs17685	0.697	rs2302437	chr7:75677016	G/A	cg16684958	chr7:75615977	POR	-0.57	-5.6	-0.54	3.07e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs9581857	0.547	rs9579094	chr13:28081495	G/A	cg22138327	chr13:27999177	GTF3A	0.84	5.53	0.53	4.15e-7	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs3749237	0.595	rs4855864	chr3:49521974	C/T	cg03060546	chr3:49711283	APEH	0.67	4.95	0.49	4.23e-6	Resting heart rate;
SKCM	cis	rs7666738	0.800	rs13107586	chr4:99028788	G/C	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7613875	0.580	rs2624819	chr3:50010571	G/T	cg24110177	chr3:50126178	RBM5	-0.7	-5.58	-0.53	3.34e-7	Body mass index;
SKCM	cis	rs9910055	0.659	rs7212573	chr17:42254281	A/G	cg13607699	chr17:42295918	UBTF	0.7	5.51	0.53	4.38e-7	Total body bone mineral density;
SKCM	cis	rs1799949	1.000	rs8077486	chr17:41212805	C/T	cg05368731	chr17:41323189	NBR1	0.87	7.32	0.64	1.93e-10	Menopause (age at onset);
SKCM	cis	rs2239547	0.603	rs7644973	chr3:53082937	C/T	cg11645453	chr3:52864694	ITIH4	0.6	4.81	0.48	7.16e-6	Schizophrenia;
SKCM	cis	rs1218582	0.774	rs2335409	chr1:154916106	G/A	cg06221963	chr1:154839813	KCNN3	-0.56	-5.71	-0.54	1.93e-7	Prostate cancer;
SKCM	cis	rs1692580	0.777	rs12136830	chr1:2189196	A/T	cg24578937	chr1:2090814	PRKCZ	0.47	5.16	0.5	1.81e-6	Coronary artery disease;
SKCM	cis	rs10504229	1.000	rs56740825	chr8:58175617	A/G	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs362296	0.698	rs362289	chr4:3256378	G/A	cg09735869	chr4:3319127	RGS12	-0.87	-7.52	-0.65	8.05e-11	Parental longevity (mother's age at death);
SKCM	cis	rs8017423	0.967	rs8009493	chr14:90690083	G/C	cg04374321	chr14:90722782	PSMC1	0.97	8.67	0.7	4.78e-13	Mortality in heart failure;
SKCM	cis	rs6430585	0.528	rs12474975	chr2:136702118	A/T	cg07169764	chr2:136633963	MCM6	1.32	11.41	0.79	2.72e-18	Corneal structure;
SKCM	cis	rs1912528	0.783	rs809955	chr4:140874760	G/A	cg11128457	chr4:140864437	MAML3	0.62	5.25	0.51	1.28e-6	Educational attainment (years of education);
SKCM	cis	rs9880211	0.948	rs34282798	chr3:136143357	G/C	cg21827317	chr3:136751795	NA	-0.65	-4.92	-0.49	4.73e-6	Body mass index;Height;
SKCM	cis	rs28595532	0.920	rs115242199	chr4:119728652	A/C	cg11846333	chr4:119757529	SEC24D	1.2	6.43	0.59	9.38e-9	Cannabis dependence symptom count;
SKCM	cis	rs7143963	0.945	rs12589771	chr14:103284276	A/G	cg23020514	chr14:103360112	TRAF3	0.78	6.95	0.62	9.96e-10	Body mass index;
SKCM	cis	rs6951245	1.000	rs118059236	chr7:1073202	A/C	cg24642844	chr7:1081250	C7orf50	-0.95	-6.4	-0.59	1.06e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs780096	0.565	rs13022659	chr2:27743630	C/T	cg05696406	chr2:27599888	SNX17	0.56	5.6	0.54	3.15e-7	Total body bone mineral density;
SKCM	cis	rs9914544	0.550	rs7215492	chr17:18655487	C/T	cg26378065	chr17:18585709	ZNF286B	0.85	6.76	0.61	2.26e-9	Educational attainment (years of education);
SKCM	cis	rs1552244	1.000	rs12152512	chr3:10143770	C/T	cg02579736	chr3:10068473	FANCD2;CIDECP	1.23	6.92	0.62	1.13e-9	Alzheimer's disease;
SKCM	cis	rs2075371	1.000	rs1868783	chr7:133975087	A/G	cg20476274	chr7:133979776	SLC35B4	1.03	10.5	0.77	1.4e-16	Mean platelet volume;
SKCM	cis	rs7829975	0.514	rs2979139	chr8:8268313	A/G	cg08975724	chr8:8085496	FLJ10661	0.64	5.05	0.5	2.8e-6	Mood instability;
SKCM	trans	rs1814175	0.817	rs1996982	chr11:49972619	G/T	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs9815354	0.680	rs114478966	chr3:42007050	T/C	cg03022575	chr3:42003672	ULK4	1.0	5.0	0.49	3.43e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs2075371	0.829	rs11770521	chr7:133936251	A/C	cg20476274	chr7:133979776	SLC35B4	0.95	9.13	0.72	5.96e-14	Mean platelet volume;
SKCM	cis	rs826838	0.935	rs11169547	chr12:39185625	C/A	cg13010199	chr12:38710504	ALG10B	0.67	5.06	0.5	2.68e-6	Heart rate;
SKCM	cis	rs514406	0.722	rs7552139	chr1:53387379	G/C	cg08859206	chr1:53392774	SCP2	-0.6	-4.82	-0.48	7.02e-6	Monocyte count;
SKCM	cis	rs9443189	0.762	rs1321162	chr6:76456347	C/T	cg01950844	chr6:76311363	SENP6	0.8	5.63	0.54	2.78e-7	Prostate cancer;
SKCM	cis	rs7666738	0.830	rs4699600	chr4:99019429	C/G	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs8060686	0.641	rs2107369	chr16:68116018	A/C	cg09117114	chr16:67998030	SLC12A4	-0.79	-5.21	-0.51	1.53e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs6951245	1.000	rs11761941	chr7:1097183	G/A	cg24642844	chr7:1081250	C7orf50	-0.93	-6.22	-0.58	2.28e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs1577917	0.629	rs6927475	chr6:86206773	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.75	6.68	0.6	3.15e-9	Response to antipsychotic treatment;
SKCM	cis	rs727563	0.520	rs132773	chr22:42031768	T/A	cg03806693	chr22:41940476	POLR3H	1.11	7.56	0.65	6.74e-11	Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs28595532	0.920	rs114262028	chr4:119734877	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs6088580	0.634	rs2184836	chr20:32963369	A/G	cg24642439	chr20:33292090	TP53INP2	-0.76	-6.02	-0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs514406	0.505	rs269286	chr1:53169018	C/T	cg16325326	chr1:53192061	ZYG11B	-0.92	-9.97	-0.75	1.44e-15	Monocyte count;
SKCM	cis	rs1577917	0.958	rs13207354	chr6:86700263	A/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.83	-8.23	-0.68	3.37e-12	Response to antipsychotic treatment;
SKCM	cis	rs1577917	0.958	rs11756615	chr6:86679835	G/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.84	-8.35	-0.69	1.97e-12	Response to antipsychotic treatment;
SKCM	cis	rs12497850	0.931	rs6791542	chr3:48787219	A/G	cg07636037	chr3:49044803	WDR6	1.0	10.66	0.77	6.82e-17	Parkinson's disease;
SKCM	cis	rs561341	1.000	rs508192	chr17:30315147	C/T	cg00745463	chr17:30367425	LRRC37B	1.1	7.67	0.66	4.01e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs7639513	0.767	rs7648488	chr3:12708946	T/C	cg23032965	chr3:12705835	RAF1	0.81	7.08	0.63	5.53e-10	Itch intensity from mosquito bite;
SKCM	cis	rs4819052	0.851	rs2838857	chr21:46681000	A/G	cg19498844	chr21:46707878	POFUT2;LOC642852	0.9	7.98	0.67	1.04e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs6835098	0.923	rs9997477	chr4:174112543	C/T	cg08422745	chr4:174089978	GALNT7	-0.86	-6.84	-0.61	1.61e-9	Dementia and core Alzheimer's disease neuropathologic changes;
SKCM	cis	rs1801251	1.000	rs283479	chr2:233648754	A/G	cg08000102	chr2:233561755	GIGYF2	0.95	7.13	0.63	4.4e-10	Coronary artery disease;
SKCM	cis	rs62238980	0.614	rs17683310	chr22:32477445	A/G	cg00543991	chr22:32367038	NA	-1.16	-4.88	-0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs875971	0.825	rs1129531	chr7:65619104	C/T	cg18876405	chr7:65276391	NA	-0.63	-6.53	-0.59	6.14e-9	Aortic root size;
SKCM	cis	rs6835098	1.000	rs4561909	chr4:174086937	A/T	cg08422745	chr4:174089978	GALNT7	-0.83	-6.53	-0.59	6.04e-9	Dementia and core Alzheimer's disease neuropathologic changes;
SKCM	cis	rs826838	1.000	rs1393537	chr12:38920961	C/T	cg13010199	chr12:38710504	ALG10B	0.84	6.66	0.6	3.54e-9	Heart rate;
SKCM	cis	rs7811142	1.000	rs7787620	chr7:100089234	A/G	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-1.02	-5.76	-0.55	1.59e-7	Platelet count;
SKCM	cis	rs7666738	0.830	rs11722272	chr4:99000839	C/T	cg17366294	chr4:99064904	C4orf37	0.62	4.9	0.49	5.04e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs514406	0.722	rs7552139	chr1:53387379	G/C	cg24675658	chr1:53192096	ZYG11B	-0.61	-4.93	-0.49	4.54e-6	Monocyte count;
SKCM	cis	rs28386778	0.933	rs2665801	chr17:61952100	C/T	cg06873352	chr17:61820015	STRADA	0.76	6.56	0.6	5.37e-9	Prudent dietary pattern;
SKCM	cis	rs7103648	1.000	rs10838709	chr11:47447346	C/T	cg20307385	chr11:47447363	PSMC3	1.08	9.26	0.72	3.38e-14	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs1878931	0.543	rs1129568	chr16:3483475	G/A	cg26668626	chr16:3451006	ZNF174;ZNF434	0.91	6.77	0.61	2.12e-9	Body mass index (adult);
SKCM	cis	rs9457247	0.534	rs4710149	chr6:167386346	T/C	cg23791538	chr6:167370224	RNASET2	0.55	4.98	0.49	3.74e-6	Crohn's disease;
SKCM	cis	rs362296	0.661	rs3095079	chr4:3265414	A/G	cg21096898	chr4:3318625	RGS12	0.75	6.69	0.6	2.99e-9	Parental longevity (mother's age at death);
SKCM	cis	rs769267	0.501	rs2965187	chr19:19522970	T/A	cg26732615	chr19:19648335	CILP2;YJEFN3	0.65	5.44	0.52	5.82e-7	Tonsillectomy;
SKCM	cis	rs9322193	0.884	rs7744105	chr6:150170444	A/G	cg11878867	chr6:150167359	LRP11	-0.53	-4.94	-0.49	4.42e-6	Lung cancer;
SKCM	cis	rs1799949	0.965	rs11654051	chr17:41419656	C/T	cg23758822	chr17:41437982	NA	0.93	7.88	0.67	1.62e-11	Menopause (age at onset);
SKCM	cis	rs9457247	0.534	rs12055488	chr6:167379570	A/G	cg23791538	chr6:167370224	RNASET2	0.55	4.87	0.48	5.78e-6	Crohn's disease;
SKCM	cis	rs9611565	0.644	rs2413652	chr22:42097238	C/T	cg03806693	chr22:41940476	POLR3H	0.94	5.97	0.56	6.72e-8	Vitiligo;
SKCM	cis	rs208515	0.525	rs10944870	chr6:66687757	G/C	cg07460842	chr6:66804631	NA	0.93	6.34	0.58	1.35e-8	Exhaled nitric oxide levels;
SKCM	cis	rs1568889	1.000	rs11602768	chr11:28351786	G/A	cg06544937	chr11:28130018	METT5D1;KIF18A	0.86	6.53	0.59	5.96e-9	Bipolar disorder;
SKCM	cis	rs9814567	1.000	rs6782563	chr3:134295959	C/T	cg06109529	chr3:134205091	CEP63;ANAPC13	0.61	4.94	0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs2836974	0.931	rs7283569	chr21:40644062	T/G	cg17971929	chr21:40555470	PSMG1	0.9	8.81	0.71	2.52e-13	Cognitive function;
SKCM	cis	rs1552244	0.938	rs7652951	chr3:10063763	A/C	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs10504229	1.000	rs9650139	chr8:58190508	G/T	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs6840360	0.550	rs62327267	chr4:152518753	G/T	cg22705602	chr4:152727874	NA	-0.52	-5.69	-0.54	2.15e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs6736997	0.544	rs715772	chr2:235602165	A/C	cg17841421	chr2:235704848	NA	0.58	4.84	0.48	6.5e-6	Pancreatic cancer;
SKCM	cis	rs875971	0.789	rs10260426	chr7:65736042	G/T	cg18876405	chr7:65276391	NA	-0.65	-6.66	-0.6	3.51e-9	Aortic root size;
SKCM	cis	rs25645	0.502	rs9895948	chr17:38108363	T/C	cg17467752	chr17:38218738	THRA	0.65	5.15	0.5	1.91e-6	Myeloid white cell count;
SKCM	cis	rs56104184	0.779	rs17272666	chr19:49356294	T/C	cg15549821	chr19:49342101	PLEKHA4	-1.14	-7.1	-0.63	5.14e-10	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs362272	0.524	rs3129334	chr4:3368526	T/C	cg21096898	chr4:3318625	RGS12	0.99	12.57	0.82	1.9e-20	Serum sulfate level;
SKCM	cis	rs10744422	1.000	rs2061101	chr12:123348925	C/A	cg25930673	chr12:123319894	HIP1R	-0.91	-4.77	-0.48	8.4e-6	Schizophrenia;
SKCM	cis	rs3818285	0.655	rs2475277	chr10:111639730	C/T	cg00817464	chr10:111662876	XPNPEP1	0.74	8.39	0.69	1.67e-12	Superior crus of antihelix expression;
SKCM	cis	rs514406	0.698	rs522259	chr1:53365481	A/G	cg24675658	chr1:53192096	ZYG11B	-0.82	-7.84	-0.66	1.89e-11	Monocyte count;
SKCM	cis	rs28386778	0.897	rs8066754	chr17:61816590	T/C	cg06873352	chr17:61820015	STRADA	0.76	6.34	0.58	1.38e-8	Prudent dietary pattern;
SKCM	cis	rs2075371	0.933	rs2544181	chr7:133944934	C/T	cg20476274	chr7:133979776	SLC35B4	1.05	10.89	0.78	2.51e-17	Mean platelet volume;
SKCM	cis	rs5753618	0.583	rs2273249	chr22:31836486	T/C	cg02404636	chr22:31891804	SFI1	0.6	5.15	0.5	1.91e-6	Colorectal cancer;
SKCM	cis	rs3845702	0.800	rs6744281	chr2:180844382	G/A	cg01881094	chr2:180872142	CWC22	-1.3	-6.15	-0.57	3.07e-8	Schizophrenia;
SKCM	cis	rs2120019	1.000	rs67544533	chr15:75361539	A/G	cg09165964	chr15:75287851	SCAMP5	-0.75	-6.28	-0.58	1.78e-8	Blood trace element (Zn levels);
SKCM	cis	rs12497850	0.765	rs12487580	chr3:49182932	G/A	cg07636037	chr3:49044803	WDR6	1.0	8.69	0.7	4.39e-13	Parkinson's disease;
SKCM	cis	rs4740619	0.619	rs10738427	chr9:16041822	C/T	cg14451791	chr9:16040625	NA	-0.47	-5.03	-0.49	3.07e-6	Body mass index;
SKCM	cis	rs3820068	0.603	rs7531396	chr1:15969870	G/C	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs8103278	0.507	rs3745802	chr19:46271177	G/T	cg14061069	chr19:46274453	DMPK	0.52	5.4	0.52	6.88e-7	Coronary artery disease;
SKCM	cis	rs997295	0.592	rs8026627	chr15:67770306	G/T	cg24247231	chr15:67904302	MAP2K5	0.6	5.1	0.5	2.3e-6	Motion sickness;
SKCM	cis	rs2239547	0.522	rs9311485	chr3:52987645	T/G	cg11645453	chr3:52864694	ITIH4	-0.58	-4.96	-0.49	3.98e-6	Schizophrenia;
SKCM	cis	rs13118159	0.573	rs7657357	chr4:1372939	C/T	cg16405210	chr4:1374714	KIAA1530	-0.73	-5.19	-0.51	1.6e-6	Longevity;
SKCM	cis	rs1707322	0.963	rs10789478	chr1:46350506	C/T	cg03146154	chr1:46216737	IPP	0.74	5.0	0.49	3.39e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs561341	0.883	rs7219239	chr17:30212016	A/G	cg00745463	chr17:30367425	LRRC37B	0.99	6.38	0.59	1.18e-8	Hip circumference adjusted for BMI;
SKCM	cis	rs2952156	0.883	rs907089	chr17:37833600	C/T	cg00129232	chr17:37814104	STARD3	-0.72	-6.43	-0.59	9.24e-9	Asthma;
SKCM	cis	rs4819052	0.851	rs1999335	chr21:46670613	A/G	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.36	0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs2739330	0.828	rs2877178	chr22:24251517	C/T	cg25703541	chr22:24373054	LOC391322	-0.78	-6.41	-0.59	1.03e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs838147	0.844	rs8105137	chr19:49249888	G/A	cg13540341	chr19:49222985	MAMSTR	0.56	4.98	0.49	3.74e-6	Dietary macronutrient intake;
SKCM	trans	rs1814175	0.571	rs12294066	chr11:49738287	C/T	cg03929089	chr4:120376271	NA	-0.85	-7.61	-0.65	5.27e-11	Height;
SKCM	cis	rs1218582	0.772	rs6656435	chr1:154876869	G/A	cg09359103	chr1:154839909	KCNN3	-0.57	-5.3	-0.51	1.05e-6	Prostate cancer;
SKCM	cis	rs2832191	0.791	rs28633762	chr21:30500070	C/T	cg24692254	chr21:30365293	RNF160	-0.9	-8.01	-0.67	9.12e-12	Dental caries;
SKCM	cis	rs10504229	0.683	rs2318148	chr8:58114955	G/A	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs2811415	0.597	rs56380765	chr3:127768878	C/A	cg09089421	chr3:127803668	RUVBL1	1.01	8.79	0.71	2.72e-13	Lung function (FEV1/FVC);
SKCM	cis	rs9894429	0.527	rs7405469	chr17:79566596	G/C	cg18240062	chr17:79603768	NPLOC4	-0.66	-5.36	-0.52	8.08e-7	Eye color traits;
SKCM	cis	rs13217239	0.646	rs12523820	chr6:27001502	A/G	cg12292205	chr6:26970375	C6orf41	0.63	5.64	0.54	2.58e-7	Schizophrenia;
SKCM	cis	rs2282032	1.000	rs56015111	chr14:90768946	G/A	cg04374321	chr14:90722782	PSMC1	0.71	4.97	0.49	3.9e-6	Longevity;
SKCM	cis	rs1218582	0.772	rs4845690	chr1:154886817	C/T	cg09359103	chr1:154839909	KCNN3	0.57	5.3	0.51	1.05e-6	Prostate cancer;
SKCM	cis	rs7809950	0.678	rs982447	chr7:106973534	T/C	cg23024343	chr7:107201750	COG5	-0.82	-7.0	-0.62	7.72e-10	Coronary artery disease;
SKCM	cis	rs7824557	0.736	rs35392635	chr8:11164349	G/C	cg21775007	chr8:11205619	TDH	0.72	6.0	0.56	5.73e-8	Retinal vascular caliber;
SKCM	cis	rs12950390	0.853	rs8078052	chr17:45859434	A/G	cg03474202	chr17:45855739	NA	-0.48	-5.39	-0.52	7.29e-7	IgG glycosylation;
SKCM	cis	rs7666738	0.830	rs7662114	chr4:99019985	A/G	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs3820928	0.874	rs13393902	chr2:227880554	A/G	cg11843606	chr2:227700838	RHBDD1	-0.62	-5.12	-0.5	2.19e-6	Pulmonary function;
SKCM	cis	rs1355223	0.552	rs2421743	chr11:34882840	C/T	cg11058730	chr11:34937778	PDHX;APIP	0.63	5.08	0.5	2.51e-6	Systemic lupus erythematosus and Systemic sclerosis;
SKCM	cis	rs2839186	0.900	rs59828751	chr21:47708918	A/G	cg13126279	chr21:47581558	C21orf56	-0.64	-5.47	-0.53	5.17e-7	Testicular germ cell tumor;
SKCM	cis	rs4925386	0.512	rs2274933	chr20:60897488	G/A	cg24112000	chr20:60950667	NA	-0.71	-5.81	-0.55	1.29e-7	Colorectal cancer;Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs3087591	1.000	rs2953015	chr17:29495341	A/G	cg24425628	chr17:29625626	OMG;NF1	0.64	5.31	0.52	9.85e-7	Hip circumference;
SKCM	cis	rs35306767	0.855	rs12774985	chr10:904245	C/T	cg26597838	chr10:835615	NA	0.8	5.89	0.55	9.29e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs77106637	1.000	rs11602858	chr11:72615069	C/G	cg03713592	chr11:72463424	ARAP1	0.99	4.99	0.49	3.63e-6	Type 2 diabetes;
SKCM	cis	rs7959452	0.901	rs1384	chr12:69747834	C/T	cg14784868	chr12:69753453	YEATS4	0.59	4.79	0.48	7.86e-6	Blood protein levels;
SKCM	cis	rs116095464	0.510	rs55750776	chr5:230467	T/C	cg22857025	chr5:266934	NA	-1.37	-8.11	-0.68	5.82e-12	Breast cancer;
SKCM	cis	rs1153858	1.000	rs9783731	chr15:45642884	C/T	cg21132104	chr15:45694354	SPATA5L1	-0.89	-7.58	-0.65	6.21e-11	Homoarginine levels;
SKCM	cis	rs9457247	0.534	rs9366078	chr6:167399512	A/G	cg23791538	chr6:167370224	RNASET2	0.53	4.8	0.48	7.37e-6	Crohn's disease;
SKCM	cis	rs7811142	0.666	rs28401739	chr7:99905684	A/G	cg00814883	chr7:100076585	TSC22D4	-0.84	-4.78	-0.48	8.01e-6	Platelet count;
SKCM	cis	rs644799	0.862	rs1150361	chr11:95633805	G/A	cg03916912	chr11:95522834	CEP57;FAM76B	0.86	6.32	0.58	1.48e-8	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs9910055	0.593	rs2905983	chr17:42212429	T/G	cg10896456	chr17:42255109	ASB16;C17orf65	-0.69	-7.17	-0.63	3.65e-10	Total body bone mineral density;
SKCM	cis	rs8177253	1.000	rs8177262	chr3:133480652	A/G	cg16414030	chr3:133502952	NA	0.69	5.78	0.55	1.49e-7	Iron status biomarkers;
SKCM	cis	rs875971	0.522	rs6960048	chr7:65408039	A/G	cg11764359	chr7:65958608	NA	0.89	6.91	0.62	1.16e-9	Aortic root size;
SKCM	cis	rs131777	0.577	rs5770928	chr22:51029091	G/C	cg25309564	chr22:51001381	C22orf41	0.78	5.27	0.51	1.2e-6	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs17685	0.672	rs10952841	chr7:75778626	A/C	cg01364799	chr7:75623366	TMEM120A	-0.69	-5.59	-0.53	3.22e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7212938	0.509	rs56199421	chr17:38090808	C/T	cg17467752	chr17:38218738	THRA	0.61	5.01	0.49	3.31e-6	Asthma and hay fever;
SKCM	cis	rs11098499	0.739	rs2203039	chr4:120132347	T/C	cg09307838	chr4:120376055	NA	-0.74	-5.47	-0.53	5.27e-7	Corneal astigmatism;
SKCM	cis	rs7666738	0.830	rs10019087	chr4:99030211	C/T	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1799949	0.965	rs8071278	chr17:41193910	A/T	cg05368731	chr17:41323189	NBR1	0.88	7.5	0.65	8.87e-11	Menopause (age at onset);
SKCM	trans	rs3749237	0.964	rs7431078	chr3:49808190	G/A	cg21659725	chr3:3221576	CRBN	0.99	7.38	0.64	1.49e-10	Resting heart rate;
SKCM	cis	rs7208859	0.623	rs216434	chr17:28922335	G/C	cg14067834	chr17:29058358	SUZ12P	1.07	4.82	0.48	6.93e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs7408868	1.000	rs4809030	chr19:15273381	A/G	cg14696996	chr19:15285081	NOTCH3	0.82	4.92	0.49	4.7e-6	Pulse pressure;
SKCM	cis	rs782590	0.774	rs2627773	chr2:55900459	A/G	cg18811423	chr2:55921094	PNPT1	0.91	7.45	0.64	1.11e-10	Metabolic syndrome;
SKCM	cis	rs999943	0.846	rs1570760	chr6:33622933	C/T	cg14003231	chr6:33640908	ITPR3	0.67	6.05	0.57	4.67e-8	Obesity (extreme);
SKCM	cis	rs910316	1.000	rs2268617	chr14:75608728	G/A	cg08847533	chr14:75593920	NEK9	0.95	9.18	0.72	4.8e-14	Height;
SKCM	cis	rs7772486	0.790	rs2249386	chr6:146186611	G/A	cg23711669	chr6:146136114	FBXO30	0.84	9.28	0.72	3.05e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7438704	0.552	rs11732338	chr4:48314058	A/G	cg15299388	chr4:48491941	ZAR1	-0.45	-5.14	-0.5	1.97e-6	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs9910055	0.762	rs184478	chr17:42209751	C/G	cg09913183	chr17:42254507	C17orf65;ASB16	-0.71	-6.5	-0.59	6.96e-9	Total body bone mineral density;
SKCM	cis	rs9913156	0.793	rs55884013	chr17:4579301	G/A	cg19197139	chr17:4613644	ARRB2	0.78	5.09	0.5	2.38e-6	Lymphocyte counts;
SKCM	cis	rs362296	0.511	rs2857861	chr4:3323767	C/T	cg24015175	chr4:3319247	RGS12	0.73	8.4	0.69	1.61e-12	Parental longevity (mother's age at death);
SKCM	cis	rs1799949	0.965	rs8176140	chr17:41251646	T/A	cg05368731	chr17:41323189	NBR1	0.89	7.49	0.65	9.23e-11	Menopause (age at onset);
SKCM	cis	rs8180040	0.966	rs6765990	chr3:47542894	G/A	cg27129171	chr3:47204927	SETD2	0.79	5.79	0.55	1.43e-7	Colorectal cancer;
SKCM	cis	rs62244186	0.535	rs59726036	chr3:44850074	G/T	cg02073558	chr3:44770973	ZNF501	0.8	7.1	0.63	4.98e-10	Depressive symptoms;
SKCM	cis	rs3087591	0.960	rs4435317	chr17:29436512	G/C	cg24425628	chr17:29625626	OMG;NF1	0.66	5.04	0.5	2.91e-6	Hip circumference;
SKCM	trans	rs3749237	0.964	rs1799845	chr3:49847623	A/G	cg21659725	chr3:3221576	CRBN	0.99	7.33	0.64	1.87e-10	Resting heart rate;
SKCM	cis	rs9788721	0.836	rs2568494	chr15:78740964	G/A	cg18825076	chr15:78729989	IREB2	-0.61	-4.85	-0.48	6.1e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;Emphysema imaging phenotypes;Emphysema distribution in smoking;Local histogram emphysema pattern;Post bronchodilator FEV1/FVC ratio in COPD;
SKCM	cis	rs473651	0.904	rs472247	chr2:239362573	G/A	cg21699342	chr2:239360505	ASB1	0.54	5.4	0.52	6.99e-7	Multiple system atrophy;
SKCM	cis	rs1552244	0.882	rs3732967	chr3:10015437	T/C	cg02579736	chr3:10068473	FANCD2;CIDECP	0.94	4.84	0.48	6.49e-6	Alzheimer's disease;
SKCM	cis	rs6061231	1.000	rs11696991	chr20:60959694	G/T	cg24112000	chr20:60950667	NA	-0.65	-7.03	-0.62	6.77e-10	Colorectal cancer;
SKCM	cis	rs6582630	0.519	rs10880194	chr12:38302836	G/A	cg26384229	chr12:38710491	ALG10B	0.81	6.57	0.6	5.18e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs12047808	0.730	rs3738423	chr1:179533915	G/A	cg09822482	chr1:179519214	C1orf125	-0.96	-4.77	-0.48	8.48e-6	Multiple sclerosis (age of onset);
SKCM	cis	rs12497850	0.931	rs6446196	chr3:49004723	A/G	cg06212747	chr3:49208901	KLHDC8B	0.68	4.9	0.49	5.06e-6	Parkinson's disease;
SKCM	cis	rs798554	1.000	rs798550	chr7:2760609	A/G	cg14895029	chr7:2775587	GNA12	-0.69	-5.07	-0.5	2.6e-6	Height;
SKCM	cis	rs2658782	0.789	rs3020076	chr11:93141058	C/T	cg15737290	chr11:93063684	CCDC67	0.68	4.81	0.48	7.23e-6	Pulmonary function decline;
SKCM	cis	rs9325144	0.624	rs10783329	chr12:39113951	C/T	cg26384229	chr12:38710491	ALG10B	-0.72	-6.37	-0.58	1.23e-8	Morning vs. evening chronotype;
SKCM	cis	rs7772486	0.790	rs9497435	chr6:146265340	C/A	cg05347473	chr6:146136440	FBXO30	-0.55	-4.97	-0.49	3.86e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs875971	0.830	rs778715	chr7:65849209	C/T	cg11764359	chr7:65958608	NA	0.8	7.47	0.65	1.01e-10	Aortic root size;
SKCM	cis	rs1403694	0.515	rs1648722	chr3:186448989	C/T	cg09332604	chr3:186435400	KNG1	-0.56	-5.67	-0.54	2.31e-7	Blood protein levels;
SKCM	cis	rs10256972	0.641	rs12702017	chr7:1129413	C/T	cg09177884	chr7:1199841	ZFAND2A	-0.76	-6.43	-0.59	9.31e-9	Longevity;Endometriosis;
SKCM	cis	rs7811142	1.000	rs11773661	chr7:100073069	G/C	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-0.99	-5.52	-0.53	4.2e-7	Platelet count;
SKCM	cis	rs2204008	0.575	rs10444564	chr12:38043782	T/C	cg26384229	chr12:38710491	ALG10B	0.83	6.72	0.61	2.69e-9	Bladder cancer;
SKCM	cis	rs3820068	0.532	rs1547034	chr1:15919049	T/A	cg13390004	chr1:15929781	NA	0.64	5.15	0.5	1.9e-6	Systolic blood pressure;
SKCM	cis	rs861020	0.563	rs12046618	chr1:210043135	C/T	cg05527609	chr1:210001259	C1orf107	0.87	6.04	0.56	4.96e-8	Orofacial clefts;
SKCM	cis	rs10503709	0.543	rs12682227	chr8:21465541	T/A	cg23716449	chr8:21608280	GFRA2	-0.49	-4.8	-0.48	7.38e-6	Blood protein levels;
SKCM	cis	rs4819052	0.851	rs7279011	chr21:46655995	G/A	cg19498844	chr21:46707878	POFUT2;LOC642852	0.84	7.19	0.63	3.46e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs6835098	0.962	rs3733477	chr4:174090004	G/A	cg08422745	chr4:174089978	GALNT7	-0.87	-6.82	-0.61	1.75e-9	Dementia and core Alzheimer's disease neuropathologic changes;
SKCM	cis	rs7772486	0.686	rs9497395	chr6:146013592	A/G	cg05347473	chr6:146136440	FBXO30	-0.6	-5.27	-0.51	1.16e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6580649	0.941	rs17122613	chr12:48460016	T/C	cg05342945	chr12:48394962	COL2A1	0.73	5.2	0.51	1.53e-6	Lung cancer;
SKCM	cis	rs2730245	0.569	rs1188955	chr7:158690866	A/G	cg24397884	chr7:158709396	WDR60	0.69	5.29	0.51	1.11e-6	Height;
SKCM	cis	rs867186	1.000	rs6060235	chr20:33691652	A/G	cg04194272	chr20:33683537	NA	-1.21	-6.8	-0.61	1.89e-9	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs7811142	0.830	rs3087502	chr7:99955364	G/A	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.19	7.5	0.65	8.66e-11	Platelet count;
SKCM	cis	rs6088590	1.000	rs6087625	chr20:33342477	A/G	cg24642439	chr20:33292090	TP53INP2	-1.02	-7.56	-0.65	6.73e-11	Coronary artery disease;
SKCM	cis	rs116095464	0.558	rs10057626	chr5:239720	T/G	cg22496380	chr5:211416	CCDC127	-0.9	-4.97	-0.49	3.94e-6	Breast cancer;
SKCM	cis	rs1707322	1.000	rs6661500	chr1:46465662	T/C	cg03146154	chr1:46216737	IPP	0.77	5.14	0.5	2.01e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs4332037	0.950	rs11771828	chr7:1941003	T/C	cg23422044	chr7:1970798	MAD1L1	-0.96	-6.52	-0.59	6.37e-9	Bipolar disorder;
SKCM	cis	rs769267	0.930	rs892021	chr19:19613480	T/C	cg26732615	chr19:19648335	CILP2;YJEFN3	0.67	7.06	0.62	6e-10	Tonsillectomy;
SKCM	cis	rs1850744	0.826	rs116509172	chr4:9594123	A/G	cg15442990	chr4:9534313	NA	-1.3	-4.84	-0.48	6.55e-6	Economic and political preferences;
SKCM	trans	rs7618501	1.000	rs57648519	chr3:49813169	C/A	cg21659725	chr3:3221576	CRBN	0.96	9.61	0.74	7.08e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs2204008	0.840	rs7136347	chr12:38453531	G/A	cg13010199	chr12:38710504	ALG10B	0.69	4.9	0.49	5.02e-6	Bladder cancer;
SKCM	cis	rs9814567	0.727	rs9809344	chr3:134342758	T/C	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.96	-0.49	4.09e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs1957429	0.808	rs1957428	chr14:65354058	T/C	cg23373153	chr14:65346875	NA	1.03	6.23	0.58	2.18e-8	Pediatric areal bone mineral density (radius);
SKCM	cis	rs12950390	0.853	rs11079791	chr17:45859099	C/T	cg03474202	chr17:45855739	NA	-0.49	-5.6	-0.54	3.05e-7	IgG glycosylation;
SKCM	cis	rs6580649	0.941	rs17122611	chr12:48458149	C/T	cg05342945	chr12:48394962	COL2A1	0.73	5.2	0.51	1.53e-6	Lung cancer;
SKCM	cis	rs681343	1.000	rs516246	chr19:49206172	C/T	cg21064579	chr19:49206444	FUT2	0.59	5.08	0.5	2.47e-6	Lung adenocarcinoma;Primary sclerosing cholangitis;Childhood ear infection;
SKCM	cis	rs1912528	0.963	rs13145728	chr4:140927812	G/C	cg11128457	chr4:140864437	MAML3	0.58	4.84	0.48	6.41e-6	Educational attainment (years of education);
SKCM	cis	rs10089	1.000	rs10463838	chr5:127518305	C/T	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.87	7.37	0.64	1.58e-10	Ileal carcinoids;
SKCM	cis	rs9926296	0.605	rs886952	chr16:89836781	G/A	cg04287289	chr16:89883240	FANCA	1.02	11.72	0.8	6.92e-19	Vitiligo;
SKCM	cis	rs4900538	0.712	rs1998420	chr14:102979624	G/C	cg18135206	chr14:102964638	TECPR2	0.64	4.79	0.48	7.71e-6	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs7119	0.604	rs2271396	chr15:77907535	C/G	cg27398640	chr15:77910606	LINGO1	0.51	4.89	0.48	5.24e-6	Type 2 diabetes;
SKCM	cis	rs17685	0.712	rs6976236	chr7:75741087	G/T	cg01364799	chr7:75623366	TMEM120A	-0.71	-5.72	-0.54	1.85e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs6121246	0.697	rs6087716	chr20:30229040	C/T	cg11595048	chr20:30225325	COX4I2	0.65	5.19	0.51	1.62e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs9611565	0.659	rs28623192	chr22:41940524	A/G	cg03806693	chr22:41940476	POLR3H	-1.13	-7.48	-0.65	9.6e-11	Vitiligo;
SKCM	cis	rs2153535	0.580	rs1932275	chr6:8442333	T/A	cg07606381	chr6:8435919	SLC35B3	0.94	6.94	0.62	1.02e-9	Motion sickness;
SKCM	cis	rs2050392	1.000	rs2265185	chr10:30691777	A/C	cg25182066	chr10:30743637	MAP3K8	-0.62	-4.99	-0.49	3.56e-6	Inflammatory bowel disease;
SKCM	cis	rs7666738	0.830	rs4699590	chr4:98974030	A/C	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7666738	0.830	rs4699597	chr4:99019031	G/A	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4803468	1.000	rs4803465	chr19:41918158	A/G	cg14132834	chr19:41945861	ATP5SL	0.77	6.08	0.57	4.18e-8	Height;
SKCM	cis	rs2836974	0.644	rs61300849	chr21:40680194	G/A	cg17971929	chr21:40555470	PSMG1	-0.74	-7.06	-0.62	5.99e-10	Cognitive function;
SKCM	cis	rs61776719	0.840	rs35267671	chr1:38397369	C/T	cg12658694	chr1:38397304	INPP5B	0.7	6.0	0.56	5.74e-8	Coronary artery disease;
SKCM	cis	rs6089584	0.816	rs6061411	chr20:60634716	C/A	cg06108461	chr20:60628389	TAF4	-0.89	-9.12	-0.72	6.39e-14	Body mass index;
SKCM	cis	rs7937682	0.889	rs490199	chr11:111487890	A/G	cg19812747	chr11:111475976	SIK2	-0.56	-4.93	-0.49	4.55e-6	Primary sclerosing cholangitis;
SKCM	cis	rs1707322	0.721	rs11211165	chr1:46157906	C/T	cg03146154	chr1:46216737	IPP	0.84	6.2	0.57	2.51e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs514406	0.861	rs10888755	chr1:53240829	A/G	cg08859206	chr1:53392774	SCP2	0.63	5.13	0.5	2.08e-6	Monocyte count;
SKCM	cis	rs6912958	0.559	rs369674	chr6:88043402	C/G	cg08069147	chr6:88032118	GJB7;C6orf162	-0.67	-5.93	-0.56	7.84e-8	Monocyte percentage of white cells;
SKCM	cis	rs7772486	0.790	rs1062067	chr6:146207563	A/G	cg05347473	chr6:146136440	FBXO30	0.55	5.12	0.5	2.16e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7100689	0.599	rs6585968	chr10:82139807	T/C	cg01528321	chr10:82214614	TSPAN14	0.84	7.81	0.66	2.15e-11	Post bronchodilator FEV1;
SKCM	cis	rs17826219	0.706	rs73271850	chr17:29142140	A/G	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Body mass index;
SKCM	cis	rs7811142	1.000	rs67239991	chr7:100046504	A/G	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-0.99	-5.52	-0.53	4.2e-7	Platelet count;
SKCM	cis	rs4919087	0.926	rs2861875	chr10:98990139	C/G	cg25902810	chr10:99078978	FRAT1	-0.6	-4.86	-0.48	5.87e-6	Monocyte count;
SKCM	trans	rs3780486	0.505	rs1411609	chr9:33137303	C/T	cg20290983	chr6:43655470	MRPS18A	0.89	9.16	0.72	5.22e-14	IgG glycosylation;
SKCM	cis	rs6463523	0.933	rs6974151	chr7:758269	T/C	cg11064039	chr7:766100	PRKAR1B;HEATR2	0.97	8.04	0.67	7.83e-12	Subjective well-being;
SKCM	cis	rs7143963	0.943	rs10133111	chr14:103377321	A/G	cg23020514	chr14:103360112	TRAF3	-0.78	-6.71	-0.6	2.79e-9	Body mass index;
SKCM	cis	rs713587	0.520	rs530951	chr2:25307005	C/T	cg04586622	chr2:25135609	ADCY3	-0.63	-4.84	-0.48	6.35e-6	Body mass index in non-asthmatics;
SKCM	cis	rs9818758	0.607	rs71324929	chr3:49044713	C/T	cg00383909	chr3:49044727	WDR6	1.19	4.95	0.49	4.21e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs7086627	0.515	rs4933390	chr10:82213081	A/C	cg00277334	chr10:82204260	NA	-0.74	-8.37	-0.69	1.84e-12	Post bronchodilator FEV1;
SKCM	cis	rs8078723	1.000	rs4795415	chr17:38157995	C/T	cg17467752	chr17:38218738	THRA	0.67	6.13	0.57	3.38e-8	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs4803468	1.000	rs4803469	chr19:41922775	A/C	cg09537434	chr19:41945824	ATP5SL	-1.1	-13.82	-0.84	1.16e-22	Height;
SKCM	cis	rs6951245	0.938	rs11764937	chr7:1092074	C/T	cg24642844	chr7:1081250	C7orf50	-0.96	-6.53	-0.59	6.12e-9	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs780096	0.546	rs1528533	chr2:27595756	G/C	cg05696406	chr2:27599888	SNX17	0.49	5.07	0.5	2.62e-6	Total body bone mineral density;
SKCM	cis	rs7659604	0.643	rs6839375	chr4:122663610	G/C	cg19748678	chr4:122722346	EXOSC9	0.75	6.06	0.57	4.57e-8	Type 2 diabetes;
SKCM	cis	rs1153858	1.000	rs1145085	chr15:45657804	A/G	cg10760299	chr15:45669010	GATM	0.63	6.32	0.58	1.49e-8	Homoarginine levels;
SKCM	cis	rs7772486	0.558	rs702322	chr6:146007166	G/A	cg23711669	chr6:146136114	FBXO30	-0.83	-7.31	-0.64	2e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1461503	0.966	rs1461502	chr11:122844927	C/G	cg27398637	chr11:122830231	C11orf63	-0.63	-4.8	-0.48	7.54e-6	Menarche (age at onset);
SKCM	cis	rs7215564	0.730	rs35718970	chr17:78585662	T/C	cg16980736	chr17:78789706	RPTOR	-0.89	-4.87	-0.48	5.8e-6	Myopia (pathological);
SKCM	cis	rs6977660	1.000	rs5017191	chr7:19820158	C/A	cg07541023	chr7:19748670	TWISTNB	0.7	4.82	0.48	6.98e-6	Thyroid stimulating hormone;
SKCM	cis	rs9790314	0.586	rs11713185	chr3:161111357	C/G	cg03342759	chr3:160939853	NMD3	-0.74	-6.6	-0.6	4.4e-9	Morning vs. evening chronotype;
SKCM	cis	rs2836974	0.897	rs8132568	chr21:40527916	C/T	cg11890956	chr21:40555474	PSMG1	1.07	13.19	0.83	1.48e-21	Cognitive function;
SKCM	cis	rs7659604	0.502	rs28522256	chr4:122709266	C/T	cg19671926	chr4:122722719	EXOSC9	0.76	6.97	0.62	9.04e-10	Type 2 diabetes;
SKCM	cis	rs10911232	0.507	rs4651137	chr1:182994300	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.64	0.6	3.83e-9	Hypertriglyceridemia;
SKCM	cis	rs959260	0.528	rs9909443	chr17:73308346	C/T	cg14668889	chr17:73230827	NUP85	0.79	6.54	0.59	5.91e-9	Systemic lupus erythematosus;
SKCM	cis	rs4132509	0.895	rs12138168	chr1:244009113	A/G	cg21452805	chr1:244014465	NA	0.91	5.58	0.53	3.29e-7	RR interval (heart rate);
SKCM	cis	rs9926296	0.546	rs7187436	chr16:89845110	A/T	cg04287289	chr16:89883240	FANCA	1.06	13.02	0.83	3e-21	Vitiligo;
SKCM	cis	rs507506	0.771	rs929229	chr17:7105399	C/T	cg25256661	chr17:7137939	DVL2	0.86	6.46	0.59	8.32e-9	Adiponectin levels;
SKCM	cis	rs6546550	0.901	rs6725425	chr2:70150674	T/C	cg02498382	chr2:70120550	SNRNP27	-0.45	-4.88	-0.48	5.4e-6	Prevalent atrial fibrillation;
SKCM	cis	rs9916302	0.706	rs8067511	chr17:37611352	C/T	cg07936489	chr17:37558343	FBXL20	-1.0	-6.99	-0.62	8.41e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs2268241	0.938	rs17878783	chr21:34779185	G/A	cg14850771	chr21:34775459	IFNGR2	1.09	6.8	0.61	1.9e-9	Obesity-related traits;
SKCM	cis	rs10461617	0.541	rs832575	chr5:56161787	C/T	cg12311346	chr5:56204834	C5orf35	-0.87	-4.88	-0.48	5.45e-6	Type 2 diabetes;
SKCM	cis	rs1153858	0.848	rs9806699	chr15:45740392	G/A	cg21132104	chr15:45694354	SPATA5L1	0.76	5.32	0.52	9.83e-7	Homoarginine levels;
SKCM	trans	rs561341	1.000	rs55736640	chr17:30333848	G/A	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs7927771	0.524	rs11039345	chr11:47720228	A/G	cg20307385	chr11:47447363	PSMC3	0.72	5.81	0.55	1.31e-7	Subjective well-being;
SKCM	cis	rs9880211	1.000	rs9878078	chr3:136237573	C/T	cg21827317	chr3:136751795	NA	-0.65	-4.92	-0.49	4.73e-6	Body mass index;Height;
SKCM	cis	rs8067545	0.532	rs56371654	chr17:19960362	G/T	cg13482628	chr17:19912719	NA	0.67	4.8	0.48	7.46e-6	Schizophrenia;
SKCM	cis	rs6089584	0.606	rs6089599	chr20:60576992	A/G	cg06108461	chr20:60628389	TAF4	0.69	5.82	0.55	1.26e-7	Body mass index;
SKCM	cis	rs1403694	0.515	rs5030058	chr3:186452415	T/G	cg09332604	chr3:186435400	KNG1	-0.55	-5.52	-0.53	4.25e-7	Blood protein levels;
SKCM	cis	rs365132	1.000	rs353464	chr5:176403023	A/G	cg16309518	chr5:176445507	NA	-0.52	-4.99	-0.49	3.54e-6	Menarche and menopause (age at onset);Menopause (age at onset);
SKCM	cis	rs1801251	0.644	rs283473	chr2:233654847	A/G	cg08000102	chr2:233561755	GIGYF2	0.79	7.08	0.63	5.45e-10	Coronary artery disease;
SKCM	cis	rs703842	1.000	rs10877013	chr12:58165085	C/T	cg04478727	chr12:58166393	METTL1;FAM119B	0.71	5.77	0.55	1.54e-7	Multiple sclerosis;
SKCM	cis	rs7829975	0.577	rs940030	chr8:8546928	A/G	cg15556689	chr8:8085844	FLJ10661	-0.61	-4.82	-0.48	6.88e-6	Mood instability;
SKCM	cis	rs250585	0.516	rs460186	chr16:23607892	G/A	cg09934309	chr16:23461721	COG7	-0.79	-5.22	-0.51	1.44e-6	Egg allergy;
SKCM	cis	rs2354432	0.607	rs59689207	chr1:146722484	G/A	cg25205988	chr1:146714368	CHD1L	-1.19	-6.56	-0.6	5.24e-9	Mitochondrial DNA levels;
SKCM	cis	rs763121	1.000	rs138464	chr22:38906432	C/T	cg06022373	chr22:39101656	GTPBP1	-0.82	-5.88	-0.55	9.85e-8	Menopause (age at onset);
SKCM	cis	rs2289583	0.503	rs12050494	chr15:75260896	G/A	cg18866210	chr15:74343476	NA	0.63	4.93	0.49	4.52e-6	Systemic lupus erythematosus;
SKCM	cis	rs4481887	1.000	rs4593862	chr1:248480176	G/T	cg00666640	chr1:248458726	OR2T12	0.64	5.69	0.54	2.13e-7	Common traits (Other);
SKCM	cis	rs9325144	0.647	rs7980932	chr12:38921583	G/T	cg26384229	chr12:38710491	ALG10B	-0.75	-6.55	-0.6	5.65e-9	Morning vs. evening chronotype;
SKCM	trans	rs9929218	0.551	rs3785135	chr16:68728976	A/C	cg04657470	chr2:198365150	HSPE1;HSPD1	-0.94	-9.49	-0.73	1.22e-14	Colorectal cancer;
SKCM	cis	rs3820928	0.967	rs4675114	chr2:227768362	C/T	cg11843606	chr2:227700838	RHBDD1	-0.64	-5.2	-0.51	1.53e-6	Pulmonary function;
SKCM	cis	rs4319547	0.915	rs10734924	chr12:123018894	T/G	cg23029597	chr12:123009494	RSRC2	-0.8	-5.82	-0.55	1.24e-7	Body mass index;
SKCM	cis	rs28386778	0.897	rs2854214	chr17:61945449	C/G	cg01411255	chr17:61851458	DDX42;CCDC47	-0.78	-5.01	-0.49	3.26e-6	Prudent dietary pattern;
SKCM	cis	rs1403694	0.515	rs822362	chr3:186453065	A/C	cg09332604	chr3:186435400	KNG1	-0.55	-5.51	-0.53	4.45e-7	Blood protein levels;
SKCM	cis	rs11718455	1.000	rs17076273	chr3:44020113	A/G	cg21419209	chr3:44054225	NA	-0.66	-5.22	-0.51	1.46e-6	Coronary artery disease;
SKCM	cis	rs3008870	0.920	rs3008865	chr1:67402838	T/C	cg08660285	chr1:67390436	MIER1;WDR78	0.92	6.05	0.57	4.69e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs9611565	0.614	rs4822053	chr22:42212936	C/A	cg03806693	chr22:41940476	POLR3H	-0.79	-5.21	-0.51	1.48e-6	Vitiligo;
SKCM	cis	rs2404602	0.692	rs58889902	chr15:77173070	A/C	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs8070128	0.688	rs59304093	chr17:17875407	A/G	cg04398451	chr17:18023971	MYO15A	-0.8	-6.01	-0.56	5.59e-8	Total body bone mineral density;
SKCM	cis	rs7937682	0.883	rs12366001	chr11:111433916	A/G	cg09085632	chr11:111637200	PPP2R1B	1.02	9.63	0.74	6.45e-15	Primary sclerosing cholangitis;
SKCM	cis	rs62238980	0.614	rs76177859	chr22:32390135	T/C	cg00543991	chr22:32367038	NA	1.15	4.87	0.48	5.76e-6	Childhood ear infection;
SKCM	cis	rs12142240	0.667	rs55887761	chr1:46826587	C/A	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	trans	rs17685	0.672	rs10952841	chr7:75778626	A/C	cg19862616	chr7:65841803	NCRNA00174	0.92	9.38	0.73	2.02e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs9467773	0.967	rs6941022	chr6:26553531	T/C	cg09904177	chr6:26538194	HMGN4	0.54	4.98	0.49	3.78e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1733410	0.504	rs11181874	chr12:37912890	C/A	cg13010199	chr12:38710504	ALG10B	-0.64	-4.92	-0.49	4.67e-6	Morning vs. evening chronotype;
SKCM	cis	rs9788721	0.836	rs17483721	chr15:78733731	C/T	cg18825076	chr15:78729989	IREB2	0.61	4.85	0.48	6.1e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;Emphysema imaging phenotypes;Emphysema distribution in smoking;Local histogram emphysema pattern;Post bronchodilator FEV1/FVC ratio in COPD;
SKCM	cis	rs11718455	0.618	rs35351588	chr3:43926386	C/G	cg21419209	chr3:44054225	NA	-0.66	-5.48	-0.53	4.97e-7	Coronary artery disease;
SKCM	cis	rs1062177	0.756	rs2964589	chr5:151118189	G/T	cg00977110	chr5:151150581	G3BP1	-0.81	-6.51	-0.59	6.76e-9	Preschool internalizing problems;
SKCM	cis	rs3892630	0.878	rs8108621	chr19:33183291	G/A	cg22980127	chr19:33182716	NUDT19	1.39	8.08	0.67	6.68e-12	Red blood cell traits;
SKCM	cis	rs9910055	0.659	rs2251165	chr17:42234748	T/C	cg09913183	chr17:42254507	C17orf65;ASB16	0.67	6.34	0.58	1.38e-8	Total body bone mineral density;
SKCM	cis	rs3892630	0.824	rs7247264	chr19:33239846	T/G	cg22980127	chr19:33182716	NUDT19	1.36	7.75	0.66	2.87e-11	Red blood cell traits;
SKCM	cis	rs3087591	0.960	rs9896041	chr17:29571326	C/G	cg24425628	chr17:29625626	OMG;NF1	-0.63	-4.95	-0.49	4.23e-6	Hip circumference;
SKCM	cis	rs780096	0.546	rs2293571	chr2:27729480	C/T	cg05696406	chr2:27599888	SNX17	0.5	5.06	0.5	2.73e-6	Total body bone mineral density;
SKCM	cis	rs1878931	0.545	rs28603	chr16:3449479	A/G	cg26668626	chr16:3451006	ZNF174;ZNF434	-0.86	-5.52	-0.53	4.23e-7	Body mass index (adult);
SKCM	cis	rs9581857	0.556	rs9581864	chr13:28041567	T/C	cg22138327	chr13:27999177	GTF3A	0.71	5.36	0.52	8.12e-7	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs11155671	0.530	rs9371223	chr6:150214806	T/C	cg05036130	chr6:150231994	NA	0.61	6.58	0.6	4.87e-9	Testicular germ cell tumor;
SKCM	cis	rs7772486	0.790	rs6923545	chr6:146244743	A/G	cg23711669	chr6:146136114	FBXO30	-0.75	-7.24	-0.63	2.71e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs611744	0.647	rs7016198	chr8:109262752	G/A	cg18478394	chr8:109455254	TTC35	0.66	5.32	0.52	9.59e-7	Dupuytren's disease;
SKCM	cis	rs4727027	0.800	rs12530946	chr7:148887942	A/G	cg23583168	chr7:148888333	NA	-0.69	-5.33	-0.52	9.37e-7	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs2839186	0.843	rs17182671	chr21:47696238	T/C	cg11766577	chr21:47581405	C21orf56	-0.68	-5.67	-0.54	2.35e-7	Testicular germ cell tumor;
SKCM	trans	rs561341	0.882	rs563539	chr17:30307958	A/G	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs6951245	0.882	rs10252404	chr7:1209607	C/A	cg18402987	chr7:1209562	NA	1.2	7.52	0.65	8.1e-11	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7659604	0.539	rs11731917	chr4:122783233	G/A	cg06713675	chr4:122721982	EXOSC9	-0.75	-7.38	-0.64	1.48e-10	Type 2 diabetes;
SKCM	cis	rs8067545	0.611	rs2158472	chr17:20171524	C/T	cg13482628	chr17:19912719	NA	-0.65	-5.44	-0.52	5.84e-7	Schizophrenia;
SKCM	cis	rs4924935	0.851	rs17743944	chr17:18809268	A/G	cg26378065	chr17:18585709	ZNF286B	-0.84	-5.53	-0.53	4.07e-7	Pancreatic cancer;
SKCM	cis	rs6582630	0.555	rs2004152	chr12:38478951	C/T	cg26384229	chr12:38710491	ALG10B	0.87	6.82	0.61	1.76e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs11950121	0.708	rs4865794	chr5:53161956	A/T	cg06476337	chr5:52856530	NDUFS4	-0.66	-4.95	-0.49	4.19e-6	Alcoholic chronic pancreatitis;
SKCM	cis	rs2760061	0.626	rs2527614	chr1:228126470	A/G	cg02753203	chr1:228287806	NA	-0.62	-5.07	-0.5	2.64e-6	Diastolic blood pressure;
SKCM	cis	rs6500395	1.000	rs1486412	chr16:48651750	A/T	cg04672837	chr16:48644449	N4BP1	0.68	5.66	0.54	2.36e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs738322	0.967	rs2092180	chr22:38571563	A/G	cg25457927	chr22:38595422	NA	-0.54	-6.14	-0.57	3.27e-8	Cutaneous nevi;
SKCM	cis	rs2120019	0.938	rs8030089	chr15:75290377	C/T	cg17294928	chr15:75287854	SCAMP5	-0.94	-9.46	-0.73	1.36e-14	Blood trace element (Zn levels);
SKCM	cis	rs7086627	0.515	rs11202959	chr10:82209672	A/G	cg00277334	chr10:82204260	NA	-0.74	-8.56	-0.7	7.89e-13	Post bronchodilator FEV1;
SKCM	cis	rs644799	0.511	rs10831420	chr11:95478209	T/C	cg03916912	chr11:95522834	CEP57;FAM76B	0.67	5.03	0.49	3.11e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs7811142	1.000	rs7783159	chr7:100017454	C/T	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.12	7.23	0.63	2.9e-10	Platelet count;
SKCM	cis	rs709400	0.598	rs11627529	chr14:104004557	C/T	cg26031613	chr14:104095156	KLC1	0.75	5.73	0.54	1.84e-7	Body mass index;
SKCM	cis	rs6665290	0.904	rs11586604	chr1:227183865	G/T	cg10327440	chr1:227177885	CDC42BPA	-1.22	-17.11	-0.89	4.01e-28	Myeloid white cell count;
SKCM	cis	rs17376456	0.877	rs13185660	chr5:93336500	G/A	cg25358565	chr5:93447407	FAM172A	1.19	7.67	0.66	4.06e-11	Diabetic retinopathy;
SKCM	cis	rs11690935	0.655	rs1028127	chr2:172530036	T/C	cg13550731	chr2:172543902	DYNC1I2	0.64	5.67	0.54	2.33e-7	Schizophrenia;
SKCM	cis	rs7917772	0.582	rs10786682	chr10:104318322	A/C	cg11453585	chr10:104263688	ACTR1A;SUFU	-0.66	-5.26	-0.51	1.22e-6	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs9325144	0.600	rs61931871	chr12:38829889	G/A	cg13010199	chr12:38710504	ALG10B	-0.65	-5.33	-0.52	9.37e-7	Morning vs. evening chronotype;
SKCM	cis	rs1799949	1.000	rs36036395	chr17:41181297	T/C	cg25072359	chr17:41440525	NA	0.63	4.88	0.48	5.43e-6	Menopause (age at onset);
SKCM	cis	rs3784262	1.000	rs7178497	chr15:58240333	C/T	cg12031962	chr15:58353849	ALDH1A2	-0.5	-6.17	-0.57	2.79e-8	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs826838	0.967	rs826876	chr12:39123843	T/C	cg26384229	chr12:38710491	ALG10B	-0.91	-8.15	-0.68	4.8e-12	Heart rate;
SKCM	cis	rs2836950	0.527	rs2836948	chr21:40599677	T/C	cg11890956	chr21:40555474	PSMG1	-0.66	-5.26	-0.51	1.22e-6	Menarche (age at onset);
SKCM	cis	rs1005277	0.579	rs1780145	chr10:38537070	A/G	cg00409905	chr10:38381863	ZNF37A	-0.62	-5.23	-0.51	1.39e-6	Extrinsic epigenetic age acceleration;
SKCM	cis	rs1957429	0.731	rs28370916	chr14:65346094	A/G	cg23373153	chr14:65346875	NA	1.07	6.14	0.57	3.19e-8	Pediatric areal bone mineral density (radius);
SKCM	cis	rs8017423	0.967	rs4904662	chr14:90729427	G/A	cg04374321	chr14:90722782	PSMC1	1.0	9.0	0.71	1.09e-13	Mortality in heart failure;
SKCM	cis	rs2836950	0.520	rs1980407	chr21:40543961	T/C	cg17971929	chr21:40555470	PSMG1	-0.76	-6.53	-0.59	6.19e-9	Menarche (age at onset);
SKCM	cis	rs931234	0.965	rs3919910	chr3:65152426	A/G	cg06271087	chr3:65342546	MAGI1	-0.54	-5.46	-0.53	5.52e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2228479	0.717	rs11649210	chr16:89807233	C/G	cg06558623	chr16:89946397	TCF25	1.01	5.8	0.55	1.33e-7	Skin colour saturation;
SKCM	cis	rs7927771	0.524	rs7943464	chr11:47886639	T/A	cg20307385	chr11:47447363	PSMC3	0.71	5.65	0.54	2.55e-7	Subjective well-being;
SKCM	cis	rs826838	1.000	rs826891	chr12:39100824	A/G	cg26384229	chr12:38710491	ALG10B	-0.97	-8.08	-0.67	6.7e-12	Heart rate;
SKCM	cis	rs4927850	0.501	rs9881504	chr3:195656614	A/G	cg12923728	chr3:195709715	SDHAP1	-0.79	-5.11	-0.5	2.22e-6	Pancreatic cancer;
SKCM	cis	rs6424115	0.830	rs3003333	chr1:24194014	A/T	cg15997130	chr1:24165203	NA	-0.63	-5.34	-0.52	8.79e-7	Immature fraction of reticulocytes;
SKCM	cis	rs8014204	0.747	rs2070598	chr14:75360906	C/T	cg06637938	chr14:75390232	RPS6KL1	-0.64	-4.78	-0.48	8.26e-6	Caffeine consumption;
SKCM	cis	rs10781543	0.845	rs10735662	chr9:139327869	A/T	cg14169450	chr9:139327907	INPP5E	0.53	5.86	0.55	1.04e-7	Monocyte percentage of white cells;
SKCM	cis	rs10911232	0.507	rs4596846	chr1:182976034	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.64	0.6	3.81e-9	Hypertriglyceridemia;
SKCM	cis	rs6982751	0.673	rs56084964	chr8:10810066	C/G	cg01383082	chr8:11323474	FAM167A	0.86	4.98	0.49	3.74e-6	Asthma and hay fever;
SKCM	cis	rs3820928	0.904	rs6735069	chr2:227893660	A/G	cg11843606	chr2:227700838	RHBDD1	-0.6	-4.78	-0.48	8.17e-6	Pulmonary function;
SKCM	cis	rs72615157	0.634	rs74742883	chr7:99785765	T/G	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.07	6.59	0.6	4.62e-9	Lung function (FEV1/FVC);
SKCM	cis	rs514406	0.547	rs377808	chr1:53190359	T/G	cg24675658	chr1:53192096	ZYG11B	-0.64	-5.25	-0.51	1.28e-6	Monocyte count;
SKCM	cis	rs208515	0.518	rs12209790	chr6:66662965	T/C	cg07460842	chr6:66804631	NA	0.91	5.61	0.54	3e-7	Exhaled nitric oxide levels;
SKCM	cis	rs9910055	0.659	rs7216294	chr17:42251095	T/C	cg08499158	chr17:42289980	UBTF	-0.73	-6.45	-0.59	8.6e-9	Total body bone mineral density;
SKCM	cis	rs6879260	0.928	rs11739624	chr5:179727290	T/C	cg23248424	chr5:179741104	GFPT2	-0.76	-5.94	-0.56	7.42e-8	Height;
SKCM	cis	rs40363	0.645	rs1635392	chr16:3517581	T/C	cg22508957	chr16:3507546	NAT15	0.57	5.04	0.5	2.97e-6	Tuberculosis;
SKCM	cis	rs10504229	0.639	rs112926738	chr8:58054939	A/G	cg02725872	chr8:58115012	NA	-0.54	-5.04	-0.5	2.97e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs1577917	1.000	rs12663651	chr6:86701655	T/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.64	-5.54	-0.53	3.92e-7	Response to antipsychotic treatment;
SKCM	cis	rs6750795	0.765	rs6742387	chr2:232354832	G/T	cg19187155	chr2:232395269	NMUR1	0.88	7.56	0.65	6.64e-11	Height;
SKCM	cis	rs2731664	0.792	rs335434	chr5:176867276	A/G	cg06532880	chr5:176731545	PRELID1;RAB24	-0.6	-5.25	-0.51	1.28e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs12477438	0.501	rs12995473	chr2:99764884	G/T	cg26064155	chr2:99771622	LIPT1;TSGA10	1.02	9.73	0.74	4.23e-15	Chronic sinus infection;
SKCM	cis	rs7208859	0.623	rs9911784	chr17:29124580	A/C	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs6904897	0.563	rs6569976	chr6:135224753	A/C	cg24558204	chr6:135376177	HBS1L	0.58	4.85	0.48	6.14e-6	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs17065868	1.000	rs9533920	chr13:45157394	G/A	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs7632954	0.566	rs11711416	chr3:8540662	A/G	cg06697448	chr3:8544912	LMCD1	-0.62	-5.25	-0.51	1.29e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	trans	rs7819412	0.806	rs10113808	chr8:10926892	C/A	cg06636001	chr8:8085503	FLJ10661	-0.89	-7.78	-0.66	2.5e-11	Triglycerides;
SKCM	cis	rs372883	0.600	rs2832298	chr21:30743863	C/G	cg24692254	chr21:30365293	RNF160	0.65	5.28	0.51	1.14e-6	Pancreatic cancer;
SKCM	cis	rs9880211	0.800	rs9858560	chr3:136517154	C/T	cg21827317	chr3:136751795	NA	-0.69	-5.26	-0.51	1.21e-6	Body mass index;Height;
SKCM	cis	rs58688157	0.960	rs60870990	chr11:613742	G/A	cg16486109	chr11:613632	IRF7	1.07	7.29	0.64	2.17e-10	Systemic lupus erythematosus;
SKCM	cis	rs829883	0.932	rs249840	chr12:98871993	T/C	cg25150519	chr12:98850993	NA	0.5	5.27	0.51	1.17e-6	Colorectal adenoma (advanced);
SKCM	cis	rs7020830	0.861	rs13295981	chr9:37330067	C/T	cg14294708	chr9:37120828	ZCCHC7	1.06	10.67	0.77	6.51e-17	Schizophrenia;
SKCM	cis	rs1577917	0.958	rs1545376	chr6:86504582	C/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.81	8.18	0.68	4.16e-12	Response to antipsychotic treatment;
SKCM	cis	rs9475752	0.793	rs13203479	chr6:56870473	A/G	cg06815302	chr6:57335405	PRIM2	0.68	4.87	0.48	5.74e-6	Menarche (age at onset);
SKCM	cis	rs1577917	0.740	rs2758842	chr6:86308731	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.75	-6.74	-0.61	2.43e-9	Response to antipsychotic treatment;
SKCM	cis	rs6951245	0.706	rs28522260	chr7:1183964	C/A	cg18402987	chr7:1209562	NA	1.18	7.4	0.64	1.36e-10	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7944584	0.563	rs61895112	chr11:47560433	T/C	cg20307385	chr11:47447363	PSMC3	0.86	5.81	0.55	1.28e-7	Fasting blood glucose;Fasting blood glucose (BMI interaction);
SKCM	cis	rs4665809	0.567	rs6546848	chr2:26444414	G/C	cg04944784	chr2:26401820	FAM59B	-0.74	-4.79	-0.48	7.81e-6	Gut microbiome composition (summer);
SKCM	cis	rs7666738	0.830	rs9999200	chr4:99030690	A/C	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6879260	1.000	rs7730585	chr5:179733440	T/C	cg23221052	chr5:179740743	GFPT2	-0.67	-5.27	-0.51	1.19e-6	Height;
SKCM	cis	rs7620457	1.000	rs7620457	chr3:183747266	A/G	cg01324343	chr3:183735012	ABCC5	-0.68	-4.86	-0.48	5.87e-6	Body mass index;
SKCM	cis	rs13118159	0.550	rs1137789	chr4:1381798	A/G	cg16405210	chr4:1374714	KIAA1530	-0.95	-7.19	-0.63	3.35e-10	Longevity;
SKCM	cis	rs6977660	1.000	rs6955510	chr7:19821333	G/C	cg05791153	chr7:19748676	TWISTNB	0.79	5.34	0.52	9.05e-7	Thyroid stimulating hormone;
SKCM	cis	rs514406	0.505	rs835609	chr1:53170494	T/C	cg16325326	chr1:53192061	ZYG11B	0.91	10.23	0.76	4.5e-16	Monocyte count;
SKCM	cis	rs7769051	1.000	rs3813347	chr6:133119778	G/A	cg22852734	chr6:133119734	C6orf192	1.01	5.42	0.52	6.37e-7	Type 2 diabetes nephropathy;
SKCM	cis	rs6951245	1.000	rs74887741	chr7:1110658	G/T	cg18402987	chr7:1209562	NA	1.15	6.09	0.57	3.95e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs13118159	0.550	rs28522910	chr4:1374774	C/T	cg02018176	chr4:1364513	KIAA1530	0.86	7.11	0.63	4.81e-10	Longevity;
SKCM	cis	rs763121	0.925	rs5750654	chr22:39051428	T/C	cg06022373	chr22:39101656	GTPBP1	0.78	5.31	0.52	1.02e-6	Menopause (age at onset);
SKCM	cis	rs9875589	0.509	rs2129888	chr3:14013826	A/T	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.57	5.73	0.54	1.84e-7	Ovarian reserve;
SKCM	cis	rs2072499	0.966	rs2842865	chr1:156159532	G/A	cg24450063	chr1:156163899	SLC25A44	1.11	10.97	0.78	1.78e-17	Testicular germ cell tumor;
SKCM	cis	rs823143	0.570	rs823084	chr1:205798313	G/T	cg07167872	chr1:205819463	PM20D1	0.94	8.83	0.71	2.27e-13	Monocyte percentage of white cells;
SKCM	cis	rs6840360	0.533	rs4696295	chr4:152717430	T/C	cg22705602	chr4:152727874	NA	0.59	7.76	0.66	2.74e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs1559088	0.600	rs58173463	chr19:33596749	C/T	cg27124370	chr19:33622961	WDR88	0.72	5.16	0.5	1.84e-6	Bone ultrasound measurement (broadband ultrasound attenuation);
SKCM	cis	rs7937682	0.855	rs521947	chr11:111492616	A/G	cg09085632	chr11:111637200	PPP2R1B	-0.97	-10.08	-0.75	8.74e-16	Primary sclerosing cholangitis;
SKCM	cis	rs9290877	0.667	rs9877870	chr3:188456755	A/C	cg17392043	chr3:188495102	LPP	-0.64	-4.93	-0.49	4.6e-6	IgE levels;
SKCM	cis	rs7618915	0.508	rs12498066	chr3:52627660	G/A	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs875971	0.660	rs10272357	chr7:66063074	G/A	cg05627663	chr7:65219948	SNORA22;CCT6P1	-0.56	-4.81	-0.48	7.26e-6	Aortic root size;
SKCM	cis	rs9399135	0.967	rs12527707	chr6:135324511	G/A	cg24558204	chr6:135376177	HBS1L	0.59	5.23	0.51	1.41e-6	Red blood cell count;
SKCM	cis	rs10504229	0.861	rs114700910	chr8:58170642	C/T	cg22535103	chr8:58192502	C8orf71	-0.75	-5.2	-0.51	1.58e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs9926296	0.744	rs154656	chr16:89708003	T/A	cg01097406	chr16:89675127	NA	0.49	5.29	0.51	1.08e-6	Vitiligo;
SKCM	cis	rs7954584	0.504	rs10840633	chr12:122377511	A/T	cg13699009	chr12:122356056	WDR66	0.59	7.32	0.64	1.91e-10	Mean corpuscular volume;
SKCM	cis	rs1506636	1.000	rs2402671	chr7:123355483	T/C	cg03229431	chr7:123269106	ASB15	-0.6	-4.83	-0.48	6.69e-6	Plateletcrit;Platelet count;
SKCM	cis	rs7772486	0.875	rs1412081	chr6:146409733	A/G	cg05347473	chr6:146136440	FBXO30	0.64	5.83	0.55	1.19e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1799949	0.929	rs799905	chr17:41277187	G/C	cg23758822	chr17:41437982	NA	0.93	7.62	0.65	5.1e-11	Menopause (age at onset);
SKCM	cis	rs2836974	0.627	rs7278985	chr21:40653767	C/T	cg11644478	chr21:40555479	PSMG1	-0.8	-7.6	-0.65	5.6e-11	Cognitive function;
SKCM	cis	rs9858542	0.953	rs9858280	chr3:49597737	T/C	cg03060546	chr3:49711283	APEH	-0.69	-5.11	-0.5	2.24e-6	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs7772486	0.840	rs2814867	chr6:146334030	C/A	cg05347473	chr6:146136440	FBXO30	0.57	5.18	0.51	1.66e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9325144	0.555	rs1843867	chr12:38703855	A/G	cg26384229	chr12:38710491	ALG10B	-0.78	-6.71	-0.61	2.77e-9	Morning vs. evening chronotype;
SKCM	cis	rs1153858	1.000	rs1145074	chr15:45703824	T/A	cg21132104	chr15:45694354	SPATA5L1	0.87	6.79	0.61	1.99e-9	Homoarginine levels;
SKCM	cis	rs8077889	0.917	rs1859048	chr17:41892039	A/C	cg26893861	chr17:41843967	DUSP3	-1.12	-7.6	-0.65	5.55e-11	Triglycerides;
SKCM	cis	rs28595532	0.545	rs17594782	chr4:119250877	G/T	cg11846333	chr4:119757529	SEC24D	1.04	5.83	0.55	1.2e-7	Cannabis dependence symptom count;
SKCM	cis	rs9486913	0.779	rs479744	chr6:109020032	A/C	cg13824859	chr6:109804376	ZBTB24	0.84	4.86	0.48	5.94e-6	High light scatter reticulocyte count;
SKCM	cis	rs473651	0.935	rs474478	chr2:239335473	C/T	cg18131467	chr2:239335373	ASB1	1.08	13.18	0.83	1.55e-21	Multiple system atrophy;
SKCM	cis	rs10193935	0.901	rs12620021	chr2:42477034	T/C	cg27598129	chr2:42591480	NA	-0.97	-6.7	-0.6	2.93e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7772486	0.875	rs1331645	chr6:146398407	C/G	cg23711669	chr6:146136114	FBXO30	0.84	7.93	0.67	1.28e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs875971	1.000	rs2077593	chr7:65892530	A/G	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	cis	rs11673344	0.670	rs35011739	chr19:37434230	A/C	cg07624650	chr19:37064219	ZNF529	-0.8	-5.23	-0.51	1.41e-6	Obesity-related traits;
SKCM	cis	rs2228479	0.850	rs74251568	chr16:89903416	A/C	cg06558623	chr16:89946397	TCF25	1.1	4.97	0.49	3.93e-6	Skin colour saturation;
SKCM	cis	rs951366	0.668	rs823154	chr1:205762406	C/T	cg07157834	chr1:205819609	PM20D1	0.82	8.24	0.68	3.28e-12	Menarche (age at onset);
SKCM	cis	rs2721195	0.967	rs10108150	chr8:145687475	A/G	cg15857475	chr8:145742913	RECQL4;LRRC14	-0.84	-7.29	-0.64	2.16e-10	Age at first birth;
SKCM	cis	rs4819052	0.851	rs9977178	chr21:46664531	G/T	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.42	0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs769267	0.895	rs2916073	chr19:19528324	T/G	cg26732615	chr19:19648335	CILP2;YJEFN3	0.69	7.06	0.62	6.13e-10	Tonsillectomy;
SKCM	cis	rs10089	1.000	rs10478798	chr5:127442394	C/T	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.91	8.89	0.71	1.79e-13	Ileal carcinoids;
SKCM	cis	rs941873	0.803	rs5015119	chr10:81101609	G/C	cg09469691	chr10:81107165	PPIF	0.74	6.71	0.6	2.79e-9	Height;
SKCM	cis	rs8067545	0.750	rs7208635	chr17:19990990	T/C	cg13482628	chr17:19912719	NA	0.73	6.54	0.6	5.78e-9	Schizophrenia;
SKCM	cis	rs56235845	0.694	rs12055081	chr5:176757191	C/T	cg06060754	chr5:176797920	RGS14	0.67	6.4	0.59	1.08e-8	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs523522	0.962	rs10744752	chr12:120900554	T/G	cg12219531	chr12:120966889	COQ5	0.88	7.08	0.63	5.62e-10	High light scatter reticulocyte count;
SKCM	cis	rs9543976	1.000	rs9573592	chr13:76197843	G/A	cg01531495	chr13:76123901	UCHL3	-0.9	-4.99	-0.49	3.52e-6	Diabetic retinopathy;
SKCM	cis	rs362296	0.550	rs3135064	chr4:3285389	T/C	cg05297308	chr4:3317976	RGS12	0.79	7.11	0.63	4.92e-10	Parental longevity (mother's age at death);
SKCM	cis	rs7772486	0.686	rs9485019	chr6:146046381	C/G	cg23711669	chr6:146136114	FBXO30	-0.82	-8.01	-0.67	9.12e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs11792861	0.816	rs3818932	chr9:111664178	T/C	cg14432460	chr9:111696404	IKBKAP;C9orf6	0.67	4.81	0.48	7.15e-6	Menarche (age at onset);
SKCM	cis	rs2243480	1.000	rs316321	chr7:65611613	G/A	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs2354432	0.607	rs58941651	chr1:146784919	T/C	cg25205988	chr1:146714368	CHD1L	-1.19	-6.56	-0.6	5.24e-9	Mitochondrial DNA levels;
SKCM	cis	rs769267	0.598	rs8108705	chr19:19675367	G/T	cg26732615	chr19:19648335	CILP2;YJEFN3	-0.57	-4.9	-0.48	5.19e-6	Tonsillectomy;
SKCM	cis	rs4665809	0.590	rs2303892	chr2:26461733	C/G	cg26119090	chr2:26468346	HADHA;HADHB	1.06	8.39	0.69	1.66e-12	Gut microbiome composition (summer);
SKCM	cis	rs7927771	0.864	rs4752838	chr11:47466006	G/A	cg05585544	chr11:47624801	NA	-0.56	-4.79	-0.48	7.65e-6	Subjective well-being;
SKCM	cis	rs1218582	0.741	rs11264283	chr1:154869552	A/G	cg06221963	chr1:154839813	KCNN3	-0.59	-5.97	-0.56	6.76e-8	Prostate cancer;
SKCM	cis	rs10791097	0.694	rs4436551	chr11:130755739	A/G	cg12179176	chr11:130786555	SNX19	-0.94	-8.4	-0.69	1.54e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs9308433	0.529	rs904321	chr1:214506550	G/C	cg06198575	chr1:214491504	SMYD2	0.79	4.85	0.48	6.29e-6	IgG glycosylation;
SKCM	cis	rs1577917	1.000	rs12199784	chr6:86726808	C/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.83	-8.07	-0.67	6.96e-12	Response to antipsychotic treatment;
SKCM	cis	rs6665290	0.901	rs2104860	chr1:227208637	G/C	cg10327440	chr1:227177885	CDC42BPA	-1.2	-16.22	-0.88	1.04e-26	Myeloid white cell count;
SKCM	cis	rs1506636	0.962	rs10273985	chr7:123309538	A/T	cg03229431	chr7:123269106	ASB15	-0.63	-5.08	-0.5	2.56e-6	Plateletcrit;Platelet count;
SKCM	cis	rs2153535	0.580	rs9405390	chr6:8466209	T/G	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs28386778	0.897	rs9913323	chr17:61851485	C/A	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs7809950	0.817	rs58052742	chr7:107210003	A/G	cg23024343	chr7:107201750	COG5	0.77	6.91	0.62	1.16e-9	Coronary artery disease;
SKCM	cis	rs4746818	1.000	rs7893492	chr10:70960448	C/T	cg11621586	chr10:70884670	VPS26A	-0.86	-5.43	-0.52	6.29e-7	Left atrial antero-posterior diameter;
SKCM	cis	rs7523273	0.925	rs12749612	chr1:208006749	A/G	cg22525895	chr1:207977042	MIR29B2	-0.78	-5.76	-0.55	1.57e-7	Schizophrenia;
SKCM	cis	rs1707322	0.963	rs1768815	chr1:46528603	G/A	cg03146154	chr1:46216737	IPP	-0.8	-5.35	-0.52	8.54e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs137603	0.603	rs137581	chr22:39677838	C/T	cg17798944	chr22:39715225	SNORD43;RPL3	-0.66	-5.76	-0.55	1.61e-7	Primary biliary cholangitis;
SKCM	cis	rs910316	0.763	rs175042	chr14:75470833	A/T	cg08847533	chr14:75593920	NEK9	-0.8	-6.59	-0.6	4.76e-9	Height;
SKCM	cis	rs116095464	0.558	rs10077076	chr5:231940	C/T	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs9815354	0.812	rs73071208	chr3:41978738	A/T	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs2242116	0.932	rs7646906	chr3:46949379	G/A	cg02527881	chr3:46936655	PTH1R	-0.54	-5.38	-0.52	7.56e-7	Birth weight;
SKCM	cis	rs7000551	0.527	rs11783730	chr8:22244897	C/T	cg12081754	chr8:22256438	SLC39A14	1.05	10.73	0.77	5.1e-17	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs9910055	0.530	rs7222349	chr17:42304644	C/T	cg08499158	chr17:42289980	UBTF	-0.79	-6.91	-0.62	1.15e-9	Total body bone mineral density;
SKCM	cis	rs12709013	0.792	rs1657165	chr16:58781884	G/A	cg02431531	chr16:59244939	NA	0.49	5.13	0.5	2.07e-6	Blood metabolite ratios;
SKCM	cis	rs28595532	0.920	rs56331118	chr4:119767054	G/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs9308433	0.529	rs4655243	chr1:214497291	A/G	cg06198575	chr1:214491504	SMYD2	0.81	5.09	0.5	2.41e-6	IgG glycosylation;
SKCM	cis	rs1577917	0.771	rs2842607	chr6:86345039	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-1.01	-11.43	-0.79	2.49e-18	Response to antipsychotic treatment;
SKCM	cis	rs2404602	0.622	rs11632365	chr15:77139080	G/A	cg23625390	chr15:77176239	SCAPER	-0.87	-8.2	-0.68	3.81e-12	Blood metabolite levels;
SKCM	cis	rs533581	0.866	rs4995274	chr16:88970040	T/C	cg16701003	chr16:89028210	CBFA2T3	0.54	5.03	0.49	3.05e-6	Social autistic-like traits;
SKCM	cis	rs2404602	0.716	rs67204011	chr15:76846555	C/T	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs28386778	0.897	rs2727287	chr17:61904728	G/A	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs7811142	0.720	rs112622797	chr7:99917416	G/A	cg00814883	chr7:100076585	TSC22D4	-0.84	-4.78	-0.48	8.01e-6	Platelet count;
SKCM	cis	rs1552244	1.000	rs9824585	chr3:10114802	T/C	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs7953508	0.506	rs3869308	chr12:93959918	A/G	cg18151635	chr12:93972918	NA	-0.72	-6.85	-0.61	1.52e-9	Pubertal anthropometrics;
SKCM	cis	rs9790314	0.846	rs7627528	chr3:160990878	A/G	cg03342759	chr3:160939853	NMD3	-0.71	-7.84	-0.66	1.91e-11	Morning vs. evening chronotype;
SKCM	cis	rs7811142	1.000	rs76913697	chr7:100002772	A/G	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.25	8.07	0.67	7e-12	Platelet count;
SKCM	cis	rs13118159	0.505	rs1250128	chr4:1257311	T/C	cg20887711	chr4:1340912	KIAA1530	-0.87	-6.65	-0.6	3.65e-9	Longevity;
SKCM	cis	rs2239547	0.657	rs2276817	chr3:52860936	C/T	cg11645453	chr3:52864694	ITIH4	0.79	7.19	0.63	3.41e-10	Schizophrenia;
SKCM	cis	rs6952808	0.575	rs2056479	chr7:1954273	G/A	cg02951883	chr7:2050386	MAD1L1	-0.65	-5.55	-0.53	3.76e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs875971	0.660	rs2013222	chr7:66035936	C/G	cg11987759	chr7:65425863	GUSB	0.69	5.9	0.56	8.74e-8	Aortic root size;
SKCM	cis	rs651907	0.557	rs3864012	chr3:101397623	T/C	cg12386194	chr3:101231763	SENP7	0.69	5.68	0.54	2.23e-7	Colorectal cancer;
SKCM	cis	rs12986445	0.711	rs10210741	chr2:26139797	C/G	cg04917511	chr2:26785460	C2orf70	0.51	4.81	0.48	7.17e-6	Multiple myeloma and monoclonal gammopathy;Multiple myeloma;
SKCM	cis	rs10504229	0.683	rs7463453	chr8:58112053	A/G	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs2032447	0.672	rs9379811	chr6:25955197	G/C	cg18357526	chr6:26021779	HIST1H4A	0.67	5.13	0.5	2.04e-6	Intelligence (multi-trait analysis);
SKCM	trans	rs1814175	0.867	rs7926002	chr11:49616018	A/G	cg15704280	chr7:45808275	SEPT13	-0.96	-8.57	-0.7	7.28e-13	Height;
SKCM	cis	rs7020830	0.898	rs308492	chr9:37298020	C/T	cg14294708	chr9:37120828	ZCCHC7	1.07	10.99	0.78	1.64e-17	Schizophrenia;
SKCM	cis	rs9300255	0.602	rs1051431	chr12:123645803	G/A	cg05973401	chr12:123451056	ABCB9	0.8	5.47	0.53	5.23e-7	Neutrophil percentage of white cells;
SKCM	cis	rs11710229	0.920	rs34646967	chr3:55476109	G/C	cg04915058	chr3:55693741	C3orf51;ERC2	0.9	5.08	0.5	2.53e-6	Response to cytadine analogues (cytosine arabinoside);
SKCM	cis	rs2243480	1.000	rs160643	chr7:65558222	C/T	cg18252515	chr7:66147081	NA	-1.3	-7.95	-0.67	1.15e-11	Diabetic kidney disease;
SKCM	cis	rs2991971	0.869	rs2453404	chr1:46014735	A/G	cg24296786	chr1:45957014	TESK2	0.65	5.25	0.51	1.28e-6	High light scatter reticulocyte count;
SKCM	cis	rs875971	0.502	rs6460311	chr7:66111873	C/T	cg18876405	chr7:65276391	NA	-0.61	-4.88	-0.48	5.42e-6	Aortic root size;
SKCM	cis	rs1707322	1.000	rs11211217	chr1:46348229	C/G	cg03146154	chr1:46216737	IPP	0.75	5.15	0.5	1.94e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs593982	1.000	rs74638829	chr11:65495571	C/T	cg08755490	chr11:65554678	OVOL1	-0.95	-7.42	-0.64	1.22e-10	Atopic dermatitis;
SKCM	cis	rs1003719	0.713	rs2835594	chr21:38466064	G/A	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs28595532	1.000	rs11931194	chr4:119631160	C/T	cg21605333	chr4:119757512	SEC24D	1.24	7.1	0.63	5.16e-10	Cannabis dependence symptom count;
SKCM	cis	rs801193	0.839	rs12534943	chr7:66070520	A/G	cg11987759	chr7:65425863	GUSB	0.69	6.01	0.56	5.68e-8	Aortic root size;
SKCM	cis	rs1552244	1.000	rs6764068	chr3:10153842	A/G	cg02579736	chr3:10068473	FANCD2;CIDECP	1.23	6.92	0.62	1.13e-9	Alzheimer's disease;
SKCM	cis	rs1801251	0.963	rs35362030	chr2:233612845	A/G	cg08000102	chr2:233561755	GIGYF2	0.87	7.05	0.62	6.23e-10	Coronary artery disease;
SKCM	cis	rs4969178	0.896	rs1976704	chr17:76401318	C/T	cg20026190	chr17:76395443	PGS1	0.59	5.01	0.49	3.3e-6	HDL cholesterol levels;
SKCM	cis	rs9818758	0.607	rs9850917	chr3:49286983	A/G	cg00383909	chr3:49044727	WDR6	0.95	4.95	0.49	4.17e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs7811142	0.943	rs67483801	chr7:100031758	G/T	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.17	7.71	0.66	3.44e-11	Platelet count;
SKCM	cis	rs561341	1.000	rs548957	chr17:30302411	G/A	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs1799949	0.965	rs4793234	chr17:41436183	A/G	cg05368731	chr17:41323189	NBR1	0.84	6.68	0.6	3.12e-9	Menopause (age at onset);
SKCM	cis	rs2304069	0.954	rs2276983	chr5:149424966	C/T	cg22760475	chr5:149380129	HMGXB3;TIGD6	0.86	5.87	0.55	1.02e-7	HIV-1 control;
SKCM	cis	rs7408868	0.908	rs45591935	chr19:15277006	T/C	cg14696996	chr19:15285081	NOTCH3	0.82	4.92	0.49	4.7e-6	Pulse pressure;
SKCM	cis	rs35306767	0.761	rs12771539	chr10:1050653	A/G	cg26597838	chr10:835615	NA	0.64	5.23	0.51	1.38e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs453301	0.624	rs2979265	chr8:8858717	G/C	cg15556689	chr8:8085844	FLJ10661	0.67	5.32	0.52	9.8e-7	Joint mobility (Beighton score);
SKCM	cis	rs55962025	0.842	rs2269477	chr4:3184464	G/T	cg09735869	chr4:3319127	RGS12	-0.65	-5.25	-0.51	1.27e-6	Parental longevity (mother's age at death);
SKCM	cis	rs13118159	0.550	rs28614045	chr4:1374695	C/A	cg05025164	chr4:1340916	KIAA1530	0.89	7.25	0.63	2.67e-10	Longevity;
SKCM	cis	rs1348850	0.645	rs11887886	chr2:178425730	C/T	cg27490568	chr2:178487706	NA	0.8	5.67	0.54	2.28e-7	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs17065868	1.000	rs57884038	chr13:45156063	A/T	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs5750830	0.649	rs5757664	chr22:39821536	A/G	cg11247378	chr22:39784982	NA	-0.47	-5.43	-0.52	6.23e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs5769765	0.913	rs2319462	chr22:50263370	C/T	cg22709217	chr22:50311962	ALG12;CRELD2	0.79	5.71	0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs2303745	0.589	rs891018	chr19:17396761	C/T	cg04248312	chr19:17393744	ANKLE1	1.11	8.18	0.68	4.15e-12	Systemic lupus erythematosus;
SKCM	cis	rs67311347	0.635	rs73071706	chr3:40288190	C/A	cg00091569	chr3:40428383	ENTPD3	0.61	5.06	0.5	2.69e-6	Renal cell carcinoma;
SKCM	cis	rs6933660	0.646	rs3816778	chr6:151773353	G/C	cg14416726	chr6:151773293	C6orf211;RMND1	-0.68	-5.66	-0.54	2.43e-7	Menarche (age at onset);
SKCM	cis	rs28386778	0.897	rs894413	chr17:61916347	A/G	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs6546550	0.835	rs3755389	chr2:70119469	T/C	cg02498382	chr2:70120550	SNRNP27	-0.46	-4.98	-0.49	3.77e-6	Prevalent atrial fibrillation;
SKCM	cis	rs4561483	0.673	rs28279	chr16:11968555	A/C	cg08843971	chr16:11963173	GSPT1	0.64	4.88	0.48	5.5e-6	Testicular germ cell tumor;
SKCM	cis	rs1799949	0.965	rs33961729	chr17:41287924	C/A	cg23758822	chr17:41437982	NA	0.92	7.8	0.66	2.3e-11	Menopause (age at onset);
SKCM	cis	rs7927771	0.832	rs56030824	chr11:47397353	G/A	cg05585544	chr11:47624801	NA	-0.58	-4.9	-0.49	5.07e-6	Subjective well-being;
SKCM	cis	rs9894429	0.646	rs7405937	chr17:79597811	G/A	cg18240062	chr17:79603768	NPLOC4	0.68	5.88	0.55	9.47e-8	Eye color traits;
SKCM	cis	rs995000	0.931	rs28641195	chr1:63128081	C/T	cg06896770	chr1:63153194	DOCK7	-0.75	-7.28	-0.64	2.33e-10	Triglyceride levels;
SKCM	cis	rs929354	0.742	rs6956046	chr7:156962874	G/A	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs6120849	0.707	rs3746444	chr20:33578251	A/G	cg24642439	chr20:33292090	TP53INP2	0.94	4.83	0.48	6.73e-6	Protein C levels;
SKCM	cis	rs501916	0.727	rs12439630	chr15:48035191	C/T	cg16110827	chr15:48056943	SEMA6D	-0.58	-4.93	-0.49	4.62e-6	Inflammatory bowel disease;Ulcerative colitis;
SKCM	cis	rs10089	1.000	rs4835941	chr5:127430905	C/T	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.92	8.45	0.69	1.25e-12	Ileal carcinoids;
SKCM	cis	rs6582630	0.519	rs4002438	chr12:38484880	C/T	cg26384229	chr12:38710491	ALG10B	0.81	6.22	0.58	2.31e-8	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs56235845	0.694	rs11738681	chr5:176761535	A/G	cg06060754	chr5:176797920	RGS14	0.63	6.03	0.56	5.13e-8	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs11608355	0.597	rs7300290	chr12:109832545	T/G	cg19025524	chr12:109796872	NA	-0.66	-5.75	-0.55	1.69e-7	Neuroticism;
SKCM	cis	rs5753618	0.504	rs5753669	chr22:31905819	T/G	cg02404636	chr22:31891804	SFI1	0.68	6.07	0.57	4.32e-8	Colorectal cancer;
SKCM	cis	rs17685	0.712	rs2158867	chr7:75815141	C/A	cg16684958	chr7:75615977	POR	0.5	4.89	0.48	5.39e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2013441	1.000	rs2703806	chr17:20108239	A/T	cg13482628	chr17:19912719	NA	-0.65	-5.21	-0.51	1.48e-6	Obesity-related traits;
SKCM	trans	rs1814175	0.645	rs2140602	chr11:50022800	G/C	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	trans	rs1814175	0.645	rs10444311	chr11:49986906	A/G	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs1577917	1.000	rs117907570	chr6:86601283	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.77	-0.66	2.68e-11	Response to antipsychotic treatment;
SKCM	cis	rs208520	1.000	rs208527	chr6:66957209	A/C	cg07460842	chr6:66804631	NA	-0.84	-5.89	-0.55	9.44e-8	Exhaled nitric oxide output;
SKCM	cis	rs4774899	0.966	rs11071305	chr15:57371178	A/G	cg01857019	chr15:57210107	LOC145783;TCF12	0.53	4.96	0.49	3.96e-6	Urinary tract infection frequency;
SKCM	cis	rs7633857	0.512	rs1868109	chr3:160682500	G/A	cg03342759	chr3:160939853	NMD3	-0.6	-4.79	-0.48	7.73e-6	Educational attainment (years of education);
SKCM	cis	rs10504229	0.683	rs7460059	chr8:58111561	C/T	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs12142240	0.698	rs79490411	chr1:46813568	G/A	cg10495392	chr1:46806563	NSUN4	0.78	5.68	0.54	2.22e-7	Menopause (age at onset);
SKCM	cis	rs703842	0.616	rs10783851	chr12:58231155	A/G	cg00677455	chr12:58241039	CTDSP2	-0.76	-5.83	-0.55	1.17e-7	Multiple sclerosis;
SKCM	trans	rs3780486	0.846	rs7850878	chr9:33126570	A/G	cg04842962	chr6:43655489	MRPS18A	1.03	10.85	0.78	2.95e-17	IgG glycosylation;
SKCM	cis	rs6951245	0.935	rs79067319	chr7:1065548	C/T	cg18402987	chr7:1209562	NA	1.14	5.99	0.56	6.11e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs4888262	0.545	rs4588013	chr16:74703388	C/T	cg01733217	chr16:74700730	RFWD3	0.87	7.0	0.62	7.93e-10	Testicular germ cell tumor;
SKCM	cis	rs11098499	0.863	rs10030660	chr4:120436704	G/A	cg24375607	chr4:120327624	NA	0.68	5.12	0.5	2.11e-6	Corneal astigmatism;
SKCM	cis	rs2839186	0.786	rs7409792	chr21:47691729	C/A	cg13012494	chr21:47604986	C21orf56	0.66	5.7	0.54	2.04e-7	Testicular germ cell tumor;
SKCM	cis	rs3845702	1.000	rs9989852	chr2:180839707	G/A	cg01881094	chr2:180872142	CWC22	-1.02	-5.29	-0.51	1.07e-6	Schizophrenia;
SKCM	cis	rs2354432	0.607	rs66486822	chr1:146802653	T/A	cg25205988	chr1:146714368	CHD1L	-1.19	-6.56	-0.6	5.24e-9	Mitochondrial DNA levels;
SKCM	cis	rs17765925	0.605	rs985105	chr7:14270475	G/T	cg11279021	chr7:14028690	ETV1	0.51	4.81	0.48	7.17e-6	Verbal declarative memory;
SKCM	cis	rs4073582	1.000	rs4073582	chr11:66050712	G/A	cg16950941	chr11:66035639	RAB1B	0.76	5.32	0.52	9.7e-7	Gout;
SKCM	cis	rs3768617	0.510	rs10797837	chr1:183075121	C/G	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs7666738	0.830	rs7687315	chr4:98900613	A/G	cg17366294	chr4:99064904	C4orf37	0.57	4.85	0.48	6.12e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2836974	0.932	rs13048178	chr21:40561012	G/T	cg11890956	chr21:40555474	PSMG1	1.11	13.42	0.84	5.75e-22	Cognitive function;
SKCM	cis	rs875971	0.522	rs1701760	chr7:65473688	A/G	cg18876405	chr7:65276391	NA	0.84	7.78	0.66	2.51e-11	Aortic root size;
SKCM	cis	rs28595532	0.920	rs17257945	chr4:119666465	T/A	cg11846333	chr4:119757529	SEC24D	1.19	6.39	0.59	1.09e-8	Cannabis dependence symptom count;
SKCM	cis	rs6732795	0.854	rs6546486	chr2:69413892	A/T	cg12784598	chr2:69240042	ANTXR1	0.69	5.02	0.49	3.22e-6	Intraocular pressure;
SKCM	cis	rs12706411	1.000	rs71571077	chr7:122048552	T/C	cg17986181	chr7:121955208	NA	-0.7	-5.19	-0.51	1.65e-6	Alzheimer disease and age of onset;
SKCM	cis	rs9394841	0.692	rs9381097	chr6:41847800	A/G	cg08135965	chr6:41755394	TOMM6	-0.75	-5.04	-0.5	2.97e-6	Mean corpuscular hemoglobin;Red cell distribution width;
SKCM	cis	rs6121246	0.559	rs10439608	chr20:30258814	T/C	cg13852791	chr20:30311386	BCL2L1	0.83	5.76	0.55	1.61e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs2228479	0.850	rs62056103	chr16:89942781	G/A	cg06558623	chr16:89946397	TCF25	1.12	5.64	0.54	2.58e-7	Skin colour saturation;
SKCM	cis	rs28386778	0.863	rs7221573	chr17:61859390	G/A	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs6089584	0.586	rs1079755	chr20:60615262	G/A	cg06108461	chr20:60628389	TAF4	-0.73	-6.87	-0.61	1.36e-9	Body mass index;
SKCM	cis	rs3820068	0.603	rs10492986	chr1:15988702	T/C	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs4888262	0.526	rs4404098	chr16:74570050	G/A	cg01733217	chr16:74700730	RFWD3	0.84	6.65	0.6	3.65e-9	Testicular germ cell tumor;
SKCM	cis	rs9486715	0.867	rs4839842	chr6:96955387	A/T	cg06623918	chr6:96969491	KIAA0776	0.8	6.58	0.6	4.94e-9	Headache;
SKCM	cis	rs7666738	0.830	rs28497822	chr4:98906873	C/T	cg05340658	chr4:99064831	C4orf37	0.61	4.95	0.49	4.24e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs55794721	0.672	rs78103988	chr1:25747655	C/T	cg02931644	chr1:25747376	RHCE	0.52	5.34	0.52	8.98e-7	Plateletcrit;Mean corpuscular volume;
SKCM	cis	rs2288073	0.965	rs36101491	chr2:24387532	C/T	cg06627628	chr2:24431161	ITSN2	-0.8	-5.64	-0.54	2.61e-7	Venous thromboembolism (SNP x SNP interaction);
SKCM	trans	rs1814175	0.817	rs11518158	chr11:49985633	G/T	cg15704280	chr7:45808275	SEPT13	-1.02	-10.66	-0.77	6.79e-17	Height;
SKCM	cis	rs829883	1.000	rs249837	chr12:98876535	A/G	cg25150519	chr12:98850993	NA	0.5	5.27	0.51	1.17e-6	Colorectal adenoma (advanced);
SKCM	cis	rs7659604	1.000	rs7660078	chr4:122665577	G/T	cg19748678	chr4:122722346	EXOSC9	0.67	5.45	0.52	5.79e-7	Type 2 diabetes;
SKCM	cis	rs748404	0.560	rs689797	chr15:43826557	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	0.68	5.14	0.5	1.98e-6	Lung cancer;
SKCM	cis	rs40363	0.645	rs250633	chr16:3523002	C/T	cg27500918	chr16:2933308	FLYWCH2	0.71	4.9	0.49	5.13e-6	Tuberculosis;
SKCM	cis	rs10779751	1.000	rs7549109	chr1:11278813	C/G	cg08854313	chr1:11322531	MTOR	-1.05	-9.83	-0.74	2.72e-15	Body mass index;
SKCM	cis	rs10193935	1.000	rs10193935	chr2:42419829	C/T	cg27598129	chr2:42591480	NA	-0.88	-6.71	-0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7193541	0.682	rs28681530	chr16:74682496	C/T	cg01733217	chr16:74700730	RFWD3	1.02	11.62	0.8	1.08e-18	Multiple myeloma;
SKCM	cis	rs1218582	0.741	rs10908447	chr1:154869742	C/T	cg24250549	chr1:154909240	PMVK	0.82	8.27	0.68	2.82e-12	Prostate cancer;
SKCM	cis	rs1639906	1.000	rs1639906	chr7:2219966	T/C	cg02951883	chr7:2050386	MAD1L1	-0.62	-4.86	-0.48	5.84e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7296418	0.675	rs1879379	chr12:123727443	G/A	cg05973401	chr12:123451056	ABCB9	0.74	5.57	0.53	3.44e-7	Platelet count;
SKCM	cis	rs867186	0.614	rs17309872	chr20:33515788	A/T	cg04194272	chr20:33683537	NA	-1.27	-5.12	-0.5	2.18e-6	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs1005277	0.602	rs1831315	chr10:38473353	T/C	cg00409905	chr10:38381863	ZNF37A	-0.65	-5.92	-0.56	8.04e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs9393692	0.875	rs6939589	chr6:26289203	C/T	cg00631329	chr6:26305371	NA	0.69	4.87	0.48	5.65e-6	Educational attainment;
SKCM	cis	rs11098499	0.955	rs4145951	chr4:120155817	A/G	cg09307838	chr4:120376055	NA	0.91	7.22	0.63	2.98e-10	Corneal astigmatism;
SKCM	cis	rs2404602	1.000	rs1117367	chr15:76872330	A/C	cg23625390	chr15:77176239	SCAPER	0.76	7.48	0.65	9.68e-11	Blood metabolite levels;
SKCM	cis	rs55962025	0.686	rs2237007	chr4:3235450	T/C	cg21096898	chr4:3318625	RGS12	-0.61	-5.04	-0.5	2.99e-6	Parental longevity (mother's age at death);
SKCM	cis	rs62238980	0.614	rs74534759	chr22:32383419	T/G	cg00543991	chr22:32367038	NA	1.15	4.87	0.48	5.76e-6	Childhood ear infection;
SKCM	cis	rs801193	0.548	rs2659904	chr7:66178602	C/A	cg18876405	chr7:65276391	NA	0.66	6.44	0.59	8.98e-9	Aortic root size;
SKCM	cis	rs7666738	0.716	rs13108535	chr4:99046324	A/G	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10754283	0.967	rs10922685	chr1:90118320	A/G	cg21401794	chr1:90099060	LRRC8C	0.73	6.31	0.58	1.57e-8	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs4243830	0.850	rs12760251	chr1:6601336	C/T	cg22792644	chr1:6614718	TAS1R1;NOL9	-1.03	-5.43	-0.52	6.19e-7	Body mass index;
SKCM	cis	rs2197308	0.655	rs1971964	chr12:37870474	C/T	cg26384229	chr12:38710491	ALG10B	0.82	6.88	0.61	1.35e-9	Morning vs. evening chronotype;
SKCM	cis	rs28595532	0.920	rs114019902	chr4:119755564	G/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs7666738	0.800	rs1559858	chr4:99024075	A/G	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4819052	1.000	rs13052356	chr21:46663588	G/A	cg02159808	chr21:46707872	POFUT2;LOC642852	0.79	5.87	0.55	1.01e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs597539	0.690	rs659465	chr11:68618964	T/G	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.81	5.33	0.52	9.43e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs2721195	0.874	rs2721173	chr8:145744429	C/T	cg15857475	chr8:145742913	RECQL4;LRRC14	0.9	9.25	0.72	3.54e-14	Age at first birth;
SKCM	cis	rs2999052	0.526	rs6439108	chr3:127745765	G/C	cg09089421	chr3:127803668	RUVBL1	-0.59	-5.59	-0.54	3.16e-7	Hypospadias;
SKCM	cis	rs7103648	0.966	rs896817	chr11:47394305	A/G	cg20307385	chr11:47447363	PSMC3	-1.08	-9.63	-0.74	6.61e-15	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs738322	0.967	rs4383	chr22:38570927	C/G	cg25457927	chr22:38595422	NA	-0.54	-6.14	-0.57	3.27e-8	Cutaneous nevi;
SKCM	cis	rs1005277	0.579	rs9299760	chr10:38377920	C/T	cg00409905	chr10:38381863	ZNF37A	-0.64	-5.96	-0.56	6.77e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs1153858	1.000	rs66714503	chr15:45648038	G/C	cg21132104	chr15:45694354	SPATA5L1	0.92	7.81	0.66	2.22e-11	Homoarginine levels;
SKCM	cis	rs12586317	0.547	rs112510746	chr14:35491833	T/G	cg16230307	chr14:35515116	FAM177A1	0.81	5.88	0.55	9.47e-8	Psoriasis;
SKCM	cis	rs1559088	0.600	rs7246566	chr19:33589618	A/T	cg17764715	chr19:33622953	WDR88	0.93	6.71	0.61	2.74e-9	Bone ultrasound measurement (broadband ultrasound attenuation);
SKCM	cis	rs7772486	0.776	rs4316025	chr6:146238032	C/T	cg05347473	chr6:146136440	FBXO30	-0.55	-5.14	-0.5	2.02e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs3820928	0.904	rs2396432	chr2:227765891	C/T	cg11843606	chr2:227700838	RHBDD1	-0.64	-5.24	-0.51	1.3e-6	Pulmonary function;
SKCM	cis	rs1552244	1.000	rs7626117	chr3:10140671	G/A	cg02579736	chr3:10068473	FANCD2;CIDECP	0.92	5.33	0.52	9.44e-7	Alzheimer's disease;
SKCM	cis	rs9815354	0.761	rs12186109	chr3:41836920	T/C	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs4803480	0.786	rs4803479	chr19:42057604	T/G	cg14881601	chr19:42905440	NA	-0.53	-4.79	-0.48	7.69e-6	Schizophrenia;
SKCM	cis	rs10256972	0.621	rs2280725	chr7:1087426	G/T	cg16145915	chr7:1198662	ZFAND2A	-0.47	-6.3	-0.58	1.63e-8	Longevity;Endometriosis;
SKCM	cis	rs4727027	0.866	rs35599790	chr7:148806012	C/T	cg23583168	chr7:148888333	NA	-0.83	-6.7	-0.6	2.89e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	trans	rs9329221	0.772	rs7824675	chr8:10243418	G/T	cg06636001	chr8:8085503	FLJ10661	-0.89	-8.17	-0.68	4.32e-12	Neuroticism;
SKCM	cis	rs6121246	0.909	rs6089070	chr20:30377773	A/G	cg11595048	chr20:30225325	COX4I2	-0.67	-5.21	-0.51	1.5e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs2153535	0.580	rs9378552	chr6:8463748	G/A	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs867186	1.000	rs2069940	chr20:33759272	C/G	cg04194272	chr20:33683537	NA	-1.02	-5.4	-0.52	7.03e-7	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs4969178	0.965	rs12451791	chr17:76397343	G/A	cg20026190	chr17:76395443	PGS1	0.61	5.29	0.51	1.08e-6	HDL cholesterol levels;
SKCM	cis	rs10504229	0.817	rs114173899	chr8:58170640	G/T	cg22535103	chr8:58192502	C8orf71	-0.75	-5.2	-0.51	1.58e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs1865760	0.927	rs6915834	chr6:25935427	A/C	cg08401836	chr6:26032486	HIST1H3B	-0.62	-5.03	-0.5	3.01e-6	Height;
SKCM	cis	rs801193	1.000	rs11773829	chr7:66141074	G/A	cg11764359	chr7:65958608	NA	-0.86	-6.6	-0.6	4.52e-9	Aortic root size;
SKCM	cis	rs651907	0.557	rs11917569	chr3:101355063	G/C	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.79	6.55	0.6	5.65e-9	Colorectal cancer;
SKCM	cis	rs854765	0.624	rs7359509	chr17:17741875	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	-0.95	-7.06	-0.62	5.98e-10	Total body bone mineral density;
SKCM	cis	rs17685	0.523	rs10246583	chr7:75746667	C/A	cg16684958	chr7:75615977	POR	0.55	5.27	0.51	1.19e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs3820068	0.603	rs10492986	chr1:15988702	T/C	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs1218582	0.710	rs9794000	chr1:154878876	T/A	cg03351412	chr1:154909251	PMVK	0.77	6.28	0.58	1.8e-8	Prostate cancer;
SKCM	cis	rs12497850	0.931	rs12493289	chr3:48905161	G/A	cg06212747	chr3:49208901	KLHDC8B	0.68	4.89	0.48	5.28e-6	Parkinson's disease;
SKCM	cis	rs2180341	0.814	rs6914131	chr6:127737489	T/C	cg24812749	chr6:127587940	RNF146	0.61	4.97	0.49	3.9e-6	Breast cancer;
SKCM	cis	rs7937682	0.663	rs35581942	chr11:111756286	C/T	cg09085632	chr11:111637200	PPP2R1B	1.1	10.72	0.77	5.29e-17	Primary sclerosing cholangitis;
SKCM	cis	rs9399137	0.507	rs7761964	chr6:135314265	T/C	cg24558204	chr6:135376177	HBS1L	0.7	6.53	0.59	6.11e-9	Glycated hemoglobin levels;Mean corpuscular volume;Hematology traits;HbA2 levels;Mean corpuscular hemoglobin;Hemoglobin levels;F-cell distribution;Platelet count;
SKCM	cis	rs2413583	0.591	rs115263847	chr22:39729777	C/T	cg17798944	chr22:39715225	SNORD43;RPL3	0.93	5.29	0.51	1.11e-6	Ulcerative colitis;Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs67311347	0.544	rs9814779	chr3:40340431	T/C	cg02782426	chr3:40428986	ENTPD3	0.52	5.3	0.51	1.06e-6	Renal cell carcinoma;
SKCM	cis	rs2295499	0.673	rs73189408	chr4:2705644	T/A	cg19433769	chr4:2420260	ZFYVE28	0.69	4.77	0.48	8.44e-6	Cognitive ability;Cognitive ability (multi-trait analysis);Intelligence (multi-trait analysis);
SKCM	cis	rs17065868	1.000	rs9645991	chr13:45165813	C/A	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs365132	1.000	rs1700490	chr5:176402401	G/A	cg16309518	chr5:176445507	NA	-0.5	-4.78	-0.48	8.22e-6	Menarche and menopause (age at onset);Menopause (age at onset);
SKCM	cis	rs7666738	0.830	rs921523	chr4:98841659	C/T	cg05340658	chr4:99064831	C4orf37	0.61	4.95	0.49	4.24e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9815354	0.812	rs17216919	chr3:41888938	G/C	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs4808199	0.901	rs11669516	chr19:19532682	G/A	cg03709012	chr19:19516395	GATAD2A	1.14	8.76	0.7	3.13e-13	Nonalcoholic fatty liver disease;
SKCM	cis	rs1577917	0.696	rs2842603	chr6:86336337	G/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.89	-8.67	-0.7	4.78e-13	Response to antipsychotic treatment;
SKCM	cis	rs1538970	0.810	rs12067642	chr1:45927517	G/T	cg05343316	chr1:45956843	TESK2	0.86	4.87	0.48	5.68e-6	Platelet count;
SKCM	cis	rs6570726	0.935	rs585292	chr6:145862228	T/C	cg23711669	chr6:146136114	FBXO30	0.71	6.79	0.61	1.98e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs35146811	0.586	rs12705067	chr7:99594726	T/C	cg22906224	chr7:99728672	NA	0.77	5.54	0.53	3.96e-7	Coronary artery disease;
SKCM	cis	rs9894429	0.646	rs7405870	chr17:79617284	G/A	cg18240062	chr17:79603768	NPLOC4	0.68	5.99	0.56	6.16e-8	Eye color traits;
SKCM	cis	rs4975616	0.839	rs2447853	chr5:1333077	A/G	cg06550200	chr5:1325588	CLPTM1L	-0.84	-7.64	-0.65	4.6e-11	Lung cancer;
SKCM	cis	rs3091242	0.967	rs665372	chr1:25719235	A/C	cg27572855	chr1:25598939	RHD	0.54	5.18	0.51	1.66e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs4481887	1.000	rs4430369	chr1:248464330	A/G	cg00666640	chr1:248458726	OR2T12	0.59	4.78	0.48	7.97e-6	Common traits (Other);
SKCM	cis	rs7772486	0.790	rs1062068	chr6:146207465	A/G	cg05347473	chr6:146136440	FBXO30	0.55	5.22	0.51	1.44e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9911578	0.704	rs72628393	chr17:56585314	A/T	cg05425664	chr17:57184151	TRIM37	0.7	5.31	0.51	1.02e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs13118159	0.505	rs1250128	chr4:1257311	T/C	cg16405210	chr4:1374714	KIAA1530	0.84	6.32	0.58	1.48e-8	Longevity;
SKCM	cis	rs362272	0.505	rs10155132	chr4:3369500	A/G	cg05297308	chr4:3317976	RGS12	1.05	12.84	0.82	6.19e-21	Serum sulfate level;
SKCM	cis	rs4561483	0.801	rs33623	chr16:12007435	A/G	cg08843971	chr16:11963173	GSPT1	0.65	4.92	0.49	4.8e-6	Testicular germ cell tumor;
SKCM	cis	rs854765	0.583	rs62064156	chr17:17822480	C/T	cg09796270	chr17:17721594	SREBF1	0.65	4.87	0.48	5.79e-6	Total body bone mineral density;
SKCM	cis	rs6500395	1.000	rs34844432	chr16:48682418	C/T	cg04672837	chr16:48644449	N4BP1	0.65	5.43	0.52	6.28e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs28386778	0.897	rs9913323	chr17:61851485	C/A	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs6582630	0.502	rs11520276	chr12:38359216	C/T	cg26384229	chr12:38710491	ALG10B	0.81	6.56	0.6	5.29e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs9660180	0.967	rs10907191	chr1:1774820	A/T	cg13866156	chr1:1669148	SLC35E2	-0.71	-5.83	-0.55	1.19e-7	Body mass index;
SKCM	trans	rs10506458	0.834	rs12426860	chr12:63387948	C/T	cg03429785	chr15:59498649	MYO1E;LDHAL6B	-1.39	-7.59	-0.65	5.95e-11	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs4253772	0.744	rs9627278	chr22:46643432	C/G	cg03482458	chr22:46692211	CN5H6.4;GTSE1	0.92	4.83	0.48	6.62e-6	LDL cholesterol;Cholesterol, total;
SKCM	trans	rs1814175	0.817	rs10839318	chr11:49657511	G/C	cg03929089	chr4:120376271	NA	-0.9	-8.24	-0.68	3.23e-12	Height;
SKCM	cis	rs6570726	0.935	rs110289	chr6:145865176	C/G	cg23711669	chr6:146136114	FBXO30	0.72	6.88	0.61	1.35e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs854765	0.547	rs4584886	chr17:17896205	C/T	cg04398451	chr17:18023971	MYO15A	-0.93	-7.53	-0.65	7.55e-11	Total body bone mineral density;
SKCM	cis	rs9475752	0.793	rs13214032	chr6:56823101	G/C	cg06815302	chr6:57335405	PRIM2	0.69	4.97	0.49	3.92e-6	Menarche (age at onset);
SKCM	cis	rs908922	0.676	rs4845788	chr1:152519496	T/C	cg09873164	chr1:152488093	CRCT1	0.77	6.02	0.56	5.44e-8	Hair morphology;
SKCM	cis	rs9325144	0.555	rs1825806	chr12:38692547	G/A	cg13010199	chr12:38710504	ALG10B	0.63	5.01	0.49	3.31e-6	Morning vs. evening chronotype;
SKCM	cis	rs9290065	0.558	rs9846254	chr3:160770370	C/T	cg03342759	chr3:160939853	NMD3	-0.72	-6.15	-0.57	3.11e-8	Kawasaki disease;
SKCM	cis	rs3820928	0.933	rs1429267	chr2:227767593	G/C	cg11843606	chr2:227700838	RHBDD1	-0.6	-4.8	-0.48	7.53e-6	Pulmonary function;
SKCM	cis	rs11249608	0.789	rs903989	chr5:178434434	C/T	cg21905437	chr5:178450457	ZNF879	0.7	5.38	0.52	7.46e-7	Pubertal anthropometrics;
SKCM	cis	rs2204008	0.837	rs10876019	chr12:37985477	C/T	cg26384229	chr12:38710491	ALG10B	0.8	6.2	0.57	2.47e-8	Bladder cancer;
SKCM	cis	rs7296418	0.738	rs10846489	chr12:123743927	A/G	cg05973401	chr12:123451056	ABCB9	-0.76	-5.89	-0.55	9.39e-8	Platelet count;
SKCM	cis	rs4523957	0.690	rs28505924	chr17:2088838	G/C	cg16513277	chr17:2031491	SMG6	-0.82	-5.69	-0.54	2.1e-7	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs9420	0.961	rs11229131	chr11:57562525	G/A	cg19752551	chr11:57585705	CTNND1	-0.7	-7.21	-0.63	3.18e-10	Schizophrenia;
SKCM	cis	rs72634258	0.519	rs36040967	chr1:7931804	A/G	cg00042356	chr1:8021962	PARK7	0.84	5.85	0.55	1.11e-7	Inflammatory bowel disease;
SKCM	cis	rs4332037	0.950	rs56403963	chr7:1946130	C/G	cg23422044	chr7:1970798	MAD1L1	-0.96	-6.52	-0.59	6.37e-9	Bipolar disorder;
SKCM	cis	rs2836974	0.568	rs414850	chr21:40543337	A/C	cg17971929	chr21:40555470	PSMG1	0.76	7.16	0.63	3.94e-10	Cognitive function;
SKCM	cis	rs2153535	0.580	rs763376	chr6:8492776	G/A	cg07606381	chr6:8435919	SLC35B3	0.86	6.25	0.58	2.06e-8	Motion sickness;
SKCM	cis	rs7809950	0.954	rs2520241	chr7:107135443	A/G	cg23024343	chr7:107201750	COG5	-0.74	-6.61	-0.6	4.39e-9	Coronary artery disease;
SKCM	cis	rs7605378	0.528	rs812760	chr2:200724372	C/T	cg23649088	chr2:200775458	C2orf69	0.67	5.31	0.52	9.99e-7	Osteoporosis;
SKCM	cis	rs17685	0.775	rs11761172	chr7:75761547	C/T	cg16489192	chr7:75678113	MDH2;STYXL1	-0.57	-5.35	-0.52	8.63e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs798554	0.679	rs2533868	chr7:2886559	G/A	cg19346786	chr7:2764209	NA	-0.65	-6.79	-0.61	1.96e-9	Height;
SKCM	cis	rs2404602	0.716	rs12907805	chr15:76690606	C/T	cg23625390	chr15:77176239	SCAPER	0.59	5.31	0.52	9.87e-7	Blood metabolite levels;
SKCM	trans	rs208520	0.661	rs4710566	chr6:66848538	G/A	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-1.11	-8.48	-0.69	1.11e-12	Exhaled nitric oxide output;
SKCM	cis	rs4819052	0.851	rs2838855	chr21:46680566	C/G	cg19498844	chr21:46707878	POFUT2;LOC642852	-0.9	-7.98	-0.67	1.04e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs4132509	1.000	rs2881275	chr1:243918313	G/C	cg21452805	chr1:244014465	NA	0.83	5.13	0.5	2.07e-6	RR interval (heart rate);
SKCM	cis	rs7103648	0.838	rs2293576	chr11:47434986	A/G	cg20307385	chr11:47447363	PSMC3	-1.03	-8.35	-0.69	1.99e-12	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs1799949	0.602	rs4600503	chr17:41414324	C/G	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.18	-0.57	2.68e-8	Menopause (age at onset);
SKCM	cis	rs6951245	1.000	rs113575110	chr7:1084394	G/A	cg18402987	chr7:1209562	NA	1.14	6.01	0.56	5.68e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7829975	0.514	rs2920991	chr8:8259117	T/A	cg06636001	chr8:8085503	FLJ10661	0.77	6.88	0.61	1.35e-9	Mood instability;
SKCM	cis	rs13118159	0.550	rs28614045	chr4:1374695	C/A	cg20887711	chr4:1340912	KIAA1530	0.93	6.95	0.62	9.67e-10	Longevity;
SKCM	cis	rs9393692	0.577	rs9358914	chr6:26262063	G/T	cg00631329	chr6:26305371	NA	-0.67	-5.0	-0.49	3.51e-6	Educational attainment;
SKCM	cis	rs28386778	0.897	rs1877318	chr17:61819960	G/A	cg06873352	chr17:61820015	STRADA	0.76	6.34	0.58	1.38e-8	Prudent dietary pattern;
SKCM	cis	rs1577917	1.000	rs7747824	chr6:86647106	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.61	-5.31	-0.52	1.02e-6	Response to antipsychotic treatment;
SKCM	cis	rs2404602	0.583	rs3759853	chr15:76587777	C/T	cg22467129	chr15:76604101	ETFA	-0.65	-5.35	-0.52	8.68e-7	Blood metabolite levels;
SKCM	cis	rs17685	0.712	rs10235086	chr7:75833138	G/T	cg01364799	chr7:75623366	TMEM120A	-0.69	-5.89	-0.55	9.23e-8	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs748404	0.697	rs504417	chr15:43554226	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	0.7	5.77	0.55	1.53e-7	Lung cancer;
SKCM	cis	rs9910055	0.762	rs2240226	chr17:42266218	C/T	cg08499158	chr17:42289980	UBTF	-0.85	-7.66	-0.66	4.36e-11	Total body bone mineral density;
SKCM	cis	rs1003719	0.762	rs34273703	chr21:38475019	A/G	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs1018836	0.923	rs10956749	chr8:91621573	G/A	cg16814680	chr8:91681699	NA	-0.62	-4.83	-0.48	6.67e-6	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs12142240	0.698	rs66847432	chr1:46832013	G/A	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs10540	1.000	rs35996687	chr11:458595	G/A	cg03576123	chr11:487126	PTDSS2	-1.59	-8.2	-0.68	3.85e-12	Body mass index;
SKCM	cis	rs4820539	0.902	rs9612237	chr22:23472954	T/C	cg14186256	chr22:23484241	RTDR1	0.85	8.15	0.68	4.78e-12	Bone mineral density;
SKCM	cis	rs116095464	0.558	rs1971229	chr5:268187	A/G	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs870825	0.929	rs72689262	chr4:185590950	C/G	cg04058563	chr4:185651563	MLF1IP	1.09	5.66	0.54	2.4e-7	Blood protein levels;
SKCM	cis	rs28595532	0.920	rs55726697	chr4:119742863	G/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs2354432	1.000	rs11239944	chr1:146691015	C/T	cg25205988	chr1:146714368	CHD1L	1.08	7.79	0.66	2.36e-11	Mitochondrial DNA levels;
SKCM	cis	rs9815354	0.812	rs73071203	chr3:41977464	A/C	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs7829975	0.560	rs6994131	chr8:8550958	G/A	cg06636001	chr8:8085503	FLJ10661	-0.71	-5.23	-0.51	1.39e-6	Mood instability;
SKCM	cis	rs4819052	0.851	rs2877019	chr21:46658647	G/A	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.36	0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs28595532	0.920	rs115797971	chr4:119779620	A/G	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs9543976	0.858	rs9530447	chr13:76166802	G/A	cg01531495	chr13:76123901	UCHL3	0.94	5.3	0.51	1.04e-6	Diabetic retinopathy;
SKCM	cis	rs12477438	0.520	rs11695751	chr2:99708247	A/C	cg14399236	chr2:99771627	LIPT1;TSGA10	1.03	9.35	0.73	2.24e-14	Chronic sinus infection;
SKCM	cis	rs28386778	0.897	rs2236736	chr17:61938248	G/T	cg06873352	chr17:61820015	STRADA	0.75	6.22	0.58	2.35e-8	Prudent dietary pattern;
SKCM	cis	rs5769765	0.908	rs7410318	chr22:50317049	T/C	cg22709217	chr22:50311962	ALG12;CRELD2	-1.01	-6.03	-0.56	5.11e-8	Schizophrenia;
SKCM	cis	rs362296	0.671	rs1006798	chr4:3258373	A/G	cg05297308	chr4:3317976	RGS12	-0.75	-6.12	-0.57	3.58e-8	Parental longevity (mother's age at death);
SKCM	cis	rs875971	0.862	rs2024192	chr7:66041447	G/T	cg18876405	chr7:65276391	NA	-0.61	-6.03	-0.56	5.23e-8	Aortic root size;
SKCM	cis	rs763121	0.889	rs6001209	chr22:39121252	C/T	cg06022373	chr22:39101656	GTPBP1	-0.78	-5.24	-0.51	1.33e-6	Menopause (age at onset);
SKCM	cis	rs7824557	0.606	rs1047950	chr8:11185096	G/C	cg21775007	chr8:11205619	TDH	0.65	5.6	0.54	3.02e-7	Retinal vascular caliber;
SKCM	cis	rs1577917	0.958	rs2084294	chr6:86565943	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.81	-7.82	-0.66	2.07e-11	Response to antipsychotic treatment;
SKCM	cis	rs899997	0.773	rs11072783	chr15:78965966	G/A	cg04896959	chr15:78267971	NA	0.6	5.1	0.5	2.35e-6	Coronary artery disease or large artery stroke;
SKCM	cis	rs826838	1.000	rs7975243	chr12:38849220	C/T	cg26384229	chr12:38710491	ALG10B	1.07	9.83	0.74	2.73e-15	Heart rate;
SKCM	cis	rs365132	0.905	rs10068703	chr5:176377069	T/A	cg16309518	chr5:176445507	NA	-0.52	-4.99	-0.49	3.57e-6	Menarche and menopause (age at onset);Menopause (age at onset);
SKCM	cis	rs912057	0.671	rs1294425	chr6:6744292	G/A	cg06612196	chr6:6737390	NA	0.66	5.47	0.53	5.25e-7	Waist-to-hip ratio adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);
SKCM	cis	rs10256972	0.552	rs2960830	chr7:1200641	T/C	cg16145915	chr7:1198662	ZFAND2A	-0.57	-8.17	-0.68	4.34e-12	Longevity;Endometriosis;
SKCM	cis	rs7772486	0.875	rs2748498	chr6:146319166	C/G	cg23711669	chr6:146136114	FBXO30	0.76	7.07	0.62	5.8e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs3820068	0.581	rs16849152	chr1:15921774	A/C	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs1218582	0.600	rs72702224	chr1:154911689	G/A	cg06221963	chr1:154839813	KCNN3	-0.55	-5.48	-0.53	5.06e-7	Prostate cancer;
SKCM	cis	rs2032447	0.714	rs199734	chr6:25940393	G/C	cg03264133	chr6:25882463	NA	-0.56	-4.86	-0.48	5.96e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs62238980	0.614	rs10483163	chr22:32459451	A/G	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs9475752	0.793	rs17685277	chr6:56823425	A/G	cg06815302	chr6:57335405	PRIM2	0.69	4.97	0.49	3.92e-6	Menarche (age at onset);
SKCM	cis	rs1218582	0.774	rs4845683	chr1:154877407	T/C	cg24250549	chr1:154909240	PMVK	0.82	8.27	0.68	2.82e-12	Prostate cancer;
SKCM	cis	rs7811142	1.000	rs11761725	chr7:100039815	C/T	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.17	7.71	0.66	3.44e-11	Platelet count;
SKCM	cis	rs7027203	0.828	rs7037960	chr9:96584028	G/A	cg14598338	chr9:96623480	NA	-0.51	-5.09	-0.5	2.38e-6	DNA methylation (variation);
SKCM	cis	rs1218582	0.711	rs4845677	chr1:154838050	C/T	cg03351412	chr1:154909251	PMVK	0.75	6.65	0.6	3.64e-9	Prostate cancer;
SKCM	cis	rs17376456	0.877	rs34595581	chr5:93369422	G/A	cg21475434	chr5:93447410	FAM172A	0.95	5.36	0.52	8.36e-7	Diabetic retinopathy;
SKCM	cis	rs9430161	0.579	rs7542164	chr1:11040223	G/A	cg02454025	chr1:11042201	C1orf127	0.96	8.79	0.71	2.74e-13	Ewing sarcoma;
SKCM	cis	rs4803468	1.000	rs2241710	chr19:41912092	G/C	cg09537434	chr19:41945824	ATP5SL	-1.1	-13.82	-0.84	1.16e-22	Height;
SKCM	cis	rs9611565	0.765	rs9607800	chr22:41784562	A/G	cg03806693	chr22:41940476	POLR3H	-0.93	-5.97	-0.56	6.68e-8	Vitiligo;
SKCM	cis	rs7208859	0.623	rs9911997	chr17:29124648	A/G	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs2836974	0.897	rs35391055	chr21:40525516	G/A	cg11644478	chr21:40555479	PSMG1	0.97	10.21	0.76	5.08e-16	Cognitive function;
SKCM	cis	rs8017423	0.967	rs11627429	chr14:90689232	G/A	cg04374321	chr14:90722782	PSMC1	-0.99	-8.87	-0.71	1.93e-13	Mortality in heart failure;
SKCM	cis	rs514406	0.698	rs1672913	chr1:53408326	A/T	cg04310824	chr1:53393297	SCP2	-0.6	-4.9	-0.49	5.01e-6	Monocyte count;
SKCM	cis	rs116095464	1.000	rs10069360	chr5:351615	A/G	cg22857025	chr5:266934	NA	-1.47	-5.15	-0.5	1.9e-6	Breast cancer;
SKCM	cis	rs7772486	0.625	rs9390355	chr6:146112942	C/T	cg23711669	chr6:146136114	FBXO30	-0.85	-9.35	-0.73	2.22e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs453301	0.506	rs686189	chr8:8623637	A/G	cg15556689	chr8:8085844	FLJ10661	-0.66	-6.19	-0.57	2.62e-8	Joint mobility (Beighton score);
SKCM	cis	rs1062177	0.694	rs2915816	chr5:151115857	G/A	cg00977110	chr5:151150581	G3BP1	-0.79	-6.57	-0.6	5.05e-9	Preschool internalizing problems;
SKCM	cis	rs3741404	0.825	rs7111753	chr11:63942189	A/G	cg19465662	chr11:63993652	NUDT22;TRPT1	0.8	5.57	0.53	3.49e-7	Platelet count;
SKCM	cis	rs72781680	1.000	rs72781665	chr2:24223086	G/A	cg08917208	chr2:24149416	ATAD2B	1.03	5.75	0.55	1.64e-7	Lymphocyte counts;
SKCM	cis	rs514406	0.565	rs897732	chr1:53382816	A/C	cg24675658	chr1:53192096	ZYG11B	-0.82	-7.84	-0.66	1.89e-11	Monocyte count;
SKCM	cis	rs3820068	0.581	rs16851851	chr1:15929628	C/G	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs523522	0.926	rs10849766	chr12:121025894	G/A	cg27279351	chr12:120934652	DYNLL1	0.9	7.97	0.67	1.07e-11	High light scatter reticulocyte count;
SKCM	cis	rs9611565	0.659	rs1810460	chr22:41927700	C/T	cg03806693	chr22:41940476	POLR3H	-1.06	-7.49	-0.65	9.18e-11	Vitiligo;
SKCM	cis	rs672059	1.000	rs625917	chr1:183157991	T/G	ch.1.3577855R	chr1:183094577	LAMC1	0.63	5.23	0.51	1.38e-6	Hypertriglyceridemia;
SKCM	cis	rs8017423	0.967	rs7147809	chr14:90715025	A/G	cg04374321	chr14:90722782	PSMC1	0.97	8.97	0.71	1.25e-13	Mortality in heart failure;
SKCM	cis	rs2180341	0.960	rs1964130	chr6:127677391	C/G	cg27446573	chr6:127587934	RNF146	0.92	6.23	0.58	2.19e-8	Breast cancer;
SKCM	cis	rs11098499	0.954	rs4345162	chr4:120312959	G/A	cg24375607	chr4:120327624	NA	0.65	4.97	0.49	3.87e-6	Corneal astigmatism;
SKCM	cis	rs1218582	0.741	rs6656494	chr1:154839799	A/G	cg24250549	chr1:154909240	PMVK	0.89	9.39	0.73	1.86e-14	Prostate cancer;
SKCM	cis	rs9900062	0.921	rs8081799	chr17:62757092	G/C	cg02097616	chr17:62675921	NA	0.72	5.92	0.56	8.01e-8	QT interval;
SKCM	cis	rs28386778	0.897	rs11079510	chr17:61820902	T/C	cg01411255	chr17:61851458	DDX42;CCDC47	0.78	5.03	0.49	3.06e-6	Prudent dietary pattern;
SKCM	cis	rs4862750	0.957	rs2375916	chr4:187903923	A/G	cg10295955	chr4:187884368	NA	-1.03	-12.6	-0.82	1.73e-20	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6598955	0.724	rs12132137	chr1:26631243	C/T	cg04990556	chr1:26633338	UBXN11	-0.59	-4.85	-0.48	6.08e-6	Obesity-related traits;
SKCM	cis	rs11155671	0.530	rs9383912	chr6:150206615	T/C	cg05036130	chr6:150231994	NA	0.6	6.88	0.61	1.35e-9	Testicular germ cell tumor;
SKCM	cis	rs10752881	0.935	rs3935221	chr1:182969010	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.73	6.62	0.6	4.17e-9	Colorectal cancer;
SKCM	cis	rs155076	1.000	rs484365	chr13:21845944	G/T	cg14456004	chr13:21872349	NA	-1.22	-6.76	-0.61	2.24e-9	White matter hyperintensity burden;
SKCM	cis	rs7584330	0.868	rs13408361	chr2:238382899	A/G	cg14458575	chr2:238380390	NA	1.05	6.59	0.6	4.66e-9	Prostate cancer;
SKCM	cis	rs600231	0.651	rs2846862	chr11:65219790	A/G	cg24009118	chr11:65545808	DKFZp761E198	0.69	4.97	0.49	3.87e-6	Bone mineral density;
SKCM	cis	rs2836974	0.568	rs2142111	chr21:40549289	G/C	cg11644478	chr21:40555479	PSMG1	0.8	7.6	0.65	5.6e-11	Cognitive function;
SKCM	cis	rs2033711	0.654	rs734380	chr19:58898963	A/C	cg13877915	chr19:58951672	ZNF132	0.86	7.95	0.67	1.15e-11	Uric acid clearance;
SKCM	cis	rs28386778	0.966	rs2008053	chr17:61954918	G/C	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.17	0.51	1.73e-6	Prudent dietary pattern;
SKCM	cis	rs17376456	0.877	rs9314099	chr5:93447375	T/C	cg21475434	chr5:93447410	FAM172A	0.97	5.42	0.52	6.39e-7	Diabetic retinopathy;
SKCM	cis	rs7843479	0.965	rs11784535	chr8:21857787	G/A	cg17168535	chr8:21777572	XPO7	0.74	5.97	0.56	6.75e-8	Mean corpuscular volume;
SKCM	cis	rs2839186	0.814	rs13052376	chr21:47707403	G/C	cg13126279	chr21:47581558	C21orf56	-0.64	-5.47	-0.53	5.17e-7	Testicular germ cell tumor;
SKCM	cis	rs1005277	0.579	rs2474563	chr10:38375938	T/C	cg00409905	chr10:38381863	ZNF37A	-0.64	-5.96	-0.56	6.77e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs1577917	1.000	rs12196411	chr6:86779762	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.83	-8.15	-0.68	4.73e-12	Response to antipsychotic treatment;
SKCM	cis	rs7100689	0.524	rs7902460	chr10:82199263	T/A	cg01528321	chr10:82214614	TSPAN14	0.73	6.14	0.57	3.26e-8	Post bronchodilator FEV1;
SKCM	cis	rs4253772	0.591	rs6007748	chr22:46657798	A/G	cg03482458	chr22:46692211	CN5H6.4;GTSE1	1.1	5.09	0.5	2.44e-6	LDL cholesterol;Cholesterol, total;
SKCM	cis	rs2153535	0.580	rs915351	chr6:8442793	C/T	cg07606381	chr6:8435919	SLC35B3	0.94	6.94	0.62	1.02e-9	Motion sickness;
SKCM	cis	rs12497850	0.931	rs4974080	chr3:49030828	A/C	cg07636037	chr3:49044803	WDR6	1.03	11.23	0.79	5.76e-18	Parkinson's disease;
SKCM	cis	rs12971120	0.891	rs3794955	chr18:72174827	C/T	cg25817165	chr18:72167213	CNDP2	-0.65	-4.87	-0.48	5.69e-6	Refractive error;
SKCM	cis	rs2730245	0.851	rs2657333	chr7:158728743	G/A	cg24397884	chr7:158709396	WDR60	-1.03	-9.52	-0.73	1.07e-14	Height;
SKCM	cis	rs873946	0.529	rs12258248	chr10:134573767	A/G	cg00988841	chr10:134556463	INPP5A	0.62	4.82	0.48	6.83e-6	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs910316	1.000	rs4903279	chr14:75546583	C/T	cg08847533	chr14:75593920	NEK9	0.95	9.18	0.72	4.88e-14	Height;
SKCM	cis	rs35306767	0.855	rs11253459	chr10:886402	C/T	cg20503657	chr10:835505	NA	0.76	5.17	0.51	1.73e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs1577917	0.958	rs7382798	chr6:86559834	C/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.32	-0.52	9.66e-7	Response to antipsychotic treatment;
SKCM	cis	rs2439831	0.850	rs28504496	chr15:44016883	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.31	7.38	0.64	1.49e-10	Lung cancer in ever smokers;
SKCM	cis	rs2841233	0.718	rs41310934	chr14:105344603	C/T	cg16576083	chr14:105354267	KIAA0284	0.6	4.77	0.48	8.29e-6	IgG glycosylation;
SKCM	cis	rs2180341	1.000	rs9385419	chr6:127597591	A/G	cg24812749	chr6:127587940	RNF146	0.86	7.32	0.64	1.92e-10	Breast cancer;
SKCM	cis	rs1298908	0.639	rs2993763	chr10:82033594	G/A	cg01528321	chr10:82214614	TSPAN14	0.66	6.21	0.58	2.36e-8	Diabetic kidney disease;
SKCM	trans	rs1814175	0.615	rs12417290	chr11:49876951	G/A	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs1005277	0.579	rs2749616	chr10:38510993	A/T	cg00409905	chr10:38381863	ZNF37A	-0.61	-5.26	-0.51	1.2e-6	Extrinsic epigenetic age acceleration;
SKCM	cis	rs28595532	0.920	rs116331303	chr4:119754542	T/C	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs2204008	0.805	rs11522896	chr12:38234427	T/C	cg13010199	chr12:38710504	ALG10B	0.69	4.99	0.49	3.57e-6	Bladder cancer;
SKCM	cis	rs7772486	0.790	rs4075694	chr6:146251108	G/C	cg05347473	chr6:146136440	FBXO30	-0.55	-4.97	-0.49	3.82e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1878931	0.668	rs11643983	chr16:3438865	G/A	cg26668626	chr16:3451006	ZNF174;ZNF434	1.08	10.56	0.77	1.06e-16	Body mass index (adult);
SKCM	cis	rs1801251	1.000	rs2592113	chr2:233669553	C/T	cg08000102	chr2:233561755	GIGYF2	0.85	7.04	0.62	6.74e-10	Coronary artery disease;
SKCM	cis	rs7772486	0.790	rs2265917	chr6:146212285	A/G	cg05347473	chr6:146136440	FBXO30	0.56	5.18	0.51	1.67e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6121246	0.583	rs28815498	chr20:30351560	T/C	cg11595048	chr20:30225325	COX4I2	0.54	4.77	0.48	8.4e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs2836974	0.623	rs7280326	chr21:40700408	A/G	cg11890956	chr21:40555474	PSMG1	-0.82	-7.64	-0.65	4.75e-11	Cognitive function;
SKCM	cis	rs6724607	1.000	rs4853513	chr2:191479455	C/T	cg27211696	chr2:191398769	TMEM194B	-0.81	-6.3	-0.58	1.63e-8	Pulse pressure;
SKCM	cis	rs9549367	0.713	rs3024761	chr13:113824090	C/G	cg00898013	chr13:113819073	PROZ	0.6	5.08	0.5	2.52e-6	Platelet distribution width;
SKCM	cis	rs2180341	0.574	rs13192350	chr6:127677762	G/T	cg27446573	chr6:127587934	RNF146	0.67	5.39	0.52	7.23e-7	Breast cancer;
SKCM	cis	rs10256972	0.684	rs2363279	chr7:1096143	A/G	cg07308232	chr7:1071921	C7orf50	-0.58	-4.86	-0.48	6e-6	Longevity;Endometriosis;
SKCM	cis	rs116095464	0.764	rs10069197	chr5:230822	G/C	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs28595532	0.920	rs116331303	chr4:119754542	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs9910055	0.659	rs7216294	chr17:42251095	T/C	cg09913183	chr17:42254507	C17orf65;ASB16	0.67	6.53	0.59	6.13e-9	Total body bone mineral density;
SKCM	cis	rs8078723	0.714	rs8070444	chr17:38151960	A/G	cg17467752	chr17:38218738	THRA	-0.61	-5.5	-0.53	4.58e-7	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs4423214	1.000	rs4944955	chr11:71167677	C/T	cg05163923	chr11:71159392	DHCR7	0.83	8.06	0.67	7.35e-12	Vitamin D levels;
SKCM	trans	rs561341	0.700	rs2074101	chr17:30228656	G/A	cg20587970	chr11:113659929	NA	-0.95	-7.58	-0.65	6.16e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs9916302	0.851	rs9909064	chr17:37500434	G/T	cg07936489	chr17:37558343	FBXL20	0.85	7.28	0.64	2.26e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs1707322	0.964	rs785516	chr1:46564758	T/G	cg03146154	chr1:46216737	IPP	-0.8	-5.28	-0.51	1.15e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7143963	1.000	rs4906269	chr14:103362017	A/C	cg23020514	chr14:103360112	TRAF3	0.83	8.6	0.7	6.32e-13	Body mass index;
SKCM	cis	rs6580649	0.941	rs1793933	chr12:48396450	G/T	cg05342945	chr12:48394962	COL2A1	-0.75	-5.04	-0.5	2.94e-6	Lung cancer;
SKCM	cis	rs4423214	0.798	rs12224205	chr11:71180992	A/G	cg05163923	chr11:71159392	DHCR7	-0.71	-6.16	-0.57	2.96e-8	Vitamin D levels;
SKCM	cis	rs9818758	0.607	rs9855123	chr3:49229457	C/T	cg00383909	chr3:49044727	WDR6	0.94	5.35	0.52	8.49e-7	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs10876993	0.890	rs1689597	chr12:58051886	G/A	cg18357645	chr12:58087776	OS9	0.61	5.65	0.54	2.52e-7	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs7179456	0.593	rs514049	chr15:59042363	A/C	cg05156742	chr15:59063176	FAM63B	-0.73	-6.02	-0.56	5.39e-8	Asperger disorder;
SKCM	cis	rs7772486	0.875	rs7739418	chr6:146359188	G/A	cg23711669	chr6:146136114	FBXO30	0.78	7.48	0.65	9.35e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4481887	0.708	rs28729425	chr1:248563027	T/C	cg22724847	chr1:248512586	OR14C36	0.58	4.97	0.49	3.94e-6	Common traits (Other);
SKCM	cis	rs17376456	1.000	rs13181660	chr5:93533658	A/G	cg21475434	chr5:93447410	FAM172A	0.98	5.66	0.54	2.4e-7	Diabetic retinopathy;
SKCM	cis	rs10911232	0.507	rs10797833	chr1:183044067	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.78	6.87	0.61	1.42e-9	Hypertriglyceridemia;
SKCM	cis	rs28595532	0.920	rs115259971	chr4:119762654	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs3096299	0.781	rs2965819	chr16:89501030	G/T	cg02187348	chr16:89574699	SPG7	-0.59	-4.95	-0.49	4.13e-6	Multiple myeloma (IgH translocation);
SKCM	cis	rs75920871	0.588	rs3181	chr11:116907043	C/T	cg01368799	chr11:117014884	PAFAH1B2	-0.61	-4.79	-0.48	7.82e-6	Subjective well-being;
SKCM	cis	rs4481887	0.604	rs4642918	chr1:248411057	A/C	cg00666640	chr1:248458726	OR2T12	-0.67	-5.33	-0.52	9.41e-7	Common traits (Other);
SKCM	cis	rs1467026	0.691	rs9985266	chr3:12803162	C/T	cg05775895	chr3:12838266	CAND2	-0.71	-5.46	-0.53	5.56e-7	P wave duration;
SKCM	cis	rs11098499	0.954	rs59866101	chr4:120296591	T/G	cg09307838	chr4:120376055	NA	0.97	7.49	0.65	9.08e-11	Corneal astigmatism;
SKCM	cis	rs2153535	0.580	rs9328488	chr6:8529411	G/C	cg07606381	chr6:8435919	SLC35B3	0.93	6.8	0.61	1.92e-9	Motion sickness;
SKCM	cis	rs13118159	0.550	rs1137789	chr4:1381798	A/G	cg19318889	chr4:1322082	MAEA	0.8	5.84	0.55	1.16e-7	Longevity;
SKCM	cis	rs1298637	0.800	rs41306165	chr1:53933225	T/C	cg09586583	chr1:54755153	SSBP3	0.57	4.82	0.48	6.85e-6	Nicotine use;
SKCM	cis	rs362296	0.698	rs3129319	chr4:3265381	A/G	cg24015175	chr4:3319247	RGS12	-0.56	-5.18	-0.51	1.68e-6	Parental longevity (mother's age at death);
SKCM	cis	rs9815354	0.812	rs35263917	chr3:41952852	T/C	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs941873	0.835	rs10762859	chr10:81103370	T/A	cg09469691	chr10:81107165	PPIF	0.76	7.32	0.64	1.91e-10	Height;
SKCM	cis	rs1153858	1.000	rs2467864	chr15:45641098	C/T	cg10760299	chr15:45669010	GATM	-0.58	-5.75	-0.55	1.63e-7	Homoarginine levels;
SKCM	trans	rs1814175	0.587	rs847628	chr11:49927064	A/T	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs1218582	0.772	rs10796934	chr1:154849479	C/G	cg09359103	chr1:154839909	KCNN3	-0.57	-5.42	-0.52	6.37e-7	Prostate cancer;
SKCM	cis	rs1577917	0.958	rs13213899	chr6:86473140	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.87	-8.66	-0.7	5.01e-13	Response to antipsychotic treatment;
SKCM	cis	rs5750830	0.649	rs5750814	chr22:39797987	T/C	cg24399712	chr22:39784796	NA	-0.61	-5.24	-0.51	1.32e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9916302	0.904	rs6503503	chr17:37514373	G/A	cg07936489	chr17:37558343	FBXL20	0.82	7.18	0.63	3.61e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs10911232	0.507	rs10911231	chr1:183051745	T/A	ch.1.3577855R	chr1:183094577	LAMC1	0.78	6.87	0.61	1.42e-9	Hypertriglyceridemia;
SKCM	cis	rs9916302	0.904	rs634365	chr17:37436966	C/T	cg07936489	chr17:37558343	FBXL20	-0.81	-6.68	-0.6	3.15e-9	Glomerular filtration rate (creatinine);
SKCM	trans	rs5756813	0.661	rs2246503	chr22:38204540	C/A	cg19894588	chr14:64061835	NA	-0.89	-7.5	-0.65	8.56e-11	Optic cup area;Vertical cup-disc ratio;
SKCM	cis	rs2286503	0.752	rs6461669	chr7:22858066	T/G	cg15401507	chr7:22894281	NA	-0.55	-5.07	-0.5	2.58e-6	Fibrinogen;
SKCM	cis	rs7220401	0.512	rs2289629	chr17:27959903	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.76	5.54	0.53	3.88e-7	Coronary artery disease;
SKCM	cis	rs9899728	0.764	rs7219493	chr17:73044188	T/C	cg27626185	chr17:73056755	KCTD2	-0.9	-5.94	-0.56	7.36e-8	Alzheimer's disease or small vessel stroke;
SKCM	cis	rs9399135	0.967	rs952674	chr6:135349157	A/G	cg24558204	chr6:135376177	HBS1L	0.6	5.36	0.52	8.17e-7	Red blood cell count;
SKCM	cis	rs6904897	0.538	rs4639353	chr6:135224328	A/G	cg24558204	chr6:135376177	HBS1L	-0.59	-4.8	-0.48	7.65e-6	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs2120019	0.938	rs2289582	chr15:75310394	T/C	cg17294928	chr15:75287854	SCAMP5	-0.89	-8.26	-0.68	2.98e-12	Blood trace element (Zn levels);
SKCM	cis	rs4523957	0.583	rs1565763	chr17:2055300	T/C	cg16513277	chr17:2031491	SMG6	-0.88	-5.81	-0.55	1.28e-7	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs9674544	0.757	rs11871214	chr17:47124902	G/T	cg11673840	chr17:47092156	IGF2BP1	-0.51	-4.9	-0.49	5.06e-6	Primary tooth development (time to first tooth eruption);Primary tooth development (number of teeth);
SKCM	cis	rs2228479	0.850	rs11644804	chr16:89976224	G/A	cg06558623	chr16:89946397	TCF25	1.09	5.41	0.52	6.7e-7	Skin colour saturation;
SKCM	cis	rs55962025	0.883	rs362273	chr4:3227419	A/G	cg11471262	chr4:3318911	RGS12	-0.64	-4.92	-0.49	4.8e-6	Parental longevity (mother's age at death);
SKCM	trans	rs9929218	0.551	rs3785134	chr16:68728938	C/T	cg04657470	chr2:198365150	HSPE1;HSPD1	0.97	10.05	0.75	1e-15	Colorectal cancer;
SKCM	cis	rs7772486	0.875	rs865913	chr6:146308874	C/T	cg23711669	chr6:146136114	FBXO30	0.76	7.08	0.63	5.66e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2910162	0.646	rs4921296	chr5:159934161	C/T	cg07816439	chr5:159797845	C1QTNF2	-0.49	-5.36	-0.52	8.05e-7	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs950027	0.596	rs2467853	chr15:45698793	T/G	cg10760299	chr15:45669010	GATM	0.57	5.42	0.52	6.44e-7	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs6545883	0.524	rs2463101	chr2:61574422	G/C	cg15711740	chr2:61764176	XPO1	0.66	5.12	0.5	2.17e-6	Tuberculosis;
SKCM	cis	rs763121	0.853	rs5750671	chr22:39094619	A/C	cg06022373	chr22:39101656	GTPBP1	0.85	6.3	0.58	1.65e-8	Menopause (age at onset);
SKCM	cis	rs8060686	0.641	rs12445396	chr16:68155121	G/A	cg04539111	chr16:67997858	SLC12A4	-0.85	-4.81	-0.48	7.14e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs10504073	0.647	rs9643394	chr8:50014427	A/G	cg00325661	chr8:49890786	NA	0.82	7.02	0.62	7.13e-10	Blood metabolite ratios;
SKCM	cis	rs4724125	0.843	rs79562994	chr7:42677764	A/T	cg09407816	chr7:42972088	MRPL32;PSMA2	0.81	4.85	0.48	6.13e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9435341	0.896	rs1730850	chr1:107597988	C/T	cg09367891	chr1:107599246	PRMT6	-0.85	-7.11	-0.63	4.84e-10	Facial morphology (factor 21, depth of nasal alae);
SKCM	cis	rs703842	0.642	rs73123375	chr12:58063664	C/T	cg04478727	chr12:58166393	METTL1;FAM119B	0.71	5.35	0.52	8.67e-7	Multiple sclerosis;
SKCM	cis	rs1707322	0.896	rs809774	chr1:46560244	T/A	cg03146154	chr1:46216737	IPP	-0.79	-5.88	-0.55	9.5e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7824557	0.614	rs2736286	chr8:11227104	A/G	cg21775007	chr8:11205619	TDH	-0.62	-5.61	-0.54	3.02e-7	Retinal vascular caliber;
SKCM	cis	rs9303401	0.659	rs34878689	chr17:56694330	G/A	cg10487724	chr17:56770010	TEX14;RAD51C	0.85	6.03	0.56	5.18e-8	Cognitive test performance;
SKCM	cis	rs10193935	0.901	rs59984817	chr2:42566909	C/G	cg27598129	chr2:42591480	NA	-0.88	-6.71	-0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs34779708	0.966	rs35777088	chr10:35409048	T/C	cg03585969	chr10:35415529	CREM	0.82	6.49	0.59	7.27e-9	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs56104184	0.775	rs55756106	chr19:49403055	A/G	cg19746536	chr19:49375674	PPP1R15A	1.16	5.93	0.56	7.67e-8	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs514406	0.679	rs61768344	chr1:53229274	G/A	cg25767906	chr1:53392781	SCP2	0.61	4.89	0.48	5.25e-6	Monocyte count;
SKCM	cis	rs9815354	0.812	rs73073337	chr3:41837497	T/C	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs2180341	0.960	rs7766942	chr6:127691323	G/T	cg24812749	chr6:127587940	RNF146	0.83	7.18	0.63	3.63e-10	Breast cancer;
SKCM	cis	rs1801251	0.778	rs778338	chr2:233740227	A/G	cg25237894	chr2:233734115	C2orf82	-0.6	-6.46	-0.59	8.3e-9	Coronary artery disease;
SKCM	cis	rs798554	0.679	rs1636250	chr7:2884433	T/C	cg04166393	chr7:2884313	GNA12	0.77	5.23	0.51	1.39e-6	Height;
SKCM	cis	rs7618501	0.521	rs11709573	chr3:49956628	C/T	cg24110177	chr3:50126178	RBM5	-0.71	-5.71	-0.54	1.95e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs11098499	0.863	rs10019674	chr4:120443489	C/T	cg09307838	chr4:120376055	NA	-0.96	-7.55	-0.65	7.08e-11	Corneal astigmatism;
SKCM	cis	rs2836950	0.502	rs2150411	chr21:40574552	G/T	cg11890956	chr21:40555474	PSMG1	-0.65	-5.09	-0.5	2.44e-6	Menarche (age at onset);
SKCM	cis	rs2836974	0.897	rs8133146	chr21:40614298	T/C	cg11890956	chr21:40555474	PSMG1	1.09	13.83	0.84	1.08e-22	Cognitive function;
SKCM	cis	rs11098499	0.865	rs11098513	chr4:120316075	A/G	cg09307838	chr4:120376055	NA	0.99	7.74	0.66	3.04e-11	Corneal astigmatism;
SKCM	cis	rs7221595	0.825	rs12939802	chr17:3933904	C/T	cg23770271	chr17:3704471	ITGAE	-0.51	-4.96	-0.49	4.01e-6	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia;
SKCM	cis	rs1348850	0.914	rs10170546	chr2:178248790	C/T	cg02961200	chr2:178257176	LOC100130691;AGPS	0.94	7.09	0.63	5.29e-10	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs6582630	0.502	rs1607867	chr12:38385463	C/T	cg26384229	chr12:38710491	ALG10B	0.81	6.6	0.6	4.58e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs2072510	0.722	rs763874	chr12:96420213	T/C	cg18817487	chr12:96390143	HAL	0.42	5.43	0.52	6.26e-7	Metabolite levels (small molecules and protein measures);
SKCM	cis	rs870825	0.616	rs72705689	chr4:185639894	A/G	cg04058563	chr4:185651563	MLF1IP	1.08	7.26	0.64	2.51e-10	Blood protein levels;
SKCM	cis	rs3087591	0.708	rs67065748	chr17:29605631	T/A	cg24425628	chr17:29625626	OMG;NF1	0.64	5.08	0.5	2.48e-6	Hip circumference;
SKCM	cis	rs9858542	0.953	rs7646366	chr3:49470668	G/A	cg03060546	chr3:49711283	APEH	-0.75	-5.53	-0.53	4.17e-7	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs36051895	0.659	rs7046511	chr9:5045695	C/T	cg02405213	chr9:5042618	JAK2	-0.65	-5.2	-0.51	1.57e-6	Pediatric autoimmune diseases;
SKCM	cis	rs3096299	0.583	rs889574	chr16:89386808	A/G	cg07708487	chr16:89387014	ANKRD11	-0.46	-5.06	-0.5	2.72e-6	Multiple myeloma (IgH translocation);
SKCM	cis	rs6952808	0.895	rs4513875	chr7:1928159	C/T	cg21782813	chr7:2030301	MAD1L1	0.54	5.43	0.52	6.25e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs8078723	0.901	rs709591	chr17:38175561	T/A	cg17467752	chr17:38218738	THRA	0.69	6.29	0.58	1.67e-8	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs854765	0.647	rs854767	chr17:18018263	A/C	cg24612305	chr17:17875800	TOM1L2;LRRC48	-0.85	-6.8	-0.61	1.85e-9	Total body bone mineral density;
SKCM	cis	rs867186	1.000	rs7268447	chr20:33649593	G/C	cg04194272	chr20:33683537	NA	-1.38	-7.2	-0.63	3.29e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs7599312	0.534	rs10207878	chr2:213409337	A/G	cg16329650	chr2:213403929	ERBB4	0.84	6.04	0.56	4.85e-8	BMI (adjusted for smoking behaviour);BMI in non-smokers;Body mass index;Body mass index (joint analysis main effects and smoking interaction);
SKCM	cis	rs769267	0.896	rs7253807	chr19:19631444	A/T	cg26732615	chr19:19648335	CILP2;YJEFN3	0.67	7.06	0.62	6e-10	Tonsillectomy;
SKCM	cis	rs4631830	0.720	rs12763717	chr10:51500874	C/G	cg16070123	chr10:51489643	NA	0.51	4.8	0.48	7.52e-6	Prostate-specific antigen levels;
SKCM	cis	rs7659604	0.676	rs7691955	chr4:122700462	A/T	cg19671926	chr4:122722719	EXOSC9	-0.66	-4.85	-0.48	6.08e-6	Type 2 diabetes;
SKCM	cis	rs6519955	0.866	rs9626920	chr22:46428993	A/G	cg05468064	chr22:46423449	NA	-0.46	-5.44	-0.52	5.99e-7	Dupuytren's disease;
SKCM	cis	rs6121246	0.559	rs6060599	chr20:30257754	T/G	cg13852791	chr20:30311386	BCL2L1	0.83	5.76	0.55	1.61e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs7772486	0.692	rs1577916	chr6:146069789	G/A	cg23711669	chr6:146136114	FBXO30	-0.89	-10.12	-0.75	7.58e-16	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9902453	0.874	rs3936006	chr17:28257660	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.8	6.3	0.58	1.61e-8	Coffee consumption (cups per day);
SKCM	cis	rs763014	1.000	rs2269558	chr16:682250	C/T	cg00908189	chr16:619842	PIGQ	0.87	7.76	0.66	2.78e-11	Height;
SKCM	cis	rs155076	1.000	rs58519241	chr13:21845006	C/A	cg14456004	chr13:21872349	NA	-1.22	-6.76	-0.61	2.24e-9	White matter hyperintensity burden;
SKCM	cis	rs12478296	0.786	rs6721704	chr2:242994923	A/G	cg06360820	chr2:242988706	NA	-1.01	-6.11	-0.57	3.7e-8	Obesity-related traits;
SKCM	cis	rs9911578	1.000	rs9807057	chr17:56889952	A/C	cg12560992	chr17:57184187	TRIM37	0.95	7.69	0.66	3.7e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs36093844	0.752	rs77197861	chr11:85547405	C/T	cg25872744	chr11:85566296	CCDC83	-0.85	-4.77	-0.48	8.27e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs28595532	0.920	rs56342843	chr4:119765070	G/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	trans	rs1814175	0.645	rs1963215	chr11:49931486	G/A	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs769267	0.864	rs7245983	chr19:19657632	A/C	cg03709012	chr19:19516395	GATAD2A	0.87	8.05	0.67	7.53e-12	Tonsillectomy;
SKCM	cis	rs9814567	1.000	rs13322305	chr3:134310791	G/A	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs611744	0.647	rs1457211	chr8:109261318	C/T	cg18478394	chr8:109455254	TTC35	-0.7	-5.6	-0.54	3.05e-7	Dupuytren's disease;
SKCM	trans	rs3780486	0.846	rs10113903	chr9:33122645	C/G	cg20290983	chr6:43655470	MRPS18A	-1.0	-10.78	-0.77	4.13e-17	IgG glycosylation;
SKCM	cis	rs684232	0.666	rs423887	chr17:593600	A/G	cg12384639	chr17:618140	VPS53	0.73	5.41	0.52	6.83e-7	Prostate cancer;
SKCM	cis	rs2033711	0.905	rs1077420	chr19:58968875	A/C	cg12042659	chr19:58951599	ZNF132	0.69	6.01	0.56	5.55e-8	Uric acid clearance;
SKCM	cis	rs9633740	1.000	rs1902660	chr10:82263683	G/C	cg01528321	chr10:82214614	TSPAN14	0.89	6.67	0.6	3.28e-9	Post bronchodilator FEV1;
SKCM	cis	rs9596863	1.000	rs1155438	chr13:54460544	G/T	ch.13.53330881F	chr13:54432880	NA	-0.83	-5.04	-0.5	2.98e-6	Epilepsy and lamotrigine-induced maculopapular eruptions;
SKCM	cis	rs2842992	0.830	rs2273819	chr6:160183325	G/C	cg16489826	chr6:160211363	TCP1;MRPL18	0.73	5.35	0.52	8.53e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs7666738	0.830	rs4699590	chr4:98974030	A/C	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs55962025	0.686	rs2237007	chr4:3235450	T/C	cg00764545	chr4:3318001	RGS12	-0.62	-5.4	-0.52	7.08e-7	Parental longevity (mother's age at death);
SKCM	cis	rs9913156	0.748	rs7219787	chr17:4562257	A/T	cg19197139	chr17:4613644	ARRB2	0.79	5.28	0.51	1.14e-6	Lymphocyte counts;
SKCM	cis	rs514406	0.729	rs534070	chr1:53308858	T/G	cg16325326	chr1:53192061	ZYG11B	0.68	5.82	0.55	1.26e-7	Monocyte count;
SKCM	cis	rs2839186	0.934	rs2839194	chr21:47699437	T/G	cg13126279	chr21:47581558	C21orf56	-0.62	-5.25	-0.51	1.29e-6	Testicular germ cell tumor;
SKCM	cis	rs4819052	0.807	rs1075788	chr21:46666564	T/G	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.36	0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs9910055	0.530	rs8072954	chr17:42294722	G/A	cg09913183	chr17:42254507	C17orf65;ASB16	0.6	5.25	0.51	1.3e-6	Total body bone mineral density;
SKCM	cis	rs9814567	0.896	rs7653807	chr3:134345724	T/C	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.65	-5.25	-0.51	1.26e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs2072499	1.000	rs2241107	chr1:156182710	C/T	cg25208724	chr1:156163844	SLC25A44	-0.95	-8.89	-0.71	1.79e-13	Testicular germ cell tumor;
SKCM	cis	rs13118159	0.573	rs4974618	chr4:1373663	C/T	cg16405210	chr4:1374714	KIAA1530	-0.9	-6.82	-0.61	1.71e-9	Longevity;
SKCM	cis	rs11105298	0.891	rs10858871	chr12:89871613	G/A	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.91	-6.01	-0.56	5.69e-8	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs16940212	0.618	rs1444942	chr15:58685813	G/C	cg16767221	chr15:57769667	CGNL1	-0.58	-4.87	-0.48	5.69e-6	HDL cholesterol levels;HDL cholesterol;
SKCM	cis	rs7208859	0.623	rs9899268	chr17:29150255	T/C	cg14067834	chr17:29058358	SUZ12P	1.0	5.15	0.5	1.88e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs9290877	0.667	rs7356022	chr3:188459669	C/T	cg17392043	chr3:188495102	LPP	-0.64	-4.93	-0.49	4.6e-6	IgE levels;
SKCM	cis	rs1707322	0.752	rs11211145	chr1:46108491	A/C	cg03146154	chr1:46216737	IPP	0.79	5.42	0.52	6.34e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs17376456	0.877	rs10055340	chr5:93317644	T/C	cg21475434	chr5:93447410	FAM172A	1.04	5.55	0.53	3.82e-7	Diabetic retinopathy;
SKCM	cis	rs10779751	0.881	rs2744815	chr1:11360957	C/T	cg08854313	chr1:11322531	MTOR	0.87	7.14	0.63	4.17e-10	Body mass index;
SKCM	cis	rs7659604	0.539	rs3217771	chr4:122739483	G/A	cg19748678	chr4:122722346	EXOSC9	0.65	5.4	0.52	7.02e-7	Type 2 diabetes;
SKCM	cis	rs2841233	0.718	rs2304755	chr14:105344568	C/T	cg16576083	chr14:105354267	KIAA0284	0.6	4.77	0.48	8.29e-6	IgG glycosylation;
SKCM	cis	rs762407	0.560	rs2018381	chr21:45180053	T/G	cg01224657	chr21:45787795	TRPM2	0.52	5.09	0.5	2.46e-6	Systolic blood pressure change trajectories;
SKCM	cis	rs394563	0.591	rs237035	chr6:149710848	C/T	cg03678062	chr6:149772716	ZC3H12D	-0.51	-6.06	-0.57	4.44e-8	Dupuytren's disease;
SKCM	cis	rs910316	1.000	rs876403	chr14:75602834	A/T	cg11812906	chr14:75593930	NEK9	0.72	5.45	0.53	5.7e-7	Height;
SKCM	cis	rs17376456	0.825	rs10064368	chr5:93266396	C/A	cg21475434	chr5:93447410	FAM172A	1.02	5.17	0.51	1.74e-6	Diabetic retinopathy;
SKCM	cis	rs2836974	0.897	rs35386515	chr21:40532047	C/T	cg17971929	chr21:40555470	PSMG1	0.87	8.48	0.69	1.1e-12	Cognitive function;
SKCM	cis	rs826838	1.000	rs1719830	chr12:39096992	T/G	cg13010199	chr12:38710504	ALG10B	-0.77	-5.95	-0.56	7.09e-8	Heart rate;
SKCM	cis	rs9581857	0.579	rs118061689	chr13:27974499	A/T	cg22138327	chr13:27999177	GTF3A	0.97	5.85	0.55	1.07e-7	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs2836974	0.897	rs34035316	chr21:40594023	T/C	cg17971929	chr21:40555470	PSMG1	0.9	8.81	0.71	2.52e-13	Cognitive function;
SKCM	cis	rs10905065	0.895	rs1567707	chr10:5853817	G/C	cg09234995	chr10:5726438	C10orf18	0.65	5.54	0.53	4.02e-7	Menopause (age at onset);
SKCM	cis	rs875971	0.545	rs1547529	chr7:65723846	T/C	cg18876405	chr7:65276391	NA	0.65	5.28	0.51	1.15e-6	Aortic root size;
SKCM	cis	rs801193	0.844	rs7779971	chr7:66161790	T/C	cg11764359	chr7:65958608	NA	0.86	6.6	0.6	4.52e-9	Aortic root size;
SKCM	cis	rs7618501	0.521	rs3733134	chr3:49939503	C/T	cg24110177	chr3:50126178	RBM5	-0.77	-5.85	-0.55	1.11e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7647973	0.516	rs4308307	chr3:49193216	C/T	cg06212747	chr3:49208901	KLHDC8B	0.8	5.71	0.54	1.96e-7	Menarche (age at onset);
SKCM	cis	rs2839186	0.900	rs56840278	chr21:47708933	T/G	cg13012494	chr21:47604986	C21orf56	0.67	5.71	0.54	1.95e-7	Testicular germ cell tumor;
SKCM	cis	rs6424115	0.867	rs34902309	chr1:24192200	A/G	cg10978503	chr1:24200527	CNR2	-0.41	-4.95	-0.49	4.12e-6	Immature fraction of reticulocytes;
SKCM	cis	rs9902453	0.904	rs9897794	chr17:28296327	A/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.94	0.56	7.46e-8	Coffee consumption (cups per day);
SKCM	cis	rs6951245	1.000	rs28399710	chr7:1070631	G/T	cg24642844	chr7:1081250	C7orf50	-0.95	-6.4	-0.59	1.06e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs4984778	0.717	rs2738892	chr16:1268758	A/G	cg07748719	chr16:1272498	TPSG1	0.66	6.49	0.59	7.34e-9	Blood protein levels;
SKCM	cis	rs1707322	1.000	rs6676982	chr1:46275401	A/T	cg03146154	chr1:46216737	IPP	0.75	5.15	0.5	1.94e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs9549367	0.529	rs55946737	chr13:113810014	A/G	cg18105134	chr13:113819100	PROZ	-0.77	-5.47	-0.53	5.16e-7	Platelet distribution width;
SKCM	cis	rs137603	0.562	rs137644	chr22:39728139	A/G	cg17798944	chr22:39715225	SNORD43;RPL3	-0.64	-5.54	-0.53	3.91e-7	Primary biliary cholangitis;
SKCM	cis	rs79839061	0.610	rs73207794	chr4:872020	T/C	cg07828340	chr4:882639	GAK	1.06	5.15	0.5	1.94e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs12926788	0.542	rs6497759	chr16:24801737	G/A	cg04756594	chr16:24857601	SLC5A11	0.72	5.19	0.51	1.65e-6	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs16854884	0.657	rs62268458	chr3:143736219	T/C	cg06585982	chr3:143692056	C3orf58	0.83	7.55	0.65	6.97e-11	Economic and political preferences (feminism/equality);
SKCM	trans	rs1814175	0.904	rs1846289	chr11:49620253	G/A	cg03929089	chr4:120376271	NA	-0.87	-7.53	-0.65	7.64e-11	Height;
SKCM	cis	rs10781543	0.776	rs11145760	chr9:139382594	G/A	cg14169450	chr9:139327907	INPP5E	0.51	5.51	0.53	4.45e-7	Monocyte percentage of white cells;
SKCM	trans	rs3780486	0.522	rs10217770	chr9:33146393	C/A	cg04842962	chr6:43655489	MRPS18A	0.85	8.18	0.68	4.23e-12	IgG glycosylation;
SKCM	cis	rs6430585	0.640	rs6716070	chr2:136544651	G/T	cg07169764	chr2:136633963	MCM6	-1.31	-13.14	-0.83	1.86e-21	Corneal structure;
SKCM	cis	rs6598955	1.000	rs6598955	chr1:26619649	C/T	cg04990556	chr1:26633338	UBXN11	0.66	5.6	0.54	3.07e-7	Obesity-related traits;
SKCM	cis	rs1577917	0.958	rs114467802	chr6:86572350	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.32	-0.52	9.66e-7	Response to antipsychotic treatment;
SKCM	cis	rs28595532	0.920	rs114963870	chr4:119758099	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs2197308	0.626	rs6581156	chr12:37858731	C/A	cg26384229	chr12:38710491	ALG10B	-0.79	-6.53	-0.59	6.17e-9	Morning vs. evening chronotype;
SKCM	cis	rs12142240	0.659	rs67547686	chr1:46832229	G/C	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs9325144	0.602	rs10785590	chr12:38694145	C/T	cg26384229	chr12:38710491	ALG10B	0.78	6.74	0.61	2.48e-9	Morning vs. evening chronotype;
SKCM	cis	rs9902453	1.000	rs59274738	chr17:28437635	C/A	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.5	0.53	4.67e-7	Coffee consumption (cups per day);
SKCM	cis	rs867186	0.920	rs6060242	chr20:33698016	T/G	cg04194272	chr20:33683537	NA	-1.14	-6.37	-0.58	1.22e-8	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs10883723	0.810	rs10748824	chr10:104274466	T/C	cg11453585	chr10:104263688	ACTR1A;SUFU	0.77	6.31	0.58	1.56e-8	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs28595532	0.841	rs114976553	chr4:119496056	A/G	cg11846333	chr4:119757529	SEC24D	1.15	6.24	0.58	2.13e-8	Cannabis dependence symptom count;
SKCM	cis	rs10779751	1.000	rs4845982	chr1:11271576	T/C	cg08854313	chr1:11322531	MTOR	0.87	6.5	0.59	6.88e-9	Body mass index;
SKCM	cis	rs875971	0.862	rs801203	chr7:66023012	A/G	cg11764359	chr7:65958608	NA	-0.75	-6.8	-0.61	1.88e-9	Aortic root size;
SKCM	cis	rs6489882	0.807	rs61266553	chr12:113371977	A/G	cg07232103	chr12:112566177	TRAFD1	0.61	4.93	0.49	4.58e-6	Chronic lymphocytic leukemia;
SKCM	cis	rs12142240	0.698	rs6696777	chr1:46810970	A/G	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs798766	1.000	rs2236786	chr4:1719294	T/C	cg24239225	chr4:1659016	FAM53A	0.68	4.82	0.48	6.98e-6	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs1153858	1.000	rs7169818	chr15:45640191	G/A	cg10760299	chr15:45669010	GATM	0.57	5.62	0.54	2.81e-7	Homoarginine levels;
SKCM	cis	rs2841277	0.645	rs28380382	chr14:105410827	C/T	cg21017887	chr14:105400489	NA	0.58	5.28	0.51	1.13e-6	Rheumatoid arthritis;
SKCM	cis	rs11098499	0.874	rs6832670	chr4:120118792	A/G	cg09307838	chr4:120376055	NA	0.84	5.94	0.56	7.49e-8	Corneal astigmatism;
SKCM	cis	rs9640161	0.659	rs17837498	chr7:150009679	A/G	cg27494647	chr7:150038898	RARRES2	0.55	4.9	0.49	5.02e-6	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs910316	0.935	rs175448	chr14:75591071	G/A	cg08847533	chr14:75593920	NEK9	-0.96	-8.88	-0.71	1.88e-13	Height;
SKCM	cis	rs10911232	0.507	rs4652767	chr1:183002483	G/C	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.64	0.6	3.83e-9	Hypertriglyceridemia;
SKCM	cis	rs56235845	0.694	rs6875461	chr5:176754665	C/T	cg17509989	chr5:176798049	RGS14	-0.69	-5.89	-0.56	9.09e-8	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs1403694	0.695	rs11919484	chr3:186432839	G/T	cg09332604	chr3:186435400	KNG1	-0.49	-4.85	-0.48	6.09e-6	Blood protein levels;
SKCM	cis	rs9311474	0.508	rs11720159	chr3:52617802	T/G	cg18404041	chr3:52824283	ITIH1	-0.53	-4.77	-0.48	8.42e-6	Electroencephalogram traits;
SKCM	cis	rs10504229	1.000	rs112284078	chr8:58191640	A/G	cg02725872	chr8:58115012	NA	-0.5	-4.87	-0.48	5.68e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs2832191	0.791	rs2251517	chr21:30531951	T/G	cg24692254	chr21:30365293	RNF160	0.92	8.16	0.68	4.6e-12	Dental caries;
SKCM	cis	rs9790314	0.846	rs9815222	chr3:160994897	C/T	cg03342759	chr3:160939853	NMD3	-0.72	-8.12	-0.68	5.59e-12	Morning vs. evening chronotype;
SKCM	cis	rs2204008	0.807	rs11182461	chr12:38539288	T/C	cg26384229	chr12:38710491	ALG10B	0.82	6.52	0.59	6.32e-9	Bladder cancer;
SKCM	cis	rs6500602	0.964	rs13335685	chr16:4469284	T/C	cg09069446	chr16:4462122	CORO7	-0.46	-4.8	-0.48	7.56e-6	Schizophrenia;
SKCM	cis	rs9682041	0.877	rs12489967	chr3:170073339	A/C	cg11886554	chr3:170076028	SKIL	0.91	5.37	0.52	7.79e-7	Glomerular filtration rate in non diabetics (creatinine);Glomerular filtration rate (creatinine);
SKCM	cis	rs2952156	0.920	rs12150298	chr17:37834541	T/C	cg00129232	chr17:37814104	STARD3	-0.74	-6.39	-0.59	1.11e-8	Asthma;
SKCM	cis	rs10752881	0.967	rs4652757	chr1:182974750	T/A	ch.1.3577855R	chr1:183094577	LAMC1	0.74	6.71	0.6	2.83e-9	Colorectal cancer;
SKCM	cis	rs1577917	1.000	rs1415753	chr6:86753074	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.83	-8.14	-0.68	5.09e-12	Response to antipsychotic treatment;
SKCM	cis	rs514406	0.698	rs511599	chr1:53362818	T/C	cg08859206	chr1:53392774	SCP2	-0.63	-5.32	-0.52	9.59e-7	Monocyte count;
SKCM	cis	rs2075371	0.863	rs2075370	chr7:133967812	A/G	cg20476274	chr7:133979776	SLC35B4	1.03	10.89	0.78	2.52e-17	Mean platelet volume;
SKCM	cis	rs3768617	0.510	rs4651145	chr1:183098900	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs6558174	0.630	rs6558176	chr8:22522502	C/T	cg03733263	chr8:22462867	KIAA1967	-0.76	-5.47	-0.53	5.3e-7	Breast cancer;
SKCM	cis	rs4332037	0.722	rs4719331	chr7:1914679	A/C	cg23422044	chr7:1970798	MAD1L1	-0.95	-6.54	-0.6	5.79e-9	Bipolar disorder;
SKCM	cis	rs854765	0.547	rs9912096	chr17:17896673	A/C	cg04398451	chr17:18023971	MYO15A	-0.87	-6.78	-0.61	2.05e-9	Total body bone mineral density;
SKCM	trans	rs208520	0.690	rs1318604	chr6:66825278	A/C	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-1.09	-8.61	-0.7	6.3e-13	Exhaled nitric oxide output;
SKCM	cis	rs35306767	0.903	rs34270014	chr10:904666	T/C	cg20503657	chr10:835505	NA	0.76	5.14	0.5	1.99e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs12971120	0.891	rs3794953	chr18:72180519	C/T	cg26446133	chr18:72167187	CNDP2	-0.68	-5.34	-0.52	8.81e-7	Refractive error;
SKCM	cis	rs2153535	0.601	rs2327059	chr6:8447071	A/G	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs2811415	0.597	rs12695504	chr3:127791388	C/G	cg09089421	chr3:127803668	RUVBL1	1.0	8.69	0.7	4.4e-13	Lung function (FEV1/FVC);
SKCM	cis	rs561341	0.941	rs550213	chr17:30317518	C/G	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs11112613	0.775	rs7959699	chr12:105959848	C/A	cg03607813	chr12:105948248	NA	0.88	5.98	0.56	6.31e-8	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;
SKCM	cis	rs75229567	0.618	rs1882194	chr12:70215086	C/G	cg10114359	chr12:70132523	RAB3IP	-1.17	-5.33	-0.52	9.41e-7	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes;
SKCM	cis	rs7666738	0.830	rs6532721	chr4:99048015	G/A	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10883723	0.668	rs12414407	chr10:104387019	A/G	cg11453585	chr10:104263688	ACTR1A;SUFU	-0.81	-6.87	-0.61	1.42e-9	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs34779708	0.966	rs4934537	chr10:35441512	C/T	cg03585969	chr10:35415529	CREM	0.72	5.89	0.56	9.14e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs72781680	0.898	rs12619525	chr2:23999565	G/C	cg08917208	chr2:24149416	ATAD2B	0.92	4.85	0.48	6.19e-6	Lymphocyte counts;
SKCM	cis	rs3845702	0.736	rs12693214	chr2:180825685	G/A	cg01881094	chr2:180872142	CWC22	-1.3	-6.15	-0.57	3.07e-8	Schizophrenia;
SKCM	cis	rs6840360	0.809	rs6846809	chr4:152730201	A/G	cg22705602	chr4:152727874	NA	0.44	5.07	0.5	2.62e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs4819052	1.000	rs733738	chr21:46666396	A/G	cg19498844	chr21:46707878	POFUT2;LOC642852	-0.87	-6.57	-0.6	5.12e-9	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs9911578	0.967	rs6503883	chr17:56917543	C/T	cg05425664	chr17:57184151	TRIM37	-0.67	-5.04	-0.5	2.91e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs10883723	0.810	rs2296586	chr10:104245575	C/T	cg11453585	chr10:104263688	ACTR1A;SUFU	0.73	5.55	0.53	3.82e-7	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs4481887	0.741	rs28468416	chr1:248564451	G/T	cg00666640	chr1:248458726	OR2T12	0.51	5.23	0.51	1.37e-6	Common traits (Other);
SKCM	cis	rs7539542	0.516	rs10732291	chr1:202891168	G/A	cg19681188	chr1:202830198	LOC148709	0.7	5.12	0.5	2.12e-6	Mean platelet volume;
SKCM	cis	rs992157	0.804	rs7559525	chr2:219150307	A/G	cg00012203	chr2:219082015	ARPC2	-0.72	-5.71	-0.54	1.99e-7	Colorectal cancer;
SKCM	cis	rs6424115	1.000	rs6424115	chr1:24153231	A/G	cg15997130	chr1:24165203	NA	-0.62	-5.42	-0.52	6.33e-7	Immature fraction of reticulocytes;
SKCM	cis	rs10504229	0.906	rs113823909	chr8:58170635	A/G	cg22535103	chr8:58192502	C8orf71	-0.75	-5.2	-0.51	1.58e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs854765	0.624	rs9899634	chr17:17727943	A/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	-0.87	-6.84	-0.61	1.59e-9	Total body bone mineral density;
SKCM	cis	rs867186	1.000	rs78202808	chr20:33667424	T/C	cg04194272	chr20:33683537	NA	-1.38	-7.2	-0.63	3.29e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs1577917	1.000	rs2812972	chr6:86669880	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.77	-0.66	2.59e-11	Response to antipsychotic treatment;
SKCM	cis	rs35146811	0.538	rs3823642	chr7:99796072	T/C	cg22906224	chr7:99728672	NA	0.65	5.19	0.51	1.6e-6	Coronary artery disease;
SKCM	cis	rs155076	1.000	rs2478824	chr13:21844144	G/C	cg14456004	chr13:21872349	NA	-1.22	-6.76	-0.61	2.24e-9	White matter hyperintensity burden;
SKCM	cis	rs2228479	0.867	rs57492102	chr16:89975572	A/G	cg00800038	chr16:89945340	TCF25	-0.96	-5.55	-0.53	3.79e-7	Skin colour saturation;
SKCM	cis	rs1577917	1.000	rs6454513	chr6:86720049	C/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.62	5.32	0.52	9.55e-7	Response to antipsychotic treatment;
SKCM	cis	rs2836974	0.590	rs9974757	chr21:40617244	T/C	cg17971929	chr21:40555470	PSMG1	-0.76	-7.16	-0.63	3.94e-10	Cognitive function;
SKCM	cis	rs13126513	0.708	rs4368610	chr4:100453746	G/T	cg05468953	chr4:100565104	NA	0.5	5.03	0.49	3.11e-6	Metabolite levels (MHPG);
SKCM	cis	rs28386778	0.897	rs2854213	chr17:61945631	T/C	cg06873352	chr17:61820015	STRADA	0.74	6.15	0.57	3.13e-8	Prudent dietary pattern;
SKCM	cis	rs2180341	1.000	rs6569480	chr6:127621748	A/G	cg24812749	chr6:127587940	RNF146	0.88	7.18	0.63	3.53e-10	Breast cancer;
SKCM	cis	rs62238980	0.614	rs116903413	chr22:32398342	C/T	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs1218582	0.688	rs2135219	chr1:154857217	G/A	cg09359103	chr1:154839909	KCNN3	-0.58	-5.33	-0.52	9.12e-7	Prostate cancer;
SKCM	cis	rs208520	0.661	rs6937856	chr6:66867468	A/G	cg07460842	chr6:66804631	NA	-1.02	-7.16	-0.63	3.84e-10	Exhaled nitric oxide output;
SKCM	cis	rs2832191	0.791	rs2832181	chr21:30481371	G/T	cg08807101	chr21:30365312	RNF160	-0.62	-4.94	-0.49	4.34e-6	Dental caries;
SKCM	cis	rs7927771	0.524	rs7124396	chr11:47787434	T/G	cg20307385	chr11:47447363	PSMC3	-0.72	-5.81	-0.55	1.31e-7	Subjective well-being;
SKCM	cis	rs7811142	1.000	rs7794485	chr7:100068936	T/C	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.17	7.71	0.66	3.44e-11	Platelet count;
SKCM	cis	rs9287719	0.639	rs2357650	chr2:10696877	C/T	cg01299579	chr2:10830716	NOL10	-0.51	-4.84	-0.48	6.48e-6	Prostate cancer;
SKCM	cis	rs4774899	1.000	rs12910094	chr15:57432559	G/A	cg01857019	chr15:57210107	LOC145783;TCF12	0.53	4.88	0.48	5.43e-6	Urinary tract infection frequency;
SKCM	cis	rs208520	0.690	rs207081	chr6:66773742	A/G	cg07460842	chr6:66804631	NA	-0.91	-6.9	-0.62	1.22e-9	Exhaled nitric oxide output;
SKCM	cis	rs17826219	0.636	rs8080829	chr17:29058730	C/T	cg14067834	chr17:29058358	SUZ12P	1.2	5.77	0.55	1.5e-7	Body mass index;
SKCM	cis	rs72781680	1.000	rs6710426	chr2:24159288	A/G	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	cis	rs3784262	1.000	rs12903551	chr15:58268372	C/T	cg12031962	chr15:58353849	ALDH1A2	-0.51	-6.6	-0.6	4.46e-9	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs9809213	1.000	rs61139766	chr3:72353797	G/A	cg09429735	chr3:71752026	EIF4E3	-0.57	-5.18	-0.51	1.71e-6	Cognitive ability;Cognitive ability (multi-trait analysis);
SKCM	cis	rs35306767	0.903	rs12778891	chr10:950130	T/A	cg25614935	chr10:1084866	C10orf110	0.82	5.39	0.52	7.4e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs763014	0.931	rs7191939	chr16:630089	C/T	cg07343612	chr16:622815	PIGQ	-0.7	-6.0	-0.56	5.84e-8	Height;
SKCM	cis	rs9911578	1.000	rs437732	chr17:56675861	A/C	cg05425664	chr17:57184151	TRIM37	-0.69	-5.21	-0.51	1.52e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs873946	0.648	rs12767126	chr10:134556992	C/T	cg18305652	chr10:134549665	INPP5A	0.59	5.72	0.54	1.88e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs7937682	0.575	rs7950926	chr11:111776437	G/C	cg09085632	chr11:111637200	PPP2R1B	1.09	10.45	0.76	1.7e-16	Primary sclerosing cholangitis;
SKCM	cis	rs1218582	0.772	rs4845693	chr1:154911257	A/G	cg06221963	chr1:154839813	KCNN3	0.54	5.31	0.52	9.9e-7	Prostate cancer;
SKCM	cis	rs2243480	1.000	rs35283677	chr7:65359233	C/T	cg18252515	chr7:66147081	NA	-1.29	-7.41	-0.64	1.3e-10	Diabetic kidney disease;
SKCM	cis	rs3820068	0.603	rs41270279	chr1:15988878	A/G	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs1153858	1.000	rs4627277	chr15:45652768	C/A	cg21132104	chr15:45694354	SPATA5L1	0.93	7.94	0.67	1.22e-11	Homoarginine levels;
SKCM	cis	rs11608355	0.597	rs2304548	chr12:109795166	T/G	cg19025524	chr12:109796872	NA	-0.64	-5.03	-0.49	3.11e-6	Neuroticism;
SKCM	cis	rs3820928	0.839	rs58580037	chr2:227876274	G/T	cg11843606	chr2:227700838	RHBDD1	-0.59	-4.77	-0.47	8.53e-6	Pulmonary function;
SKCM	cis	rs7193541	1.000	rs7193541	chr16:74664743	C/T	cg01733217	chr16:74700730	RFWD3	-0.89	-8.35	-0.69	2.01e-12	Multiple myeloma;
SKCM	cis	rs769267	0.930	rs2304098	chr19:19646272	T/C	cg26732615	chr19:19648335	CILP2;YJEFN3	0.67	7.06	0.62	6e-10	Tonsillectomy;
SKCM	cis	rs7937682	0.889	rs1784786	chr11:111486043	A/G	cg09085632	chr11:111637200	PPP2R1B	0.96	10.12	0.75	7.57e-16	Primary sclerosing cholangitis;
SKCM	cis	rs11098499	0.754	rs2036857	chr4:120249240	T/C	cg09307838	chr4:120376055	NA	0.93	7.56	0.65	6.5500000000000006e-11	Corneal astigmatism;
SKCM	cis	rs2197308	0.765	rs11182964	chr12:37935052	C/T	cg26384229	chr12:38710491	ALG10B	0.81	6.59	0.6	4.69e-9	Morning vs. evening chronotype;
SKCM	cis	rs9420	0.961	rs77993055	chr11:57522840	C/T	cg19752551	chr11:57585705	CTNND1	-0.7	-7.21	-0.63	3.18e-10	Schizophrenia;
SKCM	cis	rs7633770	0.786	rs6808214	chr3:46682746	T/C	cg11219411	chr3:46661640	NA	0.54	4.86	0.48	5.98e-6	Coronary artery disease;
SKCM	cis	rs9902453	0.817	rs4794861	chr17:28183174	A/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.78	5.38	0.52	7.43e-7	Coffee consumption (cups per day);
SKCM	cis	rs6977660	1.000	rs7791038	chr7:19798833	G/A	cg05791153	chr7:19748676	TWISTNB	0.8	5.55	0.53	3.77e-7	Thyroid stimulating hormone;
SKCM	cis	rs600231	0.708	rs2957268	chr11:65245816	A/G	cg24009118	chr11:65545808	DKFZp761E198	0.66	4.94	0.49	4.36e-6	Bone mineral density;
SKCM	cis	rs4523957	0.579	rs4790883	chr17:2087605	T/C	cg16513277	chr17:2031491	SMG6	-0.71	-5.08	-0.5	2.47e-6	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs3091242	0.900	rs35345536	chr1:25766488	A/G	cg02931644	chr1:25747376	RHCE	0.5	4.9	0.48	5.17e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs13278732	0.759	rs28522929	chr8:99064613	C/T	cg16297171	chr8:99017690	MATN2	-0.49	-4.8	-0.48	7.42e-6	Eosinophilic esophagitis (pediatric);
SKCM	cis	rs208520	0.690	rs207114	chr6:66791703	C/T	cg07460842	chr6:66804631	NA	-1.0	-7.77	-0.66	2.68e-11	Exhaled nitric oxide output;
SKCM	cis	rs8077889	0.750	rs4792921	chr17:41930107	T/G	cg26893861	chr17:41843967	DUSP3	1.31	7.65	0.65	4.46e-11	Triglycerides;
SKCM	cis	rs10504073	0.527	rs118032023	chr8:49926296	A/T	cg00325661	chr8:49890786	NA	0.79	7.15	0.63	3.99e-10	Blood metabolite ratios;
SKCM	cis	rs9951698	0.703	rs8088313	chr18:12977206	A/C	cg12848697	chr18:13133368	NA	0.53	4.96	0.49	4.04e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9303401	0.659	rs7216648	chr17:56790858	C/T	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.35	0.52	8.54e-7	Cognitive test performance;
SKCM	cis	rs9311474	0.508	rs11718420	chr3:52611413	T/C	cg18404041	chr3:52824283	ITIH1	-0.53	-4.77	-0.48	8.42e-6	Electroencephalogram traits;
SKCM	cis	rs10206020	0.921	rs9678719	chr2:1549628	A/G	cg01028140	chr2:1542097	TPO	-0.53	-5.06	-0.5	2.74e-6	IgG glycosylation;
SKCM	cis	rs2832191	0.716	rs2297252	chr21:30377104	G/A	cg08807101	chr21:30365312	RNF160	0.76	6.31	0.58	1.54e-8	Dental caries;
SKCM	cis	rs72781680	0.611	rs72781699	chr2:24277709	G/A	cg20701182	chr2:24300061	SF3B14	0.73	5.09	0.5	2.43e-6	Lymphocyte counts;
SKCM	cis	rs60871478	0.947	rs62432862	chr7:807719	G/C	cg05535760	chr7:792225	HEATR2	1.03	8.65	0.7	5.06e-13	Cerebrospinal P-tau181p levels;
SKCM	cis	rs55962025	0.855	rs2024115	chr4:3104568	A/G	cg00764545	chr4:3318001	RGS12	-0.63	-5.04	-0.5	2.98e-6	Parental longevity (mother's age at death);
SKCM	cis	rs8180040	0.932	rs1038394	chr3:47464122	A/G	cg27129171	chr3:47204927	SETD2	0.79	5.79	0.55	1.43e-7	Colorectal cancer;
SKCM	cis	rs3845702	0.736	rs259811	chr2:180787801	C/T	cg01881094	chr2:180872142	CWC22	-1.19	-5.7	-0.54	2.04e-7	Schizophrenia;
SKCM	cis	rs1405130	0.900	rs12997096	chr2:235587988	T/G	cg17841421	chr2:235704848	NA	-0.61	-5.12	-0.5	2.15e-6	Coronary artery disease;
SKCM	cis	rs4523957	0.891	rs216200	chr17:2199846	C/T	cg16513277	chr17:2031491	SMG6	0.66	4.78	0.48	8.03e-6	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs10193935	0.901	rs1044562	chr2:42516884	C/G	cg27598129	chr2:42591480	NA	-0.95	-6.75	-0.61	2.38e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs12780845	1.000	rs56015036	chr10:17226767	T/C	cg07990022	chr10:16570110	NA	-0.62	-4.99	-0.49	3.63e-6	Homocysteine levels;
SKCM	cis	rs742614	0.533	rs2747541	chr20:32418772	G/T	cg06304546	chr20:32448765	NA	-0.73	-5.91	-0.56	8.51e-8	Stearic acid (18:0) levels;
SKCM	cis	rs7178909	0.872	rs17241560	chr15:90429202	T/A	cg19708238	chr15:90437601	AP3S2	0.72	5.22	0.51	1.43e-6	Common traits (Other);
SKCM	cis	rs899997	1.000	rs11629824	chr15:79005524	T/G	cg04896959	chr15:78267971	NA	0.65	6.05	0.57	4.73e-8	Coronary artery disease or large artery stroke;
SKCM	cis	rs690037	0.551	rs690522	chr3:16377067	C/T	cg23474789	chr3:16306055	DPH3;OXNAD1	-0.68	-5.49	-0.53	4.86e-7	Optic nerve measurement (cup-to-disc ratio);Optic nerve measurement (cup area);
SKCM	cis	rs367615	0.660	rs4632850	chr5:108832883	C/G	cg17395555	chr5:108820864	NA	0.74	6.62	0.6	4.21e-9	Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs6952808	0.689	rs1107591	chr7:2041638	G/A	cg21782813	chr7:2030301	MAD1L1	0.57	5.86	0.55	1.04e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs796364	0.951	rs6722092	chr2:201059371	G/T	cg12253985	chr2:200820533	C2orf60;C2orf47	0.96	6.32	0.58	1.5e-8	Schizophrenia;
SKCM	cis	rs919433	0.963	rs2043016	chr2:198146381	C/T	cg04278110	chr2:198063759	ANKRD44	-0.7	-5.27	-0.51	1.17e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs9943753	0.525	rs983307	chr12:109815103	T/G	cg19025524	chr12:109796872	NA	-0.62	-5.66	-0.54	2.39e-7	HDL cholesterol;
SKCM	cis	rs1799949	0.501	rs9675035	chr17:41415016	A/T	cg23758822	chr17:41437982	NA	0.93	7.88	0.67	1.62e-11	Menopause (age at onset);
SKCM	cis	rs2839186	0.588	rs2839140	chr21:47616080	G/A	cg05896524	chr21:47604654	C21orf56	-0.73	-6.14	-0.57	3.26e-8	Testicular germ cell tumor;
SKCM	cis	rs9788333	0.762	rs4441120	chr13:21886863	T/A	cg25811766	chr13:21894605	NA	0.6	5.71	0.54	1.93e-7	Thiazide-induced adverse metabolic effects in hypertensive patients;
SKCM	cis	rs1799949	1.000	rs12950607	chr17:41299928	G/C	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.11	-0.57	3.67e-8	Menopause (age at onset);
SKCM	cis	rs5753618	0.504	rs8138525	chr22:32011929	T/C	cg02404636	chr22:31891804	SFI1	-0.7	-6.19	-0.57	2.63e-8	Colorectal cancer;
SKCM	cis	rs6062302	0.522	rs2236503	chr20:62224595	G/A	cg09650180	chr20:62225654	GMEB2	-0.77	-6.11	-0.57	3.64e-8	Glioblastoma;
SKCM	cis	rs3808502	0.585	rs4549730	chr8:11239078	T/G	cg21775007	chr8:11205619	TDH	-0.57	-4.8	-0.48	7.38e-6	Neuroticism;
SKCM	cis	rs2731664	0.792	rs465670	chr5:176877624	C/T	cg23176889	chr5:176863531	GRK6	-0.54	-5.66	-0.54	2.41e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7937682	0.889	rs578022	chr11:111490552	G/T	cg19812747	chr11:111475976	SIK2	-0.56	-4.93	-0.49	4.55e-6	Primary sclerosing cholangitis;
SKCM	cis	rs9905704	0.647	rs2286299	chr17:57043367	T/G	cg12560992	chr17:57184187	TRIM37	0.75	5.99	0.56	6.06e-8	Testicular germ cell tumor;
SKCM	cis	rs12142240	0.698	rs17361915	chr1:46847321	C/T	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs1218582	0.510	rs2878411	chr1:154823545	C/T	cg24250549	chr1:154909240	PMVK	0.65	5.78	0.55	1.46e-7	Prostate cancer;
SKCM	cis	rs8078723	0.714	rs3785550	chr17:38149727	C/T	cg17467752	chr17:38218738	THRA	-0.61	-5.49	-0.53	4.75e-7	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs950776	0.593	rs588765	chr15:78865425	T/C	cg06917634	chr15:78832804	PSMA4	-0.9	-7.99	-0.67	9.7e-12	Sudden cardiac arrest;
SKCM	cis	rs7666738	0.830	rs880470	chr4:98922522	A/T	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs703842	1.000	rs3782130	chr12:58161898	G/C	cg04478727	chr12:58166393	METTL1;FAM119B	0.72	5.68	0.54	2.19e-7	Multiple sclerosis;
SKCM	cis	rs28595532	0.920	rs55640619	chr4:119761999	C/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs7829975	0.511	rs2948286	chr8:8130160	A/G	cg06636001	chr8:8085503	FLJ10661	0.93	9.26	0.72	3.33e-14	Mood instability;
SKCM	cis	rs10752881	1.000	rs10797802	chr1:182973158	A/T	ch.1.3577855R	chr1:183094577	LAMC1	-0.72	-6.62	-0.6	4.15e-9	Colorectal cancer;
SKCM	cis	rs1005277	0.579	rs2505194	chr10:38393881	C/T	cg25427524	chr10:38739819	LOC399744	-0.61	-5.62	-0.54	2.89e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs12926788	0.640	rs12924246	chr16:24844629	A/G	cg04756594	chr16:24857601	SLC5A11	0.71	5.4	0.52	6.89e-7	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs9300255	0.537	rs2682429	chr12:123642955	C/G	cg00376283	chr12:123451042	ABCB9	0.82	5.61	0.54	3e-7	Neutrophil percentage of white cells;
SKCM	cis	rs910316	0.737	rs175510	chr14:75524839	G/A	cg08847533	chr14:75593920	NEK9	-0.82	-6.7	-0.6	2.91e-9	Height;
SKCM	cis	rs763014	0.931	rs11643039	chr16:634260	G/A	cg09263875	chr16:632152	PIGQ	0.67	5.82	0.55	1.24e-7	Height;
SKCM	cis	rs62238980	0.614	rs79605389	chr22:32413385	C/A	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	trans	rs7729273	0.871	rs11746326	chr5:7252052	T/A	cg15263946	chr7:25991107	NA	-0.99	-7.27	-0.64	2.35e-10	Cognitive performance;
SKCM	cis	rs3847687	1.000	rs11061291	chr12:131518875	C/T	cg13586425	chr12:131519906	GPR133	-0.48	-4.95	-0.49	4.26e-6	Longevity;
SKCM	cis	rs1218582	0.772	rs6699043	chr1:154913021	T/C	cg24250549	chr1:154909240	PMVK	0.87	8.96	0.71	1.3e-13	Prostate cancer;
SKCM	cis	rs595982	0.559	rs17206714	chr19:49362001	T/A	cg19746536	chr19:49375674	PPP1R15A	0.97	5.37	0.52	7.86e-7	Red cell distribution width;
SKCM	cis	rs7847628	0.587	rs10760117	chr9:123586737	T/G	cg09419670	chr9:123605666	PSMD5;LOC253039	0.67	6.11	0.57	3.6e-8	Birth weight;
SKCM	cis	rs7666738	0.830	rs12233741	chr4:98950296	C/T	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9905704	0.647	rs10221208	chr17:57047885	T/C	cg12560992	chr17:57184187	TRIM37	0.75	5.99	0.56	6.06e-8	Testicular germ cell tumor;
SKCM	cis	rs10870270	0.956	rs4131689	chr10:133744328	A/C	cg17892150	chr10:133769511	PPP2R2D	0.68	5.42	0.52	6.52e-7	Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals;
SKCM	cis	rs10504229	1.000	rs59383954	chr8:58189689	G/A	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs6500395	0.963	rs2111242	chr16:48708300	T/C	cg04672837	chr16:48644449	N4BP1	-0.63	-5.37	-0.52	8.01e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs2153535	0.606	rs11243253	chr6:8380193	T/C	cg07606381	chr6:8435919	SLC35B3	-0.84	-6.94	-0.62	1.01e-9	Motion sickness;
SKCM	cis	rs6138458	0.961	rs227625	chr20:24911618	T/C	cg26195577	chr20:24973756	C20orf3	1.29	8.69	0.7	4.32e-13	Blood protein levels;
SKCM	cis	rs11098499	0.954	rs2389802	chr4:120325732	C/A	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs367615	0.704	rs4286723	chr5:108835959	G/A	cg17395555	chr5:108820864	NA	0.73	6.54	0.6	5.85e-9	Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs10791097	0.667	rs4937584	chr11:130741761	A/G	cg12179176	chr11:130786555	SNX19	0.93	8.16	0.68	4.62e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs72781680	0.651	rs13019016	chr2:23894773	C/G	cg08917208	chr2:24149416	ATAD2B	0.97	4.96	0.49	3.99e-6	Lymphocyte counts;
SKCM	cis	rs4523957	0.651	rs9910413	chr17:2081419	G/A	cg16513277	chr17:2031491	SMG6	-0.79	-5.86	-0.55	1.07e-7	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs9951698	0.703	rs7237236	chr18:13011431	T/C	cg12848697	chr18:13133368	NA	0.53	4.96	0.49	4.04e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1707322	1.000	rs6429588	chr1:46454058	T/G	cg03146154	chr1:46216737	IPP	0.77	5.1	0.5	2.36e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs11585357	0.895	rs72633803	chr1:17616758	G/A	cg08277548	chr1:17600880	PADI3	-0.89	-6.31	-0.58	1.53e-8	Hair shape;
SKCM	cis	rs7772486	0.754	rs9373476	chr6:146139741	C/G	cg05347473	chr6:146136440	FBXO30	0.59	5.47	0.53	5.27e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9303401	0.659	rs17222523	chr17:56620501	A/G	cg10487724	chr17:56770010	TEX14;RAD51C	0.84	6.18	0.57	2.74e-8	Cognitive test performance;
SKCM	cis	rs4242434	0.927	rs720746	chr8:22471399	T/C	cg03733263	chr8:22462867	KIAA1967	1.09	8.99	0.71	1.11e-13	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs7193541	0.684	rs9929496	chr16:74668473	G/A	cg01733217	chr16:74700730	RFWD3	1.01	11.94	0.8	2.74e-19	Multiple myeloma;
SKCM	cis	rs4478137	0.824	rs4057791	chr4:164225132	A/C	cg06758707	chr4:164254230	NPY1R	0.95	6.19	0.57	2.56e-8	Subjective well-being (multi-trait analysis);Subjective well-being;
SKCM	cis	rs7438704	0.552	rs309880	chr4:48324028	G/A	cg15299388	chr4:48491941	ZAR1	0.45	5.11	0.5	2.23e-6	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs12464559	0.522	rs11676866	chr2:152628858	G/C	cg01189475	chr2:152685088	ARL5A	1.06	5.28	0.51	1.14e-6	Response to cognitive-behavioural therapy in anxiety disorder;
SKCM	cis	rs4523957	0.620	rs8064309	chr17:2059961	T/C	cg16513277	chr17:2031491	SMG6	-0.79	-5.63	-0.54	2.7e-7	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs12802200	0.561	rs746708	chr11:572129	C/T	cg16486109	chr11:613632	IRF7	0.9	5.56	0.53	3.7e-7	Systemic lupus erythematosus;
SKCM	cis	rs2153535	0.580	rs1932282	chr6:8477330	G/A	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs733592	0.507	rs7138917	chr12:48455255	G/A	cg24011408	chr12:48396354	COL2A1	-0.66	-4.91	-0.49	4.98e-6	Plateletcrit;
SKCM	cis	rs6087771	0.747	rs6058261	chr20:30235470	C/A	cg13852791	chr20:30311386	BCL2L1	0.72	5.08	0.5	2.47e-6	Subcortical brain region volumes;Putamen volume;
SKCM	cis	rs6430585	0.528	rs309165	chr2:136667301	T/C	cg07169764	chr2:136633963	MCM6	1.26	10.86	0.78	2.87e-17	Corneal structure;
SKCM	cis	rs9308433	0.529	rs867445	chr1:214502230	C/G	cg06198575	chr1:214491504	SMYD2	0.82	5.16	0.5	1.8e-6	IgG glycosylation;
SKCM	cis	rs10883723	0.775	rs7917158	chr10:104246471	C/A	cg11453585	chr10:104263688	ACTR1A;SUFU	0.73	5.41	0.52	6.74e-7	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs9814567	0.727	rs4543053	chr3:134351724	A/G	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.62	-5.0	-0.49	3.46e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs910316	1.000	rs3742778	chr14:75538217	A/C	cg08847533	chr14:75593920	NEK9	-0.94	-9.0	-0.71	1.07e-13	Height;
SKCM	cis	rs244731	0.959	rs6556307	chr5:176641434	C/T	cg17509989	chr5:176798049	RGS14	0.85	6.56	0.6	5.35e-9	Urate levels in lean individuals;
SKCM	cis	rs7666738	0.830	rs13149346	chr4:99009933	C/T	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs514406	0.584	rs12095247	chr1:53193796	A/C	cg16325326	chr1:53192061	ZYG11B	-1.0	-12.74	-0.82	9.53e-21	Monocyte count;
SKCM	cis	rs826838	1.000	rs10880914	chr12:38720543	C/T	cg13010199	chr12:38710504	ALG10B	0.87	6.82	0.61	1.76e-9	Heart rate;
SKCM	cis	rs738321	0.757	rs3788534	chr22:38533971	A/T	cg25457927	chr22:38595422	NA	-0.58	-6.8	-0.61	1.92e-9	Breast cancer;
SKCM	cis	rs1801251	0.778	rs2592116	chr2:233735709	G/A	cg25237894	chr2:233734115	C2orf82	-0.59	-6.34	-0.58	1.36e-8	Coronary artery disease;
SKCM	cis	rs561341	0.700	rs886223	chr17:30229877	G/T	cg13647721	chr17:30228624	UTP6	0.78	4.94	0.49	4.28e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs4808199	0.895	rs2163805	chr19:19575945	G/A	cg03709012	chr19:19516395	GATAD2A	1.13	8.68	0.7	4.53e-13	Nonalcoholic fatty liver disease;
SKCM	cis	rs561341	0.714	rs473535	chr17:30312365	A/G	cg00745463	chr17:30367425	LRRC37B	-1.11	-7.59	-0.65	5.87e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs6952808	1.000	rs6957894	chr7:1887362	G/A	cg02951883	chr7:2050386	MAD1L1	-0.71	-5.35	-0.52	8.61e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs9894429	0.646	rs8079963	chr17:79603285	C/T	cg18240062	chr17:79603768	NPLOC4	0.68	6.0	0.56	5.88e-8	Eye color traits;
SKCM	cis	rs910316	1.000	rs175449	chr14:75590846	A/T	cg08847533	chr14:75593920	NEK9	-0.96	-8.88	-0.71	1.88e-13	Height;
SKCM	cis	rs870825	0.549	rs7656993	chr4:185635159	T/C	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs151997	1.000	rs151997	chr5:50233199	A/G	cg06027927	chr5:50259733	NA	-0.69	-6.21	-0.57	2.43e-8	Callous-unemotional behaviour;
SKCM	cis	rs919433	0.927	rs6759834	chr2:198204860	C/T	cg04278110	chr2:198063759	ANKRD44	-0.72	-5.02	-0.49	3.21e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs826838	1.000	rs10506122	chr12:38699232	A/G	cg26384229	chr12:38710491	ALG10B	1.05	10.1	0.75	8.14e-16	Heart rate;
SKCM	trans	rs1814175	0.645	rs11040661	chr11:49952146	G/T	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs9467773	1.000	rs9393728	chr6:26509330	C/G	cg09904177	chr6:26538194	HMGN4	0.55	5.03	0.49	3.11e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1577917	0.876	rs1582127	chr6:86697204	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.64	-5.54	-0.53	3.92e-7	Response to antipsychotic treatment;
SKCM	cis	rs56235845	0.694	rs12055081	chr5:176757191	C/T	cg16006841	chr5:176797999	RGS14	0.69	6.42	0.59	9.83e-9	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs736408	0.677	rs678	chr3:52820981	A/T	cg18404041	chr3:52824283	ITIH1	-0.55	-4.82	-0.48	6.98e-6	Bipolar disorder;
SKCM	cis	rs1348850	0.526	rs9288003	chr2:178446572	T/G	cg27490568	chr2:178487706	NA	0.73	5.18	0.51	1.72e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs514406	0.861	rs35581164	chr1:53271373	C/G	cg16325326	chr1:53192061	ZYG11B	0.99	11.71	0.8	7.39e-19	Monocyte count;
SKCM	cis	rs2072499	0.833	rs2842870	chr1:156200671	T/C	cg25208724	chr1:156163844	SLC25A44	0.9	7.86	0.66	1.73e-11	Testicular germ cell tumor;
SKCM	cis	rs6951245	1.000	rs78861357	chr7:1095418	C/T	cg18402987	chr7:1209562	NA	1.15	6.09	0.57	3.95e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs763014	0.931	rs10903017	chr16:627920	T/C	cg00908189	chr16:619842	PIGQ	0.82	7.78	0.66	2.55e-11	Height;
SKCM	cis	rs1799949	1.000	rs2271573	chr17:41327621	A/G	cg23758822	chr17:41437982	NA	0.93	7.8	0.66	2.29e-11	Menopause (age at onset);
SKCM	cis	rs151997	0.962	rs32482	chr5:50207118	T/C	cg06027927	chr5:50259733	NA	0.66	5.78	0.55	1.45e-7	Callous-unemotional behaviour;
SKCM	cis	rs17376456	0.877	rs17374627	chr5:93296306	C/T	cg21475434	chr5:93447410	FAM172A	0.97	5.22	0.51	1.41e-6	Diabetic retinopathy;
SKCM	cis	rs61935443	0.832	rs7308359	chr12:95272904	G/T	cg21533806	chr12:95267307	NA	0.91	4.96	0.49	4.06e-6	Schizophrenia;
SKCM	cis	rs4925114	0.532	rs11655029	chr17:17649172	T/C	cg04398451	chr17:18023971	MYO15A	0.77	5.2	0.51	1.54e-6	Body mass index;
SKCM	cis	rs75229567	0.571	rs78628854	chr12:70141576	C/G	cg10114359	chr12:70132523	RAB3IP	1.41	4.95	0.49	4.12e-6	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes;
SKCM	cis	rs3768617	0.510	rs10458355	chr1:183063993	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs6840360	0.593	rs3805356	chr4:152680701	C/T	cg22705602	chr4:152727874	NA	0.6	7.87	0.67	1.7e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs362296	0.698	rs3135171	chr4:3261127	A/G	cg24015175	chr4:3319247	RGS12	-0.64	-5.96	-0.56	6.95e-8	Parental longevity (mother's age at death);
SKCM	cis	rs372883	0.648	rs1153291	chr21:30689070	G/T	cg24692254	chr21:30365293	RNF160	-0.64	-5.1	-0.5	2.29e-6	Pancreatic cancer;
SKCM	cis	rs12188164	0.610	rs6555242	chr5:416546	A/C	cg26076054	chr5:421317	AHRR	-0.59	-5.0	-0.49	3.45e-6	Cystic fibrosis severity;
SKCM	cis	rs11098499	0.863	rs13136462	chr4:120543173	C/T	cg09307838	chr4:120376055	NA	0.97	7.73	0.66	3.07e-11	Corneal astigmatism;
SKCM	cis	rs2032447	0.899	rs1090947	chr6:26076642	T/C	cg18357526	chr6:26021779	HIST1H4A	0.85	7.35	0.64	1.68e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs6879260	0.963	rs1035412	chr5:179729328	C/T	cg23248424	chr5:179741104	GFPT2	-0.7	-5.85	-0.55	1.08e-7	Height;
SKCM	cis	rs597539	0.652	rs604524	chr11:68629929	G/A	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.85	5.75	0.55	1.65e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs2404602	0.647	rs2404600	chr15:77173557	C/T	cg23625390	chr15:77176239	SCAPER	-0.85	-8.26	-0.68	2.93e-12	Blood metabolite levels;
SKCM	cis	rs17345786	0.906	rs72940399	chr3:101122575	A/T	cg11279151	chr3:101281821	RG9MTD1	-0.62	-5.03	-0.5	3.01e-6	Colonoscopy-negative controls vs population controls;
SKCM	trans	rs9329221	0.905	rs28507213	chr8:10250849	C/T	cg06636001	chr8:8085503	FLJ10661	-0.86	-7.64	-0.65	4.64e-11	Neuroticism;
SKCM	cis	rs7666738	0.830	rs17027198	chr4:98991085	G/C	cg05340658	chr4:99064831	C4orf37	0.67	5.14	0.5	1.98e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1395	1.000	rs1659695	chr2:27406944	T/A	cg14242246	chr2:27434262	C2orf28;SLC5A6	-0.47	-4.77	-0.48	8.27e-6	Blood metabolite levels;
SKCM	cis	rs2980439	0.557	rs2976876	chr8:8318850	T/C	cg15556689	chr8:8085844	FLJ10661	0.71	5.91	0.56	8.51e-8	Neuroticism;
SKCM	trans	rs17685	0.712	rs56965035	chr7:75795670	G/A	cg19862616	chr7:65841803	NCRNA00174	0.97	10.73	0.77	5.13e-17	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs6753739	0.745	rs4672911	chr2:219912538	C/T	cg09617556	chr2:219924408	IHH	0.47	4.94	0.49	4.44e-6	Height;
SKCM	cis	rs10504229	0.906	rs67389108	chr8:58193718	G/A	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs9604529	0.640	rs9525239	chr13:114840960	A/G	cg25338242	chr13:114786047	RASA3	0.81	8.37	0.69	1.8e-12	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs823143	0.570	rs1361754	chr1:205801872	C/T	cg14893161	chr1:205819251	PM20D1	-1.05	-11.72	-0.8	7.13e-19	Monocyte percentage of white cells;
SKCM	cis	rs2204008	0.502	rs2387275	chr12:38142836	G/A	cg13010199	chr12:38710504	ALG10B	0.69	5.0	0.49	3.48e-6	Bladder cancer;
SKCM	cis	rs28595532	0.920	rs56283736	chr4:119747268	A/G	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs7666738	0.800	rs2839836	chr4:98970512	A/G	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9549367	0.713	rs3024743	chr13:113821430	C/T	cg18105134	chr13:113819100	PROZ	-0.88	-6.51	-0.59	6.68e-9	Platelet distribution width;
SKCM	cis	rs1348850	0.914	rs11893448	chr2:178280013	T/C	cg02961200	chr2:178257176	LOC100130691;AGPS	0.84	6.22	0.58	2.27e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs6977660	0.714	rs6976972	chr7:19818315	C/A	cg07541023	chr7:19748670	TWISTNB	0.72	4.78	0.48	7.95e-6	Thyroid stimulating hormone;
SKCM	cis	rs7954584	0.635	rs7309024	chr12:122338334	C/T	cg13699009	chr12:122356056	WDR66	0.56	7.02	0.62	7.17e-10	Mean corpuscular volume;
SKCM	cis	rs9303401	0.614	rs35245220	chr17:56510305	G/A	cg02118635	chr17:56770003	RAD51C;TEX14	0.76	4.95	0.49	4.18e-6	Cognitive test performance;
SKCM	cis	rs7811142	0.830	rs11769057	chr7:99964661	A/G	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.2	7.87	0.67	1.7e-11	Platelet count;
SKCM	cis	rs55962025	0.883	rs82334	chr4:3225371	A/C	cg21096898	chr4:3318625	RGS12	-0.65	-4.98	-0.49	3.75e-6	Parental longevity (mother's age at death);
SKCM	cis	rs9611565	0.512	rs9611667	chr22:42187015	C/T	cg03806693	chr22:41940476	POLR3H	-1.06	-6.84	-0.61	1.61e-9	Vitiligo;
SKCM	cis	rs6977660	1.000	rs10260527	chr7:19801930	G/A	cg05791153	chr7:19748676	TWISTNB	0.8	5.55	0.53	3.77e-7	Thyroid stimulating hormone;
SKCM	cis	rs1799949	1.000	rs1060915	chr17:41234470	A/G	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.06	-0.57	4.54e-8	Menopause (age at onset);
SKCM	cis	rs7633857	0.532	rs9858335	chr3:160760146	A/G	cg03342759	chr3:160939853	NMD3	-0.62	-5.01	-0.49	3.33e-6	Educational attainment (years of education);
SKCM	cis	rs9300255	0.679	rs12817892	chr12:123728702	G/A	cg00376283	chr12:123451042	ABCB9	-0.82	-5.73	-0.54	1.83e-7	Neutrophil percentage of white cells;
SKCM	cis	rs7932354	0.528	rs11039074	chr11:47081732	C/T	cg03339077	chr11:47165057	C11orf49	-0.59	-4.79	-0.48	7.68e-6	Bone mineral density (hip);Bone mineral density;
SKCM	cis	rs55962025	0.883	rs362275	chr4:3224602	C/T	cg05297308	chr4:3317976	RGS12	-0.67	-4.88	-0.48	5.51e-6	Parental longevity (mother's age at death);
SKCM	cis	rs4975616	0.843	rs6866783	chr5:1312020	T/C	cg07493874	chr5:1342172	CLPTM1L	0.61	5.06	0.5	2.71e-6	Lung cancer;
SKCM	cis	rs1799949	0.501	rs2343819	chr17:41409653	T/G	cg23758822	chr17:41437982	NA	0.93	7.88	0.67	1.62e-11	Menopause (age at onset);
SKCM	cis	rs1568889	0.838	rs10835276	chr11:28167147	C/T	cg06544937	chr11:28130018	METT5D1;KIF18A	0.89	8.3	0.68	2.43e-12	Bipolar disorder;
SKCM	cis	rs875971	0.545	rs1796217	chr7:66085918	A/G	cg18876405	chr7:65276391	NA	-0.61	-4.87	-0.48	5.74e-6	Aortic root size;
SKCM	cis	rs801193	0.967	rs34356500	chr7:66236607	G/T	cg11987759	chr7:65425863	GUSB	-0.7	-6.08	-0.57	4.21e-8	Aortic root size;
SKCM	cis	rs910316	1.000	rs12588240	chr14:75612083	C/A	cg08847533	chr14:75593920	NEK9	0.95	9.18	0.72	4.88e-14	Height;
SKCM	cis	rs875971	0.862	rs13232191	chr7:65986648	A/G	cg11764359	chr7:65958608	NA	0.75	6.8	0.61	1.86e-9	Aortic root size;
SKCM	cis	rs10860964	0.528	rs10431456	chr12:103584668	A/G	cg20635409	chr12:103359273	NA	-0.53	-4.88	-0.48	5.61e-6	Schizophrenia;
SKCM	cis	rs11673344	0.670	rs505717	chr19:37430316	A/G	cg07624650	chr19:37064219	ZNF529	-0.8	-5.23	-0.51	1.41e-6	Obesity-related traits;
SKCM	cis	rs7143963	0.636	rs7154305	chr14:103348743	C/G	cg23020514	chr14:103360112	TRAF3	0.74	6.99	0.62	8.38e-10	Body mass index;
SKCM	cis	rs7829975	0.514	rs2979151	chr8:8258019	A/G	cg08975724	chr8:8085496	FLJ10661	-0.59	-4.79	-0.48	7.81e-6	Mood instability;
SKCM	cis	rs9858542	0.953	rs9824092	chr3:49674147	C/G	cg03060546	chr3:49711283	APEH	-0.71	-5.29	-0.51	1.07e-6	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs116095464	0.558	rs55838121	chr5:266890	G/A	cg22496380	chr5:211416	CCDC127	-0.9	-4.94	-0.49	4.42e-6	Breast cancer;
SKCM	cis	rs7111031	0.967	rs35277073	chr11:113350620	C/G	cg04642306	chr11:112834466	NCAM1	-0.45	-5.03	-0.5	3.03e-6	Subjective well-being (multi-trait analysis);Depressive symptoms (multi-trait analysis);Neuroticism;
SKCM	cis	rs3818285	1.000	rs3740138	chr10:111630931	C/T	cg00817464	chr10:111662876	XPNPEP1	-0.62	-5.04	-0.5	2.89e-6	Superior crus of antihelix expression;
SKCM	cis	rs7772486	0.686	rs9376956	chr6:145949844	T/C	cg05347473	chr6:146136440	FBXO30	0.57	5.19	0.51	1.61e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4819052	0.765	rs2838827	chr21:46656146	C/T	cg19498844	chr21:46707878	POFUT2;LOC642852	0.84	7.19	0.63	3.46e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs6570726	0.791	rs6912079	chr6:145894949	G/A	cg23711669	chr6:146136114	FBXO30	0.87	8.94	0.71	1.44e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9583531	0.527	rs6492302	chr13:111352354	C/T	cg24331049	chr13:111365604	ING1	-0.76	-5.25	-0.51	1.26e-6	Coronary artery disease;
SKCM	cis	rs35306767	0.953	rs35174953	chr10:961191	C/A	cg20503657	chr10:835505	NA	0.65	4.94	0.49	4.37e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs453301	0.686	rs7017868	chr8:8873293	G/A	cg06636001	chr8:8085503	FLJ10661	-0.76	-5.76	-0.55	1.58e-7	Joint mobility (Beighton score);
SKCM	cis	rs4555082	0.834	rs2735816	chr14:105721603	C/G	cg10792982	chr14:105748885	BRF1	-0.58	-4.93	-0.49	4.45e-6	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs5769765	0.862	rs138870	chr22:50209737	C/T	cg22709217	chr22:50311962	ALG12;CRELD2	-0.84	-5.74	-0.55	1.71e-7	Schizophrenia;
SKCM	cis	rs2839186	0.564	rs4819215	chr21:47623573	G/A	cg13126279	chr21:47581558	C21orf56	-0.68	-6.15	-0.57	3.08e-8	Testicular germ cell tumor;
SKCM	cis	rs34779708	0.966	rs17591781	chr10:35498538	G/A	cg03585969	chr10:35415529	CREM	0.78	6.28	0.58	1.75e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs8072100	0.905	rs11651766	chr17:45574931	G/T	cg08085267	chr17:45401833	C17orf57	-0.6	-4.98	-0.49	3.66e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs28595532	0.623	rs71608363	chr4:119227259	T/C	cg11846333	chr4:119757529	SEC24D	0.96	5.37	0.52	7.87e-7	Cannabis dependence symptom count;
SKCM	cis	rs362272	0.524	rs6819202	chr4:3368264	G/A	cg11471262	chr4:3318911	RGS12	0.93	10.72	0.77	5.35e-17	Serum sulfate level;
SKCM	cis	rs208520	0.690	rs207112	chr6:66792092	C/T	cg07460842	chr6:66804631	NA	-1.03	-7.65	-0.65	4.49e-11	Exhaled nitric oxide output;
SKCM	cis	rs7659604	0.702	rs61217486	chr4:122693973	T/C	cg20573242	chr4:122745356	CCNA2	0.79	6.58	0.6	4.97e-9	Type 2 diabetes;
SKCM	cis	rs6121246	0.909	rs6088962	chr20:30268184	C/T	cg11595048	chr20:30225325	COX4I2	0.67	5.21	0.51	1.5e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs7020830	0.858	rs7856690	chr9:37127545	A/T	cg14294708	chr9:37120828	ZCCHC7	1.09	9.79	0.74	3.15e-15	Schizophrenia;
SKCM	cis	rs5753618	0.509	rs2413033	chr22:31574213	A/G	cg02404636	chr22:31891804	SFI1	-0.56	-4.83	-0.48	6.78e-6	Colorectal cancer;
SKCM	cis	rs1577917	0.958	rs1545376	chr6:86504582	C/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.64	5.65	0.54	2.56e-7	Response to antipsychotic treatment;
SKCM	cis	rs7811142	1.000	rs67315960	chr7:100015124	A/G	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.16	7.68	0.66	3.87e-11	Platelet count;
SKCM	cis	rs28595532	0.920	rs116559327	chr4:119754526	T/G	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs35306767	0.855	rs55708963	chr10:925712	C/A	cg20503657	chr10:835505	NA	0.84	6.25	0.58	2.01e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs2858942	0.780	rs2858014	chr16:248357	T/C	cg08400316	chr16:204221	HBZ	0.69	4.8	0.48	7.53e-6	Mean corpuscular hemoglobin;
SKCM	trans	rs10506458	0.834	rs17738403	chr12:63389200	A/G	cg03429785	chr15:59498649	MYO1E;LDHAL6B	-1.39	-7.59	-0.65	5.95e-11	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs951366	0.873	rs823118	chr1:205723572	C/T	cg11965913	chr1:205819406	PM20D1	0.72	5.54	0.53	3.98e-7	Menarche (age at onset);
SKCM	cis	rs2204008	0.548	rs2320740	chr12:38166421	G/A	cg26384229	chr12:38710491	ALG10B	0.82	6.58	0.6	4.87e-9	Bladder cancer;
SKCM	cis	rs6570726	0.791	rs443628	chr6:145883484	T/C	cg05347473	chr6:146136440	FBXO30	0.57	5.13	0.5	2.06e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9435341	0.762	rs3861909	chr1:107544176	A/G	cg09367891	chr1:107599246	PRMT6	-0.83	-6.2	-0.57	2.51e-8	Facial morphology (factor 21, depth of nasal alae);
SKCM	cis	rs9911578	1.000	rs7207693	chr17:57016525	C/T	cg12560992	chr17:57184187	TRIM37	0.94	7.55	0.65	7.01e-11	Intelligence (multi-trait analysis);
SKCM	trans	rs1814175	0.935	rs11040463	chr11:49685574	C/T	cg15704280	chr7:45808275	SEPT13	-1.0	-9.38	-0.73	1.99e-14	Height;
SKCM	cis	rs6754311	0.638	rs2322659	chr2:136555659	A/G	cg07169764	chr2:136633963	MCM6	-0.75	-5.32	-0.52	9.5e-7	Mosquito bite size;
SKCM	cis	rs738322	0.555	rs5750549	chr22:38547172	C/T	cg25457927	chr22:38595422	NA	-0.56	-6.58	-0.6	4.97e-9	Cutaneous nevi;
SKCM	trans	rs17685	0.753	rs6464999	chr7:75787315	T/C	cg19862616	chr7:65841803	NCRNA00174	0.92	9.38	0.73	2.02e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs6951245	0.935	rs79067319	chr7:1065548	C/T	cg03188948	chr7:1209495	NA	1.11	6.11	0.57	3.68e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs798554	0.679	rs11973498	chr7:2886873	C/A	cg04166393	chr7:2884313	GNA12	0.79	5.54	0.53	3.9e-7	Height;
SKCM	cis	rs28386778	0.897	rs2584640	chr17:61863488	C/T	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs1799949	0.930	rs3765640	chr17:41276247	A/G	cg05368731	chr17:41323189	NBR1	0.89	7.91	0.67	1.38e-11	Menopause (age at onset);
SKCM	cis	rs992157	0.835	rs11677953	chr2:219121663	G/A	cg00012203	chr2:219082015	ARPC2	-0.81	-6.35	-0.58	1.32e-8	Colorectal cancer;
SKCM	cis	rs533581	0.866	rs488251	chr16:88972554	G/A	cg16701003	chr16:89028210	CBFA2T3	0.63	5.66	0.54	2.45e-7	Social autistic-like traits;
SKCM	cis	rs7193541	0.859	rs12598791	chr16:74500745	A/C	cg01733217	chr16:74700730	RFWD3	0.98	7.98	0.67	1.02e-11	Multiple myeloma;
SKCM	cis	rs854765	0.562	rs2955381	chr17:17945500	G/C	cg04398451	chr17:18023971	MYO15A	0.94	7.53	0.65	7.5e-11	Total body bone mineral density;
SKCM	cis	rs854765	0.520	rs9899355	chr17:17898243	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.09	8.63	0.7	5.68e-13	Total body bone mineral density;
SKCM	cis	rs8016982	0.611	rs8008870	chr14:81709374	C/T	cg01989461	chr14:81687754	GTF2A1	0.81	6.68	0.6	3.2e-9	Schizophrenia;
SKCM	cis	rs4664308	0.618	rs62175488	chr2:160892758	T/C	cg03641300	chr2:160917029	PLA2R1	-0.61	-4.84	-0.48	6.44e-6	Idiopathic membranous nephropathy;
SKCM	cis	rs62244186	0.566	rs55852922	chr3:44826188	A/G	cg02073558	chr3:44770973	ZNF501	0.81	7.14	0.63	4.32e-10	Depressive symptoms;
SKCM	cis	rs6088580	0.624	rs6120645	chr20:33025171	C/T	cg24642439	chr20:33292090	TP53INP2	0.76	6.02	0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs2013441	0.932	rs2526488	chr17:20098617	T/A	cg13482628	chr17:19912719	NA	-0.65	-5.21	-0.51	1.48e-6	Obesity-related traits;
SKCM	cis	rs4819052	0.611	rs11701605	chr21:46649808	G/A	cg02159808	chr21:46707872	POFUT2;LOC642852	0.76	5.38	0.52	7.52e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs2204008	0.623	rs1663281	chr12:38120936	A/G	cg26384229	chr12:38710491	ALG10B	-0.67	-5.47	-0.53	5.23e-7	Bladder cancer;
SKCM	trans	rs1814175	0.588	rs10839463	chr11:49971643	A/G	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs2841277	0.708	rs11851053	chr14:105407208	T/C	cg15352829	chr14:105391018	PLD4	-0.58	-4.81	-0.48	7.35e-6	Rheumatoid arthritis;
SKCM	cis	rs28386778	0.965	rs2854154	chr17:61981696	C/A	cg22520471	chr17:61851767	DDX42;CCDC47	-0.76	-4.82	-0.48	6.94e-6	Prudent dietary pattern;
SKCM	cis	rs6570726	0.935	rs398060	chr6:145841515	C/T	cg23711669	chr6:146136114	FBXO30	-0.76	-7.3	-0.64	2.11e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs8077889	0.956	rs4792910	chr17:41840229	T/C	cg26893861	chr17:41843967	DUSP3	1.15	6.49	0.59	7.14e-9	Triglycerides;
SKCM	cis	rs651907	0.513	rs34963630	chr3:101504817	C/T	cg12386194	chr3:101231763	SENP7	0.66	5.5	0.53	4.61e-7	Colorectal cancer;
SKCM	cis	rs875971	0.862	rs28470208	chr7:65584700	A/G	cg18876405	chr7:65276391	NA	-0.65	-6.63	-0.6	3.96e-9	Aortic root size;
SKCM	cis	rs362296	0.671	rs3135173	chr4:3257373	T/C	cg21096898	chr4:3318625	RGS12	-0.82	-7.4	-0.64	1.38e-10	Parental longevity (mother's age at death);
SKCM	cis	rs4332037	0.707	rs62435132	chr7:1891315	C/T	cg23422044	chr7:1970798	MAD1L1	-0.9	-5.81	-0.55	1.29e-7	Bipolar disorder;
SKCM	cis	rs7208859	0.573	rs7222803	chr17:29119897	A/G	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs9467773	1.000	rs6456733	chr6:26566804	C/T	cg09904177	chr6:26538194	HMGN4	0.54	4.91	0.49	4.97e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs11098499	0.604	rs34278750	chr4:120571136	G/A	cg24375607	chr4:120327624	NA	0.63	4.83	0.48	6.74e-6	Corneal astigmatism;
SKCM	cis	rs1801251	1.000	rs6738386	chr2:233602028	T/C	cg25237894	chr2:233734115	C2orf82	0.56	5.33	0.52	9.23e-7	Coronary artery disease;
SKCM	cis	rs10256972	0.758	rs2280724	chr7:1064720	A/G	cg16145915	chr7:1198662	ZFAND2A	-0.43	-5.33	-0.52	9.33e-7	Longevity;Endometriosis;
SKCM	cis	rs9790314	0.586	rs35713426	chr3:161131271	A/G	cg03342759	chr3:160939853	NMD3	-0.74	-6.62	-0.6	4.08e-9	Morning vs. evening chronotype;
SKCM	cis	rs1577917	0.545	rs1832070	chr6:86483172	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.7	6.24	0.58	2.11e-8	Response to antipsychotic treatment;
SKCM	cis	rs8072100	0.713	rs9895776	chr17:45486003	A/G	cg08085267	chr17:45401833	C17orf57	-0.62	-5.06	-0.5	2.76e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs4969178	0.832	rs4969185	chr17:76398157	G/C	cg20026190	chr17:76395443	PGS1	0.64	5.48	0.53	5.11e-7	HDL cholesterol levels;
SKCM	cis	rs763121	0.853	rs926299	chr22:39095698	C/G	cg06022373	chr22:39101656	GTPBP1	0.85	6.3	0.58	1.65e-8	Menopause (age at onset);
SKCM	cis	rs870825	0.616	rs7680639	chr4:185652915	C/T	cg04058563	chr4:185651563	MLF1IP	-1.07	-7.16	-0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs7523273	0.526	rs2745980	chr1:208018367	A/C	cg22525895	chr1:207977042	MIR29B2	0.83	6.84	0.61	1.57e-9	Schizophrenia;
SKCM	cis	rs514406	0.548	rs6670871	chr1:53212082	A/C	cg24675658	chr1:53192096	ZYG11B	0.63	5.08	0.5	2.47e-6	Monocyte count;
SKCM	cis	rs4746818	1.000	rs7901617	chr10:70904063	C/T	cg11621586	chr10:70884670	VPS26A	1.08	7.96	0.67	1.11e-11	Left atrial antero-posterior diameter;
SKCM	cis	rs4073582	0.516	rs1151539	chr11:66031660	C/T	cg14036092	chr11:66035641	RAB1B	0.75	5.91	0.56	8.39e-8	Gout;
SKCM	cis	rs931127	0.505	rs2306362	chr11:65405510	G/T	cg27068330	chr11:65405492	SIPA1	-0.84	-6.89	-0.61	1.29e-9	Systemic lupus erythematosus;
SKCM	cis	rs6665290	0.901	rs61834001	chr1:227197411	C/T	cg10327440	chr1:227177885	CDC42BPA	-1.24	-17.31	-0.89	1.95e-28	Myeloid white cell count;
SKCM	cis	rs6840360	0.554	rs58751443	chr4:152709905	A/G	cg22705602	chr4:152727874	NA	-0.57	-7.61	-0.65	5.45e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs4819052	0.851	rs9753963	chr21:46661437	G/A	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.36	0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs1577917	0.771	rs2842601	chr6:86330133	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.83	-7.76	-0.66	2.77e-11	Response to antipsychotic treatment;
SKCM	cis	rs6977660	0.943	rs12668201	chr7:19831610	A/C	cg05791153	chr7:19748676	TWISTNB	-0.79	-5.53	-0.53	4.14e-7	Thyroid stimulating hormone;
SKCM	cis	rs7666738	0.791	rs10017624	chr4:98984009	G/T	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs826838	0.967	rs7963716	chr12:38876090	C/T	cg13010199	chr12:38710504	ALG10B	0.85	6.61	0.6	4.26e-9	Heart rate;
SKCM	cis	rs6723226	0.598	rs2710629	chr2:32765844	C/T	cg02381751	chr2:32503542	YIPF4	0.73	5.92	0.56	8.03e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs1799949	0.965	rs8176087	chr17:41270666	C/A	cg23758822	chr17:41437982	NA	0.94	7.54	0.65	7.18e-11	Menopause (age at onset);
SKCM	cis	rs34779708	0.931	rs4934697	chr10:35287192	C/T	cg03585969	chr10:35415529	CREM	0.72	5.96	0.56	6.77e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs2120019	0.507	rs4886642	chr15:75228846	T/C	cg09165964	chr15:75287851	SCAMP5	-0.77	-5.51	-0.53	4.43e-7	Blood trace element (Zn levels);
SKCM	cis	rs2153535	0.580	rs9505450	chr6:8469902	C/T	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs732765	0.734	rs17101722	chr14:75114321	G/C	cg25946216	chr14:74253857	C14orf43	-0.87	-5.45	-0.53	5.68e-7	Non-small cell lung cancer;
SKCM	cis	rs67460515	0.531	rs13060601	chr3:160823159	G/A	cg03342759	chr3:160939853	NMD3	-0.71	-6.09	-0.57	4.04e-8	Parkinson's disease;
SKCM	cis	rs9814567	0.896	rs2177602	chr3:134245866	A/G	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs56104184	0.887	rs4801778	chr19:49370609	G/T	cg15549821	chr19:49342101	PLEKHA4	-0.87	-5.85	-0.55	1.07e-7	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs2033711	0.936	rs893185	chr19:58989495	A/C	cg26874164	chr19:58962979	ZNF324B	0.61	4.81	0.48	7.26e-6	Uric acid clearance;
SKCM	cis	rs8037137	0.915	rs12594752	chr15:91531995	C/T	cg15878949	chr15:91534302	PRC1	0.68	5.23	0.51	1.38e-6	Platelet count;Serous invasive ovarian cancer;High-grade serous ovarian cancer;Invasive epithelial ovarian cancer;
SKCM	cis	rs9467773	1.000	rs6910899	chr6:26524339	A/G	cg15659132	chr6:26577336	NA	0.6	5.71	0.54	1.99e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7829975	0.688	rs7826654	chr8:8379106	C/T	cg08975724	chr8:8085496	FLJ10661	0.66	5.2	0.51	1.57e-6	Mood instability;
SKCM	cis	rs748404	0.631	rs28702649	chr15:43648629	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	0.78	5.39	0.52	7.24e-7	Lung cancer;
SKCM	cis	rs28386778	0.897	rs2727295	chr17:61887693	C/T	cg06873352	chr17:61820015	STRADA	0.7	5.82	0.55	1.26e-7	Prudent dietary pattern;
SKCM	cis	rs2153535	0.601	rs1855765	chr6:8444325	C/T	cg23788917	chr6:8435910	SLC35B3	0.69	5.14	0.5	1.99e-6	Motion sickness;
SKCM	cis	rs6762	0.692	rs5030778	chr11:836008	T/C	cg16425592	chr11:842748	TSPAN4;POLR2L	-0.77	-5.46	-0.53	5.58e-7	Mean platelet volume;
SKCM	cis	rs8017423	0.765	rs8017170	chr14:90721849	T/A	cg04374321	chr14:90722782	PSMC1	1.03	9.44	0.73	1.55e-14	Mortality in heart failure;
SKCM	cis	rs9921192	0.967	rs251737	chr16:4318305	C/T	cg00021532	chr16:4324280	TFAP4	0.91	8.56	0.7	7.82e-13	Prostate-specific antigen levels;
SKCM	cis	rs28386778	0.897	rs7221853	chr17:61859836	A/G	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs9916302	0.904	rs11078898	chr17:37536480	A/G	cg07936489	chr17:37558343	FBXL20	0.84	7.23	0.63	2.81e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs8103278	0.864	rs2070737	chr19:46282890	A/T	cg11657440	chr19:46296263	DMWD	-0.95	-6.83	-0.61	1.65e-9	Coronary artery disease;
SKCM	cis	rs4237845	0.837	rs7963992	chr12:58295949	G/C	cg02175503	chr12:58329896	NA	0.79	6.89	0.62	1.27e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs4972806	0.776	rs2072589	chr2:177042871	C/T	cg14324370	chr2:177042789	NA	0.58	5.31	0.52	1.01e-6	IgG glycosylation;
SKCM	cis	rs362272	0.525	rs910568	chr4:3307373	A/G	cg24015175	chr4:3319247	RGS12	0.79	8.68	0.7	4.48e-13	Serum sulfate level;
SKCM	cis	rs9894429	1.000	rs4074915	chr17:79579230	G/A	cg18240062	chr17:79603768	NPLOC4	-0.76	-7.43	-0.64	1.2e-10	Eye color traits;
SKCM	cis	rs763014	0.898	rs4984896	chr16:625493	C/T	cg07343612	chr16:622815	PIGQ	-0.69	-5.73	-0.54	1.84e-7	Height;
SKCM	cis	rs58688157	0.960	rs1061502	chr11:614318	T/C	cg16486109	chr11:613632	IRF7	1.07	7.29	0.64	2.17e-10	Systemic lupus erythematosus;
SKCM	cis	rs8060686	0.641	rs2107369	chr16:68116018	A/C	cg04539111	chr16:67997858	SLC12A4	-0.85	-4.92	-0.49	4.75e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs9902453	0.817	rs2628170	chr17:28056612	T/A	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.82	-5.78	-0.55	1.47e-7	Coffee consumption (cups per day);
SKCM	cis	rs2303745	0.589	rs1465576	chr19:17398487	G/A	cg04248312	chr19:17393744	ANKLE1	-1.12	-8.3	-0.69	2.42e-12	Systemic lupus erythematosus;
SKCM	cis	rs17376456	0.825	rs28645862	chr5:93233128	G/C	cg25358565	chr5:93447407	FAM172A	1.26	7.82	0.66	2.11e-11	Diabetic retinopathy;
SKCM	cis	rs6461049	0.765	rs4719431	chr7:2140312	T/C	cg21782813	chr7:2030301	MAD1L1	0.48	5.13	0.5	2.08e-6	Schizophrenia;
SKCM	cis	rs4780401	0.609	rs8063099	chr16:11806714	T/G	cg01061890	chr16:11836724	TXNDC11	-0.8	-6.08	-0.57	4.16e-8	Rheumatoid arthritis;
SKCM	cis	rs1552244	1.000	rs17032299	chr3:10087638	C/T	cg02579736	chr3:10068473	FANCD2;CIDECP	1.24	6.52	0.59	6.33e-9	Alzheimer's disease;
SKCM	cis	rs7666738	0.791	rs2903142	chr4:99040071	C/T	cg05340658	chr4:99064831	C4orf37	0.67	5.12	0.5	2.14e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11673344	0.764	rs529468	chr19:37446200	T/G	cg07624650	chr19:37064219	ZNF529	-0.78	-4.82	-0.48	7.05e-6	Obesity-related traits;
SKCM	cis	rs1799949	0.965	rs799916	chr17:41243190	G/T	cg25072359	chr17:41440525	NA	-0.66	-5.19	-0.51	1.61e-6	Menopause (age at onset);
SKCM	cis	rs710216	0.536	rs710222	chr1:43413653	A/G	cg03128534	chr1:43423976	SLC2A1	0.91	7.52	0.65	7.93e-11	Red cell distribution width;
SKCM	cis	rs6545883	0.794	rs12053388	chr2:61532320	G/A	cg15711740	chr2:61764176	XPO1	0.73	5.01	0.49	3.33e-6	Tuberculosis;
SKCM	cis	rs6500395	0.775	rs4471681	chr16:48665946	C/T	cg04672837	chr16:48644449	N4BP1	0.6	4.88	0.48	5.59e-6	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs769267	1.000	rs2074089	chr19:19449603	G/A	cg26732615	chr19:19648335	CILP2;YJEFN3	-0.65	-5.91	-0.56	8.42e-8	Tonsillectomy;
SKCM	cis	rs9467773	0.967	rs9461267	chr6:26525455	T/G	cg15659132	chr6:26577336	NA	0.6	5.71	0.54	1.99e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs8014204	0.566	rs752857	chr14:75130944	C/T	cg17347104	chr14:75034677	LTBP2	-0.58	-4.78	-0.48	8.23e-6	Caffeine consumption;
SKCM	cis	rs7208859	0.623	rs73269974	chr17:29112384	C/T	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs7659604	0.676	rs6534323	chr4:122695888	G/A	cg20573242	chr4:122745356	CCNA2	0.79	6.55	0.6	5.55e-9	Type 2 diabetes;
SKCM	cis	rs10779751	0.734	rs1034528	chr1:11249132	G/C	cg08854313	chr1:11322531	MTOR	-0.97	-6.64	-0.6	3.84e-9	Body mass index;
SKCM	cis	rs2439831	0.702	rs3784275	chr15:44091386	G/A	cg02155558	chr15:43621948	ADAL;LCMT2	1.35	7.75	0.66	2.9e-11	Lung cancer in ever smokers;
SKCM	cis	rs933688	1.000	rs11948075	chr5:90680579	A/G	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.12	8.45	0.69	1.25e-12	Smoking behavior;
SKCM	cis	rs2836633	0.929	rs62217517	chr21:40033177	T/A	cg05519781	chr21:40033154	ERG	0.81	7.07	0.62	5.77e-10	Coronary artery disease;
SKCM	cis	rs10504073	0.545	rs4406405	chr8:49957261	G/C	cg00325661	chr8:49890786	NA	0.8	6.81	0.61	1.83e-9	Blood metabolite ratios;
SKCM	cis	rs1153858	1.000	rs4775909	chr15:45643042	T/C	cg10760299	chr15:45669010	GATM	0.6	5.9	0.56	8.71e-8	Homoarginine levels;
SKCM	cis	rs28386778	0.897	rs2584635	chr17:61865934	A/G	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs1218582	0.711	rs4845677	chr1:154838050	C/T	cg09359103	chr1:154839909	KCNN3	-0.59	-5.93	-0.56	7.77e-8	Prostate cancer;
SKCM	cis	rs9911578	0.967	rs12603238	chr17:57130785	C/T	cg05425664	chr17:57184151	TRIM37	0.84	6.99	0.62	8.23e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs3738772	0.633	rs919958	chr1:110053148	C/G	cg06948763	chr1:110763078	KCNC4	-0.49	-5.05	-0.5	2.81e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs55794721	0.509	rs12027110	chr1:25775682	A/T	cg27572855	chr1:25598939	RHD	0.55	5.14	0.5	1.97e-6	Plateletcrit;Mean corpuscular volume;
SKCM	cis	rs62103177	0.568	rs2365388	chr18:77973702	G/T	cg06309094	chr18:77676213	PQLC1	-0.78	-4.79	-0.48	7.94e-6	Opioid sensitivity;
SKCM	cis	rs61925898	1	rs61925898	chr12:66779537	A/G	cg16791601	chr12:66731901	HELB	-0.59	-5.07	-0.5	2.67e-6	Basophil percentage of granulocytes;Basophil percentage of white cells;
SKCM	cis	rs5769765	0.913	rs8135071	chr22:50299587	T/C	cg22709217	chr22:50311962	ALG12;CRELD2	-0.82	-5.71	-0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs2279817	1.000	rs2279815	chr1:18022066	G/T	cg17142039	chr1:18149651	ACTL8	0.58	4.88	0.48	5.6e-6	Neuroticism;
SKCM	cis	rs951366	0.764	rs708725	chr1:205744138	G/T	cg07167872	chr1:205819463	PM20D1	0.94	8.15	0.68	4.72e-12	Menarche (age at onset);
SKCM	cis	rs12044355	0.827	rs1977797	chr1:231825074	T/A	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	0.82	6.24	0.58	2.14e-8	Alzheimer's disease;
SKCM	cis	rs7809950	1.000	rs2712200	chr7:107142435	G/T	cg23024343	chr7:107201750	COG5	-0.76	-6.83	-0.61	1.64e-9	Coronary artery disease;
SKCM	cis	rs523522	0.962	rs4766968	chr12:120947788	G/C	cg27279351	chr12:120934652	DYNLL1	0.91	8.32	0.69	2.26e-12	High light scatter reticulocyte count;
SKCM	cis	rs8180040	0.903	rs2276853	chr3:47282303	G/A	cg16586182	chr3:47516702	SCAP	-0.72	-4.98	-0.49	3.73e-6	Colorectal cancer;
SKCM	cis	rs1005277	0.579	rs1780138	chr10:38501654	A/G	cg00409905	chr10:38381863	ZNF37A	-0.62	-5.82	-0.55	1.24e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs6489882	0.902	rs4767040	chr12:113374017	C/G	cg07232103	chr12:112566177	TRAFD1	0.59	4.94	0.49	4.35e-6	Chronic lymphocytic leukemia;
SKCM	cis	rs2857078	0.772	rs2079008	chr17:42322132	C/A	cg19774624	chr17:42201019	HDAC5	0.79	5.72	0.54	1.88e-7	Red cell distribution width;Reticulocyte count;
SKCM	cis	rs12926788	0.689	rs34365165	chr16:24856208	G/A	cg00339695	chr16:24857497	SLC5A11	0.76	7.05	0.62	6.32e-10	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	trans	rs8073060	0.572	rs1634683	chr17:33941560	G/C	cg19694781	chr19:47549865	TMEM160	-1.08	-8.73	-0.7	3.66e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs8070624	0.543	rs8068175	chr17:17874486	C/T	cg04398451	chr17:18023971	MYO15A	-0.8	-6.01	-0.56	5.59e-8	Total body bone mineral density;
SKCM	cis	rs6951245	0.706	rs28483034	chr7:1170171	C/A	cg03188948	chr7:1209495	NA	1.04	6.69	0.6	3.04e-9	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7772486	0.875	rs13198450	chr6:146370524	C/A	cg23711669	chr6:146136114	FBXO30	0.77	7.48	0.65	9.65e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4253772	0.688	rs113928699	chr22:46649344	G/A	cg03482458	chr22:46692211	CN5H6.4;GTSE1	1.18	5.01	0.49	3.31e-6	LDL cholesterol;Cholesterol, total;
SKCM	cis	rs2153535	0.580	rs1414346	chr6:8471574	A/G	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs2013441	0.965	rs1544421	chr17:20114217	T/C	cg13482628	chr17:19912719	NA	-0.65	-5.21	-0.51	1.48e-6	Obesity-related traits;
SKCM	cis	rs12477438	0.520	rs10865029	chr2:99718298	C/T	cg14399236	chr2:99771627	LIPT1;TSGA10	0.95	8.78	0.71	2.89e-13	Chronic sinus infection;
SKCM	cis	rs1799949	1.000	rs1824889	chr17:41421876	C/G	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.18	-0.57	2.68e-8	Menopause (age at onset);
SKCM	cis	rs1568889	1.000	rs10767693	chr11:28093926	G/C	cg06544937	chr11:28130018	METT5D1;KIF18A	0.87	8.13	0.68	5.28e-12	Bipolar disorder;
SKCM	cis	rs7666738	0.830	rs28802909	chr4:99039410	G/A	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs860295	0.702	rs11264375	chr1:155424065	C/T	cg02153340	chr1:155202674	NA	0.71	5.3	0.51	1.07e-6	Body mass index;
SKCM	cis	rs1912528	0.963	rs12509820	chr4:140937628	A/G	cg11128457	chr4:140864437	MAML3	-0.58	-4.82	-0.48	6.87e-6	Educational attainment (years of education);
SKCM	cis	rs9399135	0.636	rs4646871	chr6:135265617	A/G	cg24558204	chr6:135376177	HBS1L	-0.64	-6.04	-0.56	4.91e-8	Red blood cell count;
SKCM	cis	rs28386778	0.897	rs11654841	chr17:61838259	C/T	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs8070128	0.601	rs8080602	chr17:17954728	G/C	cg24612305	chr17:17875800	TOM1L2;LRRC48	-1.05	-9.29	-0.72	2.92e-14	Total body bone mineral density;
SKCM	cis	rs10492096	0.947	rs61918020	chr12:6605514	C/T	cg13857086	chr12:6580257	VAMP1	0.76	5.75	0.55	1.64e-7	Hip geometry;
SKCM	cis	rs12142240	0.698	rs6683192	chr1:46830257	C/T	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs10791097	0.678	rs10894272	chr11:130731081	A/G	cg12179176	chr11:130786555	SNX19	0.72	5.71	0.54	1.99e-7	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs10504229	0.953	rs66509078	chr8:58174734	G/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs4862750	0.872	rs9998173	chr4:187898778	T/A	cg10295955	chr4:187884368	NA	-1.05	-14.11	-0.85	3.63e-23	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs992157	0.710	rs12612347	chr2:219057338	C/T	cg20019365	chr2:219134978	PNKD;AAMP	-0.72	-6.22	-0.58	2.32e-8	Colorectal cancer;
SKCM	cis	rs9733	0.650	rs6698495	chr1:150564476	T/C	cg13175981	chr1:150552382	MCL1	0.74	6.71	0.6	2.8e-9	Tonsillectomy;
SKCM	cis	rs79839061	0.610	rs12651368	chr4:856787	G/A	cg07828340	chr4:882639	GAK	1.06	5.32	0.52	9.74e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs56104184	0.775	rs73061689	chr19:49397214	C/T	cg19746536	chr19:49375674	PPP1R15A	1.13	5.5	0.53	4.69e-7	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs2836974	0.829	rs8128191	chr21:40527311	A/G	cg11644478	chr21:40555479	PSMG1	0.97	10.21	0.76	5.08e-16	Cognitive function;
SKCM	cis	rs9790314	0.905	rs7632797	chr3:161002694	C/T	cg03342759	chr3:160939853	NMD3	0.72	8.23	0.68	3.32e-12	Morning vs. evening chronotype;
SKCM	cis	rs2180341	0.960	rs7756884	chr6:127684018	A/G	cg24812749	chr6:127587940	RNF146	0.83	7.24	0.63	2.76e-10	Breast cancer;
SKCM	cis	rs11249608	0.548	rs2047354	chr5:178455247	T/C	cg21905437	chr5:178450457	ZNF879	0.73	5.93	0.56	7.89e-8	Pubertal anthropometrics;
SKCM	cis	rs748404	0.631	rs2412781	chr15:43667900	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	-0.82	-6.27	-0.58	1.86e-8	Lung cancer;
SKCM	cis	rs4665809	0.549	rs34075014	chr2:26520842	T/C	cg26119090	chr2:26468346	HADHA;HADHB	1.01	7.52	0.65	8.08e-11	Gut microbiome composition (summer);
SKCM	cis	rs2760061	0.626	rs592736	chr1:228116831	A/G	cg02753203	chr1:228287806	NA	-0.62	-4.9	-0.49	5.11e-6	Diastolic blood pressure;
SKCM	cis	rs10500871	1.000	rs12361708	chr11:20215688	G/C	cg04653710	chr11:19367236	NA	0.58	5.02	0.49	3.16e-6	Educational attainment;
SKCM	cis	rs7666738	0.830	rs17484890	chr4:99013778	T/C	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2777491	1.000	rs1757455	chr15:41761332	G/T	cg18705301	chr15:41695430	NDUFAF1	-0.89	-9.04	-0.72	9.17e-14	Ulcerative colitis;
SKCM	cis	rs9660180	0.967	rs12034740	chr1:1728969	C/A	cg13866156	chr1:1669148	SLC35E2	-0.73	-6.09	-0.57	3.99e-8	Body mass index;
SKCM	cis	rs2836974	0.965	rs8134733	chr21:40683459	C/T	cg11644478	chr21:40555479	PSMG1	0.83	7.72	0.66	3.29e-11	Cognitive function;
SKCM	cis	rs7666738	0.830	rs1593569	chr4:99017485	C/G	cg17366294	chr4:99064904	C4orf37	0.6	4.98	0.49	3.66e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1580019	0.961	rs1610143	chr7:32498331	C/T	cg06627557	chr7:32535165	LSM5;AVL9	0.75	5.74	0.55	1.7e-7	Cognitive ability;
SKCM	cis	rs1799949	1.000	rs4793194	chr17:41218333	G/A	cg25918947	chr17:41365094	TMEM106A	-0.61	-5.91	-0.56	8.59e-8	Menopause (age at onset);
SKCM	cis	rs7937682	0.587	rs571594	chr11:111359334	A/G	cg09085632	chr11:111637200	PPP2R1B	0.69	5.43	0.52	6.23e-7	Primary sclerosing cholangitis;
SKCM	cis	rs28595532	0.920	rs17324968	chr4:119772316	A/G	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs28386778	0.897	rs2859619	chr17:61917686	T/C	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs2832191	0.720	rs4643617	chr21:30485278	T/C	cg08807101	chr21:30365312	RNF160	-0.62	-4.94	-0.49	4.34e-6	Dental caries;
SKCM	cis	rs7122539	0.734	rs4930391	chr11:66645254	A/G	cg12372692	chr11:66233905	PELI3	0.7	5.31	0.52	1e-6	HIV-1 susceptibility;
SKCM	cis	rs6665290	0.935	rs6659424	chr1:227197875	A/G	cg10327440	chr1:227177885	CDC42BPA	-1.24	-16.71	-0.88	1.69e-27	Myeloid white cell count;
SKCM	cis	rs372883	0.648	rs1153292	chr21:30689195	G/T	cg24692254	chr21:30365293	RNF160	-0.68	-5.46	-0.53	5.37e-7	Pancreatic cancer;
SKCM	cis	rs4975616	0.590	rs4530805	chr5:1306331	T/C	cg06550200	chr5:1325588	CLPTM1L	0.69	5.08	0.5	2.56e-6	Lung cancer;
SKCM	cis	rs1348850	0.540	rs10172355	chr2:178443225	A/G	cg27490568	chr2:178487706	NA	0.73	5.18	0.51	1.72e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs6120849	0.663	rs11698868	chr20:33549946	C/T	cg24642439	chr20:33292090	TP53INP2	0.98	5.35	0.52	8.46e-7	Protein C levels;
SKCM	cis	rs8180040	0.845	rs295441	chr3:47333295	T/A	cg27129171	chr3:47204927	SETD2	0.87	6.62	0.6	4.15e-9	Colorectal cancer;
SKCM	cis	rs8180040	0.932	rs12490058	chr3:47529063	T/C	cg16586182	chr3:47516702	SCAP	-0.76	-5.32	-0.52	9.63e-7	Colorectal cancer;
SKCM	trans	rs7618501	1.000	rs7374277	chr3:49784777	T/C	cg21659725	chr3:3221576	CRBN	-0.96	-9.61	-0.74	7.08e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs801193	0.844	rs732465	chr7:65998450	T/C	cg11987759	chr7:65425863	GUSB	-0.7	-6.12	-0.57	3.47e-8	Aortic root size;
SKCM	cis	rs4925325	0.876	rs6089560	chr20:60517325	T/G	cg13770153	chr20:60521292	NA	-1.06	-8.74	-0.7	3.5e-13	Obesity-related traits;
SKCM	cis	rs6952808	0.531	rs3778998	chr7:2180753	C/A	cg02951883	chr7:2050386	MAD1L1	-0.77	-6.09	-0.57	4.05e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs1005277	0.522	rs9417256	chr10:37976990	A/G	cg25427524	chr10:38739819	LOC399744	-0.64	-6.43	-0.59	9.2e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs9325144	0.624	rs10783330	chr12:39114084	A/G	cg26384229	chr12:38710491	ALG10B	-0.72	-6.56	-0.6	5.43e-9	Morning vs. evening chronotype;
SKCM	cis	rs9910055	0.531	rs6503490	chr17:42246656	A/G	cg13607699	chr17:42295918	UBTF	0.71	5.65	0.54	2.53e-7	Total body bone mineral density;
SKCM	cis	rs4820539	1.000	rs2267002	chr22:23456702	T/C	cg14186256	chr22:23484241	RTDR1	0.83	8.41	0.69	1.52e-12	Bone mineral density;
SKCM	cis	rs7666738	0.830	rs3846444	chr4:99032888	T/C	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7666738	0.830	rs11097598	chr4:98946057	T/C	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1577917	0.958	rs13219504	chr6:86556917	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.68	-5.91	-0.56	8.36e-8	Response to antipsychotic treatment;
SKCM	cis	rs2991971	1.000	rs518365	chr1:46010652	A/G	cg24296786	chr1:45957014	TESK2	0.66	5.27	0.51	1.18e-6	High light scatter reticulocyte count;
SKCM	cis	rs7666738	0.830	rs13129503	chr4:98987892	T/C	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2075371	0.829	rs35897155	chr7:134002711	G/A	cg20476274	chr7:133979776	SLC35B4	1.01	10.1	0.75	8.14e-16	Mean platelet volume;
SKCM	cis	rs11155671	0.530	rs4869764	chr6:150211828	T/C	cg05036130	chr6:150231994	NA	0.61	6.58	0.6	4.87e-9	Testicular germ cell tumor;
SKCM	cis	rs1577917	0.958	rs13207354	chr6:86700263	A/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.64	-5.54	-0.53	3.92e-7	Response to antipsychotic treatment;
SKCM	cis	rs875971	1.000	rs2087647	chr7:65593188	C/A	cg18876405	chr7:65276391	NA	-0.68	-6.85	-0.61	1.54e-9	Aortic root size;
SKCM	cis	rs8072100	0.688	rs8079142	chr17:45442049	G/A	cg08085267	chr17:45401833	C17orf57	-0.7	-5.61	-0.54	2.91e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs875971	0.862	rs1083554	chr7:65852341	T/C	cg11764359	chr7:65958608	NA	0.74	6.67	0.6	3.3e-9	Aortic root size;
SKCM	cis	rs11098499	0.588	rs2389874	chr4:120554991	A/G	cg09307838	chr4:120376055	NA	-0.97	-8.11	-0.68	5.87e-12	Corneal astigmatism;
SKCM	cis	rs7666738	0.830	rs28451001	chr4:98924544	T/A	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10504073	0.584	rs56068225	chr8:49923988	A/G	cg00325661	chr8:49890786	NA	0.79	7.15	0.63	3.99e-10	Blood metabolite ratios;
SKCM	cis	rs2070488	0.775	rs9838614	chr3:38537671	A/C	cg01465620	chr3:38496096	LOC100128640;ACVR2B	-0.74	-5.93	-0.56	7.79e-8	Electrocardiographic conduction measures;
SKCM	cis	rs344364	0.511	rs1742473	chr16:1953095	T/C	cg26897989	chr16:1907736	C16orf73	-0.72	-7.11	-0.63	4.82e-10	Glomerular filtration rate in chronic kidney disease;
SKCM	cis	rs28595532	0.841	rs114385163	chr4:119737058	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs6951245	0.938	rs112425403	chr7:1071531	A/G	cg24642844	chr7:1081250	C7orf50	-0.97	-6.43	-0.59	9.47e-9	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7772486	0.701	rs7772717	chr6:145954854	T/C	cg05347473	chr6:146136440	FBXO30	0.64	5.91	0.56	8.66e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7618501	0.602	rs2071207	chr3:50159844	T/C	cg05072774	chr3:49840536	C3orf54	0.71	5.48	0.53	5e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7618501	0.633	rs13060128	chr3:50025028	A/G	cg24110177	chr3:50126178	RBM5	-0.6	-5.11	-0.5	2.25e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs8014204	0.901	rs2080087	chr14:75365062	C/T	cg06637938	chr14:75390232	RPS6KL1	0.77	5.86	0.55	1.04e-7	Caffeine consumption;
SKCM	cis	rs561341	0.882	rs504887	chr17:30322881	T/A	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs2836974	0.604	rs2854727	chr21:40713787	A/G	cg11890956	chr21:40555474	PSMG1	0.74	5.92	0.56	8.22e-8	Cognitive function;
SKCM	cis	rs11608355	0.573	rs7970666	chr12:109793495	T/G	cg19025524	chr12:109796872	NA	-0.66	-5.38	-0.52	7.5e-7	Neuroticism;
SKCM	cis	rs12971120	0.891	rs12608037	chr18:72169395	A/G	cg26446133	chr18:72167187	CNDP2	-0.67	-5.21	-0.51	1.48e-6	Refractive error;
SKCM	cis	rs1348850	0.526	rs6433672	chr2:178378175	G/T	cg27490568	chr2:178487706	NA	0.89	6.43	0.59	9.33e-9	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs208520	0.954	rs12190073	chr6:66983740	T/C	cg07460842	chr6:66804631	NA	0.87	5.96	0.56	6.95e-8	Exhaled nitric oxide output;
SKCM	cis	rs861020	0.771	rs126280	chr1:210019824	A/G	cg05527609	chr1:210001259	C1orf107	1.04	8.04	0.67	7.79e-12	Orofacial clefts;
SKCM	cis	rs1395	0.677	rs113353646	chr2:27492674	C/T	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.54	5.24	0.51	1.35e-6	Blood metabolite levels;
SKCM	cis	rs748404	0.697	rs473554	chr15:43568207	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	0.7	5.68	0.54	2.19e-7	Lung cancer;
SKCM	cis	rs4478037	1.000	rs6809511	chr3:33155264	T/G	cg19404215	chr3:33155277	CRTAP	1.07	5.2	0.51	1.58e-6	Major depressive disorder;
SKCM	cis	rs12950390	0.853	rs17700008	chr17:45863591	A/C	cg03474202	chr17:45855739	NA	0.45	5.01	0.49	3.36e-6	IgG glycosylation;
SKCM	cis	rs10791097	0.694	rs4936123	chr11:130740967	G/A	cg12179176	chr11:130786555	SNX19	0.96	8.52	0.69	9.36e-13	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs9581857	0.547	rs17753763	chr13:28077734	A/G	cg22138327	chr13:27999177	GTF3A	0.84	5.53	0.53	4.15e-7	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs8060686	0.641	rs8058690	chr16:68136622	T/G	cg09117114	chr16:67998030	SLC12A4	-0.81	-5.29	-0.51	1.07e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs10489202	0.608	rs3753934	chr1:168074677	C/T	cg24449463	chr1:168025552	DCAF6	-0.81	-7.61	-0.65	5.44e-11	Schizophrenia;
SKCM	cis	rs4891159	0.584	rs2848958	chr18:74157068	C/T	cg24786174	chr18:74118243	ZNF516	0.78	7.96	0.67	1.15e-11	Longevity;
SKCM	cis	rs3793683	0.571	rs12781152	chr10:134590257	G/C	cg18305652	chr10:134549665	INPP5A	0.62	6.13	0.57	3.38e-8	Migraine;
SKCM	cis	rs995000	0.965	rs1690761	chr1:62955862	C/T	cg06896770	chr1:63153194	DOCK7	-0.75	-7.59	-0.65	5.78e-11	Triglyceride levels;
SKCM	cis	rs362296	0.511	rs2051558	chr4:3324886	G/A	cg16987761	chr4:3318072	RGS12	0.81	8.33	0.69	2.13e-12	Parental longevity (mother's age at death);
SKCM	cis	rs732528	0.559	rs7239562	chr18:48361502	A/G	cg03255741	chr18:48556964	SMAD4	-0.68	-4.95	-0.49	4.23e-6	Entorhinal cortical thickness;
SKCM	cis	rs6570726	0.935	rs380433	chr6:145859601	A/T	cg23711669	chr6:146136114	FBXO30	0.71	6.8	0.61	1.93e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7811142	0.945	rs6974282	chr7:100098295	C/T	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.22	7.91	0.67	1.43e-11	Platelet count;
SKCM	cis	rs2455601	1.000	rs72632952	chr11:8917976	T/C	cg21881798	chr11:8931708	C11orf17;ST5	-0.78	-5.59	-0.53	3.21e-7	Schizophrenia;
SKCM	cis	rs7809950	0.862	rs12112877	chr7:106941324	T/C	cg23024343	chr7:107201750	COG5	-0.68	-5.65	-0.54	2.5e-7	Coronary artery disease;
SKCM	cis	rs11710229	1.000	rs11714488	chr3:55484498	G/A	cg04915058	chr3:55693741	C3orf51;ERC2	0.89	5.04	0.5	2.9e-6	Response to cytadine analogues (cytosine arabinoside);
SKCM	cis	rs10769945	0.597	rs1877443	chr11:1968016	G/T	cg23202291	chr11:1979235	NA	0.53	5.37	0.52	7.99e-7	DNA methylation (variation);
SKCM	cis	rs2243480	0.831	rs7806717	chr7:65393174	A/G	cg18252515	chr7:66147081	NA	1.34	8.18	0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs9916302	0.904	rs7216086	chr17:37709422	G/A	cg07936489	chr17:37558343	FBXL20	-0.9	-8.15	-0.68	4.86e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs4900538	0.821	rs8016191	chr14:102825340	G/A	cg18135206	chr14:102964638	TECPR2	-0.74	-5.75	-0.55	1.65e-7	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs7772486	0.754	rs9497434	chr6:146260753	C/T	cg23711669	chr6:146136114	FBXO30	-0.76	-7.4	-0.64	1.38e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1707322	0.752	rs11211168	chr1:46163647	C/T	cg03146154	chr1:46216737	IPP	0.8	5.47	0.53	5.19e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs2439831	1.000	rs2584726	chr15:43715382	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.15	7.17	0.63	3.73e-10	Lung cancer in ever smokers;
SKCM	cis	rs854765	0.583	rs11871899	chr17:17826748	C/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.93	7.3	0.64	2.06e-10	Total body bone mineral density;
SKCM	cis	rs7598759	0.712	rs10933372	chr2:232332325	G/A	cg19187155	chr2:232395269	NMUR1	0.61	5.13	0.5	2.07e-6	Noise-induced hearing loss;
SKCM	cis	rs245880	0.740	rs245898	chr7:29194143	G/A	cg17163760	chr7:29186267	CPVL	-0.42	-5.57	-0.53	3.48e-7	Warfarin maintenance dose;
SKCM	cis	rs7666738	0.687	rs6830176	chr4:99093955	G/C	cg17366294	chr4:99064904	C4orf37	0.62	5.03	0.49	3.06e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6545883	0.894	rs2121661	chr2:61561658	A/G	cg15711740	chr2:61764176	XPO1	0.68	4.82	0.48	6.94e-6	Tuberculosis;
SKCM	cis	rs478304	0.593	rs6591188	chr11:65467953	T/C	cg27068330	chr11:65405492	SIPA1	-0.82	-7.03	-0.62	6.99e-10	Acne (severe);
SKCM	cis	rs9309711	0.772	rs9309715	chr2:3492318	C/G	cg10845886	chr2:3471009	TTC15	0.72	5.41	0.52	6.63e-7	Neurofibrillary tangles;
SKCM	cis	rs709400	0.628	rs6575984	chr14:103876454	A/G	cg26031613	chr14:104095156	KLC1	-0.68	-4.82	-0.48	6.83e-6	Body mass index;
SKCM	cis	rs12044355	0.929	rs6693517	chr1:231852444	G/A	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	0.76	5.49	0.53	4.81e-7	Alzheimer's disease;
SKCM	trans	rs561341	1.000	rs506766	chr17:30289659	T/C	cg20587970	chr11:113659929	NA	-1.18	-10.02	-0.75	1.16e-15	Hip circumference adjusted for BMI;
SKCM	cis	rs3857536	0.706	rs1418854	chr6:66893284	C/T	cg07460842	chr6:66804631	NA	-0.7	-5.08	-0.5	2.51e-6	Blood trace element (Cu levels);
SKCM	cis	rs11764590	0.694	rs6461115	chr7:2103668	A/G	cg23422044	chr7:1970798	MAD1L1	-0.84	-5.91	-0.56	8.56e-8	Neuroticism;
SKCM	cis	rs875971	0.520	rs2420597	chr7:65915986	A/G	cg11764359	chr7:65958608	NA	0.81	7.61	0.65	5.25e-11	Aortic root size;
SKCM	cis	rs1790761	0.520	rs7124513	chr11:67395714	C/T	cg24690094	chr11:67383802	NA	-0.57	-5.96	-0.56	6.91e-8	Mean corpuscular volume;
SKCM	cis	rs2197308	0.659	rs11181327	chr12:37903171	C/T	cg13010199	chr12:38710504	ALG10B	-0.64	-4.92	-0.49	4.67e-6	Morning vs. evening chronotype;
SKCM	cis	rs12497850	0.931	rs6414613	chr3:49035885	C/T	cg07636037	chr3:49044803	WDR6	1.04	11.28	0.79	4.6e-18	Parkinson's disease;
SKCM	cis	rs11098499	0.863	rs2127823	chr4:120485670	G/T	cg09307838	chr4:120376055	NA	1.0	8.27	0.68	2.8e-12	Corneal astigmatism;
SKCM	cis	rs801193	1.000	rs1553609	chr7:66197139	T/C	cg11764359	chr7:65958608	NA	0.86	6.55	0.6	5.68e-9	Aortic root size;
SKCM	cis	rs523522	0.962	rs4767904	chr12:120930798	T/G	cg27279351	chr12:120934652	DYNLL1	0.91	8.32	0.69	2.26e-12	High light scatter reticulocyte count;
SKCM	cis	rs71520386	0.530	rs10256628	chr7:22883259	G/C	cg22407942	chr7:22894828	SNORD93	0.66	4.99	0.49	3.58e-6	Fibrinogen levels;
SKCM	cis	rs10751667	0.666	rs7396677	chr11:958878	C/T	cg10932868	chr11:921992	NA	0.55	5.1	0.5	2.36e-6	Alzheimer's disease (late onset);
SKCM	cis	rs1949733	0.598	rs16842480	chr4:8535621	G/T	cg11789530	chr4:8429930	ACOX3	-0.79	-5.11	-0.5	2.25e-6	Response to antineoplastic agents;
SKCM	cis	rs17376456	0.569	rs6881815	chr5:93105666	A/G	cg25358565	chr5:93447407	FAM172A	0.86	5.45	0.53	5.59e-7	Diabetic retinopathy;
SKCM	cis	rs62238980	0.614	rs76549479	chr22:32510944	G/A	cg00543991	chr22:32367038	NA	1.17	4.81	0.48	7.24e-6	Childhood ear infection;
SKCM	cis	rs1325195	0.537	rs2636290	chr1:179096088	A/G	cg10806749	chr1:179558114	NA	-0.55	-5.21	-0.51	1.51e-6	IgE grass sensitization;
SKCM	cis	rs12142240	0.698	rs6429599	chr1:46827871	G/A	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs2050392	0.931	rs2265189	chr10:30689316	C/T	cg25182066	chr10:30743637	MAP3K8	0.68	5.26	0.51	1.23e-6	Inflammatory bowel disease;
SKCM	cis	rs2070488	1.000	rs2268757	chr3:38505853	C/T	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.99	9.05	0.72	8.53e-14	Electrocardiographic conduction measures;
SKCM	cis	rs5753618	0.583	rs738657	chr22:31841749	T/A	cg02404636	chr22:31891804	SFI1	0.61	5.56	0.53	3.6e-7	Colorectal cancer;
SKCM	cis	rs798554	0.723	rs798518	chr7:2777825	A/G	cg19346786	chr7:2764209	NA	-0.6	-6.22	-0.58	2.29e-8	Height;
SKCM	cis	rs514406	0.861	rs7417821	chr1:53295117	A/G	cg16325326	chr1:53192061	ZYG11B	0.88	8.69	0.7	4.38e-13	Monocyte count;
SKCM	cis	rs6066825	0.555	rs4810849	chr20:47289944	C/T	cg18078177	chr20:47281410	PREX1	0.67	5.69	0.54	2.1e-7	Colorectal cancer;
SKCM	cis	rs9818758	0.556	rs9814987	chr3:49207849	T/C	cg24110177	chr3:50126178	RBM5	0.88	5.26	0.51	1.23e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs3008870	1.000	rs2755244	chr1:67484470	C/T	cg08660285	chr1:67390436	MIER1;WDR78	-0.93	-6.18	-0.57	2.68e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs4930103	0.602	rs170101	chr11:2008936	C/T	cg23202291	chr11:1979235	NA	0.59	5.78	0.55	1.46e-7	DNA methylation (parent-of-origin);DNA methylation (variation);
SKCM	cis	rs4954585	0.683	rs4452212	chr2:137015991	G/A	cg05194412	chr2:137003533	NA	0.57	5.1	0.5	2.31e-6	Colorectal cancer;
SKCM	cis	rs1707322	1.000	rs1613296	chr1:46546852	A/C	cg03146154	chr1:46216737	IPP	-0.75	-4.91	-0.49	4.86e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs72634258	0.503	rs34177663	chr1:7833228	A/G	cg26816564	chr1:7831052	VAMP3	0.78	5.51	0.53	4.39e-7	Inflammatory bowel disease;
SKCM	cis	rs208520	0.690	rs7764570	chr6:66827600	G/C	cg07460842	chr6:66804631	NA	-1.06	-8.38	-0.69	1.74e-12	Exhaled nitric oxide output;
SKCM	cis	rs8180040	0.726	rs7628747	chr3:47001990	A/T	cg27129171	chr3:47204927	SETD2	0.8	6.14	0.57	3.2e-8	Colorectal cancer;
SKCM	cis	rs7666738	0.830	rs6854703	chr4:98977586	A/T	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1046896	0.739	rs2379358	chr17:80741612	G/A	cg22027946	chr17:80790580	TBCD;ZNF750	0.73	5.87	0.55	9.93e-8	Glycated hemoglobin levels;
SKCM	cis	rs1218582	0.772	rs4845689	chr1:154885524	A/G	cg03351412	chr1:154909251	PMVK	0.77	6.52	0.59	6.43e-9	Prostate cancer;
SKCM	cis	rs55962025	0.711	rs82333	chr4:3225389	C/T	cg16987761	chr4:3318072	RGS12	0.6	4.88	0.48	5.41e-6	Parental longevity (mother's age at death);
SKCM	cis	rs34779708	0.658	rs4934715	chr10:35364992	G/T	cg03585969	chr10:35415529	CREM	0.79	6.32	0.58	1.53e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs13118159	0.550	rs13123016	chr4:1340889	T/C	cg05025164	chr4:1340916	KIAA1530	0.9	7.27	0.64	2.39e-10	Longevity;
SKCM	cis	rs2120019	1.000	rs34237279	chr15:75361121	A/G	cg09165964	chr15:75287851	SCAMP5	-0.75	-6.28	-0.58	1.78e-8	Blood trace element (Zn levels);
SKCM	cis	rs875971	0.619	rs10278371	chr7:66051540	C/A	cg11764359	chr7:65958608	NA	-0.83	-6.29	-0.58	1.71e-8	Aortic root size;
SKCM	cis	rs600231	0.708	rs2957269	chr11:65243007	C/G	cg24009118	chr11:65545808	DKFZp761E198	0.66	4.94	0.49	4.36e-6	Bone mineral density;
SKCM	cis	rs8060686	0.565	rs4359427	chr16:68202747	C/T	cg09117114	chr16:67998030	SLC12A4	-0.78	-5.08	-0.5	2.56e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs362272	0.545	rs3135146	chr4:3307638	C/G	cg24015175	chr4:3319247	RGS12	-0.79	-9.44	-0.73	1.49e-14	Serum sulfate level;
SKCM	cis	rs912057	0.601	rs1294411	chr6:6739034	T/C	cg06612196	chr6:6737390	NA	0.74	6.32	0.58	1.49e-8	Waist-to-hip ratio adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);
SKCM	cis	rs362296	0.671	rs3095074	chr4:3261152	G/A	cg00764545	chr4:3318001	RGS12	-0.77	-7.14	-0.63	4.22e-10	Parental longevity (mother's age at death);
SKCM	cis	rs8014204	0.804	rs2241274	chr14:75251331	G/A	cg06637938	chr14:75390232	RPS6KL1	0.84	6.66	0.6	3.53e-9	Caffeine consumption;
SKCM	cis	rs769267	0.930	rs1047361	chr19:19606634	G/A	cg26732615	chr19:19648335	CILP2;YJEFN3	0.67	7.06	0.62	6e-10	Tonsillectomy;
SKCM	cis	rs6998277	1.000	rs34217554	chr8:103646352	T/C	cg10187029	chr8:103597600	NA	0.7	5.15	0.5	1.88e-6	Migraine;
SKCM	cis	rs2479724	0.613	rs9367113	chr6:41809801	T/G	cg17623882	chr6:41773611	USP49	-0.73	-6.04	-0.56	4.97e-8	Menarche (age at onset);
SKCM	cis	rs854765	0.647	rs712267	chr17:18021607	G/A	cg04398451	chr17:18023971	MYO15A	-1.03	-8.92	-0.71	1.58e-13	Total body bone mineral density;
SKCM	cis	rs11792861	0.926	rs11788825	chr9:111829757	T/G	cg14432460	chr9:111696404	IKBKAP;C9orf6	0.66	4.88	0.48	5.55e-6	Menarche (age at onset);
SKCM	cis	rs875971	0.862	rs709596	chr7:65825913	A/G	cg18876405	chr7:65276391	NA	0.64	6.36	0.58	1.28e-8	Aortic root size;
SKCM	cis	rs637571	0.522	rs491973	chr11:65727301	A/G	cg02427764	chr11:65769310	BANF1;EIF1AD	0.76	5.82	0.55	1.26e-7	Eosinophil percentage of white cells;
SKCM	cis	rs9583531	0.600	rs6492305	chr13:111361400	C/T	cg24331049	chr13:111365604	ING1	0.88	6.6	0.6	4.45e-9	Coronary artery disease;
SKCM	cis	rs8072100	0.676	rs7221345	chr17:45405144	G/A	cg08085267	chr17:45401833	C17orf57	-0.85	-7.16	-0.63	3.97e-10	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs1165205	0.558	rs531750	chr6:25882642	C/G	cg03264133	chr6:25882463	NA	-0.64	-6.62	-0.6	4.05e-9	Urate levels;
SKCM	cis	rs950776	0.752	rs7182583	chr15:78899210	G/C	cg06917634	chr15:78832804	PSMA4	0.84	6.75	0.61	2.33e-9	Sudden cardiac arrest;
SKCM	cis	rs8077889	0.871	rs9893111	chr17:41915767	G/A	cg26893861	chr17:41843967	DUSP3	1.1	6.79	0.61	1.95e-9	Triglycerides;
SKCM	cis	rs478222	1.000	rs478222	chr2:25301755	A/T	cg04586622	chr2:25135609	ADCY3	-0.66	-5.08	-0.5	2.52e-6	Type 1 diabetes;
SKCM	cis	rs8017423	0.904	rs11622257	chr14:90715014	C/T	cg04374321	chr14:90722782	PSMC1	-0.96	-8.98	-0.71	1.18e-13	Mortality in heart failure;
SKCM	cis	rs6061231	0.544	rs2427314	chr20:60973666	C/T	cg24112000	chr20:60950667	NA	-0.63	-6.21	-0.58	2.39e-8	Colorectal cancer;
SKCM	cis	rs362272	0.505	rs3129310	chr4:3301388	T/G	cg24015175	chr4:3319247	RGS12	0.8	9.46	0.73	1.36e-14	Serum sulfate level;
SKCM	cis	rs4919087	0.926	rs10882884	chr10:99025611	T/A	cg25902810	chr10:99078978	FRAT1	0.63	5.14	0.5	2.01e-6	Monocyte count;
SKCM	cis	rs6546550	0.694	rs12467361	chr2:70019127	G/A	cg02498382	chr2:70120550	SNRNP27	-0.47	-4.97	-0.49	3.95e-6	Prevalent atrial fibrillation;
SKCM	cis	rs9911578	1.000	rs9897326	chr17:56902297	A/G	cg05425664	chr17:57184151	TRIM37	-0.67	-5.04	-0.5	2.91e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs8060686	0.641	rs7192187	chr16:68132109	T/C	cg04539111	chr16:67997858	SLC12A4	-0.85	-4.81	-0.48	7.14e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs9790314	0.846	rs9834659	chr3:160980947	A/C	cg03342759	chr3:160939853	NMD3	-0.72	-8.12	-0.68	5.59e-12	Morning vs. evening chronotype;
SKCM	cis	rs561341	0.769	rs559228	chr17:30294527	T/C	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs11690935	0.959	rs77280952	chr2:172620151	G/C	cg13550731	chr2:172543902	DYNC1I2	-0.94	-7.71	-0.66	3.41e-11	Schizophrenia;
SKCM	cis	rs11098499	0.826	rs4472123	chr4:120236630	T/A	cg09307838	chr4:120376055	NA	0.92	7.45	0.64	1.08e-10	Corneal astigmatism;
SKCM	cis	rs3741404	0.537	rs1123251	chr11:63917601	G/T	cg05555928	chr11:63887634	MACROD1	0.77	5.63	0.54	2.7e-7	Platelet count;
SKCM	cis	rs394563	0.690	rs237009	chr6:149759552	C/T	cg16235748	chr6:149772707	ZC3H12D	-0.44	-4.78	-0.48	7.97e-6	Dupuytren's disease;
SKCM	cis	rs6429082	0.518	rs1812350	chr1:235659920	C/A	cg26050004	chr1:235667680	B3GALNT2	0.91	8.75	0.7	3.32e-13	Adiposity;
SKCM	cis	rs654950	0.783	rs668359	chr1:42003425	A/C	cg06885757	chr1:42089581	HIVEP3	-0.52	-5.34	-0.52	9.01e-7	Airway imaging phenotypes;
SKCM	cis	rs1348850	0.651	rs4893935	chr2:178240601	C/G	cg02961200	chr2:178257176	LOC100130691;AGPS	0.75	5.49	0.53	4.88e-7	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	trans	rs208520	0.507	rs9453585	chr6:66796668	C/T	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-1.12	-11.79	-0.8	5.24e-19	Exhaled nitric oxide output;
SKCM	cis	rs12497850	0.627	rs4974078	chr3:49009386	C/T	cg07636037	chr3:49044803	WDR6	0.59	5.1	0.5	2.32e-6	Parkinson's disease;
SKCM	cis	rs362272	0.524	rs2857982	chr4:3358665	G/A	cg16987761	chr4:3318072	RGS12	1.01	11.83	0.8	4.37e-19	Serum sulfate level;
SKCM	cis	rs17685	0.712	rs59659102	chr7:75710114	G/A	cg16684958	chr7:75615977	POR	0.57	5.54	0.53	4e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1005277	0.691	rs2474558	chr10:38486141	A/C	cg25427524	chr10:38739819	LOC399744	0.73	6.09	0.57	3.92e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs10489202	0.608	rs10918826	chr1:168075316	C/T	cg24449463	chr1:168025552	DCAF6	-0.81	-7.61	-0.65	5.44e-11	Schizophrenia;
SKCM	cis	rs1707322	0.686	rs11211179	chr1:46228082	A/C	cg03146154	chr1:46216737	IPP	0.83	6.17	0.57	2.87e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs2836974	0.568	rs371625	chr21:40535271	A/G	cg17971929	chr21:40555470	PSMG1	-0.76	-7.16	-0.63	3.94e-10	Cognitive function;
SKCM	cis	rs7937682	0.814	rs1619652	chr11:111469757	G/A	cg19812747	chr11:111475976	SIK2	-0.61	-4.94	-0.49	4.41e-6	Primary sclerosing cholangitis;
SKCM	cis	rs561341	1.000	rs483301	chr17:30293398	G/T	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs4243830	0.850	rs12410405	chr1:6581283	C/G	cg05709478	chr1:6581295	PLEKHG5	0.81	4.97	0.49	3.82e-6	Body mass index;
SKCM	cis	rs1799949	1.000	rs8176234	chr17:41219780	T/C	cg05368731	chr17:41323189	NBR1	0.89	7.87	0.67	1.71e-11	Menopause (age at onset);
SKCM	cis	rs10752881	0.967	rs12404594	chr1:182988027	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.73	6.47	0.59	7.97e-9	Colorectal cancer;
SKCM	cis	rs9513627	1.000	rs2390278	chr13:100159712	G/A	cg11288260	chr13:100117058	NA	0.79	4.78	0.48	8.1e-6	Obesity-related traits;
SKCM	cis	rs36093844	0.706	rs7931771	chr11:85549888	C/G	cg25872744	chr11:85566296	CCDC83	-0.85	-4.77	-0.48	8.27e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs55962025	0.711	rs116275868	chr4:3231148	G/C	cg21096898	chr4:3318625	RGS12	-0.66	-5.31	-0.52	1.01e-6	Parental longevity (mother's age at death);
SKCM	cis	rs2354432	0.556	rs4424557	chr1:146871119	A/G	cg25205988	chr1:146714368	CHD1L	1.08	5.32	0.52	9.52e-7	Mitochondrial DNA levels;
SKCM	cis	rs362272	0.545	rs2749785	chr4:3325179	G/C	cg16987761	chr4:3318072	RGS12	0.99	11.27	0.79	4.77e-18	Serum sulfate level;
SKCM	cis	rs4423214	0.840	rs1792224	chr11:71176141	C/T	cg05163923	chr11:71159392	DHCR7	-0.74	-6.65	-0.6	3.61e-9	Vitamin D levels;
SKCM	cis	rs13256369	1.000	rs10110591	chr8:8576608	G/T	cg17143192	chr8:8559678	CLDN23	-0.67	-4.94	-0.49	4.34e-6	Obesity-related traits;
SKCM	cis	rs709400	0.832	rs10145755	chr14:104121984	C/T	cg26031613	chr14:104095156	KLC1	1.05	12.89	0.82	5.14e-21	Body mass index;
SKCM	cis	rs72827839	0.516	rs72833461	chr17:45938105	T/G	cg23391107	chr17:45924227	SP6	0.67	5.75	0.55	1.63e-7	Ease of getting up in the morning;
SKCM	cis	rs7666738	0.830	rs28852677	chr4:99039509	T/G	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs28595532	0.920	rs56389935	chr4:119683571	G/A	cg14228332	chr4:119757509	SEC24D	1.07	5.49	0.53	4.77e-7	Cannabis dependence symptom count;
SKCM	cis	rs7555523	0.887	rs7518099	chr1:165736880	C/T	cg24409356	chr1:165738333	TMCO1	0.93	5.15	0.5	1.9e-6	Intraocular pressure;Glaucoma (high intraocular pressure);
SKCM	cis	rs8077889	0.917	rs72836553	chr17:41909851	A/G	cg26893861	chr17:41843967	DUSP3	1.15	7.34	0.64	1.79e-10	Triglycerides;
SKCM	cis	rs3008870	1.000	rs2985822	chr1:67404910	T/G	cg08660285	chr1:67390436	MIER1;WDR78	0.92	6.05	0.57	4.69e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs9815354	0.812	rs73828283	chr3:41835099	T/C	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs7666738	0.830	rs17550610	chr4:99008273	T/C	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7635838	0.684	rs2594968	chr3:11352442	T/C	cg00170343	chr3:11313890	ATG7	0.72	5.5	0.53	4.68e-7	HDL cholesterol;
SKCM	cis	rs7666738	0.830	rs11947027	chr4:99005941	T/C	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9926296	0.528	rs4785721	chr16:89839997	G/A	cg26513180	chr16:89883248	FANCA	0.99	11.06	0.78	1.22e-17	Vitiligo;
SKCM	cis	rs9902453	1.000	rs11080114	chr17:28407287	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.81	-5.78	-0.55	1.45e-7	Coffee consumption (cups per day);
SKCM	cis	rs6952808	1.000	rs6952808	chr7:1886535	C/G	cg02951883	chr7:2050386	MAD1L1	-0.68	-5.18	-0.51	1.68e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs57221529	0.766	rs17563576	chr5:560476	A/G	cg10555297	chr5:473380	SLC9A3;LOC25845	1.02	5.1	0.5	2.37e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs9303401	0.614	rs2007993	chr17:56590643	T/C	cg02118635	chr17:56770003	RAD51C;TEX14	0.8	5.25	0.51	1.29e-6	Cognitive test performance;
SKCM	cis	rs514406	0.505	rs146750	chr1:53183447	C/G	cg16325326	chr1:53192061	ZYG11B	0.89	10.06	0.75	9.55e-16	Monocyte count;
SKCM	cis	rs7103648	1.000	rs11039225	chr11:47430599	G/A	cg20307385	chr11:47447363	PSMC3	1.08	9.26	0.72	3.38e-14	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs151997	0.630	rs26064	chr5:50217806	T/C	cg06027927	chr5:50259733	NA	0.65	6.24	0.58	2.13e-8	Callous-unemotional behaviour;
SKCM	cis	rs4819052	0.851	rs35560973	chr21:46662573	T/C	cg19498844	chr21:46707878	POFUT2;LOC642852	0.84	7.1	0.63	5.13e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs875971	0.660	rs7807930	chr7:66087165	C/T	cg11987759	chr7:65425863	GUSB	0.67	5.8	0.55	1.36e-7	Aortic root size;
SKCM	cis	rs67311347	0.544	rs1454492	chr3:40352884	C/T	cg13409248	chr3:40428643	ENTPD3	0.57	5.32	0.52	9.61e-7	Renal cell carcinoma;
SKCM	cis	rs67311347	0.868	rs10865895	chr3:40378677	C/T	cg00091569	chr3:40428383	ENTPD3	0.65	5.58	0.53	3.36e-7	Renal cell carcinoma;
SKCM	cis	rs11690935	0.610	rs59844139	chr2:172731983	C/A	cg13550731	chr2:172543902	DYNC1I2	0.6	4.94	0.49	4.3e-6	Schizophrenia;
SKCM	cis	rs7666738	0.830	rs13328005	chr4:99055480	T/C	cg17366294	chr4:99064904	C4orf37	0.61	4.98	0.49	3.73e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7772486	0.875	rs9322044	chr6:146369608	T/C	cg05347473	chr6:146136440	FBXO30	0.57	5.24	0.51	1.31e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6489882	0.872	rs7132797	chr12:113375036	A/C	cg07232103	chr12:112566177	TRAFD1	0.59	4.8	0.48	7.54e-6	Chronic lymphocytic leukemia;
SKCM	cis	rs12142240	0.698	rs56130131	chr1:46861306	A/C	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs9896933	0.778	rs80112422	chr17:80827719	G/T	cg20578329	chr17:80767326	TBCD	-0.98	-6.54	-0.59	5.94e-9	Bone mineral accretion in asthma (oral corticosteroid dose interaction);
SKCM	cis	rs9733	0.818	rs4970924	chr1:150633079	A/G	cg13175981	chr1:150552382	MCL1	0.64	4.86	0.48	5.85e-6	Tonsillectomy;
SKCM	cis	rs4481887	0.893	rs7538645	chr1:248478137	C/T	cg00666640	chr1:248458726	OR2T12	0.66	6.0	0.56	5.9e-8	Common traits (Other);
SKCM	cis	rs7666738	0.830	rs1834647	chr4:98882915	G/A	cg17366294	chr4:99064904	C4orf37	0.59	5.01	0.49	3.26e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7149337	0.836	rs12588488	chr14:51660217	C/A	cg23942311	chr14:51606299	NA	0.62	6.95	0.62	9.82e-10	Cancer;
SKCM	cis	rs6951245	0.872	rs11768486	chr7:1101290	C/A	cg03188948	chr7:1209495	NA	1.13	6.27	0.58	1.89e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs8141529	0.778	rs763073	chr22:29215542	G/A	cg02153584	chr22:29168773	CCDC117	0.66	5.35	0.52	8.64e-7	Lymphocyte counts;
SKCM	cis	rs7927771	0.725	rs11570094	chr11:47359706	A/C	cg05585544	chr11:47624801	NA	0.59	4.89	0.48	5.22e-6	Subjective well-being;
SKCM	cis	rs801193	0.935	rs2286683	chr7:66129843	G/A	cg11987759	chr7:65425863	GUSB	0.67	5.75	0.55	1.68e-7	Aortic root size;
SKCM	cis	rs1005277	0.577	rs4934906	chr10:38015028	C/T	cg25427524	chr10:38739819	LOC399744	-0.64	-6.06	-0.57	4.44e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs2075371	0.829	rs10954442	chr7:134007587	A/G	cg20476274	chr7:133979776	SLC35B4	-1.01	-10.12	-0.75	7.39e-16	Mean platelet volume;
SKCM	cis	rs35306767	0.953	rs11253521	chr10:976416	G/C	cg20503657	chr10:835505	NA	0.62	4.81	0.48	7.29e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs7666738	0.830	rs11097605	chr4:98985167	T/C	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs8067545	0.611	rs7219908	chr17:20043036	A/G	cg13482628	chr17:19912719	NA	0.66	5.61	0.54	2.98e-7	Schizophrenia;
SKCM	cis	rs6089829	0.962	rs6089824	chr20:61659207	A/G	cg08564027	chr20:61660810	NA	0.62	5.55	0.53	3.75e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs2228479	0.702	rs62053702	chr16:89860688	G/T	cg00800038	chr16:89945340	TCF25	-0.93	-4.9	-0.48	5.16e-6	Skin colour saturation;
SKCM	cis	rs7408868	1.000	rs8107180	chr19:15275430	T/C	cg14696996	chr19:15285081	NOTCH3	0.82	4.92	0.49	4.7e-6	Pulse pressure;
SKCM	cis	rs748404	0.697	rs505249	chr15:43559960	T/A	cg02155558	chr15:43621948	ADAL;LCMT2	0.7	5.74	0.54	1.74e-7	Lung cancer;
SKCM	cis	rs1561288	0.553	rs12233169	chr2:25329272	C/T	cg04586622	chr2:25135609	ADCY3	-0.73	-5.03	-0.5	3.03e-6	Body mass index;
SKCM	cis	rs3741404	0.895	rs1860368	chr11:63994692	T/C	cg19465662	chr11:63993652	NUDT22;TRPT1	-0.82	-5.79	-0.55	1.4e-7	Platelet count;
SKCM	cis	rs2764980	1.000	rs2764979	chr10:3283882	T/C	cg11630169	chr10:3283847	NA	-0.61	-5.25	-0.51	1.27e-6	Attention deficit hyperactivity disorder and conduct disorder;
SKCM	cis	rs1005277	0.505	rs13503	chr10:38239843	C/A	cg00409905	chr10:38381863	ZNF37A	0.6	5.59	0.53	3.26e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs4819052	0.851	rs8126930	chr21:46671715	A/G	cg19498844	chr21:46707878	POFUT2;LOC642852	0.81	6.72	0.61	2.69e-9	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs6570726	0.935	rs399169	chr6:145836353	C/A	cg23711669	chr6:146136114	FBXO30	0.7	6.64	0.6	3.72e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs875971	1.000	rs10244498	chr7:66116056	A/G	cg12463550	chr7:65579703	CRCP	0.56	4.78	0.48	8.23e-6	Aortic root size;
SKCM	cis	rs1971762	0.542	rs12303370	chr12:54091807	A/C	cg16917193	chr12:54089295	NA	0.59	4.99	0.49	3.62e-6	Height;
SKCM	cis	rs995000	0.931	rs583609	chr1:62916796	T/C	cg06896770	chr1:63153194	DOCK7	0.75	6.87	0.61	1.38e-9	Triglyceride levels;
SKCM	cis	rs4555082	0.718	rs28513571	chr14:105709592	C/A	cg13114125	chr14:105738426	BRF1	-0.67	-5.59	-0.53	3.25e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs11098499	0.913	rs13126596	chr4:120140729	A/G	cg09307838	chr4:120376055	NA	0.88	6.32	0.58	1.52e-8	Corneal astigmatism;
SKCM	cis	rs910316	0.503	rs12894709	chr14:75441734	G/A	cg08847533	chr14:75593920	NEK9	0.67	4.9	0.49	5.05e-6	Height;
SKCM	cis	rs7208859	0.623	rs73271869	chr17:29152221	G/A	cg13385521	chr17:29058706	SUZ12P	0.9	4.78	0.48	8.1e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs597539	0.616	rs513476	chr11:68698996	C/T	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.82	5.41	0.52	6.82e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs995000	0.931	rs10789114	chr1:63034222	T/C	cg06896770	chr1:63153194	DOCK7	0.89	7.69	0.66	3.79e-11	Triglyceride levels;
SKCM	trans	rs8073060	0.586	rs8074800	chr17:33979148	A/G	cg19694781	chr19:47549865	TMEM160	1.0	8.56	0.7	7.62e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs1062177	1.000	rs72802204	chr5:151183183	T/C	cg00977110	chr5:151150581	G3BP1	0.84	6.68	0.6	3.14e-9	Preschool internalizing problems;
SKCM	cis	rs7598759	0.679	rs6740843	chr2:232332139	A/C	cg19187155	chr2:232395269	NMUR1	0.61	5.11	0.5	2.25e-6	Noise-induced hearing loss;
SKCM	cis	rs2836974	0.932	rs13048178	chr21:40561012	G/T	cg11644478	chr21:40555479	PSMG1	0.99	9.91	0.75	1.88e-15	Cognitive function;
SKCM	cis	rs9467773	0.620	rs2504571	chr6:26643435	C/T	cg09904177	chr6:26538194	HMGN4	0.58	5.01	0.49	3.28e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs4319547	1.000	rs10998	chr12:122989412	G/A	cg23029597	chr12:123009494	RSRC2	-0.8	-6.23	-0.58	2.16e-8	Body mass index;
SKCM	cis	rs2727020	0.704	rs4144700	chr11:49370834	C/A	cg21546286	chr11:48923668	NA	-0.53	-4.77	-0.48	8.31e-6	Coronary artery disease;
SKCM	cis	rs9815354	0.812	rs11129935	chr3:41985203	A/C	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs7666738	0.606	rs3846446	chr4:99099768	C/A	cg17366294	chr4:99064904	C4orf37	0.63	5.34	0.52	8.85e-7	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9796	0.689	rs692153	chr15:41452681	C/T	cg18705301	chr15:41695430	NDUFAF1	-0.7	-5.16	-0.5	1.81e-6	Menopause (age at onset);
SKCM	cis	rs12145833	0.538	rs12026408	chr1:243366805	G/A	cg02356786	chr1:243265016	LOC731275	1.42	5.6	0.54	3.14e-7	Obesity (early onset extreme);
SKCM	cis	rs807669	0.934	rs1780643	chr22:19191725	T/C	cg02655711	chr22:19163373	SLC25A1	0.81	7.3	0.64	2.07e-10	Metabolite levels;
SKCM	cis	rs8014204	0.870	rs3742790	chr14:75308758	C/T	cg06637938	chr14:75390232	RPS6KL1	-0.84	-6.7	-0.6	2.96e-9	Caffeine consumption;
SKCM	cis	rs7917772	0.636	rs7079231	chr10:104527341	A/G	cg11453585	chr10:104263688	ACTR1A;SUFU	0.75	5.13	0.5	2.08e-6	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs362296	0.671	rs3135173	chr4:3257373	T/C	cg24015175	chr4:3319247	RGS12	-0.65	-5.99	-0.56	5.98e-8	Parental longevity (mother's age at death);
SKCM	cis	rs1799949	0.965	rs8070179	chr17:41202688	G/A	cg05368731	chr17:41323189	NBR1	0.86	7.12	0.63	4.57e-10	Menopause (age at onset);
SKCM	cis	rs9910055	0.529	rs425038	chr17:42182028	T/C	cg19774624	chr17:42201019	HDAC5	0.85	6.68	0.6	3.19e-9	Total body bone mineral density;
SKCM	cis	rs807669	0.548	rs885978	chr22:19198226	A/G	cg02655711	chr22:19163373	SLC25A1	0.63	5.51	0.53	4.39e-7	Metabolite levels;
SKCM	cis	rs6977660	1.000	rs12531373	chr7:19816825	A/C	cg05791153	chr7:19748676	TWISTNB	0.78	5.55	0.53	3.83e-7	Thyroid stimulating hormone;
SKCM	cis	rs1784581	0.928	rs1789995	chr6:162396518	C/T	cg17173639	chr6:162384350	PARK2	-0.62	-5.55	-0.53	3.77e-7	Itch intensity from mosquito bite;
SKCM	cis	rs870825	0.860	rs72689295	chr4:185600930	T/C	cg04058563	chr4:185651563	MLF1IP	1.04	5.96	0.56	7.02e-8	Blood protein levels;
SKCM	cis	rs6582630	0.555	rs11182429	chr12:38526679	A/C	cg26384229	chr12:38710491	ALG10B	0.82	6.64	0.6	3.86e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs6102343	1	rs6102343	chr20:39924279	G/A	cg06424997	chr20:39929561	ZHX3	0.69	4.87	0.48	5.73e-6	Coronary artery disease;
SKCM	cis	rs713587	0.520	rs1530016	chr2:25305756	C/T	cg04586622	chr2:25135609	ADCY3	-0.63	-4.84	-0.48	6.44e-6	Body mass index in non-asthmatics;
SKCM	cis	rs7296418	0.922	rs12425009	chr12:123502044	C/T	cg06742321	chr12:123595122	PITPNM2	0.66	5.51	0.53	4.52e-7	Platelet count;
SKCM	cis	rs763014	0.966	rs4984904	chr16:680809	C/G	cg00908189	chr16:619842	PIGQ	0.86	7.73	0.66	3.15e-11	Height;
SKCM	cis	rs867186	1.000	rs11905354	chr20:33677164	G/A	cg04194272	chr20:33683537	NA	-1.38	-7.2	-0.63	3.29e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs514406	0.825	rs12089511	chr1:53436427	A/T	cg16325326	chr1:53192061	ZYG11B	-0.91	-9.82	-0.74	2.77e-15	Monocyte count;
SKCM	cis	rs995000	0.931	rs11207983	chr1:63012107	C/T	cg06896770	chr1:63153194	DOCK7	-0.73	-6.54	-0.6	5.83e-9	Triglyceride levels;
SKCM	cis	rs28595532	0.920	rs114223775	chr4:119775091	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs995000	0.965	rs1179765	chr1:63010110	G/C	cg06896770	chr1:63153194	DOCK7	-0.73	-6.54	-0.6	5.83e-9	Triglyceride levels;
SKCM	cis	rs7666738	0.791	rs13120773	chr4:98972589	C/T	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7666738	0.830	rs79075162	chr4:98960674	A/T	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs847649	0.692	rs6969054	chr7:102446569	T/C	cg18108683	chr7:102477205	FBXL13	-0.83	-9.35	-0.73	2.31e-14	Morning vs. evening chronotype;
SKCM	cis	rs826838	0.967	rs1719858	chr12:39124505	C/T	cg26384229	chr12:38710491	ALG10B	-0.91	-8.15	-0.68	4.8e-12	Heart rate;
SKCM	cis	rs7635838	0.654	rs346083	chr3:11280017	T/C	cg00170343	chr3:11313890	ATG7	0.77	5.36	0.52	8.2e-7	HDL cholesterol;
SKCM	cis	rs1707322	0.721	rs10157795	chr1:46228192	G/A	cg03146154	chr1:46216737	IPP	0.83	6.17	0.57	2.87e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs2439831	0.867	rs2278860	chr15:43659046	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	-1.12	-8.91	-0.71	1.61e-13	Lung cancer in ever smokers;
SKCM	cis	rs709400	0.628	rs72708854	chr14:103864885	T/C	cg26031613	chr14:104095156	KLC1	0.68	5.17	0.51	1.75e-6	Body mass index;
SKCM	cis	rs860295	0.665	rs11264367	chr1:155337338	T/C	cg02153340	chr1:155202674	NA	-0.75	-5.35	-0.52	8.38e-7	Body mass index;
SKCM	cis	rs7927771	0.929	rs12787646	chr11:47669665	T/C	cg05585544	chr11:47624801	NA	-0.59	-5.08	-0.5	2.53e-6	Subjective well-being;
SKCM	cis	rs1153858	1.000	rs2461701	chr15:45703391	G/A	cg21132104	chr15:45694354	SPATA5L1	0.89	6.95	0.62	9.91e-10	Homoarginine levels;
SKCM	cis	rs3820068	0.581	rs1547031	chr1:15918960	G/A	cg24675056	chr1:15929824	NA	0.77	5.54	0.53	4.01e-7	Systolic blood pressure;
SKCM	cis	rs55962025	0.686	rs110501	chr4:3225478	A/G	cg09735869	chr4:3319127	RGS12	-0.64	-5.27	-0.51	1.18e-6	Parental longevity (mother's age at death);
SKCM	cis	rs11098499	0.863	rs11098531	chr4:120465001	G/A	cg09307838	chr4:120376055	NA	1.0	8.27	0.68	2.8e-12	Corneal astigmatism;
SKCM	cis	rs28595532	0.841	rs116521340	chr4:119757415	C/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs12497850	0.931	rs9311432	chr3:48850443	T/A	cg07636037	chr3:49044803	WDR6	1.01	10.82	0.77	3.36e-17	Parkinson's disease;
SKCM	cis	rs28386778	0.897	rs2156903	chr17:61937179	G/A	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.36	0.52	8.08e-7	Prudent dietary pattern;
SKCM	cis	rs7843479	0.601	rs878873	chr8:21834581	T/C	cg17168535	chr8:21777572	XPO7	0.85	8.58	0.7	7.17e-13	Mean corpuscular volume;
SKCM	cis	rs2032447	0.517	rs7767546	chr6:25904067	T/C	cg18357526	chr6:26021779	HIST1H4A	0.69	5.05	0.5	2.81e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2739330	0.731	rs5751792	chr22:24401542	G/A	cg25703541	chr22:24373054	LOC391322	-0.94	-8.73	-0.7	3.57e-13	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs2839186	0.709	rs2156117	chr21:47669300	C/A	cg13012494	chr21:47604986	C21orf56	0.71	6.0	0.56	5.94e-8	Testicular germ cell tumor;
SKCM	cis	rs8180040	0.966	rs11130137	chr3:47578838	C/T	cg16586182	chr3:47516702	SCAP	-0.74	-5.13	-0.5	2.07e-6	Colorectal cancer;
SKCM	cis	rs7122539	0.734	rs2513658	chr11:66628249	G/A	cg12372692	chr11:66233905	PELI3	0.76	5.62	0.54	2.83e-7	HIV-1 susceptibility;
SKCM	cis	rs10849605	0.737	rs7300039	chr12:1068178	A/T	cg02055889	chr12:1059459	RAD52	0.66	5.28	0.51	1.14e-6	Lung cancer;
SKCM	cis	rs67460515	0.892	rs7648279	chr3:160979646	G/A	cg03342759	chr3:160939853	NMD3	-0.81	-7.1	-0.63	5.14e-10	Parkinson's disease;
SKCM	cis	rs28510890	0.720	rs17704001	chr15:93127165	G/T	cg23043611	chr15:93139145	NA	-0.77	-5.87	-0.55	1e-7	Lung cancer in ever smokers;
SKCM	cis	rs4819052	0.840	rs914217	chr21:46698299	A/G	cg02159808	chr21:46707872	POFUT2;LOC642852	0.86	6.21	0.58	2.36e-8	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs4775041	0.842	rs10468017	chr15:58678512	C/T	cg16767221	chr15:57769667	CGNL1	-0.51	-4.77	-0.48	8.5e-6	Metabolite levels;Triglycerides;HDL cholesterol;
SKCM	cis	rs11690935	0.877	rs13024846	chr2:172835803	C/T	cg13550731	chr2:172543902	DYNC1I2	-0.95	-8.29	-0.68	2.61e-12	Schizophrenia;
SKCM	cis	rs8072100	0.935	rs78737171	chr17:45668760	A/T	cg08085267	chr17:45401833	C17orf57	0.62	5.49	0.53	4.77e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs7666738	0.830	rs10049627	chr4:99025272	A/C	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs3820068	0.603	rs7537618	chr1:15977682	G/A	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs2032447	0.575	rs198847	chr6:26106619	C/A	cg18357526	chr6:26021779	HIST1H4A	-0.79	-6.6	-0.6	4.58e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs854765	0.583	rs28428991	chr17:17827649	C/T	cg04398451	chr17:18023971	MYO15A	-0.85	-6.05	-0.57	4.75e-8	Total body bone mineral density;
SKCM	cis	rs17345786	0.817	rs11720560	chr3:101328484	C/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.71	5.07	0.5	2.61e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6580649	0.941	rs72644847	chr12:48516093	C/A	cg05342945	chr12:48394962	COL2A1	0.8	5.53	0.53	4.09e-7	Lung cancer;
SKCM	trans	rs208520	0.526	rs2881644	chr6:66803535	A/C	cg15611600	chr13:45563400	KIAA1704;NUFIP1	1.12	11.86	0.8	3.85e-19	Exhaled nitric oxide output;
SKCM	cis	rs854765	0.583	rs8078105	chr17:17853782	T/C	cg04398451	chr17:18023971	MYO15A	-0.86	-5.91	-0.56	8.41e-8	Total body bone mineral density;
SKCM	cis	rs1325195	0.506	rs2636266	chr1:179199652	A/G	cg26328954	chr1:179557513	NA	0.49	5.05	0.5	2.82e-6	IgE grass sensitization;
SKCM	cis	rs10779751	0.770	rs1057079	chr1:11205058	A/G	cg08854313	chr1:11322531	MTOR	-0.94	-7.51	-0.65	8.41e-11	Body mass index;
SKCM	cis	rs6952808	0.723	rs1107592	chr7:2041432	C/T	cg04267008	chr7:1944627	MAD1L1	0.63	4.96	0.49	4.05e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs12477438	0.520	rs2632277	chr2:99778985	A/G	cg26064155	chr2:99771622	LIPT1;TSGA10	1.02	9.1	0.72	6.78e-14	Chronic sinus infection;
SKCM	cis	rs17685	0.725	rs1044483	chr7:75659815	T/C	cg01364799	chr7:75623366	TMEM120A	0.72	5.83	0.55	1.18e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs344364	0.511	rs1742463	chr16:1946110	A/G	cg26897989	chr16:1907736	C16orf73	-0.69	-7.13	-0.63	4.45e-10	Glomerular filtration rate in chronic kidney disease;
SKCM	cis	rs9880211	1.000	rs9823373	chr3:136167027	T/C	cg21827317	chr3:136751795	NA	-0.65	-4.92	-0.49	4.73e-6	Body mass index;Height;
SKCM	cis	rs28595532	0.545	rs17516526	chr4:119259199	C/G	cg11846333	chr4:119757529	SEC24D	1.04	5.83	0.55	1.2e-7	Cannabis dependence symptom count;
SKCM	cis	rs4973517	0.719	rs13029658	chr2:232843189	G/T	cg13952656	chr2:232260762	B3GNT7	-0.49	-4.88	-0.48	5.45e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs709400	0.633	rs8013101	chr14:103951772	G/C	cg26031613	chr14:104095156	KLC1	0.77	5.96	0.56	6.87e-8	Body mass index;
SKCM	cis	rs875971	0.651	rs2420596	chr7:65915983	T/C	cg18876405	chr7:65276391	NA	0.61	5.94	0.56	7.52e-8	Aortic root size;
SKCM	cis	rs9393692	0.905	rs6931391	chr6:26279235	G/C	cg00631329	chr6:26305371	NA	-0.68	-4.93	-0.49	4.49e-6	Educational attainment;
SKCM	cis	rs501120	1.000	rs1746047	chr10:44774086	T/G	cg09554077	chr10:44749378	NA	0.38	4.79	0.48	7.71e-6	Coronary artery disease;Coronary heart disease;
SKCM	cis	rs873946	0.504	rs4880275	chr10:134576552	C/T	cg26818010	chr10:134567672	INPP5A	-0.75	-5.45	-0.53	5.59e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs10911232	0.507	rs12037623	chr1:183000148	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.64	0.6	3.83e-9	Hypertriglyceridemia;
SKCM	cis	rs7954584	0.531	rs1154514	chr12:122374888	C/T	cg01765077	chr12:122356316	WDR66	0.44	4.79	0.48	7.71e-6	Mean corpuscular volume;
SKCM	cis	rs2721195	0.845	rs67392224	chr8:145707044	T/C	cg15320075	chr8:145703422	NA	-0.93	-8.33	-0.69	2.15e-12	Age at first birth;
SKCM	cis	rs8180040	0.620	rs6414435	chr3:47121140	A/G	cg27129171	chr3:47204927	SETD2	0.74	5.37	0.52	7.84e-7	Colorectal cancer;
SKCM	cis	rs2811415	0.597	rs9809497	chr3:127782514	T/C	cg09089421	chr3:127803668	RUVBL1	1.02	8.94	0.71	1.41e-13	Lung function (FEV1/FVC);
SKCM	cis	rs12216125	0.537	rs12207059	chr6:25922385	C/T	cg16482183	chr6:26056742	HIST1H1C	0.97	6.64	0.6	3.73e-9	Iron status biomarkers;
SKCM	cis	rs3785574	0.962	rs2597632	chr17:61894739	A/T	cg06601766	chr17:61851465	DDX42;CCDC47	0.73	5.38	0.52	7.7300000000000005e-07	Height;
SKCM	cis	rs28595532	0.920	rs115853212	chr4:119765354	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs9300255	0.679	rs10846507	chr12:123786492	G/T	cg00376283	chr12:123451042	ABCB9	0.78	5.26	0.51	1.24e-6	Neutrophil percentage of white cells;
SKCM	cis	rs8180040	0.800	rs6768221	chr3:47296899	C/G	cg27129171	chr3:47204927	SETD2	-0.79	-5.38	-0.52	7.6e-7	Colorectal cancer;
SKCM	cis	rs2839186	0.967	rs4819222	chr21:47707778	G/A	cg13012494	chr21:47604986	C21orf56	0.67	5.71	0.54	1.95e-7	Testicular germ cell tumor;
SKCM	cis	rs637571	0.522	rs28578718	chr11:65748400	C/A	cg26695010	chr11:65641043	EFEMP2	-0.72	-5.47	-0.53	5.29e-7	Eosinophil percentage of white cells;
SKCM	cis	rs1577917	0.771	rs9362239	chr6:86429263	G/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.88	8.6	0.7	6.56e-13	Response to antipsychotic treatment;
SKCM	cis	rs7937682	0.602	rs4936804	chr11:111743851	A/C	cg09085632	chr11:111637200	PPP2R1B	1.12	10.71	0.77	5.54e-17	Primary sclerosing cholangitis;
SKCM	cis	rs995000	0.965	rs10789118	chr1:63094692	A/G	cg06896770	chr1:63153194	DOCK7	0.95	8.93	0.71	1.48e-13	Triglyceride levels;
SKCM	cis	rs2204008	0.775	rs12369238	chr12:38176051	A/G	cg26384229	chr12:38710491	ALG10B	0.81	6.95	0.62	9.67e-10	Bladder cancer;
SKCM	cis	rs6546550	0.935	rs6747542	chr2:70106832	T/C	cg02498382	chr2:70120550	SNRNP27	-0.47	-5.25	-0.51	1.29e-6	Prevalent atrial fibrillation;
SKCM	cis	rs12497850	0.931	rs7430198	chr3:48988760	T/C	cg07636037	chr3:49044803	WDR6	1.02	11.0	0.78	1.56e-17	Parkinson's disease;
SKCM	cis	rs2243480	1.000	rs34974928	chr7:65364006	T/C	cg07424592	chr7:64974309	NA	0.99	4.9	0.49	5.08e-6	Diabetic kidney disease;
SKCM	cis	rs2836974	0.932	rs2836953	chr21:40617483	G/A	cg11644478	chr21:40555479	PSMG1	0.97	10.08	0.75	8.76e-16	Cognitive function;
SKCM	cis	rs7666738	0.830	rs6827516	chr4:98971740	T/C	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7772486	0.754	rs6922507	chr6:146250155	A/T	cg05347473	chr6:146136440	FBXO30	-0.55	-4.97	-0.49	3.82e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7824557	0.547	rs2572370	chr8:11238587	A/G	cg21775007	chr8:11205619	TDH	-0.57	-4.93	-0.49	4.47e-6	Retinal vascular caliber;
SKCM	cis	rs7940866	0.838	rs7949071	chr11:130877478	T/C	cg12179176	chr11:130786555	SNX19	0.66	4.87	0.48	5.62e-6	Schizophrenia;
SKCM	cis	rs17376456	0.935	rs10036891	chr5:93171738	T/A	cg25358565	chr5:93447407	FAM172A	1.21	7.76	0.66	2.73e-11	Diabetic retinopathy;
SKCM	cis	rs4819052	0.918	rs2330013	chr21:46658662	G/T	cg02159808	chr21:46707872	POFUT2;LOC642852	0.79	5.87	0.55	1.01e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs2204008	0.713	rs12366709	chr12:38210179	G/A	cg26384229	chr12:38710491	ALG10B	0.82	6.58	0.6	4.87e-9	Bladder cancer;
SKCM	cis	rs637571	0.565	rs570387	chr11:65637076	T/C	cg26695010	chr11:65641043	EFEMP2	0.61	4.98	0.49	3.73e-6	Eosinophil percentage of white cells;
SKCM	trans	rs17685	0.753	rs869806	chr7:75688623	C/T	cg19862616	chr7:65841803	NCRNA00174	0.95	9.34	0.73	2.39e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs4237845	0.537	rs7969844	chr12:58278271	C/T	cg02175503	chr12:58329896	NA	0.7	5.82	0.55	1.24e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs4803468	1.000	rs284658	chr19:41929988	G/A	cg09537434	chr19:41945824	ATP5SL	-1.1	-13.85	-0.84	1.02e-22	Height;
SKCM	cis	rs11098499	0.863	rs9884402	chr4:120489982	A/G	cg24375607	chr4:120327624	NA	0.69	5.47	0.53	5.35e-7	Corneal astigmatism;
SKCM	cis	rs9818758	0.607	rs35060561	chr3:49255503	T/C	cg24110177	chr3:50126178	RBM5	0.88	5.26	0.51	1.23e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs9399135	0.967	rs1014020	chr6:135334426	C/A	cg24558204	chr6:135376177	HBS1L	0.59	5.23	0.51	1.41e-6	Red blood cell count;
SKCM	cis	rs7843479	0.601	rs2306646	chr8:21846586	C/G	cg17168535	chr8:21777572	XPO7	0.79	7.46	0.65	1.06e-10	Mean corpuscular volume;
SKCM	cis	rs798554	0.959	rs798528	chr7:2772431	A/C	cg14895029	chr7:2775587	GNA12	-0.75	-5.79	-0.55	1.38e-7	Height;
SKCM	cis	rs10779751	0.734	rs7533211	chr1:11132965	G/C	cg08854313	chr1:11322531	MTOR	0.77	5.74	0.54	1.73e-7	Body mass index;
SKCM	cis	rs28386778	0.897	rs2137144	chr17:61805607	G/A	cg01411255	chr17:61851458	DDX42;CCDC47	0.8	5.2	0.51	1.57e-6	Prudent dietary pattern;
SKCM	cis	rs763014	0.966	rs35642938	chr16:642249	T/C	cg00908189	chr16:619842	PIGQ	0.82	7.78	0.66	2.54e-11	Height;
SKCM	cis	rs1799949	1.000	rs11657835	chr17:41291953	C/G	cg05368731	chr17:41323189	NBR1	0.89	7.91	0.67	1.38e-11	Menopause (age at onset);
SKCM	cis	rs2427308	0.643	rs477859	chr20:60937597	A/G	cg09594475	chr20:60884601	LAMA5	-0.6	-4.96	-0.49	3.99e-6	Colorectal cancer;
SKCM	cis	rs5417	0.610	rs222843	chr17:7145981	T/C	cg25256661	chr17:7137939	DVL2	1.02	7.23	0.63	2.86e-10	Diastolic blood pressure;
SKCM	cis	rs55823223	0.648	rs56901103	chr17:73865667	C/A	cg08125733	chr17:73851984	WBP2	1.06	5.97	0.56	6.62e-8	Psoriasis;
SKCM	cis	rs10193935	0.901	rs13393459	chr2:42463124	C/T	cg27598129	chr2:42591480	NA	-0.88	-6.71	-0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9467773	1.000	rs9986382	chr6:26550619	T/C	cg15659132	chr6:26577336	NA	0.6	5.71	0.54	1.99e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs1799949	1.000	rs8176120	chr17:41261233	C/T	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.01	-0.56	5.5e-8	Menopause (age at onset);
SKCM	cis	rs9916302	0.904	rs2061338	chr17:37421767	T/C	cg07936489	chr17:37558343	FBXL20	-0.84	-6.96	-0.62	9.48e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs9393692	0.557	rs12665035	chr6:26275649	T/C	cg13736514	chr6:26305472	NA	-0.66	-5.07	-0.5	2.58e-6	Educational attainment;
SKCM	cis	rs362272	0.545	rs2749782	chr4:3339761	A/G	cg21096898	chr4:3318625	RGS12	1.01	13.66	0.84	2.19e-22	Serum sulfate level;
SKCM	cis	rs2075371	0.501	rs1613152	chr7:134019837	A/G	cg20476274	chr7:133979776	SLC35B4	0.89	7.39	0.64	1.44e-10	Mean platelet volume;
SKCM	cis	rs28386778	0.897	rs6504177	chr17:61812655	C/T	cg06873352	chr17:61820015	STRADA	0.75	6.24	0.58	2.1e-8	Prudent dietary pattern;
SKCM	cis	rs62064224	0.791	rs11653160	chr17:30717222	A/G	cg18200150	chr17:30822561	MYO1D	0.78	6.26	0.58	1.9e-8	Schizophrenia;
SKCM	cis	rs6430585	0.646	rs1057031	chr2:136633962	G/A	cg07169764	chr2:136633963	MCM6	1.35	14.52	0.85	7.05e-24	Corneal structure;
SKCM	cis	rs561341	0.700	rs79272796	chr17:30226974	T/C	cg00745463	chr17:30367425	LRRC37B	-0.8	-5.17	-0.5	1.78e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs12986445	0.744	rs2138390	chr2:26112833	A/G	cg07291958	chr2:26785531	C2orf70	0.55	4.92	0.49	4.8e-6	Multiple myeloma and monoclonal gammopathy;Multiple myeloma;
SKCM	cis	rs9303401	0.659	rs34275691	chr17:56736640	A/T	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.35	0.52	8.54e-7	Cognitive test performance;
SKCM	cis	rs6879260	1.000	rs6879260	chr5:179731014	A/G	cg23221052	chr5:179740743	GFPT2	-0.63	-5.43	-0.52	6.18e-7	Height;
SKCM	cis	rs9297145	0.724	rs6954584	chr7:98766930	G/A	cg05967295	chr7:98741636	SMURF1	1.07	7.92	0.67	1.33e-11	Crohn's disease;Inflammatory bowel disease;Ulcerative colitis;
SKCM	cis	rs28595532	0.920	rs17325192	chr4:119780345	A/G	cg21605333	chr4:119757512	SEC24D	-1.05	-6.78	-0.61	2.05e-9	Cannabis dependence symptom count;
SKCM	cis	rs1577917	1.000	rs6914463	chr6:86653415	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.77	-0.66	2.59e-11	Response to antipsychotic treatment;
SKCM	cis	rs7666738	0.830	rs13137808	chr4:99047095	T/C	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11585357	0.793	rs11587669	chr1:17616259	C/T	cg08277548	chr1:17600880	PADI3	-0.89	-6.31	-0.58	1.53e-8	Hair shape;
SKCM	cis	rs9912468	1.000	rs9909004	chr17:64306133	C/T	cg19474267	chr17:64306194	PRKCA	-0.58	-5.06	-0.5	2.71e-6	QRS duration;QRS complex (12-leadsum);QRS complex (Sokolow-Lyon);
SKCM	cis	rs7100689	0.646	rs10400045	chr10:82077032	A/G	cg00277334	chr10:82204260	NA	-0.57	-5.38	-0.52	7.56e-7	Post bronchodilator FEV1;
SKCM	cis	rs2228479	0.850	rs11648433	chr16:89965055	G/A	cg00800038	chr16:89945340	TCF25	-0.96	-5.44	-0.52	5.85e-7	Skin colour saturation;
SKCM	cis	rs7659604	1.000	rs28433617	chr4:122664138	C/A	cg19671926	chr4:122722719	EXOSC9	-0.66	-4.98	-0.49	3.71e-6	Type 2 diabetes;
SKCM	cis	rs7811142	0.945	rs6955362	chr7:100056166	C/T	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.23	7.89	0.67	1.53e-11	Platelet count;
SKCM	cis	rs7296418	0.961	rs1790121	chr12:123604492	G/A	cg06742321	chr12:123595122	PITPNM2	0.66	5.48	0.53	4.99e-7	Platelet count;
SKCM	cis	rs1799949	1.000	rs34942571	chr17:41273379	G/C	cg23758822	chr17:41437982	NA	0.93	7.4	0.64	1.33e-10	Menopause (age at onset);
SKCM	cis	rs2760061	0.598	rs2796056	chr1:228122901	G/A	cg02753203	chr1:228287806	NA	-0.62	-5.08	-0.5	2.53e-6	Diastolic blood pressure;
SKCM	cis	rs754466	1.000	rs67059283	chr10:79683235	C/T	cg17075019	chr10:79541650	NA	-0.7	-5.72	-0.54	1.92e-7	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs6952808	0.689	rs1107591	chr7:2041638	G/A	cg02951883	chr7:2050386	MAD1L1	-0.89	-8.16	-0.68	4.65e-12	Bipolar disorder and schizophrenia;
SKCM	cis	rs17376456	0.877	rs10035340	chr5:93490465	C/T	cg25358565	chr5:93447407	FAM172A	1.24	8.18	0.68	4.18e-12	Diabetic retinopathy;
SKCM	cis	rs2479724	0.846	rs2254805	chr6:41846110	T/G	cg17623882	chr6:41773611	USP49	-0.75	-6.34	-0.58	1.35e-8	Menarche (age at onset);
SKCM	cis	rs4319547	0.741	rs4758663	chr12:122939483	A/G	cg23029597	chr12:123009494	RSRC2	-0.79	-5.94	-0.56	7.46e-8	Body mass index;
SKCM	cis	rs72949976	0.584	rs13001511	chr2:214025262	G/A	cg08319019	chr2:214017104	IKZF2	0.84	6.86	0.61	1.44e-9	Lung cancer;Squamous cell lung carcinoma;
SKCM	cis	rs875971	0.862	rs4718319	chr7:65652784	C/A	cg11764359	chr7:65958608	NA	-0.8	-7.7	-0.66	3.63e-11	Aortic root size;
SKCM	cis	rs732765	0.734	rs12323392	chr14:75115673	A/G	cg25946216	chr14:74253857	C14orf43	-0.87	-5.45	-0.53	5.68e-7	Non-small cell lung cancer;
SKCM	cis	rs1403694	0.695	rs3774291	chr3:186433471	C/T	cg09332604	chr3:186435400	KNG1	-0.5	-5.07	-0.5	2.57e-6	Blood protein levels;
SKCM	cis	rs2204008	0.605	rs4608149	chr12:38132057	G/C	cg13010199	chr12:38710504	ALG10B	0.65	4.84	0.48	6.52e-6	Bladder cancer;
SKCM	cis	rs6952808	0.531	rs3779003	chr7:2184902	C/T	cg02951883	chr7:2050386	MAD1L1	-0.67	-5.64	-0.54	2.64e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs3820928	0.874	rs1917123	chr2:227889783	T/G	cg11843606	chr2:227700838	RHBDD1	-0.61	-4.96	-0.49	4.1e-6	Pulmonary function;
SKCM	cis	rs597539	0.689	rs596874	chr11:68630874	C/T	cg11716795	chr11:68671300	MRPL21;IGHMBP2	-0.83	-5.6	-0.54	3.08e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs17345786	1.000	rs3762729	chr3:101308874	C/T	cg12386194	chr3:101231763	SENP7	0.79	6.03	0.56	5.2e-8	Colonoscopy-negative controls vs population controls;
SKCM	trans	rs3780486	0.846	rs10813950	chr9:33127640	A/G	cg20290983	chr6:43655470	MRPS18A	-0.95	-8.65	-0.7	5.06e-13	IgG glycosylation;
SKCM	cis	rs6565180	1.000	rs8049108	chr16:30376486	A/G	cg17640201	chr16:30407289	ZNF48	-0.89	-7.0	-0.62	7.72e-10	Tonsillectomy;
SKCM	cis	rs60871478	0.735	rs10950455	chr7:831451	C/T	cg05535760	chr7:792225	HEATR2	-1.24	-9.63	-0.74	6.44e-15	Cerebrospinal P-tau181p levels;
SKCM	cis	rs8060686	0.641	rs76595854	chr16:68130233	T/C	cg09117114	chr16:67998030	SLC12A4	-0.81	-5.29	-0.51	1.07e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs28386778	0.863	rs3760254	chr17:61851751	T/G	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs478304	0.934	rs537786	chr11:65494987	C/T	cg27068330	chr11:65405492	SIPA1	0.6	4.92	0.49	4.64e-6	Acne (severe);
SKCM	cis	rs3857536	0.544	rs208453	chr6:66906841	A/T	cg07460842	chr6:66804631	NA	-0.76	-5.87	-0.55	1e-7	Blood trace element (Cu levels);
SKCM	cis	rs875971	0.522	rs4502988	chr7:65297746	A/G	cg11764359	chr7:65958608	NA	0.88	6.43	0.59	9.56e-9	Aortic root size;
SKCM	cis	rs1799949	1.000	rs33946455	chr17:41321846	C/T	cg05368731	chr17:41323189	NBR1	0.89	7.98	0.67	1.03e-11	Menopause (age at onset);
SKCM	cis	rs9311474	0.508	rs6786919	chr3:52599789	A/G	cg18404041	chr3:52824283	ITIH1	-0.53	-4.77	-0.48	8.42e-6	Electroencephalogram traits;
SKCM	cis	rs8017423	0.967	rs11628881	chr14:90713833	C/T	cg04374321	chr14:90722782	PSMC1	0.97	9.06	0.72	8.41e-14	Mortality in heart failure;
SKCM	cis	rs1949733	1.000	rs3103072	chr4:8508431	C/T	cg11789530	chr4:8429930	ACOX3	-0.82	-5.81	-0.55	1.31e-7	Response to antineoplastic agents;
SKCM	cis	rs6952808	0.743	rs4721097	chr7:1877503	G/T	cg04267008	chr7:1944627	MAD1L1	-0.74	-5.87	-0.55	1.02e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs4900538	0.963	rs1885708	chr14:102960164	A/G	cg18135206	chr14:102964638	TECPR2	0.79	6.53	0.59	6.09e-9	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs933688	1.000	rs9293568	chr5:90737845	C/T	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.94	6.78	0.61	2.1e-9	Smoking behavior;
SKCM	cis	rs476633	0.691	rs28568756	chr15:41539371	G/A	cg18705301	chr15:41695430	NDUFAF1	-0.65	-4.86	-0.48	6.01e-6	Glomerular filtration rate (creatinine);
SKCM	cis	rs175714	0.845	rs175702	chr14:75971133	G/T	cg01624173	chr14:75981868	NA	-0.5	-5.14	-0.5	1.98e-6	Lymphocyte counts;
SKCM	cis	rs1218582	0.772	rs1976559	chr1:154879788	A/T	cg24250549	chr1:154909240	PMVK	0.87	8.7	0.7	4.13e-13	Prostate cancer;
SKCM	cis	rs9910055	0.573	rs113184718	chr17:42206543	A/T	cg10896456	chr17:42255109	ASB16;C17orf65	-0.68	-7.03	-0.62	6.85e-10	Total body bone mineral density;
SKCM	cis	rs7584330	0.826	rs6431544	chr2:238417728	G/A	cg14458575	chr2:238380390	NA	1.12	7.17	0.63	3.66e-10	Prostate cancer;
SKCM	cis	rs11764590	0.694	rs10235664	chr7:2086814	T/C	cg23422044	chr7:1970798	MAD1L1	-0.85	-6.45	-0.59	8.53e-9	Neuroticism;
SKCM	cis	rs10832963	0.686	rs11024743	chr11:18653712	A/G	cg20219074	chr11:18656078	SPTY2D1	0.81	6.19	0.57	2.67e-8	Breast cancer;
SKCM	cis	rs7917772	0.636	rs7897384	chr10:104529042	T/G	cg11453585	chr10:104263688	ACTR1A;SUFU	-0.69	-4.79	-0.48	7.9e-6	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs7633770	0.786	rs6442012	chr3:46686346	A/G	cg11219411	chr3:46661640	NA	0.57	5.13	0.5	2.04e-6	Coronary artery disease;
SKCM	cis	rs17685	0.712	rs56965035	chr7:75795670	G/A	cg16684958	chr7:75615977	POR	0.53	5.3	0.51	1.06e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs4665809	0.590	rs2303894	chr2:26508187	A/G	cg26119090	chr2:26468346	HADHA;HADHB	1.08	8.63	0.7	5.67e-13	Gut microbiome composition (summer);
SKCM	cis	rs644799	0.710	rs523153	chr11:95570961	G/A	cg03916912	chr11:95522834	CEP57;FAM76B	0.77	6.33	0.58	1.46e-8	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs6088580	0.634	rs6088488	chr20:32992631	T/C	cg24642439	chr20:33292090	TP53INP2	-0.76	-6.02	-0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs2905347	0.726	rs2905321	chr7:22704587	A/G	cg11983867	chr7:22539820	MGC87042	0.5	4.78	0.48	8.14e-6	Major depression and alcohol dependence;
SKCM	cis	rs4780401	0.609	rs4780399	chr16:11828701	A/T	cg01061890	chr16:11836724	TXNDC11	-0.8	-6.08	-0.57	4.24e-8	Rheumatoid arthritis;
SKCM	cis	rs12134245	0.874	rs35115044	chr1:92021650	A/G	cg25838465	chr1:92012736	NA	-0.68	-6.21	-0.58	2.4e-8	Breast cancer;
SKCM	cis	rs10540	1.000	rs12794284	chr11:477623	C/T	cg03576123	chr11:487126	PTDSS2	-1.46	-7.68	-0.66	4e-11	Body mass index;
SKCM	cis	rs10504073	0.584	rs62507178	chr8:49938572	A/C	cg00325661	chr8:49890786	NA	0.81	6.83	0.61	1.64e-9	Blood metabolite ratios;
SKCM	cis	rs1801251	1.000	rs283474	chr2:233654627	A/G	cg25237894	chr2:233734115	C2orf82	0.62	5.77	0.55	1.55e-7	Coronary artery disease;
SKCM	cis	rs4774899	0.966	rs2593237	chr15:57481049	T/C	cg01857019	chr15:57210107	LOC145783;TCF12	0.53	4.9	0.49	5.12e-6	Urinary tract infection frequency;
SKCM	cis	rs507080	0.922	rs625513	chr11:118555719	A/C	cg18045108	chr11:118530628	TREH	-0.47	-4.81	-0.48	7.24e-6	Serum metabolite levels;
SKCM	cis	rs2991971	1.000	rs2991971	chr1:46012748	C/G	cg24296786	chr1:45957014	TESK2	0.65	5.25	0.51	1.28e-6	High light scatter reticulocyte count;
SKCM	cis	rs4727027	0.868	rs10952799	chr7:148840772	C/T	cg23583168	chr7:148888333	NA	-0.8	-6.66	-0.6	3.52e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs12142240	0.698	rs4372193	chr1:46853233	G/T	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs2952156	0.876	rs2313171	chr17:37833842	T/C	cg00129232	chr17:37814104	STARD3	-0.74	-6.39	-0.59	1.11e-8	Asthma;
SKCM	cis	rs2777491	0.507	rs11854081	chr15:41646398	C/T	cg18705301	chr15:41695430	NDUFAF1	-1.18	-12.63	-0.82	1.49e-20	Ulcerative colitis;
SKCM	cis	rs62238980	0.614	rs4821024	chr22:32414501	C/T	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs17065868	1.000	rs9525962	chr13:45065391	A/G	cg10246903	chr13:45222710	NA	-0.97	-5.52	-0.53	4.22e-7	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs1185460	0.934	rs10892328	chr11:118942654	T/A	cg23280166	chr11:118938394	VPS11	0.56	5.02	0.49	3.15e-6	Coronary artery disease;
SKCM	cis	rs1550582	0.662	rs6981748	chr8:135501309	A/C	cg17885191	chr8:135476712	NA	-0.74	-5.19	-0.51	1.61e-6	Educational attainment;
SKCM	cis	rs17270561	0.562	rs74293932	chr6:26014811	C/A	cg10373733	chr6:25993375	NA	0.86	5.44	0.52	5.97e-7	Iron status biomarkers;
SKCM	cis	rs4460629	0.905	rs4971077	chr1:155128717	T/C	cg02153340	chr1:155202674	NA	-0.57	-4.94	-0.49	4.43e-6	Serum magnesium levels;
SKCM	cis	rs17685	0.697	rs2302437	chr7:75677016	G/A	cg01364799	chr7:75623366	TMEM120A	0.72	5.83	0.55	1.18e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs137603	0.602	rs9611146	chr22:39718120	G/T	cg17798944	chr22:39715225	SNORD43;RPL3	-0.64	-5.54	-0.53	3.91e-7	Primary biliary cholangitis;
SKCM	cis	rs9911578	0.839	rs7208505	chr17:57187729	C/T	cg05425664	chr17:57184151	TRIM37	-0.73	-6.26	-0.58	1.95e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs875971	0.545	rs3936065	chr7:65790564	C/T	cg18876405	chr7:65276391	NA	0.63	5.03	0.49	3.07e-6	Aortic root size;
SKCM	cis	rs8060686	0.641	rs12598256	chr16:68084021	G/A	cg04539111	chr16:67997858	SLC12A4	-0.85	-4.79	-0.48	7.74e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs941873	0.772	rs1892498	chr10:81103862	A/G	cg09469691	chr10:81107165	PPIF	0.72	6.65	0.6	3.56e-9	Height;
SKCM	cis	rs2952156	0.920	rs12940986	chr17:37836581	A/G	cg00129232	chr17:37814104	STARD3	0.68	5.7	0.54	2.08e-7	Asthma;
SKCM	cis	rs6500602	0.609	rs7202910	chr16:4518948	T/A	cg08645402	chr16:4508243	NA	0.65	5.01	0.49	3.3e-6	Schizophrenia;
SKCM	cis	rs6750795	0.569	rs1667313	chr2:232408018	A/C	cg19187155	chr2:232395269	NMUR1	0.88	7.62	0.65	5.15e-11	Height;
SKCM	cis	rs6582630	0.555	rs11610015	chr12:38508856	A/G	cg26384229	chr12:38710491	ALG10B	0.79	6.11	0.57	3.66e-8	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs6753739	0.871	rs6436113	chr2:219984898	C/T	cg09617556	chr2:219924408	IHH	0.48	5.08	0.5	2.5e-6	Height;
SKCM	cis	rs9467773	0.595	rs7767847	chr6:26597893	A/T	cg15659132	chr6:26577336	NA	0.63	5.52	0.53	4.22e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs875971	0.545	rs11770063	chr7:65783016	G/A	cg18876405	chr7:65276391	NA	0.63	5.03	0.49	3.07e-6	Aortic root size;
SKCM	cis	rs10883723	0.810	rs3818470	chr10:104263675	T/C	cg11453585	chr10:104263688	ACTR1A;SUFU	0.75	5.7	0.54	2.03e-7	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs17345786	1.000	rs7641261	chr3:101279006	C/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.73	5.46	0.53	5.37e-7	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs637571	0.522	rs7105628	chr11:65763067	C/T	cg02427764	chr11:65769310	BANF1;EIF1AD	0.77	5.98	0.56	6.43e-8	Eosinophil percentage of white cells;
SKCM	cis	rs3820928	0.967	rs4675113	chr2:227766339	G/A	cg11843606	chr2:227700838	RHBDD1	-0.6	-4.8	-0.48	7.53e-6	Pulmonary function;
SKCM	cis	rs2645694	0.626	rs2703136	chr4:77828957	T/A	cg06046430	chr4:77819534	ANKRD56	0.54	5.94	0.56	7.49e-8	Emphysema distribution in smoking;
SKCM	cis	rs7811142	0.830	rs61735533	chr7:99955866	G/A	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.2	7.87	0.67	1.7e-11	Platelet count;
SKCM	cis	rs2243480	0.901	rs35087093	chr7:65405208	C/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs1218582	0.772	rs2061690	chr1:154919080	C/T	cg09359103	chr1:154839909	KCNN3	-0.54	-4.91	-0.49	4.92e-6	Prostate cancer;
SKCM	cis	rs3820068	0.532	rs6701009	chr1:15935614	T/C	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	trans	rs66573146	0.831	rs73088564	chr4:6984553	G/C	cg07817883	chr1:32538562	TMEM39B	1.94	8.42	0.69	1.47e-12	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs801193	1.000	rs2659889	chr7:66217112	A/G	cg00343986	chr7:65444356	GUSB	0.67	4.98	0.49	3.74e-6	Aortic root size;
SKCM	cis	rs6089584	0.526	rs6089316	chr20:60627552	C/T	cg16423285	chr20:60520624	NA	-0.58	-4.92	-0.49	4.77e-6	Body mass index;
SKCM	cis	rs8017423	0.967	rs1005788	chr14:90692747	C/T	cg04374321	chr14:90722782	PSMC1	0.97	8.7	0.7	4.05e-13	Mortality in heart failure;
SKCM	cis	rs71520386	0.634	rs13240023	chr7:22867493	C/A	cg15401507	chr7:22894281	NA	0.65	4.87	0.48	5.7e-6	Fibrinogen levels;
SKCM	cis	rs55962025	0.737	rs2237006	chr4:3228492	A/G	cg16987761	chr4:3318072	RGS12	-0.6	-4.83	-0.48	6.61e-6	Parental longevity (mother's age at death);
SKCM	trans	rs3780486	0.846	rs10971420	chr9:33125000	T/C	cg20290983	chr6:43655470	MRPS18A	0.99	11.08	0.78	1.1e-17	IgG glycosylation;
SKCM	cis	rs7833790	0.963	rs28823280	chr8:82777716	G/A	cg17211192	chr8:82754475	SNX16	0.88	4.88	0.48	5.56e-6	Diastolic blood pressure;
SKCM	cis	rs2439831	0.717	rs2470132	chr15:43835481	C/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.18	7.32	0.64	1.95e-10	Lung cancer in ever smokers;
SKCM	cis	rs908922	0.676	rs12129646	chr1:152518816	C/T	cg09873164	chr1:152488093	CRCT1	0.77	6.04	0.56	5.01e-8	Hair morphology;
SKCM	cis	rs7809950	1.000	rs2250414	chr7:107140987	T/G	cg23024343	chr7:107201750	COG5	-0.76	-6.83	-0.61	1.64e-9	Coronary artery disease;
SKCM	cis	rs2204008	0.774	rs12810027	chr12:38212165	A/G	cg26384229	chr12:38710491	ALG10B	0.82	6.58	0.6	4.87e-9	Bladder cancer;
SKCM	cis	rs7824557	0.564	rs2736288	chr8:11228100	G/A	cg21775007	chr8:11205619	TDH	-0.59	-4.9	-0.48	5.19e-6	Retinal vascular caliber;
SKCM	cis	rs9640161	0.702	rs1962004	chr7:150020381	G/A	cg10018233	chr7:150070692	REPIN1	0.68	5.27	0.51	1.18e-6	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs2228479	0.681	rs10153196	chr16:89967397	A/C	cg06558623	chr16:89946397	TCF25	1.25	7.05	0.62	6.25e-10	Skin colour saturation;
SKCM	cis	rs7584330	0.868	rs13386290	chr2:238393136	G/C	cg14458575	chr2:238380390	NA	1.02	6.39	0.59	1.14e-8	Prostate cancer;
SKCM	cis	rs116095464	0.558	rs6555056	chr5:226222	T/C	cg22857025	chr5:266934	NA	-1.36	-8.0	-0.67	9.23e-12	Breast cancer;
SKCM	cis	rs2153535	0.580	rs5001324	chr6:8451604	A/T	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs4148883	0.675	rs10015824	chr4:100074544	C/G	cg12011299	chr4:100065546	ADH4	0.48	4.78	0.48	8.14e-6	Alcohol dependence;
SKCM	cis	rs2811415	0.597	rs9845369	chr3:127743443	G/C	cg09089421	chr3:127803668	RUVBL1	0.99	8.52	0.69	9.09e-13	Lung function (FEV1/FVC);
SKCM	cis	rs6598955	0.543	rs60676610	chr1:26543421	G/C	cg04990556	chr1:26633338	UBXN11	0.68	5.08	0.5	2.55e-6	Obesity-related traits;
SKCM	cis	rs798554	0.796	rs2533884	chr7:2836848	T/G	cg14895029	chr7:2775587	GNA12	-0.65	-4.95	-0.49	4.19e-6	Height;
SKCM	cis	rs11098499	0.863	rs1383533	chr4:120434576	G/A	cg09307838	chr4:120376055	NA	0.99	7.71	0.66	3.45e-11	Corneal astigmatism;
SKCM	cis	rs798554	0.679	rs2527677	chr7:2882621	A/G	cg19346786	chr7:2764209	NA	-0.66	-6.64	-0.6	3.79e-9	Height;
SKCM	cis	rs1801251	1.000	rs12987513	chr2:233622066	A/G	cg25237894	chr2:233734115	C2orf82	0.58	5.53	0.53	4.04e-7	Coronary artery disease;
SKCM	cis	rs362296	0.590	rs4690081	chr4:3262105	T/G	cg21096898	chr4:3318625	RGS12	-0.84	-8.08	-0.68	6.51e-12	Parental longevity (mother's age at death);
SKCM	cis	rs244731	1.000	rs244728	chr5:176537407	C/T	cg17509989	chr5:176798049	RGS14	0.88	5.56	0.53	3.63e-7	Urate levels in lean individuals;
SKCM	cis	rs362296	0.698	rs3135168	chr4:3262699	T/C	cg16987761	chr4:3318072	RGS12	-0.73	-6.49	-0.59	7.13e-9	Parental longevity (mother's age at death);
SKCM	cis	rs13392177	0.647	rs6718220	chr2:219066518	T/C	cg00012203	chr2:219082015	ARPC2	-0.65	-4.84	-0.48	6.33e-6	Pyoderma gangrenosum in inflammatory bowel disease;
SKCM	cis	rs875971	0.862	rs801209	chr7:66019390	G/T	cg11764359	chr7:65958608	NA	-0.75	-6.8	-0.61	1.88e-9	Aortic root size;
SKCM	cis	rs3784262	0.669	rs12148281	chr15:58311061	C/A	cg12031962	chr15:58353849	ALDH1A2	-0.42	-4.89	-0.48	5.38e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs6503525	0.591	rs8080734	chr17:38103285	G/A	cg17467752	chr17:38218738	THRA	0.66	5.35	0.52	8.5e-7	Asthma;
SKCM	cis	rs11098499	0.722	rs10006192	chr4:120263022	T/C	cg09307838	chr4:120376055	NA	0.98	8.58	0.7	6.96e-13	Corneal astigmatism;
SKCM	cis	rs2836974	0.932	rs11910151	chr21:40560262	T/C	cg11890956	chr21:40555474	PSMG1	1.11	13.42	0.84	5.75e-22	Cognitive function;
SKCM	cis	rs992157	0.560	rs6436047	chr2:219108913	A/C	cg20019365	chr2:219134978	PNKD;AAMP	0.65	5.43	0.52	6.28e-7	Colorectal cancer;
SKCM	cis	rs244731	1.000	rs244729	chr5:176539018	C/G	cg06060754	chr5:176797920	RGS14	0.75	6.48	0.59	7.46e-9	Urate levels in lean individuals;
SKCM	cis	rs7618915	0.547	rs34537256	chr3:52657472	A/G	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs9926296	0.546	rs6500442	chr16:89828862	T/C	cg27121462	chr16:89883253	FANCA	0.82	8.07	0.67	6.84e-12	Vitiligo;
SKCM	cis	rs245880	0.702	rs245884	chr7:29188475	T/G	cg17163760	chr7:29186267	CPVL	-0.42	-5.49	-0.53	4.75e-7	Warfarin maintenance dose;
SKCM	cis	rs12477438	0.520	rs4851187	chr2:99745860	G/T	cg26064155	chr2:99771622	LIPT1;TSGA10	-1.02	-9.65	-0.74	5.96e-15	Chronic sinus infection;
SKCM	cis	rs8060686	0.641	rs9938553	chr16:68183064	T/A	cg09117114	chr16:67998030	SLC12A4	-0.76	-4.98	-0.49	3.79e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs752010	0.841	rs11210498	chr1:42077958	T/G	cg06885757	chr1:42089581	HIVEP3	0.54	5.77	0.55	1.51e-7	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs6879260	0.963	rs1035412	chr5:179729328	C/T	cg13944838	chr5:179740914	GFPT2	-0.7	-5.7	-0.54	2.04e-7	Height;
SKCM	cis	rs1355223	0.583	rs2941044	chr11:34867444	A/C	cg11058730	chr11:34937778	PDHX;APIP	0.59	4.77	0.47	8.55e-6	Systemic lupus erythematosus and Systemic sclerosis;
SKCM	cis	rs1799949	1.000	rs8176233	chr17:41219804	T/C	cg23758822	chr17:41437982	NA	0.94	7.89	0.67	1.51e-11	Menopause (age at onset);
SKCM	cis	rs11718455	0.960	rs17076254	chr3:44000361	C/T	cg21419209	chr3:44054225	NA	-0.65	-5.32	-0.52	9.77e-7	Coronary artery disease;
SKCM	cis	rs1003719	0.788	rs2835577	chr21:38457457	T/C	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs4689592	0.503	rs4689064	chr4:7055603	A/G	cg19539972	chr4:7069911	GRPEL1	-0.97	-6.3	-0.58	1.62e-8	Monocyte percentage of white cells;
SKCM	cis	rs9325144	0.723	rs11169535	chr12:39183494	C/T	cg13010199	chr12:38710504	ALG10B	-0.58	-4.78	-0.48	8.04e-6	Morning vs. evening chronotype;
SKCM	cis	rs1267303	0.642	rs116078607	chr1:46999238	G/A	cg25110126	chr1:46999211	NA	0.75	5.57	0.53	3.51e-7	Monobrow;
SKCM	cis	rs1799949	1.000	rs11655505	chr17:41278377	G/A	cg05368731	chr17:41323189	NBR1	0.89	7.91	0.67	1.38e-11	Menopause (age at onset);
SKCM	cis	rs9399135	0.967	rs4637662	chr6:135298158	T/C	cg24558204	chr6:135376177	HBS1L	0.56	5.01	0.49	3.3e-6	Red blood cell count;
SKCM	cis	rs11098499	0.909	rs10020034	chr4:120294331	A/G	cg24375607	chr4:120327624	NA	0.65	4.88	0.48	5.44e-6	Corneal astigmatism;
SKCM	cis	rs875971	1.000	rs778694	chr7:65871558	A/G	cg11764359	chr7:65958608	NA	0.87	8.35	0.69	2.01e-12	Aortic root size;
SKCM	cis	rs10779751	1.000	rs11121710	chr1:11313244	T/C	cg08854313	chr1:11322531	MTOR	0.92	6.9	0.62	1.22e-9	Body mass index;
SKCM	cis	rs7811142	0.943	rs28660238	chr7:100023308	C/T	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-1.0	-5.66	-0.54	2.36e-7	Platelet count;
SKCM	cis	rs1577917	0.572	rs911927	chr6:86327860	C/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.9	-8.96	-0.71	1.27e-13	Response to antipsychotic treatment;
SKCM	cis	rs11098499	0.779	rs10011097	chr4:120310359	T/G	cg09307838	chr4:120376055	NA	0.97	7.49	0.65	9.08e-11	Corneal astigmatism;
SKCM	trans	rs3780486	0.846	rs4584234	chr9:33147479	G/A	cg04842962	chr6:43655489	MRPS18A	0.97	10.3	0.76	3.28e-16	IgG glycosylation;
SKCM	cis	rs2303745	0.589	rs6512179	chr19:17399105	T/C	cg04248312	chr19:17393744	ANKLE1	-1.12	-8.3	-0.69	2.42e-12	Systemic lupus erythematosus;
SKCM	cis	rs1799949	0.965	rs8176198	chr17:41230537	A/T	cg23758822	chr17:41437982	NA	0.87	6.42	0.59	9.58e-9	Menopause (age at onset);
SKCM	cis	rs10791097	0.694	rs3190331	chr11:130748131	C/T	cg12179176	chr11:130786555	SNX19	-0.94	-8.21	-0.68	3.74e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs2836974	0.590	rs11911822	chr21:40607843	C/T	cg11644478	chr21:40555479	PSMG1	-0.8	-7.6	-0.65	5.6e-11	Cognitive function;
SKCM	cis	rs208520	0.955	rs12216176	chr6:67005130	G/T	cg07460842	chr6:66804631	NA	0.77	5.41	0.52	6.71e-7	Exhaled nitric oxide output;
SKCM	cis	rs9486715	0.867	rs9384602	chr6:96919561	G/A	cg06623918	chr6:96969491	KIAA0776	0.8	6.49	0.59	7.32e-9	Headache;
SKCM	cis	rs9467773	0.869	rs742090	chr6:26415637	A/C	cg15659132	chr6:26577336	NA	-0.54	-4.96	-0.49	4.09e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7824557	0.564	rs2572400	chr8:11234367	T/G	cg21775007	chr8:11205619	TDH	-0.59	-5.04	-0.5	2.91e-6	Retinal vascular caliber;
SKCM	cis	rs35306767	0.903	rs765867	chr10:869901	G/T	cg20503657	chr10:835505	NA	0.75	5.43	0.52	6.09e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs12478296	1.000	rs67535150	chr2:243046099	A/G	cg06360820	chr2:242988706	NA	-0.93	-5.45	-0.53	5.66e-7	Obesity-related traits;
SKCM	cis	rs875971	1.000	rs1968225	chr7:65874773	T/C	cg11764359	chr7:65958608	NA	0.87	8.35	0.69	2.01e-12	Aortic root size;
SKCM	cis	rs854765	0.624	rs1889018	chr17:17734740	G/A	cg24612305	chr17:17875800	TOM1L2;LRRC48	-0.95	-7.11	-0.63	4.78e-10	Total body bone mineral density;
SKCM	cis	rs875971	0.540	rs4717275	chr7:65265180	C/T	cg11987759	chr7:65425863	GUSB	0.74	6.36	0.58	1.29e-8	Aortic root size;
SKCM	cis	rs7772486	0.686	rs2072911	chr6:146056801	G/A	cg23711669	chr6:146136114	FBXO30	-0.8	-7.72	-0.66	3.35e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1552244	0.882	rs66559400	chr3:10012551	G/A	cg02579736	chr3:10068473	FANCD2;CIDECP	0.94	4.84	0.48	6.49e-6	Alzheimer's disease;
SKCM	cis	rs7811142	1.000	rs11763414	chr7:100016844	C/G	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.23	8.03	0.67	8.33e-12	Platelet count;
SKCM	cis	rs2811415	0.597	rs9854763	chr3:127797890	A/G	cg09089421	chr3:127803668	RUVBL1	1.0	8.69	0.7	4.4e-13	Lung function (FEV1/FVC);
SKCM	cis	rs4523957	0.651	rs9906705	chr17:2063714	T/G	cg16513277	chr17:2031491	SMG6	-0.79	-5.63	-0.54	2.7e-7	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs28386778	0.897	rs7207005	chr17:61860355	A/G	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs2816062	0.813	rs2816053	chr1:18895819	A/G	cg18795169	chr1:18902165	NA	-0.83	-8.91	-0.71	1.59e-13	Urate levels in lean individuals;
SKCM	cis	rs2832191	0.647	rs11170	chr21:30378090	C/T	cg08807101	chr21:30365312	RNF160	0.68	5.7	0.54	2.02e-7	Dental caries;
SKCM	cis	rs2439831	0.681	rs11858152	chr15:43634196	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.17	8.32	0.69	2.25e-12	Lung cancer in ever smokers;
SKCM	cis	rs28386778	0.799	rs2955234	chr17:61983601	A/C	cg26338869	chr17:61819248	STRADA	-0.72	-4.84	-0.48	6.31e-6	Prudent dietary pattern;
SKCM	cis	rs62238980	0.614	rs76348022	chr22:32412186	C/A	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs7124681	0.584	rs12226590	chr11:47571808	T/C	cg20307385	chr11:47447363	PSMC3	0.76	5.65	0.54	2.49e-7	Body mass index (joint analysis main effects and physical activity interaction);Body mass index;Body mass index in physically active individuals;
SKCM	cis	rs7954584	0.545	rs12824593	chr12:122374108	G/A	cg13699009	chr12:122356056	WDR66	0.59	7.37	0.64	1.54e-10	Mean corpuscular volume;
SKCM	cis	rs875971	0.964	rs160635	chr7:65528918	T/C	cg11764359	chr7:65958608	NA	0.9	8.21	0.68	3.63e-12	Aortic root size;
SKCM	cis	rs28595532	0.748	rs55949457	chr4:119336174	A/G	cg21605333	chr4:119757512	SEC24D	0.95	4.91	0.49	4.92e-6	Cannabis dependence symptom count;
SKCM	cis	rs709400	0.663	rs7152202	chr14:103886757	A/G	cg26031613	chr14:104095156	KLC1	0.72	5.33	0.52	9.26e-7	Body mass index;
SKCM	cis	rs28595532	1.000	rs115965820	chr4:119586485	G/A	cg11846333	chr4:119757529	SEC24D	1.15	6.24	0.58	2.13e-8	Cannabis dependence symptom count;
SKCM	cis	rs2180341	1.000	rs2038378	chr6:127590400	C/T	cg27446573	chr6:127587934	RNF146	1.02	8.27	0.68	2.88e-12	Breast cancer;
SKCM	cis	rs440932	0.747	rs330946	chr8:9022177	A/C	cg06636001	chr8:8085503	FLJ10661	0.62	4.78	0.48	8.01e-6	High light scatter reticulocyte percentage of red cells;
SKCM	cis	rs58688157	0.705	rs936468	chr11:607175	G/A	cg17114584	chr11:613792	IRF7	0.8	5.62	0.54	2.88e-7	Systemic lupus erythematosus;
SKCM	cis	rs4975616	0.710	rs27996	chr5:1345474	A/G	cg06550200	chr5:1325588	CLPTM1L	-0.78	-6.36	-0.58	1.25e-8	Lung cancer;
SKCM	cis	rs826838	0.510	rs17523988	chr12:39222785	A/C	cg26384229	chr12:38710491	ALG10B	0.68	5.11	0.5	2.28e-6	Heart rate;
SKCM	cis	rs7945705	0.967	rs10840141	chr11:8902218	T/C	cg21881798	chr11:8931708	C11orf17;ST5	0.76	7.75	0.66	2.86e-11	Hemoglobin concentration;
SKCM	cis	rs2836974	0.931	rs8132285	chr21:40655752	T/C	cg17971929	chr21:40555470	PSMG1	0.9	8.81	0.71	2.52e-13	Cognitive function;
SKCM	cis	rs4665809	0.590	rs6716858	chr2:26423414	G/A	cg26119090	chr2:26468346	HADHA;HADHB	-0.99	-7.67	-0.66	4.17e-11	Gut microbiome composition (summer);
SKCM	cis	rs1577917	1.000	rs12213740	chr6:86656733	A/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.66	-5.74	-0.54	1.76e-7	Response to antipsychotic treatment;
SKCM	cis	rs4910157	1	rs4910157	chr11:8941215	A/G	cg13070366	chr11:9386451	NA	-0.65	-5.65	-0.54	2.48e-7	Tonsillectomy;
SKCM	cis	rs2479724	0.935	rs2025951	chr6:41827193	C/T	cg17623882	chr6:41773611	USP49	0.8	7.01	0.62	7.43e-10	Menarche (age at onset);
SKCM	cis	rs12541335	0.639	rs13257108	chr8:22165043	T/C	cg09517075	chr8:22133004	PIWIL2	0.6	5.47	0.53	5.2e-7	Hypertriglyceridemia;
SKCM	cis	rs7666738	0.830	rs10012003	chr4:99064881	A/G	cg17366294	chr4:99064904	C4orf37	0.61	4.93	0.49	4.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs929354	0.772	rs7778193	chr7:156980087	C/T	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs9911578	1.000	rs304270	chr17:56802141	A/G	cg05425664	chr17:57184151	TRIM37	0.67	5.04	0.5	2.91e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs4072980	0.545	rs7519947	chr1:38447725	T/C	cg12658694	chr1:38397304	INPP5B	-0.73	-5.26	-0.51	1.21e-6	Coronary artery disease;
SKCM	cis	rs6570726	0.846	rs371186	chr6:145886971	T/C	cg05347473	chr6:146136440	FBXO30	0.53	4.89	0.48	5.28e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2032447	0.839	rs9356995	chr6:25996673	G/A	cg18357526	chr6:26021779	HIST1H4A	0.76	5.92	0.56	8.05e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs6866344	0.697	rs62392831	chr5:178134365	A/G	cg03877680	chr5:178157825	ZNF354A	0.86	6.37	0.59	1.19e-8	Neutrophil percentage of white cells;
SKCM	cis	rs514406	0.698	rs1775540	chr1:53407893	C/A	cg24675658	chr1:53192096	ZYG11B	-0.82	-7.79	-0.66	2.45e-11	Monocyte count;
SKCM	cis	rs763014	0.966	rs7185390	chr16:666382	A/G	cg07343612	chr16:622815	PIGQ	-0.69	-5.93	-0.56	7.86e-8	Height;
SKCM	cis	rs4319547	0.615	rs2341439	chr12:122848096	C/G	cg23029597	chr12:123009494	RSRC2	-0.78	-5.74	-0.55	1.72e-7	Body mass index;
SKCM	cis	rs2304069	0.954	rs9324638	chr5:149400718	A/G	cg22760475	chr5:149380129	HMGXB3;TIGD6	-0.86	-5.42	-0.52	6.44e-7	HIV-1 control;
SKCM	cis	rs2811415	0.597	rs9827421	chr3:127775499	C/T	cg09089421	chr3:127803668	RUVBL1	1.02	8.85	0.71	2.14e-13	Lung function (FEV1/FVC);
SKCM	cis	rs7811142	1.000	rs66632384	chr7:100018904	G/A	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.16	7.68	0.66	3.87e-11	Platelet count;
SKCM	cis	rs1580019	0.563	rs13225132	chr7:32800975	A/G	cg06627557	chr7:32535165	LSM5;AVL9	0.96	8.44	0.69	1.29e-12	Cognitive ability;
SKCM	cis	rs394563	0.589	rs1900300	chr6:149641627	T/C	cg16235748	chr6:149772707	ZC3H12D	0.46	5.26	0.51	1.22e-6	Dupuytren's disease;
SKCM	cis	rs9640161	0.711	rs60268791	chr7:150023800	G/T	cg10018233	chr7:150070692	REPIN1	0.77	6.19	0.57	2.62e-8	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs1018836	0.798	rs4735295	chr8:91671608	C/A	cg16814680	chr8:91681699	NA	-0.88	-7.64	-0.65	4.73e-11	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs11098499	0.820	rs28578366	chr4:120536905	A/G	cg24375607	chr4:120327624	NA	-0.66	-5.11	-0.5	2.25e-6	Corneal astigmatism;
SKCM	cis	rs6952808	0.723	rs4721287	chr7:2028663	A/C	cg21782813	chr7:2030301	MAD1L1	0.58	5.96	0.56	6.79e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs7666738	0.830	rs13118892	chr4:98968497	T/C	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9858542	0.953	rs9862080	chr3:49674458	A/G	cg03060546	chr3:49711283	APEH	-0.71	-5.29	-0.51	1.07e-6	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs763121	0.819	rs3747173	chr22:39069045	A/G	cg06022373	chr22:39101656	GTPBP1	0.8	5.85	0.55	1.1e-7	Menopause (age at onset);
SKCM	cis	rs208520	0.661	rs207090	chr6:66783963	T/A	cg07460842	chr6:66804631	NA	-1.02	-7.44	-0.64	1.16e-10	Exhaled nitric oxide output;
SKCM	cis	rs2197308	0.740	rs11182251	chr12:37919611	C/T	cg13010199	chr12:38710504	ALG10B	-0.64	-4.92	-0.49	4.67e-6	Morning vs. evening chronotype;
SKCM	cis	rs796364	0.951	rs7586284	chr2:201068002	G/A	cg12253985	chr2:200820533	C2orf60;C2orf47	0.95	6.37	0.59	1.21e-8	Schizophrenia;
SKCM	cis	rs6977660	0.941	rs5017192	chr7:19820114	C/T	cg05791153	chr7:19748676	TWISTNB	0.79	5.34	0.52	9.05e-7	Thyroid stimulating hormone;
SKCM	cis	rs28595532	0.920	rs116607127	chr4:119731072	T/C	cg21605333	chr4:119757512	SEC24D	1.36	8.05	0.67	7.69e-12	Cannabis dependence symptom count;
SKCM	cis	rs10911232	0.507	rs4575047	chr1:182976028	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.64	0.6	3.81e-9	Hypertriglyceridemia;
SKCM	cis	rs10911232	0.507	rs6660111	chr1:183014289	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.65	0.6	3.59e-9	Hypertriglyceridemia;
SKCM	cis	rs875971	0.755	rs10228885	chr7:65780529	C/G	cg11764359	chr7:65958608	NA	-0.74	-6.75	-0.61	2.36e-9	Aortic root size;
SKCM	cis	rs6570726	0.791	rs11155432	chr6:145898761	T/C	cg23711669	chr6:146136114	FBXO30	0.88	9.09	0.72	7.08e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs3768617	0.565	rs10752898	chr1:183077896	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.76	6.59	0.6	4.7e-9	Fuchs's corneal dystrophy;
SKCM	trans	rs1814175	0.817	rs10839397	chr11:49857074	C/T	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs7829975	0.511	rs2948286	chr8:8130160	A/G	cg15556689	chr8:8085844	FLJ10661	0.84	7.92	0.67	1.36e-11	Mood instability;
SKCM	cis	rs1218582	0.774	rs1007170	chr1:154881461	G/A	cg03351412	chr1:154909251	PMVK	0.73	6.28	0.58	1.81e-8	Prostate cancer;
SKCM	cis	rs6456156	0.524	rs6932740	chr6:167466439	G/A	cg13927040	chr6:167453801	FGFR1OP	0.66	4.85	0.48	6.24e-6	Primary biliary cholangitis;
SKCM	cis	rs7772486	0.790	rs9497431	chr6:146248177	T/C	cg05347473	chr6:146136440	FBXO30	-0.55	-4.97	-0.49	3.82e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs763014	0.931	rs1981483	chr16:630665	G/A	cg00908189	chr16:619842	PIGQ	0.82	7.78	0.66	2.55e-11	Height;
SKCM	cis	rs870825	0.616	rs10428373	chr4:185639002	A/G	cg21366198	chr4:185655624	MLF1IP	-0.77	-4.84	-0.48	6.52e-6	Blood protein levels;
SKCM	cis	rs1062177	1.000	rs892006	chr5:151180890	G/T	cg00977110	chr5:151150581	G3BP1	0.84	6.73	0.61	2.58e-9	Preschool internalizing problems;
SKCM	cis	rs1348850	0.914	rs3813259	chr2:178257214	G/A	cg02961200	chr2:178257176	LOC100130691;AGPS	0.9	6.82	0.61	1.71e-9	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs4242434	0.698	rs10104039	chr8:22538384	A/G	cg03733263	chr8:22462867	KIAA1967	-0.79	-6.01	-0.56	5.57e-8	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs8060686	0.641	rs7192187	chr16:68132109	T/C	cg09117114	chr16:67998030	SLC12A4	-0.81	-5.29	-0.51	1.07e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs1506636	1.000	rs615410	chr7:123437765	T/C	cg03229431	chr7:123269106	ASB15	0.64	5.3	0.51	1.06e-6	Plateletcrit;Platelet count;
SKCM	cis	rs7811142	1.000	rs11773661	chr7:100073069	G/C	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.17	7.71	0.66	3.44e-11	Platelet count;
SKCM	cis	rs12464559	0.522	rs7583148	chr2:152620986	C/T	cg01189475	chr2:152685088	ARL5A	1.03	5.27	0.51	1.18e-6	Response to cognitive-behavioural therapy in anxiety disorder;
SKCM	cis	rs7824557	0.767	rs1897951	chr8:11169854	C/T	cg21775007	chr8:11205619	TDH	0.71	5.95	0.56	7.2e-8	Retinal vascular caliber;
SKCM	cis	rs644799	0.562	rs1254989	chr11:95508121	A/G	cg03916912	chr11:95522834	CEP57;FAM76B	0.61	4.92	0.49	4.73e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs4803468	0.967	rs3213860	chr19:41920211	T/C	cg14132834	chr19:41945861	ATP5SL	-0.77	-6.08	-0.57	4.18e-8	Height;
SKCM	cis	rs7408868	0.908	rs4809028	chr19:15273231	A/G	cg14696996	chr19:15285081	NOTCH3	0.82	4.92	0.49	4.7e-6	Pulse pressure;
SKCM	cis	rs6087990	0.871	rs1007122	chr20:31346001	C/T	cg13636640	chr20:31349939	DNMT3B	0.83	6.25	0.58	2.06e-8	Ulcerative colitis;
SKCM	cis	rs17376456	0.877	rs10066791	chr5:93350255	G/T	cg21475434	chr5:93447410	FAM172A	0.95	5.36	0.52	8.36e-7	Diabetic retinopathy;
SKCM	cis	rs2857078	0.720	rs9906669	chr17:42305706	A/G	cg19774624	chr17:42201019	HDAC5	-0.77	-6.27	-0.58	1.84e-8	Red cell distribution width;Reticulocyte count;
SKCM	cis	rs1018836	0.923	rs4735260	chr8:91617157	C/G	cg16814680	chr8:91681699	NA	0.62	4.81	0.48	7.19e-6	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs854765	0.505	rs4506969	chr17:17899839	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.08	9.02	0.71	9.86e-14	Total body bone mineral density;
SKCM	cis	rs9300255	0.722	rs12298826	chr12:123829028	A/G	cg05973401	chr12:123451056	ABCB9	-0.82	-5.72	-0.54	1.92e-7	Neutrophil percentage of white cells;
SKCM	cis	rs5758659	0.652	rs5758553	chr22:42431429	G/A	cg21144673	chr22:42017783	PPPDE2;XRCC6	-0.65	-4.94	-0.49	4.42e-6	Cognitive function;
SKCM	cis	rs873946	0.529	rs12258248	chr10:134573767	A/G	cg14275445	chr10:134560047	INPP5A	-0.55	-4.87	-0.48	5.71e-6	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs12950390	0.853	rs4794107	chr17:45843159	T/G	cg03474202	chr17:45855739	NA	-0.49	-5.58	-0.53	3.34e-7	IgG glycosylation;
SKCM	cis	rs6952808	0.862	rs4721167	chr7:1933224	C/T	cg05863683	chr7:1912471	MAD1L1	0.64	5.63	0.54	2.78e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs2952156	1.000	rs1565923	chr17:37858678	A/G	cg20243544	chr17:37824526	PNMT	0.7	5.6	0.54	3.07e-7	Asthma;
SKCM	cis	rs1218582	0.772	rs1109815	chr1:154909268	A/G	cg24250549	chr1:154909240	PMVK	0.87	8.7	0.7	4.13e-13	Prostate cancer;
SKCM	cis	rs1348850	0.514	rs4893974	chr2:178497026	A/G	cg27490568	chr2:178487706	NA	0.88	6.11	0.57	3.66e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs7086627	0.515	rs10887901	chr10:82210581	G/A	cg00277334	chr10:82204260	NA	-0.74	-8.47	-0.69	1.14e-12	Post bronchodilator FEV1;
SKCM	cis	rs4891159	0.790	rs8087557	chr18:74116848	G/C	cg24786174	chr18:74118243	ZNF516	-0.76	-7.77	-0.66	2.61e-11	Longevity;
SKCM	cis	rs10808739	0.660	rs13258167	chr8:65639566	C/T	cg05711235	chr8:65498612	NA	0.83	5.69	0.54	2.11e-7	HIV-1 susceptibility;
SKCM	cis	rs10808739	1.000	rs58994922	chr8:65641267	A/G	cg05711235	chr8:65498612	NA	-0.76	-4.88	-0.48	5.4e-6	HIV-1 susceptibility;
SKCM	cis	rs2952156	0.684	rs881844	chr17:37810218	C/G	cg20243544	chr17:37824526	PNMT	0.72	5.55	0.53	3.77e-7	Asthma;
SKCM	cis	rs28595532	0.920	rs10004184	chr4:119486801	G/T	cg11846333	chr4:119757529	SEC24D	1.15	6.24	0.58	2.13e-8	Cannabis dependence symptom count;
SKCM	cis	rs4481887	0.861	rs6676064	chr1:248443890	G/C	cg00666640	chr1:248458726	OR2T12	0.63	5.44	0.52	6.01e-7	Common traits (Other);
SKCM	cis	rs614226	1.000	rs12310837	chr12:120880572	C/T	cg01236616	chr12:121019343	POP5	1.38	7.6	0.65	5.55e-11	Type 1 diabetes nephropathy;
SKCM	cis	rs11892454	0.544	rs7571093	chr2:25992894	C/G	cg17263061	chr2:26915892	KCNK3	0.72	5.2	0.51	1.56e-6	Heschl's gyrus morphology;
SKCM	cis	rs28595532	0.920	rs114420700	chr4:119751297	T/C	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs3091242	0.933	rs28633797	chr1:25741629	C/A	cg02931644	chr1:25747376	RHCE	0.5	5.01	0.49	3.36e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs4819052	0.851	rs914214	chr21:46697820	G/T	cg02159808	chr21:46707872	POFUT2;LOC642852	0.74	5.68	0.54	2.22e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs870825	0.655	rs10013685	chr4:185617785	C/T	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs1799949	0.965	rs7223952	chr17:41194885	T/C	cg05368731	chr17:41323189	NBR1	0.88	7.5	0.65	8.87e-11	Menopause (age at onset);
SKCM	cis	rs16940212	0.618	rs920917	chr15:58688478	A/C	cg16767221	chr15:57769667	CGNL1	-0.62	-5.04	-0.5	2.97e-6	HDL cholesterol levels;HDL cholesterol;
SKCM	cis	rs854765	0.583	rs7213225	chr17:17869111	T/C	cg04398451	chr17:18023971	MYO15A	-0.86	-5.91	-0.56	8.41e-8	Total body bone mineral density;
SKCM	cis	rs56235845	0.694	rs11749830	chr5:176766547	G/A	cg16006841	chr5:176797999	RGS14	0.7	6.47	0.59	7.95e-9	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs561341	1.000	rs555629	chr17:30294136	T/C	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs763014	0.898	rs12917944	chr16:622565	A/G	cg00908189	chr16:619842	PIGQ	0.81	7.2	0.63	3.3e-10	Height;
SKCM	cis	rs17376456	0.877	rs10052428	chr5:93476530	T/C	cg21475434	chr5:93447410	FAM172A	0.97	5.42	0.52	6.39e-7	Diabetic retinopathy;
SKCM	cis	rs8180040	1.000	rs811115	chr3:47322133	C/T	cg27129171	chr3:47204927	SETD2	0.87	6.62	0.6	4.15e-9	Colorectal cancer;
SKCM	cis	rs2842992	0.830	rs2495279	chr6:160138796	C/T	cg11366901	chr6:160182831	ACAT2	0.89	7.03	0.62	6.78e-10	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs2839186	0.619	rs2187118	chr21:47611310	C/T	cg11766577	chr21:47581405	C21orf56	-0.8	-7.07	-0.63	5.68e-10	Testicular germ cell tumor;
SKCM	cis	rs1912528	0.783	rs769661	chr4:140869936	C/T	cg11128457	chr4:140864437	MAML3	0.62	5.16	0.5	1.8e-6	Educational attainment (years of education);
SKCM	cis	rs11098499	0.909	rs79704848	chr4:120309351	T/A	cg09307838	chr4:120376055	NA	0.97	7.49	0.65	9.08e-11	Corneal astigmatism;
SKCM	cis	rs2645694	0.626	rs2703143	chr4:77830441	A/G	cg06046430	chr4:77819534	ANKRD56	0.54	5.94	0.56	7.49e-8	Emphysema distribution in smoking;
SKCM	cis	rs2153535	0.580	rs9393022	chr6:8466588	T/C	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs7799006	0.527	rs2159045	chr7:2207401	T/C	cg02951883	chr7:2050386	MAD1L1	-0.65	-5.18	-0.51	1.66e-6	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);
SKCM	cis	rs7772486	0.875	rs2748501	chr6:146312258	G/A	cg05347473	chr6:146136440	FBXO30	0.55	4.91	0.49	4.94e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6912958	1.000	rs6912958	chr6:88133315	G/A	cg08069147	chr6:88032118	GJB7;C6orf162	-0.75	-6.38	-0.59	1.14e-8	Monocyte percentage of white cells;
SKCM	cis	rs854765	0.575	rs7207821	chr17:17891781	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.07	8.97	0.71	1.24e-13	Total body bone mineral density;
SKCM	cis	rs5750830	0.649	rs5750815	chr22:39798449	T/C	cg24399712	chr22:39784796	NA	-0.61	-5.07	-0.5	2.66e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7937682	0.924	rs1784782	chr11:111525764	A/C	cg09085632	chr11:111637200	PPP2R1B	-1.07	-11.3	-0.79	4.28e-18	Primary sclerosing cholangitis;
SKCM	cis	rs875971	0.862	rs12698521	chr7:65939489	T/C	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs6570726	0.791	rs400329	chr6:145879442	A/T	cg05347473	chr6:146136440	FBXO30	0.57	5.13	0.5	2.06e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs769267	0.895	rs2916073	chr19:19528324	T/G	cg03709012	chr19:19516395	GATAD2A	0.91	8.6	0.7	6.34e-13	Tonsillectomy;
SKCM	cis	rs2559856	1.000	rs10745921	chr12:102087193	A/G	cg12924262	chr12:102091054	CHPT1	0.71	5.96	0.56	6.99e-8	Blood protein levels;
SKCM	cis	rs72781680	0.752	rs72796138	chr2:23926233	C/T	cg08917208	chr2:24149416	ATAD2B	0.95	4.78	0.48	8.1e-6	Lymphocyte counts;
SKCM	cis	rs72772090	0.710	rs17479052	chr5:96065636	A/G	cg17330273	chr5:96107758	CAST;ERAP1	-0.84	-5.1	-0.5	2.29e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs2228479	0.850	rs117285117	chr16:89910250	T/G	cg00800038	chr16:89945340	TCF25	-0.98	-4.9	-0.48	5.19e-6	Skin colour saturation;
SKCM	cis	rs28595532	0.920	rs115090549	chr4:119753554	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs6088590	0.687	rs6088582	chr20:33286798	G/A	cg24642439	chr20:33292090	TP53INP2	0.75	5.35	0.52	8.46e-7	Coronary artery disease;
SKCM	cis	rs7523273	0.526	rs3849274	chr1:208021557	T/A	cg22525895	chr1:207977042	MIR29B2	-0.85	-6.62	-0.6	4.19e-9	Schizophrenia;
SKCM	cis	rs2032447	0.670	rs198845	chr6:26107790	A/C	cg03517284	chr6:25882590	NA	-0.63	-5.45	-0.53	5.7e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs2841277	0.646	rs2819419	chr14:105406238	A/C	cg15352829	chr14:105391018	PLD4	-0.57	-4.84	-0.48	6.55e-6	Rheumatoid arthritis;
SKCM	cis	rs2836974	0.897	rs2836928	chr21:40543320	C/T	cg11890956	chr21:40555474	PSMG1	1.07	13.19	0.83	1.48e-21	Cognitive function;
SKCM	cis	rs4234284	1.000	rs4350879	chr3:126974456	T/G	cg04889221	chr3:126137216	CCDC37	-0.48	-5.01	-0.49	3.31e-6	Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel);
SKCM	cis	rs2404602	0.583	rs2176623	chr15:76568579	C/T	cg23625390	chr15:77176239	SCAPER	0.67	6.26	0.58	1.91e-8	Blood metabolite levels;
SKCM	cis	rs2439831	0.850	rs10163054	chr15:44047638	G/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.35	7.75	0.66	2.9e-11	Lung cancer in ever smokers;
SKCM	cis	rs9640161	0.711	rs3735170	chr7:150034184	T/C	cg27494647	chr7:150038898	RARRES2	0.61	5.33	0.52	9.39e-7	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs6570726	0.905	rs377143	chr6:145834220	C/T	cg23711669	chr6:146136114	FBXO30	0.71	6.9	0.62	1.21e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2204008	0.905	rs7294297	chr12:38442573	T/C	cg26384229	chr12:38710491	ALG10B	0.81	6.22	0.58	2.33e-8	Bladder cancer;
SKCM	cis	rs2066819	1.000	rs41392645	chr12:56696742	A/G	cg26714650	chr12:56694279	CS	-1.69	-6.08	-0.57	4.15e-8	Psoriasis vulgaris;
SKCM	cis	rs7208859	0.623	rs28433704	chr17:29084285	G/C	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs9660180	0.837	rs915292	chr1:1792157	A/C	cg23982607	chr1:1823379	GNB1	-0.73	-6.09	-0.57	4.08e-8	Body mass index;
SKCM	cis	rs1799949	0.965	rs8176322	chr17:41195773	A/G	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.06	-0.57	4.62e-8	Menopause (age at onset);
SKCM	cis	rs66569888	0.632	rs6728600	chr2:106898653	G/T	cg15412446	chr2:106886593	NA	-0.66	-5.03	-0.5	3.05e-6	Facial morphology (factor 23);
SKCM	cis	rs1691799	0.899	rs1168294	chr12:66733988	T/C	cg16791601	chr12:66731901	HELB	-0.66	-5.81	-0.55	1.31e-7	White blood cell count (basophil);
SKCM	cis	rs1577917	0.876	rs12212808	chr6:86533972	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.33	-0.52	9.19e-7	Response to antipsychotic treatment;
SKCM	cis	rs3820068	0.603	rs16851884	chr1:15961871	A/G	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs875971	0.862	rs10950033	chr7:65739673	A/G	cg18876405	chr7:65276391	NA	-0.65	-6.57	-0.6	5.03e-9	Aortic root size;
SKCM	cis	rs875971	0.862	rs9791712	chr7:66105163	C/G	cg11764359	chr7:65958608	NA	-0.74	-6.63	-0.6	3.89e-9	Aortic root size;
SKCM	cis	rs13392177	0.684	rs62185965	chr2:219073779	T/C	cg00012203	chr2:219082015	ARPC2	-0.64	-4.89	-0.48	5.39e-6	Pyoderma gangrenosum in inflammatory bowel disease;
SKCM	cis	rs950776	0.648	rs57945453	chr15:78862845	C/T	cg06917634	chr15:78832804	PSMA4	0.85	6.83	0.61	1.68e-9	Sudden cardiac arrest;
SKCM	cis	rs801193	0.569	rs2013908	chr7:66121069	A/T	cg18876405	chr7:65276391	NA	-0.63	-6.32	-0.58	1.5e-8	Aortic root size;
SKCM	cis	rs17685	0.753	rs1104878	chr7:75685593	G/T	cg01364799	chr7:75623366	TMEM120A	-0.75	-6.05	-0.56	4.78e-8	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2739330	0.760	rs5760095	chr22:24247293	A/G	cg12419862	chr22:24373484	LOC391322	-0.79	-7.42	-0.64	1.23e-10	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs2153535	0.541	rs6938688	chr6:8521629	G/T	cg07606381	chr6:8435919	SLC35B3	0.87	6.38	0.59	1.17e-8	Motion sickness;
SKCM	cis	rs35306767	0.761	rs34480046	chr10:1027440	A/G	cg20503657	chr10:835505	NA	0.75	5.94	0.56	7.41e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs854765	0.562	rs2955381	chr17:17945500	G/C	cg24612305	chr17:17875800	TOM1L2;LRRC48	-1.05	-9.29	-0.72	2.92e-14	Total body bone mineral density;
SKCM	cis	rs362272	0.545	rs2239725	chr4:3305739	C/T	cg00764545	chr4:3318001	RGS12	0.92	11.06	0.78	1.21e-17	Serum sulfate level;
SKCM	cis	rs2836950	0.501	rs2836985	chr21:40701169	A/G	cg17971929	chr21:40555470	PSMG1	-0.65	-5.09	-0.5	2.4e-6	Menarche (age at onset);
SKCM	cis	rs867186	1.000	rs2295888	chr20:33722863	A/G	cg04194272	chr20:33683537	NA	-1.11	-6.01	-0.56	5.61e-8	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs12477438	0.520	rs13030961	chr2:99799520	C/G	cg26064155	chr2:99771622	LIPT1;TSGA10	1.0	9.17	0.72	5.12e-14	Chronic sinus infection;
SKCM	cis	rs2559856	1.000	rs2251187	chr12:102081889	G/A	cg12924262	chr12:102091054	CHPT1	0.7	5.68	0.54	2.19e-7	Blood protein levels;
SKCM	cis	rs651907	0.557	rs13077925	chr3:101488181	T/A	cg12386194	chr3:101231763	SENP7	0.66	5.4	0.52	6.96e-7	Colorectal cancer;
SKCM	cis	rs4803468	0.905	rs284662	chr19:41932275	T/C	cg09537434	chr19:41945824	ATP5SL	-1.1	-13.85	-0.84	1.02e-22	Height;
SKCM	cis	rs1957429	0.808	rs1957436	chr14:65348207	T/G	cg23373153	chr14:65346875	NA	1.11	6.32	0.58	1.52e-8	Pediatric areal bone mineral density (radius);
SKCM	cis	rs2737618	0.722	rs2737676	chr1:200086839	T/C	cg21825944	chr1:200113062	NR5A2	-0.62	-4.96	-0.49	4.03e-6	Uric acid levels;
SKCM	cis	rs7843479	1.000	rs17615788	chr8:21814739	C/T	cg17168535	chr8:21777572	XPO7	0.75	6.18	0.57	2.75e-8	Mean corpuscular volume;
SKCM	cis	rs7617480	0.756	rs990211	chr3:48721040	A/G	cg07636037	chr3:49044803	WDR6	0.78	4.82	0.48	6.91e-6	Subjective well-being (multi-trait analysis);Menarche (age at onset);
SKCM	cis	rs116095464	0.558	rs55664502	chr5:270485	T/C	cg22857025	chr5:266934	NA	-1.47	-8.33	-0.69	2.16e-12	Breast cancer;
SKCM	cis	rs6495122	0.651	rs11636952	chr15:75114322	T/C	cg14664628	chr15:75095509	CSK	-1.01	-8.32	-0.69	2.23e-12	Caffeine consumption;Diastolic blood pressure;Coffee consumption;
SKCM	cis	rs6840360	0.615	rs56319216	chr4:152463716	C/T	cg22705602	chr4:152727874	NA	-0.51	-5.78	-0.55	1.45e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs6500395	1.000	rs11644518	chr16:48616789	A/G	cg04672837	chr16:48644449	N4BP1	0.69	5.88	0.55	9.68e-8	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs9611565	0.802	rs9611577	chr22:41793090	T/G	cg03806693	chr22:41940476	POLR3H	-0.97	-6.45	-0.59	8.71e-9	Vitiligo;
SKCM	cis	rs8060686	0.641	rs112099181	chr16:68154230	T/C	cg09117114	chr16:67998030	SLC12A4	-0.81	-5.29	-0.51	1.07e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs10540	1.000	rs12417570	chr11:462684	C/T	cg03352830	chr11:487213	PTDSS2	1.09	5.25	0.51	1.27e-6	Body mass index;
SKCM	cis	rs7811142	1.000	rs11763414	chr7:100016844	C/G	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-1.0	-5.66	-0.54	2.36e-7	Platelet count;
SKCM	cis	rs13118159	0.550	rs4974611	chr4:1358449	T/C	cg02475777	chr4:1388615	CRIPAK	0.8	5.27	0.51	1.17e-6	Longevity;
SKCM	cis	rs7092929	0.882	rs645838	chr10:3560515	A/G	cg14308648	chr10:3568949	NA	0.8	5.36	0.52	8.15e-7	Coronary artery calcification;
SKCM	cis	rs72634258	0.796	rs4369247	chr1:8168993	C/T	cg00042356	chr1:8021962	PARK7	-0.86	-5.71	-0.54	1.94e-7	Inflammatory bowel disease;
SKCM	cis	rs10751667	0.643	rs6597969	chr11:928843	C/T	cg10932868	chr11:921992	NA	0.55	5.13	0.5	2.09e-6	Alzheimer's disease (late onset);
SKCM	cis	rs2857078	0.886	rs2072081	chr17:42327493	G/T	cg13607699	chr17:42295918	UBTF	0.86	5.68	0.54	2.24e-7	Red cell distribution width;Reticulocyte count;
SKCM	cis	rs2120019	0.567	rs8037152	chr15:75156996	A/T	cg17294928	chr15:75287854	SCAMP5	-0.84	-6.05	-0.57	4.64e-8	Blood trace element (Zn levels);
SKCM	cis	rs7772486	0.754	rs697054	chr6:146003770	C/T	cg23711669	chr6:146136114	FBXO30	0.87	8.05	0.67	7.51e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs933688	1.000	rs6867219	chr5:90718008	T/G	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.02	7.81	0.66	2.22e-11	Smoking behavior;
SKCM	cis	rs2180341	0.814	rs9385424	chr6:127726796	A/G	cg27446573	chr6:127587934	RNF146	0.69	5.49	0.53	4.79e-7	Breast cancer;
SKCM	cis	rs12478296	1.000	rs73007140	chr2:243010756	T/C	cg06360820	chr2:242988706	NA	-1.01	-5.87	-0.55	1e-7	Obesity-related traits;
SKCM	cis	rs5750830	0.594	rs1010169	chr22:39778167	C/T	cg11247378	chr22:39784982	NA	0.48	5.64	0.54	2.56e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs1348850	0.574	rs11889488	chr2:178426793	A/G	cg27490568	chr2:178487706	NA	-0.83	-5.67	-0.54	2.3e-7	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs778371	0.788	rs2675955	chr2:233753281	G/A	cg08000102	chr2:233561755	GIGYF2	-0.82	-5.43	-0.52	6.23e-7	Schizophrenia;
SKCM	cis	rs7666738	0.830	rs880472	chr4:98922595	C/A	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7772486	0.790	rs4314514	chr6:146260010	A/G	cg05347473	chr6:146136440	FBXO30	-0.55	-4.97	-0.49	3.86e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs56235845	0.694	rs6875461	chr5:176754665	C/T	cg06060754	chr5:176797920	RGS14	-0.64	-6.35	-0.58	1.34e-8	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs4727027	0.899	rs4727025	chr7:148862863	A/G	cg23583168	chr7:148888333	NA	-0.8	-6.62	-0.6	4.13e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs6582630	0.555	rs10880520	chr12:38464111	C/T	cg26384229	chr12:38710491	ALG10B	0.81	6.22	0.58	2.31e-8	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs4665809	0.590	rs4665315	chr2:26416036	T/G	cg26119090	chr2:26468346	HADHA;HADHB	-1.02	-7.92	-0.67	1.35e-11	Gut microbiome composition (summer);
SKCM	cis	rs1023500	0.551	rs133379	chr22:42468535	A/G	cg04733989	chr22:42467013	NAGA	0.72	5.7	0.54	2.07e-7	Schizophrenia;
SKCM	cis	rs933688	0.938	rs1477348	chr5:90707823	G/A	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.1	8.33	0.69	2.14e-12	Smoking behavior;
SKCM	cis	rs6753739	0.661	rs4674354	chr2:219903723	C/T	cg09297636	chr2:219923910	IHH	0.47	4.87	0.48	5.78e-6	Height;
SKCM	cis	rs7945705	0.869	rs2742471	chr11:9003953	C/T	cg13070366	chr11:9386451	NA	0.57	5.07	0.5	2.6e-6	Hemoglobin concentration;
SKCM	trans	rs3780486	0.505	rs959749	chr9:33147858	T/C	cg04842962	chr6:43655489	MRPS18A	0.82	8.05	0.67	7.51e-12	IgG glycosylation;
SKCM	cis	rs3087591	0.960	rs1013947	chr17:29530362	C/T	cg24425628	chr17:29625626	OMG;NF1	0.61	4.87	0.48	5.75e-6	Hip circumference;
SKCM	cis	rs2013441	0.786	rs4003797	chr17:20288900	T/C	cg13482628	chr17:19912719	NA	-0.64	-4.85	-0.48	6.3e-6	Obesity-related traits;
SKCM	cis	rs769267	0.631	rs7252981	chr19:19692579	T/C	cg26732615	chr19:19648335	CILP2;YJEFN3	-0.57	-4.85	-0.48	6.28e-6	Tonsillectomy;
SKCM	cis	rs28595532	1.000	rs11938970	chr4:119660152	A/G	cg11846333	chr4:119757529	SEC24D	1.09	5.78	0.55	1.48e-7	Cannabis dependence symptom count;
SKCM	cis	rs7809950	0.798	rs2701684	chr7:107299527	C/T	cg23024343	chr7:107201750	COG5	0.59	5.0	0.49	3.51e-6	Coronary artery disease;
SKCM	cis	rs1405130	0.967	rs3956012	chr2:235571572	T/C	cg21542780	chr2:234763377	HJURP	-0.65	-4.92	-0.49	4.75e-6	Coronary artery disease;
SKCM	trans	rs1814175	0.817	rs7927373	chr11:49957640	A/C	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs10504229	1.000	rs114486414	chr8:58185103	G/A	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs9911578	1.000	rs12453459	chr17:56624291	C/T	cg05425664	chr17:57184151	TRIM37	0.69	5.21	0.51	1.52e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9475752	0.793	rs720884	chr6:56877318	A/G	cg06815302	chr6:57335405	PRIM2	0.7	5.1	0.5	2.34e-6	Menarche (age at onset);
SKCM	cis	rs2739330	0.760	rs5751760	chr22:24243573	G/A	cg24846343	chr22:24311635	DDTL	0.66	6.27	0.58	1.87e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs9359856	0.510	rs17293240	chr6:90396370	C/T	cg13799429	chr6:90582589	CASP8AP2	0.71	4.88	0.48	5.45e-6	Bipolar disorder;
SKCM	cis	rs738321	0.701	rs2413506	chr22:38593128	T/C	cg25457927	chr22:38595422	NA	-0.66	-8.15	-0.68	4.82e-12	Breast cancer;
SKCM	cis	rs3091242	0.935	rs4233043	chr1:25765483	A/G	cg02931644	chr1:25747376	RHCE	0.5	4.9	0.48	5.17e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs782590	0.559	rs12617719	chr2:55915826	G/C	cg18811423	chr2:55921094	PNPT1	-0.75	-5.76	-0.55	1.57e-7	Metabolic syndrome;
SKCM	cis	rs9880211	0.699	rs13433688	chr3:136409171	C/T	cg21827317	chr3:136751795	NA	-0.7	-5.43	-0.52	6.12e-7	Body mass index;Height;
SKCM	cis	rs826838	1.000	rs826886	chr12:39095797	A/G	cg13010199	chr12:38710504	ALG10B	0.76	5.8	0.55	1.37e-7	Heart rate;
SKCM	cis	rs769267	1.000	rs1009136	chr19:19440428	A/G	cg26732615	chr19:19648335	CILP2;YJEFN3	-0.63	-5.77	-0.55	1.51e-7	Tonsillectomy;
SKCM	cis	rs9790314	0.875	rs459515	chr3:161092351	T/C	cg03342759	chr3:160939853	NMD3	-0.73	-8.2	-0.68	3.89e-12	Morning vs. evening chronotype;
SKCM	cis	rs7659604	0.518	rs17452156	chr4:122733623	T/C	cg20573242	chr4:122745356	CCNA2	0.75	6.39	0.59	1.11e-8	Type 2 diabetes;
SKCM	cis	rs6430585	0.697	rs115944351	chr2:136515458	G/A	cg07169764	chr2:136633963	MCM6	1.31	13.14	0.83	1.86e-21	Corneal structure;
SKCM	cis	rs12824058	0.831	rs4759450	chr12:130812732	G/A	cg26677194	chr12:130822605	PIWIL1	0.71	5.83	0.55	1.17e-7	Menopause (age at onset);
SKCM	cis	rs950776	0.518	rs11636131	chr15:78821606	C/T	cg06917634	chr15:78832804	PSMA4	1.01	10.47	0.76	1.56e-16	Sudden cardiac arrest;
SKCM	cis	rs7523050	0.643	rs34114412	chr1:109402866	C/T	cg08274380	chr1:109419600	GPSM2	1.13	5.57	0.53	3.54e-7	Fat distribution (HIV);
SKCM	cis	rs9815354	0.812	rs17215589	chr3:41831203	C/T	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs12477438	0.501	rs9941561	chr2:99753829	A/C	cg14399236	chr2:99771627	LIPT1;TSGA10	0.97	8.9	0.71	1.72e-13	Chronic sinus infection;
SKCM	cis	rs1580019	0.922	rs766658	chr7:32499391	C/T	cg06627557	chr7:32535165	LSM5;AVL9	0.75	5.74	0.55	1.7e-7	Cognitive ability;
SKCM	cis	rs7772486	0.686	rs2179323	chr6:145982786	T/G	cg05347473	chr6:146136440	FBXO30	-0.6	-5.31	-0.52	1e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2153535	0.580	rs1832101	chr6:8460177	A/G	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs7945705	0.520	rs1984791	chr11:9035027	C/T	cg21881798	chr11:8931708	C11orf17;ST5	0.56	4.99	0.49	3.56e-6	Hemoglobin concentration;
SKCM	cis	rs1218582	0.772	rs2102423	chr1:154916068	A/G	cg24250549	chr1:154909240	PMVK	0.87	8.88	0.71	1.84e-13	Prostate cancer;
SKCM	cis	rs561341	0.739	rs4795663	chr17:30214542	T/C	cg00745463	chr17:30367425	LRRC37B	0.81	5.16	0.5	1.81e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs9300255	0.537	rs2695482	chr12:123623174	C/T	cg05973401	chr12:123451056	ABCB9	0.8	5.47	0.53	5.23e-7	Neutrophil percentage of white cells;
SKCM	cis	rs6840360	0.571	rs7695866	chr4:152488110	G/A	cg22705602	chr4:152727874	NA	-0.5	-5.38	-0.52	7.49e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs35766269	0.541	rs11256014	chr10:9040564	G/A	cg05671070	chr10:8095960	FLJ45983;GATA3	0.95	4.77	0.48	8.45e-6	Recalcitrant atopic dermatitis;
SKCM	cis	rs801193	1.000	rs4279493	chr7:66226620	C/T	cg11764359	chr7:65958608	NA	0.82	6.23	0.58	2.18e-8	Aortic root size;
SKCM	cis	rs1405130	0.967	rs884062	chr2:235570734	T/G	cg21542780	chr2:234763377	HJURP	-0.65	-4.92	-0.49	4.75e-6	Coronary artery disease;
SKCM	cis	rs8067545	0.685	rs4479309	chr17:19971583	C/T	cg13482628	chr17:19912719	NA	0.73	6.54	0.6	5.78e-9	Schizophrenia;
SKCM	cis	rs9916302	0.808	rs6503515	chr17:37606433	G/T	cg07936489	chr17:37558343	FBXL20	-0.86	-7.39	-0.64	1.42e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs1029738	0.615	rs717624	chr7:22894487	T/C	cg22407942	chr7:22894828	SNORD93	-0.56	-5.02	-0.49	3.17e-6	Fibrinogen levels;
SKCM	cis	rs861020	0.606	rs695140	chr1:210005061	G/A	cg05527609	chr1:210001259	C1orf107	0.86	6.74	0.61	2.43e-9	Orofacial clefts;
SKCM	cis	rs10883723	0.810	rs17782574	chr10:104279394	G/A	cg11453585	chr10:104263688	ACTR1A;SUFU	0.77	6.31	0.58	1.56e-8	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs4332037	0.713	rs56093134	chr7:1973970	C/T	cg02825527	chr7:2087843	MAD1L1	-0.72	-4.79	-0.48	7.66e-6	Bipolar disorder;
SKCM	cis	rs870825	0.616	rs10428373	chr4:185639002	A/T	cg04058563	chr4:185651563	MLF1IP	1.08	7.26	0.64	2.51e-10	Blood protein levels;
SKCM	cis	rs4555082	1.000	rs7146683	chr14:105759385	A/G	cg13114125	chr14:105738426	BRF1	-0.7	-5.38	-0.52	7.46e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs9921222	0.597	rs3848369	chr16:415078	C/T	cg00101154	chr16:420108	MRPL28	-0.73	-5.76	-0.55	1.56e-7	Bone mineral density (spine);Bone mineral density;
SKCM	cis	rs3785574	0.962	rs2727332	chr17:61878584	T/A	cg01411255	chr17:61851458	DDX42;CCDC47	1.15	13.4	0.83	6.26e-22	Height;
SKCM	cis	rs362272	0.525	rs910568	chr4:3307373	A/G	cg16987761	chr4:3318072	RGS12	0.99	11.34	0.79	3.54e-18	Serum sulfate level;
SKCM	cis	rs6728642	1.000	rs11890407	chr2:97621647	G/C	cg00438775	chr2:97175311	NEURL3	1.17	5.3	0.51	1.03e-6	Bipolar disorder lithium response (continuous) or schizophrenia;
SKCM	cis	rs3020736	0.500	rs5996111	chr22:42493902	C/T	cg04733989	chr22:42467013	NAGA	-0.72	-5.62	-0.54	2.87e-7	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs1044826	0.667	rs2083336	chr3:139201272	T/G	cg15131784	chr3:139108705	COPB2	0.7	5.19	0.51	1.62e-6	Obesity-related traits;
SKCM	cis	rs7090367	0.555	rs11248546	chr10:125242283	C/T	cg16197717	chr10:125650957	CPXM2	-0.49	-5.16	-0.5	1.81e-6	Body mass index;
SKCM	cis	rs8072100	0.688	rs12602134	chr17:45582136	C/G	cg08085267	chr17:45401833	C17orf57	0.6	5.28	0.51	1.14e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs67311347	0.544	rs6804545	chr3:40354040	G/C	cg02782426	chr3:40428986	ENTPD3	0.5	4.99	0.49	3.64e-6	Renal cell carcinoma;
SKCM	cis	rs71636778	0.596	rs2095637	chr1:27232845	A/G	cg01689405	chr1:26370407	SLC30A2	-0.53	-4.86	-0.48	5.9e-6	Monocyte percentage of white cells;Granulocyte percentage of myeloid white cells;
SKCM	cis	rs2153535	0.601	rs9328487	chr6:8529378	G/C	cg07606381	chr6:8435919	SLC35B3	0.93	6.8	0.61	1.92e-9	Motion sickness;
SKCM	cis	rs7208859	0.623	rs28433704	chr17:29084285	G/C	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs6750795	0.507	rs1667320	chr2:232418314	G/T	cg19187155	chr2:232395269	NMUR1	0.94	8.31	0.69	2.32e-12	Height;
SKCM	cis	rs2180341	1.000	rs6569486	chr6:127708424	A/C	cg27446573	chr6:127587934	RNF146	0.9	7.59	0.65	5.96e-11	Breast cancer;
SKCM	cis	rs9640161	0.636	rs56190213	chr7:150025720	T/C	cg10018233	chr7:150070692	REPIN1	0.68	5.27	0.51	1.18e-6	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs6952808	1.000	rs4721122	chr7:1893311	C/G	cg04267008	chr7:1944627	MAD1L1	-0.77	-5.86	-0.55	1.06e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs9475752	0.793	rs34616943	chr6:56822998	C/G	cg06815302	chr6:57335405	PRIM2	0.69	4.97	0.49	3.92e-6	Menarche (age at onset);
SKCM	cis	rs7618915	0.501	rs2289247	chr3:52727257	C/T	cg18404041	chr3:52824283	ITIH1	-0.53	-4.77	-0.48	8.42e-6	Bipolar disorder;
SKCM	cis	rs72781680	0.898	rs72780191	chr2:24007122	T/C	cg08917208	chr2:24149416	ATAD2B	1.02	4.97	0.49	3.94e-6	Lymphocyte counts;
SKCM	cis	rs6089829	0.962	rs6089825	chr20:61668447	C/T	cg03213289	chr20:61660250	NA	0.49	4.81	0.48	7.26e-6	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs7215564	0.908	rs35361366	chr17:78684751	T/C	cg16980736	chr17:78789706	RPTOR	-0.88	-4.83	-0.48	6.66e-6	Myopia (pathological);
SKCM	cis	rs13278732	0.500	rs34276726	chr8:99039263	A/G	cg16297171	chr8:99017690	MATN2	-0.54	-5.13	-0.5	2.07e-6	Eosinophilic esophagitis (pediatric);
SKCM	cis	rs6840360	0.571	rs12648420	chr4:152543434	G/C	cg22705602	chr4:152727874	NA	-0.52	-5.7	-0.54	2.03e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs9457247	0.534	rs7750593	chr6:167387359	C/G	cg23791538	chr6:167370224	RNASET2	0.55	4.98	0.49	3.74e-6	Crohn's disease;
SKCM	cis	rs6598955	0.670	rs3795688	chr1:26560481	C/A	cg00938395	chr1:26633206	UBXN11	0.67	4.83	0.48	6.61e-6	Obesity-related traits;
SKCM	cis	rs769267	0.929	rs2905431	chr19:19482882	G/A	cg03709012	chr19:19516395	GATAD2A	-0.89	-8.35	-0.69	1.95e-12	Tonsillectomy;
SKCM	trans	rs7618501	0.902	rs7645061	chr3:49868842	C/T	cg21659725	chr3:3221576	CRBN	0.96	9.43	0.73	1.59e-14	Intelligence (multi-trait analysis);
SKCM	cis	rs507080	0.885	rs4938530	chr11:118560570	G/T	cg18045108	chr11:118530628	TREH	-0.47	-4.82	-0.48	6.89e-6	Serum metabolite levels;
SKCM	cis	rs3768617	0.510	rs3768618	chr1:183092491	C/A	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	trans	rs1814175	0.616	rs1722020	chr11:49904189	G/A	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs6840360	0.593	rs10222925	chr4:152690215	A/G	cg22705602	chr4:152727874	NA	-0.59	-7.93	-0.67	1.3e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs10751667	0.666	rs7395182	chr11:927553	A/C	cg06064525	chr11:970664	AP2A2	-0.55	-5.09	-0.5	2.46e-6	Alzheimer's disease (late onset);
SKCM	cis	rs4423214	0.921	rs12807827	chr11:71203790	A/C	cg05163923	chr11:71159392	DHCR7	0.81	7.25	0.63	2.68e-10	Vitamin D levels;
SKCM	cis	rs7809950	1.000	rs17154104	chr7:107090698	C/T	cg23024343	chr7:107201750	COG5	-0.82	-7.51	-0.65	8.3e-11	Coronary artery disease;
SKCM	cis	rs4332037	0.539	rs56180486	chr7:2050747	C/T	cg23422044	chr7:1970798	MAD1L1	-0.9	-5.97	-0.56	6.6e-8	Bipolar disorder;
SKCM	cis	rs6952808	0.756	rs13234214	chr7:1878860	C/T	cg02951883	chr7:2050386	MAD1L1	-0.66	-4.91	-0.49	4.86e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs9300255	0.664	rs12316131	chr12:123817796	T/C	cg05973401	chr12:123451056	ABCB9	-0.82	-5.72	-0.54	1.92e-7	Neutrophil percentage of white cells;
SKCM	cis	rs912057	0.671	rs1294427	chr6:6744546	T/G	cg06612196	chr6:6737390	NA	0.66	5.47	0.53	5.25e-7	Waist-to-hip ratio adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);
SKCM	cis	rs6977660	1.000	rs5017196	chr7:19819983	T/C	cg05791153	chr7:19748676	TWISTNB	0.79	5.4	0.52	6.86e-7	Thyroid stimulating hormone;
SKCM	trans	rs17685	0.753	rs1637039	chr7:75693009	C/T	cg19862616	chr7:65841803	NCRNA00174	0.95	9.34	0.73	2.39e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs9300255	0.602	rs1790095	chr12:123681222	G/A	cg00376283	chr12:123451042	ABCB9	0.84	5.26	0.51	1.25e-6	Neutrophil percentage of white cells;
SKCM	cis	rs997295	0.535	rs11632776	chr15:67852645	G/A	cg24247231	chr15:67904302	MAP2K5	-0.61	-5.03	-0.49	3.09e-6	Motion sickness;
SKCM	cis	rs58688157	0.705	rs12803132	chr11:586696	A/G	cg16486109	chr11:613632	IRF7	1.09	6.84	0.61	1.6e-9	Systemic lupus erythematosus;
SKCM	cis	rs6087990	0.735	rs2424928	chr20:31388636	T/C	cg13636640	chr20:31349939	DNMT3B	0.83	6.25	0.58	2.06e-8	Ulcerative colitis;
SKCM	cis	rs4803468	1.000	rs10417997	chr19:41902361	G/A	cg14132834	chr19:41945861	ATP5SL	-0.74	-5.71	-0.54	1.99e-7	Height;
SKCM	cis	rs4332037	0.950	rs7807014	chr7:1939021	T/C	cg02825527	chr7:2087843	MAD1L1	-0.73	-5.11	-0.5	2.22e-6	Bipolar disorder;
SKCM	cis	rs28386778	0.799	rs2727322	chr17:61921706	G/A	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs11098499	0.779	rs28495013	chr4:120375831	A/C	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs875971	0.825	rs59466412	chr7:65565358	A/G	cg11764359	chr7:65958608	NA	-0.83	-7.68	-0.66	3.83e-11	Aortic root size;
SKCM	cis	rs7618501	0.573	rs7634917	chr3:50049299	T/G	cg24110177	chr3:50126178	RBM5	0.6	5.11	0.5	2.25e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7927771	1.000	rs10838757	chr11:47763016	T/C	cg05585544	chr11:47624801	NA	-0.6	-5.22	-0.51	1.45e-6	Subjective well-being;
SKCM	cis	rs1218582	0.772	rs6669791	chr1:154845484	G/T	cg06221963	chr1:154839813	KCNN3	-0.61	-6.33	-0.58	1.41e-8	Prostate cancer;
SKCM	cis	rs9399135	0.967	rs4895439	chr6:135318854	A/T	cg24558204	chr6:135376177	HBS1L	0.59	5.23	0.51	1.41e-6	Red blood cell count;
SKCM	cis	rs10500871	1.000	rs12806043	chr11:20217343	C/T	cg04653710	chr11:19367236	NA	0.58	5.02	0.49	3.16e-6	Educational attainment;
SKCM	cis	rs929354	0.742	rs1182396	chr7:157031831	A/C	cg17757837	chr7:157058334	UBE3C	-0.82	-5.72	-0.54	1.87e-7	Body mass index;
SKCM	cis	rs2153535	0.580	rs9393016	chr6:8458573	T/A	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs2760061	0.819	rs964941	chr1:228193857	G/A	cg02753203	chr1:228287806	NA	0.69	5.82	0.55	1.24e-7	Diastolic blood pressure;
SKCM	cis	rs3087591	0.960	rs4795587	chr17:29587917	A/C	cg24425628	chr17:29625626	OMG;NF1	-0.63	-5.04	-0.5	3e-6	Hip circumference;
SKCM	cis	rs5769765	0.837	rs7284417	chr22:50314346	A/G	cg22709217	chr22:50311962	ALG12;CRELD2	-0.9	-6.06	-0.57	4.62e-8	Schizophrenia;
SKCM	cis	rs10911251	0.528	rs2333622	chr1:183075456	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Colorectal cancer;
SKCM	cis	rs12142240	0.698	rs6697123	chr1:46811310	A/C	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs668210	0.894	rs1786171	chr11:65769809	G/C	cg02202077	chr11:65769826	EIF1AD;BANF1	0.76	5.29	0.51	1.07e-6	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs7945705	0.870	rs4929922	chr11:8975776	A/G	cg13070366	chr11:9386451	NA	0.58	5.03	0.49	3.1e-6	Hemoglobin concentration;
SKCM	cis	rs250677	0.652	rs168751	chr5:148438264	C/T	cg18129178	chr5:148520854	ABLIM3	-0.8	-4.79	-0.48	7.9e-6	Breast cancer;
SKCM	cis	rs28595532	0.920	rs116697254	chr4:119733603	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.43	0.59	9.38e-9	Cannabis dependence symptom count;
SKCM	cis	rs8078723	0.738	rs3816472	chr17:38142677	A/C	cg17467752	chr17:38218738	THRA	-0.6	-5.31	-0.51	1.02e-6	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs62244186	0.520	rs2372828	chr3:44784949	A/G	cg15225532	chr3:44803084	KIF15;KIAA1143	-0.64	-4.91	-0.49	4.99e-6	Depressive symptoms;
SKCM	cis	rs798766	0.903	rs798726	chr4:1685211	C/T	cg05874882	chr4:1763078	NA	0.59	5.46	0.53	5.46e-7	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs6952808	0.792	rs13224989	chr7:1953766	C/G	cg05863683	chr7:1912471	MAD1L1	0.56	4.96	0.49	4.03e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs34779708	0.897	rs12830	chr10:35302705	C/T	cg03585969	chr10:35415529	CREM	0.75	6.23	0.58	2.2e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs2073499	0.872	rs58051625	chr3:50278717	G/C	cg08207895	chr3:50388901	TUSC4;CYB561D2	0.73	5.0	0.49	3.51e-6	Schizophrenia;
SKCM	cis	rs3862260	0.509	rs12076924	chr1:120165826	C/T	cg16322792	chr1:120165303	ZNF697	0.51	5.28	0.51	1.12e-6	Systemic lupus erythematosus;
SKCM	cis	rs6952808	0.964	rs6945719	chr7:1932688	G/A	cg02951883	chr7:2050386	MAD1L1	-0.71	-5.69	-0.54	2.1e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs12142240	0.698	rs6684274	chr1:46810842	A/G	cg10495392	chr1:46806563	NSUN4	-0.74	-5.73	-0.54	1.81e-7	Menopause (age at onset);
SKCM	cis	rs7647973	0.580	rs11716334	chr3:49230096	G/A	cg06212747	chr3:49208901	KLHDC8B	0.79	5.72	0.54	1.89e-7	Menarche (age at onset);
SKCM	cis	rs3784262	0.904	rs17820823	chr15:58239358	A/G	cg12031962	chr15:58353849	ALDH1A2	-0.49	-5.92	-0.56	8.28e-8	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs6982751	0.673	rs56407290	chr8:10811780	G/T	cg01383082	chr8:11323474	FAM167A	0.86	4.99	0.49	3.58e-6	Asthma and hay fever;
SKCM	trans	rs62103177	0.733	rs62096747	chr18:77619568	A/G	cg05926928	chr17:57297772	GDPD1	1.29	8.74	0.7	3.44e-13	Opioid sensitivity;
SKCM	cis	rs2204008	0.777	rs2049130	chr12:38444837	G/A	cg26384229	chr12:38710491	ALG10B	0.81	6.22	0.58	2.33e-8	Bladder cancer;
SKCM	cis	rs2228479	0.867	rs12930606	chr16:89946682	A/G	cg00800038	chr16:89945340	TCF25	-0.93	-5.34	-0.52	8.73e-7	Skin colour saturation;
SKCM	cis	rs875971	0.638	rs7793569	chr7:66116633	T/G	cg18876405	chr7:65276391	NA	-0.82	-7.48	-0.65	9.41e-11	Aortic root size;
SKCM	cis	rs35306767	0.903	rs12250937	chr10:900209	C/T	cg26597838	chr10:835615	NA	0.78	5.5	0.53	4.73e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs9902453	0.933	rs7216494	chr17:28502651	C/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.5	0.53	4.74e-7	Coffee consumption (cups per day);
SKCM	cis	rs919433	0.929	rs1366836	chr2:198172148	T/G	cg04278110	chr2:198063759	ANKRD44	-0.7	-5.12	-0.5	2.14e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs2439831	0.681	rs511673	chr15:43618863	T/C	cg27015174	chr15:43622946	ADAL;LCMT2	0.87	4.81	0.48	7.13e-6	Lung cancer in ever smokers;
SKCM	cis	rs2050392	0.767	rs10763786	chr10:30693567	G/C	cg25182066	chr10:30743637	MAP3K8	0.65	5.38	0.52	7.72e-7	Inflammatory bowel disease;
SKCM	cis	rs644799	0.965	rs602512	chr11:95561682	G/A	cg03916912	chr11:95522834	CEP57;FAM76B	0.91	7.93	0.67	1.27e-11	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs2153535	0.580	rs9406159	chr6:8464859	C/G	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs4481887	0.927	rs4390208	chr1:248472211	C/T	cg00666640	chr1:248458726	OR2T12	0.63	5.91	0.56	8.65e-8	Common traits (Other);
SKCM	cis	rs2948294	0.588	rs7011221	chr8:8114246	C/T	cg08975724	chr8:8085496	FLJ10661	0.63	4.78	0.48	8.1e-6	Red cell distribution width;
SKCM	cis	rs1801516	0.950	rs10890837	chr11:108303021	T/C	cg03165700	chr11:108093220	ATM;NPAT	-1.11	-5.06	-0.5	2.68e-6	Melanoma;
SKCM	cis	rs7980687	0.527	rs28533432	chr12:123873242	C/T	cg05973401	chr12:123451056	ABCB9	0.7	5.05	0.5	2.85e-6	Height;Educational attainment;Head circumference (infant);
SKCM	cis	rs8060686	0.641	rs79577483	chr16:68036939	A/G	cg27539214	chr16:67997921	SLC12A4	-0.85	-4.83	-0.48	6.65e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs28386778	0.897	rs2665844	chr17:61874455	A/G	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs2832191	0.703	rs2853827	chr21:30443596	T/C	cg08807101	chr21:30365312	RNF160	0.74	6.05	0.57	4.77e-8	Dental caries;
SKCM	cis	rs28386778	0.897	rs1877318	chr17:61819960	G/A	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.12	11.27	0.79	4.92e-18	Prudent dietary pattern;
SKCM	cis	rs9910055	0.530	rs11652651	chr17:42302907	A/G	cg13607699	chr17:42295918	UBTF	-0.85	-7.12	-0.63	4.56e-10	Total body bone mineral density;
SKCM	cis	rs1979654	0.525	rs17263449	chr16:86402684	A/T	cg01467047	chr16:86611690	FOXL1	-0.39	-4.85	-0.48	6.09e-6	Barrett's esophagus  or Esophageal adenocarcinoma;
SKCM	cis	rs11249608	0.548	rs6880315	chr5:178452502	G/A	cg21905437	chr5:178450457	ZNF879	0.73	5.9	0.56	8.75e-8	Pubertal anthropometrics;
SKCM	cis	rs875971	0.660	rs28698552	chr7:66005018	A/G	cg11987759	chr7:65425863	GUSB	-0.69	-5.9	-0.56	8.74e-8	Aortic root size;
SKCM	cis	rs910316	0.904	rs7156089	chr14:75645527	A/G	cg08847533	chr14:75593920	NEK9	-0.99	-9.68	-0.74	5.25e-15	Height;
SKCM	cis	rs8070624	0.543	rs11078409	chr17:17876296	C/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.04	8.4	0.69	1.6e-12	Total body bone mineral density;
SKCM	cis	rs17826219	0.706	rs9893922	chr17:29068425	T/C	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Body mass index;
SKCM	cis	rs28386778	0.897	rs8081454	chr17:61842646	A/G	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs514406	0.668	rs520281	chr1:53365235	G/C	cg24675658	chr1:53192096	ZYG11B	-0.82	-7.84	-0.66	1.89e-11	Monocyte count;
SKCM	cis	rs9790314	0.715	rs980975	chr3:160771410	G/A	cg03342759	chr3:160939853	NMD3	-0.6	-5.64	-0.54	2.62e-7	Morning vs. evening chronotype;
SKCM	cis	rs17685	0.712	rs9800948	chr7:75810473	A/G	cg16489192	chr7:75678113	MDH2;STYXL1	-0.52	-5.11	-0.5	2.2e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs6121246	0.511	rs879982	chr20:30398510	A/G	cg13852791	chr20:30311386	BCL2L1	0.82	5.69	0.54	2.09e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs7666738	0.830	rs28451101	chr4:99001190	T/C	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1799949	1.000	rs35956818	chr17:41422985	T/C	cg05368731	chr17:41323189	NBR1	0.85	7.32	0.64	1.89e-10	Menopause (age at onset);
SKCM	cis	rs8180040	0.967	rs17411375	chr3:47395135	C/T	cg27129171	chr3:47204927	SETD2	-0.87	-6.62	-0.6	4.15e-9	Colorectal cancer;
SKCM	cis	rs11098499	0.954	rs7681544	chr4:120411255	T/C	cg24375607	chr4:120327624	NA	0.65	5.01	0.49	3.32e-6	Corneal astigmatism;
SKCM	cis	rs6565180	0.962	rs35480350	chr16:30366039	G/A	cg17640201	chr16:30407289	ZNF48	-0.89	-6.64	-0.6	3.74e-9	Tonsillectomy;
SKCM	cis	rs7927771	0.864	rs60075622	chr11:47449101	T/G	cg05585544	chr11:47624801	NA	-0.56	-4.79	-0.48	7.65e-6	Subjective well-being;
SKCM	cis	rs3749237	0.595	rs4855839	chr3:49507847	G/A	cg03060546	chr3:49711283	APEH	0.67	4.95	0.49	4.23e-6	Resting heart rate;
SKCM	cis	rs362272	0.524	rs7435601	chr4:3369645	A/G	cg16987761	chr4:3318072	RGS12	0.99	10.96	0.78	1.86e-17	Serum sulfate level;
SKCM	cis	rs7829975	0.564	rs2921060	chr8:8317817	G/T	cg06636001	chr8:8085503	FLJ10661	-0.95	-9.42	-0.73	1.69e-14	Mood instability;
SKCM	cis	rs2991971	1.000	rs2934859	chr1:46017836	C/T	cg24296786	chr1:45957014	TESK2	0.65	5.25	0.51	1.28e-6	High light scatter reticulocyte count;
SKCM	cis	rs4774899	0.966	rs12904321	chr15:57507579	A/T	cg01857019	chr15:57210107	LOC145783;TCF12	0.53	4.94	0.49	4.38e-6	Urinary tract infection frequency;
SKCM	cis	rs6500395	0.962	rs9923371	chr16:48628015	C/T	cg04672837	chr16:48644449	N4BP1	0.69	5.88	0.55	9.68e-8	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs11792861	0.564	rs3816237	chr9:111718348	T/A	cg14432460	chr9:111696404	IKBKAP;C9orf6	0.77	6.58	0.6	4.9e-9	Menarche (age at onset);
SKCM	cis	rs10489202	0.657	rs3767479	chr1:168069840	C/A	cg24449463	chr1:168025552	DCAF6	-0.77	-7.11	-0.63	4.89e-10	Schizophrenia;
SKCM	cis	rs2737618	0.722	rs2258675	chr1:200091548	G/C	cg21825944	chr1:200113062	NR5A2	-0.62	-4.99	-0.49	3.52e-6	Uric acid levels;
SKCM	cis	rs17270561	0.541	rs17586946	chr6:25939053	C/T	cg16482183	chr6:26056742	HIST1H1C	0.98	6.72	0.61	2.69e-9	Iron status biomarkers;
SKCM	cis	rs2832191	0.791	rs2832198	chr21:30498240	C/T	cg24692254	chr21:30365293	RNF160	0.9	8.01	0.67	9.12e-12	Dental caries;
SKCM	cis	rs7666738	0.791	rs6853608	chr4:99047916	A/G	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7208859	0.623	rs1054397	chr17:29110196	T/C	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs763121	0.853	rs6001204	chr22:39100239	T/C	cg06022373	chr22:39101656	GTPBP1	0.85	6.3	0.58	1.65e-8	Menopause (age at onset);
SKCM	cis	rs1005277	0.522	rs11011343	chr10:38002698	A/G	cg00409905	chr10:38381863	ZNF37A	-0.58	-5.73	-0.54	1.77e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs7829975	0.742	rs882462	chr8:8678530	G/A	cg15556689	chr8:8085844	FLJ10661	0.75	7.12	0.63	4.75e-10	Mood instability;
SKCM	cis	rs8016982	0.633	rs7160342	chr14:81713427	G/C	cg01989461	chr14:81687754	GTF2A1	0.84	7.04	0.62	6.52e-10	Schizophrenia;
SKCM	cis	rs801193	0.569	rs3846973	chr7:66120035	T/C	cg11764359	chr7:65958608	NA	-0.74	-6.63	-0.6	3.89e-9	Aortic root size;
SKCM	cis	rs10193935	0.901	rs9808509	chr2:42479644	T/C	cg27598129	chr2:42591480	NA	-0.97	-6.7	-0.6	2.93e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs55720021	1	rs55720021	chr19:49144241	G/T	cg06530960	chr19:49140787	SEC1;DBP	0.78	5.42	0.52	6.45e-7	Lymphocyte percentage of white cells;Neutrophil percentage of white cells;
SKCM	cis	rs67460515	0.563	rs73023235	chr3:160864123	G/A	cg03342759	chr3:160939853	NMD3	-0.72	-6.11	-0.57	3.71e-8	Parkinson's disease;
SKCM	cis	rs10197940	0.578	rs1061305	chr2:152346979	T/C	cg19508488	chr2:152266495	RIF1	0.59	4.78	0.48	8.2e-6	Lung cancer;
SKCM	cis	rs732765	0.657	rs28461601	chr14:75228488	T/C	cg25946216	chr14:74253857	C14orf43	-0.93	-5.16	-0.5	1.82e-6	Non-small cell lung cancer;
SKCM	cis	rs854765	0.547	rs2955355	chr17:17948475	G/A	cg24612305	chr17:17875800	TOM1L2;LRRC48	-1.02	-9.54	-0.73	9.55e-15	Total body bone mineral density;
SKCM	cis	rs7847628	0.587	rs3793638	chr9:123582697	G/T	cg09419670	chr9:123605666	PSMD5;LOC253039	0.67	6.11	0.57	3.6e-8	Birth weight;
SKCM	cis	rs9633740	0.685	rs4934284	chr10:82277297	C/G	cg01528321	chr10:82214614	TSPAN14	-0.83	-4.85	-0.48	6.15e-6	Post bronchodilator FEV1;
SKCM	cis	rs9311474	0.508	rs6805156	chr3:52609362	T/C	cg18404041	chr3:52824283	ITIH1	-0.53	-4.77	-0.48	8.42e-6	Electroencephalogram traits;
SKCM	cis	rs9640161	0.783	rs35435439	chr7:150063534	C/T	cg10018233	chr7:150070692	REPIN1	0.72	6.0	0.56	5.86e-8	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs7811142	0.830	rs7792959	chr7:99972403	C/T	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.05	5.92	0.56	8.02e-8	Platelet count;
SKCM	cis	rs7659604	0.628	rs6838153	chr4:122720999	A/G	cg19748678	chr4:122722346	EXOSC9	0.72	6.24	0.58	2.1e-8	Type 2 diabetes;
SKCM	cis	rs9788682	0.624	rs518425	chr15:78883813	A/G	cg24631222	chr15:78858424	CHRNA5	0.83	5.69	0.54	2.16e-7	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs686320	0.667	rs550015	chr11:65186348	A/G	cg13521124	chr11:66064082	TMEM151A	-0.85	-4.79	-0.48	7.91e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs1568889	0.877	rs1384903	chr11:28124359	A/T	cg06544937	chr11:28130018	METT5D1;KIF18A	0.88	6.41	0.59	1.02e-8	Bipolar disorder;
SKCM	cis	rs1059312	0.500	rs12303338	chr12:129276641	C/T	cg09035930	chr12:129282057	SLC15A4	-0.86	-7.05	-0.62	6.36e-10	Systemic lupus erythematosus;
SKCM	cis	rs7215564	0.558	rs4889876	chr17:78657071	T/G	cg16980736	chr17:78789706	RPTOR	-0.89	-4.88	-0.48	5.41e-6	Myopia (pathological);
SKCM	cis	rs9443189	0.526	rs9359124	chr6:76200514	G/A	cg01950844	chr6:76311363	SENP6	0.92	4.82	0.48	6.95e-6	Prostate cancer;
SKCM	cis	rs6665290	0.669	rs3795445	chr1:227180947	A/C	cg10327440	chr1:227177885	CDC42BPA	-1.11	-10.33	-0.76	2.88e-16	Myeloid white cell count;
SKCM	cis	rs1325195	0.506	rs2636266	chr1:179199652	A/G	cg25467746	chr1:179556597	NA	0.62	5.77	0.55	1.51e-7	IgE grass sensitization;
SKCM	cis	rs2836950	0.545	rs11700449	chr21:40522419	A/T	cg11890956	chr21:40555474	PSMG1	-0.7	-5.42	-0.52	6.35e-7	Menarche (age at onset);
SKCM	cis	rs3820928	0.874	rs9288618	chr2:227872617	A/G	cg11843606	chr2:227700838	RHBDD1	-0.59	-4.81	-0.48	7.13e-6	Pulmonary function;
SKCM	cis	rs1062177	0.826	rs2915822	chr5:151130901	G/T	cg00977110	chr5:151150581	G3BP1	-0.82	-6.66	-0.6	3.43e-9	Preschool internalizing problems;
SKCM	cis	rs9300255	0.770	rs7980687	chr12:123822711	G/A	cg00376283	chr12:123451042	ABCB9	-0.78	-5.26	-0.51	1.24e-6	Neutrophil percentage of white cells;
SKCM	cis	rs7789940	0.857	rs12532935	chr7:75939698	G/C	cg10167463	chr7:75959203	YWHAG	-0.68	-4.81	-0.48	7.15e-6	Multiple sclerosis;
SKCM	cis	rs6942756	1.000	rs6971917	chr7:128976919	G/A	cg02491457	chr7:128862824	NA	-0.86	-5.48	-0.53	5.11e-7	White matter hyperintensity burden;
SKCM	cis	rs7772486	0.875	rs2492855	chr6:146296926	A/G	cg23711669	chr6:146136114	FBXO30	0.81	7.53	0.65	7.64e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs847649	0.961	rs7456502	chr7:102596022	C/A	cg18108683	chr7:102477205	FBXL13	0.82	8.63	0.7	5.57e-13	Morning vs. evening chronotype;
SKCM	trans	rs5756813	0.688	rs5995498	chr22:38196573	T/G	cg19894588	chr14:64061835	NA	-0.88	-7.39	-0.64	1.44e-10	Optic cup area;Vertical cup-disc ratio;
SKCM	cis	rs514406	0.505	rs7543239	chr1:53162416	A/G	cg16325326	chr1:53192061	ZYG11B	0.91	10.29	0.76	3.51e-16	Monocyte count;
SKCM	cis	rs9880211	0.752	rs9881831	chr3:136389718	T/C	cg21827317	chr3:136751795	NA	-0.7	-5.26	-0.51	1.25e-6	Body mass index;Height;
SKCM	cis	rs3766606	0.505	rs72633047	chr1:7935440	G/A	cg00042356	chr1:8021962	PARK7	0.86	6.01	0.56	5.55e-8	Ulcerative colitis;Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs4862750	0.914	rs6837117	chr4:187872379	C/T	cg10295955	chr4:187884368	NA	-0.9	-10.27	-0.76	3.85e-16	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7666738	0.861	rs10018654	chr4:99002226	A/G	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs208520	0.874	rs208515	chr6:66945749	A/G	cg07460842	chr6:66804631	NA	-1.05	-7.28	-0.64	2.34e-10	Exhaled nitric oxide output;
SKCM	cis	rs7618501	0.699	rs1062633	chr3:49924940	T/C	cg05072774	chr3:49840536	C3orf54	-0.71	-5.24	-0.51	1.31e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7666738	0.791	rs2903151	chr4:99027218	T/C	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9911578	0.967	rs12938821	chr17:56959422	T/C	cg12560992	chr17:57184187	TRIM37	0.94	7.55	0.65	7.01e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs826838	0.934	rs10875647	chr12:38856995	G/A	cg13010199	chr12:38710504	ALG10B	0.85	6.56	0.6	5.38e-9	Heart rate;
SKCM	cis	rs6977660	0.607	rs7357321	chr7:19817636	C/T	cg07541023	chr7:19748670	TWISTNB	0.72	4.78	0.48	7.95e-6	Thyroid stimulating hormone;
SKCM	cis	rs950776	0.684	rs61012457	chr15:78865694	C/G	cg06917634	chr15:78832804	PSMA4	0.85	6.83	0.61	1.68e-9	Sudden cardiac arrest;
SKCM	cis	rs17685	0.753	rs10262501	chr7:75668172	G/A	cg16684958	chr7:75615977	POR	-0.57	-5.6	-0.54	3.07e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2033711	0.783	rs8113810	chr19:58932106	A/G	cg03735888	chr19:58951602	ZNF132	0.7	6.08	0.57	4.17e-8	Uric acid clearance;
SKCM	cis	rs7226677	0.901	rs76927248	chr18:164964	T/G	cg22265273	chr18:580209	CETN1	-0.49	-4.86	-0.48	5.89e-6	Bipolar disorder;Bipolar disorder or major depressive disorder (combined);
SKCM	cis	rs2963155	0.518	rs864355	chr5:142633229	A/G	cg17617527	chr5:142782415	NR3C1	1.13	5.42	0.52	6.46e-7	Breast cancer;
SKCM	cis	rs7659604	0.605	rs67772833	chr4:122723106	G/A	cg20573242	chr4:122745356	CCNA2	0.68	6.03	0.56	5.07e-8	Type 2 diabetes;
SKCM	cis	rs12142240	0.698	rs72677585	chr1:46812374	T/C	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs2032447	0.531	rs428469	chr6:25898624	G/A	cg03264133	chr6:25882463	NA	-0.71	-6.43	-0.59	9.21e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs72781680	1.000	rs72796339	chr2:24143063	T/C	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	cis	rs4481887	0.790	rs4453078	chr1:248411889	A/G	cg00666640	chr1:248458726	OR2T12	-0.6	-4.94	-0.49	4.33e-6	Common traits (Other);
SKCM	cis	rs28595532	0.920	rs17259173	chr4:119777232	T/C	cg14228332	chr4:119757509	SEC24D	1.06	5.32	0.52	9.61e-7	Cannabis dependence symptom count;
SKCM	cis	rs12200782	0.505	rs9295696	chr6:26550288	C/T	cg11502198	chr6:26597334	ABT1	0.75	4.91	0.49	4.99e-6	Small cell lung carcinoma;
SKCM	cis	rs5769765	0.955	rs9616204	chr22:50303530	T/C	cg22709217	chr22:50311962	ALG12;CRELD2	-0.93	-5.88	-0.55	9.84e-8	Schizophrenia;
SKCM	cis	rs12142240	0.698	rs41294458	chr1:46810304	T/C	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs7666738	0.822	rs13110418	chr4:99046963	G/A	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11098499	0.739	rs4833612	chr4:120147596	A/C	cg09307838	chr4:120376055	NA	-0.78	-5.85	-0.55	1.1e-7	Corneal astigmatism;
SKCM	cis	rs62238980	0.614	rs4820058	chr22:32345733	A/G	cg00543991	chr22:32367038	NA	1.41	5.48	0.53	5.05e-7	Childhood ear infection;
SKCM	cis	rs9875589	0.509	rs6783645	chr3:14024542	T/C	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.52	5.19	0.51	1.65e-6	Ovarian reserve;
SKCM	cis	rs12431307	0.838	rs7323648	chr13:80642996	C/G	cg10478035	chr13:80919503	NA	0.53	5.09	0.5	2.45e-6	Obesity-related traits;
SKCM	cis	rs875971	1.000	rs7792762	chr7:66004138	T/C	cg18876405	chr7:65276391	NA	0.66	6.49	0.59	7.13e-9	Aortic root size;
SKCM	cis	rs782590	0.729	rs706548	chr2:55850106	C/G	cg18811423	chr2:55921094	PNPT1	0.89	5.68	0.54	2.2e-7	Metabolic syndrome;
SKCM	cis	rs2115536	1.000	rs2115540	chr15:80190308	A/G	cg00225070	chr15:80189496	MTHFS	0.76	5.1	0.5	2.31e-6	Eosinophil counts;Eosinophil percentage of white cells;Sum eosinophil basophil counts;Eosinophil percentage of granulocytes;Neutrophil percentage of granulocytes;
SKCM	cis	rs738322	0.805	rs11570734	chr22:38518622	A/G	cg25457927	chr22:38595422	NA	-0.53	-5.97	-0.56	6.71e-8	Cutaneous nevi;
SKCM	cis	rs208520	0.690	rs12198745	chr6:66722598	T/C	cg07460842	chr6:66804631	NA	0.91	7.37	0.64	1.54e-10	Exhaled nitric oxide output;
SKCM	cis	rs6933660	0.745	rs6557138	chr6:151732017	C/T	cg10883421	chr6:151773342	RMND1;C6orf211	0.83	7.04	0.62	6.61e-10	Menarche (age at onset);
SKCM	cis	rs1032355	0.558	rs114505328	chr4:100513694	T/A	cg25391692	chr4:100495869	MTTP	-0.82	-4.97	-0.49	3.9e-6	Celiac disease;
SKCM	cis	rs79839061	0.610	rs78590562	chr4:869715	C/T	cg07828340	chr4:882639	GAK	1.02	4.95	0.49	4.16e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1552244	0.882	rs13084194	chr3:10031492	T/A	cg02579736	chr3:10068473	FANCD2;CIDECP	0.98	4.84	0.48	6.48e-6	Alzheimer's disease;
SKCM	cis	rs1160297	0.576	rs1451458	chr2:53088905	G/C	cg07782112	chr2:53107842	NA	0.59	6.26	0.58	1.91e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs6570726	0.791	rs446362	chr6:145878716	G/T	cg23711669	chr6:146136114	FBXO30	0.87	9.14	0.72	5.82e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs711830	1.000	rs2857540	chr2:177026698	G/T	cg13092806	chr2:177043255	NA	0.64	5.6	0.54	3.08e-7	Serous invasive ovarian cancer;Epithelial ovarian cancer;Invasive epithelial ovarian cancer;Mucinous ovarian carcinoma;Low-grade serous and serous borderline ovarian cancer;Serous borderline ovarian cancer;High-grade serous ovarian cancer;
SKCM	cis	rs847649	0.961	rs10250490	chr7:102537277	A/G	cg18108683	chr7:102477205	FBXL13	-0.84	-8.44	-0.69	1.3e-12	Morning vs. evening chronotype;
SKCM	cis	rs9322193	0.961	rs9027	chr6:149916057	T/A	cg07701084	chr6:150067640	NUP43	0.64	5.13	0.5	2.1e-6	Lung cancer;
SKCM	cis	rs13118159	0.550	rs4974617	chr4:1373658	T/C	cg05025164	chr4:1340916	KIAA1530	0.89	7.25	0.63	2.67e-10	Longevity;
SKCM	trans	rs561341	1.000	rs111454793	chr17:30319267	T/C	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs7945705	0.791	rs7944560	chr11:8817276	A/T	cg21881798	chr11:8931708	C11orf17;ST5	0.63	5.5	0.53	4.67e-7	Hemoglobin concentration;
SKCM	cis	rs2153535	0.541	rs5026687	chr6:8473957	A/T	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs2836974	0.897	rs4817996	chr21:40525759	G/C	cg17971929	chr21:40555470	PSMG1	0.87	8.48	0.69	1.1e-12	Cognitive function;
SKCM	cis	rs7666738	0.830	rs4443295	chr4:99044935	G/A	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2732480	0.577	rs2732448	chr12:48730600	T/C	cg21348975	chr12:48724119	NA	-0.58	-4.88	-0.48	5.47e-6	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs875971	1.000	rs6946143	chr7:65579722	A/C	cg11764359	chr7:65958608	NA	0.87	8.66	0.7	4.87e-13	Aortic root size;
SKCM	cis	rs763121	0.853	rs9306329	chr22:39072454	C/T	cg06022373	chr22:39101656	GTPBP1	0.8	5.85	0.55	1.1e-7	Menopause (age at onset);
SKCM	cis	rs10504229	0.683	rs55637580	chr8:58135419	C/T	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs2204008	0.837	rs34381557	chr12:38181983	T/C	cg26384229	chr12:38710491	ALG10B	0.82	6.58	0.6	4.87e-9	Bladder cancer;
SKCM	cis	rs10911251	0.528	rs2093982	chr1:183094191	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.68	0.66	3.84e-11	Colorectal cancer;
SKCM	cis	rs769267	0.930	rs10414830	chr19:19562332	C/T	cg26732615	chr19:19648335	CILP2;YJEFN3	0.67	7.06	0.62	6e-10	Tonsillectomy;
SKCM	cis	rs1707322	0.827	rs6683274	chr1:46241638	T/G	cg03146154	chr1:46216737	IPP	0.78	5.22	0.51	1.45e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs6426558	0.621	rs7521639	chr1:227223736	T/C	cg10327440	chr1:227177885	CDC42BPA	0.79	6.06	0.57	4.46e-8	Neutrophil percentage of white cells;
SKCM	cis	rs12986445	0.711	rs3845682	chr2:26110064	A/T	cg04917511	chr2:26785460	C2orf70	0.52	5.02	0.49	3.15e-6	Multiple myeloma and monoclonal gammopathy;Multiple myeloma;
SKCM	cis	rs7937682	0.961	rs4936682	chr11:111629743	T/G	cg09085632	chr11:111637200	PPP2R1B	1.11	12.99	0.83	3.42e-21	Primary sclerosing cholangitis;
SKCM	cis	rs10503709	0.556	rs13257658	chr8:21473085	C/G	cg23716449	chr8:21608280	GFRA2	-0.51	-5.05	-0.5	2.8e-6	Blood protein levels;
SKCM	cis	rs9902453	0.967	rs9904336	chr17:28357080	T/A	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.81	-5.78	-0.55	1.45e-7	Coffee consumption (cups per day);
SKCM	cis	rs7824557	0.527	rs2572449	chr8:11239137	A/G	cg21775007	chr8:11205619	TDH	0.58	4.89	0.48	5.24e-6	Retinal vascular caliber;
SKCM	cis	rs3820068	0.581	rs6692489	chr1:15928517	A/G	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs7829975	0.582	rs448231	chr8:8790059	A/T	cg06636001	chr8:8085503	FLJ10661	-0.68	-5.05	-0.5	2.87e-6	Mood instability;
SKCM	cis	rs6952808	0.692	rs12666575	chr7:2004421	C/T	cg21782813	chr7:2030301	MAD1L1	0.56	5.83	0.55	1.18e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs2204008	0.550	rs11495600	chr12:38126654	C/T	cg13010199	chr12:38710504	ALG10B	0.65	4.84	0.48	6.52e-6	Bladder cancer;
SKCM	cis	rs2072510	0.722	rs2660895	chr12:96423447	T/C	cg18817487	chr12:96390143	HAL	0.43	5.68	0.54	2.18e-7	Metabolite levels (small molecules and protein measures);
SKCM	cis	rs7106204	0.748	rs7122986	chr11:24224634	G/A	ch.11.24196551F	chr11:24239977	NA	0.77	6.34	0.58	1.36e-8	Response to Homoharringtonine (cytotoxicity);
SKCM	cis	rs4642101	0.662	rs3901664	chr3:12824660	T/C	cg05775895	chr3:12838266	CAND2	0.68	6.16	0.57	2.92e-8	QRS complex (12-leadsum);
SKCM	cis	rs1552244	1.000	rs68045038	chr3:10151828	A/G	cg02579736	chr3:10068473	FANCD2;CIDECP	1.23	6.92	0.62	1.13e-9	Alzheimer's disease;
SKCM	cis	rs4819852	1.000	rs4819852	chr22:19988167	G/A	cg07821417	chr22:19972146	ARVCF	0.51	6.28	0.58	1.79e-8	Pulse pressure;
SKCM	cis	rs72634258	0.945	rs12753070	chr1:8114319	C/G	cg00042356	chr1:8021962	PARK7	1.1	7.79	0.66	2.35e-11	Inflammatory bowel disease;
SKCM	cis	rs9916302	0.904	rs602688	chr17:37439496	C/T	cg07936489	chr17:37558343	FBXL20	-0.86	-6.94	-0.62	1.02e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs2019137	0.560	rs11123172	chr2:113984303	C/T	cg11763394	chr2:113992921	PAX8;LOC440839;LOC654433	-0.64	-5.15	-0.5	1.94e-6	Lymphocyte counts;
SKCM	cis	rs2072510	0.683	rs2660840	chr12:96432507	A/C	cg18817487	chr12:96390143	HAL	0.4	5.16	0.5	1.83e-6	Metabolite levels (small molecules and protein measures);
SKCM	cis	rs611744	0.625	rs11991891	chr8:109294858	G/A	cg18478394	chr8:109455254	TTC35	0.63	4.97	0.49	3.83e-6	Dupuytren's disease;
SKCM	cis	rs9467773	0.620	rs9467810	chr6:26608261	A/C	cg09904177	chr6:26538194	HMGN4	0.57	4.87	0.48	5.81e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs35146811	0.700	rs7788301	chr7:99782753	C/G	cg22906224	chr7:99728672	NA	0.65	5.19	0.51	1.6e-6	Coronary artery disease;
SKCM	cis	rs7100689	0.646	rs1047952	chr10:82126808	C/G	cg01528321	chr10:82214614	TSPAN14	0.8	7.0	0.62	7.98e-10	Post bronchodilator FEV1;
SKCM	cis	rs7617480	0.519	rs6790914	chr3:49206318	G/C	cg06212747	chr3:49208901	KLHDC8B	0.91	6.76	0.61	2.28e-9	Subjective well-being (multi-trait analysis);Menarche (age at onset);
SKCM	cis	rs4073582	0.555	rs521109	chr11:66030948	G/A	cg14036092	chr11:66035641	RAB1B	0.77	6.04	0.56	5.02e-8	Gout;
SKCM	cis	rs7824557	0.592	rs2736280	chr8:11223022	C/A	cg21775007	chr8:11205619	TDH	0.67	6.11	0.57	3.62e-8	Retinal vascular caliber;
SKCM	cis	rs7555523	0.887	rs6696454	chr1:165707923	T/C	cg24409356	chr1:165738333	TMCO1	0.93	5.15	0.5	1.93e-6	Intraocular pressure;Glaucoma (high intraocular pressure);
SKCM	cis	rs7811142	1.000	rs2406255	chr7:100053690	T/C	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.17	7.71	0.66	3.44e-11	Platelet count;
SKCM	trans	rs561341	1.000	rs1557731	chr17:30321567	T/G	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs6951245	1.000	rs78185801	chr7:1096367	G/A	cg24642844	chr7:1081250	C7orf50	-0.93	-6.22	-0.58	2.28e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs17376456	1.000	rs17376207	chr5:93545524	C/T	cg21475434	chr5:93447410	FAM172A	-0.89	-5.45	-0.52	5.81e-7	Diabetic retinopathy;
SKCM	cis	rs9816226	0.590	rs869401	chr3:185826546	G/A	cg00760338	chr3:185826511	ETV5	0.87	6.51	0.59	6.74e-9	Obesity;Body mass index;
SKCM	cis	rs1577917	0.958	rs13207173	chr6:86457522	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.78	-7.41	-0.64	1.3100000000000001e-10	Response to antipsychotic treatment;
SKCM	cis	rs7772486	0.754	rs1055212	chr6:146058315	A/T	cg05347473	chr6:146136440	FBXO30	-0.63	-5.66	-0.54	2.38e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6088580	0.660	rs6059893	chr20:33105897	T/G	cg24642439	chr20:33292090	TP53INP2	0.76	6.02	0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs10769945	0.592	rs1635155	chr11:1972919	G/T	cg23202291	chr11:1979235	NA	-0.57	-5.33	-0.52	9.27e-7	DNA methylation (variation);
SKCM	cis	rs875971	0.862	rs6964437	chr7:65686444	A/G	cg11764359	chr7:65958608	NA	-0.75	-6.89	-0.62	1.26e-9	Aortic root size;
SKCM	cis	rs28595532	0.841	rs116329146	chr4:119733438	G/A	cg14228332	chr4:119757509	SEC24D	1.08	5.52	0.53	4.28e-7	Cannabis dependence symptom count;
SKCM	cis	rs10088262	0.629	rs12541177	chr8:124800273	G/T	cg20713898	chr8:124780851	FAM91A1	-0.7	-5.08	-0.5	2.55e-6	Pancreatic cancer;
SKCM	cis	rs4423214	1.000	rs12422045	chr11:71154820	C/T	cg05163923	chr11:71159392	DHCR7	0.78	7.56	0.65	6.6e-11	Vitamin D levels;
SKCM	cis	rs867186	1.000	rs75866240	chr20:33558839	C/T	cg04194272	chr20:33683537	NA	-1.37	-6.77	-0.61	2.18e-9	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs6089584	0.927	rs3787427	chr20:60579789	T/C	cg06108461	chr20:60628389	TAF4	-0.89	-8.18	-0.68	4.28e-12	Body mass index;
SKCM	cis	rs1218582	0.772	rs1109815	chr1:154909268	A/G	cg06221963	chr1:154839813	KCNN3	-0.59	-5.97	-0.56	6.76e-8	Prostate cancer;
SKCM	cis	rs67460515	0.892	rs11710489	chr3:161093332	G/A	cg03342759	chr3:160939853	NMD3	-0.82	-7.12	-0.63	4.74e-10	Parkinson's disease;
SKCM	cis	rs6545883	0.895	rs2256617	chr2:61679924	A/G	cg15711740	chr2:61764176	XPO1	-0.68	-4.92	-0.49	4.76e-6	Tuberculosis;
SKCM	cis	rs9309711	0.643	rs10188449	chr2:3480366	T/C	cg15506890	chr2:3487001	NA	-0.62	-5.06	-0.5	2.75e-6	Neurofibrillary tangles;
SKCM	cis	rs9902453	0.845	rs2321331	chr17:28025528	G/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.82	5.78	0.55	1.47e-7	Coffee consumption (cups per day);
SKCM	cis	rs7843479	0.965	rs11135763	chr8:21813962	A/G	cg17168535	chr8:21777572	XPO7	0.75	6.18	0.57	2.75e-8	Mean corpuscular volume;
SKCM	cis	rs10504229	0.683	rs11785258	chr8:58132893	A/G	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs9987353	0.544	rs2929469	chr8:9062656	T/G	cg15556689	chr8:8085844	FLJ10661	0.64	4.94	0.49	4.43e-6	Recombination measurement;
SKCM	cis	rs9911578	0.934	rs8081967	chr17:57072701	T/C	cg05425664	chr17:57184151	TRIM37	-0.84	-6.94	-0.62	1.03e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs76662990	1.000	rs10053091	chr5:73803701	T/C	cg01264639	chr5:73839484	NA	1.12	5.68	0.54	2.26e-7	Residual cognition;
SKCM	cis	rs8017423	0.935	rs11159960	chr14:90740012	C/T	cg04374321	chr14:90722782	PSMC1	-0.95	-8.73	-0.7	3.68e-13	Mortality in heart failure;
SKCM	cis	rs7216064	1.000	rs55939964	chr17:65869297	G/A	cg12091567	chr17:66097778	LOC651250	-0.75	-5.27	-0.51	1.19e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs9300255	0.602	rs10744147	chr12:123643729	A/G	cg00376283	chr12:123451042	ABCB9	0.8	5.4	0.52	6.99e-7	Neutrophil percentage of white cells;
SKCM	cis	rs1218582	0.741	rs4339857	chr1:154888962	A/G	cg16680214	chr1:154839983	KCNN3	-0.56	-5.01	-0.49	3.29e-6	Prostate cancer;
SKCM	cis	rs10911251	0.546	rs944971	chr1:183112505	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.76	7.28	0.64	2.26e-10	Colorectal cancer;
SKCM	cis	rs72615157	0.634	rs11762932	chr7:99792666	C/T	cg07160278	chr7:100027354	MEPCE;ZCWPW1	-0.89	-5.31	-0.52	1.01e-6	Lung function (FEV1/FVC);
SKCM	cis	rs1850744	0.702	rs10939428	chr4:9630041	A/G	cg15442990	chr4:9534313	NA	1.42	5.39	0.52	7.38e-7	Economic and political preferences;
SKCM	cis	rs748404	0.660	rs690367	chr15:43748304	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	-0.7	-5.54	-0.53	3.88e-7	Lung cancer;
SKCM	cis	rs9303401	0.573	rs34717648	chr17:56886624	T/A	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.35	0.52	8.54e-7	Cognitive test performance;
SKCM	cis	rs9611565	0.512	rs964899	chr22:42142386	G/A	cg03806693	chr22:41940476	POLR3H	1.15	7.27	0.64	2.37e-10	Vitiligo;
SKCM	cis	rs7666738	0.830	rs28416660	chr4:98899525	C/G	cg17366294	chr4:99064904	C4orf37	0.57	4.85	0.48	6.12e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1799949	0.965	rs33925201	chr17:41280682	A/G	cg05368731	chr17:41323189	NBR1	0.89	7.91	0.67	1.38e-11	Menopause (age at onset);
SKCM	cis	rs2920503	0.959	rs2920502	chr3:12329195	G/C	cg23514324	chr3:12329213	PPARG	0.6	5.03	0.49	3.11e-6	LDL cholesterol;
SKCM	cis	rs1218582	0.774	rs4845680	chr1:154863195	A/G	cg03351412	chr1:154909251	PMVK	0.78	6.55	0.6	5.5e-9	Prostate cancer;
SKCM	cis	rs17376456	0.877	rs7736620	chr5:93305762	C/T	cg21475434	chr5:93447410	FAM172A	1.04	5.55	0.53	3.82e-7	Diabetic retinopathy;
SKCM	cis	rs362272	0.524	rs13150241	chr4:3367281	A/G	cg09735869	chr4:3319127	RGS12	1.0	11.49	0.79	1.86e-18	Serum sulfate level;
SKCM	cis	rs9880211	0.635	rs10049233	chr3:135785469	G/A	cg21827317	chr3:136751795	NA	-0.7	-4.97	-0.49	3.91e-6	Body mass index;Height;
SKCM	cis	rs7149242	0.662	rs4905998	chr14:101181781	A/G	cg18089426	chr14:101175970	NA	-0.54	-5.0	-0.49	3.41e-6	Platelet count;
SKCM	cis	rs9611565	0.765	rs132920	chr22:41810170	T/C	cg03806693	chr22:41940476	POLR3H	1.02	6.92	0.62	1.13e-9	Vitiligo;
SKCM	cis	rs2839186	0.934	rs17176520	chr21:47682081	T/C	cg13012494	chr21:47604986	C21orf56	0.67	5.78	0.55	1.44e-7	Testicular germ cell tumor;
SKCM	cis	rs1912528	0.783	rs9997448	chr4:140870515	C/T	cg11128457	chr4:140864437	MAML3	0.61	5.27	0.51	1.19e-6	Educational attainment (years of education);
SKCM	cis	rs7617480	0.648	rs6766238	chr3:48801929	G/A	cg07636037	chr3:49044803	WDR6	0.9	6.65	0.6	3.64e-9	Subjective well-being (multi-trait analysis);Menarche (age at onset);
SKCM	cis	rs7772486	0.754	rs6570703	chr6:145957052	C/T	cg23711669	chr6:146136114	FBXO30	0.9	10.02	0.75	1.16e-15	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2041840	0.520	rs4670671	chr2:37396504	C/T	cg14987922	chr2:37194071	STRN	-0.74	-5.05	-0.5	2.84e-6	Chronic lymphocytic leukemia;
SKCM	cis	rs9297145	0.916	rs6969140	chr7:98753900	G/A	cg05967295	chr7:98741636	SMURF1	-1.09	-8.46	-0.69	1.21e-12	Crohn's disease;Inflammatory bowel disease;Ulcerative colitis;
SKCM	cis	rs8060686	0.641	rs7188085	chr16:68113873	A/G	cg09117114	chr16:67998030	SLC12A4	-0.81	-5.24	-0.51	1.31e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs1023500	0.573	rs133378	chr22:42467695	G/C	cg04733989	chr22:42467013	NAGA	0.72	5.77	0.55	1.52e-7	Schizophrenia;
SKCM	cis	rs752010	0.574	rs10890161	chr1:42121623	T/C	cg06885757	chr1:42089581	HIVEP3	0.47	4.98	0.49	3.8e-6	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs6933660	0.646	rs3816778	chr6:151773353	G/C	cg14262678	chr6:151773367	RMND1;C6orf211	0.73	5.86	0.55	1.07e-7	Menarche (age at onset);
SKCM	cis	rs7666738	0.830	rs7696715	chr4:98938486	T/C	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6500395	1.000	rs7195684	chr16:48710750	G/A	cg04672837	chr16:48644449	N4BP1	-0.63	-5.37	-0.52	8.01e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs372883	0.600	rs407712	chr21:30722531	G/A	cg24692254	chr21:30365293	RNF160	-0.7	-5.65	-0.54	2.49e-7	Pancreatic cancer;
SKCM	cis	rs4631830	0.683	rs11004409	chr10:51498019	G/C	cg16070123	chr10:51489643	NA	0.53	4.96	0.49	3.99e-6	Prostate-specific antigen levels;
SKCM	cis	rs1218582	0.741	rs10908446	chr1:154869559	G/A	cg09359103	chr1:154839909	KCNN3	-0.57	-5.3	-0.51	1.05e-6	Prostate cancer;
SKCM	cis	rs2905347	0.591	rs12155285	chr7:22678637	G/A	cg11983867	chr7:22539820	MGC87042	-0.48	-4.86	-0.48	5.88e-6	Major depression and alcohol dependence;
SKCM	cis	rs870825	0.587	rs58332461	chr4:185639742	G/A	cg04058563	chr4:185651563	MLF1IP	1.08	7.26	0.64	2.51e-10	Blood protein levels;
SKCM	cis	rs7208859	0.623	rs9912283	chr17:29110373	A/G	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs10207060	0.500	rs4380264	chr2:240699378	G/T	cg07506560	chr2:240697449	NA	0.76	6.36	0.58	1.26e-8	Obesity-related traits;
SKCM	cis	rs13118159	0.509	rs7688922	chr4:1361011	T/C	cg19318889	chr4:1322082	MAEA	0.77	5.52	0.53	4.34e-7	Longevity;
SKCM	cis	rs2032447	0.610	rs189911	chr6:25965942	A/G	cg18357526	chr6:26021779	HIST1H4A	0.73	5.5	0.53	4.61e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs995000	0.931	rs1168098	chr1:63121294	G/A	cg06896770	chr1:63153194	DOCK7	-0.76	-7.5	-0.65	8.71e-11	Triglyceride levels;
SKCM	cis	rs13424612	1.000	rs4149547	chr2:240933308	C/T	cg01812947	chr2:240904978	NDUFA10	0.64	4.8	0.48	7.6e-6	Odorant perception (isobutyraldehyde);
SKCM	cis	rs1552244	0.572	rs59074548	chr3:10164347	G/C	cg00149659	chr3:10157352	C3orf10	1.13	5.45	0.53	5.74e-7	Alzheimer's disease;
SKCM	cis	rs9858542	1.000	rs9823546	chr3:49705512	T/A	cg03060546	chr3:49711283	APEH	-0.74	-5.54	-0.53	3.91e-7	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs10193935	1.000	rs10210866	chr2:42387879	A/G	cg27598129	chr2:42591480	NA	-0.92	-6.79	-0.61	1.97e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs416603	0.755	rs2301127	chr16:11367477	G/A	cg00044050	chr16:11439710	C16orf75	-0.7	-4.89	-0.48	5.28e-6	Type 1 diabetes;
SKCM	cis	rs1707322	0.963	rs11211238	chr1:46449415	G/A	cg03146154	chr1:46216737	IPP	0.79	5.34	0.52	8.73e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs727563	0.635	rs5758444	chr22:42133921	T/A	cg03806693	chr22:41940476	POLR3H	1.08	6.61	0.6	4.29e-9	Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs801193	0.935	rs2659916	chr7:66151352	C/G	cg00343986	chr7:65444356	GUSB	0.7	5.14	0.5	1.98e-6	Aortic root size;
SKCM	cis	rs28374715	0.662	rs28827035	chr15:41492290	G/A	cg18705301	chr15:41695430	NDUFAF1	-0.93	-7.74	-0.66	2.94e-11	Ulcerative colitis;
SKCM	cis	rs2952156	1.000	rs4252627	chr17:37868715	C/T	cg20243544	chr17:37824526	PNMT	0.67	5.32	0.52	9.76e-7	Asthma;
SKCM	cis	rs2370759	0.898	rs113412621	chr10:32579306	C/T	cg01819863	chr10:32635814	EPC1	1.03	5.62	0.54	2.89e-7	Sexual dysfunction (female);
SKCM	cis	rs9325144	0.624	rs7312879	chr12:39150752	G/A	cg13010199	chr12:38710504	ALG10B	-0.58	-5.02	-0.49	3.2e-6	Morning vs. evening chronotype;
SKCM	cis	rs1153858	1.000	rs7169818	chr15:45640191	G/A	cg21132104	chr15:45694354	SPATA5L1	0.89	7.33	0.64	1.81e-10	Homoarginine levels;
SKCM	cis	rs7666738	0.791	rs4699324	chr4:98967496	G/A	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1669338	0.588	rs3846135	chr3:3195574	C/T	cg16797762	chr3:3221439	CRBN	-1.07	-5.8	-0.55	1.33e-7	White matter integrity;
SKCM	cis	rs1218582	0.772	rs12069356	chr1:154849771	C/T	cg24250549	chr1:154909240	PMVK	0.89	9.39	0.73	1.86e-14	Prostate cancer;
SKCM	cis	rs12497850	0.865	rs13072911	chr3:48962128	T/G	cg07636037	chr3:49044803	WDR6	1.02	11.0	0.78	1.56e-17	Parkinson's disease;
SKCM	cis	rs1799949	1.000	rs11655505	chr17:41278377	G/A	cg23758822	chr17:41437982	NA	0.92	7.8	0.66	2.3e-11	Menopause (age at onset);
SKCM	cis	rs7927771	0.826	rs2293578	chr11:47437403	C/T	cg05585544	chr11:47624801	NA	-0.61	-5.4	-0.52	7.09e-7	Subjective well-being;
SKCM	cis	rs12142240	0.698	rs12385697	chr1:46818898	T/C	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs453301	0.507	rs2929306	chr8:9084909	C/T	cg06636001	chr8:8085503	FLJ10661	-0.74	-5.72	-0.54	1.9e-7	Joint mobility (Beighton score);
SKCM	cis	rs208520	0.526	rs7776413	chr6:66783241	A/G	cg07460842	chr6:66804631	NA	-1.17	-12.77	-0.82	8.56e-21	Exhaled nitric oxide output;
SKCM	cis	rs12714314	0.756	rs1469647	chr2:1950243	C/T	cg22350835	chr2:1868857	MYT1L	0.66	5.2	0.51	1.54e-6	Type 2 diabetes (age of onset);
SKCM	cis	rs2721195	0.967	rs748193	chr8:145682115	C/T	cg15857475	chr8:145742913	RECQL4;LRRC14	0.82	7.3	0.64	2.06e-10	Age at first birth;
SKCM	cis	rs6121246	0.512	rs6060938	chr20:30363645	T/C	cg11595048	chr20:30225325	COX4I2	0.54	4.77	0.48	8.4e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs11098499	0.954	rs10024844	chr4:120311528	A/G	cg24375607	chr4:120327624	NA	0.65	4.97	0.49	3.87e-6	Corneal astigmatism;
SKCM	cis	rs1348850	0.561	rs57986285	chr2:178468663	C/T	cg05310760	chr2:178500282	PDE11A	-0.68	-4.79	-0.48	7.84e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs7816032	0.917	rs60526148	chr8:19767203	C/T	cg04035597	chr8:19794539	NA	-0.53	-5.14	-0.5	1.97e-6	Hyperactive-impulsive symptoms;
SKCM	cis	rs6921919	0.583	rs6928771	chr6:28375209	T/G	cg14547644	chr6:28411285	ZSCAN23	-0.58	-4.8	-0.48	7.46e-6	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs2842992	0.789	rs4276525	chr6:160193612	G/A	cg19482086	chr6:160211437	TCP1;MRPL18	0.86	6.82	0.61	1.71e-9	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs2737618	0.680	rs2737686	chr1:200094347	C/T	cg21825944	chr1:200113062	NR5A2	-0.62	-4.99	-0.49	3.52e-6	Uric acid levels;
SKCM	cis	rs950776	0.518	rs12910289	chr15:78822065	T/G	cg06917634	chr15:78832804	PSMA4	1.01	10.47	0.76	1.56e-16	Sudden cardiac arrest;
SKCM	cis	rs2980439	0.556	rs2921059	chr8:8317887	G/T	cg15556689	chr8:8085844	FLJ10661	0.69	5.69	0.54	2.1e-7	Neuroticism;
SKCM	cis	rs6977660	0.943	rs10254261	chr7:19846001	A/G	cg05791153	chr7:19748676	TWISTNB	-0.79	-5.51	-0.53	4.42e-7	Thyroid stimulating hormone;
SKCM	cis	rs116095464	0.558	rs10075018	chr5:239175	G/A	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs908922	0.676	rs533917	chr1:152518294	A/G	cg09873164	chr1:152488093	CRCT1	0.77	6.04	0.56	5.01e-8	Hair morphology;
SKCM	cis	rs3087591	0.960	rs12603885	chr17:29466722	C/T	cg24425628	chr17:29625626	OMG;NF1	0.64	5.18	0.51	1.72e-6	Hip circumference;
SKCM	cis	rs17376456	0.877	rs12374488	chr5:93481407	A/G	cg21475434	chr5:93447410	FAM172A	0.97	5.42	0.52	6.39e-7	Diabetic retinopathy;
SKCM	cis	rs17065868	1.000	rs9533902	chr13:45123938	C/A	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs6940638	0.531	rs12211984	chr6:26986054	G/C	cg12292205	chr6:26970375	C6orf41	0.63	5.64	0.54	2.58e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs2180341	1.000	rs6910763	chr6:127630925	T/C	cg24812749	chr6:127587940	RNF146	0.88	7.44	0.64	1.12e-10	Breast cancer;
SKCM	cis	rs798554	0.679	rs7784066	chr7:2819727	T/A	cg13628971	chr7:2884303	GNA12	0.69	4.89	0.48	5.2e-6	Height;
SKCM	cis	rs7811142	1.000	rs1000215	chr7:100004543	A/G	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.24	7.99	0.67	9.73e-12	Platelet count;
SKCM	cis	rs17376456	1.000	rs61132622	chr5:93539684	G/A	cg21475434	chr5:93447410	FAM172A	0.99	5.27	0.51	1.19e-6	Diabetic retinopathy;
SKCM	cis	rs1577917	0.958	rs2324840	chr6:86557620	T/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.32	-0.52	9.66e-7	Response to antipsychotic treatment;
SKCM	cis	rs62238980	0.614	rs74450143	chr22:32416692	A/G	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs4237845	0.591	rs4760344	chr12:58320783	A/T	cg02175503	chr12:58329896	NA	0.9	8.91	0.71	1.63e-13	Intelligence (multi-trait analysis);
SKCM	cis	rs3087591	1.000	rs2905870	chr17:29521833	G/A	cg24425628	chr17:29625626	OMG;NF1	0.61	4.87	0.48	5.75e-6	Hip circumference;
SKCM	cis	rs2033711	0.783	rs11671113	chr19:58958087	C/T	cg26874164	chr19:58962979	ZNF324B	0.63	5.22	0.51	1.46e-6	Uric acid clearance;
SKCM	cis	rs28595532	0.920	rs114544767	chr4:119728364	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.52	0.53	4.28e-7	Cannabis dependence symptom count;
SKCM	cis	rs2153535	0.580	rs9393016	chr6:8458573	T/A	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs78456975	0.550	rs10197874	chr2:1545310	A/G	cg01028140	chr2:1542097	TPO	-0.53	-5.06	-0.5	2.74e-6	Placebo response in major depressive disorder (% change in symptom score);
SKCM	cis	rs6951245	0.638	rs4720486	chr7:1146764	G/A	cg23708337	chr7:1209742	NA	0.71	4.94	0.49	4.35e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs798766	1.000	rs798754	chr4:1720757	A/G	cg05874882	chr4:1763078	NA	-0.53	-4.98	-0.49	3.7e-6	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs1153858	1.000	rs1145074	chr15:45703824	T/A	cg10760299	chr15:45669010	GATM	0.6	5.77	0.55	1.51e-7	Homoarginine levels;
SKCM	cis	rs2204008	0.538	rs11514000	chr12:38067706	A/G	cg26384229	chr12:38710491	ALG10B	0.7	5.37	0.52	7.96e-7	Bladder cancer;
SKCM	cis	rs9467773	1.000	rs6924838	chr6:26571756	C/T	cg15659132	chr6:26577336	NA	0.61	5.76	0.55	1.6e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs1355223	0.583	rs2941060	chr11:34879154	G/A	cg11058730	chr11:34937778	PDHX;APIP	0.59	4.77	0.47	8.55e-6	Systemic lupus erythematosus and Systemic sclerosis;
SKCM	cis	rs9393692	0.577	rs9358914	chr6:26262063	G/T	cg13736514	chr6:26305472	NA	-0.67	-4.85	-0.48	6.24e-6	Educational attainment;
SKCM	cis	rs3540	0.554	rs34650360	chr15:91059017	T/C	cg22089800	chr15:90895588	ZNF774	-0.68	-4.92	-0.49	4.64e-6	Allergic disease (asthma, hay fever or eczema);Lymphocyte counts;
SKCM	cis	rs763014	0.931	rs710925	chr16:633354	G/A	cg00908189	chr16:619842	PIGQ	0.82	7.78	0.66	2.55e-11	Height;
SKCM	cis	rs4930103	0.590	rs3809101	chr11:1967271	C/T	cg23202291	chr11:1979235	NA	0.63	6.74	0.61	2.45e-9	DNA methylation (parent-of-origin);DNA methylation (variation);
SKCM	cis	rs763121	0.853	rs5757200	chr22:39043491	T/G	cg06022373	chr22:39101656	GTPBP1	0.72	4.96	0.49	4.08e-6	Menopause (age at onset);
SKCM	cis	rs875971	0.522	rs7784623	chr7:65395034	T/G	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.59	4.89	0.48	5.22e-6	Aortic root size;
SKCM	cis	rs2357013	0.725	rs6545317	chr2:53227148	A/T	cg07782112	chr2:53107842	NA	-0.54	-5.44	-0.52	5.93e-7	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs951366	0.789	rs1775154	chr1:205696615	T/A	cg11965913	chr1:205819406	PM20D1	0.99	9.7	0.74	4.81e-15	Menarche (age at onset);
SKCM	cis	rs55823223	0.680	rs3744020	chr17:73871773	G/A	cg08125733	chr17:73851984	WBP2	1.0	5.3	0.51	1.03e-6	Psoriasis;
SKCM	cis	rs801193	0.660	rs10950049	chr7:66230860	T/C	cg18876405	chr7:65276391	NA	0.66	6.51	0.59	6.76e-9	Aortic root size;
SKCM	cis	rs801193	1.000	rs7785213	chr7:66138978	A/C	cg11987759	chr7:65425863	GUSB	0.67	5.75	0.55	1.68e-7	Aortic root size;
SKCM	cis	rs35306767	0.903	rs13377166	chr10:886259	G/A	cg26597838	chr10:835615	NA	0.77	5.39	0.52	7.26e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs875971	1.000	rs7781698	chr7:65896312	A/T	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	7.95e-13	Aortic root size;
SKCM	cis	rs57221529	0.766	rs12519469	chr5:581772	A/G	cg10555297	chr5:473380	SLC9A3;LOC25845	1.01	5.03	0.49	3.1e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs1348850	0.750	rs12997716	chr2:178494629	G/A	cg02961200	chr2:178257176	LOC100130691;AGPS	0.74	5.07	0.5	2.63e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs116095464	0.558	rs61492827	chr5:225774	A/G	cg22496380	chr5:211416	CCDC127	-0.96	-5.27	-0.51	1.18e-6	Breast cancer;
SKCM	cis	rs9682041	0.688	rs7621787	chr3:170146862	T/A	cg11886554	chr3:170076028	SKIL	0.94	5.5	0.53	4.7e-7	Glomerular filtration rate in non diabetics (creatinine);Glomerular filtration rate (creatinine);
SKCM	cis	rs72634258	0.945	rs161800	chr1:8042402	A/T	cg00042356	chr1:8021962	PARK7	0.91	6.19	0.57	2.58e-8	Inflammatory bowel disease;
SKCM	cis	rs7618501	0.602	rs2245365	chr3:50097319	C/A	cg05072774	chr3:49840536	C3orf54	0.67	5.06	0.5	2.7e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7618501	0.521	rs3796386	chr3:49899795	G/A	cg24110177	chr3:50126178	RBM5	-0.71	-5.36	-0.52	8.33e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7829975	0.688	rs6601703	chr8:8380224	A/G	cg15556689	chr8:8085844	FLJ10661	0.83	7.47	0.65	9.86e-11	Mood instability;
SKCM	cis	rs9916302	0.800	rs8069451	chr17:37504933	C/T	cg07936489	chr17:37558343	FBXL20	-0.85	-7.11	-0.63	4.89e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs189218934	1	rs189218934	chr15:78903987	T/C	cg24631222	chr15:78858424	CHRNA5	-0.9	-6.72	-0.61	2.7e-9	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs6951245	0.938	rs78351779	chr7:1097023	G/C	cg03188948	chr7:1209495	NA	1.13	6.27	0.58	1.89e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs8103278	1.000	rs17571725	chr19:46290822	C/T	cg11657440	chr19:46296263	DMWD	-0.96	-6.91	-0.62	1.16e-9	Coronary artery disease;
SKCM	cis	rs7826238	0.601	rs2976907	chr8:8345168	C/T	cg06636001	chr8:8085503	FLJ10661	0.92	8.4	0.69	1.56e-12	Systolic blood pressure;
SKCM	cis	rs11098499	0.954	rs6838814	chr4:120392443	G/A	cg09307838	chr4:120376055	NA	0.97	7.49	0.65	9.08e-11	Corneal astigmatism;
SKCM	cis	rs6121246	0.512	rs6060941	chr20:30367383	C/T	cg13852791	chr20:30311386	BCL2L1	0.82	5.69	0.54	2.09e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs35306767	0.761	rs11253538	chr10:1011166	C/T	cg26597838	chr10:835615	NA	0.76	6.32	0.58	1.52e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs1577917	0.655	rs2758849	chr6:86344296	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.27	-0.51	1.18e-6	Response to antipsychotic treatment;
SKCM	cis	rs2180341	0.920	rs1073931	chr6:127681762	A/T	cg27446573	chr6:127587934	RNF146	0.94	8.11	0.68	5.63e-12	Breast cancer;
SKCM	cis	rs801193	0.591	rs2707839	chr7:66193084	A/G	cg11764359	chr7:65958608	NA	0.84	7.69	0.66	3.77e-11	Aortic root size;
SKCM	cis	rs3784262	0.869	rs4646628	chr15:58255282	T/C	cg12031962	chr15:58353849	ALDH1A2	-0.47	-5.66	-0.54	2.39e-7	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs10754283	0.840	rs6428560	chr1:90102462	A/T	cg21401794	chr1:90099060	LRRC8C	0.78	7.17	0.63	3.72e-10	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs9640161	0.750	rs73170185	chr7:150030191	C/A	cg10018233	chr7:150070692	REPIN1	0.69	5.4	0.52	7.03e-7	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs1218582	0.682	rs12046459	chr1:154912017	A/C	cg06221963	chr1:154839813	KCNN3	-0.54	-5.29	-0.51	1.09e-6	Prostate cancer;
SKCM	cis	rs28386778	0.897	rs1470697	chr17:61799840	T/C	cg01411255	chr17:61851458	DDX42;CCDC47	0.79	5.1	0.5	2.35e-6	Prudent dietary pattern;
SKCM	trans	rs17685	0.672	rs1639623	chr7:75707951	A/G	cg19862616	chr7:65841803	NCRNA00174	0.94	9.45	0.73	1.46e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7586085	0.563	rs994296	chr2:166488800	G/A	cg01770810	chr2:165769913	SLC38A11	-0.51	-5.12	-0.5	2.17e-6	Total body bone mineral density;
SKCM	cis	rs3096299	0.509	rs4785691	chr16:89597221	A/G	cg27004870	chr16:88850384	FAM38A	0.57	4.85	0.48	6.23e-6	Multiple myeloma (IgH translocation);
SKCM	cis	rs67311347	1.000	rs9865348	chr3:40397658	A/C	cg00091569	chr3:40428383	ENTPD3	0.65	5.58	0.53	3.36e-7	Renal cell carcinoma;
SKCM	cis	rs6087990	0.965	rs2424903	chr20:31349315	C/T	cg13636640	chr20:31349939	DNMT3B	0.9	7.79	0.66	2.36e-11	Ulcerative colitis;
SKCM	cis	rs2439831	0.867	rs12443102	chr15:43932103	G/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.31	7.38	0.64	1.49e-10	Lung cancer in ever smokers;
SKCM	cis	rs4665809	0.556	rs10221814	chr2:26442759	C/T	cg04944784	chr2:26401820	FAM59B	-0.74	-4.79	-0.48	7.81e-6	Gut microbiome composition (summer);
SKCM	cis	rs1707322	0.721	rs28501477	chr1:46199084	A/G	cg03146154	chr1:46216737	IPP	0.84	6.2	0.57	2.51e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs1401999	0.724	rs1016752	chr3:183665062	C/G	cg01324343	chr3:183735012	ABCC5	-0.76	-6.69	-0.6	3.06e-9	Anterior chamber depth;
SKCM	cis	rs8017423	0.740	rs7152196	chr14:90703900	G/T	cg04374321	chr14:90722782	PSMC1	0.95	8.48	0.69	1.13e-12	Mortality in heart failure;
SKCM	cis	rs801193	0.569	rs6951302	chr7:66132512	T/C	cg11764359	chr7:65958608	NA	-0.74	-6.66	-0.6	3.49e-9	Aortic root size;
SKCM	cis	rs611744	0.647	rs676654	chr8:109242303	A/G	cg21045802	chr8:109455806	TTC35	0.64	4.81	0.48	7.34e-6	Dupuytren's disease;
SKCM	cis	rs2075371	0.611	rs34573600	chr7:134018937	C/T	cg20476274	chr7:133979776	SLC35B4	0.9	8.75	0.7	3.37e-13	Mean platelet volume;
SKCM	cis	rs4808199	0.895	rs10421505	chr19:19459554	C/T	cg03709012	chr19:19516395	GATAD2A	1.07	7.52	0.65	8.1e-11	Nonalcoholic fatty liver disease;
SKCM	cis	rs1023500	0.551	rs61665536	chr22:42512613	A/G	cg04733989	chr22:42467013	NAGA	-0.72	-5.62	-0.54	2.87e-7	Schizophrenia;
SKCM	cis	rs7659604	0.540	rs28394772	chr4:122678543	C/T	cg19671926	chr4:122722719	EXOSC9	0.76	6.17	0.57	2.84e-8	Type 2 diabetes;
SKCM	cis	rs1568889	0.838	rs11030220	chr11:28145769	C/G	cg06544937	chr11:28130018	METT5D1;KIF18A	0.89	8.3	0.68	2.43e-12	Bipolar disorder;
SKCM	cis	rs4891159	0.790	rs8098821	chr18:74140345	T/C	cg24786174	chr18:74118243	ZNF516	-0.75	-6.98	-0.62	8.67e-10	Longevity;
SKCM	cis	rs7296418	0.961	rs1790106	chr12:123591596	G/T	cg05973401	chr12:123451056	ABCB9	0.84	6.88	0.61	1.34e-9	Platelet count;
SKCM	cis	rs919433	0.854	rs13013049	chr2:198208664	C/T	cg04278110	chr2:198063759	ANKRD44	-0.72	-5.02	-0.49	3.21e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs2228479	0.850	rs62056069	chr16:89912000	C/T	cg00800038	chr16:89945340	TCF25	-1.0	-5.06	-0.5	2.75e-6	Skin colour saturation;
SKCM	cis	rs17376456	0.741	rs12374432	chr5:93481348	C/A	cg25358565	chr5:93447407	FAM172A	1.23	7.97	0.67	1.08e-11	Diabetic retinopathy;
SKCM	cis	rs10504229	0.683	rs16921831	chr8:58111142	G/A	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs2842992	0.830	rs2273819	chr6:160183325	G/C	cg11366901	chr6:160182831	ACAT2	0.92	7.61	0.65	5.33e-11	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs17065868	0.803	rs11618063	chr13:45195442	T/G	cg10246903	chr13:45222710	NA	0.95	5.35	0.52	8.5e-7	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs7980687	0.628	rs1609520	chr12:123735937	A/G	cg00376283	chr12:123451042	ABCB9	-0.87	-7.25	-0.63	2.63e-10	Height;Educational attainment;Head circumference (infant);
SKCM	cis	rs5758343	1	rs5758343	chr22:41816652	A/T	cg03806693	chr22:41940476	POLR3H	1.09	6.75	0.61	2.3e-9	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs829883	1.000	rs1347956	chr12:98889564	A/G	cg25150519	chr12:98850993	NA	0.5	5.27	0.51	1.17e-6	Colorectal adenoma (advanced);
SKCM	cis	rs28386778	0.863	rs2665834	chr17:61904724	T/C	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs8014204	0.604	rs7156590	chr14:75388183	C/T	cg06637938	chr14:75390232	RPS6KL1	0.84	5.85	0.55	1.1e-7	Caffeine consumption;
SKCM	cis	rs2404602	0.716	rs8025134	chr15:76781729	C/T	cg23625390	chr15:77176239	SCAPER	0.59	5.38	0.52	7.54e-7	Blood metabolite levels;
SKCM	cis	rs244731	0.919	rs12652509	chr5:176626441	A/G	cg17509989	chr5:176798049	RGS14	-0.9	-7.0	-0.62	7.86e-10	Urate levels in lean individuals;
SKCM	cis	rs7829975	0.811	rs7011229	chr8:8543324	T/C	cg15556689	chr8:8085844	FLJ10661	-0.69	-5.64	-0.54	2.65e-7	Mood instability;
SKCM	cis	rs3741404	0.825	rs11603384	chr11:63949095	G/A	cg19465662	chr11:63993652	NUDT22;TRPT1	0.81	5.41	0.52	6.59e-7	Platelet count;
SKCM	cis	rs4853012	0.838	rs72915068	chr2:74356185	G/A	cg01017244	chr2:74357527	NA	0.71	4.79	0.48	7.66e-6	Gestational age at birth (maternal effect);
SKCM	cis	rs2072510	0.966	rs11108372	chr12:96394517	A/G	cg18817487	chr12:96390143	HAL	0.42	5.42	0.52	6.54e-7	Metabolite levels (small molecules and protein measures);
SKCM	cis	rs2980439	0.783	rs2948305	chr8:8098577	G/A	cg15556689	chr8:8085844	FLJ10661	0.83	6.88	0.61	1.32e-9	Neuroticism;
SKCM	cis	rs8180040	0.726	rs4234465	chr3:47026885	C/G	cg27129171	chr3:47204927	SETD2	0.82	6.01	0.56	5.57e-8	Colorectal cancer;
SKCM	cis	rs10489202	0.633	rs4657734	chr1:168086743	C/T	cg24449463	chr1:168025552	DCAF6	-0.82	-7.36	-0.64	1.59e-10	Schizophrenia;
SKCM	cis	rs9959145	0.500	rs11664219	chr18:12531015	T/C	cg18469917	chr18:12433231	NA	-1.13	-4.77	-0.48	8.44e-6	Immune response to smallpox vaccine (IL-6);
SKCM	cis	rs801193	1.000	rs3857688	chr7:66127806	G/A	cg05627663	chr7:65219948	SNORA22;CCT6P1	-0.56	-4.84	-0.48	6.39e-6	Aortic root size;
SKCM	cis	rs4819052	0.679	rs2838859	chr21:46684517	C/T	cg02159808	chr21:46707872	POFUT2;LOC642852	0.65	5.0	0.49	3.44e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs2153535	0.580	rs1335633	chr6:8448800	C/T	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs1801251	0.964	rs10933411	chr2:233706847	A/G	cg25237894	chr2:233734115	C2orf82	-0.61	-5.9	-0.56	8.76e-8	Coronary artery disease;
SKCM	cis	rs56011263	0.553	rs73221121	chr4:722598	C/T	cg17689763	chr4:710664	PCGF3	-0.66	-4.91	-0.49	4.92e-6	White blood cell count;
SKCM	cis	rs752010	0.695	rs11210509	chr1:42109311	A/G	cg06885757	chr1:42089581	HIVEP3	0.46	5.34	0.52	8.81e-7	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs826838	0.967	rs11183022	chr12:38652519	G/A	cg26384229	chr12:38710491	ALG10B	0.95	7.92	0.67	1.32e-11	Heart rate;
SKCM	cis	rs7103648	0.603	rs3740688	chr11:47380340	G/T	cg20307385	chr11:47447363	PSMC3	0.68	4.9	0.49	5.13e-6	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs9910055	0.960	rs9911991	chr17:42278916	G/C	cg13607699	chr17:42295918	UBTF	0.82	6.32	0.58	1.47e-8	Total body bone mineral density;
SKCM	cis	rs1692580	0.777	rs7547453	chr1:2195117	C/T	cg21442419	chr1:2182373	SKI	-0.69	-7.27	-0.64	2.42e-10	Coronary artery disease;
SKCM	cis	rs67311347	0.544	rs2123998	chr3:40359005	C/G	cg00091569	chr3:40428383	ENTPD3	-0.64	-5.76	-0.55	1.6e-7	Renal cell carcinoma;
SKCM	cis	rs12047808	0.556	rs60408652	chr1:179389115	G/T	cg08037922	chr1:179521085	C1orf125;NPHS2	-1.08	-5.8	-0.55	1.32e-7	Multiple sclerosis (age of onset);
SKCM	trans	rs7618501	1.000	rs7374183	chr3:49785133	G/A	cg21659725	chr3:3221576	CRBN	-0.96	-9.61	-0.74	7.08e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs748404	0.588	rs2255410	chr15:43831097	G/A	cg02155558	chr15:43621948	ADAL;LCMT2	0.68	5.14	0.5	1.98e-6	Lung cancer;
SKCM	cis	rs7666738	0.715	rs3857216	chr4:99032129	G/T	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7811142	0.943	rs111757992	chr7:100016354	A/C	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.33	0.69	2.11e-12	Platelet count;
SKCM	cis	rs614226	1.000	rs1167727	chr12:120965508	C/A	cg01236616	chr12:121019343	POP5	1.34	8.54	0.7	8.29e-13	Type 1 diabetes nephropathy;
SKCM	cis	rs875971	1.000	rs12532998	chr7:65967459	A/C	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs6500395	0.928	rs4553627	chr16:48708801	A/T	cg04672837	chr16:48644449	N4BP1	-0.63	-5.37	-0.52	8.01e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs7569084	0.687	rs11675538	chr2:65686461	C/T	cg14775296	chr2:66672841	MEIS1	0.51	4.8	0.48	7.49e-6	Sum eosinophil basophil counts;
SKCM	cis	rs873946	0.648	rs3793673	chr10:134547732	A/C	cg26818010	chr10:134567672	INPP5A	-0.72	-5.59	-0.54	3.18e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs28386778	0.897	rs2156903	chr17:61937179	G/A	cg06873352	chr17:61820015	STRADA	0.75	6.24	0.58	2.1e-8	Prudent dietary pattern;
SKCM	cis	rs2836974	0.568	rs419469	chr21:40537234	C/T	cg11890956	chr21:40555474	PSMG1	0.9	9.41	0.73	1.7e-14	Cognitive function;
SKCM	cis	rs4319547	0.656	rs10744209	chr12:122931568	G/A	cg23029597	chr12:123009494	RSRC2	-0.77	-5.53	-0.53	4.13e-7	Body mass index;
SKCM	cis	rs7937682	0.562	rs527847	chr11:111369132	A/C	cg09085632	chr11:111637200	PPP2R1B	0.8	6.67	0.6	3.34e-9	Primary sclerosing cholangitis;
SKCM	cis	rs4975616	0.843	rs4975615	chr5:1315343	C/T	cg06550200	chr5:1325588	CLPTM1L	0.7	5.37	0.52	7.8e-7	Lung cancer;
SKCM	cis	rs1799949	1.000	rs4793189	chr17:41190715	G/A	cg25918947	chr17:41365094	TMEM106A	-0.61	-5.87	-0.55	1e-7	Menopause (age at onset);
SKCM	cis	rs10791097	0.690	rs12284540	chr11:130729772	T/C	cg12179176	chr11:130786555	SNX19	0.75	5.99	0.56	6.09e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs2836974	0.899	rs114399588	chr21:40653958	G/A	cg17971929	chr21:40555470	PSMG1	0.9	8.81	0.71	2.52e-13	Cognitive function;
SKCM	cis	rs798554	0.680	rs2533889	chr7:2900309	G/C	cg04166393	chr7:2884313	GNA12	0.75	4.99	0.49	3.59e-6	Height;
SKCM	cis	rs28595532	0.702	rs72670256	chr4:119391043	G/A	cg11846333	chr4:119757529	SEC24D	1.18	6.4	0.59	1.06e-8	Cannabis dependence symptom count;
SKCM	cis	rs9788682	1.000	rs57064725	chr15:78833036	C/A	cg24631222	chr15:78858424	CHRNA5	0.96	6.69	0.6	3.03e-9	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs1878931	0.582	rs27239	chr16:3442140	T/C	cg26668626	chr16:3451006	ZNF174;ZNF434	-0.82	-5.91	-0.56	8.44e-8	Body mass index (adult);
SKCM	cis	rs62238980	0.614	rs80035296	chr22:32387536	C/T	cg00543991	chr22:32367038	NA	1.15	4.87	0.48	5.76e-6	Childhood ear infection;
SKCM	cis	rs5760092	0.618	rs4461358	chr22:24260106	T/C	cg04234412	chr22:24373322	LOC391322	0.79	5.83	0.55	1.17e-7	Urinary 1,3-butadiene metabolite levels in smokers;
SKCM	cis	rs9814567	1.000	rs9856693	chr3:134306913	T/C	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs933688	1.000	rs11948075	chr5:90680579	A/G	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.97	6.61	0.6	4.28e-9	Smoking behavior;
SKCM	cis	rs738321	0.757	rs4820315	chr22:38518731	C/T	cg25457927	chr22:38595422	NA	-0.58	-6.71	-0.61	2.75e-9	Breast cancer;
SKCM	cis	rs9868809	0.505	rs13316551	chr3:48745167	A/C	cg00383909	chr3:49044727	WDR6	0.89	5.09	0.5	2.44e-6	Ulcerative colitis;Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs9303401	0.659	rs56162835	chr17:56687315	A/G	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.35	0.52	8.54e-7	Cognitive test performance;
SKCM	cis	rs7424096	0.527	rs4670637	chr2:37164857	T/G	cg14987922	chr2:37194071	STRN	0.87	7.09	0.63	5.3e-10	High light scatter reticulocyte percentage of red cells;
SKCM	cis	rs2842992	0.915	rs2842958	chr6:160108425	A/G	cg11366901	chr6:160182831	ACAT2	0.88	6.82	0.61	1.71e-9	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs1218582	0.774	rs1007170	chr1:154881461	G/A	cg09359103	chr1:154839909	KCNN3	-0.59	-5.81	-0.55	1.31e-7	Prostate cancer;
SKCM	cis	rs644799	0.710	rs3017756	chr11:95537358	G/A	cg25622487	chr11:95524042	FAM76B;CEP57	0.7	5.67	0.54	2.28e-7	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs10927875	1.000	rs12138117	chr1:16305279	T/C	cg21385522	chr1:16154831	NA	-0.92	-7.69	-0.66	3.73e-11	Dilated cardiomyopathy;
SKCM	cis	rs7100689	0.577	rs4934038	chr10:82057334	C/A	cg00277334	chr10:82204260	NA	-0.5	-5.0	-0.49	3.51e-6	Post bronchodilator FEV1;
SKCM	cis	rs6582630	0.519	rs4002440	chr12:38485012	A/G	cg26384229	chr12:38710491	ALG10B	0.81	6.22	0.58	2.31e-8	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs4774899	1.000	rs12914182	chr15:57424454	A/G	cg01857019	chr15:57210107	LOC145783;TCF12	0.53	4.89	0.48	5.3e-6	Urinary tract infection frequency;
SKCM	cis	rs763014	0.898	rs916414	chr16:632073	C/T	cg09263875	chr16:632152	PIGQ	0.67	5.82	0.55	1.24e-7	Height;
SKCM	cis	rs28595532	1.000	rs28600971	chr4:119712728	G/T	cg11846333	chr4:119757529	SEC24D	1.19	6.39	0.59	1.12e-8	Cannabis dependence symptom count;
SKCM	cis	rs7552404	0.924	rs1611823	chr1:76221706	T/G	cg10523679	chr1:76189770	ACADM	0.69	4.93	0.49	4.45e-6	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs11673344	0.796	rs16971886	chr19:37487975	G/A	cg07624650	chr19:37064219	ZNF529	-0.78	-4.82	-0.48	7.05e-6	Obesity-related traits;
SKCM	cis	rs17361889	0.778	rs1527219	chr7:16245752	T/C	cg09714114	chr7:16439993	ISPD	0.5	4.9	0.49	5.03e-6	Pediatric bone mineral content (hip);
SKCM	cis	rs12142240	0.628	rs56126529	chr1:46808860	C/T	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs6456156	0.586	rs13208636	chr6:167461965	T/G	cg13927040	chr6:167453801	FGFR1OP	0.66	4.85	0.48	6.24e-6	Primary biliary cholangitis;
SKCM	cis	rs1862618	0.671	rs832531	chr5:56228401	A/G	cg03609598	chr5:56110824	MAP3K1	-0.72	-5.21	-0.51	1.47e-6	Initial pursuit acceleration;
SKCM	cis	rs8141529	0.732	rs6005881	chr22:29183133	A/G	cg15103426	chr22:29168792	CCDC117	0.61	5.06	0.5	2.7e-6	Lymphocyte counts;
SKCM	cis	rs72781680	0.898	rs72786279	chr2:24063266	C/T	cg08917208	chr2:24149416	ATAD2B	1.0	4.97	0.49	3.82e-6	Lymphocyte counts;
SKCM	cis	rs4687718	0.929	rs62256001	chr3:53281076	A/G	cg07507251	chr3:52567010	NT5DC2	0.87	5.55	0.53	3.75e-7	QRS duration;
SKCM	cis	rs2980439	0.607	rs2980419	chr8:8114141	A/T	cg08975724	chr8:8085496	FLJ10661	0.86	6.87	0.61	1.42e-9	Neuroticism;
SKCM	cis	rs8067545	0.578	rs4925087	chr17:20024582	A/C	cg13482628	chr17:19912719	NA	0.66	5.58	0.53	3.39e-7	Schizophrenia;
SKCM	cis	rs908922	0.676	rs4845789	chr1:152528100	A/G	cg09873164	chr1:152488093	CRCT1	0.72	5.62	0.54	2.85e-7	Hair morphology;
SKCM	cis	rs782590	0.764	rs2054728	chr2:55818419	C/T	cg18811423	chr2:55921094	PNPT1	0.94	6.83	0.61	1.63e-9	Metabolic syndrome;
SKCM	cis	rs6952808	0.608	rs6461049	chr7:2017445	C/T	cg02951883	chr7:2050386	MAD1L1	0.79	6.63	0.6	3.99e-9	Bipolar disorder and schizophrenia;
SKCM	cis	rs75229567	0.618	rs11495622	chr12:70161286	G/A	cg10114359	chr12:70132523	RAB3IP	1.24	5.19	0.51	1.6e-6	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes;
SKCM	cis	rs9921222	0.656	rs12719801	chr16:381141	C/T	cg00101154	chr16:420108	MRPL28	-0.71	-5.74	-0.55	1.7e-7	Bone mineral density (spine);Bone mineral density;
SKCM	cis	rs9858213	1	rs9858213	chr3:49731861	G/T	cg03060546	chr3:49711283	APEH	-0.7	-4.93	-0.49	4.5e-6	Educational attainment;
SKCM	cis	rs2013441	1.000	rs2120282	chr17:20209474	C/T	cg13482628	chr17:19912719	NA	-0.67	-5.24	-0.51	1.32e-6	Obesity-related traits;
SKCM	cis	rs875971	0.862	rs10263690	chr7:65766453	G/C	cg18876405	chr7:65276391	NA	-0.64	-6.43	-0.59	9.24e-9	Aortic root size;
SKCM	cis	rs12142240	0.698	rs45517837	chr1:46859225	A/G	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	trans	rs5756813	0.661	rs2285178	chr22:38205989	T/C	cg19894588	chr14:64061835	NA	-0.89	-7.5	-0.65	8.56e-11	Optic cup area;Vertical cup-disc ratio;
SKCM	cis	rs6445797	0.632	rs1352766	chr3:56623530	G/A	cg13616963	chr3:57583610	ARF4	-0.79	-5.1	-0.5	2.35e-6	Gastritis;
SKCM	cis	rs854765	0.619	rs1101727	chr17:18016148	T/C	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.9	6.79	0.61	1.93e-9	Total body bone mineral density;
SKCM	cis	rs1707322	1.000	rs11211235	chr1:46440375	G/A	cg03146154	chr1:46216737	IPP	0.79	5.34	0.52	8.73e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs523522	0.962	rs4767905	chr12:120930835	C/T	cg12219531	chr12:120966889	COQ5	0.91	7.82	0.66	2.11e-11	High light scatter reticulocyte count;
SKCM	cis	rs9393692	1.000	rs3999544	chr6:26285867	C/T	cg00631329	chr6:26305371	NA	-0.67	-4.98	-0.49	3.66e-6	Educational attainment;
SKCM	cis	rs7770731	0.694	rs857469	chr6:14602862	C/A	cg01527307	chr6:14500441	NA	-0.54	-4.87	-0.48	5.63e-6	Response to antipsychotic treatment in schizophrenia (working memory);
SKCM	cis	rs7666738	0.830	rs11935078	chr4:99010476	T/A	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7772486	0.754	rs9390356	chr6:146118983	A/T	cg05347473	chr6:146136440	FBXO30	-0.61	-5.79	-0.55	1.41e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7555523	0.832	rs7524755	chr1:165694897	A/G	cg24409356	chr1:165738333	TMCO1	0.93	5.56	0.53	3.67e-7	Intraocular pressure;Glaucoma (high intraocular pressure);
SKCM	cis	rs67311347	0.544	rs6599088	chr3:40329288	T/C	cg00091569	chr3:40428383	ENTPD3	0.6	5.28	0.51	1.15e-6	Renal cell carcinoma;
SKCM	cis	rs11892454	0.515	rs10208202	chr2:26053576	T/C	cg17263061	chr2:26915892	KCNK3	0.69	4.98	0.49	3.73e-6	Heschl's gyrus morphology;
SKCM	cis	rs10818894	0.772	rs10120705	chr9:126692600	T/G	cg16191174	chr9:126692580	DENND1A	0.83	6.83	0.61	1.63e-9	Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU);
SKCM	cis	rs651907	0.557	rs11720745	chr3:101441690	G/A	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.81	7.1	0.63	5.08e-10	Colorectal cancer;
SKCM	cis	rs2188420	0.872	rs78564045	chr7:106552749	A/G	cg23615938	chr7:105753134	SYPL1	-0.96	-5.16	-0.5	1.85e-6	Interferon gamma levels;
SKCM	cis	rs478304	0.619	rs10791822	chr11:65428706	T/C	cg27068330	chr11:65405492	SIPA1	-0.87	-7.23	-0.63	2.89e-10	Acne (severe);
SKCM	cis	rs7937682	0.889	rs10789844	chr11:111579109	A/T	cg09085632	chr11:111637200	PPP2R1B	-1.11	-15.69	-0.87	7.68e-26	Primary sclerosing cholangitis;
SKCM	cis	rs6933660	0.646	rs6915598	chr6:151778664	T/C	cg10883421	chr6:151773342	RMND1;C6orf211	0.75	4.88	0.48	5.52e-6	Menarche (age at onset);
SKCM	cis	rs561341	1.000	rs498391	chr17:30328704	G/A	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs208520	0.874	rs208517	chr6:66947040	G/T	cg07460842	chr6:66804631	NA	-1.05	-7.28	-0.64	2.34e-10	Exhaled nitric oxide output;
SKCM	cis	rs372883	0.648	rs368322	chr21:30717151	C/T	cg24692254	chr21:30365293	RNF160	-0.64	-5.1	-0.5	2.29e-6	Pancreatic cancer;
SKCM	cis	rs7937682	0.921	rs34584980	chr11:111441537	G/A	cg09085632	chr11:111637200	PPP2R1B	1.0	8.74	0.7	3.46e-13	Primary sclerosing cholangitis;
SKCM	cis	rs55962025	0.883	rs82332	chr4:3225466	A/G	cg11471262	chr4:3318911	RGS12	-0.64	-4.92	-0.49	4.8e-6	Parental longevity (mother's age at death);
SKCM	cis	rs7216064	1.000	rs73352808	chr17:65875157	G/A	cg12091567	chr17:66097778	LOC651250	-0.74	-5.22	-0.51	1.47e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs933688	1.000	rs10073657	chr5:90689749	G/A	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.1	8.5	0.69	1.01e-12	Smoking behavior;
SKCM	cis	rs694739	0.894	rs11601860	chr11:64110422	A/T	cg02228329	chr11:64053129	BAD;GPR137	0.98	8.33	0.69	2.12e-12	Alopecia areata;Crohn's disease;Psoriasis vulgaris;
SKCM	cis	rs6665290	0.904	rs1045287	chr1:227178962	C/T	cg10327440	chr1:227177885	CDC42BPA	1.19	14.69	0.86	3.6e-24	Myeloid white cell count;
SKCM	cis	rs8180040	0.764	rs13084117	chr3:47183239	C/A	cg27129171	chr3:47204927	SETD2	0.82	6.44	0.59	9.04e-9	Colorectal cancer;
SKCM	cis	rs8067354	0.645	rs2645491	chr17:57877049	C/T	cg02344993	chr17:57696989	CLTC	0.67	4.82	0.48	6.84e-6	Hemoglobin concentration;
SKCM	cis	rs6951245	1.000	rs76833820	chr7:1070278	A/T	cg03188948	chr7:1209495	NA	1.12	6.17	0.57	2.88e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs1401999	0.546	rs56889301	chr3:183675315	T/C	cg01324343	chr3:183735012	ABCC5	0.93	10.9	0.78	2.4e-17	Anterior chamber depth;
SKCM	cis	rs9660180	0.934	rs12729990	chr1:1812035	T/A	cg13866156	chr1:1669148	SLC35E2	-0.79	-6.52	-0.59	6.44e-9	Body mass index;
SKCM	cis	rs77216612	0.840	rs11055030	chr12:12878349	G/C	cg09462578	chr12:12878428	APOLD1	-0.85	-5.59	-0.54	3.17e-7	Lymphocyte counts;
SKCM	cis	rs17065868	0.764	rs73190864	chr13:45162227	C/A	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs854765	0.647	rs2974999	chr17:17997547	T/G	cg04398451	chr17:18023971	MYO15A	-0.99	-8.76	-0.7	3.19e-13	Total body bone mineral density;
SKCM	cis	rs9814567	0.964	rs9815894	chr3:134282796	C/G	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs6570726	0.818	rs412350	chr6:145852409	T/C	cg05347473	chr6:146136440	FBXO30	0.56	5.08	0.5	2.49e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs28595532	0.841	rs56388366	chr4:119769242	A/G	cg11846333	chr4:119757529	SEC24D	1.22	6.0	0.56	5.86e-8	Cannabis dependence symptom count;
SKCM	cis	rs9303401	0.659	rs9303399	chr17:56672309	C/T	cg10487724	chr17:56770010	TEX14;RAD51C	0.84	6.03	0.56	5.23e-8	Cognitive test performance;
SKCM	cis	rs1799949	0.965	rs11651623	chr17:41329847	G/A	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.29	-0.58	1.73e-8	Menopause (age at onset);
SKCM	cis	rs1348850	0.526	rs1345138	chr2:178387100	A/T	cg27490568	chr2:178487706	NA	0.89	6.43	0.59	9.33e-9	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	trans	rs17685	0.753	rs7804598	chr7:75702578	C/T	cg19862616	chr7:65841803	NCRNA00174	0.94	9.45	0.73	1.46e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1707322	1.000	rs11211205	chr1:46321874	C/T	cg03146154	chr1:46216737	IPP	0.75	5.15	0.5	1.94e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs6547741	1.000	rs6706610	chr2:27778091	G/A	cg27432699	chr2:27873401	GPN1	0.73	6.55	0.6	5.7e-9	Oral cavity cancer;
SKCM	cis	rs867186	1.000	rs79197732	chr20:33562476	C/T	cg04194272	chr20:33683537	NA	-1.37	-6.77	-0.61	2.18e-9	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs1256061	0.624	rs1760988	chr14:64696813	A/G	cg21174375	chr14:64681225	SYNE2	0.47	4.83	0.48	6.66e-6	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs72781680	0.898	rs72788218	chr2:24090435	C/T	cg08917208	chr2:24149416	ATAD2B	0.99	5.24	0.51	1.31e-6	Lymphocyte counts;
SKCM	cis	rs7523273	0.526	rs1204708	chr1:208024062	G/C	cg22525895	chr1:207977042	MIR29B2	-0.85	-6.62	-0.6	4.19e-9	Schizophrenia;
SKCM	cis	rs72634258	0.503	rs72632055	chr1:7835774	T/G	cg26816564	chr1:7831052	VAMP3	0.78	5.51	0.53	4.39e-7	Inflammatory bowel disease;
SKCM	cis	rs4727027	0.933	rs917123	chr7:148848358	G/A	cg23583168	chr7:148888333	NA	-0.8	-6.66	-0.6	3.52e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs3857536	0.706	rs7749120	chr6:66889832	T/G	cg07460842	chr6:66804631	NA	-0.7	-5.07	-0.5	2.64e-6	Blood trace element (Cu levels);
SKCM	cis	rs7296418	0.961	rs949143	chr12:123595163	G/A	cg00376283	chr12:123451042	ABCB9	0.96	8.66	0.7	5e-13	Platelet count;
SKCM	cis	rs9790314	0.905	rs6774276	chr3:160941318	C/T	cg03342759	chr3:160939853	NMD3	-0.73	-8.19	-0.68	4.08e-12	Morning vs. evening chronotype;
SKCM	cis	rs3087591	1.000	rs2854331	chr17:29711728	G/A	cg24425628	chr17:29625626	OMG;NF1	-0.61	-4.83	-0.48	6.71e-6	Hip circumference;
SKCM	cis	rs910316	1.000	rs12879542	chr14:75507525	C/T	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.89e-7	Height;
SKCM	cis	rs3820928	0.845	rs13415319	chr2:227878936	G/C	cg11843606	chr2:227700838	RHBDD1	-0.6	-4.84	-0.48	6.37e-6	Pulmonary function;
SKCM	cis	rs17376456	0.877	rs28633397	chr5:93447048	A/G	cg21475434	chr5:93447410	FAM172A	0.97	5.42	0.52	6.39e-7	Diabetic retinopathy;
SKCM	cis	rs4242434	0.927	rs57594397	chr8:22475657	T/C	cg03733263	chr8:22462867	KIAA1967	1.12	9.6	0.74	7.28e-15	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs2075371	0.933	rs1833474	chr7:133958240	A/G	cg20476274	chr7:133979776	SLC35B4	1.03	10.88	0.78	2.61e-17	Mean platelet volume;
SKCM	cis	rs875971	0.502	rs11769702	chr7:65720516	A/C	cg18876405	chr7:65276391	NA	0.65	5.28	0.51	1.15e-6	Aortic root size;
SKCM	cis	rs708547	0.624	rs1718886	chr4:57849251	C/T	cg16868167	chr4:57843880	C4orf14;POLR2B	0.88	8.43	0.69	1.38e-12	Response to bleomycin (chromatid breaks);
SKCM	cis	rs7143963	0.943	rs8022770	chr14:103263489	C/G	cg23020514	chr14:103360112	TRAF3	0.84	7.73	0.66	3.2e-11	Body mass index;
SKCM	cis	rs1395	0.778	rs12465084	chr2:27414203	G/C	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.51	5.14	0.5	1.96e-6	Blood metabolite levels;
SKCM	cis	rs9959145	0.500	rs11665415	chr18:12536129	G/A	cg18469917	chr18:12433231	NA	-1.14	-4.81	-0.48	7.09e-6	Immune response to smallpox vaccine (IL-6);
SKCM	cis	rs2228479	0.557	rs62056064	chr16:89903843	G/A	cg00800038	chr16:89945340	TCF25	-0.96	-4.88	-0.48	5.51e-6	Skin colour saturation;
SKCM	cis	rs55962025	0.846	rs363066	chr4:3135953	G/T	cg00764545	chr4:3318001	RGS12	0.74	5.87	0.55	9.98e-8	Parental longevity (mother's age at death);
SKCM	cis	rs10256972	0.706	rs12701970	chr7:1121958	T/C	cg07092213	chr7:1199455	ZFAND2A	-0.65	-5.46	-0.53	5.5e-7	Longevity;Endometriosis;
SKCM	cis	rs28595532	0.920	rs114037572	chr4:119735609	T/G	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs3087591	0.919	rs2012581	chr17:29560800	A/G	cg24425628	chr17:29625626	OMG;NF1	-0.64	-5.22	-0.51	1.43e-6	Hip circumference;
SKCM	cis	rs6570726	0.846	rs426874	chr6:145880630	A/C	cg23711669	chr6:146136114	FBXO30	0.8	8.46	0.69	1.18e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1344694	0.566	rs4672790	chr2:216892446	C/T	cg12620499	chr2:216877984	MREG	0.81	7.59	0.65	5.9e-11	Alcohol dependence;
SKCM	cis	rs7615952	0.673	rs35955861	chr3:125626201	T/C	cg05084668	chr3:125655381	ALG1L	-1.25	-6.57	-0.6	5.19e-9	Blood pressure (smoking interaction);
SKCM	cis	rs860295	0.580	rs6672284	chr1:155277963	C/T	cg02153340	chr1:155202674	NA	-0.78	-5.42	-0.52	6.37e-7	Body mass index;
SKCM	cis	rs67311347	0.955	rs4974068	chr3:40376929	T/C	cg00091569	chr3:40428383	ENTPD3	0.65	5.58	0.53	3.36e-7	Renal cell carcinoma;
SKCM	cis	rs9467773	1.000	rs6922824	chr6:26553815	C/G	cg15659132	chr6:26577336	NA	-0.6	-5.71	-0.54	1.99e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7829975	0.688	rs7817376	chr8:8380530	C/T	cg06636001	chr8:8085503	FLJ10661	-0.82	-7.05	-0.62	6.24e-10	Mood instability;
SKCM	cis	rs12477438	0.520	rs13004491	chr2:99738008	T/C	cg26064155	chr2:99771622	LIPT1;TSGA10	1.02	10.07	0.75	9.12e-16	Chronic sinus infection;
SKCM	cis	rs1949733	1.000	rs1916326	chr4:8500023	G/A	cg11789530	chr4:8429930	ACOX3	-0.81	-5.73	-0.54	1.83e-7	Response to antineoplastic agents;
SKCM	cis	rs10193935	0.901	rs10169971	chr2:42602189	G/A	cg27598129	chr2:42591480	NA	-0.88	-6.71	-0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs867186	1.000	rs17317888	chr20:33594959	G/T	cg04194272	chr20:33683537	NA	-1.36	-7.01	-0.62	7.44e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs6998277	0.830	rs965661	chr8:103597586	C/T	cg10187029	chr8:103597600	NA	0.76	6.31	0.58	1.54e-8	Migraine;
SKCM	cis	rs8072100	0.713	rs3871595	chr17:45511388	C/T	cg08085267	chr17:45401833	C17orf57	-0.62	-5.06	-0.5	2.76e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs6489882	0.966	rs10735079	chr12:113380008	A/G	cg07232103	chr12:112566177	TRAFD1	-0.61	-4.86	-0.48	5.84e-6	Chronic lymphocytic leukemia;
SKCM	cis	rs651907	0.535	rs11714444	chr3:101513682	G/A	cg12386194	chr3:101231763	SENP7	0.68	5.74	0.54	1.73e-7	Colorectal cancer;
SKCM	cis	rs4065321	0.522	rs3744245	chr17:38146542	C/G	cg17467752	chr17:38218738	THRA	-0.74	-6.2	-0.57	2.47e-8	White blood cell count (basophil);White blood cell count;
SKCM	cis	rs78707713	0.512	rs12412776	chr10:71179502	G/A	cg23211468	chr10:71475998	NA	0.58	5.09	0.5	2.38e-6	Venous thromboembolism;
SKCM	cis	rs801193	0.967	rs34356500	chr7:66236607	G/T	cg00343986	chr7:65444356	GUSB	0.69	5.02	0.49	3.24e-6	Aortic root size;
SKCM	cis	rs2282032	1.000	rs74485471	chr14:90746112	G/A	cg04374321	chr14:90722782	PSMC1	0.7	4.85	0.48	6.26e-6	Longevity;
SKCM	cis	rs11098499	0.954	rs3733524	chr4:120423729	T/C	cg24375607	chr4:120327624	NA	0.66	5.13	0.5	2.05e-6	Corneal astigmatism;
SKCM	cis	rs2243480	1.000	rs10807702	chr7:65767843	C/T	cg18252515	chr7:66147081	NA	-1.46	-8.23	-0.68	3.36e-12	Diabetic kidney disease;
SKCM	cis	rs7666738	0.677	rs13120306	chr4:99036099	A/T	cg05340658	chr4:99064831	C4orf37	0.66	5.01	0.49	3.35e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2404602	0.735	rs1607015	chr15:76702429	C/T	cg23625390	chr15:77176239	SCAPER	-0.83	-8.06	-0.67	7.18e-12	Blood metabolite levels;
SKCM	cis	rs9910055	0.659	rs186603	chr17:42207884	C/T	cg10896456	chr17:42255109	ASB16;C17orf65	-0.68	-7.09	-0.63	5.21e-10	Total body bone mineral density;
SKCM	cis	rs9325144	0.625	rs11534879	chr12:38968165	A/G	cg13010199	chr12:38710504	ALG10B	-0.64	-5.32	-0.52	9.79e-7	Morning vs. evening chronotype;
SKCM	trans	rs62103177	0.713	rs62103186	chr18:77627574	G/C	cg05926928	chr17:57297772	GDPD1	1.29	8.74	0.7	3.44e-13	Opioid sensitivity;
SKCM	cis	rs11098499	0.863	rs3822191	chr4:120428101	A/T	cg09307838	chr4:120376055	NA	1.0	7.66	0.66	4.31e-11	Corneal astigmatism;
SKCM	cis	rs6582630	0.519	rs7305545	chr12:38349223	G/A	cg26384229	chr12:38710491	ALG10B	0.81	6.56	0.6	5.29e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs4665809	0.590	rs6716858	chr2:26423414	G/A	cg04944784	chr2:26401820	FAM59B	-0.73	-4.79	-0.48	7.9e-6	Gut microbiome composition (summer);
SKCM	cis	rs7666738	0.830	rs10028505	chr4:98962310	C/A	cg17366294	chr4:99064904	C4orf37	0.59	4.89	0.48	5.36e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10207060	0.500	rs11884577	chr2:240702216	C/G	cg07506560	chr2:240697449	NA	0.75	6.1	0.57	3.8e-8	Obesity-related traits;
SKCM	cis	rs17345786	0.906	rs72940399	chr3:101122575	A/T	cg12386194	chr3:101231763	SENP7	0.76	6.03	0.56	5.19e-8	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10911232	0.507	rs4652762	chr1:182993960	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.64	0.6	3.83e-9	Hypertriglyceridemia;
SKCM	cis	rs6866344	0.697	rs17184281	chr5:178127563	G/A	cg10224037	chr5:178157518	ZNF354A	0.75	4.92	0.49	4.75e-6	Neutrophil percentage of white cells;
SKCM	cis	rs17376456	0.877	rs10061080	chr5:93420559	A/G	cg25358565	chr5:93447407	FAM172A	1.22	7.84	0.66	1.89e-11	Diabetic retinopathy;
SKCM	cis	rs1850744	0.702	rs11939895	chr4:9630402	T/C	cg15442990	chr4:9534313	NA	1.55	5.8	0.55	1.34e-7	Economic and political preferences;
SKCM	cis	rs910316	0.726	rs175040	chr14:75469555	A/G	cg08847533	chr14:75593920	NEK9	-0.83	-7.06	-0.62	6e-10	Height;
SKCM	cis	rs9790314	0.645	rs6778254	chr3:160892792	T/C	cg03342759	chr3:160939853	NMD3	-0.65	-6.53	-0.59	6.21e-9	Morning vs. evening chronotype;
SKCM	cis	rs2439831	0.681	rs2444036	chr15:43694108	G/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.21	7.84	0.66	1.9e-11	Lung cancer in ever smokers;
SKCM	cis	rs8067354	0.645	rs2645486	chr17:57885901	T/A	cg02344993	chr17:57696989	CLTC	0.67	4.79	0.48	7.85e-6	Hemoglobin concentration;
SKCM	cis	rs2463822	1.000	rs951677	chr11:62107249	G/C	cg06239285	chr11:62104954	ASRGL1	1.25	5.93	0.56	7.79e-8	Chronic obstructive pulmonary disease-related biomarkers;
SKCM	cis	rs1577917	1.000	rs10944163	chr6:86658693	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.85	-8.62	-0.7	5.82e-13	Response to antipsychotic treatment;
SKCM	cis	rs9911578	0.874	rs302865	chr17:56756977	A/G	cg05425664	chr17:57184151	TRIM37	-0.66	-5.07	-0.5	2.61e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2251381	0.640	rs2183568	chr21:30484782	A/T	cg24692254	chr21:30365293	RNF160	-0.75	-5.64	-0.54	2.61e-7	Selective IgA deficiency;
SKCM	cis	rs7103648	0.567	rs12287076	chr11:47606865	G/C	cg20307385	chr11:47447363	PSMC3	-0.98	-7.4	-0.64	1.32e-10	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs1577917	0.917	rs35738006	chr6:86646309	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.66	-5.74	-0.54	1.76e-7	Response to antipsychotic treatment;
SKCM	cis	rs72792276	1.000	rs10519971	chr5:127379216	A/G	cg25462716	chr5:127418816	SLC12A2;FLJ33630	-0.74	-5.51	-0.53	4.48e-7	Red cell distribution width;
SKCM	cis	rs10769945	0.679	rs7105710	chr11:1918083	T/C	cg23202291	chr11:1979235	NA	0.54	5.28	0.51	1.11e-6	DNA methylation (variation);
SKCM	cis	rs7552404	0.924	rs1146574	chr1:76202671	A/G	cg03433033	chr1:76189801	ACADM	0.73	5.33	0.52	9.12e-7	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs13118159	0.767	rs2141656	chr4:1317192	C/T	cg02018176	chr4:1364513	KIAA1530	0.69	5.7	0.54	2.04e-7	Longevity;
SKCM	cis	rs6088580	0.634	rs6058041	chr20:33018008	A/G	cg24642439	chr20:33292090	TP53INP2	0.76	6.02	0.56	5.28e-8	Glomerular filtration rate (creatinine);
SKCM	trans	rs17685	0.753	rs869804	chr7:75688954	A/G	cg19862616	chr7:65841803	NCRNA00174	0.95	9.34	0.73	2.39e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7980687	0.628	rs1727332	chr12:123718301	C/T	cg00376283	chr12:123451042	ABCB9	0.86	6.7	0.6	2.95e-9	Height;Educational attainment;Head circumference (infant);
SKCM	trans	rs10506458	0.834	rs12426893	chr12:63388120	G/T	cg03429785	chr15:59498649	MYO1E;LDHAL6B	-1.39	-7.59	-0.65	5.95e-11	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs2777491	0.957	rs316614	chr15:41746625	A/G	cg18705301	chr15:41695430	NDUFAF1	-0.89	-9.04	-0.72	9.17e-14	Ulcerative colitis;
SKCM	cis	rs9467773	0.620	rs2451737	chr6:26619041	T/C	cg15659132	chr6:26577336	NA	0.62	5.4	0.52	6.91e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7666738	0.830	rs13122054	chr4:98972974	G/A	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs17376456	0.825	rs13361613	chr5:93272176	C/T	cg25358565	chr5:93447407	FAM172A	1.3	7.53	0.65	7.57e-11	Diabetic retinopathy;
SKCM	cis	rs523522	0.885	rs524735	chr12:121022099	T/C	cg27279351	chr12:120934652	DYNLL1	0.91	8.36	0.69	1.88e-12	High light scatter reticulocyte count;
SKCM	cis	rs4332037	1.000	rs6947019	chr7:1950337	G/A	cg23422044	chr7:1970798	MAD1L1	-0.95	-6.32	-0.58	1.48e-8	Bipolar disorder;
SKCM	cis	rs6585827	0.585	rs1004946	chr10:124139767	G/A	cg17834180	chr10:124768240	IKZF5;ACADSB	0.65	5.09	0.5	2.4e-6	Height;
SKCM	cis	rs2228479	0.850	rs74251570	chr16:89910068	C/A	cg06558623	chr16:89946397	TCF25	1.12	5.0	0.49	3.47e-6	Skin colour saturation;
SKCM	cis	rs1707322	1.000	rs34444543	chr1:46358862	G/A	cg03146154	chr1:46216737	IPP	0.73	4.96	0.49	4.04e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs1018836	0.669	rs6471243	chr8:91656967	C/T	cg16814680	chr8:91681699	NA	0.92	8.56	0.7	7.68e-13	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs4975616	0.686	rs37011	chr5:1348798	A/T	cg26373071	chr5:1325741	CLPTM1L	0.62	5.28	0.51	1.12e-6	Lung cancer;
SKCM	cis	rs9475752	1.000	rs1451708	chr6:56802201	T/C	cg06815302	chr6:57335405	PRIM2	0.64	4.94	0.49	4.4e-6	Menarche (age at onset);
SKCM	cis	rs4954585	0.683	rs13004902	chr2:137027680	A/G	cg05194412	chr2:137003533	NA	0.57	5.1	0.5	2.31e-6	Colorectal cancer;
SKCM	cis	rs9394841	0.667	rs9357366	chr6:41786976	T/G	cg08135965	chr6:41755394	TOMM6	0.74	4.88	0.48	5.45e-6	Mean corpuscular hemoglobin;Red cell distribution width;
SKCM	cis	rs34779708	0.966	rs12784482	chr10:35446865	A/G	cg03585969	chr10:35415529	CREM	0.72	5.89	0.56	9.14e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs593982	1.000	rs1941746	chr11:65502413	A/G	cg08755490	chr11:65554678	OVOL1	1.06	10.75	0.77	4.73e-17	Atopic dermatitis;
SKCM	cis	rs7666738	0.830	rs28622458	chr4:98916651	A/G	cg17366294	chr4:99064904	C4orf37	0.56	4.87	0.48	5.76e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1707322	0.964	rs12067716	chr1:46434428	T/A	cg03146154	chr1:46216737	IPP	0.79	5.34	0.52	8.73e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs13256369	0.851	rs11249890	chr8:8565245	G/T	cg06636001	chr8:8085503	FLJ10661	0.8	6.11	0.57	3.65e-8	Obesity-related traits;
SKCM	cis	rs2361718	0.500	rs8064429	chr17:78096187	A/C	cg09238746	chr17:78121135	EIF4A3	-0.88	-6.41	-0.59	1.01e-8	Yeast infection;
SKCM	cis	rs3820928	0.804	rs4675125	chr2:227802499	T/C	cg11843606	chr2:227700838	RHBDD1	-0.6	-4.81	-0.48	7.34e-6	Pulmonary function;
SKCM	cis	rs1577917	1.000	rs16876529	chr6:86591202	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.75	-0.66	2.83e-11	Response to antipsychotic treatment;
SKCM	cis	rs1707322	1.000	rs11211232	chr1:46411146	C/T	cg03146154	chr1:46216737	IPP	0.79	5.29	0.51	1.07e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs72615157	0.634	rs2272343	chr7:99778285	A/C	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.07	6.59	0.6	4.62e-9	Lung function (FEV1/FVC);
SKCM	cis	rs28595532	0.920	rs116834347	chr4:119774155	C/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs72634258	0.554	rs4908694	chr1:7850898	C/T	cg26816564	chr1:7831052	VAMP3	0.77	5.48	0.53	5.07e-7	Inflammatory bowel disease;
SKCM	cis	rs9300255	0.543	rs655293	chr12:123528405	G/A	cg00376283	chr12:123451042	ABCB9	0.84	5.87	0.55	1e-7	Neutrophil percentage of white cells;
SKCM	cis	rs7811142	1.000	rs11766752	chr7:100073292	A/G	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.34	0.69	2.1e-12	Platelet count;
SKCM	cis	rs738322	0.836	rs4821741	chr22:38514745	A/G	cg25457927	chr22:38595422	NA	-0.46	-5.01	-0.49	3.33e-6	Cutaneous nevi;
SKCM	cis	rs1799949	1.000	rs33920795	chr17:41329010	A/G	cg05368731	chr17:41323189	NBR1	0.88	7.87	0.67	1.65e-11	Menopause (age at onset);
SKCM	cis	rs9300255	0.543	rs1260294	chr12:123560289	T/C	cg00376283	chr12:123451042	ABCB9	-0.82	-5.67	-0.54	2.32e-7	Neutrophil percentage of white cells;
SKCM	cis	rs137603	0.644	rs470082	chr22:39715140	C/T	cg17798944	chr22:39715225	SNORD43;RPL3	-0.64	-5.48	-0.53	5.06e-7	Primary biliary cholangitis;
SKCM	cis	rs12950390	0.893	rs72831644	chr17:45824391	T/C	cg03474202	chr17:45855739	NA	-0.47	-5.21	-0.51	1.51e-6	IgG glycosylation;
SKCM	cis	rs11719291	0.833	rs11713694	chr3:48833615	G/T	cg24898236	chr3:49228699	LOC646498	0.65	4.98	0.49	3.66e-6	Cognitive function;
SKCM	cis	rs35306767	0.904	rs35667562	chr10:950630	G/A	cg26597838	chr10:835615	NA	0.83	5.92	0.56	8.26e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs2180341	0.960	rs7753913	chr6:127671296	A/G	cg27446573	chr6:127587934	RNF146	0.94	8.11	0.68	5.63e-12	Breast cancer;
SKCM	cis	rs1799949	0.602	rs4600503	chr17:41414324	C/G	cg23758822	chr17:41437982	NA	0.93	7.88	0.67	1.62e-11	Menopause (age at onset);
SKCM	cis	rs9902453	0.765	rs2127001	chr17:28098219	G/T	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.79	-5.93	-0.56	7.67e-8	Coffee consumption (cups per day);
SKCM	cis	rs597539	0.616	rs631001	chr11:68642974	C/T	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.84	5.61	0.54	3e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs17826219	0.500	rs9891256	chr17:29072692	C/T	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Body mass index;
SKCM	cis	rs798554	1.000	rs798544	chr7:2763102	A/G	cg14895029	chr7:2775587	GNA12	0.77	5.77	0.55	1.56e-7	Height;
SKCM	cis	rs2652834	1.000	rs2729783	chr15:63403316	C/T	cg04194852	chr15:63334506	TPM1	0.76	4.91	0.49	4.93e-6	HDL cholesterol;
SKCM	cis	rs7143963	0.636	rs2180393	chr14:103293845	T/C	cg23020514	chr14:103360112	TRAF3	0.7	6.62	0.6	4.11e-9	Body mass index;
SKCM	cis	rs10504229	0.639	rs16921812	chr8:58106737	C/T	cg02725872	chr8:58115012	NA	-0.53	-4.91	-0.49	4.82e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs12047808	0.841	rs112667627	chr1:179370353	A/G	cg08037922	chr1:179521085	C1orf125;NPHS2	-1.08	-5.8	-0.55	1.32e-7	Multiple sclerosis (age of onset);
SKCM	cis	rs9596863	1.000	rs9536564	chr13:54460395	G/A	ch.13.53330881F	chr13:54432880	NA	-0.83	-5.04	-0.5	2.98e-6	Epilepsy and lamotrigine-induced maculopapular eruptions;
SKCM	cis	rs1152591	0.967	rs1152589	chr14:64683926	A/T	cg21174375	chr14:64681225	SYNE2	-0.46	-5.19	-0.51	1.62e-6	Atrial fibrillation;
SKCM	cis	rs7639513	0.767	rs9861271	chr3:12707620	A/C	cg23032965	chr3:12705835	RAF1	0.81	7.08	0.63	5.53e-10	Itch intensity from mosquito bite;
SKCM	cis	rs12477438	0.501	rs17759607	chr2:99737005	T/C	cg26064155	chr2:99771622	LIPT1;TSGA10	1.01	9.65	0.74	5.91e-15	Chronic sinus infection;
SKCM	cis	rs4888262	0.545	rs7342732	chr16:74698716	A/C	cg01733217	chr16:74700730	RFWD3	0.91	7.37	0.64	1.57e-10	Testicular germ cell tumor;
SKCM	cis	rs6570726	0.935	rs408723	chr6:145838535	A/G	cg23711669	chr6:146136114	FBXO30	0.7	6.64	0.6	3.72e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs12142240	0.698	rs112089006	chr1:46812360	C/T	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs7666738	0.830	rs4699584	chr4:98952019	A/G	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2404602	0.684	rs1011083	chr15:77007527	C/T	cg23625390	chr15:77176239	SCAPER	-0.82	-7.93	-0.67	1.26e-11	Blood metabolite levels;
SKCM	cis	rs10207060	0.500	rs10181238	chr2:240709496	G/A	cg07506560	chr2:240697449	NA	0.75	6.1	0.57	3.8e-8	Obesity-related traits;
SKCM	cis	rs7824557	0.564	rs2736300	chr8:11235579	T/G	cg21775007	chr8:11205619	TDH	-0.59	-5.03	-0.5	3.01e-6	Retinal vascular caliber;
SKCM	cis	rs9388451	0.874	rs9398787	chr6:126090608	A/G	cg05901451	chr6:126070800	HEY2	-0.86	-8.58	-0.7	6.94e-13	Brugada syndrome;
SKCM	cis	rs4803468	1.000	rs3213861	chr19:41919944	A/C	cg14132834	chr19:41945861	ATP5SL	-0.77	-6.08	-0.57	4.18e-8	Height;
SKCM	cis	rs7666738	0.830	rs59751489	chr4:98933802	A/G	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7143963	0.666	rs8017944	chr14:103320048	T/G	cg23020514	chr14:103360112	TRAF3	0.76	7.28	0.64	2.32e-10	Body mass index;
SKCM	cis	rs875971	0.964	rs160635	chr7:65528918	T/C	cg11987759	chr7:65425863	GUSB	-0.56	-4.94	-0.49	4.34e-6	Aortic root size;
SKCM	cis	rs2836950	0.545	rs2836956	chr21:40623018	C/G	cg11644478	chr21:40555479	PSMG1	0.67	5.21	0.51	1.51e-6	Menarche (age at onset);
SKCM	cis	rs10504229	0.683	rs73603874	chr8:58108340	G/A	cg02725872	chr8:58115012	NA	-0.53	-4.91	-0.49	4.82e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs9479482	1.000	rs9478380	chr6:150354665	A/G	cg03788504	chr6:150331562	NA	0.47	5.33	0.52	9.3e-7	Alopecia areata;
SKCM	cis	rs6570726	0.967	rs9403706	chr6:145795187	C/T	cg23711669	chr6:146136114	FBXO30	-0.7	-6.88	-0.61	1.32e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1580019	0.520	rs13228793	chr7:32711465	C/T	cg06627557	chr7:32535165	LSM5;AVL9	0.9	7.56	0.65	6.57e-11	Cognitive ability;
SKCM	cis	rs9913156	0.748	rs55869432	chr17:4562901	A/G	cg19197139	chr17:4613644	ARRB2	0.79	5.28	0.51	1.14e-6	Lymphocyte counts;
SKCM	cis	rs4727027	0.866	rs3735311	chr7:148877737	T/C	cg23583168	chr7:148888333	NA	-0.8	-6.69	-0.6	3.09e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs208520	0.754	rs851593	chr6:66875783	C/T	cg07460842	chr6:66804631	NA	1.05	7.98	0.67	1.01e-11	Exhaled nitric oxide output;
SKCM	cis	rs12474201	0.822	rs897530	chr2:46948150	C/G	cg06386533	chr2:46925753	SOCS5	0.93	8.38	0.69	1.75e-12	Height;
SKCM	cis	rs7927771	0.524	rs11039419	chr11:47851354	C/T	cg20307385	chr11:47447363	PSMC3	0.71	5.63	0.54	2.67e-7	Subjective well-being;
SKCM	cis	rs7772486	0.875	rs7761033	chr6:146356106	C/T	cg05347473	chr6:146136440	FBXO30	0.57	5.24	0.51	1.31e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs28386778	0.897	rs4638645	chr17:61828349	T/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.12	11.27	0.79	4.92e-18	Prudent dietary pattern;
SKCM	cis	rs7772486	0.875	rs11755334	chr6:146399297	T/C	cg23711669	chr6:146136114	FBXO30	0.86	8.52	0.69	9.13e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1577917	0.771	rs7742201	chr6:86432930	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.81	-7.51	-0.65	8.16e-11	Response to antipsychotic treatment;
SKCM	cis	rs2072499	1.000	rs2072499	chr1:156169610	A/G	cg25208724	chr1:156163844	SLC25A44	1.04	9.45	0.73	1.47e-14	Testicular germ cell tumor;
SKCM	cis	rs9788721	0.592	rs28564957	chr15:78906107	C/A	cg06917634	chr15:78832804	PSMA4	-0.9	-7.95	-0.67	1.16e-11	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;Emphysema imaging phenotypes;Emphysema distribution in smoking;Local histogram emphysema pattern;Post bronchodilator FEV1/FVC ratio in COPD;
SKCM	cis	rs6061231	0.556	rs6121571	chr20:60977323	T/G	cg24112000	chr20:60950667	NA	-0.64	-6.4	-0.59	1.08e-8	Colorectal cancer;
SKCM	cis	rs4905558	0.962	rs7141028	chr14:97333357	A/C	cg11863609	chr14:97355128	NA	-0.56	-5.04	-0.5	3e-6	Neutrophil count;
SKCM	cis	rs7586085	0.522	rs10203527	chr2:166470197	C/T	cg01770810	chr2:165769913	SLC38A11	-0.49	-4.98	-0.49	3.72e-6	Total body bone mineral density;
SKCM	cis	rs5750830	0.649	rs4384886	chr22:39793766	C/T	cg24399712	chr22:39784796	NA	-0.59	-5.03	-0.5	3.01e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs17685	0.712	rs6976236	chr7:75741087	G/T	cg16489192	chr7:75678113	MDH2;STYXL1	-0.57	-5.38	-0.52	7.48e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs9543976	1.000	rs7989568	chr13:76155564	T/C	cg01531495	chr13:76123901	UCHL3	0.94	5.3	0.51	1.04e-6	Diabetic retinopathy;
SKCM	cis	rs28595532	0.841	rs114363775	chr4:119765587	G/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs909341	0.710	rs2297433	chr20:62293460	T/C	cg03999872	chr20:62272968	STMN3	0.56	4.94	0.49	4.34e-6	Atopic dermatitis;
SKCM	cis	rs7772486	0.624	rs9485018	chr6:146025731	T/C	cg23711669	chr6:146136114	FBXO30	-0.82	-8.01	-0.67	9.12e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9911578	1.000	rs302848	chr17:56686454	C/T	cg05425664	chr17:57184151	TRIM37	-0.71	-5.42	-0.52	6.53e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs501916	0.761	rs589889	chr15:48019016	C/G	cg16110827	chr15:48056943	SEMA6D	-0.58	-4.93	-0.49	4.62e-6	Inflammatory bowel disease;Ulcerative colitis;
SKCM	cis	rs7177699	0.557	rs7164479	chr15:79123054	C/T	cg04896959	chr15:78267971	NA	-0.54	-4.82	-0.48	7.01e-6	Post bronchodilator FEV1/FVC ratio;Post bronchodilator FEV1;
SKCM	cis	rs9430161	0.611	rs72644044	chr1:11034347	C/G	cg02454025	chr1:11042201	C1orf127	1.1	9.63	0.74	6.57e-15	Ewing sarcoma;
SKCM	cis	rs3784262	1.000	rs3204689	chr15:58246802	G/C	cg12031962	chr15:58353849	ALDH1A2	-0.5	-6.1	-0.57	3.75e-8	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	trans	rs3780486	0.505	rs10217267	chr9:33146528	T/C	cg04842962	chr6:43655489	MRPS18A	0.82	8.06	0.67	7.23e-12	IgG glycosylation;
SKCM	cis	rs7507204	0.530	rs4807469	chr19:3443382	G/C	cg08380311	chr19:3435252	NFIC	1.18	13.67	0.84	2.13e-22	Height;
SKCM	cis	rs798554	0.679	rs2644281	chr7:2886748	A/G	cg04166393	chr7:2884313	GNA12	0.79	5.54	0.53	3.9e-7	Height;
SKCM	cis	rs908922	0.651	rs548252	chr1:152489742	A/G	cg09873164	chr1:152488093	CRCT1	-0.71	-5.95	-0.56	7.13e-8	Hair morphology;
SKCM	cis	rs9640161	0.830	rs17173681	chr7:150059414	A/G	cg10018233	chr7:150070692	REPIN1	-0.76	-6.83	-0.61	1.64e-9	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs7772486	0.754	rs6570718	chr6:146088443	T/G	cg23711669	chr6:146136114	FBXO30	-0.9	-10.43	-0.76	1.88e-16	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2721195	1.000	rs2721195	chr8:145677011	T/C	cg15857475	chr8:145742913	RECQL4;LRRC14	-0.8	-7.07	-0.62	5.82e-10	Age at first birth;
SKCM	cis	rs2439831	1.000	rs690436	chr15:43761205	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.21	7.96	0.67	1.1e-11	Lung cancer in ever smokers;
SKCM	cis	rs9902453	0.904	rs12952179	chr17:28412687	G/A	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.77	-5.73	-0.54	1.8e-7	Coffee consumption (cups per day);
SKCM	cis	rs6598955	0.724	rs6656716	chr1:26563105	G/A	cg00938395	chr1:26633206	UBXN11	0.67	4.83	0.48	6.61e-6	Obesity-related traits;
SKCM	cis	rs1348850	0.632	rs11678875	chr2:178509068	A/G	cg02961200	chr2:178257176	LOC100130691;AGPS	0.74	4.97	0.49	3.9e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs2439831	0.850	rs28413704	chr15:44148427	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.3	6.97	0.62	9.12e-10	Lung cancer in ever smokers;
SKCM	cis	rs1577917	0.771	rs2475790	chr6:86368068	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-1.01	-11.41	-0.79	2.64e-18	Response to antipsychotic treatment;
SKCM	cis	rs870825	0.616	rs56844261	chr4:185632478	T/C	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs999943	0.846	rs9357162	chr6:33613344	G/A	cg14003231	chr6:33640908	ITPR3	0.67	6.11	0.57	3.64e-8	Obesity (extreme);
SKCM	cis	rs2404602	0.692	rs72738889	chr15:76992063	G/A	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs1799949	1.000	rs72829113	chr17:41181835	C/T	cg05368731	chr17:41323189	NBR1	0.86	7.39	0.64	1.39e-10	Menopause (age at onset);
SKCM	cis	rs701145	0.585	rs1727919	chr3:153788757	G/A	cg17054900	chr3:154042577	DHX36	1.18	5.21	0.51	1.51e-6	Coronary artery disease;
SKCM	cis	rs35306767	0.953	rs35693858	chr10:979813	C/T	cg26597838	chr10:835615	NA	0.62	4.96	0.49	3.97e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs4727027	0.866	rs10435245	chr7:148816081	C/G	cg23583168	chr7:148888333	NA	-0.84	-6.88	-0.61	1.35e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs9513627	1.000	rs7317126	chr13:100119739	T/A	cg11288260	chr13:100117058	NA	-0.75	-4.98	-0.49	3.69e-6	Obesity-related traits;
SKCM	cis	rs7666738	0.830	rs13119913	chr4:98977983	G/T	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs919433	0.662	rs2043018	chr2:198236958	G/A	cg04278110	chr2:198063759	ANKRD44	0.74	5.13	0.5	2.06e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs3789045	0.774	rs898388	chr1:204500257	C/T	cg17419461	chr1:204415978	PIK3C2B	-0.84	-5.85	-0.55	1.11e-7	Educational attainment (college completion);
SKCM	cis	rs9911578	1.000	rs11869828	chr17:56609525	G/A	cg12560992	chr17:57184187	TRIM37	-0.96	-7.74	-0.66	2.95e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs7772486	0.875	rs9403768	chr6:146406458	A/C	cg23711669	chr6:146136114	FBXO30	0.85	8.48	0.69	1.09e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2204008	0.837	rs7308714	chr12:38274307	T/C	cg26384229	chr12:38710491	ALG10B	0.87	6.83	0.61	1.63e-9	Bladder cancer;
SKCM	cis	rs6951245	1.000	rs79443843	chr7:1075245	G/A	cg24642844	chr7:1081250	C7orf50	-0.94	-6.32	-0.58	1.48e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7296418	0.922	rs1727293	chr12:123648032	C/T	cg05973401	chr12:123451056	ABCB9	0.81	6.39	0.59	1.13e-8	Platelet count;
SKCM	cis	rs7786877	1.000	rs7786877	chr7:100214015	A/G	cg16850897	chr7:100343110	ZAN	-0.68	-5.57	-0.53	3.48e-7	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs9788682	1.000	rs12438181	chr15:78812098	G/A	cg06917634	chr15:78832804	PSMA4	-0.91	-5.67	-0.54	2.32e-7	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs116095464	0.558	rs9687621	chr5:229194	C/T	cg22496380	chr5:211416	CCDC127	-1.0	-5.06	-0.5	2.7e-6	Breast cancer;
SKCM	cis	rs1801251	1.000	rs71421663	chr2:233619131	A/G	cg08000102	chr2:233561755	GIGYF2	0.87	7.05	0.62	6.23e-10	Coronary artery disease;
SKCM	cis	rs7824557	0.545	rs2572450	chr8:11229638	C/T	cg21775007	chr8:11205619	TDH	-0.65	-5.35	-0.52	8.44e-7	Retinal vascular caliber;
SKCM	cis	rs7772486	0.875	rs9403764	chr6:146360582	G/A	cg23711669	chr6:146136114	FBXO30	0.77	7.48	0.65	9.65e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1348850	0.632	rs10167783	chr2:178519041	G/A	cg02961200	chr2:178257176	LOC100130691;AGPS	0.74	4.97	0.49	3.9e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs9916302	0.784	rs4795382	chr17:37700860	A/G	cg07936489	chr17:37558343	FBXL20	-0.9	-8.11	-0.68	5.65e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs2991971	0.729	rs10890328	chr1:45905383	G/T	cg24296786	chr1:45957014	TESK2	-0.66	-5.29	-0.51	1.07e-6	High light scatter reticulocyte count;
SKCM	cis	rs2153535	0.580	rs7742689	chr6:8452433	C/A	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs28386778	0.562	rs721575	chr17:61782920	A/G	cg01411255	chr17:61851458	DDX42;CCDC47	-0.84	-6.12	-0.57	3.58e-8	Prudent dietary pattern;
SKCM	cis	rs17376456	0.877	rs10044139	chr5:93407803	T/C	cg25358565	chr5:93447407	FAM172A	1.22	7.9	0.67	1.49e-11	Diabetic retinopathy;
SKCM	cis	rs17381785	0.586	rs1874205	chr4:14971155	T/C	cg12377275	chr4:15005593	CPEB2	0.74	4.95	0.49	4.24e-6	Urate levels in overweight individuals;
SKCM	cis	rs9467773	1.000	rs9467797	chr6:26568473	A/T	cg09904177	chr6:26538194	HMGN4	0.54	4.91	0.49	4.97e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs3812762	0.868	rs7952335	chr11:8754031	A/G	cg21881798	chr11:8931708	C11orf17;ST5	0.52	4.77	0.48	8.51e-6	Hypospadias;
SKCM	cis	rs801193	0.591	rs2707839	chr7:66193084	A/G	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.51	4.93	0.49	4.45e-6	Aortic root size;
SKCM	cis	rs28386778	0.897	rs2727328	chr17:61923564	G/A	cg06873352	chr17:61820015	STRADA	0.73	6.3	0.58	1.67e-8	Prudent dietary pattern;
SKCM	cis	rs4268898	0.662	rs2891382	chr2:24511491	C/G	cg06627628	chr2:24431161	ITSN2	-0.96	-7.33	-0.64	1.83e-10	Asthma;
SKCM	cis	rs798554	0.757	rs1182185	chr7:2872233	A/G	cg19346786	chr7:2764209	NA	-0.63	-6.95	-0.62	9.84e-10	Height;
SKCM	cis	rs17685	0.712	rs6953342	chr7:75776753	T/C	cg01364799	chr7:75623366	TMEM120A	-0.65	-5.06	-0.5	2.73e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs9300255	0.739	rs1402275	chr12:123750895	A/G	cg05973401	chr12:123451056	ABCB9	0.85	6.01	0.56	5.69e-8	Neutrophil percentage of white cells;
SKCM	cis	rs9300255	0.537	rs10772993	chr12:123644714	A/G	cg05973401	chr12:123451056	ABCB9	0.78	5.29	0.51	1.09e-6	Neutrophil percentage of white cells;
SKCM	cis	rs870825	0.932	rs28594349	chr4:185574415	G/A	cg04058563	chr4:185651563	MLF1IP	1.03	5.09	0.5	2.4e-6	Blood protein levels;
SKCM	cis	rs1801251	0.896	rs7573208	chr2:233696701	C/A	cg08000102	chr2:233561755	GIGYF2	-0.79	-6.42	-0.59	9.71e-9	Coronary artery disease;
SKCM	cis	rs736408	0.812	rs2270197	chr3:52824095	T/G	cg11645453	chr3:52864694	ITIH4	0.58	4.92	0.49	4.71e-6	Bipolar disorder;
SKCM	cis	rs1799949	1.000	rs1399323	chr17:41332330	T/C	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.29	-0.58	1.73e-8	Menopause (age at onset);
SKCM	cis	rs10504073	0.584	rs60449482	chr8:49974865	G/A	cg00325661	chr8:49890786	NA	0.8	6.81	0.61	1.83e-9	Blood metabolite ratios;
SKCM	cis	rs1147199	0.585	rs1201364	chr9:87267378	C/T	cg13486759	chr9:86751815	NA	0.64	4.81	0.48	7.23e-6	Body mass index;
SKCM	cis	rs4803468	1.000	rs2241709	chr19:41912250	C/T	cg09537434	chr19:41945824	ATP5SL	-1.1	-13.82	-0.84	1.16e-22	Height;
SKCM	cis	rs514406	0.767	rs551591	chr1:53301876	A/G	cg24675658	chr1:53192096	ZYG11B	-0.82	-7.27	-0.64	2.35e-10	Monocyte count;
SKCM	cis	rs2836974	0.932	rs6517526	chr21:40581530	T/C	cg17971929	chr21:40555470	PSMG1	0.9	8.81	0.71	2.52e-13	Cognitive function;
SKCM	cis	rs7659604	0.702	rs6815790	chr4:122695385	A/C	cg19748678	chr4:122722346	EXOSC9	0.73	5.97	0.56	6.58e-8	Type 2 diabetes;
SKCM	cis	rs1843834	0.898	rs12623277	chr2:225548072	T/G	cg22455342	chr2:225449267	CUL3	0.62	4.86	0.48	5.97e-6	IgE levels in asthmatics (D.p. specific);
SKCM	cis	rs7618915	0.547	rs7642198	chr3:52677960	T/C	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs8067545	0.611	rs2703803	chr17:20107069	G/T	cg13482628	chr17:19912719	NA	-0.66	-5.5	-0.53	4.72e-7	Schizophrenia;
SKCM	cis	rs651907	0.557	rs1031710	chr3:101463895	C/T	cg12386194	chr3:101231763	SENP7	0.66	5.4	0.52	6.96e-7	Colorectal cancer;
SKCM	cis	rs1799949	0.965	rs8176087	chr17:41270666	C/A	cg05368731	chr17:41323189	NBR1	0.88	7.43	0.64	1.21e-10	Menopause (age at onset);
SKCM	cis	rs9926296	0.605	rs886952	chr16:89836781	G/A	cg27121462	chr16:89883253	FANCA	0.8	7.15	0.63	4.03e-10	Vitiligo;
SKCM	cis	rs801193	0.935	rs11772264	chr7:66176387	T/C	cg11987759	chr7:65425863	GUSB	-0.69	-5.91	-0.56	8.69e-8	Aortic root size;
SKCM	cis	rs6860806	0.507	rs272880	chr5:131670178	C/T	cg24060327	chr5:131705240	SLC22A5	-0.76	-4.94	-0.49	4.42e-6	Breast cancer;
SKCM	cis	rs12223324	0.654	rs10794338	chr11:746992	T/G	cg06073535	chr11:733406	NA	-0.73	-4.98	-0.49	3.66e-6	Fuchs's corneal dystrophy;
SKCM	cis	rs4073582	0.595	rs1151540	chr11:66041807	A/C	cg14036092	chr11:66035641	RAB1B	0.75	5.91	0.56	8.39e-8	Gout;
SKCM	cis	rs3785574	0.962	rs7215915	chr17:61828385	C/T	cg06601766	chr17:61851465	DDX42;CCDC47	0.64	4.77	0.48	8.35e-6	Height;
SKCM	cis	rs9914544	1.000	rs28436199	chr17:18751730	C/T	cg26378065	chr17:18585709	ZNF286B	0.71	4.8	0.48	7.54e-6	Educational attainment (years of education);
SKCM	cis	rs28595532	0.920	rs115294251	chr4:119772833	C/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs875971	0.862	rs1968126	chr7:66057004	A/G	cg18876405	chr7:65276391	NA	-0.63	-6.33	-0.58	1.43e-8	Aortic root size;
SKCM	cis	rs929354	0.772	rs3802124	chr7:156970609	G/A	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs271738	0.753	rs271742	chr1:234666319	T/C	cg00123090	chr1:234667087	NA	0.41	4.77	0.48	8.43e-6	Bipolar disorder;
SKCM	cis	rs34172651	0.517	rs35560136	chr16:24788915	T/A	cg04756594	chr16:24857601	SLC5A11	0.72	5.19	0.51	1.65e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs6062302	0.522	rs2297428	chr20:62221766	C/T	cg09650180	chr20:62225654	GMEB2	-0.77	-6.11	-0.57	3.64e-8	Glioblastoma;
SKCM	cis	rs6558174	0.965	rs2003908	chr8:22491518	T/C	cg03733263	chr8:22462867	KIAA1967	0.74	4.95	0.49	4.26e-6	Breast cancer;
SKCM	cis	rs1799949	1.000	rs8176083	chr17:41275151	G/C	cg23758822	chr17:41437982	NA	0.95	7.66	0.66	4.21e-11	Menopause (age at onset);
SKCM	cis	rs11098499	0.863	rs10013305	chr4:120450424	G/A	cg24375607	chr4:120327624	NA	0.68	5.27	0.51	1.16e-6	Corneal astigmatism;
SKCM	cis	rs10779751	0.734	rs2261317	chr1:11124979	A/G	cg08854313	chr1:11322531	MTOR	0.77	5.52	0.53	4.36e-7	Body mass index;
SKCM	cis	rs10791097	0.694	rs4457753	chr11:130755575	A/G	cg12179176	chr11:130786555	SNX19	0.91	8.24	0.68	3.24e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs801193	0.967	rs34356500	chr7:66236607	G/T	cg11764359	chr7:65958608	NA	0.82	6.05	0.57	4.71e-8	Aortic root size;
SKCM	cis	rs9300255	0.537	rs1716182	chr12:123686127	A/C	cg00376283	chr12:123451042	ABCB9	0.83	5.49	0.53	4.74e-7	Neutrophil percentage of white cells;
SKCM	cis	rs2072510	0.683	rs2246990	chr12:96427302	T/A	cg18817487	chr12:96390143	HAL	0.4	5.21	0.51	1.51e-6	Metabolite levels (small molecules and protein measures);
SKCM	cis	rs2228479	0.867	rs75110337	chr16:89962635	C/A	cg06558623	chr16:89946397	TCF25	1.26	6.97	0.62	9.17e-10	Skin colour saturation;
SKCM	cis	rs992157	0.775	rs7559428	chr2:219150238	A/G	cg00012203	chr2:219082015	ARPC2	-0.72	-5.71	-0.54	1.99e-7	Colorectal cancer;
SKCM	cis	rs4242434	0.672	rs900266	chr8:22485295	A/T	cg03733263	chr8:22462867	KIAA1967	0.87	6.55	0.6	5.58e-9	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs17376456	0.825	rs17314762	chr5:93231200	C/T	cg21475434	chr5:93447410	FAM172A	1.03	5.61	0.54	3e-7	Diabetic retinopathy;
SKCM	cis	rs995000	0.965	rs12047226	chr1:63105538	T/C	cg06896770	chr1:63153194	DOCK7	0.95	8.93	0.71	1.48e-13	Triglyceride levels;
SKCM	cis	rs826838	0.967	rs7299170	chr12:38789536	G/A	cg26384229	chr12:38710491	ALG10B	1.06	10.14	0.75	6.67e-16	Heart rate;
SKCM	cis	rs9399135	0.967	rs6919862	chr6:135352443	C/A	cg24558204	chr6:135376177	HBS1L	0.58	5.29	0.51	1.09e-6	Red blood cell count;
SKCM	cis	rs873946	0.648	rs12767283	chr10:134557094	C/G	cg26818010	chr10:134567672	INPP5A	-0.8	-6.13	-0.57	3.38e-8	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs6580649	0.941	rs11609399	chr12:48501161	A/T	cg05342945	chr12:48394962	COL2A1	0.8	5.44	0.52	5.98e-7	Lung cancer;
SKCM	cis	rs35306767	0.855	rs56222464	chr10:867535	C/G	cg20503657	chr10:835505	NA	0.79	5.87	0.55	1.02e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs7119	0.700	rs2867311	chr15:77902191	A/C	cg27398640	chr15:77910606	LINGO1	0.5	5.14	0.5	1.98e-6	Type 2 diabetes;
SKCM	cis	rs7772486	0.806	rs4243478	chr6:146284560	A/G	cg23711669	chr6:146136114	FBXO30	-0.77	-7.21	-0.63	3.08e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2050392	0.590	rs303433	chr10:30714963	A/T	cg25182066	chr10:30743637	MAP3K8	-0.66	-5.37	-0.52	7.75e-7	Inflammatory bowel disease;
SKCM	cis	rs9325144	0.555	rs4882279	chr12:38688918	C/A	cg26384229	chr12:38710491	ALG10B	0.78	6.74	0.61	2.48e-9	Morning vs. evening chronotype;
SKCM	cis	rs56104184	0.779	rs17206693	chr19:49360252	C/G	cg15549821	chr19:49342101	PLEKHA4	-1.23	-7.74	-0.66	3e-11	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs6545883	1.000	rs778762	chr2:61782921	G/T	cg15711740	chr2:61764176	XPO1	-0.71	-5.06	-0.5	2.69e-6	Tuberculosis;
SKCM	cis	rs6500602	0.701	rs4785969	chr16:4536934	A/T	cg08645402	chr16:4508243	NA	0.64	4.98	0.49	3.79e-6	Schizophrenia;
SKCM	cis	rs4819052	0.851	rs2255774	chr21:46683851	A/T	cg19498844	chr21:46707878	POFUT2;LOC642852	0.8	6.73	0.61	2.58e-9	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs875971	1.000	rs778696	chr7:65870813	C/G	cg18876405	chr7:65276391	NA	0.67	6.65	0.6	3.61e-9	Aortic root size;
SKCM	cis	rs694739	0.595	rs11606015	chr11:64136877	C/G	cg02228329	chr11:64053129	BAD;GPR137	0.87	6.15	0.57	3.03e-8	Alopecia areata;Crohn's disease;Psoriasis vulgaris;
SKCM	cis	rs8180040	0.764	rs11718795	chr3:47218727	G/A	cg27129171	chr3:47204927	SETD2	0.82	6.44	0.59	9.04e-9	Colorectal cancer;
SKCM	cis	rs34172651	0.583	rs200541	chr16:24733141	A/G	cg00339695	chr16:24857497	SLC5A11	-0.81	-6.52	-0.59	6.26e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs523522	0.962	rs3742052	chr12:120966921	A/G	cg12219531	chr12:120966889	COQ5	0.91	7.82	0.66	2.11e-11	High light scatter reticulocyte count;
SKCM	cis	rs2404602	0.716	rs12438077	chr15:76863601	T/C	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs7945705	0.818	rs2653613	chr11:8879105	C/T	cg21881798	chr11:8931708	C11orf17;ST5	-0.79	-8.13	-0.68	5.28e-12	Hemoglobin concentration;
SKCM	cis	rs12971120	0.947	rs8083001	chr18:72165058	A/G	cg26446133	chr18:72167187	CNDP2	-0.65	-5.48	-0.53	5.05e-7	Refractive error;
SKCM	cis	rs79839061	0.518	rs11734537	chr4:869174	A/G	cg07828340	chr4:882639	GAK	1.06	5.32	0.52	9.74e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs6570726	0.846	rs6899900	chr6:145883873	T/G	cg23711669	chr6:146136114	FBXO30	0.8	8.36	0.69	1.89e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4968361	0.892	rs58003080	chr17:57514957	A/G	cg02573089	chr17:57233042	PRR11;SKA2	1.18	5.16	0.5	1.81e-6	Schizophrenia;
SKCM	cis	rs1218582	0.744	rs6674853	chr1:154892753	G/C	cg24250549	chr1:154909240	PMVK	0.83	8.36	0.69	1.9e-12	Prostate cancer;
SKCM	cis	rs11098499	0.754	rs11724409	chr4:120252361	A/G	cg09307838	chr4:120376055	NA	0.91	7.36	0.64	1.63e-10	Corneal astigmatism;
SKCM	cis	rs1003719	0.788	rs2040341	chr21:38489753	T/C	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs9815354	0.812	rs766286	chr3:41838329	G/A	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs7927771	0.524	rs11039431	chr11:47872012	G/T	cg20307385	chr11:47447363	PSMC3	0.71	5.63	0.54	2.67e-7	Subjective well-being;
SKCM	cis	rs873946	0.586	rs12259688	chr10:134549628	A/G	cg26818010	chr10:134567672	INPP5A	-0.81	-6.34	-0.58	1.38e-8	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs951366	0.789	rs864783	chr1:205711974	T/C	cg07157834	chr1:205819609	PM20D1	0.82	7.17	0.63	3.7e-10	Menarche (age at onset);
SKCM	cis	rs3768617	0.510	rs4491025	chr1:183065183	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs9443189	0.570	rs659807	chr6:76293435	C/A	cg01950844	chr6:76311363	SENP6	0.99	6.23	0.58	2.22e-8	Prostate cancer;
SKCM	cis	rs344364	0.629	rs9806826	chr16:1894912	C/T	cg00490583	chr16:1843685	IGFALS	-0.5	-5.07	-0.5	2.58e-6	Glomerular filtration rate in chronic kidney disease;
SKCM	cis	rs10870270	1.000	rs10159746	chr10:133742677	C/T	cg17892150	chr10:133769511	PPP2R2D	-0.66	-4.89	-0.48	5.37e-6	Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals;
SKCM	cis	rs1707322	0.927	rs6690386	chr1:46253011	C/T	cg03146154	chr1:46216737	IPP	0.74	4.94	0.49	4.37e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs2228479	0.850	rs62054601	chr16:89811751	C/G	cg00800038	chr16:89945340	TCF25	-0.81	-4.79	-0.48	7.84e-6	Skin colour saturation;
SKCM	cis	rs10504229	0.817	rs60646469	chr8:58195348	T/C	cg22535103	chr8:58192502	C8orf71	-0.76	-5.07	-0.5	2.66e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs9435341	0.965	rs1335055	chr1:107624563	A/G	cg09367891	chr1:107599246	PRMT6	0.8	6.46	0.59	8.35e-9	Facial morphology (factor 21, depth of nasal alae);
SKCM	trans	rs1814175	0.817	rs10839358	chr11:49770972	G/A	cg03929089	chr4:120376271	NA	-0.9	-8.5	-0.69	9.91e-13	Height;
SKCM	cis	rs348196	0.562	rs34228076	chr1:155589792	G/T	cg02153340	chr1:155202674	NA	-0.74	-5.28	-0.51	1.14e-6	Breast cancer;
SKCM	cis	rs7937682	0.793	rs4581484	chr11:111415822	G/A	cg19812747	chr11:111475976	SIK2	0.6	5.35	0.52	8.68e-7	Primary sclerosing cholangitis;
SKCM	cis	rs8067545	0.750	rs36077949	chr17:19985782	C/T	cg13482628	chr17:19912719	NA	0.73	6.54	0.6	5.78e-9	Schizophrenia;
SKCM	cis	rs9910055	0.718	rs2526022	chr17:42213216	C/T	cg10896456	chr17:42255109	ASB16;C17orf65	0.66	6.39	0.59	1.12e-8	Total body bone mineral density;
SKCM	cis	rs9868809	0.505	rs28793701	chr3:48762683	C/G	cg00383909	chr3:49044727	WDR6	0.91	5.36	0.52	8.08e-7	Ulcerative colitis;Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs801193	0.569	rs2707847	chr7:66202871	C/G	cg11764359	chr7:65958608	NA	0.75	6.82	0.61	1.71e-9	Aortic root size;
SKCM	cis	rs96067	0.711	rs272811	chr1:36634414	G/A	cg24686825	chr1:36642396	MAP7D1	-0.77	-6.29	-0.58	1.69e-8	Corneal structure;
SKCM	cis	rs5753618	0.583	rs71324184	chr22:31752061	C/G	cg02404636	chr22:31891804	SFI1	0.56	4.88	0.48	5.44e-6	Colorectal cancer;
SKCM	cis	rs28595532	0.841	rs56388366	chr4:119769242	A/G	cg21605333	chr4:119757512	SEC24D	1.34	7.02	0.62	7.3e-10	Cannabis dependence symptom count;
SKCM	trans	rs11083271	0.590	rs62102107	chr18:25859375	C/T	cg00321150	chr11:62623587	SNORD27;SLC3A2;SNHG1;SNORD28;SNORD25;SNORD26	0.8	7.29	0.64	2.17e-10	Non-alcoholic fatty liver disease histology (lobular);
SKCM	cis	rs7811142	0.667	rs3873746	chr7:99935097	G/A	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.07	6.77	0.61	2.15e-9	Platelet count;
SKCM	cis	rs2404602	0.716	rs12592171	chr15:76755133	G/C	cg23625390	chr15:77176239	SCAPER	0.57	5.23	0.51	1.39e-6	Blood metabolite levels;
SKCM	cis	rs228769	1.000	rs228769	chr17:42193185	G/C	cg08499158	chr17:42289980	UBTF	0.87	6.24	0.58	2.11e-8	Bone mineral density (hip);Bone mineral density (spine);
SKCM	cis	rs10256972	0.552	rs2949195	chr7:1202705	G/A	cg07092213	chr7:1199455	ZFAND2A	-0.66	-5.52	-0.53	4.21e-7	Longevity;Endometriosis;
SKCM	cis	rs1707322	1.000	rs785486	chr1:46575148	G/C	cg03146154	chr1:46216737	IPP	-0.81	-5.43	-0.52	6.11e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs9467773	1.000	rs9461271	chr6:26554968	G/A	cg15659132	chr6:26577336	NA	0.6	5.71	0.54	1.99e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7111031	1.000	rs17602038	chr11:113364691	T/C	cg04642306	chr11:112834466	NCAM1	-0.45	-4.92	-0.49	4.63e-6	Subjective well-being (multi-trait analysis);Depressive symptoms (multi-trait analysis);Neuroticism;
SKCM	cis	rs4891159	0.790	rs72975930	chr18:74144645	G/A	cg24786174	chr18:74118243	ZNF516	-0.75	-6.95	-0.62	9.71e-10	Longevity;
SKCM	cis	rs3784262	0.669	rs4646597	chr15:58300768	G/A	cg12031962	chr15:58353849	ALDH1A2	-0.41	-4.82	-0.48	6.93e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	trans	rs312274	0.630	rs1822599	chr12:41231299	T/C	cg13470333	chr7:1908714	MAD1L1	0.67	7.77	0.66	2.67e-11	Metabolite levels  (X-11787);
SKCM	cis	rs16949788	1.000	rs76847935	chr15:66769613	G/A	cg08120210	chr15:66682733	MAP2K1	-0.74	-5.69	-0.54	2.1e-7	Spherical equivalent (joint analysis main effects and education interaction);
SKCM	cis	rs7811142	1.000	rs2406253	chr7:100077273	A/G	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.23	7.89	0.67	1.53e-11	Platelet count;
SKCM	cis	rs4974559	0.790	rs5019560	chr4:1324793	G/A	cg02980000	chr4:1222292	CTBP1	0.91	5.65	0.54	2.51e-7	Systolic blood pressure;
SKCM	cis	rs8170	0.603	rs4808621	chr19:17414267	C/T	cg07830086	chr19:18107778	KCNN1	-0.82	-5.17	-0.51	1.77e-6	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Ovarian cancer;Breast cancer;Epithelial ovarian cancer;
SKCM	cis	rs1124769	0.599	rs57262951	chr15:51080738	T/A	cg21246271	chr15:51200259	AP4E1	-0.74	-4.77	-0.47	8.55e-6	Cognitive performance;
SKCM	cis	rs826838	0.935	rs11168761	chr12:38997211	C/A	cg13010199	chr12:38710504	ALG10B	0.78	6.13	0.57	3.37e-8	Heart rate;
SKCM	cis	rs7666738	0.830	rs3846445	chr4:99032939	T/A	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs3020736	0.500	rs5996109	chr22:42493098	A/G	cg04733989	chr22:42467013	NAGA	-0.72	-5.62	-0.54	2.87e-7	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs9467773	1.000	rs10484442	chr6:26555879	A/G	cg15659132	chr6:26577336	NA	0.6	5.71	0.54	1.99e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs9300255	0.770	rs28683528	chr12:123845351	C/T	cg00376283	chr12:123451042	ABCB9	-0.78	-5.26	-0.51	1.24e-6	Neutrophil percentage of white cells;
SKCM	cis	rs12824058	0.831	rs7979497	chr12:130804706	C/T	cg26677194	chr12:130822605	PIWIL1	0.71	5.67	0.54	2.29e-7	Menopause (age at onset);
SKCM	cis	rs6121246	0.909	rs6060923	chr20:30336655	A/C	cg11595048	chr20:30225325	COX4I2	0.67	5.21	0.51	1.5e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs875971	1.000	rs7792762	chr7:66004138	T/C	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.52	5.03	0.49	3.12e-6	Aortic root size;
SKCM	cis	rs561341	1.000	rs4795668	chr17:30244554	G/A	cg23018236	chr17:30244563	NA	-0.48	-4.99	-0.49	3.64e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs875971	1.000	rs6961155	chr7:65933295	T/C	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	cis	rs1153858	0.943	rs7402632	chr15:45701913	A/T	cg21132104	chr15:45694354	SPATA5L1	0.89	7.21	0.63	3.12e-10	Homoarginine levels;
SKCM	cis	rs62064224	0.703	rs62065493	chr17:30822620	C/G	cg25809561	chr17:30822961	MYO1D	0.68	5.9	0.56	8.72e-8	Schizophrenia;
SKCM	cis	rs2832191	0.740	rs2832175	chr21:30475606	A/G	cg08807101	chr21:30365312	RNF160	-0.74	-6.09	-0.57	4.06e-8	Dental caries;
SKCM	cis	rs951366	0.589	rs823099	chr1:205669322	C/A	cg14159672	chr1:205819179	PM20D1	0.81	6.5	0.59	6.79e-9	Menarche (age at onset);
SKCM	cis	rs867186	1.000	rs2889873	chr20:33646841	G/A	cg04194272	chr20:33683537	NA	-1.38	-7.2	-0.63	3.29e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs76788097	0.614	rs7151034	chr14:61820669	T/G	cg13695076	chr14:61225294	MNAT1	-0.88	-4.87	-0.48	5.7e-6	Marginal zone lymphoma;
SKCM	cis	rs9910055	0.659	rs7216294	chr17:42251095	T/C	cg19774624	chr17:42201019	HDAC5	-0.87	-8.15	-0.68	4.72e-12	Total body bone mineral density;
SKCM	cis	rs5753618	0.504	rs9609329	chr22:31966313	A/C	cg02404636	chr22:31891804	SFI1	0.68	6.07	0.57	4.29e-8	Colorectal cancer;
SKCM	trans	rs66573146	1.000	rs55672215	chr4:6970529	T/C	cg07817883	chr1:32538562	TMEM39B	1.94	8.42	0.69	1.47e-12	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs9926296	0.712	rs2437957	chr16:89715648	G/A	cg01097406	chr16:89675127	NA	0.56	5.67	0.54	2.31e-7	Vitiligo;
SKCM	cis	rs7666738	0.753	rs6826709	chr4:98714553	C/G	cg17366294	chr4:99064904	C4orf37	0.58	5.11	0.5	2.2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6500395	1.000	rs3848321	chr16:48620780	A/T	cg04672837	chr16:48644449	N4BP1	0.69	5.88	0.55	9.68e-8	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs3785574	0.962	rs114027117	chr17:61939935	T/A	cg01411255	chr17:61851458	DDX42;CCDC47	1.14	11.45	0.79	2.28e-18	Height;
SKCM	cis	rs13108904	0.901	rs12509700	chr4:1296321	A/G	cg05665937	chr4:1216051	CTBP1	0.57	4.99	0.49	3.64e-6	Obesity-related traits;
SKCM	cis	rs933688	0.941	rs6452954	chr5:90735692	G/A	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.07	8.69	0.7	4.41e-13	Smoking behavior;
SKCM	cis	rs9911578	0.933	rs74370218	chr17:57095212	C/T	cg12560992	chr17:57184187	TRIM37	-1.09	-10.13	-0.75	7.02e-16	Intelligence (multi-trait analysis);
SKCM	cis	rs7666738	0.830	rs9999200	chr4:99030690	A/C	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7772486	0.743	rs2092262	chr6:146037105	C/T	cg23711669	chr6:146136114	FBXO30	-0.77	-7.51	-0.65	8.49e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs875971	0.965	rs6971509	chr7:65714970	G/T	cg18876405	chr7:65276391	NA	-0.68	-6.8	-0.61	1.91e-9	Aortic root size;
SKCM	cis	rs1577917	0.839	rs6454492	chr6:86483214	A/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.67	-5.87	-0.55	1.03e-7	Response to antipsychotic treatment;
SKCM	cis	rs4819052	0.851	rs4819040	chr21:46659762	T/C	cg19498844	chr21:46707878	POFUT2;LOC642852	0.84	7.1	0.63	5.13e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs362296	0.698	rs362282	chr4:3259671	G/A	cg05297308	chr4:3317976	RGS12	-0.75	-6.12	-0.57	3.58e-8	Parental longevity (mother's age at death);
SKCM	cis	rs7786877	0.723	rs7812235	chr7:100211486	G/C	cg16850897	chr7:100343110	ZAN	-0.67	-5.0	-0.49	3.42e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs9300255	0.596	rs10732573	chr12:123743883	G/C	cg05973401	chr12:123451056	ABCB9	0.75	5.83	0.55	1.18e-7	Neutrophil percentage of white cells;
SKCM	cis	rs644799	0.710	rs12272061	chr11:95524067	G/T	cg03916912	chr11:95522834	CEP57;FAM76B	0.8	6.71	0.6	2.8e-9	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs9916302	0.904	rs12952384	chr17:37669536	T/C	cg07936489	chr17:37558343	FBXL20	-0.9	-8.11	-0.68	5.65e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs4253772	0.513	rs6008700	chr22:46722560	C/T	cg03482458	chr22:46692211	CN5H6.4;GTSE1	1.2	5.62	0.54	2.85e-7	LDL cholesterol;Cholesterol, total;
SKCM	cis	rs7937682	0.921	rs11213940	chr11:111433927	C/A	cg22437258	chr11:111473054	SIK2	-0.71	-5.15	-0.5	1.88e-6	Primary sclerosing cholangitis;
SKCM	cis	rs56235845	0.685	rs35630910	chr5:176757841	A/C	cg16006841	chr5:176797999	RGS14	0.78	6.98	0.62	8.74e-10	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs875971	0.755	rs76288834	chr7:66069802	G/A	cg11764359	chr7:65958608	NA	-0.74	-6.63	-0.6	3.89e-9	Aortic root size;
SKCM	cis	rs208520	1.000	rs208535	chr6:66962286	G/A	cg07460842	chr6:66804631	NA	-0.84	-5.89	-0.55	9.44e-8	Exhaled nitric oxide output;
SKCM	cis	rs1577917	0.876	rs12212808	chr6:86533972	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.81	-0.66	2.19e-11	Response to antipsychotic treatment;
SKCM	cis	rs3793683	0.545	rs12784407	chr10:134589631	A/G	cg27286337	chr10:134555280	INPP5A	0.97	8.94	0.71	1.4e-13	Migraine;
SKCM	cis	rs561341	1.000	rs56903735	chr17:30254393	T/A	cg23018236	chr17:30244563	NA	-0.53	-5.27	-0.51	1.18e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs838147	0.545	rs281394	chr19:49223019	C/G	cg13540341	chr19:49222985	MAMSTR	0.6	5.78	0.55	1.46e-7	Dietary macronutrient intake;
SKCM	cis	rs8060686	0.641	rs7190079	chr16:68073834	G/A	cg09117114	chr16:67998030	SLC12A4	-0.78	-5.06	-0.5	2.72e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs4332037	0.510	rs11762803	chr7:1886805	A/G	cg23422044	chr7:1970798	MAD1L1	-0.85	-5.83	-0.55	1.18e-7	Bipolar disorder;
SKCM	cis	rs7824557	0.767	rs6991606	chr8:11176159	G/A	cg21775007	chr8:11205619	TDH	0.7	5.93	0.56	7.85e-8	Retinal vascular caliber;
SKCM	cis	rs3008870	1.000	rs12041926	chr1:67434602	A/G	cg08660285	chr1:67390436	MIER1;WDR78	0.92	6.07	0.57	4.27e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs703842	1.000	rs10747783	chr12:58176614	T/C	cg04478727	chr12:58166393	METTL1;FAM119B	0.73	5.84	0.55	1.15e-7	Multiple sclerosis;
SKCM	cis	rs7143963	0.609	rs57521303	chr14:103361937	T/C	cg23020514	chr14:103360112	TRAF3	0.7	6.83	0.61	1.67e-9	Body mass index;
SKCM	cis	rs12611334	0.929	rs56205202	chr19:40193750	A/G	cg04998674	chr19:40596855	ZNF780A	0.63	4.77	0.47	8.55e-6	Schizophrenia;
SKCM	cis	rs2404602	0.583	rs2456076	chr15:76557553	T/G	cg23625390	chr15:77176239	SCAPER	-0.69	-6.31	-0.58	1.57e-8	Blood metabolite levels;
SKCM	cis	rs2228479	0.850	rs11648689	chr16:89806732	G/A	cg00800038	chr16:89945340	TCF25	-0.81	-4.79	-0.48	7.84e-6	Skin colour saturation;
SKCM	trans	rs208520	0.526	rs7771233	chr6:66819784	A/G	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-1.04	-11.41	-0.79	2.63e-18	Exhaled nitric oxide output;
SKCM	cis	rs9300255	0.602	rs1616181	chr12:123619856	T/A	cg00376283	chr12:123451042	ABCB9	0.82	5.61	0.54	3e-7	Neutrophil percentage of white cells;
SKCM	trans	rs1814175	0.615	rs10839378	chr11:49806943	C/T	cg15704280	chr7:45808275	SEPT13	-0.93	-8.6	-0.7	6.36e-13	Height;
SKCM	cis	rs6500395	1.000	rs1420701	chr16:48730873	C/T	cg04672837	chr16:48644449	N4BP1	-0.63	-5.37	-0.52	8.01e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs1029738	0.659	rs1608553	chr7:22896231	G/C	cg22407942	chr7:22894828	SNORD93	-0.56	-5.02	-0.49	3.17e-6	Fibrinogen levels;
SKCM	cis	rs11717455	1.000	rs3922578	chr3:38861122	A/G	cg15678707	chr3:39149194	GORASP1;TTC21A	-0.84	-5.12	-0.5	2.12e-6	Systemic lupus erythematosus;
SKCM	cis	rs2839186	0.564	rs4819215	chr21:47623573	G/A	cg13012494	chr21:47604986	C21orf56	0.69	6.16	0.57	2.91e-8	Testicular germ cell tumor;
SKCM	cis	rs7208859	0.623	rs8067338	chr17:29102345	T/C	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs644799	0.965	rs10831430	chr11:95509638	T/C	cg25622487	chr11:95524042	FAM76B;CEP57	0.74	5.92	0.56	8.06e-8	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs2243480	0.706	rs34466769	chr7:65453292	A/C	cg18252515	chr7:66147081	NA	-1.22	-7.73	-0.66	3.11e-11	Diabetic kidney disease;
SKCM	cis	rs2836974	0.897	rs2836923	chr21:40524236	T/C	cg17971929	chr21:40555470	PSMG1	0.88	8.3	0.68	2.49e-12	Cognitive function;
SKCM	trans	rs9898058	0.545	rs1981705	chr17:47699153	T/C	cg25281849	chr7:127409937	SND1	1.14	7.68	0.66	3.98e-11	Milk allergy;
SKCM	cis	rs875971	1.000	rs6460296	chr7:65895139	C/T	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	cis	rs17376456	0.877	rs10476599	chr5:93383423	A/G	cg25358565	chr5:93447407	FAM172A	1.19	7.67	0.66	4.06e-11	Diabetic retinopathy;
SKCM	cis	rs2204008	0.641	rs66876045	chr12:38205713	G/A	cg26384229	chr12:38710491	ALG10B	0.82	6.58	0.6	4.87e-9	Bladder cancer;
SKCM	cis	rs10479542	0.784	rs6601050	chr5:178986261	C/G	cg09060608	chr5:178986726	RUFY1	-0.49	-4.91	-0.49	4.99e-6	Lung cancer;
SKCM	cis	rs1160297	0.609	rs1839770	chr2:53104091	G/A	cg07782112	chr2:53107842	NA	0.59	6.13	0.57	3.31e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs1506636	1.000	rs2896332	chr7:123297223	A/T	cg03229431	chr7:123269106	ASB15	-0.64	-5.18	-0.51	1.7e-6	Plateletcrit;Platelet count;
SKCM	cis	rs8060686	0.641	rs8047119	chr16:68047345	G/C	cg09117114	chr16:67998030	SLC12A4	-0.78	-5.06	-0.5	2.72e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs6089829	0.962	rs2314130	chr20:61665129	G/T	cg08564027	chr20:61660810	NA	0.63	5.65	0.54	2.56e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs6570726	0.846	rs1935616	chr6:145943512	C/T	cg05347473	chr6:146136440	FBXO30	0.57	5.19	0.51	1.61e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs561341	1.000	rs8077092	chr17:30281992	T/C	cg23018236	chr17:30244563	NA	-0.53	-5.38	-0.52	7.6e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs7772486	0.790	rs6570724	chr6:146151283	T/C	cg23711669	chr6:146136114	FBXO30	0.86	9.38	0.73	1.95e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs929354	0.742	rs7806775	chr7:156947199	A/G	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs17685	0.725	rs7795291	chr7:75725206	C/A	cg16489192	chr7:75678113	MDH2;STYXL1	-0.61	-5.55	-0.53	3.73e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs6570726	0.875	rs1883407	chr6:145823432	T/C	cg23711669	chr6:146136114	FBXO30	0.71	6.9	0.62	1.21e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4819052	0.851	rs2838855	chr21:46680566	C/G	cg02159808	chr21:46707872	POFUT2;LOC642852	-0.75	-5.99	-0.56	6.11e-8	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs4927850	0.752	rs7618864	chr3:195749561	G/A	cg12923728	chr3:195709715	SDHAP1	-0.88	-7.24	-0.63	2.8e-10	Pancreatic cancer;
SKCM	cis	rs11690935	0.655	rs12997093	chr2:172564438	A/G	cg13550731	chr2:172543902	DYNC1I2	0.62	5.36	0.52	8.35e-7	Schizophrenia;
SKCM	cis	rs2688482	0.512	rs3103953	chr3:195520597	G/A	cg11598736	chr3:195384522	SDHAP2	-1.0	-5.58	-0.53	3.31e-7	Lung disease severity in cystic fibrosis;
SKCM	cis	rs9611565	0.512	rs5758439	chr22:42131762	C/T	cg03806693	chr22:41940476	POLR3H	1.15	7.18	0.63	3.65e-10	Vitiligo;
SKCM	cis	rs1395	0.922	rs11693052	chr2:27484620	A/G	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.47	4.77	0.48	8.27e-6	Blood metabolite levels;
SKCM	cis	rs875971	0.660	rs1860468	chr7:66107252	T/C	cg11987759	chr7:65425863	GUSB	0.67	5.8	0.55	1.36e-7	Aortic root size;
SKCM	cis	rs854765	0.663	rs12941550	chr17:17753828	C/A	cg24612305	chr17:17875800	TOM1L2;LRRC48	-1.03	-7.53	-0.65	7.57e-11	Total body bone mineral density;
SKCM	cis	rs2153535	0.580	rs2225766	chr6:8481833	G/A	cg07606381	chr6:8435919	SLC35B3	0.86	6.25	0.58	2.06e-8	Motion sickness;
SKCM	cis	rs6062302	0.522	rs2282157	chr20:62227180	C/G	cg09650180	chr20:62225654	GMEB2	-0.77	-6.11	-0.57	3.64e-8	Glioblastoma;
SKCM	cis	rs2836974	1.000	rs2836974	chr21:40663181	A/G	cg11644478	chr21:40555479	PSMG1	-0.83	-7.69	-0.66	3.66e-11	Cognitive function;
SKCM	cis	rs28595532	0.920	rs56042726	chr4:119751777	T/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs941408	0.515	rs56000942	chr19:2774104	G/C	cg06609049	chr19:2785107	THOP1	1.08	9.68	0.74	5.15e-15	Total cholesterol levels;
SKCM	cis	rs1799949	0.930	rs35292991	chr17:41334016	C/A	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.29	-0.58	1.73e-8	Menopause (age at onset);
SKCM	cis	rs7296418	0.883	rs1727312	chr12:123642220	G/T	cg06742321	chr12:123595122	PITPNM2	0.66	5.38	0.52	7.49e-7	Platelet count;
SKCM	cis	rs9635963	0.798	rs67692014	chr18:21763275	C/T	cg14416559	chr18:21719381	CABYR	0.72	5.27	0.51	1.18e-6	Protein quantitative trait loci;
SKCM	cis	rs597539	0.690	rs608810	chr11:68624118	G/C	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.81	5.33	0.52	9.43e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs477895	0.938	rs28395875	chr11:64024048	G/C	cg02228329	chr11:64053129	BAD;GPR137	-1.12	-4.9	-0.49	5.09e-6	Mean platelet volume;
SKCM	cis	rs11025559	0.812	rs10833336	chr11:20514288	C/G	cg19653624	chr11:20408972	PRMT3	-0.75	-4.97	-0.49	3.89e-6	Pursuit maintenance gain;
SKCM	cis	rs67311347	1.000	rs9849992	chr3:40402140	C/T	cg00091569	chr3:40428383	ENTPD3	0.65	5.58	0.53	3.36e-7	Renal cell carcinoma;
SKCM	cis	rs9303401	0.659	rs17822735	chr17:56620167	C/T	cg10487724	chr17:56770010	TEX14;RAD51C	0.84	6.18	0.57	2.74e-8	Cognitive test performance;
SKCM	cis	rs875971	0.638	rs6960778	chr7:66071597	C/T	cg11987759	chr7:65425863	GUSB	0.68	5.8	0.55	1.34e-7	Aortic root size;
SKCM	cis	rs875971	0.505	rs1167385	chr7:65513308	G/A	cg00343986	chr7:65444356	GUSB	-0.66	-4.81	-0.48	7.33e-6	Aortic root size;
SKCM	cis	rs10779751	0.770	rs10864490	chr1:11236410	A/C	cg08854313	chr1:11322531	MTOR	0.86	5.97	0.56	6.62e-8	Body mass index;
SKCM	cis	rs684232	0.623	rs12601935	chr17:519325	G/A	cg15660573	chr17:549704	VPS53	-0.75	-5.83	-0.55	1.18e-7	Prostate cancer;
SKCM	cis	rs3096299	0.933	rs3114848	chr16:89452771	G/A	cg02187348	chr16:89574699	SPG7	0.63	5.0	0.49	3.41e-6	Multiple myeloma (IgH translocation);
SKCM	cis	rs763014	0.898	rs4984892	chr16:622325	A/G	cg07343612	chr16:622815	PIGQ	-0.69	-5.73	-0.54	1.84e-7	Height;
SKCM	cis	rs28595532	0.920	rs114724233	chr4:119754918	T/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs6121246	0.559	rs6058468	chr20:30406448	C/A	cg13852791	chr20:30311386	BCL2L1	0.82	5.69	0.54	2.09e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs1029738	0.659	rs1608553	chr7:22896231	G/C	cg06980547	chr7:22894557	NA	-0.61	-5.15	-0.5	1.88e-6	Fibrinogen levels;
SKCM	cis	rs7917772	0.503	rs6584510	chr10:104299868	T/G	cg11453585	chr10:104263688	ACTR1A;SUFU	0.78	6.33	0.58	1.47e-8	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs34172651	0.517	rs11862923	chr16:24767303	G/T	cg04756594	chr16:24857601	SLC5A11	0.72	5.19	0.51	1.65e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2303745	0.589	rs10401700	chr19:17397700	A/C	cg04248312	chr19:17393744	ANKLE1	-1.11	-8.18	-0.68	4.15e-12	Systemic lupus erythematosus;
SKCM	cis	rs798766	1.000	rs1665366	chr4:1728381	A/G	cg24239225	chr4:1659016	FAM53A	0.68	4.78	0.48	8.21e-6	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs35306767	0.715	rs11253550	chr10:1028288	C/G	cg20503657	chr10:835505	NA	0.75	5.94	0.56	7.41e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs62238980	0.614	rs4820066	chr22:32409269	T/C	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs861020	0.606	rs657844	chr1:210006873	T/G	cg05527609	chr1:210001259	C1orf107	0.86	6.74	0.61	2.43e-9	Orofacial clefts;
SKCM	cis	rs10751667	0.714	rs7396700	chr11:963863	A/C	cg10932868	chr11:921992	NA	0.55	5.1	0.5	2.36e-6	Alzheimer's disease (late onset);
SKCM	cis	rs28386778	0.830	rs2665841	chr17:61861219	A/T	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs17685	0.753	rs6951808	chr7:75772413	A/G	cg16684958	chr7:75615977	POR	0.52	5.03	0.49	3.11e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	trans	rs12599106	0.680	rs34728702	chr16:34896584	A/G	cg15383120	chr6:291909	DUSP22	-0.75	-7.36	-0.64	1.6e-10	Menopause (age at onset);
SKCM	cis	rs1559088	0.600	rs7255229	chr19:33562807	A/G	cg27124370	chr19:33622961	WDR88	0.83	6.0	0.56	5.76e-8	Bone ultrasound measurement (broadband ultrasound attenuation);
SKCM	cis	rs801193	1.000	rs4717319	chr7:66242593	A/G	cg11987759	chr7:65425863	GUSB	-0.67	-5.8	-0.55	1.35e-7	Aortic root size;
SKCM	cis	rs2811415	0.597	rs10934839	chr3:127745539	T/C	cg09089421	chr3:127803668	RUVBL1	0.99	8.52	0.69	9.09e-13	Lung function (FEV1/FVC);
SKCM	cis	rs2361718	0.500	rs8068856	chr17:78100731	A/G	cg09238746	chr17:78121135	EIF4A3	-0.89	-6.35	-0.58	1.3e-8	Yeast infection;
SKCM	cis	rs7940866	0.774	rs2162059	chr11:130831224	C/T	cg12179176	chr11:130786555	SNX19	0.81	6.66	0.6	3.46e-9	Schizophrenia;
SKCM	cis	rs950776	0.722	rs471889	chr15:78870235	T/C	cg06917634	chr15:78832804	PSMA4	-0.85	-6.83	-0.61	1.68e-9	Sudden cardiac arrest;
SKCM	cis	rs362272	0.545	rs2749785	chr4:3325179	G/C	cg11471262	chr4:3318911	RGS12	0.95	10.77	0.77	4.36e-17	Serum sulfate level;
SKCM	cis	rs2204008	0.837	rs11181857	chr12:38413255	C/G	cg26384229	chr12:38710491	ALG10B	0.82	6.3	0.58	1.6e-8	Bladder cancer;
SKCM	cis	rs6952808	0.798	rs28970524	chr7:1927484	C/T	cg05863683	chr7:1912471	MAD1L1	0.64	5.76	0.55	1.61e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs7122539	0.603	rs508443	chr11:66509369	C/T	cg12372692	chr11:66233905	PELI3	0.73	5.5	0.53	4.56e-7	HIV-1 susceptibility;
SKCM	cis	rs1878931	0.535	rs55732163	chr16:3411518	A/C	cg26668626	chr16:3451006	ZNF174;ZNF434	-0.76	-5.41	-0.52	6.74e-7	Body mass index (adult);
SKCM	cis	rs17685	0.535	rs41296542	chr7:75600008	A/G	cg01364799	chr7:75623366	TMEM120A	-0.81	-5.67	-0.54	2.3e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1801251	1.000	rs1801251	chr2:233633460	G/A	cg25237894	chr2:233734115	C2orf82	0.59	5.66	0.54	2.45e-7	Coronary artery disease;
SKCM	cis	rs9611565	0.559	rs5751160	chr22:42175695	A/G	cg03806693	chr22:41940476	POLR3H	1.2	7.59	0.65	5.96e-11	Vitiligo;
SKCM	cis	rs6461049	0.765	rs4719432	chr7:2140330	A/G	cg02951883	chr7:2050386	MAD1L1	-0.81	-7.83	-0.66	2.01e-11	Schizophrenia;
SKCM	cis	rs10504229	0.953	rs115634610	chr8:58190533	G/A	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs16854884	0.657	rs6778627	chr3:143720869	G/T	cg06585982	chr3:143692056	C3orf58	0.87	8.11	0.68	5.72e-12	Economic and political preferences (feminism/equality);
SKCM	cis	rs8180040	0.966	rs11710322	chr3:47331136	C/T	cg27129171	chr3:47204927	SETD2	-0.86	-6.85	-0.61	1.49e-9	Colorectal cancer;
SKCM	cis	rs2739330	0.752	rs2330634	chr22:24250795	C/G	cg12419862	chr22:24373484	LOC391322	-0.69	-6.27	-0.58	1.85e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs801193	0.904	rs4718405	chr7:66254646	A/G	cg11764359	chr7:65958608	NA	0.84	6.37	0.59	1.2e-8	Aortic root size;
SKCM	cis	rs9467773	1.000	rs9467791	chr6:26562486	A/G	cg09904177	chr6:26538194	HMGN4	-0.54	-4.95	-0.49	4.15e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2832191	0.791	rs2832187	chr21:30485543	T/C	cg24692254	chr21:30365293	RNF160	-0.9	-8.03	-0.67	8.39e-12	Dental caries;
SKCM	cis	rs595982	0.661	rs606400	chr19:49371498	T/C	cg19746536	chr19:49375674	PPP1R15A	1.25	15.1	0.86	7.41e-25	Red cell distribution width;
SKCM	cis	rs4423214	0.802	rs4616066	chr11:71183846	G/A	cg05163923	chr11:71159392	DHCR7	-0.71	-6.07	-0.57	4.35e-8	Vitamin D levels;
SKCM	cis	rs8017423	0.669	rs7153190	chr14:90703904	T/G	cg04374321	chr14:90722782	PSMC1	0.95	8.48	0.69	1.13e-12	Mortality in heart failure;
SKCM	cis	rs11098499	0.909	rs7681978	chr4:120383775	T/C	cg24375607	chr4:120327624	NA	0.67	5.3	0.51	1.06e-6	Corneal astigmatism;
SKCM	cis	rs208520	0.586	rs208442	chr6:66900618	T/A	cg07460842	chr6:66804631	NA	-0.78	-6.02	-0.56	5.32e-8	Exhaled nitric oxide output;
SKCM	cis	rs514406	0.929	rs483073	chr1:53314084	T/C	cg16325326	chr1:53192061	ZYG11B	0.93	9.96	0.75	1.48e-15	Monocyte count;
SKCM	cis	rs7178909	0.872	rs28865973	chr15:90435178	T/G	cg19708238	chr15:90437601	AP3S2	0.72	5.22	0.51	1.43e-6	Common traits (Other);
SKCM	cis	rs17765925	0.605	rs13241742	chr7:14267195	T/C	cg11279021	chr7:14028690	ETV1	0.52	4.82	0.48	6.95e-6	Verbal declarative memory;
SKCM	cis	rs2749592	0.550	rs12255038	chr10:37869332	T/C	cg00409905	chr10:38381863	ZNF37A	0.6	5.52	0.53	4.31e-7	Age-related hearing impairment (SNP x SNP interaction);
SKCM	cis	rs3857536	0.673	rs7759888	chr6:66891922	T/C	cg07460842	chr6:66804631	NA	-0.7	-5.08	-0.5	2.51e-6	Blood trace element (Cu levels);
SKCM	cis	rs875971	0.830	rs6950137	chr7:65976610	G/A	cg18876405	chr7:65276391	NA	0.61	5.94	0.56	7.52e-8	Aortic root size;
SKCM	cis	rs2721195	0.719	rs4925811	chr8:145802447	G/T	cg11211951	chr8:145729740	GPT	-0.56	-5.07	-0.5	2.57e-6	Age at first birth;
SKCM	cis	rs10504229	0.953	rs67677367	chr8:58175264	T/G	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs2777491	1.000	rs7177641	chr15:41743426	C/T	cg18705301	chr15:41695430	NDUFAF1	-0.87	-8.66	-0.7	4.91e-13	Ulcerative colitis;
SKCM	trans	rs9929218	0.520	rs1078621	chr16:68778996	C/T	cg04657470	chr2:198365150	HSPE1;HSPD1	0.87	7.71	0.66	3.36e-11	Colorectal cancer;
SKCM	cis	rs2235573	0.594	rs12157609	chr22:38432277	C/T	cg03683946	chr22:38051826	SH3BP1	-0.48	-4.84	-0.48	6.32e-6	Glioblastoma;Glioma;
SKCM	cis	rs12142240	0.698	rs1057535	chr1:46815898	T/C	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs3818285	0.515	rs4918471	chr10:111660500	C/A	cg00817464	chr10:111662876	XPNPEP1	-0.79	-7.71	-0.66	3.48e-11	Superior crus of antihelix expression;
SKCM	cis	rs6582630	0.555	rs10880613	chr12:38509553	C/T	cg26384229	chr12:38710491	ALG10B	0.85	6.66	0.6	3.52e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs8180040	0.966	rs11711824	chr3:47468261	C/T	cg16586182	chr3:47516702	SCAP	-0.76	-5.32	-0.52	9.63e-7	Colorectal cancer;
SKCM	cis	rs9911578	0.967	rs57869245	chr17:57106630	A/G	cg12560992	chr17:57184187	TRIM37	-1.07	-9.66	-0.74	5.61e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs2153535	0.580	rs1932279	chr6:8473653	T/C	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs826838	0.967	rs11168299	chr12:38902028	G/T	cg13010199	chr12:38710504	ALG10B	0.84	6.66	0.6	3.54e-9	Heart rate;
SKCM	cis	rs4665809	0.567	rs12999875	chr2:26414847	A/C	cg26119090	chr2:26468346	HADHA;HADHB	1.05	8.21	0.68	3.71e-12	Gut microbiome composition (summer);
SKCM	cis	rs9910055	0.639	rs227583	chr17:42231698	C/G	cg08499158	chr17:42289980	UBTF	-0.74	-6.46	-0.59	8.29e-9	Total body bone mineral density;
SKCM	cis	rs12541335	0.639	rs68063696	chr8:22153236	A/G	cg02463440	chr8:22132932	PIWIL2	0.6	5.05	0.5	2.84e-6	Hypertriglyceridemia;
SKCM	cis	rs35306767	0.903	rs12763396	chr10:927357	C/A	cg20503657	chr10:835505	NA	0.75	5.36	0.52	8.31e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs2439831	0.850	rs28564774	chr15:44125475	G/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.36	7.78	0.66	2.56e-11	Lung cancer in ever smokers;
SKCM	cis	rs478304	0.637	rs11227255	chr11:65454044	C/T	cg17480646	chr11:65405466	SIPA1	-0.67	-4.99	-0.49	3.64e-6	Acne (severe);
SKCM	cis	rs62103177	0.810	rs3902996	chr18:77630571	A/G	cg27393146	chr18:77495563	CTDP1	-0.92	-5.36	-0.52	8.37e-7	Opioid sensitivity;
SKCM	cis	rs6570726	0.620	rs12201226	chr6:145913419	A/T	cg23711669	chr6:146136114	FBXO30	0.83	6.63	0.6	4.01e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4819852	0.723	rs2238790	chr22:19983014	G/A	cg07821417	chr22:19972146	ARVCF	-0.4	-4.79	-0.48	7.81e-6	Pulse pressure;
SKCM	cis	rs2811415	0.597	rs13093679	chr3:127726005	T/C	cg09089421	chr3:127803668	RUVBL1	0.97	8.25	0.68	3.07e-12	Lung function (FEV1/FVC);
SKCM	cis	rs208515	0.525	rs10944871	chr6:66690306	A/G	cg07460842	chr6:66804631	NA	0.93	6.34	0.58	1.35e-8	Exhaled nitric oxide levels;
SKCM	cis	rs4819052	0.851	rs13047104	chr21:46673562	T/G	cg02159808	chr21:46707872	POFUT2;LOC642852	0.73	5.71	0.54	1.93e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs4523957	0.583	rs2984943	chr17:2030135	T/C	cg16513277	chr17:2031491	SMG6	-0.91	-6.21	-0.58	2.38e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs9583531	0.600	rs6492306	chr13:111361693	G/A	cg15841412	chr13:111365552	ING1	0.7	4.82	0.48	7.07e-6	Coronary artery disease;
SKCM	cis	rs1506636	1.000	rs2429619	chr7:123425599	C/G	cg03229431	chr7:123269106	ASB15	0.66	5.29	0.51	1.1e-6	Plateletcrit;Platelet count;
SKCM	cis	rs1552244	0.832	rs61056817	chr3:10027641	C/T	cg02579736	chr3:10068473	FANCD2;CIDECP	0.95	4.84	0.48	6.45e-6	Alzheimer's disease;
SKCM	cis	rs4803468	1.000	rs11880539	chr19:41918949	A/C	cg14132834	chr19:41945861	ATP5SL	0.75	5.6	0.54	3.13e-7	Height;
SKCM	cis	rs2929451	0.566	rs17658270	chr8:9153619	C/G	cg06292304	chr8:9761905	MIR124-1;LOC157627	0.68	5.45	0.53	5.72e-7	Nose size;
SKCM	cis	rs62238980	0.614	rs77112134	chr22:32394449	C/T	cg00543991	chr22:32367038	NA	1.15	4.87	0.48	5.76e-6	Childhood ear infection;
SKCM	cis	rs910316	0.789	rs175444	chr14:75601782	G/C	cg08847533	chr14:75593920	NEK9	-0.82	-6.75	-0.61	2.36e-9	Height;
SKCM	cis	rs17826219	0.500	rs28452421	chr17:29083980	G/A	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Body mass index;
SKCM	cis	rs17711722	0.727	rs35850374	chr7:65357776	A/G	cg18876405	chr7:65276391	NA	0.86	7.56	0.65	6.53e-11	Calcium levels;
SKCM	cis	rs1413885	0.549	rs7545720	chr1:65856443	G/T	cg14976592	chr1:65886160	LEPROT;LEPR	0.59	4.79	0.48	7.85e-6	Anticoagulant levels;
SKCM	cis	rs7208859	0.623	rs3752021	chr17:29111043	G/C	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs2836974	0.644	rs2836982	chr21:40689171	C/A	cg17971929	chr21:40555470	PSMG1	-0.69	-6.07	-0.57	4.38e-8	Cognitive function;
SKCM	cis	rs7599312	0.534	rs7355673	chr2:213404389	T/C	cg16329650	chr2:213403929	ERBB4	0.84	6.04	0.56	4.85e-8	BMI (adjusted for smoking behaviour);BMI in non-smokers;Body mass index;Body mass index (joint analysis main effects and smoking interaction);
SKCM	cis	rs7777484	0.517	rs2644306	chr7:2831602	A/G	cg19717773	chr7:2847554	GNA12	-0.46	-5.41	-0.52	6.83e-7	Height;
SKCM	cis	rs11690935	0.851	rs6433319	chr2:172830953	C/T	cg13550731	chr2:172543902	DYNC1I2	-0.79	-5.87	-0.55	1.02e-7	Schizophrenia;
SKCM	cis	rs7100689	0.622	rs2994389	chr10:82062257	C/G	cg00277334	chr10:82204260	NA	-0.57	-5.35	-0.52	8.66e-7	Post bronchodilator FEV1;
SKCM	cis	rs1153858	1.000	rs1820518	chr15:45694579	C/T	cg10760299	chr15:45669010	GATM	0.6	5.93	0.56	7.69e-8	Homoarginine levels;
SKCM	cis	rs12950390	0.853	rs11655112	chr17:45856563	T/C	cg03474202	chr17:45855739	NA	-0.48	-5.42	-0.52	6.43e-7	IgG glycosylation;
SKCM	cis	rs2463822	0.844	rs72923263	chr11:62161170	C/G	cg06239285	chr11:62104954	ASRGL1	-1.25	-5.93	-0.56	7.79e-8	Chronic obstructive pulmonary disease-related biomarkers;
SKCM	cis	rs2836974	0.627	rs9981301	chr21:40686078	G/C	cg11890956	chr21:40555474	PSMG1	-0.79	-7.37	-0.64	1.57e-10	Cognitive function;
SKCM	cis	rs7932354	0.528	rs7103581	chr11:47072805	G/T	cg03339077	chr11:47165057	C11orf49	-0.59	-4.79	-0.48	7.68e-6	Bone mineral density (hip);Bone mineral density;
SKCM	trans	rs1814175	0.935	rs7925863	chr11:49615802	C/A	cg03929089	chr4:120376271	NA	-0.87	-7.53	-0.65	7.64e-11	Height;
SKCM	cis	rs6088590	0.965	rs6087619	chr20:33288511	C/G	cg24642439	chr20:33292090	TP53INP2	0.99	7.57	0.65	6.51e-11	Coronary artery disease;
SKCM	cis	rs4803468	1.000	rs2231940	chr19:41944237	T/C	cg14132834	chr19:41945861	ATP5SL	0.77	5.9	0.56	9.04e-8	Height;
SKCM	cis	rs3744028	0.598	rs8066711	chr17:73885038	G/A	cg10935138	chr17:73851978	WBP2	1.13	6.53	0.59	5.98e-9	White matter hyperintensity burden;
SKCM	cis	rs2228479	0.850	rs79244293	chr16:89896220	T/C	cg06558623	chr16:89946397	TCF25	1.1	4.95	0.49	4.17e-6	Skin colour saturation;
SKCM	cis	rs1506636	1.000	rs12333705	chr7:123356062	C/T	cg03229431	chr7:123269106	ASB15	-0.6	-4.83	-0.48	6.69e-6	Plateletcrit;Platelet count;
SKCM	cis	rs7408868	0.908	rs10418660	chr19:15278635	A/G	cg14696996	chr19:15285081	NOTCH3	0.82	4.92	0.49	4.7e-6	Pulse pressure;
SKCM	cis	rs854765	0.619	rs1101727	chr17:18016148	T/C	cg04398451	chr17:18023971	MYO15A	-1.08	-9.56	-0.73	8.71e-15	Total body bone mineral density;
SKCM	cis	rs769267	0.965	rs8103496	chr19:19386015	A/G	cg26732615	chr19:19648335	CILP2;YJEFN3	0.62	5.67	0.54	2.31e-7	Tonsillectomy;
SKCM	cis	rs7772486	0.875	rs9376975	chr6:146355581	T/G	cg05347473	chr6:146136440	FBXO30	0.57	5.24	0.51	1.31e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs10808739	0.660	rs2884073	chr8:65618273	C/T	cg05711235	chr8:65498612	NA	-0.81	-5.4	-0.52	7.01e-7	HIV-1 susceptibility;
SKCM	cis	rs6545883	0.929	rs6705235	chr2:61713580	G/C	cg15711740	chr2:61764176	XPO1	-0.7	-4.93	-0.49	4.5e-6	Tuberculosis;
SKCM	cis	rs79040073	0.530	rs1055254	chr15:49620200	C/T	cg25951582	chr15:49913451	C15orf33;DTWD1	-0.72	-5.22	-0.51	1.44e-6	Lung cancer in ever smokers;
SKCM	cis	rs3784262	1.000	rs7165247	chr15:58251786	C/T	cg12031962	chr15:58353849	ALDH1A2	0.51	6.75	0.61	2.34e-9	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs2224391	0.704	rs17139985	chr6:5261603	T/C	cg09085698	chr6:5261316	LYRM4;FARS2	-0.75	-5.33	-0.52	9.43e-7	Height;
SKCM	cis	rs6500395	1.000	rs11076573	chr16:48632758	A/G	cg04672837	chr16:48644449	N4BP1	0.67	5.66	0.54	2.4e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs6500395	0.962	rs989070	chr16:48602243	G/A	cg04672837	chr16:48644449	N4BP1	0.69	5.73	0.54	1.8e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs28595532	0.920	rs114207133	chr4:119755140	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs3845702	0.736	rs72962517	chr2:180861452	G/A	cg01881094	chr2:180872142	CWC22	1.26	6.25	0.58	2.01e-8	Schizophrenia;
SKCM	cis	rs11098499	0.779	rs80242894	chr4:120375752	G/A	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs8072100	0.967	rs11871606	chr17:45732774	G/T	cg08085267	chr17:45401833	C17orf57	0.61	5.44	0.52	5.83e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs2836974	0.932	rs56306759	chr21:40608106	G/A	cg11890956	chr21:40555474	PSMG1	1.09	13.83	0.84	1.08e-22	Cognitive function;
SKCM	cis	rs2386661	0.826	rs1317516	chr10:5672720	A/G	cg12223502	chr10:5658492	NA	0.6	4.77	0.48	8.46e-6	Breast cancer;
SKCM	cis	rs1799949	0.965	rs799917	chr17:41244936	G/A	cg05368731	chr17:41323189	NBR1	0.86	6.99	0.62	8.3e-10	Menopause (age at onset);
SKCM	cis	rs2243480	1.000	rs34933526	chr7:65383199	A/G	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs72781680	0.611	rs2111884	chr2:24289472	A/T	cg20701182	chr2:24300061	SF3B14	0.72	4.88	0.48	5.42e-6	Lymphocyte counts;
SKCM	cis	rs1577917	1.000	rs12208493	chr6:86662267	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.85	-8.62	-0.7	5.82e-13	Response to antipsychotic treatment;
SKCM	cis	rs9910055	0.762	rs11080007	chr17:42265442	A/G	cg08499158	chr17:42289980	UBTF	0.83	7.2	0.63	3.24e-10	Total body bone mineral density;
SKCM	cis	rs10256972	0.721	rs6975972	chr7:1070468	A/G	cg07308232	chr7:1071921	C7orf50	-0.6	-5.01	-0.49	3.27e-6	Longevity;Endometriosis;
SKCM	cis	rs6088580	0.608	rs2105109	chr20:32971932	A/G	cg24642439	chr20:33292090	TP53INP2	-0.76	-6.02	-0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs11098499	0.954	rs56270433	chr4:120406030	C/T	cg09307838	chr4:120376055	NA	0.97	7.65	0.65	4.54e-11	Corneal astigmatism;
SKCM	cis	rs9303401	0.659	rs714959	chr17:56628601	A/G	cg10487724	chr17:56770010	TEX14;RAD51C	0.82	6.05	0.57	4.77e-8	Cognitive test performance;
SKCM	cis	rs6938	0.534	rs11636892	chr15:75266049	G/C	cg09165964	chr15:75287851	SCAMP5	0.68	5.43	0.52	6.31e-7	Breast cancer;
SKCM	cis	rs8072100	0.934	rs9905583	chr17:45741016	C/T	cg25173405	chr17:45401733	C17orf57	-0.6	-5.57	-0.53	3.43e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs8067545	0.717	rs7207625	chr17:20001612	G/A	cg13482628	chr17:19912719	NA	0.72	6.01	0.56	5.48e-8	Schizophrenia;
SKCM	cis	rs8060686	0.641	rs113258243	chr16:68086656	C/T	cg04539111	chr16:67997858	SLC12A4	-0.85	-4.79	-0.48	7.74e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs6952808	0.534	rs1113736	chr7:1992992	T/C	cg21782813	chr7:2030301	MAD1L1	0.59	6.03	0.56	5.16e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs769267	1.000	rs12985655	chr19:19442434	G/A	cg26732615	chr19:19648335	CILP2;YJEFN3	-0.64	-5.88	-0.55	9.71e-8	Tonsillectomy;
SKCM	cis	rs1529316	0.904	rs2740814	chr8:3830004	T/C	cg05999364	chr8:3269952	CSMD1	0.48	4.88	0.48	5.57e-6	Multiple sclerosis;
SKCM	cis	rs6088590	0.931	rs12625149	chr20:33425812	A/C	cg24642439	chr20:33292090	TP53INP2	-0.85	-6.12	-0.57	3.52e-8	Coronary artery disease;
SKCM	cis	rs10876993	0.928	rs2928053	chr12:58063475	T/C	cg18357645	chr12:58087776	OS9	0.65	6.01	0.56	5.71e-8	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs2439831	0.850	rs3825783	chr15:44102309	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.35	7.75	0.66	2.9e-11	Lung cancer in ever smokers;
SKCM	cis	rs1878931	0.597	rs2680221	chr16:3462595	A/G	cg26668626	chr16:3451006	ZNF174;ZNF434	-0.8	-5.17	-0.51	1.73e-6	Body mass index (adult);
SKCM	cis	rs611744	0.647	rs10106246	chr8:109268710	T/C	cg18478394	chr8:109455254	TTC35	0.66	5.27	0.51	1.16e-6	Dupuytren's disease;
SKCM	cis	rs11098499	0.908	rs7695996	chr4:120322033	C/T	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs11249608	0.511	rs58827878	chr5:178481936	C/G	cg21905437	chr5:178450457	ZNF879	0.7	5.23	0.51	1.38e-6	Pubertal anthropometrics;
SKCM	cis	rs7659604	1.000	rs35224452	chr4:122664677	C/T	cg19671926	chr4:122722719	EXOSC9	-0.64	-4.78	-0.48	8.04e-6	Type 2 diabetes;
SKCM	cis	rs2286503	0.839	rs10276099	chr7:22862950	G/A	cg15401507	chr7:22894281	NA	-0.57	-5.61	-0.54	2.99e-7	Fibrinogen;
SKCM	cis	rs62238980	0.614	rs77886759	chr22:32390956	A/G	cg00543991	chr22:32367038	NA	1.15	4.87	0.48	5.76e-6	Childhood ear infection;
SKCM	cis	rs1218582	0.741	rs10908444	chr1:154840287	G/A	cg03351412	chr1:154909251	PMVK	0.79	6.91	0.62	1.15e-9	Prostate cancer;
SKCM	cis	rs2032447	0.933	rs1540275	chr6:26036476	T/C	cg18357526	chr6:26021779	HIST1H4A	0.84	7.17	0.63	3.78e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs7215564	0.730	rs34405143	chr17:78585681	G/C	cg16980736	chr17:78789706	RPTOR	-0.89	-4.87	-0.48	5.8e-6	Myopia (pathological);
SKCM	cis	rs6752107	1.000	rs2289474	chr2:234181848	C/T	cg07618928	chr2:234183455	ATG16L1;SCARNA5	0.56	4.77	0.48	8.37e-6	Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs4819052	0.851	rs8126930	chr21:46671715	A/G	cg02159808	chr21:46707872	POFUT2;LOC642852	0.65	4.86	0.48	5.99e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7666738	0.830	rs890470	chr4:98923435	A/C	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs703842	1.000	rs10431505	chr12:58178589	A/G	cg04478727	chr12:58166393	METTL1;FAM119B	0.72	5.87	0.55	1.02e-7	Multiple sclerosis;
SKCM	cis	rs514406	0.861	rs6588443	chr1:53250650	G/A	cg16325326	chr1:53192061	ZYG11B	-0.99	-11.71	-0.8	7.39e-19	Monocyte count;
SKCM	cis	rs10751667	0.666	rs4072741	chr11:976565	T/C	cg10932868	chr11:921992	NA	0.55	5.1	0.5	2.36e-6	Alzheimer's disease (late onset);
SKCM	cis	rs992157	0.710	rs12694432	chr2:219082330	A/G	cg00012203	chr2:219082015	ARPC2	0.82	7.1	0.63	5.13e-10	Colorectal cancer;
SKCM	cis	rs933688	1.000	rs889213	chr5:90682151	C/T	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.97	6.61	0.6	4.28e-9	Smoking behavior;
SKCM	cis	rs35306767	0.903	rs11253495	chr10:937064	C/T	cg20503657	chr10:835505	NA	0.81	5.21	0.51	1.52e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs1707322	1.000	rs785497	chr1:46591903	G/C	cg03146154	chr1:46216737	IPP	-0.8	-5.28	-0.51	1.15e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs951366	0.789	rs1775154	chr1:205696615	T/A	cg14159672	chr1:205819179	PM20D1	0.95	7.68	0.66	3.89e-11	Menarche (age at onset);
SKCM	cis	rs3540	0.597	rs12708583	chr15:91050271	C/T	cg22089800	chr15:90895588	ZNF774	0.68	4.99	0.49	3.55e-6	Allergic disease (asthma, hay fever or eczema);Lymphocyte counts;
SKCM	cis	rs873917	0.577	rs784612	chr1:40122939	T/C	cg21785781	chr1:39339218	MYCBP	-0.7	-5.09	-0.5	2.39e-6	Amyotrophic lateral sclerosis;
SKCM	cis	rs6977660	0.714	rs28605851	chr7:19815219	G/A	cg05791153	chr7:19748676	TWISTNB	0.8	5.01	0.49	3.37e-6	Thyroid stimulating hormone;
SKCM	cis	rs28595532	0.764	rs116302502	chr4:119748848	T/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs56104184	0.723	rs73063524	chr19:49409004	T/C	cg19746536	chr19:49375674	PPP1R15A	1.16	5.93	0.56	7.67e-8	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs17376456	0.504	rs6898507	chr5:93082343	C/T	cg25358565	chr5:93447407	FAM172A	0.86	5.45	0.53	5.59e-7	Diabetic retinopathy;
SKCM	cis	rs2120019	0.608	rs4886414	chr15:75308650	C/T	cg17294928	chr15:75287854	SCAMP5	0.88	8.85	0.71	2.11e-13	Blood trace element (Zn levels);
SKCM	cis	rs12145833	0.748	rs11807162	chr1:243454680	C/T	cg02356786	chr1:243265016	LOC731275	1.16	5.05	0.5	2.83e-6	Obesity (early onset extreme);
SKCM	cis	rs2991971	0.967	rs937291	chr1:45957039	G/T	cg24296786	chr1:45957014	TESK2	0.69	5.65	0.54	2.47e-7	High light scatter reticulocyte count;
SKCM	cis	rs6500395	1.000	rs4493038	chr16:48683920	A/G	cg04672837	chr16:48644449	N4BP1	0.65	5.43	0.52	6.28e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs6089829	0.962	rs1060490	chr20:61665871	A/G	cg08564027	chr20:61660810	NA	0.63	5.65	0.54	2.56e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs6952808	0.692	rs6950627	chr7:2086672	C/T	cg21782813	chr7:2030301	MAD1L1	0.57	5.95	0.56	7.32e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs995000	0.931	rs998403	chr1:62928549	G/A	cg06896770	chr1:63153194	DOCK7	0.91	8.76	0.7	3.11e-13	Triglyceride levels;
SKCM	cis	rs55962025	0.711	rs2298971	chr4:3200079	A/G	cg00764545	chr4:3318001	RGS12	-0.6	-5.21	-0.51	1.52e-6	Parental longevity (mother's age at death);
SKCM	cis	rs860295	0.702	rs10752611	chr1:155509107	C/T	cg02153340	chr1:155202674	NA	-0.78	-5.52	-0.53	4.25e-7	Body mass index;
SKCM	cis	rs7666738	0.830	rs4699577	chr4:98846513	G/A	cg17366294	chr4:99064904	C4orf37	0.56	4.89	0.48	5.25e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs17685	0.753	rs1574107	chr7:75685047	A/C	cg16489192	chr7:75678113	MDH2;STYXL1	-0.61	-5.67	-0.54	2.34e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs10771431	0.810	rs10771418	chr12:9358995	A/G	cg08997352	chr12:9597637	DDX12	-0.68	-4.86	-0.48	6.01e-6	Breast size;
SKCM	cis	rs875971	0.660	rs3764903	chr7:66098482	G/A	cg00343986	chr7:65444356	GUSB	-0.68	-4.99	-0.49	3.65e-6	Aortic root size;
SKCM	cis	rs17376456	0.825	rs10051878	chr5:93064164	T/G	cg21475434	chr5:93447410	FAM172A	0.94	5.62	0.54	2.87e-7	Diabetic retinopathy;
SKCM	cis	rs6977660	0.943	rs10277755	chr7:19826843	C/A	cg05791153	chr7:19748676	TWISTNB	0.76	5.27	0.51	1.19e-6	Thyroid stimulating hormone;
SKCM	cis	rs473651	0.740	rs502349	chr2:239318389	C/T	cg18131467	chr2:239335373	ASB1	1.02	11.59	0.8	1.21e-18	Multiple system atrophy;
SKCM	cis	rs11764590	0.950	rs11514731	chr7:2051503	C/G	cg23422044	chr7:1970798	MAD1L1	-0.93	-5.92	-0.56	8.02e-8	Neuroticism;
SKCM	cis	rs4237845	0.537	rs12426201	chr12:58259752	C/T	cg00677455	chr12:58241039	CTDSP2	0.93	8.39	0.69	1.62e-12	Intelligence (multi-trait analysis);
SKCM	cis	rs2204008	0.715	rs11514282	chr12:38169056	G/T	cg13010199	chr12:38710504	ALG10B	0.65	4.84	0.48	6.52e-6	Bladder cancer;
SKCM	cis	rs7659604	1.000	rs34952897	chr4:122664409	C/T	cg19671926	chr4:122722719	EXOSC9	-0.66	-4.98	-0.49	3.71e-6	Type 2 diabetes;
SKCM	cis	rs2952156	0.959	rs907087	chr17:37828787	G/A	cg20243544	chr17:37824526	PNMT	0.73	5.79	0.55	1.43e-7	Asthma;
SKCM	cis	rs2075371	0.796	rs1643040	chr7:134011703	G/C	cg20476274	chr7:133979776	SLC35B4	0.93	9.67	0.74	5.55e-15	Mean platelet volume;
SKCM	cis	rs3820068	0.581	rs72645895	chr1:15931709	G/A	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs4253772	0.591	rs6007795	chr22:46686792	C/G	cg03482458	chr22:46692211	CN5H6.4;GTSE1	1.2	5.67	0.54	2.3e-7	LDL cholesterol;Cholesterol, total;
SKCM	cis	rs10808739	0.660	rs716283	chr8:65619966	T/G	cg05711235	chr8:65498612	NA	-0.81	-5.4	-0.52	7.01e-7	HIV-1 susceptibility;
SKCM	cis	rs9814567	1.000	rs9835204	chr3:134261342	G/T	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs2832191	0.740	rs6516890	chr21:30476812	T/A	cg08807101	chr21:30365312	RNF160	0.62	4.94	0.49	4.34e-6	Dental caries;
SKCM	cis	rs7666738	0.830	rs13101766	chr4:98957696	C/A	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs35146811	0.622	rs6946204	chr7:99589125	T/C	cg13334819	chr7:99746414	C7orf59	-0.7	-4.86	-0.48	5.97e-6	Coronary artery disease;
SKCM	cis	rs8177253	1.000	rs3811647	chr3:133484029	G/A	cg16414030	chr3:133502952	NA	-0.69	-5.83	-0.55	1.19e-7	Iron status biomarkers;
SKCM	cis	rs7772486	0.875	rs932522	chr6:146374026	A/G	cg23711669	chr6:146136114	FBXO30	-0.85	-8.52	-0.69	9.12e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs908922	0.676	rs477621	chr1:152486252	T/C	cg09873164	chr1:152488093	CRCT1	0.78	6.09	0.57	3.98e-8	Hair morphology;
SKCM	cis	rs344364	0.511	rs1657134	chr16:1953127	A/G	cg26897989	chr16:1907736	C16orf73	-0.72	-7.11	-0.63	4.82e-10	Glomerular filtration rate in chronic kidney disease;
SKCM	cis	rs737008	0.500	rs7189239	chr16:11402515	T/C	cg00044050	chr16:11439710	C16orf75	0.72	5.03	0.49	3.11e-6	Obesity-related traits;
SKCM	cis	rs854765	0.647	rs854809	chr17:18006539	C/T	cg04398451	chr17:18023971	MYO15A	-1.0	-9.22	-0.72	4.08e-14	Total body bone mineral density;
SKCM	cis	rs2811415	0.597	rs13073261	chr3:127751493	A/G	cg09089421	chr3:127803668	RUVBL1	0.99	8.52	0.69	9.09e-13	Lung function (FEV1/FVC);
SKCM	cis	rs595982	0.527	rs35023389	chr19:49377873	G/A	cg19746536	chr19:49375674	PPP1R15A	1.12	5.61	0.54	3.01e-7	Red cell distribution width;
SKCM	cis	rs72634258	0.520	rs12078018	chr1:7857309	G/A	cg26816564	chr1:7831052	VAMP3	0.75	5.36	0.52	8.06e-7	Inflammatory bowel disease;
SKCM	cis	rs12216125	0.537	rs12207059	chr6:25922385	C/T	cg17691542	chr6:26056736	HIST1H1C	1.25	9.21	0.72	4.29e-14	Iron status biomarkers;
SKCM	cis	rs7937682	0.883	rs490492	chr11:111465150	C/T	cg09085632	chr11:111637200	PPP2R1B	-1.0	-8.74	-0.7	3.47e-13	Primary sclerosing cholangitis;
SKCM	cis	rs2836633	0.931	rs2836635	chr21:40069850	A/G	cg05519781	chr21:40033154	ERG	0.7	6.19	0.57	2.56e-8	Coronary artery disease;
SKCM	cis	rs10540	1.000	rs12419766	chr11:503710	C/T	cg03576123	chr11:487126	PTDSS2	-1.43	-8.14	-0.68	5.08e-12	Body mass index;
SKCM	cis	rs10504229	0.683	rs7843919	chr8:58130792	T/C	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs2153535	0.580	rs9405390	chr6:8466209	T/G	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs1801251	1.000	rs283468	chr2:233658309	C/T	cg25237894	chr2:233734115	C2orf82	0.68	6.05	0.57	4.63e-8	Coronary artery disease;
SKCM	cis	rs9640161	0.742	rs2159235	chr7:150017228	T/C	cg10018233	chr7:150070692	REPIN1	0.69	5.73	0.54	1.78e-7	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs1185460	0.967	rs1784302	chr11:118940957	C/G	cg23280166	chr11:118938394	VPS11	0.59	5.41	0.52	6.78e-7	Coronary artery disease;
SKCM	cis	rs2404602	0.692	rs7169663	chr15:77192843	A/C	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs8177253	1.000	rs8177248	chr3:133479626	C/T	cg16414030	chr3:133502952	NA	-0.69	-5.85	-0.55	1.1e-7	Iron status biomarkers;
SKCM	cis	rs8180040	1.000	rs11714294	chr3:47339723	G/A	cg16586182	chr3:47516702	SCAP	0.71	4.85	0.48	6.25e-6	Colorectal cancer;
SKCM	cis	rs9905704	0.647	rs12940492	chr17:56954655	C/G	cg12560992	chr17:57184187	TRIM37	0.76	6.04	0.56	4.92e-8	Testicular germ cell tumor;
SKCM	cis	rs7523050	0.643	rs71655970	chr1:109403895	A/G	cg08274380	chr1:109419600	GPSM2	1.18	6.44	0.59	9.12e-9	Fat distribution (HIV);
SKCM	cis	rs28595532	0.920	rs116098781	chr4:119771613	G/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs9790314	0.875	rs336568	chr3:161072763	G/C	cg03342759	chr3:160939853	NMD3	-0.73	-8.2	-0.68	3.89e-12	Morning vs. evening chronotype;
SKCM	cis	rs1348850	0.768	rs57681892	chr2:178357645	G/C	cg02961200	chr2:178257176	LOC100130691;AGPS	0.82	5.92	0.56	8.05e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs4774899	0.966	rs11853331	chr15:57431471	C/T	cg01857019	chr15:57210107	LOC145783;TCF12	0.53	4.89	0.48	5.3e-6	Urinary tract infection frequency;
SKCM	cis	rs860295	0.702	rs10908465	chr1:155389688	C/T	cg02153340	chr1:155202674	NA	-0.77	-5.48	-0.53	4.96e-7	Body mass index;
SKCM	cis	rs8180040	0.726	rs7625070	chr3:47095518	A/G	cg27129171	chr3:47204927	SETD2	0.82	6.49	0.59	7.26e-9	Colorectal cancer;
SKCM	cis	rs7824557	0.734	rs2293856	chr8:11177447	C/T	cg21775007	chr8:11205619	TDH	0.68	5.77	0.55	1.55e-7	Retinal vascular caliber;
SKCM	cis	rs4665809	1.000	rs4665308	chr2:26330514	C/A	cg26119090	chr2:26468346	HADHA;HADHB	-0.76	-4.79	-0.48	7.86e-6	Gut microbiome composition (summer);
SKCM	cis	rs58688157	0.960	rs11246213	chr11:612967	A/G	cg03576123	chr11:487126	PTDSS2	-0.84	-5.45	-0.53	5.64e-7	Systemic lupus erythematosus;
SKCM	cis	rs11249608	0.548	rs34054398	chr5:178458371	A/G	cg21905437	chr5:178450457	ZNF879	0.71	5.45	0.53	5.65e-7	Pubertal anthropometrics;
SKCM	cis	rs7537052	0.646	rs6680302	chr1:36653540	C/T	cg24686825	chr1:36642396	MAP7D1	-0.68	-5.84	-0.55	1.13e-7	Schizophrenia;
SKCM	cis	rs709400	0.663	rs2273703	chr14:103918029	C/G	cg26031613	chr14:104095156	KLC1	0.67	5.05	0.5	2.84e-6	Body mass index;
SKCM	cis	rs9916302	0.706	rs4287601	chr17:37513852	T/C	cg07936489	chr17:37558343	FBXL20	0.98	6.84	0.61	1.56e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs10489202	1.000	rs34192847	chr1:168064317	A/T	cg24449463	chr1:168025552	DCAF6	-0.77	-5.95	-0.56	7.18e-8	Schizophrenia;
SKCM	cis	rs55823223	0.504	rs2034946	chr17:73863589	T/G	cg10935138	chr17:73851978	WBP2	1.13	6.32	0.58	1.47e-8	Psoriasis;
SKCM	cis	rs2836974	1.000	rs12710454	chr21:40656919	A/G	cg11644478	chr21:40555479	PSMG1	0.83	7.69	0.66	3.66e-11	Cognitive function;
SKCM	cis	rs250677	0.522	rs6875902	chr5:148407893	C/A	cg23229984	chr5:148520753	ABLIM3	0.6	4.9	0.48	5.18e-6	Breast cancer;
SKCM	cis	rs55962025	0.644	rs6446723	chr4:3126813	T/C	cg05297308	chr4:3317976	RGS12	-0.59	-4.79	-0.48	7.94e-6	Parental longevity (mother's age at death);
SKCM	cis	rs6500602	0.592	rs7206782	chr16:4515145	A/C	cg08645402	chr16:4508243	NA	0.65	5.03	0.49	3.06e-6	Schizophrenia;
SKCM	cis	rs1577917	0.958	rs10944168	chr6:86680156	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.65	-5.59	-0.54	3.16e-7	Response to antipsychotic treatment;
SKCM	cis	rs4481887	0.741	rs6682953	chr1:248535626	T/C	cg22724847	chr1:248512586	OR14C36	0.59	5.11	0.5	2.26e-6	Common traits (Other);
SKCM	cis	rs28595532	0.844	rs116721336	chr4:119536538	A/G	cg11846333	chr4:119757529	SEC24D	1.15	6.24	0.58	2.13e-8	Cannabis dependence symptom count;
SKCM	cis	rs796364	0.951	rs3098341	chr2:200792498	G/T	cg12253985	chr2:200820533	C2orf60;C2orf47	0.85	5.39	0.52	7.18e-7	Schizophrenia;
SKCM	cis	rs12986445	0.744	rs3845683	chr2:26110351	C/G	cg04917511	chr2:26785460	C2orf70	0.52	4.99	0.49	3.53e-6	Multiple myeloma and monoclonal gammopathy;Multiple myeloma;
SKCM	cis	rs7666738	0.830	rs13133355	chr4:98919415	A/G	cg17366294	chr4:99064904	C4orf37	0.56	4.89	0.48	5.26e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6088580	0.634	rs6088512	chr20:33095891	G/A	cg24642439	chr20:33292090	TP53INP2	0.75	6.02	0.56	5.32e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs28386778	0.865	rs2727276	chr17:61929709	G/A	cg06873352	chr17:61820015	STRADA	0.76	6.34	0.58	1.38e-8	Prudent dietary pattern;
SKCM	cis	rs3746446	0.678	rs6120777	chr20:33560172	G/A	cg24642439	chr20:33292090	TP53INP2	0.97	5.27	0.51	1.18e-6	Congenital left-sided heart lesions;
SKCM	cis	rs28595532	0.748	rs66615663	chr4:119336701	C/T	cg21605333	chr4:119757512	SEC24D	0.95	4.91	0.49	4.92e-6	Cannabis dependence symptom count;
SKCM	cis	rs55962025	0.846	rs363064	chr4:3141410	C/T	cg16987761	chr4:3318072	RGS12	-0.81	-6.16	-0.57	2.93e-8	Parental longevity (mother's age at death);
SKCM	cis	rs17065868	1.000	rs9805321	chr13:45094447	A/G	cg10246903	chr13:45222710	NA	-0.92	-5.05	-0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs33794	0.729	rs33783	chr3:45291959	G/T	cg05470468	chr3:44620074	ZNF167	0.67	4.97	0.49	3.83e-6	Lung function (forced expiratory volume in 1 second);
SKCM	cis	rs2120019	0.935	rs8043181	chr15:75380424	T/C	cg09165964	chr15:75287851	SCAMP5	-0.78	-6.63	-0.6	3.95e-9	Blood trace element (Zn levels);
SKCM	cis	rs4237845	0.537	rs11172369	chr12:58280592	T/C	cg00677455	chr12:58241039	CTDSP2	0.92	8.28	0.68	2.75e-12	Intelligence (multi-trait analysis);
SKCM	cis	rs11098499	0.866	rs13125526	chr4:120288019	G/A	cg09307838	chr4:120376055	NA	0.98	7.89	0.67	1.52e-11	Corneal astigmatism;
SKCM	cis	rs7824557	0.527	rs2736305	chr8:11237773	T/C	cg21775007	chr8:11205619	TDH	-0.57	-4.8	-0.48	7.47e-6	Retinal vascular caliber;
SKCM	cis	rs2645694	0.626	rs2703122	chr4:77821418	A/C	cg06046430	chr4:77819534	ANKRD56	0.54	5.83	0.55	1.18e-7	Emphysema distribution in smoking;
SKCM	cis	rs362272	0.524	rs881816	chr4:3365366	A/G	cg05297308	chr4:3317976	RGS12	1.05	12.6	0.82	1.68e-20	Serum sulfate level;
SKCM	cis	rs1419980	0.630	rs2377089	chr12:7737325	T/C	cg10578777	chr12:7781093	NA	0.72	5.12	0.5	2.12e-6	HDL cholesterol levels;
SKCM	trans	rs17685	0.725	rs6947068	chr7:75662056	T/C	cg19862616	chr7:65841803	NCRNA00174	-0.94	-9.39	-0.73	1.88e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7666738	0.830	rs7678911	chr4:99057430	C/T	cg05340658	chr4:99064831	C4orf37	0.66	4.87	0.48	5.74e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6430585	0.591	rs1374330	chr2:136420908	A/C	cg07169764	chr2:136633963	MCM6	1.15	8.6	0.7	6.42e-13	Corneal structure;
SKCM	cis	rs4481887	0.927	rs4244181	chr1:248471118	A/G	cg00666640	chr1:248458726	OR2T12	0.64	5.69	0.54	2.13e-7	Common traits (Other);
SKCM	cis	rs992157	0.835	rs13005100	chr2:219151767	C/T	cg20019365	chr2:219134978	PNKD;AAMP	-0.71	-6.08	-0.57	4.22e-8	Colorectal cancer;
SKCM	cis	rs9467773	0.620	rs4368798	chr6:26593471	A/G	cg15659132	chr6:26577336	NA	0.63	5.57	0.53	3.56e-7	Intelligence (multi-trait analysis);
SKCM	trans	rs12517041	1.000	rs10520890	chr5:23290143	C/T	cg19005233	chr5:140626445	PCDHB15	-0.97	-7.29	-0.64	2.2e-10	Calcium levels;
SKCM	cis	rs116095464	0.558	rs56043030	chr5:220917	A/G	cg22857025	chr5:266934	NA	-1.36	-8.0	-0.67	9.23e-12	Breast cancer;
SKCM	cis	rs4523957	0.620	rs9892754	chr17:2084565	G/T	cg16513277	chr17:2031491	SMG6	-0.79	-5.86	-0.55	1.07e-7	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs634534	0.532	rs12794370	chr11:65770413	G/A	cg02427764	chr11:65769310	BANF1;EIF1AD	0.77	5.82	0.55	1.23e-7	Sum eosinophil basophil counts;Eosinophil counts;
SKCM	cis	rs7829975	0.681	rs2271342	chr8:8643938	C/T	cg06636001	chr8:8085503	FLJ10661	0.81	7.16	0.63	3.97e-10	Mood instability;
SKCM	cis	rs763121	0.853	rs5750633	chr22:38993467	A/G	cg06022373	chr22:39101656	GTPBP1	0.82	5.62	0.54	2.79e-7	Menopause (age at onset);
SKCM	cis	rs875971	0.862	rs1167390	chr7:65575893	G/A	cg11764359	chr7:65958608	NA	-0.8	-7.66	-0.66	4.2e-11	Aortic root size;
SKCM	cis	rs7811142	1.000	rs73405353	chr7:100091215	G/A	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.25	0.68	3.05e-12	Platelet count;
SKCM	cis	rs9430161	0.611	rs12081181	chr1:11034165	T/G	cg27631724	chr1:11040367	C1orf127	0.5	4.88	0.48	5.45e-6	Ewing sarcoma;
SKCM	cis	rs116095464	0.681	rs9687745	chr5:229309	C/T	cg22857025	chr5:266934	NA	-1.37	-8.11	-0.68	5.82e-12	Breast cancer;
SKCM	cis	rs244731	0.959	rs7724098	chr5:176659570	G/A	cg17509989	chr5:176798049	RGS14	-0.88	-6.91	-0.62	1.16e-9	Urate levels in lean individuals;
SKCM	cis	rs9818758	0.607	rs13068038	chr3:49294250	C/A	cg00383909	chr3:49044727	WDR6	0.95	4.95	0.49	4.17e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs28595532	0.764	rs55704595	chr4:119780607	G/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs6088590	1.000	rs2180276	chr20:33360785	T/A	cg24642439	chr20:33292090	TP53INP2	1.01	7.39	0.64	1.39e-10	Coronary artery disease;
SKCM	cis	rs9611565	0.918	rs12484074	chr22:41752747	G/A	cg03806693	chr22:41940476	POLR3H	-0.82	-5.41	-0.52	6.61e-7	Vitiligo;
SKCM	cis	rs9486715	1.000	rs9398148	chr6:97063555	A/G	cg06623918	chr6:96969491	KIAA0776	-0.74	-6.56	-0.6	5.29e-9	Headache;
SKCM	cis	rs1799949	1.000	rs8176269	chr17:41213626	G/T	cg23758822	chr17:41437982	NA	0.94	7.87	0.67	1.68e-11	Menopause (age at onset);
SKCM	cis	rs1451375	0.572	rs3807558	chr7:50571022	A/G	cg18232548	chr7:50535776	DDC	-0.76	-4.92	-0.49	4.63e-6	Malaria;
SKCM	cis	rs826838	1.000	rs1095575	chr12:39110284	C/G	cg13010199	chr12:38710504	ALG10B	-0.74	-5.83	-0.55	1.19e-7	Heart rate;
SKCM	cis	rs10832963	0.961	rs10832954	chr11:18643559	G/A	cg09201001	chr11:18656081	SPTY2D1	1.03	11.04	0.78	1.31e-17	Breast cancer;
SKCM	cis	rs7927771	0.524	rs4752796	chr11:47841862	A/G	cg20307385	chr11:47447363	PSMC3	-0.72	-5.81	-0.55	1.31e-7	Subjective well-being;
SKCM	cis	rs2836974	0.897	rs35386515	chr21:40532047	C/T	cg11890956	chr21:40555474	PSMG1	1.07	13.19	0.83	1.48e-21	Cognitive function;
SKCM	cis	rs6840360	0.571	rs62329101	chr4:152512239	G/T	cg22705602	chr4:152727874	NA	-0.52	-5.7	-0.54	2.03e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs4819052	0.851	rs1999334	chr21:46670457	A/G	cg02159808	chr21:46707872	POFUT2;LOC642852	0.65	5.01	0.49	3.37e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs2739330	0.828	rs4820572	chr22:24250355	T/C	cg12419862	chr22:24373484	LOC391322	-0.64	-5.53	-0.53	4.15e-7	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs736408	0.546	rs3733046	chr3:52621627	C/T	cg18404041	chr3:52824283	ITIH1	-0.53	-4.77	-0.48	8.42e-6	Bipolar disorder;
SKCM	cis	rs1005277	0.505	rs10827836	chr10:38215441	A/G	cg25427524	chr10:38739819	LOC399744	0.67	6.32	0.58	1.5e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs6952808	0.771	rs10244946	chr7:1921068	A/G	cg02951883	chr7:2050386	MAD1L1	0.68	5.86	0.55	1.06e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs1577917	0.538	rs7755996	chr6:86423720	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.7	5.76	0.55	1.58e-7	Response to antipsychotic treatment;
SKCM	cis	rs2204008	0.527	rs1315367	chr12:38177487	G/T	cg26384229	chr12:38710491	ALG10B	-0.67	-5.47	-0.53	5.23e-7	Bladder cancer;
SKCM	cis	rs2842992	0.692	rs1128661	chr6:160211554	T/G	cg11366901	chr6:160182831	ACAT2	0.84	7.09	0.63	5.2e-10	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs875971	0.660	rs801211	chr7:66015689	T/G	cg18876405	chr7:65276391	NA	-0.8	-7.11	-0.63	4.86e-10	Aortic root size;
SKCM	cis	rs7666738	0.830	rs28516388	chr4:98987449	A/G	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs28374715	0.617	rs28626792	chr15:41562218	A/G	cg18705301	chr15:41695430	NDUFAF1	-0.76	-6.34	-0.58	1.39e-8	Ulcerative colitis;
SKCM	cis	rs9325144	0.532	rs1352121	chr12:39130696	A/G	cg13010199	chr12:38710504	ALG10B	-0.62	-5.44	-0.52	5.97e-7	Morning vs. evening chronotype;
SKCM	cis	rs11112613	0.713	rs60865625	chr12:105940256	A/C	cg03607813	chr12:105948248	NA	0.86	5.19	0.51	1.64e-6	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;
SKCM	cis	rs875971	0.638	rs7793569	chr7:66116633	T/G	cg00343986	chr7:65444356	GUSB	-0.68	-4.99	-0.49	3.65e-6	Aortic root size;
SKCM	cis	rs1801251	0.778	rs778340	chr2:233734083	C/T	cg25237894	chr2:233734115	C2orf82	-0.6	-6.33	-0.58	1.46e-8	Coronary artery disease;
SKCM	cis	rs17685	0.672	rs55807301	chr7:75807401	C/A	cg16489192	chr7:75678113	MDH2;STYXL1	-0.54	-5.21	-0.51	1.48e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs35306767	0.715	rs17221463	chr10:1038040	T/C	cg26597838	chr10:835615	NA	0.63	5.29	0.51	1.11e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs1577917	1.000	rs12192992	chr6:86609915	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.85	-8.62	-0.7	5.82e-13	Response to antipsychotic treatment;
SKCM	cis	rs55962025	0.883	rs3121419	chr4:3232257	C/T	cg11471262	chr4:3318911	RGS12	-0.64	-4.92	-0.49	4.8e-6	Parental longevity (mother's age at death);
SKCM	cis	rs867186	1.000	rs117802529	chr20:33786677	C/T	cg04194272	chr20:33683537	NA	-1.02	-5.4	-0.52	7.03e-7	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs10504229	1.000	rs17805656	chr8:58180318	T/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs28595532	0.920	rs115673173	chr4:119755321	C/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs6582630	0.513	rs1596446	chr12:38282160	C/T	cg26384229	chr12:38710491	ALG10B	-0.85	-6.78	-0.61	2.05e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs4665809	0.590	rs6730310	chr2:26419470	C/G	cg04944784	chr2:26401820	FAM59B	-0.75	-4.82	-0.48	6.84e-6	Gut microbiome composition (summer);
SKCM	cis	rs7927771	0.864	rs2053979	chr11:47439444	A/G	cg05585544	chr11:47624801	NA	-0.57	-4.92	-0.49	4.76e-6	Subjective well-being;
SKCM	cis	rs62238980	0.614	rs4821025	chr22:32416892	C/T	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs11098499	0.954	rs1546505	chr4:120241224	A/G	cg09307838	chr4:120376055	NA	0.95	7.34	0.64	1.8e-10	Corneal astigmatism;
SKCM	cis	rs6089584	0.566	rs2146852	chr20:60616492	T/G	cg16423285	chr20:60520624	NA	-0.57	-4.93	-0.49	4.5e-6	Body mass index;
SKCM	cis	rs2204008	0.599	rs2320526	chr12:38220405	T/A	cg26384229	chr12:38710491	ALG10B	0.81	6.95	0.62	9.67e-10	Bladder cancer;
SKCM	cis	rs798554	0.797	rs798493	chr7:2798731	A/G	cg14895029	chr7:2775587	GNA12	-0.7	-5.36	-0.52	8.13e-7	Height;
SKCM	cis	rs55962025	0.640	rs2530598	chr4:3230804	A/C	cg00764545	chr4:3318001	RGS12	0.61	5.02	0.49	3.19e-6	Parental longevity (mother's age at death);
SKCM	cis	rs875971	0.660	rs10950044	chr7:66042976	A/G	cg05627663	chr7:65219948	SNORA22;CCT6P1	-0.56	-4.84	-0.48	6.39e-6	Aortic root size;
SKCM	cis	rs7772486	0.790	rs4075694	chr6:146251108	G/C	cg23711669	chr6:146136114	FBXO30	-0.75	-7.24	-0.63	2.71e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs10256972	0.552	rs6978842	chr7:1204599	A/C	cg18765753	chr7:1198926	ZFAND2A	-0.52	-6.14	-0.57	3.29e-8	Longevity;Endometriosis;
SKCM	cis	rs28595532	0.920	rs115878132	chr4:119756239	T/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs208520	0.954	rs72884027	chr6:66995044	T/G	cg07460842	chr6:66804631	NA	0.87	5.96	0.56	6.95e-8	Exhaled nitric oxide output;
SKCM	cis	rs2386661	0.826	rs11255996	chr10:5670832	G/A	cg12223502	chr10:5658492	NA	-0.56	-4.8	-0.48	7.38e-6	Breast cancer;
SKCM	cis	rs6424115	1.000	rs4237	chr1:24114129	C/T	cg15997130	chr1:24165203	NA	0.59	4.86	0.48	5.96e-6	Immature fraction of reticulocytes;
SKCM	cis	rs3820928	0.874	rs7594505	chr2:227878562	C/G	cg11843606	chr2:227700838	RHBDD1	-0.59	-4.77	-0.47	8.53e-6	Pulmonary function;
SKCM	cis	rs2559856	1.000	rs2695284	chr12:102089318	A/G	cg12924262	chr12:102091054	CHPT1	-0.7	-6.07	-0.57	4.37e-8	Blood protein levels;
SKCM	cis	rs7666738	0.830	rs11941844	chr4:99042722	A/T	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs950776	0.616	rs647041	chr15:78880481	T/C	cg06917634	chr15:78832804	PSMA4	-0.9	-7.99	-0.67	9.7e-12	Sudden cardiac arrest;
SKCM	cis	rs1863918	0.659	rs2411988	chr5:178494100	T/C	cg21905437	chr5:178450457	ZNF879	-0.63	-5.53	-0.53	4.12e-7	Depression in response to interferon-based therapy in chronic hepatitis C;
SKCM	cis	rs561341	0.700	rs2074101	chr17:30228656	G/A	cg00745463	chr17:30367425	LRRC37B	-0.8	-5.07	-0.5	2.6e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs2153535	0.580	rs6421948	chr6:8531020	T/C	cg07606381	chr6:8435919	SLC35B3	0.93	6.8	0.61	1.92e-9	Motion sickness;
SKCM	cis	rs6840360	0.615	rs10021407	chr4:152465002	A/G	cg22705602	chr4:152727874	NA	-0.51	-5.78	-0.55	1.48e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs1799949	1.000	rs11657053	chr17:41191129	G/T	cg23758822	chr17:41437982	NA	0.91	7.51	0.65	8.13e-11	Menopause (age at onset);
SKCM	cis	rs778371	0.676	rs13024330	chr2:233715487	A/G	cg08000102	chr2:233561755	GIGYF2	0.78	5.93	0.56	7.69e-8	Schizophrenia;
SKCM	cis	rs11098499	0.542	rs7677836	chr4:120310638	T/A	cg09307838	chr4:120376055	NA	0.97	7.49	0.65	9.08e-11	Corneal astigmatism;
SKCM	cis	rs7618501	0.633	rs2883057	chr3:49998282	C/T	cg05072774	chr3:49840536	C3orf54	-0.66	-5.03	-0.49	3.12e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7772486	0.754	rs2064185	chr6:146066814	G/A	cg05347473	chr6:146136440	FBXO30	-0.61	-5.78	-0.55	1.49e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs8070128	0.583	rs7406982	chr17:17942613	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.05	9.29	0.72	2.92e-14	Total body bone mineral density;
SKCM	trans	rs561341	1.000	rs530209	chr17:30315287	A/G	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs798554	0.797	rs798488	chr7:2802522	T/C	cg19346786	chr7:2764209	NA	-0.72	-7.73	-0.66	3.17e-11	Height;
SKCM	cis	rs7772486	0.686	rs9485019	chr6:146046381	C/G	cg05347473	chr6:146136440	FBXO30	-0.55	-4.85	-0.48	6.14e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7618501	0.602	rs2301166	chr3:50148305	C/G	cg05072774	chr3:49840536	C3orf54	0.71	5.48	0.53	5e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs2439831	1.000	rs2439850	chr15:43784854	C/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.22	7.98	0.67	1.01e-11	Lung cancer in ever smokers;
SKCM	cis	rs2204008	0.774	rs11520273	chr12:38354075	A/T	cg26384229	chr12:38710491	ALG10B	0.81	6.56	0.6	5.29e-9	Bladder cancer;
SKCM	cis	rs7296418	0.675	rs1879379	chr12:123727443	G/A	cg00376283	chr12:123451042	ABCB9	0.89	7.3	0.64	2.14e-10	Platelet count;
SKCM	cis	rs6951245	0.554	rs11544331	chr7:1131411	C/T	cg23708337	chr7:1209742	NA	0.7	4.79	0.48	7.79e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs2404602	0.684	rs10851888	chr15:76902506	C/T	cg23625390	chr15:77176239	SCAPER	-0.85	-8.26	-0.68	2.93e-12	Blood metabolite levels;
SKCM	cis	rs6089829	0.962	rs2277769	chr20:61666805	C/T	cg03213289	chr20:61660250	NA	0.49	4.78	0.48	8.08e-6	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs7647973	0.516	rs4955419	chr3:49200692	T/A	cg06212747	chr3:49208901	KLHDC8B	0.79	5.62	0.54	2.87e-7	Menarche (age at onset);
SKCM	cis	rs1707322	1.000	rs946527	chr1:46485970	C/T	cg03146154	chr1:46216737	IPP	0.81	5.66	0.54	2.43e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs10504229	1.000	rs68076606	chr8:58191271	A/G	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs2153535	0.580	rs6918391	chr6:8461178	A/C	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs58688157	0.542	rs7926440	chr11:589819	C/T	cg16486109	chr11:613632	IRF7	1.02	6.35	0.58	1.3e-8	Systemic lupus erythematosus;
SKCM	cis	rs1218582	0.774	rs1007170	chr1:154881461	G/A	cg06221963	chr1:154839813	KCNN3	-0.61	-6.58	-0.6	4.97e-9	Prostate cancer;
SKCM	cis	rs62244186	0.566	rs55901755	chr3:44834707	C/T	cg15225532	chr3:44803084	KIF15;KIAA1143	0.62	4.85	0.48	6.14e-6	Depressive symptoms;
SKCM	cis	rs1405130	0.839	rs13009399	chr2:235571228	A/G	cg17841421	chr2:235704848	NA	-0.57	-4.95	-0.49	4.14e-6	Coronary artery disease;
SKCM	cis	rs854765	0.654	rs11078400	chr17:17757728	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	-1.05	-8.25	-0.68	3.1e-12	Total body bone mineral density;
SKCM	cis	rs870825	0.616	rs9631782	chr4:185626379	A/G	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs9902453	0.935	rs9909093	chr17:28271207	T/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.8	6.3	0.58	1.61e-8	Coffee consumption (cups per day);
SKCM	cis	rs801193	0.660	rs2659914	chr7:66156914	C/T	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.52	5.03	0.49	3.12e-6	Aortic root size;
SKCM	cis	rs9467773	1.000	rs9393731	chr6:26529374	C/T	cg09904177	chr6:26538194	HMGN4	0.54	4.98	0.49	3.78e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1799949	1.000	rs16940	chr17:41245237	A/G	cg25918947	chr17:41365094	TMEM106A	-0.62	-5.85	-0.55	1.1e-7	Menopause (age at onset);
SKCM	cis	rs7103648	0.630	rs7934481	chr11:47883337	C/T	cg20307385	chr11:47447363	PSMC3	0.91	7.04	0.62	6.76e-10	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs10777212	0.574	rs10777207	chr12:90265051	G/A	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.81	-5.1	-0.5	2.36e-6	Total body bone mineral density;
SKCM	cis	rs151997	0.925	rs27270	chr5:50183712	A/G	cg06027927	chr5:50259733	NA	-0.63	-5.52	-0.53	4.27e-7	Callous-unemotional behaviour;
SKCM	cis	rs9682041	0.668	rs6784631	chr3:170100476	T/C	cg11886554	chr3:170076028	SKIL	0.94	5.55	0.53	3.77e-7	Glomerular filtration rate in non diabetics (creatinine);Glomerular filtration rate (creatinine);
SKCM	cis	rs10155981	0.510	rs4719705	chr7:22592707	C/T	cg05062323	chr7:22590069	NA	-1.05	-6.05	-0.57	4.69e-8	Bilirubin levels;
SKCM	cis	rs2033711	0.905	rs1077420	chr19:58968875	A/C	cg03735888	chr19:58951602	ZNF132	0.71	6.23	0.58	2.2e-8	Uric acid clearance;
SKCM	cis	rs2243480	1.000	rs1392104	chr7:65759107	G/A	cg18252515	chr7:66147081	NA	1.34	8.18	0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs4237845	0.611	rs4583019	chr12:58316745	T/C	cg02175503	chr12:58329896	NA	0.95	9.22	0.72	4.03e-14	Intelligence (multi-trait analysis);
SKCM	cis	rs11690935	0.788	rs6715929	chr2:172877507	A/G	cg13550731	chr2:172543902	DYNC1I2	-0.86	-6.6	-0.6	4.56e-9	Schizophrenia;
SKCM	cis	rs7666738	0.830	rs6846739	chr4:99016647	G/A	cg17366294	chr4:99064904	C4orf37	0.6	4.98	0.49	3.66e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2153535	1.000	rs2153535	chr6:8369679	C/G	cg07606381	chr6:8435919	SLC35B3	-0.63	-4.8	-0.48	7.44e-6	Motion sickness;
SKCM	cis	rs12709013	0.766	rs34438483	chr16:58844434	A/G	cg02431531	chr16:59244939	NA	0.48	4.99	0.49	3.62e-6	Blood metabolite ratios;
SKCM	cis	rs867186	1.000	rs6060230	chr20:33689308	A/G	cg04194272	chr20:33683537	NA	1.21	6.8	0.61	1.89e-9	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs9911578	0.967	rs11079368	chr17:57086473	C/T	cg12560992	chr17:57184187	TRIM37	-1.09	-10.28	-0.76	3.61e-16	Intelligence (multi-trait analysis);
SKCM	cis	rs3091242	0.933	rs34006994	chr1:25780668	C/T	cg02931644	chr1:25747376	RHCE	-0.5	-4.9	-0.48	5.17e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs13256369	1.000	rs12547721	chr8:8570671	C/T	cg06636001	chr8:8085503	FLJ10661	0.75	5.77	0.55	1.54e-7	Obesity-related traits;
SKCM	cis	rs12497850	0.897	rs9681717	chr3:48872998	A/G	cg06212747	chr3:49208901	KLHDC8B	0.68	4.89	0.48	5.28e-6	Parkinson's disease;
SKCM	cis	rs7659604	0.540	rs4455438	chr4:122669550	G/A	cg19671926	chr4:122722719	EXOSC9	0.75	6.11	0.57	3.68e-8	Type 2 diabetes;
SKCM	cis	rs10256972	0.521	rs10280960	chr7:1103697	A/G	cg11360546	chr7:1094263	C7orf50	-0.42	-4.92	-0.49	4.78e-6	Longevity;Endometriosis;
SKCM	cis	rs6834538	0.597	rs1471881	chr4:113557539	T/A	cg05166686	chr4:113558556	LARP7;C4orf21	0.63	5.2	0.51	1.56e-6	Free thyroxine concentration;
SKCM	cis	rs4481887	0.893	rs6702113	chr1:248486151	T/C	cg00666640	chr1:248458726	OR2T12	0.59	5.19	0.51	1.64e-6	Common traits (Other);
SKCM	cis	rs9325144	0.647	rs10875953	chr12:39050536	G/C	cg26384229	chr12:38710491	ALG10B	-0.7	-6.26	-0.58	1.92e-8	Morning vs. evening chronotype;
SKCM	cis	rs1552244	1.000	rs33917318	chr3:10067797	T/C	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs58688157	0.921	rs12805435	chr11:612355	T/C	cg17114584	chr11:613792	IRF7	0.74	5.0	0.49	3.51e-6	Systemic lupus erythematosus;
SKCM	cis	rs4819052	0.851	rs13049337	chr21:46663460	T/G	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.42	0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs10489202	0.683	rs7515429	chr1:168066659	A/G	cg24449463	chr1:168025552	DCAF6	-0.75	-7.05	-0.62	6.38e-10	Schizophrenia;
SKCM	cis	rs684232	0.933	rs2474694	chr17:618039	G/A	cg12384639	chr17:618140	VPS53	-0.71	-5.47	-0.53	5.25e-7	Prostate cancer;
SKCM	cis	rs2839186	0.814	rs2276257	chr21:47711229	A/G	cg05896524	chr21:47604654	C21orf56	0.69	5.69	0.54	2.11e-7	Testicular germ cell tumor;
SKCM	cis	rs919433	0.783	rs3097383	chr2:198236887	A/G	cg04278110	chr2:198063759	ANKRD44	0.74	5.13	0.5	2.06e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs6450176	1.000	rs6450175	chr5:53297824	C/T	ch.5.1024479R	chr5:53302184	ARL15	-0.73	-5.04	-0.5	2.91e-6	HDL cholesterol levels;HDL cholesterol;Adiponectin levels;
SKCM	cis	rs8014204	0.762	rs10148293	chr14:75296831	C/T	cg06637938	chr14:75390232	RPS6KL1	-0.67	-5.26	-0.51	1.22e-6	Caffeine consumption;
SKCM	cis	rs763014	0.966	rs12935215	chr16:670605	T/C	cg09263875	chr16:632152	PIGQ	0.72	6.45	0.59	8.69e-9	Height;
SKCM	cis	rs35306767	0.761	rs34480046	chr10:1027440	A/G	cg26597838	chr10:835615	NA	0.76	6.22	0.58	2.29e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs72615157	0.634	rs74742883	chr7:99785765	T/G	cg07160278	chr7:100027354	MEPCE;ZCWPW1	0.97	5.98	0.56	6.44e-8	Lung function (FEV1/FVC);
SKCM	cis	rs6840360	0.571	rs11940881	chr4:152501050	C/G	cg22705602	chr4:152727874	NA	-0.51	-5.47	-0.53	5.16e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs17685	0.672	rs1894760	chr7:75852140	A/G	cg01364799	chr7:75623366	TMEM120A	-0.69	-5.66	-0.54	2.43e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2836974	0.831	rs4375956	chr21:40521788	G/A	cg11890956	chr21:40555474	PSMG1	1.11	12.74	0.82	9.4e-21	Cognitive function;
SKCM	cis	rs10905065	0.965	rs12571639	chr10:5748052	G/A	cg09234995	chr10:5726438	C10orf18	-0.64	-5.44	-0.52	6.01e-7	Menopause (age at onset);
SKCM	cis	rs600231	0.665	rs2846861	chr11:65222305	A/G	cg24009118	chr11:65545808	DKFZp761E198	0.69	5.08	0.5	2.5e-6	Bone mineral density;
SKCM	cis	rs7666738	0.830	rs10007872	chr4:99001904	T/C	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9916302	0.904	rs4794813	chr17:37670994	A/T	cg07936489	chr17:37558343	FBXL20	-0.87	-7.97	-0.67	1.07e-11	Glomerular filtration rate (creatinine);
SKCM	cis	rs10504073	0.626	rs9298106	chr8:50007508	T/G	cg00325661	chr8:49890786	NA	0.82	7.02	0.62	7.13e-10	Blood metabolite ratios;
SKCM	trans	rs2727020	0.615	rs4980435	chr11:49591576	G/A	cg15704280	chr7:45808275	SEPT13	-0.97	-9.25	-0.72	3.48e-14	Coronary artery disease;
SKCM	cis	rs854765	0.583	rs66531105	chr17:17809001	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.99	7.59	0.65	5.86e-11	Total body bone mineral density;
SKCM	cis	rs34891900	0.507	rs2587084	chr22:18140644	T/G	cg19898043	chr22:18121309	BCL2L13	0.66	4.93	0.49	4.48e-6	Sum neutrophil eosinophil counts;
SKCM	cis	rs1218582	0.772	rs10908448	chr1:154882544	A/G	cg03351412	chr1:154909251	PMVK	-0.75	-6.45	-0.59	8.45e-9	Prostate cancer;
SKCM	cis	rs362272	0.545	rs2236052	chr4:3318413	C/T	cg11471262	chr4:3318911	RGS12	-0.94	-11.72	-0.8	7.06e-19	Serum sulfate level;
SKCM	cis	rs711830	0.965	rs2072590	chr2:177042633	A/C	cg13092806	chr2:177043255	NA	0.66	5.91	0.56	8.57e-8	Serous invasive ovarian cancer;Epithelial ovarian cancer;Invasive epithelial ovarian cancer;Mucinous ovarian carcinoma;Low-grade serous and serous borderline ovarian cancer;Serous borderline ovarian cancer;High-grade serous ovarian cancer;
SKCM	cis	rs559928	0.549	rs57831436	chr11:64007297	C/T	cg02228329	chr11:64053129	BAD;GPR137	0.94	5.47	0.53	5.28e-7	Inflammatory bowel disease;Crohn's disease;Ulcerative colitis;
SKCM	cis	rs6696846	0.749	rs61822566	chr1:205078660	T/C	cg03948781	chr1:205179583	DSTYK	0.56	5.28	0.51	1.14e-6	Red blood cell count;
SKCM	cis	rs10504229	1.000	rs59549824	chr8:58186205	A/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs6430585	0.528	rs56064699	chr2:136595706	G/A	cg07169764	chr2:136633963	MCM6	1.31	13.22	0.83	1.29e-21	Corneal structure;
SKCM	cis	rs12706411	0.702	rs34565849	chr7:122058880	A/G	cg17986181	chr7:121955208	NA	-0.68	-5.06	-0.5	2.69e-6	Alzheimer disease and age of onset;
SKCM	cis	rs11098499	0.909	rs28668716	chr4:120309875	T/C	cg09307838	chr4:120376055	NA	0.97	7.49	0.65	9.08e-11	Corneal astigmatism;
SKCM	cis	rs4481887	0.741	rs11488133	chr1:248548380	T/C	cg00666640	chr1:248458726	OR2T12	0.47	4.8	0.48	7.51e-6	Common traits (Other);
SKCM	cis	rs6977660	1.000	rs6977660	chr7:19805480	C/T	cg07541023	chr7:19748670	TWISTNB	0.72	5.03	0.5	3.01e-6	Thyroid stimulating hormone;
SKCM	cis	rs7523050	0.730	rs72984628	chr1:109460808	G/A	cg08274380	chr1:109419600	GPSM2	1.06	6.64	0.6	3.76e-9	Fat distribution (HIV);
SKCM	cis	rs17065868	0.803	rs11147955	chr13:45176769	T/A	cg10246903	chr13:45222710	NA	0.94	5.07	0.5	2.6e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs12477438	0.520	rs6743355	chr2:99732360	C/G	cg14399236	chr2:99771627	LIPT1;TSGA10	0.95	8.78	0.71	2.89e-13	Chronic sinus infection;
SKCM	cis	rs2645694	0.626	rs2703116	chr4:77824289	C/T	cg03477792	chr4:77819574	ANKRD56	-0.57	-6.44	-0.59	8.83e-9	Emphysema distribution in smoking;
SKCM	cis	rs55794721	0.509	rs12027135	chr1:25775733	A/T	cg02931644	chr1:25747376	RHCE	0.5	4.9	0.48	5.17e-6	Plateletcrit;Mean corpuscular volume;
SKCM	cis	rs6933660	0.646	rs3736176	chr6:151773320	T/A	cg10883421	chr6:151773342	RMND1;C6orf211	0.87	7.73	0.66	3.17e-11	Menarche (age at onset);
SKCM	cis	rs10751667	0.643	rs7396407	chr11:929374	A/T	cg06064525	chr11:970664	AP2A2	-0.55	-5.09	-0.5	2.46e-6	Alzheimer's disease (late onset);
SKCM	cis	rs7618501	0.699	rs9862795	chr3:49915506	A/T	cg05072774	chr3:49840536	C3orf54	-0.66	-5.03	-0.49	3.1e-6	Intelligence (multi-trait analysis);
SKCM	trans	rs2727020	0.658	rs10839278	chr11:49450847	G/C	cg15704280	chr7:45808275	SEPT13	-0.87	-7.93	-0.67	1.31e-11	Coronary artery disease;
SKCM	cis	rs1014246	0.826	rs4752004	chr10:118473209	A/G	cg14919929	chr10:118506882	NA	0.74	6.13	0.57	3.38e-8	Age at smoking initiation in chronic obstructive pulmonary disease;
SKCM	cis	rs11098499	0.644	rs34835603	chr4:120553428	C/T	cg09307838	chr4:120376055	NA	0.94	7.77	0.66	2.64e-11	Corneal astigmatism;
SKCM	cis	rs6951245	0.706	rs28522260	chr7:1183964	C/A	cg23708337	chr7:1209742	NA	0.89	5.4	0.52	7.12e-7	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs2243480	1.000	rs781150	chr7:65480973	C/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs875971	0.545	rs316316	chr7:65614257	C/T	cg18876405	chr7:65276391	NA	-0.64	-5.29	-0.51	1.09e-6	Aortic root size;
SKCM	cis	rs9902453	0.757	rs12453308	chr17:28441604	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.5	0.53	4.74e-7	Coffee consumption (cups per day);
SKCM	cis	rs7666738	0.830	rs11942114	chr4:99066261	C/G	cg17366294	chr4:99064904	C4orf37	0.61	4.93	0.49	4.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4242434	0.889	rs4592028	chr8:22449484	T/C	cg03733263	chr8:22462867	KIAA1967	1.11	8.55	0.7	8.21e-13	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs1568889	1.000	rs12803716	chr11:28055111	A/G	cg06544937	chr11:28130018	METT5D1;KIF18A	0.86	7.03	0.62	6.97e-10	Bipolar disorder;
SKCM	cis	rs2354432	0.556	rs66501488	chr1:146853992	T/C	cg25205988	chr1:146714368	CHD1L	-1.11	-5.59	-0.53	3.21e-7	Mitochondrial DNA levels;
SKCM	cis	rs7103648	0.695	rs10838726	chr11:47568344	C/G	cg20307385	chr11:47447363	PSMC3	0.97	7.44	0.64	1.15e-10	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs11098499	0.909	rs11723839	chr4:120299673	G/A	cg09307838	chr4:120376055	NA	0.97	7.49	0.65	9.08e-11	Corneal astigmatism;
SKCM	cis	rs2153535	0.601	rs2143352	chr6:8530248	G/C	cg07606381	chr6:8435919	SLC35B3	0.93	6.8	0.61	1.92e-9	Motion sickness;
SKCM	cis	rs2836974	0.965	rs9941894	chr21:40634058	C/T	cg11890956	chr21:40555474	PSMG1	1.12	14.51	0.85	7.19e-24	Cognitive function;
SKCM	cis	rs6840360	0.571	rs55808836	chr4:152554991	C/T	cg22705602	chr4:152727874	NA	-0.52	-5.69	-0.54	2.15e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs875971	0.929	rs6970860	chr7:65976634	A/G	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	cis	rs9300255	0.602	rs1790098	chr12:123655481	A/C	cg05973401	chr12:123451056	ABCB9	0.83	5.5	0.53	4.69e-7	Neutrophil percentage of white cells;
SKCM	cis	rs7647973	0.600	rs13064780	chr3:49274826	T/G	cg06212747	chr3:49208901	KLHDC8B	0.78	5.59	0.54	3.15e-7	Menarche (age at onset);
SKCM	cis	rs1218582	0.804	rs869506	chr1:154859581	A/C	cg16680214	chr1:154839983	KCNN3	-0.56	-4.97	-0.49	3.89e-6	Prostate cancer;
SKCM	cis	rs28595532	0.920	rs116231457	chr4:119762396	A/C	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs854765	0.547	rs28537385	chr17:17902135	G/A	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.07	8.98	0.71	1.19e-13	Total body bone mineral density;
SKCM	cis	rs1577917	0.682	rs6935918	chr6:86283575	G/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.74	6.44	0.59	9e-9	Response to antipsychotic treatment;
SKCM	cis	rs1506636	0.889	rs619075	chr7:123426317	A/T	cg03229431	chr7:123269106	ASB15	0.66	5.21	0.51	1.53e-6	Plateletcrit;Platelet count;
SKCM	trans	rs1814175	0.645	rs10128731	chr11:50023554	G/T	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs66573146	0.831	rs11546450	chr4:7032180	G/A	cg00086871	chr4:6988644	TBC1D14	1.32	5.13	0.5	2.02e-6	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs2952156	0.652	rs11869286	chr17:37813856	C/G	cg20243544	chr17:37824526	PNMT	0.73	5.62	0.54	2.88e-7	Asthma;
SKCM	cis	rs873946	0.586	rs12251911	chr10:134570595	A/G	cg26818010	chr10:134567672	INPP5A	-0.79	-6.03	-0.56	5.11e-8	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs478304	0.627	rs11604568	chr11:65511336	G/A	cg27068330	chr11:65405492	SIPA1	-0.89	-8.2	-0.68	3.77e-12	Acne (severe);
SKCM	cis	rs7618915	0.524	rs12488461	chr3:52698417	T/C	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs34779708	0.966	rs4934536	chr10:35441169	A/G	cg03585969	chr10:35415529	CREM	0.73	6.0	0.56	5.85e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs7143963	0.887	rs11552464	chr14:103377354	T/G	cg23020514	chr14:103360112	TRAF3	0.78	6.71	0.6	2.79e-9	Body mass index;
SKCM	cis	rs754466	1.000	rs12220311	chr10:79681507	C/T	cg17075019	chr10:79541650	NA	-0.7	-5.72	-0.54	1.92e-7	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs9926296	0.572	rs8046872	chr16:89841552	T/C	cg01097406	chr16:89675127	NA	-0.48	-5.06	-0.5	2.68e-6	Vitiligo;
SKCM	cis	rs8180040	1.000	rs1076394	chr3:47322781	G/A	cg27129171	chr3:47204927	SETD2	-0.87	-6.62	-0.6	4.15e-9	Colorectal cancer;
SKCM	cis	rs9640161	0.830	rs13307276	chr7:150061525	T/C	cg10018233	chr7:150070692	REPIN1	0.73	6.44	0.59	8.89e-9	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs782590	0.837	rs782584	chr2:55921116	C/G	cg18811423	chr2:55921094	PNPT1	-0.93	-7.98	-0.67	1.01e-11	Metabolic syndrome;
SKCM	cis	rs10752881	0.740	rs1889307	chr1:183049389	T/A	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.39	0.59	1.09e-8	Colorectal cancer;
SKCM	cis	rs57221529	0.766	rs12521988	chr5:556421	C/T	cg10555297	chr5:473380	SLC9A3;LOC25845	1.05	5.35	0.52	8.71e-7	Lung disease severity in cystic fibrosis;
SKCM	cis	rs11950121	0.633	rs7700935	chr5:53159136	A/T	cg06476337	chr5:52856530	NDUFS4	-0.68	-4.8	-0.48	7.59e-6	Alcoholic chronic pancreatitis;
SKCM	cis	rs62103177	0.525	rs612913	chr18:77845882	A/G	cg06309094	chr18:77676213	PQLC1	0.82	5.02	0.49	3.21e-6	Opioid sensitivity;
SKCM	cis	rs13118159	0.509	rs7681872	chr4:1376735	G/A	cg20887711	chr4:1340912	KIAA1530	0.87	6.34	0.58	1.37e-8	Longevity;
SKCM	cis	rs10193935	0.901	rs2374429	chr2:42677888	A/G	cg27598129	chr2:42591480	NA	-0.86	-6.78	-0.61	2.03e-9	Colonoscopy-negative controls vs population controls;
SKCM	trans	rs10506458	1.000	rs73128779	chr12:63441852	T/G	cg03429785	chr15:59498649	MYO1E;LDHAL6B	-1.38	-7.54	-0.65	7.13e-11	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs6087990	0.899	rs4911110	chr20:31392366	C/T	cg13636640	chr20:31349939	DNMT3B	-0.88	-7.41	-0.64	1.32e-10	Ulcerative colitis;
SKCM	cis	rs793571	0.523	rs12439457	chr15:58982390	T/C	cg05156742	chr15:59063176	FAM63B	0.69	5.09	0.5	2.45e-6	Schizophrenia;
SKCM	cis	rs950027	0.620	rs1153860	chr15:45636584	A/G	cg21132104	chr15:45694354	SPATA5L1	-0.73	-5.77	-0.55	1.54e-7	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs17711722	0.701	rs4467826	chr7:65368708	A/G	cg11764359	chr7:65958608	NA	0.88	6.43	0.59	9.56e-9	Calcium levels;
SKCM	cis	rs9818758	0.607	rs80170003	chr3:48951640	T/C	cg00383909	chr3:49044727	WDR6	1.15	5.54	0.53	3.96e-7	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs17685	0.623	rs7782808	chr7:75768645	C/T	cg16489192	chr7:75678113	MDH2;STYXL1	-0.57	-5.35	-0.52	8.63e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs10504229	0.953	rs114806125	chr8:58182416	C/T	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs2599510	0.811	rs2710628	chr2:32758353	A/C	cg02381751	chr2:32503542	YIPF4	0.68	5.34	0.52	9e-7	Interleukin-18 levels;
SKCM	cis	rs7937682	0.883	rs510388	chr11:111451869	G/T	cg19812747	chr11:111475976	SIK2	0.6	5.1	0.5	2.37e-6	Primary sclerosing cholangitis;
SKCM	cis	rs6952808	0.594	rs3778964	chr7:2138109	C/T	cg21782813	chr7:2030301	MAD1L1	0.53	5.68	0.54	2.25e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs2228479	0.541	rs12918575	chr16:89811151	A/G	cg04287289	chr16:89883240	FANCA	0.89	4.92	0.49	4.64e-6	Skin colour saturation;
SKCM	cis	rs8062405	0.558	rs3743963	chr16:28604686	A/G	cg09445799	chr16:28968168	NFATC2IP	-0.56	-5.25	-0.51	1.26e-6	Cognitive ability (multi-trait analysis);Cognitive ability;
SKCM	cis	rs694739	0.628	rs508168	chr11:64135435	G/A	cg02228329	chr11:64053129	BAD;GPR137	0.87	6.15	0.57	3.03e-8	Alopecia areata;Crohn's disease;Psoriasis vulgaris;
SKCM	cis	rs9796	0.621	rs690733	chr15:41476465	G/A	cg18705301	chr15:41695430	NDUFAF1	-0.69	-5.11	-0.5	2.19e-6	Menopause (age at onset);
SKCM	cis	rs2204008	0.683	rs7305703	chr12:38138381	T/C	cg13010199	chr12:38710504	ALG10B	0.65	5.11	0.5	2.19e-6	Bladder cancer;
SKCM	cis	rs672059	1.000	rs483783	chr1:183162152	G/T	ch.1.3577855R	chr1:183094577	LAMC1	0.67	5.84	0.55	1.13e-7	Hypertriglyceridemia;
SKCM	cis	rs4727027	0.901	rs12671341	chr7:148805282	T/C	cg23583168	chr7:148888333	NA	-0.83	-6.7	-0.6	2.89e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs2153535	0.601	rs9406160	chr6:8464907	A/C	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs28386778	0.591	rs2584619	chr17:61913215	T/A	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs9910055	0.512	rs7209801	chr17:42323376	G/A	cg10896456	chr17:42255109	ASB16;C17orf65	0.6	4.89	0.48	5.2e-6	Total body bone mineral density;
SKCM	cis	rs2243480	1.000	rs35391607	chr7:65360829	G/A	cg07424592	chr7:64974309	NA	0.99	4.9	0.49	5.08e-6	Diabetic kidney disease;
SKCM	cis	rs910316	1.000	rs4903284	chr14:75592483	G/C	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.85e-7	Height;
SKCM	cis	rs4242434	0.726	rs10105545	chr8:22534232	A/G	cg03733263	chr8:22462867	KIAA1967	-0.8	-6.52	-0.59	6.3e-9	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs17376456	0.825	rs34967135	chr5:93221785	G/A	cg21475434	chr5:93447410	FAM172A	1.03	5.58	0.53	3.41e-7	Diabetic retinopathy;
SKCM	cis	rs13010713	0.840	rs4667115	chr2:182035403	T/C	cg21995919	chr2:182322279	ITGA4	-0.56	-5.38	-0.52	7.61e-7	Celiac disease;
SKCM	cis	rs7020830	0.867	rs563132	chr9:37245476	A/T	cg14294708	chr9:37120828	ZCCHC7	1.0	9.69	0.74	4.93e-15	Schizophrenia;
SKCM	cis	rs2836974	0.831	rs11911149	chr21:40528375	C/T	cg11890956	chr21:40555474	PSMG1	1.07	13.19	0.83	1.48e-21	Cognitive function;
SKCM	cis	rs2730245	0.527	rs2527194	chr7:158732959	G/A	cg24397884	chr7:158709396	WDR60	-1.01	-5.77	-0.55	1.53e-7	Height;
SKCM	cis	rs7618501	0.602	rs2624816	chr3:50117312	T/G	cg24110177	chr3:50126178	RBM5	0.61	5.18	0.51	1.71e-6	Intelligence (multi-trait analysis);
SKCM	trans	rs8073060	0.586	rs72829922	chr17:34044809	G/A	cg19694781	chr19:47549865	TMEM160	1.08	8.6	0.7	6.4e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs2013441	0.896	rs1812934	chr17:20030960	A/T	cg13482628	chr17:19912719	NA	-0.67	-5.14	-0.5	1.99e-6	Obesity-related traits;
SKCM	cis	rs1218582	0.772	rs2174507	chr1:154887949	C/T	cg24250549	chr1:154909240	PMVK	0.87	8.7	0.7	4.13e-13	Prostate cancer;
SKCM	cis	rs4132509	1.000	rs57824597	chr1:243930399	C/T	cg21452805	chr1:244014465	NA	0.89	5.45	0.53	5.68e-7	RR interval (heart rate);
SKCM	cis	rs854765	0.583	rs4534911	chr17:17852330	A/G	cg09796270	chr17:17721594	SREBF1	0.65	4.87	0.48	5.79e-6	Total body bone mineral density;
SKCM	cis	rs208520	0.661	rs704519	chr6:66801136	T/C	cg07460842	chr6:66804631	NA	-1.02	-7.65	-0.65	4.42e-11	Exhaled nitric oxide output;
SKCM	cis	rs28595532	0.920	rs56162974	chr4:119742333	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs1023500	0.551	rs133371	chr22:42465574	G/A	cg04733989	chr22:42467013	NAGA	0.72	5.72	0.54	1.9e-7	Schizophrenia;
SKCM	cis	rs2439831	0.850	rs12441127	chr15:44021175	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.31	7.38	0.64	1.49e-10	Lung cancer in ever smokers;
SKCM	cis	rs4642101	0.534	rs13316229	chr3:12807371	C/T	cg05775895	chr3:12838266	CAND2	0.58	4.82	0.48	6.83e-6	QRS complex (12-leadsum);
SKCM	cis	rs9790314	0.967	rs339101	chr3:161064193	A/T	cg03342759	chr3:160939853	NMD3	-0.77	-8.4	-0.69	1.61e-12	Morning vs. evening chronotype;
SKCM	cis	rs867186	1.000	rs75635914	chr20:33555815	C/T	cg04194272	chr20:33683537	NA	-1.37	-6.77	-0.61	2.18e-9	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs703842	0.963	rs2291617	chr12:58166403	T/G	cg04478727	chr12:58166393	METTL1;FAM119B	0.72	5.72	0.54	1.85e-7	Multiple sclerosis;
SKCM	cis	rs4969178	1.000	rs7212201	chr17:76393896	C/A	cg20026190	chr17:76395443	PGS1	0.63	5.45	0.53	5.6e-7	HDL cholesterol levels;
SKCM	cis	rs12477438	0.520	rs13030961	chr2:99799520	C/G	cg14399236	chr2:99771627	LIPT1;TSGA10	0.96	8.53	0.69	8.71e-13	Chronic sinus infection;
SKCM	cis	rs933688	0.941	rs2887007	chr5:90740531	A/T	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.07	8.69	0.7	4.41e-13	Smoking behavior;
SKCM	cis	rs1801251	0.963	rs6739638	chr2:233576015	G/A	cg25237894	chr2:233734115	C2orf82	0.61	5.66	0.54	2.39e-7	Coronary artery disease;
SKCM	cis	rs10193935	0.901	rs2286702	chr2:42555473	C/T	cg27598129	chr2:42591480	NA	-0.89	-6.82	-0.61	1.74e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2811415	0.597	rs9813824	chr3:127761959	C/T	cg09089421	chr3:127803668	RUVBL1	0.99	8.52	0.69	9.09e-13	Lung function (FEV1/FVC);
SKCM	cis	rs55962025	0.804	rs3775061	chr4:3238754	A/G	cg05297308	chr4:3317976	RGS12	-0.69	-5.11	-0.5	2.19e-6	Parental longevity (mother's age at death);
SKCM	cis	rs933688	1.000	rs61612071	chr5:90741470	G/A	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.07	8.52	0.69	9.25e-13	Smoking behavior;
SKCM	cis	rs11718455	1.000	rs1524885	chr3:44031847	G/A	cg21419209	chr3:44054225	NA	-0.66	-5.22	-0.51	1.42e-6	Coronary artery disease;
SKCM	cis	rs826838	0.967	rs1352123	chr12:39130992	T/C	cg26384229	chr12:38710491	ALG10B	-0.91	-8.28	-0.68	2.74e-12	Heart rate;
SKCM	cis	rs875971	0.862	rs801194	chr7:66028495	T/C	cg11764359	chr7:65958608	NA	-0.75	-6.8	-0.61	1.88e-9	Aortic root size;
SKCM	cis	rs10504229	0.683	rs903702	chr8:58128557	T/C	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs77216612	1.000	rs77216612	chr12:12877983	A/G	cg09462578	chr12:12878428	APOLD1	-0.85	-5.5	-0.53	4.58e-7	Lymphocyte counts;
SKCM	cis	rs2153535	0.580	rs4960413	chr6:8438466	C/T	cg23788917	chr6:8435910	SLC35B3	0.7	5.15	0.5	1.92e-6	Motion sickness;
SKCM	cis	rs7666738	0.830	rs9998803	chr4:99002519	C/T	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs672059	1.000	rs652753	chr1:183156569	A/T	ch.1.3577855R	chr1:183094577	LAMC1	0.63	5.23	0.51	1.38e-6	Hypertriglyceridemia;
SKCM	cis	rs875971	0.660	rs28698552	chr7:66005018	A/G	cg18876405	chr7:65276391	NA	0.8	7.11	0.63	4.86e-10	Aortic root size;
SKCM	cis	rs4689592	0.546	rs907523	chr4:7052777	A/G	cg26116260	chr4:7069785	GRPEL1	1.2	9.71	0.74	4.52e-15	Monocyte percentage of white cells;
SKCM	cis	rs10540	1.000	rs12788729	chr11:502371	G/A	cg03576123	chr11:487126	PTDSS2	-1.43	-8.14	-0.68	5.08e-12	Body mass index;
SKCM	cis	rs2952156	0.959	rs1495102	chr17:37832093	T/C	cg20243544	chr17:37824526	PNMT	0.77	5.81	0.55	1.3e-7	Asthma;
SKCM	cis	rs1003719	0.788	rs4817849	chr21:38469796	A/G	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs56235845	0.694	rs11749830	chr5:176766547	G/A	cg06060754	chr5:176797920	RGS14	0.69	6.56	0.6	5.28e-9	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs910316	0.763	rs1548807	chr14:75479582	T/G	cg08847533	chr14:75593920	NEK9	0.82	7.06	0.62	6.19e-10	Height;
SKCM	cis	rs8180040	1.000	rs8180040	chr3:47388947	A/T	cg16586182	chr3:47516702	SCAP	-0.71	-4.85	-0.48	6.25e-6	Colorectal cancer;
SKCM	cis	rs12971120	1.000	rs2278162	chr18:72175814	A/G	cg26446133	chr18:72167187	CNDP2	-0.67	-5.62	-0.54	2.8e-7	Refractive error;
SKCM	cis	rs3785574	0.650	rs2070776	chr17:62007498	A/G	cg01411255	chr17:61851458	DDX42;CCDC47	-0.72	-5.35	-0.52	8.6e-7	Height;
SKCM	cis	rs478304	0.593	rs7120713	chr11:65483374	G/C	cg27068330	chr11:65405492	SIPA1	-0.86	-7.44	-0.64	1.12e-10	Acne (severe);
SKCM	cis	rs2836974	0.666	rs2836975	chr21:40663620	A/G	cg17971929	chr21:40555470	PSMG1	-0.74	-7.06	-0.62	5.99e-10	Cognitive function;
SKCM	cis	rs9581857	0.579	rs77187836	chr13:27998646	C/A	cg22138327	chr13:27999177	GTF3A	0.95	6.38	0.59	1.14e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs2839186	0.807	rs2032226	chr21:47680352	G/A	cg11766577	chr21:47581405	C21orf56	-0.69	-5.9	-0.56	8.79e-8	Testicular germ cell tumor;
SKCM	cis	rs11734570	0.581	rs73808504	chr4:38600593	T/C	cg18361445	chr4:38666374	KLF3;FLJ13197	0.86	5.8	0.55	1.35e-7	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs1568889	1.000	rs7102106	chr11:28343953	G/A	cg06544937	chr11:28130018	METT5D1;KIF18A	0.86	7.03	0.62	6.97e-10	Bipolar disorder;
SKCM	cis	rs9951698	0.678	rs11080620	chr18:13029068	G/T	cg12848697	chr18:13133368	NA	-0.53	-4.78	-0.48	7.97e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs58688157	0.960	rs1131665	chr11:613208	T/C	cg03576123	chr11:487126	PTDSS2	-0.84	-5.45	-0.53	5.64e-7	Systemic lupus erythematosus;
SKCM	cis	rs28386778	0.863	rs3760252	chr17:61852186	G/C	cg01411255	chr17:61851458	DDX42;CCDC47	0.78	5.05	0.5	2.87e-6	Prudent dietary pattern;
SKCM	trans	rs208520	0.690	rs1563929	chr6:66702108	G/A	cg15611600	chr13:45563400	KIAA1704;NUFIP1	0.94	7.96	0.67	1.13e-11	Exhaled nitric oxide output;
SKCM	cis	rs13091206	1	rs13091206	chr3:49238718	A/G	cg07636037	chr3:49044803	WDR6	0.87	5.22	0.51	1.42e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs3820068	0.603	rs72647120	chr1:15956769	G/T	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs2839186	0.770	rs2280956	chr21:47642323	C/G	cg05896524	chr21:47604654	C21orf56	-0.68	-5.63	-0.54	2.78e-7	Testicular germ cell tumor;
SKCM	cis	rs7208859	0.623	rs9911997	chr17:29124648	A/G	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs7605378	0.528	rs281787	chr2:200784238	C/T	cg23649088	chr2:200775458	C2orf69	-0.67	-5.31	-0.52	9.99e-7	Osteoporosis;
SKCM	cis	rs7772486	0.875	rs9403763	chr6:146357655	A/G	cg23711669	chr6:146136114	FBXO30	0.77	7.48	0.65	9.65e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs3820068	0.603	rs7531396	chr1:15969870	G/C	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs11858159	0.545	rs6576320	chr15:24783254	T/C	cg24138476	chr15:25312939	SNORD116-5;SNORD116-7	0.56	4.81	0.48	7.29e-6	Platelet thrombus formation;
SKCM	cis	rs12477438	0.520	rs2632276	chr2:99779655	C/A	cg14399236	chr2:99771627	LIPT1;TSGA10	0.97	8.44	0.69	1.34e-12	Chronic sinus infection;
SKCM	cis	rs60871478	0.679	rs4076965	chr7:793272	A/G	cg05535760	chr7:792225	HEATR2	1.22	9.13	0.72	6.03e-14	Cerebrospinal P-tau181p levels;
SKCM	cis	rs6120849	0.754	rs6120790	chr20:33599090	A/T	cg24642439	chr20:33292090	TP53INP2	0.94	4.86	0.48	5.91e-6	Protein C levels;
SKCM	trans	rs17075286	1	rs17075286	chr3:43230723	C/G	cg00170973	chr17:58755074	BCAS3	-1.14	-8.02	-0.67	8.7e-12	Bipolar disorder and schizophrenia;
SKCM	cis	rs59918340	0.764	rs4961338	chr8:142230192	C/T	cg23750338	chr8:142222470	SLC45A4	-0.57	-5.51	-0.53	4.52e-7	Immature fraction of reticulocytes;
SKCM	cis	rs2070488	0.804	rs35463537	chr3:38498248	T/C	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.74	5.96	0.56	6.8e-8	Electrocardiographic conduction measures;
SKCM	cis	rs477895	0.713	rs3802933	chr11:63988102	C/T	cg07220939	chr11:64358617	SLC22A12	0.74	4.91	0.49	4.87e-6	Mean platelet volume;
SKCM	trans	rs3780486	0.846	rs913214	chr9:33135085	G/A	cg20290983	chr6:43655470	MRPS18A	1.0	11.42	0.79	2.56e-18	IgG glycosylation;
SKCM	cis	rs2204008	0.749	rs4579984	chr12:38166266	A/G	cg26384229	chr12:38710491	ALG10B	0.81	6.95	0.62	9.67e-10	Bladder cancer;
SKCM	cis	rs1784581	1.000	rs1618170	chr6:162400337	C/T	cg17173639	chr6:162384350	PARK2	-0.6	-5.16	-0.5	1.8e-6	Itch intensity from mosquito bite;
SKCM	cis	rs2153535	0.580	rs965706	chr6:8464708	G/A	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs17345786	0.511	rs1138818	chr3:101399583	C/G	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.81	7.06	0.62	6.11e-10	Colonoscopy-negative controls vs population controls;
SKCM	trans	rs1814175	0.817	rs7950856	chr11:49976394	C/T	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs3784262	0.740	rs4646582	chr15:58307381	G/C	cg12031962	chr15:58353849	ALDH1A2	-0.45	-5.45	-0.53	5.67e-7	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs66887589	0.967	rs56173225	chr4:120509972	G/A	cg09307838	chr4:120376055	NA	-0.65	-4.87	-0.48	5.72e-6	Diastolic blood pressure;
SKCM	cis	rs2354432	1.000	rs7514864	chr1:146690102	T/C	cg25205988	chr1:146714368	CHD1L	1.25	7.96	0.67	1.14e-11	Mitochondrial DNA levels;
SKCM	cis	rs6840360	0.571	rs62327270	chr4:152533618	C/T	cg22705602	chr4:152727874	NA	-0.52	-5.7	-0.54	2.03e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs10791097	0.694	rs1054869	chr11:130742630	G/A	cg12179176	chr11:130786555	SNX19	0.93	8.16	0.68	4.62e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs11098499	0.779	rs7699346	chr4:120310542	C/T	cg24375607	chr4:120327624	NA	0.65	4.97	0.49	3.87e-6	Corneal astigmatism;
SKCM	cis	rs992157	0.735	rs10932765	chr2:219099484	T/C	cg00012203	chr2:219082015	ARPC2	0.82	6.97	0.62	9.12e-10	Colorectal cancer;
SKCM	cis	rs854765	0.583	rs4413022	chr17:17858280	G/C	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.01	7.49	0.65	9.28e-11	Total body bone mineral density;
SKCM	cis	rs8072100	1.000	rs11650372	chr17:45721795	G/A	cg08085267	chr17:45401833	C17orf57	-0.63	-5.86	-0.55	1.06e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs3892630	0.878	rs11878394	chr19:33205844	G/C	cg22980127	chr19:33182716	NUDT19	1.41	8.2	0.68	3.88e-12	Red blood cell traits;
SKCM	cis	rs826838	0.967	rs1684413	chr12:39128704	G/A	cg13010199	chr12:38710504	ALG10B	-0.72	-5.73	-0.54	1.83e-7	Heart rate;
SKCM	cis	rs1005277	0.602	rs2504142	chr10:38383793	C/T	cg25427524	chr10:38739819	LOC399744	-0.69	-6.45	-0.59	8.73e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs72781680	1.000	rs75046532	chr2:24167267	A/G	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	cis	rs1799949	1.000	rs4534897	chr17:41431808	A/G	cg05368731	chr17:41323189	NBR1	0.85	7.42	0.64	1.23e-10	Menopause (age at onset);
SKCM	cis	rs9814567	0.964	rs6776203	chr3:134234345	C/T	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs6570726	0.935	rs367643	chr6:145859602	A/C	cg23711669	chr6:146136114	FBXO30	0.71	6.8	0.61	1.93e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs58688157	0.705	rs12419694	chr11:598033	C/T	cg16486109	chr11:613632	IRF7	1.06	7.98	0.67	1.03e-11	Systemic lupus erythematosus;
SKCM	cis	rs2204008	0.837	rs11611861	chr12:38357459	A/G	cg26384229	chr12:38710491	ALG10B	0.81	6.56	0.6	5.29e-9	Bladder cancer;
SKCM	cis	rs7769051	1.000	rs9493444	chr6:133125320	C/G	cg22852734	chr6:133119734	C6orf192	1.0	5.39	0.52	7.39e-7	Type 2 diabetes nephropathy;
SKCM	trans	rs1814175	0.754	rs7103235	chr11:49699191	A/G	cg03929089	chr4:120376271	NA	-0.89	-7.93	-0.67	1.28e-11	Height;
SKCM	cis	rs2721195	0.874	rs2721173	chr8:145744429	C/T	cg15320075	chr8:145703422	NA	0.79	6.74	0.61	2.49e-9	Age at first birth;
SKCM	cis	rs6921919	0.583	rs35599905	chr6:28379663	C/T	cg14547644	chr6:28411285	ZSCAN23	-0.58	-4.8	-0.48	7.46e-6	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs826838	0.935	rs7301104	chr12:39182821	C/T	cg26384229	chr12:38710491	ALG10B	0.9	7.85	0.66	1.84e-11	Heart rate;
SKCM	cis	rs28386778	0.863	rs8076760	chr17:61920497	T/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs9788682	0.948	rs905739	chr15:78845110	A/G	cg24631222	chr15:78858424	CHRNA5	0.97	6.84	0.61	1.59e-9	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs10256972	0.567	rs2960835	chr7:1202963	A/G	cg07092213	chr7:1199455	ZFAND2A	-0.68	-5.75	-0.55	1.69e-7	Longevity;Endometriosis;
SKCM	cis	rs2404602	0.647	rs4886840	chr15:77179002	A/G	cg23625390	chr15:77176239	SCAPER	-0.82	-7.93	-0.67	1.26e-11	Blood metabolite levels;
SKCM	cis	rs155076	0.938	rs485361	chr13:21845826	G/T	cg14456004	chr13:21872349	NA	-1.22	-6.76	-0.61	2.24e-9	White matter hyperintensity burden;
SKCM	cis	rs2228479	0.850	rs17226428	chr16:89842884	T/A	cg06558623	chr16:89946397	TCF25	1.05	4.81	0.48	7.23e-6	Skin colour saturation;
SKCM	cis	rs10540	1.000	rs12421457	chr11:505780	T/C	cg03576123	chr11:487126	PTDSS2	-1.43	-8.14	-0.68	5.08e-12	Body mass index;
SKCM	cis	rs6424115	0.830	rs2501426	chr1:24199364	G/A	cg15997130	chr1:24165203	NA	0.6	4.94	0.49	4.37e-6	Immature fraction of reticulocytes;
SKCM	cis	rs72781680	0.898	rs12623316	chr2:24087857	A/G	cg08917208	chr2:24149416	ATAD2B	0.99	5.24	0.51	1.31e-6	Lymphocyte counts;
SKCM	cis	rs34779708	0.931	rs34954932	chr10:35410807	G/T	cg03585969	chr10:35415529	CREM	0.79	6.21	0.58	2.4e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs10089	0.953	rs2016015	chr5:127527253	T/C	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.87	7.42	0.64	1.22e-10	Ileal carcinoids;
SKCM	cis	rs2463822	0.925	rs2513075	chr11:62102408	C/T	cg06239285	chr11:62104954	ASRGL1	1.27	6.04	0.56	4.98e-8	Chronic obstructive pulmonary disease-related biomarkers;
SKCM	cis	rs6088580	0.634	rs6058052	chr20:33047084	A/G	cg24642439	chr20:33292090	TP53INP2	0.75	6.02	0.56	5.32e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs208520	0.690	rs864314	chr6:66814830	G/A	cg07460842	chr6:66804631	NA	-1.12	-13.09	-0.83	2.28e-21	Exhaled nitric oxide output;
SKCM	cis	rs2404602	0.647	rs11631959	chr15:77040048	T/C	cg23625390	chr15:77176239	SCAPER	-0.82	-7.93	-0.67	1.26e-11	Blood metabolite levels;
SKCM	cis	rs36093844	0.698	rs55951560	chr11:85548342	T/C	cg25872744	chr11:85566296	CCDC83	-0.85	-4.77	-0.48	8.27e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs10193935	0.901	rs7594010	chr2:42534896	C/T	cg27598129	chr2:42591480	NA	-0.88	-6.71	-0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs8180040	0.903	rs7636423	chr3:47309134	C/G	cg16586182	chr3:47516702	SCAP	-0.72	-4.98	-0.49	3.73e-6	Colorectal cancer;
SKCM	cis	rs2836950	0.565	rs8134214	chr21:40542367	A/C	cg11890956	chr21:40555474	PSMG1	-0.7	-5.62	-0.54	2.84e-7	Menarche (age at onset);
SKCM	cis	rs28595532	1.000	rs55634130	chr4:119655093	C/T	cg14228332	chr4:119757509	SEC24D	0.97	4.92	0.49	4.71e-6	Cannabis dependence symptom count;
SKCM	cis	rs9486715	0.867	rs2499774	chr6:97006581	C/G	cg06623918	chr6:96969491	KIAA0776	-0.88	-7.76	-0.66	2.74e-11	Headache;
SKCM	cis	rs4689592	0.619	rs3796908	chr4:7061378	G/A	cg26116260	chr4:7069785	GRPEL1	1.12	8.15	0.68	4.78e-12	Monocyte percentage of white cells;
SKCM	cis	rs4555082	0.874	rs2015978	chr14:105720134	G/C	cg13114125	chr14:105738426	BRF1	-0.69	-5.37	-0.52	8.03e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs6951245	1.000	rs74366004	chr7:1088630	A/C	cg18402987	chr7:1209562	NA	1.14	6.01	0.56	5.68e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs875971	0.800	rs427557	chr7:65519250	A/G	cg11987759	chr7:65425863	GUSB	-0.56	-4.94	-0.49	4.34e-6	Aortic root size;
SKCM	cis	rs4819052	0.851	rs2838855	chr21:46680566	C/G	cg20896738	chr21:46707857	POFUT2;LOC642852	-0.65	-4.89	-0.48	5.35e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs72781680	0.752	rs72796119	chr2:23917179	C/T	cg08917208	chr2:24149416	ATAD2B	0.98	4.98	0.49	3.75e-6	Lymphocyte counts;
SKCM	cis	rs3820928	1.000	rs61067328	chr2:227761256	G/A	cg11843606	chr2:227700838	RHBDD1	-0.62	-4.99	-0.49	3.52e-6	Pulmonary function;
SKCM	cis	rs936229	0.749	rs7497201	chr15:75190690	A/G	cg14664628	chr15:75095509	CSK	-0.97	-7.02	-0.62	7.35e-10	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin);
SKCM	cis	rs2070488	0.636	rs2284817	chr3:38510388	A/G	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.75	5.63	0.54	2.73e-7	Electrocardiographic conduction measures;
SKCM	cis	rs514406	0.525	rs269291	chr1:53189297	C/T	cg24675658	chr1:53192096	ZYG11B	-0.64	-5.28	-0.51	1.16e-6	Monocyte count;
SKCM	cis	rs62064224	0.675	rs4795693	chr17:30636727	A/G	cg18200150	chr17:30822561	MYO1D	0.62	4.84	0.48	6.42e-6	Schizophrenia;
SKCM	cis	rs6818397	1.000	rs6818397	chr4:3434885	A/C	cg00764545	chr4:3318001	RGS12	-0.62	-5.28	-0.51	1.12e-6	LDL cholesterol levels;Total cholesterol levels;
SKCM	cis	rs6120849	0.586	rs2025096	chr20:33540000	G/A	cg24642439	chr20:33292090	TP53INP2	0.99	5.46	0.53	5.54e-7	Protein C levels;
SKCM	cis	rs12995491	0.569	rs6724281	chr2:88529531	T/G	cg18490616	chr2:88469792	THNSL2	-0.8	-6.19	-0.57	2.61e-8	Response to metformin (IC50);
SKCM	cis	rs7666738	0.830	rs13147195	chr4:98893334	G/T	cg17366294	chr4:99064904	C4orf37	0.57	4.86	0.48	6.02e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11105298	0.685	rs117578503	chr12:89836672	G/C	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.88	-6.02	-0.56	5.29e-8	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs4803468	1.000	rs284657	chr19:41929915	G/C	cg09537434	chr19:41945824	ATP5SL	-1.1	-13.85	-0.84	1.02e-22	Height;
SKCM	cis	rs4862750	0.914	rs1991255	chr4:187875340	G/A	cg10295955	chr4:187884368	NA	-1.03	-12.8	-0.82	7.39e-21	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs3784262	1.000	rs10851630	chr15:58242148	C/T	cg12031962	chr15:58353849	ALDH1A2	-0.48	-6.09	-0.57	4.07e-8	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs12142240	0.698	rs1475390	chr1:46816340	A/G	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs8068544	0.818	rs75771390	chr17:40194054	A/G	cg18442075	chr17:40169520	DNAJC7;NKIRAS2	-1.39	-7.01	-0.62	7.45e-10	Reticulocyte fraction of red cells;Reticulocyte count;
SKCM	cis	rs6665290	0.901	rs68087483	chr1:227202668	T/C	cg10327440	chr1:227177885	CDC42BPA	-1.21	-16.02	-0.88	2.21e-26	Myeloid white cell count;
SKCM	cis	rs2836974	0.932	rs8128734	chr21:40569511	G/A	cg17971929	chr21:40555470	PSMG1	0.9	8.51	0.69	9.85e-13	Cognitive function;
SKCM	cis	rs8017423	0.647	rs12882575	chr14:90820454	C/G	cg04374321	chr14:90722782	PSMC1	-0.77	-5.94	-0.56	7.46e-8	Mortality in heart failure;
SKCM	cis	rs12477438	0.508	rs2516832	chr2:99771268	G/C	cg14399236	chr2:99771627	LIPT1;TSGA10	0.97	8.9	0.71	1.72e-13	Chronic sinus infection;
SKCM	cis	rs7666738	0.830	rs13129503	chr4:98987892	T/C	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10256972	0.553	rs4236381	chr7:1165723	A/C	cg16145915	chr7:1198662	ZFAND2A	-0.57	-7.63	-0.65	4.93e-11	Longevity;Endometriosis;
SKCM	cis	rs4642101	0.737	rs9877165	chr3:12828497	C/T	cg05775895	chr3:12838266	CAND2	0.62	5.45	0.53	5.72e-7	QRS complex (12-leadsum);
SKCM	cis	rs2404602	1.000	rs2120107	chr15:76869789	A/G	cg23625390	chr15:77176239	SCAPER	0.77	7.37	0.64	1.56e-10	Blood metabolite levels;
SKCM	cis	rs801193	0.901	rs4273746	chr7:66301111	C/T	cg11764359	chr7:65958608	NA	-0.85	-6.37	-0.59	1.2e-8	Aortic root size;
SKCM	cis	rs2228479	0.850	rs62056066	chr16:89906563	G/A	cg00800038	chr16:89945340	TCF25	-1.0	-5.06	-0.5	2.75e-6	Skin colour saturation;
SKCM	trans	rs1814175	0.817	rs4881627	chr11:49953955	C/A	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs34779708	0.897	rs12764820	chr10:35386321	G/A	cg03585969	chr10:35415529	CREM	0.79	6.35	0.58	1.32e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs35306767	0.855	rs12770190	chr10:951262	C/T	cg26597838	chr10:835615	NA	0.79	5.5	0.53	4.64e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs28386778	0.830	rs2854210	chr17:61946338	C/A	cg06873352	chr17:61820015	STRADA	0.75	6.25	0.58	2.06e-8	Prudent dietary pattern;
SKCM	cis	rs2404602	0.716	rs17461634	chr15:76764107	G/A	cg23625390	chr15:77176239	SCAPER	0.59	5.38	0.52	7.54e-7	Blood metabolite levels;
SKCM	cis	rs1801251	0.752	rs2592126	chr2:233751377	A/G	cg25237894	chr2:233734115	C2orf82	-0.59	-6.28	-0.58	1.79e-8	Coronary artery disease;
SKCM	cis	rs7507204	0.723	rs12610998	chr19:3413653	T/C	cg08380311	chr19:3435252	NFIC	0.98	7.31	0.64	2.05e-10	Height;
SKCM	cis	rs870825	0.616	rs28442259	chr4:185646962	T/G	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs4820539	0.934	rs3788351	chr22:23469181	T/C	cg14186256	chr22:23484241	RTDR1	0.85	8.14	0.68	4.96e-12	Bone mineral density;
SKCM	cis	rs798554	0.836	rs13243214	chr7:2817455	G/T	cg04166393	chr7:2884313	GNA12	0.74	5.34	0.52	8.9e-7	Height;
SKCM	cis	rs13256369	0.851	rs11786125	chr8:8564570	T/G	cg15556689	chr8:8085844	FLJ10661	0.66	4.86	0.48	5.99e-6	Obesity-related traits;
SKCM	cis	rs9886651	0.869	rs4074704	chr8:128787032	C/T	cg24514600	chr8:128805414	PVT1	-0.55	-4.92	-0.49	4.71e-6	Epithelial ovarian cancer;Serous invasive ovarian cancer;
SKCM	cis	rs2120019	0.938	rs8033925	chr15:75311959	A/G	cg17294928	chr15:75287854	SCAMP5	-0.89	-8.91	-0.71	1.6e-13	Blood trace element (Zn levels);
SKCM	cis	rs2243480	1.000	rs56016656	chr7:65383481	C/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs2839186	0.872	rs13052495	chr21:47707474	G/A	cg13012494	chr21:47604986	C21orf56	0.67	5.71	0.54	1.95e-7	Testicular germ cell tumor;
SKCM	cis	rs763014	0.833	rs3743904	chr16:632767	A/G	cg00908189	chr16:619842	PIGQ	0.82	7.78	0.66	2.5e-11	Height;
SKCM	cis	rs941408	0.515	rs1640265	chr19:2784405	C/T	cg17333051	chr19:2783644	SGTA	0.47	4.82	0.48	6.85e-6	Total cholesterol levels;
SKCM	cis	rs1577917	0.958	rs12190603	chr6:86475718	C/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.61	-0.65	5.35e-11	Response to antipsychotic treatment;
SKCM	cis	rs28386778	1.000	rs2665851	chr17:61957023	T/C	cg06873352	chr17:61820015	STRADA	0.77	6.58	0.6	4.86e-9	Prudent dietary pattern;
SKCM	cis	rs801193	1.000	rs2707836	chr7:66160435	A/C	cg11987759	chr7:65425863	GUSB	-0.69	-5.9	-0.56	8.74e-8	Aortic root size;
SKCM	cis	rs57221529	0.766	rs72706606	chr5:558609	T/C	cg10555297	chr5:473380	SLC9A3;LOC25845	1.05	5.35	0.52	8.71e-7	Lung disease severity in cystic fibrosis;
SKCM	cis	rs17685	0.753	rs13240967	chr7:75658197	C/T	cg16489192	chr7:75678113	MDH2;STYXL1	0.58	5.44	0.52	5.83e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs738321	0.756	rs12167576	chr22:38512562	G/A	cg25457927	chr22:38595422	NA	-0.51	-5.73	-0.54	1.83e-7	Breast cancer;
SKCM	cis	rs11945232	0.790	rs6816224	chr4:88346510	G/A	cg23841344	chr4:88312519	HSD17B11	-0.66	-4.91	-0.49	4.9100000000000004e-06	Intelligence (multi-trait analysis);
SKCM	cis	rs12142240	0.667	rs12062	chr1:46830447	G/T	cg10495392	chr1:46806563	NSUN4	-0.74	-5.51	-0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs3785574	0.650	rs2320125	chr17:62008318	T/C	cg01411255	chr17:61851458	DDX42;CCDC47	-0.71	-5.22	-0.51	1.46e-6	Height;
SKCM	cis	rs12477438	0.559	rs6733285	chr2:99725575	T/C	cg14399236	chr2:99771627	LIPT1;TSGA10	0.93	8.28	0.68	2.67e-12	Chronic sinus infection;
SKCM	cis	rs11098499	0.569	rs55845118	chr4:120290913	T/C	cg24375607	chr4:120327624	NA	0.62	4.77	0.48	8.45e-6	Corneal astigmatism;
SKCM	cis	rs55962025	0.804	rs2269499	chr4:3239702	C/T	cg21096898	chr4:3318625	RGS12	-0.63	-4.96	-0.49	4.06e-6	Parental longevity (mother's age at death);
SKCM	cis	rs4808199	0.948	rs2074300	chr19:19380996	G/T	cg03709012	chr19:19516395	GATAD2A	1.09	7.56	0.65	6.79e-11	Nonalcoholic fatty liver disease;
SKCM	cis	rs9325144	0.510	rs7952795	chr12:38720686	C/T	cg13010199	chr12:38710504	ALG10B	0.63	4.92	0.49	4.64e-6	Morning vs. evening chronotype;
SKCM	cis	rs6570726	0.935	rs368848	chr6:145855281	A/T	cg23711669	chr6:146136114	FBXO30	0.71	6.91	0.62	1.18e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs72615157	0.664	rs6953580	chr7:99825275	A/G	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.21	8.07	0.67	7e-12	Lung function (FEV1/FVC);
SKCM	cis	rs9910055	0.530	rs7222349	chr17:42304644	C/T	cg19774624	chr17:42201019	HDAC5	-0.77	-6.27	-0.58	1.84e-8	Total body bone mineral density;
SKCM	cis	rs9926296	0.682	rs258328	chr16:89730314	C/T	cg01097406	chr16:89675127	NA	0.56	5.66	0.54	2.41e-7	Vitiligo;
SKCM	cis	rs2739330	0.828	rs2186366	chr22:24254113	A/G	cg25703541	chr22:24373054	LOC391322	0.77	6.22	0.58	2.28e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs362272	0.524	rs13150241	chr4:3367281	A/G	cg03043834	chr4:3319541	RGS12	0.59	4.85	0.48	6.17e-6	Serum sulfate level;
SKCM	cis	rs908922	0.676	rs10788842	chr1:152514588	A/T	cg09873164	chr1:152488093	CRCT1	0.76	5.93	0.56	7.7e-8	Hair morphology;
SKCM	cis	rs780096	0.546	rs2911712	chr2:27626945	A/T	cg05696406	chr2:27599888	SNX17	0.47	4.92	0.49	4.75e-6	Total body bone mineral density;
SKCM	cis	rs72615157	0.697	rs2056726	chr7:99780283	G/A	cg23667466	chr7:100026434	MEPCE;ZCWPW1	0.89	4.84	0.48	6.53e-6	Lung function (FEV1/FVC);
SKCM	cis	rs8177253	0.898	rs8177258	chr3:133480387	C/A	cg16414030	chr3:133502952	NA	-0.7	-6.0	-0.56	5.82e-8	Iron status biomarkers;
SKCM	cis	rs17818399	0.653	rs34050156	chr2:46777646	A/G	cg02822958	chr2:46747628	ATP6V1E2	0.72	5.34	0.52	9.03e-7	Height;
SKCM	cis	rs9715521	0.868	rs6856620	chr4:59820960	A/G	cg11281224	chr4:60001000	NA	-0.62	-4.94	-0.49	4.38e-6	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs992157	0.835	rs2045434	chr2:219144498	A/G	cg20019365	chr2:219134978	PNKD;AAMP	-0.72	-6.22	-0.58	2.33e-8	Colorectal cancer;
SKCM	cis	rs7666738	0.606	rs4577589	chr4:99087858	A/G	cg17366294	chr4:99064904	C4orf37	0.61	5.06	0.5	2.73e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs61935443	0.832	rs11107768	chr12:95274182	A/T	cg21533806	chr12:95267307	NA	-0.89	-5.11	-0.5	2.21e-6	Schizophrenia;
SKCM	cis	rs10876993	1.000	rs10876993	chr12:58062667	C/T	cg18357645	chr12:58087776	OS9	0.61	5.65	0.54	2.52e-7	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs1325195	0.537	rs2636289	chr1:179169815	T/A	cg10806749	chr1:179558114	NA	0.55	4.84	0.48	6.32e-6	IgE grass sensitization;
SKCM	cis	rs9815354	0.680	rs10510730	chr3:41849013	C/G	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs372883	0.613	rs1153290	chr21:30687404	G/T	cg24692254	chr21:30365293	RNF160	-0.66	-5.14	-0.5	1.95e-6	Pancreatic cancer;
SKCM	cis	rs55962025	0.804	rs362268	chr4:3242148	C/G	cg09735869	chr4:3319127	RGS12	-0.77	-6.01	-0.56	5.49e-8	Parental longevity (mother's age at death);
SKCM	cis	rs1707322	1.000	rs785493	chr1:46584859	A/G	cg03146154	chr1:46216737	IPP	-0.8	-5.28	-0.51	1.15e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs8060686	0.641	rs3743735	chr16:68119555	G/A	cg09117114	chr16:67998030	SLC12A4	-0.81	-5.29	-0.51	1.07e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs28386778	0.805	rs9911714	chr17:61828952	G/A	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.12	11.27	0.79	4.92e-18	Prudent dietary pattern;
SKCM	cis	rs2204008	0.630	rs1283300	chr12:38150227	C/T	cg26384229	chr12:38710491	ALG10B	-0.67	-5.47	-0.53	5.23e-7	Bladder cancer;
SKCM	cis	rs1218582	0.682	rs12144978	chr1:154850445	G/A	cg03351412	chr1:154909251	PMVK	0.72	5.95	0.56	7.11e-8	Prostate cancer;
SKCM	cis	rs9467773	0.620	rs1027204	chr6:26639613	T/C	cg09904177	chr6:26538194	HMGN4	0.58	5.01	0.49	3.28e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7937682	0.921	rs4616071	chr11:111440865	C/G	cg22437258	chr11:111473054	SIK2	-0.71	-5.48	-0.53	5e-7	Primary sclerosing cholangitis;
SKCM	cis	rs7296418	0.885	rs1051434	chr12:123641200	C/T	cg00376283	chr12:123451042	ABCB9	0.95	8.2	0.68	3.89e-12	Platelet count;
SKCM	cis	rs7772486	0.738	rs2246334	chr6:146183635	G/A	cg23711669	chr6:146136114	FBXO30	0.84	9.28	0.72	3.05e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs11227306	0.934	rs2303385	chr11:65640562	G/A	cg00576331	chr11:65640516	EFEMP2	0.65	5.23	0.51	1.4e-6	DNA methylation (variation);
SKCM	cis	rs2948294	0.588	rs4840913	chr8:8116906	A/C	cg06636001	chr8:8085503	FLJ10661	0.76	6.15	0.57	3.05e-8	Red cell distribution width;
SKCM	cis	rs28595532	0.920	rs114094671	chr4:119753540	G/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs3793683	0.928	rs2148666	chr10:134553785	A/G	cg27286337	chr10:134555280	INPP5A	0.97	10.86	0.78	2.94e-17	Migraine;
SKCM	cis	rs11690935	0.959	rs10167419	chr2:172649826	A/G	cg13550731	chr2:172543902	DYNC1I2	-0.91	-7.69	-0.66	3.69e-11	Schizophrenia;
SKCM	cis	rs2836974	0.965	rs2836965	chr21:40633631	C/G	cg11644478	chr21:40555479	PSMG1	-1.04	-11.77	-0.8	5.64e-19	Cognitive function;
SKCM	cis	rs4423214	0.879	rs736894	chr11:71152258	A/G	cg05163923	chr11:71159392	DHCR7	0.7	6.35	0.58	1.35e-8	Vitamin D levels;
SKCM	cis	rs6570726	0.791	rs7755253	chr6:145858893	C/G	cg05347473	chr6:146136440	FBXO30	0.56	5.08	0.5	2.49e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7633857	0.512	rs2376477	chr3:160700699	G/T	cg03342759	chr3:160939853	NMD3	-0.61	-4.91	-0.49	4.84e-6	Educational attainment (years of education);
SKCM	cis	rs7772486	0.790	rs6926076	chr6:146232804	C/T	cg05347473	chr6:146136440	FBXO30	-0.56	-5.19	-0.51	1.6e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs55962025	0.711	rs116275868	chr4:3231148	G/C	cg24015175	chr4:3319247	RGS12	-0.57	-4.86	-0.48	5.89e-6	Parental longevity (mother's age at death);
SKCM	cis	rs1707322	0.752	rs11211146	chr1:46109794	T/C	cg03146154	chr1:46216737	IPP	0.79	5.42	0.52	6.34e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs853679	0.599	rs149949	chr6:28011516	T/C	cg09551472	chr6:27280195	POM121L2	0.87	4.79	0.48	7.68e-6	Depression;
SKCM	cis	rs3820068	0.603	rs6695903	chr1:15985940	C/T	cg13390004	chr1:15929781	NA	0.64	5.21	0.51	1.49e-6	Systolic blood pressure;
SKCM	cis	rs4466137	1.000	rs4466137	chr5:82985739	A/C	cg16102102	chr5:83017553	HAPLN1	-0.55	-6.07	-0.57	4.4e-8	Prostate cancer;
SKCM	cis	rs909674	0.818	rs8137426	chr22:39844350	T/G	cg24399712	chr22:39784796	NA	-0.58	-4.8	-0.48	7.43e-6	IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis);IgG glycosylation;IgG digalactosylation phenotypes (multivariate analysis);IgG sialylation phenotypes (multivariate analysis);IgG monogalactosylation phenotypes (multivariate analysis);IgG fucosylation phenotypes (multivariate analysis);IgG N-glycosylation phenotypes (multivariate analysis);IgG disialylation phenotypes (multivariate analysis);IgG galactosylation phenotypes (multivariate analysis);Post bronchodilator FEV1;
SKCM	cis	rs3784262	0.692	rs3784256	chr15:58263046	T/A	cg12031962	chr15:58353849	ALDH1A2	-0.43	-5.15	-0.5	1.87e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs9303401	0.614	rs3887355	chr17:56538639	T/C	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.19	0.57	2.61e-8	Cognitive test performance;
SKCM	cis	rs995000	0.931	rs1168020	chr1:63009956	C/T	cg06896770	chr1:63153194	DOCK7	-0.73	-6.54	-0.6	5.83e-9	Triglyceride levels;
SKCM	cis	rs854765	0.583	rs12452219	chr17:17829423	C/T	cg04398451	chr17:18023971	MYO15A	-0.74	-5.35	-0.52	8.43e-7	Total body bone mineral density;
SKCM	cis	rs7666738	0.606	rs3846447	chr4:99099907	G/A	cg05340658	chr4:99064831	C4orf37	0.62	4.77	0.47	8.51e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10716631	1	rs10716631	chr2:219138170	T/G	cg20019365	chr2:219134978	PNKD;AAMP	0.79	7.19	0.63	3.45e-10	High light scatter reticulocyte percentage of red cells;Plateletcrit;
SKCM	cis	rs703842	1.000	rs1875124	chr12:58196802	A/G	cg04478727	chr12:58166393	METTL1;FAM119B	0.73	5.84	0.55	1.15e-7	Multiple sclerosis;
SKCM	cis	rs12497850	0.931	rs4974087	chr3:48919232	A/G	cg06212747	chr3:49208901	KLHDC8B	0.68	4.9	0.49	5.06e-6	Parkinson's disease;
SKCM	cis	rs9910055	0.659	rs2251165	chr17:42234748	T/C	cg19774624	chr17:42201019	HDAC5	-0.9	-8.45	-0.69	1.27e-12	Total body bone mineral density;
SKCM	cis	rs823143	0.570	rs823084	chr1:205798313	G/T	cg14893161	chr1:205819251	PM20D1	1.05	11.72	0.8	7.13e-19	Monocyte percentage of white cells;
SKCM	cis	rs6951245	1.000	rs76129108	chr7:1089159	G/A	cg24642844	chr7:1081250	C7orf50	-0.94	-6.32	-0.58	1.48e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7980687	0.662	rs585522	chr12:123550813	A/G	cg00376283	chr12:123451042	ABCB9	0.84	6.36	0.58	1.27e-8	Height;Educational attainment;Head circumference (infant);
SKCM	cis	rs12911832	0.727	rs2604454	chr15:59098732	C/A	cg05156742	chr15:59063176	FAM63B	0.79	6.33	0.58	1.44e-8	Schizophrenia;
SKCM	cis	rs7954584	0.626	rs10840637	chr12:122427310	A/G	cg21171335	chr12:122356390	WDR66	0.46	4.95	0.49	4.27e-6	Mean corpuscular volume;
SKCM	cis	rs9300255	0.543	rs1617156	chr12:123590165	T/C	cg05973401	chr12:123451056	ABCB9	0.81	5.57	0.53	3.45e-7	Neutrophil percentage of white cells;
SKCM	cis	rs3847687	1.000	rs78233646	chr12:131520170	G/T	cg25772418	chr12:131519998	GPR133	-0.5	-5.18	-0.51	1.68e-6	Longevity;
SKCM	cis	rs867186	1.000	rs112777695	chr20:33693177	T/G	cg04194272	chr20:33683537	NA	-1.21	-6.8	-0.61	1.89e-9	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs10193935	0.892	rs6744964	chr2:42441088	A/G	cg27598129	chr2:42591480	NA	-0.88	-6.71	-0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4969178	0.965	rs11653305	chr17:76386918	T/C	cg20026190	chr17:76395443	PGS1	0.61	5.08	0.5	2.54e-6	HDL cholesterol levels;
SKCM	cis	rs854765	0.583	rs7207395	chr17:17819335	C/T	cg04398451	chr17:18023971	MYO15A	-0.79	-5.68	-0.54	2.25e-7	Total body bone mineral density;
SKCM	cis	rs9325144	0.600	rs12297194	chr12:38735803	A/G	cg13010199	chr12:38710504	ALG10B	-0.63	-4.95	-0.49	4.15e-6	Morning vs. evening chronotype;
SKCM	cis	rs1577917	0.771	rs7762321	chr6:86412146	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.75	6.9	0.62	1.2e-9	Response to antipsychotic treatment;
SKCM	cis	rs1799949	0.965	rs12950779	chr17:41306523	C/T	cg23758822	chr17:41437982	NA	0.92	7.83	0.66	1.97e-11	Menopause (age at onset);
SKCM	cis	rs4724125	0.782	rs726150	chr7:42719069	T/C	cg09407816	chr7:42972088	MRPL32;PSMA2	0.79	4.98	0.49	3.67e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7666738	0.830	rs9884501	chr4:98893721	A/C	cg17366294	chr4:99064904	C4orf37	0.57	4.86	0.48	6.02e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9467773	1.000	rs9986382	chr6:26550619	T/C	cg09904177	chr6:26538194	HMGN4	0.54	4.98	0.49	3.78e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs4132509	0.793	rs10927046	chr1:243801190	T/C	cg21452805	chr1:244014465	NA	0.89	5.5	0.53	4.66e-7	RR interval (heart rate);
SKCM	cis	rs796364	0.950	rs56155997	chr2:200768491	C/T	cg12253985	chr2:200820533	C2orf60;C2orf47	-0.96	-5.67	-0.54	2.3e-7	Schizophrenia;
SKCM	cis	rs17685	0.712	rs7785025	chr7:75628101	C/T	cg01364799	chr7:75623366	TMEM120A	0.73	5.61	0.54	2.94e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs72781680	0.611	rs56326157	chr2:24312407	T/C	cg20701182	chr2:24300061	SF3B14	0.74	5.03	0.49	3.09e-6	Lymphocyte counts;
SKCM	cis	rs951366	0.617	rs823074	chr1:205774839	T/C	cg14159672	chr1:205819179	PM20D1	1.06	11.74	0.8	6.36e-19	Menarche (age at onset);
SKCM	cis	rs2836974	0.545	rs8128901	chr21:40710419	G/A	cg11890956	chr21:40555474	PSMG1	0.74	5.9	0.56	8.8e-8	Cognitive function;
SKCM	cis	rs7811142	0.830	rs1063945	chr7:99930447	C/T	cg00814883	chr7:100076585	TSC22D4	-0.84	-4.78	-0.48	8.01e-6	Platelet count;
SKCM	cis	rs2842992	0.830	rs2842974	chr6:160159034	C/T	cg11366901	chr6:160182831	ACAT2	0.91	7.59	0.65	5.9e-11	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs7829975	0.522	rs6601689	chr8:8172283	C/T	cg15556689	chr8:8085844	FLJ10661	0.63	5.35	0.52	8.38e-7	Mood instability;
SKCM	cis	rs9389248	0.690	rs1028314	chr6:135255710	A/C	cg24558204	chr6:135376177	HBS1L	-0.61	-5.82	-0.55	1.24e-7	High light scatter reticulocyte percentage of red cells;
SKCM	cis	rs17376456	1.000	rs66978370	chr5:93553633	G/A	cg21475434	chr5:93447410	FAM172A	0.98	5.23	0.51	1.4e-6	Diabetic retinopathy;
SKCM	cis	rs9790314	0.846	rs6441371	chr3:161008727	C/A	cg03342759	chr3:160939853	NMD3	-0.73	-8.2	-0.68	3.89e-12	Morning vs. evening chronotype;
SKCM	cis	rs1005277	0.579	rs1780136	chr10:38501453	A/G	cg00409905	chr10:38381863	ZNF37A	-0.62	-5.82	-0.55	1.24e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs854765	0.693	rs12941039	chr17:17765655	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	-0.99	-8.56	-0.7	7.73e-13	Total body bone mineral density;
SKCM	cis	rs17854409	0.764	rs8116995	chr20:61475824	A/G	cg06598544	chr20:61472147	COL9A3	-1.14	-5.76	-0.55	1.61e-7	Obesity-related traits;
SKCM	cis	rs1506636	1.000	rs676755	chr7:123439082	A/G	cg03229431	chr7:123269106	ASB15	-0.62	-5.22	-0.51	1.46e-6	Plateletcrit;Platelet count;
SKCM	cis	rs2645694	0.626	rs2645709	chr4:77824474	G/A	cg06046430	chr4:77819534	ANKRD56	0.54	5.94	0.56	7.49e-8	Emphysema distribution in smoking;
SKCM	cis	rs7523050	0.643	rs76218180	chr1:109404131	T/A	cg08274380	chr1:109419600	GPSM2	1.06	4.82	0.48	6.98e-6	Fat distribution (HIV);
SKCM	cis	rs1577917	0.883	rs9450375	chr6:86756629	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.67	5.85	0.55	1.09e-7	Response to antipsychotic treatment;
SKCM	cis	rs2731664	0.792	rs2545795	chr5:176887106	A/C	cg23176889	chr5:176863531	GRK6	-0.53	-5.4	-0.52	6.86e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs6546550	0.901	rs6741449	chr2:70156589	A/G	cg02498382	chr2:70120550	SNRNP27	-0.45	-4.88	-0.48	5.4e-6	Prevalent atrial fibrillation;
SKCM	cis	rs7336332	0.628	rs9581855	chr13:28018014	G/A	cg22138327	chr13:27999177	GTF3A	0.9	6.4	0.59	1.07e-8	Weight;
SKCM	cis	rs28595532	0.920	rs115472708	chr4:119773407	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs7824557	0.585	rs2572385	chr8:11208903	G/A	cg21775007	chr8:11205619	TDH	0.66	5.9	0.56	8.89e-8	Retinal vascular caliber;
SKCM	cis	rs12971120	0.891	rs12605820	chr18:72167802	G/A	cg26446133	chr18:72167187	CNDP2	-0.67	-5.21	-0.51	1.48e-6	Refractive error;
SKCM	cis	rs2075371	0.863	rs9641966	chr7:133961205	G/A	cg20476274	chr7:133979776	SLC35B4	0.96	9.42	0.73	1.63e-14	Mean platelet volume;
SKCM	cis	rs7772486	0.558	rs62435775	chr6:146136415	G/C	cg23711669	chr6:146136114	FBXO30	0.81	7.26	0.64	2.49e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs589448	0.902	rs2603089	chr12:69776800	C/T	cg20891283	chr12:69753455	YEATS4	-1.0	-10.45	-0.76	1.71e-16	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs875971	0.638	rs6460305	chr7:66060408	G/A	cg11764359	chr7:65958608	NA	-0.84	-6.37	-0.59	1.2e-8	Aortic root size;
SKCM	cis	rs2153535	0.580	rs6597334	chr6:8504779	C/T	cg07606381	chr6:8435919	SLC35B3	0.86	6.25	0.58	2.06e-8	Motion sickness;
SKCM	cis	rs17685	0.753	rs6951808	chr7:75772413	A/G	cg16489192	chr7:75678113	MDH2;STYXL1	-0.56	-5.23	-0.51	1.36e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs8060686	0.641	rs75909028	chr16:68089578	A/C	cg09117114	chr16:67998030	SLC12A4	-0.81	-5.29	-0.51	1.07e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs9913156	0.696	rs9905711	chr17:4558662	G/A	cg19197139	chr17:4613644	ARRB2	-0.79	-5.28	-0.51	1.14e-6	Lymphocyte counts;
SKCM	cis	rs7216064	1.000	rs12452511	chr17:65832576	A/G	cg12091567	chr17:66097778	LOC651250	-0.77	-5.53	-0.53	4.12e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs55962025	0.842	rs362271	chr4:3235518	C/T	cg11471262	chr4:3318911	RGS12	-0.65	-4.79	-0.48	7.75e-6	Parental longevity (mother's age at death);
SKCM	cis	rs55794721	0.509	rs2375313	chr1:25748235	G/A	cg02931644	chr1:25747376	RHCE	0.52	5.34	0.52	8.86e-7	Plateletcrit;Mean corpuscular volume;
SKCM	cis	rs10883723	0.810	rs10748823	chr10:104274465	C/G	cg11453585	chr10:104263688	ACTR1A;SUFU	0.77	6.31	0.58	1.56e-8	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs4819052	0.807	rs28715237	chr21:46673768	C/G	cg02159808	chr21:46707872	POFUT2;LOC642852	0.72	5.6	0.54	3.11e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs651907	0.557	rs34947019	chr3:101532235	C/T	cg12386194	chr3:101231763	SENP7	0.67	5.58	0.53	3.41e-7	Colorectal cancer;
SKCM	cis	rs7618501	0.633	rs2008877	chr3:50162291	T/G	cg05072774	chr3:49840536	C3orf54	0.67	5.15	0.5	1.94e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs875971	0.964	rs55748098	chr7:65763618	T/C	cg18876405	chr7:65276391	NA	-0.68	-6.79	-0.61	1.94e-9	Aortic root size;
SKCM	cis	rs763014	0.833	rs3743902	chr16:632728	T/C	cg07343612	chr16:622815	PIGQ	-0.7	-6.0	-0.56	5.84e-8	Height;
SKCM	cis	rs13118159	0.550	rs2336081	chr4:1350322	A/G	cg19318889	chr4:1322082	MAEA	-0.81	-6.16	-0.57	3e-8	Longevity;
SKCM	cis	rs2228479	0.618	rs62052174	chr16:89950901	G/A	cg00800038	chr16:89945340	TCF25	-0.93	-5.34	-0.52	8.73e-7	Skin colour saturation;
SKCM	cis	rs6570726	0.791	rs435671	chr6:145881215	A/G	cg05347473	chr6:146136440	FBXO30	0.57	5.13	0.5	2.06e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs12986445	0.744	rs10188206	chr2:26142632	T/A	cg07291958	chr2:26785531	C2orf70	0.54	5.0	0.49	3.43e-6	Multiple myeloma and monoclonal gammopathy;Multiple myeloma;
SKCM	cis	rs7772486	0.875	rs12194437	chr6:146411440	A/G	cg05347473	chr6:146136440	FBXO30	0.65	5.96	0.56	6.79e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs17270561	0.562	rs12199626	chr6:26013604	G/A	cg16482183	chr6:26056742	HIST1H1C	0.96	6.97	0.62	8.86e-10	Iron status biomarkers;
SKCM	cis	rs4938330	0.681	rs12271169	chr11:116980021	C/G	cg01368799	chr11:117014884	PAFAH1B2	-0.67	-4.83	-0.48	6.59e-6	Blood protein levels;
SKCM	cis	rs7666738	0.830	rs6846229	chr4:99016546	C/T	cg05340658	chr4:99064831	C4orf37	0.67	5.16	0.5	1.85e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs151997	1.000	rs152803	chr5:50212120	C/T	cg06027927	chr5:50259733	NA	0.66	5.78	0.55	1.45e-7	Callous-unemotional behaviour;
SKCM	cis	rs6840360	0.593	rs10022023	chr4:152560731	A/G	cg22705602	chr4:152727874	NA	-0.52	-5.69	-0.54	2.15e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs9788682	1.000	rs7164594	chr15:78803057	C/T	cg06917634	chr15:78832804	PSMA4	-0.9	-5.49	-0.53	4.75e-7	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	trans	rs1814175	0.645	rs1721997	chr11:49916653	T/C	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs9788721	0.836	rs2656065	chr15:78750549	G/A	cg18825076	chr15:78729989	IREB2	-0.61	-4.84	-0.48	6.47e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;Emphysema imaging phenotypes;Emphysema distribution in smoking;Local histogram emphysema pattern;Post bronchodilator FEV1/FVC ratio in COPD;
SKCM	cis	rs561341	0.941	rs4625780	chr17:30249214	A/C	cg00745463	chr17:30367425	LRRC37B	-1.04	-6.94	-0.62	1.01e-9	Hip circumference adjusted for BMI;
SKCM	cis	rs12586317	0.547	rs116499019	chr14:35441931	T/C	cg16230307	chr14:35515116	FAM177A1	0.78	5.32	0.52	9.53e-7	Psoriasis;
SKCM	cis	rs1160297	0.609	rs10208858	chr2:53094982	G/A	cg07782112	chr2:53107842	NA	0.58	6.04	0.56	5e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs3820068	0.532	rs78917815	chr1:15920821	A/G	cg24675056	chr1:15929824	NA	0.77	5.54	0.53	4.01e-7	Systolic blood pressure;
SKCM	cis	rs6547741	0.844	rs7382	chr2:27873415	G/A	cg27432699	chr2:27873401	GPN1	-0.84	-7.21	-0.63	3.15e-10	Oral cavity cancer;
SKCM	cis	rs10751667	0.643	rs10902245	chr11:953014	C/T	cg06064525	chr11:970664	AP2A2	0.54	5.08	0.5	2.52e-6	Alzheimer's disease (late onset);
SKCM	cis	rs4434138	0.664	rs62255364	chr3:52701502	C/T	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs34779708	0.966	rs7070427	chr10:35485689	A/T	cg03585969	chr10:35415529	CREM	0.78	6.18	0.57	2.72e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs4819052	0.851	rs7276591	chr21:46680156	C/T	cg02159808	chr21:46707872	POFUT2;LOC642852	0.75	5.99	0.56	6.11e-8	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs1790761	0.554	rs12787511	chr11:67401635	G/C	cg00290607	chr11:67383545	NA	-0.64	-6.24	-0.58	2.1e-8	Mean corpuscular volume;
SKCM	cis	rs7122539	0.603	rs508443	chr11:66509369	C/T	cg24851651	chr11:66362959	CCS	-0.71	-5.28	-0.51	1.14e-6	HIV-1 susceptibility;
SKCM	cis	rs9303401	0.659	rs34382037	chr17:56643550	G/T	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.61	0.54	2.94e-7	Cognitive test performance;
SKCM	cis	rs28595532	0.920	rs115090643	chr4:119729825	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.52	0.53	4.28e-7	Cannabis dependence symptom count;
SKCM	cis	rs7809950	1.000	rs7778270	chr7:107224667	A/G	cg23024343	chr7:107201750	COG5	0.82	7.69	0.66	3.82e-11	Coronary artery disease;
SKCM	cis	rs950776	0.518	rs12906846	chr15:78825295	G/A	cg06917634	chr15:78832804	PSMA4	1.01	10.47	0.76	1.56e-16	Sudden cardiac arrest;
SKCM	cis	rs35146811	0.586	rs10267212	chr7:99595422	T/C	cg22906224	chr7:99728672	NA	0.78	5.62	0.54	2.89e-7	Coronary artery disease;
SKCM	cis	rs2180341	0.576	rs2057224	chr6:127624414	C/G	cg24812749	chr6:127587940	RNF146	0.65	5.29	0.51	1.07e-6	Breast cancer;
SKCM	cis	rs6546550	0.901	rs897119	chr2:70160658	T/C	cg02498382	chr2:70120550	SNRNP27	-0.45	-4.88	-0.48	5.4e-6	Prevalent atrial fibrillation;
SKCM	cis	rs703842	1.000	rs10783847	chr12:58196447	G/A	cg04478727	chr12:58166393	METTL1;FAM119B	0.72	5.87	0.55	1.02e-7	Multiple sclerosis;
SKCM	cis	rs898097	0.691	rs7222745	chr17:80907253	C/T	cg15369054	chr17:80825471	TBCD	0.53	5.06	0.5	2.77e-6	Breast cancer;
SKCM	cis	rs875971	0.505	rs1167385	chr7:65513308	G/A	cg05627663	chr7:65219948	SNORA22;CCT6P1	-0.59	-5.08	-0.5	2.48e-6	Aortic root size;
SKCM	cis	rs7122539	0.646	rs682842	chr11:66568943	A/G	cg24851651	chr11:66362959	CCS	-0.75	-5.6	-0.54	3.11e-7	HIV-1 susceptibility;
SKCM	cis	rs2032447	0.966	rs3752416	chr6:26045929	T/C	cg18357526	chr6:26021779	HIST1H4A	0.84	7.4	0.64	1.33e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs9399137	0.507	rs4594969	chr6:135285586	A/T	cg24558204	chr6:135376177	HBS1L	0.69	6.37	0.59	1.19e-8	Glycated hemoglobin levels;Mean corpuscular volume;Hematology traits;HbA2 levels;Mean corpuscular hemoglobin;Hemoglobin levels;F-cell distribution;Platelet count;
SKCM	cis	rs6570726	0.533	rs1832374	chr6:145717752	A/G	cg23711669	chr6:146136114	FBXO30	0.61	5.28	0.51	1.14e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs34172651	0.517	rs36113933	chr16:24838862	A/G	cg04756594	chr16:24857601	SLC5A11	0.7	5.26	0.51	1.24e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs690037	0.673	rs690573	chr3:16376440	G/T	cg23474789	chr3:16306055	DPH3;OXNAD1	-0.64	-5.11	-0.5	2.22e-6	Optic nerve measurement (cup-to-disc ratio);Optic nerve measurement (cup area);
SKCM	cis	rs3008870	1.000	rs2985817	chr1:67398607	G/C	cg08660285	chr1:67390436	MIER1;WDR78	0.92	6.05	0.57	4.69e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs826838	0.904	rs7973992	chr12:39168233	T/C	cg26384229	chr12:38710491	ALG10B	0.92	8.39	0.69	1.67e-12	Heart rate;
SKCM	cis	rs6977660	0.943	rs6959678	chr7:19821759	C/A	cg07541023	chr7:19748670	TWISTNB	0.7	4.82	0.48	6.98e-6	Thyroid stimulating hormone;
SKCM	cis	rs654950	0.901	rs594656	chr1:41999873	C/T	cg06885757	chr1:42089581	HIVEP3	-0.63	-6.43	-0.59	9.24e-9	Airway imaging phenotypes;
SKCM	cis	rs11249608	0.636	rs6868893	chr5:178449826	C/A	cg21905437	chr5:178450457	ZNF879	0.74	6.14	0.57	3.29e-8	Pubertal anthropometrics;
SKCM	cis	rs11098499	0.909	rs9759478	chr4:120367998	G/A	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs826838	0.935	rs1486357	chr12:39073675	A/G	cg26384229	chr12:38710491	ALG10B	1.02	8.91	0.71	1.62e-13	Heart rate;
SKCM	cis	rs6430585	0.527	rs2304366	chr2:136467119	C/T	cg07169764	chr2:136633963	MCM6	1.01	7.39	0.64	1.44e-10	Corneal structure;
SKCM	cis	rs6066825	0.666	rs6019374	chr20:47303812	A/G	cg18078177	chr20:47281410	PREX1	0.63	5.19	0.51	1.62e-6	Colorectal cancer;
SKCM	cis	rs72615157	0.634	rs74742883	chr7:99785765	T/G	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.19	8.02	0.67	8.58e-12	Lung function (FEV1/FVC);
SKCM	cis	rs6121246	0.559	rs6060716	chr20:30274847	C/G	cg13852791	chr20:30311386	BCL2L1	0.82	5.69	0.54	2.09e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs72827839	0.644	rs72833479	chr17:45960449	G/A	cg23391107	chr17:45924227	SP6	0.69	5.81	0.55	1.29e-7	Ease of getting up in the morning;
SKCM	cis	rs28386778	0.863	rs2727288	chr17:61901197	T/A	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	trans	rs561341	1.000	rs757009	chr17:30243937	A/G	cg20587970	chr11:113659929	NA	-1.07	-8.76	-0.7	3.15e-13	Hip circumference adjusted for BMI;
SKCM	cis	rs4819052	1.000	rs13047688	chr21:46669290	G/A	cg19498844	chr21:46707878	POFUT2;LOC642852	0.87	6.81	0.61	1.82e-9	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs1790761	0.520	rs7124513	chr11:67395714	C/T	cg00864171	chr11:67383662	NA	-0.62	-5.18	-0.51	1.66e-6	Mean corpuscular volume;
SKCM	cis	rs4481887	0.893	rs7515080	chr1:248494073	A/G	cg00666640	chr1:248458726	OR2T12	0.59	4.96	0.49	4.04e-6	Common traits (Other);
SKCM	cis	rs9913156	0.789	rs72824977	chr17:4612975	C/G	cg19197139	chr17:4613644	ARRB2	0.91	6.31	0.58	1.57e-8	Lymphocyte counts;
SKCM	cis	rs1862618	0.671	rs2591968	chr5:56233541	A/G	cg03609598	chr5:56110824	MAP3K1	-0.7	-4.87	-0.48	5.81e-6	Initial pursuit acceleration;
SKCM	cis	rs3785574	0.962	rs2584623	chr17:61906679	G/A	cg01411255	chr17:61851458	DDX42;CCDC47	1.16	12.75	0.82	9.1e-21	Height;
SKCM	cis	rs1044826	0.642	rs2071388	chr3:139236683	C/T	cg15131784	chr3:139108705	COPB2	-0.68	-4.97	-0.49	3.94e-6	Obesity-related traits;
SKCM	cis	rs644148	0.868	rs2254344	chr19:45001619	C/T	cg15540054	chr19:45004280	ZNF180	-0.74	-4.81	-0.48	7.2e-6	Personality dimensions;
SKCM	cis	rs4790333	0.529	rs3101409	chr17:2258147	C/T	cg02569219	chr17:2266849	SGSM2	0.67	5.74	0.55	1.7e-7	Proinsulin levels;
SKCM	cis	rs1799949	1.000	rs2070834	chr17:41242285	T/G	cg05368731	chr17:41323189	NBR1	0.9	7.69	0.66	3.74e-11	Menopause (age at onset);
SKCM	cis	rs875971	0.830	rs6976714	chr7:65891461	G/A	cg18876405	chr7:65276391	NA	0.61	5.94	0.56	7.52e-8	Aortic root size;
SKCM	cis	rs6089584	0.546	rs6089308	chr20:60583529	C/T	cg06108461	chr20:60628389	TAF4	-0.62	-5.37	-0.52	7.93e-7	Body mass index;
SKCM	cis	rs35306767	0.855	rs34318754	chr10:890714	G/A	cg25614935	chr10:1084866	C10orf110	0.8	5.41	0.52	6.69e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs1044826	0.642	rs1080371	chr3:139210894	C/T	cg15131784	chr3:139108705	COPB2	0.7	5.19	0.51	1.62e-6	Obesity-related traits;
SKCM	cis	rs2243480	1.000	rs73142166	chr7:65375832	A/G	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	trans	rs1814175	0.645	rs28538913	chr11:50040718	C/T	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs12824058	0.678	rs11614163	chr12:130814621	C/G	cg24838063	chr12:130822603	PIWIL1	0.7	5.36	0.52	8.09e-7	Menopause (age at onset);
SKCM	cis	rs651907	0.557	rs35117343	chr3:101445126	A/G	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.81	7.1	0.63	5.08e-10	Colorectal cancer;
SKCM	cis	rs2204008	0.684	rs11514164	chr12:38036494	C/T	cg13010199	chr12:38710504	ALG10B	0.65	5.04	0.5	2.98e-6	Bladder cancer;
SKCM	cis	rs116095464	1.000	rs908116	chr5:317119	A/T	cg22857025	chr5:266934	NA	-1.63	-6.12	-0.57	3.5e-8	Breast cancer;
SKCM	cis	rs9393692	0.905	rs7761298	chr6:26278436	C/T	cg00631329	chr6:26305371	NA	-0.68	-4.93	-0.49	4.49e-6	Educational attainment;
SKCM	cis	rs1153858	1.000	rs4774578	chr15:45646051	G/A	cg21132104	chr15:45694354	SPATA5L1	0.92	7.81	0.66	2.22e-11	Homoarginine levels;
SKCM	cis	rs7100689	0.753	rs1361458	chr10:82090339	A/T	cg01528321	chr10:82214614	TSPAN14	0.78	6.74	0.61	2.47e-9	Post bronchodilator FEV1;
SKCM	cis	rs1577917	0.876	rs1582126	chr6:86697205	C/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.83	-8.23	-0.68	3.37e-12	Response to antipsychotic treatment;
SKCM	cis	rs1691799	0.899	rs903587	chr12:66746061	C/A	cg16791601	chr12:66731901	HELB	-0.65	-6.09	-0.57	4.07e-8	White blood cell count (basophil);
SKCM	cis	rs3008870	1.000	rs2815370	chr1:67503727	A/G	cg08660285	chr1:67390436	MIER1;WDR78	-0.94	-6.33	-0.58	1.46e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs28386778	0.897	rs9906247	chr17:61857314	T/C	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs34779708	0.931	rs4934719	chr10:35376769	T/C	cg03585969	chr10:35415529	CREM	0.78	6.31	0.58	1.58e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs2836974	0.932	rs35571600	chr21:40590624	A/C	cg11644478	chr21:40555479	PSMG1	0.97	10.08	0.75	8.76e-16	Cognitive function;
SKCM	trans	rs3749237	0.964	rs35210174	chr3:49812606	C/T	cg21659725	chr3:3221576	CRBN	0.99	7.38	0.64	1.49e-10	Resting heart rate;
SKCM	cis	rs2153535	0.580	rs1932282	chr6:8477330	G/A	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs3008870	1.000	rs3008888	chr1:67368965	C/T	cg08660285	chr1:67390436	MIER1;WDR78	0.95	6.45	0.59	8.62e-9	Lymphocyte percentage of white cells;
SKCM	cis	rs2228479	0.717	rs1800358	chr16:89809319	T/C	cg06558623	chr16:89946397	TCF25	1.11	6.06	0.57	4.5e-8	Skin colour saturation;
SKCM	cis	rs9443189	0.570	rs72884926	chr6:76266208	T/C	cg01950844	chr6:76311363	SENP6	0.89	5.07	0.5	2.58e-6	Prostate cancer;
SKCM	cis	rs950027	0.620	rs1145080	chr15:45681338	C/T	cg21132104	chr15:45694354	SPATA5L1	0.76	5.84	0.55	1.13e-7	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs17685	0.712	rs869805	chr7:75688596	C/T	cg01364799	chr7:75623366	TMEM120A	-0.75	-6.05	-0.56	4.78e-8	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs11718455	0.960	rs34241796	chr3:44000394	A/T	cg21419209	chr3:44054225	NA	-0.65	-5.32	-0.52	9.77e-7	Coronary artery disease;
SKCM	cis	rs35306767	0.953	rs12259338	chr10:969377	C/T	cg26597838	chr10:835615	NA	0.67	5.4	0.52	7e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs4803468	0.935	rs12602	chr19:41889748	T/C	cg14132834	chr19:41945861	ATP5SL	-0.75	-5.54	-0.53	3.96e-7	Height;
SKCM	cis	rs7216064	1.000	rs9913471	chr17:65874495	C/T	cg12091567	chr17:66097778	LOC651250	-0.75	-5.27	-0.51	1.19e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs9916302	0.706	rs7503377	chr17:37708841	A/G	cg07936489	chr17:37558343	FBXL20	-1.02	-7.74	-0.66	2.94e-11	Glomerular filtration rate (creatinine);
SKCM	cis	rs11077773	1.000	rs11077773	chr17:73060073	C/T	cg27626185	chr17:73056755	KCTD2	1.19	7.74	0.66	3.02e-11	Information processing speed;
SKCM	cis	rs4683346	0.859	rs2099022	chr3:42892048	G/A	cg06399164	chr3:42695035	ZBTB47	0.61	5.74	0.55	1.71e-7	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs9926296	0.744	rs164747	chr16:89708680	T/G	cg01097406	chr16:89675127	NA	0.54	5.47	0.53	5.21e-7	Vitiligo;
SKCM	cis	rs10791323	0.593	rs11223599	chr11:133717902	A/T	cg14349672	chr11:133703707	NA	0.63	4.9	0.48	5.19e-6	Childhood ear infection;
SKCM	cis	rs3540	0.554	rs12900987	chr15:91071776	T/C	cg22089800	chr15:90895588	ZNF774	-0.68	-4.92	-0.49	4.69e-6	Allergic disease (asthma, hay fever or eczema);Lymphocyte counts;
SKCM	cis	rs4819052	0.679	rs2236450	chr21:46702553	T/C	cg02159808	chr21:46707872	POFUT2;LOC642852	0.67	5.07	0.5	2.63e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs1348850	0.567	rs3770011	chr2:178537890	C/T	cg22681709	chr2:178499509	PDE11A	-0.68	-6.38	-0.59	1.18e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs3892630	0.878	rs1559177	chr19:33210646	A/G	cg22980127	chr19:33182716	NUDT19	1.39	7.88	0.67	1.6e-11	Red blood cell traits;
SKCM	cis	rs1051424	0.642	rs115869798	chr17:57892829	T/A	cg02344993	chr17:57696989	CLTC	0.67	4.79	0.48	7.85e-6	Obesity-related traits;
SKCM	cis	rs8078723	0.668	rs3859192	chr17:38128648	C/T	cg17467752	chr17:38218738	THRA	0.65	5.66	0.54	2.39e-7	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs10876993	0.890	rs7976852	chr12:58100551	T/G	cg18357645	chr12:58087776	OS9	0.68	6.27	0.58	1.83e-8	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs875971	0.522	rs56028712	chr7:65466565	C/T	cg18876405	chr7:65276391	NA	0.87	8.12	0.68	5.59e-12	Aortic root size;
SKCM	cis	rs2204008	0.805	rs10881112	chr12:37956611	G/A	cg13010199	chr12:38710504	ALG10B	-0.64	-5.16	-0.5	1.85e-6	Bladder cancer;
SKCM	cis	rs6750795	0.602	rs1667317	chr2:232412036	T/C	cg19187155	chr2:232395269	NMUR1	0.74	5.1	0.5	2.31e-6	Height;
SKCM	cis	rs875971	0.660	rs1860468	chr7:66107252	T/C	cg11764359	chr7:65958608	NA	-0.84	-6.37	-0.59	1.2e-8	Aortic root size;
SKCM	cis	rs704	0.585	rs1007398	chr17:26665648	A/G	cg27392559	chr17:27410759	MYO18A	-0.55	-4.85	-0.48	6.26e-6	Osteoprotegerin levels;
SKCM	cis	rs10927875	0.619	rs7537101	chr1:16150384	T/C	cg21385522	chr1:16154831	NA	-0.76	-7.66	-0.66	4.19e-11	Dilated cardiomyopathy;
SKCM	cis	rs2204008	0.713	rs12366709	chr12:38210179	G/A	cg13010199	chr12:38710504	ALG10B	0.65	4.84	0.48	6.52e-6	Bladder cancer;
SKCM	cis	rs7945705	0.747	rs2568020	chr11:8994715	C/T	cg13070366	chr11:9386451	NA	0.57	4.89	0.48	5.2e-6	Hemoglobin concentration;
SKCM	cis	rs6495122	0.532	rs2470890	chr15:75047426	C/T	cg14664628	chr15:75095509	CSK	-0.87	-6.22	-0.58	2.32e-8	Caffeine consumption;Diastolic blood pressure;Coffee consumption;
SKCM	cis	rs951366	0.903	rs823114	chr1:205719532	G/A	cg14893161	chr1:205819251	PM20D1	0.74	5.37	0.52	7.9e-7	Menarche (age at onset);
SKCM	cis	rs2204008	0.837	rs1842599	chr12:37986081	G/A	cg13010199	chr12:38710504	ALG10B	-0.63	-4.9	-0.49	5.09e-6	Bladder cancer;
SKCM	cis	rs7772486	0.558	rs9497403	chr6:146054695	T/G	cg23711669	chr6:146136114	FBXO30	-0.81	-7.01	-0.62	7.66e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7811142	1.000	rs2897358	chr7:100088640	C/G	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-1.02	-5.76	-0.55	1.59e-7	Platelet count;
SKCM	cis	rs7666738	0.830	rs62318470	chr4:98925846	A/C	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs17376456	0.809	rs12152763	chr5:93405509	T/A	cg21475434	chr5:93447410	FAM172A	0.97	5.41	0.52	6.8e-7	Diabetic retinopathy;
SKCM	cis	rs26868	0.766	rs27556	chr16:2249325	T/C	cg27608139	chr16:2294856	DCI	0.61	5.05	0.5	2.78e-6	Height;
SKCM	cis	rs2120019	1.000	rs2415253	chr15:75375699	A/G	cg09165964	chr15:75287851	SCAMP5	-0.78	-6.63	-0.6	3.95e-9	Blood trace element (Zn levels);
SKCM	cis	rs1153858	1.000	rs2668747	chr15:45617216	T/C	cg10760299	chr15:45669010	GATM	0.55	5.38	0.52	7.45e-7	Homoarginine levels;
SKCM	cis	rs12497850	0.864	rs7431857	chr3:48900347	G/A	cg06212747	chr3:49208901	KLHDC8B	0.68	4.89	0.48	5.28e-6	Parkinson's disease;
SKCM	cis	rs1580019	0.563	rs10486509	chr7:32585443	C/G	cg06627557	chr7:32535165	LSM5;AVL9	-0.94	-9.51	-0.73	1.1e-14	Cognitive ability;
SKCM	cis	rs6120849	0.754	rs7268266	chr20:33581889	T/C	cg24642439	chr20:33292090	TP53INP2	0.94	4.86	0.48	5.91e-6	Protein C levels;
SKCM	cis	rs4927850	0.709	rs6765762	chr3:195652851	G/A	cg12923728	chr3:195709715	SDHAP1	-0.91	-5.91	-0.56	8.59e-8	Pancreatic cancer;
SKCM	cis	rs2808634	0.962	rs3122014	chr1:159702161	A/C	cg14633426	chr1:159894721	TAGLN2	0.6	4.98	0.49	3.73e-6	C-reactive protein;
SKCM	cis	rs875971	0.638	rs3898855	chr7:66036398	G/C	cg11764359	chr7:65958608	NA	-0.86	-6.6	-0.6	4.52e-9	Aortic root size;
SKCM	cis	rs7772486	0.686	rs9403741	chr6:146030548	G/A	cg23711669	chr6:146136114	FBXO30	-0.82	-8.01	-0.67	9.12e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs3892630	0.878	rs8112955	chr19:33191192	C/T	cg22980127	chr19:33182716	NUDT19	1.39	8.08	0.67	6.68e-12	Red blood cell traits;
SKCM	cis	rs13108904	0.521	rs4974609	chr4:1356924	A/C	cg02018176	chr4:1364513	KIAA1530	-0.64	-5.17	-0.51	1.75e-6	Obesity-related traits;
SKCM	cis	rs9457247	0.602	rs9457262	chr6:167473685	A/G	cg07741184	chr6:167504864	NA	0.58	4.92	0.49	4.76e-6	Crohn's disease;
SKCM	cis	rs2243480	0.803	rs34804747	chr7:65412942	G/C	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs798554	0.724	rs798498	chr7:2795882	T/G	cg04166393	chr7:2884313	GNA12	0.77	5.45	0.53	5.63e-7	Height;
SKCM	cis	rs2204008	0.775	rs2387809	chr12:38363338	T/A	cg26384229	chr12:38710491	ALG10B	0.81	6.56	0.6	5.29e-9	Bladder cancer;
SKCM	cis	rs644799	1.000	rs473148	chr11:95628606	A/G	cg03916912	chr11:95522834	CEP57;FAM76B	0.85	6.32	0.58	1.53e-8	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs1639906	0.965	rs1637742	chr7:2236432	G/A	cg02951883	chr7:2050386	MAD1L1	-0.6	-4.83	-0.48	6.66e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2228479	0.867	rs62052187	chr16:89973071	G/A	cg06558623	chr16:89946397	TCF25	1.27	7.17	0.63	3.78e-10	Skin colour saturation;
SKCM	cis	rs1568889	1.000	rs16917687	chr11:28062614	G/A	cg06544937	chr11:28130018	METT5D1;KIF18A	0.86	7.03	0.62	6.97e-10	Bipolar disorder;
SKCM	cis	rs151997	0.925	rs28077	chr5:50191946	T/A	cg06027927	chr5:50259733	NA	0.63	5.52	0.53	4.27e-7	Callous-unemotional behaviour;
SKCM	cis	rs2404602	0.503	rs284909	chr15:76736628	C/T	cg23625390	chr15:77176239	SCAPER	0.66	5.81	0.55	1.29e-7	Blood metabolite levels;
SKCM	cis	rs9640161	0.711	rs55881542	chr7:150025734	G/A	cg27494647	chr7:150038898	RARRES2	0.58	4.98	0.49	3.74e-6	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs10206020	0.836	rs10202105	chr2:1553301	C/T	cg01028140	chr2:1542097	TPO	-0.53	-4.96	-0.49	4.07e-6	IgG glycosylation;
SKCM	cis	rs9910055	0.573	rs113184718	chr17:42206543	A/T	cg13607699	chr17:42295918	UBTF	-0.7	-5.44	-0.52	6.04e-7	Total body bone mineral density;
SKCM	cis	rs3820068	0.581	rs1547031	chr1:15918960	G/A	cg13390004	chr1:15929781	NA	0.67	5.29	0.51	1.11e-6	Systolic blood pressure;
SKCM	cis	rs10489202	0.657	rs201541	chr1:167992344	T/A	cg24449463	chr1:168025552	DCAF6	-0.82	-7.78	-0.66	2.46e-11	Schizophrenia;
SKCM	cis	rs6430585	0.528	rs7606267	chr2:136668123	T/C	cg07169764	chr2:136633963	MCM6	1.36	12.7	0.82	1.14e-20	Corneal structure;
SKCM	cis	rs951366	0.789	rs823137	chr1:205738302	C/T	cg11965913	chr1:205819406	PM20D1	1.0	10.25	0.76	4.15e-16	Menarche (age at onset);
SKCM	cis	rs12497850	0.864	rs12493001	chr3:49181885	A/G	cg07636037	chr3:49044803	WDR6	1.0	8.69	0.7	4.39e-13	Parkinson's disease;
SKCM	cis	rs910316	0.967	rs8007539	chr14:75664953	T/C	cg11812906	chr14:75593930	NEK9	-0.72	-5.73	-0.54	1.83e-7	Height;
SKCM	cis	rs2019137	0.560	rs4849179	chr2:113985170	C/T	cg11763394	chr2:113992921	PAX8;LOC440839;LOC654433	0.62	4.93	0.49	4.52e-6	Lymphocyte counts;
SKCM	cis	rs826838	1.000	rs826888	chr12:39104719	C/G	cg13010199	chr12:38710504	ALG10B	-0.82	-6.11	-0.57	3.61e-8	Heart rate;
SKCM	cis	rs875971	0.898	rs6977501	chr7:65693342	T/C	cg11764359	chr7:65958608	NA	-0.87	-8.35	-0.69	1.99e-12	Aortic root size;
SKCM	cis	rs7523050	0.730	rs12734623	chr1:109442654	A/G	cg08274380	chr1:109419600	GPSM2	1.15	6.57	0.6	5.22e-9	Fat distribution (HIV);
SKCM	cis	rs7666738	0.830	rs115712871	chr4:98954535	A/T	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs72781680	0.611	rs7596060	chr2:24334361	A/G	cg20701182	chr2:24300061	SF3B14	-0.73	-4.87	-0.48	5.66e-6	Lymphocyte counts;
SKCM	cis	rs7811142	1.000	rs6953107	chr7:100095664	C/T	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.19	7.92	0.67	1.33e-11	Platelet count;
SKCM	cis	rs4242434	0.854	rs13258100	chr8:22451116	A/T	cg03733263	chr8:22462867	KIAA1967	1.11	9.06	0.72	8.26e-14	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs875971	0.862	rs908915	chr7:65614651	G/T	cg18876405	chr7:65276391	NA	-0.65	-6.63	-0.6	3.96e-9	Aortic root size;
SKCM	cis	rs2243480	1.000	rs1499614	chr7:65730798	A/T	cg18252515	chr7:66147081	NA	-1.27	-7.61	-0.65	5.37e-11	Diabetic kidney disease;
SKCM	cis	rs7103648	1.000	rs12292911	chr11:47449072	C/T	cg20307385	chr11:47447363	PSMC3	1.09	9.23	0.72	3.95e-14	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs10876993	0.928	rs2640636	chr12:58077544	A/G	cg18357645	chr12:58087776	OS9	0.65	5.98	0.56	6.22e-8	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs651907	0.557	rs17411983	chr3:101399126	A/G	cg12386194	chr3:101231763	SENP7	-0.69	-5.68	-0.54	2.23e-7	Colorectal cancer;
SKCM	cis	rs2295359	0.892	rs10789224	chr1:67605134	C/T	cg03340356	chr1:67600835	NA	-0.41	-4.84	-0.48	6.39e-6	Psoriasis;
SKCM	cis	rs798766	0.904	rs13142863	chr4:1755549	T/G	cg05874882	chr4:1763078	NA	-0.6	-4.89	-0.48	5.34e-6	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs2479724	0.811	rs8393	chr6:41757836	C/A	cg17623882	chr6:41773611	USP49	0.75	6.44	0.59	8.92e-9	Menarche (age at onset);
SKCM	cis	rs1568889	1.000	rs2354427	chr11:28049623	T/A	cg06544937	chr11:28130018	METT5D1;KIF18A	0.86	7.03	0.62	6.97e-10	Bipolar disorder;
SKCM	cis	rs2439831	0.541	rs12440854	chr15:43610672	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.34	8.29	0.68	2.59e-12	Lung cancer in ever smokers;
SKCM	cis	rs17683430	0.614	rs2006253	chr22:32530256	A/C	cg00543991	chr22:32367038	NA	1.08	4.94	0.49	4.42e-6	GIP levels in response to oral glucose tolerance test (120 minutes);
SKCM	cis	rs116095464	0.558	rs13354585	chr5:242263	G/C	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs10911232	0.507	rs7547953	chr1:183031641	T/G	ch.1.3577855R	chr1:183094577	LAMC1	0.78	6.88	0.61	1.35e-9	Hypertriglyceridemia;
SKCM	cis	rs425277	0.585	rs3128294	chr1:2065343	G/C	cg03732007	chr1:2071316	PRKCZ	-0.5	-4.82	-0.48	6.82e-6	Height;
SKCM	cis	rs6570726	0.935	rs442254	chr6:145849118	T/C	cg23711669	chr6:146136114	FBXO30	0.7	6.71	0.61	2.78e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs8072100	0.713	rs57427906	chr17:45494014	G/A	cg08085267	chr17:45401833	C17orf57	-0.62	-5.06	-0.5	2.76e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs2120019	0.938	rs2120020	chr15:75316845	T/C	cg09165964	chr15:75287851	SCAMP5	-0.85	-8.74	-0.7	3.44e-13	Blood trace element (Zn levels);
SKCM	cis	rs606458	0.920	rs474707	chr11:64544135	C/T	cg07674570	chr11:65346152	EHBP1L1	0.68	4.89	0.48	5.2e-6	Urate levels;
SKCM	cis	rs8030485	0.536	rs12595749	chr15:79432359	A/G	cg10259521	chr15:79428573	NA	-0.52	-5.53	-0.53	4.05e-7	Left ventricle wall thickness;
SKCM	cis	rs6977660	1.000	rs10260527	chr7:19801930	G/A	cg07541023	chr7:19748670	TWISTNB	0.72	5.02	0.49	3.24e-6	Thyroid stimulating hormone;
SKCM	cis	rs6545883	0.826	rs1186697	chr2:61661417	G/A	cg15711740	chr2:61764176	XPO1	-0.7	-4.93	-0.49	4.5e-6	Tuberculosis;
SKCM	cis	rs67311347	0.544	rs9868700	chr3:40345408	G/A	cg00656387	chr3:40428638	ENTPD3	0.56	4.91	0.49	4.9e-6	Renal cell carcinoma;
SKCM	cis	rs2070488	0.965	rs3762788	chr3:38493852	C/A	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.97	8.85	0.71	2.08e-13	Electrocardiographic conduction measures;
SKCM	trans	rs1814175	0.817	rs28544182	chr11:50049577	G/T	cg03929089	chr4:120376271	NA	-0.93	-8.77	-0.7	3.08e-13	Height;
SKCM	cis	rs9393692	0.905	rs2393592	chr6:26285560	A/G	cg00631329	chr6:26305371	NA	-0.67	-4.9	-0.49	5.02e-6	Educational attainment;
SKCM	cis	rs8141529	0.778	rs9625566	chr22:29162506	G/A	cg15103426	chr22:29168792	CCDC117	0.61	5.01	0.49	3.32e-6	Lymphocyte counts;
SKCM	cis	rs9443189	0.813	rs2748956	chr6:76465003	G/C	cg01950844	chr6:76311363	SENP6	-0.81	-5.51	-0.53	4.51e-7	Prostate cancer;
SKCM	cis	rs875971	0.862	rs801195	chr7:66026115	A/G	cg11764359	chr7:65958608	NA	-0.75	-6.8	-0.61	1.88e-9	Aortic root size;
SKCM	cis	rs7666738	0.830	rs11944107	chr4:98931638	G/C	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7945705	0.902	rs11042152	chr11:9020987	C/T	cg13070366	chr11:9386451	NA	-0.62	-5.02	-0.49	3.18e-6	Hemoglobin concentration;
SKCM	cis	rs910316	1.000	rs2098297	chr14:75619118	G/T	cg11812906	chr14:75593930	NEK9	-0.68	-5.35	-0.52	8.4e-7	Height;
SKCM	cis	rs2153535	0.526	rs9406179	chr6:8538224	G/A	cg07606381	chr6:8435919	SLC35B3	0.92	6.41	0.59	1.04e-8	Motion sickness;
SKCM	cis	rs782590	0.902	rs782600	chr2:55848040	T/C	cg18811423	chr2:55921094	PNPT1	0.9	7.11	0.63	4.9e-10	Metabolic syndrome;
SKCM	trans	rs7618501	1.000	rs1049256	chr3:49763338	T/C	cg21659725	chr3:3221576	CRBN	-0.96	-9.61	-0.74	7.08e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs2032447	0.520	rs198818	chr6:26125711	A/C	cg18357526	chr6:26021779	HIST1H4A	-0.81	-6.69	-0.6	3.04e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs58688157	0.705	rs7122021	chr11:595810	A/G	cg17114584	chr11:613792	IRF7	0.79	5.56	0.53	3.64e-7	Systemic lupus erythematosus;
SKCM	cis	rs9611565	0.592	rs4481089	chr22:41980892	T/C	cg03806693	chr22:41940476	POLR3H	-1.06	-7.21	-0.63	3.11e-10	Vitiligo;
SKCM	cis	rs1003719	0.667	rs2298682	chr21:38444890	A/G	cg10648535	chr21:38446584	PIGP;TTC3	0.64	4.98	0.49	3.68e-6	Eye color traits;
SKCM	cis	rs7666738	0.830	rs7674095	chr4:99048158	T/A	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs28386778	0.897	rs7221853	chr17:61859836	A/G	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	trans	rs1814175	0.645	rs28627251	chr11:50048125	G/T	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs7106204	0.748	rs7947388	chr11:24224903	A/G	ch.11.24196551F	chr11:24239977	NA	0.77	6.34	0.58	1.36e-8	Response to Homoharringtonine (cytotoxicity);
SKCM	cis	rs9900062	0.535	rs753917	chr17:62673136	C/T	cg02097616	chr17:62675921	NA	0.75	6.24	0.58	2.16e-8	QT interval;
SKCM	cis	rs870825	0.550	rs35981185	chr4:185639720	A/C	cg04058563	chr4:185651563	MLF1IP	1.08	7.26	0.64	2.51e-10	Blood protein levels;
SKCM	cis	rs116095464	0.558	rs7714335	chr5:263513	T/C	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs595982	0.517	rs4801779	chr19:49406651	T/G	cg19746536	chr19:49375674	PPP1R15A	1.13	8.49	0.69	1.06e-12	Red cell distribution width;
SKCM	cis	rs28595532	0.920	rs116094766	chr4:119729291	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.43	0.59	9.38e-9	Cannabis dependence symptom count;
SKCM	cis	rs7020830	0.867	rs55845273	chr9:37362219	C/T	cg14294708	chr9:37120828	ZCCHC7	1.06	10.71	0.77	5.47e-17	Schizophrenia;
SKCM	cis	rs875971	0.660	rs6460308	chr7:66084740	T/C	cg11764359	chr7:65958608	NA	-0.84	-6.37	-0.59	1.2e-8	Aortic root size;
SKCM	cis	rs7666738	0.830	rs2865977	chr4:99017916	C/T	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1577917	0.655	rs12203963	chr6:86223316	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.64	5.41	0.52	6.63e-7	Response to antipsychotic treatment;
SKCM	cis	rs1801251	1.000	rs9653383	chr2:233670380	A/C	cg25237894	chr2:233734115	C2orf82	-0.61	-5.9	-0.56	8.76e-8	Coronary artery disease;
SKCM	cis	rs17711722	0.727	rs781151	chr7:65479878	T/C	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.61	5.21	0.51	1.48e-6	Calcium levels;
SKCM	cis	rs523522	0.602	rs7970933	chr12:120862474	G/A	cg12219531	chr12:120966889	COQ5	0.91	6.75	0.61	2.31e-9	High light scatter reticulocyte count;
SKCM	cis	rs2599510	0.755	rs67257914	chr2:32804018	G/A	cg02381751	chr2:32503542	YIPF4	0.76	5.9	0.56	8.97e-8	Interleukin-18 levels;
SKCM	cis	rs9549367	0.713	rs9549681	chr13:113829873	T/C	cg18105134	chr13:113819100	PROZ	-0.91	-6.82	-0.61	1.71e-9	Platelet distribution width;
SKCM	cis	rs3096299	0.748	rs2965822	chr16:89444677	A/T	cg08822215	chr16:89438651	ANKRD11	-0.57	-4.89	-0.48	5.3e-6	Multiple myeloma (IgH translocation);
SKCM	cis	rs2645694	0.533	rs2645674	chr4:77818202	T/C	cg06046430	chr4:77819534	ANKRD56	0.54	5.83	0.55	1.18e-7	Emphysema distribution in smoking;
SKCM	cis	rs1005277	0.540	rs289638	chr10:37923731	G/A	cg25427524	chr10:38739819	LOC399744	-0.62	-6.21	-0.57	2.43e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs6570726	0.935	rs384519	chr6:145846017	C/A	cg23711669	chr6:146136114	FBXO30	0.7	6.71	0.61	2.78e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7100689	0.646	rs1538815	chr10:82137670	A/G	cg01528321	chr10:82214614	TSPAN14	0.82	7.32	0.64	1.91e-10	Post bronchodilator FEV1;
SKCM	cis	rs28374715	0.532	rs316607	chr15:41772693	G/A	cg18705301	chr15:41695430	NDUFAF1	-1.16	-12.35	-0.81	4.82e-20	Ulcerative colitis;
SKCM	cis	rs12586317	0.534	rs28384418	chr14:35452126	C/A	cg16230307	chr14:35515116	FAM177A1	0.69	4.83	0.48	6.78e-6	Psoriasis;
SKCM	cis	rs6088580	0.634	rs6088483	chr20:32984714	T/A	cg24642439	chr20:33292090	TP53INP2	-0.76	-6.02	-0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	trans	rs17685	0.725	rs7807647	chr7:75628669	G/A	cg19862616	chr7:65841803	NCRNA00174	-0.96	-9.14	-0.72	5.89e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs3820928	0.845	rs4234065	chr2:227882006	C/T	cg11843606	chr2:227700838	RHBDD1	-0.62	-5.12	-0.5	2.19e-6	Pulmonary function;
SKCM	cis	rs10771431	0.782	rs10771415	chr12:9358223	C/T	cg08997352	chr12:9597637	DDX12	-0.68	-4.97	-0.49	3.82e-6	Breast size;
SKCM	cis	rs684232	0.602	rs2160955	chr17:560604	T/C	cg15660573	chr17:549704	VPS53	-0.76	-6.08	-0.57	4.15e-8	Prostate cancer;
SKCM	cis	rs1799949	0.965	rs7223952	chr17:41194885	T/C	cg25918947	chr17:41365094	TMEM106A	-0.62	-5.87	-0.55	1.01e-7	Menopause (age at onset);
SKCM	cis	rs6087990	0.836	rs2424909	chr20:31361861	T/C	cg13636640	chr20:31349939	DNMT3B	0.91	7.97	0.67	1.06e-11	Ulcerative colitis;
SKCM	cis	rs908922	0.651	rs6671924	chr1:152485830	T/C	cg09873164	chr1:152488093	CRCT1	0.76	5.94	0.56	7.4e-8	Hair morphology;
SKCM	cis	rs4642101	0.618	rs7612317	chr3:12820558	C/T	cg05775895	chr3:12838266	CAND2	0.68	6.16	0.57	2.99e-8	QRS complex (12-leadsum);
SKCM	cis	rs7552404	0.807	rs2066183	chr1:76153745	A/G	cg10523679	chr1:76189770	ACADM	0.7	5.05	0.5	2.83e-6	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs12142240	0.667	rs41293287	chr1:46808852	C/T	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs672059	1.000	rs480132	chr1:183161779	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.65	5.49	0.53	4.81e-7	Hypertriglyceridemia;
SKCM	cis	rs1005277	0.541	rs2472177	chr10:38384015	T/G	cg25427524	chr10:38739819	LOC399744	-0.68	-6.49	-0.59	7.18e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs6933660	0.800	rs9383900	chr6:151782816	A/C	cg10883421	chr6:151773342	RMND1;C6orf211	0.79	6.85	0.61	1.51e-9	Menarche (age at onset);
SKCM	cis	rs2197308	0.692	rs7488528	chr12:37912971	G/A	cg13010199	chr12:38710504	ALG10B	0.65	4.93	0.49	4.48e-6	Morning vs. evening chronotype;
SKCM	cis	rs867186	1.000	rs73903019	chr20:33727779	G/T	cg04194272	chr20:33683537	NA	-1.11	-6.01	-0.56	5.7e-8	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	trans	rs8073060	0.544	rs225244	chr17:33946581	A/G	cg19694781	chr19:47549865	TMEM160	1.08	8.69	0.7	4.26e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs7618915	0.570	rs11130319	chr3:52755592	A/T	cg18404041	chr3:52824283	ITIH1	-0.58	-5.14	-0.5	2e-6	Bipolar disorder;
SKCM	cis	rs9916302	0.706	rs649180	chr17:37464959	A/C	cg07936489	chr17:37558343	FBXL20	1.0	7.19	0.63	3.42e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs9399137	0.507	rs6918512	chr6:135284839	T/G	cg24558204	chr6:135376177	HBS1L	0.69	6.37	0.59	1.19e-8	Glycated hemoglobin levels;Mean corpuscular volume;Hematology traits;HbA2 levels;Mean corpuscular hemoglobin;Hemoglobin levels;F-cell distribution;Platelet count;
SKCM	cis	rs2760061	0.598	rs590657	chr1:228117581	A/C	cg18477163	chr1:228402036	OBSCN	-0.46	-5.1	-0.5	2.36e-6	Diastolic blood pressure;
SKCM	cis	rs6570726	0.791	rs401561	chr6:145835917	G/T	cg05347473	chr6:146136440	FBXO30	0.53	4.78	0.48	8.07e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9916302	0.752	rs9901219	chr17:37558369	T/G	cg07936489	chr17:37558343	FBXL20	1.01	8.81	0.71	2.54e-13	Glomerular filtration rate (creatinine);
SKCM	cis	rs1577917	0.771	rs9450290	chr6:86233397	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.78	7.21	0.63	3.17e-10	Response to antipsychotic treatment;
SKCM	cis	rs73157695	0.676	rs2839060	chr21:47342116	A/G	cg10605724	chr21:47966967	DIP2A	0.7	5.17	0.51	1.75e-6	Myopia;
SKCM	cis	rs9894429	1.000	rs11651264	chr17:79576394	A/G	cg18240062	chr17:79603768	NPLOC4	-0.76	-7.43	-0.64	1.2e-10	Eye color traits;
SKCM	cis	rs13010713	0.806	rs4667130	chr2:182060695	C/T	cg21995919	chr2:182322279	ITGA4	-0.53	-5.12	-0.5	2.18e-6	Celiac disease;
SKCM	cis	rs600231	0.719	rs7114809	chr11:65251444	A/G	cg24009118	chr11:65545808	DKFZp761E198	0.66	4.94	0.49	4.36e-6	Bone mineral density;
SKCM	cis	rs801193	1.000	rs2055682	chr7:66260289	A/G	cg11987759	chr7:65425863	GUSB	-0.67	-5.75	-0.55	1.68e-7	Aortic root size;
SKCM	cis	rs959260	0.623	rs4542691	chr17:73326965	T/C	cg14668889	chr17:73230827	NUP85	-0.75	-6.29	-0.58	1.72e-8	Systemic lupus erythematosus;
SKCM	cis	rs4975616	0.869	rs452932	chr5:1330253	T/C	cg26373071	chr5:1325741	CLPTM1L	0.74	6.91	0.62	1.18e-9	Lung cancer;
SKCM	cis	rs7296418	0.885	rs1790104	chr12:123709409	C/T	cg05973401	chr12:123451056	ABCB9	0.77	5.86	0.55	1.07e-7	Platelet count;
SKCM	cis	rs7666738	0.830	rs58367603	chr4:99015350	T/C	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6665290	0.935	rs12409755	chr1:227196949	A/T	cg10327440	chr1:227177885	CDC42BPA	-1.24	-17.31	-0.89	1.95e-28	Myeloid white cell count;
SKCM	cis	rs7552404	0.924	rs1303169	chr1:76195041	T/C	cg22875332	chr1:76189707	ACADM	0.7	4.82	0.48	6.96e-6	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs2228479	0.850	rs17226519	chr16:89839854	T/C	cg06558623	chr16:89946397	TCF25	1.11	5.26	0.51	1.23e-6	Skin colour saturation;
SKCM	trans	rs561341	1.000	rs55978022	chr17:30275937	T/C	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs7809950	0.953	rs2520263	chr7:107179119	T/C	cg23024343	chr7:107201750	COG5	-0.77	-6.95	-0.62	9.61e-10	Coronary artery disease;
SKCM	cis	rs13108904	0.875	rs1732099	chr4:1282696	T/C	cg05025164	chr4:1340916	KIAA1530	-0.6	-4.82	-0.48	6.9e-6	Obesity-related traits;
SKCM	cis	rs6753739	0.826	rs7599778	chr2:219961660	G/C	cg09617556	chr2:219924408	IHH	0.48	4.96	0.49	4.03e-6	Height;
SKCM	cis	rs798554	0.836	rs798502	chr7:2789880	G/T	cg04166393	chr7:2884313	GNA12	-0.75	-5.22	-0.51	1.47e-6	Height;
SKCM	cis	rs2836974	0.897	rs68090597	chr21:40535633	A/G	cg11890956	chr21:40555474	PSMG1	1.07	13.19	0.83	1.48e-21	Cognitive function;
SKCM	cis	rs748404	0.631	rs8042688	chr15:43638525	G/A	cg02155558	chr15:43621948	ADAL;LCMT2	0.84	6.38	0.59	1.17e-8	Lung cancer;
SKCM	cis	rs1692580	0.777	rs10910037	chr1:2184280	T/C	cg21442419	chr1:2182373	SKI	-0.7	-7.15	-0.63	4e-10	Coronary artery disease;
SKCM	cis	rs908922	0.676	rs1970283	chr1:152495619	G/C	cg09873164	chr1:152488093	CRCT1	0.78	6.09	0.57	4.03e-8	Hair morphology;
SKCM	cis	rs9902453	1.000	rs55971458	chr17:28427016	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.5	0.53	4.67e-7	Coffee consumption (cups per day);
SKCM	cis	rs453301	0.658	rs6983877	chr8:8904639	T/C	cg15556689	chr8:8085844	FLJ10661	-0.71	-5.31	-0.52	9.95e-7	Joint mobility (Beighton score);
SKCM	cis	rs10769945	0.606	rs217236	chr11:1981259	T/C	cg23202291	chr11:1979235	NA	-0.68	-6.55	-0.6	5.55e-9	DNA methylation (variation);
SKCM	cis	rs17685	0.671	rs60303271	chr7:75760008	A/G	cg01364799	chr7:75623366	TMEM120A	-0.7	-5.69	-0.54	2.09e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs4891159	0.756	rs8084155	chr18:74134952	A/G	cg24786174	chr18:74118243	ZNF516	-0.74	-7.5	-0.65	8.87e-11	Longevity;
SKCM	cis	rs3845702	1.000	rs259808	chr2:180791419	T/G	cg01881094	chr2:180872142	CWC22	-0.98	-5.45	-0.53	5.68e-7	Schizophrenia;
SKCM	cis	rs9911578	0.967	rs11656413	chr17:57082013	A/C	cg05425664	chr17:57184151	TRIM37	0.82	6.77	0.61	2.14e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs12044355	0.927	rs61835382	chr1:231833225	T/A	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	0.77	5.78	0.55	1.45e-7	Alzheimer's disease;
SKCM	cis	rs9875589	0.509	rs4047237	chr3:14012861	T/C	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.57	5.73	0.54	1.84e-7	Ovarian reserve;
SKCM	cis	rs7666738	0.830	rs35644814	chr4:98886111	G/C	cg17366294	chr4:99064904	C4orf37	0.57	4.86	0.48	6.02e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1568889	1.000	rs9783375	chr11:28033667	C/T	cg06544937	chr11:28130018	METT5D1;KIF18A	0.83	6.32	0.58	1.5e-8	Bipolar disorder;
SKCM	cis	rs6835098	0.962	rs6851632	chr4:174109611	A/G	cg08422745	chr4:174089978	GALNT7	-0.86	-6.84	-0.61	1.61e-9	Dementia and core Alzheimer's disease neuropathologic changes;
SKCM	cis	rs16854884	1.000	rs34639473	chr3:143821293	T/A	cg06585982	chr3:143692056	C3orf58	0.74	5.7	0.54	2.02e-7	Economic and political preferences (feminism/equality);
SKCM	cis	rs9910055	0.530	rs8072954	chr17:42294722	G/A	cg10896456	chr17:42255109	ASB16;C17orf65	0.54	4.88	0.48	5.61e-6	Total body bone mineral density;
SKCM	cis	rs72792276	1.000	rs72794361	chr5:127435188	A/T	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.75	5.12	0.5	2.11e-6	Red cell distribution width;
SKCM	cis	rs9911578	1.000	rs7216680	chr17:56988243	G/C	cg05425664	chr17:57184151	TRIM37	-0.67	-5.04	-0.5	2.91e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs10089	0.953	rs758180	chr5:127354423	T/A	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.88	7.64	0.65	4.76e-11	Ileal carcinoids;
SKCM	cis	rs7772486	0.654	rs4896829	chr6:145953675	T/A	cg23711669	chr6:146136114	FBXO30	0.84	8.9	0.71	1.66e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs35306767	0.903	rs7914758	chr10:891702	T/C	cg25614935	chr10:1084866	C10orf110	0.8	5.41	0.52	6.69e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs1577917	0.710	rs9342041	chr6:86280875	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.88	8.76	0.7	3.13e-13	Response to antipsychotic treatment;
SKCM	cis	rs9858542	1.000	rs9836291	chr3:49697459	G/A	cg03060546	chr3:49711283	APEH	-0.76	-5.65	-0.54	2.56e-7	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs4237845	0.844	rs7306124	chr12:58303349	A/T	cg02175503	chr12:58329896	NA	0.8	7.57	0.65	6.48e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs6089829	0.962	rs9679865	chr20:61666132	C/G	cg08564027	chr20:61660810	NA	0.63	5.64	0.54	2.64e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs2836974	0.549	rs34160989	chr21:40554118	C/G	cg11644478	chr21:40555479	PSMG1	0.86	5.66	0.54	2.38e-7	Cognitive function;
SKCM	cis	rs637571	0.584	rs7107912	chr11:65603252	G/A	cg26695010	chr11:65641043	EFEMP2	0.7	5.66	0.54	2.43e-7	Eosinophil percentage of white cells;
SKCM	cis	rs7927771	1.000	rs4752857	chr11:47655752	C/T	cg05585544	chr11:47624801	NA	-0.63	-5.5	-0.53	4.73e-7	Subjective well-being;
SKCM	cis	rs10752881	1.000	rs10797811	chr1:182984432	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.73	6.47	0.59	7.97e-9	Colorectal cancer;
SKCM	cis	rs55962025	0.883	rs362273	chr4:3227419	A/G	cg24015175	chr4:3319247	RGS12	-0.63	-5.42	-0.52	6.54e-7	Parental longevity (mother's age at death);
SKCM	cis	rs10504229	0.683	rs55881798	chr8:58106406	T/C	cg02725872	chr8:58115012	NA	-0.53	-4.91	-0.49	4.82e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs1568889	1.000	rs61889027	chr11:28281908	C/T	cg06544937	chr11:28130018	METT5D1;KIF18A	0.86	6.09	0.57	4.01e-8	Bipolar disorder;
SKCM	cis	rs7438704	0.552	rs62309397	chr4:48327241	C/T	cg15299388	chr4:48491941	ZAR1	0.44	5.09	0.5	2.43e-6	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs4665809	0.590	rs10197494	chr2:26445550	A/G	cg26119090	chr2:26468346	HADHA;HADHB	-1.06	-8.39	-0.69	1.66e-12	Gut microbiome composition (summer);
SKCM	cis	rs10504229	0.639	rs56066782	chr8:58105857	A/G	cg02725872	chr8:58115012	NA	-0.53	-4.91	-0.49	4.82e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs28386778	0.863	rs2665834	chr17:61904724	T/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs11651000	0.857	rs57171311	chr17:45826168	A/G	cg24803719	chr17:45855879	NA	-0.53	-5.04	-0.5	2.93e-6	IgG glycosylation;
SKCM	cis	rs763121	0.925	rs9611008	chr22:39098787	T/C	cg06022373	chr22:39101656	GTPBP1	0.82	5.96	0.56	6.8e-8	Menopause (age at onset);
SKCM	cis	rs3820068	0.581	rs1547033	chr1:15918988	T/C	cg24675056	chr1:15929824	NA	0.77	5.54	0.53	4.01e-7	Systolic blood pressure;
SKCM	cis	rs9902453	0.765	rs3102560	chr17:28029938	T/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.79	5.93	0.56	7.67e-8	Coffee consumption (cups per day);
SKCM	cis	rs7633770	0.749	rs6442011	chr3:46685722	C/T	cg11219411	chr3:46661640	NA	0.54	4.86	0.48	5.98e-6	Coronary artery disease;
SKCM	cis	rs7408868	0.908	rs62113794	chr19:15277337	C/A	cg14696996	chr19:15285081	NOTCH3	0.83	4.91	0.49	4.84e-6	Pulse pressure;
SKCM	cis	rs826838	0.838	rs11183646	chr12:38799846	A/T	cg13010199	chr12:38710504	ALG10B	0.86	6.84	0.61	1.61e-9	Heart rate;
SKCM	cis	rs10028773	0.666	rs12498657	chr4:120262866	G/C	cg09307838	chr4:120376055	NA	0.98	8.16	0.68	4.55e-12	Educational attainment;
SKCM	cis	rs769267	0.896	rs2315610	chr19:19597240	T/C	cg26732615	chr19:19648335	CILP2;YJEFN3	0.67	7.06	0.62	6e-10	Tonsillectomy;
SKCM	cis	rs4803468	0.967	rs13345590	chr19:41886455	T/G	cg09537434	chr19:41945824	ATP5SL	-1.08	-13.01	-0.83	3.1e-21	Height;
SKCM	cis	rs885518	0.852	rs7040895	chr9:21785660	A/G	cg08390209	chr9:22005563	CDKN2BAS;CDKN2B	0.75	4.8	0.48	7.36e-6	Lung adenocarcinoma;
SKCM	cis	rs208520	0.690	rs12192710	chr6:66718137	C/T	cg07460842	chr6:66804631	NA	0.91	7.35	0.64	1.66e-10	Exhaled nitric oxide output;
SKCM	cis	rs67460515	0.563	rs13085336	chr3:160880599	G/A	cg03342759	chr3:160939853	NMD3	-0.7	-5.83	-0.55	1.21e-7	Parkinson's disease;
SKCM	cis	rs919433	0.783	rs2565158	chr2:198236103	T/A	cg04278110	chr2:198063759	ANKRD44	0.74	5.13	0.5	2.06e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs67311347	1.000	rs9829800	chr3:40443927	T/C	cg00091569	chr3:40428383	ENTPD3	0.64	5.47	0.53	5.17e-7	Renal cell carcinoma;
SKCM	cis	rs3785574	0.924	rs2727292	chr17:61893747	A/G	cg01411255	chr17:61851458	DDX42;CCDC47	1.16	12.75	0.82	9.1e-21	Height;
SKCM	cis	rs829883	0.639	rs829898	chr12:98857675	A/C	cg25150519	chr12:98850993	NA	0.51	5.06	0.5	2.7e-6	Colorectal adenoma (advanced);
SKCM	cis	rs1218582	0.804	rs4845678	chr1:154853295	A/G	cg16680214	chr1:154839983	KCNN3	-0.56	-4.97	-0.49	3.89e-6	Prostate cancer;
SKCM	cis	rs6121246	0.512	rs6060938	chr20:30363645	T/C	cg13852791	chr20:30311386	BCL2L1	0.82	5.69	0.54	2.09e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs9290065	0.538	rs9840600	chr3:160769101	G/A	cg03342759	chr3:160939853	NMD3	-0.63	-4.78	-0.48	8.04e-6	Kawasaki disease;
SKCM	cis	rs738322	0.574	rs738323	chr22:38569527	C/T	cg25457927	chr22:38595422	NA	-0.55	-6.39	-0.59	1.13e-8	Cutaneous nevi;
SKCM	cis	rs912057	0.671	rs1294428	chr6:6744623	A/G	cg06612196	chr6:6737390	NA	0.66	5.47	0.53	5.25e-7	Waist-to-hip ratio adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);
SKCM	cis	rs1799949	0.965	rs8071278	chr17:41193910	A/T	cg25918947	chr17:41365094	TMEM106A	-0.62	-5.87	-0.55	1.01e-7	Menopause (age at onset);
SKCM	cis	rs28386778	0.897	rs7501614	chr17:61802612	T/C	cg01411255	chr17:61851458	DDX42;CCDC47	0.79	5.1	0.5	2.35e-6	Prudent dietary pattern;
SKCM	cis	rs13118159	0.550	rs4974617	chr4:1373658	T/C	cg19318889	chr4:1322082	MAEA	0.79	5.72	0.54	1.9e-7	Longevity;
SKCM	cis	rs9633740	1.000	rs1870138	chr10:82269611	A/G	cg01528321	chr10:82214614	TSPAN14	0.85	6.76	0.61	2.22e-9	Post bronchodilator FEV1;
SKCM	cis	rs684232	0.644	rs2543781	chr17:602469	C/G	cg12384639	chr17:618140	VPS53	0.69	5.27	0.51	1.17e-6	Prostate cancer;
SKCM	cis	rs10906466	0.869	rs10450542	chr10:13802704	G/C	cg19695507	chr10:13526193	BEND7	-0.52	-4.82	-0.48	6.89e-6	Migraine;
SKCM	cis	rs9581857	0.615	rs79793528	chr13:28007823	G/A	cg22138327	chr13:27999177	GTF3A	0.94	6.32	0.58	1.51e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs8067545	0.750	rs888423	chr17:19999409	G/A	cg13482628	chr17:19912719	NA	0.7	5.94	0.56	7.54e-8	Schizophrenia;
SKCM	cis	rs763014	0.932	rs2384975	chr16:651115	G/T	cg09263875	chr16:632152	PIGQ	0.69	6.18	0.57	2.73e-8	Height;
SKCM	cis	rs7539542	0.622	rs10800883	chr1:202900558	C/A	cg19681188	chr1:202830198	LOC148709	0.66	4.85	0.48	6.16e-6	Mean platelet volume;
SKCM	cis	rs4927850	1.000	rs4927704	chr3:195738228	C/T	cg12923728	chr3:195709715	SDHAP1	-0.98	-6.88	-0.61	1.36e-9	Pancreatic cancer;
SKCM	cis	rs7772486	0.748	rs2748484	chr6:146333653	C/T	cg23711669	chr6:146136114	FBXO30	0.77	7.16	0.63	3.9e-10	Lobe attachment (rater-scored or self-reported);
SKCM	trans	rs1814175	0.616	rs10839388	chr11:49842603	C/T	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs2991971	0.967	rs60608374	chr1:46008913	G/A	cg15896098	chr1:45966115	MMACHC;CCDC163P	-0.57	-4.83	-0.48	6.6e-6	High light scatter reticulocyte count;
SKCM	cis	rs6424115	1.000	rs2256179	chr1:24132305	A/G	cg15997130	chr1:24165203	NA	-0.61	-5.36	-0.52	8.23e-7	Immature fraction of reticulocytes;
SKCM	cis	rs4237845	0.551	rs116263297	chr12:58273445	A/C	cg02175503	chr12:58329896	NA	0.73	5.88	0.55	9.8e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs6951245	1.000	rs74366004	chr7:1088630	A/C	cg24642844	chr7:1081250	C7orf50	-0.94	-6.32	-0.58	1.48e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs2382817	0.580	rs6756265	chr2:219095554	G/A	cg20019365	chr2:219134978	PNKD;AAMP	-0.66	-5.49	-0.53	4.76e-7	Ulcerative colitis;Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs62238980	0.614	rs79924624	chr22:32497245	A/G	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs4148883	0.629	rs10009145	chr4:100047929	G/A	cg12011299	chr4:100065546	ADH4	0.51	5.12	0.5	2.17e-6	Alcohol dependence;
SKCM	cis	rs6840360	0.615	rs1877188	chr4:152607931	T/C	cg22705602	chr4:152727874	NA	-0.58	-7.78	-0.66	2.55e-11	Intelligence (multi-trait analysis);
SKCM	trans	rs3780486	0.846	rs73484568	chr9:33132492	G/A	cg04842962	chr6:43655489	MRPS18A	1.03	10.85	0.78	2.95e-17	IgG glycosylation;
SKCM	cis	rs7772486	0.754	rs6915718	chr6:146100676	A/G	cg05347473	chr6:146136440	FBXO30	-0.61	-5.81	-0.55	1.31e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1042058	0.565	rs650110	chr10:30753132	A/G	cg25182066	chr10:30743637	MAP3K8	-0.7	-6.22	-0.58	2.29e-8	Inflammatory bowel disease;Crohn's disease;Ulcerative colitis;
SKCM	cis	rs763014	0.865	rs8909	chr16:633851	T/C	cg09263875	chr16:632152	PIGQ	0.67	5.82	0.55	1.24e-7	Height;
SKCM	cis	rs8078723	1.000	rs4795412	chr17:38150604	C/T	cg17467752	chr17:38218738	THRA	0.64	5.71	0.54	1.97e-7	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs67311347	0.544	rs9864601	chr3:40345318	C/T	cg00656387	chr3:40428638	ENTPD3	0.56	4.99	0.49	3.54e-6	Renal cell carcinoma;
SKCM	cis	rs13256369	1.000	rs4840352	chr8:8573508	A/G	cg06636001	chr8:8085503	FLJ10661	0.74	5.69	0.54	2.15e-7	Obesity-related traits;
SKCM	cis	rs55962025	0.628	rs67950027	chr4:3152786	A/C	cg09735869	chr4:3319127	RGS12	-0.64	-4.98	-0.49	3.7e-6	Parental longevity (mother's age at death);
SKCM	cis	rs6545883	0.929	rs1838978	chr2:61540923	T/C	cg15711740	chr2:61764176	XPO1	0.79	5.44	0.52	5.96e-7	Tuberculosis;
SKCM	cis	rs10911251	0.528	rs10911263	chr1:183115018	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.76	7.28	0.64	2.3e-10	Colorectal cancer;
SKCM	cis	rs62238980	0.614	rs117517889	chr22:32469452	C/T	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs951366	0.844	rs823096	chr1:205679887	G/T	cg17178900	chr1:205818956	PM20D1	0.66	5.2	0.51	1.56e-6	Menarche (age at onset);
SKCM	cis	rs10256972	0.681	rs12702016	chr7:1129392	C/T	cg16145915	chr7:1198662	ZFAND2A	-0.56	-7.9	-0.67	1.47e-11	Longevity;Endometriosis;
SKCM	cis	rs769267	0.930	rs9917108	chr19:19572785	A/G	cg26732615	chr19:19648335	CILP2;YJEFN3	0.67	7.06	0.62	6e-10	Tonsillectomy;
SKCM	cis	rs12762955	0.561	rs6560863	chr10:1013535	C/A	cg26597838	chr10:835615	NA	-0.7	-5.86	-0.55	1.05e-7	Response to angiotensin II receptor blocker therapy;
SKCM	cis	rs2427308	0.643	rs477859	chr20:60937597	A/G	cg24112000	chr20:60950667	NA	0.69	6.6	0.6	4.48e-9	Colorectal cancer;
SKCM	cis	rs4253772	0.591	rs6519994	chr22:46656805	A/G	cg03482458	chr22:46692211	CN5H6.4;GTSE1	-1.13	-5.41	-0.52	6.8e-7	LDL cholesterol;Cholesterol, total;
SKCM	cis	rs6461049	0.800	rs3800909	chr7:2159594	C/G	cg21782813	chr7:2030301	MAD1L1	0.48	5.11	0.5	2.27e-6	Schizophrenia;
SKCM	cis	rs9467773	1.000	rs9467782	chr6:26542773	G/A	cg15659132	chr6:26577336	NA	0.6	5.71	0.54	1.99e-7	Intelligence (multi-trait analysis);
SKCM	trans	rs3780486	0.505	rs10758194	chr9:33157419	G/T	cg20290983	chr6:43655470	MRPS18A	0.82	8.72	0.7	3.79e-13	IgG glycosylation;
SKCM	cis	rs9910055	0.552	rs12937114	chr17:42325073	A/G	cg09913183	chr17:42254507	C17orf65;ASB16	0.64	5.05	0.5	2.87e-6	Total body bone mineral density;
SKCM	cis	rs732765	0.734	rs17183139	chr14:75153950	G/A	cg25946216	chr14:74253857	C14orf43	-0.79	-4.97	-0.49	3.83e-6	Non-small cell lung cancer;
SKCM	cis	rs7119	0.666	rs2516302	chr15:77879842	C/G	cg27398640	chr15:77910606	LINGO1	0.53	4.78	0.48	8.12e-6	Type 2 diabetes;
SKCM	cis	rs6582630	0.519	rs12582285	chr12:38298753	C/T	cg26384229	chr12:38710491	ALG10B	0.81	6.57	0.6	5.18e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs9926296	0.533	rs12102297	chr16:89812762	C/A	cg03388025	chr16:89894329	SPIRE2	0.49	4.95	0.49	4.24e-6	Vitiligo;
SKCM	cis	rs11673344	0.633	rs519606	chr19:37433229	C/T	cg07624650	chr19:37064219	ZNF529	-0.78	-4.98	-0.49	3.69e-6	Obesity-related traits;
SKCM	cis	rs614226	0.630	rs503335	chr12:120960057	C/T	cg01236616	chr12:121019343	POP5	-1.7	-5.45	-0.53	5.73e-7	Type 1 diabetes nephropathy;
SKCM	cis	rs9815354	0.767	rs60943892	chr3:41852307	T/C	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs782590	1.000	rs782590	chr2:55843413	C/T	cg18811423	chr2:55921094	PNPT1	0.9	6.98	0.62	8.78e-10	Metabolic syndrome;
SKCM	cis	rs10883723	0.810	rs7094751	chr10:104274818	G/A	cg11453585	chr10:104263688	ACTR1A;SUFU	0.77	6.31	0.58	1.56e-8	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs7937682	0.889	rs484013	chr11:111495779	G/A	cg19812747	chr11:111475976	SIK2	-0.56	-4.95	-0.49	4.24e-6	Primary sclerosing cholangitis;
SKCM	cis	rs867186	1.000	rs117573845	chr20:33651621	A/G	cg04194272	chr20:33683537	NA	-1.38	-7.2	-0.63	3.29e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs6580649	0.941	rs6580651	chr12:48429933	A/T	cg05342945	chr12:48394962	COL2A1	0.73	5.2	0.51	1.53e-6	Lung cancer;
SKCM	cis	rs1850744	0.702	rs73802915	chr4:9603200	G/A	cg15442990	chr4:9534313	NA	-1.37	-4.8	-0.48	7.38e-6	Economic and political preferences;
SKCM	cis	rs2836950	0.501	rs2836984	chr21:40700949	A/C	cg17971929	chr21:40555470	PSMG1	-0.65	-5.09	-0.5	2.4e-6	Menarche (age at onset);
SKCM	cis	rs611744	0.573	rs674580	chr8:109251690	C/G	cg18478394	chr8:109455254	TTC35	0.65	5.48	0.53	4.97e-7	Dupuytren's disease;
SKCM	cis	rs9911578	1.000	rs12940681	chr17:56933622	T/C	cg12560992	chr17:57184187	TRIM37	0.94	7.55	0.65	7.01e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs2921073	0.605	rs2976933	chr8:8254875	A/G	cg08975724	chr8:8085496	FLJ10661	0.68	4.95	0.49	4.26e-6	Parkinson's disease;
SKCM	cis	rs7824557	0.564	rs12550129	chr8:11233917	C/T	cg21775007	chr8:11205619	TDH	-0.61	-5.09	-0.5	2.37e-6	Retinal vascular caliber;
SKCM	cis	rs6545883	1.000	rs778758	chr2:61782161	T/C	cg15711740	chr2:61764176	XPO1	-0.73	-5.26	-0.51	1.21e-6	Tuberculosis;
SKCM	cis	rs6582630	0.555	rs10880607	chr12:38508184	A/G	cg26384229	chr12:38710491	ALG10B	0.85	6.66	0.6	3.52e-9	Drug-induced liver injury (flucloxacillin);
SKCM	trans	rs8073060	0.516	rs2376177	chr17:33938089	T/G	cg19694781	chr19:47549865	TMEM160	-1.08	-8.69	-0.7	4.26e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs11098499	0.754	rs12507565	chr4:120251121	G/A	cg09307838	chr4:120376055	NA	0.91	7.36	0.64	1.63e-10	Corneal astigmatism;
SKCM	cis	rs11122272	0.732	rs999010	chr1:231495316	A/G	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	-0.63	-5.17	-0.51	1.75e-6	Hemoglobin concentration;
SKCM	cis	rs7659604	0.540	rs10007956	chr4:122700669	A/T	cg19671926	chr4:122722719	EXOSC9	0.75	6.93	0.62	1.07e-9	Type 2 diabetes;
SKCM	trans	rs8073060	0.544	rs1080352	chr17:34002362	A/G	cg19694781	chr19:47549865	TMEM160	-1.04	-8.28	-0.68	2.65e-12	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs12044355	0.927	rs12043433	chr1:231843591	A/G	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	0.76	5.49	0.53	4.81e-7	Alzheimer's disease;
SKCM	cis	rs514406	0.505	rs447581	chr1:53177098	T/C	cg16325326	chr1:53192061	ZYG11B	0.89	10.06	0.75	9.55e-16	Monocyte count;
SKCM	cis	rs9880211	0.660	rs9289514	chr3:136493203	C/T	cg21827317	chr3:136751795	NA	-0.74	-5.43	-0.52	6.11e-7	Body mass index;Height;
SKCM	cis	rs992157	0.798	rs2382818	chr2:219155907	A/T	cg20019365	chr2:219134978	PNKD;AAMP	-0.71	-6.09	-0.57	3.95e-8	Colorectal cancer;
SKCM	cis	rs1577917	1.000	rs12207305	chr6:86723502	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.63	-5.38	-0.52	7.46e-7	Response to antipsychotic treatment;
SKCM	cis	rs56235845	0.665	rs4976685	chr5:176766177	C/T	cg17509989	chr5:176798049	RGS14	-0.66	-5.64	-0.54	2.58e-7	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs2034088	0.965	rs28537324	chr17:443527	A/G	cg06217071	chr17:408420	NA	0.49	5.41	0.52	6.64e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs1691799	0.899	rs1177555	chr12:66727568	A/G	cg16791601	chr12:66731901	HELB	-0.63	-5.46	-0.53	5.43e-7	White blood cell count (basophil);
SKCM	cis	rs62238980	0.522	rs118120290	chr22:32399262	T/C	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs6121246	0.865	rs6058421	chr20:30295013	G/C	cg11595048	chr20:30225325	COX4I2	0.67	5.21	0.51	1.5e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs4900538	0.855	rs72698602	chr14:102880454	T/C	cg18135206	chr14:102964638	TECPR2	-0.71	-5.36	-0.52	8.09e-7	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs7811142	1.000	rs2406253	chr7:100077273	A/G	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.17	7.71	0.66	3.44e-11	Platelet count;
SKCM	cis	rs9905704	0.624	rs6503891	chr17:57065924	A/C	cg12560992	chr17:57184187	TRIM37	0.76	6.22	0.58	2.29e-8	Testicular germ cell tumor;
SKCM	cis	rs7843479	0.601	rs4872209	chr8:21848832	A/T	cg17168535	chr8:21777572	XPO7	0.85	8.6	0.7	6.46e-13	Mean corpuscular volume;
SKCM	trans	rs1814175	0.617	rs6486020	chr11:49769149	T/G	cg15704280	chr7:45808275	SEPT13	-0.93	-8.6	-0.7	6.36e-13	Height;
SKCM	cis	rs4808199	1.000	rs60321073	chr19:19499598	A/G	cg03709012	chr19:19516395	GATAD2A	1.13	8.66	0.7	4.94e-13	Nonalcoholic fatty liver disease;
SKCM	cis	rs995000	0.965	rs7520810	chr1:63095711	C/T	cg06896770	chr1:63153194	DOCK7	0.76	7.11	0.63	4.85e-10	Triglyceride levels;
SKCM	cis	rs3820068	0.581	rs72645877	chr1:15928106	G/T	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs2204008	0.744	rs11514358	chr12:38255526	G/A	cg13010199	chr12:38710504	ALG10B	0.69	4.92	0.49	4.72e-6	Bladder cancer;
SKCM	cis	rs11105298	0.891	rs10506972	chr12:89861529	T/C	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.88	-6.05	-0.57	4.76e-8	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs116095464	0.558	rs10055354	chr5:243794	G/A	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs3540	0.533	rs12916560	chr15:91056259	A/C	cg22089800	chr15:90895588	ZNF774	-0.68	-4.91	-0.49	4.84e-6	Allergic disease (asthma, hay fever or eczema);Lymphocyte counts;
SKCM	cis	rs1059312	1.000	rs1059312	chr12:129278864	A/G	cg09035930	chr12:129282057	SLC15A4	-0.82	-8.75	-0.7	3.34e-13	Systemic lupus erythematosus;
SKCM	cis	rs2243480	1.000	rs34970380	chr7:65431493	C/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs7618915	0.547	rs4687638	chr3:52651966	A/C	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs362296	0.597	rs3129320	chr4:3265130	G/C	cg11471262	chr4:3318911	RGS12	-0.6	-5.08	-0.5	2.5e-6	Parental longevity (mother's age at death);
SKCM	cis	rs28595532	0.920	rs114792862	chr4:119759938	G/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs28386778	0.897	rs2854221	chr17:61941445	G/T	cg06873352	chr17:61820015	STRADA	0.75	6.22	0.58	2.35e-8	Prudent dietary pattern;
SKCM	cis	rs34779708	0.931	rs55724039	chr10:35465397	A/G	cg03585969	chr10:35415529	CREM	0.75	6.26	0.58	1.9e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs854765	0.583	rs8078138	chr17:17811251	C/T	cg09796270	chr17:17721594	SREBF1	0.65	4.87	0.48	5.79e-6	Total body bone mineral density;
SKCM	trans	rs7819412	0.806	rs2898256	chr8:10932695	G/C	cg06636001	chr8:8085503	FLJ10661	-0.88	-7.42	-0.64	1.22e-10	Triglycerides;
SKCM	cis	rs4891159	0.527	rs689642	chr18:74119120	A/C	cg24786174	chr18:74118243	ZNF516	0.81	8.75	0.7	3.27e-13	Longevity;
SKCM	cis	rs473651	0.904	rs10929275	chr2:239323169	A/G	cg18131467	chr2:239335373	ASB1	1.09	12.94	0.83	4.13e-21	Multiple system atrophy;
SKCM	cis	rs35146811	0.806	rs1534310	chr7:99699169	A/T	cg13334819	chr7:99746414	C7orf59	-0.76	-5.36	-0.52	8.08e-7	Coronary artery disease;
SKCM	trans	rs1814175	0.817	rs10769648	chr11:50013992	T/C	cg03929089	chr4:120376271	NA	-0.93	-8.77	-0.7	3.08e-13	Height;
SKCM	cis	rs9467773	0.620	rs2101582	chr6:26622734	C/T	cg09904177	chr6:26538194	HMGN4	0.58	5.15	0.5	1.91e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs12478296	1.000	rs55777943	chr2:243040686	T/C	cg06360820	chr2:242988706	NA	-1.0	-5.16	-0.5	1.83e-6	Obesity-related traits;
SKCM	cis	rs7772486	0.686	rs4896827	chr6:145953338	T/A	cg05347473	chr6:146136440	FBXO30	0.58	5.3	0.51	1.05e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs62108261	0.655	rs76051190	chr19:38473458	C/T	cg14299480	chr19:38876666	GGN	1.28	4.85	0.48	6.07e-6	Tuberculosis;
SKCM	trans	rs1814175	0.817	rs4881645	chr11:49791168	G/A	cg15704280	chr7:45808275	SEPT13	-1.03	-10.73	-0.77	5.17e-17	Height;
SKCM	cis	rs3892630	0.824	rs35700505	chr19:33325006	C/T	cg22980127	chr19:33182716	NUDT19	1.28	7.12	0.63	4.62e-10	Red blood cell traits;
SKCM	cis	rs2243480	0.908	rs2460431	chr7:65622846	A/G	cg18252515	chr7:66147081	NA	1.34	8.18	0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs9872999	1	rs9872999	chr3:133457514	C/T	cg16262614	chr3:133464971	TF	0.44	5.37	0.52	7.82e-7	Iron status biomarkers;
SKCM	cis	rs10256972	0.524	rs6945202	chr7:1116558	T/C	cg09177884	chr7:1199841	ZFAND2A	-0.73	-5.75	-0.55	1.68e-7	Longevity;Endometriosis;
SKCM	cis	rs801193	0.660	rs4610622	chr7:66224497	T/C	cg11764359	chr7:65958608	NA	0.83	7.69	0.66	3.75e-11	Aortic root size;
SKCM	cis	rs10193935	0.901	rs222471	chr2:42638057	C/T	cg27598129	chr2:42591480	NA	0.87	6.7	0.6	2.92e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs151997	0.830	rs27282	chr5:50198970	G/A	cg06027927	chr5:50259733	NA	0.65	6.23	0.58	2.2e-8	Callous-unemotional behaviour;
SKCM	cis	rs7659604	0.539	rs3217753	chr4:122746325	A/G	cg20573242	chr4:122745356	CCNA2	0.75	6.39	0.59	1.11e-8	Type 2 diabetes;
SKCM	cis	rs2842992	0.672	rs7738253	chr6:160193917	G/T	cg19482086	chr6:160211437	TCP1;MRPL18	0.87	6.48	0.59	7.71e-9	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs2153535	0.580	rs1932275	chr6:8442333	T/A	cg23788917	chr6:8435910	SLC35B3	0.69	5.14	0.5	1.99e-6	Motion sickness;
SKCM	cis	rs28595532	0.800	rs111626798	chr4:119352517	C/T	cg11846333	chr4:119757529	SEC24D	1.16	6.33	0.58	1.42e-8	Cannabis dependence symptom count;
SKCM	cis	rs7590368	1.000	rs13429247	chr2:10960529	A/G	cg15705551	chr2:10952987	PDIA6	0.76	4.88	0.48	5.52e-6	Educational attainment (years of education);
SKCM	cis	rs2075371	0.764	rs1643034	chr7:134006176	A/G	cg20476274	chr7:133979776	SLC35B4	1.02	10.68	0.77	6.2e-17	Mean platelet volume;
SKCM	cis	rs116095464	0.614	rs28736753	chr5:274081	G/A	cg22857025	chr5:266934	NA	-1.48	-8.11	-0.68	5.64e-12	Breast cancer;
SKCM	cis	rs7613875	0.620	rs34312088	chr3:50032133	C/T	cg24110177	chr3:50126178	RBM5	-0.7	-5.58	-0.53	3.34e-7	Body mass index;
SKCM	cis	rs709400	1.000	rs7150141	chr14:104129352	G/A	cg26031613	chr14:104095156	KLC1	1.05	12.89	0.82	5.14e-21	Body mass index;
SKCM	cis	rs28595532	0.920	rs10018977	chr4:119785229	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs9906944	0.545	rs11079850	chr17:47092252	G/T	cg10950924	chr17:47092072	IGF2BP1	-0.61	-5.56	-0.53	3.64e-7	Intelligence (multi-trait analysis);Body fat percentage;
SKCM	cis	rs798554	0.679	rs1636253	chr7:2885123	A/G	cg04166393	chr7:2884313	GNA12	0.79	5.54	0.53	3.9e-7	Height;
SKCM	cis	rs3785574	0.962	rs114027117	chr17:61939935	T/A	cg06873352	chr17:61820015	STRADA	0.57	4.85	0.48	6.3e-6	Height;
SKCM	cis	rs752010	0.695	rs12134166	chr1:42105867	C/T	cg06885757	chr1:42089581	HIVEP3	0.51	6.04	0.56	4.83e-8	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs7027203	0.828	rs10761287	chr9:96609150	A/G	cg14598338	chr9:96623480	NA	-0.5	-5.12	-0.5	2.12e-6	DNA methylation (variation);
SKCM	cis	rs951366	0.668	rs823154	chr1:205762406	C/T	cg17178900	chr1:205818956	PM20D1	0.77	7.25	0.63	2.6200000000000003e-10	Menarche (age at onset);
SKCM	cis	rs668210	0.793	rs1151514	chr11:65758854	G/A	cg20909159	chr11:65625947	CFL1	-0.73	-4.87	-0.48	5.78e-6	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs8180040	0.900	rs4858894	chr3:47484953	C/G	cg27129171	chr3:47204927	SETD2	0.79	5.79	0.55	1.43e-7	Colorectal cancer;
SKCM	cis	rs250585	0.667	rs419743	chr16:23603682	T/A	cg09934309	chr16:23461721	COG7	-0.83	-5.53	-0.53	4.06e-7	Egg allergy;
SKCM	cis	rs936229	0.749	rs6495127	chr15:75194490	C/T	cg14664628	chr15:75095509	CSK	-0.99	-7.09	-0.63	5.3e-10	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin);
SKCM	cis	rs28386778	0.897	rs1062791	chr17:61896487	C/T	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.22	0.79	6.03e-18	Prudent dietary pattern;
SKCM	cis	rs9467773	0.620	rs2494694	chr6:26619328	A/T	cg15659132	chr6:26577336	NA	0.62	5.4	0.52	6.91e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs427394	1.000	rs427394	chr5:6745875	A/G	cg10857441	chr5:6722123	POLS	-0.62	-6.36	-0.58	1.27e-8	Menopause (age at onset);
SKCM	cis	rs17685	0.725	rs7807647	chr7:75628669	G/A	cg16489192	chr7:75678113	MDH2;STYXL1	0.58	5.14	0.5	1.97e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1707322	0.752	rs10430105	chr1:46138876	G/A	cg03146154	chr1:46216737	IPP	0.8	5.57	0.53	3.52e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs10089	1.000	rs883074	chr5:127445823	C/T	cg25462716	chr5:127418816	SLC12A2;FLJ33630	-0.92	-7.88	-0.67	1.61e-11	Ileal carcinoids;
SKCM	cis	rs2120019	1.000	rs12185102	chr15:75352201	G/A	cg09165964	chr15:75287851	SCAMP5	-0.75	-6.7	-0.6	2.88e-9	Blood trace element (Zn levels);
SKCM	cis	rs7598759	0.617	rs6437017	chr2:232327584	C/A	cg19187155	chr2:232395269	NMUR1	0.62	4.98	0.49	3.8e-6	Noise-induced hearing loss;
SKCM	cis	rs7100689	0.784	rs10749562	chr10:82108253	G/T	cg00277334	chr10:82204260	NA	-0.56	-5.2	-0.51	1.59e-6	Post bronchodilator FEV1;
SKCM	cis	rs6736997	0.564	rs4663483	chr2:235611137	C/T	cg17841421	chr2:235704848	NA	0.59	5.16	0.5	1.84e-6	Pancreatic cancer;
SKCM	cis	rs2243480	1.000	rs2707844	chr7:66059509	G/A	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs861020	1.000	rs12134698	chr1:209987801	C/A	cg09163369	chr1:210001066	C1orf107	-0.77	-5.01	-0.49	3.31e-6	Orofacial clefts;
SKCM	cis	rs1865760	0.929	rs1816546	chr6:25938252	C/T	cg08401836	chr6:26032486	HIST1H3B	-0.62	-5.06	-0.5	2.76e-6	Height;
SKCM	cis	rs9611565	0.659	rs202653	chr22:41840158	C/T	cg03806693	chr22:41940476	POLR3H	1.07	6.74	0.61	2.44e-9	Vitiligo;
SKCM	cis	rs8038465	0.638	rs8036954	chr15:73974282	T/C	cg15420318	chr15:73925796	NPTN	0.61	4.89	0.48	5.19e-6	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs9399135	0.967	rs7773126	chr6:135318390	A/G	cg24558204	chr6:135376177	HBS1L	0.59	5.23	0.51	1.41e-6	Red blood cell count;
SKCM	cis	rs28386778	0.897	rs2665823	chr17:61885917	G/A	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs372883	0.648	rs382732	chr21:30719010	A/G	cg24692254	chr21:30365293	RNF160	0.63	4.95	0.49	4.17e-6	Pancreatic cancer;
SKCM	cis	rs854765	0.647	rs4365346	chr17:17989373	G/T	cg04398451	chr17:18023971	MYO15A	-1.02	-8.72	-0.7	3.81e-13	Total body bone mineral density;
SKCM	cis	rs9303401	0.614	rs68100606	chr17:56500898	G/A	cg02118635	chr17:56770003	RAD51C;TEX14	0.78	5.17	0.51	1.73e-6	Cognitive test performance;
SKCM	cis	rs137603	0.562	rs470080	chr22:39712368	C/T	cg17798944	chr22:39715225	SNORD43;RPL3	-0.66	-5.7	-0.54	2.01e-7	Primary biliary cholangitis;
SKCM	cis	rs9381040	0.701	rs722442	chr6:41089681	A/G	cg03644281	chr6:41068752	NFYA;LOC221442	-0.72	-4.85	-0.48	6.1e-6	Alzheimer's disease (late onset);
SKCM	cis	rs34779708	0.931	rs4934709	chr10:35339324	A/C	cg03585969	chr10:35415529	CREM	-0.71	-5.74	-0.54	1.75e-7	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs7633857	0.512	rs7611005	chr3:160698549	A/T	cg03342759	chr3:160939853	NMD3	-0.61	-4.91	-0.49	4.84e-6	Educational attainment (years of education);
SKCM	cis	rs1707322	1.000	rs785510	chr1:46528618	T/C	cg03146154	chr1:46216737	IPP	-0.79	-5.2	-0.51	1.55e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs4803468	1.000	rs166925	chr19:41926098	T/C	cg09537434	chr19:41945824	ATP5SL	-1.1	-13.85	-0.84	1.02e-22	Height;
SKCM	cis	rs17376456	0.825	rs17372725	chr5:93135588	C/A	cg25358565	chr5:93447407	FAM172A	1.19	7.78	0.66	2.52e-11	Diabetic retinopathy;
SKCM	cis	rs951366	0.789	rs7536483	chr1:205718858	A/T	cg11965913	chr1:205819406	PM20D1	0.99	9.74	0.74	3.96e-15	Menarche (age at onset);
SKCM	cis	rs2243480	0.901	rs1701759	chr7:65470932	G/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs7945705	0.738	rs11042067	chr11:8815453	T/C	cg21881798	chr11:8931708	C11orf17;ST5	-0.69	-6.92	-0.62	1.1e-9	Hemoglobin concentration;
SKCM	cis	rs4555082	0.874	rs56263609	chr14:105756944	C/T	cg13114125	chr14:105738426	BRF1	-0.73	-5.62	-0.54	2.79e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs951366	0.789	rs1775154	chr1:205696615	T/A	cg07167872	chr1:205819463	PM20D1	0.96	7.98	0.67	1.01e-11	Menarche (age at onset);
SKCM	cis	rs10876993	0.893	rs7979246	chr12:58092554	A/G	cg18357645	chr12:58087776	OS9	0.68	6.27	0.58	1.83e-8	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs10779751	1.000	rs4845987	chr1:11306279	G/C	cg08854313	chr1:11322531	MTOR	1.04	10.13	0.75	7.04e-16	Body mass index;
SKCM	cis	rs2204008	0.570	rs1315664	chr12:38138274	A/G	cg26384229	chr12:38710491	ALG10B	-0.67	-5.47	-0.53	5.23e-7	Bladder cancer;
SKCM	cis	rs7811142	1.000	rs73161759	chr7:100009994	T/C	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.11	6.45	0.59	8.66e-9	Platelet count;
SKCM	cis	rs7953508	0.711	rs3825199	chr12:93976954	A/G	cg18151635	chr12:93972918	NA	-0.7	-6.05	-0.57	4.75e-8	Pubertal anthropometrics;
SKCM	cis	rs908922	0.651	rs1572534	chr1:152509689	G/A	cg09873164	chr1:152488093	CRCT1	0.78	6.09	0.57	4.03e-8	Hair morphology;
SKCM	cis	rs12971120	1.000	rs2278162	chr18:72175814	A/G	cg25817165	chr18:72167213	CNDP2	-0.61	-4.8	-0.48	7.57e-6	Refractive error;
SKCM	cis	rs651907	0.557	rs34376498	chr3:101480156	C/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.81	7.08	0.63	5.59e-10	Colorectal cancer;
SKCM	cis	rs1348850	0.958	rs1545364	chr2:178462882	G/T	cg02961200	chr2:178257176	LOC100130691;AGPS	0.84	6.61	0.6	4.29e-9	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	trans	rs1814175	0.754	rs10219245	chr11:49645052	C/T	cg15704280	chr7:45808275	SEPT13	-1.03	-10.38	-0.76	2.38e-16	Height;
SKCM	cis	rs2268241	0.938	rs11088251	chr21:34770810	A/C	cg14850771	chr21:34775459	IFNGR2	0.91	5.51	0.53	4.55e-7	Obesity-related traits;
SKCM	cis	rs1790761	0.520	rs1551884	chr11:67399601	C/G	cg00864171	chr11:67383662	NA	-0.62	-5.18	-0.51	1.66e-6	Mean corpuscular volume;
SKCM	cis	rs28386778	0.897	rs2727330	chr17:61925498	A/G	cg22520471	chr17:61851767	DDX42;CCDC47	-0.79	-5.41	-0.52	6.84e-7	Prudent dietary pattern;
SKCM	cis	rs6570726	0.935	rs416987	chr6:145847005	G/C	cg23711669	chr6:146136114	FBXO30	0.7	6.71	0.61	2.78e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2836974	0.568	rs7282604	chr21:40536910	C/T	cg11644478	chr21:40555479	PSMG1	-0.81	-7.84	-0.66	1.91e-11	Cognitive function;
SKCM	cis	rs12926788	0.542	rs11862971	chr16:24767574	C/A	cg04756594	chr16:24857601	SLC5A11	0.72	5.19	0.51	1.65e-6	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs3785574	0.962	rs4968660	chr17:61792221	G/A	cg06601766	chr17:61851465	DDX42;CCDC47	0.66	4.98	0.49	3.74e-6	Height;
SKCM	cis	rs4423214	0.840	rs1619577	chr11:71181485	C/T	cg05163923	chr11:71159392	DHCR7	-0.71	-6.16	-0.57	2.96e-8	Vitamin D levels;
SKCM	cis	rs1218582	0.688	rs58629129	chr1:154910930	T/C	cg09359103	chr1:154839909	KCNN3	-0.56	-5.17	-0.51	1.74e-6	Prostate cancer;
SKCM	cis	rs7193541	0.673	rs12716769	chr16:74652537	T/C	cg01733217	chr16:74700730	RFWD3	1.04	12.01	0.81	2.07e-19	Multiple myeloma;
SKCM	cis	rs10504229	0.906	rs73607868	chr8:58172482	T/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs1799949	1.000	rs72829113	chr17:41181835	C/T	cg23758822	chr17:41437982	NA	0.91	7.51	0.65	8.13e-11	Menopause (age at onset);
SKCM	cis	rs67311347	0.544	rs2278927	chr3:40350447	G/A	cg02782426	chr3:40428986	ENTPD3	0.54	5.49	0.53	4.78e-7	Renal cell carcinoma;
SKCM	cis	rs1577917	0.958	rs1591437	chr6:86525305	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.86	-8.7	-0.7	4.12e-13	Response to antipsychotic treatment;
SKCM	cis	rs9911578	1.000	rs4482353	chr17:56896834	A/G	cg12560992	chr17:57184187	TRIM37	0.95	7.69	0.66	3.7e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs1843834	0.505	rs4674911	chr2:225345254	A/G	cg22455342	chr2:225449267	CUL3	0.71	5.32	0.52	9.67e-7	IgE levels in asthmatics (D.p. specific);
SKCM	cis	rs2404602	0.611	rs2404734	chr15:76936165	T/C	cg23625390	chr15:77176239	SCAPER	-0.85	-8.26	-0.68	2.93e-12	Blood metabolite levels;
SKCM	cis	rs17685	0.632	rs1859793	chr7:75821283	G/A	cg01364799	chr7:75623366	TMEM120A	-0.64	-5.26	-0.51	1.2e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7772486	0.743	rs62433835	chr6:146032688	C/G	cg23711669	chr6:146136114	FBXO30	-0.77	-7.51	-0.65	8.49e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1218582	0.772	rs4845400	chr1:154872523	C/T	cg03351412	chr1:154909251	PMVK	0.77	6.52	0.59	6.43e-9	Prostate cancer;
SKCM	cis	rs4925325	0.915	rs2427246	chr20:60517047	T/C	cg16423285	chr20:60520624	NA	-1.05	-7.1	-0.63	5.13e-10	Obesity-related traits;
SKCM	cis	rs798554	0.836	rs798500	chr7:2790685	C/T	cg04166393	chr7:2884313	GNA12	-0.72	-4.99	-0.49	3.52e-6	Height;
SKCM	cis	rs4819052	0.959	rs8130866	chr21:46672112	G/A	cg20896738	chr21:46707857	POFUT2;LOC642852	0.74	5.35	0.52	8.71e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs35306767	0.855	rs2050944	chr10:918910	T/C	cg25614935	chr10:1084866	C10orf110	0.75	4.94	0.49	4.38e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs875971	0.862	rs3926380	chr7:66080645	G/T	cg11764359	chr7:65958608	NA	-0.74	-6.63	-0.6	3.89e-9	Aortic root size;
SKCM	cis	rs711244	0.532	rs4670181	chr2:37226903	G/C	cg14987922	chr2:37194071	STRN	0.69	4.99	0.49	3.59e-6	Mean platelet volume;
SKCM	cis	rs17345786	0.511	rs13061565	chr3:101392270	T/C	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.81	6.96	0.62	9.48e-10	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2742234	0.910	rs2505505	chr10:43648221	G/T	cg15022308	chr10:43447071	NA	-0.58	-5.0	-0.49	3.41e-6	Hirschsprung disease;
SKCM	cis	rs10751667	0.621	rs10794348	chr11:939941	G/A	cg10932868	chr11:921992	NA	0.55	5.13	0.5	2.09e-6	Alzheimer's disease (late onset);
SKCM	cis	rs2599510	0.811	rs176410	chr2:32643437	C/G	cg02381751	chr2:32503542	YIPF4	-0.7	-5.9	-0.56	8.88e-8	Interleukin-18 levels;
SKCM	cis	rs55962025	0.804	rs2269499	chr4:3239702	C/T	cg24015175	chr4:3319247	RGS12	-0.62	-5.4	-0.52	6.9e-7	Parental longevity (mother's age at death);
SKCM	cis	rs7824557	0.614	rs2060456	chr8:11213363	C/T	cg21775007	chr8:11205619	TDH	0.66	5.72	0.54	1.91e-7	Retinal vascular caliber;
SKCM	cis	rs2013441	0.965	rs2703820	chr17:20121479	G/A	cg13482628	chr17:19912719	NA	-0.65	-5.21	-0.51	1.48e-6	Obesity-related traits;
SKCM	cis	rs875971	0.660	rs10215132	chr7:66054406	C/A	cg11764359	chr7:65958608	NA	-0.83	-6.29	-0.58	1.71e-8	Aortic root size;
SKCM	cis	rs2439831	1.000	rs550239	chr15:43720197	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.15	7.17	0.63	3.73e-10	Lung cancer in ever smokers;
SKCM	cis	rs7772486	0.875	rs1331637	chr6:146337087	T/C	cg05347473	chr6:146136440	FBXO30	0.57	5.18	0.51	1.66e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2180341	0.538	rs3756993	chr6:127651551	A/C	cg27446573	chr6:127587934	RNF146	0.69	5.45	0.53	5.72e-7	Breast cancer;
SKCM	cis	rs9902453	1.000	rs7207021	chr17:28400516	C/A	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.81	-5.78	-0.55	1.45e-7	Coffee consumption (cups per day);
SKCM	cis	rs875971	0.505	rs6955582	chr7:65431686	A/G	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.62	5.36	0.52	8.11e-7	Aortic root size;
SKCM	cis	rs67460515	0.500	rs9822435	chr3:160748068	A/T	cg03342759	chr3:160939853	NMD3	-0.66	-5.09	-0.5	2.43e-6	Parkinson's disease;
SKCM	cis	rs711244	0.783	rs2252032	chr2:37099339	C/T	cg14987922	chr2:37194071	STRN	0.62	4.78	0.48	8.22e-6	Mean platelet volume;
SKCM	cis	rs1395	0.778	rs2580761	chr2:27426362	G/A	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.51	5.14	0.5	1.96e-6	Blood metabolite levels;
SKCM	cis	rs10504073	0.584	rs55795863	chr8:49898055	A/G	cg00325661	chr8:49890786	NA	0.79	7.15	0.63	3.99e-10	Blood metabolite ratios;
SKCM	cis	rs9640161	0.783	rs1132261	chr7:150059987	G/A	cg10018233	chr7:150070692	REPIN1	0.76	6.83	0.61	1.64e-9	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs6951245	1.000	rs75488469	chr7:1102122	A/G	cg18402987	chr7:1209562	NA	1.15	6.09	0.57	3.95e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs801193	0.904	rs4718405	chr7:66254646	A/G	cg00343986	chr7:65444356	GUSB	0.68	4.99	0.49	3.65e-6	Aortic root size;
SKCM	cis	rs1577917	1.000	rs34581302	chr6:86705948	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.83	-8.23	-0.68	3.37e-12	Response to antipsychotic treatment;
SKCM	cis	rs8014204	0.935	rs2300596	chr14:75353855	C/T	cg06637938	chr14:75390232	RPS6KL1	0.79	6.1	0.57	3.82e-8	Caffeine consumption;
SKCM	cis	rs10752881	0.967	rs10911186	chr1:182972542	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.72	6.41	0.59	1.01e-8	Colorectal cancer;
SKCM	cis	rs2188420	0.872	rs74473926	chr7:106503069	G/A	cg23615938	chr7:105753134	SYPL1	-1.07	-5.88	-0.55	9.55e-8	Interferon gamma levels;
SKCM	cis	rs7143963	0.636	rs2403103	chr14:103309622	G/A	cg23020514	chr14:103360112	TRAF3	0.74	7.1	0.63	5.18e-10	Body mass index;
SKCM	cis	rs7954584	0.567	rs11043251	chr12:122373279	C/T	cg22618164	chr12:122356400	WDR66	0.54	5.44	0.52	6.02e-7	Mean corpuscular volume;
SKCM	cis	rs854765	0.547	rs2955355	chr17:17948475	G/A	cg04398451	chr17:18023971	MYO15A	0.84	6.78	0.61	2.05e-9	Total body bone mineral density;
SKCM	cis	rs7772486	0.875	rs1331644	chr6:146398660	T/C	cg05347473	chr6:146136440	FBXO30	0.64	5.65	0.54	2.52e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs17376456	0.877	rs17083455	chr5:93446380	A/C	cg25358565	chr5:93447407	FAM172A	1.23	7.97	0.67	1.08e-11	Diabetic retinopathy;
SKCM	cis	rs2153535	0.580	rs9406163	chr6:8466642	C/T	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs2070488	0.804	rs13092473	chr3:38458958	A/G	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.75	6.16	0.57	2.93e-8	Electrocardiographic conduction measures;
SKCM	cis	rs7705819	0.722	rs9284985	chr5:172893123	C/T	cg18875607	chr5:172924909	NA	0.44	4.8	0.48	7.51e-6	Stroke;
SKCM	cis	rs7191439	0.583	rs9935872	chr16:88788477	A/G	cg27087555	chr16:88793112	FAM38A	-1.23	-5.45	-0.53	5.72e-7	Plateletcrit;
SKCM	cis	rs2841277	0.646	rs3742935	chr14:105405599	G/C	cg15352829	chr14:105391018	PLD4	-0.58	-4.81	-0.48	7.35e-6	Rheumatoid arthritis;
SKCM	cis	rs13118159	0.527	rs6599308	chr4:1387780	A/G	cg02475777	chr4:1388615	CRIPAK	0.93	6.25	0.58	2e-8	Longevity;
SKCM	cis	rs5995756	0.736	rs17401961	chr22:40012284	G/A	cg10455938	chr22:40058150	CACNA1I	-0.6	-5.05	-0.5	2.86e-6	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs11764590	0.694	rs6977161	chr7:2099361	T/C	cg23422044	chr7:1970798	MAD1L1	-0.81	-6.16	-0.57	2.98e-8	Neuroticism;
SKCM	cis	rs2032447	0.802	rs199755	chr6:25990367	G/A	cg18357526	chr6:26021779	HIST1H4A	0.75	5.72	0.54	1.9e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs477895	0.713	rs11600867	chr11:63972052	T/A	cg07220939	chr11:64358617	SLC22A12	0.74	4.94	0.49	4.37e-6	Mean platelet volume;
SKCM	cis	rs611744	0.538	rs2298605	chr8:109272006	T/C	cg18478394	chr8:109455254	TTC35	0.64	5.45	0.53	5.7e-7	Dupuytren's disease;
SKCM	cis	rs951366	0.789	rs823152	chr1:205736285	G/A	cg17178900	chr1:205818956	PM20D1	0.77	6.6	0.6	4.58e-9	Menarche (age at onset);
SKCM	cis	rs801193	1.000	rs2286684	chr7:66129830	G/T	cg05627663	chr7:65219948	SNORA22;CCT6P1	-0.56	-4.84	-0.48	6.39e-6	Aortic root size;
SKCM	cis	rs7937682	0.847	rs500163	chr11:111462649	T/G	cg19812747	chr11:111475976	SIK2	-0.61	-4.94	-0.49	4.41e-6	Primary sclerosing cholangitis;
SKCM	cis	rs2836974	0.623	rs34240248	chr21:40685239	A/G	cg11890956	chr21:40555474	PSMG1	-0.82	-8.04	-0.67	7.71e-12	Cognitive function;
SKCM	cis	rs2153535	0.580	rs1577470	chr6:8462426	G/A	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs875971	0.867	rs1002053	chr7:65798545	G/A	cg11764359	chr7:65958608	NA	-0.88	-8.54	-0.7	8.36e-13	Aortic root size;
SKCM	cis	rs875971	1.000	rs6945843	chr7:65734783	G/A	cg11764359	chr7:65958608	NA	-0.88	-8.54	-0.7	8.32e-13	Aortic root size;
SKCM	cis	rs9543976	1.000	rs2031236	chr13:76169777	C/T	cg16409306	chr13:76195284	LMO7	-0.82	-4.83	-0.48	6.75e-6	Diabetic retinopathy;
SKCM	cis	rs769267	0.895	rs2965182	chr19:19548246	A/G	cg03709012	chr19:19516395	GATAD2A	0.9	8.7	0.7	4.14e-13	Tonsillectomy;
SKCM	cis	rs9604529	0.557	rs61967979	chr13:114743190	C/T	cg04826882	chr13:114838756	RASA3	-0.99	-4.79	-0.48	7.76e-6	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs271738	0.747	rs172035	chr1:234667113	T/G	cg00123090	chr1:234667087	NA	0.41	4.77	0.48	8.43e-6	Bipolar disorder;
SKCM	cis	rs7618501	0.540	rs11130241	chr3:50131459	A/T	cg05072774	chr3:49840536	C3orf54	0.71	5.48	0.53	5e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs3096299	0.730	rs3102380	chr16:89390416	T/C	cg08822215	chr16:89438651	ANKRD11	-0.53	-4.89	-0.48	5.23e-6	Multiple myeloma (IgH translocation);
SKCM	cis	rs16854884	0.770	rs7653331	chr3:143810909	G/A	cg06585982	chr3:143692056	C3orf58	0.71	5.45	0.53	5.6e-7	Economic and political preferences (feminism/equality);
SKCM	cis	rs8064299	0.967	rs880827	chr17:72767435	C/T	cg25054828	chr17:72772726	NAT9;TMEM104	-0.78	-7.04	-0.62	6.68e-10	Monocyte count;
SKCM	cis	rs7809950	0.637	rs3801964	chr7:106836242	T/C	cg23024343	chr7:107201750	COG5	-0.79	-6.66	-0.6	3.47e-9	Coronary artery disease;
SKCM	cis	rs769267	1.000	rs3764567	chr19:19440066	C/T	cg26732615	chr19:19648335	CILP2;YJEFN3	-0.66	-6.17	-0.57	2.81e-8	Tonsillectomy;
SKCM	cis	rs9325144	0.555	rs2387847	chr12:38687434	C/T	cg13010199	chr12:38710504	ALG10B	0.63	5.01	0.49	3.31e-6	Morning vs. evening chronotype;
SKCM	cis	rs3845702	0.736	rs72960660	chr2:180832482	A/G	cg01881094	chr2:180872142	CWC22	1.3	6.15	0.57	3.07e-8	Schizophrenia;
SKCM	cis	rs57221529	0.766	rs28563961	chr5:554498	C/G	cg10555297	chr5:473380	SLC9A3;LOC25845	1.1	5.56	0.53	3.68e-7	Lung disease severity in cystic fibrosis;
SKCM	cis	rs2836974	0.584	rs7276774	chr21:40628725	T/G	cg17971929	chr21:40555470	PSMG1	-0.76	-7.16	-0.63	3.94e-10	Cognitive function;
SKCM	cis	rs2479724	0.636	rs41273794	chr6:41755708	C/T	cg17623882	chr6:41773611	USP49	0.71	5.15	0.5	1.91e-6	Menarche (age at onset);
SKCM	cis	rs597539	0.690	rs552517	chr11:68625286	T/G	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.81	5.33	0.52	9.43e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs854765	0.693	rs12936037	chr17:17777245	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	-0.99	-8.56	-0.7	7.73e-13	Total body bone mineral density;
SKCM	cis	rs13217239	0.646	rs7747454	chr6:27034253	T/G	cg12292205	chr6:26970375	C6orf41	-0.58	-5.13	-0.5	2.03e-6	Schizophrenia;
SKCM	cis	rs9389248	0.690	rs2294321	chr6:135253048	T/G	cg24558204	chr6:135376177	HBS1L	-0.59	-5.27	-0.51	1.17e-6	High light scatter reticulocyte percentage of red cells;
SKCM	cis	rs2502731	0.504	rs7853212	chr9:130955238	A/G	cg13642260	chr9:130955380	CIZ1	-0.82	-7.48	-0.65	9.55e-11	Attention deficit hyperactivity disorder;
SKCM	cis	rs6912958	0.514	rs1980792	chr6:87889917	A/G	cg08069147	chr6:88032118	GJB7;C6orf162	-0.65	-5.44	-0.52	5.92e-7	Monocyte percentage of white cells;
SKCM	cis	rs9818758	0.556	rs11716614	chr3:49017208	C/G	cg00383909	chr3:49044727	WDR6	1.19	4.94	0.49	4.36e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs798554	0.679	rs1636254	chr7:2885724	T/C	cg19346786	chr7:2764209	NA	-0.65	-6.79	-0.61	1.96e-9	Height;
SKCM	cis	rs9581857	0.685	rs9319370	chr13:28042493	G/T	cg22138327	chr13:27999177	GTF3A	0.92	6.1	0.57	3.78e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs11673344	0.764	rs519551	chr19:37455948	C/G	cg07624650	chr19:37064219	ZNF529	-0.78	-4.82	-0.48	7.05e-6	Obesity-related traits;
SKCM	cis	rs2658782	1.000	rs2658782	chr11:93166731	T/G	cg15737290	chr11:93063684	CCDC67	0.77	5.49	0.53	4.89e-7	Pulmonary function decline;
SKCM	cis	rs7208859	0.573	rs73267865	chr17:29064204	C/G	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs2842992	0.830	rs2025190	chr6:160138241	C/T	cg11366901	chr6:160182831	ACAT2	0.88	6.81	0.61	1.79e-9	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs907612	0.638	rs907611	chr11:1874072	G/A	cg02118564	chr11:1241341	NA	-0.44	-4.84	-0.48	6.47e-6	Monocyte percentage of white cells;Monocyte count;Granulocyte percentage of myeloid white cells;
SKCM	cis	rs11734570	0.581	rs76682731	chr4:38586045	T/C	cg18361445	chr4:38666374	KLF3;FLJ13197	0.88	6.02	0.56	5.34e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs875971	0.660	rs12698534	chr7:65986845	C/T	cg18876405	chr7:65276391	NA	0.8	7.11	0.63	4.86e-10	Aortic root size;
SKCM	cis	rs12597458	0.763	rs7195958	chr16:72036577	A/G	cg01557791	chr16:72042693	DHODH	0.96	8.2	0.68	3.8e-12	Prostate cancer;
SKCM	cis	rs17376456	0.877	rs10213956	chr5:93460839	C/T	cg21475434	chr5:93447410	FAM172A	0.97	5.42	0.52	6.39e-7	Diabetic retinopathy;
SKCM	cis	rs2594989	0.887	rs2437684	chr3:11593261	C/T	cg00170343	chr3:11313890	ATG7	-0.97	-5.42	-0.52	6.41e-7	Circulating chemerin levels;
SKCM	cis	rs929354	0.772	rs6459737	chr7:156975136	G/A	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs9371601	0.859	rs214942	chr6:152711002	T/C	cg25291603	chr6:152002969	NA	-0.45	-4.82	-0.48	7.02e-6	Bipolar disorder;Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);
SKCM	cis	rs17376456	0.569	rs2045020	chr5:93224466	T/C	cg25358565	chr5:93447407	FAM172A	-0.92	-5.69	-0.54	2.17e-7	Diabetic retinopathy;
SKCM	cis	rs40363	0.645	rs1690447	chr16:3519211	T/C	cg22508957	chr16:3507546	NAT15	0.56	4.85	0.48	6.08e-6	Tuberculosis;
SKCM	cis	rs9303401	0.659	rs34426768	chr17:56683385	C/T	cg10487724	chr17:56770010	TEX14;RAD51C	0.85	6.03	0.56	5.18e-8	Cognitive test performance;
SKCM	cis	rs7178909	0.872	rs57715404	chr15:90433958	T/C	cg19708238	chr15:90437601	AP3S2	0.72	5.22	0.51	1.43e-6	Common traits (Other);
SKCM	cis	rs13118159	0.801	rs1128427	chr4:1330759	T/C	cg20887711	chr4:1340912	KIAA1530	0.71	5.23	0.51	1.39e-6	Longevity;
SKCM	cis	rs1552244	0.572	rs6783705	chr3:10164783	A/G	cg00149659	chr3:10157352	C3orf10	1.13	5.45	0.53	5.74e-7	Alzheimer's disease;
SKCM	cis	rs1799949	1.000	rs33946455	chr17:41321846	C/T	cg23758822	chr17:41437982	NA	0.92	7.83	0.66	1.97e-11	Menopause (age at onset);
SKCM	cis	rs929354	0.742	rs10251112	chr7:156963524	A/G	cg17757837	chr7:157058334	UBE3C	0.79	5.47	0.53	5.17e-7	Body mass index;
SKCM	cis	rs2811415	0.597	rs13059751	chr3:127782662	T/C	cg09089421	chr3:127803668	RUVBL1	1.01	8.78	0.71	2.82e-13	Lung function (FEV1/FVC);
SKCM	cis	rs17685	0.702	rs6960598	chr7:75772991	T/C	cg16684958	chr7:75615977	POR	0.52	4.92	0.49	4.73e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs10927875	0.632	rs2862162	chr1:16142960	A/C	cg21385522	chr1:16154831	NA	0.99	11.22	0.79	6.01e-18	Dilated cardiomyopathy;
SKCM	cis	rs11148252	0.553	rs7999849	chr13:53249414	A/G	cg00495681	chr13:53174319	NA	0.59	4.79	0.48	7.94e-6	Lewy body disease;
SKCM	cis	rs2153535	0.541	rs6923558	chr6:8461467	T/G	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs769267	0.965	rs12977937	chr19:19429975	C/G	cg03709012	chr19:19516395	GATAD2A	0.84	6.97	0.62	9.13e-10	Tonsillectomy;
SKCM	cis	rs4423214	1.000	rs11606631	chr11:71164121	C/A	cg05163923	chr11:71159392	DHCR7	0.83	8.06	0.67	7.35e-12	Vitamin D levels;
SKCM	cis	rs3741404	0.825	rs11604782	chr11:63946650	G/A	cg19465662	chr11:63993652	NUDT22;TRPT1	0.81	5.41	0.52	6.59e-7	Platelet count;
SKCM	cis	rs11098499	0.954	rs11098526	chr4:120390359	C/T	cg24375607	chr4:120327624	NA	0.65	4.97	0.49	3.87e-6	Corneal astigmatism;
SKCM	cis	rs2357013	0.752	rs55992015	chr2:53170717	C/T	cg07782112	chr2:53107842	NA	-0.6	-5.88	-0.55	9.64e-8	Hemostatic factors and hematological phenotypes;
SKCM	trans	rs561341	0.943	rs508566	chr17:30289861	G/C	cg20587970	chr11:113659929	NA	-1.17	-10.4	-0.76	2.14e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs3820928	0.845	rs13419076	chr2:227873028	A/G	cg11843606	chr2:227700838	RHBDD1	-0.59	-4.81	-0.48	7.13e-6	Pulmonary function;
SKCM	cis	rs1110701	0.525	rs11764792	chr7:50496841	C/T	cg18232548	chr7:50535776	DDC	-0.68	-5.49	-0.53	4.8e-7	Acute lymphoblastic leukemia (childhood);
SKCM	cis	rs2153535	0.563	rs1796687	chr6:8536118	C/G	cg23788917	chr6:8435910	SLC35B3	0.63	4.92	0.49	4.66e-6	Motion sickness;
SKCM	cis	rs1878931	0.597	rs37814	chr16:3455247	C/T	cg26668626	chr16:3451006	ZNF174;ZNF434	-0.78	-5.63	-0.54	2.75e-7	Body mass index (adult);
SKCM	cis	rs4481887	0.790	rs6587440	chr1:248415662	A/G	cg00666640	chr1:248458726	OR2T12	0.66	5.38	0.52	7.43e-7	Common traits (Other);
SKCM	cis	rs4234284	1.000	rs13074166	chr3:126957297	T/A	cg04889221	chr3:126137216	CCDC37	-0.45	-4.78	-0.48	8e-6	Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel);
SKCM	cis	rs941408	1.000	rs1076447	chr19:2792128	C/G	cg06609049	chr19:2785107	THOP1	0.84	6.96	0.62	9.33e-10	Total cholesterol levels;
SKCM	cis	rs7000551	0.581	rs4872487	chr8:22256414	C/T	cg12081754	chr8:22256438	SLC39A14	1.0	10.67	0.77	6.48e-17	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs7809950	1.000	rs10258385	chr7:107243350	T/C	cg23024343	chr7:107201750	COG5	0.83	7.64	0.65	4.65e-11	Coronary artery disease;
SKCM	cis	rs7799006	0.527	rs73039284	chr7:2221583	C/G	cg02951883	chr7:2050386	MAD1L1	-0.61	-4.89	-0.48	5.39e-6	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);
SKCM	cis	rs6089584	0.854	rs6061407	chr20:60622048	A/C	cg06108461	chr20:60628389	TAF4	-0.89	-8.72	-0.7	3.75e-13	Body mass index;
SKCM	cis	rs96067	0.711	rs795047	chr1:36637708	C/T	cg24686825	chr1:36642396	MAP7D1	0.66	5.2	0.51	1.54e-6	Corneal structure;
SKCM	cis	rs1799949	0.965	rs7223952	chr17:41194885	T/C	cg25072359	chr17:41440525	NA	0.63	4.85	0.48	6.24e-6	Menopause (age at onset);
SKCM	cis	rs1005277	0.563	rs2505216	chr10:38482830	T/C	cg25427524	chr10:38739819	LOC399744	-0.78	-7.75	-0.66	2.83e-11	Extrinsic epigenetic age acceleration;
SKCM	cis	rs2760061	0.505	rs708109	chr1:228190657	C/T	cg02753203	chr1:228287806	NA	0.83	7.49	0.65	8.97e-11	Diastolic blood pressure;
SKCM	cis	rs9815354	0.812	rs56183581	chr3:41848492	C/T	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs1957429	0.803	rs10873177	chr14:65318228	G/C	cg23373153	chr14:65346875	NA	1.07	5.91	0.56	8.58e-8	Pediatric areal bone mineral density (radius);
SKCM	cis	rs514406	0.895	rs1925673	chr1:53326984	T/G	cg16325326	chr1:53192061	ZYG11B	0.94	10.05	0.75	1.02e-15	Monocyte count;
SKCM	cis	rs61612642	0.537	rs6915565	chr6:42192582	G/A	cg01092361	chr6:42185687	MRPS10	0.97	5.41	0.52	6.71e-7	Eosinophil percentage of white cells;Sum eosinophil basophil counts;Eosinophil percentage of granulocytes;Eosinophil counts;
SKCM	cis	rs151997	0.569	rs62367393	chr5:50270360	C/A	cg06027927	chr5:50259733	NA	0.61	5.4	0.52	6.86e-7	Callous-unemotional behaviour;
SKCM	cis	rs9834970	0.588	rs4441609	chr3:36892717	T/C	cg25202636	chr3:37035158	MLH1;EPM2AIP1	0.69	5.2	0.51	1.56e-6	Bipolar disorder with mood-incongruent psychosis;Subjective response to lithium treatment;Bipolar disorder;Schizophrenia or bipolar disorder;Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);
SKCM	cis	rs1005277	0.579	rs1740732	chr10:38491385	C/T	cg00409905	chr10:38381863	ZNF37A	-0.65	-6.23	-0.58	2.18e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs7811142	1.000	rs7809801	chr7:100072031	T/C	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.17	7.71	0.66	3.44e-11	Platelet count;
SKCM	cis	rs9467773	0.838	rs3734540	chr6:26463321	A/C	cg15659132	chr6:26577336	NA	0.55	5.02	0.49	3.16e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7666738	0.830	rs7679299	chr4:99057620	C/A	cg05340658	chr4:99064831	C4orf37	0.66	4.87	0.48	5.74e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1799949	0.965	rs11650132	chr17:41326087	T/G	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.25	-0.58	2.03e-8	Menopause (age at onset);
SKCM	cis	rs1153858	1.000	rs4774579	chr15:45651803	G/A	cg21132104	chr15:45694354	SPATA5L1	0.93	7.94	0.67	1.22e-11	Homoarginine levels;
SKCM	cis	rs7666738	0.791	rs10856933	chr4:98958542	C/A	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs561341	1.000	rs8064843	chr17:30245744	A/G	cg00745463	chr17:30367425	LRRC37B	-1.03	-7.06	-0.62	6.16e-10	Hip circumference adjusted for BMI;
SKCM	cis	rs35306767	0.953	rs34405399	chr10:981015	G/A	cg26597838	chr10:835615	NA	0.62	4.96	0.49	3.97e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs7178909	0.902	rs28372736	chr15:90437858	T/C	cg19708238	chr15:90437601	AP3S2	0.72	5.22	0.51	1.43e-6	Common traits (Other);
SKCM	cis	rs6878727	0.549	rs2561485	chr5:123645843	C/G	cg01806427	chr5:123737813	NA	0.58	5.07	0.5	2.64e-6	Breast cancer;
SKCM	cis	rs12824058	0.831	rs4759658	chr12:130815872	C/T	cg24838063	chr12:130822603	PIWIL1	0.78	6.99	0.62	8.22e-10	Menopause (age at onset);
SKCM	cis	rs10197940	0.753	rs2290368	chr2:152266473	T/C	cg19508488	chr2:152266495	RIF1	0.62	5.21	0.51	1.48e-6	Lung cancer;
SKCM	cis	rs7666738	0.830	rs957742	chr4:99029409	C/T	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4819052	0.851	rs13052344	chr21:46676101	C/T	cg19498844	chr21:46707878	POFUT2;LOC642852	0.88	7.69	0.66	3.74e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs992157	0.643	rs10191283	chr2:219056755	G/A	cg20019365	chr2:219134978	PNKD;AAMP	0.72	6.34	0.58	1.38e-8	Colorectal cancer;
SKCM	cis	rs7100689	0.556	rs6585971	chr10:82145057	G/C	cg00277334	chr10:82204260	NA	-0.53	-4.96	-0.49	4.02e-6	Post bronchodilator FEV1;
SKCM	cis	rs2228479	0.850	rs34033205	chr16:89922959	G/T	cg06558623	chr16:89946397	TCF25	1.12	5.0	0.49	3.47e-6	Skin colour saturation;
SKCM	cis	rs6665290	0.935	rs1929862	chr1:227199718	G/A	cg10327440	chr1:227177885	CDC42BPA	-1.21	-15.92	-0.87	3.26e-26	Myeloid white cell count;
SKCM	cis	rs2033711	0.728	rs4801586	chr19:58934528	A/G	cg00825309	chr19:58991885	ZNF446	-0.69	-5.59	-0.53	3.19e-7	Uric acid clearance;
SKCM	cis	rs1218582	0.772	rs6683557	chr1:154852307	C/G	cg03351412	chr1:154909251	PMVK	0.77	6.54	0.6	5.71e-9	Prostate cancer;
SKCM	cis	rs7772486	0.641	rs9390374	chr6:146368175	A/T	cg23711669	chr6:146136114	FBXO30	0.76	5.99	0.56	6.05e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs10883723	0.810	rs61873733	chr10:104251458	G/A	cg11453585	chr10:104263688	ACTR1A;SUFU	0.75	5.7	0.54	2.03e-7	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs4268898	0.662	rs12052954	chr2:24425620	C/T	cg06627628	chr2:24431161	ITSN2	0.92	6.98	0.62	8.52e-10	Asthma;
SKCM	cis	rs908922	0.676	rs4845780	chr1:152488846	T/G	cg09873164	chr1:152488093	CRCT1	0.76	5.94	0.56	7.4e-8	Hair morphology;
SKCM	cis	rs6598955	0.543	rs60433268	chr1:26548055	A/C	cg04990556	chr1:26633338	UBXN11	0.68	5.08	0.5	2.55e-6	Obesity-related traits;
SKCM	cis	rs2070488	0.804	rs13100195	chr3:38482539	A/G	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.72	5.78	0.55	1.46e-7	Electrocardiographic conduction measures;
SKCM	cis	rs11700980	0.748	rs11701355	chr21:30285594	A/G	cg24692254	chr21:30365293	RNF160	-0.89	-5.03	-0.5	3e-6	QRS complex (12-leadsum);
SKCM	cis	rs17685	0.753	rs2286830	chr7:75693963	C/T	cg01364799	chr7:75623366	TMEM120A	0.74	5.89	0.56	9.1e-8	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs28595532	0.858	rs58613168	chr4:119487013	T/G	cg21605333	chr4:119757512	SEC24D	1.28	6.08	0.57	4.22e-8	Cannabis dependence symptom count;
SKCM	cis	rs2836974	0.644	rs1882779	chr21:40690938	T/C	cg11644478	chr21:40555479	PSMG1	-0.67	-5.64	-0.54	2.66e-7	Cognitive function;
SKCM	cis	rs1267303	0.642	rs6670699	chr1:46997270	C/T	cg25110126	chr1:46999211	NA	0.74	5.54	0.53	3.89e-7	Monobrow;
SKCM	cis	rs4803455	0.565	rs11083616	chr19:41865643	A/G	cg09537434	chr19:41945824	ATP5SL	0.75	5.8	0.55	1.37e-7	Migraine;Coronary artery disease;
SKCM	cis	rs2404602	0.618	rs12442266	chr15:76567142	T/C	cg22467129	chr15:76604101	ETFA	-0.65	-5.35	-0.52	8.68e-7	Blood metabolite levels;
SKCM	cis	rs151997	0.537	rs11746939	chr5:50268856	G/A	cg06027927	chr5:50259733	NA	0.63	5.67	0.54	2.32e-7	Callous-unemotional behaviour;
SKCM	cis	rs9640161	0.750	rs1983440	chr7:150023941	G/C	cg10018233	chr7:150070692	REPIN1	0.75	6.05	0.56	4.81e-8	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs5760092	0.755	rs6003959	chr22:24264395	C/T	cg25703541	chr22:24373054	LOC391322	0.73	5.13	0.5	2.09e-6	Urinary 1,3-butadiene metabolite levels in smokers;
SKCM	cis	rs10911232	0.507	rs10911222	chr1:183047363	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.78	6.87	0.61	1.42e-9	Hypertriglyceridemia;
SKCM	cis	rs10256972	0.758	rs4723649	chr7:1071905	T/C	cg07308232	chr7:1071921	C7orf50	-0.62	-5.28	-0.51	1.15e-6	Longevity;Endometriosis;
SKCM	cis	rs4974559	0.790	rs6850727	chr4:1323273	G/C	cg02980000	chr4:1222292	CTBP1	0.91	5.65	0.54	2.51e-7	Systolic blood pressure;
SKCM	cis	rs34779708	0.733	rs3853672	chr10:35549606	A/C	cg03585969	chr10:35415529	CREM	0.73	5.18	0.51	1.72e-6	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs12142240	0.698	rs68012736	chr1:46839510	A/G	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs208520	0.690	rs207077	chr6:66769855	A/C	cg07460842	chr6:66804631	NA	-0.86	-6.61	-0.6	4.37e-9	Exhaled nitric oxide output;
SKCM	cis	rs561341	0.714	rs474455	chr17:30312465	A/T	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs7811142	1.000	rs6979335	chr7:100089860	T/C	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.25	0.68	3.05e-12	Platelet count;
SKCM	cis	rs9633740	1.000	rs10749609	chr10:82249752	G/A	cg01528321	chr10:82214614	TSPAN14	0.74	5.47	0.53	5.32e-7	Post bronchodilator FEV1;
SKCM	cis	rs1348850	0.519	rs1544002	chr2:178529534	C/T	cg22681709	chr2:178499509	PDE11A	-0.61	-5.27	-0.51	1.17e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs9549367	0.713	rs2146750	chr13:113822530	A/G	cg18105134	chr13:113819100	PROZ	0.75	5.32	0.52	9.53e-7	Platelet distribution width;
SKCM	cis	rs208520	0.837	rs208471	chr6:66916749	A/C	cg07460842	chr6:66804631	NA	-0.9	-6.89	-0.61	1.29e-9	Exhaled nitric oxide output;
SKCM	cis	rs9611565	0.571	rs7364123	chr22:42216326	A/G	cg03806693	chr22:41940476	POLR3H	-0.81	-5.5	-0.53	4.73e-7	Vitiligo;
SKCM	cis	rs2014572	0.870	rs10426580	chr19:57756221	G/A	cg24459738	chr19:57751996	ZNF805	-0.64	-5.29	-0.51	1.1e-6	Hyperactive-impulsive symptoms;
SKCM	cis	rs9581857	0.579	rs76578450	chr13:27982656	C/A	cg22138327	chr13:27999177	GTF3A	0.95	6.38	0.59	1.14e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs2255932	0.945	rs2686426	chr3:183211128	C/T	cg20852557	chr3:184035519	EIF4G1	-0.65	-5.51	-0.53	4.48e-7	Interleukin-1-beta levels;
SKCM	cis	rs10504229	0.683	rs11785260	chr8:58132906	A/G	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs3847687	1.000	rs11061292	chr12:131518981	T/A	cg13586425	chr12:131519906	GPR133	-0.5	-5.38	-0.52	7.46e-7	Longevity;
SKCM	cis	rs9303401	0.527	rs12939313	chr17:56755616	A/T	cg02118635	chr17:56770003	RAD51C;TEX14	0.78	5.01	0.49	3.27e-6	Cognitive test performance;
SKCM	cis	rs4319547	0.695	rs4758648	chr12:122900460	A/G	cg23029597	chr12:123009494	RSRC2	-0.67	-4.97	-0.49	3.85e-6	Body mass index;
SKCM	cis	rs7959452	0.836	rs12827594	chr12:69729434	G/A	cg20891283	chr12:69753455	YEATS4	0.71	6.13	0.57	3.44e-8	Blood protein levels;
SKCM	cis	rs6582630	0.519	rs2387812	chr12:38381480	A/G	cg26384229	chr12:38710491	ALG10B	0.81	6.6	0.6	4.58e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs55962025	0.662	rs362309	chr4:3240915	G/C	cg16987761	chr4:3318072	RGS12	-0.62	-5.08	-0.5	2.52e-6	Parental longevity (mother's age at death);
SKCM	cis	rs96067	0.711	rs11263861	chr1:36628033	G/A	cg24686825	chr1:36642396	MAP7D1	-0.67	-5.22	-0.51	1.44e-6	Corneal structure;
SKCM	cis	rs67311347	0.544	rs9868700	chr3:40345408	G/A	cg00091569	chr3:40428383	ENTPD3	0.6	5.1	0.5	2.32e-6	Renal cell carcinoma;
SKCM	cis	rs7824557	0.767	rs2060463	chr8:11161610	T/G	cg21775007	chr8:11205619	TDH	0.72	6.0	0.56	5.73e-8	Retinal vascular caliber;
SKCM	cis	rs899997	0.773	rs62010525	chr15:78968310	C/G	cg04896959	chr15:78267971	NA	-0.57	-4.77	-0.48	8.46e-6	Coronary artery disease or large artery stroke;
SKCM	cis	rs7829975	0.582	rs11783950	chr8:8597831	A/C	cg15556689	chr8:8085844	FLJ10661	-0.69	-5.68	-0.54	2.23e-7	Mood instability;
SKCM	cis	rs4819052	0.807	rs1075788	chr21:46666564	T/G	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.42	0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs634534	0.622	rs552130	chr11:65732800	T/C	cg02427764	chr11:65769310	BANF1;EIF1AD	0.65	5.17	0.51	1.75e-6	Sum eosinophil basophil counts;Eosinophil counts;
SKCM	cis	rs7659604	1.000	rs73844281	chr4:122664688	A/G	cg19671926	chr4:122722719	EXOSC9	-0.64	-4.78	-0.48	8.04e-6	Type 2 diabetes;
SKCM	cis	rs10504229	0.683	rs903706	chr8:58128134	T/G	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs10808739	0.660	rs7009078	chr8:65659136	G/A	cg05711235	chr8:65498612	NA	-0.8	-5.2	-0.51	1.54e-6	HIV-1 susceptibility;
SKCM	cis	rs8067545	0.611	rs2703805	chr17:20107773	T/C	cg13482628	chr17:19912719	NA	-0.66	-5.49	-0.53	4.88e-7	Schizophrenia;
SKCM	cis	rs1577917	1.000	rs13196930	chr6:86652245	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.85	-8.62	-0.7	5.82e-13	Response to antipsychotic treatment;
SKCM	cis	rs7106204	0.748	rs7946633	chr11:24237411	C/T	ch.11.24196551F	chr11:24239977	NA	0.76	6.03	0.56	5.06e-8	Response to Homoharringtonine (cytotoxicity);
SKCM	cis	rs10905065	0.833	rs6602259	chr10:5844628	C/T	cg09234995	chr10:5726438	C10orf18	-0.64	-5.5	-0.53	4.63e-7	Menopause (age at onset);
SKCM	trans	rs17685	0.712	rs11764119	chr7:75812358	T/G	cg19862616	chr7:65841803	NCRNA00174	0.94	10.42	0.76	1.95e-16	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs6977660	0.714	rs6977079	chr7:19818207	G/A	cg07541023	chr7:19748670	TWISTNB	0.72	4.78	0.48	7.95e-6	Thyroid stimulating hormone;
SKCM	cis	rs4808199	0.847	rs34647936	chr19:19548239	T/G	cg03709012	chr19:19516395	GATAD2A	1.14	8.76	0.7	3.13e-13	Nonalcoholic fatty liver disease;
SKCM	trans	rs3780486	0.881	rs10738906	chr9:33135634	T/C	cg20290983	chr6:43655470	MRPS18A	1.0	11.51	0.79	1.75e-18	IgG glycosylation;
SKCM	cis	rs8141529	0.732	rs5997408	chr22:29207915	G/A	cg02153584	chr22:29168773	CCDC117	0.66	5.35	0.52	8.64e-7	Lymphocyte counts;
SKCM	cis	rs2228479	0.572	rs62054252	chr16:89896834	G/A	cg06558623	chr16:89946397	TCF25	1.1	4.95	0.49	4.17e-6	Skin colour saturation;
SKCM	cis	rs4561483	0.801	rs154148	chr16:11956478	T/C	cg08843971	chr16:11963173	GSPT1	-0.72	-5.54	-0.53	3.97e-7	Testicular germ cell tumor;
SKCM	cis	rs67460515	0.563	rs1599375	chr3:160897771	C/T	cg03342759	chr3:160939853	NMD3	0.69	5.81	0.55	1.27e-7	Parkinson's disease;
SKCM	cis	rs155076	0.711	rs9550724	chr13:21885030	G/T	cg11317459	chr13:21872234	NA	1.39	8.89	0.71	1.78e-13	White matter hyperintensity burden;
SKCM	cis	rs16854884	0.657	rs35193361	chr3:143716420	A/G	cg06585982	chr3:143692056	C3orf58	0.85	7.51	0.65	8.22e-11	Economic and political preferences (feminism/equality);
SKCM	cis	rs1801251	1.000	rs6761324	chr2:233582793	T/G	cg08000102	chr2:233561755	GIGYF2	0.89	6.91	0.62	1.15e-9	Coronary artery disease;
SKCM	cis	rs6121246	0.909	rs6058450	chr20:30343911	G/A	cg11595048	chr20:30225325	COX4I2	0.71	5.48	0.53	5.11e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs11098499	0.820	rs28535956	chr4:120536858	C/T	cg09307838	chr4:120376055	NA	-0.97	-7.62	-0.65	5.05e-11	Corneal astigmatism;
SKCM	cis	rs2952156	0.959	rs2517956	chr17:37843859	G/A	cg00129232	chr17:37814104	STARD3	-0.63	-4.84	-0.48	6.46e-6	Asthma;
SKCM	cis	rs6121246	0.609	rs1009453	chr20:30404840	C/G	cg13852791	chr20:30311386	BCL2L1	0.82	5.64	0.54	2.59e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs28595532	0.920	rs116799007	chr4:119763562	A/G	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs2228479	0.867	rs35542367	chr16:89965825	G/C	cg06558623	chr16:89946397	TCF25	1.26	6.97	0.62	9.17e-10	Skin colour saturation;
SKCM	cis	rs2777491	0.957	rs6493002	chr15:41709195	C/G	cg18705301	chr15:41695430	NDUFAF1	-0.9	-9.24	-0.72	3.67e-14	Ulcerative colitis;
SKCM	cis	rs7666738	0.830	rs4699595	chr4:99012827	A/G	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9913156	0.894	rs28365158	chr17:4620928	T/C	cg00122941	chr17:4613640	ARRB2	0.78	4.9	0.48	5.15e-6	Lymphocyte counts;
SKCM	cis	rs7666738	0.830	rs1967980	chr4:98966426	C/G	cg17366294	chr4:99064904	C4orf37	0.59	4.89	0.48	5.36e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10193935	0.892	rs13413028	chr2:42394865	C/G	cg27598129	chr2:42591480	NA	-0.92	-6.79	-0.61	1.97e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6580649	0.941	rs17122612	chr12:48459488	C/G	cg05342945	chr12:48394962	COL2A1	0.73	5.2	0.51	1.53e-6	Lung cancer;
SKCM	cis	rs10504229	1.000	rs61212428	chr8:58173963	G/A	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs7666738	0.830	rs6532719	chr4:99043691	A/G	cg17366294	chr4:99064904	C4orf37	0.6	4.9	0.49	5.04e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2228479	0.850	rs62052212	chr16:89981960	G/A	cg00800038	chr16:89945340	TCF25	-0.99	-5.64	-0.54	2.57e-7	Skin colour saturation;
SKCM	cis	rs1552244	0.935	rs7652190	chr3:10105150	G/A	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs9902453	0.904	rs9900112	chr17:28282910	T/A	cg26525008	chr17:28256777	EFCAB5;SSH2	0.8	6.28	0.58	1.79e-8	Coffee consumption (cups per day);
SKCM	cis	rs7618915	0.524	rs10433615	chr3:52638482	C/T	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs2243480	1.000	rs6964530	chr7:65718851	G/C	cg18252515	chr7:66147081	NA	1.35	8.3	0.68	2.45e-12	Diabetic kidney disease;
SKCM	cis	rs8072100	1.000	rs11870935	chr17:45732605	G/A	cg08085267	chr17:45401833	C17orf57	0.63	5.86	0.55	1.06e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs796364	0.951	rs7565005	chr2:201013277	A/G	cg12253985	chr2:200820533	C2orf60;C2orf47	-0.94	-6.2	-0.57	2.47e-8	Schizophrenia;
SKCM	cis	rs16854884	0.632	rs4563409	chr3:143682122	T/G	cg06585982	chr3:143692056	C3orf58	0.81	7.63	0.65	4.89e-11	Economic and political preferences (feminism/equality);
SKCM	cis	rs59918340	0.728	rs10875467	chr8:142233396	A/C	cg23750338	chr8:142222470	SLC45A4	-0.62	-5.88	-0.55	9.57e-8	Immature fraction of reticulocytes;
SKCM	cis	rs12995491	0.569	rs6724281	chr2:88529531	T/G	cg14558114	chr2:88469736	THNSL2	-0.59	-4.82	-0.48	6.92e-6	Response to metformin (IC50);
SKCM	cis	rs8062405	0.540	rs480400	chr16:28574615	A/G	cg09445799	chr16:28968168	NFATC2IP	-0.5	-4.89	-0.48	5.34e-6	Cognitive ability (multi-trait analysis);Cognitive ability;
SKCM	cis	rs9858542	0.953	rs35115732	chr3:49475155	T/C	cg03060546	chr3:49711283	APEH	-0.75	-5.53	-0.53	4.17e-7	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs72615157	0.595	rs112241539	chr7:99847237	C/T	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.05	5.98	0.56	6.25e-8	Lung function (FEV1/FVC);
SKCM	cis	rs6463523	0.933	rs4724821	chr7:762544	C/T	cg11064039	chr7:766100	PRKAR1B;HEATR2	1.01	8.72	0.7	3.81e-13	Subjective well-being;
SKCM	cis	rs875971	0.862	rs3893216	chr7:65790707	G/C	cg11764359	chr7:65958608	NA	-0.74	-6.75	-0.61	2.36e-9	Aortic root size;
SKCM	cis	rs9303401	0.659	rs35564417	chr17:56718286	G/T	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.35	0.52	8.54e-7	Cognitive test performance;
SKCM	cis	rs9399135	0.967	rs6910530	chr6:135332770	C/T	cg24558204	chr6:135376177	HBS1L	0.59	5.23	0.51	1.41e-6	Red blood cell count;
SKCM	cis	rs2072499	1.000	rs2253809	chr1:156172125	T/C	cg25208724	chr1:156163844	SLC25A44	1.04	9.45	0.73	1.47e-14	Testicular germ cell tumor;
SKCM	cis	rs10504229	1.000	rs17216711	chr8:58170856	T/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs870825	0.616	rs6814278	chr4:185644417	G/C	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs2479724	0.811	rs6905726	chr6:41750812	T/C	cg17623882	chr6:41773611	USP49	0.74	6.27	0.58	1.89e-8	Menarche (age at onset);
SKCM	cis	rs11892454	0.515	rs2176180	chr2:26030368	C/T	cg17263061	chr2:26915892	KCNK3	0.7	5.01	0.49	3.31e-6	Heschl's gyrus morphology;
SKCM	cis	rs62238980	0.614	rs117185558	chr22:32403523	A/G	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs3784262	0.740	rs33960206	chr15:58288731	C/G	cg12031962	chr15:58353849	ALDH1A2	-0.45	-5.37	-0.52	7.83e-7	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs796364	0.951	rs59695400	chr2:201021325	C/T	cg12253985	chr2:200820533	C2orf60;C2orf47	-0.95	-6.14	-0.57	3.28e-8	Schizophrenia;
SKCM	trans	rs2727020	0.576	rs10839305	chr11:49598733	T/C	cg03929089	chr4:120376271	NA	-0.84	-7.33	-0.64	1.8e-10	Coronary artery disease;
SKCM	cis	rs17376456	0.504	rs7702649	chr5:93065149	C/A	cg21475434	chr5:93447410	FAM172A	0.8	5.02	0.49	3.21e-6	Diabetic retinopathy;
SKCM	cis	rs2479724	0.870	rs7766817	chr6:41918104	T/A	cg17623882	chr6:41773611	USP49	-0.71	-5.53	-0.53	4.07e-7	Menarche (age at onset);
SKCM	cis	rs4820539	1.000	rs4820539	chr22:23477970	C/T	cg14186256	chr22:23484241	RTDR1	-0.84	-8.0	-0.67	9.3e-12	Bone mineral density;
SKCM	cis	rs7829975	0.623	rs10092965	chr8:8373485	A/G	cg15556689	chr8:8085844	FLJ10661	0.69	5.33	0.52	9.15e-7	Mood instability;
SKCM	cis	rs919433	0.963	rs1896854	chr2:198147776	G/T	cg04278110	chr2:198063759	ANKRD44	-0.68	-5.08	-0.5	2.47e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs12497850	0.864	rs4955410	chr3:49181218	A/G	cg06212747	chr3:49208901	KLHDC8B	0.77	5.0	0.49	3.39e-6	Parkinson's disease;
SKCM	cis	rs4819052	0.851	rs10470245	chr21:46658912	A/G	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.42	0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs2228479	0.717	rs2074904	chr16:89811546	A/G	cg06558623	chr16:89946397	TCF25	1.03	5.59	0.53	3.23e-7	Skin colour saturation;
SKCM	cis	rs854765	0.583	rs8080823	chr17:17864048	T/C	cg09796270	chr17:17721594	SREBF1	0.65	4.87	0.48	5.79e-6	Total body bone mineral density;
SKCM	cis	rs7208859	0.623	rs8067035	chr17:29102188	T/C	cg14067834	chr17:29058358	SUZ12P	1.04	5.28	0.51	1.12e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs3008870	1.000	rs2985794	chr1:67425311	T/G	cg08660285	chr1:67390436	MIER1;WDR78	0.92	6.05	0.57	4.69e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs7589728	0.563	rs12479338	chr2:88444513	C/T	cg04511125	chr2:88470314	THNSL2	1.07	6.66	0.6	3.43e-9	Plasma clusterin levels;
SKCM	cis	rs769267	0.930	rs10282	chr19:19619317	T/C	cg26732615	chr19:19648335	CILP2;YJEFN3	0.67	7.06	0.62	6e-10	Tonsillectomy;
SKCM	cis	rs1405130	1.000	rs13031727	chr2:235564046	A/G	cg17841421	chr2:235704848	NA	-0.57	-4.82	-0.48	7.05e-6	Coronary artery disease;
SKCM	cis	rs7945705	0.791	rs4579928	chr11:8815704	A/G	cg21881798	chr11:8931708	C11orf17;ST5	0.65	6.63	0.6	3.98e-9	Hemoglobin concentration;
SKCM	cis	rs838147	0.815	rs28400015	chr19:49250633	G/A	cg13540341	chr19:49222985	MAMSTR	0.56	4.98	0.49	3.74e-6	Dietary macronutrient intake;
SKCM	cis	rs4774899	0.966	rs12050751	chr15:57495060	A/G	cg01857019	chr15:57210107	LOC145783;TCF12	0.54	4.88	0.48	5.49e-6	Urinary tract infection frequency;
SKCM	cis	rs2404602	0.735	rs11629888	chr15:76719880	A/T	cg23625390	chr15:77176239	SCAPER	-0.81	-7.6	-0.65	5.56e-11	Blood metabolite levels;
SKCM	cis	rs2832191	0.791	rs2832186	chr21:30484151	A/C	cg24692254	chr21:30365293	RNF160	-0.9	-8.03	-0.67	8.39e-12	Dental caries;
SKCM	cis	rs9303401	0.659	rs34556735	chr17:56694447	A/C	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.31	0.51	1.02e-6	Cognitive test performance;
SKCM	trans	rs8073060	0.586	rs6505487	chr17:33996850	A/G	cg19694781	chr19:47549865	TMEM160	-1.04	-8.66	-0.7	4.98e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs2228479	0.717	rs11644967	chr16:89806614	T/A	cg04287289	chr16:89883240	FANCA	0.89	4.84	0.48	6.44e-6	Skin colour saturation;
SKCM	cis	rs9913156	0.748	rs55986729	chr17:4560499	G/T	cg19197139	chr17:4613644	ARRB2	0.79	5.28	0.51	1.14e-6	Lymphocyte counts;
SKCM	cis	rs4919087	1.000	rs10786333	chr10:99090390	A/G	cg25902810	chr10:99078978	FRAT1	-0.62	-4.9	-0.49	5.02e-6	Monocyte count;
SKCM	cis	rs11690935	0.838	rs10432423	chr2:172753295	G/A	cg13550731	chr2:172543902	DYNC1I2	-0.83	-6.37	-0.59	1.21e-8	Schizophrenia;
SKCM	cis	rs6952808	0.531	rs3778998	chr7:2180753	C/A	cg05863683	chr7:1912471	MAD1L1	0.6	4.98	0.49	3.78e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs9467773	1.000	rs1535277	chr6:26567802	G/T	cg15659132	chr6:26577336	NA	0.61	5.76	0.55	1.6e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs793571	0.500	rs2555356	chr15:59016431	T/G	cg05156742	chr15:59063176	FAM63B	0.69	5.0	0.49	3.48e-6	Schizophrenia;
SKCM	cis	rs9910055	0.659	rs8079310	chr17:42270291	A/G	cg10896456	chr17:42255109	ASB16;C17orf65	0.69	7.37	0.64	1.54e-10	Total body bone mineral density;
SKCM	cis	rs2439831	0.867	rs2584702	chr15:43684914	C/A	cg02155558	chr15:43621948	ADAL;LCMT2	1.22	8.31	0.69	2.36e-12	Lung cancer in ever smokers;
SKCM	cis	rs3540	0.512	rs3930162	chr15:91075129	C/T	cg22089800	chr15:90895588	ZNF774	-0.64	-4.84	-0.48	6.45e-6	Allergic disease (asthma, hay fever or eczema);Lymphocyte counts;
SKCM	cis	rs875971	0.895	rs10755833	chr7:65913917	A/G	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	cis	rs10504229	0.679	rs17801003	chr8:58050930	A/G	cg02725872	chr8:58115012	NA	-0.52	-4.83	-0.48	6.68e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs7143963	0.666	rs7145509	chr14:103329430	A/C	cg23020514	chr14:103360112	TRAF3	-0.71	-7.05	-0.62	6.3e-10	Body mass index;
SKCM	cis	rs1577917	0.793	rs9362245	chr6:86496320	G/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.68	-5.97	-0.56	6.52e-8	Response to antipsychotic treatment;
SKCM	cis	rs3818285	0.610	rs642938	chr10:111633025	A/C	cg00817464	chr10:111662876	XPNPEP1	0.74	8.64	0.7	5.42e-13	Superior crus of antihelix expression;
SKCM	cis	rs2921073	0.509	rs2976931	chr8:8257317	C/A	cg15556689	chr8:8085844	FLJ10661	0.65	5.56	0.53	3.59e-7	Parkinson's disease;
SKCM	cis	rs35306767	0.903	rs11253462	chr10:889323	T/G	cg26597838	chr10:835615	NA	0.77	5.39	0.52	7.26e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs7590720	1.000	rs934156	chr2:216901482	C/T	cg12620499	chr2:216877984	MREG	-0.9	-7.92	-0.67	1.36e-11	Alcohol dependence;
SKCM	cis	rs9325144	0.647	rs61937754	chr12:39060543	T/C	cg13010199	chr12:38710504	ALG10B	-0.6	-5.09	-0.5	2.4e-6	Morning vs. evening chronotype;
SKCM	cis	rs2836974	0.966	rs2836977	chr21:40666066	T/C	cg11644478	chr21:40555479	PSMG1	0.83	7.69	0.66	3.66e-11	Cognitive function;
SKCM	cis	rs35306767	0.951	rs12777021	chr10:967270	T/C	cg26597838	chr10:835615	NA	0.73	5.98	0.56	6.25e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs9818758	0.607	rs12715434	chr3:49295025	G/C	cg00383909	chr3:49044727	WDR6	0.95	4.95	0.49	4.17e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs17376456	1.000	rs34854140	chr5:93538169	G/A	cg25358565	chr5:93447407	FAM172A	1.23	8.18	0.68	4.19e-12	Diabetic retinopathy;
SKCM	cis	rs4919087	1.000	rs10786327	chr10:99071408	C/T	cg25902810	chr10:99078978	FRAT1	0.67	5.12	0.5	2.14e-6	Monocyte count;
SKCM	cis	rs9467773	0.620	rs2494696	chr6:26620894	A/G	cg09904177	chr6:26538194	HMGN4	0.58	5.01	0.49	3.28e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs875971	0.545	rs67397473	chr7:65633305	A/G	cg18876405	chr7:65276391	NA	0.64	5.29	0.51	1.09e-6	Aortic root size;
SKCM	cis	rs9325144	0.647	rs12229104	chr12:39110811	T/A	cg13010199	chr12:38710504	ALG10B	-0.62	-5.26	-0.51	1.22e-6	Morning vs. evening chronotype;
SKCM	cis	rs12497850	0.931	rs7431710	chr3:48935583	G/A	cg07636037	chr3:49044803	WDR6	1.02	11.0	0.78	1.56e-17	Parkinson's disease;
SKCM	cis	rs9902453	0.845	rs7209622	chr17:28256807	C/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.8	6.3	0.58	1.61e-8	Coffee consumption (cups per day);
SKCM	cis	rs7659604	1.000	rs6814995	chr4:122664963	A/T	cg19748678	chr4:122722346	EXOSC9	-0.69	-5.52	-0.53	4.31e-7	Type 2 diabetes;
SKCM	cis	rs34779708	0.966	rs4934538	chr10:35472150	T/C	cg03585969	chr10:35415529	CREM	0.75	6.26	0.58	1.9e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs5769765	0.862	rs9616381	chr22:50312382	G/A	cg22709217	chr22:50311962	ALG12;CRELD2	-0.94	-5.91	-0.56	8.37e-8	Schizophrenia;
SKCM	cis	rs2836974	0.830	rs2735309	chr21:40715313	C/T	cg11644478	chr21:40555479	PSMG1	0.74	6.37	0.58	1.21e-8	Cognitive function;
SKCM	cis	rs854765	0.647	rs6826	chr17:18011140	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.83	6.5	0.59	6.85e-9	Total body bone mineral density;
SKCM	cis	rs11122272	0.735	rs2486727	chr1:231539245	A/G	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	-0.64	-5.18	-0.51	1.66e-6	Hemoglobin concentration;
SKCM	cis	rs80130819	0.688	rs4760692	chr12:48587549	T/C	cg13203223	chr12:49319398	FKBP11	0.93	4.87	0.48	5.66e-6	Prostate cancer;
SKCM	cis	rs2204008	0.775	rs11182513	chr12:38560252	G/C	cg26384229	chr12:38710491	ALG10B	0.84	7.0	0.62	7.88e-10	Bladder cancer;
SKCM	cis	rs7618501	0.633	rs2883057	chr3:49998282	C/T	cg24110177	chr3:50126178	RBM5	-0.6	-5.1	-0.5	2.36e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9926296	0.585	rs1800337	chr16:89845194	A/G	cg27121462	chr16:89883253	FANCA	0.83	7.7	0.66	3.5e-11	Vitiligo;
SKCM	cis	rs7940866	0.801	rs2113929	chr11:130835974	G/A	cg12179176	chr11:130786555	SNX19	0.79	6.17	0.57	2.79e-8	Schizophrenia;
SKCM	cis	rs3816788	0.837	rs6557640	chr8:21771731	A/T	cg17168535	chr8:21777572	XPO7	0.65	5.7	0.54	2.05e-7	Lung cancer in ever smokers;
SKCM	cis	rs7191751	0.502	rs34402621	chr16:86323433	C/T	cg07524214	chr16:86825363	NA	-0.59	-4.92	-0.49	4.63e-6	Response to platinum-based chemotherapy (cisplatin);
SKCM	cis	rs7772486	0.846	rs1474871	chr6:146406294	G/A	cg23711669	chr6:146136114	FBXO30	0.86	8.52	0.69	9.39e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs362296	0.671	rs3095074	chr4:3261152	G/A	cg09735869	chr4:3319127	RGS12	-0.8	-7.1	-0.63	5.13e-10	Parental longevity (mother's age at death);
SKCM	cis	rs17376456	0.569	rs7736892	chr5:93205597	G/A	cg25358565	chr5:93447407	FAM172A	-0.88	-5.63	-0.54	2.71e-7	Diabetic retinopathy;
SKCM	cis	rs10492096	1.000	rs11064218	chr12:6586261	C/T	cg13857086	chr12:6580257	VAMP1	0.95	7.06	0.62	5.97e-10	Hip geometry;
SKCM	cis	rs35146811	0.555	rs2527896	chr7:99537653	A/G	cg22906224	chr7:99728672	NA	0.72	4.96	0.49	4.08e-6	Coronary artery disease;
SKCM	cis	rs1577917	0.958	rs6900436	chr6:86506288	T/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.84	-0.66	1.96e-11	Response to antipsychotic treatment;
SKCM	cis	rs2836974	0.831	rs4375956	chr21:40521788	G/A	cg11644478	chr21:40555479	PSMG1	0.99	9.72	0.74	4.41e-15	Cognitive function;
SKCM	cis	rs28386778	0.863	rs2727355	chr17:61931790	C/T	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.12	11.27	0.79	4.92e-18	Prudent dietary pattern;
SKCM	cis	rs870825	0.616	rs7682505	chr4:185640648	C/T	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs3091242	0.967	rs1053438	chr1:25687901	T/C	cg27572855	chr1:25598939	RHD	-0.54	-5.28	-0.51	1.15e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs6570726	0.764	rs1912023	chr6:145824278	C/A	cg23711669	chr6:146136114	FBXO30	0.79	7.93	0.67	1.26e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1153858	1.000	rs1890565	chr15:45663299	T/C	cg10760299	chr15:45669010	GATM	0.62	6.35	0.58	1.3e-8	Homoarginine levels;
SKCM	cis	rs1577917	1.000	rs10455449	chr6:86592226	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.86	-8.66	-0.7	4.89e-13	Response to antipsychotic treatment;
SKCM	cis	rs10754283	0.756	rs17441836	chr1:90135433	C/T	cg21401794	chr1:90099060	LRRC8C	0.76	6.43	0.59	9.3e-9	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs995000	0.509	rs912540	chr1:63135127	A/G	cg06896770	chr1:63153194	DOCK7	-0.76	-5.29	-0.51	1.11e-6	Triglyceride levels;
SKCM	cis	rs11122272	0.735	rs2437150	chr1:231488524	A/G	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	0.58	4.94	0.49	4.4e-6	Hemoglobin concentration;
SKCM	cis	rs6570726	0.755	rs2092297	chr6:145893765	A/G	cg05347473	chr6:146136440	FBXO30	0.57	5.08	0.5	2.47e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2075671	0.857	rs11772849	chr7:100308412	G/A	cg20848291	chr7:100343083	ZAN	-0.68	-5.32	-0.52	9.76e-7	Other erythrocyte phenotypes;
SKCM	cis	rs2243480	1.000	rs35046236	chr7:65408613	T/C	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs2839186	0.934	rs4819221	chr21:47695417	G/T	cg13012494	chr21:47604986	C21orf56	-0.63	-5.38	-0.52	7.54e-7	Testicular germ cell tumor;
SKCM	cis	rs6430585	0.528	rs309159	chr2:136684940	C/T	cg07169764	chr2:136633963	MCM6	1.27	10.82	0.77	3.46e-17	Corneal structure;
SKCM	cis	rs7772486	0.686	rs702305	chr6:145973840	A/G	cg05347473	chr6:146136440	FBXO30	-0.61	-5.46	-0.53	5.55e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs17685	0.535	rs6953065	chr7:75601169	A/G	cg16684958	chr7:75615977	POR	-0.62	-5.17	-0.51	1.75e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs3845702	0.736	rs6727890	chr2:180832675	T/C	cg01881094	chr2:180872142	CWC22	-1.3	-6.15	-0.57	3.07e-8	Schizophrenia;
SKCM	cis	rs12824058	1.000	rs12824058	chr12:130804334	A/G	cg26677194	chr12:130822605	PIWIL1	0.71	6.21	0.58	2.42e-8	Menopause (age at onset);
SKCM	cis	rs11098499	0.779	rs72918579	chr4:120333222	G/C	cg24375607	chr4:120327624	NA	0.66	5.12	0.5	2.19e-6	Corneal astigmatism;
SKCM	cis	rs2013441	0.932	rs3850782	chr17:20181940	A/C	cg13482628	chr17:19912719	NA	-0.66	-5.12	-0.5	2.18e-6	Obesity-related traits;
SKCM	cis	rs28595532	0.841	rs55823625	chr4:119780600	T/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs736408	0.812	rs2239699	chr3:52827915	C/T	cg11645453	chr3:52864694	ITIH4	0.62	4.93	0.49	4.57e-6	Bipolar disorder;
SKCM	cis	rs7772486	0.875	rs2748483	chr6:146335560	A/T	cg05347473	chr6:146136440	FBXO30	-0.58	-4.84	-0.48	6.46e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6582630	0.555	rs7301250	chr12:38596244	G/T	cg13010199	chr12:38710504	ALG10B	0.65	5.09	0.5	2.38e-6	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs9815354	0.812	rs73079360	chr3:41888372	T/A	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs10504229	0.679	rs7839948	chr8:58130607	A/G	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs2836974	0.863	rs1065242	chr21:40567716	C/G	cg11644478	chr21:40555479	PSMG1	0.97	10.08	0.75	8.76e-16	Cognitive function;
SKCM	cis	rs8060686	0.641	rs36086450	chr16:68046996	A/C	cg09117114	chr16:67998030	SLC12A4	-0.78	-5.06	-0.5	2.72e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs1865760	0.534	rs72834629	chr6:26023032	C/T	cg16482183	chr6:26056742	HIST1H1C	0.68	5.49	0.53	4.88e-7	Height;
SKCM	cis	rs6120849	0.754	rs6119560	chr20:33606977	G/C	cg24642439	chr20:33292090	TP53INP2	0.94	4.86	0.48	5.91e-6	Protein C levels;
SKCM	cis	rs17376456	1.000	rs6867042	chr5:93555761	C/T	cg21475434	chr5:93447410	FAM172A	0.98	5.23	0.51	1.4e-6	Diabetic retinopathy;
SKCM	cis	rs899997	1.000	rs1814880	chr15:79021140	T/C	cg04896959	chr15:78267971	NA	0.6	5.14	0.5	2.01e-6	Coronary artery disease or large artery stroke;
SKCM	cis	rs28785552	0.800	rs10853855	chr19:53232293	A/G	cg10871876	chr19:53194124	ZNF83	0.66	4.79	0.48	7.82e-6	Response to paliperidone in schizophrenia (PANSS score);
SKCM	cis	rs2839186	0.721	rs3788252	chr21:47661235	C/T	cg05896524	chr21:47604654	C21orf56	0.69	5.89	0.55	9.17e-8	Testicular germ cell tumor;
SKCM	cis	rs12971120	0.838	rs2241510	chr18:72180739	G/A	cg26446133	chr18:72167187	CNDP2	-0.68	-5.34	-0.52	8.81e-7	Refractive error;
SKCM	cis	rs9790314	0.723	rs1026572	chr3:160887654	A/G	cg03342759	chr3:160939853	NMD3	-0.69	-6.89	-0.62	1.28e-9	Morning vs. evening chronotype;
SKCM	cis	rs8180040	0.739	rs12488225	chr3:47235107	G/A	cg27129171	chr3:47204927	SETD2	0.81	6.36	0.58	1.25e-8	Colorectal cancer;
SKCM	cis	rs9463078	0.683	rs227851	chr6:44699209	A/C	cg25276700	chr6:44698697	NA	0.41	4.83	0.48	6.67e-6	Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder;
SKCM	cis	rs1065656	0.500	rs2575352	chr16:1835393	A/G	cg26897989	chr16:1907736	C16orf73	0.57	5.36	0.52	8.27e-7	Insulin-like growth factors;
SKCM	cis	rs854765	0.624	rs9902941	chr17:17733760	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	-0.95	-7.11	-0.63	4.78e-10	Total body bone mineral density;
SKCM	cis	rs16854884	0.657	rs6766685	chr3:143736916	C/T	cg06585982	chr3:143692056	C3orf58	0.87	8.11	0.68	5.72e-12	Economic and political preferences (feminism/equality);
SKCM	cis	rs4740619	0.640	rs1359953	chr9:15928495	A/T	cg14451791	chr9:16040625	NA	0.44	5.28	0.51	1.12e-6	Body mass index;
SKCM	cis	rs4319547	0.698	rs4039670	chr12:122822655	A/G	cg23029597	chr12:123009494	RSRC2	-0.73	-5.22	-0.51	1.41e-6	Body mass index;
SKCM	cis	rs7666738	0.830	rs7697315	chr4:98938764	T/C	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9910055	1.000	rs9910055	chr17:42283037	C/T	cg09913183	chr17:42254507	C17orf65;ASB16	0.69	6.02	0.56	5.3e-8	Total body bone mineral density;
SKCM	cis	rs6952808	0.689	rs2008263	chr7:2048335	A/G	cg21782813	chr7:2030301	MAD1L1	0.59	6.49	0.59	7.27e-9	Bipolar disorder and schizophrenia;
SKCM	cis	rs7954584	0.567	rs11043246	chr12:122368944	G/A	cg22618164	chr12:122356400	WDR66	0.54	5.44	0.52	6.02e-7	Mean corpuscular volume;
SKCM	cis	rs2404602	0.684	rs11072602	chr15:76873467	T/C	cg23625390	chr15:77176239	SCAPER	-0.82	-7.93	-0.67	1.26e-11	Blood metabolite levels;
SKCM	cis	rs2839186	0.872	rs2250213	chr21:47674275	G/A	cg13012494	chr21:47604986	C21orf56	0.68	5.97	0.56	6.58e-8	Testicular germ cell tumor;
SKCM	cis	rs2841277	0.646	rs2819419	chr14:105406238	A/C	cg19901468	chr14:105411992	AHNAK2	-0.9	-6.91	-0.62	1.16e-9	Rheumatoid arthritis;
SKCM	cis	rs3020736	0.500	rs6002623	chr22:42513761	G/A	cg04733989	chr22:42467013	NAGA	-0.72	-5.62	-0.54	2.87e-7	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs2841277	0.708	rs28600075	chr14:105408315	T/C	cg19901468	chr14:105411992	AHNAK2	-0.98	-7.76	-0.66	2.7e-11	Rheumatoid arthritis;
SKCM	cis	rs9926296	0.512	rs11076626	chr16:89865103	T/A	cg27121462	chr16:89883253	FANCA	0.82	7.47	0.65	9.85e-11	Vitiligo;
SKCM	cis	rs9814567	1.000	rs6785027	chr3:134211649	A/G	cg06109529	chr3:134205091	CEP63;ANAPC13	0.67	5.36	0.52	8.3e-7	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs711830	1.000	rs2113559	chr2:177031099	A/G	cg13092806	chr2:177043255	NA	0.65	5.81	0.55	1.31e-7	Serous invasive ovarian cancer;Epithelial ovarian cancer;Invasive epithelial ovarian cancer;Mucinous ovarian carcinoma;Low-grade serous and serous borderline ovarian cancer;Serous borderline ovarian cancer;High-grade serous ovarian cancer;
SKCM	cis	rs17376456	0.877	rs12109629	chr5:93359702	A/G	cg25358565	chr5:93447407	FAM172A	1.19	7.78	0.66	2.52e-11	Diabetic retinopathy;
SKCM	cis	rs7684253	0.565	rs6830774	chr4:57816306	T/C	cg11939399	chr4:57773300	REST	0.43	4.94	0.49	4.33e-6	Migraine;
SKCM	cis	rs7666738	0.830	rs28444709	chr4:99028496	A/T	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs12824058	0.831	rs12297939	chr12:130811923	G/C	cg24838063	chr12:130822603	PIWIL1	0.78	6.91	0.62	1.19e-9	Menopause (age at onset);
SKCM	cis	rs870825	0.616	rs28672716	chr4:185647345	G/A	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs910316	0.763	rs175490	chr14:75545685	A/G	cg08847533	chr14:75593920	NEK9	0.82	6.74	0.61	2.5e-9	Height;
SKCM	cis	rs28386778	0.863	rs11649912	chr17:61797515	T/A	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.36	0.52	8.08e-7	Prudent dietary pattern;
SKCM	cis	rs2739330	0.587	rs4820571	chr22:24242973	A/G	cg25703541	chr22:24373054	LOC391322	-0.8	-6.45	-0.59	8.53e-9	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs1801251	0.963	rs35395584	chr2:233573698	G/C	cg25237894	chr2:233734115	C2orf82	0.61	5.66	0.54	2.39e-7	Coronary artery disease;
SKCM	cis	rs28386778	0.897	rs2727326	chr17:61923016	G/A	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs2075371	0.865	rs2544172	chr7:133931338	T/C	cg20476274	chr7:133979776	SLC35B4	1.03	10.83	0.77	3.28e-17	Mean platelet volume;
SKCM	cis	rs2730245	1.000	rs2657345	chr7:158744169	T/C	cg24397884	chr7:158709396	WDR60	-1.04	-9.08	-0.72	7.4e-14	Height;
SKCM	cis	rs1005277	0.579	rs1740749	chr10:38521646	A/G	cg25427524	chr10:38739819	LOC399744	-0.69	-6.79	-0.61	1.96e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs873946	0.504	rs12775990	chr10:134575836	C/T	cg26818010	chr10:134567672	INPP5A	-0.77	-5.48	-0.53	5.01e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs4819052	0.851	rs2330012	chr21:46658592	G/A	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.42	0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs1555322	1.000	rs2425027	chr20:33849390	C/G	cg24158546	chr20:34542777	SCAND1	-1.01	-4.78	-0.48	7.97e-6	Attention deficit hyperactivity disorder;
SKCM	cis	rs35306767	0.807	rs1013505	chr10:953273	C/T	cg25614935	chr10:1084866	C10orf110	0.81	5.27	0.51	1.18e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs244731	0.959	rs9313752	chr5:176645435	G/T	cg16006841	chr5:176797999	RGS14	-0.69	-5.17	-0.51	1.74e-6	Urate levels in lean individuals;
SKCM	cis	rs28386778	1.000	rs2955241	chr17:61968113	G/C	cg22520471	chr17:61851767	DDX42;CCDC47	0.77	5.08	0.5	2.55e-6	Prudent dietary pattern;
SKCM	cis	rs72634258	0.554	rs34020118	chr1:7895015	C/T	cg26816564	chr1:7831052	VAMP3	0.75	5.36	0.52	8.06e-7	Inflammatory bowel disease;
SKCM	cis	rs60871478	0.786	rs7807878	chr7:833878	T/C	cg05535760	chr7:792225	HEATR2	-1.14	-9.99	-0.75	1.3e-15	Cerebrospinal P-tau181p levels;
SKCM	cis	rs4819052	0.655	rs2330103	chr21:46694514	C/T	cg02159808	chr21:46707872	POFUT2;LOC642852	0.67	5.07	0.5	2.63e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs12764182	1.000	rs12764182	chr10:77891246	G/T	cg27465618	chr10:78875746	KCNMA1	-0.58	-4.97	-0.49	3.84e-6	QRS complex (Cornell);
SKCM	cis	rs33794	0.508	rs245208	chr3:45244445	C/T	cg05470468	chr3:44620074	ZNF167	0.69	4.79	0.48	7.78e-6	Lung function (forced expiratory volume in 1 second);
SKCM	cis	rs7020830	0.931	rs13288178	chr9:37107799	A/G	cg14294708	chr9:37120828	ZCCHC7	1.08	9.76	0.74	3.58e-15	Schizophrenia;
SKCM	trans	rs17685	0.712	rs11770149	chr7:75791644	G/A	cg19862616	chr7:65841803	NCRNA00174	0.93	9.44	0.73	1.49e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs854765	0.547	rs7224047	chr17:17932931	G/A	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.05	9.29	0.72	2.92e-14	Total body bone mineral density;
SKCM	cis	rs951366	0.617	rs9438393	chr1:205782718	A/G	cg26354017	chr1:205819088	PM20D1	1.03	11.41	0.79	2.66e-18	Menarche (age at onset);
SKCM	cis	rs2224391	0.784	rs35048711	chr6:5262235	G/T	cg09085698	chr6:5261316	LYRM4;FARS2	-0.78	-5.8	-0.55	1.34e-7	Height;
SKCM	cis	rs17376456	0.825	rs28610997	chr5:93248374	T/C	cg21475434	chr5:93447410	FAM172A	1.02	5.17	0.51	1.74e-6	Diabetic retinopathy;
SKCM	cis	rs11792861	0.926	rs7470160	chr9:111844246	C/A	cg14432460	chr9:111696404	IKBKAP;C9orf6	0.66	4.81	0.48	7.17e-6	Menarche (age at onset);
SKCM	cis	rs58688157	0.705	rs7122021	chr11:595810	A/G	cg03576123	chr11:487126	PTDSS2	-0.8	-5.19	-0.51	1.61e-6	Systemic lupus erythematosus;
SKCM	cis	rs4665809	0.590	rs1865324	chr2:26417533	C/A	cg26119090	chr2:26468346	HADHA;HADHB	-1.02	-8.05	-0.67	7.59e-12	Gut microbiome composition (summer);
SKCM	cis	rs35306767	0.761	rs11253557	chr10:1043667	C/T	cg26597838	chr10:835615	NA	0.64	5.22	0.51	1.43e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs709400	1.000	rs61995780	chr14:104120612	A/G	cg26031613	chr14:104095156	KLC1	1.05	12.89	0.82	5.14e-21	Body mass index;
SKCM	cis	rs875971	1.000	rs10215948	chr7:65747786	G/A	cg11764359	chr7:65958608	NA	-0.88	-8.54	-0.7	8.32e-13	Aortic root size;
SKCM	cis	rs1003719	0.788	rs2835592	chr21:38464387	G/A	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs951366	0.764	rs708725	chr1:205744138	G/T	cg07157834	chr1:205819609	PM20D1	0.79	7.23	0.63	2.83e-10	Menarche (age at onset);
SKCM	cis	rs9896933	0.832	rs75552659	chr17:80804630	G/A	cg20578329	chr17:80767326	TBCD	-0.97	-6.45	-0.59	8.49e-9	Bone mineral accretion in asthma (oral corticosteroid dose interaction);
SKCM	cis	rs12477438	0.520	rs1453563	chr2:99720267	C/G	cg14399236	chr2:99771627	LIPT1;TSGA10	0.93	8.28	0.68	2.67e-12	Chronic sinus infection;
SKCM	cis	rs6495122	0.699	rs3784789	chr15:75082552	C/G	cg14664628	chr15:75095509	CSK	-0.93	-6.98	-0.62	8.62e-10	Caffeine consumption;Diastolic blood pressure;Coffee consumption;
SKCM	trans	rs2727020	0.576	rs10839305	chr11:49598733	T/C	cg15704280	chr7:45808275	SEPT13	-0.97	-9.25	-0.72	3.48e-14	Coronary artery disease;
SKCM	cis	rs10754283	0.967	rs10754285	chr1:90116587	A/G	cg21401794	chr1:90099060	LRRC8C	0.78	6.87	0.61	1.42e-9	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs9486715	0.867	rs9486444	chr6:96963619	A/G	cg06623918	chr6:96969491	KIAA0776	0.8	6.52	0.59	6.33e-9	Headache;
SKCM	cis	rs9809213	1.000	rs61327071	chr3:72356292	C/T	cg09429735	chr3:71752026	EIF4E3	-0.57	-5.18	-0.51	1.71e-6	Cognitive ability;Cognitive ability (multi-trait analysis);
SKCM	cis	rs910316	1.000	rs10136948	chr14:75511075	C/T	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.89e-7	Height;
SKCM	cis	rs7599312	0.534	rs7607363	chr2:213402705	A/G	cg16329650	chr2:213403929	ERBB4	0.84	6.04	0.56	4.85e-8	BMI (adjusted for smoking behaviour);BMI in non-smokers;Body mass index;Body mass index (joint analysis main effects and smoking interaction);
SKCM	cis	rs10791097	0.720	rs7119425	chr11:130733185	C/T	cg12179176	chr11:130786555	SNX19	0.87	7.34	0.64	1.8e-10	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs12711979	0.509	rs13005405	chr2:3826324	C/T	cg17052675	chr2:3827356	NA	-0.87	-9.65	-0.74	5.94e-15	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs10489202	0.634	rs11582396	chr1:168077636	C/T	cg24449463	chr1:168025552	DCAF6	-0.8	-7.21	-0.63	3.13e-10	Schizophrenia;
SKCM	cis	rs826838	0.935	rs1684407	chr12:39127270	C/T	cg26384229	chr12:38710491	ALG10B	-0.96	-8.83	-0.71	2.26e-13	Heart rate;
SKCM	cis	rs873946	0.504	rs12254034	chr10:134571007	T/C	cg00988841	chr10:134556463	INPP5A	0.63	4.86	0.48	5.95e-6	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs17711722	0.727	rs1880555	chr7:65432567	T/C	cg11764359	chr7:65958608	NA	0.87	6.65	0.6	3.58e-9	Calcium levels;
SKCM	cis	rs780096	0.525	rs13388159	chr2:27648284	A/T	cg05696406	chr2:27599888	SNX17	0.52	5.32	0.52	9.71e-7	Total body bone mineral density;
SKCM	cis	rs9916302	0.904	rs650106	chr17:37451559	A/G	cg07936489	chr17:37558343	FBXL20	0.84	6.75	0.61	2.32e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs1580019	0.961	rs11765387	chr7:32494790	T/C	cg06627557	chr7:32535165	LSM5;AVL9	0.74	5.64	0.54	2.59e-7	Cognitive ability;
SKCM	cis	rs561341	1.000	rs483301	chr17:30293398	G/T	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs7659604	0.728	rs3924987	chr4:122689784	G/T	cg19671926	chr4:122722719	EXOSC9	-0.7	-4.97	-0.49	3.88e-6	Type 2 diabetes;
SKCM	cis	rs1550582	0.662	rs7812708	chr8:135500832	C/T	cg17885191	chr8:135476712	NA	0.77	5.47	0.53	5.26e-7	Educational attainment;
SKCM	cis	rs8103278	0.507	rs16939	chr19:46276056	C/A	cg14061069	chr19:46274453	DMPK	0.52	5.4	0.52	6.88e-7	Coronary artery disease;
SKCM	cis	rs17376456	0.877	rs34595581	chr5:93369422	G/A	cg25358565	chr5:93447407	FAM172A	1.19	7.78	0.66	2.52e-11	Diabetic retinopathy;
SKCM	cis	rs7777484	0.534	rs2533890	chr7:2828743	C/T	cg09658497	chr7:2847517	GNA12	-0.39	-4.96	-0.49	3.95e-6	Height;
SKCM	cis	rs854765	0.583	rs4414547	chr17:17859052	G/T	cg04398451	chr17:18023971	MYO15A	-0.86	-5.91	-0.56	8.41e-8	Total body bone mineral density;
SKCM	cis	rs875971	0.628	rs6974355	chr7:65841981	A/G	cg11987759	chr7:65425863	GUSB	-0.67	-5.85	-0.55	1.1e-7	Aortic root size;
SKCM	cis	rs1403694	0.695	rs13317089	chr3:186436217	G/C	cg09332604	chr3:186435400	KNG1	-0.49	-4.88	-0.48	5.53e-6	Blood protein levels;
SKCM	cis	rs5750830	0.621	rs743838	chr22:39824707	T/G	cg11247378	chr22:39784982	NA	-0.46	-5.1	-0.5	2.28e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs6570726	0.738	rs4495284	chr6:145916617	T/A	cg23711669	chr6:146136114	FBXO30	0.85	7.97	0.67	1.05e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs71520386	0.530	rs10256628	chr7:22883259	G/C	cg00365470	chr7:22893924	NA	0.73	4.83	0.48	6.66e-6	Fibrinogen levels;
SKCM	cis	rs709400	0.567	rs1961600	chr14:103862144	G/A	cg26031613	chr14:104095156	KLC1	0.71	5.42	0.52	6.49e-7	Body mass index;
SKCM	cis	rs854765	0.583	rs6502627	chr17:17849671	C/T	cg04398451	chr17:18023971	MYO15A	-0.86	-5.91	-0.56	8.41e-8	Total body bone mineral density;
SKCM	cis	rs17685	0.712	rs7794454	chr7:75776010	A/G	cg01364799	chr7:75623366	TMEM120A	0.63	5.03	0.49	3.11e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs4794106	0.792	rs11365	chr17:48211533	T/G	cg13127421	chr17:48202128	SAMD14	-0.76	-6.01	-0.56	5.62e-8	Temporomandibular joint disorder;
SKCM	cis	rs28374715	0.532	rs3204853	chr15:41689166	C/A	cg18705301	chr15:41695430	NDUFAF1	-1.21	-13.94	-0.84	7.01e-23	Ulcerative colitis;
SKCM	cis	rs2295499	0.676	rs232722	chr4:2734626	T/G	cg19433769	chr4:2420260	ZFYVE28	0.67	4.83	0.48	6.59e-6	Cognitive ability;Cognitive ability (multi-trait analysis);Intelligence (multi-trait analysis);
SKCM	cis	rs2952156	0.876	rs2313171	chr17:37833842	T/C	cg20243544	chr17:37824526	PNMT	0.71	5.74	0.54	1.74e-7	Asthma;
SKCM	cis	rs1799949	1.000	rs4793194	chr17:41218333	G/A	cg05368731	chr17:41323189	NBR1	0.89	7.87	0.67	1.71e-11	Menopause (age at onset);
SKCM	cis	rs4332037	0.539	rs55988458	chr7:2059761	G/A	cg23422044	chr7:1970798	MAD1L1	-0.89	-5.89	-0.55	9.2e-8	Bipolar disorder;
SKCM	cis	rs55962025	0.669	rs28403215	chr4:3172439	C/T	cg16987761	chr4:3318072	RGS12	-0.59	-4.96	-0.49	3.95e-6	Parental longevity (mother's age at death);
SKCM	cis	rs7618915	0.571	rs1961958	chr3:52585990	A/G	cg18404041	chr3:52824283	ITIH1	-0.55	-4.88	-0.48	5.55e-6	Bipolar disorder;
SKCM	cis	rs67311347	0.544	rs1454492	chr3:40352884	C/T	cg00091569	chr3:40428383	ENTPD3	0.64	5.64	0.54	2.66e-7	Renal cell carcinoma;
SKCM	cis	rs2645694	0.911	rs2703147	chr4:77831307	C/T	cg06046430	chr4:77819534	ANKRD56	0.56	5.59	0.53	3.25e-7	Emphysema distribution in smoking;
SKCM	cis	rs595982	0.527	rs17272673	chr19:49362992	C/A	cg15549821	chr19:49342101	PLEKHA4	-0.87	-5.39	-0.52	7.35e-7	Red cell distribution width;
SKCM	cis	rs4478037	1.000	rs9841225	chr3:33156335	A/G	cg19404215	chr3:33155277	CRTAP	1.07	5.2	0.51	1.58e-6	Major depressive disorder;
SKCM	cis	rs875971	0.545	rs73146609	chr7:65767464	A/G	cg18876405	chr7:65276391	NA	0.63	5.07	0.5	2.57e-6	Aortic root size;
SKCM	cis	rs1577917	0.958	rs12198971	chr6:86525445	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.81	-0.66	2.19e-11	Response to antipsychotic treatment;
SKCM	cis	rs7178909	0.872	rs61345389	chr15:90435885	T/C	cg19708238	chr15:90437601	AP3S2	0.72	5.22	0.51	1.43e-6	Common traits (Other);
SKCM	cis	rs7020830	0.898	rs6476617	chr9:37200103	G/A	cg14294708	chr9:37120828	ZCCHC7	1.07	10.81	0.77	3.56e-17	Schizophrenia;
SKCM	cis	rs7103648	0.695	rs7933019	chr11:47509137	G/C	cg20307385	chr11:47447363	PSMC3	0.97	7.44	0.64	1.15e-10	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs8078723	0.738	rs4065321	chr17:38143548	C/T	cg17467752	chr17:38218738	THRA	-0.61	-5.5	-0.53	4.67e-7	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs6089829	1.000	rs6089829	chr20:61669036	C/T	cg08564027	chr20:61660810	NA	-0.61	-5.49	-0.53	4.9e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs6951245	0.935	rs112554101	chr7:1065535	A/G	cg24642844	chr7:1081250	C7orf50	-0.8	-5.93	-0.56	7.86e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs362296	0.511	rs2051558	chr4:3324886	G/A	cg21096898	chr4:3318625	RGS12	0.87	10.14	0.75	6.76e-16	Parental longevity (mother's age at death);
SKCM	cis	rs6840360	0.571	rs62327272	chr4:152545090	A/C	cg22705602	chr4:152727874	NA	-0.52	-5.7	-0.54	2.03e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs1014246	0.848	rs58568639	chr10:118456886	C/G	cg14919929	chr10:118506882	NA	0.77	5.73	0.54	1.78e-7	Age at smoking initiation in chronic obstructive pulmonary disease;
SKCM	cis	rs1799949	0.965	rs8176310	chr17:41199913	T/C	cg25918947	chr17:41365094	TMEM106A	-0.61	-5.63	-0.54	2.76e-7	Menopause (age at onset);
SKCM	cis	rs3784262	0.900	rs12911071	chr15:58314848	G/A	cg12031962	chr15:58353849	ALDH1A2	-0.5	-6.27	-0.58	1.85e-8	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs5769765	0.908	rs9616396	chr22:50317825	T/C	cg22709217	chr22:50311962	ALG12;CRELD2	-0.99	-6.09	-0.57	4.04e-8	Schizophrenia;
SKCM	cis	rs8060686	0.565	rs8057577	chr16:68033143	C/T	cg27539214	chr16:67997921	SLC12A4	-0.85	-4.87	-0.48	5.66e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs67311347	0.544	rs6599088	chr3:40329288	T/C	cg00656387	chr3:40428638	ENTPD3	0.56	5.01	0.49	3.25e-6	Renal cell carcinoma;
SKCM	cis	rs58688157	0.705	rs36060383	chr11:598723	A/C	cg16486109	chr11:613632	IRF7	1.08	7.48	0.65	9.51e-11	Systemic lupus erythematosus;
SKCM	cis	rs2153535	0.580	rs6597337	chr6:8531652	C/T	cg07606381	chr6:8435919	SLC35B3	0.93	6.8	0.61	1.92e-9	Motion sickness;
SKCM	cis	rs2180341	0.824	rs9321076	chr6:127655614	G/A	cg24812749	chr6:127587940	RNF146	0.85	7.3	0.64	2.08e-10	Breast cancer;
SKCM	cis	rs17376456	1.000	rs12187701	chr5:93522290	A/G	cg25358565	chr5:93447407	FAM172A	1.23	8.18	0.68	4.19e-12	Diabetic retinopathy;
SKCM	cis	rs875971	0.929	rs6970860	chr7:65976634	A/G	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs9815354	0.812	rs73069209	chr3:41939781	G/A	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs769267	0.965	rs13964	chr19:19468710	C/G	cg03709012	chr19:19516395	GATAD2A	-0.86	-7.13	-0.63	4.48e-10	Tonsillectomy;
SKCM	cis	rs7666738	0.791	rs34790496	chr4:98930516	C/T	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7772486	0.846	rs1331636	chr6:146338826	T/C	cg23711669	chr6:146136114	FBXO30	0.76	7.15	0.63	4.1e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6121246	0.821	rs6121209	chr20:30311258	G/C	cg11595048	chr20:30225325	COX4I2	0.67	5.21	0.51	1.5e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs8016982	0.698	rs8021385	chr14:81704682	G/A	cg01989461	chr14:81687754	GTF2A1	0.88	6.91	0.62	1.18e-9	Schizophrenia;
SKCM	cis	rs854765	0.583	rs11871899	chr17:17826748	C/G	cg04398451	chr17:18023971	MYO15A	-0.79	-5.68	-0.54	2.25e-7	Total body bone mineral density;
SKCM	cis	rs754466	0.580	rs10762763	chr10:79560803	C/G	cg17075019	chr10:79541650	NA	-0.72	-6.64	-0.6	3.77e-9	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs6087990	0.899	rs1333469	chr20:31361249	C/T	cg13636640	chr20:31349939	DNMT3B	0.91	7.97	0.67	1.06e-11	Ulcerative colitis;
SKCM	cis	rs4523957	0.614	rs2316512	chr17:2064710	A/T	cg16513277	chr17:2031491	SMG6	-0.81	-5.86	-0.55	1.06e-7	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs523522	0.962	rs10849758	chr12:120971149	C/T	cg12219531	chr12:120966889	COQ5	0.91	7.82	0.66	2.11e-11	High light scatter reticulocyte count;
SKCM	cis	rs1949733	0.598	rs869602	chr4:8535371	G/T	cg11789530	chr4:8429930	ACOX3	-0.79	-5.11	-0.5	2.25e-6	Response to antineoplastic agents;
SKCM	cis	rs12477438	0.520	rs11883676	chr2:99800814	G/T	cg14399236	chr2:99771627	LIPT1;TSGA10	0.92	7.99	0.67	9.76e-12	Chronic sinus infection;
SKCM	cis	rs9300255	0.543	rs520088	chr12:123522150	C/G	cg05973401	chr12:123451056	ABCB9	0.81	5.57	0.53	3.45e-7	Neutrophil percentage of white cells;
SKCM	trans	rs1814175	0.558	rs5025146	chr11:49795724	C/G	cg15704280	chr7:45808275	SEPT13	-0.93	-8.6	-0.7	6.36e-13	Height;
SKCM	cis	rs9911578	0.967	rs302842	chr17:56728102	C/G	cg05425664	chr17:57184151	TRIM37	-0.69	-5.21	-0.51	1.52e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs11098499	0.954	rs878373	chr4:120237484	A/T	cg09307838	chr4:120376055	NA	0.95	7.57	0.65	6.44e-11	Corneal astigmatism;
SKCM	cis	rs4888262	0.526	rs8056718	chr16:74612030	G/C	cg01733217	chr16:74700730	RFWD3	0.88	7.23	0.63	2.91e-10	Testicular germ cell tumor;
SKCM	cis	rs6424115	0.771	rs2229586	chr1:24200903	G/C	cg15997130	chr1:24165203	NA	0.6	4.94	0.49	4.37e-6	Immature fraction of reticulocytes;
SKCM	cis	rs9311474	0.508	rs3796353	chr3:52593230	C/T	cg18404041	chr3:52824283	ITIH1	-0.53	-4.77	-0.48	8.42e-6	Electroencephalogram traits;
SKCM	cis	rs394563	0.967	rs420099	chr6:149794290	A/C	cg03678062	chr6:149772716	ZC3H12D	-0.48	-4.94	-0.49	4.4e-6	Dupuytren's disease;
SKCM	cis	rs71520386	0.632	rs1474349	chr7:22853765	G/A	cg00309339	chr7:22893653	NA	0.66	4.92	0.49	4.76e-6	Fibrinogen levels;
SKCM	cis	rs11717455	1.000	rs11718422	chr3:38859186	C/T	cg15678707	chr3:39149194	GORASP1;TTC21A	-0.89	-5.27	-0.51	1.16e-6	Systemic lupus erythematosus;
SKCM	cis	rs4268898	0.662	rs72795824	chr2:24435837	T/C	cg06627628	chr2:24431161	ITSN2	-0.92	-7.12	-0.63	4.73e-10	Asthma;
SKCM	cis	rs2070488	0.574	rs57754356	chr3:38488706	C/G	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.74	5.96	0.56	6.8e-8	Electrocardiographic conduction measures;
SKCM	cis	rs13278732	0.500	rs7012838	chr8:99043333	G/A	cg16297171	chr8:99017690	MATN2	-0.54	-5.13	-0.5	2.07e-6	Eosinophilic esophagitis (pediatric);
SKCM	cis	rs778371	0.788	rs4973569	chr2:233767037	A/G	cg08000102	chr2:233561755	GIGYF2	-0.74	-4.91	-0.49	4.85e-6	Schizophrenia;
SKCM	cis	rs6120849	0.901	rs13037296	chr20:33749228	T/A	cg24642439	chr20:33292090	TP53INP2	0.95	5.17	0.51	1.74e-6	Protein C levels;
SKCM	cis	rs71636778	0.543	rs12749822	chr1:27221963	T/C	cg01689405	chr1:26370407	SLC30A2	-0.53	-4.86	-0.48	5.9e-6	Monocyte percentage of white cells;Granulocyte percentage of myeloid white cells;
SKCM	cis	rs9467773	0.649	rs2145318	chr6:26496603	T/A	cg15659132	chr6:26577336	NA	0.58	5.4	0.52	7.06e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs10540	1.000	rs61876334	chr11:487201	T/C	cg03576123	chr11:487126	PTDSS2	-1.4	-7.12	-0.63	4.72e-10	Body mass index;
SKCM	cis	rs72792276	0.818	rs3805610	chr5:127487719	C/G	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.75	5.6	0.54	3.08e-7	Red cell distribution width;
SKCM	cis	rs9290065	0.538	rs9860182	chr3:160768962	T/C	cg03342759	chr3:160939853	NMD3	-0.63	-4.78	-0.48	8.04e-6	Kawasaki disease;
SKCM	cis	rs11690935	0.851	rs7573003	chr2:172741415	T/A	cg13550731	chr2:172543902	DYNC1I2	-0.92	-7.64	-0.65	4.73e-11	Schizophrenia;
SKCM	cis	rs7940866	0.903	rs10750457	chr11:130850277	T/C	cg12179176	chr11:130786555	SNX19	0.76	5.7	0.54	2.07e-7	Schizophrenia;
SKCM	cis	rs1799949	1.000	rs11657835	chr17:41291953	C/G	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.11	-0.57	3.67e-8	Menopause (age at onset);
SKCM	cis	rs9790314	1.000	rs1600209	chr3:161038217	A/T	cg03342759	chr3:160939853	NMD3	-0.72	-7.87	-0.67	1.65e-11	Morning vs. evening chronotype;
SKCM	cis	rs807669	1.000	rs807669	chr22:19154522	T/C	cg02655711	chr22:19163373	SLC25A1	0.71	6.56	0.6	5.3300000000000004e-09	Metabolite levels;
SKCM	trans	rs208520	0.690	rs207108	chr6:66794096	T/C	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-1.02	-7.49	-0.65	9.2e-11	Exhaled nitric oxide output;
SKCM	cis	rs6087990	0.735	rs2424921	chr20:31385814	C/T	cg13636640	chr20:31349939	DNMT3B	0.83	6.24	0.58	2.13e-8	Ulcerative colitis;
SKCM	cis	rs9284813	0.696	rs2660745	chr3:87101747	A/G	cg25342577	chr3:87135140	NA	0.53	4.9	0.48	5.16e-6	Prostate cancer;
SKCM	cis	rs12532878	0.652	rs11768465	chr7:100198386	C/T	cg16850897	chr7:100343110	ZAN	-0.72	-5.29	-0.51	1.07e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs7772486	0.875	rs9390377	chr6:146386932	G/A	cg05347473	chr6:146136440	FBXO30	0.63	5.8	0.55	1.34e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2050392	0.517	rs160018	chr10:30772703	T/C	cg25182066	chr10:30743637	MAP3K8	-0.65	-5.47	-0.53	5.26e-7	Inflammatory bowel disease;
SKCM	cis	rs711830	0.965	rs2857532	chr2:177033283	A/G	cg13092806	chr2:177043255	NA	0.65	5.81	0.55	1.31e-7	Serous invasive ovarian cancer;Epithelial ovarian cancer;Invasive epithelial ovarian cancer;Mucinous ovarian carcinoma;Low-grade serous and serous borderline ovarian cancer;Serous borderline ovarian cancer;High-grade serous ovarian cancer;
SKCM	cis	rs651907	0.935	rs2929922	chr3:101587934	A/T	cg12386194	chr3:101231763	SENP7	0.64	4.97	0.49	3.92e-6	Colorectal cancer;
SKCM	cis	rs12711979	0.509	rs13000873	chr2:3823705	T/C	cg17052675	chr2:3827356	NA	-0.82	-8.9	-0.71	1.66e-13	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs7824557	0.767	rs7837036	chr8:11175489	A/G	cg21775007	chr8:11205619	TDH	0.7	6.01	0.56	5.54e-8	Retinal vascular caliber;
SKCM	cis	rs7937682	0.883	rs517982	chr11:111462687	T/C	cg19812747	chr11:111475976	SIK2	-0.61	-4.94	-0.49	4.41e-6	Primary sclerosing cholangitis;
SKCM	cis	rs2832191	0.935	rs11910475	chr21:30519702	T/C	cg24692254	chr21:30365293	RNF160	-0.76	-6.81	-0.61	1.79e-9	Dental caries;
SKCM	cis	rs3793683	0.597	rs12783367	chr10:134587334	T/C	cg26818010	chr10:134567672	INPP5A	-0.72	-5.42	-0.52	6.55e-7	Migraine;
SKCM	cis	rs72827839	0.740	rs4299189	chr17:45946180	G/A	cg23391107	chr17:45924227	SP6	0.76	6.9	0.62	1.2e-9	Ease of getting up in the morning;
SKCM	trans	rs1814175	0.587	rs7937757	chr11:49978342	G/A	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs4237845	0.773	rs6650217	chr12:58289072	T/G	cg00677455	chr12:58241039	CTDSP2	0.68	5.69	0.54	2.11e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7618501	0.699	rs11713193	chr3:49924424	G/A	cg24110177	chr3:50126178	RBM5	-0.63	-5.16	-0.5	1.86e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2255932	1.000	rs2662767	chr3:183212393	A/G	cg20852557	chr3:184035519	EIF4G1	-0.65	-5.51	-0.53	4.48e-7	Interleukin-1-beta levels;
SKCM	cis	rs9894429	0.966	rs6565604	chr17:79589242	G/A	cg18240062	chr17:79603768	NPLOC4	0.77	7.47	0.65	9.79e-11	Eye color traits;
SKCM	cis	rs6951245	1.000	rs77346188	chr7:1114023	C/A	cg24642844	chr7:1081250	C7orf50	-0.93	-6.24	-0.58	2.11e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs4555082	0.874	rs28822720	chr14:105746282	T/C	cg13114125	chr14:105738426	BRF1	-0.69	-5.39	-0.52	7.2e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs2439831	0.850	rs12441861	chr15:44060883	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.35	7.75	0.66	2.9e-11	Lung cancer in ever smokers;
SKCM	cis	rs2239547	0.618	rs13083728	chr3:52868445	G/A	cg11645453	chr3:52864694	ITIH4	0.79	7.19	0.63	3.41e-10	Schizophrenia;
SKCM	cis	rs13336428	0.730	rs3946124	chr16:1525779	A/G	cg08008072	chr16:1524255	CLCN7	0.55	6.45	0.59	8.49e-9	Bone mineral density;
SKCM	cis	rs7937682	0.883	rs11213941	chr11:111434094	T/C	cg09085632	chr11:111637200	PPP2R1B	1.01	9.83	0.74	2.69e-15	Primary sclerosing cholangitis;
SKCM	cis	rs6430585	0.702	rs2304601	chr2:136528034	C/A	cg07169764	chr2:136633963	MCM6	1.31	13.14	0.83	1.86e-21	Corneal structure;
SKCM	cis	rs2204008	0.840	rs7957966	chr12:37953629	A/G	cg26384229	chr12:38710491	ALG10B	-0.76	-6.55	-0.6	5.53e-9	Bladder cancer;
SKCM	cis	rs17711722	0.727	rs1880555	chr7:65432567	T/C	cg11987759	chr7:65425863	GUSB	-0.75	-6.72	-0.61	2.68e-9	Calcium levels;
SKCM	cis	rs4481887	0.927	rs12039929	chr1:248482018	G/A	cg00666640	chr1:248458726	OR2T12	0.66	6.0	0.56	5.9e-8	Common traits (Other);
SKCM	cis	rs11098499	0.909	rs79026312	chr4:120440677	C/A	cg09307838	chr4:120376055	NA	1.0	7.87	0.67	1.69e-11	Corneal astigmatism;
SKCM	cis	rs738322	0.804	rs4821743	chr22:38514906	A/G	cg25457927	chr22:38595422	NA	-0.46	-5.01	-0.49	3.33e-6	Cutaneous nevi;
SKCM	cis	rs2153535	0.563	rs1737586	chr6:8535897	C/T	cg07606381	chr6:8435919	SLC35B3	0.87	6.42	0.59	9.87e-9	Motion sickness;
SKCM	cis	rs6951245	0.554	rs10246354	chr7:1132456	C/T	cg18402987	chr7:1209562	NA	0.77	5.02	0.49	3.16e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs5753618	0.504	rs9606848	chr22:31901867	G/A	cg02404636	chr22:31891804	SFI1	0.67	6.03	0.56	5.16e-8	Colorectal cancer;
SKCM	cis	rs4523957	0.748	rs12603592	chr17:2119818	A/T	cg16513277	chr17:2031491	SMG6	-0.75	-5.38	-0.52	7.62e-7	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs2842992	0.830	rs1998365	chr6:160179535	A/T	cg19482086	chr6:160211437	TCP1;MRPL18	0.86	6.82	0.61	1.71e-9	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs11992162	0.967	rs10112888	chr8:11830208	G/C	cg08071915	chr8:12219732	FAM66A	-0.65	-4.78	-0.48	8.06e-6	Monocyte count;
SKCM	cis	rs9399135	0.967	rs4896121	chr6:135293645	T/C	cg24558204	chr6:135376177	HBS1L	0.55	4.98	0.49	3.73e-6	Red blood cell count;
SKCM	cis	rs9300255	0.739	rs1879380	chr12:123739111	G/A	cg05973401	chr12:123451056	ABCB9	-0.84	-5.94	-0.56	7.59e-8	Neutrophil percentage of white cells;
SKCM	cis	rs1395	0.744	rs11686131	chr2:27508710	C/T	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.56	5.2	0.51	1.56e-6	Blood metabolite levels;
SKCM	cis	rs2836974	0.897	rs2836929	chr21:40543811	T/C	cg17971929	chr21:40555470	PSMG1	0.87	8.48	0.69	1.1e-12	Cognitive function;
SKCM	cis	rs9583531	0.527	rs3818496	chr13:111358488	G/A	cg24331049	chr13:111365604	ING1	0.83	6.25	0.58	2e-8	Coronary artery disease;
SKCM	cis	rs11098499	0.954	rs2892848	chr4:120381341	C/T	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs7927771	0.542	rs7102205	chr11:47745374	C/T	cg20307385	chr11:47447363	PSMC3	0.71	5.63	0.54	2.67e-7	Subjective well-being;
SKCM	trans	rs1814175	0.740	rs10839439	chr11:49918240	C/T	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs1799949	0.896	rs8176098	chr17:41268206	A/C	cg05368731	chr17:41323189	NBR1	0.9	7.89	0.67	1.52e-11	Menopause (age at onset);
SKCM	cis	rs950027	0.620	rs1153860	chr15:45636584	A/G	cg10760299	chr15:45669010	GATM	-0.51	-5.08	-0.5	2.49e-6	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs7927771	0.832	rs1317164	chr11:47419757	G/T	cg05585544	chr11:47624801	NA	-0.6	-5.32	-0.52	9.58e-7	Subjective well-being;
SKCM	cis	rs4077515	0.935	rs3088081	chr9:139270149	A/G	cg14169450	chr9:139327907	INPP5E	0.48	5.41	0.52	6.62e-7	Ulcerative colitis;IgA nephropathy;Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs875971	0.540	rs781152	chr7:65479572	T/A	cg00343986	chr7:65444356	GUSB	0.67	4.81	0.48	7.3e-6	Aortic root size;
SKCM	cis	rs17608059	0.566	rs17676459	chr17:13910515	A/G	cg11395062	chr17:14139857	CDRT15	0.69	5.9	0.56	8.76e-8	Temperament;
SKCM	cis	rs1023500	0.596	rs133369	chr22:42463814	C/T	cg04733989	chr22:42467013	NAGA	0.72	5.71	0.54	1.97e-7	Schizophrenia;
SKCM	cis	rs4727027	0.866	rs1405124	chr7:148779618	C/T	cg23583168	chr7:148888333	NA	-0.8	-6.66	-0.6	3.5e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs10489202	0.909	rs61809580	chr1:168091602	A/C	cg24449463	chr1:168025552	DCAF6	-0.84	-5.47	-0.53	5.29e-7	Schizophrenia;
SKCM	cis	rs875971	0.825	rs1000464	chr7:65777909	G/C	cg18876405	chr7:65276391	NA	-0.64	-6.34	-0.58	1.35e-8	Aortic root size;
SKCM	cis	rs2153535	0.580	rs2184584	chr6:8468407	T/C	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs1451375	0.617	rs880029	chr7:50569927	G/C	cg18232548	chr7:50535776	DDC	-0.77	-4.99	-0.49	3.59e-6	Malaria;
SKCM	cis	rs9894429	0.752	rs6565610	chr17:79592652	A/G	cg18240062	chr17:79603768	NPLOC4	0.91	10.36	0.76	2.55e-16	Eye color traits;
SKCM	cis	rs1799949	0.930	rs35292991	chr17:41334016	C/A	cg23758822	chr17:41437982	NA	0.93	7.84	0.66	1.91e-11	Menopause (age at onset);
SKCM	cis	rs2836974	0.796	rs77153312	chr21:40695499	G/A	cg11890956	chr21:40555474	PSMG1	0.99	10.41	0.76	2.05e-16	Cognitive function;
SKCM	cis	rs654950	0.934	rs654220	chr1:42002556	A/T	cg06885757	chr1:42089581	HIVEP3	-0.66	-6.69	-0.6	3.03e-9	Airway imaging phenotypes;
SKCM	cis	rs10256972	0.758	rs9801444	chr7:1080444	A/C	cg07308232	chr7:1071921	C7orf50	0.6	5.1	0.5	2.31e-6	Longevity;Endometriosis;
SKCM	cis	rs7193541	0.684	rs9931225	chr16:74699293	T/C	cg01733217	chr16:74700730	RFWD3	1.05	12.02	0.81	1.97e-19	Multiple myeloma;
SKCM	cis	rs875971	0.597	rs11771318	chr7:66062480	G/T	cg11764359	chr7:65958608	NA	-0.86	-6.63	-0.6	3.96e-9	Aortic root size;
SKCM	cis	rs798554	0.679	rs1639036	chr7:2885089	G/A	cg19346786	chr7:2764209	NA	-0.65	-6.79	-0.61	1.96e-9	Height;
SKCM	cis	rs4481887	0.741	rs7540715	chr1:248544206	C/T	cg00666640	chr1:248458726	OR2T12	0.47	4.85	0.48	6.07e-6	Common traits (Other);
SKCM	cis	rs992157	0.835	rs6729058	chr2:219148369	G/A	cg00012203	chr2:219082015	ARPC2	-0.72	-5.71	-0.54	1.99e-7	Colorectal cancer;
SKCM	cis	rs910316	0.737	rs175055	chr14:75488946	T/G	cg08847533	chr14:75593920	NEK9	-0.8	-6.59	-0.6	4.76e-9	Height;
SKCM	cis	rs995000	0.931	rs11207969	chr1:62911751	A/G	cg06896770	chr1:63153194	DOCK7	0.74	7.27	0.64	2.4e-10	Triglyceride levels;
SKCM	cis	rs6582630	0.537	rs7299661	chr12:38527713	C/T	cg26384229	chr12:38710491	ALG10B	0.82	6.64	0.6	3.86e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs1799949	0.628	rs4474733	chr17:41433660	G/T	cg23758822	chr17:41437982	NA	0.81	5.98	0.56	6.38e-8	Menopause (age at onset);
SKCM	cis	rs9910055	1.000	rs2071167	chr17:42287519	A/G	cg13607699	chr17:42295918	UBTF	-0.83	-7.1	-0.63	4.98e-10	Total body bone mineral density;
SKCM	cis	rs12477438	0.501	rs6753063	chr2:99801469	A/G	cg14399236	chr2:99771627	LIPT1;TSGA10	0.92	7.99	0.67	9.76e-12	Chronic sinus infection;
SKCM	cis	rs6500395	1.000	rs9925406	chr16:48671436	C/A	cg04672837	chr16:48644449	N4BP1	0.63	5.29	0.51	1.08e-6	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs4332037	1.000	rs10240470	chr7:1949971	G/T	cg02825527	chr7:2087843	MAD1L1	0.7	4.83	0.48	6.81e-6	Bipolar disorder;
SKCM	cis	rs9611565	0.659	rs9611609	chr22:41945357	C/A	cg03806693	chr22:41940476	POLR3H	-1.13	-7.48	-0.65	9.6e-11	Vitiligo;
SKCM	cis	rs8017423	0.904	rs11621127	chr14:90802050	G/A	cg04374321	chr14:90722782	PSMC1	-1.03	-9.68	-0.74	5.19e-15	Mortality in heart failure;
SKCM	cis	rs1707322	0.721	rs6429574	chr1:46134054	A/G	cg03146154	chr1:46216737	IPP	0.82	6.1	0.57	3.89e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7552404	0.924	rs1146581	chr1:76213024	T/G	cg10523679	chr1:76189770	ACADM	0.69	5.01	0.49	3.35e-6	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs3784262	0.565	rs8041644	chr15:58266833	C/T	cg12031962	chr15:58353849	ALDH1A2	-0.41	-4.82	-0.48	6.83e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs7927771	1.000	rs1317149	chr11:47486885	C/T	cg05585544	chr11:47624801	NA	-0.64	-5.54	-0.53	3.93e-7	Subjective well-being;
SKCM	cis	rs796364	1.000	rs281788	chr2:200783705	A/T	cg12253985	chr2:200820533	C2orf60;C2orf47	0.85	5.39	0.52	7.18e-7	Schizophrenia;
SKCM	cis	rs870825	0.616	rs4623060	chr4:185642943	A/G	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs9899728	0.572	rs9915968	chr17:73059616	G/C	cg27626185	chr17:73056755	KCTD2	-0.87	-6.13	-0.57	3.31e-8	Alzheimer's disease or small vessel stroke;
SKCM	cis	rs910316	1.000	rs7156105	chr14:75541954	C/A	cg08847533	chr14:75593920	NEK9	0.95	9.18	0.72	4.8e-14	Height;
SKCM	trans	rs1814175	0.645	rs1851869	chr11:49960552	T/C	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs7537052	0.669	rs6686192	chr1:36642991	C/T	cg24686825	chr1:36642396	MAP7D1	-0.76	-6.51	-0.59	6.72e-9	Schizophrenia;
SKCM	cis	rs12711979	0.509	rs10178286	chr2:3823821	A/G	cg17052675	chr2:3827356	NA	0.83	8.96	0.71	1.27e-13	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs17685	0.925	rs1057868	chr7:75615006	C/T	cg16684958	chr7:75615977	POR	0.71	7.13	0.63	4.53e-10	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs4774899	0.966	rs12904501	chr15:57507617	C/T	cg01857019	chr15:57210107	LOC145783;TCF12	0.53	4.94	0.49	4.38e-6	Urinary tract infection frequency;
SKCM	cis	rs6866344	0.570	rs1132338	chr5:178139442	T/G	cg10224037	chr5:178157518	ZNF354A	0.83	6.14	0.57	3.17e-8	Neutrophil percentage of white cells;
SKCM	cis	rs4523957	0.552	rs2760742	chr17:2019037	A/G	cg16513277	chr17:2031491	SMG6	-0.81	-5.98	-0.56	6.24e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs7666738	0.830	rs1120708	chr4:98931260	G/C	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7666738	0.753	rs28463863	chr4:98844444	T/C	cg05340658	chr4:99064831	C4orf37	0.62	5.04	0.5	2.89e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs742614	0.533	rs736953	chr20:32415089	G/T	cg06304546	chr20:32448765	NA	-0.73	-5.91	-0.56	8.64e-8	Stearic acid (18:0) levels;
SKCM	cis	rs8180040	0.932	rs11712445	chr3:47434552	T/C	cg16586182	chr3:47516702	SCAP	-0.76	-5.32	-0.52	9.63e-7	Colorectal cancer;
SKCM	cis	rs4332037	0.539	rs11764590	chr7:2032803	C/T	cg02825527	chr7:2087843	MAD1L1	-0.74	-5.03	-0.49	3.09e-6	Bipolar disorder;
SKCM	cis	rs6952808	0.609	rs6950151	chr7:1953521	T/C	cg03354898	chr7:1950403	MAD1L1	-0.55	-5.65	-0.54	2.56e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs4724125	0.960	rs1504841	chr7:42712650	G/A	cg09407816	chr7:42972088	MRPL32;PSMA2	0.8	4.89	0.48	5.35e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs672059	1.000	rs638781	chr1:183157358	T/G	ch.1.3577855R	chr1:183094577	LAMC1	0.63	5.23	0.51	1.38e-6	Hypertriglyceridemia;
SKCM	cis	rs919433	0.680	rs12621129	chr2:198265350	T/C	cg04278110	chr2:198063759	ANKRD44	-0.7	-4.79	-0.48	7.87e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs7666738	0.830	rs6833822	chr4:98951354	G/A	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9325144	0.624	rs10506126	chr12:39123244	G/A	cg26384229	chr12:38710491	ALG10B	-0.74	-6.94	-0.62	1.02e-9	Morning vs. evening chronotype;
SKCM	cis	rs1799949	0.965	rs799917	chr17:41244936	G/A	cg25918947	chr17:41365094	TMEM106A	-0.61	-5.61	-0.54	3.01e-7	Menopause (age at onset);
SKCM	cis	rs7937682	0.889	rs490199	chr11:111487890	A/G	cg09085632	chr11:111637200	PPP2R1B	-0.97	-10.08	-0.75	8.74e-16	Primary sclerosing cholangitis;
SKCM	cis	rs4975616	0.773	rs414965	chr5:1324121	G/A	cg06550200	chr5:1325588	CLPTM1L	-0.83	-6.78	-0.61	2.02e-9	Lung cancer;
SKCM	cis	rs4819052	0.851	rs2877018	chr21:46658306	G/A	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.42	0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs1325195	0.506	rs2636266	chr1:179199652	A/G	cg24632843	chr1:179557954	NA	0.62	5.07	0.5	2.62e-6	IgE grass sensitization;
SKCM	cis	rs2032447	0.641	rs442601	chr6:25934524	G/A	cg18357526	chr6:26021779	HIST1H4A	0.78	6.13	0.57	3.31e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs6809651	0.524	rs4686730	chr3:185805993	C/T	cg00760338	chr3:185826511	ETV5	-0.92	-5.82	-0.55	1.23e-7	Body mass index in physically active individuals;Glomerular filtration rate (creatinine);Body mass index (joint analysis main effects and physical activity interaction);Body mass index;Body mass index in physically inactive individuals;
SKCM	cis	rs1707322	1.000	rs785519	chr1:46568562	C/T	cg03146154	chr1:46216737	IPP	-0.81	-5.43	-0.52	6.11e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs77362122	0.614	rs1187322	chr9:87283317	C/G	cg13486759	chr9:86751815	NA	-0.65	-4.87	-0.48	5.73e-6	3-hydroxypropylmercapturic acid levels in smokers;
SKCM	cis	rs10791097	0.547	rs12365680	chr11:130749059	C/T	cg12179176	chr11:130786555	SNX19	0.87	7.66	0.66	4.35e-11	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs875971	0.830	rs1167406	chr7:65556936	G/C	cg11764359	chr7:65958608	NA	-0.83	-7.86	-0.66	1.78e-11	Aortic root size;
SKCM	cis	rs1577917	0.740	rs9353320	chr6:86244848	C/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.74	6.42	0.59	9.66e-9	Response to antipsychotic treatment;
SKCM	cis	rs6500395	1.000	rs12599744	chr16:48716729	G/A	cg04672837	chr16:48644449	N4BP1	-0.63	-5.37	-0.52	8.01e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs71520386	0.579	rs4394299	chr7:22865382	A/C	cg00309339	chr7:22893653	NA	0.66	4.94	0.49	4.33e-6	Fibrinogen levels;
SKCM	cis	rs1801251	1.000	rs13003675	chr2:233584109	C/T	cg25237894	chr2:233734115	C2orf82	0.61	5.66	0.54	2.39e-7	Coronary artery disease;
SKCM	cis	rs7100689	0.646	rs2095994	chr10:82127956	G/A	cg01528321	chr10:82214614	TSPAN14	0.8	7.0	0.62	7.98e-10	Post bronchodilator FEV1;
SKCM	cis	rs514406	0.793	rs12402415	chr1:53218539	G/T	cg16325326	chr1:53192061	ZYG11B	-0.89	-9.16	-0.72	5.19e-14	Monocyte count;
SKCM	cis	rs1577917	0.545	rs7755958	chr6:86488511	G/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.7	6.23	0.58	2.17e-8	Response to antipsychotic treatment;
SKCM	cis	rs6977660	0.652	rs10254427	chr7:19816240	C/T	cg05791153	chr7:19748676	TWISTNB	0.75	4.89	0.48	5.37e-6	Thyroid stimulating hormone;
SKCM	cis	rs35306767	0.903	rs12769431	chr10:922633	T/C	cg20503657	chr10:835505	NA	0.8	5.99	0.56	6.17e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs362272	0.524	rs6819202	chr4:3368264	G/A	cg00764545	chr4:3318001	RGS12	0.98	13.3	0.83	9.46e-22	Serum sulfate level;
SKCM	cis	rs595982	0.559	rs17272680	chr19:49364511	A/G	cg15549821	chr19:49342101	PLEKHA4	0.85	5.24	0.51	1.36e-6	Red cell distribution width;
SKCM	cis	rs6459804	1.000	rs6459805	chr7:157510294	T/C	cg27240775	chr7:156793224	NA	-0.7	-5.02	-0.49	3.21e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs9303401	0.580	rs12946396	chr17:57164195	T/A	cg10487724	chr17:56770010	TEX14;RAD51C	0.79	4.97	0.49	3.86e-6	Cognitive test performance;
SKCM	cis	rs875971	0.964	rs778735	chr7:65814809	C/A	cg11764359	chr7:65958608	NA	0.88	8.54	0.7	8.36e-13	Aortic root size;
SKCM	cis	rs3791556	1.000	rs2411429	chr2:240113928	A/G	cg14530444	chr2:239432329	NA	0.62	4.9	0.49	5.03e-6	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);
SKCM	cis	rs12926788	0.546	rs200537	chr16:24747787	G/C	cg00339695	chr16:24857497	SLC5A11	-0.8	-6.43	-0.59	9.38e-9	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs9389248	0.500	rs116273677	chr6:135339135	A/C	cg24558204	chr6:135376177	HBS1L	0.58	5.06	0.5	2.73e-6	High light scatter reticulocyte percentage of red cells;
SKCM	cis	rs10089	1.000	rs72794401	chr5:127517626	C/T	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.87	7.37	0.64	1.58e-10	Ileal carcinoids;
SKCM	cis	rs10193935	0.901	rs10200353	chr2:42509554	A/G	cg27598129	chr2:42591480	NA	-0.94	-6.42	-0.59	9.88e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs514406	0.861	rs7524476	chr1:53240212	C/T	cg16325326	chr1:53192061	ZYG11B	-1.01	-11.9	-0.8	3.23e-19	Monocyte count;
SKCM	cis	rs1552244	0.882	rs13100734	chr3:10022878	A/G	cg02579736	chr3:10068473	FANCD2;CIDECP	0.94	4.84	0.48	6.49e-6	Alzheimer's disease;
SKCM	cis	rs2278034	0.578	rs881753	chr3:195606770	C/T	cg01181863	chr3:195395398	SDHAP2	0.7	4.88	0.48	5.41e-6	Bronchopulmonary dysplasia;
SKCM	cis	rs58688157	0.960	rs10902178	chr11:612843	T/G	cg03576123	chr11:487126	PTDSS2	-0.84	-5.45	-0.53	5.64e-7	Systemic lupus erythematosus;
SKCM	cis	rs4819052	0.851	rs2838857	chr21:46681000	A/G	cg02159808	chr21:46707872	POFUT2;LOC642852	0.75	5.99	0.56	6.11e-8	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7143963	0.636	rs8003422	chr14:103321603	G/A	cg23020514	chr14:103360112	TRAF3	0.74	7.1	0.63	5.18e-10	Body mass index;
SKCM	cis	rs7178909	0.800	rs3825866	chr15:90437638	A/T	cg19708238	chr15:90437601	AP3S2	0.72	5.22	0.51	1.43e-6	Common traits (Other);
SKCM	cis	rs2228479	0.850	rs62054601	chr16:89811751	C/G	cg06558623	chr16:89946397	TCF25	1.03	5.59	0.53	3.23e-7	Skin colour saturation;
SKCM	cis	rs870825	0.655	rs35397385	chr4:185639095	C/T	cg04058563	chr4:185651563	MLF1IP	1.08	7.26	0.64	2.51e-10	Blood protein levels;
SKCM	cis	rs8180040	0.966	rs17476234	chr3:47326298	G/A	cg27129171	chr3:47204927	SETD2	-0.87	-6.62	-0.6	4.15e-9	Colorectal cancer;
SKCM	cis	rs7666738	0.791	rs34437628	chr4:99029232	C/G	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10911232	0.507	rs6668980	chr1:183018857	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.65	0.6	3.59e-9	Hypertriglyceridemia;
SKCM	cis	rs77216612	0.835	rs56692845	chr12:12887811	C/T	cg09462578	chr12:12878428	APOLD1	-0.81	-5.6	-0.54	3.13e-7	Lymphocyte counts;
SKCM	cis	rs7959452	0.590	rs10878974	chr12:69781528	C/G	cg14784868	chr12:69753453	YEATS4	0.8	7.6	0.65	5.66e-11	Blood protein levels;
SKCM	cis	rs2836974	0.931	rs13625	chr21:40669083	G/T	cg17971929	chr21:40555470	PSMG1	0.86	8.49	0.69	1.04e-12	Cognitive function;
SKCM	cis	rs507080	0.922	rs519982	chr11:118565231	C/T	cg18045108	chr11:118530628	TREH	-0.47	-4.81	-0.48	7.17e-6	Serum metabolite levels;
SKCM	cis	rs13108904	0.651	rs875475	chr4:1192409	G/A	cg05025164	chr4:1340916	KIAA1530	0.71	5.52	0.53	4.22e-7	Obesity-related traits;
SKCM	cis	rs9467773	1.000	rs9467796	chr6:26568411	A/G	cg09904177	chr6:26538194	HMGN4	0.54	4.91	0.49	4.97e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7772486	0.875	rs1331644	chr6:146398660	T/C	cg23711669	chr6:146136114	FBXO30	0.89	8.79	0.71	2.78e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6545883	0.929	rs2252662	chr2:61670731	T/C	cg15711740	chr2:61764176	XPO1	-0.68	-4.92	-0.49	4.76e-6	Tuberculosis;
SKCM	cis	rs9399135	0.967	rs4896125	chr6:135342569	C/T	cg24558204	chr6:135376177	HBS1L	0.6	5.36	0.52	8.17e-7	Red blood cell count;
SKCM	cis	rs9300255	0.639	rs1716171	chr12:123716376	C/T	cg00376283	chr12:123451042	ABCB9	0.83	5.37	0.52	8.04e-7	Neutrophil percentage of white cells;
SKCM	cis	rs6500395	1.000	rs11859909	chr16:48668441	T/C	cg04672837	chr16:48644449	N4BP1	0.63	5.29	0.51	1.08e-6	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs55962025	0.711	rs116275868	chr4:3231148	G/C	cg09735869	chr4:3319127	RGS12	-0.68	-5.38	-0.52	7.55e-7	Parental longevity (mother's age at death);
SKCM	cis	rs793571	0.523	rs7163162	chr15:58983588	T/A	cg05156742	chr15:59063176	FAM63B	0.69	5.09	0.5	2.45e-6	Schizophrenia;
SKCM	cis	rs7829975	0.511	rs1543238	chr8:8134809	A/G	cg15556689	chr8:8085844	FLJ10661	0.84	7.92	0.67	1.36e-11	Mood instability;
SKCM	cis	rs754466	0.580	rs11002289	chr10:79532580	G/A	cg17075019	chr10:79541650	NA	-0.78	-7.19	-0.63	3.37e-10	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs11148252	0.512	rs9526950	chr13:53174463	C/A	cg00495681	chr13:53174319	NA	0.83	7.44	0.64	1.16e-10	Lewy body disease;
SKCM	cis	rs28386778	0.863	rs9897229	chr17:61782325	T/C	cg06873352	chr17:61820015	STRADA	0.72	5.77	0.55	1.56e-7	Prudent dietary pattern;
SKCM	cis	rs12711979	0.509	rs10205540	chr2:3827839	A/G	cg17052675	chr2:3827356	NA	-0.85	-9.31	-0.73	2.76e-14	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs992157	0.764	rs2891076	chr2:219184398	C/T	cg00012203	chr2:219082015	ARPC2	0.76	5.65	0.54	2.54e-7	Colorectal cancer;
SKCM	cis	rs992157	0.764	rs4552182	chr2:219184872	G/T	cg20019365	chr2:219134978	PNKD;AAMP	0.74	5.94	0.56	7.66e-8	Colorectal cancer;
SKCM	cis	rs28386778	0.897	rs8073515	chr17:61795328	A/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.13	11.24	0.79	5.56e-18	Prudent dietary pattern;
SKCM	cis	rs2841233	0.692	rs2304757	chr14:105344347	C/G	cg16576083	chr14:105354267	KIAA0284	0.6	4.77	0.48	8.29e-6	IgG glycosylation;
SKCM	cis	rs147649347	1	rs147649347	chr2:24210076	GATAA/G	cg08917208	chr2:24149416	ATAD2B	1.02	5.84	0.55	1.16e-7	Reticulocyte count;Reticulocyte fraction of red cells;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs11690935	1.000	rs2138348	chr2:172558172	A/C	cg13550731	chr2:172543902	DYNC1I2	1.04	9.7	0.74	4.68e-15	Schizophrenia;
SKCM	cis	rs4975616	0.714	rs61574973	chr5:1309168	T/C	cg26373071	chr5:1325741	CLPTM1L	-0.61	-4.84	-0.48	6.46e-6	Lung cancer;
SKCM	cis	rs870825	0.616	rs14969	chr4:185615764	C/A	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs7937682	0.924	rs875258	chr11:111530607	C/A	cg09085632	chr11:111637200	PPP2R1B	-1.05	-12.29	-0.81	6.25e-20	Primary sclerosing cholangitis;
SKCM	cis	rs7584330	0.554	rs6760890	chr2:238400645	G/A	cg08992911	chr2:238395768	MLPH	1.01	4.91	0.49	4.93e-6	Prostate cancer;
SKCM	cis	rs875971	0.522	rs709604	chr7:65497434	A/G	cg05627663	chr7:65219948	SNORA22;CCT6P1	-0.64	-5.58	-0.53	3.37e-7	Aortic root size;
SKCM	cis	rs870825	0.655	rs12502771	chr4:185635834	T/C	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs709400	0.633	rs7160208	chr14:103965528	G/A	cg26031613	chr14:104095156	KLC1	0.76	5.79	0.55	1.43e-7	Body mass index;
SKCM	cis	rs1799949	1.000	rs12944458	chr17:41180772	C/T	cg23758822	chr17:41437982	NA	0.91	7.51	0.65	8.13e-11	Menopause (age at onset);
SKCM	cis	rs34779708	0.966	rs17591163	chr10:35465279	G/C	cg03585969	chr10:35415529	CREM	0.75	6.26	0.58	1.9e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs7659604	0.676	rs4516739	chr4:122699741	G/T	cg06713675	chr4:122721982	EXOSC9	-0.76	-7.34	-0.64	1.77e-10	Type 2 diabetes;
SKCM	cis	rs17376456	0.877	rs9314092	chr5:93326362	A/G	cg21475434	chr5:93447410	FAM172A	0.94	5.55	0.53	3.86e-7	Diabetic retinopathy;
SKCM	cis	rs66569888	0.789	rs1317569	chr2:106735490	C/A	cg15412446	chr2:106886593	NA	-0.72	-5.04	-0.5	2.93e-6	Facial morphology (factor 23);
SKCM	cis	rs2072510	1.000	rs2072512	chr12:96408976	T/A	cg18817487	chr12:96390143	HAL	0.42	5.61	0.54	3.01e-7	Metabolite levels (small molecules and protein measures);
SKCM	cis	rs8103278	0.507	rs7260651	chr19:46260245	G/A	cg14061069	chr19:46274453	DMPK	0.52	5.4	0.52	7.04e-7	Coronary artery disease;
SKCM	cis	rs17685	0.725	rs4728548	chr7:75654632	A/T	cg16684958	chr7:75615977	POR	-0.64	-6.42	-0.59	9.58e-9	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs362296	0.624	rs362287	chr4:3257593	C/T	cg16987761	chr4:3318072	RGS12	-0.76	-6.39	-0.59	1.1e-8	Parental longevity (mother's age at death);
SKCM	cis	rs9388451	0.874	rs1159974	chr6:126090277	C/T	cg05901451	chr6:126070800	HEY2	0.8	8.01	0.67	8.9e-12	Brugada syndrome;
SKCM	cis	rs951366	0.966	rs11240565	chr1:205722958	C/T	cg11965913	chr1:205819406	PM20D1	-0.63	-4.85	-0.48	6.09e-6	Menarche (age at onset);
SKCM	cis	rs8060686	0.565	rs36046686	chr16:68122269	T/C	cg09117114	chr16:67998030	SLC12A4	-0.81	-5.29	-0.51	1.07e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs7793919	0.726	rs10232008	chr7:4783206	T/G	cg09789173	chr7:4769017	FOXK1	0.88	6.99	0.62	8.18e-10	Mosquito bite size;
SKCM	cis	rs4332037	1.000	rs10240470	chr7:1949971	G/T	cg23422044	chr7:1970798	MAD1L1	0.96	6.42	0.59	9.89e-9	Bipolar disorder;
SKCM	cis	rs6558174	0.930	rs1038311	chr8:22489247	T/C	cg03733263	chr8:22462867	KIAA1967	0.74	5.27	0.51	1.17e-6	Breast cancer;
SKCM	cis	rs2243480	1.000	rs34703416	chr7:65300642	A/G	cg18252515	chr7:66147081	NA	-1.29	-7.36	-0.64	1.6e-10	Diabetic kidney disease;
SKCM	cis	rs7811142	1.000	rs28490152	chr7:100020982	G/A	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.23	8.03	0.67	8.33e-12	Platelet count;
SKCM	trans	rs8073060	0.586	rs225280	chr17:33976296	C/T	cg19694781	chr19:47549865	TMEM160	-1.0	-8.56	-0.7	7.62e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs8017423	0.967	rs59006192	chr14:90706456	C/T	cg04374321	chr14:90722782	PSMC1	0.97	8.87	0.71	1.91e-13	Mortality in heart failure;
SKCM	cis	rs12824058	0.831	rs7299065	chr12:130809661	A/T	cg24838063	chr12:130822603	PIWIL1	0.78	6.91	0.62	1.19e-9	Menopause (age at onset);
SKCM	cis	rs2014572	0.904	rs10412465	chr19:57753931	T/C	cg24459738	chr19:57751996	ZNF805	-0.63	-5.12	-0.5	2.12e-6	Hyperactive-impulsive symptoms;
SKCM	cis	rs708547	0.676	rs11133470	chr4:57864926	G/T	cg16868167	chr4:57843880	C4orf14;POLR2B	0.9	8.48	0.69	1.12e-12	Response to bleomycin (chromatid breaks);
SKCM	cis	rs854765	0.583	rs8078105	chr17:17853782	T/C	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.01	7.49	0.65	9.28e-11	Total body bone mineral density;
SKCM	cis	rs8072100	0.967	rs2317826	chr17:45730899	C/T	cg25173405	chr17:45401733	C17orf57	-0.59	-5.49	-0.53	4.83e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs12950390	0.853	rs10445375	chr17:45864314	C/T	cg03474202	chr17:45855739	NA	0.47	5.3	0.51	1.03e-6	IgG glycosylation;
SKCM	cis	rs7959452	0.532	rs2291005	chr12:69764388	A/G	cg20891283	chr12:69753455	YEATS4	0.91	9.31	0.73	2.74e-14	Blood protein levels;
SKCM	cis	rs10504229	1.000	rs56255635	chr8:58178264	T/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	trans	rs10506458	1.000	rs73128794	chr12:63445313	C/T	cg03429785	chr15:59498649	MYO1E;LDHAL6B	-1.38	-7.54	-0.65	7.13e-11	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs6977660	1.000	rs35784097	chr7:19818848	A/G	cg07541023	chr7:19748670	TWISTNB	0.7	4.82	0.48	6.98e-6	Thyroid stimulating hormone;
SKCM	cis	rs1707322	1.000	rs4460583	chr1:46449918	C/G	cg03146154	chr1:46216737	IPP	0.79	5.34	0.52	8.73e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs11105298	0.891	rs10858909	chr12:89935387	C/T	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.85	-5.33	-0.52	9.32e-7	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs7555523	0.887	rs4657477	chr1:165736175	C/T	cg24409356	chr1:165738333	TMCO1	0.86	5.19	0.51	1.61e-6	Intraocular pressure;Glaucoma (high intraocular pressure);
SKCM	cis	rs470903	0.945	rs470498	chr18:74711721	C/G	cg05896682	chr18:74964030	GALR1	-0.54	-4.98	-0.49	3.68e-6	Paclitaxel disposition in epithelial ovarian cancer;
SKCM	cis	rs9815354	0.812	rs967619	chr3:41876710	C/G	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs208520	0.754	rs851592	chr6:66875175	G/T	cg07460842	chr6:66804631	NA	-0.97	-7.03	-0.62	6.8e-10	Exhaled nitric oxide output;
SKCM	cis	rs7659604	1.000	rs28618203	chr4:122663935	T/C	cg19748678	chr4:122722346	EXOSC9	0.68	5.59	0.53	3.23e-7	Type 2 diabetes;
SKCM	cis	rs453301	0.624	rs2288671	chr8:8860894	T/C	cg06636001	chr8:8085503	FLJ10661	0.75	6.06	0.57	4.53e-8	Joint mobility (Beighton score);
SKCM	cis	rs60871478	0.679	rs62432204	chr7:758283	T/C	cg05535760	chr7:792225	HEATR2	1.12	9.63	0.74	6.58e-15	Cerebrospinal P-tau181p levels;
SKCM	cis	rs2075371	1.000	rs432487	chr7:133990114	T/G	cg20476274	chr7:133979776	SLC35B4	1.01	10.44	0.76	1.77e-16	Mean platelet volume;
SKCM	cis	rs7959452	0.590	rs11177628	chr12:69765421	G/A	cg14784868	chr12:69753453	YEATS4	0.8	7.57	0.65	6.41e-11	Blood protein levels;
SKCM	cis	rs2404602	0.735	rs11635463	chr15:76762986	C/T	cg23625390	chr15:77176239	SCAPER	-0.83	-8.16	-0.68	4.7e-12	Blood metabolite levels;
SKCM	cis	rs2832191	0.791	rs2251517	chr21:30531951	T/G	cg08807101	chr21:30365312	RNF160	0.63	4.97	0.49	3.81e-6	Dental caries;
SKCM	cis	rs7599312	0.534	rs6435711	chr2:213410065	G/A	cg16329650	chr2:213403929	ERBB4	0.84	5.99	0.56	6.14e-8	BMI (adjusted for smoking behaviour);BMI in non-smokers;Body mass index;Body mass index (joint analysis main effects and smoking interaction);
SKCM	cis	rs709400	0.770	rs7142883	chr14:104066645	G/A	cg26031613	chr14:104095156	KLC1	1.11	12.72	0.82	1.04e-20	Body mass index;
SKCM	cis	rs6547631	0.622	rs6740635	chr2:85933527	C/G	cg24620635	chr2:85921963	GNLY	0.83	5.93	0.56	7.94e-8	Blood protein levels;
SKCM	cis	rs6088580	0.634	rs6059880	chr20:33088669	G/A	cg24642439	chr20:33292090	TP53INP2	0.75	6.02	0.56	5.32e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs9951698	0.703	rs10221326	chr18:13036034	T/G	cg12848697	chr18:13133368	NA	0.53	4.96	0.49	4.04e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs4132509	0.649	rs12140040	chr1:243871922	G/A	cg21452805	chr1:244014465	NA	0.91	4.98	0.49	3.68e-6	RR interval (heart rate);
SKCM	cis	rs7772486	0.774	rs2247571	chr6:146219533	T/A	cg23711669	chr6:146136114	FBXO30	0.67	6.4	0.59	1.08e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7786877	0.723	rs11764045	chr7:100212754	C/T	cg20848291	chr7:100343083	ZAN	-0.67	-5.15	-0.5	1.9e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs3087591	0.922	rs2341348	chr17:29534867	C/T	cg24425628	chr17:29625626	OMG;NF1	0.64	5.22	0.51	1.43e-6	Hip circumference;
SKCM	cis	rs9300255	0.679	rs4759420	chr12:123794871	G/C	cg00376283	chr12:123451042	ABCB9	0.78	5.26	0.51	1.24e-6	Neutrophil percentage of white cells;
SKCM	cis	rs6951245	0.554	rs35126802	chr7:1134842	C/T	cg23708337	chr7:1209742	NA	0.7	4.8	0.48	7.53e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs72634258	0.519	rs35197830	chr1:7930983	A/G	cg00042356	chr1:8021962	PARK7	0.7	4.92	0.49	4.77e-6	Inflammatory bowel disease;
SKCM	cis	rs7100689	0.646	rs1290317	chr10:82062531	C/A	cg01528321	chr10:82214614	TSPAN14	0.75	6.26	0.58	1.91e-8	Post bronchodilator FEV1;
SKCM	cis	rs801193	0.967	rs2707841	chr7:66157020	A/G	cg18876405	chr7:65276391	NA	0.8	7.11	0.63	4.86e-10	Aortic root size;
SKCM	cis	rs7666738	0.830	rs7678250	chr4:98922109	G/A	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs17711722	0.727	rs781151	chr7:65479878	T/C	cg11987759	chr7:65425863	GUSB	-0.77	-6.93	-0.62	1.09e-9	Calcium levels;
SKCM	cis	rs908922	0.651	rs4845442	chr1:152485545	G/A	cg09873164	chr1:152488093	CRCT1	0.77	5.99	0.56	6.03e-8	Hair morphology;
SKCM	cis	rs2836974	0.584	rs34436313	chr21:40685246	A/G	cg11890956	chr21:40555474	PSMG1	-0.82	-8.04	-0.67	7.71e-12	Cognitive function;
SKCM	cis	rs11098499	0.863	rs34868248	chr4:120442430	A/G	cg09307838	chr4:120376055	NA	0.97	7.66	0.66	4.19e-11	Corneal astigmatism;
SKCM	cis	rs12950390	0.853	rs12451815	chr17:45855956	A/G	cg03474202	chr17:45855739	NA	-0.49	-5.71	-0.54	1.95e-7	IgG glycosylation;
SKCM	cis	rs2204008	0.616	rs1607852	chr12:38398125	G/A	cg26384229	chr12:38710491	ALG10B	0.88	6.86	0.61	1.46e-9	Bladder cancer;
SKCM	cis	rs2777491	0.574	rs11635906	chr15:41779260	A/G	cg18705301	chr15:41695430	NDUFAF1	-1.17	-11.41	-0.79	2.67e-18	Ulcerative colitis;
SKCM	cis	rs7945705	0.869	rs4909952	chr11:8963946	A/G	cg13070366	chr11:9386451	NA	-0.62	-5.37	-0.52	7.91e-7	Hemoglobin concentration;
SKCM	cis	rs6951245	0.938	rs78351779	chr7:1097023	G/C	cg18402987	chr7:1209562	NA	1.15	6.09	0.57	3.95e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs593982	0.925	rs585272	chr11:65505289	A/G	cg08755490	chr11:65554678	OVOL1	1.06	10.75	0.77	4.73e-17	Atopic dermatitis;
SKCM	cis	rs1325195	0.537	rs2636290	chr1:179096088	A/G	cg25467746	chr1:179556597	NA	-0.63	-6.12	-0.57	3.49e-8	IgE grass sensitization;
SKCM	cis	rs782590	0.643	rs13032503	chr2:55739093	C/T	cg18811423	chr2:55921094	PNPT1	-0.68	-5.01	-0.49	3.25e-6	Metabolic syndrome;
SKCM	cis	rs3820068	0.506	rs17448966	chr1:15990983	T/G	cg13390004	chr1:15929781	NA	0.64	5.19	0.51	1.61e-6	Systolic blood pressure;
SKCM	cis	rs7666738	0.830	rs6833312	chr4:98951356	A/T	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1005277	0.579	rs2472182	chr10:38388865	T/C	cg25427524	chr10:38739819	LOC399744	-0.69	-6.45	-0.59	8.73e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs17641971	0.599	rs818555	chr8:49999211	A/G	cg00325661	chr8:49890786	NA	-0.73	-6.69	-0.6	3.07e-9	Blood metabolite levels;
SKCM	cis	rs654950	0.840	rs647146	chr1:41986286	G/A	cg06885757	chr1:42089581	HIVEP3	0.6	6.77	0.61	2.12e-9	Airway imaging phenotypes;
SKCM	cis	rs2153535	0.601	rs2327054	chr6:8443130	T/C	cg23788917	chr6:8435910	SLC35B3	0.73	5.44	0.52	5.82e-7	Motion sickness;
SKCM	cis	rs67460515	0.563	rs7618924	chr3:160855599	A/G	cg03342759	chr3:160939853	NMD3	-0.72	-6.2	-0.57	2.46e-8	Parkinson's disease;
SKCM	cis	rs58688157	0.705	rs12419618	chr11:611531	G/A	cg03576123	chr11:487126	PTDSS2	-0.79	-4.83	-0.48	6.81e-6	Systemic lupus erythematosus;
SKCM	cis	rs10849605	0.661	rs4765655	chr12:1067758	T/C	cg02055889	chr12:1059459	RAD52	0.63	4.83	0.48	6.62e-6	Lung cancer;
SKCM	cis	rs28386778	0.897	rs4968597	chr17:61805747	G/A	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.13	11.24	0.79	5.56e-18	Prudent dietary pattern;
SKCM	cis	rs6087990	0.765	rs6058900	chr20:31400673	T/C	cg13636640	chr20:31349939	DNMT3B	0.77	6.01	0.56	5.51e-8	Ulcerative colitis;
SKCM	cis	rs56235845	0.694	rs36102285	chr5:176774018	C/T	cg17509989	chr5:176798049	RGS14	0.72	5.9	0.56	8.83e-8	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs514406	0.893	rs6682024	chr1:53439525	T/C	cg08859206	chr1:53392774	SCP2	0.6	4.82	0.48	6.91e-6	Monocyte count;
SKCM	cis	rs9951698	0.667	rs9783859	chr18:12998929	G/T	cg12848697	chr18:13133368	NA	0.53	4.9	0.48	5.18e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs10416265	0.502	rs7245411	chr19:33543029	A/T	cg27124370	chr19:33622961	WDR88	0.8	5.48	0.53	5.13e-7	Bone properties (heel);
SKCM	cis	rs6665290	0.904	rs3738729	chr1:227191227	C/T	cg10327440	chr1:227177885	CDC42BPA	-1.24	-16.91	-0.89	8.11e-28	Myeloid white cell count;
SKCM	cis	rs61776719	0.738	rs7555461	chr1:38444749	T/C	cg12658694	chr1:38397304	INPP5B	-0.7	-6.21	-0.58	2.4e-8	Coronary artery disease;
SKCM	cis	rs1552244	0.935	rs35148833	chr3:10116937	C/A	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs769267	0.930	rs892021	chr19:19613480	T/C	cg03709012	chr19:19516395	GATAD2A	0.89	8.62	0.7	5.89e-13	Tonsillectomy;
SKCM	cis	rs6840360	0.571	rs4696275	chr4:152530981	C/T	cg22705602	chr4:152727874	NA	-0.52	-5.7	-0.54	2.03e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs3818285	0.544	rs9787456	chr10:111711822	A/G	cg00817464	chr10:111662876	XPNPEP1	-0.73	-7.02	-0.62	7.34e-10	Superior crus of antihelix expression;
SKCM	cis	rs6121246	0.559	rs1062794	chr20:30381758	G/C	cg11595048	chr20:30225325	COX4I2	0.54	4.77	0.48	8.4e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs3768617	0.510	rs10797839	chr1:183077797	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.81	7.48	0.65	9.63e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs3768617	0.565	rs2022392	chr1:183104863	T/A	ch.1.3577855R	chr1:183094577	LAMC1	0.76	7.31	0.64	1.97e-10	Fuchs's corneal dystrophy;
SKCM	cis	rs9325144	0.560	rs11183046	chr12:38655270	A/T	cg26384229	chr12:38710491	ALG10B	-0.69	-5.66	-0.54	2.36e-7	Morning vs. evening chronotype;
SKCM	cis	rs3087591	1.000	rs2905791	chr17:29472888	T/C	cg24425628	chr17:29625626	OMG;NF1	0.64	5.21	0.51	1.49e-6	Hip circumference;
SKCM	cis	rs55728055	0.661	rs7293143	chr22:32013365	A/G	cg01338084	chr22:32026380	PISD	-1.62	-5.14	-0.5	1.99e-6	Age-related hearing impairment;
SKCM	cis	rs17065868	0.803	rs9595151	chr13:45126626	G/A	cg10246903	chr13:45222710	NA	0.95	5.35	0.52	8.5e-7	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs854765	0.583	rs8070128	chr17:17804725	C/T	cg09796270	chr17:17721594	SREBF1	-0.66	-4.9	-0.49	5.07e-6	Total body bone mineral density;
SKCM	cis	rs589448	0.902	rs2603090	chr12:69777188	G/A	cg14784868	chr12:69753453	YEATS4	0.84	7.68	0.66	3.87e-11	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs3135063	0.504	rs78139882	chr4:3287361	C/T	cg24015175	chr4:3319247	RGS12	0.66	4.78	0.48	8.24e-6	Blood protein levels;
SKCM	cis	rs2153535	0.580	rs6900007	chr6:8474035	C/T	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs875971	0.505	rs6955582	chr7:65431686	A/G	cg11987759	chr7:65425863	GUSB	-0.77	-7.0	-0.62	8.02e-10	Aortic root size;
SKCM	cis	rs12474201	0.894	rs34401107	chr2:46972768	A/C	cg06386533	chr2:46925753	SOCS5	1.03	9.82	0.74	2.8e-15	Height;
SKCM	cis	rs17376456	0.877	rs55832164	chr5:93436579	C/T	cg21475434	chr5:93447410	FAM172A	0.97	5.42	0.52	6.39e-7	Diabetic retinopathy;
SKCM	cis	rs7666738	0.791	rs34152299	chr4:98929862	G/C	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7959452	0.640	rs4274230	chr12:69700772	T/G	cg20891283	chr12:69753455	YEATS4	0.76	6.95	0.62	9.76e-10	Blood protein levels;
SKCM	cis	rs10752881	1.000	rs8179283	chr1:182974602	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.74	6.7	0.6	2.91e-9	Colorectal cancer;
SKCM	cis	rs208520	0.690	rs12202401	chr6:66760544	A/G	cg07460842	chr6:66804631	NA	0.92	6.93	0.62	1.09e-9	Exhaled nitric oxide output;
SKCM	cis	rs2153535	0.580	rs5001322	chr6:8451608	A/G	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs7659604	1.000	rs10005932	chr4:122664782	T/C	cg06713675	chr4:122721982	EXOSC9	-0.65	-5.78	-0.55	1.48e-7	Type 2 diabetes;
SKCM	cis	rs155076	1.000	rs2783107	chr13:21837532	C/A	cg14456004	chr13:21872349	NA	-1.23	-6.77	-0.61	2.15e-9	White matter hyperintensity burden;
SKCM	cis	rs6951245	1.000	rs2363286	chr7:1091625	A/G	cg24642844	chr7:1081250	C7orf50	-0.87	-6.15	-0.57	3.14e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs12451471	0.637	rs7567	chr17:78093549	G/T	cg06718696	chr17:78121285	EIF4A3	0.9	6.15	0.57	3.1e-8	Plateletcrit;Mean corpuscular hemoglobin concentration;
SKCM	cis	rs17685	0.753	rs10251863	chr7:75790192	T/C	cg16489192	chr7:75678113	MDH2;STYXL1	-0.57	-5.49	-0.53	4.89e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs870825	0.616	rs35533356	chr4:185639134	A/G	cg04058563	chr4:185651563	MLF1IP	1.08	7.26	0.64	2.51e-10	Blood protein levels;
SKCM	cis	rs5769765	0.955	rs8139758	chr22:50261123	G/T	cg22709217	chr22:50311962	ALG12;CRELD2	0.79	5.71	0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs6582630	0.555	rs2387598	chr12:38510472	G/A	cg26384229	chr12:38710491	ALG10B	-0.79	-6.42	-0.59	9.91e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs1218582	0.741	rs10908446	chr1:154869559	G/A	cg03351412	chr1:154909251	PMVK	0.77	6.52	0.59	6.43e-9	Prostate cancer;
SKCM	trans	rs8073060	0.586	rs225305	chr17:33921160	C/T	cg19694781	chr19:47549865	TMEM160	-1.08	-8.73	-0.7	3.66e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs28595532	0.920	rs116106661	chr4:119749794	A/G	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs73201462	1.000	rs13067650	chr3:127889542	T/A	cg09089421	chr3:127803668	RUVBL1	1.0	5.11	0.5	2.22e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs4919694	1.000	rs11191439	chr10:104638723	C/T	cg04362960	chr10:104952993	NT5C2	-0.76	-4.92	-0.49	4.65e-6	Arsenic metabolism;
SKCM	cis	rs2204008	0.744	rs11168870	chr12:37973333	A/G	cg26384229	chr12:38710491	ALG10B	0.8	6.2	0.57	2.47e-8	Bladder cancer;
SKCM	cis	rs3818285	0.504	rs7100154	chr10:111650150	T/C	cg00817464	chr10:111662876	XPNPEP1	-0.68	-5.88	-0.55	9.57e-8	Superior crus of antihelix expression;
SKCM	cis	rs10911232	0.507	rs35782443	chr1:183051502	A/C	ch.1.3577855R	chr1:183094577	LAMC1	0.78	6.87	0.61	1.42e-9	Hypertriglyceridemia;
SKCM	cis	rs7940866	0.745	rs1368853	chr11:130866084	A/G	cg12179176	chr11:130786555	SNX19	0.73	5.54	0.53	4e-7	Schizophrenia;
SKCM	cis	rs7772486	0.536	rs9373467	chr6:145955605	C/T	cg05347473	chr6:146136440	FBXO30	0.68	6.17	0.57	2.9e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2842992	0.789	rs3818300	chr6:160201677	G/A	cg19482086	chr6:160211437	TCP1;MRPL18	0.86	6.82	0.61	1.71e-9	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs2228479	0.619	rs78001663	chr16:89896331	C/A	cg06558623	chr16:89946397	TCF25	1.1	4.95	0.49	4.17e-6	Skin colour saturation;
SKCM	cis	rs9910055	0.615	rs189049	chr17:42197213	A/C	cg13607699	chr17:42295918	UBTF	-0.7	-5.5	-0.53	4.73e-7	Total body bone mineral density;
SKCM	cis	rs1577917	1.000	rs955227	chr6:86651032	C/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.66	-5.74	-0.54	1.76e-7	Response to antipsychotic treatment;
SKCM	cis	rs4689592	0.503	rs11937667	chr4:7057037	C/G	cg26116260	chr4:7069785	GRPEL1	-1.08	-7.34	-0.64	1.76e-10	Monocyte percentage of white cells;
SKCM	trans	rs17685	0.593	rs56265719	chr7:75796269	C/T	cg19862616	chr7:65841803	NCRNA00174	0.93	9.44	0.73	1.49e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs13256369	1.000	rs13266699	chr8:8570313	A/T	cg06636001	chr8:8085503	FLJ10661	-0.72	-5.56	-0.53	3.65e-7	Obesity-related traits;
SKCM	cis	rs634534	0.622	rs1192168	chr11:65730945	T/G	cg26695010	chr11:65641043	EFEMP2	-0.65	-5.32	-0.52	9.77e-7	Sum eosinophil basophil counts;Eosinophil counts;
SKCM	cis	rs950027	0.620	rs2467862	chr15:45643843	T/G	cg21132104	chr15:45694354	SPATA5L1	0.76	5.84	0.55	1.16e-7	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs722599	0.501	rs2286912	chr14:75385437	C/T	cg08847533	chr14:75593920	NEK9	-0.6	-4.83	-0.48	6.64e-6	IgG glycosylation;
SKCM	cis	rs2836950	0.565	rs2150413	chr21:40614878	C/T	cg11890956	chr21:40555474	PSMG1	-0.66	-5.26	-0.51	1.22e-6	Menarche (age at onset);
SKCM	cis	rs912057	0.632	rs1294432	chr6:6745027	C/T	cg06612196	chr6:6737390	NA	0.66	5.46	0.53	5.49e-7	Waist-to-hip ratio adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);
SKCM	cis	rs860295	0.580	rs10908461	chr1:155275727	C/T	cg02153340	chr1:155202674	NA	-0.78	-5.42	-0.52	6.37e-7	Body mass index;
SKCM	cis	rs7772486	0.790	rs3923579	chr6:146230232	C/G	cg05347473	chr6:146136440	FBXO30	-0.56	-5.28	-0.51	1.12e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs28595532	0.920	rs115090549	chr4:119753554	T/C	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs3785574	0.962	rs62077512	chr17:61851435	C/T	cg01411255	chr17:61851458	DDX42;CCDC47	1.11	12.47	0.82	2.97e-20	Height;
SKCM	cis	rs10504229	0.683	rs2088217	chr8:58113124	C/T	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs2404602	0.647	rs12914196	chr15:76941361	C/T	cg23625390	chr15:77176239	SCAPER	-0.85	-8.26	-0.68	2.93e-12	Blood metabolite levels;
SKCM	cis	rs727563	0.636	rs2413653	chr22:42106996	T/C	cg03806693	chr22:41940476	POLR3H	1.11	6.72	0.61	2.72e-9	Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs7932354	0.502	rs10769233	chr11:47072655	T/C	cg03339077	chr11:47165057	C11orf49	-0.59	-4.79	-0.48	7.68e-6	Bone mineral density (hip);Bone mineral density;
SKCM	cis	rs8177253	0.965	rs1525889	chr3:133490033	A/C	cg16414030	chr3:133502952	NA	-0.7	-5.93	-0.56	7.88e-8	Iron status biomarkers;
SKCM	cis	rs17213078	0.505	rs737101	chr2:106732545	C/T	cg15412446	chr2:106886593	NA	0.61	5.03	0.5	3.01e-6	Facial morphology (factor 23);
SKCM	cis	rs6061231	0.755	rs11699160	chr20:60958651	T/C	cg24112000	chr20:60950667	NA	-0.6	-6.44	-0.59	9.06e-9	Colorectal cancer;
SKCM	cis	rs9303401	0.614	rs28687626	chr17:57191904	G/A	cg10487724	chr17:56770010	TEX14;RAD51C	0.8	4.88	0.48	5.41e-6	Cognitive test performance;
SKCM	cis	rs2439831	0.850	rs544122	chr15:43775732	A/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.47	9.43	0.73	1.57e-14	Lung cancer in ever smokers;
SKCM	cis	rs2243480	0.615	rs34363376	chr7:65939536	T/C	cg18252515	chr7:66147081	NA	-1.35	-8.04	-0.67	7.88e-12	Diabetic kidney disease;
SKCM	cis	rs3857536	0.740	rs7766407	chr6:66885658	C/A	cg07460842	chr6:66804631	NA	-0.7	-5.07	-0.5	2.64e-6	Blood trace element (Cu levels);
SKCM	cis	rs72792276	1.000	rs13357283	chr5:127423114	G/T	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.75	5.12	0.5	2.11e-6	Red cell distribution width;
SKCM	cis	rs9894429	0.505	rs35570626	chr17:79611084	A/G	cg18240062	chr17:79603768	NPLOC4	0.68	6.07	0.57	4.41e-8	Eye color traits;
SKCM	cis	rs12824058	0.798	rs4759652	chr12:130808771	C/T	cg26677194	chr12:130822605	PIWIL1	0.7	5.67	0.54	2.3e-7	Menopause (age at onset);
SKCM	cis	rs651907	0.535	rs17347156	chr3:101504674	G/A	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.79	6.85	0.61	1.51e-9	Colorectal cancer;
SKCM	cis	rs7552404	0.920	rs1612097	chr1:76218875	C/T	cg10523679	chr1:76189770	ACADM	0.69	4.93	0.49	4.45e-6	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs6952808	0.717	rs12534679	chr7:1926745	G/A	cg03354898	chr7:1950403	MAD1L1	-0.53	-5.04	-0.5	2.94e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs2842992	0.915	rs2842985	chr6:160085434	C/T	cg11366901	chr6:160182831	ACAT2	0.93	6.93	0.62	1.05e-9	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs9858542	0.953	rs11706370	chr3:49441091	G/A	cg03060546	chr3:49711283	APEH	-0.69	-5.16	-0.5	1.85e-6	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs8103278	0.507	rs4802275	chr19:46260375	C/T	cg12641515	chr19:46296257	DMWD	0.78	6.24	0.58	2.1e-8	Coronary artery disease;
SKCM	cis	rs9300255	0.679	rs10772998	chr12:123721177	T/G	cg05973401	chr12:123451056	ABCB9	0.86	6.11	0.57	3.69e-8	Neutrophil percentage of white cells;
SKCM	cis	rs6500395	0.962	rs3743780	chr16:48647480	A/G	cg04672837	chr16:48644449	N4BP1	0.69	5.75	0.55	1.65e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs644799	0.601	rs568878	chr11:95578694	G/T	cg25622487	chr11:95524042	FAM76B;CEP57	0.61	4.88	0.48	5.44e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs6951245	1.000	rs78308415	chr7:1072634	G/A	cg03188948	chr7:1209495	NA	1.12	6.17	0.57	2.88e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs2832191	0.933	rs2832236	chr21:30547602	C/T	cg24692254	chr21:30365293	RNF160	-0.77	-7.0	-0.62	7.88e-10	Dental caries;
SKCM	cis	rs7953508	0.711	rs11107117	chr12:93979419	T/C	cg18151635	chr12:93972918	NA	-0.73	-6.41	-0.59	1.02e-8	Pubertal anthropometrics;
SKCM	cis	rs7940866	0.740	rs7131121	chr11:130806424	A/G	cg12179176	chr11:130786555	SNX19	0.75	5.91	0.56	8.4e-8	Schizophrenia;
SKCM	cis	rs6450176	1.000	rs10805455	chr5:53302302	T/G	ch.5.1024479R	chr5:53302184	ARL15	-0.71	-4.88	-0.48	5.49e-6	HDL cholesterol levels;HDL cholesterol;Adiponectin levels;
SKCM	cis	rs7208859	0.623	rs12103508	chr17:29086781	T/G	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs6061231	0.837	rs6061235	chr20:60978524	C/G	cg24112000	chr20:60950667	NA	-0.65	-6.01	-0.56	5.71e-8	Colorectal cancer;
SKCM	cis	rs12540874	0.663	rs1451371	chr7:50553051	T/C	cg18232548	chr7:50535776	DDC	-0.83	-6.36	-0.58	1.26e-8	Systemic sclerosis;
SKCM	cis	rs1552244	0.572	rs3843008	chr3:10173742	C/T	cg02579736	chr3:10068473	FANCD2;CIDECP	1.09	4.81	0.48	7.34e-6	Alzheimer's disease;
SKCM	cis	rs2836974	0.666	rs4818015	chr21:40675493	A/C	cg11644478	chr21:40555479	PSMG1	0.72	6.47	0.59	7.83e-9	Cognitive function;
SKCM	cis	rs2645694	0.626	rs2703136	chr4:77828957	T/A	cg03477792	chr4:77819574	ANKRD56	0.57	6.42	0.59	9.57e-9	Emphysema distribution in smoking;
SKCM	cis	rs2832191	0.791	rs2832186	chr21:30484151	A/C	cg08807101	chr21:30365312	RNF160	-0.62	-4.94	-0.49	4.34e-6	Dental caries;
SKCM	cis	rs7945705	0.846	rs2742540	chr11:8899528	A/G	cg21881798	chr11:8931708	C11orf17;ST5	0.76	8.18	0.68	4.15e-12	Hemoglobin concentration;
SKCM	cis	rs28595532	0.764	rs115986119	chr4:119767785	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs16854884	0.837	rs4362712	chr3:143801076	G/A	cg06585982	chr3:143692056	C3orf58	0.72	5.63	0.54	2.78e-7	Economic and political preferences (feminism/equality);
SKCM	cis	rs763121	0.853	rs35565791	chr22:39063011	C/A	cg06022373	chr22:39101656	GTPBP1	0.78	5.63	0.54	2.7e-7	Menopause (age at onset);
SKCM	cis	rs7680126	0.596	rs10489070	chr4:10276352	C/G	cg11511795	chr4:10463749	NA	-0.64	-4.96	-0.49	3.99e-6	Urate levels in lean individuals;Urate levels in overweight individuals;Urate levels in obese individuals;
SKCM	cis	rs4974559	1.000	rs4974559	chr4:1380848	C/T	cg02980000	chr4:1222292	CTBP1	-0.8	-5.53	-0.53	4.11e-7	Systolic blood pressure;
SKCM	cis	rs2153535	0.580	rs9406143	chr6:8444583	C/T	cg23788917	chr6:8435910	SLC35B3	0.69	5.14	0.5	1.99e-6	Motion sickness;
SKCM	cis	rs66573146	1.000	rs6812771	chr4:6964048	G/A	cg00086871	chr4:6988644	TBC1D14	1.43	5.33	0.52	9.25e-7	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs8017423	0.967	rs8021881	chr14:90722276	T/C	cg04374321	chr14:90722782	PSMC1	1.03	9.44	0.73	1.55e-14	Mortality in heart failure;
SKCM	cis	rs673604	1.000	rs60037734	chr1:35679187	G/T	cg12633102	chr1:35676489	NA	-0.68	-5.35	-0.52	8.54e-7	Endometrial cancer;
SKCM	cis	rs9902453	0.765	rs2617883	chr17:28120488	G/A	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.81	-6.26	-0.58	1.93e-8	Coffee consumption (cups per day);
SKCM	cis	rs4808199	0.947	rs754255	chr19:19578890	T/C	cg03709012	chr19:19516395	GATAD2A	1.13	8.66	0.7	4.94e-13	Nonalcoholic fatty liver disease;
SKCM	cis	rs4481887	0.888	rs12042602	chr1:248482053	C/T	cg00666640	chr1:248458726	OR2T12	0.66	6.0	0.56	5.9e-8	Common traits (Other);
SKCM	cis	rs9543976	1.000	rs4885324	chr13:76173747	G/A	cg16409306	chr13:76195284	LMO7	0.84	4.79	0.48	7.87e-6	Diabetic retinopathy;
SKCM	cis	rs62238980	0.614	rs4820060	chr22:32366415	C/T	cg00543991	chr22:32367038	NA	1.28	5.18	0.51	1.68e-6	Childhood ear infection;
SKCM	cis	rs3793683	0.556	rs2803989	chr10:134560596	C/T	cg18305652	chr10:134549665	INPP5A	0.62	6.84	0.61	1.56e-9	Migraine;
SKCM	cis	rs826838	0.935	rs980571	chr12:39127532	C/G	cg26384229	chr12:38710491	ALG10B	-0.91	-8.28	-0.68	2.74e-12	Heart rate;
SKCM	cis	rs55794721	0.543	rs1293260	chr1:25709104	C/G	cg27572855	chr1:25598939	RHD	0.54	5.17	0.5	1.79e-6	Plateletcrit;Mean corpuscular volume;
SKCM	cis	rs6840360	0.593	rs4696286	chr4:152606547	G/A	cg22705602	chr4:152727874	NA	-0.58	-7.78	-0.66	2.55e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs11098499	0.865	rs4001305	chr4:120359236	G/T	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs3818285	0.515	rs12258440	chr10:111676799	C/T	cg00817464	chr10:111662876	XPNPEP1	-0.75	-7.37	-0.64	1.57e-10	Superior crus of antihelix expression;
SKCM	cis	rs4332037	0.901	rs11767040	chr7:1945468	C/T	cg23422044	chr7:1970798	MAD1L1	-0.96	-6.52	-0.59	6.37e-9	Bipolar disorder;
SKCM	cis	rs780096	0.526	rs1647267	chr2:27651054	A/T	cg05696406	chr2:27599888	SNX17	0.51	5.22	0.51	1.46e-6	Total body bone mineral density;
SKCM	cis	rs1005277	0.528	rs2057228	chr10:38515766	T/C	cg25427524	chr10:38739819	LOC399744	-0.69	-6.79	-0.61	1.96e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs8103278	0.507	rs62111759	chr19:46296230	A/T	cg12641515	chr19:46296257	DMWD	0.8	6.39	0.59	1.1e-8	Coronary artery disease;
SKCM	cis	rs801193	0.935	rs3800820	chr7:66147178	C/T	cg11764359	chr7:65958608	NA	-0.86	-6.6	-0.6	4.52e-9	Aortic root size;
SKCM	cis	rs1801516	1.000	rs10890844	chr11:108334127	T/C	cg03165700	chr11:108093220	ATM;NPAT	-1.18	-5.35	-0.52	8.48e-7	Melanoma;
SKCM	cis	rs3008870	0.959	rs56707923	chr1:67388016	T/C	cg08660285	chr1:67390436	MIER1;WDR78	0.98	6.56	0.6	5.45e-9	Lymphocyte percentage of white cells;
SKCM	cis	rs10779751	0.770	rs2486922	chr1:11124885	T/C	cg08854313	chr1:11322531	MTOR	0.77	5.52	0.53	4.36e-7	Body mass index;
SKCM	cis	rs3768617	0.510	rs10752903	chr1:183100863	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs854765	0.647	rs2974998	chr17:17995619	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.88	6.64	0.6	3.8e-9	Total body bone mineral density;
SKCM	cis	rs13217239	0.646	rs4269366	chr6:27016413	C/T	cg12292205	chr6:26970375	C6orf41	0.6	5.22	0.51	1.46e-6	Schizophrenia;
SKCM	cis	rs875971	0.660	rs2013222	chr7:66035936	C/G	cg11764359	chr7:65958608	NA	-0.86	-6.6	-0.6	4.52e-9	Aortic root size;
SKCM	cis	rs28386778	0.897	rs7212196	chr17:61834981	T/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.12	11.26	0.79	5.02e-18	Prudent dietary pattern;
SKCM	cis	rs3784262	0.669	rs12905608	chr15:58314139	C/T	cg12031962	chr15:58353849	ALDH1A2	-0.41	-4.82	-0.48	6.93e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs9910055	0.552	rs4793084	chr17:42317371	G/T	cg13607699	chr17:42295918	UBTF	-0.94	-7.39	-0.64	1.41e-10	Total body bone mineral density;
SKCM	cis	rs1799949	0.965	rs35954893	chr17:41333786	A/G	cg05368731	chr17:41323189	NBR1	0.87	7.74	0.66	3.01e-11	Menopause (age at onset);
SKCM	cis	rs11098499	0.780	rs10013652	chr4:120292256	A/G	cg24375607	chr4:120327624	NA	0.63	4.86	0.48	5.9e-6	Corneal astigmatism;
SKCM	cis	rs561341	1.000	rs546519	chr17:30297682	T/G	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs9911578	1.000	rs8076121	chr17:57041699	G/A	cg12560992	chr17:57184187	TRIM37	0.94	7.55	0.65	7.01e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs6977660	1.000	rs5017193	chr7:19820103	G/A	cg07541023	chr7:19748670	TWISTNB	0.7	4.82	0.48	6.98e-6	Thyroid stimulating hormone;
SKCM	cis	rs2243480	0.803	rs35480979	chr7:65357084	A/G	cg07424592	chr7:64974309	NA	0.99	4.9	0.49	5.08e-6	Diabetic kidney disease;
SKCM	cis	rs9611565	0.512	rs132784	chr22:42052363	G/A	cg03806693	chr22:41940476	POLR3H	1.06	6.41	0.59	1.01e-8	Vitiligo;
SKCM	cis	rs34779708	0.897	rs7900480	chr10:35338699	A/G	cg03585969	chr10:35415529	CREM	-0.66	-5.26	-0.51	1.23e-6	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs9300255	0.566	rs1716169	chr12:123716930	A/T	cg00376283	chr12:123451042	ABCB9	0.8	5.15	0.5	1.9e-6	Neutrophil percentage of white cells;
SKCM	cis	rs2153535	0.601	rs9505451	chr6:8469950	C/T	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs7786877	0.521	rs2293767	chr7:100361675	A/G	cg20848291	chr7:100343083	ZAN	0.62	4.93	0.49	4.49e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs910316	1.000	rs10142865	chr14:75555624	G/A	cg11812906	chr14:75593930	NEK9	0.69	5.22	0.51	1.47e-6	Height;
SKCM	cis	rs10883723	0.737	rs7074444	chr10:104249922	A/G	cg11453585	chr10:104263688	ACTR1A;SUFU	0.74	5.6	0.54	3.13e-7	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs12478296	0.792	rs6755390	chr2:243012998	C/T	cg06360820	chr2:242988706	NA	-0.96	-4.93	-0.49	4.56e-6	Obesity-related traits;
SKCM	cis	rs28785552	0.966	rs7247272	chr19:53236331	C/T	cg10871876	chr19:53194124	ZNF83	-0.68	-5.0	-0.49	3.46e-6	Response to paliperidone in schizophrenia (PANSS score);
SKCM	cis	rs829883	1.000	rs249839	chr12:98872364	T/C	cg25150519	chr12:98850993	NA	0.5	5.27	0.51	1.17e-6	Colorectal adenoma (advanced);
SKCM	cis	rs208520	1.000	rs208521	chr6:66953625	C/T	cg07460842	chr6:66804631	NA	-0.84	-5.89	-0.55	9.44e-8	Exhaled nitric oxide output;
SKCM	cis	rs3784262	0.740	rs4646598	chr15:58300328	G/C	cg12031962	chr15:58353849	ALDH1A2	-0.45	-5.37	-0.52	7.83e-7	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs10781543	0.839	rs7863766	chr9:139381314	T/G	cg14169450	chr9:139327907	INPP5E	0.51	5.57	0.53	3.51e-7	Monocyte percentage of white cells;
SKCM	cis	rs1577917	0.958	rs12209668	chr6:86566517	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.32	-0.52	9.66e-7	Response to antipsychotic treatment;
SKCM	cis	rs4423214	0.840	rs1790341	chr11:71177578	T/C	cg05163923	chr11:71159392	DHCR7	-0.74	-6.65	-0.6	3.61e-9	Vitamin D levels;
SKCM	cis	rs672059	1.000	rs544352	chr1:183157546	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.63	5.23	0.51	1.38e-6	Hypertriglyceridemia;
SKCM	cis	rs28595532	1.000	rs115915387	chr4:119640854	C/T	cg21605333	chr4:119757512	SEC24D	1.24	7.1	0.63	5.16e-10	Cannabis dependence symptom count;
SKCM	cis	rs2841277	0.708	rs10083490	chr14:105402418	A/G	cg21017887	chr14:105400489	NA	-0.55	-4.95	-0.49	4.27e-6	Rheumatoid arthritis;
SKCM	cis	rs7659604	1.000	rs35249024	chr4:122664538	C/A	cg19671926	chr4:122722719	EXOSC9	-0.66	-4.98	-0.49	3.71e-6	Type 2 diabetes;
SKCM	cis	rs798554	1.000	rs798559	chr7:2758341	T/C	cg14895029	chr7:2775587	GNA12	-0.68	-4.86	-0.48	6.02e-6	Height;
SKCM	cis	rs12477438	0.677	rs12475034	chr2:99699464	A/G	cg26064155	chr2:99771622	LIPT1;TSGA10	-0.73	-4.84	-0.48	6.41e-6	Chronic sinus infection;
SKCM	cis	rs4332037	1.000	rs62442899	chr7:1948454	C/T	cg23422044	chr7:1970798	MAD1L1	-0.96	-6.52	-0.59	6.37e-9	Bipolar disorder;
SKCM	cis	rs7124681	0.584	rs7950674	chr11:47871017	T/C	cg20307385	chr11:47447363	PSMC3	0.72	5.81	0.55	1.31e-7	Body mass index (joint analysis main effects and physical activity interaction);Body mass index;Body mass index in physically active individuals;
SKCM	cis	rs7666738	0.578	rs1989109	chr4:98881246	T/A	cg17366294	chr4:99064904	C4orf37	0.57	4.84	0.48	6.52e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs67460515	0.563	rs4494975	chr3:160866768	C/T	cg03342759	chr3:160939853	NMD3	-0.71	-5.95	-0.56	7.28e-8	Parkinson's disease;
SKCM	cis	rs2075671	0.903	rs62482249	chr7:100262357	C/A	cg16850897	chr7:100343110	ZAN	-0.65	-4.78	-0.48	8.2e-6	Other erythrocyte phenotypes;
SKCM	cis	rs12477438	0.520	rs720229	chr2:99704273	T/C	cg14399236	chr2:99771627	LIPT1;TSGA10	0.96	8.23	0.68	3.38e-12	Chronic sinus infection;
SKCM	cis	rs523522	0.962	rs4767903	chr12:120930046	G/A	cg12219531	chr12:120966889	COQ5	0.91	7.82	0.66	2.11e-11	High light scatter reticulocyte count;
SKCM	cis	rs17685	0.593	rs56265719	chr7:75796269	C/T	cg16684958	chr7:75615977	POR	0.53	5.18	0.51	1.7e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs910316	0.967	rs4903285	chr14:75609268	A/T	cg08847533	chr14:75593920	NEK9	0.95	9.18	0.72	4.88e-14	Height;
SKCM	cis	rs4972806	0.814	rs6710370	chr2:177045969	T/C	cg03152288	chr2:177042942	NA	0.57	4.99	0.49	3.6e-6	IgG glycosylation;
SKCM	cis	rs11098499	0.863	rs3775858	chr4:120486028	A/G	cg09307838	chr4:120376055	NA	1.0	8.27	0.68	2.8e-12	Corneal astigmatism;
SKCM	cis	rs72781680	0.898	rs79023848	chr2:24038174	C/A	cg08917208	chr2:24149416	ATAD2B	1.02	5.54	0.53	3.94e-7	Lymphocyte counts;
SKCM	cis	rs9604529	0.640	rs9525239	chr13:114840960	A/G	cg21747549	chr13:114804483	RASA3	-0.62	-5.25	-0.51	1.29e-6	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs7959452	0.640	rs4761154	chr12:69705362	A/G	cg14784868	chr12:69753453	YEATS4	-0.72	-6.56	-0.6	5.31e-9	Blood protein levels;
SKCM	cis	rs2730245	1.000	rs2527199	chr7:158737113	G/A	cg24397884	chr7:158709396	WDR60	-1.03	-9.13	-0.72	5.94e-14	Height;
SKCM	cis	rs28595532	0.841	rs115924581	chr4:119786333	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs2153535	0.580	rs4587214	chr6:8454119	T/C	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs2072499	0.966	rs2253677	chr1:156171296	C/G	cg25208724	chr1:156163844	SLC25A44	-1.08	-10.29	-0.76	3.5e-16	Testicular germ cell tumor;
SKCM	cis	rs34172651	0.517	rs11642954	chr16:24824248	G/A	cg04756594	chr16:24857601	SLC5A11	0.71	5.04	0.5	2.92e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9913156	0.517	rs8069382	chr17:4612874	G/T	cg19197139	chr17:4613644	ARRB2	0.68	5.23	0.51	1.36e-6	Lymphocyte counts;
SKCM	cis	rs5769765	0.955	rs61136468	chr22:50312679	A/G	cg22709217	chr22:50311962	ALG12;CRELD2	-0.9	-5.94	-0.56	7.46e-8	Schizophrenia;
SKCM	cis	rs16854884	0.586	rs2011080	chr3:143756149	T/G	cg06585982	chr3:143692056	C3orf58	0.87	8.34	0.69	2.04e-12	Economic and political preferences (feminism/equality);
SKCM	cis	rs2839186	0.708	rs17183123	chr21:47671961	G/C	cg05896524	chr21:47604654	C21orf56	0.72	5.75	0.55	1.64e-7	Testicular germ cell tumor;
SKCM	cis	rs9543976	0.858	rs8192763	chr13:76179170	A/T	cg16409306	chr13:76195284	LMO7	0.84	4.79	0.48	7.87e-6	Diabetic retinopathy;
SKCM	cis	rs2120019	0.786	rs12911421	chr15:75287822	C/A	cg17294928	chr15:75287854	SCAMP5	0.92	9.59	0.74	7.92e-15	Blood trace element (Zn levels);
SKCM	cis	rs3771570	0.901	rs55811034	chr2:242406245	C/T	cg07612300	chr2:242033426	MTERFD2;SNED1	0.86	5.03	0.49	3.06e-6	Prostate cancer;
SKCM	cis	rs801193	1.000	rs2707845	chr7:66198798	C/T	cg11987759	chr7:65425863	GUSB	-0.69	-5.91	-0.56	8.69e-8	Aortic root size;
SKCM	cis	rs72634258	0.891	rs404381	chr1:8080745	C/T	cg00042356	chr1:8021962	PARK7	0.91	6.19	0.57	2.58e-8	Inflammatory bowel disease;
SKCM	cis	rs2153535	0.542	rs9393012	chr6:8439809	G/A	cg23788917	chr6:8435910	SLC35B3	0.69	5.14	0.5	1.99e-6	Motion sickness;
SKCM	cis	rs10193935	0.605	rs10169492	chr2:42401961	G/T	cg27598129	chr2:42591480	NA	-0.92	-6.79	-0.61	1.97e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9902453	1.000	rs9897206	chr17:28406108	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.81	-5.78	-0.55	1.45e-7	Coffee consumption (cups per day);
SKCM	cis	rs34172651	0.517	rs189919	chr16:24737741	G/A	cg04756594	chr16:24857601	SLC5A11	-0.72	-5.09	-0.5	2.4e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs17685	0.753	rs1637039	chr7:75693009	C/T	cg16684958	chr7:75615977	POR	0.59	5.63	0.54	2.69e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs10504229	0.639	rs2318145	chr8:58114867	A/G	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs801193	0.904	rs4718405	chr7:66254646	A/G	cg18876405	chr7:65276391	NA	0.82	7.48	0.65	9.41e-11	Aortic root size;
SKCM	cis	rs1799949	1.000	rs4793189	chr17:41190715	G/A	cg23758822	chr17:41437982	NA	0.91	7.51	0.65	8.13e-11	Menopause (age at onset);
SKCM	cis	rs861020	0.630	rs627069	chr1:210004613	C/G	cg05527609	chr1:210001259	C1orf107	0.86	6.74	0.61	2.43e-9	Orofacial clefts;
SKCM	cis	rs10256972	0.552	rs7805591	chr7:1210745	A/G	cg07092213	chr7:1199455	ZFAND2A	-0.68	-5.56	-0.53	3.57e-7	Longevity;Endometriosis;
SKCM	cis	rs1032355	0.558	rs76564762	chr4:100523402	C/T	cg25391692	chr4:100495869	MTTP	-0.95	-4.92	-0.49	4.68e-6	Celiac disease;
SKCM	cis	rs2479724	1.000	rs1536703	chr6:41852755	C/T	cg17623882	chr6:41773611	USP49	-0.68	-5.79	-0.55	1.41e-7	Menarche (age at onset);
SKCM	cis	rs6430585	1.000	rs6732236	chr2:136501509	T/G	cg07169764	chr2:136633963	MCM6	0.97	7.55	0.65	6.94e-11	Corneal structure;
SKCM	cis	rs1147199	0.531	rs1001905	chr9:87272519	A/G	cg13486759	chr9:86751815	NA	-0.63	-4.79	-0.48	7.93e-6	Body mass index;
SKCM	cis	rs933688	1.000	rs6869717	chr5:90694797	G/A	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.96	6.6	0.6	4.58e-9	Smoking behavior;
SKCM	cis	rs10751667	0.714	rs7395879	chr11:963855	G/C	cg10932868	chr11:921992	NA	0.55	5.1	0.5	2.36e-6	Alzheimer's disease (late onset);
SKCM	cis	rs651907	0.557	rs34947019	chr3:101532235	C/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.78	6.76	0.61	2.27e-9	Colorectal cancer;
SKCM	cis	rs7772486	0.686	rs702305	chr6:145973840	A/G	cg23711669	chr6:146136114	FBXO30	-0.9	-9.54	-0.73	9.76e-15	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs8180040	0.764	rs11708451	chr3:47198826	G/A	cg27129171	chr3:47204927	SETD2	0.82	6.44	0.59	9.04e-9	Colorectal cancer;
SKCM	cis	rs9916302	0.706	rs11655972	chr17:37407072	C/T	cg07936489	chr17:37558343	FBXL20	-0.98	-6.58	-0.6	4.83e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs7447593	0.518	rs4074995	chr5:176797343	C/T	cg06060754	chr5:176797920	RGS14	0.77	8.24	0.68	3.28e-12	Urinary electrolytes (magnesium/calcium ratio);
SKCM	cis	rs10256972	0.521	rs7457418	chr7:1110255	C/T	cg09177884	chr7:1199841	ZFAND2A	-0.63	-4.84	-0.48	6.44e-6	Longevity;Endometriosis;
SKCM	cis	rs778371	1.000	rs778371	chr2:233743109	A/G	cg08000102	chr2:233561755	GIGYF2	-0.79	-5.27	-0.51	1.18e-6	Schizophrenia;
SKCM	cis	rs13256369	0.774	rs11777719	chr8:8581038	A/G	cg06636001	chr8:8085503	FLJ10661	0.71	5.15	0.5	1.89e-6	Obesity-related traits;
SKCM	cis	rs28595532	0.920	rs114213539	chr4:119758794	G/C	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs1639906	0.893	rs13233298	chr7:2227707	C/T	cg02951883	chr7:2050386	MAD1L1	-0.6	-4.98	-0.49	3.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs59574136	1	rs59574136	chr7:2036460	T/C	cg21782813	chr7:2030301	MAD1L1	0.57	5.86	0.55	1.05e-7	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs651907	0.557	rs34181125	chr3:101490278	A/G	cg12386194	chr3:101231763	SENP7	0.66	5.34	0.52	8.97e-7	Colorectal cancer;
SKCM	cis	rs2839186	0.967	rs2839191	chr21:47695395	C/G	cg05896524	chr21:47604654	C21orf56	0.68	5.58	0.53	3.33e-7	Testicular germ cell tumor;
SKCM	trans	rs1814175	0.591	rs11040589	chr11:49862449	A/G	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs6546550	0.901	rs11893500	chr2:70154187	T/C	cg02498382	chr2:70120550	SNRNP27	-0.45	-4.88	-0.48	5.4e-6	Prevalent atrial fibrillation;
SKCM	cis	rs58688157	0.960	rs702966	chr11:611919	C/G	cg16486109	chr11:613632	IRF7	1.07	7.29	0.64	2.17e-10	Systemic lupus erythematosus;
SKCM	cis	rs8072100	1.000	rs3809868	chr17:45750596	G/A	cg08085267	chr17:45401833	C17orf57	0.64	5.93	0.56	7.83e-8	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs362272	0.545	rs2239725	chr4:3305739	C/T	cg03043834	chr4:3319541	RGS12	0.66	5.84	0.55	1.16e-7	Serum sulfate level;
SKCM	cis	rs2652834	1.000	rs2652833	chr15:63396885	C/A	cg04194852	chr15:63334506	TPM1	0.76	4.78	0.48	8.15e-6	HDL cholesterol;
SKCM	trans	rs1814175	0.817	rs7483795	chr11:49704930	G/A	cg03929089	chr4:120376271	NA	-0.9	-8.54	-0.7	8.58e-13	Height;
SKCM	cis	rs10754283	0.967	rs6663363	chr1:90116854	A/G	cg21401794	chr1:90099060	LRRC8C	0.73	6.31	0.58	1.57e-8	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs9300255	0.602	rs11057192	chr12:123693420	T/C	cg05973401	chr12:123451056	ABCB9	0.82	5.4	0.52	6.97e-7	Neutrophil percentage of white cells;
SKCM	cis	rs709400	0.930	rs2274268	chr14:104029378	C/G	cg26031613	chr14:104095156	KLC1	1.06	11.49	0.79	1.88e-18	Body mass index;
SKCM	cis	rs4132509	1.000	rs73124169	chr1:243804939	T/C	cg21452805	chr1:244014465	NA	0.85	5.44	0.52	5.97e-7	RR interval (heart rate);
SKCM	cis	rs2204008	0.774	rs2387811	chr12:38369794	C/A	cg26384229	chr12:38710491	ALG10B	0.87	6.82	0.61	1.73e-9	Bladder cancer;
SKCM	cis	rs6977660	0.660	rs13225400	chr7:19817016	A/G	cg05791153	chr7:19748676	TWISTNB	0.77	5.02	0.49	3.23e-6	Thyroid stimulating hormone;
SKCM	cis	rs2836974	0.899	rs114399588	chr21:40653958	G/A	cg11644478	chr21:40555479	PSMG1	0.97	10.08	0.75	8.76e-16	Cognitive function;
SKCM	cis	rs2180341	0.960	rs3756996	chr6:127664258	G/C	cg27446573	chr6:127587934	RNF146	0.94	8.06	0.67	7.08e-12	Breast cancer;
SKCM	cis	rs17376456	0.877	rs9314095	chr5:93425495	T/C	cg25358565	chr5:93447407	FAM172A	1.23	7.97	0.67	1.08e-11	Diabetic retinopathy;
SKCM	cis	rs7666738	0.830	rs10017557	chr4:98983969	G/A	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6500395	1.000	rs12447645	chr16:48694440	A/G	cg04672837	chr16:48644449	N4BP1	-0.65	-5.43	-0.52	6.29e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs7809950	0.678	rs75617662	chr7:107030439	G/A	cg23024343	chr7:107201750	COG5	-0.84	-7.33	-0.64	1.84e-10	Coronary artery disease;
SKCM	cis	rs7937682	0.960	rs480293	chr11:111469132	A/C	cg19812747	chr11:111475976	SIK2	-0.61	-4.94	-0.49	4.41e-6	Primary sclerosing cholangitis;
SKCM	cis	rs10489202	1.000	rs2420	chr1:167886502	A/T	cg24449463	chr1:168025552	DCAF6	-0.73	-5.27	-0.51	1.18e-6	Schizophrenia;
SKCM	cis	rs637571	0.522	rs550435	chr11:65732651	G/A	cg26695010	chr11:65641043	EFEMP2	-0.68	-5.2	-0.51	1.57e-6	Eosinophil percentage of white cells;
SKCM	cis	rs10504073	0.647	rs10957357	chr8:49988587	C/A	cg00325661	chr8:49890786	NA	0.78	6.77	0.61	2.18e-9	Blood metabolite ratios;
SKCM	cis	rs13256369	0.950	rs13270006	chr8:8574197	C/A	cg06636001	chr8:8085503	FLJ10661	0.72	5.31	0.52	9.88e-7	Obesity-related traits;
SKCM	cis	rs763014	0.898	rs916416	chr16:632198	T/A	cg09263875	chr16:632152	PIGQ	0.67	5.82	0.55	1.24e-7	Height;
SKCM	cis	rs62238980	0.614	rs75179575	chr22:32426433	C/G	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs72781680	0.752	rs72796130	chr2:23919740	T/C	cg08917208	chr2:24149416	ATAD2B	0.98	4.98	0.49	3.75e-6	Lymphocyte counts;
SKCM	cis	rs28386778	0.897	rs7222189	chr17:61836372	T/C	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.36	0.52	8.06e-7	Prudent dietary pattern;
SKCM	cis	rs4665809	0.590	rs4665840	chr2:26444962	C/T	cg26119090	chr2:26468346	HADHA;HADHB	-1.06	-8.39	-0.69	1.66e-12	Gut microbiome composition (summer);
SKCM	cis	rs3087591	0.960	rs2952984	chr17:29469614	T/C	cg24425628	chr17:29625626	OMG;NF1	0.63	4.96	0.49	4.03e-6	Hip circumference;
SKCM	cis	rs7989336	0.515	rs1925104	chr13:97019647	G/T	cg02788400	chr13:96296983	DZIP1	0.55	4.8	0.48	7.62e-6	Obesity;
SKCM	cis	rs1577917	0.959	rs2816822	chr6:86658292	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.67	-5.86	-0.55	1.07e-7	Response to antipsychotic treatment;
SKCM	cis	rs4819052	0.851	rs35560973	chr21:46662573	T/C	cg02159808	chr21:46707872	POFUT2;LOC642852	0.68	5.17	0.5	1.78e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs55962025	0.804	rs2071703	chr4:3241413	A/C	cg24015175	chr4:3319247	RGS12	-0.69	-5.92	-0.56	8.11e-8	Parental longevity (mother's age at death);
SKCM	cis	rs2228479	0.867	rs2270459	chr16:89979851	A/C	cg00800038	chr16:89945340	TCF25	0.85	5.19	0.51	1.65e-6	Skin colour saturation;
SKCM	cis	rs950027	0.620	rs1145076	chr15:45684508	G/T	cg10760299	chr15:45669010	GATM	0.57	5.71	0.54	1.99e-7	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs533581	0.844	rs564669	chr16:88968540	T/C	cg16701003	chr16:89028210	CBFA2T3	0.61	5.85	0.55	1.07e-7	Social autistic-like traits;
SKCM	cis	rs1395	0.925	rs1659701	chr2:27414877	T/C	cg14242246	chr2:27434262	C2orf28;SLC5A6	-0.47	-4.77	-0.48	8.27e-6	Blood metabolite levels;
SKCM	cis	rs4819052	0.851	rs2838856	chr21:46680766	T/G	cg19498844	chr21:46707878	POFUT2;LOC642852	0.9	7.98	0.67	1.04e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs9583531	0.600	rs7984468	chr13:111362093	C/A	cg15841412	chr13:111365552	ING1	0.73	4.88	0.48	5.56e-6	Coronary artery disease;
SKCM	cis	rs1799949	1.000	rs8176103	chr17:41267050	G/A	cg23758822	chr17:41437982	NA	0.97	8.1	0.68	5.94e-12	Menopause (age at onset);
SKCM	cis	rs4819052	0.851	rs2838864	chr21:46711474	A/T	cg19498844	chr21:46707878	POFUT2;LOC642852	-0.9	-7.67	-0.66	4.1e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs9300255	0.602	rs1790126	chr12:123683563	C/T	cg05973401	chr12:123451056	ABCB9	0.81	5.37	0.52	7.77e-7	Neutrophil percentage of white cells;
SKCM	cis	rs7044106	0.762	rs10760110	chr9:123412563	A/G	cg09419670	chr9:123605666	PSMD5;LOC253039	-0.55	-4.88	-0.48	5.59e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs3768617	0.510	rs10752904	chr1:183101038	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs4900538	0.819	rs72698595	chr14:102863099	G/A	cg18135206	chr14:102964638	TECPR2	-0.71	-5.36	-0.52	8.09e-7	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs4689592	0.513	rs4689586	chr4:7067413	A/G	cg19539972	chr4:7069911	GRPEL1	1.01	6.97	0.62	8.88e-10	Monocyte percentage of white cells;
SKCM	cis	rs7666738	0.830	rs28619044	chr4:98789814	G/C	cg17366294	chr4:99064904	C4orf37	0.57	4.86	0.48	6.02e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7959452	0.535	rs11615712	chr12:69619736	A/T	cg20891283	chr12:69753455	YEATS4	-0.61	-5.37	-0.52	7.85e-7	Blood protein levels;
SKCM	cis	rs4555082	0.830	rs2816614	chr14:105727359	C/T	cg13114125	chr14:105738426	BRF1	-0.69	-5.47	-0.53	5.33e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs3820068	0.581	rs3940061	chr1:15941276	C/T	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs12497850	0.931	rs9876848	chr3:48844059	G/A	cg07636037	chr3:49044803	WDR6	0.97	10.25	0.76	4.16e-16	Parkinson's disease;
SKCM	cis	rs11098499	0.657	rs10434028	chr4:120294464	T/G	cg09307838	chr4:120376055	NA	1.03	8.45	0.69	1.25e-12	Corneal astigmatism;
SKCM	cis	rs5769765	0.773	rs9616378	chr22:50311973	A/G	cg22709217	chr22:50311962	ALG12;CRELD2	-0.94	-5.91	-0.56	8.37e-8	Schizophrenia;
SKCM	cis	rs7927771	0.864	rs2868459	chr11:47454972	C/G	cg05585544	chr11:47624801	NA	-0.56	-4.79	-0.48	7.65e-6	Subjective well-being;
SKCM	cis	rs864745	0.967	rs849138	chr7:28177338	G/A	cg15170557	chr7:28214983	JAZF1	-0.66	-6.96	-0.62	9.39e-10	Crohn's disease;Type 2 diabetes;
SKCM	cis	rs9300255	0.739	rs1402275	chr12:123750895	A/G	cg00376283	chr12:123451042	ABCB9	0.82	5.63	0.54	2.74e-7	Neutrophil percentage of white cells;
SKCM	cis	rs6088580	0.634	rs6120642	chr20:33012531	A/G	cg24642439	chr20:33292090	TP53INP2	0.76	5.83	0.55	1.2e-7	Glomerular filtration rate (creatinine);
SKCM	cis	rs13118159	0.509	rs4974556	chr4:1358141	G/C	cg19318889	chr4:1322082	MAEA	0.77	5.52	0.53	4.34e-7	Longevity;
SKCM	cis	rs4268898	0.608	rs72793980	chr2:24428859	T/C	cg06627628	chr2:24431161	ITSN2	-0.75	-6.07	-0.57	4.39e-8	Asthma;
SKCM	cis	rs7027203	0.790	rs10123836	chr9:96584109	G/T	cg14598338	chr9:96623480	NA	-0.51	-5.09	-0.5	2.38e-6	DNA methylation (variation);
SKCM	cis	rs829883	0.966	rs249818	chr12:98896994	A/C	cg25150519	chr12:98850993	NA	0.5	5.3	0.51	1.07e-6	Colorectal adenoma (advanced);
SKCM	cis	rs9857592	1.000	rs9868600	chr3:16847424	T/C	cg17339521	chr3:16555597	RFTN1	0.56	4.87	0.48	5.71e-6	Neuroticism;
SKCM	cis	rs10779751	1.000	rs2016559	chr1:11269917	G/T	cg08854313	chr1:11322531	MTOR	0.87	6.47	0.59	7.89e-9	Body mass index;
SKCM	cis	rs28386778	0.897	rs1062787	chr17:61896004	T/C	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs7772486	0.790	rs9403756	chr6:146257761	C/G	cg05347473	chr6:146136440	FBXO30	-0.56	-5.02	-0.49	3.24e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1577917	0.958	rs1838958	chr6:86563968	G/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.81	-7.82	-0.66	2.07e-11	Response to antipsychotic treatment;
SKCM	cis	rs7811142	1.000	rs67239991	chr7:100046504	A/G	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.12	6.51	0.59	6.68e-9	Platelet count;
SKCM	cis	rs28386778	0.897	rs7207005	chr17:61860355	A/G	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs7590720	0.788	rs4674050	chr2:216907322	G/T	cg12620499	chr2:216877984	MREG	0.96	9.25	0.72	3.48e-14	Alcohol dependence;
SKCM	cis	rs9902453	0.845	rs12602426	chr17:28158815	T/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.8	5.4	0.52	6.96e-7	Coffee consumption (cups per day);
SKCM	cis	rs798554	0.796	rs2533884	chr7:2836848	T/G	cg04166393	chr7:2884313	GNA12	0.71	4.95	0.49	4.21e-6	Height;
SKCM	cis	rs9914544	0.933	rs11871889	chr17:18771425	T/C	cg26306683	chr17:18585705	ZNF286B	0.71	5.13	0.5	2.06e-6	Educational attainment (years of education);
SKCM	cis	rs875971	0.830	rs587360	chr7:65522698	C/A	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.54	5.01	0.49	3.28e-6	Aortic root size;
SKCM	cis	rs6582630	0.513	rs11181246	chr12:38302670	C/T	cg26384229	chr12:38710491	ALG10B	0.81	6.57	0.6	5.18e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs2730245	0.527	rs1188974	chr7:158665748	C/T	cg24397884	chr7:158709396	WDR60	0.87	5.0	0.49	3.39e-6	Height;
SKCM	cis	rs1797081	0.967	rs780633	chr10:16863161	C/T	cg23933602	chr10:16859644	RSU1	0.99	15.14	0.86	6.28e-25	Platelet distribution width;
SKCM	cis	rs7809950	0.678	rs7788271	chr7:106985873	A/G	cg23024343	chr7:107201750	COG5	-0.82	-7.0	-0.62	7.72e-10	Coronary artery disease;
SKCM	cis	rs6951245	1.000	rs6951245	chr7:1058193	G/A	cg24642844	chr7:1081250	C7orf50	-0.95	-6.39	-0.59	1.13e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs2991971	0.934	rs11211129	chr1:45983080	C/T	cg24296786	chr1:45957014	TESK2	0.67	5.4	0.52	6.86e-7	High light scatter reticulocyte count;
SKCM	cis	rs13118159	0.505	rs1250128	chr4:1257311	T/C	cg02018176	chr4:1364513	KIAA1530	-0.8	-6.5	-0.59	7.02e-9	Longevity;
SKCM	cis	rs4423214	0.840	rs3794057	chr11:71186744	G/A	cg05163923	chr11:71159392	DHCR7	-0.71	-6.07	-0.57	4.35e-8	Vitamin D levels;
SKCM	cis	rs28595532	0.920	rs114462478	chr4:119752656	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs6570726	0.935	rs7757387	chr6:145816726	G/T	cg23711669	chr6:146136114	FBXO30	0.68	6.53	0.59	6.07e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs8017423	0.935	rs11624295	chr14:90695612	T/G	cg04374321	chr14:90722782	PSMC1	0.97	8.7	0.7	4.05e-13	Mortality in heart failure;
SKCM	cis	rs711830	1.000	rs6433571	chr2:177039578	G/T	cg13092806	chr2:177043255	NA	0.66	5.91	0.56	8.57e-8	Serous invasive ovarian cancer;Epithelial ovarian cancer;Invasive epithelial ovarian cancer;Mucinous ovarian carcinoma;Low-grade serous and serous borderline ovarian cancer;Serous borderline ovarian cancer;High-grade serous ovarian cancer;
SKCM	cis	rs9682041	0.561	rs6790483	chr3:170154406	G/A	cg11886554	chr3:170076028	SKIL	0.87	5.1	0.5	2.32e-6	Glomerular filtration rate in non diabetics (creatinine);Glomerular filtration rate (creatinine);
SKCM	cis	rs763014	0.898	rs35666389	chr16:629458	A/G	cg07343612	chr16:622815	PIGQ	-0.7	-6.0	-0.56	5.8e-8	Height;
SKCM	cis	rs1029738	0.615	rs3757447	chr7:22894735	A/T	cg22407942	chr7:22894828	SNORD93	-0.56	-5.02	-0.49	3.17e-6	Fibrinogen levels;
SKCM	cis	rs9435341	0.930	rs61798463	chr1:107565934	G/A	cg09367891	chr1:107599246	PRMT6	0.82	6.58	0.6	4.8e-9	Facial morphology (factor 21, depth of nasal alae);
SKCM	cis	rs9325144	0.600	rs2171405	chr12:38741030	G/T	cg13010199	chr12:38710504	ALG10B	-0.66	-5.38	-0.52	7.7300000000000005e-07	Morning vs. evening chronotype;
SKCM	cis	rs7811142	0.945	rs6974282	chr7:100098295	C/T	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.11	6.3	0.58	1.66e-8	Platelet count;
SKCM	cis	rs1912528	0.963	rs13150296	chr4:140933504	G/A	cg11128457	chr4:140864437	MAML3	0.58	4.82	0.48	6.87e-6	Educational attainment (years of education);
SKCM	cis	rs1348850	0.632	rs1405718	chr2:178499809	C/T	cg02961200	chr2:178257176	LOC100130691;AGPS	0.74	4.97	0.49	3.9e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs2929278	0.617	rs694461	chr15:44096063	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	-0.73	-5.07	-0.5	2.58e-6	Schizophrenia;
SKCM	cis	rs7772486	0.905	rs9373486	chr6:146446024	C/G	cg23711669	chr6:146136114	FBXO30	-0.66	-5.56	-0.53	3.63e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs3008870	1.000	rs2065001	chr1:67486509	C/G	cg08660285	chr1:67390436	MIER1;WDR78	0.91	6.05	0.56	4.78e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs2739330	0.791	rs9612520	chr22:24269459	G/T	cg12419862	chr22:24373484	LOC391322	-0.83	-8.07	-0.67	6.84e-12	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs9916302	0.660	rs665413	chr17:37455678	T/A	cg07936489	chr17:37558343	FBXL20	1.0	7.19	0.63	3.42e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs1003719	0.788	rs4572679	chr21:38453227	T/C	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs738322	0.574	rs28653361	chr22:38570700	C/A	cg25457927	chr22:38595422	NA	-0.6	-7.08	-0.63	5.46e-10	Cutaneous nevi;
SKCM	cis	rs6430585	0.591	rs4585083	chr2:136486342	C/T	cg07169764	chr2:136633963	MCM6	1.15	8.6	0.7	6.43e-13	Corneal structure;
SKCM	cis	rs507080	0.922	rs546890	chr11:118557198	T/C	cg18045108	chr11:118530628	TREH	-0.47	-4.81	-0.48	7.24e-6	Serum metabolite levels;
SKCM	cis	rs17685	0.753	rs7788763	chr7:75651665	T/C	cg01364799	chr7:75623366	TMEM120A	0.67	5.14	0.5	1.98e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs11098499	0.908	rs12504149	chr4:120318577	G/A	cg24375607	chr4:120327624	NA	0.65	4.97	0.49	3.87e-6	Corneal astigmatism;
SKCM	cis	rs6921919	0.583	rs6899389	chr6:28381140	C/A	cg14547644	chr6:28411285	ZSCAN23	-0.58	-4.8	-0.48	7.46e-6	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs2404602	0.530	rs12915184	chr15:76965922	G/A	cg23625390	chr15:77176239	SCAPER	-0.86	-8.0	-0.67	9.21e-12	Blood metabolite levels;
SKCM	cis	rs1185460	0.967	rs1784459	chr11:118938388	C/A	cg23280166	chr11:118938394	VPS11	0.59	5.41	0.52	6.78e-7	Coronary artery disease;
SKCM	cis	rs909341	0.678	rs6011018	chr20:62303622	T/G	cg03999872	chr20:62272968	STMN3	0.54	4.79	0.48	7.9e-6	Atopic dermatitis;
SKCM	cis	rs7523273	1.000	rs1142469	chr1:207965427	G/A	cg22525895	chr1:207977042	MIR29B2	-0.8	-5.96	-0.56	6.91e-8	Schizophrenia;
SKCM	cis	rs7937682	0.824	rs577044	chr11:111490420	G/T	cg09085632	chr11:111637200	PPP2R1B	-0.96	-9.87	-0.75	2.29e-15	Primary sclerosing cholangitis;
SKCM	cis	rs2842992	0.830	rs752779	chr6:160133957	G/A	cg19482086	chr6:160211437	TCP1;MRPL18	0.79	5.86	0.55	1.07e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs28595532	0.920	rs114653217	chr4:119769216	G/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs875971	0.965	rs6971509	chr7:65714970	G/T	cg11764359	chr7:65958608	NA	-0.88	-8.55	-0.7	7.89e-13	Aortic root size;
SKCM	cis	rs4891159	0.584	rs689878	chr18:74152017	C/T	cg24786174	chr18:74118243	ZNF516	0.78	8.02	0.67	8.74e-12	Longevity;
SKCM	cis	rs4746818	1.000	rs7091695	chr10:70964997	A/G	cg11621586	chr10:70884670	VPS26A	-0.97	-5.84	-0.55	1.15e-7	Left atrial antero-posterior diameter;
SKCM	cis	rs72781680	0.898	rs72790310	chr2:24116716	C/T	cg08917208	chr2:24149416	ATAD2B	0.99	5.24	0.51	1.31e-6	Lymphocyte counts;
SKCM	cis	rs4865169	0.560	rs1277311	chr4:57902761	C/T	cg16868167	chr4:57843880	C4orf14;POLR2B	0.64	4.99	0.49	3.65e-6	Breast cancer;
SKCM	cis	rs6951245	1.000	rs78185801	chr7:1096367	G/A	cg18402987	chr7:1209562	NA	1.15	6.09	0.57	3.95e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs4481887	1.000	rs4489592	chr1:248470697	A/T	cg00666640	chr1:248458726	OR2T12	0.64	5.69	0.54	2.13e-7	Common traits (Other);
SKCM	cis	rs507080	0.922	rs585039	chr11:118563381	C/A	cg18045108	chr11:118530628	TREH	-0.47	-4.81	-0.48	7.17e-6	Serum metabolite levels;
SKCM	cis	rs11112613	0.775	rs7299470	chr12:105961773	G/A	cg03607813	chr12:105948248	NA	0.85	5.58	0.53	3.31e-7	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;
SKCM	cis	rs2952156	0.684	rs931992	chr17:37821435	G/T	cg20243544	chr17:37824526	PNMT	0.71	5.53	0.53	4.12e-7	Asthma;
SKCM	cis	rs875971	0.660	rs79009421	chr7:66068509	G/C	cg00343986	chr7:65444356	GUSB	-0.68	-4.99	-0.49	3.65e-6	Aortic root size;
SKCM	cis	rs4242434	0.819	rs1059592	chr8:22477778	G/A	cg03733263	chr8:22462867	KIAA1967	0.96	7.65	0.65	4.4e-11	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs362296	0.550	rs3135064	chr4:3285389	T/C	cg16987761	chr4:3318072	RGS12	0.71	6.2	0.57	2.54e-8	Parental longevity (mother's age at death);
SKCM	cis	rs10256972	0.521	rs7457418	chr7:1110255	C/T	cg11360546	chr7:1094263	C7orf50	-0.42	-4.85	-0.48	6.09e-6	Longevity;Endometriosis;
SKCM	cis	rs7523273	1.000	rs34385765	chr1:207993637	A/G	cg22525895	chr1:207977042	MIR29B2	-0.78	-5.76	-0.55	1.57e-7	Schizophrenia;
SKCM	cis	rs12464559	0.649	rs77285017	chr2:152705927	T/A	cg01189475	chr2:152685088	ARL5A	-1.37	-5.53	-0.53	4.18e-7	Response to cognitive-behavioural therapy in anxiety disorder;
SKCM	cis	rs2652834	1.000	rs2652816	chr15:63403368	C/T	cg04194852	chr15:63334506	TPM1	0.75	4.93	0.49	4.55e-6	HDL cholesterol;
SKCM	trans	rs7618501	1.000	rs7648987	chr3:49868455	A/G	cg21659725	chr3:3221576	CRBN	0.96	9.43	0.73	1.59e-14	Intelligence (multi-trait analysis);
SKCM	cis	rs2153535	0.601	rs4140585	chr6:8503298	T/A	cg07606381	chr6:8435919	SLC35B3	0.86	6.25	0.58	2.06e-8	Motion sickness;
SKCM	cis	rs2153535	0.541	rs9392222	chr6:8467649	G/A	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs2070488	0.766	rs4679050	chr3:38482007	G/A	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.72	5.78	0.55	1.46e-7	Electrocardiographic conduction measures;
SKCM	cis	rs28595532	0.920	rs114162429	chr4:119741078	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs2204008	0.837	rs11172728	chr12:38070042	C/A	cg26384229	chr12:38710491	ALG10B	0.81	6.83	0.61	1.69e-9	Bladder cancer;
SKCM	cis	rs12586317	0.620	rs76293361	chr14:35570889	G/A	cg16230307	chr14:35515116	FAM177A1	0.7	5.12	0.5	2.16e-6	Psoriasis;
SKCM	cis	rs9896933	0.614	rs3785511	chr17:80886316	G/T	cg20578329	chr17:80767326	TBCD	0.89	5.69	0.54	2.1e-7	Bone mineral accretion in asthma (oral corticosteroid dose interaction);
SKCM	cis	rs778371	0.874	rs938575	chr2:233768788	G/A	cg08000102	chr2:233561755	GIGYF2	-0.74	-4.91	-0.49	4.85e-6	Schizophrenia;
SKCM	cis	rs7020830	0.898	rs13290794	chr9:37183628	C/T	cg14294708	chr9:37120828	ZCCHC7	1.04	10.86	0.78	2.9e-17	Schizophrenia;
SKCM	cis	rs2153535	0.541	rs9328471	chr6:8468842	T/C	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs4819052	0.851	rs2838833	chr21:46665160	C/T	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.41	0.52	6.6e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs17685	0.671	rs10274404	chr7:75706634	G/A	cg01364799	chr7:75623366	TMEM120A	-0.72	-5.81	-0.55	1.31e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs250585	0.667	rs446056	chr16:23600013	G/A	cg09934309	chr16:23461721	COG7	-0.94	-6.18	-0.57	2.76e-8	Egg allergy;
SKCM	cis	rs1799949	1.000	rs1824889	chr17:41421876	C/G	cg23758822	chr17:41437982	NA	0.93	7.88	0.67	1.62e-11	Menopause (age at onset);
SKCM	cis	rs9761603	0.662	rs9761827	chr4:138416511	G/A	cg12033966	chr4:138453416	PCDH18	0.56	4.81	0.48	7.24e-6	Diastolic blood pressure;
SKCM	cis	rs867186	1.000	rs8119827	chr20:33726873	C/T	cg04194272	chr20:33683537	NA	-1.11	-6.01	-0.56	5.7e-8	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs56104184	0.775	rs73061695	chr19:49399988	T/C	cg19746536	chr19:49375674	PPP1R15A	1.16	5.93	0.56	7.67e-8	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs9905704	0.647	rs33922512	chr17:57114148	C/G	cg05425664	chr17:57184151	TRIM37	0.58	4.8	0.48	7.36e-6	Testicular germ cell tumor;
SKCM	cis	rs2836974	0.568	rs7282604	chr21:40536910	C/T	cg17971929	chr21:40555470	PSMG1	-0.76	-7.35	-0.64	1.71e-10	Cognitive function;
SKCM	cis	rs3091242	0.933	rs926438	chr1:25753638	C/T	cg02931644	chr1:25747376	RHCE	0.54	5.43	0.52	6.26e-7	Erythrocyte sedimentation rate;
SKCM	cis	rs2013441	1.000	rs2703817	chr17:20119677	A/C	cg13482628	chr17:19912719	NA	-0.65	-5.06	-0.5	2.69e-6	Obesity-related traits;
SKCM	cis	rs9926296	0.605	rs6500449	chr16:89856393	T/C	cg04287289	chr16:89883240	FANCA	1.03	11.38	0.79	2.98e-18	Vitiligo;
SKCM	cis	rs769267	1.000	rs7247309	chr19:19439631	A/T	cg26732615	chr19:19648335	CILP2;YJEFN3	-0.65	-6.08	-0.57	4.12e-8	Tonsillectomy;
SKCM	cis	rs2760061	0.598	rs849904	chr1:228137145	G/C	cg02753203	chr1:228287806	NA	-0.62	-5.02	-0.49	3.13e-6	Diastolic blood pressure;
SKCM	cis	rs28595532	0.920	rs112097820	chr4:119746532	G/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs7666738	0.830	rs7678567	chr4:99057346	A/G	cg17366294	chr4:99064904	C4orf37	0.61	4.93	0.49	4.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs34375054	0.525	rs7133864	chr12:125606180	C/T	cg25124228	chr12:125621409	AACS	-0.8	-6.56	-0.6	5.45e-9	Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs1005277	0.505	rs1208689	chr10:38097775	C/G	cg25427524	chr10:38739819	LOC399744	-0.68	-6.52	-0.59	6.36e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs801193	0.844	rs2244022	chr7:66202430	A/G	cg18876405	chr7:65276391	NA	0.79	6.84	0.61	1.56e-9	Aortic root size;
SKCM	cis	rs668210	0.739	rs543952	chr11:65744275	T/C	cg20909159	chr11:65625947	CFL1	-0.79	-5.13	-0.5	2.05e-6	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs936229	0.861	rs7176022	chr15:75107880	G/T	cg14664628	chr15:75095509	CSK	1.16	10.49	0.77	1.43e-16	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin);
SKCM	cis	rs17685	0.753	rs10251863	chr7:75790192	T/C	cg16684958	chr7:75615977	POR	0.53	5.3	0.51	1.06e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs6424115	0.867	rs2501432	chr1:24201920	T/C	cg15997130	chr1:24165203	NA	0.6	4.94	0.49	4.37e-6	Immature fraction of reticulocytes;
SKCM	cis	rs6952808	0.609	rs6950151	chr7:1953521	T/C	cg02951883	chr7:2050386	MAD1L1	-0.66	-5.58	-0.53	3.29e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs28595532	0.841	rs114123875	chr4:119733408	A/G	cg21605333	chr4:119757512	SEC24D	1.36	8.05	0.67	7.69e-12	Cannabis dependence symptom count;
SKCM	cis	rs910316	1.000	rs13099	chr14:75599155	G/A	cg11812906	chr14:75593930	NEK9	-0.72	-5.45	-0.53	5.72e-7	Height;
SKCM	cis	rs2153535	0.601	rs2327091	chr6:8540369	G/A	cg23788917	chr6:8435910	SLC35B3	0.69	4.92	0.49	4.79e-6	Motion sickness;
SKCM	cis	rs9739070	1	rs9739070	chr12:123771032	A/G	cg05973401	chr12:123451056	ABCB9	0.82	5.72	0.54	1.92e-7	Allergy;
SKCM	cis	rs1805008	0.535	rs4785621	chr16:90130735	C/T	cg08547343	chr16:90038815	CENPBD1;AFG3L1	-0.97	-5.09	-0.5	2.37e-6	Skin colour saturation;
SKCM	cis	rs9300255	0.602	rs1790131	chr12:123701010	G/T	cg05973401	chr12:123451056	ABCB9	0.81	5.37	0.52	7.77e-7	Neutrophil percentage of white cells;
SKCM	cis	rs2153535	0.580	rs7743418	chr6:8438128	A/C	cg07606381	chr6:8435919	SLC35B3	0.93	6.77	0.61	2.18e-9	Motion sickness;
SKCM	cis	rs1023500	0.573	rs2269524	chr22:42475703	T/G	cg04733989	chr22:42467013	NAGA	-0.72	-5.72	-0.54	1.9e-7	Schizophrenia;
SKCM	cis	rs1801251	1.000	rs4517962	chr2:233578337	T/C	cg08000102	chr2:233561755	GIGYF2	0.89	6.91	0.62	1.15e-9	Coronary artery disease;
SKCM	cis	rs9916302	0.706	rs9909304	chr17:37500508	G/T	cg07936489	chr17:37558343	FBXL20	0.98	6.84	0.61	1.56e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs738321	0.725	rs5756926	chr22:38542613	T/C	cg25457927	chr22:38595422	NA	-0.58	-6.71	-0.61	2.75e-9	Breast cancer;
SKCM	cis	rs514406	0.644	rs1855127	chr1:53199594	A/G	cg16325326	chr1:53192061	ZYG11B	-0.86	-9.02	-0.71	9.97e-14	Monocyte count;
SKCM	cis	rs9951698	0.693	rs9949682	chr18:12999821	C/T	cg12848697	chr18:13133368	NA	0.53	4.9	0.48	5.18e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1153858	1.000	rs12909158	chr15:45621174	A/G	cg10760299	chr15:45669010	GATM	0.56	5.36	0.52	8.35e-7	Homoarginine levels;
SKCM	cis	rs7552404	0.924	rs1303169	chr1:76195041	T/C	cg10523679	chr1:76189770	ACADM	0.7	5.18	0.51	1.72e-6	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs4930103	0.619	rs10769945	chr11:1985127	C/T	cg23202291	chr11:1979235	NA	0.66	6.88	0.61	1.32e-9	DNA methylation (parent-of-origin);DNA methylation (variation);
SKCM	cis	rs7772486	0.686	rs6570705	chr6:145961201	C/T	cg23711669	chr6:146136114	FBXO30	0.9	10.02	0.75	1.16e-15	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs62103177	0.535	rs34299914	chr18:77949236	C/A	cg27393146	chr18:77495563	CTDP1	-0.81	-5.53	-0.53	4.15e-7	Opioid sensitivity;
SKCM	cis	rs1577917	1.000	rs6923148	chr6:86767786	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.77	7.45	0.64	1.1e-10	Response to antipsychotic treatment;
SKCM	cis	rs8014204	0.806	rs11159105	chr14:75298052	C/T	cg06637938	chr14:75390232	RPS6KL1	0.83	6.65	0.6	3.64e-9	Caffeine consumption;
SKCM	cis	rs875971	0.540	rs781152	chr7:65479572	T/A	cg11764359	chr7:65958608	NA	0.87	6.57	0.6	5.09e-9	Aortic root size;
SKCM	cis	rs17065868	0.803	rs7320306	chr13:45197429	A/G	cg10246903	chr13:45222710	NA	0.95	5.35	0.52	8.5e-7	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs6121246	0.559	rs6087771	chr20:30306724	A/G	cg11595048	chr20:30225325	COX4I2	0.54	4.77	0.48	8.4e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs6088590	1.000	rs6088595	chr20:33358499	T/A	cg24642439	chr20:33292090	TP53INP2	0.96	6.62	0.6	4.07e-9	Coronary artery disease;
SKCM	cis	rs1218582	0.741	rs10908446	chr1:154869559	G/A	cg06221963	chr1:154839813	KCNN3	-0.59	-5.97	-0.56	6.76e-8	Prostate cancer;
SKCM	cis	rs35306767	0.715	rs17221456	chr10:1037234	T/C	cg26597838	chr10:835615	NA	0.71	5.89	0.55	9.38e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs28595532	0.920	rs114659035	chr4:119740028	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs6062496	0.587	rs3787102	chr20:62295943	C/T	cg27236539	chr20:62289627	RTEL1	0.72	4.95	0.49	4.16e-6	Crohn's disease;Inflammatory bowel disease;Ulcerative colitis;
SKCM	cis	rs769267	0.965	rs1469712	chr19:19528821	C/A	cg03709012	chr19:19516395	GATAD2A	0.9	8.51	0.69	9.68e-13	Tonsillectomy;
SKCM	cis	rs561341	1.000	rs537166	chr17:30326827	C/T	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs2836974	0.899	rs34433511	chr21:40618883	A/C	cg17971929	chr21:40555470	PSMG1	0.9	8.81	0.71	2.52e-13	Cognitive function;
SKCM	cis	rs6570726	0.818	rs437147	chr6:145875423	A/T	cg23711669	chr6:146136114	FBXO30	0.87	9.14	0.72	5.82e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2033711	0.870	rs7408188	chr19:58939389	T/G	cg03735888	chr19:58951602	ZNF132	0.7	6.08	0.57	4.23e-8	Uric acid clearance;
SKCM	cis	rs7666738	0.830	rs13112037	chr4:98976986	A/T	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs798554	0.679	rs2527681	chr7:2892384	A/T	cg19346786	chr7:2764209	NA	-0.66	-6.62	-0.6	4.06e-9	Height;
SKCM	cis	rs6089829	0.962	rs6089825	chr20:61668447	C/T	cg08564027	chr20:61660810	NA	0.63	5.68	0.54	2.21e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs2404602	0.669	rs12595313	chr15:76978370	A/G	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs61935443	0.720	rs10859780	chr12:95282601	T/C	cg21533806	chr12:95267307	NA	0.94	5.46	0.53	5.46e-7	Schizophrenia;
SKCM	trans	rs561341	1.000	rs15654	chr17:30326360	A/C	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs7208859	0.623	rs76633166	chr17:29113365	C/T	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs2952156	0.883	rs12150603	chr17:37834715	G/A	cg20243544	chr17:37824526	PNMT	0.69	5.56	0.53	3.67e-7	Asthma;
SKCM	cis	rs11764590	0.694	rs7797112	chr7:2085165	T/C	cg02825527	chr7:2087843	MAD1L1	-0.65	-5.12	-0.5	2.17e-6	Neuroticism;
SKCM	cis	rs1577917	0.958	rs10944147	chr6:86550786	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.87	-8.71	-0.7	3.92e-13	Response to antipsychotic treatment;
SKCM	cis	rs10504229	1.000	rs61998258	chr8:58192284	T/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs11098499	0.863	rs7695620	chr4:120452776	G/A	cg09307838	chr4:120376055	NA	0.97	7.66	0.66	4.19e-11	Corneal astigmatism;
SKCM	cis	rs1403694	0.695	rs3821815	chr3:186434262	A/G	cg09332604	chr3:186435400	KNG1	-0.49	-4.89	-0.48	5.2e-6	Blood protein levels;
SKCM	cis	rs9420	0.961	rs10896647	chr11:57571883	C/T	cg19752551	chr11:57585705	CTNND1	-0.71	-7.2	-0.63	3.22e-10	Schizophrenia;
SKCM	cis	rs2760061	0.819	rs964941	chr1:228193857	G/A	cg18477163	chr1:228402036	OBSCN	0.48	5.65	0.54	2.56e-7	Diastolic blood pressure;
SKCM	trans	rs561341	0.830	rs2301765	chr17:30202056	T/A	cg20587970	chr11:113659929	NA	1.07	8.37	0.69	1.77e-12	Hip circumference adjusted for BMI;
SKCM	cis	rs6724607	0.905	rs10173771	chr2:191439248	T/C	cg21644426	chr2:191273491	MFSD6	0.7	4.93	0.49	4.6e-6	Pulse pressure;
SKCM	cis	rs35306767	0.761	rs11253559	chr10:1044809	T/C	cg25614935	chr10:1084866	C10orf110	0.76	6.0	0.56	5.95e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs1799949	0.965	rs33961729	chr17:41287924	C/A	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.11	-0.57	3.67e-8	Menopause (age at onset);
SKCM	cis	rs2404602	0.511	rs12148386	chr15:77254544	T/C	cg23625390	chr15:77176239	SCAPER	0.63	5.26	0.51	1.22e-6	Blood metabolite levels;
SKCM	cis	rs5769765	0.955	rs9616368	chr22:50303533	C/G	cg22709217	chr22:50311962	ALG12;CRELD2	-0.93	-5.88	-0.55	9.84e-8	Schizophrenia;
SKCM	cis	rs365132	1.000	rs365132	chr5:176378574	G/T	cg16309518	chr5:176445507	NA	-0.52	-5.0	-0.49	3.47e-6	Menarche and menopause (age at onset);Menopause (age at onset);
SKCM	cis	rs826838	1.000	rs10880914	chr12:38720543	C/T	cg26384229	chr12:38710491	ALG10B	1.09	10.33	0.76	2.97e-16	Heart rate;
SKCM	cis	rs9420	0.961	rs12805841	chr11:57443842	G/A	cg19752551	chr11:57585705	CTNND1	-0.7	-6.97	-0.62	9.17e-10	Schizophrenia;
SKCM	cis	rs1577917	0.682	rs1173419	chr6:86402163	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.89	-9.15	-0.72	5.46e-14	Response to antipsychotic treatment;
SKCM	cis	rs28386778	0.863	rs894414	chr17:61916384	T/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs10256972	0.539	rs2949174	chr7:1213923	T/C	cg07092213	chr7:1199455	ZFAND2A	-0.67	-5.39	-0.52	7.39e-7	Longevity;Endometriosis;
SKCM	cis	rs826838	0.678	rs11182781	chr12:38610178	C/T	cg26384229	chr12:38710491	ALG10B	0.81	6.79	0.61	1.94e-9	Heart rate;
SKCM	cis	rs651907	0.557	rs7629753	chr3:101371922	C/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	-0.78	-6.75	-0.61	2.4e-9	Colorectal cancer;
SKCM	cis	rs6951245	1.000	rs79683221	chr7:1096139	A/G	cg24642844	chr7:1081250	C7orf50	-0.93	-6.22	-0.58	2.28e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs514406	0.929	rs2607095	chr1:53325639	T/C	cg16325326	chr1:53192061	ZYG11B	0.94	10.05	0.75	1.02e-15	Monocyte count;
SKCM	cis	rs2228479	0.867	rs73276534	chr16:89950557	A/G	cg06558623	chr16:89946397	TCF25	1.25	7.23	0.63	2.87e-10	Skin colour saturation;
SKCM	cis	rs9880211	0.800	rs28390205	chr3:136364850	C/G	cg21827317	chr3:136751795	NA	-0.7	-5.43	-0.52	6.12e-7	Body mass index;Height;
SKCM	cis	rs11690935	0.959	rs75922913	chr2:172620152	T/C	cg13550731	chr2:172543902	DYNC1I2	-0.94	-7.71	-0.66	3.41e-11	Schizophrenia;
SKCM	cis	rs67311347	1.000	rs9874499	chr3:40441908	C/T	cg00091569	chr3:40428383	ENTPD3	0.64	5.47	0.53	5.17e-7	Renal cell carcinoma;
SKCM	trans	rs561341	0.882	rs2521594	chr17:30302087	C/T	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs2662368	0.521	rs62364881	chr5:77090927	G/A	cg06972615	chr5:77081292	NA	0.59	4.93	0.49	4.58e-6	Platelet distribution width;
SKCM	cis	rs7772486	0.597	rs2246132	chr6:146182515	C/G	cg23711669	chr6:146136114	FBXO30	0.8	7.2	0.63	3.25e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9486715	0.867	rs3860243	chr6:96905303	T/G	cg06623918	chr6:96969491	KIAA0776	0.84	7.41	0.64	1.29e-10	Headache;
SKCM	cis	rs6582630	0.555	rs10880625	chr12:38526612	A/C	cg26384229	chr12:38710491	ALG10B	0.83	6.59	0.6	4.61e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs2204008	0.627	rs10878486	chr12:38148601	T/G	cg26384229	chr12:38710491	ALG10B	0.82	6.46	0.59	8.2e-9	Bladder cancer;
SKCM	cis	rs2204008	0.837	rs73112346	chr12:38357606	C/T	cg26384229	chr12:38710491	ALG10B	0.87	6.82	0.61	1.73e-9	Bladder cancer;
SKCM	cis	rs1218582	0.803	rs7531728	chr1:154840516	C/A	cg16680214	chr1:154839983	KCNN3	-0.54	-5.01	-0.49	3.36e-6	Prostate cancer;
SKCM	cis	rs9420	0.961	rs7121169	chr11:57452543	G/A	cg19752551	chr11:57585705	CTNND1	-0.7	-6.97	-0.62	9.17e-10	Schizophrenia;
SKCM	cis	rs4905558	0.927	rs8013081	chr14:97283686	T/C	cg11863609	chr14:97355128	NA	-0.55	-4.79	-0.48	7.83e-6	Neutrophil count;
SKCM	cis	rs1065656	0.553	rs344360	chr16:1839221	T/C	cg26897989	chr16:1907736	C16orf73	0.62	6.45	0.59	8.73e-9	Insulin-like growth factors;
SKCM	cis	rs1538970	0.924	rs12097497	chr1:45880669	C/T	cg05343316	chr1:45956843	TESK2	0.92	4.97	0.49	3.9e-6	Platelet count;
SKCM	cis	rs9916302	0.851	rs11657899	chr17:37626963	G/A	cg07936489	chr17:37558343	FBXL20	-0.9	-8.1	-0.68	6.05e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs7666738	0.830	rs7657497	chr4:99044028	A/G	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11155671	0.530	rs7742993	chr6:150205095	G/A	cg09699651	chr6:150184138	LRP11	0.56	4.83	0.48	6.66e-6	Testicular germ cell tumor;
SKCM	trans	rs9929218	0.529	rs2296404	chr16:68729525	C/T	cg04657470	chr2:198365150	HSPE1;HSPD1	0.96	9.4	0.73	1.79e-14	Colorectal cancer;
SKCM	cis	rs2439831	0.850	rs12101756	chr15:44053887	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.35	7.75	0.66	2.9e-11	Lung cancer in ever smokers;
SKCM	cis	rs951366	1.000	rs4951261	chr1:205717823	A/C	cg11965913	chr1:205819406	PM20D1	-0.63	-4.8	-0.48	7.52e-6	Menarche (age at onset);
SKCM	cis	rs2811415	0.569	rs1057220	chr3:127799983	A/C	cg09089421	chr3:127803668	RUVBL1	1.0	8.69	0.7	4.4e-13	Lung function (FEV1/FVC);
SKCM	cis	rs6461049	0.800	rs3800913	chr7:2163237	A/G	cg02951883	chr7:2050386	MAD1L1	-0.72	-6.5	-0.59	6.89e-9	Schizophrenia;
SKCM	cis	rs9926296	0.744	rs460984	chr16:89713174	C/T	cg01097406	chr16:89675127	NA	0.56	5.67	0.54	2.31e-7	Vitiligo;
SKCM	cis	rs4905558	1.000	rs4270096	chr14:97315536	C/T	cg11863609	chr14:97355128	NA	-0.54	-4.88	-0.48	5.52e-6	Neutrophil count;
SKCM	cis	rs8177179	0.967	rs4443173	chr3:133439378	A/G	cg16262614	chr3:133464971	TF	0.43	5.47	0.53	5.22e-7	Iron status biomarkers (transferrin levels);
SKCM	cis	rs9911578	0.967	rs8075786	chr17:56819216	T/C	cg05425664	chr17:57184151	TRIM37	-0.69	-5.21	-0.51	1.52e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs10256972	0.539	rs2949174	chr7:1213923	T/C	cg09177884	chr7:1199841	ZFAND2A	-0.71	-5.45	-0.52	5.8e-7	Longevity;Endometriosis;
SKCM	cis	rs644799	0.710	rs12273579	chr11:95524421	G/A	cg03916912	chr11:95522834	CEP57;FAM76B	0.8	6.71	0.6	2.8e-9	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs801193	0.569	rs10950050	chr7:66239588	A/C	cg11764359	chr7:65958608	NA	0.72	6.64	0.6	3.7e-9	Aortic root size;
SKCM	cis	rs4975616	0.714	rs61574973	chr5:1309168	T/C	cg06550200	chr5:1325588	CLPTM1L	0.69	5.18	0.51	1.7e-6	Lung cancer;
SKCM	cis	rs67311347	0.866	rs3214006	chr3:40352134	C/T	cg00091569	chr3:40428383	ENTPD3	0.67	5.66	0.54	2.45e-7	Renal cell carcinoma;
SKCM	cis	rs6545883	0.894	rs2694642	chr2:61596180	A/G	cg15711740	chr2:61764176	XPO1	0.68	4.82	0.48	6.94e-6	Tuberculosis;
SKCM	cis	rs9467773	0.869	rs1796520	chr6:26410800	C/T	cg15659132	chr6:26577336	NA	-0.54	-4.98	-0.49	3.67e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs34311866	0.748	rs10029038	chr4:899352	T/C	cg07828340	chr4:882639	GAK	1.04	5.98	0.56	6.3e-8	Parkinson's disease;
SKCM	cis	rs1707322	0.890	rs2297883	chr1:46511487	G/C	cg03146154	chr1:46216737	IPP	-0.77	-5.36	-0.52	8.35e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs2228479	0.618	rs17233623	chr16:89811209	C/T	cg04287289	chr16:89883240	FANCA	0.89	4.92	0.49	4.64e-6	Skin colour saturation;
SKCM	cis	rs28595532	0.920	rs116697254	chr4:119733603	T/C	cg21605333	chr4:119757512	SEC24D	1.36	8.05	0.67	7.69e-12	Cannabis dependence symptom count;
SKCM	cis	rs6463523	0.933	rs79984239	chr7:766220	A/G	cg05729249	chr7:766119	PRKAR1B;HEATR2	0.96	8.08	0.68	6.56e-12	Subjective well-being;
SKCM	cis	rs875971	0.545	rs10261710	chr7:65714189	T/A	cg18876405	chr7:65276391	NA	0.65	5.28	0.51	1.15e-6	Aortic root size;
SKCM	cis	rs1577917	0.958	rs12196175	chr6:86779370	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.83	-8.15	-0.68	4.73e-12	Response to antipsychotic treatment;
SKCM	cis	rs2302190	0.882	rs2270098	chr17:56572081	C/T	cg25885038	chr17:56607967	SEPT4	-0.72	-4.81	-0.48	7.23e-6	Vitamin D levels;
SKCM	trans	rs1814175	0.645	rs10128563	chr11:50023681	T/C	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs875971	0.862	rs801194	chr7:66028495	T/C	cg18876405	chr7:65276391	NA	-0.61	-6.03	-0.56	5.23e-8	Aortic root size;
SKCM	cis	rs6879260	1.000	rs1035411	chr5:179729519	A/G	cg23248424	chr5:179741104	GFPT2	-0.74	-6.08	-0.57	4.11e-8	Height;
SKCM	cis	rs9790314	0.628	rs1599381	chr3:160867680	G/A	cg03342759	chr3:160939853	NMD3	-0.68	-6.9	-0.62	1.24e-9	Morning vs. evening chronotype;
SKCM	cis	rs9902453	0.817	rs3115089	chr17:28031881	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.82	5.78	0.55	1.47e-7	Coffee consumption (cups per day);
SKCM	cis	rs6089829	0.855	rs4809459	chr20:61661345	C/T	cg08564027	chr20:61660810	NA	0.62	5.55	0.53	3.75e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs1005277	0.505	rs7069702	chr10:38247359	G/T	cg25427524	chr10:38739819	LOC399744	0.68	6.62	0.6	4.11e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs12477438	0.501	rs7349217	chr2:99815146	T/G	cg14399236	chr2:99771627	LIPT1;TSGA10	0.92	7.99	0.67	9.76e-12	Chronic sinus infection;
SKCM	cis	rs9906944	0.545	rs2088140	chr17:47094599	T/C	cg11673840	chr17:47092156	IGF2BP1	-0.54	-5.1	-0.5	2.33e-6	Intelligence (multi-trait analysis);Body fat percentage;
SKCM	cis	rs3008870	0.920	rs3008860	chr1:67391003	G/C	cg08660285	chr1:67390436	MIER1;WDR78	0.92	6.09	0.57	3.92e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs6500602	0.679	rs736685	chr16:4508606	T/C	cg08645402	chr16:4508243	NA	0.59	5.14	0.5	2e-6	Schizophrenia;
SKCM	cis	rs2952156	0.920	rs2517957	chr17:37838716	G/A	cg20243544	chr17:37824526	PNMT	0.68	5.37	0.52	7.74e-7	Asthma;
SKCM	cis	rs732528	0.501	rs6508038	chr18:48360595	G/T	cg03255741	chr18:48556964	SMAD4	-0.68	-4.95	-0.49	4.15e-6	Entorhinal cortical thickness;
SKCM	cis	rs6062302	0.522	rs2872810	chr20:62241931	C/T	cg09650180	chr20:62225654	GMEB2	0.78	6.22	0.58	2.28e-8	Glioblastoma;
SKCM	cis	rs362296	0.624	rs362287	chr4:3257593	C/T	cg24015175	chr4:3319247	RGS12	-0.65	-5.99	-0.56	5.98e-8	Parental longevity (mother's age at death);
SKCM	cis	rs8017423	0.608	rs12588149	chr14:90822676	G/A	cg04374321	chr14:90722782	PSMC1	-0.69	-5.35	-0.52	8.58e-7	Mortality in heart failure;
SKCM	cis	rs7666738	0.830	rs13139024	chr4:99020700	C/T	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1014246	0.826	rs11197802	chr10:118472000	T/A	cg14919929	chr10:118506882	NA	-0.76	-6.57	-0.6	5.13e-9	Age at smoking initiation in chronic obstructive pulmonary disease;
SKCM	cis	rs941408	0.928	rs2260414	chr19:2796316	G/A	cg06609049	chr19:2785107	THOP1	0.82	7.03	0.62	6.99e-10	Total cholesterol levels;
SKCM	cis	rs7793919	0.764	rs6944865	chr7:4766383	A/T	cg09789173	chr7:4769017	FOXK1	0.92	7.96	0.67	1.11e-11	Mosquito bite size;
SKCM	cis	rs796364	1.000	rs71424239	chr2:200725473	T/C	cg12253985	chr2:200820533	C2orf60;C2orf47	-0.96	-5.67	-0.54	2.3e-7	Schizophrenia;
SKCM	trans	rs1814175	0.509	rs60698301	chr11:49877672	G/A	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs2228479	0.850	rs11640188	chr16:89807732	C/T	cg06558623	chr16:89946397	TCF25	1.03	5.59	0.53	3.23e-7	Skin colour saturation;
SKCM	cis	rs28595532	0.925	rs116785973	chr4:119611350	G/A	cg14228332	chr4:119757509	SEC24D	0.97	4.92	0.49	4.71e-6	Cannabis dependence symptom count;
SKCM	cis	rs597539	0.652	rs668576	chr11:68668208	A/G	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.83	5.52	0.53	4.36e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs28595532	0.920	rs17257945	chr4:119666465	T/A	cg21605333	chr4:119757512	SEC24D	1.34	7.8	0.66	2.27e-11	Cannabis dependence symptom count;
SKCM	cis	rs3008870	0.959	rs4655658	chr1:67389608	C/T	cg08660285	chr1:67390436	MIER1;WDR78	0.98	6.56	0.6	5.45e-9	Lymphocyte percentage of white cells;
SKCM	cis	rs7666738	0.830	rs10012167	chr4:99048579	T/C	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs35306767	0.903	rs4522091	chr10:874116	G/T	cg20503657	chr10:835505	NA	0.75	5.43	0.52	6.09e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs12047808	0.730	rs913516	chr1:179524650	T/G	cg09822482	chr1:179519214	C1orf125	-0.96	-4.77	-0.48	8.48e-6	Multiple sclerosis (age of onset);
SKCM	cis	rs9902453	0.619	rs2244585	chr17:28072176	G/A	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.82	-5.94	-0.56	7.58e-8	Coffee consumption (cups per day);
SKCM	cis	rs929354	0.742	rs7784442	chr7:156934475	G/C	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs7336332	0.598	rs74183666	chr13:28007765	A/T	cg22138327	chr13:27999177	GTF3A	0.91	6.51	0.59	6.52e-9	Weight;
SKCM	cis	rs6598955	0.543	rs79778574	chr1:26538482	A/G	cg04990556	chr1:26633338	UBXN11	0.68	5.08	0.5	2.55e-6	Obesity-related traits;
SKCM	cis	rs28595532	0.920	rs115797971	chr4:119779620	A/G	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs4808199	0.895	rs8105094	chr19:19374061	C/T	cg03709012	chr19:19516395	GATAD2A	1.09	7.02	0.62	7.15e-10	Nonalcoholic fatty liver disease;
SKCM	cis	rs72634258	0.945	rs12736494	chr1:8136016	G/A	cg00042356	chr1:8021962	PARK7	1.1	7.72	0.66	3.22e-11	Inflammatory bowel disease;
SKCM	cis	rs606458	0.920	rs637332	chr11:64528750	A/G	cg07674570	chr11:65346152	EHBP1L1	0.68	4.87	0.48	5.76e-6	Urate levels;
SKCM	cis	rs11112613	0.713	rs68053161	chr12:105950035	G/C	cg03607813	chr12:105948248	NA	0.83	5.77	0.55	1.55e-7	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;
SKCM	cis	rs28595532	0.920	rs114584210	chr4:119773363	G/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs732765	0.734	rs12891243	chr14:75208656	G/A	cg25946216	chr14:74253857	C14orf43	-0.8	-5.15	-0.5	1.88e-6	Non-small cell lung cancer;
SKCM	cis	rs12586317	0.513	rs74564132	chr14:35472882	C/T	cg16230307	chr14:35515116	FAM177A1	0.81	5.88	0.55	9.47e-8	Psoriasis;
SKCM	cis	rs67311347	0.955	rs11719205	chr3:40417258	G/A	cg00091569	chr3:40428383	ENTPD3	0.62	5.47	0.53	5.15e-7	Renal cell carcinoma;
SKCM	cis	rs2243480	1.000	rs1553174	chr7:65731194	T/C	cg18252515	chr7:66147081	NA	1.34	8.18	0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs769267	0.930	rs751856	chr19:19602945	A/G	cg03709012	chr19:19516395	GATAD2A	0.89	8.62	0.7	5.89e-13	Tonsillectomy;
SKCM	cis	rs561341	0.941	rs8081016	chr17:30331751	A/G	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs4423214	1.000	rs1044482	chr11:71155171	C/T	cg05163923	chr11:71159392	DHCR7	0.8	7.94	0.67	1.23e-11	Vitamin D levels;
SKCM	cis	rs936229	0.861	rs7180484	chr15:75115416	G/T	cg14664628	chr15:75095509	CSK	1.16	10.49	0.77	1.43e-16	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin);
SKCM	cis	rs2836974	0.568	rs429955	chr21:40539760	G/A	cg17971929	chr21:40555470	PSMG1	0.76	7.16	0.63	3.94e-10	Cognitive function;
SKCM	cis	rs995000	0.931	rs1627591	chr1:62989807	C/T	cg06896770	chr1:63153194	DOCK7	-0.74	-6.81	-0.61	1.77e-9	Triglyceride levels;
SKCM	cis	rs12142240	0.667	rs45524035	chr1:46862780	C/T	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs654950	0.783	rs640688	chr1:42001831	A/G	cg06885757	chr1:42089581	HIVEP3	-0.59	-6.35	-0.58	1.33e-8	Airway imaging phenotypes;
SKCM	trans	rs208520	0.690	rs207119	chr6:66786408	C/T	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-1.02	-7.49	-0.65	9.2e-11	Exhaled nitric oxide output;
SKCM	cis	rs7216064	1.000	rs7223930	chr17:65842186	G/A	cg12091567	chr17:66097778	LOC651250	-0.77	-5.53	-0.53	4.06e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs3784262	0.669	rs12915508	chr15:58302036	G/A	cg12031962	chr15:58353849	ALDH1A2	-0.42	-4.89	-0.48	5.38e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs28386778	0.897	rs2727327	chr17:61923422	G/A	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs926938	0.520	rs969273	chr1:115256669	G/A	cg12756093	chr1:115239321	AMPD1	-0.73	-5.46	-0.53	5.45e-7	Autism;
SKCM	cis	rs1580019	0.813	rs2044839	chr7:32500805	A/C	cg06627557	chr7:32535165	LSM5;AVL9	0.77	5.86	0.55	1.03e-7	Cognitive ability;
SKCM	cis	rs908922	0.636	rs474086	chr1:152513431	C/T	cg09873164	chr1:152488093	CRCT1	0.76	5.93	0.56	7.7e-8	Hair morphology;
SKCM	cis	rs644799	0.735	rs10831432	chr11:95516040	C/A	cg25622487	chr11:95524042	FAM76B;CEP57	0.76	6.46	0.59	8.32e-9	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs798554	0.836	rs798502	chr7:2789880	G/T	cg14895029	chr7:2775587	GNA12	0.69	5.14	0.5	2.02e-6	Height;
SKCM	cis	rs7100689	0.622	rs1417221	chr10:82100428	G/A	cg00277334	chr10:82204260	NA	-0.57	-5.15	-0.5	1.9e-6	Post bronchodilator FEV1;
SKCM	cis	rs2204008	0.749	rs10880692	chr12:38592918	C/G	cg26384229	chr12:38710491	ALG10B	-0.85	-6.92	-0.62	1.12e-9	Bladder cancer;
SKCM	cis	rs7215564	0.908	rs34135683	chr17:78652903	G/T	cg16980736	chr17:78789706	RPTOR	-0.91	-4.92	-0.49	4.67e-6	Myopia (pathological);
SKCM	cis	rs9913156	0.793	rs55782417	chr17:4562845	G/A	cg19197139	chr17:4613644	ARRB2	0.79	5.28	0.51	1.14e-6	Lymphocyte counts;
SKCM	cis	rs9926664	0.591	rs11649549	chr16:85935797	A/G	cg16682899	chr16:85508110	NA	-0.49	-5.45	-0.53	5.72e-7	Sum basophil neutrophil counts;Neutrophil count;
SKCM	cis	rs1005277	0.579	rs1740749	chr10:38521646	A/G	cg00409905	chr10:38381863	ZNF37A	-0.62	-5.82	-0.55	1.24e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs7847628	0.550	rs12343516	chr9:123603469	A/C	cg09419670	chr9:123605666	PSMD5;LOC253039	0.64	5.83	0.55	1.21e-7	Birth weight;
SKCM	cis	rs9910055	0.540	rs609292	chr17:42180436	G/A	cg09913183	chr17:42254507	C17orf65;ASB16	-0.58	-4.79	-0.48	7.84e-6	Total body bone mineral density;
SKCM	cis	rs9475752	0.793	rs35735810	chr6:56843715	C/T	cg06815302	chr6:57335405	PRIM2	0.59	4.78	0.48	8.1e-6	Menarche (age at onset);
SKCM	cis	rs9788721	0.802	rs56219465	chr15:78742579	A/G	cg18825076	chr15:78729989	IREB2	-0.61	-4.81	-0.48	7.31e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;Emphysema imaging phenotypes;Emphysema distribution in smoking;Local histogram emphysema pattern;Post bronchodilator FEV1/FVC ratio in COPD;
SKCM	cis	rs208520	1.000	rs72884025	chr6:66994185	T/C	cg07460842	chr6:66804631	NA	0.87	5.96	0.56	6.95e-8	Exhaled nitric oxide output;
SKCM	cis	rs7090367	0.572	rs1571423	chr10:125249982	C/T	cg16197717	chr10:125650957	CPXM2	-0.65	-4.82	-0.48	6.96e-6	Body mass index;
SKCM	cis	rs367615	0.506	rs246102	chr5:108699695	C/G	cg17395555	chr5:108820864	NA	-0.65	-5.29	-0.51	1.1e-6	Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs1862618	0.853	rs33322	chr5:56175226	A/G	cg12311346	chr5:56204834	C5orf35	-0.75	-4.86	-0.48	5.96e-6	Initial pursuit acceleration;
SKCM	cis	rs992157	0.932	rs1870125	chr2:219187901	C/T	cg20019365	chr2:219134978	PNKD;AAMP	0.78	6.35	0.58	1.34e-8	Colorectal cancer;
SKCM	cis	rs7769051	1.000	rs73554431	chr6:133129922	T/G	cg22852734	chr6:133119734	C6orf192	0.98	5.0	0.49	3.46e-6	Type 2 diabetes nephropathy;
SKCM	cis	rs7216064	0.636	rs4638	chr17:66039350	A/G	cg12091567	chr17:66097778	LOC651250	0.89	6.71	0.6	2.8e-9	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs2228479	0.718	rs62054253	chr16:89896932	T/C	cg06558623	chr16:89946397	TCF25	1.1	4.95	0.49	4.17e-6	Skin colour saturation;
SKCM	cis	rs7618501	0.633	rs9866695	chr3:50069452	G/T	cg24110177	chr3:50126178	RBM5	0.61	5.29	0.51	1.09e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs6500395	0.926	rs8057777	chr16:48565643	T/C	cg04672837	chr16:48644449	N4BP1	0.72	6.04	0.56	4.96e-8	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs3540	0.554	rs113942266	chr15:91072990	A/G	cg22089800	chr15:90895588	ZNF774	-0.68	-4.92	-0.49	4.69e-6	Allergic disease (asthma, hay fever or eczema);Lymphocyte counts;
SKCM	cis	rs4689592	0.619	rs3796908	chr4:7061378	G/A	cg19539972	chr4:7069911	GRPEL1	0.96	6.44	0.59	8.83e-9	Monocyte percentage of white cells;
SKCM	cis	rs7829975	0.626	rs907183	chr8:8729761	C/G	cg08975724	chr8:8085496	FLJ10661	-0.62	-4.8	-0.48	7.49e-6	Mood instability;
SKCM	cis	rs13424612	0.965	rs2289407	chr2:240954110	A/G	cg01812947	chr2:240904978	NDUFA10	0.66	5.18	0.51	1.68e-6	Odorant perception (isobutyraldehyde);
SKCM	cis	rs2836974	1.000	rs28360661	chr21:40681972	G/C	cg17971929	chr21:40555470	PSMG1	0.86	8.47	0.69	1.18e-12	Cognitive function;
SKCM	cis	rs151997	1.000	rs152854	chr5:50223206	G/A	cg06027927	chr5:50259733	NA	-0.66	-5.78	-0.55	1.45e-7	Callous-unemotional behaviour;
SKCM	cis	rs6121246	0.909	rs6060960	chr20:30394517	G/T	cg11595048	chr20:30225325	COX4I2	-0.67	-5.21	-0.51	1.5e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs9911578	1.000	rs2567911	chr17:56734977	A/G	cg05425664	chr17:57184151	TRIM37	-0.69	-5.21	-0.51	1.52e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2479724	0.755	rs4318867	chr6:41753670	G/T	cg17623882	chr6:41773611	USP49	0.75	6.44	0.59	8.92e-9	Menarche (age at onset);
SKCM	cis	rs2842992	0.747	rs9365095	chr6:160192928	T/G	cg11366901	chr6:160182831	ACAT2	0.94	7.85	0.66	1.81e-11	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs1801251	1.000	rs3817311	chr2:233612557	C/T	cg25237894	chr2:233734115	C2orf82	0.56	5.33	0.52	9.23e-7	Coronary artery disease;
SKCM	cis	rs362296	0.698	rs3095073	chr4:3263138	C/T	cg21096898	chr4:3318625	RGS12	-0.78	-7.77	-0.66	2.63e-11	Parental longevity (mother's age at death);
SKCM	cis	rs9902453	0.967	rs6505155	chr17:28372783	A/T	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.81	-5.78	-0.55	1.45e-7	Coffee consumption (cups per day);
SKCM	cis	rs1692580	0.774	rs10797416	chr1:2182342	T/C	cg24578937	chr1:2090814	PRKCZ	0.45	4.86	0.48	6.06e-6	Coronary artery disease;
SKCM	cis	rs2033711	0.755	rs4801587	chr19:58936679	C/A	cg03735888	chr19:58951602	ZNF132	0.7	6.08	0.57	4.22e-8	Uric acid clearance;
SKCM	cis	rs12142240	0.698	rs77185326	chr1:46818417	T/C	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs4724125	0.883	rs56125752	chr7:42681505	C/T	cg09407816	chr7:42972088	MRPL32;PSMA2	0.81	4.85	0.48	6.13e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7772486	0.875	rs2474356	chr6:146296798	G/A	cg23711669	chr6:146136114	FBXO30	0.77	7.38	0.64	1.47e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9393692	0.557	rs9379845	chr6:26291601	C/T	cg13736514	chr6:26305472	NA	-0.67	-5.02	-0.49	3.24e-6	Educational attainment;
SKCM	cis	rs6121246	0.821	rs6119718	chr20:30331074	A/G	cg11595048	chr20:30225325	COX4I2	0.67	5.21	0.51	1.5e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs6582630	0.502	rs2204008	chr12:38439203	C/T	cg26384229	chr12:38710491	ALG10B	0.81	6.15	0.57	3.08e-8	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs2070488	0.861	rs2067082	chr3:38438182	C/G	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.97	8.96	0.71	1.29e-13	Electrocardiographic conduction measures;
SKCM	cis	rs875971	1.000	rs7783613	chr7:65805261	C/T	cg11764359	chr7:65958608	NA	-0.88	-8.54	-0.7	8.36e-13	Aortic root size;
SKCM	cis	rs4332037	0.552	rs11773627	chr7:2002733	A/G	cg23422044	chr7:1970798	MAD1L1	-0.91	-6.01	-0.56	5.6e-8	Bipolar disorder;
SKCM	cis	rs67311347	0.568	rs9864544	chr3:40336204	T/C	cg00656387	chr3:40428638	ENTPD3	0.57	5.05	0.5	2.81e-6	Renal cell carcinoma;
SKCM	cis	rs7208859	0.623	rs7208088	chr17:29143667	C/T	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs9475752	0.793	rs35899012	chr6:56862909	G/A	cg06815302	chr6:57335405	PRIM2	0.59	4.78	0.48	8.1e-6	Menarche (age at onset);
SKCM	cis	rs3741404	0.825	rs2845597	chr11:63954370	G/A	cg19465662	chr11:63993652	NUDT22;TRPT1	0.82	5.54	0.53	3.96e-7	Platelet count;
SKCM	cis	rs9420	0.961	rs71484461	chr11:57488890	G/A	cg19752551	chr11:57585705	CTNND1	-0.7	-6.84	-0.61	1.6e-9	Schizophrenia;
SKCM	cis	rs644799	0.542	rs10831417	chr11:95467262	A/G	cg03916912	chr11:95522834	CEP57;FAM76B	-0.65	-4.97	-0.49	3.84e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs514406	0.929	rs515857	chr1:53336859	A/G	cg16325326	chr1:53192061	ZYG11B	0.85	7.91	0.67	1.4e-11	Monocyte count;
SKCM	cis	rs6088580	0.634	rs2378133	chr20:32919505	C/G	cg24642439	chr20:33292090	TP53INP2	-0.72	-5.7	-0.54	2.06e-7	Glomerular filtration rate (creatinine);
SKCM	cis	rs11112613	0.775	rs10507194	chr12:105959488	G/A	cg03607813	chr12:105948248	NA	0.88	6.01	0.56	5.5e-8	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;
SKCM	cis	rs9868809	0.505	rs13063223	chr3:48750340	G/A	cg00383909	chr3:49044727	WDR6	0.89	5.09	0.5	2.44e-6	Ulcerative colitis;Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs7633770	0.841	rs11130100	chr3:46679198	A/T	cg11219411	chr3:46661640	NA	-0.7	-6.91	-0.62	1.15e-9	Coronary artery disease;
SKCM	cis	rs782590	0.837	rs2627769	chr2:55927288	G/C	cg18811423	chr2:55921094	PNPT1	0.96	8.25	0.68	3.09e-12	Metabolic syndrome;
SKCM	cis	rs67311347	0.544	rs12635762	chr3:40332759	C/T	cg00091569	chr3:40428383	ENTPD3	-0.57	-4.95	-0.49	4.21e-6	Renal cell carcinoma;
SKCM	cis	rs1034435	0.755	rs5768681	chr22:48894501	C/T	cg05992904	chr22:48892994	FAM19A5	-0.59	-4.85	-0.48	6.27e-6	Late-onset Alzheimer's disease;
SKCM	cis	rs2228479	0.867	rs2270459	chr16:89979851	A/C	cg06558623	chr16:89946397	TCF25	-1.22	-7.35	-0.64	1.68e-10	Skin colour saturation;
SKCM	cis	rs17854409	1.000	rs66634465	chr20:61482306	C/T	cg06598544	chr20:61472147	COL9A3	-1.17	-5.57	-0.53	3.51e-7	Obesity-related traits;
SKCM	cis	rs2842992	0.789	rs3818300	chr6:160201677	G/A	cg16489826	chr6:160211363	TCP1;MRPL18	0.73	5.42	0.52	6.39e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs11718455	0.960	rs11720974	chr3:43999111	G/C	cg21419209	chr3:44054225	NA	-0.65	-5.32	-0.52	9.77e-7	Coronary artery disease;
SKCM	cis	rs1506636	1.000	rs1911145	chr7:123363658	A/G	cg03229431	chr7:123269106	ASB15	-0.6	-4.83	-0.48	6.69e-6	Plateletcrit;Platelet count;
SKCM	cis	rs11252926	0.563	rs11252290	chr10:461989	C/T	cg18196295	chr10:418757	DIP2C	0.61	4.9	0.49	5.03e-6	Psychosis in Alzheimer's disease;
SKCM	cis	rs8016982	0.698	rs12590764	chr14:81704417	G/A	cg01989461	chr14:81687754	GTF2A1	0.88	6.91	0.62	1.18e-9	Schizophrenia;
SKCM	cis	rs709400	0.628	rs10141120	chr14:103923008	T/C	cg26031613	chr14:104095156	KLC1	0.72	5.58	0.53	3.39e-7	Body mass index;
SKCM	cis	rs9633740	0.842	rs1870140	chr10:82246749	A/G	cg01528321	chr10:82214614	TSPAN14	0.84	6.18	0.57	2.72e-8	Post bronchodilator FEV1;
SKCM	cis	rs1046896	0.553	rs9893885	chr17:80837107	C/T	cg02711726	chr17:80685570	FN3KRP	-0.79	-6.01	-0.56	5.55e-8	Glycated hemoglobin levels;
SKCM	cis	rs748404	0.697	rs530188	chr15:43545314	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	0.72	5.9	0.56	8.97e-8	Lung cancer;
SKCM	cis	rs9467773	1.000	rs9295695	chr6:26528250	C/T	cg09904177	chr6:26538194	HMGN4	-0.54	-4.98	-0.49	3.78e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2439831	1.000	rs2245790	chr15:43744457	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.1	7.54	0.65	7.34e-11	Lung cancer in ever smokers;
SKCM	cis	rs10911232	0.507	rs4652766	chr1:182994336	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.64	0.6	3.83e-9	Hypertriglyceridemia;
SKCM	cis	rs8170	0.603	rs11086068	chr19:17420165	T/C	cg07830086	chr19:18107778	KCNN1	-0.8	-4.99	-0.49	3.54e-6	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Ovarian cancer;Breast cancer;Epithelial ovarian cancer;
SKCM	cis	rs951366	0.617	rs823075	chr1:205774897	C/T	cg17178900	chr1:205818956	PM20D1	0.83	8.3	0.68	2.44e-12	Menarche (age at onset);
SKCM	cis	rs10911251	0.528	rs10911248	chr1:183080564	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Colorectal cancer;
SKCM	cis	rs6120849	0.901	rs11696967	chr20:33743609	A/C	cg24642439	chr20:33292090	TP53INP2	0.91	5.05	0.5	2.83e-6	Protein C levels;
SKCM	cis	rs7824557	0.628	rs7831346	chr8:11193530	C/T	cg21775007	chr8:11205619	TDH	0.72	6.73	0.61	2.51e-9	Retinal vascular caliber;
SKCM	cis	rs7811142	0.830	rs7792525	chr7:99972122	A/G	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.19	7.5	0.65	8.66e-11	Platelet count;
SKCM	cis	rs11098499	0.908	rs71614449	chr4:120387055	C/T	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs2737618	0.722	rs2737680	chr1:200088559	C/A	cg21825944	chr1:200113062	NR5A2	-0.59	-4.96	-0.49	3.98e-6	Uric acid levels;
SKCM	cis	rs1218582	0.772	rs10796935	chr1:154891363	G/T	cg16680214	chr1:154839983	KCNN3	-0.56	-5.01	-0.49	3.29e-6	Prostate cancer;
SKCM	cis	rs703842	0.642	rs11536137	chr12:58056426	C/A	cg04478727	chr12:58166393	METTL1;FAM119B	0.71	5.38	0.52	7.66e-7	Multiple sclerosis;
SKCM	cis	rs4687718	0.929	rs77351539	chr3:53277546	G/C	cg07507251	chr3:52567010	NT5DC2	0.82	5.33	0.52	9.24e-7	QRS duration;
SKCM	cis	rs10808739	0.660	rs11984829	chr8:65655434	C/T	cg05711235	chr8:65498612	NA	-0.81	-5.4	-0.52	7.01e-7	HIV-1 susceptibility;
SKCM	cis	rs867186	1.000	rs12105996	chr20:33731010	G/A	cg04194272	chr20:33683537	NA	-1.11	-6.01	-0.56	5.7e-8	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs7954584	0.813	rs12827200	chr12:122451278	G/A	cg22618164	chr12:122356400	WDR66	0.48	4.82	0.48	7.07e-6	Mean corpuscular volume;
SKCM	cis	rs72772090	0.710	rs1559085	chr5:96078702	A/G	cg17330273	chr5:96107758	CAST;ERAP1	-0.84	-5.14	-0.5	1.96e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs6754311	0.608	rs3739020	chr2:136602491	T/G	cg07169764	chr2:136633963	MCM6	0.89	6.42	0.59	9.86e-9	Mosquito bite size;
SKCM	cis	rs7635838	0.684	rs346079	chr3:11328139	G/A	cg00170343	chr3:11313890	ATG7	0.73	5.55	0.53	3.74e-7	HDL cholesterol;
SKCM	cis	rs9583531	0.600	rs6492306	chr13:111361693	G/A	cg24331049	chr13:111365604	ING1	0.83	6.25	0.58	2e-8	Coronary artery disease;
SKCM	cis	rs9815354	0.812	rs4264702	chr3:41952539	T/A	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs116095464	0.558	rs6866776	chr5:264495	C/T	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs9910055	0.593	rs2905983	chr17:42212429	T/G	cg19774624	chr17:42201019	HDAC5	0.93	8.8	0.71	2.6e-13	Total body bone mineral density;
SKCM	cis	rs453301	0.686	rs28665409	chr8:8869277	G/A	cg06636001	chr8:8085503	FLJ10661	-0.75	-5.62	-0.54	2.83e-7	Joint mobility (Beighton score);
SKCM	cis	rs12477438	0.520	rs6717723	chr2:99756930	T/C	cg26064155	chr2:99771622	LIPT1;TSGA10	1.05	10.1	0.75	7.95e-16	Chronic sinus infection;
SKCM	cis	rs72634258	0.554	rs35123409	chr1:7878568	C/T	cg26816564	chr1:7831052	VAMP3	0.79	4.93	0.49	4.48e-6	Inflammatory bowel disease;
SKCM	cis	rs7618915	0.547	rs3755806	chr3:52643685	C/T	cg18404041	chr3:52824283	ITIH1	0.56	5.05	0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs11105298	0.891	rs12228177	chr12:89862030	G/T	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.88	-6.05	-0.57	4.76e-8	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs3091242	0.933	rs4649084	chr1:25752617	A/G	cg02931644	chr1:25747376	RHCE	0.53	5.35	0.52	8.54e-7	Erythrocyte sedimentation rate;
SKCM	cis	rs911263	0.961	rs1885013	chr14:68754695	G/A	cg18825221	chr14:68749962	RAD51L1	0.52	5.54	0.53	3.99e-7	Primary biliary cholangitis;
SKCM	cis	rs10808739	0.623	rs62521114	chr8:65637942	C/T	cg05711235	chr8:65498612	NA	-0.83	-5.59	-0.53	3.21e-7	HIV-1 susceptibility;
SKCM	cis	rs1801251	1.000	rs283471	chr2:233656627	G/A	cg08000102	chr2:233561755	GIGYF2	0.94	6.85	0.61	1.49e-9	Coronary artery disease;
SKCM	cis	rs3820068	0.581	rs58425551	chr1:15922518	A/G	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs2243480	0.901	rs73142137	chr7:65343442	A/T	cg07424592	chr7:64974309	NA	0.99	4.9	0.49	5.08e-6	Diabetic kidney disease;
SKCM	cis	rs57221529	0.709	rs111352378	chr5:577079	G/A	cg26208419	chr5:473447	SLC9A3;LOC25845	1.05	5.37	0.52	7.95e-7	Lung disease severity in cystic fibrosis;
SKCM	cis	rs757110	0.866	rs5215	chr11:17408630	C/T	cg15432903	chr11:17409602	KCNJ11	0.56	5.54	0.53	4.03e-7	Type 2 diabetes;
SKCM	cis	rs2836974	0.932	rs2836953	chr21:40617483	G/A	cg11890956	chr21:40555474	PSMG1	1.09	13.83	0.84	1.08e-22	Cognitive function;
SKCM	cis	rs7666738	0.830	rs7673880	chr4:99057262	A/G	cg05340658	chr4:99064831	C4orf37	0.68	4.97	0.49	3.89e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2721195	1.000	rs11784118	chr8:145684978	G/A	cg17328964	chr8:145687451	CYHR1	0.75	6.97	0.62	8.93e-10	Age at first birth;
SKCM	cis	rs28595532	0.920	rs115240535	chr4:119745395	G/C	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs4889855	0.614	rs9898443	chr17:78469357	C/T	cg16591659	chr17:78472290	NA	0.51	5.25	0.51	1.29e-6	Fractional excretion of uric acid;
SKCM	cis	rs72781680	0.898	rs72782138	chr2:24048162	T/C	cg08917208	chr2:24149416	ATAD2B	1.0	4.97	0.49	3.82e-6	Lymphocyte counts;
SKCM	cis	rs11098499	1.000	rs6837898	chr4:120179154	C/T	cg09307838	chr4:120376055	NA	0.95	7.75	0.66	2.84e-11	Corneal astigmatism;
SKCM	cis	rs34779708	0.966	rs11010129	chr10:35510822	T/C	cg03585969	chr10:35415529	CREM	0.78	6.28	0.58	1.75e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs7017252	1.000	rs7815993	chr8:129951769	A/G	cg08633665	chr8:128972829	MIR1205;PVT1	0.44	5.02	0.49	3.13e-6	Nonsyndromic cleft lip with cleft palate;
SKCM	cis	rs9818758	0.607	rs56306491	chr3:49314960	G/A	cg00383909	chr3:49044727	WDR6	1.21	5.18	0.51	1.71e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs4561483	0.801	rs33643	chr16:11986149	A/G	cg08843971	chr16:11963173	GSPT1	-0.66	-5.08	-0.5	2.49e-6	Testicular germ cell tumor;
SKCM	cis	rs72717009	0.825	rs12722986	chr1:161465420	A/G	cg23840854	chr1:161414152	NA	-0.99	-5.66	-0.54	2.44e-7	Rheumatoid arthritis;
SKCM	cis	rs2033711	0.936	rs7257999	chr19:58964860	C/G	cg11952622	chr19:58962976	ZNF324B	0.69	5.28	0.51	1.13e-6	Uric acid clearance;
SKCM	cis	rs1059312	0.808	rs900982	chr12:129304369	G/A	cg09035930	chr12:129282057	SLC15A4	0.79	8.34	0.69	2.06e-12	Systemic lupus erythematosus;
SKCM	cis	rs10927875	0.619	rs28537253	chr1:16148600	A/C	cg21385522	chr1:16154831	NA	-0.74	-7.56	-0.65	6.63e-11	Dilated cardiomyopathy;
SKCM	cis	rs17376456	0.825	rs13164315	chr5:93147421	A/G	cg25358565	chr5:93447407	FAM172A	1.19	7.78	0.66	2.52e-11	Diabetic retinopathy;
SKCM	cis	rs6952808	0.723	rs60432611	chr7:2029629	G/C	cg21782813	chr7:2030301	MAD1L1	0.57	5.93	0.56	7.93e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs11209185	0.602	rs12029657	chr1:68432702	G/C	cg17031739	chr1:67600172	NA	0.5	4.85	0.48	6.17e-6	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs66573146	1.000	rs56074877	chr4:6990374	C/T	cg00086871	chr4:6988644	TBC1D14	1.29	5.03	0.5	3.04e-6	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs992157	0.798	rs2382818	chr2:219155907	A/T	cg00012203	chr2:219082015	ARPC2	-0.73	-5.73	-0.54	1.83e-7	Colorectal cancer;
SKCM	trans	rs3780486	0.846	rs10813954	chr9:33137596	A/C	cg04842962	chr6:43655489	MRPS18A	1.03	10.87	0.78	2.78e-17	IgG glycosylation;
SKCM	cis	rs929354	0.772	rs1182432	chr7:157029176	A/G	cg17757837	chr7:157058334	UBE3C	0.79	5.78	0.55	1.49e-7	Body mass index;
SKCM	cis	rs2243480	1.000	rs2460422	chr7:65601505	C/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs933688	1.000	rs10045280	chr5:90717675	T/A	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.05	8.45	0.69	1.26e-12	Smoking behavior;
SKCM	cis	rs3785574	0.650	rs2320125	chr17:62008318	T/C	cg11494091	chr17:61959527	GH2	-0.56	-5.4	-0.52	7.11e-7	Height;
SKCM	cis	rs798554	0.679	rs1639036	chr7:2885089	G/A	cg04166393	chr7:2884313	GNA12	0.79	5.54	0.53	3.9e-7	Height;
SKCM	cis	rs2832191	0.716	rs9983051	chr21:30371890	C/T	cg08807101	chr21:30365312	RNF160	0.74	6.04	0.56	4.89e-8	Dental caries;
SKCM	cis	rs9309711	0.666	rs4321399	chr2:3481659	G/A	cg15506890	chr2:3487001	NA	-0.62	-5.04	-0.5	2.89e-6	Neurofibrillary tangles;
SKCM	cis	rs17065868	0.803	rs9533891	chr13:45099224	C/T	cg10246903	chr13:45222710	NA	0.95	5.35	0.52	8.5e-7	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs1801251	1.000	rs36007169	chr2:233621834	A/G	cg08000102	chr2:233561755	GIGYF2	0.88	7.07	0.63	5.69e-10	Coronary artery disease;
SKCM	cis	rs2836974	0.568	rs2183573	chr21:40574305	A/G	cg17971929	chr21:40555470	PSMG1	-0.75	-6.9	-0.62	1.22e-9	Cognitive function;
SKCM	cis	rs2980439	0.818	rs2948294	chr8:8094961	A/G	cg06636001	chr8:8085503	FLJ10661	1.0	9.49	0.73	1.23e-14	Neuroticism;
SKCM	cis	rs2204008	0.837	rs12146734	chr12:38237079	A/G	cg26384229	chr12:38710491	ALG10B	0.87	6.9	0.62	1.21e-9	Bladder cancer;
SKCM	cis	rs5760092	0.618	rs5996631	chr22:24256894	T/C	cg25703541	chr22:24373054	LOC391322	0.84	5.6	0.54	3.14e-7	Urinary 1,3-butadiene metabolite levels in smokers;
SKCM	cis	rs2153535	0.580	rs9505448	chr6:8459804	A/G	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs11098499	0.874	rs17839089	chr4:120111069	A/G	cg09307838	chr4:120376055	NA	0.86	6.08	0.57	4.13e-8	Corneal astigmatism;
SKCM	cis	rs6547631	0.622	rs10206121	chr2:85930169	T/A	cg24620635	chr2:85921963	GNLY	0.9	6.43	0.59	9.4e-9	Blood protein levels;
SKCM	cis	rs1799949	0.965	rs8071278	chr17:41193910	A/T	cg23758822	chr17:41437982	NA	0.94	7.62	0.65	5e-11	Menopause (age at onset);
SKCM	cis	rs10504229	0.635	rs72649130	chr8:58053810	G/T	cg02725872	chr8:58115012	NA	-0.54	-5.04	-0.5	2.97e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs4243830	0.850	rs3761927	chr1:6601773	T/C	cg22792644	chr1:6614718	TAS1R1;NOL9	-1.06	-5.63	-0.54	2.69e-7	Body mass index;
SKCM	cis	rs9790314	0.502	rs2404342	chr3:161092562	C/T	cg03342759	chr3:160939853	NMD3	-0.82	-7.01	-0.62	7.46e-10	Morning vs. evening chronotype;
SKCM	cis	rs7917772	0.503	rs2031601	chr10:104308064	T/G	cg11453585	chr10:104263688	ACTR1A;SUFU	0.76	6.2	0.57	2.5e-8	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs1707322	1.000	rs785465	chr1:46522577	G/T	cg03146154	chr1:46216737	IPP	0.71	4.79	0.48	7.82e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs9910055	0.593	rs2905983	chr17:42212429	T/G	cg13607699	chr17:42295918	UBTF	-0.71	-5.61	-0.54	3.01e-7	Total body bone mineral density;
SKCM	cis	rs9611565	0.659	rs12483786	chr22:41938536	A/G	cg03806693	chr22:41940476	POLR3H	-1.11	-7.56	-0.65	6.67e-11	Vitiligo;
SKCM	cis	rs8017423	0.935	rs11626869	chr14:90788985	A/G	cg04374321	chr14:90722782	PSMC1	-1.04	-9.71	-0.74	4.52e-15	Mortality in heart failure;
SKCM	cis	rs478304	0.651	rs4014195	chr11:65506822	C/G	cg27068330	chr11:65405492	SIPA1	0.84	8.0	0.67	9.32e-12	Acne (severe);
SKCM	cis	rs6977660	0.652	rs10486362	chr7:19755224	A/G	cg02470904	chr7:20686108	ABCB5	-1.14	-5.27	-0.51	1.16e-6	Thyroid stimulating hormone;
SKCM	cis	rs9926296	0.585	rs6500450	chr16:89858024	A/G	cg26513180	chr16:89883248	FANCA	0.96	11.17	0.78	7.65e-18	Vitiligo;
SKCM	cis	rs9300255	0.739	rs12824957	chr12:123750228	T/C	cg05973401	chr12:123451056	ABCB9	-0.83	-5.84	-0.55	1.13e-7	Neutrophil percentage of white cells;
SKCM	cis	rs9640161	0.702	rs1962004	chr7:150020381	G/A	cg27494647	chr7:150038898	RARRES2	0.58	4.98	0.49	3.74e-6	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs736408	0.540	rs4687637	chr3:52634092	C/T	cg18404041	chr3:52824283	ITIH1	-0.53	-4.77	-0.48	8.42e-6	Bipolar disorder;
SKCM	cis	rs7618915	0.501	rs2336149	chr3:52692124	G/A	cg18404041	chr3:52824283	ITIH1	-0.53	-4.77	-0.48	8.42e-6	Bipolar disorder;
SKCM	cis	rs17685	0.753	rs1639609	chr7:75683581	T/C	cg16684958	chr7:75615977	POR	0.59	5.63	0.54	2.69e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2070488	0.804	rs13092539	chr3:38458725	G/A	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.75	6.16	0.57	2.93e-8	Electrocardiographic conduction measures;
SKCM	cis	rs9790314	0.586	rs16832246	chr3:161109916	A/G	cg03342759	chr3:160939853	NMD3	0.7	6.21	0.58	2.41e-8	Morning vs. evening chronotype;
SKCM	cis	rs7772486	0.790	rs7742333	chr6:146159029	A/G	cg23711669	chr6:146136114	FBXO30	-0.89	-10.01	-0.75	1.21e-15	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs28595532	0.920	rs115464801	chr4:119730673	T/C	cg21605333	chr4:119757512	SEC24D	1.36	8.05	0.67	7.69e-12	Cannabis dependence symptom count;
SKCM	cis	rs7397814	0.558	rs4764447	chr12:9579109	C/T	cg27502298	chr12:9555721	NA	0.69	5.04	0.5	2.92e-6	IgG glycosylation;
SKCM	cis	rs28595532	0.920	rs114938162	chr4:119756407	T/G	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs10504229	1.000	rs66477954	chr8:58187810	C/T	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs1799949	1.000	rs36036395	chr17:41181297	T/C	cg23758822	chr17:41437982	NA	0.91	7.51	0.65	8.13e-11	Menopause (age at onset);
SKCM	cis	rs9910055	0.762	rs227579	chr17:42223134	A/T	cg19774624	chr17:42201019	HDAC5	0.87	7.51	0.65	8.49e-11	Total body bone mineral density;
SKCM	cis	rs561341	0.830	rs7218801	chr17:30217778	A/G	cg00745463	chr17:30367425	LRRC37B	0.99	6.38	0.59	1.18e-8	Hip circumference adjusted for BMI;
SKCM	cis	rs2204008	0.837	rs2892296	chr12:37969785	C/T	cg13010199	chr12:38710504	ALG10B	-0.63	-4.9	-0.49	5.09e-6	Bladder cancer;
SKCM	cis	rs10256972	0.647	rs10233430	chr7:1051664	T/C	cg02733842	chr7:1102375	C7orf50	-0.46	-4.8	-0.48	7.4e-6	Longevity;Endometriosis;
SKCM	cis	rs606458	0.920	rs684720	chr11:64548429	C/G	cg07674570	chr11:65346152	EHBP1L1	0.68	4.94	0.49	4.41e-6	Urate levels;
SKCM	cis	rs782590	0.620	rs4322879	chr2:55797033	G/T	cg18811423	chr2:55921094	PNPT1	-0.68	-4.97	-0.49	3.82e-6	Metabolic syndrome;
SKCM	cis	rs60871478	0.898	rs34766380	chr7:786862	G/A	cg04727924	chr7:799746	HEATR2	-0.6	-4.8	-0.48	7.39e-6	Cerebrospinal P-tau181p levels;
SKCM	cis	rs992157	0.764	rs1870124	chr2:219187740	C/T	cg00012203	chr2:219082015	ARPC2	0.75	5.54	0.53	3.92e-7	Colorectal cancer;
SKCM	cis	rs7208859	0.524	rs77498725	chr17:29063986	C/T	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs995000	0.931	rs10889330	chr1:62939466	G/C	cg06896770	chr1:63153194	DOCK7	0.61	5.77	0.55	1.55e-7	Triglyceride levels;
SKCM	cis	rs4423214	1.000	rs12797951	chr11:71143266	G/T	cg05163923	chr11:71159392	DHCR7	-0.8	-7.94	-0.67	1.23e-11	Vitamin D levels;
SKCM	cis	rs870825	0.550	rs57301026	chr4:185646505	C/G	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs1005277	0.579	rs2472175	chr10:38382901	T/G	cg00409905	chr10:38381863	ZNF37A	-0.64	-5.96	-0.56	6.77e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs523522	0.962	rs12371550	chr12:120987643	C/T	cg27279351	chr12:120934652	DYNLL1	0.91	8.32	0.69	2.26e-12	High light scatter reticulocyte count;
SKCM	cis	rs4727027	0.933	rs12704062	chr7:148827865	G/A	cg23583168	chr7:148888333	NA	-0.82	-6.56	-0.6	5.29e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs7666738	0.830	rs17027216	chr4:99009152	G/C	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs752010	0.746	rs11210499	chr1:42089703	C/T	cg06885757	chr1:42089581	HIVEP3	-0.47	-4.86	-0.48	6.01e-6	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs514406	0.708	rs536621	chr1:53309097	A/G	cg08859206	chr1:53392774	SCP2	-0.66	-5.39	-0.52	7.22e-7	Monocyte count;
SKCM	cis	rs56104184	0.779	rs2131093	chr19:49350693	A/T	cg15549821	chr19:49342101	PLEKHA4	-1.17	-7.17	-0.63	3.79e-10	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs13118159	0.550	rs11941200	chr4:1369093	C/G	cg19318889	chr4:1322082	MAEA	0.8	5.88	0.55	9.62e-8	Longevity;
SKCM	cis	rs1401999	0.628	rs6798870	chr3:183740350	G/A	cg01324343	chr3:183735012	ABCC5	0.66	6.47	0.59	7.84e-9	Anterior chamber depth;
SKCM	cis	rs2645694	0.626	rs2703120	chr4:77822470	G/A	cg03477792	chr4:77819574	ANKRD56	0.57	6.37	0.58	1.22e-8	Emphysema distribution in smoking;
SKCM	cis	rs9611565	0.840	rs9607799	chr22:41777558	A/G	cg03806693	chr22:41940476	POLR3H	-0.86	-5.89	-0.55	9.19e-8	Vitiligo;
SKCM	cis	rs826838	1.000	rs7315028	chr12:38710523	G/A	cg13010199	chr12:38710504	ALG10B	0.87	6.82	0.61	1.76e-9	Heart rate;
SKCM	cis	rs1691799	0.899	rs1168302	chr12:66737518	C/T	cg16791601	chr12:66731901	HELB	-0.66	-5.81	-0.55	1.31e-7	White blood cell count (basophil);
SKCM	cis	rs10905065	0.862	rs9423948	chr10:5742491	G/A	cg11519256	chr10:5708881	ASB13	0.6	5.49	0.53	4.89e-7	Menopause (age at onset);
SKCM	cis	rs3862260	0.509	rs3795662	chr1:120165135	G/T	cg16322792	chr1:120165303	ZNF697	0.5	5.32	0.52	9.47e-7	Systemic lupus erythematosus;
SKCM	cis	rs7216064	0.953	rs4791300	chr17:65930772	A/G	cg12091567	chr17:66097778	LOC651250	-0.78	-5.34	-0.52	8.92e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs2644899	0.750	rs2607414	chr19:41267129	C/T	cg24958765	chr19:41283667	RAB4B	0.84	5.34	0.52	8.92e-7	Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs2836950	0.501	rs2836980	chr21:40687618	G/T	cg17971929	chr21:40555470	PSMG1	-0.64	-5.1	-0.5	2.31e-6	Menarche (age at onset);
SKCM	cis	rs6866344	0.570	rs1071882	chr5:178136040	C/T	cg03877680	chr5:178157825	ZNF354A	0.92	7.46	0.65	1.04e-10	Neutrophil percentage of white cells;
SKCM	cis	rs2243480	1.000	rs431076	chr7:65600320	A/C	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs11098499	0.954	rs17046116	chr4:120387259	G/A	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs8067545	0.586	rs2526478	chr17:20130452	A/G	cg13482628	chr17:19912719	NA	0.66	5.59	0.53	3.23e-7	Schizophrenia;
SKCM	cis	rs28595532	0.920	rs17259173	chr4:119777232	T/C	cg21605333	chr4:119757512	SEC24D	1.41	8.39	0.69	1.68e-12	Cannabis dependence symptom count;
SKCM	cis	rs362272	0.524	rs10937924	chr4:3374898	T/C	cg24015175	chr4:3319247	RGS12	0.82	9.7	0.74	4.86e-15	Serum sulfate level;
SKCM	cis	rs9549367	0.713	rs9549691	chr13:113861606	A/C	cg24722198	chr13:113567732	NA	0.5	5.15	0.5	1.92e-6	Platelet distribution width;
SKCM	cis	rs7959452	0.535	rs7308481	chr12:69659299	A/G	cg14784868	chr12:69753453	YEATS4	0.63	5.53	0.53	4.18e-7	Blood protein levels;
SKCM	cis	rs2952156	0.920	rs2934956	chr17:37830447	T/A	cg20243544	chr17:37824526	PNMT	0.75	6.2	0.57	2.48e-8	Asthma;
SKCM	cis	rs11098499	0.722	rs1814814	chr4:120258124	C/G	cg09307838	chr4:120376055	NA	1.01	8.56	0.7	7.76e-13	Corneal astigmatism;
SKCM	cis	rs801193	0.660	rs10950049	chr7:66230860	T/C	cg11764359	chr7:65958608	NA	0.83	7.7	0.66	3.62e-11	Aortic root size;
SKCM	cis	rs478304	0.619	rs10896028	chr11:65432187	A/T	cg27068330	chr11:65405492	SIPA1	-0.86	-7.05	-0.62	6.38e-10	Acne (severe);
SKCM	cis	rs6121246	0.697	rs6060446	chr20:30231637	T/C	cg11595048	chr20:30225325	COX4I2	0.65	5.19	0.51	1.62e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs2197308	0.692	rs1904964	chr12:37933241	T/A	cg26384229	chr12:38710491	ALG10B	0.81	6.59	0.6	4.69e-9	Morning vs. evening chronotype;
SKCM	cis	rs2346177	0.542	rs13020043	chr2:46698431	A/T	cg02822958	chr2:46747628	ATP6V1E2	0.71	5.3	0.51	1.03e-6	HDL cholesterol;
SKCM	cis	rs2832191	1.000	rs2832191	chr21:30489300	A/C	cg24692254	chr21:30365293	RNF160	-0.76	-6.91	-0.62	1.17e-9	Dental caries;
SKCM	cis	rs10754283	0.934	rs6661282	chr1:90119992	C/T	cg21401794	chr1:90099060	LRRC8C	0.73	6.2	0.57	2.51e-8	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs7296418	0.922	rs1727293	chr12:123648032	C/T	cg06742321	chr12:123595122	PITPNM2	0.67	5.5	0.53	4.59e-7	Platelet count;
SKCM	cis	rs1799949	1.000	rs35956818	chr17:41422985	T/C	cg23758822	chr17:41437982	NA	0.93	7.88	0.67	1.62e-11	Menopause (age at onset);
SKCM	cis	rs2952156	0.920	rs12150298	chr17:37834541	T/C	cg20243544	chr17:37824526	PNMT	0.71	5.74	0.54	1.74e-7	Asthma;
SKCM	cis	rs2228479	0.850	rs57267516	chr16:89903552	G/A	cg06558623	chr16:89946397	TCF25	1.1	4.97	0.49	3.93e-6	Skin colour saturation;
SKCM	cis	rs2842992	0.714	rs2475564	chr6:160123673	A/G	cg11366901	chr6:160182831	ACAT2	0.86	6.69	0.6	3.01e-9	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs911555	0.504	rs8021368	chr14:104074810	G/A	cg24130564	chr14:104152367	KLC1	-0.58	-5.11	-0.5	2.27e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7772486	0.686	rs4896833	chr6:145965673	T/G	cg23711669	chr6:146136114	FBXO30	0.9	10.02	0.75	1.16e-15	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs28595532	0.920	rs116795224	chr4:119734570	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.43	0.59	9.38e-9	Cannabis dependence symptom count;
SKCM	cis	rs3091242	0.904	rs6661533	chr1:25771715	A/G	cg27572855	chr1:25598939	RHD	0.53	5.06	0.5	2.67e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs1577917	1.000	rs35419329	chr6:86702291	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.64	-5.54	-0.53	3.92e-7	Response to antipsychotic treatment;
SKCM	cis	rs5769765	0.862	rs9616386	chr22:50313179	G/A	cg22709217	chr22:50311962	ALG12;CRELD2	-0.94	-5.91	-0.56	8.37e-8	Schizophrenia;
SKCM	cis	rs11626933	1.000	rs3742669	chr14:90767746	C/A	cg14092571	chr14:90743983	NA	0.87	8.75	0.7	3.28e-13	Gut microbiota (bacterial taxa);
SKCM	cis	rs8180040	0.966	rs62260711	chr3:47564491	G/C	cg16586182	chr3:47516702	SCAP	0.74	5.04	0.5	2.89e-6	Colorectal cancer;
SKCM	cis	rs6752107	1.000	rs2289472	chr2:234182240	C/T	cg07618928	chr2:234183455	ATG16L1;SCARNA5	0.56	4.77	0.48	8.37e-6	Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs763014	0.865	rs2384977	chr16:625388	C/T	cg07343612	chr16:622815	PIGQ	-0.69	-5.73	-0.54	1.84e-7	Height;
SKCM	cis	rs1005277	0.579	rs1740737	chr10:38499365	G/T	cg00409905	chr10:38381863	ZNF37A	-0.6	-5.14	-0.5	1.96e-6	Extrinsic epigenetic age acceleration;
SKCM	cis	rs9814567	1.000	rs9990351	chr3:134239191	A/T	cg06109529	chr3:134205091	CEP63;ANAPC13	0.62	4.97	0.49	3.92e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	trans	rs66573146	0.831	rs6851488	chr4:6987412	C/T	cg07817883	chr1:32538562	TMEM39B	1.94	8.42	0.69	1.47e-12	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs875971	0.755	rs76288834	chr7:66069802	G/A	cg18876405	chr7:65276391	NA	-0.63	-6.32	-0.58	1.5e-8	Aortic root size;
SKCM	cis	rs2033711	0.783	rs8113810	chr19:58932106	A/G	cg00825309	chr19:58991885	ZNF446	-0.69	-5.6	-0.54	3.08e-7	Uric acid clearance;
SKCM	cis	rs6665290	0.582	rs72764213	chr1:227207391	C/T	cg10327440	chr1:227177885	CDC42BPA	-1.2	-16.22	-0.88	1.04e-26	Myeloid white cell count;
SKCM	cis	rs362296	0.698	rs3135172	chr4:3258735	A/G	cg24015175	chr4:3319247	RGS12	-0.65	-5.94	-0.56	7.49e-8	Parental longevity (mother's age at death);
SKCM	cis	rs7772486	0.875	rs7739418	chr6:146359188	G/A	cg05347473	chr6:146136440	FBXO30	0.57	5.12	0.5	2.13e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4803468	1.000	rs2241708	chr19:41912270	C/T	cg14132834	chr19:41945861	ATP5SL	-0.77	-6.08	-0.57	4.18e-8	Height;
SKCM	cis	rs1062177	1.000	rs17741826	chr5:151149262	C/T	cg00977110	chr5:151150581	G3BP1	-0.79	-6.51	-0.59	6.71e-9	Preschool internalizing problems;
SKCM	cis	rs1044826	0.619	rs57357132	chr3:139118358	A/T	cg15131784	chr3:139108705	COPB2	-0.68	-5.03	-0.49	3.1e-6	Obesity-related traits;
SKCM	trans	rs1814175	0.615	rs4545557	chr11:50027329	A/C	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs7666738	0.830	rs10440379	chr4:98902822	G/T	cg17366294	chr4:99064904	C4orf37	0.57	4.85	0.48	6.12e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs992157	0.710	rs13026485	chr2:219057984	C/T	cg20019365	chr2:219134978	PNKD;AAMP	-0.72	-6.34	-0.58	1.38e-8	Colorectal cancer;
SKCM	cis	rs7772486	0.641	rs9390370	chr6:146357569	C/T	cg05347473	chr6:146136440	FBXO30	0.68	5.68	0.54	2.22e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2658782	0.547	rs3020054	chr11:93055556	C/T	cg15737290	chr11:93063684	CCDC67	0.96	9.08	0.72	7.5e-14	Pulmonary function decline;
SKCM	cis	rs6866344	0.697	rs6873150	chr5:178125704	G/A	cg03877680	chr5:178157825	ZNF354A	0.8	5.58	0.53	3.3e-7	Neutrophil percentage of white cells;
SKCM	cis	rs514406	0.798	rs504816	chr1:53307957	T/G	cg08859206	chr1:53392774	SCP2	-0.64	-5.03	-0.5	3.04e-6	Monocyte count;
SKCM	cis	rs668210	0.793	rs506873	chr11:65767215	A/C	cg20909159	chr11:65625947	CFL1	0.72	4.89	0.48	5.24e-6	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs634534	0.591	rs688862	chr11:65733393	A/G	cg26695010	chr11:65641043	EFEMP2	-0.64	-5.07	-0.5	2.58e-6	Sum eosinophil basophil counts;Eosinophil counts;
SKCM	cis	rs1348850	0.567	rs2222711	chr2:178534110	G/T	cg22681709	chr2:178499509	PDE11A	-0.64	-5.62	-0.54	2.85e-7	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs829883	0.872	rs1641637	chr12:98890564	G/A	cg25150519	chr12:98850993	NA	0.5	5.3	0.51	1.07e-6	Colorectal adenoma (advanced);
SKCM	cis	rs7100689	0.577	rs1143694	chr10:82040052	C/T	cg01528321	chr10:82214614	TSPAN14	-0.81	-7.65	-0.65	4.37e-11	Post bronchodilator FEV1;
SKCM	cis	rs7954584	0.545	rs12824593	chr12:122374108	G/A	cg21171335	chr12:122356390	WDR66	0.46	4.99	0.49	3.52e-6	Mean corpuscular volume;
SKCM	cis	rs7772486	0.790	rs2265918	chr6:146219164	A/G	cg23711669	chr6:146136114	FBXO30	0.78	7.7	0.66	3.53e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9300255	0.602	rs949142	chr12:123634043	T/C	cg00376283	chr12:123451042	ABCB9	0.8	5.4	0.52	7.12e-7	Neutrophil percentage of white cells;
SKCM	cis	rs7811142	1.000	rs68116612	chr7:100006493	G/A	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.23	8.03	0.67	8.33e-12	Platelet count;
SKCM	cis	rs4319547	0.915	rs3803005	chr12:123110654	T/C	cg23029597	chr12:123009494	RSRC2	-0.78	-5.99	-0.56	6.19e-8	Body mass index;
SKCM	cis	rs8060686	0.641	rs8044014	chr16:68209872	T/C	cg09117114	chr16:67998030	SLC12A4	-0.78	-5.08	-0.5	2.56e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs4803468	0.905	rs284662	chr19:41932275	T/C	cg14132834	chr19:41945861	ATP5SL	-0.77	-6.04	-0.56	4.87e-8	Height;
SKCM	cis	rs7666738	0.830	rs34890015	chr4:99023769	A/T	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2760061	0.819	rs708112	chr1:228192452	G/A	cg02753203	chr1:228287806	NA	0.69	5.77	0.55	1.51e-7	Diastolic blood pressure;
SKCM	cis	rs9309711	0.772	rs9752251	chr2:3489869	C/T	cg10845886	chr2:3471009	TTC15	-0.76	-5.38	-0.52	7.66e-7	Neurofibrillary tangles;
SKCM	cis	rs11822910	0.645	rs7122734	chr11:57190420	C/T	cg00522883	chr11:57194120	SLC43A3	-0.66	-5.07	-0.5	2.59e-6	Platelet distribution width;
SKCM	cis	rs8070624	0.543	rs57728924	chr17:17875342	A/G	cg04398451	chr17:18023971	MYO15A	-0.8	-6.01	-0.56	5.59e-8	Total body bone mineral density;
SKCM	cis	rs992157	0.710	rs6752254	chr2:219058743	C/T	cg00012203	chr2:219082015	ARPC2	0.85	7.47	0.65	1.01e-10	Colorectal cancer;
SKCM	cis	rs2836974	0.897	rs8132295	chr21:40527774	A/G	cg11890956	chr21:40555474	PSMG1	-1.07	-13.19	-0.83	1.48e-21	Cognitive function;
SKCM	cis	rs9300255	0.664	rs28636834	chr12:123871070	A/C	cg05973401	chr12:123451056	ABCB9	-0.83	-5.78	-0.55	1.47e-7	Neutrophil percentage of white cells;
SKCM	cis	rs1801251	1.000	rs11555646	chr2:233599904	A/C	cg08000102	chr2:233561755	GIGYF2	0.87	7.05	0.62	6.23e-10	Coronary artery disease;
SKCM	cis	rs701145	0.640	rs357495	chr3:153939099	A/G	cg17054900	chr3:154042577	DHX36	1.19	5.1	0.5	2.37e-6	Coronary artery disease;
SKCM	cis	rs11098499	0.569	rs10023641	chr4:120258410	C/G	cg09307838	chr4:120376055	NA	0.97	8.31	0.69	2.31e-12	Corneal astigmatism;
SKCM	cis	rs7666738	0.753	rs9991512	chr4:99007205	T/C	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs71520386	0.632	rs12532938	chr7:22860495	A/C	cg00309339	chr7:22893653	NA	0.67	4.97	0.49	3.82e-6	Fibrinogen levels;
SKCM	cis	rs2836974	0.965	rs8134733	chr21:40683459	C/T	cg11890956	chr21:40555474	PSMG1	0.99	11.24	0.79	5.58e-18	Cognitive function;
SKCM	cis	rs362296	0.530	rs3129316	chr4:3287906	A/G	cg11471262	chr4:3318911	RGS12	0.81	8.32	0.69	2.28e-12	Parental longevity (mother's age at death);
SKCM	cis	rs6582630	0.555	rs10880544	chr12:38473464	G/C	cg26384229	chr12:38710491	ALG10B	0.81	6.22	0.58	2.31e-8	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs875971	0.862	rs1981799	chr7:65955559	T/C	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs780096	0.527	rs59644396	chr2:27646083	A/G	cg05696406	chr2:27599888	SNX17	0.49	5.07	0.5	2.62e-6	Total body bone mineral density;
SKCM	cis	rs854765	0.583	rs8078583	chr17:17811465	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.93	7.3	0.64	2.06e-10	Total body bone mineral density;
SKCM	cis	rs1850744	0.702	rs115723792	chr4:9570902	C/G	cg15442990	chr4:9534313	NA	-1.42	-5.71	-0.54	1.92e-7	Economic and political preferences;
SKCM	cis	rs17685	0.712	rs10235738	chr7:75773460	G/A	cg16489192	chr7:75678113	MDH2;STYXL1	-0.52	-4.78	-0.48	8.22e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs8103278	0.507	rs4802276	chr19:46260748	T/C	cg11657440	chr19:46296263	DMWD	1.06	10.47	0.76	1.56e-16	Coronary artery disease;
SKCM	cis	rs1799949	0.965	rs34616041	chr17:41188786	G/A	cg25918947	chr17:41365094	TMEM106A	-0.61	-5.87	-0.55	1e-7	Menopause (age at onset);
SKCM	cis	rs365132	0.934	rs149307	chr5:176471591	C/T	cg16309518	chr5:176445507	NA	-0.49	-4.77	-0.48	8.4e-6	Menarche and menopause (age at onset);Menopause (age at onset);
SKCM	cis	rs501120	1.000	rs503859	chr10:44753560	G/C	cg09554077	chr10:44749378	NA	0.38	4.93	0.49	4.52e-6	Coronary artery disease;Coronary heart disease;
SKCM	cis	rs10779751	0.959	rs2092642	chr1:11317320	C/T	cg08854313	chr1:11322531	MTOR	1.04	10.13	0.75	7.04e-16	Body mass index;
SKCM	cis	rs597539	0.690	rs647661	chr11:68625875	T/C	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.82	5.51	0.53	4.49e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs6061231	0.701	rs6061505	chr20:60960211	G/A	cg24112000	chr20:60950667	NA	-0.61	-6.27	-0.58	1.89e-8	Colorectal cancer;
SKCM	cis	rs34891900	0.507	rs12167823	chr22:18124362	G/A	cg19898043	chr22:18121309	BCL2L13	0.65	4.78	0.48	8.04e-6	Sum neutrophil eosinophil counts;
SKCM	cis	rs2304069	0.954	rs10045945	chr5:149419297	C/T	cg22760475	chr5:149380129	HMGXB3;TIGD6	0.88	5.87	0.55	9.98e-8	HIV-1 control;
SKCM	cis	rs17065868	1.000	rs9533938	chr13:45222796	T/A	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs9814567	0.964	rs9815983	chr3:134222507	G/T	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.66	-5.15	-0.5	1.88e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs1577917	1.000	rs68171315	chr6:86707400	A/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.83	-8.23	-0.68	3.37e-12	Response to antipsychotic treatment;
SKCM	cis	rs6952808	0.692	rs11773316	chr7:2027354	C/T	cg21782813	chr7:2030301	MAD1L1	0.58	5.96	0.56	6.79e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs8070128	0.688	rs59304093	chr17:17875407	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.01	8.61	0.7	6.26e-13	Total body bone mineral density;
SKCM	cis	rs7215564	0.908	rs35374347	chr17:78642244	C/T	cg16980736	chr17:78789706	RPTOR	-0.9	-4.87	-0.48	5.65e-6	Myopia (pathological);
SKCM	cis	rs28386778	0.863	rs2584637	chr17:61942952	T/C	cg06873352	chr17:61820015	STRADA	0.74	6.15	0.57	3.13e-8	Prudent dietary pattern;
SKCM	cis	rs9300255	0.679	rs28583837	chr12:123863620	G/A	cg05973401	chr12:123451056	ABCB9	-0.82	-5.72	-0.54	1.92e-7	Neutrophil percentage of white cells;
SKCM	cis	rs7786877	0.500	rs2272572	chr7:100285888	C/T	cg20848291	chr7:100343083	ZAN	-0.71	-5.38	-0.52	7.53e-7	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs58688157	0.705	rs12803132	chr11:586696	A/G	cg17114584	chr11:613792	IRF7	0.86	5.74	0.54	1.74e-7	Systemic lupus erythematosus;
SKCM	cis	rs11614062	1.000	rs11614062	chr12:93956672	A/T	cg18151635	chr12:93972918	NA	-0.77	-6.19	-0.57	2.56e-8	Height;
SKCM	cis	rs8067545	0.611	rs2703775	chr17:20134466	A/G	cg13482628	chr17:19912719	NA	-0.65	-5.44	-0.52	5.84e-7	Schizophrenia;
SKCM	cis	rs7208859	0.673	rs9907197	chr17:29018263	C/T	cg14067834	chr17:29058358	SUZ12P	1.0	5.43	0.52	6.23e-7	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs9381040	0.655	rs9381032	chr6:41044986	A/T	cg04346459	chr6:41068666	NFYA;LOC221442	-0.71	-5.0	-0.49	3.5e-6	Alzheimer's disease (late onset);
SKCM	cis	rs478304	0.651	rs11600918	chr11:65511965	A/G	cg17480646	chr11:65405466	SIPA1	-0.7	-5.63	-0.54	2.68e-7	Acne (severe);
SKCM	cis	rs2839186	0.872	rs13052495	chr21:47707474	G/A	cg13126279	chr21:47581558	C21orf56	-0.64	-5.47	-0.53	5.17e-7	Testicular germ cell tumor;
SKCM	cis	rs12478296	0.681	rs55802421	chr2:243033962	C/T	cg06360820	chr2:242988706	NA	-0.91	-5.31	-0.52	1.01e-6	Obesity-related traits;
SKCM	cis	rs7584330	0.666	rs937386	chr2:238364039	C/T	cg14458575	chr2:238380390	NA	1.07	7.26	0.64	2.49e-10	Prostate cancer;
SKCM	cis	rs6753739	0.784	rs10168527	chr2:219972375	G/C	cg09617556	chr2:219924408	IHH	0.48	5.08	0.5	2.5e-6	Height;
SKCM	cis	rs2197308	0.765	rs68029712	chr12:37906585	T/G	cg26384229	chr12:38710491	ALG10B	0.82	6.88	0.61	1.35e-9	Morning vs. evening chronotype;
SKCM	cis	rs6500395	0.926	rs11645193	chr16:48594229	C/T	cg04672837	chr16:48644449	N4BP1	0.69	5.73	0.54	1.8e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs34779708	0.966	rs4934539	chr10:35472199	A/G	cg03585969	chr10:35415529	CREM	0.75	6.23	0.58	2.19e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs4234284	1.000	rs13094201	chr3:126957294	A/G	cg04889221	chr3:126137216	CCDC37	-0.45	-4.78	-0.48	8e-6	Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel);
SKCM	cis	rs7666738	0.791	rs4699329	chr4:99056212	G/A	cg05340658	chr4:99064831	C4orf37	0.67	5.08	0.5	2.51e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs5417	1.000	rs5417	chr17:7185062	C/A	cg25256661	chr17:7137939	DVL2	-0.81	-6.59	-0.6	4.68e-9	Diastolic blood pressure;
SKCM	cis	rs2841277	0.708	rs10083490	chr14:105402418	A/G	cg19901468	chr14:105411992	AHNAK2	0.97	7.79	0.66	2.38e-11	Rheumatoid arthritis;
SKCM	cis	rs7082209	0.528	rs12412586	chr10:44851778	C/T	cg17436666	chr10:44806146	NA	0.93	4.95	0.49	4.26e-6	Resistance to Mycobacterium tuberculosis in HIV-positive individuals measured by a negative tuberculin skin test (continuous);
SKCM	trans	rs561341	1.000	rs510264	chr17:30323414	A/G	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs4740619	0.630	rs1169480	chr9:15895834	T/G	cg14451791	chr9:16040625	NA	0.44	5.15	0.5	1.92e-6	Body mass index;
SKCM	cis	rs1707322	1.000	rs3922886	chr1:46473902	A/T	cg03146154	chr1:46216737	IPP	0.75	5.11	0.5	2.24e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs875971	0.660	rs801192	chr7:66031952	C/G	cg11987759	chr7:65425863	GUSB	0.69	5.9	0.56	8.74e-8	Aortic root size;
SKCM	cis	rs28595532	0.545	rs72677057	chr4:119264162	A/T	cg21605333	chr4:119757512	SEC24D	0.96	5.21	0.51	1.47e-6	Cannabis dependence symptom count;
SKCM	cis	rs28595532	0.668	rs56410164	chr4:119331625	A/G	cg21605333	chr4:119757512	SEC24D	0.95	4.91	0.49	4.92e-6	Cannabis dependence symptom count;
SKCM	cis	rs2645694	0.532	rs2645706	chr4:77829606	A/C	cg03477792	chr4:77819574	ANKRD56	0.57	6.42	0.59	9.57e-9	Emphysema distribution in smoking;
SKCM	cis	rs2645694	0.533	rs2645681	chr4:77820949	G/A	cg03477792	chr4:77819574	ANKRD56	0.57	6.38	0.59	1.18e-8	Emphysema distribution in smoking;
SKCM	cis	rs1153858	1.000	rs10519022	chr15:45663684	C/T	cg10760299	chr15:45669010	GATM	-0.61	-6.08	-0.57	4.11e-8	Homoarginine levels;
SKCM	cis	rs1801516	0.950	rs17108024	chr11:108333536	C/T	cg17114932	chr11:108092898	ATM;NPAT	-1.11	-5.0	-0.49	3.43e-6	Melanoma;
SKCM	cis	rs1218582	0.772	rs6656435	chr1:154876869	G/A	cg03351412	chr1:154909251	PMVK	0.77	6.52	0.59	6.43e-9	Prostate cancer;
SKCM	cis	rs6582630	0.555	rs7305352	chr12:38473800	T/C	cg26384229	chr12:38710491	ALG10B	0.87	6.82	0.61	1.76e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs17065868	1.000	rs12184878	chr13:45115319	C/T	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs77106637	0.860	rs7129793	chr11:72455885	C/T	cg03713592	chr11:72463424	ARAP1	1.07	5.58	0.53	3.38e-7	Type 2 diabetes;
SKCM	cis	rs11098499	0.874	rs10022508	chr4:120115228	A/G	cg09307838	chr4:120376055	NA	0.86	6.08	0.57	4.13e-8	Corneal astigmatism;
SKCM	cis	rs6582630	0.555	rs7305352	chr12:38473800	T/C	cg13010199	chr12:38710504	ALG10B	0.69	4.9	0.49	5.02e-6	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs523522	0.962	rs55848094	chr12:120966659	G/A	cg27279351	chr12:120934652	DYNLL1	0.91	8.32	0.69	2.26e-12	High light scatter reticulocyte count;
SKCM	cis	rs1552244	1.000	rs17032277	chr3:10077023	T/C	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs2243480	1.000	rs2177703	chr7:65391717	C/A	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs7666738	0.791	rs2081622	chr4:98927369	T/C	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs12142240	0.698	rs966907	chr1:46817125	C/G	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs9913156	0.793	rs55677157	chr17:4576620	C/T	cg19197139	chr17:4613644	ARRB2	0.78	5.09	0.5	2.38e-6	Lymphocyte counts;
SKCM	cis	rs75920871	0.588	rs4548653	chr11:116903316	G/A	cg01368799	chr11:117014884	PAFAH1B2	-0.64	-4.92	-0.49	4.78e-6	Subjective well-being;
SKCM	cis	rs995000	0.839	rs1168028	chr1:62969431	G/A	cg06896770	chr1:63153194	DOCK7	-0.62	-5.59	-0.54	3.15e-7	Triglyceride levels;
SKCM	cis	rs10791097	0.667	rs1893019	chr11:130756664	C/G	cg12179176	chr11:130786555	SNX19	0.91	8.08	0.67	6.64e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs6430585	0.591	rs3098103	chr2:136656094	T/C	cg07169764	chr2:136633963	MCM6	1.32	11.41	0.79	2.72e-18	Corneal structure;
SKCM	cis	rs2153535	0.601	rs1737581	chr6:8539138	A/G	cg23788917	chr6:8435910	SLC35B3	0.7	4.93	0.49	4.59e-6	Motion sickness;
SKCM	cis	rs854765	0.964	rs854810	chr17:18006421	G/C	cg04398451	chr17:18023971	MYO15A	0.62	4.85	0.48	6.29e-6	Total body bone mineral density;
SKCM	cis	rs6088590	0.561	rs6059932	chr20:33175466	C/T	cg24642439	chr20:33292090	TP53INP2	0.76	5.84	0.55	1.13e-7	Coronary artery disease;
SKCM	cis	rs12926788	0.640	rs73551577	chr16:24845143	G/A	cg00339695	chr16:24857497	SLC5A11	0.77	6.53	0.59	6.12e-9	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs9325144	0.723	rs1586373	chr12:39181582	G/A	cg26384229	chr12:38710491	ALG10B	-0.7	-6.44	-0.59	9.12e-9	Morning vs. evening chronotype;
SKCM	cis	rs6840360	0.615	rs4696266	chr4:152463421	A/G	cg22705602	chr4:152727874	NA	-0.51	-5.78	-0.55	1.45e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs6121246	0.559	rs6058465	chr20:30397691	G/A	cg11595048	chr20:30225325	COX4I2	0.54	4.77	0.48	8.4e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs208520	1.000	rs208529	chr6:66957549	T/C	cg07460842	chr6:66804631	NA	-0.84	-5.89	-0.55	9.44e-8	Exhaled nitric oxide output;
SKCM	cis	rs7100689	0.646	rs1538823	chr10:82088040	C/A	cg01528321	chr10:82214614	TSPAN14	0.76	6.26	0.58	1.94e-8	Post bronchodilator FEV1;
SKCM	cis	rs561341	1.000	rs8077092	chr17:30281992	T/C	cg00745463	chr17:30367425	LRRC37B	-1.11	-7.66	-0.66	4.35e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs748404	0.560	rs1869258	chr15:43803621	A/C	cg02155558	chr15:43621948	ADAL;LCMT2	0.71	5.37	0.52	7.82e-7	Lung cancer;
SKCM	cis	rs9325144	0.600	rs11183505	chr12:38759110	G/T	cg26384229	chr12:38710491	ALG10B	-0.75	-6.52	-0.59	6.23e-9	Morning vs. evening chronotype;
SKCM	cis	rs617791	0.530	rs10791835	chr11:65750924	C/A	cg27068330	chr11:65405492	SIPA1	-0.68	-4.9	-0.49	5.12e-6	Breast cancer;
SKCM	cis	rs2645694	0.626	rs2703116	chr4:77824289	C/T	cg06046430	chr4:77819534	ANKRD56	-0.55	-6.04	-0.56	4.92e-8	Emphysema distribution in smoking;
SKCM	cis	rs28595532	0.920	rs115372254	chr4:119771735	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs11428934	1	rs11428934	chr19:49144245	T/TG	cg06677660	chr19:49140777	SEC1;DBP	0.87	6.34	0.58	1.35e-8	Sum neutrophil eosinophil counts;Sum basophil neutrophil counts;Neutrophil count;Granulocyte count;
SKCM	cis	rs7659604	0.537	rs6823818	chr4:122731699	G/C	cg06713675	chr4:122721982	EXOSC9	-0.75	-7.26	-0.64	2.47e-10	Type 2 diabetes;
SKCM	cis	rs7959452	0.590	rs56054057	chr12:69775972	C/T	cg14784868	chr12:69753453	YEATS4	0.8	7.56	0.65	6.53e-11	Blood protein levels;
SKCM	cis	rs5753618	0.554	rs5753648	chr22:31879465	A/G	cg02404636	chr22:31891804	SFI1	0.68	5.91	0.56	8.36e-8	Colorectal cancer;
SKCM	cis	rs769267	1.000	rs2074089	chr19:19449603	G/A	cg03709012	chr19:19516395	GATAD2A	-0.84	-6.79	-0.61	1.97e-9	Tonsillectomy;
SKCM	cis	rs7809950	0.678	rs7803151	chr7:106934246	G/A	cg23024343	chr7:107201750	COG5	-0.78	-6.7	-0.6	2.97e-9	Coronary artery disease;
SKCM	cis	rs2204008	0.640	rs2320744	chr12:38162389	A/G	cg13010199	chr12:38710504	ALG10B	0.65	4.84	0.48	6.52e-6	Bladder cancer;
SKCM	cis	rs870825	1.000	rs9995633	chr4:185584441	C/T	cg04058563	chr4:185651563	MLF1IP	1.09	5.66	0.54	2.4e-7	Blood protein levels;
SKCM	trans	rs561341	0.660	rs7406043	chr17:30220152	C/G	cg20587970	chr11:113659929	NA	-1.06	-8.37	-0.69	1.82e-12	Hip circumference adjusted for BMI;
SKCM	cis	rs826838	1.000	rs4768328	chr12:39129315	C/T	cg26384229	chr12:38710491	ALG10B	-0.91	-8.28	-0.68	2.74e-12	Heart rate;
SKCM	cis	rs2404602	0.647	rs7181506	chr15:76935677	G/T	cg23625390	chr15:77176239	SCAPER	0.85	8.52	0.69	9.1e-13	Blood metabolite levels;
SKCM	cis	rs7927771	0.832	rs10769258	chr11:47391039	C/T	cg05585544	chr11:47624801	NA	0.56	4.84	0.48	6.52e-6	Subjective well-being;
SKCM	cis	rs7980687	0.628	rs2851443	chr12:123694250	C/T	cg00376283	chr12:123451042	ABCB9	0.86	6.55	0.6	5.68e-9	Height;Educational attainment;Head circumference (infant);
SKCM	cis	rs6087990	0.735	rs1040555	chr20:31380201	A/T	cg13636640	chr20:31349939	DNMT3B	-0.87	-6.71	-0.61	2.77e-9	Ulcerative colitis;
SKCM	cis	rs6546550	0.901	rs6721891	chr2:70146121	A/G	cg02498382	chr2:70120550	SNRNP27	-0.45	-4.88	-0.48	5.4e-6	Prevalent atrial fibrillation;
SKCM	cis	rs798554	0.836	rs2260230	chr7:2822986	T/A	cg19346786	chr7:2764209	NA	-0.66	-7.19	-0.63	3.45e-10	Height;
SKCM	cis	rs2228479	0.541	rs9922515	chr16:89954138	G/C	cg00800038	chr16:89945340	TCF25	-0.93	-5.57	-0.53	3.49e-7	Skin colour saturation;
SKCM	cis	rs55823223	0.752	rs34974290	chr17:73888354	G/A	cg10935138	chr17:73851978	WBP2	1.14	6.46	0.59	8.19e-9	Psoriasis;
SKCM	cis	rs6835098	1.000	rs10031414	chr4:174084953	A/C	cg08422745	chr4:174089978	GALNT7	-0.83	-6.46	-0.59	8.18e-9	Dementia and core Alzheimer's disease neuropathologic changes;
SKCM	cis	rs28595532	1.000	rs17323012	chr4:119605671	A/G	cg11846333	chr4:119757529	SEC24D	1.22	5.73	0.54	1.78e-7	Cannabis dependence symptom count;
SKCM	cis	rs6951245	1.000	rs78185558	chr7:1090183	G/C	cg24642844	chr7:1081250	C7orf50	-0.94	-6.32	-0.58	1.48e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7772486	0.720	rs6570713	chr6:146075085	G/A	cg05347473	chr6:146136440	FBXO30	-0.6	-5.68	-0.54	2.21e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7666738	0.830	rs34890015	chr4:99023769	A/T	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	trans	rs1814175	0.817	rs4881658	chr11:49941123	G/A	cg15704280	chr7:45808275	SEPT13	-1.06	-11.16	-0.78	7.82e-18	Height;
SKCM	cis	rs4073582	0.595	rs1115508	chr11:65923149	A/G	cg16950941	chr11:66035639	RAB1B	0.86	7.29	0.64	2.22e-10	Gout;
SKCM	cis	rs2839186	0.903	rs61182475	chr21:47707050	T/A	cg13012494	chr21:47604986	C21orf56	0.67	5.71	0.54	1.95e-7	Testicular germ cell tumor;
SKCM	cis	rs8067545	0.750	rs4924804	chr17:19991839	C/T	cg13482628	chr17:19912719	NA	0.73	6.46	0.59	8.09e-9	Schizophrenia;
SKCM	cis	rs798766	1.000	rs11729657	chr4:1737585	T/C	cg05874882	chr4:1763078	NA	-0.56	-4.89	-0.48	5.37e-6	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs7811142	1.000	rs11771419	chr7:99988403	A/G	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-1.0	-5.66	-0.54	2.36e-7	Platelet count;
SKCM	cis	rs9660180	0.868	rs12567685	chr1:1806647	T/C	cg17747265	chr1:1875780	NA	-0.58	-5.2	-0.51	1.55e-6	Body mass index;
SKCM	cis	rs873917	0.577	rs784611	chr1:40125988	T/A	cg21785781	chr1:39339218	MYCBP	-0.69	-5.12	-0.5	2.18e-6	Amyotrophic lateral sclerosis;
SKCM	cis	rs6087990	0.735	rs910083	chr20:31378690	A/C	cg13636640	chr20:31349939	DNMT3B	0.83	6.36	0.58	1.28e-8	Ulcerative colitis;
SKCM	cis	rs7208859	0.623	rs11658022	chr17:29085359	A/T	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs28386778	0.897	rs7210443	chr17:61785374	A/G	cg22520471	chr17:61851767	DDX42;CCDC47	0.79	5.35	0.52	8.58e-7	Prudent dietary pattern;
SKCM	cis	rs1799949	0.896	rs33933393	chr17:41317432	C/T	cg05368731	chr17:41323189	NBR1	0.89	7.98	0.67	1.03e-11	Menopause (age at onset);
SKCM	cis	rs10256972	0.616	rs6463001	chr7:1108272	A/C	cg16145915	chr7:1198662	ZFAND2A	-0.45	-5.34	-0.52	9.05e-7	Longevity;Endometriosis;
SKCM	cis	rs17065868	0.881	rs61947996	chr13:45164330	A/G	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs9475752	0.793	rs35090265	chr6:56847813	A/G	cg06815302	chr6:57335405	PRIM2	0.59	4.78	0.48	8.1e-6	Menarche (age at onset);
SKCM	cis	rs7618501	0.633	rs12496973	chr3:50002245	T/C	cg05072774	chr3:49840536	C3orf54	-0.67	-5.06	-0.5	2.73e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs780096	0.546	rs1647284	chr2:27608115	C/T	cg05696406	chr2:27599888	SNX17	0.49	5.07	0.5	2.62e-6	Total body bone mineral density;
SKCM	cis	rs7666738	0.830	rs10022389	chr4:99022229	T/C	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	trans	rs1814175	0.676	rs1851859	chr11:49860405	A/T	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs796364	0.951	rs36086821	chr2:201067436	G/A	cg12253985	chr2:200820533	C2orf60;C2orf47	0.95	6.37	0.59	1.21e-8	Schizophrenia;
SKCM	cis	rs36093844	0.615	rs77258124	chr11:85578081	G/A	cg25872744	chr11:85566296	CCDC83	-0.85	-4.83	-0.48	6.66e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs62103177	0.608	rs4442895	chr18:77826399	C/G	cg27393146	chr18:77495563	CTDP1	0.81	6.0	0.56	5.9e-8	Opioid sensitivity;
SKCM	cis	rs9435341	0.965	rs9435441	chr1:107603330	C/G	cg09367891	chr1:107599246	PRMT6	-0.84	-7.24	-0.63	2.75e-10	Facial morphology (factor 21, depth of nasal alae);
SKCM	cis	rs250585	0.667	rs464162	chr16:23591715	C/G	cg09934309	chr16:23461721	COG7	-0.94	-6.18	-0.57	2.76e-8	Egg allergy;
SKCM	cis	rs1278769	0.786	rs9577175	chr13:113543355	C/T	cg00823993	chr13:113535758	ATP11A	0.61	5.36	0.52	8.16e-7	Interstitial lung disease;
SKCM	cis	rs10256972	0.721	rs4720249	chr7:1072563	C/G	cg07308232	chr7:1071921	C7orf50	-0.62	-5.28	-0.51	1.15e-6	Longevity;Endometriosis;
SKCM	trans	rs10506458	0.915	rs17738485	chr12:63394932	T/C	cg03429785	chr15:59498649	MYO1E;LDHAL6B	-1.38	-7.54	-0.65	7.13e-11	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs5769765	0.908	rs7410601	chr22:50317187	C/T	cg22709217	chr22:50311962	ALG12;CRELD2	-0.97	-5.83	-0.55	1.21e-7	Schizophrenia;
SKCM	cis	rs910316	0.967	rs4384542	chr14:75658013	A/C	cg11812906	chr14:75593930	NEK9	-0.74	-5.75	-0.55	1.69e-7	Height;
SKCM	cis	rs28595532	0.920	rs56027489	chr4:119780882	A/G	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs7772486	0.790	rs9376970	chr6:146241472	A/C	cg23711669	chr6:146136114	FBXO30	-0.79	-8.12	-0.68	5.39e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs11098499	0.954	rs9993199	chr4:120392873	A/G	cg09307838	chr4:120376055	NA	-0.98	-7.86	-0.66	1.75e-11	Corneal astigmatism;
SKCM	cis	rs4642101	0.737	rs4447735	chr3:12825513	C/T	cg05775895	chr3:12838266	CAND2	0.63	5.82	0.55	1.22e-7	QRS complex (12-leadsum);
SKCM	trans	rs7819412	0.749	rs11991118	chr8:10939273	A/C	cg06636001	chr8:8085503	FLJ10661	0.9	8.13	0.68	5.2e-12	Triglycerides;
SKCM	cis	rs9905704	0.624	rs34718875	chr17:57072461	G/A	cg12560992	chr17:57184187	TRIM37	0.74	6.06	0.57	4.62e-8	Testicular germ cell tumor;
SKCM	cis	rs7772486	0.875	rs1125461	chr6:146417653	C/T	cg23711669	chr6:146136114	FBXO30	0.84	8.1	0.68	6.12e-12	Lobe attachment (rater-scored or self-reported);
SKCM	trans	rs1814175	0.645	rs847632	chr11:49926097	C/T	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs28386778	0.897	rs2236737	chr17:61938100	C/T	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.36	0.52	8.37e-7	Prudent dietary pattern;
SKCM	cis	rs35306767	0.668	rs12356612	chr10:1055055	C/T	cg26597838	chr10:835615	NA	0.6	4.97	0.49	3.86e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs873946	0.586	rs3793684	chr10:134568645	G/A	cg27286337	chr10:134555280	INPP5A	0.99	8.98	0.71	1.2e-13	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs8072100	0.713	rs8075058	chr17:45482857	A/G	cg08085267	chr17:45401833	C17orf57	-0.62	-5.03	-0.49	3.05e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs9868809	0.505	rs9877685	chr3:48748588	C/T	cg00383909	chr3:49044727	WDR6	0.89	5.09	0.5	2.44e-6	Ulcerative colitis;Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs2836974	0.965	rs8130984	chr21:40639966	A/C	cg11644478	chr21:40555479	PSMG1	0.99	10.48	0.76	1.51e-16	Cognitive function;
SKCM	cis	rs2180341	0.781	rs7760652	chr6:127572096	A/G	cg27446573	chr6:127587934	RNF146	0.88	7.22	0.63	2.99e-10	Breast cancer;
SKCM	cis	rs1577917	0.958	rs7739241	chr6:86575796	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.39	-0.52	7.24e-7	Response to antipsychotic treatment;
SKCM	cis	rs936229	0.749	rs6495126	chr15:75175026	C/T	cg14664628	chr15:75095509	CSK	0.98	7.16	0.63	3.83e-10	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin);
SKCM	cis	rs10193935	0.901	rs6720837	chr2:42463173	A/T	cg27598129	chr2:42591480	NA	-0.88	-6.71	-0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs908922	0.676	rs7531317	chr1:152528439	A/C	cg09873164	chr1:152488093	CRCT1	0.72	5.62	0.54	2.85e-7	Hair morphology;
SKCM	cis	rs10504229	0.683	rs1495865	chr8:58141160	T/G	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs28595532	0.920	rs114938162	chr4:119756407	T/G	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs10779751	1.000	rs1205592	chr1:11305663	C/T	cg08854313	chr1:11322531	MTOR	0.88	6.6	0.6	4.48e-9	Body mass index;
SKCM	cis	rs3020736	0.500	rs764481	chr22:42518426	G/A	cg04733989	chr22:42467013	NAGA	-0.72	-5.62	-0.54	2.87e-7	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs7659604	0.676	rs6534323	chr4:122695888	G/A	cg06713675	chr4:122721982	EXOSC9	-0.74	-6.67	-0.6	3.28e-9	Type 2 diabetes;
SKCM	cis	rs9911578	1.000	rs9911578	chr17:56953147	C/T	cg05425664	chr17:57184151	TRIM37	-0.67	-5.04	-0.5	2.91e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs4746818	1.000	rs7071904	chr10:70903005	C/T	cg11621586	chr10:70884670	VPS26A	1.08	7.96	0.67	1.11e-11	Left atrial antero-posterior diameter;
SKCM	cis	rs1801251	1.000	rs1446308	chr2:233639309	T/C	cg25237894	chr2:233734115	C2orf82	0.6	5.8	0.55	1.36e-7	Coronary artery disease;
SKCM	cis	rs11098499	0.865	rs4507344	chr4:120307485	C/A	cg24375607	chr4:120327624	NA	0.66	4.96	0.49	4.06e-6	Corneal astigmatism;
SKCM	cis	rs2836974	0.829	rs34227163	chr21:40551943	A/G	cg17971929	chr21:40555470	PSMG1	0.87	8.48	0.69	1.1e-12	Cognitive function;
SKCM	cis	rs11122272	0.735	rs2491416	chr1:231547335	T/C	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	0.63	5.21	0.51	1.51e-6	Hemoglobin concentration;
SKCM	cis	rs3785574	0.650	rs3815358	chr17:62010270	A/G	cg01411255	chr17:61851458	DDX42;CCDC47	-0.7	-5.06	-0.5	2.75e-6	Height;
SKCM	cis	rs72781680	0.898	rs72788214	chr2:24087621	A/C	cg08917208	chr2:24149416	ATAD2B	0.99	5.24	0.51	1.31e-6	Lymphocyte counts;
SKCM	cis	rs7809950	0.911	rs7778250	chr7:107224565	C/A	cg23024343	chr7:107201750	COG5	0.82	7.69	0.66	3.82e-11	Coronary artery disease;
SKCM	cis	rs1005277	0.579	rs2103938	chr10:38493998	T/G	cg00409905	chr10:38381863	ZNF37A	-0.65	-6.21	-0.58	2.36e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs8072100	0.875	rs62073966	chr17:45600013	T/A	cg25173405	chr17:45401733	C17orf57	0.56	5.13	0.5	2.07e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs752010	0.695	rs12123834	chr1:42105727	T/C	cg06885757	chr1:42089581	HIVEP3	0.51	6.04	0.56	4.83e-8	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs116095464	0.558	rs10065584	chr5:253997	G/A	cg22857025	chr5:266934	NA	-1.43	-7.97	-0.67	1.07e-11	Breast cancer;
SKCM	cis	rs13256369	0.851	rs11249889	chr8:8564992	G/T	cg15556689	chr8:8085844	FLJ10661	0.65	4.77	0.48	8.39e-6	Obesity-related traits;
SKCM	cis	rs13118159	0.505	rs1250128	chr4:1257311	T/C	cg05025164	chr4:1340916	KIAA1530	-0.83	-6.91	-0.62	1.17e-9	Longevity;
SKCM	cis	rs17685	0.753	rs2108274	chr7:75781636	C/A	cg01364799	chr7:75623366	TMEM120A	-0.69	-5.59	-0.53	3.22e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs507080	0.885	rs7926959	chr11:118559866	T/C	cg18045108	chr11:118530628	TREH	-0.47	-4.82	-0.48	6.89e-6	Serum metabolite levels;
SKCM	cis	rs362296	0.698	rs362283	chr4:3259558	T/C	cg24015175	chr4:3319247	RGS12	-0.65	-5.94	-0.56	7.49e-8	Parental longevity (mother's age at death);
SKCM	cis	rs9388451	0.807	rs1269175	chr6:126040435	A/G	cg05901451	chr6:126070800	HEY2	0.73	6.75	0.61	2.32e-9	Brugada syndrome;
SKCM	cis	rs3784262	0.709	rs4080	chr15:58201341	C/G	cg12031962	chr15:58353849	ALDH1A2	0.5	5.53	0.53	4.19e-7	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs7945705	0.902	rs2016942	chr11:8938787	A/G	cg13070366	chr11:9386451	NA	-0.64	-5.4	-0.52	6.94e-7	Hemoglobin concentration;
SKCM	cis	rs9910055	0.821	rs4473241	chr17:42281282	G/T	cg10896456	chr17:42255109	ASB16;C17orf65	0.64	6.15	0.57	3.11e-8	Total body bone mineral density;
SKCM	cis	rs6952808	0.717	rs10950422	chr7:1926577	T/C	cg03354898	chr7:1950403	MAD1L1	-0.53	-5.04	-0.5	2.94e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs6977660	1.000	rs4719584	chr7:19823388	T/C	cg07541023	chr7:19748670	TWISTNB	0.7	4.82	0.48	6.98e-6	Thyroid stimulating hormone;
SKCM	cis	rs7945705	0.747	rs2742480	chr11:8993130	A/G	cg13070366	chr11:9386451	NA	0.56	4.89	0.48	5.34e-6	Hemoglobin concentration;
SKCM	cis	rs1336900	0.641	rs6587756	chr1:150546865	A/T	cg17724175	chr1:150552817	MCL1	-0.66	-5.3	-0.51	1.06e-6	Blood protein levels;
SKCM	cis	rs7824557	0.614	rs10503421	chr8:11221313	C/T	cg21775007	chr8:11205619	TDH	0.68	6.27	0.58	1.88e-8	Retinal vascular caliber;
SKCM	cis	rs7811142	1.000	rs7803454	chr7:99991548	C/T	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.33	0.69	2.11e-12	Platelet count;
SKCM	cis	rs71444571	1	rs71444571	chr12:123771015	G/A	cg05973401	chr12:123451056	ABCB9	-0.82	-5.72	-0.54	1.92e-7	Lymphocyte percentage of white cells;
SKCM	cis	rs801193	1.000	rs4717310	chr7:66161007	C/T	cg11987759	chr7:65425863	GUSB	-0.69	-5.9	-0.56	8.74e-8	Aortic root size;
SKCM	cis	rs4919694	0.901	rs12264456	chr10:104830634	C/T	cg04362960	chr10:104952993	NT5C2	0.76	4.92	0.49	4.65e-6	Arsenic metabolism;
SKCM	cis	rs2839186	0.616	rs4819213	chr21:47619300	G/A	cg11766577	chr21:47581405	C21orf56	0.78	6.92	0.62	1.14e-9	Testicular germ cell tumor;
SKCM	cis	rs7824557	0.564	rs13274106	chr8:11233958	A/G	cg21775007	chr8:11205619	TDH	-0.61	-5.09	-0.5	2.37e-6	Retinal vascular caliber;
SKCM	cis	rs13118159	0.550	rs11941200	chr4:1369093	C/G	cg05025164	chr4:1340916	KIAA1530	0.9	7.35	0.64	1.66e-10	Longevity;
SKCM	cis	rs4689592	0.546	rs10937784	chr4:7060935	G/C	cg19539972	chr4:7069911	GRPEL1	0.97	6.63	0.6	3.94e-9	Monocyte percentage of white cells;
SKCM	cis	rs9517302	0.544	rs2281766	chr13:99098882	A/C	cg22223119	chr13:99095684	FARP1	-0.71	-4.81	-0.48	7.08e-6	Obesity-related traits;
SKCM	cis	rs2204008	0.837	rs4312131	chr12:38181087	G/T	cg13010199	chr12:38710504	ALG10B	0.65	4.84	0.48	6.52e-6	Bladder cancer;
SKCM	cis	rs10911232	0.507	rs4129857	chr1:183004547	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.64	0.6	3.83e-9	Hypertriglyceridemia;
SKCM	cis	rs72634258	0.503	rs707457	chr1:7831064	C/A	cg26816564	chr1:7831052	VAMP3	0.78	5.51	0.53	4.39e-7	Inflammatory bowel disease;
SKCM	cis	rs11098499	0.629	rs28369518	chr4:120271630	T/C	cg09307838	chr4:120376055	NA	0.94	7.73	0.66	3.07e-11	Corneal astigmatism;
SKCM	cis	rs6430585	0.528	rs895285	chr2:136710554	A/G	cg07169764	chr2:136633963	MCM6	1.34	11.77	0.8	5.58e-19	Corneal structure;
SKCM	cis	rs7772486	0.790	rs11760	chr6:146205973	G/T	cg05347473	chr6:146136440	FBXO30	0.55	5.12	0.5	2.16e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7666738	0.830	rs34212748	chr4:99068708	G/A	cg17366294	chr4:99064904	C4orf37	0.61	4.93	0.49	4.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs12497850	0.931	rs7623023	chr3:48914238	G/A	cg06212747	chr3:49208901	KLHDC8B	0.68	4.89	0.48	5.28e-6	Parkinson's disease;
SKCM	cis	rs951366	0.789	rs823152	chr1:205736285	G/A	cg14159672	chr1:205819179	PM20D1	0.96	8.14	0.68	4.94e-12	Menarche (age at onset);
SKCM	cis	rs752010	0.644	rs6700390	chr1:42112554	A/G	cg06885757	chr1:42089581	HIVEP3	0.5	5.5	0.53	4.7e-7	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs1401999	0.659	rs4912518	chr3:183752027	C/T	cg01324343	chr3:183735012	ABCC5	-0.74	-7.92	-0.67	1.32e-11	Anterior chamber depth;
SKCM	cis	rs4853012	0.752	rs13413795	chr2:74349839	G/A	cg01017244	chr2:74357527	NA	0.72	4.85	0.48	6.17e-6	Gestational age at birth (maternal effect);
SKCM	cis	rs2153535	0.580	rs7453115	chr6:8447261	A/G	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs7811142	1.000	rs60844404	chr7:100080474	A/T	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.19	7.92	0.67	1.33e-11	Platelet count;
SKCM	cis	rs155076	0.666	rs4770128	chr13:21881922	A/G	cg11317459	chr13:21872234	NA	1.34	7.87	0.67	1.71e-11	White matter hyperintensity burden;
SKCM	cis	rs6430585	0.528	rs614193	chr2:136653925	A/T	cg07169764	chr2:136633963	MCM6	1.23	9.82	0.74	2.83e-15	Corneal structure;
SKCM	cis	rs62238980	0.614	rs117305417	chr22:32400975	T/C	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs4803468	1.000	rs10409485	chr19:41920765	C/T	cg09537434	chr19:41945824	ATP5SL	1.13	14.17	0.85	2.83e-23	Height;
SKCM	cis	rs9467773	1.000	rs6930120	chr6:26555484	A/G	cg09904177	chr6:26538194	HMGN4	0.54	4.98	0.49	3.78e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs17065868	0.881	rs61948029	chr13:45186684	C/T	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs1799949	1.000	rs3092988	chr17:41201702	C/T	cg23758822	chr17:41437982	NA	0.94	7.82	0.66	2.13e-11	Menopause (age at onset);
SKCM	cis	rs902774	0.515	rs2363635	chr12:53354622	T/C	cg05393297	chr12:53359155	NA	-0.67	-6.86	-0.61	1.46e-9	Prostate cancer;
SKCM	cis	rs1707322	1.000	rs10890359	chr1:46336635	A/G	cg03146154	chr1:46216737	IPP	0.74	5.0	0.49	3.39e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs763014	0.833	rs3743903	chr16:632736	T/C	cg07343612	chr16:622815	PIGQ	-0.7	-6.0	-0.56	5.84e-8	Height;
SKCM	cis	rs12188164	1.000	rs12188164	chr5:428236	C/A	cg26076054	chr5:421317	AHRR	-0.61	-4.8	-0.48	7.47e-6	Cystic fibrosis severity;
SKCM	cis	rs561341	1.000	rs1681718	chr17:30296445	G/A	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs9611565	0.765	rs132915	chr22:41805782	T/C	cg03806693	chr22:41940476	POLR3H	1.02	6.92	0.62	1.13e-9	Vitiligo;
SKCM	cis	rs12134245	0.776	rs12124682	chr1:91995542	A/G	cg02896835	chr1:92012615	NA	-0.66	-6.35	-0.58	1.3e-8	Breast cancer;
SKCM	cis	rs2839186	0.933	rs56955294	chr21:47708953	A/G	cg05896524	chr21:47604654	C21orf56	0.69	5.67	0.54	2.29e-7	Testicular germ cell tumor;
SKCM	cis	rs9467773	0.844	rs2393669	chr6:26503873	C/T	cg15659132	chr6:26577336	NA	0.61	5.82	0.55	1.24e-7	Intelligence (multi-trait analysis);
SKCM	trans	rs6481128	0.778	rs1733760	chr10:56698174	T/C	cg04272632	chr1:34629400	CSMD2	0.69	7.66	0.66	4.26e-11	Extraversion;
SKCM	cis	rs910316	0.737	rs175049	chr14:75481368	C/T	cg08847533	chr14:75593920	NEK9	-0.8	-6.59	-0.6	4.76e-9	Height;
SKCM	cis	rs7666738	0.830	rs4699580	chr4:98930673	T/C	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2072499	1.000	rs2072499	chr1:156169610	A/G	cg24450063	chr1:156163899	SLC25A44	1.03	10.12	0.75	7.26e-16	Testicular germ cell tumor;
SKCM	cis	rs55962025	0.711	rs4690010	chr4:3159719	G/T	cg16987761	chr4:3318072	RGS12	-0.57	-4.81	-0.48	7.2e-6	Parental longevity (mother's age at death);
SKCM	cis	rs2224391	1.000	rs9784870	chr6:5261359	A/G	cg09085698	chr6:5261316	LYRM4;FARS2	-0.77	-5.73	-0.54	1.79e-7	Height;
SKCM	cis	rs1005277	0.505	rs200936	chr10:38134935	T/C	cg00409905	chr10:38381863	ZNF37A	-0.62	-5.81	-0.55	1.29e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs17685	0.712	rs28506984	chr7:75763484	A/G	cg16489192	chr7:75678113	MDH2;STYXL1	-0.57	-5.35	-0.52	8.63e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs9926296	0.605	rs12709094	chr16:89853017	A/G	cg04287289	chr16:89883240	FANCA	1.03	11.44	0.79	2.36e-18	Vitiligo;
SKCM	cis	rs2836974	0.897	rs3945	chr21:40566067	A/G	cg17971929	chr21:40555470	PSMG1	0.9	8.81	0.71	2.52e-13	Cognitive function;
SKCM	cis	rs2243480	1.000	rs1723270	chr7:65469830	T/G	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs7100689	0.622	rs4933378	chr10:82147057	T/C	cg00277334	chr10:82204260	NA	-0.53	-4.96	-0.49	4.02e-6	Post bronchodilator FEV1;
SKCM	cis	rs2839186	0.867	rs13050387	chr21:47701423	C/T	cg05896524	chr21:47604654	C21orf56	0.67	5.49	0.53	4.77e-7	Testicular germ cell tumor;
SKCM	cis	rs7584330	0.737	rs12465714	chr2:238365637	C/T	cg14458575	chr2:238380390	NA	0.86	6.22	0.58	2.31e-8	Prostate cancer;
SKCM	cis	rs6087990	0.965	rs742630	chr20:31350664	C/G	cg13636640	chr20:31349939	DNMT3B	0.9	7.79	0.66	2.36e-11	Ulcerative colitis;
SKCM	cis	rs1878931	0.507	rs67218524	chr16:3403057	G/T	cg26668626	chr16:3451006	ZNF174;ZNF434	-0.79	-5.55	-0.53	3.72e-7	Body mass index (adult);
SKCM	cis	rs2832191	0.791	rs2832197	chr21:30497790	T/C	cg24692254	chr21:30365293	RNF160	-0.9	-8.01	-0.67	9.12e-12	Dental caries;
SKCM	cis	rs428668	0.523	rs3926389	chr5:150677806	C/T	cg11125805	chr5:150678162	SLC36A3	0.5	6.16	0.57	2.91e-8	Skin aging (microtopography measurement);
SKCM	cis	rs10504229	0.679	rs72649132	chr8:58054615	G/A	cg02725872	chr8:58115012	NA	-0.54	-5.04	-0.5	2.97e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs995000	0.965	rs3913007	chr1:62921586	T/C	cg06896770	chr1:63153194	DOCK7	0.92	8.7	0.7	4.13e-13	Triglyceride levels;
SKCM	cis	rs17685	0.753	rs1104879	chr7:75685568	C/T	cg16489192	chr7:75678113	MDH2;STYXL1	-0.6	-5.51	-0.53	4.43e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2404602	0.684	rs3910756	chr15:76945369	C/T	cg23625390	chr15:77176239	SCAPER	-0.86	-7.95	-0.67	1.17e-11	Blood metabolite levels;
SKCM	cis	rs10751667	0.666	rs7395402	chr11:950293	A/G	cg06064525	chr11:970664	AP2A2	0.55	5.04	0.5	2.9e-6	Alzheimer's disease (late onset);
SKCM	cis	rs875971	0.862	rs6460306	chr7:66060793	T/C	cg11764359	chr7:65958608	NA	-0.74	-6.64	-0.6	3.76e-9	Aortic root size;
SKCM	cis	rs2228479	0.867	rs12930056	chr16:89946649	C/A	cg00800038	chr16:89945340	TCF25	-0.93	-5.34	-0.52	8.73e-7	Skin colour saturation;
SKCM	cis	rs2839186	0.770	rs2839171	chr21:47673247	C/T	cg13126279	chr21:47581558	C21orf56	0.69	5.92	0.56	8.33e-8	Testicular germ cell tumor;
SKCM	cis	rs11718455	0.960	rs34019365	chr3:44004735	G/A	cg21419209	chr3:44054225	NA	-0.65	-5.32	-0.52	9.77e-7	Coronary artery disease;
SKCM	cis	rs6539267	0.847	rs17217845	chr12:106697802	C/T	cg00173435	chr12:106696525	TCP11L2	-0.85	-5.31	-0.52	9.99e-7	Tourette syndrome;
SKCM	cis	rs17818399	0.712	rs13008088	chr2:46781580	C/G	cg02822958	chr2:46747628	ATP6V1E2	0.7	5.16	0.5	1.83e-6	Height;
SKCM	cis	rs2832077	0.527	rs9981922	chr21:30212718	A/G	cg24692254	chr21:30365293	RNF160	-0.75	-5.62	-0.54	2.79e-7	Cognitive test performance;
SKCM	cis	rs6582630	0.502	rs11514371	chr12:38306306	G/C	cg26384229	chr12:38710491	ALG10B	0.81	6.57	0.6	5.18e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs561341	1.000	rs501957	chr17:30314504	C/T	cg00745463	chr17:30367425	LRRC37B	-1.09	-7.71	-0.66	3.44e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs7618915	0.547	rs12486847	chr3:52691112	T/C	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs826838	0.935	rs1486357	chr12:39073675	A/G	cg13010199	chr12:38710504	ALG10B	0.82	6.15	0.57	3.05e-8	Heart rate;
SKCM	cis	rs3820928	1.000	rs59904960	chr2:227761269	T/C	cg11843606	chr2:227700838	RHBDD1	-0.62	-4.99	-0.49	3.52e-6	Pulmonary function;
SKCM	cis	rs9611565	0.694	rs79011	chr22:41866938	A/G	cg03806693	chr22:41940476	POLR3H	0.96	6.02	0.56	5.31e-8	Vitiligo;
SKCM	cis	rs362296	0.530	rs3129316	chr4:3287906	A/G	cg21096898	chr4:3318625	RGS12	0.85	9.26	0.72	3.38e-14	Parental longevity (mother's age at death);
SKCM	cis	rs28386778	0.829	rs1877317	chr17:61776479	T/C	cg22520471	chr17:61851767	DDX42;CCDC47	0.79	5.33	0.52	9.21e-7	Prudent dietary pattern;
SKCM	cis	rs11098499	0.710	rs6851130	chr4:120133712	G/A	cg09307838	chr4:120376055	NA	-0.78	-5.85	-0.55	1.1e-7	Corneal astigmatism;
SKCM	cis	rs2739330	0.752	rs2330634	chr22:24250795	C/G	cg24846343	chr22:24311635	DDTL	0.6	5.58	0.53	3.39e-7	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	trans	rs10506458	0.834	rs58821476	chr12:63389425	T/C	cg03429785	chr15:59498649	MYO1E;LDHAL6B	-1.39	-7.59	-0.65	5.95e-11	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs9916302	0.904	rs2338797	chr17:37548241	G/A	cg07936489	chr17:37558343	FBXL20	0.84	7.23	0.63	2.81e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs7927771	0.864	rs112060627	chr11:47426956	G/A	cg05585544	chr11:47624801	NA	-0.6	-5.32	-0.52	9.58e-7	Subjective well-being;
SKCM	cis	rs4862750	0.794	rs7692427	chr4:187901727	G/A	cg10295955	chr4:187884368	NA	-1.04	-13.97	-0.85	6.27e-23	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2153535	0.504	rs4493781	chr6:8473941	G/C	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs12148488	0.738	rs4886417	chr15:75330159	T/G	cg09165964	chr15:75287851	SCAMP5	0.67	5.23	0.51	1.38e-6	Caffeine consumption;
SKCM	cis	rs4819052	0.565	rs35776291	chr21:46706142	T/C	cg02159808	chr21:46707872	POFUT2;LOC642852	0.67	5.06	0.5	2.77e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7959452	0.527	rs4761157	chr12:69780907	A/G	cg14784868	chr12:69753453	YEATS4	0.8	7.6	0.65	5.66e-11	Blood protein levels;
SKCM	cis	rs763014	0.931	rs710925	chr16:633354	G/A	cg09263875	chr16:632152	PIGQ	0.67	5.82	0.55	1.24e-7	Height;
SKCM	cis	rs9894429	0.789	rs35887231	chr17:79587126	G/A	cg18240062	chr17:79603768	NPLOC4	0.91	10.36	0.76	2.55e-16	Eye color traits;
SKCM	cis	rs4853012	0.838	rs6707729	chr2:74344685	G/A	cg01017244	chr2:74357527	NA	0.7	4.78	0.48	8.1e-6	Gestational age at birth (maternal effect);
SKCM	cis	rs2304069	0.913	rs9324637	chr5:149390947	T/C	cg22760475	chr5:149380129	HMGXB3;TIGD6	0.84	6.17	0.57	2.89e-8	HIV-1 control;
SKCM	cis	rs5769765	0.908	rs2319464	chr22:50265777	A/G	cg22709217	chr22:50311962	ALG12;CRELD2	0.79	5.71	0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs2354432	0.556	rs11239965	chr1:146753907	C/A	cg25205988	chr1:146714368	CHD1L	-1.17	-6.52	-0.59	6.27e-9	Mitochondrial DNA levels;
SKCM	trans	rs12599106	0.839	rs34769185	chr16:34654349	G/A	cg15383120	chr6:291909	DUSP22	-0.78	-7.35	-0.64	1.69e-10	Menopause (age at onset);
SKCM	cis	rs16912285	0.584	rs7131124	chr11:24249455	A/G	ch.11.24196551F	chr11:24239977	NA	0.76	5.99	0.56	6.16e-8	Visceral adipose tissue/subcutaneous adipose tissue ratio;
SKCM	cis	rs9926296	0.715	rs2115401	chr16:89740609	A/G	cg01097406	chr16:89675127	NA	-0.46	-5.21	-0.51	1.51e-6	Vitiligo;
SKCM	cis	rs875971	0.862	rs709609	chr7:65560561	A/G	cg11764359	chr7:65958608	NA	-0.83	-7.86	-0.66	1.78e-11	Aortic root size;
SKCM	cis	rs611744	0.583	rs1448148	chr8:109333074	T/A	cg21045802	chr8:109455806	TTC35	0.62	4.78	0.48	8.01e-6	Dupuytren's disease;
SKCM	cis	rs9486715	0.867	rs9384628	chr6:96960232	T/C	cg06623918	chr6:96969491	KIAA0776	0.8	6.58	0.6	4.94e-9	Headache;
SKCM	cis	rs870825	0.698	rs72703549	chr4:185623963	T/C	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs6580649	0.941	rs7959755	chr12:48446318	T/A	cg05342945	chr12:48394962	COL2A1	0.73	5.2	0.51	1.53e-6	Lung cancer;
SKCM	cis	rs4808199	1.000	rs7258508	chr19:19475469	T/C	cg03709012	chr19:19516395	GATAD2A	1.1	8.13	0.68	5.33e-12	Nonalcoholic fatty liver disease;
SKCM	cis	rs62238980	0.614	rs74924328	chr22:32416228	G/A	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs7772486	0.727	rs12190966	chr6:146146820	T/G	cg05347473	chr6:146136440	FBXO30	0.58	5.35	0.52	8.51e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs8078723	0.690	rs3785549	chr17:38149724	T/C	cg17467752	chr17:38218738	THRA	-0.61	-5.49	-0.53	4.75e-7	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs4481887	1.000	rs4481887	chr1:248496863	A/G	cg00666640	chr1:248458726	OR2T12	0.59	4.94	0.49	4.38e-6	Common traits (Other);
SKCM	cis	rs28595532	0.920	rs55985953	chr4:119764971	T/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs2836974	0.739	rs12482181	chr21:40548852	A/G	cg11890956	chr21:40555474	PSMG1	1.07	13.19	0.83	1.48e-21	Cognitive function;
SKCM	cis	rs67460515	0.563	rs4521287	chr3:160812752	C/T	cg03342759	chr3:160939853	NMD3	-0.68	-5.77	-0.55	1.53e-7	Parkinson's disease;
SKCM	cis	rs12188164	0.543	rs890972	chr5:462465	C/A	cg26076054	chr5:421317	AHRR	0.62	5.47	0.53	5.27e-7	Cystic fibrosis severity;
SKCM	cis	rs1499614	1.000	rs2707830	chr7:66167645	T/C	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Gout;
SKCM	cis	rs34779708	0.966	rs34296409	chr10:35404613	C/G	cg03585969	chr10:35415529	CREM	0.82	6.49	0.59	7.27e-9	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs2303745	0.589	rs11882562	chr19:17395055	C/G	cg04248312	chr19:17393744	ANKLE1	1.11	8.18	0.68	4.15e-12	Systemic lupus erythematosus;
SKCM	cis	rs2013441	0.613	rs12451841	chr17:20004875	G/A	cg13482628	chr17:19912719	NA	0.7	5.29	0.51	1.1e-6	Obesity-related traits;
SKCM	cis	rs4819052	0.851	rs914218	chr21:46698445	G/C	cg02159808	chr21:46707872	POFUT2;LOC642852	0.74	5.68	0.54	2.22e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs1044826	0.642	rs9826544	chr3:139162831	A/G	cg15131784	chr3:139108705	COPB2	0.7	5.18	0.51	1.67e-6	Obesity-related traits;
SKCM	cis	rs1046896	1.000	rs28485881	chr17:80690014	G/A	cg22027946	chr17:80790580	TBCD;ZNF750	0.58	4.89	0.48	5.35e-6	Glycated hemoglobin levels;
SKCM	cis	rs7809950	1.000	rs10273733	chr7:107258121	A/G	cg23024343	chr7:107201750	COG5	0.81	7.37	0.64	1.54e-10	Coronary artery disease;
SKCM	cis	rs34375054	0.660	rs57031290	chr12:125593053	A/G	cg25124228	chr12:125621409	AACS	-0.71	-5.63	-0.54	2.74e-7	Post bronchodilator FEV1/FVC ratio;
SKCM	trans	rs1814175	0.754	rs7103235	chr11:49699191	A/G	cg15704280	chr7:45808275	SEPT13	-0.99	-9.38	-0.73	2e-14	Height;
SKCM	cis	rs17685	0.623	rs7782808	chr7:75768645	C/T	cg16684958	chr7:75615977	POR	0.55	5.27	0.51	1.19e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs4919087	0.892	rs10786319	chr10:99008951	T/C	cg25902810	chr10:99078978	FRAT1	0.64	5.14	0.5	1.97e-6	Monocyte count;
SKCM	trans	rs5756813	0.661	rs7286550	chr22:38196760	G/A	cg19894588	chr14:64061835	NA	-0.88	-7.39	-0.64	1.44e-10	Optic cup area;Vertical cup-disc ratio;
SKCM	cis	rs2282032	0.527	rs8009799	chr14:90766365	A/G	cg04374321	chr14:90722782	PSMC1	0.69	5.54	0.53	3.96e-7	Longevity;
SKCM	cis	rs7927771	0.560	rs4752858	chr11:47685829	C/T	cg20307385	chr11:47447363	PSMC3	-0.72	-5.81	-0.55	1.31e-7	Subjective well-being;
SKCM	cis	rs13256369	0.951	rs12679360	chr8:8566269	G/T	cg15556689	chr8:8085844	FLJ10661	-0.65	-5.41	-0.52	6.66e-7	Obesity-related traits;
SKCM	cis	rs9583531	0.574	rs61971615	chr13:111353111	C/T	cg24331049	chr13:111365604	ING1	-0.82	-5.52	-0.53	4.29e-7	Coronary artery disease;
SKCM	cis	rs11098499	0.779	rs80242894	chr4:120375752	G/A	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs10754283	0.967	rs2185195	chr1:90106697	T/C	cg21401794	chr1:90099060	LRRC8C	0.74	6.4	0.59	1.09e-8	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs7666738	0.830	rs7696568	chr4:99005333	A/T	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2762353	0.562	rs1165206	chr6:25867566	G/A	cg16906712	chr6:26217615	HIST1H2BG;HIST1H2AE	0.58	5.65	0.54	2.54e-7	Blood metabolite levels;
SKCM	trans	rs1814175	0.529	rs10839396	chr11:49852406	G/T	cg15704280	chr7:45808275	SEPT13	0.88	7.52	0.65	8.06e-11	Height;
SKCM	cis	rs6952808	0.792	rs4421257	chr7:1955152	T/C	cg02951883	chr7:2050386	MAD1L1	-0.69	-5.89	-0.55	9.41e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs7192750	0.583	rs2550043	chr16:72067491	T/C	cg14768367	chr16:72042858	DHODH	0.91	4.88	0.48	5.56e-6	LDL cholesterol levels;Total cholesterol levels;
SKCM	cis	rs2811415	0.597	rs3733158	chr3:127787157	A/G	cg09089421	chr3:127803668	RUVBL1	1.0	8.69	0.7	4.4e-13	Lung function (FEV1/FVC);
SKCM	cis	rs6430585	0.528	rs16832205	chr2:136684632	G/A	cg07169764	chr2:136633963	MCM6	1.32	11.41	0.79	2.72e-18	Corneal structure;
SKCM	cis	rs1059312	0.808	rs2170989	chr12:129291317	T/C	cg09035930	chr12:129282057	SLC15A4	-0.77	-8.03	-0.67	8.18e-12	Systemic lupus erythematosus;
SKCM	cis	rs737337	0.623	rs17699089	chr19:11343795	A/G	cg00586551	chr19:11347513	LOC55908;DOCK6	0.72	4.82	0.48	7.04e-6	HDL cholesterol;HDL cholesterol levels;
SKCM	cis	rs1557765	0.527	rs10832782	chr11:17397273	G/C	cg15432903	chr11:17409602	KCNJ11	0.54	5.07	0.5	2.61e-6	Body mass index;Social communication problems;
SKCM	cis	rs3741404	0.560	rs12362602	chr11:63908660	G/A	cg05555928	chr11:63887634	MACROD1	0.79	5.13	0.5	2.07e-6	Platelet count;
SKCM	cis	rs9303401	0.659	rs36109237	chr17:56653834	A/G	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.13	0.57	3.42e-8	Cognitive test performance;
SKCM	cis	rs7945705	0.870	rs1109305	chr11:8955272	C/T	cg21881798	chr11:8931708	C11orf17;ST5	0.78	7.6	0.65	5.5e-11	Hemoglobin concentration;
SKCM	cis	rs2361718	0.500	rs4889970	chr17:78096086	C/T	cg09238746	chr17:78121135	EIF4A3	0.91	7.16	0.63	3.88e-10	Yeast infection;
SKCM	cis	rs11690935	0.921	rs10200608	chr2:172597929	G/A	cg13550731	chr2:172543902	DYNC1I2	-0.95	-8.21	-0.68	3.64e-12	Schizophrenia;
SKCM	cis	rs12709013	0.792	rs62064940	chr16:58830464	C/T	cg02431531	chr16:59244939	NA	0.48	4.99	0.49	3.62e-6	Blood metabolite ratios;
SKCM	cis	rs28595532	0.920	rs115354352	chr4:119750358	T/C	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs2836974	0.931	rs7283569	chr21:40644062	T/G	cg11644478	chr21:40555479	PSMG1	0.97	10.08	0.75	8.76e-16	Cognitive function;
SKCM	cis	rs17685	0.672	rs10952841	chr7:75778626	A/C	cg16489192	chr7:75678113	MDH2;STYXL1	-0.56	-5.23	-0.51	1.36e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1799949	1.000	rs12944597	chr17:41187684	A/C	cg23758822	chr17:41437982	NA	0.91	7.51	0.65	8.13e-11	Menopause (age at onset);
SKCM	cis	rs1635	0.826	rs7750106	chr6:28223680	C/A	cg15743358	chr6:28303923	ZNF323	-1.1	-4.98	-0.49	3.66e-6	Schizophrenia;
SKCM	cis	rs453301	0.624	rs2979265	chr8:8858717	G/C	cg06636001	chr8:8085503	FLJ10661	0.77	6.27	0.58	1.83e-8	Joint mobility (Beighton score);
SKCM	cis	rs6547741	1.000	rs6750943	chr2:27777904	T/G	cg27432699	chr2:27873401	GPN1	0.73	6.55	0.6	5.7e-9	Oral cavity cancer;
SKCM	cis	rs2739330	0.791	rs9612520	chr22:24269459	G/T	cg04234412	chr22:24373322	LOC391322	-0.71	-6.0	-0.56	5.76e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs1395	0.778	rs60631624	chr2:27497815	T/G	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.57	5.17	0.51	1.73e-6	Blood metabolite levels;
SKCM	trans	rs66573146	1.000	rs66573146	chr4:6984464	C/G	cg07817883	chr1:32538562	TMEM39B	2.0	8.02	0.67	8.59e-12	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs4631830	0.720	rs12412140	chr10:51503977	T/C	cg16070123	chr10:51489643	NA	0.51	4.84	0.48	6.5e-6	Prostate-specific antigen levels;
SKCM	cis	rs870825	0.929	rs10015218	chr4:185589789	T/C	cg04058563	chr4:185651563	MLF1IP	1.09	5.66	0.54	2.4e-7	Blood protein levels;
SKCM	cis	rs1160297	0.585	rs12614959	chr2:53090302	T/C	cg07782112	chr2:53107842	NA	0.59	6.26	0.58	1.92e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs2839186	0.967	rs17176131	chr21:47705237	T/C	cg13126279	chr21:47581558	C21orf56	-0.64	-5.47	-0.53	5.17e-7	Testicular germ cell tumor;
SKCM	cis	rs2941509	1.000	rs17676923	chr17:38050125	C/T	cg12655416	chr17:38077870	ORMDL3	-0.5	-5.35	-0.52	8.58e-7	Systemic lupus erythematosus;
SKCM	cis	rs7100689	0.646	rs10788586	chr10:82117435	A/G	cg01528321	chr10:82214614	TSPAN14	0.8	7.0	0.62	7.98e-10	Post bronchodilator FEV1;
SKCM	cis	rs1348850	0.914	rs7565022	chr2:178320222	A/T	cg02961200	chr2:178257176	LOC100130691;AGPS	0.82	6.21	0.58	2.42e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs9300255	0.537	rs1790101	chr12:123704844	T/C	cg05973401	chr12:123451056	ABCB9	0.81	5.36	0.52	8.18e-7	Neutrophil percentage of white cells;
SKCM	cis	rs10754283	0.934	rs6684676	chr1:90102173	C/T	cg21401794	chr1:90099060	LRRC8C	0.78	7.17	0.63	3.72e-10	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs793571	0.590	rs17190727	chr15:59073790	C/A	cg05156742	chr15:59063176	FAM63B	0.68	4.84	0.48	6.5e-6	Schizophrenia;
SKCM	cis	rs7772486	0.875	rs6938972	chr6:146410608	G/A	cg05347473	chr6:146136440	FBXO30	0.65	5.96	0.56	6.79e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1218582	0.772	rs1976559	chr1:154879788	A/T	cg03351412	chr1:154909251	PMVK	0.77	6.52	0.59	6.43e-9	Prostate cancer;
SKCM	cis	rs151997	0.925	rs27570	chr5:50191974	G/A	cg06027927	chr5:50259733	NA	0.63	5.52	0.53	4.27e-7	Callous-unemotional behaviour;
SKCM	cis	rs7772486	0.790	rs2254283	chr6:146204289	T/C	cg05347473	chr6:146136440	FBXO30	0.55	5.06	0.5	2.71e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7917772	0.536	rs4919667	chr10:104426011	A/G	cg11453585	chr10:104263688	ACTR1A;SUFU	-0.74	-5.56	-0.53	3.6e-7	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs873946	0.586	rs12251911	chr10:134570595	A/G	cg27286337	chr10:134555280	INPP5A	0.99	8.87	0.71	1.93e-13	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs6088580	0.634	rs6142164	chr20:33006597	C/T	cg24642439	chr20:33292090	TP53INP2	-0.76	-6.02	-0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs34779708	0.931	rs58159560	chr10:35351249	C/T	cg03585969	chr10:35415529	CREM	0.76	6.26	0.58	1.91e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs1395	0.813	rs11685326	chr2:27453679	A/G	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.51	5.14	0.5	1.96e-6	Blood metabolite levels;
SKCM	cis	rs637571	0.522	rs503524	chr11:65751764	C/T	cg02427764	chr11:65769310	BANF1;EIF1AD	0.77	5.89	0.55	9.2e-8	Eosinophil percentage of white cells;
SKCM	cis	rs7215564	0.818	rs112155856	chr17:78594573	A/T	cg16980736	chr17:78789706	RPTOR	-0.89	-4.87	-0.48	5.8e-6	Myopia (pathological);
SKCM	cis	rs2836974	0.666	rs12626405	chr21:40663121	G/T	cg11890956	chr21:40555474	PSMG1	-0.81	-8.01	-0.67	8.94e-12	Cognitive function;
SKCM	cis	rs710216	0.536	rs710221	chr1:43414200	G/A	cg03128534	chr1:43423976	SLC2A1	0.92	7.68	0.66	3.85e-11	Red cell distribution width;
SKCM	cis	rs13256369	0.851	rs12541477	chr8:8563895	G/A	cg15556689	chr8:8085844	FLJ10661	0.65	4.77	0.48	8.39e-6	Obesity-related traits;
SKCM	cis	rs875971	0.660	rs801192	chr7:66031952	C/G	cg18876405	chr7:65276391	NA	-0.8	-7.11	-0.63	4.86e-10	Aortic root size;
SKCM	cis	rs12586317	0.514	rs74590021	chr14:35490113	T/G	cg16230307	chr14:35515116	FAM177A1	0.81	5.88	0.55	9.47e-8	Psoriasis;
SKCM	cis	rs6545883	0.894	rs2694639	chr2:61595291	G/A	cg15711740	chr2:61764176	XPO1	0.68	4.82	0.48	6.94e-6	Tuberculosis;
SKCM	cis	rs2153535	0.541	rs4637688	chr6:8446501	A/G	cg23788917	chr6:8435910	SLC35B3	0.68	4.98	0.49	3.66e-6	Motion sickness;
SKCM	cis	rs28386778	0.897	rs2727328	chr17:61923564	G/A	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.07	10.78	0.77	4.13e-17	Prudent dietary pattern;
SKCM	cis	rs668210	0.947	rs559161	chr11:65761637	A/G	cg02202077	chr11:65769826	EIF1AD;BANF1	0.73	4.92	0.49	4.67e-6	Cerebrospinal fluid biomarker levels;
SKCM	trans	rs1814175	0.645	rs1722000	chr11:49917928	A/C	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs208520	0.526	rs4710310	chr6:66802808	T/C	cg07460842	chr6:66804631	NA	-1.15	-12.99	-0.83	3.31e-21	Exhaled nitric oxide output;
SKCM	cis	rs1568889	0.838	rs7125749	chr11:28154692	A/T	cg06544937	chr11:28130018	METT5D1;KIF18A	0.89	8.3	0.68	2.43e-12	Bipolar disorder;
SKCM	cis	rs3091242	0.933	rs3093584	chr1:25668714	T/C	cg02931644	chr1:25747376	RHCE	-0.51	-5.05	-0.5	2.84e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs4803468	0.967	rs11670583	chr19:41920440	A/T	cg09537434	chr19:41945824	ATP5SL	-1.1	-13.82	-0.84	1.16e-22	Height;
SKCM	cis	rs875971	0.862	rs908915	chr7:65614651	G/T	cg11764359	chr7:65958608	NA	-0.8	-7.66	-0.66	4.2e-11	Aortic root size;
SKCM	trans	rs62103177	0.759	rs7227794	chr18:77610925	C/T	cg05926928	chr17:57297772	GDPD1	1.27	8.28	0.68	2.73e-12	Opioid sensitivity;
SKCM	cis	rs72949976	0.584	rs12471432	chr2:214022893	A/T	cg08319019	chr2:214017104	IKZF2	0.84	6.86	0.61	1.47e-9	Lung cancer;Squamous cell lung carcinoma;
SKCM	cis	rs644799	1.000	rs3177463	chr11:95502128	G/C	cg25622487	chr11:95524042	FAM76B;CEP57	0.73	5.9	0.56	9e-8	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs9814567	0.964	rs1534028	chr3:134284639	G/C	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs1577917	0.958	rs12216074	chr6:86520002	C/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.74	-0.66	3e-11	Response to antipsychotic treatment;
SKCM	cis	rs7143963	1.000	rs72704727	chr14:103357249	C/T	cg23020514	chr14:103360112	TRAF3	0.9	8.63	0.7	5.58e-13	Body mass index;
SKCM	cis	rs875971	0.862	rs6460279	chr7:65662761	T/C	cg11764359	chr7:65958608	NA	-0.75	-6.89	-0.62	1.26e-9	Aortic root size;
SKCM	cis	rs2836974	0.863	rs12483216	chr21:40539614	T/C	cg11644478	chr21:40555479	PSMG1	0.97	10.21	0.76	5.08e-16	Cognitive function;
SKCM	cis	rs514406	0.698	rs567880	chr1:53348564	T/G	cg24675658	chr1:53192096	ZYG11B	-0.82	-7.54	-0.65	7.43e-11	Monocyte count;
SKCM	cis	rs66573146	1.000	rs66712119	chr4:6965428	A/T	cg00086871	chr4:6988644	TBC1D14	1.43	5.33	0.52	9.25e-7	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs1799949	1.000	rs8176083	chr17:41275151	G/C	cg25918947	chr17:41365094	TMEM106A	-0.6	-5.59	-0.53	3.2e-7	Menopause (age at onset);
SKCM	cis	rs7584330	0.955	rs58643200	chr2:238389855	A/G	cg14458575	chr2:238380390	NA	0.98	6.49	0.59	7.27e-9	Prostate cancer;
SKCM	cis	rs6942756	1.000	rs6467243	chr7:129001508	A/G	cg02491457	chr7:128862824	NA	-0.77	-4.79	-0.48	7.85e-6	White matter hyperintensity burden;
SKCM	cis	rs7666738	0.830	rs28687737	chr4:99009226	G/A	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs208520	0.690	rs9345764	chr6:66820597	C/T	cg07460842	chr6:66804631	NA	-1.03	-8.35	-0.69	1.94e-12	Exhaled nitric oxide output;
SKCM	cis	rs11700980	0.636	rs2832138	chr21:30284123	G/A	cg24692254	chr21:30365293	RNF160	-0.89	-5.03	-0.5	3e-6	QRS complex (12-leadsum);
SKCM	cis	rs6582630	0.519	rs8186992	chr12:38325848	C/T	cg26384229	chr12:38710491	ALG10B	0.81	6.67	0.6	3.38e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs7296418	0.630	rs11608305	chr12:123791165	C/G	cg00376283	chr12:123451042	ABCB9	0.82	6.54	0.6	5.78e-9	Platelet count;
SKCM	cis	rs2188420	0.872	rs17847822	chr7:106523670	G/C	cg23615938	chr7:105753134	SYPL1	-0.89	-5.08	-0.5	2.49e-6	Interferon gamma levels;
SKCM	cis	rs8180040	0.553	rs7620997	chr3:47214122	C/T	cg27129171	chr3:47204927	SETD2	-0.75	-5.37	-0.52	7.85e-7	Colorectal cancer;
SKCM	cis	rs514406	0.825	rs12089511	chr1:53436427	A/T	cg24675658	chr1:53192096	ZYG11B	0.63	5.12	0.5	2.14e-6	Monocyte count;
SKCM	cis	rs1577917	0.655	rs9342045	chr6:86425148	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.79	6.97	0.62	9.01e-10	Response to antipsychotic treatment;
SKCM	cis	rs7208859	0.524	rs28760584	chr17:29141017	G/A	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs7772486	0.790	rs2265472	chr6:146220758	G/C	cg23711669	chr6:146136114	FBXO30	0.78	7.7	0.66	3.53e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7772486	0.754	rs9386133	chr6:146141213	A/G	cg23711669	chr6:146136114	FBXO30	0.89	8.0	0.67	9.58e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs763121	0.706	rs3827356	chr22:39064806	G/T	cg06022373	chr22:39101656	GTPBP1	-0.76	-5.35	-0.52	8.58e-7	Menopause (age at onset);
SKCM	cis	rs244731	1.000	rs244728	chr5:176537407	C/T	cg16006841	chr5:176797999	RGS14	0.79	5.41	0.52	6.7e-7	Urate levels in lean individuals;
SKCM	cis	rs870825	0.616	rs57316663	chr4:185630011	T/C	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs12477438	0.798	rs4622780	chr2:99631760	C/G	cg26064155	chr2:99771622	LIPT1;TSGA10	-0.72	-4.86	-0.48	6e-6	Chronic sinus infection;
SKCM	cis	rs11252926	0.673	rs7096559	chr10:499188	C/T	cg18196295	chr10:418757	DIP2C	0.66	5.69	0.54	2.12e-7	Psychosis in Alzheimer's disease;
SKCM	cis	rs72634258	0.786	rs4405150	chr1:8173672	T/C	cg00042356	chr1:8021962	PARK7	-0.81	-5.27	-0.51	1.16e-6	Inflammatory bowel disease;
SKCM	cis	rs763121	0.853	rs6001191	chr22:39074452	T/C	cg06022373	chr22:39101656	GTPBP1	0.8	5.79	0.55	1.42e-7	Menopause (age at onset);
SKCM	cis	rs1153858	1.000	rs2114501	chr15:45670316	G/A	cg10760299	chr15:45669010	GATM	0.62	6.35	0.58	1.3e-8	Homoarginine levels;
SKCM	cis	rs55823223	0.648	rs72860389	chr17:73866071	C/T	cg10935138	chr17:73851978	WBP2	1.19	7.17	0.63	3.81e-10	Psoriasis;
SKCM	trans	rs8073060	0.614	rs225279	chr17:33974214	A/G	cg19694781	chr19:47549865	TMEM160	-1.0	-8.56	-0.7	7.62e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs55962025	0.804	rs2071703	chr4:3241413	A/C	cg16987761	chr4:3318072	RGS12	-0.7	-5.23	-0.51	1.39e-6	Parental longevity (mother's age at death);
SKCM	cis	rs6951245	0.935	rs118132455	chr7:1068232	C/A	cg03188948	chr7:1209495	NA	1.12	6.17	0.57	2.88e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs2836950	0.502	rs12627205	chr21:40630027	C/T	cg11890956	chr21:40555474	PSMG1	-0.66	-5.26	-0.51	1.22e-6	Menarche (age at onset);
SKCM	cis	rs4819052	0.851	rs2838839	chr21:46667858	C/G	cg19498844	chr21:46707878	POFUT2;LOC642852	-0.85	-7.36	-0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs9790314	0.540	rs9844862	chr3:161076188	G/A	cg03342759	chr3:160939853	NMD3	-0.79	-6.94	-0.62	1.01e-9	Morning vs. evening chronotype;
SKCM	cis	rs362296	0.661	rs3095079	chr4:3265414	A/G	cg11471262	chr4:3318911	RGS12	0.72	6.37	0.58	1.24e-8	Parental longevity (mother's age at death);
SKCM	cis	rs9911578	0.935	rs2302189	chr17:56584205	A/C	cg05425664	chr17:57184151	TRIM37	0.7	5.44	0.52	5.9e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs1577917	1.000	rs10944170	chr6:86685469	A/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.64	-5.54	-0.53	3.92e-7	Response to antipsychotic treatment;
SKCM	cis	rs76662990	1.000	rs10074975	chr5:73800469	A/G	cg01264639	chr5:73839484	NA	1.1	5.52	0.53	4.27e-7	Residual cognition;
SKCM	cis	rs7937682	0.921	rs688354	chr11:111438762	A/G	cg22437258	chr11:111473054	SIK2	0.7	5.43	0.52	6.28e-7	Primary sclerosing cholangitis;
SKCM	cis	rs854765	0.663	rs12941550	chr17:17753828	C/A	cg04398451	chr17:18023971	MYO15A	0.87	5.86	0.55	1.04e-7	Total body bone mineral density;
SKCM	cis	rs362296	0.671	rs1006798	chr4:3258373	A/G	cg16987761	chr4:3318072	RGS12	-0.75	-6.27	-0.58	1.83e-8	Parental longevity (mother's age at death);
SKCM	cis	rs11249608	0.548	rs17078988	chr5:178459283	A/G	cg21905437	chr5:178450457	ZNF879	0.74	5.6	0.54	3.15e-7	Pubertal anthropometrics;
SKCM	cis	rs13118159	0.550	rs1137789	chr4:1381798	A/G	cg05025164	chr4:1340916	KIAA1530	0.9	7.26	0.63	2.55e-10	Longevity;
SKCM	cis	rs10791097	0.765	rs10894269	chr11:130722789	C/T	cg12179176	chr11:130786555	SNX19	0.76	6.15	0.57	3.11e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs394563	0.726	rs6906384	chr6:149664540	G/A	cg03678062	chr6:149772716	ZC3H12D	0.49	5.53	0.53	4.05e-7	Dupuytren's disease;
SKCM	cis	rs4862750	0.915	rs6835681	chr4:187903476	A/G	cg10295955	chr4:187884368	NA	-1.06	-13.25	-0.83	1.18e-21	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2032447	0.670	rs198852	chr6:26104448	A/G	cg03517284	chr6:25882590	NA	0.63	5.51	0.53	4.52e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs9443189	0.570	rs661229	chr6:76293793	G/A	cg01950844	chr6:76311363	SENP6	0.99	6.23	0.58	2.22e-8	Prostate cancer;
SKCM	cis	rs7772486	0.754	rs702324	chr6:146008793	A/G	cg23711669	chr6:146136114	FBXO30	-0.86	-8.38	-0.69	1.69e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs10751667	0.558	rs12276666	chr11:1022119	G/A	cg18297705	chr11:1994927	NA	0.68	5.03	0.5	3.01e-6	Alzheimer's disease (late onset);
SKCM	cis	rs72634258	0.786	rs9434993	chr1:8179744	G/C	cg00042356	chr1:8021962	PARK7	0.77	5.09	0.5	2.4e-6	Inflammatory bowel disease;
SKCM	cis	rs4665809	0.556	rs4665322	chr2:26434605	C/G	cg04944784	chr2:26401820	FAM59B	-0.74	-4.82	-0.48	7e-6	Gut microbiome composition (summer);
SKCM	cis	rs9790314	1.000	rs336577	chr3:161066294	C/T	cg03342759	chr3:160939853	NMD3	-0.72	-7.89	-0.67	1.53e-11	Morning vs. evening chronotype;
SKCM	cis	rs7247513	0.964	rs1864083	chr19:12707302	T/C	cg01871581	chr19:12707946	ZNF490	-0.7	-4.91	-0.49	4.88e-6	Bipolar disorder;
SKCM	cis	rs2075371	0.796	rs1646645	chr7:134012232	G/T	cg11752832	chr7:134001865	SLC35B4	-0.55	-4.8	-0.48	7.47e-6	Mean platelet volume;
SKCM	cis	rs7824557	0.767	rs10104728	chr8:11171300	A/G	cg21775007	chr8:11205619	TDH	0.7	5.97	0.56	6.64e-8	Retinal vascular caliber;
SKCM	cis	rs873946	0.648	rs1548281	chr10:134552982	C/T	cg27286337	chr10:134555280	INPP5A	0.92	8.2	0.68	3.78e-12	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs35306767	0.761	rs11253558	chr10:1043983	T/C	cg25614935	chr10:1084866	C10orf110	0.76	6.0	0.56	5.95e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs7666738	0.791	rs10022061	chr4:98926821	T/C	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1218582	0.772	rs7528532	chr1:154874440	C/T	cg09359103	chr1:154839909	KCNN3	-0.57	-5.3	-0.51	1.05e-6	Prostate cancer;
SKCM	cis	rs4862750	0.874	rs6822062	chr4:187895553	T/C	cg10295955	chr4:187884368	NA	-1.04	-14.07	-0.85	4.23e-23	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs507080	0.885	rs533144	chr11:118559247	C/A	cg18045108	chr11:118530628	TREH	-0.47	-4.81	-0.48	7.24e-6	Serum metabolite levels;
SKCM	cis	rs1506636	1.000	rs684548	chr7:123397102	A/T	cg03229431	chr7:123269106	ASB15	0.64	5.19	0.51	1.63e-6	Plateletcrit;Platelet count;
SKCM	cis	rs10883723	0.810	rs7093028	chr10:104259417	A/G	cg11453585	chr10:104263688	ACTR1A;SUFU	0.75	5.7	0.54	2.03e-7	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs9916302	0.706	rs9890198	chr17:37457480	A/C	cg07936489	chr17:37558343	FBXL20	1.0	7.19	0.63	3.42e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs7635838	0.686	rs347589	chr3:11288419	A/G	cg00170343	chr3:11313890	ATG7	0.8	5.69	0.54	2.11e-7	HDL cholesterol;
SKCM	cis	rs3784262	1.000	rs7495968	chr15:58244103	C/G	cg12031962	chr15:58353849	ALDH1A2	0.5	6.1	0.57	3.75e-8	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs1577917	0.958	rs36053156	chr6:86575509	T/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.87	-8.85	-0.71	2.15e-13	Response to antipsychotic treatment;
SKCM	cis	rs875971	0.545	rs12673308	chr7:65631361	C/A	cg18876405	chr7:65276391	NA	0.64	5.29	0.51	1.09e-6	Aortic root size;
SKCM	cis	rs10911251	0.528	rs4652777	chr1:183091992	T/G	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Colorectal cancer;
SKCM	cis	rs9910055	0.708	rs2631298	chr17:42219832	T/C	cg10896456	chr17:42255109	ASB16;C17orf65	0.69	7.17	0.63	3.65e-10	Total body bone mineral density;
SKCM	cis	rs3749237	0.595	rs4855873	chr3:49459114	A/C	cg03060546	chr3:49711283	APEH	0.67	4.95	0.49	4.23e-6	Resting heart rate;
SKCM	cis	rs7772486	0.625	rs2050027	chr6:146116113	C/G	cg05347473	chr6:146136440	FBXO30	-0.56	-5.22	-0.51	1.47e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs67311347	0.955	rs4974067	chr3:40374551	C/T	cg00091569	chr3:40428383	ENTPD3	0.65	5.56	0.53	3.7e-7	Renal cell carcinoma;
SKCM	cis	rs6121246	0.909	rs1075698	chr20:30387992	G/C	cg11595048	chr20:30225325	COX4I2	0.67	5.21	0.51	1.5e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs561341	1.000	rs72821952	chr17:30248133	T/A	cg00745463	chr17:30367425	LRRC37B	-1.12	-7.43	-0.64	1.2e-10	Hip circumference adjusted for BMI;
SKCM	cis	rs2836950	0.565	rs2836930	chr21:40545656	A/G	cg11644478	chr21:40555479	PSMG1	-0.67	-5.3	-0.51	1.04e-6	Menarche (age at onset);
SKCM	cis	rs35306767	0.903	rs17159950	chr10:875287	T/G	cg25614935	chr10:1084866	C10orf110	0.78	5.14	0.5	2e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs1577917	0.771	rs2842607	chr6:86345039	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.83	-7.64	-0.65	4.74e-11	Response to antipsychotic treatment;
SKCM	cis	rs1048238	0.506	rs7547314	chr1:16186722	G/A	cg21385522	chr1:16154831	NA	0.63	5.24	0.51	1.34e-6	Systolic blood pressure;
SKCM	trans	rs208520	0.545	rs10944874	chr6:66752080	C/T	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-1.05	-11.43	-0.79	2.43e-18	Exhaled nitric oxide output;
SKCM	trans	rs66573146	0.831	rs56031152	chr4:6973832	C/A	cg07817883	chr1:32538562	TMEM39B	1.94	8.42	0.69	1.47e-12	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs6424115	0.830	rs2501425	chr1:24199339	A/C	cg15997130	chr1:24165203	NA	0.6	4.94	0.49	4.37e-6	Immature fraction of reticulocytes;
SKCM	cis	rs6951245	1.000	rs2363286	chr7:1091625	A/G	cg18402987	chr7:1209562	NA	1.04	5.66	0.54	2.4e-7	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs6665290	0.935	rs6693535	chr1:227197685	G/A	cg10327440	chr1:227177885	CDC42BPA	-1.24	-17.31	-0.89	1.95e-28	Myeloid white cell count;
SKCM	cis	rs2279817	0.820	rs924686	chr1:18027726	C/A	cg17142039	chr1:18149651	ACTL8	0.58	4.93	0.49	4.48e-6	Neuroticism;
SKCM	cis	rs2836974	0.526	rs418359	chr21:40536734	T/C	cg17971929	chr21:40555470	PSMG1	-0.76	-7.16	-0.63	3.94e-10	Cognitive function;
SKCM	cis	rs854765	0.583	rs4077198	chr17:17834563	T/C	cg04398451	chr17:18023971	MYO15A	-0.85	-6.05	-0.57	4.75e-8	Total body bone mineral density;
SKCM	cis	rs28386778	0.799	rs2584612	chr17:61932204	A/G	cg06873352	chr17:61820015	STRADA	0.76	6.34	0.58	1.38e-8	Prudent dietary pattern;
SKCM	cis	rs2243480	1.000	rs4548056	chr7:65298873	A/G	cg07424592	chr7:64974309	NA	0.99	4.9	0.49	5.08e-6	Diabetic kidney disease;
SKCM	cis	rs7811142	1.000	rs60478351	chr7:100089017	C/T	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-1.02	-5.76	-0.55	1.59e-7	Platelet count;
SKCM	cis	rs875971	0.628	rs6974355	chr7:65841981	A/G	cg00343986	chr7:65444356	GUSB	0.68	5.1	0.5	2.35e-6	Aortic root size;
SKCM	cis	rs6500395	0.962	rs868792	chr16:48640632	T/C	cg04672837	chr16:48644449	N4BP1	0.69	5.75	0.55	1.65e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs17213078	0.510	rs17032713	chr2:106886839	T/C	cg23109721	chr2:106886537	NA	-0.7	-5.06	-0.5	2.74e-6	Facial morphology (factor 23);
SKCM	cis	rs7940866	0.903	rs7130842	chr11:130836269	A/G	cg12179176	chr11:130786555	SNX19	0.77	5.87	0.55	9.89e-8	Schizophrenia;
SKCM	cis	rs9875589	0.509	rs28865280	chr3:14064958	C/T	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.5	5.15	0.5	1.9e-6	Ovarian reserve;
SKCM	cis	rs6582630	0.502	rs11520261	chr12:38332019	T/G	cg26384229	chr12:38710491	ALG10B	0.78	6.66	0.6	3.54e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs7666738	0.761	rs13136913	chr4:98998031	C/T	cg05340658	chr4:99064831	C4orf37	0.67	5.14	0.5	1.98e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs28386778	0.897	rs2854214	chr17:61945449	C/G	cg23090583	chr17:61904693	PSMC5;FTSJ3	-1.12	-11.2	-0.79	6.65e-18	Prudent dietary pattern;
SKCM	cis	rs995000	0.899	rs11207985	chr1:63013786	A/G	cg06896770	chr1:63153194	DOCK7	-0.73	-6.54	-0.6	5.83e-9	Triglyceride levels;
SKCM	cis	rs523522	0.962	rs3213565	chr12:120992401	C/T	cg27279351	chr12:120934652	DYNLL1	0.91	8.32	0.69	2.26e-12	High light scatter reticulocyte count;
SKCM	cis	rs763121	0.853	rs4821816	chr22:39113134	G/A	cg06022373	chr22:39101656	GTPBP1	0.81	6.18	0.57	2.7e-8	Menopause (age at onset);
SKCM	cis	rs3820928	0.904	rs2195487	chr2:227759720	G/C	cg11843606	chr2:227700838	RHBDD1	-0.64	-5.19	-0.51	1.64e-6	Pulmonary function;
SKCM	cis	rs6951245	1.000	rs79327308	chr7:1108141	A/C	cg24642844	chr7:1081250	C7orf50	-0.93	-6.22	-0.58	2.28e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs6088580	0.602	rs6059840	chr20:33030405	G/A	cg24642439	chr20:33292090	TP53INP2	0.76	6.02	0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs9902453	0.904	rs4994353	chr17:28386280	T/A	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.79	-5.74	-0.54	1.76e-7	Coffee consumption (cups per day);
SKCM	cis	rs854765	0.583	rs4244602	chr17:17841456	A/G	cg04398451	chr17:18023971	MYO15A	-0.79	-5.68	-0.54	2.25e-7	Total body bone mineral density;
SKCM	cis	rs875971	0.505	rs2462573	chr7:65507392	C/T	cg00343986	chr7:65444356	GUSB	-0.66	-4.81	-0.48	7.33e-6	Aortic root size;
SKCM	cis	rs1568889	1.000	rs61236373	chr11:28212720	C/G	cg06544937	chr11:28130018	METT5D1;KIF18A	0.86	6.87	0.61	1.4e-9	Bipolar disorder;
SKCM	cis	rs6545883	0.894	rs4672431	chr2:61519922	C/A	cg15711740	chr2:61764176	XPO1	0.68	4.82	0.48	6.94e-6	Tuberculosis;
SKCM	cis	rs60871478	0.786	rs56390623	chr7:837811	G/C	cg05535760	chr7:792225	HEATR2	-1.01	-8.04	-0.67	7.83e-12	Cerebrospinal P-tau181p levels;
SKCM	cis	rs28595532	0.920	rs114243409	chr4:119756585	C/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs17361889	0.752	rs4721485	chr7:16282473	G/A	cg09714114	chr7:16439993	ISPD	0.51	5.25	0.51	1.27e-6	Pediatric bone mineral content (hip);
SKCM	cis	rs28595532	0.920	rs17324807	chr4:119770638	G/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs7666738	0.791	rs60028147	chr4:99046618	G/A	cg05340658	chr4:99064831	C4orf37	0.65	4.93	0.49	4.52e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs12541335	0.590	rs11136002	chr8:22217082	C/T	cg09517075	chr8:22133004	PIWIL2	0.59	5.64	0.54	2.66e-7	Hypertriglyceridemia;
SKCM	cis	rs11098499	0.863	rs11098531	chr4:120465001	G/A	cg24375607	chr4:120327624	NA	0.69	5.47	0.53	5.35e-7	Corneal astigmatism;
SKCM	cis	rs3784262	0.935	rs4646636	chr15:58251034	A/G	cg12031962	chr15:58353849	ALDH1A2	-0.46	-5.46	-0.53	5.4e-7	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs769267	0.929	rs2905421	chr19:19457908	G/T	cg26732615	chr19:19648335	CILP2;YJEFN3	0.62	5.46	0.53	5.58e-7	Tonsillectomy;
SKCM	cis	rs7666738	0.830	rs11935078	chr4:99010476	T/A	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6089584	0.925	rs35683654	chr20:60625401	G/T	cg06108461	chr20:60628389	TAF4	0.83	7.06	0.62	6.04e-10	Body mass index;
SKCM	cis	rs6952808	0.895	rs12669518	chr7:1921429	G/C	cg21782813	chr7:2030301	MAD1L1	0.55	5.65	0.54	2.48e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs13118159	0.527	rs6599309	chr4:1388115	C/G	cg20887711	chr4:1340912	KIAA1530	0.95	6.67	0.6	3.29e-9	Longevity;
SKCM	cis	rs28386778	0.897	rs2665823	chr17:61885917	G/A	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs4727027	0.635	rs12111923	chr7:148885877	G/A	cg23583168	chr7:148888333	NA	-0.79	-5.53	-0.53	4.07e-7	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs873946	0.648	rs12769533	chr10:134548685	C/T	cg27286337	chr10:134555280	INPP5A	-0.91	-8.66	-0.7	4.97e-13	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs7635838	0.718	rs2606736	chr3:11400249	C/T	cg00170343	chr3:11313890	ATG7	0.7	5.58	0.53	3.29e-7	HDL cholesterol;
SKCM	cis	rs7647973	0.577	rs6446247	chr3:49102001	A/T	cg07636037	chr3:49044803	WDR6	0.97	7.24	0.63	2.76e-10	Menarche (age at onset);
SKCM	cis	rs875971	1.000	rs1544549	chr7:66090663	T/A	cg18876405	chr7:65276391	NA	-0.68	-6.83	-0.61	1.63e-9	Aortic root size;
SKCM	cis	rs3820068	0.581	rs59684759	chr1:15919893	A/G	cg13390004	chr1:15929781	NA	0.67	5.29	0.51	1.11e-6	Systolic blood pressure;
SKCM	cis	rs9443189	0.570	rs504446	chr6:76326939	T/C	cg01950844	chr6:76311363	SENP6	0.99	6.57	0.6	5.02e-9	Prostate cancer;
SKCM	cis	rs2732480	0.577	rs2450994	chr12:48721832	G/A	cg21348975	chr12:48724119	NA	-0.58	-4.88	-0.48	5.47e-6	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs910316	0.763	rs175057	chr14:75489632	C/T	cg08847533	chr14:75593920	NEK9	-0.8	-6.02	-0.56	5.4e-8	Height;
SKCM	cis	rs2361718	0.521	rs2361724	chr17:78099114	G/A	cg09238746	chr17:78121135	EIF4A3	-0.89	-6.35	-0.58	1.3e-8	Yeast infection;
SKCM	cis	rs4689592	0.546	rs10937782	chr4:7057106	G/C	cg26116260	chr4:7069785	GRPEL1	1.2	9.71	0.74	4.52e-15	Monocyte percentage of white cells;
SKCM	cis	rs1799949	1.000	rs1060915	chr17:41234470	A/G	cg05368731	chr17:41323189	NBR1	0.9	7.89	0.67	1.52e-11	Menopause (age at onset);
SKCM	cis	rs116095464	0.558	rs9654452	chr5:299561	C/T	cg22857025	chr5:266934	NA	-1.5	-8.16	-0.68	4.68e-12	Breast cancer;
SKCM	cis	rs9467773	1.000	rs4713006	chr6:26519872	A/G	cg15659132	chr6:26577336	NA	0.6	5.71	0.54	1.99e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs4332037	0.851	rs28728306	chr7:1961814	C/A	cg23422044	chr7:1970798	MAD1L1	-1.05	-7.23	-0.63	2.89e-10	Bipolar disorder;
SKCM	cis	rs668210	0.947	rs610497	chr11:65765551	C/T	cg02202077	chr11:65769826	EIF1AD;BANF1	0.73	4.92	0.49	4.67e-6	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs40363	0.645	rs250633	chr16:3523002	C/T	cg22508957	chr16:3507546	NAT15	0.58	5.01	0.49	3.33e-6	Tuberculosis;
SKCM	cis	rs4972806	0.775	rs2857534	chr2:177035676	G/T	cg03152288	chr2:177042942	NA	0.57	4.99	0.49	3.52e-6	IgG glycosylation;
SKCM	cis	rs1691799	0.899	rs4762091	chr12:66747863	A/G	cg16791601	chr12:66731901	HELB	-0.65	-6.09	-0.57	4.07e-8	White blood cell count (basophil);
SKCM	trans	rs1814175	0.645	rs10839382	chr11:49823172	C/T	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs807669	0.934	rs762523	chr22:19180589	A/G	cg02655711	chr22:19163373	SLC25A1	0.78	7.22	0.63	3.03e-10	Metabolite levels;
SKCM	cis	rs1577917	0.740	rs12212560	chr6:86342679	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.74	-6.58	-0.6	4.95e-9	Response to antipsychotic treatment;
SKCM	cis	rs7666738	0.830	rs13149779	chr4:99010145	G/T	cg05340658	chr4:99064831	C4orf37	0.66	5.29	0.51	1.11e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs17685	0.753	rs13240404	chr7:75675719	C/T	cg16489192	chr7:75678113	MDH2;STYXL1	0.58	5.44	0.52	5.83e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs3008870	0.916	rs2025608	chr1:67422550	C/T	cg08660285	chr1:67390436	MIER1;WDR78	0.92	6.05	0.57	4.69e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs4724125	0.807	rs4724119	chr7:42675798	G/C	cg09407816	chr7:42972088	MRPL32;PSMA2	0.81	5.2	0.51	1.58e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs798554	0.759	rs2644291	chr7:2890456	T/C	cg19346786	chr7:2764209	NA	-0.66	-6.79	-0.61	1.94e-9	Height;
SKCM	cis	rs1475911	1.000	rs55645900	chr21:43515728	G/T	cg24372256	chr21:43528868	UMODL1;C21orf128	-0.69	-4.83	-0.48	6.81e-6	IgG glycosylation;
SKCM	cis	rs3820068	0.581	rs16851876	chr1:15950628	A/T	cg24675056	chr1:15929824	NA	-0.75	-5.43	-0.52	6.22e-7	Systolic blood pressure;
SKCM	cis	rs7247513	0.856	rs2162863	chr19:12699777	G/T	cg01871581	chr19:12707946	ZNF490	-0.69	-4.81	-0.48	7.29e-6	Bipolar disorder;
SKCM	cis	rs7772486	0.790	rs2265919	chr6:146221753	A/G	cg05347473	chr6:146136440	FBXO30	0.56	5.18	0.51	1.67e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7584330	0.910	rs880930	chr2:238396872	G/C	cg14458575	chr2:238380390	NA	0.97	6.37	0.58	1.23e-8	Prostate cancer;
SKCM	cis	rs34779708	0.931	rs4007289	chr10:35269790	G/A	cg03585969	chr10:35415529	CREM	0.74	6.04	0.56	5e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs992157	0.661	rs10171839	chr2:219051314	C/T	cg20019365	chr2:219134978	PNKD;AAMP	0.78	6.58	0.6	4.93e-9	Colorectal cancer;
SKCM	cis	rs36093844	0.752	rs78820266	chr11:85558257	T/G	cg25872744	chr11:85566296	CCDC83	-0.85	-4.77	-0.48	8.27e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs7666738	0.830	rs58696666	chr4:99006913	C/T	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs56104184	0.830	rs17206679	chr19:49342237	C/G	cg15549821	chr19:49342101	PLEKHA4	-1.24	-7.83	-0.66	1.99e-11	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs1348850	0.914	rs6761593	chr2:178451600	A/G	cg02961200	chr2:178257176	LOC100130691;AGPS	-0.76	-5.69	-0.54	2.12e-7	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs1048238	0.506	rs10927867	chr1:16177285	A/G	cg21385522	chr1:16154831	NA	0.65	5.56	0.53	3.61e-7	Systolic blood pressure;
SKCM	cis	rs995000	0.931	rs1168086	chr1:63112389	A/G	cg06896770	chr1:63153194	DOCK7	-0.76	-7.17	-0.63	3.77e-10	Triglyceride levels;
SKCM	cis	rs9467773	1.000	rs9467774	chr6:26505036	C/A	cg09904177	chr6:26538194	HMGN4	0.55	5.03	0.49	3.11e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2842992	0.958	rs2758318	chr6:160069637	C/G	cg19482086	chr6:160211437	TCP1;MRPL18	0.78	5.74	0.54	1.73e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs4077515	0.874	rs35670379	chr9:139270606	T/C	cg14169450	chr9:139327907	INPP5E	0.48	5.41	0.52	6.71e-7	Ulcerative colitis;IgA nephropathy;Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs7647973	0.516	rs4536858	chr3:49193081	A/G	cg07636037	chr3:49044803	WDR6	0.87	7.23	0.63	2.87e-10	Menarche (age at onset);
SKCM	cis	rs951366	0.585	rs72750964	chr1:205675240	C/T	cg24503407	chr1:205819492	PM20D1	0.71	5.92	0.56	8.12e-8	Menarche (age at onset);
SKCM	cis	rs6500395	1.000	rs55671623	chr16:48631154	A/G	cg04672837	chr16:48644449	N4BP1	0.67	5.66	0.54	2.4e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs7940866	0.774	rs10894292	chr11:130820757	C/T	cg12179176	chr11:130786555	SNX19	0.78	5.82	0.55	1.23e-7	Schizophrenia;
SKCM	cis	rs28595532	0.920	rs114544767	chr4:119728364	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.43	0.59	9.38e-9	Cannabis dependence symptom count;
SKCM	cis	rs4819052	0.851	rs13050359	chr21:46672671	T/G	cg02159808	chr21:46707872	POFUT2;LOC642852	0.73	5.71	0.54	1.93e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7937682	0.632	rs14133	chr11:111782697	C/G	cg09085632	chr11:111637200	PPP2R1B	1.13	10.25	0.76	4.14e-16	Primary sclerosing cholangitis;
SKCM	cis	rs4740619	0.619	rs1410455	chr9:16042277	A/G	cg14451791	chr9:16040625	NA	-0.47	-5.03	-0.49	3.1e-6	Body mass index;
SKCM	cis	rs1577917	0.655	rs9450311	chr6:86376586	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.67	5.68	0.54	2.22e-7	Response to antipsychotic treatment;
SKCM	cis	rs28595532	0.925	rs116785973	chr4:119611350	G/A	cg21605333	chr4:119757512	SEC24D	1.24	7.1	0.63	5.16e-10	Cannabis dependence symptom count;
SKCM	cis	rs10876993	0.928	rs1628552	chr12:58082142	C/T	cg18357645	chr12:58087776	OS9	0.65	5.97	0.56	6.61e-8	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs2729354	0.502	rs2848641	chr11:57263068	G/C	cg00522883	chr11:57194120	SLC43A3	-0.61	-5.05	-0.5	2.78e-6	Blood protein levels;
SKCM	cis	rs10193935	0.792	rs6735571	chr2:42491951	C/T	cg27598129	chr2:42591480	NA	-0.95	-6.84	-0.61	1.6e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs738322	1.000	rs738320	chr22:38568715	G/T	cg25457927	chr22:38595422	NA	-0.47	-5.1	-0.5	2.32e-6	Cutaneous nevi;
SKCM	cis	rs3796619	1.000	rs4974638	chr4:1099201	G/A	cg27284194	chr4:1044797	NA	0.66	4.77	0.48	8.45e-6	Recombination rate (males);
SKCM	cis	rs738321	0.757	rs2235345	chr22:38518177	C/T	cg25457927	chr22:38595422	NA	-0.58	-6.71	-0.61	2.75e-9	Breast cancer;
SKCM	cis	rs6450176	1.000	rs5024170	chr5:53300827	C/A	ch.5.1024479R	chr5:53302184	ARL15	-0.71	-4.89	-0.48	5.27e-6	HDL cholesterol levels;HDL cholesterol;Adiponectin levels;
SKCM	cis	rs9633740	0.947	rs1878036	chr10:82280137	T/G	cg01528321	chr10:82214614	TSPAN14	0.84	6.36	0.58	1.27e-8	Post bronchodilator FEV1;
SKCM	cis	rs4665809	0.590	rs35532350	chr2:26441605	T/C	cg26119090	chr2:26468346	HADHA;HADHB	-1.06	-8.39	-0.69	1.66e-12	Gut microbiome composition (summer);
SKCM	cis	rs3859192	0.577	rs25645	chr17:38173143	G/A	cg17467752	chr17:38218738	THRA	-0.75	-6.28	-0.58	1.75e-8	White blood cell count;
SKCM	cis	rs7937682	0.889	rs12360825	chr11:111528786	A/T	cg09085632	chr11:111637200	PPP2R1B	-1.03	-11.65	-0.8	9.4e-19	Primary sclerosing cholangitis;
SKCM	cis	rs7786877	0.723	rs7812123	chr7:100211556	C/A	cg16850897	chr7:100343110	ZAN	-0.67	-5.0	-0.49	3.42e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs910316	0.935	rs3742771	chr14:75599647	A/G	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.89e-7	Height;
SKCM	cis	rs2836950	0.545	rs1888489	chr21:40533164	T/C	cg11644478	chr21:40555479	PSMG1	-0.67	-5.33	-0.52	9.15e-7	Menarche (age at onset);
SKCM	cis	rs870825	0.616	rs7658186	chr4:185622509	T/C	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	trans	rs3780486	0.801	rs3780495	chr9:33125942	A/C	cg20290983	chr6:43655470	MRPS18A	1.0	11.51	0.79	1.7e-18	IgG glycosylation;
SKCM	cis	rs9796	0.745	rs2947493	chr15:41375694	G/A	cg00616447	chr15:41694635	NDUFAF1	0.75	4.77	0.48	8.36e-6	Menopause (age at onset);
SKCM	cis	rs477895	0.713	rs2282490	chr11:63962152	T/C	cg07220939	chr11:64358617	SLC22A12	0.74	4.99	0.49	3.58e-6	Mean platelet volume;
SKCM	cis	rs2075371	1.000	rs2241336	chr7:133979578	A/G	cg11752832	chr7:134001865	SLC35B4	0.59	4.87	0.48	5.66e-6	Mean platelet volume;
SKCM	cis	rs4619890	0.528	rs28558196	chr4:7880360	T/A	cg08722675	chr4:8412549	ACOX3	0.54	4.94	0.49	4.32e-6	Glaucoma (primary open-angle);
SKCM	cis	rs7666738	0.830	rs4323111	chr4:98952276	A/G	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10779751	0.734	rs910660	chr1:11130643	C/T	cg08854313	chr1:11322531	MTOR	-0.77	-5.51	-0.53	4.52e-7	Body mass index;
SKCM	cis	rs3784262	0.669	rs17820990	chr15:58349568	C/T	cg12031962	chr15:58353849	ALDH1A2	-0.42	-4.89	-0.48	5.38e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs10256972	0.591	rs6950319	chr7:1161324	A/G	cg16145915	chr7:1198662	ZFAND2A	-0.57	-7.67	-0.66	4.13e-11	Longevity;Endometriosis;
SKCM	cis	rs7143963	0.609	rs4906270	chr14:103364737	G/T	cg23020514	chr14:103360112	TRAF3	0.73	6.5	0.59	6.92e-9	Body mass index;
SKCM	cis	rs9921222	0.521	rs78867928	chr16:368986	C/T	cg00101154	chr16:420108	MRPL28	-0.63	-5.15	-0.5	1.9e-6	Bone mineral density (spine);Bone mineral density;
SKCM	cis	rs2455601	1.000	rs12418190	chr11:8899818	G/C	cg21881798	chr11:8931708	C11orf17;ST5	-0.94	-5.96	-0.56	7.03e-8	Schizophrenia;
SKCM	cis	rs116095464	0.558	rs113796397	chr5:246503	A/G	cg22496380	chr5:211416	CCDC127	-0.89	-4.92	-0.49	4.78e-6	Breast cancer;
SKCM	cis	rs2549003	0.966	rs10213701	chr5:131824064	T/A	cg21138405	chr5:131827807	IRF1	0.42	4.98	0.49	3.75e-6	Asthma (sex interaction);
SKCM	cis	rs72792276	1.000	rs17839658	chr5:127423013	A/G	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.75	5.13	0.5	2.05e-6	Red cell distribution width;
SKCM	cis	rs35306767	0.909	rs12264390	chr10:959111	T/C	cg20503657	chr10:835505	NA	0.65	4.94	0.49	4.37e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs11139399	0.613	rs11139380	chr9:84340976	C/G	cg13729285	chr9:84764156	NA	0.55	5.34	0.52	8.81e-7	Hippocampal atrophy;
SKCM	cis	rs6952808	0.595	rs2398705	chr7:2164995	G/A	cg02951883	chr7:2050386	MAD1L1	-0.76	-6.91	-0.62	1.14e-9	Bipolar disorder and schizophrenia;
SKCM	cis	rs7511006	0.893	rs6010202	chr22:50644177	G/A	cg16473166	chr22:50639996	SELO	0.65	5.32	0.52	9.66e-7	Obesity-related traits;
SKCM	cis	rs6120849	0.901	rs6088735	chr20:33745676	C/T	cg24642439	chr20:33292090	TP53INP2	0.94	5.15	0.5	1.89e-6	Protein C levels;
SKCM	cis	rs7811142	0.830	rs6945952	chr7:99981775	A/G	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.2	7.87	0.67	1.7e-11	Platelet count;
SKCM	cis	rs867186	1.000	rs7269138	chr20:33570007	T/C	cg04194272	chr20:33683537	NA	-1.22	-6.74	-0.61	2.42e-9	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs1707322	0.682	rs28508523	chr1:46189625	G/A	cg03146154	chr1:46216737	IPP	0.81	6.0	0.56	5.79e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs9818758	0.556	rs9880309	chr3:49304329	G/C	cg00383909	chr3:49044727	WDR6	0.95	4.95	0.49	4.17e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs7584330	0.740	rs11896232	chr2:238438124	T/C	cg14458575	chr2:238380390	NA	0.76	5.03	0.49	3.1e-6	Prostate cancer;
SKCM	cis	rs1577917	0.740	rs9344542	chr6:86393905	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.82	7.72	0.66	3.22e-11	Response to antipsychotic treatment;
SKCM	cis	rs9788682	0.747	rs8042059	chr15:78907859	A/C	cg24631222	chr15:78858424	CHRNA5	0.72	5.08	0.5	2.49e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs208520	0.690	rs851468	chr6:66825875	G/A	cg07460842	chr6:66804631	NA	-1.09	-8.46	-0.69	1.22e-12	Exhaled nitric oxide output;
SKCM	cis	rs6495122	0.699	rs12905199	chr15:75070196	A/G	cg14664628	chr15:75095509	CSK	-0.93	-6.98	-0.62	8.62e-10	Caffeine consumption;Diastolic blood pressure;Coffee consumption;
SKCM	cis	rs9300255	0.543	rs1260294	chr12:123560289	T/C	cg05973401	chr12:123451056	ABCB9	-0.79	-5.4	-0.52	7e-7	Neutrophil percentage of white cells;
SKCM	cis	rs12541335	0.639	rs13257108	chr8:22165043	T/C	cg26039829	chr8:22132926	PIWIL2	0.64	5.59	0.54	3.17e-7	Hypertriglyceridemia;
SKCM	cis	rs2204008	0.777	rs6582664	chr12:37947022	A/G	cg26384229	chr12:38710491	ALG10B	-0.76	-6.51	-0.59	6.66e-9	Bladder cancer;
SKCM	cis	rs936229	0.813	rs3784790	chr15:75081745	G/C	cg14664628	chr15:75095509	CSK	-1.15	-9.89	-0.75	2.08e-15	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin);
SKCM	cis	rs1878931	0.582	rs9937267	chr16:3421073	C/T	cg26668626	chr16:3451006	ZNF174;ZNF434	0.82	5.95	0.56	7.24e-8	Body mass index (adult);
SKCM	cis	rs10489202	0.535	rs12736786	chr1:167988283	C/G	cg24449463	chr1:168025552	DCAF6	-0.79	-7.39	-0.64	1.42e-10	Schizophrenia;
SKCM	cis	rs344364	0.511	rs1742464	chr16:1947335	A/G	cg26897989	chr16:1907736	C16orf73	0.69	7.13	0.63	4.45e-10	Glomerular filtration rate in chronic kidney disease;
SKCM	cis	rs28595532	0.841	rs56046449	chr4:119769302	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs11098499	0.722	rs1814814	chr4:120258124	C/G	cg24375607	chr4:120327624	NA	0.64	4.98	0.49	3.76e-6	Corneal astigmatism;
SKCM	cis	rs2836974	0.583	rs9636957	chr21:40705847	G/A	cg17971929	chr21:40555470	PSMG1	-0.71	-6.15	-0.57	3.14e-8	Cognitive function;
SKCM	cis	rs875971	1.000	rs6460292	chr7:65810075	G/A	cg11764359	chr7:65958608	NA	-0.88	-8.54	-0.7	8.36e-13	Aortic root size;
SKCM	cis	rs2243480	1.000	rs160648	chr7:65543384	C/A	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs2279817	1.000	rs2279816	chr1:18021867	T/C	cg17142039	chr1:18149651	ACTL8	0.58	4.88	0.48	5.6e-6	Neuroticism;
SKCM	cis	rs854765	0.547	rs7212167	chr17:17913504	G/A	cg04398451	chr17:18023971	MYO15A	-0.87	-6.78	-0.61	2.05e-9	Total body bone mineral density;
SKCM	cis	rs7666738	0.830	rs1896154	chr4:99021161	T/C	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6582630	0.519	rs8189618	chr12:38276281	A/C	cg13010199	chr12:38710504	ALG10B	0.69	4.92	0.49	4.72e-6	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs9303401	0.659	rs62083362	chr17:56846464	A/G	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.35	0.52	8.54e-7	Cognitive test performance;
SKCM	cis	rs11098499	0.738	rs72918577	chr4:120326701	G/A	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs4803455	0.565	rs2241713	chr19:41869468	C/G	cg09537434	chr19:41945824	ATP5SL	0.82	6.5	0.59	6.86e-9	Migraine;Coronary artery disease;
SKCM	cis	rs861020	0.630	rs656566	chr1:210006603	C/T	cg05527609	chr1:210001259	C1orf107	0.86	6.74	0.61	2.43e-9	Orofacial clefts;
SKCM	cis	rs2841233	0.692	rs75824199	chr14:105344157	G/A	cg16576083	chr14:105354267	KIAA0284	0.6	4.78	0.48	7.96e-6	IgG glycosylation;
SKCM	cis	rs2070488	0.965	rs13079145	chr3:38517992	T/G	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.98	9.34	0.73	2.34e-14	Electrocardiographic conduction measures;
SKCM	cis	rs2197308	0.765	rs10880643	chr12:37926452	C/T	cg26384229	chr12:38710491	ALG10B	-0.76	-6.24	-0.58	2.08e-8	Morning vs. evening chronotype;
SKCM	cis	rs1547553	1	rs1547553	chr18:77926197	C/A	cg14906638	chr18:78001859	PARD6G	-1.08	-5.26	-0.51	1.23e-6	Age-related hearing impairment (SNP x SNP interaction);
SKCM	cis	rs6500395	1.000	rs7185899	chr16:48714101	A/G	cg04672837	chr16:48644449	N4BP1	-0.63	-5.37	-0.52	8.01e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs7772486	0.875	rs2748501	chr6:146312258	G/A	cg23711669	chr6:146136114	FBXO30	0.77	7.32	0.64	1.92e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs67460515	0.892	rs4856703	chr3:161047720	G/T	cg03342759	chr3:160939853	NMD3	-0.81	-7.1	-0.63	5.14e-10	Parkinson's disease;
SKCM	cis	rs2180341	0.782	rs4487601	chr6:127723521	A/G	cg27446573	chr6:127587934	RNF146	0.68	5.3	0.51	1.06e-6	Breast cancer;
SKCM	cis	rs7666738	0.791	rs1559860	chr4:99024422	C/T	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11585357	0.895	rs2977305	chr1:17613737	A/T	cg08277548	chr1:17600880	PADI3	0.89	6.31	0.58	1.53e-8	Hair shape;
SKCM	cis	rs933688	0.877	rs10474352	chr5:90732225	C/T	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.95	6.56	0.6	5.34e-9	Smoking behavior;
SKCM	cis	rs4927850	0.881	rs7624638	chr3:195748729	C/T	cg01181863	chr3:195395398	SDHAP2	-0.76	-4.85	-0.48	6.14e-6	Pancreatic cancer;
SKCM	cis	rs1185460	0.967	rs11217133	chr11:118928249	G/A	cg23280166	chr11:118938394	VPS11	0.57	5.11	0.5	2.21e-6	Coronary artery disease;
SKCM	cis	rs7809950	0.648	rs114452520	chr7:107176780	C/T	cg23024343	chr7:107201750	COG5	-0.77	-6.95	-0.62	9.61e-10	Coronary artery disease;
SKCM	cis	rs9803723	0.682	rs11804893	chr1:25462079	C/T	cg20685674	chr1:26233538	STMN1	-0.48	-4.83	-0.48	6.77e-6	Male-pattern baldness;
SKCM	cis	rs6088580	0.634	rs6059867	chr20:33078103	C/T	cg24642439	chr20:33292090	TP53INP2	0.75	5.96	0.56	6.8e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs6500395	0.962	rs2101372	chr16:48627306	G/A	cg04672837	chr16:48644449	N4BP1	0.69	5.88	0.55	9.68e-8	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs35146811	0.844	rs13223792	chr7:99675659	T/G	cg22906224	chr7:99728672	NA	0.82	6.34	0.58	1.37e-8	Coronary artery disease;
SKCM	cis	rs654950	0.841	rs2759247	chr1:41991756	G/C	cg06885757	chr1:42089581	HIVEP3	-0.64	-7.17	-0.63	3.67e-10	Airway imaging phenotypes;
SKCM	cis	rs1005277	0.540	rs11011351	chr10:38030525	A/G	cg25427524	chr10:38739819	LOC399744	-0.64	-6.06	-0.57	4.44e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs8103278	0.507	rs7246377	chr19:46292259	G/A	cg11657440	chr19:46296263	DMWD	1.07	10.43	0.76	1.87e-16	Coronary artery disease;
SKCM	cis	rs116095464	0.558	rs6872854	chr5:209038	G/T	cg22496380	chr5:211416	CCDC127	-0.96	-5.27	-0.51	1.18e-6	Breast cancer;
SKCM	cis	rs60871478	0.545	rs35400476	chr7:795686	A/G	cg05535760	chr7:792225	HEATR2	1.02	8.22	0.68	3.49e-12	Cerebrospinal P-tau181p levels;
SKCM	cis	rs801193	1.000	rs3857688	chr7:66127806	G/A	cg18876405	chr7:65276391	NA	-0.82	-7.53	-0.65	7.59e-11	Aortic root size;
SKCM	cis	rs7666738	0.830	rs9992639	chr4:98940400	G/T	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6866344	0.697	rs62392832	chr5:178134395	T/C	cg10224037	chr5:178157518	ZNF354A	0.81	5.68	0.54	2.26e-7	Neutrophil percentage of white cells;
SKCM	cis	rs8067545	0.720	rs6587206	chr17:19881587	T/C	cg13482628	chr17:19912719	NA	0.65	4.77	0.48	8.36e-6	Schizophrenia;
SKCM	cis	rs8077889	0.672	rs3785810	chr17:41850689	C/G	cg26893861	chr17:41843967	DUSP3	1.42	13.18	0.83	1.53e-21	Triglycerides;
SKCM	cis	rs9902453	0.612	rs2617868	chr17:28073247	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.79	-5.93	-0.56	7.67e-8	Coffee consumption (cups per day);
SKCM	trans	rs1814175	0.645	rs1818895	chr11:50031523	G/T	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs873946	0.564	rs2803991	chr10:134557068	A/G	cg26818010	chr10:134567672	INPP5A	-0.71	-5.47	-0.53	5.3e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs4665809	0.590	rs2289019	chr2:26420809	G/C	cg26119090	chr2:26468346	HADHA;HADHB	-1.02	-8.05	-0.67	7.59e-12	Gut microbiome composition (summer);
SKCM	cis	rs55962025	0.711	rs4690072	chr4:3122507	T/G	cg05297308	chr4:3317976	RGS12	-0.59	-4.79	-0.48	7.94e-6	Parental longevity (mother's age at death);
SKCM	cis	rs7937682	0.883	rs2212520	chr11:111462096	C/T	cg09085632	chr11:111637200	PPP2R1B	-1.0	-8.74	-0.7	3.47e-13	Primary sclerosing cholangitis;
SKCM	cis	rs7523050	0.643	rs7551313	chr1:109399881	G/A	cg08274380	chr1:109419600	GPSM2	1.13	5.57	0.53	3.54e-7	Fat distribution (HIV);
SKCM	cis	rs875971	0.862	rs13232191	chr7:65986648	A/G	cg18876405	chr7:65276391	NA	0.61	6.06	0.57	4.57e-8	Aortic root size;
SKCM	cis	rs1799949	1.000	rs11653231	chr17:41331460	G/A	cg05368731	chr17:41323189	NBR1	0.87	7.74	0.66	3.01e-11	Menopause (age at onset);
SKCM	cis	rs6809651	0.524	rs6444105	chr3:185811301	C/T	cg00760338	chr3:185826511	ETV5	-0.9	-5.81	-0.55	1.32e-7	Body mass index in physically active individuals;Glomerular filtration rate (creatinine);Body mass index (joint analysis main effects and physical activity interaction);Body mass index;Body mass index in physically inactive individuals;
SKCM	cis	rs9902453	0.726	rs4795523	chr17:28176314	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.83	6.37	0.59	1.2e-8	Coffee consumption (cups per day);
SKCM	cis	rs6495122	0.644	rs62029217	chr15:75261899	C/T	cg17294928	chr15:75287854	SCAMP5	0.7	5.35	0.52	8.66e-7	Caffeine consumption;Diastolic blood pressure;Coffee consumption;
SKCM	cis	rs951366	0.617	rs823080	chr1:205789282	G/A	cg07157834	chr1:205819609	PM20D1	0.92	11.4	0.79	2.72e-18	Menarche (age at onset);
SKCM	cis	rs11249608	0.548	rs62393076	chr5:178450646	C/G	cg21905437	chr5:178450457	ZNF879	0.76	6.46	0.59	8.29e-9	Pubertal anthropometrics;
SKCM	cis	rs28595532	0.920	rs56227053	chr4:119772460	C/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs2013441	1.000	rs2526484	chr17:20103760	A/G	cg13482628	chr17:19912719	NA	-0.65	-5.21	-0.51	1.48e-6	Obesity-related traits;
SKCM	cis	rs8141529	0.764	rs8137969	chr22:29228484	G/C	cg02153584	chr22:29168773	CCDC117	0.62	5.02	0.49	3.15e-6	Lymphocyte counts;
SKCM	cis	rs13040088	1.000	rs910831	chr20:61558775	T/C	cg23096297	chr20:61557774	DIDO1	0.81	6.12	0.57	3.54e-8	Menopause (age at onset);
SKCM	cis	rs873946	0.564	rs2803991	chr10:134557068	A/G	cg27286337	chr10:134555280	INPP5A	0.95	8.68	0.7	4.55e-13	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs2014572	0.967	rs10413671	chr19:57763489	G/A	cg24459738	chr19:57751996	ZNF805	-0.64	-5.17	-0.5	1.79e-6	Hyperactive-impulsive symptoms;
SKCM	cis	rs6489882	0.966	rs7311182	chr12:113379123	T/C	cg07232103	chr12:112566177	TRAFD1	0.6	4.78	0.48	8.16e-6	Chronic lymphocytic leukemia;
SKCM	cis	rs71520386	0.632	rs10279864	chr7:22863824	C/G	cg00309339	chr7:22893653	NA	0.67	4.97	0.49	3.82e-6	Fibrinogen levels;
SKCM	cis	rs929354	0.742	rs886677	chr7:157003782	T/A	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs55962025	0.804	rs3775061	chr4:3238754	A/G	cg00764545	chr4:3318001	RGS12	-0.69	-5.62	-0.54	2.86e-7	Parental longevity (mother's age at death);
SKCM	cis	rs11690935	0.959	rs10207085	chr2:172585885	T/G	cg13550731	chr2:172543902	DYNC1I2	-0.95	-8.21	-0.68	3.64e-12	Schizophrenia;
SKCM	cis	rs7772486	0.754	rs702318	chr6:146005873	G/T	cg05347473	chr6:146136440	FBXO30	-0.68	-6.17	-0.57	2.79e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs116095464	0.619	rs2303741	chr5:218356	T/C	cg22857025	chr5:266934	NA	-1.36	-8.0	-0.67	9.23e-12	Breast cancer;
SKCM	cis	rs67311347	0.544	rs13062243	chr3:40336789	G/A	cg13409248	chr3:40428643	ENTPD3	0.57	5.57	0.53	3.48e-7	Renal cell carcinoma;
SKCM	cis	rs9325144	0.600	rs10880934	chr12:38730455	C/T	cg13010199	chr12:38710504	ALG10B	-0.65	-5.36	-0.52	8.31e-7	Morning vs. evening chronotype;
SKCM	cis	rs9394841	0.692	rs2395795	chr6:41802354	G/A	cg08135965	chr6:41755394	TOMM6	0.74	4.88	0.48	5.45e-6	Mean corpuscular hemoglobin;Red cell distribution width;
SKCM	cis	rs9868809	0.772	rs9877794	chr3:48718388	G/C	cg00383909	chr3:49044727	WDR6	0.89	4.92	0.49	4.79e-6	Ulcerative colitis;Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs10089	0.904	rs2228112	chr5:127469859	A/G	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.89	8.95	0.71	1.34e-13	Ileal carcinoids;
SKCM	cis	rs72781680	0.611	rs55905755	chr2:24330264	T/C	cg20701182	chr2:24300061	SF3B14	0.74	5.03	0.49	3.09e-6	Lymphocyte counts;
SKCM	cis	rs854765	0.663	rs1108648	chr17:17750558	G/A	cg24612305	chr17:17875800	TOM1L2;LRRC48	-0.98	-7.53	-0.65	7.54e-11	Total body bone mineral density;
SKCM	cis	rs344364	0.511	rs2906912	chr16:1953151	G/A	cg26897989	chr16:1907736	C16orf73	-0.72	-7.11	-0.63	4.82e-10	Glomerular filtration rate in chronic kidney disease;
SKCM	cis	rs614226	0.872	rs787827	chr12:120937794	A/G	cg01236616	chr12:121019343	POP5	1.34	8.54	0.7	8.29e-13	Type 1 diabetes nephropathy;
SKCM	cis	rs28595532	1.000	rs115706377	chr4:119628481	G/A	cg11846333	chr4:119757529	SEC24D	1.15	6.24	0.58	2.13e-8	Cannabis dependence symptom count;
SKCM	cis	rs17854409	0.881	rs1046784	chr20:61472808	G/C	cg06598544	chr20:61472147	COL9A3	-1.13	-5.47	-0.53	5.33e-7	Obesity-related traits;
SKCM	cis	rs7927771	0.965	rs34958982	chr11:47547046	T/C	cg05585544	chr11:47624801	NA	-0.64	-5.54	-0.53	3.93e-7	Subjective well-being;
SKCM	cis	rs7811142	1.000	rs7794485	chr7:100068936	T/C	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.23	7.89	0.67	1.53e-11	Platelet count;
SKCM	cis	rs1801251	1.000	rs1022330	chr2:233577330	G/A	cg08000102	chr2:233561755	GIGYF2	0.89	6.91	0.62	1.15e-9	Coronary artery disease;
SKCM	cis	rs9894429	0.966	rs10871499	chr17:79589006	G/A	cg18240062	chr17:79603768	NPLOC4	0.77	7.47	0.65	9.79e-11	Eye color traits;
SKCM	cis	rs1707322	0.721	rs6429575	chr1:46134216	G/C	cg03146154	chr1:46216737	IPP	0.82	6.1	0.57	3.89e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs1218582	0.741	rs11264281	chr1:154867221	A/G	cg03351412	chr1:154909251	PMVK	0.74	6.32	0.58	1.52e-8	Prostate cancer;
SKCM	cis	rs6951245	1.000	rs77760339	chr7:1083927	G/T	cg18402987	chr7:1209562	NA	1.14	6.01	0.56	5.68e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7216064	1.000	rs62084208	chr17:65827443	C/T	cg12091567	chr17:66097778	LOC651250	-0.75	-5.28	-0.51	1.11e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs507080	0.922	rs533646	chr11:118566746	C/G	cg18045108	chr11:118530628	TREH	-0.48	-5.15	-0.5	1.88e-6	Serum metabolite levels;
SKCM	cis	rs7772486	0.688	rs1884364	chr6:146337817	C/G	cg23711669	chr6:146136114	FBXO30	0.76	6.0	0.56	5.76e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs11628318	1.000	rs12892184	chr14:103040300	C/A	cg01864069	chr14:103024347	NA	-0.7	-5.02	-0.49	3.25e-6	Platelet count;
SKCM	cis	rs9399135	0.935	rs2150680	chr6:135347131	G/C	cg24558204	chr6:135376177	HBS1L	0.6	5.36	0.52	8.17e-7	Red blood cell count;
SKCM	cis	rs9815354	0.812	rs73077360	chr3:41850054	C/T	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs7945705	0.818	rs10769948	chr11:8761782	C/T	cg21881798	chr11:8931708	C11orf17;ST5	-0.69	-7.09	-0.63	5.39e-10	Hemoglobin concentration;
SKCM	cis	rs2153535	0.580	rs1932276	chr6:8442593	G/A	cg23788917	chr6:8435910	SLC35B3	0.69	5.14	0.5	1.99e-6	Motion sickness;
SKCM	cis	rs992157	0.798	rs7557709	chr2:219167529	G/A	cg20019365	chr2:219134978	PNKD;AAMP	0.72	6.12	0.57	3.48e-8	Colorectal cancer;
SKCM	cis	rs8180040	0.966	rs9683177	chr3:47490493	G/A	cg27129171	chr3:47204927	SETD2	0.79	5.79	0.55	1.43e-7	Colorectal cancer;
SKCM	cis	rs7666738	0.830	rs34313689	chr4:99013689	T/C	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs28386778	0.897	rs2665795	chr17:61925272	A/G	cg23090583	chr17:61904693	PSMC5;FTSJ3	-1.1	-11.09	-0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs34779708	0.966	rs10827492	chr10:35429825	A/G	cg03585969	chr10:35415529	CREM	-0.75	-6.33	-0.58	1.42e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs8060686	0.641	rs73612208	chr16:68206844	G/A	cg09117114	chr16:67998030	SLC12A4	-0.78	-5.08	-0.5	2.56e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs3091242	0.967	rs3093614	chr1:25677844	T/A	cg02931644	chr1:25747376	RHCE	-0.5	-4.96	-0.49	4.01e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs992157	0.764	rs13020391	chr2:219184436	C/T	cg00012203	chr2:219082015	ARPC2	-0.77	-5.58	-0.53	3.31e-7	Colorectal cancer;
SKCM	cis	rs10504229	0.679	rs75402323	chr8:58136227	A/G	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs3091242	1.000	rs3091242	chr1:25674785	C/T	cg02931644	chr1:25747376	RHCE	0.51	5.05	0.5	2.84e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs875971	0.830	rs6950137	chr7:65976610	G/A	cg11764359	chr7:65958608	NA	0.81	7.61	0.65	5.25e-11	Aortic root size;
SKCM	cis	rs2842992	1.000	rs2758322	chr6:160075188	G/T	cg19482086	chr6:160211437	TCP1;MRPL18	0.77	5.68	0.54	2.26e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs2404602	0.692	rs55864032	chr15:77122548	A/G	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs7959452	0.535	rs1350166	chr12:69636314	G/T	cg20891283	chr12:69753455	YEATS4	0.73	6.37	0.59	1.2e-8	Blood protein levels;
SKCM	cis	rs2204008	0.628	rs10876106	chr12:37990767	A/G	cg26384229	chr12:38710491	ALG10B	0.79	6.58	0.6	4.85e-9	Bladder cancer;
SKCM	cis	rs7666738	0.830	rs10012271	chr4:99065154	A/C	cg17366294	chr4:99064904	C4orf37	0.61	4.93	0.49	4.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs3768617	0.510	rs3768624	chr1:183079252	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs1799949	0.965	rs8176193	chr17:41231516	C/T	cg23758822	chr17:41437982	NA	0.93	7.82	0.66	2.1e-11	Menopause (age at onset);
SKCM	cis	rs1577917	0.655	rs2758848	chr6:86347605	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.74	-6.61	-0.6	4.24e-9	Response to antipsychotic treatment;
SKCM	cis	rs17376456	1.000	rs13181660	chr5:93533658	A/G	cg25358565	chr5:93447407	FAM172A	1.23	8.31	0.69	2.39e-12	Diabetic retinopathy;
SKCM	cis	rs9300255	0.568	rs1621194	chr12:123651018	T/C	cg00376283	chr12:123451042	ABCB9	0.82	5.61	0.54	3e-7	Neutrophil percentage of white cells;
SKCM	cis	rs2412819	0.597	rs78282429	chr15:43922003	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	0.73	5.43	0.52	6.13e-7	Lung cancer;
SKCM	cis	rs9790314	0.503	rs6441374	chr3:161064540	A/T	cg03342759	chr3:160939853	NMD3	-0.76	-6.37	-0.58	1.23e-8	Morning vs. evening chronotype;
SKCM	cis	rs9914544	1.000	rs1634409	chr17:18836177	C/T	cg26378065	chr17:18585709	ZNF286B	0.7	4.8	0.48	7.48e-6	Educational attainment (years of education);
SKCM	cis	rs28595532	0.841	rs114966236	chr4:119733437	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.52	0.53	4.28e-7	Cannabis dependence symptom count;
SKCM	cis	rs8060686	0.641	rs16957696	chr16:68039850	C/T	cg09117114	chr16:67998030	SLC12A4	-0.78	-5.11	-0.5	2.21e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs9325144	0.581	rs2730929	chr12:38942739	T/C	cg13010199	chr12:38710504	ALG10B	-0.71	-5.77	-0.55	1.52e-7	Morning vs. evening chronotype;
SKCM	cis	rs2929278	0.617	rs4617832	chr15:44030579	G/A	cg02155558	chr15:43621948	ADAL;LCMT2	-0.74	-5.27	-0.51	1.2e-6	Schizophrenia;
SKCM	trans	rs17685	0.753	rs1637037	chr7:75692927	C/T	cg19862616	chr7:65841803	NCRNA00174	0.95	9.34	0.73	2.39e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2243480	1.000	rs7792391	chr7:65773429	A/G	cg18252515	chr7:66147081	NA	1.34	8.18	0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs40363	0.620	rs1137454	chr16:3533577	C/G	cg27500918	chr16:2933308	FLYWCH2	-0.7	-4.78	-0.48	8e-6	Tuberculosis;
SKCM	cis	rs2980439	0.783	rs2955587	chr8:8098079	A/G	cg08975724	chr8:8085496	FLJ10661	0.82	6.64	0.6	3.83e-9	Neuroticism;
SKCM	cis	rs1707322	0.721	rs10890341	chr1:46147240	C/A	cg03146154	chr1:46216737	IPP	0.8	5.57	0.53	3.52e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7666738	0.791	rs60028147	chr4:99046618	G/A	cg17366294	chr4:99064904	C4orf37	0.59	4.84	0.48	6.52e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs782590	0.582	rs2627767	chr2:55926815	A/T	cg18811423	chr2:55921094	PNPT1	0.95	7.26	0.63	2.52e-10	Metabolic syndrome;
SKCM	cis	rs7100689	0.556	rs946893	chr10:82023524	A/G	cg01528321	chr10:82214614	TSPAN14	0.79	7.37	0.64	1.54e-10	Post bronchodilator FEV1;
SKCM	cis	rs2811415	0.597	rs2033445	chr3:127730507	A/G	cg09089421	chr3:127803668	RUVBL1	0.99	8.49	0.69	1.07e-12	Lung function (FEV1/FVC);
SKCM	cis	rs2439831	0.702	rs7171750	chr15:44025858	G/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.35	7.72	0.66	3.27e-11	Lung cancer in ever smokers;
SKCM	cis	rs1005277	0.579	rs2021649	chr10:38392122	C/T	cg00409905	chr10:38381863	ZNF37A	-0.64	-5.96	-0.56	6.77e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs1405130	0.900	rs12692151	chr2:235587612	T/C	cg17841421	chr2:235704848	NA	-0.57	-4.79	-0.48	7.65e-6	Coronary artery disease;
SKCM	cis	rs2839186	0.709	rs2156117	chr21:47669300	C/A	cg11766577	chr21:47581405	C21orf56	-0.76	-6.51	-0.59	6.59e-9	Testicular germ cell tumor;
SKCM	cis	rs314370	0.951	rs17881696	chr7:100493359	G/A	cg10426581	chr7:100472382	SRRT	0.67	5.64	0.54	2.57e-7	Resting heart rate;
SKCM	cis	rs8017423	0.647	rs12883000	chr14:90820557	G/A	cg04374321	chr14:90722782	PSMC1	-0.77	-5.94	-0.56	7.46e-8	Mortality in heart failure;
SKCM	cis	rs362272	0.524	rs7435601	chr4:3369645	A/G	cg11471262	chr4:3318911	RGS12	0.97	10.95	0.78	1.97e-17	Serum sulfate level;
SKCM	cis	rs1218582	0.772	rs4845682	chr1:154877105	T/C	cg03351412	chr1:154909251	PMVK	0.77	6.52	0.59	6.43e-9	Prostate cancer;
SKCM	cis	rs11098499	0.604	rs2389882	chr4:120566733	A/C	cg24375607	chr4:120327624	NA	0.63	4.79	0.48	7.69e-6	Corneal astigmatism;
SKCM	cis	rs6089584	0.586	rs4925216	chr20:60599923	G/A	cg16423285	chr20:60520624	NA	-0.6	-5.1	-0.5	2.37e-6	Body mass index;
SKCM	cis	rs7811142	1.000	rs11761725	chr7:100039815	C/T	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-0.99	-5.52	-0.53	4.2e-7	Platelet count;
SKCM	cis	rs7208859	0.623	rs79607958	chr17:28934548	T/G	cg14067834	chr17:29058358	SUZ12P	1.25	5.05	0.5	2.78e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs7100689	0.725	rs2185425	chr10:82139941	T/C	cg00277334	chr10:82204260	NA	-0.51	-4.96	-0.49	4.01e-6	Post bronchodilator FEV1;
SKCM	cis	rs62244186	0.566	rs55852922	chr3:44826188	A/G	cg15225532	chr3:44803084	KIF15;KIAA1143	0.62	4.85	0.48	6.14e-6	Depressive symptoms;
SKCM	cis	rs4481887	0.741	rs6421453	chr1:248533285	A/G	cg22724847	chr1:248512586	OR14C36	0.59	5.07	0.5	2.63e-6	Common traits (Other);
SKCM	cis	rs12477438	0.798	rs17708218	chr2:99696284	C/A	cg26064155	chr2:99771622	LIPT1;TSGA10	-0.72	-4.86	-0.48	6e-6	Chronic sinus infection;
SKCM	cis	rs6952808	0.500	rs3800902	chr7:2144378	C/T	cg21782813	chr7:2030301	MAD1L1	0.53	5.68	0.54	2.25e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs6558174	0.965	rs4872524	chr8:22489537	A/G	cg03733263	chr8:22462867	KIAA1967	0.76	5.31	0.52	1.02e-6	Breast cancer;
SKCM	cis	rs7100689	0.753	rs2185426	chr10:82120887	G/A	cg00277334	chr10:82204260	NA	-0.52	-4.89	-0.48	5.24e-6	Post bronchodilator FEV1;
SKCM	cis	rs9660180	0.967	rs6664664	chr1:1751264	G/A	cg13866156	chr1:1669148	SLC35E2	-0.72	-6.0	-0.56	5.95e-8	Body mass index;
SKCM	cis	rs12477438	0.520	rs6542865	chr2:99764521	C/T	cg14399236	chr2:99771627	LIPT1;TSGA10	0.97	8.9	0.71	1.72e-13	Chronic sinus infection;
SKCM	cis	rs748404	0.697	rs579651	chr15:43558376	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	0.7	5.74	0.54	1.74e-7	Lung cancer;
SKCM	cis	rs3820928	0.692	rs2396434	chr2:227775223	G/T	cg11843606	chr2:227700838	RHBDD1	-0.62	-5.01	-0.49	3.25e-6	Pulmonary function;
SKCM	cis	rs8180040	0.871	rs11716661	chr3:47517773	G/T	cg16586182	chr3:47516702	SCAP	0.76	5.34	0.52	8.83e-7	Colorectal cancer;
SKCM	trans	rs6601530	0.564	rs733395	chr8:10621960	A/G	cg03550506	chr22:32149733	DEPDC5	-0.68	-7.37	-0.64	1.56e-10	Carotid intima media thickness;
SKCM	cis	rs1957429	0.901	rs3813423	chr14:65347475	C/A	cg23373153	chr14:65346875	NA	1.11	6.32	0.58	1.52e-8	Pediatric areal bone mineral density (radius);
SKCM	cis	rs2153535	0.580	rs6921036	chr6:8455400	G/A	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs6545883	0.929	rs2600663	chr2:61540687	A/G	cg15711740	chr2:61764176	XPO1	0.79	5.44	0.52	5.96e-7	Tuberculosis;
SKCM	cis	rs362272	0.505	rs60208975	chr4:3364530	A/G	cg24015175	chr4:3319247	RGS12	0.84	10.12	0.75	7.34e-16	Serum sulfate level;
SKCM	cis	rs11098499	0.954	rs13113483	chr4:120309039	C/T	cg24375607	chr4:120327624	NA	0.65	4.97	0.49	3.87e-6	Corneal astigmatism;
SKCM	cis	rs7824557	0.527	rs2736298	chr8:11235136	C/G	cg21775007	chr8:11205619	TDH	-0.59	-5.04	-0.5	3e-6	Retinal vascular caliber;
SKCM	cis	rs4242434	0.819	rs7843128	chr8:22473465	T/C	cg03733263	chr8:22462867	KIAA1967	1.02	8.7	0.7	4.12e-13	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs8078723	0.714	rs3859187	chr17:38150613	C/A	cg17467752	chr17:38218738	THRA	-0.58	-5.16	-0.5	1.81e-6	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs9303401	0.659	rs2072316	chr17:56604813	G/T	cg02118635	chr17:56770003	RAD51C;TEX14	0.8	5.5	0.53	4.66e-7	Cognitive test performance;
SKCM	cis	rs28595532	0.920	rs114670456	chr4:119771202	A/G	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs2228479	0.850	rs12600051	chr16:89992072	G/T	cg00800038	chr16:89945340	TCF25	-0.99	-5.64	-0.54	2.57e-7	Skin colour saturation;
SKCM	cis	rs3785574	0.962	rs2727331	chr17:61926990	G/T	cg06873352	chr17:61820015	STRADA	0.56	4.83	0.48	6.66e-6	Height;
SKCM	cis	rs4132509	0.895	rs6674314	chr1:243920895	A/G	cg21452805	chr1:244014465	NA	0.86	5.52	0.53	4.32e-7	RR interval (heart rate);
SKCM	cis	rs1065656	0.581	rs1065666	chr16:1839134	T/C	cg26897989	chr16:1907736	C16orf73	0.62	6.45	0.59	8.73e-9	Insulin-like growth factors;
SKCM	cis	rs4523957	0.890	rs62069332	chr17:2112720	A/G	cg16513277	chr17:2031491	SMG6	-0.72	-4.87	-0.48	5.82e-6	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs4803468	1.000	rs2569754	chr19:41936734	A/G	cg14132834	chr19:41945861	ATP5SL	-0.77	-5.9	-0.56	9.04e-8	Height;
SKCM	cis	rs34779708	0.931	rs4934721	chr10:35377715	A/G	cg03585969	chr10:35415529	CREM	0.78	6.2	0.57	2.48e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs13108904	0.905	rs34490749	chr4:1217981	A/G	cg02018176	chr4:1364513	KIAA1530	0.65	5.26	0.51	1.24e-6	Obesity-related traits;
SKCM	cis	rs35306767	0.953	rs12354639	chr10:963681	G/A	cg20503657	chr10:835505	NA	0.66	5.15	0.5	1.88e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs75804782	0.557	rs10178728	chr2:239360121	T/A	cg18131467	chr2:239335373	ASB1	-0.97	-5.19	-0.51	1.61e-6	Morning vs. evening chronotype;Chronotype;
SKCM	cis	rs3766606	0.505	rs60057745	chr1:7946819	G/A	cg00042356	chr1:8021962	PARK7	0.83	5.14	0.5	1.96e-6	Ulcerative colitis;Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs1799949	0.965	rs8176130	chr17:41258043	C/T	cg05368731	chr17:41323189	NBR1	0.88	7.75	0.66	2.84e-11	Menopause (age at onset);
SKCM	cis	rs12926788	0.546	rs200531	chr16:24756172	G/A	cg04756594	chr16:24857601	SLC5A11	-0.72	-5.19	-0.51	1.65e-6	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs1577917	0.771	rs10944133	chr6:86358984	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.82	-7.6	-0.65	5.57e-11	Response to antipsychotic treatment;
SKCM	cis	rs2204008	0.583	rs11520077	chr12:38066271	T/G	cg26384229	chr12:38710491	ALG10B	0.68	5.15	0.5	1.89e-6	Bladder cancer;
SKCM	cis	rs10911232	0.507	rs4652769	chr1:183009196	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.64	0.6	3.83e-9	Hypertriglyceridemia;
SKCM	cis	rs4924935	1.000	rs2158100	chr17:18811479	A/G	cg26378065	chr17:18585709	ZNF286B	-0.77	-5.58	-0.53	3.37e-7	Pancreatic cancer;
SKCM	cis	rs9911578	1.000	rs3744109	chr17:56594197	C/T	cg12560992	chr17:57184187	TRIM37	-0.92	-7.25	-0.63	2.64e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs7666738	0.791	rs7678564	chr4:99057341	A/G	cg17366294	chr4:99064904	C4orf37	0.61	4.93	0.49	4.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2721195	0.967	rs1480000	chr8:145702007	C/T	cg11211951	chr8:145729740	GPT	-0.64	-5.99	-0.56	6.06e-8	Age at first birth;
SKCM	cis	rs999943	0.846	rs9366826	chr6:33619184	C/G	cg14003231	chr6:33640908	ITPR3	0.64	5.76	0.55	1.58e-7	Obesity (extreme);
SKCM	cis	rs11148252	0.532	rs9526975	chr13:53255804	C/T	cg00495681	chr13:53174319	NA	0.8	6.81	0.61	1.78e-9	Lewy body disease;
SKCM	cis	rs870825	0.616	rs4256263	chr4:185622959	C/A	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs910316	0.967	rs4903293	chr14:75656568	A/G	cg11812906	chr14:75593930	NEK9	-0.74	-5.75	-0.55	1.69e-7	Height;
SKCM	cis	rs875971	0.638	rs801205	chr7:66022144	C/A	cg11764359	chr7:65958608	NA	-0.86	-6.6	-0.6	4.52e-9	Aortic root size;
SKCM	cis	rs6066825	0.644	rs2143563	chr20:47320211	A/G	cg18078177	chr20:47281410	PREX1	0.64	5.19	0.51	1.6e-6	Colorectal cancer;
SKCM	cis	rs760805	1.000	rs4649037	chr1:25258301	G/T	cg22509179	chr1:25234806	RUNX3	-0.75	-6.22	-0.58	2.26e-8	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs116095464	0.558	rs56342538	chr5:225796	T/C	cg22857025	chr5:266934	NA	-1.36	-8.0	-0.67	9.23e-12	Breast cancer;
SKCM	cis	rs2243480	1.000	rs34560516	chr7:65404092	A/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs13118159	0.550	rs4974612	chr4:1364543	A/G	cg02018176	chr4:1364513	KIAA1530	0.95	7.96	0.67	1.12e-11	Longevity;
SKCM	cis	rs71520386	0.607	rs28617621	chr7:22857682	A/G	cg00309339	chr7:22893653	NA	0.67	4.97	0.49	3.82e-6	Fibrinogen levels;
SKCM	cis	rs561341	0.769	rs7217004	chr17:30178092	A/G	cg00745463	chr17:30367425	LRRC37B	0.86	4.89	0.48	5.2e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs7618501	0.633	rs3774733	chr3:50037123	C/G	cg24110177	chr3:50126178	RBM5	-0.6	-5.11	-0.5	2.25e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9325144	0.647	rs12231313	chr12:39101929	C/T	cg26384229	chr12:38710491	ALG10B	-0.72	-6.39	-0.59	1.12e-8	Morning vs. evening chronotype;
SKCM	cis	rs4727027	0.754	rs11764892	chr7:148858916	G/A	cg23583168	chr7:148888333	NA	-0.8	-5.43	-0.52	6.09e-7	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs1577917	1.000	rs1018184	chr6:86648475	G/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.6	5.0	0.49	3.46e-6	Response to antipsychotic treatment;
SKCM	cis	rs1153858	1.000	rs12441971	chr15:45671957	A/T	cg10760299	chr15:45669010	GATM	0.62	6.35	0.58	1.3e-8	Homoarginine levels;
SKCM	cis	rs35306767	0.761	rs11253537	chr10:1010735	G/A	cg20503657	chr10:835505	NA	0.76	6.08	0.57	4.18e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs1065656	0.553	rs344359	chr16:1838640	T/C	cg26897989	chr16:1907736	C16orf73	0.62	6.51	0.59	6.53e-9	Insulin-like growth factors;
SKCM	cis	rs8017423	0.967	rs12889636	chr14:90689953	A/C	cg04374321	chr14:90722782	PSMC1	-0.99	-8.87	-0.71	1.93e-13	Mortality in heart failure;
SKCM	cis	rs1218582	0.741	rs7544528	chr1:154844585	C/T	cg16680214	chr1:154839983	KCNN3	-0.54	-5.01	-0.49	3.36e-6	Prostate cancer;
SKCM	cis	rs10779751	1.000	rs2253213	chr1:11265785	A/G	cg08854313	chr1:11322531	MTOR	0.82	5.82	0.55	1.25e-7	Body mass index;
SKCM	cis	rs2034088	0.833	rs9748016	chr17:410451	G/T	cg13332499	chr17:408570	NA	0.45	4.78	0.48	7.96e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs72781680	1.000	rs72781658	chr2:24220141	A/G	cg08917208	chr2:24149416	ATAD2B	1.07	5.99	0.56	6.1e-8	Lymphocyte counts;
SKCM	cis	rs67311347	1.000	rs11129876	chr3:40401636	C/T	cg00091569	chr3:40428383	ENTPD3	-0.61	-5.4	-0.52	6.91e-7	Renal cell carcinoma;
SKCM	cis	rs854765	0.647	rs8066764	chr17:17974668	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.87	6.53	0.59	6.16e-9	Total body bone mineral density;
SKCM	cis	rs7552404	0.924	rs1146574	chr1:76202671	A/G	cg10523679	chr1:76189770	ACADM	0.69	5.07	0.5	2.67e-6	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs2282032	0.527	rs3742666	chr14:90767860	T/C	cg04374321	chr14:90722782	PSMC1	0.67	5.37	0.52	7.94e-7	Longevity;
SKCM	cis	rs11098499	0.954	rs7654587	chr4:120388406	C/T	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs2645694	0.626	rs2703119	chr4:77823640	C/T	cg03477792	chr4:77819574	ANKRD56	0.57	6.32	0.58	1.47e-8	Emphysema distribution in smoking;
SKCM	cis	rs9394841	0.667	rs9367112	chr6:41769920	T/C	cg08135965	chr6:41755394	TOMM6	0.75	4.96	0.49	3.96e-6	Mean corpuscular hemoglobin;Red cell distribution width;
SKCM	cis	rs67460515	0.892	rs11718905	chr3:161051793	G/A	cg03342759	chr3:160939853	NMD3	-0.81	-6.86	-0.61	1.43e-9	Parkinson's disease;
SKCM	cis	rs3892630	0.878	rs6510277	chr19:33183669	C/A	cg22980127	chr19:33182716	NUDT19	1.39	8.08	0.67	6.68e-12	Red blood cell traits;
SKCM	cis	rs10179986	0.930	rs1879018	chr2:134872561	A/G	cg14579516	chr2:135677120	CCNT2	0.73	5.02	0.49	3.14e-6	Glucose homeostasis traits;
SKCM	cis	rs10927875	0.894	rs10927878	chr1:16319957	C/T	cg21385522	chr1:16154831	NA	-0.88	-7.19	-0.63	3.49e-10	Dilated cardiomyopathy;
SKCM	cis	rs992157	0.560	rs4674275	chr2:219097738	G/A	cg00012203	chr2:219082015	ARPC2	-0.78	-6.52	-0.59	6.36e-9	Colorectal cancer;
SKCM	cis	rs6840360	0.615	rs6831810	chr4:152461995	A/G	cg22705602	chr4:152727874	NA	-0.51	-5.78	-0.55	1.45e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs9399135	0.967	rs9389254	chr6:135330709	C/T	cg24558204	chr6:135376177	HBS1L	0.59	5.23	0.51	1.41e-6	Red blood cell count;
SKCM	cis	rs1153858	1.000	rs7402650	chr15:45701895	C/T	cg21132104	chr15:45694354	SPATA5L1	0.89	7.21	0.63	3.12e-10	Homoarginine levels;
SKCM	cis	rs6840360	0.550	rs11723438	chr4:152531801	C/T	cg22705602	chr4:152727874	NA	0.5	5.38	0.52	7.47e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs3091242	0.933	rs9645452	chr1:25668326	C/T	cg02931644	chr1:25747376	RHCE	-0.51	-5.05	-0.5	2.84e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs28595532	0.920	rs116062544	chr4:119735548	G/C	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs9910055	0.529	rs228765	chr17:42186422	C/T	cg09913183	chr17:42254507	C17orf65;ASB16	-0.58	-4.83	-0.48	6.59e-6	Total body bone mineral density;
SKCM	cis	rs4891159	0.790	rs77878087	chr18:74116337	G/A	cg24786174	chr18:74118243	ZNF516	-0.75	-7.23	-0.63	2.84e-10	Longevity;
SKCM	cis	rs6088590	1.000	rs6088607	chr20:33378733	C/T	cg24642439	chr20:33292090	TP53INP2	1.01	7.2	0.63	3.23e-10	Coronary artery disease;
SKCM	cis	rs11626933	1.000	rs2236402	chr14:90734378	C/G	cg14092571	chr14:90743983	NA	-0.96	-8.75	-0.7	3.33e-13	Gut microbiota (bacterial taxa);
SKCM	cis	rs4642101	0.662	rs9874893	chr3:12833079	C/G	cg05775895	chr3:12838266	CAND2	0.66	5.55	0.53	3.86e-7	QRS complex (12-leadsum);
SKCM	cis	rs28595532	0.920	rs114210107	chr4:119734491	G/A	cg11846333	chr4:119757529	SEC24D	1.19	6.29	0.58	1.74e-8	Cannabis dependence symptom count;
SKCM	cis	rs4268898	0.662	rs9784114	chr2:24437517	C/T	cg06627628	chr2:24431161	ITSN2	-0.92	-7.12	-0.63	4.73e-10	Asthma;
SKCM	cis	rs77106637	0.860	rs1552224	chr11:72433098	A/C	cg03713592	chr11:72463424	ARAP1	1.06	5.79	0.55	1.39e-7	Type 2 diabetes;
SKCM	cis	rs2645694	0.626	rs2645705	chr4:77830434	G/A	cg06046430	chr4:77819534	ANKRD56	0.54	5.94	0.56	7.49e-8	Emphysema distribution in smoking;
SKCM	cis	rs9467773	0.620	rs2504567	chr6:26662920	C/G	cg09904177	chr6:26538194	HMGN4	0.58	5.01	0.49	3.28e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs12477438	0.520	rs6712704	chr2:99719687	C/T	cg14399236	chr2:99771627	LIPT1;TSGA10	0.95	8.78	0.71	2.89e-13	Chronic sinus infection;
SKCM	cis	rs28595532	1.000	rs115965820	chr4:119586485	G/A	cg21605333	chr4:119757512	SEC24D	1.24	7.1	0.63	5.16e-10	Cannabis dependence symptom count;
SKCM	cis	rs7727544	0.660	rs272886	chr5:131665840	T/C	cg24060327	chr5:131705240	SLC22A5	-0.69	-5.1	-0.5	2.36e-6	Blood metabolite levels;
SKCM	cis	rs9951698	0.667	rs7234094	chr18:13007480	T/G	cg12848697	chr18:13133368	NA	0.53	4.9	0.48	5.18e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9815354	0.812	rs73073364	chr3:41843058	T/C	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs10504229	0.683	rs11775506	chr8:58133639	G/T	cg02725872	chr8:58115012	NA	-0.54	-5.22	-0.51	1.44e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs2153535	0.563	rs1737584	chr6:8536742	C/T	cg07606381	chr6:8435919	SLC35B3	0.87	6.38	0.59	1.17e-8	Motion sickness;
SKCM	cis	rs6598955	0.670	rs11247892	chr1:26592727	A/G	cg00938395	chr1:26633206	UBXN11	0.7	4.92	0.49	4.63e-6	Obesity-related traits;
SKCM	cis	rs2836950	0.545	rs2836952	chr21:40616651	G/C	cg11644478	chr21:40555479	PSMG1	-0.64	-5.02	-0.49	3.17e-6	Menarche (age at onset);
SKCM	cis	rs2153535	0.580	rs6597330	chr6:8492076	T/C	cg07606381	chr6:8435919	SLC35B3	0.86	6.25	0.58	2.06e-8	Motion sickness;
SKCM	cis	rs28386778	0.897	rs8079818	chr17:61824667	C/G	cg01411255	chr17:61851458	DDX42;CCDC47	0.78	5.03	0.49	3.06e-6	Prudent dietary pattern;
SKCM	cis	rs9300255	0.544	rs1727310	chr12:123660510	A/G	cg00376283	chr12:123451042	ABCB9	0.84	5.1	0.5	2.35e-6	Neutrophil percentage of white cells;
SKCM	cis	rs16854884	0.657	rs1867608	chr3:143752938	G/A	cg06585982	chr3:143692056	C3orf58	0.87	8.11	0.68	5.72e-12	Economic and political preferences (feminism/equality);
SKCM	cis	rs4523957	0.583	rs7225168	chr17:2023089	T/G	cg16513277	chr17:2031491	SMG6	-0.81	-5.98	-0.56	6.24e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs1003719	0.667	rs2298684	chr21:38445095	G/A	cg10648535	chr21:38446584	PIGP;TTC3	0.64	4.98	0.49	3.72e-6	Eye color traits;
SKCM	cis	rs1401999	0.628	rs7639048	chr3:183746044	A/G	cg01324343	chr3:183735012	ABCC5	0.64	6.59	0.6	4.67e-9	Anterior chamber depth;
SKCM	cis	rs7124681	0.565	rs2904127	chr11:47817290	A/G	cg20307385	chr11:47447363	PSMC3	0.71	5.63	0.54	2.67e-7	Body mass index (joint analysis main effects and physical activity interaction);Body mass index;Body mass index in physically active individuals;
SKCM	cis	rs78456975	0.941	rs13423300	chr2:1553809	C/A	cg01028140	chr2:1542097	TPO	-0.6	-5.14	-0.5	2.02e-6	Placebo response in major depressive disorder (% change in symptom score);
SKCM	cis	rs7811142	0.562	rs7786844	chr7:99934008	T/G	cg00814883	chr7:100076585	TSC22D4	-0.84	-4.78	-0.48	8.01e-6	Platelet count;
SKCM	cis	rs4481887	0.861	rs4309013	chr1:248480768	C/T	cg00666640	chr1:248458726	OR2T12	0.66	6.0	0.56	5.9e-8	Common traits (Other);
SKCM	cis	rs17376456	0.825	rs17314825	chr5:93234937	A/G	cg21475434	chr5:93447410	FAM172A	1.03	5.61	0.54	3e-7	Diabetic retinopathy;
SKCM	cis	rs9905704	0.647	rs9898048	chr17:57108543	C/T	cg12560992	chr17:57184187	TRIM37	0.74	5.99	0.56	6.21e-8	Testicular germ cell tumor;
SKCM	cis	rs4423214	1.000	rs12807718	chr11:71171170	T/C	cg05163923	chr11:71159392	DHCR7	0.83	8.11	0.68	5.77e-12	Vitamin D levels;
SKCM	cis	rs10504073	0.584	rs4873304	chr8:49922733	G/A	cg00325661	chr8:49890786	NA	0.79	7.15	0.63	3.99e-10	Blood metabolite ratios;
SKCM	cis	rs6087990	0.965	rs2424899	chr20:31343543	A/C	cg13636640	chr20:31349939	DNMT3B	0.94	8.2	0.68	3.92e-12	Ulcerative colitis;
SKCM	cis	rs17711722	0.740	rs7809991	chr7:65406218	A/G	cg11987759	chr7:65425863	GUSB	-0.76	-6.8	-0.61	1.89e-9	Calcium levels;
SKCM	cis	rs1348850	0.789	rs13027959	chr2:178275887	G/A	cg02961200	chr2:178257176	LOC100130691;AGPS	0.84	6.3	0.58	1.65e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs10876993	0.890	rs810204	chr12:58075733	T/C	cg18357645	chr12:58087776	OS9	0.65	5.98	0.56	6.22e-8	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs875971	0.505	rs2462573	chr7:65507392	C/T	cg05627663	chr7:65219948	SNORA22;CCT6P1	-0.59	-5.08	-0.5	2.48e-6	Aortic root size;
SKCM	cis	rs10504229	1.000	rs111915672	chr8:58191665	T/C	cg02725872	chr8:58115012	NA	-0.5	-4.87	-0.48	5.68e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs919433	0.963	rs4850428	chr2:198169772	G/A	cg04278110	chr2:198063759	ANKRD44	-0.69	-4.8	-0.48	7.58e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs9910055	0.615	rs189049	chr17:42197213	A/C	cg08499158	chr17:42289980	UBTF	0.73	6.32	0.58	1.53e-8	Total body bone mineral density;
SKCM	cis	rs7100689	0.622	rs4536152	chr10:82119242	C/T	cg01528321	chr10:82214614	TSPAN14	0.86	7.75	0.66	2.88e-11	Post bronchodilator FEV1;
SKCM	cis	rs7772486	0.806	rs4075695	chr6:146250959	A/G	cg23711669	chr6:146136114	FBXO30	-0.74	-6.96	-0.62	9.36e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs3820928	0.900	rs6754155	chr2:227784961	A/G	cg11843606	chr2:227700838	RHBDD1	-0.6	-4.81	-0.48	7.17e-6	Pulmonary function;
SKCM	cis	rs17376456	1.000	rs58734583	chr5:93532155	C/T	cg25358565	chr5:93447407	FAM172A	1.23	8.18	0.68	4.19e-12	Diabetic retinopathy;
SKCM	cis	rs9910055	0.550	rs113844752	chr17:42297631	C/A	cg08499158	chr17:42289980	UBTF	-0.86	-7.69	-0.66	3.74e-11	Total body bone mineral density;
SKCM	cis	rs12824058	0.831	rs4759658	chr12:130815872	C/T	cg26677194	chr12:130822605	PIWIL1	0.71	5.91	0.56	8.57e-8	Menopause (age at onset);
SKCM	cis	rs17065868	1.000	rs61947999	chr13:45166125	G/T	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	trans	rs17685	0.712	rs60232511	chr7:75800082	A/G	cg19862616	chr7:65841803	NCRNA00174	0.97	10.73	0.77	5.13e-17	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs28595532	0.920	rs55758547	chr4:119769475	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs554111	0.686	rs519209	chr1:21043790	C/T	cg01072550	chr1:21505969	NA	0.6	4.91	0.49	4.81e-6	Facial morphology (factor 17, height of vermillion upper lip);
SKCM	trans	rs5756813	0.661	rs6000898	chr22:38202399	T/C	cg19894588	chr14:64061835	NA	-0.89	-7.5	-0.65	8.56e-11	Optic cup area;Vertical cup-disc ratio;
SKCM	cis	rs801193	0.967	rs2420827	chr7:66147101	G/A	cg00343986	chr7:65444356	GUSB	-0.71	-5.23	-0.51	1.4e-6	Aortic root size;
SKCM	cis	rs4242434	0.892	rs34269854	chr8:22465160	G/C	cg03733263	chr8:22462867	KIAA1967	1.07	9.15	0.72	5.54e-14	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs2760061	0.819	rs708115	chr1:228198046	C/T	cg02753203	chr1:228287806	NA	0.74	6.31	0.58	1.56e-8	Diastolic blood pressure;
SKCM	cis	rs7937682	0.883	rs1612013	chr11:111456293	A/G	cg09085632	chr11:111637200	PPP2R1B	-1.04	-9.98	-0.75	1.38e-15	Primary sclerosing cholangitis;
SKCM	cis	rs10504229	1.000	rs67236942	chr8:58176525	T/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs875971	1.000	rs7789554	chr7:65946038	A/G	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	cis	rs34172651	0.517	rs200526	chr16:24760511	C/T	cg04756594	chr16:24857601	SLC5A11	-0.72	-5.19	-0.51	1.65e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9660180	0.935	rs2180311	chr1:1748734	T/C	cg23982607	chr1:1823379	GNB1	-0.7	-5.97	-0.56	6.5e-8	Body mass index;
SKCM	cis	rs9640161	0.659	rs7781827	chr7:150008858	T/C	cg27494647	chr7:150038898	RARRES2	0.55	4.9	0.49	5.02e-6	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs6570726	0.846	rs973856	chr6:145781916	C/T	cg23711669	chr6:146136114	FBXO30	-0.77	-7.28	-0.64	2.29e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2153535	0.580	rs6920779	chr6:8437624	C/T	cg23788917	chr6:8435910	SLC35B3	0.64	4.83	0.48	6.63e-6	Motion sickness;
SKCM	cis	rs1799949	1.000	rs8176103	chr17:41267050	G/A	cg25918947	chr17:41365094	TMEM106A	-0.62	-5.91	-0.56	8.55e-8	Menopause (age at onset);
SKCM	cis	rs1801251	1.000	rs283475	chr2:233654381	A/C	cg08000102	chr2:233561755	GIGYF2	-0.91	-7.17	-0.63	3.69e-10	Coronary artery disease;
SKCM	cis	rs7811142	0.720	rs112622797	chr7:99917416	G/A	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.08	6.85	0.61	1.49e-9	Platelet count;
SKCM	cis	rs7659604	0.935	rs73844280	chr4:122664687	G/A	cg19748678	chr4:122722346	EXOSC9	0.66	5.44	0.52	5.83e-7	Type 2 diabetes;
SKCM	cis	rs6951245	1.000	rs79327308	chr7:1108141	A/C	cg03188948	chr7:1209495	NA	1.13	6.27	0.58	1.89e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs6424115	0.830	rs1130320	chr1:24200606	A/G	cg15997130	chr1:24165203	NA	0.6	4.94	0.49	4.37e-6	Immature fraction of reticulocytes;
SKCM	cis	rs6547631	0.836	rs10169536	chr2:85912860	C/A	cg24620635	chr2:85921963	GNLY	0.74	6.04	0.56	4.84e-8	Blood protein levels;
SKCM	cis	rs3768617	0.510	rs7549768	chr1:183097382	T/G	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.69	0.66	3.68e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs875971	1.000	rs1363055	chr7:65943275	A/G	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs2243480	1.000	rs410128	chr7:65603173	C/T	cg18252515	chr7:66147081	NA	-1.34	-7.61	-0.65	5.39e-11	Diabetic kidney disease;
SKCM	cis	rs514406	0.607	rs6696940	chr1:53203427	C/T	cg24675658	chr1:53192096	ZYG11B	0.62	4.95	0.49	4.21e-6	Monocyte count;
SKCM	cis	rs9611565	0.512	rs2050031	chr22:42152266	A/G	cg03806693	chr22:41940476	POLR3H	1.16	6.72	0.61	2.63e-9	Vitiligo;
SKCM	cis	rs1707322	1.000	rs1768801	chr1:46549137	C/G	cg03146154	chr1:46216737	IPP	-0.81	-5.43	-0.52	6.11e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs8060686	0.641	rs9932251	chr16:68131732	G/A	cg04539111	chr16:67997858	SLC12A4	-0.85	-4.81	-0.48	7.14e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs8060686	0.641	rs12600199	chr16:68069742	C/T	cg09117114	chr16:67998030	SLC12A4	-0.78	-5.08	-0.5	2.5e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs870825	0.929	rs72689266	chr4:185591053	T/C	cg04058563	chr4:185651563	MLF1IP	1.09	5.66	0.54	2.4e-7	Blood protein levels;
SKCM	cis	rs9910055	0.530	rs11656758	chr17:42301541	A/G	cg19774624	chr17:42201019	HDAC5	-0.77	-6.27	-0.58	1.84e-8	Total body bone mineral density;
SKCM	cis	rs4727027	0.933	rs4727028	chr7:148874666	A/G	cg23583168	chr7:148888333	NA	0.8	6.69	0.6	3.09e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs5760092	0.618	rs5996631	chr22:24256894	T/C	cg24846343	chr22:24311635	DDTL	-0.69	-5.4	-0.52	7.04e-7	Urinary 1,3-butadiene metabolite levels in smokers;
SKCM	cis	rs7100689	0.577	rs2185427	chr10:82056667	G/T	cg01528321	chr10:82214614	TSPAN14	-0.76	-7.25	-0.63	2.57e-10	Post bronchodilator FEV1;
SKCM	cis	rs478304	0.651	rs11227281	chr11:65496558	T/C	cg27068330	chr11:65405492	SIPA1	-0.89	-8.21	-0.68	3.71e-12	Acne (severe);
SKCM	cis	rs2204008	0.665	rs11179830	chr12:38220966	T/C	cg26384229	chr12:38710491	ALG10B	0.81	6.95	0.62	9.67e-10	Bladder cancer;
SKCM	cis	rs13108904	0.557	rs1250086	chr4:1248051	G/A	cg05025164	chr4:1340916	KIAA1530	-0.64	-5.05	-0.5	2.8e-6	Obesity-related traits;
SKCM	cis	rs2228479	0.850	rs62056103	chr16:89942781	G/A	cg00800038	chr16:89945340	TCF25	-0.96	-5.44	-0.52	5.85e-7	Skin colour saturation;
SKCM	cis	rs7193541	0.640	rs4072222	chr16:74706736	A/C	cg01733217	chr16:74700730	RFWD3	1.07	12.26	0.81	7.15e-20	Multiple myeloma;
SKCM	cis	rs116095464	1.000	rs7723693	chr5:306032	G/A	cg22857025	chr5:266934	NA	-1.64	-6.14	-0.57	3.18e-8	Breast cancer;
SKCM	cis	rs6424115	0.793	rs2502998	chr1:24198327	T/A	cg15997130	chr1:24165203	NA	0.6	4.94	0.49	4.37e-6	Immature fraction of reticulocytes;
SKCM	cis	rs55794721	0.509	rs2982358	chr1:25745204	G/T	cg02931644	chr1:25747376	RHCE	0.5	5.01	0.49	3.36e-6	Plateletcrit;Mean corpuscular volume;
SKCM	cis	rs1348850	0.645	rs10181259	chr2:178428256	C/A	cg05310760	chr2:178500282	PDE11A	-0.61	-4.94	-0.49	4.31e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs1577917	0.916	rs4142546	chr6:86505311	G/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.84	-0.66	1.96e-11	Response to antipsychotic treatment;
SKCM	cis	rs9858542	0.953	rs11710037	chr3:49675334	C/G	cg03060546	chr3:49711283	APEH	-0.71	-5.29	-0.51	1.07e-6	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs2842992	0.872	rs9456440	chr6:160074463	G/T	cg19482086	chr6:160211437	TCP1;MRPL18	0.83	5.83	0.55	1.18e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs6570726	0.935	rs374000	chr6:145855290	C/T	cg23711669	chr6:146136114	FBXO30	0.71	6.91	0.62	1.18e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9381040	0.626	rs2272986	chr6:41037778	C/T	cg04346459	chr6:41068666	NFYA;LOC221442	-0.71	-5.0	-0.49	3.5e-6	Alzheimer's disease (late onset);
SKCM	cis	rs6570726	0.599	rs426371	chr6:145886469	A/G	cg05347473	chr6:146136440	FBXO30	-0.66	-5.61	-0.54	2.92e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1417770	0.899	rs1149649	chr1:56657497	A/G	cg27547053	chr1:56531471	NA	0.57	4.82	0.48	7.07e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs11098499	0.863	rs2170276	chr4:120485824	A/C	cg24375607	chr4:120327624	NA	0.69	5.47	0.53	5.35e-7	Corneal astigmatism;
SKCM	cis	rs1949733	1.000	rs2631758	chr4:8495304	G/A	cg11789530	chr4:8429930	ACOX3	-0.83	-5.84	-0.55	1.12e-7	Response to antineoplastic agents;
SKCM	cis	rs10927875	0.631	rs945418	chr1:16344730	T/C	cg21385522	chr1:16154831	NA	0.67	4.83	0.48	6.73e-6	Dilated cardiomyopathy;
SKCM	cis	rs2731664	0.792	rs1130857	chr5:176863519	G/C	cg23176889	chr5:176863531	GRK6	-0.5	-5.31	-0.52	1.02e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs459571	1.000	rs467387	chr9:136907005	G/A	cg13789015	chr9:136890014	NCRNA00094	0.75	6.46	0.59	8.1e-9	Platelet distribution width;
SKCM	cis	rs7666738	0.830	rs10012003	chr4:99064881	A/G	cg05340658	chr4:99064831	C4orf37	0.66	4.87	0.48	5.74e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2559856	1.000	rs2695292	chr12:102087290	G/A	cg12924262	chr12:102091054	CHPT1	0.71	5.96	0.56	6.99e-8	Blood protein levels;
SKCM	cis	rs1059312	0.966	rs7135968	chr12:129280066	G/A	cg09035930	chr12:129282057	SLC15A4	0.8	8.41	0.69	1.52e-12	Systemic lupus erythematosus;
SKCM	cis	rs7216064	0.531	rs6504573	chr17:66015963	C/T	cg12091567	chr17:66097778	LOC651250	-0.78	-6.32	-0.58	1.5e-8	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs875971	0.964	rs6978721	chr7:65883204	A/G	cg18876405	chr7:65276391	NA	0.67	6.65	0.6	3.61e-9	Aortic root size;
SKCM	cis	rs2032447	0.898	rs807205	chr6:26075035	C/G	cg18357526	chr6:26021779	HIST1H4A	0.85	7.35	0.64	1.68e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs7537052	0.669	rs4652903	chr1:36642858	C/T	cg24686825	chr1:36642396	MAP7D1	-0.76	-6.51	-0.59	6.72e-9	Schizophrenia;
SKCM	cis	rs7618501	0.602	rs2071206	chr3:50160109	G/A	cg24110177	chr3:50126178	RBM5	0.61	5.29	0.51	1.09e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7904368	0.659	rs3740169	chr10:16873547	C/T	cg23933602	chr10:16859644	RSU1	1.03	5.43	0.52	6.1e-7	Ratio of the peak velocity of the mitral E-Wave divided by the peak velocity of the mitral A-wave.;
SKCM	cis	rs28595532	1.000	rs56225646	chr4:119651217	T/C	cg11846333	chr4:119757529	SEC24D	1.15	6.24	0.58	2.13e-8	Cannabis dependence symptom count;
SKCM	cis	rs992157	1.000	rs736731	chr2:219120588	A/G	cg20019365	chr2:219134978	PNKD;AAMP	0.81	7.35	0.64	1.68e-10	Colorectal cancer;
SKCM	cis	rs3844535	1	rs3844535	chr14:81884515	A/G	cg02996355	chr14:81879375	NA	-0.81	-6.03	-0.56	5.11e-8	Plateletcrit;Platelet count;
SKCM	cis	rs362296	0.698	rs362279	chr4:3260072	G/A	cg05297308	chr4:3317976	RGS12	-0.79	-6.61	-0.6	4.25e-9	Parental longevity (mother's age at death);
SKCM	cis	rs1878931	0.543	rs17612463	chr16:3420479	G/C	cg26668626	chr16:3451006	ZNF174;ZNF434	0.82	5.95	0.56	7.24e-8	Body mass index (adult);
SKCM	cis	rs8014204	0.935	rs10141438	chr14:75354600	A/G	cg06637938	chr14:75390232	RPS6KL1	-0.8	-6.28	-0.58	1.8e-8	Caffeine consumption;
SKCM	cis	rs35146811	0.844	rs59261051	chr7:99650429	C/T	cg22906224	chr7:99728672	NA	0.8	5.95	0.56	7.24e-8	Coronary artery disease;
SKCM	cis	rs951366	0.903	rs823114	chr1:205719532	G/A	cg11965913	chr1:205819406	PM20D1	0.72	5.54	0.53	3.98e-7	Menarche (age at onset);
SKCM	cis	rs12477438	0.734	rs4851184	chr2:99666434	T/C	cg26064155	chr2:99771622	LIPT1;TSGA10	-0.72	-4.86	-0.48	6e-6	Chronic sinus infection;
SKCM	cis	rs13118159	0.899	rs3796613	chr4:1353321	A/T	cg20887711	chr4:1340912	KIAA1530	0.68	5.12	0.5	2.17e-6	Longevity;
SKCM	cis	rs796364	1.000	rs35594306	chr2:200775125	T/C	cg12253985	chr2:200820533	C2orf60;C2orf47	-0.96	-5.67	-0.54	2.3e-7	Schizophrenia;
SKCM	cis	rs2153535	0.580	rs6597326	chr6:8482019	A/C	cg07606381	chr6:8435919	SLC35B3	0.86	6.25	0.58	2.06e-8	Motion sickness;
SKCM	cis	rs2070433	0.706	rs55696586	chr21:47733918	T/C	cg05998816	chr21:47859926	PCNT	0.8	4.98	0.49	3.78e-6	Lymphocyte counts;
SKCM	cis	rs1218582	0.772	rs4845688	chr1:154884142	T/C	cg06221963	chr1:154839813	KCNN3	-0.59	-5.97	-0.56	6.76e-8	Prostate cancer;
SKCM	cis	rs875971	0.862	rs778720	chr7:65846275	A/C	cg11764359	chr7:65958608	NA	-0.8	-7.44	-0.64	1.11e-10	Aortic root size;
SKCM	cis	rs2832191	0.679	rs2705659	chr21:30363908	G/C	cg24692254	chr21:30365293	RNF160	1.01	9.45	0.73	1.44e-14	Dental caries;
SKCM	cis	rs798554	0.679	rs1639066	chr7:2892972	A/G	cg19346786	chr7:2764209	NA	-0.65	-6.79	-0.61	2.01e-9	Height;
SKCM	cis	rs1577917	0.771	rs4383777	chr6:86435960	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.95	9.52	0.73	1.05e-14	Response to antipsychotic treatment;
SKCM	cis	rs1577917	0.687	rs1470531	chr6:86507369	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.37	-0.52	7.87e-7	Response to antipsychotic treatment;
SKCM	cis	rs7945705	0.875	rs2568065	chr11:8889648	C/T	cg21881798	chr11:8931708	C11orf17;ST5	-0.78	-8.68	-0.7	4.5e-13	Hemoglobin concentration;
SKCM	cis	rs7772486	0.875	rs2748483	chr6:146335560	A/T	cg23711669	chr6:146136114	FBXO30	-0.77	-6.71	-0.6	2.79e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs11155671	0.530	rs9383914	chr6:150207234	T/G	cg05036130	chr6:150231994	NA	0.6	6.88	0.61	1.31e-9	Testicular germ cell tumor;
SKCM	cis	rs7927771	0.832	rs4752990	chr11:47410393	G/A	cg01152729	chr11:47593274	PTPMT1	-0.51	-4.92	-0.49	4.64e-6	Subjective well-being;
SKCM	trans	rs17685	0.753	rs6976532	chr7:75681094	A/G	cg19862616	chr7:65841803	NCRNA00174	0.88	8.87	0.71	1.9e-13	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7100689	0.784	rs10887838	chr10:82161380	G/A	cg01528321	chr10:82214614	TSPAN14	0.94	9.27	0.72	3.2e-14	Post bronchodilator FEV1;
SKCM	cis	rs35306767	0.903	rs11253492	chr10:936873	T/C	cg26597838	chr10:835615	NA	0.78	5.08	0.5	2.51e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs10138752	0.643	rs17756651	chr14:69097407	C/T	cg08271153	chr14:69726221	GALNTL1	-0.67	-5.12	-0.5	2.11e-6	Neutrophil count;White blood cell count;Myeloid white cell count;Granulocyte count;Sum neutrophil eosinophil counts;Sum basophil neutrophil counts;
SKCM	cis	rs2404602	0.669	rs9788684	chr15:77194838	A/T	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	6.03e-7	Blood metabolite levels;
SKCM	cis	rs4481887	1.000	rs4360555	chr1:248468591	G/T	cg00666640	chr1:248458726	OR2T12	0.61	5.6	0.54	3.11e-7	Common traits (Other);
SKCM	cis	rs11763147	1	rs11763147	chr7:65326821	C/T	cg18876405	chr7:65276391	NA	-0.85	-7.58	-0.65	6.15e-11	Corneal structure;
SKCM	cis	rs28386778	0.897	rs1470697	chr17:61799840	T/C	cg06873352	chr17:61820015	STRADA	0.75	6.24	0.58	2.1e-8	Prudent dietary pattern;
SKCM	cis	rs7647973	0.516	rs4308307	chr3:49193216	C/T	cg07636037	chr3:49044803	WDR6	0.87	7.23	0.63	2.87e-10	Menarche (age at onset);
SKCM	cis	rs1348850	0.632	rs12471621	chr2:178502353	T/C	cg22681709	chr2:178499509	PDE11A	-0.69	-5.98	-0.56	6.36e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs898097	0.812	rs72859941	chr17:80837459	G/A	cg15369054	chr17:80825471	TBCD	0.66	6.18	0.57	2.69e-8	Breast cancer;
SKCM	cis	rs17376456	0.569	rs6556834	chr5:93123067	C/T	cg25358565	chr5:93447407	FAM172A	-0.86	-5.45	-0.53	5.59e-7	Diabetic retinopathy;
SKCM	cis	rs644799	0.601	rs662168	chr11:95586982	C/T	cg25622487	chr11:95524042	FAM76B;CEP57	0.63	4.98	0.49	3.7e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs589448	0.902	rs315131	chr12:69761839	T/G	cg22834771	chr12:69754056	YEATS4	-0.71	-5.79	-0.55	1.39e-7	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs12142240	0.698	rs56284503	chr1:46847127	C/G	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs798554	0.797	rs2107964	chr7:2863574	G/A	cg19346786	chr7:2764209	NA	-0.64	-6.76	-0.61	2.22e-9	Height;
SKCM	cis	rs1153858	1.000	rs11858495	chr15:45637662	A/G	cg10760299	chr15:45669010	GATM	-0.54	-5.1	-0.5	2.34e-6	Homoarginine levels;
SKCM	cis	rs9583531	0.600	rs4773241	chr13:111363021	A/G	cg15841412	chr13:111365552	ING1	0.73	4.88	0.48	5.56e-6	Coronary artery disease;
SKCM	cis	rs908922	0.628	rs488393	chr1:152489548	C/T	cg09873164	chr1:152488093	CRCT1	0.75	5.95	0.56	7.3e-8	Hair morphology;
SKCM	cis	rs11098499	0.863	rs3775844	chr4:120428033	G/A	cg09307838	chr4:120376055	NA	1.0	7.66	0.66	4.31e-11	Corneal astigmatism;
SKCM	cis	rs6879260	0.963	rs11738924	chr5:179727308	A/G	cg23221052	chr5:179740743	GFPT2	-0.73	-5.75	-0.55	1.68e-7	Height;
SKCM	cis	rs12474201	0.925	rs1058157	chr2:46988275	G/A	cg06386533	chr2:46925753	SOCS5	1.04	9.75	0.74	3.75e-15	Height;
SKCM	cis	rs6723226	0.557	rs62136260	chr2:32575447	T/C	cg02381751	chr2:32503542	YIPF4	-0.67	-5.05	-0.5	2.87e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2066819	1.000	rs2643623	chr12:56689725	G/C	cg26714650	chr12:56694279	CS	1.71	6.71	0.61	2.74e-9	Psoriasis vulgaris;
SKCM	cis	rs9611565	0.512	rs5996063	chr22:42168767	G/A	cg03806693	chr22:41940476	POLR3H	1.16	6.33	0.58	1.45e-8	Vitiligo;
SKCM	cis	rs7666738	0.830	rs4699603	chr4:99056172	T/C	cg05340658	chr4:99064831	C4orf37	0.67	5.08	0.5	2.51e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs17685	0.712	rs28506984	chr7:75763484	A/G	cg01364799	chr7:75623366	TMEM120A	-0.7	-5.69	-0.54	2.09e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2836974	0.831	rs11911149	chr21:40528375	C/T	cg17971929	chr21:40555470	PSMG1	0.87	8.48	0.69	1.1e-12	Cognitive function;
SKCM	cis	rs1862618	0.573	rs185220	chr5:56205357	A/G	cg12311346	chr5:56204834	C5orf35	-0.85	-5.95	-0.56	7.35e-8	Initial pursuit acceleration;
SKCM	cis	rs1964356	0.967	rs17701675	chr8:8850633	A/G	cg06636001	chr8:8085503	FLJ10661	-0.65	-5.05	-0.5	2.8e-6	Mean corpuscular volume;
SKCM	cis	rs1401999	0.621	rs1000952	chr3:183755822	G/A	cg01324343	chr3:183735012	ABCC5	0.69	6.55	0.6	5.61e-9	Anterior chamber depth;
SKCM	cis	rs6665290	0.904	rs2297415	chr1:227172903	G/A	cg10327440	chr1:227177885	CDC42BPA	-1.26	-16.84	-0.89	1.06e-27	Myeloid white cell count;
SKCM	cis	rs2153535	0.580	rs2184586	chr6:8474182	A/G	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs2739330	0.828	rs4822454	chr22:24255208	G/A	cg12419862	chr22:24373484	LOC391322	-0.63	-5.49	-0.53	4.83e-7	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs1799949	0.864	rs60309406	chr17:41435665	C/T	cg25918947	chr17:41365094	TMEM106A	-0.64	-6.21	-0.58	2.38e-8	Menopause (age at onset);
SKCM	cis	rs9902453	0.933	rs9303628	chr17:28527228	T/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.78	5.71	0.54	1.92e-7	Coffee consumption (cups per day);
SKCM	cis	rs2354432	0.607	rs57078845	chr1:146722222	G/A	cg25205988	chr1:146714368	CHD1L	-1.19	-6.56	-0.6	5.24e-9	Mitochondrial DNA levels;
SKCM	cis	rs6951245	0.744	rs10265758	chr7:1172518	C/T	cg03188948	chr7:1209495	NA	1.04	6.69	0.6	3.04e-9	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs6912958	1.000	rs2223880	chr6:88167897	C/T	cg08069147	chr6:88032118	GJB7;C6orf162	-0.73	-6.39	-0.59	1.11e-8	Monocyte percentage of white cells;
SKCM	cis	rs271738	0.747	rs271741	chr1:234666251	A/G	cg00123090	chr1:234667087	NA	0.41	4.77	0.48	8.43e-6	Bipolar disorder;
SKCM	cis	rs2204008	0.539	rs1283295	chr12:38146014	A/C	cg26384229	chr12:38710491	ALG10B	-0.67	-5.47	-0.53	5.23e-7	Bladder cancer;
SKCM	cis	rs10791097	0.694	rs2236711	chr11:130739284	G/A	cg12179176	chr11:130786555	SNX19	0.93	8.16	0.68	4.62e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs2243480	0.708	rs35825036	chr7:65986502	T/C	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs561341	0.843	rs879945	chr17:30242796	G/A	cg23018236	chr17:30244563	NA	-0.52	-5.3	-0.51	1.05e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs9902453	0.765	rs34585141	chr17:28336432	G/T	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.82	-6.4	-0.59	1.06e-8	Coffee consumption (cups per day);
SKCM	cis	rs9916302	0.706	rs1054488	chr17:37687968	A/G	cg07936489	chr17:37558343	FBXL20	-1.01	-8.17	-0.68	4.34e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs72615157	0.697	rs2056726	chr7:99780283	G/A	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.19	8.02	0.67	8.58e-12	Lung function (FEV1/FVC);
SKCM	cis	rs72634258	0.554	rs7556518	chr1:7847846	G/A	cg26816564	chr1:7831052	VAMP3	0.78	5.51	0.53	4.39e-7	Inflammatory bowel disease;
SKCM	cis	rs2072499	0.966	rs6427307	chr1:156190083	A/G	cg24450063	chr1:156163899	SLC25A44	1.03	9.45	0.73	1.45e-14	Testicular germ cell tumor;
SKCM	cis	rs10883723	0.810	rs2296585	chr10:104245549	C/T	cg11453585	chr10:104263688	ACTR1A;SUFU	0.74	5.48	0.53	5.01e-7	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs1218582	0.774	rs1007170	chr1:154881461	G/A	cg16680214	chr1:154839983	KCNN3	-0.55	-5.08	-0.5	2.54e-6	Prostate cancer;
SKCM	cis	rs6866344	0.570	rs56236920	chr5:178144617	C/T	cg10224037	chr5:178157518	ZNF354A	0.88	6.55	0.6	5.55e-9	Neutrophil percentage of white cells;
SKCM	cis	rs992157	0.767	rs2014615	chr2:219171191	A/G	cg00012203	chr2:219082015	ARPC2	0.73	5.86	0.55	1.04e-7	Colorectal cancer;
SKCM	cis	rs10504229	0.683	rs16921814	chr8:58107421	A/T	cg02725872	chr8:58115012	NA	-0.53	-4.91	-0.49	4.82e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs875971	0.862	rs2420611	chr7:65999320	A/G	cg11764359	chr7:65958608	NA	0.75	6.8	0.61	1.86e-9	Aortic root size;
SKCM	cis	rs10027350	0.714	rs3796791	chr4:25134045	A/G	cg23315637	chr4:24664006	NA	-0.54	-5.0	-0.49	3.42e-6	Childhood ear infection;
SKCM	cis	rs7824557	0.701	rs2060465	chr8:11162609	T/C	cg21775007	chr8:11205619	TDH	0.72	6.0	0.56	5.73e-8	Retinal vascular caliber;
SKCM	cis	rs6998277	0.830	rs6981007	chr8:103598257	G/C	cg10187029	chr8:103597600	NA	0.76	6.31	0.58	1.54e-8	Migraine;
SKCM	cis	rs2014572	0.967	rs8112572	chr19:57759612	T/C	cg24459738	chr19:57751996	ZNF805	-0.64	-5.17	-0.5	1.79e-6	Hyperactive-impulsive symptoms;
SKCM	cis	rs2836974	0.932	rs8129416	chr21:40617145	C/T	cg11890956	chr21:40555474	PSMG1	1.09	13.83	0.84	1.08e-22	Cognitive function;
SKCM	cis	rs9875589	0.509	rs6442423	chr3:14016062	G/A	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.57	5.73	0.54	1.84e-7	Ovarian reserve;
SKCM	cis	rs2204008	0.640	rs11520199	chr12:38211026	T/C	cg13010199	chr12:38710504	ALG10B	0.65	4.84	0.48	6.52e-6	Bladder cancer;
SKCM	cis	rs35306767	0.903	rs11253462	chr10:889323	T/G	cg25614935	chr10:1084866	C10orf110	0.82	5.39	0.52	7.4e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs10256972	0.591	rs10229680	chr7:1158565	C/T	cg07092213	chr7:1199455	ZFAND2A	-0.67	-5.32	-0.52	9.84e-7	Longevity;Endometriosis;
SKCM	cis	rs684232	0.623	rs391002	chr17:535441	T/G	cg15660573	chr17:549704	VPS53	-0.76	-6.08	-0.57	4.15e-8	Prostate cancer;
SKCM	cis	rs7659604	0.967	rs10008348	chr4:122666987	A/C	cg19748678	chr4:122722346	EXOSC9	0.67	5.4	0.52	6.89e-7	Type 2 diabetes;
SKCM	cis	rs4523957	0.651	rs9906968	chr17:2077493	G/C	cg16513277	chr17:2031491	SMG6	-0.79	-5.86	-0.55	1.07e-7	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs362272	0.524	rs2749781	chr4:3346617	T/C	cg03043834	chr4:3319541	RGS12	0.6	5.17	0.5	1.78e-6	Serum sulfate level;
SKCM	cis	rs9300255	0.602	rs2682431	chr12:123703226	T/A	cg05973401	chr12:123451056	ABCB9	0.81	5.37	0.52	7.77e-7	Neutrophil percentage of white cells;
SKCM	cis	rs1799949	1.000	rs11653253	chr17:41182662	G/A	cg23758822	chr17:41437982	NA	0.91	7.51	0.65	8.13e-11	Menopause (age at onset);
SKCM	cis	rs7666738	0.830	rs1527517	chr4:98931907	C/T	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs12142240	0.698	rs56130131	chr1:46861306	A/C	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs7666738	0.830	rs28818180	chr4:98953625	A/G	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10791097	0.694	rs2155752	chr11:130755998	C/T	cg12179176	chr11:130786555	SNX19	0.91	8.08	0.67	6.64e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs2228479	0.867	rs62056110	chr16:89946388	A/C	cg00800038	chr16:89945340	TCF25	-0.93	-5.34	-0.52	8.73e-7	Skin colour saturation;
SKCM	cis	rs875971	0.642	rs35526611	chr7:66094008	C/T	cg18876405	chr7:65276391	NA	-0.82	-7.48	-0.65	9.41e-11	Aortic root size;
SKCM	cis	rs7666738	0.830	rs28516388	chr4:98987449	A/G	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2013441	1.000	rs2703785	chr17:20152418	C/T	cg13482628	chr17:19912719	NA	-0.64	-5.04	-0.5	2.94e-6	Obesity-related traits;
SKCM	cis	rs17685	0.672	rs1639618	chr7:75701987	T/C	cg16489192	chr7:75678113	MDH2;STYXL1	-0.58	-5.46	-0.53	5.43e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs9910055	0.593	rs58392387	chr17:42297889	A/G	cg19774624	chr17:42201019	HDAC5	-0.75	-5.89	-0.56	9.12e-8	Total body bone mineral density;
SKCM	cis	rs453301	0.686	rs28482034	chr8:8869664	G/A	cg15556689	chr8:8085844	FLJ10661	-0.76	-5.93	-0.56	7.98e-8	Joint mobility (Beighton score);
SKCM	cis	rs875971	0.660	rs801190	chr7:66033033	C/T	cg18876405	chr7:65276391	NA	-0.8	-7.11	-0.63	4.86e-10	Aortic root size;
SKCM	cis	rs7659604	1.000	rs7660078	chr4:122665577	G/T	cg06713675	chr4:122721982	EXOSC9	-0.64	-5.68	-0.54	2.24e-7	Type 2 diabetes;
SKCM	cis	rs1552244	0.810	rs4019706	chr3:10112862	G/A	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs72634258	0.554	rs17374292	chr1:7881234	C/T	cg26816564	chr1:7831052	VAMP3	0.76	5.6	0.54	3.07e-7	Inflammatory bowel disease;
SKCM	cis	rs6121246	0.909	rs6060812	chr20:30292803	C/T	cg11595048	chr20:30225325	COX4I2	0.67	5.21	0.51	1.5e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs3768617	0.510	rs6424884	chr1:183065904	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs7666738	0.830	rs10021044	chr4:99002488	A/T	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2404602	0.716	rs2164101	chr15:76749117	A/G	cg23625390	chr15:77176239	SCAPER	0.57	5.23	0.51	1.39e-6	Blood metabolite levels;
SKCM	cis	rs9549367	0.577	rs776904	chr13:113810542	C/T	cg18105134	chr13:113819100	PROZ	-0.77	-5.47	-0.53	5.16e-7	Platelet distribution width;
SKCM	cis	rs11718455	0.767	rs6782500	chr3:43990260	A/G	cg21419209	chr3:44054225	NA	0.59	4.79	0.48	7.72e-6	Coronary artery disease;
SKCM	trans	rs17685	0.712	rs28506984	chr7:75763484	A/G	cg19862616	chr7:65841803	NCRNA00174	0.94	9.49	0.73	1.22e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs28595532	0.920	rs114213539	chr4:119758794	G/C	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs1801251	0.929	rs12694917	chr2:233707611	C/T	cg25237894	chr2:233734115	C2orf82	-0.58	-5.74	-0.54	1.75e-7	Coronary artery disease;
SKCM	cis	rs870825	0.581	rs28602720	chr4:185630598	T/C	cg04058563	chr4:185651563	MLF1IP	1.08	7.26	0.64	2.51e-10	Blood protein levels;
SKCM	cis	rs12824058	0.831	rs55726136	chr12:130810312	G/A	cg26677194	chr12:130822605	PIWIL1	0.71	5.83	0.55	1.17e-7	Menopause (age at onset);
SKCM	cis	rs9868809	0.505	rs11706203	chr3:48746239	T/A	cg00383909	chr3:49044727	WDR6	0.89	5.09	0.5	2.44e-6	Ulcerative colitis;Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs1153858	0.943	rs67045941	chr15:45677011	A/G	cg10760299	chr15:45669010	GATM	0.62	6.35	0.58	1.3e-8	Homoarginine levels;
SKCM	cis	rs17685	0.753	rs10476	chr7:75696420	C/T	cg16489192	chr7:75678113	MDH2;STYXL1	0.56	5.04	0.5	2.95e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs35146811	0.695	rs1623264	chr7:99811204	G/C	cg22906224	chr7:99728672	NA	-0.72	-5.76	-0.55	1.61e-7	Coronary artery disease;
SKCM	cis	rs35955841	0.569	rs1570295	chr14:65310367	C/T	cg23373153	chr14:65346875	NA	0.66	4.92	0.49	4.74e-6	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity;
SKCM	cis	rs6445797	0.632	rs9985254	chr3:56629269	G/T	cg13616963	chr3:57583610	ARF4	-0.79	-5.06	-0.5	2.71e-6	Gastritis;
SKCM	cis	rs10927875	0.894	rs34957618	chr1:16320499	G/C	cg21385522	chr1:16154831	NA	-0.88	-7.19	-0.63	3.49e-10	Dilated cardiomyopathy;
SKCM	cis	rs6752107	0.967	rs3792111	chr2:234179690	C/T	cg07618928	chr2:234183455	ATG16L1;SCARNA5	0.56	4.77	0.48	8.37e-6	Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs2816062	0.813	rs2745321	chr1:18889198	G/C	cg18795169	chr1:18902165	NA	-0.82	-8.11	-0.68	5.85e-12	Urate levels in lean individuals;
SKCM	cis	rs4819052	0.851	rs28622522	chr21:46676599	G/T	cg02159808	chr21:46707872	POFUT2;LOC642852	0.73	5.71	0.54	1.93e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7811142	1.000	rs68116612	chr7:100006493	G/A	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.16	7.68	0.66	3.87e-11	Platelet count;
SKCM	cis	rs870825	0.616	rs7678864	chr4:185635158	C/T	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs995000	0.899	rs1305521	chr1:62949034	A/G	cg06896770	chr1:63153194	DOCK7	-0.76	-7.3	-0.64	2.08e-10	Triglyceride levels;
SKCM	cis	rs10256972	0.567	rs7782651	chr7:1159895	T/G	cg16145915	chr7:1198662	ZFAND2A	-0.59	-8.09	-0.68	6.4e-12	Longevity;Endometriosis;
SKCM	cis	rs1801251	0.963	rs66549961	chr2:233602293	A/G	cg08000102	chr2:233561755	GIGYF2	0.87	7.05	0.62	6.23e-10	Coronary artery disease;
SKCM	cis	rs60871478	1.000	rs4720930	chr7:808073	G/A	cg05535760	chr7:792225	HEATR2	1.02	8.66	0.7	4.97e-13	Cerebrospinal P-tau181p levels;
SKCM	cis	rs2153535	0.580	rs9406162	chr6:8466196	C/T	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs2439831	0.867	rs496584	chr15:43831923	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.14	6.69	0.6	3.08e-9	Lung cancer in ever smokers;
SKCM	cis	rs801193	1.000	rs2659906	chr7:66165310	T/C	cg11764359	chr7:65958608	NA	0.86	6.6	0.6	4.52e-9	Aortic root size;
SKCM	cis	rs35306767	0.903	rs7067865	chr10:908387	C/T	cg26597838	chr10:835615	NA	0.75	5.51	0.53	4.53e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs919433	0.648	rs6434933	chr2:198426960	G/A	cg04278110	chr2:198063759	ANKRD44	0.76	5.08	0.5	2.52e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs899997	0.814	rs28661610	chr15:78985317	G/A	cg04896959	chr15:78267971	NA	-0.63	-5.51	-0.53	4.41e-7	Coronary artery disease or large artery stroke;
SKCM	cis	rs7829975	0.660	rs10093926	chr8:8549020	A/C	cg15556689	chr8:8085844	FLJ10661	-0.68	-5.65	-0.54	2.49e-7	Mood instability;
SKCM	cis	rs7523050	0.643	rs12725689	chr1:109405151	T/C	cg08274380	chr1:109419600	GPSM2	1.18	6.44	0.59	9.12e-9	Fat distribution (HIV);
SKCM	cis	rs28595532	0.920	rs116739193	chr4:119771024	G/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs7666738	0.830	rs4443293	chr4:99063120	G/A	cg17366294	chr4:99064904	C4orf37	0.61	4.93	0.49	4.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs8014204	0.816	rs10144023	chr14:75291531	T/C	cg06637938	chr14:75390232	RPS6KL1	0.71	5.54	0.53	3.92e-7	Caffeine consumption;
SKCM	cis	rs80282103	0.618	rs1079389	chr10:1161980	A/G	cg19207066	chr10:1251074	ADARB2	-0.76	-4.94	-0.49	4.41e-6	Glomerular filtration rate (creatinine);
SKCM	cis	rs7106204	0.748	rs7101572	chr11:24213982	A/G	ch.11.24196551F	chr11:24239977	NA	0.76	6.16	0.57	2.98e-8	Response to Homoharringtonine (cytotoxicity);
SKCM	cis	rs9926296	0.605	rs8046243	chr16:89852133	A/G	cg04287289	chr16:89883240	FANCA	1.03	12.03	0.81	1.91e-19	Vitiligo;
SKCM	cis	rs4319547	0.695	rs1973463	chr12:122938003	A/G	cg23029597	chr12:123009494	RSRC2	-0.77	-5.53	-0.53	4.13e-7	Body mass index;
SKCM	cis	rs7100689	0.556	rs10788541	chr10:82016530	T/G	cg01528321	chr10:82214614	TSPAN14	0.81	7.7	0.66	3.61e-11	Post bronchodilator FEV1;
SKCM	cis	rs514406	0.858	rs574853	chr1:53310959	A/T	cg16325326	chr1:53192061	ZYG11B	0.92	9.61	0.74	7.02e-15	Monocyte count;
SKCM	cis	rs1707322	0.893	rs9919275	chr1:46441360	A/C	cg03146154	chr1:46216737	IPP	0.79	5.34	0.52	8.73e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs17376456	0.877	rs28575883	chr5:93346035	T/C	cg21475434	chr5:93447410	FAM172A	0.95	5.35	0.52	8.56e-7	Diabetic retinopathy;
SKCM	cis	rs9815354	0.812	rs10510731	chr3:41853310	C/T	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs9815354	0.812	rs73071338	chr3:41824328	G/A	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs35306767	0.903	rs17159950	chr10:875287	T/G	cg20503657	chr10:835505	NA	0.75	5.18	0.51	1.71e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs58688157	0.774	rs59115876	chr11:613757	A/G	cg17114584	chr11:613792	IRF7	0.74	5.0	0.49	3.51e-6	Systemic lupus erythematosus;
SKCM	cis	rs7659604	0.539	rs2063165	chr4:122750005	A/G	cg06713675	chr4:122721982	EXOSC9	-0.75	-7.26	-0.64	2.47e-10	Type 2 diabetes;
SKCM	cis	rs7569084	0.687	rs12614851	chr2:65685184	T/C	cg14775296	chr2:66672841	MEIS1	0.51	4.8	0.48	7.49e-6	Sum eosinophil basophil counts;
SKCM	cis	rs654950	0.875	rs4660544	chr1:41996871	T/C	cg06885757	chr1:42089581	HIVEP3	-0.64	-7.03	-0.62	6.98e-10	Airway imaging phenotypes;
SKCM	cis	rs6500602	0.701	rs4786508	chr16:4568043	G/A	cg08645402	chr16:4508243	NA	0.65	5.19	0.51	1.62e-6	Schizophrenia;
SKCM	cis	rs2204008	0.616	rs1607852	chr12:38398125	G/A	cg13010199	chr12:38710504	ALG10B	0.69	4.89	0.48	5.2e-6	Bladder cancer;
SKCM	cis	rs9815354	0.812	rs17282671	chr3:41887455	T/C	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs9300255	0.739	rs1969354	chr12:123741776	T/C	cg00376283	chr12:123451042	ABCB9	0.84	5.91	0.56	8.5e-8	Neutrophil percentage of white cells;
SKCM	cis	rs2072510	0.722	rs2540489	chr12:96426502	T/C	cg18817487	chr12:96390143	HAL	0.43	5.68	0.54	2.18e-7	Metabolite levels (small molecules and protein measures);
SKCM	cis	rs9733	0.818	rs11204702	chr1:150663507	C/A	cg13175981	chr1:150552382	MCL1	0.64	4.86	0.48	5.85e-6	Tonsillectomy;
SKCM	cis	rs12142240	0.738	rs41293277	chr1:46806550	C/T	cg10495392	chr1:46806563	NSUN4	0.74	5.37	0.52	7.75e-7	Menopause (age at onset);
SKCM	cis	rs28386778	0.897	rs4968663	chr17:61835603	A/T	cg06873352	chr17:61820015	STRADA	0.76	6.34	0.58	1.38e-8	Prudent dietary pattern;
SKCM	cis	rs2594989	0.733	rs2616539	chr3:11580371	C/A	cg00170343	chr3:11313890	ATG7	0.98	5.18	0.51	1.72e-6	Circulating chemerin levels;
SKCM	cis	rs6121246	0.609	rs2377317	chr20:30402502	A/G	cg13852791	chr20:30311386	BCL2L1	-0.82	-5.64	-0.54	2.59e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs600231	0.708	rs602838	chr11:65253247	T/G	cg24009118	chr11:65545808	DKFZp761E198	0.66	4.94	0.49	4.36e-6	Bone mineral density;
SKCM	cis	rs9902453	0.967	rs4493117	chr17:28489770	G/A	cg26525008	chr17:28256777	EFCAB5;SSH2	0.79	6.03	0.56	5.24e-8	Coffee consumption (cups per day);
SKCM	cis	rs2019137	0.560	rs10206269	chr2:113990393	C/A	cg12889195	chr2:113992843	PAX8;LOC440839;LOC654433	0.77	5.64	0.54	2.65e-7	Lymphocyte counts;
SKCM	cis	rs801193	0.660	rs4610622	chr7:66224497	T/C	cg18876405	chr7:65276391	NA	0.66	6.5	0.59	7.03e-9	Aortic root size;
SKCM	cis	rs6724607	1.000	rs13410230	chr2:191446252	A/G	cg27211696	chr2:191398769	TMEM194B	0.8	6.53	0.59	6.07e-9	Pulse pressure;
SKCM	trans	rs7618501	0.966	rs13063621	chr3:49821625	T/C	cg21659725	chr3:3221576	CRBN	0.96	9.61	0.74	7.08e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs514406	0.861	rs72637996	chr1:53249618	A/T	cg24675658	chr1:53192096	ZYG11B	0.61	4.93	0.49	4.58e-6	Monocyte count;
SKCM	cis	rs951366	0.617	rs823075	chr1:205774897	C/T	cg11965913	chr1:205819406	PM20D1	1.01	12.76	0.82	8.95e-21	Menarche (age at onset);
SKCM	cis	rs1153858	1.000	rs16942568	chr15:45677390	T/C	cg10760299	chr15:45669010	GATM	0.62	6.35	0.58	1.3e-8	Homoarginine levels;
SKCM	cis	rs2013441	1.000	rs2703815	chr17:20118499	C/T	cg13482628	chr17:19912719	NA	0.65	5.08	0.5	2.52e-6	Obesity-related traits;
SKCM	cis	rs763014	0.865	rs8675	chr16:633843	A/G	cg00908189	chr16:619842	PIGQ	0.82	7.78	0.66	2.55e-11	Height;
SKCM	cis	rs28595532	0.841	rs114970257	chr4:119756937	G/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs561341	1.000	rs55978022	chr17:30275937	T/C	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs2439831	1.000	rs2584725	chr15:43793135	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.22	7.98	0.67	1.01e-11	Lung cancer in ever smokers;
SKCM	cis	rs6087771	0.781	rs6089067	chr20:30358894	G/C	cg13852791	chr20:30311386	BCL2L1	0.82	5.64	0.54	2.59e-7	Subcortical brain region volumes;Putamen volume;
SKCM	cis	rs7666738	0.830	rs35752787	chr4:98935202	G/A	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs28595532	0.920	rs115240535	chr4:119745395	G/C	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs6815814	0.950	rs5743557	chr4:38806827	G/A	cg02016764	chr4:38805732	TLR1	-0.76	-5.4	-0.52	6.95e-7	Breast cancer;
SKCM	cis	rs950027	0.620	rs2486274	chr15:45666228	G/T	cg21132104	chr15:45694354	SPATA5L1	0.76	5.84	0.55	1.13e-7	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs8077889	0.871	rs8065043	chr17:41900984	G/A	cg26893861	chr17:41843967	DUSP3	1.2	7.85	0.66	1.82e-11	Triglycerides;
SKCM	cis	rs2811415	0.597	rs10934844	chr3:127749651	T/C	cg09089421	chr3:127803668	RUVBL1	0.99	8.52	0.69	9.09e-13	Lung function (FEV1/FVC);
SKCM	cis	rs7927771	0.524	rs2869024	chr11:47674101	G/A	cg20307385	chr11:47447363	PSMC3	-0.72	-5.81	-0.55	1.31e-7	Subjective well-being;
SKCM	cis	rs4481887	1.000	rs4244172	chr1:248466838	A/G	cg00666640	chr1:248458726	OR2T12	0.6	5.14	0.5	1.98e-6	Common traits (Other);
SKCM	cis	rs7811142	1.000	rs11763414	chr7:100016844	C/G	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.16	7.68	0.66	3.87e-11	Platelet count;
SKCM	cis	rs2204008	0.744	rs11514071	chr12:38392076	C/T	cg26384229	chr12:38710491	ALG10B	0.81	6.6	0.6	4.58e-9	Bladder cancer;
SKCM	cis	rs867186	0.688	rs6060225	chr20:33686404	C/G	cg04194272	chr20:33683537	NA	-1.21	-6.8	-0.61	1.89e-9	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs6570726	0.764	rs451108	chr6:145844309	T/C	cg23711669	chr6:146136114	FBXO30	0.81	8.22	0.68	3.49e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs992157	0.710	rs7569907	chr2:219070551	C/T	cg00012203	chr2:219082015	ARPC2	0.84	7.36	0.64	1.6e-10	Colorectal cancer;
SKCM	cis	rs6120849	0.663	rs6119548	chr20:33552612	A/G	cg24642439	chr20:33292090	TP53INP2	0.98	5.35	0.52	8.46e-7	Protein C levels;
SKCM	cis	rs6982751	0.611	rs4840526	chr8:10807119	C/T	cg01383082	chr8:11323474	FAM167A	0.86	4.98	0.49	3.74e-6	Asthma and hay fever;
SKCM	cis	rs2816062	0.760	rs2244192	chr1:18890939	A/T	cg18795169	chr1:18902165	NA	-0.82	-8.11	-0.68	5.67e-12	Urate levels in lean individuals;
SKCM	cis	rs867186	1.000	rs75287019	chr20:33721261	C/G	cg04194272	chr20:33683537	NA	-1.11	-6.05	-0.57	4.73e-8	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs7833790	1.000	rs7833384	chr8:82730915	T/C	cg17211192	chr8:82754475	SNX16	-0.94	-5.12	-0.5	2.15e-6	Diastolic blood pressure;
SKCM	cis	rs736408	0.812	rs2071506	chr3:52826276	T/C	cg11645453	chr3:52864694	ITIH4	0.58	4.87	0.48	5.71e-6	Bipolar disorder;
SKCM	cis	rs4561483	0.801	rs33620	chr16:12008546	C/G	cg08843971	chr16:11963173	GSPT1	-0.66	-5.08	-0.5	2.49e-6	Testicular germ cell tumor;
SKCM	cis	rs28386778	0.742	rs3020617	chr17:61947303	A/G	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.09	0.5	2.44e-6	Prudent dietary pattern;
SKCM	cis	rs6500602	0.701	rs6500614	chr16:4573938	A/G	cg08645402	chr16:4508243	NA	0.64	5.11	0.5	2.26e-6	Schizophrenia;
SKCM	cis	rs35955747	0.669	rs878718	chr22:31552702	C/T	cg13145458	chr22:31556086	RNF185	-0.62	-4.79	-0.48	7.86e-6	Neutrophil count;Sum basophil neutrophil counts;
SKCM	cis	rs3785574	0.962	rs2584630	chr17:61887561	T/A	cg06601766	chr17:61851465	DDX42;CCDC47	0.71	5.29	0.51	1.09e-6	Height;
SKCM	cis	rs9926296	0.546	rs7187436	chr16:89845110	A/T	cg26513180	chr16:89883248	FANCA	0.99	11.33	0.79	3.79e-18	Vitiligo;
SKCM	cis	rs10503709	0.581	rs35884349	chr8:21441035	G/A	cg24196612	chr8:21608193	GFRA2	-0.5	-4.92	-0.49	4.66e-6	Blood protein levels;
SKCM	cis	rs12478296	0.786	rs55876934	chr2:243033816	C/T	cg06360820	chr2:242988706	NA	-0.91	-5.31	-0.52	1.01e-6	Obesity-related traits;
SKCM	cis	rs2760061	0.583	rs708118	chr1:228201801	A/G	cg02753203	chr1:228287806	NA	-0.77	-7.17	-0.63	3.79e-10	Diastolic blood pressure;
SKCM	cis	rs763014	0.966	rs15564	chr16:677854	G/T	cg07343612	chr16:622815	PIGQ	-0.67	-5.48	-0.53	5.01e-7	Height;
SKCM	cis	rs1298637	0.683	rs7543581	chr1:53922155	C/T	cg09586583	chr1:54755153	SSBP3	0.63	5.37	0.52	7.79e-7	Nicotine use;
SKCM	cis	rs8180040	0.966	rs12486969	chr3:47429003	G/C	cg27129171	chr3:47204927	SETD2	-0.79	-5.79	-0.55	1.43e-7	Colorectal cancer;
SKCM	cis	rs17065868	1.000	rs73188772	chr13:45062476	C/A	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs12120353	0.702	rs780607	chr1:4550547	G/C	cg15022359	chr1:4193126	NA	-0.62	-5.2	-0.51	1.56e-6	Anxiety disorder;
SKCM	cis	rs4523957	0.614	rs2760736	chr17:2036653	A/G	cg16513277	chr17:2031491	SMG6	-0.91	-6.21	-0.58	2.38e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs4423214	0.610	rs12789253	chr11:71125765	G/A	cg05163923	chr11:71159392	DHCR7	0.59	5.4	0.52	6.93e-7	Vitamin D levels;
SKCM	cis	rs6083	0.512	rs17269397	chr15:58857378	A/G	cg05156742	chr15:59063176	FAM63B	-0.71	-4.91	-0.49	4.94e-6	Schizophrenia;
SKCM	cis	rs4819052	0.851	rs2838829	chr21:46664040	A/C	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.42	0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs10256972	0.553	rs4236381	chr7:1165723	A/C	cg07092213	chr7:1199455	ZFAND2A	-0.65	-5.14	-0.5	1.96e-6	Longevity;Endometriosis;
SKCM	cis	rs28595532	0.841	rs115851302	chr4:119776504	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs7953508	0.750	rs7310512	chr12:93976703	C/T	cg18151635	chr12:93972918	NA	-0.71	-6.22	-0.58	2.32e-8	Pubertal anthropometrics;
SKCM	cis	rs10876993	0.806	rs1689598	chr12:58050500	G/C	cg18357645	chr12:58087776	OS9	0.61	5.65	0.54	2.52e-7	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs3784262	0.654	rs4646568	chr15:58344290	A/G	cg12031962	chr15:58353849	ALDH1A2	0.46	5.91	0.56	8.55e-8	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs4619890	0.528	rs62289337	chr4:7877939	G/A	cg08722675	chr4:8412549	ACOX3	0.54	5.06	0.5	2.68e-6	Glaucoma (primary open-angle);
SKCM	cis	rs6570726	0.905	rs1355146	chr6:145781741	A/C	cg23711669	chr6:146136114	FBXO30	-0.68	-6.55	-0.6	5.51e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4969178	0.931	rs3826323	chr17:76400268	C/G	cg20026190	chr17:76395443	PGS1	0.59	5.01	0.49	3.3e-6	HDL cholesterol levels;
SKCM	cis	rs3845702	0.736	rs72962575	chr2:180862133	C/G	cg01881094	chr2:180872142	CWC22	1.24	6.04	0.56	4.96e-8	Schizophrenia;
SKCM	cis	rs55962025	0.883	rs3121419	chr4:3232257	C/T	cg24015175	chr4:3319247	RGS12	-0.63	-5.42	-0.52	6.54e-7	Parental longevity (mother's age at death);
SKCM	cis	rs2204008	0.774	rs11616004	chr12:38278822	G/A	cg26384229	chr12:38710491	ALG10B	0.87	6.83	0.61	1.63e-9	Bladder cancer;
SKCM	cis	rs365132	0.934	rs183686	chr5:176494102	A/G	cg16309518	chr5:176445507	NA	-0.51	-4.83	-0.48	6.72e-6	Menarche and menopause (age at onset);Menopause (age at onset);
SKCM	cis	rs10504229	1.000	rs60454728	chr8:58173781	G/A	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs6951245	0.529	rs10262070	chr7:1141738	C/T	cg23708337	chr7:1209742	NA	0.71	4.94	0.49	4.35e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs67311347	0.544	rs9833640	chr3:40354941	T/A	cg02782426	chr3:40428986	ENTPD3	0.5	4.99	0.49	3.64e-6	Renal cell carcinoma;
SKCM	cis	rs6546550	0.935	rs13392884	chr2:70036711	A/G	cg02498382	chr2:70120550	SNRNP27	-0.46	-5.07	-0.5	2.61e-6	Prevalent atrial fibrillation;
SKCM	cis	rs995000	0.965	rs10889332	chr1:62950858	A/G	cg06896770	chr1:63153194	DOCK7	-0.73	-7.32	-0.64	1.9e-10	Triglyceride levels;
SKCM	cis	rs36051895	0.659	rs7025540	chr9:5043152	T/C	cg02405213	chr9:5042618	JAK2	-0.63	-5.04	-0.5	2.91e-6	Pediatric autoimmune diseases;
SKCM	cis	rs5750830	0.649	rs5750822	chr22:39826788	C/T	cg24399712	chr22:39784796	NA	-0.62	-5.34	-0.52	8.82e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs1005277	0.579	rs2474568	chr10:38383147	A/T	cg00409905	chr10:38381863	ZNF37A	-0.66	-5.85	-0.55	1.1e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs875971	0.929	rs34406470	chr7:65929956	A/G	cg18876405	chr7:65276391	NA	0.65	6.31	0.58	1.57e-8	Aortic root size;
SKCM	cis	rs854765	0.583	rs4925125	chr17:17794444	T/C	cg24612305	chr17:17875800	TOM1L2;LRRC48	-1.02	-7.99	-0.67	9.88e-12	Total body bone mineral density;
SKCM	cis	rs561341	1.000	rs55962687	chr17:30260369	C/T	cg23018236	chr17:30244563	NA	-0.56	-5.58	-0.53	3.31e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs1348850	0.598	rs1405717	chr2:178500101	G/T	cg22681709	chr2:178499509	PDE11A	-0.69	-5.98	-0.56	6.36e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs561341	0.843	rs879945	chr17:30242796	G/A	cg12193833	chr17:30244370	NA	-0.49	-4.92	-0.49	4.75e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs62079673	0.527	rs9788998	chr17:80605644	A/G	cg27136344	chr17:80606911	WDR45L	0.79	7.95	0.67	1.2e-11	Breast cancer;
SKCM	cis	rs12142240	0.698	rs66847432	chr1:46832013	G/A	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs9921222	0.564	rs9923059	chr16:381590	C/A	cg00101154	chr16:420108	MRPL28	-0.71	-5.74	-0.55	1.72e-7	Bone mineral density (spine);Bone mineral density;
SKCM	trans	rs208520	0.690	rs207094	chr6:66799009	G/A	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-1.01	-7.5	-0.65	8.58e-11	Exhaled nitric oxide output;
SKCM	cis	rs13118159	0.527	rs9328733	chr4:1388583	A/G	cg16405210	chr4:1374714	KIAA1530	-0.97	-6.97	-0.62	9.15e-10	Longevity;
SKCM	cis	rs7666738	0.830	rs13145011	chr4:98993410	G/A	cg17366294	chr4:99064904	C4orf37	0.6	4.98	0.49	3.8e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs936229	0.749	rs4886633	chr15:75178207	G/A	cg14664628	chr15:75095509	CSK	-0.98	-7.16	-0.63	3.83e-10	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin);
SKCM	cis	rs34172651	0.517	rs12927710	chr16:24790282	A/C	cg00339695	chr16:24857497	SLC5A11	0.8	6.43	0.59	9.38e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs9911578	0.967	rs2611781	chr17:56703124	C/G	cg12560992	chr17:57184187	TRIM37	0.95	7.69	0.66	3.7e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs9814567	1.000	rs9871305	chr3:134213538	C/T	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.64	-5.06	-0.5	2.77e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	trans	rs8073060	0.586	rs6505486	chr17:33996776	G/A	cg19694781	chr19:47549865	TMEM160	-1.04	-8.28	-0.68	2.65e-12	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs2153535	0.505	rs1335629	chr6:8491863	C/T	cg07606381	chr6:8435919	SLC35B3	0.86	6.25	0.58	2.06e-8	Motion sickness;
SKCM	cis	rs11098499	0.954	rs17005535	chr4:120411562	C/T	cg09307838	chr4:120376055	NA	0.99	8.02	0.67	8.7e-12	Corneal astigmatism;
SKCM	cis	rs1577917	1.000	rs12213149	chr6:86668644	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.66	-5.74	-0.54	1.76e-7	Response to antipsychotic treatment;
SKCM	cis	rs11098499	0.909	rs1809406	chr4:120377122	G/A	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs2594989	0.733	rs2616538	chr3:11581076	G/T	cg00170343	chr3:11313890	ATG7	0.98	5.18	0.51	1.72e-6	Circulating chemerin levels;
SKCM	cis	rs514406	0.679	rs541852	chr1:53256834	A/G	cg25767906	chr1:53392781	SCP2	0.6	5.02	0.49	3.18e-6	Monocyte count;
SKCM	cis	rs2839186	0.749	rs62226488	chr21:47710517	C/T	cg11766577	chr21:47581405	C21orf56	-0.71	-6.01	-0.56	5.6e-8	Testicular germ cell tumor;
SKCM	cis	rs875971	0.830	rs427575	chr7:65519219	A/G	cg18876405	chr7:65276391	NA	0.75	7.32	0.64	1.93e-10	Aortic root size;
SKCM	cis	rs10170846	0.626	rs9288575	chr2:223495133	A/C	cg25565276	chr2:223520875	FARSB	1.2	7.77	0.66	2.58e-11	Schizophrenia (inflammation and infection response interaction);
SKCM	cis	rs3820928	0.839	rs4675123	chr2:227800205	T/C	cg11843606	chr2:227700838	RHBDD1	-0.6	-4.81	-0.48	7.34e-6	Pulmonary function;
SKCM	cis	rs2228479	0.557	rs2293584	chr16:89888686	C/G	cg06558623	chr16:89946397	TCF25	1.1	4.95	0.49	4.17e-6	Skin colour saturation;
SKCM	cis	rs7618501	0.633	rs9853222	chr3:50022926	T/C	cg24110177	chr3:50126178	RBM5	-0.6	-5.11	-0.5	2.25e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs3820928	0.874	rs12105952	chr2:227864521	G/A	cg11843606	chr2:227700838	RHBDD1	-0.59	-4.81	-0.48	7.33e-6	Pulmonary function;
SKCM	cis	rs155076	0.711	rs4769158	chr13:21881975	T/C	cg14456004	chr13:21872349	NA	1.3	7.55	0.65	6.84e-11	White matter hyperintensity burden;
SKCM	cis	rs9790314	1.000	rs6775627	chr3:160953609	A/G	cg03342759	chr3:160939853	NMD3	-0.72	-7.89	-0.67	1.53e-11	Morning vs. evening chronotype;
SKCM	cis	rs10448080	0.879	rs240946	chr8:28568905	A/G	cg21221873	chr8:28261942	NA	-0.52	-4.85	-0.48	6.2e-6	Height;
SKCM	cis	rs910316	0.967	rs11159116	chr14:75550584	G/T	cg08847533	chr14:75593920	NEK9	0.95	9.18	0.72	4.88e-14	Height;
SKCM	cis	rs7208859	0.673	rs9915139	chr17:29158515	A/G	cg13385521	chr17:29058706	SUZ12P	0.89	4.77	0.48	8.47e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs875971	0.862	rs2024192	chr7:66041447	G/T	cg11764359	chr7:65958608	NA	-0.75	-6.8	-0.61	1.88e-9	Aortic root size;
SKCM	cis	rs4665809	0.590	rs17528590	chr2:26505858	A/G	cg26119090	chr2:26468346	HADHA;HADHB	1.08	8.63	0.7	5.67e-13	Gut microbiome composition (summer);
SKCM	cis	rs2413583	0.591	rs79605405	chr22:39696638	C/A	cg17798944	chr22:39715225	SNORD43;RPL3	0.92	5.12	0.5	2.12e-6	Ulcerative colitis;Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs514406	0.505	rs269293	chr1:53187767	A/C	cg16325326	chr1:53192061	ZYG11B	0.92	10.34	0.76	2.75e-16	Monocyte count;
SKCM	cis	rs9325144	0.510	rs6582599	chr12:38715965	T/G	cg13010199	chr12:38710504	ALG10B	0.63	4.92	0.49	4.68e-6	Morning vs. evening chronotype;
SKCM	cis	rs9796	0.636	rs1983400	chr15:41373029	T/C	cg18705301	chr15:41695430	NDUFAF1	-0.78	-5.56	-0.53	3.68e-7	Menopause (age at onset);
SKCM	cis	rs7666738	0.830	rs1115616	chr4:99006603	A/C	cg05340658	chr4:99064831	C4orf37	0.66	5.07	0.5	2.64e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7169304	0.531	rs59356430	chr15:49617032	T/C	cg25951582	chr15:49913451	C15orf33;DTWD1	-0.72	-5.22	-0.51	1.44e-6	Lung adenocarcinoma;Lung cancer;Lung cancer in ever smokers;
SKCM	cis	rs1577917	1.000	rs1995688	chr6:86632319	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.66	-5.74	-0.54	1.76e-7	Response to antipsychotic treatment;
SKCM	cis	rs514406	0.861	rs7513052	chr1:53241360	C/T	cg16325326	chr1:53192061	ZYG11B	-0.87	-8.87	-0.71	1.94e-13	Monocyte count;
SKCM	cis	rs933688	1.000	rs2839728	chr5:90727412	G/A	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.05	8.46	0.69	1.19e-12	Smoking behavior;
SKCM	cis	rs9790314	1.000	rs336585	chr3:161081670	A/G	cg03342759	chr3:160939853	NMD3	-0.72	-8.03	-0.67	8.11e-12	Morning vs. evening chronotype;
SKCM	cis	rs116095464	0.558	rs6874745	chr5:264527	A/G	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs1707322	1.000	rs4524994	chr1:46370263	A/G	cg03146154	chr1:46216737	IPP	0.74	5.06	0.5	2.76e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7193541	0.510	rs79473128	chr16:74589192	G/A	cg01733217	chr16:74700730	RFWD3	0.87	6.54	0.59	5.91e-9	Multiple myeloma;
SKCM	cis	rs9300255	0.544	rs1727309	chr12:123658258	A/G	cg00376283	chr12:123451042	ABCB9	0.84	5.1	0.5	2.35e-6	Neutrophil percentage of white cells;
SKCM	cis	rs6570726	0.764	rs451108	chr6:145844309	T/C	cg05347473	chr6:146136440	FBXO30	0.54	4.9	0.49	5.07e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs933688	1.000	rs6866191	chr5:90746852	G/A	cg12630606	chr5:90679528	LOC100129716;ARRDC3	0.98	7.81	0.66	2.22e-11	Smoking behavior;
SKCM	cis	rs9325144	0.647	rs11168819	chr12:39011082	C/A	cg13010199	chr12:38710504	ALG10B	-0.64	-5.54	-0.53	3.95e-7	Morning vs. evening chronotype;
SKCM	cis	rs250585	0.516	rs426745	chr16:23601535	C/T	cg09934309	chr16:23461721	COG7	-0.74	-4.95	-0.49	4.13e-6	Egg allergy;
SKCM	cis	rs8014204	0.935	rs4903267	chr14:75360419	G/T	cg06637938	chr14:75390232	RPS6KL1	-0.78	-6.05	-0.57	4.66e-8	Caffeine consumption;
SKCM	cis	rs4724125	0.921	rs4342494	chr7:42718109	G/C	cg09407816	chr7:42972088	MRPL32;PSMA2	0.79	4.79	0.48	7.72e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9475752	0.744	rs34399458	chr6:56848842	C/T	cg06815302	chr6:57335405	PRIM2	0.65	5.03	0.49	3.12e-6	Menarche (age at onset);
SKCM	cis	rs11155671	0.530	rs6557133	chr6:150195384	G/T	cg05036130	chr6:150231994	NA	0.59	5.89	0.56	9.17e-8	Testicular germ cell tumor;
SKCM	cis	rs763121	0.752	rs5757222	chr22:39060473	C/T	cg06022373	chr22:39101656	GTPBP1	0.74	5.24	0.51	1.35e-6	Menopause (age at onset);
SKCM	cis	rs861020	0.606	rs689210	chr1:210013723	A/C	cg05527609	chr1:210001259	C1orf107	0.86	6.74	0.61	2.43e-9	Orofacial clefts;
SKCM	cis	rs2282300	0.739	rs34234618	chr11:30241701	T/C	cg25418670	chr11:30344373	C11orf46	-0.65	-4.93	-0.49	4.5e-6	Morning vs. evening chronotype;
SKCM	cis	rs11098499	0.954	rs3733519	chr4:120423448	A/G	cg24375607	chr4:120327624	NA	0.66	5.13	0.5	2.05e-6	Corneal astigmatism;
SKCM	cis	rs72781680	1.000	rs72796359	chr2:24160545	T/C	cg08917208	chr2:24149416	ATAD2B	1.02	5.84	0.55	1.16e-7	Lymphocyte counts;
SKCM	cis	rs11690935	0.879	rs908671	chr2:172690265	C/G	cg13550731	chr2:172543902	DYNC1I2	-0.9	-7.44	-0.64	1.11e-10	Schizophrenia;
SKCM	cis	rs9900062	0.546	rs2676294	chr17:62710764	A/G	cg02097616	chr17:62675921	NA	-0.74	-6.14	-0.57	3.26e-8	QT interval;
SKCM	cis	rs782590	0.774	rs782637	chr2:55894247	T/C	cg18811423	chr2:55921094	PNPT1	0.91	7.45	0.64	1.08e-10	Metabolic syndrome;
SKCM	cis	rs362296	0.671	rs1006798	chr4:3258373	A/G	cg24015175	chr4:3319247	RGS12	-0.65	-5.94	-0.56	7.49e-8	Parental longevity (mother's age at death);
SKCM	cis	rs7824557	0.585	rs2572382	chr8:11211302	T/G	cg21775007	chr8:11205619	TDH	0.67	5.9	0.56	8.86e-8	Retinal vascular caliber;
SKCM	cis	rs1577917	1.000	rs6936048	chr6:86702608	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.83	-8.23	-0.68	3.37e-12	Response to antipsychotic treatment;
SKCM	cis	rs28530618	0.603	rs750401	chr20:31246638	G/C	cg25730142	chr20:32031702	SNTA1	0.61	4.93	0.49	4.58e-6	Birth weight;
SKCM	cis	rs7684253	0.587	rs4339274	chr4:57747634	A/G	cg11939399	chr4:57773300	REST	-0.42	-4.86	-0.48	5.94e-6	Migraine;
SKCM	cis	rs7666738	0.830	rs7662596	chr4:99019962	G/T	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs867186	1.000	rs11908683	chr20:33720920	T/C	cg04194272	chr20:33683537	NA	-1.11	-6.05	-0.57	4.73e-8	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs561341	0.714	rs547473	chr17:30297560	T/G	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs4727027	0.704	rs12537763	chr7:148903984	G/A	cg23583168	chr7:148888333	NA	-0.77	-6.15	-0.57	3.14e-8	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs10791097	0.694	rs2155750	chr11:130751261	A/C	cg12179176	chr11:130786555	SNX19	0.91	8.28	0.68	2.74e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs7208859	0.573	rs7214313	chr17:29138596	T/C	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs13118159	0.505	rs1250128	chr4:1257311	T/C	cg02475777	chr4:1388615	CRIPAK	-0.75	-5.17	-0.5	1.78e-6	Longevity;
SKCM	cis	rs4132509	0.793	rs6694738	chr1:243715210	C/A	cg21452805	chr1:244014465	NA	0.9	5.81	0.55	1.31e-7	RR interval (heart rate);
SKCM	trans	rs8073060	0.544	rs17550716	chr17:33893208	A/G	cg19694781	chr19:47549865	TMEM160	1.04	8.53	0.69	8.9e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs7666738	0.830	rs13140676	chr4:98804978	C/T	cg17366294	chr4:99064904	C4orf37	0.57	4.86	0.48	6.02e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1691799	0.867	rs1168316	chr12:66746239	A/G	cg16791601	chr12:66731901	HELB	-0.65	-6.09	-0.57	4.07e-8	White blood cell count (basophil);
SKCM	cis	rs708547	0.624	rs1277284	chr4:57855361	T/G	cg16868167	chr4:57843880	C4orf14;POLR2B	0.9	8.48	0.69	1.12e-12	Response to bleomycin (chromatid breaks);
SKCM	cis	rs2228479	0.764	rs11641201	chr16:89983276	T/C	cg00800038	chr16:89945340	TCF25	-0.97	-5.76	-0.55	1.59e-7	Skin colour saturation;
SKCM	cis	rs2204008	0.837	rs12366727	chr12:38365748	A/C	cg26384229	chr12:38710491	ALG10B	0.87	6.82	0.61	1.73e-9	Bladder cancer;
SKCM	cis	rs6977660	0.714	rs10229108	chr7:19824253	G/A	cg07541023	chr7:19748670	TWISTNB	0.72	4.78	0.48	7.95e-6	Thyroid stimulating hormone;
SKCM	cis	rs1405130	0.869	rs884064	chr2:235570541	G/C	cg21542780	chr2:234763377	HJURP	-0.64	-4.89	-0.48	5.21e-6	Coronary artery disease;
SKCM	trans	rs1814175	0.935	rs11040438	chr11:49622521	G/A	cg15704280	chr7:45808275	SEPT13	-1.0	-9.43	-0.73	1.61e-14	Height;
SKCM	cis	rs9640161	0.789	rs60283368	chr7:150023258	G/A	cg10018233	chr7:150070692	REPIN1	0.77	6.19	0.57	2.62e-8	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs875971	0.862	rs13226170	chr7:65999298	G/A	cg18876405	chr7:65276391	NA	0.61	6.06	0.57	4.57e-8	Aortic root size;
SKCM	cis	rs7829975	0.514	rs2945873	chr8:8260445	C/T	cg06636001	chr8:8085503	FLJ10661	0.78	6.69	0.6	3.02e-9	Mood instability;
SKCM	cis	rs7000551	0.606	rs7844699	chr8:22248920	G/T	cg12081754	chr8:22256438	SLC39A14	-1.07	-10.87	-0.78	2.77e-17	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs951366	0.789	rs7536483	chr1:205718858	A/T	cg07157834	chr1:205819609	PM20D1	0.82	7.24	0.63	2.77e-10	Menarche (age at onset);
SKCM	cis	rs28595532	0.920	rs114262028	chr4:119734877	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs2224391	1.000	rs2753249	chr6:5263475	T/G	cg09085698	chr6:5261316	LYRM4;FARS2	-0.77	-5.73	-0.54	1.79e-7	Height;
SKCM	cis	rs2479724	0.846	rs2254474	chr6:41843044	T/G	cg17623882	chr6:41773611	USP49	-0.75	-6.35	-0.58	1.35e-8	Menarche (age at onset);
SKCM	cis	rs72781680	0.898	rs12623333	chr2:24111823	T/G	cg08917208	chr2:24149416	ATAD2B	1.0	5.41	0.52	6.82e-7	Lymphocyte counts;
SKCM	cis	rs16866061	0.515	rs11695326	chr2:225415134	A/G	cg12698349	chr2:225449008	CUL3	0.94	10.01	0.75	1.22e-15	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs4683346	1.000	rs4683344	chr3:42884204	G/C	cg06399164	chr3:42695035	ZBTB47	0.61	5.74	0.55	1.71e-7	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs703842	0.865	rs10877011	chr12:58124992	T/G	cg04478727	chr12:58166393	METTL1;FAM119B	0.8	5.98	0.56	6.34e-8	Multiple sclerosis;
SKCM	cis	rs2019137	0.560	rs11123172	chr2:113984303	C/T	cg21550016	chr2:113992930	PAX8;LOC440839;LOC654433	-0.65	-5.09	-0.5	2.4e-6	Lymphocyte counts;
SKCM	cis	rs769267	0.895	rs1000237	chr19:19518316	T/A	cg03709012	chr19:19516395	GATAD2A	0.91	8.6	0.7	6.53e-13	Tonsillectomy;
SKCM	cis	rs9322193	1.000	rs9399693	chr6:149933854	C/T	cg07701084	chr6:150067640	NUP43	0.6	4.79	0.48	7.78e-6	Lung cancer;
SKCM	trans	rs561341	0.941	rs8066558	chr17:30272879	G/T	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs651907	0.557	rs12629658	chr3:101356535	A/G	cg12386194	chr3:101231763	SENP7	0.75	6.3	0.58	1.64e-8	Colorectal cancer;
SKCM	cis	rs7584330	0.740	rs13418586	chr2:238445593	A/G	cg14458575	chr2:238380390	NA	0.75	5.11	0.5	2.23e-6	Prostate cancer;
SKCM	cis	rs4319547	0.794	rs61954972	chr12:123074167	T/G	cg23029597	chr12:123009494	RSRC2	-0.81	-5.99	-0.56	6.21e-8	Body mass index;
SKCM	cis	rs873946	0.648	rs35417213	chr10:134553749	A/G	cg18305652	chr10:134549665	INPP5A	0.58	6.01	0.56	5.55e-8	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs734999	0.549	rs6670198	chr1:2520527	T/C	cg18163442	chr1:2779061	NA	-0.43	-4.8	-0.48	7.59e-6	Ulcerative colitis;
SKCM	cis	rs995000	0.931	rs10158897	chr1:62912919	C/T	cg06896770	chr1:63153194	DOCK7	0.92	8.7	0.7	4.13e-13	Triglyceride levels;
SKCM	cis	rs6062496	0.609	rs2872811	chr20:62290193	G/T	cg27236539	chr20:62289627	RTEL1	0.72	4.95	0.49	4.16e-6	Crohn's disease;Inflammatory bowel disease;Ulcerative colitis;
SKCM	cis	rs427394	0.735	rs416689	chr5:6740855	C/T	cg10857441	chr5:6722123	POLS	-0.68	-7.2	-0.63	3.25e-10	Menopause (age at onset);
SKCM	cis	rs11098499	0.863	rs3775845	chr4:120432447	T/C	cg24375607	chr4:120327624	NA	0.7	5.37	0.52	7.82e-7	Corneal astigmatism;
SKCM	cis	rs875971	0.545	rs2173571	chr7:65770379	G/A	cg18876405	chr7:65276391	NA	0.63	5.07	0.5	2.57e-6	Aortic root size;
SKCM	cis	rs2204008	0.658	rs11181310	chr12:38315963	C/A	cg26384229	chr12:38710491	ALG10B	0.81	6.57	0.6	5.18e-9	Bladder cancer;
SKCM	cis	rs11671005	0.695	rs8106061	chr19:58917990	G/C	cg11952622	chr19:58962976	ZNF324B	0.71	5.3	0.51	1.04e-6	Mean platelet volume;
SKCM	cis	rs782590	0.837	rs782585	chr2:55922930	C/T	cg18811423	chr2:55921094	PNPT1	0.93	7.98	0.67	1.01e-11	Metabolic syndrome;
SKCM	cis	rs7937682	0.855	rs490897	chr11:111487914	A/G	cg19812747	chr11:111475976	SIK2	-0.56	-4.93	-0.49	4.55e-6	Primary sclerosing cholangitis;
SKCM	cis	rs10929159	0.928	rs7598567	chr2:236920673	A/G	cg14226755	chr2:236923322	AGAP1	0.29	4.77	0.48	8.43e-6	Parkinson's disease;
SKCM	cis	rs9815354	0.812	rs17284313	chr3:41986787	G/T	cg03022575	chr3:42003672	ULK4	-1.02	-5.17	-0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs9325144	0.752	rs12300353	chr12:39154492	G/C	cg13010199	chr12:38710504	ALG10B	-0.59	-4.94	-0.49	4.39e-6	Morning vs. evening chronotype;
SKCM	cis	rs2858942	0.818	rs2685123	chr16:248418	T/C	cg08400316	chr16:204221	HBZ	0.69	4.8	0.48	7.53e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs62064224	0.702	rs2302277	chr17:30791509	C/G	cg18200150	chr17:30822561	MYO1D	0.73	6.5	0.59	7.02e-9	Schizophrenia;
SKCM	cis	rs12048904	0.619	rs10875346	chr1:101328083	T/C	cg00063077	chr1:101360652	SLC30A7;EXTL2	0.85	6.73	0.61	2.58e-9	Multiple sclerosis;
SKCM	cis	rs1577917	0.654	rs9450284	chr6:86199329	G/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.83	7.95	0.67	1.19e-11	Response to antipsychotic treatment;
SKCM	cis	rs763121	0.853	rs35522482	chr22:39063015	C/A	cg06022373	chr22:39101656	GTPBP1	0.78	5.63	0.54	2.7e-7	Menopause (age at onset);
SKCM	cis	rs6089584	0.606	rs7270469	chr20:60577258	G/A	cg16423285	chr20:60520624	NA	-0.61	-5.15	-0.5	1.93e-6	Body mass index;
SKCM	cis	rs7772486	0.790	rs1133832	chr6:146205604	C/T	cg23711669	chr6:146136114	FBXO30	-0.73	-6.76	-0.61	2.22e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7772486	0.754	rs9373476	chr6:146139741	C/G	cg23711669	chr6:146136114	FBXO30	0.89	9.86	0.74	2.39e-15	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs11677370	0.561	rs12986995	chr2:3826965	G/A	cg17052675	chr2:3827356	NA	-0.62	-5.11	-0.5	2.24e-6	Type 2 diabetes;
SKCM	cis	rs6951245	1.000	rs11763793	chr7:1094342	A/G	cg24642844	chr7:1081250	C7orf50	-0.93	-6.22	-0.58	2.28e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs6088580	0.634	rs6087580	chr20:32992592	A/G	cg24642439	chr20:33292090	TP53INP2	-0.76	-6.02	-0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs4819052	1.000	rs9306123	chr21:46709922	A/G	cg20896738	chr21:46707857	POFUT2;LOC642852	0.76	5.3	0.51	1.03e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs2739330	0.761	rs5760176	chr22:24402321	A/G	cg04234412	chr22:24373322	LOC391322	0.82	7.85	0.66	1.82e-11	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs1413885	0.516	rs6588138	chr1:65838366	A/G	cg14976592	chr1:65886160	LEPROT;LEPR	0.59	5.1	0.5	2.32e-6	Anticoagulant levels;
SKCM	cis	rs2072510	0.722	rs2540496	chr12:96406503	G/A	cg18817487	chr12:96390143	HAL	0.43	5.68	0.54	2.25e-7	Metabolite levels (small molecules and protein measures);
SKCM	cis	rs28595532	0.920	rs115860482	chr4:119759546	A/G	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs9900062	0.586	rs12600679	chr17:62687327	T/G	cg02097616	chr17:62675921	NA	0.76	6.31	0.58	1.54e-8	QT interval;
SKCM	cis	rs3820928	0.874	rs67513858	chr2:227804819	A/C	cg11843606	chr2:227700838	RHBDD1	-0.6	-4.81	-0.48	7.17e-6	Pulmonary function;
SKCM	cis	rs760805	0.965	rs11249203	chr1:25258585	G/C	cg22509179	chr1:25234806	RUNX3	-0.75	-6.22	-0.58	2.26e-8	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs13118159	0.509	rs7688922	chr4:1361011	T/C	cg20887711	chr4:1340912	KIAA1530	0.98	7.46	0.65	1.04e-10	Longevity;
SKCM	cis	rs7193541	0.694	rs8061942	chr16:74691362	C/T	cg01733217	chr16:74700730	RFWD3	1.02	11.62	0.8	1.08e-18	Multiple myeloma;
SKCM	cis	rs2836950	0.561	rs34705151	chr21:40553344	G/A	cg11890956	chr21:40555474	PSMG1	-0.7	-5.62	-0.54	2.84e-7	Menarche (age at onset);
SKCM	cis	rs7919656	1.000	rs7919656	chr10:50026020	C/T	cg20434666	chr10:49893406	WDFY4	0.45	4.95	0.49	4.15e-6	Clinically amyopathic dermatomyositis;
SKCM	cis	rs9300255	0.679	rs10846507	chr12:123786492	G/T	cg05973401	chr12:123451056	ABCB9	0.82	5.72	0.54	1.92e-7	Neutrophil percentage of white cells;
SKCM	cis	rs9916302	0.861	rs11658219	chr17:37709782	G/A	cg07936489	chr17:37558343	FBXL20	-0.85	-7.16	-0.63	3.89e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs7143963	0.636	rs7157267	chr14:103350813	T/C	cg23020514	chr14:103360112	TRAF3	0.74	6.99	0.62	8.38e-10	Body mass index;
SKCM	cis	rs2842992	0.830	rs1853259	chr6:160147441	A/G	cg11366901	chr6:160182831	ACAT2	-0.9	-6.99	-0.62	8.17e-10	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs7666738	0.570	rs11097612	chr4:99079772	T/C	cg17366294	chr4:99064904	C4orf37	0.61	5.06	0.5	2.73e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9640161	0.750	rs11764936	chr7:150025915	G/T	cg27494647	chr7:150038898	RARRES2	0.58	4.98	0.49	3.74e-6	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs11105298	0.786	rs10858867	chr12:89851166	C/T	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.88	-6.03	-0.56	5.22e-8	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs1401999	0.966	rs2139560	chr3:183653869	A/G	cg01324343	chr3:183735012	ABCC5	0.9	10.25	0.76	4.24e-16	Anterior chamber depth;
SKCM	cis	rs28735056	0.591	rs62101204	chr18:77712832	G/A	cg20368463	chr18:77673604	PQLC1	0.66	4.97	0.49	3.92e-6	Schizophrenia;
SKCM	cis	rs4243830	0.850	rs12030607	chr1:6601007	T/A	cg22792644	chr1:6614718	TAS1R1;NOL9	1.06	5.63	0.54	2.69e-7	Body mass index;
SKCM	cis	rs6840360	0.571	rs11944139	chr4:152505291	T/C	cg22705602	chr4:152727874	NA	-0.52	-5.58	-0.53	3.28e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs17826219	0.706	rs61643715	chr17:29057762	A/G	cg14067834	chr17:29058358	SUZ12P	1.2	5.77	0.55	1.5e-7	Body mass index;
SKCM	cis	rs11585357	0.895	rs72633812	chr1:17623140	T/C	cg08277548	chr1:17600880	PADI3	-0.89	-6.31	-0.58	1.53e-8	Hair shape;
SKCM	cis	rs2760061	0.599	rs644794	chr1:228148670	T/C	cg02753203	chr1:228287806	NA	-0.6	-4.94	-0.49	4.34e-6	Diastolic blood pressure;
SKCM	cis	rs6089829	0.962	rs6011544	chr20:61658782	T/C	cg08564027	chr20:61660810	NA	0.62	5.55	0.53	3.75e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs1577917	0.740	rs9450302	chr6:86289673	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.89	8.58	0.7	7.11e-13	Response to antipsychotic treatment;
SKCM	cis	rs7100689	0.622	rs1890890	chr10:82090643	A/T	cg01528321	chr10:82214614	TSPAN14	0.76	6.21	0.58	2.39e-8	Post bronchodilator FEV1;
SKCM	cis	rs62238980	0.614	rs76592979	chr22:32413239	G/C	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs4969178	0.930	rs12452576	chr17:76386037	A/C	cg20026190	chr17:76395443	PGS1	0.61	5.08	0.5	2.54e-6	HDL cholesterol levels;
SKCM	cis	rs3087591	0.960	rs9903754	chr17:29634468	G/A	cg24425628	chr17:29625626	OMG;NF1	-0.64	-4.97	-0.49	3.84e-6	Hip circumference;
SKCM	cis	rs9899728	0.539	rs12940199	chr17:73054759	C/T	cg27626185	chr17:73056755	KCTD2	-1.22	-7.67	-0.66	4.17e-11	Alzheimer's disease or small vessel stroke;
SKCM	cis	rs1506636	0.962	rs2896335	chr7:123376855	A/T	cg03229431	chr7:123269106	ASB15	-0.6	-4.83	-0.48	6.69e-6	Plateletcrit;Platelet count;
SKCM	cis	rs11822910	1.000	rs2439448	chr11:57199211	T/C	cg00522883	chr11:57194120	SLC43A3	0.72	6.18	0.57	2.76e-8	Platelet distribution width;
SKCM	cis	rs2952156	0.883	rs2517960	chr17:37846521	T/C	cg20243544	chr17:37824526	PNMT	0.66	5.18	0.51	1.68e-6	Asthma;
SKCM	cis	rs7937682	0.883	rs484834	chr11:111465761	G/C	cg19812747	chr11:111475976	SIK2	-0.61	-4.98	-0.49	3.76e-6	Primary sclerosing cholangitis;
SKCM	cis	rs17065868	1.000	rs17277505	chr13:45105586	A/C	cg10246903	chr13:45222710	NA	0.91	4.85	0.48	6.1e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs6570726	0.935	rs9390329	chr6:145828026	T/C	cg23711669	chr6:146136114	FBXO30	0.73	7.14	0.63	4.25e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs782590	0.783	rs7594279	chr2:55812073	T/G	cg18811423	chr2:55921094	PNPT1	0.87	6.82	0.61	1.71e-9	Metabolic syndrome;
SKCM	cis	rs9399137	0.507	rs7748708	chr6:135275142	G/A	cg24558204	chr6:135376177	HBS1L	0.69	6.37	0.59	1.21e-8	Glycated hemoglobin levels;Mean corpuscular volume;Hematology traits;HbA2 levels;Mean corpuscular hemoglobin;Hemoglobin levels;F-cell distribution;Platelet count;
SKCM	cis	rs208520	0.874	rs208469	chr6:66915891	T/C	cg07460842	chr6:66804631	NA	-0.9	-6.89	-0.61	1.29e-9	Exhaled nitric oxide output;
SKCM	cis	rs1577917	0.958	rs36042496	chr6:86524214	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.81	-0.66	2.19e-11	Response to antipsychotic treatment;
SKCM	cis	rs7523050	0.642	rs12044219	chr1:109481236	T/C	cg08274380	chr1:109419600	GPSM2	1.01	5.12	0.5	2.18e-6	Fat distribution (HIV);
SKCM	cis	rs875971	0.505	rs1723275	chr7:65504633	G/C	cg11987759	chr7:65425863	GUSB	0.76	6.75	0.61	2.34e-9	Aortic root size;
SKCM	cis	rs250677	0.652	rs36042	chr5:148439782	G/T	cg18129178	chr5:148520854	ABLIM3	-0.8	-4.79	-0.48	7.9e-6	Breast cancer;
SKCM	cis	rs4423214	0.959	rs12794668	chr11:71168715	C/T	cg05163923	chr11:71159392	DHCR7	0.82	8.01	0.67	8.84e-12	Vitamin D levels;
SKCM	cis	rs11098499	0.863	rs13149407	chr4:120437825	A/G	cg09307838	chr4:120376055	NA	0.98	7.45	0.64	1.07e-10	Corneal astigmatism;
SKCM	cis	rs7927771	1.000	rs11039255	chr11:47495746	G/T	cg05585544	chr11:47624801	NA	-0.63	-5.5	-0.53	4.73e-7	Subjective well-being;
SKCM	cis	rs362272	0.524	rs13150241	chr4:3367281	A/G	cg21096898	chr4:3318625	RGS12	1.01	12.88	0.82	5.24e-21	Serum sulfate level;
SKCM	cis	rs7247513	0.964	rs4371272	chr19:12711281	A/T	cg01871581	chr19:12707946	ZNF490	-0.68	-4.86	-0.48	6.02e-6	Bipolar disorder;
SKCM	cis	rs8180040	0.966	rs17476234	chr3:47326298	G/A	cg16586182	chr3:47516702	SCAP	0.71	4.85	0.48	6.25e-6	Colorectal cancer;
SKCM	trans	rs561341	1.000	rs113115092	chr17:30284164	G/A	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs7666738	0.830	rs113999196	chr4:99041961	C/T	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs116095464	0.558	rs34629844	chr5:200829	A/G	cg22857025	chr5:266934	NA	-1.44	-7.74	-0.66	2.94e-11	Breast cancer;
SKCM	cis	rs9910055	0.762	rs2240226	chr17:42266218	C/T	cg19774624	chr17:42201019	HDAC5	-0.89	-7.83	-0.66	1.97e-11	Total body bone mineral density;
SKCM	cis	rs57221529	0.713	rs56328416	chr5:591138	G/A	cg09888920	chr5:474111	LOC25845;SLC9A3	0.99	4.79	0.48	7.91e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs9880211	1.000	rs17364492	chr3:136204437	G/T	cg21827317	chr3:136751795	NA	0.64	4.78	0.48	8.21e-6	Body mass index;Height;
SKCM	cis	rs7552404	0.924	rs114752222	chr1:76180878	C/T	cg03433033	chr1:76189801	ACADM	0.77	5.59	0.53	3.23e-7	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs55962025	0.804	rs2071703	chr4:3241413	A/C	cg05297308	chr4:3317976	RGS12	-0.73	-5.36	-0.52	8.37e-7	Parental longevity (mother's age at death);
SKCM	cis	rs1552244	0.872	rs6771931	chr3:10113408	C/G	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs8067545	0.935	rs7209734	chr17:19988543	C/A	cg13482628	chr17:19912719	NA	0.72	5.83	0.55	1.17e-7	Schizophrenia;
SKCM	cis	rs473651	1.000	rs473651	chr2:239335401	A/C	cg18131467	chr2:239335373	ASB1	1.08	13.18	0.83	1.55e-21	Multiple system atrophy;
SKCM	cis	rs1942	1.000	rs1942	chr15:41774423	A/G	cg18705301	chr15:41695430	NDUFAF1	-0.68	-5.17	-0.51	1.74e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs1461503	0.966	rs11218907	chr11:122841562	A/G	cg27398637	chr11:122830231	C11orf63	-0.63	-4.8	-0.48	7.54e-6	Menarche (age at onset);
SKCM	cis	rs6952808	0.929	rs11768206	chr7:1932151	T/G	cg21782813	chr7:2030301	MAD1L1	0.55	5.45	0.53	5.72e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs9914544	0.564	rs1859083	chr17:18843306	C/T	cg26378065	chr17:18585709	ZNF286B	-0.8	-6.36	-0.58	1.27e-8	Educational attainment (years of education);
SKCM	cis	rs763121	0.853	rs138706	chr22:39137834	C/G	cg06022373	chr22:39101656	GTPBP1	0.8	4.94	0.49	4.38e-6	Menopause (age at onset);
SKCM	cis	rs763121	0.889	rs1837988	chr22:38901094	A/G	cg06022373	chr22:39101656	GTPBP1	0.77	5.52	0.53	4.3e-7	Menopause (age at onset);
SKCM	cis	rs11098499	0.954	rs17009122	chr4:120362403	G/A	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs875971	0.660	rs28698552	chr7:66005018	A/G	cg11764359	chr7:65958608	NA	0.86	6.6	0.6	4.52e-9	Aortic root size;
SKCM	cis	rs28595532	0.920	rs114333298	chr4:119765305	C/A	cg14228332	chr4:119757509	SEC24D	1.09	5.6	0.54	3.03e-7	Cannabis dependence symptom count;
SKCM	cis	rs6500395	1.000	rs1420704	chr16:48716902	C/T	cg04672837	chr16:48644449	N4BP1	-0.63	-5.37	-0.52	8.01e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs1799949	1.000	rs8176212	chr17:41226601	G/C	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.06	-0.57	4.62e-8	Menopause (age at onset);
SKCM	cis	rs11690935	0.632	rs11690807	chr2:172628120	G/A	cg13550731	chr2:172543902	DYNC1I2	0.63	5.45	0.52	5.8e-7	Schizophrenia;
SKCM	cis	rs1707322	0.716	rs10890342	chr1:46157087	C/T	cg03146154	chr1:46216737	IPP	0.81	5.62	0.54	2.87e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs17685	0.753	rs2868203	chr7:75680026	G/A	cg01364799	chr7:75623366	TMEM120A	0.72	5.83	0.55	1.18e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7772486	0.875	rs854146	chr6:146341033	A/G	cg05347473	chr6:146136440	FBXO30	0.57	5.18	0.51	1.66e-6	Lobe attachment (rater-scored or self-reported);
SKCM	trans	rs1814175	0.817	rs4881623	chr11:49804991	C/T	cg03929089	chr4:120376271	NA	-0.9	-8.5	-0.69	9.91e-13	Height;
SKCM	cis	rs11098499	0.619	rs28502463	chr4:120257023	T/C	cg09307838	chr4:120376055	NA	0.93	7.53	0.65	7.72e-11	Corneal astigmatism;
SKCM	cis	rs4073582	0.595	rs10896104	chr11:66001869	C/T	cg16950941	chr11:66035639	RAB1B	0.82	7.01	0.62	7.59e-10	Gout;
SKCM	cis	rs2120019	1.000	rs12324912	chr15:75361006	G/A	cg09165964	chr15:75287851	SCAMP5	-0.75	-6.28	-0.58	1.78e-8	Blood trace element (Zn levels);
SKCM	cis	rs9581857	0.547	rs75800999	chr13:28055293	A/G	cg22138327	chr13:27999177	GTF3A	0.92	6.09	0.57	3.94e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs9910055	0.529	rs2523161	chr17:42179405	C/T	cg19774624	chr17:42201019	HDAC5	0.83	6.53	0.59	5.96e-9	Total body bone mineral density;
SKCM	trans	rs1814175	0.817	rs1390676	chr11:50056778	C/T	cg03929089	chr4:120376271	NA	-0.93	-8.8	-0.71	2.63e-13	Height;
SKCM	cis	rs11098499	0.604	rs2389886	chr4:120570422	C/T	cg24375607	chr4:120327624	NA	0.64	4.9	0.49	5.06e-6	Corneal astigmatism;
SKCM	cis	rs9323205	0.577	rs9672038	chr14:51724856	A/G	cg23942311	chr14:51606299	NA	-0.51	-5.62	-0.54	2.87e-7	Cancer;
SKCM	cis	rs79839061	0.520	rs11730111	chr4:942833	C/T	cg07828340	chr4:882639	GAK	0.93	4.97	0.49	3.93e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs769267	0.930	rs3752151	chr19:19616026	T/C	cg03709012	chr19:19516395	GATAD2A	0.89	8.62	0.7	5.89e-13	Tonsillectomy;
SKCM	cis	rs7809950	0.861	rs10264412	chr7:107183877	G/A	cg23024343	chr7:107201750	COG5	-0.87	-8.11	-0.68	5.78e-12	Coronary artery disease;
SKCM	cis	rs11105306	1	rs11105306	chr12:89897388	C/T	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.91	-5.95	-0.56	7.22e-8	NT-proBNP levels in acute coronary syndrome;
SKCM	trans	rs62103177	0.810	rs62103187	chr18:77627633	G/C	cg05926928	chr17:57297772	GDPD1	1.29	8.74	0.7	3.44e-13	Opioid sensitivity;
SKCM	cis	rs12709013	0.792	rs12600206	chr16:58807073	C/T	cg02431531	chr16:59244939	NA	0.48	5.01	0.49	3.26e-6	Blood metabolite ratios;
SKCM	cis	rs2463822	1.000	rs2513744	chr11:62077785	C/A	cg06239285	chr11:62104954	ASRGL1	1.22	5.6	0.54	3.03e-7	Chronic obstructive pulmonary disease-related biomarkers;
SKCM	cis	rs10791097	0.694	rs4937581	chr11:130740335	T/C	cg12179176	chr11:130786555	SNX19	0.93	8.2	0.68	3.79e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs35766269	0.541	rs7478031	chr10:9040571	A/G	cg05671070	chr10:8095960	FLJ45983;GATA3	0.95	4.77	0.48	8.45e-6	Recalcitrant atopic dermatitis;
SKCM	cis	rs28595532	0.920	rs116401323	chr4:119721727	C/T	cg14228332	chr4:119757509	SEC24D	1.07	5.49	0.53	4.77e-7	Cannabis dependence symptom count;
SKCM	cis	rs7954584	0.635	rs7309024	chr12:122338334	C/T	cg21171335	chr12:122356390	WDR66	0.45	4.95	0.49	4.18e-6	Mean corpuscular volume;
SKCM	cis	rs2370759	1.000	rs2225152	chr10:32574759	T/C	cg01819863	chr10:32635814	EPC1	1.05	5.81	0.55	1.27e-7	Sexual dysfunction (female);
SKCM	trans	rs1814175	0.619	rs10769623	chr11:49865926	C/T	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs12986445	0.947	rs6728684	chr2:26150773	T/G	cg04917511	chr2:26785460	C2orf70	0.53	4.93	0.49	4.51e-6	Multiple myeloma and monoclonal gammopathy;Multiple myeloma;
SKCM	cis	rs1691799	0.899	rs1168314	chr12:66746937	A/G	cg16791601	chr12:66731901	HELB	-0.65	-6.09	-0.57	4.07e-8	White blood cell count (basophil);
SKCM	cis	rs25645	0.502	rs17609240	chr17:38110689	T/G	cg17467752	chr17:38218738	THRA	0.65	5.23	0.51	1.41e-6	Myeloid white cell count;
SKCM	cis	rs1707322	0.686	rs2230659	chr1:46078884	C/T	cg03146154	chr1:46216737	IPP	-0.83	-6.17	-0.57	2.83e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs9880211	0.800	rs115050567	chr3:136515659	G/C	cg21827317	chr3:136751795	NA	-0.69	-5.26	-0.51	1.21e-6	Body mass index;Height;
SKCM	cis	rs7100689	0.784	rs7082705	chr10:82170856	C/T	cg01528321	chr10:82214614	TSPAN14	-0.93	-9.58	-0.74	8.3e-15	Post bronchodilator FEV1;
SKCM	cis	rs2811415	0.597	rs11721156	chr3:127796627	C/T	cg09089421	chr3:127803668	RUVBL1	1.0	8.69	0.7	4.4e-13	Lung function (FEV1/FVC);
SKCM	cis	rs7091068	0.550	rs7079013	chr10:95487878	A/C	cg20715218	chr10:95462985	C10orf4	0.76	7.2	0.63	3.2e-10	Urinary tract infection frequency;
SKCM	cis	rs2760061	0.598	rs849904	chr1:228137145	G/C	cg18477163	chr1:228402036	OBSCN	-0.43	-4.86	-0.48	5.88e-6	Diastolic blood pressure;
SKCM	cis	rs2652834	0.950	rs2729789	chr15:63400345	G/A	cg04194852	chr15:63334506	TPM1	0.76	4.78	0.48	8.09e-6	HDL cholesterol;
SKCM	cis	rs2204008	0.720	rs11180923	chr12:38255172	A/T	cg13010199	chr12:38710504	ALG10B	0.69	4.92	0.49	4.72e-6	Bladder cancer;
SKCM	cis	rs2404602	0.692	rs1838048	chr15:76931679	A/G	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs9880211	0.800	rs35422852	chr3:136505915	A/T	cg21827317	chr3:136751795	NA	-0.7	-5.38	-0.52	7.54e-7	Body mass index;Height;
SKCM	cis	rs2204008	0.837	rs11169157	chr12:37980047	T/C	cg13010199	chr12:38710504	ALG10B	0.63	4.83	0.48	6.7e-6	Bladder cancer;
SKCM	cis	rs9880211	1.000	rs34757183	chr3:136143668	G/T	cg21827317	chr3:136751795	NA	-0.65	-4.92	-0.49	4.73e-6	Body mass index;Height;
SKCM	cis	rs1784581	1.000	rs1615717	chr6:162400612	C/T	cg17173639	chr6:162384350	PARK2	-0.6	-5.16	-0.5	1.8e-6	Itch intensity from mosquito bite;
SKCM	cis	rs1801251	1.000	rs2044449	chr2:233718808	G/A	cg08000102	chr2:233561755	GIGYF2	-0.85	-7.04	-0.62	6.74e-10	Coronary artery disease;
SKCM	cis	rs1843834	0.505	rs4674911	chr2:225345254	A/G	cg12698349	chr2:225449008	CUL3	0.84	6.93	0.62	1.09e-9	IgE levels in asthmatics (D.p. specific);
SKCM	cis	rs9796	0.835	rs3100807	chr15:41292206	G/A	cg00616447	chr15:41694635	NDUFAF1	-0.71	-4.97	-0.49	3.83e-6	Menopause (age at onset);
SKCM	cis	rs861020	0.959	rs641348	chr1:209992043	A/G	cg05527609	chr1:210001259	C1orf107	1.02	6.38	0.59	1.17e-8	Orofacial clefts;
SKCM	cis	rs2153535	0.580	rs7767756	chr6:8453428	A/C	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs4727027	0.901	rs4727017	chr7:148822062	A/G	cg23583168	chr7:148888333	NA	-0.82	-6.56	-0.6	5.29e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs11764590	0.694	rs4721359	chr7:2104951	A/G	cg23422044	chr7:1970798	MAD1L1	-0.83	-6.36	-0.58	1.26e-8	Neuroticism;
SKCM	cis	rs1801251	1.000	rs2592102	chr2:233726772	G/T	cg08000102	chr2:233561755	GIGYF2	-0.89	-7.15	-0.63	4.05e-10	Coronary artery disease;
SKCM	cis	rs55794721	0.509	rs6699896	chr1:25762902	A/T	cg27572855	chr1:25598939	RHD	0.53	5.06	0.5	2.67e-6	Plateletcrit;Mean corpuscular volume;
SKCM	cis	rs9911578	0.935	rs7216698	chr17:57007495	G/A	cg12560992	chr17:57184187	TRIM37	0.92	7.21	0.63	3.16e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs6665290	0.870	rs17600725	chr1:227204231	A/G	cg10327440	chr1:227177885	CDC42BPA	-1.21	-15.56	-0.87	1.27e-25	Myeloid white cell count;
SKCM	cis	rs12497850	0.897	rs7373778	chr3:48836392	C/G	cg07636037	chr3:49044803	WDR6	0.97	10.25	0.76	4.16e-16	Parkinson's disease;
SKCM	cis	rs9814567	0.806	rs2293293	chr3:134322742	A/G	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.64	-5.16	-0.5	1.85e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs2153535	0.580	rs7743686	chr6:8526111	A/G	cg23788917	chr6:8435910	SLC35B3	0.68	4.98	0.49	3.66e-6	Motion sickness;
SKCM	cis	rs798554	0.797	rs1182183	chr7:2873136	C/T	cg04166393	chr7:2884313	GNA12	0.67	4.8	0.48	7.51e-6	Height;
SKCM	cis	rs875971	0.660	rs7807944	chr7:66087195	C/G	cg05627663	chr7:65219948	SNORA22;CCT6P1	-0.56	-4.81	-0.48	7.26e-6	Aortic root size;
SKCM	cis	rs7829975	0.500	rs7841082	chr8:8168987	C/T	cg15556689	chr8:8085844	FLJ10661	-0.61	-5.25	-0.51	1.3e-6	Mood instability;
SKCM	cis	rs9788682	1.000	rs7181447	chr15:78814567	A/G	cg24631222	chr15:78858424	CHRNA5	0.94	6.59	0.6	4.67e-9	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs2857078	0.654	rs4793083	chr17:42312973	C/T	cg13607699	chr17:42295918	UBTF	-0.86	-7.13	-0.63	4.36e-10	Red cell distribution width;Reticulocyte count;
SKCM	cis	rs589448	0.902	rs315113	chr12:69786543	G/T	cg14784868	chr12:69753453	YEATS4	-0.83	-7.68	-0.66	3.89e-11	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs6121246	0.609	rs6089054	chr20:30323141	A/G	cg13852791	chr20:30311386	BCL2L1	0.82	5.64	0.54	2.59e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs6430585	0.583	rs79633114	chr2:136586825	C/T	cg07169764	chr2:136633963	MCM6	1.31	13.22	0.83	1.29e-21	Corneal structure;
SKCM	cis	rs4253772	0.637	rs56017104	chr22:46651982	A/G	cg03482458	chr22:46692211	CN5H6.4;GTSE1	1.18	5.01	0.49	3.31e-6	LDL cholesterol;Cholesterol, total;
SKCM	cis	rs950776	0.752	rs62010328	chr15:78894971	C/T	cg06917634	chr15:78832804	PSMA4	0.84	7.0	0.62	7.78e-10	Sudden cardiac arrest;
SKCM	cis	rs801193	0.967	rs2707853	chr7:66214010	G/A	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.56	4.82	0.48	7.04e-6	Aortic root size;
SKCM	cis	rs9300255	0.602	rs1790131	chr12:123701010	G/T	cg00376283	chr12:123451042	ABCB9	0.83	5.49	0.53	4.74e-7	Neutrophil percentage of white cells;
SKCM	cis	rs10880689	1	rs10880689	chr12:37930102	A/G	cg13010199	chr12:38710504	ALG10B	0.63	4.95	0.49	4.18e-6	Resting heart rate;
SKCM	cis	rs780096	0.526	rs780107	chr2:27684734	A/G	cg05696406	chr2:27599888	SNX17	0.51	5.22	0.51	1.46e-6	Total body bone mineral density;
SKCM	cis	rs1005277	0.522	rs289645	chr10:37943642	T/C	cg25427524	chr10:38739819	LOC399744	-0.63	-5.97	-0.56	6.64e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs6089829	0.962	rs11086151	chr20:61664644	C/T	cg08564027	chr20:61660810	NA	0.63	5.65	0.54	2.56e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs1577917	0.958	rs36042496	chr6:86524214	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.33	-0.52	9.19e-7	Response to antipsychotic treatment;
SKCM	cis	rs929354	0.772	rs6459738	chr7:156998532	T/G	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	trans	rs17685	0.784	rs1613890	chr7:75735037	T/C	cg19862616	chr7:65841803	NCRNA00174	0.95	9.02	0.71	9.98e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1552244	1.000	rs34179822	chr3:10140017	A/G	cg02579736	chr3:10068473	FANCD2;CIDECP	1.23	6.92	0.62	1.13e-9	Alzheimer's disease;
SKCM	cis	rs1005277	0.579	rs1740732	chr10:38491385	C/T	cg25427524	chr10:38739819	LOC399744	-0.73	-7.43	-0.64	1.16e-10	Extrinsic epigenetic age acceleration;
SKCM	cis	rs2072499	0.750	rs909269	chr1:156192028	C/T	cg25208724	chr1:156163844	SLC25A44	0.89	6.38	0.59	1.16e-8	Testicular germ cell tumor;
SKCM	cis	rs10870270	0.956	rs11146325	chr10:133767529	A/G	cg17892150	chr10:133769511	PPP2R2D	-0.67	-4.99	-0.49	3.55e-6	Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals;
SKCM	cis	rs6500395	0.926	rs1039343	chr16:48577507	T/G	cg04672837	chr16:48644449	N4BP1	0.7	5.71	0.54	1.92e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs7818345	0.586	rs10481428	chr8:19279447	G/A	cg03393445	chr8:19249545	SH2D4A	0.64	5.78	0.55	1.47e-7	Language performance in older adults (adjusted for episodic memory);
SKCM	cis	rs7618501	0.633	rs2624843	chr3:49997963	G/A	cg05072774	chr3:49840536	C3orf54	-0.66	-5.03	-0.49	3.12e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1018836	0.886	rs10956750	chr8:91621704	G/C	cg16814680	chr8:91681699	NA	-0.64	-4.9	-0.49	5e-6	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs651907	0.640	rs771575	chr3:101619359	G/A	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.75	5.24	0.51	1.34e-6	Colorectal cancer;
SKCM	cis	rs7666738	0.830	rs969048	chr4:98988921	T/C	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7539542	0.556	rs6692075	chr1:202881302	C/T	cg19681188	chr1:202830198	LOC148709	0.72	5.21	0.51	1.52e-6	Mean platelet volume;
SKCM	cis	rs6570726	0.935	rs434298	chr6:145846873	G/A	cg23711669	chr6:146136114	FBXO30	0.69	6.76	0.61	2.23e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7208859	0.623	rs7503542	chr17:29073830	A/C	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs28595532	0.920	rs115084148	chr4:119739290	A/G	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs7408868	0.908	rs10416777	chr19:15276923	C/T	cg14696996	chr19:15285081	NOTCH3	0.82	4.92	0.49	4.7e-6	Pulse pressure;
SKCM	cis	rs910316	1.000	rs175443	chr14:75601963	C/T	cg11812906	chr14:75593930	NEK9	-0.72	-5.45	-0.53	5.72e-7	Height;
SKCM	cis	rs2463822	0.844	rs7104149	chr11:62171627	A/G	cg06239285	chr11:62104954	ASRGL1	-1.06	-5.26	-0.51	1.21e-6	Chronic obstructive pulmonary disease-related biomarkers;
SKCM	cis	rs17065868	1.000	rs9525984	chr13:45149662	G/A	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs736408	0.545	rs6445529	chr3:52662722	T/A	cg18404041	chr3:52824283	ITIH1	-0.53	-4.77	-0.48	8.43e-6	Bipolar disorder;
SKCM	cis	rs71520386	0.607	rs28617621	chr7:22857682	A/G	cg15401507	chr7:22894281	NA	0.67	4.96	0.49	4.03e-6	Fibrinogen levels;
SKCM	cis	rs155076	1.000	rs598754	chr13:21845010	C/A	cg11317459	chr13:21872234	NA	-1.24	-6.91	-0.62	1.19e-9	White matter hyperintensity burden;
SKCM	cis	rs1218582	0.774	rs1007170	chr1:154881461	G/A	cg24250549	chr1:154909240	PMVK	0.82	8.27	0.68	2.82e-12	Prostate cancer;
SKCM	cis	rs875971	0.522	rs1917563	chr7:65415647	C/T	cg18876405	chr7:65276391	NA	-0.84	-7.83	-0.66	1.98e-11	Aortic root size;
SKCM	cis	rs9911578	0.874	rs302865	chr17:56756977	A/G	cg12560992	chr17:57184187	TRIM37	0.91	7.58	0.65	6.07e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs2857078	0.720	rs9906669	chr17:42305706	A/G	cg10896456	chr17:42255109	ASB16;C17orf65	0.54	4.88	0.48	5.61e-6	Red cell distribution width;Reticulocyte count;
SKCM	cis	rs4911259	0.552	rs6057663	chr20:31463071	G/T	cg13636640	chr20:31349939	DNMT3B	-0.74	-6.15	-0.57	3.04e-8	Inflammatory bowel disease;
SKCM	cis	rs6570726	0.935	rs424263	chr6:145840073	A/C	cg23711669	chr6:146136114	FBXO30	0.7	6.64	0.6	3.72e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7536201	0.738	rs6690896	chr1:25305607	G/A	cg24722749	chr1:24969476	SRRM1	0.64	5.03	0.49	3.11e-6	Psoriasis vulgaris;
SKCM	cis	rs651907	0.557	rs11917569	chr3:101355063	G/C	cg12386194	chr3:101231763	SENP7	0.75	6.3	0.58	1.64e-8	Colorectal cancer;
SKCM	cis	rs1348850	0.958	rs1548067	chr2:178462914	C/T	cg02961200	chr2:178257176	LOC100130691;AGPS	0.84	6.61	0.6	4.29e-9	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	trans	rs7618501	1.000	rs6446295	chr3:49809063	G/T	cg21659725	chr3:3221576	CRBN	0.96	9.61	0.74	7.08e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs6087990	0.965	rs2424904	chr20:31352316	T/C	cg13636640	chr20:31349939	DNMT3B	0.95	8.73	0.7	3.68e-13	Ulcerative colitis;
SKCM	cis	rs9788682	1.000	rs9788682	chr15:78802586	A/G	cg06917634	chr15:78832804	PSMA4	0.9	5.26	0.51	1.23e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs72615157	0.595	rs112241539	chr7:99847237	C/T	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.18	7.4	0.64	1.33e-10	Lung function (FEV1/FVC);
SKCM	cis	rs7772486	0.875	rs6909827	chr6:146365738	A/G	cg05347473	chr6:146136440	FBXO30	0.57	5.12	0.5	2.13e-6	Lobe attachment (rater-scored or self-reported);
SKCM	trans	rs1814175	0.616	rs1794139	chr11:49910855	C/T	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs116095464	0.614	rs4371799	chr5:268192	C/A	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs561341	1.000	rs497479	chr17:30328605	C/T	cg23018236	chr17:30244563	NA	-0.54	-5.51	-0.53	4.46e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs2180341	0.842	rs7739679	chr6:127545428	G/A	cg24812749	chr6:127587940	RNF146	0.93	6.75	0.61	2.34e-9	Breast cancer;
SKCM	cis	rs34172651	0.517	rs874484	chr16:24803242	T/C	cg06028605	chr16:24865363	SLC5A11	0.59	4.98	0.49	3.66e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1843834	0.539	rs6749402	chr2:225443901	T/G	cg12698349	chr2:225449008	CUL3	0.88	7.02	0.62	7.26e-10	IgE levels in asthmatics (D.p. specific);
SKCM	cis	rs62064224	0.791	rs72811096	chr17:30647302	A/T	cg18200150	chr17:30822561	MYO1D	0.74	5.94	0.56	7.56e-8	Schizophrenia;
SKCM	trans	rs208520	0.690	rs851468	chr6:66825875	G/A	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-1.09	-8.61	-0.7	6.3e-13	Exhaled nitric oxide output;
SKCM	cis	rs28595532	0.764	rs115011450	chr4:119778171	C/T	cg21605333	chr4:119757512	SEC24D	1.41	8.39	0.69	1.68e-12	Cannabis dependence symptom count;
SKCM	cis	rs867186	1.000	rs7271729	chr20:33610992	C/T	cg04194272	chr20:33683537	NA	-1.38	-7.2	-0.63	3.29e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs2652834	0.904	rs8032506	chr15:63371644	G/A	cg04194852	chr15:63334506	TPM1	-0.75	-5.04	-0.5	2.99e-6	HDL cholesterol;
SKCM	cis	rs12047808	0.841	rs78233610	chr1:179369617	G/A	cg08037922	chr1:179521085	C1orf125;NPHS2	-1.08	-5.8	-0.55	1.32e-7	Multiple sclerosis (age of onset);
SKCM	cis	rs28374715	0.662	rs72737792	chr15:41515589	G/C	cg18705301	chr15:41695430	NDUFAF1	-0.94	-7.84	-0.66	1.88e-11	Ulcerative colitis;
SKCM	cis	rs116095464	0.558	rs7736600	chr5:231337	A/C	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs3784262	0.669	rs4646626	chr15:58256127	C/T	cg12031962	chr15:58353849	ALDH1A2	-0.42	-5.23	-0.51	1.37e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs16866061	1.000	rs72972378	chr2:225372562	A/G	cg02879423	chr2:224806760	WDFY1	0.69	5.02	0.49	3.2e-6	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs9911578	1.000	rs8079774	chr17:56908188	A/G	cg12560992	chr17:57184187	TRIM37	0.94	7.55	0.65	7.01e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs1577917	1.000	rs12205336	chr6:86722367	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.63	-5.38	-0.52	7.46e-7	Response to antipsychotic treatment;
SKCM	cis	rs951366	0.617	rs823075	chr1:205774897	C/T	cg14159672	chr1:205819179	PM20D1	1.06	11.74	0.8	6.36e-19	Menarche (age at onset);
SKCM	cis	rs9911578	1.000	rs2055779	chr17:57030561	A/G	cg12560992	chr17:57184187	TRIM37	0.94	7.55	0.65	7.01e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs367615	0.512	rs246105	chr5:108672946	C/T	cg17395555	chr5:108820864	NA	0.71	5.76	0.55	1.62e-7	Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs9300255	0.510	rs1727322	chr12:123699520	A/G	cg00376283	chr12:123451042	ABCB9	0.8	5.29	0.51	1.08e-6	Neutrophil percentage of white cells;
SKCM	cis	rs9399135	0.967	rs12527683	chr6:135324534	C/T	cg24558204	chr6:135376177	HBS1L	0.59	5.24	0.51	1.32e-6	Red blood cell count;
SKCM	cis	rs7111031	1.000	rs7934649	chr11:113372671	C/T	cg04642306	chr11:112834466	NCAM1	0.46	4.85	0.48	6.15e-6	Subjective well-being (multi-trait analysis);Depressive symptoms (multi-trait analysis);Neuroticism;
SKCM	cis	rs116095464	0.558	rs10076655	chr5:239464	G/C	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	trans	rs1814175	0.817	rs28502006	chr11:50049930	T/C	cg15704280	chr7:45808275	SEPT13	-1.05	-11.07	-0.78	1.14e-17	Height;
SKCM	cis	rs12044355	0.858	rs3738401	chr1:231830295	G/A	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	0.88	6.74	0.61	2.46e-9	Alzheimer's disease;
SKCM	cis	rs9815354	0.812	rs17218441	chr3:41987044	A/G	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs7980687	0.574	rs10744149	chr12:123708490	T/A	cg00376283	chr12:123451042	ABCB9	0.83	5.43	0.52	6.17e-7	Height;Educational attainment;Head circumference (infant);
SKCM	cis	rs854765	0.663	rs1052299	chr17:17750419	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	-1.01	-7.84	-0.66	1.94e-11	Total body bone mineral density;
SKCM	cis	rs763121	0.853	rs9610986	chr22:39025277	T/C	cg06022373	chr22:39101656	GTPBP1	0.72	4.96	0.49	4.08e-6	Menopause (age at onset);
SKCM	cis	rs1065656	0.553	rs344357	chr16:1836255	C/G	cg26897989	chr16:1907736	C16orf73	-0.56	-5.74	-0.54	1.74e-7	Insulin-like growth factors;
SKCM	cis	rs3820068	0.603	rs67349836	chr1:15966176	T/C	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs2439831	0.867	rs3809481	chr15:43662829	G/A	cg02155558	chr15:43621948	ADAL;LCMT2	1.43	8.5	0.69	1.02e-12	Lung cancer in ever smokers;
SKCM	cis	rs3135063	0.847	rs1138690	chr4:3291401	G/T	cg24015175	chr4:3319247	RGS12	0.56	5.43	0.52	6.21e-7	Blood protein levels;
SKCM	cis	rs4771122	0.697	rs1475220	chr13:28037448	G/C	cg22138327	chr13:27999177	GTF3A	-0.89	-6.57	-0.6	5.21e-9	Body mass index;
SKCM	cis	rs1707322	0.963	rs12022335	chr1:46402732	C/A	cg03146154	chr1:46216737	IPP	0.77	5.36	0.52	8.35e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs6977660	0.714	rs12536561	chr7:19816659	G/A	cg07541023	chr7:19748670	TWISTNB	0.72	4.78	0.48	7.95e-6	Thyroid stimulating hormone;
SKCM	cis	rs12497850	0.931	rs9840684	chr3:48893780	T/C	cg07636037	chr3:49044803	WDR6	1.01	10.82	0.77	3.36e-17	Parkinson's disease;
SKCM	cis	rs763014	0.931	rs2071982	chr16:630405	T/G	cg07343612	chr16:622815	PIGQ	-0.7	-6.0	-0.56	5.84e-8	Height;
SKCM	cis	rs2479724	0.870	rs3747753	chr6:41753380	G/T	cg17623882	chr6:41773611	USP49	0.78	6.91	0.62	1.19e-9	Menarche (age at onset);
SKCM	cis	rs6835098	1.000	rs6814857	chr4:174082805	T/A	cg08422745	chr4:174089978	GALNT7	-0.83	-6.3	-0.58	1.63e-8	Dementia and core Alzheimer's disease neuropathologic changes;
SKCM	cis	rs8180040	0.966	rs12636851	chr3:47463567	C/T	cg27129171	chr3:47204927	SETD2	0.79	5.79	0.55	1.43e-7	Colorectal cancer;
SKCM	cis	rs8017423	0.967	rs4904663	chr14:90729565	G/T	cg04374321	chr14:90722782	PSMC1	1.0	9.0	0.71	1.09e-13	Mortality in heart failure;
SKCM	cis	rs684232	0.835	rs1833459	chr17:562244	C/T	cg20012309	chr17:1538416	SCARF1	0.5	5.09	0.5	2.4e-6	Prostate cancer;
SKCM	cis	rs2739330	0.587	rs4820571	chr22:24242973	A/G	cg12419862	chr22:24373484	LOC391322	-0.68	-5.92	-0.56	8.27e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs6580649	1.000	rs10783227	chr12:48400617	C/T	cg05342945	chr12:48394962	COL2A1	-0.73	-5.4	-0.52	7.06e-7	Lung cancer;
SKCM	cis	rs10927875	0.597	rs61782184	chr1:16150976	G/A	cg21385522	chr1:16154831	NA	-1.0	-12.12	-0.81	1.28e-19	Dilated cardiomyopathy;
SKCM	cis	rs4862750	0.872	rs13143414	chr4:187878213	G/A	cg10295955	chr4:187884368	NA	-1.04	-14.07	-0.85	4.23e-23	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6952808	1.000	rs4719319	chr7:1888094	G/A	cg02951883	chr7:2050386	MAD1L1	-0.71	-5.35	-0.52	8.61e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs16949788	1.000	rs16949793	chr15:66593948	A/G	cg08120210	chr15:66682733	MAP2K1	0.74	5.82	0.55	1.23e-7	Spherical equivalent (joint analysis main effects and education interaction);
SKCM	cis	rs17376456	0.877	rs12374463	chr5:93483569	C/G	cg25358565	chr5:93447407	FAM172A	1.23	7.97	0.67	1.08e-11	Diabetic retinopathy;
SKCM	cis	rs11719291	0.667	rs9877542	chr3:48748545	C/T	cg00383909	chr3:49044727	WDR6	0.89	5.09	0.5	2.44e-6	Cognitive function;
SKCM	cis	rs433852	0.718	rs550455	chr19:49136515	A/G	cg06530960	chr19:49140787	SEC1;DBP	-0.8	-5.91	-0.56	8.35e-8	Elevated serum carcinoembryonic antigen levels;Posterior cortical atrophy and Alzheimer's disease;
SKCM	cis	rs926938	0.520	rs6671984	chr1:115257521	C/T	cg12756093	chr1:115239321	AMPD1	-0.73	-5.59	-0.53	3.26e-7	Autism;
SKCM	cis	rs1552244	0.935	rs41520445	chr3:10153141	A/C	cg02579736	chr3:10068473	FANCD2;CIDECP	-1.23	-6.92	-0.62	1.13e-9	Alzheimer's disease;
SKCM	cis	rs1005277	0.579	rs1780139	chr10:38503018	C/T	cg25427524	chr10:38739819	LOC399744	-0.69	-6.79	-0.61	1.96e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs589448	0.867	rs623853	chr12:69753830	G/A	cg22834771	chr12:69754056	YEATS4	-0.71	-5.79	-0.55	1.39e-7	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs10540	1.000	rs35255804	chr11:492617	G/A	cg03576123	chr11:487126	PTDSS2	-1.41	-7.85	-0.66	1.82e-11	Body mass index;
SKCM	cis	rs4132509	1.000	rs10927040	chr1:243731693	T/C	cg21452805	chr1:244014465	NA	0.74	4.92	0.49	4.77e-6	RR interval (heart rate);
SKCM	cis	rs8017423	1.000	rs4900028	chr14:90685594	C/T	cg04374321	chr14:90722782	PSMC1	0.95	8.38	0.69	1.69e-12	Mortality in heart failure;
SKCM	cis	rs9910055	0.718	rs7212854	chr17:42254417	A/G	cg10896456	chr17:42255109	ASB16;C17orf65	0.66	6.43	0.59	9.35e-9	Total body bone mineral density;
SKCM	cis	rs4332037	0.539	rs11764590	chr7:2032803	C/T	cg23422044	chr7:1970798	MAD1L1	-0.92	-5.87	-0.55	1.02e-7	Bipolar disorder;
SKCM	cis	rs2832191	0.632	rs2246777	chr21:30309586	T/C	cg24692254	chr21:30365293	RNF160	-0.98	-9.31	-0.73	2.76e-14	Dental caries;
SKCM	cis	rs4664308	0.967	rs17241792	chr2:160915205	C/T	cg03641300	chr2:160917029	PLA2R1	-0.63	-4.81	-0.48	7.36e-6	Idiopathic membranous nephropathy;
SKCM	cis	rs763014	0.898	rs4984669	chr16:624713	C/T	cg07343612	chr16:622815	PIGQ	-0.69	-5.73	-0.54	1.84e-7	Height;
SKCM	cis	rs644799	1.000	rs617999	chr11:95589935	A/G	cg03916912	chr11:95522834	CEP57;FAM76B	0.87	6.76	0.61	2.27e-9	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs2980439	0.818	rs2945249	chr8:8094726	G/A	cg15556689	chr8:8085844	FLJ10661	0.86	7.03	0.62	6.77e-10	Neuroticism;
SKCM	cis	rs1577917	0.538	rs7755996	chr6:86423720	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.85	7.64	0.65	4.77e-11	Response to antipsychotic treatment;
SKCM	cis	rs10504073	0.669	rs341799	chr8:50036574	A/G	cg00325661	chr8:49890786	NA	0.8	6.91	0.62	1.16e-9	Blood metabolite ratios;
SKCM	cis	rs1577917	1.000	rs12204365	chr6:86700532	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.64	-5.54	-0.53	3.92e-7	Response to antipsychotic treatment;
SKCM	cis	rs7811142	0.830	rs11765869	chr7:99964789	T/G	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.05	5.92	0.56	8.02e-8	Platelet count;
SKCM	trans	rs3780486	0.522	rs1328898	chr9:33163271	A/G	cg04842962	chr6:43655489	MRPS18A	0.82	8.05	0.67	7.51e-12	IgG glycosylation;
SKCM	trans	rs877282	0.891	rs11253393	chr10:788824	G/T	cg22713356	chr15:30763199	NA	1.35	7.57	0.65	6.52e-11	Uric acid levels;
SKCM	cis	rs950776	0.667	rs57728226	chr15:78929350	G/C	cg06917634	chr15:78832804	PSMA4	0.71	5.12	0.5	2.17e-6	Sudden cardiac arrest;
SKCM	cis	rs7666738	0.791	rs10033994	chr4:98969582	C/T	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9910055	0.762	rs7213436	chr17:42252163	A/G	cg13607699	chr17:42295918	UBTF	-0.79	-6.25	-0.58	2.03e-8	Total body bone mineral density;
SKCM	cis	rs11098499	0.708	rs11732686	chr4:120252330	C/A	cg09307838	chr4:120376055	NA	0.91	7.36	0.64	1.63e-10	Corneal astigmatism;
SKCM	cis	rs6430585	0.528	rs309154	chr2:136726567	C/T	cg07169764	chr2:136633963	MCM6	1.31	11.38	0.79	3.01e-18	Corneal structure;
SKCM	cis	rs1799949	1.000	rs34059614	chr17:41303071	C/T	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.11	-0.57	3.67e-8	Menopause (age at onset);
SKCM	cis	rs2832191	0.597	rs8127842	chr21:30516461	G/A	cg24692254	chr21:30365293	RNF160	-0.76	-6.41	-0.59	1.03e-8	Dental caries;
SKCM	cis	rs2204008	0.604	rs11172718	chr12:38069819	T/C	cg26384229	chr12:38710491	ALG10B	0.81	6.83	0.61	1.69e-9	Bladder cancer;
SKCM	cis	rs2370759	1.000	rs7910776	chr10:32639093	C/T	cg01819863	chr10:32635814	EPC1	0.8	4.77	0.48	8.43e-6	Sexual dysfunction (female);
SKCM	cis	rs854765	0.647	rs9303144	chr17:17977355	T/C	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.88	6.62	0.6	4.16e-9	Total body bone mineral density;
SKCM	cis	rs34172651	0.517	rs2547040	chr16:24736408	G/C	cg00339695	chr16:24857497	SLC5A11	-0.81	-6.52	-0.59	6.26e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs9443189	0.855	rs1321161	chr6:76454182	G/A	cg01950844	chr6:76311363	SENP6	-0.77	-5.31	-0.52	9.96e-7	Prostate cancer;
SKCM	cis	rs644799	0.931	rs496305	chr11:95567035	C/T	cg03916912	chr11:95522834	CEP57;FAM76B	0.88	7.53	0.65	7.59e-11	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs2839186	0.749	rs62226488	chr21:47710517	C/T	cg13126279	chr21:47581558	C21orf56	-0.64	-5.47	-0.53	5.17e-7	Testicular germ cell tumor;
SKCM	cis	rs6977660	1.000	rs13233821	chr7:19813637	A/C	cg07541023	chr7:19748670	TWISTNB	0.72	5.03	0.5	3.01e-6	Thyroid stimulating hormone;
SKCM	cis	rs867186	1.000	rs8121957	chr20:33676109	T/C	cg04194272	chr20:33683537	NA	-1.38	-7.2	-0.63	3.29e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs72634258	0.842	rs4908727	chr1:8163122	C/T	cg00042356	chr1:8021962	PARK7	0.87	5.8	0.55	1.37e-7	Inflammatory bowel disease;
SKCM	cis	rs4332037	0.624	rs56256289	chr7:1892529	C/T	cg23422044	chr7:1970798	MAD1L1	-0.88	-5.65	-0.54	2.56e-7	Bipolar disorder;
SKCM	cis	rs1577917	0.839	rs12216103	chr6:86571128	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.69	-6.15	-0.57	3.1e-8	Response to antipsychotic treatment;
SKCM	cis	rs6089584	0.893	rs6089305	chr20:60571817	T/C	cg06108461	chr20:60628389	TAF4	-0.84	-7.42	-0.64	1.21e-10	Body mass index;
SKCM	trans	rs1814175	0.904	rs7924371	chr11:49620595	C/T	cg15704280	chr7:45808275	SEPT13	-1.0	-9.43	-0.73	1.61e-14	Height;
SKCM	cis	rs8014204	0.544	rs2286913	chr14:75386576	G/A	cg06637938	chr14:75390232	RPS6KL1	0.93	6.67	0.6	3.27e-9	Caffeine consumption;
SKCM	cis	rs1003719	0.762	rs4399800	chr21:38489478	G/T	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs6582630	0.519	rs8189461	chr12:38374870	G/T	cg26384229	chr12:38710491	ALG10B	0.81	6.56	0.6	5.29e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs10800309	0.667	rs10157489	chr1:161463019	A/G	cg07967677	chr1:161008977	TSTD1	0.51	5.41	0.52	6.59e-7	Inflammatory bowel disease;Ulcerative colitis;
SKCM	cis	rs8017423	0.967	rs6575120	chr14:90725094	C/T	cg04374321	chr14:90722782	PSMC1	1.01	8.9	0.71	1.66e-13	Mortality in heart failure;
SKCM	cis	rs4774899	0.966	rs10518899	chr15:57491182	G/A	cg01857019	chr15:57210107	LOC145783;TCF12	0.54	4.88	0.48	5.49e-6	Urinary tract infection frequency;
SKCM	cis	rs72945132	0.562	rs7951959	chr11:70234272	A/G	cg14191688	chr11:70257035	CTTN	0.83	4.77	0.48	8.32e-6	Coronary artery disease;
SKCM	cis	rs2295499	0.643	rs4690088	chr4:2698865	C/T	cg19433769	chr4:2420260	ZFYVE28	0.71	5.14	0.5	2e-6	Cognitive ability;Cognitive ability (multi-trait analysis);Intelligence (multi-trait analysis);
SKCM	cis	rs11792861	0.591	rs4978763	chr9:111728067	C/T	cg14432460	chr9:111696404	IKBKAP;C9orf6	0.77	6.62	0.6	4.08e-9	Menarche (age at onset);
SKCM	cis	rs1707322	0.721	rs4431884	chr1:46101323	C/T	cg03146154	chr1:46216737	IPP	0.82	6.1	0.57	3.89e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs588177	1.000	rs588177	chr11:64024056	C/A	cg02228329	chr11:64053129	BAD;GPR137	0.81	5.22	0.51	1.42e-6	High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs7666738	0.830	rs11097605	chr4:98985167	T/C	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10716631	1	rs10716631	chr2:219138170	T/G	cg00012203	chr2:219082015	ARPC2	0.82	6.96	0.62	9.29e-10	High light scatter reticulocyte percentage of red cells;Plateletcrit;
SKCM	cis	rs523522	0.962	rs3759394	chr12:120933173	C/A	cg27279351	chr12:120934652	DYNLL1	0.91	8.32	0.69	2.26e-12	High light scatter reticulocyte count;
SKCM	cis	rs7927771	0.864	rs11600581	chr11:47448497	T/C	cg05585544	chr11:47624801	NA	-0.56	-4.79	-0.48	7.65e-6	Subjective well-being;
SKCM	cis	rs12142240	0.698	rs17357621	chr1:46807697	C/T	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs7584330	0.955	rs7581882	chr2:238390745	T/C	cg14458575	chr2:238380390	NA	0.98	6.49	0.59	7.27e-9	Prostate cancer;
SKCM	cis	rs752010	0.543	rs1570355	chr1:42042317	C/T	cg06885757	chr1:42089581	HIVEP3	0.55	6.52	0.59	6.28e-9	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs6131100	1.000	rs6131096	chr20:10417511	A/G	cg06433879	chr20:10200138	SNAP25	1.19	4.84	0.48	6.48e-6	Fasting blood glucose adjusted for BMI;
SKCM	cis	rs2839186	0.967	rs4819222	chr21:47707778	G/A	cg05896524	chr21:47604654	C21orf56	0.69	5.67	0.54	2.29e-7	Testicular germ cell tumor;
SKCM	cis	rs7843479	0.898	rs4311656	chr8:21802276	T/G	cg17168535	chr8:21777572	XPO7	0.71	5.49	0.53	4.77e-7	Mean corpuscular volume;
SKCM	cis	rs28374715	0.532	rs316606	chr15:41772202	A/C	cg18705301	chr15:41695430	NDUFAF1	-1.16	-12.35	-0.81	4.82e-20	Ulcerative colitis;
SKCM	cis	rs2404602	1.000	rs4886818	chr15:76880939	G/A	cg23625390	chr15:77176239	SCAPER	0.76	7.48	0.65	9.68e-11	Blood metabolite levels;
SKCM	cis	rs1401796	1	rs1401796	chr17:54839759	G/T	cg24778909	chr17:54670875	NOG	0.64	4.85	0.48	6.11e-6	Height;
SKCM	cis	rs847649	1.000	rs9718453	chr7:102594976	T/G	cg18108683	chr7:102477205	FBXL13	0.82	8.63	0.7	5.57e-13	Morning vs. evening chronotype;
SKCM	cis	rs2739330	0.760	rs5760095	chr22:24247293	A/G	cg04234412	chr22:24373322	LOC391322	-0.66	-5.42	-0.52	6.36e-7	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs2070488	1.000	rs36006749	chr3:38443312	T/C	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.97	9.14	0.72	5.9e-14	Electrocardiographic conduction measures;
SKCM	cis	rs4523957	0.583	rs8067895	chr17:2030234	G/A	cg16513277	chr17:2031491	SMG6	-0.91	-6.21	-0.58	2.38e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	trans	rs561341	1.000	rs72821952	chr17:30248133	T/A	cg20587970	chr11:113659929	NA	-1.19	-9.97	-0.75	1.44e-15	Hip circumference adjusted for BMI;
SKCM	cis	rs4819052	1.000	rs733738	chr21:46666396	A/G	cg20896738	chr21:46707857	POFUT2;LOC642852	-0.73	-5.09	-0.5	2.44e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs1577917	1.000	rs12203493	chr6:86758642	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.83	-8.14	-0.68	5.09e-12	Response to antipsychotic treatment;
SKCM	cis	rs17826219	0.706	rs8075107	chr17:29106649	C/A	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Body mass index;
SKCM	cis	rs10540	1.000	rs61876342	chr11:496193	T/G	cg03576123	chr11:487126	PTDSS2	-1.43	-8.14	-0.68	5.08e-12	Body mass index;
SKCM	cis	rs2901656	0.677	rs1063412	chr1:172410967	G/A	cg03748243	chr1:172413542	C1orf105;PIGC	0.49	4.78	0.48	8.23e-6	Red cell distribution width;Platelet distribution width;
SKCM	cis	rs4891159	0.790	rs35516239	chr18:74129942	C/T	cg24786174	chr18:74118243	ZNF516	-0.74	-7.05	-0.62	6.2e-10	Longevity;
SKCM	cis	rs11098499	0.863	rs2291185	chr4:120434833	C/A	cg24375607	chr4:120327624	NA	0.7	5.37	0.52	7.82e-7	Corneal astigmatism;
SKCM	cis	rs763014	0.865	rs4006748	chr16:632225	T/C	cg07343612	chr16:622815	PIGQ	-0.7	-6.0	-0.56	5.84e-8	Height;
SKCM	cis	rs12134245	0.719	rs61798831	chr1:91996588	C/T	cg02896835	chr1:92012615	NA	-0.66	-6.27	-0.58	1.82e-8	Breast cancer;
SKCM	cis	rs2034088	0.897	rs12452970	chr17:444517	T/C	cg06217071	chr17:408420	NA	0.49	5.41	0.52	6.64e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs10489202	1.000	rs12727036	chr1:167972147	A/G	cg24449463	chr1:168025552	DCAF6	-0.78	-5.84	-0.55	1.15e-7	Schizophrenia;
SKCM	cis	rs11098499	0.866	rs3756156	chr4:120524841	G/A	cg24375607	chr4:120327624	NA	0.66	5.19	0.51	1.64e-6	Corneal astigmatism;
SKCM	cis	rs7811142	0.830	rs11765869	chr7:99964789	T/G	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.19	7.5	0.65	8.66e-11	Platelet count;
SKCM	cis	rs12709013	0.792	rs1646270	chr16:58779727	T/C	cg02431531	chr16:59244939	NA	0.49	5.13	0.5	2.03e-6	Blood metabolite ratios;
SKCM	cis	rs12497850	0.931	rs7636057	chr3:48992582	C/T	cg06212747	chr3:49208901	KLHDC8B	0.68	4.9	0.49	5.06e-6	Parkinson's disease;
SKCM	cis	rs10905065	0.898	rs2892078	chr10:5831138	A/G	cg09234995	chr10:5726438	C10orf18	0.65	5.72	0.54	1.91e-7	Menopause (age at onset);
SKCM	cis	rs933688	1.000	rs6452953	chr5:90723034	T/G	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.94	6.54	0.6	5.73e-9	Smoking behavior;
SKCM	cis	rs9815354	0.812	rs73069208	chr3:41939198	C/T	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs11249608	0.636	rs13361077	chr5:178449174	G/C	cg21905437	chr5:178450457	ZNF879	0.71	6.0	0.56	5.9e-8	Pubertal anthropometrics;
SKCM	cis	rs4924935	1.000	rs1737947	chr17:18831432	A/G	cg26378065	chr17:18585709	ZNF286B	-0.74	-5.49	-0.53	4.82e-7	Pancreatic cancer;
SKCM	cis	rs1577917	0.917	rs1579886	chr6:86557191	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.32	-0.52	9.66e-7	Response to antipsychotic treatment;
SKCM	cis	rs10791097	0.694	rs12361892	chr11:130744490	T/G	cg12179176	chr11:130786555	SNX19	0.93	8.16	0.68	4.64e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs4975616	0.836	rs460073	chr5:1336459	T/C	cg07493874	chr5:1342172	CLPTM1L	-0.7	-6.57	-0.6	5.12e-9	Lung cancer;
SKCM	cis	rs1799949	0.931	rs34410138	chr17:41279770	A/G	cg23758822	chr17:41437982	NA	0.92	7.8	0.66	2.3e-11	Menopause (age at onset);
SKCM	cis	rs10504073	0.584	rs1511365	chr8:49975321	A/T	cg00325661	chr8:49890786	NA	0.81	6.96	0.62	9.37e-10	Blood metabolite ratios;
SKCM	cis	rs1707322	1.000	rs1588663	chr1:46548825	G/A	cg03146154	chr1:46216737	IPP	-0.81	-5.43	-0.52	6.11e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs9894429	0.621	rs7502337	chr17:79588470	T/C	cg18240062	chr17:79603768	NPLOC4	0.7	5.92	0.56	8.21e-8	Eye color traits;
SKCM	cis	rs1692580	0.846	rs377599	chr1:2164699	C/T	cg24578937	chr1:2090814	PRKCZ	0.48	5.21	0.51	1.51e-6	Coronary artery disease;
SKCM	cis	rs8082590	1	rs8082590	chr17:17958402	G/A	cg04398451	chr17:18023971	MYO15A	0.84	6.78	0.61	2.05e-9	Schizophrenia;
SKCM	cis	rs13118159	0.509	rs4974556	chr4:1358141	G/C	cg16405210	chr4:1374714	KIAA1530	-0.94	-7.07	-0.62	5.87e-10	Longevity;
SKCM	cis	rs75920871	0.588	rs1815788	chr11:116834971	T/C	cg01368799	chr11:117014884	PAFAH1B2	-0.64	-5.14	-0.5	1.97e-6	Subjective well-being;
SKCM	cis	rs6500602	1.000	rs12447826	chr16:4464617	T/C	cg09069446	chr16:4462122	CORO7	-0.46	-4.8	-0.48	7.56e-6	Schizophrenia;
SKCM	cis	rs12477438	0.520	rs6542866	chr2:99764592	T/C	cg14399236	chr2:99771627	LIPT1;TSGA10	0.95	8.41	0.69	1.48e-12	Chronic sinus infection;
SKCM	cis	rs7937682	0.924	rs875257	chr11:111530453	A/G	cg09085632	chr11:111637200	PPP2R1B	-1.05	-12.29	-0.81	6.25e-20	Primary sclerosing cholangitis;
SKCM	cis	rs362296	0.698	rs3135171	chr4:3261127	A/G	cg11471262	chr4:3318911	RGS12	-0.79	-7.34	-0.64	1.78e-10	Parental longevity (mother's age at death);
SKCM	cis	rs2477686	0.526	rs2477690	chr1:2395563	G/A	cg12929805	chr1:2399054	NA	-0.55	-5.64	-0.54	2.64e-7	Non-obstructive azoospermia;
SKCM	cis	rs2228479	0.850	rs62052660	chr16:89847420	T/A	cg06558623	chr16:89946397	TCF25	1.06	4.86	0.48	5.99e-6	Skin colour saturation;
SKCM	cis	rs7605378	0.528	rs281791	chr2:200850402	A/G	cg23649088	chr2:200775458	C2orf69	-0.68	-5.35	-0.52	8.4e-7	Osteoporosis;
SKCM	trans	rs1814175	0.715	rs11040586	chr11:49858432	T/A	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs6952808	0.723	rs11765550	chr7:2027324	G/A	cg02951883	chr7:2050386	MAD1L1	-0.85	-7.59	-0.65	5.94e-11	Bipolar disorder and schizophrenia;
SKCM	cis	rs4819052	0.851	rs7281263	chr21:46695606	T/C	cg02159808	chr21:46707872	POFUT2;LOC642852	0.74	5.68	0.54	2.22e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs1799949	1.000	rs8176269	chr17:41213626	G/T	cg05368731	chr17:41323189	NBR1	0.9	7.94	0.67	1.23e-11	Menopause (age at onset);
SKCM	cis	rs854765	0.547	rs2955385	chr17:17939247	C/T	cg04398451	chr17:18023971	MYO15A	-0.94	-7.53	-0.65	7.5e-11	Total body bone mineral density;
SKCM	cis	rs36093844	0.527	rs55791429	chr11:85761906	T/C	cg25872744	chr11:85566296	CCDC83	-0.81	-4.79	-0.48	7.71e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs854765	0.693	rs11657074	chr17:17770355	G/A	cg24612305	chr17:17875800	TOM1L2;LRRC48	-0.99	-8.56	-0.7	7.73e-13	Total body bone mineral density;
SKCM	cis	rs6952808	1.000	rs6954521	chr7:1886865	C/A	cg02951883	chr7:2050386	MAD1L1	-0.71	-5.35	-0.52	8.61e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs7666738	0.830	rs7664305	chr4:99037691	G/A	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7772486	0.875	rs9373483	chr6:146364194	A/G	cg05347473	chr6:146136440	FBXO30	0.57	5.12	0.5	2.13e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs28386778	0.897	rs2584608	chr17:61936710	A/G	cg01411255	chr17:61851458	DDX42;CCDC47	0.79	5.1	0.5	2.35e-6	Prudent dietary pattern;
SKCM	cis	rs9581857	0.579	rs2780341	chr13:27996401	C/T	cg22138327	chr13:27999177	GTF3A	-0.95	-6.38	-0.59	1.14e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs4332037	0.575	rs55952733	chr7:2070680	G/A	cg23422044	chr7:1970798	MAD1L1	-0.91	-6.07	-0.57	4.38e-8	Bipolar disorder;
SKCM	cis	rs8180040	0.966	rs13072802	chr3:47346415	G/C	cg27129171	chr3:47204927	SETD2	0.87	6.62	0.6	4.15e-9	Colorectal cancer;
SKCM	cis	rs11858159	0.546	rs8036910	chr15:24813454	T/G	cg24138476	chr15:25312939	SNORD116-5;SNORD116-7	0.56	4.86	0.48	6.06e-6	Platelet thrombus formation;
SKCM	cis	rs28595532	0.841	rs114976553	chr4:119496056	A/G	cg14228332	chr4:119757509	SEC24D	0.97	4.92	0.49	4.71e-6	Cannabis dependence symptom count;
SKCM	cis	rs523522	0.962	rs670568	chr12:121021206	C/T	cg27279351	chr12:120934652	DYNLL1	0.91	8.36	0.69	1.88e-12	High light scatter reticulocyte count;
SKCM	cis	rs1499614	1.000	rs1638731	chr7:66144679	C/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Gout;
SKCM	cis	rs1005277	0.603	rs1998062	chr10:38457652	G/C	cg00409905	chr10:38381863	ZNF37A	-0.67	-6.22	-0.58	2.33e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs17376456	0.825	rs35426871	chr5:93291613	C/T	cg25358565	chr5:93447407	FAM172A	1.24	6.76	0.61	2.23e-9	Diabetic retinopathy;
SKCM	cis	rs5769765	1.000	rs4824106	chr22:50267822	T/C	cg22709217	chr22:50311962	ALG12;CRELD2	0.79	5.71	0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs9388451	0.839	rs4897155	chr6:126095144	C/A	cg05901451	chr6:126070800	HEY2	-0.74	-6.54	-0.6	5.79e-9	Brugada syndrome;
SKCM	cis	rs9443189	0.570	rs7770824	chr6:76408189	G/A	cg01950844	chr6:76311363	SENP6	0.98	6.54	0.59	5.95e-9	Prostate cancer;
SKCM	cis	rs6582630	0.519	rs1607882	chr12:38361657	G/A	cg26384229	chr12:38710491	ALG10B	0.79	6.56	0.6	5.34e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs58688157	0.592	rs12803048	chr11:584243	C/T	cg17114584	chr11:613792	IRF7	0.86	5.74	0.54	1.74e-7	Systemic lupus erythematosus;
SKCM	cis	rs6450176	1.000	rs6450176	chr5:53298025	G/A	ch.5.1024479R	chr5:53302184	ARL15	-0.73	-5.04	-0.5	2.91e-6	HDL cholesterol levels;HDL cholesterol;Adiponectin levels;
SKCM	cis	rs701145	0.585	rs454837	chr3:153915417	T/C	cg17054900	chr3:154042577	DHX36	1.25	5.36	0.52	8.3e-7	Coronary artery disease;
SKCM	cis	rs10193935	0.786	rs13399052	chr2:42385151	G/A	cg27598129	chr2:42591480	NA	-0.92	-6.79	-0.61	1.97e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10212363	0.713	rs62272107	chr3:101895225	C/T	cg09399236	chr3:101293650	PCNP	-0.65	-4.79	-0.48	7.75e-6	Waist-to-hip circumference ratio (alcohol intake interaction);
SKCM	cis	rs9796	0.870	rs2925342	chr15:41305733	A/G	cg00616447	chr15:41694635	NDUFAF1	-0.71	-4.97	-0.49	3.83e-6	Menopause (age at onset);
SKCM	cis	rs9815354	0.597	rs80066790	chr3:42000843	A/G	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs7811142	0.945	rs34989573	chr7:100097895	C/T	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.21	7.59	0.65	5.9e-11	Platelet count;
SKCM	cis	rs17685	0.753	rs7788763	chr7:75651665	T/C	cg16684958	chr7:75615977	POR	-0.56	-5.31	-0.52	9.96e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs832540	0.898	rs331498	chr5:56249842	C/G	cg03609598	chr5:56110824	MAP3K1	0.68	5.22	0.51	1.47e-6	Coronary artery disease;
SKCM	cis	rs801193	1.000	rs13239306	chr7:66136017	T/G	cg11987759	chr7:65425863	GUSB	0.65	5.74	0.54	1.76e-7	Aortic root size;
SKCM	cis	rs2404602	0.692	rs1471780	chr15:77026526	T/C	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs6582630	0.574	rs12146797	chr12:38436499	T/C	cg26384229	chr12:38710491	ALG10B	0.82	6.3	0.58	1.6e-8	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs2153535	0.580	rs4960423	chr6:8477210	C/T	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs763121	0.849	rs12004	chr22:38877461	T/G	cg06022373	chr22:39101656	GTPBP1	0.74	5.32	0.52	9.65e-7	Menopause (age at onset);
SKCM	cis	rs2033711	0.818	rs4801595	chr19:58978517	G/A	cg12042659	chr19:58951599	ZNF132	0.75	6.61	0.6	4.39e-9	Uric acid clearance;
SKCM	cis	rs362296	0.698	rs3095073	chr4:3263138	C/T	cg09735869	chr4:3319127	RGS12	-0.72	-6.51	-0.59	6.5e-9	Parental longevity (mother's age at death);
SKCM	cis	rs2032447	0.531	rs428469	chr6:25898624	G/A	cg18357526	chr6:26021779	HIST1H4A	0.74	5.16	0.5	1.81e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2180341	1.000	rs9321073	chr6:127609691	C/T	cg27446573	chr6:127587934	RNF146	1.0	8.68	0.7	4.48e-13	Breast cancer;
SKCM	cis	rs72781680	0.611	rs72783605	chr2:24287864	A/G	cg20701182	chr2:24300061	SF3B14	0.73	5.09	0.5	2.43e-6	Lymphocyte counts;
SKCM	cis	rs2731664	0.792	rs2731662	chr5:176872494	C/T	cg23176889	chr5:176863531	GRK6	0.49	4.89	0.48	5.33e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1957429	0.901	rs1951490	chr14:65346957	G/T	cg23373153	chr14:65346875	NA	1.07	6.14	0.57	3.19e-8	Pediatric areal bone mineral density (radius);
SKCM	cis	rs2050392	0.624	rs2489842	chr10:30721991	T/C	cg25182066	chr10:30743637	MAP3K8	-0.65	-5.3	-0.51	1.05e-6	Inflammatory bowel disease;
SKCM	cis	rs860295	0.702	rs475550	chr1:155652081	A/T	cg02153340	chr1:155202674	NA	-0.68	-4.81	-0.48	7.17e-6	Body mass index;
SKCM	cis	rs1005277	0.563	rs2505216	chr10:38482830	T/C	cg00409905	chr10:38381863	ZNF37A	-0.65	-5.92	-0.56	8.04e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs9902453	0.904	rs7208579	chr17:28263067	C/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.8	6.3	0.58	1.61e-8	Coffee consumption (cups per day);
SKCM	cis	rs208520	0.955	rs208538	chr6:66964492	C/G	cg07460842	chr6:66804631	NA	-0.84	-5.89	-0.55	9.44e-8	Exhaled nitric oxide output;
SKCM	cis	rs829883	0.664	rs829864	chr12:98850195	C/T	cg25150519	chr12:98850993	NA	0.51	5.06	0.5	2.7e-6	Colorectal adenoma (advanced);
SKCM	cis	rs7937682	0.587	rs611607	chr11:111349765	C/T	cg09085632	chr11:111637200	PPP2R1B	-0.74	-6.16	-0.57	2.98e-8	Primary sclerosing cholangitis;
SKCM	cis	rs372883	0.648	rs1003772	chr21:30736145	A/T	cg24692254	chr21:30365293	RNF160	0.68	5.46	0.53	5.37e-7	Pancreatic cancer;
SKCM	cis	rs9420	0.961	rs7949841	chr11:57524700	G/C	cg19752551	chr11:57585705	CTNND1	-0.7	-7.21	-0.63	3.18e-10	Schizophrenia;
SKCM	cis	rs2153535	0.505	rs9405395	chr6:8468622	T/A	cg07606381	chr6:8435919	SLC35B3	0.94	6.72	0.61	2.69e-9	Motion sickness;
SKCM	cis	rs1577917	0.958	rs4707236	chr6:86583967	A/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.81	-7.9	-0.67	1.44e-11	Response to antipsychotic treatment;
SKCM	cis	rs769267	0.930	rs9917108	chr19:19572785	A/G	cg03709012	chr19:19516395	GATAD2A	0.89	8.62	0.7	5.89e-13	Tonsillectomy;
SKCM	cis	rs7659604	0.539	rs11098648	chr4:122759872	C/T	cg19748678	chr4:122722346	EXOSC9	0.66	5.4	0.52	7.12e-7	Type 2 diabetes;
SKCM	cis	rs8060686	0.641	rs113704872	chr16:68032598	G/A	cg27539214	chr16:67997921	SLC12A4	-0.85	-4.87	-0.48	5.66e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs1559088	0.600	rs7256470	chr19:33558085	C/A	cg27124370	chr19:33622961	WDR88	0.83	6.0	0.56	5.76e-8	Bone ultrasound measurement (broadband ultrasound attenuation);
SKCM	cis	rs9682041	1.000	rs15709	chr3:170110529	T/A	cg11886554	chr3:170076028	SKIL	0.93	5.5	0.53	4.62e-7	Glomerular filtration rate in non diabetics (creatinine);Glomerular filtration rate (creatinine);
SKCM	cis	rs801193	0.967	rs3800823	chr7:66147110	C/A	cg00343986	chr7:65444356	GUSB	-0.71	-5.32	-0.52	9.64e-7	Aortic root size;
SKCM	cis	rs1577917	0.771	rs3812133	chr6:86354411	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.98	-9.62	-0.74	6.89e-15	Response to antipsychotic treatment;
SKCM	cis	rs11690935	0.959	rs6433314	chr2:172660971	A/G	cg13550731	chr2:172543902	DYNC1I2	-0.92	-7.75	-0.66	2.89e-11	Schizophrenia;
SKCM	cis	rs10504229	0.953	rs6985942	chr8:58173412	T/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs7143963	0.945	rs72702792	chr14:103279303	A/G	cg23020514	chr14:103360112	TRAF3	0.78	6.81	0.61	1.79e-9	Body mass index;
SKCM	cis	rs3091242	0.933	rs11802413	chr1:25760920	A/G	cg27572855	chr1:25598939	RHD	-0.52	-5.01	-0.49	3.27e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs709400	0.930	rs57447494	chr14:104034569	G/A	cg26031613	chr14:104095156	KLC1	1.06	11.49	0.79	1.88e-18	Body mass index;
SKCM	cis	rs7829975	0.777	rs6989926	chr8:8547313	A/C	cg06636001	chr8:8085503	FLJ10661	-0.66	-5.23	-0.51	1.38e-6	Mood instability;
SKCM	cis	rs933688	0.938	rs7705465	chr5:90680949	G/A	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.97	6.61	0.6	4.28e-9	Smoking behavior;
SKCM	trans	rs66573146	0.808	rs73202120	chr4:7005588	A/G	cg07817883	chr1:32538562	TMEM39B	1.96	8.48	0.69	1.11e-12	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs3008870	1.000	rs35365746	chr1:67438900	G/A	cg08660285	chr1:67390436	MIER1;WDR78	-0.92	-6.07	-0.57	4.27e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs9875589	0.509	rs1873005	chr3:14060223	G/A	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.52	5.24	0.51	1.34e-6	Ovarian reserve;
SKCM	cis	rs875971	1.000	rs11974219	chr7:65647410	C/T	cg18876405	chr7:65276391	NA	-0.68	-6.85	-0.61	1.54e-9	Aortic root size;
SKCM	cis	rs55823223	0.648	rs936394	chr17:73852008	C/A	cg10935138	chr17:73851978	WBP2	1.15	7.57	0.65	6.31e-11	Psoriasis;
SKCM	cis	rs7829975	0.846	rs11779061	chr8:8549432	G/A	cg06636001	chr8:8085503	FLJ10661	-0.83	-6.96	-0.62	9.44e-10	Mood instability;
SKCM	cis	rs151997	0.671	rs27281	chr5:50200764	C/T	cg06027927	chr5:50259733	NA	0.65	6.24	0.58	2.13e-8	Callous-unemotional behaviour;
SKCM	cis	rs12971120	1.000	rs3829640	chr18:72174980	A/G	cg26446133	chr18:72167187	CNDP2	-0.67	-5.69	-0.54	2.09e-7	Refractive error;
SKCM	cis	rs7296418	0.961	rs12425850	chr12:123501972	T/C	cg05973401	chr12:123451056	ABCB9	0.82	6.64	0.6	3.81e-9	Platelet count;
SKCM	cis	rs9300255	0.602	rs4372492	chr12:123697357	T/C	cg00376283	chr12:123451042	ABCB9	0.83	5.49	0.53	4.74e-7	Neutrophil percentage of white cells;
SKCM	cis	rs4332037	0.664	rs56259105	chr7:1978002	T/C	cg23422044	chr7:1970798	MAD1L1	-1.05	-7.41	-0.64	1.3e-10	Bipolar disorder;
SKCM	cis	rs1799949	1.000	rs11654452	chr17:41189383	G/T	cg23758822	chr17:41437982	NA	0.91	7.51	0.65	8.13e-11	Menopause (age at onset);
SKCM	cis	rs28386778	0.897	rs1043127	chr17:61791210	T/G	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.13	11.24	0.79	5.56e-18	Prudent dietary pattern;
SKCM	cis	rs2836974	0.931	rs7283569	chr21:40644062	T/G	cg11890956	chr21:40555474	PSMG1	1.09	13.83	0.84	1.08e-22	Cognitive function;
SKCM	cis	rs11532322	1	rs11532322	chr12:123731423	A/G	cg00376283	chr12:123451042	ABCB9	0.87	7.25	0.63	2.63e-10	Schizophrenia;
SKCM	cis	rs12044355	0.929	rs11122323	chr1:231848933	G/A	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	0.76	5.49	0.53	4.81e-7	Alzheimer's disease;
SKCM	cis	rs2760061	0.784	rs708116	chr1:228198196	C/A	cg18477163	chr1:228402036	OBSCN	0.49	5.77	0.55	1.52e-7	Diastolic blood pressure;
SKCM	cis	rs6547741	0.844	rs55826602	chr2:27863452	A/G	cg27432699	chr2:27873401	GPN1	-0.84	-7.21	-0.63	3.15e-10	Oral cavity cancer;
SKCM	cis	rs2204008	0.774	rs9669565	chr12:38294428	C/A	cg26384229	chr12:38710491	ALG10B	0.81	6.57	0.6	5.18e-9	Bladder cancer;
SKCM	cis	rs1059312	0.932	rs7960920	chr12:129283149	T/C	cg09035930	chr12:129282057	SLC15A4	0.79	8.71	0.7	3.99e-13	Systemic lupus erythematosus;
SKCM	cis	rs7528419	1.000	rs629301	chr1:109818306	G/T	cg00908766	chr1:109817496	CELSR2	0.46	5.18	0.51	1.69e-6	Coronary artery disease (myocardial infartum, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease);Myocardial infarction;Lipoprotein-associated phospholipase A2 activity and mass;Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease;Cholesterol, total;Coronary artery disease;
SKCM	cis	rs1559088	0.600	rs10423965	chr19:33600319	T/G	cg27124370	chr19:33622961	WDR88	0.8	5.6	0.54	3.13e-7	Bone ultrasound measurement (broadband ultrasound attenuation);
SKCM	cis	rs2404602	1.000	rs2404741	chr15:76851735	C/T	cg23625390	chr15:77176239	SCAPER	0.74	7.26	0.63	2.52e-10	Blood metabolite levels;
SKCM	cis	rs17685	0.753	rs6953665	chr7:75769049	C/T	cg01364799	chr7:75623366	TMEM120A	-0.7	-5.69	-0.54	2.09e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs9467773	1.000	rs6924838	chr6:26571756	C/T	cg09904177	chr6:26538194	HMGN4	0.54	4.91	0.49	4.97e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2836974	0.897	rs6517513	chr21:40526878	A/G	cg17971929	chr21:40555470	PSMG1	0.87	8.48	0.69	1.1e-12	Cognitive function;
SKCM	cis	rs867186	1.000	rs717593	chr20:33652964	G/C	cg04194272	chr20:33683537	NA	-1.38	-7.2	-0.63	3.29e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs9921222	0.502	rs12929878	chr16:412447	G/A	cg00101154	chr16:420108	MRPL28	-0.71	-5.99	-0.56	6.19e-8	Bone mineral density (spine);Bone mineral density;
SKCM	cis	rs2153535	0.541	rs4637688	chr6:8446501	A/G	cg07606381	chr6:8435919	SLC35B3	0.93	6.8	0.61	1.92e-9	Motion sickness;
SKCM	cis	rs9399135	1.000	rs35123050	chr6:135302740	G/A	cg24558204	chr6:135376177	HBS1L	0.56	5.01	0.49	3.3e-6	Red blood cell count;
SKCM	cis	rs6582630	0.502	rs11520278	chr12:38359642	T/A	cg13010199	chr12:38710504	ALG10B	0.68	4.85	0.48	6.3e-6	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs763014	0.865	rs710924	chr16:633353	T/C	cg00908189	chr16:619842	PIGQ	0.82	7.78	0.66	2.55e-11	Height;
SKCM	cis	rs600231	0.623	rs3015966	chr11:65217589	T/C	cg24009118	chr11:65545808	DKFZp761E198	0.8	5.67	0.54	2.29e-7	Bone mineral density;
SKCM	cis	rs4523957	0.786	rs9897624	chr17:2121745	A/G	cg16513277	chr17:2031491	SMG6	-0.73	-4.95	-0.49	4.13e-6	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs9868809	0.505	rs11719291	chr3:48735706	A/G	cg00383909	chr3:49044727	WDR6	0.89	5.09	0.5	2.44e-6	Ulcerative colitis;Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs4728302	0.583	rs12707091	chr7:133185749	A/G	cg10665199	chr7:133106180	EXOC4	0.68	4.82	0.48	6.87e-6	Intelligence;Intelligence (multi-trait analysis);
SKCM	cis	rs992157	0.764	rs10932774	chr2:219191569	A/G	cg00012203	chr2:219082015	ARPC2	0.75	5.55	0.53	3.77e-7	Colorectal cancer;
SKCM	cis	rs1799949	1.000	rs11653069	chr17:41283377	C/T	cg23758822	chr17:41437982	NA	0.92	7.8	0.66	2.3e-11	Menopause (age at onset);
SKCM	cis	rs9325144	0.647	rs1875609	chr12:39018259	C/T	cg26384229	chr12:38710491	ALG10B	-0.73	-6.63	-0.6	3.88e-9	Morning vs. evening chronotype;
SKCM	cis	rs1799949	0.501	rs2343819	chr17:41409653	T/G	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.18	-0.57	2.68e-8	Menopause (age at onset);
SKCM	cis	rs7927771	0.524	rs10742820	chr11:47781057	C/T	cg20307385	chr11:47447363	PSMC3	-0.72	-5.81	-0.55	1.31e-7	Subjective well-being;
SKCM	cis	rs12478296	0.901	rs67951957	chr2:243004901	A/G	cg06360820	chr2:242988706	NA	-1.02	-5.87	-0.55	1.03e-7	Obesity-related traits;
SKCM	cis	rs910316	1.000	rs9805979	chr14:75566209	G/A	cg08847533	chr14:75593920	NEK9	0.95	9.18	0.72	4.88e-14	Height;
SKCM	cis	rs6582630	0.502	rs11522899	chr12:38270637	T/C	cg13010199	chr12:38710504	ALG10B	0.69	4.92	0.49	4.72e-6	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs6879260	1.000	rs7730585	chr5:179733440	T/C	cg13944838	chr5:179740914	GFPT2	-0.7	-5.33	-0.52	9.41e-7	Height;
SKCM	cis	rs2832191	0.679	rs2705659	chr21:30363908	G/C	cg08807101	chr21:30365312	RNF160	0.76	6.34	0.58	1.38e-8	Dental caries;
SKCM	cis	rs1580019	0.961	rs11768506	chr7:32494788	A/C	cg06627557	chr7:32535165	LSM5;AVL9	0.74	5.64	0.54	2.59e-7	Cognitive ability;
SKCM	cis	rs754466	0.606	rs11002315	chr10:79617385	T/G	cg17075019	chr10:79541650	NA	-0.72	-6.51	-0.59	6.75e-9	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs7932354	0.554	rs6485721	chr11:47040854	A/G	cg03339077	chr11:47165057	C11orf49	-0.61	-4.99	-0.49	3.57e-6	Bone mineral density (hip);Bone mineral density;
SKCM	cis	rs614226	0.938	rs787824	chr12:120924638	A/G	cg01236616	chr12:121019343	POP5	-1.32	-8.41	-0.69	1.5e-12	Type 1 diabetes nephropathy;
SKCM	cis	rs1506636	1.000	rs656425	chr7:123424525	A/C	cg03229431	chr7:123269106	ASB15	0.66	5.29	0.51	1.1e-6	Plateletcrit;Platelet count;
SKCM	cis	rs208520	0.690	rs851458	chr6:66813279	T/G	cg07460842	chr6:66804631	NA	-0.98	-7.7	-0.66	3.58e-11	Exhaled nitric oxide output;
SKCM	cis	rs55962025	0.686	rs362314	chr4:3235241	A/G	cg16987761	chr4:3318072	RGS12	-0.6	-4.85	-0.48	6.07e-6	Parental longevity (mother's age at death);
SKCM	cis	rs12706411	0.764	rs12706413	chr7:122075328	C/T	cg17986181	chr7:121955208	NA	-0.65	-5.01	-0.49	3.36e-6	Alzheimer disease and age of onset;
SKCM	cis	rs950776	0.518	rs952215	chr15:78819153	C/T	cg06917634	chr15:78832804	PSMA4	-1.01	-10.48	-0.76	1.5e-16	Sudden cardiac arrest;
SKCM	cis	rs7811142	0.830	rs7341507	chr7:99951315	A/G	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.15	7.36	0.64	1.62e-10	Platelet count;
SKCM	cis	rs4819052	0.851	rs28676615	chr21:46676576	G/C	cg02159808	chr21:46707872	POFUT2;LOC642852	0.73	5.71	0.54	1.93e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs28374715	0.532	rs7168431	chr15:41672384	A/G	cg18705301	chr15:41695430	NDUFAF1	-1.24	-13.92	-0.84	7.63e-23	Ulcerative colitis;
SKCM	cis	rs7552404	0.924	rs7550974	chr1:76204185	A/G	cg10523679	chr1:76189770	ACADM	0.69	5.07	0.5	2.67e-6	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs2075371	1.000	rs2544210	chr7:133971535	C/T	cg20476274	chr7:133979776	SLC35B4	1.03	10.47	0.76	1.56e-16	Mean platelet volume;
SKCM	cis	rs6933660	0.646	rs9397051	chr6:151778325	C/T	cg10883421	chr6:151773342	RMND1;C6orf211	0.84	7.31	0.64	2.02e-10	Menarche (age at onset);
SKCM	cis	rs919433	0.889	rs788001	chr2:198213720	C/T	cg04278110	chr2:198063759	ANKRD44	0.72	4.87	0.48	5.77e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs6061231	1.000	rs67941642	chr20:60958108	C/T	cg24112000	chr20:60950667	NA	-0.6	-5.96	-0.56	6.97e-8	Colorectal cancer;
SKCM	cis	rs7191700	0.673	rs12325495	chr16:11418328	C/T	cg00044050	chr16:11439710	C16orf75	0.72	5.03	0.5	3.01e-6	Multiple sclerosis;
SKCM	cis	rs28595532	0.841	rs115987912	chr4:119737085	C/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs7945705	0.776	rs11042069	chr11:8817315	G/A	cg21881798	chr11:8931708	C11orf17;ST5	0.66	6.51	0.59	6.59e-9	Hemoglobin concentration;
SKCM	cis	rs4803468	1.000	rs10422956	chr19:41901261	C/T	cg09537434	chr19:41945824	ATP5SL	-1.08	-13.01	-0.83	3.1e-21	Height;
SKCM	cis	rs7772486	0.790	rs2256998	chr6:146207657	A/C	cg23711669	chr6:146136114	FBXO30	0.76	7.55	0.65	7.1e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2836974	0.831	rs4375956	chr21:40521788	G/A	cg17971929	chr21:40555470	PSMG1	0.88	7.97	0.67	1.08e-11	Cognitive function;
SKCM	cis	rs9430161	0.611	rs2003046	chr1:11032827	C/A	cg02454025	chr1:11042201	C1orf127	1.07	9.97	0.75	1.47e-15	Ewing sarcoma;
SKCM	trans	rs1814175	0.562	rs1794130	chr11:49903764	T/A	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs5769765	0.862	rs9616774	chr22:50290599	G/A	cg22709217	chr22:50311962	ALG12;CRELD2	-0.79	-5.71	-0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs10193935	0.901	rs92303	chr2:42656337	A/G	cg27598129	chr2:42591480	NA	0.97	6.87	0.61	1.39e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1799949	1.000	rs3092988	chr17:41201702	C/T	cg25918947	chr17:41365094	TMEM106A	-0.62	-5.89	-0.55	9.22e-8	Menopause (age at onset);
SKCM	cis	rs2439831	0.867	rs2447196	chr15:43893818	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	-1.36	-8.29	-0.68	2.64e-12	Lung cancer in ever smokers;
SKCM	cis	rs1568889	1.000	rs12802157	chr11:28060285	A/C	cg06544937	chr11:28130018	METT5D1;KIF18A	0.86	7.03	0.62	6.97e-10	Bipolar disorder;
SKCM	cis	rs7811142	1.000	rs11761725	chr7:100039815	C/T	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.12	6.51	0.59	6.68e-9	Platelet count;
SKCM	cis	rs67460515	0.529	rs11712713	chr3:160852471	A/G	cg03342759	chr3:160939853	NMD3	-0.68	-5.67	-0.54	2.3e-7	Parkinson's disease;
SKCM	cis	rs995000	0.929	rs12042319	chr1:63049819	C/T	cg06896770	chr1:63153194	DOCK7	0.89	7.37	0.64	1.57e-10	Triglyceride levels;
SKCM	cis	rs62064224	0.658	rs62065460	chr17:30715007	A/G	cg25809561	chr17:30822961	MYO1D	0.67	5.12	0.5	2.13e-6	Schizophrenia;
SKCM	cis	rs769267	0.930	rs10419912	chr19:19597055	A/G	cg26732615	chr19:19648335	CILP2;YJEFN3	-0.67	-7.06	-0.62	6e-10	Tonsillectomy;
SKCM	cis	rs4243830	0.850	rs3986417	chr1:6622011	T/C	cg22792644	chr1:6614718	TAS1R1;NOL9	-1.23	-4.84	-0.48	6.43e-6	Body mass index;
SKCM	cis	rs6866344	0.697	rs62392833	chr5:178135452	T/A	cg10224037	chr5:178157518	ZNF354A	0.83	5.91	0.56	8.48e-8	Neutrophil percentage of white cells;
SKCM	cis	rs826838	0.802	rs10785619	chr12:38742897	T/A	cg26384229	chr12:38710491	ALG10B	0.95	8.03	0.67	8.33e-12	Heart rate;
SKCM	cis	rs2286503	1.000	rs17724311	chr7:22876793	G/C	cg15401507	chr7:22894281	NA	-0.58	-5.16	-0.5	1.85e-6	Fibrinogen;
SKCM	cis	rs9910055	0.571	rs10208	chr17:42300278	C/T	cg19774624	chr17:42201019	HDAC5	-0.74	-5.93	-0.56	7.98e-8	Total body bone mineral density;
SKCM	cis	rs7811142	1.000	rs6953107	chr7:100095664	C/T	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.14	6.58	0.6	4.83e-9	Platelet count;
SKCM	cis	rs4727027	0.866	rs3927307	chr7:148774869	C/T	cg23583168	chr7:148888333	NA	-0.82	-6.45	-0.59	8.44e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs3820928	0.874	rs4675137	chr2:227883910	G/C	cg11843606	chr2:227700838	RHBDD1	-0.62	-5.12	-0.5	2.19e-6	Pulmonary function;
SKCM	cis	rs1707322	0.686	rs1541131	chr1:46084934	G/A	cg03146154	chr1:46216737	IPP	-0.83	-6.17	-0.57	2.83e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs372883	0.600	rs1153277	chr21:30666867	A/T	cg24692254	chr21:30365293	RNF160	-0.7	-5.42	-0.52	6.49e-7	Pancreatic cancer;
SKCM	cis	rs9910055	0.659	rs7212573	chr17:42254281	A/G	cg09913183	chr17:42254507	C17orf65;ASB16	0.68	6.42	0.59	9.65e-9	Total body bone mineral density;
SKCM	cis	rs55962025	0.855	rs6855981	chr4:3148276	A/G	cg05297308	chr4:3317976	RGS12	0.63	5.0	0.49	3.51e-6	Parental longevity (mother's age at death);
SKCM	cis	rs4523957	0.651	rs4790315	chr17:2070529	T/C	cg16513277	chr17:2031491	SMG6	-0.82	-6.05	-0.57	4.65e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs2836974	0.931	rs2989330	chr21:40716209	A/G	cg11890956	chr21:40555474	PSMG1	0.96	9.75	0.74	3.9e-15	Cognitive function;
SKCM	cis	rs17826219	0.500	rs61685770	chr17:29085713	G/A	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Body mass index;
SKCM	cis	rs13118159	0.772	rs80346978	chr4:1400313	C/T	cg20887711	chr4:1340912	KIAA1530	0.73	5.13	0.5	2.09e-6	Longevity;
SKCM	cis	rs4819852	1.000	rs1034566	chr22:19984277	C/T	cg07821417	chr22:19972146	ARVCF	0.49	6.43	0.59	9.2e-9	Pulse pressure;
SKCM	cis	rs1957429	0.901	rs3813422	chr14:65347404	G/A	cg23373153	chr14:65346875	NA	1.11	6.32	0.58	1.52e-8	Pediatric areal bone mineral density (radius);
SKCM	cis	rs4900538	0.827	rs1046651	chr14:102971016	T/C	cg18135206	chr14:102964638	TECPR2	0.71	5.7	0.54	2.06e-7	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs9467773	0.967	rs6924865	chr6:26521353	A/G	cg15659132	chr6:26577336	NA	0.6	5.71	0.54	1.99e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs2251381	0.741	rs2735966	chr21:30538174	G/A	cg24692254	chr21:30365293	RNF160	0.78	6.33	0.58	1.46e-8	Selective IgA deficiency;
SKCM	cis	rs6938	0.534	rs12907898	chr15:75207872	C/T	cg09165964	chr15:75287851	SCAMP5	0.62	4.91	0.49	4.99e-6	Breast cancer;
SKCM	cis	rs9790314	0.718	rs6774635	chr3:160847908	A/G	cg03342759	chr3:160939853	NMD3	-0.62	-6.25	-0.58	2.03e-8	Morning vs. evening chronotype;
SKCM	cis	rs722599	0.501	rs759058	chr14:75382971	A/G	cg08847533	chr14:75593920	NEK9	0.6	4.88	0.48	5.58e-6	IgG glycosylation;
SKCM	cis	rs2404602	0.684	rs4886819	chr15:76901698	C/T	cg23625390	chr15:77176239	SCAPER	-0.85	-8.26	-0.68	2.93e-12	Blood metabolite levels;
SKCM	cis	rs1691799	0.867	rs1168344	chr12:66758213	G/A	cg16791601	chr12:66731901	HELB	-0.63	-5.63	-0.54	2.72e-7	White blood cell count (basophil);
SKCM	cis	rs6570726	0.599	rs455001	chr6:145854450	A/T	cg05347473	chr6:146136440	FBXO30	0.64	5.46	0.53	5.57e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs589448	0.933	rs523398	chr12:69752775	C/T	cg22834771	chr12:69754056	YEATS4	-0.71	-5.79	-0.55	1.39e-7	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs62238980	0.614	rs116859544	chr22:32433155	A/T	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs1912528	0.963	rs36072649	chr4:140939110	T/A	cg11128457	chr4:140864437	MAML3	0.58	4.82	0.48	6.89e-6	Educational attainment (years of education);
SKCM	cis	rs644799	0.542	rs10831416	chr11:95467220	A/G	cg03916912	chr11:95522834	CEP57;FAM76B	0.64	4.82	0.48	6.99e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs7809950	0.678	rs2395868	chr7:106897500	C/T	cg23024343	chr7:107201750	COG5	0.76	6.58	0.6	5.01e-9	Coronary artery disease;
SKCM	cis	rs3091242	0.933	rs35530120	chr1:25785451	A/G	cg02931644	chr1:25747376	RHCE	-0.5	-4.9	-0.48	5.17e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs807669	0.807	rs807431	chr22:19242361	G/A	cg02655711	chr22:19163373	SLC25A1	0.59	5.54	0.53	3.88e-7	Metabolite levels;
SKCM	cis	rs801193	1.000	rs7788576	chr7:66148302	G/A	cg00343986	chr7:65444356	GUSB	-0.7	-5.14	-0.5	1.98e-6	Aortic root size;
SKCM	cis	rs67460515	0.596	rs35589595	chr3:160930984	G/A	cg03342759	chr3:160939853	NMD3	-0.72	-6.14	-0.57	3.19e-8	Parkinson's disease;
SKCM	cis	rs8070624	0.574	rs11078408	chr17:17876011	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.04	8.4	0.69	1.6e-12	Total body bone mineral density;
SKCM	cis	rs3091242	0.934	rs686631	chr1:25719599	A/T	cg27572855	chr1:25598939	RHD	0.52	4.98	0.49	3.79e-6	Erythrocyte sedimentation rate;
SKCM	trans	rs11722228	0.549	rs41268389	chr4:10099277	G/A	cg26043149	chr18:55253948	FECH	0.93	7.98	0.67	1.02e-11	Gout;Urate levels;Serum uric acid levels;
SKCM	cis	rs10193935	0.901	rs6544529	chr2:42510652	A/T	cg27598129	chr2:42591480	NA	-0.96	-6.78	-0.61	2.09e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6840360	0.615	rs9884167	chr4:152470799	A/G	cg22705602	chr4:152727874	NA	-0.51	-5.78	-0.55	1.48e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs9916302	0.706	rs4795375	chr17:37662932	T/C	cg07936489	chr17:37558343	FBXL20	-1.03	-7.61	-0.65	5.23e-11	Glomerular filtration rate (creatinine);
SKCM	cis	rs1799949	0.773	rs2137990	chr17:41317896	T/A	cg25918947	chr17:41365094	TMEM106A	0.62	5.98	0.56	6.35e-8	Menopause (age at onset);
SKCM	cis	rs28595532	0.920	rs116548907	chr4:119735285	G/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs4724125	0.920	rs3913703	chr7:42704271	A/G	cg09407816	chr7:42972088	MRPL32;PSMA2	0.81	5.09	0.5	2.38e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7811142	0.943	rs111757992	chr7:100016354	A/C	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.16	7.68	0.66	3.87e-11	Platelet count;
SKCM	cis	rs116095464	0.558	rs6869925	chr5:264036	A/G	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs10504229	1.000	rs56350499	chr8:58178139	C/T	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs5750830	0.594	rs6001568	chr22:39775786	G/A	cg24399712	chr22:39784796	NA	-0.6	-5.0	-0.49	3.49e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs11122272	0.735	rs2491410	chr1:231532287	C/T	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	-0.65	-5.32	-0.52	9.49e-7	Hemoglobin concentration;
SKCM	cis	rs12497850	0.931	rs62262517	chr3:49134914	T/G	cg06212747	chr3:49208901	KLHDC8B	0.7	4.99	0.49	3.6e-6	Parkinson's disease;
SKCM	cis	rs4819052	0.851	rs13048789	chr21:46660714	A/G	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.42	0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7208859	0.623	rs7208441	chr17:29143863	C/T	cg14067834	chr17:29058358	SUZ12P	0.99	5.23	0.51	1.41e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs2836974	0.931	rs13047663	chr21:40708818	C/T	cg11644478	chr21:40555479	PSMG1	0.82	7.13	0.63	4.36e-10	Cognitive function;
SKCM	cis	rs7103648	0.669	rs10437655	chr11:47391948	G/A	cg20307385	chr11:47447363	PSMC3	1.07	9.29	0.72	2.9e-14	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs7824557	0.564	rs2736302	chr8:11236419	T/C	cg21775007	chr8:11205619	TDH	-0.59	-5.03	-0.5	3.01e-6	Retinal vascular caliber;
SKCM	cis	rs875971	0.798	rs7789615	chr7:65878661	A/G	cg18876405	chr7:65276391	NA	0.63	6.34	0.58	1.39e-8	Aortic root size;
SKCM	cis	rs908922	1.000	rs908922	chr1:152454591	C/T	cg09873164	chr1:152488093	CRCT1	0.87	5.0	0.49	3.43e-6	Hair morphology;
SKCM	cis	rs9682041	0.673	rs1511175	chr3:170076006	C/G	cg11886554	chr3:170076028	SKIL	0.94	5.55	0.53	3.77e-7	Glomerular filtration rate in non diabetics (creatinine);Glomerular filtration rate (creatinine);
SKCM	cis	rs28386778	0.897	rs4968598	chr17:61835579	T/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.12	11.27	0.79	4.92e-18	Prudent dietary pattern;
SKCM	cis	rs875971	0.522	rs9530	chr7:65425894	A/G	cg11764359	chr7:65958608	NA	0.88	6.71	0.6	2.8e-9	Aortic root size;
SKCM	cis	rs2842992	0.830	rs2273819	chr6:160183325	G/C	cg19482086	chr6:160211437	TCP1;MRPL18	0.86	6.71	0.61	2.75e-9	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs8177253	0.829	rs9813689	chr3:133514822	C/T	cg16414030	chr3:133502952	NA	-0.69	-5.55	-0.53	3.78e-7	Iron status biomarkers;
SKCM	cis	rs644799	1.000	rs472231	chr11:95532166	A/G	cg03916912	chr11:95522834	CEP57;FAM76B	0.92	8.04	0.67	8e-12	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs8180040	0.726	rs1463393	chr3:46994987	G/A	cg27129171	chr3:47204927	SETD2	-0.82	-6.47	-0.59	7.73e-9	Colorectal cancer;
SKCM	cis	rs9910055	0.530	rs11656758	chr17:42301541	A/G	cg10896456	chr17:42255109	ASB16;C17orf65	0.54	4.88	0.48	5.61e-6	Total body bone mineral density;
SKCM	cis	rs4523957	0.583	rs2641438	chr17:2017786	C/G	cg16513277	chr17:2031491	SMG6	-0.81	-5.98	-0.56	6.24e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs6570726	1.000	rs374464	chr6:145846679	A/C	cg23711669	chr6:146136114	FBXO30	0.71	6.93	0.62	1.06e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6435862	0.500	rs12477063	chr2:215673664	C/T	cg04004882	chr2:215674386	BARD1	-0.82	-6.25	-0.58	2.05e-8	Neuroblastoma (high-risk);
SKCM	cis	rs12120353	0.702	rs780613	chr1:4551552	C/T	cg15022359	chr1:4193126	NA	-0.6	-5.21	-0.51	1.47e-6	Anxiety disorder;
SKCM	cis	rs2730245	0.593	rs842699	chr7:158663404	T/A	cg24397884	chr7:158709396	WDR60	0.66	5.1	0.5	2.35e-6	Height;
SKCM	cis	rs1850744	0.609	rs11939928	chr4:9630491	T/G	cg15442990	chr4:9534313	NA	1.4	5.3	0.51	1.04e-6	Economic and political preferences;
SKCM	cis	rs9926296	0.605	rs12448860	chr16:89849629	T/A	cg26513180	chr16:89883248	FANCA	0.96	10.53	0.77	1.25e-16	Vitiligo;
SKCM	cis	rs2033711	0.818	rs4801595	chr19:58978517	G/A	cg26874164	chr19:58962979	ZNF324B	0.66	5.42	0.52	6.48e-7	Uric acid clearance;
SKCM	cis	rs951366	0.646	rs1772159	chr1:205759195	G/A	cg14159672	chr1:205819179	PM20D1	0.99	9.52	0.73	1.08e-14	Menarche (age at onset);
SKCM	cis	rs8141529	0.778	rs763073	chr22:29215542	G/A	cg15103426	chr22:29168792	CCDC117	0.62	5.2	0.51	1.57e-6	Lymphocyte counts;
SKCM	cis	rs11148252	0.532	rs9526975	chr13:53255804	C/T	cg12458913	chr13:53173898	NA	0.61	5.58	0.53	3.32e-7	Lewy body disease;
SKCM	cis	rs56235845	0.964	rs11746443	chr5:176798306	G/A	cg16006841	chr5:176797999	RGS14	0.87	9.24	0.72	3.74e-14	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs919433	0.889	rs10931782	chr2:198211579	G/A	cg04278110	chr2:198063759	ANKRD44	-0.72	-5.02	-0.49	3.21e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs35146811	0.844	rs12705070	chr7:99656927	A/G	cg13334819	chr7:99746414	C7orf59	-0.75	-5.43	-0.52	6.23e-7	Coronary artery disease;
SKCM	cis	rs17376456	0.809	rs13177800	chr5:93307350	T/C	cg21475434	chr5:93447410	FAM172A	1.04	5.55	0.53	3.82e-7	Diabetic retinopathy;
SKCM	cis	rs62064224	0.593	rs916663	chr17:30835833	A/C	cg25809561	chr17:30822961	MYO1D	-0.61	-5.5	-0.53	4.73e-7	Schizophrenia;
SKCM	cis	rs7927771	0.931	rs4752801	chr11:47907641	A/G	cg05585544	chr11:47624801	NA	-0.63	-5.49	-0.53	4.87e-7	Subjective well-being;
SKCM	cis	rs2019137	0.539	rs6755040	chr2:113981137	T/C	cg12889195	chr2:113992843	PAX8;LOC440839;LOC654433	0.75	5.59	0.53	3.21e-7	Lymphocyte counts;
SKCM	trans	rs6481128	0.778	rs1616289	chr10:56700268	A/G	cg04272632	chr1:34629400	CSMD2	0.69	7.66	0.66	4.26e-11	Extraversion;
SKCM	cis	rs10254284	0.959	rs11771411	chr7:28149761	T/C	cg15170557	chr7:28214983	JAZF1	-0.6	-5.09	-0.5	2.45e-6	Lymphocyte percentage of white cells;Systemic lupus erythematosus;
SKCM	cis	rs55962025	0.711	rs2285086	chr4:3089259	C/T	cg09735869	chr4:3319127	RGS12	0.58	4.77	0.48	8.42e-6	Parental longevity (mother's age at death);
SKCM	cis	rs4523957	0.855	rs9897160	chr17:2121566	A/G	cg16513277	chr17:2031491	SMG6	-0.73	-4.95	-0.49	4.13e-6	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs60871478	1.000	rs62432861	chr7:807649	G/A	cg05535760	chr7:792225	HEATR2	0.97	8.12	0.68	5.6e-12	Cerebrospinal P-tau181p levels;
SKCM	cis	rs4272321	1	rs4272321	chr7:157951835	A/G	cg23602909	chr7:157956050	PTPRN2	-0.37	-4.94	-0.49	4.29e-6	Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7937682	0.883	rs517982	chr11:111462687	T/C	cg09085632	chr11:111637200	PPP2R1B	-1.0	-8.74	-0.7	3.47e-13	Primary sclerosing cholangitis;
SKCM	cis	rs10540	0.908	rs1044707	chr11:491334	G/T	cg03576123	chr11:487126	PTDSS2	1.34	7.36	0.64	1.6e-10	Body mass index;
SKCM	cis	rs7940866	0.738	rs10894308	chr11:130891895	G/A	cg12179176	chr11:130786555	SNX19	0.72	5.25	0.51	1.29e-6	Schizophrenia;
SKCM	cis	rs9485372	1.000	rs9485369	chr6:149604833	A/T	cg03072286	chr6:150262044	ULBP2	-0.55	-4.89	-0.48	5.3e-6	Breast cancer;
SKCM	cis	rs7646501	0.765	rs4858574	chr3:24056988	G/A	cg22892432	chr3:24537792	THRB	0.57	4.83	0.48	6.64e-6	Cognitive ability;Intelligence;
SKCM	cis	rs8077889	0.750	rs72836564	chr17:41935064	G/A	cg26893861	chr17:41843967	DUSP3	1.23	6.83	0.61	1.63e-9	Triglycerides;
SKCM	cis	rs9911578	1.000	rs4398153	chr17:56968181	T/C	cg05425664	chr17:57184151	TRIM37	0.67	5.04	0.5	2.91e-6	Intelligence (multi-trait analysis);
SKCM	trans	rs561341	0.882	rs72825748	chr17:30367396	G/A	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs4150161	0.656	rs1056612	chr16:84211788	G/C	cg10106505	chr16:84220380	TAF1C	-1.29	-5.55	-0.53	3.72e-7	Systolic blood pressure response to hydrochlorothiazide in hypertension;
SKCM	cis	rs701145	0.550	rs450115	chr3:153923418	A/C	cg17054900	chr3:154042577	DHX36	1.25	5.36	0.52	8.3e-7	Coronary artery disease;
SKCM	cis	rs10504073	0.669	rs12548464	chr8:50023867	C/T	cg00325661	chr8:49890786	NA	0.77	6.76	0.61	2.21e-9	Blood metabolite ratios;
SKCM	cis	rs3096299	0.685	rs4329923	chr16:89560178	C/T	cg02187348	chr16:89574699	SPG7	0.64	5.35	0.52	8.65e-7	Multiple myeloma (IgH translocation);
SKCM	cis	rs17270561	0.579	rs10456326	chr6:25919662	G/A	cg16482183	chr6:26056742	HIST1H1C	0.97	6.64	0.6	3.73e-9	Iron status biomarkers;
SKCM	cis	rs57221529	0.766	rs58015612	chr5:580665	A/T	cg09888920	chr5:474111	LOC25845;SLC9A3	0.99	4.79	0.48	7.91e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs651907	0.514	rs10936744	chr3:101433440	C/T	cg12386194	chr3:101231763	SENP7	0.69	5.68	0.54	2.23e-7	Colorectal cancer;
SKCM	cis	rs6545883	0.831	rs9309336	chr2:61763165	T/C	cg15711740	chr2:61764176	XPO1	-0.76	-5.3	-0.51	1.04e-6	Tuberculosis;
SKCM	cis	rs10504229	0.593	rs17192845	chr8:58053339	C/T	cg02725872	chr8:58115012	NA	-0.54	-5.04	-0.5	2.97e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs1023500	0.573	rs133370	chr22:42465260	T/C	cg04733989	chr22:42467013	NAGA	0.72	5.72	0.54	1.9e-7	Schizophrenia;
SKCM	trans	rs2727020	0.513	rs10839307	chr11:49609843	A/C	cg15704280	chr7:45808275	SEPT13	-0.99	-9.29	-0.72	2.97e-14	Coronary artery disease;
SKCM	cis	rs6430585	0.527	rs57530667	chr2:136444338	A/G	cg07169764	chr2:136633963	MCM6	1.02	7.68	0.66	3.84e-11	Corneal structure;
SKCM	cis	rs10193935	0.792	rs10204778	chr2:42498121	G/T	cg27598129	chr2:42591480	NA	-0.94	-6.72	-0.61	2.65e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs875971	0.825	rs66981195	chr7:66079035	C/A	cg11764359	chr7:65958608	NA	-0.74	-6.63	-0.6	3.89e-9	Aortic root size;
SKCM	cis	rs9549367	0.713	rs4907599	chr13:113861441	C/T	cg24722198	chr13:113567732	NA	-0.52	-5.25	-0.51	1.3e-6	Platelet distribution width;
SKCM	cis	rs34172651	0.517	rs874484	chr16:24803242	T/C	cg04756594	chr16:24857601	SLC5A11	0.72	5.19	0.51	1.65e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7555523	0.887	rs4269750	chr1:165711510	C/T	cg24409356	chr1:165738333	TMCO1	0.93	5.15	0.5	1.93e-6	Intraocular pressure;Glaucoma (high intraocular pressure);
SKCM	cis	rs785830	0.871	rs494637	chr9:267606	G/A	cg14500300	chr9:211689	NA	0.52	4.87	0.48	5.72e-6	Platelet distribution width;
SKCM	cis	rs7666738	0.830	rs60007031	chr4:98824753	G/C	cg17366294	chr4:99064904	C4orf37	0.56	4.87	0.48	5.62e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1850744	0.826	rs7659176	chr4:9721066	A/G	cg15442990	chr4:9534313	NA	1.44	5.56	0.53	3.59e-7	Economic and political preferences;
SKCM	cis	rs769267	0.930	rs4808957	chr19:19567248	A/G	cg03709012	chr19:19516395	GATAD2A	0.89	8.62	0.7	5.89e-13	Tonsillectomy;
SKCM	cis	rs7100689	0.622	rs7090351	chr10:82142047	T/G	cg01528321	chr10:82214614	TSPAN14	0.85	7.69	0.66	3.74e-11	Post bronchodilator FEV1;
SKCM	cis	rs933688	1.000	rs1541674	chr5:90660447	T/C	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.12	8.55	0.7	7.9e-13	Smoking behavior;
SKCM	cis	rs55823223	0.564	rs1463485	chr17:73851791	C/G	cg10935138	chr17:73851978	WBP2	1.13	7.39	0.64	1.43e-10	Psoriasis;
SKCM	cis	rs782590	0.935	rs782652	chr2:55862775	C/A	cg18811423	chr2:55921094	PNPT1	0.92	7.46	0.65	1.02e-10	Metabolic syndrome;
SKCM	cis	rs1552244	0.572	rs73117481	chr3:10160132	C/T	cg00149659	chr3:10157352	C3orf10	1.13	5.45	0.53	5.74e-7	Alzheimer's disease;
SKCM	cis	rs9543976	1.000	rs73223984	chr13:76181141	G/A	cg16409306	chr13:76195284	LMO7	-0.84	-4.79	-0.48	7.87e-6	Diabetic retinopathy;
SKCM	cis	rs4474742	1	rs4474742	chr17:28065578	A/T	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.82	-5.94	-0.56	7.58e-8	Monocyte count;
SKCM	trans	rs208520	0.526	rs1385219	chr6:66754476	C/T	cg15611600	chr13:45563400	KIAA1704;NUFIP1	1.02	10.99	0.78	1.62e-17	Exhaled nitric oxide output;
SKCM	cis	rs344364	0.511	rs2982453	chr16:1949520	G/A	cg26897989	chr16:1907736	C16orf73	-0.69	-7.13	-0.63	4.45e-10	Glomerular filtration rate in chronic kidney disease;
SKCM	cis	rs10207060	0.500	rs56346503	chr2:240719409	T/C	cg07506560	chr2:240697449	NA	0.75	6.1	0.57	3.8e-8	Obesity-related traits;
SKCM	cis	rs864745	0.967	rs860262	chr7:28194397	C/A	cg15170557	chr7:28214983	JAZF1	-0.7	-6.83	-0.61	1.68e-9	Crohn's disease;Type 2 diabetes;
SKCM	cis	rs1153858	1.000	rs1618874	chr15:45622786	A/G	cg10760299	chr15:45669010	GATM	0.53	5.01	0.49	3.33e-6	Homoarginine levels;
SKCM	cis	rs244731	0.959	rs4976677	chr5:176629546	G/A	cg17509989	chr5:176798049	RGS14	-0.9	-7.0	-0.62	7.86e-10	Urate levels in lean individuals;
SKCM	cis	rs8177179	0.967	rs10935085	chr3:133459735	C/T	cg16262614	chr3:133464971	TF	0.44	5.37	0.52	7.82e-7	Iron status biomarkers (transferrin levels);
SKCM	cis	rs28386778	0.897	rs8069969	chr17:61822223	T/G	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.36	0.52	8.06e-7	Prudent dietary pattern;
SKCM	trans	rs7819412	0.806	rs17723229	chr8:10930069	A/C	cg06636001	chr8:8085503	FLJ10661	-0.89	-7.85	-0.66	1.87e-11	Triglycerides;
SKCM	cis	rs61776719	0.875	rs10890238	chr1:38445654	A/T	cg12658694	chr1:38397304	INPP5B	0.76	7.41	0.64	1.3e-10	Coronary artery disease;
SKCM	cis	rs17376456	0.825	rs10053405	chr5:93275403	A/G	cg25358565	chr5:93447407	FAM172A	-1.13	-5.63	-0.54	2.68e-7	Diabetic retinopathy;
SKCM	cis	rs2346177	0.519	rs35509718	chr2:46696793	T/C	cg02822958	chr2:46747628	ATP6V1E2	0.71	5.3	0.51	1.03e-6	HDL cholesterol;
SKCM	cis	rs6933660	0.760	rs3806982	chr6:151774916	G/A	cg10883421	chr6:151773342	RMND1;C6orf211	0.81	6.76	0.61	2.24e-9	Menarche (age at onset);
SKCM	cis	rs561341	1.000	rs72823785	chr17:30273784	C/T	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs116095464	0.558	rs1971229	chr5:268187	A/G	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs9388451	0.839	rs3966775	chr6:126067655	C/A	cg05901451	chr6:126070800	HEY2	-0.82	-8.19	-0.68	4.04e-12	Brugada syndrome;
SKCM	cis	rs4073582	0.595	rs801736	chr11:65928430	A/T	cg16950941	chr11:66035639	RAB1B	0.81	6.87	0.61	1.41e-9	Gout;
SKCM	cis	rs763121	0.853	rs5757231	chr22:39071658	C/T	cg06022373	chr22:39101656	GTPBP1	-0.78	-5.5	-0.53	4.65e-7	Menopause (age at onset);
SKCM	cis	rs8180040	0.903	rs2276854	chr3:47276968	C/T	cg27129171	chr3:47204927	SETD2	0.85	6.39	0.59	1.11e-8	Colorectal cancer;
SKCM	cis	rs4975616	0.869	rs370348	chr5:1331219	A/G	cg06550200	chr5:1325588	CLPTM1L	-0.86	-7.74	-0.66	2.94e-11	Lung cancer;
SKCM	cis	rs72781680	0.898	rs10490752	chr2:24025132	C/T	cg08917208	chr2:24149416	ATAD2B	0.92	4.85	0.48	6.19e-6	Lymphocyte counts;
SKCM	cis	rs4808199	0.947	rs10401193	chr19:19591066	A/G	cg03709012	chr19:19516395	GATAD2A	1.13	8.66	0.7	4.94e-13	Nonalcoholic fatty liver disease;
SKCM	cis	rs1799949	1.000	rs12942277	chr17:41187974	G/C	cg05368731	chr17:41323189	NBR1	0.86	7.39	0.64	1.39e-10	Menopause (age at onset);
SKCM	cis	rs9790314	0.871	rs336561	chr3:161125305	C/T	cg03342759	chr3:160939853	NMD3	-0.72	-7.14	-0.63	4.27e-10	Morning vs. evening chronotype;
SKCM	cis	rs7666738	0.830	rs13136930	chr4:98937933	A/T	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2836974	0.897	rs2026265	chr21:40595517	G/A	cg17971929	chr21:40555470	PSMG1	0.9	8.81	0.71	2.52e-13	Cognitive function;
SKCM	cis	rs7666738	0.830	rs1869897	chr4:98730997	C/T	cg17366294	chr4:99064904	C4orf37	0.59	5.11	0.5	2.25e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2153535	0.580	rs969421	chr6:8451949	A/C	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs58688157	0.705	rs7943546	chr11:612148	T/C	cg17114584	chr11:613792	IRF7	0.81	5.63	0.54	2.69e-7	Systemic lupus erythematosus;
SKCM	cis	rs7208859	0.623	rs9895785	chr17:29107708	C/T	cg13385521	chr17:29058706	SUZ12P	-1.07	-5.12	-0.5	2.16e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs4642101	0.793	rs56082700	chr3:12833833	T/C	cg05775895	chr3:12838266	CAND2	0.62	5.45	0.53	5.72e-7	QRS complex (12-leadsum);
SKCM	cis	rs2204008	0.652	rs11513964	chr12:37998214	C/G	cg26384229	chr12:38710491	ALG10B	0.8	6.2	0.57	2.47e-8	Bladder cancer;
SKCM	cis	rs763121	0.925	rs4821797	chr22:39016182	T/C	cg06022373	chr22:39101656	GTPBP1	0.78	5.3	0.51	1.03e-6	Menopause (age at onset);
SKCM	cis	rs11098499	0.865	rs28634456	chr4:120375778	A/G	cg09307838	chr4:120376055	NA	0.97	7.85	0.66	1.85e-11	Corneal astigmatism;
SKCM	cis	rs2072510	1.000	rs2072510	chr12:96403199	A/G	cg18817487	chr12:96390143	HAL	-0.42	-5.61	-0.54	3.01e-7	Metabolite levels (small molecules and protein measures);
SKCM	trans	rs1814175	0.740	rs10839439	chr11:49918240	C/T	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs694739	0.796	rs479777	chr11:64107477	A/G	cg23796481	chr11:64053134	BAD;GPR137	0.75	6.08	0.57	4.08e-8	Alopecia areata;Crohn's disease;Psoriasis vulgaris;
SKCM	cis	rs7208859	0.623	rs7217984	chr17:29092766	G/A	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs914615	0.508	rs7535292	chr1:155127749	T/C	cg02153340	chr1:155202674	NA	-0.57	-4.94	-0.49	4.42e-6	Urinary albumin-to-creatinine ratio;
SKCM	cis	rs1799949	0.894	rs36062488	chr17:41337472	C/T	cg23758822	chr17:41437982	NA	-0.94	-7.67	-0.66	4.03e-11	Menopause (age at onset);
SKCM	cis	rs35306767	0.903	rs11253458	chr10:882843	T/C	cg26597838	chr10:835615	NA	0.77	5.39	0.52	7.26e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs60871478	0.947	rs7790823	chr7:788923	T/G	cg05535760	chr7:792225	HEATR2	1.01	8.42	0.69	1.45e-12	Cerebrospinal P-tau181p levels;
SKCM	cis	rs826838	0.967	rs1719854	chr12:39127707	G/A	cg26384229	chr12:38710491	ALG10B	-0.91	-8.28	-0.68	2.74e-12	Heart rate;
SKCM	cis	rs1048257	0.553	rs2819421	chr14:105408811	A/G	cg19901468	chr14:105411992	AHNAK2	-0.95	-7.32	-0.64	1.9e-10	Systemic lupus erythematosus;
SKCM	cis	rs244731	0.881	rs62397242	chr5:176738538	C/A	cg16006841	chr5:176797999	RGS14	0.87	6.99	0.62	8.27e-10	Urate levels in lean individuals;
SKCM	cis	rs7208859	0.623	rs11651857	chr17:28926362	G/T	cg14067834	chr17:29058358	SUZ12P	1.08	4.95	0.49	4.21e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs8014204	0.935	rs3742786	chr14:75373011	A/G	cg06637938	chr14:75390232	RPS6KL1	-0.78	-5.95	-0.56	7.25e-8	Caffeine consumption;
SKCM	cis	rs9910055	0.821	rs4473241	chr17:42281282	G/T	cg08499158	chr17:42289980	UBTF	-0.77	-6.46	-0.59	8.21e-9	Total body bone mineral density;
SKCM	cis	rs3784262	0.669	rs4646564	chr15:58351797	G/A	cg12031962	chr15:58353849	ALDH1A2	-0.42	-4.89	-0.48	5.38e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs1801251	0.752	rs2675966	chr2:233735543	T/C	cg25237894	chr2:233734115	C2orf82	-0.59	-6.34	-0.58	1.36e-8	Coronary artery disease;
SKCM	cis	rs10870270	0.957	rs3829156	chr10:133789386	C/G	cg17892150	chr10:133769511	PPP2R2D	-0.67	-4.82	-0.48	7.02e-6	Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals;
SKCM	cis	rs1707322	0.686	rs61784833	chr1:46233772	T/C	cg03146154	chr1:46216737	IPP	0.84	6.26	0.58	1.97e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs507080	0.845	rs509641	chr11:118558952	T/C	cg18045108	chr11:118530628	TREH	-0.47	-4.81	-0.48	7.24e-6	Serum metabolite levels;
SKCM	cis	rs4423214	0.959	rs12800438	chr11:71171003	G/A	cg05163923	chr11:71159392	DHCR7	0.83	8.11	0.68	5.77e-12	Vitamin D levels;
SKCM	cis	rs4243830	0.850	rs7552196	chr1:6590502	G/A	cg22792644	chr1:6614718	TAS1R1;NOL9	-1.09	-5.23	-0.51	1.41e-6	Body mass index;
SKCM	cis	rs9926296	0.585	rs8058009	chr16:89856439	G/A	cg26513180	chr16:89883248	FANCA	1.02	7.35	0.64	1.66e-10	Vitiligo;
SKCM	cis	rs959260	0.557	rs55762977	chr17:73309338	A/G	cg14668889	chr17:73230827	NUP85	0.81	6.57	0.6	5.05e-9	Systemic lupus erythematosus;
SKCM	cis	rs6582630	0.519	rs11514056	chr12:38284001	G/T	cg26384229	chr12:38710491	ALG10B	0.85	6.78	0.61	2.05e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs2303759	0.515	rs2334867	chr19:49788205	C/T	cg05022225	chr19:49866942	DKKL1;TEAD2	-0.69	-5.27	-0.51	1.2e-6	Multiple sclerosis;
SKCM	cis	rs2204008	0.715	rs12815986	chr12:38343869	G/A	cg13010199	chr12:38710504	ALG10B	0.69	4.92	0.49	4.75e-6	Bladder cancer;
SKCM	cis	rs763014	0.966	rs4247097	chr16:654224	G/A	cg09263875	chr16:632152	PIGQ	0.69	6.18	0.57	2.73e-8	Height;
SKCM	cis	rs9910055	0.529	rs228764	chr17:42185469	A/G	cg19774624	chr17:42201019	HDAC5	0.83	6.53	0.59	6.08e-9	Total body bone mineral density;
SKCM	cis	rs780096	0.546	rs8179225	chr2:27737181	A/G	cg05696406	chr2:27599888	SNX17	0.51	5.09	0.5	2.45e-6	Total body bone mineral density;
SKCM	cis	rs910316	0.810	rs77939209	chr14:75670070	A/G	cg08847533	chr14:75593920	NEK9	-1.0	-9.18	-0.72	4.82e-14	Height;
SKCM	trans	rs17685	0.753	rs4728586	chr7:75802869	T/C	cg19862616	chr7:65841803	NCRNA00174	0.97	10.73	0.77	5.13e-17	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7666738	0.830	rs921523	chr4:98841659	C/T	cg17366294	chr4:99064904	C4orf37	0.56	4.92	0.49	4.8e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs597539	0.552	rs6591360	chr11:68718669	G/T	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.74	4.92	0.49	4.79e-6	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs2255932	1.000	rs2256061	chr3:183212026	A/G	cg20852557	chr3:184035519	EIF4G1	0.69	5.91	0.56	8.48e-8	Interleukin-1-beta levels;
SKCM	cis	rs60871478	0.636	rs73045423	chr7:893952	G/A	cg05535760	chr7:792225	HEATR2	-1.3	-7.8	-0.66	2.27e-11	Cerebrospinal P-tau181p levels;
SKCM	cis	rs826838	0.754	rs2387920	chr12:38626351	A/G	cg13010199	chr12:38710504	ALG10B	0.64	4.91	0.49	4.85e-6	Heart rate;
SKCM	cis	rs77216612	0.877	rs72656645	chr12:12881055	A/G	cg09462578	chr12:12878428	APOLD1	-0.84	-5.53	-0.53	4.17e-7	Lymphocyte counts;
SKCM	cis	rs870825	0.860	rs72689297	chr4:185600957	A/T	cg04058563	chr4:185651563	MLF1IP	1.04	5.96	0.56	7.02e-8	Blood protein levels;
SKCM	cis	rs34375054	0.660	rs57491100	chr12:125593010	C/T	cg25124228	chr12:125621409	AACS	-0.71	-5.63	-0.54	2.74e-7	Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs6580649	0.941	rs78649179	chr12:48508196	T/A	cg05342945	chr12:48394962	COL2A1	0.79	5.39	0.52	7.22e-7	Lung cancer;
SKCM	cis	rs7666738	0.861	rs28829607	chr4:98964325	G/C	cg17366294	chr4:99064904	C4orf37	0.59	4.89	0.48	5.36e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2839186	0.770	rs2839171	chr21:47673247	C/T	cg11766577	chr21:47581405	C21orf56	0.76	6.51	0.59	6.55e-9	Testicular germ cell tumor;
SKCM	cis	rs2404602	0.647	rs11072607	chr15:76908529	C/T	cg23625390	chr15:77176239	SCAPER	-0.85	-8.26	-0.68	2.93e-12	Blood metabolite levels;
SKCM	cis	rs1401999	0.898	rs6443928	chr3:183729487	C/T	cg01324343	chr3:183735012	ABCC5	0.88	10.48	0.76	1.5e-16	Anterior chamber depth;
SKCM	cis	rs798766	0.903	rs811316	chr4:1689377	T/C	cg05874882	chr4:1763078	NA	-0.67	-5.9	-0.56	8.91e-8	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs7829975	0.593	rs2921051	chr8:8320104	C/A	cg08975724	chr8:8085496	FLJ10661	0.78	6.85	0.61	1.52e-9	Mood instability;
SKCM	cis	rs7408868	0.706	rs2238642	chr19:15282237	T/C	cg14696996	chr19:15285081	NOTCH3	0.82	4.92	0.49	4.7e-6	Pulse pressure;
SKCM	cis	rs11098499	0.532	rs12512646	chr4:120585733	G/A	cg09307838	chr4:120376055	NA	0.93	7.7	0.66	3.54e-11	Corneal astigmatism;
SKCM	cis	rs77216612	0.835	rs10845621	chr12:12887977	C/T	cg09462578	chr12:12878428	APOLD1	-0.81	-5.6	-0.54	3.13e-7	Lymphocyte counts;
SKCM	cis	rs8170	0.603	rs971693	chr19:17422649	G/C	cg07830086	chr19:18107778	KCNN1	-0.8	-4.99	-0.49	3.54e-6	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Ovarian cancer;Breast cancer;Epithelial ovarian cancer;
SKCM	cis	rs7539542	0.622	rs10920529	chr1:202902597	G/A	cg19681188	chr1:202830198	LOC148709	0.66	4.85	0.48	6.16e-6	Mean platelet volume;
SKCM	cis	rs644799	0.710	rs473852	chr11:95568757	C/A	cg03916912	chr11:95522834	CEP57;FAM76B	0.77	6.33	0.58	1.46e-8	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs1153858	1.000	rs4534782	chr15:45652933	G/A	cg10760299	chr15:45669010	GATM	0.62	6.35	0.58	1.3e-8	Homoarginine levels;
SKCM	cis	rs6088590	1.000	rs6120705	chr20:33313740	T/C	cg24642439	chr20:33292090	TP53INP2	1.01	7.39	0.64	1.39e-10	Coronary artery disease;
SKCM	cis	rs9902453	0.933	rs8074028	chr17:28461687	T/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.5	0.53	4.74e-7	Coffee consumption (cups per day);
SKCM	cis	rs6545883	0.965	rs766447	chr2:61735569	C/T	cg15711740	chr2:61764176	XPO1	-0.73	-5.27	-0.51	1.19e-6	Tuberculosis;
SKCM	cis	rs2033711	0.870	rs4801270	chr19:58932762	C/A	cg00825309	chr19:58991885	ZNF446	-0.69	-5.59	-0.53	3.19e-7	Uric acid clearance;
SKCM	cis	rs11690935	0.959	rs3770452	chr2:172668682	A/G	cg13550731	chr2:172543902	DYNC1I2	-0.99	-8.58	-0.7	7.21e-13	Schizophrenia;
SKCM	cis	rs5769765	1.000	rs5769765	chr22:50271176	G/A	cg22709217	chr22:50311962	ALG12;CRELD2	0.79	5.71	0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs7659604	1.000	rs7689714	chr4:122665943	T/A	cg06713675	chr4:122721982	EXOSC9	-0.61	-5.5	-0.53	4.64e-7	Type 2 diabetes;
SKCM	cis	rs28386778	0.897	rs1877318	chr17:61819960	G/A	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.36	0.52	8.06e-7	Prudent dietary pattern;
SKCM	cis	rs6952808	0.692	rs6950627	chr7:2086672	C/T	cg02951883	chr7:2050386	MAD1L1	-0.83	-7.46	-0.65	1.05e-10	Bipolar disorder and schizophrenia;
SKCM	cis	rs2811415	0.597	rs1057156	chr3:127800071	A/G	cg09089421	chr3:127803668	RUVBL1	0.99	8.46	0.69	1.23e-12	Lung function (FEV1/FVC);
SKCM	cis	rs847649	1.000	rs847649	chr7:102556011	C/T	cg18108683	chr7:102477205	FBXL13	-0.81	-8.31	-0.69	2.36e-12	Morning vs. evening chronotype;
SKCM	cis	rs6952808	0.575	rs6950330	chr7:1953606	T/C	cg21782813	chr7:2030301	MAD1L1	0.51	5.42	0.52	6.33e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs116095464	0.558	rs9312978	chr5:221930	C/G	cg22857025	chr5:266934	NA	-1.44	-7.74	-0.66	2.94e-11	Breast cancer;
SKCM	cis	rs589448	0.902	rs2603090	chr12:69777188	G/A	cg20891283	chr12:69753455	YEATS4	0.98	9.95	0.75	1.58e-15	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs7208859	0.623	rs28627615	chr17:29145817	G/C	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs2243480	1.000	rs35396113	chr7:65495461	C/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs440932	1.000	rs440932	chr8:9026929	T/C	cg06636001	chr8:8085503	FLJ10661	0.65	4.88	0.48	5.55e-6	High light scatter reticulocyte percentage of red cells;
SKCM	cis	rs875971	0.660	rs13224319	chr7:66007363	A/G	cg11764359	chr7:65958608	NA	0.86	6.6	0.6	4.52e-9	Aortic root size;
SKCM	cis	rs9399135	0.967	rs59329760	chr6:135342437	G/A	cg24558204	chr6:135376177	HBS1L	0.6	5.36	0.52	8.17e-7	Red blood cell count;
SKCM	cis	rs2439831	0.867	rs12323999	chr15:43683115	T/A	cg02155558	chr15:43621948	ADAL;LCMT2	1.22	8.31	0.69	2.36e-12	Lung cancer in ever smokers;
SKCM	cis	rs10905065	0.930	rs7909988	chr10:5736388	A/T	cg09234995	chr10:5726438	C10orf18	-0.62	-5.48	-0.53	4.94e-7	Menopause (age at onset);
SKCM	cis	rs11098499	0.954	rs56270433	chr4:120406030	C/T	cg24375607	chr4:120327624	NA	0.66	5.09	0.5	2.44e-6	Corneal astigmatism;
SKCM	cis	rs908922	0.651	rs10888493	chr1:152503913	G/A	cg09873164	chr1:152488093	CRCT1	0.76	5.93	0.56	7.7e-8	Hair morphology;
SKCM	cis	rs3540	0.576	rs10152871	chr15:91047469	G/A	cg22089800	chr15:90895588	ZNF774	-0.68	-4.92	-0.49	4.72e-6	Allergic disease (asthma, hay fever or eczema);Lymphocyte counts;
SKCM	cis	rs1577917	0.917	rs13196576	chr6:86534066	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.33	-0.52	9.19e-7	Response to antipsychotic treatment;
SKCM	cis	rs2839186	0.647	rs9976233	chr21:47616913	G/A	cg05896524	chr21:47604654	C21orf56	-0.73	-6.14	-0.57	3.26e-8	Testicular germ cell tumor;
SKCM	cis	rs12802244	1	rs12802244	chr11:47932666	G/A	cg05585544	chr11:47624801	NA	-0.66	-5.76	-0.55	1.6e-7	Neuroticism;
SKCM	cis	rs9911578	0.867	rs72628394	chr17:57121313	C/T	cg12560992	chr17:57184187	TRIM37	-1.07	-9.66	-0.74	5.61e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs10911232	0.507	rs4397624	chr1:183053131	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.78	6.87	0.61	1.42e-9	Hypertriglyceridemia;
SKCM	cis	rs9399135	0.967	rs9376082	chr6:135346389	T/A	cg24558204	chr6:135376177	HBS1L	0.6	5.36	0.52	8.17e-7	Red blood cell count;
SKCM	cis	rs4919087	0.962	rs10882883	chr10:99013312	A/G	cg25902810	chr10:99078978	FRAT1	0.64	5.14	0.5	1.97e-6	Monocyte count;
SKCM	cis	rs2730245	1.000	rs6965685	chr7:158726462	C/T	cg24397884	chr7:158709396	WDR60	1.03	9.52	0.73	1.07e-14	Height;
SKCM	cis	rs1552244	0.882	rs6796419	chr3:10040812	G/A	cg02579736	chr3:10068473	FANCD2;CIDECP	0.94	4.84	0.48	6.49e-6	Alzheimer's disease;
SKCM	cis	rs6998277	0.830	rs6468836	chr8:103602630	A/G	cg10187029	chr8:103597600	NA	0.76	6.31	0.58	1.54e-8	Migraine;
SKCM	cis	rs798554	0.796	rs2533884	chr7:2836848	T/G	cg19346786	chr7:2764209	NA	-0.65	-7.13	-0.63	4.53e-10	Height;
SKCM	cis	rs8067545	0.611	rs6587219	chr17:20034531	T/G	cg13482628	chr17:19912719	NA	0.66	5.61	0.54	2.98e-7	Schizophrenia;
SKCM	cis	rs7666738	0.830	rs1593572	chr4:98979322	A/G	cg17366294	chr4:99064904	C4orf37	-0.6	-4.87	-0.48	5.68e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs60871478	0.786	rs55940979	chr7:837740	T/G	cg05535760	chr7:792225	HEATR2	-1.13	-9.07	-0.72	7.74e-14	Cerebrospinal P-tau181p levels;
SKCM	trans	rs561341	1.000	rs4795667	chr17:30244443	T/C	cg20587970	chr11:113659929	NA	-0.98	-7.89	-0.67	1.56e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs939658	0.683	rs1474256	chr15:79463847	C/T	cg10259521	chr15:79428573	NA	-0.49	-5.07	-0.5	2.6e-6	Refractive error;
SKCM	cis	rs208515	0.556	rs12206707	chr6:66697182	A/G	cg07460842	chr6:66804631	NA	0.93	6.34	0.58	1.37e-8	Exhaled nitric oxide levels;
SKCM	cis	rs2839186	0.814	rs13052376	chr21:47707403	G/C	cg05896524	chr21:47604654	C21orf56	0.69	5.67	0.54	2.29e-7	Testicular germ cell tumor;
SKCM	cis	rs35306767	0.909	rs12264390	chr10:959111	T/C	cg26597838	chr10:835615	NA	0.67	5.22	0.51	1.44e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs28595532	0.920	rs114243409	chr4:119756585	C/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs875971	0.789	rs10260426	chr7:65736042	G/T	cg11764359	chr7:65958608	NA	-0.76	-7.0	-0.62	8.03e-10	Aortic root size;
SKCM	cis	rs7215564	0.730	rs34484282	chr17:78684663	G/A	cg16980736	chr17:78789706	RPTOR	-0.88	-4.83	-0.48	6.66e-6	Myopia (pathological);
SKCM	cis	rs561341	0.941	rs501773	chr17:30314435	T/G	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs738322	0.553	rs28565947	chr22:38570775	C/G	cg25457927	chr22:38595422	NA	-0.6	-7.08	-0.63	5.46e-10	Cutaneous nevi;
SKCM	cis	rs59918340	0.764	rs10101692	chr8:142230823	C/T	cg23750338	chr8:142222470	SLC45A4	0.63	5.98	0.56	6.36e-8	Immature fraction of reticulocytes;
SKCM	cis	rs9469913	0.551	rs3800406	chr6:35133074	A/G	cg16257762	chr6:35748837	C6orf127	-0.78	-5.2	-0.51	1.57e-6	Body mass index (joint analysis main effects and physical activity interaction);Body mass index;Body mass index in physically active individuals;
SKCM	cis	rs968451	0.547	rs11704319	chr22:39722886	A/G	cg17798944	chr22:39715225	SNORD43;RPL3	-1.08	-11.08	-0.78	1.09e-17	Primary biliary cholangitis;
SKCM	cis	rs10791097	0.629	rs11222361	chr11:130731424	T/G	cg12179176	chr11:130786555	SNX19	0.72	5.67	0.54	2.28e-7	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs35146811	0.624	rs1727134	chr7:99813672	T/C	cg22906224	chr7:99728672	NA	-0.71	-5.61	-0.54	2.95e-7	Coronary artery disease;
SKCM	cis	rs2811415	0.597	rs1042907	chr3:127789172	G/C	cg09089421	chr3:127803668	RUVBL1	1.0	8.69	0.7	4.4e-13	Lung function (FEV1/FVC);
SKCM	cis	rs1691799	0.867	rs1168343	chr12:66758581	C/T	cg16791601	chr12:66731901	HELB	-0.63	-5.63	-0.54	2.72e-7	White blood cell count (basophil);
SKCM	cis	rs6570726	0.902	rs4895678	chr6:145935510	C/T	cg23711669	chr6:146136114	FBXO30	0.69	6.4	0.59	1.08e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4319547	0.695	rs113841747	chr12:122886088	G/T	cg23029597	chr12:123009494	RSRC2	0.73	5.37	0.52	7.93e-7	Body mass index;
SKCM	cis	rs2153535	0.580	rs9392220	chr6:8457946	G/A	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs5769765	0.908	rs9616213	chr22:50317851	T/G	cg22709217	chr22:50311962	ALG12;CRELD2	-0.99	-6.09	-0.57	4.04e-8	Schizophrenia;
SKCM	cis	rs644799	1.000	rs651445	chr11:95539122	T/A	cg25622487	chr11:95524042	FAM76B;CEP57	0.66	5.12	0.5	2.18e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs4073582	0.595	rs801731	chr11:65938446	G/C	cg14036092	chr11:66035641	RAB1B	0.74	5.8	0.55	1.34e-7	Gout;
SKCM	trans	rs1814175	0.817	rs4405313	chr11:50013636	G/A	cg15704280	chr7:45808275	SEPT13	-1.05	-11.07	-0.78	1.14e-17	Height;
SKCM	cis	rs62103177	0.608	rs551643	chr18:77838970	C/G	cg06309094	chr18:77676213	PQLC1	0.82	5.02	0.49	3.21e-6	Opioid sensitivity;
SKCM	cis	rs908922	0.627	rs11590073	chr1:152500810	C/T	cg09873164	chr1:152488093	CRCT1	0.76	5.93	0.56	7.7e-8	Hair morphology;
SKCM	cis	rs9910055	0.573	rs228768	chr17:42191893	A/C	cg08499158	chr17:42289980	UBTF	-0.71	-5.64	-0.54	2.6e-7	Total body bone mineral density;
SKCM	cis	rs17685	0.672	rs10952841	chr7:75778626	A/C	cg16684958	chr7:75615977	POR	0.52	5.03	0.49	3.11e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs17270561	0.609	rs1937127	chr6:25769872	G/T	cg19271133	chr6:26027581	HIST1H4B	0.61	4.79	0.48	7.77e-6	Iron status biomarkers;
SKCM	cis	rs514406	0.893	rs1242326	chr1:53399104	C/A	cg08859206	chr1:53392774	SCP2	-0.62	-5.01	-0.49	3.28e-6	Monocyte count;
SKCM	cis	rs4819052	0.851	rs2838845	chr21:46670812	A/G	cg19498844	chr21:46707878	POFUT2;LOC642852	0.89	7.64	0.65	4.59e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	trans	rs1814175	0.645	rs10128563	chr11:50023681	T/C	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs7659604	0.540	rs11934307	chr4:122677514	G/A	cg19671926	chr4:122722719	EXOSC9	0.77	6.27	0.58	1.89e-8	Type 2 diabetes;
SKCM	cis	rs561341	0.883	rs6505274	chr17:30344581	G/T	cg23018236	chr17:30244563	NA	-0.52	-5.56	-0.53	3.64e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs6840360	0.638	rs2406974	chr4:152601841	G/A	cg22705602	chr4:152727874	NA	-0.56	-7.27	-0.64	2.38e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs1707322	1.000	rs12097761	chr1:46291162	T/C	cg03146154	chr1:46216737	IPP	0.74	5.0	0.49	3.39e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs763014	0.931	rs59476302	chr16:629006	C/T	cg07343612	chr16:622815	PIGQ	-0.7	-6.0	-0.56	5.84e-8	Height;
SKCM	cis	rs28386778	0.668	rs2286564	chr17:62009991	A/G	cg23090583	chr17:61904693	PSMC5;FTSJ3	-0.78	-6.42	-0.59	9.98e-9	Prudent dietary pattern;
SKCM	cis	rs514406	0.505	rs374662	chr1:53164549	C/A	cg16325326	chr1:53192061	ZYG11B	0.91	10.29	0.76	3.51e-16	Monocyte count;
SKCM	cis	rs9303401	0.614	rs34920953	chr17:56589406	G/A	cg10487724	chr17:56770010	TEX14;RAD51C	0.85	6.03	0.56	5.14e-8	Cognitive test performance;
SKCM	cis	rs1348850	0.914	rs10194648	chr2:178337031	G/A	cg02961200	chr2:178257176	LOC100130691;AGPS	0.82	5.92	0.56	8.05e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs440932	0.747	rs330946	chr8:9022177	A/C	cg15556689	chr8:8085844	FLJ10661	0.62	4.91	0.49	4.81e-6	High light scatter reticulocyte percentage of red cells;
SKCM	cis	rs6977660	0.714	rs10229108	chr7:19824253	G/A	cg05791153	chr7:19748676	TWISTNB	0.77	5.02	0.49	3.23e-6	Thyroid stimulating hormone;
SKCM	cis	rs875971	0.577	rs34888281	chr7:65585771	C/T	cg11764359	chr7:65958608	NA	-0.93	-7.45	-0.64	1.09e-10	Aortic root size;
SKCM	cis	rs6500395	0.775	rs4277341	chr16:48664387	T/G	cg04672837	chr16:48644449	N4BP1	0.6	4.88	0.48	5.59e-6	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs708547	0.830	rs1713983	chr4:57883084	A/G	cg16868167	chr4:57843880	C4orf14;POLR2B	0.74	5.22	0.51	1.46e-6	Response to bleomycin (chromatid breaks);
SKCM	cis	rs6504249	0.893	rs2521827	chr17:62692728	T/G	cg02097616	chr17:62675921	NA	0.76	6.4	0.59	1.08e-8	Joint mobility (Beighton score);
SKCM	cis	rs801193	1.000	rs2659889	chr7:66217112	A/G	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.56	4.82	0.48	7.04e-6	Aortic root size;
SKCM	cis	rs6912958	0.703	rs6903219	chr6:88096498	G/A	cg08069147	chr6:88032118	GJB7;C6orf162	0.63	5.29	0.51	1.09e-6	Monocyte percentage of white cells;
SKCM	cis	rs67311347	0.544	rs9877105	chr3:40333366	T/C	cg00091569	chr3:40428383	ENTPD3	0.6	5.28	0.51	1.15e-6	Renal cell carcinoma;
SKCM	cis	rs2204008	0.774	rs11495721	chr12:38337224	A/C	cg26384229	chr12:38710491	ALG10B	0.81	6.56	0.6	5.29e-9	Bladder cancer;
SKCM	cis	rs951366	0.617	rs9438393	chr1:205782718	A/G	cg14893161	chr1:205819251	PM20D1	1.07	13.37	0.83	7.13e-22	Menarche (age at onset);
SKCM	cis	rs3812762	0.957	rs6484008	chr11:8754148	A/G	cg21881798	chr11:8931708	C11orf17;ST5	0.52	4.77	0.48	8.51e-6	Hypospadias;
SKCM	cis	rs758747	0.514	rs735830	chr16:3695354	A/G	cg02127172	chr16:3629620	NA	-0.61	-4.8	-0.48	7.44e-6	Body mass index;
SKCM	cis	rs75229567	0.618	rs10219700	chr12:70201730	A/G	cg10114359	chr12:70132523	RAB3IP	-1.17	-5.33	-0.52	9.41e-7	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes;
SKCM	cis	rs1799949	1.000	rs4793215	chr17:41318932	G/A	cg05368731	chr17:41323189	NBR1	0.89	7.98	0.67	1.03e-11	Menopause (age at onset);
SKCM	cis	rs2289583	0.517	rs2004278	chr15:75264363	C/T	cg18866210	chr15:74343476	NA	0.63	4.93	0.49	4.52e-6	Systemic lupus erythematosus;
SKCM	cis	rs17381785	0.545	rs1494947	chr4:14969983	T/G	cg12377275	chr4:15005593	CPEB2	0.83	5.79	0.55	1.44e-7	Urate levels in overweight individuals;
SKCM	cis	rs732765	0.734	rs6574189	chr14:75166493	C/T	cg15890469	chr14:75408846	PGF	0.57	4.77	0.48	8.34e-6	Non-small cell lung cancer;
SKCM	cis	rs2050392	0.928	rs2250077	chr10:30702929	A/G	cg25182066	chr10:30743637	MAP3K8	-0.71	-6.26	-0.58	1.98e-8	Inflammatory bowel disease;
SKCM	cis	rs8078723	0.677	rs8073254	chr17:38149350	C/G	cg17467752	chr17:38218738	THRA	-0.61	-5.49	-0.53	4.75e-7	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs6753739	0.661	rs6736922	chr2:219903258	T/G	cg09617556	chr2:219924408	IHH	0.49	5.15	0.5	1.89e-6	Height;
SKCM	cis	rs7666738	0.830	rs3852123	chr4:98697586	A/G	cg17366294	chr4:99064904	C4orf37	0.56	4.86	0.48	5.96e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7599312	0.534	rs6435711	chr2:213410065	G/A	cg20637307	chr2:213403960	ERBB4	0.77	5.57	0.53	3.48e-7	BMI (adjusted for smoking behaviour);BMI in non-smokers;Body mass index;Body mass index (joint analysis main effects and smoking interaction);
SKCM	cis	rs9916302	0.706	rs590051	chr17:37446571	T/C	cg07936489	chr17:37558343	FBXL20	1.0	7.19	0.63	3.42e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs9910055	0.530	rs2269906	chr17:42294337	G/T	cg13607699	chr17:42295918	UBTF	-0.85	-7.14	-0.63	4.19e-10	Total body bone mineral density;
SKCM	cis	rs1801251	0.964	rs12472839	chr2:233559615	A/G	cg25237894	chr2:233734115	C2orf82	0.58	5.27	0.51	1.16e-6	Coronary artery disease;
SKCM	cis	rs6723226	0.881	rs10181198	chr2:32686582	A/G	cg02381751	chr2:32503542	YIPF4	0.78	5.54	0.53	3.98e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs3820068	0.532	rs6701009	chr1:15935614	T/C	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs7777754	0.512	rs11238131	chr7:50538589	T/C	cg18232548	chr7:50535776	DDC	-0.92	-7.04	-0.62	6.47e-10	Response to zileuton treatment in asthma (FEV1 change interaction);
SKCM	cis	rs10504229	0.683	rs2291765	chr8:58142874	C/T	cg02725872	chr8:58115012	NA	-0.49	-4.95	-0.49	4.23e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs9420	1.000	rs9420	chr11:57510294	A/G	cg19752551	chr11:57585705	CTNND1	0.7	7.21	0.63	3.18e-10	Schizophrenia;
SKCM	cis	rs7811142	1.000	rs7787620	chr7:100089234	A/G	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.24	7.92	0.67	1.36e-11	Platelet count;
SKCM	cis	rs67311347	0.544	rs12054197	chr3:40337562	C/T	cg02782426	chr3:40428986	ENTPD3	0.52	5.3	0.51	1.06e-6	Renal cell carcinoma;
SKCM	cis	rs875971	0.893	rs62465470	chr7:65601218	T/C	cg18876405	chr7:65276391	NA	-0.65	-6.63	-0.6	3.96e-9	Aortic root size;
SKCM	cis	rs6500395	1.000	rs1362636	chr16:48712779	T/C	cg04672837	chr16:48644449	N4BP1	-0.63	-5.37	-0.52	8.01e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs12477438	0.520	rs13012481	chr2:99754290	C/A	cg26064155	chr2:99771622	LIPT1;TSGA10	1.05	10.1	0.75	7.95e-16	Chronic sinus infection;
SKCM	cis	rs13266463	0.830	rs7014552	chr8:143410423	A/G	cg16886403	chr8:143471632	TSNARE1	0.8	5.64	0.54	2.66e-7	Schizophrenia;
SKCM	cis	rs8077889	0.917	rs72836556	chr17:41911824	G/T	cg26893861	chr17:41843967	DUSP3	1.15	7.34	0.64	1.79e-10	Triglycerides;
SKCM	cis	rs9911578	0.813	rs8066773	chr17:56601552	A/G	cg05425664	chr17:57184151	TRIM37	-0.65	-4.78	-0.48	8.15e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs96067	0.711	rs272827	chr1:36627191	C/T	cg24686825	chr1:36642396	MAP7D1	0.73	5.89	0.56	9.16e-8	Corneal structure;
SKCM	cis	rs2730245	0.527	rs842707	chr7:158656012	C/T	cg24397884	chr7:158709396	WDR60	0.99	5.61	0.54	2.97e-7	Height;
SKCM	cis	rs709400	0.663	rs10141388	chr14:103939679	A/G	cg26031613	chr14:104095156	KLC1	0.72	5.65	0.54	2.49e-7	Body mass index;
SKCM	cis	rs909674	0.514	rs7423	chr22:39781429	C/T	cg11247378	chr22:39784982	NA	-0.48	-5.77	-0.55	1.51e-7	IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis);IgG glycosylation;IgG digalactosylation phenotypes (multivariate analysis);IgG sialylation phenotypes (multivariate analysis);IgG monogalactosylation phenotypes (multivariate analysis);IgG fucosylation phenotypes (multivariate analysis);IgG N-glycosylation phenotypes (multivariate analysis);IgG disialylation phenotypes (multivariate analysis);IgG galactosylation phenotypes (multivariate analysis);Post bronchodilator FEV1;
SKCM	cis	rs9814567	0.929	rs13316205	chr3:134223563	G/A	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.65	-5.0	-0.49	3.43e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs2836974	0.899	rs34433511	chr21:40618883	A/C	cg11644478	chr21:40555479	PSMG1	0.97	10.08	0.75	8.76e-16	Cognitive function;
SKCM	cis	rs9899728	0.539	rs35928207	chr17:73033629	T/G	cg27626185	chr17:73056755	KCTD2	-1.34	-7.89	-0.67	1.55e-11	Alzheimer's disease or small vessel stroke;
SKCM	cis	rs3087591	0.960	rs2953012	chr17:29496486	A/G	cg24425628	chr17:29625626	OMG;NF1	0.64	5.31	0.52	9.85e-7	Hip circumference;
SKCM	cis	rs870825	0.616	rs28660669	chr4:185623312	C/T	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs17685	0.890	rs76021834	chr7:75607155	A/G	cg16684958	chr7:75615977	POR	0.68	6.57	0.6	5.03e-9	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs8060686	0.641	rs112099181	chr16:68154230	T/C	cg04539111	chr16:67997858	SLC12A4	-0.85	-4.81	-0.48	7.14e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs910316	0.591	rs7157158	chr14:75457238	A/G	cg08847533	chr14:75593920	NEK9	0.82	7.08	0.63	5.47e-10	Height;
SKCM	cis	rs7296418	0.630	rs28419092	chr12:123812629	G/C	cg00376283	chr12:123451042	ABCB9	0.82	6.54	0.6	5.78e-9	Platelet count;
SKCM	cis	rs2239547	0.522	rs2336669	chr3:52994138	C/T	cg11645453	chr3:52864694	ITIH4	-0.58	-4.96	-0.49	3.98e-6	Schizophrenia;
SKCM	cis	rs7937682	0.889	rs11213969	chr11:111528441	A/G	cg09085632	chr11:111637200	PPP2R1B	-1.05	-12.29	-0.81	6.25e-20	Primary sclerosing cholangitis;
SKCM	cis	rs823143	0.570	rs823084	chr1:205798313	G/T	cg23034840	chr1:205782522	SLC41A1	0.64	4.84	0.48	6.53e-6	Monocyte percentage of white cells;
SKCM	cis	rs7811142	0.830	rs73401450	chr7:99981859	G/C	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.2	7.87	0.67	1.7e-11	Platelet count;
SKCM	cis	rs9325144	0.555	rs1843867	chr12:38703855	A/G	cg13010199	chr12:38710504	ALG10B	-0.63	-4.92	-0.49	4.64e-6	Morning vs. evening chronotype;
SKCM	cis	rs7829975	0.742	rs7832968	chr8:8652889	G/A	cg15556689	chr8:8085844	FLJ10661	0.67	5.68	0.54	2.2e-7	Mood instability;
SKCM	cis	rs3820928	0.874	rs6728239	chr2:227856552	A/G	cg11843606	chr2:227700838	RHBDD1	-0.61	-4.89	-0.48	5.28e-6	Pulmonary function;
SKCM	cis	rs10779751	0.762	rs6671083	chr1:11325910	A/G	cg08854313	chr1:11322531	MTOR	-0.73	-4.97	-0.49	3.93e-6	Body mass index;
SKCM	cis	rs9467773	0.620	rs2451738	chr6:26618459	A/T	cg15659132	chr6:26577336	NA	-0.62	-5.4	-0.52	6.91e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7829975	0.742	rs882462	chr8:8678530	G/A	cg06636001	chr8:8085503	FLJ10661	0.78	7.27	0.64	2.37e-10	Mood instability;
SKCM	cis	rs8177179	0.967	rs4994582	chr3:133437566	G/C	cg16262614	chr3:133464971	TF	0.43	5.24	0.51	1.33e-6	Iron status biomarkers (transferrin levels);
SKCM	cis	rs6105452	0.504	rs6110751	chr20:15684024	T/C	cg04678219	chr20:16554259	KIF16B	0.84	4.79	0.48	7.67e-6	Epstein-Barr virus copy number in lymphoblastoid cell lines;
SKCM	cis	rs7772486	0.790	rs4896852	chr6:146284621	T/C	cg23711669	chr6:146136114	FBXO30	-0.78	-7.4	-0.64	1.36e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs362296	0.661	rs3095078	chr4:3265479	C/T	cg05297308	chr4:3317976	RGS12	-0.69	-5.85	-0.55	1.12e-7	Parental longevity (mother's age at death);
SKCM	cis	rs2816062	0.813	rs2816040	chr1:18889536	C/T	cg15026089	chr1:19640712	PQLC2	0.45	4.85	0.48	6.18e-6	Urate levels in lean individuals;
SKCM	cis	rs9814567	1.000	rs9864439	chr3:134298671	T/C	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs12706411	1.000	rs35760934	chr7:122058843	T/C	cg17986181	chr7:121955208	NA	-0.68	-5.06	-0.5	2.69e-6	Alzheimer disease and age of onset;
SKCM	cis	rs1577917	1.000	rs34622557	chr6:86630852	C/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.85	-8.62	-0.7	5.82e-13	Response to antipsychotic treatment;
SKCM	cis	rs4332037	0.539	rs11772627	chr7:2109821	G/C	cg23422044	chr7:1970798	MAD1L1	-0.9	-5.61	-0.54	2.93e-7	Bipolar disorder;
SKCM	cis	rs7647973	0.516	rs4536858	chr3:49193081	A/G	cg06212747	chr3:49208901	KLHDC8B	0.8	5.71	0.54	1.96e-7	Menarche (age at onset);
SKCM	cis	rs870825	0.655	rs7683556	chr4:185632019	T/A	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs4689592	0.546	rs2359012	chr4:7066053	A/C	cg19539972	chr4:7069911	GRPEL1	1.0	6.82	0.61	1.76e-9	Monocyte percentage of white cells;
SKCM	cis	rs151997	0.962	rs39955	chr5:50187501	C/A	cg06027927	chr5:50259733	NA	0.63	5.52	0.53	4.27e-7	Callous-unemotional behaviour;
SKCM	cis	rs1147199	0.585	rs1187368	chr9:87273696	A/G	cg13486759	chr9:86751815	NA	-0.63	-4.79	-0.48	7.93e-6	Body mass index;
SKCM	cis	rs8064299	0.597	rs3785539	chr17:72775099	A/G	cg25054828	chr17:72772726	NAT9;TMEM104	0.94	9.18	0.72	4.84e-14	Monocyte count;
SKCM	cis	rs7959452	0.535	rs10784771	chr12:69621264	A/G	cg20891283	chr12:69753455	YEATS4	0.65	5.75	0.55	1.64e-7	Blood protein levels;
SKCM	cis	rs1799949	0.929	rs12937015	chr17:41307473	A/C	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.15	-0.57	3.16e-8	Menopause (age at onset);
SKCM	cis	rs7149337	0.805	rs2999357	chr14:51606001	C/G	cg23942311	chr14:51606299	NA	0.65	7.48	0.65	9.58e-11	Cancer;
SKCM	cis	rs801193	0.935	rs11772264	chr7:66176387	T/C	cg18876405	chr7:65276391	NA	0.8	7.11	0.63	4.88e-10	Aortic root size;
SKCM	cis	rs3015469	0.507	rs10144496	chr14:51082183	C/A	cg25716415	chr14:50559312	C14orf183	0.5	4.8	0.48	7.53e-6	Plasma amyloid beta peptide concentrations (ABx-40);
SKCM	cis	rs875971	1.000	rs3981131	chr7:65951677	A/G	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs116095464	0.558	rs62346508	chr5:203668	T/C	cg22857025	chr5:266934	NA	-1.44	-7.74	-0.66	2.94e-11	Breast cancer;
SKCM	cis	rs4808199	0.948	rs1859287	chr19:19422187	T/C	cg03709012	chr19:19516395	GATAD2A	1.08	7.53	0.65	7.65e-11	Nonalcoholic fatty liver disease;
SKCM	cis	rs9325144	0.671	rs7486919	chr12:38767997	A/G	cg26384229	chr12:38710491	ALG10B	-0.75	-6.52	-0.59	6.23e-9	Morning vs. evening chronotype;
SKCM	cis	rs10504229	0.906	rs2270608	chr8:58194688	T/C	cg22535103	chr8:58192502	C8orf71	-0.82	-5.42	-0.52	6.35e-7	Developmental language disorder (linguistic errors);
SKCM	cis	rs7524258	0.868	rs4908451	chr1:7299618	C/G	cg07173049	chr1:7289937	CAMTA1	-0.42	-4.87	-0.48	5.79e-6	Tourette's syndrome or obsessive-compulsive disorder;
SKCM	cis	rs4819052	0.851	rs8131143	chr21:46671646	C/G	cg19498844	chr21:46707878	POFUT2;LOC642852	-0.85	-7.36	-0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7618501	0.501	rs7627864	chr3:49926613	C/G	cg24110177	chr3:50126178	RBM5	-0.77	-5.85	-0.55	1.11e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs4733781	0.736	rs7018225	chr8:131361477	A/G	cg03598731	chr8:130996123	NA	-0.56	-4.81	-0.48	7.22e-6	Tuberculosis;
SKCM	cis	rs10849605	0.698	rs7955986	chr12:1067254	C/T	cg02055889	chr12:1059459	RAD52	0.66	5.25	0.51	1.3e-6	Lung cancer;
SKCM	cis	rs2836633	0.929	rs11701577	chr21:40028906	C/T	cg05519781	chr21:40033154	ERG	0.81	7.07	0.62	5.77e-10	Coronary artery disease;
SKCM	cis	rs2204008	0.837	rs11168504	chr12:37964922	G/T	cg26384229	chr12:38710491	ALG10B	0.8	6.2	0.57	2.47e-8	Bladder cancer;
SKCM	cis	rs9611565	0.592	rs5751129	chr22:42015765	C/T	cg03806693	chr22:41940476	POLR3H	1.11	7.58	0.65	6e-11	Vitiligo;
SKCM	cis	rs4803468	1.000	rs284652	chr19:41928652	C/T	cg09537434	chr19:41945824	ATP5SL	-1.1	-13.85	-0.84	1.02e-22	Height;
SKCM	cis	rs2760061	0.626	rs592736	chr1:228116831	A/G	cg18477163	chr1:228402036	OBSCN	-0.43	-4.79	-0.48	7.85e-6	Diastolic blood pressure;
SKCM	cis	rs228769	0.636	rs11656104	chr17:42258965	A/T	cg19774624	chr17:42201019	HDAC5	-0.92	-7.39	-0.64	1.4e-10	Bone mineral density (hip);Bone mineral density (spine);
SKCM	cis	rs6089584	0.850	rs881993	chr20:60623862	A/G	cg06108461	chr20:60628389	TAF4	-0.89	-9.05	-0.72	8.53e-14	Body mass index;
SKCM	cis	rs7829975	0.633	rs2979181	chr8:8323088	A/T	cg06636001	chr8:8085503	FLJ10661	0.97	9.57	0.73	8.42e-15	Mood instability;
SKCM	trans	rs2727020	0.575	rs10769587	chr11:49549849	C/G	cg15704280	chr7:45808275	SEPT13	-0.96	-8.57	-0.7	7.28e-13	Coronary artery disease;
SKCM	cis	rs9583531	0.600	rs6492305	chr13:111361400	C/T	cg15841412	chr13:111365552	ING1	0.73	4.88	0.48	5.56e-6	Coronary artery disease;
SKCM	cis	rs1059312	1.000	rs7302634	chr12:129279931	C/T	cg09035930	chr12:129282057	SLC15A4	0.79	8.29	0.68	2.61e-12	Systemic lupus erythematosus;
SKCM	cis	rs55962025	0.737	rs2237006	chr4:3228492	A/G	cg09735869	chr4:3319127	RGS12	-0.65	-5.33	-0.52	9.21e-7	Parental longevity (mother's age at death);
SKCM	cis	rs9399137	0.507	rs28384513	chr6:135376209	T/G	cg24558204	chr6:135376177	HBS1L	0.67	5.92	0.56	8.02e-8	Glycated hemoglobin levels;Mean corpuscular volume;Hematology traits;HbA2 levels;Mean corpuscular hemoglobin;Hemoglobin levels;F-cell distribution;Platelet count;
SKCM	cis	rs7772486	0.727	rs10223508	chr6:146285205	C/T	cg23711669	chr6:146136114	FBXO30	-0.79	-7.45	-0.64	1.1e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9300255	0.510	rs1790133	chr12:123698518	T/G	cg00376283	chr12:123451042	ABCB9	0.84	5.54	0.53	3.89e-7	Neutrophil percentage of white cells;
SKCM	cis	rs6952808	0.771	rs10244946	chr7:1921068	A/G	cg21782813	chr7:2030301	MAD1L1	-0.51	-5.38	-0.52	7.6e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs4319547	0.656	rs28730465	chr12:122863864	A/C	cg23029597	chr12:123009494	RSRC2	0.72	5.31	0.52	1.01e-6	Body mass index;
SKCM	cis	rs8072100	0.582	rs3826536	chr17:45501967	T/A	cg08085267	chr17:45401833	C17orf57	-0.62	-5.06	-0.5	2.76e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs2739330	0.828	rs2330635	chr22:24251344	T/C	cg24846343	chr22:24311635	DDTL	0.63	6.0	0.56	5.93e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs1218582	0.596	rs11264275	chr1:154825270	G/T	cg06221963	chr1:154839813	KCNN3	0.51	5.26	0.51	1.24e-6	Prostate cancer;
SKCM	cis	rs7009516	0.819	rs13257101	chr8:24223583	A/T	cg01759110	chr8:24241694	ADAMDEC1	-0.45	-4.77	-0.48	8.33e-6	Hair greying;
SKCM	cis	rs854765	0.583	rs4925125	chr17:17794444	T/C	cg04398451	chr17:18023971	MYO15A	0.85	6.05	0.57	4.71e-8	Total body bone mineral density;
SKCM	cis	rs4237845	0.967	rs4553410	chr12:58301211	G/A	cg00677455	chr12:58241039	CTDSP2	0.65	5.22	0.51	1.44e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs11673344	0.764	rs826303	chr19:37442451	C/A	cg07624650	chr19:37064219	ZNF529	-0.78	-4.82	-0.48	7.05e-6	Obesity-related traits;
SKCM	cis	rs4780401	0.632	rs8055462	chr16:11834821	T/C	cg01061890	chr16:11836724	TXNDC11	-0.77	-5.58	-0.53	3.29e-7	Rheumatoid arthritis;
SKCM	cis	rs2991971	0.934	rs2991974	chr1:46020654	A/G	cg24296786	chr1:45957014	TESK2	0.65	5.25	0.51	1.28e-6	High light scatter reticulocyte count;
SKCM	cis	rs1878931	0.726	rs3843728	chr16:3448251	T/C	cg26668626	chr16:3451006	ZNF174;ZNF434	1.11	10.52	0.77	1.29e-16	Body mass index (adult);
SKCM	cis	rs752010	0.644	rs7413657	chr1:42103382	T/C	cg06885757	chr1:42089581	HIVEP3	0.54	6.26	0.58	1.92e-8	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs72634258	0.554	rs4908705	chr1:7926401	C/T	cg00042356	chr1:8021962	PARK7	0.7	4.85	0.48	6.07e-6	Inflammatory bowel disease;
SKCM	cis	rs6840360	0.571	rs17275536	chr4:152498625	C/T	cg22705602	chr4:152727874	NA	-0.51	-5.48	-0.53	5.11e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs748404	0.697	rs475227	chr15:43546446	G/C	cg02155558	chr15:43621948	ADAL;LCMT2	0.72	5.9	0.56	8.97e-8	Lung cancer;
SKCM	cis	rs4665809	0.590	rs72809688	chr2:26516579	G/A	cg26119090	chr2:26468346	HADHA;HADHB	1.08	8.63	0.7	5.67e-13	Gut microbiome composition (summer);
SKCM	cis	rs9911578	1.000	rs2643119	chr17:56827760	G/T	cg05425664	chr17:57184151	TRIM37	-0.69	-5.21	-0.51	1.52e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs929354	0.772	rs6969244	chr7:157004012	A/G	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs8180040	0.966	rs2101247	chr3:47494303	G/A	cg27129171	chr3:47204927	SETD2	-0.79	-5.79	-0.55	1.43e-7	Colorectal cancer;
SKCM	cis	rs8016982	0.674	rs3815953	chr14:81685482	G/A	cg01989461	chr14:81687754	GTF2A1	0.88	7.42	0.64	1.23e-10	Schizophrenia;
SKCM	cis	rs17685	0.753	rs1637044	chr7:75703744	T/C	cg16684958	chr7:75615977	POR	0.57	5.54	0.53	4e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1580019	0.961	rs766657	chr7:32499510	A/G	cg06627557	chr7:32535165	LSM5;AVL9	0.75	5.74	0.55	1.7e-7	Cognitive ability;
SKCM	cis	rs9911578	1.000	rs12449365	chr17:56600660	C/G	cg12560992	chr17:57184187	TRIM37	-0.95	-7.69	-0.66	3.7e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs3091242	0.900	rs1811832	chr1:25753565	G/A	cg02931644	chr1:25747376	RHCE	0.53	5.35	0.52	8.54e-7	Erythrocyte sedimentation rate;
SKCM	cis	rs2243480	1.000	rs10807701	chr7:65724686	C/A	cg18252515	chr7:66147081	NA	1.34	8.18	0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs8077889	1.000	rs2079005	chr17:41865627	T/G	cg26893861	chr17:41843967	DUSP3	1.24	7.74	0.66	3.04e-11	Triglycerides;
SKCM	cis	rs701145	0.640	rs2122365	chr3:153930808	T/G	cg17054900	chr3:154042577	DHX36	1.19	5.1	0.5	2.37e-6	Coronary artery disease;
SKCM	cis	rs6449957	0.801	rs6449953	chr5:67456530	A/G	cg09038926	chr5:67483109	NA	-0.65	-4.97	-0.49	3.92e-6	Cleft lip with or without cleft palate;
SKCM	cis	rs801193	0.967	rs2420827	chr7:66147101	G/A	cg11987759	chr7:65425863	GUSB	0.7	6.08	0.57	4.15e-8	Aortic root size;
SKCM	cis	rs9308433	0.529	rs4655246	chr1:214502898	G/C	cg06198575	chr1:214491504	SMYD2	0.82	5.16	0.5	1.8e-6	IgG glycosylation;
SKCM	cis	rs13118159	0.550	rs11946956	chr4:1369094	T/G	cg20887711	chr4:1340912	KIAA1530	0.96	7.3	0.64	2.14e-10	Longevity;
SKCM	cis	rs11098499	0.955	rs7685268	chr4:120162188	G/A	cg09307838	chr4:120376055	NA	0.95	7.75	0.66	2.84e-11	Corneal astigmatism;
SKCM	cis	rs9788682	0.947	rs7169584	chr15:78822660	A/T	cg24631222	chr15:78858424	CHRNA5	0.95	6.6	0.6	4.46e-9	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs875971	0.825	rs1129531	chr7:65619104	C/T	cg11764359	chr7:65958608	NA	-0.82	-8.26	-0.68	2.98e-12	Aortic root size;
SKCM	cis	rs8017423	0.934	rs11159952	chr14:90684874	T/C	cg04374321	chr14:90722782	PSMC1	0.95	8.38	0.69	1.69e-12	Mortality in heart failure;
SKCM	cis	rs1577917	0.917	rs1838959	chr6:86556804	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.32	-0.52	9.66e-7	Response to antipsychotic treatment;
SKCM	cis	rs67311347	0.544	rs9821440	chr3:40342347	T/C	cg00091569	chr3:40428383	ENTPD3	0.62	5.45	0.53	5.72e-7	Renal cell carcinoma;
SKCM	cis	rs376008	0.963	rs401502	chr19:18180413	C/G	cg20557202	chr19:17982930	SLC5A5	-0.38	-4.83	-0.48	6.71e-6	Blood protein levels;
SKCM	cis	rs9902453	0.845	rs3115099	chr17:28019293	T/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.82	5.78	0.55	1.47e-7	Coffee consumption (cups per day);
SKCM	cis	rs778371	0.723	rs12619195	chr2:233678326	G/A	cg08000102	chr2:233561755	GIGYF2	-0.84	-6.87	-0.61	1.38e-9	Schizophrenia;
SKCM	cis	rs4972806	0.849	rs2857535	chr2:177036211	G/A	cg13092806	chr2:177043255	NA	0.57	5.4	0.52	6.85e-7	IgG glycosylation;
SKCM	cis	rs478304	0.654	rs7947604	chr11:65442059	G/C	cg17480646	chr11:65405466	SIPA1	-0.66	-4.87	-0.48	5.75e-6	Acne (severe);
SKCM	cis	rs17376456	0.757	rs10066431	chr5:93198204	A/G	cg21475434	chr5:93447410	FAM172A	0.95	5.31	0.51	1.02e-6	Diabetic retinopathy;
SKCM	cis	rs854765	0.624	rs12952723	chr17:17731651	T/C	cg04398451	chr17:18023971	MYO15A	0.72	4.77	0.48	8.27e-6	Total body bone mineral density;
SKCM	cis	rs950776	0.518	rs12902493	chr15:78819275	C/G	cg06917634	chr15:78832804	PSMA4	1.01	10.48	0.76	1.5e-16	Sudden cardiac arrest;
SKCM	cis	rs9911578	0.935	rs117819974	chr17:57002324	C/T	cg05425664	chr17:57184151	TRIM37	-0.67	-5.04	-0.5	2.91e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs4819052	0.885	rs28576202	chr21:46674684	G/A	cg02159808	chr21:46707872	POFUT2;LOC642852	0.73	5.71	0.54	1.93e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs854765	0.547	rs2955383	chr17:17941364	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.02	9.54	0.73	9.55e-15	Total body bone mineral density;
SKCM	cis	rs2243480	1.000	rs6460261	chr7:65215580	T/C	cg18252515	chr7:66147081	NA	1.32	8.71	0.7	3.95e-13	Diabetic kidney disease;
SKCM	cis	rs7666738	0.830	rs34892904	chr4:98938097	T/C	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs362272	0.524	rs2749781	chr4:3346617	T/C	cg16987761	chr4:3318072	RGS12	0.97	11.41	0.79	2.63e-18	Serum sulfate level;
SKCM	cis	rs589448	0.538	rs683790	chr12:69751434	T/G	cg20891283	chr12:69753455	YEATS4	0.71	5.42	0.52	6.57e-7	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs6121246	0.609	rs4453755	chr20:30331047	G/A	cg13852791	chr20:30311386	BCL2L1	0.82	5.64	0.54	2.59e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs35306767	0.951	rs55742421	chr10:961037	A/C	cg26597838	chr10:835615	NA	0.73	5.81	0.55	1.3e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs2239547	0.563	rs6797399	chr3:52905917	G/A	cg11645453	chr3:52864694	ITIH4	0.76	6.87	0.61	1.4e-9	Schizophrenia;
SKCM	cis	rs838147	0.844	rs12611211	chr19:49248331	G/A	cg13540341	chr19:49222985	MAMSTR	0.56	5.06	0.5	2.77e-6	Dietary macronutrient intake;
SKCM	cis	rs7523050	0.643	rs7551142	chr1:109399710	G/T	cg08274380	chr1:109419600	GPSM2	1.13	5.57	0.53	3.54e-7	Fat distribution (HIV);
SKCM	cis	rs9300255	0.602	rs1790095	chr12:123681222	G/A	cg05973401	chr12:123451056	ABCB9	0.82	5.12	0.5	2.17e-6	Neutrophil percentage of white cells;
SKCM	cis	rs12477438	0.501	rs7608938	chr2:99782226	C/T	cg14399236	chr2:99771627	LIPT1;TSGA10	0.97	8.66	0.7	4.83e-13	Chronic sinus infection;
SKCM	cis	rs2730245	1.000	rs2730245	chr7:158724789	G/C	cg24397884	chr7:158709396	WDR60	-1.03	-9.52	-0.73	1.07e-14	Height;
SKCM	cis	rs1799949	0.930	rs4584865	chr17:41424919	C/G	cg05368731	chr17:41323189	NBR1	0.85	7.32	0.64	1.89e-10	Menopause (age at onset);
SKCM	cis	rs673604	1.000	rs7512578	chr1:35677847	T/C	cg12633102	chr1:35676489	NA	-0.68	-5.35	-0.52	8.54e-7	Endometrial cancer;
SKCM	cis	rs860295	0.650	rs12027412	chr1:155908930	G/A	cg02153340	chr1:155202674	NA	0.74	5.33	0.52	9.15e-7	Body mass index;
SKCM	cis	rs1799949	1.000	rs1135214	chr17:41292323	T/C	cg05368731	chr17:41323189	NBR1	0.89	7.91	0.67	1.38e-11	Menopause (age at onset);
SKCM	cis	rs8180040	0.966	rs57346147	chr3:47410564	C/G	cg16586182	chr3:47516702	SCAP	0.72	4.95	0.49	4.15e-6	Colorectal cancer;
SKCM	cis	rs9300255	0.507	rs1615350	chr12:123650335	C/T	cg00376283	chr12:123451042	ABCB9	0.91	7.02	0.62	7.23e-10	Neutrophil percentage of white cells;
SKCM	cis	rs55823223	0.504	rs56098714	chr17:73860303	T/C	cg10935138	chr17:73851978	WBP2	1.18	7.17	0.63	3.66e-10	Psoriasis;
SKCM	cis	rs8070624	0.574	rs9914127	chr17:17875836	A/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.04	8.4	0.69	1.6e-12	Total body bone mineral density;
SKCM	cis	rs1577917	0.958	rs1816937	chr6:86557251	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.32	-0.52	9.66e-7	Response to antipsychotic treatment;
SKCM	trans	rs561341	0.831	rs11658469	chr17:30206426	T/C	cg20587970	chr11:113659929	NA	1.07	8.37	0.69	1.77e-12	Hip circumference adjusted for BMI;
SKCM	cis	rs4555082	0.874	rs78923231	chr14:105754033	C/T	cg13114125	chr14:105738426	BRF1	-0.73	-5.62	-0.54	2.79e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs7537052	0.669	rs475591	chr1:36642420	T/C	cg24686825	chr1:36642396	MAP7D1	-0.84	-7.75	-0.66	2.88e-11	Schizophrenia;
SKCM	cis	rs701145	0.643	rs453699	chr3:153924784	A/G	cg17054900	chr3:154042577	DHX36	1.25	5.36	0.52	8.3e-7	Coronary artery disease;
SKCM	cis	rs71520386	0.634	rs13240023	chr7:22867493	C/A	cg00309339	chr7:22893653	NA	0.66	4.94	0.49	4.33e-6	Fibrinogen levels;
SKCM	cis	rs362272	0.524	rs13150241	chr4:3367281	A/G	cg11471262	chr4:3318911	RGS12	0.96	11.18	0.78	7.27e-18	Serum sulfate level;
SKCM	cis	rs861020	0.677	rs2049998	chr1:210031154	C/T	cg05527609	chr1:210001259	C1orf107	-1.17	-8.0	-0.67	9.57e-12	Orofacial clefts;
SKCM	cis	rs9303401	0.659	rs35539277	chr17:56853833	G/A	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.31	0.51	1.02e-6	Cognitive test performance;
SKCM	cis	rs56104184	0.775	rs73061699	chr19:49400511	T/C	cg19746536	chr19:49375674	PPP1R15A	1.16	5.93	0.56	7.67e-8	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs2204008	0.837	rs11180482	chr12:38235950	G/A	cg13010199	chr12:38710504	ALG10B	0.69	4.99	0.49	3.57e-6	Bladder cancer;
SKCM	cis	rs2730245	0.661	rs842696	chr7:158662698	T/C	cg24397884	chr7:158709396	WDR60	0.66	5.1	0.5	2.35e-6	Height;
SKCM	cis	rs951366	0.764	rs823143	chr1:205743425	A/C	cg07157834	chr1:205819609	PM20D1	0.82	7.37	0.64	1.55e-10	Menarche (age at onset);
SKCM	cis	rs769267	0.965	rs2315281	chr19:19480099	G/A	cg26732615	chr19:19648335	CILP2;YJEFN3	-0.69	-7.26	-0.64	2.46e-10	Tonsillectomy;
SKCM	cis	rs28595532	0.841	rs114107504	chr4:119771080	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs7666738	0.791	rs11729596	chr4:99045461	A/G	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9921192	1.000	rs251734	chr16:4321441	A/G	cg00021532	chr16:4324280	TFAP4	0.89	8.22	0.68	3.53e-12	Prostate-specific antigen levels;
SKCM	cis	rs9309711	0.922	rs13385119	chr2:3484521	G/A	cg10845886	chr2:3471009	TTC15	-0.85	-6.6	-0.6	4.42e-9	Neurofibrillary tangles;
SKCM	cis	rs7769051	0.615	rs12209144	chr6:133191064	A/T	cg22852734	chr6:133119734	C6orf192	1.03	5.44	0.52	5.94e-7	Type 2 diabetes nephropathy;
SKCM	cis	rs7666738	0.753	rs1830230	chr4:99026186	G/C	cg17366294	chr4:99064904	C4orf37	0.61	5.18	0.51	1.69e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11112613	0.713	rs73184084	chr12:105952615	T/A	cg03607813	chr12:105948248	NA	0.84	5.44	0.52	5.84e-7	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;
SKCM	cis	rs155076	1.000	rs2478824	chr13:21844144	G/C	cg11317459	chr13:21872234	NA	-1.24	-6.91	-0.62	1.19e-9	White matter hyperintensity burden;
SKCM	cis	rs362296	0.698	rs3135172	chr4:3258735	A/G	cg11471262	chr4:3318911	RGS12	-0.77	-6.77	-0.61	2.14e-9	Parental longevity (mother's age at death);
SKCM	cis	rs5753618	0.504	rs9609296	chr22:31891784	T/G	cg02404636	chr22:31891804	SFI1	0.65	5.79	0.55	1.4e-7	Colorectal cancer;
SKCM	cis	rs875971	0.545	rs4441996	chr7:65588220	T/C	cg18876405	chr7:65276391	NA	-0.64	-5.29	-0.51	1.09e-6	Aortic root size;
SKCM	cis	rs867186	1.000	rs80109502	chr20:33587596	G/A	cg04194272	chr20:33683537	NA	-1.36	-7.01	-0.62	7.44e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs9581857	0.725	rs9581853	chr13:28016236	T/C	cg22138327	chr13:27999177	GTF3A	0.93	6.24	0.58	2.1e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs1801251	1.000	rs2592102	chr2:233726772	G/T	cg25237894	chr2:233734115	C2orf82	-0.6	-5.8	-0.55	1.36e-7	Coronary artery disease;
SKCM	cis	rs561341	1.000	rs7216102	chr17:30259450	A/G	cg23018236	chr17:30244563	NA	-0.52	-5.5	-0.53	4.62e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs10751667	0.666	rs7934963	chr11:957220	C/T	cg06064525	chr11:970664	AP2A2	-0.54	-5.12	-0.5	2.13e-6	Alzheimer's disease (late onset);
SKCM	cis	rs10504229	1.000	rs114312649	chr8:58182539	C/G	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs2836974	0.897	rs13047678	chr21:40708853	C/T	cg11644478	chr21:40555479	PSMG1	0.82	7.13	0.63	4.36e-10	Cognitive function;
SKCM	cis	rs10808739	0.660	rs10808740	chr8:65655289	A/G	cg05711235	chr8:65498612	NA	-0.81	-5.4	-0.52	7.01e-7	HIV-1 susceptibility;
SKCM	cis	rs8072100	0.539	rs36043200	chr17:45629406	G/A	cg08085267	chr17:45401833	C17orf57	0.58	5.23	0.51	1.4e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs28595532	0.920	rs115006522	chr4:119732499	A/G	cg14228332	chr4:119757509	SEC24D	1.08	5.52	0.53	4.28e-7	Cannabis dependence symptom count;
SKCM	cis	rs17685	0.672	rs56343450	chr7:75796235	C/T	cg16489192	chr7:75678113	MDH2;STYXL1	-0.57	-5.49	-0.53	4.89e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs60871478	0.636	rs4721600	chr7:871728	C/T	cg05535760	chr7:792225	HEATR2	-1.27	-7.4	-0.64	1.35e-10	Cerebrospinal P-tau181p levels;
SKCM	cis	rs951366	0.789	rs823110	chr1:205701078	G/C	cg07157834	chr1:205819609	PM20D1	0.82	7.17	0.63	3.7e-10	Menarche (age at onset);
SKCM	cis	rs116095464	0.510	rs73016876	chr5:244475	T/C	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs7584330	0.868	rs7569197	chr2:238383073	A/G	cg14458575	chr2:238380390	NA	1.05	6.59	0.6	4.66e-9	Prostate cancer;
SKCM	cis	rs12621256	0.617	rs13010961	chr2:155250028	G/C	cg10179911	chr2:154333568	NA	-0.73	-4.83	-0.48	6.56e-6	Liver enzyme levels (alanine transaminase);
SKCM	cis	rs941408	1.000	rs1736177	chr19:2791624	C/T	cg06609049	chr19:2785107	THOP1	0.86	7.04	0.62	6.59e-10	Total cholesterol levels;
SKCM	cis	rs10838687	0.673	rs6485716	chr11:46981646	A/G	cg05584439	chr11:47213196	NA	-0.8	-4.84	-0.48	6.53e-6	Proinsulin levels;
SKCM	cis	rs7666738	0.830	rs28618180	chr4:98912184	A/C	cg05340658	chr4:99064831	C4orf37	0.6	4.83	0.48	6.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2832191	0.740	rs2012645	chr21:30445961	G/A	cg08807101	chr21:30365312	RNF160	0.74	6.09	0.57	4.06e-8	Dental caries;
SKCM	cis	rs7789940	0.904	rs12531348	chr7:75937191	G/C	cg10167463	chr7:75959203	YWHAG	-0.64	-4.91	-0.49	4.93e-6	Multiple sclerosis;
SKCM	cis	rs2404602	0.684	rs1603860	chr15:76849591	A/T	cg23625390	chr15:77176239	SCAPER	-0.85	-8.26	-0.68	2.93e-12	Blood metabolite levels;
SKCM	cis	rs10911232	0.560	rs6697320	chr1:183037377	T/G	ch.1.3577855R	chr1:183094577	LAMC1	0.7	5.86	0.55	1.06e-7	Hypertriglyceridemia;
SKCM	cis	rs12824058	0.799	rs4759656	chr12:130815804	G/A	cg26677194	chr12:130822605	PIWIL1	0.71	5.91	0.56	8.57e-8	Menopause (age at onset);
SKCM	cis	rs8070624	0.543	rs11870660	chr17:17877096	C/T	cg04398451	chr17:18023971	MYO15A	-0.8	-6.01	-0.56	5.59e-8	Total body bone mineral density;
SKCM	cis	rs6754311	0.509	rs3820794	chr2:136505546	C/T	cg07169764	chr2:136633963	MCM6	-0.89	-6.61	-0.6	4.34e-9	Mosquito bite size;
SKCM	cis	rs861020	1.000	rs632746	chr1:209982515	C/T	cg05527609	chr1:210001259	C1orf107	1.04	7.42	0.64	1.27e-10	Orofacial clefts;
SKCM	cis	rs7811142	0.667	rs3873746	chr7:99935097	G/A	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.06	6.07	0.57	4.31e-8	Platelet count;
SKCM	cis	rs9814567	0.963	rs9844537	chr3:134238341	G/A	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs2050392	0.517	rs619864	chr10:30750950	A/G	cg25182066	chr10:30743637	MAP3K8	0.7	6.31	0.58	1.53e-8	Inflammatory bowel disease;
SKCM	cis	rs10779751	0.708	rs2746640	chr1:11292952	T/A	cg08854313	chr1:11322531	MTOR	0.92	7.13	0.63	4.46e-10	Body mass index;
SKCM	cis	rs1799949	0.965	rs34616041	chr17:41188786	G/A	cg25072359	chr17:41440525	NA	0.63	4.88	0.48	5.43e-6	Menopause (age at onset);
SKCM	cis	rs11105298	0.891	rs10777184	chr12:89919568	C/T	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.91	-5.65	-0.54	2.56e-7	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs28595532	0.920	rs116401323	chr4:119721727	C/T	cg11846333	chr4:119757529	SEC24D	1.19	6.39	0.59	1.12e-8	Cannabis dependence symptom count;
SKCM	cis	rs4237845	0.513	rs7134797	chr12:58263852	C/T	cg02175503	chr12:58329896	NA	0.73	5.92	0.56	8.27e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs860295	0.650	rs4661151	chr1:155903408	C/T	cg02153340	chr1:155202674	NA	0.68	4.99	0.49	3.64e-6	Body mass index;
SKCM	cis	rs7904368	0.568	rs10752061	chr10:16853900	A/G	cg23933602	chr10:16859644	RSU1	0.98	7.81	0.66	2.24e-11	Ratio of the peak velocity of the mitral E-Wave divided by the peak velocity of the mitral A-wave.;
SKCM	cis	rs854765	0.583	rs4341796	chr17:17839024	C/A	cg09796270	chr17:17721594	SREBF1	0.65	4.87	0.48	5.79e-6	Total body bone mineral density;
SKCM	cis	rs4319547	0.695	rs10744211	chr12:122931820	A/G	cg23029597	chr12:123009494	RSRC2	-0.77	-5.53	-0.53	4.13e-7	Body mass index;
SKCM	cis	rs9381040	0.655	rs2268187	chr6:41042993	G/A	cg03644281	chr6:41068752	NFYA;LOC221442	-0.72	-4.81	-0.48	7.24e-6	Alzheimer's disease (late onset);
SKCM	cis	rs2153535	0.580	rs6938071	chr6:8464845	A/T	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs4808199	0.947	rs4808960	chr19:19574277	G/C	cg03709012	chr19:19516395	GATAD2A	1.13	8.66	0.7	4.94e-13	Nonalcoholic fatty liver disease;
SKCM	cis	rs611744	0.647	rs9969614	chr8:109260581	A/G	cg18478394	chr8:109455254	TTC35	0.67	5.33	0.52	9.45e-7	Dupuytren's disease;
SKCM	cis	rs1801251	1.000	rs2100053	chr2:233719516	G/T	cg08000102	chr2:233561755	GIGYF2	-0.91	-7.38	-0.64	1.48e-10	Coronary artery disease;
SKCM	cis	rs7772486	0.654	rs1011597	chr6:146075672	A/C	cg23711669	chr6:146136114	FBXO30	-0.83	-9.12	-0.72	6.36e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1032355	0.558	rs79606973	chr4:100517144	T/A	cg25391692	chr4:100495869	MTTP	-0.82	-4.97	-0.49	3.9e-6	Celiac disease;
SKCM	cis	rs6445797	0.632	rs7612599	chr3:56647934	A/G	cg13616963	chr3:57583610	ARF4	-0.76	-4.92	-0.49	4.78e-6	Gastritis;
SKCM	cis	rs6500395	1.000	rs11649236	chr16:48632478	C/T	cg04672837	chr16:48644449	N4BP1	0.67	5.66	0.54	2.4e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs62238980	0.614	rs74928243	chr22:32439681	C/T	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs1124769	0.827	rs77725238	chr15:51099645	G/A	cg21246271	chr15:51200259	AP4E1	-0.77	-4.82	-0.48	6.85e-6	Cognitive performance;
SKCM	cis	rs992157	0.764	rs3731861	chr2:219191256	T/C	cg00012203	chr2:219082015	ARPC2	-0.75	-5.4	-0.52	6.96e-7	Colorectal cancer;
SKCM	cis	rs7953508	0.506	rs12425869	chr12:93961353	A/G	cg18151635	chr12:93972918	NA	-0.71	-6.95	-0.62	9.98e-10	Pubertal anthropometrics;
SKCM	cis	rs9911578	0.967	rs12603238	chr17:57130785	C/T	cg12560992	chr17:57184187	TRIM37	-1.09	-10.28	-0.76	3.61e-16	Intelligence (multi-trait analysis);
SKCM	trans	rs561341	0.556	rs542244	chr17:30307242	T/C	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs7179456	0.544	rs2555357	chr15:59087115	A/G	cg05156742	chr15:59063176	FAM63B	0.74	5.95	0.56	7.32e-8	Asperger disorder;
SKCM	cis	rs7937682	0.921	rs34584980	chr11:111441537	G/A	cg19812747	chr11:111475976	SIK2	0.66	5.48	0.53	5.09e-7	Primary sclerosing cholangitis;
SKCM	cis	rs2153535	0.580	rs4960411	chr6:8438231	C/G	cg23788917	chr6:8435910	SLC35B3	0.7	5.15	0.5	1.92e-6	Motion sickness;
SKCM	cis	rs9790314	0.779	rs1609688	chr3:160877096	T/G	cg03342759	chr3:160939853	NMD3	-0.64	-6.49	-0.59	7.1e-9	Morning vs. evening chronotype;
SKCM	cis	rs1005277	0.602	rs2504142	chr10:38383793	C/T	cg00409905	chr10:38381863	ZNF37A	-0.64	-5.96	-0.56	6.77e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs35306767	0.903	rs11253485	chr10:919362	C/T	cg26597838	chr10:835615	NA	0.78	5.5	0.53	4.73e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs6750795	0.518	rs1434519	chr2:232433761	A/G	cg19187155	chr2:232395269	NMUR1	0.65	5.02	0.49	3.24e-6	Height;
SKCM	cis	rs10504229	0.636	rs77753517	chr8:58115897	C/T	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs933688	1.000	rs6867091	chr5:90734333	C/G	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.04	8.87	0.71	1.92e-13	Smoking behavior;
SKCM	cis	rs208520	0.690	rs851467	chr6:66802721	A/G	cg07460842	chr6:66804631	NA	-1.02	-7.65	-0.65	4.42e-11	Exhaled nitric oxide output;
SKCM	cis	rs523522	0.962	rs11065149	chr12:120956963	G/A	cg12219531	chr12:120966889	COQ5	0.91	7.82	0.66	2.11e-11	High light scatter reticulocyte count;
SKCM	cis	rs4972806	0.814	rs2113560	chr2:177030986	T/C	cg03152288	chr2:177042942	NA	0.57	4.97	0.49	3.84e-6	IgG glycosylation;
SKCM	cis	rs7542091	0.748	rs2357231	chr1:210028454	A/C	cg05527609	chr1:210001259	C1orf107	0.62	4.78	0.48	8.16e-6	Monobrow;
SKCM	cis	rs4919087	1.000	rs12221430	chr10:99061386	C/G	cg25902810	chr10:99078978	FRAT1	0.65	4.99	0.49	3.65e-6	Monocyte count;
SKCM	cis	rs6570726	0.935	rs408768	chr6:145871735	A/G	cg23711669	chr6:146136114	FBXO30	0.71	6.74	0.61	2.47e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs3768617	0.510	rs1886500	chr1:183095048	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs11718455	0.960	rs17076255	chr3:44002093	C/T	cg21419209	chr3:44054225	NA	-0.65	-5.32	-0.52	9.77e-7	Coronary artery disease;
SKCM	cis	rs7772486	0.790	rs1832362	chr6:146179955	C/T	cg05347473	chr6:146136440	FBXO30	0.58	5.45	0.53	5.72e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7659604	0.967	rs10008348	chr4:122666987	A/C	cg06713675	chr4:122721982	EXOSC9	-0.64	-5.64	-0.54	2.59e-7	Type 2 diabetes;
SKCM	cis	rs245880	0.740	rs245897	chr7:29193940	C/T	cg17163760	chr7:29186267	CPVL	0.41	5.53	0.53	4.04e-7	Warfarin maintenance dose;
SKCM	cis	rs6120849	0.754	rs13433216	chr20:33616301	T/C	cg24642439	chr20:33292090	TP53INP2	0.94	4.86	0.48	5.91e-6	Protein C levels;
SKCM	cis	rs1032355	0.558	rs6837699	chr4:100520521	G/A	cg25391692	chr4:100495869	MTTP	-0.95	-4.92	-0.49	4.68e-6	Celiac disease;
SKCM	trans	rs561341	0.941	rs4625780	chr17:30249214	A/C	cg20587970	chr11:113659929	NA	-1.11	-9.15	-0.72	5.45e-14	Hip circumference adjusted for BMI;
SKCM	cis	rs6570726	0.935	rs449377	chr6:145852437	C/G	cg23711669	chr6:146136114	FBXO30	0.7	6.63	0.6	3.94e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9640161	0.636	rs56190213	chr7:150025720	T/C	cg27494647	chr7:150038898	RARRES2	0.58	4.98	0.49	3.74e-6	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs2282032	0.883	rs10143036	chr14:90774914	T/G	cg04374321	chr14:90722782	PSMC1	0.74	5.14	0.5	2.02e-6	Longevity;
SKCM	cis	rs372883	0.648	rs15092	chr21:30718201	G/A	cg24692254	chr21:30365293	RNF160	-0.68	-5.46	-0.53	5.37e-7	Pancreatic cancer;
SKCM	cis	rs4481887	0.927	rs4581306	chr1:248476158	C/A	cg00666640	chr1:248458726	OR2T12	0.63	5.91	0.56	8.65e-8	Common traits (Other);
SKCM	cis	rs2075371	0.933	rs1421482	chr7:133964383	A/G	cg20476274	chr7:133979776	SLC35B4	1.03	10.89	0.78	2.52e-17	Mean platelet volume;
SKCM	cis	rs7191751	0.543	rs57705566	chr16:86306431	A/C	cg07524214	chr16:86825363	NA	-0.57	-4.79	-0.48	7.79e-6	Response to platinum-based chemotherapy (cisplatin);
SKCM	cis	rs28595532	1.000	rs115915387	chr4:119640854	C/T	cg14228332	chr4:119757509	SEC24D	0.97	4.92	0.49	4.71e-6	Cannabis dependence symptom count;
SKCM	cis	rs1014246	0.848	rs11197798	chr10:118457277	C/T	cg14919929	chr10:118506882	NA	0.77	5.73	0.54	1.78e-7	Age at smoking initiation in chronic obstructive pulmonary disease;
SKCM	cis	rs7789940	0.904	rs61294900	chr7:75937212	A/T	cg10167463	chr7:75959203	YWHAG	-0.64	-4.91	-0.49	4.93e-6	Multiple sclerosis;
SKCM	cis	rs561341	1.000	rs55959993	chr17:30254771	C/G	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.53	-0.65	7.52e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs644799	1.000	rs2508289	chr11:95624669	A/G	cg03916912	chr11:95522834	CEP57;FAM76B	0.84	6.63	0.6	3.93e-9	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs453301	0.658	rs9329175	chr8:8866661	C/T	cg06636001	chr8:8085503	FLJ10661	-0.73	-5.6	-0.54	3.15e-7	Joint mobility (Beighton score);
SKCM	cis	rs2204008	0.694	rs11179394	chr12:38210389	A/G	cg26384229	chr12:38710491	ALG10B	-0.67	-5.43	-0.52	6.28e-7	Bladder cancer;
SKCM	cis	rs4481887	0.741	rs6587471	chr1:248560741	C/T	cg22724847	chr1:248512586	OR14C36	0.58	4.9	0.49	5.07e-6	Common traits (Other);
SKCM	cis	rs780096	0.526	rs1647266	chr2:27693485	T/C	cg05696406	chr2:27599888	SNX17	0.51	5.22	0.51	1.46e-6	Total body bone mineral density;
SKCM	cis	rs459571	0.959	rs461462	chr9:136911272	C/T	cg13789015	chr9:136890014	NCRNA00094	0.7	5.65	0.54	2.48e-7	Platelet distribution width;
SKCM	cis	rs1005277	0.522	rs289649	chr10:37975384	T/C	cg00409905	chr10:38381863	ZNF37A	-0.58	-5.74	-0.55	1.7e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs2153535	0.580	rs2327058	chr6:8447018	C/T	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs11585357	0.895	rs72633808	chr1:17618665	A/G	cg08277548	chr1:17600880	PADI3	-0.89	-6.31	-0.58	1.53e-8	Hair shape;
SKCM	cis	rs1799949	0.536	rs4793227	chr17:41412250	A/C	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.07	-0.57	4.38e-8	Menopause (age at onset);
SKCM	cis	rs3820928	0.605	rs4675124	chr2:227802354	G/A	cg11843606	chr2:227700838	RHBDD1	-0.61	-4.8	-0.48	7.36e-6	Pulmonary function;
SKCM	cis	rs12197554	1.000	rs12202591	chr6:130638504	G/T	cg26931050	chr6:130757762	TMEM200A	-0.6	-4.86	-0.48	5.95e-6	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);Exploratory eye movement dysfunction in schizophrenia (number of eye fixations);Exploratory eye movement dysfunction in schizophrenia (responsive search score);
SKCM	cis	rs1218582	0.741	rs7544528	chr1:154844585	C/T	cg03351412	chr1:154909251	PMVK	0.75	6.65	0.6	3.64e-9	Prostate cancer;
SKCM	cis	rs16866061	1.000	rs11688397	chr2:225393173	C/T	cg02879423	chr2:224806760	WDFY1	0.67	4.81	0.48	7.16e-6	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs4242434	0.927	rs2272718	chr8:22457388	G/A	cg03733263	chr8:22462867	KIAA1967	1.09	8.99	0.71	1.11e-13	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs875971	1.000	rs778722	chr7:65844828	T/C	cg18876405	chr7:65276391	NA	0.67	6.65	0.6	3.61e-9	Aortic root size;
SKCM	cis	rs2404602	0.618	rs12442266	chr15:76567142	T/C	cg23625390	chr15:77176239	SCAPER	0.69	6.31	0.58	1.57e-8	Blood metabolite levels;
SKCM	cis	rs7811142	0.830	rs6948685	chr7:99970188	C/T	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.05	5.92	0.56	8.02e-8	Platelet count;
SKCM	cis	rs854765	0.547	rs6502633	chr17:17941037	G/C	cg04398451	chr17:18023971	MYO15A	-0.94	-7.53	-0.65	7.5e-11	Total body bone mineral density;
SKCM	cis	rs9467773	1.000	rs1884946	chr6:26545308	C/G	cg09904177	chr6:26538194	HMGN4	0.54	4.95	0.49	4.16e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs17376456	0.932	rs3940842	chr5:93534858	C/A	cg21475434	chr5:93447410	FAM172A	0.99	5.65	0.54	2.49e-7	Diabetic retinopathy;
SKCM	cis	rs992157	0.764	rs4672886	chr2:219185545	C/T	cg20019365	chr2:219134978	PNKD;AAMP	-0.74	-5.94	-0.56	7.67e-8	Colorectal cancer;
SKCM	cis	rs3793683	0.520	rs12769959	chr10:134579026	A/C	cg00988841	chr10:134556463	INPP5A	0.61	4.82	0.48	6.86e-6	Migraine;
SKCM	cis	rs514406	0.825	rs487453	chr1:53271225	T/C	cg16325326	chr1:53192061	ZYG11B	-0.87	-9.17	-0.72	5.03e-14	Monocyte count;
SKCM	trans	rs17685	0.753	rs1806885	chr7:75785612	T/G	cg19862616	chr7:65841803	NCRNA00174	0.92	9.38	0.73	2.02e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs62238980	0.614	rs2413063	chr22:32458252	A/C	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs28595532	0.844	rs115573749	chr4:119756848	T/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs17102884	0.506	rs11845397	chr14:75404587	G/A	cg08847533	chr14:75593920	NEK9	-0.66	-5.09	-0.5	2.41e-6	Neuroticism;
SKCM	cis	rs2842992	0.724	rs2273823	chr6:160211485	T/C	cg11366901	chr6:160182831	ACAT2	0.84	7.09	0.63	5.2e-10	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs950027	0.596	rs2467865	chr15:45638307	T/C	cg21132104	chr15:45694354	SPATA5L1	0.76	6.14	0.57	3.2e-8	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs6570726	0.935	rs453609	chr6:145812332	T/C	cg23711669	chr6:146136114	FBXO30	0.71	6.93	0.62	1.09e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs11098499	0.908	rs28559989	chr4:120386627	C/T	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs9880211	0.699	rs34804893	chr3:136339970	G/A	cg21827317	chr3:136751795	NA	-0.7	-5.43	-0.52	6.12e-7	Body mass index;Height;
SKCM	cis	rs28735056	0.591	rs2277724	chr18:77694294	C/A	cg20368463	chr18:77673604	PQLC1	-0.73	-5.73	-0.54	1.78e-7	Schizophrenia;
SKCM	cis	rs1014246	0.541	rs2011695	chr10:118507219	A/C	cg14919929	chr10:118506882	NA	-0.75	-5.08	-0.5	2.47e-6	Age at smoking initiation in chronic obstructive pulmonary disease;
SKCM	cis	rs28595532	0.920	rs114057512	chr4:119750179	G/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	trans	rs1814175	0.817	rs1621090	chr11:49895868	C/A	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs1577917	0.874	rs11756621	chr6:86740063	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.63	-5.41	-0.52	6.81e-7	Response to antipsychotic treatment;
SKCM	cis	rs10911232	0.507	rs6672306	chr1:183058898	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.76	6.87	0.61	1.39e-9	Hypertriglyceridemia;
SKCM	cis	rs1957429	0.808	rs6573580	chr14:65331766	C/G	cg23373153	chr14:65346875	NA	1.15	6.01	0.56	5.48e-8	Pediatric areal bone mineral density (radius);
SKCM	cis	rs9790314	0.695	rs7637086	chr3:160836822	T/C	cg03342759	chr3:160939853	NMD3	-0.69	-6.9	-0.62	1.22e-9	Morning vs. evening chronotype;
SKCM	cis	rs4332037	0.906	rs6461009	chr7:1952139	T/C	cg23422044	chr7:1970798	MAD1L1	0.95	6.32	0.58	1.48e-8	Bipolar disorder;
SKCM	cis	rs2032447	0.714	rs199739	chr6:25960509	A/C	cg03517284	chr6:25882590	NA	-0.61	-5.0	-0.49	3.4e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2836974	0.932	rs6517523	chr21:40557332	T/C	cg11644478	chr21:40555479	PSMG1	0.99	9.91	0.75	1.88e-15	Cognitive function;
SKCM	cis	rs7552404	0.924	rs2275378	chr1:76198436	T/C	cg03433033	chr1:76189801	ACADM	0.76	5.58	0.53	3.34e-7	Blood metabolite levels;Acylcarnitine levels;
SKCM	trans	rs561341	0.941	rs7215147	chr17:30266711	G/A	cg20587970	chr11:113659929	NA	-1.07	-9.16	-0.72	5.2e-14	Hip circumference adjusted for BMI;
SKCM	cis	rs11792861	0.888	rs75543406	chr9:111816903	A/T	cg14432460	chr9:111696404	IKBKAP;C9orf6	0.66	4.79	0.48	7.77e-6	Menarche (age at onset);
SKCM	cis	rs28386778	0.830	rs2665798	chr17:61921397	C/T	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs7927771	0.832	rs4752990	chr11:47410393	G/A	cg05585544	chr11:47624801	NA	-0.6	-5.32	-0.52	9.58e-7	Subjective well-being;
SKCM	cis	rs4975616	0.869	rs452384	chr5:1330840	T/C	cg06550200	chr5:1325588	CLPTM1L	-0.86	-7.74	-0.66	2.94e-11	Lung cancer;
SKCM	cis	rs1023500	0.551	rs2301521	chr22:42423110	G/C	cg04733989	chr22:42467013	NAGA	0.77	6.03	0.56	5.2100000000000003e-08	Schizophrenia;
SKCM	cis	rs10927875	0.864	rs1976402	chr1:16143779	G/A	cg21385522	chr1:16154831	NA	-1.03	-8.46	-0.69	1.22e-12	Dilated cardiomyopathy;
SKCM	cis	rs1707322	0.752	rs11211171	chr1:46168642	A/G	cg03146154	chr1:46216737	IPP	0.8	5.47	0.53	5.19e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs208520	0.690	rs12202913	chr6:66734198	C/T	cg07460842	chr6:66804631	NA	0.92	7.44	0.64	1.12e-10	Exhaled nitric oxide output;
SKCM	cis	rs35306767	0.903	rs35957139	chr10:884889	C/T	cg26597838	chr10:835615	NA	0.79	5.77	0.55	1.54e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs13118159	0.550	rs11941200	chr4:1369093	C/G	cg02018176	chr4:1364513	KIAA1530	0.9	7.31	0.64	2.02e-10	Longevity;
SKCM	cis	rs951366	0.617	rs9438393	chr1:205782718	A/G	cg17178900	chr1:205818956	PM20D1	0.83	8.3	0.68	2.44e-12	Menarche (age at onset);
SKCM	cis	rs116095464	1.000	rs6863730	chr5:325003	G/T	cg22857025	chr5:266934	NA	-1.63	-6.12	-0.57	3.5e-8	Breast cancer;
SKCM	cis	rs4919694	1.000	rs80327774	chr10:104656671	T/C	cg04362960	chr10:104952993	NT5C2	0.81	5.07	0.5	2.63e-6	Arsenic metabolism;
SKCM	cis	rs13118159	0.573	rs4974618	chr4:1373663	C/T	cg19318889	chr4:1322082	MAEA	0.77	5.71	0.54	1.98e-7	Longevity;
SKCM	cis	rs72634258	0.699	rs2493214	chr1:7994420	A/G	cg00042356	chr1:8021962	PARK7	0.75	6.34	0.58	1.38e-8	Inflammatory bowel disease;
SKCM	cis	rs17826219	0.500	rs61685770	chr17:29085713	G/A	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Body mass index;
SKCM	cis	rs17376456	0.569	rs10076965	chr5:93094972	G/A	cg25358565	chr5:93447407	FAM172A	0.86	5.45	0.53	5.59e-7	Diabetic retinopathy;
SKCM	cis	rs875971	0.862	rs1167399	chr7:65561877	G/A	cg18876405	chr7:65276391	NA	-0.67	-6.79	-0.61	2.01e-9	Aortic root size;
SKCM	cis	rs514406	0.607	rs1930305	chr1:53195481	G/T	cg24675658	chr1:53192096	ZYG11B	0.62	4.98	0.49	3.72e-6	Monocyte count;
SKCM	cis	rs11718455	0.920	rs4682927	chr3:44033299	C/A	cg21419209	chr3:44054225	NA	-0.66	-5.22	-0.51	1.42e-6	Coronary artery disease;
SKCM	cis	rs6582630	0.519	rs8189609	chr12:38281408	A/G	cg26384229	chr12:38710491	ALG10B	0.87	6.83	0.61	1.63e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs4891159	0.548	rs609487	chr18:74134382	C/G	cg24786174	chr18:74118243	ZNF516	-0.78	-8.33	-0.69	2.19e-12	Longevity;
SKCM	cis	rs875971	0.862	rs17747530	chr7:65994729	G/C	cg18876405	chr7:65276391	NA	0.61	6.06	0.57	4.57e-8	Aortic root size;
SKCM	cis	rs6570726	0.935	rs397418	chr6:145842362	C/T	cg23711669	chr6:146136114	FBXO30	0.69	6.39	0.59	1.13e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs782590	0.935	rs782568	chr2:55881538	T/C	cg18811423	chr2:55921094	PNPT1	0.88	7.32	0.64	1.89e-10	Metabolic syndrome;
SKCM	cis	rs6762	0.692	rs7928925	chr11:839155	G/A	cg16425592	chr11:842748	TSPAN4;POLR2L	-0.77	-5.42	-0.52	6.34e-7	Mean platelet volume;
SKCM	trans	rs9329221	0.905	rs6601451	chr8:10243681	C/G	cg06636001	chr8:8085503	FLJ10661	-0.89	-8.19	-0.68	4.01e-12	Neuroticism;
SKCM	cis	rs4803468	0.967	rs3745290	chr19:41890003	C/T	cg14132834	chr19:41945861	ATP5SL	-0.74	-5.71	-0.54	1.99e-7	Height;
SKCM	cis	rs6840360	0.571	rs7685697	chr4:152558849	A/G	cg22705602	chr4:152727874	NA	-0.52	-5.69	-0.54	2.15e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs8072100	0.967	rs4239163	chr17:45755954	C/T	cg08085267	chr17:45401833	C17orf57	-0.62	-5.5	-0.53	4.69e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs4819052	0.851	rs9754134	chr21:46661751	T/C	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.36	0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7666738	0.830	rs4502686	chr4:98765117	T/C	cg17366294	chr4:99064904	C4orf37	0.59	5.09	0.5	2.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6933660	0.720	rs6913515	chr6:151753470	G/C	cg10883421	chr6:151773342	RMND1;C6orf211	0.82	6.83	0.61	1.69e-9	Menarche (age at onset);
SKCM	cis	rs55962025	0.804	rs3775061	chr4:3238754	A/G	cg24015175	chr4:3319247	RGS12	-0.63	-5.47	-0.53	5.33e-7	Parental longevity (mother's age at death);
SKCM	cis	rs6674970	0.777	rs12087892	chr1:151118500	T/C	cg11822372	chr1:151115635	SEMA6C	-0.92	-7.57	-0.65	6.43e-11	Childhood ear infection;
SKCM	cis	rs206936	0.752	rs62399870	chr6:34249341	T/C	cg12284521	chr6:34113943	NA	-0.73	-4.95	-0.49	4.26e-6	Body mass index;
SKCM	cis	rs12762955	0.519	rs10795306	chr10:1019138	A/T	cg26597838	chr10:835615	NA	-0.7	-5.76	-0.55	1.56e-7	Response to angiotensin II receptor blocker therapy;
SKCM	cis	rs9300255	0.620	rs1727311	chr12:123660716	T/G	cg00376283	chr12:123451042	ABCB9	0.84	5.1	0.5	2.35e-6	Neutrophil percentage of white cells;
SKCM	cis	rs4642101	0.662	rs57411588	chr3:12820384	C/G	cg05775895	chr3:12838266	CAND2	0.68	6.16	0.57	2.99e-8	QRS complex (12-leadsum);
SKCM	cis	rs2836974	0.897	rs2836944	chr21:40593539	G/A	cg11890956	chr21:40555474	PSMG1	1.09	13.83	0.84	1.08e-22	Cognitive function;
SKCM	trans	rs561341	0.882	rs16967101	chr17:30377162	A/G	cg20587970	chr11:113659929	NA	-1.13	-9.74	-0.74	3.92e-15	Hip circumference adjusted for BMI;
SKCM	cis	rs9911578	1.000	rs4372750	chr17:57013803	A/C	cg05425664	chr17:57184151	TRIM37	0.65	5.13	0.5	2.07e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs941408	1.000	rs1736181	chr19:2797703	C/T	cg06609049	chr19:2785107	THOP1	0.85	7.48	0.65	9.34e-11	Total cholesterol levels;
SKCM	cis	rs854765	0.624	rs11657423	chr17:17728574	T/C	cg24612305	chr17:17875800	TOM1L2;LRRC48	-0.87	-6.84	-0.61	1.56e-9	Total body bone mineral density;
SKCM	cis	rs4746818	0.793	rs2805913	chr10:70858062	A/G	cg11621586	chr10:70884670	VPS26A	0.87	6.79	0.61	1.94e-9	Left atrial antero-posterior diameter;
SKCM	cis	rs2836974	0.897	rs2836927	chr21:40543216	T/C	cg17971929	chr21:40555470	PSMG1	0.87	8.48	0.69	1.1e-12	Cognitive function;
SKCM	cis	rs2404602	0.735	rs2436994	chr15:76801063	G/C	cg23625390	chr15:77176239	SCAPER	-0.78	-7.52	-0.65	7.81e-11	Blood metabolite levels;
SKCM	cis	rs2153535	0.580	rs1414349	chr6:8472290	A/G	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs362296	0.671	rs3135173	chr4:3257373	T/C	cg11471262	chr4:3318911	RGS12	-0.77	-6.76	-0.61	2.21e-9	Parental longevity (mother's age at death);
SKCM	cis	rs12474201	0.832	rs6738426	chr2:46986416	A/G	cg06386533	chr2:46925753	SOCS5	0.99	9.11	0.72	6.61e-14	Height;
SKCM	cis	rs10504229	1.000	rs72650885	chr8:58175131	G/A	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs2228479	0.850	rs17233664	chr16:89810628	C/T	cg00800038	chr16:89945340	TCF25	-0.81	-4.79	-0.48	7.84e-6	Skin colour saturation;
SKCM	cis	rs9467773	0.933	rs35355150	chr6:26526039	G/A	cg15659132	chr6:26577336	NA	0.61	5.84	0.55	1.13e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7020830	0.867	rs1472169	chr9:37209396	C/T	cg14294708	chr9:37120828	ZCCHC7	1.01	9.63	0.74	6.48e-15	Schizophrenia;
SKCM	cis	rs2204008	0.539	rs2703682	chr12:38107969	A/G	cg26384229	chr12:38710491	ALG10B	0.67	5.21	0.51	1.5e-6	Bladder cancer;
SKCM	cis	rs1005277	0.540	rs116205409	chr10:38478970	G/A	cg00409905	chr10:38381863	ZNF37A	-0.65	-5.92	-0.56	8.04e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs1577917	1.000	rs12200330	chr6:86656653	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.66	-5.74	-0.54	1.76e-7	Response to antipsychotic treatment;
SKCM	cis	rs9906944	0.603	rs10853104	chr17:47092076	C/T	cg11673840	chr17:47092156	IGF2BP1	-0.52	-4.83	-0.48	6.71e-6	Intelligence (multi-trait analysis);Body fat percentage;
SKCM	cis	rs28595532	0.841	rs115209862	chr4:119742225	G/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs10089	1.000	rs7703634	chr5:127509223	A/C	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.87	7.69	0.66	3.82e-11	Ileal carcinoids;
SKCM	cis	rs2072499	1.000	rs2241107	chr1:156182710	C/T	cg24450063	chr1:156163899	SLC25A44	-0.91	-8.75	-0.7	3.35e-13	Testicular germ cell tumor;
SKCM	cis	rs6088590	0.648	rs6058105	chr20:33271719	C/T	cg24642439	chr20:33292090	TP53INP2	0.77	5.6	0.54	3.12e-7	Coronary artery disease;
SKCM	cis	rs12047808	0.556	rs60408652	chr1:179389115	G/T	cg09822482	chr1:179519214	C1orf125	-0.95	-5.17	-0.51	1.78e-6	Multiple sclerosis (age of onset);
SKCM	cis	rs9399135	0.967	rs9399129	chr6:135285148	C/A	cg24558204	chr6:135376177	HBS1L	0.56	5.07	0.5	2.64e-6	Red blood cell count;
SKCM	cis	rs2070488	1.000	rs13074160	chr3:38455650	G/T	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.97	9.16	0.72	5.28e-14	Electrocardiographic conduction measures;
SKCM	cis	rs8038465	0.615	rs6495075	chr15:73981005	A/G	cg15420318	chr15:73925796	NPTN	0.69	5.38	0.52	7.7e-7	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs10256972	0.527	rs28671326	chr7:1174973	G/A	cg16145915	chr7:1198662	ZFAND2A	-0.59	-7.96	-0.67	1.11e-11	Longevity;Endometriosis;
SKCM	cis	rs28830936	0.510	rs7174099	chr15:42099059	A/G	cg17847044	chr15:42102381	MAPKBP1	-0.44	-5.77	-0.55	1.53e-7	Diastolic blood pressure;
SKCM	cis	rs763121	0.776	rs5757177	chr22:39007174	A/C	cg06022373	chr22:39101656	GTPBP1	0.82	5.44	0.52	5.97e-7	Menopause (age at onset);
SKCM	cis	rs7824557	0.602	rs7834139	chr8:11206363	C/G	cg21775007	chr8:11205619	TDH	0.72	6.4	0.59	1.09e-8	Retinal vascular caliber;
SKCM	cis	rs67311347	0.544	rs67533651	chr3:40338367	T/A	cg13409248	chr3:40428643	ENTPD3	0.57	5.57	0.53	3.48e-7	Renal cell carcinoma;
SKCM	trans	rs8073060	0.544	rs225258	chr17:33956883	C/T	cg19694781	chr19:47549865	TMEM160	-1.03	-7.84	-0.66	1.91e-11	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs561341	0.609	rs4795659	chr17:30187139	C/G	cg00745463	chr17:30367425	LRRC37B	0.88	5.18	0.51	1.66e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs5750830	0.597	rs4821889	chr22:39777254	T/C	cg11247378	chr22:39784982	NA	-0.47	-5.61	-0.54	2.93e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs6952808	0.531	rs3778991	chr7:2172455	G/A	cg02951883	chr7:2050386	MAD1L1	-0.75	-6.55	-0.6	5.51e-9	Bipolar disorder and schizophrenia;
SKCM	cis	rs8060686	0.641	rs8060893	chr16:68191608	A/T	cg09117114	chr16:67998030	SLC12A4	-0.76	-4.93	-0.49	4.58e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs17685	0.753	rs7804598	chr7:75702578	C/T	cg16684958	chr7:75615977	POR	0.57	5.54	0.53	4e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2732480	0.577	rs2634691	chr12:48708259	G/T	cg21348975	chr12:48724119	NA	-0.6	-4.97	-0.49	3.88e-6	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs1799949	1.000	rs8070085	chr17:41341984	C/T	cg23758822	chr17:41437982	NA	-0.88	-6.81	-0.61	1.82e-9	Menopause (age at onset);
SKCM	cis	rs7829975	0.577	rs17684466	chr8:8545233	G/A	cg15556689	chr8:8085844	FLJ10661	-0.69	-5.37	-0.52	7.85e-7	Mood instability;
SKCM	cis	rs11098499	0.566	rs7664440	chr4:120578540	A/G	cg24375607	chr4:120327624	NA	0.63	4.83	0.48	6.74e-6	Corneal astigmatism;
SKCM	cis	rs2070677	0.668	rs7899159	chr10:135431451	C/T	cg04120329	chr10:135160120	PRAP1	0.9	4.77	0.47	8.52e-6	Gout;
SKCM	cis	rs875971	0.793	rs460678	chr7:65527200	C/G	cg11764359	chr7:65958608	NA	0.9	8.21	0.68	3.63e-12	Aortic root size;
SKCM	cis	rs870825	0.616	rs4444872	chr4:185628405	A/G	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs651907	0.535	rs12633089	chr3:101528763	C/T	cg12386194	chr3:101231763	SENP7	0.68	5.74	0.54	1.73e-7	Colorectal cancer;
SKCM	cis	rs3768617	0.510	rs3768629	chr1:183074582	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.81	7.75	0.66	2.85e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs78456975	0.689	rs13391992	chr2:1542153	G/A	cg01028140	chr2:1542097	TPO	-0.58	-5.33	-0.52	9.25e-7	Placebo response in major depressive disorder (% change in symptom score);
SKCM	cis	rs28386778	1.000	rs2665849	chr17:61953670	T/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.06	0.78	1.21e-17	Prudent dietary pattern;
SKCM	cis	rs9325144	0.555	rs7960411	chr12:38703019	A/G	cg13010199	chr12:38710504	ALG10B	-0.65	-5.17	-0.51	1.73e-6	Morning vs. evening chronotype;
SKCM	cis	rs1799949	0.965	rs7212284	chr17:41205941	A/G	cg05368731	chr17:41323189	NBR1	0.86	7.12	0.63	4.57e-10	Menopause (age at onset);
SKCM	cis	rs1405130	0.839	rs13018439	chr2:235565912	G/A	cg21542780	chr2:234763377	HJURP	-0.64	-4.89	-0.48	5.21e-6	Coronary artery disease;
SKCM	cis	rs651907	0.557	rs2303474	chr3:101371899	G/T	cg12386194	chr3:101231763	SENP7	0.72	5.95	0.56	7.15e-8	Colorectal cancer;
SKCM	cis	rs798554	0.797	rs35957220	chr7:2812632	C/G	cg04166393	chr7:2884313	GNA12	0.77	5.36	0.52	8.26e-7	Height;
SKCM	cis	rs1005277	0.540	rs2474598	chr10:38430296	C/T	cg25427524	chr10:38739819	LOC399744	0.67	6.39	0.59	1.12e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs1799949	0.929	rs12937015	chr17:41307473	A/C	cg23758822	chr17:41437982	NA	0.92	7.83	0.66	1.97e-11	Menopause (age at onset);
SKCM	cis	rs3857536	0.740	rs4710572	chr6:66890361	C/A	cg07460842	chr6:66804631	NA	-0.7	-5.08	-0.5	2.51e-6	Blood trace element (Cu levels);
SKCM	cis	rs709400	0.628	rs11622356	chr14:103912195	C/T	cg26031613	chr14:104095156	KLC1	0.74	5.44	0.52	5.98e-7	Body mass index;
SKCM	cis	rs80130819	0.515	rs6580656	chr12:48570604	C/T	cg05342945	chr12:48394962	COL2A1	-0.8	-4.83	-0.48	6.71e-6	Prostate cancer;
SKCM	cis	rs801193	1.000	rs2659912	chr7:66157999	G/C	cg11764359	chr7:65958608	NA	0.86	6.6	0.6	4.52e-9	Aortic root size;
SKCM	cis	rs7954584	0.567	rs10840632	chr12:122375460	C/T	cg21171335	chr12:122356390	WDR66	0.45	4.97	0.49	3.83e-6	Mean corpuscular volume;
SKCM	cis	rs933688	1.000	rs2059208	chr5:90732065	A/T	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.92	6.33	0.58	1.44e-8	Smoking behavior;
SKCM	cis	rs12586317	0.547	rs77780729	chr14:35496176	C/A	cg16230307	chr14:35515116	FAM177A1	0.81	5.88	0.55	9.47e-8	Psoriasis;
SKCM	cis	rs8180040	1.000	rs295458	chr3:47385585	C/A	cg16586182	chr3:47516702	SCAP	-0.72	-4.93	-0.49	4.51e-6	Colorectal cancer;
SKCM	cis	rs16854884	0.673	rs34379944	chr3:143785766	G/A	cg06585982	chr3:143692056	C3orf58	0.75	6.14	0.57	3.25e-8	Economic and political preferences (feminism/equality);
SKCM	cis	rs3768617	0.510	rs10737245	chr1:183100884	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs3820068	0.603	rs932602	chr1:15986087	A/G	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs73201462	1.000	rs11715394	chr3:127893564	A/T	cg09089421	chr3:127803668	RUVBL1	1.0	5.11	0.5	2.22e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs2760061	0.784	rs708116	chr1:228198196	C/A	cg02753203	chr1:228287806	NA	0.74	6.31	0.58	1.56e-8	Diastolic blood pressure;
SKCM	cis	rs7843479	0.509	rs3758156	chr8:21770796	A/G	cg17168535	chr8:21777572	XPO7	0.65	5.7	0.54	2.05e-7	Mean corpuscular volume;
SKCM	cis	rs4466137	0.830	rs6886442	chr5:82973210	A/C	cg16102102	chr5:83017553	HAPLN1	0.5	5.47	0.53	5.28e-7	Prostate cancer;
SKCM	cis	rs13118159	0.509	rs9683830	chr4:1377873	A/G	cg05025164	chr4:1340916	KIAA1530	0.89	7.15	0.63	4.11e-10	Longevity;
SKCM	cis	rs16854884	0.837	rs13062793	chr3:143808387	A/G	cg06585982	chr3:143692056	C3orf58	0.69	5.25	0.51	1.28e-6	Economic and political preferences (feminism/equality);
SKCM	cis	rs34779708	0.966	rs4934540	chr10:35474699	T/C	cg03585969	chr10:35415529	CREM	0.78	6.52	0.59	6.29e-9	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs7937682	0.855	rs7934922	chr11:111500026	T/C	cg09085632	chr11:111637200	PPP2R1B	-1.07	-11.23	-0.79	5.72e-18	Primary sclerosing cholangitis;
SKCM	cis	rs28374715	0.578	rs10518717	chr15:41623368	C/G	cg18705301	chr15:41695430	NDUFAF1	-1.21	-12.61	-0.82	1.61e-20	Ulcerative colitis;
SKCM	cis	rs6952808	0.601	rs3778978	chr7:2159817	A/G	cg21782813	chr7:2030301	MAD1L1	0.52	5.53	0.53	4.09e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs6952808	0.862	rs4721167	chr7:1933224	C/T	cg21782813	chr7:2030301	MAD1L1	0.56	5.64	0.54	2.64e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs56104184	0.775	rs73061697	chr19:49400000	C/T	cg19746536	chr19:49375674	PPP1R15A	1.16	5.93	0.56	7.67e-8	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs6089584	1.000	rs6089581	chr20:60562394	G/A	cg06108461	chr20:60628389	TAF4	-0.81	-7.11	-0.63	4.79e-10	Body mass index;
SKCM	cis	rs137761	0.576	rs8136516	chr22:44126950	G/T	cg12729397	chr22:44208276	EFCAB6	0.69	5.1	0.5	2.35e-6	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs16949788	1.000	rs80298548	chr15:66690448	A/G	cg08120210	chr15:66682733	MAP2K1	-0.74	-5.82	-0.55	1.23e-7	Spherical equivalent (joint analysis main effects and education interaction);
SKCM	cis	rs939658	0.683	rs11634726	chr15:79465894	A/G	cg10259521	chr15:79428573	NA	0.49	5.05	0.5	2.87e-6	Refractive error;
SKCM	cis	rs11098499	0.954	rs6857105	chr4:120222298	C/G	cg09307838	chr4:120376055	NA	0.97	7.78	0.66	2.52e-11	Corneal astigmatism;
SKCM	cis	rs67460515	0.596	rs4856700	chr3:160922951	A/C	cg03342759	chr3:160939853	NMD3	-0.72	-6.14	-0.57	3.19e-8	Parkinson's disease;
SKCM	cis	rs995000	0.931	rs746735	chr1:63113511	C/A	cg06896770	chr1:63153194	DOCK7	-0.76	-7.17	-0.63	3.77e-10	Triglyceride levels;
SKCM	cis	rs36051895	0.695	rs10974915	chr9:5016818	A/G	cg02405213	chr9:5042618	JAK2	-0.63	-4.8	-0.48	7.62e-6	Pediatric autoimmune diseases;
SKCM	cis	rs951366	0.764	rs823141	chr1:205741426	T/C	cg07157834	chr1:205819609	PM20D1	0.82	7.37	0.64	1.55e-10	Menarche (age at onset);
SKCM	cis	rs7927771	0.524	rs11039415	chr11:47845814	A/G	cg20307385	chr11:47447363	PSMC3	0.71	5.63	0.54	2.67e-7	Subjective well-being;
SKCM	cis	rs28595532	0.920	rs56364904	chr4:119742504	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs11148252	0.904	rs9568732	chr13:52993412	A/G	cg00495681	chr13:53174319	NA	-0.61	-5.2	-0.51	1.55e-6	Lewy body disease;
SKCM	cis	rs4319547	0.620	rs12372756	chr12:122815130	A/G	cg23029597	chr12:123009494	RSRC2	-0.73	-5.22	-0.51	1.41e-6	Body mass index;
SKCM	cis	rs28386778	0.966	rs2008053	chr17:61954918	G/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	10.54	0.77	1.18e-16	Prudent dietary pattern;
SKCM	cis	rs367615	0.537	rs431669	chr5:108663115	G/A	cg17395555	chr5:108820864	NA	0.71	5.78	0.55	1.47e-7	Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs10489202	1.000	rs12407660	chr1:167954363	C/T	cg24449463	chr1:168025552	DCAF6	-0.76	-5.87	-0.55	1.02e-7	Schizophrenia;
SKCM	cis	rs60871478	0.634	rs62432213	chr7:781412	G/C	cg05535760	chr7:792225	HEATR2	1.05	8.61	0.7	6.09e-13	Cerebrospinal P-tau181p levels;
SKCM	cis	rs6724607	1.000	rs13006708	chr2:191471428	G/A	cg27211696	chr2:191398769	TMEM194B	-0.8	-6.53	-0.59	6.07e-9	Pulse pressure;
SKCM	cis	rs5769765	0.955	rs9616366	chr22:50301178	C/T	cg22709217	chr22:50311962	ALG12;CRELD2	-0.82	-5.71	-0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs9790314	0.967	rs6762645	chr3:160948349	T/G	cg03342759	chr3:160939853	NMD3	-0.72	-7.89	-0.67	1.53e-11	Morning vs. evening chronotype;
SKCM	cis	rs72615157	0.634	rs2272343	chr7:99778285	A/C	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.19	8.02	0.67	8.58e-12	Lung function (FEV1/FVC);
SKCM	cis	rs1059312	0.932	rs7962918	chr12:129288534	T/C	cg09035930	chr12:129282057	SLC15A4	0.83	9.36	0.73	2.13e-14	Systemic lupus erythematosus;
SKCM	cis	rs6089829	0.925	rs6122086	chr20:61664528	T/C	cg08564027	chr20:61660810	NA	0.63	5.65	0.54	2.56e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs9951698	0.703	rs7226616	chr18:13009905	T/C	cg12848697	chr18:13133368	NA	0.53	4.96	0.49	4.04e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs11139399	0.612	rs6559639	chr9:84349691	A/G	cg13729285	chr9:84764156	NA	0.47	4.85	0.48	6.29e-6	Hippocampal atrophy;
SKCM	cis	rs17608059	0.566	rs8070294	chr17:13896302	G/C	cg27005118	chr17:13972210	COX10	-0.43	-4.83	-0.48	6.77e-6	Temperament;
SKCM	cis	rs4803468	0.967	rs16975238	chr19:41944985	T/A	cg14132834	chr19:41945861	ATP5SL	0.77	5.9	0.56	9.04e-8	Height;
SKCM	cis	rs910316	1.000	rs7303	chr14:75520065	T/C	cg08847533	chr14:75593920	NEK9	0.95	9.18	0.72	4.8e-14	Height;
SKCM	cis	rs28386778	0.863	rs3760256	chr17:61821161	A/G	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.12	11.27	0.79	4.92e-18	Prudent dietary pattern;
SKCM	cis	rs57221529	0.766	rs58015612	chr5:580665	A/T	cg26208419	chr5:473447	SLC9A3;LOC25845	1.01	5.18	0.51	1.7e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs4727027	0.651	rs12704068	chr7:148856153	T/C	cg23583168	chr7:148888333	NA	-0.79	-5.36	-0.52	8.32e-7	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs11892454	0.515	rs10173557	chr2:26077722	C/A	cg17263061	chr2:26915892	KCNK3	0.67	4.79	0.48	7.8e-6	Heschl's gyrus morphology;
SKCM	cis	rs4974559	0.594	rs11946384	chr4:1313566	T/C	cg02980000	chr4:1222292	CTBP1	0.89	5.16	0.5	1.85e-6	Systolic blood pressure;
SKCM	cis	rs6753739	0.745	rs1455836	chr2:219912866	T/G	cg09617556	chr2:219924408	IHH	0.47	4.94	0.49	4.44e-6	Height;
SKCM	cis	rs9325144	0.647	rs4616077	chr12:39092364	T/C	cg13010199	chr12:38710504	ALG10B	-0.62	-5.34	-0.52	8.94e-7	Morning vs. evening chronotype;
SKCM	cis	rs933688	0.938	rs10063683	chr5:90714595	G/A	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.1	8.33	0.69	2.14e-12	Smoking behavior;
SKCM	cis	rs11098499	0.954	rs13151285	chr4:120314741	C/A	cg09307838	chr4:120376055	NA	0.97	7.49	0.65	9.08e-11	Corneal astigmatism;
SKCM	cis	rs6723226	0.708	rs2754513	chr2:32782763	G/A	cg02381751	chr2:32503542	YIPF4	0.85	5.98	0.56	6.27e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs7927771	0.524	rs7118747	chr11:47889545	C/T	cg20307385	chr11:47447363	PSMC3	-0.72	-5.82	-0.55	1.26e-7	Subjective well-being;
SKCM	cis	rs4808199	0.948	rs757001	chr19:19448808	G/A	cg03709012	chr19:19516395	GATAD2A	1.08	7.53	0.65	7.65e-11	Nonalcoholic fatty liver disease;
SKCM	cis	rs2070488	1.000	rs2268753	chr3:38500189	C/T	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.98	9.09	0.72	7.18e-14	Electrocardiographic conduction measures;
SKCM	cis	rs2204008	0.774	rs11520237	chr12:38266978	G/A	cg26384229	chr12:38710491	ALG10B	0.87	6.83	0.61	1.63e-9	Bladder cancer;
SKCM	cis	rs28374715	0.662	rs522063	chr15:41476209	A/G	cg18705301	chr15:41695430	NDUFAF1	0.93	7.74	0.66	2.94e-11	Ulcerative colitis;
SKCM	cis	rs12911832	1.000	rs12911832	chr15:58985904	A/T	cg05156742	chr15:59063176	FAM63B	0.75	5.49	0.53	4.87e-7	Schizophrenia;
SKCM	cis	rs3820928	0.935	rs113195824	chr2:227769139	A/G	cg11843606	chr2:227700838	RHBDD1	-0.63	-4.93	-0.49	4.47e-6	Pulmonary function;
SKCM	cis	rs2594989	0.779	rs2447603	chr3:11590261	T/C	cg00170343	chr3:11313890	ATG7	-1.01	-5.62	-0.54	2.88e-7	Circulating chemerin levels;
SKCM	cis	rs6430585	0.583	rs2304370	chr2:136561735	G/A	cg07169764	chr2:136633963	MCM6	1.04	8.25	0.68	3.12e-12	Corneal structure;
SKCM	cis	rs898097	0.845	rs7213006	chr17:80899928	T/C	cg15369054	chr17:80825471	TBCD	-0.57	-5.11	-0.5	2.26e-6	Breast cancer;
SKCM	cis	rs9894429	0.634	rs11655346	chr17:79572399	A/G	cg18240062	chr17:79603768	NPLOC4	-0.68	-5.9	-0.56	8.85e-8	Eye color traits;
SKCM	cis	rs7402982	0.934	rs8028620	chr15:99202875	C/T	cg03437748	chr15:99193247	IGF1R	0.88	5.85	0.55	1.12e-7	Birth weight;
SKCM	cis	rs909341	0.710	rs6010998	chr20:62294402	A/T	cg03999872	chr20:62272968	STMN3	0.55	4.98	0.49	3.75e-6	Atopic dermatitis;
SKCM	cis	rs6840360	0.571	rs62327278	chr4:152558790	G/C	cg22705602	chr4:152727874	NA	-0.52	-5.69	-0.54	2.15e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs478304	0.651	rs948494	chr11:65552118	G/A	cg17480646	chr11:65405466	SIPA1	-0.69	-5.16	-0.5	1.84e-6	Acne (severe);
SKCM	cis	rs9325144	0.534	rs1843866	chr12:38703160	G/T	cg26384229	chr12:38710491	ALG10B	0.78	6.71	0.61	2.77e-9	Morning vs. evening chronotype;
SKCM	cis	rs3008870	1.000	rs2815357	chr1:67491854	T/C	cg08660285	chr1:67390436	MIER1;WDR78	0.95	6.51	0.59	6.68e-9	Lymphocyte percentage of white cells;
SKCM	cis	rs3820068	0.581	rs72645861	chr1:15920314	A/G	cg24675056	chr1:15929824	NA	0.77	5.54	0.53	4.01e-7	Systolic blood pressure;
SKCM	cis	rs2239547	0.603	rs34230854	chr3:53078590	C/A	cg11645453	chr3:52864694	ITIH4	0.6	4.81	0.48	7.16e-6	Schizophrenia;
SKCM	cis	rs514406	0.792	rs481440	chr1:53344976	C/T	cg08859206	chr1:53392774	SCP2	-0.63	-5.18	-0.51	1.72e-6	Monocyte count;
SKCM	cis	rs6912958	0.535	rs448580	chr6:88040399	A/C	cg08069147	chr6:88032118	GJB7;C6orf162	0.62	5.12	0.5	2.12e-6	Monocyte percentage of white cells;
SKCM	cis	rs35306767	0.903	rs12244253	chr10:889320	G/T	cg26597838	chr10:835615	NA	0.77	5.39	0.52	7.26e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs10808739	0.660	rs6995461	chr8:65659573	T/C	cg05711235	chr8:65498612	NA	-0.8	-5.2	-0.51	1.54e-6	HIV-1 susceptibility;
SKCM	cis	rs1218582	0.772	rs7528532	chr1:154874440	C/T	cg06221963	chr1:154839813	KCNN3	-0.59	-5.97	-0.56	6.76e-8	Prostate cancer;
SKCM	cis	rs11098499	0.780	rs7692994	chr4:120427489	C/A	cg24375607	chr4:120327624	NA	0.7	5.4	0.52	7e-7	Corneal astigmatism;
SKCM	cis	rs995000	0.965	rs1168022	chr1:63007721	A/T	cg06896770	chr1:63153194	DOCK7	-0.73	-6.54	-0.6	5.83e-9	Triglyceride levels;
SKCM	cis	rs514406	0.825	rs7523761	chr1:53250915	T/C	cg24675658	chr1:53192096	ZYG11B	0.61	4.93	0.49	4.58e-6	Monocyte count;
SKCM	cis	rs4332037	0.539	rs4470910	chr7:2071723	C/T	cg23422044	chr7:1970798	MAD1L1	-0.91	-6.07	-0.57	4.38e-8	Bipolar disorder;
SKCM	cis	rs875971	0.862	rs880166	chr7:65670762	T/C	cg11764359	chr7:65958608	NA	-0.8	-7.7	-0.66	3.63e-11	Aortic root size;
SKCM	cis	rs4523957	0.818	rs4790887	chr17:2130592	C/A	cg16513277	chr17:2031491	SMG6	0.72	4.85	0.48	6.14e-6	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs2180341	0.814	rs6569488	chr6:127726256	C/T	cg27446573	chr6:127587934	RNF146	0.69	5.49	0.53	4.79e-7	Breast cancer;
SKCM	cis	rs9815354	0.812	rs113144620	chr3:42008312	A/G	cg03022575	chr3:42003672	ULK4	1.0	5.0	0.49	3.43e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs11098499	0.908	rs12504149	chr4:120318577	G/A	cg09307838	chr4:120376055	NA	0.97	7.49	0.65	9.08e-11	Corneal astigmatism;
SKCM	cis	rs763014	0.898	rs1045277	chr16:633125	T/C	cg09263875	chr16:632152	PIGQ	0.67	5.82	0.55	1.24e-7	Height;
SKCM	cis	rs826838	0.967	rs1719854	chr12:39127707	G/A	cg13010199	chr12:38710504	ALG10B	-0.72	-5.73	-0.54	1.83e-7	Heart rate;
SKCM	cis	rs9311474	1.000	rs1060330	chr3:52288945	T/C	cg18404041	chr3:52824283	ITIH1	-0.53	-4.84	-0.48	6.39e-6	Electroencephalogram traits;
SKCM	cis	rs2243480	1.000	rs13310597	chr7:65598540	A/G	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs62103177	0.608	rs8088089	chr18:77832154	A/G	cg27393146	chr18:77495563	CTDP1	0.86	5.72	0.54	1.88e-7	Opioid sensitivity;
SKCM	cis	rs12497850	0.865	rs7649458	chr3:48920127	C/T	cg06212747	chr3:49208901	KLHDC8B	0.68	4.9	0.49	5.06e-6	Parkinson's disease;
SKCM	cis	rs6570726	0.837	rs419991	chr6:145864212	C/T	cg23711669	chr6:146136114	FBXO30	0.71	6.79	0.61	1.98e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2645694	0.532	rs2645706	chr4:77829606	A/C	cg06046430	chr4:77819534	ANKRD56	0.54	5.94	0.56	7.49e-8	Emphysema distribution in smoking;
SKCM	cis	rs3785574	0.886	rs62077504	chr17:61837734	A/G	cg01411255	chr17:61851458	DDX42;CCDC47	1.11	12.47	0.82	2.97e-20	Height;
SKCM	cis	rs28595532	0.920	rs115841156	chr4:119740073	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs6541297	1.000	rs6541297	chr1:230283506	G/A	cg05784532	chr1:230284198	GALNT2	0.53	4.84	0.48	6.45e-6	Coronary artery disease;
SKCM	cis	rs6062302	0.522	rs13038448	chr20:62218453	C/T	cg09650180	chr20:62225654	GMEB2	-0.79	-6.26	-0.58	1.93e-8	Glioblastoma;
SKCM	cis	rs7811142	0.775	rs1636980	chr7:99938864	A/G	cg21679810	chr7:100027352	MEPCE;ZCWPW1	-1.18	-7.87	-0.67	1.7e-11	Platelet count;
SKCM	cis	rs1799949	0.965	rs8176130	chr17:41258043	C/T	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.01	-0.56	5.5e-8	Menopause (age at onset);
SKCM	cis	rs66573146	0.539	rs56659624	chr4:7069377	G/C	cg26116260	chr4:7069785	GRPEL1	-1.13	-5.04	-0.5	2.89e-6	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs4481887	0.927	rs4381224	chr1:248456826	A/T	cg00666640	chr1:248458726	OR2T12	0.6	4.9	0.49	5.01e-6	Common traits (Other);
SKCM	cis	rs10540	1.000	rs71487296	chr11:500282	G/A	cg03576123	chr11:487126	PTDSS2	-1.43	-8.14	-0.68	5.08e-12	Body mass index;
SKCM	cis	rs2811415	0.597	rs12695503	chr3:127769174	C/A	cg09089421	chr3:127803668	RUVBL1	1.01	8.79	0.71	2.72e-13	Lung function (FEV1/FVC);
SKCM	cis	rs3008870	1.000	rs3008854	chr1:67385951	T/C	cg08660285	chr1:67390436	MIER1;WDR78	0.98	6.56	0.6	5.45e-9	Lymphocyte percentage of white cells;
SKCM	cis	rs9910055	0.664	rs433610	chr17:42197281	A/G	cg10896456	chr17:42255109	ASB16;C17orf65	-0.66	-6.32	-0.58	1.5e-8	Total body bone mineral density;
SKCM	cis	rs6951245	0.554	rs11544331	chr7:1131411	C/T	cg18402987	chr7:1209562	NA	0.82	5.39	0.52	7.25e-7	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7666738	0.791	rs6851549	chr4:99029827	G/A	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6840360	0.615	rs10001603	chr4:152647577	T/A	cg22705602	chr4:152727874	NA	-0.6	-8.01	-0.67	8.85e-12	Intelligence (multi-trait analysis);
SKCM	cis	rs7809950	0.834	rs3801946	chr7:107242995	T/A	cg23024343	chr7:107201750	COG5	0.84	7.72	0.66	3.23e-11	Coronary artery disease;
SKCM	cis	rs6665290	0.935	rs17600627	chr1:227201449	A/G	cg10327440	chr1:227177885	CDC42BPA	-1.21	-16.02	-0.88	2.21e-26	Myeloid white cell count;
SKCM	cis	rs28386778	0.897	rs2665833	chr17:61906846	T/C	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs10207060	0.500	rs4365487	chr2:240706803	T/C	cg07506560	chr2:240697449	NA	0.75	6.1	0.57	3.8e-8	Obesity-related traits;
SKCM	cis	rs1401999	1.000	rs9858774	chr3:183652736	G/A	cg01324343	chr3:183735012	ABCC5	0.89	10.08	0.75	8.94e-16	Anterior chamber depth;
SKCM	cis	rs908922	0.523	rs4845786	chr1:152510144	A/G	cg09873164	chr1:152488093	CRCT1	0.78	6.09	0.57	4.03e-8	Hair morphology;
SKCM	cis	rs769267	0.930	rs4808203	chr19:19568659	A/G	cg26732615	chr19:19648335	CILP2;YJEFN3	0.67	6.72	0.61	2.65e-9	Tonsillectomy;
SKCM	cis	rs1976403	0.510	rs1697421	chr1:21823292	C/T	cg02390115	chr1:21767211	NBPF3	0.5	5.33	0.52	9.3e-7	Liver enzyme levels (alkaline phosphatase);
SKCM	cis	rs7937682	0.632	rs11214009	chr11:111683142	T/C	cg09085632	chr11:111637200	PPP2R1B	1.09	10.48	0.76	1.52e-16	Primary sclerosing cholangitis;
SKCM	cis	rs738322	0.934	rs133019	chr22:38573035	A/G	cg25457927	chr22:38595422	NA	-0.56	-6.45	-0.59	8.42e-9	Cutaneous nevi;
SKCM	cis	rs10193935	0.901	rs9789740	chr2:42486799	A/G	cg27598129	chr2:42591480	NA	-0.95	-6.75	-0.61	2.38e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs796364	0.951	rs12613687	chr2:200999256	C/T	cg12253985	chr2:200820533	C2orf60;C2orf47	-0.98	-6.28	-0.58	1.82e-8	Schizophrenia;
SKCM	cis	rs2832191	0.716	rs9983051	chr21:30371890	C/T	cg24692254	chr21:30365293	RNF160	0.98	8.98	0.71	1.17e-13	Dental caries;
SKCM	cis	rs9902453	0.740	rs2617867	chr17:28049399	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.79	-5.93	-0.56	7.67e-8	Coffee consumption (cups per day);
SKCM	cis	rs2228479	0.850	rs17233567	chr16:89813821	G/A	cg00800038	chr16:89945340	TCF25	-0.81	-4.79	-0.48	7.84e-6	Skin colour saturation;
SKCM	cis	rs7843479	1.000	rs10503715	chr8:21850687	G/A	cg17168535	chr8:21777572	XPO7	0.74	6.19	0.57	2.61e-8	Mean corpuscular volume;
SKCM	cis	rs7937682	0.883	rs549143	chr11:111463779	C/T	cg19812747	chr11:111475976	SIK2	-0.61	-4.94	-0.49	4.41e-6	Primary sclerosing cholangitis;
SKCM	cis	rs7020830	0.861	rs6476622	chr9:37308049	T/A	cg14294708	chr9:37120828	ZCCHC7	1.06	10.67	0.77	6.51e-17	Schizophrenia;
SKCM	cis	rs7927771	0.524	rs11039377	chr11:47789776	C/T	cg20307385	chr11:47447363	PSMC3	0.72	5.81	0.55	1.31e-7	Subjective well-being;
SKCM	cis	rs9911578	1.000	rs8071916	chr17:56660279	A/G	cg12560992	chr17:57184187	TRIM37	0.94	7.61	0.65	5.39e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs9467773	0.935	rs1056668	chr6:26510605	C/T	cg15659132	chr6:26577336	NA	0.64	6.17	0.57	2.9e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs7937682	0.737	rs663763	chr11:111422217	C/T	cg09085632	chr11:111637200	PPP2R1B	-0.81	-6.99	-0.62	8.14e-10	Primary sclerosing cholangitis;
SKCM	cis	rs9815354	0.812	rs114034165	chr3:41823297	G/A	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs7666738	0.791	rs1967978	chr4:98966152	T/C	cg05340658	chr4:99064831	C4orf37	0.64	4.91	0.49	4.97e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs3020736	0.500	rs4147638	chr22:42487900	G/A	cg04733989	chr22:42467013	NAGA	-0.72	-5.62	-0.54	2.87e-7	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs28386778	1.000	rs2665851	chr17:61957023	T/C	cg26338869	chr17:61819248	STRADA	0.72	4.89	0.48	5.36e-6	Prudent dietary pattern;
SKCM	cis	rs7666738	0.830	rs34461023	chr4:99023751	C/T	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6977660	1.000	rs7791038	chr7:19798833	G/A	cg07541023	chr7:19748670	TWISTNB	0.72	5.02	0.49	3.24e-6	Thyroid stimulating hormone;
SKCM	cis	rs9325144	0.600	rs2171405	chr12:38741030	G/T	cg26384229	chr12:38710491	ALG10B	-0.76	-6.52	-0.59	6.44e-9	Morning vs. evening chronotype;
SKCM	cis	rs6456156	0.524	rs6934043	chr6:167466449	C/T	cg13927040	chr6:167453801	FGFR1OP	0.66	4.85	0.48	6.24e-6	Primary biliary cholangitis;
SKCM	cis	rs875971	0.597	rs11771318	chr7:66062480	G/T	cg11987759	chr7:65425863	GUSB	0.68	5.79	0.55	1.42e-7	Aortic root size;
SKCM	cis	rs4819052	1.000	rs9984901	chr21:46663952	C/T	cg19498844	chr21:46707878	POFUT2;LOC642852	0.87	6.8	0.61	1.88e-9	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7772486	0.790	rs2254257	chr6:146203724	C/T	cg23711669	chr6:146136114	FBXO30	0.74	7.4	0.64	1.33e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs910316	0.763	rs175036	chr14:75464295	C/T	cg08847533	chr14:75593920	NEK9	-0.83	-7.06	-0.62	6e-10	Height;
SKCM	cis	rs17376456	0.825	rs13161885	chr5:93071242	A/C	cg21475434	chr5:93447410	FAM172A	0.94	5.62	0.54	2.87e-7	Diabetic retinopathy;
SKCM	cis	rs58688157	0.960	rs12422022	chr11:613192	A/G	cg17114584	chr11:613792	IRF7	0.74	5.0	0.49	3.51e-6	Systemic lupus erythematosus;
SKCM	cis	rs2559856	1.000	rs2695281	chr12:102089999	G/A	cg12924262	chr12:102091054	CHPT1	0.66	5.54	0.53	3.93e-7	Blood protein levels;
SKCM	cis	rs709400	0.663	rs11628969	chr14:103940911	G/A	cg26031613	chr14:104095156	KLC1	0.77	5.96	0.56	6.87e-8	Body mass index;
SKCM	cis	rs11601602	0.576	rs4075635	chr11:28511643	A/G	cg06544937	chr11:28130018	METT5D1;KIF18A	0.82	5.61	0.54	2.97e-7	Obesity-related traits;
SKCM	cis	rs5753618	0.504	rs9606847	chr22:31901789	G/C	cg02404636	chr22:31891804	SFI1	0.67	6.03	0.56	5.16e-8	Colorectal cancer;
SKCM	cis	rs7772486	0.743	rs1292339	chr6:145967086	C/T	cg23711669	chr6:146136114	FBXO30	-0.83	-8.65	-0.7	5.07e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs950776	0.518	rs12915428	chr15:78823368	G/A	cg06917634	chr15:78832804	PSMA4	1.01	10.47	0.76	1.56e-16	Sudden cardiac arrest;
SKCM	cis	rs28386778	0.897	rs894413	chr17:61916347	A/G	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs644799	0.710	rs519511	chr11:95538270	G/A	cg25622487	chr11:95524042	FAM76B;CEP57	0.7	5.67	0.54	2.28e-7	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs1005277	0.579	rs1780137	chr10:38501475	C/G	cg00409905	chr10:38381863	ZNF37A	-0.57	-4.89	-0.48	5.33e-6	Extrinsic epigenetic age acceleration;
SKCM	cis	rs71520386	0.632	rs35353454	chr7:22861739	T/C	cg00309339	chr7:22893653	NA	0.67	4.97	0.49	3.82e-6	Fibrinogen levels;
SKCM	cis	rs589448	0.872	rs315111	chr12:69784695	G/A	cg22834771	chr12:69754056	YEATS4	-0.7	-5.72	-0.54	1.91e-7	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs9640161	0.750	rs11769348	chr7:150026753	C/T	cg10018233	chr7:150070692	REPIN1	-0.68	-5.27	-0.51	1.18e-6	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs28595532	0.920	rs116246794	chr4:119732491	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.52	0.53	4.28e-7	Cannabis dependence symptom count;
SKCM	cis	rs10927875	0.578	rs10927859	chr1:16141862	C/T	cg21385522	chr1:16154831	NA	-0.98	-11.13	-0.78	8.82e-18	Dilated cardiomyopathy;
SKCM	cis	rs1799949	0.965	rs1842147	chr17:41435192	C/T	cg25918947	chr17:41365094	TMEM106A	-0.65	-6.35	-0.58	1.32e-8	Menopause (age at onset);
SKCM	cis	rs2836950	0.565	rs8131132	chr21:40538256	T/C	cg11644478	chr21:40555479	PSMG1	-0.67	-5.3	-0.51	1.04e-6	Menarche (age at onset);
SKCM	cis	rs9486715	0.867	rs2475025	chr6:96988696	A/T	cg06623918	chr6:96969491	KIAA0776	-0.82	-7.31	-0.64	1.98e-10	Headache;
SKCM	cis	rs7666738	0.830	rs991168	chr4:98928293	T/C	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4332037	0.506	rs62442924	chr7:1989976	C/T	cg23422044	chr7:1970798	MAD1L1	-0.99	-6.35	-0.58	1.34e-8	Bipolar disorder;
SKCM	cis	rs67311347	0.544	rs9833640	chr3:40354941	T/A	cg13409248	chr3:40428643	ENTPD3	0.57	5.32	0.52	9.61e-7	Renal cell carcinoma;
SKCM	cis	rs9916302	0.904	rs8068427	chr17:37511517	G/A	cg07936489	chr17:37558343	FBXL20	0.82	7.18	0.63	3.61e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs7666738	0.830	rs6532720	chr4:99043781	C/T	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs55823223	0.564	rs2034947	chr17:73863929	T/C	cg08125733	chr17:73851984	WBP2	1.06	6.07	0.57	4.35e-8	Psoriasis;
SKCM	cis	rs9640161	0.750	rs11538922	chr7:150035183	C/T	cg10018233	chr7:150070692	REPIN1	0.71	5.54	0.53	3.98e-7	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs7811142	1.000	rs2897358	chr7:100088640	C/G	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.24	7.92	0.67	1.36e-11	Platelet count;
SKCM	cis	rs12142240	0.660	rs72890715	chr1:46852077	A/G	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs6061231	0.793	rs6061512	chr20:60976929	G/A	cg24112000	chr20:60950667	NA	-0.65	-6.01	-0.56	5.71e-8	Colorectal cancer;
SKCM	cis	rs208520	0.690	rs207108	chr6:66794096	T/C	cg07460842	chr6:66804631	NA	-1.03	-7.65	-0.65	4.49e-11	Exhaled nitric oxide output;
SKCM	cis	rs5769765	0.908	rs9616376	chr22:50310829	A/G	cg22709217	chr22:50311962	ALG12;CRELD2	-0.94	-5.91	-0.56	8.37e-8	Schizophrenia;
SKCM	cis	rs12047808	0.778	rs55682857	chr1:179362402	A/T	cg09822482	chr1:179519214	C1orf125	-0.95	-5.17	-0.51	1.78e-6	Multiple sclerosis (age of onset);
SKCM	cis	rs7824557	0.606	rs2736270	chr8:11192593	G/A	cg21775007	chr8:11205619	TDH	0.67	5.89	0.55	9.33e-8	Retinal vascular caliber;
SKCM	cis	rs992157	1.000	rs10932766	chr2:219122090	G/A	cg20019365	chr2:219134978	PNKD;AAMP	0.81	7.35	0.64	1.68e-10	Colorectal cancer;
SKCM	cis	rs6547741	1.000	rs1528402	chr2:27857517	G/A	cg27432699	chr2:27873401	GPN1	0.73	6.65	0.6	3.7e-9	Oral cavity cancer;
SKCM	cis	rs362272	0.505	rs10155132	chr4:3369500	A/G	cg16987761	chr4:3318072	RGS12	1.01	11.83	0.8	4.37e-19	Serum sulfate level;
SKCM	cis	rs10504229	0.906	rs61638902	chr8:58193511	A/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs12142240	0.698	rs56909107	chr1:46808224	A/C	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs4972806	0.668	rs2072588	chr2:177042930	G/C	cg03152288	chr2:177042942	NA	0.57	4.99	0.49	3.6e-6	IgG glycosylation;
SKCM	cis	rs10256972	0.591	rs6950319	chr7:1161324	A/G	cg09177884	chr7:1199841	ZFAND2A	-0.76	-6.07	-0.57	4.43e-8	Longevity;Endometriosis;
SKCM	cis	rs1799949	1.000	rs4340367	chr17:41307772	G/A	cg05368731	chr17:41323189	NBR1	0.89	7.98	0.67	1.03e-11	Menopause (age at onset);
SKCM	cis	rs12497850	0.897	rs9884022	chr3:48956862	G/C	cg07636037	chr3:49044803	WDR6	1.02	10.99	0.78	1.63e-17	Parkinson's disease;
SKCM	cis	rs1797081	0.646	rs7090256	chr10:16851949	T/G	cg23933602	chr10:16859644	RSU1	0.88	6.37	0.58	1.21e-8	Platelet distribution width;
SKCM	cis	rs769267	0.629	rs7245672	chr19:19699963	T/C	cg26732615	chr19:19648335	CILP2;YJEFN3	-0.59	-4.89	-0.48	5.25e-6	Tonsillectomy;
SKCM	cis	rs7666738	0.830	rs1426662	chr4:98990319	C/T	cg17366294	chr4:99064904	C4orf37	0.6	4.98	0.49	3.8e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs8077889	0.956	rs61608877	chr17:41848713	A/C	cg26893861	chr17:41843967	DUSP3	1.21	7.19	0.63	3.38e-10	Triglycerides;
SKCM	cis	rs9325144	0.555	rs7301258	chr12:38706942	C/T	cg13010199	chr12:38710504	ALG10B	0.64	5.05	0.5	2.79e-6	Morning vs. evening chronotype;
SKCM	cis	rs2439831	1.000	rs2264239	chr15:43765533	C/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.21	7.96	0.67	1.1e-11	Lung cancer in ever smokers;
SKCM	cis	rs1003719	0.788	rs2835584	chr21:38460338	A/T	cg10648535	chr21:38446584	PIGP;TTC3	0.62	5.0	0.49	3.4e-6	Eye color traits;
SKCM	cis	rs6582630	0.593	rs7134006	chr12:38596245	A/C	cg26384229	chr12:38710491	ALG10B	0.78	6.45	0.59	8.67e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs2033711	0.840	rs4801590	chr19:58961813	G/C	cg11952622	chr19:58962976	ZNF324B	0.63	4.85	0.48	6.28e-6	Uric acid clearance;
SKCM	cis	rs823143	0.570	rs823082	chr1:205786935	C/T	cg26354017	chr1:205819088	PM20D1	-0.99	-10.1	-0.75	8.04e-16	Monocyte percentage of white cells;
SKCM	cis	rs6087990	0.871	rs2424905	chr20:31352927	T/C	cg13636640	chr20:31349939	DNMT3B	0.92	7.77	0.66	2.58e-11	Ulcerative colitis;
SKCM	cis	rs4319547	1.000	rs9705654	chr12:123083508	T/C	cg23029597	chr12:123009494	RSRC2	-0.75	-5.69	-0.54	2.09e-7	Body mass index;
SKCM	cis	rs6570726	0.599	rs9403725	chr6:145897622	A/T	cg23711669	chr6:146136114	FBXO30	-0.9	-7.76	-0.66	2.73e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1865760	0.929	rs9358896	chr6:25943197	C/A	cg08401836	chr6:26032486	HIST1H3B	-0.62	-5.06	-0.5	2.76e-6	Height;
SKCM	cis	rs7590720	1.000	rs7559031	chr2:216902583	A/G	cg12620499	chr2:216877984	MREG	0.9	7.34	0.64	1.75e-10	Alcohol dependence;
SKCM	cis	rs8042680	0.554	rs7180016	chr15:91526275	C/T	cg15878949	chr15:91534302	PRC1	0.57	4.78	0.48	8.23e-6	Type 2 diabetes;
SKCM	cis	rs9399135	0.967	rs2327578	chr6:135329969	C/T	cg24558204	chr6:135376177	HBS1L	0.59	5.23	0.51	1.41e-6	Red blood cell count;
SKCM	cis	rs1577917	0.655	rs9444351	chr6:86247799	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.64	5.42	0.52	6.36e-7	Response to antipsychotic treatment;
SKCM	cis	rs2120019	0.567	rs72625793	chr15:75207083	A/G	cg09165964	chr15:75287851	SCAMP5	-0.81	-5.8	-0.55	1.34e-7	Blood trace element (Zn levels);
SKCM	cis	rs3809863	0.602	rs11650072	chr17:45393665	A/G	cg25173405	chr17:45401733	C17orf57	-0.72	-5.35	-0.52	8.44e-7	Glaucoma (primary open-angle);
SKCM	cis	rs10089	1.000	rs1864922	chr5:127420700	T/C	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.93	8.45	0.69	1.24e-12	Ileal carcinoids;
SKCM	cis	rs7424096	0.582	rs7600245	chr2:37220614	A/C	cg14987922	chr2:37194071	STRN	0.99	6.05	0.57	4.73e-8	High light scatter reticulocyte percentage of red cells;
SKCM	cis	rs867186	1.000	rs55946144	chr20:33629610	T/C	cg04194272	chr20:33683537	NA	-1.38	-7.2	-0.63	3.29e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs35306767	0.951	rs11253530	chr10:993729	T/C	cg20503657	chr10:835505	NA	0.74	6.1	0.57	3.89e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs2303759	0.709	rs7256363	chr19:49827804	C/T	cg05022225	chr19:49866942	DKKL1;TEAD2	0.7	5.05	0.5	2.78e-6	Multiple sclerosis;
SKCM	cis	rs10929159	0.928	rs6749436	chr2:236919992	A/G	cg14226755	chr2:236923322	AGAP1	0.29	4.77	0.48	8.43e-6	Parkinson's disease;
SKCM	cis	rs762407	0.560	rs11089096	chr21:45188955	C/G	cg01224657	chr21:45787795	TRPM2	0.5	4.92	0.49	4.8e-6	Systolic blood pressure change trajectories;
SKCM	cis	rs2486288	0.539	rs2433601	chr15:45716425	T/C	cg21132104	chr15:45694354	SPATA5L1	0.74	5.41	0.52	6.68e-7	Glomerular filtration rate;
SKCM	cis	rs3820068	0.581	rs58567918	chr1:15925823	A/G	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs1153858	1.000	rs7164602	chr15:45671325	A/G	cg10760299	chr15:45669010	GATM	0.62	6.35	0.58	1.3e-8	Homoarginine levels;
SKCM	cis	rs7772486	0.790	rs9390365	chr6:146235626	A/G	cg05347473	chr6:146136440	FBXO30	-0.56	-5.3	-0.51	1.06e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2180341	0.883	rs6904630	chr6:127696869	A/G	cg27446573	chr6:127587934	RNF146	0.93	8.09	0.68	6.27e-12	Breast cancer;
SKCM	cis	rs533581	0.866	rs502258	chr16:88968547	G/A	cg16701003	chr16:89028210	CBFA2T3	0.57	4.86	0.48	5.91e-6	Social autistic-like traits;
SKCM	cis	rs826838	0.935	rs4583043	chr12:38645147	T/G	cg26384229	chr12:38710491	ALG10B	0.94	7.46	0.65	1.04e-10	Heart rate;
SKCM	cis	rs28595532	0.920	rs115681185	chr4:119757700	G/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs2836633	0.929	rs2836602	chr21:40039169	A/T	cg05519781	chr21:40033154	ERG	-0.78	-6.88	-0.61	1.33e-9	Coronary artery disease;
SKCM	cis	rs11098499	0.821	rs28665282	chr4:120384186	C/T	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs28595532	0.920	rs10025640	chr4:119787451	G/A	cg14228332	chr4:119757509	SEC24D	1.08	5.52	0.53	4.28e-7	Cannabis dependence symptom count;
SKCM	cis	rs4332037	0.539	rs57148375	chr7:2025001	G/C	cg23422044	chr7:1970798	MAD1L1	-0.9	-5.68	-0.54	2.24e-7	Bipolar disorder;
SKCM	cis	rs2286503	0.780	rs2240727	chr7:22852512	C/T	cg15401507	chr7:22894281	NA	-0.55	-5.04	-0.5	2.94e-6	Fibrinogen;
SKCM	cis	rs7599312	0.553	rs6710653	chr2:213404893	A/G	cg20637307	chr2:213403960	ERBB4	0.76	5.6	0.54	3.12e-7	BMI (adjusted for smoking behaviour);BMI in non-smokers;Body mass index;Body mass index (joint analysis main effects and smoking interaction);
SKCM	cis	rs854765	0.647	rs4349203	chr17:17989425	T/A	cg04398451	chr17:18023971	MYO15A	-1.0	-8.32	-0.69	2.25e-12	Total body bone mineral density;
SKCM	cis	rs9916302	0.514	rs4794817	chr17:37794351	T/A	cg20243544	chr17:37824526	PNMT	0.75	5.41	0.52	6.79e-7	Glomerular filtration rate (creatinine);
SKCM	cis	rs478304	0.654	rs6591185	chr11:65455742	A/G	cg27068330	chr11:65405492	SIPA1	-0.91	-7.66	-0.66	4.2e-11	Acne (severe);
SKCM	cis	rs9818758	0.607	rs9837625	chr3:49215966	C/T	cg00383909	chr3:49044727	WDR6	0.94	5.35	0.52	8.49e-7	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs8072100	0.764	rs4794371	chr17:45627693	G/C	cg08085267	chr17:45401833	C17orf57	0.59	5.13	0.5	2.09e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs561341	1.000	rs117979353	chr17:30272866	A/G	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs7937682	0.632	rs10891294	chr11:111699224	C/T	cg09085632	chr11:111637200	PPP2R1B	1.08	10.53	0.77	1.23e-16	Primary sclerosing cholangitis;
SKCM	cis	rs16854884	1.000	rs16854884	chr3:143778708	A/C	cg06585982	chr3:143692056	C3orf58	0.74	5.69	0.54	2.17e-7	Economic and political preferences (feminism/equality);
SKCM	cis	rs778371	0.676	rs921055	chr2:233697337	A/C	cg08000102	chr2:233561755	GIGYF2	-0.8	-6.41	-0.59	1.04e-8	Schizophrenia;
SKCM	trans	rs17685	0.712	rs59659102	chr7:75710114	G/A	cg19862616	chr7:65841803	NCRNA00174	0.94	9.45	0.73	1.46e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs17711722	0.727	rs2658585	chr7:65461941	A/T	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.63	5.48	0.53	5.11e-7	Calcium levels;
SKCM	cis	rs7119	0.635	rs2667767	chr15:77876031	T/C	cg27398640	chr15:77910606	LINGO1	0.55	4.84	0.48	6.31e-6	Type 2 diabetes;
SKCM	cis	rs4523957	0.890	rs2281727	chr17:2117945	A/G	cg16513277	chr17:2031491	SMG6	-0.74	-5.06	-0.5	2.76e-6	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs10088262	0.591	rs13270541	chr8:124794849	G/A	cg20713898	chr8:124780851	FAM91A1	-0.7	-5.08	-0.5	2.55e-6	Pancreatic cancer;
SKCM	cis	rs875971	0.545	rs316305	chr7:65617971	G/A	cg18876405	chr7:65276391	NA	-0.64	-5.29	-0.51	1.09e-6	Aortic root size;
SKCM	cis	rs6582630	0.555	rs34730221	chr12:38405140	C/T	cg26384229	chr12:38710491	ALG10B	-0.8	-6.31	-0.58	1.56e-8	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs561341	0.883	rs72821942	chr17:30234460	C/T	cg00745463	chr17:30367425	LRRC37B	-1.04	-6.76	-0.61	2.28e-9	Hip circumference adjusted for BMI;
SKCM	trans	rs1814175	0.645	rs1851849	chr11:50012164	G/A	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs28374715	0.662	rs72737786	chr15:41500361	G/T	cg18705301	chr15:41695430	NDUFAF1	-0.93	-7.74	-0.66	2.94e-11	Ulcerative colitis;
SKCM	cis	rs2072499	0.767	rs3001789	chr1:156197614	T/G	cg24450063	chr1:156163899	SLC25A44	0.79	6.76	0.61	2.21e-9	Testicular germ cell tumor;
SKCM	cis	rs4819052	0.808	rs2246697	chr21:46689999	G/A	cg19498844	chr21:46707878	POFUT2;LOC642852	0.91	7.84	0.66	1.92e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs9896933	0.723	rs7224189	chr17:80782227	C/T	cg20578329	chr17:80767326	TBCD	-0.95	-6.52	-0.59	6.33e-9	Bone mineral accretion in asthma (oral corticosteroid dose interaction);
SKCM	cis	rs7122539	0.646	rs9633985	chr11:66520608	A/T	cg24851651	chr11:66362959	CCS	0.69	5.02	0.49	3.25e-6	HIV-1 susceptibility;
SKCM	cis	rs1267303	0.600	rs57100184	chr1:47004710	A/C	cg25110126	chr1:46999211	NA	0.74	5.49	0.53	4.86e-7	Monobrow;
SKCM	cis	rs7666738	0.830	rs11940273	chr4:98979965	T/A	cg17366294	chr4:99064904	C4orf37	0.59	4.85	0.48	6.29e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs3096299	0.967	rs28575874	chr16:89469890	C/T	cg02187348	chr16:89574699	SPG7	0.63	5.04	0.5	2.93e-6	Multiple myeloma (IgH translocation);
SKCM	cis	rs7666738	0.830	rs13138063	chr4:99050438	A/C	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2013441	0.965	rs2703790	chr17:20163209	G/A	cg13482628	chr17:19912719	NA	-0.64	-5.04	-0.5	2.94e-6	Obesity-related traits;
SKCM	cis	rs2243480	1.000	rs4718333	chr7:65772758	T/C	cg18252515	chr7:66147081	NA	1.34	8.18	0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs2839186	0.934	rs2839197	chr21:47708133	A/G	cg13126279	chr21:47581558	C21orf56	-0.64	-5.47	-0.53	5.17e-7	Testicular germ cell tumor;
SKCM	cis	rs7811142	0.830	rs11761253	chr7:99939321	C/T	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.06	6.05	0.56	4.82e-8	Platelet count;
SKCM	cis	rs7666738	0.791	rs4440223	chr4:99044796	G/A	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs28595532	0.920	rs114928651	chr4:119734194	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.43	0.59	9.38e-9	Cannabis dependence symptom count;
SKCM	cis	rs7149337	0.869	rs10137481	chr14:51694614	C/T	cg23942311	chr14:51606299	NA	0.61	6.66	0.6	3.42e-9	Cancer;
SKCM	cis	rs9300255	0.568	rs1790090	chr12:123633424	G/A	cg00376283	chr12:123451042	ABCB9	0.8	5.4	0.52	7.12e-7	Neutrophil percentage of white cells;
SKCM	cis	rs4253772	0.637	rs9627350	chr22:46663017	A/G	cg03482458	chr22:46692211	CN5H6.4;GTSE1	1.1	5.09	0.5	2.44e-6	LDL cholesterol;Cholesterol, total;
SKCM	cis	rs17065868	0.881	rs9590837	chr13:45145355	G/T	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs2204008	0.624	rs2320449	chr12:38224190	T/C	cg26384229	chr12:38710491	ALG10B	0.81	6.23	0.58	2.23e-8	Bladder cancer;
SKCM	trans	rs7618501	0.722	rs9853458	chr3:49783211	A/C	cg21659725	chr3:3221576	CRBN	-0.96	-9.61	-0.74	7.08e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs951366	0.789	rs823094	chr1:205689807	G/T	cg07167872	chr1:205819463	PM20D1	-0.71	-5.56	-0.53	3.57e-7	Menarche (age at onset);
SKCM	cis	rs56235845	0.796	rs13153019	chr5:176782218	T/C	cg17509989	chr5:176798049	RGS14	0.93	7.08	0.63	5.65e-10	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs17376456	0.825	rs13357713	chr5:93145423	T/C	cg21475434	chr5:93447410	FAM172A	0.95	5.36	0.52	8.36e-7	Diabetic retinopathy;
SKCM	cis	rs4253772	0.637	rs3087501	chr22:46647909	A/G	cg03482458	chr22:46692211	CN5H6.4;GTSE1	1.11	4.96	0.49	4.03e-6	LDL cholesterol;Cholesterol, total;
SKCM	cis	rs673604	1.000	rs11264120	chr1:35676595	G/A	cg12633102	chr1:35676489	NA	-0.68	-5.35	-0.52	8.54e-7	Endometrial cancer;
SKCM	cis	rs1405130	0.839	rs11693749	chr2:235569891	C/T	cg21542780	chr2:234763377	HJURP	-0.64	-4.89	-0.48	5.21e-6	Coronary artery disease;
SKCM	cis	rs28386778	0.897	rs2584617	chr17:61925298	C/T	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs3540	0.597	rs3743409	chr15:91045539	T/A	cg22089800	chr15:90895588	ZNF774	-0.68	-4.92	-0.49	4.72e-6	Allergic disease (asthma, hay fever or eczema);Lymphocyte counts;
SKCM	cis	rs2721195	1.000	rs6599530	chr8:145677418	C/G	cg15857475	chr8:145742913	RECQL4;LRRC14	-0.8	-7.07	-0.62	5.82e-10	Age at first birth;
SKCM	cis	rs7552404	0.883	rs2185436	chr1:76203783	A/G	cg03433033	chr1:76189801	ACADM	0.73	5.33	0.52	9.12e-7	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs12611334	0.895	rs8106628	chr19:40185062	G/C	cg04998674	chr19:40596855	ZNF780A	0.63	4.77	0.47	8.55e-6	Schizophrenia;
SKCM	cis	rs12478296	0.685	rs6705935	chr2:242995110	C/T	cg06360820	chr2:242988706	NA	-1.01	-6.11	-0.57	3.7e-8	Obesity-related traits;
SKCM	cis	rs941408	0.515	rs1736188	chr19:2782368	A/G	cg06609049	chr19:2785107	THOP1	1.13	10.16	0.75	6.14e-16	Total cholesterol levels;
SKCM	cis	rs12477438	0.520	rs13023744	chr2:99738224	C/T	cg14399236	chr2:99771627	LIPT1;TSGA10	1.0	9.4	0.73	1.85e-14	Chronic sinus infection;
SKCM	cis	rs9913156	0.748	rs55981776	chr17:4561401	T/C	cg19197139	chr17:4613644	ARRB2	0.79	5.28	0.51	1.14e-6	Lymphocyte counts;
SKCM	cis	rs867186	1.000	rs60866116	chr20:33726150	T/C	cg04194272	chr20:33683537	NA	-1.11	-6.01	-0.56	5.61e-8	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs7635838	0.785	rs904475	chr3:11535417	G/A	cg00170343	chr3:11313890	ATG7	0.68	4.89	0.48	5.22e-6	HDL cholesterol;
SKCM	cis	rs62103177	0.608	rs551643	chr18:77838970	C/G	cg27393146	chr18:77495563	CTDP1	0.85	5.67	0.54	2.3e-7	Opioid sensitivity;
SKCM	cis	rs35306767	0.715	rs1871622	chr10:1049309	T/G	cg26597838	chr10:835615	NA	0.64	5.23	0.51	1.38e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs9818758	0.556	rs9814987	chr3:49207849	T/C	cg24898236	chr3:49228699	LOC646498	0.65	4.98	0.49	3.66e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs6500395	0.928	rs7199206	chr16:48702538	A/G	cg04672837	chr16:48644449	N4BP1	-0.65	-5.4	-0.52	7.07e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs35306767	0.903	rs35567307	chr10:915804	G/C	cg25614935	chr10:1084866	C10orf110	0.78	5.09	0.5	2.42e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs4911259	0.593	rs6058924	chr20:31464467	G/A	cg13636640	chr20:31349939	DNMT3B	-0.74	-6.15	-0.57	3.04e-8	Inflammatory bowel disease;
SKCM	cis	rs941873	0.803	rs2105461	chr10:81101679	A/G	cg09469691	chr10:81107165	PPIF	-0.71	-6.48	-0.59	7.55e-9	Height;
SKCM	cis	rs2180341	1.000	rs3798852	chr6:127636733	A/G	cg27446573	chr6:127587934	RNF146	0.94	8.06	0.67	7.08e-12	Breast cancer;
SKCM	cis	rs57221529	0.664	rs72704802	chr5:554211	C/T	cg17284070	chr5:473007	LOC25845	1.04	4.82	0.48	6.85e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs1790761	0.504	rs61894496	chr11:67391907	C/T	cg00290607	chr11:67383545	NA	0.59	6.29	0.58	1.69e-8	Mean corpuscular volume;
SKCM	cis	rs1153858	1.000	rs7181167	chr15:45686236	C/G	cg10760299	chr15:45669010	GATM	0.6	5.93	0.56	7.69e-8	Homoarginine levels;
SKCM	cis	rs870825	0.616	rs9631783	chr4:185626511	C/T	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs875971	1.000	rs709595	chr7:65817333	G/C	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	7.98e-13	Aortic root size;
SKCM	cis	rs7772486	0.875	rs863820	chr6:146347402	C/T	cg23711669	chr6:146136114	FBXO30	-0.75	-7.02	-0.62	7.08e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1577917	0.681	rs4707211	chr6:86232710	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.76	6.82	0.61	1.72e-9	Response to antipsychotic treatment;
SKCM	cis	rs6840360	0.554	rs62329088	chr4:152471289	C/T	cg22705602	chr4:152727874	NA	-0.51	-5.78	-0.55	1.48e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs9303401	0.573	rs34717648	chr17:56886624	T/A	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.16	0.57	2.91e-8	Cognitive test performance;
SKCM	cis	rs2115536	1.000	rs2903105	chr15:80189523	C/G	cg00225070	chr15:80189496	MTHFS	0.76	5.1	0.5	2.31e-6	Eosinophil counts;Eosinophil percentage of white cells;Sum eosinophil basophil counts;Eosinophil percentage of granulocytes;Neutrophil percentage of granulocytes;
SKCM	cis	rs867186	1.000	rs10485508	chr20:33605098	C/T	cg04194272	chr20:33683537	NA	-1.38	-7.2	-0.63	3.29e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs55962025	0.883	rs362336	chr4:3213832	G/A	cg16987761	chr4:3318072	RGS12	-0.66	-4.86	-0.48	6.06e-6	Parental longevity (mother's age at death);
SKCM	cis	rs2832191	0.720	rs2832194	chr21:30494250	T/C	cg24692254	chr21:30365293	RNF160	-0.9	-8.03	-0.67	8.39e-12	Dental caries;
SKCM	cis	rs7507204	0.906	rs11671513	chr19:3429937	C/T	cg08380311	chr19:3435252	NFIC	0.93	7.7	0.66	3.58e-11	Height;
SKCM	cis	rs72781680	0.950	rs72796343	chr2:24147631	G/A	cg08917208	chr2:24149416	ATAD2B	1.02	5.84	0.55	1.16e-7	Lymphocyte counts;
SKCM	trans	rs1814175	0.781	rs2866734	chr11:49886338	A/G	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs62103177	0.564	rs1715230	chr18:77848002	C/T	cg27393146	chr18:77495563	CTDP1	-0.82	-5.7	-0.54	2.08e-7	Opioid sensitivity;
SKCM	cis	rs11920354	0.642	rs9812878	chr3:47182787	T/C	cg27129171	chr3:47204927	SETD2	0.75	5.37	0.52	7.85e-7	Granulocyte count;Sum neutrophil eosinophil counts;
SKCM	cis	rs155076	0.702	rs482731	chr13:21846075	G/A	cg14456004	chr13:21872349	NA	-1.15	-6.75	-0.61	2.38e-9	White matter hyperintensity burden;
SKCM	cis	rs9788682	1.000	rs7181447	chr15:78814567	A/G	cg06917634	chr15:78832804	PSMA4	-0.85	-5.3	-0.51	1.05e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs17376456	0.877	rs10063045	chr5:93457584	A/T	cg21475434	chr5:93447410	FAM172A	1.01	5.61	0.54	2.92e-7	Diabetic retinopathy;
SKCM	cis	rs9814567	1.000	rs6790466	chr3:134197740	C/T	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.68	-5.33	-0.52	9.31e-7	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs3749237	0.595	rs11130199	chr3:49538799	T/C	cg03060546	chr3:49711283	APEH	0.67	4.95	0.49	4.23e-6	Resting heart rate;
SKCM	cis	rs9309711	0.772	rs9309714	chr2:3491830	G/C	cg10845886	chr2:3471009	TTC15	-0.73	-5.26	-0.51	1.21e-6	Neurofibrillary tangles;
SKCM	cis	rs35146811	0.586	rs12666107	chr7:99778019	G/C	cg22906224	chr7:99728672	NA	0.68	5.15	0.5	1.89e-6	Coronary artery disease;
SKCM	cis	rs995000	0.965	rs11207980	chr1:62992749	T/C	cg06896770	chr1:63153194	DOCK7	0.92	8.25	0.68	3.08e-12	Triglyceride levels;
SKCM	cis	rs2839186	0.872	rs13046834	chr21:47701485	T/C	cg11766577	chr21:47581405	C21orf56	-0.68	-5.69	-0.54	2.1e-7	Testicular germ cell tumor;
SKCM	cis	rs362296	0.698	rs3135172	chr4:3258735	A/G	cg21096898	chr4:3318625	RGS12	-0.81	-7.35	-0.64	1.69e-10	Parental longevity (mother's age at death);
SKCM	cis	rs6121246	0.909	rs6087778	chr20:30354142	G/A	cg11595048	chr20:30225325	COX4I2	0.67	5.21	0.51	1.5e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs9486715	0.867	rs9486181	chr6:96868132	G/A	cg06623918	chr6:96969491	KIAA0776	0.79	7.09	0.63	5.34e-10	Headache;
SKCM	cis	rs875971	0.638	rs35986979	chr7:66088990	G/A	cg11764359	chr7:65958608	NA	-0.84	-6.37	-0.59	1.2e-8	Aortic root size;
SKCM	cis	rs7408868	1.000	rs10410514	chr19:15277610	C/T	cg14696996	chr19:15285081	NOTCH3	0.82	4.92	0.49	4.7e-6	Pulse pressure;
SKCM	cis	rs6754311	0.551	rs9287442	chr2:136522710	A/G	cg07169764	chr2:136633963	MCM6	-0.85	-6.11	-0.57	3.66e-8	Mosquito bite size;
SKCM	cis	rs1577917	0.771	rs10944133	chr6:86358984	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-1.01	-11.41	-0.79	2.64e-18	Response to antipsychotic treatment;
SKCM	cis	rs7829975	0.667	rs1877119	chr8:8707197	C/G	cg06636001	chr8:8085503	FLJ10661	0.71	6.16	0.57	3.01e-8	Mood instability;
SKCM	cis	rs7954584	0.567	rs11043243	chr12:122356370	G/C	cg01765077	chr12:122356316	WDR66	0.44	4.84	0.48	6.48e-6	Mean corpuscular volume;
SKCM	cis	rs2836974	0.867	rs77959119	chr21:40542768	G/A	cg17971929	chr21:40555470	PSMG1	0.89	8.63	0.7	5.63e-13	Cognitive function;
SKCM	cis	rs10540	1.000	rs12788729	chr11:502371	G/A	cg03352830	chr11:487213	PTDSS2	0.94	4.91	0.49	4.87e-6	Body mass index;
SKCM	cis	rs8072100	0.837	rs62074055	chr17:45771933	G/C	cg08085267	chr17:45401833	C17orf57	-0.6	-5.06	-0.5	2.74e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs7020830	0.861	rs2291589	chr9:37079661	T/G	cg14294708	chr9:37120828	ZCCHC7	1.1	9.97	0.75	1.45e-15	Schizophrenia;
SKCM	cis	rs6545883	0.965	rs7591345	chr2:61729641	T/A	cg15711740	chr2:61764176	XPO1	-0.73	-5.27	-0.51	1.19e-6	Tuberculosis;
SKCM	cis	rs933688	1.000	rs7720132	chr5:90745105	T/C	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.94	6.78	0.61	2.1e-9	Smoking behavior;
SKCM	cis	rs4423214	0.819	rs7938885	chr11:71170043	T/C	cg05163923	chr11:71159392	DHCR7	0.83	8.11	0.68	5.77e-12	Vitamin D levels;
SKCM	cis	rs11098499	0.863	rs12502389	chr4:120454191	A/G	cg09307838	chr4:120376055	NA	0.97	7.66	0.66	4.19e-11	Corneal astigmatism;
SKCM	cis	rs8072100	0.840	rs2136751	chr17:45456093	A/G	cg08085267	chr17:45401833	C17orf57	-0.61	-5.1	-0.5	2.3e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs2559856	0.935	rs2559864	chr12:102084710	C/G	cg12924262	chr12:102091054	CHPT1	0.71	5.68	0.54	2.19e-7	Blood protein levels;
SKCM	cis	rs7945705	0.902	rs10769979	chr11:9010659	C/T	cg21881798	chr11:8931708	C11orf17;ST5	0.84	8.2	0.68	3.84e-12	Hemoglobin concentration;
SKCM	cis	rs1799949	1.000	rs1399323	chr17:41332330	T/C	cg23758822	chr17:41437982	NA	0.93	7.84	0.66	1.91e-11	Menopause (age at onset);
SKCM	cis	rs7829975	0.514	rs2979151	chr8:8258019	A/G	cg06636001	chr8:8085503	FLJ10661	-0.74	-6.51	-0.59	6.58e-9	Mood instability;
SKCM	cis	rs16851055	0.817	rs7620622	chr3:140804947	A/G	cg23174148	chr3:141174337	NA	-0.59	-4.79	-0.48	7.82e-6	Stroke (ischemic);Ischemic stroke;
SKCM	cis	rs644799	1.000	rs651445	chr11:95539122	T/A	cg03916912	chr11:95522834	CEP57;FAM76B	0.92	8.04	0.67	8e-12	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs8180040	0.967	rs4858856	chr3:47565424	G/A	cg27129171	chr3:47204927	SETD2	0.82	5.92	0.56	8.29e-8	Colorectal cancer;
SKCM	cis	rs4132509	1.000	rs9287269	chr1:243954551	G/A	cg21452805	chr1:244014465	NA	0.88	5.15	0.5	1.92e-6	RR interval (heart rate);
SKCM	cis	rs3784262	0.967	rs12148907	chr15:58296450	T/A	cg12031962	chr15:58353849	ALDH1A2	-0.5	-6.27	-0.58	1.85e-8	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	trans	rs208520	0.560	rs2351880	chr6:66863707	G/A	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-1.07	-8.05	-0.67	7.52e-12	Exhaled nitric oxide output;
SKCM	cis	rs35306767	0.855	rs55697724	chr10:885622	T/C	cg20503657	chr10:835505	NA	0.79	5.57	0.53	3.52e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs17685	0.753	rs4728586	chr7:75802869	T/C	cg16489192	chr7:75678113	MDH2;STYXL1	-0.57	-5.49	-0.53	4.89e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs3809566	0.526	rs35829897	chr15:63334688	G/C	cg05507819	chr15:63340323	TPM1	-0.89	-5.16	-0.5	1.86e-6	Platelet count;
SKCM	cis	rs473651	0.967	rs483042	chr2:239335320	A/G	cg21699342	chr2:239360505	ASB1	0.49	4.79	0.48	7.71e-6	Multiple system atrophy;
SKCM	cis	rs2239547	0.618	rs4687658	chr3:52860366	C/G	cg11645453	chr3:52864694	ITIH4	0.79	7.19	0.63	3.41e-10	Schizophrenia;
SKCM	cis	rs28595532	0.920	rs114207133	chr4:119755140	T/C	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs4332037	0.539	rs56016347	chr7:2060126	C/T	cg23422044	chr7:1970798	MAD1L1	-0.89	-5.79	-0.55	1.38e-7	Bipolar disorder;
SKCM	cis	rs9894429	0.608	rs8477	chr17:79618059	C/T	cg18240062	chr17:79603768	NPLOC4	0.68	5.99	0.56	6.16e-8	Eye color traits;
SKCM	cis	rs10489202	0.913	rs380753	chr1:168035273	G/T	cg24449463	chr1:168025552	DCAF6	-0.8	-6.48	-0.59	7.41e-9	Schizophrenia;
SKCM	cis	rs2180341	0.960	rs6913424	chr6:127707010	A/C	cg24812749	chr6:127587940	RNF146	0.83	7.21	0.63	3.1e-10	Breast cancer;
SKCM	cis	rs9388451	0.839	rs3799711	chr6:126075313	C/T	cg05901451	chr6:126070800	HEY2	0.79	7.54	0.65	7.37e-11	Brugada syndrome;
SKCM	cis	rs7100689	0.577	rs1340385	chr10:82058851	G/A	cg01528321	chr10:82214614	TSPAN14	0.73	6.58	0.6	4.89e-9	Post bronchodilator FEV1;
SKCM	cis	rs7829975	0.688	rs7826654	chr8:8379106	C/T	cg06636001	chr8:8085503	FLJ10661	0.83	7.14	0.63	4.27e-10	Mood instability;
SKCM	cis	rs2839186	0.647	rs9976233	chr21:47616913	G/A	cg11766577	chr21:47581405	C21orf56	0.78	6.92	0.62	1.14e-9	Testicular germ cell tumor;
SKCM	cis	rs1577917	0.958	rs12208227	chr6:86670944	G/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.88	-8.86	-0.71	1.99e-13	Response to antipsychotic treatment;
SKCM	cis	rs9325144	0.647	rs12227834	chr12:38849246	G/C	cg26384229	chr12:38710491	ALG10B	-0.75	-6.25	-0.58	2.06e-8	Morning vs. evening chronotype;
SKCM	cis	rs769267	0.930	rs2304098	chr19:19646272	T/C	cg03709012	chr19:19516395	GATAD2A	0.89	8.62	0.7	5.89e-13	Tonsillectomy;
SKCM	cis	rs9911578	1.000	rs7216680	chr17:56988243	G/C	cg12560992	chr17:57184187	TRIM37	0.94	7.55	0.65	7.01e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs1863918	0.590	rs4701028	chr5:178483806	C/T	cg21905437	chr5:178450457	ZNF879	0.59	5.12	0.5	2.11e-6	Depression in response to interferon-based therapy in chronic hepatitis C;
SKCM	cis	rs1850744	0.826	rs11729940	chr4:9574743	G/A	cg15442990	chr4:9534313	NA	-1.43	-5.75	-0.55	1.68e-7	Economic and political preferences;
SKCM	cis	rs2760061	0.819	rs708114	chr1:228197496	G/A	cg18477163	chr1:228402036	OBSCN	0.49	5.8	0.55	1.32e-7	Diastolic blood pressure;
SKCM	cis	rs7659604	0.539	rs11098645	chr4:122729251	G/A	cg19748678	chr4:122722346	EXOSC9	0.68	5.71	0.54	2e-7	Type 2 diabetes;
SKCM	cis	rs738322	0.600	rs6001031	chr22:38556260	G/T	cg25457927	chr22:38595422	NA	0.56	6.48	0.59	7.61e-9	Cutaneous nevi;
SKCM	cis	rs12477438	0.520	rs11123765	chr2:99768064	T/C	cg14399236	chr2:99771627	LIPT1;TSGA10	1.01	9.53	0.73	1.01e-14	Chronic sinus infection;
SKCM	cis	rs11112613	0.713	rs58066965	chr12:105952505	C/G	cg03607813	chr12:105948248	NA	0.84	5.44	0.52	5.84e-7	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;
SKCM	cis	rs6500395	1.000	rs8059819	chr16:48682834	A/G	cg04672837	chr16:48644449	N4BP1	-0.64	-5.23	-0.51	1.39e-6	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs1577917	1.000	rs35385043	chr6:86648546	T/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.61	-5.31	-0.52	1.02e-6	Response to antipsychotic treatment;
SKCM	cis	rs1405130	0.869	rs11688577	chr2:235567050	A/G	cg17841421	chr2:235704848	NA	-0.57	-4.95	-0.49	4.14e-6	Coronary artery disease;
SKCM	cis	rs8177179	0.560	rs8177237	chr3:133476421	C/G	cg16414030	chr3:133502952	NA	-0.63	-5.12	-0.5	2.13e-6	Iron status biomarkers (transferrin levels);
SKCM	cis	rs7149337	0.752	rs8021773	chr14:51691528	C/T	cg23942311	chr14:51606299	NA	0.52	5.7	0.54	2.05e-7	Cancer;
SKCM	cis	rs11126435	0.516	rs6707302	chr2:74761422	T/C	cg03813688	chr2:74740991	TLX2	0.71	5.11	0.5	2.22e-6	Age-related hearing impairment (SNP x SNP interaction);
SKCM	cis	rs12478296	0.786	rs28802397	chr2:243049730	G/A	cg06360820	chr2:242988706	NA	-0.91	-5.25	-0.51	1.28e-6	Obesity-related traits;
SKCM	cis	rs9951698	0.703	rs6505777	chr18:13008369	A/G	cg12848697	chr18:13133368	NA	0.53	4.9	0.48	5.18e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2952156	0.920	rs2517959	chr17:37846512	A/T	cg00129232	chr17:37814104	STARD3	-0.63	-4.84	-0.48	6.46e-6	Asthma;
SKCM	cis	rs7666738	0.830	rs10022331	chr4:98960392	C/A	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs867186	1.000	rs74626382	chr20:33746668	G/T	cg04194272	chr20:33683537	NA	-1.1	-5.79	-0.55	1.38e-7	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs3008870	0.958	rs12143044	chr1:67460054	A/T	cg08660285	chr1:67390436	MIER1;WDR78	-0.92	-6.07	-0.57	4.27e-8	Lymphocyte percentage of white cells;
SKCM	trans	rs1814175	0.511	rs61905634	chr11:49819736	G/A	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs2066819	1.000	rs808919	chr12:56647911	C/G	cg26714650	chr12:56694279	CS	1.69	5.64	0.54	2.58e-7	Psoriasis vulgaris;
SKCM	cis	rs1348850	0.597	rs13014512	chr2:178470851	T/A	cg05310760	chr2:178500282	PDE11A	-0.72	-4.83	-0.48	6.66e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs7666738	0.830	rs1426662	chr4:98990319	C/T	cg05340658	chr4:99064831	C4orf37	0.67	5.14	0.5	1.98e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs12451471	0.667	rs12942002	chr17:78101629	C/G	cg06718696	chr17:78121285	EIF4A3	0.9	6.26	0.58	1.91e-8	Plateletcrit;Mean corpuscular hemoglobin concentration;
SKCM	cis	rs4819052	0.851	rs13047598	chr21:46660777	G/T	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.42	0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs8072100	0.967	rs7219303	chr17:45737701	A/G	cg25173405	chr17:45401733	C17orf57	0.57	5.13	0.5	2.07e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs11098499	0.954	rs7681544	chr4:120411255	T/C	cg09307838	chr4:120376055	NA	0.99	8.02	0.67	8.7e-12	Corneal astigmatism;
SKCM	cis	rs7818345	0.631	rs10102696	chr8:19273012	C/A	cg03393445	chr8:19249545	SH2D4A	0.62	5.61	0.54	2.99e-7	Language performance in older adults (adjusted for episodic memory);
SKCM	cis	rs732765	0.657	rs10134147	chr14:75216814	G/C	cg25946216	chr14:74253857	C14orf43	-0.93	-5.16	-0.5	1.82e-6	Non-small cell lung cancer;
SKCM	cis	rs1878931	0.582	rs9921152	chr16:3421199	A/G	cg26668626	chr16:3451006	ZNF174;ZNF434	0.82	5.95	0.56	7.24e-8	Body mass index (adult);
SKCM	cis	rs2404602	1.000	rs12898430	chr15:76874923	G/A	cg23625390	chr15:77176239	SCAPER	0.76	7.48	0.65	9.68e-11	Blood metabolite levels;
SKCM	cis	rs1790761	0.692	rs10444362	chr11:67333090	G/A	cg00290607	chr11:67383545	NA	0.51	5.38	0.52	7.59e-7	Mean corpuscular volume;
SKCM	cis	rs7666738	0.830	rs11941961	chr4:99065654	G/T	cg05340658	chr4:99064831	C4orf37	0.66	4.87	0.48	5.74e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs3892630	0.757	rs8109823	chr19:33183316	A/G	cg22980127	chr19:33182716	NUDT19	1.39	8.08	0.67	6.68e-12	Red blood cell traits;
SKCM	cis	rs752010	0.714	rs2148635	chr1:42082452	C/T	cg06885757	chr1:42089581	HIVEP3	-0.49	-4.86	-0.48	5.85e-6	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs9389248	0.690	rs6939543	chr6:135255143	A/G	cg24558204	chr6:135376177	HBS1L	-0.62	-5.86	-0.55	1.06e-7	High light scatter reticulocyte percentage of red cells;
SKCM	cis	rs561341	0.739	rs9906455	chr17:30215669	G/A	cg00745463	chr17:30367425	LRRC37B	0.94	5.96	0.56	6.78e-8	Hip circumference adjusted for BMI;
SKCM	cis	rs6519955	0.755	rs9627566	chr22:46427974	G/C	cg05468064	chr22:46423449	NA	0.56	6.23	0.58	2.19e-8	Dupuytren's disease;
SKCM	cis	rs6665290	0.904	rs2297418	chr1:227192579	A/C	cg10327440	chr1:227177885	CDC42BPA	-1.24	-16.91	-0.89	8.11e-28	Myeloid white cell count;
SKCM	cis	rs6840360	0.593	rs2175409	chr4:152701656	A/G	cg22705602	chr4:152727874	NA	-0.57	-7.4	-0.64	1.33e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs908922	0.584	rs10888500	chr1:152532749	G/A	cg09873164	chr1:152488093	CRCT1	0.69	5.07	0.5	2.67e-6	Hair morphology;
SKCM	cis	rs951366	0.873	rs823118	chr1:205723572	C/T	cg07157834	chr1:205819609	PM20D1	0.68	5.33	0.52	9.26e-7	Menarche (age at onset);
SKCM	cis	rs736408	0.608	rs35004449	chr3:52852897	G/T	cg11645453	chr3:52864694	ITIH4	0.74	6.69	0.6	3.06e-9	Bipolar disorder;
SKCM	cis	rs9902453	0.715	rs2628176	chr17:28139292	A/T	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.8	-5.4	-0.52	6.96e-7	Coffee consumption (cups per day);
SKCM	cis	rs28386778	0.734	rs7210724	chr17:61799198	T/C	cg01411255	chr17:61851458	DDX42;CCDC47	0.79	5.1	0.5	2.35e-6	Prudent dietary pattern;
SKCM	cis	rs6933660	0.760	rs6904364	chr6:151754273	T/C	cg10883421	chr6:151773342	RMND1;C6orf211	0.83	6.55	0.6	5.6e-9	Menarche (age at onset);
SKCM	cis	rs1552244	1.000	rs9820598	chr3:10117912	C/G	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs873946	0.564	rs35831787	chr10:134546346	T/C	cg00988841	chr10:134556463	INPP5A	0.61	4.97	0.49	3.86e-6	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs3796619	0.961	rs62294748	chr4:1082999	G/A	cg27284194	chr4:1044797	NA	0.67	4.8	0.48	7.53e-6	Recombination rate (males);
SKCM	cis	rs7208859	0.623	rs78071511	chr17:29128154	C/T	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs362272	0.545	rs2239725	chr4:3305739	C/T	cg21096898	chr4:3318625	RGS12	0.97	12.13	0.81	1.21e-19	Serum sulfate level;
SKCM	cis	rs7666738	0.546	rs13105521	chr4:98734419	C/T	cg17366294	chr4:99064904	C4orf37	0.62	4.94	0.49	4.37e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs17270561	0.525	rs12201678	chr6:25978993	C/T	cg10373733	chr6:25993375	NA	0.86	5.43	0.52	6.24e-7	Iron status biomarkers;
SKCM	cis	rs7772486	0.875	rs2814875	chr6:146305810	G/A	cg23711669	chr6:146136114	FBXO30	0.75	6.79	0.61	1.99e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs3008870	1.000	rs2985811	chr1:67377722	G/T	cg08660285	chr1:67390436	MIER1;WDR78	0.97	6.52	0.59	6.39e-9	Lymphocyte percentage of white cells;
SKCM	cis	rs55962025	0.883	rs362275	chr4:3224602	C/T	cg24015175	chr4:3319247	RGS12	-0.63	-5.42	-0.52	6.54e-7	Parental longevity (mother's age at death);
SKCM	cis	rs478304	0.651	rs11227279	chr11:65495211	G/A	cg17480646	chr11:65405466	SIPA1	-0.71	-5.64	-0.54	2.62e-7	Acne (severe);
SKCM	cis	rs4919087	1.000	rs11189122	chr10:99072595	G/A	cg25902810	chr10:99078978	FRAT1	0.67	5.12	0.5	2.14e-6	Monocyte count;
SKCM	cis	rs12477438	0.501	rs11688004	chr2:99735052	G/T	cg26064155	chr2:99771622	LIPT1;TSGA10	1.01	9.65	0.74	5.91e-15	Chronic sinus infection;
SKCM	cis	rs875971	0.964	rs778723	chr7:65829497	T/C	cg18876405	chr7:65276391	NA	0.68	6.79	0.61	2.01e-9	Aortic root size;
SKCM	cis	rs10905065	0.965	rs2890365	chr10:5773876	C/A	cg09234995	chr10:5726438	C10orf18	0.61	5.13	0.5	2.06e-6	Menopause (age at onset);
SKCM	cis	rs1165205	0.558	rs793144	chr6:25879321	C/T	cg03264133	chr6:25882463	NA	-0.59	-5.93	-0.56	7.82e-8	Urate levels;
SKCM	cis	rs910316	0.673	rs2012627	chr14:75443103	C/T	cg08847533	chr14:75593920	NEK9	0.85	7.48	0.65	9.3e-11	Height;
SKCM	cis	rs12464559	0.522	rs4664498	chr2:152575417	A/G	cg01189475	chr2:152685088	ARL5A	1.03	5.24	0.51	1.32e-6	Response to cognitive-behavioural therapy in anxiety disorder;
SKCM	cis	rs875971	1.000	rs6958277	chr7:65979349	A/G	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	cis	rs4919694	1.000	rs17727391	chr10:104836101	C/A	cg04362960	chr10:104952993	NT5C2	0.76	4.92	0.49	4.65e-6	Arsenic metabolism;
SKCM	cis	rs7666738	0.753	rs11097607	chr4:99011640	C/T	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs3859192	0.561	rs12451547	chr17:38181168	T/C	cg17467752	chr17:38218738	THRA	-0.76	-6.37	-0.58	1.22e-8	White blood cell count;
SKCM	cis	rs4642101	0.640	rs7629354	chr3:12827746	T/G	cg05775895	chr3:12838266	CAND2	0.59	5.11	0.5	2.22e-6	QRS complex (12-leadsum);
SKCM	cis	rs3768617	0.510	rs10752900	chr1:183086238	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs637571	0.522	rs1151512	chr11:65757533	G/A	cg26695010	chr11:65641043	EFEMP2	-0.72	-5.5	-0.53	4.69e-7	Eosinophil percentage of white cells;
SKCM	cis	rs7772486	0.846	rs866473	chr6:146353414	A/C	cg05347473	chr6:146136440	FBXO30	0.57	5.24	0.51	1.31e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs561341	1.000	rs530715	chr17:30320544	T/G	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs611744	0.647	rs674391	chr8:109242803	A/T	cg18478394	chr8:109455254	TTC35	0.64	5.19	0.51	1.63e-6	Dupuytren's disease;
SKCM	cis	rs651907	0.557	rs35117343	chr3:101445126	A/G	cg12386194	chr3:101231763	SENP7	0.68	5.59	0.54	3.16e-7	Colorectal cancer;
SKCM	cis	rs10089	1.000	rs73337363	chr5:127483597	A/G	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.9	8.98	0.71	1.17e-13	Ileal carcinoids;
SKCM	cis	rs1466045	0.676	rs4758536	chr11:3160953	C/T	cg18044967	chr11:2334942	TSPAN32	-0.46	-5.0	-0.49	3.46e-6	Cisplatin-induced ototoxicity;
SKCM	cis	rs9911578	0.692	rs411988	chr17:56709034	G/A	cg12560992	chr17:57184187	TRIM37	0.7	4.98	0.49	3.71e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2839186	0.786	rs7409792	chr21:47691729	C/A	cg05896524	chr21:47604654	C21orf56	0.68	5.72	0.54	1.92e-7	Testicular germ cell tumor;
SKCM	cis	rs7215564	0.818	rs4889776	chr17:78592385	C/T	cg16980736	chr17:78789706	RPTOR	-0.87	-4.83	-0.48	6.64e-6	Myopia (pathological);
SKCM	cis	rs854765	0.583	rs7207395	chr17:17819335	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.93	7.3	0.64	2.06e-10	Total body bone mineral density;
SKCM	cis	rs9303401	0.625	rs34963822	chr17:56988424	C/A	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.16	0.57	2.91e-8	Cognitive test performance;
SKCM	cis	rs12477438	0.501	rs2632260	chr2:99771590	G/T	cg14399236	chr2:99771627	LIPT1;TSGA10	1.01	9.53	0.73	1.01e-14	Chronic sinus infection;
SKCM	cis	rs1707322	1.000	rs3922887	chr1:46473802	A/G	cg03146154	chr1:46216737	IPP	0.75	5.11	0.5	2.24e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs2836974	0.568	rs452377	chr21:40537183	T/C	cg11890956	chr21:40555474	PSMG1	0.88	9.14	0.72	5.76e-14	Cognitive function;
SKCM	cis	rs35306767	0.903	rs17159970	chr10:935601	T/C	cg20503657	chr10:835505	NA	0.82	5.58	0.53	3.39e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs910316	1.000	rs12589376	chr14:75561152	C/T	cg08847533	chr14:75593920	NEK9	0.95	9.18	0.72	4.88e-14	Height;
SKCM	cis	rs7086627	0.515	rs10887903	chr10:82210641	C/T	cg00277334	chr10:82204260	NA	-0.73	-9.6	-0.74	7.45e-15	Post bronchodilator FEV1;
SKCM	cis	rs17826219	0.568	rs7213925	chr17:29121634	A/G	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Body mass index;
SKCM	cis	rs8077889	0.719	rs2079006	chr17:41865745	C/G	cg26893861	chr17:41843967	DUSP3	1.39	13.03	0.83	2.86e-21	Triglycerides;
SKCM	cis	rs7103648	0.966	rs11500477	chr11:47409051	T/A	cg20307385	chr11:47447363	PSMC3	1.06	9.21	0.72	4.19e-14	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs801193	0.967	rs2707853	chr7:66214010	G/A	cg11987759	chr7:65425863	GUSB	-0.67	-5.75	-0.55	1.67e-7	Aortic root size;
SKCM	cis	rs826838	1.000	rs11168218	chr12:38884466	A/G	cg13010199	chr12:38710504	ALG10B	0.84	6.66	0.6	3.54e-9	Heart rate;
SKCM	cis	rs12478296	1.000	rs56292923	chr2:243039986	C/T	cg06360820	chr2:242988706	NA	-0.92	-5.32	-0.52	9.84e-7	Obesity-related traits;
SKCM	cis	rs6921919	0.583	rs13201726	chr6:28385551	T/A	cg14547644	chr6:28411285	ZSCAN23	-0.58	-4.8	-0.48	7.46e-6	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs1799949	0.526	rs4352088	chr17:41414679	A/G	cg23758822	chr17:41437982	NA	0.93	7.88	0.67	1.62e-11	Menopause (age at onset);
SKCM	cis	rs12142240	0.698	rs72677589	chr1:46817770	T/C	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs3818285	0.544	rs7899805	chr10:111671177	G/A	cg00817464	chr10:111662876	XPNPEP1	-0.75	-7.37	-0.64	1.57e-10	Superior crus of antihelix expression;
SKCM	cis	rs1218582	0.741	rs11264281	chr1:154867221	A/G	cg16680214	chr1:154839983	KCNN3	-0.55	-5.04	-0.5	2.9e-6	Prostate cancer;
SKCM	cis	rs9325144	0.577	rs10876008	chr12:39126750	T/C	cg13010199	chr12:38710504	ALG10B	-0.62	-5.4	-0.52	6.84e-7	Morning vs. evening chronotype;
SKCM	cis	rs7811142	0.830	rs3087502	chr7:99955364	G/A	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.2	7.87	0.67	1.7e-11	Platelet count;
SKCM	cis	rs798554	0.679	rs2644281	chr7:2886748	A/G	cg19346786	chr7:2764209	NA	-0.65	-6.79	-0.61	1.96e-9	Height;
SKCM	cis	rs2013441	0.965	rs2386485	chr17:20095246	G/A	cg13482628	chr17:19912719	NA	-0.65	-5.21	-0.51	1.48e-6	Obesity-related traits;
SKCM	cis	rs7091957	0.534	rs10430616	chr10:134438951	G/A	cg27286337	chr10:134555280	INPP5A	-0.66	-5.53	-0.53	4.15e-7	Gait speed in old age;
SKCM	cis	rs2836974	0.583	rs8132993	chr21:40716410	T/C	cg11890956	chr21:40555474	PSMG1	0.72	5.72	0.54	1.88e-7	Cognitive function;
SKCM	cis	rs11585357	0.793	rs112597506	chr1:17628832	A/G	cg08277548	chr1:17600880	PADI3	-0.89	-6.31	-0.58	1.53e-8	Hair shape;
SKCM	cis	rs4972806	0.814	rs4246626	chr2:177046430	A/C	cg03152288	chr2:177042942	NA	0.57	4.99	0.49	3.6e-6	IgG glycosylation;
SKCM	cis	rs561341	0.505	rs548298	chr17:30297494	C/A	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs951366	0.789	rs823137	chr1:205738302	C/T	cg14159672	chr1:205819179	PM20D1	0.96	8.14	0.68	4.94e-12	Menarche (age at onset);
SKCM	cis	rs1912528	0.783	rs797090	chr4:140867514	A/G	cg11128457	chr4:140864437	MAML3	0.62	5.31	0.52	1e-6	Educational attainment (years of education);
SKCM	cis	rs2354432	0.607	rs6685775	chr1:146744294	A/G	cg25205988	chr1:146714368	CHD1L	-1.17	-6.52	-0.59	6.27e-9	Mitochondrial DNA levels;
SKCM	cis	rs6977660	0.943	rs10249996	chr7:19844935	G/A	cg05791153	chr7:19748676	TWISTNB	0.79	5.51	0.53	4.42e-7	Thyroid stimulating hormone;
SKCM	cis	rs875971	1.000	rs6957199	chr7:65978519	T/C	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs72781680	0.950	rs72796402	chr2:24180104	A/G	cg08917208	chr2:24149416	ATAD2B	1.02	5.84	0.55	1.16e-7	Lymphocyte counts;
SKCM	cis	rs7666738	0.830	rs9307218	chr4:99024885	T/C	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9790314	0.747	rs9990115	chr3:160838412	C/G	cg03342759	chr3:160939853	NMD3	-0.62	-6.25	-0.58	2.03e-8	Morning vs. evening chronotype;
SKCM	cis	rs17376456	0.825	rs10052662	chr5:93271385	A/G	cg21475434	chr5:93447410	FAM172A	1.02	5.17	0.51	1.74e-6	Diabetic retinopathy;
SKCM	cis	rs62103177	0.513	rs9945153	chr18:77598450	C/T	cg27393146	chr18:77495563	CTDP1	-0.95	-5.5	-0.53	4.56e-7	Opioid sensitivity;
SKCM	cis	rs28595532	0.920	rs17259284	chr4:119779298	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs995000	0.965	rs10789112	chr1:62957758	T/C	cg06896770	chr1:63153194	DOCK7	0.91	7.99	0.67	9.98e-12	Triglyceride levels;
SKCM	cis	rs595982	0.527	rs56021835	chr19:49369989	G/A	cg15549821	chr19:49342101	PLEKHA4	-0.87	-5.21	-0.51	1.48e-6	Red cell distribution width;
SKCM	cis	rs17376456	0.825	rs66564678	chr5:93165894	C/T	cg25358565	chr5:93447407	FAM172A	1.15	7.74	0.66	2.99e-11	Diabetic retinopathy;
SKCM	cis	rs2920503	0.659	rs17029006	chr3:12329452	C/T	cg23514324	chr3:12329213	PPARG	0.6	4.77	0.48	8.5e-6	LDL cholesterol;
SKCM	cis	rs2204008	0.807	rs8186948	chr12:38325101	C/G	cg26384229	chr12:38710491	ALG10B	0.81	6.67	0.6	3.38e-9	Bladder cancer;
SKCM	cis	rs34779708	0.966	rs12765038	chr10:35416513	G/C	cg03585969	chr10:35415529	CREM	0.78	6.18	0.57	2.7e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	trans	rs17082664	1.000	rs17082664	chr6:152738754	A/G	cg07251887	chr17:73641809	LOC100130933;RECQL5	0.98	7.72	0.66	3.31e-11	Bipolar disorder;Bipolar disorder or major depressive disorder (combined);
SKCM	cis	rs6977660	0.714	rs7357319	chr7:19817525	A/G	cg07541023	chr7:19748670	TWISTNB	0.72	4.78	0.48	7.95e-6	Thyroid stimulating hormone;
SKCM	cis	rs1552244	1.000	rs9881859	chr3:10072814	A/T	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs9902453	0.740	rs2628189	chr17:28088813	G/A	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.76	-5.75	-0.55	1.69e-7	Coffee consumption (cups per day);
SKCM	cis	rs3749237	0.537	rs4459909	chr3:49469217	T/C	cg03060546	chr3:49711283	APEH	0.67	4.95	0.49	4.23e-6	Resting heart rate;
SKCM	cis	rs1799949	1.000	rs35070007	chr17:41316747	C/G	cg25918947	chr17:41365094	TMEM106A	0.61	5.69	0.54	2.14e-7	Menopause (age at onset);
SKCM	cis	rs362296	0.590	rs4690081	chr4:3262105	T/G	cg05297308	chr4:3317976	RGS12	-0.77	-6.61	-0.6	4.37e-9	Parental longevity (mother's age at death);
SKCM	cis	rs11098499	0.657	rs10434028	chr4:120294464	T/G	cg24375607	chr4:120327624	NA	0.67	5.11	0.5	2.25e-6	Corneal astigmatism;
SKCM	cis	rs3785574	0.962	rs7219920	chr17:61811642	C/G	cg06601766	chr17:61851465	DDX42;CCDC47	0.66	4.98	0.49	3.74e-6	Height;
SKCM	cis	rs8060686	0.641	rs12447640	chr16:68150527	A/G	cg04539111	chr16:67997858	SLC12A4	-0.85	-4.81	-0.48	7.14e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs3784262	1.000	rs12910113	chr15:58248373	A/C	cg12031962	chr15:58353849	ALDH1A2	-0.5	-6.1	-0.57	3.75e-8	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs1799949	0.501	rs35399157	chr17:41411602	G/C	cg05368731	chr17:41323189	NBR1	0.85	7.32	0.64	1.89e-10	Menopause (age at onset);
SKCM	cis	rs2354432	0.556	rs34602039	chr1:146850972	G/A	cg25205988	chr1:146714368	CHD1L	-1.11	-5.59	-0.53	3.21e-7	Mitochondrial DNA levels;
SKCM	cis	rs3091242	0.728	rs706845	chr1:25730713	G/A	cg27572855	chr1:25598939	RHD	0.53	5.11	0.5	2.22e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs7216064	0.601	rs35453056	chr17:66039668	A/G	cg12091567	chr17:66097778	LOC651250	0.89	6.71	0.6	2.8e-9	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs9911578	1.000	rs11869828	chr17:56609525	G/A	cg05425664	chr17:57184151	TRIM37	0.69	5.2	0.51	1.56e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2839186	0.721	rs13051200	chr21:47701693	A/T	cg13126279	chr21:47581558	C21orf56	-0.62	-5.25	-0.51	1.29e-6	Testicular germ cell tumor;
SKCM	cis	rs6570726	0.935	rs421690	chr6:145834594	A/C	cg23711669	chr6:146136114	FBXO30	0.7	6.64	0.6	3.72e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6696846	0.749	rs11578293	chr1:205070178	T/C	cg00857998	chr1:205179979	DSTYK	0.59	4.83	0.48	6.79e-6	Red blood cell count;
SKCM	cis	rs6430585	0.583	rs58116536	chr2:136585323	C/T	cg07169764	chr2:136633963	MCM6	1.31	13.22	0.83	1.29e-21	Corneal structure;
SKCM	cis	rs6088580	0.634	rs6088478	chr20:32971719	T/C	cg24642439	chr20:33292090	TP53INP2	-0.76	-6.02	-0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs9420	0.961	rs11570190	chr11:57560452	A/C	cg19752551	chr11:57585705	CTNND1	-0.69	-7.02	-0.62	7.36e-10	Schizophrenia;
SKCM	cis	rs9399135	0.967	rs7763836	chr6:135362378	T/C	cg24558204	chr6:135376177	HBS1L	0.57	5.01	0.49	3.34e-6	Red blood cell count;
SKCM	cis	rs62238980	0.614	rs74321309	chr22:32483022	C/T	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs2991971	0.967	rs12133294	chr1:45988764	C/T	cg24296786	chr1:45957014	TESK2	0.65	5.16	0.5	1.81e-6	High light scatter reticulocyte count;
SKCM	cis	rs362296	0.698	rs3135168	chr4:3262699	T/C	cg09735869	chr4:3319127	RGS12	-0.76	-6.84	-0.61	1.61e-9	Parental longevity (mother's age at death);
SKCM	cis	rs10504229	0.683	rs55714371	chr8:58131846	T/G	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs950027	0.787	rs1153845	chr15:45724729	C/T	cg21132104	chr15:45694354	SPATA5L1	-0.69	-4.84	-0.48	6.53e-6	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs35306767	0.855	rs11253499	chr10:944090	A/C	cg20503657	chr10:835505	NA	0.76	5.41	0.52	6.82e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs867186	1.000	rs34174778	chr20:33544277	C/G	cg04194272	chr20:33683537	NA	-1.36	-7.01	-0.62	7.44e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs2243480	0.803	rs403089	chr7:65517723	T/C	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs9430161	0.579	rs6696575	chr1:11037136	G/A	cg02454025	chr1:11042201	C1orf127	1.02	9.27	0.72	3.19e-14	Ewing sarcoma;
SKCM	cis	rs137761	0.576	rs5764210	chr22:44076134	T/G	cg12729397	chr22:44208276	EFCAB6	0.69	4.95	0.49	4.25e-6	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs473651	0.935	rs482775	chr2:239335403	G/C	cg21699342	chr2:239360505	ASB1	0.49	4.79	0.48	7.71e-6	Multiple system atrophy;
SKCM	cis	rs9902453	0.868	rs8066602	chr17:28523085	T/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.78	5.71	0.54	1.92e-7	Coffee consumption (cups per day);
SKCM	cis	rs4237845	0.680	rs10877033	chr12:58283731	T/C	cg00677455	chr12:58241039	CTDSP2	0.69	5.66	0.54	2.41e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7208859	0.524	rs57670615	chr17:29069498	A/G	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs9911578	1.000	rs9901114	chr17:56575208	G/A	cg05425664	chr17:57184151	TRIM37	0.7	5.23	0.51	1.41e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs4332037	0.510	rs58673065	chr7:1885600	A/G	cg23422044	chr7:1970798	MAD1L1	-0.87	-5.87	-0.55	1.01e-7	Bipolar disorder;
SKCM	cis	rs951366	0.844	rs823096	chr1:205679887	G/T	cg24503407	chr1:205819492	PM20D1	0.81	6.43	0.59	9.51e-9	Menarche (age at onset);
SKCM	cis	rs3784262	1.000	rs12907038	chr15:58244032	C/G	cg12031962	chr15:58353849	ALDH1A2	-0.47	-5.68	-0.54	2.25e-7	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs1552244	1.000	rs12374115	chr3:10134766	A/G	cg02579736	chr3:10068473	FANCD2;CIDECP	-1.32	-7.35	-0.64	1.72e-10	Alzheimer's disease;
SKCM	cis	rs7811142	1.000	rs11559117	chr7:100076614	A/G	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.23	7.89	0.67	1.53e-11	Platelet count;
SKCM	cis	rs28699126	0.504	rs1056632	chr2:26512733	T/G	cg26119090	chr2:26468346	HADHA;HADHB	1.08	8.63	0.7	5.67e-13	Mean corpuscular hemoglobin;
SKCM	cis	rs2204008	0.627	rs10878488	chr12:38148666	G/A	cg26384229	chr12:38710491	ALG10B	0.82	6.46	0.59	8.2e-9	Bladder cancer;
SKCM	cis	rs4803468	1.000	rs284650	chr19:41927129	A/G	cg09537434	chr19:41945824	ATP5SL	-1.1	-13.85	-0.84	1.02e-22	Height;
SKCM	cis	rs514406	0.698	rs1672913	chr1:53408326	A/T	cg16325326	chr1:53192061	ZYG11B	0.65	5.64	0.54	2.61e-7	Monocyte count;
SKCM	cis	rs17376456	0.877	rs12716457	chr5:93397627	T/C	cg21475434	chr5:93447410	FAM172A	0.95	5.35	0.52	8.56e-7	Diabetic retinopathy;
SKCM	trans	rs11722228	0.549	rs55848383	chr4:10081117	C/A	cg26043149	chr18:55253948	FECH	0.93	7.98	0.67	1.02e-11	Gout;Urate levels;Serum uric acid levels;
SKCM	cis	rs1692580	0.807	rs260508	chr1:2187085	T/G	cg24578937	chr1:2090814	PRKCZ	0.47	5.16	0.5	1.81e-6	Coronary artery disease;
SKCM	cis	rs17685	0.753	rs10262501	chr7:75668172	G/A	cg16489192	chr7:75678113	MDH2;STYXL1	0.58	5.44	0.52	5.83e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1635	0.655	rs723476	chr6:28305104	C/T	cg15743358	chr6:28303923	ZNF323	-1.27	-5.15	-0.5	1.92e-6	Schizophrenia;
SKCM	cis	rs7584330	0.780	rs12474519	chr2:238377012	G/A	cg14458575	chr2:238380390	NA	0.88	5.71	0.54	1.93e-7	Prostate cancer;
SKCM	cis	rs11155671	0.530	rs7758033	chr6:150208135	T/C	cg05036130	chr6:150231994	NA	0.6	6.88	0.61	1.31e-9	Testicular germ cell tumor;
SKCM	cis	rs35306767	0.953	rs10904583	chr10:983498	T/C	cg26597838	chr10:835615	NA	0.65	5.35	0.52	8.7e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs10870270	1.000	rs11146338	chr10:133770291	C/G	cg17892150	chr10:133769511	PPP2R2D	-0.66	-4.86	-0.48	5.92e-6	Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals;
SKCM	cis	rs6565180	1.000	rs11646130	chr16:30376959	T/C	cg17640201	chr16:30407289	ZNF48	-0.9	-6.68	-0.6	3.17e-9	Tonsillectomy;
SKCM	cis	rs12474201	0.928	rs13025984	chr2:46938789	T/C	cg06386533	chr2:46925753	SOCS5	1.01	9.25	0.72	3.5e-14	Height;
SKCM	cis	rs7438704	0.552	rs309867	chr4:48331850	A/G	cg15299388	chr4:48491941	ZAR1	0.44	5.02	0.49	3.23e-6	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs11098499	0.731	rs10015579	chr4:120271802	T/C	cg09307838	chr4:120376055	NA	0.94	7.73	0.66	3.07e-11	Corneal astigmatism;
SKCM	cis	rs11690935	0.921	rs6710698	chr2:172596078	G/C	cg13550731	chr2:172543902	DYNC1I2	-0.99	-8.78	-0.7	2.9e-13	Schizophrenia;
SKCM	cis	rs10832963	0.924	rs10500834	chr11:18638712	A/T	cg09201001	chr11:18656081	SPTY2D1	1.03	11.04	0.78	1.31e-17	Breast cancer;
SKCM	cis	rs4272321	1	rs4272321	chr7:157951835	A/G	cg19268477	chr7:157951471	PTPRN2	0.35	4.79	0.48	7.93e-6	Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes;
SKCM	cis	rs12142240	0.659	rs67547686	chr1:46832229	G/C	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs2224391	1.000	rs9504369	chr6:5261575	T/C	cg09085698	chr6:5261316	LYRM4;FARS2	-0.75	-5.33	-0.52	9.43e-7	Height;
SKCM	cis	rs9896933	0.832	rs77512810	chr17:80804589	C/T	cg20578329	chr17:80767326	TBCD	-0.97	-6.45	-0.59	8.49e-9	Bone mineral accretion in asthma (oral corticosteroid dose interaction);
SKCM	cis	rs10876993	0.928	rs813854	chr12:58071347	A/G	cg18357645	chr12:58087776	OS9	0.65	5.98	0.56	6.22e-8	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs1003719	0.788	rs7277657	chr21:38469523	A/G	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs2072732	0.851	rs72630915	chr1:2980578	C/T	cg23686029	chr1:3435989	MEGF6	0.56	4.81	0.48	7.23e-6	Plateletcrit;
SKCM	cis	rs4523957	0.855	rs12601834	chr17:2112431	C/T	cg16513277	chr17:2031491	SMG6	-0.72	-4.87	-0.48	5.82e-6	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs2832191	0.716	rs7509628	chr21:30454252	C/T	cg08807101	chr21:30365312	RNF160	0.74	6.09	0.57	4.06e-8	Dental caries;
SKCM	cis	rs854765	0.647	rs854817	chr17:18021882	T/C	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.92	6.9	0.62	1.24e-9	Total body bone mineral density;
SKCM	cis	rs17854409	0.881	rs6011430	chr20:61497014	C/T	cg06598544	chr20:61472147	COL9A3	1.03	5.65	0.54	2.52e-7	Obesity-related traits;
SKCM	cis	rs9796	0.689	rs692195	chr15:41444894	G/C	cg18705301	chr15:41695430	NDUFAF1	-0.74	-5.35	-0.52	8.47e-7	Menopause (age at onset);
SKCM	cis	rs875971	0.964	rs778721	chr7:65845397	C/G	cg18876405	chr7:65276391	NA	0.67	6.65	0.6	3.61e-9	Aortic root size;
SKCM	cis	rs9399137	0.507	rs6923512	chr6:135335268	A/G	cg24558204	chr6:135376177	HBS1L	-0.71	-6.51	-0.59	6.77e-9	Glycated hemoglobin levels;Mean corpuscular volume;Hematology traits;HbA2 levels;Mean corpuscular hemoglobin;Hemoglobin levels;F-cell distribution;Platelet count;
SKCM	cis	rs17376456	0.825	rs6877030	chr5:93201841	C/A	cg21475434	chr5:93447410	FAM172A	0.95	5.31	0.51	1.02e-6	Diabetic retinopathy;
SKCM	cis	rs7216064	0.954	rs4790973	chr17:65951133	C/T	cg12091567	chr17:66097778	LOC651250	-0.78	-5.3	-0.51	1.06e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs908922	1.000	rs1199150	chr1:152455602	T/C	cg09873164	chr1:152488093	CRCT1	0.92	5.17	0.51	1.75e-6	Hair morphology;
SKCM	cis	rs4924935	1.000	rs35341640	chr17:18818228	G/A	cg26378065	chr17:18585709	ZNF286B	-0.77	-5.58	-0.53	3.37e-7	Pancreatic cancer;
SKCM	cis	rs760805	1.000	rs7517302	chr1:25254317	C/T	cg22509179	chr1:25234806	RUNX3	-0.75	-6.22	-0.58	2.26e-8	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs28595532	0.688	rs116580819	chr4:119767362	T/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs4819052	0.807	rs28715237	chr21:46673768	C/G	cg20896738	chr21:46707857	POFUT2;LOC642852	0.64	4.8	0.48	7.53e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs72827839	0.516	rs111630961	chr17:45938097	T/G	cg23391107	chr17:45924227	SP6	0.67	5.75	0.55	1.63e-7	Ease of getting up in the morning;
SKCM	cis	rs2439831	1.000	rs689647	chr15:43762196	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.21	7.96	0.67	1.1e-11	Lung cancer in ever smokers;
SKCM	cis	rs7843479	0.582	rs7818254	chr8:21798316	C/T	cg17168535	chr8:21777572	XPO7	0.89	8.71	0.7	4.01e-13	Mean corpuscular volume;
SKCM	cis	rs28386778	0.897	rs2036911	chr17:61794839	A/T	cg01411255	chr17:61851458	DDX42;CCDC47	0.79	5.1	0.5	2.35e-6	Prudent dietary pattern;
SKCM	cis	rs9926296	0.585	rs6500450	chr16:89858024	A/G	cg04287289	chr16:89883240	FANCA	1.01	12.31	0.81	5.84e-20	Vitiligo;
SKCM	cis	rs7772486	0.686	rs2092263	chr6:146029687	G/A	cg23711669	chr6:146136114	FBXO30	-0.82	-8.01	-0.67	9.12e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs62238980	0.521	rs733907	chr22:32462564	T/C	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs7843479	0.582	rs11779655	chr8:21794041	A/G	cg17168535	chr8:21777572	XPO7	-0.82	-8.31	-0.69	2.33e-12	Mean corpuscular volume;
SKCM	cis	rs875971	0.522	rs2008188	chr7:65429013	G/C	cg11987759	chr7:65425863	GUSB	-0.77	-6.89	-0.62	1.26e-9	Aortic root size;
SKCM	cis	rs7296418	0.961	rs1790094	chr12:123586688	T/C	cg00376283	chr12:123451042	ABCB9	0.95	8.5	0.69	1.03e-12	Platelet count;
SKCM	cis	rs9931543	0.678	rs876245	chr16:56291212	A/G	cg00348762	chr16:56228114	DKFZP434H168;GNAO1	0.66	5.55	0.53	3.75e-7	Subjective well-being;
SKCM	cis	rs1218582	0.710	rs4845685	chr1:154878300	C/A	cg03351412	chr1:154909251	PMVK	0.77	6.52	0.59	6.43e-9	Prostate cancer;
SKCM	cis	rs34779708	0.966	rs34630580	chr10:35449228	A/G	cg03585969	chr10:35415529	CREM	0.72	5.89	0.56	9.14e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs12477438	0.501	rs11685756	chr2:99766215	T/C	cg14399236	chr2:99771627	LIPT1;TSGA10	0.97	8.9	0.71	1.72e-13	Chronic sinus infection;
SKCM	cis	rs4481887	0.741	rs6674078	chr1:248543026	G/A	cg00666640	chr1:248458726	OR2T12	0.47	4.85	0.48	6.07e-6	Common traits (Other);
SKCM	cis	rs2439831	0.681	rs28578454	chr15:43603032	G/A	cg02155558	chr15:43621948	ADAL;LCMT2	1.34	8.29	0.68	2.59e-12	Lung cancer in ever smokers;
SKCM	cis	rs7772486	0.875	rs2814874	chr6:146305895	C/T	cg23711669	chr6:146136114	FBXO30	0.75	6.79	0.61	1.99e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6951245	0.554	rs79367977	chr7:1152657	G/A	cg23708337	chr7:1209742	NA	0.73	5.05	0.5	2.78e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs6840360	0.554	rs61308159	chr4:152728941	G/A	cg22705602	chr4:152727874	NA	0.56	7.66	0.65	4.36e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs12048904	0.505	rs11166511	chr1:101240686	G/C	cg16556008	chr1:101360663	SLC30A7;EXTL2	-0.83	-5.84	-0.55	1.14e-7	Multiple sclerosis;
SKCM	cis	rs9790314	1.000	rs6441373	chr3:161026717	T/G	cg03342759	chr3:160939853	NMD3	-0.72	-7.87	-0.67	1.65e-11	Morning vs. evening chronotype;
SKCM	cis	rs9815354	0.812	rs73081370	chr3:41916258	G/C	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs4724125	0.883	rs10951691	chr7:42680159	G/A	cg09407816	chr7:42972088	MRPL32;PSMA2	0.81	4.85	0.48	6.29e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs763014	0.966	rs12935215	chr16:670605	T/C	cg00908189	chr16:619842	PIGQ	0.82	7.61	0.65	5.42e-11	Height;
SKCM	cis	rs1046896	0.552	rs12602280	chr17:80805421	G/C	cg02711726	chr17:80685570	FN3KRP	-0.75	-5.6	-0.54	3.07e-7	Glycated hemoglobin levels;
SKCM	cis	rs62244186	0.545	rs725866	chr3:44765533	A/G	cg02073558	chr3:44770973	ZNF501	0.86	7.8	0.66	2.34e-11	Depressive symptoms;
SKCM	cis	rs9814567	0.964	rs4974480	chr3:134178562	A/T	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.67	-5.59	-0.53	3.23e-7	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs2439831	0.867	rs2243434	chr15:43689867	A/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.22	8.31	0.69	2.36e-12	Lung cancer in ever smokers;
SKCM	cis	rs478304	0.651	rs12225620	chr11:65505448	T/C	cg17480646	chr11:65405466	SIPA1	-0.71	-5.64	-0.54	2.62e-7	Acne (severe);
SKCM	cis	rs12477438	0.520	rs13798	chr2:99813614	T/C	cg26064155	chr2:99771622	LIPT1;TSGA10	0.97	8.85	0.71	2.11e-13	Chronic sinus infection;
SKCM	cis	rs1211375	0.628	rs3859141	chr16:245079	T/C	cg03788090	chr16:233062	NA	-0.55	-4.95	-0.49	4.13e-6	Hematology traits;Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs1801251	0.896	rs2197563	chr2:233687080	G/A	cg08000102	chr2:233561755	GIGYF2	-0.79	-6.42	-0.59	9.71e-9	Coronary artery disease;
SKCM	cis	rs1707322	0.963	rs6429581	chr1:46319096	G/A	cg03146154	chr1:46216737	IPP	0.74	5.0	0.49	3.39e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs72634258	0.554	rs4908699	chr1:7905274	G/A	cg26816564	chr1:7831052	VAMP3	0.75	4.93	0.49	4.55e-6	Inflammatory bowel disease;
SKCM	cis	rs4746818	1.000	rs906218	chr10:70960913	C/T	cg11621586	chr10:70884670	VPS26A	0.93	7.37	0.64	1.52e-10	Left atrial antero-posterior diameter;
SKCM	cis	rs4900538	0.963	rs942023	chr14:102972170	T/C	cg18135206	chr14:102964638	TECPR2	0.79	6.53	0.59	6.09e-9	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs3820068	0.603	rs6695903	chr1:15985940	C/T	cg24675056	chr1:15929824	NA	0.68	4.93	0.49	4.62e-6	Systolic blood pressure;
SKCM	cis	rs847649	0.692	rs10257317	chr7:102447056	T/C	cg18108683	chr7:102477205	FBXL13	-0.83	-9.35	-0.73	2.31e-14	Morning vs. evening chronotype;
SKCM	cis	rs2050392	0.737	rs7898978	chr10:30699800	T/C	cg25182066	chr10:30743637	MAP3K8	0.67	5.59	0.54	3.17e-7	Inflammatory bowel disease;
SKCM	cis	rs16854884	0.632	rs62267390	chr3:143644067	A/T	cg06585982	chr3:143692056	C3orf58	0.8	7.27	0.64	2.39e-10	Economic and political preferences (feminism/equality);
SKCM	cis	rs13424612	0.896	rs878925	chr2:240918502	A/G	cg01812947	chr2:240904978	NDUFA10	0.64	4.86	0.48	6e-6	Odorant perception (isobutyraldehyde);
SKCM	cis	rs28595532	1.000	rs114039398	chr4:119631627	T/C	cg21605333	chr4:119757512	SEC24D	1.24	7.1	0.63	5.16e-10	Cannabis dependence symptom count;
SKCM	cis	rs79839061	0.610	rs2279181	chr4:882643	A/G	cg07828340	chr4:882639	GAK	-1.04	-5.72	-0.54	1.88e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7772486	0.790	rs2814879	chr6:146201743	T/C	cg23711669	chr6:146136114	FBXO30	0.85	9.32	0.73	2.57e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs34779708	0.931	rs12240347	chr10:35359475	A/G	cg03585969	chr10:35415529	CREM	0.76	6.1	0.57	3.85e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs908922	0.676	rs4240883	chr1:152526260	C/T	cg09873164	chr1:152488093	CRCT1	0.72	5.62	0.54	2.85e-7	Hair morphology;
SKCM	cis	rs28386778	0.966	rs2854161	chr17:61976093	T/C	cg06873352	chr17:61820015	STRADA	-0.7	-5.66	-0.54	2.37e-7	Prudent dietary pattern;
SKCM	cis	rs1552244	0.572	rs17032426	chr3:10167112	G/A	cg00149659	chr3:10157352	C3orf10	1.13	5.45	0.53	5.74e-7	Alzheimer's disease;
SKCM	cis	rs10752881	1.000	rs8179282	chr1:182974598	C/G	ch.1.3577855R	chr1:183094577	LAMC1	0.74	6.7	0.6	2.91e-9	Colorectal cancer;
SKCM	cis	rs8016982	0.609	rs8009519	chr14:81702503	C/G	cg01989461	chr14:81687754	GTF2A1	0.87	7.17	0.63	3.8e-10	Schizophrenia;
SKCM	cis	rs3091242	0.933	rs35497030	chr1:25783066	A/G	cg02931644	chr1:25747376	RHCE	-0.5	-4.9	-0.48	5.17e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs10193935	0.792	rs7559001	chr2:42474301	C/T	cg27598129	chr2:42591480	NA	-0.94	-6.73	-0.61	2.59e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs910316	1.000	rs12589815	chr14:75544101	C/T	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.85e-7	Height;
SKCM	cis	rs7100689	0.577	rs10749550	chr10:82031197	A/G	cg01528321	chr10:82214614	TSPAN14	0.78	7.3	0.64	2.13e-10	Post bronchodilator FEV1;
SKCM	cis	rs1799949	1.000	rs11079056	chr17:41300799	C/A	cg05368731	chr17:41323189	NBR1	0.89	7.91	0.67	1.38e-11	Menopause (age at onset);
SKCM	cis	rs8017423	0.967	rs7154683	chr14:90700692	A/G	cg04374321	chr14:90722782	PSMC1	0.98	8.82	0.71	2.38e-13	Mortality in heart failure;
SKCM	cis	rs9549367	0.713	rs2476328	chr13:113829350	C/T	cg18105134	chr13:113819100	PROZ	0.91	6.82	0.61	1.71e-9	Platelet distribution width;
SKCM	cis	rs2404602	1.000	rs12443137	chr15:76840832	G/T	cg23625390	chr15:77176239	SCAPER	0.75	7.27	0.64	2.44e-10	Blood metabolite levels;
SKCM	cis	rs57221529	0.766	rs72703042	chr5:579269	C/T	cg10555297	chr5:473380	SLC9A3;LOC25845	1.09	5.49	0.53	4.82e-7	Lung disease severity in cystic fibrosis;
SKCM	cis	rs2120019	1.000	rs2415255	chr15:75332412	A/G	cg17294928	chr15:75287854	SCAMP5	-0.91	-8.76	-0.7	3.17e-13	Blood trace element (Zn levels);
SKCM	cis	rs7953249	0.656	rs1732391	chr12:121392341	C/T	cg02403541	chr12:121454288	C12orf43	-0.68	-5.05	-0.5	2.82e-6	Invasive epithelial ovarian cancer;High-grade serous ovarian cancer;Chronic obstructive pulmonary disease-related biomarkers;N-glycan levels;Serous invasive ovarian cancer;Epithelial ovarian cancer;
SKCM	cis	rs10777212	0.520	rs10777205	chr12:90247669	C/T	cg08166232	chr12:89918718	WDR51B;GALNT4	0.85	5.37	0.52	7.93e-7	Total body bone mineral density;
SKCM	cis	rs13256369	0.802	rs13256404	chr8:8562974	T/C	cg15556689	chr8:8085844	FLJ10661	0.65	4.77	0.48	8.39e-6	Obesity-related traits;
SKCM	cis	rs4888262	0.564	rs8050850	chr16:74582597	C/A	cg01733217	chr16:74700730	RFWD3	0.89	7.31	0.64	1.98e-10	Testicular germ cell tumor;
SKCM	cis	rs2295499	0.515	rs56026329	chr4:2737538	T/C	cg19433769	chr4:2420260	ZFYVE28	0.74	5.05	0.5	2.8e-6	Cognitive ability;Cognitive ability (multi-trait analysis);Intelligence (multi-trait analysis);
SKCM	cis	rs703842	1.000	rs2069502	chr12:58144665	A/G	cg04478727	chr12:58166393	METTL1;FAM119B	-0.67	-5.28	-0.51	1.15e-6	Multiple sclerosis;
SKCM	cis	rs6066825	0.644	rs926629	chr20:47335736	A/G	cg18078177	chr20:47281410	PREX1	0.63	5.09	0.5	2.44e-6	Colorectal cancer;
SKCM	cis	rs2153535	0.521	rs6939827	chr6:8461360	C/G	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs7584330	0.737	rs60187585	chr2:238365159	C/T	cg14458575	chr2:238380390	NA	0.86	6.22	0.58	2.31e-8	Prostate cancer;
SKCM	cis	rs9902453	0.817	rs2729449	chr17:28089751	T/C	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.8	-5.62	-0.54	2.79e-7	Coffee consumption (cups per day);
SKCM	cis	rs2832191	0.716	rs8132085	chr21:30501389	G/T	cg08807101	chr21:30365312	RNF160	-0.67	-5.43	-0.52	6.21e-7	Dental caries;
SKCM	cis	rs10504229	0.683	rs16921808	chr8:58106049	C/T	cg02725872	chr8:58115012	NA	-0.53	-4.91	-0.49	4.82e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs2811415	0.597	rs2304018	chr3:127779306	G/A	cg09089421	chr3:127803668	RUVBL1	1.01	8.77	0.7	2.97e-13	Lung function (FEV1/FVC);
SKCM	cis	rs478304	0.651	rs11227279	chr11:65495211	G/A	cg27068330	chr11:65405492	SIPA1	-0.89	-8.21	-0.68	3.71e-12	Acne (severe);
SKCM	cis	rs9815354	0.812	rs55916959	chr3:41849130	G/A	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs28374715	0.681	rs28687846	chr15:41599902	C/T	cg18705301	chr15:41695430	NDUFAF1	-1.14	-12.27	-0.81	6.92e-20	Ulcerative colitis;
SKCM	cis	rs801193	0.613	rs2659900	chr7:66184443	G/C	cg11764359	chr7:65958608	NA	0.83	7.67	0.66	4.11e-11	Aortic root size;
SKCM	cis	rs4740619	0.619	rs10962260	chr9:16039883	T/G	cg14451791	chr9:16040625	NA	-0.47	-5.03	-0.49	3.07e-6	Body mass index;
SKCM	cis	rs2739330	0.828	rs2877178	chr22:24251517	C/T	cg12419862	chr22:24373484	LOC391322	-0.67	-5.89	-0.55	9.45e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs35306767	0.903	rs12244355	chr10:944465	T/C	cg20503657	chr10:835505	NA	0.76	5.41	0.52	6.82e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs6952808	0.692	rs11765549	chr7:2027311	G/T	cg02951883	chr7:2050386	MAD1L1	-0.84	-7.46	-0.65	1.04e-10	Bipolar disorder and schizophrenia;
SKCM	cis	rs870825	0.616	rs4519834	chr4:185633865	A/G	cg04058563	chr4:185651563	MLF1IP	-0.99	-6.99	-0.62	8.22e-10	Blood protein levels;
SKCM	cis	rs8067545	0.578	rs4925091	chr17:20066988	T/C	cg13482628	chr17:19912719	NA	0.66	5.49	0.53	4.88e-7	Schizophrenia;
SKCM	cis	rs1577917	0.739	rs9344532	chr6:86234070	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.96	9.65	0.74	5.83e-15	Response to antipsychotic treatment;
SKCM	cis	rs2153535	0.580	rs2152347	chr6:8474281	A/G	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs6089829	0.962	rs1116450	chr20:61658210	T/C	cg03213289	chr20:61660250	NA	0.52	5.03	0.49	3.12e-6	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs35146811	0.735	rs1727130	chr7:99811464	C/G	cg22906224	chr7:99728672	NA	-0.72	-5.76	-0.55	1.61e-7	Coronary artery disease;
SKCM	cis	rs2153535	0.580	rs4960421	chr6:8459292	C/T	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs2760061	0.626	rs2313118	chr1:228118084	T/C	cg02753203	chr1:228287806	NA	-0.63	-4.96	-0.49	3.99e-6	Diastolic blood pressure;
SKCM	cis	rs11098499	0.866	rs6857892	chr4:120282696	G/T	cg24375607	chr4:120327624	NA	0.62	4.77	0.48	8.45e-6	Corneal astigmatism;
SKCM	cis	rs7666738	0.830	rs13112131	chr4:98976784	G/A	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs514406	0.798	rs576650	chr1:53327207	C/T	cg24675658	chr1:53192096	ZYG11B	-0.79	-6.62	-0.6	4.04e-9	Monocyte count;
SKCM	cis	rs459571	0.916	rs109536	chr9:136889987	G/C	cg13789015	chr9:136890014	NCRNA00094	0.77	6.63	0.6	3.95e-9	Platelet distribution width;
SKCM	cis	rs2941509	1.000	rs113263629	chr17:38063849	A/T	cg12655416	chr17:38077870	ORMDL3	-0.48	-5.25	-0.51	1.26e-6	Systemic lupus erythematosus;
SKCM	cis	rs473651	0.935	rs520765	chr2:239354712	C/T	cg18131467	chr2:239335373	ASB1	1.09	13.66	0.84	2.21e-22	Multiple system atrophy;
SKCM	cis	rs7927771	0.929	rs66749409	chr11:47568074	C/T	cg05585544	chr11:47624801	NA	-0.63	-5.5	-0.53	4.73e-7	Subjective well-being;
SKCM	cis	rs2033711	0.870	rs3764534	chr19:58929136	G/A	cg12042659	chr19:58951599	ZNF132	0.68	5.86	0.55	1.04e-7	Uric acid clearance;
SKCM	cis	rs870825	0.860	rs28696121	chr4:185598743	G/A	cg04058563	chr4:185651563	MLF1IP	1.02	5.81	0.55	1.27e-7	Blood protein levels;
SKCM	cis	rs2243480	1.000	rs437889	chr7:65509234	G/A	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs10504229	0.861	rs6990796	chr8:58183097	G/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs561341	1.000	rs1557731	chr17:30321567	T/G	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs6570726	0.791	rs6923074	chr6:145893332	T/C	cg23711669	chr6:146136114	FBXO30	0.87	8.94	0.71	1.44e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9902453	0.808	rs76039587	chr17:28233760	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.81	5.79	0.55	1.43e-7	Coffee consumption (cups per day);
SKCM	cis	rs9303401	0.614	rs12947982	chr17:57140301	A/G	cg10487724	chr17:56770010	TEX14;RAD51C	0.79	4.97	0.49	3.86e-6	Cognitive test performance;
SKCM	cis	rs7666738	0.830	rs7678557	chr4:99057329	A/G	cg17366294	chr4:99064904	C4orf37	0.61	4.93	0.49	4.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	trans	rs1814175	0.615	rs12417290	chr11:49876951	G/A	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs2842992	0.915	rs2758350	chr6:160118056	A/G	cg19482086	chr6:160211437	TCP1;MRPL18	0.77	5.94	0.56	7.36e-8	Age-related macular degeneration (geographic atrophy);
SKCM	trans	rs561341	1.000	rs72823785	chr17:30273784	C/T	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs2404602	0.735	rs2461870	chr15:76813920	T/G	cg23625390	chr15:77176239	SCAPER	-0.78	-7.52	-0.65	7.81e-11	Blood metabolite levels;
SKCM	cis	rs2032447	0.670	rs198820	chr6:26124243	G/A	cg03517284	chr6:25882590	NA	0.62	5.34	0.52	8.73e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs5769765	0.773	rs7410291	chr22:50300078	A/G	cg22709217	chr22:50311962	ALG12;CRELD2	-0.82	-5.71	-0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs2153535	0.580	rs2184585	chr6:8474168	G/A	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs7927771	1.000	rs7947730	chr11:47786184	C/T	cg05585544	chr11:47624801	NA	-0.6	-5.22	-0.51	1.45e-6	Subjective well-being;
SKCM	cis	rs3096299	0.866	rs4238829	chr16:89462262	G/A	cg08822215	chr16:89438651	ANKRD11	-0.56	-4.86	-0.48	6.05e-6	Multiple myeloma (IgH translocation);
SKCM	cis	rs62238980	0.614	rs17683448	chr22:32487744	C/T	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs71520386	0.579	rs4394299	chr7:22865382	A/C	cg15401507	chr7:22894281	NA	0.65	4.87	0.48	5.7e-6	Fibrinogen levels;
SKCM	cis	rs3806843	0.735	rs801168	chr5:140080298	A/G	cg26395211	chr5:140044315	WDR55	0.61	4.91	0.49	4.99e-6	Depressive symptoms (multi-trait analysis);
SKCM	cis	rs7959452	0.718	rs10878963	chr12:69717166	T/G	cg20891283	chr12:69753455	YEATS4	0.65	5.39	0.52	7.36e-7	Blood protein levels;
SKCM	cis	rs28386778	0.863	rs3760252	chr17:61852186	G/C	cg26338869	chr17:61819248	STRADA	0.75	5.17	0.51	1.77e-6	Prudent dietary pattern;
SKCM	cis	rs1570989	0.841	rs9369032	chr6:12025822	C/T	cg17804551	chr6:12015979	HIVEP1	-0.51	-4.79	-0.48	7.77e-6	Alcohol and nicotine co-dependence;
SKCM	cis	rs1059312	1.000	rs7135854	chr12:129279988	G/C	cg09035930	chr12:129282057	SLC15A4	0.8	8.41	0.69	1.52e-12	Systemic lupus erythematosus;
SKCM	cis	rs754466	0.606	rs11002310	chr10:79596030	A/C	cg17075019	chr10:79541650	NA	-0.76	-6.94	-0.62	1.04e-9	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs1577917	0.655	rs7766485	chr6:86263555	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.62	5.18	0.51	1.69e-6	Response to antipsychotic treatment;
SKCM	cis	rs12048904	0.595	rs2295280	chr1:101342497	T/C	cg16556008	chr1:101360663	SLC30A7;EXTL2	0.83	7.31	0.64	2.05e-10	Multiple sclerosis;
SKCM	cis	rs6582630	0.555	rs35284307	chr12:38509999	T/G	cg26384229	chr12:38710491	ALG10B	0.79	6.42	0.59	9.91e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs2243480	1.000	rs68189316	chr7:65409169	C/G	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs9303401	0.614	rs66480139	chr17:57101538	G/A	cg10487724	chr17:56770010	TEX14;RAD51C	0.79	4.97	0.49	3.86e-6	Cognitive test performance;
SKCM	cis	rs873946	0.586	rs57431984	chr10:134567697	C/T	cg26818010	chr10:134567672	INPP5A	-0.8	-6.11	-0.57	3.7e-8	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs826838	1.000	rs11168217	chr12:38884278	T/C	cg26384229	chr12:38710491	ALG10B	1.04	9.75	0.74	3.88e-15	Heart rate;
SKCM	cis	rs6570726	0.791	rs952406	chr6:145925616	C/A	cg23711669	chr6:146136114	FBXO30	0.81	7.67	0.66	4.05e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1707322	0.721	rs11211157	chr1:46132844	T/C	cg03146154	chr1:46216737	IPP	0.82	6.1	0.57	3.89e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs57221529	0.766	rs4245972	chr5:578572	A/G	cg10555297	chr5:473380	SLC9A3;LOC25845	1.09	5.49	0.53	4.82e-7	Lung disease severity in cystic fibrosis;
SKCM	cis	rs72634258	0.645	rs35554366	chr1:7962661	T/C	cg00042356	chr1:8021962	PARK7	0.91	6.15	0.57	3.14e-8	Inflammatory bowel disease;
SKCM	cis	rs55962025	0.883	rs362336	chr4:3213832	G/A	cg11471262	chr4:3318911	RGS12	-0.66	-4.98	-0.49	3.72e-6	Parental longevity (mother's age at death);
SKCM	cis	rs6500395	0.962	rs9936883	chr16:48676443	G/A	cg04672837	chr16:48644449	N4BP1	0.65	5.43	0.52	6.28e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs9905704	0.671	rs28709536	chr17:57008912	C/A	cg12560992	chr17:57184187	TRIM37	0.76	6.03	0.56	5.1e-8	Testicular germ cell tumor;
SKCM	cis	rs2839186	0.749	rs62226488	chr21:47710517	C/T	cg05896524	chr21:47604654	C21orf56	0.69	5.67	0.54	2.29e-7	Testicular germ cell tumor;
SKCM	cis	rs10088262	0.629	rs7827665	chr8:124804190	G/A	cg20713898	chr8:124780851	FAM91A1	-0.7	-5.08	-0.5	2.55e-6	Pancreatic cancer;
SKCM	cis	rs4132509	0.739	rs10927033	chr1:243695539	C/A	cg21452805	chr1:244014465	NA	0.88	5.46	0.53	5.57e-7	RR interval (heart rate);
SKCM	cis	rs12477438	0.520	rs11123764	chr2:99750677	T/C	cg26064155	chr2:99771622	LIPT1;TSGA10	1.02	9.73	0.74	4.23e-15	Chronic sinus infection;
SKCM	cis	rs17345786	0.906	rs58835747	chr3:101243634	T/C	cg11279151	chr3:101281821	RG9MTD1	-0.6	-4.8	-0.48	7.38e-6	Colonoscopy-negative controls vs population controls;
SKCM	trans	rs208520	0.690	rs12198297	chr6:66714665	G/A	cg15611600	chr13:45563400	KIAA1704;NUFIP1	0.91	7.45	0.64	1.1e-10	Exhaled nitric oxide output;
SKCM	cis	rs2197308	0.765	rs11182481	chr12:37926019	T/C	cg13010199	chr12:38710504	ALG10B	0.63	4.95	0.49	4.18e-6	Morning vs. evening chronotype;
SKCM	cis	rs4819052	0.851	rs13052312	chr21:46662359	T/C	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.36	0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs9611565	0.625	rs73178625	chr22:41928320	G/C	cg03806693	chr22:41940476	POLR3H	-1.09	-7.35	-0.64	1.67e-10	Vitiligo;
SKCM	cis	rs34779708	0.966	rs11010102	chr10:35411066	T/A	cg03585969	chr10:35415529	CREM	0.79	6.21	0.58	2.4e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs847649	0.731	rs10808120	chr7:102672234	A/G	cg18108683	chr7:102477205	FBXL13	-0.8	-7.54	-0.65	7.18e-11	Morning vs. evening chronotype;
SKCM	cis	rs6090583	0.738	rs4810571	chr20:45525672	A/G	cg11607196	chr20:44572160	PCIF1	-0.62	-5.15	-0.5	1.93e-6	Waist-to-hip ratio adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction);Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs2836974	0.899	rs68004583	chr21:40659587	T/C	cg11890956	chr21:40555474	PSMG1	0.99	11.14	0.78	8.38e-18	Cognitive function;
SKCM	cis	rs28595532	0.920	rs114751999	chr4:119759651	G/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs875971	0.660	rs10229345	chr7:65982168	G/C	cg11987759	chr7:65425863	GUSB	-0.69	-5.97	-0.56	6.66e-8	Aortic root size;
SKCM	cis	rs11098499	0.954	rs3890049	chr4:120326283	T/A	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs1577917	1.000	rs10455456	chr6:86670322	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.86	-8.61	-0.7	6.29e-13	Response to antipsychotic treatment;
SKCM	cis	rs35306767	0.761	rs12770173	chr10:1027108	A/C	cg25614935	chr10:1084866	C10orf110	0.68	4.84	0.48	6.55e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs6951245	0.529	rs76001997	chr7:1152615	C/T	cg23708337	chr7:1209742	NA	0.73	5.05	0.5	2.78e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs8017423	0.967	rs11623275	chr14:90721335	C/T	cg04374321	chr14:90722782	PSMC1	1.03	9.44	0.73	1.55e-14	Mortality in heart failure;
SKCM	cis	rs9916302	0.680	rs2271308	chr17:37817482	T/C	cg00129232	chr17:37814104	STARD3	-0.68	-5.65	-0.54	2.47e-7	Glomerular filtration rate (creatinine);
SKCM	cis	rs4481887	0.962	rs6587452	chr1:248485931	C/T	cg00666640	chr1:248458726	OR2T12	0.59	4.98	0.49	3.73e-6	Common traits (Other);
SKCM	cis	rs854765	0.718	rs6502629	chr17:17869642	A/G	cg04398451	chr17:18023971	MYO15A	-0.71	-4.8	-0.48	7.37e-6	Total body bone mineral density;
SKCM	cis	rs9303401	0.659	rs34878689	chr17:56694330	G/A	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.31	0.51	1.02e-6	Cognitive test performance;
SKCM	cis	rs10256972	0.514	rs2140578	chr7:1214003	T/C	cg09177884	chr7:1199841	ZFAND2A	-0.74	-5.99	-0.56	6.13e-8	Longevity;Endometriosis;
SKCM	cis	rs7584330	0.737	rs937392	chr2:238367130	C/T	cg14458575	chr2:238380390	NA	0.86	6.22	0.58	2.31e-8	Prostate cancer;
SKCM	cis	rs3087591	1.000	rs2854322	chr17:29699416	C/T	cg24425628	chr17:29625626	OMG;NF1	0.64	5.1	0.5	2.32e-6	Hip circumference;
SKCM	cis	rs4972806	0.849	rs2113561	chr2:177030925	G/A	cg13092806	chr2:177043255	NA	0.57	5.4	0.52	6.85e-7	IgG glycosylation;
SKCM	cis	rs7296418	0.961	rs1727307	chr12:123575742	A/G	cg00376283	chr12:123451042	ABCB9	0.96	8.66	0.7	5.01e-13	Platelet count;
SKCM	cis	rs7811142	0.830	rs61735533	chr7:99955866	G/A	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.05	5.92	0.56	8.02e-8	Platelet count;
SKCM	cis	rs4237845	0.611	rs10877036	chr12:58321650	A/G	cg23860436	chr12:58378763	NA	-0.47	-4.82	-0.48	7.05e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs12709013	0.792	rs36098613	chr16:58844466	T/G	cg02431531	chr16:59244939	NA	0.48	4.99	0.49	3.62e-6	Blood metabolite ratios;
SKCM	cis	rs798554	0.757	rs1182176	chr7:2874601	A/G	cg19346786	chr7:2764209	NA	-0.62	-6.93	-0.62	1.09e-9	Height;
SKCM	cis	rs7811142	1.000	rs11769700	chr7:100090049	T/C	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.25	0.68	3.05e-12	Platelet count;
SKCM	cis	rs9910055	0.530	rs11652651	chr17:42302907	A/G	cg08499158	chr17:42289980	UBTF	0.78	6.77	0.61	2.14e-9	Total body bone mineral density;
SKCM	cis	rs2013441	0.965	rs6587063	chr17:20193940	T/C	cg13482628	chr17:19912719	NA	-0.66	-5.12	-0.5	2.18e-6	Obesity-related traits;
SKCM	cis	rs3749237	0.595	rs17595772	chr3:49409704	G/A	cg03060546	chr3:49711283	APEH	0.67	4.86	0.48	5.96e-6	Resting heart rate;
SKCM	cis	rs829883	0.664	rs1096148	chr12:98851005	A/G	cg25150519	chr12:98850993	NA	0.51	5.06	0.5	2.7e-6	Colorectal adenoma (advanced);
SKCM	cis	rs2180341	0.960	rs6900074	chr6:127685893	A/G	cg27446573	chr6:127587934	RNF146	0.93	8.09	0.68	6.27e-12	Breast cancer;
SKCM	cis	rs1799949	1.000	rs8074136	chr17:41342313	A/C	cg05368731	chr17:41323189	NBR1	0.87	7.74	0.66	3.01e-11	Menopause (age at onset);
SKCM	cis	rs5753618	0.561	rs5749265	chr22:31796897	A/C	cg02404636	chr22:31891804	SFI1	0.58	4.97	0.49	3.86e-6	Colorectal cancer;
SKCM	cis	rs7937682	1.000	rs505372	chr11:111507189	A/C	cg09085632	chr11:111637200	PPP2R1B	-1.06	-10.97	-0.78	1.82e-17	Primary sclerosing cholangitis;
SKCM	cis	rs9325144	0.600	rs10785615	chr12:38733627	G/C	cg13010199	chr12:38710504	ALG10B	0.64	5.11	0.5	2.28e-6	Morning vs. evening chronotype;
SKCM	cis	rs11098499	0.954	rs10034623	chr4:120397829	G/A	cg24375607	chr4:120327624	NA	0.66	5.09	0.5	2.44e-6	Corneal astigmatism;
SKCM	cis	rs4523957	0.690	rs4790884	chr17:2105299	G/C	cg16513277	chr17:2031491	SMG6	-0.71	-4.84	-0.48	6.47e-6	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs10876993	0.928	rs10877008	chr12:58103592	A/G	cg18357645	chr12:58087776	OS9	0.68	6.27	0.58	1.83e-8	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs7927771	0.542	rs6485775	chr11:47773518	A/G	cg20307385	chr11:47447363	PSMC3	-0.74	-5.98	-0.56	6.35e-8	Subjective well-being;
SKCM	cis	rs13108904	0.967	rs62293658	chr4:1276416	T/C	cg05025164	chr4:1340916	KIAA1530	-0.6	-4.82	-0.48	6.9e-6	Obesity-related traits;
SKCM	cis	rs250585	0.588	rs152458	chr16:23577267	C/A	cg09934309	chr16:23461721	COG7	-0.96	-6.13	-0.57	3.44e-8	Egg allergy;
SKCM	cis	rs17685	0.753	rs10952840	chr7:75772878	C/T	cg16684958	chr7:75615977	POR	0.52	5.03	0.49	3.11e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs6598955	0.543	rs12122527	chr1:26549748	C/T	cg04990556	chr1:26633338	UBXN11	0.67	5.04	0.5	2.93e-6	Obesity-related traits;
SKCM	cis	rs908922	0.676	rs7547628	chr1:152527738	T/C	cg09873164	chr1:152488093	CRCT1	0.77	6.02	0.56	5.46e-8	Hair morphology;
SKCM	cis	rs9916302	0.904	rs7221875	chr17:37543328	G/A	cg07936489	chr17:37558343	FBXL20	0.85	7.3	0.64	2.08e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs9926296	0.744	rs164748	chr16:89708292	C/G	cg01097406	chr16:89675127	NA	0.53	5.63	0.54	2.73e-7	Vitiligo;
SKCM	cis	rs9300255	0.506	rs11057251	chr12:123791227	A/G	cg00376283	chr12:123451042	ABCB9	-0.82	-6.54	-0.6	5.78e-9	Neutrophil percentage of white cells;
SKCM	cis	rs9303401	0.659	rs17222621	chr17:56695923	C/T	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.16	0.57	2.91e-8	Cognitive test performance;
SKCM	cis	rs6690583	0.697	rs4907126	chr1:85523453	C/T	cg12387700	chr1:85514134	MCOLN3	-0.75	-5.06	-0.5	2.68e-6	Serum sulfate level;
SKCM	cis	rs6580649	0.941	rs757556	chr12:48502493	C/T	cg05342945	chr12:48394962	COL2A1	0.79	5.36	0.52	8.37e-7	Lung cancer;
SKCM	cis	rs875971	0.756	rs2901210	chr7:66017505	G/A	cg11764359	chr7:65958608	NA	-0.75	-6.8	-0.61	1.88e-9	Aortic root size;
SKCM	cis	rs28595532	0.764	rs56359736	chr4:119769689	G/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs860295	0.557	rs915181	chr1:155914772	C/T	cg02153340	chr1:155202674	NA	-0.7	-4.77	-0.48	8.38e-6	Body mass index;
SKCM	cis	rs9911578	1.000	rs9892795	chr17:57023054	G/C	cg12560992	chr17:57184187	TRIM37	0.94	7.55	0.65	7.01e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs28386778	0.863	rs2251164	chr17:61884120	G/A	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs10197940	0.648	rs7587301	chr2:152347600	A/G	cg19508488	chr2:152266495	RIF1	0.62	4.97	0.49	3.9e-6	Lung cancer;
SKCM	cis	rs2836950	0.545	rs8132143	chr21:40584258	A/T	cg17971929	chr21:40555470	PSMG1	-0.73	-6.17	-0.57	2.86e-8	Menarche (age at onset);
SKCM	cis	rs1559088	0.573	rs1270591	chr19:33622942	C/T	cg27124370	chr19:33622961	WDR88	-0.84	-6.27	-0.58	1.9e-8	Bone ultrasound measurement (broadband ultrasound attenuation);
SKCM	cis	rs12986445	0.947	rs6738270	chr2:26150589	G/T	cg04917511	chr2:26785460	C2orf70	0.51	4.84	0.48	6.42e-6	Multiple myeloma and monoclonal gammopathy;Multiple myeloma;
SKCM	trans	rs10506458	0.915	rs12424908	chr12:63402364	G/A	cg03429785	chr15:59498649	MYO1E;LDHAL6B	-1.38	-7.54	-0.65	7.13e-11	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs7843479	1.000	rs2306641	chr8:21833965	A/G	cg17168535	chr8:21777572	XPO7	-0.77	-6.35	-0.58	1.3e-8	Mean corpuscular volume;
SKCM	cis	rs10504229	0.683	rs34859456	chr8:58117722	A/C	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs7945705	0.747	rs2742480	chr11:8993130	A/G	cg21881798	chr11:8931708	C11orf17;ST5	-0.81	-8.71	-0.7	4.03e-13	Hemoglobin concentration;
SKCM	cis	rs9399135	0.967	rs4896123	chr6:135295410	T/G	cg24558204	chr6:135376177	HBS1L	0.55	4.98	0.49	3.73e-6	Red blood cell count;
SKCM	cis	rs7584330	0.704	rs72620821	chr2:238362615	C/A	cg14458575	chr2:238380390	NA	1.07	7.26	0.64	2.49e-10	Prostate cancer;
SKCM	cis	rs7843479	0.582	rs7009693	chr8:21775314	C/T	cg17168535	chr8:21777572	XPO7	0.75	6.68	0.6	3.12e-9	Mean corpuscular volume;
SKCM	cis	rs9660180	1.000	rs3737628	chr1:1722932	C/T	cg17747265	chr1:1875780	NA	-0.55	-5.28	-0.51	1.15e-6	Body mass index;
SKCM	cis	rs13118159	0.771	rs13117476	chr4:1334721	A/G	cg02018176	chr4:1364513	KIAA1530	0.66	5.4	0.52	7.09e-7	Longevity;
SKCM	cis	rs870825	0.616	rs6552802	chr4:185620751	C/G	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	trans	rs10506458	1.000	rs1495013	chr12:63428188	C/T	cg03429785	chr15:59498649	MYO1E;LDHAL6B	-1.38	-7.54	-0.65	7.13e-11	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs6952808	0.531	rs3800922	chr7:2184505	A/G	cg21782813	chr7:2030301	MAD1L1	0.52	5.13	0.5	2.09e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs7826238	0.601	rs2976907	chr8:8345168	C/T	cg15556689	chr8:8085844	FLJ10661	0.81	6.95	0.62	9.82e-10	Systolic blood pressure;
SKCM	cis	rs9915657	0.870	rs35271702	chr17:70140516	G/A	cg06234051	chr17:70120541	SOX9	-0.62	-5.33	-0.52	9.26e-7	Thyroid hormone levels;
SKCM	cis	rs10927875	1.000	rs4307563	chr1:16313788	C/T	cg21385522	chr1:16154831	NA	-0.94	-7.73	-0.66	3.06e-11	Dilated cardiomyopathy;
SKCM	cis	rs7769051	1.000	rs6934161	chr6:133124077	C/T	cg22852734	chr6:133119734	C6orf192	-1.01	-5.55	-0.53	3.79e-7	Type 2 diabetes nephropathy;
SKCM	cis	rs28595532	0.858	rs58613168	chr4:119487013	T/G	cg11846333	chr4:119757529	SEC24D	1.21	5.61	0.54	2.94e-7	Cannabis dependence symptom count;
SKCM	cis	rs5753618	0.583	rs5753628	chr22:31860322	A/G	cg02404636	chr22:31891804	SFI1	0.6	5.13	0.5	2.03e-6	Colorectal cancer;
SKCM	cis	rs7666738	0.830	rs4699591	chr4:98974171	A/G	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10193935	0.901	rs6733464	chr2:42563597	A/G	cg27598129	chr2:42591480	NA	-0.88	-6.71	-0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9916302	0.904	rs9894500	chr17:37515735	G/C	cg07936489	chr17:37558343	FBXL20	0.82	7.18	0.63	3.61e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs12709013	0.716	rs11647582	chr16:58835378	C/G	cg02431531	chr16:59244939	NA	0.48	4.99	0.49	3.62e-6	Blood metabolite ratios;
SKCM	cis	rs6570726	0.818	rs9390338	chr6:145908265	A/G	cg23711669	chr6:146136114	FBXO30	0.88	8.39	0.69	1.67e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2243480	1.000	rs160655	chr7:65533214	T/C	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs1348850	0.958	rs11689550	chr2:178456298	A/G	cg02961200	chr2:178257176	LOC100130691;AGPS	0.79	6.11	0.57	3.66e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs2832191	1.000	rs8131214	chr21:30483386	T/G	cg24692254	chr21:30365293	RNF160	-0.79	-7.24	-0.63	2.72e-10	Dental caries;
SKCM	cis	rs3793683	0.597	rs2182620	chr10:134590715	C/T	cg27286337	chr10:134555280	INPP5A	0.97	8.94	0.71	1.4e-13	Migraine;
SKCM	cis	rs5769765	0.874	rs11703411	chr22:50258751	G/A	cg22709217	chr22:50311962	ALG12;CRELD2	0.8	5.67	0.54	2.28e-7	Schizophrenia;
SKCM	cis	rs7772486	0.641	rs960385	chr6:146371074	G/A	cg05347473	chr6:146136440	FBXO30	0.68	5.68	0.54	2.22e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs709400	1.000	rs861536	chr14:104167564	A/G	cg26031613	chr14:104095156	KLC1	1.05	12.89	0.82	5.14e-21	Body mass index;
SKCM	cis	rs6088590	0.735	rs6060003	chr20:33294945	T/C	cg24642439	chr20:33292090	TP53INP2	0.8	6.08	0.57	4.23e-8	Coronary artery disease;
SKCM	cis	rs1348850	0.874	rs6742951	chr2:178340766	G/C	cg02961200	chr2:178257176	LOC100130691;AGPS	0.91	6.63	0.6	4.02e-9	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs7208859	0.623	rs216445	chr17:28933576	A/G	cg14067834	chr17:29058358	SUZ12P	1.08	4.95	0.49	4.21e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	trans	rs17685	0.753	rs2868203	chr7:75680026	G/A	cg19862616	chr7:65841803	NCRNA00174	-0.94	-9.39	-0.73	1.88e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs4975616	0.804	rs381949	chr5:1322468	G/A	cg26373071	chr5:1325741	CLPTM1L	0.68	5.69	0.54	2.15e-7	Lung cancer;
SKCM	cis	rs9815354	0.556	rs55953604	chr3:42004428	A/G	cg03022575	chr3:42003672	ULK4	1.0	5.0	0.49	3.43e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs6461049	0.734	rs1558465	chr7:2151398	G/C	cg02951883	chr7:2050386	MAD1L1	-0.75	-6.95	-0.62	9.76e-10	Schizophrenia;
SKCM	cis	rs3820068	0.603	rs41270279	chr1:15988878	A/G	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs875971	0.862	rs6978028	chr7:65886300	G/C	cg18876405	chr7:65276391	NA	0.63	6.34	0.58	1.39e-8	Aortic root size;
SKCM	cis	rs597539	0.652	rs569777	chr11:68706848	G/A	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.87	5.81	0.55	1.3e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs2072510	0.722	rs2247330	chr12:96424122	C/T	cg18817487	chr12:96390143	HAL	-0.43	-5.57	-0.53	3.51e-7	Metabolite levels (small molecules and protein measures);
SKCM	cis	rs17065868	1.000	rs9533921	chr13:45158608	G/A	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs2242194	0.844	rs11264295	chr1:154987526	C/T	cg06221963	chr1:154839813	KCNN3	-0.54	-5.35	-0.52	8.41e-7	Schizophrenia;
SKCM	cis	rs189798	0.738	rs330908	chr8:8995166	A/G	cg06636001	chr8:8085503	FLJ10661	0.69	5.38	0.52	7.48e-7	Myopia (pathological);
SKCM	cis	rs11098499	0.909	rs28571712	chr4:120375980	G/A	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	trans	rs10506458	1.000	rs12425655	chr12:63434463	C/T	cg03429785	chr15:59498649	MYO1E;LDHAL6B	-1.39	-7.94	-0.67	1.24e-11	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs17685	0.753	rs869806	chr7:75688623	C/T	cg16684958	chr7:75615977	POR	0.59	5.63	0.54	2.69e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs11155671	0.530	rs7763849	chr6:150206380	C/T	cg05036130	chr6:150231994	NA	0.55	6.26	0.58	1.96e-8	Testicular germ cell tumor;
SKCM	cis	rs41369048	0.502	rs7519520	chr1:221068808	C/G	cg03536711	chr1:221509067	LOC400804	0.52	4.91	0.49	4.88e-6	Sum eosinophil basophil counts;Eosinophil counts;
SKCM	cis	rs9910055	0.718	rs2526022	chr17:42213216	C/T	cg08499158	chr17:42289980	UBTF	-0.85	-7.6	-0.65	5.61e-11	Total body bone mineral density;
SKCM	cis	rs7618501	0.633	rs4688758	chr3:50028385	G/A	cg24110177	chr3:50126178	RBM5	-0.6	-5.11	-0.5	2.25e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs17685	0.712	rs869805	chr7:75688596	C/T	cg16489192	chr7:75678113	MDH2;STYXL1	-0.6	-5.51	-0.53	4.43e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2243480	1.000	rs6966322	chr7:65646754	A/G	cg18252515	chr7:66147081	NA	1.34	8.18	0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs72634258	0.554	rs1012477	chr1:7858135	C/G	cg26816564	chr1:7831052	VAMP3	-0.75	-5.36	-0.52	8.06e-7	Inflammatory bowel disease;
SKCM	cis	rs1577917	0.958	rs9647601	chr6:86449827	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.78	-7.41	-0.64	1.3100000000000001e-10	Response to antipsychotic treatment;
SKCM	cis	rs367615	0.704	rs6889301	chr5:108835181	C/T	cg17395555	chr5:108820864	NA	0.73	6.54	0.6	5.85e-9	Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs763014	0.932	rs2384974	chr16:651279	C/G	cg07343612	chr16:622815	PIGQ	-0.66	-5.57	-0.53	3.48e-7	Height;
SKCM	cis	rs2439831	0.681	rs28653441	chr15:43677262	G/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.21	7.84	0.66	1.9e-11	Lung cancer in ever smokers;
SKCM	cis	rs34779708	0.733	rs4934740	chr10:35547141	C/T	cg03585969	chr10:35415529	CREM	0.71	5.25	0.51	1.27e-6	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs752010	0.967	rs752011	chr1:42092929	C/T	cg06885757	chr1:42089581	HIVEP3	0.59	5.78	0.55	1.46e-7	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs4423214	0.570	rs7118246	chr11:71231124	G/C	cg05163923	chr11:71159392	DHCR7	0.78	6.03	0.56	5.2e-8	Vitamin D levels;
SKCM	cis	rs875971	0.862	rs10276077	chr7:65728411	A/G	cg18876405	chr7:65276391	NA	-0.65	-6.57	-0.6	5.03e-9	Aortic root size;
SKCM	cis	rs35146811	0.844	rs12705070	chr7:99656927	A/G	cg22906224	chr7:99728672	NA	0.79	5.89	0.55	9.18e-8	Coronary artery disease;
SKCM	cis	rs870825	0.616	rs10025167	chr4:185649551	A/C	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs9611565	0.840	rs2234052	chr22:41777241	A/G	cg03806693	chr22:41940476	POLR3H	-0.86	-5.89	-0.55	9.19e-8	Vitiligo;
SKCM	cis	rs7945705	0.747	rs10840158	chr11:9020897	A/C	cg21881798	chr11:8931708	C11orf17;ST5	-0.82	-8.13	-0.68	5.29e-12	Hemoglobin concentration;
SKCM	cis	rs7666738	0.830	rs969049	chr4:98988857	C/T	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs28595532	0.688	rs116053430	chr4:119731375	G/A	cg21605333	chr4:119757512	SEC24D	1.36	8.05	0.67	7.69e-12	Cannabis dependence symptom count;
SKCM	cis	rs1348850	0.872	rs4893959	chr2:178400204	G/A	cg02961200	chr2:178257176	LOC100130691;AGPS	0.77	5.62	0.54	2.89e-7	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs10504229	0.683	rs949856	chr8:58144496	G/A	cg02725872	chr8:58115012	NA	-0.54	-5.26	-0.51	1.23e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs6598955	0.724	rs869683	chr1:26570993	T/A	cg00938395	chr1:26633206	UBXN11	0.7	4.95	0.49	4.18e-6	Obesity-related traits;
SKCM	cis	rs3768617	0.528	rs10911240	chr1:183062948	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs71520386	0.607	rs4308627	chr7:22879904	C/T	cg00309339	chr7:22893653	NA	0.75	5.69	0.54	2.12e-7	Fibrinogen levels;
SKCM	cis	rs9910055	0.530	rs2269907	chr17:42294215	G/A	cg10896456	chr17:42255109	ASB16;C17orf65	0.54	4.88	0.48	5.61e-6	Total body bone mineral density;
SKCM	cis	rs9475752	0.793	rs34027274	chr6:56848687	A/G	cg06815302	chr6:57335405	PRIM2	0.65	5.03	0.49	3.12e-6	Menarche (age at onset);
SKCM	cis	rs2197308	0.605	rs2387437	chr12:37919367	T/C	cg26384229	chr12:38710491	ALG10B	0.8	6.92	0.62	1.14e-9	Morning vs. evening chronotype;
SKCM	cis	rs9325144	0.600	rs34138871	chr12:38735261	A/G	cg13010199	chr12:38710504	ALG10B	0.64	5.11	0.5	2.28e-6	Morning vs. evening chronotype;
SKCM	cis	rs35146811	0.695	rs1727132	chr7:99812297	T/C	cg22906224	chr7:99728672	NA	-0.72	-5.76	-0.55	1.61e-7	Coronary artery disease;
SKCM	cis	rs9611565	0.512	rs7291736	chr22:42124874	C/A	cg03806693	chr22:41940476	POLR3H	1.11	6.72	0.61	2.72e-9	Vitiligo;
SKCM	cis	rs2333194	0.772	rs8016034	chr14:73812188	C/A	cg08936952	chr14:74026160	HEATR4	0.54	4.89	0.48	5.2e-6	Bipolar disorder with mood-incongruent psychosis;
SKCM	cis	rs7208859	0.573	rs7223803	chr17:29077193	A/G	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs4819052	0.851	rs35871601	chr21:46675214	C/T	cg02159808	chr21:46707872	POFUT2;LOC642852	0.73	5.71	0.54	1.93e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs589448	0.934	rs554591	chr12:69753847	T/C	cg22834771	chr12:69754056	YEATS4	-0.71	-5.79	-0.55	1.39e-7	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs9733	0.650	rs61820165	chr1:150555987	C/T	cg13175981	chr1:150552382	MCL1	0.75	6.65	0.6	3.62e-9	Tonsillectomy;
SKCM	cis	rs6570726	0.935	rs428659	chr6:145827039	T/C	cg23711669	chr6:146136114	FBXO30	0.7	6.64	0.6	3.72e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs875971	0.577	rs35072105	chr7:65609817	A/G	cg11987759	chr7:65425863	GUSB	0.72	6.38	0.59	1.17e-8	Aortic root size;
SKCM	cis	rs4803468	1.000	rs284651	chr19:41928336	T/C	cg09537434	chr19:41945824	ATP5SL	-1.1	-13.85	-0.84	1.02e-22	Height;
SKCM	cis	rs5758511	0.689	rs55906806	chr22:42644471	C/T	cg26793846	chr22:42538988	CYP2D7P1	-0.72	-4.82	-0.48	6.88e-6	Birth weight;
SKCM	cis	rs7613875	0.620	rs7634441	chr3:50071677	G/A	cg24110177	chr3:50126178	RBM5	0.7	5.8	0.55	1.38e-7	Body mass index;
SKCM	cis	rs4523957	0.620	rs58187837	chr17:2073272	G/C	cg16513277	chr17:2031491	SMG6	-0.9	-6.21	-0.58	2.36e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs2153535	0.580	rs7743418	chr6:8438128	A/C	cg23788917	chr6:8435910	SLC35B3	0.7	5.15	0.5	1.92e-6	Motion sickness;
SKCM	cis	rs9910055	0.529	rs228748	chr17:42174390	G/A	cg09913183	chr17:42254507	C17orf65;ASB16	-0.59	-4.78	-0.48	8.16e-6	Total body bone mineral density;
SKCM	cis	rs16866061	1.000	rs3768886	chr2:225450161	G/C	cg12698349	chr2:225449008	CUL3	1.02	8.59	0.7	6.79e-13	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs7824557	0.767	rs3808513	chr8:11157460	G/T	cg21775007	chr8:11205619	TDH	-0.69	-5.73	-0.54	1.83e-7	Retinal vascular caliber;
SKCM	cis	rs4900538	0.819	rs72700604	chr14:102882307	G/A	cg18135206	chr14:102964638	TECPR2	-0.71	-5.36	-0.52	8.09e-7	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs854765	0.583	rs4925126	chr17:17798633	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.03	8.06	0.67	7.19e-12	Total body bone mineral density;
SKCM	cis	rs28595532	0.920	rs114649974	chr4:119735341	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs362272	0.545	rs2749785	chr4:3325179	G/C	cg24015175	chr4:3319247	RGS12	0.83	9.59	0.74	7.74e-15	Serum sulfate level;
SKCM	cis	rs1405130	0.967	rs4663461	chr2:235568491	T/C	cg21542780	chr2:234763377	HJURP	-0.65	-4.92	-0.49	4.75e-6	Coronary artery disease;
SKCM	cis	rs1005277	0.579	rs2472176	chr10:38382921	T/C	cg00409905	chr10:38381863	ZNF37A	-0.64	-5.96	-0.56	6.77e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs4891159	0.548	rs690423	chr18:74117984	G/A	cg24786174	chr18:74118243	ZNF516	0.81	8.75	0.7	3.27e-13	Longevity;
SKCM	cis	rs3784262	0.967	rs35511675	chr15:58266978	T/A	cg12031962	chr15:58353849	ALDH1A2	-0.51	-6.6	-0.6	4.46e-9	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs9660180	0.967	rs12034740	chr1:1728969	C/A	cg23982607	chr1:1823379	GNB1	-0.7	-6.06	-0.57	4.55e-8	Body mass index;
SKCM	cis	rs780096	0.506	rs1647285	chr2:27714511	A/C	cg05696406	chr2:27599888	SNX17	0.51	5.21	0.51	1.49e-6	Total body bone mineral density;
SKCM	cis	rs9916302	0.904	rs68178216	chr17:37526241	A/C	cg07936489	chr17:37558343	FBXL20	0.82	7.19	0.63	3.4e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs9300255	0.544	rs2049114	chr12:123657338	T/C	cg05973401	chr12:123451056	ABCB9	0.83	5.14	0.5	2.01e-6	Neutrophil percentage of white cells;
SKCM	cis	rs9916302	0.706	rs584377	chr17:37460128	G/A	cg07936489	chr17:37558343	FBXL20	1.0	7.19	0.63	3.42e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs523522	0.924	rs11065150	chr12:120958875	T/G	cg12219531	chr12:120966889	COQ5	0.91	7.82	0.66	2.11e-11	High light scatter reticulocyte count;
SKCM	cis	rs3020736	0.500	rs4147641	chr22:42482502	C/G	cg04733989	chr22:42467013	NAGA	-0.72	-5.62	-0.54	2.87e-7	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs6570726	0.791	rs387376	chr6:145822565	T/C	cg23711669	chr6:146136114	FBXO30	0.79	7.93	0.67	1.26e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs3087591	1.000	rs984125	chr17:29547254	A/G	cg24425628	chr17:29625626	OMG;NF1	0.64	5.22	0.51	1.43e-6	Hip circumference;
SKCM	cis	rs1160297	0.576	rs12617374	chr2:53107105	C/T	cg07782112	chr2:53107842	NA	0.57	6.1	0.57	3.86e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs6762	0.719	rs28620453	chr11:836971	G/C	cg16425592	chr11:842748	TSPAN4;POLR2L	-0.8	-5.94	-0.56	7.55e-8	Mean platelet volume;
SKCM	cis	rs2279817	0.863	rs11203441	chr1:18026725	C/T	cg17142039	chr1:18149651	ACTL8	0.6	5.15	0.5	1.93e-6	Neuroticism;
SKCM	cis	rs2204008	0.748	rs8186658	chr12:38301461	A/C	cg26384229	chr12:38710491	ALG10B	0.78	6.56	0.6	5.26e-9	Bladder cancer;
SKCM	cis	rs2836950	0.501	rs35994303	chr21:40686020	C/T	cg11890956	chr21:40555474	PSMG1	-0.67	-5.25	-0.51	1.29e-6	Menarche (age at onset);
SKCM	cis	rs995000	0.931	rs12074528	chr1:63010871	T/C	cg06896770	chr1:63153194	DOCK7	-0.73	-6.54	-0.6	5.83e-9	Triglyceride levels;
SKCM	cis	rs992157	0.710	rs12694432	chr2:219082330	A/G	cg20019365	chr2:219134978	PNKD;AAMP	0.73	6.42	0.59	9.59e-9	Colorectal cancer;
SKCM	cis	rs7811142	0.779	rs77370288	chr7:99947897	A/T	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.19	7.5	0.65	8.66e-11	Platelet count;
SKCM	cis	rs3784262	1.000	rs4646627	chr15:58255305	A/G	cg12031962	chr15:58353849	ALDH1A2	-0.5	-6.33	-0.58	1.42e-8	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs7666738	0.830	rs28878289	chr4:98855181	C/T	cg17366294	chr4:99064904	C4orf37	0.56	4.87	0.48	5.62e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1552244	1.000	rs57631744	chr3:10118962	T/C	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs4523957	0.614	rs2984941	chr17:2031543	A/G	cg16513277	chr17:2031491	SMG6	-0.81	-5.98	-0.56	6.24e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs7927771	0.864	rs2293580	chr11:47440283	T/A	cg05585544	chr11:47624801	NA	0.56	4.79	0.48	7.65e-6	Subjective well-being;
SKCM	cis	rs7937682	0.883	rs1784776	chr11:111472392	C/T	cg19812747	chr11:111475976	SIK2	-0.59	-5.0	-0.49	3.44e-6	Primary sclerosing cholangitis;
SKCM	cis	rs10504229	0.683	rs72649188	chr8:58108829	A/G	cg02725872	chr8:58115012	NA	-0.53	-4.91	-0.49	4.82e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs2941509	1.000	rs75760678	chr17:38048721	C/T	cg12655416	chr17:38077870	ORMDL3	-0.5	-5.35	-0.52	8.58e-7	Systemic lupus erythematosus;
SKCM	cis	rs17376456	0.877	rs17315943	chr5:93442830	T/C	cg21475434	chr5:93447410	FAM172A	0.97	5.42	0.52	6.39e-7	Diabetic retinopathy;
SKCM	cis	rs7635838	0.819	rs7637414	chr3:11522228	C/G	cg00170343	chr3:11313890	ATG7	0.69	5.24	0.51	1.34e-6	HDL cholesterol;
SKCM	cis	rs2929278	0.589	rs7174732	chr15:44038463	C/A	cg02155558	chr15:43621948	ADAL;LCMT2	-0.76	-5.17	-0.51	1.74e-6	Schizophrenia;
SKCM	cis	rs7100689	0.646	rs1340380	chr10:82115619	T/C	cg01528321	chr10:82214614	TSPAN14	0.79	6.83	0.61	1.63e-9	Post bronchodilator FEV1;
SKCM	cis	rs801193	0.569	rs13226966	chr7:66233623	A/G	cg11764359	chr7:65958608	NA	0.75	6.84	0.61	1.6e-9	Aortic root size;
SKCM	cis	rs6942756	0.806	rs2718115	chr7:128871532	A/G	cg02491457	chr7:128862824	NA	0.7	4.79	0.48	7.71e-6	White matter hyperintensity burden;
SKCM	cis	rs910316	0.763	rs175450	chr14:75590340	G/A	cg08847533	chr14:75593920	NEK9	-0.82	-6.75	-0.61	2.36e-9	Height;
SKCM	cis	rs7618915	0.773	rs10510760	chr3:52650348	G/A	cg18404041	chr3:52824283	ITIH1	-0.59	-5.32	-0.52	9.69e-7	Bipolar disorder;
SKCM	cis	rs2857078	0.720	rs9901595	chr17:42305699	G/A	cg08499158	chr17:42289980	UBTF	-0.79	-6.91	-0.62	1.15e-9	Red cell distribution width;Reticulocyte count;
SKCM	cis	rs7666738	0.830	rs1834647	chr4:98882915	G/A	cg05340658	chr4:99064831	C4orf37	0.61	4.78	0.48	8.09e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs155076	1.000	rs261430	chr13:21865242	C/T	cg14456004	chr13:21872349	NA	-1.28	-7.28	-0.64	2.31e-10	White matter hyperintensity burden;
SKCM	cis	rs2811415	0.597	rs3774796	chr3:127780473	C/T	cg09089421	chr3:127803668	RUVBL1	-0.99	-8.44	-0.69	1.33e-12	Lung function (FEV1/FVC);
SKCM	cis	rs933688	1.000	rs2839728	chr5:90727412	G/A	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.1	8.62	0.7	5.93e-13	Smoking behavior;
SKCM	cis	rs2463822	0.925	rs1528730	chr11:62081181	A/C	cg06239285	chr11:62104954	ASRGL1	1.25	5.79	0.55	1.4e-7	Chronic obstructive pulmonary disease-related biomarkers;
SKCM	trans	rs8073060	0.660	rs58266733	chr17:34003812	A/T	cg19694781	chr19:47549865	TMEM160	-1.04	-8.28	-0.68	2.65e-12	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs589448	0.902	rs642786	chr12:69758462	T/C	cg22834771	chr12:69754056	YEATS4	-0.71	-5.79	-0.55	1.39e-7	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs644799	0.710	rs1852535	chr11:95501241	A/G	cg25622487	chr11:95524042	FAM76B;CEP57	0.75	6.38	0.59	1.16e-8	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs854765	0.505	rs2955358	chr17:17946623	A/G	cg04398451	chr17:18023971	MYO15A	0.84	6.72	0.61	2.67e-9	Total body bone mineral density;
SKCM	cis	rs17065868	0.881	rs61948037	chr13:45210806	C/T	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs7811142	0.943	rs11769886	chr7:99998607	G/A	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.11	6.45	0.59	8.66e-9	Platelet count;
SKCM	cis	rs13108904	0.936	rs4974540	chr4:1213463	C/T	cg02018176	chr4:1364513	KIAA1530	0.65	5.26	0.51	1.24e-6	Obesity-related traits;
SKCM	cis	rs595982	0.559	rs73061643	chr19:49368151	A/G	cg15549821	chr19:49342101	PLEKHA4	-0.87	-5.29	-0.51	1.09e-6	Red cell distribution width;
SKCM	cis	rs738322	0.775	rs13056506	chr22:38580917	G/T	cg25457927	chr22:38595422	NA	0.61	7.78	0.66	2.47e-11	Cutaneous nevi;
SKCM	cis	rs34779708	0.931	rs4934724	chr10:35393669	C/T	cg03585969	chr10:35415529	CREM	0.79	6.38	0.59	1.15e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs9875589	0.509	rs2731332	chr3:14110083	G/C	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.53	5.31	0.52	9.98e-7	Ovarian reserve;
SKCM	cis	rs3820068	0.603	rs1122387	chr1:15947282	T/C	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs11098499	0.863	rs11947234	chr4:120474859	A/G	cg24375607	chr4:120327624	NA	0.69	5.47	0.53	5.35e-7	Corneal astigmatism;
SKCM	cis	rs2228479	0.850	rs2238532	chr16:89863672	T/C	cg00800038	chr16:89945340	TCF25	-0.94	-4.77	-0.48	8.39e-6	Skin colour saturation;
SKCM	cis	rs9913156	0.707	rs72835625	chr17:4560274	G/A	cg19197139	chr17:4613644	ARRB2	0.79	5.28	0.51	1.14e-6	Lymphocyte counts;
SKCM	cis	rs10479542	0.784	rs7702303	chr5:178986436	G/A	cg19723775	chr5:179050963	HNRNPH1	0.6	4.87	0.48	5.8e-6	Lung cancer;
SKCM	cis	rs826838	0.967	rs980572	chr12:39127673	A/C	cg26384229	chr12:38710491	ALG10B	0.9	8.18	0.68	4.15e-12	Heart rate;
SKCM	cis	rs7086627	0.515	rs10887896	chr10:82210144	A/C	cg00277334	chr10:82204260	NA	-0.74	-8.56	-0.7	7.89e-13	Post bronchodilator FEV1;
SKCM	cis	rs314370	0.951	rs13226502	chr7:100506381	C/T	cg10426581	chr7:100472382	SRRT	0.67	5.6	0.54	3.12e-7	Resting heart rate;
SKCM	cis	rs7945705	0.967	rs1569408	chr11:8909732	G/A	cg21881798	chr11:8931708	C11orf17;ST5	0.77	7.81	0.66	2.17e-11	Hemoglobin concentration;
SKCM	cis	rs9443189	0.570	rs504323	chr6:76294965	A/G	cg01950844	chr6:76311363	SENP6	-0.92	-5.98	-0.56	6.25e-8	Prostate cancer;
SKCM	cis	rs9300255	0.510	rs1727323	chr12:123698790	T/C	cg00376283	chr12:123451042	ABCB9	0.83	5.49	0.53	4.74e-7	Neutrophil percentage of white cells;
SKCM	cis	rs1499614	0.803	rs1796229	chr7:66119661	G/A	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Gout;
SKCM	cis	rs4319547	0.695	rs10773167	chr12:122934001	C/T	cg23029597	chr12:123009494	RSRC2	-0.77	-5.53	-0.53	4.13e-7	Body mass index;
SKCM	cis	rs28386778	0.687	rs59596917	chr17:61806264	T/A	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.13	11.24	0.79	5.56e-18	Prudent dietary pattern;
SKCM	cis	rs7666738	0.830	rs6831588	chr4:98977356	T/G	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs801193	0.569	rs35070132	chr7:66238083	C/T	cg11764359	chr7:65958608	NA	0.75	6.83	0.61	1.63e-9	Aortic root size;
SKCM	cis	rs34779708	0.897	rs9665538	chr10:35461038	T/C	cg03585969	chr10:35415529	CREM	0.75	5.94	0.56	7.46e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs7447593	0.666	rs10866705	chr5:176801131	G/T	cg06060754	chr5:176797920	RGS14	-0.63	-6.92	-0.62	1.1e-9	Urinary electrolytes (magnesium/calcium ratio);
SKCM	cis	rs28595532	0.764	rs116158926	chr4:119730572	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.52	0.53	4.28e-7	Cannabis dependence symptom count;
SKCM	cis	rs34172651	0.517	rs12927710	chr16:24790282	A/C	cg04756594	chr16:24857601	SLC5A11	0.72	5.19	0.51	1.65e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs13256369	0.851	rs11249889	chr8:8564992	G/T	cg06636001	chr8:8085503	FLJ10661	0.8	6.11	0.57	3.65e-8	Obesity-related traits;
SKCM	cis	rs3845702	0.736	rs1904850	chr2:180852767	A/G	cg01881094	chr2:180872142	CWC22	-1.3	-6.21	-0.58	2.36e-8	Schizophrenia;
SKCM	cis	rs67311347	0.544	rs2887965	chr3:40334154	A/G	cg00656387	chr3:40428638	ENTPD3	-0.56	-5.01	-0.49	3.25e-6	Renal cell carcinoma;
SKCM	cis	rs1577917	0.839	rs12664634	chr6:86579414	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.69	-6.19	-0.57	2.61e-8	Response to antipsychotic treatment;
SKCM	cis	rs1799949	0.860	rs8176279	chr17:41210396	A/C	cg05368731	chr17:41323189	NBR1	0.85	6.99	0.62	8.28e-10	Menopause (age at onset);
SKCM	cis	rs13126513	0.519	rs12641768	chr4:100558594	C/A	cg05468953	chr4:100565104	NA	0.5	4.87	0.48	5.72e-6	Metabolite levels (MHPG);
SKCM	cis	rs4481887	1.000	rs6666690	chr1:248465323	T/C	cg00666640	chr1:248458726	OR2T12	0.59	4.98	0.49	3.72e-6	Common traits (Other);
SKCM	cis	rs1218582	0.772	rs10796935	chr1:154891363	G/T	cg03351412	chr1:154909251	PMVK	0.77	6.52	0.59	6.43e-9	Prostate cancer;
SKCM	cis	rs2019137	0.560	rs4849179	chr2:113985170	C/T	cg12889195	chr2:113992843	PAX8;LOC440839;LOC654433	0.72	5.34	0.52	9.06e-7	Lymphocyte counts;
SKCM	cis	rs2243480	1.000	rs6974723	chr7:65637939	C/T	cg18252515	chr7:66147081	NA	1.34	8.18	0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs1218582	0.710	rs9794000	chr1:154878876	T/A	cg09359103	chr1:154839909	KCNN3	-0.56	-5.0	-0.49	3.48e-6	Prostate cancer;
SKCM	cis	rs9834970	0.566	rs4327336	chr3:36896270	C/T	cg25202636	chr3:37035158	MLH1;EPM2AIP1	0.68	5.08	0.5	2.49e-6	Bipolar disorder with mood-incongruent psychosis;Subjective response to lithium treatment;Bipolar disorder;Schizophrenia or bipolar disorder;Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);
SKCM	cis	rs2836974	0.533	rs4817999	chr21:40554355	C/A	cg17971929	chr21:40555470	PSMG1	-0.76	-7.16	-0.63	3.94e-10	Cognitive function;
SKCM	cis	rs3784262	0.669	rs4646645	chr15:58245151	A/G	cg12031962	chr15:58353849	ALDH1A2	-0.42	-4.79	-0.48	7.75e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs7659604	0.702	rs58649165	chr4:122693752	C/A	cg06713675	chr4:122721982	EXOSC9	-0.7	-6.63	-0.6	3.9e-9	Type 2 diabetes;
SKCM	cis	rs62103177	0.564	rs1715230	chr18:77848002	C/T	cg06309094	chr18:77676213	PQLC1	-0.79	-5.05	-0.5	2.81e-6	Opioid sensitivity;
SKCM	cis	rs9815354	0.812	rs73081321	chr3:41890231	G/A	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs6840360	0.571	rs7692700	chr4:152552797	C/T	cg22705602	chr4:152727874	NA	-0.52	-5.69	-0.54	2.15e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs1577917	1.000	rs12199516	chr6:86726221	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.83	-8.07	-0.67	6.96e-12	Response to antipsychotic treatment;
SKCM	cis	rs1211375	0.563	rs1203980	chr16:264642	C/T	cg03788090	chr16:233062	NA	0.56	4.85	0.48	6.16e-6	Hematology traits;Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs7666738	0.830	rs17558193	chr4:99049593	A/G	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs72781680	0.582	rs72783611	chr2:24291445	C/T	cg20701182	chr2:24300061	SF3B14	0.72	4.88	0.48	5.42e-6	Lymphocyte counts;
SKCM	cis	rs1799949	0.931	rs34474989	chr17:41445410	A/T	cg25918947	chr17:41365094	TMEM106A	-0.72	-6.72	-0.61	2.71e-9	Menopause (age at onset);
SKCM	cis	rs7666738	0.830	rs10470894	chr4:99039107	G/A	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2832191	0.740	rs2832168	chr21:30463695	G/A	cg24692254	chr21:30365293	RNF160	0.99	9.05	0.72	8.59e-14	Dental caries;
SKCM	cis	rs763121	0.853	rs3788544	chr22:39064966	C/T	cg06022373	chr22:39101656	GTPBP1	0.79	5.54	0.53	3.97e-7	Menopause (age at onset);
SKCM	cis	rs8077889	0.917	rs72836547	chr17:41902799	G/T	cg26893861	chr17:41843967	DUSP3	1.15	7.34	0.64	1.79e-10	Triglycerides;
SKCM	cis	rs561341	1.000	rs72823787	chr17:30283809	A/T	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs919433	0.680	rs788018	chr2:198265526	A/G	cg04278110	chr2:198063759	ANKRD44	0.7	4.79	0.48	7.87e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs9420	0.925	rs78587207	chr11:57654991	T/G	cg19752551	chr11:57585705	CTNND1	-0.7	-6.64	-0.6	3.79e-9	Schizophrenia;
SKCM	cis	rs56235845	0.694	rs9313758	chr5:176773091	T/G	cg17509989	chr5:176798049	RGS14	0.68	5.86	0.55	1.05e-7	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs7772486	0.875	rs9399573	chr6:146403255	A/T	cg23711669	chr6:146136114	FBXO30	0.86	8.52	0.69	9.39e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2901656	0.652	rs3213563	chr1:172412995	T/C	cg03748243	chr1:172413542	C1orf105;PIGC	0.49	4.78	0.48	8.23e-6	Red cell distribution width;Platelet distribution width;
SKCM	cis	rs28595532	0.920	rs116514715	chr4:119756280	G/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs644799	1.000	rs1944074	chr11:95511445	C/A	cg25622487	chr11:95524042	FAM76B;CEP57	0.73	5.9	0.56	8.71e-8	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs17376456	0.597	rs1031423	chr5:93276883	A/G	cg25358565	chr5:93447407	FAM172A	-0.79	-5.23	-0.51	1.39e-6	Diabetic retinopathy;
SKCM	cis	rs10504073	0.669	rs818558	chr8:50030855	A/G	cg00325661	chr8:49890786	NA	0.79	6.86	0.61	1.47e-9	Blood metabolite ratios;
SKCM	cis	rs867186	1.000	rs17092215	chr20:33595913	C/T	cg04194272	chr20:33683537	NA	-1.36	-7.01	-0.62	7.44e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs7666738	0.830	rs13149404	chr4:99070236	A/G	cg17366294	chr4:99064904	C4orf37	0.61	4.93	0.49	4.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs317689	0.581	rs315132	chr12:69761996	G/C	cg20891283	chr12:69753455	YEATS4	0.74	5.64	0.54	2.65e-7	Response to diuretic therapy;
SKCM	cis	rs9818758	0.607	rs34326553	chr3:49134429	A/G	cg24110177	chr3:50126178	RBM5	0.87	4.86	0.48	6e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs854765	0.583	rs10048206	chr17:17866897	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.01	7.49	0.65	9.28e-11	Total body bone mineral density;
SKCM	cis	rs2274273	0.673	rs2209808	chr14:55807695	A/T	cg26246078	chr14:56151250	KTN1	0.7	4.85	0.48	6.2e-6	Protein biomarker;
SKCM	cis	rs17826219	0.706	rs55764512	chr17:29085758	G/A	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Body mass index;
SKCM	cis	rs3213545	0.659	rs2259693	chr12:121457995	G/A	cg02403541	chr12:121454288	C12orf43	0.8	7.04	0.62	6.62e-10	Subjective well-being;Cardiovascular disease risk factors;
SKCM	cis	rs6665290	0.835	rs11578479	chr1:227210888	A/T	cg10327440	chr1:227177885	CDC42BPA	-1.21	-15.89	-0.87	3.56e-26	Myeloid white cell count;
SKCM	cis	rs769267	0.965	rs2905425	chr19:19475717	G/C	cg26732615	chr19:19648335	CILP2;YJEFN3	-0.69	-7.17	-0.63	3.7e-10	Tonsillectomy;
SKCM	cis	rs754466	0.606	rs11002306	chr10:79591519	A/T	cg17075019	chr10:79541650	NA	-0.85	-7.14	-0.63	4.23e-10	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs4555082	0.718	rs2816619	chr14:105732551	G/C	cg13114125	chr14:105738426	BRF1	-0.72	-5.59	-0.54	3.16e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs12586317	0.620	rs2295104	chr14:35579927	A/G	cg16230307	chr14:35515116	FAM177A1	-0.73	-5.44	-0.52	5.84e-7	Psoriasis;
SKCM	cis	rs10503709	0.581	rs12681323	chr8:21443556	C/T	cg24196612	chr8:21608193	GFRA2	-0.5	-4.92	-0.49	4.66e-6	Blood protein levels;
SKCM	cis	rs6570726	0.791	rs1280276	chr6:145892350	A/C	cg23711669	chr6:146136114	FBXO30	0.87	8.94	0.71	1.44e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2404602	0.583	rs2456076	chr15:76557553	T/G	cg22467129	chr15:76604101	ETFA	0.65	5.35	0.52	8.68e-7	Blood metabolite levels;
SKCM	cis	rs2836974	0.568	rs4816620	chr21:40613786	A/G	cg17971929	chr21:40555470	PSMG1	-0.76	-7.16	-0.63	3.94e-10	Cognitive function;
SKCM	cis	rs13118159	0.550	rs11946956	chr4:1369094	T/G	cg02475777	chr4:1388615	CRIPAK	0.84	5.66	0.54	2.37e-7	Longevity;
SKCM	cis	rs992157	0.560	rs6436047	chr2:219108913	A/C	cg00012203	chr2:219082015	ARPC2	0.81	6.78	0.61	2.06e-9	Colorectal cancer;
SKCM	cis	rs2842992	0.692	rs9347342	chr6:160193129	T/C	cg16489826	chr6:160211363	TCP1;MRPL18	0.74	6.04	0.56	4.85e-8	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs9790314	0.663	rs7630674	chr3:160813597	G/A	cg03342759	chr3:160939853	NMD3	-0.62	-6.4	-0.59	1.04e-8	Morning vs. evening chronotype;
SKCM	cis	rs9910055	0.659	rs2246287	chr17:42232442	C/G	cg19774624	chr17:42201019	HDAC5	-0.9	-8.49	-0.69	1.04e-12	Total body bone mineral density;
SKCM	cis	rs12711979	0.904	rs12329356	chr2:3868533	G/C	cg17052675	chr2:3827356	NA	-0.56	-5.27	-0.51	1.17e-6	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs28595532	0.841	rs115907265	chr4:119730593	G/A	cg14228332	chr4:119757509	SEC24D	1.08	5.52	0.53	4.28e-7	Cannabis dependence symptom count;
SKCM	cis	rs9457247	0.534	rs9355610	chr6:167383075	G/A	cg23791538	chr6:167370224	RNASET2	0.55	4.94	0.49	4.42e-6	Crohn's disease;
SKCM	cis	rs694739	1.000	rs1783521	chr11:64106291	T/C	cg23796481	chr11:64053134	BAD;GPR137	0.78	6.17	0.57	2.8e-8	Alopecia areata;Crohn's disease;Psoriasis vulgaris;
SKCM	cis	rs2197308	0.740	rs10880619	chr12:37922720	T/C	cg26384229	chr12:38710491	ALG10B	0.82	6.88	0.61	1.35e-9	Morning vs. evening chronotype;
SKCM	cis	rs4819052	0.851	rs35064782	chr21:46674360	G/A	cg02159808	chr21:46707872	POFUT2;LOC642852	0.73	5.71	0.54	1.93e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs4595586	0.546	rs11169801	chr12:39241429	G/A	cg26384229	chr12:38710491	ALG10B	0.68	5.11	0.5	2.27e-6	Morning vs. evening chronotype;
SKCM	cis	rs593982	1.000	rs665191	chr11:65493658	G/A	cg08755490	chr11:65554678	OVOL1	0.92	6.52	0.59	6.49e-9	Atopic dermatitis;
SKCM	cis	rs6815814	0.950	rs56408159	chr4:38812116	T/A	cg02016764	chr4:38805732	TLR1	-0.77	-5.49	-0.53	4.78e-7	Breast cancer;
SKCM	cis	rs908922	0.887	rs1538084	chr1:152496012	A/C	cg09873164	chr1:152488093	CRCT1	0.84	5.03	0.49	3.11e-6	Hair morphology;
SKCM	cis	rs6089584	0.821	rs4925332	chr20:60604639	C/T	cg06108461	chr20:60628389	TAF4	-0.92	-8.05	-0.67	7.56e-12	Body mass index;
SKCM	cis	rs4132509	1.000	rs6681863	chr1:243982709	C/G	cg21452805	chr1:244014465	NA	0.88	5.2	0.51	1.58e-6	RR interval (heart rate);
SKCM	cis	rs992157	0.710	rs56364928	chr2:219059058	G/A	cg20019365	chr2:219134978	PNKD;AAMP	0.72	6.34	0.58	1.4e-8	Colorectal cancer;
SKCM	cis	rs4481887	1.000	rs4508046	chr1:248488988	T/C	cg00666640	chr1:248458726	OR2T12	0.59	4.98	0.49	3.73e-6	Common traits (Other);
SKCM	cis	rs17065868	1.000	rs9533873	chr13:45060304	T/C	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs7296418	0.663	rs11057284	chr12:123830692	G/C	cg00376283	chr12:123451042	ABCB9	0.82	6.54	0.6	5.78e-9	Platelet count;
SKCM	cis	rs4900538	0.855	rs1210074	chr14:102889098	G/A	cg18135206	chr14:102964638	TECPR2	-0.72	-5.29	-0.51	1.1e-6	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs10193935	1.000	rs62144748	chr2:42419468	C/T	cg27598129	chr2:42591480	NA	-0.88	-6.71	-0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs873946	0.586	rs3829130	chr10:134563122	C/T	cg14275445	chr10:134560047	INPP5A	-0.55	-4.8	-0.48	7.38e-6	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs9910055	0.615	rs189049	chr17:42197213	A/C	cg19774624	chr17:42201019	HDAC5	0.93	8.88	0.71	1.85e-13	Total body bone mineral density;
SKCM	cis	rs7149337	0.805	rs71422017	chr14:51612417	A/T	cg23942311	chr14:51606299	NA	0.65	7.48	0.65	9.58e-11	Cancer;
SKCM	cis	rs208520	0.661	rs150263	chr6:66777620	T/C	cg07460842	chr6:66804631	NA	-0.91	-6.9	-0.62	1.22e-9	Exhaled nitric oxide output;
SKCM	cis	rs2404602	0.684	rs2454451	chr15:76861461	G/T	cg23625390	chr15:77176239	SCAPER	0.82	7.93	0.67	1.26e-11	Blood metabolite levels;
SKCM	cis	rs1348850	0.632	rs11682717	chr2:178499240	C/G	cg02961200	chr2:178257176	LOC100130691;AGPS	0.73	4.83	0.48	6.61e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs847649	0.804	rs4729866	chr7:102685561	A/C	cg18108683	chr7:102477205	FBXL13	0.82	7.69	0.66	3.72e-11	Morning vs. evening chronotype;
SKCM	cis	rs12142240	0.698	rs17361812	chr1:46814008	C/T	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs861020	0.606	rs627459	chr1:210004682	C/G	cg05527609	chr1:210001259	C1orf107	0.86	6.74	0.61	2.43e-9	Orofacial clefts;
SKCM	cis	rs4268898	0.679	rs2543666	chr2:24446042	C/T	cg06627628	chr2:24431161	ITSN2	0.84	6.91	0.62	1.18e-9	Asthma;
SKCM	cis	rs7296418	0.663	rs4553407	chr12:123750748	G/C	cg00376283	chr12:123451042	ABCB9	0.8	6.34	0.58	1.38e-8	Platelet count;
SKCM	cis	rs4332037	0.851	rs34040190	chr7:1920356	G/A	cg23422044	chr7:1970798	MAD1L1	-0.93	-6.16	-0.57	3.02e-8	Bipolar disorder;
SKCM	cis	rs1707322	0.752	rs28568986	chr1:46207743	C/T	cg03146154	chr1:46216737	IPP	0.8	5.47	0.53	5.19e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs12047808	0.841	rs16854064	chr1:179363275	A/C	cg09822482	chr1:179519214	C1orf125	0.95	5.17	0.51	1.78e-6	Multiple sclerosis (age of onset);
SKCM	cis	rs875971	0.767	rs12668005	chr7:65909021	T/C	cg18876405	chr7:65276391	NA	0.61	6.04	0.56	5.03e-8	Aortic root size;
SKCM	cis	rs4423214	0.610	rs12793607	chr11:71129316	C/T	cg05163923	chr11:71159392	DHCR7	-0.59	-5.29	-0.51	1.09e-6	Vitamin D levels;
SKCM	trans	rs1814175	0.615	rs7113020	chr11:49746540	C/T	cg15704280	chr7:45808275	SEPT13	-1.01	-9.85	-0.74	2.46e-15	Height;
SKCM	cis	rs9611565	0.649	rs202657	chr22:41844786	G/T	cg03806693	chr22:41940476	POLR3H	1.08	7.21	0.63	3.11e-10	Vitiligo;
SKCM	cis	rs12142240	0.698	rs6667861	chr1:46815749	T/C	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs28595532	0.920	rs115994609	chr4:119777273	G/A	cg14228332	chr4:119757509	SEC24D	1.06	5.32	0.52	9.61e-7	Cannabis dependence symptom count;
SKCM	cis	rs644799	1.000	rs481630	chr11:95582447	G/C	cg03916912	chr11:95522834	CEP57;FAM76B	0.88	7.53	0.65	7.59e-11	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs9910055	0.529	rs2523161	chr17:42179405	C/T	cg09913183	chr17:42254507	C17orf65;ASB16	-0.58	-4.79	-0.48	7.84e-6	Total body bone mineral density;
SKCM	cis	rs9926296	0.632	rs6500440	chr16:89810823	T/C	cg01097406	chr16:89675127	NA	-0.45	-4.86	-0.48	6.02e-6	Vitiligo;
SKCM	cis	rs2731664	0.756	rs335433	chr5:176867207	T/C	cg23176889	chr5:176863531	GRK6	-0.5	-5.31	-0.52	1.02e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs34779708	0.966	rs12774834	chr10:35400070	A/T	cg03585969	chr10:35415529	CREM	0.82	6.49	0.59	7.27e-9	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs2836974	0.899	rs34176878	chr21:40548855	C/A	cg11644478	chr21:40555479	PSMG1	0.98	9.93	0.75	1.72e-15	Cognitive function;
SKCM	cis	rs144079028	1	rs144079028	chr2:26109750	TTTTA/T	cg07291958	chr2:26785531	C2orf70	0.52	4.86	0.48	5.84e-6	Breast cancer;
SKCM	cis	rs1153858	1.000	rs12441971	chr15:45671957	A/T	cg21132104	chr15:45694354	SPATA5L1	0.93	7.94	0.67	1.22e-11	Homoarginine levels;
SKCM	cis	rs2120019	1.000	rs7175720	chr15:75348962	C/G	cg09165964	chr15:75287851	SCAMP5	0.74	6.32	0.58	1.51e-8	Blood trace element (Zn levels);
SKCM	cis	rs701145	0.585	rs365119	chr3:153916502	A/T	cg17054900	chr3:154042577	DHX36	1.25	5.36	0.52	8.3e-7	Coronary artery disease;
SKCM	cis	rs9467773	0.620	rs2101582	chr6:26622734	C/T	cg15659132	chr6:26577336	NA	0.58	5.2	0.51	1.56e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs28595532	1.000	rs17258106	chr4:119675406	C/T	cg21605333	chr4:119757512	SEC24D	-1.35	-7.92	-0.67	1.37e-11	Cannabis dependence symptom count;
SKCM	cis	rs4803468	0.934	rs2317131	chr19:41885151	C/T	cg09537434	chr19:41945824	ATP5SL	-1.08	-13.01	-0.83	3.1e-21	Height;
SKCM	cis	rs4481887	0.927	rs4460676	chr1:248431781	G/A	cg00666640	chr1:248458726	OR2T12	0.61	5.28	0.51	1.14e-6	Common traits (Other);
SKCM	cis	rs4746818	1.000	rs10823313	chr10:70952115	G/A	cg11621586	chr10:70884670	VPS26A	0.93	7.37	0.64	1.52e-10	Left atrial antero-posterior diameter;
SKCM	cis	rs2836950	0.565	rs7279497	chr21:40531306	A/G	cg17971929	chr21:40555470	PSMG1	0.76	6.57	0.6	5.21e-9	Menarche (age at onset);
SKCM	cis	rs8180040	0.545	rs9311403	chr3:47138878	T/C	cg27129171	chr3:47204927	SETD2	0.74	5.37	0.52	7.84e-7	Colorectal cancer;
SKCM	cis	rs769267	0.965	rs2905425	chr19:19475717	G/C	cg03709012	chr19:19516395	GATAD2A	-0.87	-8.1	-0.68	6.13e-12	Tonsillectomy;
SKCM	cis	rs9910055	0.639	rs11656871	chr17:42269141	G/C	cg08499158	chr17:42289980	UBTF	-0.73	-6.45	-0.59	8.6e-9	Total body bone mineral density;
SKCM	cis	rs7100689	0.784	rs10736342	chr10:82130005	A/G	cg01528321	chr10:82214614	TSPAN14	0.82	7.43	0.64	1.2e-10	Post bronchodilator FEV1;
SKCM	cis	rs6547741	0.844	rs9678851	chr2:27887034	C/A	cg27432699	chr2:27873401	GPN1	-0.84	-7.21	-0.63	3.15e-10	Oral cavity cancer;
SKCM	cis	rs2404602	0.647	rs55778276	chr15:77136590	T/A	cg23625390	chr15:77176239	SCAPER	-0.85	-8.26	-0.68	2.93e-12	Blood metabolite levels;
SKCM	cis	rs780096	0.526	rs780102	chr2:27659491	T/C	cg05696406	chr2:27599888	SNX17	0.51	5.22	0.51	1.46e-6	Total body bone mineral density;
SKCM	cis	rs11098499	1.000	rs10029750	chr4:120172543	A/G	cg09307838	chr4:120376055	NA	0.95	7.75	0.66	2.84e-11	Corneal astigmatism;
SKCM	cis	rs9393692	0.905	rs9379843	chr6:26289435	A/G	cg00631329	chr6:26305371	NA	-0.69	-4.94	-0.49	4.31e-6	Educational attainment;
SKCM	cis	rs6952808	0.717	rs10950422	chr7:1926577	T/C	cg02951883	chr7:2050386	MAD1L1	-0.75	-6.49	-0.59	7.22e-9	Bipolar disorder and schizophrenia;
SKCM	cis	rs116095464	0.558	rs62346506	chr5:201594	T/C	cg22496380	chr5:211416	CCDC127	-1.0	-5.11	-0.5	2.25e-6	Breast cancer;
SKCM	cis	rs1577917	0.958	rs7747897	chr6:86647349	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.66	-5.74	-0.54	1.76e-7	Response to antipsychotic treatment;
SKCM	cis	rs2645694	0.533	rs2645680	chr4:77820956	T/C	cg03477792	chr4:77819574	ANKRD56	0.57	6.38	0.59	1.18e-8	Emphysema distribution in smoking;
SKCM	cis	rs7216064	1.000	rs4271626	chr17:65930133	G/A	cg12091567	chr17:66097778	LOC651250	-0.76	-5.15	-0.5	1.87e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs9611565	0.681	rs5751094	chr22:41803279	C/T	cg03806693	chr22:41940476	POLR3H	1.02	6.92	0.62	1.13e-9	Vitiligo;
SKCM	cis	rs2739330	0.652	rs2000469	chr22:24245292	A/G	cg24846343	chr22:24311635	DDTL	0.68	6.27	0.58	1.89e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs2070488	0.560	rs1381798	chr3:38437471	C/T	cg01465620	chr3:38496096	LOC100128640;ACVR2B	-0.77	-5.71	-0.54	1.94e-7	Electrocardiographic conduction measures;
SKCM	cis	rs992157	0.643	rs10191283	chr2:219056755	G/A	cg00012203	chr2:219082015	ARPC2	0.85	7.47	0.65	9.82e-11	Colorectal cancer;
SKCM	cis	rs875971	0.660	rs801190	chr7:66033033	C/T	cg00343986	chr7:65444356	GUSB	-0.7	-5.14	-0.5	1.98e-6	Aortic root size;
SKCM	cis	rs13256369	0.802	rs11249883	chr8:8561537	G/A	cg06636001	chr8:8085503	FLJ10661	0.75	5.73	0.54	1.81e-7	Obesity-related traits;
SKCM	cis	rs62238980	0.614	rs33954397	chr22:32506143	C/T	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs7666738	0.830	rs6854594	chr4:99065312	A/T	cg17366294	chr4:99064904	C4orf37	0.61	4.93	0.49	4.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs651907	0.535	rs11707250	chr3:101509371	A/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	-0.76	-6.27	-0.58	1.89e-8	Colorectal cancer;
SKCM	cis	rs2413583	0.591	rs75026781	chr22:39720821	T/A	cg17798944	chr22:39715225	SNORD43;RPL3	0.93	5.27	0.51	1.16e-6	Ulcerative colitis;Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs208520	1.000	rs12212063	chr6:66985148	C/A	cg07460842	chr6:66804631	NA	0.87	5.96	0.56	6.95e-8	Exhaled nitric oxide output;
SKCM	cis	rs7143963	0.609	rs7140494	chr14:103291698	C/T	cg23020514	chr14:103360112	TRAF3	-0.73	-6.75	-0.61	2.31e-9	Body mass index;
SKCM	cis	rs2303745	0.589	rs11086065	chr19:17395003	A/G	cg04248312	chr19:17393744	ANKLE1	-1.11	-8.18	-0.68	4.15e-12	Systemic lupus erythematosus;
SKCM	cis	rs6952808	0.723	rs4721282	chr7:2025040	A/G	cg04267008	chr7:1944627	MAD1L1	-0.62	-4.87	-0.48	5.7e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs6120849	0.754	rs6120813	chr20:33642112	T/C	cg24642439	chr20:33292090	TP53INP2	0.94	4.86	0.48	5.91e-6	Protein C levels;
SKCM	cis	rs12926788	0.689	rs7186308	chr16:24848471	A/G	cg00339695	chr16:24857497	SLC5A11	0.82	7.06	0.62	5.96e-10	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs611744	0.669	rs13251024	chr8:109258333	T/C	cg18478394	chr8:109455254	TTC35	0.66	5.33	0.52	9.43e-7	Dupuytren's disease;
SKCM	cis	rs6696846	0.749	rs7515178	chr1:205084120	G/A	cg03948781	chr1:205179583	DSTYK	0.56	5.28	0.51	1.14e-6	Red blood cell count;
SKCM	cis	rs992157	0.796	rs55680399	chr2:219160621	T/C	cg20019365	chr2:219134978	PNKD;AAMP	0.71	6.11	0.57	3.64e-8	Colorectal cancer;
SKCM	cis	rs8072100	0.782	rs28507314	chr17:45551402	C/T	cg08085267	chr17:45401833	C17orf57	-0.62	-5.08	-0.5	2.48e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs6424115	0.830	rs1105	chr1:24200800	T/C	cg15997130	chr1:24165203	NA	0.6	4.94	0.49	4.37e-6	Immature fraction of reticulocytes;
SKCM	cis	rs4766646	0.619	rs7304559	chr12:110289501	T/G	cg08114617	chr12:110271441	TRPV4	0.51	4.85	0.48	6.08e-6	Metabolite levels (MHPG);
SKCM	cis	rs6570726	0.935	rs391524	chr6:145823844	A/G	cg23711669	chr6:146136114	FBXO30	0.7	6.64	0.6	3.72e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9926296	0.605	rs12709094	chr16:89853017	A/G	cg27121462	chr16:89883253	FANCA	0.81	7.04	0.62	6.64e-10	Vitiligo;
SKCM	cis	rs873946	0.564	rs12263364	chr10:134555548	G/T	cg27286337	chr10:134555280	INPP5A	0.92	8.33	0.69	2.12e-12	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs1850744	0.826	rs114657516	chr4:9593857	C/G	cg15442990	chr4:9534313	NA	-1.3	-4.84	-0.48	6.55e-6	Economic and political preferences;
SKCM	cis	rs245880	0.740	rs245889	chr7:29190626	C/T	cg17163760	chr7:29186267	CPVL	-0.4	-5.37	-0.52	7.91e-7	Warfarin maintenance dose;
SKCM	cis	rs4481887	1.000	rs6663817	chr1:248495613	A/G	cg00666640	chr1:248458726	OR2T12	0.59	4.94	0.49	4.38e-6	Common traits (Other);
SKCM	cis	rs28595532	0.748	rs115651241	chr4:119363509	C/T	cg21605333	chr4:119757512	SEC24D	1.01	5.23	0.51	1.39e-6	Cannabis dependence symptom count;
SKCM	cis	rs372883	0.613	rs1153274	chr21:30660026	T/C	cg24692254	chr21:30365293	RNF160	-0.68	-5.22	-0.51	1.47e-6	Pancreatic cancer;
SKCM	cis	rs72615157	0.716	rs75779608	chr7:99768957	C/T	cg07160278	chr7:100027354	MEPCE;ZCWPW1	0.99	5.96	0.56	6.79e-8	Lung function (FEV1/FVC);
SKCM	cis	rs12047808	0.730	rs745317	chr1:179525311	C/T	cg09822482	chr1:179519214	C1orf125	-0.96	-4.78	-0.48	8.1e-6	Multiple sclerosis (age of onset);
SKCM	cis	rs2120019	1.000	rs2415255	chr15:75332412	A/G	cg09165964	chr15:75287851	SCAMP5	-0.82	-7.72	-0.66	3.24e-11	Blood trace element (Zn levels);
SKCM	cis	rs1538970	0.781	rs10890330	chr1:45920406	G/A	cg05343316	chr1:45956843	TESK2	0.92	4.94	0.49	4.42e-6	Platelet count;
SKCM	cis	rs6598955	1.000	rs10902728	chr1:26598281	T/C	cg04990556	chr1:26633338	UBXN11	0.67	5.87	0.55	1e-7	Obesity-related traits;
SKCM	cis	rs459571	0.959	rs2810491	chr9:136923331	C/T	cg13789015	chr9:136890014	NCRNA00094	-0.72	-6.18	-0.57	2.67e-8	Platelet distribution width;
SKCM	cis	rs2836950	0.502	rs12627205	chr21:40630027	C/T	cg17971929	chr21:40555470	PSMG1	-0.73	-6.17	-0.57	2.86e-8	Menarche (age at onset);
SKCM	cis	rs72781680	1.000	rs72781671	chr2:24231123	A/G	cg08917208	chr2:24149416	ATAD2B	1.07	5.99	0.56	6.1e-8	Lymphocyte counts;
SKCM	cis	rs9911578	0.967	rs405684	chr17:56777148	T/C	cg05425664	chr17:57184151	TRIM37	-0.69	-5.21	-0.51	1.52e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1029738	0.615	rs717624	chr7:22894487	T/C	cg15401507	chr7:22894281	NA	-0.64	-5.89	-0.55	9.27e-8	Fibrinogen levels;
SKCM	cis	rs55962025	0.883	rs82334	chr4:3225371	A/C	cg11471262	chr4:3318911	RGS12	-0.64	-4.92	-0.49	4.8e-6	Parental longevity (mother's age at death);
SKCM	cis	rs561341	1.000	rs564714	chr17:30318404	C/T	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs2730245	0.636	rs2657382	chr7:158650941	G/A	cg24397884	chr7:158709396	WDR60	0.71	5.41	0.52	6.65e-7	Height;
SKCM	cis	rs875971	0.522	rs10807697	chr7:65416170	A/G	cg18876405	chr7:65276391	NA	0.84	7.61	0.65	5.42e-11	Aortic root size;
SKCM	cis	rs507080	0.883	rs527475	chr11:118563239	G/A	cg18045108	chr11:118530628	TREH	-0.47	-4.81	-0.48	7.17e-6	Serum metabolite levels;
SKCM	cis	rs2832077	0.527	rs2738953	chr21:30238363	G/C	cg24692254	chr21:30365293	RNF160	0.65	4.85	0.48	6.13e-6	Cognitive test performance;
SKCM	cis	rs9880211	0.800	rs75901823	chr3:136494151	T/A	cg21827317	chr3:136751795	NA	-0.74	-5.43	-0.52	6.11e-7	Body mass index;Height;
SKCM	cis	rs394563	0.690	rs237009	chr6:149759552	C/T	cg03678062	chr6:149772716	ZC3H12D	-0.5	-5.55	-0.53	3.72e-7	Dupuytren's disease;
SKCM	cis	rs2228479	0.850	rs2238525	chr16:89809902	T/C	cg00800038	chr16:89945340	TCF25	-0.81	-4.79	-0.48	7.84e-6	Skin colour saturation;
SKCM	cis	rs4642101	0.597	rs9865624	chr3:12822786	T/A	cg05775895	chr3:12838266	CAND2	0.63	5.82	0.55	1.22e-7	QRS complex (12-leadsum);
SKCM	cis	rs72781680	1.000	rs56339200	chr2:24188194	C/A	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	cis	rs6545883	0.929	rs10190332	chr2:61619267	T/G	cg15711740	chr2:61764176	XPO1	0.7	4.93	0.49	4.5e-6	Tuberculosis;
SKCM	cis	rs2239547	0.603	rs59989280	chr3:53098875	T/C	cg11645453	chr3:52864694	ITIH4	0.62	5.0	0.49	3.5e-6	Schizophrenia;
SKCM	cis	rs709400	1.000	rs8018979	chr14:104109087	G/A	cg26031613	chr14:104095156	KLC1	1.04	12.52	0.82	2.35e-20	Body mass index;
SKCM	cis	rs13256369	0.802	rs11249885	chr8:8562008	C/T	cg17143192	chr8:8559678	CLDN23	0.74	5.61	0.54	2.95e-7	Obesity-related traits;
SKCM	cis	rs116095464	0.614	rs78905930	chr5:246560	G/A	cg22857025	chr5:266934	NA	-1.37	-8.31	-0.69	2.38e-12	Breast cancer;
SKCM	cis	rs28386778	0.863	rs1376110	chr17:61779927	A/C	cg01411255	chr17:61851458	DDX42;CCDC47	0.79	4.97	0.49	3.86e-6	Prudent dietary pattern;
SKCM	cis	rs1405130	0.839	rs1405132	chr2:235567460	G/T	cg21542780	chr2:234763377	HJURP	-0.64	-4.89	-0.48	5.21e-6	Coronary artery disease;
SKCM	cis	rs7647973	0.890	rs73073004	chr3:49490020	A/G	cg07636037	chr3:49044803	WDR6	-0.86	-5.08	-0.5	2.48e-6	Menarche (age at onset);
SKCM	cis	rs589448	0.902	rs315124	chr12:69771727	G/A	cg14784868	chr12:69753453	YEATS4	0.84	7.67	0.66	4.02e-11	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs7191439	0.728	rs4238687	chr16:88788903	T/G	cg27087555	chr16:88793112	FAM38A	-1.23	-5.46	-0.53	5.44e-7	Plateletcrit;
SKCM	cis	rs933688	0.938	rs7720235	chr5:90659329	A/T	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.12	8.55	0.7	7.9e-13	Smoking behavior;
SKCM	cis	rs2739330	0.828	rs5760108	chr22:24252668	G/T	cg24846343	chr22:24311635	DDTL	0.61	5.85	0.55	1.1e-7	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs6474412	0.588	rs10107450	chr8:42629895	C/T	cg11207534	chr8:41686438	ANK1	-0.75	-4.97	-0.49	3.92e-6	Smoking behavior;
SKCM	cis	rs769267	0.965	rs2269873	chr19:19392401	T/C	cg03709012	chr19:19516395	GATAD2A	0.8	6.4	0.59	1.07e-8	Tonsillectomy;
SKCM	cis	rs2842992	0.830	rs2758312	chr6:160153452	G/A	cg11366901	chr6:160182831	ACAT2	0.93	7.53	0.65	7.58e-11	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs637571	0.522	rs3016868	chr11:65764383	C/T	cg02427764	chr11:65769310	BANF1;EIF1AD	0.77	5.98	0.56	6.43e-8	Eosinophil percentage of white cells;
SKCM	cis	rs6500395	1.000	rs7184144	chr16:48606077	C/T	cg04672837	chr16:48644449	N4BP1	0.69	5.73	0.54	1.8e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs9297145	0.761	rs28545226	chr7:98732472	A/T	cg05967295	chr7:98741636	SMURF1	1.07	8.36	0.69	1.86e-12	Crohn's disease;Inflammatory bowel disease;Ulcerative colitis;
SKCM	cis	rs2836974	0.863	rs8132333	chr21:40527900	A/G	cg17971929	chr21:40555470	PSMG1	0.87	8.48	0.69	1.1e-12	Cognitive function;
SKCM	cis	rs28386778	0.897	rs7222189	chr17:61836372	T/C	cg06873352	chr17:61820015	STRADA	0.76	6.34	0.58	1.38e-8	Prudent dietary pattern;
SKCM	cis	rs9611565	0.659	rs9611602	chr22:41908405	T/C	cg03806693	chr22:41940476	POLR3H	-1.11	-7.55	-0.65	6.93e-11	Vitiligo;
SKCM	cis	rs28595532	1.000	rs115915387	chr4:119640854	C/T	cg11846333	chr4:119757529	SEC24D	1.15	6.24	0.58	2.13e-8	Cannabis dependence symptom count;
SKCM	cis	rs4819052	1.000	rs2297284	chr21:46705345	G/A	cg19498844	chr21:46707878	POFUT2;LOC642852	0.95	7.7	0.66	3.5e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs727563	0.593	rs132770	chr22:42017264	A/G	cg03806693	chr22:41940476	POLR3H	1.11	7.56	0.65	6.74e-11	Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs9875589	0.509	rs11927267	chr3:14073992	T/G	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.5	5.15	0.5	1.9e-6	Ovarian reserve;
SKCM	cis	rs17608059	0.566	rs59795106	chr17:13912057	A/T	cg11395062	chr17:14139857	CDRT15	0.67	5.46	0.53	5.57e-7	Temperament;
SKCM	cis	rs3820928	0.605	rs7560867	chr2:227780945	C/A	cg11843606	chr2:227700838	RHBDD1	-0.61	-4.8	-0.48	7.48e-6	Pulmonary function;
SKCM	cis	rs1218582	0.596	rs4845676	chr1:154827861	C/G	cg24250549	chr1:154909240	PMVK	0.65	5.7	0.54	2e-7	Prostate cancer;
SKCM	cis	rs2842992	0.768	rs2273824	chr6:160211445	C/T	cg16489826	chr6:160211363	TCP1;MRPL18	0.71	5.51	0.53	4.52e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs9788682	0.747	rs6495308	chr15:78907656	A/G	cg24631222	chr15:78858424	CHRNA5	0.79	5.77	0.55	1.55e-7	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs9916302	0.904	rs8079303	chr17:37530755	G/C	cg07936489	chr17:37558343	FBXL20	0.85	7.3	0.64	2.13e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs58688157	0.705	rs2396545	chr11:601785	T/C	cg03576123	chr11:487126	PTDSS2	-0.8	-5.15	-0.5	1.88e-6	Systemic lupus erythematosus;
SKCM	cis	rs2153535	0.541	rs9379207	chr6:8458186	C/T	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs950027	0.620	rs1153855	chr15:45660758	C/G	cg21132104	chr15:45694354	SPATA5L1	0.76	5.84	0.55	1.13e-7	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs2836974	0.932	rs8129416	chr21:40617145	C/T	cg11644478	chr21:40555479	PSMG1	0.97	10.08	0.75	8.76e-16	Cognitive function;
SKCM	cis	rs826838	0.874	rs10880943	chr12:38734317	C/T	cg26384229	chr12:38710491	ALG10B	1.09	10.33	0.76	2.97e-16	Heart rate;
SKCM	cis	rs7811142	0.943	rs66958101	chr7:100074020	G/A	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.17	7.71	0.66	3.44e-11	Platelet count;
SKCM	cis	rs7945705	0.967	rs1569408	chr11:8909732	G/A	cg13070366	chr11:9386451	NA	-0.6	-5.36	-0.52	8.38e-7	Hemoglobin concentration;
SKCM	cis	rs12926788	0.542	rs6497759	chr16:24801737	G/A	cg00339695	chr16:24857497	SLC5A11	0.8	6.43	0.59	9.38e-9	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs6461049	0.800	rs3778977	chr7:2159746	C/T	cg02951883	chr7:2050386	MAD1L1	-0.72	-6.48	-0.59	7.62e-9	Schizophrenia;
SKCM	cis	rs9393692	0.557	rs12665035	chr6:26275649	T/C	cg00631329	chr6:26305371	NA	-0.67	-5.2	-0.51	1.53e-6	Educational attainment;
SKCM	cis	rs2439831	0.681	rs1837959	chr15:43698679	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.21	7.84	0.66	1.9e-11	Lung cancer in ever smokers;
SKCM	cis	rs4253772	0.591	rs8135363	chr22:46651713	T/C	cg03482458	chr22:46692211	CN5H6.4;GTSE1	1.11	4.96	0.49	4.03e-6	LDL cholesterol;Cholesterol, total;
SKCM	cis	rs875971	0.862	rs28470208	chr7:65584700	A/G	cg11764359	chr7:65958608	NA	-0.8	-7.66	-0.66	4.2e-11	Aortic root size;
SKCM	cis	rs6951245	1.000	rs79443843	chr7:1075245	G/A	cg03188948	chr7:1209495	NA	1.12	6.25	0.58	2.02e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs1218582	0.772	rs6669791	chr1:154845484	G/T	cg24250549	chr1:154909240	PMVK	0.9	9.53	0.73	1.01e-14	Prostate cancer;
SKCM	cis	rs17818399	0.749	rs4142759	chr2:46783890	A/G	cg02822958	chr2:46747628	ATP6V1E2	0.69	5.0	0.49	3.4e-6	Height;
SKCM	cis	rs523522	0.962	rs4767903	chr12:120930046	G/A	cg27279351	chr12:120934652	DYNLL1	0.91	8.32	0.69	2.26e-12	High light scatter reticulocyte count;
SKCM	cis	rs6121246	0.559	rs6060915	chr20:30330306	A/G	cg11595048	chr20:30225325	COX4I2	0.54	4.77	0.48	8.4e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs7027203	0.828	rs4743934	chr9:96581893	A/G	cg14598338	chr9:96623480	NA	-0.51	-5.09	-0.5	2.43e-6	DNA methylation (variation);
SKCM	cis	rs1799949	0.894	rs71367985	chr17:41374463	G/A	cg23758822	chr17:41437982	NA	0.94	7.73	0.66	3.08e-11	Menopause (age at onset);
SKCM	cis	rs1005277	0.540	rs1814077	chr10:37992018	G/C	cg00409905	chr10:38381863	ZNF37A	-0.58	-5.73	-0.54	1.77e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs2153535	0.580	rs9379206	chr6:8458021	C/A	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs2032447	0.670	rs198852	chr6:26104448	A/G	cg18357526	chr6:26021779	HIST1H4A	-0.77	-6.27	-0.58	1.85e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs7917772	0.503	rs1409310	chr10:104282265	T/C	cg11453585	chr10:104263688	ACTR1A;SUFU	0.77	6.31	0.58	1.56e-8	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs7666738	0.830	rs13115356	chr4:98933171	T/C	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs3091242	0.933	rs1534954	chr1:25761924	A/T	cg27572855	chr1:25598939	RHD	0.53	5.06	0.5	2.73e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs936229	0.813	rs1378938	chr15:75096443	T/C	cg14664628	chr15:75095509	CSK	-1.19	-10.84	-0.78	3.12e-17	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin);
SKCM	cis	rs709400	0.663	rs11628213	chr14:103952453	A/C	cg26031613	chr14:104095156	KLC1	0.77	5.96	0.56	6.87e-8	Body mass index;
SKCM	cis	rs2559856	1.000	rs2695296	chr12:102085487	T/C	cg12924262	chr12:102091054	CHPT1	0.71	5.68	0.54	2.19e-7	Blood protein levels;
SKCM	cis	rs17376456	1.000	rs17323433	chr5:93551028	G/A	cg21475434	chr5:93447410	FAM172A	0.98	5.23	0.51	1.4e-6	Diabetic retinopathy;
SKCM	cis	rs7208859	0.623	rs9890855	chr17:29111707	G/C	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs951366	0.844	rs823096	chr1:205679887	G/T	cg14159672	chr1:205819179	PM20D1	0.9	7.07	0.62	5.85e-10	Menarche (age at onset);
SKCM	cis	rs854765	0.647	rs721669	chr17:18005073	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.85	6.57	0.6	5.08e-9	Total body bone mineral density;
SKCM	cis	rs6952808	0.609	rs4721190	chr7:1954732	A/G	cg03354898	chr7:1950403	MAD1L1	0.52	5.31	0.52	1e-6	Bipolar disorder and schizophrenia;
SKCM	trans	rs1814175	0.817	rs11493756	chr11:50017885	T/C	cg03929089	chr4:120376271	NA	-0.93	-8.77	-0.7	3.08e-13	Height;
SKCM	cis	rs9815354	0.812	rs111277902	chr3:41950312	C/T	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs28595532	0.920	rs113034745	chr4:119750044	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs17685	0.753	rs11972240	chr7:75694079	A/C	cg16489192	chr7:75678113	MDH2;STYXL1	-0.6	-5.51	-0.53	4.43e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs6500395	1.000	rs11076578	chr16:48714520	C/G	cg04672837	chr16:48644449	N4BP1	-0.63	-5.37	-0.52	8.01e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs9814567	0.896	rs4245907	chr3:134347876	C/G	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.65	-5.25	-0.51	1.26e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs12586317	0.547	rs10134907	chr14:35499211	A/C	cg16230307	chr14:35515116	FAM177A1	0.81	5.88	0.55	9.47e-8	Psoriasis;
SKCM	trans	rs1814175	0.715	rs1722007	chr11:49897319	T/C	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs35306767	0.903	rs34847097	chr10:902252	A/T	cg25614935	chr10:1084866	C10orf110	0.83	5.45	0.53	5.64e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs10193935	0.901	rs222468	chr2:42642531	C/T	cg27598129	chr2:42591480	NA	-0.88	-6.71	-0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9926296	0.568	rs7203907	chr16:89833774	C/G	cg27121462	chr16:89883253	FANCA	0.81	7.33	0.64	1.81e-10	Vitiligo;
SKCM	cis	rs6545883	0.859	rs2600661	chr2:61543081	T/C	cg15711740	chr2:61764176	XPO1	0.79	5.44	0.52	5.96e-7	Tuberculosis;
SKCM	cis	rs7772486	0.790	rs9497425	chr6:146234197	G/A	cg23711669	chr6:146136114	FBXO30	-0.78	-7.74	-0.66	3.05e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs10900020	1.000	rs12357893	chr10:44828631	A/C	cg25956097	chr10:44163499	NA	0.93	4.81	0.48	7.24e-6	Schizophrenia;
SKCM	cis	rs151997	1.000	rs251043	chr5:50215997	A/G	cg06027927	chr5:50259733	NA	0.66	5.78	0.55	1.45e-7	Callous-unemotional behaviour;
SKCM	cis	rs7666738	0.830	rs7698771	chr4:98986479	T/G	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6570726	0.791	rs1280276	chr6:145892350	A/C	cg05347473	chr6:146136440	FBXO30	0.57	5.08	0.5	2.47e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs11673344	0.764	rs565721	chr19:37455831	G/A	cg07624650	chr19:37064219	ZNF529	-0.78	-4.82	-0.48	7.05e-6	Obesity-related traits;
SKCM	cis	rs752010	0.902	rs60743712	chr1:42076629	G/A	cg06885757	chr1:42089581	HIVEP3	0.59	6.31	0.58	1.54e-8	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs6951245	1.000	rs884977	chr7:1066410	T/C	cg21664854	chr7:1097933	C7orf50;GPR146	0.88	4.78	0.48	8.25e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs854765	0.551	rs8070748	chr17:17859421	A/G	cg04398451	chr17:18023971	MYO15A	-0.86	-5.91	-0.56	8.41e-8	Total body bone mineral density;
SKCM	cis	rs854765	0.547	rs9894138	chr17:17964345	G/A	cg24612305	chr17:17875800	TOM1L2;LRRC48	-1.02	-9.54	-0.73	9.55e-15	Total body bone mineral density;
SKCM	cis	rs2413583	0.591	rs117385880	chr22:39721299	A/G	cg17798944	chr22:39715225	SNORD43;RPL3	0.93	5.27	0.51	1.16e-6	Ulcerative colitis;Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs951366	0.789	rs823137	chr1:205738302	C/T	cg24503407	chr1:205819492	PM20D1	0.9	7.9	0.67	1.45e-11	Menarche (age at onset);
SKCM	cis	rs1878931	0.501	rs9302871	chr16:3415512	T/C	cg26668626	chr16:3451006	ZNF174;ZNF434	0.88	7.37	0.64	1.52e-10	Body mass index (adult);
SKCM	cis	rs4077515	0.649	rs3087886	chr9:139301583	T/C	cg14169450	chr9:139327907	INPP5E	0.48	5.19	0.51	1.6e-6	Ulcerative colitis;IgA nephropathy;Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs12120353	0.702	rs780615	chr1:4551726	G/C	cg15022359	chr1:4193126	NA	-0.6	-5.21	-0.51	1.47e-6	Anxiety disorder;
SKCM	cis	rs8060686	0.565	rs75735284	chr16:68126635	C/A	cg04539111	chr16:67997858	SLC12A4	-0.85	-4.81	-0.48	7.14e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs9814567	0.964	rs9820150	chr3:134223011	C/G	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.63	-4.96	-0.49	4.06e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs11098499	0.754	rs10213554	chr4:120260785	A/G	cg09307838	chr4:120376055	NA	-0.93	-7.37	-0.64	1.52e-10	Corneal astigmatism;
SKCM	cis	rs2841277	0.720	rs11160827	chr14:105422228	C/T	cg14403583	chr14:105418241	AHNAK2	-0.92	-7.76	-0.66	2.74e-11	Rheumatoid arthritis;
SKCM	cis	rs9911578	1.000	rs7215808	chr17:56940742	G/C	cg12560992	chr17:57184187	TRIM37	0.94	7.39	0.64	1.44e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs2857078	0.772	rs4793086	chr17:42320751	C/T	cg13607699	chr17:42295918	UBTF	-0.93	-7.19	-0.63	3.43e-10	Red cell distribution width;Reticulocyte count;
SKCM	cis	rs4727027	1.000	rs4727027	chr7:148869277	C/T	cg23583168	chr7:148888333	NA	-0.78	-6.67	-0.6	3.27e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs995000	0.839	rs1168026	chr1:62970996	T/C	cg06896770	chr1:63153194	DOCK7	-0.62	-5.59	-0.54	3.15e-7	Triglyceride levels;
SKCM	cis	rs9368481	0.761	rs6918835	chr6:27017827	T/G	cg12292205	chr6:26970375	C6orf41	-0.71	-6.4	-0.59	1.07e-8	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs425277	1.000	rs262641	chr1:2104981	C/T	cg24578937	chr1:2090814	PRKCZ	-0.44	-4.77	-0.48	8.45e-6	Height;
SKCM	cis	rs4555082	1.000	rs7146643	chr14:105757392	A/G	cg13114125	chr14:105738426	BRF1	-0.66	-4.94	-0.49	4.42e-6	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs6723226	0.806	rs6543658	chr2:32718849	G/A	cg02381751	chr2:32503542	YIPF4	0.9	6.23	0.58	2.21e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs6500395	1.000	rs1872655	chr16:48670883	A/C	cg04672837	chr16:48644449	N4BP1	0.63	5.29	0.51	1.08e-6	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs870825	0.860	rs72703518	chr4:185602109	T/C	cg04058563	chr4:185651563	MLF1IP	1.04	5.96	0.56	7.02e-8	Blood protein levels;
SKCM	cis	rs17685	0.884	rs3823882	chr7:75631913	T/C	cg16684958	chr7:75615977	POR	-0.67	-6.56	-0.6	5.3300000000000004e-09	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs72792276	1.000	rs17164395	chr5:127395526	T/C	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.74	5.01	0.49	3.33e-6	Red cell distribution width;
SKCM	cis	rs1707322	0.752	rs4586014	chr1:46150443	A/G	cg03146154	chr1:46216737	IPP	0.8	5.47	0.53	5.34e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs2836950	0.565	rs7278297	chr21:40625752	A/C	cg17971929	chr21:40555470	PSMG1	-0.73	-6.17	-0.57	2.86e-8	Menarche (age at onset);
SKCM	cis	rs2727020	0.729	rs1917325	chr11:49370004	G/A	cg21546286	chr11:48923668	NA	-0.53	-4.77	-0.48	8.31e-6	Coronary artery disease;
SKCM	cis	rs2032447	0.507	rs199748	chr6:25909045	C/G	cg03517284	chr6:25882590	NA	-0.72	-6.25	-0.58	2.05e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs2836950	0.509	rs11088466	chr21:40580017	T/A	cg17971929	chr21:40555470	PSMG1	-0.73	-6.17	-0.57	2.86e-8	Menarche (age at onset);
SKCM	cis	rs798554	0.959	rs798558	chr7:2758935	T/G	cg19346786	chr7:2764209	NA	-0.67	-6.87	-0.61	1.42e-9	Height;
SKCM	trans	rs1814175	0.645	rs28454367	chr11:50045708	G/A	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs9303401	0.659	rs7210700	chr17:56668186	G/A	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.27	0.51	1.17e-6	Cognitive test performance;
SKCM	cis	rs7659604	0.560	rs769238	chr4:122744942	G/A	cg06713675	chr4:122721982	EXOSC9	-0.75	-7.26	-0.64	2.47e-10	Type 2 diabetes;
SKCM	cis	rs875971	0.638	rs6960778	chr7:66071597	C/T	cg11764359	chr7:65958608	NA	-0.84	-6.42	-0.59	9.89e-9	Aortic root size;
SKCM	cis	rs7824557	0.564	rs35009431	chr8:11232788	G/A	cg21775007	chr8:11205619	TDH	-0.61	-5.1	-0.5	2.36e-6	Retinal vascular caliber;
SKCM	cis	rs951366	0.789	rs1775154	chr1:205696615	T/A	cg14893161	chr1:205819251	PM20D1	1.05	9.81	0.74	2.86e-15	Menarche (age at onset);
SKCM	cis	rs1790761	0.520	rs1551884	chr11:67399601	C/G	cg00290607	chr11:67383545	NA	-0.66	-6.89	-0.62	1.27e-9	Mean corpuscular volume;
SKCM	cis	rs10504073	0.647	rs12549138	chr8:50007203	C/T	cg00325661	chr8:49890786	NA	0.79	6.79	0.61	1.99e-9	Blood metabolite ratios;
SKCM	cis	rs875971	0.825	rs4587224	chr7:65736182	G/A	cg18876405	chr7:65276391	NA	-0.65	-6.57	-0.6	5.03e-9	Aortic root size;
SKCM	cis	rs10256972	0.514	rs2140578	chr7:1214003	T/C	cg16145915	chr7:1198662	ZFAND2A	-0.58	-7.97	-0.67	1.06e-11	Longevity;Endometriosis;
SKCM	cis	rs7772486	0.790	rs9403749	chr6:146162239	A/G	cg05347473	chr6:146136440	FBXO30	0.63	6.16	0.57	2.98e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2980439	0.525	rs2980508	chr8:8171732	C/T	cg15556689	chr8:8085844	FLJ10661	0.69	6.08	0.57	4.14e-8	Neuroticism;
SKCM	cis	rs6938	0.534	rs8025447	chr15:75192222	T/G	cg09165964	chr15:75287851	SCAMP5	0.62	4.79	0.48	7.73e-6	Breast cancer;
SKCM	cis	rs4819052	0.851	rs2838845	chr21:46670812	A/G	cg02159808	chr21:46707872	POFUT2;LOC642852	0.71	5.42	0.52	6.38e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs6665290	0.904	rs1343743	chr1:227183125	C/T	cg10327440	chr1:227177885	CDC42BPA	-1.25	-17.46	-0.89	1.15e-28	Myeloid white cell count;
SKCM	cis	rs11098499	0.739	rs9996382	chr4:120151012	C/T	cg09307838	chr4:120376055	NA	0.78	5.85	0.55	1.1e-7	Corneal astigmatism;
SKCM	cis	rs17685	0.753	rs1637045	chr7:75703895	T/C	cg16684958	chr7:75615977	POR	0.55	5.28	0.51	1.12e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs9486715	0.867	rs4839687	chr6:96951732	C/A	cg06623918	chr6:96969491	KIAA0776	0.8	6.58	0.6	4.94e-9	Headache;
SKCM	cis	rs763014	0.865	rs2071979	chr16:624114	A/G	cg09263875	chr16:632152	PIGQ	0.68	5.71	0.54	1.98e-7	Height;
SKCM	cis	rs2075371	0.835	rs1646724	chr7:134001875	T/G	cg20476274	chr7:133979776	SLC35B4	1.07	11.43	0.79	2.45e-18	Mean platelet volume;
SKCM	cis	rs1799949	1.000	rs2037076	chr17:41305883	G/A	cg05368731	chr17:41323189	NBR1	0.89	7.98	0.67	1.03e-11	Menopause (age at onset);
SKCM	cis	rs7945705	0.967	rs10769973	chr11:8928615	C/G	cg21881798	chr11:8931708	C11orf17;ST5	0.8	7.95	0.67	1.18e-11	Hemoglobin concentration;
SKCM	cis	rs6952808	0.609	rs6950151	chr7:1953521	T/C	cg04267008	chr7:1944627	MAD1L1	-0.6	-4.81	-0.48	7.27e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs12142240	0.698	rs17361791	chr1:46812519	A/G	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs8067545	0.717	rs34401389	chr17:19989436	A/T	cg13482628	chr17:19912719	NA	0.73	6.54	0.6	5.78e-9	Schizophrenia;
SKCM	cis	rs28595532	0.920	rs55758547	chr4:119769475	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs2836974	0.932	rs6517527	chr21:40581751	G/A	cg11890956	chr21:40555474	PSMG1	1.09	13.83	0.84	1.08e-22	Cognitive function;
SKCM	cis	rs7937682	1.000	rs2186839	chr11:111534442	T/G	cg09085632	chr11:111637200	PPP2R1B	-1.03	-11.65	-0.8	9.4e-19	Primary sclerosing cholangitis;
SKCM	cis	rs9809213	1.000	rs4077773	chr3:72351179	G/C	cg09429735	chr3:71752026	EIF4E3	-0.58	-5.68	-0.54	2.25e-7	Cognitive ability;Cognitive ability (multi-trait analysis);
SKCM	cis	rs919433	0.929	rs7592511	chr2:198177974	A/G	cg04278110	chr2:198063759	ANKRD44	-0.7	-5.12	-0.5	2.14e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs523522	0.885	rs524735	chr12:121022099	T/C	cg12219531	chr12:120966889	COQ5	0.9	7.63	0.65	4.83e-11	High light scatter reticulocyte count;
SKCM	cis	rs763121	0.853	rs6519119	chr22:38989007	C/G	cg06022373	chr22:39101656	GTPBP1	0.72	4.96	0.49	4.08e-6	Menopause (age at onset);
SKCM	cis	rs4862750	0.872	rs13101380	chr4:187894744	G/A	cg10295955	chr4:187884368	NA	-1.04	-14.07	-0.85	4.23e-23	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2404602	0.692	rs7174673	chr15:77071998	T/C	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs13118159	0.509	rs7681872	chr4:1376735	G/A	cg19318889	chr4:1322082	MAEA	0.78	5.8	0.55	1.38e-7	Longevity;
SKCM	cis	rs9902453	0.791	rs3098950	chr17:27998385	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.79	5.94	0.56	7.41e-8	Coffee consumption (cups per day);
SKCM	cis	rs4975616	0.869	rs452932	chr5:1330253	T/C	cg06550200	chr5:1325588	CLPTM1L	-0.86	-7.74	-0.66	2.94e-11	Lung cancer;
SKCM	cis	rs11098499	0.909	rs9759478	chr4:120367998	G/A	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs651907	0.535	rs11712309	chr3:101519097	T/C	cg12386194	chr3:101231763	SENP7	0.68	5.74	0.54	1.73e-7	Colorectal cancer;
SKCM	cis	rs5751150	1	rs5751150	chr22:42153292	T/G	cg03806693	chr22:41940476	POLR3H	1.16	6.72	0.61	2.63e-9	Cannabis dependence symptom count;
SKCM	cis	rs9910055	0.614	rs12944572	chr17:42245241	T/C	cg08499158	chr17:42289980	UBTF	-0.75	-6.5	-0.59	6.98e-9	Total body bone mineral density;
SKCM	cis	rs561341	1.000	rs8070262	chr17:30262467	A/G	cg00745463	chr17:30367425	LRRC37B	-1.01	-6.84	-0.61	1.58e-9	Hip circumference adjusted for BMI;
SKCM	cis	rs7772486	0.686	rs1569540	chr6:146069112	A/G	cg05347473	chr6:146136440	FBXO30	-0.54	-4.96	-0.49	3.97e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1059312	0.966	rs12370194	chr12:129277250	A/T	cg09035930	chr12:129282057	SLC15A4	0.82	8.71	0.7	3.91e-13	Systemic lupus erythematosus;
SKCM	cis	rs1577917	0.958	rs12660846	chr6:86573809	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.81	-7.82	-0.66	2.07e-11	Response to antipsychotic treatment;
SKCM	cis	rs9399135	0.967	rs1041481	chr6:135335063	G/A	cg24558204	chr6:135376177	HBS1L	0.59	5.22	0.51	1.42e-6	Red blood cell count;
SKCM	cis	rs11098499	0.954	rs10017371	chr4:120293776	A/G	cg24375607	chr4:120327624	NA	0.64	4.79	0.48	7.76e-6	Corneal astigmatism;
SKCM	cis	rs9788682	0.894	rs4461039	chr15:78817447	A/T	cg06917634	chr15:78832804	PSMA4	0.85	5.3	0.51	1.05e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs1760803	0.754	rs2879788	chr1:154204310	A/T	cg26808167	chr1:154192205	UBAP2L;C1orf43	-0.57	-5.04	-0.5	2.97e-6	Nicotine dependence;
SKCM	cis	rs4820539	1.000	rs885964	chr22:23461003	G/C	cg14186256	chr22:23484241	RTDR1	0.86	8.58	0.7	6.98e-13	Bone mineral density;
SKCM	cis	rs10540	1.000	rs12801148	chr11:511707	T/G	cg03576123	chr11:487126	PTDSS2	-1.45	-7.95	-0.67	1.17e-11	Body mass index;
SKCM	cis	rs8180040	1.000	rs807810	chr3:47403892	G/A	cg16586182	chr3:47516702	SCAP	0.71	4.85	0.48	6.25e-6	Colorectal cancer;
SKCM	cis	rs2559856	0.904	rs2695283	chr12:102089391	G/C	cg12924262	chr12:102091054	CHPT1	0.69	5.85	0.55	1.08e-7	Blood protein levels;
SKCM	cis	rs9902453	0.791	rs7219163	chr17:28210703	A/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.85	6.69	0.6	3.07e-9	Coffee consumption (cups per day);
SKCM	cis	rs1577917	0.958	rs16876530	chr6:86595641	T/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.75	-0.66	2.83e-11	Response to antipsychotic treatment;
SKCM	cis	rs34779708	0.771	rs12098283	chr10:35478115	G/T	cg03585969	chr10:35415529	CREM	0.78	6.52	0.59	6.47e-9	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs7103648	0.897	rs3758675	chr11:47400602	G/A	cg20307385	chr11:47447363	PSMC3	0.96	6.89	0.61	1.29e-9	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs8070463	0.515	rs11655943	chr17:45385640	A/G	cg08085267	chr17:45401833	C17orf57	-0.62	-5.04	-0.5	2.97e-6	Multiple sclerosis;Ankylosing spondylitis;
SKCM	cis	rs12477438	0.520	rs4850897	chr2:99768419	A/G	cg26064155	chr2:99771622	LIPT1;TSGA10	1.01	9.39	0.73	1.86e-14	Chronic sinus infection;
SKCM	cis	rs4523957	0.583	rs923864	chr17:2031507	C/T	cg16513277	chr17:2031491	SMG6	-0.91	-6.21	-0.58	2.38e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs77106637	0.932	rs2886599	chr11:72721271	C/A	cg03713592	chr11:72463424	ARAP1	0.99	4.99	0.49	3.63e-6	Type 2 diabetes;
SKCM	cis	rs2760061	0.626	rs2527614	chr1:228126470	A/G	cg18477163	chr1:228402036	OBSCN	-0.42	-4.83	-0.48	6.63e-6	Diastolic blood pressure;
SKCM	cis	rs9790314	0.871	rs336551	chr3:161109720	T/C	cg03342759	chr3:160939853	NMD3	-0.72	-7.13	-0.63	4.41e-10	Morning vs. evening chronotype;
SKCM	cis	rs2836974	0.526	rs1888488	chr21:40686521	C/T	cg11644478	chr21:40555479	PSMG1	-0.64	-5.33	-0.52	9.27e-7	Cognitive function;
SKCM	cis	rs514406	0.679	rs11585495	chr1:53244331	T/C	cg27535305	chr1:53392650	SCP2	0.55	4.97	0.49	3.93e-6	Monocyte count;
SKCM	cis	rs514406	0.792	rs1242201	chr1:53344748	G/A	cg24675658	chr1:53192096	ZYG11B	-0.78	-6.68	-0.6	3.22e-9	Monocyte count;
SKCM	cis	rs7659604	1.000	rs28618203	chr4:122663935	T/C	cg06713675	chr4:122721982	EXOSC9	-0.65	-5.83	-0.55	1.21e-7	Type 2 diabetes;
SKCM	cis	rs870825	0.655	rs67798981	chr4:185619567	A/T	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs6089584	0.854	rs6061985	chr20:60622362	T/C	cg06108461	chr20:60628389	TAF4	-0.89	-8.72	-0.7	3.75e-13	Body mass index;
SKCM	cis	rs2075671	0.810	rs12531792	chr7:100280624	G/A	cg20848291	chr7:100343083	ZAN	-0.71	-5.38	-0.52	7.64e-7	Other erythrocyte phenotypes;
SKCM	cis	rs748404	0.631	rs6493086	chr15:43655394	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	0.85	6.35	0.58	1.29e-8	Lung cancer;
SKCM	cis	rs34172651	0.517	rs11647120	chr16:24819806	A/G	cg04756594	chr16:24857601	SLC5A11	0.72	5.19	0.51	1.65e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1799949	0.930	rs2298861	chr17:41176831	G/A	cg05368731	chr17:41323189	NBR1	0.85	7.18	0.63	3.55e-10	Menopause (age at onset);
SKCM	cis	rs2153535	0.580	rs9505458	chr6:8479215	A/G	cg07606381	chr6:8435919	SLC35B3	0.86	6.25	0.58	2.06e-8	Motion sickness;
SKCM	cis	rs4803468	1.000	rs3810175	chr19:41904396	C/T	cg14132834	chr19:41945861	ATP5SL	0.74	5.71	0.54	1.99e-7	Height;
SKCM	cis	rs1707322	0.721	rs12043945	chr1:46106922	T/A	cg03146154	chr1:46216737	IPP	0.82	6.1	0.57	3.89e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs6088580	0.634	rs4258875	chr20:32924895	C/A	cg24642439	chr20:33292090	TP53INP2	-0.76	-6.02	-0.56	5.31e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs1799949	0.965	rs12950779	chr17:41306523	C/T	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.15	-0.57	3.16e-8	Menopause (age at onset);
SKCM	cis	rs17711722	0.701	rs4467826	chr7:65368708	A/G	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.61	5.06	0.5	2.75e-6	Calcium levels;
SKCM	cis	rs6982751	0.673	rs73196845	chr8:10807578	G/A	cg01383082	chr8:11323474	FAM167A	0.86	4.98	0.49	3.74e-6	Asthma and hay fever;
SKCM	cis	rs71520386	0.632	rs28526185	chr7:22871318	T/C	cg15401507	chr7:22894281	NA	0.65	4.87	0.48	5.7e-6	Fibrinogen levels;
SKCM	cis	rs4478137	0.931	rs12509756	chr4:164237464	A/T	cg06758707	chr4:164254230	NPY1R	0.93	6.88	0.61	1.35e-9	Subjective well-being (multi-trait analysis);Subjective well-being;
SKCM	cis	rs453301	0.653	rs11784393	chr8:8903134	C/T	cg15556689	chr8:8085844	FLJ10661	0.67	5.22	0.51	1.45e-6	Joint mobility (Beighton score);
SKCM	cis	rs9300255	0.568	rs1790102	chr12:123704890	G/A	cg00376283	chr12:123451042	ABCB9	0.83	5.49	0.53	4.74e-7	Neutrophil percentage of white cells;
SKCM	cis	rs8072100	0.967	rs4289035	chr17:45707211	C/T	cg25173405	chr17:45401733	C17orf57	-0.57	-5.13	-0.5	2.07e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs7772486	0.875	rs2328712	chr6:146344563	T/C	cg05347473	chr6:146136440	FBXO30	0.57	5.06	0.5	2.68e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs35306767	0.855	rs56222464	chr10:867535	C/G	cg26597838	chr10:835615	NA	0.79	6.08	0.57	4.12e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs12188164	0.747	rs12188321	chr5:428418	C/G	cg26076054	chr5:421317	AHRR	-0.58	-5.16	-0.5	1.83e-6	Cystic fibrosis severity;
SKCM	cis	rs35306767	0.761	rs12770910	chr10:1050318	A/G	cg26597838	chr10:835615	NA	0.64	5.23	0.51	1.38e-6	Eosinophil percentage of granulocytes;
SKCM	trans	rs1814175	0.585	rs4881661	chr11:50000117	A/G	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs1218582	0.745	rs1580943	chr1:154865125	G/A	cg03351412	chr1:154909251	PMVK	0.78	6.55	0.6	5.5e-9	Prostate cancer;
SKCM	cis	rs7829975	0.623	rs10092965	chr8:8373485	A/G	cg06636001	chr8:8085503	FLJ10661	0.67	4.92	0.49	4.67e-6	Mood instability;
SKCM	cis	rs12477438	0.520	rs6741772	chr2:99738961	A/G	cg14399236	chr2:99771627	LIPT1;TSGA10	0.95	8.78	0.71	2.89e-13	Chronic sinus infection;
SKCM	cis	rs7635838	0.785	rs2606738	chr3:11396562	T/C	cg00170343	chr3:11313890	ATG7	0.7	5.19	0.51	1.61e-6	HDL cholesterol;
SKCM	cis	rs6500395	0.775	rs11640119	chr16:48662840	C/T	cg04672837	chr16:48644449	N4BP1	0.6	4.91	0.49	4.99e-6	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs2404602	0.692	rs7350777	chr15:76985441	G/A	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs1577917	0.883	rs6454505	chr6:86592362	G/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.67	-5.74	-0.54	1.73e-7	Response to antipsychotic treatment;
SKCM	cis	rs7552404	0.961	rs1767458	chr1:76219155	A/G	cg03433033	chr1:76189801	ACADM	0.76	5.41	0.52	6.62e-7	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs7659604	1.000	rs35901586	chr4:122664757	T/A	cg19748678	chr4:122722346	EXOSC9	0.66	5.44	0.52	5.83e-7	Type 2 diabetes;
SKCM	cis	rs35306767	0.715	rs12772979	chr10:1034412	C/T	cg25614935	chr10:1084866	C10orf110	0.68	4.84	0.48	6.55e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs514406	0.929	rs11206035	chr1:53323571	T/C	cg16325326	chr1:53192061	ZYG11B	0.94	10.05	0.75	1.02e-15	Monocyte count;
SKCM	cis	rs4819052	0.851	rs7276828	chr21:46695039	T/G	cg02159808	chr21:46707872	POFUT2;LOC642852	0.74	5.68	0.54	2.22e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs55962025	0.846	rs16843804	chr4:3104390	C/T	cg24015175	chr4:3319247	RGS12	-0.57	-4.79	-0.48	7.81e-6	Parental longevity (mother's age at death);
SKCM	cis	rs919433	1.000	rs6761919	chr2:198163328	A/G	cg04278110	chr2:198063759	ANKRD44	-0.72	-5.33	-0.52	9.25e-7	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs6840360	0.550	rs4696289	chr4:152621237	C/T	cg22705602	chr4:152727874	NA	-0.51	-5.49	-0.53	4.93e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs6502050	0.723	rs8077209	chr17:80163221	A/G	cg13939156	chr17:80058883	NA	-0.52	-4.89	-0.48	5.29e-6	Life satisfaction;
SKCM	cis	rs8180040	0.966	rs13072802	chr3:47346415	G/C	cg16586182	chr3:47516702	SCAP	-0.71	-4.85	-0.48	6.25e-6	Colorectal cancer;
SKCM	cis	rs654950	0.875	rs687835	chr1:41998904	G/C	cg06885757	chr1:42089581	HIVEP3	0.65	7.07	0.62	5.9e-10	Airway imaging phenotypes;
SKCM	cis	rs9911578	0.757	rs8081906	chr17:56631907	A/T	cg12560992	chr17:57184187	TRIM37	-0.83	-6.02	-0.56	5.39e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs4727027	0.866	rs12666477	chr7:148812322	A/G	cg23583168	chr7:148888333	NA	-0.83	-6.7	-0.6	2.89e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs10876993	0.928	rs774890	chr12:58068388	C/T	cg18357645	chr12:58087776	OS9	0.65	6.01	0.56	5.71e-8	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs10503709	0.762	rs7817322	chr8:21446149	G/A	cg23716449	chr8:21608280	GFRA2	0.51	5.23	0.51	1.38e-6	Blood protein levels;
SKCM	cis	rs9790314	1.000	rs456611	chr3:161097268	A/G	cg03342759	chr3:160939853	NMD3	-0.75	-7.89	-0.67	1.52e-11	Morning vs. evening chronotype;
SKCM	cis	rs365132	0.967	rs11740768	chr5:176339499	G/A	cg16309518	chr5:176445507	NA	-0.52	-5.14	-0.5	1.97e-6	Menarche and menopause (age at onset);Menopause (age at onset);
SKCM	cis	rs801193	1.000	rs7782320	chr7:66177098	C/T	cg11764359	chr7:65958608	NA	0.86	6.55	0.6	5.68e-9	Aortic root size;
SKCM	cis	rs1577917	1.000	rs12205548	chr6:86759770	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.83	-8.14	-0.68	5.09e-12	Response to antipsychotic treatment;
SKCM	cis	rs9911578	0.967	rs9907940	chr17:56663842	A/G	cg05425664	chr17:57184151	TRIM37	-0.69	-5.2	-0.51	1.55e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs72615157	0.634	rs79986079	chr7:99802044	C/T	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.1	6.69	0.6	3.04e-9	Lung function (FEV1/FVC);
SKCM	trans	rs1814175	0.647	rs10839394	chr11:49844747	T/C	cg03929089	chr4:120376271	NA	-0.9	-8.61	-0.7	6.1e-13	Height;
SKCM	cis	rs2282032	1.000	rs115026813	chr14:90747728	A/G	cg04374321	chr14:90722782	PSMC1	0.71	4.93	0.49	4.54e-6	Longevity;
SKCM	cis	rs9467773	0.933	rs2024970	chr6:26497520	T/A	cg15659132	chr6:26577336	NA	0.57	5.33	0.52	9.42e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs4481887	0.927	rs4523548	chr1:248472399	G/T	cg00666640	chr1:248458726	OR2T12	0.63	5.91	0.56	8.65e-8	Common traits (Other);
SKCM	cis	rs11098499	1.000	rs12506395	chr4:120185094	C/T	cg09307838	chr4:120376055	NA	0.95	7.75	0.66	2.84e-11	Corneal astigmatism;
SKCM	cis	rs9894429	0.934	rs35868252	chr17:79575472	C/G	cg18240062	chr17:79603768	NPLOC4	-0.76	-7.43	-0.64	1.2e-10	Eye color traits;
SKCM	cis	rs2836974	0.897	rs34394827	chr21:40528087	T/C	cg17971929	chr21:40555470	PSMG1	0.87	8.48	0.69	1.1e-12	Cognitive function;
SKCM	cis	rs17711722	0.523	rs365896	chr7:65510697	A/G	cg18876405	chr7:65276391	NA	-0.63	-4.87	-0.48	5.73e-6	Calcium levels;
SKCM	cis	rs7666738	0.753	rs1527520	chr4:98929164	A/G	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs477895	0.713	rs12787852	chr11:63954648	G/A	cg07220939	chr11:64358617	SLC22A12	0.74	4.99	0.49	3.58e-6	Mean platelet volume;
SKCM	cis	rs6582630	0.502	rs11520234	chr12:38255005	G/A	cg26384229	chr12:38710491	ALG10B	0.87	6.83	0.61	1.63e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs9916302	0.706	rs594794	chr17:37453485	T/C	cg07936489	chr17:37558343	FBXL20	1.0	7.19	0.63	3.42e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs72634258	0.945	rs2641116	chr1:8029494	T/G	cg00042356	chr1:8021962	PARK7	0.95	6.4	0.59	1.09e-8	Inflammatory bowel disease;
SKCM	cis	rs875971	1.000	rs1540651	chr7:65650121	C/T	cg18876405	chr7:65276391	NA	-0.68	-6.85	-0.61	1.51e-9	Aortic root size;
SKCM	cis	rs9911578	1.000	rs8076121	chr17:57041699	G/A	cg05425664	chr17:57184151	TRIM37	-0.67	-5.04	-0.5	2.91e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1395	0.925	rs1659676	chr2:27399294	C/T	cg14242246	chr2:27434262	C2orf28;SLC5A6	-0.48	-5.01	-0.49	3.36e-6	Blood metabolite levels;
SKCM	cis	rs9394841	0.692	rs9381095	chr6:41806708	T/A	cg08135965	chr6:41755394	TOMM6	0.74	4.88	0.48	5.45e-6	Mean corpuscular hemoglobin;Red cell distribution width;
SKCM	cis	rs2243480	1.000	rs160646	chr7:65556280	C/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs6545883	0.895	rs2177961	chr2:61560264	T/C	cg15711740	chr2:61764176	XPO1	0.72	5.13	0.5	2.07e-6	Tuberculosis;
SKCM	cis	rs5753618	0.555	rs5749291	chr22:31907523	C/G	cg02404636	chr22:31891804	SFI1	0.68	6.07	0.57	4.32e-8	Colorectal cancer;
SKCM	cis	rs2243480	1.000	rs34136756	chr7:65381256	A/G	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs7122539	0.768	rs7931485	chr11:66578635	G/A	cg12372692	chr11:66233905	PELI3	-0.66	-4.94	-0.49	4.4e-6	HIV-1 susceptibility;
SKCM	cis	rs12477438	0.539	rs12999417	chr2:99865548	A/G	cg26064155	chr2:99771622	LIPT1;TSGA10	-0.99	-8.9	-0.71	1.68e-13	Chronic sinus infection;
SKCM	cis	rs17685	0.725	rs7795291	chr7:75725206	C/A	cg16684958	chr7:75615977	POR	0.56	5.13	0.5	2.03e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7666738	0.830	rs115712871	chr4:98954535	A/T	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10838687	0.606	rs4494268	chr11:47038220	A/G	cg05584439	chr11:47213196	NA	-0.8	-4.84	-0.48	6.53e-6	Proinsulin levels;
SKCM	cis	rs8180040	1.000	rs11130127	chr3:47398793	C/G	cg16586182	chr3:47516702	SCAP	0.71	4.85	0.48	6.25e-6	Colorectal cancer;
SKCM	cis	rs763121	0.853	rs138716	chr22:39146527	C/T	cg06022373	chr22:39101656	GTPBP1	0.82	5.06	0.5	2.74e-6	Menopause (age at onset);
SKCM	cis	rs4740619	0.587	rs10756740	chr9:16037723	T/C	cg14451791	chr9:16040625	NA	-0.47	-5.03	-0.49	3.07e-6	Body mass index;
SKCM	cis	rs826838	1.000	rs11514441	chr12:38775190	C/T	cg13010199	chr12:38710504	ALG10B	0.86	6.84	0.61	1.61e-9	Heart rate;
SKCM	cis	rs2066819	1.000	rs773664	chr12:56702176	C/T	cg26714650	chr12:56694279	CS	1.71	6.71	0.61	2.74e-9	Psoriasis vulgaris;
SKCM	cis	rs7599312	0.553	rs6710653	chr2:213404893	A/G	cg16329650	chr2:213403929	ERBB4	0.84	6.04	0.56	4.85e-8	BMI (adjusted for smoking behaviour);BMI in non-smokers;Body mass index;Body mass index (joint analysis main effects and smoking interaction);
SKCM	cis	rs7020830	0.825	rs10973248	chr9:37197768	C/T	cg14294708	chr9:37120828	ZCCHC7	1.08	10.89	0.78	2.5e-17	Schizophrenia;
SKCM	cis	rs7772486	0.597	rs7746618	chr6:146281367	T/C	cg05347473	chr6:146136440	FBXO30	-0.66	-5.46	-0.53	5.58e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7216064	1.000	rs62084238	chr17:65856573	T/A	cg12091567	chr17:66097778	LOC651250	-0.75	-5.27	-0.51	1.19e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs589448	0.967	rs634512	chr12:69754012	C/T	cg20891283	chr12:69753455	YEATS4	0.98	9.89	0.75	2.06e-15	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs514406	0.679	rs545719	chr1:53304922	T/C	cg08859206	chr1:53392774	SCP2	-0.65	-5.26	-0.51	1.22e-6	Monocyte count;
SKCM	cis	rs11122272	0.735	rs2739518	chr1:231537633	C/T	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	-0.6	-4.8	-0.48	7.45e-6	Hemoglobin concentration;
SKCM	cis	rs9911578	1.000	rs7342903	chr17:56914588	C/G	cg05425664	chr17:57184151	TRIM37	-0.67	-5.04	-0.5	2.91e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs4073582	0.595	rs708471	chr11:65931008	A/G	cg16950941	chr11:66035639	RAB1B	0.81	6.87	0.61	1.41e-9	Gout;
SKCM	cis	rs58688157	0.921	rs12805435	chr11:612355	T/C	cg16486109	chr11:613632	IRF7	1.07	7.29	0.64	2.17e-10	Systemic lupus erythematosus;
SKCM	cis	rs7647973	0.848	rs4955426	chr3:49143438	C/A	cg07636037	chr3:49044803	WDR6	0.89	5.48	0.53	5e-7	Menarche (age at onset);
SKCM	cis	rs72772090	0.710	rs11750400	chr5:96077968	A/T	cg17330273	chr5:96107758	CAST;ERAP1	-0.84	-5.14	-0.5	1.96e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs7666738	0.830	rs34135615	chr4:99001325	C/T	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9611565	0.512	rs2899347	chr22:42158204	T/C	cg03806693	chr22:41940476	POLR3H	1.17	7.66	0.66	4.23e-11	Vitiligo;
SKCM	cis	rs867186	0.841	rs76223987	chr20:33618472	T/C	cg04194272	chr20:33683537	NA	-1.38	-7.2	-0.63	3.29e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs9308433	0.529	rs9430133	chr1:214496313	C/T	cg06198575	chr1:214491504	SMYD2	0.81	5.09	0.5	2.41e-6	IgG glycosylation;
SKCM	cis	rs10504229	0.679	rs11781858	chr8:58038406	C/T	cg02725872	chr8:58115012	NA	-0.52	-4.85	-0.48	6.18e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs35146811	0.844	rs10281368	chr7:99655897	A/G	cg13334819	chr7:99746414	C7orf59	-0.75	-5.43	-0.52	6.23e-7	Coronary artery disease;
SKCM	cis	rs9914544	1.000	rs1634411	chr17:18833810	C/T	cg26378065	chr17:18585709	ZNF286B	0.71	4.89	0.48	5.37e-6	Educational attainment (years of education);
SKCM	cis	rs514406	0.679	rs541852	chr1:53256834	A/G	cg08859206	chr1:53392774	SCP2	0.67	5.36	0.52	8.11e-7	Monocyte count;
SKCM	cis	rs28386778	1.000	rs2955241	chr17:61968113	G/C	cg06873352	chr17:61820015	STRADA	0.73	6.0	0.56	5.92e-8	Prudent dietary pattern;
SKCM	cis	rs2404602	0.735	rs283789	chr15:76777577	G/A	cg23625390	chr15:77176239	SCAPER	0.82	7.97	0.67	1.06e-11	Blood metabolite levels;
SKCM	cis	rs910316	0.967	rs175451	chr14:75589729	C/T	cg08847533	chr14:75593920	NEK9	-0.96	-8.88	-0.71	1.88e-13	Height;
SKCM	cis	rs6066825	0.644	rs6090894	chr20:47334688	G/T	cg18078177	chr20:47281410	PREX1	0.63	4.96	0.49	4.07e-6	Colorectal cancer;
SKCM	cis	rs9399135	0.967	rs4142299	chr6:135377186	G/T	cg24558204	chr6:135376177	HBS1L	0.56	4.77	0.48	8.29e-6	Red blood cell count;
SKCM	cis	rs7954584	0.626	rs10840637	chr12:122427310	A/G	cg22168489	chr12:122356033	WDR66	0.49	4.95	0.49	4.18e-6	Mean corpuscular volume;
SKCM	cis	rs10138752	0.643	rs2145156	chr14:69095279	G/A	cg08271153	chr14:69726221	GALNTL1	-0.67	-5.12	-0.5	2.11e-6	Neutrophil count;White blood cell count;Myeloid white cell count;Granulocyte count;Sum neutrophil eosinophil counts;Sum basophil neutrophil counts;
SKCM	cis	rs1707322	0.685	rs56177313	chr1:46225806	A/C	cg03146154	chr1:46216737	IPP	0.84	6.26	0.58	1.97e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs9788682	0.694	rs3825845	chr15:78910258	C/T	cg24631222	chr15:78858424	CHRNA5	0.76	5.88	0.55	9.49e-8	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs6952808	0.543	rs4719436	chr7:2141239	G/A	cg02951883	chr7:2050386	MAD1L1	-0.79	-7.4	-0.64	1.37e-10	Bipolar disorder and schizophrenia;
SKCM	cis	rs4077515	0.874	rs4498662	chr9:139290251	C/G	cg21253087	chr9:139290292	SNAPC4	0.55	4.77	0.48	8.34e-6	Ulcerative colitis;IgA nephropathy;Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs2153535	0.542	rs4440510	chr6:8471818	C/T	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs206936	0.528	rs79954907	chr6:34401259	C/G	cg12284521	chr6:34113943	NA	-0.9	-5.22	-0.51	1.43e-6	Body mass index;
SKCM	cis	rs2832191	0.632	rs1984011	chr21:30337831	T/A	cg08807101	chr21:30365312	RNF160	-0.76	-6.32	-0.58	1.52e-8	Dental caries;
SKCM	cis	rs7100689	0.725	rs2487074	chr10:82064104	A/G	cg01528321	chr10:82214614	TSPAN14	0.81	7.3	0.64	2.14e-10	Post bronchodilator FEV1;
SKCM	cis	rs654950	0.806	rs1815257	chr1:42041479	A/C	cg06885757	chr1:42089581	HIVEP3	-0.63	-6.44	-0.59	8.96e-9	Airway imaging phenotypes;
SKCM	cis	rs7772486	0.817	rs9386145	chr6:146363519	A/T	cg05347473	chr6:146136440	FBXO30	0.57	5.12	0.5	2.13e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2839186	0.588	rs7280110	chr21:47619039	G/A	cg11766577	chr21:47581405	C21orf56	0.78	6.92	0.62	1.14e-9	Testicular germ cell tumor;
SKCM	cis	rs1568889	0.838	rs11030229	chr11:28173634	T/C	cg06544937	chr11:28130018	METT5D1;KIF18A	0.89	8.3	0.68	2.43e-12	Bipolar disorder;
SKCM	cis	rs2032447	0.670	rs198845	chr6:26107790	A/C	cg18357526	chr6:26021779	HIST1H4A	0.79	6.45	0.59	8.68e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs651907	0.557	rs36002990	chr3:101437862	G/A	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.81	7.1	0.63	5.08e-10	Colorectal cancer;
SKCM	cis	rs28595532	0.920	rs115464801	chr4:119730673	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.52	0.53	4.28e-7	Cannabis dependence symptom count;
SKCM	cis	rs4862750	0.832	rs10007858	chr4:187877492	A/G	cg10295955	chr4:187884368	NA	-1.04	-14.07	-0.85	4.23e-23	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7552404	0.807	rs2066183	chr1:76153745	A/G	cg03433033	chr1:76189801	ACADM	0.78	5.67	0.54	2.36e-7	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs8141529	0.732	rs5752798	chr22:29181868	A/G	cg02153584	chr22:29168773	CCDC117	0.68	5.57	0.53	3.52e-7	Lymphocyte counts;
SKCM	cis	rs4819052	0.851	rs4819049	chr21:46673086	C/G	cg20896738	chr21:46707857	POFUT2;LOC642852	0.64	4.82	0.48	6.85e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs13424612	0.965	rs58652766	chr2:240904884	G/A	cg01812947	chr2:240904978	NDUFA10	0.63	4.8	0.48	7.43e-6	Odorant perception (isobutyraldehyde);
SKCM	cis	rs873946	0.557	rs4880427	chr10:134591389	T/C	cg26818010	chr10:134567672	INPP5A	-0.81	-6.31	-0.58	1.55e-8	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs9790314	0.586	rs11710086	chr3:161125858	A/T	cg03342759	chr3:160939853	NMD3	-0.74	-6.62	-0.6	4.08e-9	Morning vs. evening chronotype;
SKCM	cis	rs7811142	0.943	rs28660238	chr7:100023308	C/T	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.33	0.69	2.11e-12	Platelet count;
SKCM	cis	rs473651	0.935	rs35080527	chr2:239351387	T/C	cg21699342	chr2:239360505	ASB1	0.51	5.04	0.5	2.92e-6	Multiple system atrophy;
SKCM	cis	rs9611565	0.546	rs5758430	chr22:42109844	G/T	cg03806693	chr22:41940476	POLR3H	1.08	6.67	0.6	3.27e-9	Vitiligo;
SKCM	cis	rs6063399	0.546	rs237480	chr20:47993898	A/C	cg05303999	chr20:47988955	KCNB1	0.65	5.23	0.51	1.36e-6	Obesity-related traits;
SKCM	cis	rs875971	0.508	rs10950045	chr7:66066373	T/C	cg11987759	chr7:65425863	GUSB	0.69	6.02	0.56	5.47e-8	Aortic root size;
SKCM	cis	rs7617480	0.519	rs6790914	chr3:49206318	G/C	cg07636037	chr3:49044803	WDR6	0.72	5.33	0.52	9.32e-7	Subjective well-being (multi-trait analysis);Menarche (age at onset);
SKCM	cis	rs796364	0.901	rs4673762	chr2:201065171	C/G	cg12253985	chr2:200820533	C2orf60;C2orf47	0.95	6.37	0.59	1.21e-8	Schizophrenia;
SKCM	cis	rs597539	0.652	rs613128	chr11:68638058	G/T	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.84	5.61	0.54	3e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs801193	1.000	rs2707856	chr7:66211010	A/T	cg11987759	chr7:65425863	GUSB	-0.66	-5.74	-0.54	1.74e-7	Aortic root size;
SKCM	cis	rs7772486	0.790	rs9403749	chr6:146162239	A/G	cg23711669	chr6:146136114	FBXO30	0.86	9.43	0.73	1.59e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6762	0.719	rs28655651	chr11:837121	G/C	cg16425592	chr11:842748	TSPAN4;POLR2L	-0.8	-5.94	-0.56	7.55e-8	Mean platelet volume;
SKCM	cis	rs1912528	0.963	rs17373738	chr4:140935264	C/G	cg11128457	chr4:140864437	MAML3	0.58	4.82	0.48	6.87e-6	Educational attainment (years of education);
SKCM	cis	rs7937682	0.961	rs7119563	chr11:111543916	T/A	cg09085632	chr11:111637200	PPP2R1B	1.02	11.79	0.8	5.18e-19	Primary sclerosing cholangitis;
SKCM	cis	rs2070488	1.000	rs4147025	chr3:38456531	C/T	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.97	9.16	0.72	5.28e-14	Electrocardiographic conduction measures;
SKCM	cis	rs35955841	0.898	rs7154019	chr14:65310091	C/G	cg23373153	chr14:65346875	NA	0.63	4.96	0.49	4.01e-6	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity;
SKCM	cis	rs7793919	0.628	rs4720402	chr7:4780961	T/G	cg09789173	chr7:4769017	FOXK1	0.89	7.04	0.62	6.74e-10	Mosquito bite size;
SKCM	cis	rs6598955	0.543	rs4585968	chr1:26535146	G/A	cg04990556	chr1:26633338	UBXN11	0.68	5.08	0.5	2.55e-6	Obesity-related traits;
SKCM	cis	rs7666738	0.830	rs28451101	chr4:99001190	T/C	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1799949	0.929	rs799905	chr17:41277187	G/C	cg25918947	chr17:41365094	TMEM106A	-0.62	-5.9	-0.56	8.91e-8	Menopause (age at onset);
SKCM	cis	rs13010713	0.840	rs4667128	chr2:182060285	T/C	cg21995919	chr2:182322279	ITGA4	-0.53	-5.12	-0.5	2.18e-6	Celiac disease;
SKCM	cis	rs2153535	0.580	rs1928184	chr6:8532108	T/A	cg23788917	chr6:8435910	SLC35B3	0.68	4.98	0.49	3.66e-6	Motion sickness;
SKCM	cis	rs4724125	0.741	rs13223034	chr7:42701627	C/T	cg09407816	chr7:42972088	MRPL32;PSMA2	0.81	5.13	0.5	2.03e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs936229	1.000	rs936228	chr15:75132164	T/C	cg14664628	chr15:75095509	CSK	-1.05	-8.24	-0.68	3.25e-12	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin);
SKCM	cis	rs11098499	0.691	rs10010355	chr4:120261043	A/G	cg09307838	chr4:120376055	NA	0.97	8.31	0.69	2.31e-12	Corneal astigmatism;
SKCM	cis	rs2841277	0.770	rs10149193	chr14:105403474	C/T	cg19901468	chr14:105411992	AHNAK2	-0.98	-7.76	-0.66	2.7e-11	Rheumatoid arthritis;
SKCM	cis	rs2243480	1.000	rs160634	chr7:65528664	C/T	cg18252515	chr7:66147081	NA	1.35	8.36	0.69	1.88e-12	Diabetic kidney disease;
SKCM	cis	rs35306767	0.903	rs61830933	chr10:934195	G/A	cg20503657	chr10:835505	NA	0.92	6.59	0.6	4.73e-9	Eosinophil percentage of granulocytes;
SKCM	cis	rs2228479	0.850	rs11639788	chr16:89807543	G/A	cg00800038	chr16:89945340	TCF25	-0.81	-4.79	-0.48	7.84e-6	Skin colour saturation;
SKCM	cis	rs4683346	1.000	rs4683342	chr3:42877433	G/C	cg06399164	chr3:42695035	ZBTB47	0.61	5.74	0.55	1.71e-7	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs4862750	0.914	rs9998558	chr4:187874691	A/G	cg10295955	chr4:187884368	NA	-1.04	-14.14	-0.85	3.15e-23	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7100689	0.784	rs4934083	chr10:82116501	G/C	cg01528321	chr10:82214614	TSPAN14	0.81	7.28	0.64	2.28e-10	Post bronchodilator FEV1;
SKCM	trans	rs561341	1.000	rs56903735	chr17:30254393	T/A	cg20587970	chr11:113659929	NA	-1.19	-10.36	-0.76	2.61e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs9399135	1.000	rs11754265	chr6:135356216	C/G	cg24558204	chr6:135376177	HBS1L	0.61	5.36	0.52	8.38e-7	Red blood cell count;
SKCM	cis	rs12497850	0.864	rs4279134	chr3:49156676	A/G	cg07636037	chr3:49044803	WDR6	1.03	9.16	0.72	5.21e-14	Parkinson's disease;
SKCM	cis	rs854765	0.505	rs4924832	chr17:17897739	A/G	cg04398451	chr17:18023971	MYO15A	-0.87	-6.49	-0.59	7.13e-9	Total body bone mineral density;
SKCM	cis	rs1218582	0.772	rs4845690	chr1:154886817	C/T	cg16680214	chr1:154839983	KCNN3	0.56	5.01	0.49	3.29e-6	Prostate cancer;
SKCM	cis	rs9325144	0.556	rs34565156	chr12:39028239	G/A	cg13010199	chr12:38710504	ALG10B	-0.64	-5.53	-0.53	4.12e-7	Morning vs. evening chronotype;
SKCM	cis	rs244731	0.920	rs67008484	chr5:176735383	T/C	cg16006841	chr5:176797999	RGS14	0.82	6.53	0.59	6.16e-9	Urate levels in lean individuals;
SKCM	cis	rs1568889	1.000	rs61889046	chr11:28297024	A/G	cg06544937	chr11:28130018	METT5D1;KIF18A	0.85	6.7	0.6	2.96e-9	Bipolar disorder;
SKCM	cis	rs1552244	1.000	rs113522867	chr3:10154503	T/C	cg02579736	chr3:10068473	FANCD2;CIDECP	1.23	6.8	0.61	1.9e-9	Alzheimer's disease;
SKCM	cis	rs7666738	0.752	rs62318905	chr4:99036103	T/G	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2842992	0.789	rs2146163	chr6:160224346	T/C	cg16489826	chr6:160211363	TCP1;MRPL18	0.68	4.93	0.49	4.57e-6	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs4888262	0.514	rs8048239	chr16:74578317	A/T	cg01733217	chr16:74700730	RFWD3	0.84	6.82	0.61	1.75e-9	Testicular germ cell tumor;
SKCM	cis	rs34172651	0.517	rs11639856	chr16:24788645	A/T	cg00339695	chr16:24857497	SLC5A11	-0.8	-6.43	-0.59	9.38e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs2070488	0.896	rs11914389	chr3:38527215	T/C	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.98	9.25	0.72	3.55e-14	Electrocardiographic conduction measures;
SKCM	cis	rs929843	1	rs929843	chr16:70045748	A/C	cg09409435	chr16:70099608	PDXDC2	0.84	5.52	0.53	4.29e-7	Menarche (age at onset);
SKCM	cis	rs9393692	0.905	rs6916289	chr6:26289122	A/T	cg00631329	chr6:26305371	NA	-0.69	-4.94	-0.49	4.31e-6	Educational attainment;
SKCM	cis	rs28595532	1.000	rs115706377	chr4:119628481	G/A	cg21605333	chr4:119757512	SEC24D	1.24	7.1	0.63	5.16e-10	Cannabis dependence symptom count;
SKCM	cis	rs7824557	0.620	rs6996368	chr8:11182704	G/A	cg21775007	chr8:11205619	TDH	0.72	6.73	0.61	2.61e-9	Retinal vascular caliber;
SKCM	cis	rs78456975	0.527	rs10206020	chr2:1557927	A/G	cg01028140	chr2:1542097	TPO	-0.49	-4.88	-0.48	5.52e-6	Placebo response in major depressive disorder (% change in symptom score);
SKCM	cis	rs55823223	0.648	rs66584478	chr17:73870203	G/A	cg10935138	chr17:73851978	WBP2	1.2	7.38	0.64	1.45e-10	Psoriasis;
SKCM	cis	rs9815354	0.812	rs73081372	chr3:41917993	C/T	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs2760061	0.659	rs708107	chr1:228189495	C/T	cg02753203	chr1:228287806	NA	0.66	5.44	0.52	6.04e-7	Diastolic blood pressure;
SKCM	cis	rs362296	0.530	rs3129316	chr4:3287906	A/G	cg00764545	chr4:3318001	RGS12	0.8	8.41	0.69	1.5e-12	Parental longevity (mother's age at death);
SKCM	cis	rs7216064	1.000	rs6504555	chr17:65940727	A/G	cg12091567	chr17:66097778	LOC651250	0.78	5.34	0.52	8.92e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs2404602	0.684	rs11072600	chr15:76867915	T/C	cg23625390	chr15:77176239	SCAPER	-0.85	-8.26	-0.68	2.93e-12	Blood metabolite levels;
SKCM	cis	rs2816062	0.813	rs2816044	chr1:18892826	A/G	cg18795169	chr1:18902165	NA	-0.81	-8.09	-0.68	6.43e-12	Urate levels in lean individuals;
SKCM	cis	rs6546550	0.901	rs6729760	chr2:70161032	C/T	cg02498382	chr2:70120550	SNRNP27	-0.48	-5.28	-0.51	1.12e-6	Prevalent atrial fibrillation;
SKCM	trans	rs7618501	1.000	rs11709680	chr3:49745188	C/T	cg21659725	chr3:3221576	CRBN	-0.96	-9.61	-0.74	7.08e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs2952156	0.920	rs2517955	chr17:37843681	C/T	cg20243544	chr17:37824526	PNMT	0.66	5.18	0.51	1.68e-6	Asthma;
SKCM	cis	rs151997	1.000	rs26063	chr5:50216718	G/A	cg06027927	chr5:50259733	NA	0.66	5.78	0.55	1.45e-7	Callous-unemotional behaviour;
SKCM	cis	rs4242434	0.927	rs3735901	chr8:22462374	T/C	cg03733263	chr8:22462867	KIAA1967	1.07	9.15	0.72	5.54e-14	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs2836950	0.565	rs8130320	chr21:40580258	C/T	cg17971929	chr21:40555470	PSMG1	-0.73	-6.17	-0.57	2.86e-8	Menarche (age at onset);
SKCM	cis	rs1348850	0.914	rs7587604	chr2:178309848	T/A	cg02961200	chr2:178257176	LOC100130691;AGPS	0.82	6.21	0.58	2.42e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs4481887	0.927	rs10788765	chr1:248445642	A/G	cg00666640	chr1:248458726	OR2T12	-0.61	-5.46	-0.53	5.47e-7	Common traits (Other);
SKCM	cis	rs10791097	0.694	rs1050071	chr11:130747231	C/G	cg12179176	chr11:130786555	SNX19	0.95	7.57	0.65	6.44e-11	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs5769765	0.825	rs9616780	chr22:50292763	T/C	cg22709217	chr22:50311962	ALG12;CRELD2	-0.79	-5.71	-0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs6930083	0.605	rs3829964	chr6:36644498	T/C	cg08179530	chr6:36648295	CDKN1A	0.72	5.64	0.54	2.61e-7	Coronary artery disease;
SKCM	cis	rs131805	1.000	rs131805	chr22:50964153	T/C	cg09435190	chr22:50968297	TYMP	0.67	4.86	0.48	5.92e-6	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs12477438	0.501	rs2632284	chr2:99775865	C/G	cg14399236	chr2:99771627	LIPT1;TSGA10	1.01	9.53	0.73	1.01e-14	Chronic sinus infection;
SKCM	cis	rs951366	0.789	rs823110	chr1:205701078	G/C	cg17178900	chr1:205818956	PM20D1	0.73	5.84	0.55	1.13e-7	Menarche (age at onset);
SKCM	cis	rs17826219	0.636	rs4055314	chr17:29079769	T/C	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Body mass index;
SKCM	cis	rs3087591	0.960	rs2905869	chr17:29519016	C/A	cg24425628	chr17:29625626	OMG;NF1	0.61	4.87	0.48	5.75e-6	Hip circumference;
SKCM	trans	rs8073060	0.586	rs226087	chr17:34017652	T/C	cg19694781	chr19:47549865	TMEM160	-1.04	-8.53	-0.69	8.9e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs929354	0.713	rs6459733	chr7:156930550	G/C	cg17757837	chr7:157058334	UBE3C	0.79	5.2	0.51	1.56e-6	Body mass index;
SKCM	cis	rs35306767	0.903	rs11253462	chr10:889323	T/G	cg20503657	chr10:835505	NA	0.76	5.17	0.51	1.73e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs9815354	0.812	rs11129932	chr3:41838767	C/A	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs7647973	0.731	rs7617480	chr3:49210732	G/T	cg06212747	chr3:49208901	KLHDC8B	-0.91	-5.05	-0.5	2.8e-6	Menarche (age at onset);
SKCM	cis	rs8180040	0.966	rs1872164	chr3:47415100	G/A	cg27129171	chr3:47204927	SETD2	-0.79	-5.79	-0.55	1.43e-7	Colorectal cancer;
SKCM	cis	rs875971	0.522	rs4718285	chr7:65292005	A/G	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.61	5.06	0.5	2.75e-6	Aortic root size;
SKCM	cis	rs9814567	1.000	rs11706117	chr3:134212526	T/C	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.64	-5.06	-0.5	2.77e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs2749592	0.550	rs9733309	chr10:37882405	G/A	cg00409905	chr10:38381863	ZNF37A	0.64	6.19	0.57	2.65e-8	Age-related hearing impairment (SNP x SNP interaction);
SKCM	cis	rs947211	0.948	rs12565968	chr1:205755046	A/G	cg07157834	chr1:205819609	PM20D1	-0.66	-5.23	-0.51	1.39e-6	Parkinson's disease;
SKCM	cis	rs9951698	0.703	rs7241536	chr18:13033974	G/A	cg12848697	chr18:13133368	NA	0.53	4.96	0.49	4.04e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1790761	0.667	rs658768	chr11:67337808	G/A	cg00290607	chr11:67383545	NA	0.51	5.38	0.52	7.43e-7	Mean corpuscular volume;
SKCM	cis	rs17685	0.753	rs8200	chr7:75696606	C/G	cg16684958	chr7:75615977	POR	-0.57	-5.6	-0.54	3.07e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2836974	0.644	rs11088472	chr21:40699376	A/C	cg11644478	chr21:40555479	PSMG1	-0.67	-5.63	-0.54	2.71e-7	Cognitive function;
SKCM	cis	rs995000	0.965	rs4587594	chr1:63133930	G/A	cg06896770	chr1:63153194	DOCK7	0.94	8.99	0.71	1.12e-13	Triglyceride levels;
SKCM	cis	rs3091242	0.933	rs61775167	chr1:25780893	A/G	cg02931644	chr1:25747376	RHCE	-0.5	-4.9	-0.48	5.17e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs4919087	0.748	rs1687369	chr10:98976923	G/A	cg25902810	chr10:99078978	FRAT1	-0.65	-4.83	-0.48	6.69e-6	Monocyte count;
SKCM	cis	rs17784882	0.524	rs7433300	chr3:47120640	G/A	cg27129171	chr3:47204927	SETD2	0.75	5.45	0.53	5.61e-7	QT interval;
SKCM	trans	rs8170	0.603	rs4808621	chr19:17414267	C/T	cg07395094	chr5:139554569	C5orf32	-0.88	-7.29	-0.64	2.16e-10	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Ovarian cancer;Breast cancer;Epithelial ovarian cancer;
SKCM	cis	rs748404	0.578	rs2278856	chr15:43631356	G/A	cg02155558	chr15:43621948	ADAL;LCMT2	0.82	6.68	0.6	3.24e-9	Lung cancer;
SKCM	cis	rs36093844	0.651	rs55978615	chr11:85546391	C/T	cg25872744	chr11:85566296	CCDC83	-0.85	-4.77	-0.48	8.27e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs1799949	0.930	rs2298861	chr17:41176831	G/A	cg23758822	chr17:41437982	NA	0.92	7.49	0.65	9.02e-11	Menopause (age at onset);
SKCM	cis	rs875971	0.520	rs12666485	chr7:65625122	T/C	cg18876405	chr7:65276391	NA	0.64	5.29	0.51	1.09e-6	Aortic root size;
SKCM	cis	rs11098499	0.909	rs6842762	chr4:120398236	A/T	cg09307838	chr4:120376055	NA	0.97	7.65	0.65	4.54e-11	Corneal astigmatism;
SKCM	cis	rs1348850	0.526	rs78587445	chr2:178461339	G/T	cg27490568	chr2:178487706	NA	-0.92	-6.22	-0.58	2.29e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs9543976	1.000	rs1535724	chr13:76183273	G/C	cg01531495	chr13:76123901	UCHL3	0.9	4.99	0.49	3.52e-6	Diabetic retinopathy;
SKCM	cis	rs13118159	0.573	rs7657357	chr4:1372939	C/T	cg02018176	chr4:1364513	KIAA1530	0.73	5.62	0.54	2.85e-7	Longevity;
SKCM	cis	rs17376456	1.000	rs9968691	chr5:93509756	C/G	cg25358565	chr5:93447407	FAM172A	1.23	8.18	0.68	4.19e-12	Diabetic retinopathy;
SKCM	cis	rs1799949	0.602	rs8176257	chr17:41216205	G/T	cg25918947	chr17:41365094	TMEM106A	-0.56	-5.0	-0.49	3.4e-6	Menopause (age at onset);
SKCM	cis	rs4665809	0.549	rs17527979	chr2:26428132	A/G	cg26119090	chr2:26468346	HADHA;HADHB	-0.96	-7.12	-0.63	4.62e-10	Gut microbiome composition (summer);
SKCM	cis	rs3768617	0.510	rs10911247	chr1:183076993	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs4132509	0.744	rs320305	chr1:243859909	G/T	cg21452805	chr1:244014465	NA	0.94	5.23	0.51	1.38e-6	RR interval (heart rate);
SKCM	cis	rs28595532	0.920	rs114789346	chr4:119748652	G/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs9902453	0.904	rs8071742	chr17:28361669	A/C	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.81	-5.78	-0.55	1.45e-7	Coffee consumption (cups per day);
SKCM	cis	rs1401999	0.714	rs7646621	chr3:183640865	A/C	cg01324343	chr3:183735012	ABCC5	-0.63	-5.78	-0.55	1.44e-7	Anterior chamber depth;
SKCM	cis	rs116095464	0.558	rs10067021	chr5:221490	C/T	cg22496380	chr5:211416	CCDC127	-0.96	-5.27	-0.51	1.18e-6	Breast cancer;
SKCM	cis	rs16854884	0.660	rs990320	chr3:143796305	T/C	cg06585982	chr3:143692056	C3orf58	0.63	5.11	0.5	2.24e-6	Economic and political preferences (feminism/equality);
SKCM	cis	rs9815354	0.812	rs17280952	chr3:41810834	T/C	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs1538970	0.924	rs12037201	chr1:45941349	G/T	cg05343316	chr1:45956843	TESK2	0.96	4.92	0.49	4.72e-6	Platelet count;
SKCM	cis	rs798554	0.679	rs2527681	chr7:2892384	A/T	cg04166393	chr7:2884313	GNA12	0.81	5.46	0.53	5.41e-7	Height;
SKCM	cis	rs10479542	0.784	rs7702303	chr5:178986436	G/A	cg09060608	chr5:178986726	RUFY1	0.49	4.95	0.49	4.21e-6	Lung cancer;
SKCM	cis	rs7809950	1.000	rs2293658	chr7:107270567	C/T	cg23024343	chr7:107201750	COG5	-0.86	-8.01	-0.67	8.94e-12	Coronary artery disease;
SKCM	cis	rs826838	1.000	rs10875991	chr12:39108886	G/C	cg26384229	chr12:38710491	ALG10B	0.97	8.59	0.7	6.84e-13	Heart rate;
SKCM	cis	rs11718455	0.960	rs4682713	chr3:44013191	G/C	cg21419209	chr3:44054225	NA	-0.66	-5.22	-0.51	1.46e-6	Coronary artery disease;
SKCM	cis	rs28386778	1.000	rs2665849	chr17:61953670	T/C	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.32	0.52	9.5e-7	Prudent dietary pattern;
SKCM	cis	rs7666738	0.716	rs13108535	chr4:99046324	A/G	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2180341	1.000	rs7453272	chr6:127633959	C/T	cg27446573	chr6:127587934	RNF146	-0.97	-8.47	-0.69	1.13e-12	Breast cancer;
SKCM	cis	rs6952808	0.600	rs2895202	chr7:2131829	T/C	cg21782813	chr7:2030301	MAD1L1	0.52	5.49	0.53	4.82e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs4820539	1.000	rs3827316	chr22:23468538	T/C	cg14186256	chr22:23484241	RTDR1	0.85	8.17	0.68	4.37e-12	Bone mineral density;
SKCM	cis	rs2075371	1.000	rs1421486	chr7:133985196	T/C	cg20476274	chr7:133979776	SLC35B4	1.01	10.44	0.76	1.77e-16	Mean platelet volume;
SKCM	cis	rs2204008	0.522	rs117743143	chr12:38030824	C/T	cg13010199	chr12:38710504	ALG10B	0.62	4.84	0.48	6.53e-6	Bladder cancer;
SKCM	cis	rs7917772	0.503	rs11191326	chr10:104302959	C/T	cg11453585	chr10:104263688	ACTR1A;SUFU	0.78	6.33	0.58	1.47e-8	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs7584330	0.740	rs13426236	chr2:238447940	A/G	cg14458575	chr2:238380390	NA	0.78	4.82	0.48	7.03e-6	Prostate cancer;
SKCM	cis	rs35306767	0.807	rs12768348	chr10:899224	T/G	cg20503657	chr10:835505	NA	0.78	5.53	0.53	4.14e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs780096	0.526	rs780106	chr2:27681598	A/C	cg05696406	chr2:27599888	SNX17	0.51	5.22	0.51	1.46e-6	Total body bone mineral density;
SKCM	cis	rs6951245	1.000	rs80094748	chr7:1103958	G/A	cg18402987	chr7:1209562	NA	1.17	6.18	0.57	2.73e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs35306767	0.903	rs12244253	chr10:889320	G/T	cg25614935	chr10:1084866	C10orf110	0.82	5.39	0.52	7.4e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs72615157	0.634	rs7789890	chr7:99800559	G/T	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.04	6.47	0.59	7.78e-9	Lung function (FEV1/FVC);
SKCM	cis	rs9790314	1.000	rs336567	chr3:161073046	A/G	cg03342759	chr3:160939853	NMD3	-0.72	-7.89	-0.67	1.53e-11	Morning vs. evening chronotype;
SKCM	cis	rs597539	0.652	rs579136	chr11:68637476	C/G	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.84	5.61	0.54	3e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs7666738	0.830	rs6854594	chr4:99065312	A/T	cg05340658	chr4:99064831	C4orf37	0.66	4.87	0.48	5.74e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7020830	0.830	rs13296413	chr9:37258105	C/T	cg14294708	chr9:37120828	ZCCHC7	0.99	9.35	0.73	2.31e-14	Schizophrenia;
SKCM	cis	rs2404602	0.716	rs1946650	chr15:76848463	T/C	cg23625390	chr15:77176239	SCAPER	0.59	5.38	0.52	7.54e-7	Blood metabolite levels;
SKCM	cis	rs6089829	0.692	rs6122349	chr20:61664096	T/C	cg08564027	chr20:61660810	NA	0.58	4.81	0.48	7.33e-6	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs55962025	0.846	rs363066	chr4:3135953	G/T	cg05297308	chr4:3317976	RGS12	0.73	5.31	0.52	1.02e-6	Parental longevity (mother's age at death);
SKCM	cis	rs3768617	0.510	rs3768620	chr1:183092237	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs1580019	0.587	rs6951955	chr7:32548761	A/T	cg06627557	chr7:32535165	LSM5;AVL9	0.95	9.08	0.72	7.65e-14	Cognitive ability;
SKCM	cis	rs9926296	0.548	rs12447465	chr16:89829895	C/T	cg04287289	chr16:89883240	FANCA	1.03	12.35	0.81	4.89e-20	Vitiligo;
SKCM	cis	rs2739330	0.789	rs5760109	chr22:24252938	C/G	cg12419862	chr22:24373484	LOC391322	-0.64	-5.56	-0.53	3.66e-7	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs2204008	0.567	rs2703685	chr12:38081423	G/C	cg26384229	chr12:38710491	ALG10B	0.7	5.73	0.54	1.84e-7	Bladder cancer;
SKCM	cis	rs11098499	0.863	rs2306456	chr4:120472422	C/G	cg09307838	chr4:120376055	NA	1.0	8.27	0.68	2.8e-12	Corneal astigmatism;
SKCM	cis	rs561341	1.000	rs4795667	chr17:30244443	T/C	cg12193833	chr17:30244370	NA	-0.47	-4.79	-0.48	7.65e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs6565180	0.888	rs12447833	chr16:30390314	T/C	cg17640201	chr16:30407289	ZNF48	0.91	6.82	0.61	1.72e-9	Tonsillectomy;
SKCM	cis	rs6450176	1.000	rs1445887	chr5:53299376	A/T	ch.5.1024479R	chr5:53302184	ARL15	-0.71	-4.88	-0.48	5.49e-6	HDL cholesterol levels;HDL cholesterol;Adiponectin levels;
SKCM	cis	rs951366	0.789	rs864783	chr1:205711974	T/C	cg14159672	chr1:205819179	PM20D1	0.95	7.66	0.66	4.22e-11	Menarche (age at onset);
SKCM	cis	rs8017423	0.967	rs55962513	chr14:90729460	C/G	cg04374321	chr14:90722782	PSMC1	1.0	9.0	0.71	1.09e-13	Mortality in heart failure;
SKCM	cis	rs3741151	1.000	rs112840535	chr11:73066771	G/A	cg17517138	chr11:73019481	ARHGEF17	1.27	4.87	0.48	5.81e-6	GIP levels in response to oral glucose tolerance test (120 minutes);
SKCM	cis	rs1577917	0.958	rs13213899	chr6:86473140	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.67	-5.74	-0.54	1.73e-7	Response to antipsychotic treatment;
SKCM	cis	rs793571	0.590	rs474875	chr15:59086703	A/C	cg05156742	chr15:59063176	FAM63B	0.71	5.22	0.51	1.44e-6	Schizophrenia;
SKCM	cis	rs732765	0.689	rs10139925	chr14:75123076	C/T	cg25946216	chr14:74253857	C14orf43	-0.91	-5.84	-0.55	1.13e-7	Non-small cell lung cancer;
SKCM	cis	rs9467773	0.596	rs2451750	chr6:26646579	A/T	cg09904177	chr6:26538194	HMGN4	0.58	5.01	0.49	3.28e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs6952808	0.717	rs12534679	chr7:1926745	G/A	cg02951883	chr7:2050386	MAD1L1	-0.75	-6.49	-0.59	7.22e-9	Bipolar disorder and schizophrenia;
SKCM	cis	rs35306767	0.622	rs66462130	chr10:1022108	C/T	cg26597838	chr10:835615	NA	0.76	6.22	0.58	2.29e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs9581857	0.546	rs9581837	chr13:27965764	G/T	cg22138327	chr13:27999177	GTF3A	0.93	5.39	0.52	7.18e-7	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs2153535	0.580	rs4140586	chr6:8503192	A/G	cg07606381	chr6:8435919	SLC35B3	0.86	6.25	0.58	2.06e-8	Motion sickness;
SKCM	cis	rs875971	0.895	rs10755833	chr7:65913917	A/G	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs6598955	0.724	rs7526545	chr1:26569990	C/A	cg00938395	chr1:26633206	UBXN11	0.7	4.95	0.49	4.18e-6	Obesity-related traits;
SKCM	cis	rs703842	1.000	rs11172335	chr12:58175201	C/T	cg04478727	chr12:58166393	METTL1;FAM119B	0.73	5.84	0.55	1.15e-7	Multiple sclerosis;
SKCM	cis	rs1153858	1.000	rs12591058	chr15:45640172	T/C	cg21132104	chr15:45694354	SPATA5L1	0.89	7.61	0.65	5.27e-11	Homoarginine levels;
SKCM	cis	rs1790761	0.520	rs4930461	chr11:67394895	A/G	cg00864171	chr11:67383662	NA	0.62	5.18	0.51	1.66e-6	Mean corpuscular volume;
SKCM	cis	rs951366	0.789	rs823095	chr1:205679239	G/A	cg26354017	chr1:205819088	PM20D1	0.89	7.4	0.64	1.33e-10	Menarche (age at onset);
SKCM	cis	rs9910055	0.821	rs4473241	chr17:42281282	G/T	cg09913183	chr17:42254507	C17orf65;ASB16	0.67	6.11	0.57	3.65e-8	Total body bone mineral density;
SKCM	cis	rs514406	0.861	rs7513052	chr1:53241360	C/T	cg24675658	chr1:53192096	ZYG11B	0.61	4.78	0.48	8e-6	Monocyte count;
SKCM	cis	rs6840360	0.615	rs12641441	chr4:152607623	A/G	cg22705602	chr4:152727874	NA	-0.57	-7.52	-0.65	8.09e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs7615952	0.611	rs79405914	chr3:125723623	C/T	cg05084668	chr3:125655381	ALG1L	-1.29	-6.33	-0.58	1.42e-8	Blood pressure (smoking interaction);
SKCM	cis	rs13020137	1	rs13020137	chr2:130757304	A/G	cg01750780	chr2:131451266	NA	0.56	4.84	0.48	6.36e-6	Schizophrenia;
SKCM	cis	rs79839061	0.610	rs11732965	chr4:869359	C/A	cg07828340	chr4:882639	GAK	1.06	5.32	0.52	9.74e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs933688	1.000	rs10073935	chr5:90742188	A/G	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.01	8.43	0.69	1.41e-12	Smoking behavior;
SKCM	cis	rs9399135	0.967	rs4896119	chr6:135293391	C/T	cg24558204	chr6:135376177	HBS1L	0.56	5.07	0.5	2.64e-6	Red blood cell count;
SKCM	cis	rs6840360	0.615	rs72728173	chr4:152469373	C/T	cg22705602	chr4:152727874	NA	-0.51	-5.78	-0.55	1.45e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs6500395	0.962	rs55782524	chr16:48557493	A/G	cg04672837	chr16:48644449	N4BP1	0.66	5.45	0.53	5.72e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs8060686	0.641	rs11075665	chr16:68070774	C/T	cg09117114	chr16:67998030	SLC12A4	-0.78	-5.06	-0.5	2.72e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs7666738	0.830	rs10028692	chr4:98962585	C/T	cg05340658	chr4:99064831	C4orf37	0.64	4.91	0.49	4.97e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1475911	0.708	rs66994219	chr21:43521647	G/A	cg24372256	chr21:43528868	UMODL1;C21orf128	-0.73	-5.33	-0.52	9.25e-7	IgG glycosylation;
SKCM	cis	rs2832191	0.550	rs66484040	chr21:30511691	G/A	cg24692254	chr21:30365293	RNF160	-0.76	-6.41	-0.59	1.03e-8	Dental caries;
SKCM	cis	rs57221529	0.766	rs12522140	chr5:587261	C/A	cg10555297	chr5:473380	SLC9A3;LOC25845	1.01	5.03	0.49	3.1e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs950776	1.000	rs950776	chr15:78926018	A/G	cg06917634	chr15:78832804	PSMA4	0.78	6.18	0.57	2.78e-8	Sudden cardiac arrest;
SKCM	cis	rs2033711	0.870	rs7259841	chr19:58951123	T/C	cg00825309	chr19:58991885	ZNF446	-0.62	-4.99	-0.49	3.63e-6	Uric acid clearance;
SKCM	cis	rs7215564	0.908	rs74000899	chr17:78653542	T/C	cg16980736	chr17:78789706	RPTOR	-0.91	-4.92	-0.49	4.67e-6	Myopia (pathological);
SKCM	cis	rs478304	0.654	rs10896029	chr11:65452952	C/T	cg17480646	chr11:65405466	SIPA1	-0.67	-4.99	-0.49	3.64e-6	Acne (severe);
SKCM	cis	rs910316	0.934	rs7141705	chr14:75655352	G/C	cg11812906	chr14:75593930	NEK9	-0.74	-5.75	-0.55	1.69e-7	Height;
SKCM	cis	rs6752107	1.000	rs2241879	chr2:234183468	G/A	cg07618928	chr2:234183455	ATG16L1;SCARNA5	0.56	4.77	0.48	8.37e-6	Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs752010	0.630	rs11210507	chr1:42105488	T/C	cg06885757	chr1:42089581	HIVEP3	0.51	6.04	0.56	4.83e-8	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs17345786	1.000	rs55641278	chr3:101290577	G/A	cg11279151	chr3:101281821	RG9MTD1	-0.63	-4.87	-0.48	5.81e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs898097	0.801	rs68141193	chr17:80878816	C/T	cg15369054	chr17:80825471	TBCD	0.68	6.39	0.59	1.12e-8	Breast cancer;
SKCM	cis	rs7811142	0.775	rs6946768	chr7:99954393	G/A	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.07	6.7	0.6	2.88e-9	Platelet count;
SKCM	cis	rs2836974	0.568	rs419469	chr21:40537234	C/T	cg17971929	chr21:40555470	PSMG1	0.77	7.35	0.64	1.69e-10	Cognitive function;
SKCM	cis	rs4555082	0.834	rs2735817	chr14:105717796	A/G	cg13114125	chr14:105738426	BRF1	0.71	5.77	0.55	1.54e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs344364	0.511	rs2982433	chr16:1954508	A/G	cg26897989	chr16:1907736	C16orf73	-0.72	-7.11	-0.63	4.82e-10	Glomerular filtration rate in chronic kidney disease;
SKCM	cis	rs13118159	0.573	rs7664763	chr4:1352305	A/G	cg20887711	chr4:1340912	KIAA1530	0.99	7.59	0.65	5.92e-11	Longevity;
SKCM	cis	rs1577917	0.666	rs6454471	chr6:86214456	T/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.97	10.74	0.77	4.95e-17	Response to antipsychotic treatment;
SKCM	cis	rs501916	0.743	rs3743281	chr15:48056958	C/T	cg16110827	chr15:48056943	SEMA6D	-0.64	-4.99	-0.49	3.59e-6	Inflammatory bowel disease;Ulcerative colitis;
SKCM	cis	rs936229	0.690	rs2472299	chr15:75033400	C/T	cg14664628	chr15:75095509	CSK	1.02	8.61	0.7	6.17e-13	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin);
SKCM	cis	rs523522	0.673	rs643372	chr12:121022640	C/G	cg12219531	chr12:120966889	COQ5	0.9	7.63	0.65	4.83e-11	High light scatter reticulocyte count;
SKCM	cis	rs10155981	0.510	rs28673155	chr7:22593935	C/T	cg05062323	chr7:22590069	NA	-1.04	-5.94	-0.56	7.37e-8	Bilirubin levels;
SKCM	cis	rs561341	0.941	rs7215147	chr17:30266711	G/A	cg23018236	chr17:30244563	NA	-0.52	-5.5	-0.53	4.62e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs12142240	0.698	rs28578741	chr1:46825176	T/C	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs6952808	0.929	rs12532128	chr7:1925454	T/C	cg02951883	chr7:2050386	MAD1L1	-0.72	-5.92	-0.56	8.26e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs611744	0.647	rs1379336	chr8:109276606	G/T	cg18478394	chr8:109455254	TTC35	0.63	5.04	0.5	2.94e-6	Dupuytren's disease;
SKCM	cis	rs1799949	0.965	rs9911630	chr17:41188342	A/G	cg25918947	chr17:41365094	TMEM106A	-0.59	-5.23	-0.51	1.41e-6	Menopause (age at onset);
SKCM	cis	rs12477438	0.520	rs11692699	chr2:99730657	T/C	cg14399236	chr2:99771627	LIPT1;TSGA10	0.95	8.78	0.71	2.89e-13	Chronic sinus infection;
SKCM	cis	rs7666738	0.791	rs1830231	chr4:99026185	A/C	cg05340658	chr4:99064831	C4orf37	0.66	5.07	0.5	2.6e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7666738	0.830	rs11097608	chr4:99011693	T/C	cg17366294	chr4:99064904	C4orf37	0.6	4.99	0.49	3.61e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7843479	0.965	rs11135742	chr8:21802910	A/T	cg17168535	chr8:21777572	XPO7	0.72	5.56	0.53	3.59e-7	Mean corpuscular volume;
SKCM	cis	rs3087591	0.960	rs2905883	chr17:29550141	G/A	cg24425628	chr17:29625626	OMG;NF1	0.64	5.22	0.51	1.43e-6	Hip circumference;
SKCM	cis	rs4819052	0.851	rs4819038	chr21:46659393	C/T	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.36	0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	trans	rs8073060	0.586	rs4796101	chr17:33998593	C/T	cg19694781	chr19:47549865	TMEM160	-1.04	-8.28	-0.68	2.65e-12	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs7666738	0.830	rs13134216	chr4:98919765	C/T	cg05340658	chr4:99064831	C4orf37	0.61	4.86	0.48	5.87e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs59918340	0.764	rs4961258	chr8:142232878	A/G	cg23750338	chr8:142222470	SLC45A4	-0.63	-6.06	-0.57	4.51e-8	Immature fraction of reticulocytes;
SKCM	cis	rs1801251	0.727	rs6437071	chr2:233568793	G/A	cg08000102	chr2:233561755	GIGYF2	0.82	7.01	0.62	7.47e-10	Coronary artery disease;
SKCM	cis	rs17685	0.753	rs10251863	chr7:75790192	T/C	cg01364799	chr7:75623366	TMEM120A	-0.7	-5.84	-0.55	1.16e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs4423214	1.000	rs11600860	chr11:71164019	T/C	cg05163923	chr11:71159392	DHCR7	0.83	8.06	0.67	7.35e-12	Vitamin D levels;
SKCM	cis	rs3785574	0.962	rs2597632	chr17:61894739	A/T	cg06873352	chr17:61820015	STRADA	0.56	4.82	0.48	6.86e-6	Height;
SKCM	cis	rs2777491	0.789	rs316617	chr15:41795900	C/T	cg18705301	chr15:41695430	NDUFAF1	0.95	9.29	0.72	3e-14	Ulcerative colitis;
SKCM	cis	rs4727027	0.933	rs12540094	chr7:148847178	A/G	cg23583168	chr7:148888333	NA	0.78	6.62	0.6	4.21e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs7772486	0.790	rs2254288	chr6:146204470	G/A	cg23711669	chr6:146136114	FBXO30	0.76	7.45	0.64	1.08e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs17345786	1.000	rs7641261	chr3:101279006	C/T	cg11279151	chr3:101281821	RG9MTD1	-0.65	-5.35	-0.52	8.43e-7	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4642101	0.765	rs9872103	chr3:12827452	G/T	cg05775895	chr3:12838266	CAND2	0.62	5.45	0.53	5.72e-7	QRS complex (12-leadsum);
SKCM	cis	rs72634258	0.740	rs6665452	chr1:8172492	A/T	cg00042356	chr1:8021962	PARK7	-0.84	-5.53	-0.53	4.17e-7	Inflammatory bowel disease;
SKCM	cis	rs9399137	0.507	rs7768278	chr6:135274957	T/C	cg24558204	chr6:135376177	HBS1L	0.69	6.37	0.59	1.21e-8	Glycated hemoglobin levels;Mean corpuscular volume;Hematology traits;HbA2 levels;Mean corpuscular hemoglobin;Hemoglobin levels;F-cell distribution;Platelet count;
SKCM	cis	rs7646501	0.765	rs79752255	chr3:24052350	G/C	cg22892432	chr3:24537792	THRB	0.58	4.96	0.49	4.09e-6	Cognitive ability;Intelligence;
SKCM	cis	rs1401999	1.000	rs6805913	chr3:183662924	T/G	cg01324343	chr3:183735012	ABCC5	0.93	10.72	0.77	5.28e-17	Anterior chamber depth;
SKCM	cis	rs4891159	0.790	rs9950025	chr18:74113596	C/G	cg24786174	chr18:74118243	ZNF516	0.75	7.23	0.63	2.84e-10	Longevity;
SKCM	cis	rs870825	0.616	rs7654208	chr4:185648877	C/T	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs16854884	0.770	rs1530477	chr3:143819506	A/G	cg06585982	chr3:143692056	C3orf58	-0.65	-5.3	-0.51	1.06e-6	Economic and political preferences (feminism/equality);
SKCM	cis	rs12497850	0.864	rs4513485	chr3:49139966	G/A	cg06212747	chr3:49208901	KLHDC8B	0.75	4.97	0.49	3.91e-6	Parkinson's disease;
SKCM	cis	rs2836950	0.565	rs2836943	chr21:40592611	C/T	cg11644478	chr21:40555479	PSMG1	-0.63	-5.02	-0.49	3.14e-6	Menarche (age at onset);
SKCM	cis	rs8060686	0.641	rs59708959	chr16:68123916	A/T	cg09117114	chr16:67998030	SLC12A4	-0.81	-5.29	-0.51	1.07e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs854765	0.583	rs8070722	chr17:17813562	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.99	7.59	0.65	5.86e-11	Total body bone mineral density;
SKCM	cis	rs823143	0.570	rs823082	chr1:205786935	C/T	cg07157834	chr1:205819609	PM20D1	-0.84	-8.71	-0.7	4.03e-13	Monocyte percentage of white cells;
SKCM	cis	rs8028182	0.549	rs4886696	chr15:75664570	A/T	cg20655648	chr15:75932815	IMP3	-0.7	-4.84	-0.48	6.52e-6	Sudden cardiac arrest;
SKCM	cis	rs72717009	0.825	rs9427399	chr1:161476533	T/C	cg23840854	chr1:161414152	NA	-0.99	-5.66	-0.54	2.44e-7	Rheumatoid arthritis;
SKCM	cis	rs6952808	0.531	rs3779003	chr7:2184902	C/T	cg05863683	chr7:1912471	MAD1L1	0.6	5.51	0.53	4.47e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs1005277	0.579	rs2021649	chr10:38392122	C/T	cg25427524	chr10:38739819	LOC399744	-0.69	-6.45	-0.59	8.73e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs28374715	0.532	rs316604	chr15:41775221	C/T	cg18705301	chr15:41695430	NDUFAF1	-1.16	-12.35	-0.81	4.82e-20	Ulcerative colitis;
SKCM	cis	rs561341	1.000	rs550923	chr17:30327013	G/C	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs875971	0.660	rs7807944	chr7:66087195	C/G	cg18876405	chr7:65276391	NA	-0.82	-7.48	-0.65	9.41e-11	Aortic root size;
SKCM	cis	rs28595532	0.920	rs115294251	chr4:119772833	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs870825	0.616	rs28563856	chr4:185635581	G/A	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs6089584	0.528	rs881994	chr20:60623931	G/A	cg06108461	chr20:60628389	TAF4	-0.76	-7.13	-0.63	4.54e-10	Body mass index;
SKCM	cis	rs709400	0.567	rs11624343	chr14:103859156	T/A	cg26031613	chr14:104095156	KLC1	0.71	5.39	0.52	7.39e-7	Body mass index;
SKCM	cis	rs17685	0.712	rs10235086	chr7:75833138	G/T	cg16684958	chr7:75615977	POR	0.5	4.88	0.48	5.44e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1005277	0.579	rs2504140	chr10:38387579	T/G	cg25427524	chr10:38739819	LOC399744	-0.69	-6.45	-0.59	8.73e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs7475343	0.501	rs6601924	chr10:5247302	T/C	cg05358397	chr10:5550470	NA	-0.83	-5.13	-0.5	2.08e-6	Intelligence;
SKCM	cis	rs2050392	0.517	rs602097	chr10:30747546	C/T	cg25182066	chr10:30743637	MAP3K8	-0.71	-5.99	-0.56	6.01e-8	Inflammatory bowel disease;
SKCM	cis	rs2836974	0.932	rs13048178	chr21:40561012	G/T	cg17971929	chr21:40555470	PSMG1	0.9	8.42	0.69	1.45e-12	Cognitive function;
SKCM	cis	rs2929278	0.617	rs663214	chr15:44113782	T/G	cg02155558	chr15:43621948	ADAL;LCMT2	-0.7	-5.07	-0.5	2.66e-6	Schizophrenia;
SKCM	cis	rs1692580	0.807	rs12138597	chr1:2189477	T/C	cg21442419	chr1:2182373	SKI	-0.69	-7.27	-0.64	2.42e-10	Coronary artery disease;
SKCM	cis	rs4132509	1.000	rs10927043	chr1:243762208	C/T	cg21452805	chr1:244014465	NA	0.76	4.92	0.49	4.77e-6	RR interval (heart rate);
SKCM	cis	rs7772486	0.754	rs10872580	chr6:146140281	C/T	cg05347473	chr6:146136440	FBXO30	-0.58	-5.44	-0.52	6e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs473651	0.935	rs10170056	chr2:239339291	G/C	cg18131467	chr2:239335373	ASB1	1.09	11.83	0.8	4.46e-19	Multiple system atrophy;
SKCM	cis	rs11098499	0.780	rs10013652	chr4:120292256	A/G	cg09307838	chr4:120376055	NA	0.98	7.86	0.66	1.76e-11	Corneal astigmatism;
SKCM	cis	rs1401999	1.000	rs2313217	chr3:183635997	A/G	cg01324343	chr3:183735012	ABCC5	0.89	9.98	0.75	1.37e-15	Anterior chamber depth;
SKCM	cis	rs28595532	1.000	rs115004746	chr4:119642137	C/T	cg11846333	chr4:119757529	SEC24D	1.15	6.24	0.58	2.13e-8	Cannabis dependence symptom count;
SKCM	cis	rs2836974	0.590	rs11911822	chr21:40607843	C/T	cg11890956	chr21:40555474	PSMG1	-0.88	-9.14	-0.72	5.76e-14	Cognitive function;
SKCM	cis	rs6088580	0.634	rs6059868	chr20:33079460	A/G	cg24642439	chr20:33292090	TP53INP2	0.76	6.02	0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs9910055	0.530	rs7222349	chr17:42304644	C/T	cg09913183	chr17:42254507	C17orf65;ASB16	0.6	5.25	0.51	1.3e-6	Total body bone mineral density;
SKCM	cis	rs4237845	0.611	rs10877036	chr12:58321650	A/G	cg02175503	chr12:58329896	NA	-1.02	-10.18	-0.76	5.77e-16	Intelligence (multi-trait analysis);
SKCM	cis	rs735396	0.627	rs2264778	chr12:121450354	C/A	cg02403541	chr12:121454288	C12orf43	0.81	7.23	0.63	2.89e-10	N-glycan levels;
SKCM	cis	rs8072100	0.967	rs8078880	chr17:45676526	G/C	cg25173405	chr17:45401733	C17orf57	0.58	5.23	0.51	1.39e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs1577917	0.655	rs9359658	chr6:86305769	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.9	8.96	0.71	1.27e-13	Response to antipsychotic treatment;
SKCM	cis	rs9467773	1.000	rs6930120	chr6:26555484	A/G	cg15659132	chr6:26577336	NA	0.6	5.71	0.54	1.99e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs651907	0.557	rs7651406	chr3:101393296	C/T	cg12386194	chr3:101231763	SENP7	0.71	5.94	0.56	7.61e-8	Colorectal cancer;
SKCM	cis	rs7666738	0.830	rs62318472	chr4:98926030	G/A	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9611565	0.546	rs5758431	chr22:42109917	A/G	cg03806693	chr22:41940476	POLR3H	1.08	6.67	0.6	3.27e-9	Vitiligo;
SKCM	cis	rs2243480	1.000	rs313832	chr7:65550891	G/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs9916302	0.706	rs1877030	chr17:37740161	T/C	cg07936489	chr17:37558343	FBXL20	-1.0	-6.75	-0.61	2.3e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs763121	0.719	rs9610995	chr22:39057763	C/T	cg06022373	chr22:39101656	GTPBP1	0.74	5.21	0.51	1.5e-6	Menopause (age at onset);
SKCM	cis	rs9420	0.961	rs7936998	chr11:57639017	G/A	cg19752551	chr11:57585705	CTNND1	-0.68	-6.44	-0.59	8.81e-9	Schizophrenia;
SKCM	cis	rs654950	0.875	rs116747365	chr1:41994792	C/T	cg06885757	chr1:42089581	HIVEP3	-0.64	-7.03	-0.62	6.98e-10	Airway imaging phenotypes;
SKCM	cis	rs62064224	0.791	rs17806082	chr17:30705346	G/C	cg25809561	chr17:30822961	MYO1D	0.66	5.09	0.5	2.45e-6	Schizophrenia;
SKCM	cis	rs8177179	0.505	rs1405023	chr3:133481128	T/C	cg16414030	chr3:133502952	NA	0.65	5.24	0.51	1.34e-6	Iron status biomarkers (transferrin levels);
SKCM	cis	rs2439831	0.867	rs2255051	chr15:43846161	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.18	7.32	0.64	1.95e-10	Lung cancer in ever smokers;
SKCM	cis	rs561341	1.000	rs4795669	chr17:30244701	C/T	cg13647721	chr17:30228624	UTP6	0.77	4.81	0.48	7.1e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs7216064	1.000	rs62084213	chr17:65842016	A/G	cg12091567	chr17:66097778	LOC651250	-0.77	-5.53	-0.53	4.06e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs8017423	1.000	rs4904644	chr14:90665689	A/G	cg04374321	chr14:90722782	PSMC1	-0.97	-8.65	-0.7	5.13e-13	Mortality in heart failure;
SKCM	cis	rs427394	1.000	rs274672	chr5:6744176	G/A	cg10857441	chr5:6722123	POLS	-0.62	-6.56	-0.6	5.44e-9	Menopause (age at onset);
SKCM	cis	rs67311347	0.544	rs9864664	chr3:40336226	T/C	cg13409248	chr3:40428643	ENTPD3	0.58	5.63	0.54	2.68e-7	Renal cell carcinoma;
SKCM	cis	rs9581857	0.685	rs9319369	chr13:28042323	A/T	cg22138327	chr13:27999177	GTF3A	0.92	6.1	0.57	3.78e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs7100689	0.646	rs1953972	chr10:82145666	A/G	cg01528321	chr10:82214614	TSPAN14	0.84	7.53	0.65	7.69e-11	Post bronchodilator FEV1;
SKCM	cis	rs72634258	1.000	rs72634258	chr1:8150638	T/C	cg00042356	chr1:8021962	PARK7	1.08	7.23	0.63	2.87e-10	Inflammatory bowel disease;
SKCM	cis	rs597539	0.652	rs627731	chr11:68698663	A/C	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.82	5.41	0.52	6.82e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs11608355	0.506	rs11066471	chr12:109828039	T/C	cg19025524	chr12:109796872	NA	-0.65	-5.01	-0.49	3.36e-6	Neuroticism;
SKCM	cis	rs1949733	0.656	rs6845969	chr4:8402465	A/T	cg11789530	chr4:8429930	ACOX3	0.7	5.15	0.5	1.87e-6	Response to antineoplastic agents;
SKCM	cis	rs7523273	0.548	rs3109808	chr1:207948477	C/A	cg22525895	chr1:207977042	MIR29B2	0.8	6.94	0.62	1.01e-9	Schizophrenia;
SKCM	cis	rs2180341	0.920	rs9401951	chr6:127671632	A/C	cg27446573	chr6:127587934	RNF146	0.9	7.84	0.66	1.91e-11	Breast cancer;
SKCM	cis	rs3785574	0.924	rs2727292	chr17:61893747	A/G	cg06601766	chr17:61851465	DDX42;CCDC47	0.73	5.38	0.52	7.7300000000000005e-07	Height;
SKCM	cis	rs7666738	0.791	rs11097601	chr4:98960103	C/T	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs62103177	0.535	rs62101568	chr18:77934671	G/A	cg27393146	chr18:77495563	CTDP1	-0.78	-5.12	-0.5	2.14e-6	Opioid sensitivity;
SKCM	cis	rs6951245	0.808	rs79672483	chr7:994756	G/A	cg03188948	chr7:1209495	NA	0.97	4.95	0.49	4.26e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs1577917	0.958	rs12213431	chr6:86500956	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.64	-5.6	-0.54	3.09e-7	Response to antipsychotic treatment;
SKCM	cis	rs10791097	0.668	rs10791102	chr11:130744977	G/A	cg12179176	chr11:130786555	SNX19	0.93	8.16	0.68	4.64e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs1218582	0.710	rs9793588	chr1:154878878	C/G	cg03351412	chr1:154909251	PMVK	0.77	6.28	0.58	1.8e-8	Prostate cancer;
SKCM	cis	rs6951245	1.000	rs28528096	chr7:1070912	G/C	cg24642844	chr7:1081250	C7orf50	-0.95	-6.4	-0.59	1.06e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7666738	0.830	rs11727235	chr4:98946331	T/C	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2836974	0.602	rs2037925	chr21:40699931	C/T	cg11644478	chr21:40555479	PSMG1	-0.67	-5.63	-0.54	2.71e-7	Cognitive function;
SKCM	cis	rs11098499	0.954	rs6834796	chr4:120414693	A/C	cg09307838	chr4:120376055	NA	0.99	8.1	0.68	6.11e-12	Corneal astigmatism;
SKCM	cis	rs12986445	0.846	rs2176182	chr2:26109402	A/T	cg07291958	chr2:26785531	C2orf70	0.54	4.96	0.49	4e-6	Multiple myeloma and monoclonal gammopathy;Multiple myeloma;
SKCM	cis	rs66887589	0.967	rs2892869	chr4:120521297	T/C	cg09307838	chr4:120376055	NA	-0.65	-4.87	-0.48	5.72e-6	Diastolic blood pressure;
SKCM	cis	rs875971	0.522	rs1617484	chr7:65463095	G/A	cg18876405	chr7:65276391	NA	0.84	7.97	0.67	1.07e-11	Aortic root size;
SKCM	cis	rs2369304	0.627	rs10132791	chr14:96225049	A/C	cg09320993	chr14:95623691	DICER1;FLJ45244	-0.74	-4.89	-0.48	5.28e-6	Neutrophil count;
SKCM	cis	rs2075371	0.897	rs12667905	chr7:134000812	A/C	cg20476274	chr7:133979776	SLC35B4	1.0	9.99	0.75	1.32e-15	Mean platelet volume;
SKCM	cis	rs4481887	0.800	rs10788780	chr1:248483598	G/A	cg00666640	chr1:248458726	OR2T12	0.63	5.91	0.56	8.65e-8	Common traits (Other);
SKCM	cis	rs55823223	0.564	rs4572466	chr17:73846314	A/C	cg10935138	chr17:73851978	WBP2	1.14	7.5	0.65	8.85e-11	Psoriasis;
SKCM	cis	rs6500395	1.000	rs1872654	chr16:48671050	C/T	cg04672837	chr16:48644449	N4BP1	0.63	5.29	0.51	1.08e-6	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs2153535	0.580	rs1319169	chr6:8464456	G/A	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs798554	0.644	rs7783400	chr7:2894434	A/C	cg19346786	chr7:2764209	NA	0.54	5.41	0.52	6.81e-7	Height;
SKCM	cis	rs7772486	0.754	rs4896841	chr6:146041522	T/C	cg23711669	chr6:146136114	FBXO30	-0.88	-9.08	-0.72	7.6e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs933688	1.000	rs2059207	chr5:90731931	C/A	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.93	6.49	0.59	7.31e-9	Smoking behavior;
SKCM	cis	rs6598955	0.724	rs7547520	chr1:26592310	C/T	cg04990556	chr1:26633338	UBXN11	-0.6	-4.85	-0.48	6.28e-6	Obesity-related traits;
SKCM	cis	rs5760092	0.627	rs6519489	chr22:24261846	G/A	cg25703541	chr22:24373054	LOC391322	0.77	5.37	0.52	7.8e-7	Urinary 1,3-butadiene metabolite levels in smokers;
SKCM	cis	rs6430585	0.702	rs3213890	chr2:136552188	G/A	cg07169764	chr2:136633963	MCM6	1.32	13.34	0.83	7.99e-22	Corneal structure;
SKCM	cis	rs34779708	0.702	rs4007272	chr10:35546859	T/G	cg03585969	chr10:35415529	CREM	0.71	5.25	0.51	1.27e-6	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs116095464	0.558	rs7713524	chr5:276200	C/T	cg22857025	chr5:266934	NA	1.47	8.33	0.69	2.16e-12	Breast cancer;
SKCM	cis	rs9814567	1.000	rs1498718	chr3:134205920	A/G	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.69	-5.47	-0.53	5.15e-7	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs7829975	0.774	rs1039915	chr8:8679614	T/C	cg06636001	chr8:8085503	FLJ10661	0.78	7.27	0.64	2.38e-10	Mood instability;
SKCM	cis	rs7954584	0.635	rs11043242	chr12:122356293	G/C	cg13699009	chr12:122356056	WDR66	0.58	7.14	0.63	4.34e-10	Mean corpuscular volume;
SKCM	cis	rs7659604	0.540	rs4240264	chr4:122683818	A/G	cg19671926	chr4:122722719	EXOSC9	0.76	6.27	0.58	1.82e-8	Type 2 diabetes;
SKCM	cis	rs9910055	0.530	rs11656758	chr17:42301541	A/G	cg13607699	chr17:42295918	UBTF	0.86	7.36	0.64	1.62e-10	Total body bone mineral density;
SKCM	cis	rs56104184	0.775	rs73061694	chr19:49399978	T/C	cg19746536	chr19:49375674	PPP1R15A	1.16	5.93	0.56	7.67e-8	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs2243480	1.000	rs1796228	chr7:66033084	G/A	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs6753739	0.661	rs6736922	chr2:219903258	T/G	cg09297636	chr2:219923910	IHH	0.47	4.87	0.48	5.78e-6	Height;
SKCM	cis	rs11098499	0.754	rs12513083	chr4:120249612	A/T	cg09307838	chr4:120376055	NA	0.91	7.36	0.64	1.63e-10	Corneal astigmatism;
SKCM	cis	rs12586317	0.547	rs112138868	chr14:35444385	C/T	cg16230307	chr14:35515116	FAM177A1	0.75	5.06	0.5	2.72e-6	Psoriasis;
SKCM	trans	rs1814175	0.645	rs1851853	chr11:49953434	C/T	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs854765	0.693	rs12936037	chr17:17777245	A/G	cg04398451	chr17:18023971	MYO15A	0.83	6.49	0.59	7.17e-9	Total body bone mineral density;
SKCM	cis	rs12048904	0.505	rs4517368	chr1:101255052	C/T	cg16556008	chr1:101360663	SLC30A7;EXTL2	-0.81	-5.99	-0.56	6.19e-8	Multiple sclerosis;
SKCM	cis	rs7772486	0.875	rs2224121	chr6:146343214	G/A	cg05347473	chr6:146136440	FBXO30	0.57	5.06	0.5	2.68e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs778371	0.874	rs1083522	chr2:233745521	C/T	cg08000102	chr2:233561755	GIGYF2	-0.84	-6.11	-0.57	3.7e-8	Schizophrenia;
SKCM	cis	rs3087591	1.000	rs2905795	chr17:29547601	A/G	cg24425628	chr17:29625626	OMG;NF1	0.64	5.22	0.51	1.43e-6	Hip circumference;
SKCM	cis	rs11105298	0.891	rs10858894	chr12:89914261	T/C	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.91	-5.65	-0.54	2.56e-7	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs6951245	0.938	rs78351779	chr7:1097023	G/C	cg24642844	chr7:1081250	C7orf50	-0.93	-6.22	-0.58	2.28e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs28386778	0.933	rs2665801	chr17:61952100	C/T	cg01411255	chr17:61851458	DDX42;CCDC47	0.76	4.89	0.48	5.22e-6	Prudent dietary pattern;
SKCM	cis	rs12780845	1.000	rs7082376	chr10:17232223	C/T	cg07990022	chr10:16570110	NA	-0.61	-4.82	-0.48	6.82e-6	Homocysteine levels;
SKCM	cis	rs116095464	0.614	rs56299325	chr5:220594	C/T	cg22857025	chr5:266934	NA	-1.36	-8.0	-0.67	9.23e-12	Breast cancer;
SKCM	cis	rs1577917	0.796	rs12661231	chr6:86544471	T/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.69	-6.15	-0.57	3.1e-8	Response to antipsychotic treatment;
SKCM	cis	rs1348850	0.526	rs2141157	chr2:178374112	C/T	cg27490568	chr2:178487706	NA	0.9	6.86	0.61	1.42e-9	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs17376456	0.825	rs1470150	chr5:93138654	C/T	cg21475434	chr5:93447410	FAM172A	-0.84	-4.87	-0.48	5.76e-6	Diabetic retinopathy;
SKCM	cis	rs1799949	1.000	rs2037075	chr17:41305826	G/T	cg05368731	chr17:41323189	NBR1	0.87	7.99	0.67	9.64e-12	Menopause (age at onset);
SKCM	cis	rs28595532	0.546	rs36058627	chr4:119233201	G/T	cg14228332	chr4:119757509	SEC24D	0.99	5.58	0.53	3.31e-7	Cannabis dependence symptom count;
SKCM	cis	rs6570726	0.764	rs376257	chr6:145862949	G/A	cg05347473	chr6:146136440	FBXO30	0.55	4.97	0.49	3.81e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4924935	1.000	rs6502674	chr17:18776897	A/G	cg26378065	chr17:18585709	ZNF286B	0.77	5.58	0.53	3.37e-7	Pancreatic cancer;
SKCM	cis	rs2239547	0.657	rs7620706	chr3:52891756	A/T	cg11645453	chr3:52864694	ITIH4	0.79	7.19	0.63	3.41e-10	Schizophrenia;
SKCM	cis	rs12497850	0.931	rs7636057	chr3:48992582	C/T	cg07636037	chr3:49044803	WDR6	1.02	11.0	0.78	1.56e-17	Parkinson's disease;
SKCM	cis	rs875971	0.619	rs2302918	chr7:66000932	A/G	cg11764359	chr7:65958608	NA	0.86	6.57	0.6	5.13e-9	Aortic root size;
SKCM	cis	rs10504229	0.683	rs72649187	chr8:58108320	A/G	cg02725872	chr8:58115012	NA	-0.53	-4.91	-0.49	4.82e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs10256972	0.758	rs11979275	chr7:1069335	A/T	cg07308232	chr7:1071921	C7orf50	-0.62	-5.28	-0.51	1.15e-6	Longevity;Endometriosis;
SKCM	cis	rs12709013	0.590	rs982848	chr16:58738198	A/G	cg02431531	chr16:59244939	NA	0.49	5.0	0.49	3.39e-6	Blood metabolite ratios;
SKCM	cis	rs6547741	0.743	rs7564625	chr2:27862397	C/T	cg27432699	chr2:27873401	GPN1	-0.84	-7.21	-0.63	3.15e-10	Oral cavity cancer;
SKCM	cis	rs9611565	0.659	rs4822036	chr22:41936019	A/G	cg03806693	chr22:41940476	POLR3H	-1.11	-7.56	-0.65	6.67e-11	Vitiligo;
SKCM	cis	rs2439831	0.850	rs7183809	chr15:44120868	T/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.36	7.78	0.66	2.56e-11	Lung cancer in ever smokers;
SKCM	cis	rs7937682	0.575	rs11604704	chr11:111764396	G/A	cg09085632	chr11:111637200	PPP2R1B	1.09	10.45	0.76	1.7e-16	Primary sclerosing cholangitis;
SKCM	cis	rs4819052	0.851	rs10470246	chr21:46659017	C/G	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.35	0.64	1.68e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs1577917	1.000	rs12665321	chr6:86769289	C/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.64	-5.49	-0.53	4.77e-7	Response to antipsychotic treatment;
SKCM	cis	rs11103631	0.823	rs4841952	chr9:137904004	G/T	cg00948900	chr9:137997205	OLFM1	0.5	4.96	0.49	4.1e-6	Trans-epidermal water loss;
SKCM	cis	rs668210	0.793	rs522553	chr11:65771669	T/C	cg20909159	chr11:65625947	CFL1	-0.69	-4.79	-0.48	7.93e-6	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs798554	0.959	rs798557	chr7:2758982	G/A	cg19346786	chr7:2764209	NA	-0.67	-6.94	-0.62	1.01e-9	Height;
SKCM	cis	rs4665809	0.941	rs41285975	chr2:26351144	T/C	cg26119090	chr2:26468346	HADHA;HADHB	-0.76	-4.79	-0.48	7.86e-6	Gut microbiome composition (summer);
SKCM	cis	rs1577917	0.959	rs12201739	chr6:86720739	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.63	-5.4	-0.52	7.05e-7	Response to antipsychotic treatment;
SKCM	cis	rs6430585	0.528	rs79826902	chr2:136670419	G/A	cg07169764	chr2:136633963	MCM6	1.32	11.41	0.79	2.72e-18	Corneal structure;
SKCM	cis	rs4790333	0.715	rs2447110	chr17:2261677	A/G	cg02569219	chr17:2266849	SGSM2	0.68	6.1	0.57	3.82e-8	Proinsulin levels;
SKCM	cis	rs11122272	0.701	rs2486725	chr1:231540288	G/C	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	-0.64	-5.18	-0.51	1.66e-6	Hemoglobin concentration;
SKCM	cis	rs7772486	0.764	rs2265471	chr6:146220250	G/A	cg05347473	chr6:146136440	FBXO30	0.56	5.18	0.51	1.67e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs13010713	0.840	rs4666717	chr2:182062284	A/G	cg21995919	chr2:182322279	ITGA4	-0.53	-5.11	-0.5	2.2e-6	Celiac disease;
SKCM	cis	rs11098499	0.955	rs35197422	chr4:120169314	T/G	cg09307838	chr4:120376055	NA	0.94	7.67	0.66	4.16e-11	Corneal astigmatism;
SKCM	cis	rs854765	0.583	rs4077198	chr17:17834563	T/C	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.0	7.64	0.65	4.64e-11	Total body bone mineral density;
SKCM	cis	rs589448	0.967	rs634512	chr12:69754012	C/T	cg14784868	chr12:69753453	YEATS4	0.84	7.65	0.65	4.54e-11	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs651907	0.535	rs13094911	chr3:101519021	T/C	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.78	6.72	0.61	2.65e-9	Colorectal cancer;
SKCM	cis	rs2739330	0.828	rs5760099	chr22:24248414	G/A	cg04234412	chr22:24373322	LOC391322	-0.64	-5.14	-0.5	1.97e-6	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs950776	0.518	rs55690619	chr15:78833612	A/G	cg06917634	chr15:78832804	PSMA4	-1.01	-10.47	-0.76	1.56e-16	Sudden cardiac arrest;
SKCM	cis	rs9902453	0.933	rs7216487	chr17:28502642	C/A	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.5	0.53	4.74e-7	Coffee consumption (cups per day);
SKCM	cis	rs35306767	0.903	rs11815185	chr10:923617	T/A	cg20503657	chr10:835505	NA	0.75	5.36	0.52	8.31e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs12464559	0.522	rs4414677	chr2:152624932	A/C	cg01189475	chr2:152685088	ARL5A	-1.01	-5.25	-0.51	1.3e-6	Response to cognitive-behavioural therapy in anxiety disorder;
SKCM	cis	rs2204008	0.837	rs11169157	chr12:37980047	T/C	cg26384229	chr12:38710491	ALG10B	0.78	6.42	0.59	9.98e-9	Bladder cancer;
SKCM	cis	rs4954585	0.708	rs13034241	chr2:137021263	G/A	cg05194412	chr2:137003533	NA	0.57	5.1	0.5	2.31e-6	Colorectal cancer;
SKCM	cis	rs3784262	0.669	rs12909423	chr15:58292433	C/G	cg12031962	chr15:58353849	ALDH1A2	0.42	5.01	0.49	3.26e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs7666738	0.753	rs2903143	chr4:99040480	C/T	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs208520	0.955	rs17644076	chr6:67004973	A/G	cg07460842	chr6:66804631	NA	-0.91	-6.4	-0.59	1.08e-8	Exhaled nitric oxide output;
SKCM	cis	rs2153535	0.580	rs9379213	chr6:8474945	G/A	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs1160297	0.601	rs1828337	chr2:53096942	G/T	cg07782112	chr2:53107842	NA	0.57	5.96	0.56	6.84e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs875971	1.000	rs697970	chr7:65560052	G/C	cg18876405	chr7:65276391	NA	-0.71	-7.04	-0.62	6.64e-10	Aortic root size;
SKCM	trans	rs1814175	0.765	rs11493326	chr11:50018063	T/C	cg03929089	chr4:120376271	NA	-0.94	-8.71	-0.7	3.92e-13	Height;
SKCM	cis	rs17685	0.849	rs3815455	chr7:75611756	C/T	cg16489192	chr7:75678113	MDH2;STYXL1	-0.67	-6.1	-0.57	3.81e-8	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs3812762	0.912	rs4929936	chr11:8792622	C/T	cg21881798	chr11:8931708	C11orf17;ST5	-0.55	-5.06	-0.5	2.7e-6	Hypospadias;
SKCM	cis	rs344364	0.511	rs1742395	chr16:1955965	G/A	cg26897989	chr16:1907736	C16orf73	-0.72	-7.11	-0.63	4.82e-10	Glomerular filtration rate in chronic kidney disease;
SKCM	cis	rs372883	0.638	rs117213	chr21:30720536	G/A	cg24692254	chr21:30365293	RNF160	-0.64	-5.1	-0.5	2.29e-6	Pancreatic cancer;
SKCM	cis	rs6087990	1.000	rs2018002	chr20:31351623	A/T	cg13636640	chr20:31349939	DNMT3B	0.98	9.42	0.73	1.68e-14	Ulcerative colitis;
SKCM	cis	rs637571	0.522	rs28578718	chr11:65748400	C/A	cg02427764	chr11:65769310	BANF1;EIF1AD	0.77	5.89	0.55	9.2e-8	Eosinophil percentage of white cells;
SKCM	cis	rs898097	0.690	rs3785520	chr17:80895745	T/C	cg15369054	chr17:80825471	TBCD	-0.58	-5.1	-0.5	2.28e-6	Breast cancer;
SKCM	cis	rs7119	0.700	rs4886519	chr15:77893885	A/G	cg27398640	chr15:77910606	LINGO1	0.52	5.17	0.51	1.78e-6	Type 2 diabetes;
SKCM	cis	rs7923452	0.507	rs215494	chr10:30776589	T/G	cg25182066	chr10:30743637	MAP3K8	-0.62	-5.32	-0.52	9.64e-7	Itch intensity from mosquito bite;
SKCM	cis	rs2235573	0.594	rs4821730	chr22:38441587	A/G	cg03683946	chr22:38051826	SH3BP1	-0.48	-4.89	-0.48	5.27e-6	Glioblastoma;Glioma;
SKCM	cis	rs55962025	0.662	rs362309	chr4:3240915	G/C	cg00764545	chr4:3318001	RGS12	-0.64	-5.56	-0.53	3.63e-7	Parental longevity (mother's age at death);
SKCM	cis	rs7208859	0.673	rs9899525	chr17:29120296	T/A	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs55962025	0.711	rs363063	chr4:3141488	G/A	cg00764545	chr4:3318001	RGS12	-0.63	-5.56	-0.53	3.57e-7	Parental longevity (mother's age at death);
SKCM	cis	rs2204008	0.701	rs3898237	chr12:38219714	A/G	cg26384229	chr12:38710491	ALG10B	0.82	6.58	0.6	4.87e-9	Bladder cancer;
SKCM	cis	rs9790314	0.846	rs12495310	chr3:160970956	T/A	cg03342759	chr3:160939853	NMD3	-0.72	-8.12	-0.68	5.59e-12	Morning vs. evening chronotype;
SKCM	cis	rs2832191	0.791	rs2065270	chr21:30485420	T/C	cg24692254	chr21:30365293	RNF160	-0.9	-8.03	-0.67	8.39e-12	Dental caries;
SKCM	cis	rs72781680	0.706	rs72796108	chr2:23904990	C/A	cg08917208	chr2:24149416	ATAD2B	0.98	5.0	0.49	3.41e-6	Lymphocyte counts;
SKCM	cis	rs854765	0.583	rs950966	chr17:17783748	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	-0.99	-8.26	-0.68	2.96e-12	Total body bone mineral density;
SKCM	cis	rs12762955	0.561	rs7076107	chr10:1043647	T/C	cg20503657	chr10:835505	NA	-0.55	-4.78	-0.48	8.19e-6	Response to angiotensin II receptor blocker therapy;
SKCM	cis	rs2721195	0.683	rs6989368	chr8:145813457	A/G	cg15320075	chr8:145703422	NA	0.82	6.76	0.61	2.22e-9	Age at first birth;
SKCM	cis	rs7772486	0.790	rs7753833	chr6:146161432	C/A	cg23711669	chr6:146136114	FBXO30	0.85	9.3	0.73	2.85e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4740619	0.584	rs2794634	chr9:15899764	A/C	cg14451791	chr9:16040625	NA	0.43	5.0	0.49	3.46e-6	Body mass index;
SKCM	cis	rs1707322	0.963	rs6666763	chr1:46436451	C/A	cg03146154	chr1:46216737	IPP	0.79	5.34	0.52	8.73e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs13256369	0.755	rs12680167	chr8:8562467	A/G	cg06636001	chr8:8085503	FLJ10661	0.8	6.11	0.57	3.65e-8	Obesity-related traits;
SKCM	cis	rs11098499	0.954	rs11940028	chr4:120411907	T/C	cg09307838	chr4:120376055	NA	0.99	8.02	0.67	8.7e-12	Corneal astigmatism;
SKCM	cis	rs362296	0.671	rs3135173	chr4:3257373	T/C	cg05297308	chr4:3317976	RGS12	-0.76	-6.17	-0.57	2.88e-8	Parental longevity (mother's age at death);
SKCM	cis	rs2836974	0.965	rs7354783	chr21:40652992	G/A	cg11890956	chr21:40555474	PSMG1	1.09	13.73	0.84	1.66e-22	Cognitive function;
SKCM	cis	rs6558174	0.863	rs17746902	chr8:22491980	A/C	cg03733263	chr8:22462867	KIAA1967	-0.77	-5.38	-0.52	7.63e-7	Breast cancer;
SKCM	cis	rs1395	0.778	rs4665959	chr2:27443256	C/T	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.51	5.14	0.5	1.96e-6	Blood metabolite levels;
SKCM	cis	rs6840360	0.615	rs55932132	chr4:152463897	G/T	cg22705602	chr4:152727874	NA	-0.51	-5.78	-0.55	1.45e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs854765	0.583	rs11650649	chr17:17790319	C/A	cg24612305	chr17:17875800	TOM1L2;LRRC48	-0.96	-7.66	-0.65	4.36e-11	Total body bone mineral density;
SKCM	cis	rs12474201	0.963	rs3829835	chr2:46925789	C/T	cg06386533	chr2:46925753	SOCS5	1.02	9.28	0.72	3.15e-14	Height;
SKCM	cis	rs12478296	0.685	rs67829386	chr2:242992276	T/A	cg06360820	chr2:242988706	NA	-1.0	-6.26	-0.58	1.97e-8	Obesity-related traits;
SKCM	cis	rs4740619	0.619	rs4740631	chr9:16030126	G/C	cg14451791	chr9:16040625	NA	-0.47	-4.95	-0.49	4.24e-6	Body mass index;
SKCM	cis	rs80282103	0.618	rs74117849	chr10:1165425	A/G	cg19207066	chr10:1251074	ADARB2	-0.76	-4.94	-0.49	4.41e-6	Glomerular filtration rate (creatinine);
SKCM	cis	rs1843834	0.539	rs3912999	chr2:225390089	C/T	cg12698349	chr2:225449008	CUL3	0.82	6.79	0.61	1.94e-9	IgE levels in asthmatics (D.p. specific);
SKCM	cis	rs899997	1.000	rs4887078	chr15:79011073	C/T	cg04896959	chr15:78267971	NA	0.62	5.66	0.54	2.38e-7	Coronary artery disease or large artery stroke;
SKCM	cis	rs8072100	1.000	rs8072100	chr17:45674687	A/T	cg25173405	chr17:45401733	C17orf57	0.6	5.61	0.54	3.01e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs2952156	0.883	rs8077172	chr17:37834977	G/T	cg00129232	chr17:37814104	STARD3	-0.74	-6.39	-0.59	1.11e-8	Asthma;
SKCM	cis	rs9381040	0.655	rs7775972	chr6:41038116	A/C	cg04346459	chr6:41068666	NFYA;LOC221442	-0.72	-5.07	-0.5	2.63e-6	Alzheimer's disease (late onset);
SKCM	cis	rs2777491	1.000	rs316605	chr15:41771591	G/A	cg18705301	chr15:41695430	NDUFAF1	-0.89	-9.04	-0.72	9.17e-14	Ulcerative colitis;
SKCM	cis	rs1568889	0.938	rs6484358	chr11:28260364	A/T	cg06544937	chr11:28130018	METT5D1;KIF18A	0.86	6.78	0.61	2.05e-9	Bipolar disorder;
SKCM	cis	rs10489202	0.583	rs203777	chr1:167876616	C/T	cg24449463	chr1:168025552	DCAF6	-0.91	-7.84	-0.66	1.92e-11	Schizophrenia;
SKCM	cis	rs995000	0.931	rs11207990	chr1:63041086	T/C	cg06896770	chr1:63153194	DOCK7	-0.72	-6.62	-0.6	4.14e-9	Triglyceride levels;
SKCM	cis	rs875971	0.862	rs1983372	chr7:65611351	C/T	cg18876405	chr7:65276391	NA	-0.65	-6.63	-0.6	3.96e-9	Aortic root size;
SKCM	cis	rs4665809	0.590	rs13019536	chr2:26526978	C/A	cg26119090	chr2:26468346	HADHA;HADHB	-0.79	-5.17	-0.51	1.77e-6	Gut microbiome composition (summer);
SKCM	cis	rs1577917	1.000	rs12216328	chr6:86703418	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.83	-8.23	-0.68	3.37e-12	Response to antipsychotic treatment;
SKCM	cis	rs2739330	0.753	rs4822452	chr22:24254363	C/T	cg04234412	chr22:24373322	LOC391322	-0.59	-4.87	-0.48	5.77e-6	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs933688	0.877	rs10474352	chr5:90732225	C/T	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.1	8.39	0.69	1.66e-12	Smoking behavior;
SKCM	cis	rs116095464	0.614	rs10067482	chr5:219328	T/G	cg22496380	chr5:211416	CCDC127	-0.96	-5.27	-0.51	1.18e-6	Breast cancer;
SKCM	cis	rs2836974	0.965	rs9941894	chr21:40634058	C/T	cg17971929	chr21:40555470	PSMG1	0.92	9.15	0.72	5.48e-14	Cognitive function;
SKCM	cis	rs17685	0.753	rs1806885	chr7:75785612	T/G	cg16684958	chr7:75615977	POR	0.52	5.03	0.49	3.11e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs4481887	0.861	rs10788776	chr1:248479177	T/C	cg00666640	chr1:248458726	OR2T12	0.63	5.91	0.56	8.65e-8	Common traits (Other);
SKCM	cis	rs59918340	0.764	rs4961256	chr8:142229946	G/A	cg23750338	chr8:142222470	SLC45A4	0.62	6.07	0.57	4.35e-8	Immature fraction of reticulocytes;
SKCM	cis	rs2836974	0.568	rs4816620	chr21:40613786	A/G	cg11644478	chr21:40555479	PSMG1	-0.8	-7.6	-0.65	5.6e-11	Cognitive function;
SKCM	cis	rs79040073	0.530	rs73394357	chr15:49592511	T/C	cg25951582	chr15:49913451	C15orf33;DTWD1	-0.68	-4.97	-0.49	3.88e-6	Lung cancer in ever smokers;
SKCM	cis	rs9485372	0.891	rs9498286	chr6:149607513	G/A	cg03072286	chr6:150262044	ULBP2	-0.55	-4.89	-0.48	5.3e-6	Breast cancer;
SKCM	cis	rs72634258	0.945	rs397349	chr1:8074872	A/C	cg00042356	chr1:8021962	PARK7	0.85	6.13	0.57	3.37e-8	Inflammatory bowel disease;
SKCM	cis	rs875971	0.862	rs10274883	chr7:66116091	C/T	cg18876405	chr7:65276391	NA	-0.63	-6.32	-0.58	1.5e-8	Aortic root size;
SKCM	cis	rs6547741	0.935	rs6761095	chr2:27778010	G/T	cg27432699	chr2:27873401	GPN1	0.73	6.55	0.6	5.7e-9	Oral cavity cancer;
SKCM	cis	rs7937682	0.889	rs493865	chr11:111495178	A/C	cg19812747	chr11:111475976	SIK2	-0.56	-4.93	-0.49	4.55e-6	Primary sclerosing cholangitis;
SKCM	cis	rs9916302	0.904	rs585961	chr17:37444036	G/A	cg07936489	chr17:37558343	FBXL20	0.84	6.75	0.61	2.32e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs6952808	0.929	rs12532128	chr7:1925454	T/C	cg04267008	chr7:1944627	MAD1L1	-0.63	-4.77	-0.47	8.53e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs7666738	0.830	rs1876192	chr4:98727555	T/C	cg17366294	chr4:99064904	C4orf37	0.59	5.11	0.5	2.25e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1348850	0.526	rs6723014	chr2:178410586	G/A	cg02961200	chr2:178257176	LOC100130691;AGPS	0.92	5.16	0.5	1.82e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs1160297	0.585	rs12713227	chr2:53090018	A/G	cg07782112	chr2:53107842	NA	0.58	5.8	0.55	1.34e-7	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs1005277	0.541	rs2263163	chr10:38389887	G/A	cg25427524	chr10:38739819	LOC399744	-0.69	-6.45	-0.59	8.73e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs10504229	0.638	rs7826839	chr8:58132075	G/T	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs2836950	0.502	rs12627205	chr21:40630027	C/T	cg11644478	chr21:40555479	PSMG1	-0.64	-5.02	-0.49	3.17e-6	Menarche (age at onset);
SKCM	cis	rs11252926	0.598	rs4881256	chr10:453831	T/A	cg18196295	chr10:418757	DIP2C	0.67	5.68	0.54	2.18e-7	Psychosis in Alzheimer's disease;
SKCM	cis	rs72781680	1.000	rs72781689	chr2:24256349	C/T	cg08917208	chr2:24149416	ATAD2B	1.11	5.76	0.55	1.6e-7	Lymphocyte counts;
SKCM	cis	rs2836974	0.526	rs1888488	chr21:40686521	C/T	cg11890956	chr21:40555474	PSMG1	-0.79	-7.37	-0.64	1.57e-10	Cognitive function;
SKCM	cis	rs847649	0.842	rs7789252	chr7:102624227	C/A	cg18108683	chr7:102477205	FBXL13	-0.86	-8.53	-0.69	8.74e-13	Morning vs. evening chronotype;
SKCM	cis	rs7539542	0.556	rs4950888	chr1:202872625	C/T	cg19681188	chr1:202830198	LOC148709	0.81	5.65	0.54	2.54e-7	Mean platelet volume;
SKCM	cis	rs875971	0.825	rs59466412	chr7:65565358	A/G	cg18876405	chr7:65276391	NA	-0.66	-6.48	-0.59	7.49e-9	Aortic root size;
SKCM	cis	rs72781680	1.000	rs7581107	chr2:24173565	C/T	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	cis	rs9916302	0.904	rs7210488	chr17:37539819	T/G	cg07936489	chr17:37558343	FBXL20	0.84	7.23	0.63	2.81e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs6840360	0.571	rs62327269	chr4:152527973	G/C	cg22705602	chr4:152727874	NA	-0.52	-5.7	-0.54	2.03e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs769267	0.965	rs4808937	chr19:19398005	A/G	cg26732615	chr19:19648335	CILP2;YJEFN3	0.64	5.94	0.56	7.41e-8	Tonsillectomy;
SKCM	cis	rs12682352	0.602	rs6988939	chr8:8666916	C/T	cg15556689	chr8:8085844	FLJ10661	0.62	4.86	0.48	5.85e-6	Neuroticism;
SKCM	cis	rs3008870	1.000	rs3008870	chr1:67418027	C/T	cg08660285	chr1:67390436	MIER1;WDR78	0.92	6.05	0.57	4.69e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs899997	1.000	rs11072793	chr15:79006442	C/T	cg04896959	chr15:78267971	NA	0.64	5.87	0.55	1.02e-7	Coronary artery disease or large artery stroke;
SKCM	cis	rs67311347	0.544	rs1454492	chr3:40352884	C/T	cg02782426	chr3:40428986	ENTPD3	0.5	4.99	0.49	3.64e-6	Renal cell carcinoma;
SKCM	cis	rs867186	1.000	rs117236853	chr20:33667783	C/A	cg04194272	chr20:33683537	NA	-1.38	-7.2	-0.63	3.29e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs801193	1.000	rs11773829	chr7:66141074	G/A	cg00343986	chr7:65444356	GUSB	-0.7	-5.14	-0.5	1.98e-6	Aortic root size;
SKCM	cis	rs6570726	0.791	rs422099	chr6:145806936	C/T	cg23711669	chr6:146136114	FBXO30	0.78	7.23	0.63	2.87e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs12926788	0.640	rs73551577	chr16:24845143	G/A	cg04756594	chr16:24857601	SLC5A11	0.71	5.4	0.52	6.89e-7	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs35146811	0.735	rs2272345	chr7:99797031	C/G	cg22906224	chr7:99728672	NA	0.65	5.19	0.51	1.6e-6	Coronary artery disease;
SKCM	cis	rs1865760	0.622	rs9968910	chr6:26072095	A/C	cg17691542	chr6:26056736	HIST1H1C	0.76	5.85	0.55	1.1e-7	Height;
SKCM	cis	rs9322193	0.961	rs9767713	chr6:149909377	T/G	cg07701084	chr6:150067640	NUP43	0.65	5.26	0.51	1.23e-6	Lung cancer;
SKCM	cis	rs7772486	0.875	rs7766595	chr6:146364507	A/T	cg05347473	chr6:146136440	FBXO30	0.57	5.12	0.5	2.13e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1153858	1.000	rs1554521	chr15:45664189	A/T	cg14582100	chr15:45693742	SPATA5L1	-0.66	-5.09	-0.5	2.38e-6	Homoarginine levels;
SKCM	cis	rs12044355	0.827	rs7552519	chr1:231824147	G/A	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	0.82	6.24	0.58	2.14e-8	Alzheimer's disease;
SKCM	cis	rs2991971	0.934	rs7903	chr1:45976472	G/C	cg24296786	chr1:45957014	TESK2	0.69	5.65	0.54	2.47e-7	High light scatter reticulocyte count;
SKCM	cis	rs1707322	0.821	rs10749857	chr1:46248143	C/T	cg03146154	chr1:46216737	IPP	0.78	5.24	0.51	1.35e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs12110303	1	rs12110303	chr5:90662839	G/T	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.06	8.4	0.69	1.58e-12	Breast cancer;
SKCM	cis	rs7772486	0.790	rs10223507	chr6:146285204	C/A	cg23711669	chr6:146136114	FBXO30	-0.79	-7.52	-0.65	7.82e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7769051	1.000	rs58832890	chr6:133127139	C/T	cg22852734	chr6:133119734	C6orf192	0.95	4.82	0.48	6.89e-6	Type 2 diabetes nephropathy;
SKCM	cis	rs703842	0.616	rs10877024	chr12:58226709	C/T	cg00677455	chr12:58241039	CTDSP2	0.75	5.94	0.56	7.38e-8	Multiple sclerosis;
SKCM	cis	rs9911578	1.000	rs1631237	chr17:56734695	A/G	cg05425664	chr17:57184151	TRIM37	-0.69	-5.21	-0.51	1.52e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2991971	1.000	rs667626	chr1:46020551	T/C	cg24296786	chr1:45957014	TESK2	0.65	5.25	0.51	1.28e-6	High light scatter reticulocyte count;
SKCM	cis	rs6840360	0.571	rs12647566	chr4:152482525	C/T	cg22705602	chr4:152727874	NA	-0.5	-5.38	-0.52	7.49e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs2204008	0.715	rs12815986	chr12:38343869	G/A	cg26384229	chr12:38710491	ALG10B	0.88	7.02	0.62	7.15e-10	Bladder cancer;
SKCM	cis	rs6665290	0.935	rs1929863	chr1:227195728	C/T	cg10327440	chr1:227177885	CDC42BPA	-1.24	-17.42	-0.89	1.29e-28	Myeloid white cell count;
SKCM	cis	rs4481887	0.927	rs4390209	chr1:248472613	A/T	cg00666640	chr1:248458726	OR2T12	0.63	5.91	0.56	8.65e-8	Common traits (Other);
SKCM	cis	rs4132509	1.000	rs7534117	chr1:243964902	A/C	cg21452805	chr1:244014465	NA	-0.8	-5.52	-0.53	4.28e-7	RR interval (heart rate);
SKCM	cis	rs6088580	0.634	rs6088502	chr20:33037644	A/T	cg24642439	chr20:33292090	TP53INP2	0.75	6.02	0.56	5.32e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs7666738	0.830	rs2865951	chr4:99040191	C/T	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs12986445	0.711	rs3845681	chr2:26110057	G/A	cg07291958	chr2:26785531	C2orf70	0.53	4.9	0.49	5.04e-6	Multiple myeloma and monoclonal gammopathy;Multiple myeloma;
SKCM	cis	rs17270561	0.541	rs2009610	chr6:25967068	C/T	cg16482183	chr6:26056742	HIST1H1C	0.98	7.08	0.63	5.65e-10	Iron status biomarkers;
SKCM	cis	rs17376456	0.877	rs28637444	chr5:93495548	C/T	cg21475434	chr5:93447410	FAM172A	0.99	5.62	0.54	2.81e-7	Diabetic retinopathy;
SKCM	cis	rs748404	0.697	rs1095389	chr15:43566671	G/A	cg02155558	chr15:43621948	ADAL;LCMT2	0.7	5.68	0.54	2.19e-7	Lung cancer;
SKCM	cis	rs2811415	0.561	rs9839328	chr3:127763216	T/C	cg09089421	chr3:127803668	RUVBL1	0.99	8.52	0.69	9.09e-13	Lung function (FEV1/FVC);
SKCM	cis	rs3008870	1.000	rs1137656	chr1:67451602	A/C	cg08660285	chr1:67390436	MIER1;WDR78	-0.92	-6.07	-0.57	4.27e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs11718455	0.960	rs35711021	chr3:44004791	G/A	cg21419209	chr3:44054225	NA	-0.65	-5.32	-0.52	9.77e-7	Coronary artery disease;
SKCM	cis	rs9926296	0.529	rs7195906	chr16:89806347	A/T	cg26513180	chr16:89883248	FANCA	0.96	11.74	0.8	6.4e-19	Vitiligo;
SKCM	cis	rs17685	0.753	rs1574107	chr7:75685047	A/C	cg01364799	chr7:75623366	TMEM120A	-0.73	-5.77	-0.55	1.5e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs6424115	0.800	rs2229581	chr1:24201094	G/C	cg15997130	chr1:24165203	NA	0.6	4.94	0.49	4.37e-6	Immature fraction of reticulocytes;
SKCM	cis	rs28595532	0.920	rs114683212	chr4:119760209	A/G	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs1799949	1.000	rs16941	chr17:41244435	T/C	cg25918947	chr17:41365094	TMEM106A	-0.62	-5.98	-0.56	6.24e-8	Menopause (age at onset);
SKCM	cis	rs35306767	0.761	rs11253559	chr10:1044809	T/C	cg26597838	chr10:835615	NA	0.64	5.14	0.5	2.02e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs9303401	0.527	rs7224468	chr17:56749943	C/T	cg10487724	chr17:56770010	TEX14;RAD51C	0.83	5.82	0.55	1.22e-7	Cognitive test performance;
SKCM	cis	rs2836974	0.545	rs3167757	chr21:40714478	C/T	cg17971929	chr21:40555470	PSMG1	0.71	5.84	0.55	1.15e-7	Cognitive function;
SKCM	cis	rs763014	0.966	rs4144003	chr16:645968	C/T	cg09263875	chr16:632152	PIGQ	0.67	5.83	0.55	1.2e-7	Height;
SKCM	cis	rs7659604	0.967	rs34949254	chr4:122664344	G/A	cg19748678	chr4:122722346	EXOSC9	0.68	5.59	0.53	3.23e-7	Type 2 diabetes;
SKCM	cis	rs7772486	0.558	rs62435775	chr6:146136415	G/C	cg05347473	chr6:146136440	FBXO30	0.69	6.14	0.57	3.26e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6089584	0.962	rs6142913	chr20:60566950	A/G	cg06108461	chr20:60628389	TAF4	-0.82	-7.35	-0.64	1.7e-10	Body mass index;
SKCM	cis	rs12142240	0.659	rs111723629	chr1:46853361	G/T	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs12368653	0.544	rs11172304	chr12:58097862	T/C	cg18357645	chr12:58087776	OS9	0.59	5.58	0.53	3.34e-7	Multiple sclerosis;
SKCM	cis	rs17376456	0.877	rs7701011	chr5:93311456	G/A	cg25358565	chr5:93447407	FAM172A	1.23	7.26	0.63	2.53e-10	Diabetic retinopathy;
SKCM	cis	rs6547631	0.592	rs2070966	chr2:85922860	G/T	cg24620635	chr2:85921963	GNLY	0.85	6.11	0.57	3.66e-8	Blood protein levels;
SKCM	cis	rs9910055	0.659	rs721769	chr17:42261588	T/G	cg09913183	chr17:42254507	C17orf65;ASB16	0.67	6.53	0.59	6.13e-9	Total body bone mineral density;
SKCM	cis	rs8060686	0.641	rs111632263	chr16:68233122	T/A	cg09117114	chr16:67998030	SLC12A4	-0.76	-4.91	-0.49	4.9e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs708547	0.874	rs1718837	chr4:57871203	A/G	cg16868167	chr4:57843880	C4orf14;POLR2B	0.74	5.24	0.51	1.31e-6	Response to bleomycin (chromatid breaks);
SKCM	cis	rs1707322	1.000	rs10890372	chr1:46391020	T/G	cg03146154	chr1:46216737	IPP	0.74	5.06	0.5	2.76e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7523273	0.606	rs10449303	chr1:207961058	A/G	cg22525895	chr1:207977042	MIR29B2	-0.83	-6.96	-0.62	9.59e-10	Schizophrenia;
SKCM	cis	rs798766	0.859	rs798727	chr4:1685137	C/T	cg05874882	chr4:1763078	NA	-0.68	-6.1	-0.57	3.9e-8	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs2075371	0.611	rs11762920	chr7:134018514	C/T	cg11752832	chr7:134001865	SLC35B4	0.56	4.82	0.48	7.07e-6	Mean platelet volume;
SKCM	cis	rs9902453	1.000	rs4533340	chr17:28277951	G/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.81	5.79	0.55	1.43e-7	Coffee consumption (cups per day);
SKCM	cis	rs6977660	0.507	rs72591448	chr7:19775298	C/T	cg05791153	chr7:19748676	TWISTNB	0.93	4.92	0.49	4.79e-6	Thyroid stimulating hormone;
SKCM	cis	rs1147199	0.531	rs1659412	chr9:87278152	G/A	cg13486759	chr9:86751815	NA	-0.65	-4.87	-0.48	5.73e-6	Body mass index;
SKCM	cis	rs28595532	0.920	rs17325017	chr4:119774607	A/G	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs2732480	0.577	rs2634684	chr12:48730875	C/T	cg21466736	chr12:48725269	NA	0.59	4.84	0.48	6.41e-6	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs80130819	0.748	rs2409001	chr12:48594490	T/C	cg13203223	chr12:49319398	FKBP11	0.92	5.07	0.5	2.59e-6	Prostate cancer;
SKCM	cis	rs1707322	1.000	rs785478	chr1:46491635	C/T	cg03146154	chr1:46216737	IPP	-0.77	-5.36	-0.52	8.35e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs4555082	0.834	rs28489970	chr14:105748862	T/C	cg13114125	chr14:105738426	BRF1	-0.69	-5.47	-0.53	5.33e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs2120019	0.507	rs4886642	chr15:75228846	T/C	cg17294928	chr15:75287854	SCAMP5	-0.8	-5.45	-0.53	5.6e-7	Blood trace element (Zn levels);
SKCM	cis	rs28595532	0.920	rs17325192	chr4:119780345	A/G	cg14228332	chr4:119757509	SEC24D	-0.83	-4.78	-0.48	8.11e-6	Cannabis dependence symptom count;
SKCM	cis	rs13108904	0.905	rs34490749	chr4:1217981	A/G	cg05665937	chr4:1216051	CTBP1	0.58	5.0	0.49	3.49e-6	Obesity-related traits;
SKCM	cis	rs440932	0.757	rs330943	chr8:9021026	G/A	cg06636001	chr8:8085503	FLJ10661	0.64	5.0	0.49	3.45e-6	High light scatter reticulocyte percentage of red cells;
SKCM	cis	rs8078723	0.546	rs8067817	chr17:38163936	C/T	cg17467752	chr17:38218738	THRA	0.69	6.15	0.57	3.16e-8	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs870825	0.616	rs28463742	chr4:185611005	G/A	cg04058563	chr4:185651563	MLF1IP	0.97	6.94	0.62	1.03e-9	Blood protein levels;
SKCM	cis	rs3789045	0.560	rs1008833	chr1:204426295	A/G	cg17419461	chr1:204415978	PIK3C2B	-0.89	-6.73	-0.61	2.54e-9	Educational attainment (college completion);
SKCM	cis	rs7937682	0.575	rs1940391	chr11:111776891	G/A	cg09085632	chr11:111637200	PPP2R1B	1.09	10.45	0.76	1.7e-16	Primary sclerosing cholangitis;
SKCM	cis	rs72781680	0.898	rs72782136	chr2:24047344	A/G	cg08917208	chr2:24149416	ATAD2B	1.0	4.97	0.49	3.82e-6	Lymphocyte counts;
SKCM	cis	rs10876993	0.890	rs4760165	chr12:58063801	C/T	cg18357645	chr12:58087776	OS9	0.65	6.01	0.56	5.71e-8	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs4819052	0.851	rs13050359	chr21:46672671	T/G	cg19498844	chr21:46707878	POFUT2;LOC642852	0.88	7.69	0.66	3.74e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs801193	1.000	rs6958520	chr7:66151453	T/C	cg18876405	chr7:65276391	NA	0.8	7.11	0.63	4.86e-10	Aortic root size;
SKCM	cis	rs644799	0.932	rs572015	chr11:95637416	T/A	cg03916912	chr11:95522834	CEP57;FAM76B	0.85	6.44	0.59	9.15e-9	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs3785574	0.927	rs2008018	chr17:61954471	C/T	cg23090583	chr17:61904693	PSMC5;FTSJ3	0.65	4.95	0.49	4.24e-6	Height;
SKCM	cis	rs10905065	0.804	rs2175630	chr10:5834736	A/C	cg09234995	chr10:5726438	C10orf18	0.66	5.69	0.54	2.15e-7	Menopause (age at onset);
SKCM	cis	rs1401999	0.690	rs6768149	chr3:183636195	T/C	cg01324343	chr3:183735012	ABCC5	0.65	6.11	0.57	3.74e-8	Anterior chamber depth;
SKCM	cis	rs644799	0.710	rs519511	chr11:95538270	G/A	cg03916912	chr11:95522834	CEP57;FAM76B	0.8	6.71	0.6	2.8e-9	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs2197308	0.565	rs4123923	chr12:37857684	T/C	cg26384229	chr12:38710491	ALG10B	0.82	6.88	0.61	1.35e-9	Morning vs. evening chronotype;
SKCM	cis	rs8060686	0.641	rs75909028	chr16:68089578	A/C	cg04539111	chr16:67997858	SLC12A4	-0.85	-4.81	-0.48	7.14e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs1552244	1.000	rs112847840	chr3:10101652	C/T	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs514406	0.661	rs562641	chr1:53374666	C/T	cg16325326	chr1:53192061	ZYG11B	0.65	5.65	0.54	2.56e-7	Monocyte count;
SKCM	cis	rs1003719	0.788	rs1543749	chr21:38446621	A/G	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs1401999	0.807	rs9869029	chr3:183735286	C/G	cg01324343	chr3:183735012	ABCC5	0.88	10.48	0.76	1.5e-16	Anterior chamber depth;
SKCM	cis	rs244731	0.959	rs6872021	chr5:176610012	G/A	cg17509989	chr5:176798049	RGS14	-0.9	-7.0	-0.62	7.86e-10	Urate levels in lean individuals;
SKCM	cis	rs9875589	0.509	rs1906538	chr3:14014169	C/T	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.51	5.17	0.51	1.73e-6	Ovarian reserve;
SKCM	cis	rs2180341	0.814	rs9401958	chr6:127736357	T/G	cg27446573	chr6:127587934	RNF146	0.69	5.49	0.53	4.79e-7	Breast cancer;
SKCM	cis	rs2836974	0.644	rs11088471	chr21:40699313	A/G	cg17971929	chr21:40555470	PSMG1	-0.71	-6.2	-0.57	2.5e-8	Cognitive function;
SKCM	cis	rs593982	0.920	rs10896044	chr11:65554680	C/G	cg08755490	chr11:65554678	OVOL1	1.04	9.73	0.74	4.15e-15	Atopic dermatitis;
SKCM	cis	rs9815354	0.812	rs73073361	chr3:41842926	C/G	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs28595532	0.920	rs55633605	chr4:119761589	G/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs11098499	0.661	rs10015965	chr4:120268237	A/G	cg09307838	chr4:120376055	NA	0.96	8.24	0.68	3.19e-12	Corneal astigmatism;
SKCM	cis	rs10089	0.904	rs3087889	chr5:127524944	T/A	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.88	7.75	0.66	2.87e-11	Ileal carcinoids;
SKCM	cis	rs763014	0.931	rs1981483	chr16:630665	G/A	cg07343612	chr16:622815	PIGQ	-0.7	-6.0	-0.56	5.84e-8	Height;
SKCM	cis	rs7809950	0.906	rs2395907	chr7:107253304	A/G	cg23024343	chr7:107201750	COG5	0.89	8.22	0.68	3.58e-12	Coronary artery disease;
SKCM	cis	rs2742234	1.000	rs1864395	chr10:43655697	G/A	cg15022308	chr10:43447071	NA	-0.58	-5.0	-0.49	3.41e-6	Hirschsprung disease;
SKCM	cis	rs6942756	1.000	rs2141075	chr7:128877305	C/T	cg02491457	chr7:128862824	NA	0.76	4.89	0.48	5.29e-6	White matter hyperintensity burden;
SKCM	cis	rs8180040	0.593	rs12715421	chr3:47084859	A/G	cg27129171	chr3:47204927	SETD2	0.74	5.37	0.52	7.84e-7	Colorectal cancer;
SKCM	cis	rs137761	0.576	rs743797	chr22:44059059	T/C	cg12729397	chr22:44208276	EFCAB6	0.68	4.85	0.48	6.1e-6	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs780096	0.546	rs1104	chr2:27599875	T/G	cg05696406	chr2:27599888	SNX17	0.49	5.07	0.5	2.62e-6	Total body bone mineral density;
SKCM	cis	rs9300255	0.544	rs1716157	chr12:123670473	T/C	cg00376283	chr12:123451042	ABCB9	0.86	5.28	0.51	1.12e-6	Neutrophil percentage of white cells;
SKCM	cis	rs6089829	0.926	rs7273917	chr20:61665975	G/A	cg03213289	chr20:61660250	NA	0.49	4.81	0.48	7.29e-6	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs3857536	0.740	rs7756519	chr6:66892275	A/G	cg07460842	chr6:66804631	NA	-0.7	-5.08	-0.5	2.51e-6	Blood trace element (Cu levels);
SKCM	trans	rs17685	0.664	rs9801113	chr7:75792031	C/T	cg19862616	chr7:65841803	NCRNA00174	0.97	10.73	0.77	5.13e-17	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs933688	1.000	rs2052553	chr5:90729906	C/T	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.1	8.62	0.7	5.93e-13	Smoking behavior;
SKCM	cis	rs12497850	0.931	rs9840050	chr3:49133310	A/G	cg07636037	chr3:49044803	WDR6	1.06	11.54	0.79	1.54e-18	Parkinson's disease;
SKCM	cis	rs7937682	0.961	rs4935790	chr11:111633014	T/C	cg09085632	chr11:111637200	PPP2R1B	1.11	12.99	0.83	3.42e-21	Primary sclerosing cholangitis;
SKCM	cis	rs7618501	0.633	rs4688689	chr3:50035542	C/T	cg24110177	chr3:50126178	RBM5	-0.57	-4.81	-0.48	7.31e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs6062302	0.522	rs3787107	chr20:62230576	G/A	cg09650180	chr20:62225654	GMEB2	-0.78	-6.22	-0.58	2.28e-8	Glioblastoma;
SKCM	cis	rs1912483	0.505	rs11079772	chr17:45393739	A/C	cg25173405	chr17:45401733	C17orf57	0.77	5.76	0.55	1.59e-7	Coronary artery disease;
SKCM	cis	rs11098499	0.909	rs28632018	chr4:120386730	T/C	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs10256972	0.616	rs4998392	chr7:1113344	A/C	cg16145915	chr7:1198662	ZFAND2A	-0.47	-5.89	-0.56	9.16e-8	Longevity;Endometriosis;
SKCM	cis	rs4803468	1.000	rs284652	chr19:41928652	C/T	cg14132834	chr19:41945861	ATP5SL	-0.77	-6.04	-0.56	4.87e-8	Height;
SKCM	cis	rs709400	0.691	rs12888077	chr14:103872553	G/T	cg26031613	chr14:104095156	KLC1	-0.71	-5.2	-0.51	1.58e-6	Body mass index;
SKCM	cis	rs60871478	0.853	rs62432864	chr7:808405	T/G	cg05535760	chr7:792225	HEATR2	1.01	8.26	0.68	2.97e-12	Cerebrospinal P-tau181p levels;
SKCM	cis	rs60871478	1.000	rs67721251	chr7:825114	T/C	cg04727924	chr7:799746	HEATR2	-0.63	-4.99	-0.49	3.63e-6	Cerebrospinal P-tau181p levels;
SKCM	cis	rs17376456	1.000	rs35184505	chr5:93561535	A/G	cg25358565	chr5:93447407	FAM172A	1.3	8.21	0.68	3.63e-12	Diabetic retinopathy;
SKCM	cis	rs11098499	0.954	rs10017371	chr4:120293776	A/G	cg09307838	chr4:120376055	NA	0.97	7.43	0.64	1.17e-10	Corneal astigmatism;
SKCM	cis	rs9916302	0.904	rs801426	chr17:37441109	C/T	cg07936489	chr17:37558343	FBXL20	0.84	6.96	0.62	9.48e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs2857078	0.772	rs2079008	chr17:42322132	C/A	cg09913183	chr17:42254507	C17orf65;ASB16	-0.63	-5.06	-0.5	2.71e-6	Red cell distribution width;Reticulocyte count;
SKCM	cis	rs10504073	0.647	rs56057508	chr8:49982793	G/T	cg00325661	chr8:49890786	NA	0.78	6.8	0.61	1.91e-9	Blood metabolite ratios;
SKCM	cis	rs7811142	0.666	rs28401739	chr7:99905684	A/G	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.21	8.05	0.67	7.68e-12	Platelet count;
SKCM	cis	rs28595532	0.844	rs115573749	chr4:119756848	T/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs66887589	0.967	rs59516282	chr4:120502016	G/A	cg09307838	chr4:120376055	NA	-0.65	-4.87	-0.48	5.72e-6	Diastolic blood pressure;
SKCM	cis	rs9913156	0.707	rs9902000	chr17:4582426	A/C	cg19197139	chr17:4613644	ARRB2	-0.79	-5.36	-0.52	8.23e-7	Lymphocyte counts;
SKCM	cis	rs13385731	1.000	rs13385731	chr2:33701890	A/G	cg26822501	chr2:33171334	LTBP1	1.05	5.22	0.51	1.43e-6	Systemic lupus erythematosus;
SKCM	cis	rs1801251	0.964	rs12472839	chr2:233559615	A/G	cg08000102	chr2:233561755	GIGYF2	0.83	6.21	0.58	2.39e-8	Coronary artery disease;
SKCM	cis	rs8017423	0.647	rs4904677	chr14:90819245	C/T	cg04374321	chr14:90722782	PSMC1	-0.77	-5.94	-0.56	7.46e-8	Mortality in heart failure;
SKCM	cis	rs2243480	1.000	rs34703416	chr7:65300642	A/G	cg07424592	chr7:64974309	NA	0.98	4.85	0.48	6.22e-6	Diabetic kidney disease;
SKCM	cis	rs6087990	1.000	rs1007123	chr20:31345840	G/A	cg13636640	chr20:31349939	DNMT3B	0.91	7.99	0.67	9.7e-12	Ulcerative colitis;
SKCM	cis	rs703842	1.000	rs2072052	chr12:58146719	A/C	cg04478727	chr12:58166393	METTL1;FAM119B	0.66	5.2	0.51	1.58e-6	Multiple sclerosis;
SKCM	cis	rs7953249	0.722	rs2255531	chr12:121414915	G/A	cg02403541	chr12:121454288	C12orf43	0.64	4.92	0.49	4.65e-6	Invasive epithelial ovarian cancer;High-grade serous ovarian cancer;Chronic obstructive pulmonary disease-related biomarkers;N-glycan levels;Serous invasive ovarian cancer;Epithelial ovarian cancer;
SKCM	cis	rs2204008	0.777	rs8189597	chr12:38307739	G/C	cg13010199	chr12:38710504	ALG10B	-0.68	-4.93	-0.49	4.6e-6	Bladder cancer;
SKCM	cis	rs12995491	0.569	rs6724281	chr2:88529531	T/G	cg07952391	chr2:88470173	THNSL2	-0.77	-5.75	-0.55	1.65e-7	Response to metformin (IC50);
SKCM	cis	rs870825	0.932	rs13136635	chr4:185574807	C/T	cg04058563	chr4:185651563	MLF1IP	-1.03	-5.09	-0.5	2.4e-6	Blood protein levels;
SKCM	cis	rs1799949	0.930	rs8176194	chr17:41231221	A/C	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.06	-0.57	4.54e-8	Menopause (age at onset);
SKCM	cis	rs8067545	0.750	rs28666381	chr17:19984809	C/G	cg13482628	chr17:19912719	NA	0.73	6.54	0.6	5.78e-9	Schizophrenia;
SKCM	cis	rs9581857	0.685	rs9581856	chr13:28025615	G/C	cg22138327	chr13:27999177	GTF3A	0.93	6.24	0.58	2.1e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs9886651	0.869	rs4074703	chr8:128786990	C/T	cg24514600	chr8:128805414	PVT1	-0.55	-4.92	-0.49	4.71e-6	Epithelial ovarian cancer;Serous invasive ovarian cancer;
SKCM	cis	rs10504073	0.584	rs10504070	chr8:49978554	A/G	cg00325661	chr8:49890786	NA	-0.8	-6.81	-0.61	1.83e-9	Blood metabolite ratios;
SKCM	cis	rs7937682	0.889	rs1789359	chr11:111475995	T/A	cg19812747	chr11:111475976	SIK2	-0.56	-4.93	-0.49	4.55e-6	Primary sclerosing cholangitis;
SKCM	cis	rs116095464	0.558	rs9312957	chr5:202194	C/T	cg22496380	chr5:211416	CCDC127	-1.0	-5.11	-0.5	2.25e-6	Breast cancer;
SKCM	cis	rs2721195	1.000	rs1871541	chr8:145681713	G/T	cg15320075	chr8:145703422	NA	-0.86	-7.3	-0.64	2.1e-10	Age at first birth;
SKCM	cis	rs798554	0.680	rs1713912	chr7:2895784	C/A	cg04166393	chr7:2884313	GNA12	0.73	4.8	0.48	7.64e-6	Height;
SKCM	cis	rs2204008	0.902	rs11520218	chr12:38223227	G/A	cg26384229	chr12:38710491	ALG10B	0.81	6.23	0.58	2.23e-8	Bladder cancer;
SKCM	cis	rs4132509	0.948	rs12136624	chr1:243981611	C/A	cg21452805	chr1:244014465	NA	0.88	5.2	0.51	1.58e-6	RR interval (heart rate);
SKCM	cis	rs2033711	0.870	rs6510152	chr19:58953319	C/T	cg13877915	chr19:58951672	ZNF132	0.95	10.4	0.76	2.17e-16	Uric acid clearance;
SKCM	cis	rs12047808	0.841	rs59949433	chr1:179357486	G/A	cg08037922	chr1:179521085	C1orf125;NPHS2	-1.08	-5.8	-0.55	1.32e-7	Multiple sclerosis (age of onset);
SKCM	cis	rs9393692	0.905	rs9393693	chr6:26277408	C/A	cg00631329	chr6:26305371	NA	-0.68	-4.93	-0.49	4.49e-6	Educational attainment;
SKCM	cis	rs12477438	0.520	rs4347885	chr2:99804007	G/A	cg14399236	chr2:99771627	LIPT1;TSGA10	0.96	8.62	0.7	5.82e-13	Chronic sinus infection;
SKCM	cis	rs727563	0.635	rs713988	chr22:42159072	A/G	cg03806693	chr22:41940476	POLR3H	1.17	7.66	0.66	4.23e-11	Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs7811142	1.000	rs67471932	chr7:100009985	C/G	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.16	7.68	0.66	3.87e-11	Platelet count;
SKCM	cis	rs2243480	1.000	rs778729	chr7:65824419	T/C	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	trans	rs1814175	0.645	rs7395438	chr11:49877379	G/T	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs28386778	0.897	rs8077013	chr17:61850392	C/T	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs7726839	0.540	rs61580655	chr5:597564	A/G	cg10555297	chr5:473380	SLC9A3;LOC25845	1.02	4.87	0.48	5.72e-6	Obesity-related traits;
SKCM	cis	rs873946	0.648	rs12782123	chr10:134554662	G/A	cg26818010	chr10:134567672	INPP5A	-0.82	-6.64	-0.6	3.79e-9	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs2072499	0.966	rs2842869	chr1:156160696	A/G	cg25208724	chr1:156163844	SLC25A44	1.1	9.86	0.74	2.35e-15	Testicular germ cell tumor;
SKCM	cis	rs7659604	0.502	rs10013916	chr4:122702179	T/G	cg19671926	chr4:122722719	EXOSC9	0.76	6.97	0.62	9.04e-10	Type 2 diabetes;
SKCM	cis	rs6570726	0.791	rs447992	chr6:145817184	C/T	cg23711669	chr6:146136114	FBXO30	0.79	7.93	0.67	1.26e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs55823223	0.503	rs9906971	chr17:73848477	A/G	cg08125733	chr17:73851984	WBP2	1.06	6.6	0.6	4.51e-9	Psoriasis;
SKCM	cis	rs4561483	0.801	rs33640	chr16:11986874	C/T	cg08843971	chr16:11963173	GSPT1	-0.66	-5.08	-0.5	2.49e-6	Testicular germ cell tumor;
SKCM	cis	rs9910055	0.664	rs433610	chr17:42197281	A/G	cg09913183	chr17:42254507	C17orf65;ASB16	-0.71	-6.57	-0.6	5.15e-9	Total body bone mineral density;
SKCM	cis	rs12134245	0.747	rs35654098	chr1:92001452	T/A	cg02896835	chr1:92012615	NA	-0.65	-5.99	-0.56	6.15e-8	Breast cancer;
SKCM	cis	rs9815354	0.855	rs73071261	chr3:42003369	C/A	cg03022575	chr3:42003672	ULK4	1.0	5.0	0.49	3.43e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs4478137	0.931	rs56233753	chr4:164249023	A/G	cg06758707	chr4:164254230	NPY1R	0.95	6.12	0.57	3.47e-8	Subjective well-being (multi-trait analysis);Subjective well-being;
SKCM	cis	rs11098499	0.645	rs78422072	chr4:120281042	C/T	cg09307838	chr4:120376055	NA	0.98	7.89	0.67	1.52e-11	Corneal astigmatism;
SKCM	cis	rs4925325	0.955	rs1776262	chr20:60516023	G/T	cg25789511	chr20:60757919	GTPBP5	-0.79	-4.94	-0.49	4.37e-6	Obesity-related traits;
SKCM	cis	rs1801251	1.000	rs2044449	chr2:233718808	G/A	cg25237894	chr2:233734115	C2orf82	-0.58	-5.74	-0.54	1.75e-7	Coronary artery disease;
SKCM	cis	rs4972806	0.849	rs2113561	chr2:177030925	G/A	cg14324370	chr2:177042789	NA	0.56	5.09	0.5	2.42e-6	IgG glycosylation;
SKCM	cis	rs7666738	0.830	rs7662199	chr4:99019766	G/A	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4555082	0.957	rs2816622	chr14:105733114	T/C	cg13114125	chr14:105738426	BRF1	-0.73	-5.73	-0.54	1.79e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs801193	0.844	rs732465	chr7:65998450	T/C	cg11764359	chr7:65958608	NA	0.81	6.09	0.57	4.07e-8	Aortic root size;
SKCM	cis	rs709400	0.628	rs7155014	chr14:103863970	C/G	cg26031613	chr14:104095156	KLC1	0.73	5.4	0.52	7.09e-7	Body mass index;
SKCM	cis	rs17685	0.753	rs55812043	chr7:75747241	T/C	cg16684958	chr7:75615977	POR	0.55	5.27	0.51	1.19e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs9902453	0.904	rs11080115	chr17:28408070	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.82	-6.4	-0.59	1.06e-8	Coffee consumption (cups per day);
SKCM	cis	rs7811142	0.830	rs6948685	chr7:99970188	C/T	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.2	7.87	0.67	1.7e-11	Platelet count;
SKCM	cis	rs7100689	0.622	rs2342816	chr10:82086546	G/A	cg01528321	chr10:82214614	TSPAN14	0.76	6.26	0.58	1.94e-8	Post bronchodilator FEV1;
SKCM	cis	rs9796	0.866	rs2176998	chr15:41420807	A/G	cg18705301	chr15:41695430	NDUFAF1	-0.73	-5.45	-0.53	5.67e-7	Menopause (age at onset);
SKCM	cis	rs941873	0.835	rs4246944	chr10:81105684	C/T	cg09469691	chr10:81107165	PPIF	0.71	7.19	0.63	3.45e-10	Height;
SKCM	cis	rs11098499	0.722	rs10025925	chr4:120271744	A/T	cg09307838	chr4:120376055	NA	0.94	7.73	0.66	3.07e-11	Corneal astigmatism;
SKCM	cis	rs394563	0.591	rs237018	chr6:149743930	A/G	cg03678062	chr6:149772716	ZC3H12D	-0.5	-5.43	-0.52	6.1e-7	Dupuytren's disease;
SKCM	cis	rs3741151	1.000	rs76764824	chr11:73073580	C/T	cg17517138	chr11:73019481	ARHGEF17	1.27	4.87	0.48	5.81e-6	GIP levels in response to oral glucose tolerance test (120 minutes);
SKCM	cis	rs2730245	0.594	rs2657343	chr7:158745472	G/A	cg08767743	chr7:158673942	WDR60	0.56	4.91	0.49	4.82e-6	Height;
SKCM	cis	rs742614	0.533	rs13041078	chr20:32435497	G/T	cg06304546	chr20:32448765	NA	-0.73	-5.91	-0.56	8.51e-8	Stearic acid (18:0) levels;
SKCM	cis	rs28386778	0.897	rs3744293	chr17:61841788	T/A	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs1348850	0.597	rs13014417	chr2:178417835	T/G	cg27490568	chr2:178487706	NA	0.8	5.67	0.54	2.28e-7	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs1552244	0.816	rs13059144	chr3:10010197	A/C	cg02579736	chr3:10068473	FANCD2;CIDECP	0.94	4.84	0.48	6.49e-6	Alzheimer's disease;
SKCM	cis	rs2243480	1.000	rs316317	chr7:65613637	G/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs10883723	0.810	rs7090034	chr10:104281155	C/G	cg11453585	chr10:104263688	ACTR1A;SUFU	0.77	6.31	0.58	1.56e-8	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs548181	1.000	rs548181	chr11:125461709	A/G	cg03464685	chr11:125439445	EI24	1.39	8.97	0.71	1.23e-13	Schizophrenia;Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);
SKCM	cis	rs4523957	0.583	rs8068508	chr17:2047624	A/G	cg16513277	chr17:2031491	SMG6	-0.88	-5.81	-0.55	1.28e-7	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs1153858	0.725	rs74572151	chr15:45647526	T/G	cg10760299	chr15:45669010	GATM	0.62	6.33	0.58	1.42e-8	Homoarginine levels;
SKCM	cis	rs71007656	1	rs71007656	chr10:37970845	CGGCTG/C	cg00409905	chr10:38381863	ZNF37A	-0.58	-5.75	-0.55	1.64e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs6952808	0.771	rs10275045	chr7:1920826	C/T	cg02951883	chr7:2050386	MAD1L1	-0.68	-5.82	-0.55	1.26e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs7937682	1.000	rs10502147	chr11:111569931	G/A	cg09085632	chr11:111637200	PPP2R1B	1.02	11.79	0.8	5.18e-19	Primary sclerosing cholangitis;
SKCM	cis	rs9311474	0.508	rs17052256	chr3:52593119	A/G	cg18404041	chr3:52824283	ITIH1	-0.53	-4.77	-0.48	8.42e-6	Electroencephalogram traits;
SKCM	cis	rs35306767	0.855	rs34251037	chr10:867884	C/T	cg20503657	chr10:835505	NA	0.79	5.87	0.55	1.02e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs4642101	0.561	rs7641959	chr3:12810755	G/C	cg05775895	chr3:12838266	CAND2	0.58	4.82	0.48	6.83e-6	QRS complex (12-leadsum);
SKCM	cis	rs490608	0.602	rs12021631	chr1:155321678	A/T	cg02153340	chr1:155202674	NA	-0.75	-5.46	-0.53	5.56e-7	Inflammatory bowel disease;
SKCM	cis	rs7027203	0.688	rs4075733	chr9:96624645	C/T	cg14598338	chr9:96623480	NA	-0.48	-5.23	-0.51	1.4e-6	DNA methylation (variation);
SKCM	cis	rs2075371	0.829	rs9641970	chr7:134004887	C/A	cg20476274	chr7:133979776	SLC35B4	1.01	10.1	0.75	8.14e-16	Mean platelet volume;
SKCM	cis	rs9796	0.621	rs1659228	chr15:41471978	A/G	cg18705301	chr15:41695430	NDUFAF1	-0.7	-5.18	-0.51	1.67e-6	Menopause (age at onset);
SKCM	cis	rs6736997	0.544	rs11687639	chr2:235605915	T/C	cg17841421	chr2:235704848	NA	-0.64	-5.12	-0.5	2.18e-6	Pancreatic cancer;
SKCM	cis	rs1801251	1.000	rs6745879	chr2:233590007	A/G	cg08000102	chr2:233561755	GIGYF2	0.89	6.95	0.62	9.95e-10	Coronary artery disease;
SKCM	cis	rs8072100	0.713	rs9807106	chr17:45457102	G/T	cg08085267	chr17:45401833	C17orf57	-0.62	-5.06	-0.5	2.76e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs9790314	0.846	rs13083229	chr3:161008125	G/A	cg03342759	chr3:160939853	NMD3	-0.72	-8.12	-0.68	5.59e-12	Morning vs. evening chronotype;
SKCM	cis	rs7809950	0.598	rs2283038	chr7:106835410	C/T	cg23024343	chr7:107201750	COG5	-0.8	-6.7	-0.6	2.91e-9	Coronary artery disease;
SKCM	cis	rs4132509	1.000	rs320320	chr1:243835186	A/G	cg21452805	chr1:244014465	NA	0.8	4.78	0.48	8.19e-6	RR interval (heart rate);
SKCM	cis	rs2832191	0.632	rs2246777	chr21:30309586	T/C	cg08807101	chr21:30365312	RNF160	-0.74	-6.32	-0.58	1.5e-8	Dental caries;
SKCM	cis	rs362272	0.545	rs2236052	chr4:3318413	C/T	cg24015175	chr4:3319247	RGS12	-0.81	-10.2	-0.76	5.3e-16	Serum sulfate level;
SKCM	cis	rs9399135	0.935	rs9376086	chr6:135371329	T/C	cg24558204	chr6:135376177	HBS1L	0.58	5.05	0.5	2.86e-6	Red blood cell count;
SKCM	cis	rs3744028	0.625	rs78866233	chr17:73880788	A/C	cg09249101	chr17:74520697	NA	-0.56	-4.82	-0.48	6.86e-6	White matter hyperintensity burden;
SKCM	cis	rs2303745	0.589	rs6512182	chr19:17399476	G/T	cg04248312	chr19:17393744	ANKLE1	-1.12	-8.3	-0.69	2.42e-12	Systemic lupus erythematosus;
SKCM	cis	rs507080	0.922	rs558781	chr11:118564397	G/T	cg18045108	chr11:118530628	TREH	-0.47	-4.81	-0.48	7.17e-6	Serum metabolite levels;
SKCM	cis	rs9814567	1.000	rs62269547	chr3:134214042	T/C	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.67	-5.25	-0.51	1.28e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs897984	0.920	rs11150599	chr16:30897456	T/C	cg00531865	chr16:30841666	NA	0.56	4.8	0.48	7.54e-6	Dementia with Lewy bodies;
SKCM	cis	rs2857078	0.720	rs9901595	chr17:42305699	G/A	cg09913183	chr17:42254507	C17orf65;ASB16	0.6	5.25	0.51	1.3e-6	Red cell distribution width;Reticulocyte count;
SKCM	cis	rs6088580	0.634	rs6059829	chr20:33017074	G/A	cg24642439	chr20:33292090	TP53INP2	0.76	6.02	0.56	5.28e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs4423214	1.000	rs7935125	chr11:71184190	C/A	cg05163923	chr11:71159392	DHCR7	0.81	7.55	0.65	6.83e-11	Vitamin D levels;
SKCM	cis	rs7143963	0.636	rs10133709	chr14:103310758	A/T	cg23020514	chr14:103360112	TRAF3	0.74	7.1	0.63	5.18e-10	Body mass index;
SKCM	cis	rs11139399	0.613	rs10867801	chr9:84338588	T/C	cg13729285	chr9:84764156	NA	0.53	5.02	0.49	3.17e-6	Hippocampal atrophy;
SKCM	cis	rs2050392	0.928	rs6481677	chr10:30701816	A/G	cg25182066	chr10:30743637	MAP3K8	-0.72	-6.21	-0.58	2.39e-8	Inflammatory bowel disease;
SKCM	cis	rs9467773	0.620	rs2494694	chr6:26619328	A/T	cg09904177	chr6:26538194	HMGN4	0.58	5.01	0.49	3.28e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs4972806	0.776	rs2072589	chr2:177042871	C/T	cg03152288	chr2:177042942	NA	0.57	4.99	0.49	3.6e-6	IgG glycosylation;
SKCM	cis	rs2014572	0.967	rs10421632	chr19:57764770	G/A	cg24459738	chr19:57751996	ZNF805	-0.63	-5.12	-0.5	2.17e-6	Hyperactive-impulsive symptoms;
SKCM	cis	rs7726839	0.507	rs60068988	chr5:597668	T/C	cg10555297	chr5:473380	SLC9A3;LOC25845	1.02	4.87	0.48	5.72e-6	Obesity-related traits;
SKCM	cis	rs2153535	0.580	rs6941771	chr6:8494452	T/G	cg07606381	chr6:8435919	SLC35B3	0.86	6.25	0.58	2.06e-8	Motion sickness;
SKCM	cis	rs3820068	0.532	rs78917815	chr1:15920821	A/G	cg13390004	chr1:15929781	NA	0.67	5.29	0.51	1.11e-6	Systolic blood pressure;
SKCM	cis	rs3820068	0.603	rs7516453	chr1:15972558	C/G	cg24675056	chr1:15929824	NA	0.8	5.64	0.54	2.66e-7	Systolic blood pressure;
SKCM	cis	rs34172651	0.517	rs2547040	chr16:24736408	G/C	cg06028605	chr16:24865363	SLC5A11	-0.59	-4.87	-0.48	5.67e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs6952808	0.689	rs11771625	chr7:2050401	C/T	cg21782813	chr7:2030301	MAD1L1	0.59	6.11	0.57	3.64e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs919433	0.929	rs4850788	chr2:198182940	G/A	cg04278110	chr2:198063759	ANKRD44	-0.7	-5.12	-0.5	2.14e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs854765	0.534	rs7207461	chr17:17949789	T/G	cg04398451	chr17:18023971	MYO15A	0.94	7.53	0.65	7.5e-11	Total body bone mineral density;
SKCM	cis	rs7824557	0.579	rs10098322	chr8:11196295	C/G	cg21775007	chr8:11205619	TDH	0.71	6.74	0.61	2.5e-9	Retinal vascular caliber;
SKCM	cis	rs995000	0.931	rs1629122	chr1:63046578	C/A	cg06896770	chr1:63153194	DOCK7	-0.76	-7.44	-0.64	1.13e-10	Triglyceride levels;
SKCM	cis	rs769267	0.965	rs1469712	chr19:19528821	C/A	cg26732615	chr19:19648335	CILP2;YJEFN3	0.69	7.16	0.63	3.82e-10	Tonsillectomy;
SKCM	cis	rs8180040	0.653	rs6808742	chr3:47051512	G/A	cg27129171	chr3:47204927	SETD2	0.78	5.98	0.56	6.37e-8	Colorectal cancer;
SKCM	cis	rs7772486	0.686	rs1292336	chr6:145967818	T/C	cg23711669	chr6:146136114	FBXO30	-0.9	-9.43	-0.73	1.62e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1577917	1.000	rs10944169	chr6:86683036	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.83	-8.15	-0.68	4.79e-12	Response to antipsychotic treatment;
SKCM	cis	rs870825	0.616	rs6552804	chr4:185637699	A/G	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs7143963	0.636	rs28483070	chr14:103292110	T/C	cg23020514	chr14:103360112	TRAF3	0.73	6.9	0.62	1.23e-9	Body mass index;
SKCM	cis	rs16854884	0.657	rs7642774	chr3:143723272	T/A	cg06585982	chr3:143692056	C3orf58	0.87	8.11	0.68	5.72e-12	Economic and political preferences (feminism/equality);
SKCM	cis	rs644799	0.965	rs10831425	chr11:95500628	T/C	cg03916912	chr11:95522834	CEP57;FAM76B	0.95	8.73	0.7	3.62e-13	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	trans	rs17685	0.712	rs56088021	chr7:75852480	C/T	cg19862616	chr7:65841803	NCRNA00174	0.92	9.34	0.73	2.41e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs6762	0.748	rs7929032	chr11:839078	G/A	cg16425592	chr11:842748	TSPAN4;POLR2L	-0.79	-5.75	-0.55	1.65e-7	Mean platelet volume;
SKCM	cis	rs860295	0.702	rs12041534	chr1:155407096	A/G	cg02153340	chr1:155202674	NA	0.76	5.62	0.54	2.87e-7	Body mass index;
SKCM	cis	rs6570726	0.791	rs1509213	chr6:145783360	G/A	cg23711669	chr6:146136114	FBXO30	-0.79	-7.37	-0.64	1.58e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1005277	0.541	rs1740741	chr10:38515334	C/T	cg25427524	chr10:38739819	LOC399744	-0.69	-6.79	-0.61	1.96e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs6547631	0.622	rs1837115	chr2:85928411	C/A	cg24620635	chr2:85921963	GNLY	0.9	6.4	0.59	1.06e-8	Blood protein levels;
SKCM	cis	rs3818285	0.655	rs623980	chr10:111646147	C/T	cg00817464	chr10:111662876	XPNPEP1	-0.73	-7.7	-0.66	3.51e-11	Superior crus of antihelix expression;
SKCM	cis	rs4972806	0.775	rs2857534	chr2:177035676	G/T	cg13092806	chr2:177043255	NA	0.57	5.4	0.52	6.85e-7	IgG glycosylation;
SKCM	cis	rs873946	0.564	rs12772704	chr10:134557318	G/A	cg18305652	chr10:134549665	INPP5A	0.59	5.72	0.54	1.88e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs3008870	1.000	rs2815361	chr1:67494591	G/T	cg08660285	chr1:67390436	MIER1;WDR78	0.95	6.51	0.59	6.68e-9	Lymphocyte percentage of white cells;
SKCM	cis	rs3771570	1.000	rs73004354	chr2:242356239	G/T	cg07612300	chr2:242033426	MTERFD2;SNED1	0.87	4.77	0.47	8.54e-6	Prostate cancer;
SKCM	cis	rs7208859	0.623	rs9916727	chr17:29107472	A/G	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs10876993	0.928	rs1689586	chr12:58079586	A/T	cg18357645	chr12:58087776	OS9	0.65	5.97	0.56	6.61e-8	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs2153535	0.580	rs1414350	chr6:8472331	C/T	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs7843479	0.601	rs1058486	chr8:21862551	A/G	cg17168535	chr8:21777572	XPO7	0.83	7.48	0.65	9.37e-11	Mean corpuscular volume;
SKCM	cis	rs17345786	1.000	rs73863360	chr3:101316837	G/A	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.71	5.07	0.5	2.61e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2115536	1.000	rs11072871	chr15:80197931	T/C	cg00225070	chr15:80189496	MTHFS	0.77	5.32	0.52	9.75e-7	Eosinophil counts;Eosinophil percentage of white cells;Sum eosinophil basophil counts;Eosinophil percentage of granulocytes;Neutrophil percentage of granulocytes;
SKCM	cis	rs1218582	0.772	rs4240875	chr1:154885782	G/A	cg09359103	chr1:154839909	KCNN3	-0.57	-5.3	-0.51	1.05e-6	Prostate cancer;
SKCM	cis	rs7666738	0.830	rs6846229	chr4:99016546	C/T	cg17366294	chr4:99064904	C4orf37	0.6	4.98	0.49	3.66e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1790761	0.667	rs4147581	chr11:67351585	C/G	cg00290607	chr11:67383545	NA	0.5	5.25	0.51	1.26e-6	Mean corpuscular volume;
SKCM	cis	rs10540	1.000	rs35996687	chr11:458595	G/A	cg03352830	chr11:487213	PTDSS2	1.09	5.25	0.51	1.27e-6	Body mass index;
SKCM	cis	rs7666738	0.830	rs7657179	chr4:98948569	G/A	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9549367	0.713	rs2146750	chr13:113822530	A/G	cg24722198	chr13:113567732	NA	-0.54	-5.31	-0.52	1.01e-6	Platelet distribution width;
SKCM	cis	rs2811415	0.597	rs9848345	chr3:127779220	C/T	cg09089421	chr3:127803668	RUVBL1	1.01	8.77	0.7	2.97e-13	Lung function (FEV1/FVC);
SKCM	cis	rs2153535	0.967	rs10484750	chr6:8378609	A/G	cg07606381	chr6:8435919	SLC35B3	-0.63	-5.12	-0.5	2.15e-6	Motion sickness;
SKCM	cis	rs873946	0.517	rs7071784	chr10:134559980	T/C	cg14275445	chr10:134560047	INPP5A	-0.53	-4.87	-0.48	5.81e-6	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs708547	0.575	rs6847086	chr4:57791864	A/G	cg16868167	chr4:57843880	C4orf14;POLR2B	-0.63	-5.1	-0.5	2.35e-6	Response to bleomycin (chromatid breaks);
SKCM	cis	rs2739330	0.796	rs2154594	chr22:24254055	A/G	cg25703541	chr22:24373054	LOC391322	0.76	5.65	0.54	2.56e-7	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	trans	rs1814175	0.817	rs1319547	chr11:49916705	C/T	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs55962025	0.846	rs363064	chr4:3141410	C/T	cg05297308	chr4:3317976	RGS12	-0.83	-6.14	-0.57	3.2e-8	Parental longevity (mother's age at death);
SKCM	cis	rs995000	0.895	rs10889348	chr1:63078222	A/T	cg06896770	chr1:63153194	DOCK7	0.95	8.64	0.7	5.4e-13	Triglyceride levels;
SKCM	cis	rs6952808	0.531	rs4721441	chr7:2184060	A/G	cg02951883	chr7:2050386	MAD1L1	-0.78	-6.93	-0.62	1.09e-9	Bipolar disorder and schizophrenia;
SKCM	cis	rs7659604	1.000	rs6846232	chr4:122664805	A/G	cg19748678	chr4:122722346	EXOSC9	0.66	5.44	0.52	5.83e-7	Type 2 diabetes;
SKCM	cis	rs2836974	0.829	rs8128191	chr21:40527311	A/G	cg17971929	chr21:40555470	PSMG1	0.87	8.48	0.69	1.1e-12	Cognitive function;
SKCM	cis	rs7537052	0.564	rs6669395	chr1:36653717	A/G	cg24686825	chr1:36642396	MAP7D1	-0.68	-5.84	-0.55	1.13e-7	Schizophrenia;
SKCM	cis	rs1707322	1.000	rs785484	chr1:46574015	T/C	cg03146154	chr1:46216737	IPP	-0.8	-5.28	-0.51	1.15e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs4774899	0.966	rs12901671	chr15:57514268	A/G	cg01857019	chr15:57210107	LOC145783;TCF12	0.53	4.78	0.48	8.03e-6	Urinary tract infection frequency;
SKCM	cis	rs4969178	0.965	rs8077859	chr17:76386335	C/T	cg20026190	chr17:76395443	PGS1	0.61	5.08	0.5	2.54e-6	HDL cholesterol levels;
SKCM	cis	rs798766	1.000	rs13112415	chr4:1756167	G/C	cg05874882	chr4:1763078	NA	-0.6	-4.83	-0.48	6.7e-6	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs17685	0.753	rs869804	chr7:75688954	A/G	cg16489192	chr7:75678113	MDH2;STYXL1	-0.6	-5.51	-0.53	4.43e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs36051895	0.659	rs2149555	chr9:5053743	C/T	cg02405213	chr9:5042618	JAK2	-0.64	-5.21	-0.51	1.51e-6	Pediatric autoimmune diseases;
SKCM	cis	rs2075371	0.830	rs1421478	chr7:133922793	T/A	cg20476274	chr7:133979776	SLC35B4	0.96	9.09	0.72	7.1e-14	Mean platelet volume;
SKCM	cis	rs28386778	0.901	rs2854194	chr17:61952110	T/G	cg01411255	chr17:61851458	DDX42;CCDC47	0.76	4.89	0.48	5.22e-6	Prudent dietary pattern;
SKCM	trans	rs1814175	0.645	rs1851850	chr11:50012168	G/A	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs6570726	0.791	rs11155426	chr6:145817130	T/C	cg23711669	chr6:146136114	FBXO30	0.79	7.93	0.67	1.26e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9894429	0.752	rs7502883	chr17:79588557	T/C	cg18240062	chr17:79603768	NPLOC4	0.92	10.2	0.76	5.16e-16	Eye color traits;
SKCM	cis	rs9894429	0.646	rs9905639	chr17:79614154	A/G	cg18240062	chr17:79603768	NPLOC4	0.67	6.1	0.57	3.76e-8	Eye color traits;
SKCM	cis	rs875971	0.638	rs3898855	chr7:66036398	G/C	cg18876405	chr7:65276391	NA	-0.8	-7.11	-0.63	4.86e-10	Aortic root size;
SKCM	cis	rs7772486	0.875	rs2073287	chr6:146350264	T/C	cg05347473	chr6:146136440	FBXO30	0.57	5.12	0.5	2.13e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4423214	0.592	rs10898223	chr11:71219264	G/A	cg05163923	chr11:71159392	DHCR7	-0.7	-4.91	-0.49	4.92e-6	Vitamin D levels;
SKCM	cis	rs8072100	0.713	rs4968228	chr17:45497548	T/C	cg08085267	chr17:45401833	C17orf57	-0.62	-5.06	-0.5	2.76e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs1577917	0.739	rs6922	chr6:86205323	T/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.79	7.26	0.64	2.46e-10	Response to antipsychotic treatment;
SKCM	cis	rs6951245	0.872	rs74360401	chr7:1067403	G/A	cg03188948	chr7:1209495	NA	1.12	6.17	0.57	2.88e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs12477438	0.520	rs2632276	chr2:99779655	C/A	cg26064155	chr2:99771622	LIPT1;TSGA10	0.99	8.61	0.7	6.07e-13	Chronic sinus infection;
SKCM	cis	rs2991971	0.967	rs11211130	chr1:45986852	G/C	cg24296786	chr1:45957014	TESK2	0.65	5.16	0.5	1.81e-6	High light scatter reticulocyte count;
SKCM	cis	rs763121	0.853	rs3761454	chr22:39066820	C/T	cg06022373	chr22:39101656	GTPBP1	0.78	5.63	0.54	2.7e-7	Menopause (age at onset);
SKCM	cis	rs7447593	0.626	rs3812036	chr5:176813404	C/T	cg16006841	chr5:176797999	RGS14	0.8	8.01	0.67	8.82e-12	Urinary electrolytes (magnesium/calcium ratio);
SKCM	cis	rs2839186	0.616	rs4819213	chr21:47619300	G/A	cg13126279	chr21:47581558	C21orf56	0.69	6.1	0.57	3.8e-8	Testicular germ cell tumor;
SKCM	cis	rs826838	1.000	rs11183469	chr12:38752311	G/A	cg26384229	chr12:38710491	ALG10B	1.06	10.14	0.75	6.67e-16	Heart rate;
SKCM	cis	rs9611565	0.559	rs7290990	chr22:41964357	C/A	cg03806693	chr22:41940476	POLR3H	-1.04	-6.96	-0.62	9.22e-10	Vitiligo;
SKCM	cis	rs801193	0.569	rs2707824	chr7:66189243	A/G	cg11764359	chr7:65958608	NA	0.75	6.79	0.61	1.95e-9	Aortic root size;
SKCM	cis	rs4820539	1.000	rs3788347	chr22:23467804	G/A	cg14186256	chr22:23484241	RTDR1	0.86	7.98	0.67	1.05e-11	Bone mineral density;
SKCM	cis	rs7659604	0.846	rs60340409	chr4:122666355	G/C	cg19671926	chr4:122722719	EXOSC9	-0.65	-4.79	-0.48	7.93e-6	Type 2 diabetes;
SKCM	cis	rs561341	1.000	rs72823789	chr17:30284084	G/A	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs801193	1.000	rs62466794	chr7:66191579	G/A	cg18876405	chr7:65276391	NA	0.8	7.11	0.63	4.88e-10	Aortic root size;
SKCM	cis	rs10504229	0.683	rs62621195	chr8:58133964	G/A	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs875971	0.522	rs1968127	chr7:66056803	C/T	cg18876405	chr7:65276391	NA	-0.82	-7.53	-0.65	7.59e-11	Aortic root size;
SKCM	cis	rs12477438	0.520	rs34766932	chr2:99737273	G/A	cg14399236	chr2:99771627	LIPT1;TSGA10	0.95	8.78	0.71	2.89e-13	Chronic sinus infection;
SKCM	cis	rs561341	0.783	rs512698	chr17:30292507	G/T	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs13217239	0.646	rs10946898	chr6:27003884	T/C	cg12292205	chr6:26970375	C6orf41	0.63	5.64	0.54	2.58e-7	Schizophrenia;
SKCM	cis	rs55962025	0.855	rs4498089	chr4:3080199	A/G	cg00764545	chr4:3318001	RGS12	-0.59	-4.82	-0.48	6.84e-6	Parental longevity (mother's age at death);
SKCM	cis	rs561341	1.000	rs72825712	chr17:30316119	A/T	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs6736997	1.000	rs6736997	chr2:235615197	A/C	cg17841421	chr2:235704848	NA	0.59	5.15	0.5	1.93e-6	Pancreatic cancer;
SKCM	cis	rs7937682	0.924	rs7924683	chr11:111555796	C/A	cg09085632	chr11:111637200	PPP2R1B	-1.06	-13.01	-0.83	3.13e-21	Primary sclerosing cholangitis;
SKCM	cis	rs9858542	0.953	rs11922013	chr3:49458355	G/C	cg03060546	chr3:49711283	APEH	-0.75	-5.53	-0.53	4.17e-7	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs7633770	0.786	rs1402148	chr3:46678295	C/T	cg11219411	chr3:46661640	NA	0.54	4.86	0.48	5.98e-6	Coronary artery disease;
SKCM	cis	rs1559088	0.522	rs7254912	chr19:33554151	A/G	cg17764715	chr19:33622953	WDR88	0.92	6.76	0.61	2.24e-9	Bone ultrasound measurement (broadband ultrasound attenuation);
SKCM	cis	rs28595532	0.920	rs114683212	chr4:119760209	A/G	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs1218582	0.740	rs1977879	chr1:154879743	G/A	cg16680214	chr1:154839983	KCNN3	-0.56	-5.01	-0.49	3.29e-6	Prostate cancer;
SKCM	cis	rs2070488	1.000	rs2276540	chr3:38512507	G/A	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.98	9.09	0.72	7.18e-14	Electrocardiographic conduction measures;
SKCM	cis	rs9549367	0.673	rs575453	chr13:113837871	C/A	cg18105134	chr13:113819100	PROZ	0.87	6.56	0.6	5.34e-9	Platelet distribution width;
SKCM	cis	rs6866344	0.661	rs72812606	chr5:178129094	A/T	cg03877680	chr5:178157825	ZNF354A	0.82	5.7	0.54	2.03e-7	Neutrophil percentage of white cells;
SKCM	cis	rs116095464	0.558	rs6555052	chr5:224268	G/A	cg22496380	chr5:211416	CCDC127	-0.96	-5.27	-0.51	1.18e-6	Breast cancer;
SKCM	cis	rs752010	0.619	rs4393146	chr1:42118766	A/G	cg06885757	chr1:42089581	HIVEP3	0.57	6.21	0.58	2.4e-8	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs1799949	0.965	rs33988650	chr17:41287880	A/G	cg05368731	chr17:41323189	NBR1	0.89	7.91	0.67	1.38e-11	Menopause (age at onset);
SKCM	cis	rs7666738	0.753	rs13122897	chr4:98936185	C/A	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs17780086	0.529	rs7406406	chr17:30220153	T/G	cg00745463	chr17:30367425	LRRC37B	-0.78	-5.08	-0.5	2.53e-6	Height;
SKCM	cis	rs55823223	0.564	rs58363746	chr17:73850819	C/T	cg08125733	chr17:73851984	WBP2	1.06	6.6	0.6	4.51e-9	Psoriasis;
SKCM	cis	rs362272	0.545	rs3135146	chr4:3307638	C/G	cg09735869	chr4:3319127	RGS12	-0.96	-11.44	-0.79	2.3e-18	Serum sulfate level;
SKCM	cis	rs4727027	0.801	rs12666337	chr7:148796253	C/T	cg23583168	chr7:148888333	NA	-0.82	-6.49	-0.59	7.11e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs7659604	0.539	rs2063165	chr4:122750005	A/G	cg19748678	chr4:122722346	EXOSC9	0.65	5.4	0.52	7.02e-7	Type 2 diabetes;
SKCM	cis	rs9325144	0.723	rs11169535	chr12:39183494	C/T	cg26384229	chr12:38710491	ALG10B	-0.71	-6.25	-0.58	2.02e-8	Morning vs. evening chronotype;
SKCM	cis	rs9402673	0.558	rs9688342	chr6:135323026	A/T	cg24558204	chr6:135376177	HBS1L	0.59	5.23	0.51	1.41e-6	Reticulocyte count;High light scatter reticulocyte count;
SKCM	cis	rs870825	0.655	rs28661636	chr4:185634218	A/C	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs6565180	1.000	rs68051857	chr16:30360011	A/G	cg17640201	chr16:30407289	ZNF48	-0.93	-7.41	-0.64	1.29e-10	Tonsillectomy;
SKCM	cis	rs12497850	0.863	rs4858799	chr3:48728204	G/C	cg07636037	chr3:49044803	WDR6	0.9	9.1	0.72	6.77e-14	Parkinson's disease;
SKCM	cis	rs11098499	0.863	rs2170276	chr4:120485824	A/C	cg09307838	chr4:120376055	NA	1.0	8.27	0.68	2.8e-12	Corneal astigmatism;
SKCM	cis	rs748404	0.578	rs552701	chr15:43613810	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	0.82	6.24	0.58	2.08e-8	Lung cancer;
SKCM	cis	rs823143	0.570	rs1361754	chr1:205801872	C/T	cg14159672	chr1:205819179	PM20D1	-0.99	-9.66	-0.74	5.63e-15	Monocyte percentage of white cells;
SKCM	cis	rs1475911	0.671	rs12483409	chr21:43521902	G/A	cg24372256	chr21:43528868	UMODL1;C21orf128	-0.73	-5.33	-0.52	9.25e-7	IgG glycosylation;
SKCM	cis	rs7523050	0.643	rs12729998	chr1:109405505	T/C	cg08274380	chr1:109419600	GPSM2	1.18	6.44	0.59	9.12e-9	Fat distribution (HIV);
SKCM	cis	rs1059312	1.000	rs7970815	chr12:129288366	G/A	cg09035930	chr12:129282057	SLC15A4	0.8	8.82	0.71	2.36e-13	Systemic lupus erythematosus;
SKCM	cis	rs2070488	1.000	rs1002675	chr3:38445226	C/T	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.99	9.76	0.74	3.59e-15	Electrocardiographic conduction measures;
SKCM	trans	rs17685	0.796	rs3757594	chr7:75678644	G/A	cg19862616	chr7:65841803	NCRNA00174	-0.94	-9.39	-0.73	1.88e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs28595532	0.844	rs116721336	chr4:119536538	A/G	cg21605333	chr4:119757512	SEC24D	1.24	7.1	0.63	5.16e-10	Cannabis dependence symptom count;
SKCM	cis	rs10089	1.000	rs10060181	chr5:127475573	A/G	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.9	9.15	0.72	5.44e-14	Ileal carcinoids;
SKCM	cis	rs244731	1.000	rs244728	chr5:176537407	C/T	cg06060754	chr5:176797920	RGS14	0.82	5.98	0.56	6.34e-8	Urate levels in lean individuals;
SKCM	cis	rs769267	0.965	rs2315025	chr19:19426609	C/T	cg03709012	chr19:19516395	GATAD2A	0.84	6.97	0.62	9.13e-10	Tonsillectomy;
SKCM	cis	rs13118159	0.550	rs2336081	chr4:1350322	A/G	cg02018176	chr4:1364513	KIAA1530	-0.89	-7.62	-0.65	5.13e-11	Longevity;
SKCM	cis	rs11098499	0.738	rs28408407	chr4:120376030	C/G	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs3784262	0.765	rs8026952	chr15:58276950	C/A	cg12031962	chr15:58353849	ALDH1A2	-0.45	-5.34	-0.52	9.08e-7	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs17711722	0.690	rs116823227	chr7:65331001	A/G	cg18876405	chr7:65276391	NA	0.8	6.59	0.6	4.69e-9	Calcium levels;
SKCM	cis	rs4332037	0.901	rs11767040	chr7:1945468	C/T	cg02825527	chr7:2087843	MAD1L1	-0.73	-5.11	-0.5	2.22e-6	Bipolar disorder;
SKCM	cis	rs11098499	1.000	rs11726229	chr4:120211580	C/T	cg09307838	chr4:120376055	NA	0.96	8.12	0.68	5.43e-12	Corneal astigmatism;
SKCM	cis	rs7959452	0.640	rs1598543	chr12:69688757	G/T	cg20891283	chr12:69753455	YEATS4	0.77	7.18	0.63	3.5e-10	Blood protein levels;
SKCM	cis	rs9325144	0.555	rs4550281	chr12:38689937	A/G	cg13010199	chr12:38710504	ALG10B	0.63	5.01	0.49	3.31e-6	Morning vs. evening chronotype;
SKCM	cis	rs9916302	0.561	rs12453198	chr17:37741879	T/C	cg07936489	chr17:37558343	FBXL20	-0.85	-5.92	-0.56	8.06e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs9818758	0.607	rs11719220	chr3:49245201	A/G	cg24110177	chr3:50126178	RBM5	0.84	5.0	0.49	3.47e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs2836974	0.897	rs8128102	chr21:40606414	G/A	cg11644478	chr21:40555479	PSMG1	0.97	10.08	0.75	8.76e-16	Cognitive function;
SKCM	cis	rs2594989	0.779	rs2437685	chr3:11593013	A/G	cg00170343	chr3:11313890	ATG7	0.97	5.42	0.52	6.41e-7	Circulating chemerin levels;
SKCM	cis	rs55823223	0.648	rs11867582	chr17:73857306	A/G	cg08125733	chr17:73851984	WBP2	1.06	5.97	0.56	6.62e-8	Psoriasis;
SKCM	cis	rs3087591	0.887	rs2905796	chr17:29537586	G/A	cg24425628	chr17:29625626	OMG;NF1	0.64	5.22	0.51	1.43e-6	Hip circumference;
SKCM	cis	rs752010	0.668	rs10890147	chr1:42089725	A/T	cg06885757	chr1:42089581	HIVEP3	0.72	7.64	0.65	4.6e-11	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs6547741	1.000	rs6547741	chr2:27855924	G/A	cg27432699	chr2:27873401	GPN1	0.73	6.65	0.6	3.7e-9	Oral cavity cancer;
SKCM	cis	rs1298637	0.655	rs55899711	chr1:53919491	C/T	cg09586583	chr1:54755153	SSBP3	0.62	5.3	0.51	1.05e-6	Nicotine use;
SKCM	cis	rs1559088	0.546	rs11881543	chr19:33559372	T/G	cg27124370	chr19:33622961	WDR88	0.83	6.0	0.56	5.76e-8	Bone ultrasound measurement (broadband ultrasound attenuation);
SKCM	cis	rs801193	0.548	rs2109297	chr7:66122384	G/A	cg11764359	chr7:65958608	NA	-0.74	-6.66	-0.6	3.49e-9	Aortic root size;
SKCM	cis	rs8072100	0.840	rs12453233	chr17:45454570	C/T	cg25173405	chr17:45401733	C17orf57	-0.57	-4.77	-0.48	8.45e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs514406	0.698	rs522259	chr1:53365481	A/G	cg16325326	chr1:53192061	ZYG11B	0.65	5.65	0.54	2.56e-7	Monocyte count;
SKCM	cis	rs28595532	0.920	rs115372254	chr4:119771735	T/C	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs875971	0.522	rs1617484	chr7:65463095	G/A	cg00343986	chr7:65444356	GUSB	0.65	4.83	0.48	6.58e-6	Aortic root size;
SKCM	cis	rs2739330	0.703	rs5760112	chr22:24259772	C/G	cg04234412	chr22:24373322	LOC391322	-0.61	-5.19	-0.51	1.61e-6	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs507080	0.922	rs555356	chr11:118558078	G/T	cg18045108	chr11:118530628	TREH	-0.47	-4.81	-0.48	7.24e-6	Serum metabolite levels;
SKCM	cis	rs11098499	0.954	rs12510138	chr4:120423935	C/G	cg09307838	chr4:120376055	NA	0.98	8.11	0.68	5.81e-12	Corneal astigmatism;
SKCM	cis	rs798554	1.000	rs798536	chr7:2766383	G/A	cg19346786	chr7:2764209	NA	-0.6	-6.13	-0.57	3.41e-8	Height;
SKCM	cis	rs1538970	0.816	rs10789464	chr1:45959102	C/T	cg05343316	chr1:45956843	TESK2	0.94	4.82	0.48	7.07e-6	Platelet count;
SKCM	cis	rs1506636	1.000	rs7779099	chr7:123295964	C/T	cg03229431	chr7:123269106	ASB15	-0.62	-4.92	-0.49	4.73e-6	Plateletcrit;Platelet count;
SKCM	cis	rs1218582	0.741	rs4339857	chr1:154888962	A/G	cg06221963	chr1:154839813	KCNN3	-0.59	-5.97	-0.56	6.76e-8	Prostate cancer;
SKCM	cis	rs2455601	0.786	rs3763914	chr11:8940703	G/T	cg21881798	chr11:8931708	C11orf17;ST5	-0.8	-5.59	-0.53	3.23e-7	Schizophrenia;
SKCM	cis	rs6424115	1.000	rs35385477	chr1:24155924	G/A	cg15997130	chr1:24165203	NA	0.62	5.42	0.52	6.33e-7	Immature fraction of reticulocytes;
SKCM	cis	rs826838	1.000	rs11610522	chr12:38687575	C/T	cg26384229	chr12:38710491	ALG10B	1.08	9.62	0.74	6.73e-15	Heart rate;
SKCM	cis	rs1348850	0.668	rs6734683	chr2:178494012	C/G	cg27490568	chr2:178487706	NA	0.79	5.95	0.56	7.25e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs748404	0.660	rs2602141	chr15:43724646	A/C	cg02155558	chr15:43621948	ADAL;LCMT2	0.77	6.13	0.57	3.35e-8	Lung cancer;
SKCM	cis	rs7824557	0.591	rs2060457	chr8:11213250	C/T	cg21775007	chr8:11205619	TDH	0.66	5.72	0.54	1.91e-7	Retinal vascular caliber;
SKCM	cis	rs6743226	0.934	rs6704615	chr2:242228733	A/G	cg10021735	chr2:242295487	FARP2	-0.55	-4.82	-0.48	7e-6	Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction);Waist circumference adjusted for BMI (adjusted for smoking behaviour);Waist circumference adjusted for BMI in non-smokers;
SKCM	cis	rs801193	0.660	rs2659914	chr7:66156914	C/T	cg11764359	chr7:65958608	NA	0.83	7.67	0.66	4.11e-11	Aortic root size;
SKCM	cis	rs6951245	0.935	rs11763765	chr7:1060510	C/T	cg18402987	chr7:1209562	NA	1.14	5.99	0.56	6.11e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs6977660	1.000	rs5017196	chr7:19819983	T/C	cg07541023	chr7:19748670	TWISTNB	0.71	4.86	0.48	6.02e-6	Thyroid stimulating hormone;
SKCM	cis	rs6582630	0.502	rs7311700	chr12:38463232	T/A	cg13010199	chr12:38710504	ALG10B	0.69	4.9	0.49	5.02e-6	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs9303401	0.659	rs7223708	chr17:56896398	A/G	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.16	0.57	2.91e-8	Cognitive test performance;
SKCM	cis	rs6951245	0.554	rs58210047	chr7:1149381	G/A	cg03188948	chr7:1209495	NA	0.83	5.88	0.55	9.86e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs6952808	0.929	rs34145223	chr7:1926237	G/A	cg21782813	chr7:2030301	MAD1L1	0.54	5.45	0.53	5.61e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs933688	1.000	rs889213	chr5:90682151	C/T	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.01	7.62	0.65	5.01e-11	Smoking behavior;
SKCM	cis	rs10779751	1.000	rs1135172	chr1:11301714	C/T	cg08854313	chr1:11322531	MTOR	-0.92	-6.91	-0.62	1.19e-9	Body mass index;
SKCM	cis	rs597539	0.652	rs602364	chr11:68662167	C/T	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.82	5.44	0.52	5.87e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs763014	0.898	rs12917944	chr16:622565	A/G	cg09263875	chr16:632152	PIGQ	0.68	5.72	0.54	1.92e-7	Height;
SKCM	cis	rs2836974	0.545	rs8128901	chr21:40710419	G/A	cg17971929	chr21:40555470	PSMG1	0.73	5.98	0.56	6.23e-8	Cognitive function;
SKCM	cis	rs2842992	0.830	rs1998365	chr6:160179535	A/T	cg11366901	chr6:160182831	ACAT2	0.94	7.85	0.66	1.81e-11	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs6089584	0.566	rs6061964	chr20:60607536	G/A	cg06108461	chr20:60628389	TAF4	-0.73	-6.66	-0.6	3.43e-9	Body mass index;
SKCM	cis	rs9911578	1.000	rs9892795	chr17:57023054	G/C	cg05425664	chr17:57184151	TRIM37	-0.67	-5.04	-0.5	2.91e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9660180	1.000	rs3737628	chr1:1722932	C/T	cg23982607	chr1:1823379	GNB1	-0.68	-6.09	-0.57	3.97e-8	Body mass index;
SKCM	cis	rs12762955	0.561	rs7075141	chr10:1091195	C/T	cg20503657	chr10:835505	NA	-0.54	-4.94	-0.49	4.35e-6	Response to angiotensin II receptor blocker therapy;
SKCM	cis	rs6545883	0.894	rs10177303	chr2:61594459	G/A	cg15711740	chr2:61764176	XPO1	0.68	4.82	0.48	6.94e-6	Tuberculosis;
SKCM	cis	rs7618501	0.602	rs34831713	chr3:50118748	T/C	cg24110177	chr3:50126178	RBM5	0.61	5.18	0.51	1.71e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9814567	0.896	rs4435682	chr3:134344182	C/T	cg06109529	chr3:134205091	CEP63;ANAPC13	0.63	5.1	0.5	2.35e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs992157	0.737	rs3731860	chr2:219156979	G/A	cg20019365	chr2:219134978	PNKD;AAMP	-0.71	-6.02	-0.56	5.39e-8	Colorectal cancer;
SKCM	cis	rs12477438	0.520	rs6542864	chr2:99725223	A/G	cg14399236	chr2:99771627	LIPT1;TSGA10	0.95	8.78	0.71	2.89e-13	Chronic sinus infection;
SKCM	cis	rs2839186	0.749	rs62226489	chr21:47710519	T/C	cg11766577	chr21:47581405	C21orf56	-0.71	-6.01	-0.56	5.6e-8	Testicular germ cell tumor;
SKCM	cis	rs208520	1.000	rs9453663	chr6:66976077	A/G	cg07460842	chr6:66804631	NA	0.85	6.05	0.56	4.8e-8	Exhaled nitric oxide output;
SKCM	trans	rs12599106	0.584	rs12929704	chr16:34898258	C/A	cg03395511	chr6:291903	DUSP22	-0.73	-7.95	-0.67	1.15e-11	Menopause (age at onset);
SKCM	cis	rs2033711	0.870	rs7259841	chr19:58951123	T/C	cg12042659	chr19:58951599	ZNF132	0.66	5.75	0.55	1.63e-7	Uric acid clearance;
SKCM	cis	rs11105298	0.891	rs11105316	chr12:89925200	T/G	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.87	-5.78	-0.55	1.46e-7	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs7106204	0.858	rs2403889	chr11:24210226	T/C	ch.11.24196551F	chr11:24239977	NA	0.77	5.97	0.56	6.6e-8	Response to Homoharringtonine (cytotoxicity);
SKCM	cis	rs1577917	0.958	rs2875456	chr6:86602284	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.67	-5.89	-0.55	9.22e-8	Response to antipsychotic treatment;
SKCM	cis	rs6121246	0.559	rs6087779	chr20:30370566	T/C	cg11595048	chr20:30225325	COX4I2	0.54	4.77	0.48	8.4e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs9902453	0.899	rs1979572	chr17:28511978	G/A	cg26525008	chr17:28256777	EFCAB5;SSH2	0.75	5.19	0.51	1.64e-6	Coffee consumption (cups per day);
SKCM	cis	rs9913156	0.639	rs72824971	chr17:4604270	A/G	cg19197139	chr17:4613644	ARRB2	0.8	5.34	0.52	8.82e-7	Lymphocyte counts;
SKCM	cis	rs11098499	0.863	rs13140391	chr4:120503437	A/G	cg09307838	chr4:120376055	NA	1.0	8.27	0.68	2.8e-12	Corneal astigmatism;
SKCM	cis	rs4727027	0.899	rs11771339	chr7:148854132	A/T	cg23583168	chr7:148888333	NA	-0.8	-6.66	-0.6	3.52e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs362296	0.511	rs2051558	chr4:3324886	G/A	cg11471262	chr4:3318911	RGS12	0.8	8.54	0.7	8.46e-13	Parental longevity (mother's age at death);
SKCM	cis	rs34172651	0.517	rs8059004	chr16:24837905	G/A	cg04756594	chr16:24857601	SLC5A11	0.71	5.02	0.49	3.15e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs477895	0.713	rs12575642	chr11:63979643	G/T	cg07220939	chr11:64358617	SLC22A12	0.68	4.84	0.48	6.31e-6	Mean platelet volume;
SKCM	cis	rs35306767	0.903	rs11253495	chr10:937064	C/T	cg25614935	chr10:1084866	C10orf110	0.79	4.77	0.48	8.48e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs1799949	0.965	rs9646413	chr17:41426157	A/G	cg05368731	chr17:41323189	NBR1	0.83	6.99	0.62	8.32e-10	Menopause (age at onset);
SKCM	cis	rs2739330	0.731	rs2000468	chr22:24241611	G/T	cg25703541	chr22:24373054	LOC391322	-0.92	-8.42	-0.69	1.47e-12	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs72772090	0.710	rs17400685	chr5:96066366	A/C	cg17330273	chr5:96107758	CAST;ERAP1	0.88	5.33	0.52	9.11e-7	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs155076	1.000	rs261369	chr13:21868420	C/A	cg11317459	chr13:21872234	NA	-1.33	-7.9	-0.67	1.49e-11	White matter hyperintensity burden;
SKCM	cis	rs1005277	0.522	rs7090858	chr10:38003670	A/C	cg00409905	chr10:38381863	ZNF37A	0.59	5.75	0.55	1.67e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs3785574	0.962	rs2247435	chr17:61892862	G/A	cg06873352	chr17:61820015	STRADA	0.56	4.82	0.48	6.86e-6	Height;
SKCM	cis	rs7945705	0.846	rs4929912	chr11:8816695	A/G	cg21881798	chr11:8931708	C11orf17;ST5	-0.68	-6.16	-0.57	2.95e-8	Hemoglobin concentration;
SKCM	cis	rs1348850	0.914	rs10170667	chr2:178336878	A/G	cg02961200	chr2:178257176	LOC100130691;AGPS	0.83	6.14	0.57	3.21e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs4891159	0.527	rs34956524	chr18:74130480	A/G	cg24786174	chr18:74118243	ZNF516	0.79	8.44	0.69	1.31e-12	Longevity;
SKCM	cis	rs17685	0.753	rs1637045	chr7:75703895	T/C	cg01364799	chr7:75623366	TMEM120A	-0.69	-5.56	-0.53	3.59e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs798554	0.757	rs1182178	chr7:2873763	G/A	cg04166393	chr7:2884313	GNA12	0.67	4.8	0.48	7.51e-6	Height;
SKCM	cis	rs782590	0.967	rs1975487	chr2:55809054	A/G	cg18811423	chr2:55921094	PNPT1	0.87	6.87	0.61	1.38e-9	Metabolic syndrome;
SKCM	cis	rs2153535	0.580	rs9328479	chr6:8519646	A/G	cg07606381	chr6:8435919	SLC35B3	0.87	6.38	0.59	1.17e-8	Motion sickness;
SKCM	cis	rs6921919	0.609	rs36018474	chr6:28385529	C/G	cg14547644	chr6:28411285	ZSCAN23	-0.58	-4.8	-0.48	7.46e-6	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs3820928	1.000	rs1835158	chr2:227763993	C/A	cg11843606	chr2:227700838	RHBDD1	-0.64	-5.17	-0.51	1.73e-6	Pulmonary function;
SKCM	cis	rs597539	0.652	rs559032	chr11:68710847	G/T	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.89	6.13	0.57	3.3e-8	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs10751667	0.666	rs10902242	chr11:949700	G/A	cg10932868	chr11:921992	NA	0.55	5.1	0.5	2.36e-6	Alzheimer's disease (late onset);
SKCM	cis	rs738322	0.726	rs5750561	chr22:38595260	A/T	cg25457927	chr22:38595422	NA	0.58	7.88	0.67	1.59e-11	Cutaneous nevi;
SKCM	cis	rs644799	1.000	rs546809	chr11:95579938	A/G	cg03916912	chr11:95522834	CEP57;FAM76B	0.88	7.53	0.65	7.59e-11	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs4332037	0.805	rs10278591	chr7:1921362	A/G	cg02825527	chr7:2087843	MAD1L1	0.64	4.79	0.48	7.7e-6	Bipolar disorder;
SKCM	cis	rs933688	1.000	rs10045280	chr5:90717675	T/A	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.94	6.58	0.6	4.82e-9	Smoking behavior;
SKCM	cis	rs9926296	0.508	rs1558184	chr16:89842374	T/G	cg26513180	chr16:89883248	FANCA	0.97	10.42	0.76	1.94e-16	Vitiligo;
SKCM	cis	rs6461049	0.519	rs3778992	chr7:2175313	C/G	cg02951883	chr7:2050386	MAD1L1	-0.59	-5.11	-0.5	2.21e-6	Schizophrenia;
SKCM	cis	rs9790314	0.723	rs10936223	chr3:160884313	C/A	cg03342759	chr3:160939853	NMD3	-0.69	-6.89	-0.62	1.28e-9	Morning vs. evening chronotype;
SKCM	cis	rs7618501	0.516	rs2856236	chr3:50161717	A/C	cg24110177	chr3:50126178	RBM5	0.6	5.21	0.51	1.51e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7666738	0.830	rs7691433	chr4:98968118	A/T	cg17366294	chr4:99064904	C4orf37	0.61	5.25	0.51	1.25e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6546550	0.901	rs10496174	chr2:70153436	T/G	cg02498382	chr2:70120550	SNRNP27	-0.45	-4.88	-0.48	5.4e-6	Prevalent atrial fibrillation;
SKCM	cis	rs2836974	0.800	rs73221174	chr21:40540939	T/C	cg17971929	chr21:40555470	PSMG1	0.9	8.95	0.71	1.37e-13	Cognitive function;
SKCM	cis	rs2952156	0.920	rs11078919	chr17:37835755	T/C	cg20243544	chr17:37824526	PNMT	0.69	5.53	0.53	4.15e-7	Asthma;
SKCM	cis	rs2072499	0.833	rs2251847	chr1:156204047	G/A	cg25208724	chr1:156163844	SLC25A44	0.91	7.96	0.67	1.14e-11	Testicular germ cell tumor;
SKCM	trans	rs11722228	0.508	rs61335146	chr4:10130793	G/C	cg26043149	chr18:55253948	FECH	0.95	8.68	0.7	4.6e-13	Gout;Urate levels;Serum uric acid levels;
SKCM	cis	rs5750830	0.649	rs4337572	chr22:39800704	C/G	cg11247378	chr22:39784982	NA	-0.49	-5.98	-0.56	6.33e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs10911232	0.507	rs4266836	chr1:183029070	T/G	ch.1.3577855R	chr1:183094577	LAMC1	0.77	6.89	0.62	1.27e-9	Hypertriglyceridemia;
SKCM	cis	rs9640161	0.830	rs1051764	chr7:150070663	T/C	cg10018233	chr7:150070692	REPIN1	0.81	9.18	0.72	4.91e-14	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs6912958	0.559	rs242280	chr6:88048714	G/A	cg08069147	chr6:88032118	GJB7;C6orf162	0.65	5.83	0.55	1.21e-7	Monocyte percentage of white cells;
SKCM	cis	rs507080	0.922	rs493834	chr11:118567444	A/G	cg18045108	chr11:118530628	TREH	-0.48	-5.15	-0.5	1.88e-6	Serum metabolite levels;
SKCM	cis	rs9640161	0.830	rs3757423	chr7:150067714	A/G	cg10018233	chr7:150070692	REPIN1	-0.78	-8.62	-0.7	5.77e-13	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs2836974	0.897	rs2836932	chr21:40546717	G/A	cg11890956	chr21:40555474	PSMG1	1.07	13.19	0.83	1.48e-21	Cognitive function;
SKCM	cis	rs7632954	0.567	rs6808372	chr3:8534693	T/C	cg06697448	chr3:8544912	LMCD1	-0.56	-4.9	-0.49	5.06e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs1559088	0.546	rs11881543	chr19:33559372	T/G	cg17764715	chr19:33622953	WDR88	0.92	6.76	0.61	2.24e-9	Bone ultrasound measurement (broadband ultrasound attenuation);
SKCM	cis	rs826838	0.935	rs11169547	chr12:39185625	C/A	cg26384229	chr12:38710491	ALG10B	0.9	7.85	0.66	1.84e-11	Heart rate;
SKCM	cis	rs908922	0.676	rs945789	chr1:152512705	C/A	cg09873164	chr1:152488093	CRCT1	0.76	5.93	0.56	7.7e-8	Hair morphology;
SKCM	cis	rs11098499	0.779	rs7356491	chr4:120381974	C/T	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs55962025	0.883	rs362275	chr4:3224602	C/T	cg00764545	chr4:3318001	RGS12	-0.71	-5.79	-0.55	1.39e-7	Parental longevity (mother's age at death);
SKCM	cis	rs11098499	0.754	rs10212775	chr4:120239244	G/C	cg09307838	chr4:120376055	NA	0.93	7.56	0.65	6.5500000000000006e-11	Corneal astigmatism;
SKCM	cis	rs2839186	0.721	rs13051200	chr21:47701693	A/T	cg11766577	chr21:47581405	C21orf56	-0.68	-5.69	-0.54	2.1e-7	Testicular germ cell tumor;
SKCM	cis	rs2836974	0.931	rs2836968	chr21:40642386	A/G	cg17971929	chr21:40555470	PSMG1	0.9	8.87	0.71	1.93e-13	Cognitive function;
SKCM	cis	rs8042680	0.554	rs8035844	chr15:91519642	C/T	cg15878949	chr15:91534302	PRC1	0.61	5.07	0.5	2.61e-6	Type 2 diabetes;
SKCM	cis	rs1862618	0.853	rs832582	chr5:56177743	G/A	cg12311346	chr5:56204834	C5orf35	-0.75	-4.86	-0.48	5.96e-6	Initial pursuit acceleration;
SKCM	cis	rs5753618	0.509	rs2079431	chr22:31564334	C/T	cg02404636	chr22:31891804	SFI1	-0.57	-4.94	-0.49	4.4e-6	Colorectal cancer;
SKCM	cis	rs8060686	0.641	rs12445396	chr16:68155121	G/A	cg09117114	chr16:67998030	SLC12A4	-0.81	-5.29	-0.51	1.07e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs875971	0.522	rs709604	chr7:65497434	A/G	cg11764359	chr7:65958608	NA	-0.87	-6.61	-0.6	4.37e-9	Aortic root size;
SKCM	cis	rs11098499	0.954	rs6849171	chr4:120409549	G/A	cg24375607	chr4:120327624	NA	0.66	5.09	0.5	2.44e-6	Corneal astigmatism;
SKCM	cis	rs7811142	1.000	rs67471932	chr7:100009985	C/G	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.23	8.03	0.67	8.33e-12	Platelet count;
SKCM	cis	rs6952808	0.723	rs4721295	chr7:2036669	G/T	cg21782813	chr7:2030301	MAD1L1	-0.53	-5.31	-0.52	9.95e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs4332037	0.906	rs6461009	chr7:1952139	T/C	cg02825527	chr7:2087843	MAD1L1	0.71	4.95	0.49	4.19e-6	Bipolar disorder;
SKCM	cis	rs8063761	0.689	rs4785763	chr16:90066936	G/T	cg08547343	chr16:90038815	CENPBD1;AFG3L1	-0.85	-6.67	-0.6	3.33e-9	Squamous cell carcinoma;
SKCM	cis	rs8060686	0.641	rs3785109	chr16:68118311	G/A	cg09117114	chr16:67998030	SLC12A4	-0.8	-5.22	-0.51	1.47e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs9303401	0.659	rs72828726	chr17:56951217	C/G	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.16	0.57	2.91e-8	Cognitive test performance;
SKCM	cis	rs7772486	0.846	rs9403767	chr6:146402386	G/T	cg23711669	chr6:146136114	FBXO30	0.83	7.86	0.66	1.79e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4665809	0.590	rs17528653	chr2:26507724	T/C	cg26119090	chr2:26468346	HADHA;HADHB	1.08	8.63	0.7	5.67e-13	Gut microbiome composition (summer);
SKCM	cis	rs6952808	0.756	rs4719311	chr7:1881813	C/T	cg04267008	chr7:1944627	MAD1L1	-0.75	-5.75	-0.55	1.63e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs711830	1.000	rs1318778	chr2:177037831	C/G	cg13092806	chr2:177043255	NA	0.67	6.18	0.57	2.68e-8	Serous invasive ovarian cancer;Epithelial ovarian cancer;Invasive epithelial ovarian cancer;Mucinous ovarian carcinoma;Low-grade serous and serous borderline ovarian cancer;Serous borderline ovarian cancer;High-grade serous ovarian cancer;
SKCM	cis	rs4774899	0.966	rs62022237	chr15:57513613	C/T	cg01857019	chr15:57210107	LOC145783;TCF12	0.54	4.83	0.48	6.73e-6	Urinary tract infection frequency;
SKCM	cis	rs11098499	0.863	rs7695620	chr4:120452776	G/A	cg24375607	chr4:120327624	NA	0.68	5.27	0.51	1.16e-6	Corneal astigmatism;
SKCM	cis	rs9303401	0.614	rs34900851	chr17:56566399	G/A	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.19	0.57	2.61e-8	Cognitive test performance;
SKCM	cis	rs9467773	0.935	rs9461270	chr6:26544110	A/G	cg09904177	chr6:26538194	HMGN4	0.54	4.98	0.49	3.78e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs208520	0.690	rs12213928	chr6:66762978	G/A	cg07460842	chr6:66804631	NA	0.93	7.0	0.62	7.87e-10	Exhaled nitric oxide output;
SKCM	cis	rs801193	0.967	rs2707849	chr7:66152712	T/C	cg00343986	chr7:65444356	GUSB	0.7	5.14	0.5	1.98e-6	Aortic root size;
SKCM	cis	rs1215050	0.904	rs9307215	chr4:98813965	A/G	cg17366294	chr4:99064904	C4orf37	0.54	4.81	0.48	7.09e-6	Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs8017423	0.967	rs11624725	chr14:90713609	G/T	cg04374321	chr14:90722782	PSMC1	-1.03	-9.53	-0.73	1.04e-14	Mortality in heart failure;
SKCM	cis	rs7666738	0.800	rs7683737	chr4:99070880	A/T	cg05340658	chr4:99064831	C4orf37	0.66	4.87	0.48	5.74e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2404602	0.587	rs17380507	chr15:77235361	C/T	cg23625390	chr15:77176239	SCAPER	0.64	5.68	0.54	2.22e-7	Blood metabolite levels;
SKCM	cis	rs12709013	0.792	rs12935488	chr16:58800224	C/T	cg02431531	chr16:59244939	NA	0.48	5.11	0.5	2.25e-6	Blood metabolite ratios;
SKCM	cis	rs9914544	0.628	rs4630608	chr17:18678548	C/T	cg26306683	chr17:18585705	ZNF286B	0.64	4.88	0.48	5.59e-6	Educational attainment (years of education);
SKCM	cis	rs10504229	1.000	rs57186557	chr8:58177277	A/G	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs875971	0.660	rs1860468	chr7:66107252	T/C	cg00343986	chr7:65444356	GUSB	-0.68	-4.99	-0.49	3.65e-6	Aortic root size;
SKCM	cis	rs4332037	0.901	rs7791899	chr7:1935988	T/C	cg23422044	chr7:1970798	MAD1L1	-0.95	-6.45	-0.59	8.43e-9	Bipolar disorder;
SKCM	cis	rs28595532	0.920	rs114093638	chr4:119729819	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.43	0.59	9.38e-9	Cannabis dependence symptom count;
SKCM	trans	rs1814175	0.645	rs7928714	chr11:49887622	G/A	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs6977660	1.000	rs12673970	chr7:19813018	T/C	cg05791153	chr7:19748676	TWISTNB	0.79	5.53	0.53	4.14e-7	Thyroid stimulating hormone;
SKCM	cis	rs910316	1.000	rs4322591	chr14:75600697	C/T	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.85e-7	Height;
SKCM	cis	rs9880211	0.800	rs35210994	chr3:136496136	A/C	cg21827317	chr3:136751795	NA	-0.74	-5.43	-0.52	6.11e-7	Body mass index;Height;
SKCM	cis	rs13118159	0.771	rs13117476	chr4:1334721	A/G	cg20887711	chr4:1340912	KIAA1530	0.71	5.36	0.52	8.21e-7	Longevity;
SKCM	cis	rs4780401	0.573	rs8045673	chr16:11804385	C/A	cg01061890	chr16:11836724	TXNDC11	-0.8	-6.08	-0.57	4.16e-8	Rheumatoid arthritis;
SKCM	cis	rs72634258	0.945	rs225131	chr1:8095486	T/C	cg00042356	chr1:8021962	PARK7	0.9	6.09	0.57	3.99e-8	Inflammatory bowel disease;
SKCM	cis	rs4631830	0.720	rs4935573	chr10:51504385	A/G	cg16070123	chr10:51489643	NA	0.51	4.84	0.48	6.5e-6	Prostate-specific antigen levels;
SKCM	cis	rs7191439	0.722	rs6500491	chr16:88783521	T/C	cg02389323	chr16:88786976	FAM38A	1.58	6.59	0.6	4.66e-9	Plateletcrit;
SKCM	cis	rs9475752	0.793	rs28360538	chr6:56827936	T/A	cg06815302	chr6:57335405	PRIM2	0.65	5.03	0.49	3.12e-6	Menarche (age at onset);
SKCM	cis	rs2228479	0.702	rs11649501	chr16:89850957	A/T	cg06558623	chr16:89946397	TCF25	1.06	4.86	0.48	5.99e-6	Skin colour saturation;
SKCM	cis	rs7666738	0.830	rs62318504	chr4:98935558	T/G	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs59918340	0.692	rs6983780	chr8:142231944	G/A	cg23750338	chr8:142222470	SLC45A4	0.62	6.04	0.56	4.98e-8	Immature fraction of reticulocytes;
SKCM	cis	rs2842992	0.724	rs2273827	chr6:160211339	C/A	cg19482086	chr6:160211437	TCP1;MRPL18	0.87	7.46	0.65	1.04e-10	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs7336332	0.569	rs7988412	chr13:28000282	C/T	cg22138327	chr13:27999177	GTF3A	0.88	6.54	0.6	5.76e-9	Weight;
SKCM	cis	rs11098499	0.866	rs13125526	chr4:120288019	G/A	cg24375607	chr4:120327624	NA	0.62	4.77	0.48	8.45e-6	Corneal astigmatism;
SKCM	cis	rs1218582	0.772	rs2102423	chr1:154916068	A/G	cg06221963	chr1:154839813	KCNN3	-0.53	-5.11	-0.5	2.22e-6	Prostate cancer;
SKCM	cis	rs7824557	0.510	rs1435274	chr8:11235910	G/A	cg21775007	chr8:11205619	TDH	-0.57	-4.8	-0.48	7.47e-6	Retinal vascular caliber;
SKCM	cis	rs9325144	0.555	rs7968322	chr12:38792348	T/C	cg26384229	chr12:38710491	ALG10B	-0.75	-6.52	-0.59	6.23e-9	Morning vs. evening chronotype;
SKCM	cis	rs1878931	0.580	rs4578649	chr16:3407258	C/T	cg26668626	chr16:3451006	ZNF174;ZNF434	-0.94	-8.3	-0.68	2.48e-12	Body mass index (adult);
SKCM	cis	rs1401999	0.966	rs2292998	chr3:183663833	T/C	cg01324343	chr3:183735012	ABCC5	0.93	10.72	0.77	5.28e-17	Anterior chamber depth;
SKCM	cis	rs7618915	0.570	rs11130312	chr3:52675055	A/C	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs778371	0.723	rs6739794	chr2:233576165	G/A	cg08000102	chr2:233561755	GIGYF2	0.88	7.21	0.63	3.12e-10	Schizophrenia;
SKCM	cis	rs875971	0.522	rs2008188	chr7:65429013	G/C	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.61	5.18	0.51	1.66e-6	Aortic root size;
SKCM	cis	rs801193	1.000	rs2659912	chr7:66157999	G/C	cg18876405	chr7:65276391	NA	0.8	7.11	0.63	4.86e-10	Aortic root size;
SKCM	cis	rs12478296	1.000	rs55717005	chr2:243041071	T/A	cg06360820	chr2:242988706	NA	-0.92	-5.32	-0.52	9.84e-7	Obesity-related traits;
SKCM	cis	rs11249608	0.636	rs62393070	chr5:178447943	A/G	cg21905437	chr5:178450457	ZNF879	0.74	6.14	0.57	3.21e-8	Pubertal anthropometrics;
SKCM	cis	rs17376456	0.877	rs9314101	chr5:93461593	A/T	cg21475434	chr5:93447410	FAM172A	0.97	5.42	0.52	6.39e-7	Diabetic retinopathy;
SKCM	cis	rs7937682	0.921	rs4616071	chr11:111440865	C/G	cg19812747	chr11:111475976	SIK2	0.64	5.42	0.52	6.47e-7	Primary sclerosing cholangitis;
SKCM	cis	rs1707322	0.752	rs28890893	chr1:46186576	T/G	cg03146154	chr1:46216737	IPP	0.8	5.47	0.53	5.19e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs459571	0.920	rs455073	chr9:136909141	G/C	cg13789015	chr9:136890014	NCRNA00094	0.7	5.5	0.53	4.66e-7	Platelet distribution width;
SKCM	cis	rs6598955	0.670	rs3795685	chr1:26601385	A/G	cg04990556	chr1:26633338	UBXN11	0.59	4.88	0.48	5.46e-6	Obesity-related traits;
SKCM	trans	rs561341	0.769	rs559228	chr17:30294527	T/C	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs137761	0.576	rs4823126	chr22:44050598	C/T	cg12729397	chr22:44208276	EFCAB6	0.69	5.04	0.5	2.9e-6	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs62103177	0.608	rs34383580	chr18:77833263	A/G	cg06309094	chr18:77676213	PQLC1	0.82	5.02	0.49	3.21e-6	Opioid sensitivity;
SKCM	cis	rs1799949	1.000	rs4793231	chr17:41427469	A/G	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.2	-0.57	2.51e-8	Menopause (age at onset);
SKCM	cis	rs362296	0.661	rs3121420	chr4:3264210	T/C	cg05297308	chr4:3317976	RGS12	-0.69	-5.74	-0.54	1.75e-7	Parental longevity (mother's age at death);
SKCM	cis	rs67460515	0.563	rs1585481	chr3:160901481	C/T	cg03342759	chr3:160939853	NMD3	-0.73	-6.13	-0.57	3.34e-8	Parkinson's disease;
SKCM	cis	rs8060686	0.641	rs7199588	chr16:68224582	C/T	cg09117114	chr16:67998030	SLC12A4	-0.77	-5.0	-0.49	3.46e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs2074977	0.530	rs10401784	chr19:3445721	A/C	cg08380311	chr19:3435252	NFIC	0.76	5.79	0.55	1.4e-7	Height;
SKCM	cis	rs362272	0.524	rs2857982	chr4:3358665	G/A	cg00764545	chr4:3318001	RGS12	1.01	13.55	0.84	3.44e-22	Serum sulfate level;
SKCM	cis	rs4862750	1.000	rs4862750	chr4:187904043	C/T	cg10295955	chr4:187884368	NA	-1.03	-12.6	-0.82	1.73e-20	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs12824058	0.831	rs12831363	chr12:130814013	C/T	cg24838063	chr12:130822603	PIWIL1	-0.8	-6.99	-0.62	8.2e-10	Menopause (age at onset);
SKCM	cis	rs17065868	1.000	rs9525988	chr13:45172189	G/T	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs9325144	0.647	rs3759139	chr12:39087609	G/A	cg13010199	chr12:38710504	ALG10B	-0.64	-5.46	-0.53	5.57e-7	Morning vs. evening chronotype;
SKCM	cis	rs9399135	0.816	rs4134030	chr6:135354094	G/T	cg24558204	chr6:135376177	HBS1L	0.6	5.36	0.52	8.17e-7	Red blood cell count;
SKCM	cis	rs365132	1.000	rs7718874	chr5:176358065	A/G	cg16309518	chr5:176445507	NA	-0.52	-5.15	-0.5	1.91e-6	Menarche and menopause (age at onset);Menopause (age at onset);
SKCM	cis	rs651907	0.557	rs11914318	chr3:101453858	C/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.81	7.1	0.63	5.08e-10	Colorectal cancer;
SKCM	cis	rs2404602	0.532	rs284892	chr15:76721037	A/G	cg23625390	chr15:77176239	SCAPER	0.64	5.64	0.54	2.59e-7	Blood metabolite levels;
SKCM	cis	rs1218582	0.741	rs11264283	chr1:154869552	A/G	cg24250549	chr1:154909240	PMVK	0.87	8.7	0.7	4.13e-13	Prostate cancer;
SKCM	cis	rs7959452	0.535	rs7133487	chr12:69774377	G/A	cg20891283	chr12:69753455	YEATS4	0.9	9.17	0.72	4.95e-14	Blood protein levels;
SKCM	cis	rs67311347	0.544	rs13098483	chr3:40342743	G/C	cg02782426	chr3:40428986	ENTPD3	0.53	5.47	0.53	5.31e-7	Renal cell carcinoma;
SKCM	cis	rs1577917	0.771	rs2842609	chr6:86296788	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.79	-7.29	-0.64	2.22e-10	Response to antipsychotic treatment;
SKCM	cis	rs17065868	1.000	rs9316088	chr13:45104665	C/T	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs1059312	0.778	rs4760594	chr12:129296865	T/A	cg09035930	chr12:129282057	SLC15A4	0.77	8.03	0.67	8.18e-12	Systemic lupus erythematosus;
SKCM	cis	rs7666738	0.830	rs1967977	chr4:98966141	A/G	cg17366294	chr4:99064904	C4orf37	0.59	4.89	0.48	5.36e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4819052	0.851	rs4819043	chr21:46660078	G/A	cg02159808	chr21:46707872	POFUT2;LOC642852	0.69	5.36	0.52	8.31e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs748404	0.578	rs573615	chr15:43614281	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	0.82	6.24	0.58	2.08e-8	Lung cancer;
SKCM	cis	rs875971	0.516	rs6945322	chr7:65336056	T/C	cg18876405	chr7:65276391	NA	0.86	7.56	0.65	6.53e-11	Aortic root size;
SKCM	cis	rs9815354	0.812	rs17215883	chr3:41841873	C/T	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs2841233	0.718	rs61995995	chr14:105344293	C/T	cg16576083	chr14:105354267	KIAA0284	0.6	4.77	0.48	8.29e-6	IgG glycosylation;
SKCM	cis	rs2153535	0.580	rs1119691	chr6:8460452	C/T	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs7216064	1.000	rs2052187	chr17:65834737	T/C	cg12091567	chr17:66097778	LOC651250	-0.77	-5.53	-0.53	4.06e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs8141529	0.764	rs5752809	chr22:29225500	G/A	cg15103426	chr22:29168792	CCDC117	0.61	5.13	0.5	2.06e-6	Lymphocyte counts;
SKCM	cis	rs17376456	0.877	rs10476601	chr5:93402522	G/A	cg21475434	chr5:93447410	FAM172A	0.97	5.41	0.52	6.8e-7	Diabetic retinopathy;
SKCM	cis	rs11719291	0.833	rs11709246	chr3:48859498	G/A	cg24898236	chr3:49228699	LOC646498	0.65	4.98	0.49	3.66e-6	Cognitive function;
SKCM	cis	rs2180341	1.000	rs6569482	chr6:127631371	C/T	cg27446573	chr6:127587934	RNF146	1.01	8.78	0.7	2.93e-13	Breast cancer;
SKCM	cis	rs6546550	0.901	rs4144081	chr2:70155482	G/A	cg02498382	chr2:70120550	SNRNP27	-0.45	-4.88	-0.48	5.4e-6	Prevalent atrial fibrillation;
SKCM	trans	rs1814175	0.616	rs1722001	chr11:49894427	A/G	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs4242434	0.892	rs1809452	chr8:22491397	G/A	cg03733263	chr8:22462867	KIAA1967	1.06	8.57	0.7	7.26e-13	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs11673344	0.704	rs826290	chr19:37428445	C/T	cg07624650	chr19:37064219	ZNF529	-0.8	-5.23	-0.51	1.41e-6	Obesity-related traits;
SKCM	cis	rs6424115	1.000	rs7519554	chr1:24154566	T/A	cg15997130	chr1:24165203	NA	-0.62	-5.42	-0.52	6.33e-7	Immature fraction of reticulocytes;
SKCM	cis	rs11098499	0.604	rs10022185	chr4:120571765	C/G	cg09307838	chr4:120376055	NA	1.01	8.35	0.69	2.01e-12	Corneal astigmatism;
SKCM	cis	rs11710229	0.764	rs34375078	chr3:55471649	G/A	cg04915058	chr3:55693741	C3orf51;ERC2	0.9	5.08	0.5	2.53e-6	Response to cytadine analogues (cytosine arabinoside);
SKCM	cis	rs514406	0.800	rs7548519	chr1:53294473	A/G	cg16325326	chr1:53192061	ZYG11B	0.88	8.69	0.7	4.38e-13	Monocyte count;
SKCM	cis	rs7666738	0.830	rs1349757	chr4:99058763	C/G	cg05340658	chr4:99064831	C4orf37	0.66	4.87	0.48	5.74e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4808199	0.948	rs968525	chr19:19459215	C/T	cg03709012	chr19:19516395	GATAD2A	1.1	7.83	0.66	2.03e-11	Nonalcoholic fatty liver disease;
SKCM	cis	rs7954584	0.567	rs11043251	chr12:122373279	C/T	cg21171335	chr12:122356390	WDR66	0.46	4.99	0.49	3.52e-6	Mean corpuscular volume;
SKCM	cis	rs798554	0.836	rs798500	chr7:2790685	C/T	cg14895029	chr7:2775587	GNA12	0.7	5.36	0.52	8.13e-7	Height;
SKCM	cis	rs651907	0.557	rs3094296	chr3:101400167	A/G	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.77	6.98	0.62	8.55e-10	Colorectal cancer;
SKCM	cis	rs4242434	0.672	rs900267	chr8:22485258	T/C	cg03733263	chr8:22462867	KIAA1967	0.86	6.48	0.59	7.49e-9	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs2243480	1.000	rs57057549	chr7:65405738	A/G	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs10905065	0.965	rs7100576	chr10:5784649	G/A	cg09234995	chr10:5726438	C10orf18	-0.62	-5.25	-0.51	1.27e-6	Menopause (age at onset);
SKCM	cis	rs6424115	0.830	rs2503002	chr1:24196957	C/G	cg15997130	chr1:24165203	NA	0.58	4.83	0.48	6.73e-6	Immature fraction of reticulocytes;
SKCM	cis	rs780096	0.506	rs56076827	chr2:27676287	A/T	cg05696406	chr2:27599888	SNX17	0.51	5.06	0.5	2.75e-6	Total body bone mineral density;
SKCM	cis	rs514406	0.679	rs11585495	chr1:53244331	T/C	cg16325326	chr1:53192061	ZYG11B	-0.64	-5.01	-0.49	3.3e-6	Monocyte count;
SKCM	cis	rs854765	0.583	rs4925123	chr17:17784374	A/G	cg09796270	chr17:17721594	SREBF1	-0.64	-4.91	-0.49	4.89e-6	Total body bone mineral density;
SKCM	trans	rs17685	0.712	rs1859792	chr7:75789264	T/C	cg19862616	chr7:65841803	NCRNA00174	0.91	8.9	0.71	1.7e-13	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1577917	1.000	rs13217384	chr6:86720000	C/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.87	-8.27	-0.68	2.87e-12	Response to antipsychotic treatment;
SKCM	cis	rs1185460	0.967	rs1786685	chr11:118938957	G/A	cg23280166	chr11:118938394	VPS11	0.59	5.41	0.52	6.78e-7	Coronary artery disease;
SKCM	cis	rs12134245	0.776	rs13447526	chr1:91983174	A/G	cg25838465	chr1:92012736	NA	0.79	8.99	0.71	1.12e-13	Breast cancer;
SKCM	cis	rs55728055	0.661	rs55894054	chr22:31976299	T/C	cg01338084	chr22:32026380	PISD	1.5	5.03	0.49	3.11e-6	Age-related hearing impairment;
SKCM	cis	rs4523957	0.583	rs4349181	chr17:2040963	A/G	cg16513277	chr17:2031491	SMG6	-0.91	-6.21	-0.58	2.38e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs1348850	0.750	rs13031008	chr2:178477114	G/A	cg02961200	chr2:178257176	LOC100130691;AGPS	0.75	5.19	0.51	1.64e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs10540	1.000	rs61876323	chr11:462855	G/A	cg03352830	chr11:487213	PTDSS2	0.96	4.77	0.48	8.46e-6	Body mass index;
SKCM	trans	rs561341	0.700	rs6505266	chr17:30225813	G/A	cg20587970	chr11:113659929	NA	-0.93	-7.33	-0.64	1.86e-10	Hip circumference adjusted for BMI;
SKCM	cis	rs634534	0.622	rs531612	chr11:65705432	C/T	cg17985854	chr11:65770987	BANF1;EIF1AD	-0.56	-5.39	-0.52	7.24e-7	Sum eosinophil basophil counts;Eosinophil counts;
SKCM	cis	rs514406	0.525	rs269291	chr1:53189297	C/T	cg16325326	chr1:53192061	ZYG11B	1.02	13.83	0.84	1.11e-22	Monocyte count;
SKCM	cis	rs17270561	0.541	rs2009610	chr6:25967068	C/T	cg10373733	chr6:25993375	NA	0.83	5.08	0.5	2.53e-6	Iron status biomarkers;
SKCM	cis	rs10193935	0.901	rs62142596	chr2:42529339	C/T	cg27598129	chr2:42591480	NA	-0.89	-6.82	-0.61	1.74e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7666738	0.791	rs6833691	chr4:98951508	A/G	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9894429	1.000	rs7406003	chr17:79597597	C/T	cg18240062	chr17:79603768	NPLOC4	0.77	7.45	0.64	1.08e-10	Eye color traits;
SKCM	cis	rs1395	0.778	rs72810794	chr2:27401260	C/T	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.51	5.15	0.5	1.94e-6	Blood metabolite levels;
SKCM	cis	rs12497850	0.897	rs9850134	chr3:48957147	A/G	cg07636037	chr3:49044803	WDR6	1.02	11.0	0.78	1.56e-17	Parkinson's disease;
SKCM	cis	rs6565180	0.926	rs4788409	chr16:30393771	G/A	cg17640201	chr16:30407289	ZNF48	0.94	7.06	0.62	6.08e-10	Tonsillectomy;
SKCM	cis	rs6424115	0.830	rs1130321	chr1:24200524	C/T	cg15997130	chr1:24165203	NA	0.6	4.94	0.49	4.37e-6	Immature fraction of reticulocytes;
SKCM	cis	rs4888262	0.508	rs4887779	chr16:74647795	A/G	cg01733217	chr16:74700730	RFWD3	-0.88	-7.15	-0.63	4.15e-10	Testicular germ cell tumor;
SKCM	cis	rs732765	0.657	rs10135451	chr14:75229187	C/A	cg25946216	chr14:74253857	C14orf43	-0.93	-5.16	-0.5	1.82e-6	Non-small cell lung cancer;
SKCM	cis	rs1635	0.826	rs1233710	chr6:28215446	C/T	cg15743358	chr6:28303923	ZNF323	-1.19	-4.86	-0.48	5.94e-6	Schizophrenia;
SKCM	cis	rs10089	1.000	rs72794392	chr5:127490061	A/T	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.88	7.81	0.66	2.17e-11	Ileal carcinoids;
SKCM	cis	rs995000	0.899	rs11207976	chr1:62976751	G/A	cg06896770	chr1:63153194	DOCK7	0.72	6.64	0.6	3.74e-9	Triglyceride levels;
SKCM	cis	rs7666738	0.830	rs2903154	chr4:99048151	A/G	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7772486	0.790	rs9376968	chr6:146180364	T/C	cg23711669	chr6:146136114	FBXO30	0.82	8.71	0.7	3.98e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6977660	1.000	rs12531373	chr7:19816825	A/C	cg07541023	chr7:19748670	TWISTNB	0.71	5.08	0.5	2.49e-6	Thyroid stimulating hormone;
SKCM	cis	rs899997	0.954	rs4887091	chr15:79043580	T/C	cg04896959	chr15:78267971	NA	0.58	5.13	0.5	2.03e-6	Coronary artery disease or large artery stroke;
SKCM	cis	rs73072330	0.643	rs56298666	chr3:47667218	A/G	cg09665691	chr3:47563885	NA	1.39	5.49	0.53	4.78e-7	Stem cell growth factor beta levels;
SKCM	cis	rs9768139	0.935	rs10434944	chr7:158116911	C/T	cg26308704	chr7:158325586	PTPRN2;MIR595	0.36	4.9	0.49	5.01e-6	Calcium levels;
SKCM	cis	rs2739330	0.760	rs5751760	chr22:24243573	G/A	cg04234412	chr22:24373322	LOC391322	-0.65	-5.37	-0.52	7.88e-7	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs17685	0.796	rs3757594	chr7:75678644	G/A	cg16684958	chr7:75615977	POR	-0.57	-5.6	-0.54	3.07e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2072499	0.695	rs112223391	chr1:156156094	G/A	cg24450063	chr1:156163899	SLC25A44	0.88	6.76	0.61	2.25e-9	Testicular germ cell tumor;
SKCM	cis	rs116095464	1.000	rs56075848	chr5:308352	T/C	cg22857025	chr5:266934	NA	-1.49	-6.25	-0.58	2.04e-8	Breast cancer;
SKCM	cis	rs9303401	0.659	rs12948133	chr17:56673602	T/C	cg10487724	chr17:56770010	TEX14;RAD51C	0.87	6.24	0.58	2.15e-8	Cognitive test performance;
SKCM	cis	rs1580019	0.563	rs34319173	chr7:32585904	G/A	cg06627557	chr7:32535165	LSM5;AVL9	0.97	9.63	0.74	6.6e-15	Cognitive ability;
SKCM	cis	rs9900062	0.628	rs9807032	chr17:62757146	T/C	cg02097616	chr17:62675921	NA	0.73	5.96	0.56	6.77e-8	QT interval;
SKCM	cis	rs4891159	0.660	rs4891160	chr18:74102135	C/T	cg24786174	chr18:74118243	ZNF516	0.65	6.39	0.59	1.13e-8	Longevity;
SKCM	cis	rs995000	0.931	rs2131926	chr1:63026011	C/T	cg06896770	chr1:63153194	DOCK7	-0.72	-6.46	-0.59	8.17e-9	Triglyceride levels;
SKCM	cis	rs1799949	0.894	rs71367985	chr17:41374463	G/A	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.04	-0.56	4.93e-8	Menopause (age at onset);
SKCM	cis	rs9902453	0.845	rs116840018	chr17:28232049	G/A	cg26525008	chr17:28256777	EFCAB5;SSH2	0.81	5.79	0.55	1.43e-7	Coffee consumption (cups per day);
SKCM	cis	rs80130819	0.515	rs917055	chr12:48385576	A/G	cg05342945	chr12:48394962	COL2A1	-0.69	-4.89	-0.48	5.25e-6	Prostate cancer;
SKCM	cis	rs875971	0.545	rs73142245	chr7:65691649	A/G	cg18876405	chr7:65276391	NA	0.63	5.14	0.5	1.98e-6	Aortic root size;
SKCM	cis	rs9902453	1.000	rs9891871	chr17:28370191	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.81	-5.78	-0.55	1.45e-7	Coffee consumption (cups per day);
SKCM	cis	rs7927771	0.524	rs3816605	chr11:47857253	T/C	cg20307385	chr11:47447363	PSMC3	0.72	5.81	0.55	1.31e-7	Subjective well-being;
SKCM	cis	rs10256972	0.552	rs2960837	chr7:1203957	A/G	cg16145915	chr7:1198662	ZFAND2A	-0.57	-8.16	-0.68	4.69e-12	Longevity;Endometriosis;
SKCM	cis	rs501120	0.810	rs622472	chr10:44749211	A/C	cg09554077	chr10:44749378	NA	0.4	5.12	0.5	2.16e-6	Coronary artery disease;Coronary heart disease;
SKCM	cis	rs7666738	0.791	rs1967978	chr4:98966152	T/C	cg17366294	chr4:99064904	C4orf37	0.59	4.89	0.48	5.36e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9788682	1.000	rs61204066	chr15:78815298	G/A	cg06917634	chr15:78832804	PSMA4	-0.85	-5.3	-0.51	1.05e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs34779708	0.966	rs10827487	chr10:35406878	T/A	cg03585969	chr10:35415529	CREM	0.82	6.46	0.59	8.35e-9	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs4888262	0.545	rs4072450	chr16:74666634	G/C	cg01733217	chr16:74700730	RFWD3	0.89	7.54	0.65	7.26e-11	Testicular germ cell tumor;
SKCM	cis	rs7726839	0.540	rs72703080	chr5:595238	A/G	cg10555297	chr5:473380	SLC9A3;LOC25845	1.06	4.8	0.48	7.45e-6	Obesity-related traits;
SKCM	cis	rs2732480	0.537	rs1061986	chr12:48736439	T/C	cg21348975	chr12:48724119	NA	-0.62	-5.41	-0.52	6.74e-7	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs2033711	0.622	rs975947	chr19:58898193	C/T	cg13877915	chr19:58951672	ZNF132	0.87	7.9	0.67	1.5e-11	Uric acid clearance;
SKCM	cis	rs4974559	0.790	rs11933855	chr4:1315183	C/T	cg02980000	chr4:1222292	CTBP1	0.89	5.33	0.52	9.41e-7	Systolic blood pressure;
SKCM	cis	rs2268241	0.877	rs9975473	chr21:34776441	T/G	cg14850771	chr21:34775459	IFNGR2	1.15	6.49	0.59	7.08e-9	Obesity-related traits;
SKCM	cis	rs1401999	1.000	rs10937158	chr3:183708439	T/C	cg01324343	chr3:183735012	ABCC5	0.84	9.29	0.72	2.91e-14	Anterior chamber depth;
SKCM	cis	rs742320	0.756	rs3765263	chr16:840378	A/G	cg02106180	chr16:845767	CHTF18	0.67	5.28	0.51	1.16e-6	Mean corpuscular volume;
SKCM	cis	rs11105298	0.891	rs12369195	chr12:89934972	G/C	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.83	-5.18	-0.51	1.66e-6	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs9303401	0.614	rs62084384	chr17:57126842	G/A	cg10487724	chr17:56770010	TEX14;RAD51C	0.8	5.05	0.5	2.83e-6	Cognitive test performance;
SKCM	cis	rs1692580	0.777	rs12136830	chr1:2189196	A/T	cg21442419	chr1:2182373	SKI	-0.69	-7.27	-0.64	2.42e-10	Coronary artery disease;
SKCM	cis	rs910316	1.000	rs876402	chr14:75601862	C/T	cg08847533	chr14:75593920	NEK9	-0.96	-8.26	-0.68	2.94e-12	Height;
SKCM	cis	rs2413583	0.591	rs17305131	chr22:39718564	T/C	cg17798944	chr22:39715225	SNORD43;RPL3	0.92	5.12	0.5	2.12e-6	Ulcerative colitis;Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs7927771	0.524	rs10838732	chr11:47607940	C/G	cg20307385	chr11:47447363	PSMC3	0.77	5.86	0.55	1.06e-7	Subjective well-being;
SKCM	cis	rs2072510	0.932	rs10859999	chr12:96391334	A/G	cg18817487	chr12:96390143	HAL	-0.42	-5.47	-0.53	5.17e-7	Metabolite levels (small molecules and protein measures);
SKCM	cis	rs7927771	0.725	rs11039265	chr11:47523214	C/A	cg05585544	chr11:47624801	NA	-0.63	-5.49	-0.53	4.91e-7	Subjective well-being;
SKCM	cis	rs6580649	0.831	rs4760620	chr12:48559642	A/G	cg05342945	chr12:48394962	COL2A1	-0.79	-5.39	-0.52	7.22e-7	Lung cancer;
SKCM	trans	rs10506458	1.000	rs73127086	chr12:63415626	G/A	cg03429785	chr15:59498649	MYO1E;LDHAL6B	-1.38	-7.54	-0.65	7.13e-11	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs8014204	0.604	rs12147862	chr14:75384471	C/T	cg06637938	chr14:75390232	RPS6KL1	-0.89	-6.24	-0.58	2.09e-8	Caffeine consumption;
SKCM	cis	rs7937682	0.632	rs11608193	chr11:111732215	T/C	cg09085632	chr11:111637200	PPP2R1B	1.12	10.15	0.75	6.42e-16	Primary sclerosing cholangitis;
SKCM	cis	rs10779751	0.922	rs2295079	chr1:11322565	C/G	cg08854313	chr1:11322531	MTOR	1.07	10.51	0.77	1.36e-16	Body mass index;
SKCM	cis	rs34779708	0.733	rs7081597	chr10:35546331	G/C	cg03585969	chr10:35415529	CREM	0.71	5.25	0.51	1.27e-6	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs1552244	0.572	rs59132826	chr3:10169725	G/A	cg00149659	chr3:10157352	C3orf10	1.13	5.45	0.53	5.74e-7	Alzheimer's disease;
SKCM	cis	rs6951245	1.000	rs11768761	chr7:1069807	A/G	cg24642844	chr7:1081250	C7orf50	-0.95	-6.4	-0.59	1.06e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs1405130	0.869	rs12995365	chr2:235565703	A/G	cg21542780	chr2:234763377	HJURP	-0.64	-4.89	-0.48	5.21e-6	Coronary artery disease;
SKCM	cis	rs2032447	0.966	rs7756117	chr6:26046565	A/G	cg18357526	chr6:26021779	HIST1H4A	-0.79	-7.02	-0.62	7.14e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs6500395	1.000	rs7191028	chr16:48626023	T/C	cg04672837	chr16:48644449	N4BP1	0.69	5.88	0.55	9.68e-8	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs10769945	0.572	rs217206	chr11:1974542	G/A	cg23202291	chr11:1979235	NA	-0.54	-5.69	-0.54	2.1e-7	DNA methylation (variation);
SKCM	cis	rs17376456	0.825	rs56108532	chr5:93276342	C/T	cg25358565	chr5:93447407	FAM172A	1.3	7.53	0.65	7.57e-11	Diabetic retinopathy;
SKCM	cis	rs2243480	1.000	rs2420170	chr7:65656053	T/C	cg18252515	chr7:66147081	NA	1.36	8.16	0.68	4.6e-12	Diabetic kidney disease;
SKCM	cis	rs9325144	0.647	rs34963631	chr12:38912260	T/A	cg26384229	chr12:38710491	ALG10B	-0.72	-6.08	-0.57	4.14e-8	Morning vs. evening chronotype;
SKCM	cis	rs7143963	0.502	rs11629241	chr14:103379225	T/C	cg23020514	chr14:103360112	TRAF3	0.61	4.96	0.49	4.04e-6	Body mass index;
SKCM	cis	rs2239547	0.522	rs9831409	chr3:52985711	A/T	cg11645453	chr3:52864694	ITIH4	-0.58	-4.96	-0.49	3.98e-6	Schizophrenia;
SKCM	cis	rs4619890	0.528	rs17770213	chr4:7896866	C/T	cg08722675	chr4:8412549	ACOX3	-0.52	-4.91	-0.49	4.93e-6	Glaucoma (primary open-angle);
SKCM	cis	rs11671005	0.695	rs8106061	chr19:58917990	G/C	cg03735888	chr19:58951602	ZNF132	0.75	6.41	0.59	1.01e-8	Mean platelet volume;
SKCM	trans	rs8073060	0.586	rs9649	chr17:34050934	C/T	cg19694781	chr19:47549865	TMEM160	1.08	8.6	0.7	6.4e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs3791406	0.500	rs11124180	chr2:240031909	C/G	cg14550559	chr2:240039617	HDAC4	-1.08	-5.35	-0.52	8.47e-7	Skin aging (microtopography measurement);
SKCM	cis	rs936229	0.768	rs11072509	chr15:75114374	C/G	cg14664628	chr15:75095509	CSK	-1.16	-10.49	-0.77	1.43e-16	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin);
SKCM	cis	rs826838	1.000	rs10875717	chr12:38911174	T/C	cg13010199	chr12:38710504	ALG10B	0.84	6.66	0.6	3.54e-9	Heart rate;
SKCM	cis	rs2228479	0.850	rs1800355	chr16:89813194	C/T	cg06558623	chr16:89946397	TCF25	1.03	5.59	0.53	3.23e-7	Skin colour saturation;
SKCM	cis	rs2645694	0.626	rs2703120	chr4:77822470	G/A	cg06046430	chr4:77819534	ANKRD56	0.54	5.85	0.55	1.09e-7	Emphysema distribution in smoking;
SKCM	cis	rs2180341	0.960	rs9398842	chr6:127674662	T/C	cg27446573	chr6:127587934	RNF146	0.94	8.11	0.68	5.63e-12	Breast cancer;
SKCM	cis	rs7215564	0.730	rs34579757	chr17:78700077	G/A	cg16980736	chr17:78789706	RPTOR	-0.87	-4.81	-0.48	7.12e-6	Myopia (pathological);
SKCM	cis	rs7843479	0.601	rs7220	chr8:21863290	G/A	cg17168535	chr8:21777572	XPO7	0.85	7.77	0.66	2.62e-11	Mean corpuscular volume;
SKCM	cis	rs2836974	0.800	rs12482857	chr21:40514861	T/C	cg11890956	chr21:40555474	PSMG1	1.1	13.08	0.83	2.37e-21	Cognitive function;
SKCM	cis	rs1799949	1.000	rs12944430	chr17:41330820	C/G	cg23758822	chr17:41437982	NA	0.93	7.84	0.66	1.91e-11	Menopause (age at onset);
SKCM	cis	rs801193	1.000	rs4279493	chr7:66226620	C/T	cg18876405	chr7:65276391	NA	0.82	7.51	0.65	8.26e-11	Aortic root size;
SKCM	cis	rs1395	1.000	rs2014252	chr2:27462405	T/A	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.47	4.77	0.48	8.27e-6	Blood metabolite levels;
SKCM	cis	rs1218582	0.804	rs4845678	chr1:154853295	A/G	cg09359103	chr1:154839909	KCNN3	-0.57	-5.25	-0.51	1.26e-6	Prostate cancer;
SKCM	cis	rs6951245	1.000	rs74369356	chr7:1071711	T/C	cg24642844	chr7:1081250	C7orf50	-0.95	-6.4	-0.59	1.06e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs514406	0.627	rs485128	chr1:53344583	T/C	cg08859206	chr1:53392774	SCP2	-0.61	-4.8	-0.48	7.61e-6	Monocyte count;
SKCM	cis	rs7124681	0.565	rs2203712	chr11:47534964	T/C	cg20307385	chr11:47447363	PSMC3	0.77	5.86	0.55	1.06e-7	Body mass index (joint analysis main effects and physical activity interaction);Body mass index;Body mass index in physically active individuals;
SKCM	cis	rs11098499	0.818	rs10008791	chr4:120431469	A/C	cg24375607	chr4:120327624	NA	0.7	5.37	0.52	7.82e-7	Corneal astigmatism;
SKCM	cis	rs651907	0.557	rs3864012	chr3:101397623	T/C	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.81	7.06	0.62	6.11e-10	Colorectal cancer;
SKCM	cis	rs1799949	0.965	rs11650132	chr17:41326087	T/G	cg23758822	chr17:41437982	NA	0.93	7.87	0.67	1.66e-11	Menopause (age at onset);
SKCM	cis	rs9902453	0.817	rs62068620	chr17:28167674	A/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.8	5.4	0.52	6.96e-7	Coffee consumption (cups per day);
SKCM	cis	rs11098499	0.954	rs71629403	chr4:120372567	C/T	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs752010	0.543	rs7545381	chr1:42044183	T/A	cg06885757	chr1:42089581	HIVEP3	0.54	6.17	0.57	2.85e-8	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs2072499	0.868	rs2758600	chr1:156195205	C/T	cg25208724	chr1:156163844	SLC25A44	0.99	8.46	0.69	1.2e-12	Testicular germ cell tumor;
SKCM	cis	rs1451375	0.572	rs11575463	chr7:50547173	A/G	cg18232548	chr7:50535776	DDC	-0.71	-4.77	-0.48	8.5e-6	Malaria;
SKCM	cis	rs12048904	0.619	rs10875347	chr1:101333737	T/C	cg16556008	chr1:101360663	SLC30A7;EXTL2	0.99	7.97	0.67	1.07e-11	Multiple sclerosis;
SKCM	cis	rs17376456	0.877	rs67066109	chr5:93494101	G/C	cg25358565	chr5:93447407	FAM172A	1.24	8.18	0.68	4.18e-12	Diabetic retinopathy;
SKCM	cis	rs910316	0.687	rs11627442	chr14:75669649	A/G	cg08847533	chr14:75593920	NEK9	-0.82	-6.19	-0.57	2.62e-8	Height;
SKCM	cis	rs3796619	1.000	rs4045481	chr4:1090625	C/T	cg27284194	chr4:1044797	NA	0.69	4.88	0.48	5.58e-6	Recombination rate (males);
SKCM	cis	rs6724607	0.905	rs10173771	chr2:191439248	T/C	cg27211696	chr2:191398769	TMEM194B	0.75	5.87	0.55	1.02e-7	Pulse pressure;
SKCM	cis	rs9611565	0.512	rs4820446	chr22:42215684	C/T	cg03806693	chr22:41940476	POLR3H	-1.12	-6.49	-0.59	7.19e-9	Vitiligo;
SKCM	cis	rs4523957	0.651	rs9895342	chr17:2081647	T/C	cg16513277	chr17:2031491	SMG6	-0.79	-5.86	-0.55	1.07e-7	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs17685	0.753	rs1637037	chr7:75692927	C/T	cg16489192	chr7:75678113	MDH2;STYXL1	-0.6	-5.51	-0.53	4.43e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2952156	0.920	rs9303274	chr17:37836353	T/C	cg00129232	chr17:37814104	STARD3	-0.7	-5.89	-0.55	9.38e-8	Asthma;
SKCM	cis	rs7408868	1.000	rs757475	chr19:15273749	C/T	cg14696996	chr19:15285081	NOTCH3	0.82	4.92	0.49	4.7e-6	Pulse pressure;
SKCM	cis	rs1912483	0.505	rs11079772	chr17:45393739	A/C	cg08085267	chr17:45401833	C17orf57	0.86	6.68	0.6	3.19e-9	Coronary artery disease;
SKCM	cis	rs7809950	0.817	rs4727679	chr7:107085018	T/C	cg23024343	chr7:107201750	COG5	-0.88	-8.2	-0.68	3.87e-12	Coronary artery disease;
SKCM	cis	rs2599510	0.811	rs2583713	chr2:32822729	A/G	cg02381751	chr2:32503542	YIPF4	0.77	5.87	0.55	9.89e-8	Interleukin-18 levels;
SKCM	cis	rs2188420	0.872	rs79521537	chr7:106513926	T/C	cg23615938	chr7:105753134	SYPL1	-0.89	-5.08	-0.5	2.49e-6	Interferon gamma levels;
SKCM	cis	rs61524473	1	rs61524473	chr15:45646283	T/C	cg21132104	chr15:45694354	SPATA5L1	0.92	7.81	0.66	2.22e-11	Metabolite levels (small molecules and protein measures);
SKCM	cis	rs634534	0.622	rs593525	chr11:65727799	T/C	cg17985854	chr11:65770987	BANF1;EIF1AD	0.52	5.02	0.49	3.18e-6	Sum eosinophil basophil counts;Eosinophil counts;
SKCM	cis	rs738321	0.757	rs5750546	chr22:38542499	C/T	cg25457927	chr22:38595422	NA	-0.58	-6.71	-0.61	2.75e-9	Breast cancer;
SKCM	cis	rs2153535	0.580	rs6927589	chr6:8456632	A/G	cg07606381	chr6:8435919	SLC35B3	-0.93	-6.84	-0.61	1.58e-9	Motion sickness;
SKCM	cis	rs748404	0.631	rs3809482	chr15:43661802	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	0.85	6.35	0.58	1.29e-8	Lung cancer;
SKCM	cis	rs208515	0.525	rs12214310	chr6:66666308	A/G	cg07460842	chr6:66804631	NA	0.94	5.82	0.55	1.22e-7	Exhaled nitric oxide levels;
SKCM	cis	rs7824557	0.602	rs11784458	chr8:11204184	G/A	cg21775007	chr8:11205619	TDH	0.71	6.31	0.58	1.57e-8	Retinal vascular caliber;
SKCM	cis	rs8170	0.603	rs8109328	chr19:17417955	C/T	cg07830086	chr19:18107778	KCNN1	-0.8	-4.99	-0.49	3.54e-6	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Ovarian cancer;Breast cancer;Epithelial ovarian cancer;
SKCM	cis	rs9809213	0.731	rs4128691	chr3:72349863	C/T	cg23333146	chr3:71731211	EIF4E3	-0.51	-5.24	-0.51	1.34e-6	Cognitive ability;Cognitive ability (multi-trait analysis);
SKCM	cis	rs8077889	0.956	rs55768269	chr17:41888997	C/T	cg26893861	chr17:41843967	DUSP3	1.13	7.37	0.64	1.57e-10	Triglycerides;
SKCM	cis	rs7666738	0.830	rs13101766	chr4:98957696	C/A	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs3820068	0.603	rs72647120	chr1:15956769	G/T	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs7927771	0.507	rs1483988	chr11:47899030	C/T	cg20307385	chr11:47447363	PSMC3	0.71	5.63	0.54	2.73e-7	Subjective well-being;
SKCM	cis	rs2153535	0.580	rs2327060	chr6:8447111	G/A	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs1395	0.922	rs13404327	chr2:27519153	G/T	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.48	4.8	0.48	7.56e-6	Blood metabolite levels;
SKCM	cis	rs4319547	0.619	rs7973869	chr12:122874284	G/C	cg23029597	chr12:123009494	RSRC2	-0.72	-5.31	-0.52	1.01e-6	Body mass index;
SKCM	cis	rs4332037	0.539	rs55773130	chr7:2070554	T/C	cg23422044	chr7:1970798	MAD1L1	-0.91	-6.07	-0.57	4.38e-8	Bipolar disorder;
SKCM	cis	rs2836974	0.932	rs6517523	chr21:40557332	T/C	cg17971929	chr21:40555470	PSMG1	0.9	8.42	0.69	1.45e-12	Cognitive function;
SKCM	cis	rs7959452	0.590	rs11177644	chr12:69785748	A/G	cg14784868	chr12:69753453	YEATS4	0.74	6.97	0.62	8.96e-10	Blood protein levels;
SKCM	cis	rs8170	0.603	rs3745187	chr19:17414126	C/T	cg07830086	chr19:18107778	KCNN1	-0.82	-5.17	-0.51	1.77e-6	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Ovarian cancer;Breast cancer;Epithelial ovarian cancer;
SKCM	cis	rs9486715	1.000	rs3798297	chr6:97062835	C/T	cg06623918	chr6:96969491	KIAA0776	-0.74	-6.56	-0.6	5.29e-9	Headache;
SKCM	cis	rs2991971	0.933	rs666720	chr1:46020795	T/C	cg24296786	chr1:45957014	TESK2	0.69	5.77	0.55	1.52e-7	High light scatter reticulocyte count;
SKCM	cis	rs2153535	0.580	rs2184582	chr6:8447793	G/A	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs2841277	0.708	rs28454709	chr14:105405942	G/A	cg15352829	chr14:105391018	PLD4	-0.58	-4.81	-0.48	7.35e-6	Rheumatoid arthritis;
SKCM	trans	rs208520	0.690	rs4710311	chr6:66823223	C/T	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-0.96	-7.79	-0.66	2.38e-11	Exhaled nitric oxide output;
SKCM	cis	rs3213545	0.700	rs2260445	chr12:121468863	C/A	cg15155738	chr12:121454335	C12orf43	0.67	5.07	0.5	2.64e-6	Subjective well-being;Cardiovascular disease risk factors;
SKCM	cis	rs34779708	0.733	rs7914560	chr10:35548099	G/A	cg03585969	chr10:35415529	CREM	0.71	5.25	0.51	1.27e-6	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs2070488	0.775	rs2300669	chr3:38541318	C/A	cg01465620	chr3:38496096	LOC100128640;ACVR2B	-0.75	-6.03	-0.56	5.19e-8	Electrocardiographic conduction measures;
SKCM	cis	rs28595532	0.920	rs17324884	chr4:119771477	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs62238980	0.522	rs117656576	chr22:32515901	G/A	cg00543991	chr22:32367038	NA	1.17	4.81	0.48	7.24e-6	Childhood ear infection;
SKCM	cis	rs72634258	0.945	rs225132	chr1:8095500	A/C	cg00042356	chr1:8021962	PARK7	0.91	6.19	0.57	2.58e-8	Inflammatory bowel disease;
SKCM	cis	rs6540556	0.954	rs611861	chr1:209937251	C/G	cg05527609	chr1:210001259	C1orf107	-0.91	-5.14	-0.5	1.97e-6	Red blood cell count;
SKCM	cis	rs4888262	0.508	rs12598701	chr16:74539904	G/A	cg01733217	chr16:74700730	RFWD3	0.88	6.99	0.62	8.2e-10	Testicular germ cell tumor;
SKCM	cis	rs6879260	1.000	rs888922	chr5:179731635	C/G	cg02891314	chr5:179741120	GFPT2	-0.67	-5.69	-0.54	2.11e-7	Height;
SKCM	cis	rs2836974	0.897	rs2836973	chr21:40654928	A/G	cg11644478	chr21:40555479	PSMG1	0.97	10.08	0.75	8.76e-16	Cognitive function;
SKCM	cis	rs244731	0.959	rs7721671	chr5:176630984	A/G	cg16006841	chr5:176797999	RGS14	-0.81	-6.84	-0.61	1.55e-9	Urate levels in lean individuals;
SKCM	cis	rs782590	0.967	rs62165173	chr2:55741666	T/C	cg18811423	chr2:55921094	PNPT1	0.79	5.94	0.56	7.6e-8	Metabolic syndrome;
SKCM	cis	rs1048238	0.545	rs848199	chr1:16292742	C/T	cg21385522	chr1:16154831	NA	-0.62	-5.32	-0.52	9.58e-7	Systolic blood pressure;
SKCM	cis	rs992157	0.764	rs2382827	chr2:219184387	G/A	cg00012203	chr2:219082015	ARPC2	0.76	5.65	0.54	2.54e-7	Colorectal cancer;
SKCM	cis	rs2228479	0.867	rs11646448	chr16:89966357	A/T	cg06558623	chr16:89946397	TCF25	1.24	6.84	0.61	1.61e-9	Skin colour saturation;
SKCM	cis	rs12497850	0.897	rs7432989	chr3:49105136	A/G	cg06212747	chr3:49208901	KLHDC8B	0.7	4.94	0.49	4.32e-6	Parkinson's disease;
SKCM	cis	rs7555523	0.887	rs2251768	chr1:165738311	A/T	cg24409356	chr1:165738333	TMCO1	0.93	5.15	0.5	1.93e-6	Intraocular pressure;Glaucoma (high intraocular pressure);
SKCM	cis	rs7523273	0.548	rs2724381	chr1:207949017	T/C	cg22525895	chr1:207977042	MIR29B2	0.81	7.08	0.63	5.47e-10	Schizophrenia;
SKCM	cis	rs514406	0.505	rs269290	chr1:53167027	A/T	cg16325326	chr1:53192061	ZYG11B	0.91	10.29	0.76	3.51e-16	Monocyte count;
SKCM	cis	rs10905065	0.895	rs1858447	chr10:5852230	A/G	cg09234995	chr10:5726438	C10orf18	0.62	5.04	0.5	2.97e-6	Menopause (age at onset);
SKCM	cis	rs873946	0.564	rs12242672	chr10:134555609	A/T	cg27286337	chr10:134555280	INPP5A	0.93	8.65	0.7	5.25e-13	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs5769765	1.000	rs4597652	chr22:50270570	A/G	cg22709217	chr22:50311962	ALG12;CRELD2	0.79	5.71	0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs1005277	1.000	rs1005277	chr10:38218259	A/C	cg00409905	chr10:38381863	ZNF37A	0.75	5.74	0.54	1.74e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs7618501	0.602	rs2013208	chr3:50129399	C/T	cg24110177	chr3:50126178	RBM5	0.61	5.18	0.51	1.71e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9814567	1.000	rs9968172	chr3:134231251	A/G	cg06109529	chr3:134205091	CEP63;ANAPC13	0.6	4.84	0.48	6.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs1691799	0.899	rs1168327	chr12:66728842	G/A	cg16791601	chr12:66731901	HELB	-0.63	-5.46	-0.53	5.43e-7	White blood cell count (basophil);
SKCM	cis	rs861020	0.563	rs35898529	chr1:210053096	G/A	cg05527609	chr1:210001259	C1orf107	-0.94	-6.39	-0.59	1.11e-8	Orofacial clefts;
SKCM	cis	rs2730245	0.527	rs1188971	chr7:158664463	G/T	cg24397884	chr7:158709396	WDR60	0.98	5.56	0.53	3.7e-7	Height;
SKCM	cis	rs1059312	0.966	rs2291349	chr12:129284248	T/C	cg09035930	chr12:129282057	SLC15A4	0.81	8.93	0.71	1.45e-13	Systemic lupus erythematosus;
SKCM	cis	rs4683346	0.731	rs11923822	chr3:42922177	C/G	cg06399164	chr3:42695035	ZBTB47	0.55	5.11	0.5	2.22e-6	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs2731664	0.740	rs2731670	chr5:176848019	G/T	cg23176889	chr5:176863531	GRK6	0.47	4.97	0.49	3.95e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs6952808	1.000	rs12540579	chr7:1882227	C/A	cg02951883	chr7:2050386	MAD1L1	-0.71	-5.35	-0.52	8.61e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs28595532	0.841	rs112953035	chr4:119752450	T/C	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs9796	0.700	rs2305656	chr15:41279519	T/A	cg18705301	chr15:41695430	NDUFAF1	-0.66	-5.19	-0.51	1.65e-6	Menopause (age at onset);
SKCM	cis	rs10193935	0.818	rs10221927	chr2:42546680	A/C	cg27598129	chr2:42591480	NA	-0.9	-6.88	-0.61	1.33e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1059312	0.500	rs10734964	chr12:129286486	C/T	cg09035930	chr12:129282057	SLC15A4	0.84	6.98	0.62	8.47e-10	Systemic lupus erythematosus;
SKCM	cis	rs10751667	0.643	rs10751669	chr11:942344	C/G	cg06064525	chr11:970664	AP2A2	0.55	5.09	0.5	2.45e-6	Alzheimer's disease (late onset);
SKCM	cis	rs7811142	0.830	rs11765869	chr7:99964789	T/G	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.07	6.7	0.6	2.88e-9	Platelet count;
SKCM	cis	rs3213545	0.700	rs2260445	chr12:121468863	C/A	cg02403541	chr12:121454288	C12orf43	0.75	6.31	0.58	1.56e-8	Subjective well-being;Cardiovascular disease risk factors;
SKCM	cis	rs1552244	0.810	rs7612908	chr3:10089148	A/G	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs1005277	0.579	rs2505198	chr10:38393183	A/C	cg25427524	chr10:38739819	LOC399744	-0.68	-6.49	-0.59	7.18e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs1969363	0.531	rs11495331	chr12:38110702	A/G	cg26384229	chr12:38710491	ALG10B	0.67	5.2	0.51	1.59e-6	Morning vs. evening chronotype;
SKCM	cis	rs2404602	0.647	rs11072616	chr15:76985269	T/C	cg23625390	chr15:77176239	SCAPER	-0.82	-7.93	-0.67	1.26e-11	Blood metabolite levels;
SKCM	cis	rs4523957	0.620	rs898749	chr17:2085185	G/A	cg16513277	chr17:2031491	SMG6	-0.79	-5.86	-0.55	1.07e-7	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs801193	1.000	rs62466793	chr7:66191517	G/A	cg11764359	chr7:65958608	NA	0.86	6.55	0.6	5.68e-9	Aortic root size;
SKCM	cis	rs7106204	0.702	rs11826172	chr11:24233998	G/A	ch.11.24196551F	chr11:24239977	NA	0.77	6.13	0.57	3.44e-8	Response to Homoharringtonine (cytotoxicity);
SKCM	cis	rs860295	0.702	rs12040100	chr1:155611847	G/T	cg02153340	chr1:155202674	NA	-0.76	-5.61	-0.54	2.96e-7	Body mass index;
SKCM	cis	rs9790314	0.690	rs7614375	chr3:160851331	A/T	cg03342759	chr3:160939853	NMD3	-0.69	-6.89	-0.61	1.3e-9	Morning vs. evening chronotype;
SKCM	cis	rs72781680	0.699	rs72794291	chr2:23897935	C/T	cg08917208	chr2:24149416	ATAD2B	1.0	5.01	0.49	3.3e-6	Lymphocyte counts;
SKCM	cis	rs1005277	0.505	rs7099777	chr10:38183569	A/C	cg25427524	chr10:38739819	LOC399744	0.68	6.4	0.59	1.06e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs9815354	0.638	rs12634670	chr3:41875299	G/C	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs1639906	0.895	rs35038526	chr7:2213106	A/G	cg21782813	chr7:2030301	MAD1L1	-0.52	-5.38	-0.52	7.71e-7	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4555082	0.957	rs3825762	chr14:105752404	T/C	cg13114125	chr14:105738426	BRF1	-0.73	-5.67	-0.54	2.28e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs1797081	0.840	rs10904820	chr10:16848473	A/G	cg23933602	chr10:16859644	RSU1	1.0	11.82	0.8	4.61e-19	Platelet distribution width;
SKCM	cis	rs208520	0.690	rs1304672	chr6:66847973	A/G	cg07460842	chr6:66804631	NA	0.98	6.73	0.61	2.58e-9	Exhaled nitric oxide output;
SKCM	trans	rs1116547	0.602	rs6878001	chr5:112813100	T/C	cg09257824	chr11:32455642	WT1	-0.91	-7.41	-0.64	1.32e-10	Cerebral amyloid angiopathy;
SKCM	cis	rs4919087	0.892	rs10882880	chr10:99008068	G/A	cg25902810	chr10:99078978	FRAT1	0.64	5.14	0.5	1.97e-6	Monocyte count;
SKCM	cis	rs116095464	0.558	rs56127718	chr5:270273	G/T	cg22857025	chr5:266934	NA	-1.47	-8.33	-0.69	2.16e-12	Breast cancer;
SKCM	cis	rs2721195	0.967	rs1480000	chr8:145702007	C/T	cg15857475	chr8:145742913	RECQL4;LRRC14	-0.86	-7.94	-0.67	1.22e-11	Age at first birth;
SKCM	cis	rs9910055	0.636	rs7089	chr17:42269017	T/C	cg13607699	chr17:42295918	UBTF	0.71	5.74	0.55	1.72e-7	Total body bone mineral density;
SKCM	cis	rs9916302	0.821	rs1966915	chr17:37425262	A/C	cg07936489	chr17:37558343	FBXL20	-0.84	-6.96	-0.62	9.48e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs35306767	0.855	rs55697724	chr10:885622	T/C	cg26597838	chr10:835615	NA	0.79	5.77	0.55	1.54e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs36093844	0.706	rs1445501	chr11:85542876	G/A	cg25872744	chr11:85566296	CCDC83	-0.85	-4.77	-0.48	8.27e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs420259	0.516	rs11074562	chr16:23499700	C/T	cg10006042	chr16:23042421	NA	-0.37	-4.93	-0.49	4.57e-6	Bipolar disorder;
SKCM	cis	rs4819052	1.000	rs28628220	chr21:46663741	G/C	cg20896738	chr21:46707857	POFUT2;LOC642852	0.74	5.35	0.52	8.71e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs597539	0.652	rs686390	chr11:68656077	T/C	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.82	5.44	0.52	5.87e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs7666738	0.830	rs4699603	chr4:99056172	T/C	cg17366294	chr4:99064904	C4orf37	0.61	4.98	0.49	3.73e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6753739	0.661	rs2219220	chr2:219906714	T/C	cg09617556	chr2:219924408	IHH	0.51	5.37	0.52	7.78e-7	Height;
SKCM	cis	rs1034435	0.755	rs6007871	chr22:48894392	C/G	cg05992904	chr22:48892994	FAM19A5	-0.59	-4.8	-0.48	7.49e-6	Late-onset Alzheimer's disease;
SKCM	cis	rs6546550	0.869	rs6712827	chr2:70156540	C/G	cg02498382	chr2:70120550	SNRNP27	-0.45	-4.88	-0.48	5.4e-6	Prevalent atrial fibrillation;
SKCM	cis	rs870825	0.860	rs62339895	chr4:185598681	A/G	cg04058563	chr4:185651563	MLF1IP	-1.02	-5.81	-0.55	1.27e-7	Blood protein levels;
SKCM	cis	rs3741404	0.757	rs2282492	chr11:63918589	A/G	cg19465662	chr11:63993652	NUDT22;TRPT1	0.74	5.22	0.51	1.47e-6	Platelet count;
SKCM	cis	rs9875589	0.509	rs2168718	chr3:14084157	A/G	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.5	5.15	0.5	1.9e-6	Ovarian reserve;
SKCM	cis	rs2153535	0.601	rs2143353	chr6:8530111	T/G	cg07606381	chr6:8435919	SLC35B3	0.93	6.8	0.61	1.92e-9	Motion sickness;
SKCM	cis	rs1577917	0.545	rs9294338	chr6:86474368	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.63	5.36	0.52	8.06e-7	Response to antipsychotic treatment;
SKCM	cis	rs651907	0.967	rs694936	chr3:101587793	A/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.75	6.05	0.56	4.82e-8	Colorectal cancer;
SKCM	cis	rs1799949	1.000	rs11654452	chr17:41189383	G/T	cg05368731	chr17:41323189	NBR1	0.86	7.39	0.64	1.39e-10	Menopause (age at onset);
SKCM	cis	rs9611565	0.765	rs202663	chr22:41812819	T/C	cg03806693	chr22:41940476	POLR3H	1.02	6.92	0.62	1.13e-9	Vitiligo;
SKCM	cis	rs9581857	0.556	rs9579085	chr13:28041039	G/A	cg22138327	chr13:27999177	GTF3A	0.71	5.36	0.52	8.12e-7	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs9814567	1.000	rs1863913	chr3:134200205	C/T	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.7	-5.54	-0.53	3.92e-7	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs9640161	0.830	rs3735165	chr7:150068371	T/C	cg10018233	chr7:150070692	REPIN1	0.81	9.03	0.71	9.35e-14	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs910316	1.000	rs910316	chr14:75626042	A/C	cg08847533	chr14:75593920	NEK9	0.96	9.14	0.72	5.68e-14	Height;
SKCM	cis	rs3768617	0.510	rs2027083	chr1:183088330	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs2153535	0.580	rs718502	chr6:8527400	T/C	cg23788917	chr6:8435910	SLC35B3	0.68	4.98	0.49	3.66e-6	Motion sickness;
SKCM	cis	rs17376456	0.825	rs12188163	chr5:93250608	A/G	cg25358565	chr5:93447407	FAM172A	-1.2	-7.54	-0.65	7.35e-11	Diabetic retinopathy;
SKCM	cis	rs860295	0.676	rs5020058	chr1:155507543	T/A	cg02153340	chr1:155202674	NA	-0.79	-5.59	-0.54	3.18e-7	Body mass index;
SKCM	cis	rs6547631	0.565	rs10204426	chr2:85903908	C/A	cg24620635	chr2:85921963	GNLY	0.76	6.55	0.6	5.48e-9	Blood protein levels;
SKCM	cis	rs2952156	0.684	rs931992	chr17:37821435	G/T	cg07936489	chr17:37558343	FBXL20	-0.68	-4.89	-0.48	5.37e-6	Asthma;
SKCM	cis	rs7100689	0.646	rs7894762	chr10:82086779	C/G	cg00277334	chr10:82204260	NA	-0.57	-5.34	-0.52	8.88e-7	Post bronchodilator FEV1;
SKCM	cis	rs793571	0.502	rs387812	chr15:59074786	T/C	cg05156742	chr15:59063176	FAM63B	0.74	5.95	0.56	7.32e-8	Schizophrenia;
SKCM	cis	rs7666738	0.783	rs10028584	chr4:98962404	C/T	cg17366294	chr4:99064904	C4orf37	0.59	4.89	0.48	5.36e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9549367	0.713	rs2480949	chr13:113853149	T/C	cg18105134	chr13:113819100	PROZ	0.88	6.6	0.6	4.59e-9	Platelet distribution width;
SKCM	cis	rs13256369	0.802	rs11249885	chr8:8562008	C/T	cg06636001	chr8:8085503	FLJ10661	0.7	5.28	0.51	1.14e-6	Obesity-related traits;
SKCM	cis	rs875971	0.660	rs1860470	chr7:66103694	G/C	cg11987759	chr7:65425863	GUSB	0.67	5.8	0.55	1.36e-7	Aortic root size;
SKCM	cis	rs704	0.605	rs2071379	chr17:26695832	A/G	cg27392559	chr17:27410759	MYO18A	-0.55	-4.98	-0.49	3.67e-6	Osteoprotegerin levels;
SKCM	cis	rs854765	0.547	rs2955370	chr17:17966945	C/T	cg04398451	chr17:18023971	MYO15A	0.94	7.53	0.65	7.5e-11	Total body bone mineral density;
SKCM	cis	rs7666738	0.830	rs2865980	chr4:99027422	T/G	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7786877	0.503	rs4729601	chr7:100251141	C/T	cg16850897	chr7:100343110	ZAN	-0.66	-4.81	-0.48	7.25e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs6951245	0.678	rs28600085	chr7:1169636	C/T	cg23708337	chr7:1209742	NA	0.87	5.34	0.52	8.89e-7	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7191751	0.543	rs62051080	chr16:86306155	A/G	cg07524214	chr16:86825363	NA	-0.57	-4.79	-0.48	7.79e-6	Response to platinum-based chemotherapy (cisplatin);
SKCM	cis	rs9911578	1.000	rs9898626	chr17:56698219	C/G	cg05425664	chr17:57184151	TRIM37	-0.69	-5.21	-0.51	1.52e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs11585357	0.709	rs735281	chr1:17616194	T/C	cg08277548	chr1:17600880	PADI3	0.89	6.31	0.58	1.53e-8	Hair shape;
SKCM	cis	rs644799	1.000	rs544119	chr11:95538624	G/A	cg03916912	chr11:95522834	CEP57;FAM76B	0.92	8.04	0.67	8e-12	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs2955117	0.504	rs59766347	chr3:127783236	C/G	cg09089421	chr3:127803668	RUVBL1	-0.6	-5.76	-0.55	1.61e-7	Gestational age at birth (maternal effect);
SKCM	cis	rs3008870	0.583	rs17497947	chr1:67457199	G/T	cg08660285	chr1:67390436	MIER1;WDR78	-0.94	-6.07	-0.57	4.4e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs769267	0.930	rs2099334	chr19:19578450	A/G	cg03709012	chr19:19516395	GATAD2A	0.89	8.62	0.7	5.89e-13	Tonsillectomy;
SKCM	cis	rs7826238	0.594	rs2948285	chr8:8130538	A/T	cg06636001	chr8:8085503	FLJ10661	0.94	8.65	0.7	5.23e-13	Systolic blood pressure;
SKCM	cis	rs13336428	0.730	rs28653458	chr16:1525850	T/C	cg08008072	chr16:1524255	CLCN7	-0.53	-5.95	-0.56	7.17e-8	Bone mineral density;
SKCM	cis	rs11155671	0.530	rs9371542	chr6:150213085	A/T	cg05036130	chr6:150231994	NA	0.61	6.58	0.6	4.87e-9	Testicular germ cell tumor;
SKCM	cis	rs1003719	0.762	rs2835598	chr21:38466669	T/C	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs798554	0.797	rs798491	chr7:2800521	A/G	cg19346786	chr7:2764209	NA	-0.68	-7.05	-0.62	6.19e-10	Height;
SKCM	cis	rs9815354	0.812	rs4299460	chr3:41952445	A/C	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs1552244	1.000	rs722509	chr3:10102377	T/A	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs4803468	1.000	rs10417311	chr19:41902038	G/A	cg09537434	chr19:41945824	ATP5SL	-1.08	-13.01	-0.83	3.1e-21	Height;
SKCM	cis	rs17376456	0.825	rs17314074	chr5:93161467	T/C	cg21475434	chr5:93447410	FAM172A	0.92	5.05	0.5	2.85e-6	Diabetic retinopathy;
SKCM	cis	rs4242434	0.927	rs11136093	chr8:22479988	C/G	cg03733263	chr8:22462867	KIAA1967	1.06	8.66	0.7	4.91e-13	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs4724125	0.883	rs13224220	chr7:42696500	G/A	cg09407816	chr7:42972088	MRPL32;PSMA2	0.82	4.94	0.49	4.3e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2732480	0.577	rs2634681	chr12:48733084	C/T	cg21348975	chr12:48724119	NA	0.59	5.35	0.52	8.42e-7	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs2439831	0.571	rs2470121	chr15:43937618	G/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.31	7.38	0.64	1.49e-10	Lung cancer in ever smokers;
SKCM	cis	rs2204008	0.660	rs2874343	chr12:38239096	C/T	cg13010199	chr12:38710504	ALG10B	0.69	4.99	0.49	3.57e-6	Bladder cancer;
SKCM	cis	rs763121	0.853	rs2072798	chr22:39148483	G/A	cg06022373	chr22:39101656	GTPBP1	0.82	5.06	0.5	2.74e-6	Menopause (age at onset);
SKCM	cis	rs34779708	0.931	rs72789690	chr10:35382817	T/C	cg03585969	chr10:35415529	CREM	0.78	6.31	0.58	1.58e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs1799949	0.965	rs11080034	chr17:41443014	T/C	cg25918947	chr17:41365094	TMEM106A	-0.65	-6.19	-0.57	2.56e-8	Menopause (age at onset);
SKCM	cis	rs6951245	0.872	rs112309216	chr7:1100296	A/T	cg24642844	chr7:1081250	C7orf50	-0.93	-6.22	-0.58	2.28e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs10504229	1.000	rs17805602	chr8:58179915	A/G	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs7666738	0.791	rs13149968	chr4:99070262	G/T	cg05340658	chr4:99064831	C4orf37	0.66	4.87	0.48	5.74e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10504229	1.000	rs76944716	chr8:58191643	T/C	cg02725872	chr8:58115012	NA	-0.5	-4.87	-0.48	5.68e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs9818758	0.607	rs13077498	chr3:49313978	C/T	cg00383909	chr3:49044727	WDR6	0.95	4.95	0.49	4.17e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs1799949	1.000	rs8176297	chr17:41203325	T/A	cg23758822	chr17:41437982	NA	0.94	7.82	0.66	2.13e-11	Menopause (age at onset);
SKCM	cis	rs10751667	0.643	rs7479473	chr11:929111	C/T	cg10932868	chr11:921992	NA	0.55	5.13	0.5	2.09e-6	Alzheimer's disease (late onset);
SKCM	cis	rs933688	1.000	rs9293568	chr5:90737845	C/T	cg12630606	chr5:90679528	LOC100129716;ARRDC3	0.98	7.81	0.66	2.22e-11	Smoking behavior;
SKCM	cis	rs1003719	0.788	rs9981226	chr21:38452127	C/T	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs28595532	0.920	rs116305850	chr4:119779892	A/G	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs55962025	0.551	rs362296	chr4:3247007	C/A	cg21096898	chr4:3318625	RGS12	-0.62	-4.95	-0.49	4.13e-6	Parental longevity (mother's age at death);
SKCM	cis	rs7666738	0.783	rs10028584	chr4:98962404	C/T	cg05340658	chr4:99064831	C4orf37	0.64	4.91	0.49	4.97e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4774899	1.000	rs12899588	chr15:57476858	A/G	cg01857019	chr15:57210107	LOC145783;TCF12	0.53	4.9	0.49	5.12e-6	Urinary tract infection frequency;
SKCM	cis	rs8179	0.700	rs42040	chr7:92245927	C/T	cg27455918	chr7:92370191	CDK6	-0.55	-4.95	-0.49	4.23e-6	Sum neutrophil eosinophil counts;Sum basophil neutrophil counts;Neutrophil count;White blood cell count;Myeloid white cell count;Granulocyte count;White blood cell count (basophil);
SKCM	cis	rs9814567	1.000	rs9809619	chr3:134280948	G/T	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs2070488	0.965	rs2051216	chr3:38562288	C/T	cg01465620	chr3:38496096	LOC100128640;ACVR2B	-1.01	-8.97	-0.71	1.22e-13	Electrocardiographic conduction measures;
SKCM	cis	rs9880211	1.000	rs28811905	chr3:136252052	T/C	cg21827317	chr3:136751795	NA	-0.65	-4.92	-0.49	4.73e-6	Body mass index;Height;
SKCM	cis	rs1401999	0.628	rs1520195	chr3:183736882	G/A	cg01324343	chr3:183735012	ABCC5	0.65	6.42	0.59	9.91e-9	Anterior chamber depth;
SKCM	cis	rs11098499	0.542	rs7677836	chr4:120310638	T/A	cg24375607	chr4:120327624	NA	0.65	4.97	0.49	3.87e-6	Corneal astigmatism;
SKCM	cis	rs854765	0.583	rs11650649	chr17:17790319	C/A	cg04398451	chr17:18023971	MYO15A	0.79	5.69	0.54	2.13e-7	Total body bone mineral density;
SKCM	cis	rs2439831	0.681	rs528517	chr15:43612925	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.2	8.73	0.7	3.66e-13	Lung cancer in ever smokers;
SKCM	cis	rs2842992	0.915	rs2842985	chr6:160085434	C/T	cg19482086	chr6:160211437	TCP1;MRPL18	0.82	5.72	0.54	1.86e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs2839186	0.900	rs2839200	chr21:47709095	C/T	cg11766577	chr21:47581405	C21orf56	-0.71	-6.01	-0.56	5.6e-8	Testicular germ cell tumor;
SKCM	trans	rs5756813	1.000	rs5756813	chr22:38175477	A/C	cg19894588	chr14:64061835	NA	-0.88	-7.88	-0.67	1.57e-11	Optic cup area;Vertical cup-disc ratio;
SKCM	cis	rs9910055	0.529	rs228749	chr17:42174570	A/G	cg19774624	chr17:42201019	HDAC5	0.83	6.53	0.59	6.08e-9	Total body bone mineral density;
SKCM	cis	rs875971	0.825	rs28480509	chr7:66099224	A/G	cg11764359	chr7:65958608	NA	-0.74	-6.63	-0.6	3.89e-9	Aortic root size;
SKCM	cis	rs7811142	0.943	rs66958101	chr7:100074020	G/A	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.34	0.69	2.1e-12	Platelet count;
SKCM	cis	rs782590	0.967	rs62165172	chr2:55736237	A/G	cg18811423	chr2:55921094	PNPT1	0.79	5.94	0.56	7.54e-8	Metabolic syndrome;
SKCM	cis	rs10256972	0.657	rs4311576	chr7:1010285	C/G	cg07930192	chr7:1003750	NA	0.52	5.07	0.5	2.65e-6	Longevity;Endometriosis;
SKCM	cis	rs11098499	0.954	rs6820115	chr4:120398182	T/C	cg24375607	chr4:120327624	NA	0.67	5.17	0.51	1.77e-6	Corneal astigmatism;
SKCM	cis	rs3789045	0.774	rs12031912	chr1:204476113	A/G	cg17419461	chr1:204415978	PIK3C2B	-0.84	-5.83	-0.55	1.19e-7	Educational attainment (college completion);
SKCM	cis	rs1552244	0.816	rs56271597	chr3:10042790	C/T	cg02579736	chr3:10068473	FANCD2;CIDECP	0.98	4.84	0.48	6.48e-6	Alzheimer's disease;
SKCM	cis	rs7017252	1.000	rs1372448	chr8:129950323	T/A	cg08633665	chr8:128972829	MIR1205;PVT1	-0.44	-5.12	-0.5	2.18e-6	Nonsyndromic cleft lip with cleft palate;
SKCM	cis	rs9987353	0.589	rs1053036	chr8:9060077	A/G	cg15556689	chr8:8085844	FLJ10661	-0.61	-4.92	-0.49	4.76e-6	Recombination measurement;
SKCM	cis	rs3768617	0.510	rs1413389	chr1:183096668	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs7666738	0.724	rs28451676	chr4:98966990	C/T	cg17366294	chr4:99064904	C4orf37	0.59	4.89	0.48	5.36e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6061231	0.624	rs8668	chr20:60964064	C/T	cg24112000	chr20:60950667	NA	0.64	6.42	0.59	9.7e-9	Colorectal cancer;
SKCM	cis	rs7811142	0.945	rs6978739	chr7:100098680	C/G	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.22	7.91	0.67	1.43e-11	Platelet count;
SKCM	cis	rs2228479	0.764	rs7186976	chr16:89961593	A/G	cg06558623	chr16:89946397	TCF25	1.27	7.17	0.63	3.78e-10	Skin colour saturation;
SKCM	cis	rs8180040	0.966	rs17784882	chr3:47544003	C/A	cg16586182	chr3:47516702	SCAP	0.73	4.95	0.49	4.12e-6	Colorectal cancer;
SKCM	cis	rs7598759	0.548	rs6750795	chr2:232378231	T/C	cg19187155	chr2:232395269	NMUR1	0.89	8.01	0.67	8.87e-12	Noise-induced hearing loss;
SKCM	cis	rs2760061	0.598	rs605410	chr1:228116281	A/G	cg18477163	chr1:228402036	OBSCN	-0.43	-4.79	-0.48	7.93e-6	Diastolic blood pressure;
SKCM	cis	rs867186	1.000	rs73903017	chr20:33724758	A/G	cg04194272	chr20:33683537	NA	-1.11	-6.01	-0.56	5.61e-8	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs6500395	1.000	rs6500397	chr16:48642235	T/C	cg04672837	chr16:48644449	N4BP1	0.69	5.75	0.55	1.65e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs427394	0.632	rs169285	chr5:6736587	G/C	cg10857441	chr5:6722123	POLS	-0.7	-7.54	-0.65	7.4e-11	Menopause (age at onset);
SKCM	cis	rs6430585	0.528	rs309162	chr2:136690783	T/A	cg07169764	chr2:136633963	MCM6	1.35	12.22	0.81	8.51e-20	Corneal structure;
SKCM	cis	rs514406	0.893	rs6661115	chr1:53426148	G/A	cg08859206	chr1:53392774	SCP2	0.66	5.27	0.51	1.19e-6	Monocyte count;
SKCM	cis	rs9911578	1.000	rs1494977	chr17:56863064	C/T	cg05425664	chr17:57184151	TRIM37	-0.69	-5.21	-0.51	1.52e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs3020736	0.500	rs9620026	chr22:42498578	C/T	cg04733989	chr22:42467013	NAGA	-0.72	-5.62	-0.54	2.87e-7	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs7618915	0.547	rs34017441	chr3:52742413	T/C	cg18404041	chr3:52824283	ITIH1	-0.56	-4.94	-0.49	4.32e-6	Bipolar disorder;
SKCM	cis	rs4237845	0.773	rs6650218	chr12:58289078	T/A	cg00677455	chr12:58241039	CTDSP2	0.68	5.69	0.54	2.11e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs1799949	1.000	rs9646412	chr17:41425893	A/T	cg05368731	chr17:41323189	NBR1	0.86	7.45	0.64	1.08e-10	Menopause (age at onset);
SKCM	cis	rs61935443	0.720	rs10859783	chr12:95285339	A/G	cg21533806	chr12:95267307	NA	0.93	5.49	0.53	4.91e-7	Schizophrenia;
SKCM	cis	rs684232	0.602	rs384628	chr17:554912	G/A	cg15660573	chr17:549704	VPS53	-0.76	-6.08	-0.57	4.15e-8	Prostate cancer;
SKCM	cis	rs710865	0.527	rs2275403	chr1:19557713	C/G	cg13387374	chr1:19411106	UBR4	-0.75	-6.45	-0.59	8.58e-9	Brain structure;
SKCM	cis	rs7666738	0.830	rs969049	chr4:98988857	C/T	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10254284	0.851	rs740123	chr7:28166455	G/C	cg15170557	chr7:28214983	JAZF1	-0.61	-5.29	-0.51	1.08e-6	Lymphocyte percentage of white cells;Systemic lupus erythematosus;
SKCM	cis	rs2197308	0.765	rs2387436	chr12:37935337	C/T	cg26384229	chr12:38710491	ALG10B	-0.76	-6.51	-0.59	6.66e-9	Morning vs. evening chronotype;
SKCM	cis	rs4319547	0.956	rs9988963	chr12:122991478	C/G	cg23029597	chr12:123009494	RSRC2	-0.83	-6.25	-0.58	2e-8	Body mass index;
SKCM	cis	rs12926788	0.689	rs7186308	chr16:24848471	A/G	cg06028605	chr16:24865363	SLC5A11	0.57	4.98	0.49	3.68e-6	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs62238980	0.614	rs117655982	chr22:32461141	T/C	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs2842992	0.872	rs2758330	chr6:160104844	G/T	cg11366901	chr6:160182831	ACAT2	0.88	6.82	0.61	1.71e-9	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs10540	1.000	rs12418639	chr11:473300	A/C	cg03576123	chr11:487126	PTDSS2	1.36	7.35	0.64	1.67e-10	Body mass index;
SKCM	cis	rs10088262	0.629	rs6990565	chr8:124785645	C/A	cg20713898	chr8:124780851	FAM91A1	-0.71	-5.38	-0.52	7.63e-7	Pancreatic cancer;
SKCM	cis	rs1348850	0.914	rs12693120	chr2:178283288	A/G	cg02961200	chr2:178257176	LOC100130691;AGPS	0.84	6.22	0.58	2.27e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs28510890	0.754	rs8033582	chr15:93125888	T/C	cg23043611	chr15:93139145	NA	-0.72	-5.15	-0.5	1.94e-6	Lung cancer in ever smokers;
SKCM	trans	rs8170	0.603	rs3745187	chr19:17414126	C/T	cg07395094	chr5:139554569	C5orf32	-0.88	-7.29	-0.64	2.16e-10	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Ovarian cancer;Breast cancer;Epithelial ovarian cancer;
SKCM	cis	rs12971120	0.685	rs34780792	chr18:72173278	G/A	cg25817165	chr18:72167213	CNDP2	-0.65	-4.84	-0.48	6.37e-6	Refractive error;
SKCM	cis	rs11098499	0.863	rs3775854	chr4:120471971	C/T	cg24375607	chr4:120327624	NA	0.69	5.47	0.53	5.35e-7	Corneal astigmatism;
SKCM	cis	rs7666738	0.830	rs4699600	chr4:99019429	C/G	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs433852	0.718	rs550455	chr19:49136515	A/G	cg06677660	chr19:49140777	SEC1;DBP	-0.86	-6.29	-0.58	1.74e-8	Elevated serum carcinoembryonic antigen levels;Posterior cortical atrophy and Alzheimer's disease;
SKCM	cis	rs561341	0.883	rs1034627	chr17:30219569	C/T	cg00745463	chr17:30367425	LRRC37B	-0.89	-5.53	-0.53	4.11e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs8060686	0.641	rs73598006	chr16:68074454	C/G	cg09117114	chr16:67998030	SLC12A4	-0.78	-5.06	-0.5	2.72e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs7666738	0.830	rs35938349	chr4:98974998	T/C	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs17065868	1.000	rs9533878	chr13:45073536	T/A	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs7336332	0.800	rs9805452	chr13:28047908	C/T	cg22138327	chr13:27999177	GTF3A	0.74	5.59	0.54	3.16e-7	Weight;
SKCM	cis	rs17685	0.712	rs1859792	chr7:75789264	T/C	cg01364799	chr7:75623366	TMEM120A	-0.66	-5.17	-0.51	1.73e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs12477438	0.520	rs6717723	chr2:99756930	T/C	cg14399236	chr2:99771627	LIPT1;TSGA10	1.01	9.53	0.73	1.01e-14	Chronic sinus infection;
SKCM	cis	rs9858542	0.903	rs11917431	chr3:49644012	C/T	cg03060546	chr3:49711283	APEH	-0.73	-5.41	-0.52	6.82e-7	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	trans	rs17685	0.753	rs13240967	chr7:75658197	C/T	cg19862616	chr7:65841803	NCRNA00174	-0.94	-9.39	-0.73	1.88e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7811142	1.000	rs11766752	chr7:100073292	A/G	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.12	6.51	0.59	6.68e-9	Platelet count;
SKCM	cis	rs796364	0.951	rs7608668	chr2:201000017	T/C	cg12253985	chr2:200820533	C2orf60;C2orf47	-0.94	-6.2	-0.57	2.47e-8	Schizophrenia;
SKCM	cis	rs34779708	0.966	rs11010135	chr10:35518063	A/G	cg03585969	chr10:35415529	CREM	0.75	6.09	0.57	4.01e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs7666738	0.830	rs28761309	chr4:98867393	C/T	cg17366294	chr4:99064904	C4orf37	0.56	4.87	0.48	5.62e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9902453	0.933	rs60694493	chr17:28473256	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.5	0.53	4.74e-7	Coffee consumption (cups per day);
SKCM	cis	rs4400599	0.569	rs10797058	chr1:154200704	T/C	cg26808167	chr1:154192205	UBAP2L;C1orf43	-0.54	-4.9	-0.49	5.01e-6	Platelet distribution width;
SKCM	cis	rs4900538	0.855	rs12587464	chr14:102886561	G/C	cg18135206	chr14:102964638	TECPR2	-0.72	-5.29	-0.51	1.08e-6	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs2228479	0.541	rs62052173	chr16:89950739	T/C	cg06558623	chr16:89946397	TCF25	1.25	7.23	0.63	2.87e-10	Skin colour saturation;
SKCM	cis	rs8067545	0.750	rs28637614	chr17:19985108	G/T	cg13482628	chr17:19912719	NA	0.73	6.54	0.6	5.78e-9	Schizophrenia;
SKCM	cis	rs8177253	1.000	rs8177272	chr3:133482870	C/T	cg16414030	chr3:133502952	NA	-0.7	-5.93	-0.56	7.88e-8	Iron status biomarkers;
SKCM	cis	rs3768617	0.510	rs12095664	chr1:183101686	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs754466	0.580	rs2289308	chr10:79579251	G/A	cg17075019	chr10:79541650	NA	-0.8	-6.94	-0.62	1e-9	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs2243480	1.000	rs6460260	chr7:65215455	T/C	cg18252515	chr7:66147081	NA	1.32	8.71	0.7	3.95e-13	Diabetic kidney disease;
SKCM	cis	rs7772486	0.727	rs2235481	chr6:146056848	T/C	cg23711669	chr6:146136114	FBXO30	-0.81	-7.01	-0.62	7.66e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs10832963	0.924	rs10500834	chr11:18638712	A/T	cg20219074	chr11:18656078	SPTY2D1	0.8	6.7	0.6	2.86e-9	Breast cancer;
SKCM	cis	rs995000	0.931	rs1168009	chr1:62943954	G/A	cg06896770	chr1:63153194	DOCK7	-0.64	-5.96	-0.56	6.81e-8	Triglyceride levels;
SKCM	cis	rs7216064	1.000	rs35243555	chr17:65876477	G/C	cg12091567	chr17:66097778	LOC651250	-0.75	-5.27	-0.51	1.19e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs1218582	0.745	rs1580943	chr1:154865125	G/A	cg24250549	chr1:154909240	PMVK	0.87	8.69	0.7	4.22e-13	Prostate cancer;
SKCM	cis	rs7772486	0.875	rs9403764	chr6:146360582	G/A	cg05347473	chr6:146136440	FBXO30	0.57	5.24	0.51	1.31e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs12142240	0.698	rs72890727	chr1:46860237	G/A	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs12477438	0.520	rs6542865	chr2:99764521	C/T	cg26064155	chr2:99771622	LIPT1;TSGA10	1.02	9.73	0.74	4.23e-15	Chronic sinus infection;
SKCM	cis	rs10876993	0.890	rs12302351	chr12:58062590	T/C	cg18357645	chr12:58087776	OS9	0.61	5.62	0.54	2.9e-7	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs34779708	0.931	rs12242882	chr10:35347860	G/C	cg03585969	chr10:35415529	CREM	0.73	6.03	0.56	5.13e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs7635838	0.586	rs347617	chr3:11278211	C/T	cg00170343	chr3:11313890	ATG7	0.78	5.86	0.55	1.07e-7	HDL cholesterol;
SKCM	cis	rs1029738	0.659	rs1608553	chr7:22896231	G/C	cg00365470	chr7:22893924	NA	-0.64	-5.12	-0.5	2.11e-6	Fibrinogen levels;
SKCM	cis	rs644799	1.000	rs596277	chr11:95566886	G/A	cg03916912	chr11:95522834	CEP57;FAM76B	0.88	7.54	0.65	7.15e-11	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs1568889	0.838	rs11030206	chr11:28099747	C/T	cg06544937	chr11:28130018	METT5D1;KIF18A	0.89	8.4	0.69	1.55e-12	Bipolar disorder;
SKCM	cis	rs9902453	0.765	rs12601647	chr17:28164953	C/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.8	6.02	0.56	5.28e-8	Coffee consumption (cups per day);
SKCM	cis	rs875971	0.545	rs7787063	chr7:65628999	G/A	cg18876405	chr7:65276391	NA	0.64	5.29	0.51	1.09e-6	Aortic root size;
SKCM	cis	rs1577917	0.771	rs9362239	chr6:86429263	G/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.71	6.17	0.57	2.82e-8	Response to antipsychotic treatment;
SKCM	cis	rs17376456	0.877	rs28418572	chr5:93144161	A/C	cg21475434	chr5:93447410	FAM172A	0.95	5.36	0.52	8.36e-7	Diabetic retinopathy;
SKCM	cis	rs4820539	0.708	rs5751591	chr22:23489042	G/A	cg14186256	chr22:23484241	RTDR1	0.91	8.08	0.67	6.61e-12	Bone mineral density;
SKCM	cis	rs933688	1.000	rs332529	chr5:90789470	G/A	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.01	8.01	0.67	9.03e-12	Smoking behavior;
SKCM	cis	rs17711722	0.585	rs6942660	chr7:65302406	C/T	cg11987759	chr7:65425863	GUSB	-0.75	-6.42	-0.59	9.94e-9	Calcium levels;
SKCM	cis	rs2180341	1.000	rs9398838	chr6:127635285	C/T	cg24812749	chr6:127587940	RNF146	0.84	7.25	0.63	2.6e-10	Breast cancer;
SKCM	cis	rs6951245	1.000	rs77702926	chr7:1088838	G/A	cg24642844	chr7:1081250	C7orf50	-0.94	-6.32	-0.58	1.48e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs2228479	0.867	rs12930606	chr16:89946682	A/G	cg06558623	chr16:89946397	TCF25	1.26	6.97	0.62	9.17e-10	Skin colour saturation;
SKCM	cis	rs9788682	0.655	rs578776	chr15:78888400	G/A	cg24631222	chr15:78858424	CHRNA5	0.83	5.72	0.54	1.88e-7	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs3768617	0.510	rs10797849	chr1:183088988	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs6463523	0.525	rs11763218	chr7:852281	T/C	cg11064039	chr7:766100	PRKAR1B;HEATR2	-0.96	-6.33	-0.58	1.45e-8	Subjective well-being;
SKCM	cis	rs55823223	0.680	rs3744017	chr17:73871467	G/A	cg10935138	chr17:73851978	WBP2	1.13	6.37	0.59	1.19e-8	Psoriasis;
SKCM	cis	rs748404	0.650	rs556851	chr15:43571219	A/T	cg02155558	chr15:43621948	ADAL;LCMT2	0.72	5.88	0.55	9.48e-8	Lung cancer;
SKCM	trans	rs3749237	1.000	rs6804655	chr3:49738945	C/T	cg21659725	chr3:3221576	CRBN	0.99	7.35	0.64	1.71e-10	Resting heart rate;
SKCM	cis	rs2228479	0.867	rs73276534	chr16:89950557	A/G	cg00800038	chr16:89945340	TCF25	-0.94	-5.67	-0.54	2.3e-7	Skin colour saturation;
SKCM	cis	rs10808739	1.000	rs4737199	chr8:65641907	A/G	cg05711235	chr8:65498612	NA	-0.76	-4.88	-0.48	5.4e-6	HIV-1 susceptibility;
SKCM	cis	rs6952808	0.692	rs60755037	chr7:2030104	G/A	cg02951883	chr7:2050386	MAD1L1	-0.85	-7.58	-0.65	6.15e-11	Bipolar disorder and schizophrenia;
SKCM	trans	rs1814175	0.817	rs10839465	chr11:49981554	C/A	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs2153535	0.580	rs2327062	chr6:8453858	G/A	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	trans	rs1116547	0.602	rs6883441	chr5:112798855	G/A	cg09257824	chr11:32455642	WT1	-0.91	-7.41	-0.64	1.32e-10	Cerebral amyloid angiopathy;
SKCM	cis	rs4919087	0.810	rs1468069	chr10:98988759	A/C	cg25902810	chr10:99078978	FRAT1	0.62	4.92	0.49	4.63e-6	Monocyte count;
SKCM	cis	rs9788682	1.000	rs9788682	chr15:78802586	A/G	cg24631222	chr15:78858424	CHRNA5	-0.99	-6.6	-0.6	4.4e-9	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs826838	0.967	rs12823908	chr12:38845686	T/C	cg26384229	chr12:38710491	ALG10B	1.05	10.1	0.75	8.14e-16	Heart rate;
SKCM	cis	rs10791097	0.765	rs4622274	chr11:130729486	C/T	cg12179176	chr11:130786555	SNX19	0.75	5.92	0.56	8.18e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs2644899	0.750	rs2604869	chr19:41283693	G/A	cg24958765	chr19:41283667	RAB4B	0.83	5.3	0.51	1.05e-6	Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs1577917	0.958	rs12202188	chr6:86562700	C/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.32	-0.52	9.66e-7	Response to antipsychotic treatment;
SKCM	cis	rs7772486	0.623	rs735535	chr6:146036829	C/T	cg23711669	chr6:146136114	FBXO30	-0.82	-8.12	-0.68	5.44e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs763121	0.853	rs138705	chr22:39133803	C/T	cg06022373	chr22:39101656	GTPBP1	0.78	4.94	0.49	4.29e-6	Menopause (age at onset);
SKCM	cis	rs7552404	0.924	rs1251075	chr1:76190569	C/G	cg10523679	chr1:76189770	ACADM	0.72	5.11	0.5	2.2e-6	Blood metabolite levels;Acylcarnitine levels;
SKCM	trans	rs208520	0.754	rs12204635	chr6:66740779	C/A	cg15611600	chr13:45563400	KIAA1704;NUFIP1	0.92	7.47	0.65	9.89e-11	Exhaled nitric oxide output;
SKCM	cis	rs929354	0.707	rs1182445	chr7:157024428	C/G	cg17757837	chr7:157058334	UBE3C	-0.81	-5.67	-0.54	2.3e-7	Body mass index;
SKCM	cis	rs1062177	0.855	rs919262	chr5:151266084	C/T	cg00977110	chr5:151150581	G3BP1	-0.71	-6.05	-0.57	4.63e-8	Preschool internalizing problems;
SKCM	cis	rs1692580	0.870	rs262680	chr1:2167149	C/T	cg21442419	chr1:2182373	SKI	-0.48	-4.82	-0.48	6.88e-6	Coronary artery disease;
SKCM	trans	rs1814175	0.817	rs7947526	chr11:49983654	T/C	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs801193	0.569	rs13242290	chr7:66121885	G/A	cg11764359	chr7:65958608	NA	-0.74	-6.56	-0.6	5.43e-9	Aortic root size;
SKCM	cis	rs34779708	0.801	rs34592588	chr10:35540134	A/G	cg03585969	chr10:35415529	CREM	0.74	5.42	0.52	6.41e-7	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs1577917	1.000	rs10944170	chr6:86685469	A/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.83	-8.23	-0.68	3.37e-12	Response to antipsychotic treatment;
SKCM	cis	rs9640161	0.673	rs11773351	chr7:150030963	T/C	cg27494647	chr7:150038898	RARRES2	0.6	5.25	0.51	1.3e-6	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs2354432	0.556	rs1932979	chr1:146708912	A/G	cg25205988	chr1:146714368	CHD1L	-1.19	-6.54	-0.59	5.94e-9	Mitochondrial DNA levels;
SKCM	cis	rs7191439	0.626	rs8059794	chr16:88787388	C/T	cg02389323	chr16:88786976	FAM38A	1.23	5.39	0.52	7.25e-7	Plateletcrit;
SKCM	cis	rs6952808	0.792	rs2056480	chr7:1954301	A/G	cg21782813	chr7:2030301	MAD1L1	-0.54	-5.74	-0.54	1.73e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs875971	0.545	rs73378304	chr7:65640747	G/A	cg11764359	chr7:65958608	NA	0.68	4.81	0.48	7.31e-6	Aortic root size;
SKCM	cis	rs1799949	1.000	rs1799966	chr17:41223094	T/C	cg05368731	chr17:41323189	NBR1	0.89	7.87	0.67	1.71e-11	Menopause (age at onset);
SKCM	cis	rs2357013	0.725	rs1858211	chr2:53165520	G/C	cg07782112	chr2:53107842	NA	-0.6	-5.88	-0.55	9.64e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs8014204	0.935	rs1799900	chr14:75367740	G/A	cg06637938	chr14:75390232	RPS6KL1	-0.78	-5.95	-0.56	7.2e-8	Caffeine consumption;
SKCM	cis	rs757110	0.770	rs4439492	chr11:17386733	C/T	cg15432903	chr11:17409602	KCNJ11	0.51	4.86	0.48	5.99e-6	Type 2 diabetes;
SKCM	cis	rs7215564	0.908	rs55886624	chr17:78658657	G/A	cg16980736	chr17:78789706	RPTOR	-0.89	-4.88	-0.48	5.41e-6	Myopia (pathological);
SKCM	cis	rs2404602	0.655	rs3829489	chr15:77223256	A/C	cg23625390	chr15:77176239	SCAPER	0.59	5.24	0.51	1.35e-6	Blood metabolite levels;
SKCM	cis	rs9911578	1.000	rs1971659	chr17:57004787	A/G	cg05425664	chr17:57184151	TRIM37	-0.67	-5.04	-0.5	2.91e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs17711722	0.701	rs781143	chr7:65439879	G/C	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.63	5.48	0.53	5.11e-7	Calcium levels;
SKCM	cis	rs9911578	0.967	rs72628392	chr17:56506160	A/G	cg05425664	chr17:57184151	TRIM37	0.65	4.88	0.48	5.52e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs8177253	0.761	rs1830084	chr3:133508464	A/T	cg01448562	chr3:133502909	NA	0.56	4.83	0.48	6.66e-6	Iron status biomarkers;
SKCM	trans	rs1814175	0.645	rs11040671	chr11:49958776	G/A	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs208520	0.955	rs9453664	chr6:66976079	A/C	cg07460842	chr6:66804631	NA	0.85	6.05	0.56	4.8e-8	Exhaled nitric oxide output;
SKCM	cis	rs3771570	1.000	rs62190370	chr2:242384194	C/G	cg07612300	chr2:242033426	MTERFD2;SNED1	0.88	4.93	0.49	4.46e-6	Prostate cancer;
SKCM	cis	rs7296418	0.961	rs11613937	chr12:123520071	C/T	cg05973401	chr12:123451056	ABCB9	0.8	6.5	0.59	7.04e-9	Platelet count;
SKCM	cis	rs561341	0.714	rs55925849	chr17:30253085	C/T	cg23018236	chr17:30244563	NA	-0.53	-5.27	-0.51	1.18e-6	Hip circumference adjusted for BMI;
SKCM	trans	rs8073060	0.586	rs225303	chr17:33922149	A/G	cg19694781	chr19:47549865	TMEM160	1.07	8.59	0.7	6.89e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs17685	0.664	rs9801113	chr7:75792031	C/T	cg01364799	chr7:75623366	TMEM120A	-0.7	-5.84	-0.55	1.16e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs854765	0.547	rs2955380	chr17:17944349	A/G	cg04398451	chr17:18023971	MYO15A	0.94	7.53	0.65	7.5e-11	Total body bone mineral density;
SKCM	cis	rs7772486	0.875	rs854148	chr6:146310979	G/C	cg23711669	chr6:146136114	FBXO30	0.76	7.08	0.63	5.66e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2032447	0.670	rs198834	chr6:26114372	G/A	cg03517284	chr6:25882590	NA	0.63	5.41	0.52	6.74e-7	Intelligence (multi-trait analysis);
SKCM	trans	rs1814175	0.645	rs28436748	chr11:50046422	G/A	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs1405130	0.839	rs13009399	chr2:235571228	A/G	cg21542780	chr2:234763377	HJURP	-0.64	-4.89	-0.48	5.21e-6	Coronary artery disease;
SKCM	cis	rs12541335	0.639	rs4565458	chr8:22154133	T/C	cg26039829	chr8:22132926	PIWIL2	0.61	5.15	0.5	1.87e-6	Hypertriglyceridemia;
SKCM	cis	rs453301	0.686	rs13252797	chr8:8861430	A/G	cg15556689	chr8:8085844	FLJ10661	0.74	6.16	0.57	3.03e-8	Joint mobility (Beighton score);
SKCM	cis	rs3768617	0.528	rs4651144	chr1:183097421	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.69	0.66	3.68e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs853679	0.599	rs149990	chr6:27998258	G/A	cg09551472	chr6:27280195	POM121L2	0.87	4.79	0.48	7.68e-6	Depression;
SKCM	cis	rs2941509	1.000	rs112599791	chr17:38072475	G/A	cg12655416	chr17:38077870	ORMDL3	-0.48	-5.27	-0.51	1.17e-6	Systemic lupus erythematosus;
SKCM	cis	rs2439831	1.000	rs690316	chr15:43737880	C/A	cg02155558	chr15:43621948	ADAL;LCMT2	1.12	8.03	0.67	8.1e-12	Lung cancer in ever smokers;
SKCM	cis	rs55962025	0.842	rs362306	chr4:3242100	C/T	cg16987761	chr4:3318072	RGS12	-0.73	-5.62	-0.54	2.8e-7	Parental longevity (mother's age at death);
SKCM	cis	rs2811415	0.597	rs11721281	chr3:127790935	G/A	cg09089421	chr3:127803668	RUVBL1	1.0	8.69	0.7	4.4e-13	Lung function (FEV1/FVC);
SKCM	cis	rs28595532	0.545	rs55699931	chr4:119249835	G/A	cg11846333	chr4:119757529	SEC24D	1.04	5.83	0.55	1.2e-7	Cannabis dependence symptom count;
SKCM	cis	rs12451471	0.500	rs8077056	chr17:78076006	C/T	cg06718696	chr17:78121285	EIF4A3	0.85	5.57	0.53	3.55e-7	Plateletcrit;Mean corpuscular hemoglobin concentration;
SKCM	cis	rs1325195	0.537	rs2793804	chr1:179201000	C/T	cg25467746	chr1:179556597	NA	0.62	5.77	0.55	1.51e-7	IgE grass sensitization;
SKCM	cis	rs7811142	1.000	rs6979335	chr7:100089860	T/C	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.19	7.92	0.67	1.33e-11	Platelet count;
SKCM	cis	rs9475752	1.000	rs1451707	chr6:56801877	A/G	cg06815302	chr6:57335405	PRIM2	0.65	5.25	0.51	1.26e-6	Menarche (age at onset);
SKCM	cis	rs798766	1.000	rs2305188	chr4:1739592	A/G	cg05874882	chr4:1763078	NA	-0.56	-4.89	-0.48	5.37e-6	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs3768617	0.510	rs2027078	chr1:183073478	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs9911578	0.933	rs2531725	chr17:56517962	G/A	cg12560992	chr17:57184187	TRIM37	0.9	7.1	0.63	5.08e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs919433	1.000	rs2195510	chr2:198161195	A/G	cg04278110	chr2:198063759	ANKRD44	-0.72	-5.33	-0.52	9.25e-7	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs5769765	0.908	rs4074304	chr22:50309446	G/A	cg22709217	chr22:50311962	ALG12;CRELD2	-0.94	-5.91	-0.56	8.37e-8	Schizophrenia;
SKCM	cis	rs2841277	0.676	rs10438246	chr14:105410183	T/C	cg21017887	chr14:105400489	NA	0.58	5.28	0.51	1.13e-6	Rheumatoid arthritis;
SKCM	trans	rs208520	0.690	rs1100981	chr6:66852052	T/C	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-1.07	-7.99	-0.67	9.73e-12	Exhaled nitric oxide output;
SKCM	cis	rs9457247	0.663	rs9295384	chr6:167448113	T/A	cg13927040	chr6:167453801	FGFR1OP	0.63	5.15	0.5	1.93e-6	Crohn's disease;
SKCM	cis	rs644799	0.672	rs11021307	chr11:95501407	C/T	cg03916912	chr11:95522834	CEP57;FAM76B	0.83	7.22	0.63	3.06e-10	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs9325144	0.541	rs7303395	chr12:38664124	C/T	cg26384229	chr12:38710491	ALG10B	-0.69	-5.66	-0.54	2.36e-7	Morning vs. evening chronotype;
SKCM	cis	rs10751667	0.666	rs6597958	chr11:978087	C/T	cg10932868	chr11:921992	NA	0.55	5.1	0.5	2.36e-6	Alzheimer's disease (late onset);
SKCM	cis	rs4481887	0.927	rs4564179	chr1:248472422	T/C	cg00666640	chr1:248458726	OR2T12	0.62	5.67	0.54	2.29e-7	Common traits (Other);
SKCM	cis	rs6138458	1.000	rs227621	chr20:24910528	A/C	cg26195577	chr20:24973756	C20orf3	1.29	8.69	0.7	4.32e-13	Blood protein levels;
SKCM	cis	rs6570726	0.791	rs440477	chr6:145854188	C/T	cg05347473	chr6:146136440	FBXO30	0.56	5.08	0.5	2.49e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs8064299	0.597	rs7210318	chr17:72783385	T/C	cg25054828	chr17:72772726	NAT9;TMEM104	0.94	9.71	0.74	4.65e-15	Monocyte count;
SKCM	cis	rs4343996	0.902	rs4521670	chr7:3383603	C/T	cg25153887	chr7:2442910	CHST12	0.69	4.78	0.48	8.22e-6	Motion sickness;
SKCM	cis	rs10504229	0.683	rs16921829	chr8:58110950	A/G	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs995000	0.931	rs11207984	chr1:63013396	C/T	cg06896770	chr1:63153194	DOCK7	-0.73	-6.54	-0.6	5.83e-9	Triglyceride levels;
SKCM	cis	rs1707322	0.963	rs4459051	chr1:46451203	A/G	cg03146154	chr1:46216737	IPP	0.79	5.34	0.52	8.73e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs9611565	0.649	rs5751144	chr22:42128097	A/G	cg03806693	chr22:41940476	POLR3H	-0.79	-5.05	-0.5	2.87e-6	Vitiligo;
SKCM	cis	rs727563	0.555	rs5751136	chr22:42075581	T/A	cg03806693	chr22:41940476	POLR3H	1.12	7.65	0.65	4.54e-11	Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs9911578	0.967	rs7502208	chr17:57165097	G/A	cg05425664	chr17:57184151	TRIM37	-0.83	-7.07	-0.62	5.91e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs1461503	0.868	rs7126785	chr11:122839564	C/A	cg27398637	chr11:122830231	C11orf63	-0.63	-4.8	-0.48	7.54e-6	Menarche (age at onset);
SKCM	cis	rs6665290	0.669	rs3738725	chr1:227174210	T/C	cg10327440	chr1:227177885	CDC42BPA	-1.08	-9.9	-0.75	1.95e-15	Myeloid white cell count;
SKCM	cis	rs7000551	0.560	rs4872483	chr8:22255684	C/T	cg12081754	chr8:22256438	SLC39A14	0.87	7.96	0.67	1.1e-11	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs1710278	0.506	rs12765977	chr10:127736306	C/T	cg09487594	chr10:127585144	FANK1	0.63	5.52	0.53	4.33e-7	Exploratory eye movement dysfunction in schizophrenia (number of eye fixations);
SKCM	cis	rs9814567	1.000	rs6793487	chr3:134299426	C/G	cg06109529	chr3:134205091	CEP63;ANAPC13	0.61	4.94	0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs28386778	0.799	rs2955234	chr17:61983601	A/C	cg06873352	chr17:61820015	STRADA	-0.67	-5.29	-0.51	1.09e-6	Prudent dietary pattern;
SKCM	cis	rs7959452	0.590	rs10878974	chr12:69781528	C/G	cg20891283	chr12:69753455	YEATS4	0.93	9.67	0.74	5.4e-15	Blood protein levels;
SKCM	cis	rs7584330	0.737	rs13397017	chr2:238361241	G/A	cg14458575	chr2:238380390	NA	0.88	6.21	0.57	2.43e-8	Prostate cancer;
SKCM	cis	rs2839186	0.771	rs13046451	chr21:47641373	T/A	cg13012494	chr21:47604986	C21orf56	-0.67	-5.81	-0.55	1.29e-7	Testicular germ cell tumor;
SKCM	cis	rs7772486	0.754	rs857881	chr6:145970793	C/A	cg23711669	chr6:146136114	FBXO30	-0.96	-10.71	-0.77	5.67e-17	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs12762955	0.507	rs10737004	chr10:1039019	T/C	cg26597838	chr10:835615	NA	-0.54	-4.88	-0.48	5.57e-6	Response to angiotensin II receptor blocker therapy;
SKCM	cis	rs854765	0.547	rs6502633	chr17:17941037	G/C	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.05	9.29	0.72	2.92e-14	Total body bone mineral density;
SKCM	cis	rs28386778	0.863	rs6504178	chr17:61812733	A/G	cg06873352	chr17:61820015	STRADA	-0.76	-6.49	-0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs34779708	0.736	rs34195979	chr10:35549817	T/C	cg03585969	chr10:35415529	CREM	0.73	5.25	0.51	1.3e-6	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs11718455	0.961	rs3846068	chr3:44029835	G/A	cg21419209	chr3:44054225	NA	-0.62	-4.94	-0.49	4.43e-6	Coronary artery disease;
SKCM	cis	rs72615157	0.634	rs7789890	chr7:99800559	G/T	cg23667466	chr7:100026434	MEPCE;ZCWPW1	0.92	4.97	0.49	3.93e-6	Lung function (FEV1/FVC);
SKCM	cis	rs11098499	0.738	rs34965784	chr4:120361586	G/C	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs6430585	0.702	rs746857	chr2:136554890	G/A	cg07169764	chr2:136633963	MCM6	-1.32	-13.34	-0.83	7.99e-22	Corneal structure;
SKCM	cis	rs769267	0.929	rs2905421	chr19:19457908	G/T	cg03709012	chr19:19516395	GATAD2A	0.82	6.52	0.59	6.23e-9	Tonsillectomy;
SKCM	cis	rs7666738	0.830	rs9998582	chr4:98938949	T/C	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs910316	1.000	rs7156105	chr14:75541954	C/A	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.85e-7	Height;
SKCM	cis	rs10089	0.953	rs4836358	chr5:127376869	A/G	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.92	8.29	0.68	2.54e-12	Ileal carcinoids;
SKCM	cis	rs2120019	0.935	rs12591119	chr15:75355944	A/G	cg09165964	chr15:75287851	SCAMP5	-0.75	-6.28	-0.58	1.78e-8	Blood trace element (Zn levels);
SKCM	cis	rs12541335	0.590	rs11136002	chr8:22217082	C/T	cg26039829	chr8:22132926	PIWIL2	0.62	5.59	0.53	3.28e-7	Hypertriglyceridemia;
SKCM	cis	rs736408	0.500	rs2878762	chr3:52919002	T/C	cg11645453	chr3:52864694	ITIH4	0.72	6.35	0.58	1.32e-8	Bipolar disorder;
SKCM	cis	rs3820068	0.581	rs72645879	chr1:15928199	A/G	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs2645694	0.603	rs2703123	chr4:77821154	C/T	cg06046430	chr4:77819534	ANKRD56	0.54	5.83	0.55	1.18e-7	Emphysema distribution in smoking;
SKCM	cis	rs763121	0.819	rs5757169	chr22:39003495	G/A	cg06022373	chr22:39101656	GTPBP1	0.82	5.62	0.54	2.79e-7	Menopause (age at onset);
SKCM	cis	rs3785574	0.962	rs2584623	chr17:61906679	G/A	cg06601766	chr17:61851465	DDX42;CCDC47	0.73	5.38	0.52	7.7300000000000005e-07	Height;
SKCM	cis	rs137603	0.644	rs137620	chr22:39709776	T/C	cg17798944	chr22:39715225	SNORD43;RPL3	-0.62	-5.26	-0.51	1.24e-6	Primary biliary cholangitis;
SKCM	cis	rs10503709	0.556	rs13263772	chr8:21479481	G/A	cg23716449	chr8:21608280	GFRA2	-0.54	-5.4	-0.52	6.95e-7	Blood protein levels;
SKCM	cis	rs7666738	0.791	rs1426674	chr4:98924247	C/A	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2721195	0.967	rs748193	chr8:145682115	C/T	cg15320075	chr8:145703422	NA	0.88	7.51	0.65	8.2e-11	Age at first birth;
SKCM	cis	rs2439831	0.850	rs12441984	chr15:44126285	C/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.36	7.78	0.66	2.56e-11	Lung cancer in ever smokers;
SKCM	cis	rs8017423	0.935	rs7160304	chr14:90752908	G/T	cg04374321	chr14:90722782	PSMC1	0.93	8.33	0.69	2.15e-12	Mortality in heart failure;
SKCM	cis	rs13118159	0.527	rs6599309	chr4:1388115	C/G	cg02475777	chr4:1388615	CRIPAK	0.93	6.25	0.58	2e-8	Longevity;
SKCM	cis	rs595982	0.559	rs4802516	chr19:49366170	T/C	cg19746536	chr19:49375674	PPP1R15A	1.02	5.66	0.54	2.39e-7	Red cell distribution width;
SKCM	cis	rs67311347	0.956	rs12633446	chr3:40505661	G/A	cg00091569	chr3:40428383	ENTPD3	-0.61	-4.84	-0.48	6.46e-6	Renal cell carcinoma;
SKCM	cis	rs7927771	0.524	rs10838739	chr11:47672743	A/G	cg20307385	chr11:47447363	PSMC3	-0.74	-5.98	-0.56	6.3e-8	Subjective well-being;
SKCM	cis	rs7111031	1.000	rs11601054	chr11:113336172	C/T	cg04642306	chr11:112834466	NCAM1	-0.47	-5.0	-0.49	3.41e-6	Subjective well-being (multi-trait analysis);Depressive symptoms (multi-trait analysis);Neuroticism;
SKCM	cis	rs1568889	0.887	rs7102237	chr11:28344296	A/C	cg06544937	chr11:28130018	METT5D1;KIF18A	0.89	8.44	0.69	1.31e-12	Bipolar disorder;
SKCM	cis	rs9916302	0.904	rs2338800	chr17:37498149	C/G	cg07936489	chr17:37558343	FBXL20	0.83	7.03	0.62	6.81e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs3857536	0.740	rs7773577	chr6:66892124	G/A	cg07460842	chr6:66804631	NA	-0.7	-5.08	-0.5	2.51e-6	Blood trace element (Cu levels);
SKCM	cis	rs362296	0.698	rs3095082	chr4:3263617	C/A	cg00764545	chr4:3318001	RGS12	-0.7	-6.61	-0.6	4.34e-9	Parental longevity (mother's age at death);
SKCM	cis	rs870825	0.616	rs7680779	chr4:185652830	G/C	cg04058563	chr4:185651563	MLF1IP	-1.07	-7.16	-0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs3008870	0.583	rs2031495	chr1:67421714	G/T	cg08660285	chr1:67390436	MIER1;WDR78	0.94	6.05	0.57	4.77e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs6088580	0.609	rs2378205	chr20:33110803	C/G	cg24642439	chr20:33292090	TP53INP2	0.76	6.02	0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs1552244	0.808	rs7615088	chr3:10035896	A/T	cg02579736	chr3:10068473	FANCD2;CIDECP	0.94	4.84	0.48	6.49e-6	Alzheimer's disease;
SKCM	cis	rs2836974	0.605	rs2836988	chr21:40707975	A/G	cg17971929	chr21:40555470	PSMG1	-0.71	-6.18	-0.57	2.69e-8	Cognitive function;
SKCM	cis	rs6912958	0.559	rs242281	chr6:88048916	A/C	cg08069147	chr6:88032118	GJB7;C6orf162	0.65	5.83	0.55	1.21e-7	Monocyte percentage of white cells;
SKCM	cis	rs870825	0.929	rs72689265	chr4:185590982	A/G	cg04058563	chr4:185651563	MLF1IP	1.09	5.66	0.54	2.4e-7	Blood protein levels;
SKCM	cis	rs1797081	0.901	rs703059	chr10:16876402	G/A	cg23933602	chr10:16859644	RSU1	1.05	12.54	0.82	2.18e-20	Platelet distribution width;
SKCM	cis	rs9300255	0.602	rs1716177	chr12:123655457	C/T	cg05973401	chr12:123451056	ABCB9	0.83	5.5	0.53	4.69e-7	Neutrophil percentage of white cells;
SKCM	cis	rs801193	0.967	rs2707841	chr7:66157020	A/G	cg11987759	chr7:65425863	GUSB	-0.69	-5.9	-0.56	8.74e-8	Aortic root size;
SKCM	cis	rs7777484	0.534	rs2258709	chr7:2832365	C/T	cg19717773	chr7:2847554	GNA12	0.49	5.96	0.56	6.98e-8	Height;
SKCM	cis	rs7811142	0.943	rs73403312	chr7:100024153	T/C	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.16	7.68	0.66	3.87e-11	Platelet count;
SKCM	cis	rs7811142	1.000	rs60844404	chr7:100080474	A/T	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.14	6.58	0.6	4.83e-9	Platelet count;
SKCM	cis	rs2354432	1.000	rs2354432	chr1:146693229	C/T	cg25205988	chr1:146714368	CHD1L	1.3	8.06	0.67	7.12e-12	Mitochondrial DNA levels;
SKCM	cis	rs11105298	0.891	rs10858896	chr12:89920184	C/T	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.91	-5.65	-0.54	2.56e-7	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs28595532	0.920	rs56252481	chr4:119754023	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs1577917	0.771	rs2475790	chr6:86368068	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.82	-7.6	-0.65	5.57e-11	Response to antipsychotic treatment;
SKCM	cis	rs939658	0.683	rs1560895	chr15:79468082	A/G	cg10259521	chr15:79428573	NA	0.47	4.84	0.48	6.53e-6	Refractive error;
SKCM	cis	rs10504229	0.683	rs7459958	chr8:58111905	G/T	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs35306767	0.903	rs11253494	chr10:937047	C/T	cg26597838	chr10:835615	NA	0.81	5.45	0.53	5.69e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs17685	0.625	rs1639630	chr7:75730499	T/C	cg01364799	chr7:75623366	TMEM120A	-0.79	-6.37	-0.58	1.23e-8	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs12477438	0.501	rs9941561	chr2:99753829	A/C	cg26064155	chr2:99771622	LIPT1;TSGA10	1.02	9.73	0.74	4.23e-15	Chronic sinus infection;
SKCM	cis	rs13118159	0.527	rs9328733	chr4:1388583	A/G	cg19318889	chr4:1322082	MAEA	0.76	5.1	0.5	2.3e-6	Longevity;
SKCM	cis	rs28386778	0.897	rs1982400	chr17:61793818	T/C	cg06873352	chr17:61820015	STRADA	0.74	6.08	0.57	4.13e-8	Prudent dietary pattern;
SKCM	cis	rs4862750	0.830	rs13152425	chr4:187894726	A/T	cg10295955	chr4:187884368	NA	-1.02	-12.26	-0.81	7.13e-20	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs763014	0.931	rs2071981	chr16:630025	C/G	cg07343612	chr16:622815	PIGQ	-0.7	-6.0	-0.56	5.84e-8	Height;
SKCM	cis	rs13256369	0.756	rs13282580	chr8:8562903	C/T	cg15556689	chr8:8085844	FLJ10661	0.65	4.77	0.48	8.39e-6	Obesity-related traits;
SKCM	cis	rs2070488	0.730	rs2268759	chr3:38514327	G/A	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.76	6.05	0.57	4.68e-8	Electrocardiographic conduction measures;
SKCM	cis	rs2857078	0.732	rs9893756	chr17:42321109	T/C	cg13607699	chr17:42295918	UBTF	-0.94	-7.39	-0.64	1.41e-10	Red cell distribution width;Reticulocyte count;
SKCM	cis	rs17376456	0.877	rs56373208	chr5:93491276	C/A	cg25358565	chr5:93447407	FAM172A	1.24	8.18	0.68	4.18e-12	Diabetic retinopathy;
SKCM	cis	rs11673344	0.704	rs510757	chr19:37422802	C/T	cg07624650	chr19:37064219	ZNF529	0.8	5.23	0.51	1.41e-6	Obesity-related traits;
SKCM	cis	rs8180040	0.966	rs13064843	chr3:47415467	C/T	cg27129171	chr3:47204927	SETD2	0.79	5.79	0.55	1.43e-7	Colorectal cancer;
SKCM	cis	rs12458462	0.892	rs12456692	chr18:77482189	C/T	cg11879182	chr18:77439856	CTDP1	0.92	7.87	0.67	1.67e-11	Monocyte count;
SKCM	cis	rs910316	1.000	rs2300601	chr14:75639571	A/G	cg08847533	chr14:75593920	NEK9	0.91	7.96	0.67	1.12e-11	Height;
SKCM	cis	rs7247513	0.927	rs34956595	chr19:12702797	A/C	cg01871581	chr19:12707946	ZNF490	-0.7	-4.91	-0.49	4.88e-6	Bipolar disorder;
SKCM	cis	rs367615	0.552	rs2963023	chr5:108730070	C/T	cg17395555	chr5:108820864	NA	-0.64	-5.22	-0.51	1.45e-6	Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs208520	0.789	rs9351549	chr6:66871851	A/G	cg07460842	chr6:66804631	NA	-0.97	-7.03	-0.62	6.8e-10	Exhaled nitric oxide output;
SKCM	cis	rs6951245	0.529	rs10262070	chr7:1141738	C/T	cg18402987	chr7:1209562	NA	0.82	5.43	0.52	6.18e-7	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs2836974	0.897	rs8128102	chr21:40606414	G/A	cg11890956	chr21:40555474	PSMG1	1.09	13.83	0.84	1.08e-22	Cognitive function;
SKCM	cis	rs11585357	0.793	rs11588418	chr1:17616445	A/G	cg08277548	chr1:17600880	PADI3	-0.89	-6.31	-0.58	1.53e-8	Hair shape;
SKCM	cis	rs2243480	1.000	rs35825738	chr7:65318027	A/G	cg07424592	chr7:64974309	NA	0.99	4.9	0.49	5.08e-6	Diabetic kidney disease;
SKCM	cis	rs754466	0.580	rs12357670	chr10:79558180	T/C	cg17075019	chr10:79541650	NA	-0.74	-6.52	-0.59	6.26e-9	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs28386778	0.863	rs3826341	chr17:61819222	C/A	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.12	11.27	0.79	4.92e-18	Prudent dietary pattern;
SKCM	cis	rs11792861	0.591	rs10979613	chr9:111687584	A/G	cg14432460	chr9:111696404	IKBKAP;C9orf6	0.73	6.36	0.58	1.27e-8	Menarche (age at onset);
SKCM	cis	rs2836974	0.739	rs12482181	chr21:40548852	A/G	cg11644478	chr21:40555479	PSMG1	0.97	10.21	0.76	5.08e-16	Cognitive function;
SKCM	cis	rs1799949	1.000	rs8176318	chr17:41197274	G/T	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.06	-0.57	4.62e-8	Menopause (age at onset);
SKCM	cis	rs8014204	0.587	rs6574201	chr14:75387256	T/C	cg06637938	chr14:75390232	RPS6KL1	-0.89	-6.24	-0.58	2.09e-8	Caffeine consumption;
SKCM	cis	rs7826238	0.539	rs2945891	chr8:8155475	C/T	cg15556689	chr8:8085844	FLJ10661	0.63	5.0	0.49	3.5e-6	Systolic blood pressure;
SKCM	cis	rs13278732	0.500	rs11996042	chr8:99028182	A/G	cg16297171	chr8:99017690	MATN2	-0.57	-5.34	-0.52	8.94e-7	Eosinophilic esophagitis (pediatric);
SKCM	cis	rs9788721	0.836	rs2656052	chr15:78740932	A/C	cg18825076	chr15:78729989	IREB2	-0.61	-4.85	-0.48	6.1e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;Emphysema imaging phenotypes;Emphysema distribution in smoking;Local histogram emphysema pattern;Post bronchodilator FEV1/FVC ratio in COPD;
SKCM	cis	rs67460515	0.892	rs11711695	chr3:161057593	A/G	cg03342759	chr3:160939853	NMD3	-0.78	-6.78	-0.61	2.03e-9	Parkinson's disease;
SKCM	cis	rs4481887	1.000	rs4244174	chr1:248467956	A/G	cg00666640	chr1:248458726	OR2T12	0.61	5.6	0.54	3.11e-7	Common traits (Other);
SKCM	trans	rs1814175	0.645	rs28447324	chr11:50046629	C/A	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs9394841	0.646	rs9471676	chr6:41815192	C/T	cg08135965	chr6:41755394	TOMM6	0.74	4.88	0.48	5.45e-6	Mean corpuscular hemoglobin;Red cell distribution width;
SKCM	cis	rs910316	1.000	rs10142626	chr14:75555636	A/T	cg11812906	chr14:75593930	NEK9	0.69	5.22	0.51	1.47e-6	Height;
SKCM	cis	rs10751667	0.666	rs7394427	chr11:970405	G/A	cg10932868	chr11:921992	NA	0.55	5.1	0.5	2.36e-6	Alzheimer's disease (late onset);
SKCM	cis	rs7666738	0.830	rs1967979	chr4:98966201	G/T	cg17366294	chr4:99064904	C4orf37	0.59	4.89	0.48	5.36e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6430585	0.528	rs3098102	chr2:136654833	C/T	cg07169764	chr2:136633963	MCM6	1.23	9.91	0.75	1.87e-15	Corneal structure;
SKCM	cis	rs2836974	0.965	rs6517538	chr21:40656242	C/T	cg11644478	chr21:40555479	PSMG1	0.97	10.08	0.75	8.76e-16	Cognitive function;
SKCM	cis	rs7617480	0.648	rs14018	chr3:48784270	G/A	cg07636037	chr3:49044803	WDR6	0.86	5.83	0.55	1.17e-7	Subjective well-being (multi-trait analysis);Menarche (age at onset);
SKCM	cis	rs5769765	0.862	rs9616380	chr22:50312225	T/C	cg22709217	chr22:50311962	ALG12;CRELD2	-0.94	-5.91	-0.56	8.37e-8	Schizophrenia;
SKCM	cis	rs4924935	1.000	rs4924935	chr17:18753870	C/T	cg26378065	chr17:18585709	ZNF286B	0.74	5.37	0.52	7.92e-7	Pancreatic cancer;
SKCM	cis	rs35306767	0.715	rs11253539	chr10:1011347	G/A	cg26597838	chr10:835615	NA	0.76	6.32	0.58	1.52e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs3091242	0.900	rs35345536	chr1:25766488	A/G	cg27572855	chr1:25598939	RHD	0.53	5.06	0.5	2.67e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs7399018	0.739	rs10747608	chr12:51616582	A/G	cg25754956	chr12:51612065	POU6F1	0.88	6.59	0.6	4.65e-9	Cisplatin-induced ototoxicity;
SKCM	cis	rs9790314	1.000	rs189270	chr3:161063504	T/C	cg03342759	chr3:160939853	NMD3	-0.72	-7.89	-0.67	1.53e-11	Morning vs. evening chronotype;
SKCM	trans	rs1814175	0.702	rs7481418	chr11:49759932	C/T	cg15704280	chr7:45808275	SEPT13	-1.01	-9.31	-0.73	2.7e-14	Height;
SKCM	cis	rs55962025	0.737	rs7685686	chr4:3207142	A/G	cg21096898	chr4:3318625	RGS12	-0.6	-5.08	-0.5	2.47e-6	Parental longevity (mother's age at death);
SKCM	cis	rs7208859	0.623	rs7212991	chr17:29143749	T/C	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs9902453	1.000	rs4239227	chr17:28389103	A/C	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.81	-5.78	-0.55	1.45e-7	Coffee consumption (cups per day);
SKCM	cis	rs9902453	0.753	rs3097118	chr17:27978466	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.75	0.55	1.67e-7	Coffee consumption (cups per day);
SKCM	cis	rs1799949	1.000	rs34572725	chr17:41428666	G/A	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.2	-0.57	2.51e-8	Menopause (age at onset);
SKCM	cis	rs7824557	0.564	rs2736294	chr8:11234626	T/C	cg21775007	chr8:11205619	TDH	-0.59	-5.04	-0.5	2.96e-6	Retinal vascular caliber;
SKCM	cis	rs885814	0.619	rs5024467	chr1:21899607	C/T	cg25601136	chr1:21766849	NBPF3	0.74	4.91	0.49	4.89e-6	Response to TNF-alpha inhibitors in rheumatoid arthritis;
SKCM	cis	rs6570726	0.935	rs413916	chr6:145831400	T/C	cg23711669	chr6:146136114	FBXO30	0.7	6.64	0.6	3.72e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7618501	0.574	rs6765484	chr3:50041313	C/T	cg05072774	chr3:49840536	C3orf54	0.67	5.13	0.5	2.08e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs35306767	0.953	rs11253509	chr10:964306	C/T	cg26597838	chr10:835615	NA	0.67	5.4	0.52	7e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs6977660	0.660	rs10239332	chr7:19824465	A/G	cg05791153	chr7:19748676	TWISTNB	0.77	5.02	0.49	3.23e-6	Thyroid stimulating hormone;
SKCM	cis	rs2204008	0.643	rs1315347	chr12:38162494	C/T	cg26384229	chr12:38710491	ALG10B	-0.67	-5.47	-0.53	5.23e-7	Bladder cancer;
SKCM	cis	rs155076	0.711	rs4770129	chr13:21882059	T/G	cg11317459	chr13:21872234	NA	1.34	7.87	0.67	1.71e-11	White matter hyperintensity burden;
SKCM	cis	rs9902453	0.726	rs3115092	chr17:28036350	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.79	5.93	0.56	7.67e-8	Coffee consumption (cups per day);
SKCM	cis	rs13118159	0.742	rs34947293	chr4:1335034	T/C	cg20887711	chr4:1340912	KIAA1530	0.71	5.35	0.52	8.53e-7	Longevity;
SKCM	cis	rs1137	0.516	rs150137	chr2:74946741	A/G	cg02845591	chr2:74730523	LOC151534;LBX2	0.91	5.27	0.51	1.16e-6	Myopia (pathological);
SKCM	cis	rs595982	0.527	rs17206707	chr19:49361441	A/C	cg15549821	chr19:49342101	PLEKHA4	-0.87	-5.39	-0.52	7.35e-7	Red cell distribution width;
SKCM	cis	rs7829975	0.511	rs1401390	chr8:8136410	C/T	cg15556689	chr8:8085844	FLJ10661	0.84	7.92	0.67	1.36e-11	Mood instability;
SKCM	cis	rs9914544	0.708	rs113103355	chr17:18663414	A/G	cg26378065	chr17:18585709	ZNF286B	0.86	5.95	0.56	7.25e-8	Educational attainment (years of education);
SKCM	cis	rs7569084	0.687	rs7577452	chr2:65683828	C/T	cg14775296	chr2:66672841	MEIS1	0.51	4.8	0.48	7.49e-6	Sum eosinophil basophil counts;
SKCM	cis	rs514406	0.571	rs11206004	chr1:53210958	G/A	cg16325326	chr1:53192061	ZYG11B	-0.86	-9.08	-0.72	7.46e-14	Monocyte count;
SKCM	cis	rs9300255	0.596	rs10734901	chr12:123743447	G/A	cg00376283	chr12:123451042	ABCB9	0.87	7.25	0.63	2.63e-10	Neutrophil percentage of white cells;
SKCM	cis	rs6088580	0.634	rs2378134	chr20:32938085	C/T	cg24642439	chr20:33292090	TP53INP2	-0.76	-6.03	-0.56	5.24e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs7618501	0.633	rs11130234	chr3:50024758	G/T	cg24110177	chr3:50126178	RBM5	-0.6	-5.11	-0.5	2.25e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs16854884	0.770	rs6782024	chr3:143816936	G/C	cg06585982	chr3:143692056	C3orf58	0.7	5.58	0.53	3.36e-7	Economic and political preferences (feminism/equality);
SKCM	cis	rs7666738	0.830	rs2167892	chr4:99048503	G/C	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs13010713	0.840	rs4667114	chr2:182035192	T/A	cg21995919	chr2:182322279	ITGA4	-0.56	-5.38	-0.52	7.61e-7	Celiac disease;
SKCM	cis	rs6582630	0.502	rs7312212	chr12:38274760	T/G	cg13010199	chr12:38710504	ALG10B	0.66	4.8	0.48	7.64e-6	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs6066825	0.644	rs6066823	chr20:47338768	C/G	cg18078177	chr20:47281410	PREX1	0.63	5.09	0.5	2.44e-6	Colorectal cancer;
SKCM	cis	rs6089584	0.507	rs6061999	chr20:60637429	G/A	cg06108461	chr20:60628389	TAF4	-0.8	-7.72	-0.66	3.25e-11	Body mass index;
SKCM	cis	rs12477438	0.501	rs12992218	chr2:99753834	G/A	cg14399236	chr2:99771627	LIPT1;TSGA10	0.97	8.9	0.71	1.72e-13	Chronic sinus infection;
SKCM	cis	rs7666738	0.830	rs6855393	chr4:99056534	T/C	cg05340658	chr4:99064831	C4orf37	0.67	5.08	0.5	2.51e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs514406	0.861	rs505444	chr1:53251860	C/T	cg16325326	chr1:53192061	ZYG11B	0.99	11.71	0.8	7.39e-19	Monocyte count;
SKCM	cis	rs1799949	0.965	rs11651623	chr17:41329847	G/A	cg23758822	chr17:41437982	NA	0.93	7.84	0.66	1.91e-11	Menopause (age at onset);
SKCM	trans	rs3780486	0.801	rs10971424	chr9:33138775	T/C	cg04842962	chr6:43655489	MRPS18A	1.03	10.87	0.78	2.78e-17	IgG glycosylation;
SKCM	cis	rs9788682	0.948	rs905739	chr15:78845110	A/G	cg06917634	chr15:78832804	PSMA4	-0.8	-4.86	-0.48	5.87e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs10754283	0.934	rs6428563	chr1:90111583	T/A	cg21401794	chr1:90099060	LRRC8C	0.73	6.34	0.58	1.35e-8	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs2153535	0.580	rs718502	chr6:8527400	T/C	cg07606381	chr6:8435919	SLC35B3	0.93	6.8	0.61	1.92e-9	Motion sickness;
SKCM	cis	rs9926296	0.605	rs1800287	chr16:89858525	C/G	cg27121462	chr16:89883253	FANCA	0.81	7.31	0.64	2.02e-10	Vitiligo;
SKCM	cis	rs16949788	1.000	rs76623374	chr15:66767868	C/G	cg08120210	chr15:66682733	MAP2K1	-0.74	-5.69	-0.54	2.1e-7	Spherical equivalent (joint analysis main effects and education interaction);
SKCM	cis	rs763014	0.898	rs4984893	chr16:623082	A/G	cg07343612	chr16:622815	PIGQ	-0.69	-5.73	-0.54	1.84e-7	Height;
SKCM	cis	rs2479724	0.846	rs2251084	chr6:41838119	T/C	cg17623882	chr6:41773611	USP49	-0.75	-6.35	-0.58	1.35e-8	Menarche (age at onset);
SKCM	cis	rs9303401	0.659	rs12602808	chr17:56698420	A/G	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.35	0.52	8.54e-7	Cognitive test performance;
SKCM	cis	rs17608059	1.000	rs17608059	chr17:13910549	C/T	cg11395062	chr17:14139857	CDRT15	0.61	5.37	0.52	7.9e-7	Temperament;
SKCM	cis	rs6088580	0.601	rs6059872	chr20:33082775	C/A	cg24642439	chr20:33292090	TP53INP2	0.76	6.02	0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs9906944	0.545	rs11079851	chr17:47092310	G/C	cg10950924	chr17:47092072	IGF2BP1	-0.61	-5.56	-0.53	3.64e-7	Intelligence (multi-trait analysis);Body fat percentage;
SKCM	cis	rs6089584	0.507	rs6061990	chr20:60628429	T/G	cg16423285	chr20:60520624	NA	-0.59	-5.14	-0.5	2e-6	Body mass index;
SKCM	cis	rs7959452	0.590	rs28778648	chr12:69771911	C/A	cg14784868	chr12:69753453	YEATS4	0.78	7.38	0.64	1.5e-10	Blood protein levels;
SKCM	cis	rs8070624	0.574	rs11078408	chr17:17876011	A/G	cg04398451	chr17:18023971	MYO15A	-0.91	-6.7	-0.6	2.96e-9	Total body bone mineral density;
SKCM	cis	rs686320	1.000	rs1787666	chr11:65249089	A/C	cg20446641	chr11:66243077	PELI3	0.82	5.06	0.5	2.74e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs912057	0.833	rs1294426	chr6:6744477	T/C	cg06612196	chr6:6737390	NA	0.58	4.91	0.49	4.81e-6	Waist-to-hip ratio adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);
SKCM	cis	rs9640161	0.750	rs11764936	chr7:150025915	G/T	cg10018233	chr7:150070692	REPIN1	0.68	5.27	0.51	1.18e-6	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs6500395	0.962	rs9937134	chr16:48577683	T/A	cg04672837	chr16:48644449	N4BP1	0.7	5.71	0.54	1.92e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs28595532	0.920	rs114262028	chr4:119734877	C/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs7666738	0.830	rs13110410	chr4:98920018	T/C	cg17366294	chr4:99064904	C4orf37	0.57	4.85	0.48	6.12e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4853012	0.838	rs72915068	chr2:74356185	G/A	cg05890377	chr2:74357713	NA	0.61	5.41	0.52	6.67e-7	Gestational age at birth (maternal effect);
SKCM	cis	rs3768617	0.510	rs2296290	chr1:183079412	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs3820068	0.529	rs79570154	chr1:15990912	T/C	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs8180040	0.934	rs62260710	chr3:47564462	C/G	cg27129171	chr3:47204927	SETD2	-0.82	-5.92	-0.56	8.29e-8	Colorectal cancer;
SKCM	cis	rs931234	0.965	rs931232	chr3:65153023	G/T	cg06271087	chr3:65342546	MAGI1	-0.54	-5.46	-0.53	5.52e-7	Lobe attachment (rater-scored or self-reported);
SKCM	trans	rs1814175	0.745	rs7483456	chr11:49774613	C/T	cg03929089	chr4:120376271	NA	-0.9	-8.5	-0.69	9.91e-13	Height;
SKCM	cis	rs55823223	0.517	rs56018637	chr17:73884948	C/T	cg08125733	chr17:73851984	WBP2	1.01	5.53	0.53	4.13e-7	Psoriasis;
SKCM	cis	rs9611565	0.918	rs7290404	chr22:41749796	C/T	cg03806693	chr22:41940476	POLR3H	-0.84	-5.67	-0.54	2.28e-7	Vitiligo;
SKCM	cis	rs2836974	0.865	rs7282624	chr21:40667040	C/T	cg17971929	chr21:40555470	PSMG1	0.86	8.49	0.69	1.04e-12	Cognitive function;
SKCM	cis	rs6665290	0.904	rs3795451	chr1:227181923	C/T	cg10327440	chr1:227177885	CDC42BPA	-1.24	-17.11	-0.89	4.05e-28	Myeloid white cell count;
SKCM	cis	rs7666738	0.830	rs1426666	chr4:99030887	A/G	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2243480	1.000	rs1873494	chr7:65649899	T/C	cg18252515	chr7:66147081	NA	1.36	8.16	0.68	4.6e-12	Diabetic kidney disease;
SKCM	cis	rs1799949	1.000	rs11653231	chr17:41331460	G/A	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.29	-0.58	1.73e-8	Menopause (age at onset);
SKCM	cis	rs6087990	0.806	rs2424918	chr20:31382770	C/T	cg13636640	chr20:31349939	DNMT3B	0.92	8.06	0.67	7.3e-12	Ulcerative colitis;
SKCM	cis	rs28386778	0.863	rs9207	chr17:61823899	C/T	cg06873352	chr17:61820015	STRADA	0.76	6.34	0.58	1.38e-8	Prudent dietary pattern;
SKCM	cis	rs7590368	0.961	rs13432104	chr2:10960661	T/C	cg15705551	chr2:10952987	PDIA6	0.76	4.88	0.48	5.52e-6	Educational attainment (years of education);
SKCM	cis	rs3091242	0.933	rs35497030	chr1:25783066	A/G	cg27572855	chr1:25598939	RHD	-0.53	-5.06	-0.5	2.67e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs61776719	0.817	rs17531077	chr1:38415507	A/G	cg17077180	chr1:38461687	NA	0.51	4.94	0.49	4.34e-6	Coronary artery disease;
SKCM	cis	rs1506636	1.000	rs12706545	chr7:123348744	C/T	cg03229431	chr7:123269106	ASB15	-0.63	-5.2	-0.51	1.58e-6	Plateletcrit;Platelet count;
SKCM	cis	rs9308433	0.529	rs10465697	chr1:214499948	T/C	cg06198575	chr1:214491504	SMYD2	0.81	5.09	0.5	2.41e-6	IgG glycosylation;
SKCM	cis	rs7843479	0.601	rs4872204	chr8:21841396	T/C	cg17168535	chr8:21777572	XPO7	0.84	8.38	0.69	1.73e-12	Mean corpuscular volume;
SKCM	cis	rs1707322	0.686	rs2050376	chr1:46078630	C/T	cg03146154	chr1:46216737	IPP	0.83	6.17	0.57	2.83e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7937682	0.960	rs480293	chr11:111469132	A/C	cg09085632	chr11:111637200	PPP2R1B	-1.0	-8.74	-0.7	3.47e-13	Primary sclerosing cholangitis;
SKCM	cis	rs7590720	0.819	rs1344694	chr2:216893637	T/G	cg12620499	chr2:216877984	MREG	0.96	10.05	0.75	1.03e-15	Alcohol dependence;
SKCM	cis	rs860295	0.650	rs2993207	chr1:155873314	A/G	cg02153340	chr1:155202674	NA	0.73	5.24	0.51	1.34e-6	Body mass index;
SKCM	cis	rs2120019	0.935	rs8042409	chr15:75350433	G/A	cg17294928	chr15:75287854	SCAMP5	-0.82	-7.36	-0.64	1.58e-10	Blood trace element (Zn levels);
SKCM	cis	rs67311347	0.544	rs9877105	chr3:40333366	T/C	cg02782426	chr3:40428986	ENTPD3	0.51	5.2	0.51	1.57e-6	Renal cell carcinoma;
SKCM	cis	rs7617480	0.648	rs4974088	chr3:48898749	T/C	cg07636037	chr3:49044803	WDR6	0.92	6.81	0.61	1.82e-9	Subjective well-being (multi-trait analysis);Menarche (age at onset);
SKCM	cis	rs35306767	0.903	rs35567307	chr10:915804	G/C	cg20503657	chr10:835505	NA	0.77	5.32	0.52	9.76e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs7635838	0.619	rs346087	chr3:11274354	A/G	cg00170343	chr3:11313890	ATG7	0.7	4.82	0.48	6.96e-6	HDL cholesterol;
SKCM	cis	rs6754311	0.597	rs6760329	chr2:136544752	A/G	cg07169764	chr2:136633963	MCM6	-0.86	-6.37	-0.59	1.2e-8	Mosquito bite size;
SKCM	cis	rs28735056	0.563	rs55642704	chr18:77688124	C/T	cg20368463	chr18:77673604	PQLC1	-0.72	-5.6	-0.54	3.03e-7	Schizophrenia;
SKCM	cis	rs644799	1.000	rs487609	chr11:95588102	T/G	cg03916912	chr11:95522834	CEP57;FAM76B	0.88	7.53	0.65	7.59e-11	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs8016982	0.633	rs55822231	chr14:81708677	C/T	cg01989461	chr14:81687754	GTF2A1	0.85	7.06	0.62	6.13e-10	Schizophrenia;
SKCM	cis	rs57221529	0.766	rs56350081	chr5:583198	G/A	cg26208419	chr5:473447	SLC9A3;LOC25845	1.01	5.18	0.51	1.7e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs2204008	0.782	rs117824012	chr12:38215517	T/C	cg26384229	chr12:38710491	ALG10B	0.82	6.58	0.6	4.87e-9	Bladder cancer;
SKCM	cis	rs4803468	1.000	rs9304593	chr19:41942875	A/C	cg09537434	chr19:41945824	ATP5SL	1.1	13.21	0.83	1.39e-21	Height;
SKCM	cis	rs7809950	0.954	rs2520245	chr7:107137428	G/C	cg23024343	chr7:107201750	COG5	-0.76	-6.83	-0.61	1.64e-9	Coronary artery disease;
SKCM	cis	rs763014	0.898	rs8060585	chr16:635794	C/G	cg09263875	chr16:632152	PIGQ	0.67	5.82	0.55	1.24e-7	Height;
SKCM	cis	rs7666738	0.830	rs11097606	chr4:99011486	C/T	cg05340658	chr4:99064831	C4orf37	0.66	4.88	0.48	5.47e-6	Colonoscopy-negative controls vs population controls;
SKCM	trans	rs66573146	1.000	rs55833486	chr4:6978729	C/A	cg07817883	chr1:32538562	TMEM39B	1.94	8.42	0.69	1.47e-12	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs7843479	0.965	rs9314269	chr8:21804989	A/G	cg17168535	chr8:21777572	XPO7	0.71	5.34	0.52	8.96e-7	Mean corpuscular volume;
SKCM	cis	rs736408	0.634	rs11717836	chr3:52807736	A/G	cg18404041	chr3:52824283	ITIH1	-0.56	-4.96	-0.49	4.04e-6	Bipolar disorder;
SKCM	cis	rs7811142	1.000	rs73405353	chr7:100091215	G/A	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.19	7.92	0.67	1.33e-11	Platelet count;
SKCM	cis	rs28785552	0.800	rs10853854	chr19:53232128	A/G	cg10871876	chr19:53194124	ZNF83	-0.66	-4.79	-0.48	7.82e-6	Response to paliperidone in schizophrenia (PANSS score);
SKCM	cis	rs3540	0.533	rs7495080	chr15:91056681	G/A	cg22089800	chr15:90895588	ZNF774	-0.68	-4.91	-0.49	4.84e-6	Allergic disease (asthma, hay fever or eczema);Lymphocyte counts;
SKCM	cis	rs2842992	0.830	rs2758352	chr6:160122921	A/G	cg19482086	chr6:160211437	TCP1;MRPL18	0.78	5.83	0.55	1.17e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs651907	0.557	rs7645391	chr3:101361506	C/G	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.81	6.95	0.62	9.97e-10	Colorectal cancer;
SKCM	cis	rs4665809	0.531	rs3892649	chr2:26457267	T/G	cg26119090	chr2:26468346	HADHA;HADHB	1.06	8.39	0.69	1.66e-12	Gut microbiome composition (summer);
SKCM	cis	rs7727544	0.735	rs272867	chr5:131681057	G/A	cg24060327	chr5:131705240	SLC22A5	-0.67	-4.84	-0.48	6.32e-6	Blood metabolite levels;
SKCM	cis	rs72781680	0.898	rs12612492	chr2:24093756	C/T	cg08917208	chr2:24149416	ATAD2B	1.04	5.78	0.55	1.45e-7	Lymphocyte counts;
SKCM	cis	rs7917772	0.503	rs11191325	chr10:104302933	G/A	cg11453585	chr10:104263688	ACTR1A;SUFU	0.78	6.33	0.58	1.47e-8	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs1003719	0.762	rs3787786	chr21:38463436	T/C	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs9513627	0.573	rs4771336	chr13:100210610	T/G	cg25919922	chr13:100150906	NA	0.94	6.18	0.57	2.71e-8	Obesity-related traits;
SKCM	cis	rs8072100	0.935	rs8070759	chr17:45638760	C/T	cg25173405	chr17:45401733	C17orf57	0.56	5.06	0.5	2.76e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs2842992	0.724	rs2273823	chr6:160211485	T/C	cg16489826	chr6:160211363	TCP1;MRPL18	0.71	5.51	0.53	4.52e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs35306767	0.807	rs11253513	chr10:968450	C/T	cg20503657	chr10:835505	NA	0.66	5.15	0.5	1.88e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs35306767	0.903	rs34270014	chr10:904666	T/C	cg25614935	chr10:1084866	C10orf110	0.83	5.45	0.53	5.64e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs2836974	0.568	rs8130795	chr21:40549983	T/A	cg11644478	chr21:40555479	PSMG1	0.8	7.6	0.65	5.6e-11	Cognitive function;
SKCM	cis	rs9926296	0.533	rs12102297	chr16:89812762	C/A	cg27121462	chr16:89883253	FANCA	0.83	8.18	0.68	4.26e-12	Vitiligo;
SKCM	cis	rs80282103	0.618	rs17155886	chr10:1145182	A/G	cg19207066	chr10:1251074	ADARB2	-0.69	-4.84	-0.48	6.38e-6	Glomerular filtration rate (creatinine);
SKCM	cis	rs912057	0.526	rs737449	chr6:6733729	A/G	cg06612196	chr6:6737390	NA	-0.77	-6.58	-0.6	4.84e-9	Waist-to-hip ratio adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);
SKCM	cis	rs10876993	0.928	rs2640629	chr12:58065448	C/T	cg18357645	chr12:58087776	OS9	0.66	5.93	0.56	7.96e-8	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs3892630	0.878	rs2903759	chr19:33195947	A/G	cg22980127	chr19:33182716	NUDT19	1.39	8.08	0.67	6.68e-12	Red blood cell traits;
SKCM	cis	rs9788682	0.747	rs8042494	chr15:78908010	C/T	cg24631222	chr15:78858424	CHRNA5	0.81	6.34	0.58	1.35e-8	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs17376456	0.597	rs10866760	chr5:93338335	G/A	cg25358565	chr5:93447407	FAM172A	-0.76	-4.85	-0.48	6.08e-6	Diabetic retinopathy;
SKCM	cis	rs9393692	0.905	rs34916901	chr6:26286149	G/T	cg00631329	chr6:26305371	NA	-0.67	-4.77	-0.47	8.51e-6	Educational attainment;
SKCM	cis	rs2841277	0.708	rs9671643	chr14:105408030	A/G	cg19901468	chr14:105411992	AHNAK2	-0.98	-7.76	-0.66	2.7e-11	Rheumatoid arthritis;
SKCM	cis	rs8070624	0.543	rs7219320	chr17:17880877	A/G	cg04398451	chr17:18023971	MYO15A	-0.8	-6.01	-0.56	5.59e-8	Total body bone mineral density;
SKCM	cis	rs4481887	0.893	rs10736379	chr1:248455876	A/T	cg00666640	chr1:248458726	OR2T12	0.58	4.83	0.48	6.68e-6	Common traits (Other);
SKCM	cis	rs823143	0.570	rs823084	chr1:205798313	G/T	cg14159672	chr1:205819179	PM20D1	0.99	9.66	0.74	5.63e-15	Monocyte percentage of white cells;
SKCM	cis	rs875971	0.545	rs316323	chr7:65610989	C/T	cg18876405	chr7:65276391	NA	-0.64	-5.29	-0.51	1.09e-6	Aortic root size;
SKCM	cis	rs17376456	0.825	rs10057130	chr5:93282557	C/T	cg25358565	chr5:93447407	FAM172A	1.31	7.46	0.65	1.04e-10	Diabetic retinopathy;
SKCM	cis	rs7216064	0.589	rs7213585	chr17:66062316	A/T	cg12091567	chr17:66097778	LOC651250	-0.99	-6.79	-0.61	2.01e-9	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs933688	1.000	rs2052553	chr5:90729906	C/T	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.05	8.46	0.69	1.19e-12	Smoking behavior;
SKCM	cis	rs1577917	1.000	rs6940458	chr6:86644992	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.85	-8.62	-0.7	5.82e-13	Response to antipsychotic treatment;
SKCM	cis	rs1218582	0.772	rs11264282	chr1:154867370	G/A	cg24250549	chr1:154909240	PMVK	0.87	8.7	0.7	4.2e-13	Prostate cancer;
SKCM	cis	rs9640161	0.789	rs2159234	chr7:150020422	A/T	cg10018233	chr7:150070692	REPIN1	0.75	6.05	0.56	4.81e-8	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs2777491	0.872	rs61037359	chr15:41585926	T/C	cg18705301	chr15:41695430	NDUFAF1	-0.93	-8.72	-0.7	3.71e-13	Ulcerative colitis;
SKCM	cis	rs9467773	0.967	rs7753565	chr6:26560012	A/G	cg09904177	chr6:26538194	HMGN4	0.54	4.98	0.49	3.78e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs8078723	0.933	rs4794822	chr17:38156712	C/T	cg17467752	chr17:38218738	THRA	0.67	6.13	0.57	3.38e-8	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs1218582	0.774	rs4845680	chr1:154863195	A/G	cg16680214	chr1:154839983	KCNN3	-0.56	-4.97	-0.49	3.89e-6	Prostate cancer;
SKCM	cis	rs2204008	0.713	rs2320522	chr12:38251438	C/T	cg13010199	chr12:38710504	ALG10B	0.69	4.92	0.49	4.72e-6	Bladder cancer;
SKCM	cis	rs453301	0.653	rs1045529	chr8:8890098	A/G	cg06636001	chr8:8085503	FLJ10661	-0.72	-5.82	-0.55	1.24e-7	Joint mobility (Beighton score);
SKCM	cis	rs17376456	0.825	rs10051878	chr5:93064164	T/G	cg25358565	chr5:93447407	FAM172A	1.17	8.0	0.67	9.26e-12	Diabetic retinopathy;
SKCM	cis	rs72781680	1.000	rs72796329	chr2:24141912	G/A	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	cis	rs870825	0.616	rs10022834	chr4:185649431	A/G	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs763014	0.838	rs4984670	chr16:641044	A/G	cg09263875	chr16:632152	PIGQ	0.65	5.48	0.53	5.04e-7	Height;
SKCM	cis	rs1577917	0.958	rs12208227	chr6:86670944	G/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.68	-5.8	-0.55	1.33e-7	Response to antipsychotic treatment;
SKCM	cis	rs595982	0.546	rs12461075	chr19:49399821	G/A	cg19746536	chr19:49375674	PPP1R15A	1.15	8.7	0.7	4.1e-13	Red cell distribution width;
SKCM	cis	rs13217239	0.646	rs10456352	chr6:26990358	A/T	cg12292205	chr6:26970375	C6orf41	0.63	5.64	0.54	2.58e-7	Schizophrenia;
SKCM	cis	rs11718455	0.960	rs35666538	chr3:44004826	A/G	cg21419209	chr3:44054225	NA	-0.65	-5.32	-0.52	9.77e-7	Coronary artery disease;
SKCM	cis	rs28595532	0.920	rs10001115	chr4:119781867	A/C	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs7666738	0.747	rs2865955	chr4:99040518	A/C	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9660180	0.967	rs61422524	chr1:1767565	C/A	cg13866156	chr1:1669148	SLC35E2	-0.71	-5.83	-0.55	1.19e-7	Body mass index;
SKCM	cis	rs7937682	0.710	rs674230	chr11:111437887	A/G	cg09085632	chr11:111637200	PPP2R1B	-1.01	-9.83	-0.74	2.69e-15	Primary sclerosing cholangitis;
SKCM	cis	rs6952808	0.723	rs4721295	chr7:2036669	G/T	cg02951883	chr7:2050386	MAD1L1	0.88	8.07	0.67	6.99e-12	Bipolar disorder and schizophrenia;
SKCM	cis	rs9457247	1.000	rs10946199	chr6:167404492	G/A	cg23791538	chr6:167370224	RNASET2	-0.52	-4.92	-0.49	4.74e-6	Crohn's disease;
SKCM	cis	rs6429082	0.521	rs704711	chr1:235629802	G/A	cg26050004	chr1:235667680	B3GALNT2	0.92	8.94	0.71	1.39e-13	Adiposity;
SKCM	cis	rs2777491	0.574	rs1757468	chr15:41743574	T/A	cg18705301	chr15:41695430	NDUFAF1	-1.19	-13.25	-0.83	1.15e-21	Ulcerative colitis;
SKCM	cis	rs554111	0.963	rs666371	chr1:21041555	A/G	cg01072550	chr1:21505969	NA	-0.62	-5.03	-0.5	3.04e-6	Facial morphology (factor 17, height of vermillion upper lip);
SKCM	cis	rs4975616	0.804	rs31489	chr5:1342714	C/A	cg06550200	chr5:1325588	CLPTM1L	-0.83	-6.79	-0.61	1.96e-9	Lung cancer;
SKCM	cis	rs1801251	1.000	rs4517962	chr2:233578337	T/C	cg25237894	chr2:233734115	C2orf82	0.61	5.66	0.54	2.39e-7	Coronary artery disease;
SKCM	cis	rs9640161	0.617	rs56019796	chr7:150009226	T/C	cg27494647	chr7:150038898	RARRES2	0.55	4.9	0.49	5.02e-6	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs7613875	0.537	rs6446195	chr3:50070853	A/G	cg24110177	chr3:50126178	RBM5	0.7	5.8	0.55	1.38e-7	Body mass index;
SKCM	cis	rs56235845	0.694	rs12055081	chr5:176757191	C/T	cg17509989	chr5:176798049	RGS14	0.7	5.74	0.55	1.7e-7	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs1799949	1.000	rs35330014	chr17:41212547	C/T	cg05368731	chr17:41323189	NBR1	0.89	7.87	0.67	1.71e-11	Menopause (age at onset);
SKCM	cis	rs4689592	0.513	rs3857178	chr4:7066516	G/A	cg19539972	chr4:7069911	GRPEL1	1.01	6.97	0.62	8.88e-10	Monocyte percentage of white cells;
SKCM	cis	rs6942756	1.000	rs2012919	chr7:128890812	C/T	cg02491457	chr7:128862824	NA	-0.75	-4.77	-0.48	8.45e-6	White matter hyperintensity burden;
SKCM	trans	rs1814175	0.616	rs1851848	chr11:49992254	G/C	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs854765	0.594	rs8066560	chr17:17728043	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	-0.94	-6.82	-0.61	1.71e-9	Total body bone mineral density;
SKCM	cis	rs614226	0.938	rs7963543	chr12:120923948	C/A	cg01236616	chr12:121019343	POP5	1.32	8.41	0.69	1.5e-12	Type 1 diabetes nephropathy;
SKCM	cis	rs995000	0.868	rs10889357	chr1:63160282	C/T	cg06896770	chr1:63153194	DOCK7	0.85	7.58	0.65	5.97e-11	Triglyceride levels;
SKCM	cis	rs9790314	0.690	rs6783085	chr3:160830929	A/G	cg03342759	chr3:160939853	NMD3	-0.69	-6.9	-0.62	1.22e-9	Morning vs. evening chronotype;
SKCM	cis	rs3780486	0.757	rs10813949	chr9:33123464	G/A	cg13443165	chr9:33130375	B4GALT1	-0.6	-5.71	-0.54	1.97e-7	IgG glycosylation;
SKCM	cis	rs10876993	0.728	rs1082503	chr12:58036717	G/A	cg18357645	chr12:58087776	OS9	0.59	5.38	0.52	7.71e-7	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs7599312	0.534	rs6735626	chr2:213403972	G/A	cg16329650	chr2:213403929	ERBB4	0.84	6.04	0.56	4.85e-8	BMI (adjusted for smoking behaviour);BMI in non-smokers;Body mass index;Body mass index (joint analysis main effects and smoking interaction);
SKCM	cis	rs6088580	0.634	rs4911422	chr20:32999345	T/C	cg24642439	chr20:33292090	TP53INP2	-0.76	-6.02	-0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs11608355	0.508	rs12817730	chr12:109799330	G/A	cg19025524	chr12:109796872	NA	-0.71	-5.37	-0.52	7.81e-7	Neuroticism;
SKCM	cis	rs35306767	0.855	rs35666723	chr10:867346	A/G	cg20503657	chr10:835505	NA	0.79	5.87	0.55	1.02e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs7666738	0.830	rs62318503	chr4:98935479	T/C	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2070488	0.965	rs1870915	chr3:38494228	G/C	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.99	8.84	0.71	2.18e-13	Electrocardiographic conduction measures;
SKCM	cis	rs2842992	0.789	rs9355748	chr6:160194882	G/A	cg19482086	chr6:160211437	TCP1;MRPL18	0.86	6.82	0.61	1.71e-9	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs1801251	0.835	rs1446310	chr2:233683245	G/C	cg08000102	chr2:233561755	GIGYF2	-0.81	-6.23	-0.58	2.16e-8	Coronary artery disease;
SKCM	cis	rs12971120	0.891	rs2278158	chr18:72178300	G/T	cg26446133	chr18:72167187	CNDP2	-0.68	-5.34	-0.52	8.81e-7	Refractive error;
SKCM	cis	rs7809950	0.678	rs17153981	chr7:106922106	A/G	cg23024343	chr7:107201750	COG5	-0.78	-6.7	-0.6	2.97e-9	Coronary artery disease;
SKCM	cis	rs867186	0.920	rs6058182	chr20:33696486	C/T	cg04194272	chr20:33683537	NA	-1.21	-6.8	-0.61	1.89e-9	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs1403694	0.695	rs1050274	chr3:186435370	G/A	cg09332604	chr3:186435400	KNG1	-0.5	-5.07	-0.5	2.57e-6	Blood protein levels;
SKCM	cis	rs7683537	0.501	rs2171838	chr4:185667404	A/G	cg04058563	chr4:185651563	MLF1IP	-0.96	-7.13	-0.63	4.4e-10	Systemic lupus erythematosus;
SKCM	cis	rs7666738	0.830	rs28728124	chr4:99001116	G/T	cg05340658	chr4:99064831	C4orf37	0.66	5.1	0.5	2.29e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4523957	0.690	rs11867782	chr17:2090507	T/G	cg16513277	chr17:2031491	SMG6	-0.82	-5.69	-0.54	2.1e-7	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs1799922	0.708	rs339054	chr7:128382511	G/T	cg07017242	chr7:128047441	IMPDH1	-0.39	-5.03	-0.49	3.08e-6	Primary tooth development (number of teeth);Primary tooth development (time to first tooth eruption);
SKCM	cis	rs9430161	0.579	rs7542354	chr1:11040385	G/A	cg02454025	chr1:11042201	C1orf127	0.96	8.79	0.71	2.74e-13	Ewing sarcoma;
SKCM	cis	rs9899728	0.572	rs4365317	chr17:73059820	C/G	cg27626185	chr17:73056755	KCTD2	-0.87	-6.13	-0.57	3.31e-8	Alzheimer's disease or small vessel stroke;
SKCM	cis	rs60871478	0.636	rs10245785	chr7:894422	T/C	cg05535760	chr7:792225	HEATR2	-1.3	-7.8	-0.66	2.27e-11	Cerebrospinal P-tau181p levels;
SKCM	cis	rs651907	0.557	rs59596156	chr3:101394217	C/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.81	6.96	0.62	9.48e-10	Colorectal cancer;
SKCM	cis	rs11646917	0.578	rs4238758	chr16:51446763	C/T	cg01194320	chr16:50493166	NA	0.58	4.83	0.48	6.71e-6	Optic cup area;
SKCM	cis	rs2228479	0.867	rs62052189	chr16:89975555	G/C	cg00800038	chr16:89945340	TCF25	-0.96	-5.55	-0.53	3.79e-7	Skin colour saturation;
SKCM	cis	rs9910055	0.529	rs228767	chr17:42188311	C/G	cg19774624	chr17:42201019	HDAC5	0.84	6.88	0.61	1.31e-9	Total body bone mineral density;
SKCM	cis	rs11098499	0.863	rs7664986	chr4:120429952	A/C	cg09307838	chr4:120376055	NA	1.0	7.66	0.66	4.31e-11	Corneal astigmatism;
SKCM	cis	rs7772486	0.790	rs1854900	chr6:146331382	G/A	cg05347473	chr6:146136440	FBXO30	0.57	5.18	0.51	1.66e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs8042680	0.554	rs1867226	chr15:91523713	C/G	cg15878949	chr15:91534302	PRC1	0.62	5.11	0.5	2.19e-6	Type 2 diabetes;
SKCM	trans	rs941408	1.000	rs1736184	chr19:2810248	G/A	cg22153745	chr1:153894579	GATAD2B	-0.8	-7.43	-0.64	1.2e-10	Total cholesterol levels;
SKCM	cis	rs17685	0.884	rs8565	chr7:75630274	T/C	cg16489192	chr7:75678113	MDH2;STYXL1	0.62	5.54	0.53	3.99e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7336332	0.598	rs75439483	chr13:28010512	A/G	cg22138327	chr13:27999177	GTF3A	0.9	6.4	0.59	1.07e-8	Weight;
SKCM	cis	rs40363	0.645	rs40447	chr16:3514841	G/A	cg22508957	chr16:3507546	NAT15	0.58	5.0	0.49	3.43e-6	Tuberculosis;
SKCM	cis	rs2439831	0.618	rs999026	chr15:43690215	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.21	7.84	0.66	1.9e-11	Lung cancer in ever smokers;
SKCM	cis	rs2905347	0.560	rs2905312	chr7:22682942	T/C	cg00394316	chr7:22539822	MGC87042	-0.45	-4.77	-0.48	8.45e-6	Major depression and alcohol dependence;
SKCM	cis	rs7091068	0.536	rs7893369	chr10:95410147	A/G	cg20715218	chr10:95462985	C10orf4	0.78	6.39	0.59	1.13e-8	Urinary tract infection frequency;
SKCM	cis	rs7659604	0.539	rs3217771	chr4:122739483	G/A	cg20573242	chr4:122745356	CCNA2	0.75	6.39	0.59	1.11e-8	Type 2 diabetes;
SKCM	cis	rs8017423	0.874	rs4900029	chr14:90686257	T/A	cg04374321	chr14:90722782	PSMC1	0.97	8.67	0.7	4.78e-13	Mortality in heart failure;
SKCM	cis	rs6840360	0.615	rs58977077	chr4:152470239	T/G	cg22705602	chr4:152727874	NA	-0.51	-5.78	-0.55	1.48e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs28386778	0.863	rs6504178	chr17:61812733	A/G	cg22520471	chr17:61851767	DDX42;CCDC47	-0.78	-5.31	-0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs420259	0.516	rs152455	chr16:23583073	G/A	cg10006042	chr16:23042421	NA	0.36	4.85	0.48	6.15e-6	Bipolar disorder;
SKCM	cis	rs2228479	1.000	rs62052180	chr16:89963289	C/G	cg06558623	chr16:89946397	TCF25	1.26	6.97	0.62	9.17e-10	Skin colour saturation;
SKCM	cis	rs3785574	0.962	rs2584614	chr17:61929445	C/T	cg06873352	chr17:61820015	STRADA	0.56	4.83	0.48	6.66e-6	Height;
SKCM	cis	rs344364	0.602	rs2745193	chr16:1853959	A/G	cg00490583	chr16:1843685	IGFALS	0.5	4.8	0.48	7.49e-6	Glomerular filtration rate in chronic kidney disease;
SKCM	cis	rs523522	0.962	rs11065149	chr12:120956963	G/A	cg27279351	chr12:120934652	DYNLL1	0.91	8.32	0.69	2.26e-12	High light scatter reticulocyte count;
SKCM	cis	rs7666738	0.830	rs11731478	chr4:99001686	A/G	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs35306767	0.903	rs11253458	chr10:882843	T/C	cg20503657	chr10:835505	NA	0.76	5.17	0.51	1.73e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs3820928	1.000	rs11686072	chr2:227777493	A/T	cg11843606	chr2:227700838	RHBDD1	-0.61	-4.88	-0.48	5.44e-6	Pulmonary function;
SKCM	cis	rs6840360	0.571	rs4696101	chr4:152528513	A/G	cg22705602	chr4:152727874	NA	-0.52	-5.7	-0.54	2.03e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs9911578	1.000	rs9898916	chr17:57048660	C/T	cg12560992	chr17:57184187	TRIM37	0.94	7.55	0.65	7.01e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs6665290	0.935	rs6670924	chr1:227196048	A/C	cg10327440	chr1:227177885	CDC42BPA	-1.24	-17.42	-0.89	1.29e-28	Myeloid white cell count;
SKCM	cis	rs6430585	0.697	rs1050115	chr2:136511817	A/G	cg07169764	chr2:136633963	MCM6	1.31	13.14	0.83	1.86e-21	Corneal structure;
SKCM	cis	rs2901656	0.677	rs2301455	chr1:172418268	C/T	cg03748243	chr1:172413542	C1orf105;PIGC	0.49	4.86	0.48	5.99e-6	Red cell distribution width;Platelet distribution width;
SKCM	cis	rs760805	0.965	rs4648883	chr1:25261203	T/C	cg22509179	chr1:25234806	RUNX3	-0.71	-5.87	-0.55	9.94e-8	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs2839186	0.770	rs2839984	chr21:47671690	A/G	cg13012494	chr21:47604986	C21orf56	0.7	5.9	0.56	9.05e-8	Testicular germ cell tumor;
SKCM	cis	rs17345786	0.861	rs11711808	chr3:101235101	T/C	cg12386194	chr3:101231763	SENP7	0.84	6.27	0.58	1.83e-8	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7772486	0.754	rs12199362	chr6:146118225	A/G	cg23711669	chr6:146136114	FBXO30	0.9	10.38	0.76	2.38e-16	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2243480	1.000	rs35421653	chr7:65363429	C/A	cg18252515	chr7:66147081	NA	-1.29	-7.41	-0.64	1.3e-10	Diabetic kidney disease;
SKCM	cis	rs4724125	0.883	rs13223303	chr7:42692711	T/C	cg09407816	chr7:42972088	MRPL32;PSMA2	0.83	4.98	0.49	3.78e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs34779708	0.966	rs4934736	chr10:35496868	G/A	cg03585969	chr10:35415529	CREM	0.79	6.32	0.58	1.52e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs1559088	0.576	rs11084707	chr19:33612873	C/T	cg17764715	chr19:33622953	WDR88	0.99	8.06	0.67	7.32e-12	Bone ultrasound measurement (broadband ultrasound attenuation);
SKCM	cis	rs2120019	1.000	rs7167285	chr15:75368769	A/G	cg17294928	chr15:75287854	SCAMP5	-0.82	-6.77	-0.61	2.13e-9	Blood trace element (Zn levels);
SKCM	cis	rs7666738	0.830	rs2114425	chr4:99023967	T/C	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2991971	0.903	rs2991973	chr1:46020632	G/A	cg24296786	chr1:45957014	TESK2	0.63	5.03	0.5	3.03e-6	High light scatter reticulocyte count;
SKCM	cis	rs870825	0.616	rs6825561	chr4:185615532	A/T	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs898097	0.812	rs55794221	chr17:80849003	G/A	cg15369054	chr17:80825471	TBCD	0.66	6.18	0.57	2.69e-8	Breast cancer;
SKCM	cis	rs9880211	0.644	rs6799320	chr3:135802439	G/A	cg21827317	chr3:136751795	NA	-0.67	-4.9	-0.49	5.06e-6	Body mass index;Height;
SKCM	cis	rs8067545	0.750	rs7223305	chr17:19990986	A/G	cg13482628	chr17:19912719	NA	0.73	6.54	0.6	5.78e-9	Schizophrenia;
SKCM	cis	rs9300255	0.596	rs7304782	chr12:123719444	A/G	cg05973401	chr12:123451056	ABCB9	-0.75	-5.86	-0.55	1.06e-7	Neutrophil percentage of white cells;
SKCM	cis	rs7208859	0.623	rs3752020	chr17:29111125	T/G	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs9875589	0.533	rs12490233	chr3:13977365	G/A	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.51	5.17	0.51	1.73e-6	Ovarian reserve;
SKCM	cis	rs1552244	0.882	rs68080705	chr3:10025743	C/T	cg02579736	chr3:10068473	FANCD2;CIDECP	0.93	4.77	0.48	8.35e-6	Alzheimer's disease;
SKCM	cis	rs17376456	0.569	rs12653528	chr5:93212833	T/C	cg25358565	chr5:93447407	FAM172A	-0.88	-5.63	-0.54	2.71e-7	Diabetic retinopathy;
SKCM	cis	rs514406	0.893	rs479569	chr1:53352407	C/T	cg24675658	chr1:53192096	ZYG11B	-0.63	-5.03	-0.49	3.12e-6	Monocyte count;
SKCM	cis	rs7674861	0.508	rs11936646	chr4:151348200	C/T	cg03779973	chr4:151001971	DCLK2	0.56	4.89	0.48	5.35e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs3768617	0.510	rs3768619	chr1:183092404	C/G	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs7772486	0.641	rs2253757	chr6:146199686	C/T	cg23711669	chr6:146136114	FBXO30	0.81	7.34	0.64	1.8e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs941408	1.000	rs1736179	chr19:2795516	T/A	cg06609049	chr19:2785107	THOP1	0.82	6.91	0.62	1.18e-9	Total cholesterol levels;
SKCM	cis	rs910316	0.839	rs35977276	chr14:75637359	A/C	cg08847533	chr14:75593920	NEK9	-0.96	-9.14	-0.72	5.68e-14	Height;
SKCM	cis	rs2243480	1.000	rs316304	chr7:65616894	T/C	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs2439831	0.717	rs7165471	chr15:43644788	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.39	9.42	0.73	1.62e-14	Lung cancer in ever smokers;
SKCM	cis	rs4891159	0.757	rs11665518	chr18:74147054	C/T	cg24786174	chr18:74118243	ZNF516	-0.74	-6.88	-0.61	1.33e-9	Longevity;
SKCM	cis	rs28386778	0.897	rs968719	chr17:61908271	C/T	cg26338869	chr17:61819248	STRADA	0.74	4.99	0.49	3.58e-6	Prudent dietary pattern;
SKCM	cis	rs13118159	0.527	rs1250119	chr4:1261336	G/A	cg02018176	chr4:1364513	KIAA1530	-0.8	-6.5	-0.59	7.02e-9	Longevity;
SKCM	cis	rs995000	0.931	rs11207970	chr1:62915473	C/T	cg06896770	chr1:63153194	DOCK7	0.93	8.62	0.7	5.81e-13	Triglyceride levels;
SKCM	cis	rs1580019	0.961	rs2392056	chr7:32498953	T/C	cg06627557	chr7:32535165	LSM5;AVL9	0.75	5.74	0.55	1.7e-7	Cognitive ability;
SKCM	cis	rs28595532	0.920	rs116094766	chr4:119729291	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.52	0.53	4.28e-7	Cannabis dependence symptom count;
SKCM	cis	rs933688	1.000	rs332529	chr5:90789470	G/A	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.06	8.02	0.67	8.55e-12	Smoking behavior;
SKCM	cis	rs28595532	0.841	rs114385163	chr4:119737058	C/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs9790314	0.875	rs336582	chr3:161082659	C/T	cg03342759	chr3:160939853	NMD3	-0.73	-8.2	-0.68	3.89e-12	Morning vs. evening chronotype;
SKCM	cis	rs1577917	0.958	rs2324817	chr6:86462654	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.78	-7.41	-0.64	1.3100000000000001e-10	Response to antipsychotic treatment;
SKCM	cis	rs11098499	0.908	rs28499576	chr4:120386677	G/A	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs7647973	0.600	rs11920267	chr3:49275964	G/A	cg07636037	chr3:49044803	WDR6	0.83	6.82	0.61	1.76e-9	Menarche (age at onset);
SKCM	cis	rs2033711	0.870	rs7409473	chr19:58939165	A/G	cg12042659	chr19:58951599	ZNF132	0.68	5.87	0.55	1e-7	Uric acid clearance;
SKCM	cis	rs8103278	0.507	rs7260651	chr19:46260245	G/A	cg11657440	chr19:46296263	DMWD	1.06	10.47	0.76	1.56e-16	Coronary artery disease;
SKCM	cis	rs12497850	0.931	rs9682444	chr3:48852639	A/G	cg06212747	chr3:49208901	KLHDC8B	0.68	4.89	0.48	5.28e-6	Parkinson's disease;
SKCM	cis	rs12926788	0.689	rs1862450	chr16:24856775	A/G	cg00339695	chr16:24857497	SLC5A11	-0.76	-7.05	-0.62	6.32e-10	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs7666738	0.830	rs17550630	chr4:99008332	G/T	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9399137	0.507	rs11759077	chr6:135381351	A/G	cg24558204	chr6:135376177	HBS1L	0.64	5.49	0.53	4.93e-7	Glycated hemoglobin levels;Mean corpuscular volume;Hematology traits;HbA2 levels;Mean corpuscular hemoglobin;Hemoglobin levels;F-cell distribution;Platelet count;
SKCM	cis	rs2842992	0.789	rs2295901	chr6:160201295	C/A	cg19482086	chr6:160211437	TCP1;MRPL18	0.86	6.82	0.61	1.71e-9	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs644799	0.710	rs10765771	chr11:95521044	A/G	cg25622487	chr11:95524042	FAM76B;CEP57	0.71	5.99	0.56	6.07e-8	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs514406	0.893	rs499195	chr1:53344907	C/T	cg16325326	chr1:53192061	ZYG11B	0.91	9.82	0.74	2.8e-15	Monocyte count;
SKCM	cis	rs561341	1.000	rs56903735	chr17:30254393	T/A	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.53	-0.65	7.52e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs2243480	0.614	rs34032527	chr7:65565141	C/G	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs9303401	0.659	rs12944971	chr17:56988801	A/T	cg10487724	chr17:56770010	TEX14;RAD51C	0.85	6.03	0.56	5.18e-8	Cognitive test performance;
SKCM	cis	rs28595532	0.920	rs116428408	chr4:119758514	G/C	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs10540	1.000	rs12419716	chr11:503385	C/G	cg03576123	chr11:487126	PTDSS2	-1.43	-8.14	-0.68	5.08e-12	Body mass index;
SKCM	cis	rs11945232	1.000	rs10027786	chr4:88347512	A/G	cg23841344	chr4:88312519	HSD17B11	-0.66	-4.91	-0.49	4.9100000000000004e-06	Intelligence (multi-trait analysis);
SKCM	cis	rs10927875	0.619	rs12121764	chr1:16138059	A/T	cg21385522	chr1:16154831	NA	-0.75	-7.21	-0.63	3.09e-10	Dilated cardiomyopathy;
SKCM	cis	rs6121246	0.697	rs6060912	chr20:30325755	C/A	cg11595048	chr20:30225325	COX4I2	0.67	5.21	0.51	1.5e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs7552404	0.924	rs7550974	chr1:76204185	A/G	cg03433033	chr1:76189801	ACADM	0.73	5.33	0.52	9.12e-7	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs2033711	0.905	rs893186	chr19:58969179	C/A	cg03735888	chr19:58951602	ZNF132	0.71	6.23	0.58	2.2e-8	Uric acid clearance;
SKCM	cis	rs2033711	0.837	rs3764535	chr19:58929052	G/A	cg00825309	chr19:58991885	ZNF446	-0.69	-5.6	-0.54	3.15e-7	Uric acid clearance;
SKCM	cis	rs10876993	0.893	rs1678504	chr12:58085498	G/C	cg18357645	chr12:58087776	OS9	0.67	6.23	0.58	2.19e-8	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs2153535	0.580	rs1119690	chr6:8460660	G/A	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs362272	0.505	rs3129310	chr4:3301388	T/G	cg05297308	chr4:3317976	RGS12	1.0	11.55	0.79	1.46e-18	Serum sulfate level;
SKCM	cis	rs28386778	0.799	rs2665836	chr17:61898135	C/A	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs5753618	0.555	rs9609304	chr22:31897795	T/C	cg02404636	chr22:31891804	SFI1	0.68	6.07	0.57	4.32e-8	Colorectal cancer;
SKCM	trans	rs2727020	0.658	rs4980440	chr11:49386017	C/T	cg15704280	chr7:45808275	SEPT13	-0.85	-7.4	-0.64	1.33e-10	Coronary artery disease;
SKCM	cis	rs9660180	0.839	rs12040826	chr1:1705287	A/C	cg17747265	chr1:1875780	NA	-0.54	-4.98	-0.49	3.74e-6	Body mass index;
SKCM	cis	rs8014204	0.804	rs35641442	chr14:75207263	G/A	cg06637938	chr14:75390232	RPS6KL1	0.83	6.52	0.59	6.37e-9	Caffeine consumption;
SKCM	cis	rs9393692	0.840	rs9358915	chr6:26277268	G/A	cg00631329	chr6:26305371	NA	-0.68	-4.93	-0.49	4.49e-6	Educational attainment;
SKCM	trans	rs1814175	0.817	rs12295885	chr11:50036762	T/G	cg03929089	chr4:120376271	NA	-0.93	-8.77	-0.7	3.08e-13	Height;
SKCM	cis	rs72772090	1.000	rs72772090	chr5:96036311	G/C	cg17330273	chr5:96107758	CAST;ERAP1	-0.8	-4.79	-0.48	7.69e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs6088580	0.584	rs2378203	chr20:32993846	A/T	cg24642439	chr20:33292090	TP53INP2	-0.76	-6.02	-0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs8060686	0.641	rs12448677	chr16:68209741	G/A	cg09117114	chr16:67998030	SLC12A4	-0.77	-5.03	-0.49	3.12e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs12709013	0.792	rs12595974	chr16:58803036	T/C	cg02431531	chr16:59244939	NA	0.48	4.99	0.49	3.62e-6	Blood metabolite ratios;
SKCM	cis	rs2070488	0.775	rs13072731	chr3:38533335	A/C	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.75	6.03	0.56	5.19e-8	Electrocardiographic conduction measures;
SKCM	cis	rs7666738	0.791	rs1559860	chr4:99024422	C/T	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2075371	0.932	rs1035328	chr7:133978419	T/C	cg20476274	chr7:133979776	SLC35B4	1.03	10.58	0.77	9.96e-17	Mean platelet volume;
SKCM	cis	rs6120849	0.901	rs6060270	chr20:33736814	G/T	cg24642439	chr20:33292090	TP53INP2	0.91	5.05	0.5	2.83e-6	Protein C levels;
SKCM	cis	rs2354432	0.556	rs2353975	chr1:146837703	C/A	cg25205988	chr1:146714368	CHD1L	1.11	5.59	0.53	3.21e-7	Mitochondrial DNA levels;
SKCM	cis	rs1552244	1.000	rs2272123	chr3:10140115	G/A	cg02579736	chr3:10068473	FANCD2;CIDECP	1.23	6.92	0.62	1.13e-9	Alzheimer's disease;
SKCM	cis	rs8038465	0.622	rs17185294	chr15:73858415	C/T	cg15420318	chr15:73925796	NPTN	-0.66	-5.34	-0.52	8.73e-7	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs4423214	1.000	rs11606612	chr11:71164047	C/A	cg05163923	chr11:71159392	DHCR7	0.83	8.06	0.67	7.35e-12	Vitamin D levels;
SKCM	cis	rs1707322	0.717	rs2991989	chr1:46082965	C/T	cg03146154	chr1:46216737	IPP	-0.8	-5.59	-0.53	3.22e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7937682	0.924	rs12791699	chr11:111505880	T/C	cg09085632	chr11:111637200	PPP2R1B	-1.07	-11.3	-0.79	4.28e-18	Primary sclerosing cholangitis;
SKCM	cis	rs10504073	0.584	rs7818507	chr8:49918423	G/T	cg00325661	chr8:49890786	NA	0.79	7.15	0.63	3.99e-10	Blood metabolite ratios;
SKCM	cis	rs8067354	0.645	rs2665400	chr17:57880201	G/A	cg02344993	chr17:57696989	CLTC	0.67	4.79	0.48	7.85e-6	Hemoglobin concentration;
SKCM	cis	rs701145	0.585	rs357494	chr3:153937753	G/A	cg17054900	chr3:154042577	DHX36	1.19	5.1	0.5	2.37e-6	Coronary artery disease;
SKCM	cis	rs16854884	0.538	rs61359084	chr3:143738362	T/C	cg06585982	chr3:143692056	C3orf58	0.87	7.77	0.66	2.66e-11	Economic and political preferences (feminism/equality);
SKCM	cis	rs10832963	1.000	rs10832956	chr11:18645668	A/G	cg09201001	chr11:18656081	SPTY2D1	1.03	11.04	0.78	1.31e-17	Breast cancer;
SKCM	cis	rs651907	0.535	rs11714444	chr3:101513682	G/A	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.78	6.72	0.61	2.65e-9	Colorectal cancer;
SKCM	cis	rs1799949	0.965	rs11650913	chr17:41331597	T/C	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.29	-0.58	1.73e-8	Menopause (age at onset);
SKCM	cis	rs10504229	0.906	rs7846666	chr8:58172302	T/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs2032447	0.670	rs198815	chr6:26127271	A/G	cg18357526	chr6:26021779	HIST1H4A	-0.8	-6.65	-0.6	3.57e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs8177253	1.000	rs6762719	chr3:133480817	A/G	cg16414030	chr3:133502952	NA	-0.69	-5.78	-0.55	1.49e-7	Iron status biomarkers;
SKCM	cis	rs6570726	0.935	rs419847	chr6:145827278	A/G	cg23711669	chr6:146136114	FBXO30	0.7	6.64	0.6	3.72e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2235573	0.625	rs8142174	chr22:38427963	C/T	cg03683946	chr22:38051826	SH3BP1	-0.49	-4.98	-0.49	3.72e-6	Glioblastoma;Glioma;
SKCM	cis	rs2288073	0.965	rs13387930	chr2:24414400	A/G	cg06627628	chr2:24431161	ITSN2	-0.84	-5.79	-0.55	1.43e-7	Venous thromboembolism (SNP x SNP interaction);
SKCM	cis	rs10256972	0.521	rs871019	chr7:1105230	A/G	cg09177884	chr7:1199841	ZFAND2A	-0.63	-4.84	-0.48	6.44e-6	Longevity;Endometriosis;
SKCM	cis	rs1692580	0.870	rs590367	chr1:2162944	C/T	cg21442419	chr1:2182373	SKI	-0.69	-6.96	-0.62	9.57e-10	Coronary artery disease;
SKCM	cis	rs847649	1.000	rs4620204	chr7:102594217	T/C	cg18108683	chr7:102477205	FBXL13	0.82	8.63	0.7	5.57e-13	Morning vs. evening chronotype;
SKCM	cis	rs9475752	0.552	rs71564864	chr6:56734394	A/G	cg06815302	chr6:57335405	PRIM2	0.66	4.88	0.48	5.58e-6	Menarche (age at onset);
SKCM	cis	rs7188801	0.665	rs71390846	chr16:86714715	G/C	cg00354437	chr16:87133690	NA	-0.72	-5.33	-0.52	9.1e-7	Bone properties (heel);
SKCM	cis	rs2346177	0.542	rs718849	chr2:46698116	G/A	cg02822958	chr2:46747628	ATP6V1E2	0.76	5.6	0.54	3.07e-7	HDL cholesterol;
SKCM	cis	rs9910055	0.512	rs7209801	chr17:42323376	G/A	cg13607699	chr17:42295918	UBTF	0.92	6.95	0.62	9.88e-10	Total body bone mineral density;
SKCM	cis	rs9894429	0.538	rs9747080	chr17:79606704	A/G	cg18240062	chr17:79603768	NPLOC4	0.78	7.57	0.65	6.34e-11	Eye color traits;
SKCM	cis	rs9611565	0.649	rs5758434	chr22:42116163	G/A	cg03806693	chr22:41940476	POLR3H	0.81	5.48	0.53	5.13e-7	Vitiligo;
SKCM	cis	rs801193	0.967	rs2707841	chr7:66157020	A/G	cg00343986	chr7:65444356	GUSB	0.7	5.14	0.5	1.98e-6	Aortic root size;
SKCM	cis	rs7937682	1.000	rs11608122	chr11:111535105	C/T	cg09085632	chr11:111637200	PPP2R1B	1.03	11.65	0.8	9.4e-19	Primary sclerosing cholangitis;
SKCM	cis	rs1801516	0.950	rs17108024	chr11:108333536	C/T	cg01991180	chr11:108092276	ATM;NPAT	-1.0	-4.8	-0.48	7.48e-6	Melanoma;
SKCM	cis	rs6951245	0.638	rs4720486	chr7:1146764	G/A	cg18402987	chr7:1209562	NA	0.82	5.43	0.52	6.18e-7	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7927771	0.864	rs112060627	chr11:47426956	G/A	cg01152729	chr11:47593274	PTPMT1	-0.51	-4.92	-0.49	4.64e-6	Subjective well-being;
SKCM	cis	rs2479724	0.805	rs11756454	chr6:41798578	T/A	cg17623882	chr6:41773611	USP49	0.74	6.24	0.58	2.09e-8	Menarche (age at onset);
SKCM	cis	rs2204008	0.837	rs7315255	chr12:37949279	G/A	cg26384229	chr12:38710491	ALG10B	0.81	6.59	0.6	4.69e-9	Bladder cancer;
SKCM	cis	rs17683430	0.702	rs75351557	chr22:32416688	A/C	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	GIP levels in response to oral glucose tolerance test (120 minutes);
SKCM	trans	rs1814175	0.754	rs28663627	chr11:50048829	C/T	cg03929089	chr4:120376271	NA	-0.93	-8.77	-0.7	3.08e-13	Height;
SKCM	cis	rs208520	1.000	rs12209225	chr6:66996443	G/T	cg07460842	chr6:66804631	NA	0.87	5.96	0.56	6.95e-8	Exhaled nitric oxide output;
SKCM	cis	rs4728302	0.559	rs12707093	chr7:133200817	C/T	cg10665199	chr7:133106180	EXOC4	0.75	5.18	0.51	1.69e-6	Intelligence;Intelligence (multi-trait analysis);
SKCM	cis	rs769267	0.740	rs2965185	chr19:19525792	T/C	cg03709012	chr19:19516395	GATAD2A	0.77	5.41	0.52	6.67e-7	Tonsillectomy;
SKCM	cis	rs7772486	0.875	rs9403768	chr6:146406458	A/C	cg05347473	chr6:146136440	FBXO30	0.65	5.96	0.56	6.79e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9910055	1.000	rs9910055	chr17:42283037	C/T	cg08499158	chr17:42289980	UBTF	-0.89	-7.83	-0.66	2.05e-11	Total body bone mineral density;
SKCM	cis	rs55728055	0.661	rs7286496	chr22:31983760	G/A	cg01338084	chr22:32026380	PISD	1.5	5.03	0.49	3.11e-6	Age-related hearing impairment;
SKCM	cis	rs7937682	0.814	rs1784788	chr11:111486136	T/G	cg09085632	chr11:111637200	PPP2R1B	-0.97	-10.11	-0.75	7.73e-16	Primary sclerosing cholangitis;
SKCM	cis	rs365132	1.000	rs2292256	chr5:176333126	C/T	cg16309518	chr5:176445507	NA	-0.52	-5.25	-0.51	1.28e-6	Menarche and menopause (age at onset);Menopause (age at onset);
SKCM	cis	rs7772486	0.534	rs34541797	chr6:146205304	A/G	cg05347473	chr6:146136440	FBXO30	0.66	5.59	0.53	3.25e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9902453	1.000	rs4328498	chr17:28344276	G/A	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.8	-5.57	-0.53	3.54e-7	Coffee consumption (cups per day);
SKCM	cis	rs10876993	0.890	rs774888	chr12:58036506	A/G	cg18357645	chr12:58087776	OS9	0.59	5.34	0.52	8.89e-7	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs4619890	0.510	rs7687428	chr4:7889487	T/C	cg08722675	chr4:8412549	ACOX3	0.53	5.01	0.49	3.37e-6	Glaucoma (primary open-angle);
SKCM	cis	rs7216064	1.000	rs6504548	chr17:65886048	T/C	cg12091567	chr17:66097778	LOC651250	-0.76	-5.42	-0.52	6.34e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs7811142	1.000	rs4472444	chr7:100070758	T/C	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-0.99	-5.52	-0.53	4.2e-7	Platelet count;
SKCM	cis	rs9916302	0.851	rs6503518	chr17:37660469	A/G	cg07936489	chr17:37558343	FBXL20	-0.9	-8.1	-0.68	6.05e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs769267	0.930	rs4808203	chr19:19568659	A/G	cg03709012	chr19:19516395	GATAD2A	0.95	9.34	0.73	2.34e-14	Tonsillectomy;
SKCM	cis	rs208520	1.000	rs72882079	chr6:66973878	T/C	cg07460842	chr6:66804631	NA	0.86	6.07	0.57	4.28e-8	Exhaled nitric oxide output;
SKCM	trans	rs561341	1.000	rs4795669	chr17:30244701	C/T	cg20587970	chr11:113659929	NA	-0.98	-7.89	-0.67	1.56e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs3816788	0.792	rs729180	chr8:21817245	C/T	cg17168535	chr8:21777572	XPO7	0.8	7.3	0.64	2.15e-10	Lung cancer in ever smokers;
SKCM	cis	rs3776081	0.821	rs3776078	chr5:149524179	C/G	cg11060666	chr5:148851518	NA	-0.39	-4.84	-0.48	6.37e-6	Blood protein levels;
SKCM	cis	rs8038465	0.638	rs12591473	chr15:73967485	A/T	cg15420318	chr15:73925796	NPTN	0.6	4.83	0.48	6.76e-6	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs6089829	0.855	rs6090203	chr20:61663632	G/A	cg08564027	chr20:61660810	NA	0.63	5.65	0.54	2.56e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs11098499	0.865	rs9996417	chr4:120295862	T/C	cg24375607	chr4:120327624	NA	0.65	4.85	0.48	6.14e-6	Corneal astigmatism;
SKCM	cis	rs1707322	0.964	rs785499	chr1:46592420	G/A	cg03146154	chr1:46216737	IPP	-0.8	-5.28	-0.51	1.15e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs4077515	0.967	rs11794847	chr9:139271747	G/A	cg14169450	chr9:139327907	INPP5E	0.47	5.31	0.52	9.92e-7	Ulcerative colitis;IgA nephropathy;Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs6089584	0.566	rs6061401	chr20:60607482	G/A	cg06108461	chr20:60628389	TAF4	-0.73	-6.74	-0.61	2.46e-9	Body mass index;
SKCM	cis	rs28595532	0.748	rs72670248	chr4:119335536	A/C	cg21605333	chr4:119757512	SEC24D	0.95	4.91	0.49	4.92e-6	Cannabis dependence symptom count;
SKCM	cis	rs875971	1.000	rs4717292	chr7:65895598	G/A	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	cis	rs4555082	0.957	rs8022526	chr14:105756485	A/G	cg13114125	chr14:105738426	BRF1	-0.7	-5.44	-0.52	5.86e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs9660180	0.967	rs12044597	chr1:1708801	A/G	cg17747265	chr1:1875780	NA	-0.54	-4.95	-0.49	4.15e-6	Body mass index;
SKCM	cis	rs2836974	0.897	rs3945	chr21:40566067	A/G	cg11644478	chr21:40555479	PSMG1	0.97	10.08	0.75	8.76e-16	Cognitive function;
SKCM	cis	rs10779751	1.000	rs2024627	chr1:11298790	T/C	cg08854313	chr1:11322531	MTOR	0.92	7.09	0.63	5.2400000000000005e-10	Body mass index;
SKCM	cis	rs3892630	0.824	rs2287884	chr19:33321447	A/G	cg22980127	chr19:33182716	NUDT19	1.26	6.97	0.62	8.86e-10	Red blood cell traits;
SKCM	cis	rs2354432	0.556	rs2353984	chr1:146813358	C/T	cg25205988	chr1:146714368	CHD1L	1.19	6.54	0.6	5.86e-9	Mitochondrial DNA levels;
SKCM	cis	rs2153535	0.540	rs9378557	chr6:8517381	T/C	cg07606381	chr6:8435919	SLC35B3	0.87	6.38	0.59	1.17e-8	Motion sickness;
SKCM	cis	rs6545883	0.899	rs1562309	chr2:61770126	C/A	cg15711740	chr2:61764176	XPO1	-0.76	-5.3	-0.51	1.03e-6	Tuberculosis;
SKCM	cis	rs2836974	0.666	rs11910705	chr21:40685604	C/T	cg11644478	chr21:40555479	PSMG1	-0.68	-5.96	-0.56	6.94e-8	Cognitive function;
SKCM	cis	rs7666738	0.830	rs9998682	chr4:98939009	T/C	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9902453	1.000	rs9896062	chr17:28357047	G/A	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.81	-5.78	-0.55	1.45e-7	Coffee consumption (cups per day);
SKCM	cis	rs7811142	1.000	rs73161759	chr7:100009994	T/C	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.23	8.03	0.67	8.33e-12	Platelet count;
SKCM	cis	rs826838	0.967	rs4768329	chr12:39129394	T/C	cg13010199	chr12:38710504	ALG10B	-0.72	-5.73	-0.54	1.83e-7	Heart rate;
SKCM	cis	rs875971	1.000	rs1182882	chr7:65562063	C/T	cg11764359	chr7:65958608	NA	-0.89	-8.44	-0.69	1.29e-12	Aortic root size;
SKCM	cis	rs2243480	1.000	rs778704	chr7:65863467	T/C	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs28386778	0.799	rs2955234	chr17:61983601	A/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	-0.96	-8.05	-0.67	7.49e-12	Prudent dietary pattern;
SKCM	trans	rs1814175	0.592	rs1794161	chr11:49898825	A/C	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs1348850	0.914	rs12469386	chr2:178358281	A/G	cg02961200	chr2:178257176	LOC100130691;AGPS	-0.82	-6.13	-0.57	3.43e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs7959452	0.557	rs7980883	chr12:69778914	C/T	cg14784868	chr12:69753453	YEATS4	0.8	7.56	0.65	6.58e-11	Blood protein levels;
SKCM	cis	rs13118159	0.550	rs9685761	chr4:1377942	C/G	cg02475777	chr4:1388615	CRIPAK	0.75	5.14	0.5	2.02e-6	Longevity;
SKCM	cis	rs6500395	1.000	rs3848319	chr16:48610933	T/C	cg04672837	chr16:48644449	N4BP1	0.7	5.94	0.56	7.61e-8	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs1062177	0.855	rs62395861	chr5:151269270	A/G	cg00977110	chr5:151150581	G3BP1	0.81	6.51	0.59	6.59e-9	Preschool internalizing problems;
SKCM	cis	rs459571	0.959	rs2520100	chr9:136918137	A/T	cg13789015	chr9:136890014	NCRNA00094	0.7	5.7	0.54	2.08e-7	Platelet distribution width;
SKCM	cis	rs2050392	0.799	rs303429	chr10:30708441	C/T	cg25182066	chr10:30743637	MAP3K8	-0.69	-5.58	-0.53	3.41e-7	Inflammatory bowel disease;
SKCM	cis	rs6582630	0.519	rs11495724	chr12:38337507	T/C	cg26384229	chr12:38710491	ALG10B	0.81	6.67	0.6	3.38e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs2842992	0.789	rs9365093	chr6:160175819	C/G	cg16489826	chr6:160211363	TCP1;MRPL18	0.73	5.42	0.52	6.39e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs7937682	0.737	rs542275	chr11:111431614	C/T	cg19812747	chr11:111475976	SIK2	-0.55	-4.8	-0.48	7.63e-6	Primary sclerosing cholangitis;
SKCM	cis	rs6547631	0.622	rs1437744	chr2:85925084	G/A	cg24620635	chr2:85921963	GNLY	0.9	6.65	0.6	3.58e-9	Blood protein levels;
SKCM	cis	rs7954584	0.611	rs3887885	chr12:122336486	C/T	cg13699009	chr12:122356056	WDR66	0.56	7.02	0.62	7.17e-10	Mean corpuscular volume;
SKCM	cis	rs2297440	0.506	rs2236504	chr20:62224762	C/T	cg09650180	chr20:62225654	GMEB2	-0.77	-6.11	-0.57	3.64e-8	Glioma;Non-glioblastoma glioma;Glioblastoma;
SKCM	cis	rs4862750	0.914	rs9995391	chr4:187873749	A/T	cg10295955	chr4:187884368	NA	1.01	12.02	0.81	1.95e-19	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs854765	0.547	rs2955359	chr17:17946730	T/C	cg24612305	chr17:17875800	TOM1L2;LRRC48	-1.05	-9.29	-0.72	2.92e-14	Total body bone mineral density;
SKCM	cis	rs7618501	0.633	rs6771546	chr3:49968572	T/C	cg05072774	chr3:49840536	C3orf54	-0.66	-5.03	-0.49	3.12e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs8072100	0.846	rs4264433	chr17:45737275	A/T	cg25173405	chr17:45401733	C17orf57	0.6	5.52	0.53	4.22e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs9910055	0.529	rs190144	chr17:42164584	A/G	cg19774624	chr17:42201019	HDAC5	0.81	6.4	0.59	1.05e-8	Total body bone mineral density;
SKCM	cis	rs951366	0.789	rs823152	chr1:205736285	G/A	cg07157834	chr1:205819609	PM20D1	0.81	7.26	0.64	2.51e-10	Menarche (age at onset);
SKCM	cis	rs2295499	0.515	rs56026329	chr4:2737538	T/C	cg12595016	chr4:2061930	NAT8L	0.69	4.94	0.49	4.36e-6	Cognitive ability;Cognitive ability (multi-trait analysis);Intelligence (multi-trait analysis);
SKCM	cis	rs798554	0.679	rs2533870	chr7:2885274	C/G	cg19346786	chr7:2764209	NA	0.61	6.47	0.59	7.84e-9	Height;
SKCM	cis	rs561341	0.843	rs879944	chr17:30242803	A/G	cg12193833	chr17:30244370	NA	-0.49	-4.92	-0.49	4.75e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs7296418	0.630	rs11057238	chr12:123767971	C/A	cg00376283	chr12:123451042	ABCB9	0.82	6.54	0.6	5.78e-9	Platelet count;
SKCM	cis	rs62238980	0.614	rs743764	chr22:32459217	C/T	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs4555082	0.874	rs1882846	chr14:105717448	G/C	cg13114125	chr14:105738426	BRF1	-0.68	-5.65	-0.54	2.48e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs3091242	0.933	rs926438	chr1:25753638	C/T	cg27572855	chr1:25598939	RHD	0.57	5.57	0.53	3.48e-7	Erythrocyte sedimentation rate;
SKCM	cis	rs6952808	0.723	rs4721287	chr7:2028663	A/C	cg02951883	chr7:2050386	MAD1L1	-0.84	-7.52	-0.65	7.81e-11	Bipolar disorder and schizophrenia;
SKCM	cis	rs7772486	0.790	rs9497435	chr6:146265340	C/A	cg23711669	chr6:146136114	FBXO30	-0.77	-7.44	-0.64	1.14e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6500602	0.927	rs7200817	chr16:4480598	G/C	cg09069446	chr16:4462122	CORO7	-0.46	-4.89	-0.48	5.32e-6	Schizophrenia;
SKCM	cis	rs7811142	0.830	rs73401443	chr7:99977582	T/G	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.07	6.7	0.6	2.88e-9	Platelet count;
SKCM	cis	rs4523957	0.583	rs2984940	chr17:2023825	A/G	cg16513277	chr17:2031491	SMG6	-0.81	-5.98	-0.56	6.24e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs9300255	0.506	rs11057251	chr12:123791227	A/G	cg05973401	chr12:123451056	ABCB9	-0.72	-5.48	-0.53	5.12e-7	Neutrophil percentage of white cells;
SKCM	cis	rs769267	0.895	rs2965189	chr19:19519518	G/T	cg26732615	chr19:19648335	CILP2;YJEFN3	0.69	7.02	0.62	7.14e-10	Tonsillectomy;
SKCM	cis	rs8077889	0.750	rs231533	chr17:41945588	A/G	cg26893861	chr17:41843967	DUSP3	-1.04	-5.52	-0.53	4.34e-7	Triglycerides;
SKCM	cis	rs9583531	0.600	rs9521909	chr13:111362170	A/G	cg24331049	chr13:111365604	ING1	0.88	6.6	0.6	4.45e-9	Coronary artery disease;
SKCM	cis	rs2721195	0.967	rs1985022	chr8:145684031	C/T	cg15857475	chr8:145742913	RECQL4;LRRC14	0.78	6.78	0.61	2.08e-9	Age at first birth;
SKCM	cis	rs1395	1.000	rs7593448	chr2:27449293	C/G	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.47	4.87	0.48	5.75e-6	Blood metabolite levels;
SKCM	cis	rs1949733	1.000	rs1880023	chr4:8480831	C/T	cg11789530	chr4:8429930	ACOX3	-0.83	-5.75	-0.55	1.66e-7	Response to antineoplastic agents;
SKCM	cis	rs11252926	0.574	rs10904065	chr10:423226	G/T	cg18196295	chr10:418757	DIP2C	-0.66	-4.9	-0.49	5.13e-6	Psychosis in Alzheimer's disease;
SKCM	cis	rs909674	0.515	rs9611170	chr22:39784845	G/C	cg24399712	chr22:39784796	NA	-0.57	-4.94	-0.49	4.36e-6	IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis);IgG glycosylation;IgG digalactosylation phenotypes (multivariate analysis);IgG sialylation phenotypes (multivariate analysis);IgG monogalactosylation phenotypes (multivariate analysis);IgG fucosylation phenotypes (multivariate analysis);IgG N-glycosylation phenotypes (multivariate analysis);IgG disialylation phenotypes (multivariate analysis);IgG galactosylation phenotypes (multivariate analysis);Post bronchodilator FEV1;
SKCM	cis	rs8017423	0.935	rs2104704	chr14:90696609	A/G	cg04374321	chr14:90722782	PSMC1	-1.0	-9.04	-0.72	9.19e-14	Mortality in heart failure;
SKCM	cis	rs12477438	0.501	rs2516833	chr2:99777405	T/C	cg14399236	chr2:99771627	LIPT1;TSGA10	0.97	8.66	0.7	4.83e-13	Chronic sinus infection;
SKCM	cis	rs9894429	1.000	rs7222241	chr17:79574714	C/G	cg18240062	chr17:79603768	NPLOC4	0.78	7.61	0.65	5.37e-11	Eye color traits;
SKCM	cis	rs2777491	0.789	rs1655557	chr15:41787972	C/G	cg18705301	chr15:41695430	NDUFAF1	-0.96	-9.25	-0.72	3.51e-14	Ulcerative colitis;
SKCM	cis	rs864745	0.902	rs12531540	chr7:28162674	C/T	cg15170557	chr7:28214983	JAZF1	-0.66	-6.87	-0.61	1.38e-9	Crohn's disease;Type 2 diabetes;
SKCM	cis	rs1862618	0.671	rs2591966	chr5:56233688	T/G	cg03609598	chr5:56110824	MAP3K1	0.72	5.16	0.5	1.86e-6	Initial pursuit acceleration;
SKCM	cis	rs1799949	1.000	rs8176212	chr17:41226601	G/C	cg23758822	chr17:41437982	NA	0.94	7.87	0.67	1.68e-11	Menopause (age at onset);
SKCM	cis	rs1642645	0.533	rs6681444	chr1:42555221	T/C	cg18174678	chr1:42801761	FOXJ3	-0.53	-4.83	-0.48	6.69e-6	Left ventricular obstructive tract defect (maternal effect);
SKCM	cis	rs7829975	0.626	rs907183	chr8:8729761	C/G	cg15556689	chr8:8085844	FLJ10661	-0.74	-6.21	-0.57	2.44e-8	Mood instability;
SKCM	cis	rs10489202	0.632	rs202265	chr1:167990231	G/C	cg24449463	chr1:168025552	DCAF6	-0.81	-7.88	-0.67	1.58e-11	Schizophrenia;
SKCM	cis	rs1153858	1.000	rs4775907	chr15:45638647	G/A	cg10760299	chr15:45669010	GATM	0.58	6.04	0.56	4.83e-8	Homoarginine levels;
SKCM	cis	rs523522	0.962	rs4766968	chr12:120947788	G/C	cg12219531	chr12:120966889	COQ5	0.91	7.82	0.66	2.11e-11	High light scatter reticulocyte count;
SKCM	cis	rs919433	0.619	rs699318	chr2:198281743	T/C	cg04278110	chr2:198063759	ANKRD44	0.7	4.79	0.48	7.87e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs2836974	0.644	rs2836986	chr21:40702136	A/C	cg17971929	chr21:40555470	PSMG1	-0.71	-6.2	-0.57	2.5e-8	Cognitive function;
SKCM	cis	rs9467773	1.000	rs28558133	chr6:26531433	G/C	cg09904177	chr6:26538194	HMGN4	0.54	4.98	0.49	3.78e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs6120849	0.617	rs12480442	chr20:33648388	C/G	cg24642439	chr20:33292090	TP53INP2	0.94	4.86	0.48	5.91e-6	Protein C levels;
SKCM	cis	rs7666738	0.830	rs17483521	chr4:98974058	A/T	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9910055	0.529	rs228766	chr17:42186813	A/G	cg09913183	chr17:42254507	C17orf65;ASB16	-0.58	-4.83	-0.48	6.59e-6	Total body bone mineral density;
SKCM	cis	rs11098499	0.954	rs10031665	chr4:120422852	T/C	cg09307838	chr4:120376055	NA	0.99	8.1	0.68	6.11e-12	Corneal astigmatism;
SKCM	trans	rs1814175	0.817	rs10839465	chr11:49981554	C/A	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs6088590	0.561	rs6059918	chr20:33150503	C/T	cg24642439	chr20:33292090	TP53INP2	0.76	5.84	0.55	1.13e-7	Coronary artery disease;
SKCM	cis	rs2404602	0.583	rs2139190	chr15:76555539	G/C	cg23625390	chr15:77176239	SCAPER	0.69	6.31	0.58	1.57e-8	Blood metabolite levels;
SKCM	cis	rs7296418	0.816	rs1790096	chr12:123710364	C/T	cg05973401	chr12:123451056	ABCB9	0.77	5.86	0.55	1.07e-7	Platelet count;
SKCM	cis	rs4481887	1.000	rs6671789	chr1:248482931	G/A	cg00666640	chr1:248458726	OR2T12	0.64	5.69	0.54	2.13e-7	Common traits (Other);
SKCM	cis	rs651907	0.557	rs11710533	chr3:101351472	G/A	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.79	6.55	0.6	5.65e-9	Colorectal cancer;
SKCM	cis	rs7122539	0.646	rs682842	chr11:66568943	A/G	cg12372692	chr11:66233905	PELI3	0.73	5.38	0.52	7.47e-7	HIV-1 susceptibility;
SKCM	cis	rs847649	0.731	rs7785272	chr7:102671023	A/G	cg18108683	chr7:102477205	FBXL13	-0.8	-7.54	-0.65	7.18e-11	Morning vs. evening chronotype;
SKCM	cis	rs60871478	0.730	rs62432226	chr7:792973	T/C	cg05535760	chr7:792225	HEATR2	1.2	10.0	0.75	1.27e-15	Cerebrospinal P-tau181p levels;
SKCM	cis	rs11690935	0.959	rs10204622	chr2:172588982	C/T	cg13550731	chr2:172543902	DYNC1I2	-0.95	-8.21	-0.68	3.64e-12	Schizophrenia;
SKCM	cis	rs826838	1.000	rs7953227	chr12:38946193	G/A	cg26384229	chr12:38710491	ALG10B	1.08	9.74	0.74	4.07e-15	Heart rate;
SKCM	cis	rs9604529	0.640	rs9525239	chr13:114840960	A/G	cg10224581	chr13:114742421	NA	-0.79	-7.66	-0.66	4.32e-11	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs2836974	0.897	rs2836928	chr21:40543320	C/T	cg17971929	chr21:40555470	PSMG1	0.87	8.48	0.69	1.1e-12	Cognitive function;
SKCM	cis	rs67311347	0.544	rs2278927	chr3:40350447	G/A	cg00091569	chr3:40428383	ENTPD3	0.63	5.49	0.53	4.82e-7	Renal cell carcinoma;
SKCM	cis	rs7829975	0.539	rs71537846	chr8:8542120	T/C	cg15556689	chr8:8085844	FLJ10661	-0.62	-4.9	-0.49	5.12e-6	Mood instability;
SKCM	cis	rs908922	0.676	rs4845441	chr1:152485421	C/T	cg09873164	chr1:152488093	CRCT1	0.76	5.85	0.55	1.1e-7	Hair morphology;
SKCM	cis	rs644799	1.000	rs586498	chr11:95537828	C/T	cg25622487	chr11:95524042	FAM76B;CEP57	0.66	5.12	0.5	2.18e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs6088580	0.634	rs6088471	chr20:32932643	C/A	cg24642439	chr20:33292090	TP53INP2	-0.76	-6.02	-0.56	5.31e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs8133974	0.941	rs41360844	chr21:36481471	C/G	cg00621029	chr21:35747559	FAM165B	0.71	4.87	0.48	5.72e-6	Eosinophil counts;Eosinophil percentage of granulocytes;Sum eosinophil basophil counts;
SKCM	cis	rs7090367	0.555	rs2479901	chr10:125255073	A/G	cg16197717	chr10:125650957	CPXM2	-0.48	-5.12	-0.5	2.16e-6	Body mass index;
SKCM	cis	rs1799949	0.965	rs9911630	chr17:41188342	A/G	cg05368731	chr17:41323189	NBR1	0.9	7.23	0.63	2.81e-10	Menopause (age at onset);
SKCM	cis	rs12044355	0.827	rs11583715	chr1:231829039	C/T	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	-0.89	-6.96	-0.62	9.23e-10	Alzheimer's disease;
SKCM	cis	rs6762	0.748	rs5030780	chr11:838110	C/T	cg16425592	chr11:842748	TSPAN4;POLR2L	-0.8	-5.94	-0.56	7.55e-8	Mean platelet volume;
SKCM	cis	rs6704768	0.545	rs5004510	chr2:233679275	A/C	cg08000102	chr2:233561755	GIGYF2	-0.78	-5.91	-0.56	8.57e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs514406	0.679	rs499239	chr1:53310594	A/G	cg16325326	chr1:53192061	ZYG11B	0.68	5.82	0.55	1.25e-7	Monocyte count;
SKCM	cis	rs34779708	0.966	rs35146199	chr10:35460939	T/C	cg03585969	chr10:35415529	CREM	0.75	5.93	0.56	7.75e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs4727027	0.522	rs6956736	chr7:148893472	G/C	cg23583168	chr7:148888333	NA	-0.78	-5.37	-0.52	7.92e-7	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs362296	0.583	rs35658829	chr4:3255738	T/G	cg09735869	chr4:3319127	RGS12	-0.73	-6.24	-0.58	2.1e-8	Parental longevity (mother's age at death);
SKCM	cis	rs8017423	0.967	rs2277516	chr14:90722824	G/C	cg04374321	chr14:90722782	PSMC1	1.03	9.44	0.73	1.55e-14	Mortality in heart failure;
SKCM	cis	rs11098499	0.863	rs3822190	chr4:120428098	G/A	cg24375607	chr4:120327624	NA	0.7	5.38	0.52	7.69e-7	Corneal astigmatism;
SKCM	cis	rs9910055	0.636	rs7089	chr17:42269017	T/C	cg09913183	chr17:42254507	C17orf65;ASB16	0.67	6.53	0.59	6.13e-9	Total body bone mineral density;
SKCM	cis	rs12142240	0.698	rs12385695	chr1:46819021	A/G	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	trans	rs17685	0.753	rs4728550	chr7:75670988	C/A	cg19862616	chr7:65841803	NCRNA00174	-0.94	-9.39	-0.73	1.88e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs362296	0.698	rs3135168	chr4:3262699	T/C	cg21096898	chr4:3318625	RGS12	-0.8	-7.82	-0.66	2.09e-11	Parental longevity (mother's age at death);
SKCM	cis	rs2032447	0.839	rs199750	chr6:26016462	A/G	cg03517284	chr6:25882590	NA	0.61	4.81	0.48	7.11e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs3091242	0.781	rs71652378	chr1:25721457	G/C	cg27572855	chr1:25598939	RHD	0.56	5.52	0.53	4.35e-7	Erythrocyte sedimentation rate;
SKCM	cis	rs873946	0.586	rs12783078	chr10:134569706	C/T	cg27286337	chr10:134555280	INPP5A	0.99	8.98	0.71	1.2e-13	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs826838	0.874	rs11183816	chr12:38834656	T/G	cg13010199	chr12:38710504	ALG10B	0.86	6.84	0.61	1.61e-9	Heart rate;
SKCM	cis	rs75920871	0.588	rs7112111	chr11:116980858	T/G	cg01368799	chr11:117014884	PAFAH1B2	-0.67	-4.83	-0.48	6.66e-6	Subjective well-being;
SKCM	cis	rs951366	0.789	rs7536483	chr1:205718858	A/T	cg07167872	chr1:205819463	PM20D1	0.96	8.05	0.67	7.63e-12	Menarche (age at onset);
SKCM	cis	rs10779751	0.734	rs2791648	chr1:11132638	G/T	cg08854313	chr1:11322531	MTOR	0.77	5.52	0.53	4.36e-7	Body mass index;
SKCM	cis	rs28595532	0.920	rs115675321	chr4:119742153	A/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs1707322	0.752	rs4660880	chr1:46111040	C/T	cg03146154	chr1:46216737	IPP	0.83	5.62	0.54	2.85e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs1577917	0.958	rs12196175	chr6:86779370	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.64	-5.49	-0.53	4.77e-7	Response to antipsychotic treatment;
SKCM	cis	rs950027	0.620	rs1145093	chr15:45649813	C/A	cg10760299	chr15:45669010	GATM	0.57	5.69	0.54	2.09e-7	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs769267	0.965	rs2965188	chr19:19522557	G/A	cg26732615	chr19:19648335	CILP2;YJEFN3	0.69	7.16	0.63	3.82e-10	Tonsillectomy;
SKCM	cis	rs7954584	0.567	rs11043246	chr12:122368944	G/A	cg21171335	chr12:122356390	WDR66	0.46	4.99	0.49	3.52e-6	Mean corpuscular volume;
SKCM	cis	rs7106204	0.748	rs11027754	chr11:24203657	G/C	ch.11.24196551F	chr11:24239977	NA	0.83	6.17	0.57	2.83e-8	Response to Homoharringtonine (cytotoxicity);
SKCM	trans	rs561341	1.000	rs550923	chr17:30327013	G/C	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs2836974	0.865	rs34778912	chr21:40667037	T/G	cg11890956	chr21:40555474	PSMG1	0.99	11.14	0.78	8.38e-18	Cognitive function;
SKCM	cis	rs4727027	0.737	rs10278971	chr7:148780659	A/T	cg23583168	chr7:148888333	NA	-0.81	-6.45	-0.59	8.75e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs62238980	0.614	rs77511414	chr22:32406941	A/T	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs875971	0.767	rs1695815	chr7:65831344	A/G	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	7.89e-13	Aortic root size;
SKCM	cis	rs708547	0.647	rs781668	chr4:57825140	C/T	cg16868167	chr4:57843880	C4orf14;POLR2B	-0.73	-5.45	-0.52	5.77e-7	Response to bleomycin (chromatid breaks);
SKCM	cis	rs875971	1.000	rs937495	chr7:65779798	A/G	cg11764359	chr7:65958608	NA	-0.88	-8.54	-0.7	8.36e-13	Aortic root size;
SKCM	cis	rs17345786	0.861	rs17402964	chr3:101067945	C/T	cg12386194	chr3:101231763	SENP7	0.77	6.14	0.57	3.26e-8	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2952156	0.883	rs907088	chr17:37833567	G/C	cg00129232	chr17:37814104	STARD3	-0.74	-6.39	-0.59	1.11e-8	Asthma;
SKCM	cis	rs12586317	0.620	rs7147571	chr14:35530236	T/C	cg16230307	chr14:35515116	FAM177A1	0.79	5.61	0.54	2.96e-7	Psoriasis;
SKCM	cis	rs6942756	1.000	rs67520056	chr7:128982075	A/G	cg02491457	chr7:128862824	NA	-0.86	-5.48	-0.53	5.11e-7	White matter hyperintensity burden;
SKCM	cis	rs801193	1.000	rs2707856	chr7:66211010	A/T	cg00343986	chr7:65444356	GUSB	0.69	5.15	0.5	1.93e-6	Aortic root size;
SKCM	cis	rs637571	0.726	rs526631	chr11:65681965	T/G	cg26695010	chr11:65641043	EFEMP2	0.69	5.17	0.51	1.73e-6	Eosinophil percentage of white cells;
SKCM	cis	rs35306767	0.903	rs35957139	chr10:884889	C/T	cg25614935	chr10:1084866	C10orf110	0.8	5.41	0.52	6.69e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs2072499	0.931	rs1052053	chr1:156202173	A/G	cg25208724	chr1:156163844	SLC25A44	0.98	8.95	0.71	1.37e-13	Testicular germ cell tumor;
SKCM	cis	rs2645694	0.626	rs2645708	chr4:77822682	G/A	cg03477792	chr4:77819574	ANKRD56	0.57	6.37	0.58	1.22e-8	Emphysema distribution in smoking;
SKCM	cis	rs709400	0.663	rs62007681	chr14:103884651	G/A	cg26031613	chr14:104095156	KLC1	0.69	5.03	0.49	3.05e-6	Body mass index;
SKCM	cis	rs854765	0.583	rs11650649	chr17:17790319	C/A	cg09796270	chr17:17721594	SREBF1	-0.66	-4.9	-0.49	5.07e-6	Total body bone mineral density;
SKCM	cis	rs9611565	0.592	rs5758405	chr22:42076381	C/A	cg03806693	chr22:41940476	POLR3H	1.12	7.67	0.66	4.1e-11	Vitiligo;
SKCM	cis	rs7959452	0.562	rs10878975	chr12:69782044	G/C	cg14784868	chr12:69753453	YEATS4	0.8	7.6	0.65	5.66e-11	Blood protein levels;
SKCM	cis	rs7659604	0.539	rs1507995	chr4:122748308	G/A	cg06713675	chr4:122721982	EXOSC9	-0.75	-7.26	-0.64	2.47e-10	Type 2 diabetes;
SKCM	cis	rs4820539	1.000	rs885965	chr22:23461425	A/G	cg14186256	chr22:23484241	RTDR1	0.84	8.13	0.68	5.23e-12	Bone mineral density;
SKCM	cis	rs7945705	0.837	rs10769981	chr11:9024460	T/C	cg21881798	chr11:8931708	C11orf17;ST5	0.79	7.29	0.64	2.22e-10	Hemoglobin concentration;
SKCM	cis	rs6977660	0.943	rs10274447	chr7:19850640	C/T	cg05791153	chr7:19748676	TWISTNB	0.79	5.51	0.53	4.42e-7	Thyroid stimulating hormone;
SKCM	cis	rs7100689	0.646	rs1572819	chr10:82112488	A/G	cg00277334	chr10:82204260	NA	-0.56	-5.36	-0.52	8.1e-7	Post bronchodilator FEV1;
SKCM	cis	rs9894429	0.700	rs113915083	chr17:79552696	G/C	cg18240062	chr17:79603768	NPLOC4	-0.91	-10.36	-0.76	2.55e-16	Eye color traits;
SKCM	cis	rs7296418	0.885	rs1051434	chr12:123641200	C/T	cg06742321	chr12:123595122	PITPNM2	0.66	5.38	0.52	7.49e-7	Platelet count;
SKCM	cis	rs56104184	0.830	rs55966626	chr19:49342396	G/T	cg15549821	chr19:49342101	PLEKHA4	-1.24	-7.83	-0.66	1.99e-11	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs2354432	0.556	rs59180647	chr1:146772062	C/T	cg25205988	chr1:146714368	CHD1L	-1.19	-6.56	-0.6	5.24e-9	Mitochondrial DNA levels;
SKCM	cis	rs13118159	0.573	rs7657357	chr4:1372939	C/T	cg20887711	chr4:1340912	KIAA1530	0.74	5.19	0.51	1.64e-6	Longevity;
SKCM	cis	rs7100689	0.784	rs1870142	chr10:82182296	G/A	cg00277334	chr10:82204260	NA	-0.53	-4.96	-0.49	4.1e-6	Post bronchodilator FEV1;
SKCM	cis	rs28386778	0.897	rs1062787	chr17:61896004	T/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs3780486	0.801	rs3780495	chr9:33125942	A/C	cg13443165	chr9:33130375	B4GALT1	-0.55	-4.99	-0.49	3.65e-6	IgG glycosylation;
SKCM	cis	rs908922	0.676	rs1856119	chr1:152512483	A/G	cg09873164	chr1:152488093	CRCT1	0.76	5.93	0.56	7.7e-8	Hair morphology;
SKCM	cis	rs7811142	1.000	rs73161762	chr7:100014846	C/T	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.1	6.33	0.58	1.43e-8	Platelet count;
SKCM	cis	rs7772486	0.790	rs9403756	chr6:146257761	C/G	cg23711669	chr6:146136114	FBXO30	-0.78	-7.36	-0.64	1.64e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs73001065	0.591	rs2285626	chr19:19467545	C/T	cg03709012	chr19:19516395	GATAD2A	1.15	5.1	0.5	2.34e-6	LDL cholesterol;
SKCM	cis	rs4975616	0.869	rs421284	chr5:1325590	T/C	cg06550200	chr5:1325588	CLPTM1L	-0.86	-7.74	-0.66	2.94e-11	Lung cancer;
SKCM	cis	rs6879260	1.000	rs7730585	chr5:179733440	T/C	cg02891314	chr5:179741120	GFPT2	-0.73	-5.62	-0.54	2.85e-7	Height;
SKCM	cis	rs12142240	0.698	rs67142569	chr1:46828460	C/T	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs6570726	0.791	rs365747	chr6:145866784	C/T	cg05347473	chr6:146136440	FBXO30	0.57	5.14	0.5	1.95e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6570726	1.000	rs441477	chr6:145848243	C/T	cg23711669	chr6:146136114	FBXO30	0.73	6.93	0.62	1.07e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs17685	0.753	rs4732542	chr7:75663203	A/G	cg16489192	chr7:75678113	MDH2;STYXL1	-0.54	-4.93	-0.49	4.46e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1059312	0.808	rs10847693	chr12:129292006	G/A	cg09035930	chr12:129282057	SLC15A4	0.77	8.03	0.67	8.18e-12	Systemic lupus erythematosus;
SKCM	cis	rs3820068	0.581	rs34453754	chr1:15993208	G/C	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs651907	1.000	rs651907	chr3:101600724	T/C	cg12386194	chr3:101231763	SENP7	0.65	5.07	0.5	2.61e-6	Colorectal cancer;
SKCM	cis	rs11112613	0.713	rs2374502	chr12:105938939	T/C	cg03607813	chr12:105948248	NA	0.88	5.48	0.53	5.12e-7	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;
SKCM	cis	rs35306767	0.953	rs11253509	chr10:964306	C/T	cg20503657	chr10:835505	NA	0.66	5.15	0.5	1.88e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs10744422	1.000	rs7309225	chr12:123288439	A/G	cg25930673	chr12:123319894	HIP1R	-0.97	-4.83	-0.48	6.68e-6	Schizophrenia;
SKCM	cis	rs9325144	0.555	rs4882284	chr12:38710459	C/T	cg13010199	chr12:38710504	ALG10B	-0.62	-4.81	-0.48	7.21e-6	Morning vs. evening chronotype;
SKCM	cis	rs7937682	0.824	rs11213962	chr11:111506027	G/A	cg09085632	chr11:111637200	PPP2R1B	-1.07	-11.3	-0.79	4.28e-18	Primary sclerosing cholangitis;
SKCM	cis	rs28374715	0.532	rs28703570	chr15:41679492	G/A	cg18705301	chr15:41695430	NDUFAF1	-1.21	-13.94	-0.84	7.01e-23	Ulcerative colitis;
SKCM	cis	rs1577917	0.740	rs7752502	chr6:86410651	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.89	9.15	0.72	5.56e-14	Response to antipsychotic treatment;
SKCM	cis	rs7106204	0.590	rs7115417	chr11:24247696	A/G	ch.11.24196551F	chr11:24239977	NA	0.77	6.11	0.57	3.73e-8	Response to Homoharringtonine (cytotoxicity);
SKCM	cis	rs7635838	0.617	rs2122031	chr3:11314143	G/A	cg00170343	chr3:11313890	ATG7	0.79	6.01	0.56	5.5e-8	HDL cholesterol;
SKCM	cis	rs2180341	0.960	rs9375503	chr6:127677071	T/C	cg27446573	chr6:127587934	RNF146	0.94	8.11	0.68	5.63e-12	Breast cancer;
SKCM	cis	rs2739330	0.796	rs5760106	chr22:24250645	A/C	cg24846343	chr22:24311635	DDTL	-0.63	-5.99	-0.56	6.04e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs9951698	0.678	rs529620	chr18:13123876	C/G	cg12848697	chr18:13133368	NA	0.53	4.78	0.48	7.97e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1843834	0.505	rs3820763	chr2:225347270	A/G	cg12698349	chr2:225449008	CUL3	-0.84	-6.93	-0.62	1.09e-9	IgE levels in asthmatics (D.p. specific);
SKCM	cis	rs7829975	0.501	rs4840353	chr8:8580570	A/G	cg06636001	chr8:8085503	FLJ10661	-0.65	-4.86	-0.48	5.84e-6	Mood instability;
SKCM	cis	rs854765	0.533	rs2955354	chr17:17948716	G/C	cg24612305	chr17:17875800	TOM1L2;LRRC48	-1.05	-9.29	-0.72	2.92e-14	Total body bone mineral density;
SKCM	cis	rs7100689	0.646	rs6585946	chr10:82118292	G/T	cg01528321	chr10:82214614	TSPAN14	0.8	7.0	0.62	7.98e-10	Post bronchodilator FEV1;
SKCM	trans	rs17685	0.753	rs10262501	chr7:75668172	G/A	cg19862616	chr7:65841803	NCRNA00174	-0.94	-9.39	-0.73	1.88e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1552244	1.000	rs6442147	chr3:10078247	A/G	cg02579736	chr3:10068473	FANCD2;CIDECP	1.23	6.92	0.62	1.13e-9	Alzheimer's disease;
SKCM	cis	rs2072499	0.838	rs2758619	chr1:156162559	A/G	cg25208724	chr1:156163844	SLC25A44	1.1	9.86	0.74	2.35e-15	Testicular germ cell tumor;
SKCM	cis	rs72781680	1.000	rs72781634	chr2:24199102	C/T	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	cis	rs6088580	0.634	rs6059856	chr20:33057954	G/C	cg24642439	chr20:33292090	TP53INP2	0.75	6.02	0.56	5.32e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs9467773	0.620	rs2451711	chr6:26663110	A/G	cg15659132	chr6:26577336	NA	0.62	5.4	0.52	6.91e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs6500395	0.962	rs9934626	chr16:48602761	G/C	cg04672837	chr16:48644449	N4BP1	0.69	5.73	0.54	1.8e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs244731	0.959	rs9313752	chr5:176645435	G/T	cg17509989	chr5:176798049	RGS14	-0.77	-5.37	-0.52	7.83e-7	Urate levels in lean individuals;
SKCM	cis	rs4332037	0.539	rs11762545	chr7:2060775	C/T	cg23422044	chr7:1970798	MAD1L1	-0.89	-5.79	-0.55	1.38e-7	Bipolar disorder;
SKCM	cis	rs7666738	0.830	rs7678250	chr4:98922109	G/A	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11098499	0.754	rs9991959	chr4:120253773	C/T	cg09307838	chr4:120376055	NA	-0.88	-7.11	-0.63	4.86e-10	Corneal astigmatism;
SKCM	cis	rs7666738	0.830	rs28456179	chr4:98991439	A/G	cg17366294	chr4:99064904	C4orf37	0.6	4.98	0.49	3.8e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7927771	0.524	rs7110300	chr11:47848442	T/G	cg20307385	chr11:47447363	PSMC3	0.71	5.63	0.54	2.67e-7	Subjective well-being;
SKCM	cis	rs57221529	0.709	rs72706612	chr5:561198	C/T	cg10555297	chr5:473380	SLC9A3;LOC25845	1.02	5.1	0.5	2.37e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs7659604	0.539	rs11098648	chr4:122759872	C/T	cg20573242	chr4:122745356	CCNA2	0.75	6.45	0.59	8.59e-9	Type 2 diabetes;
SKCM	cis	rs7659604	0.702	rs61217486	chr4:122693973	T/C	cg19748678	chr4:122722346	EXOSC9	0.7	5.67	0.54	2.31e-7	Type 2 diabetes;
SKCM	cis	rs2439831	0.717	rs690170	chr15:43810422	G/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.34	7.06	0.62	6.18e-10	Lung cancer in ever smokers;
SKCM	cis	rs10654220	1	rs10654220	chr12:123703422	A/AGTT	cg05973401	chr12:123451056	ABCB9	0.79	5.2	0.51	1.59e-6	Platelet count;
SKCM	trans	rs7618501	1.000	rs7372725	chr3:49790544	C/A	cg21659725	chr3:3221576	CRBN	-0.96	-9.61	-0.74	7.08e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs7919656	1.000	rs10776647	chr10:50030864	C/T	cg00386007	chr10:50143337	WDFY4	-0.43	-4.97	-0.49	3.83e-6	Clinically amyopathic dermatomyositis;
SKCM	cis	rs6912958	1.000	rs9450701	chr6:88173167	T/C	cg08069147	chr6:88032118	GJB7;C6orf162	-0.64	-5.47	-0.53	5.2e-7	Monocyte percentage of white cells;
SKCM	cis	rs17685	0.712	rs56088021	chr7:75852480	C/T	cg16489192	chr7:75678113	MDH2;STYXL1	-0.53	-4.9	-0.49	5.05e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs10193935	0.901	rs1496329	chr2:42688797	T/C	cg27598129	chr2:42591480	NA	0.96	6.39	0.59	1.09e-8	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs35306767	0.671	rs11253473	chr10:906826	A/G	cg26597838	chr10:835615	NA	0.76	5.33	0.52	9.2e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs9303401	0.614	rs56284918	chr17:57178838	A/G	cg10487724	chr17:56770010	TEX14;RAD51C	0.79	4.97	0.49	3.86e-6	Cognitive test performance;
SKCM	cis	rs4780401	0.609	rs35902600	chr16:11800848	C/T	cg01061890	chr16:11836724	TXNDC11	-0.8	-6.08	-0.57	4.16e-8	Rheumatoid arthritis;
SKCM	cis	rs11098499	0.909	rs11098530	chr4:120413154	C/T	cg24375607	chr4:120327624	NA	0.65	5.01	0.49	3.32e-6	Corneal astigmatism;
SKCM	cis	rs9910055	0.762	rs2631299	chr17:42219773	G/T	cg19774624	chr17:42201019	HDAC5	-0.91	-8.04	-0.67	8e-12	Total body bone mineral density;
SKCM	cis	rs8180040	1.000	rs807936	chr3:47322496	C/T	cg27129171	chr3:47204927	SETD2	0.87	6.62	0.6	4.15e-9	Colorectal cancer;
SKCM	cis	rs1218582	0.772	rs4845682	chr1:154877105	T/C	cg09359103	chr1:154839909	KCNN3	-0.57	-5.3	-0.51	1.05e-6	Prostate cancer;
SKCM	cis	rs7336332	0.628	rs9581854	chr13:28017782	C/T	cg22138327	chr13:27999177	GTF3A	0.9	6.4	0.59	1.07e-8	Weight;
SKCM	cis	rs6570726	0.935	rs384806	chr6:145814889	C/G	cg23711669	chr6:146136114	FBXO30	0.71	6.77	0.61	2.18e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7296418	0.630	rs11057238	chr12:123767971	C/A	cg05973401	chr12:123451056	ABCB9	0.72	5.48	0.53	5.12e-7	Platelet count;
SKCM	cis	rs2204008	0.715	rs3899385	chr12:38169880	C/G	cg13010199	chr12:38710504	ALG10B	0.65	4.84	0.48	6.52e-6	Bladder cancer;
SKCM	cis	rs2033711	0.870	rs3764534	chr19:58929136	G/A	cg03735888	chr19:58951602	ZNF132	0.7	6.07	0.57	4.34e-8	Uric acid clearance;
SKCM	cis	rs926938	0.557	rs6667218	chr1:115238982	G/A	cg12756093	chr1:115239321	AMPD1	-0.75	-5.62	-0.54	2.89e-7	Autism;
SKCM	cis	rs9916302	0.706	rs9899069	chr17:37540772	A/G	cg07936489	chr17:37558343	FBXL20	0.96	6.76	0.61	2.28e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs10193935	0.901	rs62142639	chr2:42600019	C/G	cg27598129	chr2:42591480	NA	-0.88	-6.71	-0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs3820928	1.000	rs4673173	chr2:227769493	A/C	cg11843606	chr2:227700838	RHBDD1	-0.62	-4.92	-0.49	4.77e-6	Pulmonary function;
SKCM	cis	rs72792276	1.000	rs72792276	chr5:127364126	C/A	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.74	5.01	0.49	3.33e-6	Red cell distribution width;
SKCM	cis	rs151997	0.720	rs152096	chr5:50213850	A/G	cg06027927	chr5:50259733	NA	0.65	6.24	0.58	2.13e-8	Callous-unemotional behaviour;
SKCM	cis	rs2733201	1.000	rs12913809	chr15:44293211	G/T	cg02155558	chr15:43621948	ADAL;LCMT2	-1.25	-4.88	-0.48	5.56e-6	Lipoprotein phospholipase A2 activity in cardiovascular disease;
SKCM	cis	rs8180040	0.966	rs6792461	chr3:47473168	C/T	cg16586182	chr3:47516702	SCAP	0.76	5.32	0.52	9.63e-7	Colorectal cancer;
SKCM	cis	rs941408	1.000	rs1736183	chr19:2809672	A/G	cg06609049	chr19:2785107	THOP1	0.8	6.8	0.61	1.92e-9	Total cholesterol levels;
SKCM	cis	rs1799949	0.930	rs2298861	chr17:41176831	G/A	cg25072359	chr17:41440525	NA	0.62	4.79	0.48	7.92e-6	Menopause (age at onset);
SKCM	cis	rs7208859	0.573	rs8064686	chr17:29134839	C/T	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs9457247	0.624	rs17524252	chr6:167466978	T/G	cg07741184	chr6:167504864	NA	0.59	5.01	0.49	3.32e-6	Crohn's disease;
SKCM	cis	rs2404602	0.598	rs71405204	chr15:76635305	C/G	cg23625390	chr15:77176239	SCAPER	-0.81	-7.19	-0.63	3.44e-10	Blood metabolite levels;
SKCM	cis	rs9467773	1.000	rs6926629	chr6:26499903	T/C	cg15659132	chr6:26577336	NA	0.61	5.82	0.55	1.24e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs11690935	1.000	rs6721680	chr2:172543913	G/T	cg13550731	chr2:172543902	DYNC1I2	0.98	8.89	0.71	1.79e-13	Schizophrenia;
SKCM	cis	rs9300255	0.620	rs1716173	chr12:123660721	A/T	cg00376283	chr12:123451042	ABCB9	0.86	5.28	0.51	1.12e-6	Neutrophil percentage of white cells;
SKCM	cis	rs9910055	0.659	rs7207464	chr17:42245033	C/T	cg19774624	chr17:42201019	HDAC5	-0.9	-8.49	-0.69	1.04e-12	Total body bone mineral density;
SKCM	cis	rs17345786	0.602	rs11923273	chr3:101337863	T/C	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.75	6.02	0.56	5.36e-8	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs17376456	0.825	rs12716453	chr5:93271697	T/C	cg25358565	chr5:93447407	FAM172A	1.3	7.53	0.65	7.57e-11	Diabetic retinopathy;
SKCM	cis	rs7927771	0.832	rs10838697	chr11:47384484	T/A	cg01152729	chr11:47593274	PTPMT1	-0.51	-4.88	-0.48	5.53e-6	Subjective well-being;
SKCM	cis	rs28386778	0.897	rs2036911	chr17:61794839	A/T	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.13	11.24	0.79	5.56e-18	Prudent dietary pattern;
SKCM	cis	rs8060686	0.641	rs8059305	chr16:68036666	A/C	cg09117114	chr16:67998030	SLC12A4	-0.7	-5.29	-0.51	1.1e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs7927771	0.524	rs10838746	chr11:47706291	A/G	cg20307385	chr11:47447363	PSMC3	0.71	5.63	0.54	2.67e-7	Subjective well-being;
SKCM	cis	rs3091242	0.967	rs3091240	chr1:25676935	G/T	cg27572855	chr1:25598939	RHD	0.55	5.35	0.52	8.54e-7	Erythrocyte sedimentation rate;
SKCM	cis	rs7208859	0.623	rs8067338	chr17:29102345	T/C	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs7296418	0.699	rs11057254	chr12:123794581	A/C	cg05973401	chr12:123451056	ABCB9	0.72	5.48	0.53	5.12e-7	Platelet count;
SKCM	cis	rs34172651	0.517	rs200528	chr16:24759131	A/G	cg06028605	chr16:24865363	SLC5A11	-0.59	-4.98	-0.49	3.66e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs6951245	1.000	rs74785791	chr7:1088494	T/C	cg24642844	chr7:1081250	C7orf50	-0.94	-6.32	-0.58	1.48e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs6430585	0.583	rs6728946	chr2:136635343	C/G	cg07169764	chr2:136633963	MCM6	1.35	14.63	0.86	4.5e-24	Corneal structure;
SKCM	cis	rs10256972	0.577	rs6962809	chr7:1208889	A/G	cg07092213	chr7:1199455	ZFAND2A	-0.67	-5.49	-0.53	4.79e-7	Longevity;Endometriosis;
SKCM	cis	rs875971	0.862	rs13536	chr7:66019190	G/A	cg11764359	chr7:65958608	NA	-0.75	-6.8	-0.61	1.88e-9	Aortic root size;
SKCM	cis	rs3820928	0.605	rs4281898	chr2:227855493	A/C	cg11843606	chr2:227700838	RHBDD1	-0.63	-5.12	-0.5	2.11e-6	Pulmonary function;
SKCM	cis	rs4746818	1.000	rs6480385	chr10:70904785	A/T	cg11621586	chr10:70884670	VPS26A	1.08	7.96	0.67	1.11e-11	Left atrial antero-posterior diameter;
SKCM	cis	rs7618915	0.508	rs11717043	chr3:52656092	A/T	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs28595532	0.920	rs116550416	chr4:119753467	A/C	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs2731664	0.792	rs2630767	chr5:176870700	T/C	cg23176889	chr5:176863531	GRK6	-0.51	-5.18	-0.51	1.66e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7927771	0.524	rs6485763	chr11:47627302	C/T	cg20307385	chr11:47447363	PSMC3	0.77	5.82	0.55	1.24e-7	Subjective well-being;
SKCM	cis	rs860295	0.841	rs7556102	chr1:155368203	C/A	cg02153340	chr1:155202674	NA	0.73	5.57	0.53	3.53e-7	Body mass index;
SKCM	cis	rs11992186	0.505	rs7845203	chr8:8145440	A/G	cg15556689	chr8:8085844	FLJ10661	0.66	6.15	0.57	3.08e-8	Neuroticism;
SKCM	cis	rs9640161	0.830	rs35635199	chr7:150063342	C/T	cg10018233	chr7:150070692	REPIN1	0.72	6.0	0.56	5.86e-8	Blood protein levels;Circulating chemerin levels;
SKCM	trans	rs1814175	0.645	rs1851844	chr11:50021773	T/C	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs9814567	1.000	rs62271515	chr3:134300507	T/A	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs854765	0.583	rs9890341	chr17:17823175	G/C	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.0	7.64	0.65	4.64e-11	Total body bone mineral density;
SKCM	cis	rs28386778	0.897	rs2665832	chr17:61912261	C/T	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs1957429	0.901	rs1467571	chr14:65347682	C/T	cg23373153	chr14:65346875	NA	1.11	6.32	0.58	1.52e-8	Pediatric areal bone mineral density (radius);
SKCM	cis	rs2228479	0.618	rs3212371	chr16:89987201	A/G	cg00800038	chr16:89945340	TCF25	-0.97	-5.76	-0.55	1.59e-7	Skin colour saturation;
SKCM	cis	rs6753739	0.661	rs2219220	chr2:219906714	T/C	cg09297636	chr2:219923910	IHH	0.47	4.99	0.49	3.57e-6	Height;
SKCM	cis	rs703842	1.000	rs703842	chr12:58162739	C/T	cg04478727	chr12:58166393	METTL1;FAM119B	-0.72	-5.76	-0.55	1.59e-7	Multiple sclerosis;
SKCM	cis	rs62238980	0.614	rs117160277	chr22:32417939	A/G	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs13096357	0.520	rs17080319	chr3:48732480	T/C	cg00383909	chr3:49044727	WDR6	0.89	5.09	0.5	2.44e-6	Cognitive ability (multi-trait analysis);
SKCM	cis	rs11098499	0.909	rs78332141	chr4:120375782	C/T	cg09307838	chr4:120376055	NA	0.97	7.85	0.66	1.85e-11	Corneal astigmatism;
SKCM	cis	rs2921073	0.510	rs2976944	chr8:8270914	T/C	cg06636001	chr8:8085503	FLJ10661	0.76	6.77	0.61	2.16e-9	Parkinson's disease;
SKCM	cis	rs2645694	0.626	rs2703129	chr4:77818548	T/C	cg03477792	chr4:77819574	ANKRD56	0.57	6.38	0.59	1.18e-8	Emphysema distribution in smoking;
SKCM	cis	rs28595532	0.920	rs116550416	chr4:119753467	A/C	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs6570726	0.846	rs9376954	chr6:145943737	T/A	cg05347473	chr6:146136440	FBXO30	0.56	5.15	0.5	1.9e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7208859	0.623	rs28556733	chr17:29083945	T/G	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs67311347	0.544	rs1902073	chr3:40333497	C/T	cg02782426	chr3:40428986	ENTPD3	0.51	5.2	0.51	1.57e-6	Renal cell carcinoma;
SKCM	cis	rs131777	0.508	rs140518	chr22:50999182	C/T	cg25309564	chr22:51001381	C22orf41	0.98	6.8	0.61	1.86e-9	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs62238980	0.614	rs117209345	chr22:32504935	G/C	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs875971	1.000	rs6961717	chr7:65587537	C/T	cg18876405	chr7:65276391	NA	-0.68	-6.85	-0.61	1.54e-9	Aortic root size;
SKCM	cis	rs9303401	0.659	rs56162835	chr17:56687315	A/G	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.16	0.57	2.91e-8	Cognitive test performance;
SKCM	cis	rs847649	0.842	rs11976237	chr7:102641383	A/G	cg18108683	chr7:102477205	FBXL13	0.82	7.72	0.66	3.33e-11	Morning vs. evening chronotype;
SKCM	cis	rs2836974	0.799	rs13047550	chr21:40515495	T/C	cg11890956	chr21:40555474	PSMG1	1.1	13.67	0.84	2.12e-22	Cognitive function;
SKCM	cis	rs10155981	0.510	rs28439106	chr7:22592349	T/C	cg05062323	chr7:22590069	NA	-1.05	-6.05	-0.57	4.69e-8	Bilirubin levels;
SKCM	cis	rs7666738	0.830	rs4699597	chr4:99019031	G/A	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10751667	0.666	rs7124480	chr11:971601	G/A	cg06064525	chr11:970664	AP2A2	-0.53	-4.84	-0.48	6.52e-6	Alzheimer's disease (late onset);
SKCM	cis	rs17685	0.753	rs10476	chr7:75696420	C/T	cg16684958	chr7:75615977	POR	-0.57	-5.38	-0.52	7.72e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2072510	0.750	rs2660898	chr12:96425997	T/G	cg18817487	chr12:96390143	HAL	0.43	5.68	0.54	2.18e-7	Metabolite levels (small molecules and protein measures);
SKCM	cis	rs6951245	1.000	rs884977	chr7:1066410	T/C	cg24642844	chr7:1081250	C7orf50	-0.93	-6.25	-0.58	2.05e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs11122272	0.705	rs1416914	chr1:231533196	C/T	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	-0.65	-5.32	-0.52	9.49e-7	Hemoglobin concentration;
SKCM	cis	rs35306767	0.903	rs11253488	chr10:922482	G/C	cg20503657	chr10:835505	NA	0.75	5.34	0.52	8.77e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs801193	0.591	rs4506088	chr7:66135457	G/A	cg11764359	chr7:65958608	NA	-0.74	-6.66	-0.6	3.49e-9	Aortic root size;
SKCM	cis	rs951366	0.789	rs823094	chr1:205689807	G/T	cg11965913	chr1:205819406	PM20D1	-0.78	-7.01	-0.62	7.38e-10	Menarche (age at onset);
SKCM	cis	rs244731	0.959	rs7724098	chr5:176659570	G/A	cg06060754	chr5:176797920	RGS14	-0.8	-7.11	-0.63	4.94e-10	Urate levels in lean individuals;
SKCM	cis	rs2153535	0.580	rs1414344	chr6:8471365	C/A	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs459571	0.959	rs410876	chr9:136893867	C/A	cg13789015	chr9:136890014	NCRNA00094	0.77	6.63	0.6	3.95e-9	Platelet distribution width;
SKCM	cis	rs4234284	1.000	rs5001789	chr3:126974392	C/T	cg04889221	chr3:126137216	CCDC37	-0.48	-4.81	-0.48	7.29e-6	Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel);
SKCM	cis	rs16866061	1.000	rs10498163	chr2:225434445	A/G	cg12698349	chr2:225449008	CUL3	1.01	8.51	0.69	9.75e-13	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs523522	0.924	rs11065150	chr12:120958875	T/G	cg27279351	chr12:120934652	DYNLL1	0.91	8.32	0.69	2.26e-12	High light scatter reticulocyte count;
SKCM	cis	rs4803468	1.000	rs3213861	chr19:41919944	A/C	cg09537434	chr19:41945824	ATP5SL	-1.1	-13.82	-0.84	1.16e-22	Height;
SKCM	cis	rs941408	0.515	rs1640262	chr19:2779134	C/T	cg17333051	chr19:2783644	SGTA	-0.47	-5.11	-0.5	2.21e-6	Total cholesterol levels;
SKCM	cis	rs9796	0.689	rs11855797	chr15:41434679	C/T	cg18705301	chr15:41695430	NDUFAF1	-0.76	-5.34	-0.52	8.78e-7	Menopause (age at onset);
SKCM	cis	rs11105298	0.891	rs10858881	chr12:89891474	T/G	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.9	-5.8	-0.55	1.36e-7	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs7143963	0.666	rs7161606	chr14:103307110	A/C	cg23020514	chr14:103360112	TRAF3	0.77	7.14	0.63	4.31e-10	Body mass index;
SKCM	cis	rs875971	0.756	rs2901210	chr7:66017505	G/A	cg18876405	chr7:65276391	NA	-0.61	-6.03	-0.56	5.23e-8	Aortic root size;
SKCM	cis	rs1218582	0.741	rs705094	chr1:154917314	G/A	cg06221963	chr1:154839813	KCNN3	-0.55	-5.4	-0.52	6.96e-7	Prostate cancer;
SKCM	cis	rs8072100	0.840	rs12453233	chr17:45454570	C/T	cg08085267	chr17:45401833	C17orf57	-0.62	-5.15	-0.5	1.88e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs10808739	0.660	rs9918790	chr8:65628180	T/C	cg05711235	chr8:65498612	NA	-0.81	-5.4	-0.52	7.01e-7	HIV-1 susceptibility;
SKCM	cis	rs875971	0.862	rs6971059	chr7:66067032	A/G	cg18876405	chr7:65276391	NA	-0.63	-6.33	-0.58	1.43e-8	Aortic root size;
SKCM	cis	rs314370	0.904	rs314373	chr7:100456595	G/A	cg10426581	chr7:100472382	SRRT	0.75	6.29	0.58	1.7e-8	Resting heart rate;
SKCM	cis	rs6545883	0.859	rs13004855	chr2:61505072	C/T	cg15711740	chr2:61764176	XPO1	0.75	5.19	0.51	1.6e-6	Tuberculosis;
SKCM	cis	rs12762955	0.507	rs7095853	chr10:1040798	T/C	cg25614935	chr10:1084866	C10orf110	-0.58	-4.85	-0.48	6.19e-6	Response to angiotensin II receptor blocker therapy;
SKCM	cis	rs11098499	0.863	rs13140409	chr4:120503460	A/G	cg09307838	chr4:120376055	NA	1.0	8.27	0.68	2.8e-12	Corneal astigmatism;
SKCM	cis	rs870825	0.616	rs1401358	chr4:185640057	C/T	cg04058563	chr4:185651563	MLF1IP	1.0	6.93	0.62	1.07e-9	Blood protein levels;
SKCM	cis	rs57221529	0.545	rs55955015	chr5:575182	A/G	cg26208419	chr5:473447	SLC9A3;LOC25845	1.05	5.37	0.52	7.95e-7	Lung disease severity in cystic fibrosis;
SKCM	cis	rs2070488	0.965	rs13093640	chr3:38487176	A/G	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.97	8.85	0.71	2.08e-13	Electrocardiographic conduction measures;
SKCM	cis	rs3771570	0.579	rs62190373	chr2:242388685	G/A	cg07612300	chr2:242033426	MTERFD2;SNED1	0.88	4.93	0.49	4.46e-6	Prostate cancer;
SKCM	cis	rs2251381	0.778	rs2245021	chr21:30546841	C/T	cg24692254	chr21:30365293	RNF160	0.78	6.33	0.58	1.46e-8	Selective IgA deficiency;
SKCM	cis	rs2033711	0.905	rs893186	chr19:58969179	C/A	cg13877915	chr19:58951672	ZNF132	0.87	8.53	0.69	8.78e-13	Uric acid clearance;
SKCM	cis	rs4423214	0.840	rs1792227	chr11:71177412	A/G	cg05163923	chr11:71159392	DHCR7	-0.74	-6.65	-0.6	3.61e-9	Vitamin D levels;
SKCM	cis	rs362272	0.505	rs60208975	chr4:3364530	A/G	cg11471262	chr4:3318911	RGS12	0.94	10.86	0.78	2.9e-17	Serum sulfate level;
SKCM	cis	rs6835098	1.000	rs4695826	chr4:174089426	T/G	cg08422745	chr4:174089978	GALNT7	-0.87	-6.8	-0.61	1.91e-9	Dementia and core Alzheimer's disease neuropathologic changes;
SKCM	cis	rs6430585	0.528	rs499483	chr2:136652524	G/A	cg07169764	chr2:136633963	MCM6	1.33	11.27	0.79	4.81e-18	Corneal structure;
SKCM	cis	rs8008758	0.517	rs1772028	chr14:101693861	C/G	cg26224664	chr14:101693935	NA	-0.44	-5.69	-0.54	2.15e-7	Body mass index (alcohol intake interaction);
SKCM	cis	rs9910055	1.000	rs2071167	chr17:42287519	A/G	cg10896456	chr17:42255109	ASB16;C17orf65	-0.55	-5.19	-0.51	1.62e-6	Total body bone mineral density;
SKCM	cis	rs8078723	0.933	rs55846942	chr17:38164470	G/A	cg17467752	chr17:38218738	THRA	0.68	6.3	0.58	1.61e-8	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs1799949	0.965	rs2236762	chr17:41226675	A/T	cg23758822	chr17:41437982	NA	0.93	7.55	0.65	6.9e-11	Menopause (age at onset);
SKCM	cis	rs6500395	0.926	rs1120275	chr16:48598737	T/G	cg04672837	chr16:48644449	N4BP1	0.66	5.28	0.51	1.14e-6	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs1218582	0.741	rs883718	chr1:154846274	C/T	cg09359103	chr1:154839909	KCNN3	-0.57	-5.42	-0.52	6.37e-7	Prostate cancer;
SKCM	cis	rs2832077	0.527	rs2776210	chr21:30268558	A/G	cg24692254	chr21:30365293	RNF160	0.78	6.03	0.56	5.15e-8	Cognitive test performance;
SKCM	cis	rs6500395	1.000	rs871902	chr16:48593779	A/G	cg04672837	chr16:48644449	N4BP1	0.69	5.73	0.54	1.8e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs12142240	0.698	rs41534051	chr1:46828734	A/G	cg10495392	chr1:46806563	NSUN4	0.75	5.75	0.55	1.68e-7	Menopause (age at onset);
SKCM	cis	rs7103648	0.669	rs12577383	chr11:47774238	C/T	cg20307385	chr11:47447363	PSMC3	0.91	7.0	0.62	7.82e-10	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs77216612	0.874	rs11055034	chr12:12890626	C/A	cg04607235	chr12:12878440	APOLD1	-0.89	-6.26	-0.58	1.91e-8	Lymphocyte counts;
SKCM	cis	rs4727027	0.866	rs7778766	chr7:148806729	A/G	cg23583168	chr7:148888333	NA	-0.83	-6.7	-0.6	2.89e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs875971	0.522	rs56028712	chr7:65466565	C/T	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.63	5.49	0.53	4.87e-7	Aortic root size;
SKCM	cis	rs9733	0.818	rs6694531	chr1:150683512	C/A	cg13175981	chr1:150552382	MCL1	0.64	4.86	0.48	5.85e-6	Tonsillectomy;
SKCM	cis	rs514406	0.861	rs4926577	chr1:53226788	C/A	cg16325326	chr1:53192061	ZYG11B	-1.01	-11.9	-0.8	3.23e-19	Monocyte count;
SKCM	cis	rs9911578	0.935	rs304261	chr17:56813782	A/G	cg12560992	chr17:57184187	TRIM37	0.95	7.69	0.66	3.7e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs754466	0.651	rs11818687	chr10:79637709	C/T	cg17075019	chr10:79541650	NA	-0.73	-6.34	-0.58	1.41e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs9916302	0.706	rs6503500	chr17:37485925	C/T	cg07936489	chr17:37558343	FBXL20	-1.01	-6.95	-0.62	9.98e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs6121246	0.559	rs6121172	chr20:30296095	A/C	cg13852791	chr20:30311386	BCL2L1	0.82	5.69	0.54	2.09e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs34779708	0.643	rs4275563	chr10:35545286	G/A	cg03585969	chr10:35415529	CREM	0.71	5.25	0.51	1.27e-6	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs13118159	0.767	rs2141656	chr4:1317192	C/T	cg05025164	chr4:1340916	KIAA1530	0.61	4.83	0.48	6.62e-6	Longevity;
SKCM	cis	rs2235573	0.653	rs6519095	chr22:38431917	G/A	cg03683946	chr22:38051826	SH3BP1	-0.48	-4.84	-0.48	6.32e-6	Glioblastoma;Glioma;
SKCM	cis	rs12971120	0.947	rs7241558	chr18:72169267	A/T	cg26446133	chr18:72167187	CNDP2	-0.67	-5.65	-0.54	2.54e-7	Refractive error;
SKCM	cis	rs62238980	0.614	rs17683471	chr22:32487815	C/G	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs6952808	0.717	rs6967442	chr7:1926090	A/G	cg04267008	chr7:1944627	MAD1L1	-0.68	-5.44	-0.52	5.99e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs11098499	0.863	rs1010739	chr4:120463471	C/T	cg09307838	chr4:120376055	NA	1.04	8.77	0.7	2.98e-13	Corneal astigmatism;
SKCM	cis	rs6500395	0.775	rs28481630	chr16:48663664	G/C	cg04672837	chr16:48644449	N4BP1	0.6	4.91	0.49	4.99e-6	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs1165205	0.558	rs793144	chr6:25879321	C/T	cg12310025	chr6:25882481	NA	-0.67	-6.91	-0.62	1.18e-9	Urate levels;
SKCM	cis	rs116095464	0.558	rs7736600	chr5:231337	A/C	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs2404602	0.583	rs12913096	chr15:76551852	C/T	cg23625390	chr15:77176239	SCAPER	0.69	6.31	0.58	1.57e-8	Blood metabolite levels;
SKCM	cis	rs8177253	0.829	rs6794945	chr3:133518463	A/G	cg16414030	chr3:133502952	NA	0.7	5.53	0.53	4.06e-7	Iron status biomarkers;
SKCM	cis	rs7937682	0.632	rs3944619	chr11:111774743	A/G	cg09085632	chr11:111637200	PPP2R1B	1.1	10.72	0.77	5.29e-17	Primary sclerosing cholangitis;
SKCM	cis	rs801193	1.000	rs62466793	chr7:66191517	G/A	cg00343986	chr7:65444356	GUSB	0.7	5.19	0.51	1.63e-6	Aortic root size;
SKCM	cis	rs7666738	0.830	rs1967977	chr4:98966141	A/G	cg05340658	chr4:99064831	C4orf37	0.64	4.91	0.49	4.97e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs919433	1.000	rs2889363	chr2:198163699	A/G	cg04278110	chr2:198063759	ANKRD44	-0.72	-5.33	-0.52	9.25e-7	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs362296	0.590	rs4690081	chr4:3262105	T/G	cg11471262	chr4:3318911	RGS12	-0.79	-7.34	-0.64	1.79e-10	Parental longevity (mother's age at death);
SKCM	cis	rs13040088	1.000	rs2295000	chr20:61536938	A/G	cg23096297	chr20:61557774	DIDO1	-0.79	-6.04	-0.56	4.97e-8	Menopause (age at onset);
SKCM	cis	rs1577917	0.771	rs4441928	chr6:86241894	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.98	10.89	0.78	2.49e-17	Response to antipsychotic treatment;
SKCM	cis	rs7666738	0.753	rs7698541	chr4:98986351	T/A	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs67311347	1.000	rs7617989	chr3:40512463	A/G	cg00091569	chr3:40428383	ENTPD3	-0.61	-4.84	-0.48	6.46e-6	Renal cell carcinoma;
SKCM	cis	rs9818758	0.607	rs34566463	chr3:49245077	T/C	cg24110177	chr3:50126178	RBM5	0.84	5.0	0.49	3.47e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs17065868	1.000	rs9525991	chr13:45183869	T/C	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs992157	0.835	rs12987180	chr2:219144089	G/A	cg00012203	chr2:219082015	ARPC2	-0.74	-5.97	-0.56	6.53e-8	Colorectal cancer;
SKCM	cis	rs7590720	1.000	rs4674051	chr2:216907512	G/C	cg12620499	chr2:216877984	MREG	0.9	7.66	0.66	4.32e-11	Alcohol dependence;
SKCM	cis	rs11098499	0.657	rs4463052	chr4:120313258	T/C	cg09307838	chr4:120376055	NA	0.97	7.49	0.65	9.08e-11	Corneal astigmatism;
SKCM	cis	rs3820928	0.810	rs10175929	chr2:227858609	T/C	cg11843606	chr2:227700838	RHBDD1	-0.61	-4.89	-0.48	5.28e-6	Pulmonary function;
SKCM	cis	rs1577917	0.696	rs2842617	chr6:86309698	C/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.9	-8.96	-0.71	1.27e-13	Response to antipsychotic treatment;
SKCM	cis	rs7811142	0.830	rs6965458	chr7:99973402	G/A	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.2	7.87	0.67	1.7e-11	Platelet count;
SKCM	cis	rs4150161	0.591	rs3759977	chr16:84221170	T/A	cg10106505	chr16:84220380	TAF1C	-1.34	-5.38	-0.52	7.55e-7	Systolic blood pressure response to hydrochlorothiazide in hypertension;
SKCM	cis	rs875971	0.723	rs28391294	chr7:65654315	T/C	cg11764359	chr7:65958608	NA	-0.8	-7.7	-0.66	3.63e-11	Aortic root size;
SKCM	cis	rs992157	1.000	rs6736362	chr2:219115108	C/T	cg20019365	chr2:219134978	PNKD;AAMP	0.81	7.43	0.64	1.21e-10	Colorectal cancer;
SKCM	cis	rs10028773	0.700	rs7690338	chr4:120256468	C/G	cg09307838	chr4:120376055	NA	0.93	7.53	0.65	7.72e-11	Educational attainment;
SKCM	cis	rs7647973	0.769	rs6772452	chr3:49040462	A/G	cg07636037	chr3:49044803	WDR6	0.97	7.33	0.64	1.85e-10	Menarche (age at onset);
SKCM	cis	rs561341	1.000	rs555629	chr17:30294136	T/C	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs561341	1.000	rs72825712	chr17:30316119	A/T	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs6951245	1.000	rs111899361	chr7:1112348	C/T	cg24642844	chr7:1081250	C7orf50	-0.93	-6.22	-0.58	2.28e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs28386778	1.000	rs2665851	chr17:61957023	T/C	cg22520471	chr17:61851767	DDX42;CCDC47	0.79	5.32	0.52	9.46e-7	Prudent dietary pattern;
SKCM	cis	rs6952808	0.531	rs3778991	chr7:2172455	G/A	cg21782813	chr7:2030301	MAD1L1	0.52	5.36	0.52	8.21e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs936229	0.654	rs762551	chr15:75041917	C/A	cg14664628	chr15:75095509	CSK	-1.12	-9.18	-0.72	4.89e-14	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin);
SKCM	cis	rs13108904	0.935	rs1680072	chr4:1281695	T/G	cg05025164	chr4:1340916	KIAA1530	-0.6	-4.82	-0.48	6.9e-6	Obesity-related traits;
SKCM	cis	rs77106637	0.929	rs74333814	chr11:72457487	C/T	cg03713592	chr11:72463424	ARAP1	1.09	5.63	0.54	2.71e-7	Type 2 diabetes;
SKCM	cis	rs992157	1.000	rs992157	chr2:219154781	A/G	cg20019365	chr2:219134978	PNKD;AAMP	-0.72	-6.45	-0.59	8.53e-9	Colorectal cancer;
SKCM	cis	rs1577917	1.000	rs955227	chr6:86651032	C/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.85	-8.62	-0.7	5.82e-13	Response to antipsychotic treatment;
SKCM	cis	rs9914544	1.000	rs1037036	chr17:18764077	C/T	cg26378065	chr17:18585709	ZNF286B	0.73	5.1	0.5	2.3e-6	Educational attainment (years of education);
SKCM	cis	rs611744	0.647	rs647907	chr8:109251374	T/C	cg18478394	chr8:109455254	TTC35	0.66	5.33	0.52	9.43e-7	Dupuytren's disease;
SKCM	cis	rs1801516	1.000	rs7103222	chr11:108309239	C/T	cg03165700	chr11:108093220	ATM;NPAT	-1.11	-5.06	-0.5	2.68e-6	Melanoma;
SKCM	trans	rs3780486	0.846	rs3824458	chr9:33144809	C/T	cg20290983	chr6:43655470	MRPS18A	0.96	11.17	0.78	7.53e-18	IgG glycosylation;
SKCM	cis	rs12438659	1	rs12438659	chr15:78824924	G/A	cg24631222	chr15:78858424	CHRNA5	0.95	6.6	0.6	4.46e-9	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs17376456	0.542	rs10476588	chr5:93208330	C/T	cg25358565	chr5:93447407	FAM172A	-0.88	-5.29	-0.51	1.07e-6	Diabetic retinopathy;
SKCM	cis	rs995000	0.931	rs1168036	chr1:62962734	A/G	cg06896770	chr1:63153194	DOCK7	-0.74	-6.81	-0.61	1.77e-9	Triglyceride levels;
SKCM	cis	rs2204008	0.560	rs1315354	chr12:38165716	A/G	cg26384229	chr12:38710491	ALG10B	-0.67	-5.47	-0.53	5.23e-7	Bladder cancer;
SKCM	cis	rs12120353	0.702	rs780612	chr1:4551471	C/A	cg15022359	chr1:4193126	NA	-0.6	-5.21	-0.51	1.47e-6	Anxiety disorder;
SKCM	cis	rs2721195	0.967	rs10108150	chr8:145687475	A/G	cg17328964	chr8:145687451	CYHR1	0.68	5.77	0.55	1.54e-7	Age at first birth;
SKCM	cis	rs8077889	0.917	rs72836559	chr17:41913529	C/T	cg26893861	chr17:41843967	DUSP3	1.15	7.34	0.64	1.79e-10	Triglycerides;
SKCM	cis	rs4332037	0.586	rs62442944	chr7:2015047	T/G	cg23422044	chr7:1970798	MAD1L1	-0.88	-5.57	-0.53	3.53e-7	Bipolar disorder;
SKCM	cis	rs875971	0.862	rs7803416	chr7:65954199	A/G	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	cis	rs8077889	0.672	rs1234612	chr17:41840802	A/G	cg26893861	chr17:41843967	DUSP3	1.4	11.94	0.8	2.7e-19	Triglycerides;
SKCM	cis	rs801193	0.569	rs2659907	chr7:66164032	G/A	cg18876405	chr7:65276391	NA	0.63	6.16	0.57	2.98e-8	Aortic root size;
SKCM	cis	rs55962025	0.883	rs3121419	chr4:3232257	C/T	cg09735869	chr4:3319127	RGS12	-0.73	-5.58	-0.53	3.31e-7	Parental longevity (mother's age at death);
SKCM	cis	rs951366	0.844	rs823096	chr1:205679887	G/T	cg11965913	chr1:205819406	PM20D1	0.92	8.46	0.69	1.2e-12	Menarche (age at onset);
SKCM	cis	rs17213078	0.602	rs4851113	chr2:106747009	G/C	cg15412446	chr2:106886593	NA	0.66	5.71	0.54	1.94e-7	Facial morphology (factor 23);
SKCM	cis	rs9660180	1.000	rs9660180	chr1:1723031	G/A	cg23982607	chr1:1823379	GNB1	-0.7	-6.09	-0.57	3.92e-8	Body mass index;
SKCM	cis	rs2836974	0.627	rs7278985	chr21:40653767	C/T	cg11890956	chr21:40555474	PSMG1	-0.88	-9.14	-0.72	5.76e-14	Cognitive function;
SKCM	cis	rs9814567	1.000	rs9289471	chr3:134230811	A/G	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.62	-5.13	-0.5	2.1e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs7954584	0.567	rs10840632	chr12:122375460	C/T	cg13699009	chr12:122356056	WDR66	0.58	7.6	0.65	5.58e-11	Mean corpuscular volume;
SKCM	cis	rs116095464	0.558	rs62346526	chr5:220614	T/C	cg22857025	chr5:266934	NA	-1.36	-8.0	-0.67	9.23e-12	Breast cancer;
SKCM	cis	rs6933660	0.800	rs6930557	chr6:151755806	G/A	cg14416726	chr6:151773293	C6orf211;RMND1	-0.61	-4.78	-0.48	8.04e-6	Menarche (age at onset);
SKCM	cis	rs2268241	0.938	rs28653198	chr21:34782395	A/C	cg14850771	chr21:34775459	IFNGR2	1.09	6.8	0.61	1.9e-9	Obesity-related traits;
SKCM	cis	rs6500395	1.000	rs1115758	chr16:48599609	T/C	cg04672837	chr16:48644449	N4BP1	0.69	5.73	0.54	1.8e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs9910055	0.762	rs2526021	chr17:42213347	G/A	cg13607699	chr17:42295918	UBTF	0.79	6.21	0.58	2.4e-8	Total body bone mineral density;
SKCM	cis	rs36093844	0.626	rs72959197	chr11:85710996	T/C	cg25872744	chr11:85566296	CCDC83	-0.81	-4.79	-0.48	7.84e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs7633857	0.532	rs9839984	chr3:160768912	C/T	cg03342759	chr3:160939853	NMD3	-0.66	-5.12	-0.5	2.16e-6	Educational attainment (years of education);
SKCM	cis	rs189798	0.807	rs9949	chr8:8994512	A/G	cg06636001	chr8:8085503	FLJ10661	0.77	5.33	0.52	9.19e-7	Myopia (pathological);
SKCM	cis	rs17711722	0.701	rs781145	chr7:65440370	A/C	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.63	5.48	0.53	5.11e-7	Calcium levels;
SKCM	cis	rs12142240	0.698	rs17357759	chr1:46832534	A/G	cg14993813	chr1:46806288	NSUN4	-0.7	-4.94	-0.49	4.35e-6	Menopause (age at onset);
SKCM	cis	rs6840360	0.571	rs17360371	chr4:152565374	C/T	cg22705602	chr4:152727874	NA	-0.5	-5.45	-0.52	5.81e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs6933660	0.800	rs6930557	chr6:151755806	G/A	cg10883421	chr6:151773342	RMND1;C6orf211	0.82	6.87	0.61	1.38e-9	Menarche (age at onset);
SKCM	cis	rs11098499	0.615	rs28551750	chr4:120264901	C/T	cg09307838	chr4:120376055	NA	0.98	8.58	0.7	6.96e-13	Corneal astigmatism;
SKCM	cis	rs9911578	0.785	rs10853008	chr17:56993407	T/C	cg12560992	chr17:57184187	TRIM37	-0.82	-5.85	-0.55	1.09e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs6951245	0.580	rs78894484	chr7:1138721	T/G	cg03188948	chr7:1209495	NA	0.83	5.87	0.55	1.01e-7	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs9322193	0.567	rs7747457	chr6:150213502	T/A	cg05036130	chr6:150231994	NA	0.61	6.58	0.6	4.87e-9	Lung cancer;
SKCM	cis	rs7511006	0.893	rs760743	chr22:50647375	C/T	cg16473166	chr22:50639996	SELO	0.66	5.34	0.52	8.74e-7	Obesity-related traits;
SKCM	cis	rs2921073	0.510	rs2976944	chr8:8270914	T/C	cg15556689	chr8:8085844	FLJ10661	0.66	5.64	0.54	2.66e-7	Parkinson's disease;
SKCM	cis	rs28595532	0.920	rs115242199	chr4:119728652	A/C	cg14228332	chr4:119757509	SEC24D	1.08	5.52	0.53	4.28e-7	Cannabis dependence symptom count;
SKCM	cis	rs2749592	0.550	rs9733309	chr10:37882405	G/A	cg25427524	chr10:38739819	LOC399744	0.58	5.3	0.51	1.04e-6	Age-related hearing impairment (SNP x SNP interaction);
SKCM	cis	rs1692580	0.846	rs377599	chr1:2164699	C/T	cg21442419	chr1:2182373	SKI	-0.69	-6.96	-0.62	9.57e-10	Coronary artery disease;
SKCM	cis	rs873946	0.504	rs12775990	chr10:134575836	C/T	cg18305652	chr10:134549665	INPP5A	0.61	5.72	0.54	1.88e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs6570726	0.526	rs4896805	chr6:145735429	C/A	cg23711669	chr6:146136114	FBXO30	-0.65	-6.2	-0.57	2.54e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6430585	0.528	rs309122	chr2:136761853	A/G	cg07169764	chr2:136633963	MCM6	1.26	10.97	0.78	1.76e-17	Corneal structure;
SKCM	cis	rs10504073	0.647	rs62507252	chr8:50028795	C/G	cg00325661	chr8:49890786	NA	0.79	6.76	0.61	2.29e-9	Blood metabolite ratios;
SKCM	cis	rs55962025	0.842	rs362306	chr4:3242100	C/T	cg05297308	chr4:3317976	RGS12	-0.7	-5.16	-0.5	1.8e-6	Parental longevity (mother's age at death);
SKCM	cis	rs7659604	0.676	rs4516739	chr4:122699741	G/T	cg19748678	chr4:122722346	EXOSC9	0.67	5.55	0.53	3.82e-7	Type 2 diabetes;
SKCM	cis	rs4423214	0.959	rs11233747	chr11:71171642	G/A	cg05163923	chr11:71159392	DHCR7	0.83	8.11	0.68	5.77e-12	Vitamin D levels;
SKCM	cis	rs7666738	0.830	rs7687958	chr4:99014495	T/C	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6754311	0.731	rs1470457	chr2:136581848	A/G	cg07169764	chr2:136633963	MCM6	0.86	6.46	0.59	8.2e-9	Mosquito bite size;
SKCM	cis	rs2836974	0.544	rs8128919	chr21:40711862	C/T	cg11890956	chr21:40555474	PSMG1	0.74	5.9	0.56	8.8e-8	Cognitive function;
SKCM	cis	rs763014	0.931	rs7199839	chr16:636126	T/C	cg00908189	chr16:619842	PIGQ	0.82	7.78	0.66	2.55e-11	Height;
SKCM	cis	rs67311347	0.713	rs114569261	chr3:40314580	G/A	cg00091569	chr3:40428383	ENTPD3	0.64	5.46	0.53	5.4e-7	Renal cell carcinoma;
SKCM	cis	rs28595532	0.920	rs114080496	chr4:119726372	C/T	cg14228332	chr4:119757509	SEC24D	1.07	5.49	0.53	4.77e-7	Cannabis dependence symptom count;
SKCM	cis	rs4972806	0.849	rs2857541	chr2:177029086	C/T	cg13092806	chr2:177043255	NA	0.58	5.39	0.52	7.25e-7	IgG glycosylation;
SKCM	cis	rs13118159	0.550	rs10016557	chr4:1363628	C/T	cg05025164	chr4:1340916	KIAA1530	-0.84	-6.78	-0.61	2.1e-9	Longevity;
SKCM	cis	rs3096299	0.967	rs2965830	chr16:89460290	T/C	cg02187348	chr16:89574699	SPG7	0.63	5.04	0.5	2.93e-6	Multiple myeloma (IgH translocation);
SKCM	cis	rs2180341	0.618	rs11961994	chr6:127649350	A/G	cg27446573	chr6:127587934	RNF146	-0.7	-5.64	-0.54	2.65e-7	Breast cancer;
SKCM	cis	rs62238980	0.614	rs976916	chr22:32428558	G/A	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs60871478	0.588	rs6952577	chr7:872100	C/T	cg05535760	chr7:792225	HEATR2	1.27	7.52	0.65	7.81e-11	Cerebrospinal P-tau181p levels;
SKCM	cis	rs727563	0.638	rs4820443	chr22:42193913	A/G	cg03806693	chr22:41940476	POLR3H	-1.05	-7.08	-0.63	5.54e-10	Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs911263	0.961	rs8008961	chr14:68752643	A/G	cg18825221	chr14:68749962	RAD51L1	0.55	5.77	0.55	1.56e-7	Primary biliary cholangitis;
SKCM	cis	rs28386778	0.591	rs2584619	chr17:61913215	T/A	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs9611565	0.765	rs132908	chr22:41801795	G/A	cg03806693	chr22:41940476	POLR3H	1.02	6.92	0.62	1.13e-9	Vitiligo;
SKCM	cis	rs561341	0.714	rs75861674	chr17:30304317	A/G	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.76	-0.66	2.72e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs2204008	0.774	rs7959048	chr12:37948276	T/A	cg26384229	chr12:38710491	ALG10B	0.81	6.59	0.6	4.69e-9	Bladder cancer;
SKCM	cis	rs1218582	0.772	rs4240875	chr1:154885782	G/A	cg24250549	chr1:154909240	PMVK	0.87	8.7	0.7	4.13e-13	Prostate cancer;
SKCM	cis	rs28386778	0.897	rs8073515	chr17:61795328	A/C	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.36	0.52	8.08e-7	Prudent dietary pattern;
SKCM	cis	rs4803468	1.000	rs3816037	chr19:41918009	C/T	cg14132834	chr19:41945861	ATP5SL	-0.77	-6.08	-0.57	4.18e-8	Height;
SKCM	cis	rs6942756	0.876	rs57263220	chr7:129010858	C/A	cg02491457	chr7:128862824	NA	-0.79	-4.92	-0.49	4.8e-6	White matter hyperintensity burden;
SKCM	cis	rs951366	0.617	rs823074	chr1:205774839	T/C	cg24503407	chr1:205819492	PM20D1	0.98	10.86	0.78	2.94e-17	Menarche (age at onset);
SKCM	cis	rs6121246	0.609	rs6060983	chr20:30420924	T/C	cg13852791	chr20:30311386	BCL2L1	0.87	6.0	0.56	5.94e-8	Mean corpuscular hemoglobin;
SKCM	cis	rs7937682	0.632	rs1045282	chr11:111754574	A/C	cg09085632	chr11:111637200	PPP2R1B	1.07	9.99	0.75	1.34e-15	Primary sclerosing cholangitis;
SKCM	cis	rs362272	0.525	rs910568	chr4:3307373	A/G	cg11471262	chr4:3318911	RGS12	0.95	10.82	0.77	3.44e-17	Serum sulfate level;
SKCM	cis	rs10751667	0.666	rs7944815	chr11:959776	C/T	cg10932868	chr11:921992	NA	0.55	5.1	0.5	2.36e-6	Alzheimer's disease (late onset);
SKCM	cis	rs9788682	1.000	rs2036534	chr15:78826948	T/C	cg24631222	chr15:78858424	CHRNA5	0.95	6.6	0.6	4.46e-9	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs17345786	0.954	rs17508319	chr3:101318903	G/A	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.71	5.07	0.5	2.61e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs67311347	0.544	rs7644181	chr3:40355665	A/G	cg13409248	chr3:40428643	ENTPD3	-0.55	-4.97	-0.49	3.85e-6	Renal cell carcinoma;
SKCM	cis	rs9399137	0.507	rs4896128	chr6:135349756	A/G	cg24558204	chr6:135376177	HBS1L	-0.67	-6.06	-0.57	4.59e-8	Glycated hemoglobin levels;Mean corpuscular volume;Hematology traits;HbA2 levels;Mean corpuscular hemoglobin;Hemoglobin levels;F-cell distribution;Platelet count;
SKCM	cis	rs394563	0.589	rs1900300	chr6:149641627	T/C	cg03678062	chr6:149772716	ZC3H12D	0.53	6.27	0.58	1.88e-8	Dupuytren's disease;
SKCM	cis	rs5750830	0.594	rs6001587	chr22:39819008	T/C	cg11247378	chr22:39784982	NA	-0.47	-5.43	-0.52	6.23e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs4819052	0.851	rs1999333	chr21:46670401	C/G	cg02159808	chr21:46707872	POFUT2;LOC642852	0.69	5.25	0.51	1.29e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs35306767	0.671	rs11253473	chr10:906826	A/G	cg25614935	chr10:1084866	C10orf110	0.83	5.45	0.53	5.64e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs11098499	0.821	rs10032151	chr4:120391628	C/T	cg09307838	chr4:120376055	NA	0.97	7.49	0.65	9.08e-11	Corneal astigmatism;
SKCM	cis	rs6952808	0.582	rs10479762	chr7:2045351	T/C	cg02951883	chr7:2050386	MAD1L1	0.8	7.12	0.63	4.63e-10	Bipolar disorder and schizophrenia;
SKCM	trans	rs1814175	0.645	rs1963215	chr11:49931486	G/A	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs116095464	0.558	rs28635197	chr5:279071	T/C	cg22857025	chr5:266934	NA	-1.47	-8.33	-0.69	2.16e-12	Breast cancer;
SKCM	cis	rs9926296	0.605	rs12448860	chr16:89849629	T/A	cg27121462	chr16:89883253	FANCA	0.84	7.64	0.65	4.76e-11	Vitiligo;
SKCM	trans	rs1814175	0.817	rs1621090	chr11:49895868	C/A	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs5750830	0.621	rs5757665	chr22:39821641	A/G	cg24399712	chr22:39784796	NA	-0.6	-5.01	-0.49	3.31e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2760061	0.626	rs591582	chr1:228117360	C/A	cg18477163	chr1:228402036	OBSCN	-0.46	-5.1	-0.5	2.36e-6	Diastolic blood pressure;
SKCM	cis	rs2243480	1.000	rs451396	chr7:65484074	T/A	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs6840360	0.809	rs6847303	chr4:152730221	G/A	cg22705602	chr4:152727874	NA	0.43	4.89	0.48	5.2e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2859741	0.546	rs10489413	chr1:37513906	C/T	cg09363841	chr1:37513479	NA	-0.54	-5.01	-0.49	3.26e-6	Forced expiratory volume in 1 second (environmental tobacco smoke interaction);
SKCM	cis	rs4481887	0.830	rs4474289	chr1:248474972	T/A	cg00666640	chr1:248458726	OR2T12	0.63	5.91	0.56	8.65e-8	Common traits (Other);
SKCM	cis	rs6580649	0.943	rs3803183	chr12:48398080	T/A	cg05342945	chr12:48394962	COL2A1	-0.76	-5.48	-0.53	5.05e-7	Lung cancer;
SKCM	cis	rs7824557	0.606	rs2736264	chr8:11186639	G/C	cg21775007	chr8:11205619	TDH	0.65	5.6	0.54	3.02e-7	Retinal vascular caliber;
SKCM	cis	rs3087591	0.922	rs2905806	chr17:29502507	A/G	cg24425628	chr17:29625626	OMG;NF1	0.61	4.87	0.48	5.75e-6	Hip circumference;
SKCM	cis	rs10504229	0.906	rs113857287	chr8:58191683	T/C	cg22535103	chr8:58192502	C8orf71	-0.75	-5.24	-0.51	1.31e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs8060686	0.641	rs57408712	chr16:68242573	G/C	cg09117114	chr16:67998030	SLC12A4	-0.77	-5.03	-0.49	3.12e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs10751667	0.666	rs10902235	chr11:938892	T/C	cg10932868	chr11:921992	NA	0.54	5.05	0.5	2.81e-6	Alzheimer's disease (late onset);
SKCM	cis	rs473651	0.901	rs563282	chr2:239329736	T/C	cg21699342	chr2:239360505	ASB1	0.52	4.95	0.49	4.21e-6	Multiple system atrophy;
SKCM	cis	rs4727027	0.804	rs13231262	chr7:148886058	C/T	cg23583168	chr7:148888333	NA	-0.78	-6.4	-0.59	1.06e-8	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs7618915	0.547	rs62253700	chr3:52625019	T/A	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	trans	rs561341	1.000	rs2470267	chr17:30274132	G/A	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs2072499	0.966	rs2853646	chr1:156189626	C/T	cg25208724	chr1:156163844	SLC25A44	1.04	8.81	0.71	2.51e-13	Testicular germ cell tumor;
SKCM	cis	rs1799949	1.000	rs4793236	chr17:41436440	T/C	cg23758822	chr17:41437982	NA	0.97	7.84	0.66	1.96e-11	Menopause (age at onset);
SKCM	cis	rs9814567	0.964	rs10935113	chr3:134173091	T/C	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.7	-5.81	-0.55	1.31e-7	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs11155671	0.530	rs1334510	chr6:150201179	A/G	cg05036130	chr6:150231994	NA	0.53	5.59	0.53	3.28e-7	Testicular germ cell tumor;
SKCM	cis	rs8180040	0.966	rs60369822	chr3:47479735	A/C	cg16586182	chr3:47516702	SCAP	0.76	5.32	0.52	9.63e-7	Colorectal cancer;
SKCM	cis	rs8060686	0.516	rs7194894	chr16:68145062	C/T	cg09117114	chr16:67998030	SLC12A4	-0.81	-5.29	-0.51	1.07e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs35306767	0.903	rs11253493	chr10:936931	T/C	cg26597838	chr10:835615	NA	0.78	5.08	0.5	2.51e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs908922	0.676	rs4112785	chr1:152533115	G/C	cg09873164	chr1:152488093	CRCT1	0.72	5.62	0.54	2.85e-7	Hair morphology;
SKCM	cis	rs4481887	0.741	rs4360554	chr1:248553206	C/T	cg00666640	chr1:248458726	OR2T12	0.51	5.21	0.51	1.47e-6	Common traits (Other);
SKCM	cis	rs7772486	0.875	rs7767660	chr6:146436550	T/C	cg05347473	chr6:146136440	FBXO30	0.56	5.24	0.51	1.35e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs611744	0.647	rs631775	chr8:109252746	T/C	cg18478394	chr8:109455254	TTC35	0.66	5.33	0.52	9.43e-7	Dupuytren's disease;
SKCM	cis	rs709400	1.000	rs3915733	chr14:104147353	G/A	cg26031613	chr14:104095156	KLC1	1.05	12.89	0.82	5.14e-21	Body mass index;
SKCM	cis	rs28386778	0.863	rs6919	chr17:61909485	A/T	cg01411255	chr17:61851458	DDX42;CCDC47	-0.78	-5.01	-0.49	3.26e-6	Prudent dietary pattern;
SKCM	cis	rs7932354	0.528	rs7125807	chr11:47041163	G/T	cg03339077	chr11:47165057	C11orf49	0.58	4.81	0.48	7.17e-6	Bone mineral density (hip);Bone mineral density;
SKCM	cis	rs10193935	1.000	rs58962161	chr2:42400278	T/A	cg27598129	chr2:42591480	NA	-0.92	-6.79	-0.61	1.97e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs8180040	0.966	rs57346147	chr3:47410564	C/G	cg27129171	chr3:47204927	SETD2	-0.8	-5.93	-0.56	7.96e-8	Colorectal cancer;
SKCM	cis	rs929354	0.709	rs1182363	chr7:157019151	A/G	cg17757837	chr7:157058334	UBE3C	-0.81	-5.67	-0.54	2.3e-7	Body mass index;
SKCM	cis	rs10256972	0.591	rs11766651	chr7:1161646	A/G	cg16145915	chr7:1198662	ZFAND2A	-0.56	-7.48	-0.65	9.43e-11	Longevity;Endometriosis;
SKCM	cis	rs1577917	1.000	rs34581302	chr6:86705948	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.64	-5.54	-0.53	3.92e-7	Response to antipsychotic treatment;
SKCM	cis	rs2749592	0.550	rs7917262	chr10:37874602	A/C	cg25427524	chr10:38739819	LOC399744	0.56	5.12	0.5	2.12e-6	Age-related hearing impairment (SNP x SNP interaction);
SKCM	cis	rs2842992	0.830	rs2758352	chr6:160122921	A/G	cg11366901	chr6:160182831	ACAT2	0.86	6.69	0.6	3.06e-9	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs9399137	0.507	rs6940258	chr6:135366132	C/T	cg24558204	chr6:135376177	HBS1L	0.66	5.84	0.55	1.15e-7	Glycated hemoglobin levels;Mean corpuscular volume;Hematology traits;HbA2 levels;Mean corpuscular hemoglobin;Hemoglobin levels;F-cell distribution;Platelet count;
SKCM	cis	rs17685	0.672	rs1639618	chr7:75701987	T/C	cg16684958	chr7:75615977	POR	0.57	5.54	0.53	4e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs875971	0.862	rs7798630	chr7:65771479	G/C	cg18876405	chr7:65276391	NA	-0.64	-6.43	-0.59	9.24e-9	Aortic root size;
SKCM	cis	rs7618915	0.570	rs4687633	chr3:52630548	G/A	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs9325144	0.723	rs11169519	chr12:39177441	G/A	cg26384229	chr12:38710491	ALG10B	-0.7	-6.42	-0.59	9.71e-9	Morning vs. evening chronotype;
SKCM	cis	rs67460515	0.596	rs35127376	chr3:160927289	T/C	cg03342759	chr3:160939853	NMD3	-0.72	-6.14	-0.57	3.19e-8	Parkinson's disease;
SKCM	cis	rs6545883	0.794	rs778152	chr2:61608540	C/A	cg15711740	chr2:61764176	XPO1	0.68	4.82	0.48	6.94e-6	Tuberculosis;
SKCM	cis	rs7772486	0.875	rs7761033	chr6:146356106	C/T	cg23711669	chr6:146136114	FBXO30	0.77	7.48	0.65	9.65e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs763121	0.853	rs4820345	chr22:39091151	T/C	cg06022373	chr22:39101656	GTPBP1	0.78	5.59	0.53	3.27e-7	Menopause (age at onset);
SKCM	cis	rs9916302	0.904	rs755500	chr17:37409865	C/T	cg07936489	chr17:37558343	FBXL20	-0.81	-6.87	-0.61	1.4e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs80130819	0.591	rs17122651	chr12:48496660	C/T	cg05342945	chr12:48394962	COL2A1	0.8	5.47	0.53	5.21e-7	Prostate cancer;
SKCM	cis	rs11690935	1.000	rs35549875	chr2:172532392	A/G	cg13550731	chr2:172543902	DYNC1I2	0.95	8.21	0.68	3.64e-12	Schizophrenia;
SKCM	cis	rs1403694	0.515	rs1648699	chr3:186449890	G/C	cg09332604	chr3:186435400	KNG1	-0.56	-5.67	-0.54	2.31e-7	Blood protein levels;
SKCM	cis	rs9611565	0.840	rs3788584	chr22:41779073	T/A	cg03806693	chr22:41940476	POLR3H	-0.86	-5.89	-0.55	9.19e-8	Vitiligo;
SKCM	cis	rs644799	1.000	rs557079	chr11:95530125	C/G	cg25622487	chr11:95524042	FAM76B;CEP57	0.66	5.12	0.5	2.18e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs16854884	1.000	rs13068298	chr3:143772247	T/C	cg06585982	chr3:143692056	C3orf58	0.74	5.69	0.54	2.17e-7	Economic and political preferences (feminism/equality);
SKCM	cis	rs28595532	0.920	rs56302600	chr4:119770162	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs595982	0.702	rs623520	chr19:49369943	A/G	cg19746536	chr19:49375674	PPP1R15A	1.27	15.67	0.87	8.32e-26	Red cell distribution width;
SKCM	cis	rs1801251	1.000	rs3816334	chr2:233708806	A/G	cg08000102	chr2:233561755	GIGYF2	-0.89	-7.22	-0.63	3.02e-10	Coronary artery disease;
SKCM	cis	rs861020	1.000	rs622832	chr1:209974232	A/C	cg05527609	chr1:210001259	C1orf107	1.06	7.54	0.65	7.37e-11	Orofacial clefts;
SKCM	cis	rs6570726	0.764	rs9403733	chr6:145912311	A/C	cg23711669	chr6:146136114	FBXO30	0.88	8.37	0.69	1.84e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4819052	0.851	rs28501512	chr21:46676702	C/T	cg19498844	chr21:46707878	POFUT2;LOC642852	0.88	7.69	0.66	3.74e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs2197308	0.667	rs11181073	chr12:37898543	A/G	cg13010199	chr12:38710504	ALG10B	0.63	4.95	0.49	4.18e-6	Morning vs. evening chronotype;
SKCM	cis	rs7927771	0.826	rs7925389	chr11:47466790	A/T	cg05585544	chr11:47624801	NA	-0.56	-4.79	-0.48	7.65e-6	Subjective well-being;
SKCM	cis	rs4803468	1.000	rs284654	chr19:41928724	G/A	cg09537434	chr19:41945824	ATP5SL	-1.1	-13.85	-0.84	1.02e-22	Height;
SKCM	cis	rs2858942	0.818	rs2685123	chr16:248418	T/C	cg03788090	chr16:233062	NA	-0.6	-4.85	-0.48	6.26e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs4819052	0.851	rs2838837	chr21:46665988	C/T	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.36	0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7666738	0.753	rs10033138	chr4:98981922	A/C	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1799949	0.929	rs12937015	chr17:41307473	A/C	cg05368731	chr17:41323189	NBR1	0.89	7.98	0.67	1.03e-11	Menopause (age at onset);
SKCM	cis	rs9796	0.621	rs58109657	chr15:41471750	A/G	cg18705301	chr15:41695430	NDUFAF1	0.7	5.18	0.51	1.67e-6	Menopause (age at onset);
SKCM	cis	rs9543976	1.000	rs9543976	chr13:76136648	G/A	cg01531495	chr13:76123901	UCHL3	0.94	5.2	0.51	1.54e-6	Diabetic retinopathy;
SKCM	cis	rs12586317	0.547	rs78609489	chr14:35497285	T/C	cg16230307	chr14:35515116	FAM177A1	0.81	5.88	0.55	9.47e-8	Psoriasis;
SKCM	cis	rs1348850	0.645	rs10181259	chr2:178428256	C/A	cg02961200	chr2:178257176	LOC100130691;AGPS	0.79	4.79	0.48	7.79e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs17685	0.753	rs10264760	chr7:75749694	A/G	cg01364799	chr7:75623366	TMEM120A	-0.7	-5.69	-0.54	2.09e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs11155671	0.530	rs7774787	chr6:150209432	G/A	cg05036130	chr6:150231994	NA	0.61	6.58	0.6	4.87e-9	Testicular germ cell tumor;
SKCM	cis	rs9611565	0.918	rs9611562	chr22:41760172	T/G	cg03806693	chr22:41940476	POLR3H	-0.84	-5.67	-0.54	2.28e-7	Vitiligo;
SKCM	cis	rs6582630	0.502	rs1915395	chr12:38420726	A/G	cg13010199	chr12:38710504	ALG10B	0.69	4.89	0.48	5.2e-6	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs137761	0.576	rs1894489	chr22:44094969	A/G	cg12729397	chr22:44208276	EFCAB6	-0.72	-4.96	-0.49	4.03e-6	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs4819052	0.819	rs13046807	chr21:46672286	A/G	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.36	0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs9308433	0.553	rs1048791	chr1:214511519	T/C	cg06198575	chr1:214491504	SMYD2	0.81	5.01	0.49	3.34e-6	IgG glycosylation;
SKCM	cis	rs28595532	0.841	rs114363775	chr4:119765587	G/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs13118159	0.801	rs13147602	chr4:1332175	A/G	cg02018176	chr4:1364513	KIAA1530	0.67	5.5	0.53	4.59e-7	Longevity;
SKCM	cis	rs995000	0.899	rs1168099	chr1:63122859	C/A	cg06896770	chr1:63153194	DOCK7	-0.76	-7.5	-0.65	8.71e-11	Triglyceride levels;
SKCM	cis	rs216303	0.841	rs2239160	chr12:6162754	A/G	cg22867714	chr12:6169044	VWF	-0.98	-5.51	-0.53	4.52e-7	Low vWF levels;
SKCM	cis	rs1348850	0.651	rs4893936	chr2:178240676	C/G	cg02961200	chr2:178257176	LOC100130691;AGPS	0.74	5.1	0.5	2.34e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs8067545	0.611	rs7216599	chr17:20015600	G/C	cg13482628	chr17:19912719	NA	0.66	5.5	0.53	4.72e-7	Schizophrenia;
SKCM	cis	rs7475343	0.501	rs3750572	chr10:5247376	T/C	cg05358397	chr10:5550470	NA	0.83	5.07	0.5	2.61e-6	Intelligence;
SKCM	cis	rs7208859	0.623	rs73269913	chr17:29092183	T/C	cg14067834	chr17:29058358	SUZ12P	1.05	5.25	0.51	1.26e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs514406	0.893	rs1242330	chr1:53396842	T/G	cg16325326	chr1:53192061	ZYG11B	0.89	9.33	0.73	2.51e-14	Monocyte count;
SKCM	cis	rs11681884	0.710	rs3181052	chr2:113886049	C/T	cg09250933	chr2:114035619	PAX8;LOC440839	-0.57	-5.13	-0.5	2.07e-6	Stroke;
SKCM	cis	rs10193935	1.000	rs12622910	chr2:42398918	C/A	cg27598129	chr2:42591480	NA	-0.92	-6.79	-0.61	1.97e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs3008870	1.000	rs2755248	chr1:67492624	A/G	cg08660285	chr1:67390436	MIER1;WDR78	0.95	6.51	0.59	6.68e-9	Lymphocyte percentage of white cells;
SKCM	cis	rs684232	0.602	rs331008	chr17:544617	C/T	cg15660573	chr17:549704	VPS53	-0.76	-6.08	-0.57	4.15e-8	Prostate cancer;
SKCM	cis	rs10504229	0.683	rs72650847	chr8:58136825	C/T	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs929354	0.772	rs10229630	chr7:157004790	C/T	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs1461503	0.966	rs10790547	chr11:122842110	T/A	cg27398637	chr11:122830231	C11orf63	-0.63	-4.8	-0.48	7.54e-6	Menarche (age at onset);
SKCM	cis	rs910316	1.000	rs175436	chr14:75608683	C/G	cg11812906	chr14:75593930	NEK9	-0.73	-5.14	-0.5	2e-6	Height;
SKCM	cis	rs7659604	0.582	rs3217780	chr4:122737278	T/C	cg20573242	chr4:122745356	CCNA2	0.75	6.39	0.59	1.11e-8	Type 2 diabetes;
SKCM	cis	rs271738	0.779	rs823495	chr1:234667247	A/T	cg00123090	chr1:234667087	NA	0.41	4.8	0.48	7.38e-6	Bipolar disorder;
SKCM	cis	rs17376456	0.569	rs2045021	chr5:93224222	G/A	cg21475434	chr5:93447410	FAM172A	-0.82	-4.84	-0.48	6.46e-6	Diabetic retinopathy;
SKCM	cis	rs3785574	0.962	rs2584628	chr17:61894578	T/C	cg06873352	chr17:61820015	STRADA	0.56	4.82	0.48	6.86e-6	Height;
SKCM	cis	rs9329289	0.603	rs2458705	chr10:2541377	A/G	cg15501526	chr10:2543763	NA	0.6	4.84	0.48	6.54e-6	Age-related hearing impairment;
SKCM	cis	rs2204008	0.806	rs11525001	chr12:38234397	A/G	cg13010199	chr12:38710504	ALG10B	0.69	5.21	0.51	1.47e-6	Bladder cancer;
SKCM	cis	rs6696846	0.777	rs2369526	chr1:205054406	C/T	cg00857998	chr1:205179979	DSTYK	0.59	4.83	0.48	6.79e-6	Red blood cell count;
SKCM	trans	rs11722228	0.508	rs2241473	chr4:10085949	G/A	cg26043149	chr18:55253948	FECH	0.93	7.87	0.67	1.66e-11	Gout;Urate levels;Serum uric acid levels;
SKCM	cis	rs1799949	1.000	rs12944430	chr17:41330820	C/G	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.29	-0.58	1.73e-8	Menopause (age at onset);
SKCM	cis	rs854765	0.724	rs2955371	chr17:17967397	G/A	cg24612305	chr17:17875800	TOM1L2;LRRC48	-0.95	-7.82	-0.66	2.08e-11	Total body bone mineral density;
SKCM	cis	rs1256061	0.603	rs1256036	chr14:64743332	C/T	cg21174375	chr14:64681225	SYNE2	0.47	4.95	0.49	4.15e-6	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs12477438	0.798	rs1349779	chr2:99645055	T/C	cg26064155	chr2:99771622	LIPT1;TSGA10	-0.73	-4.91	-0.49	4.97e-6	Chronic sinus infection;
SKCM	cis	rs8072100	0.764	rs2644349	chr17:45641743	G/A	cg25173405	chr17:45401733	C17orf57	0.56	5.06	0.5	2.76e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs769267	0.965	rs2905426	chr19:19478022	G/T	cg26732615	chr19:19648335	CILP2;YJEFN3	-0.68	-7.1	-0.63	5.11e-10	Tonsillectomy;
SKCM	cis	rs9902453	0.904	rs12936302	chr17:28349476	G/A	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.82	-6.4	-0.59	1.06e-8	Coffee consumption (cups per day);
SKCM	cis	rs6570726	0.791	rs6923074	chr6:145893332	T/C	cg05347473	chr6:146136440	FBXO30	0.57	5.08	0.5	2.47e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6545883	0.894	rs2600660	chr2:61549600	G/T	cg15711740	chr2:61764176	XPO1	0.7	4.85	0.48	6.09e-6	Tuberculosis;
SKCM	cis	rs3741404	0.594	rs11231704	chr11:63898182	C/T	cg05555928	chr11:63887634	MACROD1	0.87	6.18	0.57	2.72e-8	Platelet count;
SKCM	cis	rs9303401	0.659	rs62083525	chr17:56658088	A/G	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.27	0.51	1.17e-6	Cognitive test performance;
SKCM	cis	rs1805008	0.608	rs34019730	chr16:89812930	G/A	cg02628002	chr16:89649608	CPNE7	1.12	4.98	0.49	3.69e-6	Skin colour saturation;
SKCM	cis	rs11098499	0.863	rs3822190	chr4:120428098	G/A	cg09307838	chr4:120376055	NA	1.0	7.66	0.66	4.31e-11	Corneal astigmatism;
SKCM	cis	rs9818758	0.607	rs11706052	chr3:49064110	A/G	cg00383909	chr3:49044727	WDR6	1.05	5.85	0.55	1.11e-7	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs9921192	1.000	rs251733	chr16:4321605	A/T	cg00021532	chr16:4324280	TFAP4	0.89	8.22	0.68	3.53e-12	Prostate-specific antigen levels;
SKCM	cis	rs2243480	1.000	rs906134	chr7:65444288	G/C	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs2991971	0.934	rs11580609	chr1:45975856	C/G	cg24296786	chr1:45957014	TESK2	0.69	5.65	0.54	2.47e-7	High light scatter reticulocyte count;
SKCM	cis	rs28595532	0.920	rs115576008	chr4:119736967	T/C	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs8017423	0.630	rs12589687	chr14:90819570	C/G	cg04374321	chr14:90722782	PSMC1	-0.77	-5.94	-0.56	7.46e-8	Mortality in heart failure;
SKCM	cis	rs798766	0.779	rs55895920	chr4:1735930	C/T	cg05874882	chr4:1763078	NA	-0.56	-4.89	-0.48	5.37e-6	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs870825	0.616	rs6552808	chr4:185642865	G/T	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs4820539	0.966	rs2267000	chr22:23455366	A/G	cg14186256	chr22:23484241	RTDR1	0.82	8.12	0.68	5.44e-12	Bone mineral density;
SKCM	cis	rs875971	0.522	rs6960048	chr7:65408039	A/G	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.6	5.14	0.5	2.02e-6	Aortic root size;
SKCM	cis	rs611744	0.647	rs2594358	chr8:109256018	A/G	cg18478394	chr8:109455254	TTC35	0.71	5.65	0.54	2.47e-7	Dupuytren's disease;
SKCM	cis	rs6461049	0.765	rs10224497	chr7:2149967	A/G	cg02951883	chr7:2050386	MAD1L1	-0.79	-7.64	-0.65	4.63e-11	Schizophrenia;
SKCM	cis	rs867186	1.000	rs6060245	chr20:33699625	A/G	cg04194272	chr20:33683537	NA	-1.14	-6.37	-0.58	1.22e-8	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs2832191	0.791	rs2832196	chr21:30497412	G/A	cg08807101	chr21:30365312	RNF160	-0.61	-4.78	-0.48	8.17e-6	Dental caries;
SKCM	cis	rs875971	0.965	rs28682868	chr7:65689809	C/T	cg11764359	chr7:65958608	NA	-0.87	-8.34	-0.69	2.07e-12	Aortic root size;
SKCM	cis	rs6840360	0.615	rs4696095	chr4:152467243	A/G	cg22705602	chr4:152727874	NA	-0.51	-5.78	-0.55	1.45e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs1218582	0.774	rs12036859	chr1:154859940	A/C	cg06221963	chr1:154839813	KCNN3	0.62	6.79	0.61	1.99e-9	Prostate cancer;
SKCM	cis	rs7937682	0.632	rs11214015	chr11:111719417	A/T	cg09085632	chr11:111637200	PPP2R1B	-1.12	-10.44	-0.76	1.8e-16	Primary sclerosing cholangitis;
SKCM	cis	rs684232	0.602	rs2543775	chr17:557123	G/A	cg15660573	chr17:549704	VPS53	-0.76	-6.08	-0.57	4.15e-8	Prostate cancer;
SKCM	cis	rs875971	0.638	rs35986979	chr7:66088990	G/A	cg05627663	chr7:65219948	SNORA22;CCT6P1	-0.56	-4.81	-0.48	7.26e-6	Aortic root size;
SKCM	cis	rs35306767	0.761	rs12770173	chr10:1027108	A/C	cg26597838	chr10:835615	NA	0.76	6.22	0.58	2.29e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs10504229	0.683	rs11774585	chr8:58132685	G/A	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs9858542	1.000	rs9822268	chr3:49719729	G/A	cg03060546	chr3:49711283	APEH	-0.72	-5.37	-0.52	7.79e-7	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs4819052	0.851	rs2236444	chr21:46678226	T/C	cg20896738	chr21:46707857	POFUT2;LOC642852	0.65	4.88	0.48	5.58e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs514406	0.763	rs7535088	chr1:53215042	A/G	cg16325326	chr1:53192061	ZYG11B	-1.01	-11.9	-0.8	3.23e-19	Monocyte count;
SKCM	cis	rs57221529	0.766	rs12522140	chr5:587261	C/A	cg09888920	chr5:474111	LOC25845;SLC9A3	0.99	4.79	0.48	7.91e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs911263	0.961	rs2104047	chr14:68754417	T/C	cg18825221	chr14:68749962	RAD51L1	0.52	5.54	0.53	3.99e-7	Primary biliary cholangitis;
SKCM	cis	rs2842992	0.830	rs1475123	chr6:160178007	A/G	cg11366901	chr6:160182831	ACAT2	0.95	6.98	0.62	8.46e-10	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs28386778	0.897	rs2597634	chr17:61878144	G/A	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs28595532	0.688	rs116566508	chr4:119619195	G/A	cg21605333	chr4:119757512	SEC24D	1.24	7.1	0.63	5.16e-10	Cannabis dependence symptom count;
SKCM	cis	rs28595532	0.748	rs72670248	chr4:119335536	A/C	cg11846333	chr4:119757529	SEC24D	1.19	6.71	0.6	2.81e-9	Cannabis dependence symptom count;
SKCM	cis	rs2228479	0.850	rs117285117	chr16:89910250	T/G	cg06558623	chr16:89946397	TCF25	1.12	4.99	0.49	3.62e-6	Skin colour saturation;
SKCM	cis	rs7809950	0.953	rs2520267	chr7:107187497	T/C	cg23024343	chr7:107201750	COG5	-0.77	-6.95	-0.62	9.61e-10	Coronary artery disease;
SKCM	cis	rs4555082	0.834	rs2816623	chr14:105733295	G/A	cg13114125	chr14:105738426	BRF1	-0.72	-5.59	-0.54	3.16e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs12540874	0.542	rs4947582	chr7:50566090	C/T	cg18232548	chr7:50535776	DDC	-0.71	-5.48	-0.53	5.12e-7	Systemic sclerosis;
SKCM	cis	rs2228479	0.850	rs11649162	chr16:89807131	C/A	cg00800038	chr16:89945340	TCF25	-0.81	-4.79	-0.48	7.84e-6	Skin colour saturation;
SKCM	cis	rs7772486	0.875	rs2814863	chr6:146347299	C/T	cg05347473	chr6:146136440	FBXO30	-0.59	-5.29	-0.51	1.09e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4803468	0.967	rs11670583	chr19:41920440	A/T	cg14132834	chr19:41945861	ATP5SL	-0.77	-6.08	-0.57	4.18e-8	Height;
SKCM	cis	rs9430161	0.611	rs72644044	chr1:11034347	C/G	cg27631724	chr1:11040367	C1orf127	0.52	4.77	0.48	8.41e-6	Ewing sarcoma;
SKCM	cis	rs6977660	0.943	rs10263564	chr7:19842898	G/C	cg05791153	chr7:19748676	TWISTNB	0.79	5.51	0.53	4.42e-7	Thyroid stimulating hormone;
SKCM	cis	rs7178909	0.872	rs2165070	chr15:90408976	C/A	cg19708238	chr15:90437601	AP3S2	0.75	5.31	0.52	1.01e-6	Common traits (Other);
SKCM	cis	rs28595532	1.000	rs17323012	chr4:119605671	A/G	cg21605333	chr4:119757512	SEC24D	1.29	6.27	0.58	1.86e-8	Cannabis dependence symptom count;
SKCM	cis	rs57221529	0.766	rs72706608	chr5:559203	C/T	cg26208419	chr5:473447	SLC9A3;LOC25845	0.96	4.9	0.49	5.03e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs2354432	0.607	rs7537483	chr1:146709877	C/G	cg25205988	chr1:146714368	CHD1L	1.19	6.54	0.59	5.94e-9	Mitochondrial DNA levels;
SKCM	cis	rs344364	0.511	rs2982447	chr16:1947413	C/T	cg26897989	chr16:1907736	C16orf73	0.69	7.13	0.63	4.45e-10	Glomerular filtration rate in chronic kidney disease;
SKCM	cis	rs875971	0.660	rs3857686	chr7:66036191	C/T	cg18876405	chr7:65276391	NA	-0.8	-7.11	-0.63	4.86e-10	Aortic root size;
SKCM	cis	rs17685	0.753	rs1637045	chr7:75703895	T/C	cg16489192	chr7:75678113	MDH2;STYXL1	-0.56	-5.19	-0.51	1.6e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs801193	1.000	rs4717310	chr7:66161007	C/T	cg11764359	chr7:65958608	NA	0.86	6.6	0.6	4.52e-9	Aortic root size;
SKCM	cis	rs7247513	0.892	rs2861407	chr19:12711495	T/C	cg01871581	chr19:12707946	ZNF490	-0.71	-5.06	-0.5	2.77e-6	Bipolar disorder;
SKCM	cis	rs427394	0.802	rs274718	chr5:6720988	G/T	cg10857441	chr5:6722123	POLS	-0.7	-7.36	-0.64	1.6e-10	Menopause (age at onset);
SKCM	cis	rs11585357	0.947	rs11585119	chr1:17605792	C/A	cg08277548	chr1:17600880	PADI3	-0.9	-6.36	-0.58	1.26e-8	Hair shape;
SKCM	cis	rs4523957	0.579	rs903160	chr17:2091765	C/T	cg16513277	chr17:2031491	SMG6	-0.71	-5.08	-0.5	2.47e-6	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs72615157	0.613	rs56089143	chr7:99819844	G/A	cg23667466	chr7:100026434	MEPCE;ZCWPW1	0.91	4.87	0.48	5.74e-6	Lung function (FEV1/FVC);
SKCM	cis	rs2739330	0.760	rs1002286	chr22:24257337	A/G	cg24846343	chr22:24311635	DDTL	-0.61	-5.74	-0.55	1.72e-7	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs4724125	0.782	rs1857759	chr7:42707211	C/T	cg09407816	chr7:42972088	MRPL32;PSMA2	0.8	5.07	0.5	2.66e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs875971	0.660	rs62465434	chr7:66005152	A/C	cg00343986	chr7:65444356	GUSB	0.7	5.14	0.5	1.98e-6	Aortic root size;
SKCM	cis	rs2836974	0.897	rs14194	chr21:40549466	T/C	cg17971929	chr21:40555470	PSMG1	0.87	8.48	0.69	1.1e-12	Cognitive function;
SKCM	cis	rs9911578	0.967	rs6416932	chr17:57148991	G/A	cg05425664	chr17:57184151	TRIM37	-0.84	-7.03	-0.62	6.82e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs6951245	1.000	rs74347384	chr7:1072440	G/A	cg03188948	chr7:1209495	NA	1.12	6.17	0.57	2.88e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs10911232	0.507	rs4652763	chr1:182994084	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.64	0.6	3.83e-9	Hypertriglyceridemia;
SKCM	cis	rs736408	0.812	rs1076425	chr3:52825462	A/G	cg11645453	chr3:52864694	ITIH4	0.58	4.87	0.48	5.71e-6	Bipolar disorder;
SKCM	cis	rs3791556	1.000	rs3791556	chr2:240112972	G/A	cg14530444	chr2:239432329	NA	0.62	4.9	0.49	5.03e-6	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);
SKCM	cis	rs2243480	0.711	rs1626926	chr7:65435792	C/T	cg18252515	chr7:66147081	NA	-1.35	-8.23	-0.68	3.3e-12	Diabetic kidney disease;
SKCM	cis	rs8060686	0.641	rs55790290	chr16:68180242	A/G	cg09117114	chr16:67998030	SLC12A4	-0.76	-4.93	-0.49	4.58e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs1046896	0.627	rs7225515	chr17:80795783	C/T	cg02711726	chr17:80685570	FN3KRP	-0.77	-5.75	-0.55	1.66e-7	Glycated hemoglobin levels;
SKCM	cis	rs10504229	0.683	rs61364624	chr8:58134339	T/A	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs6089584	0.893	rs2281735	chr20:60582540	T/A	cg16423285	chr20:60520624	NA	-0.6	-4.84	-0.48	6.51e-6	Body mass index;
SKCM	cis	rs6445797	0.632	rs9985253	chr3:56629250	G/C	cg13616963	chr3:57583610	ARF4	-0.79	-5.06	-0.5	2.71e-6	Gastritis;
SKCM	cis	rs9790314	1.000	rs336570	chr3:161072054	A/G	cg03342759	chr3:160939853	NMD3	0.72	7.89	0.67	1.53e-11	Morning vs. evening chronotype;
SKCM	cis	rs2777491	1.000	rs316609	chr15:41743828	T/A	cg18705301	chr15:41695430	NDUFAF1	-0.89	-9.04	-0.72	9.17e-14	Ulcerative colitis;
SKCM	cis	rs11105298	0.891	rs10858854	chr12:89835728	C/A	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.88	-6.03	-0.56	5.22e-8	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs875971	1.000	rs6961717	chr7:65587537	C/T	cg11764359	chr7:65958608	NA	-0.86	-8.23	-0.68	3.44e-12	Aortic root size;
SKCM	cis	rs870825	0.698	rs2696046	chr4:185599972	G/A	cg04058563	chr4:185651563	MLF1IP	-1.04	-5.96	-0.56	7.02e-8	Blood protein levels;
SKCM	cis	rs10503709	0.861	rs4739260	chr8:21444742	C/T	cg23716449	chr8:21608280	GFRA2	0.51	5.23	0.51	1.38e-6	Blood protein levels;
SKCM	cis	rs35306767	0.715	rs17293580	chr10:1034895	T/C	cg20503657	chr10:835505	NA	0.75	5.94	0.56	7.41e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs11763147	1	rs11763147	chr7:65326821	C/T	cg11764359	chr7:65958608	NA	-0.87	-6.43	-0.59	9.26e-9	Corneal structure;
SKCM	cis	rs9875589	0.509	rs4685061	chr3:14043823	G/A	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.5	5.15	0.5	1.9e-6	Ovarian reserve;
SKCM	cis	rs6665290	0.904	rs6684821	chr1:227190233	G/A	cg10327440	chr1:227177885	CDC42BPA	-1.24	-16.91	-0.89	8.11e-28	Myeloid white cell count;
SKCM	cis	rs9790314	0.747	rs1610158	chr3:160815050	A/G	cg03342759	chr3:160939853	NMD3	0.61	5.86	0.55	1.07e-7	Morning vs. evening chronotype;
SKCM	cis	rs875971	0.895	rs12531677	chr7:65769086	G/A	cg18876405	chr7:65276391	NA	-0.64	-6.43	-0.59	9.24e-9	Aortic root size;
SKCM	cis	rs11098499	0.780	rs12504773	chr4:120562149	G/C	cg09307838	chr4:120376055	NA	1.0	8.12	0.68	5.39e-12	Corneal astigmatism;
SKCM	cis	rs796364	1.000	rs1658807	chr2:200767512	C/T	cg12253985	chr2:200820533	C2orf60;C2orf47	0.85	5.39	0.52	7.18e-7	Schizophrenia;
SKCM	cis	rs116095464	0.558	rs6878061	chr5:223072	A/G	cg22857025	chr5:266934	NA	-1.36	-8.0	-0.67	9.23e-12	Breast cancer;
SKCM	cis	rs1577917	1.000	rs12216203	chr6:86675301	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.86	-8.61	-0.7	6.29e-13	Response to antipsychotic treatment;
SKCM	cis	rs4803468	0.967	rs4802116	chr19:41905540	C/T	cg14132834	chr19:41945861	ATP5SL	-0.74	-5.71	-0.54	1.99e-7	Height;
SKCM	cis	rs4819052	0.807	rs7283915	chr21:46671288	T/C	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.42	0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs2839186	0.872	rs13052233	chr21:47707284	G/T	cg11766577	chr21:47581405	C21orf56	-0.71	-6.01	-0.56	5.6e-8	Testicular germ cell tumor;
SKCM	cis	rs8141529	0.732	rs2269577	chr22:29196757	G/C	cg02153584	chr22:29168773	CCDC117	0.67	5.41	0.52	6.6e-7	Lymphocyte counts;
SKCM	cis	rs2120019	0.938	rs2304903	chr15:75315778	A/G	cg17294928	chr15:75287854	SCAMP5	-0.89	-8.91	-0.71	1.6e-13	Blood trace element (Zn levels);
SKCM	cis	rs1801251	1.000	rs991873	chr2:233711046	A/G	cg25237894	chr2:233734115	C2orf82	-0.61	-5.9	-0.56	8.76e-8	Coronary artery disease;
SKCM	cis	rs1790761	0.667	rs11227837	chr11:67336424	A/T	cg00290607	chr11:67383545	NA	0.51	5.38	0.52	7.43e-7	Mean corpuscular volume;
SKCM	cis	rs2832191	0.720	rs2832200	chr21:30499165	G/A	cg08807101	chr21:30365312	RNF160	-0.61	-4.78	-0.48	8.17e-6	Dental caries;
SKCM	cis	rs6066825	0.555	rs6019378	chr20:47309716	C/T	cg18078177	chr20:47281410	PREX1	0.64	5.15	0.5	1.9e-6	Colorectal cancer;
SKCM	cis	rs933688	0.818	rs10052492	chr5:90759930	T/A	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.9	6.28	0.58	1.8e-8	Smoking behavior;
SKCM	cis	rs2404602	0.532	rs206205	chr15:76736091	T/G	cg23625390	chr15:77176239	SCAPER	0.66	5.81	0.55	1.29e-7	Blood metabolite levels;
SKCM	cis	rs832540	0.669	rs832539	chr5:56199386	A/C	cg03609598	chr5:56110824	MAP3K1	-0.95	-6.18	-0.57	2.67e-8	Coronary artery disease;
SKCM	cis	rs1707322	0.928	rs61785614	chr1:46446047	A/G	cg03146154	chr1:46216737	IPP	0.79	5.34	0.52	8.73e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs2549003	0.934	rs2549006	chr5:131827065	A/G	cg21138405	chr5:131827807	IRF1	-0.42	-4.95	-0.49	4.25e-6	Asthma (sex interaction);
SKCM	cis	rs6580649	0.943	rs9651993	chr12:48404692	G/A	cg05342945	chr12:48394962	COL2A1	-0.82	-5.86	-0.55	1.06e-7	Lung cancer;
SKCM	cis	rs873946	0.648	rs12766166	chr10:134556403	G/C	cg27286337	chr10:134555280	INPP5A	0.92	8.08	0.68	6.49e-12	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs9420	0.961	rs576859	chr11:57480623	A/C	cg19752551	chr11:57585705	CTNND1	0.69	7.13	0.63	4.4e-10	Schizophrenia;
SKCM	cis	rs7666738	0.830	rs115279324	chr4:99042114	T/C	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs208520	0.779	rs208446	chr6:66903515	T/C	cg07460842	chr6:66804631	NA	-0.91	-6.87	-0.61	1.41e-9	Exhaled nitric oxide output;
SKCM	cis	rs867186	1.000	rs6060222	chr20:33682570	A/C	cg04194272	chr20:33683537	NA	-1.21	-6.8	-0.61	1.89e-9	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs9604529	0.640	rs9525239	chr13:114840960	A/G	cg27119904	chr13:114814333	RASA3	0.4	4.88	0.48	5.45e-6	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs2050392	0.965	rs1543725	chr10:30698873	A/G	cg25182066	chr10:30743637	MAP3K8	-0.66	-5.69	-0.54	2.11e-7	Inflammatory bowel disease;
SKCM	cis	rs870825	0.616	rs2310110	chr4:185647902	G/A	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs2153535	0.541	rs6908504	chr6:8456778	A/G	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs1850744	0.702	rs73802912	chr4:9602497	G/A	cg15442990	chr4:9534313	NA	-1.38	-5.09	-0.5	2.44e-6	Economic and political preferences;
SKCM	cis	rs801193	1.000	rs2659915	chr7:66153101	A/G	cg00343986	chr7:65444356	GUSB	0.71	5.22	0.51	1.46e-6	Aortic root size;
SKCM	cis	rs35306767	0.903	rs17159970	chr10:935601	T/C	cg26597838	chr10:835615	NA	0.77	5.25	0.51	1.27e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs2153535	0.580	rs6920779	chr6:8437624	C/T	cg07606381	chr6:8435919	SLC35B3	0.85	6.26	0.58	1.94e-8	Motion sickness;
SKCM	cis	rs1153858	1.000	rs4271549	chr15:45652730	G/A	cg21132104	chr15:45694354	SPATA5L1	0.93	7.94	0.67	1.22e-11	Homoarginine levels;
SKCM	cis	rs11098499	0.954	rs35063680	chr4:120387102	T/C	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs9818758	0.607	rs9862483	chr3:49195441	G/A	cg00383909	chr3:49044727	WDR6	1.05	5.85	0.55	1.11e-7	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs7666738	0.830	rs1111541	chr4:99033860	A/G	cg17366294	chr4:99064904	C4orf37	-0.65	-5.21	-0.51	1.49e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs17376456	1.000	rs9968749	chr5:93509559	A/G	cg25358565	chr5:93447407	FAM172A	1.23	8.18	0.68	4.19e-12	Diabetic retinopathy;
SKCM	cis	rs763121	0.853	rs1056610	chr22:39080078	C/T	cg06022373	chr22:39101656	GTPBP1	-0.87	-6.14	-0.57	3.29e-8	Menopause (age at onset);
SKCM	cis	rs7399018	0.643	rs7398442	chr12:51612021	G/T	cg25754956	chr12:51612065	POU6F1	0.87	7.41	0.64	1.29e-10	Cisplatin-induced ototoxicity;
SKCM	cis	rs2243480	1.000	rs11538349	chr7:65421871	C/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs36093844	0.660	rs1445500	chr11:85542482	A/C	cg25872744	chr11:85566296	CCDC83	-0.85	-4.77	-0.48	8.27e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs7191439	0.674	rs4782429	chr16:88792097	A/G	cg27087555	chr16:88793112	FAM38A	-1.34	-6.54	-0.59	5.95e-9	Plateletcrit;
SKCM	cis	rs72781680	0.898	rs17763224	chr2:24213776	T/C	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	cis	rs7523273	0.606	rs2796263	chr1:207915978	T/C	cg22525895	chr1:207977042	MIR29B2	0.78	6.6	0.6	4.57e-9	Schizophrenia;
SKCM	cis	rs6088590	1.000	rs910870	chr20:33292893	T/C	cg24642439	chr20:33292090	TP53INP2	0.98	7.36	0.64	1.65e-10	Coronary artery disease;
SKCM	cis	rs55962025	0.883	rs363099	chr4:3162056	C/T	cg24015175	chr4:3319247	RGS12	-0.57	-5.03	-0.49	3.09e-6	Parental longevity (mother's age at death);
SKCM	cis	rs155076	1.000	rs564685	chr13:21846879	A/G	cg14456004	chr13:21872349	NA	-1.22	-6.76	-0.61	2.24e-9	White matter hyperintensity burden;
SKCM	cis	rs2777491	0.540	rs7164684	chr15:41705008	G/T	cg18705301	chr15:41695430	NDUFAF1	-1.21	-13.94	-0.84	7.01e-23	Ulcerative colitis;
SKCM	cis	rs6500395	1.000	rs2354579	chr16:48601521	T/C	cg04672837	chr16:48644449	N4BP1	0.69	5.73	0.54	1.8e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs2304069	1.000	rs7737689	chr5:149396159	C/A	cg22760475	chr5:149380129	HMGXB3;TIGD6	0.81	5.93	0.56	7.74e-8	HIV-1 control;
SKCM	cis	rs4642101	0.694	rs12631514	chr3:12838293	G/C	cg05775895	chr3:12838266	CAND2	0.66	5.82	0.55	1.26e-7	QRS complex (12-leadsum);
SKCM	cis	rs992157	0.835	rs13005100	chr2:219151767	C/T	cg00012203	chr2:219082015	ARPC2	-0.72	-5.71	-0.54	1.99e-7	Colorectal cancer;
SKCM	cis	rs2645694	0.533	rs2703125	chr4:77819900	T/C	cg06046430	chr4:77819534	ANKRD56	0.53	5.66	0.54	2.41e-7	Emphysema distribution in smoking;
SKCM	cis	rs992157	0.932	rs1473901	chr2:219188838	C/T	cg00012203	chr2:219082015	ARPC2	0.8	6.09	0.57	4.06e-8	Colorectal cancer;
SKCM	cis	rs4654899	0.758	rs6702331	chr1:21516107	A/T	cg01072550	chr1:21505969	NA	-0.62	-4.77	-0.47	8.55e-6	Superior frontal gyrus grey matter volume;
SKCM	cis	rs7666738	0.830	rs3896704	chr4:99034252	C/T	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1059312	0.932	rs11059916	chr12:129287609	C/A	cg09035930	chr12:129282057	SLC15A4	0.8	8.82	0.71	2.36e-13	Systemic lupus erythematosus;
SKCM	cis	rs4862750	0.914	rs6814259	chr4:187872337	T/C	cg10295955	chr4:187884368	NA	-0.9	-10.27	-0.76	3.85e-16	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs8060686	0.641	rs12598274	chr16:68084099	G/A	cg04539111	chr16:67997858	SLC12A4	-0.85	-4.79	-0.48	7.74e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs7402982	0.934	rs8027457	chr15:99204101	A/G	cg03437748	chr15:99193247	IGF1R	0.88	5.84	0.55	1.16e-7	Birth weight;
SKCM	cis	rs929354	1.000	rs1182377	chr7:157048403	T/C	cg17757837	chr7:157058334	UBE3C	-0.92	-6.66	-0.6	3.41e-9	Body mass index;
SKCM	cis	rs9911578	1.000	rs12936058	chr17:57017420	T/C	cg05425664	chr17:57184151	TRIM37	-0.67	-5.04	-0.5	2.91e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs11764590	0.694	rs10276536	chr7:2086960	C/T	cg23422044	chr7:1970798	MAD1L1	-0.82	-6.27	-0.58	1.82e-8	Neuroticism;
SKCM	cis	rs208520	0.874	rs208481	chr6:66922636	A/G	cg07460842	chr6:66804631	NA	-0.9	-6.89	-0.61	1.29e-9	Exhaled nitric oxide output;
SKCM	cis	rs7954584	0.546	rs10840630	chr12:122352445	C/T	cg01765077	chr12:122356316	WDR66	0.44	4.84	0.48	6.48e-6	Mean corpuscular volume;
SKCM	cis	rs11098499	0.863	rs13136462	chr4:120543173	C/T	cg24375607	chr4:120327624	NA	0.64	4.91	0.49	4.99e-6	Corneal astigmatism;
SKCM	trans	rs561341	0.882	rs2428337	chr17:30299467	C/T	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs9815354	0.812	rs17283677	chr3:41926148	C/T	cg03022575	chr3:42003672	ULK4	-1.02	-5.17	-0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs7843479	0.601	rs12056476	chr8:21854188	T/A	cg17168535	chr8:21777572	XPO7	0.83	7.96	0.67	1.11e-11	Mean corpuscular volume;
SKCM	cis	rs6815814	0.950	rs55830619	chr4:38807364	G/A	cg02016764	chr4:38805732	TLR1	-0.76	-5.35	-0.52	8.5e-7	Breast cancer;
SKCM	cis	rs1401999	1.000	rs6800217	chr3:183685893	T/C	cg01324343	chr3:183735012	ABCC5	0.93	10.93	0.78	2.14e-17	Anterior chamber depth;
SKCM	cis	rs9467773	1.000	rs10214634	chr6:26564582	T/A	cg09904177	chr6:26538194	HMGN4	0.54	4.98	0.49	3.78e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2980439	0.783	rs2948305	chr8:8098577	G/A	cg08975724	chr8:8085496	FLJ10661	0.81	6.45	0.59	8.72e-9	Neuroticism;
SKCM	cis	rs12971120	0.947	rs34676212	chr18:72170006	A/G	cg26446133	chr18:72167187	CNDP2	-0.67	-5.66	-0.54	2.4e-7	Refractive error;
SKCM	cis	rs6866344	0.697	rs11749438	chr5:178131245	C/T	cg03877680	chr5:178157825	ZNF354A	0.79	5.72	0.54	1.85e-7	Neutrophil percentage of white cells;
SKCM	cis	rs12145833	0.596	rs12026068	chr1:243440352	A/G	cg02356786	chr1:243265016	LOC731275	1.28	4.82	0.48	6.99e-6	Obesity (early onset extreme);
SKCM	cis	rs11945232	0.624	rs13130945	chr4:88371491	G/A	cg23841344	chr4:88312519	HSD17B11	-0.74	-4.96	-0.49	3.96e-6	Intelligence (multi-trait analysis);
SKCM	trans	rs62103177	0.713	rs3744886	chr18:77659561	G/T	cg05926928	chr17:57297772	GDPD1	1.3	8.86	0.71	2.01e-13	Opioid sensitivity;
SKCM	cis	rs738322	0.967	rs133017	chr22:38572637	A/C	cg25457927	chr22:38595422	NA	-0.56	-6.45	-0.59	8.42e-9	Cutaneous nevi;
SKCM	cis	rs17361889	0.613	rs4721484	chr7:16282403	A/T	cg09714114	chr7:16439993	ISPD	0.54	5.25	0.51	1.29e-6	Pediatric bone mineral content (hip);
SKCM	cis	rs66573146	0.831	rs66645969	chr4:6985614	G/A	cg00086871	chr4:6988644	TBC1D14	1.29	5.03	0.5	3.04e-6	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs1046896	0.553	rs8073413	chr17:80836005	G/A	cg02711726	chr17:80685570	FN3KRP	-0.79	-6.01	-0.56	5.55e-8	Glycated hemoglobin levels;
SKCM	cis	rs3845702	1.000	rs3768837	chr2:180835792	T/A	cg01881094	chr2:180872142	CWC22	-1.02	-5.29	-0.51	1.07e-6	Schizophrenia;
SKCM	cis	rs6582630	0.502	rs3902522	chr12:38271203	T/C	cg13010199	chr12:38710504	ALG10B	0.66	4.8	0.48	7.64e-6	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs2153535	0.580	rs9378556	chr6:8514695	A/G	cg07606381	chr6:8435919	SLC35B3	0.87	6.38	0.59	1.17e-8	Motion sickness;
SKCM	cis	rs72634258	0.786	rs6577468	chr1:8183921	T/C	cg00042356	chr1:8021962	PARK7	0.81	5.45	0.53	5.69e-7	Inflammatory bowel disease;
SKCM	cis	rs1577917	0.874	rs11756621	chr6:86740063	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.82	-8.0	-0.67	9.55e-12	Response to antipsychotic treatment;
SKCM	cis	rs854765	0.547	rs4459604	chr17:17888549	A/G	cg04398451	chr17:18023971	MYO15A	-0.87	-6.94	-0.62	1.03e-9	Total body bone mineral density;
SKCM	cis	rs950776	0.616	rs495090	chr15:78870003	A/G	cg06917634	chr15:78832804	PSMA4	-0.85	-6.83	-0.61	1.68e-9	Sudden cardiac arrest;
SKCM	cis	rs561341	0.843	rs4795666	chr17:30241409	A/G	cg23018236	chr17:30244563	NA	-0.52	-5.3	-0.51	1.05e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs9926296	0.581	rs6500457	chr16:89898764	C/G	cg01097406	chr16:89675127	NA	0.45	4.79	0.48	7.71e-6	Vitiligo;
SKCM	trans	rs1814175	0.645	rs7395438	chr11:49877379	G/T	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs7809950	0.678	rs2301801	chr7:106870746	T/C	cg23024343	chr7:107201750	COG5	-0.75	-6.63	-0.6	4.03e-9	Coronary artery disease;
SKCM	cis	rs2153535	0.580	rs7742794	chr6:8459723	C/A	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs1005277	0.579	rs2474567	chr10:38382492	C/T	cg25427524	chr10:38739819	LOC399744	-0.69	-6.45	-0.59	8.73e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs4925325	0.956	rs1776263	chr20:60515820	A/G	cg13770153	chr20:60521292	NA	-0.83	-6.04	-0.56	5e-8	Obesity-related traits;
SKCM	cis	rs28386778	0.897	rs3785572	chr17:61829989	C/T	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.12	11.27	0.79	4.92e-18	Prudent dietary pattern;
SKCM	cis	rs11710229	1.000	rs9846018	chr3:55483427	G/C	cg04915058	chr3:55693741	C3orf51;ERC2	0.89	5.04	0.5	2.9e-6	Response to cytadine analogues (cytosine arabinoside);
SKCM	cis	rs7119	0.667	rs907392	chr15:77903393	T/C	cg27398640	chr15:77910606	LINGO1	0.51	5.21	0.51	1.51e-6	Type 2 diabetes;
SKCM	cis	rs9325144	0.560	rs11183150	chr12:38674698	A/G	cg13010199	chr12:38710504	ALG10B	-0.61	-4.87	-0.48	5.63e-6	Morning vs. evening chronotype;
SKCM	trans	rs1814175	0.645	rs847639	chr11:49919603	C/T	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs11673344	0.704	rs1644711	chr19:37417322	C/G	cg07624650	chr19:37064219	ZNF529	-0.8	-5.24	-0.51	1.31e-6	Obesity-related traits;
SKCM	cis	rs12142240	0.698	rs66911505	chr1:46823298	A/G	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs1348850	0.958	rs4243390	chr2:178468008	G/A	cg02961200	chr2:178257176	LOC100130691;AGPS	0.84	6.61	0.6	4.29e-9	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs10791097	0.694	rs7942621	chr11:130751308	C/G	cg12179176	chr11:130786555	SNX19	0.91	8.28	0.68	2.74e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs561341	1.000	rs576985	chr17:30323323	C/T	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs7772486	0.658	rs6570706	chr6:145962922	T/C	cg05347473	chr6:146136440	FBXO30	0.57	5.19	0.51	1.61e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7772486	0.701	rs7772717	chr6:145954854	T/C	cg23711669	chr6:146136114	FBXO30	0.93	10.47	0.76	1.56e-16	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7772486	0.686	rs2328708	chr6:146095739	G/A	cg05347473	chr6:146136440	FBXO30	-0.55	-5.07	-0.5	2.6e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7100689	0.622	rs10887798	chr10:82131613	G/A	cg01528321	chr10:82214614	TSPAN14	0.81	7.09	0.63	5.35e-10	Post bronchodilator FEV1;
SKCM	cis	rs10089	1.000	rs4836360	chr5:127458161	T/C	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.91	8.89	0.71	1.79e-13	Ileal carcinoids;
SKCM	cis	rs6951245	1.000	rs113066613	chr7:1094128	T/C	cg03188948	chr7:1209495	NA	1.13	6.27	0.58	1.89e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs10256972	0.786	rs3735686	chr7:1062527	G/A	cg07308232	chr7:1071921	C7orf50	-0.6	-5.19	-0.51	1.6e-6	Longevity;Endometriosis;
SKCM	cis	rs9916302	0.645	rs1053651	chr17:37822311	A/C	cg20243544	chr17:37824526	PNMT	0.72	5.99	0.56	6.2e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs3820068	0.581	rs6693694	chr1:15980135	G/T	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs4332037	0.722	rs60346318	chr7:1915824	C/G	cg23422044	chr7:1970798	MAD1L1	-0.95	-6.54	-0.6	5.79e-9	Bipolar disorder;
SKCM	cis	rs9513627	0.510	rs4365162	chr13:100212614	G/C	cg11288260	chr13:100117058	NA	0.79	4.78	0.48	8.1e-6	Obesity-related traits;
SKCM	cis	rs752010	0.530	rs10789401	chr1:42081111	A/G	cg06885757	chr1:42089581	HIVEP3	0.7	7.28	0.64	2.3e-10	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs912057	0.585	rs1745341	chr6:6744990	T/C	cg06612196	chr6:6737390	NA	0.66	5.46	0.53	5.49e-7	Waist-to-hip ratio adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);
SKCM	cis	rs7811142	1.000	rs11761784	chr7:100039970	C/T	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.12	6.51	0.59	6.68e-9	Platelet count;
SKCM	cis	rs9325144	0.723	rs3887436	chr12:39189526	A/C	cg26384229	chr12:38710491	ALG10B	-0.71	-6.25	-0.58	2.02e-8	Morning vs. evening chronotype;
SKCM	cis	rs4481887	0.927	rs12042598	chr1:248482016	C/T	cg00666640	chr1:248458726	OR2T12	0.63	5.91	0.56	8.65e-8	Common traits (Other);
SKCM	cis	rs28595532	0.920	rs115838006	chr4:119754356	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs1843834	0.574	rs6436499	chr2:225456551	A/T	cg22455342	chr2:225449267	CUL3	0.78	5.75	0.55	1.63e-7	IgE levels in asthmatics (D.p. specific);
SKCM	cis	rs1476679	1.000	rs1476679	chr7:100004446	C/T	cg22906224	chr7:99728672	NA	-0.63	-4.86	-0.48	5.9e-6	Alzheimer's disease (late onset);
SKCM	trans	rs561341	0.941	rs2470236	chr17:30304940	G/C	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs6456156	0.565	rs2181058	chr6:167465330	A/T	cg13927040	chr6:167453801	FGFR1OP	0.66	4.85	0.48	6.24e-6	Primary biliary cholangitis;
SKCM	cis	rs7208859	0.623	rs34756112	chr17:29113016	A/G	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs79390277	0.579	rs8044066	chr16:69113369	T/A	cg00596184	chr16:69350052	VPS4A	-0.77	-5.06	-0.5	2.72e-6	Primary sclerosing cholangitis;
SKCM	cis	rs10927875	0.722	rs6696912	chr1:16338474	T/C	cg21385522	chr1:16154831	NA	0.66	4.77	0.48	8.39e-6	Dilated cardiomyopathy;
SKCM	cis	rs931234	0.622	rs4557104	chr3:65232772	G/A	cg06271087	chr3:65342546	MAGI1	-0.5	-5.18	-0.51	1.72e-6	Lobe attachment (rater-scored or self-reported);
SKCM	trans	rs1814175	0.817	rs3974439	chr11:50022607	G/A	cg15704280	chr7:45808275	SEPT13	-1.05	-11.07	-0.78	1.14e-17	Height;
SKCM	cis	rs7772486	0.846	rs1331636	chr6:146338826	T/C	cg05347473	chr6:146136440	FBXO30	0.57	5.18	0.51	1.66e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2658782	1.000	rs2605583	chr11:93164957	T/A	cg15737290	chr11:93063684	CCDC67	0.72	4.88	0.48	5.5e-6	Pulmonary function decline;
SKCM	cis	rs473651	0.904	rs501333	chr2:239336045	G/A	cg18131467	chr2:239335373	ASB1	1.08	13.29	0.83	9.89e-22	Multiple system atrophy;
SKCM	cis	rs593982	1.000	rs650619	chr11:65506483	G/A	cg08755490	chr11:65554678	OVOL1	1.06	10.75	0.77	4.73e-17	Atopic dermatitis;
SKCM	cis	rs561341	1.000	rs546748	chr17:30324293	A/C	cg00745463	chr17:30367425	LRRC37B	-1.05	-7.06	-0.62	5.99e-10	Hip circumference adjusted for BMI;
SKCM	cis	rs1799949	1.000	rs2037075	chr17:41305826	G/T	cg25918947	chr17:41365094	TMEM106A	-0.6	-6.08	-0.57	4.25e-8	Menopause (age at onset);
SKCM	cis	rs1401999	1.000	rs2872249	chr3:183636273	T/A	cg01324343	chr3:183735012	ABCC5	0.89	9.99	0.75	1.35e-15	Anterior chamber depth;
SKCM	cis	rs7106204	0.748	rs4382909	chr11:24236618	C/T	ch.11.24196551F	chr11:24239977	NA	0.77	6.13	0.57	3.44e-8	Response to Homoharringtonine (cytotoxicity);
SKCM	cis	rs7829975	0.684	rs488904	chr8:8587571	T/G	cg15556689	chr8:8085844	FLJ10661	-0.62	-5.2	-0.51	1.59e-6	Mood instability;
SKCM	cis	rs12541335	0.639	rs7003478	chr8:22201123	A/G	cg02463440	chr8:22132932	PIWIL2	0.64	5.6	0.54	3.03e-7	Hypertriglyceridemia;
SKCM	cis	rs11112613	0.713	rs12296355	chr12:105953321	C/A	cg03607813	chr12:105948248	NA	0.84	5.44	0.52	5.84e-7	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;
SKCM	cis	rs9399135	0.660	rs4646868	chr6:135271946	A/G	cg24558204	chr6:135376177	HBS1L	0.67	6.16	0.57	2.91e-8	Red blood cell count;
SKCM	cis	rs7666738	0.830	rs7659420	chr4:98878714	G/C	cg17366294	chr4:99064904	C4orf37	0.57	4.84	0.48	6.52e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7829975	0.688	rs7817376	chr8:8380530	C/T	cg15556689	chr8:8085844	FLJ10661	-0.83	-7.47	-0.65	9.83e-11	Mood instability;
SKCM	cis	rs7811142	0.562	rs7786844	chr7:99934008	T/G	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.08	6.85	0.61	1.49e-9	Platelet count;
SKCM	cis	rs58688157	0.705	rs12800061	chr11:587425	C/A	cg17114584	chr11:613792	IRF7	0.86	5.74	0.54	1.74e-7	Systemic lupus erythematosus;
SKCM	cis	rs4819052	0.851	rs10470247	chr21:46659018	T/C	cg02159808	chr21:46707872	POFUT2;LOC642852	0.69	5.36	0.52	8.31e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs8070128	0.637	rs4925133	chr17:17884801	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.05	8.42	0.69	1.46e-12	Total body bone mineral density;
SKCM	cis	rs2386661	0.784	rs2386652	chr10:5676326	G/A	cg12223502	chr10:5658492	NA	-0.56	-4.84	-0.48	6.49e-6	Breast cancer;
SKCM	cis	rs826838	0.967	rs1684414	chr12:39129553	A/G	cg26384229	chr12:38710491	ALG10B	-0.91	-8.28	-0.68	2.74e-12	Heart rate;
SKCM	cis	rs11098499	0.863	rs12508173	chr4:120318526	T/C	cg24375607	chr4:120327624	NA	0.65	4.97	0.49	3.87e-6	Corneal astigmatism;
SKCM	cis	rs394563	0.559	rs13219868	chr6:149686518	T/G	cg16235748	chr6:149772707	ZC3H12D	0.44	4.98	0.49	3.72e-6	Dupuytren's disease;
SKCM	cis	rs7829975	0.564	rs2976855	chr8:8301794	G/A	cg15556689	chr8:8085844	FLJ10661	0.68	5.53	0.53	4.15e-7	Mood instability;
SKCM	cis	rs13278732	0.500	rs13265127	chr8:99050266	C/T	cg16297171	chr8:99017690	MATN2	-0.54	-5.13	-0.5	2.07e-6	Eosinophilic esophagitis (pediatric);
SKCM	cis	rs12824058	0.844	rs10744458	chr12:130805820	C/T	cg24838063	chr12:130822603	PIWIL1	-0.69	-6.52	-0.59	6.33e-9	Menopause (age at onset);
SKCM	cis	rs9467773	1.000	rs9357010	chr6:26527945	C/G	cg09904177	chr6:26538194	HMGN4	0.54	5.12	0.5	2.13e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs11892454	0.544	rs7582924	chr2:25997020	T/C	cg17263061	chr2:26915892	KCNK3	0.71	5.15	0.5	1.88e-6	Heschl's gyrus morphology;
SKCM	cis	rs7208859	0.623	rs9915546	chr17:29132144	G/T	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs875971	0.862	rs10276077	chr7:65728411	A/G	cg11764359	chr7:65958608	NA	-0.82	-7.87	-0.67	1.68e-11	Aortic root size;
SKCM	trans	rs17767294	1.000	rs17767294	chr6:28054198	A/G	cg04411342	chr3:133103339	TMEM108	1.09	7.63	0.65	4.88e-11	Parkinson's disease;
SKCM	cis	rs7927771	0.524	rs10742814	chr11:47554337	G/A	cg20307385	chr11:47447363	PSMC3	0.77	5.86	0.55	1.06e-7	Subjective well-being;
SKCM	cis	rs17376456	1.000	rs9968749	chr5:93509559	A/G	cg21475434	chr5:93447410	FAM172A	0.99	5.65	0.54	2.49e-7	Diabetic retinopathy;
SKCM	cis	rs2180341	1.000	rs9398838	chr6:127635285	C/T	cg27446573	chr6:127587934	RNF146	0.94	8.06	0.67	7.08e-12	Breast cancer;
SKCM	cis	rs1580019	0.961	rs4357201	chr7:32496333	T/C	cg06627557	chr7:32535165	LSM5;AVL9	0.74	5.64	0.54	2.59e-7	Cognitive ability;
SKCM	cis	rs7937682	1.000	rs4936661	chr11:111587495	G/A	cg09085632	chr11:111637200	PPP2R1B	1.08	13.23	0.83	1.26e-21	Primary sclerosing cholangitis;
SKCM	cis	rs2180341	0.889	rs9321074	chr6:127618019	G/A	cg24812749	chr6:127587940	RNF146	0.87	7.33	0.64	1.85e-10	Breast cancer;
SKCM	cis	rs1048238	0.506	rs10737911	chr1:16167855	C/T	cg21385522	chr1:16154831	NA	-0.67	-5.72	-0.54	1.92e-7	Systolic blood pressure;
SKCM	cis	rs6546550	0.901	rs4852375	chr2:70125988	C/G	cg02498382	chr2:70120550	SNRNP27	-0.48	-5.28	-0.51	1.12e-6	Prevalent atrial fibrillation;
SKCM	cis	rs4481887	0.708	rs6696691	chr1:248539720	T/C	cg00666640	chr1:248458726	OR2T12	0.5	5.23	0.51	1.4e-6	Common traits (Other);
SKCM	cis	rs2075371	0.863	rs34231360	chr7:133944988	A/C	cg20476274	chr7:133979776	SLC35B4	0.96	9.41	0.73	1.76e-14	Mean platelet volume;
SKCM	cis	rs7927771	0.524	rs12785949	chr11:47729770	C/T	cg20307385	chr11:47447363	PSMC3	0.71	5.63	0.54	2.67e-7	Subjective well-being;
SKCM	trans	rs7618501	1.000	rs2271961	chr3:49878113	C/T	cg21659725	chr3:3221576	CRBN	-0.96	-9.46	-0.73	1.37e-14	Intelligence (multi-trait analysis);
SKCM	cis	rs62238980	0.614	rs117581209	chr22:32420212	T/C	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs60871478	1.000	rs62432223	chr7:787959	A/G	cg04727924	chr7:799746	HEATR2	-0.6	-4.8	-0.48	7.39e-6	Cerebrospinal P-tau181p levels;
SKCM	cis	rs13118159	0.556	rs4974615	chr4:1373551	A/G	cg16405210	chr4:1374714	KIAA1530	0.9	6.86	0.61	1.44e-9	Longevity;
SKCM	cis	rs8060686	0.641	rs111227007	chr16:68093138	T/A	cg04539111	chr16:67997858	SLC12A4	-0.85	-4.81	-0.48	7.14e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs9913156	0.589	rs7213481	chr17:4547906	C/T	cg19197139	chr17:4613644	ARRB2	0.78	5.05	0.5	2.83e-6	Lymphocyte counts;
SKCM	cis	rs1401999	1.000	rs7620350	chr3:183710053	A/T	cg01324343	chr3:183735012	ABCC5	0.84	9.29	0.72	2.91e-14	Anterior chamber depth;
SKCM	trans	rs8073060	0.586	rs225286	chr17:33930458	G/A	cg19694781	chr19:47549865	TMEM160	-1.08	-8.69	-0.7	4.26e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs9790314	1.000	rs3849524	chr3:161015589	C/T	cg03342759	chr3:160939853	NMD3	-0.68	-7.07	-0.62	5.85e-10	Morning vs. evening chronotype;
SKCM	cis	rs6952808	0.717	rs10950422	chr7:1926577	T/C	cg04267008	chr7:1944627	MAD1L1	-0.69	-5.6	-0.54	3.06e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs6580649	0.882	rs2286022	chr12:48436647	G/A	cg05342945	chr12:48394962	COL2A1	0.72	5.35	0.52	8.71e-7	Lung cancer;
SKCM	cis	rs4268898	0.636	rs72803210	chr2:24615710	A/G	cg06627628	chr2:24431161	ITSN2	-0.88	-6.72	-0.61	2.64e-9	Asthma;
SKCM	cis	rs28374715	0.510	rs8034073	chr15:41545613	A/C	cg18705301	chr15:41695430	NDUFAF1	-0.76	-6.48	-0.59	7.46e-9	Ulcerative colitis;
SKCM	cis	rs4862750	0.874	rs6553027	chr4:187875777	T/C	cg10295955	chr4:187884368	NA	-1.04	-13.63	-0.84	2.47e-22	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6121246	0.559	rs6060922	chr20:30333909	C/T	cg11595048	chr20:30225325	COX4I2	0.54	4.77	0.48	8.4e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs6951245	1.000	rs78158942	chr7:1090440	G/T	cg18402987	chr7:1209562	NA	1.14	6.01	0.56	5.68e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs10504229	0.683	rs6999351	chr8:58127227	C/T	cg02725872	chr8:58115012	NA	-0.52	-4.97	-0.49	3.92e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs11637445	0.858	rs55986190	chr15:67929328	C/T	cg24247231	chr15:67904302	MAP2K5	-0.63	-4.87	-0.48	5.66e-6	Posterior cortical atrophy and Alzheimer's disease;
SKCM	cis	rs1005277	0.579	rs1780115	chr10:38524773	C/T	cg00409905	chr10:38381863	ZNF37A	-0.62	-5.82	-0.55	1.24e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs12711979	1.000	rs6542655	chr2:3872434	T/C	cg17052675	chr2:3827356	NA	-0.56	-5.27	-0.51	1.17e-6	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs9902453	0.872	rs34698290	chr17:28500465	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.5	0.53	4.74e-7	Coffee consumption (cups per day);
SKCM	cis	rs763121	0.889	rs2267390	chr22:38889657	C/T	cg06022373	chr22:39101656	GTPBP1	0.79	5.48	0.53	4.96e-7	Menopause (age at onset);
SKCM	cis	rs362272	0.505	rs60208975	chr4:3364530	A/G	cg03043834	chr4:3319541	RGS12	0.58	4.84	0.48	6.52e-6	Serum sulfate level;
SKCM	cis	rs9796	0.689	rs28409432	chr15:41447454	G/A	cg18705301	chr15:41695430	NDUFAF1	-0.74	-5.35	-0.52	8.47e-7	Menopause (age at onset);
SKCM	cis	rs933688	1.000	rs10059163	chr5:90742444	C/T	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.07	8.69	0.7	4.41e-13	Smoking behavior;
SKCM	cis	rs801193	1.000	rs2707845	chr7:66198798	C/T	cg11764359	chr7:65958608	NA	0.86	6.55	0.6	5.68e-9	Aortic root size;
SKCM	cis	rs7208859	0.623	rs11650982	chr17:29129955	A/G	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs62103177	0.608	rs8088089	chr18:77832154	A/G	cg06309094	chr18:77676213	PQLC1	0.83	5.04	0.5	2.89e-6	Opioid sensitivity;
SKCM	cis	rs9902453	0.765	rs2447935	chr17:28057524	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.79	-5.93	-0.56	7.67e-8	Coffee consumption (cups per day);
SKCM	cis	rs10905065	0.827	rs7089100	chr10:5849877	C/G	cg09234995	chr10:5726438	C10orf18	-0.64	-5.4	-0.52	6.93e-7	Menopause (age at onset);
SKCM	cis	rs116095464	0.558	rs6872854	chr5:209038	G/T	cg22857025	chr5:266934	NA	-1.36	-8.0	-0.67	9.23e-12	Breast cancer;
SKCM	cis	rs875971	0.862	rs10282433	chr7:65721439	G/A	cg18876405	chr7:65276391	NA	-0.65	-6.59	-0.6	4.73e-9	Aortic root size;
SKCM	cis	rs12188164	0.965	rs11742144	chr5:422178	G/A	cg26076054	chr5:421317	AHRR	-0.61	-4.81	-0.48	7.2e-6	Cystic fibrosis severity;
SKCM	cis	rs16866061	0.515	rs1027340	chr2:225370554	C/A	cg12698349	chr2:225449008	CUL3	0.94	10.48	0.76	1.54e-16	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs8180040	1.000	rs807936	chr3:47322496	C/T	cg16586182	chr3:47516702	SCAP	-0.71	-4.85	-0.48	6.25e-6	Colorectal cancer;
SKCM	cis	rs992157	0.764	rs2015863	chr2:219185161	C/T	cg00012203	chr2:219082015	ARPC2	-0.75	-5.54	-0.53	3.92e-7	Colorectal cancer;
SKCM	cis	rs7659604	0.728	rs6852923	chr4:122688324	G/A	cg06713675	chr4:122721982	EXOSC9	-0.76	-6.79	-0.61	1.96e-9	Type 2 diabetes;
SKCM	cis	rs6570726	0.791	rs621382	chr6:145799144	T/C	cg23711669	chr6:146136114	FBXO30	0.78	7.23	0.63	2.87e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7959452	0.605	rs12819406	chr12:69696400	G/T	cg14784868	chr12:69753453	YEATS4	0.66	5.86	0.55	1.03e-7	Blood protein levels;
SKCM	cis	rs9868809	0.772	rs12107252	chr3:48691316	T/C	cg00383909	chr3:49044727	WDR6	0.93	4.95	0.49	4.2e-6	Ulcerative colitis;Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs250585	0.667	rs460905	chr16:23595744	G/A	cg09934309	chr16:23461721	COG7	-0.94	-6.18	-0.57	2.76e-8	Egg allergy;
SKCM	cis	rs7590720	1.000	rs934154	chr2:216901933	C/T	cg12620499	chr2:216877984	MREG	0.89	7.79	0.66	2.43e-11	Alcohol dependence;
SKCM	cis	rs7666738	0.830	rs2865949	chr4:99039967	A/G	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs3741151	1.000	rs79794992	chr11:73049352	A/G	cg17517138	chr11:73019481	ARHGEF17	1.27	4.87	0.48	5.63e-6	GIP levels in response to oral glucose tolerance test (120 minutes);
SKCM	cis	rs9388451	0.903	rs9388446	chr6:126064920	T/A	cg05901451	chr6:126070800	HEY2	-0.79	-7.92	-0.67	1.33e-11	Brugada syndrome;
SKCM	cis	rs7937682	0.793	rs7130440	chr11:111417779	A/G	cg19812747	chr11:111475976	SIK2	0.6	5.35	0.52	8.68e-7	Primary sclerosing cholangitis;
SKCM	cis	rs7635838	0.819	rs904474	chr3:11524648	C/G	cg00170343	chr3:11313890	ATG7	0.69	5.18	0.51	1.69e-6	HDL cholesterol;
SKCM	trans	rs8073060	0.559	rs17550632	chr17:33890883	G/C	cg19694781	chr19:47549865	TMEM160	1.08	8.69	0.7	4.26e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs6500395	0.584	rs4028684	chr16:48741222	A/G	cg04672837	chr16:48644449	N4BP1	0.75	5.29	0.51	1.11e-6	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs2764980	1.000	rs2764978	chr10:3283385	C/G	cg11630169	chr10:3283847	NA	-0.61	-5.25	-0.51	1.26e-6	Attention deficit hyperactivity disorder and conduct disorder;
SKCM	cis	rs9951698	0.703	rs7234960	chr18:13018071	A/G	cg12848697	chr18:13133368	NA	0.52	4.78	0.48	8.02e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9394841	0.692	rs9381094	chr6:41800629	T/C	cg08135965	chr6:41755394	TOMM6	0.74	4.88	0.48	5.45e-6	Mean corpuscular hemoglobin;Red cell distribution width;
SKCM	cis	rs7618501	0.633	rs35065728	chr3:50009176	T/C	cg24110177	chr3:50126178	RBM5	-0.6	-5.08	-0.5	2.55e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs10876993	0.890	rs1092472	chr12:58036688	G/T	cg18357645	chr12:58087776	OS9	0.59	5.38	0.52	7.71e-7	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs561341	0.740	rs11080174	chr17:30208521	C/A	cg00745463	chr17:30367425	LRRC37B	0.94	5.95	0.56	7.18e-8	Hip circumference adjusted for BMI;
SKCM	cis	rs1062177	1.000	rs2964576	chr5:151150602	T/G	cg00977110	chr5:151150581	G3BP1	0.79	6.51	0.59	6.71e-9	Preschool internalizing problems;
SKCM	cis	rs3820928	0.904	rs10933161	chr2:227764872	A/G	cg11843606	chr2:227700838	RHBDD1	-0.64	-5.22	-0.51	1.45e-6	Pulmonary function;
SKCM	cis	rs6815814	0.898	rs5743562	chr4:38806096	T/C	cg02016764	chr4:38805732	TLR1	-0.76	-5.4	-0.52	6.95e-7	Breast cancer;
SKCM	cis	rs4319547	0.915	rs11058402	chr12:122981053	A/G	cg23029597	chr12:123009494	RSRC2	-0.82	-6.33	-0.58	1.46e-8	Body mass index;
SKCM	cis	rs3785574	0.962	rs35448669	chr17:61938923	G/A	cg06601766	chr17:61851465	DDX42;CCDC47	0.72	5.36	0.52	8.34e-7	Height;
SKCM	cis	rs12478296	0.792	rs6738361	chr2:243014257	C/T	cg06360820	chr2:242988706	NA	-0.99	-5.31	-0.52	9.94e-7	Obesity-related traits;
SKCM	cis	rs7811142	1.000	rs73161762	chr7:100014846	C/T	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.21	7.64	0.65	4.61e-11	Platelet count;
SKCM	cis	rs34375054	0.526	rs4412800	chr12:125674742	C/T	cg25124228	chr12:125621409	AACS	0.71	4.88	0.48	5.53e-6	Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs1865760	0.928	rs9295673	chr6:25912094	T/G	cg08401836	chr6:26032486	HIST1H3B	-0.61	-4.83	-0.48	6.76e-6	Height;
SKCM	cis	rs561341	1.000	rs550264	chr17:30317540	G/T	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs10911251	0.546	rs10911260	chr1:183106230	A/C	ch.1.3577855R	chr1:183094577	LAMC1	-0.73	-7.4	-0.64	1.33e-10	Colorectal cancer;
SKCM	cis	rs1506636	1.000	rs60689684	chr7:123370403	C/T	cg03229431	chr7:123269106	ASB15	0.59	4.79	0.48	7.87e-6	Plateletcrit;Platelet count;
SKCM	cis	rs17711722	0.727	rs781151	chr7:65479878	T/C	cg11764359	chr7:65958608	NA	0.87	6.57	0.6	5.09e-9	Calcium levels;
SKCM	cis	rs9513627	1.000	rs4466950	chr13:100166875	G/T	cg11288260	chr13:100117058	NA	0.83	4.97	0.49	3.8e-6	Obesity-related traits;
SKCM	cis	rs826838	0.904	rs7973992	chr12:39168233	T/C	cg13010199	chr12:38710504	ALG10B	0.68	5.26	0.51	1.21e-6	Heart rate;
SKCM	cis	rs16854884	0.586	rs7650172	chr3:143729408	G/C	cg06585982	chr3:143692056	C3orf58	0.87	8.34	0.69	2.04e-12	Economic and political preferences (feminism/equality);
SKCM	cis	rs873946	0.586	rs36084869	chr10:134566069	G/A	cg27286337	chr10:134555280	INPP5A	0.99	8.98	0.71	1.2e-13	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs2302190	0.882	rs3809709	chr17:56590559	C/T	cg25885038	chr17:56607967	SEPT4	-0.71	-4.79	-0.48	7.86e-6	Vitamin D levels;
SKCM	cis	rs514406	0.661	rs550561	chr1:53375134	C/T	cg04310824	chr1:53393297	SCP2	-0.6	-4.88	-0.48	5.44e-6	Monocyte count;
SKCM	cis	rs6456156	0.792	rs10946214	chr6:167516122	G/A	cg07741184	chr6:167504864	NA	0.5	4.77	0.48	8.26e-6	Primary biliary cholangitis;
SKCM	cis	rs4332037	0.539	rs34571717	chr7:2106855	T/C	cg23422044	chr7:1970798	MAD1L1	-0.81	-6.09	-0.57	4.02e-8	Bipolar disorder;
SKCM	cis	rs28386778	0.787	rs2665827	chr17:61961350	G/C	cg26338869	chr17:61819248	STRADA	0.73	4.95	0.49	4.14e-6	Prudent dietary pattern;
SKCM	trans	rs1814175	0.817	rs6486044	chr11:49982718	C/T	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs2354432	0.607	rs9661159	chr1:146757923	G/A	cg25205988	chr1:146714368	CHD1L	-1.19	-6.57	-0.6	5.02e-9	Mitochondrial DNA levels;
SKCM	cis	rs2836950	0.527	rs2836948	chr21:40599677	T/C	cg11644478	chr21:40555479	PSMG1	-0.64	-5.02	-0.49	3.17e-6	Menarche (age at onset);
SKCM	cis	rs244731	0.959	rs918459	chr5:176669030	C/T	cg17509989	chr5:176798049	RGS14	-0.81	-6.76	-0.61	2.23e-9	Urate levels in lean individuals;
SKCM	cis	rs4925386	0.840	rs8124907	chr20:60913127	A/G	cg24112000	chr20:60950667	NA	-0.7	-6.61	-0.6	4.27e-9	Colorectal cancer;Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs1062177	0.855	rs6884630	chr5:151268997	A/T	cg00977110	chr5:151150581	G3BP1	0.71	5.97	0.56	6.52e-8	Preschool internalizing problems;
SKCM	cis	rs2836974	0.897	rs1571709	chr21:40553980	T/C	cg11890956	chr21:40555474	PSMG1	1.09	13.7	0.84	1.86e-22	Cognitive function;
SKCM	cis	rs561341	1.000	rs535151	chr17:30317405	C/T	cg00745463	chr17:30367425	LRRC37B	-1.05	-7.06	-0.62	5.99e-10	Hip circumference adjusted for BMI;
SKCM	cis	rs7659604	0.967	rs28529384	chr4:122664215	T/C	cg19671926	chr4:122722719	EXOSC9	-0.66	-4.98	-0.49	3.71e-6	Type 2 diabetes;
SKCM	trans	rs1814175	0.817	rs7932683	chr11:49983640	G/A	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs7811142	0.943	rs67196635	chr7:100025564	T/C	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.34	0.69	2.1e-12	Platelet count;
SKCM	cis	rs1005277	0.522	rs289650	chr10:37975505	G/T	cg00409905	chr10:38381863	ZNF37A	-0.56	-5.33	-0.52	9.27e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs6089829	0.925	rs3746748	chr20:61667526	C/T	cg08564027	chr20:61660810	NA	0.63	5.65	0.54	2.46e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs2243480	1.000	rs9769882	chr7:65642925	T/C	cg18252515	chr7:66147081	NA	1.34	8.18	0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs2204008	0.713	rs2320522	chr12:38251438	C/T	cg26384229	chr12:38710491	ALG10B	0.87	6.83	0.61	1.63e-9	Bladder cancer;
SKCM	cis	rs2243480	1.000	rs7456042	chr7:65299778	T/C	cg07424592	chr7:64974309	NA	0.99	4.9	0.49	5.08e-6	Diabetic kidney disease;
SKCM	cis	rs12048904	0.533	rs1590580	chr1:101292668	A/G	cg00063077	chr1:101360652	SLC30A7;EXTL2	0.77	5.44	0.52	6.05e-7	Multiple sclerosis;
SKCM	cis	rs9926296	0.565	rs8055825	chr16:89832848	C/T	cg04287289	chr16:89883240	FANCA	1.03	12.35	0.81	4.89e-20	Vitiligo;
SKCM	cis	rs72781680	0.848	rs2339926	chr2:24045734	C/G	cg08917208	chr2:24149416	ATAD2B	1.0	4.97	0.49	3.82e-6	Lymphocyte counts;
SKCM	cis	rs6952808	0.895	rs4513875	chr7:1928159	C/T	cg05863683	chr7:1912471	MAD1L1	0.65	5.79	0.55	1.43e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs7811142	1.000	rs7783550	chr7:99987805	A/G	cg07160278	chr7:100027354	MEPCE;ZCWPW1	-1.19	-7.83	-0.66	2.04e-11	Platelet count;
SKCM	cis	rs7772486	0.790	rs2243665	chr6:146208120	A/C	cg23711669	chr6:146136114	FBXO30	0.76	6.87	0.61	1.36e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs523522	0.962	rs603574	chr12:120998443	A/G	cg12219531	chr12:120966889	COQ5	0.89	7.53	0.65	7.52e-11	High light scatter reticulocyte count;
SKCM	cis	rs10492096	0.947	rs61918022	chr12:6614521	C/T	cg13857086	chr12:6580257	VAMP1	0.76	5.75	0.55	1.64e-7	Hip geometry;
SKCM	cis	rs10791097	0.667	rs12363163	chr11:130744509	A/G	cg12179176	chr11:130786555	SNX19	0.93	8.16	0.68	4.64e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs6138458	1.000	rs11905625	chr20:24977065	A/C	cg26195577	chr20:24973756	C20orf3	1.29	8.85	0.71	2.07e-13	Blood protein levels;
SKCM	cis	rs8177253	1.000	rs1358023	chr3:133484393	T/C	cg16414030	chr3:133502952	NA	-0.69	-5.83	-0.55	1.19e-7	Iron status biomarkers;
SKCM	cis	rs72949976	0.864	rs13389834	chr2:214025112	G/A	cg08319019	chr2:214017104	IKZF2	-0.74	-5.58	-0.53	3.32e-7	Lung cancer;Squamous cell lung carcinoma;
SKCM	cis	rs6840360	0.615	rs9996320	chr4:152610587	T/G	cg22705602	chr4:152727874	NA	-0.6	-7.96	-0.67	1.12e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs748404	0.631	rs560191	chr15:43767774	G/C	cg02155558	chr15:43621948	ADAL;LCMT2	0.72	5.54	0.53	3.99e-7	Lung cancer;
SKCM	cis	rs2180341	1.000	rs6569479	chr6:127606588	A/G	cg27446573	chr6:127587934	RNF146	0.95	8.24	0.68	3.17e-12	Breast cancer;
SKCM	cis	rs6977660	0.943	rs6959678	chr7:19821759	C/A	cg05791153	chr7:19748676	TWISTNB	0.79	5.34	0.52	9.05e-7	Thyroid stimulating hormone;
SKCM	trans	rs561341	0.739	rs7213369	chr17:30211878	G/A	cg20587970	chr11:113659929	NA	1.03	7.94	0.67	1.24e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs10504229	0.683	rs2318147	chr8:58114931	C/T	cg02725872	chr8:58115012	NA	-0.49	-4.95	-0.49	4.23e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs6570726	0.935	rs414222	chr6:145850482	C/T	cg23711669	chr6:146136114	FBXO30	0.7	6.71	0.61	2.78e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7666738	0.830	rs2865979	chr4:99027137	T/C	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4954585	0.683	rs11678502	chr2:136994454	C/T	cg05194412	chr2:137003533	NA	0.56	4.93	0.49	4.5e-6	Colorectal cancer;
SKCM	cis	rs8180040	0.764	rs62246375	chr3:47014464	G/A	cg27129171	chr3:47204927	SETD2	-0.79	-6.01	-0.56	5.49e-8	Colorectal cancer;
SKCM	cis	rs477895	1.000	rs477895	chr11:64048912	C/T	cg02228329	chr11:64053129	BAD;GPR137	1.12	5.08	0.5	2.51e-6	Mean platelet volume;
SKCM	cis	rs9394841	0.692	rs9394837	chr6:41848088	G/A	cg08135965	chr6:41755394	TOMM6	0.77	5.04	0.5	2.91e-6	Mean corpuscular hemoglobin;Red cell distribution width;
SKCM	cis	rs6952808	0.729	rs35797753	chr7:1954914	G/A	cg21782813	chr7:2030301	MAD1L1	0.53	5.6	0.54	3.1e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs2836633	0.929	rs4143428	chr21:40030582	G/T	cg05519781	chr21:40033154	ERG	0.81	7.07	0.62	5.77e-10	Coronary artery disease;
SKCM	cis	rs9815354	0.812	rs7639859	chr3:42001987	C/T	cg03022575	chr3:42003672	ULK4	1.0	5.0	0.49	3.43e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs2304069	0.954	rs6579767	chr5:149406271	C/T	cg22760475	chr5:149380129	HMGXB3;TIGD6	0.79	5.92	0.56	8.17e-8	HIV-1 control;
SKCM	cis	rs1799949	1.000	rs4793189	chr17:41190715	G/A	cg25072359	chr17:41440525	NA	0.63	4.88	0.48	5.43e-6	Menopause (age at onset);
SKCM	cis	rs2963155	0.518	rs712189	chr5:142631258	C/T	cg17617527	chr5:142782415	NR3C1	1.13	5.42	0.52	6.46e-7	Breast cancer;
SKCM	cis	rs2073499	1.000	rs10510755	chr3:50281168	C/T	cg08207895	chr3:50388901	TUSC4;CYB561D2	0.73	5.0	0.49	3.51e-6	Schizophrenia;
SKCM	cis	rs13118159	0.550	rs4974617	chr4:1373658	T/C	cg02018176	chr4:1364513	KIAA1530	0.89	7.24	0.63	2.72e-10	Longevity;
SKCM	cis	rs62064224	0.765	rs62065463	chr17:30732405	G/T	cg25809561	chr17:30822961	MYO1D	0.73	5.63	0.54	2.76e-7	Schizophrenia;
SKCM	cis	rs7027203	0.759	rs10761282	chr9:96586175	G/A	cg14598338	chr9:96623480	NA	-0.48	-4.81	-0.48	7.29e-6	DNA methylation (variation);
SKCM	cis	rs826838	1.000	rs11183196	chr12:38685915	G/T	cg13010199	chr12:38710504	ALG10B	0.87	6.54	0.59	5.91e-9	Heart rate;
SKCM	cis	rs10540	1.000	rs61876335	chr11:488878	T/C	cg03576123	chr11:487126	PTDSS2	-1.4	-7.12	-0.63	4.72e-10	Body mass index;
SKCM	cis	rs995000	0.899	rs1168031	chr1:62967987	C/T	cg06896770	chr1:63153194	DOCK7	-0.62	-5.59	-0.54	3.15e-7	Triglyceride levels;
SKCM	cis	rs2120019	1.000	rs2083731	chr15:75368538	A/C	cg09165964	chr15:75287851	SCAMP5	-0.78	-6.63	-0.6	3.95e-9	Blood trace element (Zn levels);
SKCM	cis	rs2842992	0.830	rs2758320	chr6:160070676	T/G	cg11366901	chr6:160182831	ACAT2	0.92	6.82	0.61	1.7e-9	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs6952808	0.771	rs4719336	chr7:1916397	T/C	cg05863683	chr7:1912471	MAD1L1	0.58	5.25	0.51	1.28e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs75920871	0.588	rs6589580	chr11:116819873	G/A	cg01368799	chr11:117014884	PAFAH1B2	-0.7	-5.58	-0.53	3.39e-7	Subjective well-being;
SKCM	cis	rs3862260	0.509	rs10802124	chr1:120164252	G/A	cg16322792	chr1:120165303	ZNF697	0.5	5.32	0.52	9.47e-7	Systemic lupus erythematosus;
SKCM	cis	rs10504229	1.000	rs58371676	chr8:58189382	G/A	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs870825	0.616	rs55674580	chr4:185626605	C/G	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs4665809	0.549	rs72809635	chr2:26411674	G/A	cg26119090	chr2:26468346	HADHA;HADHB	0.99	7.13	0.63	4.44e-10	Gut microbiome composition (summer);
SKCM	cis	rs752010	0.574	rs2148636	chr1:42119844	C/T	cg06885757	chr1:42089581	HIVEP3	-0.47	-5.15	-0.5	1.87e-6	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs4481887	0.676	rs7520659	chr1:248527586	C/A	cg22724847	chr1:248512586	OR14C36	0.62	5.32	0.52	9.49e-7	Common traits (Other);
SKCM	cis	rs644799	1.000	rs474252	chr11:95619292	G/C	cg03916912	chr11:95522834	CEP57;FAM76B	0.85	6.71	0.6	2.82e-9	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs7098414	0.530	rs4146515	chr10:82116602	G/A	cg00277334	chr10:82204260	NA	-0.57	-5.5	-0.53	4.59e-7	Post bronchodilator FEV1;
SKCM	cis	rs1957429	0.808	rs4902325	chr14:65330843	A/G	cg23373153	chr14:65346875	NA	-1.12	-6.09	-0.57	4.06e-8	Pediatric areal bone mineral density (radius);
SKCM	cis	rs28386778	0.897	rs9915552	chr17:61869095	G/A	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs7772486	0.875	rs1330939	chr6:146308518	T/A	cg23711669	chr6:146136114	FBXO30	0.76	6.83	0.61	1.66e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs798554	0.757	rs1182172	chr7:2878103	G/A	cg19346786	chr7:2764209	NA	-0.64	-6.91	-0.62	1.15e-9	Height;
SKCM	cis	rs2839186	0.619	rs55689527	chr21:47622727	A/G	cg13012494	chr21:47604986	C21orf56	0.71	6.18	0.57	2.77e-8	Testicular germ cell tumor;
SKCM	cis	rs17065868	1.000	rs9595149	chr13:45124858	C/A	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs933688	1.000	rs11950530	chr5:90688740	A/G	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.1	8.33	0.69	2.14e-12	Smoking behavior;
SKCM	cis	rs4975616	0.836	rs460073	chr5:1336459	T/C	cg26373071	chr5:1325741	CLPTM1L	0.74	6.91	0.62	1.18e-9	Lung cancer;
SKCM	cis	rs1691799	0.899	rs1060724	chr12:66740444	T/C	cg16791601	chr12:66731901	HELB	-0.66	-5.81	-0.55	1.31e-7	White blood cell count (basophil);
SKCM	cis	rs4481887	0.893	rs1339990	chr1:248509495	C/T	cg00666640	chr1:248458726	OR2T12	-0.53	-4.77	-0.48	8.43e-6	Common traits (Other);
SKCM	cis	rs12986445	0.711	rs6754861	chr2:26137994	T/A	cg07291958	chr2:26785531	C2orf70	0.53	4.93	0.49	4.56e-6	Multiple myeloma and monoclonal gammopathy;Multiple myeloma;
SKCM	cis	rs875971	0.522	rs709604	chr7:65497434	A/G	cg18876405	chr7:65276391	NA	-0.86	-8.04	-0.67	7.9e-12	Aortic root size;
SKCM	cis	rs763121	0.962	rs5757130	chr22:38937794	G/A	cg06022373	chr22:39101656	GTPBP1	0.75	5.67	0.54	2.32e-7	Menopause (age at onset);
SKCM	cis	rs2120019	0.786	rs12911421	chr15:75287822	C/A	cg09165964	chr15:75287851	SCAMP5	0.99	12.54	0.82	2.16e-20	Blood trace element (Zn levels);
SKCM	cis	rs6665290	0.545	rs6426584	chr1:227374949	A/T	cg10327440	chr1:227177885	CDC42BPA	-1.12	-9.36	-0.73	2.18e-14	Myeloid white cell count;
SKCM	cis	rs1577917	0.771	rs4145082	chr6:86352016	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-1.01	-11.37	-0.79	3.18e-18	Response to antipsychotic treatment;
SKCM	cis	rs2239547	0.522	rs2581805	chr3:52979050	T/C	cg11645453	chr3:52864694	ITIH4	-0.58	-4.96	-0.49	3.98e-6	Schizophrenia;
SKCM	cis	rs17826219	0.636	rs7221463	chr17:29080551	A/C	cg14067834	chr17:29058358	SUZ12P	1.05	5.32	0.52	9.48e-7	Body mass index;
SKCM	cis	rs801193	1.000	rs17566701	chr7:66193183	T/C	cg18876405	chr7:65276391	NA	0.8	7.12	0.63	4.75e-10	Aortic root size;
SKCM	cis	rs3785574	0.927	rs2008018	chr17:61954471	C/T	cg11494091	chr17:61959527	GH2	0.6	5.42	0.52	6.4e-7	Height;
SKCM	cis	rs1799949	1.000	rs1060915	chr17:41234470	A/G	cg23758822	chr17:41437982	NA	0.93	7.82	0.66	2.1e-11	Menopause (age at onset);
SKCM	cis	rs7811142	1.000	rs7809801	chr7:100072031	T/C	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-0.99	-5.52	-0.53	4.2e-7	Platelet count;
SKCM	cis	rs9303401	0.659	rs12935851	chr17:56600244	C/A	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.59	0.53	3.19e-7	Cognitive test performance;
SKCM	cis	rs769267	0.965	rs8103496	chr19:19386015	A/G	cg03709012	chr19:19516395	GATAD2A	0.81	6.49	0.59	7.18e-9	Tonsillectomy;
SKCM	cis	rs1153858	0.943	rs1145079	chr15:45681761	T/C	cg21132104	chr15:45694354	SPATA5L1	0.93	7.66	0.66	4.2e-11	Homoarginine levels;
SKCM	cis	rs4975616	0.804	rs462608	chr5:1336626	T/A	cg06550200	chr5:1325588	CLPTM1L	-0.83	-6.78	-0.61	2.07e-9	Lung cancer;
SKCM	cis	rs8014204	0.762	rs8016389	chr14:75287554	T/C	cg06637938	chr14:75390232	RPS6KL1	0.71	5.55	0.53	3.78e-7	Caffeine consumption;
SKCM	cis	rs2439831	0.850	rs28684672	chr15:44107662	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.35	7.75	0.66	2.9e-11	Lung cancer in ever smokers;
SKCM	cis	rs932287	0.540	rs4910442	chr11:9044337	T/C	cg21881798	chr11:8931708	C11orf17;ST5	0.8	7.22	0.63	3.06e-10	Colonoscopy-negative controls vs population controls;
SKCM	trans	rs3749237	1.000	rs11710675	chr3:49751900	C/A	cg21659725	chr3:3221576	CRBN	0.99	7.4	0.64	1.35e-10	Resting heart rate;
SKCM	cis	rs28595532	0.920	rs115986613	chr4:119752156	G/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs16866061	1.000	rs72972378	chr2:225372562	A/G	cg12698349	chr2:225449008	CUL3	1.03	8.81	0.71	2.51e-13	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs2839186	0.770	rs2839984	chr21:47671690	A/G	cg13126279	chr21:47581558	C21orf56	-0.69	-5.92	-0.56	8.33e-8	Testicular germ cell tumor;
SKCM	cis	rs7959452	0.640	rs4761154	chr12:69705362	A/G	cg20891283	chr12:69753455	YEATS4	-0.83	-8.07	-0.67	6.91e-12	Blood protein levels;
SKCM	cis	rs7100689	0.725	rs10736340	chr10:82061071	C/T	cg00277334	chr10:82204260	NA	-0.58	-5.69	-0.54	2.16e-7	Post bronchodilator FEV1;
SKCM	cis	rs10752881	0.935	rs10797834	chr1:183048749	T/G	ch.1.3577855R	chr1:183094577	LAMC1	0.78	6.87	0.61	1.42e-9	Colorectal cancer;
SKCM	cis	rs7829975	0.840	rs572366	chr8:8578794	A/T	cg06636001	chr8:8085503	FLJ10661	0.8	7.19	0.63	3.49e-10	Mood instability;
SKCM	cis	rs801193	1.000	rs4279493	chr7:66226620	C/T	cg11987759	chr7:65425863	GUSB	-0.67	-5.76	-0.55	1.59e-7	Aortic root size;
SKCM	cis	rs7666738	0.861	rs5010991	chr4:98972179	A/G	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs13108904	0.935	rs1732100	chr4:1281761	C/T	cg05025164	chr4:1340916	KIAA1530	-0.6	-4.82	-0.48	6.9e-6	Obesity-related traits;
SKCM	cis	rs941408	0.515	rs7253128	chr19:2776982	C/T	cg06609049	chr19:2785107	THOP1	1.09	10.19	0.76	5.37e-16	Total cholesterol levels;
SKCM	cis	rs897984	0.762	rs897986	chr16:30980902	T/C	cg00531865	chr16:30841666	NA	0.59	4.97	0.49	3.81e-6	Dementia with Lewy bodies;
SKCM	cis	rs7811142	1.000	rs67471932	chr7:100009985	C/G	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.11	6.45	0.59	8.66e-9	Platelet count;
SKCM	cis	rs2072499	0.898	rs2736609	chr1:156202640	C/T	cg24450063	chr1:156163899	SLC25A44	0.78	6.43	0.59	9.49e-9	Testicular germ cell tumor;
SKCM	cis	rs4423214	0.921	rs11603330	chr11:71153459	C/A	cg05163923	chr11:71159392	DHCR7	0.79	7.43	0.64	1.19e-10	Vitamin D levels;
SKCM	trans	rs1814175	0.817	rs1615305	chr11:49895222	T/A	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs2832191	0.716	rs2249028	chr21:30365322	G/A	cg08807101	chr21:30365312	RNF160	0.76	6.34	0.58	1.38e-8	Dental caries;
SKCM	cis	rs6951245	0.872	rs76161580	chr7:1100307	G/T	cg18402987	chr7:1209562	NA	1.15	6.09	0.57	3.95e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	trans	rs17685	0.671	rs60303271	chr7:75760008	A/G	cg19862616	chr7:65841803	NCRNA00174	0.94	9.49	0.73	1.22e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs6582630	0.519	rs1607868	chr12:38385512	G/T	cg13010199	chr12:38710504	ALG10B	0.64	4.84	0.48	6.4e-6	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs514406	0.661	rs562641	chr1:53374666	C/T	cg08859206	chr1:53392774	SCP2	-0.63	-5.32	-0.52	9.59e-7	Monocyte count;
SKCM	cis	rs10503709	0.861	rs1383579	chr8:21448582	G/A	cg23716449	chr8:21608280	GFRA2	0.52	5.32	0.52	9.7e-7	Blood protein levels;
SKCM	cis	rs1506636	0.962	rs1506640	chr7:123349627	T/G	cg03229431	chr7:123269106	ASB15	-0.64	-5.21	-0.51	1.5e-6	Plateletcrit;Platelet count;
SKCM	cis	rs6942756	1.000	rs67997229	chr7:128957366	G/C	cg02491457	chr7:128862824	NA	-0.86	-5.48	-0.53	5.11e-7	White matter hyperintensity burden;
SKCM	cis	rs9911578	0.900	rs8067264	chr17:57182793	G/C	cg05425664	chr17:57184151	TRIM37	-0.83	-7.07	-0.62	5.91e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs7659604	0.846	rs60340409	chr4:122666355	G/C	cg06713675	chr4:122721982	EXOSC9	-0.64	-5.68	-0.54	2.24e-7	Type 2 diabetes;
SKCM	cis	rs1790761	0.504	rs61894496	chr11:67391907	C/T	cg24690094	chr11:67383802	NA	0.51	5.4	0.52	7.04e-7	Mean corpuscular volume;
SKCM	cis	rs9926296	0.643	rs12596429	chr16:89841374	T/C	cg01097406	chr16:89675127	NA	-0.48	-5.06	-0.5	2.68e-6	Vitiligo;
SKCM	cis	rs875971	0.767	rs61348003	chr7:66005934	C/T	cg18876405	chr7:65276391	NA	0.61	6.03	0.56	5.23e-8	Aortic root size;
SKCM	cis	rs2153535	0.580	rs7743686	chr6:8526111	A/G	cg07606381	chr6:8435919	SLC35B3	0.93	6.8	0.61	1.92e-9	Motion sickness;
SKCM	cis	rs2721195	0.654	rs4610795	chr8:145881333	C/T	cg15857475	chr8:145742913	RECQL4;LRRC14	-0.87	-7.61	-0.65	5.3e-11	Age at first birth;
SKCM	cis	rs3820068	0.603	rs17448778	chr1:15985306	A/G	cg24675056	chr1:15929824	NA	0.73	5.44	0.52	6.03e-7	Systolic blood pressure;
SKCM	cis	rs28386778	0.897	rs8077013	chr17:61850392	C/T	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs951366	0.528	rs1172198	chr1:205662718	C/T	cg14159672	chr1:205819179	PM20D1	0.79	6.02	0.56	5.35e-8	Menarche (age at onset);
SKCM	cis	rs9611565	0.659	rs4822037	chr22:41945113	G/T	cg03806693	chr22:41940476	POLR3H	-1.13	-7.48	-0.65	9.6e-11	Vitiligo;
SKCM	cis	rs752010	0.811	rs10749836	chr1:42086860	G/C	cg06885757	chr1:42089581	HIVEP3	0.49	4.83	0.48	6.73e-6	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs992157	0.735	rs13388024	chr2:219097773	A/G	cg20019365	chr2:219134978	PNKD;AAMP	0.72	6.4	0.59	1.07e-8	Colorectal cancer;
SKCM	cis	rs7772486	0.790	rs2253880	chr6:146200774	T/C	cg05347473	chr6:146136440	FBXO30	0.58	5.45	0.53	5.72e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6430585	0.528	rs111682961	chr2:136653848	C/T	cg07169764	chr2:136633963	MCM6	1.33	11.27	0.79	4.81e-18	Corneal structure;
SKCM	cis	rs9926296	0.605	rs6500449	chr16:89856393	T/C	cg26513180	chr16:89883248	FANCA	0.96	9.91	0.75	1.84e-15	Vitiligo;
SKCM	cis	rs4150161	0.591	rs1056616	chr16:84211718	C/T	cg10106505	chr16:84220380	TAF1C	-1.06	-5.35	-0.52	8.69e-7	Systolic blood pressure response to hydrochlorothiazide in hypertension;
SKCM	cis	rs9660180	0.875	rs4648727	chr1:1776269	C/A	cg13866156	chr1:1669148	SLC35E2	0.7	5.67	0.54	2.35e-7	Body mass index;
SKCM	cis	rs860295	0.812	rs11264363	chr1:155318308	C/G	cg02153340	chr1:155202674	NA	-0.74	-5.94	-0.56	7.48e-8	Body mass index;
SKCM	cis	rs9325144	0.647	rs12424190	chr12:39111206	A/T	cg26384229	chr12:38710491	ALG10B	-0.74	-6.76	-0.61	2.26e-9	Morning vs. evening chronotype;
SKCM	cis	rs72717009	0.778	rs9427400	chr1:161477204	C/T	cg23840854	chr1:161414152	NA	-0.99	-5.66	-0.54	2.44e-7	Rheumatoid arthritis;
SKCM	cis	rs801193	0.569	rs7800620	chr7:66223688	T/C	cg18876405	chr7:65276391	NA	0.61	6.02	0.56	5.36e-8	Aortic root size;
SKCM	cis	rs910316	1.000	rs12590452	chr14:75548756	T/C	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.89e-7	Height;
SKCM	cis	rs9894429	0.716	rs7405578	chr17:79588306	C/A	cg18240062	chr17:79603768	NPLOC4	0.92	10.41	0.76	2.09e-16	Eye color traits;
SKCM	cis	rs28386778	0.787	rs2665827	chr17:61961350	G/C	cg22520471	chr17:61851767	DDX42;CCDC47	0.79	5.33	0.52	9.37e-7	Prudent dietary pattern;
SKCM	cis	rs875971	0.830	rs778711	chr7:65851657	G/A	cg18876405	chr7:65276391	NA	0.63	6.34	0.58	1.39e-8	Aortic root size;
SKCM	cis	rs62238980	0.614	rs74925531	chr22:32417582	G/A	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs17376456	0.825	rs10072232	chr5:93398890	G/A	cg25358565	chr5:93447407	FAM172A	1.19	7.67	0.66	4.06e-11	Diabetic retinopathy;
SKCM	cis	rs10832963	1.000	rs4757676	chr11:18640477	C/T	cg20219074	chr11:18656078	SPTY2D1	0.8	6.7	0.6	2.86e-9	Breast cancer;
SKCM	cis	rs2243480	0.522	rs431168	chr7:65511604	G/T	cg18252515	chr7:66147081	NA	-1.39	-7.61	-0.65	5.44e-11	Diabetic kidney disease;
SKCM	cis	rs8072100	0.640	rs3851808	chr17:45425144	C/T	cg25173405	chr17:45401733	C17orf57	-0.61	-4.81	-0.48	7.08e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs8072100	0.967	rs8075411	chr17:45676760	C/T	cg25173405	chr17:45401733	C17orf57	0.58	5.23	0.51	1.39e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs372883	0.554	rs10154065	chr21:30749480	G/C	cg24692254	chr21:30365293	RNF160	0.66	5.14	0.5	1.96e-6	Pancreatic cancer;
SKCM	cis	rs6977660	1.000	rs13231036	chr7:19806141	G/A	cg07541023	chr7:19748670	TWISTNB	0.72	5.03	0.5	3.01e-6	Thyroid stimulating hormone;
SKCM	cis	rs6430585	0.528	rs12476127	chr2:136763242	A/G	cg07169764	chr2:136633963	MCM6	1.34	12.58	0.82	1.9e-20	Corneal structure;
SKCM	cis	rs6089829	0.962	rs6122350	chr20:61664617	A/G	cg08564027	chr20:61660810	NA	0.63	5.65	0.54	2.56e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs9910055	0.659	rs227584	chr17:42225547	A/C	cg13607699	chr17:42295918	UBTF	0.71	5.65	0.54	2.53e-7	Total body bone mineral density;
SKCM	cis	rs769267	0.931	rs2965193	chr19:19454828	G/A	cg26732615	chr19:19648335	CILP2;YJEFN3	-0.65	-5.91	-0.56	8.42e-8	Tonsillectomy;
SKCM	cis	rs12477438	0.765	rs6749059	chr2:99591021	G/C	cg26064155	chr2:99771622	LIPT1;TSGA10	-0.72	-4.79	-0.48	7.68e-6	Chronic sinus infection;
SKCM	cis	rs12477438	0.700	rs12467679	chr2:99654449	G/A	cg26064155	chr2:99771622	LIPT1;TSGA10	-0.72	-4.86	-0.48	6e-6	Chronic sinus infection;
SKCM	cis	rs2304069	1.000	rs216126	chr5:149428424	G/C	cg22760475	chr5:149380129	HMGXB3;TIGD6	0.87	5.98	0.56	6.46e-8	HIV-1 control;
SKCM	cis	rs875971	0.895	rs4718349	chr7:65909011	C/G	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	cis	rs10256972	0.521	rs7811577	chr7:1102829	C/G	cg09177884	chr7:1199841	ZFAND2A	-0.62	-4.78	-0.48	8.22e-6	Longevity;Endometriosis;
SKCM	cis	rs2727020	0.729	rs10839268	chr11:49380328	G/A	cg21546286	chr11:48923668	NA	-0.53	-4.77	-0.48	8.31e-6	Coronary artery disease;
SKCM	cis	rs3892630	0.824	rs34425841	chr19:33231619	C/T	cg22980127	chr19:33182716	NUDT19	1.36	7.75	0.66	2.87e-11	Red blood cell traits;
SKCM	cis	rs7119	0.667	rs907390	chr15:77902419	T/C	cg27398640	chr15:77910606	LINGO1	0.5	5.14	0.5	1.98e-6	Type 2 diabetes;
SKCM	cis	rs10751667	0.643	rs7395592	chr11:934094	C/G	cg06064525	chr11:970664	AP2A2	-0.55	-4.85	-0.48	6.12e-6	Alzheimer's disease (late onset);
SKCM	cis	rs2842992	0.768	rs2273824	chr6:160211445	C/T	cg11366901	chr6:160182831	ACAT2	0.84	7.09	0.63	5.2e-10	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs55823223	0.517	rs1551619	chr17:73885805	C/T	cg10935138	chr17:73851978	WBP2	1.13	6.53	0.59	5.98e-9	Psoriasis;
SKCM	cis	rs4819052	0.655	rs2330103	chr21:46694514	C/T	cg19498844	chr21:46707878	POFUT2;LOC642852	0.83	7.01	0.62	7.55e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs4481887	0.927	rs9651176	chr1:248447343	A/G	cg00666640	chr1:248458726	OR2T12	0.58	4.88	0.48	5.46e-6	Common traits (Other);
SKCM	cis	rs2153535	0.580	rs915352	chr6:8442766	G/A	cg07606381	chr6:8435919	SLC35B3	0.94	6.94	0.62	1.02e-9	Motion sickness;
SKCM	cis	rs2228479	0.717	rs11644967	chr16:89806614	T/A	cg00800038	chr16:89945340	TCF25	-0.85	-4.95	-0.49	4.2e-6	Skin colour saturation;
SKCM	cis	rs6665290	0.935	rs11588904	chr1:227196211	T/C	cg10327440	chr1:227177885	CDC42BPA	-1.24	-17.42	-0.89	1.29e-28	Myeloid white cell count;
SKCM	cis	rs8177253	0.896	rs34252038	chr3:133490621	G/T	cg16414030	chr3:133502952	NA	-0.7	-5.93	-0.56	7.88e-8	Iron status biomarkers;
SKCM	cis	rs12497850	0.931	rs9311434	chr3:48884147	T/C	cg06212747	chr3:49208901	KLHDC8B	0.68	4.89	0.48	5.28e-6	Parkinson's disease;
SKCM	cis	rs1577917	0.958	rs10944136	chr6:86448499	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.78	-7.25	-0.63	2.67e-10	Response to antipsychotic treatment;
SKCM	cis	rs995000	0.965	rs1168046	chr1:62983693	A/C	cg06896770	chr1:63153194	DOCK7	-0.74	-6.81	-0.61	1.77e-9	Triglyceride levels;
SKCM	trans	rs1814175	0.559	rs1818892	chr11:49863084	C/A	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs8053891	0.585	rs12926804	chr16:71994932	A/G	cg04254540	chr16:71951199	KIAA0174	-1.1	-6.0	-0.56	5.8e-8	Coronary artery disease;
SKCM	cis	rs7590720	0.819	rs6435931	chr2:216892754	C/G	cg12620499	chr2:216877984	MREG	0.96	10.23	0.76	4.63e-16	Alcohol dependence;
SKCM	cis	rs72615157	0.634	rs74774557	chr7:99810425	A/G	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.22	8.34	0.69	2.08e-12	Lung function (FEV1/FVC);
SKCM	cis	rs9858542	1.000	rs4283605	chr3:49678651	A/G	cg03060546	chr3:49711283	APEH	-0.76	-5.67	-0.54	2.31e-7	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs1552244	0.572	rs66514627	chr3:10166632	A/C	cg00149659	chr3:10157352	C3orf10	1.13	5.45	0.53	5.74e-7	Alzheimer's disease;
SKCM	cis	rs6088580	0.609	rs945674	chr20:32964247	G/C	cg24642439	chr20:33292090	TP53INP2	-0.76	-6.02	-0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs864745	0.579	rs849336	chr7:28224053	A/G	cg15170557	chr7:28214983	JAZF1	-0.53	-4.95	-0.49	4.18e-6	Crohn's disease;Type 2 diabetes;
SKCM	cis	rs6952808	0.582	rs10479762	chr7:2045351	T/C	cg21782813	chr7:2030301	MAD1L1	-0.57	-6.12	-0.57	3.59e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs2286503	0.752	rs2286504	chr7:22854847	G/T	cg15401507	chr7:22894281	NA	-0.55	-5.07	-0.5	2.58e-6	Fibrinogen;
SKCM	cis	rs17685	0.671	rs10274404	chr7:75706634	G/A	cg16684958	chr7:75615977	POR	0.57	5.54	0.53	4e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs9910055	0.762	rs2240226	chr17:42266218	C/T	cg10896456	chr17:42255109	ASB16;C17orf65	0.66	6.43	0.59	9.35e-9	Total body bone mineral density;
SKCM	cis	rs6570726	0.764	rs9322028	chr6:145895797	G/T	cg23711669	chr6:146136114	FBXO30	0.87	8.94	0.71	1.44e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4974559	0.895	rs28493051	chr4:1331030	A/C	cg02980000	chr4:1222292	CTBP1	0.8	5.18	0.51	1.68e-6	Systolic blood pressure;
SKCM	cis	rs932287	0.536	rs10840160	chr11:9053536	C/T	cg21881798	chr11:8931708	C11orf17;ST5	-0.62	-5.34	-0.52	8.98e-7	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2658782	0.756	rs3019223	chr11:93084182	G/A	cg15737290	chr11:93063684	CCDC67	0.81	5.48	0.53	4.98e-7	Pulmonary function decline;
SKCM	cis	rs6952808	0.692	rs11765549	chr7:2027311	G/T	cg21782813	chr7:2030301	MAD1L1	0.57	5.92	0.56	8.2e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs427394	0.659	rs274674	chr5:6755460	C/T	cg10857441	chr5:6722123	POLS	-0.65	-6.96	-0.62	9.31e-10	Menopause (age at onset);
SKCM	cis	rs561341	1.000	rs542132	chr17:30307193	A/T	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs453301	0.506	rs476845	chr8:8622877	A/G	cg15556689	chr8:8085844	FLJ10661	-0.63	-5.77	-0.55	1.54e-7	Joint mobility (Beighton score);
SKCM	cis	rs17376456	0.757	rs1031424	chr5:93139706	G/C	cg21475434	chr5:93447410	FAM172A	0.95	5.36	0.52	8.36e-7	Diabetic retinopathy;
SKCM	cis	rs3820068	0.581	rs56128111	chr1:15928948	T/G	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs6570726	0.935	rs376991	chr6:145828073	G/C	cg23711669	chr6:146136114	FBXO30	0.7	6.64	0.6	3.72e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2019137	0.560	rs10206269	chr2:113990393	C/A	cg23156509	chr2:114033830	PAX8;LOC440839	-0.57	-4.79	-0.48	7.93e-6	Lymphocyte counts;
SKCM	cis	rs7945705	0.967	rs10769973	chr11:8928615	C/G	cg13070366	chr11:9386451	NA	-0.65	-5.57	-0.53	3.47e-7	Hemoglobin concentration;
SKCM	cis	rs995000	0.931	rs4329540	chr1:63027024	C/T	cg06896770	chr1:63153194	DOCK7	-0.72	-6.46	-0.59	8.17e-9	Triglyceride levels;
SKCM	cis	rs2652834	1.000	rs7181141	chr15:63398552	A/G	cg04194852	chr15:63334506	TPM1	0.76	4.78	0.48	8.15e-6	HDL cholesterol;
SKCM	cis	rs1549118	0.669	rs11621178	chr14:78375228	A/G	cg02326285	chr14:79111719	NRXN3	0.58	4.84	0.48	6.47e-6	Resting heart rate;
SKCM	cis	rs10876993	0.890	rs1678516	chr12:58047458	G/A	cg18357645	chr12:58087776	OS9	0.61	5.65	0.54	2.52e-7	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs2811415	0.597	rs9821500	chr3:127734929	T/C	cg09089421	chr3:127803668	RUVBL1	1.0	8.57	0.7	7.53e-13	Lung function (FEV1/FVC);
SKCM	cis	rs823143	0.570	rs823084	chr1:205798313	G/T	cg11965913	chr1:205819406	PM20D1	0.98	10.97	0.78	1.81e-17	Monocyte percentage of white cells;
SKCM	cis	rs6840360	0.571	rs4696110	chr4:152671325	G/A	cg22705602	chr4:152727874	NA	-0.6	-8.01	-0.67	8.85e-12	Intelligence (multi-trait analysis);
SKCM	cis	rs936229	0.768	rs936226	chr15:75069282	C/T	cg14664628	chr15:75095509	CSK	-1.16	-9.61	-0.74	7.2e-15	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin);
SKCM	cis	rs7809950	0.817	rs2237671	chr7:107131528	A/T	cg23024343	chr7:107201750	COG5	-0.83	-7.82	-0.66	2.06e-11	Coronary artery disease;
SKCM	cis	rs6138458	1.000	rs6707	chr20:24944166	C/T	cg26195577	chr20:24973756	C20orf3	1.29	8.85	0.71	2.07e-13	Blood protein levels;
SKCM	cis	rs6570726	0.935	rs367612	chr6:145828987	A/G	cg23711669	chr6:146136114	FBXO30	0.71	6.9	0.62	1.21e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4790333	1.000	rs4790333	chr17:2262703	A/G	cg02569219	chr17:2266849	SGSM2	-0.78	-6.92	-0.62	1.1e-9	Proinsulin levels;
SKCM	cis	rs6066825	0.644	rs761272	chr20:47315581	A/G	cg18078177	chr20:47281410	PREX1	0.64	5.2	0.51	1.57e-6	Colorectal cancer;
SKCM	cis	rs7177699	0.581	rs7181432	chr15:79123779	C/T	cg04896959	chr15:78267971	NA	-0.54	-4.84	-0.48	6.39e-6	Post bronchodilator FEV1/FVC ratio;Post bronchodilator FEV1;
SKCM	cis	rs4481887	0.927	rs4534422	chr1:248479482	A/G	cg00666640	chr1:248458726	OR2T12	0.66	6.0	0.56	5.9e-8	Common traits (Other);
SKCM	cis	rs9815354	0.767	rs73830585	chr3:42003698	T/A	cg03022575	chr3:42003672	ULK4	1.0	5.0	0.49	3.43e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs9894429	0.789	rs8074989	chr17:79598728	G/C	cg18240062	chr17:79603768	NPLOC4	0.91	10.35	0.76	2.68e-16	Eye color traits;
SKCM	cis	rs9640161	0.789	rs4554381	chr7:150025567	G/A	cg10018233	chr7:150070692	REPIN1	0.77	6.19	0.57	2.62e-8	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs35146811	0.844	rs59261051	chr7:99650429	C/T	cg13334819	chr7:99746414	C7orf59	-0.75	-5.37	-0.52	7.8e-7	Coronary artery disease;
SKCM	cis	rs7336332	0.598	rs76249173	chr13:28010445	A/G	cg22138327	chr13:27999177	GTF3A	0.9	6.4	0.59	1.07e-8	Weight;
SKCM	cis	rs9604529	0.628	rs61967980	chr13:114743579	T/C	cg04826882	chr13:114838756	RASA3	-0.99	-4.79	-0.48	7.76e-6	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs951366	0.559	rs823101	chr1:205667006	T/C	cg24503407	chr1:205819492	PM20D1	0.67	5.03	0.49	3.05e-6	Menarche (age at onset);
SKCM	cis	rs6570726	0.935	rs401888	chr6:145831535	A/G	cg23711669	chr6:146136114	FBXO30	0.7	6.64	0.6	3.72e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs10256972	0.621	rs2363285	chr7:1091644	C/T	cg11360546	chr7:1094263	C7orf50	-0.42	-5.15	-0.5	1.93e-6	Longevity;Endometriosis;
SKCM	cis	rs9916302	0.851	rs7220650	chr17:37487168	A/G	cg07936489	chr17:37558343	FBXL20	0.81	7.21	0.63	3.09e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs912057	0.609	rs1294431	chr6:6745003	G/C	cg06612196	chr6:6737390	NA	0.66	5.44	0.52	6.01e-7	Waist-to-hip ratio adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);
SKCM	cis	rs28595532	0.920	rs17258830	chr4:119725543	A/T	cg14228332	chr4:119757509	SEC24D	-1.07	-5.49	-0.53	4.77e-7	Cannabis dependence symptom count;
SKCM	cis	rs5769765	0.837	rs4824110	chr22:50271631	T/A	cg22709217	chr22:50311962	ALG12;CRELD2	0.79	5.71	0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs17345786	0.861	rs74768235	chr3:101142821	T/C	cg12386194	chr3:101231763	SENP7	0.73	5.36	0.52	8.23e-7	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6582630	0.519	rs1851130	chr12:38507819	C/T	cg26384229	chr12:38710491	ALG10B	0.79	6.11	0.57	3.66e-8	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs1048238	0.506	rs848195	chr1:16286522	A/G	cg21385522	chr1:16154831	NA	-0.62	-5.32	-0.52	9.58e-7	Systolic blood pressure;
SKCM	cis	rs9902453	0.780	rs57037139	chr17:28173283	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.83	5.76	0.55	1.61e-7	Coffee consumption (cups per day);
SKCM	trans	rs11083271	0.590	rs57432702	chr18:25858076	C/G	cg00321150	chr11:62623587	SNORD27;SLC3A2;SNHG1;SNORD28;SNORD25;SNORD26	0.8	7.29	0.64	2.17e-10	Non-alcoholic fatty liver disease histology (lobular);
SKCM	cis	rs7208859	0.573	rs8064686	chr17:29134839	C/T	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs6840360	0.615	rs7669761	chr4:152609304	G/A	cg22705602	chr4:152727874	NA	-0.61	-7.83	-0.66	2.04e-11	Intelligence (multi-trait analysis);
SKCM	trans	rs1814175	0.817	rs10839358	chr11:49770972	G/A	cg15704280	chr7:45808275	SEPT13	-1.03	-10.73	-0.77	5.17e-17	Height;
SKCM	cis	rs10927875	0.596	rs1806990	chr1:16129377	G/A	cg21385522	chr1:16154831	NA	-0.98	-11.21	-0.79	6.28e-18	Dilated cardiomyopathy;
SKCM	cis	rs4819052	0.851	rs2236445	chr21:46678453	T/C	cg02159808	chr21:46707872	POFUT2;LOC642852	0.74	5.83	0.55	1.2e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs8060686	0.621	rs35432211	chr16:68095449	T/C	cg04539111	chr16:67997858	SLC12A4	-0.85	-4.81	-0.48	7.14e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs501120	1.000	rs622956	chr10:44755183	A/G	cg09554077	chr10:44749378	NA	0.38	4.93	0.49	4.52e-6	Coronary artery disease;Coronary heart disease;
SKCM	cis	rs10911232	0.507	rs10752890	chr1:183021910	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.66	0.6	3.53e-9	Hypertriglyceridemia;
SKCM	cis	rs16940212	0.618	rs7497636	chr15:58685631	C/T	cg16767221	chr15:57769667	CGNL1	-0.58	-4.87	-0.48	5.69e-6	HDL cholesterol levels;HDL cholesterol;
SKCM	cis	rs7599312	0.534	rs10180824	chr2:213407975	G/A	cg16329650	chr2:213403929	ERBB4	0.84	6.04	0.56	4.85e-8	BMI (adjusted for smoking behaviour);BMI in non-smokers;Body mass index;Body mass index (joint analysis main effects and smoking interaction);
SKCM	cis	rs4808199	0.948	rs8108647	chr19:19427623	A/G	cg03709012	chr19:19516395	GATAD2A	1.08	7.53	0.65	7.65e-11	Nonalcoholic fatty liver disease;
SKCM	cis	rs4925325	0.876	rs6089560	chr20:60517325	T/G	cg16423285	chr20:60520624	NA	-1.02	-7.32	-0.64	1.94e-10	Obesity-related traits;
SKCM	cis	rs28386778	0.897	rs2137144	chr17:61805607	G/A	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	10.83	0.77	3.28e-17	Prudent dietary pattern;
SKCM	cis	rs684232	0.688	rs2657633	chr17:600502	C/T	cg12384639	chr17:618140	VPS53	0.72	5.68	0.54	2.2e-7	Prostate cancer;
SKCM	cis	rs514406	0.893	rs6661115	chr1:53426148	G/A	cg16325326	chr1:53192061	ZYG11B	-0.86	-8.31	-0.69	2.4e-12	Monocyte count;
SKCM	cis	rs1005277	0.579	rs9418322	chr10:38377296	G/T	cg25427524	chr10:38739819	LOC399744	-0.69	-6.45	-0.59	8.73e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs11098499	0.863	rs6853998	chr4:120475860	C/A	cg24375607	chr4:120327624	NA	0.69	5.47	0.53	5.35e-7	Corneal astigmatism;
SKCM	cis	rs1799949	0.965	rs9897425	chr17:41430179	C/G	cg23758822	chr17:41437982	NA	0.92	7.82	0.66	2.09e-11	Menopause (age at onset);
SKCM	cis	rs2777491	0.957	rs1757454	chr15:41777934	A/G	cg18705301	chr15:41695430	NDUFAF1	-0.9	-8.79	-0.71	2.78e-13	Ulcerative colitis;
SKCM	cis	rs6089829	0.889	rs6062773	chr20:61663262	G/C	cg08564027	chr20:61660810	NA	0.63	5.65	0.54	2.56e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs3768617	0.510	rs35968946	chr1:183114871	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.76	7.28	0.64	2.3e-10	Fuchs's corneal dystrophy;
SKCM	cis	rs9815354	0.767	rs17280980	chr3:41810949	A/T	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs7811142	1.000	rs4472444	chr7:100070758	T/C	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.23	7.89	0.67	1.53e-11	Platelet count;
SKCM	cis	rs1707322	1.000	rs1768807	chr1:46510570	A/G	cg03146154	chr1:46216737	IPP	-0.77	-5.36	-0.52	8.35e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs9322193	0.923	rs2342765	chr6:150180009	C/G	cg05036130	chr6:150231994	NA	0.52	5.39	0.52	7.24e-7	Lung cancer;
SKCM	cis	rs2153535	0.580	rs1577467	chr6:8444241	G/A	cg23788917	chr6:8435910	SLC35B3	0.69	5.14	0.5	1.99e-6	Motion sickness;
SKCM	cis	rs8060686	0.641	rs116821144	chr16:68081341	A/G	cg09117114	chr16:67998030	SLC12A4	-0.78	-5.08	-0.5	2.5e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs1790761	0.554	rs3758938	chr11:67402362	T/G	cg00290607	chr11:67383545	NA	-0.67	-6.59	-0.6	4.74e-9	Mean corpuscular volume;
SKCM	cis	rs7772486	0.790	rs6923545	chr6:146244743	A/G	cg05347473	chr6:146136440	FBXO30	-0.55	-4.97	-0.49	3.82e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs11249608	0.600	rs13359570	chr5:178449249	T/G	cg21905437	chr5:178450457	ZNF879	0.71	6.0	0.56	5.9e-8	Pubertal anthropometrics;
SKCM	cis	rs2760061	0.583	rs708113	chr1:228192753	T/A	cg02753203	chr1:228287806	NA	0.8	7.41	0.64	1.29e-10	Diastolic blood pressure;
SKCM	cis	rs9325144	0.555	rs10748433	chr12:38696352	C/G	cg26384229	chr12:38710491	ALG10B	0.78	6.74	0.61	2.48e-9	Morning vs. evening chronotype;
SKCM	cis	rs1577917	0.917	rs12202170	chr6:86590386	A/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.86	-8.66	-0.7	4.89e-13	Response to antipsychotic treatment;
SKCM	cis	rs34172651	0.517	rs34172679	chr16:24840381	C/T	cg06028605	chr16:24865363	SLC5A11	0.56	4.93	0.49	4.61e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9814567	1.000	rs9876658	chr3:134179453	A/G	cg06109529	chr3:134205091	CEP63;ANAPC13	0.59	4.86	0.48	6.05e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs1799949	1.000	rs8176109	chr17:41265776	A/G	cg23758822	chr17:41437982	NA	0.92	7.68	0.66	3.96e-11	Menopause (age at onset);
SKCM	cis	rs1348850	0.958	rs12471741	chr2:178448196	A/G	cg02961200	chr2:178257176	LOC100130691;AGPS	0.78	6.01	0.56	5.57e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs11155671	0.530	rs4458704	chr6:150232879	A/C	cg05036130	chr6:150231994	NA	0.57	5.57	0.53	3.45e-7	Testicular germ cell tumor;
SKCM	cis	rs9943753	0.525	rs7957928	chr12:109835975	C/G	cg19025524	chr12:109796872	NA	-0.6	-5.63	-0.54	2.69e-7	HDL cholesterol;
SKCM	cis	rs10504229	1.000	rs3814486	chr8:58191226	A/T	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs2070488	0.699	rs6599205	chr3:38529440	C/G	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.73	5.78	0.55	1.47e-7	Electrocardiographic conduction measures;
SKCM	cis	rs7772486	0.714	rs1883365	chr6:146076749	C/T	cg05347473	chr6:146136440	FBXO30	-0.55	-5.11	-0.5	2.22e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs854765	0.583	rs9635697	chr17:17870394	T/A	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.01	7.49	0.65	9.28e-11	Total body bone mineral density;
SKCM	cis	rs2073499	1.000	rs4141060	chr3:50300117	T/C	cg05260129	chr3:50388622	TUSC4;CYB561D2	0.88	5.71	0.54	1.98e-7	Schizophrenia;
SKCM	trans	rs561341	0.883	rs6505274	chr17:30344581	G/T	cg20587970	chr11:113659929	NA	-1.08	-9.66	-0.74	5.77e-15	Hip circumference adjusted for BMI;
SKCM	cis	rs709400	0.663	rs7145113	chr14:103945414	A/G	cg26031613	chr14:104095156	KLC1	0.77	5.96	0.56	6.87e-8	Body mass index;
SKCM	cis	rs2304069	0.954	rs1469691	chr5:149386716	G/A	cg22760475	chr5:149380129	HMGXB3;TIGD6	0.84	6.09	0.57	3.98e-8	HIV-1 control;
SKCM	cis	rs1401999	0.714	rs13066518	chr3:183635498	T/A	cg01324343	chr3:183735012	ABCC5	0.66	6.27	0.58	1.86e-8	Anterior chamber depth;
SKCM	cis	rs514406	0.798	rs575138	chr1:53328394	C/G	cg24675658	chr1:53192096	ZYG11B	-0.79	-6.62	-0.6	4.04e-9	Monocyte count;
SKCM	cis	rs1059312	0.966	rs12368452	chr12:129277164	C/A	cg09035930	chr12:129282057	SLC15A4	0.82	8.72	0.7	3.79e-13	Systemic lupus erythematosus;
SKCM	cis	rs2836974	0.897	rs8128102	chr21:40606414	G/A	cg17971929	chr21:40555470	PSMG1	0.9	8.81	0.71	2.52e-13	Cognitive function;
SKCM	cis	rs908922	0.676	rs11205018	chr1:152496249	T/G	cg09873164	chr1:152488093	CRCT1	0.76	5.93	0.56	7.7e-8	Hair morphology;
SKCM	cis	rs3820068	0.603	rs998032	chr1:15989918	T/C	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs6089584	0.566	rs2146852	chr20:60616492	T/G	cg06108461	chr20:60628389	TAF4	-0.73	-6.66	-0.6	3.43e-9	Body mass index;
SKCM	cis	rs9581857	0.547	rs1235848	chr13:28111559	G/T	cg22138327	chr13:27999177	GTF3A	-0.85	-5.62	-0.54	2.9e-7	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs2764980	1.000	rs2764980	chr10:3284007	C/T	cg11630169	chr10:3283847	NA	0.62	5.43	0.52	6.19e-7	Attention deficit hyperactivity disorder and conduct disorder;
SKCM	cis	rs4891159	0.584	rs690397	chr18:74117767	C/T	cg24786174	chr18:74118243	ZNF516	0.81	8.75	0.7	3.24e-13	Longevity;
SKCM	cis	rs7811142	0.943	rs28578163	chr7:100044754	A/G	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.17	7.71	0.66	3.44e-11	Platelet count;
SKCM	cis	rs793571	0.502	rs411007	chr15:59078502	G/C	cg05156742	chr15:59063176	FAM63B	0.74	5.95	0.56	7.32e-8	Schizophrenia;
SKCM	cis	rs3768617	0.510	rs10797851	chr1:183098001	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs2243480	1.000	rs13220979	chr7:65363204	G/A	cg18252515	chr7:66147081	NA	-1.29	-7.41	-0.64	1.3e-10	Diabetic kidney disease;
SKCM	cis	rs10911232	0.507	rs4642853	chr1:182996242	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.64	0.6	3.83e-9	Hypertriglyceridemia;
SKCM	cis	rs2070488	0.775	rs2051213	chr3:38560254	C/T	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.74	5.88	0.55	9.48e-8	Electrocardiographic conduction measures;
SKCM	cis	rs440932	0.757	rs330945	chr8:9021933	T/C	cg15556689	chr8:8085844	FLJ10661	0.62	4.88	0.48	5.56e-6	High light scatter reticulocyte percentage of red cells;
SKCM	cis	rs9796	0.835	rs28455998	chr15:41430969	T/A	cg18705301	chr15:41695430	NDUFAF1	-0.72	-5.31	-0.52	9.9e-7	Menopause (age at onset);
SKCM	cis	rs10256972	0.684	rs4724039	chr7:1111633	A/G	cg16145915	chr7:1198662	ZFAND2A	-0.46	-5.72	-0.54	1.84e-7	Longevity;Endometriosis;
SKCM	cis	rs4900538	0.963	rs4906205	chr14:102932447	A/G	cg18135206	chr14:102964638	TECPR2	0.75	5.89	0.55	9.35e-8	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs7793919	0.726	rs10261971	chr7:4776547	A/G	cg09789173	chr7:4769017	FOXK1	0.91	7.04	0.62	6.66e-10	Mosquito bite size;
SKCM	cis	rs9733	0.621	rs12746899	chr1:150579678	A/T	cg13175981	chr1:150552382	MCL1	0.72	6.31	0.58	1.57e-8	Tonsillectomy;
SKCM	cis	rs709400	0.659	rs3825566	chr14:103852725	C/T	cg26031613	chr14:104095156	KLC1	-0.75	-5.99	-0.56	6.14e-8	Body mass index;
SKCM	cis	rs1799949	0.864	rs60309406	chr17:41435665	C/T	cg05368731	chr17:41323189	NBR1	0.88	7.53	0.65	7.47e-11	Menopause (age at onset);
SKCM	cis	rs754466	0.651	rs10824582	chr10:79603688	T/C	cg17075019	chr10:79541650	NA	-0.72	-6.4	-0.59	1.07e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs10504073	0.647	rs62507246	chr8:50013449	G/A	cg00325661	chr8:49890786	NA	0.79	6.79	0.61	1.99e-9	Blood metabolite ratios;
SKCM	cis	rs9467773	0.873	rs9295698	chr6:26566099	T/A	cg15659132	chr6:26577336	NA	0.6	5.71	0.54	1.99e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7666738	0.791	rs7665273	chr4:98997413	C/A	cg05340658	chr4:99064831	C4orf37	0.7	5.45	0.53	5.66e-7	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1005277	0.579	rs2474586	chr10:38418882	T/C	cg00409905	chr10:38381863	ZNF37A	-0.66	-6.16	-0.57	3e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs55794721	0.509	rs12027135	chr1:25775733	A/T	cg27572855	chr1:25598939	RHD	0.53	5.06	0.5	2.67e-6	Plateletcrit;Mean corpuscular volume;
SKCM	cis	rs7552404	0.889	rs1250874	chr1:76190978	A/G	cg22875332	chr1:76189707	ACADM	0.7	4.82	0.48	6.96e-6	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs11098499	0.863	rs34308924	chr4:120481431	T/C	cg24375607	chr4:120327624	NA	0.69	5.47	0.53	5.35e-7	Corneal astigmatism;
SKCM	cis	rs2204008	0.540	rs1672425	chr12:38122842	G/A	cg26384229	chr12:38710491	ALG10B	-0.67	-5.47	-0.53	5.23e-7	Bladder cancer;
SKCM	cis	rs3820928	0.839	rs4673174	chr2:227801316	A/T	cg11843606	chr2:227700838	RHBDD1	-0.6	-4.81	-0.48	7.34e-6	Pulmonary function;
SKCM	cis	rs4819052	0.851	rs2838864	chr21:46711474	A/T	cg02159808	chr21:46707872	POFUT2;LOC642852	-0.7	-5.24	-0.51	1.33e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs4853012	0.941	rs78128123	chr2:74347525	C/T	cg05890377	chr2:74357713	NA	0.61	4.87	0.48	5.79e-6	Gestational age at birth (maternal effect);
SKCM	cis	rs6089829	0.962	rs4586690	chr20:61658595	G/T	cg08564027	chr20:61660810	NA	0.62	5.55	0.53	3.75e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs1692580	0.807	rs4648627	chr1:2200404	C/T	cg24578937	chr1:2090814	PRKCZ	0.47	5.16	0.5	1.81e-6	Coronary artery disease;
SKCM	cis	rs7945705	0.692	rs2742470	chr11:9004002	C/T	cg21881798	chr11:8931708	C11orf17;ST5	-0.84	-9.3	-0.72	2.89e-14	Hemoglobin concentration;
SKCM	cis	rs1801251	1.000	rs12474040	chr2:233615345	T/G	cg25237894	chr2:233734115	C2orf82	0.56	5.33	0.52	9.23e-7	Coronary artery disease;
SKCM	cis	rs11749727	0.623	rs13153506	chr5:179607388	A/G	cg03126616	chr5:179003843	RUFY1	0.53	4.87	0.48	5.69e-6	Initial pursuit acceleration;
SKCM	cis	rs13118159	0.509	rs4974554	chr4:1356967	A/C	cg19318889	chr4:1322082	MAEA	0.77	5.52	0.53	4.34e-7	Longevity;
SKCM	cis	rs10504229	0.569	rs75466737	chr8:58055034	A/G	cg02725872	chr8:58115012	NA	-0.54	-5.04	-0.5	2.97e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs4974559	0.790	rs28712208	chr4:1316695	A/T	cg02980000	chr4:1222292	CTBP1	0.89	5.33	0.52	9.41e-7	Systolic blood pressure;
SKCM	cis	rs4481887	1.000	rs10888362	chr1:248483975	A/G	cg00666640	chr1:248458726	OR2T12	-0.61	-5.82	-0.55	1.26e-7	Common traits (Other);
SKCM	cis	rs208520	0.690	rs176289	chr6:66766522	C/T	cg07460842	chr6:66804631	NA	-0.92	-6.93	-0.62	1.09e-9	Exhaled nitric oxide output;
SKCM	cis	rs62103177	0.759	rs7227794	chr18:77610925	C/T	cg27393146	chr18:77495563	CTDP1	-0.95	-5.5	-0.53	4.56e-7	Opioid sensitivity;
SKCM	cis	rs6860806	0.507	rs2631362	chr5:131707293	A/G	cg24060327	chr5:131705240	SLC22A5	0.76	4.81	0.48	7.23e-6	Breast cancer;
SKCM	cis	rs9325144	0.723	rs3887436	chr12:39189526	A/C	cg13010199	chr12:38710504	ALG10B	-0.58	-4.78	-0.48	8.04e-6	Morning vs. evening chronotype;
SKCM	cis	rs7937682	0.961	rs11828343	chr11:111491322	A/G	cg19812747	chr11:111475976	SIK2	0.56	4.94	0.49	4.39e-6	Primary sclerosing cholangitis;
SKCM	cis	rs4423214	1.000	rs2276362	chr11:71174452	A/G	cg05163923	chr11:71159392	DHCR7	0.83	8.11	0.68	5.77e-12	Vitamin D levels;
SKCM	cis	rs10791097	0.694	rs2155751	chr11:130755240	G/A	cg12179176	chr11:130786555	SNX19	0.91	8.24	0.68	3.24e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs7811142	1.000	rs11764818	chr7:100043055	G/A	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.23	7.89	0.67	1.53e-11	Platelet count;
SKCM	cis	rs9905704	0.624	rs34718875	chr17:57072461	G/A	cg05425664	chr17:57184151	TRIM37	-0.6	-4.95	-0.49	4.15e-6	Testicular germ cell tumor;
SKCM	cis	rs9815354	0.812	rs113300894	chr3:41984243	G/C	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs72827839	0.740	rs72823509	chr17:46044589	G/A	cg23391107	chr17:45924227	SP6	0.65	5.2	0.51	1.54e-6	Ease of getting up in the morning;
SKCM	cis	rs420259	0.516	rs6497664	chr16:23485353	G/C	cg10006042	chr16:23042421	NA	-0.37	-4.91	-0.49	4.87e-6	Bipolar disorder;
SKCM	cis	rs1046896	0.594	rs9914570	chr17:80783721	C/T	cg22027946	chr17:80790580	TBCD;ZNF750	0.7	5.29	0.51	1.09e-6	Glycated hemoglobin levels;
SKCM	cis	rs7945705	0.967	rs7123861	chr11:8892323	G/A	cg13070366	chr11:9386451	NA	-0.59	-5.1	-0.5	2.36e-6	Hemoglobin concentration;
SKCM	cis	rs6952808	0.929	rs11761270	chr7:1923695	C/T	cg05863683	chr7:1912471	MAD1L1	0.63	5.64	0.54	2.58e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs950776	0.518	rs8053	chr15:78841220	T/C	cg06917634	chr15:78832804	PSMA4	-1.01	-10.48	-0.76	1.5e-16	Sudden cardiac arrest;
SKCM	cis	rs28374715	0.733	rs7167706	chr15:41569644	C/A	cg18705301	chr15:41695430	NDUFAF1	-1.04	-9.5	-0.73	1.18e-14	Ulcerative colitis;
SKCM	cis	rs63406760	1	rs63406760	chr12:123742692	TG/T	cg00376283	chr12:123451042	ABCB9	0.84	5.91	0.56	8.5e-8	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs701145	0.585	rs1727920	chr3:153788588	C/T	cg17054900	chr3:154042577	DHX36	1.18	5.21	0.51	1.51e-6	Coronary artery disease;
SKCM	cis	rs9910055	0.512	rs7209801	chr17:42323376	G/A	cg19774624	chr17:42201019	HDAC5	-0.79	-5.63	-0.54	2.78e-7	Total body bone mineral density;
SKCM	cis	rs7216064	0.953	rs12450907	chr17:65870644	T/G	cg12091567	chr17:66097778	LOC651250	-0.75	-5.27	-0.51	1.19e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs6546550	0.901	rs6546556	chr2:70139001	A/G	cg02498382	chr2:70120550	SNRNP27	-0.45	-4.88	-0.48	5.4e-6	Prevalent atrial fibrillation;
SKCM	cis	rs854765	0.547	rs7224047	chr17:17932931	G/A	cg04398451	chr17:18023971	MYO15A	-0.94	-7.53	-0.65	7.5e-11	Total body bone mineral density;
SKCM	cis	rs7777484	0.534	rs2258709	chr7:2832365	C/T	cg09658497	chr7:2847517	GNA12	0.38	4.85	0.48	6.1e-6	Height;
SKCM	cis	rs3820068	0.532	rs72647105	chr1:15935238	C/G	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs769267	0.895	rs2315279	chr19:19479936	C/A	cg26732615	chr19:19648335	CILP2;YJEFN3	-0.69	-7.26	-0.64	2.46e-10	Tonsillectomy;
SKCM	cis	rs2153535	0.526	rs7748404	chr6:8472500	A/T	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs4975616	0.869	rs380286	chr5:1320247	G/A	cg06550200	chr5:1325588	CLPTM1L	-0.86	-7.74	-0.66	2.95e-11	Lung cancer;
SKCM	cis	rs854765	0.647	rs7406744	chr17:17981938	C/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.88	6.66	0.6	3.47e-9	Total body bone mineral density;
SKCM	cis	rs12477438	0.520	rs7605843	chr2:99811894	C/T	cg26064155	chr2:99771622	LIPT1;TSGA10	0.97	8.85	0.71	2.11e-13	Chronic sinus infection;
SKCM	cis	rs1568889	1.000	rs16917735	chr11:28119980	A/T	cg06544937	chr11:28130018	METT5D1;KIF18A	-0.87	-6.77	-0.61	2.19e-9	Bipolar disorder;
SKCM	cis	rs9911578	0.839	rs7208505	chr17:57187729	C/T	cg12560992	chr17:57184187	TRIM37	0.92	8.24	0.68	3.29e-12	Intelligence (multi-trait analysis);
SKCM	cis	rs1580019	0.587	rs10951338	chr7:32560089	A/G	cg06627557	chr7:32535165	LSM5;AVL9	0.94	9.12	0.72	6.39e-14	Cognitive ability;
SKCM	cis	rs694739	1.000	rs11231757	chr11:64106317	C/T	cg23796481	chr11:64053134	BAD;GPR137	0.79	6.22	0.58	2.27e-8	Alopecia areata;Crohn's disease;Psoriasis vulgaris;
SKCM	cis	rs763014	0.865	rs2384977	chr16:625388	C/T	cg09263875	chr16:632152	PIGQ	0.68	5.71	0.54	1.98e-7	Height;
SKCM	cis	rs7666738	0.830	rs7664340	chr4:99037820	C/T	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1355223	0.583	rs2941057	chr11:34882220	G/A	cg11058730	chr11:34937778	PDHX;APIP	0.63	5.08	0.5	2.51e-6	Systemic lupus erythematosus and Systemic sclerosis;
SKCM	cis	rs1005277	0.505	rs200910	chr10:38108176	C/T	cg25427524	chr10:38739819	LOC399744	-0.68	-6.52	-0.59	6.36e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs823143	0.570	rs823084	chr1:205798313	G/T	cg17178900	chr1:205818956	PM20D1	0.82	7.95	0.67	1.17e-11	Monocyte percentage of white cells;
SKCM	cis	rs13392177	0.637	rs61041183	chr2:219056380	G/A	cg00012203	chr2:219082015	ARPC2	0.68	5.24	0.51	1.32e-6	Pyoderma gangrenosum in inflammatory bowel disease;
SKCM	cis	rs757110	0.770	rs11024271	chr11:17395540	T/C	cg15432903	chr11:17409602	KCNJ11	0.51	4.86	0.48	6.04e-6	Type 2 diabetes;
SKCM	cis	rs16866061	1.000	rs2047134	chr2:225347713	A/C	cg12698349	chr2:225449008	CUL3	1.02	8.75	0.7	3.32e-13	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs7666738	0.830	rs28867388	chr4:98962794	A/T	cg05340658	chr4:99064831	C4orf37	0.64	4.91	0.49	4.97e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9880211	0.613	rs10222451	chr3:135877413	G/C	cg21827317	chr3:136751795	NA	-0.68	-5.3	-0.51	1.05e-6	Body mass index;Height;
SKCM	cis	rs854765	0.693	rs9907246	chr17:17770965	T/C	cg04398451	chr17:18023971	MYO15A	0.85	6.46	0.59	8.36e-9	Total body bone mineral density;
SKCM	cis	rs28595532	0.920	rs55726697	chr4:119742863	G/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs2204008	0.869	rs34438288	chr12:38211582	G/T	cg13010199	chr12:38710504	ALG10B	0.65	4.84	0.48	6.52e-6	Bladder cancer;
SKCM	cis	rs875971	0.540	rs781152	chr7:65479572	T/A	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.61	5.21	0.51	1.48e-6	Aortic root size;
SKCM	cis	rs514406	0.830	rs533935	chr1:53308807	T/C	cg16325326	chr1:53192061	ZYG11B	0.99	10.98	0.78	1.68e-17	Monocyte count;
SKCM	cis	rs1799949	1.000	rs8176296	chr17:41203591	T/C	cg25918947	chr17:41365094	TMEM106A	-0.62	-5.89	-0.55	9.22e-8	Menopause (age at onset);
SKCM	cis	rs16854884	0.657	rs35788195	chr3:143739311	C/T	cg06585982	chr3:143692056	C3orf58	0.83	7.55	0.65	6.97e-11	Economic and political preferences (feminism/equality);
SKCM	cis	rs933688	0.759	rs1423593	chr5:90752351	T/G	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.93	6.51	0.59	6.73e-9	Smoking behavior;
SKCM	cis	rs2463822	0.748	rs2513053	chr11:62109473	T/A	cg06239285	chr11:62104954	ASRGL1	1.25	5.93	0.56	7.79e-8	Chronic obstructive pulmonary disease-related biomarkers;
SKCM	cis	rs12971120	0.838	rs3794950	chr18:72182965	G/A	cg26446133	chr18:72167187	CNDP2	-0.71	-5.21	-0.51	1.52e-6	Refractive error;
SKCM	cis	rs10754283	0.934	rs1934043	chr1:90106645	C/T	cg21401794	chr1:90099060	LRRC8C	0.74	6.4	0.59	1.09e-8	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs798554	0.797	rs798493	chr7:2798731	A/G	cg04166393	chr7:2884313	GNA12	0.72	4.99	0.49	3.52e-6	Height;
SKCM	cis	rs875971	0.545	rs13311962	chr7:66068129	C/T	cg18876405	chr7:65276391	NA	-0.61	-4.91	-0.49	4.98e-6	Aortic root size;
SKCM	cis	rs992157	0.835	rs6729058	chr2:219148369	G/A	cg20019365	chr2:219134978	PNKD;AAMP	-0.71	-6.08	-0.57	4.22e-8	Colorectal cancer;
SKCM	cis	rs9611565	0.625	rs12483991	chr22:41935285	A/G	cg03806693	chr22:41940476	POLR3H	-0.79	-5.36	-0.52	8.05e-7	Vitiligo;
SKCM	cis	rs1692580	0.870	rs590367	chr1:2162944	C/T	cg24578937	chr1:2090814	PRKCZ	0.48	5.21	0.51	1.51e-6	Coronary artery disease;
SKCM	cis	rs951366	0.789	rs823121	chr1:205724302	A/G	cg17178900	chr1:205818956	PM20D1	-0.72	-5.79	-0.55	1.41e-7	Menarche (age at onset);
SKCM	cis	rs7772486	0.776	rs4316025	chr6:146238032	C/T	cg23711669	chr6:146136114	FBXO30	-0.74	-7.32	-0.64	1.89e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7192750	0.583	rs8046916	chr16:72047751	C/G	cg14768367	chr16:72042858	DHODH	-0.91	-4.83	-0.48	6.72e-6	LDL cholesterol levels;Total cholesterol levels;
SKCM	cis	rs9581857	0.685	rs60787915	chr13:28022298	C/T	cg22138327	chr13:27999177	GTF3A	0.72	5.05	0.5	2.88e-6	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs28595532	0.920	rs116366070	chr4:119764180	A/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs4400599	0.618	rs4393149	chr1:154195753	G/A	cg26808167	chr1:154192205	UBAP2L;C1orf43	-0.54	-4.9	-0.49	5.01e-6	Platelet distribution width;
SKCM	cis	rs7618501	0.633	rs12485600	chr3:50025530	A/G	cg05072774	chr3:49840536	C3orf54	-0.67	-5.06	-0.5	2.73e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs116095464	0.558	rs61689490	chr5:224904	T/C	cg22857025	chr5:266934	NA	-1.36	-8.0	-0.67	9.23e-12	Breast cancer;
SKCM	cis	rs1801251	1.000	rs1044480	chr2:233633736	A/G	cg25237894	chr2:233734115	C2orf82	0.59	5.66	0.54	2.45e-7	Coronary artery disease;
SKCM	cis	rs1018697	0.518	rs284846	chr10:104557290	T/C	cg04362960	chr10:104952993	NT5C2	-0.76	-4.81	-0.48	7.14e-6	Colorectal adenoma (advanced);
SKCM	cis	rs12142240	0.698	rs6679898	chr1:46820589	A/C	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs7786877	0.511	rs11770534	chr7:100245876	T/C	cg20848291	chr7:100343083	ZAN	-0.73	-5.48	-0.53	5.02e-7	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs12477438	0.520	rs34252185	chr2:99737646	A/G	cg14399236	chr2:99771627	LIPT1;TSGA10	1.0	9.4	0.73	1.85e-14	Chronic sinus infection;
SKCM	cis	rs2239547	0.522	rs6773040	chr3:52935428	C/A	cg11645453	chr3:52864694	ITIH4	-0.78	-7.13	-0.63	4.44e-10	Schizophrenia;
SKCM	cis	rs992157	0.710	rs6719789	chr2:219057810	G/T	cg20019365	chr2:219134978	PNKD;AAMP	-0.73	-6.41	-0.59	1.03e-8	Colorectal cancer;
SKCM	cis	rs28595532	0.920	rs114333298	chr4:119765305	C/A	cg11846333	chr4:119757529	SEC24D	1.21	6.55	0.6	5.6e-9	Cannabis dependence symptom count;
SKCM	cis	rs2749592	0.531	rs994804	chr10:37900140	A/C	cg00409905	chr10:38381863	ZNF37A	0.62	6.08	0.57	4.16e-8	Age-related hearing impairment (SNP x SNP interaction);
SKCM	cis	rs2120019	1.000	rs67544533	chr15:75361539	A/G	cg17294928	chr15:75287854	SCAMP5	-0.83	-7.08	-0.63	5.44e-10	Blood trace element (Zn levels);
SKCM	cis	rs4969178	0.965	rs4969179	chr17:76391454	A/C	cg20026190	chr17:76395443	PGS1	0.65	5.44	0.52	5.83e-7	HDL cholesterol levels;
SKCM	cis	rs9902453	1.000	rs12600855	chr17:28279591	A/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.79	5.66	0.54	2.42e-7	Coffee consumption (cups per day);
SKCM	cis	rs35766269	0.541	rs7081200	chr10:9044023	T/C	cg05671070	chr10:8095960	FLJ45983;GATA3	0.95	4.77	0.48	8.45e-6	Recalcitrant atopic dermatitis;
SKCM	cis	rs6840360	0.571	rs17360385	chr4:152587970	C/A	cg22705602	chr4:152727874	NA	-0.52	-5.66	-0.54	2.38e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs727563	0.635	rs2899348	chr22:42164516	C/G	cg03806693	chr22:41940476	POLR3H	1.17	6.7	0.6	2.92e-9	Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs12142240	0.698	rs72677587	chr1:46813982	G/A	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs5769765	1.000	rs2295409	chr22:50261060	G/C	cg22709217	chr22:50311962	ALG12;CRELD2	0.79	5.71	0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs10751667	0.621	rs7394862	chr11:927500	T/C	cg10932868	chr11:921992	NA	0.55	5.13	0.5	2.09e-6	Alzheimer's disease (late onset);
SKCM	cis	rs801193	0.569	rs2659892	chr7:66200305	A/G	cg11764359	chr7:65958608	NA	0.75	6.82	0.61	1.71e-9	Aortic root size;
SKCM	cis	rs4555082	0.915	rs79048296	chr14:105754944	G/A	cg13114125	chr14:105738426	BRF1	-0.65	-5.11	-0.5	2.27e-6	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs1577917	0.917	rs2084293	chr6:86566002	A/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.32	-0.52	9.66e-7	Response to antipsychotic treatment;
SKCM	cis	rs17065868	1.000	rs9525964	chr13:45065549	A/G	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs8017423	0.967	rs7151776	chr14:90724803	A/G	cg04374321	chr14:90722782	PSMC1	1.03	9.23	0.72	3.83e-14	Mortality in heart failure;
SKCM	trans	rs17685	0.925	rs1057868	chr7:75615006	C/T	cg19862616	chr7:65841803	NCRNA00174	0.91	7.93	0.67	1.29e-11	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs4972806	0.814	rs4246626	chr2:177046430	A/C	cg14324370	chr2:177042789	NA	0.58	5.31	0.52	1.01e-6	IgG glycosylation;
SKCM	cis	rs514406	0.861	rs12141260	chr1:53300127	C/T	cg16325326	chr1:53192061	ZYG11B	1.0	11.05	0.78	1.25e-17	Monocyte count;
SKCM	cis	rs2839186	0.868	rs2839199	chr21:47708269	T/C	cg05896524	chr21:47604654	C21orf56	0.69	5.67	0.54	2.29e-7	Testicular germ cell tumor;
SKCM	cis	rs10872587	0.657	rs11155459	chr6:146578751	A/G	cg05347473	chr6:146136440	FBXO30	-0.71	-5.63	-0.54	2.73e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9300255	0.596	rs11057207	chr12:123730891	T/G	cg05973401	chr12:123451056	ABCB9	0.75	5.83	0.55	1.18e-7	Neutrophil percentage of white cells;
SKCM	cis	rs2032447	0.736	rs115810	chr6:25975883	G/C	cg18357526	chr6:26021779	HIST1H4A	0.75	5.8	0.55	1.35e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs17685	0.712	rs1637049	chr7:75729975	C/G	cg16684958	chr7:75615977	POR	0.56	5.12	0.5	2.19e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2842992	0.715	rs2277073	chr6:160182749	G/A	cg11366901	chr6:160182831	ACAT2	0.94	7.85	0.66	1.81e-11	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs860295	0.595	rs490498	chr1:155880952	G/A	cg02153340	chr1:155202674	NA	0.74	5.29	0.51	1.09e-6	Body mass index;
SKCM	cis	rs372883	0.648	rs4817279	chr21:30638285	T/C	cg24692254	chr21:30365293	RNF160	-0.68	-5.22	-0.51	1.47e-6	Pancreatic cancer;
SKCM	cis	rs34375054	0.660	rs900411	chr12:125612839	C/T	cg25124228	chr12:125621409	AACS	-0.72	-5.25	-0.51	1.29e-6	Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs561341	1.000	rs2470267	chr17:30274132	G/A	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs4819052	0.851	rs2838849	chr21:46671027	A/G	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.42	0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs826838	0.967	rs12823908	chr12:38845686	T/C	cg13010199	chr12:38710504	ALG10B	0.83	6.69	0.6	3.1e-9	Heart rate;
SKCM	cis	rs2732480	0.557	rs2409004	chr12:48721451	T/C	cg21348975	chr12:48724119	NA	-0.58	-4.88	-0.48	5.47e-6	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs17376456	1.000	rs10514382	chr5:93566534	G/A	cg25358565	chr5:93447407	FAM172A	1.35	7.99	0.67	9.93e-12	Diabetic retinopathy;
SKCM	cis	rs3091242	0.900	rs1811832	chr1:25753565	G/A	cg27572855	chr1:25598939	RHD	0.56	5.49	0.53	4.9e-7	Erythrocyte sedimentation rate;
SKCM	cis	rs60871478	0.735	rs7802011	chr7:760442	A/G	cg13798912	chr7:905769	UNC84A	0.74	4.94	0.49	4.39e-6	Cerebrospinal P-tau181p levels;
SKCM	cis	rs7618915	0.547	rs3774365	chr3:52642487	T/C	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs875971	0.862	rs10278014	chr7:66051264	C/T	cg18876405	chr7:65276391	NA	-0.63	-6.31	-0.58	1.6e-8	Aortic root size;
SKCM	cis	rs2839186	0.967	rs17176131	chr21:47705237	T/C	cg05896524	chr21:47604654	C21orf56	0.69	5.67	0.54	2.29e-7	Testicular germ cell tumor;
SKCM	cis	rs9910055	0.664	rs433610	chr17:42197281	A/G	cg08499158	chr17:42289980	UBTF	0.84	7.47	0.65	1.01e-10	Total body bone mineral density;
SKCM	cis	rs35306767	0.903	rs34847097	chr10:902252	A/T	cg26597838	chr10:835615	NA	0.76	5.33	0.52	9.2e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs873946	0.586	rs12783078	chr10:134569706	C/T	cg26818010	chr10:134567672	INPP5A	-0.8	-6.11	-0.57	3.7e-8	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs7953249	0.618	rs7954039	chr12:121398654	A/C	cg02403541	chr12:121454288	C12orf43	-0.65	-4.92	-0.49	4.66e-6	Invasive epithelial ovarian cancer;High-grade serous ovarian cancer;Chronic obstructive pulmonary disease-related biomarkers;N-glycan levels;Serous invasive ovarian cancer;Epithelial ovarian cancer;
SKCM	cis	rs9303401	0.538	rs2240259	chr17:56458129	A/C	cg25039879	chr17:56429692	SUPT4H1	0.8	4.82	0.48	6.85e-6	Cognitive test performance;
SKCM	cis	rs514406	0.668	rs12037492	chr1:53440816	G/T	cg08859206	chr1:53392774	SCP2	0.64	5.22	0.51	1.44e-6	Monocyte count;
SKCM	cis	rs3820068	0.581	rs1122386	chr1:15946877	C/T	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	trans	rs5756813	1.000	rs1129448	chr22:38170026	G/A	cg19894588	chr14:64061835	NA	0.89	7.81	0.66	2.21e-11	Optic cup area;Vertical cup-disc ratio;
SKCM	cis	rs919433	0.963	rs12617117	chr2:198155170	T/A	cg04278110	chr2:198063759	ANKRD44	-0.69	-4.8	-0.48	7.58e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs1577917	0.917	rs13196576	chr6:86534066	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.81	-0.66	2.19e-11	Response to antipsychotic treatment;
SKCM	cis	rs4803468	1.000	rs284663	chr19:41932612	C/T	cg09537434	chr19:41945824	ATP5SL	-1.1	-13.85	-0.84	1.02e-22	Height;
SKCM	cis	rs2033711	0.783	rs11671113	chr19:58958087	C/T	cg12042659	chr19:58951599	ZNF132	0.68	5.97	0.56	6.53e-8	Uric acid clearance;
SKCM	cis	rs13108904	0.870	rs3755927	chr4:1238246	G/A	cg02018176	chr4:1364513	KIAA1530	0.62	4.94	0.49	4.42e-6	Obesity-related traits;
SKCM	cis	rs2204008	0.805	rs11179579	chr12:38213957	A/C	cg13010199	chr12:38710504	ALG10B	0.65	4.84	0.48	6.52e-6	Bladder cancer;
SKCM	cis	rs17376456	0.877	rs9885329	chr5:93380278	G/A	cg21475434	chr5:93447410	FAM172A	0.95	5.35	0.52	8.56e-7	Diabetic retinopathy;
SKCM	cis	rs9486715	0.867	rs4438964	chr6:96917563	T/G	cg06623918	chr6:96969491	KIAA0776	0.79	6.38	0.59	1.16e-8	Headache;
SKCM	cis	rs5750830	0.649	rs6001588	chr22:39819049	G/C	cg11247378	chr22:39784982	NA	-0.47	-5.43	-0.52	6.23e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs2070433	1.000	rs11701310	chr21:47962836	G/C	cg05998816	chr21:47859926	PCNT	0.74	4.86	0.48	6e-6	Lymphocyte counts;
SKCM	cis	rs2749592	0.531	rs994804	chr10:37900140	A/C	cg25427524	chr10:38739819	LOC399744	0.57	5.36	0.52	8.21e-7	Age-related hearing impairment (SNP x SNP interaction);
SKCM	cis	rs10791097	0.667	rs4937585	chr11:130741940	A/G	cg12179176	chr11:130786555	SNX19	0.93	8.16	0.68	4.62e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs4803468	0.967	rs284661	chr19:41932120	C/T	cg09537434	chr19:41945824	ATP5SL	-1.1	-13.85	-0.84	1.02e-22	Height;
SKCM	cis	rs1577917	0.958	rs1335442	chr6:86466692	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.87	-8.66	-0.7	5.01e-13	Response to antipsychotic treatment;
SKCM	cis	rs561341	0.709	rs11542477	chr17:30185892	A/G	cg00745463	chr17:30367425	LRRC37B	0.91	5.32	0.52	9.79e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs1799949	0.965	rs4793204	chr17:41279298	A/G	cg23758822	chr17:41437982	NA	0.92	7.8	0.66	2.3e-11	Menopause (age at onset);
SKCM	cis	rs13108904	0.901	rs7668661	chr4:1300172	A/G	cg05665937	chr4:1216051	CTBP1	0.57	4.97	0.49	3.83e-6	Obesity-related traits;
SKCM	cis	rs637571	0.512	rs660118	chr11:65735174	G/C	cg02427764	chr11:65769310	BANF1;EIF1AD	0.75	5.68	0.54	2.19e-7	Eosinophil percentage of white cells;
SKCM	cis	rs6938	0.575	rs12902515	chr15:75160998	G/C	cg09165964	chr15:75287851	SCAMP5	0.61	4.97	0.49	3.82e-6	Breast cancer;
SKCM	cis	rs860295	0.651	rs6692183	chr1:155304327	T/G	cg02153340	chr1:155202674	NA	-0.8	-5.64	-0.54	2.63e-7	Body mass index;
SKCM	cis	rs873946	0.648	rs12771651	chr10:134554482	C/A	cg27286337	chr10:134555280	INPP5A	0.91	8.09	0.68	6.21e-12	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs9905704	0.647	rs3809723	chr17:57061978	T/G	cg12560992	chr17:57184187	TRIM37	0.75	6.0	0.56	5.91e-8	Testicular germ cell tumor;
SKCM	cis	rs763121	0.853	rs5750622	chr22:38956464	C/G	cg06022373	chr22:39101656	GTPBP1	0.78	5.85	0.55	1.08e-7	Menopause (age at onset);
SKCM	cis	rs782590	0.967	rs6545506	chr2:55798108	A/G	cg18811423	chr2:55921094	PNPT1	-0.88	-6.87	-0.61	1.37e-9	Metabolic syndrome;
SKCM	cis	rs7103648	0.864	rs12801188	chr11:47388214	G/A	cg20307385	chr11:47447363	PSMC3	0.96	6.92	0.62	1.12e-9	Diastolic blood pressure;Systolic blood pressure;
SKCM	trans	rs66573146	0.803	rs59742225	chr4:6969942	C/T	cg07817883	chr1:32538562	TMEM39B	2.0	8.02	0.67	8.59e-12	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs651907	0.557	rs36002990	chr3:101437862	G/A	cg12386194	chr3:101231763	SENP7	0.68	5.59	0.54	3.16e-7	Colorectal cancer;
SKCM	cis	rs67311347	0.544	rs2278929	chr3:40351008	C/G	cg13409248	chr3:40428643	ENTPD3	-0.55	-4.97	-0.49	3.85e-6	Renal cell carcinoma;
SKCM	cis	rs7945705	0.747	rs11042150	chr11:9010819	T/C	cg13070366	chr11:9386451	NA	0.57	4.86	0.48	6.04e-6	Hemoglobin concentration;
SKCM	cis	rs763014	0.931	rs10903017	chr16:627920	T/C	cg09263875	chr16:632152	PIGQ	0.67	5.82	0.55	1.24e-7	Height;
SKCM	cis	rs9486715	0.830	rs2475023	chr6:96996833	G/A	cg06623918	chr6:96969491	KIAA0776	-0.82	-7.29	-0.64	2.2e-10	Headache;
SKCM	cis	rs4665809	0.590	rs3806514	chr2:26466772	C/T	cg26119090	chr2:26468346	HADHA;HADHB	1.03	7.99	0.67	9.69e-12	Gut microbiome composition (summer);
SKCM	cis	rs10503709	0.568	rs13252056	chr8:21460293	A/G	cg23716449	chr8:21608280	GFRA2	0.49	5.18	0.51	1.69e-6	Blood protein levels;
SKCM	cis	rs6547631	0.622	rs10210321	chr2:85928128	A/C	cg24620635	chr2:85921963	GNLY	0.9	6.65	0.6	3.58e-9	Blood protein levels;
SKCM	cis	rs11792861	0.851	rs4542004	chr9:111814478	A/G	cg14432460	chr9:111696404	IKBKAP;C9orf6	0.66	4.93	0.49	4.62e-6	Menarche (age at onset);
SKCM	cis	rs4803468	1.000	rs284649	chr19:41926838	C/T	cg09537434	chr19:41945824	ATP5SL	-1.1	-13.85	-0.84	1.02e-22	Height;
SKCM	cis	rs672059	1.000	rs566625	chr1:183161441	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.65	5.49	0.53	4.87e-7	Hypertriglyceridemia;
SKCM	cis	rs6866344	0.697	rs17184344	chr5:178129281	A/G	cg10224037	chr5:178157518	ZNF354A	0.76	5.34	0.52	9.06e-7	Neutrophil percentage of white cells;
SKCM	cis	rs4481887	0.676	rs7524978	chr1:248527319	A/T	cg22724847	chr1:248512586	OR14C36	0.62	5.29	0.51	1.09e-6	Common traits (Other);
SKCM	cis	rs9900062	0.560	rs11656678	chr17:62681505	G/A	cg02097616	chr17:62675921	NA	0.75	6.15	0.57	3.11e-8	QT interval;
SKCM	cis	rs7208859	0.623	rs12103440	chr17:29086657	A/G	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs34115320	1	rs34115320	chr7:148783936	CT/C	cg23583168	chr7:148888333	NA	-0.78	-6.08	-0.57	4.19e-8	Sum basophil neutrophil counts;Neutrophil count;
SKCM	cis	rs2014572	0.967	rs7248000	chr19:57762139	C/T	cg24459738	chr19:57751996	ZNF805	-0.62	-5.06	-0.5	2.71e-6	Hyperactive-impulsive symptoms;
SKCM	cis	rs769267	0.930	rs4808955	chr19:19552413	T/C	cg03709012	chr19:19516395	GATAD2A	0.89	8.62	0.7	5.89e-13	Tonsillectomy;
SKCM	cis	rs10771431	0.817	rs17202253	chr12:9361850	A/G	cg08997352	chr12:9597637	DDX12	-0.68	-4.86	-0.48	6.01e-6	Breast size;
SKCM	cis	rs2032447	0.867	rs9295683	chr6:26069495	C/T	cg18357526	chr6:26021779	HIST1H4A	0.85	7.58	0.65	6.14e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs11718455	0.960	rs11929518	chr3:44016874	A/G	cg21419209	chr3:44054225	NA	-0.66	-5.22	-0.51	1.46e-6	Coronary artery disease;
SKCM	cis	rs752010	1.000	rs752010	chr1:42093015	C/T	cg06885757	chr1:42089581	HIVEP3	0.62	6.25	0.58	2.04e-8	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs933688	1.000	rs61612071	chr5:90741470	G/A	cg12630606	chr5:90679528	LOC100129716;ARRDC3	0.98	7.81	0.66	2.22e-11	Smoking behavior;
SKCM	cis	rs10791097	0.748	rs4937580	chr11:130734270	T/C	cg12179176	chr11:130786555	SNX19	0.93	8.4	0.69	1.6e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs13064447	1.000	rs13064447	chr3:12753131	C/A	cg05775895	chr3:12838266	CAND2	-0.65	-4.98	-0.49	3.72e-6	Major depression and alcohol dependence;
SKCM	cis	rs2243480	1.000	rs160643	chr7:65558222	C/T	cg07424592	chr7:64974309	NA	0.93	4.77	0.48	8.28e-6	Diabetic kidney disease;
SKCM	cis	rs6547631	0.622	rs10180391	chr2:85926345	C/T	cg24620635	chr2:85921963	GNLY	0.9	6.4	0.59	1.06e-8	Blood protein levels;
SKCM	cis	rs796364	0.951	rs12620298	chr2:201047184	C/T	cg12253985	chr2:200820533	C2orf60;C2orf47	-0.94	-6.25	-0.58	2e-8	Schizophrenia;
SKCM	cis	rs2303759	0.918	rs10405465	chr19:49869298	C/T	cg05022225	chr19:49866942	DKKL1;TEAD2	0.65	4.94	0.49	4.32e-6	Multiple sclerosis;
SKCM	cis	rs6121246	0.908	rs17093657	chr20:30428894	G/A	cg11595048	chr20:30225325	COX4I2	0.65	5.03	0.49	3.1e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs17685	0.753	rs2108274	chr7:75781636	C/A	cg16684958	chr7:75615977	POR	0.52	5.03	0.49	3.11e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2153535	0.580	rs7761937	chr6:8459434	A/T	cg07606381	chr6:8435919	SLC35B3	0.92	6.62	0.6	4.21e-9	Motion sickness;
SKCM	cis	rs2153535	0.580	rs7742689	chr6:8452433	C/A	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs2727020	0.731	rs10450572	chr11:49281073	T/C	cg21546286	chr11:48923668	NA	0.54	4.9	0.48	5.15e-6	Coronary artery disease;
SKCM	cis	rs9926296	0.585	rs8058009	chr16:89856439	G/A	cg04287289	chr16:89883240	FANCA	1.03	7.23	0.63	2.92e-10	Vitiligo;
SKCM	cis	rs8103278	0.701	rs116959973	chr19:46252333	A/T	cg11657440	chr19:46296263	DMWD	-1.04	-6.11	-0.57	3.68e-8	Coronary artery disease;
SKCM	cis	rs2243480	1.000	rs1499613	chr7:65730860	G/A	cg18252515	chr7:66147081	NA	1.34	8.18	0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs6570726	0.791	rs370112	chr6:145859853	T/G	cg23711669	chr6:146136114	FBXO30	0.85	8.86	0.71	1.97e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9443189	0.570	rs9341532	chr6:76403674	A/G	cg01950844	chr6:76311363	SENP6	0.98	6.54	0.59	5.95e-9	Prostate cancer;
SKCM	cis	rs151997	0.671	rs395557	chr5:50215832	G/T	cg06027927	chr5:50259733	NA	0.65	6.24	0.58	2.13e-8	Callous-unemotional behaviour;
SKCM	cis	rs1153858	1.000	rs16952714	chr15:45650358	G/A	cg21132104	chr15:45694354	SPATA5L1	0.93	7.94	0.67	1.22e-11	Homoarginine levels;
SKCM	cis	rs9733	0.650	rs4970923	chr1:150608300	A/G	cg13175981	chr1:150552382	MCL1	0.66	5.53	0.53	4.09e-7	Tonsillectomy;
SKCM	cis	rs8060686	0.641	rs2285910	chr16:68104422	T/C	cg04539111	chr16:67997858	SLC12A4	-0.85	-4.81	-0.48	7.14e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs523522	0.962	rs603574	chr12:120998443	A/G	cg27279351	chr12:120934652	DYNLL1	0.9	8.2	0.68	3.93e-12	High light scatter reticulocyte count;
SKCM	cis	rs1577917	1.000	rs12200330	chr6:86656653	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.85	-8.62	-0.7	5.82e-13	Response to antipsychotic treatment;
SKCM	cis	rs11585357	0.895	rs4625336	chr1:17630964	G/T	cg08277548	chr1:17600880	PADI3	-0.89	-6.31	-0.58	1.53e-8	Hair shape;
SKCM	cis	rs71520386	0.632	rs10269414	chr7:22856293	G/A	cg15401507	chr7:22894281	NA	0.66	4.92	0.49	4.66e-6	Fibrinogen levels;
SKCM	cis	rs11098499	0.644	rs10050092	chr4:120532085	T/C	cg09307838	chr4:120376055	NA	0.94	7.77	0.66	2.64e-11	Corneal astigmatism;
SKCM	cis	rs6089829	0.962	rs7273930	chr20:61666017	G/A	cg08564027	chr20:61660810	NA	0.63	5.64	0.54	2.64e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs2836974	0.863	rs12483216	chr21:40539614	T/C	cg11890956	chr21:40555474	PSMG1	1.07	13.19	0.83	1.48e-21	Cognitive function;
SKCM	cis	rs1218582	0.710	rs7553195	chr1:154837796	T/C	cg16680214	chr1:154839983	KCNN3	-0.54	-5.01	-0.49	3.36e-6	Prostate cancer;
SKCM	cis	rs2839186	0.903	rs61182475	chr21:47707050	T/A	cg13126279	chr21:47581558	C21orf56	-0.64	-5.47	-0.53	5.17e-7	Testicular germ cell tumor;
SKCM	cis	rs2832191	0.716	rs7509628	chr21:30454252	C/T	cg24692254	chr21:30365293	RNF160	0.99	9.05	0.72	8.59e-14	Dental caries;
SKCM	cis	rs1577917	0.958	rs10944144	chr6:86537755	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.68	-5.91	-0.56	8.36e-8	Response to antipsychotic treatment;
SKCM	cis	rs2204008	0.777	rs11179774	chr12:38219559	A/C	cg13010199	chr12:38710504	ALG10B	0.65	4.84	0.48	6.52e-6	Bladder cancer;
SKCM	cis	rs12142240	0.698	rs41293273	chr1:46806393	T/C	cg10495392	chr1:46806563	NSUN4	0.74	5.37	0.52	7.75e-7	Menopause (age at onset);
SKCM	cis	rs7666738	0.830	rs10034619	chr4:98970067	G/C	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2243480	0.908	rs313822	chr7:65573939	G/A	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	trans	rs11722228	0.522	rs2241468	chr4:10113905	G/A	cg26043149	chr18:55253948	FECH	0.93	7.58	0.65	6.09e-11	Gout;Urate levels;Serum uric acid levels;
SKCM	cis	rs9814567	0.896	rs13089566	chr3:134349710	G/C	cg06109529	chr3:134205091	CEP63;ANAPC13	0.63	5.1	0.5	2.35e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs208520	0.802	rs208516	chr6:66946119	T/C	cg07460842	chr6:66804631	NA	-1.05	-7.28	-0.64	2.34e-10	Exhaled nitric oxide output;
SKCM	cis	rs2033711	0.870	rs4801583	chr19:58918405	A/G	cg13877915	chr19:58951672	ZNF132	0.95	9.91	0.75	1.91e-15	Uric acid clearance;
SKCM	cis	rs6088590	1.000	rs6088590	chr20:33313566	T/C	cg24642439	chr20:33292090	TP53INP2	1.01	7.39	0.64	1.39e-10	Coronary artery disease;
SKCM	cis	rs9902453	0.716	rs3098949	chr17:27978694	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.76	5.63	0.54	2.72e-7	Coffee consumption (cups per day);
SKCM	cis	rs26868	0.766	rs26867	chr16:2249410	T/C	cg27608139	chr16:2294856	DCI	0.61	5.05	0.5	2.78e-6	Height;
SKCM	cis	rs9325144	0.577	rs12314639	chr12:39119869	T/C	cg26384229	chr12:38710491	ALG10B	-0.72	-6.61	-0.6	4.24e-9	Morning vs. evening chronotype;
SKCM	cis	rs6977660	0.941	rs5017192	chr7:19820114	C/T	cg07541023	chr7:19748670	TWISTNB	0.7	4.82	0.48	6.98e-6	Thyroid stimulating hormone;
SKCM	cis	rs4727027	0.899	rs6944096	chr7:148870026	A/G	cg23583168	chr7:148888333	NA	-0.75	-6.12	-0.57	3.55e-8	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs9790314	0.715	rs980976	chr3:160771668	T/G	cg03342759	chr3:160939853	NMD3	-0.6	-5.64	-0.54	2.62e-7	Morning vs. evening chronotype;
SKCM	cis	rs7659604	0.702	rs6815790	chr4:122695385	A/C	cg06713675	chr4:122721982	EXOSC9	-0.73	-6.67	-0.6	3.37e-9	Type 2 diabetes;
SKCM	cis	rs875971	0.929	rs778712	chr7:65849978	C/T	cg11764359	chr7:65958608	NA	0.87	8.35	0.69	2.01e-12	Aortic root size;
SKCM	cis	rs11822910	0.724	rs7106223	chr11:57190448	A/G	cg00522883	chr11:57194120	SLC43A3	-0.81	-4.83	-0.48	6.66e-6	Platelet distribution width;
SKCM	cis	rs3749237	0.615	rs55957735	chr3:49438158	G/A	cg03060546	chr3:49711283	APEH	0.67	4.86	0.48	5.96e-6	Resting heart rate;
SKCM	cis	rs1799949	0.965	rs8176193	chr17:41231516	C/T	cg05368731	chr17:41323189	NBR1	0.9	7.89	0.67	1.52e-11	Menopause (age at onset);
SKCM	cis	rs7659604	0.846	rs35986491	chr4:122664528	A/T	cg19748678	chr4:122722346	EXOSC9	0.68	5.59	0.53	3.23e-7	Type 2 diabetes;
SKCM	cis	rs8180040	0.966	rs11711824	chr3:47468261	C/T	cg27129171	chr3:47204927	SETD2	0.79	5.79	0.55	1.43e-7	Colorectal cancer;
SKCM	cis	rs1799949	1.000	rs4792981	chr17:41308274	A/G	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.15	-0.57	3.16e-8	Menopause (age at onset);
SKCM	cis	rs796364	1.000	rs11680723	chr2:200810957	C/G	cg12253985	chr2:200820533	C2orf60;C2orf47	-1.0	-5.5	-0.53	4.63e-7	Schizophrenia;
SKCM	cis	rs55962025	0.711	rs2071662	chr4:3223891	T/C	cg21096898	chr4:3318625	RGS12	-0.61	-5.04	-0.5	2.99e-6	Parental longevity (mother's age at death);
SKCM	cis	rs11155671	0.530	rs4870080	chr6:150202644	T/C	cg05036130	chr6:150231994	NA	0.62	6.95	0.62	9.86e-10	Testicular germ cell tumor;
SKCM	cis	rs62103177	0.810	rs62103188	chr18:77627661	G/A	cg27393146	chr18:77495563	CTDP1	-0.92	-5.36	-0.52	8.37e-7	Opioid sensitivity;
SKCM	cis	rs6879260	1.000	rs6879260	chr5:179731014	A/G	cg02891314	chr5:179741120	GFPT2	-0.66	-5.61	-0.54	3.01e-7	Height;
SKCM	cis	rs2153535	0.580	rs915351	chr6:8442793	C/T	cg23788917	chr6:8435910	SLC35B3	0.69	5.14	0.5	1.99e-6	Motion sickness;
SKCM	cis	rs950027	0.620	rs1617634	chr15:45615578	A/G	cg21132104	chr15:45694354	SPATA5L1	0.78	5.93	0.56	7.7e-8	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs7208859	0.623	rs9912440	chr17:29148772	A/G	cg14067834	chr17:29058358	SUZ12P	1.04	5.17	0.5	1.79e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs208520	0.690	rs207118	chr6:66788948	T/A	cg07460842	chr6:66804631	NA	-1.03	-7.65	-0.65	4.49e-11	Exhaled nitric oxide output;
SKCM	cis	rs7666738	0.791	rs10856933	chr4:98958542	C/A	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4803468	1.000	rs284658	chr19:41929988	G/A	cg14132834	chr19:41945861	ATP5SL	-0.77	-6.04	-0.56	4.87e-8	Height;
SKCM	cis	rs2033711	0.870	rs11084545	chr19:58951693	G/C	cg13877915	chr19:58951672	ZNF132	0.97	11.08	0.78	1.13e-17	Uric acid clearance;
SKCM	cis	rs28386778	0.591	rs2584619	chr17:61913215	T/A	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs1577917	0.739	rs9450318	chr6:86427177	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.76	6.73	0.61	2.58e-9	Response to antipsychotic treatment;
SKCM	cis	rs7639513	0.520	rs79141906	chr3:12711977	A/C	cg23032965	chr3:12705835	RAF1	0.78	6.49	0.59	7.27e-9	Itch intensity from mosquito bite;
SKCM	cis	rs12474201	0.862	rs13025595	chr2:46977893	A/G	cg06386533	chr2:46925753	SOCS5	0.9	8.1	0.68	5.9e-12	Height;
SKCM	cis	rs10256972	0.577	rs2949179	chr7:1209885	C/G	cg18765753	chr7:1198926	ZFAND2A	-0.52	-5.74	-0.54	1.73e-7	Longevity;Endometriosis;
SKCM	cis	rs867186	1.000	rs7274866	chr20:33608616	A/G	cg04194272	chr20:33683537	NA	-1.38	-7.2	-0.63	3.29e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs694739	0.930	rs574087	chr11:64102948	A/G	cg23796481	chr11:64053134	BAD;GPR137	0.77	5.93	0.56	7.72e-8	Alopecia areata;Crohn's disease;Psoriasis vulgaris;
SKCM	cis	rs7666738	0.830	rs11723283	chr4:99001617	C/T	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4900538	0.963	rs1190554	chr14:102918686	T/C	cg18135206	chr14:102964638	TECPR2	0.8	6.34	0.58	1.39e-8	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs6866344	0.697	rs11742808	chr5:178131658	G/A	cg03877680	chr5:178157825	ZNF354A	0.79	5.72	0.54	1.85e-7	Neutrophil percentage of white cells;
SKCM	cis	rs709400	0.663	rs62007687	chr14:103903763	G/T	cg26031613	chr14:104095156	KLC1	0.72	5.3	0.51	1.04e-6	Body mass index;
SKCM	cis	rs7584330	0.910	rs6713555	chr2:238398182	A/G	cg14458575	chr2:238380390	NA	-0.96	-5.53	-0.53	4.08e-7	Prostate cancer;
SKCM	cis	rs7666738	0.830	rs17550735	chr4:99014076	T/G	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2153535	0.580	rs1115078	chr6:8449638	G/A	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs367615	0.537	rs1965670	chr5:108649798	A/T	cg17395555	chr5:108820864	NA	-0.7	-5.83	-0.55	1.17e-7	Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs995000	0.931	rs1748200	chr1:63046039	T/C	cg06896770	chr1:63153194	DOCK7	-0.76	-7.44	-0.64	1.13e-10	Triglyceride levels;
SKCM	cis	rs736408	0.812	rs2240920	chr3:52831009	A/G	cg11645453	chr3:52864694	ITIH4	-0.65	-5.57	-0.53	3.48e-7	Bipolar disorder;
SKCM	cis	rs1559088	0.600	rs7246566	chr19:33589618	A/T	cg27124370	chr19:33622961	WDR88	0.8	5.6	0.54	3.13e-7	Bone ultrasound measurement (broadband ultrasound attenuation);
SKCM	cis	rs873946	0.590	rs12259699	chr10:134549692	A/G	cg27286337	chr10:134555280	INPP5A	0.94	8.43	0.69	1.36e-12	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs10540	1.000	rs61876323	chr11:462855	G/A	cg03576123	chr11:487126	PTDSS2	-1.46	-7.68	-0.66	4e-11	Body mass index;
SKCM	cis	rs7824557	0.591	rs2736282	chr8:11225480	C/T	cg21775007	chr8:11205619	TDH	0.67	5.93	0.56	7.93e-8	Retinal vascular caliber;
SKCM	cis	rs7659604	0.521	rs4240263	chr4:122683623	C/T	cg19671926	chr4:122722719	EXOSC9	0.78	6.38	0.59	1.18e-8	Type 2 diabetes;
SKCM	cis	rs1403694	0.695	rs67173199	chr3:186432858	G/A	cg09332604	chr3:186435400	KNG1	-0.49	-4.85	-0.48	6.09e-6	Blood protein levels;
SKCM	cis	rs1062177	1.000	rs2915880	chr5:151147334	G/A	cg00977110	chr5:151150581	G3BP1	0.81	6.32	0.58	1.51e-8	Preschool internalizing problems;
SKCM	cis	rs8141529	0.584	rs58004020	chr22:29257050	A/T	cg02153584	chr22:29168773	CCDC117	0.64	5.13	0.5	2.1e-6	Lymphocyte counts;
SKCM	cis	rs6089584	0.566	rs6061963	chr20:60607480	C/G	cg06108461	chr20:60628389	TAF4	-0.73	-6.74	-0.61	2.46e-9	Body mass index;
SKCM	cis	rs738322	0.742	rs4821767	chr22:38614129	G/T	cg25457927	chr22:38595422	NA	0.49	5.57	0.53	3.48e-7	Cutaneous nevi;
SKCM	cis	rs1642645	0.533	rs6678972	chr1:42555280	A/G	cg18174678	chr1:42801761	FOXJ3	-0.53	-4.83	-0.48	6.69e-6	Left ventricular obstructive tract defect (maternal effect);
SKCM	cis	rs7772486	0.846	rs9376976	chr6:146355605	T/C	cg05347473	chr6:146136440	FBXO30	0.57	5.24	0.51	1.31e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs28386778	0.897	rs2028567	chr17:61915326	G/A	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs2204008	0.720	rs11180923	chr12:38255172	A/T	cg26384229	chr12:38710491	ALG10B	0.87	6.83	0.61	1.63e-9	Bladder cancer;
SKCM	cis	rs2204008	0.712	rs12371182	chr12:38321143	A/C	cg26384229	chr12:38710491	ALG10B	0.87	6.94	0.62	1e-9	Bladder cancer;
SKCM	cis	rs8077889	0.956	rs116979403	chr17:41849105	G/A	cg26893861	chr17:41843967	DUSP3	1.23	7.32	0.64	1.91e-10	Triglycerides;
SKCM	cis	rs1568889	0.838	rs3812738	chr11:28129982	C/A	cg06544937	chr11:28130018	METT5D1;KIF18A	0.88	8.2	0.68	3.8e-12	Bipolar disorder;
SKCM	cis	rs9303401	0.614	rs2240719	chr17:56582477	G/C	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.35	0.52	8.42e-7	Cognitive test performance;
SKCM	cis	rs2153535	0.580	rs2327051	chr6:8441150	A/G	cg07606381	chr6:8435919	SLC35B3	-0.87	-6.66	-0.6	3.54e-9	Motion sickness;
SKCM	cis	rs2836974	0.568	rs8130795	chr21:40549983	T/A	cg11890956	chr21:40555474	PSMG1	0.88	9.14	0.72	5.76e-14	Cognitive function;
SKCM	cis	rs17376456	0.825	rs17372725	chr5:93135588	C/A	cg21475434	chr5:93447410	FAM172A	0.95	5.36	0.52	8.36e-7	Diabetic retinopathy;
SKCM	cis	rs10876993	0.928	rs10082911	chr12:58104104	C/A	cg18357645	chr12:58087776	OS9	0.68	6.27	0.58	1.83e-8	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs1048238	0.506	rs6668183	chr1:16173814	G/C	cg21385522	chr1:16154831	NA	0.65	5.56	0.53	3.61e-7	Systolic blood pressure;
SKCM	cis	rs1059312	1.000	rs3825180	chr12:129279242	A/G	cg09035930	chr12:129282057	SLC15A4	-0.81	-8.6	-0.7	6.49e-13	Systemic lupus erythematosus;
SKCM	cis	rs6752107	1.000	rs6431654	chr2:234161769	C/T	cg23050873	chr2:234184376	ATG16L1;SCARNA5	0.62	4.83	0.48	6.71e-6	Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs9894429	0.646	rs6565609	chr17:79592267	G/A	cg18240062	chr17:79603768	NPLOC4	0.68	5.88	0.55	9.47e-8	Eye color traits;
SKCM	cis	rs7659604	0.728	rs3924987	chr4:122689784	G/T	cg06713675	chr4:122721982	EXOSC9	-0.75	-6.51	-0.59	6.72e-9	Type 2 diabetes;
SKCM	cis	rs35306767	0.716	rs34487581	chr10:897201	G/A	cg26597838	chr10:835615	NA	0.79	5.7	0.54	2.01e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs6500395	0.735	rs7204345	chr16:48666726	T/C	cg04672837	chr16:48644449	N4BP1	0.6	4.88	0.48	5.59e-6	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs2836950	0.527	rs2836958	chr21:40623526	T/C	cg17971929	chr21:40555470	PSMG1	-0.73	-6.17	-0.57	2.86e-8	Menarche (age at onset);
SKCM	cis	rs1639906	0.895	rs3800926	chr7:2205956	G/A	cg21782813	chr7:2030301	MAD1L1	-0.52	-5.32	-0.52	9.82e-7	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2811415	0.628	rs13067034	chr3:127750310	C/T	cg09089421	chr3:127803668	RUVBL1	0.99	8.52	0.69	9.09e-13	Lung function (FEV1/FVC);
SKCM	cis	rs7829975	0.593	rs2921064	chr8:8316637	C/T	cg08975724	chr8:8085496	FLJ10661	0.71	5.68	0.54	2.2e-7	Mood instability;
SKCM	cis	rs4665809	1.000	rs6546766	chr2:26328680	T/C	cg26119090	chr2:26468346	HADHA;HADHB	-0.76	-4.79	-0.48	7.86e-6	Gut microbiome composition (summer);
SKCM	cis	rs2836974	0.899	rs34176878	chr21:40548855	C/A	cg17971929	chr21:40555470	PSMG1	0.88	8.17	0.68	4.43e-12	Cognitive function;
SKCM	cis	rs7618915	0.531	rs77146033	chr3:52701501	G/T	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs4400599	0.618	rs4845610	chr1:154205428	T/C	cg26808167	chr1:154192205	UBAP2L;C1orf43	-0.54	-4.9	-0.49	5.01e-6	Platelet distribution width;
SKCM	cis	rs12682352	0.602	rs6988939	chr8:8666916	C/T	cg06636001	chr8:8085503	FLJ10661	0.75	6.19	0.57	2.58e-8	Neuroticism;
SKCM	cis	rs7666738	0.830	rs3846443	chr4:99032666	G/A	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7208859	0.573	rs8070182	chr17:29135594	A/C	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs1799949	0.965	rs799910	chr17:41279561	G/C	cg23758822	chr17:41437982	NA	0.93	7.62	0.65	5.1e-11	Menopause (age at onset);
SKCM	cis	rs10916772	0.938	rs12048103	chr1:20684504	C/G	cg05356564	chr1:21044770	KIF17	-0.62	-5.15	-0.5	1.88e-6	Psychosis proneness (perceptual aberration scale);
SKCM	cis	rs362296	0.698	rs362282	chr4:3259671	G/A	cg21096898	chr4:3318625	RGS12	-0.81	-7.35	-0.64	1.69e-10	Parental longevity (mother's age at death);
SKCM	cis	rs16854884	1.000	rs13067695	chr3:143781054	C/T	cg06585982	chr3:143692056	C3orf58	0.74	5.69	0.54	2.17e-7	Economic and political preferences (feminism/equality);
SKCM	cis	rs72781680	0.752	rs72796116	chr2:23913769	C/T	cg08917208	chr2:24149416	ATAD2B	0.98	4.98	0.49	3.75e-6	Lymphocyte counts;
SKCM	cis	rs17608059	0.566	rs5005684	chr17:13910633	T/C	cg11395062	chr17:14139857	CDRT15	0.69	5.9	0.56	8.76e-8	Temperament;
SKCM	cis	rs2180341	0.960	rs7751865	chr6:127683040	G/A	cg24812749	chr6:127587940	RNF146	0.83	7.24	0.63	2.76e-10	Breast cancer;
SKCM	cis	rs9905704	0.624	rs8080071	chr17:57093825	C/T	cg12560992	chr17:57184187	TRIM37	-0.74	-6.08	-0.57	4.13e-8	Testicular germ cell tumor;
SKCM	cis	rs2439831	1.000	rs690002	chr15:43729349	C/A	cg02155558	chr15:43621948	ADAL;LCMT2	1.14	7.92	0.67	1.34e-11	Lung cancer in ever smokers;
SKCM	cis	rs992157	0.798	rs12053514	chr2:219167965	C/T	cg20019365	chr2:219134978	PNKD;AAMP	-0.72	-6.12	-0.57	3.48e-8	Colorectal cancer;
SKCM	cis	rs7000551	0.527	rs12677619	chr8:22243326	G/A	cg12081754	chr8:22256438	SLC39A14	1.03	10.44	0.76	1.84e-16	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs2730245	0.527	rs712199	chr7:158662250	A/G	cg24397884	chr7:158709396	WDR60	1.02	6.25	0.58	2.06e-8	Height;
SKCM	cis	rs4234284	1.000	rs6767820	chr3:126976217	G/C	cg04889221	chr3:126137216	CCDC37	-0.48	-5.01	-0.49	3.31e-6	Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel);
SKCM	cis	rs523522	0.962	rs9788155	chr12:120938408	G/A	cg12219531	chr12:120966889	COQ5	0.91	7.82	0.66	2.11e-11	High light scatter reticulocyte count;
SKCM	cis	rs62238980	0.614	rs4820067	chr22:32430097	G/C	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs344364	0.511	rs2982446	chr16:1947153	C/T	cg26897989	chr16:1907736	C16orf73	-0.69	-7.13	-0.63	4.45e-10	Glomerular filtration rate in chronic kidney disease;
SKCM	cis	rs12145833	0.538	rs4658547	chr1:243391131	T/G	cg02356786	chr1:243265016	LOC731275	-1.3	-5.27	-0.51	1.19e-6	Obesity (early onset extreme);
SKCM	cis	rs2072499	1.000	rs2253809	chr1:156172125	T/C	cg24450063	chr1:156163899	SLC25A44	1.03	10.12	0.75	7.26e-16	Testicular germ cell tumor;
SKCM	cis	rs1568889	1.000	rs12804198	chr11:28143114	C/A	cg06544937	chr11:28130018	METT5D1;KIF18A	0.87	7.0	0.62	7.86e-10	Bipolar disorder;
SKCM	cis	rs7296418	0.699	rs11608297	chr12:123826642	T/C	cg00376283	chr12:123451042	ABCB9	0.82	6.54	0.6	5.78e-9	Platelet count;
SKCM	cis	rs2013441	1.000	rs2526462	chr17:20079460	A/T	cg13482628	chr17:19912719	NA	-0.67	-5.24	-0.51	1.32e-6	Obesity-related traits;
SKCM	cis	rs2243480	1.000	rs1499614	chr7:65730798	A/T	cg25985355	chr7:65971099	NA	-0.81	-4.82	-0.48	7.01e-6	Diabetic kidney disease;
SKCM	cis	rs6500395	0.775	rs7198145	chr16:48666500	A/C	cg04672837	chr16:48644449	N4BP1	0.62	5.08	0.5	2.49e-6	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs9393692	0.645	rs2179152	chr6:26325888	T/C	cg00631329	chr6:26305371	NA	-0.7	-4.84	-0.48	6.33e-6	Educational attainment;
SKCM	cis	rs9814567	1.000	rs4974493	chr3:134219993	C/T	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.63	-4.96	-0.49	4.06e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs10504073	0.565	rs974780	chr8:49930976	G/A	cg00325661	chr8:49890786	NA	0.79	7.15	0.63	3.99e-10	Blood metabolite ratios;
SKCM	cis	rs3820928	1.000	rs7592387	chr2:227777095	A/G	cg11843606	chr2:227700838	RHBDD1	-0.61	-4.88	-0.48	5.44e-6	Pulmonary function;
SKCM	trans	rs9929218	0.551	rs9888942	chr16:68727572	A/G	cg04657470	chr2:198365150	HSPE1;HSPD1	0.98	10.11	0.75	7.75e-16	Colorectal cancer;
SKCM	cis	rs6087990	0.735	rs2424906	chr20:31359109	A/G	cg13636640	chr20:31349939	DNMT3B	0.87	6.84	0.61	1.61e-9	Ulcerative colitis;
SKCM	cis	rs2439831	0.850	rs10438303	chr15:44016417	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.31	7.38	0.64	1.49e-10	Lung cancer in ever smokers;
SKCM	cis	rs3749237	0.595	rs1568661	chr3:49520958	A/G	cg03060546	chr3:49711283	APEH	0.67	4.83	0.48	6.8e-6	Resting heart rate;
SKCM	cis	rs7666738	0.830	rs9995386	chr4:98907826	T/C	cg17366294	chr4:99064904	C4orf37	0.56	4.92	0.49	4.8e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs34779708	0.897	rs9787566	chr10:35279455	T/A	cg03585969	chr10:35415529	CREM	0.72	5.96	0.56	6.77e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs9430161	0.564	rs12081176	chr1:11034145	T/C	cg27631724	chr1:11040367	C1orf127	0.5	4.88	0.48	5.45e-6	Ewing sarcoma;
SKCM	cis	rs950027	0.620	rs35861938	chr15:45637343	T/C	cg10760299	chr15:45669010	GATM	0.53	5.42	0.52	6.45e-7	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs453301	0.624	rs2915251	chr8:8867411	G/C	cg06636001	chr8:8085503	FLJ10661	0.76	5.74	0.55	1.7e-7	Joint mobility (Beighton score);
SKCM	cis	rs1799949	1.000	rs8176145	chr17:41249094	A/G	cg23758822	chr17:41437982	NA	0.94	7.65	0.65	4.42e-11	Menopause (age at onset);
SKCM	cis	rs11098499	0.866	rs6824111	chr4:120285968	T/A	cg24375607	chr4:120327624	NA	0.62	4.77	0.48	8.45e-6	Corneal astigmatism;
SKCM	cis	rs9916302	0.768	rs11078900	chr17:37614641	C/T	cg07936489	chr17:37558343	FBXL20	-0.9	-8.1	-0.68	6.05e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs1577917	0.839	rs1838956	chr6:86565263	A/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.69	-6.15	-0.57	3.1e-8	Response to antipsychotic treatment;
SKCM	cis	rs4237845	0.611	rs7298370	chr12:58318897	C/T	cg02175503	chr12:58329896	NA	0.96	9.73	0.74	4.21e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs910316	1.000	rs12589876	chr14:75544189	G/A	cg08847533	chr14:75593920	NEK9	0.95	9.18	0.72	4.8e-14	Height;
SKCM	cis	rs244731	1.000	rs244729	chr5:176539018	C/G	cg17509989	chr5:176798049	RGS14	0.82	6.21	0.58	2.36e-8	Urate levels in lean individuals;
SKCM	cis	rs7666738	0.830	rs1426672	chr4:98923984	T/C	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9399137	0.507	rs13209780	chr6:135344795	G/C	cg24558204	chr6:135376177	HBS1L	0.68	6.29	0.58	1.7e-8	Glycated hemoglobin levels;Mean corpuscular volume;Hematology traits;HbA2 levels;Mean corpuscular hemoglobin;Hemoglobin levels;F-cell distribution;Platelet count;
SKCM	cis	rs13118159	0.509	rs1882098	chr4:1352431	T/C	cg02475777	chr4:1388615	CRIPAK	0.79	5.23	0.51	1.37e-6	Longevity;
SKCM	cis	rs6952808	0.743	rs4719308	chr7:1877502	T/G	cg04267008	chr7:1944627	MAD1L1	-0.73	-5.82	-0.55	1.26e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs362272	0.545	rs2749783	chr4:3326098	A/C	cg24015175	chr4:3319247	RGS12	0.85	10.18	0.76	5.79e-16	Serum sulfate level;
SKCM	cis	rs2832191	0.720	rs7277028	chr21:30494604	T/C	cg24692254	chr21:30365293	RNF160	-0.9	-8.03	-0.67	8.39e-12	Dental caries;
SKCM	cis	rs2204008	0.837	rs2127955	chr12:37969194	A/G	cg13010199	chr12:38710504	ALG10B	0.64	5.08	0.5	2.5e-6	Bladder cancer;
SKCM	cis	rs9467773	1.000	rs9461271	chr6:26554968	G/A	cg09904177	chr6:26538194	HMGN4	0.54	4.98	0.49	3.78e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs228769	0.653	rs2523162	chr17:42179281	A/G	cg08499158	chr17:42289980	UBTF	0.71	4.9	0.49	5.08e-6	Bone mineral density (hip);Bone mineral density (spine);
SKCM	cis	rs4924935	0.781	rs2472694	chr17:18848498	A/G	cg26378065	chr17:18585709	ZNF286B	0.84	5.5	0.53	4.65e-7	Pancreatic cancer;
SKCM	cis	rs17685	0.712	rs6464994	chr7:75784668	C/T	cg01364799	chr7:75623366	TMEM120A	-0.65	-5.06	-0.5	2.73e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs9910055	0.530	rs2269906	chr17:42294337	G/T	cg10896456	chr17:42255109	ASB16;C17orf65	-0.54	-4.9	-0.48	5.16e-6	Total body bone mineral density;
SKCM	cis	rs362296	0.661	rs3095077	chr4:3265710	A/G	cg05297308	chr4:3317976	RGS12	0.69	5.75	0.55	1.66e-7	Parental longevity (mother's age at death);
SKCM	cis	rs5769765	1.000	rs5770741	chr22:50270215	A/G	cg22709217	chr22:50311962	ALG12;CRELD2	0.79	5.71	0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs9486715	0.830	rs4425602	chr6:96893906	G/A	cg06623918	chr6:96969491	KIAA0776	0.79	7.09	0.63	5.34e-10	Headache;
SKCM	cis	rs17685	0.736	rs4732594	chr7:75753273	T/C	cg01364799	chr7:75623366	TMEM120A	-0.7	-5.69	-0.54	2.09e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs6565180	1.000	rs11862806	chr16:30364071	A/G	cg17640201	chr16:30407289	ZNF48	-0.9	-7.1	-0.63	5e-10	Tonsillectomy;
SKCM	cis	rs9300255	0.507	rs1727302	chr12:123632930	G/A	cg00376283	chr12:123451042	ABCB9	0.91	6.97	0.62	9.16e-10	Neutrophil percentage of white cells;
SKCM	cis	rs7666738	0.830	rs1426668	chr4:98945585	T/A	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs34779708	0.931	rs9663401	chr10:35278849	G/T	cg03585969	chr10:35415529	CREM	0.72	5.96	0.56	6.77e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs9611565	0.568	rs5758441	chr22:42132888	C/A	cg03806693	chr22:41940476	POLR3H	0.84	5.47	0.53	5.32e-7	Vitiligo;
SKCM	cis	rs17685	0.725	rs6947068	chr7:75662056	T/C	cg16489192	chr7:75678113	MDH2;STYXL1	0.58	5.44	0.52	5.83e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs151997	0.649	rs152688	chr5:50211776	C/T	cg06027927	chr5:50259733	NA	0.65	6.24	0.58	2.13e-8	Callous-unemotional behaviour;
SKCM	cis	rs4911259	0.552	rs13038017	chr20:31467551	T/C	cg13636640	chr20:31349939	DNMT3B	-0.74	-6.15	-0.57	3.04e-8	Inflammatory bowel disease;
SKCM	cis	rs4665809	0.590	rs62130493	chr2:26516418	C/T	cg26119090	chr2:26468346	HADHA;HADHB	1.08	8.63	0.7	5.67e-13	Gut microbiome composition (summer);
SKCM	cis	rs7953249	0.594	rs11065384	chr12:121423285	T/C	cg02403541	chr12:121454288	C12orf43	-0.66	-5.39	-0.52	7.29e-7	Invasive epithelial ovarian cancer;High-grade serous ovarian cancer;Chronic obstructive pulmonary disease-related biomarkers;N-glycan levels;Serous invasive ovarian cancer;Epithelial ovarian cancer;
SKCM	cis	rs1799949	0.965	rs33988650	chr17:41287880	A/G	cg23758822	chr17:41437982	NA	0.92	7.8	0.66	2.3e-11	Menopause (age at onset);
SKCM	cis	rs7666738	0.830	rs10028692	chr4:98962585	C/T	cg17366294	chr4:99064904	C4orf37	0.59	4.89	0.48	5.36e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7980687	0.678	rs7132277	chr12:123593382	C/T	cg00376283	chr12:123451042	ABCB9	-0.83	-5.67	-0.54	2.3e-7	Height;Educational attainment;Head circumference (infant);
SKCM	cis	rs9399137	0.507	rs6940878	chr6:135366309	G/A	cg24558204	chr6:135376177	HBS1L	0.66	5.85	0.55	1.12e-7	Glycated hemoglobin levels;Mean corpuscular volume;Hematology traits;HbA2 levels;Mean corpuscular hemoglobin;Hemoglobin levels;F-cell distribution;Platelet count;
SKCM	cis	rs9467773	0.967	rs9461267	chr6:26525455	T/G	cg09904177	chr6:26538194	HMGN4	0.54	4.98	0.49	3.78e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9910055	0.659	rs112114764	chr17:42201041	G/T	cg08499158	chr17:42289980	UBTF	0.73	6.25	0.58	2.01e-8	Total body bone mineral density;
SKCM	cis	rs1153858	1.000	rs10444821	chr15:45647236	C/T	cg10760299	chr15:45669010	GATM	0.62	6.33	0.58	1.42e-8	Homoarginine levels;
SKCM	cis	rs1912483	0.545	rs35161461	chr17:45401757	A/G	cg25173405	chr17:45401733	C17orf57	-0.75	-5.33	-0.52	9.2e-7	Coronary artery disease;
SKCM	cis	rs7945705	0.935	rs1883098	chr11:8890594	G/A	cg21881798	chr11:8931708	C11orf17;ST5	-0.79	-8.57	-0.7	7.37e-13	Hemoglobin concentration;
SKCM	cis	rs6089584	0.566	rs6061972	chr20:60610245	C/T	cg06108461	chr20:60628389	TAF4	-0.73	-6.66	-0.6	3.43e-9	Body mass index;
SKCM	cis	rs951366	0.646	rs1772159	chr1:205759195	G/A	cg07157834	chr1:205819609	PM20D1	0.82	8.27	0.68	2.76e-12	Menarche (age at onset);
SKCM	cis	rs4740619	0.619	rs7040690	chr9:16038049	G/C	cg14451791	chr9:16040625	NA	-0.47	-5.03	-0.49	3.07e-6	Body mass index;
SKCM	cis	rs250585	0.667	rs463399	chr16:23608882	C/T	cg09934309	chr16:23461721	COG7	-0.83	-5.56	-0.53	3.6e-7	Egg allergy;
SKCM	cis	rs1552244	0.832	rs67145301	chr3:10197314	G/A	cg02579736	chr3:10068473	FANCD2;CIDECP	1.23	6.74	0.61	2.48e-9	Alzheimer's disease;
SKCM	cis	rs7811142	0.830	rs6979910	chr7:99940630	A/C	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.06	6.05	0.56	4.82e-8	Platelet count;
SKCM	cis	rs244731	0.920	rs67008484	chr5:176735383	T/C	cg17509989	chr5:176798049	RGS14	0.92	6.93	0.62	1.06e-9	Urate levels in lean individuals;
SKCM	cis	rs10540	1.000	rs12417570	chr11:462684	C/T	cg03576123	chr11:487126	PTDSS2	-1.59	-8.2	-0.68	3.85e-12	Body mass index;
SKCM	cis	rs8067545	0.611	rs8066143	chr17:20048355	A/C	cg13482628	chr17:19912719	NA	0.66	5.58	0.53	3.39e-7	Schizophrenia;
SKCM	cis	rs3096299	0.658	rs4291902	chr16:89560315	G/C	cg02187348	chr16:89574699	SPG7	0.62	4.92	0.49	4.71e-6	Multiple myeloma (IgH translocation);
SKCM	trans	rs3780486	0.505	rs10758188	chr9:33123386	C/T	cg20290983	chr6:43655470	MRPS18A	-0.87	-9.38	-0.73	1.94e-14	IgG glycosylation;
SKCM	cis	rs2073499	1.000	rs2236948	chr3:50409826	A/G	cg05260129	chr3:50388622	TUSC4;CYB561D2	0.78	4.8	0.48	7.38e-6	Schizophrenia;
SKCM	cis	rs80130819	0.515	rs1476608	chr12:48493731	C/T	cg05342945	chr12:48394962	COL2A1	-0.75	-5.19	-0.51	1.6e-6	Prostate cancer;
SKCM	cis	rs11690935	0.959	rs7572215	chr2:172634228	G/A	cg13550731	chr2:172543902	DYNC1I2	-0.95	-8.21	-0.68	3.64e-12	Schizophrenia;
SKCM	cis	rs67311347	0.544	rs9814779	chr3:40340431	T/C	cg00656387	chr3:40428638	ENTPD3	0.56	4.98	0.49	3.71e-6	Renal cell carcinoma;
SKCM	cis	rs1046896	1.000	rs1046896	chr17:80685533	A/G	cg02711726	chr17:80685570	FN3KRP	0.69	6.03	0.56	5.24e-8	Glycated hemoglobin levels;
SKCM	cis	rs7937682	0.737	rs679032	chr11:111423286	G/T	cg19812747	chr11:111475976	SIK2	-0.56	-4.88	-0.48	5.57e-6	Primary sclerosing cholangitis;
SKCM	cis	rs514406	0.729	rs534070	chr1:53308858	T/G	cg24675658	chr1:53192096	ZYG11B	-0.86	-7.93	-0.67	1.3e-11	Monocyte count;
SKCM	cis	rs9916302	0.706	rs7212621	chr17:37527911	T/G	cg07936489	chr17:37558343	FBXL20	0.98	6.83	0.61	1.67e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs12142240	0.583	rs5013330	chr1:46815154	G/A	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs155076	0.938	rs536209	chr13:21847714	C/T	cg14456004	chr13:21872349	NA	-1.22	-6.76	-0.61	2.24e-9	White matter hyperintensity burden;
SKCM	cis	rs7100689	0.753	rs1856773	chr10:82060484	T/A	cg01528321	chr10:82214614	TSPAN14	0.81	7.3	0.64	2.14e-10	Post bronchodilator FEV1;
SKCM	cis	rs13256369	0.901	rs13251887	chr8:8568678	G/A	cg06636001	chr8:8085503	FLJ10661	0.77	5.93	0.56	7.8e-8	Obesity-related traits;
SKCM	cis	rs1401999	0.674	rs562	chr3:183637845	T/C	cg01324343	chr3:183735012	ABCC5	0.65	6.11	0.57	3.74e-8	Anterior chamber depth;
SKCM	cis	rs28595532	0.545	rs17594782	chr4:119250877	G/T	cg21605333	chr4:119757512	SEC24D	0.96	5.21	0.51	1.47e-6	Cannabis dependence symptom count;
SKCM	cis	rs12477438	0.798	rs6705583	chr2:99602625	T/C	cg26064155	chr2:99771622	LIPT1;TSGA10	-0.72	-4.79	-0.48	7.68e-6	Chronic sinus infection;
SKCM	cis	rs116095464	0.558	rs10079760	chr5:230778	A/G	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs2841277	0.741	rs9672139	chr14:105408182	T/G	cg15352829	chr14:105391018	PLD4	-0.65	-6.42	-0.59	9.62e-9	Rheumatoid arthritis;
SKCM	cis	rs79839061	0.656	rs11726912	chr4:887868	A/C	cg07828340	chr4:882639	GAK	1.06	5.86	0.55	1.06e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs4423214	1.000	rs3794060	chr11:71187679	C/T	cg05163923	chr11:71159392	DHCR7	0.81	7.55	0.65	6.83e-11	Vitamin D levels;
SKCM	cis	rs2013441	1.000	rs2526483	chr17:20112216	A/G	cg13482628	chr17:19912719	NA	-0.65	-5.21	-0.51	1.48e-6	Obesity-related traits;
SKCM	cis	rs1707322	0.964	rs785508	chr1:46527159	G/A	cg03146154	chr1:46216737	IPP	-0.78	-5.79	-0.55	1.38e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs62103177	0.565	rs473119	chr18:77849459	T/G	cg27393146	chr18:77495563	CTDP1	0.82	5.7	0.54	2.08e-7	Opioid sensitivity;
SKCM	cis	rs9788721	0.836	rs72738718	chr15:78735438	G/C	cg18825076	chr15:78729989	IREB2	-0.61	-4.85	-0.48	6.1e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;Emphysema imaging phenotypes;Emphysema distribution in smoking;Local histogram emphysema pattern;Post bronchodilator FEV1/FVC ratio in COPD;
SKCM	cis	rs9733	0.621	rs6669122	chr1:150591732	A/G	cg13175981	chr1:150552382	MCL1	0.72	6.31	0.58	1.57e-8	Tonsillectomy;
SKCM	cis	rs12142240	0.698	rs68012736	chr1:46839510	A/G	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs6089584	0.566	rs6061972	chr20:60610245	C/T	cg16423285	chr20:60520624	NA	-0.57	-4.93	-0.49	4.5e-6	Body mass index;
SKCM	cis	rs6951245	0.935	rs11763765	chr7:1060510	C/T	cg03188948	chr7:1209495	NA	1.11	6.11	0.57	3.68e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs2777491	1.000	rs2777491	chr15:41735710	T/G	cg18705301	chr15:41695430	NDUFAF1	-0.89	-9.04	-0.72	9.17e-14	Ulcerative colitis;
SKCM	cis	rs7927771	0.965	rs56400411	chr11:47586376	T/G	cg05585544	chr11:47624801	NA	-0.63	-5.5	-0.53	4.73e-7	Subjective well-being;
SKCM	cis	rs1046896	0.514	rs67735447	chr17:80823042	G/T	cg22027946	chr17:80790580	TBCD;ZNF750	0.67	4.9	0.48	5.16e-6	Glycated hemoglobin levels;
SKCM	cis	rs801193	0.636	rs10233806	chr7:66118248	G/C	cg18876405	chr7:65276391	NA	-0.65	-6.27	-0.58	1.86e-8	Aortic root size;
SKCM	cis	rs875971	0.660	rs1860468	chr7:66107252	T/C	cg05627663	chr7:65219948	SNORA22;CCT6P1	-0.56	-4.81	-0.48	7.26e-6	Aortic root size;
SKCM	cis	rs6982751	0.673	rs4841464	chr8:10807231	C/T	cg01383082	chr8:11323474	FAM167A	0.86	4.98	0.49	3.74e-6	Asthma and hay fever;
SKCM	cis	rs35146811	0.659	rs863450	chr7:99821685	C/T	cg22906224	chr7:99728672	NA	-0.71	-5.61	-0.54	2.99e-7	Coronary artery disease;
SKCM	cis	rs1348850	0.632	rs13008857	chr2:178514468	G/A	cg22681709	chr2:178499509	PDE11A	-0.68	-5.83	-0.55	1.17e-7	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs5753618	0.555	rs9609302	chr22:31895987	A/C	cg02404636	chr22:31891804	SFI1	0.68	6.07	0.57	4.32e-8	Colorectal cancer;
SKCM	cis	rs651907	0.557	rs7645391	chr3:101361506	C/G	cg12386194	chr3:101231763	SENP7	0.72	5.97	0.56	6.65e-8	Colorectal cancer;
SKCM	cis	rs8180040	0.966	rs17784882	chr3:47544003	C/A	cg27129171	chr3:47204927	SETD2	-0.81	-5.82	-0.55	1.26e-7	Colorectal cancer;
SKCM	cis	rs7824557	0.564	rs2572379	chr8:11237480	A/G	cg21775007	chr8:11205619	TDH	-0.58	-4.77	-0.48	8.29e-6	Retinal vascular caliber;
SKCM	cis	rs60871478	0.588	rs4721358	chr7:844372	G/A	cg05535760	chr7:792225	HEATR2	-0.84	-5.85	-0.55	1.12e-7	Cerebrospinal P-tau181p levels;
SKCM	cis	rs2243480	1.000	rs35283677	chr7:65359233	C/T	cg07424592	chr7:64974309	NA	0.99	4.9	0.49	5.08e-6	Diabetic kidney disease;
SKCM	cis	rs7945705	0.935	rs2568061	chr11:8886260	A/G	cg21881798	chr11:8931708	C11orf17;ST5	-0.79	-8.52	-0.69	9.25e-13	Hemoglobin concentration;
SKCM	cis	rs7666738	0.830	rs28687737	chr4:99009226	G/A	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9325144	1.000	rs10506124	chr12:39019236	C/A	cg26384229	chr12:38710491	ALG10B	-0.61	-4.77	-0.48	8.43e-6	Morning vs. evening chronotype;
SKCM	cis	rs5769765	1.000	rs738711	chr22:50282603	A/G	cg22709217	chr22:50311962	ALG12;CRELD2	0.79	5.71	0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs9300255	0.602	rs1106240	chr12:123626982	C/T	cg05973401	chr12:123451056	ABCB9	0.77	5.19	0.51	1.66e-6	Neutrophil percentage of white cells;
SKCM	cis	rs11924390	0.800	rs1648698	chr3:186449582	G/C	cg09332604	chr3:186435400	KNG1	-0.56	-5.67	-0.54	2.31e-7	Adiponectin levels;
SKCM	cis	rs7618915	1.000	rs3852064	chr3:52349412	G/T	cg14092988	chr3:52407081	DNAH1	0.64	4.81	0.48	7.27e-6	Bipolar disorder;
SKCM	cis	rs7937682	0.575	rs7127010	chr11:111770782	C/T	cg09085632	chr11:111637200	PPP2R1B	1.09	10.45	0.76	1.7e-16	Primary sclerosing cholangitis;
SKCM	cis	rs7772486	0.846	rs2144478	chr6:146381445	A/G	cg23711669	chr6:146136114	FBXO30	0.86	8.52	0.69	9.13e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs763121	0.819	rs5757160	chr22:38989646	T/C	cg06022373	chr22:39101656	GTPBP1	0.82	5.62	0.54	2.79e-7	Menopause (age at onset);
SKCM	cis	rs11679564	0.714	rs4389320	chr2:37172531	T/C	cg14987922	chr2:37194071	STRN	0.85	6.41	0.59	1.02e-8	Immature fraction of reticulocytes;
SKCM	cis	rs6952808	0.692	rs10950473	chr7:1999453	G/A	cg21782813	chr7:2030301	MAD1L1	0.57	6.05	0.57	4.68e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs7843479	0.601	rs11135764	chr8:21814004	A/G	cg17168535	chr8:21777572	XPO7	0.84	8.06	0.67	7.32e-12	Mean corpuscular volume;
SKCM	cis	rs17376456	0.877	rs10476526	chr5:93461916	G/A	cg25358565	chr5:93447407	FAM172A	1.23	7.97	0.67	1.08e-11	Diabetic retinopathy;
SKCM	cis	rs1023500	0.507	rs6002600	chr22:42488906	G/A	cg04733989	chr22:42467013	NAGA	-0.72	-5.62	-0.54	2.87e-7	Schizophrenia;
SKCM	cis	rs9633740	1.000	rs7900536	chr10:82253701	G/T	cg01528321	chr10:82214614	TSPAN14	0.85	6.73	0.61	2.54e-9	Post bronchodilator FEV1;
SKCM	cis	rs4665809	0.590	rs34728554	chr2:26481959	C/G	cg26119090	chr2:26468346	HADHA;HADHB	1.06	8.39	0.69	1.66e-12	Gut microbiome composition (summer);
SKCM	cis	rs9894429	0.683	rs112612275	chr17:79552604	C/A	cg18240062	chr17:79603768	NPLOC4	-0.91	-10.36	-0.76	2.55e-16	Eye color traits;
SKCM	cis	rs769267	0.930	rs4808208	chr19:19650096	A/G	cg26732615	chr19:19648335	CILP2;YJEFN3	0.67	7.09	0.63	5.41e-10	Tonsillectomy;
SKCM	cis	rs4689592	0.503	rs10516184	chr4:7060959	C/T	cg26116260	chr4:7069785	GRPEL1	1.02	7.08	0.63	5.58e-10	Monocyte percentage of white cells;
SKCM	cis	rs6665290	0.669	rs3768424	chr1:227177444	A/G	cg10327440	chr1:227177885	CDC42BPA	-1.08	-9.89	-0.75	2.02e-15	Myeloid white cell count;
SKCM	cis	rs1325195	0.520	rs2636288	chr1:179227845	T/C	cg25467746	chr1:179556597	NA	0.59	5.65	0.54	2.48e-7	IgE grass sensitization;
SKCM	cis	rs11658309	1	rs11658309	chr17:17762247	T/G	cg04398451	chr17:18023971	MYO15A	0.92	6.67	0.6	3.3e-9	Strep throat;
SKCM	cis	rs17685	0.753	rs2302435	chr7:75676987	G/A	cg16489192	chr7:75678113	MDH2;STYXL1	0.58	5.44	0.52	5.83e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2836974	0.897	rs13339986	chr21:40605982	T/C	cg11890956	chr21:40555474	PSMG1	1.09	13.6	0.84	2.8e-22	Cognitive function;
SKCM	cis	rs4237845	0.537	rs7312623	chr12:58262523	G/T	cg00677455	chr12:58241039	CTDSP2	0.91	8.28	0.68	2.66e-12	Intelligence (multi-trait analysis);
SKCM	cis	rs5750830	0.649	rs5757659	chr22:39812409	A/C	cg11247378	chr22:39784982	NA	-0.44	-5.3	-0.51	1.05e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs5750830	0.620	rs1007337	chr22:39781585	C/T	cg11247378	chr22:39784982	NA	-0.49	-5.84	-0.55	1.14e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs362272	0.545	rs3135146	chr4:3307638	C/G	cg05297308	chr4:3317976	RGS12	-1.01	-12.35	-0.81	4.86e-20	Serum sulfate level;
SKCM	cis	rs6545883	0.929	rs2593626	chr2:61665184	C/A	cg15711740	chr2:61764176	XPO1	-0.7	-4.93	-0.49	4.5e-6	Tuberculosis;
SKCM	cis	rs7917772	0.502	rs2296583	chr10:104244322	T/G	cg11453585	chr10:104263688	ACTR1A;SUFU	0.73	5.41	0.52	6.74e-7	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs8014204	0.816	rs28426374	chr14:75346740	C/T	cg06637938	chr14:75390232	RPS6KL1	-0.64	-4.78	-0.48	8.26e-6	Caffeine consumption;
SKCM	cis	rs910316	1.000	rs7142235	chr14:75559963	T/C	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.89e-7	Height;
SKCM	cis	rs17685	0.753	rs13240404	chr7:75675719	C/T	cg01364799	chr7:75623366	TMEM120A	0.72	5.83	0.55	1.18e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs3785574	0.962	rs57553639	chr17:61848499	C/T	cg01411255	chr17:61851458	DDX42;CCDC47	1.11	12.47	0.82	2.97e-20	Height;
SKCM	cis	rs7666738	0.830	rs4492007	chr4:98959848	A/T	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs875971	0.792	rs6971752	chr7:65737986	G/A	cg11764359	chr7:65958608	NA	-0.82	-7.87	-0.67	1.68e-11	Aortic root size;
SKCM	cis	rs7945705	0.902	rs1560569	chr11:8939887	C/T	cg13070366	chr11:9386451	NA	0.62	5.32	0.52	9.62e-7	Hemoglobin concentration;
SKCM	cis	rs8141529	0.732	rs5997408	chr22:29207915	G/A	cg15103426	chr22:29168792	CCDC117	0.62	5.2	0.51	1.57e-6	Lymphocyte counts;
SKCM	cis	rs992157	0.560	rs7605980	chr2:219100869	C/G	cg20019365	chr2:219134978	PNKD;AAMP	0.66	5.47	0.53	5.2e-7	Colorectal cancer;
SKCM	cis	rs9790314	1.000	rs9846756	chr3:160983809	A/C	cg03342759	chr3:160939853	NMD3	-0.71	-7.45	-0.64	1.11e-10	Morning vs. evening chronotype;
SKCM	cis	rs7945705	0.714	rs2653570	chr11:8987823	A/G	cg13070366	chr11:9386451	NA	0.57	4.89	0.48	5.2e-6	Hemoglobin concentration;
SKCM	cis	rs2032447	0.839	rs6901039	chr6:26000885	A/C	cg18357526	chr6:26021779	HIST1H4A	0.86	6.85	0.61	1.52e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs35306767	0.903	rs35957139	chr10:884889	C/T	cg20503657	chr10:835505	NA	0.79	5.57	0.53	3.52e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs870825	0.655	rs10033035	chr4:185630880	T/C	cg04058563	chr4:185651563	MLF1IP	1.08	7.26	0.64	2.51e-10	Blood protein levels;
SKCM	cis	rs7937682	0.921	rs1944119	chr11:111436387	A/G	cg09085632	chr11:111637200	PPP2R1B	0.97	8.24	0.68	3.25e-12	Primary sclerosing cholangitis;
SKCM	cis	rs10256972	0.685	rs10263665	chr7:1110628	A/G	cg16145915	chr7:1198662	ZFAND2A	-0.46	-5.4	-0.52	6.93e-7	Longevity;Endometriosis;
SKCM	cis	rs362296	0.583	rs35658829	chr4:3255738	T/G	cg11471262	chr4:3318911	RGS12	-0.71	-6.26	-0.58	1.97e-8	Parental longevity (mother's age at death);
SKCM	cis	rs35306767	0.903	rs12244355	chr10:944465	T/C	cg26597838	chr10:835615	NA	0.76	5.58	0.53	3.35e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs2811415	0.597	rs11706281	chr3:127803922	A/G	cg09089421	chr3:127803668	RUVBL1	1.0	8.69	0.7	4.4e-13	Lung function (FEV1/FVC);
SKCM	cis	rs1561288	0.553	rs12233134	chr2:25329016	C/T	cg04586622	chr2:25135609	ADCY3	-0.74	-5.18	-0.51	1.72e-6	Body mass index;
SKCM	cis	rs6570726	0.791	rs9373464	chr6:145907167	T/C	cg23711669	chr6:146136114	FBXO30	0.86	7.97	0.67	1.06e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs208520	0.754	rs7753158	chr6:66875633	A/C	cg07460842	chr6:66804631	NA	-0.95	-6.5	-0.59	6.82e-9	Exhaled nitric oxide output;
SKCM	cis	rs8060686	0.641	rs113896227	chr16:68101480	C/T	cg04539111	chr16:67997858	SLC12A4	-0.85	-4.81	-0.48	7.14e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs3847687	1.000	rs11061303	chr12:131526322	A/G	cg13586425	chr12:131519906	GPR133	-0.54	-5.93	-0.56	7.78e-8	Longevity;
SKCM	cis	rs6952808	0.689	rs1107591	chr7:2041638	G/A	cg04267008	chr7:1944627	MAD1L1	-0.64	-4.8	-0.48	7.63e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs7216064	1.000	rs7221651	chr17:65832390	A/G	cg12091567	chr17:66097778	LOC651250	0.73	5.11	0.5	2.21e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs914615	0.552	rs12752585	chr1:155135406	G/A	cg02153340	chr1:155202674	NA	-0.56	-4.83	-0.48	6.72e-6	Urinary albumin-to-creatinine ratio;
SKCM	cis	rs151997	1.000	rs152690	chr5:50213584	A/T	cg06027927	chr5:50259733	NA	0.66	5.78	0.55	1.45e-7	Callous-unemotional behaviour;
SKCM	cis	rs2463822	1.000	rs2513747	chr11:62098735	T/C	cg06239285	chr11:62104954	ASRGL1	1.27	6.04	0.56	4.98e-8	Chronic obstructive pulmonary disease-related biomarkers;
SKCM	cis	rs2075371	1.000	rs2598297	chr7:133993001	T/G	cg20476274	chr7:133979776	SLC35B4	1.03	10.69	0.77	5.94e-17	Mean platelet volume;
SKCM	cis	rs11098499	0.863	rs2306457	chr4:120472839	T/A	cg24375607	chr4:120327624	NA	0.66	5.06	0.5	2.73e-6	Corneal astigmatism;
SKCM	cis	rs7666738	0.830	rs1426667	chr4:98949772	T/C	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10751667	0.666	rs7395321	chr11:940280	C/T	cg10932868	chr11:921992	NA	0.54	5.05	0.5	2.81e-6	Alzheimer's disease (late onset);
SKCM	cis	rs2836974	0.899	rs35774464	chr21:40580169	G/A	cg11644478	chr21:40555479	PSMG1	0.97	10.08	0.75	8.76e-16	Cognitive function;
SKCM	cis	rs10751667	0.666	rs6597962	chr11:976351	C/T	cg06064525	chr11:970664	AP2A2	-0.53	-4.9	-0.48	5.15e-6	Alzheimer's disease (late onset);
SKCM	cis	rs16854884	0.657	rs6783089	chr3:143738034	T/C	cg06585982	chr3:143692056	C3orf58	0.87	8.11	0.68	5.72e-12	Economic and political preferences (feminism/equality);
SKCM	cis	rs910316	1.000	rs4899544	chr14:75546556	C/T	cg08847533	chr14:75593920	NEK9	0.95	9.18	0.72	4.88e-14	Height;
SKCM	cis	rs4819052	0.765	rs2838868	chr21:46714641	A/G	cg19498844	chr21:46707878	POFUT2;LOC642852	-0.91	-6.7	-0.6	2.9e-9	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs2228479	0.867	rs11646448	chr16:89966357	A/T	cg00800038	chr16:89945340	TCF25	-0.92	-5.25	-0.51	1.27e-6	Skin colour saturation;
SKCM	cis	rs58688157	0.705	rs12419720	chr11:598205	C/G	cg03576123	chr11:487126	PTDSS2	-0.8	-5.19	-0.51	1.61e-6	Systemic lupus erythematosus;
SKCM	cis	rs9549367	0.664	rs9549689	chr13:113848387	G/A	cg18105134	chr13:113819100	PROZ	-0.91	-6.86	-0.61	1.45e-9	Platelet distribution width;
SKCM	cis	rs28595532	0.920	rs116514715	chr4:119756280	G/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs1557765	0.527	rs2018218	chr11:17390855	A/G	cg15432903	chr11:17409602	KCNJ11	0.53	5.06	0.5	2.7e-6	Body mass index;Social communication problems;
SKCM	cis	rs13010713	0.840	rs10209191	chr2:182058891	A/G	cg21995919	chr2:182322279	ITGA4	-0.53	-5.12	-0.5	2.18e-6	Celiac disease;
SKCM	cis	rs7659604	0.702	rs6815790	chr4:122695385	A/C	cg20573242	chr4:122745356	CCNA2	0.78	6.48	0.59	7.5e-9	Type 2 diabetes;
SKCM	cis	rs7954584	0.604	rs34159444	chr12:122416667	A/G	cg21171335	chr12:122356390	WDR66	0.46	5.02	0.49	3.2e-6	Mean corpuscular volume;
SKCM	cis	rs1707322	0.685	rs11211177	chr1:46226349	A/G	cg03146154	chr1:46216737	IPP	0.79	5.56	0.53	3.68e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs9910055	0.573	rs228768	chr17:42191893	A/C	cg10896456	chr17:42255109	ASB16;C17orf65	0.58	5.29	0.51	1.07e-6	Total body bone mineral density;
SKCM	cis	rs4919694	1.000	rs11191545	chr10:104829793	C/T	cg04362960	chr10:104952993	NT5C2	0.77	5.01	0.49	3.25e-6	Arsenic metabolism;
SKCM	cis	rs9300255	0.544	rs1716175	chr12:123658388	A/T	cg00376283	chr12:123451042	ABCB9	0.86	5.28	0.51	1.12e-6	Neutrophil percentage of white cells;
SKCM	cis	rs13118159	0.556	rs4974615	chr4:1373551	A/G	cg19318889	chr4:1322082	MAEA	-0.78	-5.78	-0.55	1.49e-7	Longevity;
SKCM	cis	rs34779708	0.931	rs7099036	chr10:35349574	C/T	cg03585969	chr10:35415529	CREM	0.76	6.24	0.58	2.11e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs875971	0.862	rs1983372	chr7:65611351	C/T	cg11764359	chr7:65958608	NA	-0.8	-7.66	-0.66	4.2e-11	Aortic root size;
SKCM	cis	rs2013441	1.000	rs12451216	chr17:20025840	C/A	cg13482628	chr17:19912719	NA	0.64	4.82	0.48	7.04e-6	Obesity-related traits;
SKCM	cis	rs10752881	1.000	rs10797812	chr1:182984597	A/G	ch.1.3577855R	chr1:183094577	LAMC1	-0.72	-6.47	-0.59	7.82e-9	Colorectal cancer;
SKCM	cis	rs17376456	1.000	rs34013242	chr5:93507947	C/T	cg25358565	chr5:93447407	FAM172A	1.23	8.18	0.68	4.19e-12	Diabetic retinopathy;
SKCM	cis	rs2836974	0.897	rs35064900	chr21:40555492	A/G	cg17971929	chr21:40555470	PSMG1	0.89	8.73	0.7	3.6e-13	Cognitive function;
SKCM	cis	rs28386778	0.897	rs2854213	chr17:61945631	T/C	cg22520471	chr17:61851767	DDX42;CCDC47	0.79	5.33	0.52	9.35e-7	Prudent dietary pattern;
SKCM	cis	rs11718455	0.960	rs13082990	chr3:44005172	T/C	cg21419209	chr3:44054225	NA	-0.65	-5.32	-0.52	9.77e-7	Coronary artery disease;
SKCM	cis	rs4319547	0.661	rs10773172	chr12:122939655	G/A	cg23029597	chr12:123009494	RSRC2	-0.8	-6.06	-0.57	4.61e-8	Body mass index;
SKCM	cis	rs4972806	0.668	rs2072588	chr2:177042930	G/C	cg13092806	chr2:177043255	NA	0.57	5.37	0.52	7.9e-7	IgG glycosylation;
SKCM	cis	rs1577917	0.839	rs6454504	chr6:86580330	C/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.69	-6.19	-0.57	2.61e-8	Response to antipsychotic treatment;
SKCM	cis	rs7179456	0.513	rs593742	chr15:59045774	A/G	cg05156742	chr15:59063176	FAM63B	0.78	5.95	0.56	7.07e-8	Asperger disorder;
SKCM	cis	rs3820068	0.532	rs74057713	chr1:15944620	G/C	cg24675056	chr1:15929824	NA	0.73	5.44	0.52	6.03e-7	Systolic blood pressure;
SKCM	cis	rs9611565	0.765	rs132905	chr22:41799106	C/A	cg03806693	chr22:41940476	POLR3H	1.02	6.92	0.62	1.13e-9	Vitiligo;
SKCM	cis	rs514406	0.668	rs12037492	chr1:53440816	G/T	cg24675658	chr1:53192096	ZYG11B	0.81	7.42	0.64	1.22e-10	Monocyte count;
SKCM	cis	rs12188164	1.000	rs72717411	chr5:429124	C/G	cg26076054	chr5:421317	AHRR	-0.61	-4.8	-0.48	7.47e-6	Cystic fibrosis severity;
SKCM	cis	rs12824058	0.831	rs12829373	chr12:130814114	G/C	cg24838063	chr12:130822603	PIWIL1	0.78	6.99	0.62	8.22e-10	Menopause (age at onset);
SKCM	cis	rs1801251	0.711	rs778339	chr2:233739678	T/C	cg25237894	chr2:233734115	C2orf82	-0.6	-6.46	-0.59	8.3e-9	Coronary artery disease;
SKCM	cis	rs10193935	0.901	rs9309082	chr2:42581412	A/G	cg27598129	chr2:42591480	NA	-0.88	-6.75	-0.61	2.36e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs12478296	0.681	rs6598999	chr2:242994405	C/A	cg06360820	chr2:242988706	NA	-1.0	-6.11	-0.57	3.66e-8	Obesity-related traits;
SKCM	cis	rs561341	0.824	rs1978115	chr17:30220776	A/C	cg00745463	chr17:30367425	LRRC37B	-1.07	-6.83	-0.61	1.68e-9	Hip circumference adjusted for BMI;
SKCM	cis	rs875971	0.798	rs6460304	chr7:65964728	G/A	cg11764359	chr7:65958608	NA	0.81	7.61	0.65	5.25e-11	Aortic root size;
SKCM	trans	rs561341	0.623	rs4795665	chr17:30233657	C/T	cg20587970	chr11:113659929	NA	-1.08	-8.41	-0.69	1.54e-12	Hip circumference adjusted for BMI;
SKCM	cis	rs875971	0.545	rs221986	chr7:65570310	T/C	cg18876405	chr7:65276391	NA	-0.67	-5.32	-0.52	9.82e-7	Aortic root size;
SKCM	cis	rs1218582	0.774	rs4845679	chr1:154861187	G/T	cg24250549	chr1:154909240	PMVK	0.82	8.28	0.68	2.73e-12	Prostate cancer;
SKCM	cis	rs11105298	0.891	rs10858851	chr12:89830870	C/T	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.87	-6.04	-0.56	4.87e-8	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs4481887	1.000	rs4916125	chr1:248466583	A/T	cg00666640	chr1:248458726	OR2T12	0.6	5.14	0.5	1.98e-6	Common traits (Other);
SKCM	cis	rs4523957	0.560	rs1994884	chr17:2084008	G/A	cg16513277	chr17:2031491	SMG6	-0.79	-5.86	-0.55	1.07e-7	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs13118159	0.550	rs1137789	chr4:1381798	A/G	cg02018176	chr4:1364513	KIAA1530	0.89	7.17	0.63	3.69e-10	Longevity;
SKCM	cis	rs9815354	0.812	rs73077361	chr3:41850146	G/A	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs875971	0.862	rs11763189	chr7:65983529	G/A	cg18876405	chr7:65276391	NA	0.61	5.95	0.56	7.05e-8	Aortic root size;
SKCM	cis	rs9858542	1.000	rs9882740	chr3:49702484	T/C	cg03060546	chr3:49711283	APEH	-0.76	-5.7	-0.54	2.04e-7	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs933688	1.000	rs6867091	chr5:90734333	C/G	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.9	6.82	0.61	1.73e-9	Smoking behavior;
SKCM	cis	rs2999083	0.524	rs9827325	chr3:127736174	T/C	cg09089421	chr3:127803668	RUVBL1	1.0	8.57	0.7	7.53e-13	Post bronchodilator FEV1/FVC ratio;Post bronchodilator FEV1;
SKCM	cis	rs7811142	0.945	rs34989573	chr7:100097895	C/T	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.22	7.91	0.67	1.43e-11	Platelet count;
SKCM	cis	rs7659604	0.539	rs7699776	chr4:122753885	A/G	cg20573242	chr4:122745356	CCNA2	0.75	6.45	0.59	8.59e-9	Type 2 diabetes;
SKCM	cis	rs6087990	0.735	rs2424914	chr20:31374520	A/G	cg13636640	chr20:31349939	DNMT3B	0.83	6.36	0.58	1.28e-8	Ulcerative colitis;
SKCM	cis	rs501916	0.605	rs17332642	chr15:48080805	G/A	cg16110827	chr15:48056943	SEMA6D	-0.62	-4.79	-0.48	7.7e-6	Inflammatory bowel disease;Ulcerative colitis;
SKCM	cis	rs4268898	0.636	rs9636438	chr2:24460566	C/T	cg06627628	chr2:24431161	ITSN2	0.95	7.28	0.64	2.28e-10	Asthma;
SKCM	cis	rs2836974	0.965	rs8134733	chr21:40683459	C/T	cg17971929	chr21:40555470	PSMG1	0.86	8.47	0.69	1.18e-12	Cognitive function;
SKCM	cis	rs189798	0.807	rs330905	chr8:8993551	A/T	cg06636001	chr8:8085503	FLJ10661	0.74	5.33	0.52	9.14e-7	Myopia (pathological);
SKCM	cis	rs875971	1.000	rs11974264	chr7:65647582	C/G	cg18876405	chr7:65276391	NA	-0.68	-6.85	-0.61	1.54e-9	Aortic root size;
SKCM	cis	rs72615157	0.628	rs7801070	chr7:99847147	T/G	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.03	5.8	0.55	1.34e-7	Lung function (FEV1/FVC);
SKCM	cis	rs7666738	0.822	rs28367231	chr4:98845726	G/T	cg17366294	chr4:99064904	C4orf37	0.56	4.89	0.48	5.25e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4523957	0.579	rs903162	chr17:2092200	C/T	cg16513277	chr17:2031491	SMG6	-0.69	-4.91	-0.49	4.88e-6	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs8180040	0.966	rs807932	chr3:47354241	C/T	cg16586182	chr3:47516702	SCAP	-0.71	-4.85	-0.48	6.25e-6	Colorectal cancer;
SKCM	cis	rs7666738	0.830	rs10029849	chr4:99059362	T/C	cg17366294	chr4:99064904	C4orf37	0.61	4.93	0.49	4.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9910055	0.615	rs189049	chr17:42197213	A/C	cg09913183	chr17:42254507	C17orf65;ASB16	-0.68	-6.49	-0.59	7.27e-9	Total body bone mineral density;
SKCM	cis	rs7811142	0.830	rs11769057	chr7:99964661	A/G	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.05	5.92	0.56	8.02e-8	Platelet count;
SKCM	cis	rs228769	1.000	rs12937692	chr17:42256430	G/A	cg19774624	chr17:42201019	HDAC5	-0.89	-6.21	-0.58	2.39e-8	Bone mineral density (hip);Bone mineral density (spine);
SKCM	cis	rs1062177	0.826	rs1549920	chr5:151140844	A/T	cg00977110	chr5:151150581	G3BP1	0.78	6.44	0.59	8.79e-9	Preschool internalizing problems;
SKCM	cis	rs2832191	0.716	rs1888439	chr21:30454457	A/G	cg08807101	chr21:30365312	RNF160	0.73	6.1	0.57	3.86e-8	Dental caries;
SKCM	cis	rs2204008	0.774	rs11495520	chr12:38060605	T/G	cg26384229	chr12:38710491	ALG10B	0.81	6.45	0.59	8.61e-9	Bladder cancer;
SKCM	cis	rs317689	0.613	rs315112	chr12:69785926	T/A	cg20891283	chr12:69753455	YEATS4	0.75	5.84	0.55	1.14e-7	Response to diuretic therapy;
SKCM	cis	rs7954584	0.567	rs1720037	chr12:122382229	G/T	cg21171335	chr12:122356390	WDR66	-0.47	-5.05	-0.5	2.87e-6	Mean corpuscular volume;
SKCM	cis	rs9611565	0.921	rs8137373	chr22:41729216	A/G	cg03806693	chr22:41940476	POLR3H	0.83	5.33	0.52	9.11e-7	Vitiligo;
SKCM	cis	rs7811142	0.830	rs1063945	chr7:99930447	C/T	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.08	6.85	0.61	1.49e-9	Platelet count;
SKCM	cis	rs17345786	0.798	rs1609159	chr3:101275902	A/C	cg11279151	chr3:101281821	RG9MTD1	-0.61	-4.83	-0.48	6.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9513627	0.915	rs7327204	chr13:100126952	C/T	cg11288260	chr13:100117058	NA	-0.72	-5.03	-0.49	3.09e-6	Obesity-related traits;
SKCM	cis	rs7666738	0.830	rs2865978	chr4:99017946	G/T	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7937682	0.961	rs552387	chr11:111490047	T/G	cg09085632	chr11:111637200	PPP2R1B	-0.96	-9.87	-0.75	2.29e-15	Primary sclerosing cholangitis;
SKCM	cis	rs757110	0.705	rs10832778	chr11:17394073	C/G	cg15432903	chr11:17409602	KCNJ11	0.51	4.84	0.48	6.54e-6	Type 2 diabetes;
SKCM	cis	rs7100689	0.725	rs2185425	chr10:82139941	T/C	cg01528321	chr10:82214614	TSPAN14	0.86	8.52	0.69	9.09e-13	Post bronchodilator FEV1;
SKCM	cis	rs1577917	0.958	rs12207374	chr6:86656645	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.85	-8.62	-0.7	5.82e-13	Response to antipsychotic treatment;
SKCM	cis	rs7829975	0.501	rs2980769	chr8:8320291	G/A	cg08975724	chr8:8085496	FLJ10661	0.62	4.94	0.49	4.42e-6	Mood instability;
SKCM	cis	rs589448	0.900	rs588493	chr12:69751986	G/A	cg14784868	chr12:69753453	YEATS4	0.84	7.65	0.65	4.54e-11	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs11585357	0.895	rs72646798	chr1:17614422	C/T	cg08277548	chr1:17600880	PADI3	-0.89	-6.31	-0.58	1.53e-8	Hair shape;
SKCM	cis	rs6424115	0.830	rs2502994	chr1:24199363	T/C	cg15997130	chr1:24165203	NA	0.6	4.94	0.49	4.37e-6	Immature fraction of reticulocytes;
SKCM	cis	rs7811142	1.000	rs6962151	chr7:100028484	T/C	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.12	6.51	0.59	6.68e-9	Platelet count;
SKCM	cis	rs10503709	0.861	rs1481007	chr8:21447615	G/A	cg23716449	chr8:21608280	GFRA2	0.52	5.32	0.52	9.7e-7	Blood protein levels;
SKCM	trans	rs1814175	0.509	rs60698301	chr11:49877672	G/A	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs17685	0.753	rs13240404	chr7:75675719	C/T	cg16684958	chr7:75615977	POR	-0.57	-5.6	-0.54	3.07e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs11098499	0.604	rs12642411	chr4:120580525	T/C	cg09307838	chr4:120376055	NA	1.01	8.35	0.69	2.01e-12	Corneal astigmatism;
SKCM	cis	rs1707322	1.000	rs4489497	chr1:46438698	C/T	cg03146154	chr1:46216737	IPP	0.79	5.34	0.52	8.73e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs941408	1.000	rs1736182	chr19:2798686	T/G	cg06609049	chr19:2785107	THOP1	0.85	7.48	0.65	9.34e-11	Total cholesterol levels;
SKCM	cis	rs344364	0.511	rs12599337	chr16:1946751	A/G	cg26897989	chr16:1907736	C16orf73	0.68	6.96	0.62	9.23e-10	Glomerular filtration rate in chronic kidney disease;
SKCM	cis	rs57221529	0.709	rs4957056	chr5:570105	T/C	cg10555297	chr5:473380	SLC9A3;LOC25845	1.01	5.0	0.49	3.48e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs9926296	0.568	rs4420527	chr16:89814188	C/T	cg04287289	chr16:89883240	FANCA	-1.02	-12.25	-0.81	7.46e-20	Vitiligo;
SKCM	cis	rs7772486	0.686	rs857879	chr6:145974043	C/A	cg23711669	chr6:146136114	FBXO30	-0.9	-9.43	-0.73	1.62e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2204008	0.627	rs11176531	chr12:38152166	T/G	cg13010199	chr12:38710504	ALG10B	0.7	4.91	0.49	4.9e-6	Bladder cancer;
SKCM	cis	rs7208859	0.623	rs12103440	chr17:29086657	A/G	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs7937682	0.883	rs510388	chr11:111451869	G/T	cg22437258	chr11:111473054	SIK2	-0.66	-5.03	-0.49	3.05e-6	Primary sclerosing cholangitis;
SKCM	cis	rs875971	1.000	rs6958484	chr7:65599446	G/A	cg18876405	chr7:65276391	NA	-0.68	-6.85	-0.61	1.54e-9	Aortic root size;
SKCM	cis	rs9611565	0.568	rs5751159	chr22:42175365	G/A	cg03806693	chr22:41940476	POLR3H	0.88	5.75	0.55	1.68e-7	Vitiligo;
SKCM	cis	rs3008870	0.959	rs2985808	chr1:67367741	T/C	cg08660285	chr1:67390436	MIER1;WDR78	0.95	6.45	0.59	8.62e-9	Lymphocyte percentage of white cells;
SKCM	cis	rs514406	0.679	rs960570	chr1:53237763	A/G	cg08859206	chr1:53392774	SCP2	0.68	5.34	0.52	8.91e-7	Monocyte count;
SKCM	cis	rs7811142	0.666	rs28401739	chr7:99905684	A/G	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.08	6.85	0.61	1.49e-9	Platelet count;
SKCM	cis	rs7811142	1.000	rs68116612	chr7:100006493	G/A	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-1.0	-5.66	-0.54	2.36e-7	Platelet count;
SKCM	cis	rs10838687	0.673	rs4576779	chr11:47121547	C/G	cg05584439	chr11:47213196	NA	0.8	4.8	0.48	7.6e-6	Proinsulin levels;
SKCM	cis	rs13256369	0.901	rs12681298	chr8:8566235	A/G	cg06636001	chr8:8085503	FLJ10661	-0.72	-5.46	-0.53	5.47e-7	Obesity-related traits;
SKCM	cis	rs5750830	0.621	rs5757665	chr22:39821641	A/G	cg11247378	chr22:39784982	NA	-0.47	-5.43	-0.52	6.23e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs8017423	0.866	rs10184	chr14:90744672	G/A	cg04374321	chr14:90722782	PSMC1	-0.96	-8.66	-0.7	4.99e-13	Mortality in heart failure;
SKCM	cis	rs4862750	0.957	rs6858853	chr4:187903412	A/C	cg10295955	chr4:187884368	NA	0.98	11.49	0.79	1.9e-18	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6840360	0.615	rs4696268	chr4:152464723	G/A	cg22705602	chr4:152727874	NA	-0.51	-5.78	-0.55	1.48e-7	Intelligence (multi-trait analysis);
SKCM	trans	rs11083271	0.631	rs8090052	chr18:25857767	A/G	cg00321150	chr11:62623587	SNORD27;SLC3A2;SNHG1;SNORD28;SNORD25;SNORD26	0.82	7.53	0.65	7.5e-11	Non-alcoholic fatty liver disease histology (lobular);
SKCM	cis	rs6061231	0.675	rs755726	chr20:60962624	T/C	cg24112000	chr20:60950667	NA	-0.61	-6.18	-0.57	2.69e-8	Colorectal cancer;
SKCM	cis	rs912057	0.932	rs1294406	chr6:6737737	A/G	cg06612196	chr6:6737390	NA	0.6	5.19	0.51	1.63e-6	Waist-to-hip ratio adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);
SKCM	cis	rs9790314	0.846	rs4856714	chr3:160961824	T/C	cg03342759	chr3:160939853	NMD3	-0.72	-8.12	-0.68	5.59e-12	Morning vs. evening chronotype;
SKCM	cis	rs17065868	1.000	rs61948010	chr13:45186674	T/G	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs2842992	0.830	rs2758312	chr6:160153452	G/A	cg19482086	chr6:160211437	TCP1;MRPL18	0.83	6.28	0.58	1.75e-8	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs1799949	1.000	rs4792981	chr17:41308274	A/G	cg05368731	chr17:41323189	NBR1	0.89	7.98	0.67	1.03e-11	Menopause (age at onset);
SKCM	cis	rs9902453	0.817	rs2321333	chr17:28140857	A/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.8	6.02	0.56	5.27e-8	Coffee consumption (cups per day);
SKCM	cis	rs7811142	1.000	rs2897358	chr7:100088640	C/G	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.19	7.92	0.67	1.33e-11	Platelet count;
SKCM	cis	rs9868809	0.772	rs9877501	chr3:48718390	C/G	cg00383909	chr3:49044727	WDR6	0.89	4.92	0.49	4.79e-6	Ulcerative colitis;Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs6570726	0.791	rs7765675	chr6:145915077	A/C	cg23711669	chr6:146136114	FBXO30	0.88	8.37	0.69	1.84e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2153535	0.601	rs2143353	chr6:8530111	T/G	cg23788917	chr6:8435910	SLC35B3	0.68	4.98	0.49	3.66e-6	Motion sickness;
SKCM	cis	rs4727027	0.645	rs12704072	chr7:148904888	G/A	cg23583168	chr7:148888333	NA	-0.77	-6.07	-0.57	4.35e-8	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs9443189	0.813	rs2842556	chr6:76447204	T/C	cg01950844	chr6:76311363	SENP6	-0.72	-4.95	-0.49	4.13e-6	Prostate cancer;
SKCM	cis	rs12824058	0.767	rs4759654	chr12:130815559	A/G	cg26677194	chr12:130822605	PIWIL1	0.71	5.91	0.56	8.57e-8	Menopause (age at onset);
SKCM	cis	rs6565180	0.888	rs13333093	chr16:30407269	C/A	cg17640201	chr16:30407289	ZNF48	1.02	9.28	0.72	3.05e-14	Tonsillectomy;
SKCM	cis	rs12477438	0.520	rs11123761	chr2:99705903	A/G	cg14399236	chr2:99771627	LIPT1;TSGA10	0.98	8.71	0.7	3.93e-13	Chronic sinus infection;
SKCM	cis	rs514406	0.929	rs554301	chr1:53321948	A/T	cg16325326	chr1:53192061	ZYG11B	-0.92	-9.93	-0.75	1.75e-15	Monocyte count;
SKCM	cis	rs737337	0.623	rs12463177	chr19:11341680	G/C	cg00586551	chr19:11347513	LOC55908;DOCK6	0.82	5.92	0.56	8.18e-8	HDL cholesterol;HDL cholesterol levels;
SKCM	cis	rs798766	1.000	rs4865463	chr4:1742400	T/C	cg24239225	chr4:1659016	FAM53A	-0.72	-4.87	-0.48	5.66e-6	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs10791111	1	rs10791111	chr11:130856099	T/G	cg12179176	chr11:130786555	SNX19	0.79	6.04	0.56	4.9e-8	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs778371	0.697	rs2344613	chr2:233603065	C/G	cg08000102	chr2:233561755	GIGYF2	0.85	6.56	0.6	5.46e-9	Schizophrenia;
SKCM	cis	rs684232	0.602	rs394747	chr17:562495	C/G	cg15660573	chr17:549704	VPS53	0.76	6.15	0.57	3.13e-8	Prostate cancer;
SKCM	cis	rs1552244	0.748	rs9862221	chr3:10059658	G/T	cg02579736	chr3:10068473	FANCD2;CIDECP	1.25	6.99	0.62	8.1e-10	Alzheimer's disease;
SKCM	cis	rs28386778	0.901	rs2854194	chr17:61952110	T/G	cg06873352	chr17:61820015	STRADA	0.76	6.56	0.6	5.37e-9	Prudent dietary pattern;
SKCM	trans	rs1814175	0.791	rs1722011	chr11:49899340	G/C	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs763121	0.853	rs2281020	chr22:39064406	A/G	cg06022373	chr22:39101656	GTPBP1	0.78	5.63	0.54	2.7e-7	Menopause (age at onset);
SKCM	cis	rs861020	0.630	rs686582	chr1:210008673	A/C	cg05527609	chr1:210001259	C1orf107	0.86	6.84	0.61	1.61e-9	Orofacial clefts;
SKCM	cis	rs651907	0.535	rs11717638	chr3:101505468	A/G	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.78	6.78	0.61	2.03e-9	Colorectal cancer;
SKCM	cis	rs6951245	0.554	rs4724294	chr7:1139695	G/A	cg18402987	chr7:1209562	NA	0.82	5.43	0.52	6.16e-7	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7666738	0.791	rs2903151	chr4:99027218	T/C	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7336332	0.941	rs9579097	chr13:28084337	C/T	cg22138327	chr13:27999177	GTF3A	0.84	5.53	0.53	4.15e-7	Weight;
SKCM	cis	rs34779708	0.733	rs61449529	chr10:35543914	T/C	cg03585969	chr10:35415529	CREM	0.74	5.42	0.52	6.41e-7	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs11098499	0.866	rs10518329	chr4:120401835	A/G	cg09307838	chr4:120376055	NA	0.99	8.06	0.67	7.23e-12	Corneal astigmatism;
SKCM	cis	rs2072499	0.966	rs6427304	chr1:156156789	A/G	cg25208724	chr1:156163844	SLC25A44	1.02	9.14	0.72	5.65e-14	Testicular germ cell tumor;
SKCM	cis	rs10808739	0.660	rs34237366	chr8:65641578	A/G	cg05711235	chr8:65498612	NA	-0.83	-5.59	-0.53	3.21e-7	HIV-1 susceptibility;
SKCM	trans	rs17685	0.753	rs1639617	chr7:75701728	A/G	cg19862616	chr7:65841803	NCRNA00174	0.94	9.45	0.73	1.46e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs80282103	0.618	rs1079390	chr10:1161653	C/A	cg19207066	chr10:1251074	ADARB2	-0.76	-4.94	-0.49	4.41e-6	Glomerular filtration rate (creatinine);
SKCM	cis	rs763014	0.593	rs28455838	chr16:681966	T/C	cg00908189	chr16:619842	PIGQ	0.87	7.69	0.66	3.82e-11	Height;
SKCM	cis	rs28595532	0.920	rs114659035	chr4:119740028	C/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs910316	0.967	rs4903292	chr14:75656245	A/G	cg08847533	chr14:75593920	NEK9	0.99	8.55	0.7	7.94e-13	Height;
SKCM	cis	rs6951245	0.872	rs77434655	chr7:1098405	G/A	cg18402987	chr7:1209562	NA	1.15	6.09	0.57	3.95e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs4927850	0.958	rs1975582	chr3:195751439	G/T	cg12923728	chr3:195709715	SDHAP1	-0.93	-6.36	-0.58	1.24e-8	Pancreatic cancer;
SKCM	cis	rs4819052	0.851	rs2838839	chr21:46667858	C/G	cg02159808	chr21:46707872	POFUT2;LOC642852	-0.7	-5.42	-0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs6952808	0.823	rs58222895	chr7:1885064	G/A	cg02951883	chr7:2050386	MAD1L1	-0.69	-5.0	-0.49	3.38e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs17685	0.796	rs3757594	chr7:75678644	G/A	cg16489192	chr7:75678113	MDH2;STYXL1	0.58	5.44	0.52	5.83e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs10504229	1.000	rs59797486	chr8:58174435	T/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	trans	rs3780486	0.846	rs7873903	chr9:33142728	G/A	cg04842962	chr6:43655489	MRPS18A	1.01	11.0	0.78	1.57e-17	IgG glycosylation;
SKCM	cis	rs2839186	1.000	rs2839181	chr21:47685939	A/G	cg05896524	chr21:47604654	C21orf56	0.7	5.89	0.55	9.21e-8	Testicular germ cell tumor;
SKCM	cis	rs2836950	0.520	rs8130240	chr21:40538108	G/A	cg11890956	chr21:40555474	PSMG1	-0.7	-5.62	-0.54	2.84e-7	Menarche (age at onset);
SKCM	cis	rs6809651	0.524	rs56940353	chr3:185798296	T/C	cg00760338	chr3:185826511	ETV5	-0.9	-5.81	-0.55	1.32e-7	Body mass index in physically active individuals;Glomerular filtration rate (creatinine);Body mass index (joint analysis main effects and physical activity interaction);Body mass index;Body mass index in physically inactive individuals;
SKCM	cis	rs7659604	0.521	rs9993206	chr4:122686957	A/G	cg19671926	chr4:122722719	EXOSC9	0.78	6.61	0.6	4.36e-9	Type 2 diabetes;
SKCM	cis	rs28374715	0.580	rs8030228	chr15:41636867	A/G	cg18705301	chr15:41695430	NDUFAF1	-1.09	-11.04	-0.78	1.34e-17	Ulcerative colitis;
SKCM	cis	rs6089829	0.888	rs4809465	chr20:61671156	G/C	cg03213289	chr20:61660250	NA	0.51	5.07	0.5	2.58e-6	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs3793683	0.545	rs12784446	chr10:134589094	T/G	cg26818010	chr10:134567672	INPP5A	-0.73	-5.53	-0.53	4.09e-7	Migraine;
SKCM	cis	rs17345786	0.861	rs79181492	chr3:101216021	G/A	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.69	4.77	0.48	8.47e-6	Colonoscopy-negative controls vs population controls;
SKCM	trans	rs1814175	0.791	rs11040513	chr11:49778153	G/C	cg03929089	chr4:120376271	NA	-0.9	-8.5	-0.69	9.91e-13	Height;
SKCM	cis	rs4523957	0.651	rs8068642	chr17:2060353	T/C	cg16513277	chr17:2031491	SMG6	-0.79	-5.63	-0.54	2.7e-7	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs2413583	0.818	rs9611131	chr22:39662480	T/C	cg17798944	chr22:39715225	SNORD43;RPL3	0.83	4.86	0.48	6.06e-6	Ulcerative colitis;Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs362296	0.615	rs34030762	chr4:3255736	C/A	cg11471262	chr4:3318911	RGS12	-0.71	-6.26	-0.58	1.97e-8	Parental longevity (mother's age at death);
SKCM	cis	rs1691799	0.899	rs1168351	chr12:66752505	A/G	cg16791601	chr12:66731901	HELB	-0.63	-5.72	-0.54	1.89e-7	White blood cell count (basophil);
SKCM	cis	rs735396	0.770	rs2264782	chr12:121432603	C/T	cg02403541	chr12:121454288	C12orf43	0.61	4.79	0.48	7.92e-6	N-glycan levels;
SKCM	cis	rs11098499	0.569	rs55845118	chr4:120290913	T/C	cg09307838	chr4:120376055	NA	0.98	7.89	0.67	1.52e-11	Corneal astigmatism;
SKCM	cis	rs1461503	0.966	rs4936764	chr11:122844492	G/A	cg27398637	chr11:122830231	C11orf63	-0.63	-4.8	-0.48	7.54e-6	Menarche (age at onset);
SKCM	cis	rs7552404	0.924	rs67757078	chr1:76169456	G/A	cg03433033	chr1:76189801	ACADM	0.78	5.67	0.54	2.36e-7	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs7618501	0.574	rs6765484	chr3:50041313	C/T	cg24110177	chr3:50126178	RBM5	0.59	5.03	0.49	3.08e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9303401	0.659	rs12946852	chr17:57013337	G/C	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.16	0.57	2.91e-8	Cognitive test performance;
SKCM	cis	rs13217239	0.646	rs62401067	chr6:27018101	T/A	cg12292205	chr6:26970375	C6orf41	0.57	4.92	0.49	4.79e-6	Schizophrenia;
SKCM	cis	rs2019137	0.539	rs11123170	chr2:113978940	C/G	cg23156509	chr2:114033830	PAX8;LOC440839	-0.56	-4.81	-0.48	7.3e-6	Lymphocyte counts;
SKCM	cis	rs10876993	0.928	rs1689587	chr12:58075398	A/G	cg18357645	chr12:58087776	OS9	0.65	5.98	0.56	6.22e-8	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs4819052	1.000	rs9984901	chr21:46663952	C/T	cg02159808	chr21:46707872	POFUT2;LOC642852	0.79	5.87	0.55	1.01e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs6912958	0.525	rs59322	chr6:88020521	C/A	cg08069147	chr6:88032118	GJB7;C6orf162	0.64	5.7	0.54	2.03e-7	Monocyte percentage of white cells;
SKCM	cis	rs2354432	0.607	rs6593751	chr1:146726023	A/G	cg25205988	chr1:146714368	CHD1L	-1.19	-6.56	-0.6	5.24e-9	Mitochondrial DNA levels;
SKCM	cis	rs6121246	0.559	rs6119650	chr20:30258480	C/A	cg13852791	chr20:30311386	BCL2L1	0.83	5.76	0.55	1.61e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs10754283	0.901	rs4520403	chr1:90112840	T/G	cg21401794	chr1:90099060	LRRC8C	0.73	6.34	0.58	1.35e-8	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs9790314	0.967	rs9821201	chr3:160996155	G/C	cg03342759	chr3:160939853	NMD3	-0.72	-7.89	-0.67	1.53e-11	Morning vs. evening chronotype;
SKCM	cis	rs1218582	0.741	rs11264281	chr1:154867221	A/G	cg09359103	chr1:154839909	KCNN3	-0.59	-5.77	-0.55	1.54e-7	Prostate cancer;
SKCM	cis	rs10927875	0.722	rs1763606	chr1:16338282	A/G	cg21385522	chr1:16154831	NA	0.66	4.77	0.48	8.39e-6	Dilated cardiomyopathy;
SKCM	cis	rs2645694	0.626	rs2703121	chr4:77822328	C/G	cg06046430	chr4:77819534	ANKRD56	0.54	5.85	0.55	1.09e-7	Emphysema distribution in smoking;
SKCM	cis	rs362296	0.624	rs362287	chr4:3257593	C/T	cg11471262	chr4:3318911	RGS12	-0.77	-6.76	-0.61	2.21e-9	Parental longevity (mother's age at death);
SKCM	cis	rs4727027	0.704	rs13229244	chr7:148898219	A/C	cg23583168	chr7:148888333	NA	0.77	6.15	0.57	3.14e-8	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs1344694	0.548	rs12468812	chr2:216905867	C/T	cg12620499	chr2:216877984	MREG	0.77	6.52	0.59	6.4e-9	Alcohol dependence;
SKCM	cis	rs875971	1.000	rs1167411	chr7:65539264	C/G	cg18876405	chr7:65276391	NA	-0.71	-7.03	-0.62	6.83e-10	Aortic root size;
SKCM	cis	rs6500602	0.701	rs8129	chr16:4562351	A/G	cg08645402	chr16:4508243	NA	0.62	4.9	0.49	5.12e-6	Schizophrenia;
SKCM	cis	rs3087591	0.919	rs2072131	chr17:29559588	G/C	cg24425628	chr17:29625626	OMG;NF1	-0.64	-5.22	-0.51	1.43e-6	Hip circumference;
SKCM	cis	rs2075371	0.796	rs1646645	chr7:134012232	G/T	cg20476274	chr7:133979776	SLC35B4	-0.93	-9.97	-0.75	1.44e-15	Mean platelet volume;
SKCM	cis	rs2243480	0.764	rs2460423	chr7:65601216	A/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs992157	0.735	rs13393821	chr2:219076742	C/G	cg20019365	chr2:219134978	PNKD;AAMP	0.72	6.4	0.59	1.07e-8	Colorectal cancer;
SKCM	cis	rs10754283	0.967	rs6657988	chr1:90106745	G/C	cg21401794	chr1:90099060	LRRC8C	0.74	6.4	0.59	1.09e-8	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs1577917	0.917	rs1584273	chr6:86524577	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.81	-0.66	2.19e-11	Response to antipsychotic treatment;
SKCM	cis	rs1799949	1.000	rs11657053	chr17:41191129	G/T	cg05368731	chr17:41323189	NBR1	0.86	7.39	0.64	1.39e-10	Menopause (age at onset);
SKCM	cis	rs2120019	0.938	rs35911108	chr15:75322179	G/A	cg09165964	chr15:75287851	SCAMP5	-0.85	-8.74	-0.7	3.44e-13	Blood trace element (Zn levels);
SKCM	cis	rs7772486	0.754	rs4896838	chr6:146015451	T/C	cg23711669	chr6:146136114	FBXO30	-0.95	-10.09	-0.75	8.43e-16	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs798554	0.797	rs1182184	chr7:2872446	G/A	cg19346786	chr7:2764209	NA	-0.63	-6.95	-0.62	9.84e-10	Height;
SKCM	cis	rs875971	0.800	rs427557	chr7:65519250	A/G	cg11764359	chr7:65958608	NA	0.9	8.21	0.68	3.63e-12	Aortic root size;
SKCM	cis	rs10503709	0.861	rs1383577	chr8:21448658	A/G	cg23716449	chr8:21608280	GFRA2	0.49	4.95	0.49	4.11e-6	Blood protein levels;
SKCM	cis	rs7811142	1.000	rs6953107	chr7:100095664	C/T	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.24	7.92	0.67	1.36e-11	Platelet count;
SKCM	cis	rs9880211	0.800	rs13433683	chr3:136518670	C/T	cg21827317	chr3:136751795	NA	0.7	5.18	0.51	1.67e-6	Body mass index;Height;
SKCM	cis	rs2730245	0.527	rs2527197	chr7:158735260	G/A	cg24397884	chr7:158709396	WDR60	-1.01	-5.77	-0.55	1.53e-7	Height;
SKCM	cis	rs28595532	0.920	rs114390336	chr4:119771452	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs6546550	0.901	rs6739780	chr2:70138111	G/A	cg02498382	chr2:70120550	SNRNP27	-0.45	-4.88	-0.48	5.4e-6	Prevalent atrial fibrillation;
SKCM	cis	rs854765	0.583	rs4553680	chr17:17857722	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.93	7.3	0.64	2.06e-10	Total body bone mineral density;
SKCM	trans	rs561341	0.941	rs112569713	chr17:30271738	C/T	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs2857078	0.720	rs9906669	chr17:42305706	A/G	cg13607699	chr17:42295918	UBTF	0.86	7.36	0.64	1.62e-10	Red cell distribution width;Reticulocyte count;
SKCM	cis	rs992157	0.835	rs7585702	chr2:219146607	T/C	cg00012203	chr2:219082015	ARPC2	-0.72	-5.71	-0.54	1.99e-7	Colorectal cancer;
SKCM	cis	rs1153858	1.000	rs4775911	chr15:45649787	G/T	cg21132104	chr15:45694354	SPATA5L1	-0.92	-8.18	-0.68	4.12e-12	Homoarginine levels;
SKCM	cis	rs4481887	0.861	rs4644528	chr1:248472508	T/A	cg00666640	chr1:248458726	OR2T12	0.63	5.91	0.56	8.65e-8	Common traits (Other);
SKCM	cis	rs2013441	1.000	rs4924809	chr17:20044673	C/T	cg13482628	chr17:19912719	NA	0.67	5.25	0.51	1.28e-6	Obesity-related traits;
SKCM	cis	rs798554	1.000	rs798562	chr7:2757938	C/T	cg19346786	chr7:2764209	NA	-0.67	-6.8	-0.61	1.85e-9	Height;
SKCM	cis	rs10848704	0.637	rs11062351	chr12:2881763	C/T	cg19995117	chr12:2880862	NA	0.45	5.01	0.49	3.35e-6	Quantitative traits;
SKCM	cis	rs4683346	1.000	rs11129978	chr3:42883576	A/G	cg06399164	chr3:42695035	ZBTB47	-0.61	-5.71	-0.54	1.95e-7	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs11098499	0.954	rs6846442	chr4:120326323	G/A	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs1577917	0.876	rs1582127	chr6:86697204	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.83	-8.23	-0.68	3.37e-12	Response to antipsychotic treatment;
SKCM	cis	rs1797081	1.000	rs2603807	chr10:16872797	A/G	cg23933602	chr10:16859644	RSU1	1.01	13.22	0.83	1.31e-21	Platelet distribution width;
SKCM	cis	rs13256369	0.826	rs12678414	chr8:8586016	G/T	cg06636001	chr8:8085503	FLJ10661	0.68	4.97	0.49	3.9e-6	Obesity-related traits;
SKCM	cis	rs929354	0.772	rs1182364	chr7:157017912	T/C	cg17757837	chr7:157058334	UBE3C	-0.81	-5.67	-0.54	2.3e-7	Body mass index;
SKCM	cis	rs11098499	0.865	rs11098513	chr4:120316075	A/G	cg24375607	chr4:120327624	NA	0.66	5.02	0.49	3.17e-6	Corneal astigmatism;
SKCM	cis	rs9300255	0.602	rs1727314	chr12:123640664	C/A	cg05973401	chr12:123451056	ABCB9	0.8	5.47	0.53	5.23e-7	Neutrophil percentage of white cells;
SKCM	cis	rs7208859	0.623	rs7208441	chr17:29143863	C/T	cg13385521	chr17:29058706	SUZ12P	0.97	5.26	0.51	1.24e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs8177253	1.000	rs1525892	chr3:133484712	C/T	cg16414030	chr3:133502952	NA	-0.7	-5.93	-0.56	7.88e-8	Iron status biomarkers;
SKCM	cis	rs8180040	1.000	rs811115	chr3:47322133	C/T	cg16586182	chr3:47516702	SCAP	-0.71	-4.85	-0.48	6.25e-6	Colorectal cancer;
SKCM	cis	rs614226	0.935	rs588132	chr12:121024066	A/G	cg01236616	chr12:121019343	POP5	1.37	8.37	0.69	1.79e-12	Type 1 diabetes nephropathy;
SKCM	cis	rs4919087	0.962	rs10748694	chr10:99056190	A/T	cg25902810	chr10:99078978	FRAT1	0.67	5.5	0.53	4.57e-7	Monocyte count;
SKCM	cis	rs2479724	0.625	rs9394835	chr6:41818200	A/T	cg17623882	chr6:41773611	USP49	-0.75	-6.56	-0.6	5.25e-9	Menarche (age at onset);
SKCM	cis	rs4975616	0.710	rs27996	chr5:1345474	A/G	cg26373071	chr5:1325741	CLPTM1L	0.66	5.49	0.53	4.82e-7	Lung cancer;
SKCM	cis	rs4724125	0.883	rs1504840	chr7:42692906	T/C	cg09407816	chr7:42972088	MRPL32;PSMA2	0.83	4.99	0.49	3.61e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2180341	1.000	rs2057223	chr6:127637374	T/C	cg27446573	chr6:127587934	RNF146	0.94	8.08	0.68	6.49e-12	Breast cancer;
SKCM	cis	rs394563	0.775	rs448420	chr6:149785802	T/C	cg03678062	chr6:149772716	ZC3H12D	-0.48	-4.96	-0.49	4.11e-6	Dupuytren's disease;
SKCM	cis	rs459571	0.959	rs456205	chr9:136911146	G/A	cg13789015	chr9:136890014	NCRNA00094	0.7	5.65	0.54	2.48e-7	Platelet distribution width;
SKCM	cis	rs34891900	0.507	rs9605364	chr22:18127437	G/A	cg19898043	chr22:18121309	BCL2L13	0.65	4.85	0.48	6.18e-6	Sum neutrophil eosinophil counts;
SKCM	cis	rs2120019	1.000	rs7167285	chr15:75368769	A/G	cg09165964	chr15:75287851	SCAMP5	-0.78	-6.63	-0.6	3.95e-9	Blood trace element (Zn levels);
SKCM	cis	rs8017423	1.000	rs8017423	chr14:90679910	A/G	cg04374321	chr14:90722782	PSMC1	0.95	8.38	0.69	1.69e-12	Mortality in heart failure;
SKCM	cis	rs7843479	0.601	rs4872207	chr8:21842751	C/G	cg17168535	chr8:21777572	XPO7	-0.87	-8.6	-0.7	6.47e-13	Mean corpuscular volume;
SKCM	cis	rs763121	0.962	rs1980455	chr22:38925719	A/C	cg06022373	chr22:39101656	GTPBP1	0.78	5.66	0.54	2.4e-7	Menopause (age at onset);
SKCM	cis	rs116095464	0.558	rs73024831	chr5:257192	A/G	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs9393692	0.905	rs9393694	chr6:26279296	T/C	cg00631329	chr6:26305371	NA	-0.68	-4.93	-0.49	4.49e-6	Educational attainment;
SKCM	cis	rs997295	0.556	rs10468041	chr15:67773203	G/T	cg24247231	chr15:67904302	MAP2K5	-0.6	-5.1	-0.5	2.3e-6	Motion sickness;
SKCM	cis	rs12477438	0.520	rs11677247	chr2:99756358	A/G	cg26064155	chr2:99771622	LIPT1;TSGA10	1.02	9.73	0.74	4.23e-15	Chronic sinus infection;
SKCM	cis	rs9308433	0.529	rs4655332	chr1:214490756	G/A	cg06198575	chr1:214491504	SMYD2	0.79	4.94	0.49	4.44e-6	IgG glycosylation;
SKCM	cis	rs11098499	0.954	rs11729521	chr4:120416788	T/C	cg09307838	chr4:120376055	NA	0.99	8.1	0.68	6.11e-12	Corneal astigmatism;
SKCM	cis	rs9325144	0.560	rs10506127	chr12:39126686	C/G	cg26384229	chr12:38710491	ALG10B	-0.81	-7.85	-0.66	1.82e-11	Morning vs. evening chronotype;
SKCM	cis	rs9815354	0.812	rs17214987	chr3:41810481	C/T	cg03022575	chr3:42003672	ULK4	-1.05	-5.42	-0.52	6.39e-7	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs738322	0.555	rs5750547	chr22:38546700	A/G	cg25457927	chr22:38595422	NA	0.56	7.04	0.62	6.73e-10	Cutaneous nevi;
SKCM	cis	rs2251381	0.750	rs2255055	chr21:30537045	C/T	cg24692254	chr21:30365293	RNF160	0.78	6.33	0.58	1.46e-8	Selective IgA deficiency;
SKCM	cis	rs561341	1.000	rs757009	chr17:30243937	A/G	cg12193833	chr17:30244370	NA	-0.49	-4.83	-0.48	6.62e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs3784262	1.000	rs7170896	chr15:58252393	T/A	cg12031962	chr15:58353849	ALDH1A2	-0.52	-6.92	-0.62	1.1e-9	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs2439831	0.681	rs999047	chr15:43688916	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.21	7.84	0.66	1.9e-11	Lung cancer in ever smokers;
SKCM	cis	rs644799	0.965	rs11021313	chr11:95506907	G/C	cg25622487	chr11:95524042	FAM76B;CEP57	0.74	5.91	0.56	8.37e-8	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs3892630	0.529	rs35300319	chr19:33409948	G/A	cg22980127	chr19:33182716	NUDT19	0.85	4.89	0.48	5.32e-6	Red blood cell traits;
SKCM	cis	rs9902453	1.000	rs7221743	chr17:28407876	T/G	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.81	-5.78	-0.55	1.45e-7	Coffee consumption (cups per day);
SKCM	cis	rs12706411	1.000	rs35636140	chr7:122048141	C/T	cg17986181	chr7:121955208	NA	-0.7	-5.19	-0.51	1.65e-6	Alzheimer disease and age of onset;
SKCM	cis	rs9902453	0.904	rs12939344	chr17:28328819	C/G	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.82	-6.4	-0.59	1.06e-8	Coffee consumption (cups per day);
SKCM	cis	rs1878931	0.501	rs9635547	chr16:3416664	C/T	cg26668626	chr16:3451006	ZNF174;ZNF434	0.86	6.89	0.62	1.27e-9	Body mass index (adult);
SKCM	cis	rs1669338	0.588	rs3804783	chr3:3184442	C/T	cg16797762	chr3:3221439	CRBN	-1.1	-6.31	-0.58	1.55e-8	White matter integrity;
SKCM	cis	rs8078723	0.701	rs2305482	chr17:38140927	A/C	cg17467752	chr17:38218738	THRA	-0.61	-5.49	-0.53	4.75e-7	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs7215564	0.643	rs59992540	chr17:78658265	G/A	cg16980736	chr17:78789706	RPTOR	-0.89	-4.88	-0.48	5.41e-6	Myopia (pathological);
SKCM	cis	rs2228479	0.681	rs4287569	chr16:89957815	A/G	cg00800038	chr16:89945340	TCF25	-0.93	-5.57	-0.53	3.49e-7	Skin colour saturation;
SKCM	cis	rs9916302	0.706	rs597069	chr17:37458512	G/T	cg07936489	chr17:37558343	FBXL20	1.0	7.19	0.63	3.42e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs72781680	1.000	rs12616250	chr2:24211550	T/C	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	cis	rs3741404	0.931	rs594942	chr11:64006292	T/C	cg19465662	chr11:63993652	NUDT22;TRPT1	-0.76	-5.36	-0.52	8.24e-7	Platelet count;
SKCM	cis	rs1032355	0.558	rs41275715	chr4:100533913	C/T	cg25391692	chr4:100495869	MTTP	-0.82	-4.97	-0.49	3.9e-6	Celiac disease;
SKCM	trans	rs2727020	0.595	rs11040416	chr11:49566429	C/T	cg15704280	chr7:45808275	SEPT13	-0.97	-9.25	-0.72	3.48e-14	Coronary artery disease;
SKCM	cis	rs7666738	0.791	rs10856934	chr4:99010844	A/G	cg17366294	chr4:99064904	C4orf37	-0.58	-4.83	-0.48	6.75e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2204008	0.619	rs11178987	chr12:38201258	C/T	cg26384229	chr12:38710491	ALG10B	-0.67	-5.47	-0.53	5.23e-7	Bladder cancer;
SKCM	cis	rs3820068	0.581	rs16851855	chr1:15930869	G/A	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs5769765	0.954	rs5770739	chr22:50268014	C/G	cg22709217	chr22:50311962	ALG12;CRELD2	0.79	5.71	0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs62238980	0.908	rs117753937	chr22:32595919	C/T	cg00543991	chr22:32367038	NA	1.26	4.89	0.48	5.2e-6	Childhood ear infection;
SKCM	cis	rs2204008	0.744	rs1115514	chr12:38280140	C/T	cg13010199	chr12:38710504	ALG10B	0.66	4.8	0.48	7.64e-6	Bladder cancer;
SKCM	cis	rs17685	0.712	rs11770149	chr7:75791644	G/A	cg16684958	chr7:75615977	POR	0.53	5.18	0.51	1.7e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1707322	0.929	rs785500	chr1:46593044	C/T	cg03146154	chr1:46216737	IPP	-0.81	-5.43	-0.52	6.11e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7945705	0.967	rs34842234	chr11:8891894	G/A	cg21881798	chr11:8931708	C11orf17;ST5	0.76	7.65	0.65	4.47e-11	Hemoglobin concentration;
SKCM	cis	rs2376682	0.625	rs6885983	chr5:117981154	C/T	cg16362014	chr5:118321556	DTWD2	1.14	5.29	0.51	1.09e-6	Diisocyanate-induced asthma;
SKCM	cis	rs8014204	0.604	rs2159906	chr14:75390912	G/T	cg06637938	chr14:75390232	RPS6KL1	0.93	6.62	0.6	4.11e-9	Caffeine consumption;
SKCM	cis	rs116095464	0.558	rs55833259	chr5:286728	G/A	cg22857025	chr5:266934	NA	-1.58	-8.14	-0.68	4.99e-12	Breast cancer;
SKCM	cis	rs2721195	0.845	rs3757966	chr8:145744618	G/A	cg02133234	chr8:144922496	NRBP2	-0.48	-4.8	-0.48	7.49e-6	Age at first birth;
SKCM	cis	rs6138458	1.000	rs6114988	chr20:24977586	C/T	cg26195577	chr20:24973756	C20orf3	1.29	8.85	0.71	2.07e-13	Blood protein levels;
SKCM	cis	rs644799	1.000	rs12786522	chr11:95522858	G/C	cg25622487	chr11:95524042	FAM76B;CEP57	0.69	5.47	0.53	5.26e-7	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs7119	0.700	rs4886883	chr15:77888924	C/T	cg27398640	chr15:77910606	LINGO1	-0.51	-5.1	-0.5	2.32e-6	Type 2 diabetes;
SKCM	cis	rs11098499	0.909	rs2127821	chr4:120394535	T/C	cg24375607	chr4:120327624	NA	0.66	5.09	0.5	2.44e-6	Corneal astigmatism;
SKCM	cis	rs7635838	0.819	rs6776159	chr3:11519324	A/G	cg00170343	chr3:11313890	ATG7	0.69	5.26	0.51	1.22e-6	HDL cholesterol;
SKCM	cis	rs9790314	0.747	rs4616689	chr3:160856269	A/G	cg03342759	chr3:160939853	NMD3	-0.58	-5.75	-0.55	1.63e-7	Morning vs. evening chronotype;
SKCM	cis	rs6089829	0.888	rs4809268	chr20:61675249	C/G	cg03213289	chr20:61660250	NA	0.51	5.07	0.5	2.58e-6	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs35306767	0.953	rs1539174	chr10:974870	C/G	cg26597838	chr10:835615	NA	0.71	5.21	0.51	1.5e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs7659604	0.935	rs73844280	chr4:122664687	G/A	cg06713675	chr4:122721982	EXOSC9	-0.65	-5.78	-0.55	1.48e-7	Type 2 diabetes;
SKCM	cis	rs4888262	0.545	rs7193959	chr16:74664969	T/A	cg01733217	chr16:74700730	RFWD3	0.89	7.54	0.65	7.26e-11	Testicular germ cell tumor;
SKCM	cis	rs367615	0.552	rs2963024	chr5:108730773	C/T	cg17395555	chr5:108820864	NA	-0.67	-5.66	-0.54	2.46e-7	Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs4423214	1.000	rs7928249	chr11:71161063	A/G	cg05163923	chr11:71159392	DHCR7	0.8	7.75	0.66	2.89e-11	Vitamin D levels;
SKCM	cis	rs28530618	0.603	rs11167173	chr20:31241612	A/T	cg25730142	chr20:32031702	SNTA1	0.61	4.93	0.49	4.58e-6	Birth weight;
SKCM	cis	rs1568889	1.000	rs7945367	chr11:28166272	G/T	cg06544937	chr11:28130018	METT5D1;KIF18A	0.87	7.0	0.62	7.86e-10	Bipolar disorder;
SKCM	cis	rs2153535	0.580	rs7763190	chr6:8484197	G/A	cg07606381	chr6:8435919	SLC35B3	0.86	6.25	0.58	2.06e-8	Motion sickness;
SKCM	cis	rs11241713	1.000	rs58358701	chr5:123146190	A/T	cg14868599	chr5:123999154	ZNF608	-0.77	-4.77	-0.47	8.53e-6	Amyotrophic lateral sclerosis;
SKCM	cis	rs9916302	0.706	rs8075737	chr17:37727316	C/T	cg07936489	chr17:37558343	FBXL20	1.04	9.89	0.75	2.03e-15	Glomerular filtration rate (creatinine);
SKCM	cis	rs3820068	0.603	rs6696286	chr1:15968770	C/T	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs11623869	0.772	rs12587310	chr14:103907286	G/A	cg26031613	chr14:104095156	KLC1	-0.74	-5.55	-0.53	3.78e-7	Bone mineral density;
SKCM	cis	rs1395	0.744	rs4665962	chr2:27515105	A/G	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.56	5.2	0.51	1.56e-6	Blood metabolite levels;
SKCM	cis	rs4774899	0.966	rs12914481	chr15:57484613	G/A	cg01857019	chr15:57210107	LOC145783;TCF12	0.53	4.94	0.49	4.38e-6	Urinary tract infection frequency;
SKCM	cis	rs7937682	0.575	rs34558891	chr11:111737912	C/T	cg09085632	chr11:111637200	PPP2R1B	1.12	10.71	0.77	5.54e-17	Primary sclerosing cholangitis;
SKCM	cis	rs8072100	0.967	rs11656855	chr17:45714655	C/T	cg25173405	chr17:45401733	C17orf57	0.57	5.13	0.5	2.07e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs6912958	0.559	rs373646	chr6:88056896	A/G	cg08069147	chr6:88032118	GJB7;C6orf162	0.68	6.23	0.58	2.19e-8	Monocyte percentage of white cells;
SKCM	cis	rs17818399	0.547	rs4953400	chr2:46777208	T/A	cg02822958	chr2:46747628	ATP6V1E2	0.72	5.35	0.52	8.56e-7	Height;
SKCM	cis	rs11690935	0.959	rs1474074	chr2:172659852	G/A	cg13550731	chr2:172543902	DYNC1I2	-0.92	-7.75	-0.66	2.89e-11	Schizophrenia;
SKCM	cis	rs7143963	0.636	rs10149939	chr14:103345467	G/A	cg23020514	chr14:103360112	TRAF3	0.74	6.99	0.62	8.38e-10	Body mass index;
SKCM	cis	rs654950	1.000	rs646228	chr1:41986066	A/C	cg06885757	chr1:42089581	HIVEP3	0.61	6.54	0.59	5.88e-9	Airway imaging phenotypes;
SKCM	cis	rs4727027	0.870	rs1568945	chr7:148874112	T/G	cg23583168	chr7:148888333	NA	-0.79	-6.65	-0.6	3.57e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs1218582	0.740	rs1977879	chr1:154879743	G/A	cg24250549	chr1:154909240	PMVK	0.87	8.7	0.7	4.13e-13	Prostate cancer;
SKCM	cis	rs7044106	0.762	rs10739570	chr9:123381222	C/T	cg09419670	chr9:123605666	PSMD5;LOC253039	0.58	4.98	0.49	3.68e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs28386778	0.897	rs2584627	chr17:61901439	T/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs6539267	0.741	rs2279759	chr12:106694988	T/C	cg02476566	chr12:106696527	TCP11L2	0.71	5.03	0.49	3.1e-6	Tourette syndrome;
SKCM	cis	rs11892454	0.544	rs6739177	chr2:25952796	T/C	cg17263061	chr2:26915892	KCNK3	0.71	5.07	0.5	2.6e-6	Heschl's gyrus morphology;
SKCM	cis	rs28386778	0.830	rs2597636	chr17:61876010	A/G	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs208520	0.770	rs1342960	chr6:66883514	T/C	cg07460842	chr6:66804631	NA	-0.91	-7.07	-0.63	5.76e-10	Exhaled nitric oxide output;
SKCM	cis	rs137603	0.623	rs470075	chr22:39686806	G/A	cg17798944	chr22:39715225	SNORD43;RPL3	-0.67	-5.78	-0.55	1.46e-7	Primary biliary cholangitis;
SKCM	cis	rs6500395	0.735	rs2883641	chr16:48664446	T/C	cg04672837	chr16:48644449	N4BP1	0.6	4.8	0.48	7.37e-6	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs854765	0.624	rs7359509	chr17:17741875	A/G	cg04398451	chr17:18023971	MYO15A	0.71	4.78	0.48	8.23e-6	Total body bone mineral density;
SKCM	cis	rs9913156	0.841	rs34230287	chr17:4613630	C/T	cg00122941	chr17:4613640	ARRB2	0.78	4.87	0.48	5.64e-6	Lymphocyte counts;
SKCM	cis	rs6840360	0.554	rs6849111	chr4:152708874	T/C	cg22705602	chr4:152727874	NA	-0.57	-7.61	-0.65	5.45e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs362272	0.524	rs13150241	chr4:3367281	A/G	cg05297308	chr4:3317976	RGS12	1.05	12.84	0.82	6.19e-21	Serum sulfate level;
SKCM	cis	rs2404602	0.660	rs11852777	chr15:76929792	A/G	cg23625390	chr15:77176239	SCAPER	-0.85	-8.26	-0.68	2.93e-12	Blood metabolite levels;
SKCM	cis	rs3892630	0.878	rs7246451	chr19:33209614	C/G	cg22980127	chr19:33182716	NUDT19	1.39	7.88	0.67	1.6e-11	Red blood cell traits;
SKCM	cis	rs1850744	0.702	rs10805314	chr4:9703181	T/G	cg15442990	chr4:9534313	NA	1.19	5.21	0.51	1.49e-6	Economic and political preferences;
SKCM	cis	rs28386778	0.830	rs67905415	chr17:61841236	G/A	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs7811142	1.000	rs7811142	chr7:100065443	A/T	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.17	7.71	0.66	3.44e-11	Platelet count;
SKCM	cis	rs4242434	0.854	rs3064	chr8:22451688	C/G	cg03733263	chr8:22462867	KIAA1967	-1.05	-9.63	-0.74	6.55e-15	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs6951245	1.000	rs11768761	chr7:1069807	A/G	cg03188948	chr7:1209495	NA	1.12	6.17	0.57	2.88e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs9325144	0.555	rs4882358	chr12:38726640	A/G	cg13010199	chr12:38710504	ALG10B	0.64	5.11	0.5	2.28e-6	Morning vs. evening chronotype;
SKCM	cis	rs9583531	0.657	rs7337126	chr13:111376788	A/G	cg24331049	chr13:111365604	ING1	0.85	6.32	0.58	1.48e-8	Coronary artery disease;
SKCM	cis	rs7829975	0.711	rs4841051	chr8:8685646	C/T	cg06636001	chr8:8085503	FLJ10661	-0.78	-7.42	-0.64	1.22e-10	Mood instability;
SKCM	cis	rs1878931	0.582	rs40633	chr16:3425325	A/G	cg26668626	chr16:3451006	ZNF174;ZNF434	-0.77	-5.37	-0.52	7.88e-7	Body mass index (adult);
SKCM	cis	rs2288073	0.965	rs10173949	chr2:24410256	A/C	cg06627628	chr2:24431161	ITSN2	-0.8	-5.47	-0.53	5.21e-7	Venous thromboembolism (SNP x SNP interaction);
SKCM	cis	rs7523273	0.606	rs859706	chr1:207962270	G/A	cg22525895	chr1:207977042	MIR29B2	-0.77	-6.38	-0.59	1.14e-8	Schizophrenia;
SKCM	cis	rs17376456	0.877	rs7728736	chr5:93404277	C/T	cg21475434	chr5:93447410	FAM172A	0.97	5.41	0.52	6.8e-7	Diabetic retinopathy;
SKCM	cis	rs7828089	0.819	rs7846557	chr8:22243654	T/C	cg12081754	chr8:22256438	SLC39A14	0.69	5.1	0.5	2.36e-6	Verbal declarative memory;
SKCM	cis	rs394563	0.559	rs7753269	chr6:149671360	G/A	cg16235748	chr6:149772707	ZC3H12D	0.44	5.07	0.5	2.66e-6	Dupuytren's disease;
SKCM	cis	rs847649	1.000	rs1100046	chr7:102549295	T/A	cg18108683	chr7:102477205	FBXL13	-0.81	-8.31	-0.69	2.36e-12	Morning vs. evening chronotype;
SKCM	cis	rs1005277	0.579	rs2472182	chr10:38388865	T/C	cg00409905	chr10:38381863	ZNF37A	-0.64	-5.96	-0.56	6.77e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs2333194	0.875	rs10220356	chr14:73809476	C/T	cg08936952	chr14:74026160	HEATR4	-0.53	-4.86	-0.48	5.96e-6	Bipolar disorder with mood-incongruent psychosis;
SKCM	cis	rs644799	1.000	rs473155	chr11:95596873	C/T	cg03916912	chr11:95522834	CEP57;FAM76B	0.89	7.14	0.63	4.24e-10	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs80033912	0.626	rs71324982	chr3:49669948	G/A	cg07636037	chr3:49044803	WDR6	0.73	5.31	0.52	1.01e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7511006	0.858	rs2294402	chr22:50654428	T/G	cg16473166	chr22:50639996	SELO	0.71	5.94	0.56	7.47e-8	Obesity-related traits;
SKCM	cis	rs561341	1.000	rs2344312	chr17:30243583	G/T	cg00745463	chr17:30367425	LRRC37B	-1.01	-6.3	-0.58	1.66e-8	Hip circumference adjusted for BMI;
SKCM	cis	rs2455601	1.000	rs12223690	chr11:8901824	G/A	cg21881798	chr11:8931708	C11orf17;ST5	-0.94	-5.96	-0.56	7.03e-8	Schizophrenia;
SKCM	cis	rs6840360	0.550	rs7683134	chr4:152503362	A/C	cg22705602	chr4:152727874	NA	-0.51	-5.51	-0.53	4.44e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs826838	1.000	rs11168367	chr12:38913397	T/G	cg26384229	chr12:38710491	ALG10B	1.04	9.75	0.74	3.88e-15	Heart rate;
SKCM	cis	rs11098499	0.909	rs7659501	chr4:120371552	G/T	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs6066825	0.605	rs761274	chr20:47315362	T/C	cg18078177	chr20:47281410	PREX1	0.64	5.2	0.51	1.57e-6	Colorectal cancer;
SKCM	cis	rs703842	1.000	rs10877014	chr12:58167661	A/G	cg04478727	chr12:58166393	METTL1;FAM119B	0.71	5.76	0.55	1.57e-7	Multiple sclerosis;
SKCM	cis	rs6463523	0.815	rs66886645	chr7:763853	C/A	cg06242242	chr7:766104	PRKAR1B;HEATR2	1.1	9.92	0.75	1.82e-15	Subjective well-being;
SKCM	cis	rs4560672	1.000	rs13198418	chr6:158568256	G/C	cg10592926	chr6:157876961	ZDHHC14	0.53	4.97	0.49	3.9e-6	Smoking quantity;
SKCM	cis	rs71520386	0.632	rs10224533	chr7:22861141	T/G	cg15401507	chr7:22894281	NA	0.67	4.96	0.49	4.03e-6	Fibrinogen levels;
SKCM	cis	rs2204008	0.515	rs11495471	chr12:38027178	G/A	cg13010199	chr12:38710504	ALG10B	0.66	4.96	0.49	3.96e-6	Bladder cancer;
SKCM	cis	rs7208859	0.623	rs78071511	chr17:29128154	C/T	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs34779708	0.931	rs11010132	chr10:35517265	C/G	cg03585969	chr10:35415529	CREM	0.76	6.17	0.57	2.86e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs2033711	0.870	rs11669741	chr19:58960481	C/T	cg11952622	chr19:58962976	ZNF324B	-0.63	-4.85	-0.48	6.28e-6	Uric acid clearance;
SKCM	cis	rs362296	0.698	rs362279	chr4:3260072	G/A	cg16987761	chr4:3318072	RGS12	-0.77	-6.59	-0.6	4.7e-9	Parental longevity (mother's age at death);
SKCM	cis	rs8180040	1.000	rs11130127	chr3:47398793	C/G	cg27129171	chr3:47204927	SETD2	-0.87	-6.62	-0.6	4.15e-9	Colorectal cancer;
SKCM	cis	rs2404602	0.552	rs4886823	chr15:76965402	A/G	cg23625390	chr15:77176239	SCAPER	-0.83	-7.63	-0.65	4.83e-11	Blood metabolite levels;
SKCM	cis	rs9916302	0.660	rs4795379	chr17:37674683	T/G	cg07936489	chr17:37558343	FBXL20	-1.03	-7.61	-0.65	5.23e-11	Glomerular filtration rate (creatinine);
SKCM	cis	rs2180341	0.842	rs9375492	chr6:127545492	C/T	cg27446573	chr6:127587934	RNF146	-1.07	-7.89	-0.67	1.55e-11	Breast cancer;
SKCM	cis	rs3812762	0.833	rs10500705	chr11:8805261	A/G	cg21881798	chr11:8931708	C11orf17;ST5	-0.54	-4.9	-0.49	5.09e-6	Hypospadias;
SKCM	cis	rs778371	0.915	rs748002	chr2:233757679	G/A	cg08000102	chr2:233561755	GIGYF2	-0.83	-5.93	-0.56	7.93e-8	Schizophrenia;
SKCM	cis	rs28386778	0.830	rs2665798	chr17:61921397	C/T	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs35306767	0.622	rs66462130	chr10:1022108	C/T	cg25614935	chr10:1084866	C10orf110	0.68	4.84	0.48	6.55e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs933688	1.000	rs7720132	chr5:90745105	T/C	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.07	8.52	0.69	9.25e-13	Smoking behavior;
SKCM	cis	rs6977660	0.941	rs5017197	chr7:19819967	T/A	cg05791153	chr7:19748676	TWISTNB	0.79	5.4	0.52	6.86e-7	Thyroid stimulating hormone;
SKCM	cis	rs2243480	0.803	rs423187	chr7:65509499	G/C	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs6879260	0.963	rs11748619	chr5:179727399	C/G	cg23248424	chr5:179741104	GFPT2	-0.76	-5.94	-0.56	7.42e-8	Height;
SKCM	cis	rs2836974	0.644	rs61300849	chr21:40680194	G/A	cg11644478	chr21:40555479	PSMG1	-0.69	-6.11	-0.57	3.59e-8	Cognitive function;
SKCM	cis	rs2013441	0.965	rs2703808	chr17:20109665	A/C	cg13482628	chr17:19912719	NA	-0.65	-5.21	-0.51	1.48e-6	Obesity-related traits;
SKCM	cis	rs7208859	0.623	rs9891166	chr17:29111902	G/A	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs9814567	1.000	rs2370641	chr3:134222161	A/C	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.66	-5.15	-0.5	1.88e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs28386778	1.000	rs3020613	chr17:61955983	A/G	cg22520471	chr17:61851767	DDX42;CCDC47	0.79	5.32	0.52	9.46e-7	Prudent dietary pattern;
SKCM	cis	rs9596863	1.000	rs7993989	chr13:54464591	C/T	ch.13.53330881F	chr13:54432880	NA	-0.83	-5.05	-0.5	2.82e-6	Epilepsy and lamotrigine-induced maculopapular eruptions;
SKCM	cis	rs9640161	0.742	rs2108853	chr7:150017589	A/C	cg10018233	chr7:150070692	REPIN1	0.75	6.04	0.56	4.86e-8	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs6809651	0.524	rs4686728	chr3:185795333	C/T	cg00760338	chr3:185826511	ETV5	0.92	5.8	0.55	1.32e-7	Body mass index in physically active individuals;Glomerular filtration rate (creatinine);Body mass index (joint analysis main effects and physical activity interaction);Body mass index;Body mass index in physically inactive individuals;
SKCM	cis	rs7044106	0.762	rs10760107	chr9:123383630	T/C	cg09419670	chr9:123605666	PSMD5;LOC253039	0.58	4.98	0.49	3.68e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs7772486	0.686	rs1292336	chr6:145967818	T/C	cg05347473	chr6:146136440	FBXO30	-0.6	-5.31	-0.52	1e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1461503	0.809	rs7121955	chr11:122845478	A/T	cg27398637	chr11:122830231	C11orf63	-0.7	-4.97	-0.49	3.8e-6	Menarche (age at onset);
SKCM	cis	rs12477438	0.501	rs11683188	chr2:99724512	T/C	cg26064155	chr2:99771622	LIPT1;TSGA10	1.01	9.65	0.74	5.91e-15	Chronic sinus infection;
SKCM	cis	rs6545883	1.000	rs6742276	chr2:61768745	G/A	cg15711740	chr2:61764176	XPO1	-0.73	-5.26	-0.51	1.21e-6	Tuberculosis;
SKCM	cis	rs8072100	0.840	rs9900360	chr17:45491979	C/T	cg25173405	chr17:45401733	C17orf57	-0.57	-4.77	-0.48	8.45e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs763014	0.966	rs15564	chr16:677854	G/T	cg09263875	chr16:632152	PIGQ	0.71	6.12	0.57	3.49e-8	Height;
SKCM	cis	rs1062177	0.855	rs919263	chr5:151265853	A/G	cg00977110	chr5:151150581	G3BP1	0.74	5.79	0.55	1.41e-7	Preschool internalizing problems;
SKCM	cis	rs2013441	1.000	rs8079701	chr17:20216565	G/A	cg13482628	chr17:19912719	NA	-0.63	-4.83	-0.48	6.59e-6	Obesity-related traits;
SKCM	cis	rs28386778	0.897	rs2584608	chr17:61936710	A/G	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.13	11.24	0.79	5.56e-18	Prudent dietary pattern;
SKCM	cis	rs6736997	0.903	rs10929052	chr2:235619006	C/T	cg17841421	chr2:235704848	NA	0.59	5.12	0.5	2.13e-6	Pancreatic cancer;
SKCM	cis	rs929354	0.772	rs3802118	chr7:156986814	T/C	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs501120	0.925	rs684521	chr10:44752523	G/A	cg09554077	chr10:44749378	NA	0.38	4.93	0.49	4.52e-6	Coronary artery disease;Coronary heart disease;
SKCM	cis	rs8017423	0.647	rs1958346	chr14:90824011	G/T	cg04374321	chr14:90722782	PSMC1	-0.73	-5.53	-0.53	4.08e-7	Mortality in heart failure;
SKCM	cis	rs2929278	0.617	rs11070410	chr15:44057045	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	-0.71	-5.1	-0.5	2.35e-6	Schizophrenia;
SKCM	cis	rs67311347	0.911	rs6773917	chr3:40469254	G/T	cg00091569	chr3:40428383	ENTPD3	0.62	5.09	0.5	2.4e-6	Renal cell carcinoma;
SKCM	cis	rs9303401	0.573	rs67378767	chr17:57194237	G/T	cg10487724	chr17:56770010	TEX14;RAD51C	0.8	4.97	0.49	3.94e-6	Cognitive test performance;
SKCM	cis	rs1639906	1.000	rs1637759	chr7:2220053	C/T	cg02951883	chr7:2050386	MAD1L1	-0.61	-4.88	-0.48	5.49e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs250585	0.667	rs380618	chr16:23606273	C/T	cg09934309	chr16:23461721	COG7	0.83	5.56	0.53	3.6e-7	Egg allergy;
SKCM	cis	rs11690935	0.959	rs12185567	chr2:172560729	A/C	cg13550731	chr2:172543902	DYNC1I2	0.93	7.52	0.65	7.86e-11	Schizophrenia;
SKCM	cis	rs854765	0.654	rs11078400	chr17:17757728	A/G	cg04398451	chr17:18023971	MYO15A	0.92	6.67	0.6	3.3e-9	Total body bone mineral density;
SKCM	cis	rs2070488	0.662	rs7652475	chr3:38481341	C/T	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.75	5.63	0.54	2.73e-7	Electrocardiographic conduction measures;
SKCM	cis	rs7811142	1.000	rs6979335	chr7:100089860	T/C	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.24	7.92	0.67	1.36e-11	Platelet count;
SKCM	cis	rs28386778	0.830	rs2665841	chr17:61861219	A/T	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs1552244	0.832	rs73024591	chr3:10203194	A/T	cg02579736	chr3:10068473	FANCD2;CIDECP	1.14	6.16	0.57	2.96e-8	Alzheimer's disease;
SKCM	cis	rs11098499	0.580	rs12509234	chr4:120319434	T/C	cg09307838	chr4:120376055	NA	0.97	7.49	0.65	9.08e-11	Corneal astigmatism;
SKCM	cis	rs7584330	0.910	rs6757376	chr2:238400036	G/C	cg14458575	chr2:238380390	NA	0.94	6.04	0.56	4.9e-8	Prostate cancer;
SKCM	cis	rs8180040	1.000	rs2302278	chr3:47361082	G/T	cg27129171	chr3:47204927	SETD2	-0.88	-6.57	-0.6	5.01e-9	Colorectal cancer;
SKCM	cis	rs7937682	0.632	rs11603779	chr11:111781047	A/C	cg09085632	chr11:111637200	PPP2R1B	1.09	9.02	0.71	1e-13	Primary sclerosing cholangitis;
SKCM	cis	rs9513627	0.588	rs9585073	chr13:100128516	A/G	cg11288260	chr13:100117058	NA	-0.8	-4.77	-0.48	8.48e-6	Obesity-related traits;
SKCM	cis	rs514406	0.505	rs405208	chr1:53176674	C/T	cg16325326	chr1:53192061	ZYG11B	0.89	10.06	0.75	9.55e-16	Monocyte count;
SKCM	cis	rs7438704	0.573	rs2883132	chr4:48320064	A/C	cg15299388	chr4:48491941	ZAR1	-0.45	-5.21	-0.51	1.47e-6	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs228769	0.636	rs11656104	chr17:42258965	A/T	cg08499158	chr17:42289980	UBTF	-0.85	-6.79	-0.61	1.99e-9	Bone mineral density (hip);Bone mineral density (spine);
SKCM	cis	rs684232	0.644	rs1227030	chr17:619882	C/T	cg12384639	chr17:618140	VPS53	0.73	5.62	0.54	2.81e-7	Prostate cancer;
SKCM	cis	rs3820068	0.581	rs16851841	chr1:15922713	A/G	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs7829975	0.714	rs4840362	chr8:8670082	C/G	cg15556689	chr8:8085844	FLJ10661	-0.65	-5.69	-0.54	2.15e-7	Mood instability;
SKCM	cis	rs9916302	0.706	rs8182252	chr17:37727950	T/C	cg07936489	chr17:37558343	FBXL20	1.07	10.02	0.75	1.14e-15	Glomerular filtration rate (creatinine);
SKCM	cis	rs8067545	0.586	rs2526463	chr17:20078297	G/A	cg13482628	chr17:19912719	NA	-0.66	-5.58	-0.53	3.37e-7	Schizophrenia;
SKCM	cis	rs10876993	0.928	rs1689592	chr12:58057773	C/T	cg18357645	chr12:58087776	OS9	0.61	5.65	0.54	2.52e-7	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs17685	0.743	rs10277259	chr7:75802674	A/C	cg16489192	chr7:75678113	MDH2;STYXL1	-0.57	-5.49	-0.53	4.89e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7666738	0.830	rs4492007	chr4:98959848	A/T	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11690935	0.921	rs7355523	chr2:172744421	T/C	cg13550731	chr2:172543902	DYNC1I2	-0.96	-8.29	-0.68	2.6e-12	Schizophrenia;
SKCM	cis	rs1348850	0.567	rs1527401	chr2:178522104	C/T	cg22681709	chr2:178499509	PDE11A	-0.56	-4.96	-0.49	3.99e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs362272	0.524	rs10937924	chr4:3374898	T/C	cg09735869	chr4:3319127	RGS12	0.93	10.12	0.75	7.48e-16	Serum sulfate level;
SKCM	cis	rs62238980	0.614	rs75091642	chr22:32449078	C/A	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs7666738	0.830	rs2865980	chr4:99027422	T/G	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2941509	1.000	rs3169574	chr17:38077485	G/A	cg12655416	chr17:38077870	ORMDL3	-0.48	-5.27	-0.51	1.17e-6	Systemic lupus erythematosus;
SKCM	cis	rs997295	0.570	rs72747464	chr15:67818540	C/T	cg24247231	chr15:67904302	MAP2K5	-0.61	-5.03	-0.49	3.06e-6	Motion sickness;
SKCM	cis	rs10791097	0.677	rs11222359	chr11:130730648	A/G	cg12179176	chr11:130786555	SNX19	0.75	5.95	0.56	7.12e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs1577917	0.958	rs34622605	chr6:86456519	G/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.67	-5.77	-0.55	1.54e-7	Response to antipsychotic treatment;
SKCM	cis	rs2948294	0.588	rs12544596	chr8:8116346	A/T	cg08975724	chr8:8085496	FLJ10661	0.63	4.83	0.48	6.73e-6	Red cell distribution width;
SKCM	cis	rs72634258	0.945	rs17523802	chr1:8021740	G/A	cg00042356	chr1:8021962	PARK7	1.04	7.35	0.64	1.67e-10	Inflammatory bowel disease;
SKCM	cis	rs11098499	0.691	rs17009144	chr4:120270795	C/T	cg09307838	chr4:120376055	NA	-0.94	-7.73	-0.66	3.07e-11	Corneal astigmatism;
SKCM	cis	rs71636778	0.543	rs11810321	chr1:27220521	T/G	cg01689405	chr1:26370407	SLC30A2	-0.53	-4.86	-0.48	5.9e-6	Monocyte percentage of white cells;Granulocyte percentage of myeloid white cells;
SKCM	cis	rs478304	0.593	rs4645927	chr11:65482827	C/T	cg27068330	chr11:65405492	SIPA1	-0.86	-7.44	-0.64	1.12e-10	Acne (severe);
SKCM	cis	rs17376456	1.000	rs67150649	chr5:93292377	A/G	cg25358565	chr5:93447407	FAM172A	1.24	6.76	0.61	2.23e-9	Diabetic retinopathy;
SKCM	cis	rs56011263	0.687	rs4690293	chr4:706101	A/G	cg17689763	chr4:710664	PCGF3	-0.66	-5.42	-0.52	6.48e-7	White blood cell count;
SKCM	cis	rs1577917	1.000	rs35761942	chr6:86629504	C/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.85	-8.62	-0.7	5.82e-13	Response to antipsychotic treatment;
SKCM	cis	rs561341	0.714	rs7218466	chr17:30263314	A/G	cg00745463	chr17:30367425	LRRC37B	-1.01	-6.84	-0.61	1.58e-9	Hip circumference adjusted for BMI;
SKCM	cis	rs10751667	0.643	rs10902244	chr11:949981	A/G	cg06064525	chr11:970664	AP2A2	-0.54	-5.12	-0.5	2.13e-6	Alzheimer's disease (late onset);
SKCM	cis	rs7666738	0.791	rs62318907	chr4:99037120	C/T	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1552244	1.000	rs2272125	chr3:10138069	A/C	cg02579736	chr3:10068473	FANCD2;CIDECP	1.23	6.92	0.62	1.13e-9	Alzheimer's disease;
SKCM	cis	rs8037137	0.915	rs76119208	chr15:91535329	G/T	cg15878949	chr15:91534302	PRC1	0.68	5.23	0.51	1.38e-6	Platelet count;Serous invasive ovarian cancer;High-grade serous ovarian cancer;Invasive epithelial ovarian cancer;
SKCM	cis	rs9902453	0.689	rs56788338	chr17:28186557	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.83	6.37	0.59	1.2e-8	Coffee consumption (cups per day);
SKCM	cis	rs3785574	0.924	rs2727292	chr17:61893747	A/G	cg06873352	chr17:61820015	STRADA	0.56	4.82	0.48	6.86e-6	Height;
SKCM	cis	rs9300255	0.602	rs1727315	chr12:123638930	A/G	cg05973401	chr12:123451056	ABCB9	-0.85	-5.71	-0.54	1.93e-7	Neutrophil percentage of white cells;
SKCM	cis	rs2032447	0.802	rs12346	chr6:26097046	T/C	cg03517284	chr6:25882590	NA	-0.59	-5.02	-0.49	3.24e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7659604	0.540	rs4833775	chr4:122716826	T/C	cg19671926	chr4:122722719	EXOSC9	0.76	6.97	0.62	9.04e-10	Type 2 diabetes;
SKCM	cis	rs12044355	0.892	rs12048349	chr1:231850323	G/A	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	0.73	5.26	0.51	1.24e-6	Alzheimer's disease;
SKCM	cis	rs6500395	0.926	rs9936446	chr16:48645807	G/C	cg04672837	chr16:48644449	N4BP1	0.69	5.68	0.54	2.26e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs875971	0.545	rs313828	chr7:65552614	T/C	cg18876405	chr7:65276391	NA	-0.67	-5.32	-0.52	9.82e-7	Aortic root size;
SKCM	cis	rs10751667	0.643	rs12278229	chr11:946985	A/G	cg06064525	chr11:970664	AP2A2	-0.53	-4.92	-0.49	4.78e-6	Alzheimer's disease (late onset);
SKCM	cis	rs798554	0.721	rs2527680	chr7:2892361	C/T	cg19346786	chr7:2764209	NA	-0.67	-6.93	-0.62	1.09e-9	Height;
SKCM	cis	rs6087771	0.851	rs6087775	chr20:30325765	G/A	cg13852791	chr20:30311386	BCL2L1	0.82	5.64	0.54	2.59e-7	Subcortical brain region volumes;Putamen volume;
SKCM	cis	rs10832963	1.000	rs11024739	chr11:18645843	A/C	cg09201001	chr11:18656081	SPTY2D1	-1.07	-11.79	-0.8	5.15e-19	Breast cancer;
SKCM	cis	rs11792861	0.816	rs2304779	chr9:111670513	C/T	cg14432460	chr9:111696404	IKBKAP;C9orf6	-0.67	-4.96	-0.49	4e-6	Menarche (age at onset);
SKCM	cis	rs801193	0.773	rs801207	chr7:66020590	T/C	cg11764359	chr7:65958608	NA	-0.81	-6.09	-0.57	4.07e-8	Aortic root size;
SKCM	cis	rs1003719	0.762	rs1015551	chr21:38449510	G/A	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs2197308	0.765	rs11182434	chr12:37923968	C/A	cg13010199	chr12:38710504	ALG10B	0.65	4.93	0.49	4.48e-6	Morning vs. evening chronotype;
SKCM	cis	rs2013441	0.613	rs4925082	chr17:19994673	C/T	cg13482628	chr17:19912719	NA	-0.7	-5.51	-0.53	4.43e-7	Obesity-related traits;
SKCM	cis	rs9926296	0.527	rs1800335	chr16:89846195	A/G	cg04287289	chr16:89883240	FANCA	1.04	12.56	0.82	2.03e-20	Vitiligo;
SKCM	cis	rs748404	0.660	rs542898	chr15:43719392	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	0.73	5.42	0.52	6.48e-7	Lung cancer;
SKCM	cis	rs992157	1.000	rs13003334	chr2:219124921	T/A	cg00012203	chr2:219082015	ARPC2	0.83	6.98	0.62	8.66e-10	Colorectal cancer;
SKCM	cis	rs3820928	0.904	rs2396431	chr2:227765488	G/A	cg11843606	chr2:227700838	RHBDD1	-0.64	-5.25	-0.51	1.26e-6	Pulmonary function;
SKCM	cis	rs769267	0.930	rs10422819	chr19:19643028	C/A	cg03709012	chr19:19516395	GATAD2A	0.89	8.62	0.7	5.89e-13	Tonsillectomy;
SKCM	cis	rs34779708	0.733	rs3936503	chr10:35549257	A/G	cg03585969	chr10:35415529	CREM	-0.68	-5.04	-0.5	3e-6	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs8067545	0.611	rs11868116	chr17:20029593	T/C	cg13482628	chr17:19912719	NA	0.66	5.61	0.54	2.98e-7	Schizophrenia;
SKCM	cis	rs16854884	0.739	rs1075113	chr3:143760535	C/T	cg06585982	chr3:143692056	C3orf58	0.63	5.27	0.51	1.2e-6	Economic and political preferences (feminism/equality);
SKCM	cis	rs5769765	0.773	rs9616208	chr22:50313359	G/A	cg22709217	chr22:50311962	ALG12;CRELD2	-0.94	-5.91	-0.56	8.37e-8	Schizophrenia;
SKCM	cis	rs4975616	0.773	rs414965	chr5:1324121	G/A	cg26373071	chr5:1325741	CLPTM1L	0.68	5.7	0.54	2.02e-7	Lung cancer;
SKCM	cis	rs703842	1.000	rs1599932	chr12:58177943	G/A	cg04478727	chr12:58166393	METTL1;FAM119B	0.73	5.84	0.55	1.15e-7	Multiple sclerosis;
SKCM	cis	rs9815354	0.812	rs73069356	chr3:41752845	G/A	cg03022575	chr3:42003672	ULK4	1.04	5.11	0.5	2.22e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs8067545	0.611	rs2703781	chr17:20144714	A/G	cg13482628	chr17:19912719	NA	-0.65	-5.44	-0.52	5.84e-7	Schizophrenia;
SKCM	cis	rs6089584	0.816	rs6061410	chr20:60625329	A/G	cg13770153	chr20:60521292	NA	-0.57	-4.9	-0.49	5.11e-6	Body mass index;
SKCM	cis	rs8060686	0.641	rs8064114	chr16:68240185	G/A	cg09117114	chr16:67998030	SLC12A4	-0.78	-5.08	-0.5	2.56e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs796364	1.000	rs4263095	chr2:200830137	A/C	cg12253985	chr2:200820533	C2orf60;C2orf47	-0.9	-5.65	-0.54	2.47e-7	Schizophrenia;
SKCM	cis	rs870825	0.698	rs28412823	chr4:185638829	T/C	cg04058563	chr4:185651563	MLF1IP	1.08	7.26	0.64	2.51e-10	Blood protein levels;
SKCM	cis	rs9916302	0.706	rs9906612	chr17:37547631	A/C	cg07936489	chr17:37558343	FBXL20	0.97	6.82	0.61	1.73e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs9916302	0.861	rs2338801	chr17:37490780	G/T	cg07936489	chr17:37558343	FBXL20	0.86	7.35	0.64	1.67e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs116095464	0.558	rs62347683	chr5:230331	C/T	cg22496380	chr5:211416	CCDC127	-0.95	-5.22	-0.51	1.42e-6	Breast cancer;
SKCM	cis	rs35306767	0.903	rs11253475	chr10:907262	C/A	cg26597838	chr10:835615	NA	0.78	5.5	0.53	4.73e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs7106204	0.748	rs2403891	chr11:24213130	C/T	ch.11.24196551F	chr11:24239977	NA	0.77	5.97	0.56	6.6e-8	Response to Homoharringtonine (cytotoxicity);
SKCM	cis	rs6087990	0.966	rs1883730	chr20:31337487	T/A	cg13636640	chr20:31349939	DNMT3B	0.94	8.17	0.68	4.5e-12	Ulcerative colitis;
SKCM	cis	rs7615952	0.611	rs78137633	chr3:125775061	C/T	cg05084668	chr3:125655381	ALG1L	-1.29	-6.33	-0.58	1.42e-8	Blood pressure (smoking interaction);
SKCM	cis	rs801193	0.967	rs2707853	chr7:66214010	G/A	cg11764359	chr7:65958608	NA	0.82	6.24	0.58	2.14e-8	Aortic root size;
SKCM	cis	rs2228479	0.867	rs34272502	chr16:89949000	G/C	cg06558623	chr16:89946397	TCF25	1.26	6.97	0.62	9.17e-10	Skin colour saturation;
SKCM	cis	rs7613875	0.620	rs7430334	chr3:50078221	T/C	cg24110177	chr3:50126178	RBM5	0.74	5.95	0.56	7.25e-8	Body mass index;
SKCM	cis	rs7843479	0.601	rs10109521	chr8:21829948	G/A	cg17168535	chr8:21777572	XPO7	0.85	8.07	0.67	6.96e-12	Mean corpuscular volume;
SKCM	cis	rs875971	0.830	rs427575	chr7:65519219	A/G	cg11764359	chr7:65958608	NA	0.9	8.21	0.68	3.63e-12	Aortic root size;
SKCM	cis	rs3847687	0.869	rs11061300	chr12:131523261	G/A	cg13586425	chr12:131519906	GPR133	-0.49	-5.36	-0.52	8.11e-7	Longevity;
SKCM	cis	rs7829975	0.593	rs2921077	chr8:8304502	C/T	cg06636001	chr8:8085503	FLJ10661	0.8	6.43	0.59	9.41e-9	Mood instability;
SKCM	cis	rs55962025	0.662	rs362309	chr4:3240915	G/C	cg09735869	chr4:3319127	RGS12	-0.69	-5.8	-0.55	1.33e-7	Parental longevity (mother's age at death);
SKCM	cis	rs28595532	0.844	rs55845920	chr4:119490085	C/T	cg14228332	chr4:119757509	SEC24D	0.97	4.92	0.49	4.71e-6	Cannabis dependence symptom count;
SKCM	cis	rs7829975	0.774	rs1039915	chr8:8679614	T/C	cg15556689	chr8:8085844	FLJ10661	0.75	7.11	0.63	4.83e-10	Mood instability;
SKCM	cis	rs3768617	0.510	rs6666259	chr1:183102855	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.79	7.59	0.65	5.75e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs9660180	0.967	rs6603802	chr1:1812521	C/T	cg23982607	chr1:1823379	GNB1	-0.73	-6.09	-0.57	3.97e-8	Body mass index;
SKCM	cis	rs7618915	0.501	rs7611731	chr3:52692721	T/C	cg18404041	chr3:52824283	ITIH1	-0.53	-4.77	-0.48	8.42e-6	Bipolar disorder;
SKCM	cis	rs736408	0.609	rs2336545	chr3:52787603	C/T	cg18404041	chr3:52824283	ITIH1	0.56	4.94	0.49	4.32e-6	Bipolar disorder;
SKCM	cis	rs1032355	0.643	rs1491237	chr4:100538423	A/G	cg25391692	chr4:100495869	MTTP	-0.82	-4.97	-0.49	3.9e-6	Celiac disease;
SKCM	cis	rs28595532	0.920	rs116634064	chr4:119736514	C/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs8038465	0.615	rs11072430	chr15:73981701	A/G	cg15420318	chr15:73925796	NPTN	-0.62	-4.92	-0.49	4.68e-6	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	trans	rs1814175	0.630	rs1722019	chr11:49904102	G/A	cg15704280	chr7:45808275	SEPT13	-0.86	-8.14	-0.68	5.04e-12	Height;
SKCM	cis	rs995000	0.931	rs12037659	chr1:62923863	C/T	cg06896770	chr1:63153194	DOCK7	0.91	8.76	0.7	3.11e-13	Triglyceride levels;
SKCM	cis	rs860295	0.871	rs12724079	chr1:155433942	A/G	cg02153340	chr1:155202674	NA	0.72	5.5	0.53	4.67e-7	Body mass index;
SKCM	cis	rs17376456	0.825	rs67328989	chr5:93243133	T/A	cg25358565	chr5:93447407	FAM172A	1.3	7.53	0.65	7.57e-11	Diabetic retinopathy;
SKCM	cis	rs2204008	0.840	rs11181795	chr12:38401129	A/G	cg26384229	chr12:38710491	ALG10B	0.82	6.3	0.58	1.6e-8	Bladder cancer;
SKCM	cis	rs7829975	0.500	rs7841082	chr8:8168987	C/T	cg06636001	chr8:8085503	FLJ10661	-0.7	-6.08	-0.57	4.24e-8	Mood instability;
SKCM	cis	rs919433	0.926	rs787996	chr2:198216805	A/G	cg04278110	chr2:198063759	ANKRD44	0.73	5.0	0.49	3.51e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs3892630	0.558	rs4588103	chr19:33352770	G/A	cg22980127	chr19:33182716	NUDT19	0.86	4.94	0.49	4.39e-6	Red blood cell traits;
SKCM	cis	rs2070433	1.000	rs2839306	chr21:47954219	G/T	cg05998816	chr21:47859926	PCNT	-0.73	-4.79	-0.48	7.94e-6	Lymphocyte counts;
SKCM	cis	rs12477438	0.520	rs1453563	chr2:99720267	C/G	cg26064155	chr2:99771622	LIPT1;TSGA10	1.01	9.65	0.74	5.91e-15	Chronic sinus infection;
SKCM	cis	rs826838	0.967	rs11169387	chr12:39145737	C/T	cg13010199	chr12:38710504	ALG10B	0.7	5.44	0.52	5.85e-7	Heart rate;
SKCM	cis	rs875971	0.793	rs460678	chr7:65527200	C/G	cg11987759	chr7:65425863	GUSB	-0.56	-4.94	-0.49	4.34e-6	Aortic root size;
SKCM	cis	rs12950390	0.853	rs11658511	chr17:45856918	T/C	cg03474202	chr17:45855739	NA	-0.48	-5.42	-0.52	6.43e-7	IgG glycosylation;
SKCM	cis	rs7772486	0.754	rs9497401	chr6:146051271	T/C	cg05347473	chr6:146136440	FBXO30	-0.63	-5.66	-0.54	2.38e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7809950	0.817	rs2204833	chr7:107283069	T/C	cg23024343	chr7:107201750	COG5	0.87	7.75	0.66	2.9e-11	Coronary artery disease;
SKCM	cis	rs875971	0.577	rs34888281	chr7:65585771	C/T	cg18876405	chr7:65276391	NA	-0.82	-7.41	-0.64	1.3100000000000001e-10	Aortic root size;
SKCM	cis	rs7027203	0.828	rs10761288	chr9:96609363	C/T	cg14598338	chr9:96623480	NA	-0.47	-4.95	-0.49	4.21e-6	DNA methylation (variation);
SKCM	cis	rs11892454	0.515	rs13405775	chr2:26026986	C/T	cg17263061	chr2:26915892	KCNK3	0.7	5.01	0.49	3.31e-6	Heschl's gyrus morphology;
SKCM	cis	rs2439831	1.000	rs2444250	chr15:43785051	C/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.22	7.98	0.67	1.01e-11	Lung cancer in ever smokers;
SKCM	cis	rs9660180	0.935	rs9786942	chr1:1759213	A/G	cg17747265	chr1:1875780	NA	-0.56	-5.15	-0.5	1.91e-6	Body mass index;
SKCM	cis	rs11098499	0.866	rs6857892	chr4:120282696	G/T	cg09307838	chr4:120376055	NA	0.98	7.89	0.67	1.52e-11	Corneal astigmatism;
SKCM	cis	rs12134245	1.000	rs12134245	chr1:92021464	C/T	cg02896835	chr1:92012615	NA	-0.62	-5.55	-0.53	3.79e-7	Breast cancer;
SKCM	cis	rs17376456	0.569	rs2045020	chr5:93224466	T/C	cg21475434	chr5:93447410	FAM172A	-0.82	-4.84	-0.48	6.46e-6	Diabetic retinopathy;
SKCM	cis	rs2832191	0.791	rs28633762	chr21:30500070	C/T	cg08807101	chr21:30365312	RNF160	-0.61	-4.78	-0.48	8.17e-6	Dental caries;
SKCM	cis	rs1912528	0.783	rs769662	chr4:140868894	G/A	cg11128457	chr4:140864437	MAML3	0.64	5.47	0.53	5.17e-7	Educational attainment (years of education);
SKCM	cis	rs17376456	0.935	rs10036891	chr5:93171738	T/A	cg21475434	chr5:93447410	FAM172A	0.98	5.5	0.53	4.7e-7	Diabetic retinopathy;
SKCM	cis	rs7772486	0.875	rs6570738	chr6:146412695	G/A	cg23711669	chr6:146136114	FBXO30	0.86	8.52	0.69	9.39e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs10504229	1.000	rs58608483	chr8:58195269	T/G	cg22535103	chr8:58192502	C8orf71	-0.76	-5.07	-0.5	2.66e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs116095464	0.558	rs10057492	chr5:239503	T/C	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs9325144	0.581	rs2653758	chr12:38946233	G/T	cg13010199	chr12:38710504	ALG10B	-0.69	-5.97	-0.56	6.66e-8	Morning vs. evening chronotype;
SKCM	cis	rs2952156	0.883	rs8077172	chr17:37834977	G/T	cg20243544	chr17:37824526	PNMT	0.71	5.74	0.54	1.74e-7	Asthma;
SKCM	cis	rs6088580	0.634	rs6087587	chr20:33058628	G/T	cg24642439	chr20:33292090	TP53INP2	0.76	6.02	0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs7769051	0.803	rs34334052	chr6:133231829	C/T	cg22852734	chr6:133119734	C6orf192	1.04	5.04	0.5	2.99e-6	Type 2 diabetes nephropathy;
SKCM	cis	rs1799949	0.965	rs4239149	chr17:41328095	A/G	cg23758822	chr17:41437982	NA	-0.94	-7.7	-0.66	3.66e-11	Menopause (age at onset);
SKCM	cis	rs655601	0.558	rs11544558	chr5:180235737	C/A	cg13724780	chr5:180237085	MGAT1	1.29	5.15	0.5	1.93e-6	Quantitative traits;
SKCM	cis	rs7945705	0.776	rs2316865	chr11:8815470	A/G	cg21881798	chr11:8931708	C11orf17;ST5	0.66	6.51	0.59	6.59e-9	Hemoglobin concentration;
SKCM	cis	rs708547	0.836	rs1277287	chr4:57853147	C/G	cg16868167	chr4:57843880	C4orf14;POLR2B	0.95	9.17	0.72	5.01e-14	Response to bleomycin (chromatid breaks);
SKCM	cis	rs6570726	0.905	rs421032	chr6:145827771	A/G	cg23711669	chr6:146136114	FBXO30	0.73	7.14	0.63	4.25e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7666738	0.830	rs10470893	chr4:99038756	C/T	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs12926788	0.689	rs7186308	chr16:24848471	A/G	cg04756594	chr16:24857601	SLC5A11	0.69	5.1	0.5	2.35e-6	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs34779708	0.897	rs4934716	chr10:35369299	A/G	cg03585969	chr10:35415529	CREM	0.78	6.3	0.58	1.6e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs3820928	1.000	rs4675116	chr2:227769607	A/C	cg11843606	chr2:227700838	RHBDD1	-0.64	-5.2	-0.51	1.53e-6	Pulmonary function;
SKCM	cis	rs6977660	0.660	rs12531278	chr7:19816439	A/T	cg07541023	chr7:19748670	TWISTNB	0.72	4.78	0.48	7.95e-6	Thyroid stimulating hormone;
SKCM	cis	rs9611565	0.694	rs202639	chr22:41856137	T/A	cg03806693	chr22:41940476	POLR3H	1.13	7.36	0.64	1.63e-10	Vitiligo;
SKCM	cis	rs9911578	1.000	rs2531734	chr17:56550804	T/C	cg12560992	chr17:57184187	TRIM37	-0.92	-7.26	-0.64	2.5e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs8017423	0.967	rs61592400	chr14:90703252	T/C	cg04374321	chr14:90722782	PSMC1	0.97	8.87	0.71	1.91e-13	Mortality in heart failure;
SKCM	cis	rs2760061	0.598	rs658238	chr1:228121291	A/G	cg18477163	chr1:228402036	OBSCN	-0.43	-4.87	-0.48	5.62e-6	Diastolic blood pressure;
SKCM	cis	rs929354	1.000	rs1182413	chr7:157058557	G/A	cg17757837	chr7:157058334	UBE3C	-0.93	-7.21	-0.63	3.17e-10	Body mass index;
SKCM	cis	rs561341	0.843	rs2028067	chr17:30239698	T/C	cg12193833	chr17:30244370	NA	-0.49	-4.92	-0.49	4.75e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs1577917	1.000	rs12201741	chr6:86602619	G/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.86	-8.63	-0.7	5.66e-13	Response to antipsychotic treatment;
SKCM	cis	rs2153535	0.553	rs2984099	chr6:8637274	C/T	cg07606381	chr6:8435919	SLC35B3	-0.83	-5.22	-0.51	1.43e-6	Motion sickness;
SKCM	cis	rs6463523	0.864	rs73047957	chr7:759373	A/T	cg11064039	chr7:766100	PRKAR1B;HEATR2	0.98	8.14	0.68	5.06e-12	Subjective well-being;
SKCM	cis	rs7296418	0.663	rs28450974	chr12:123861420	G/A	cg00376283	chr12:123451042	ABCB9	0.82	6.54	0.6	5.78e-9	Platelet count;
SKCM	cis	rs4774899	0.899	rs12906335	chr15:57487091	A/T	cg01857019	chr15:57210107	LOC145783;TCF12	0.52	4.79	0.48	7.67e-6	Urinary tract infection frequency;
SKCM	cis	rs11822910	0.724	rs60961847	chr11:57184224	G/A	cg00522883	chr11:57194120	SLC43A3	0.77	4.84	0.48	6.47e-6	Platelet distribution width;
SKCM	cis	rs8037137	0.915	rs8028409	chr15:91506422	A/T	cg15878949	chr15:91534302	PRC1	0.67	5.12	0.5	2.13e-6	Platelet count;Serous invasive ovarian cancer;High-grade serous ovarian cancer;Invasive epithelial ovarian cancer;
SKCM	cis	rs7772486	0.720	rs6901888	chr6:146023144	A/G	cg23711669	chr6:146136114	FBXO30	-0.88	-9.08	-0.72	7.6e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs11690935	0.921	rs3770445	chr2:172708919	T/C	cg13550731	chr2:172543902	DYNC1I2	-0.95	-8.21	-0.68	3.64e-12	Schizophrenia;
SKCM	cis	rs1577917	0.958	rs12205492	chr6:86475976	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.7	-5.97	-0.56	6.68e-8	Response to antipsychotic treatment;
SKCM	cis	rs899997	0.862	rs11072787	chr15:78972977	T/C	cg04896959	chr15:78267971	NA	-0.56	-4.92	-0.49	4.63e-6	Coronary artery disease or large artery stroke;
SKCM	cis	rs3091242	0.900	rs1883427	chr1:25744468	C/T	cg27572855	chr1:25598939	RHD	0.53	5.11	0.5	2.22e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs793571	0.590	rs347115	chr15:59082959	C/T	cg05156742	chr15:59063176	FAM63B	0.69	4.96	0.49	4.11e-6	Schizophrenia;
SKCM	cis	rs941873	0.772	rs7086293	chr10:81103247	T/C	cg09469691	chr10:81107165	PPIF	0.72	6.81	0.61	1.8e-9	Height;
SKCM	cis	rs8067545	0.586	rs2526459	chr17:20090042	G/T	cg13482628	chr17:19912719	NA	-0.66	-5.6	-0.54	3.13e-7	Schizophrenia;
SKCM	cis	rs870825	0.929	rs871253	chr4:185589234	G/A	cg04058563	chr4:185651563	MLF1IP	1.09	5.66	0.54	2.39e-7	Blood protein levels;
SKCM	cis	rs7666738	0.830	rs1967979	chr4:98966201	G/T	cg05340658	chr4:99064831	C4orf37	0.64	4.91	0.49	4.97e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4237845	0.837	rs7954591	chr12:58299037	A/G	cg02175503	chr12:58329896	NA	0.82	7.59	0.65	5.79e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs11673344	0.734	rs496872	chr19:37439481	C/T	cg07624650	chr19:37064219	ZNF529	-0.8	-5.02	-0.49	3.25e-6	Obesity-related traits;
SKCM	cis	rs11719291	0.915	rs11557629	chr3:48732223	G/A	cg00383909	chr3:49044727	WDR6	0.89	5.09	0.5	2.44e-6	Cognitive function;
SKCM	cis	rs754466	0.580	rs12356063	chr10:79558131	G/C	cg17075019	chr10:79541650	NA	-0.73	-6.33	-0.58	1.42e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs554111	0.656	rs12021529	chr1:21306161	C/T	cg01072550	chr1:21505969	NA	-0.65	-5.42	-0.52	6.42e-7	Facial morphology (factor 17, height of vermillion upper lip);
SKCM	cis	rs4780401	0.609	rs4781143	chr16:11809721	T/G	cg01061890	chr16:11836724	TXNDC11	-0.77	-5.59	-0.53	3.27e-7	Rheumatoid arthritis;
SKCM	cis	rs155076	1.000	rs261427	chr13:21860998	G/A	cg11317459	chr13:21872234	NA	-1.32	-7.62	-0.65	5.15e-11	White matter hyperintensity burden;
SKCM	cis	rs6951245	1.000	rs80031817	chr7:1096793	T/C	cg18402987	chr7:1209562	NA	1.15	6.09	0.57	3.95e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs910316	0.967	rs175479	chr14:75561871	A/C	cg11812906	chr14:75593930	NEK9	-0.72	-5.45	-0.53	5.72e-7	Height;
SKCM	cis	rs6570726	0.620	rs367693	chr6:145815949	G/A	cg05347473	chr6:146136440	FBXO30	0.62	5.34	0.52	8.97e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs595982	0.661	rs657008	chr19:49373632	A/G	cg19746536	chr19:49375674	PPP1R15A	1.25	15.1	0.86	7.41e-25	Red cell distribution width;
SKCM	cis	rs2153535	0.526	rs1796689	chr6:8536433	A/C	cg07606381	chr6:8435919	SLC35B3	0.86	6.28	0.58	1.8e-8	Motion sickness;
SKCM	cis	rs2180341	1.000	rs6904520	chr6:127629802	T/C	cg24812749	chr6:127587940	RNF146	0.88	7.44	0.64	1.12e-10	Breast cancer;
SKCM	cis	rs7937682	0.889	rs578022	chr11:111490552	G/T	cg09085632	chr11:111637200	PPP2R1B	-0.97	-10.08	-0.75	8.74e-16	Primary sclerosing cholangitis;
SKCM	cis	rs66573146	0.831	rs56031152	chr4:6973832	C/A	cg00086871	chr4:6988644	TBC1D14	1.29	5.03	0.5	3.04e-6	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs8177253	1.000	rs8177261	chr3:133480588	A/C	cg16414030	chr3:133502952	NA	-0.69	-5.78	-0.55	1.49e-7	Iron status biomarkers;
SKCM	cis	rs10193935	1.000	rs10171023	chr2:42407093	G/C	cg27598129	chr2:42591480	NA	-0.92	-6.79	-0.61	1.97e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9815354	0.812	rs111967505	chr3:41873157	C/T	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs7100689	0.784	rs10736342	chr10:82130005	A/G	cg00277334	chr10:82204260	NA	-0.52	-4.89	-0.48	5.24e-6	Post bronchodilator FEV1;
SKCM	cis	rs8072100	0.967	rs4239162	chr17:45755810	G/A	cg25173405	chr17:45401733	C17orf57	-0.58	-5.19	-0.51	1.6e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs4803468	1.000	rs878082	chr19:41897674	G/A	cg09537434	chr19:41945824	ATP5SL	-1.08	-13.01	-0.83	3.1e-21	Height;
SKCM	cis	rs1707322	0.721	rs11211166	chr1:46157942	G/A	cg03146154	chr1:46216737	IPP	0.84	6.2	0.57	2.51e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs1348850	0.645	rs11889272	chr2:178432378	C/T	cg27490568	chr2:178487706	NA	0.8	5.67	0.54	2.32e-7	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs2243480	1.000	rs73142122	chr7:65311298	C/A	cg18252515	chr7:66147081	NA	-1.29	-7.41	-0.64	1.3e-10	Diabetic kidney disease;
SKCM	cis	rs12047808	0.841	rs79893062	chr1:179378787	C/T	cg08037922	chr1:179521085	C1orf125;NPHS2	-1.08	-5.8	-0.55	1.32e-7	Multiple sclerosis (age of onset);
SKCM	cis	rs4561483	0.801	rs4511557	chr16:11949458	T/C	cg08843971	chr16:11963173	GSPT1	0.7	5.39	0.52	7.27e-7	Testicular germ cell tumor;
SKCM	cis	rs5760092	0.618	rs5996631	chr22:24256894	T/C	cg04234412	chr22:24373322	LOC391322	0.78	5.62	0.54	2.88e-7	Urinary 1,3-butadiene metabolite levels in smokers;
SKCM	cis	rs9303401	0.614	rs2240719	chr17:56582477	G/C	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.16	0.57	2.93e-8	Cognitive test performance;
SKCM	cis	rs8016982	0.674	rs2288499	chr14:81660997	C/T	cg01989461	chr14:81687754	GTF2A1	0.88	7.42	0.64	1.26e-10	Schizophrenia;
SKCM	cis	rs2439831	1.000	rs2444032	chr15:43755346	A/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.19	7.52	0.65	7.82e-11	Lung cancer in ever smokers;
SKCM	cis	rs16866061	0.962	rs16866045	chr2:225413020	G/A	cg12698349	chr2:225449008	CUL3	1.01	8.51	0.69	9.75e-13	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs1863824	0.625	rs11202023	chr10:88165453	C/T	cg07322936	chr10:88137208	NA	-0.59	-5.02	-0.49	3.17e-6	Schizophrenia;
SKCM	cis	rs10193935	0.901	rs7570083	chr2:42517859	G/A	cg27598129	chr2:42591480	NA	-0.95	-6.75	-0.61	2.38e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs763014	0.865	rs4006748	chr16:632225	T/C	cg00908189	chr16:619842	PIGQ	0.82	7.78	0.66	2.55e-11	Height;
SKCM	cis	rs10876993	0.855	rs1678520	chr12:58049319	C/G	cg18357645	chr12:58087776	OS9	0.61	5.65	0.54	2.52e-7	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs1577917	0.740	rs2758843	chr6:86328431	A/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.88	-8.75	-0.7	3.33e-13	Response to antipsychotic treatment;
SKCM	cis	rs10193935	0.901	rs2286701	chr2:42555636	T/C	cg27598129	chr2:42591480	NA	-0.89	-6.82	-0.61	1.74e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs12142240	0.667	rs66990604	chr1:46822073	G/A	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs208520	0.874	rs208456	chr6:66907942	A/G	cg07460842	chr6:66804631	NA	-0.91	-6.87	-0.61	1.41e-9	Exhaled nitric oxide output;
SKCM	cis	rs17065868	0.892	rs9533912	chr13:45139961	T/C	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs2075371	0.611	rs12531769	chr7:134016899	C/G	cg11752832	chr7:134001865	SLC35B4	0.56	4.82	0.48	7.07e-6	Mean platelet volume;
SKCM	cis	rs2204008	0.805	rs2874289	chr12:38258420	G/A	cg26384229	chr12:38710491	ALG10B	0.87	6.83	0.61	1.63e-9	Bladder cancer;
SKCM	cis	rs17826219	0.500	rs2874724	chr17:29072433	T/C	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Body mass index;
SKCM	cis	rs2153535	0.580	rs1577470	chr6:8462426	G/A	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs8067545	0.750	rs4924805	chr17:19997205	C/G	cg13482628	chr17:19912719	NA	0.71	6.15	0.57	3.07e-8	Schizophrenia;
SKCM	cis	rs1691799	0.867	rs1168342	chr12:66758734	A/T	cg16791601	chr12:66731901	HELB	-0.63	-5.63	-0.54	2.72e-7	White blood cell count (basophil);
SKCM	cis	rs2180341	0.961	rs910720	chr6:127619070	T/C	cg24812749	chr6:127587940	RNF146	0.87	7.33	0.64	1.85e-10	Breast cancer;
SKCM	trans	rs1814175	0.647	rs10769646	chr11:49992204	C/A	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs8180040	0.652	rs13077398	chr3:47011120	G/C	cg27129171	chr3:47204927	SETD2	0.79	6.01	0.56	5.49e-8	Colorectal cancer;
SKCM	cis	rs10540	0.730	rs61876338	chr11:493730	A/G	cg03352830	chr11:487213	PTDSS2	0.93	4.88	0.48	5.56e-6	Body mass index;
SKCM	cis	rs7826238	0.524	rs2921055	chr8:8319342	C/A	cg15556689	chr8:8085844	FLJ10661	0.71	5.91	0.56	8.51e-8	Systolic blood pressure;
SKCM	cis	rs2033711	0.936	rs7257999	chr19:58964860	C/G	cg13877915	chr19:58951672	ZNF132	0.93	9.57	0.73	8.57e-15	Uric acid clearance;
SKCM	cis	rs4862750	1.000	rs4862751	chr4:187904050	G/A	cg10295955	chr4:187884368	NA	-1.03	-12.6	-0.82	1.73e-20	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1153858	1.000	rs4774577	chr15:45644685	A/C	cg10760299	chr15:45669010	GATM	0.62	6.33	0.58	1.42e-8	Homoarginine levels;
SKCM	cis	rs11673344	0.764	rs547483	chr19:37441365	C/T	cg07624650	chr19:37064219	ZNF529	0.78	4.82	0.48	7.05e-6	Obesity-related traits;
SKCM	cis	rs35306767	0.953	rs35693858	chr10:979813	C/T	cg20503657	chr10:835505	NA	0.62	4.81	0.48	7.29e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs3540	0.554	rs12443252	chr15:91064690	C/T	cg22089800	chr15:90895588	ZNF774	-0.68	-4.92	-0.49	4.64e-6	Allergic disease (asthma, hay fever or eczema);Lymphocyte counts;
SKCM	cis	rs1799949	1.000	rs33994002	chr17:41328818	T/A	cg23758822	chr17:41437982	NA	0.93	7.87	0.67	1.66e-11	Menopause (age at onset);
SKCM	cis	rs2599510	0.744	rs2254106	chr2:32768797	G/A	cg02381751	chr2:32503542	YIPF4	0.78	6.31	0.58	1.54e-8	Interleukin-18 levels;
SKCM	cis	rs1850744	0.609	rs76304666	chr4:9590479	G/A	cg15442990	chr4:9534313	NA	-1.4	-5.12	-0.5	2.11e-6	Economic and political preferences;
SKCM	cis	rs16949788	1.000	rs16949788	chr15:66590037	T/C	cg08120210	chr15:66682733	MAP2K1	-0.73	-5.55	-0.53	3.77e-7	Spherical equivalent (joint analysis main effects and education interaction);
SKCM	cis	rs7772486	0.875	rs10457793	chr6:146415403	A/G	cg05347473	chr6:146136440	FBXO30	0.65	5.96	0.56	6.79e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs950027	0.620	rs1145076	chr15:45684508	G/T	cg21132104	chr15:45694354	SPATA5L1	0.76	5.84	0.55	1.13e-7	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs6952808	0.693	rs10950413	chr7:1912988	A/G	cg02951883	chr7:2050386	MAD1L1	-0.68	-5.69	-0.54	2.12e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs2439831	0.867	rs2255440	chr15:43830467	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.18	7.32	0.64	1.95e-10	Lung cancer in ever smokers;
SKCM	cis	rs13040088	0.935	rs62200158	chr20:61557906	C/T	cg23096297	chr20:61557774	DIDO1	0.79	6.27	0.58	1.88e-8	Menopause (age at onset);
SKCM	cis	rs7552404	0.765	rs1251078	chr1:76189488	C/G	cg10523679	chr1:76189770	ACADM	-0.83	-6.48	-0.59	7.42e-9	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs3020736	0.500	rs7292241	chr22:42492063	G/A	cg04733989	chr22:42467013	NAGA	-0.72	-5.62	-0.54	2.87e-7	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs4268898	0.571	rs1986478	chr2:24468545	G/A	cg06627628	chr2:24431161	ITSN2	-0.94	-7.34	-0.64	1.73e-10	Asthma;
SKCM	cis	rs11098499	0.731	rs9995026	chr4:120490499	T/A	cg09307838	chr4:120376055	NA	1.0	8.27	0.68	2.8e-12	Corneal astigmatism;
SKCM	cis	rs7809950	0.815	rs62482495	chr7:106965009	A/G	cg23024343	chr7:107201750	COG5	-0.82	-7.0	-0.62	7.72e-10	Coronary artery disease;
SKCM	cis	rs1552244	1.000	rs6793396	chr3:10110927	T/C	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs7777754	0.512	rs3757472	chr7:50537983	A/C	cg18232548	chr7:50535776	DDC	-0.92	-7.04	-0.62	6.47e-10	Response to zileuton treatment in asthma (FEV1 change interaction);
SKCM	cis	rs5750830	0.649	rs4821894	chr22:39809820	G/C	cg11247378	chr22:39784982	NA	-0.48	-5.54	-0.53	4.01e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs899997	0.906	rs1994018	chr15:79025584	G/A	cg04896959	chr15:78267971	NA	-0.6	-4.86	-0.48	5.93e-6	Coronary artery disease or large artery stroke;
SKCM	cis	rs75229567	0.618	rs11177853	chr12:70184924	A/G	cg10114359	chr12:70132523	RAB3IP	1.2	5.17	0.51	1.74e-6	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes;
SKCM	cis	rs17345786	0.520	rs12638134	chr3:101334609	G/T	cg12386194	chr3:101231763	SENP7	0.62	5.24	0.51	1.33e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs478304	0.651	rs4014192	chr11:65498915	C/T	cg27068330	chr11:65405492	SIPA1	-0.89	-8.21	-0.68	3.71e-12	Acne (severe);
SKCM	cis	rs7811142	1.000	rs73405353	chr7:100091215	G/A	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-1.02	-5.76	-0.55	1.59e-7	Platelet count;
SKCM	cis	rs9916302	0.706	rs4795358	chr17:37573065	A/C	cg07936489	chr17:37558343	FBXL20	-0.99	-6.94	-0.62	1e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs17345786	0.906	rs72946021	chr3:101250008	T/G	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.74	5.49	0.53	4.94e-7	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs12497850	0.865	rs7649458	chr3:48920127	C/T	cg07636037	chr3:49044803	WDR6	1.02	11.0	0.78	1.56e-17	Parkinson's disease;
SKCM	cis	rs10752881	1.000	rs10752887	chr1:182990834	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.65	0.6	3.65e-9	Colorectal cancer;
SKCM	cis	rs1707322	1.000	rs785506	chr1:46540652	C/T	cg03146154	chr1:46216737	IPP	-0.83	-5.56	-0.53	3.62e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs798554	0.757	rs960273	chr7:2857876	T/C	cg04166393	chr7:2884313	GNA12	0.72	5.11	0.5	2.27e-6	Height;
SKCM	cis	rs898097	0.567	rs8076119	chr17:80910061	A/G	cg15369054	chr17:80825471	TBCD	-0.58	-5.51	-0.53	4.37e-7	Breast cancer;
SKCM	cis	rs9325144	0.600	rs1825807	chr12:38737007	T/C	cg26384229	chr12:38710491	ALG10B	0.78	6.83	0.61	1.68e-9	Morning vs. evening chronotype;
SKCM	cis	rs2439831	1.000	rs561863	chr15:43761352	G/A	cg02155558	chr15:43621948	ADAL;LCMT2	1.21	7.96	0.67	1.1e-11	Lung cancer in ever smokers;
SKCM	cis	rs748404	0.697	rs498227	chr15:43573052	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	0.73	5.95	0.56	7.18e-8	Lung cancer;
SKCM	cis	rs2941509	1.000	rs2123685	chr17:38053889	T/C	cg12655416	chr17:38077870	ORMDL3	-0.5	-5.35	-0.52	8.58e-7	Systemic lupus erythematosus;
SKCM	cis	rs11690935	0.959	rs7604918	chr2:172588094	G/A	cg13550731	chr2:172543902	DYNC1I2	-0.95	-8.21	-0.68	3.64e-12	Schizophrenia;
SKCM	cis	rs501120	1.000	rs915083	chr10:44755406	T/G	cg09554077	chr10:44749378	NA	0.38	4.93	0.49	4.52e-6	Coronary artery disease;Coronary heart disease;
SKCM	cis	rs2075671	0.903	rs62482249	chr7:100262357	C/A	cg20848291	chr7:100343083	ZAN	-0.72	-5.55	-0.53	3.84e-7	Other erythrocyte phenotypes;
SKCM	cis	rs453301	0.686	rs1045527	chr8:8890041	A/G	cg06636001	chr8:8085503	FLJ10661	-0.73	-5.55	-0.53	3.74e-7	Joint mobility (Beighton score);
SKCM	cis	rs7524258	0.868	rs2412152	chr1:7303213	C/T	cg07173049	chr1:7289937	CAMTA1	0.42	4.85	0.48	6.16e-6	Tourette's syndrome or obsessive-compulsive disorder;
SKCM	cis	rs6089584	0.546	rs4925337	chr20:60637637	T/C	cg06108461	chr20:60628389	TAF4	-0.78	-7.4	-0.64	1.37e-10	Body mass index;
SKCM	cis	rs58688157	0.705	rs7943546	chr11:612148	T/C	cg16486109	chr11:613632	IRF7	1.06	7.08	0.63	5.43e-10	Systemic lupus erythematosus;
SKCM	cis	rs9913156	0.894	rs35741745	chr17:4620897	A/G	cg00122941	chr17:4613640	ARRB2	0.76	4.82	0.48	7.01e-6	Lymphocyte counts;
SKCM	cis	rs754466	0.957	rs61854183	chr10:79698077	T/C	cg17075019	chr10:79541650	NA	-0.64	-4.83	-0.48	6.56e-6	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs501120	1.000	rs501120	chr10:44753867	T/C	cg09554077	chr10:44749378	NA	0.38	4.93	0.49	4.52e-6	Coronary artery disease;Coronary heart disease;
SKCM	cis	rs7659604	0.539	rs7686084	chr4:122764725	A/C	cg06713675	chr4:122721982	EXOSC9	-0.75	-7.38	-0.64	1.48e-10	Type 2 diabetes;
SKCM	cis	rs4819052	0.679	rs4819053	chr21:46711357	C/T	cg19498844	chr21:46707878	POFUT2;LOC642852	-0.83	-6.91	-0.62	1.18e-9	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs9916302	0.851	rs11078906	chr17:37662767	C/T	cg07936489	chr17:37558343	FBXL20	-0.9	-8.1	-0.68	6.05e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs2013441	0.613	rs9901125	chr17:20008929	A/G	cg13482628	chr17:19912719	NA	0.7	5.24	0.51	1.31e-6	Obesity-related traits;
SKCM	cis	rs11098499	0.909	rs28668716	chr4:120309875	T/C	cg24375607	chr4:120327624	NA	0.65	4.97	0.49	3.87e-6	Corneal astigmatism;
SKCM	cis	rs8180040	0.577	rs12493425	chr3:47176946	T/G	cg27129171	chr3:47204927	SETD2	0.74	5.37	0.52	7.84e-7	Colorectal cancer;
SKCM	cis	rs8141529	0.764	rs5752809	chr22:29225500	G/A	cg02153584	chr22:29168773	CCDC117	0.62	5.02	0.49	3.15e-6	Lymphocyte counts;
SKCM	cis	rs9880211	1.000	rs12695649	chr3:136271916	T/C	cg21827317	chr3:136751795	NA	-0.65	-4.92	-0.49	4.73e-6	Body mass index;Height;
SKCM	cis	rs1577917	0.958	rs12215232	chr6:86785430	G/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.83	-8.15	-0.68	4.73e-12	Response to antipsychotic treatment;
SKCM	cis	rs60871478	0.898	rs4725241	chr7:796883	C/T	cg05535760	chr7:792225	HEATR2	1.02	8.66	0.7	4.97e-13	Cerebrospinal P-tau181p levels;
SKCM	trans	rs208520	0.690	rs12201219	chr6:66748862	A/T	cg15611600	chr13:45563400	KIAA1704;NUFIP1	0.92	7.47	0.65	9.89e-11	Exhaled nitric oxide output;
SKCM	cis	rs10504229	0.906	rs7842855	chr8:58167718	G/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.82	-0.48	7.06e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs6570726	0.791	rs436498	chr6:145876347	G/A	cg23711669	chr6:146136114	FBXO30	0.87	9.14	0.72	5.82e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6500602	0.647	rs4786514	chr16:4576798	A/C	cg08645402	chr16:4508243	NA	0.62	4.98	0.49	3.74e-6	Schizophrenia;
SKCM	cis	rs2652834	1.000	rs8032104	chr15:63400584	A/G	cg04194852	chr15:63334506	TPM1	0.76	4.78	0.48	8.15e-6	HDL cholesterol;
SKCM	cis	rs826838	1.000	rs826851	chr12:39112639	A/G	cg26384229	chr12:38710491	ALG10B	-0.94	-7.76	-0.66	2.69e-11	Heart rate;
SKCM	cis	rs593982	0.858	rs537385	chr11:65504900	G/A	cg08755490	chr11:65554678	OVOL1	1.06	10.75	0.77	4.73e-17	Atopic dermatitis;
SKCM	cis	rs1797081	0.542	rs2603796	chr10:16871456	C/T	cg23933602	chr10:16859644	RSU1	0.93	8.55	0.7	8.12e-13	Platelet distribution width;
SKCM	cis	rs9309711	0.623	rs7569694	chr2:3483390	T/G	cg15506890	chr2:3487001	NA	-0.62	-5.04	-0.5	2.89e-6	Neurofibrillary tangles;
SKCM	trans	rs1814175	0.817	rs10769613	chr11:49769692	G/A	cg15704280	chr7:45808275	SEPT13	-1.03	-10.73	-0.77	5.17e-17	Height;
SKCM	cis	rs854765	0.718	rs12943500	chr17:17790588	C/T	cg04398451	chr17:18023971	MYO15A	0.71	4.81	0.48	7.2e-6	Total body bone mineral density;
SKCM	cis	rs6598955	0.724	rs884533	chr1:26585657	G/T	cg04990556	chr1:26633338	UBXN11	-0.6	-4.82	-0.48	6.93e-6	Obesity-related traits;
SKCM	cis	rs67311347	0.544	rs2278929	chr3:40351008	C/G	cg00091569	chr3:40428383	ENTPD3	-0.64	-5.45	-0.52	5.81e-7	Renal cell carcinoma;
SKCM	trans	rs1814175	0.754	rs10219245	chr11:49645052	C/T	cg03929089	chr4:120376271	NA	-0.9	-8.24	-0.68	3.23e-12	Height;
SKCM	cis	rs644799	0.965	rs10831425	chr11:95500628	T/C	cg25622487	chr11:95524042	FAM76B;CEP57	0.72	5.82	0.55	1.26e-7	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs7772486	0.875	rs2777484	chr6:146334162	A/G	cg23711669	chr6:146136114	FBXO30	0.77	7.16	0.63	3.9e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs362272	0.505	rs13104157	chr4:3366950	T/C	cg24015175	chr4:3319247	RGS12	0.83	10.34	0.76	2.77e-16	Serum sulfate level;
SKCM	cis	rs11252926	0.565	rs60553947	chr10:474284	T/C	cg18196295	chr10:418757	DIP2C	-0.69	-5.83	-0.55	1.2e-7	Psychosis in Alzheimer's disease;
SKCM	cis	rs9914544	0.933	rs11871889	chr17:18771425	T/C	cg26378065	chr17:18585709	ZNF286B	0.71	4.8	0.48	7.54e-6	Educational attainment (years of education);
SKCM	cis	rs7809950	1.000	rs7809950	chr7:107237807	T/C	cg23024343	chr7:107201750	COG5	0.83	7.64	0.65	4.65e-11	Coronary artery disease;
SKCM	cis	rs769267	0.930	rs3794993	chr19:19611550	G/T	cg26732615	chr19:19648335	CILP2;YJEFN3	0.67	7.06	0.62	6e-10	Tonsillectomy;
SKCM	cis	rs1348850	0.567	rs7605609	chr2:178534942	C/G	cg22681709	chr2:178499509	PDE11A	-0.69	-6.21	-0.57	2.44e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs362296	0.698	rs362289	chr4:3256378	G/A	cg21096898	chr4:3318625	RGS12	-0.87	-7.92	-0.67	1.35e-11	Parental longevity (mother's age at death);
SKCM	cis	rs7635838	0.687	rs7625495	chr3:11377918	G/T	cg00170343	chr3:11313890	ATG7	0.7	5.54	0.53	3.93e-7	HDL cholesterol;
SKCM	cis	rs1957429	0.901	rs1957435	chr14:65349697	G/A	cg23373153	chr14:65346875	NA	1.11	6.32	0.58	1.52e-8	Pediatric areal bone mineral density (radius);
SKCM	cis	rs28386778	0.897	rs2854221	chr17:61941445	G/T	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.36	0.52	8.37e-7	Prudent dietary pattern;
SKCM	cis	rs7216064	0.953	rs75231441	chr17:65885485	A/G	cg12091567	chr17:66097778	LOC651250	-0.75	-5.27	-0.51	1.19e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs7811142	1.000	rs7811142	chr7:100065443	A/T	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.23	7.89	0.67	1.53e-11	Platelet count;
SKCM	cis	rs10883723	0.810	rs7079810	chr10:104243883	C/T	cg11453585	chr10:104263688	ACTR1A;SUFU	0.73	5.4	0.52	6.85e-7	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs2991971	0.967	rs6661321	chr1:45954599	C/G	cg24296786	chr1:45957014	TESK2	0.69	5.65	0.54	2.47e-7	High light scatter reticulocyte count;
SKCM	cis	rs1865760	0.622	rs9968910	chr6:26072095	A/C	cg16482183	chr6:26056742	HIST1H1C	0.67	5.45	0.53	5.68e-7	Height;
SKCM	cis	rs2721195	0.967	rs748195	chr8:145682514	T/C	cg17328964	chr8:145687451	CYHR1	-0.73	-6.58	-0.6	4.98e-9	Age at first birth;
SKCM	cis	rs778371	0.649	rs13021823	chr2:233686862	A/G	cg08000102	chr2:233561755	GIGYF2	-0.8	-6.38	-0.59	1.17e-8	Schizophrenia;
SKCM	cis	rs7613875	0.600	rs2624826	chr3:50155468	T/G	cg24110177	chr3:50126178	RBM5	0.73	5.81	0.55	1.28e-7	Body mass index;
SKCM	cis	rs6951245	1.000	rs79617366	chr7:1111958	G/C	cg18402987	chr7:1209562	NA	1.15	6.09	0.57	3.95e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs2952156	0.920	rs14050	chr17:37828072	C/T	cg20243544	chr17:37824526	PNMT	0.74	5.59	0.53	3.2e-7	Asthma;
SKCM	cis	rs644799	1.000	rs509720	chr11:95562771	T/C	cg03916912	chr11:95522834	CEP57;FAM76B	0.88	7.53	0.65	7.59e-11	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs208520	0.821	rs9363572	chr6:67012231	C/T	cg07460842	chr6:66804631	NA	0.82	5.43	0.52	6.08e-7	Exhaled nitric oxide output;
SKCM	cis	rs17345786	0.906	rs11710016	chr3:101120030	A/C	cg12386194	chr3:101231763	SENP7	-0.78	-6.15	-0.57	3.06e-8	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6840360	0.593	rs867800	chr4:152691470	T/C	cg22705602	chr4:152727874	NA	-0.59	-7.93	-0.67	1.3e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs7618915	0.547	rs4130905	chr3:52709831	A/T	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs2439831	0.681	rs484029	chr15:43619560	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.2	8.73	0.7	3.66e-13	Lung cancer in ever smokers;
SKCM	cis	rs12142240	0.698	rs6667861	chr1:46815749	T/C	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs5769765	1.000	rs5770742	chr22:50270309	T/C	cg22709217	chr22:50311962	ALG12;CRELD2	0.79	5.71	0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs6580649	0.941	rs726354	chr12:48500334	G/A	cg05342945	chr12:48394962	COL2A1	0.8	5.44	0.52	5.98e-7	Lung cancer;
SKCM	trans	rs2727020	0.553	rs3907576	chr11:49536639	A/C	cg15704280	chr7:45808275	SEPT13	-0.95	-8.53	-0.69	8.99e-13	Coronary artery disease;
SKCM	cis	rs4803468	0.934	rs11880674	chr19:41889423	A/T	cg14132834	chr19:41945861	ATP5SL	-0.72	-5.38	-0.52	7.65e-7	Height;
SKCM	cis	rs2224391	1.000	rs9504370	chr6:5261601	T/C	cg09085698	chr6:5261316	LYRM4;FARS2	-0.75	-5.33	-0.52	9.43e-7	Height;
SKCM	cis	rs1005277	0.579	rs1740747	chr10:38520465	G/A	cg00409905	chr10:38381863	ZNF37A	-0.62	-5.82	-0.55	1.24e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs7918232	0.574	rs10458708	chr10:27455605	C/T	cg14442939	chr10:27389572	ANKRD26	0.78	6.26	0.58	1.95e-8	Breast cancer;
SKCM	cis	rs7809950	1.000	rs67982599	chr7:107100104	T/G	cg23024343	chr7:107201750	COG5	-0.74	-6.61	-0.6	4.39e-9	Coronary artery disease;
SKCM	cis	rs2153535	0.542	rs9393012	chr6:8439809	G/A	cg07606381	chr6:8435919	SLC35B3	0.94	6.94	0.62	1.02e-9	Motion sickness;
SKCM	cis	rs7647973	0.516	rs4499638	chr3:49202782	C/G	cg06212747	chr3:49208901	KLHDC8B	0.79	5.62	0.54	2.87e-7	Menarche (age at onset);
SKCM	cis	rs7659604	0.702	rs58649165	chr4:122693752	C/A	cg19748678	chr4:122722346	EXOSC9	0.67	5.72	0.54	1.88e-7	Type 2 diabetes;
SKCM	trans	rs7618501	1.000	rs60205400	chr3:49800272	C/T	cg21659725	chr3:3221576	CRBN	0.96	9.61	0.74	7.08e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs763014	0.898	rs2384978	chr16:625384	T/C	cg07343612	chr16:622815	PIGQ	-0.69	-5.73	-0.54	1.84e-7	Height;
SKCM	cis	rs7824557	0.737	rs2293855	chr8:11177410	G/A	cg21775007	chr8:11205619	TDH	0.7	5.93	0.56	7.85e-8	Retinal vascular caliber;
SKCM	cis	rs72634258	0.554	rs4562654	chr1:7934423	A/T	cg00042356	chr1:8021962	PARK7	0.86	6.01	0.56	5.55e-8	Inflammatory bowel disease;
SKCM	cis	rs12142240	0.698	rs67200518	chr1:46835777	T/C	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs10492096	1.000	rs12422771	chr12:6580273	G/T	cg13857086	chr12:6580257	VAMP1	0.97	7.41	0.64	1.3100000000000001e-10	Hip geometry;
SKCM	cis	rs6121246	0.954	rs6060989	chr20:30429763	C/T	cg11595048	chr20:30225325	COX4I2	0.65	5.03	0.49	3.1e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs9611565	0.729	rs4822027	chr22:41786227	G/A	cg03806693	chr22:41940476	POLR3H	-0.99	-6.37	-0.58	1.23e-8	Vitiligo;
SKCM	cis	rs2153535	0.580	rs7743995	chr6:8496212	A/G	cg07606381	chr6:8435919	SLC35B3	0.85	6.21	0.58	2.39e-8	Motion sickness;
SKCM	cis	rs1692580	0.777	rs10910037	chr1:2184280	T/C	cg24578937	chr1:2090814	PRKCZ	0.45	4.86	0.48	6.06e-6	Coronary artery disease;
SKCM	cis	rs2739330	0.731	rs2000468	chr22:24241611	G/T	cg24846343	chr22:24311635	DDTL	0.57	5.2	0.51	1.54e-6	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs7772486	0.790	rs9386141	chr6:146268623	T/A	cg05347473	chr6:146136440	FBXO30	-0.55	-4.97	-0.49	3.86e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs62238980	0.614	rs56199077	chr22:32436213	T/C	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs7772486	0.875	rs2207785	chr6:146332784	T/G	cg23711669	chr6:146136114	FBXO30	0.76	7.15	0.63	4.1e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs870825	0.616	rs2130394	chr4:185642577	C/A	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs2243480	1.000	rs387676	chr7:65598220	C/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs1577917	1.000	rs12207610	chr6:86688016	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.83	-8.23	-0.68	3.37e-12	Response to antipsychotic treatment;
SKCM	cis	rs55962025	0.686	rs362314	chr4:3235241	A/G	cg21096898	chr4:3318625	RGS12	-0.61	-5.07	-0.5	2.57e-6	Parental longevity (mother's age at death);
SKCM	cis	rs738321	0.756	rs4821740	chr22:38514423	C/G	cg25457927	chr22:38595422	NA	-0.51	-5.73	-0.54	1.83e-7	Breast cancer;
SKCM	cis	rs7216064	0.655	rs8078543	chr17:66037251	G/T	cg12091567	chr17:66097778	LOC651250	0.89	6.71	0.6	2.8e-9	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs7666738	0.830	rs2865981	chr4:99031493	G/A	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1577917	0.761	rs117452258	chr6:86554211	G/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.81	-7.82	-0.66	2.07e-11	Response to antipsychotic treatment;
SKCM	cis	rs12497850	0.931	rs1134591	chr3:48972892	C/T	cg06212747	chr3:49208901	KLHDC8B	0.7	5.24	0.51	1.35e-6	Parkinson's disease;
SKCM	cis	rs11718455	0.883	rs2372579	chr3:44034003	A/T	cg21419209	chr3:44054225	NA	-0.66	-5.22	-0.51	1.42e-6	Coronary artery disease;
SKCM	cis	rs17685	0.633	rs3801471	chr7:75696188	T/G	cg16684958	chr7:75615977	POR	0.58	5.52	0.53	4.24e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs6866344	0.697	rs11749438	chr5:178131245	C/T	cg10224037	chr5:178157518	ZNF354A	0.76	5.31	0.52	1.01e-6	Neutrophil percentage of white cells;
SKCM	cis	rs28735056	0.508	rs67651675	chr18:77673562	A/G	cg20368463	chr18:77673604	PQLC1	-0.84	-7.75	-0.66	2.8e-11	Schizophrenia;
SKCM	cis	rs28595532	1.000	rs115706377	chr4:119628481	G/A	cg14228332	chr4:119757509	SEC24D	0.97	4.92	0.49	4.71e-6	Cannabis dependence symptom count;
SKCM	cis	rs6547631	0.622	rs1561285	chr2:85924384	C/G	cg24620635	chr2:85921963	GNLY	0.9	6.65	0.6	3.58e-9	Blood protein levels;
SKCM	cis	rs9916302	0.752	rs8071300	chr17:37508524	G/C	cg07936489	chr17:37558343	FBXL20	0.98	6.84	0.61	1.56e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs2033711	0.870	rs11669741	chr19:58960481	C/T	cg26874164	chr19:58962979	ZNF324B	-0.62	-5.11	-0.5	2.28e-6	Uric acid clearance;
SKCM	cis	rs116095464	0.558	rs7708515	chr5:234989	C/G	cg22496380	chr5:211416	CCDC127	-0.88	-5.11	-0.5	2.2e-6	Breast cancer;
SKCM	cis	rs12950390	0.814	rs4794099	chr17:45838358	T/C	cg03474202	chr17:45855739	NA	-0.49	-5.6	-0.54	3.04e-7	IgG glycosylation;
SKCM	cis	rs2346177	0.519	rs2121698	chr2:46709571	C/T	cg02822958	chr2:46747628	ATP6V1E2	0.76	5.58	0.53	3.38e-7	HDL cholesterol;
SKCM	cis	rs1046896	0.594	rs67813226	chr17:80851134	G/A	cg02711726	chr17:80685570	FN3KRP	-0.77	-6.05	-0.56	4.82e-8	Glycated hemoglobin levels;
SKCM	cis	rs603446	0.967	rs3741301	chr11:116631391	T/C	cg23900293	chr11:115924505	NA	-0.44	-4.8	-0.48	7.51e-6	Triglycerides;
SKCM	cis	rs4975616	0.869	rs465498	chr5:1325803	A/G	cg06550200	chr5:1325588	CLPTM1L	-0.86	-7.74	-0.66	2.94e-11	Lung cancer;
SKCM	cis	rs10540	1.000	rs35068485	chr11:466032	A/T	cg03352830	chr11:487213	PTDSS2	0.96	4.77	0.48	8.46e-6	Body mass index;
SKCM	cis	rs36093844	0.642	rs17148585	chr11:85620823	C/T	cg02149136	chr11:85995039	NA	0.65	5.01	0.49	3.38e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs11098499	0.863	rs10019674	chr4:120443489	C/T	cg24375607	chr4:120327624	NA	-0.65	-5.02	-0.49	3.19e-6	Corneal astigmatism;
SKCM	cis	rs769267	0.965	rs2074303	chr19:19381755	C/T	cg26732615	chr19:19648335	CILP2;YJEFN3	0.62	5.67	0.54	2.31e-7	Tonsillectomy;
SKCM	cis	rs672059	1.000	rs546183	chr1:183157753	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.63	5.23	0.51	1.38e-6	Hypertriglyceridemia;
SKCM	cis	rs8042680	0.554	rs59902579	chr15:91515489	C/T	cg15878949	chr15:91534302	PRC1	0.61	5.08	0.5	2.53e-6	Type 2 diabetes;
SKCM	cis	rs11098499	0.789	rs9991166	chr4:120237851	G/A	cg09307838	chr4:120376055	NA	0.93	7.56	0.65	6.5500000000000006e-11	Corneal astigmatism;
SKCM	cis	rs9911578	0.967	rs72628392	chr17:56506160	A/G	cg12560992	chr17:57184187	TRIM37	-0.9	-7.03	-0.62	6.99e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs2354432	0.556	rs7525622	chr1:146774116	G/A	cg25205988	chr1:146714368	CHD1L	-1.19	-6.56	-0.6	5.24e-9	Mitochondrial DNA levels;
SKCM	cis	rs910316	0.967	rs11159116	chr14:75550584	G/T	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.89e-7	Height;
SKCM	cis	rs17685	0.725	rs6467993	chr7:75719350	G/A	cg16489192	chr7:75678113	MDH2;STYXL1	-0.58	-5.46	-0.53	5.43e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1325195	0.537	rs4651014	chr1:179073039	C/G	cg25467746	chr1:179556597	NA	-0.67	-6.12	-0.57	3.45e-8	IgE grass sensitization;
SKCM	cis	rs9913156	0.841	rs56239958	chr17:4600280	G/C	cg19197139	chr17:4613644	ARRB2	0.8	5.34	0.52	8.82e-7	Lymphocyte counts;
SKCM	cis	rs17685	0.884	rs3823882	chr7:75631913	T/C	cg16489192	chr7:75678113	MDH2;STYXL1	0.62	5.54	0.53	3.99e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7208859	0.623	rs7212991	chr17:29143749	T/C	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs2463822	0.925	rs74692811	chr11:62156572	G/A	cg06239285	chr11:62104954	ASRGL1	-1.26	-5.85	-0.55	1.08e-7	Chronic obstructive pulmonary disease-related biomarkers;
SKCM	cis	rs7666738	0.830	rs62318906	chr4:99037110	C/T	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11608355	0.521	rs6606703	chr12:109813665	C/T	cg19025524	chr12:109796872	NA	-0.68	-6.16	-0.57	2.91e-8	Neuroticism;
SKCM	cis	rs12142240	0.660	rs6679080	chr1:46819779	A/T	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs7811142	0.779	rs28680963	chr7:99905475	C/G	cg00814883	chr7:100076585	TSC22D4	-0.84	-4.78	-0.48	8.01e-6	Platelet count;
SKCM	cis	rs67460515	0.563	rs11717272	chr3:160810355	A/G	cg03342759	chr3:160939853	NMD3	-0.68	-5.86	-0.55	1.04e-7	Parkinson's disease;
SKCM	cis	rs9543976	1.000	rs9573592	chr13:76197843	G/A	cg16409306	chr13:76195284	LMO7	-0.84	-4.79	-0.48	7.87e-6	Diabetic retinopathy;
SKCM	cis	rs2153535	0.580	rs9378551	chr6:8463744	A/G	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs9911578	1.000	rs654778	chr17:56736473	A/C	cg12560992	chr17:57184187	TRIM37	0.95	7.69	0.66	3.7e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs11646917	0.578	rs11649001	chr16:51444271	T/C	cg01194320	chr16:50493166	NA	-0.58	-4.83	-0.48	6.72e-6	Optic cup area;
SKCM	cis	rs600231	0.623	rs587080	chr11:65253800	A/C	cg24009118	chr11:65545808	DKFZp761E198	0.66	4.94	0.49	4.36e-6	Bone mineral density;
SKCM	cis	rs28595532	0.920	rs113034745	chr4:119750044	T/C	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs9399135	0.967	rs9402676	chr6:135355507	C/T	cg24558204	chr6:135376177	HBS1L	0.6	5.36	0.52	8.17e-7	Red blood cell count;
SKCM	cis	rs10946507	0.687	rs9393227	chr6:22100912	G/A	cg06057918	chr6:22070094	FLJ22536	0.6	4.83	0.48	6.66e-6	Spherical equivalent (joint analysis main effects and education interaction);
SKCM	cis	rs2070488	0.804	rs13059256	chr3:38504315	T/C	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.74	5.96	0.56	6.8e-8	Electrocardiographic conduction measures;
SKCM	cis	rs9420	0.961	rs12804972	chr11:57463767	T/C	cg19752551	chr11:57585705	CTNND1	-0.7	-6.97	-0.62	9.17e-10	Schizophrenia;
SKCM	cis	rs11626933	1.000	rs11626933	chr14:90754311	A/G	cg14092571	chr14:90743983	NA	-0.87	-7.88	-0.67	1.6e-11	Gut microbiota (bacterial taxa);
SKCM	cis	rs873946	0.564	rs12772704	chr10:134557318	G/A	cg27286337	chr10:134555280	INPP5A	0.96	8.42	0.69	1.47e-12	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs28595532	0.920	rs114789346	chr4:119748652	G/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs644799	0.562	rs671320	chr11:95578780	G/T	cg03916912	chr11:95522834	CEP57;FAM76B	0.63	4.91	0.49	4.9e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs9393692	0.905	rs1124999	chr6:26287043	G/T	cg00631329	chr6:26305371	NA	-0.67	-4.77	-0.47	8.51e-6	Educational attainment;
SKCM	cis	rs7659604	0.689	rs59131059	chr4:122666357	C/T	cg06713675	chr4:122721982	EXOSC9	-0.64	-5.68	-0.54	2.24e-7	Type 2 diabetes;
SKCM	cis	rs7772486	0.875	rs1929523	chr6:146339989	T/A	cg23711669	chr6:146136114	FBXO30	0.76	7.15	0.63	4.1e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2479724	0.901	rs1051130	chr6:41903782	A/C	cg17623882	chr6:41773611	USP49	-0.72	-5.8	-0.55	1.36e-7	Menarche (age at onset);
SKCM	cis	rs7208859	0.623	rs9899692	chr17:29156939	C/T	cg13385521	chr17:29058706	SUZ12P	0.9	4.78	0.48	8.1e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs736408	0.677	rs2286798	chr3:52821177	G/T	cg18404041	chr3:52824283	ITIH1	0.55	4.83	0.48	6.62e-6	Bipolar disorder;
SKCM	cis	rs2439831	0.850	rs2277531	chr15:44069069	G/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.34	7.45	0.64	1.11e-10	Lung cancer in ever smokers;
SKCM	cis	rs6977660	0.660	rs7357202	chr7:19817911	T/A	cg07541023	chr7:19748670	TWISTNB	0.72	4.78	0.48	7.95e-6	Thyroid stimulating hormone;
SKCM	cis	rs1799949	1.000	rs4793212	chr17:41302750	T/C	cg05368731	chr17:41323189	NBR1	0.89	7.91	0.67	1.38e-11	Menopause (age at onset);
SKCM	cis	rs8072100	0.713	rs4968257	chr17:45430534	A/G	cg08085267	chr17:45401833	C17orf57	-0.7	-5.58	-0.53	3.33e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs1405130	0.727	rs4233610	chr2:235573045	G/A	cg21542780	chr2:234763377	HJURP	-0.64	-4.89	-0.48	5.21e-6	Coronary artery disease;
SKCM	cis	rs2072499	0.865	rs2758608	chr1:156202860	A/T	cg25208724	chr1:156163844	SLC25A44	0.91	7.9	0.67	1.46e-11	Testicular germ cell tumor;
SKCM	cis	rs17685	0.712	rs7778735	chr7:75770237	T/C	cg01364799	chr7:75623366	TMEM120A	-0.7	-5.69	-0.54	2.09e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs684232	0.931	rs410157	chr17:598240	T/C	cg12384639	chr17:618140	VPS53	0.66	4.96	0.49	4.05e-6	Prostate cancer;
SKCM	cis	rs12586317	0.620	rs17103042	chr14:35575428	T/C	cg16230307	chr14:35515116	FAM177A1	0.7	5.12	0.5	2.16e-6	Psoriasis;
SKCM	cis	rs1005277	0.522	rs7090858	chr10:38003670	A/C	cg25427524	chr10:38739819	LOC399744	0.64	6.35	0.58	1.3e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs34779708	0.966	rs12260130	chr10:35467671	C/T	cg03585969	chr10:35415529	CREM	0.76	6.27	0.58	1.83e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs7523050	0.730	rs12729728	chr1:109431110	C/A	cg08274380	chr1:109419600	GPSM2	1.15	6.57	0.6	5.22e-9	Fat distribution (HIV);
SKCM	cis	rs9388451	0.772	rs1268064	chr6:126042578	G/A	cg05901451	chr6:126070800	HEY2	0.77	7.22	0.63	2.96e-10	Brugada syndrome;
SKCM	cis	rs28386778	0.863	rs7221573	chr17:61859390	G/A	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs11252926	0.574	rs4881254	chr10:453567	C/T	cg18196295	chr10:418757	DIP2C	0.67	5.68	0.54	2.18e-7	Psychosis in Alzheimer's disease;
SKCM	cis	rs11098499	0.754	rs28643450	chr4:120245242	G/A	cg09307838	chr4:120376055	NA	0.93	7.56	0.65	6.5500000000000006e-11	Corneal astigmatism;
SKCM	cis	rs875971	0.862	rs778736	chr7:65813848	C/T	cg18876405	chr7:65276391	NA	0.63	6.39	0.59	1.12e-8	Aortic root size;
SKCM	cis	rs9543976	1.000	rs3818355	chr13:76196867	C/T	cg16409306	chr13:76195284	LMO7	0.84	4.79	0.48	7.87e-6	Diabetic retinopathy;
SKCM	cis	rs477895	1.000	rs7938380	chr11:64034866	G/A	cg02228329	chr11:64053129	BAD;GPR137	-1.16	-5.29	-0.51	1.08e-6	Mean platelet volume;
SKCM	cis	rs2033711	0.837	rs3764535	chr19:58929052	G/A	cg12042659	chr19:58951599	ZNF132	0.68	5.87	0.55	1.01e-7	Uric acid clearance;
SKCM	cis	rs9611565	0.765	rs132909	chr22:41802031	G/A	cg03806693	chr22:41940476	POLR3H	1.02	6.92	0.62	1.13e-9	Vitiligo;
SKCM	cis	rs344364	0.529	rs186941	chr16:1930088	T/C	cg26897989	chr16:1907736	C16orf73	0.68	7.18	0.63	3.5e-10	Glomerular filtration rate in chronic kidney disease;
SKCM	cis	rs7666738	0.830	rs7664340	chr4:99037820	C/T	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs35306767	0.761	rs11253560	chr10:1047226	T/G	cg26597838	chr10:835615	NA	0.64	5.23	0.51	1.38e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs9581857	0.685	rs10467687	chr13:28036516	G/A	cg22138327	chr13:27999177	GTF3A	0.93	6.24	0.58	2.1e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs6582630	0.555	rs10880612	chr12:38509427	A/G	cg26384229	chr12:38710491	ALG10B	0.79	6.11	0.57	3.66e-8	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs10207060	0.500	rs72992164	chr2:240711780	G/A	cg07506560	chr2:240697449	NA	0.75	6.1	0.57	3.8e-8	Obesity-related traits;
SKCM	cis	rs17711722	0.701	rs4467826	chr7:65368708	A/G	cg11987759	chr7:65425863	GUSB	-0.75	-6.42	-0.59	9.94e-9	Calcium levels;
SKCM	cis	rs72792276	1.000	rs56657382	chr5:127387338	G/A	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.74	5.01	0.49	3.33e-6	Red cell distribution width;
SKCM	cis	rs2075371	1.000	rs7486	chr7:133975183	A/G	cg20476274	chr7:133979776	SLC35B4	1.03	10.5	0.77	1.4e-16	Mean platelet volume;
SKCM	cis	rs72772090	0.710	rs10515244	chr5:96078337	C/G	cg17330273	chr5:96107758	CAST;ERAP1	-0.84	-5.14	-0.5	1.96e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs17376456	0.825	rs10038831	chr5:93124115	C/T	cg21475434	chr5:93447410	FAM172A	0.9	4.99	0.49	3.65e-6	Diabetic retinopathy;
SKCM	cis	rs6952808	0.789	rs35729895	chr7:1885069	C/T	cg04267008	chr7:1944627	MAD1L1	-0.81	-6.06	-0.57	4.49e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs6430585	0.528	rs6743537	chr2:136702601	C/T	cg07169764	chr2:136633963	MCM6	1.27	10.36	0.76	2.57e-16	Corneal structure;
SKCM	cis	rs72615157	0.613	rs56089143	chr7:99819844	G/A	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.08	6.51	0.59	6.7e-9	Lung function (FEV1/FVC);
SKCM	cis	rs8070624	0.574	rs9914127	chr17:17875836	A/T	cg04398451	chr17:18023971	MYO15A	-0.91	-6.7	-0.6	2.96e-9	Total body bone mineral density;
SKCM	cis	rs66573146	0.803	rs59742225	chr4:6969942	C/T	cg00086871	chr4:6988644	TBC1D14	1.43	5.33	0.52	9.25e-7	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs8077889	1.000	rs17674998	chr17:41879544	A/G	cg26893861	chr17:41843967	DUSP3	1.11	7.49	0.65	9.21e-11	Triglycerides;
SKCM	cis	rs7666738	0.830	rs28810677	chr4:99043193	C/T	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs12048904	0.619	rs3737581	chr1:101341083	A/G	cg00063077	chr1:101360652	SLC30A7;EXTL2	0.86	6.4	0.59	1.04e-8	Multiple sclerosis;
SKCM	cis	rs1325195	0.537	rs3818433	chr1:179079190	C/T	cg10806749	chr1:179558114	NA	0.59	5.59	0.53	3.21e-7	IgE grass sensitization;
SKCM	cis	rs2153535	0.580	rs9393023	chr6:8469994	T/G	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs10256972	0.577	rs6962809	chr7:1208889	A/G	cg09177884	chr7:1199841	ZFAND2A	-0.75	-6.1	-0.57	3.75e-8	Longevity;Endometriosis;
SKCM	cis	rs1153858	1.000	rs4627277	chr15:45652768	C/A	cg10760299	chr15:45669010	GATM	0.62	6.35	0.58	1.3e-8	Homoarginine levels;
SKCM	trans	rs7618501	1.000	rs11716575	chr3:49744890	A/G	cg21659725	chr3:3221576	CRBN	-0.97	-9.69	-0.74	4.96e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs4819052	0.851	rs2236446	chr21:46678985	T/C	cg19498844	chr21:46707878	POFUT2;LOC642852	0.88	7.69	0.66	3.74e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs6840360	0.593	rs6855883	chr4:152688997	A/G	cg22705602	chr4:152727874	NA	-0.59	-7.95	-0.67	1.19e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs7191439	0.728	rs4238687	chr16:88788903	T/G	cg02389323	chr16:88786976	FAM38A	1.24	5.42	0.52	6.31e-7	Plateletcrit;
SKCM	cis	rs2731664	0.792	rs335420	chr5:176898619	C/T	cg23176889	chr5:176863531	GRK6	0.51	5.21	0.51	1.52e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs826838	0.935	rs1843639	chr12:39178919	C/A	cg26384229	chr12:38710491	ALG10B	0.92	8.39	0.69	1.67e-12	Heart rate;
SKCM	cis	rs10193935	0.901	rs59890734	chr2:42595662	G/A	cg27598129	chr2:42591480	NA	-0.88	-6.71	-0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs12477438	0.520	rs1044575	chr2:99812070	G/A	cg14399236	chr2:99771627	LIPT1;TSGA10	0.92	7.99	0.67	9.76e-12	Chronic sinus infection;
SKCM	cis	rs7811142	1.000	rs4463351	chr7:100078226	G/A	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.12	6.51	0.59	6.68e-9	Platelet count;
SKCM	cis	rs67460515	0.926	rs13062740	chr3:161024208	G/A	cg03342759	chr3:160939853	NMD3	-0.81	-7.1	-0.63	5.14e-10	Parkinson's disease;
SKCM	cis	rs2303759	0.709	rs2278405	chr19:49812403	A/C	cg05022225	chr19:49866942	DKKL1;TEAD2	-0.68	-4.98	-0.49	3.71e-6	Multiple sclerosis;
SKCM	trans	rs1814175	0.645	rs1721995	chr11:49915488	A/G	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs4654899	0.758	rs1609558	chr1:21525228	C/T	cg01072550	chr1:21505969	NA	0.64	4.88	0.48	5.58e-6	Superior frontal gyrus grey matter volume;
SKCM	cis	rs28595532	0.841	rs114965278	chr4:119743694	T/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs2811415	0.597	rs56211835	chr3:127803232	C/T	cg09089421	chr3:127803668	RUVBL1	1.0	8.69	0.7	4.4e-13	Lung function (FEV1/FVC);
SKCM	cis	rs1577917	0.958	rs2121594	chr6:86576854	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.87	-8.85	-0.71	2.15e-13	Response to antipsychotic treatment;
SKCM	cis	rs992157	0.560	rs7578940	chr2:219083318	G/T	cg20019365	chr2:219134978	PNKD;AAMP	-0.66	-5.52	-0.53	4.37e-7	Colorectal cancer;
SKCM	cis	rs116095464	0.558	rs9312979	chr5:222057	A/C	cg22857025	chr5:266934	NA	-1.44	-7.74	-0.66	2.94e-11	Breast cancer;
SKCM	cis	rs1552244	0.766	rs34232505	chr3:10186216	T/A	cg02579736	chr3:10068473	FANCD2;CIDECP	1.21	6.76	0.61	2.21e-9	Alzheimer's disease;
SKCM	cis	rs7020830	0.571	rs7031314	chr9:37376122	A/T	cg14294708	chr9:37120828	ZCCHC7	-0.86	-5.91	-0.56	8.67e-8	Schizophrenia;
SKCM	cis	rs2479724	0.840	rs10498752	chr6:41768510	T/C	cg17623882	chr6:41773611	USP49	0.81	7.17	0.63	3.8e-10	Menarche (age at onset);
SKCM	cis	rs1707322	1.000	rs6682683	chr1:46342337	A/G	cg03146154	chr1:46216737	IPP	0.75	5.15	0.5	1.94e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs9790314	0.521	rs13084746	chr3:161086038	G/A	cg03342759	chr3:160939853	NMD3	-0.79	-6.79	-0.61	1.97e-9	Morning vs. evening chronotype;
SKCM	cis	rs7829975	0.714	rs4841042	chr8:8664622	A/G	cg15556689	chr8:8085844	FLJ10661	-0.69	-5.96	-0.56	6.88e-8	Mood instability;
SKCM	cis	rs561341	0.882	rs28649357	chr17:30367190	A/G	cg23018236	chr17:30244563	NA	-0.53	-5.45	-0.53	5.66e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs7789940	0.904	rs56919252	chr7:75937520	T/C	cg10167463	chr7:75959203	YWHAG	-0.65	-4.95	-0.49	4.13e-6	Multiple sclerosis;
SKCM	cis	rs8060686	0.641	rs7201742	chr16:68099821	T/G	cg09117114	chr16:67998030	SLC12A4	-0.81	-5.29	-0.51	1.07e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs753778	0.602	rs9792	chr8:142205237	C/T	cg18755752	chr8:142205143	DENND3	0.66	5.63	0.54	2.78e-7	Reticulocyte fraction of red cells;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs875971	0.660	rs801217	chr7:66010577	C/T	cg00343986	chr7:65444356	GUSB	-0.7	-5.14	-0.5	1.98e-6	Aortic root size;
SKCM	cis	rs4555082	0.874	rs2816612	chr14:105723103	C/T	cg13114125	chr14:105738426	BRF1	-0.69	-5.47	-0.53	5.33e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs6062302	0.522	rs13043255	chr20:62218916	C/G	cg09650180	chr20:62225654	GMEB2	-0.82	-6.36	-0.58	1.25e-8	Glioblastoma;
SKCM	cis	rs10155981	0.510	rs4722159	chr7:22584279	C/G	cg05062323	chr7:22590069	NA	-1.0	-6.04	-0.56	4.9e-8	Bilirubin levels;
SKCM	cis	rs4727027	0.933	rs28767030	chr7:148825918	T/G	cg23583168	chr7:148888333	NA	-0.82	-6.56	-0.6	5.29e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs947211	0.898	rs10900524	chr1:205748309	G/A	cg07157834	chr1:205819609	PM20D1	0.7	5.08	0.5	2.47e-6	Parkinson's disease;
SKCM	cis	rs694739	0.734	rs663743	chr11:64107735	G/A	cg23796481	chr11:64053134	BAD;GPR137	0.78	6.22	0.58	2.3e-8	Alopecia areata;Crohn's disease;Psoriasis vulgaris;
SKCM	cis	rs8067354	0.645	rs2645492	chr17:57875554	A/G	cg02344993	chr17:57696989	CLTC	-0.67	-4.82	-0.48	6.84e-6	Hemoglobin concentration;
SKCM	cis	rs7539542	0.622	rs6688148	chr1:202906644	T/G	cg19681188	chr1:202830198	LOC148709	0.66	4.85	0.48	6.16e-6	Mean platelet volume;
SKCM	cis	rs2594989	0.733	rs6777022	chr3:11577636	G/A	cg00170343	chr3:11313890	ATG7	-0.98	-5.18	-0.51	1.72e-6	Circulating chemerin levels;
SKCM	cis	rs1451375	0.617	rs2876829	chr7:50566762	A/G	cg18232548	chr7:50535776	DDC	0.76	4.92	0.49	4.63e-6	Malaria;
SKCM	cis	rs2286503	0.901	rs10950922	chr7:22854006	C/T	cg15401507	chr7:22894281	NA	-0.57	-5.56	-0.53	3.57e-7	Fibrinogen;
SKCM	cis	rs11098499	0.779	rs7699346	chr4:120310542	C/T	cg09307838	chr4:120376055	NA	0.97	7.49	0.65	9.08e-11	Corneal astigmatism;
SKCM	cis	rs28595532	0.920	rs116791817	chr4:119763303	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs826838	1.000	rs826838	chr12:39106731	C/T	cg26384229	chr12:38710491	ALG10B	-0.9	-7.89	-0.67	1.54e-11	Heart rate;
SKCM	cis	rs597539	0.727	rs632984	chr11:68620271	C/T	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.81	5.33	0.52	9.43e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs1577917	1.000	rs10455158	chr6:86672825	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.66	-5.72	-0.54	1.88e-7	Response to antipsychotic treatment;
SKCM	cis	rs7772486	0.806	rs2265477	chr6:146212338	T/C	cg23711669	chr6:146136114	FBXO30	0.74	7.31	0.64	2.05e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs8067545	0.611	rs2526486	chr17:20101626	T/G	cg13482628	chr17:19912719	NA	-0.66	-5.5	-0.53	4.72e-7	Schizophrenia;
SKCM	cis	rs28595532	0.920	rs116612909	chr4:119749823	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs10754283	0.967	rs6428561	chr1:90102619	G/A	cg21401794	chr1:90099060	LRRC8C	0.78	7.17	0.63	3.72e-10	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs6089584	0.927	rs1886007	chr20:60581049	G/A	cg06108461	chr20:60628389	TAF4	-0.89	-8.18	-0.68	4.28e-12	Body mass index;
SKCM	cis	rs7215564	0.730	rs76008137	chr17:78586213	G/C	cg16980736	chr17:78789706	RPTOR	-0.89	-4.87	-0.48	5.8e-6	Myopia (pathological);
SKCM	cis	rs9916302	0.904	rs4795384	chr17:37716771	C/G	cg07936489	chr17:37558343	FBXL20	-0.88	-8.0	-0.67	9.29e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs60871478	0.679	rs6962050	chr7:817201	A/G	cg05535760	chr7:792225	HEATR2	1.21	10.42	0.76	1.96e-16	Cerebrospinal P-tau181p levels;
SKCM	cis	rs3820928	0.874	rs10194663	chr2:227875369	T/A	cg11843606	chr2:227700838	RHBDD1	-0.59	-4.81	-0.48	7.13e-6	Pulmonary function;
SKCM	cis	rs10504229	0.683	rs34804288	chr8:58117570	C/A	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs9790314	1.000	rs1478565	chr3:161027464	C/T	cg03342759	chr3:160939853	NMD3	-0.72	-7.87	-0.67	1.65e-11	Morning vs. evening chronotype;
SKCM	cis	rs56104184	0.723	rs1058483	chr19:49407660	G/A	cg19746536	chr19:49375674	PPP1R15A	1.16	5.93	0.56	7.67e-8	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs9900062	0.586	rs6504250	chr17:62680553	T/C	cg02097616	chr17:62675921	NA	0.75	6.24	0.58	2.16e-8	QT interval;
SKCM	cis	rs1029738	0.615	rs3757447	chr7:22894735	A/T	cg15401507	chr7:22894281	NA	-0.64	-5.89	-0.55	9.27e-8	Fibrinogen levels;
SKCM	cis	rs782590	0.643	rs13009906	chr2:55739434	A/G	cg18811423	chr2:55921094	PNPT1	-0.68	-4.99	-0.49	3.59e-6	Metabolic syndrome;
SKCM	cis	rs2404602	0.608	rs12911035	chr15:76606591	T/C	cg23625390	chr15:77176239	SCAPER	0.66	5.88	0.55	9.59e-8	Blood metabolite levels;
SKCM	cis	rs7953508	0.636	rs10859535	chr12:93979892	A/G	cg18151635	chr12:93972918	NA	-0.73	-6.41	-0.59	1.02e-8	Pubertal anthropometrics;
SKCM	cis	rs1218582	0.628	rs12130132	chr1:154880386	C/T	cg24250549	chr1:154909240	PMVK	0.81	7.59	0.65	5.77e-11	Prostate cancer;
SKCM	cis	rs7824557	0.564	rs2572395	chr8:11235360	A/C	cg21775007	chr8:11205619	TDH	-0.58	-4.88	-0.48	5.56e-6	Retinal vascular caliber;
SKCM	cis	rs1799949	1.000	rs4793231	chr17:41427469	A/G	cg23758822	chr17:41437982	NA	0.92	7.82	0.66	2.13e-11	Menopause (age at onset);
SKCM	cis	rs9875589	0.509	rs11718142	chr3:14018793	G/T	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.51	5.17	0.51	1.73e-6	Ovarian reserve;
SKCM	cis	rs12926788	0.689	rs34365165	chr16:24856208	G/A	cg04756594	chr16:24857601	SLC5A11	0.62	4.86	0.48	6.04e-6	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	trans	rs561341	1.000	rs113676348	chr17:30244327	A/G	cg20587970	chr11:113659929	NA	-0.98	-7.89	-0.67	1.56e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs6088590	1.000	rs12626122	chr20:33425800	A/G	cg24642439	chr20:33292090	TP53INP2	0.94	6.42	0.59	9.97e-9	Coronary artery disease;
SKCM	cis	rs9790314	1.000	rs459697	chr3:161093420	G/A	cg03342759	chr3:160939853	NMD3	-0.76	-8.28	-0.68	2.74e-12	Morning vs. evening chronotype;
SKCM	cis	rs2153535	0.580	rs6905237	chr6:8471790	A/T	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs9303401	0.659	rs12150536	chr17:56640834	C/T	cg10487724	chr17:56770010	TEX14;RAD51C	0.84	6.24	0.58	2.07e-8	Cognitive test performance;
SKCM	cis	rs10791097	0.694	rs10894275	chr11:130756251	C/T	cg12179176	chr11:130786555	SNX19	0.91	8.08	0.67	6.64e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs703842	0.616	rs871871	chr12:58219681	G/A	cg00677455	chr12:58241039	CTDSP2	0.72	5.8	0.55	1.37e-7	Multiple sclerosis;
SKCM	cis	rs7811142	1.000	rs11763414	chr7:100016844	C/G	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.11	6.45	0.59	8.66e-9	Platelet count;
SKCM	cis	rs7828089	0.846	rs11136017	chr8:22238030	T/G	cg12081754	chr8:22256438	SLC39A14	0.7	5.24	0.51	1.31e-6	Verbal declarative memory;
SKCM	cis	rs9815354	0.857	rs73830583	chr3:41996948	C/T	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs854765	0.663	rs1052299	chr17:17750419	A/G	cg04398451	chr17:18023971	MYO15A	0.78	5.31	0.52	1.02e-6	Total body bone mineral density;
SKCM	cis	rs7945705	0.967	rs10769968	chr11:8907583	G/C	cg13070366	chr11:9386451	NA	-0.6	-5.36	-0.52	8.38e-7	Hemoglobin concentration;
SKCM	cis	rs4727027	0.704	rs12535154	chr7:148895304	G/A	cg23583168	chr7:148888333	NA	-0.77	-6.17	-0.57	2.83e-8	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs9910055	0.529	rs183462	chr17:42183376	G/C	cg19774624	chr17:42201019	HDAC5	0.83	6.53	0.59	6.08e-9	Total body bone mineral density;
SKCM	cis	rs6424115	0.964	rs2473375	chr1:24136545	C/T	cg15997130	chr1:24165203	NA	0.64	5.22	0.51	1.45e-6	Immature fraction of reticulocytes;
SKCM	cis	rs763014	0.932	rs2384974	chr16:651279	C/G	cg00908189	chr16:619842	PIGQ	0.79	7.31	0.64	2.05e-10	Height;
SKCM	cis	rs10089	1.000	rs1559263	chr5:127512873	A/C	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.87	7.69	0.66	3.82e-11	Ileal carcinoids;
SKCM	cis	rs72615157	0.539	rs12673441	chr7:99670328	A/T	cg22004693	chr7:99632812	ZKSCAN1	0.68	5.0	0.49	3.5e-6	Lung function (FEV1/FVC);
SKCM	cis	rs2019137	0.560	rs7578633	chr2:113978650	C/T	cg23156509	chr2:114033830	PAX8;LOC440839	-0.56	-4.81	-0.48	7.3e-6	Lymphocyte counts;
SKCM	cis	rs4819052	0.851	rs7275874	chr21:46671223	C/T	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.36	0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs4132509	0.793	rs12037013	chr1:243784207	G/A	cg21452805	chr1:244014465	NA	0.84	4.95	0.49	4.24e-6	RR interval (heart rate);
SKCM	cis	rs7208859	0.623	rs3752021	chr17:29111043	G/C	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	trans	rs561341	0.800	rs7209766	chr17:30234848	T/A	cg20587970	chr11:113659929	NA	-1.08	-8.41	-0.69	1.54e-12	Hip circumference adjusted for BMI;
SKCM	cis	rs7940866	0.838	rs7122268	chr11:130892029	A/T	cg12179176	chr11:130786555	SNX19	0.72	5.4	0.52	6.98e-7	Schizophrenia;
SKCM	cis	rs748404	0.697	rs493177	chr15:43543258	A/C	cg02155558	chr15:43621948	ADAL;LCMT2	0.65	5.51	0.53	4.51e-7	Lung cancer;
SKCM	cis	rs9300255	0.602	rs1716168	chr12:123651966	C/G	cg05973401	chr12:123451056	ABCB9	-0.81	-5.57	-0.53	3.45e-7	Neutrophil percentage of white cells;
SKCM	cis	rs1799949	0.965	rs799912	chr17:41257134	T/C	cg19454999	chr17:41278357	BRCA1;NBR2	0.52	4.81	0.48	7.16e-6	Menopause (age at onset);
SKCM	cis	rs9420	0.961	rs11605731	chr11:57524089	C/G	cg19752551	chr11:57585705	CTNND1	-0.7	-7.21	-0.63	3.18e-10	Schizophrenia;
SKCM	cis	rs2302777	0.507	rs1007655	chr17:38111419	G/A	cg17467752	chr17:38218738	THRA	0.65	5.2	0.51	1.53e-6	Multiple myeloma (hyperdiploidy);
SKCM	cis	rs2842992	0.724	rs4709368	chr6:160204127	C/T	cg16489826	chr6:160211363	TCP1;MRPL18	-0.67	-5.34	-0.52	8.98e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs595982	0.527	rs12151238	chr19:49368613	T/C	cg15549821	chr19:49342101	PLEKHA4	-0.87	-5.29	-0.51	1.09e-6	Red cell distribution width;
SKCM	cis	rs2658782	0.826	rs1975820	chr11:93081815	G/A	cg15737290	chr11:93063684	CCDC67	0.82	5.74	0.55	1.7e-7	Pulmonary function decline;
SKCM	cis	rs10779751	0.887	rs6686835	chr1:11305316	G/A	cg08854313	chr1:11322531	MTOR	0.94	7.36	0.64	1.6e-10	Body mass index;
SKCM	cis	rs7666738	0.830	rs28887893	chr4:98963006	G/A	cg05340658	chr4:99064831	C4orf37	0.64	4.91	0.49	4.97e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4803468	1.000	rs11670668	chr19:41920454	G/C	cg09537434	chr19:41945824	ATP5SL	-1.1	-13.82	-0.84	1.16e-22	Height;
SKCM	cis	rs929354	0.772	rs1002389	chr7:156968323	C/G	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs75229567	0.618	rs78294090	chr12:70209959	G/T	cg10114359	chr12:70132523	RAB3IP	1.24	5.19	0.51	1.6e-6	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes;
SKCM	cis	rs7666738	0.791	rs13125277	chr4:99009922	T/G	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2832191	0.967	rs2832216	chr21:30521921	C/T	cg24692254	chr21:30365293	RNF160	0.76	6.81	0.61	1.79e-9	Dental caries;
SKCM	cis	rs17376456	0.825	rs17314797	chr5:93234845	T/A	cg21475434	chr5:93447410	FAM172A	1.03	5.61	0.54	3e-7	Diabetic retinopathy;
SKCM	cis	rs7824557	0.628	rs11777746	chr8:11204755	T/C	cg21775007	chr8:11205619	TDH	0.71	6.28	0.58	1.82e-8	Retinal vascular caliber;
SKCM	cis	rs6762	0.748	rs7936838	chr11:839093	G/C	cg16425592	chr11:842748	TSPAN4;POLR2L	-0.79	-5.75	-0.55	1.65e-7	Mean platelet volume;
SKCM	cis	rs769267	0.930	rs2288852	chr19:19605348	T/C	cg03709012	chr19:19516395	GATAD2A	0.89	8.62	0.7	5.89e-13	Tonsillectomy;
SKCM	cis	rs2832191	0.692	rs8134627	chr21:30349069	C/T	cg08807101	chr21:30365312	RNF160	-0.76	-6.32	-0.58	1.52e-8	Dental caries;
SKCM	cis	rs875971	0.862	rs10240949	chr7:65804417	A/G	cg11764359	chr7:65958608	NA	-0.81	-7.6	-0.65	5.6e-11	Aortic root size;
SKCM	cis	rs2811415	0.531	rs9839861	chr3:127742405	G/T	cg09089421	chr3:127803668	RUVBL1	0.99	8.52	0.69	9.09e-13	Lung function (FEV1/FVC);
SKCM	cis	rs7615952	0.673	rs9841194	chr3:125635739	C/T	cg05084668	chr3:125655381	ALG1L	-1.25	-6.57	-0.6	5.19e-9	Blood pressure (smoking interaction);
SKCM	cis	rs1878931	0.615	rs4786412	chr16:3440390	C/T	cg26668626	chr16:3451006	ZNF174;ZNF434	1.08	10.56	0.77	1.06e-16	Body mass index (adult);
SKCM	cis	rs875971	1.000	rs1544549	chr7:66090663	T/A	cg11764359	chr7:65958608	NA	-0.82	-7.48	-0.65	9.59e-11	Aortic root size;
SKCM	cis	rs17376456	0.569	rs6556839	chr5:93206292	T/C	cg25358565	chr5:93447407	FAM172A	-0.88	-5.63	-0.54	2.71e-7	Diabetic retinopathy;
SKCM	cis	rs907612	0.638	rs907613	chr11:1874292	G/A	cg02118564	chr11:1241341	NA	-0.44	-4.84	-0.48	6.47e-6	Monocyte percentage of white cells;Monocyte count;Granulocyte percentage of myeloid white cells;
SKCM	cis	rs10504229	1.000	rs7007805	chr8:58179327	G/A	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs6951245	1.000	rs79422648	chr7:1080241	T/C	cg24642844	chr7:1081250	C7orf50	-0.94	-6.32	-0.58	1.48e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7809950	0.678	rs7777950	chr7:107004672	T/C	cg23024343	chr7:107201750	COG5	-0.82	-6.98	-0.62	8.55e-10	Coronary artery disease;
SKCM	cis	rs2204008	0.805	rs3863360	chr12:37966432	C/T	cg13010199	chr12:38710504	ALG10B	0.63	4.83	0.48	6.7e-6	Bladder cancer;
SKCM	cis	rs1843834	0.539	rs12694643	chr2:225446603	A/G	cg12698349	chr2:225449008	CUL3	0.88	7.02	0.62	7.26e-10	IgE levels in asthmatics (D.p. specific);
SKCM	cis	rs798554	0.644	rs1639040	chr7:2884116	G/T	cg04166393	chr7:2884313	GNA12	0.79	5.54	0.53	3.9e-7	Height;
SKCM	cis	rs7247513	0.892	rs1864081	chr19:12707978	G/A	cg01871581	chr19:12707946	ZNF490	-0.7	-4.91	-0.49	4.88e-6	Bipolar disorder;
SKCM	cis	rs17376456	0.825	rs13155452	chr5:93164449	C/T	cg25358565	chr5:93447407	FAM172A	-1.1	-7.44	-0.64	1.15e-10	Diabetic retinopathy;
SKCM	cis	rs796364	0.951	rs1105964	chr2:201000776	T/A	cg12253985	chr2:200820533	C2orf60;C2orf47	-0.98	-6.28	-0.58	1.82e-8	Schizophrenia;
SKCM	cis	rs801193	0.967	rs1110414	chr7:66205582	A/G	cg00343986	chr7:65444356	GUSB	0.7	5.19	0.51	1.63e-6	Aortic root size;
SKCM	cis	rs6502050	0.761	rs9908277	chr17:80060829	T/C	cg13939156	chr17:80058883	NA	0.51	4.86	0.48	5.96e-6	Life satisfaction;
SKCM	cis	rs909674	0.818	rs5750833	chr22:39843091	C/A	cg11247378	chr22:39784982	NA	-0.43	-4.97	-0.49	3.89e-6	IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis);IgG glycosylation;IgG digalactosylation phenotypes (multivariate analysis);IgG sialylation phenotypes (multivariate analysis);IgG monogalactosylation phenotypes (multivariate analysis);IgG fucosylation phenotypes (multivariate analysis);IgG N-glycosylation phenotypes (multivariate analysis);IgG disialylation phenotypes (multivariate analysis);IgG galactosylation phenotypes (multivariate analysis);Post bronchodilator FEV1;
SKCM	cis	rs244731	1.000	rs244729	chr5:176539018	C/G	cg16006841	chr5:176797999	RGS14	0.74	6.07	0.57	4.39e-8	Urate levels in lean individuals;
SKCM	cis	rs9467773	1.000	rs1078679	chr6:26568741	C/T	cg09904177	chr6:26538194	HMGN4	0.54	4.91	0.49	4.97e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs55794721	0.509	rs6699113	chr1:25777743	C/T	cg27572855	chr1:25598939	RHD	0.53	5.06	0.5	2.67e-6	Plateletcrit;Mean corpuscular volume;
SKCM	cis	rs9858542	1.000	rs13085791	chr3:49721798	C/A	cg03060546	chr3:49711283	APEH	-0.72	-5.37	-0.52	7.79e-7	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs473651	0.503	rs515342	chr2:239367296	A/G	cg18131467	chr2:239335373	ASB1	-0.89	-6.29	-0.58	1.73e-8	Multiple system atrophy;
SKCM	cis	rs7945705	0.902	rs2012696	chr11:8995818	A/C	cg21881798	chr11:8931708	C11orf17;ST5	0.81	8.38	0.69	1.71e-12	Hemoglobin concentration;
SKCM	cis	rs2439831	0.850	rs2957637	chr15:43951118	C/A	cg02155558	chr15:43621948	ADAL;LCMT2	1.31	7.38	0.64	1.49e-10	Lung cancer in ever smokers;
SKCM	cis	rs116095464	0.867	rs10061296	chr5:312253	G/A	cg22857025	chr5:266934	NA	-1.64	-6.14	-0.57	3.18e-8	Breast cancer;
SKCM	cis	rs7666738	0.830	rs4699598	chr4:99019158	C/T	cg05340658	chr4:99064831	C4orf37	0.65	5.08	0.5	2.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs35306767	0.903	rs1341741	chr10:888073	A/G	cg25614935	chr10:1084866	C10orf110	0.82	5.39	0.52	7.4e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs3892630	0.588	rs2112917	chr19:33317543	C/T	cg22980127	chr19:33182716	NUDT19	1.25	7.0	0.62	8.02e-10	Red blood cell traits;
SKCM	cis	rs57221529	0.766	rs4245972	chr5:578572	A/G	cg26208419	chr5:473447	SLC9A3;LOC25845	1.05	5.37	0.52	7.95e-7	Lung disease severity in cystic fibrosis;
SKCM	cis	rs9902453	0.967	rs56129908	chr17:28421382	T/A	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.5	0.53	4.67e-7	Coffee consumption (cups per day);
SKCM	cis	rs7666738	0.791	rs7684521	chr4:99071219	A/G	cg05340658	chr4:99064831	C4orf37	0.66	4.87	0.48	5.74e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs3981351	0.528	rs12768908	chr10:115443894	C/T	cg24846397	chr10:115438155	CASP7	-0.6	-6.2	-0.57	2.54e-8	Obesity-related traits;
SKCM	cis	rs6570726	0.935	rs425717	chr6:145838620	A/T	cg23711669	chr6:146136114	FBXO30	0.7	6.64	0.6	3.72e-9	Lobe attachment (rater-scored or self-reported);
SKCM	trans	rs1814175	0.817	rs7947286	chr11:49874657	C/T	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs55794721	0.611	rs74937936	chr1:25747646	G/A	cg27572855	chr1:25598939	RHD	0.58	5.82	0.55	1.23e-7	Plateletcrit;Mean corpuscular volume;
SKCM	cis	rs769267	0.930	rs10414830	chr19:19562332	C/T	cg03709012	chr19:19516395	GATAD2A	0.89	8.62	0.7	5.89e-13	Tonsillectomy;
SKCM	trans	rs17685	0.712	rs28456330	chr7:75810542	A/G	cg19862616	chr7:65841803	NCRNA00174	0.94	10.42	0.76	1.95e-16	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7193541	0.965	rs4402594	chr16:74701360	C/T	cg01733217	chr16:74700730	RFWD3	0.9	8.43	0.69	1.39e-12	Multiple myeloma;
SKCM	cis	rs55962025	0.551	rs362296	chr4:3247007	C/A	cg24015175	chr4:3319247	RGS12	-0.55	-4.84	-0.48	6.35e-6	Parental longevity (mother's age at death);
SKCM	cis	rs1005277	0.579	rs2474608	chr10:38457109	C/T	cg00409905	chr10:38381863	ZNF37A	-0.67	-6.21	-0.58	2.41e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs7811142	1.000	rs67163493	chr7:100023838	C/T	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-1.0	-5.66	-0.54	2.36e-7	Platelet count;
SKCM	cis	rs9583531	0.600	rs7986286	chr13:111357207	A/G	cg15841412	chr13:111365552	ING1	0.73	4.87	0.48	5.76e-6	Coronary artery disease;
SKCM	cis	rs7208859	0.573	rs56031503	chr17:29075665	T/C	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs10752881	0.875	rs10797825	chr1:183024581	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.77	6.87	0.61	1.37e-9	Colorectal cancer;
SKCM	cis	rs4862750	0.872	rs7672831	chr4:187898882	C/T	cg10295955	chr4:187884368	NA	-1.01	-13.83	-0.84	1.08e-22	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2153535	0.563	rs6942177	chr6:8534460	A/G	cg23788917	chr6:8435910	SLC35B3	-0.69	-5.08	-0.5	2.51e-6	Motion sickness;
SKCM	cis	rs16940212	0.618	rs76679589	chr15:58686691	C/T	cg16767221	chr15:57769667	CGNL1	-0.57	-4.8	-0.48	7.52e-6	HDL cholesterol levels;HDL cholesterol;
SKCM	cis	rs2228479	0.850	rs45524643	chr16:89815824	G/A	cg00800038	chr16:89945340	TCF25	-0.92	-5.12	-0.5	2.15e-6	Skin colour saturation;
SKCM	cis	rs910316	0.935	rs11159119	chr14:75636967	C/T	cg11812906	chr14:75593930	NEK9	-0.68	-5.27	-0.51	1.2e-6	Height;
SKCM	cis	rs875971	0.756	rs4718328	chr7:65693337	A/G	cg18876405	chr7:65276391	NA	-0.64	-6.46	-0.59	8.16e-9	Aortic root size;
SKCM	cis	rs9790314	0.812	rs2004862	chr3:161135638	C/T	cg03342759	chr3:160939853	NMD3	-0.68	-6.84	-0.61	1.55e-9	Morning vs. evening chronotype;
SKCM	cis	rs12142240	0.698	rs66575205	chr1:46814092	T/G	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs875971	0.862	rs6460290	chr7:65809106	G/A	cg18876405	chr7:65276391	NA	-0.64	-6.34	-0.58	1.35e-8	Aortic root size;
SKCM	cis	rs7927771	0.524	rs12226431	chr11:47805856	G/A	cg20307385	chr11:47447363	PSMC3	0.71	5.63	0.54	2.67e-7	Subjective well-being;
SKCM	cis	rs875971	1.000	rs55962648	chr7:65625751	C/G	cg18876405	chr7:65276391	NA	-0.68	-6.85	-0.61	1.54e-9	Aortic root size;
SKCM	cis	rs9300255	0.537	rs1727334	chr12:123714236	A/G	cg05973401	chr12:123451056	ABCB9	0.82	5.31	0.51	1.02e-6	Neutrophil percentage of white cells;
SKCM	cis	rs2841277	0.836	rs2841268	chr14:105386039	T/C	cg15352829	chr14:105391018	PLD4	0.62	5.72	0.54	1.9e-7	Rheumatoid arthritis;
SKCM	cis	rs651907	0.535	rs11707250	chr3:101509371	A/T	cg12386194	chr3:101231763	SENP7	-0.66	-5.21	-0.51	1.52e-6	Colorectal cancer;
SKCM	cis	rs875971	0.522	rs10807697	chr7:65416170	A/G	cg00343986	chr7:65444356	GUSB	0.67	4.77	0.47	8.55e-6	Aortic root size;
SKCM	trans	rs17685	0.672	rs56343450	chr7:75796235	C/T	cg19862616	chr7:65841803	NCRNA00174	0.97	10.73	0.77	5.13e-17	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1691799	0.899	rs1183272	chr12:66735421	T/C	cg16791601	chr12:66731901	HELB	-0.66	-5.81	-0.55	1.31e-7	White blood cell count (basophil);
SKCM	cis	rs1124769	0.619	rs12904435	chr15:51110203	G/T	cg21246271	chr15:51200259	AP4E1	-0.77	-4.94	-0.49	4.31e-6	Cognitive performance;
SKCM	cis	rs7100689	0.646	rs1340384	chr10:82088702	T/A	cg01528321	chr10:82214614	TSPAN14	0.76	6.26	0.58	1.94e-8	Post bronchodilator FEV1;
SKCM	cis	rs1707322	0.686	rs2991977	chr1:46053683	G/A	cg03146154	chr1:46216737	IPP	-0.77	-5.57	-0.53	3.45e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs3768617	0.510	rs10752896	chr1:183068516	A/C	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.67	0.66	4.01e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs2120019	1.000	rs8036197	chr15:75370232	T/C	cg17294928	chr15:75287854	SCAMP5	-0.82	-6.77	-0.61	2.13e-9	Blood trace element (Zn levels);
SKCM	cis	rs12824058	0.831	rs12320318	chr12:130812335	T/C	cg24838063	chr12:130822603	PIWIL1	0.78	6.91	0.62	1.19e-9	Menopause (age at onset);
SKCM	cis	rs10193935	0.901	rs10169411	chr2:42637749	G/A	cg27598129	chr2:42591480	NA	-0.88	-6.71	-0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7828089	0.542	rs7332050	chr8:22265294	G/T	cg12081754	chr8:22256438	SLC39A14	0.83	6.75	0.61	2.37e-9	Verbal declarative memory;
SKCM	cis	rs1529316	0.846	rs2627471	chr8:3824735	T/C	cg05999364	chr8:3269952	CSMD1	0.53	5.54	0.53	3.93e-7	Multiple sclerosis;
SKCM	cis	rs362296	0.661	rs3095077	chr4:3265710	A/G	cg24015175	chr4:3319247	RGS12	0.55	5.07	0.5	2.62e-6	Parental longevity (mother's age at death);
SKCM	cis	rs17376456	0.877	rs9885329	chr5:93380278	G/A	cg25358565	chr5:93447407	FAM172A	1.19	7.67	0.66	4.06e-11	Diabetic retinopathy;
SKCM	cis	rs2153535	0.580	rs6597318	chr6:8437289	G/A	cg23788917	chr6:8435910	SLC35B3	0.64	4.82	0.48	6.93e-6	Motion sickness;
SKCM	cis	rs1707322	1.000	rs10789479	chr1:46352500	T/C	cg03146154	chr1:46216737	IPP	0.74	5.0	0.49	3.39e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs933688	0.938	rs12110065	chr5:90718474	A/G	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.05	8.45	0.69	1.26e-12	Smoking behavior;
SKCM	cis	rs7027203	0.663	rs4428726	chr9:96623559	T/G	cg14598338	chr9:96623480	NA	-0.5	-5.43	-0.52	6.16e-7	DNA methylation (variation);
SKCM	cis	rs860295	0.541	rs11264359	chr1:155282829	A/G	cg02153340	chr1:155202674	NA	-0.69	-4.93	-0.49	4.5e-6	Body mass index;
SKCM	cis	rs7666738	0.830	rs28818218	chr4:98880575	A/C	cg17366294	chr4:99064904	C4orf37	0.57	4.84	0.48	6.52e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2404602	0.669	rs17367297	chr15:77158026	A/C	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs1799949	0.965	rs799910	chr17:41279561	G/C	cg25918947	chr17:41365094	TMEM106A	-0.62	-5.9	-0.56	8.91e-8	Menopause (age at onset);
SKCM	cis	rs9902453	0.619	rs2255489	chr17:28084974	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.85	-5.77	-0.55	1.51e-7	Coffee consumption (cups per day);
SKCM	cis	rs2816062	0.735	rs2816045	chr1:18892999	A/G	cg18795169	chr1:18902165	NA	-0.83	-8.91	-0.71	1.58e-13	Urate levels in lean individuals;
SKCM	cis	rs7100689	0.784	rs3802637	chr10:82179699	G/C	cg01528321	chr10:82214614	TSPAN14	0.98	10.11	0.75	7.91e-16	Post bronchodilator FEV1;
SKCM	cis	rs752010	0.756	rs6600380	chr1:42054814	C/T	cg06885757	chr1:42089581	HIVEP3	-0.64	-6.54	-0.6	5.81e-9	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs28595532	0.920	rs115681185	chr4:119757700	G/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs1419980	0.722	rs752452	chr12:7781021	G/A	cg10578777	chr12:7781093	NA	0.72	5.12	0.5	2.12e-6	HDL cholesterol levels;
SKCM	cis	rs9910055	0.659	rs227580	chr17:42223068	C/T	cg19774624	chr17:42201019	HDAC5	0.92	8.71	0.7	4.03e-13	Total body bone mineral density;
SKCM	cis	rs8072100	0.967	rs4338849	chr17:45512483	A/G	cg25173405	chr17:45401733	C17orf57	-0.6	-5.39	-0.52	7.18e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs908922	0.676	rs525960	chr1:152497866	T/A	cg09873164	chr1:152488093	CRCT1	0.76	5.93	0.56	7.7e-8	Hair morphology;
SKCM	cis	rs11098499	0.863	rs11731756	chr4:120478696	T/G	cg09307838	chr4:120376055	NA	1.0	8.27	0.68	2.8e-12	Corneal astigmatism;
SKCM	cis	rs2739330	0.828	rs5760102	chr22:24248761	T/C	cg04234412	chr22:24373322	LOC391322	-0.63	-5.08	-0.5	2.52e-6	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs1862618	0.802	rs832547	chr5:56183941	C/G	cg12311346	chr5:56204834	C5orf35	-0.76	-5.02	-0.49	3.2e-6	Initial pursuit acceleration;
SKCM	cis	rs2479724	0.935	rs2254936	chr6:41846569	A/G	cg17623882	chr6:41773611	USP49	-0.79	-6.74	-0.61	2.4e-9	Menarche (age at onset);
SKCM	cis	rs6977660	0.943	rs9638765	chr7:19840616	G/A	cg07541023	chr7:19748670	TWISTNB	0.7	4.92	0.49	4.79e-6	Thyroid stimulating hormone;
SKCM	cis	rs7772486	0.712	rs6570726	chr6:146159460	T/C	cg23711669	chr6:146136114	FBXO30	0.7	6.69	0.6	3.03e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2721195	0.845	rs4244611	chr8:145739924	G/A	cg15320075	chr8:145703422	NA	0.83	7.2	0.63	3.25e-10	Age at first birth;
SKCM	cis	rs60871478	1.000	rs9195	chr7:825786	C/T	cg05535760	chr7:792225	HEATR2	-1.0	-8.35	-0.69	1.97e-12	Cerebrospinal P-tau181p levels;
SKCM	cis	rs7216064	1.000	rs2365764	chr17:65857714	G/A	cg12091567	chr17:66097778	LOC651250	-0.75	-5.27	-0.51	1.19e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs11764590	0.950	rs11514731	chr7:2051503	C/G	cg02825527	chr7:2087843	MAD1L1	-0.74	-5.05	-0.5	2.84e-6	Neuroticism;
SKCM	cis	rs875971	0.862	rs6962717	chr7:65883735	G/A	cg18876405	chr7:65276391	NA	0.63	6.25	0.58	2.06e-8	Aortic root size;
SKCM	cis	rs8180040	0.654	rs6766230	chr3:47196209	C/A	cg27129171	chr3:47204927	SETD2	0.74	5.3	0.51	1.05e-6	Colorectal cancer;
SKCM	cis	rs10504229	1.000	rs66796009	chr8:58174529	G/A	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs2153535	0.580	rs7747306	chr6:8453663	C/G	cg07606381	chr6:8435919	SLC35B3	-0.94	-6.87	-0.61	1.4e-9	Motion sickness;
SKCM	cis	rs1577917	0.771	rs9362233	chr6:86358247	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.82	-7.6	-0.65	5.57e-11	Response to antipsychotic treatment;
SKCM	cis	rs6570726	0.791	rs2096201	chr6:145934273	C/T	cg23711669	chr6:146136114	FBXO30	0.87	8.2	0.68	3.83e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6951245	1.000	rs78308415	chr7:1072634	G/A	cg21664854	chr7:1097933	C7orf50;GPR146	0.89	4.79	0.48	7.66e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs732765	0.734	rs1057500	chr14:75205116	G/A	cg25946216	chr14:74253857	C14orf43	-0.8	-5.15	-0.5	1.88e-6	Non-small cell lung cancer;
SKCM	cis	rs4975616	0.714	rs27069	chr5:1347128	C/T	cg26373071	chr5:1325741	CLPTM1L	0.64	5.34	0.52	8.89e-7	Lung cancer;
SKCM	cis	rs7618501	0.699	rs2777888	chr3:49898000	A/G	cg05072774	chr3:49840536	C3orf54	-0.7	-5.25	-0.51	1.3e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs950027	0.620	rs1153857	chr15:45659095	G/T	cg10760299	chr15:45669010	GATM	0.57	5.71	0.54	1.99e-7	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs6500395	1.000	rs9936004	chr16:48566088	A/G	cg04672837	chr16:48644449	N4BP1	0.72	6.04	0.56	4.96e-8	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs798554	0.757	rs1182177	chr7:2874540	C/T	cg19346786	chr7:2764209	NA	-0.62	-6.93	-0.62	1.09e-9	Height;
SKCM	cis	rs7639513	0.767	rs3806661	chr3:12705855	A/G	cg23032965	chr3:12705835	RAF1	0.81	7.08	0.63	5.53e-10	Itch intensity from mosquito bite;
SKCM	cis	rs3087591	0.919	rs2285892	chr17:29553485	G/A	cg24425628	chr17:29625626	OMG;NF1	-0.64	-5.22	-0.51	1.43e-6	Hip circumference;
SKCM	cis	rs13392177	0.660	rs10932762	chr2:219076213	G/C	cg00012203	chr2:219082015	ARPC2	-0.64	-4.89	-0.48	5.39e-6	Pyoderma gangrenosum in inflammatory bowel disease;
SKCM	cis	rs11764590	0.724	rs55669426	chr7:2090129	G/C	cg02825527	chr7:2087843	MAD1L1	-0.62	-4.97	-0.49	3.84e-6	Neuroticism;
SKCM	cis	rs4774899	1.000	rs12906042	chr15:57479668	A/C	cg01857019	chr15:57210107	LOC145783;TCF12	0.53	4.9	0.49	5.12e-6	Urinary tract infection frequency;
SKCM	cis	rs7092929	0.941	rs615019	chr10:3563318	T/C	cg14308648	chr10:3568949	NA	0.76	5.2	0.51	1.56e-6	Coronary artery calcification;
SKCM	cis	rs34779708	0.931	rs7084196	chr10:35367161	T/C	cg03585969	chr10:35415529	CREM	0.78	6.3	0.58	1.6e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs9467773	0.620	rs2494700	chr6:26631306	C/T	cg15659132	chr6:26577336	NA	0.62	5.4	0.52	6.91e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs931234	0.965	rs931233	chr3:65153035	T/G	cg06271087	chr3:65342546	MAGI1	-0.54	-5.46	-0.53	5.52e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs66573146	1.000	rs66573146	chr4:6984464	C/G	cg00086871	chr4:6988644	TBC1D14	1.43	5.33	0.52	9.25e-7	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs433852	0.904	rs8102492	chr19:49140809	A/C	cg06677660	chr19:49140777	SEC1;DBP	0.82	5.55	0.53	3.81e-7	Elevated serum carcinoembryonic antigen levels;Posterior cortical atrophy and Alzheimer's disease;
SKCM	cis	rs7103648	0.966	rs10838702	chr11:47410888	G/T	cg20307385	chr11:47447363	PSMC3	1.06	9.25	0.72	3.6e-14	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs2836974	0.526	rs1888488	chr21:40686521	C/T	cg17971929	chr21:40555470	PSMG1	-0.69	-6.07	-0.57	4.38e-8	Cognitive function;
SKCM	cis	rs8180040	0.620	rs6767907	chr3:47162661	C/T	cg27129171	chr3:47204927	SETD2	-0.74	-5.37	-0.52	7.84e-7	Colorectal cancer;
SKCM	cis	rs875971	0.964	rs778708	chr7:65856319	T/C	cg11764359	chr7:65958608	NA	0.87	8.35	0.69	2.01e-12	Aortic root size;
SKCM	trans	rs1814175	0.791	rs1722023	chr11:49908136	G/C	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs2404602	0.679	rs12899871	chr15:76757347	T/C	cg23625390	chr15:77176239	SCAPER	0.57	5.23	0.51	1.39e-6	Blood metabolite levels;
SKCM	cis	rs853679	0.545	rs35949109	chr6:28025926	T/C	cg06761719	chr6:27280190	POM121L2	0.91	5.18	0.51	1.72e-6	Depression;
SKCM	cis	rs6089584	0.606	rs7270666	chr20:60577598	C/T	cg06108461	chr20:60628389	TAF4	-0.68	-5.88	-0.55	9.6e-8	Body mass index;
SKCM	cis	rs3820928	0.874	rs13403281	chr2:227880769	G/A	cg11843606	chr2:227700838	RHBDD1	-0.64	-5.28	-0.51	1.13e-6	Pulmonary function;
SKCM	cis	rs55962025	0.883	rs363099	chr4:3162056	C/T	cg09735869	chr4:3319127	RGS12	-0.65	-5.21	-0.51	1.52e-6	Parental longevity (mother's age at death);
SKCM	cis	rs2386661	0.826	rs4749834	chr10:5671808	G/A	cg12223502	chr10:5658492	NA	-0.55	-4.77	-0.48	8.41e-6	Breast cancer;
SKCM	cis	rs11098499	0.697	rs10020027	chr4:120381879	G/C	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs910316	0.967	rs2010678	chr14:75567178	C/T	cg08847533	chr14:75593920	NEK9	0.95	9.18	0.72	4.88e-14	Height;
SKCM	cis	rs3768617	0.510	rs10797846	chr1:183087485	A/T	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs2842992	0.747	rs733319	chr6:160221475	A/G	cg19482086	chr6:160211437	TCP1;MRPL18	0.81	5.82	0.55	1.23e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs10791097	0.694	rs1893017	chr11:130756253	C/T	cg12179176	chr11:130786555	SNX19	0.91	8.08	0.67	6.64e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs736408	0.812	rs2071506	chr3:52826276	T/C	cg18404041	chr3:52824283	ITIH1	-0.64	-5.73	-0.54	1.84e-7	Bipolar disorder;
SKCM	cis	rs6952808	0.717	rs10950422	chr7:1926577	T/C	cg21782813	chr7:2030301	MAD1L1	0.52	5.29	0.51	1.08e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs208520	0.955	rs28684412	chr6:66979430	A/C	cg07460842	chr6:66804631	NA	0.87	6.25	0.58	2.01e-8	Exhaled nitric oxide output;
SKCM	cis	rs3771570	1.000	rs62193221	chr2:242354632	T/C	cg07612300	chr2:242033426	MTERFD2;SNED1	0.87	4.77	0.47	8.54e-6	Prostate cancer;
SKCM	cis	rs17376456	0.877	rs9314093	chr5:93333347	G/A	cg25358565	chr5:93447407	FAM172A	1.19	7.67	0.66	4.06e-11	Diabetic retinopathy;
SKCM	cis	rs4561483	0.771	rs7202234	chr16:11942322	A/G	cg08843971	chr16:11963173	GSPT1	0.7	5.46	0.53	5.44e-7	Testicular germ cell tumor;
SKCM	cis	rs250585	0.667	rs465017	chr16:23608871	A/G	cg09934309	chr16:23461721	COG7	-0.83	-5.56	-0.53	3.6e-7	Egg allergy;
SKCM	cis	rs2836974	0.583	rs9981884	chr21:40585633	G/A	cg11644478	chr21:40555479	PSMG1	0.72	5.93	0.56	7.85e-8	Cognitive function;
SKCM	cis	rs6938	0.596	rs11072511	chr15:75159433	A/G	cg09165964	chr15:75287851	SCAMP5	0.6	4.86	0.48	5.93e-6	Breast cancer;
SKCM	cis	rs6951245	1.000	rs11763835	chr7:1094513	A/G	cg24642844	chr7:1081250	C7orf50	-0.93	-6.22	-0.58	2.28e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs589448	0.872	rs315111	chr12:69784695	G/A	cg20891283	chr12:69753455	YEATS4	0.99	10.29	0.76	3.5e-16	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs28386778	0.897	rs894406	chr17:61901657	A/G	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs28595532	0.623	rs34082100	chr4:119220563	C/T	cg11846333	chr4:119757529	SEC24D	0.99	5.62	0.54	2.82e-7	Cannabis dependence symptom count;
SKCM	cis	rs72717009	0.825	rs867624	chr1:161467837	A/T	cg23840854	chr1:161414152	NA	-0.99	-5.66	-0.54	2.44e-7	Rheumatoid arthritis;
SKCM	cis	rs2013441	1.000	rs2703774	chr17:20133538	C/T	cg13482628	chr17:19912719	NA	-0.67	-5.41	-0.52	6.77e-7	Obesity-related traits;
SKCM	cis	rs2034088	0.833	rs11247554	chr17:407465	C/A	cg06217071	chr17:408420	NA	0.47	5.11	0.5	2.19e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs6087990	1.000	rs6087990	chr20:31349908	T/C	cg13636640	chr20:31349939	DNMT3B	0.98	9.42	0.73	1.68e-14	Ulcerative colitis;
SKCM	cis	rs12497850	0.931	rs7627404	chr3:48819668	A/C	cg07636037	chr3:49044803	WDR6	0.97	10.25	0.76	4.16e-16	Parkinson's disease;
SKCM	cis	rs823143	0.570	rs823084	chr1:205798313	G/T	cg24739457	chr1:205821442	NA	0.62	5.89	0.55	9.18e-8	Monocyte percentage of white cells;
SKCM	cis	rs9300255	0.568	rs1790108	chr12:123636841	A/G	cg05973401	chr12:123451056	ABCB9	0.79	5.37	0.52	8.03e-7	Neutrophil percentage of white cells;
SKCM	cis	rs2811415	0.597	rs11719889	chr3:127805780	G/A	cg09089421	chr3:127803668	RUVBL1	1.0	8.69	0.7	4.4e-13	Lung function (FEV1/FVC);
SKCM	cis	rs3135063	0.847	rs1138690	chr4:3291401	G/T	cg09735869	chr4:3319127	RGS12	0.64	5.6	0.54	3.13e-7	Blood protein levels;
SKCM	cis	rs2721195	1.000	rs2721195	chr8:145677011	T/C	cg11211951	chr8:145729740	GPT	-0.63	-5.98	-0.56	6.27e-8	Age at first birth;
SKCM	cis	rs933688	1.000	rs60513756	chr5:90727692	A/C	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.95	6.51	0.59	6.7e-9	Smoking behavior;
SKCM	cis	rs826838	1.000	rs11610522	chr12:38687575	C/T	cg13010199	chr12:38710504	ALG10B	0.87	6.54	0.59	5.91e-9	Heart rate;
SKCM	cis	rs1552244	0.882	rs13088350	chr3:10044626	T/C	cg02579736	chr3:10068473	FANCD2;CIDECP	0.94	4.84	0.48	6.49e-6	Alzheimer's disease;
SKCM	cis	rs1949733	1.000	rs3103071	chr4:8508579	C/G	cg11789530	chr4:8429930	ACOX3	-0.82	-5.81	-0.55	1.31e-7	Response to antineoplastic agents;
SKCM	cis	rs3808502	0.647	rs7821302	chr8:11236572	T/A	cg21775007	chr8:11205619	TDH	-0.59	-5.03	-0.5	3.01e-6	Neuroticism;
SKCM	cis	rs62238980	0.614	rs79592323	chr22:32442742	A/G	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs17685	0.753	rs10233282	chr7:75790081	C/T	cg16489192	chr7:75678113	MDH2;STYXL1	-0.57	-5.49	-0.53	4.89e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs9912468	0.933	rs35183571	chr17:64305015	T/C	cg19474267	chr17:64306194	PRKCA	0.63	5.43	0.52	6.14e-7	QRS duration;QRS complex (12-leadsum);QRS complex (Sokolow-Lyon);
SKCM	cis	rs2836633	0.894	rs55955614	chr21:40037330	T/G	cg05519781	chr21:40033154	ERG	0.78	6.88	0.61	1.33e-9	Coronary artery disease;
SKCM	cis	rs4665809	0.531	rs34081866	chr2:26475940	C/T	cg04944784	chr2:26401820	FAM59B	0.74	4.79	0.48	7.81e-6	Gut microbiome composition (summer);
SKCM	cis	rs55823223	0.648	rs11869977	chr17:73857382	C/G	cg10935138	chr17:73851978	WBP2	1.18	7.03	0.62	6.86e-10	Psoriasis;
SKCM	cis	rs11098499	0.863	rs3775854	chr4:120471971	C/T	cg09307838	chr4:120376055	NA	1.0	8.27	0.68	2.8e-12	Corneal astigmatism;
SKCM	cis	rs4727027	0.901	rs4727019	chr7:148822266	A/G	cg23583168	chr7:148888333	NA	-0.82	-6.56	-0.6	5.29e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs875971	0.862	rs2088653	chr7:65808608	G/A	cg18876405	chr7:65276391	NA	-0.64	-6.42	-0.59	9.88e-9	Aortic root size;
SKCM	cis	rs875971	0.862	rs10950033	chr7:65739673	A/G	cg11764359	chr7:65958608	NA	-0.82	-7.87	-0.67	1.68e-11	Aortic root size;
SKCM	cis	rs2396545	0.680	rs35467761	chr11:571568	A/G	cg17114584	chr11:613792	IRF7	0.82	5.24	0.51	1.31e-6	Systemic lupus erythematosus and Systemic sclerosis;
SKCM	cis	rs2251381	0.606	rs8129515	chr21:30520167	C/G	cg08807101	chr21:30365312	RNF160	0.65	4.77	0.48	8.45e-6	Selective IgA deficiency;
SKCM	cis	rs6952808	0.609	rs6950151	chr7:1953521	T/C	cg21782813	chr7:2030301	MAD1L1	0.51	5.42	0.52	6.33e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs2439831	0.850	rs3736180	chr15:44106624	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.35	7.75	0.66	2.9e-11	Lung cancer in ever smokers;
SKCM	cis	rs59918340	0.728	rs35257077	chr8:142235049	C/T	cg23750338	chr8:142222470	SLC45A4	-0.66	-6.33	-0.58	1.42e-8	Immature fraction of reticulocytes;
SKCM	cis	rs453301	0.653	rs2956244	chr8:8885166	A/G	cg15556689	chr8:8085844	FLJ10661	0.69	5.86	0.55	1.05e-7	Joint mobility (Beighton score);
SKCM	cis	rs995000	0.895	rs11208001	chr1:63130431	C/T	cg06896770	chr1:63153194	DOCK7	0.75	7.28	0.64	2.34e-10	Triglyceride levels;
SKCM	cis	rs801193	1.000	rs62466793	chr7:66191517	G/A	cg11987759	chr7:65425863	GUSB	-0.69	-5.91	-0.56	8.69e-8	Aortic root size;
SKCM	trans	rs1814175	0.817	rs4405313	chr11:50013636	G/A	cg03929089	chr4:120376271	NA	-0.93	-8.77	-0.7	3.08e-13	Height;
SKCM	cis	rs72949976	0.864	rs10176806	chr2:214022596	T/G	cg08319019	chr2:214017104	IKZF2	-0.74	-5.58	-0.53	3.39e-7	Lung cancer;Squamous cell lung carcinoma;
SKCM	cis	rs28386778	0.897	rs4968663	chr17:61835603	A/T	cg01411255	chr17:61851458	DDX42;CCDC47	0.78	5.03	0.49	3.06e-6	Prudent dietary pattern;
SKCM	cis	rs1799949	0.536	rs4793227	chr17:41412250	A/C	cg05368731	chr17:41323189	NBR1	0.83	7.1	0.63	5.07e-10	Menopause (age at onset);
SKCM	cis	rs7945705	0.712	rs61876274	chr11:9019190	A/T	cg13070366	chr11:9386451	NA	-0.64	-5.22	-0.51	1.43e-6	Hemoglobin concentration;
SKCM	cis	rs6461049	0.800	rs1860831	chr7:2160931	T/C	cg02951883	chr7:2050386	MAD1L1	-0.74	-7.09	-0.63	5.29e-10	Schizophrenia;
SKCM	cis	rs8067545	0.611	rs2013443	chr17:20023109	G/C	cg13482628	chr17:19912719	NA	0.66	5.58	0.53	3.39e-7	Schizophrenia;
SKCM	cis	rs6815814	0.950	rs11722889	chr4:38810975	C/T	cg02016764	chr4:38805732	TLR1	-0.77	-5.49	-0.53	4.78e-7	Breast cancer;
SKCM	cis	rs12682352	0.652	rs1567398	chr8:8726804	A/C	cg06636001	chr8:8085503	FLJ10661	-0.7	-5.51	-0.53	4.46e-7	Neuroticism;
SKCM	cis	rs71636778	0.543	rs75305560	chr1:27242521	T/G	cg01689405	chr1:26370407	SLC30A2	-0.52	-4.79	-0.48	7.94e-6	Monocyte percentage of white cells;Granulocyte percentage of myeloid white cells;
SKCM	cis	rs8014204	1.000	rs10483863	chr14:75322327	A/G	cg06637938	chr14:75390232	RPS6KL1	-0.66	-4.83	-0.48	6.72e-6	Caffeine consumption;
SKCM	cis	rs2279817	1.000	rs4920619	chr1:18023112	A/G	cg17142039	chr1:18149651	ACTL8	0.62	5.19	0.51	1.66e-6	Neuroticism;
SKCM	cis	rs7772486	0.686	rs9390357	chr6:146129347	A/G	cg05347473	chr6:146136440	FBXO30	0.58	5.28	0.51	1.12e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs35079168	0.809	rs11103483	chr9:137287874	G/A	cg00753924	chr9:137298813	RXRA	-0.75	-5.07	-0.5	2.57e-6	Intelligence;
SKCM	cis	rs7103648	0.695	rs6485758	chr11:47530024	G/A	cg20307385	chr11:47447363	PSMC3	0.97	7.44	0.64	1.15e-10	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs9911578	1.000	rs9904879	chr17:56864422	G/A	cg05425664	chr17:57184151	TRIM37	-0.69	-5.21	-0.51	1.52e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7666738	0.830	rs13138920	chr4:99020786	A/G	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11608355	0.538	rs7305165	chr12:109804222	G/A	cg19025524	chr12:109796872	NA	-0.67	-6.07	-0.57	4.3e-8	Neuroticism;
SKCM	cis	rs28386778	0.897	rs7221853	chr17:61859836	A/G	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs1003719	0.788	rs2835582	chr21:38458773	C/G	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.0	0.49	3.44e-6	Eye color traits;
SKCM	cis	rs11098499	0.863	rs3733525	chr4:120447048	A/G	cg24375607	chr4:120327624	NA	0.68	5.27	0.51	1.16e-6	Corneal astigmatism;
SKCM	cis	rs2836974	0.897	rs2836973	chr21:40654928	A/G	cg11890956	chr21:40555474	PSMG1	1.09	13.83	0.84	1.08e-22	Cognitive function;
SKCM	cis	rs10504073	0.647	rs4873096	chr8:49995201	A/G	cg00325661	chr8:49890786	NA	0.78	6.77	0.61	2.18e-9	Blood metabolite ratios;
SKCM	cis	rs10503709	0.542	rs12682357	chr8:21445254	C/T	cg23716449	chr8:21608280	GFRA2	-0.48	-4.81	-0.48	7.25e-6	Blood protein levels;
SKCM	cis	rs995000	0.899	rs11577840	chr1:62991369	T/C	cg06896770	chr1:63153194	DOCK7	-0.74	-6.81	-0.61	1.77e-9	Triglyceride levels;
SKCM	cis	rs514406	0.607	rs1930305	chr1:53195481	G/T	cg16325326	chr1:53192061	ZYG11B	-1.0	-12.3	-0.81	6.1e-20	Monocyte count;
SKCM	cis	rs28595532	0.920	rs114796605	chr4:119744472	C/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs8180040	0.627	rs58956475	chr3:47224615	G/C	cg27129171	chr3:47204927	SETD2	-0.74	-5.3	-0.51	1.05e-6	Colorectal cancer;
SKCM	cis	rs6088590	1.000	rs2295354	chr20:33356541	T/C	cg24642439	chr20:33292090	TP53INP2	1.01	7.2	0.63	3.23e-10	Coronary artery disease;
SKCM	cis	rs2732480	0.577	rs2634678	chr12:48735538	C/G	cg21348975	chr12:48724119	NA	-0.62	-5.41	-0.52	6.74e-7	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs951366	0.789	rs823110	chr1:205701078	G/C	cg14893161	chr1:205819251	PM20D1	1.04	9.81	0.74	2.9e-15	Menarche (age at onset);
SKCM	cis	rs7143963	0.636	rs9324052	chr14:103344307	C/A	cg23020514	chr14:103360112	TRAF3	0.74	6.99	0.62	8.38e-10	Body mass index;
SKCM	cis	rs17376456	0.825	rs1470150	chr5:93138654	C/T	cg25358565	chr5:93447407	FAM172A	-1.11	-7.37	-0.64	1.55e-10	Diabetic retinopathy;
SKCM	cis	rs7811142	1.000	rs7809801	chr7:100072031	T/C	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.12	6.51	0.59	6.68e-9	Platelet count;
SKCM	cis	rs13161895	0.702	rs73810942	chr5:179499267	C/A	cg02702477	chr5:179499311	RNF130	1.02	5.13	0.5	2.03e-6	LDL cholesterol;
SKCM	cis	rs28595532	0.920	rs56302600	chr4:119770162	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs6087990	0.735	rs1040554	chr20:31380073	C/T	cg13636640	chr20:31349939	DNMT3B	0.87	6.72	0.61	2.64e-9	Ulcerative colitis;
SKCM	cis	rs1580019	0.961	rs3801328	chr7:32496930	T/C	cg06627557	chr7:32535165	LSM5;AVL9	0.75	5.74	0.55	1.7e-7	Cognitive ability;
SKCM	cis	rs951366	0.764	rs708725	chr1:205744138	G/T	cg11965913	chr1:205819406	PM20D1	0.97	9.9	0.75	1.99e-15	Menarche (age at onset);
SKCM	cis	rs13424612	0.965	rs4149544	chr2:240943162	C/T	cg01812947	chr2:240904978	NDUFA10	0.7	5.65	0.54	2.48e-7	Odorant perception (isobutyraldehyde);
SKCM	cis	rs9911578	0.839	rs11658694	chr17:57205174	T/C	cg05425664	chr17:57184151	TRIM37	-0.77	-6.13	-0.57	3.37e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs6540556	0.954	rs7536882	chr1:209936673	C/G	cg05527609	chr1:210001259	C1orf107	-0.88	-4.92	-0.49	4.67e-6	Red blood cell count;
SKCM	cis	rs16854884	0.657	rs35959290	chr3:143725566	T/A	cg06585982	chr3:143692056	C3orf58	0.83	7.55	0.65	6.97e-11	Economic and political preferences (feminism/equality);
SKCM	cis	rs9815354	0.812	rs77732985	chr3:41945872	G/A	cg03022575	chr3:42003672	ULK4	1.05	5.28	0.51	1.11e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs6121246	0.512	rs6058384	chr20:30276409	A/T	cg13852791	chr20:30311386	BCL2L1	0.82	5.69	0.54	2.09e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs4689592	0.503	rs59640165	chr4:7051661	G/A	cg19539972	chr4:7069911	GRPEL1	-0.97	-6.37	-0.58	1.24e-8	Monocyte percentage of white cells;
SKCM	cis	rs7811142	0.943	rs3900792	chr7:100004577	C/G	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.33	0.69	2.11e-12	Platelet count;
SKCM	cis	rs6570726	0.846	rs6570698	chr6:145918635	C/G	cg23711669	chr6:146136114	FBXO30	0.79	7.47	0.65	9.74e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1153858	1.000	rs7171577	chr15:45627979	G/A	cg21132104	chr15:45694354	SPATA5L1	0.89	7.18	0.63	3.58e-10	Homoarginine levels;
SKCM	cis	rs875971	0.660	rs13224319	chr7:66007363	A/G	cg18876405	chr7:65276391	NA	0.8	7.11	0.63	4.86e-10	Aortic root size;
SKCM	cis	rs9611565	0.649	rs79009	chr22:41860864	C/A	cg03806693	chr22:41940476	POLR3H	1.13	7.36	0.64	1.63e-10	Vitiligo;
SKCM	cis	rs709400	0.663	rs1022736	chr14:103998423	G/C	cg26031613	chr14:104095156	KLC1	0.69	5.35	0.52	8.62e-7	Body mass index;
SKCM	cis	rs2228479	0.867	rs62052185	chr16:89969254	C/T	cg06558623	chr16:89946397	TCF25	1.26	6.97	0.62	9.17e-10	Skin colour saturation;
SKCM	cis	rs7666738	0.606	rs6852813	chr4:99084671	G/A	cg17366294	chr4:99064904	C4orf37	0.61	5.06	0.5	2.73e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1023500	0.573	rs133377	chr22:42466950	C/T	cg04733989	chr22:42467013	NAGA	0.72	5.72	0.54	1.9e-7	Schizophrenia;
SKCM	cis	rs1801251	0.893	rs11687128	chr2:233608901	T/C	cg25237894	chr2:233734115	C2orf82	0.56	5.33	0.52	9.23e-7	Coronary artery disease;
SKCM	cis	rs9910055	0.659	rs112114764	chr17:42201041	G/T	cg19774624	chr17:42201019	HDAC5	0.93	8.78	0.71	2.86e-13	Total body bone mineral density;
SKCM	cis	rs2832191	0.791	rs7282843	chr21:30475226	A/G	cg08807101	chr21:30365312	RNF160	0.62	4.94	0.49	4.34e-6	Dental caries;
SKCM	cis	rs9910055	0.762	rs2631299	chr17:42219773	G/T	cg13607699	chr17:42295918	UBTF	0.77	5.93	0.56	7.83e-8	Total body bone mineral density;
SKCM	cis	rs4819052	0.851	rs8134392	chr21:46663790	A/G	cg02159808	chr21:46707872	POFUT2;LOC642852	-0.7	-5.41	-0.52	6.6e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs362272	0.545	rs2749782	chr4:3339761	A/G	cg00764545	chr4:3318001	RGS12	0.99	13.61	0.84	2.68e-22	Serum sulfate level;
SKCM	cis	rs9858542	0.953	rs6446264	chr3:49417243	C/A	cg03060546	chr3:49711283	APEH	-0.69	-5.16	-0.5	1.85e-6	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs10883723	0.810	rs2296590	chr10:104262628	G/A	cg11453585	chr10:104263688	ACTR1A;SUFU	0.75	5.7	0.54	2.03e-7	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs35766269	0.541	rs7081353	chr10:9044335	A/G	cg05671070	chr10:8095960	FLJ45983;GATA3	0.95	4.77	0.48	8.45e-6	Recalcitrant atopic dermatitis;
SKCM	cis	rs6500395	1.000	rs1106386	chr16:48593065	C/A	cg04672837	chr16:48644449	N4BP1	0.69	5.73	0.54	1.8e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs9309711	0.643	rs4264589	chr2:3481098	G/T	cg15506890	chr2:3487001	NA	-0.62	-5.04	-0.5	2.89e-6	Neurofibrillary tangles;
SKCM	trans	rs62103177	0.789	rs7242289	chr18:77603291	C/T	cg05926928	chr17:57297772	GDPD1	1.27	8.28	0.68	2.73e-12	Opioid sensitivity;
SKCM	cis	rs1005277	0.541	rs1740741	chr10:38515334	C/T	cg00409905	chr10:38381863	ZNF37A	-0.62	-5.82	-0.55	1.24e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs2396545	0.680	rs35467761	chr11:571568	A/G	cg16486109	chr11:613632	IRF7	1.06	6.36	0.58	1.26e-8	Systemic lupus erythematosus and Systemic sclerosis;
SKCM	cis	rs4780401	0.609	rs9923954	chr16:11816855	G/T	cg01061890	chr16:11836724	TXNDC11	-0.77	-5.59	-0.54	3.18e-7	Rheumatoid arthritis;
SKCM	cis	rs8017423	1.000	rs10129210	chr14:90668379	G/T	cg04374321	chr14:90722782	PSMC1	0.94	8.42	0.69	1.42e-12	Mortality in heart failure;
SKCM	cis	rs12142240	0.698	rs6429599	chr1:46827871	G/A	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs2354432	0.556	rs7516165	chr1:146866418	G/T	cg25205988	chr1:146714368	CHD1L	1.08	5.32	0.52	9.52e-7	Mitochondrial DNA levels;
SKCM	cis	rs9916302	0.904	rs11867312	chr17:37597748	C/T	cg07936489	chr17:37558343	FBXL20	-0.85	-7.35	-0.64	1.71e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs1218582	0.844	rs6699080	chr1:154834911	G/A	cg03351412	chr1:154909251	PMVK	0.74	6.63	0.6	3.94e-9	Prostate cancer;
SKCM	cis	rs2228479	0.850	rs12596934	chr16:89841605	T/G	cg06558623	chr16:89946397	TCF25	1.06	4.84	0.48	6.45e-6	Skin colour saturation;
SKCM	cis	rs1979654	0.543	rs16940985	chr16:86403723	C/G	cg05448715	chr16:87090352	NA	-0.47	-5.04	-0.5	2.92e-6	Barrett's esophagus  or Esophageal adenocarcinoma;
SKCM	cis	rs9814567	1.000	rs9863786	chr3:134247203	C/G	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs875971	0.964	rs6945019	chr7:65922458	C/G	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	cis	rs1577917	0.958	rs10944137	chr6:86454314	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.87	-8.7	-0.7	4.17e-13	Response to antipsychotic treatment;
SKCM	cis	rs2658782	0.654	rs2248524	chr11:93255715	G/A	cg15737290	chr11:93063684	CCDC67	0.81	5.69	0.54	2.13e-7	Pulmonary function decline;
SKCM	cis	rs17685	0.712	rs9800948	chr7:75810473	A/G	cg01364799	chr7:75623366	TMEM120A	-0.68	-5.87	-0.55	9.91e-8	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7666738	0.830	rs1120708	chr4:98931260	G/C	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7666738	0.830	rs2865989	chr4:99067532	G/A	cg17366294	chr4:99064904	C4orf37	0.61	4.93	0.49	4.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10751667	0.600	rs10794342	chr11:924904	C/T	cg10932868	chr11:921992	NA	0.54	5.12	0.5	2.14e-6	Alzheimer's disease (late onset);
SKCM	cis	rs453301	0.522	rs1964356	chr8:8853270	G/T	cg15556689	chr8:8085844	FLJ10661	0.69	5.37	0.52	7.98e-7	Joint mobility (Beighton score);
SKCM	cis	rs3768617	0.510	rs1886499	chr1:183095024	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs17685	0.753	rs1637037	chr7:75692927	C/T	cg16684958	chr7:75615977	POR	0.59	5.63	0.54	2.69e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs523522	0.962	rs2393590	chr12:120913900	G/A	cg12219531	chr12:120966889	COQ5	0.91	7.85	0.66	1.84e-11	High light scatter reticulocyte count;
SKCM	cis	rs9896933	0.708	rs9908751	chr17:80791830	C/T	cg20578329	chr17:80767326	TBCD	0.76	5.67	0.54	2.29e-7	Bone mineral accretion in asthma (oral corticosteroid dose interaction);
SKCM	cis	rs2019137	0.539	rs6755040	chr2:113981137	T/C	cg21550016	chr2:113992930	PAX8;LOC440839;LOC654433	0.64	5.02	0.49	3.19e-6	Lymphocyte counts;
SKCM	cis	rs951366	0.528	rs1172198	chr1:205662718	C/T	cg14893161	chr1:205819251	PM20D1	0.84	6.9	0.62	1.21e-9	Menarche (age at onset);
SKCM	cis	rs860295	0.650	rs11264422	chr1:155907823	T/A	cg02153340	chr1:155202674	NA	0.74	5.29	0.51	1.09e-6	Body mass index;
SKCM	cis	rs1707322	0.716	rs28375469	chr1:46195375	T/C	cg03146154	chr1:46216737	IPP	0.81	5.62	0.54	2.87e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs8180040	0.900	rs10865946	chr3:47425060	T/G	cg27129171	chr3:47204927	SETD2	0.79	5.79	0.55	1.43e-7	Colorectal cancer;
SKCM	cis	rs10089	0.552	rs17607942	chr5:127555435	C/T	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.65	5.2	0.51	1.55e-6	Ileal carcinoids;
SKCM	cis	rs1267303	0.642	rs61783087	chr1:46999955	T/C	cg25110126	chr1:46999211	NA	0.75	5.57	0.53	3.51e-7	Monobrow;
SKCM	cis	rs4808199	0.649	rs34755166	chr19:19665581	G/A	cg03709012	chr19:19516395	GATAD2A	0.89	4.88	0.48	5.5e-6	Nonalcoholic fatty liver disease;
SKCM	cis	rs12497850	0.931	rs3774628	chr3:48801840	C/T	cg07636037	chr3:49044803	WDR6	0.96	9.67	0.74	5.43e-15	Parkinson's disease;
SKCM	cis	rs597205	0.881	rs11102344	chr1:112386635	C/T	cg22162010	chr1:113249994	RHOC	0.85	4.85	0.48	6.17e-6	Gut microbiota (bacterial taxa);
SKCM	cis	rs56235845	0.796	rs13153019	chr5:176782218	T/C	cg06060754	chr5:176797920	RGS14	0.83	7.06	0.62	6.05e-10	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs12142240	0.731	rs12385693	chr1:46818921	A/C	cg14993813	chr1:46806288	NSUN4	-0.72	-4.83	-0.48	6.8e-6	Menopause (age at onset);
SKCM	cis	rs2439831	0.867	rs935901	chr15:43651256	G/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.43	8.5	0.69	1.02e-12	Lung cancer in ever smokers;
SKCM	cis	rs708547	0.647	rs1718839	chr4:57827206	A/G	cg16868167	chr4:57843880	C4orf14;POLR2B	0.73	5.45	0.52	5.77e-7	Response to bleomycin (chromatid breaks);
SKCM	cis	rs7523050	0.643	rs35526993	chr1:109405107	A/T	cg08274380	chr1:109419600	GPSM2	1.18	6.44	0.59	9.12e-9	Fat distribution (HIV);
SKCM	cis	rs9443189	0.526	rs9359132	chr6:76289553	G/A	cg01950844	chr6:76311363	SENP6	0.99	6.07	0.57	4.36e-8	Prostate cancer;
SKCM	cis	rs2739330	0.753	rs4822452	chr22:24254363	C/T	cg24846343	chr22:24311635	DDTL	0.61	5.85	0.55	1.1e-7	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs6570726	0.791	rs436156	chr6:145874873	A/G	cg05347473	chr6:146136440	FBXO30	0.57	5.13	0.5	2.06e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs709400	0.663	rs3742458	chr14:103950368	A/G	cg26031613	chr14:104095156	KLC1	0.77	5.96	0.56	6.87e-8	Body mass index;
SKCM	cis	rs637571	0.522	rs12792888	chr11:65761446	C/T	cg02427764	chr11:65769310	BANF1;EIF1AD	0.77	5.98	0.56	6.3e-8	Eosinophil percentage of white cells;
SKCM	cis	rs7523273	0.526	rs1204706	chr1:208021060	G/T	cg22525895	chr1:207977042	MIR29B2	-0.85	-6.65	-0.6	3.69e-9	Schizophrenia;
SKCM	cis	rs875971	0.522	rs34973832	chr7:65396204	A/G	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.59	4.9	0.49	5.01e-6	Aortic root size;
SKCM	cis	rs992157	1.000	rs3731859	chr2:219124222	G/A	cg00012203	chr2:219082015	ARPC2	0.83	6.98	0.62	8.66e-10	Colorectal cancer;
SKCM	cis	rs2243480	1.000	rs13220979	chr7:65363204	G/A	cg07424592	chr7:64974309	NA	0.99	4.9	0.49	5.08e-6	Diabetic kidney disease;
SKCM	cis	rs7666738	0.830	rs2903150	chr4:99027184	T/C	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	trans	rs1814175	0.791	rs10839468	chr11:49986288	A/G	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs7772486	0.686	rs2328708	chr6:146095739	G/A	cg23711669	chr6:146136114	FBXO30	-0.86	-9.33	-0.73	2.43e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2370759	1.000	rs76467481	chr10:32610740	T/G	cg01819863	chr10:32635814	EPC1	0.95	5.14	0.5	1.95e-6	Sexual dysfunction (female);
SKCM	cis	rs6545883	0.895	rs4430924	chr2:61703856	A/G	cg15711740	chr2:61764176	XPO1	-0.7	-4.88	-0.48	5.43e-6	Tuberculosis;
SKCM	cis	rs1577917	0.958	rs12203457	chr6:86689277	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.83	-8.23	-0.68	3.37e-12	Response to antipsychotic treatment;
SKCM	cis	rs8008758	0.534	rs1763216	chr14:101691410	C/T	cg26224664	chr14:101693935	NA	-0.41	-5.03	-0.5	3.01e-6	Body mass index (alcohol intake interaction);
SKCM	cis	rs8063761	0.576	rs6500463	chr16:90043506	C/G	cg08547343	chr16:90038815	CENPBD1;AFG3L1	1.15	10.47	0.76	1.61e-16	Squamous cell carcinoma;
SKCM	cis	rs9300255	0.512	rs2851436	chr12:123667354	G/T	cg00376283	chr12:123451042	ABCB9	0.86	5.28	0.51	1.12e-6	Neutrophil percentage of white cells;
SKCM	cis	rs2197308	0.765	rs12824529	chr12:37931656	T/C	cg26384229	chr12:38710491	ALG10B	0.81	6.59	0.6	4.69e-9	Morning vs. evening chronotype;
SKCM	cis	rs17376456	0.877	rs12716456	chr5:93397557	A/G	cg25358565	chr5:93447407	FAM172A	1.19	7.67	0.66	4.06e-11	Diabetic retinopathy;
SKCM	cis	rs1348850	0.651	rs4893821	chr2:178229352	A/G	cg02961200	chr2:178257176	LOC100130691;AGPS	-0.79	-5.84	-0.55	1.13e-7	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs4132509	1.000	rs4132509	chr1:243943084	A/C	cg21452805	chr1:244014465	NA	-0.84	-4.93	-0.49	4.47e-6	RR interval (heart rate);
SKCM	cis	rs2075371	0.734	rs13225086	chr7:134011411	C/T	cg20476274	chr7:133979776	SLC35B4	0.94	9.09	0.72	7.09e-14	Mean platelet volume;
SKCM	cis	rs7824557	0.564	rs2572394	chr8:11235393	A/G	cg21775007	chr8:11205619	TDH	-0.59	-5.03	-0.5	3.01e-6	Retinal vascular caliber;
SKCM	cis	rs875971	1.000	rs875971	chr7:65617595	A/G	cg11764359	chr7:65958608	NA	-0.86	-8.23	-0.68	3.44e-12	Aortic root size;
SKCM	cis	rs9815354	0.556	rs60966614	chr3:42005166	A/G	cg03022575	chr3:42003672	ULK4	1.0	5.0	0.49	3.43e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs9902453	0.726	rs3110494	chr17:27976597	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.79	5.71	0.54	1.94e-7	Coffee consumption (cups per day);
SKCM	cis	rs6951245	0.935	rs11763765	chr7:1060510	C/T	cg21664854	chr7:1097933	C7orf50;GPR146	0.9	4.86	0.48	6.05e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7927771	0.965	rs3817335	chr11:47643891	T/A	cg05585544	chr11:47624801	NA	-0.64	-5.51	-0.53	4.43e-7	Subjective well-being;
SKCM	cis	rs1568889	1.000	rs33937991	chr11:28045260	A/G	cg06544937	chr11:28130018	METT5D1;KIF18A	0.86	7.03	0.62	6.97e-10	Bipolar disorder;
SKCM	cis	rs6951245	0.935	rs76525951	chr7:1096013	C/T	cg03188948	chr7:1209495	NA	1.13	6.27	0.58	1.89e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7843479	0.965	rs11135741	chr8:21801091	C/T	cg17168535	chr8:21777572	XPO7	0.75	6.11	0.57	3.72e-8	Mean corpuscular volume;
SKCM	cis	rs9581857	0.685	rs12584061	chr13:28024544	C/T	cg22138327	chr13:27999177	GTF3A	0.72	5.05	0.5	2.88e-6	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs7829975	0.628	rs1109618	chr8:8571364	A/T	cg06636001	chr8:8085503	FLJ10661	-0.69	-5.31	-0.52	9.85e-7	Mood instability;
SKCM	cis	rs9911578	1.000	rs1267545	chr17:56646909	A/G	cg05425664	chr17:57184151	TRIM37	-0.68	-5.16	-0.5	1.85e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7772486	0.597	rs9386136	chr6:146158300	A/T	cg23711669	chr6:146136114	FBXO30	0.81	7.18	0.63	3.51e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs826838	0.967	rs11169387	chr12:39145737	C/T	cg26384229	chr12:38710491	ALG10B	0.95	8.75	0.7	3.24e-13	Heart rate;
SKCM	cis	rs561341	0.602	rs114562703	chr17:30233899	G/T	cg00745463	chr17:30367425	LRRC37B	-0.99	-6.33	-0.58	1.46e-8	Hip circumference adjusted for BMI;
SKCM	cis	rs7215564	0.908	rs56078934	chr17:78658849	A/C	cg16980736	chr17:78789706	RPTOR	-0.89	-4.88	-0.48	5.41e-6	Myopia (pathological);
SKCM	cis	rs2286503	0.966	rs2286507	chr7:22854760	T/C	cg15401507	chr7:22894281	NA	-0.57	-5.61	-0.54	2.99e-7	Fibrinogen;
SKCM	cis	rs8014204	0.804	rs35769520	chr14:75255115	G/A	cg06637938	chr14:75390232	RPS6KL1	0.84	6.66	0.6	3.53e-9	Caffeine consumption;
SKCM	cis	rs826838	1.000	rs860400	chr12:39081279	A/G	cg13010199	chr12:38710504	ALG10B	-0.82	-6.22	-0.58	2.26e-8	Heart rate;
SKCM	cis	rs13118159	0.550	rs2878607	chr4:1353310	G/C	cg16405210	chr4:1374714	KIAA1530	-0.95	-7.15	-0.63	4e-10	Longevity;
SKCM	cis	rs60871478	0.588	rs56205589	chr7:910419	G/A	cg05535760	chr7:792225	HEATR2	-1.34	-8.04	-0.67	7.79e-12	Cerebrospinal P-tau181p levels;
SKCM	cis	rs2243480	1.000	rs1701758	chr7:65470201	T/A	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs995000	0.931	rs1168089	chr1:63113719	T/C	cg06896770	chr1:63153194	DOCK7	-0.76	-7.17	-0.63	3.77e-10	Triglyceride levels;
SKCM	cis	rs1577917	0.655	rs12203963	chr6:86223316	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.76	6.81	0.61	1.84e-9	Response to antipsychotic treatment;
SKCM	cis	rs780096	0.546	rs4425043	chr2:27733452	G/A	cg05696406	chr2:27599888	SNX17	0.51	5.09	0.5	2.45e-6	Total body bone mineral density;
SKCM	cis	rs2721195	1.000	rs6599530	chr8:145677418	C/G	cg11211951	chr8:145729740	GPT	-0.63	-5.98	-0.56	6.27e-8	Age at first birth;
SKCM	cis	rs2836974	0.533	rs418298	chr21:40536654	A/T	cg11890956	chr21:40555474	PSMG1	0.91	9.5	0.73	1.14e-14	Cognitive function;
SKCM	cis	rs7937682	0.889	rs558736	chr11:111500760	C/G	cg09085632	chr11:111637200	PPP2R1B	-1.07	-11.23	-0.79	5.72e-18	Primary sclerosing cholangitis;
SKCM	cis	rs8017423	0.935	rs716122	chr14:90792313	A/C	cg04374321	chr14:90722782	PSMC1	-1.04	-9.75	-0.74	3.8e-15	Mortality in heart failure;
SKCM	cis	rs2072499	0.900	rs2248080	chr1:156195971	T/A	cg24450063	chr1:156163899	SLC25A44	0.92	7.69	0.66	3.75e-11	Testicular germ cell tumor;
SKCM	cis	rs6921919	0.525	rs11760133	chr6:28386739	A/T	cg14547644	chr6:28411285	ZSCAN23	-0.58	-4.8	-0.48	7.46e-6	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs875971	1.000	rs6963646	chr7:65685767	T/C	cg11764359	chr7:65958608	NA	-0.86	-8.23	-0.68	3.44e-12	Aortic root size;
SKCM	trans	rs62103177	0.733	rs62103193	chr18:77629217	C/T	cg05926928	chr17:57297772	GDPD1	1.29	8.74	0.7	3.44e-13	Opioid sensitivity;
SKCM	cis	rs2304069	0.826	rs245076	chr5:149350648	C/T	cg22760475	chr5:149380129	HMGXB3;TIGD6	0.66	4.77	0.48	8.27e-6	HIV-1 control;
SKCM	cis	rs2204008	0.837	rs11183232	chr12:37941053	A/G	cg26384229	chr12:38710491	ALG10B	0.8	7.0	0.62	8.01e-10	Bladder cancer;
SKCM	cis	rs7772486	0.720	rs6931553	chr6:146112348	T/C	cg05347473	chr6:146136440	FBXO30	-0.61	-5.8	-0.55	1.37e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1577917	0.655	rs7766485	chr6:86263555	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.73	6.45	0.59	8.66e-9	Response to antipsychotic treatment;
SKCM	cis	rs9611565	0.694	rs202637	chr22:41853928	A/G	cg03806693	chr22:41940476	POLR3H	1.06	6.38	0.59	1.18e-8	Vitiligo;
SKCM	cis	rs10540	1.000	rs10540	chr11:494662	G/A	cg03352830	chr11:487213	PTDSS2	0.93	4.88	0.48	5.56e-6	Body mass index;
SKCM	cis	rs514406	0.861	rs2477741	chr1:53265278	A/G	cg16325326	chr1:53192061	ZYG11B	-0.99	-11.71	-0.8	7.39e-19	Monocyte count;
SKCM	cis	rs11532322	1	rs11532322	chr12:123731423	A/G	cg05973401	chr12:123451056	ABCB9	0.75	5.83	0.55	1.18e-7	Schizophrenia;
SKCM	cis	rs3820068	0.603	rs1980607	chr1:15975237	A/G	cg24675056	chr1:15929824	NA	0.73	5.44	0.52	6.03e-7	Systolic blood pressure;
SKCM	cis	rs9325144	0.625	rs12227353	chr12:38734542	C/T	cg13010199	chr12:38710504	ALG10B	-0.65	-5.36	-0.52	8.31e-7	Morning vs. evening chronotype;
SKCM	cis	rs763014	0.932	rs2384975	chr16:651115	G/T	cg07343612	chr16:622815	PIGQ	-0.67	-5.78	-0.55	1.47e-7	Height;
SKCM	cis	rs244731	0.919	rs12652509	chr5:176626441	A/G	cg06060754	chr5:176797920	RGS14	-0.82	-7.22	-0.63	2.97e-10	Urate levels in lean individuals;
SKCM	cis	rs2228479	1.000	rs11642267	chr16:89957635	T/C	cg06558623	chr16:89946397	TCF25	1.12	5.64	0.54	2.58e-7	Skin colour saturation;
SKCM	cis	rs2120019	0.938	rs2289582	chr15:75310394	T/C	cg09165964	chr15:75287851	SCAMP5	-0.83	-7.83	-0.66	2e-11	Blood trace element (Zn levels);
SKCM	cis	rs6840360	0.571	rs11931934	chr4:152552082	A/G	cg22705602	chr4:152727874	NA	-0.52	-5.69	-0.54	2.15e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7216064	1.000	rs7216064	chr17:65898809	G/A	cg12091567	chr17:66097778	LOC651250	-0.76	-5.15	-0.5	1.87e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs6977660	1.000	rs7779902	chr7:19803491	G/A	cg05791153	chr7:19748676	TWISTNB	0.79	5.53	0.53	4.14e-7	Thyroid stimulating hormone;
SKCM	cis	rs1218582	0.741	rs2335407	chr1:154843347	A/G	cg03351412	chr1:154909251	PMVK	-0.75	-6.65	-0.6	3.64e-9	Prostate cancer;
SKCM	cis	rs28595532	0.748	rs72670258	chr4:119391660	A/T	cg11846333	chr4:119757529	SEC24D	1.18	6.4	0.59	1.06e-8	Cannabis dependence symptom count;
SKCM	cis	rs6430585	0.527	rs76380759	chr2:136438517	G/A	cg07169764	chr2:136633963	MCM6	1.02	7.68	0.66	3.84e-11	Corneal structure;
SKCM	cis	rs7666738	0.830	rs6532701	chr4:98745134	C/T	cg17366294	chr4:99064904	C4orf37	0.59	5.05	0.5	2.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2894969	0.664	rs11252703	chr10:4795125	A/T	cg03822858	chr10:4066499	NA	0.64	5.24	0.51	1.32e-6	Major depressive disorder;
SKCM	cis	rs910316	0.967	rs10246	chr14:75544470	T/A	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.85e-7	Height;
SKCM	cis	rs28595532	0.920	rs17324968	chr4:119772316	A/G	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs2502731	0.504	rs7853212	chr9:130955238	A/G	cg09976142	chr9:130955436	CIZ1	-0.78	-7.97	-0.67	1.09e-11	Attention deficit hyperactivity disorder;
SKCM	cis	rs875971	0.545	rs67688847	chr7:65626051	G/A	cg18876405	chr7:65276391	NA	0.64	5.29	0.51	1.09e-6	Aortic root size;
SKCM	cis	rs9914544	1.000	rs1634411	chr17:18833810	C/T	cg26306683	chr17:18585705	ZNF286B	0.68	4.92	0.49	4.68e-6	Educational attainment (years of education);
SKCM	cis	rs3785574	0.962	rs2584632	chr17:61880641	G/A	cg06601766	chr17:61851465	DDX42;CCDC47	0.67	5.02	0.49	3.14e-6	Height;
SKCM	cis	rs1799949	1.000	rs8176077	chr17:41276348	T/C	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.11	-0.57	3.67e-8	Menopause (age at onset);
SKCM	cis	rs11764590	0.694	rs11762413	chr7:2090387	C/G	cg23422044	chr7:1970798	MAD1L1	-0.85	-6.45	-0.59	8.53e-9	Neuroticism;
SKCM	cis	rs6834538	0.597	rs4834291	chr4:113482718	C/T	cg05166686	chr4:113558556	LARP7;C4orf21	0.6	5.03	0.49	3.1e-6	Free thyroxine concentration;
SKCM	cis	rs7937682	0.889	rs10749984	chr11:111492861	T/C	cg19812747	chr11:111475976	SIK2	-0.56	-4.93	-0.49	4.55e-6	Primary sclerosing cholangitis;
SKCM	cis	rs4242434	0.927	rs10095121	chr8:22538426	A/G	cg03733263	chr8:22462867	KIAA1967	0.87	6.83	0.61	1.65e-9	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs4555082	1.000	rs7146012	chr14:105757566	G/A	cg13114125	chr14:105738426	BRF1	-0.67	-5.24	-0.51	1.35e-6	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs17376456	1.000	rs34756085	chr5:93556294	A/G	cg25358565	chr5:93447407	FAM172A	1.22	8.06	0.67	7.15e-12	Diabetic retinopathy;
SKCM	cis	rs2764980	1.000	rs11251794	chr10:3283931	C/T	cg11630169	chr10:3283847	NA	-0.61	-5.25	-0.51	1.27e-6	Attention deficit hyperactivity disorder and conduct disorder;
SKCM	cis	rs7192750	0.562	rs152838	chr16:72105702	C/T	cg14768367	chr16:72042858	DHODH	0.9	4.95	0.49	4.11e-6	LDL cholesterol levels;Total cholesterol levels;
SKCM	cis	rs736408	0.609	rs13082208	chr3:52781539	T/G	cg18404041	chr3:52824283	ITIH1	-0.56	-4.94	-0.49	4.32e-6	Bipolar disorder;
SKCM	cis	rs11098499	0.954	rs10005644	chr4:120298477	T/C	cg24375607	chr4:120327624	NA	0.65	4.97	0.49	3.87e-6	Corneal astigmatism;
SKCM	cis	rs1218582	0.774	rs11264284	chr1:154875793	C/T	cg03351412	chr1:154909251	PMVK	0.73	6.28	0.58	1.81e-8	Prostate cancer;
SKCM	cis	rs34779708	0.733	rs11010146	chr10:35541561	T/A	cg03585969	chr10:35415529	CREM	0.74	5.42	0.52	6.41e-7	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs6951245	0.938	rs117729148	chr7:1108531	G/A	cg18402987	chr7:1209562	NA	1.15	6.09	0.57	3.95e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs798554	0.683	rs1182155	chr7:2902890	C/G	cg04166393	chr7:2884313	GNA12	0.79	5.27	0.51	1.16e-6	Height;
SKCM	cis	rs6089829	0.925	rs6122087	chr20:61664553	T/C	cg08564027	chr20:61660810	NA	0.63	5.65	0.54	2.56e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs9815354	0.812	rs116393551	chr3:41865476	G/A	cg03022575	chr3:42003672	ULK4	1.04	5.01	0.49	3.31e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs35306767	0.761	rs12359796	chr10:1021479	G/C	cg25614935	chr10:1084866	C10orf110	0.68	4.84	0.48	6.55e-6	Eosinophil percentage of granulocytes;
SKCM	trans	rs1814175	0.616	rs847641	chr11:49919261	T/C	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs4242434	0.927	rs746011	chr8:22457804	C/T	cg03733263	chr8:22462867	KIAA1967	1.09	8.99	0.71	1.11e-13	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs9818758	0.607	rs56004653	chr3:49072228	T/C	cg00383909	chr3:49044727	WDR6	1.16	4.82	0.48	6.9e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs2652834	1.000	rs2729833	chr15:63397044	G/A	cg04194852	chr15:63334506	TPM1	0.78	4.97	0.49	3.88e-6	HDL cholesterol;
SKCM	cis	rs514406	0.571	rs11206004	chr1:53210958	G/A	cg24675658	chr1:53192096	ZYG11B	0.65	5.46	0.53	5.56e-7	Monocyte count;
SKCM	cis	rs7666738	0.830	rs11097606	chr4:99011486	C/T	cg17366294	chr4:99064904	C4orf37	0.63	5.11	0.5	2.25e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6977660	0.507	rs28402966	chr7:19774469	A/C	cg05791153	chr7:19748676	TWISTNB	0.93	4.92	0.49	4.79e-6	Thyroid stimulating hormone;
SKCM	cis	rs780096	0.505	rs12475426	chr2:27599132	G/A	cg05696406	chr2:27599888	SNX17	0.48	4.99	0.49	3.62e-6	Total body bone mineral density;
SKCM	cis	rs7528419	1.000	rs12740374	chr1:109817590	G/T	cg00908766	chr1:109817496	CELSR2	-0.45	-5.02	-0.49	3.17e-6	Coronary artery disease (myocardial infartum, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease);Myocardial infarction;Lipoprotein-associated phospholipase A2 activity and mass;Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease;Cholesterol, total;Coronary artery disease;
SKCM	cis	rs12824058	0.831	rs11060825	chr12:130807905	A/G	cg24838063	chr12:130822603	PIWIL1	0.76	6.66	0.6	3.44e-9	Menopause (age at onset);
SKCM	cis	rs2188420	0.872	rs6961244	chr7:106530481	A/C	cg23615938	chr7:105753134	SYPL1	-0.89	-5.06	-0.5	2.73e-6	Interferon gamma levels;
SKCM	cis	rs6474412	0.588	rs6474418	chr8:42631284	G/C	cg11207534	chr8:41686438	ANK1	-0.73	-4.8	-0.48	7.53e-6	Smoking behavior;
SKCM	cis	rs1153858	1.000	rs16952714	chr15:45650358	G/A	cg10760299	chr15:45669010	GATM	0.62	6.35	0.58	1.3e-8	Homoarginine levels;
SKCM	cis	rs28595532	0.920	rs56104443	chr4:119752052	G/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs6570726	0.620	rs12201226	chr6:145913419	A/T	cg05347473	chr6:146136440	FBXO30	0.65	5.14	0.5	1.98e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs992157	0.798	rs4996257	chr2:219162836	C/T	cg00012203	chr2:219082015	ARPC2	0.73	5.86	0.55	1.03e-7	Colorectal cancer;
SKCM	cis	rs754466	0.510	rs55893027	chr10:79588209	C/T	cg17075019	chr10:79541650	NA	-0.6	-5.23	-0.51	1.38e-6	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs9325144	0.560	rs11183090	chr12:38662293	G/C	cg26384229	chr12:38710491	ALG10B	-0.61	-4.93	-0.49	4.57e-6	Morning vs. evening chronotype;
SKCM	cis	rs9796	0.621	rs691702	chr15:41474399	C/G	cg18705301	chr15:41695430	NDUFAF1	-0.69	-5.11	-0.5	2.19e-6	Menopause (age at onset);
SKCM	cis	rs67311347	0.568	rs57287242	chr3:40335538	T/C	cg00656387	chr3:40428638	ENTPD3	0.57	5.05	0.5	2.81e-6	Renal cell carcinoma;
SKCM	cis	rs6450176	1.000	rs3776715	chr5:53299095	T/C	ch.5.1024479R	chr5:53302184	ARL15	-0.71	-4.88	-0.48	5.49e-6	HDL cholesterol levels;HDL cholesterol;Adiponectin levels;
SKCM	cis	rs995000	0.931	rs11207986	chr1:63018170	T/C	cg06896770	chr1:63153194	DOCK7	-0.73	-6.54	-0.6	5.83e-9	Triglyceride levels;
SKCM	cis	rs2357013	0.752	rs2048310	chr2:53225842	G/T	cg07782112	chr2:53107842	NA	-0.53	-5.21	-0.51	1.49e-6	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs12621445	1	rs12621445	chr2:24154964	C/T	cg08917208	chr2:24149416	ATAD2B	1.02	5.84	0.55	1.16e-7	Immature fraction of reticulocytes;
SKCM	cis	rs6087990	0.899	rs4911262	chr20:31393352	G/A	cg13636640	chr20:31349939	DNMT3B	0.91	7.97	0.67	1.06e-11	Ulcerative colitis;
SKCM	cis	rs6840360	0.615	rs4696096	chr4:152475387	A/G	cg22705602	chr4:152727874	NA	-0.51	-5.78	-0.55	1.48e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs8077889	0.672	rs4793028	chr17:41857212	T/C	cg26893861	chr17:41843967	DUSP3	1.39	13.03	0.83	2.86e-21	Triglycerides;
SKCM	cis	rs6951245	1.000	rs78896566	chr7:1080182	C/G	cg24642844	chr7:1081250	C7orf50	-0.94	-6.32	-0.58	1.48e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs2204008	0.774	rs8186954	chr12:38318566	C/A	cg26384229	chr12:38710491	ALG10B	0.8	6.67	0.6	3.35e-9	Bladder cancer;
SKCM	cis	rs9640161	0.789	rs28439010	chr7:150046276	C/T	cg10018233	chr7:150070692	REPIN1	0.71	5.69	0.54	2.09e-7	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs6598955	0.724	rs10902731	chr1:26600793	A/G	cg00938395	chr1:26633206	UBXN11	0.67	4.83	0.48	6.71e-6	Obesity-related traits;
SKCM	cis	rs7106204	0.748	rs4360697	chr11:24217160	A/G	ch.11.24196551F	chr11:24239977	NA	0.77	6.39	0.59	1.09e-8	Response to Homoharringtonine (cytotoxicity);
SKCM	cis	rs2836974	0.897	rs68090597	chr21:40535633	A/G	cg17971929	chr21:40555470	PSMG1	0.87	8.48	0.69	1.1e-12	Cognitive function;
SKCM	cis	rs73201462	1.000	rs2955129	chr3:127929207	T/G	cg09089421	chr3:127803668	RUVBL1	-1.0	-5.11	-0.5	2.22e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs2549003	1.000	rs2070731	chr5:131819798	T/C	cg21138405	chr5:131827807	IRF1	0.42	4.92	0.49	4.66e-6	Asthma (sex interaction);
SKCM	cis	rs6120849	0.754	rs6088686	chr20:33623437	C/T	cg24642439	chr20:33292090	TP53INP2	0.94	4.86	0.48	5.91e-6	Protein C levels;
SKCM	cis	rs6977660	0.941	rs4721825	chr7:19823427	A/C	cg07541023	chr7:19748670	TWISTNB	0.7	4.82	0.48	6.98e-6	Thyroid stimulating hormone;
SKCM	cis	rs4924935	0.748	rs9915894	chr17:18752778	T/C	cg26378065	chr17:18585709	ZNF286B	0.85	5.05	0.5	2.87e-6	Pancreatic cancer;
SKCM	cis	rs7772486	0.764	rs7762562	chr6:146158994	T/C	cg05347473	chr6:146136440	FBXO30	0.57	5.36	0.52	8.27e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs769267	0.930	rs2301784	chr19:19390749	G/A	cg03709012	chr19:19516395	GATAD2A	0.81	6.49	0.59	7.18e-9	Tonsillectomy;
SKCM	cis	rs8077889	0.871	rs8081101	chr17:41904332	C/T	cg26893861	chr17:41843967	DUSP3	1.15	7.34	0.64	1.79e-10	Triglycerides;
SKCM	cis	rs17376456	1.000	rs34013242	chr5:93507947	C/T	cg21475434	chr5:93447410	FAM172A	0.99	5.65	0.54	2.49e-7	Diabetic retinopathy;
SKCM	cis	rs1552244	1.000	rs113771705	chr3:10075983	T/C	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs3087591	1.000	rs2952978	chr17:29474744	A/C	cg24425628	chr17:29625626	OMG;NF1	0.64	5.26	0.51	1.21e-6	Hip circumference;
SKCM	trans	rs9929218	0.551	rs2296409	chr16:68713730	G/A	cg04657470	chr2:198365150	HSPE1;HSPD1	0.97	10.87	0.78	2.77e-17	Colorectal cancer;
SKCM	cis	rs2075371	1.000	rs1862047	chr7:133978078	G/C	cg20476274	chr7:133979776	SLC35B4	1.01	10.44	0.76	1.77e-16	Mean platelet volume;
SKCM	cis	rs9818758	0.607	rs9855123	chr3:49229457	C/T	cg24898236	chr3:49228699	LOC646498	0.64	4.94	0.49	4.39e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs847649	0.732	rs56269620	chr7:102489456	A/G	cg18108683	chr7:102477205	FBXL13	-0.83	-8.81	-0.71	2.53e-13	Morning vs. evening chronotype;
SKCM	cis	rs116095464	1.000	rs2015774	chr5:312958	G/T	cg22857025	chr5:266934	NA	-1.64	-6.42	-0.59	9.96e-9	Breast cancer;
SKCM	cis	rs738322	0.967	rs6001038	chr22:38570585	A/G	cg25457927	chr22:38595422	NA	-0.54	-6.14	-0.57	3.27e-8	Cutaneous nevi;
SKCM	cis	rs11690935	0.959	rs6709156	chr2:172591944	T/C	cg13550731	chr2:172543902	DYNC1I2	-0.95	-8.1	-0.68	6.14e-12	Schizophrenia;
SKCM	cis	rs2404602	0.735	rs11632222	chr15:76712927	C/G	cg23625390	chr15:77176239	SCAPER	-0.83	-8.06	-0.67	7.18e-12	Blood metabolite levels;
SKCM	cis	rs6570726	0.935	rs400968	chr6:145819718	A/G	cg23711669	chr6:146136114	FBXO30	0.71	6.9	0.62	1.21e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1577917	1.000	rs12665321	chr6:86769289	C/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.83	-8.15	-0.68	4.73e-12	Response to antipsychotic treatment;
SKCM	cis	rs12478296	0.581	rs4973645	chr2:242993577	T/C	cg06360820	chr2:242988706	NA	-1.16	-6.34	-0.58	1.36e-8	Obesity-related traits;
SKCM	cis	rs2841277	0.676	rs4264326	chr14:105411700	A/G	cg19901468	chr14:105411992	AHNAK2	-0.9	-6.85	-0.61	1.55e-9	Rheumatoid arthritis;
SKCM	cis	rs597539	0.652	rs514833	chr11:68657734	C/T	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.82	5.44	0.52	5.87e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs1707322	0.686	rs3014251	chr1:46077428	G/C	cg03146154	chr1:46216737	IPP	-0.8	-5.88	-0.55	9.61e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7772486	0.875	rs11155452	chr6:146424631	C/T	cg23711669	chr6:146136114	FBXO30	0.85	8.48	0.69	1.09e-12	Lobe attachment (rater-scored or self-reported);
SKCM	trans	rs561341	0.941	rs501773	chr17:30314435	T/G	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs873946	0.648	rs3750578	chr10:134563366	A/G	cg14275445	chr10:134560047	INPP5A	-0.55	-4.8	-0.48	7.38e-6	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs763014	0.833	rs3743902	chr16:632728	T/C	cg00908189	chr16:619842	PIGQ	0.82	7.78	0.66	2.55e-11	Height;
SKCM	cis	rs9430161	0.598	rs34350247	chr1:11034460	A/G	cg02454025	chr1:11042201	C1orf127	1.06	9.89	0.75	2.03e-15	Ewing sarcoma;
SKCM	cis	rs28595532	0.920	rs17259284	chr4:119779298	T/C	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs12188164	0.620	rs56070387	chr5:482531	A/T	cg26076054	chr5:421317	AHRR	-0.64	-4.79	-0.48	7.79e-6	Cystic fibrosis severity;
SKCM	cis	rs2439831	1.000	rs2444029	chr15:43737484	G/A	cg02155558	chr15:43621948	ADAL;LCMT2	1.12	8.05	0.67	7.58e-12	Lung cancer in ever smokers;
SKCM	cis	rs7584330	0.737	rs6431540	chr2:238360966	T/C	cg14458575	chr2:238380390	NA	0.88	6.21	0.57	2.43e-8	Prostate cancer;
SKCM	cis	rs7940866	0.801	rs10894296	chr11:130840433	T/G	cg12179176	chr11:130786555	SNX19	0.79	6.17	0.57	2.88e-8	Schizophrenia;
SKCM	cis	rs62158211	0.826	rs62158168	chr2:114078381	C/G	cg17784749	chr2:114082611	LOC440839	0.79	5.76	0.55	1.6e-7	Sleep duration (oversleepers vs undersleepers);Sleep traits (multi-trait analysis);Sleep duration;
SKCM	cis	rs7086627	0.515	rs10887900	chr10:82210265	A/G	cg00277334	chr10:82204260	NA	-0.77	-9.05	-0.72	8.73e-14	Post bronchodilator FEV1;
SKCM	cis	rs951366	0.668	rs823154	chr1:205762406	C/T	cg07167872	chr1:205819463	PM20D1	0.99	9.84	0.74	2.6e-15	Menarche (age at onset);
SKCM	cis	rs3087591	0.922	rs12950506	chr17:29598392	A/G	cg24425628	chr17:29625626	OMG;NF1	0.64	5.08	0.5	2.48e-6	Hip circumference;
SKCM	cis	rs2159324	1.000	rs2109065	chr19:45695610	T/A	cg17904997	chr19:44952572	ZNF229	-0.61	-5.15	-0.5	1.89e-6	Quantitative traits;
SKCM	cis	rs854765	0.547	rs8069811	chr17:17922280	G/A	cg04398451	chr17:18023971	MYO15A	-0.86	-6.73	-0.61	2.55e-9	Total body bone mineral density;
SKCM	cis	rs2072499	0.868	rs2758600	chr1:156195205	C/T	cg24450063	chr1:156163899	SLC25A44	0.94	8.13	0.68	5.19e-12	Testicular germ cell tumor;
SKCM	cis	rs77106637	1.000	rs76793820	chr11:72619860	G/A	cg03713592	chr11:72463424	ARAP1	0.99	4.99	0.49	3.63e-6	Type 2 diabetes;
SKCM	cis	rs6430585	0.528	rs309166	chr2:136667487	C/T	cg07169764	chr2:136633963	MCM6	1.22	9.48	0.73	1.27e-14	Corneal structure;
SKCM	cis	rs6952808	0.717	rs6967442	chr7:1926090	A/G	cg21782813	chr7:2030301	MAD1L1	0.53	5.47	0.53	5.33e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs34779708	0.931	rs7079205	chr10:35324619	C/T	cg03585969	chr10:35415529	CREM	0.78	6.81	0.61	1.77e-9	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs941408	1.000	rs1640273	chr19:2803227	C/T	cg06609049	chr19:2785107	THOP1	0.79	6.94	0.62	1.03e-9	Total cholesterol levels;
SKCM	cis	rs3784262	0.869	rs12903792	chr15:58261280	C/T	cg12031962	chr15:58353849	ALDH1A2	-0.49	-6.48	-0.59	7.67e-9	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs860295	0.639	rs10908469	chr1:155468732	A/C	cg02153340	chr1:155202674	NA	-0.81	-5.81	-0.55	1.3e-7	Body mass index;
SKCM	cis	rs6582630	0.555	rs10880421	chr12:38423015	C/T	cg26384229	chr12:38710491	ALG10B	0.88	6.86	0.61	1.46e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs2721195	1.000	rs11542372	chr8:145677089	G/A	cg17328964	chr8:145687451	CYHR1	0.75	6.87	0.61	1.38e-9	Age at first birth;
SKCM	cis	rs9902453	0.765	rs2628185	chr17:28070107	G/A	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.79	-5.93	-0.56	7.67e-8	Coffee consumption (cups per day);
SKCM	cis	rs4888262	0.508	rs4544266	chr16:74660993	C/A	cg01733217	chr16:74700730	RFWD3	0.86	6.82	0.61	1.71e-9	Testicular germ cell tumor;
SKCM	cis	rs910316	1.000	rs4903275	chr14:75512509	C/T	cg08847533	chr14:75593920	NEK9	0.95	9.18	0.72	4.92e-14	Height;
SKCM	cis	rs1949733	1.000	rs6447875	chr4:8503206	T/C	cg11789530	chr4:8429930	ACOX3	0.81	5.8	0.55	1.36e-7	Response to antineoplastic agents;
SKCM	cis	rs769267	0.930	rs4808967	chr19:19640524	A/G	cg03709012	chr19:19516395	GATAD2A	0.9	8.51	0.69	9.68e-13	Tonsillectomy;
SKCM	cis	rs6580649	0.941	rs72644842	chr12:48448274	A/G	cg05342945	chr12:48394962	COL2A1	0.73	5.2	0.51	1.53e-6	Lung cancer;
SKCM	cis	rs6546550	0.901	rs897120	chr2:70160982	C/T	cg02498382	chr2:70120550	SNRNP27	0.45	4.99	0.49	3.61e-6	Prevalent atrial fibrillation;
SKCM	cis	rs950027	0.787	rs1153845	chr15:45724729	C/T	cg10760299	chr15:45669010	GATM	-0.54	-5.04	-0.5	3e-6	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs7598759	0.712	rs6727372	chr2:232331906	T/G	cg19187155	chr2:232395269	NMUR1	0.61	4.99	0.49	3.52e-6	Noise-induced hearing loss;
SKCM	cis	rs7511006	0.859	rs7292228	chr22:50649560	C/G	cg16473166	chr22:50639996	SELO	0.65	5.22	0.51	1.47e-6	Obesity-related traits;
SKCM	cis	rs7666738	0.753	rs4699604	chr4:99056353	T/C	cg05340658	chr4:99064831	C4orf37	0.65	4.9	0.49	5.1e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs17608059	0.545	rs9915045	chr17:13902636	G/T	cg11395062	chr17:14139857	CDRT15	0.66	5.76	0.55	1.61e-7	Temperament;
SKCM	cis	rs2842992	0.662	rs2273826	chr6:160211421	A/G	cg19482086	chr6:160211437	TCP1;MRPL18	0.87	7.46	0.65	1.04e-10	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs992157	0.764	rs2382827	chr2:219184387	G/A	cg20019365	chr2:219134978	PNKD;AAMP	0.74	5.95	0.56	7.08e-8	Colorectal cancer;
SKCM	cis	rs7296418	0.754	rs1619283	chr12:123717362	A/G	cg00376283	chr12:123451042	ABCB9	0.95	8.11	0.68	5.78e-12	Platelet count;
SKCM	cis	rs28595532	0.582	rs71608361	chr4:119224081	T/C	cg11846333	chr4:119757529	SEC24D	0.96	5.37	0.52	7.87e-7	Cannabis dependence symptom count;
SKCM	cis	rs9910055	0.530	rs2269907	chr17:42294215	G/A	cg19774624	chr17:42201019	HDAC5	-0.77	-6.27	-0.58	1.84e-8	Total body bone mineral density;
SKCM	cis	rs561341	0.700	rs886223	chr17:30229877	G/T	cg00745463	chr17:30367425	LRRC37B	-0.8	-5.07	-0.5	2.6e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs11764590	0.694	rs10241537	chr7:2083358	A/G	cg23422044	chr7:1970798	MAD1L1	-0.82	-6.27	-0.58	1.82e-8	Neuroticism;
SKCM	cis	rs10206020	0.921	rs6605278	chr2:1547230	C/T	cg01028140	chr2:1542097	TPO	-0.53	-5.06	-0.5	2.74e-6	IgG glycosylation;
SKCM	cis	rs2072499	0.900	rs2248080	chr1:156195971	T/A	cg25208724	chr1:156163844	SLC25A44	0.97	7.94	0.67	1.23e-11	Testicular germ cell tumor;
SKCM	cis	rs7666738	0.830	rs9995386	chr4:98907826	T/C	cg05340658	chr4:99064831	C4orf37	0.61	4.95	0.49	4.24e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs28595532	0.920	rs116514715	chr4:119756280	G/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs7635838	0.718	rs2594973	chr3:11395821	C/G	cg00170343	chr3:11313890	ATG7	0.7	5.58	0.53	3.29e-7	HDL cholesterol;
SKCM	cis	rs2153535	0.541	rs1414353	chr6:8485642	C/G	cg07606381	chr6:8435919	SLC35B3	0.86	6.25	0.58	2.06e-8	Motion sickness;
SKCM	cis	rs7666738	0.830	rs11725095	chr4:99009711	T/A	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7772486	0.754	rs6921073	chr6:146144377	G/A	cg05347473	chr6:146136440	FBXO30	0.58	5.35	0.52	8.51e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs3768617	0.565	rs4233194	chr1:183060917	G/C	ch.1.3577855R	chr1:183094577	LAMC1	0.76	6.8	0.61	1.86e-9	Fuchs's corneal dystrophy;
SKCM	cis	rs9886651	0.905	rs10110243	chr8:128805020	A/G	cg24514600	chr8:128805414	PVT1	-0.54	-4.99	-0.49	3.59e-6	Epithelial ovarian cancer;Serous invasive ovarian cancer;
SKCM	trans	rs8073060	0.586	rs35542792	chr17:33903886	A/G	cg19694781	chr19:47549865	TMEM160	1.08	8.69	0.7	4.26e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs7143963	1.000	rs4553557	chr14:103309743	C/T	cg23020514	chr14:103360112	TRAF3	0.9	8.54	0.7	8.45e-13	Body mass index;
SKCM	cis	rs2857078	0.654	rs4793083	chr17:42312973	C/T	cg08499158	chr17:42289980	UBTF	0.8	6.83	0.61	1.62e-9	Red cell distribution width;Reticulocyte count;
SKCM	cis	rs7552404	0.924	rs1146580	chr1:76209935	T/C	cg03433033	chr1:76189801	ACADM	0.73	5.3	0.51	1.05e-6	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs17376456	0.877	rs35747258	chr5:93310129	C/T	cg21475434	chr5:93447410	FAM172A	1.04	5.55	0.53	3.82e-7	Diabetic retinopathy;
SKCM	cis	rs7618915	0.547	rs4687636	chr3:52633929	G/A	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs778371	0.697	rs4973564	chr2:233718440	A/G	cg08000102	chr2:233561755	GIGYF2	-0.86	-7.45	-0.64	1.1e-10	Schizophrenia;
SKCM	cis	rs2153535	0.580	rs6597318	chr6:8437289	G/A	cg07606381	chr6:8435919	SLC35B3	0.85	6.21	0.58	2.37e-8	Motion sickness;
SKCM	cis	rs10927875	0.800	rs1627145	chr1:16328116	C/T	cg21385522	chr1:16154831	NA	0.77	6.09	0.57	4.05e-8	Dilated cardiomyopathy;
SKCM	cis	rs6582630	0.519	rs11182457	chr12:38538331	G/A	cg26384229	chr12:38710491	ALG10B	0.82	6.52	0.59	6.37e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs9467773	1.000	rs6926629	chr6:26499903	T/C	cg09904177	chr6:26538194	HMGN4	0.55	5.03	0.49	3.11e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs28595532	0.920	rs115706007	chr4:119733638	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.52	0.53	4.28e-7	Cannabis dependence symptom count;
SKCM	cis	rs875971	0.505	rs1167386	chr7:65513096	G/A	cg00343986	chr7:65444356	GUSB	-0.66	-4.81	-0.48	7.33e-6	Aortic root size;
SKCM	cis	rs36093844	0.706	rs78680968	chr11:85543480	C/T	cg25872744	chr11:85566296	CCDC83	-0.85	-4.77	-0.48	8.27e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs8180040	0.967	rs807935	chr3:47321669	A/G	cg27129171	chr3:47204927	SETD2	0.87	6.62	0.6	4.15e-9	Colorectal cancer;
SKCM	cis	rs597205	0.881	rs11102347	chr1:112391809	T/C	cg22162010	chr1:113249994	RHOC	0.84	4.82	0.48	7.04e-6	Gut microbiota (bacterial taxa);
SKCM	cis	rs6570726	0.764	rs4896821	chr6:145896181	G/A	cg23711669	chr6:146136114	FBXO30	0.79	8.06	0.67	7.28e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs28595532	0.920	rs56302600	chr4:119770162	T/C	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs7618915	0.501	rs6804145	chr3:52694198	C/T	cg18404041	chr3:52824283	ITIH1	-0.53	-4.77	-0.48	8.42e-6	Bipolar disorder;
SKCM	cis	rs7927771	0.524	rs4752798	chr11:47886364	T/C	cg20307385	chr11:47447363	PSMC3	-0.72	-5.82	-0.55	1.26e-7	Subjective well-being;
SKCM	cis	rs11585357	1.000	rs11585357	chr1:17601165	C/T	cg08277548	chr1:17600880	PADI3	-0.9	-6.36	-0.58	1.26e-8	Hair shape;
SKCM	cis	rs1153858	1.000	rs1554521	chr15:45664189	A/T	cg21132104	chr15:45694354	SPATA5L1	-0.94	-8.09	-0.68	6.29e-12	Homoarginine levels;
SKCM	cis	rs4689592	0.503	rs56099074	chr4:7071259	A/G	cg19539972	chr4:7069911	GRPEL1	-0.96	-6.24	-0.58	2.08e-8	Monocyte percentage of white cells;
SKCM	cis	rs4975616	0.869	rs467095	chr5:1336221	T/C	cg26373071	chr5:1325741	CLPTM1L	0.74	6.91	0.62	1.18e-9	Lung cancer;
SKCM	cis	rs8180040	0.764	rs4682852	chr3:47177772	C/T	cg27129171	chr3:47204927	SETD2	0.82	6.49	0.59	7.26e-9	Colorectal cancer;
SKCM	cis	rs7945705	0.967	rs2568090	chr11:8849495	T/C	cg21881798	chr11:8931708	C11orf17;ST5	0.66	6.3	0.58	1.63e-8	Hemoglobin concentration;
SKCM	cis	rs6582630	0.502	rs11520234	chr12:38255005	G/A	cg13010199	chr12:38710504	ALG10B	0.69	4.92	0.49	4.72e-6	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs4865169	1.000	rs4865169	chr4:57879792	C/T	cg13432339	chr4:58211039	NA	0.44	4.79	0.48	7.83e-6	Breast cancer;
SKCM	cis	rs3806843	0.766	rs801399	chr5:140034844	C/T	cg26395211	chr5:140044315	WDR55	0.62	4.81	0.48	7.34e-6	Depressive symptoms (multi-trait analysis);
SKCM	cis	rs7786877	0.761	rs11772705	chr7:100298904	T/C	cg16850897	chr7:100343110	ZAN	-0.65	-4.87	-0.48	5.78e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs514406	0.621	rs1930306	chr1:53195686	C/G	cg16325326	chr1:53192061	ZYG11B	-1.0	-12.3	-0.81	6.1e-20	Monocyte count;
SKCM	cis	rs2836950	0.545	rs11701805	chr21:40618683	T/C	cg11644478	chr21:40555479	PSMG1	-0.64	-5.02	-0.49	3.17e-6	Menarche (age at onset);
SKCM	cis	rs7919656	0.935	rs10776648	chr10:50030932	A/G	cg00386007	chr10:50143337	WDFY4	-0.43	-4.97	-0.49	3.83e-6	Clinically amyopathic dermatomyositis;
SKCM	cis	rs7945705	0.818	rs2742537	chr11:8908389	G/A	cg21881798	chr11:8931708	C11orf17;ST5	-0.8	-8.91	-0.71	1.64e-13	Hemoglobin concentration;
SKCM	trans	rs3780486	0.505	rs10813959	chr9:33166234	C/T	cg04842962	chr6:43655489	MRPS18A	-0.88	-8.27	-0.68	2.82e-12	IgG glycosylation;
SKCM	cis	rs748404	0.723	rs573169	chr15:43550581	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	0.69	5.79	0.55	1.41e-7	Lung cancer;
SKCM	cis	rs62238980	0.614	rs77162015	chr22:32485616	G/T	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs9325144	0.505	rs7955162	chr12:38711658	G/A	cg13010199	chr12:38710504	ALG10B	0.74	5.47	0.53	5.15e-7	Morning vs. evening chronotype;
SKCM	cis	rs6879260	0.928	rs11739624	chr5:179727290	T/C	cg13944838	chr5:179740914	GFPT2	-0.74	-5.63	-0.54	2.77e-7	Height;
SKCM	cis	rs6088580	0.634	rs6059887	chr20:33101102	C/G	cg24642439	chr20:33292090	TP53INP2	0.76	6.02	0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs7666738	0.830	rs10005120	chr4:99038200	A/G	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2836950	0.545	rs1888489	chr21:40533164	T/C	cg11890956	chr21:40555474	PSMG1	-0.71	-5.66	-0.54	2.38e-7	Menarche (age at onset);
SKCM	cis	rs9300255	0.544	rs10772995	chr12:123671761	T/C	cg05973401	chr12:123451056	ABCB9	0.83	5.14	0.5	2.01e-6	Neutrophil percentage of white cells;
SKCM	cis	rs752010	0.574	rs10890157	chr1:42117689	C/G	cg06885757	chr1:42089581	HIVEP3	0.49	5.24	0.51	1.35e-6	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs1062177	1.000	rs2016409	chr5:151126324	G/T	cg00977110	chr5:151150581	G3BP1	-0.87	-6.87	-0.61	1.4e-9	Preschool internalizing problems;
SKCM	cis	rs7824557	0.627	rs7838897	chr8:11207326	C/A	cg21775007	chr8:11205619	TDH	0.7	6.25	0.58	2.02e-8	Retinal vascular caliber;
SKCM	cis	rs7772486	0.790	rs3924498	chr6:146233338	A/T	cg05347473	chr6:146136440	FBXO30	-0.56	-5.3	-0.51	1.06e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1568889	0.641	rs34857148	chr11:28481976	T/A	cg06544937	chr11:28130018	METT5D1;KIF18A	0.91	5.68	0.54	2.22e-7	Bipolar disorder;
SKCM	cis	rs1691799	0.899	rs1168358	chr12:66748664	A/G	cg16791601	chr12:66731901	HELB	-0.57	-4.84	-0.48	6.5e-6	White blood cell count (basophil);
SKCM	cis	rs2463822	1.000	rs1881534	chr11:62085083	A/G	cg06239285	chr11:62104954	ASRGL1	1.25	5.93	0.56	7.79e-8	Chronic obstructive pulmonary disease-related biomarkers;
SKCM	cis	rs9611565	0.571	rs2050032	chr22:42152429	C/T	cg03806693	chr22:41940476	POLR3H	0.81	4.95	0.49	4.19e-6	Vitiligo;
SKCM	cis	rs9733	0.650	rs2048558	chr1:150571730	A/G	cg13175981	chr1:150552382	MCL1	0.74	6.71	0.6	2.8e-9	Tonsillectomy;
SKCM	cis	rs12541335	0.639	rs7003478	chr8:22201123	A/G	cg09517075	chr8:22133004	PIWIL2	0.6	5.51	0.53	4.45e-7	Hypertriglyceridemia;
SKCM	cis	rs13010713	0.840	rs7355617	chr2:182092655	T/C	cg21995919	chr2:182322279	ITGA4	-0.56	-4.83	-0.48	6.77e-6	Celiac disease;
SKCM	cis	rs10791097	0.720	rs4936121	chr11:130733878	A/G	cg12179176	chr11:130786555	SNX19	0.98	8.58	0.7	7.15e-13	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs2836974	0.966	rs2836977	chr21:40666066	T/C	cg11890956	chr21:40555474	PSMG1	0.99	11.14	0.78	8.38e-18	Cognitive function;
SKCM	cis	rs754466	0.606	rs3740250	chr10:79580101	C/T	cg17075019	chr10:79541650	NA	-0.79	-6.72	-0.61	2.69e-9	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs2839186	0.900	rs2839196	chr21:47708037	G/A	cg05896524	chr21:47604654	C21orf56	0.67	5.54	0.53	3.87e-7	Testicular germ cell tumor;
SKCM	cis	rs427394	0.582	rs274661	chr5:6704848	C/T	cg10857441	chr5:6722123	POLS	-0.69	-7.39	-0.64	1.4e-10	Menopause (age at onset);
SKCM	cis	rs2304069	0.954	rs1962603	chr5:149393006	G/T	cg22760475	chr5:149380129	HMGXB3;TIGD6	0.84	6.17	0.57	2.89e-8	HIV-1 control;
SKCM	cis	rs7590720	0.840	rs705648	chr2:216933792	C/T	cg12620499	chr2:216877984	MREG	0.81	5.99	0.56	6.17e-8	Alcohol dependence;
SKCM	cis	rs4555082	0.957	rs10140586	chr14:105749582	A/G	cg13114125	chr14:105738426	BRF1	-0.73	-5.67	-0.54	2.28e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs1048238	0.506	rs7552077	chr1:16196759	A/G	cg21385522	chr1:16154831	NA	0.64	5.46	0.53	5.46e-7	Systolic blood pressure;
SKCM	cis	rs6977660	0.714	rs6945533	chr7:19813913	G/C	cg05791153	chr7:19748676	TWISTNB	0.8	5.01	0.49	3.37e-6	Thyroid stimulating hormone;
SKCM	cis	rs867186	1.000	rs6060244	chr20:33699435	A/G	cg04194272	chr20:33683537	NA	1.06	6.3	0.58	1.63e-8	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs823143	0.570	rs1361754	chr1:205801872	C/T	cg24739457	chr1:205821442	NA	-0.62	-5.89	-0.55	9.18e-8	Monocyte percentage of white cells;
SKCM	cis	rs6088590	0.648	rs6059991	chr20:33280836	C/T	cg24642439	chr20:33292090	TP53INP2	0.79	5.66	0.54	2.45e-7	Coronary artery disease;
SKCM	cis	rs6951245	1.000	rs113066613	chr7:1094128	T/C	cg18402987	chr7:1209562	NA	1.15	6.09	0.57	3.95e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs6087990	0.806	rs1474738	chr20:31380309	G/A	cg13636640	chr20:31349939	DNMT3B	0.92	8.06	0.67	7.3e-12	Ulcerative colitis;
SKCM	cis	rs28386778	0.863	rs3760256	chr17:61821161	A/G	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.36	0.52	8.06e-7	Prudent dietary pattern;
SKCM	cis	rs1046896	0.739	rs28459016	chr17:80741194	G/A	cg22027946	chr17:80790580	TBCD;ZNF750	0.73	5.87	0.55	9.93e-8	Glycated hemoglobin levels;
SKCM	cis	rs362296	0.583	rs35658829	chr4:3255738	T/G	cg00764545	chr4:3318001	RGS12	-0.72	-6.59	-0.6	4.63e-9	Parental longevity (mother's age at death);
SKCM	cis	rs28595532	0.764	rs116158926	chr4:119730572	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.43	0.59	9.38e-9	Cannabis dependence symptom count;
SKCM	cis	rs4555082	0.874	rs113291192	chr14:105738181	C/T	cg13114125	chr14:105738426	BRF1	-0.69	-5.47	-0.53	5.33e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs72781680	0.851	rs12612830	chr2:24134599	C/T	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	cis	rs1348850	0.526	rs59972556	chr2:178399561	A/G	cg27490568	chr2:178487706	NA	0.9	6.86	0.61	1.42e-9	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs2836974	0.897	rs34394827	chr21:40528087	T/C	cg11890956	chr21:40555474	PSMG1	1.07	13.19	0.83	1.48e-21	Cognitive function;
SKCM	cis	rs7666738	0.800	rs7683737	chr4:99070880	A/T	cg17366294	chr4:99064904	C4orf37	0.61	4.93	0.49	4.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs440932	0.887	rs398801	chr8:9031704	A/T	cg15556689	chr8:8085844	FLJ10661	-0.63	-4.91	-0.49	4.87e-6	High light scatter reticulocyte percentage of red cells;
SKCM	cis	rs2032447	0.639	rs198810	chr6:26128618	A/G	cg18357526	chr6:26021779	HIST1H4A	-0.8	-6.7	-0.6	2.88e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs873946	0.648	rs12766166	chr10:134556403	G/C	cg26818010	chr10:134567672	INPP5A	-0.82	-6.58	-0.6	4.81e-9	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs778371	0.752	rs283487	chr2:233644011	A/G	cg08000102	chr2:233561755	GIGYF2	0.82	6.38	0.59	1.14e-8	Schizophrenia;
SKCM	cis	rs2180341	0.618	rs11154396	chr6:127638911	C/T	cg24812749	chr6:127587940	RNF146	0.64	5.31	0.51	1.02e-6	Breast cancer;
SKCM	cis	rs28595532	0.688	rs116173135	chr4:119721949	C/T	cg21605333	chr4:119757512	SEC24D	1.35	7.92	0.67	1.37e-11	Cannabis dependence symptom count;
SKCM	cis	rs1707322	0.656	rs3014210	chr1:46066608	A/G	cg03146154	chr1:46216737	IPP	-0.82	-5.81	-0.55	1.28e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs9814567	0.964	rs6805388	chr3:134173534	T/C	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.68	-5.62	-0.54	2.8e-7	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs72781680	0.848	rs55725028	chr2:23966447	A/G	cg08917208	chr2:24149416	ATAD2B	0.95	4.78	0.48	8.1e-6	Lymphocyte counts;
SKCM	cis	rs910316	0.763	rs735452	chr14:75497984	A/G	cg08847533	chr14:75593920	NEK9	-0.84	-7.17	-0.63	3.77e-10	Height;
SKCM	trans	rs561341	1.000	rs7210970	chr17:30262169	G/A	cg20587970	chr11:113659929	NA	-1.07	-8.84	-0.71	2.25e-13	Hip circumference adjusted for BMI;
SKCM	trans	rs1814175	0.647	rs1404157	chr11:49917301	G/C	cg15704280	chr7:45808275	SEPT13	-0.86	-8.14	-0.68	5.04e-12	Height;
SKCM	cis	rs9911578	1.000	rs12453049	chr17:56611372	C/T	cg12560992	chr17:57184187	TRIM37	-0.96	-7.74	-0.66	2.95e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs1799949	0.965	rs11656945	chr17:41330265	A/G	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.29	-0.58	1.73e-8	Menopause (age at onset);
SKCM	cis	rs9902453	0.845	rs7218113	chr17:28372130	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.82	-6.4	-0.59	1.06e-8	Coffee consumption (cups per day);
SKCM	cis	rs4820539	0.966	rs2267001	chr22:23456696	T/C	cg14186256	chr22:23484241	RTDR1	0.83	8.41	0.69	1.52e-12	Bone mineral density;
SKCM	cis	rs2599510	0.783	rs2568464	chr2:32848658	C/T	cg02381751	chr2:32503542	YIPF4	-0.72	-5.63	-0.54	2.73e-7	Interleukin-18 levels;
SKCM	cis	rs3768617	0.510	rs6424889	chr1:183091796	G/C	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs995000	0.839	rs1168034	chr1:62963914	G/C	cg06896770	chr1:63153194	DOCK7	-0.62	-5.59	-0.54	3.15e-7	Triglyceride levels;
SKCM	cis	rs208520	0.507	rs9453585	chr6:66796668	C/T	cg07460842	chr6:66804631	NA	-1.16	-13.2	-0.83	1.4e-21	Exhaled nitric oxide output;
SKCM	cis	rs951366	0.617	rs823080	chr1:205789282	G/A	cg14893161	chr1:205819251	PM20D1	1.1	15.35	0.87	2.84e-25	Menarche (age at onset);
SKCM	cis	rs995000	0.899	rs4495740	chr1:63124465	T/G	cg06896770	chr1:63153194	DOCK7	0.93	9.04	0.72	8.97e-14	Triglyceride levels;
SKCM	cis	rs71520386	0.632	rs71520387	chr7:22869676	C/A	cg00309339	chr7:22893653	NA	0.66	4.94	0.49	4.33e-6	Fibrinogen levels;
SKCM	cis	rs12950390	0.853	rs59513807	chr17:45867925	G/A	cg03474202	chr17:45855739	NA	-0.48	-5.41	-0.52	6.6e-7	IgG glycosylation;
SKCM	cis	rs763014	0.931	rs10903017	chr16:627920	T/C	cg07343612	chr16:622815	PIGQ	-0.7	-6.0	-0.56	5.84e-8	Height;
SKCM	cis	rs13040088	1.000	rs13040088	chr20:61549202	A/G	cg23096297	chr20:61557774	DIDO1	0.79	6.43	0.59	9.56e-9	Menopause (age at onset);
SKCM	cis	rs6424115	0.830	rs2229584	chr1:24200969	T/C	cg15997130	chr1:24165203	NA	0.6	4.94	0.49	4.37e-6	Immature fraction of reticulocytes;
SKCM	cis	rs11098499	0.863	rs6858592	chr4:120458692	G/A	cg09307838	chr4:120376055	NA	0.97	7.66	0.66	4.19e-11	Corneal astigmatism;
SKCM	cis	rs6083	0.571	rs17190678	chr15:58847372	C/G	cg05156742	chr15:59063176	FAM63B	-0.72	-5.26	-0.51	1.23e-6	Schizophrenia;
SKCM	cis	rs362296	0.511	rs2857861	chr4:3323767	C/T	cg11471262	chr4:3318911	RGS12	0.79	8.3	0.68	2.45e-12	Parental longevity (mother's age at death);
SKCM	cis	rs709400	1.000	rs57218990	chr14:104128007	T/A	cg26031613	chr14:104095156	KLC1	1.05	12.89	0.82	5.14e-21	Body mass index;
SKCM	cis	rs34172651	0.517	rs36113933	chr16:24838862	A/G	cg00339695	chr16:24857497	SLC5A11	0.75	6.32	0.58	1.5e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs617791	0.669	rs4994056	chr11:65750997	G/A	cg26695010	chr11:65641043	EFEMP2	-0.72	-5.47	-0.53	5.29e-7	Breast cancer;
SKCM	cis	rs2013441	1.000	rs2703816	chr17:20118887	A/G	cg13482628	chr17:19912719	NA	-0.65	-5.21	-0.51	1.48e-6	Obesity-related traits;
SKCM	cis	rs1499614	1.000	rs2659903	chr7:66180931	G/A	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Gout;
SKCM	cis	rs769267	0.930	rs892022	chr19:19613381	G/A	cg26732615	chr19:19648335	CILP2;YJEFN3	0.67	7.06	0.62	6e-10	Tonsillectomy;
SKCM	cis	rs10256972	0.758	rs11980081	chr7:1069372	T/C	cg16145915	chr7:1198662	ZFAND2A	-0.46	-5.64	-0.54	2.57e-7	Longevity;Endometriosis;
SKCM	cis	rs10924970	0.503	rs1987092	chr1:235494235	C/G	cg26050004	chr1:235667680	B3GALNT2	0.63	4.95	0.49	4.24e-6	Asthma;
SKCM	cis	rs7829975	0.514	rs2920983	chr8:8268063	G/C	cg06636001	chr8:8085503	FLJ10661	0.8	6.93	0.62	1.08e-9	Mood instability;
SKCM	cis	rs28595532	0.925	rs56200441	chr4:119497440	T/G	cg14228332	chr4:119757509	SEC24D	0.97	4.92	0.49	4.71e-6	Cannabis dependence symptom count;
SKCM	cis	rs4242434	0.819	rs7826059	chr8:22512068	T/C	cg03733263	chr8:22462867	KIAA1967	-0.97	-7.88	-0.67	1.64e-11	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs1858740	0.509	rs196375	chr3:38422919	C/T	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.88	7.46	0.65	1.05e-10	Schizophrenia;
SKCM	cis	rs11098499	0.708	rs1546506	chr4:120241240	T/C	cg09307838	chr4:120376055	NA	0.93	7.56	0.65	6.5500000000000006e-11	Corneal astigmatism;
SKCM	cis	rs2836974	0.836	rs1041440	chr21:40627325	C/T	cg17971929	chr21:40555470	PSMG1	0.9	8.81	0.71	2.52e-13	Cognitive function;
SKCM	cis	rs10489202	0.955	rs17557162	chr1:167985950	A/T	cg24449463	chr1:168025552	DCAF6	0.73	5.72	0.54	1.84e-7	Schizophrenia;
SKCM	cis	rs9611565	0.569	rs188057	chr22:41822305	T/G	cg03806693	chr22:41940476	POLR3H	1.13	7.36	0.64	1.63e-10	Vitiligo;
SKCM	cis	rs1707322	0.789	rs10789473	chr1:46248131	C/T	cg03146154	chr1:46216737	IPP	0.81	5.94	0.56	7.43e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7666738	0.830	rs2114426	chr4:98933130	C/T	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2952156	0.920	rs9303274	chr17:37836353	T/C	cg20243544	chr17:37824526	PNMT	0.67	5.35	0.52	8.48e-7	Asthma;
SKCM	cis	rs4819052	0.851	rs2838828	chr21:46663423	A/G	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.42	0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs17826219	0.636	rs12946563	chr17:29103166	C/G	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Body mass index;
SKCM	cis	rs137603	0.644	rs137635	chr22:39720656	G/C	cg17798944	chr22:39715225	SNORD43;RPL3	-0.64	-5.54	-0.53	3.91e-7	Primary biliary cholangitis;
SKCM	cis	rs7000551	0.508	rs11780977	chr8:22245028	G/A	cg12081754	chr8:22256438	SLC39A14	1.06	11.51	0.79	1.71e-18	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs826838	1.000	rs851934	chr12:39104453	G/T	cg26384229	chr12:38710491	ALG10B	-0.97	-8.08	-0.67	6.7e-12	Heart rate;
SKCM	cis	rs13118159	0.550	rs4974617	chr4:1373658	T/C	cg16405210	chr4:1374714	KIAA1530	-0.95	-7.27	-0.64	2.43e-10	Longevity;
SKCM	cis	rs1577917	0.740	rs9344533	chr6:86236188	C/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.88	8.74	0.7	3.41e-13	Response to antipsychotic treatment;
SKCM	cis	rs875971	1.000	rs2036264	chr7:65799904	G/A	cg18876405	chr7:65276391	NA	-0.68	-6.79	-0.61	1.96e-9	Aortic root size;
SKCM	cis	rs2730245	0.645	rs4909282	chr7:158699797	T/C	cg24397884	chr7:158709396	WDR60	0.7	5.35	0.52	8.59e-7	Height;
SKCM	cis	rs6541297	0.878	rs4846905	chr1:230279582	C/T	cg05784532	chr1:230284198	GALNT2	-0.54	-4.79	-0.48	7.94e-6	Coronary artery disease;
SKCM	cis	rs523522	0.962	rs651627	chr12:121009198	C/T	cg12219531	chr12:120966889	COQ5	0.9	7.63	0.65	4.83e-11	High light scatter reticulocyte count;
SKCM	cis	rs763121	0.853	rs2284073	chr22:39105948	T/C	cg06022373	chr22:39101656	GTPBP1	0.85	6.3	0.58	1.65e-8	Menopause (age at onset);
SKCM	cis	rs6545883	0.507	rs10169662	chr2:61507936	T/C	cg15711740	chr2:61764176	XPO1	0.66	5.12	0.5	2.17e-6	Tuberculosis;
SKCM	cis	rs11700980	0.636	rs17797032	chr21:30265585	G/A	cg24692254	chr21:30365293	RNF160	-0.89	-5.07	-0.5	2.6e-6	QRS complex (12-leadsum);
SKCM	cis	rs62064224	1.000	rs62064224	chr17:30635115	G/A	cg25809561	chr17:30822961	MYO1D	0.67	5.19	0.51	1.63e-6	Schizophrenia;
SKCM	cis	rs2732480	0.577	rs1489108	chr12:48738781	G/A	cg21348975	chr12:48724119	NA	-0.61	-5.2	-0.51	1.58e-6	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs7927771	0.524	rs10838740	chr11:47679980	A/G	cg20307385	chr11:47447363	PSMC3	0.71	5.63	0.54	2.67e-7	Subjective well-being;
SKCM	cis	rs4803468	1.000	rs4803463	chr19:41911040	C/G	cg09537434	chr19:41945824	ATP5SL	-1.1	-13.82	-0.84	1.16e-22	Height;
SKCM	cis	rs7811142	1.000	rs11764818	chr7:100043055	G/A	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.12	6.51	0.59	6.68e-9	Platelet count;
SKCM	cis	rs995000	0.899	rs35529421	chr1:62965621	T/A	cg06896770	chr1:63153194	DOCK7	0.74	6.38	0.59	1.16e-8	Triglyceride levels;
SKCM	cis	rs11098499	0.566	rs17051356	chr4:120585308	C/T	cg09307838	chr4:120376055	NA	0.97	7.96	0.67	1.11e-11	Corneal astigmatism;
SKCM	cis	rs6547631	0.622	rs1437743	chr2:85924989	A/G	cg24620635	chr2:85921963	GNLY	-0.93	-6.74	-0.61	2.48e-9	Blood protein levels;
SKCM	cis	rs514406	0.679	rs545719	chr1:53304922	T/C	cg24675658	chr1:53192096	ZYG11B	-0.88	-8.23	-0.68	3.38e-12	Monocyte count;
SKCM	cis	rs7208859	0.573	rs73267829	chr17:29003939	G/A	cg14067834	chr17:29058358	SUZ12P	1.05	5.55	0.53	3.71e-7	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs35146811	0.735	rs1727140	chr7:99815399	T/A	cg22906224	chr7:99728672	NA	-0.72	-5.77	-0.55	1.52e-7	Coronary artery disease;
SKCM	cis	rs8103278	1.000	rs7258283	chr19:46335511	C/T	cg11657440	chr19:46296263	DMWD	-0.9	-6.05	-0.56	4.8e-8	Coronary artery disease;
SKCM	cis	rs9926296	0.712	rs447735	chr16:89734349	T/C	cg01097406	chr16:89675127	NA	0.55	5.55	0.53	3.74e-7	Vitiligo;
SKCM	cis	rs7927771	0.832	rs1542321	chr11:47379615	G/A	cg05585544	chr11:47624801	NA	0.57	4.86	0.48	6.06e-6	Subjective well-being;
SKCM	cis	rs6942756	0.876	rs28636722	chr7:129015151	C/T	cg02491457	chr7:128862824	NA	-0.77	-4.77	-0.47	8.53e-6	White matter hyperintensity burden;
SKCM	cis	rs1003719	0.788	rs2835574	chr21:38455324	C/A	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs597539	0.615	rs629426	chr11:68671104	A/G	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.82	5.72	0.54	1.89e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs9420	0.890	rs547891	chr11:57499065	C/T	cg19752551	chr11:57585705	CTNND1	0.7	7.2	0.63	3.34e-10	Schizophrenia;
SKCM	cis	rs875971	0.862	rs11773628	chr7:65982631	G/T	cg18876405	chr7:65276391	NA	-0.62	-6.15	-0.57	3.11e-8	Aortic root size;
SKCM	cis	rs7613875	0.580	rs6808044	chr3:50136165	A/G	cg24110177	chr3:50126178	RBM5	0.73	5.81	0.55	1.28e-7	Body mass index;
SKCM	cis	rs245880	0.740	rs245887	chr7:29190408	G/A	cg17163760	chr7:29186267	CPVL	-0.4	-5.37	-0.52	7.91e-7	Warfarin maintenance dose;
SKCM	cis	rs2836974	0.897	rs7280375	chr21:40552408	C/T	cg11890956	chr21:40555474	PSMG1	-1.08	-13.61	-0.84	2.64e-22	Cognitive function;
SKCM	cis	rs7772486	0.686	rs4896828	chr6:145953339	A/C	cg23711669	chr6:146136114	FBXO30	0.88	9.43	0.73	1.6e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs3008870	0.959	rs2815353	chr1:67483372	A/G	cg08660285	chr1:67390436	MIER1;WDR78	0.91	5.96	0.56	6.81e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs911263	0.961	rs2208397	chr14:68753287	T/G	cg18825221	chr14:68749962	RAD51L1	0.53	5.54	0.53	3.88e-7	Primary biliary cholangitis;
SKCM	cis	rs748404	0.631	rs6493084	chr15:43647627	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	0.84	6.38	0.59	1.17e-8	Lung cancer;
SKCM	cis	rs17685	0.558	rs60787921	chr7:75792844	C/A	cg16684958	chr7:75615977	POR	0.53	5.3	0.51	1.06e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1577917	1.000	rs7756203	chr6:86627707	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.85	-8.62	-0.7	5.82e-13	Response to antipsychotic treatment;
SKCM	cis	rs13118159	0.573	rs7664763	chr4:1352305	A/G	cg16405210	chr4:1374714	KIAA1530	-0.94	-7.02	-0.62	7.06e-10	Longevity;
SKCM	cis	rs2836974	0.897	rs1984022	chr21:40596085	G/A	cg11644478	chr21:40555479	PSMG1	0.97	10.08	0.75	8.76e-16	Cognitive function;
SKCM	cis	rs2070488	1.000	rs6772046	chr3:38479660	C/T	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.98	9.09	0.72	7.18e-14	Electrocardiographic conduction measures;
SKCM	trans	rs3749237	0.964	rs2234385	chr3:49846041	G/A	cg21659725	chr3:3221576	CRBN	0.99	7.33	0.64	1.87e-10	Resting heart rate;
SKCM	cis	rs7772486	0.754	rs9399561	chr6:145955687	C/G	cg23711669	chr6:146136114	FBXO30	0.94	11.16	0.78	7.87e-18	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs875971	1.000	rs6958277	chr7:65979349	A/G	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs4132509	1.000	rs2125230	chr1:243885848	A/G	cg21452805	chr1:244014465	NA	-0.83	-4.81	-0.48	7.2e-6	RR interval (heart rate);
SKCM	cis	rs8141529	0.764	rs5752807	chr22:29223169	A/G	cg15103426	chr22:29168792	CCDC117	0.62	5.2	0.51	1.57e-6	Lymphocyte counts;
SKCM	cis	rs11098499	0.909	rs28793658	chr4:120307214	A/C	cg09307838	chr4:120376055	NA	0.97	7.49	0.65	9.08e-11	Corneal astigmatism;
SKCM	trans	rs3780486	0.801	rs56687083	chr9:33132134	A/G	cg04842962	chr6:43655489	MRPS18A	1.03	10.85	0.78	2.95e-17	IgG glycosylation;
SKCM	cis	rs2841277	0.738	rs1036713	chr14:105396693	C/G	cg15352829	chr14:105391018	PLD4	0.58	5.02	0.49	3.14e-6	Rheumatoid arthritis;
SKCM	cis	rs4819052	0.851	rs7276591	chr21:46680156	C/T	cg19498844	chr21:46707878	POFUT2;LOC642852	0.9	7.98	0.67	1.04e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs1218582	0.772	rs877343	chr1:154910012	A/G	cg03351412	chr1:154909251	PMVK	0.75	6.33	0.58	1.44e-8	Prostate cancer;
SKCM	cis	rs13118159	0.527	rs6599308	chr4:1387780	A/G	cg05025164	chr4:1340916	KIAA1530	0.88	6.6	0.6	4.46e-9	Longevity;
SKCM	cis	rs2839186	0.933	rs56955294	chr21:47708953	A/G	cg11766577	chr21:47581405	C21orf56	-0.71	-6.01	-0.56	5.6e-8	Testicular germ cell tumor;
SKCM	cis	rs10193935	0.901	rs17029411	chr2:42479149	G/A	cg27598129	chr2:42591480	NA	-0.97	-6.7	-0.6	2.93e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs910316	1.000	rs4899546	chr14:75594946	G/C	cg08847533	chr14:75593920	NEK9	0.95	9.17	0.72	5.03e-14	Height;
SKCM	cis	rs2153535	0.607	rs9502722	chr6:8541483	C/T	cg23788917	chr6:8435910	SLC35B3	0.69	4.92	0.49	4.79e-6	Motion sickness;
SKCM	cis	rs7216064	0.954	rs8079291	chr17:65887622	A/G	cg12091567	chr17:66097778	LOC651250	-0.75	-5.27	-0.51	1.19e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs752010	0.841	rs6661784	chr1:42080312	A/T	cg06885757	chr1:42089581	HIVEP3	0.52	5.4	0.52	7.09e-7	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs9902453	0.836	rs62070337	chr17:28466257	G/A	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.5	0.53	4.74e-7	Coffee consumption (cups per day);
SKCM	cis	rs9303401	0.659	rs12935851	chr17:56600244	C/A	cg10487724	chr17:56770010	TEX14;RAD51C	0.84	6.15	0.57	3.1e-8	Cognitive test performance;
SKCM	cis	rs7833790	1.000	rs7460277	chr8:82709777	T/C	cg17211192	chr8:82754475	SNX16	-0.96	-5.21	-0.51	1.48e-6	Diastolic blood pressure;
SKCM	cis	rs6138458	1.000	rs1977540	chr20:24900290	G/T	cg26195577	chr20:24973756	C20orf3	-1.22	-8.58	-0.7	7.01e-13	Blood protein levels;
SKCM	cis	rs61867294	0.578	rs7090949	chr10:106826482	T/C	cg05291666	chr10:106073406	ITPRIP	-0.77	-4.95	-0.49	4.19e-6	Schizophrenia;
SKCM	cis	rs7208859	0.623	rs7219361	chr17:29080393	G/A	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs6546550	0.901	rs6546553	chr2:70111711	C/A	cg02498382	chr2:70120550	SNRNP27	-0.45	-4.97	-0.49	3.81e-6	Prevalent atrial fibrillation;
SKCM	cis	rs10752881	0.652	rs10911262	chr1:183114956	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.76	7.12	0.63	4.7e-10	Colorectal cancer;
SKCM	cis	rs7917772	0.503	rs7914389	chr10:104295402	T/C	cg11453585	chr10:104263688	ACTR1A;SUFU	0.78	6.33	0.58	1.47e-8	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs7618501	0.665	rs7621352	chr3:50070763	A/C	cg24110177	chr3:50126178	RBM5	0.61	5.31	0.52	1.01e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs3892630	0.824	rs34748593	chr19:33240447	T/C	cg22980127	chr19:33182716	NUDT19	1.36	7.75	0.66	2.87e-11	Red blood cell traits;
SKCM	cis	rs1577917	0.958	rs6921315	chr6:86471668	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.6	-5.1	-0.5	2.3e-6	Response to antipsychotic treatment;
SKCM	cis	rs7618915	0.547	rs62255371	chr3:52747321	A/G	cg18404041	chr3:52824283	ITIH1	-0.56	-4.94	-0.49	4.33e-6	Bipolar disorder;
SKCM	cis	rs67311347	0.544	rs6762121	chr3:40355313	G/A	cg00656387	chr3:40428638	ENTPD3	0.55	4.77	0.48	8.39e-6	Renal cell carcinoma;
SKCM	cis	rs514406	0.698	rs522259	chr1:53365481	A/G	cg08859206	chr1:53392774	SCP2	-0.63	-5.32	-0.52	9.59e-7	Monocyte count;
SKCM	cis	rs919433	0.927	rs1429412	chr2:198190894	A/G	cg04278110	chr2:198063759	ANKRD44	-0.71	-4.94	-0.49	4.44e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs11792861	0.555	rs4978767	chr9:111762925	C/T	cg14432460	chr9:111696404	IKBKAP;C9orf6	0.77	6.2	0.57	2.46e-8	Menarche (age at onset);
SKCM	cis	rs763121	0.853	rs6001184	chr22:39052116	C/T	cg06022373	chr22:39101656	GTPBP1	0.72	4.96	0.49	4.08e-6	Menopause (age at onset);
SKCM	cis	rs11718455	0.960	rs13081767	chr3:44004468	T/C	cg21419209	chr3:44054225	NA	-0.65	-5.32	-0.52	9.77e-7	Coronary artery disease;
SKCM	cis	rs9951698	0.601	rs1973779	chr18:12997773	A/G	cg12848697	chr18:13133368	NA	0.53	4.9	0.48	5.18e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs10791097	0.694	rs2155749	chr11:130751094	G/T	cg12179176	chr11:130786555	SNX19	0.91	8.28	0.68	2.74e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs6840360	0.533	rs13139327	chr4:152728590	A/C	cg22705602	chr4:152727874	NA	-0.55	-7.42	-0.64	1.26e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs6121246	0.559	rs6058352	chr20:30269179	T/C	cg11595048	chr20:30225325	COX4I2	0.54	4.77	0.48	8.4e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs867186	1.000	rs55734215	chr20:33585437	C/T	cg04194272	chr20:33683537	NA	-1.36	-7.01	-0.62	7.44e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs34172651	0.517	rs7204288	chr16:24784531	A/G	cg04756594	chr16:24857601	SLC5A11	0.72	5.19	0.51	1.65e-6	Intelligence (multi-trait analysis);
SKCM	trans	rs10506458	0.915	rs12426017	chr12:63396272	T/G	cg03429785	chr15:59498649	MYO1E;LDHAL6B	-1.38	-7.54	-0.65	7.13e-11	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs10754283	0.967	rs6428562	chr1:90102665	G/A	cg21401794	chr1:90099060	LRRC8C	0.78	7.17	0.63	3.72e-10	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs55823223	0.618	rs11867339	chr17:73862093	A/G	cg10935138	chr17:73851978	WBP2	1.22	7.2	0.63	3.29e-10	Psoriasis;
SKCM	cis	rs1801251	0.964	rs6748027	chr2:233629552	T/C	cg08000102	chr2:233561755	GIGYF2	0.89	7.19	0.63	3.47e-10	Coronary artery disease;
SKCM	cis	rs7937682	0.961	rs1784784	chr11:111483185	C/T	cg09085632	chr11:111637200	PPP2R1B	-0.96	-10.09	-0.75	8.53e-16	Primary sclerosing cholangitis;
SKCM	cis	rs11098499	0.863	rs9997631	chr4:120469995	C/G	cg09307838	chr4:120376055	NA	1.0	8.27	0.68	2.8e-12	Corneal astigmatism;
SKCM	cis	rs854765	0.647	rs2974999	chr17:17997547	T/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.85	6.57	0.6	5.08e-9	Total body bone mineral density;
SKCM	cis	rs3096299	0.503	rs9925045	chr16:89556476	T/C	cg02187348	chr16:89574699	SPG7	0.65	5.19	0.51	1.65e-6	Multiple myeloma (IgH translocation);
SKCM	cis	rs6921919	0.583	rs6922169	chr6:28382932	G/A	cg14547644	chr6:28411285	ZSCAN23	-0.58	-4.8	-0.48	7.46e-6	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs801193	1.000	rs6958520	chr7:66151453	T/C	cg11987759	chr7:65425863	GUSB	-0.69	-5.9	-0.56	8.74e-8	Aortic root size;
SKCM	cis	rs798554	1.000	rs798554	chr7:2759795	C/T	cg19346786	chr7:2764209	NA	-0.67	-6.94	-0.62	1.01e-9	Height;
SKCM	cis	rs4891159	0.513	rs2554831	chr18:74113513	C/G	cg24786174	chr18:74118243	ZNF516	0.78	7.91	0.67	1.43e-11	Longevity;
SKCM	cis	rs10193935	0.901	rs13429697	chr2:42529818	C/T	cg27598129	chr2:42591480	NA	-0.88	-6.71	-0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6952808	0.689	rs2008263	chr7:2048335	A/G	cg04267008	chr7:1944627	MAD1L1	-0.64	-5.04	-0.5	2.99e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs11105298	0.891	rs4842661	chr12:89930399	A/G	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.84	-5.23	-0.51	1.39e-6	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs71520386	0.632	rs1029738	chr7:22874047	C/A	cg15401507	chr7:22894281	NA	0.66	4.99	0.49	3.52e-6	Fibrinogen levels;
SKCM	cis	rs854765	0.929	rs854766	chr17:18012775	A/G	cg04398451	chr17:18023971	MYO15A	-0.64	-4.82	-0.48	7.07e-6	Total body bone mineral density;
SKCM	cis	rs10752881	1.000	rs4402094	chr1:182986441	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.73	6.47	0.59	7.97e-9	Colorectal cancer;
SKCM	cis	rs7086627	0.515	rs10887899	chr10:82210214	G/A	cg00277334	chr10:82204260	NA	-0.74	-8.56	-0.7	7.89e-13	Post bronchodilator FEV1;
SKCM	cis	rs2439831	1.000	rs2467426	chr15:43989518	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.2	6.92	0.62	1.12e-9	Lung cancer in ever smokers;
SKCM	cis	rs2153535	0.580	rs9392220	chr6:8457946	G/A	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs28386778	0.897	rs2727290	chr17:61894728	G/T	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs6066825	0.644	rs4810864	chr20:47319142	G/C	cg18078177	chr20:47281410	PREX1	0.64	5.2	0.51	1.57e-6	Colorectal cancer;
SKCM	cis	rs798766	1.000	rs798767	chr4:1734281	A/G	cg05874882	chr4:1763078	NA	-0.56	-4.89	-0.48	5.37e-6	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs6977660	0.652	rs4721826	chr7:19823804	T/C	cg05791153	chr7:19748676	TWISTNB	0.77	5.02	0.49	3.23e-6	Thyroid stimulating hormone;
SKCM	cis	rs6570726	0.791	rs9390336	chr6:145896823	A/T	cg05347473	chr6:146136440	FBXO30	0.58	5.16	0.5	1.82e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4803468	1.000	rs10409485	chr19:41920765	C/T	cg14132834	chr19:41945861	ATP5SL	0.77	5.87	0.55	1.01e-7	Height;
SKCM	cis	rs9880211	0.752	rs9820717	chr3:136346613	C/A	cg21827317	chr3:136751795	NA	-0.69	-5.28	-0.51	1.13e-6	Body mass index;Height;
SKCM	cis	rs9790314	0.905	rs7611367	chr3:161003182	A/G	cg03342759	chr3:160939853	NMD3	0.69	7.26	0.64	2.48e-10	Morning vs. evening chronotype;
SKCM	cis	rs35146811	0.735	rs858505	chr7:99819577	G/A	cg22906224	chr7:99728672	NA	-0.71	-5.61	-0.54	2.99e-7	Coronary artery disease;
SKCM	cis	rs4689592	0.513	rs3857177	chr4:7066332	G/A	cg26116260	chr4:7069785	GRPEL1	1.21	9.51	0.73	1.09e-14	Monocyte percentage of white cells;
SKCM	cis	rs1153858	0.668	rs63603561	chr15:45593323	T/A	cg21132104	chr15:45694354	SPATA5L1	-0.86	-5.79	-0.55	1.38e-7	Homoarginine levels;
SKCM	cis	rs870825	0.616	rs2130393	chr4:185642335	T/C	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs28595532	0.841	rs115725150	chr4:119768647	T/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs6582630	0.519	rs4436613	chr12:38293653	T/C	cg26384229	chr12:38710491	ALG10B	0.8	6.55	0.6	5.47e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs11098499	0.863	rs6858777	chr4:120475966	A/G	cg24375607	chr4:120327624	NA	0.69	5.47	0.53	5.35e-7	Corneal astigmatism;
SKCM	cis	rs4319547	0.656	rs3817011	chr12:122819566	C/T	cg23029597	chr12:123009494	RSRC2	-0.73	-5.22	-0.51	1.41e-6	Body mass index;
SKCM	cis	rs10088262	0.634	rs7815695	chr8:124783978	C/G	cg02993010	chr8:124780839	FAM91A1	-0.75	-5.13	-0.5	2.06e-6	Pancreatic cancer;
SKCM	cis	rs7296418	0.663	rs28450974	chr12:123861420	G/A	cg05973401	chr12:123451056	ABCB9	0.72	5.48	0.53	5.12e-7	Platelet count;
SKCM	cis	rs7980687	0.678	rs7132277	chr12:123593382	C/T	cg05973401	chr12:123451056	ABCB9	-0.8	-5.41	-0.52	6.59e-7	Height;Educational attainment;Head circumference (infant);
SKCM	cis	rs28386778	0.897	rs7221853	chr17:61859836	A/G	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs7927771	0.524	rs10838769	chr11:47825333	A/G	cg20307385	chr11:47447363	PSMC3	-0.72	-5.81	-0.55	1.31e-7	Subjective well-being;
SKCM	cis	rs4423214	1.000	rs3750997	chr11:71158841	A/C	cg05163923	chr11:71159392	DHCR7	0.74	7.31	0.64	2.04e-10	Vitamin D levels;
SKCM	cis	rs4332037	0.624	rs58169303	chr7:1883274	T/C	cg23422044	chr7:1970798	MAD1L1	-0.89	-5.73	-0.54	1.8e-7	Bipolar disorder;
SKCM	cis	rs7959452	0.527	rs4761157	chr12:69780907	A/G	cg20891283	chr12:69753455	YEATS4	0.93	9.67	0.74	5.4e-15	Blood protein levels;
SKCM	cis	rs10089	1.000	rs10089	chr5:127522543	C/T	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.86	7.22	0.63	3.05e-10	Ileal carcinoids;
SKCM	cis	rs7772486	0.754	rs9497401	chr6:146051271	T/C	cg23711669	chr6:146136114	FBXO30	-0.88	-8.81	-0.71	2.53e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9325144	0.723	rs11169482	chr12:39164327	A/T	cg26384229	chr12:38710491	ALG10B	0.7	6.4	0.59	1.06e-8	Morning vs. evening chronotype;
SKCM	cis	rs2243480	1.000	rs35735127	chr7:65300423	G/T	cg18252515	chr7:66147081	NA	-1.29	-7.41	-0.64	1.3e-10	Diabetic kidney disease;
SKCM	cis	rs151997	0.924	rs32480	chr5:50208099	G/A	cg06027927	chr5:50259733	NA	0.66	5.78	0.55	1.45e-7	Callous-unemotional behaviour;
SKCM	cis	rs1707322	0.682	rs10890335	chr1:46100394	G/C	cg03146154	chr1:46216737	IPP	0.8	5.57	0.53	3.52e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs1325195	0.800	rs2793817	chr1:179244389	T/A	cg13848905	chr1:179560700	TDRD5	-0.53	-4.93	-0.49	4.49e-6	IgE grass sensitization;
SKCM	cis	rs79839061	0.610	rs2279182	chr4:882625	T/G	cg07828340	chr4:882639	GAK	1.04	5.72	0.54	1.88e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs9910055	0.762	rs227579	chr17:42223134	A/T	cg13607699	chr17:42295918	UBTF	-0.83	-6.71	-0.6	2.83e-9	Total body bone mineral density;
SKCM	cis	rs7160336	0.529	rs11626725	chr14:74473434	T/C	cg00934624	chr14:74318234	PTGR2	-0.5	-4.87	-0.48	5.71e-6	Blood protein levels;
SKCM	cis	rs8180040	0.932	rs11712445	chr3:47434552	T/C	cg27129171	chr3:47204927	SETD2	0.79	5.79	0.55	1.43e-7	Colorectal cancer;
SKCM	cis	rs7726839	0.540	rs57306627	chr5:597643	T/C	cg10555297	chr5:473380	SLC9A3;LOC25845	1.02	4.87	0.48	5.72e-6	Obesity-related traits;
SKCM	cis	rs6500395	0.925	rs9933148	chr16:48672099	C/T	cg04672837	chr16:48644449	N4BP1	0.63	5.29	0.51	1.08e-6	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs9910055	0.659	rs112114764	chr17:42201041	G/T	cg10896456	chr17:42255109	ASB16;C17orf65	-0.68	-7.0	-0.62	7.92e-10	Total body bone mineral density;
SKCM	cis	rs12477438	0.539	rs12999417	chr2:99865548	A/G	cg14399236	chr2:99771627	LIPT1;TSGA10	-0.94	-8.06	-0.67	7.35e-12	Chronic sinus infection;
SKCM	cis	rs17685	0.712	rs60232511	chr7:75800082	A/G	cg01364799	chr7:75623366	TMEM120A	-0.7	-5.84	-0.55	1.16e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs875971	0.862	rs13226170	chr7:65999298	G/A	cg11764359	chr7:65958608	NA	0.75	6.8	0.61	1.86e-9	Aortic root size;
SKCM	cis	rs875971	0.520	rs2420597	chr7:65915986	A/G	cg18876405	chr7:65276391	NA	0.61	5.94	0.56	7.52e-8	Aortic root size;
SKCM	cis	rs4077515	0.577	rs3812584	chr9:139312719	C/T	cg14169450	chr9:139327907	INPP5E	-0.46	-4.85	-0.48	6.28e-6	Ulcerative colitis;IgA nephropathy;Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs17685	0.712	rs11764119	chr7:75812358	T/G	cg01364799	chr7:75623366	TMEM120A	-0.69	-5.81	-0.55	1.28e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs28595532	1.000	rs114039398	chr4:119631627	T/C	cg11846333	chr4:119757529	SEC24D	1.15	6.24	0.58	2.13e-8	Cannabis dependence symptom count;
SKCM	cis	rs7552404	0.924	rs1313071	chr1:76195542	C/G	cg22875332	chr1:76189707	ACADM	0.7	4.82	0.48	6.96e-6	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs12824058	0.831	rs11060826	chr12:130809931	G/C	cg24838063	chr12:130822603	PIWIL1	0.78	6.91	0.62	1.19e-9	Menopause (age at onset);
SKCM	cis	rs8017423	0.935	rs3742667	chr14:90767856	T/C	cg04374321	chr14:90722782	PSMC1	-0.95	-8.73	-0.7	3.68e-13	Mortality in heart failure;
SKCM	cis	rs2404602	0.710	rs2469541	chr15:76562118	C/T	cg22467129	chr15:76604101	ETFA	0.59	4.98	0.49	3.66e-6	Blood metabolite levels;
SKCM	cis	rs1577917	1.000	rs12190604	chr6:86716215	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.83	-8.15	-0.68	4.84e-12	Response to antipsychotic treatment;
SKCM	cis	rs7811142	1.000	rs67315960	chr7:100015124	A/G	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.23	8.03	0.67	8.33e-12	Platelet count;
SKCM	cis	rs2075671	0.903	rs10953300	chr7:100263784	C/G	cg20848291	chr7:100343083	ZAN	-0.71	-5.38	-0.52	7.43e-7	Other erythrocyte phenotypes;
SKCM	cis	rs33794	0.901	rs28288	chr3:45290007	C/T	cg25630594	chr3:44914870	TGM4	0.58	5.06	0.5	2.7e-6	Lung function (forced expiratory volume in 1 second);
SKCM	cis	rs8077889	0.750	rs34462326	chr17:41932210	T/C	cg26893861	chr17:41843967	DUSP3	1.23	6.83	0.61	1.63e-9	Triglycerides;
SKCM	cis	rs950776	0.518	rs2869055	chr15:78822388	G/C	cg06917634	chr15:78832804	PSMA4	-0.99	-10.03	-0.75	1.08e-15	Sudden cardiac arrest;
SKCM	cis	rs2228479	0.850	rs12598316	chr16:89916600	C/A	cg06558623	chr16:89946397	TCF25	1.12	5.0	0.49	3.47e-6	Skin colour saturation;
SKCM	cis	rs62238980	0.614	rs79738052	chr22:32455812	G/A	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs7937682	0.883	rs1789358	chr11:111474116	G/A	cg09085632	chr11:111637200	PPP2R1B	-1.02	-10.07	-0.75	9.14e-16	Primary sclerosing cholangitis;
SKCM	cis	rs2070488	1.000	rs1002676	chr3:38444932	A/C	cg01465620	chr3:38496096	LOC100128640;ACVR2B	-0.96	-8.82	-0.71	2.39e-13	Electrocardiographic conduction measures;
SKCM	cis	rs2153535	0.580	rs1335633	chr6:8448800	C/T	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs2836950	0.545	rs8132424	chr21:40584412	A/T	cg11890956	chr21:40555474	PSMG1	0.66	5.19	0.51	1.61e-6	Menarche (age at onset);
SKCM	cis	rs4862750	0.872	rs6821507	chr4:187876829	G/T	cg10295955	chr4:187884368	NA	1.05	14.7	0.86	3.52e-24	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs12479254	0.701	rs6718026	chr2:242495392	C/T	cg14086599	chr2:241536098	CAPN10	-0.54	-4.79	-0.48	7.77e-6	Brain structure;
SKCM	cis	rs951366	0.617	rs823080	chr1:205789282	G/A	cg14159672	chr1:205819179	PM20D1	1.08	13.01	0.83	3.05e-21	Menarche (age at onset);
SKCM	cis	rs7523050	0.730	rs12079547	chr1:109469314	A/C	cg08274380	chr1:109419600	GPSM2	1.07	6.49	0.59	7.36e-9	Fat distribution (HIV);
SKCM	cis	rs8180040	1.000	rs295461	chr3:47368010	T/C	cg16586182	chr3:47516702	SCAP	-0.72	-4.93	-0.49	4.51e-6	Colorectal cancer;
SKCM	cis	rs6088580	0.634	rs6141465	chr20:32967314	T/C	cg24642439	chr20:33292090	TP53INP2	-0.76	-6.02	-0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs7666738	0.753	rs13120995	chr4:98972762	A/G	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs8180040	1.000	rs553989	chr3:47400328	A/G	cg16586182	chr3:47516702	SCAP	0.71	4.85	0.48	6.25e-6	Colorectal cancer;
SKCM	cis	rs208520	0.690	rs866452	chr6:66849936	A/T	cg07460842	chr6:66804631	NA	-1.09	-8.36	-0.69	1.88e-12	Exhaled nitric oxide output;
SKCM	cis	rs2239547	0.603	rs6789219	chr3:53098938	C/G	cg11645453	chr3:52864694	ITIH4	0.62	5.0	0.49	3.5e-6	Schizophrenia;
SKCM	cis	rs6860806	0.507	rs272883	chr5:131668698	A/G	cg24060327	chr5:131705240	SLC22A5	-0.76	-4.94	-0.49	4.42e-6	Breast cancer;
SKCM	cis	rs7811142	0.667	rs3873746	chr7:99935097	G/A	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.21	7.8	0.66	2.26e-11	Platelet count;
SKCM	cis	rs362296	0.597	rs3129320	chr4:3265130	G/C	cg05297308	chr4:3317976	RGS12	-0.64	-5.28	-0.51	1.15e-6	Parental longevity (mother's age at death);
SKCM	cis	rs6952808	0.575	rs6950330	chr7:1953606	T/C	cg03354898	chr7:1950403	MAD1L1	-0.55	-5.65	-0.54	2.56e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs12477438	0.520	rs7604557	chr2:99747829	A/G	cg26064155	chr2:99771622	LIPT1;TSGA10	1.05	10.1	0.75	7.95e-16	Chronic sinus infection;
SKCM	cis	rs9790314	0.586	rs34727114	chr3:161138929	A/C	cg03342759	chr3:160939853	NMD3	-0.74	-6.65	-0.6	3.56e-9	Morning vs. evening chronotype;
SKCM	cis	rs10870270	0.957	rs9971084	chr10:133788747	G/C	cg17892150	chr10:133769511	PPP2R2D	-0.71	-5.06	-0.5	2.78e-6	Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals;
SKCM	cis	rs28595532	0.841	rs116329146	chr4:119733438	G/A	cg21605333	chr4:119757512	SEC24D	1.36	8.05	0.67	7.69e-12	Cannabis dependence symptom count;
SKCM	cis	rs7811142	0.830	rs73401450	chr7:99981859	G/C	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.05	5.92	0.56	8.02e-8	Platelet count;
SKCM	cis	rs12682352	0.602	rs28399241	chr8:8663215	C/T	cg06636001	chr8:8085503	FLJ10661	0.72	6.03	0.56	5.2100000000000003e-08	Neuroticism;
SKCM	cis	rs9611565	0.592	rs8779	chr22:42070276	T/C	cg03806693	chr22:41940476	POLR3H	1.12	7.53	0.65	7.69e-11	Vitiligo;
SKCM	cis	rs6089584	0.927	rs2296081	chr20:60572663	G/T	cg06108461	chr20:60628389	TAF4	-0.86	-7.59	-0.65	5.83e-11	Body mass index;
SKCM	cis	rs6580649	0.943	rs1990029	chr12:48407987	C/T	cg05342945	chr12:48394962	COL2A1	-0.82	-5.86	-0.55	1.06e-7	Lung cancer;
SKCM	cis	rs2288073	1.000	rs2288073	chr2:24413298	C/T	cg06627628	chr2:24431161	ITSN2	0.82	5.77	0.55	1.53e-7	Venous thromboembolism (SNP x SNP interaction);
SKCM	cis	rs2760061	0.626	rs596675	chr1:228117892	G/A	cg18477163	chr1:228402036	OBSCN	-0.46	-5.1	-0.5	2.36e-6	Diastolic blood pressure;
SKCM	cis	rs6952808	0.624	rs60137119	chr7:2083664	A/G	cg21782813	chr7:2030301	MAD1L1	0.56	5.79	0.55	1.38e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs453301	0.624	rs4841083	chr8:8870428	A/G	cg06636001	chr8:8085503	FLJ10661	0.79	6.05	0.56	4.81e-8	Joint mobility (Beighton score);
SKCM	cis	rs736408	0.812	rs1075653	chr3:52825528	T/C	cg18404041	chr3:52824283	ITIH1	-0.64	-5.73	-0.54	1.84e-7	Bipolar disorder;
SKCM	cis	rs155076	0.666	rs2015241	chr13:21888254	A/G	cg11317459	chr13:21872234	NA	1.39	8.89	0.71	1.78e-13	White matter hyperintensity burden;
SKCM	cis	rs9309711	0.666	rs11127430	chr2:3485242	G/C	cg15506890	chr2:3487001	NA	-0.68	-5.36	-0.52	8.33e-7	Neurofibrillary tangles;
SKCM	trans	rs561341	0.739	rs6505267	chr17:30225950	A/C	cg20587970	chr11:113659929	NA	-1.06	-8.2	-0.68	3.94e-12	Hip circumference adjusted for BMI;
SKCM	cis	rs6461049	0.766	rs10256077	chr7:2171450	C/T	cg21782813	chr7:2030301	MAD1L1	-0.48	-5.03	-0.49	3.05e-6	Schizophrenia;
SKCM	trans	rs9929218	0.551	rs2274240	chr16:68725486	A/G	cg04657470	chr2:198365150	HSPE1;HSPD1	0.98	10.26	0.76	4.01e-16	Colorectal cancer;
SKCM	cis	rs2255932	0.575	rs4859119	chr3:183234854	A/G	cg20852557	chr3:184035519	EIF4G1	0.66	5.0	0.49	3.41e-6	Interleukin-1-beta levels;
SKCM	cis	rs933688	1.000	rs4382199	chr5:90744228	A/G	cg12630606	chr5:90679528	LOC100129716;ARRDC3	0.98	7.81	0.66	2.22e-11	Smoking behavior;
SKCM	cis	rs523522	0.962	rs10849757	chr12:120964014	G/A	cg12219531	chr12:120966889	COQ5	0.91	7.82	0.66	2.11e-11	High light scatter reticulocyte count;
SKCM	cis	rs7828089	0.934	rs12544427	chr8:22263115	C/T	cg02463440	chr8:22132932	PIWIL2	-0.62	-4.91	-0.49	4.98e-6	Verbal declarative memory;
SKCM	cis	rs6088580	0.634	rs1205344	chr20:32918298	G/A	cg24642439	chr20:33292090	TP53INP2	-0.72	-5.7	-0.54	2.06e-7	Glomerular filtration rate (creatinine);
SKCM	cis	rs6835098	0.961	rs17322893	chr4:174122556	A/G	cg08422745	chr4:174089978	GALNT7	0.85	6.55	0.6	5.69e-9	Dementia and core Alzheimer's disease neuropathologic changes;
SKCM	cis	rs926938	0.520	rs2007231	chr1:115266306	C/T	cg12756093	chr1:115239321	AMPD1	-0.73	-5.71	-0.54	1.97e-7	Autism;
SKCM	cis	rs1395	0.778	rs11693001	chr2:27412744	C/T	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.51	5.14	0.5	1.96e-6	Blood metabolite levels;
SKCM	cis	rs7666738	0.830	rs1405767	chr4:98965295	T/C	cg05340658	chr4:99064831	C4orf37	0.64	4.91	0.49	4.97e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7191700	0.583	rs243314	chr16:11385104	G/C	cg00044050	chr16:11439710	C16orf75	0.72	5.16	0.5	1.82e-6	Multiple sclerosis;
SKCM	cis	rs6500395	1.000	rs3826174	chr16:48591012	T/C	cg04672837	chr16:48644449	N4BP1	0.69	5.73	0.54	1.8e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs4073582	0.595	rs528842	chr11:66032390	G/A	cg16950941	chr11:66035639	RAB1B	0.82	7.01	0.62	7.59e-10	Gout;
SKCM	cis	rs2739330	0.731	rs2000468	chr22:24241611	G/T	cg12419862	chr22:24373484	LOC391322	-0.82	-8.17	-0.68	4.47e-12	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs861020	0.916	rs669694	chr1:209950760	C/G	cg09163369	chr1:210001066	C1orf107	0.83	5.44	0.52	5.83e-7	Orofacial clefts;
SKCM	cis	rs737337	0.623	rs12974173	chr19:11333359	A/T	cg00586551	chr19:11347513	LOC55908;DOCK6	0.81	5.92	0.56	8.3e-8	HDL cholesterol;HDL cholesterol levels;
SKCM	cis	rs11718455	1.000	rs11917515	chr3:44020237	A/G	cg21419209	chr3:44054225	NA	-0.66	-5.22	-0.51	1.46e-6	Coronary artery disease;
SKCM	cis	rs738322	0.600	rs4821751	chr22:38564457	T/C	cg25457927	chr22:38595422	NA	-0.53	-6.14	-0.57	3.24e-8	Cutaneous nevi;
SKCM	cis	rs3008870	1.000	rs2985795	chr1:67426223	A/G	cg08660285	chr1:67390436	MIER1;WDR78	0.92	6.05	0.57	4.69e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs3768617	0.510	rs4651140	chr1:183096952	G/T	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs1577917	1.000	rs1018184	chr6:86648475	G/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.82	7.85	0.66	1.84e-11	Response to antipsychotic treatment;
SKCM	cis	rs1005277	0.522	rs289647	chr10:37968278	A/G	cg00409905	chr10:38381863	ZNF37A	-0.61	-6.09	-0.57	3.92e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs2839186	0.709	rs2839176	chr21:47678173	A/G	cg13126279	chr21:47581558	C21orf56	-0.55	-4.82	-0.48	6.84e-6	Testicular germ cell tumor;
SKCM	cis	rs3820928	0.874	rs55743026	chr2:227802813	G/A	cg11843606	chr2:227700838	RHBDD1	-0.6	-4.81	-0.48	7.34e-6	Pulmonary function;
SKCM	cis	rs801193	0.935	rs3800820	chr7:66147178	C/T	cg11987759	chr7:65425863	GUSB	0.69	5.9	0.56	8.74e-8	Aortic root size;
SKCM	cis	rs6904897	0.538	rs4639353	chr6:135224328	A/G	cg22676075	chr6:135203613	NA	-0.73	-6.81	-0.61	1.83e-9	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs9443189	0.570	rs775075	chr6:76380035	A/C	cg01950844	chr6:76311363	SENP6	-1.02	-6.34	-0.58	1.39e-8	Prostate cancer;
SKCM	cis	rs1707322	0.752	rs28438704	chr1:46170544	G/A	cg03146154	chr1:46216737	IPP	0.84	6.2	0.57	2.51e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs875971	0.522	rs34973832	chr7:65396204	A/G	cg11764359	chr7:65958608	NA	0.86	6.24	0.58	2.14e-8	Aortic root size;
SKCM	cis	rs847649	1.000	rs847648	chr7:102553850	C/T	cg18108683	chr7:102477205	FBXL13	-0.81	-8.31	-0.69	2.36e-12	Morning vs. evening chronotype;
SKCM	cis	rs13098911	0.540	rs78380307	chr3:46174331	T/C	cg22986271	chr3:45730975	SACM1L	-0.9	-4.91	-0.49	4.83e-6	Celiac disease;
SKCM	cis	rs116095464	0.558	rs10055405	chr5:265666	C/T	cg22496380	chr5:211416	CCDC127	-0.9	-4.95	-0.49	4.12e-6	Breast cancer;
SKCM	cis	rs2188420	0.872	rs59316453	chr7:106567108	C/T	cg23615938	chr7:105753134	SYPL1	-0.95	-5.14	-0.5	1.96e-6	Interferon gamma levels;
SKCM	cis	rs17065868	1.000	rs7319249	chr13:45128282	A/G	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs6500395	0.926	rs11076570	chr16:48597915	G/A	cg04672837	chr16:48644449	N4BP1	0.69	5.73	0.54	1.8e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs12682352	0.650	rs13265731	chr8:8673320	T/C	cg15556689	chr8:8085844	FLJ10661	0.63	5.05	0.5	2.82e-6	Neuroticism;
SKCM	cis	rs2075371	0.611	rs34573600	chr7:134018937	C/T	cg11752832	chr7:134001865	SLC35B4	0.56	4.82	0.48	7.07e-6	Mean platelet volume;
SKCM	cis	rs2439831	0.850	rs28595038	chr15:44044859	A/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.35	7.72	0.66	3.27e-11	Lung cancer in ever smokers;
SKCM	cis	rs2836950	0.565	rs2150413	chr21:40614878	C/T	cg11644478	chr21:40555479	PSMG1	-0.64	-5.02	-0.49	3.17e-6	Menarche (age at onset);
SKCM	cis	rs7772486	0.790	rs6926657	chr6:146255794	G/A	cg05347473	chr6:146136440	FBXO30	-0.55	-4.9	-0.49	5.11e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs875971	0.505	rs6955582	chr7:65431686	A/G	cg11764359	chr7:65958608	NA	0.86	6.46	0.59	8.21e-9	Aortic root size;
SKCM	cis	rs1850744	0.702	rs10939427	chr4:9628538	G/A	cg15442990	chr4:9534313	NA	1.56	5.85	0.55	1.11e-7	Economic and political preferences;
SKCM	cis	rs1799949	1.000	rs8176297	chr17:41203325	T/A	cg05368731	chr17:41323189	NBR1	0.89	7.67	0.66	4.08e-11	Menopause (age at onset);
SKCM	cis	rs854765	0.583	rs11078406	chr17:17840823	G/T	cg04398451	chr17:18023971	MYO15A	-0.85	-6.05	-0.57	4.75e-8	Total body bone mineral density;
SKCM	cis	rs3859192	0.599	rs12451897	chr17:38179275	G/T	cg17467752	chr17:38218738	THRA	-0.76	-6.37	-0.58	1.22e-8	White blood cell count;
SKCM	cis	rs873946	0.586	rs12782567	chr10:134576709	C/G	cg18305652	chr10:134549665	INPP5A	-0.6	-5.9	-0.56	8.84e-8	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs870825	0.616	rs6552806	chr4:185638231	C/T	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs362272	0.505	rs3129310	chr4:3301388	T/G	cg09735869	chr4:3319127	RGS12	0.97	11.09	0.78	1.05e-17	Serum sulfate level;
SKCM	cis	rs9902453	0.967	rs56326816	chr17:28492805	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.5	0.53	4.74e-7	Coffee consumption (cups per day);
SKCM	cis	rs7811142	0.779	rs28680963	chr7:99905475	C/G	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.21	7.77	0.66	2.57e-11	Platelet count;
SKCM	cis	rs362272	0.524	rs10937924	chr4:3374898	T/C	cg05297308	chr4:3317976	RGS12	1.02	12.29	0.81	6.17e-20	Serum sulfate level;
SKCM	cis	rs1843834	0.505	rs2140508	chr2:225355839	G/T	cg12698349	chr2:225449008	CUL3	0.83	6.68	0.6	3.25e-9	IgE levels in asthmatics (D.p. specific);
SKCM	cis	rs9467773	0.935	rs1056668	chr6:26510605	C/T	cg05180451	chr6:27185764	NA	-0.51	-4.9	-0.49	5.1e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9916302	0.904	rs10432031	chr17:37397852	G/A	cg07936489	chr17:37558343	FBXL20	-0.89	-7.67	-0.66	4.08e-11	Glomerular filtration rate (creatinine);
SKCM	cis	rs12709013	0.792	rs11076263	chr16:58807199	G/T	cg02431531	chr16:59244939	NA	0.48	5.01	0.49	3.26e-6	Blood metabolite ratios;
SKCM	cis	rs8017423	0.647	rs4904679	chr14:90821801	C/T	cg04374321	chr14:90722782	PSMC1	-0.73	-5.53	-0.53	4.13e-7	Mortality in heart failure;
SKCM	cis	rs62244186	0.566	rs55901755	chr3:44834707	C/T	cg02073558	chr3:44770973	ZNF501	0.81	7.14	0.63	4.32e-10	Depressive symptoms;
SKCM	cis	rs9467773	0.620	rs9461275	chr6:26590801	C/T	cg15659132	chr6:26577336	NA	0.63	5.57	0.53	3.56e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs34779708	0.931	rs4934533	chr10:35359619	A/G	cg03585969	chr10:35415529	CREM	0.76	6.1	0.57	3.85e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs1577917	0.771	rs2783171	chr6:86382765	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	1.02	11.58	0.8	1.29e-18	Response to antipsychotic treatment;
SKCM	cis	rs55823223	0.752	rs3744027	chr17:73888743	G/A	cg10935138	chr17:73851978	WBP2	1.14	6.46	0.59	8.19e-9	Psoriasis;
SKCM	cis	rs561341	0.556	rs542244	chr17:30307242	T/C	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs76662990	1.000	rs76662990	chr5:73847916	A/G	cg01264639	chr5:73839484	NA	0.98	5.27	0.51	1.19e-6	Residual cognition;
SKCM	cis	rs644799	0.710	rs10831433	chr11:95519787	C/T	cg03916912	chr11:95522834	CEP57;FAM76B	0.77	6.76	0.61	2.29e-9	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs4332037	0.722	rs4721140	chr7:1917635	A/T	cg23422044	chr7:1970798	MAD1L1	-0.92	-6.58	-0.6	4.86e-9	Bipolar disorder;
SKCM	cis	rs9660180	0.935	rs2180311	chr1:1748734	T/C	cg17747265	chr1:1875780	NA	-0.55	-5.07	-0.5	2.6e-6	Body mass index;
SKCM	trans	rs1814175	0.712	rs9665784	chr11:50030617	C/T	cg15704280	chr7:45808275	SEPT13	-1.05	-11.07	-0.78	1.14e-17	Height;
SKCM	cis	rs4619890	0.528	rs62289339	chr4:7878981	C/G	cg08722675	chr4:8412549	ACOX3	0.54	4.94	0.49	4.32e-6	Glaucoma (primary open-angle);
SKCM	cis	rs9915657	0.870	rs4140902	chr17:70133750	A/G	cg06234051	chr17:70120541	SOX9	-0.62	-5.35	-0.52	8.49e-7	Thyroid hormone levels;
SKCM	cis	rs2050392	0.517	rs2480299	chr10:30743197	G/A	cg25182066	chr10:30743637	MAP3K8	-0.71	-6.2	-0.57	2.48e-8	Inflammatory bowel disease;
SKCM	cis	rs17376456	0.877	rs13153245	chr5:93374891	G/A	cg25358565	chr5:93447407	FAM172A	1.19	7.78	0.66	2.52e-11	Diabetic retinopathy;
SKCM	cis	rs17685	0.712	rs60721456	chr7:75743820	T/A	cg16684958	chr7:75615977	POR	0.55	5.25	0.51	1.27e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs10751667	0.666	rs7396473	chr11:966181	T/C	cg10932868	chr11:921992	NA	0.55	5.1	0.5	2.36e-6	Alzheimer's disease (late onset);
SKCM	cis	rs35306767	0.953	rs12762973	chr10:960761	C/G	cg25614935	chr10:1084866	C10orf110	0.67	4.85	0.48	6.07e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs7772486	0.597	rs6912351	chr6:146264071	T/C	cg23711669	chr6:146136114	FBXO30	-0.8	-6.55	-0.6	5.54e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs58688157	0.572	rs936472	chr11:593453	T/C	cg16486109	chr11:613632	IRF7	0.82	6.64	0.6	3.85e-9	Systemic lupus erythematosus;
SKCM	cis	rs8067545	0.512	rs4925071	chr17:19954499	T/C	cg13482628	chr17:19912719	NA	0.67	4.8	0.48	7.46e-6	Schizophrenia;
SKCM	cis	rs12142240	0.698	rs41294478	chr1:46818442	G/A	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs55962025	0.588	rs362312	chr4:3237644	T/C	cg09735869	chr4:3319127	RGS12	-0.66	-5.99	-0.56	6.09e-8	Parental longevity (mother's age at death);
SKCM	cis	rs1799949	0.965	rs11658499	chr17:41334749	C/T	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.29	-0.58	1.73e-8	Menopause (age at onset);
SKCM	cis	rs951366	0.789	rs823137	chr1:205738302	C/T	cg07167872	chr1:205819463	PM20D1	0.96	8.35	0.69	2e-12	Menarche (age at onset);
SKCM	cis	rs8180040	0.903	rs11710013	chr3:47296921	T/C	cg27129171	chr3:47204927	SETD2	0.85	6.39	0.59	1.11e-8	Colorectal cancer;
SKCM	cis	rs7100689	0.577	rs4934038	chr10:82057334	C/A	cg01528321	chr10:82214614	TSPAN14	0.75	6.99	0.62	8.16e-10	Post bronchodilator FEV1;
SKCM	cis	rs61776719	0.875	rs4072980	chr1:38456106	G/A	cg12658694	chr1:38397304	INPP5B	-0.77	-7.04	-0.62	6.48e-10	Coronary artery disease;
SKCM	cis	rs3789045	0.685	rs12036042	chr1:204469314	T/C	cg17419461	chr1:204415978	PIK3C2B	-0.86	-5.72	-0.54	1.89e-7	Educational attainment (college completion);
SKCM	cis	rs362296	0.698	rs362266	chr4:3259632	C/G	cg11471262	chr4:3318911	RGS12	-0.75	-6.76	-0.61	2.27e-9	Parental longevity (mother's age at death);
SKCM	cis	rs7666738	0.830	rs13108422	chr4:99059267	G/A	cg05340658	chr4:99064831	C4orf37	0.66	4.87	0.48	5.74e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs459571	0.792	rs55923934	chr9:136888233	C/G	cg13789015	chr9:136890014	NCRNA00094	0.77	6.63	0.6	3.95e-9	Platelet distribution width;
SKCM	cis	rs1552244	0.810	rs35711405	chr3:10116939	C/T	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs523522	0.962	rs3893104	chr12:120903936	G/A	cg27279351	chr12:120934652	DYNLL1	0.9	7.95	0.67	1.18e-11	High light scatter reticulocyte count;
SKCM	cis	rs11098499	0.908	rs7696649	chr4:120322177	G/A	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs11155671	0.530	rs6933882	chr6:150210802	A/G	cg05036130	chr6:150231994	NA	0.61	6.58	0.6	4.87e-9	Testicular germ cell tumor;
SKCM	trans	rs208520	0.690	rs12194057	chr6:66745616	A/G	cg15611600	chr13:45563400	KIAA1704;NUFIP1	0.92	7.47	0.65	9.89e-11	Exhaled nitric oxide output;
SKCM	cis	rs28386778	0.897	rs2584639	chr17:61863732	C/T	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs3820068	0.581	rs72645889	chr1:15930251	T/G	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs2204008	0.744	rs2222344	chr12:38406832	T/G	cg26384229	chr12:38710491	ALG10B	0.82	6.3	0.58	1.6e-8	Bladder cancer;
SKCM	cis	rs2153535	0.580	rs4960411	chr6:8438231	C/G	cg07606381	chr6:8435919	SLC35B3	0.93	6.77	0.61	2.18e-9	Motion sickness;
SKCM	cis	rs11992186	0.597	rs77717027	chr8:8591632	T/C	cg15556689	chr8:8085844	FLJ10661	-0.62	-4.86	-0.48	5.84e-6	Neuroticism;
SKCM	cis	rs861020	0.606	rs2184919	chr1:210000015	C/T	cg05527609	chr1:210001259	C1orf107	-0.88	-6.84	-0.61	1.59e-9	Orofacial clefts;
SKCM	cis	rs7937682	0.961	rs1784784	chr11:111483185	C/T	cg19812747	chr11:111475976	SIK2	-0.55	-4.94	-0.49	4.39e-6	Primary sclerosing cholangitis;
SKCM	cis	rs2070488	0.695	rs6599201	chr3:38476614	A/G	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.74	6.01	0.56	5.5e-8	Electrocardiographic conduction measures;
SKCM	cis	rs860295	0.665	rs12028416	chr1:155401161	G/T	cg02153340	chr1:155202674	NA	-0.77	-5.48	-0.53	4.96e-7	Body mass index;
SKCM	cis	rs17065868	0.881	rs9525979	chr13:45118207	T/C	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs9467773	1.000	rs10946835	chr6:26533757	C/T	cg09904177	chr6:26538194	HMGN4	0.54	4.98	0.49	3.78e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs12497850	0.864	rs6779394	chr3:49157771	G/A	cg07636037	chr3:49044803	WDR6	1.03	9.16	0.72	5.21e-14	Parkinson's disease;
SKCM	cis	rs28386778	0.897	rs6504185	chr17:61848792	A/G	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs7811142	0.830	rs76798830	chr7:99952828	C/T	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.2	7.87	0.67	1.7e-11	Platelet count;
SKCM	cis	rs2243480	0.901	rs57126451	chr7:65416306	T/C	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs1760803	0.754	rs12028554	chr1:154223101	G/A	cg26808167	chr1:154192205	UBAP2L;C1orf43	-0.56	-4.92	-0.49	4.74e-6	Nicotine dependence;
SKCM	cis	rs763121	0.853	rs3747170	chr22:39067331	G/A	cg06022373	chr22:39101656	GTPBP1	0.78	5.63	0.54	2.7e-7	Menopause (age at onset);
SKCM	cis	rs748404	0.697	rs574065	chr15:43550655	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	-0.69	-5.79	-0.55	1.41e-7	Lung cancer;
SKCM	cis	rs12541335	0.639	rs11779277	chr8:22200683	C/T	cg09517075	chr8:22133004	PIWIL2	0.6	5.51	0.53	4.45e-7	Hypertriglyceridemia;
SKCM	cis	rs200895692	1	rs200895692	chr1:43421956	CGCCTGTAATCCCAG/C	cg03128534	chr1:43423976	SLC2A1	0.86	5.16	0.5	1.8e-6	Monocyte count;
SKCM	cis	rs12711979	0.509	rs10200764	chr2:3827772	C/G	cg17052675	chr2:3827356	NA	-0.85	-9.31	-0.73	2.76e-14	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs514406	0.505	rs269287	chr1:53168842	T/C	cg16325326	chr1:53192061	ZYG11B	0.91	10.23	0.76	4.5e-16	Monocyte count;
SKCM	cis	rs908922	0.651	rs1885531	chr1:152480233	T/G	cg09873164	chr1:152488093	CRCT1	0.86	6.01	0.56	5.64e-8	Hair morphology;
SKCM	cis	rs10754283	0.967	rs6698273	chr1:90106791	T/A	cg21401794	chr1:90099060	LRRC8C	0.74	6.4	0.59	1.09e-8	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs2836974	0.627	rs7278985	chr21:40653767	C/T	cg17971929	chr21:40555470	PSMG1	-0.76	-7.16	-0.63	3.94e-10	Cognitive function;
SKCM	cis	rs6840360	0.638	rs6816002	chr4:152589439	C/T	cg22705602	chr4:152727874	NA	-0.56	-7.12	-0.63	4.73e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs7937682	0.711	rs4938792	chr11:111420936	T/C	cg19812747	chr11:111475976	SIK2	0.56	4.89	0.48	5.32e-6	Primary sclerosing cholangitis;
SKCM	cis	rs514406	0.727	rs61768342	chr1:53217028	G/A	cg16325326	chr1:53192061	ZYG11B	-0.88	-8.89	-0.71	1.75e-13	Monocyte count;
SKCM	cis	rs9467773	1.000	rs2255070	chr6:26501777	C/G	cg15659132	chr6:26577336	NA	0.61	5.77	0.55	1.52e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs936229	0.861	rs12441505	chr15:75107311	A/C	cg14664628	chr15:75095509	CSK	-1.16	-10.49	-0.77	1.43e-16	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin);
SKCM	cis	rs9910055	0.747	rs2905981	chr17:42238625	C/T	cg09913183	chr17:42254507	C17orf65;ASB16	0.7	6.49	0.59	7.35e-9	Total body bone mineral density;
SKCM	cis	rs642803	0.527	rs1647570	chr11:65568256	A/T	cg08755490	chr11:65554678	OVOL1	-0.65	-5.0	-0.49	3.43e-6	Urate levels;
SKCM	cis	rs7666738	0.830	rs10009206	chr4:99056900	A/C	cg05340658	chr4:99064831	C4orf37	-0.68	-5.13	-0.5	2.04e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6540556	0.954	rs6696463	chr1:209933757	G/C	cg05527609	chr1:210001259	C1orf107	-0.86	-4.8	-0.48	7.39e-6	Red blood cell count;
SKCM	cis	rs4927850	0.881	rs7624638	chr3:195748729	C/T	cg12923728	chr3:195709715	SDHAP1	-0.93	-6.36	-0.58	1.24e-8	Pancreatic cancer;
SKCM	cis	rs6912958	0.559	rs451829	chr6:88041919	A/G	cg08069147	chr6:88032118	GJB7;C6orf162	0.64	5.61	0.54	2.97e-7	Monocyte percentage of white cells;
SKCM	cis	rs17711722	0.653	rs2460421	chr7:65491123	A/T	cg05627663	chr7:65219948	SNORA22;CCT6P1	-0.61	-5.59	-0.54	3.17e-7	Calcium levels;
SKCM	cis	rs870825	0.616	rs28608669	chr4:185632890	T/C	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs7511006	0.893	rs17248273	chr22:50658570	A/G	cg16473166	chr22:50639996	SELO	0.71	5.74	0.55	1.72e-7	Obesity-related traits;
SKCM	cis	rs7659604	1.000	rs7689722	chr4:122665955	T/C	cg06713675	chr4:122721982	EXOSC9	-0.61	-5.5	-0.53	4.64e-7	Type 2 diabetes;
SKCM	cis	rs17270561	0.525	rs10484432	chr6:26008876	G/A	cg16482183	chr6:26056742	HIST1H1C	0.98	7.24	0.63	2.75e-10	Iron status biomarkers;
SKCM	cis	rs738322	1.000	rs4382	chr22:38570842	T/C	cg25457927	chr22:38595422	NA	-0.54	-6.14	-0.57	3.27e-8	Cutaneous nevi;
SKCM	cis	rs6570726	0.738	rs7746330	chr6:145899257	A/C	cg23711669	chr6:146136114	FBXO30	0.88	9.09	0.72	7.08e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2050392	0.624	rs303449	chr10:30726845	G/A	cg25182066	chr10:30743637	MAP3K8	-0.65	-5.3	-0.51	1.05e-6	Inflammatory bowel disease;
SKCM	cis	rs71520386	0.632	rs2286500	chr7:22856804	T/C	cg15401507	chr7:22894281	NA	0.67	4.96	0.49	4.03e-6	Fibrinogen levels;
SKCM	cis	rs10911251	0.546	rs3768625	chr1:183078712	G/T	ch.1.3577855R	chr1:183094577	LAMC1	0.81	7.7	0.66	3.57e-11	Colorectal cancer;
SKCM	cis	rs1153858	1.000	rs12591058	chr15:45640172	T/C	cg10760299	chr15:45669010	GATM	0.57	5.67	0.54	2.31e-7	Homoarginine levels;
SKCM	cis	rs6951245	1.000	rs76388414	chr7:1100694	G/A	cg18402987	chr7:1209562	NA	1.15	6.09	0.57	3.95e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs6952808	0.564	rs55865401	chr7:2145720	G/C	cg21782813	chr7:2030301	MAD1L1	0.51	5.49	0.53	4.92e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs910316	0.967	rs4384542	chr14:75658013	A/C	cg08847533	chr14:75593920	NEK9	-0.98	-9.72	-0.74	4.28e-15	Height;
SKCM	cis	rs72781680	0.898	rs72796158	chr2:23935727	T/C	cg08917208	chr2:24149416	ATAD2B	0.95	4.78	0.48	8.1e-6	Lymphocyte counts;
SKCM	cis	rs738322	0.870	rs2277844	chr22:38577515	G/A	cg25457927	chr22:38595422	NA	0.61	7.54	0.65	7.31e-11	Cutaneous nevi;
SKCM	cis	rs4523957	0.583	rs2760737	chr17:2024647	C/T	cg16513277	chr17:2031491	SMG6	-0.81	-5.98	-0.56	6.24e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs28386778	0.933	rs2665801	chr17:61952100	C/T	cg26338869	chr17:61819248	STRADA	0.7	4.79	0.48	7.67e-6	Prudent dietary pattern;
SKCM	cis	rs4237845	0.586	rs4760174	chr12:58320436	G/A	cg23860436	chr12:58378763	NA	0.46	4.93	0.49	4.53e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7666738	0.791	rs10033211	chr4:98995624	T/A	cg17366294	chr4:99064904	C4orf37	0.6	4.98	0.49	3.8e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1577917	0.710	rs1059306	chr6:86388109	G/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	1.02	11.58	0.8	1.29e-18	Response to antipsychotic treatment;
SKCM	cis	rs4819052	0.851	rs7275468	chr21:46656499	C/A	cg02159808	chr21:46707872	POFUT2;LOC642852	0.68	5.17	0.5	1.78e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs2075371	0.932	rs34664116	chr7:133984878	G/A	cg20476274	chr7:133979776	SLC35B4	0.97	9.7	0.74	4.7e-15	Mean platelet volume;
SKCM	cis	rs7208859	0.623	rs59447372	chr17:29057585	C/T	cg14067834	chr17:29058358	SUZ12P	1.2	5.77	0.55	1.5e-7	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs9926664	0.591	rs305083	chr16:85935878	A/G	cg16682899	chr16:85508110	NA	-0.55	-5.62	-0.54	2.84e-7	Sum basophil neutrophil counts;Neutrophil count;
SKCM	trans	rs1814175	0.565	rs4881721	chr11:49761851	G/A	cg15704280	chr7:45808275	SEPT13	-0.82	-7.89	-0.67	1.53e-11	Height;
SKCM	cis	rs2836950	0.520	rs2836966	chr21:40637521	A/G	cg11644478	chr21:40555479	PSMG1	-0.64	-5.04	-0.5	2.95e-6	Menarche (age at onset);
SKCM	cis	rs28595532	0.920	rs56389935	chr4:119683571	G/A	cg21605333	chr4:119757512	SEC24D	1.35	7.92	0.67	1.37e-11	Cannabis dependence symptom count;
SKCM	cis	rs6933660	0.800	rs13201167	chr6:151773504	T/C	cg10883421	chr6:151773342	RMND1;C6orf211	0.82	7.01	0.62	7.69e-10	Menarche (age at onset);
SKCM	cis	rs798554	0.679	rs13230995	chr7:2887284	G/A	cg04166393	chr7:2884313	GNA12	0.79	5.54	0.53	3.9e-7	Height;
SKCM	cis	rs801193	0.569	rs7782587	chr7:66166472	C/T	cg18876405	chr7:65276391	NA	0.61	6.01	0.56	5.49e-8	Aortic root size;
SKCM	cis	rs2204008	0.837	rs11612125	chr12:38213212	C/T	cg13010199	chr12:38710504	ALG10B	0.65	4.84	0.48	6.52e-6	Bladder cancer;
SKCM	cis	rs3815308	0.524	rs4807212	chr19:2194657	C/T	cg07648048	chr19:2810561	THOP1	0.58	4.85	0.48	6.13e-6	Breast cancer;
SKCM	cis	rs4319547	0.760	rs61954973	chr12:123074168	T/C	cg23029597	chr12:123009494	RSRC2	-0.81	-5.99	-0.56	6.21e-8	Body mass index;
SKCM	cis	rs11155671	0.530	rs9322228	chr6:150209309	C/G	cg05036130	chr6:150231994	NA	0.61	6.58	0.6	4.87e-9	Testicular germ cell tumor;
SKCM	cis	rs7980687	0.550	rs1727324	chr12:123698603	A/T	cg05973401	chr12:123451056	ABCB9	0.79	5.2	0.51	1.59e-6	Height;Educational attainment;Head circumference (infant);
SKCM	cis	rs4820539	0.966	rs5751590	chr22:23486830	A/C	cg14186256	chr22:23484241	RTDR1	0.85	8.19	0.68	4.09e-12	Bone mineral density;
SKCM	cis	rs155076	1.000	rs261407	chr13:21855213	C/A	cg11317459	chr13:21872234	NA	-1.24	-6.91	-0.62	1.19e-9	White matter hyperintensity burden;
SKCM	cis	rs10256972	0.732	rs12701856	chr7:1107707	C/T	cg16145915	chr7:1198662	ZFAND2A	-0.47	-5.89	-0.56	9.16e-8	Longevity;Endometriosis;
SKCM	cis	rs7927771	0.524	rs12286721	chr11:47701528	G/T	cg20307385	chr11:47447363	PSMC3	-0.72	-5.81	-0.55	1.31e-7	Subjective well-being;
SKCM	cis	rs9303401	0.659	rs17822807	chr17:56687190	A/C	cg10487724	chr17:56770010	TEX14;RAD51C	0.85	6.03	0.56	5.18e-8	Cognitive test performance;
SKCM	cis	rs1348850	0.567	rs3821006	chr2:178537694	G/A	cg02961200	chr2:178257176	LOC100130691;AGPS	0.66	4.82	0.48	6.84e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs4523957	0.583	rs2760739	chr17:2024217	C/T	cg16513277	chr17:2031491	SMG6	-0.81	-5.98	-0.56	6.24e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs1059312	0.808	rs4760537	chr12:129301299	C/A	cg09035930	chr12:129282057	SLC15A4	0.8	8.25	0.68	3.05e-12	Systemic lupus erythematosus;
SKCM	cis	rs2836974	0.931	rs13047663	chr21:40708818	C/T	cg17971929	chr21:40555470	PSMG1	0.83	7.56	0.65	6.6e-11	Cognitive function;
SKCM	cis	rs6430585	0.583	rs9636213	chr2:136589278	G/A	cg07169764	chr2:136633963	MCM6	-1.26	-11.77	-0.8	5.63e-19	Corneal structure;
SKCM	cis	rs7590368	1.000	rs17456225	chr2:10963238	C/G	cg15705551	chr2:10952987	PDIA6	0.76	4.88	0.48	5.52e-6	Educational attainment (years of education);
SKCM	cis	rs875971	0.522	rs9530	chr7:65425894	A/G	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.62	5.29	0.51	1.1e-6	Aortic root size;
SKCM	cis	rs2346177	0.554	rs34854267	chr2:46708542	T/C	cg02822958	chr2:46747628	ATP6V1E2	0.73	5.31	0.52	9.9e-7	HDL cholesterol;
SKCM	cis	rs9368481	0.554	rs2754603	chr6:26965139	T/C	cg12292205	chr6:26970375	C6orf41	-0.71	-6.4	-0.59	1.05e-8	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs2070488	0.804	rs4678605	chr3:38444489	T/A	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.73	5.95	0.56	7.08e-8	Electrocardiographic conduction measures;
SKCM	cis	rs7447593	0.518	rs4074995	chr5:176797343	C/T	cg17509989	chr5:176798049	RGS14	0.9	8.96	0.71	1.31e-13	Urinary electrolytes (magnesium/calcium ratio);
SKCM	cis	rs7917772	0.582	rs7907417	chr10:104370662	A/G	cg11453585	chr10:104263688	ACTR1A;SUFU	-0.63	-4.83	-0.48	6.74e-6	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs362272	0.545	rs2749785	chr4:3325179	G/C	cg05297308	chr4:3317976	RGS12	1.03	11.77	0.8	5.66e-19	Serum sulfate level;
SKCM	cis	rs362296	0.590	rs4690081	chr4:3262105	T/G	cg09735869	chr4:3319127	RGS12	-0.79	-7.05	-0.62	6.41e-10	Parental longevity (mother's age at death);
SKCM	cis	rs1003719	0.751	rs7280371	chr21:38450008	T/C	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs798554	0.797	rs798497	chr7:2795957	A/G	cg04166393	chr7:2884313	GNA12	0.72	4.99	0.49	3.52e-6	Height;
SKCM	cis	rs1552244	0.882	rs7636817	chr3:10014876	G/T	cg02579736	chr3:10068473	FANCD2;CIDECP	0.94	4.84	0.48	6.49e-6	Alzheimer's disease;
SKCM	cis	rs9988450	1	rs9988450	chr1:62924448	C/T	cg06896770	chr1:63153194	DOCK7	0.74	7.18	0.63	3.62e-10	Triglycerides;
SKCM	cis	rs477895	0.713	rs35095324	chr11:63948412	G/A	cg07220939	chr11:64358617	SLC22A12	0.74	4.99	0.49	3.58e-6	Mean platelet volume;
SKCM	cis	rs11950121	0.674	rs10940347	chr5:53161856	A/T	cg06476337	chr5:52856530	NDUFS4	-0.66	-4.95	-0.49	4.19e-6	Alcoholic chronic pancreatitis;
SKCM	cis	rs35146811	0.735	rs7811662	chr7:99792608	A/G	cg22906224	chr7:99728672	NA	0.65	5.19	0.51	1.6e-6	Coronary artery disease;
SKCM	cis	rs4689592	0.503	rs2292461	chr4:7058473	C/T	cg19539972	chr4:7069911	GRPEL1	1.0	6.55	0.6	5.57e-9	Monocyte percentage of white cells;
SKCM	cis	rs992157	0.735	rs12990082	chr2:219102332	C/T	cg00012203	chr2:219082015	ARPC2	0.84	7.36	0.64	1.6e-10	Colorectal cancer;
SKCM	cis	rs11098499	0.604	rs2389882	chr4:120566733	A/C	cg09307838	chr4:120376055	NA	0.99	7.89	0.67	1.5e-11	Corneal astigmatism;
SKCM	trans	rs1814175	0.564	rs12416819	chr11:49755567	T/C	cg15704280	chr7:45808275	SEPT13	-1.01	-9.85	-0.74	2.46e-15	Height;
SKCM	cis	rs875971	0.617	rs810400	chr7:66022889	G/C	cg11987759	chr7:65425863	GUSB	0.69	5.9	0.56	8.74e-8	Aortic root size;
SKCM	cis	rs28595532	0.920	rs114019902	chr4:119755564	G/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs3741151	1.000	rs76570090	chr11:73066321	A/T	cg17517138	chr11:73019481	ARHGEF17	1.27	4.87	0.48	5.81e-6	GIP levels in response to oral glucose tolerance test (120 minutes);
SKCM	cis	rs67311347	0.544	rs67533651	chr3:40338367	T/A	cg00656387	chr3:40428638	ENTPD3	0.56	4.98	0.49	3.71e-6	Renal cell carcinoma;
SKCM	cis	rs6952808	0.782	rs4236271	chr7:1881369	C/T	cg02951883	chr7:2050386	MAD1L1	-0.65	-4.89	-0.48	5.24e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs1185460	0.967	rs1177562	chr11:118949331	C/T	cg23280166	chr11:118938394	VPS11	0.59	5.29	0.51	1.1e-6	Coronary artery disease;
SKCM	cis	rs933688	1.000	rs10073935	chr5:90742188	A/G	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.92	6.76	0.61	2.21e-9	Smoking behavior;
SKCM	cis	rs2439831	0.867	rs2899082	chr15:43656043	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.39	9.42	0.73	1.62e-14	Lung cancer in ever smokers;
SKCM	cis	rs4819052	0.851	rs2236443	chr21:46678174	T/C	cg19498844	chr21:46707878	POFUT2;LOC642852	0.88	7.66	0.66	4.2e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs16949788	1.000	rs9806474	chr15:66646513	C/T	cg08120210	chr15:66682733	MAP2K1	-0.74	-5.82	-0.55	1.23e-7	Spherical equivalent (joint analysis main effects and education interaction);
SKCM	cis	rs523522	0.962	rs12309824	chr12:120990582	A/C	cg27279351	chr12:120934652	DYNLL1	0.91	8.32	0.69	2.26e-12	High light scatter reticulocyte count;
SKCM	cis	rs12971120	0.838	rs3794950	chr18:72182965	G/A	cg25817165	chr18:72167213	CNDP2	-0.69	-4.82	-0.48	6.85e-6	Refractive error;
SKCM	cis	rs798554	0.679	rs2644300	chr7:2883071	G/A	cg19346786	chr7:2764209	NA	-0.66	-6.64	-0.6	3.79e-9	Height;
SKCM	cis	rs875971	0.638	rs10249404	chr7:66046724	G/A	cg11764359	chr7:65958608	NA	-0.83	-6.29	-0.58	1.71e-8	Aortic root size;
SKCM	cis	rs10911251	0.546	rs1051473	chr1:183114146	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.76	7.28	0.64	2.26e-10	Colorectal cancer;
SKCM	cis	rs1577917	0.958	rs34765423	chr6:86484448	C/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.71	-6.14	-0.57	3.29e-8	Response to antipsychotic treatment;
SKCM	cis	rs1005277	0.579	rs2008449	chr10:38414204	A/T	cg00409905	chr10:38381863	ZNF37A	0.64	6.42	0.59	9.83e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs875971	0.790	rs10257911	chr7:65743770	A/G	cg18876405	chr7:65276391	NA	-0.65	-6.66	-0.6	3.51e-9	Aortic root size;
SKCM	cis	rs9399135	0.935	rs987690	chr6:135350379	A/G	cg24558204	chr6:135376177	HBS1L	0.6	5.36	0.52	8.17e-7	Red blood cell count;
SKCM	cis	rs6952808	0.929	rs34145223	chr7:1926237	G/A	cg02951883	chr7:2050386	MAD1L1	-0.72	-5.92	-0.56	8.26e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs7927771	0.896	rs12794570	chr11:47658314	C/T	cg05585544	chr11:47624801	NA	-0.63	-5.5	-0.53	4.73e-7	Subjective well-being;
SKCM	cis	rs761746	0.705	rs2092905	chr22:31966274	T/C	cg25791279	chr22:32026902	PISD	-0.81	-4.89	-0.48	5.39e-6	Intelligence;
SKCM	cis	rs654950	0.875	rs633297	chr1:41985453	A/C	cg06885757	chr1:42089581	HIVEP3	0.61	6.72	0.61	2.67e-9	Airway imaging phenotypes;
SKCM	cis	rs2395909	1	rs2395909	chr7:107292663	G/A	cg23024343	chr7:107201750	COG5	0.65	5.64	0.54	2.6e-7	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;
SKCM	cis	rs7193541	0.684	rs7201320	chr16:74694058	T/G	cg01733217	chr16:74700730	RFWD3	0.99	10.34	0.76	2.84e-16	Multiple myeloma;
SKCM	cis	rs2197308	0.667	rs61920838	chr12:37856814	T/C	cg26384229	chr12:38710491	ALG10B	-0.79	-6.53	-0.59	6.17e-9	Morning vs. evening chronotype;
SKCM	cis	rs2013441	1.000	rs2526472	chr17:20137888	G/A	cg13482628	chr17:19912719	NA	-0.64	-5.04	-0.5	2.94e-6	Obesity-related traits;
SKCM	cis	rs7811142	0.943	rs67483801	chr7:100031758	G/T	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.23	7.89	0.67	1.53e-11	Platelet count;
SKCM	cis	rs11710229	1.000	rs11709866	chr3:55487222	A/T	cg04915058	chr3:55693741	C3orf51;ERC2	0.9	5.08	0.5	2.53e-6	Response to cytadine analogues (cytosine arabinoside);
SKCM	cis	rs732765	0.657	rs11844957	chr14:75224651	T/C	cg25946216	chr14:74253857	C14orf43	-0.93	-5.16	-0.5	1.82e-6	Non-small cell lung cancer;
SKCM	cis	rs11098499	0.739	rs7441137	chr4:120133221	G/T	cg09307838	chr4:120376055	NA	-0.78	-5.85	-0.55	1.1e-7	Corneal astigmatism;
SKCM	cis	rs9549367	0.713	rs9577211	chr13:113830718	G/C	cg18105134	chr13:113819100	PROZ	-0.88	-6.49	-0.59	7.3e-9	Platelet distribution width;
SKCM	cis	rs6500395	0.963	rs6500405	chr16:48690486	C/T	cg04672837	chr16:48644449	N4BP1	-0.65	-5.43	-0.52	6.29e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs34779708	0.931	rs2001893	chr10:35300623	G/A	cg03585969	chr10:35415529	CREM	0.73	6.02	0.56	5.27e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs28595532	0.920	rs17325192	chr4:119780345	A/G	cg11846333	chr4:119757529	SEC24D	-0.93	-5.56	-0.53	3.71e-7	Cannabis dependence symptom count;
SKCM	cis	rs6723226	0.764	rs176403	chr2:32637864	C/A	cg02381751	chr2:32503542	YIPF4	-0.89	-6.52	-0.59	6.26e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs4819052	0.788	rs13049700	chr21:46701909	G/C	cg19498844	chr21:46707878	POFUT2;LOC642852	0.83	6.36	0.58	1.27e-8	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs3096299	0.719	rs2353581	chr16:89518908	T/C	cg02187348	chr16:89574699	SPG7	0.55	4.84	0.48	6.44e-6	Multiple myeloma (IgH translocation);
SKCM	cis	rs8078723	1.000	rs59925331	chr17:38169273	C/G	cg17467752	chr17:38218738	THRA	0.68	6.3	0.58	1.61e-8	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs875971	1.000	rs1540651	chr7:65650121	C/T	cg11764359	chr7:65958608	NA	-0.86	-8.24	-0.68	3.26e-12	Aortic root size;
SKCM	cis	rs798502	0.541	rs2644307	chr7:2832973	G/A	cg19346786	chr7:2764209	NA	-0.44	-5.02	-0.49	3.2e-6	Waist circumference adjusted for BMI (adjusted for smoking behaviour);Inflammatory bowel disease;Waist circumference adjusted for BMI in non-smokers;Ulcerative colitis;Waist circumference adjusted for body mass index;Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction);
SKCM	cis	rs561341	1.000	rs55736640	chr17:30333848	G/A	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs2404602	0.647	rs907593	chr15:77196953	G/A	cg23625390	chr15:77176239	SCAPER	-0.85	-8.22	-0.68	3.49e-12	Blood metabolite levels;
SKCM	cis	rs10503709	0.542	rs1021065	chr8:21448797	A/C	cg23716449	chr8:21608280	GFRA2	-0.51	-5.2	-0.51	1.58e-6	Blood protein levels;
SKCM	cis	rs9911578	1.000	rs2270097	chr17:56572070	G/A	cg05425664	chr17:57184151	TRIM37	0.69	5.23	0.51	1.38e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1799949	1.000	rs8074136	chr17:41342313	A/C	cg23758822	chr17:41437982	NA	0.93	7.84	0.66	1.91e-11	Menopause (age at onset);
SKCM	cis	rs875971	0.895	rs7788984	chr7:65915616	A/G	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs7666738	0.830	rs10049985	chr4:99023517	C/T	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9443189	0.813	rs2748948	chr6:76437994	T/A	cg01950844	chr6:76311363	SENP6	-0.75	-5.29	-0.51	1.1e-6	Prostate cancer;
SKCM	cis	rs1218582	0.682	rs12046459	chr1:154912017	A/C	cg03351412	chr1:154909251	PMVK	0.76	6.45	0.59	8.5e-9	Prostate cancer;
SKCM	cis	rs3087591	0.922	rs757383	chr17:29596045	C/G	cg24425628	chr17:29625626	OMG;NF1	0.64	5.08	0.5	2.48e-6	Hip circumference;
SKCM	cis	rs6998277	0.830	rs12543008	chr8:103603747	C/T	cg10187029	chr8:103597600	NA	0.73	6.03	0.56	5.19e-8	Migraine;
SKCM	cis	rs6570726	0.935	rs382910	chr6:145865941	G/A	cg23711669	chr6:146136114	FBXO30	0.7	6.76	0.61	2.25e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs28386778	0.897	rs2859619	chr17:61917686	T/C	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	trans	rs1814175	0.817	rs7947286	chr11:49874657	C/T	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs6430585	0.528	rs2278682	chr2:136743143	G/C	cg07169764	chr2:136633963	MCM6	1.25	10.32	0.76	3.02e-16	Corneal structure;
SKCM	cis	rs7618501	0.633	rs2526751	chr3:50064867	T/C	cg05072774	chr3:49840536	C3orf54	0.68	5.06	0.5	2.67e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs72781680	1.000	rs72781649	chr2:24210864	A/G	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	cis	rs12586317	0.553	rs3809448	chr14:35515096	C/T	cg16230307	chr14:35515116	FAM177A1	0.83	6.08	0.57	4.19e-8	Psoriasis;
SKCM	cis	rs4862750	0.872	rs6811837	chr4:187898162	G/A	cg10295955	chr4:187884368	NA	-1.05	-14.11	-0.85	3.63e-23	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9325144	0.532	rs12812406	chr12:38719802	G/A	cg26384229	chr12:38710491	ALG10B	-0.76	-6.4	-0.59	1.05e-8	Morning vs. evening chronotype;
SKCM	cis	rs17685	0.890	rs76021834	chr7:75607155	A/G	cg16489192	chr7:75678113	MDH2;STYXL1	-0.62	-5.41	-0.52	6.74e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7666738	0.544	rs35160902	chr4:98974690	A/T	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6570726	0.967	rs373704	chr6:145860618	C/A	cg23711669	chr6:146136114	FBXO30	0.68	6.58	0.6	4.98e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9926296	0.681	rs12923946	chr16:89821080	C/T	cg01097406	chr16:89675127	NA	-0.44	-4.77	-0.48	8.5e-6	Vitiligo;
SKCM	cis	rs72615157	0.561	rs113844570	chr7:99873778	A/C	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.18	7.4	0.64	1.33e-10	Lung function (FEV1/FVC);
SKCM	cis	rs854765	0.647	rs854790	chr17:18028318	C/G	cg04398451	chr17:18023971	MYO15A	-1.01	-8.55	-0.7	8.1e-13	Total body bone mineral density;
SKCM	cis	rs10800309	0.667	rs10157489	chr1:161463019	A/G	cg13906823	chr1:161008824	TSTD1	0.49	4.86	0.48	5.88e-6	Inflammatory bowel disease;Ulcerative colitis;
SKCM	cis	rs736408	0.812	rs6778329	chr3:52824610	G/A	cg11645453	chr3:52864694	ITIH4	0.58	4.92	0.49	4.71e-6	Bipolar disorder;
SKCM	cis	rs9902453	0.904	rs4077465	chr17:28300144	T/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.82	6.4	0.59	1.06e-8	Coffee consumption (cups per day);
SKCM	cis	rs7666738	0.830	rs6829567	chr4:99047340	T/C	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10489202	1.000	rs3767474	chr1:168062398	C/T	cg24449463	chr1:168025552	DCAF6	-0.77	-5.95	-0.56	7.18e-8	Schizophrenia;
SKCM	cis	rs2241584	0.715	rs4868644	chr5:175947051	C/T	cg06525892	chr5:175792454	ARL10	-0.53	-4.81	-0.48	7.31e-6	Menopause (age at onset);
SKCM	cis	rs709400	0.859	rs7154948	chr14:104022944	C/T	cg26031613	chr14:104095156	KLC1	1.0	10.44	0.76	1.82e-16	Body mass index;
SKCM	cis	rs6952808	0.500	rs3778996	chr7:2177190	G/A	cg21782813	chr7:2030301	MAD1L1	0.52	5.13	0.5	2.09e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs6545883	0.862	rs1880866	chr2:61698972	G/C	cg15711740	chr2:61764176	XPO1	-0.68	-4.87	-0.48	5.76e-6	Tuberculosis;
SKCM	cis	rs13064447	0.967	rs12637499	chr3:12756946	C/T	cg05775895	chr3:12838266	CAND2	-0.61	-4.98	-0.49	3.75e-6	Major depression and alcohol dependence;
SKCM	cis	rs61612642	0.537	rs73434275	chr6:42156239	G/A	cg01092361	chr6:42185687	MRPS10	0.99	5.67	0.54	2.34e-7	Eosinophil percentage of white cells;Sum eosinophil basophil counts;Eosinophil percentage of granulocytes;Eosinophil counts;
SKCM	cis	rs62064224	0.765	rs62065463	chr17:30732405	G/T	cg18200150	chr17:30822561	MYO1D	0.81	6.45	0.59	8.71e-9	Schizophrenia;
SKCM	cis	rs7666738	0.830	rs13139078	chr4:99020774	C/T	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1403694	0.515	rs1622922	chr3:186449884	C/T	cg09332604	chr3:186435400	KNG1	-0.56	-5.67	-0.54	2.31e-7	Blood protein levels;
SKCM	cis	rs12497850	0.931	rs7616815	chr3:48779715	C/T	cg06212747	chr3:49208901	KLHDC8B	0.66	4.79	0.48	7.65e-6	Parkinson's disease;
SKCM	cis	rs9902453	0.780	rs7210991	chr17:28190961	T/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.83	5.76	0.55	1.61e-7	Coffee consumption (cups per day);
SKCM	cis	rs1256061	0.603	rs1256041	chr14:64738029	A/G	cg21174375	chr14:64681225	SYNE2	0.47	4.95	0.49	4.15e-6	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs2404602	0.684	rs12591622	chr15:76930655	A/T	cg23625390	chr15:77176239	SCAPER	-0.85	-8.26	-0.68	2.93e-12	Blood metabolite levels;
SKCM	cis	rs8060686	0.641	rs8058690	chr16:68136622	T/G	cg04539111	chr16:67997858	SLC12A4	-0.85	-4.81	-0.48	7.14e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs10876993	0.928	rs1678532	chr12:58055197	T/G	cg18357645	chr12:58087776	OS9	0.61	5.65	0.54	2.52e-7	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs28595532	0.920	rs114390336	chr4:119771452	C/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs9467773	0.595	rs7767847	chr6:26597893	A/T	cg09904177	chr6:26538194	HMGN4	0.57	4.89	0.48	5.24e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2295499	0.673	rs12506536	chr4:2712403	T/C	cg19433769	chr4:2420260	ZFYVE28	0.69	4.77	0.48	8.44e-6	Cognitive ability;Cognitive ability (multi-trait analysis);Intelligence (multi-trait analysis);
SKCM	cis	rs208515	0.556	rs10455193	chr6:66691456	G/A	cg07460842	chr6:66804631	NA	0.93	6.34	0.58	1.37e-8	Exhaled nitric oxide levels;
SKCM	cis	rs9467773	0.620	rs2504567	chr6:26662920	C/G	cg15659132	chr6:26577336	NA	0.62	5.4	0.52	6.91e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs2354432	0.556	rs2883319	chr1:146838177	A/G	cg25205988	chr1:146714368	CHD1L	-1.11	-5.59	-0.53	3.21e-7	Mitochondrial DNA levels;
SKCM	cis	rs11122272	0.735	rs2244986	chr1:231537452	C/T	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	-0.6	-4.8	-0.48	7.45e-6	Hemoglobin concentration;
SKCM	cis	rs1878931	0.559	rs11643501	chr16:3392752	T/C	cg26668626	chr16:3451006	ZNF174;ZNF434	0.84	6.46	0.59	8.37e-9	Body mass index (adult);
SKCM	cis	rs4481887	0.893	rs10888337	chr1:248428227	A/G	cg00666640	chr1:248458726	OR2T12	-0.63	-5.4	-0.52	7.11e-7	Common traits (Other);
SKCM	cis	rs7937682	0.889	rs559482	chr11:111497902	G/A	cg09085632	chr11:111637200	PPP2R1B	-1.07	-11.23	-0.79	5.72e-18	Primary sclerosing cholangitis;
SKCM	cis	rs1799949	1.000	rs4793215	chr17:41318932	G/A	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.15	-0.57	3.16e-8	Menopause (age at onset);
SKCM	cis	rs3818285	0.632	rs536343	chr10:111632879	T/C	cg00817464	chr10:111662876	XPNPEP1	0.74	8.64	0.7	5.42e-13	Superior crus of antihelix expression;
SKCM	cis	rs5753618	0.504	rs5749295	chr22:31932895	A/T	cg02404636	chr22:31891804	SFI1	0.63	5.92	0.56	8.29e-8	Colorectal cancer;
SKCM	cis	rs72781680	1.000	rs72781683	chr2:24247423	T/C	cg08917208	chr2:24149416	ATAD2B	1.05	5.95	0.56	7.17e-8	Lymphocyte counts;
SKCM	cis	rs28595532	0.920	rs28837152	chr4:119782868	G/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs9913156	0.748	rs7215274	chr17:4561834	A/G	cg19197139	chr17:4613644	ARRB2	0.79	5.28	0.51	1.14e-6	Lymphocyte counts;
SKCM	cis	rs2439831	0.850	rs16965120	chr15:44100342	T/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.35	7.75	0.66	2.9e-11	Lung cancer in ever smokers;
SKCM	cis	rs875971	0.862	rs1612452	chr7:65573896	T/A	cg11764359	chr7:65958608	NA	-0.8	-7.66	-0.66	4.2e-11	Aortic root size;
SKCM	cis	rs28595532	1.000	rs56000725	chr4:119637675	G/A	cg11846333	chr4:119757529	SEC24D	1.15	6.24	0.58	2.13e-8	Cannabis dependence symptom count;
SKCM	cis	rs12709013	0.792	rs1646276	chr16:58783558	T/G	cg02431531	chr16:59244939	NA	0.49	5.13	0.5	2.07e-6	Blood metabolite ratios;
SKCM	cis	rs28386778	0.897	rs9915552	chr17:61869095	G/A	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs3087591	0.960	rs2905802	chr17:29520084	T/C	cg24425628	chr17:29625626	OMG;NF1	0.61	4.87	0.48	5.75e-6	Hip circumference;
SKCM	cis	rs12714314	1.000	rs12714314	chr2:1943617	C/T	cg22350835	chr2:1868857	MYT1L	0.66	5.51	0.53	4.5e-7	Type 2 diabetes (age of onset);
SKCM	cis	rs3020736	0.500	rs8143153	chr22:42515637	G/C	cg04733989	chr22:42467013	NAGA	-0.72	-5.62	-0.54	2.87e-7	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs6912958	0.582	rs242285	chr6:88070743	G/A	cg08069147	chr6:88032118	GJB7;C6orf162	0.72	6.72	0.61	2.68e-9	Monocyte percentage of white cells;
SKCM	cis	rs2063714	0.640	rs9397978	chr6:157193250	A/G	cg01608493	chr6:156720309	NA	-0.46	-4.77	-0.48	8.43e-6	Sitting height ratio;
SKCM	cis	rs933688	1.000	rs60513756	chr5:90727692	A/C	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.11	8.46	0.69	1.19e-12	Smoking behavior;
SKCM	cis	rs873946	0.517	rs2803990	chr10:134560340	A/G	cg27286337	chr10:134555280	INPP5A	0.95	9.28	0.72	3.03e-14	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs2197308	0.765	rs117216293	chr12:37882982	T/C	cg13010199	chr12:38710504	ALG10B	-0.64	-4.92	-0.49	4.77e-6	Morning vs. evening chronotype;
SKCM	cis	rs3845702	0.736	rs72960664	chr2:180832672	C/T	cg01881094	chr2:180872142	CWC22	1.3	6.15	0.57	3.07e-8	Schizophrenia;
SKCM	cis	rs6066825	0.644	rs6095248	chr20:47320932	A/G	cg18078177	chr20:47281410	PREX1	0.64	5.19	0.51	1.6e-6	Colorectal cancer;
SKCM	cis	rs7555523	0.830	rs6660601	chr1:165695855	C/T	cg24409356	chr1:165738333	TMCO1	0.93	5.15	0.5	1.93e-6	Intraocular pressure;Glaucoma (high intraocular pressure);
SKCM	cis	rs873946	0.586	rs3793684	chr10:134568645	G/A	cg26818010	chr10:134567672	INPP5A	-0.8	-6.11	-0.57	3.7e-8	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs453301	0.606	rs7462373	chr8:8899318	G/C	cg06636001	chr8:8085503	FLJ10661	-0.79	-5.83	-0.55	1.21e-7	Joint mobility (Beighton score);
SKCM	cis	rs4555082	0.874	rs2816626	chr14:105735425	G/A	cg13114125	chr14:105738426	BRF1	-0.69	-5.47	-0.53	5.33e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs9818758	0.882	rs74926817	chr3:49378833	C/G	cg05072774	chr3:49840536	C3orf54	0.75	4.78	0.48	8.15e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs11628318	0.853	rs7140280	chr14:103026991	C/T	cg01864069	chr14:103024347	NA	-0.76	-5.12	-0.5	2.17e-6	Platelet count;
SKCM	cis	rs9300255	0.569	rs1790115	chr12:123620270	C/G	cg05973401	chr12:123451056	ABCB9	0.8	5.47	0.53	5.23e-7	Neutrophil percentage of white cells;
SKCM	cis	rs7666738	0.830	rs35276471	chr4:99068691	A/T	cg17366294	chr4:99064904	C4orf37	0.61	4.93	0.49	4.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs782590	0.902	rs2586947	chr2:55854009	C/G	cg18811423	chr2:55921094	PNPT1	0.91	7.38	0.64	1.46e-10	Metabolic syndrome;
SKCM	cis	rs28386778	0.769	rs6504179	chr17:61812995	T/G	cg06873352	chr17:61820015	STRADA	0.7	5.71	0.54	1.98e-7	Prudent dietary pattern;
SKCM	cis	rs28386778	0.897	rs2584601	chr17:61940977	T/C	cg22520471	chr17:61851767	DDX42;CCDC47	0.81	5.36	0.52	8.22e-7	Prudent dietary pattern;
SKCM	cis	rs875971	0.862	rs4368860	chr7:65608482	C/G	cg11764359	chr7:65958608	NA	-0.8	-7.66	-0.66	4.2e-11	Aortic root size;
SKCM	cis	rs9303401	0.614	rs34678056	chr17:57177549	G/A	cg10487724	chr17:56770010	TEX14;RAD51C	0.79	4.97	0.49	3.86e-6	Cognitive test performance;
SKCM	cis	rs782590	0.902	rs782601	chr2:55848244	T/C	cg18811423	chr2:55921094	PNPT1	0.9	7.11	0.63	4.9e-10	Metabolic syndrome;
SKCM	cis	rs7458786	1	rs7458786	chr7:102662478	G/A	cg18108683	chr7:102477205	FBXL13	-0.75	-5.61	-0.54	2.91e-7	Breast cancer;
SKCM	cis	rs7772486	0.790	rs2485632	chr6:146193228	A/G	cg05347473	chr6:146136440	FBXO30	0.58	5.45	0.53	5.72e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6582630	0.519	rs9738104	chr12:38338459	A/C	cg13010199	chr12:38710504	ALG10B	0.68	4.82	0.48	6.82e-6	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs637571	0.522	rs538954	chr11:65756808	A/G	cg26695010	chr11:65641043	EFEMP2	-0.72	-5.5	-0.53	4.69e-7	Eosinophil percentage of white cells;
SKCM	cis	rs9381040	0.655	rs9381032	chr6:41044986	A/T	cg03644281	chr6:41068752	NFYA;LOC221442	-0.72	-4.81	-0.48	7.24e-6	Alzheimer's disease (late onset);
SKCM	cis	rs2153535	0.584	rs9502723	chr6:8541504	G/A	cg23788917	chr6:8435910	SLC35B3	0.69	4.92	0.49	4.79e-6	Motion sickness;
SKCM	cis	rs7647973	0.621	rs3774800	chr3:49334768	A/G	cg07636037	chr3:49044803	WDR6	-0.79	-6.34	-0.58	1.4e-8	Menarche (age at onset);
SKCM	cis	rs8017423	0.647	rs4904680	chr14:90822075	C/T	cg04374321	chr14:90722782	PSMC1	-0.73	-5.53	-0.53	4.08e-7	Mortality in heart failure;
SKCM	cis	rs7772486	0.686	rs1569540	chr6:146069112	A/G	cg23711669	chr6:146136114	FBXO30	-0.84	-9.08	-0.72	7.59e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7552404	0.924	rs1611823	chr1:76221706	T/G	cg03433033	chr1:76189801	ACADM	0.76	5.41	0.52	6.62e-7	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs6546550	0.835	rs13002091	chr2:70118388	C/T	cg02498382	chr2:70120550	SNRNP27	-0.46	-5.07	-0.5	2.66e-6	Prevalent atrial fibrillation;
SKCM	cis	rs860295	0.557	rs7534795	chr1:155275553	C/T	cg02153340	chr1:155202674	NA	-0.78	-5.42	-0.52	6.37e-7	Body mass index;
SKCM	cis	rs151997	0.671	rs3991902	chr5:50203749	A/T	cg06027927	chr5:50259733	NA	0.65	6.24	0.58	2.13e-8	Callous-unemotional behaviour;
SKCM	cis	rs17685	0.753	rs1859791	chr7:75786043	T/C	cg16684958	chr7:75615977	POR	0.52	5.03	0.49	3.11e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1153858	1.000	rs7494956	chr15:45668565	T/C	cg10760299	chr15:45669010	GATM	0.62	6.35	0.58	1.3e-8	Homoarginine levels;
SKCM	trans	rs7618501	1.000	rs11130219	chr3:49752427	C/T	cg21659725	chr3:3221576	CRBN	-0.96	-9.61	-0.74	7.08e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs80130819	0.515	rs1635536	chr12:48385945	A/G	cg05342945	chr12:48394962	COL2A1	-0.69	-4.89	-0.48	5.25e-6	Prostate cancer;
SKCM	cis	rs701145	0.585	rs6789213	chr3:153792795	T/C	cg17054900	chr3:154042577	DHX36	1.19	5.25	0.51	1.26e-6	Coronary artery disease;
SKCM	cis	rs9902453	0.933	rs9898353	chr17:28451865	T/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.5	0.53	4.74e-7	Coffee consumption (cups per day);
SKCM	cis	rs6088580	0.634	rs6059878	chr20:33087166	A/T	cg24642439	chr20:33292090	TP53INP2	0.76	6.02	0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs12950390	0.853	rs11655336	chr17:45858836	A/G	cg03474202	chr17:45855739	NA	0.47	5.21	0.51	1.51e-6	IgG glycosylation;
SKCM	cis	rs67311347	0.544	rs12635762	chr3:40332759	C/T	cg13409248	chr3:40428643	ENTPD3	-0.52	-4.98	-0.49	3.79e-6	Renal cell carcinoma;
SKCM	cis	rs854765	0.547	rs2955370	chr17:17966945	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	-1.05	-9.29	-0.72	2.92e-14	Total body bone mineral density;
SKCM	cis	rs1552244	0.882	rs17050660	chr3:10001772	A/G	cg02579736	chr3:10068473	FANCD2;CIDECP	-0.98	-4.89	-0.48	5.25e-6	Alzheimer's disease;
SKCM	cis	rs2836974	0.799	rs13047550	chr21:40515495	T/C	cg17971929	chr21:40555470	PSMG1	0.9	8.74	0.7	3.45e-13	Cognitive function;
SKCM	cis	rs801193	1.000	rs3778909	chr7:66255646	G/C	cg00343986	chr7:65444356	GUSB	0.68	4.99	0.49	3.65e-6	Aortic root size;
SKCM	cis	rs9911578	1.000	rs11079365	chr17:56945430	T/C	cg05425664	chr17:57184151	TRIM37	-0.67	-5.04	-0.5	2.91e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs62244186	0.566	rs6766221	chr3:44882784	C/T	cg02073558	chr3:44770973	ZNF501	0.8	7.05	0.62	6.39e-10	Depressive symptoms;
SKCM	cis	rs2910162	0.646	rs4921296	chr5:159934161	C/T	cg07751793	chr5:159797843	C1QTNF2	-0.47	-5.11	-0.5	2.28e-6	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs12134245	0.776	rs625525	chr1:91997593	C/T	cg25838465	chr1:92012736	NA	-0.79	-8.66	-0.7	5.02e-13	Breast cancer;
SKCM	cis	rs709400	0.633	rs45441198	chr14:104002611	T/C	cg26031613	chr14:104095156	KLC1	0.74	5.79	0.55	1.42e-7	Body mass index;
SKCM	cis	rs67311347	0.544	rs12633295	chr3:40335292	G/T	cg00091569	chr3:40428383	ENTPD3	-0.6	-5.1	-0.5	2.36e-6	Renal cell carcinoma;
SKCM	cis	rs10540	1.000	rs71487292	chr11:486076	G/A	cg03576123	chr11:487126	PTDSS2	-1.53	-7.58	-0.65	6.15e-11	Body mass index;
SKCM	cis	rs7569084	0.663	rs1437461	chr2:65679712	C/T	cg14775296	chr2:66672841	MEIS1	0.51	4.81	0.48	7.15e-6	Sum eosinophil basophil counts;
SKCM	cis	rs28595532	0.920	rs114168088	chr4:119772666	G/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs10484885	0.680	rs72921943	chr6:90581542	A/C	cg13799429	chr6:90582589	CASP8AP2	-0.7	-6.15	-0.57	3.05e-8	QRS interval (sulfonylurea treatment interaction);
SKCM	cis	rs7772486	0.754	rs6932863	chr6:146021255	A/T	cg05347473	chr6:146136440	FBXO30	-0.62	-5.7	-0.54	2.08e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2180341	0.924	rs9285459	chr6:127631113	T/C	cg24812749	chr6:127587940	RNF146	0.88	7.44	0.64	1.12e-10	Breast cancer;
SKCM	cis	rs9910055	0.529	rs400460	chr17:42182770	A/G	cg08499158	chr17:42289980	UBTF	0.72	5.52	0.53	4.25e-7	Total body bone mineral density;
SKCM	cis	rs1580019	0.961	rs1868776	chr7:32494435	G/T	cg06627557	chr7:32535165	LSM5;AVL9	-0.74	-5.64	-0.54	2.59e-7	Cognitive ability;
SKCM	cis	rs6952808	0.798	rs28970524	chr7:1927484	C/T	cg04267008	chr7:1944627	MAD1L1	-0.63	-4.77	-0.47	8.53e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs10927875	0.632	rs6699394	chr1:16145143	C/A	cg21385522	chr1:16154831	NA	-0.99	-12.1	-0.81	1.42e-19	Dilated cardiomyopathy;
SKCM	cis	rs9581857	0.547	rs9581871	chr13:28085767	G/A	cg22138327	chr13:27999177	GTF3A	0.84	5.53	0.53	4.15e-7	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs7772486	0.875	rs854145	chr6:146349650	C/T	cg05347473	chr6:146136440	FBXO30	0.57	5.12	0.5	2.13e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs3540	0.533	rs11633692	chr15:91056043	G/A	cg22089800	chr15:90895588	ZNF774	-0.68	-4.91	-0.49	4.84e-6	Allergic disease (asthma, hay fever or eczema);Lymphocyte counts;
SKCM	cis	rs72781680	0.948	rs72790326	chr2:24126153	C/T	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	cis	rs11098499	0.863	rs10013305	chr4:120450424	G/A	cg09307838	chr4:120376055	NA	0.97	7.66	0.66	4.19e-11	Corneal astigmatism;
SKCM	cis	rs58688157	0.626	rs7941198	chr11:571681	A/G	cg16486109	chr11:613632	IRF7	0.89	5.45	0.53	5.7e-7	Systemic lupus erythematosus;
SKCM	cis	rs1799949	0.965	rs6503727	chr17:41312859	C/T	cg23758822	chr17:41437982	NA	0.95	7.49	0.65	8.9e-11	Menopause (age at onset);
SKCM	cis	rs6121246	0.559	rs6121243	chr20:30415094	C/G	cg11595048	chr20:30225325	COX4I2	0.54	4.77	0.48	8.4e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs2858942	0.770	rs2858092	chr16:270288	C/A	cg08400316	chr16:204221	HBZ	-0.74	-5.14	-0.5	1.97e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs1577917	1.000	rs12663690	chr6:86640162	C/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.68	5.89	0.55	9.43e-8	Response to antipsychotic treatment;
SKCM	cis	rs9910055	0.683	rs7220138	chr17:42254011	C/G	cg08499158	chr17:42289980	UBTF	-0.73	-6.45	-0.59	8.6e-9	Total body bone mineral density;
SKCM	cis	rs7659604	1.000	rs7659943	chr4:122665560	C/T	cg19748678	chr4:122722346	EXOSC9	0.69	5.59	0.53	3.21e-7	Type 2 diabetes;
SKCM	cis	rs4268898	0.662	rs2303296	chr2:24432839	A/G	cg06627628	chr2:24431161	ITSN2	-0.92	-7.12	-0.63	4.73e-10	Asthma;
SKCM	cis	rs1577917	0.958	rs11755048	chr6:86514334	A/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.73	-6.02	-0.56	5.4e-8	Response to antipsychotic treatment;
SKCM	cis	rs28595532	0.920	rs56252481	chr4:119754023	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs826838	0.900	rs11169301	chr12:39128497	C/A	cg26384229	chr12:38710491	ALG10B	0.96	8.86	0.71	2.02e-13	Heart rate;
SKCM	cis	rs8017423	0.935	rs11624890	chr14:90738165	T/A	cg04374321	chr14:90722782	PSMC1	-0.95	-8.73	-0.7	3.68e-13	Mortality in heart failure;
SKCM	cis	rs67311347	0.544	rs6599088	chr3:40329288	T/C	cg13409248	chr3:40428643	ENTPD3	0.57	5.58	0.53	3.37e-7	Renal cell carcinoma;
SKCM	cis	rs57221529	0.709	rs72706611	chr5:561146	C/A	cg10555297	chr5:473380	SLC9A3;LOC25845	1.02	5.1	0.5	2.37e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs875971	0.508	rs10253883	chr7:66061138	T/C	cg11764359	chr7:65958608	NA	-0.79	-5.88	-0.55	9.67e-8	Aortic root size;
SKCM	cis	rs1957429	0.808	rs763346	chr14:65330386	A/G	cg23373153	chr14:65346875	NA	-1.12	-6.09	-0.57	4.06e-8	Pediatric areal bone mineral density (radius);
SKCM	cis	rs2455601	0.786	rs3751064	chr11:8958903	T/C	cg21881798	chr11:8931708	C11orf17;ST5	-0.76	-5.43	-0.52	6.07e-7	Schizophrenia;
SKCM	cis	rs62238980	0.614	rs4821020	chr22:32414089	G/C	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs951366	0.789	rs823130	chr1:205714372	C/T	cg14893161	chr1:205819251	PM20D1	1.04	9.81	0.74	2.9e-15	Menarche (age at onset);
SKCM	cis	rs4332037	0.539	rs11762636	chr7:2061111	C/A	cg23422044	chr7:1970798	MAD1L1	-0.89	-5.79	-0.55	1.38e-7	Bipolar disorder;
SKCM	cis	rs11098499	0.954	rs10024844	chr4:120311528	A/G	cg09307838	chr4:120376055	NA	0.97	7.49	0.65	9.08e-11	Corneal astigmatism;
SKCM	cis	rs7666738	0.753	rs1527520	chr4:98929164	A/G	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs752010	0.662	rs10890154	chr1:42106740	C/T	cg06885757	chr1:42089581	HIVEP3	0.47	5.24	0.51	1.33e-6	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs561341	1.000	rs4795669	chr17:30244701	C/T	cg12193833	chr17:30244370	NA	-0.47	-4.79	-0.48	7.65e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs2153535	0.563	rs3117071	chr6:8537908	C/T	cg23788917	chr6:8435910	SLC35B3	0.69	5.04	0.5	2.93e-6	Motion sickness;
SKCM	cis	rs6580649	0.941	rs4760683	chr12:48516296	T/C	cg05342945	chr12:48394962	COL2A1	0.7	4.91	0.49	4.85e-6	Lung cancer;
SKCM	cis	rs8037137	0.915	rs112770790	chr15:91507495	G/A	cg15878949	chr15:91534302	PRC1	0.68	5.28	0.51	1.15e-6	Platelet count;Serous invasive ovarian cancer;High-grade serous ovarian cancer;Invasive epithelial ovarian cancer;
SKCM	cis	rs9430161	0.611	rs72644043	chr1:11033051	T/A	cg27631724	chr1:11040367	C1orf127	0.5	4.85	0.48	6.08e-6	Ewing sarcoma;
SKCM	cis	rs2204008	0.805	rs7296063	chr12:37964775	T/G	cg26384229	chr12:38710491	ALG10B	0.8	6.2	0.57	2.47e-8	Bladder cancer;
SKCM	cis	rs4862750	0.872	rs9997374	chr4:187877549	T/A	cg10295955	chr4:187884368	NA	-1.04	-14.07	-0.85	4.23e-23	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4790333	0.967	rs2002863	chr17:2269769	C/T	cg02569219	chr17:2266849	SGSM2	0.84	7.08	0.63	5.6e-10	Proinsulin levels;
SKCM	cis	rs28595532	0.920	rs115688334	chr4:119770805	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs2013441	1.000	rs2703787	chr17:20158665	A/G	cg13482628	chr17:19912719	NA	-0.64	-5.04	-0.5	2.94e-6	Obesity-related traits;
SKCM	cis	rs6066825	0.546	rs2598	chr20:47241618	A/G	cg18078177	chr20:47281410	PREX1	0.65	5.11	0.5	2.23e-6	Colorectal cancer;
SKCM	cis	rs72781680	1.000	rs12614452	chr2:24194608	C/T	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	cis	rs12477438	0.798	rs972768	chr2:99682397	G/C	cg26064155	chr2:99771622	LIPT1;TSGA10	-0.72	-4.86	-0.48	6e-6	Chronic sinus infection;
SKCM	cis	rs12044355	0.789	rs953244	chr1:231823583	C/A	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	0.82	6.24	0.58	2.14e-8	Alzheimer's disease;
SKCM	cis	rs473651	0.904	rs472247	chr2:239362573	G/A	cg18131467	chr2:239335373	ASB1	1.09	13.55	0.84	3.36e-22	Multiple system atrophy;
SKCM	cis	rs7666738	0.830	rs13125432	chr4:98961253	G/A	cg05340658	chr4:99064831	C4orf37	0.64	4.91	0.49	4.97e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs13118159	0.767	rs2141656	chr4:1317192	C/T	cg20887711	chr4:1340912	KIAA1530	0.73	5.61	0.54	2.98e-7	Longevity;
SKCM	cis	rs71520386	0.632	rs9692432	chr7:22868863	G/A	cg15401507	chr7:22894281	NA	0.65	4.87	0.48	5.7e-6	Fibrinogen levels;
SKCM	cis	rs28595532	0.764	rs115877991	chr4:119728298	C/T	cg21605333	chr4:119757512	SEC24D	1.36	8.05	0.67	7.69e-12	Cannabis dependence symptom count;
SKCM	cis	rs9902453	0.934	rs34433787	chr17:28496780	T/A	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.5	0.53	4.74e-7	Coffee consumption (cups per day);
SKCM	cis	rs7666738	0.830	rs13328005	chr4:99055480	T/C	cg05340658	chr4:99064831	C4orf37	0.67	5.08	0.5	2.51e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs116095464	0.558	rs7715108	chr5:264661	A/G	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs4925386	0.840	rs6143035	chr20:60920700	C/T	cg24112000	chr20:60950667	NA	0.74	7.01	0.62	7.4e-10	Colorectal cancer;Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs7666738	0.893	rs11729640	chr4:99052699	C/T	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10489202	0.632	rs3767476	chr1:168066940	C/T	cg24449463	chr1:168025552	DCAF6	-0.77	-7.46	-0.65	1.02e-10	Schizophrenia;
SKCM	cis	rs7772486	0.875	rs9403763	chr6:146357655	A/G	cg05347473	chr6:146136440	FBXO30	0.57	5.24	0.51	1.31e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7666738	0.791	rs12233867	chr4:98950233	A/G	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2286503	0.966	rs2286507	chr7:22854760	T/C	cg00309339	chr7:22893653	NA	-0.5	-4.77	-0.48	8.35e-6	Fibrinogen;
SKCM	cis	rs7264396	0.943	rs224421	chr20:34145461	C/T	cg23207816	chr20:34252616	CPNE1;RBM12	0.7	4.83	0.48	6.68e-6	Total cholesterol levels;
SKCM	cis	rs7829975	0.508	rs1594437	chr8:8825875	T/C	cg06636001	chr8:8085503	FLJ10661	0.75	5.34	0.52	8.98e-7	Mood instability;
SKCM	cis	rs9640161	0.830	rs3757424	chr7:150067679	C/A	cg10018233	chr7:150070692	REPIN1	0.81	9.03	0.71	9.35e-14	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs9910055	0.571	rs28897216	chr17:42240824	A/G	cg13607699	chr17:42295918	UBTF	0.72	5.7	0.54	2.05e-7	Total body bone mineral density;
SKCM	cis	rs7937682	0.883	rs566647	chr11:111466607	A/G	cg22437258	chr11:111473054	SIK2	-0.63	-4.87	-0.48	5.75e-6	Primary sclerosing cholangitis;
SKCM	cis	rs6570726	0.764	rs366673	chr6:145814628	T/A	cg23711669	chr6:146136114	FBXO30	0.79	7.93	0.67	1.26e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs995000	0.783	rs6686331	chr1:63182135	C/T	cg06896770	chr1:63153194	DOCK7	-0.79	-6.9	-0.62	1.21e-9	Triglyceride levels;
SKCM	cis	rs9900062	0.507	rs7225993	chr17:62708284	C/G	cg02097616	chr17:62675921	NA	0.75	6.4	0.59	1.08e-8	QT interval;
SKCM	cis	rs9394841	0.667	rs9394831	chr6:41753084	C/T	cg08135965	chr6:41755394	TOMM6	0.75	4.96	0.49	3.96e-6	Mean corpuscular hemoglobin;Red cell distribution width;
SKCM	cis	rs752010	1.000	rs2077172	chr1:42093340	A/G	cg06885757	chr1:42089581	HIVEP3	0.62	6.25	0.58	2.04e-8	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs7811142	0.943	rs66958101	chr7:100074020	G/A	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-0.99	-5.52	-0.53	4.2e-7	Platelet count;
SKCM	cis	rs4631830	0.720	rs11004415	chr10:51498181	G/A	cg16070123	chr10:51489643	NA	0.53	4.96	0.49	3.99e-6	Prostate-specific antigen levels;
SKCM	cis	rs514406	0.861	rs11206011	chr1:53235910	T/C	cg16325326	chr1:53192061	ZYG11B	-0.87	-8.87	-0.71	1.94e-13	Monocyte count;
SKCM	cis	rs7296418	0.518	rs28825193	chr12:123878262	T/C	cg00376283	chr12:123451042	ABCB9	0.81	6.01	0.56	5.56e-8	Platelet count;
SKCM	cis	rs9902453	0.765	rs8079209	chr17:28186773	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.83	6.37	0.59	1.2e-8	Coffee consumption (cups per day);
SKCM	cis	rs7178909	0.902	rs8034116	chr15:90441568	A/G	cg19708238	chr15:90437601	AP3S2	0.72	5.22	0.51	1.43e-6	Common traits (Other);
SKCM	cis	rs10197940	0.810	rs4664045	chr2:152267072	T/G	cg19508488	chr2:152266495	RIF1	0.63	5.17	0.5	1.79e-6	Lung cancer;
SKCM	cis	rs7618501	0.603	rs72942333	chr3:49986118	T/C	cg24110177	chr3:50126178	RBM5	-0.6	-5.1	-0.5	2.36e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9902453	0.765	rs3102555	chr17:28044101	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.79	5.93	0.56	7.67e-8	Coffee consumption (cups per day);
SKCM	cis	rs1401999	1.000	rs939337	chr3:183701147	G/C	cg01324343	chr3:183735012	ABCC5	0.86	9.5	0.73	1.18e-14	Anterior chamber depth;
SKCM	cis	rs7772486	0.790	rs9497425	chr6:146234197	G/A	cg05347473	chr6:146136440	FBXO30	-0.56	-5.19	-0.51	1.6e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2439831	0.850	rs7181039	chr15:44179112	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.25	6.45	0.59	8.71e-9	Lung cancer in ever smokers;
SKCM	cis	rs6546550	0.904	rs3771537	chr2:70038792	A/C	cg02498382	chr2:70120550	SNRNP27	-0.46	-5.17	-0.51	1.75e-6	Prevalent atrial fibrillation;
SKCM	cis	rs2404602	0.692	rs2117369	chr15:76748861	A/T	cg23625390	chr15:77176239	SCAPER	0.57	5.23	0.51	1.39e-6	Blood metabolite levels;
SKCM	cis	rs9393692	0.905	rs1125000	chr6:26287256	C/T	cg00631329	chr6:26305371	NA	-0.69	-4.92	-0.49	4.7e-6	Educational attainment;
SKCM	trans	rs1814175	0.588	rs4076322	chr11:49745094	G/A	cg15704280	chr7:45808275	SEPT13	-0.97	-9.35	-0.73	2.25e-14	Height;
SKCM	cis	rs8016982	0.633	rs7141288	chr14:81710232	C/A	cg01989461	chr14:81687754	GTF2A1	0.8	6.57	0.6	5.01e-9	Schizophrenia;
SKCM	cis	rs17683430	0.702	rs117983733	chr22:32387606	C/T	cg00543991	chr22:32367038	NA	1.15	4.87	0.48	5.76e-6	GIP levels in response to oral glucose tolerance test (120 minutes);
SKCM	cis	rs7945705	0.840	rs10840136	chr11:8885024	C/T	cg13070366	chr11:9386451	NA	0.55	4.78	0.48	8.04e-6	Hemoglobin concentration;
SKCM	cis	rs10504073	0.647	rs59064792	chr8:50018337	A/C	cg00325661	chr8:49890786	NA	0.79	6.79	0.61	1.99e-9	Blood metabolite ratios;
SKCM	cis	rs919433	1.000	rs1560277	chr2:198187903	C/T	cg04278110	chr2:198063759	ANKRD44	0.71	5.11	0.5	2.27e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs9300255	0.544	rs1727310	chr12:123660510	A/G	cg05973401	chr12:123451056	ABCB9	0.81	4.98	0.49	3.78e-6	Neutrophil percentage of white cells;
SKCM	cis	rs35306767	0.903	rs11815185	chr10:923617	T/A	cg26597838	chr10:835615	NA	0.75	5.51	0.53	4.53e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs6500395	1.000	rs9928051	chr16:48557316	T/A	cg04672837	chr16:48644449	N4BP1	0.66	5.45	0.53	5.72e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs2033711	0.818	rs4801595	chr19:58978517	G/A	cg00825309	chr19:58991885	ZNF446	-0.65	-5.14	-0.5	2e-6	Uric acid clearance;
SKCM	cis	rs1799949	1.000	rs34059614	chr17:41303071	C/T	cg23758822	chr17:41437982	NA	0.92	7.8	0.66	2.3e-11	Menopause (age at onset);
SKCM	cis	rs2204008	0.542	rs34770471	chr12:38009613	C/T	cg26384229	chr12:38710491	ALG10B	0.81	6.45	0.59	8.61e-9	Bladder cancer;
SKCM	cis	rs6424115	0.867	rs10917431	chr1:24174093	T/G	cg15997130	chr1:24165203	NA	-0.57	-4.77	-0.48	8.44e-6	Immature fraction of reticulocytes;
SKCM	cis	rs10504229	1.000	rs116995796	chr8:58181960	G/A	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs28386778	0.830	rs2665841	chr17:61861219	A/T	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs9611565	0.802	rs73176694	chr22:41786788	C/T	cg03806693	chr22:41940476	POLR3H	-0.93	-5.97	-0.56	6.68e-8	Vitiligo;
SKCM	cis	rs11105298	0.891	rs11105313	chr12:89923376	A/T	cg08166232	chr12:89918718	WDR51B;GALNT4	0.93	6.01	0.56	5.66e-8	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs7659604	0.539	rs7686200	chr4:122764553	C/T	cg20573242	chr4:122745356	CCNA2	0.76	6.54	0.59	5.89e-9	Type 2 diabetes;
SKCM	cis	rs2404602	0.647	rs907594	chr15:77197745	C/A	cg23625390	chr15:77176239	SCAPER	-0.82	-7.89	-0.67	1.51e-11	Blood metabolite levels;
SKCM	cis	rs6445797	0.632	rs114096928	chr3:56637772	C/T	cg13616963	chr3:57583610	ARF4	-0.76	-4.89	-0.48	5.37e-6	Gastritis;
SKCM	cis	rs473651	0.935	rs520765	chr2:239354712	C/T	cg21699342	chr2:239360505	ASB1	0.54	5.41	0.52	6.67e-7	Multiple system atrophy;
SKCM	cis	rs2832191	0.626	rs2254796	chr21:30341891	A/G	cg24692254	chr21:30365293	RNF160	-0.89	-7.78	-0.66	2.56e-11	Dental caries;
SKCM	cis	rs9486715	0.838	rs9386473	chr6:96873341	C/A	cg06623918	chr6:96969491	KIAA0776	0.8	6.99	0.62	8.13e-10	Headache;
SKCM	cis	rs28374715	0.609	rs8043237	chr15:41514298	G/A	cg18705301	chr15:41695430	NDUFAF1	-0.94	-7.84	-0.66	1.88e-11	Ulcerative colitis;
SKCM	cis	rs10504073	0.584	rs17642664	chr8:49942945	A/G	cg00325661	chr8:49890786	NA	0.8	6.81	0.61	1.83e-9	Blood metabolite ratios;
SKCM	cis	rs2762353	0.562	rs1165206	chr6:25867566	G/A	cg15326795	chr6:26217500	HIST1H2BG;HIST1H2AE	0.51	4.91	0.49	4.9100000000000004e-06	Blood metabolite levels;
SKCM	cis	rs2599510	0.811	rs2710625	chr2:32822957	G/A	cg02381751	chr2:32503542	YIPF4	0.76	5.83	0.55	1.18e-7	Interleukin-18 levels;
SKCM	cis	rs873946	0.504	rs3793681	chr10:134564451	T/C	cg18305652	chr10:134549665	INPP5A	0.6	6.1	0.57	3.88e-8	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs7811142	0.830	rs6955367	chr7:99961194	A/G	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.01	5.58	0.53	3.33e-7	Platelet count;
SKCM	trans	rs561341	0.714	rs473535	chr17:30312365	A/G	cg20587970	chr11:113659929	NA	-1.18	-10.15	-0.75	6.41e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs6582630	0.537	rs7310749	chr12:38400472	C/T	cg26384229	chr12:38710491	ALG10B	0.82	6.3	0.58	1.6e-8	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs1799949	0.965	rs34633610	chr17:41419385	A/G	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.18	-0.57	2.68e-8	Menopause (age at onset);
SKCM	cis	rs9475752	0.793	rs34979183	chr6:56842763	G/C	cg06815302	chr6:57335405	PRIM2	0.59	4.78	0.48	8.1e-6	Menarche (age at onset);
SKCM	trans	rs561341	0.941	rs4525554	chr17:30312819	T/C	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs7216064	1.000	rs62085992	chr17:65923083	T/A	cg12091567	chr17:66097778	LOC651250	-0.75	-4.97	-0.49	3.81e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs2952156	1.000	rs2934971	chr17:37854507	G/T	cg20243544	chr17:37824526	PNMT	0.7	5.6	0.54	3.03e-7	Asthma;
SKCM	trans	rs3780486	0.505	rs7868663	chr9:33141229	A/G	cg20290983	chr6:43655470	MRPS18A	0.85	8.96	0.71	1.29e-13	IgG glycosylation;
SKCM	cis	rs6424115	0.830	rs3003336	chr1:24201448	C/T	cg15997130	chr1:24165203	NA	0.6	4.94	0.49	4.37e-6	Immature fraction of reticulocytes;
SKCM	cis	rs763121	0.925	rs4821815	chr22:39105707	G/A	cg06022373	chr22:39101656	GTPBP1	0.82	5.96	0.56	6.8e-8	Menopause (age at onset);
SKCM	cis	rs7143963	0.666	rs7154352	chr14:103323947	T/C	cg23020514	chr14:103360112	TRAF3	0.74	7.1	0.63	5.18e-10	Body mass index;
SKCM	cis	rs3784262	0.669	rs2414527	chr15:58256672	A/G	cg12031962	chr15:58353849	ALDH1A2	0.42	5.23	0.51	1.37e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs2836950	0.565	rs8130320	chr21:40580258	C/T	cg11890956	chr21:40555474	PSMG1	-0.66	-5.26	-0.51	1.22e-6	Menarche (age at onset);
SKCM	cis	rs9325144	0.600	rs6582630	chr12:38743508	A/G	cg26384229	chr12:38710491	ALG10B	-0.79	-7.0	-0.62	8.02e-10	Morning vs. evening chronotype;
SKCM	trans	rs1814175	0.646	rs61904497	chr11:49883449	A/T	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs28595532	0.841	rs115907265	chr4:119730593	G/A	cg21605333	chr4:119757512	SEC24D	1.36	8.05	0.67	7.69e-12	Cannabis dependence symptom count;
SKCM	cis	rs67311347	1.000	rs6599094	chr3:40399593	A/G	cg00091569	chr3:40428383	ENTPD3	0.61	5.36	0.52	8.37e-7	Renal cell carcinoma;
SKCM	cis	rs9640161	0.742	rs11767726	chr7:150018096	A/C	cg10018233	chr7:150070692	REPIN1	-0.75	-6.05	-0.56	4.81e-8	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs394563	0.967	rs438852	chr6:149794533	C/T	cg03678062	chr6:149772716	ZC3H12D	0.5	5.01	0.49	3.37e-6	Dupuytren's disease;
SKCM	cis	rs1467026	0.719	rs17037220	chr3:12818103	A/G	cg05775895	chr3:12838266	CAND2	0.64	5.33	0.52	9.13e-7	P wave duration;
SKCM	cis	rs514406	0.698	rs11206055	chr1:53436632	A/T	cg04310824	chr1:53393297	SCP2	0.6	4.85	0.48	6.25e-6	Monocyte count;
SKCM	cis	rs2153535	0.580	rs4960421	chr6:8459292	C/T	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs1062177	0.756	rs2915827	chr5:151119705	T/A	cg00977110	chr5:151150581	G3BP1	-0.78	-5.72	-0.54	1.85e-7	Preschool internalizing problems;
SKCM	cis	rs62238980	0.614	rs117960638	chr22:32417569	C/T	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs801193	1.000	rs2707850	chr7:66203870	G/T	cg11764359	chr7:65958608	NA	0.86	6.55	0.6	5.68e-9	Aortic root size;
SKCM	cis	rs870825	0.929	rs56106324	chr4:185589901	C/A	cg04058563	chr4:185651563	MLF1IP	1.09	5.66	0.54	2.4e-7	Blood protein levels;
SKCM	cis	rs1577917	1.000	rs13199006	chr6:86608708	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.61	-5.31	-0.52	1.02e-6	Response to antipsychotic treatment;
SKCM	cis	rs7772486	0.686	rs9390348	chr6:146044748	C/T	cg23711669	chr6:146136114	FBXO30	-0.82	-8.01	-0.67	9.12e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6904897	0.563	rs4896117	chr6:135229400	T/C	cg24558204	chr6:135376177	HBS1L	-0.62	-5.15	-0.5	1.87e-6	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs737337	1.000	rs737337	chr19:11347493	T/C	cg00586551	chr19:11347513	LOC55908;DOCK6	0.84	5.32	0.52	9.71e-7	HDL cholesterol;HDL cholesterol levels;
SKCM	cis	rs951366	0.789	rs823152	chr1:205736285	G/A	cg14893161	chr1:205819251	PM20D1	1.06	10.5	0.77	1.41e-16	Menarche (age at onset);
SKCM	cis	rs951366	0.764	rs823141	chr1:205741426	T/C	cg14159672	chr1:205819179	PM20D1	0.97	8.21	0.68	3.64e-12	Menarche (age at onset);
SKCM	cis	rs2304069	0.542	rs3020829	chr5:149426966	A/G	cg22760475	chr5:149380129	HMGXB3;TIGD6	0.86	5.02	0.49	3.15e-6	HIV-1 control;
SKCM	cis	rs7264396	0.790	rs2425097	chr20:34308926	C/T	cg23207816	chr20:34252616	CPNE1;RBM12	0.8	4.85	0.48	6.13e-6	Total cholesterol levels;
SKCM	trans	rs1814175	0.645	rs28549248	chr11:50042740	C/T	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs17376456	0.877	rs28539612	chr5:93499099	C/T	cg25358565	chr5:93447407	FAM172A	1.24	8.18	0.68	4.18e-12	Diabetic retinopathy;
SKCM	cis	rs6461049	0.765	rs3800908	chr7:2159437	C/T	cg21782813	chr7:2030301	MAD1L1	0.48	5.27	0.51	1.18e-6	Schizophrenia;
SKCM	cis	rs875971	0.522	rs9530	chr7:65425894	A/G	cg18876405	chr7:65276391	NA	0.82	7.29	0.64	2.18e-10	Aortic root size;
SKCM	cis	rs2836974	0.681	rs8128827	chr21:40710547	C/T	cg11644478	chr21:40555479	PSMG1	0.81	7.12	0.63	4.7e-10	Cognitive function;
SKCM	cis	rs11098499	0.738	rs72918577	chr4:120326701	G/A	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs1218582	0.774	rs4845679	chr1:154861187	G/T	cg06221963	chr1:154839813	KCNN3	-0.6	-6.45	-0.59	8.51e-9	Prostate cancer;
SKCM	cis	rs12706411	0.764	rs9656294	chr7:122084586	A/C	cg17986181	chr7:121955208	NA	-0.65	-5.01	-0.49	3.36e-6	Alzheimer disease and age of onset;
SKCM	cis	rs34779708	0.931	rs72789609	chr10:35306206	C/T	cg03585969	chr10:35415529	CREM	0.75	6.23	0.58	2.2e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs72781680	0.898	rs72788212	chr2:24087385	G/A	cg08917208	chr2:24149416	ATAD2B	0.99	5.24	0.51	1.31e-6	Lymphocyte counts;
SKCM	cis	rs9913156	0.793	rs72835643	chr17:4573612	G/A	cg19197139	chr17:4613644	ARRB2	0.79	5.45	0.53	5.64e-7	Lymphocyte counts;
SKCM	cis	rs9660180	0.967	rs11260623	chr1:1781456	G/T	cg13866156	chr1:1669148	SLC35E2	-0.72	-6.0	-0.56	5.95e-8	Body mass index;
SKCM	cis	rs60871478	1.000	rs34761279	chr7:794471	A/G	cg05535760	chr7:792225	HEATR2	1.17	10.16	0.75	6.17e-16	Cerebrospinal P-tau181p levels;
SKCM	cis	rs763014	0.931	rs3752568	chr16:628302	A/G	cg00908189	chr16:619842	PIGQ	0.82	7.78	0.66	2.55e-11	Height;
SKCM	cis	rs12497850	0.931	rs10780033	chr3:48891275	T/C	cg07636037	chr3:49044803	WDR6	1.01	10.82	0.77	3.36e-17	Parkinson's disease;
SKCM	cis	rs3771570	0.901	rs62190413	chr2:242417950	G/A	cg07612300	chr2:242033426	MTERFD2;SNED1	0.88	4.9	0.48	5.13e-6	Prostate cancer;
SKCM	cis	rs151997	0.962	rs27714	chr5:50180396	G/C	cg06027927	chr5:50259733	NA	0.63	5.35	0.52	8.43e-7	Callous-unemotional behaviour;
SKCM	cis	rs73201462	1.000	rs2955101	chr3:128009612	A/G	cg09089421	chr3:127803668	RUVBL1	-1.0	-5.11	-0.5	2.22e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs992157	0.764	rs1870123	chr2:219187698	G/A	cg20019365	chr2:219134978	PNKD;AAMP	0.74	5.94	0.56	7.66e-8	Colorectal cancer;
SKCM	cis	rs10752881	1.000	rs4233193	chr1:182970865	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.73	6.64	0.6	3.82e-9	Colorectal cancer;
SKCM	cis	rs801193	1.000	rs62466794	chr7:66191579	G/A	cg11987759	chr7:65425863	GUSB	-0.69	-5.91	-0.56	8.69e-8	Aortic root size;
SKCM	cis	rs2333194	0.846	rs6574118	chr14:73811992	A/G	cg08936952	chr14:74026160	HEATR4	0.53	4.86	0.48	5.96e-6	Bipolar disorder with mood-incongruent psychosis;
SKCM	cis	rs12971120	1.000	rs3829640	chr18:72174980	A/G	cg25817165	chr18:72167213	CNDP2	-0.61	-4.86	-0.48	5.91e-6	Refractive error;
SKCM	cis	rs763014	0.833	rs916415	chr16:632115	G/A	cg00908189	chr16:619842	PIGQ	0.82	7.78	0.66	2.55e-11	Height;
SKCM	cis	rs143111788	1	rs143111788	chr6:41919175	CCAGCTACT/C	cg17623882	chr6:41773611	USP49	-0.71	-5.53	-0.53	4.07e-7	Red cell distribution width;
SKCM	cis	rs9788682	0.948	rs59133824	chr15:78833450	C/A	cg06917634	chr15:78832804	PSMA4	-0.82	-4.96	-0.49	3.97e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs9394841	0.692	rs35085306	chr6:41856002	A/G	cg08135965	chr6:41755394	TOMM6	0.77	5.04	0.5	2.91e-6	Mean corpuscular hemoglobin;Red cell distribution width;
SKCM	trans	rs561341	1.000	rs72821971	chr17:30269343	T/G	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs10504073	0.669	rs57085792	chr8:50018355	T/C	cg00325661	chr8:49890786	NA	0.79	6.79	0.61	1.99e-9	Blood metabolite ratios;
SKCM	cis	rs870825	0.550	rs28525282	chr4:185631468	T/C	cg04058563	chr4:185651563	MLF1IP	1.08	7.26	0.64	2.51e-10	Blood protein levels;
SKCM	cis	rs9325144	0.647	rs12831609	chr12:39051576	C/A	cg13010199	chr12:38710504	ALG10B	-0.62	-5.28	-0.51	1.14e-6	Morning vs. evening chronotype;
SKCM	cis	rs992157	0.717	rs11692780	chr2:219149163	A/G	cg00012203	chr2:219082015	ARPC2	-0.72	-5.71	-0.54	1.99e-7	Colorectal cancer;
SKCM	cis	rs6952808	0.601	rs3800882	chr7:2120758	G/A	cg21782813	chr7:2030301	MAD1L1	0.56	6.37	0.58	1.23e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs427394	0.659	rs187295	chr5:6734326	C/T	cg10857441	chr5:6722123	POLS	-0.71	-7.53	-0.65	7.53e-11	Menopause (age at onset);
SKCM	cis	rs11626933	1.000	rs45463097	chr14:90744188	G/A	cg14092571	chr14:90743983	NA	-0.92	-8.33	-0.69	2.11e-12	Gut microbiota (bacterial taxa);
SKCM	cis	rs763121	0.744	rs5757140	chr22:38957013	T/C	cg06022373	chr22:39101656	GTPBP1	0.78	5.85	0.55	1.08e-7	Menopause (age at onset);
SKCM	cis	rs362296	0.530	rs3129316	chr4:3287906	A/G	cg24015175	chr4:3319247	RGS12	0.69	7.39	0.64	1.43e-10	Parental longevity (mother's age at death);
SKCM	cis	rs7811142	1.000	rs7811142	chr7:100065443	A/T	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.12	6.51	0.59	6.68e-9	Platelet count;
SKCM	cis	rs62238980	0.614	rs76010922	chr22:32471678	G/A	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs9911578	0.587	rs7502947	chr17:57229716	G/A	cg12560992	chr17:57184187	TRIM37	0.9	6.59	0.6	4.74e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs4332037	0.707	rs4721096	chr7:1877311	T/C	cg23422044	chr7:1970798	MAD1L1	0.89	5.56	0.53	3.58e-7	Bipolar disorder;
SKCM	cis	rs4466137	0.953	rs1585153	chr5:83000385	A/T	cg16102102	chr5:83017553	HAPLN1	-0.58	-6.17	-0.57	2.84e-8	Prostate cancer;
SKCM	cis	rs35306767	0.855	rs12774985	chr10:904245	C/T	cg25614935	chr10:1084866	C10orf110	0.77	5.12	0.5	2.15e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs28595532	0.920	rs114080496	chr4:119726372	C/T	cg21605333	chr4:119757512	SEC24D	1.35	7.92	0.67	1.37e-11	Cannabis dependence symptom count;
SKCM	cis	rs6500395	0.962	rs13331902	chr16:48644989	A/G	cg04672837	chr16:48644449	N4BP1	0.69	5.68	0.54	2.26e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs3784262	0.631	rs4646560	chr15:58353546	C/G	cg12031962	chr15:58353849	ALDH1A2	-0.41	-4.82	-0.48	6.93e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs10193935	0.901	rs6727657	chr2:42632117	A/G	cg27598129	chr2:42591480	NA	-0.88	-6.71	-0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11098499	0.954	rs12507964	chr4:120413061	T/A	cg09307838	chr4:120376055	NA	0.99	8.02	0.67	8.7e-12	Corneal astigmatism;
SKCM	cis	rs995000	0.931	rs6587976	chr1:62945631	C/T	cg06896770	chr1:63153194	DOCK7	0.74	7.06	0.62	6.02e-10	Triglyceride levels;
SKCM	cis	rs9790314	0.765	rs4856768	chr3:161004392	G/A	cg03342759	chr3:160939853	NMD3	-0.72	-7.96	-0.67	1.13e-11	Morning vs. evening chronotype;
SKCM	cis	rs473651	0.692	rs579511	chr2:239334914	C/G	cg18131467	chr2:239335373	ASB1	1.05	12.59	0.82	1.8e-20	Multiple system atrophy;
SKCM	cis	rs7119	0.700	rs60701760	chr15:77888152	G/A	cg27398640	chr15:77910606	LINGO1	0.49	4.84	0.48	6.38e-6	Type 2 diabetes;
SKCM	cis	rs2050392	0.624	rs303444	chr10:30729347	C/T	cg25182066	chr10:30743637	MAP3K8	-0.65	-5.3	-0.51	1.05e-6	Inflammatory bowel disease;
SKCM	cis	rs6582630	0.502	rs11522899	chr12:38270637	T/C	cg26384229	chr12:38710491	ALG10B	0.87	6.83	0.61	1.63e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs9911578	1.000	rs1971659	chr17:57004787	A/G	cg12560992	chr17:57184187	TRIM37	0.94	7.55	0.65	7.01e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs801193	0.967	rs2707853	chr7:66214010	G/A	cg18876405	chr7:65276391	NA	0.82	7.53	0.65	7.55e-11	Aortic root size;
SKCM	cis	rs9894429	1.000	rs7213129	chr17:79581573	C/T	cg18240062	chr17:79603768	NPLOC4	0.76	7.43	0.64	1.2e-10	Eye color traits;
SKCM	cis	rs9916302	0.851	rs11868029	chr17:37650304	A/G	cg07936489	chr17:37558343	FBXL20	-0.87	-7.96	-0.67	1.13e-11	Glomerular filtration rate (creatinine);
SKCM	cis	rs2439831	0.717	rs10518820	chr15:43888976	G/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.38	7.91	0.67	1.41e-11	Lung cancer in ever smokers;
SKCM	trans	rs8073060	0.586	rs4796098	chr17:33913436	T/C	cg19694781	chr19:47549865	TMEM160	1.08	8.69	0.7	4.26e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs7666738	0.830	rs13125537	chr4:98978428	A/G	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9796	0.717	rs2947494	chr15:41375741	C/T	cg18705301	chr15:41695430	NDUFAF1	-0.78	-5.56	-0.53	3.68e-7	Menopause (age at onset);
SKCM	cis	rs4481887	0.888	rs4525076	chr1:248456876	T/G	cg00666640	chr1:248458726	OR2T12	0.6	4.9	0.49	5.01e-6	Common traits (Other);
SKCM	cis	rs2836974	0.966	rs7283420	chr21:40666865	T/C	cg11890956	chr21:40555474	PSMG1	0.99	11.14	0.78	8.38e-18	Cognitive function;
SKCM	cis	rs10500871	1.000	rs10500871	chr11:20215756	C/T	cg04653710	chr11:19367236	NA	0.57	4.95	0.49	4.27e-6	Educational attainment;
SKCM	cis	rs798554	0.836	rs2260230	chr7:2822986	T/A	cg04166393	chr7:2884313	GNA12	0.71	4.99	0.49	3.6e-6	Height;
SKCM	cis	rs5769765	0.773	rs6520065	chr22:50294470	A/T	cg22709217	chr22:50311962	ALG12;CRELD2	-0.79	-5.71	-0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs6580649	0.941	rs1635529	chr12:48395102	T/G	cg05342945	chr12:48394962	COL2A1	-0.74	-5.0	-0.49	3.48e-6	Lung cancer;
SKCM	cis	rs7635838	0.620	rs1666988	chr3:11284950	A/G	cg00170343	chr3:11313890	ATG7	0.8	5.67	0.54	2.29e-7	HDL cholesterol;
SKCM	cis	rs9322193	0.504	rs7771014	chr6:150205446	T/A	cg05036130	chr6:150231994	NA	0.59	6.69	0.6	2.98e-9	Lung cancer;
SKCM	cis	rs801193	0.967	rs1110414	chr7:66205582	A/G	cg11987759	chr7:65425863	GUSB	-0.69	-5.91	-0.56	8.69e-8	Aortic root size;
SKCM	cis	rs2439831	0.867	rs2412780	chr15:43655794	G/A	cg02155558	chr15:43621948	ADAL;LCMT2	1.39	9.42	0.73	1.62e-14	Lung cancer in ever smokers;
SKCM	trans	rs1814175	0.935	rs11040465	chr11:49689323	C/T	cg15704280	chr7:45808275	SEPT13	-1.05	-9.75	-0.74	3.91e-15	Height;
SKCM	cis	rs2153535	0.580	rs9392223	chr6:8468650	G/A	cg23788917	chr6:8435910	SLC35B3	0.68	4.86	0.48	5.99e-6	Motion sickness;
SKCM	cis	rs9430161	0.579	rs9659356	chr1:11034817	A/G	cg02454025	chr1:11042201	C1orf127	1.06	10.12	0.75	7.39e-16	Ewing sarcoma;
SKCM	cis	rs2836974	0.666	rs35182074	chr21:40685284	A/C	cg17971929	chr21:40555470	PSMG1	-0.73	-6.88	-0.61	1.32e-9	Cognitive function;
SKCM	cis	rs9913156	0.841	rs72824957	chr17:4590496	C/T	cg19197139	chr17:4613644	ARRB2	0.8	5.32	0.52	9.73e-7	Lymphocyte counts;
SKCM	cis	rs10779751	1.000	rs11121702	chr1:11293147	C/T	cg08854313	chr1:11322531	MTOR	0.92	7.09	0.63	5.2400000000000005e-10	Body mass index;
SKCM	cis	rs1799949	0.860	rs8176279	chr17:41210396	A/C	cg25918947	chr17:41365094	TMEM106A	-0.61	-5.63	-0.54	2.77e-7	Menopause (age at onset);
SKCM	cis	rs1577917	1.000	rs12216203	chr6:86675301	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.66	-5.72	-0.54	1.88e-7	Response to antipsychotic treatment;
SKCM	cis	rs16854884	0.657	rs2099543	chr3:143742164	C/T	cg06585982	chr3:143692056	C3orf58	0.87	8.11	0.68	5.72e-12	Economic and political preferences (feminism/equality);
SKCM	cis	rs7666738	0.830	rs4699589	chr4:98973889	A/G	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs12478296	1.000	rs11899408	chr2:243014630	A/G	cg06360820	chr2:242988706	NA	-0.92	-5.65	-0.54	2.55e-7	Obesity-related traits;
SKCM	cis	rs1707322	0.685	rs28617418	chr1:46189526	T/A	cg03146154	chr1:46216737	IPP	0.84	6.2	0.57	2.51e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7208859	0.623	rs55814012	chr17:29077697	T/A	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs7772486	0.875	rs6930975	chr6:146387111	C/T	cg23711669	chr6:146136114	FBXO30	0.86	8.52	0.69	9.13e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs17376456	0.825	rs72786702	chr5:93254656	A/C	cg21475434	chr5:93447410	FAM172A	1.02	5.17	0.51	1.74e-6	Diabetic retinopathy;
SKCM	cis	rs11098499	0.722	rs7673476	chr4:120248683	C/T	cg09307838	chr4:120376055	NA	0.88	6.97	0.62	8.89e-10	Corneal astigmatism;
SKCM	cis	rs10416265	0.503	rs1981818	chr19:33615122	C/T	cg27124370	chr19:33622961	WDR88	-0.76	-5.63	-0.54	2.71e-7	Bone properties (heel);
SKCM	cis	rs62103177	0.810	rs62103189	chr18:77627815	G/A	cg27393146	chr18:77495563	CTDP1	-0.92	-5.36	-0.52	8.37e-7	Opioid sensitivity;
SKCM	cis	rs28386778	0.897	rs2028567	chr17:61915326	G/A	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs2836974	1.000	rs2836974	chr21:40663181	A/G	cg11890956	chr21:40555474	PSMG1	-0.99	-11.14	-0.78	8.38e-18	Cognitive function;
SKCM	cis	rs514406	0.708	rs536621	chr1:53309097	A/G	cg04310824	chr1:53393297	SCP2	-0.61	-4.81	-0.48	7.3e-6	Monocyte count;
SKCM	cis	rs9916302	0.904	rs679995	chr17:37441679	A/T	cg07936489	chr17:37558343	FBXL20	0.77	6.12	0.57	3.57e-8	Glomerular filtration rate (creatinine);
SKCM	trans	rs6101567	0.740	rs6028473	chr20:38135687	A/G	cg12399162	chr6:7141575	RREB1	0.92	7.29	0.64	2.24e-10	Nose size;
SKCM	cis	rs9633740	0.685	rs10749608	chr10:82243986	A/G	cg01528321	chr10:82214614	TSPAN14	0.9	5.34	0.52	9.05e-7	Post bronchodilator FEV1;
SKCM	cis	rs7539542	0.556	rs10753925	chr1:202854488	C/T	cg19681188	chr1:202830198	LOC148709	0.85	5.82	0.55	1.22e-7	Mean platelet volume;
SKCM	cis	rs8018967	0.622	rs2041073	chr14:73972535	C/T	cg08936952	chr14:74026160	HEATR4	-0.64	-6.49	-0.59	7.38e-9	Blood metabolite ratios;
SKCM	cis	rs3008870	1.000	rs2985818	chr1:67398916	G/A	cg08660285	chr1:67390436	MIER1;WDR78	0.92	6.05	0.57	4.69e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs7809950	1.000	rs2712191	chr7:107182724	C/G	cg23024343	chr7:107201750	COG5	-0.77	-6.95	-0.62	9.61e-10	Coronary artery disease;
SKCM	cis	rs6951245	0.786	rs77943789	chr7:1140158	C/T	cg03188948	chr7:1209495	NA	1.03	6.33	0.58	1.41e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7690543	1.000	rs7690543	chr4:68056613	C/T	cg02995770	chr4:68929413	TMPRSS11F;SYT14L	1.07	5.16	0.5	1.81e-6	Glucose homeostasis traits;
SKCM	cis	rs6912958	1.000	rs6454630	chr6:88171357	C/G	cg08069147	chr6:88032118	GJB7;C6orf162	0.62	5.5	0.53	4.67e-7	Monocyte percentage of white cells;
SKCM	cis	rs5769765	0.773	rs4075331	chr22:50302850	A/G	cg22709217	chr22:50311962	ALG12;CRELD2	-0.87	-5.83	-0.55	1.18e-7	Schizophrenia;
SKCM	cis	rs3784262	0.692	rs12907125	chr15:58282621	C/A	cg12031962	chr15:58353849	ALDH1A2	-0.42	-4.83	-0.48	6.81e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs7103648	0.569	rs10769282	chr11:47626492	T/G	cg20307385	chr11:47447363	PSMC3	0.97	7.36	0.64	1.59e-10	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs6430585	0.528	rs75753154	chr2:136665711	T/C	cg07169764	chr2:136633963	MCM6	1.36	12.7	0.82	1.14e-20	Corneal structure;
SKCM	cis	rs11105298	0.891	rs10858879	chr12:89886578	A/T	cg08166232	chr12:89918718	WDR51B;GALNT4	0.88	6.02	0.56	5.26e-8	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs8180040	0.967	rs4858856	chr3:47565424	G/A	cg16586182	chr3:47516702	SCAP	-0.74	-5.04	-0.5	2.89e-6	Colorectal cancer;
SKCM	cis	rs1577917	0.958	rs4707229	chr6:86546237	C/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.81	-7.82	-0.66	2.07e-11	Response to antipsychotic treatment;
SKCM	cis	rs1799949	1.000	rs8176109	chr17:41265776	A/G	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.01	-0.56	5.5e-8	Menopause (age at onset);
SKCM	cis	rs7954584	0.523	rs11043280	chr12:122426643	T/C	cg01765077	chr12:122356316	WDR66	0.45	4.97	0.49	3.89e-6	Mean corpuscular volume;
SKCM	cis	rs4808199	0.947	rs1465695	chr19:19588546	A/C	cg03709012	chr19:19516395	GATAD2A	1.13	8.66	0.7	4.94e-13	Nonalcoholic fatty liver disease;
SKCM	cis	rs73001065	0.551	rs56397647	chr19:19642795	C/T	cg03709012	chr19:19516395	GATAD2A	1.16	5.47	0.53	5.19e-7	LDL cholesterol;
SKCM	cis	rs7659604	0.539	rs56159666	chr4:122782879	G/A	cg20573242	chr4:122745356	CCNA2	0.76	6.54	0.59	5.89e-9	Type 2 diabetes;
SKCM	cis	rs8180040	0.620	rs1811652	chr3:47208698	C/G	cg27129171	chr3:47204927	SETD2	-0.74	-5.3	-0.51	1.05e-6	Colorectal cancer;
SKCM	cis	rs7216064	1.000	rs62084240	chr17:65859233	C/A	cg12091567	chr17:66097778	LOC651250	-0.75	-5.27	-0.51	1.19e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs8077889	0.703	rs72836567	chr17:41945776	G/A	cg26893861	chr17:41843967	DUSP3	0.89	4.9	0.49	5.02e-6	Triglycerides;
SKCM	cis	rs3809863	0.602	rs6504833	chr17:45396087	A/G	cg25173405	chr17:45401733	C17orf57	-0.72	-5.25	-0.51	1.27e-6	Glaucoma (primary open-angle);
SKCM	cis	rs950776	0.616	rs6495307	chr15:78890321	C/T	cg06917634	chr15:78832804	PSMA4	0.9	7.99	0.67	9.7e-12	Sudden cardiac arrest;
SKCM	cis	rs34779708	0.750	rs35032841	chr10:35312687	G/A	cg03585969	chr10:35415529	CREM	0.73	6.02	0.56	5.38e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs2842992	0.830	rs752779	chr6:160133957	G/A	cg11366901	chr6:160182831	ACAT2	0.89	7.03	0.62	6.78e-10	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs11098499	0.863	rs1010739	chr4:120463471	C/T	cg24375607	chr4:120327624	NA	0.65	4.98	0.49	3.66e-6	Corneal astigmatism;
SKCM	cis	rs951366	0.789	rs823110	chr1:205701078	G/C	cg14159672	chr1:205819179	PM20D1	0.95	7.66	0.66	4.22e-11	Menarche (age at onset);
SKCM	cis	rs651907	0.535	rs35799195	chr3:101521927	A/G	cg12386194	chr3:101231763	SENP7	0.68	5.74	0.54	1.73e-7	Colorectal cancer;
SKCM	cis	rs1790761	0.554	rs12787511	chr11:67401635	G/C	cg24690094	chr11:67383802	NA	-0.59	-5.91	-0.56	8.61e-8	Mean corpuscular volume;
SKCM	cis	rs7666738	0.830	rs6840766	chr4:99016260	C/G	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs999943	0.846	rs9348923	chr6:33617924	C/T	cg14003231	chr6:33640908	ITPR3	0.67	6.11	0.57	3.64e-8	Obesity (extreme);
SKCM	cis	rs782590	0.902	rs3762513	chr2:55762957	C/T	cg18811423	chr2:55921094	PNPT1	0.83	6.16	0.57	2.92e-8	Metabolic syndrome;
SKCM	cis	rs1005277	0.579	rs932538	chr10:38381314	T/C	cg00409905	chr10:38381863	ZNF37A	-0.64	-6.18	-0.57	2.68e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs67311347	1.000	rs6599102	chr3:40468406	G/A	cg00091569	chr3:40428383	ENTPD3	0.62	5.09	0.5	2.4e-6	Renal cell carcinoma;
SKCM	cis	rs597539	0.652	rs636049	chr11:68667198	A/C	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.87	5.93	0.56	7.94e-8	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs12497850	0.931	rs4974079	chr3:48906469	T/G	cg07636037	chr3:49044803	WDR6	1.01	10.82	0.77	3.36e-17	Parkinson's disease;
SKCM	cis	rs654950	0.775	rs28972757	chr1:41993013	T/C	cg06885757	chr1:42089581	HIVEP3	-0.64	-7.17	-0.63	3.67e-10	Airway imaging phenotypes;
SKCM	cis	rs7666738	0.830	rs28594127	chr4:99001121	T/G	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4727027	0.704	rs12704071	chr7:148904795	C/T	cg23583168	chr7:148888333	NA	-0.76	-6.05	-0.57	4.7e-8	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs7829975	0.624	rs7823056	chr8:8382705	A/G	cg15556689	chr8:8085844	FLJ10661	0.86	7.49	0.65	9.08e-11	Mood instability;
SKCM	cis	rs910316	0.967	rs7146523	chr14:75659880	T/C	cg11812906	chr14:75593930	NEK9	-0.74	-5.75	-0.55	1.69e-7	Height;
SKCM	cis	rs4972806	0.849	rs2857541	chr2:177029086	C/T	cg03152288	chr2:177042942	NA	0.57	4.91	0.49	4.82e-6	IgG glycosylation;
SKCM	cis	rs12142240	0.698	rs41294478	chr1:46818442	G/A	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs7100689	0.646	rs10400045	chr10:82077032	A/G	cg01528321	chr10:82214614	TSPAN14	0.76	6.29	0.58	1.72e-8	Post bronchodilator FEV1;
SKCM	cis	rs17685	0.753	rs7804598	chr7:75702578	C/T	cg16489192	chr7:75678113	MDH2;STYXL1	-0.58	-5.46	-0.53	5.43e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs17376456	1.000	rs58734583	chr5:93532155	C/T	cg21475434	chr5:93447410	FAM172A	0.99	5.65	0.54	2.49e-7	Diabetic retinopathy;
SKCM	cis	rs3784262	1.000	rs12908953	chr15:58277812	A/G	cg12031962	chr15:58353849	ALDH1A2	-0.53	-6.78	-0.61	2.07e-9	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs59918340	0.764	rs3824234	chr8:142229370	T/C	cg23750338	chr8:142222470	SLC45A4	0.61	5.82	0.55	1.24e-7	Immature fraction of reticulocytes;
SKCM	cis	rs3820928	0.874	rs4144328	chr2:227790187	A/C	cg11843606	chr2:227700838	RHBDD1	-0.6	-4.81	-0.48	7.34e-6	Pulmonary function;
SKCM	cis	rs10860964	0.605	rs10745955	chr12:103564402	T/C	cg20635409	chr12:103359273	NA	-0.54	-4.87	-0.48	5.74e-6	Schizophrenia;
SKCM	cis	rs7772486	0.686	rs9497380	chr6:145955305	T/C	cg23711669	chr6:146136114	FBXO30	0.9	10.02	0.75	1.16e-15	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7523050	0.643	rs17621851	chr1:109400835	C/T	cg08274380	chr1:109419600	GPSM2	1.13	5.57	0.53	3.54e-7	Fat distribution (HIV);
SKCM	cis	rs4727027	0.833	rs2107846	chr7:148832774	G/A	cg23583168	chr7:148888333	NA	-0.82	-6.56	-0.6	5.29e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs875971	0.862	rs2420611	chr7:65999320	A/G	cg18876405	chr7:65276391	NA	0.61	6.06	0.57	4.57e-8	Aortic root size;
SKCM	cis	rs62238980	0.614	rs118009794	chr22:32470485	G/A	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs2842992	0.872	rs1570318	chr6:160111473	C/T	cg19482086	chr6:160211437	TCP1;MRPL18	0.77	5.55	0.53	3.77e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs8072100	0.935	rs12943464	chr17:45690351	A/T	cg08085267	chr17:45401833	C17orf57	0.61	5.49	0.53	4.77e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs28595532	0.920	rs56117870	chr4:119766583	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs1799949	1.000	rs3950989	chr17:41237953	G/A	cg23758822	chr17:41437982	NA	0.95	7.86	0.66	1.79e-11	Menopause (age at onset);
SKCM	cis	rs798554	1.000	rs798540	chr7:2764130	G/A	cg14895029	chr7:2775587	GNA12	-0.75	-5.52	-0.53	4.32e-7	Height;
SKCM	cis	rs13256369	0.802	rs13255789	chr8:8562791	T/C	cg06636001	chr8:8085503	FLJ10661	0.8	6.11	0.57	3.65e-8	Obesity-related traits;
SKCM	cis	rs4243830	0.510	rs7518459	chr1:6596678	C/G	cg22792644	chr1:6614718	TAS1R1;NOL9	-1.06	-5.63	-0.54	2.69e-7	Body mass index;
SKCM	cis	rs7772486	0.754	rs4895682	chr6:146062861	G/A	cg05347473	chr6:146136440	FBXO30	-0.61	-5.77	-0.55	1.53e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs703842	0.616	rs7489290	chr12:58228588	C/G	cg00677455	chr12:58241039	CTDSP2	0.75	5.93	0.56	7.79e-8	Multiple sclerosis;
SKCM	cis	rs7103648	0.553	rs12803857	chr11:47890172	G/A	cg20307385	chr11:47447363	PSMC3	0.81	5.61	0.54	2.98e-7	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs995000	0.868	rs10889360	chr1:63173918	C/T	cg06896770	chr1:63153194	DOCK7	0.86	7.71	0.66	3.46e-11	Triglyceride levels;
SKCM	cis	rs929354	0.772	rs6957939	chr7:156978485	T/C	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs9926296	0.533	rs7190823	chr16:89866043	A/G	cg26513180	chr16:89883248	FANCA	0.95	10.51	0.77	1.35e-16	Vitiligo;
SKCM	trans	rs10506458	0.915	rs56321182	chr12:63392023	C/T	cg03429785	chr15:59498649	MYO1E;LDHAL6B	-1.39	-7.59	-0.65	5.95e-11	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs929354	0.605	rs7806314	chr7:156946903	A/T	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs9858542	0.953	rs9878943	chr3:49434654	G/A	cg03060546	chr3:49711283	APEH	-0.69	-5.16	-0.5	1.85e-6	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs7666738	0.830	rs10000573	chr4:99048785	G/C	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs155076	0.625	rs4769159	chr13:21881978	A/C	cg11317459	chr13:21872234	NA	1.34	7.87	0.67	1.71e-11	White matter hyperintensity burden;
SKCM	cis	rs9916302	0.706	rs12947506	chr17:37707592	A/G	cg07936489	chr17:37558343	FBXL20	-1.12	-8.32	-0.69	2.23e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs597539	0.652	rs667989	chr11:68685776	T/A	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.84	5.25	0.51	1.29e-6	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs1580019	1.000	rs1580019	chr7:32493169	A/T	cg06627557	chr7:32535165	LSM5;AVL9	-0.77	-5.98	-0.56	6.39e-8	Cognitive ability;
SKCM	cis	rs4252707	1	rs4252707	chr1:204508147	G/A	cg17419461	chr1:204415978	PIK3C2B	-0.84	-5.96	-0.56	6.92e-8	Glioma;Non-glioblastoma glioma;
SKCM	cis	rs875971	1.000	rs1167612	chr7:65567976	C/A	cg18876405	chr7:65276391	NA	-0.71	-7.04	-0.62	6.64e-10	Aortic root size;
SKCM	cis	rs7218675	0.634	rs3935439	chr17:73504911	T/C	cg16555002	chr17:72736021	RAB37	-0.47	-4.83	-0.48	6.73e-6	Lung function (FEV1);
SKCM	cis	rs7927771	0.839	rs7124681	chr11:47529947	C/A	cg05585544	chr11:47624801	NA	-0.64	-5.52	-0.53	4.33e-7	Subjective well-being;
SKCM	cis	rs55962025	0.846	rs363064	chr4:3141410	C/T	cg09735869	chr4:3319127	RGS12	-0.85	-6.57	-0.6	5.21e-9	Parental longevity (mother's age at death);
SKCM	cis	rs2836974	0.897	rs2836929	chr21:40543811	T/C	cg11644478	chr21:40555479	PSMG1	0.97	10.21	0.76	5.08e-16	Cognitive function;
SKCM	cis	rs6089829	0.962	rs6062776	chr20:61663736	A/G	cg08564027	chr20:61660810	NA	0.63	5.65	0.54	2.56e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs10089	1.000	rs10478803	chr5:127488855	T/C	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.88	8.14	0.68	5.15e-12	Ileal carcinoids;
SKCM	cis	rs34779708	0.931	rs4934704	chr10:35332164	C/T	cg03585969	chr10:35415529	CREM	0.76	6.23	0.58	2.17e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs2404602	0.692	rs35138393	chr15:76977617	G/A	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs1218582	0.772	rs10908448	chr1:154882544	A/G	cg16680214	chr1:154839983	KCNN3	0.54	4.81	0.48	7.12e-6	Prostate cancer;
SKCM	cis	rs9911578	1.000	rs2079703	chr17:56603978	G/A	cg05425664	chr17:57184151	TRIM37	0.69	5.2	0.51	1.56e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs6500395	1.000	rs4785536	chr16:48712980	C/T	cg04672837	chr16:48644449	N4BP1	-0.63	-5.37	-0.52	8.01e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs11098499	0.754	rs1814813	chr4:120258207	G/T	cg09307838	chr4:120376055	NA	-1.0	-7.95	-0.67	1.16e-11	Corneal astigmatism;
SKCM	cis	rs3806843	0.706	rs2563302	chr5:140079051	T/C	cg26395211	chr5:140044315	WDR55	0.61	4.82	0.48	7.06e-6	Depressive symptoms (multi-trait analysis);
SKCM	cis	rs10504073	0.584	rs4873307	chr8:49950417	C/T	cg00325661	chr8:49890786	NA	0.8	6.81	0.61	1.83e-9	Blood metabolite ratios;
SKCM	cis	rs1850744	0.826	rs115893429	chr4:9593818	G/A	cg15442990	chr4:9534313	NA	-1.3	-4.84	-0.48	6.55e-6	Economic and political preferences;
SKCM	cis	rs55962025	0.883	rs362273	chr4:3227419	A/G	cg16987761	chr4:3318072	RGS12	-0.65	-4.81	-0.48	7.21e-6	Parental longevity (mother's age at death);
SKCM	cis	rs950027	0.620	rs2453533	chr15:45641225	C/A	cg21132104	chr15:45694354	SPATA5L1	0.76	6.14	0.57	3.2e-8	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs61776719	0.817	rs2170169	chr1:38408164	G/A	cg12658694	chr1:38397304	INPP5B	0.68	5.91	0.56	8.6e-8	Coronary artery disease;
SKCM	cis	rs11098499	0.863	rs3775847	chr4:120447642	A/C	cg09307838	chr4:120376055	NA	0.97	7.66	0.66	4.19e-11	Corneal astigmatism;
SKCM	cis	rs5769765	1.000	rs2319458	chr22:50236306	G/A	cg22709217	chr22:50311962	ALG12;CRELD2	-0.88	-6.04	-0.56	5.03e-8	Schizophrenia;
SKCM	cis	rs4319547	0.695	rs4758662	chr12:122924778	G/A	cg23029597	chr12:123009494	RSRC2	-0.78	-5.86	-0.55	1.06e-7	Body mass index;
SKCM	cis	rs9303401	0.527	rs2116450	chr17:56745561	C/T	cg02118635	chr17:56770003	RAD51C;TEX14	0.77	5.03	0.49	3.06e-6	Cognitive test performance;
SKCM	cis	rs2032447	0.670	rs198850	chr6:26104670	A/C	cg03517284	chr6:25882590	NA	0.63	5.51	0.53	4.52e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs6762	0.748	rs7928935	chr11:839127	G/A	cg16425592	chr11:842748	TSPAN4;POLR2L	-0.76	-5.36	-0.52	8.23e-7	Mean platelet volume;
SKCM	cis	rs7666738	0.678	rs7670805	chr4:99008763	A/G	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9581857	0.685	rs9319368	chr13:28042275	T/G	cg22138327	chr13:27999177	GTF3A	0.93	6.24	0.58	2.1e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs992157	1.000	rs11554825	chr2:219125809	C/T	cg20019365	chr2:219134978	PNKD;AAMP	0.81	7.35	0.64	1.68e-10	Colorectal cancer;
SKCM	cis	rs9303401	0.659	rs12600349	chr17:57054245	A/G	cg10487724	chr17:56770010	TEX14;RAD51C	-0.86	-6.16	-0.57	2.91e-8	Cognitive test performance;
SKCM	cis	rs8072100	0.967	rs62076549	chr17:45579555	T/G	cg08085267	chr17:45401833	C17orf57	0.57	4.85	0.48	6.1e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	trans	rs1814175	0.645	rs28839231	chr11:50044292	G/T	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs7586085	0.522	rs2034710	chr2:166467351	A/C	cg01770810	chr2:165769913	SLC38A11	0.49	4.97	0.49	3.85e-6	Total body bone mineral density;
SKCM	cis	rs867186	1.000	rs6579211	chr20:33605857	G/A	cg04194272	chr20:33683537	NA	-1.38	-7.2	-0.63	3.29e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs1577917	0.771	rs2484355	chr6:86394403	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.94	-10.18	-0.76	5.62e-16	Response to antipsychotic treatment;
SKCM	cis	rs9858542	0.953	rs34588335	chr3:49407660	G/C	cg03060546	chr3:49711283	APEH	-0.69	-5.16	-0.5	1.85e-6	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs11945232	0.624	rs112791869	chr4:88369598	A/G	cg23841344	chr4:88312519	HSD17B11	-0.74	-4.96	-0.49	3.96e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs28595532	0.920	rs114037572	chr4:119735609	T/G	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs116095464	0.558	rs112343653	chr5:257174	G/A	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs17685	0.725	rs6467993	chr7:75719350	G/A	cg01364799	chr7:75623366	TMEM120A	-0.72	-5.81	-0.55	1.31e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs807669	0.548	rs723414	chr22:19185736	G/A	cg02655711	chr22:19163373	SLC25A1	0.65	5.67	0.54	2.31e-7	Metabolite levels;
SKCM	cis	rs1669338	0.588	rs73005226	chr3:3195369	A/G	cg16797762	chr3:3221439	CRBN	-1.07	-5.8	-0.55	1.33e-7	White matter integrity;
SKCM	cis	rs7647973	0.580	rs35218722	chr3:49275805	A/G	cg07636037	chr3:49044803	WDR6	0.83	6.82	0.61	1.76e-9	Menarche (age at onset);
SKCM	cis	rs7100689	0.577	rs2282367	chr10:82040346	A/G	cg00277334	chr10:82204260	NA	-0.48	-4.77	-0.48	8.48e-6	Post bronchodilator FEV1;
SKCM	cis	rs763121	0.853	rs2064088	chr22:39053382	A/G	cg06022373	chr22:39101656	GTPBP1	0.72	4.96	0.49	4.08e-6	Menopause (age at onset);
SKCM	cis	rs28386778	0.897	rs2727326	chr17:61923016	G/A	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs208520	0.690	rs4386800	chr6:66755242	A/G	cg07460842	chr6:66804631	NA	0.87	7.01	0.62	7.4e-10	Exhaled nitric oxide output;
SKCM	cis	rs10832963	0.847	rs4237722	chr11:18639363	T/C	cg20219074	chr11:18656078	SPTY2D1	0.79	6.6	0.6	4.56e-9	Breast cancer;
SKCM	cis	rs2070488	1.000	rs2268758	chr3:38514049	C/T	cg01465620	chr3:38496096	LOC100128640;ACVR2B	1.02	9.51	0.73	1.13e-14	Electrocardiographic conduction measures;
SKCM	cis	rs2228479	0.702	rs17233176	chr16:89832751	G/C	cg06558623	chr16:89946397	TCF25	1.11	5.26	0.51	1.23e-6	Skin colour saturation;
SKCM	cis	rs2811415	0.597	rs35944498	chr3:127731662	T/C	cg09089421	chr3:127803668	RUVBL1	1.0	8.57	0.7	7.53e-13	Lung function (FEV1/FVC);
SKCM	cis	rs933688	0.938	rs6866923	chr5:90669352	A/C	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.12	8.55	0.7	7.9e-13	Smoking behavior;
SKCM	cis	rs10883723	0.773	rs2296587	chr10:104245588	G/A	cg11453585	chr10:104263688	ACTR1A;SUFU	0.74	5.42	0.52	6.55e-7	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs11098499	0.909	rs79026312	chr4:120440677	C/A	cg24375607	chr4:120327624	NA	0.68	5.25	0.51	1.27e-6	Corneal astigmatism;
SKCM	trans	rs1814175	0.715	rs1722007	chr11:49897319	T/C	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs941408	1.000	rs2741990	chr19:2796644	C/T	cg06609049	chr19:2785107	THOP1	0.83	7.0	0.62	7.78e-10	Total cholesterol levels;
SKCM	cis	rs9894429	0.789	rs6565611	chr17:79598319	T/C	cg18240062	chr17:79603768	NPLOC4	0.91	10.35	0.76	2.68e-16	Eye color traits;
SKCM	cis	rs1799949	0.965	rs34616041	chr17:41188786	G/A	cg05368731	chr17:41323189	NBR1	0.86	7.39	0.64	1.39e-10	Menopause (age at onset);
SKCM	cis	rs1153858	1.000	rs7164602	chr15:45671325	A/G	cg21132104	chr15:45694354	SPATA5L1	0.93	7.94	0.67	1.22e-11	Homoarginine levels;
SKCM	cis	rs11764590	0.694	rs6972969	chr7:2099331	A/G	cg02825527	chr7:2087843	MAD1L1	-0.62	-4.92	-0.49	4.67e-6	Neuroticism;
SKCM	cis	rs1801251	1.000	rs6746294	chr2:233583050	C/G	cg08000102	chr2:233561755	GIGYF2	-0.85	-6.47	-0.59	8.03e-9	Coronary artery disease;
SKCM	cis	rs668210	0.793	rs534201	chr11:65776728	A/T	cg20909159	chr11:65625947	CFL1	-0.77	-5.27	-0.51	1.18e-6	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs9513627	1.000	rs4285989	chr13:100132342	A/G	cg11288260	chr13:100117058	NA	0.8	4.77	0.48	8.48e-6	Obesity-related traits;
SKCM	cis	rs933688	1.000	rs12655973	chr5:90736537	A/G	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.01	8.43	0.69	1.41e-12	Smoking behavior;
SKCM	cis	rs870825	0.616	rs6833858	chr4:185639961	C/T	cg04058563	chr4:185651563	MLF1IP	1.08	7.44	0.64	1.13e-10	Blood protein levels;
SKCM	cis	rs6088580	0.634	rs945673	chr20:32964265	C/A	cg24642439	chr20:33292090	TP53INP2	-0.76	-5.91	-0.56	8.36e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs4237845	0.742	rs6650219	chr12:58289100	T/C	cg00677455	chr12:58241039	CTDSP2	0.68	5.69	0.54	2.11e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7635838	0.596	rs347599	chr3:11258191	C/T	cg00170343	chr3:11313890	ATG7	-0.65	-4.78	-0.48	8.02e-6	HDL cholesterol;
SKCM	cis	rs854765	0.583	rs11078405	chr17:17824978	G/T	cg04398451	chr17:18023971	MYO15A	-0.79	-5.68	-0.54	2.23e-7	Total body bone mineral density;
SKCM	cis	rs1218582	0.661	rs4845695	chr1:154911798	A/G	cg09359103	chr1:154839909	KCNN3	-0.53	-4.81	-0.48	7.13e-6	Prostate cancer;
SKCM	cis	rs2439831	0.867	rs2920781	chr15:43924682	G/A	cg02155558	chr15:43621948	ADAL;LCMT2	1.41	8.33	0.69	2.19e-12	Lung cancer in ever smokers;
SKCM	cis	rs7100689	0.784	rs4258322	chr10:82184770	T/C	cg01528321	chr10:82214614	TSPAN14	0.97	10.1	0.75	8.2e-16	Post bronchodilator FEV1;
SKCM	cis	rs9911578	0.839	rs1871751	chr17:57190368	A/G	cg05425664	chr17:57184151	TRIM37	-0.77	-6.51	-0.59	6.77e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs6835098	1.000	rs28477433	chr4:174085820	T/C	cg08422745	chr4:174089978	GALNT7	-0.83	-6.46	-0.59	8.18e-9	Dementia and core Alzheimer's disease neuropathologic changes;
SKCM	cis	rs1801516	0.950	rs4754319	chr11:108294773	A/T	cg03165700	chr11:108093220	ATM;NPAT	-1.11	-5.06	-0.5	2.68e-6	Melanoma;
SKCM	cis	rs672059	1.000	rs660602	chr1:183162774	T/G	ch.1.3577855R	chr1:183094577	LAMC1	0.65	5.56	0.53	3.69e-7	Hypertriglyceridemia;
SKCM	cis	rs2439831	0.867	rs8039638	chr15:43634405	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.39	9.42	0.73	1.62e-14	Lung cancer in ever smokers;
SKCM	cis	rs4727027	0.866	rs2373438	chr7:148780287	C/A	cg23583168	chr7:148888333	NA	-0.8	-6.31	-0.58	1.59e-8	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs7772486	0.701	rs2244308	chr6:146213706	C/T	cg23711669	chr6:146136114	FBXO30	0.78	7.7	0.66	3.53e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs55962025	0.842	rs362267	chr4:3243218	C/T	cg05297308	chr4:3317976	RGS12	-0.71	-5.23	-0.51	1.41e-6	Parental longevity (mother's age at death);
SKCM	cis	rs6977660	1.000	rs6973890	chr7:19820497	T/C	cg07541023	chr7:19748670	TWISTNB	0.7	4.82	0.48	6.98e-6	Thyroid stimulating hormone;
SKCM	cis	rs80130819	0.748	rs2732446	chr12:48690177	T/C	cg13203223	chr12:49319398	FKBP11	0.88	4.86	0.48	6.03e-6	Prostate cancer;
SKCM	trans	rs9898058	0.599	rs76888881	chr17:47719432	G/A	cg25281849	chr7:127409937	SND1	1.14	7.67	0.66	4.05e-11	Milk allergy;
SKCM	cis	rs826838	0.838	rs11183646	chr12:38799846	A/T	cg26384229	chr12:38710491	ALG10B	1.06	10.14	0.75	6.67e-16	Heart rate;
SKCM	cis	rs7618915	0.571	rs2289249	chr3:52597664	G/A	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs2228479	0.867	rs62052168	chr16:89947203	G/A	cg06558623	chr16:89946397	TCF25	1.12	5.64	0.54	2.58e-7	Skin colour saturation;
SKCM	cis	rs4900538	0.927	rs1190544	chr14:102903398	G/A	cg18135206	chr14:102964638	TECPR2	-0.77	-6.19	-0.57	2.57e-8	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs6952808	0.723	rs60432611	chr7:2029629	G/C	cg02951883	chr7:2050386	MAD1L1	-0.85	-7.58	-0.65	6.15e-11	Bipolar disorder and schizophrenia;
SKCM	cis	rs1707322	0.752	rs6662164	chr1:46146230	T/A	cg03146154	chr1:46216737	IPP	0.83	5.76	0.55	1.61e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7666738	0.830	rs72882693	chr4:98960804	T/A	cg17366294	chr4:99064904	C4orf37	0.59	4.89	0.48	5.36e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1153858	1.000	rs7494956	chr15:45668565	T/C	cg21132104	chr15:45694354	SPATA5L1	0.93	7.94	0.67	1.22e-11	Homoarginine levels;
SKCM	cis	rs8103278	0.507	rs1865116	chr19:46294510	G/A	cg14061069	chr19:46274453	DMPK	0.49	4.77	0.48	8.47e-6	Coronary artery disease;
SKCM	cis	rs801193	1.000	rs2420824	chr7:66131116	G/A	cg11987759	chr7:65425863	GUSB	0.67	5.75	0.55	1.68e-7	Aortic root size;
SKCM	cis	rs875971	0.522	rs4502988	chr7:65297746	A/G	cg18876405	chr7:65276391	NA	0.86	7.56	0.65	6.53e-11	Aortic root size;
SKCM	cis	rs7020830	0.858	rs67036212	chr9:37133538	A/G	cg14294708	chr9:37120828	ZCCHC7	1.1	10.41	0.76	2.09e-16	Schizophrenia;
SKCM	cis	rs4400599	0.642	rs10797061	chr1:154206212	C/T	cg26808167	chr1:154192205	UBAP2L;C1orf43	-0.55	-4.98	-0.49	3.73e-6	Platelet distribution width;
SKCM	cis	rs761746	0.739	rs5753690	chr22:31950005	C/T	cg25791279	chr22:32026902	PISD	0.83	5.0	0.49	3.46e-6	Intelligence;
SKCM	cis	rs6951245	0.935	rs61753396	chr7:1105372	A/G	cg03188948	chr7:1209495	NA	1.13	6.27	0.58	1.89e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7666738	0.830	rs13138438	chr4:99050545	C/A	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10489202	0.583	rs203782	chr1:167882386	A/G	cg24449463	chr1:168025552	DCAF6	0.77	6.92	0.62	1.12e-9	Schizophrenia;
SKCM	cis	rs867186	1.000	rs11167254	chr20:33654584	C/T	cg04194272	chr20:33683537	NA	-1.38	-7.2	-0.63	3.29e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs7208859	0.573	rs73267873	chr17:29068457	C/T	cg14067834	chr17:29058358	SUZ12P	0.99	5.11	0.5	2.22e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs72949976	1.000	rs72949976	chr2:214034104	C/T	cg08319019	chr2:214017104	IKZF2	-0.71	-5.33	-0.52	9.18e-7	Lung cancer;Squamous cell lung carcinoma;
SKCM	cis	rs7772486	0.754	rs9390356	chr6:146118983	A/T	cg23711669	chr6:146136114	FBXO30	-0.9	-10.61	-0.77	8.57e-17	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs10754283	0.967	rs10801764	chr1:90121751	T/G	cg21401794	chr1:90099060	LRRC8C	0.77	6.37	0.58	1.23e-8	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs8077889	0.750	rs12453611	chr17:41931735	A/G	cg26893861	chr17:41843967	DUSP3	1.31	7.65	0.65	4.46e-11	Triglycerides;
SKCM	cis	rs7666738	0.830	rs34412187	chr4:99010454	A/G	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1577917	0.740	rs9344533	chr6:86236188	C/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.73	6.52	0.59	6.4e-9	Response to antipsychotic treatment;
SKCM	cis	rs55962025	0.842	rs362267	chr4:3243218	C/T	cg00764545	chr4:3318001	RGS12	-0.74	-6.0	-0.56	5.76e-8	Parental longevity (mother's age at death);
SKCM	cis	rs17065868	1.000	rs61948032	chr13:45199422	C/T	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs208520	0.690	rs207082	chr6:66773796	G/A	cg07460842	chr6:66804631	NA	-0.91	-6.9	-0.62	1.22e-9	Exhaled nitric oxide output;
SKCM	cis	rs752010	0.619	rs10736421	chr1:42106230	G/A	cg06885757	chr1:42089581	HIVEP3	0.57	6.45	0.59	8.75e-9	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs1559088	0.576	rs7251626	chr19:33578470	C/A	cg17764715	chr19:33622953	WDR88	0.94	7.41	0.64	1.27e-10	Bone ultrasound measurement (broadband ultrasound attenuation);
SKCM	cis	rs910316	1.000	rs4903289	chr14:75623988	C/T	cg08847533	chr14:75593920	NEK9	-0.94	-9.44	-0.73	1.54e-14	Height;
SKCM	cis	rs1577917	0.958	rs12197463	chr6:86445242	T/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.44	-0.52	5.96e-7	Response to antipsychotic treatment;
SKCM	cis	rs11764590	0.694	rs56072378	chr7:2104364	A/G	cg23422044	chr7:1970798	MAD1L1	-0.87	-6.13	-0.57	3.36e-8	Neuroticism;
SKCM	cis	rs1577917	1.000	rs34852683	chr6:86702330	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.64	-5.54	-0.53	3.92e-7	Response to antipsychotic treatment;
SKCM	cis	rs860554	0.528	rs12120625	chr1:201306510	A/G	cg01828733	chr1:201708932	NAV1	0.51	4.97	0.49	3.83e-6	Panic disorder;
SKCM	cis	rs6087990	0.735	rs2424922	chr20:31386449	T/C	cg13636640	chr20:31349939	DNMT3B	0.83	6.25	0.58	2.06e-8	Ulcerative colitis;
SKCM	cis	rs12145833	0.596	rs3926866	chr1:243437632	G/C	cg02356786	chr1:243265016	LOC731275	1.47	5.27	0.51	1.17e-6	Obesity (early onset extreme);
SKCM	cis	rs3820068	0.603	rs72647138	chr1:15980929	C/T	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs34375054	0.525	rs10846829	chr12:125595058	G/C	cg25124228	chr12:125621409	AACS	-0.81	-6.57	-0.6	5.21e-9	Post bronchodilator FEV1/FVC ratio;
SKCM	trans	rs208520	0.690	rs10455594	chr6:66737894	C/G	cg15611600	chr13:45563400	KIAA1704;NUFIP1	0.92	7.47	0.65	9.89e-11	Exhaled nitric oxide output;
SKCM	cis	rs875971	0.660	rs801211	chr7:66015689	T/G	cg11764359	chr7:65958608	NA	-0.86	-6.6	-0.6	4.52e-9	Aortic root size;
SKCM	cis	rs10860964	0.605	rs7963232	chr12:103563372	T/C	cg20635409	chr12:103359273	NA	-0.55	-4.94	-0.49	4.36e-6	Schizophrenia;
SKCM	cis	rs595982	0.559	rs73061643	chr19:49368151	A/G	cg19746536	chr19:49375674	PPP1R15A	1.01	5.56	0.53	3.61e-7	Red cell distribution width;
SKCM	cis	rs769267	0.931	rs2965197	chr19:19470910	C/T	cg03709012	chr19:19516395	GATAD2A	-0.86	-7.13	-0.63	4.48e-10	Tonsillectomy;
SKCM	cis	rs7666738	0.830	rs10017201	chr4:98983561	G/A	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2180341	0.961	rs3798857	chr6:127659473	A/T	cg27446573	chr6:127587934	RNF146	0.94	8.08	0.68	6.49e-12	Breast cancer;
SKCM	cis	rs1165205	0.558	rs793144	chr6:25879321	C/T	cg03517284	chr6:25882590	NA	-0.69	-6.73	-0.61	2.61e-9	Urate levels;
SKCM	cis	rs62238980	0.522	rs117246042	chr22:32454080	T/C	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs11098499	0.570	rs6832740	chr4:120546136	T/C	cg09307838	chr4:120376055	NA	0.94	7.77	0.66	2.64e-11	Corneal astigmatism;
SKCM	cis	rs55962025	0.883	rs3755883	chr4:3223250	A/G	cg11471262	chr4:3318911	RGS12	-0.68	-5.13	-0.5	2.07e-6	Parental longevity (mother's age at death);
SKCM	cis	rs9910055	0.529	rs228746	chr17:42173752	T/C	cg08499158	chr17:42289980	UBTF	0.72	5.61	0.54	2.95e-7	Total body bone mineral density;
SKCM	trans	rs11722228	0.522	rs7681250	chr4:10133013	G/T	cg26043149	chr18:55253948	FECH	0.95	8.7	0.7	4.05e-13	Gout;Urate levels;Serum uric acid levels;
SKCM	cis	rs7100689	0.646	rs1934693	chr10:82125650	T/C	cg01528321	chr10:82214614	TSPAN14	0.8	7.0	0.62	7.98e-10	Post bronchodilator FEV1;
SKCM	trans	rs3780486	0.846	rs3780487	chr9:33139237	T/C	cg20290983	chr6:43655470	MRPS18A	1.0	11.51	0.79	1.75e-18	IgG glycosylation;
SKCM	cis	rs7216064	1.000	rs2365468	chr17:65841318	C/T	cg12091567	chr17:66097778	LOC651250	-0.79	-5.72	-0.54	1.9e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs1799949	1.000	rs12942277	chr17:41187974	G/C	cg25918947	chr17:41365094	TMEM106A	-0.61	-5.87	-0.55	1e-7	Menopause (age at onset);
SKCM	cis	rs875971	0.964	rs12668936	chr7:65914404	C/T	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	cis	rs28595532	0.920	rs115103359	chr4:119739608	A/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs7666738	0.606	rs3846447	chr4:99099907	G/A	cg17366294	chr4:99064904	C4orf37	0.63	5.34	0.52	8.85e-7	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6951245	0.554	rs79367977	chr7:1152657	G/A	cg18402987	chr7:1209562	NA	0.83	5.53	0.53	4.06e-7	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs1799949	0.965	rs799912	chr17:41257134	T/C	cg05368731	chr17:41323189	NBR1	0.87	7.36	0.64	1.62e-10	Menopause (age at onset);
SKCM	cis	rs1850744	0.536	rs9998663	chr4:9627053	C/T	cg15442990	chr4:9534313	NA	1.55	5.8	0.55	1.34e-7	Economic and political preferences;
SKCM	cis	rs17065868	1.000	rs61947968	chr13:45090314	G/T	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs8078723	0.668	rs56030650	chr17:38131187	C/A	cg17467752	chr17:38218738	THRA	0.6	5.19	0.51	1.66e-6	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs7666738	0.800	rs2865988	chr4:99067807	T/C	cg05340658	chr4:99064831	C4orf37	0.66	4.87	0.48	5.74e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9814567	1.000	rs1814337	chr3:134200682	C/T	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.7	-5.54	-0.53	3.92e-7	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs34172651	0.517	rs2287783	chr16:24831727	C/T	cg06028605	chr16:24865363	SLC5A11	0.59	4.95	0.49	4.26e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs4555082	0.874	rs28785556	chr14:105745388	A/T	cg13114125	chr14:105738426	BRF1	-0.71	-5.43	-0.52	6.28e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs7143963	0.636	rs8004192	chr14:103337253	T/C	cg23020514	chr14:103360112	TRAF3	0.74	6.99	0.62	8.38e-10	Body mass index;
SKCM	cis	rs867186	1.000	rs79439610	chr20:33654689	C/A	cg04194272	chr20:33683537	NA	-1.38	-7.2	-0.63	3.29e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs6912958	0.559	rs242279	chr6:88048191	A/G	cg08069147	chr6:88032118	GJB7;C6orf162	0.65	5.83	0.55	1.21e-7	Monocyte percentage of white cells;
SKCM	cis	rs769267	0.929	rs34538000	chr19:19481379	G/T	cg26732615	chr19:19648335	CILP2;YJEFN3	-0.69	-7.26	-0.64	2.46e-10	Tonsillectomy;
SKCM	cis	rs6121246	0.559	rs1062794	chr20:30381758	G/C	cg13852791	chr20:30311386	BCL2L1	0.82	5.69	0.54	2.09e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs28386778	0.724	rs35092235	chr17:61944621	T/C	cg22520471	chr17:61851767	DDX42;CCDC47	0.79	5.33	0.52	9.35e-7	Prudent dietary pattern;
SKCM	cis	rs4820318	1	rs4820318	chr22:38570313	G/A	cg25457927	chr22:38595422	NA	-0.58	-6.77	-0.61	2.14e-9	Breast cancer;
SKCM	cis	rs854765	0.663	rs3744115	chr17:17749822	G/A	cg24612305	chr17:17875800	TOM1L2;LRRC48	-1.09	-8.47	-0.69	1.17e-12	Total body bone mineral density;
SKCM	cis	rs7772486	0.790	rs6570724	chr6:146151283	T/C	cg05347473	chr6:146136440	FBXO30	0.57	5.36	0.52	8.27e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6582630	0.537	rs8189533	chr12:38391068	A/G	cg13010199	chr12:38710504	ALG10B	0.69	4.89	0.48	5.2e-6	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs1577917	0.655	rs9342045	chr6:86425148	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.66	5.54	0.53	4.01e-7	Response to antipsychotic treatment;
SKCM	cis	rs875971	0.660	rs10281080	chr7:66042441	T/C	cg11764359	chr7:65958608	NA	-0.83	-6.29	-0.58	1.71e-8	Aortic root size;
SKCM	cis	rs2050392	0.630	rs303428	chr10:30739058	C/T	cg25182066	chr10:30743637	MAP3K8	0.62	5.4	0.52	7.1e-7	Inflammatory bowel disease;
SKCM	cis	rs9682041	1.000	rs9682041	chr3:170091902	C/T	cg11886554	chr3:170076028	SKIL	0.93	5.5	0.53	4.62e-7	Glomerular filtration rate in non diabetics (creatinine);Glomerular filtration rate (creatinine);
SKCM	cis	rs826838	1.000	rs851934	chr12:39104453	G/T	cg13010199	chr12:38710504	ALG10B	-0.82	-6.28	-0.58	1.77e-8	Heart rate;
SKCM	cis	rs2836974	0.831	rs2836921	chr21:40516070	C/T	cg11890956	chr21:40555474	PSMG1	1.08	12.18	0.81	9.92e-20	Cognitive function;
SKCM	cis	rs7618501	0.633	rs4688690	chr3:50022292	G/A	cg05072774	chr3:49840536	C3orf54	-0.67	-5.06	-0.5	2.73e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9486715	0.758	rs9386528	chr6:96928514	G/A	cg06623918	chr6:96969491	KIAA0776	-0.69	-5.24	-0.51	1.33e-6	Headache;
SKCM	cis	rs992157	0.835	rs12987219	chr2:219144149	G/A	cg20019365	chr2:219134978	PNKD;AAMP	-0.72	-6.22	-0.58	2.33e-8	Colorectal cancer;
SKCM	cis	rs10791097	0.694	rs7940027	chr11:130745591	A/G	cg12179176	chr11:130786555	SNX19	0.93	8.16	0.68	4.64e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs28374715	0.733	rs9568	chr15:41573612	G/T	cg18705301	chr15:41695430	NDUFAF1	-1.09	-11.7	-0.8	7.67e-19	Ulcerative colitis;
SKCM	cis	rs7666738	0.546	rs10018080	chr4:98758436	C/A	cg17366294	chr4:99064904	C4orf37	0.65	5.08	0.5	2.55e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2404602	0.692	rs12910734	chr15:77149931	A/G	cg23625390	chr15:77176239	SCAPER	0.59	5.12	0.5	2.13e-6	Blood metabolite levels;
SKCM	cis	rs8072100	0.607	rs9894594	chr17:45461383	A/G	cg08085267	chr17:45401833	C17orf57	-0.62	-5.03	-0.49	3.05e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs7959452	0.640	rs4761233	chr12:69722880	T/C	cg20891283	chr12:69753455	YEATS4	0.8	7.63	0.65	4.95e-11	Blood protein levels;
SKCM	cis	rs1032355	0.558	rs17533020	chr4:100509167	C/T	cg25391692	chr4:100495869	MTTP	0.77	4.94	0.49	4.38e-6	Celiac disease;
SKCM	cis	rs1005277	0.522	rs9418276	chr10:37940116	G/T	cg00409905	chr10:38381863	ZNF37A	-0.6	-5.59	-0.53	3.22e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs2739330	0.828	rs5751770	chr22:24252842	A/G	cg25703541	chr22:24373054	LOC391322	-0.78	-6.61	-0.6	4.24e-9	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs1707322	0.686	rs1547924	chr1:46085112	C/T	cg03146154	chr1:46216737	IPP	0.84	6.14	0.57	3.19e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs10193935	0.901	rs13426988	chr2:42604081	G/A	cg27598129	chr2:42591480	NA	-0.96	-6.71	-0.61	2.74e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs782590	0.694	rs2627775	chr2:55877113	C/T	cg18811423	chr2:55921094	PNPT1	0.85	5.92	0.56	8.08e-8	Metabolic syndrome;
SKCM	cis	rs2013441	1.000	rs2703821	chr17:20121526	C/T	cg13482628	chr17:19912719	NA	-0.65	-5.14	-0.5	1.96e-6	Obesity-related traits;
SKCM	trans	rs1814175	0.935	rs28586931	chr11:49693872	G/A	cg03929089	chr4:120376271	NA	-0.88	-7.69	-0.66	3.73e-11	Height;
SKCM	cis	rs3768617	0.510	rs10911239	chr1:183062450	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs34779708	0.931	rs12771399	chr10:35452377	C/T	cg03585969	chr10:35415529	CREM	0.75	5.95	0.56	7.12e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs10504229	0.683	rs72650839	chr8:58130029	C/T	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs7103648	0.808	rs7103835	chr11:47461693	G/A	cg20307385	chr11:47447363	PSMC3	0.93	6.51	0.59	6.55e-9	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs7659604	0.540	rs11724322	chr4:122697850	A/T	cg19671926	chr4:122722719	EXOSC9	0.76	6.97	0.62	9.04e-10	Type 2 diabetes;
SKCM	cis	rs427394	0.664	rs274696	chr5:6732213	A/C	cg10857441	chr5:6722123	POLS	-0.66	-6.72	-0.61	2.68e-9	Menopause (age at onset);
SKCM	cis	rs6952808	0.595	rs3800916	chr7:2166072	C/T	cg02951883	chr7:2050386	MAD1L1	-0.76	-6.91	-0.62	1.14e-9	Bipolar disorder and schizophrenia;
SKCM	cis	rs7937682	0.632	rs4441050	chr11:111772506	C/T	cg09085632	chr11:111637200	PPP2R1B	1.1	10.72	0.77	5.29e-17	Primary sclerosing cholangitis;
SKCM	cis	rs7584330	0.737	rs1497127	chr2:238369282	A/G	cg14458575	chr2:238380390	NA	0.9	6.07	0.57	4.34e-8	Prostate cancer;
SKCM	cis	rs12986445	0.711	rs3845682	chr2:26110064	A/T	cg07291958	chr2:26785531	C2orf70	0.52	4.86	0.48	5.84e-6	Multiple myeloma and monoclonal gammopathy;Multiple myeloma;
SKCM	cis	rs12586317	0.547	rs10146699	chr14:35483577	G/A	cg16230307	chr14:35515116	FAM177A1	0.81	5.88	0.55	9.47e-8	Psoriasis;
SKCM	cis	rs995000	0.899	rs1168027	chr1:62970184	T/C	cg06896770	chr1:63153194	DOCK7	-0.74	-6.81	-0.61	1.77e-9	Triglyceride levels;
SKCM	cis	rs6003958	1	rs6003958	chr22:24264089	T/G	cg04234412	chr22:24373322	LOC391322	0.73	5.61	0.54	2.92e-7	S-phenylmercapturic acid levels in smokers;
SKCM	trans	rs3749237	0.964	rs1799843	chr3:49849723	G/A	cg21659725	chr3:3221576	CRBN	0.99	7.33	0.64	1.87e-10	Resting heart rate;
SKCM	cis	rs2688482	0.557	rs3103952	chr3:195522690	T/C	cg11598736	chr3:195384522	SDHAP2	1.09	6.27	0.58	1.87e-8	Lung disease severity in cystic fibrosis;
SKCM	cis	rs2836974	0.899	rs8127087	chr21:40544502	C/T	cg11644478	chr21:40555479	PSMG1	0.97	10.21	0.76	5.08e-16	Cognitive function;
SKCM	cis	rs778371	0.676	rs4973563	chr2:233716421	C/T	cg08000102	chr2:233561755	GIGYF2	-0.83	-6.48	-0.59	7.59e-9	Schizophrenia;
SKCM	cis	rs11626933	1.000	rs6575122	chr14:90753556	A/G	cg14092571	chr14:90743983	NA	-0.87	-7.88	-0.67	1.6e-11	Gut microbiota (bacterial taxa);
SKCM	cis	rs1799949	0.860	rs8176279	chr17:41210396	A/C	cg23758822	chr17:41437982	NA	0.93	7.52	0.65	7.85e-11	Menopause (age at onset);
SKCM	cis	rs941408	0.515	rs759066	chr19:2775337	G/T	cg06609049	chr19:2785107	THOP1	1.1	10.0	0.75	1.25e-15	Total cholesterol levels;
SKCM	cis	rs7772486	0.790	rs9791313	chr6:146266172	T/C	cg05347473	chr6:146136440	FBXO30	-0.55	-4.97	-0.49	3.86e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs28595532	0.920	rs115430947	chr4:119737149	C/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs9300255	0.602	rs1727316	chr12:123618603	C/T	cg00376283	chr12:123451042	ABCB9	0.82	5.61	0.54	3e-7	Neutrophil percentage of white cells;
SKCM	cis	rs6545883	0.894	rs2694634	chr2:61551435	T/C	cg15711740	chr2:61764176	XPO1	0.69	4.9	0.49	5.01e-6	Tuberculosis;
SKCM	cis	rs742614	0.533	rs6059497	chr20:32446960	C/G	cg06304546	chr20:32448765	NA	-0.73	-5.91	-0.56	8.51e-8	Stearic acid (18:0) levels;
SKCM	cis	rs7149337	0.805	rs3007164	chr14:51646935	A/G	cg23942311	chr14:51606299	NA	0.62	6.95	0.62	9.82e-10	Cancer;
SKCM	cis	rs732765	0.734	rs888418	chr14:75119296	C/T	cg25946216	chr14:74253857	C14orf43	-0.87	-5.45	-0.53	5.68e-7	Non-small cell lung cancer;
SKCM	cis	rs7953508	0.711	rs11107120	chr12:93985482	T/C	cg18151635	chr12:93972918	NA	-0.75	-6.58	-0.6	4.82e-9	Pubertal anthropometrics;
SKCM	cis	rs4819052	0.851	rs13052312	chr21:46662359	T/C	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.42	0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs2204008	0.715	rs12368462	chr12:38336116	C/G	cg26384229	chr12:38710491	ALG10B	0.81	6.67	0.6	3.38e-9	Bladder cancer;
SKCM	cis	rs9911578	1.000	rs1057068	chr17:56598439	T/C	cg05425664	chr17:57184151	TRIM37	0.7	5.21	0.51	1.52e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2739330	0.731	rs5751792	chr22:24401542	G/A	cg12419862	chr22:24373484	LOC391322	-0.91	-10.17	-0.76	5.84e-16	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs941408	0.964	rs1736186	chr19:2815372	A/G	cg06609049	chr19:2785107	THOP1	0.81	7.0	0.62	7.89e-10	Total cholesterol levels;
SKCM	cis	rs589448	0.902	rs528974	chr12:69765918	A/T	cg20891283	chr12:69753455	YEATS4	0.98	9.89	0.75	2.06e-15	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs7408868	0.831	rs7245850	chr19:15274585	A/C	cg14696996	chr19:15285081	NOTCH3	0.82	4.92	0.49	4.7e-6	Pulse pressure;
SKCM	cis	rs8078723	0.866	rs11078934	chr17:38189793	C/T	cg17467752	chr17:38218738	THRA	0.77	7.12	0.63	4.69e-10	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs9435341	0.965	rs12401598	chr1:107580533	C/A	cg09367891	chr1:107599246	PRMT6	0.84	7.05	0.62	6.33e-10	Facial morphology (factor 21, depth of nasal alae);
SKCM	cis	rs57214277	0.508	rs6828688	chr4:185257359	G/C	cg12654155	chr4:185238627	NA	0.68	5.44	0.52	5.84e-7	Chronic lymphocytic leukemia;
SKCM	cis	rs826838	1.000	rs9795768	chr12:39012479	T/C	cg13010199	chr12:38710504	ALG10B	0.78	6.13	0.57	3.37e-8	Heart rate;
SKCM	cis	rs854765	0.583	rs7207395	chr17:17819335	C/T	cg09796270	chr17:17721594	SREBF1	0.65	4.87	0.48	5.79e-6	Total body bone mineral density;
SKCM	cis	rs34779708	0.733	rs4244997	chr10:35547254	T/C	cg03585969	chr10:35415529	CREM	0.71	5.25	0.51	1.27e-6	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs12478296	1.000	rs73007138	chr2:243007041	C/T	cg06360820	chr2:242988706	NA	-1.02	-4.97	-0.49	3.94e-6	Obesity-related traits;
SKCM	cis	rs2836974	0.674	rs1011413	chr21:40638241	A/G	cg11890956	chr21:40555474	PSMG1	-0.88	-9.02	-0.71	9.89e-14	Cognitive function;
SKCM	cis	rs3820068	0.581	rs74054797	chr1:15926217	G/A	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs2404602	0.679	rs12908421	chr15:76881794	T/G	cg23625390	chr15:77176239	SCAPER	0.59	5.12	0.5	2.13e-6	Blood metabolite levels;
SKCM	cis	rs9581857	0.579	rs3759433	chr13:27997999	C/T	cg22138327	chr13:27999177	GTF3A	0.84	5.95	0.56	7.05e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs1801251	1.000	rs36007169	chr2:233621834	A/G	cg25237894	chr2:233734115	C2orf82	0.58	5.53	0.53	4.04e-7	Coronary artery disease;
SKCM	cis	rs1707322	1.000	rs7547284	chr1:46319565	C/G	cg03146154	chr1:46216737	IPP	0.75	5.15	0.5	1.94e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs950027	0.620	rs872192	chr15:45614502	A/G	cg21132104	chr15:45694354	SPATA5L1	0.78	5.93	0.56	7.7e-8	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs554111	1.000	rs554111	chr1:21042300	C/G	cg01072550	chr1:21505969	NA	-0.62	-4.98	-0.49	3.77e-6	Facial morphology (factor 17, height of vermillion upper lip);
SKCM	cis	rs4619890	0.510	rs7663026	chr4:7889068	C/T	cg08722675	chr4:8412549	ACOX3	0.53	5.01	0.49	3.37e-6	Glaucoma (primary open-angle);
SKCM	cis	rs7932354	0.528	rs4752957	chr11:47125632	T/G	cg03339077	chr11:47165057	C11orf49	-0.61	-5.27	-0.51	1.16e-6	Bone mineral density (hip);Bone mineral density;
SKCM	cis	rs506338	0.517	rs490192	chr11:64471369	C/T	cg04317338	chr11:64019027	PLCB3	0.78	4.86	0.48	5.96e-6	Body mass index;Urate levels;
SKCM	cis	rs7772486	0.764	rs7745696	chr6:146162829	T/C	cg23711669	chr6:146136114	FBXO30	0.85	9.55	0.73	9.36e-15	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs17345786	0.798	rs1609159	chr3:101275902	A/C	cg12386194	chr3:101231763	SENP7	0.73	5.59	0.53	3.28e-7	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs8060686	0.641	rs55725810	chr16:68189636	C/T	cg09117114	chr16:67998030	SLC12A4	-0.76	-4.93	-0.49	4.58e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs80130819	0.688	rs10783233	chr12:48590899	C/G	cg13203223	chr12:49319398	FKBP11	0.93	4.87	0.48	5.66e-6	Prostate cancer;
SKCM	cis	rs9902453	0.578	rs8073217	chr17:28164263	G/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.8	6.02	0.56	5.46e-8	Coffee consumption (cups per day);
SKCM	cis	rs2243480	0.901	rs35256305	chr7:65306405	T/C	cg18252515	chr7:66147081	NA	-1.29	-7.41	-0.64	1.3e-10	Diabetic kidney disease;
SKCM	cis	rs875971	0.522	rs4718286	chr7:65292764	A/G	cg11764359	chr7:65958608	NA	0.88	6.43	0.59	9.56e-9	Aortic root size;
SKCM	cis	rs9902453	1.000	rs28664971	chr17:28437410	A/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.79	6.04	0.56	5.02e-8	Coffee consumption (cups per day);
SKCM	cis	rs62244186	0.593	rs9814298	chr3:44871899	T/A	cg02073558	chr3:44770973	ZNF501	0.8	7.05	0.62	6.39e-10	Depressive symptoms;
SKCM	cis	rs12586317	0.547	rs2383693	chr14:35500205	A/C	cg16230307	chr14:35515116	FAM177A1	0.81	5.88	0.55	9.47e-8	Psoriasis;
SKCM	cis	rs7809950	0.678	rs6949634	chr7:106984684	G/T	cg23024343	chr7:107201750	COG5	-0.82	-7.0	-0.62	7.72e-10	Coronary artery disease;
SKCM	cis	rs4819052	0.679	rs2838859	chr21:46684517	C/T	cg19498844	chr21:46707878	POFUT2;LOC642852	0.81	6.83	0.61	1.69e-9	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs4683346	1.000	rs17030478	chr3:42893486	A/G	cg06399164	chr3:42695035	ZBTB47	0.62	5.8	0.55	1.35e-7	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs7809950	0.635	rs62483629	chr7:106866178	T/C	cg23024343	chr7:107201750	COG5	-0.77	-6.61	-0.6	4.37e-9	Coronary artery disease;
SKCM	cis	rs8180040	0.932	rs11711265	chr3:47558448	T/C	cg27129171	chr3:47204927	SETD2	0.81	5.82	0.55	1.26e-7	Colorectal cancer;
SKCM	cis	rs12986445	0.711	rs2891481	chr2:26119337	C/T	cg07291958	chr2:26785531	C2orf70	0.53	4.86	0.48	5.93e-6	Multiple myeloma and monoclonal gammopathy;Multiple myeloma;
SKCM	cis	rs11098499	0.691	rs10028773	chr4:120265259	C/G	cg09307838	chr4:120376055	NA	-0.99	-8.68	-0.7	4.54e-13	Corneal astigmatism;
SKCM	cis	rs9399137	0.507	rs4289677	chr6:135275485	A/G	cg24558204	chr6:135376177	HBS1L	0.69	6.21	0.58	2.38e-8	Glycated hemoglobin levels;Mean corpuscular volume;Hematology traits;HbA2 levels;Mean corpuscular hemoglobin;Hemoglobin levels;F-cell distribution;Platelet count;
SKCM	cis	rs7399018	0.739	rs6580811	chr12:51612501	T/C	cg20712883	chr12:51590929	POU6F1	0.64	5.03	0.49	3.09e-6	Cisplatin-induced ototoxicity;
SKCM	cis	rs875971	0.638	rs3898855	chr7:66036398	G/C	cg11987759	chr7:65425863	GUSB	0.69	5.9	0.56	8.74e-8	Aortic root size;
SKCM	cis	rs6912958	0.559	rs1201409	chr6:88055264	T/C	cg08069147	chr6:88032118	GJB7;C6orf162	0.64	5.71	0.54	1.98e-7	Monocyte percentage of white cells;
SKCM	cis	rs2072499	0.966	rs1060604	chr1:156184268	T/C	cg24450063	chr1:156163899	SLC25A44	0.95	8.3	0.68	2.5e-12	Testicular germ cell tumor;
SKCM	cis	rs7811142	0.943	rs67483801	chr7:100031758	G/T	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.12	6.51	0.59	6.68e-9	Platelet count;
SKCM	cis	rs72634258	0.945	rs28624	chr1:8084355	G/T	cg00042356	chr1:8021962	PARK7	-0.88	-6.27	-0.58	1.87e-8	Inflammatory bowel disease;
SKCM	cis	rs595982	0.559	rs17206700	chr19:49361255	A/G	cg15549821	chr19:49342101	PLEKHA4	-0.86	-5.78	-0.55	1.5e-7	Red cell distribution width;
SKCM	cis	rs2033711	0.936	rs882609	chr19:58991479	G/A	cg26874164	chr19:58962979	ZNF324B	0.61	4.81	0.48	7.26e-6	Uric acid clearance;
SKCM	cis	rs1843834	0.505	rs7585047	chr2:225373897	C/T	cg22455342	chr2:225449267	CUL3	0.71	5.32	0.52	9.67e-7	IgE levels in asthmatics (D.p. specific);
SKCM	cis	rs1218582	0.772	rs4845693	chr1:154911257	A/G	cg09359103	chr1:154839909	KCNN3	0.52	4.77	0.47	8.53e-6	Prostate cancer;
SKCM	cis	rs9815354	0.812	rs78342280	chr3:41948810	G/A	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs933688	1.000	rs332529	chr5:90789470	G/A	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.92	6.35	0.58	1.32e-8	Smoking behavior;
SKCM	cis	rs2243480	1.000	rs313799	chr7:65494330	A/G	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs9611565	0.592	rs80477	chr22:42001183	C/T	cg03806693	chr22:41940476	POLR3H	1.1	7.26	0.64	2.51e-10	Vitiligo;
SKCM	cis	rs6951245	0.935	rs61753396	chr7:1105372	A/G	cg18402987	chr7:1209562	NA	1.15	6.09	0.57	3.95e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs11892454	0.544	rs7599961	chr2:26006479	A/G	cg17263061	chr2:26915892	KCNK3	0.68	4.92	0.49	4.65e-6	Heschl's gyrus morphology;
SKCM	cis	rs589448	0.902	rs315124	chr12:69771727	G/A	cg20891283	chr12:69753455	YEATS4	0.98	9.91	0.75	1.85e-15	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs12586317	0.547	rs13379372	chr14:35483882	A/C	cg16230307	chr14:35515116	FAM177A1	0.81	5.88	0.55	9.47e-8	Psoriasis;
SKCM	cis	rs3820068	0.581	rs72645890	chr1:15930602	A/G	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs1451375	0.617	rs7790758	chr7:50561544	G/A	cg18232548	chr7:50535776	DDC	-0.76	-5.06	-0.5	2.7e-6	Malaria;
SKCM	cis	rs9435341	0.965	rs2335104	chr1:107583641	A/T	cg09367891	chr1:107599246	PRMT6	0.86	7.37	0.64	1.57e-10	Facial morphology (factor 21, depth of nasal alae);
SKCM	cis	rs76662990	1.000	rs10079756	chr5:73797377	A/C	cg01264639	chr5:73839484	NA	1.12	5.42	0.52	6.47e-7	Residual cognition;
SKCM	cis	rs7659604	0.702	rs58649165	chr4:122693752	C/A	cg20573242	chr4:122745356	CCNA2	0.75	6.57	0.6	5.07e-9	Type 2 diabetes;
SKCM	cis	rs2072499	0.966	rs1137703	chr1:156184458	T/C	cg24450063	chr1:156163899	SLC25A44	1.04	9.67	0.74	5.49e-15	Testicular germ cell tumor;
SKCM	cis	rs1669338	0.588	rs62228634	chr3:3184985	A/G	cg16797762	chr3:3221439	CRBN	-1.06	-5.9	-0.56	8.84e-8	White matter integrity;
SKCM	cis	rs9733	0.566	rs11204675	chr1:150570985	A/C	cg13175981	chr1:150552382	MCL1	0.74	6.35	0.58	1.3e-8	Tonsillectomy;
SKCM	cis	rs738322	0.935	rs4384	chr22:38572440	G/C	cg25457927	chr22:38595422	NA	-0.57	-6.85	-0.61	1.55e-9	Cutaneous nevi;
SKCM	cis	rs9381040	0.626	rs2272986	chr6:41037778	C/T	cg03644281	chr6:41068752	NFYA;LOC221442	-0.72	-4.81	-0.48	7.24e-6	Alzheimer's disease (late onset);
SKCM	cis	rs752010	0.905	rs4525030	chr1:42091307	G/C	cg06885757	chr1:42089581	HIVEP3	0.5	5.1	0.5	2.36e-6	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs12478296	1.000	rs55767645	chr2:242999350	G/A	cg06360820	chr2:242988706	NA	-1.05	-5.13	-0.5	2.04e-6	Obesity-related traits;
SKCM	cis	rs2559856	1.000	rs10778139	chr12:102083202	C/T	cg12924262	chr12:102091054	CHPT1	-0.73	-5.97	-0.56	6.63e-8	Blood protein levels;
SKCM	cis	rs28595532	0.925	rs116785973	chr4:119611350	G/A	cg11846333	chr4:119757529	SEC24D	1.15	6.24	0.58	2.13e-8	Cannabis dependence symptom count;
SKCM	cis	rs28595532	0.841	rs116452272	chr4:119770802	T/C	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs17213078	0.602	rs4851926	chr2:106742660	A/G	cg15412446	chr2:106886593	NA	0.69	5.92	0.56	8.17e-8	Facial morphology (factor 23);
SKCM	cis	rs769267	0.930	rs4808964	chr19:19603692	A/C	cg03709012	chr19:19516395	GATAD2A	-0.89	-8.62	-0.7	5.89e-13	Tonsillectomy;
SKCM	cis	rs2011503	0.882	rs10401714	chr19:19363630	G/A	cg11584989	chr19:19387371	SF4	0.78	5.16	0.5	1.85e-6	Bipolar disorder;
SKCM	cis	rs7829975	0.782	rs6990746	chr8:8547811	A/G	cg15556689	chr8:8085844	FLJ10661	-0.7	-5.74	-0.55	1.71e-7	Mood instability;
SKCM	cis	rs9467773	0.620	rs2504566	chr6:26660488	G/C	cg09904177	chr6:26538194	HMGN4	0.58	5.01	0.49	3.28e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs6724607	1.000	rs28452331	chr2:191471847	C/T	cg27211696	chr2:191398769	TMEM194B	-0.8	-6.55	-0.6	5.64e-9	Pulse pressure;
SKCM	cis	rs4727027	0.901	rs66800495	chr7:148763702	T/C	cg23583168	chr7:148888333	NA	-0.82	-6.51	-0.59	6.53e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs867186	1.000	rs76191812	chr20:33563911	G/A	cg04194272	chr20:33683537	NA	-1.37	-6.77	-0.61	2.18e-9	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs7811142	0.830	rs10085549	chr7:99983135	C/T	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.19	7.61	0.65	5.32e-11	Platelet count;
SKCM	cis	rs780096	0.546	rs35073769	chr2:27731376	C/T	cg05696406	chr2:27599888	SNX17	0.51	5.09	0.5	2.45e-6	Total body bone mineral density;
SKCM	cis	rs992157	0.644	rs6741757	chr2:219182748	T/C	cg00012203	chr2:219082015	ARPC2	0.73	5.42	0.52	6.48e-7	Colorectal cancer;
SKCM	cis	rs2050392	1.000	rs2480280	chr10:30696092	A/G	cg25182066	chr10:30743637	MAP3K8	-0.68	-5.76	-0.55	1.59e-7	Inflammatory bowel disease;
SKCM	cis	rs6866344	0.561	rs55974982	chr5:178141421	G/A	cg03877680	chr5:178157825	ZNF354A	0.91	7.37	0.64	1.54e-10	Neutrophil percentage of white cells;
SKCM	cis	rs1580019	0.563	rs34201720	chr7:32568935	G/A	cg06627557	chr7:32535165	LSM5;AVL9	0.94	9.12	0.72	6.39e-14	Cognitive ability;
SKCM	cis	rs9910055	0.747	rs2905981	chr17:42238625	C/T	cg13607699	chr17:42295918	UBTF	0.79	6.25	0.58	2.03e-8	Total body bone mineral density;
SKCM	cis	rs1183201	0.505	rs1165201	chr6:25874823	A/C	cg12310025	chr6:25882481	NA	-0.54	-5.27	-0.51	1.19e-6	Uric acid levels;
SKCM	cis	rs6500395	1.000	rs7206647	chr16:48709220	G/C	cg04672837	chr16:48644449	N4BP1	-0.63	-5.37	-0.52	8.01e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs7829975	0.755	rs3789849	chr8:8687054	G/C	cg06636001	chr8:8085503	FLJ10661	0.71	5.41	0.52	6.71e-7	Mood instability;
SKCM	cis	rs873946	0.648	rs3793673	chr10:134547732	A/C	cg27286337	chr10:134555280	INPP5A	0.92	8.33	0.69	2.15e-12	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs2070488	0.745	rs9838792	chr3:38546726	G/A	cg01465620	chr3:38496096	LOC100128640;ACVR2B	-0.74	-5.92	-0.56	8.05e-8	Electrocardiographic conduction measures;
SKCM	cis	rs514406	1.000	rs514406	chr1:53330458	A/G	cg16325326	chr1:53192061	ZYG11B	0.88	8.54	0.69	8.6e-13	Monocyte count;
SKCM	cis	rs2730245	0.527	rs62476462	chr7:158686619	A/G	cg24397884	chr7:158709396	WDR60	0.98	5.56	0.53	3.7e-7	Height;
SKCM	cis	rs4975616	0.843	rs6866783	chr5:1312020	T/C	cg06550200	chr5:1325588	CLPTM1L	0.7	5.21	0.51	1.48e-6	Lung cancer;
SKCM	cis	rs9393692	0.875	rs9358917	chr6:26284417	T/C	cg00631329	chr6:26305371	NA	-0.68	-4.93	-0.49	4.49e-6	Educational attainment;
SKCM	cis	rs2204008	0.837	rs11519926	chr12:38348992	G/A	cg26384229	chr12:38710491	ALG10B	0.87	6.82	0.61	1.73e-9	Bladder cancer;
SKCM	cis	rs362296	0.671	rs1006798	chr4:3258373	A/G	cg00764545	chr4:3318001	RGS12	-0.74	-6.48	-0.59	7.39e-9	Parental longevity (mother's age at death);
SKCM	cis	rs870825	0.616	rs28459754	chr4:185636280	C/A	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs9911578	0.817	rs304264	chr17:56749628	A/G	cg05425664	chr17:57184151	TRIM37	-0.66	-5.07	-0.5	2.61e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7359257	0.576	rs11638507	chr15:67874045	C/T	cg24247231	chr15:67904302	MAP2K5	-0.69	-5.76	-0.55	1.56e-7	Menarche (age at onset);
SKCM	cis	rs2204008	0.652	rs11520002	chr12:38022179	G/T	cg13010199	chr12:38710504	ALG10B	0.66	4.96	0.49	3.96e-6	Bladder cancer;
SKCM	cis	rs769267	0.930	rs1865034	chr19:19605763	C/T	cg26732615	chr19:19648335	CILP2;YJEFN3	0.67	7.06	0.62	6e-10	Tonsillectomy;
SKCM	cis	rs7584330	0.737	rs1390985	chr2:238367420	G/A	cg14458575	chr2:238380390	NA	0.88	6.21	0.57	2.43e-8	Prostate cancer;
SKCM	cis	rs10751667	0.643	rs10751669	chr11:942344	C/G	cg10932868	chr11:921992	NA	-0.54	-5.12	-0.5	2.17e-6	Alzheimer's disease (late onset);
SKCM	cis	rs8141529	0.764	rs5762854	chr22:29246278	T/C	cg15103426	chr22:29168792	CCDC117	0.63	5.38	0.52	7.6e-7	Lymphocyte counts;
SKCM	trans	rs11722228	0.549	rs56146302	chr4:10081052	C/T	cg26043149	chr18:55253948	FECH	0.93	7.98	0.67	1.02e-11	Gout;Urate levels;Serum uric acid levels;
SKCM	cis	rs12477438	0.520	rs2516827	chr2:99772565	C/T	cg26064155	chr2:99771622	LIPT1;TSGA10	1.02	9.73	0.74	4.23e-15	Chronic sinus infection;
SKCM	cis	rs10489202	0.632	rs202273	chr1:167919963	A/G	cg24449463	chr1:168025552	DCAF6	-0.77	-7.7	-0.66	3.54e-11	Schizophrenia;
SKCM	cis	rs2019137	0.560	rs10175462	chr2:113988492	G/A	cg11763394	chr2:113992921	PAX8;LOC440839;LOC654433	0.62	4.93	0.49	4.52e-6	Lymphocyte counts;
SKCM	cis	rs4820539	0.966	rs2301554	chr22:23484254	A/C	cg14186256	chr22:23484241	RTDR1	0.87	8.8	0.71	2.6e-13	Bone mineral density;
SKCM	cis	rs782590	0.967	rs1823893	chr2:55788921	T/C	cg18811423	chr2:55921094	PNPT1	0.84	6.59	0.6	4.8e-9	Metabolic syndrome;
SKCM	cis	rs6952808	0.595	rs3800917	chr7:2167939	A/G	cg21782813	chr7:2030301	MAD1L1	-0.55	-5.77	-0.55	1.5e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs1799949	1.000	rs34572725	chr17:41428666	G/A	cg23758822	chr17:41437982	NA	0.92	7.82	0.66	2.13e-11	Menopause (age at onset);
SKCM	cis	rs2066819	1.000	rs116535779	chr12:56739261	A/G	cg26714650	chr12:56694279	CS	-1.71	-6.71	-0.61	2.74e-9	Psoriasis vulgaris;
SKCM	cis	rs9796	0.689	rs9888710	chr15:41446153	G/C	cg18705301	chr15:41695430	NDUFAF1	-0.74	-5.35	-0.52	8.47e-7	Menopause (age at onset);
SKCM	cis	rs55962025	0.883	rs61792530	chr4:3145866	T/C	cg00764545	chr4:3318001	RGS12	-0.71	-5.89	-0.55	9.27e-8	Parental longevity (mother's age at death);
SKCM	cis	rs10504229	0.679	rs11783444	chr8:58131267	A/G	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs9325144	0.647	rs12231313	chr12:39101929	C/T	cg13010199	chr12:38710504	ALG10B	-0.64	-5.44	-0.52	6.02e-7	Morning vs. evening chronotype;
SKCM	cis	rs7589728	0.514	rs78204719	chr2:88460747	G/C	cg04511125	chr2:88470314	THNSL2	1.07	6.66	0.6	3.43e-9	Plasma clusterin levels;
SKCM	cis	rs6952808	0.771	rs10269191	chr7:1915731	A/G	cg21782813	chr7:2030301	MAD1L1	0.5	5.13	0.5	2.05e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs943437	0.877	rs633177	chr6:112272939	T/C	cg25325257	chr6:112272685	NA	-0.88	-4.78	-0.48	8.21e-6	Parkinson's disease;
SKCM	cis	rs9910055	0.659	rs2246287	chr17:42232442	C/G	cg09913183	chr17:42254507	C17orf65;ASB16	0.67	6.36	0.58	1.27e-8	Total body bone mineral density;
SKCM	cis	rs1568889	1.000	rs7937117	chr11:28370038	C/G	cg06544937	chr11:28130018	METT5D1;KIF18A	0.86	6.53	0.59	5.96e-9	Bipolar disorder;
SKCM	cis	rs9902453	0.845	rs2259855	chr17:28097860	T/C	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.78	-5.37	-0.52	7.89e-7	Coffee consumption (cups per day);
SKCM	cis	rs1577917	0.560	rs12193777	chr6:86246709	C/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.64	5.42	0.52	6.36e-7	Response to antipsychotic treatment;
SKCM	cis	rs28595532	0.920	rs115214765	chr4:119728167	C/T	cg21605333	chr4:119757512	SEC24D	1.36	8.05	0.67	7.69e-12	Cannabis dependence symptom count;
SKCM	cis	rs6430585	0.583	rs1435577	chr2:136624947	C/G	cg07169764	chr2:136633963	MCM6	1.31	13.05	0.83	2.59e-21	Corneal structure;
SKCM	cis	rs2952156	1.000	rs2934967	chr17:37870378	G/A	cg20243544	chr17:37824526	PNMT	0.69	5.57	0.53	3.53e-7	Asthma;
SKCM	cis	rs875971	1.000	rs6961990	chr7:65888570	C/A	cg18876405	chr7:65276391	NA	0.67	6.65	0.6	3.61e-9	Aortic root size;
SKCM	cis	rs9875589	0.509	rs2733556	chr3:14100172	A/T	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.52	5.22	0.51	1.44e-6	Ovarian reserve;
SKCM	cis	rs17376456	0.741	rs7718842	chr5:93480568	G/A	cg21475434	chr5:93447410	FAM172A	0.97	5.42	0.52	6.39e-7	Diabetic retinopathy;
SKCM	cis	rs1707322	1.000	rs785469	chr1:46521091	C/T	cg03146154	chr1:46216737	IPP	-0.77	-5.36	-0.52	8.35e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7829975	0.514	rs2976926	chr8:8261624	T/C	cg15556689	chr8:8085844	FLJ10661	0.68	5.81	0.55	1.28e-7	Mood instability;
SKCM	cis	rs7843479	0.562	rs11774629	chr8:21859315	C/T	cg17168535	chr8:21777572	XPO7	0.84	8.04	0.67	7.78e-12	Mean corpuscular volume;
SKCM	cis	rs9467773	0.935	rs1884947	chr6:26553273	G/T	cg15659132	chr6:26577336	NA	0.6	5.61	0.54	2.95e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs1878931	0.501	rs9921169	chr16:3421261	A/T	cg26668626	chr16:3451006	ZNF174;ZNF434	0.88	7.36	0.64	1.59e-10	Body mass index (adult);
SKCM	cis	rs208346	0.612	rs208356	chr7:2775825	A/T	cg19717773	chr7:2847554	GNA12	0.58	5.78	0.55	1.48e-7	Loneliness (linear analysis);
SKCM	cis	rs875971	1.000	rs7801282	chr7:65613687	C/T	cg18876405	chr7:65276391	NA	-0.68	-6.85	-0.61	1.54e-9	Aortic root size;
SKCM	cis	rs4665809	0.531	rs12987980	chr2:26462093	A/T	cg26119090	chr2:26468346	HADHA;HADHB	1.06	8.39	0.69	1.66e-12	Gut microbiome composition (summer);
SKCM	cis	rs4253772	0.591	rs6007727	chr22:46650959	G/A	cg03482458	chr22:46692211	CN5H6.4;GTSE1	1.11	4.96	0.49	4.03e-6	LDL cholesterol;Cholesterol, total;
SKCM	cis	rs6500395	1.000	rs1039340	chr16:48574637	A/C	cg04672837	chr16:48644449	N4BP1	0.69	5.6	0.54	3.1e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs7149337	0.869	rs7159770	chr14:51691835	G/A	cg23942311	chr14:51606299	NA	0.61	6.66	0.6	3.42e-9	Cancer;
SKCM	cis	rs7809950	1.000	rs2237677	chr7:107202502	A/C	cg23024343	chr7:107201750	COG5	-0.72	-6.55	-0.6	5.54e-9	Coronary artery disease;
SKCM	cis	rs7666738	0.753	rs7659724	chr4:98944063	C/T	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6952808	0.756	rs4719311	chr7:1881813	C/T	cg02951883	chr7:2050386	MAD1L1	-0.65	-4.89	-0.48	5.24e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs2243480	1.000	rs34529418	chr7:65403209	A/G	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs9814567	1.000	rs12490835	chr3:134223730	T/C	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.64	-4.96	-0.49	4.1e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs1529316	0.874	rs2554502	chr8:3825051	C/A	cg05999364	chr8:3269952	CSMD1	0.52	5.49	0.53	4.8e-7	Multiple sclerosis;
SKCM	cis	rs7618501	0.633	rs4688758	chr3:50028385	G/A	cg05072774	chr3:49840536	C3orf54	-0.67	-5.06	-0.5	2.73e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs847649	0.731	rs13222980	chr7:102703898	A/G	cg18108683	chr7:102477205	FBXL13	0.8	7.43	0.64	1.21e-10	Morning vs. evening chronotype;
SKCM	cis	rs10504229	0.683	rs16921819	chr8:58107936	G/T	cg02725872	chr8:58115012	NA	-0.53	-4.91	-0.49	4.82e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs7666738	0.830	rs11725652	chr4:98878362	G/A	cg17366294	chr4:99064904	C4orf37	0.57	4.84	0.48	6.52e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7296418	0.883	rs1727312	chr12:123642220	G/T	cg00376283	chr12:123451042	ABCB9	0.95	8.2	0.68	3.89e-12	Platelet count;
SKCM	cis	rs2836974	0.644	rs2836981	chr21:40688365	C/T	cg11644478	chr21:40555479	PSMG1	-0.66	-5.54	-0.53	3.87e-7	Cognitive function;
SKCM	cis	rs6951245	1.000	rs78185558	chr7:1090183	G/C	cg18402987	chr7:1209562	NA	1.14	6.01	0.56	5.68e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs67460515	0.563	rs11720263	chr3:160848293	T/C	cg03342759	chr3:160939853	NMD3	-0.72	-6.17	-0.57	2.79e-8	Parkinson's disease;
SKCM	cis	rs7772486	0.686	rs1415744	chr6:146022531	C/T	cg05347473	chr6:146136440	FBXO30	0.54	4.88	0.48	5.54e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs372883	0.600	rs1153276	chr21:30661694	T/C	cg24692254	chr21:30365293	RNF160	-0.7	-5.42	-0.52	6.49e-7	Pancreatic cancer;
SKCM	cis	rs7428	0.527	rs7608892	chr2:85542718	G/A	cg24342717	chr2:85555507	TGOLN2	-0.61	-4.78	-0.48	8.12e-6	Ear protrusion;
SKCM	cis	rs7937682	0.593	rs1944111	chr11:111364432	G/C	cg09085632	chr11:111637200	PPP2R1B	0.75	5.64	0.54	2.57e-7	Primary sclerosing cholangitis;
SKCM	cis	rs9399135	0.967	rs10872427	chr6:135353452	T/C	cg24558204	chr6:135376177	HBS1L	0.58	5.29	0.51	1.09e-6	Red blood cell count;
SKCM	cis	rs6500395	1.000	rs11640463	chr16:48644434	A/T	cg04672837	chr16:48644449	N4BP1	0.69	5.75	0.55	1.65e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs4132509	1.000	rs12116882	chr1:243959106	G/A	cg21452805	chr1:244014465	NA	0.87	5.16	0.5	1.81e-6	RR interval (heart rate);
SKCM	cis	rs4555082	0.915	rs66527719	chr14:105750523	C/G	cg13114125	chr14:105738426	BRF1	-0.73	-5.74	-0.55	1.7e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs2948294	0.588	rs4840913	chr8:8116906	A/C	cg15556689	chr8:8085844	FLJ10661	0.68	5.51	0.53	4.38e-7	Red cell distribution width;
SKCM	cis	rs908922	0.676	rs6587681	chr1:152512135	C/T	cg09873164	chr1:152488093	CRCT1	0.76	5.93	0.56	7.7e-8	Hair morphology;
SKCM	cis	rs10193935	0.901	rs6752455	chr2:42543577	A/C	cg27598129	chr2:42591480	NA	-0.89	-6.82	-0.61	1.74e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4150161	1.000	rs4150161	chr16:84214236	T/C	cg10106505	chr16:84220380	TAF1C	-1.14	-4.78	-0.48	7.95e-6	Systolic blood pressure response to hydrochlorothiazide in hypertension;
SKCM	cis	rs28595532	0.920	rs114462478	chr4:119752656	T/C	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs1707322	1.000	rs6657720	chr1:46386269	G/A	cg03146154	chr1:46216737	IPP	0.74	5.06	0.5	2.76e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs1218582	0.741	rs10908444	chr1:154840287	G/A	cg24250549	chr1:154909240	PMVK	0.89	9.39	0.73	1.86e-14	Prostate cancer;
SKCM	cis	rs2180341	0.782	rs4897214	chr6:127723625	G/T	cg27446573	chr6:127587934	RNF146	0.68	5.3	0.51	1.06e-6	Breast cancer;
SKCM	cis	rs6835098	0.924	rs12639929	chr4:174156538	C/T	cg08422745	chr4:174089978	GALNT7	-0.79	-5.9	-0.56	8.88e-8	Dementia and core Alzheimer's disease neuropathologic changes;
SKCM	cis	rs867186	1.000	rs35552264	chr20:33544973	A/T	cg04194272	chr20:33683537	NA	-1.37	-6.77	-0.61	2.18e-9	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs2032447	0.798	rs807214	chr6:26061769	G/C	cg18357526	chr6:26021779	HIST1H4A	0.85	7.35	0.64	1.68e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs860295	0.702	rs10908470	chr1:155527013	A/C	cg02153340	chr1:155202674	NA	-0.74	-5.75	-0.55	1.64e-7	Body mass index;
SKCM	cis	rs17826219	0.636	rs2449770	chr17:29101064	G/T	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Body mass index;
SKCM	cis	rs9916302	0.706	rs9908131	chr17:37520449	T/C	cg07936489	chr17:37558343	FBXL20	0.98	6.83	0.61	1.67e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs17361889	0.778	rs6963052	chr7:16211529	C/T	cg09714114	chr7:16439993	ISPD	0.51	4.88	0.48	5.58e-6	Pediatric bone mineral content (hip);
SKCM	cis	rs9325144	0.647	rs35254764	chr12:39102928	T/C	cg26384229	chr12:38710491	ALG10B	-0.72	-6.39	-0.59	1.12e-8	Morning vs. evening chronotype;
SKCM	cis	rs2019137	0.539	rs6755040	chr2:113981137	T/C	cg11763394	chr2:113992921	PAX8;LOC440839;LOC654433	0.63	5.03	0.49	3.11e-6	Lymphocyte counts;
SKCM	cis	rs17345786	0.798	rs9817043	chr3:101281852	A/G	cg11279151	chr3:101281821	RG9MTD1	-0.61	-4.94	-0.49	4.29e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4665809	0.590	rs6730317	chr2:26419482	C/T	cg26119090	chr2:26468346	HADHA;HADHB	-0.99	-7.2	-0.63	3.22e-10	Gut microbiome composition (summer);
SKCM	cis	rs67311347	0.544	rs6769627	chr3:40327845	G/A	cg00656387	chr3:40428638	ENTPD3	0.55	4.85	0.48	6.19e-6	Renal cell carcinoma;
SKCM	cis	rs7523050	0.643	rs7522324	chr1:109399644	T/C	cg08274380	chr1:109419600	GPSM2	1.13	5.57	0.53	3.54e-7	Fat distribution (HIV);
SKCM	cis	rs2777491	0.957	rs919961	chr15:41651721	A/G	cg18705301	chr15:41695430	NDUFAF1	-0.89	-9.03	-0.71	9.52e-14	Ulcerative colitis;
SKCM	cis	rs4853012	0.941	rs4852329	chr2:74354544	A/G	cg05890377	chr2:74357713	NA	0.6	5.02	0.49	3.19e-6	Gestational age at birth (maternal effect);
SKCM	cis	rs11148252	0.595	rs4884522	chr13:53053768	C/A	cg00495681	chr13:53174319	NA	0.6	4.92	0.49	4.62e-6	Lewy body disease;
SKCM	cis	rs7811142	1.000	rs73161759	chr7:100009994	T/C	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.33	0.69	2.11e-12	Platelet count;
SKCM	cis	rs763121	0.853	rs2413545	chr22:39092524	C/T	cg06022373	chr22:39101656	GTPBP1	0.78	5.59	0.53	3.27e-7	Menopause (age at onset);
SKCM	cis	rs2354432	0.891	rs2165743	chr1:146690319	C/T	cg25205988	chr1:146714368	CHD1L	1.25	7.96	0.67	1.14e-11	Mitochondrial DNA levels;
SKCM	cis	rs875971	1.000	rs6460296	chr7:65895139	C/T	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs826838	1.000	rs12366971	chr12:38737687	T/G	cg26384229	chr12:38710491	ALG10B	1.08	10.26	0.76	3.99e-16	Heart rate;
SKCM	cis	rs2032447	0.901	rs1540276	chr6:26028819	T/G	cg18357526	chr6:26021779	HIST1H4A	0.84	7.17	0.63	3.78e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs11098499	0.909	rs10014719	chr4:120320715	G/A	cg24375607	chr4:120327624	NA	0.65	4.97	0.49	3.87e-6	Corneal astigmatism;
SKCM	cis	rs875971	0.638	rs801216	chr7:66011667	T/C	cg18876405	chr7:65276391	NA	-0.8	-7.11	-0.63	4.86e-10	Aortic root size;
SKCM	cis	rs13040088	1.000	rs10854167	chr20:61533039	G/C	cg23096297	chr20:61557774	DIDO1	0.76	5.83	0.55	1.18e-7	Menopause (age at onset);
SKCM	cis	rs17376456	0.825	rs13164315	chr5:93147421	A/G	cg21475434	chr5:93447410	FAM172A	0.95	5.36	0.52	8.36e-7	Diabetic retinopathy;
SKCM	cis	rs7937682	0.924	rs564601	chr11:111594077	T/C	cg09085632	chr11:111637200	PPP2R1B	-1.12	-14.09	-0.85	3.9e-23	Primary sclerosing cholangitis;
SKCM	cis	rs66691851	0.504	rs863930	chr3:135949737	T/G	cg21827317	chr3:136751795	NA	0.65	5.3	0.51	1.03e-6	Neuroticism;Schizophrenia;
SKCM	cis	rs9309711	0.736	rs9309717	chr2:3495078	C/T	cg10845886	chr2:3471009	TTC15	0.82	5.52	0.53	4.25e-7	Neurofibrillary tangles;
SKCM	cis	rs6500395	1.000	rs3919552	chr16:48716328	C/T	cg04672837	chr16:48644449	N4BP1	-0.63	-5.37	-0.52	8.01e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs752010	0.695	rs10890155	chr1:42107843	C/T	cg06885757	chr1:42089581	HIVEP3	0.51	6.04	0.56	4.83e-8	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs11690935	0.959	rs11904009	chr2:172627343	T/G	cg13550731	chr2:172543902	DYNC1I2	-0.95	-8.21	-0.68	3.64e-12	Schizophrenia;
SKCM	cis	rs9583531	0.527	rs12875067	chr13:111365104	A/G	cg15841412	chr13:111365552	ING1	0.73	4.88	0.48	5.56e-6	Coronary artery disease;
SKCM	cis	rs2836974	0.583	rs9636957	chr21:40705847	G/A	cg11890956	chr21:40555474	PSMG1	-0.82	-7.57	-0.65	6.49e-11	Cognitive function;
SKCM	cis	rs9300255	0.602	rs1106240	chr12:123626982	C/T	cg00376283	chr12:123451042	ABCB9	0.77	5.2	0.51	1.59e-6	Neutrophil percentage of white cells;
SKCM	cis	rs6138458	1.000	rs6114984	chr20:24976610	A/G	cg26195577	chr20:24973756	C20orf3	1.29	8.85	0.71	2.07e-13	Blood protein levels;
SKCM	trans	rs4387258	0.539	rs551966	chr10:29474198	A/G	cg26514080	chr1:33239538	KIAA1522	-0.84	-7.45	-0.64	1.09e-10	Methotrexate phramacokinetics (acute lymphoblastic leukemia);
SKCM	cis	rs1405130	0.869	rs11693175	chr2:235569442	T/A	cg21542780	chr2:234763377	HJURP	-0.65	-4.92	-0.49	4.75e-6	Coronary artery disease;
SKCM	cis	rs28386778	0.897	rs5020097	chr17:61814198	G/C	cg01411255	chr17:61851458	DDX42;CCDC47	0.81	4.96	0.49	3.98e-6	Prudent dietary pattern;
SKCM	cis	rs17376456	0.569	rs7702348	chr5:93065683	A/G	cg25358565	chr5:93447407	FAM172A	-0.95	-6.44	-0.59	9.13e-9	Diabetic retinopathy;
SKCM	cis	rs898097	0.841	rs11656358	chr17:80853956	G/A	cg15369054	chr17:80825471	TBCD	0.68	6.38	0.59	1.17e-8	Breast cancer;
SKCM	cis	rs11673344	0.704	rs571340	chr19:37424883	C/T	cg07624650	chr19:37064219	ZNF529	-0.79	-5.16	-0.5	1.82e-6	Obesity-related traits;
SKCM	cis	rs1355223	0.583	rs1553757	chr11:34867089	G/A	cg11058730	chr11:34937778	PDHX;APIP	0.59	4.77	0.47	8.55e-6	Systemic lupus erythematosus and Systemic sclerosis;
SKCM	cis	rs561341	1.000	rs546519	chr17:30297682	T/G	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs478304	0.654	rs10896034	chr11:65460783	T/A	cg27068330	chr11:65405492	SIPA1	-0.89	-7.62	-0.65	5.13e-11	Acne (severe);
SKCM	cis	rs9814567	1.000	rs6766818	chr3:134226159	C/T	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.59	-4.77	-0.48	8.36e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs6933660	0.646	rs3816778	chr6:151773353	G/C	cg10883421	chr6:151773342	RMND1;C6orf211	0.87	7.73	0.66	3.17e-11	Menarche (age at onset);
SKCM	cis	rs9926296	0.585	rs6500441	chr16:89828669	C/G	cg27121462	chr16:89883253	FANCA	0.83	7.93	0.67	1.31e-11	Vitiligo;
SKCM	cis	rs17376456	0.877	rs56373208	chr5:93491276	C/A	cg21475434	chr5:93447410	FAM172A	0.99	5.62	0.54	2.81e-7	Diabetic retinopathy;
SKCM	cis	rs8072100	0.807	rs4561509	chr17:45781799	G/A	cg08085267	chr17:45401833	C17orf57	-0.6	-5.06	-0.5	2.74e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs2228479	0.557	rs11648881	chr16:89862434	T/C	cg00800038	chr16:89945340	TCF25	-0.94	-4.77	-0.48	8.39e-6	Skin colour saturation;
SKCM	cis	rs10504073	0.647	rs12546839	chr8:50009020	C/T	cg00325661	chr8:49890786	NA	0.79	6.79	0.61	1.99e-9	Blood metabolite ratios;
SKCM	cis	rs77106637	0.929	rs1059000	chr11:72504972	G/C	cg03713592	chr11:72463424	ARAP1	1.07	5.61	0.54	2.94e-7	Type 2 diabetes;
SKCM	cis	rs2836974	0.931	rs2776309	chr21:40715791	A/G	cg11890956	chr21:40555474	PSMG1	0.95	9.76	0.74	3.69e-15	Cognitive function;
SKCM	cis	rs34172651	0.517	rs8059004	chr16:24837905	G/A	cg00339695	chr16:24857497	SLC5A11	0.78	6.12	0.57	3.51e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs9911578	0.839	rs56360354	chr17:57202927	A/G	cg05425664	chr17:57184151	TRIM37	-0.77	-6.13	-0.57	3.37e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs9815354	0.812	rs60796012	chr3:41908668	T/C	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs12709013	0.792	rs12325054	chr16:58783708	C/T	cg02431531	chr16:59244939	NA	0.49	5.16	0.5	1.85e-6	Blood metabolite ratios;
SKCM	cis	rs10504073	0.669	rs341801	chr8:50037784	A/G	cg00325661	chr8:49890786	NA	0.8	6.91	0.62	1.16e-9	Blood metabolite ratios;
SKCM	cis	rs55962025	0.883	rs59613878	chr4:3139152	C/T	cg05297308	chr4:3317976	RGS12	-0.77	-5.74	-0.54	1.76e-7	Parental longevity (mother's age at death);
SKCM	cis	rs9633740	1.000	rs7910643	chr10:82251769	G/A	cg01528321	chr10:82214614	TSPAN14	0.85	6.72	0.61	2.73e-9	Post bronchodilator FEV1;
SKCM	cis	rs2180341	0.566	rs982306	chr6:127777039	T/C	cg27446573	chr6:127587934	RNF146	0.78	6.34	0.58	1.37e-8	Breast cancer;
SKCM	cis	rs4665809	0.627	rs13032756	chr2:26489730	A/T	cg26119090	chr2:26468346	HADHA;HADHB	1.05	8.22	0.68	3.6e-12	Gut microbiome composition (summer);
SKCM	cis	rs362272	0.545	rs2749783	chr4:3326098	A/C	cg16987761	chr4:3318072	RGS12	0.97	10.89	0.78	2.49e-17	Serum sulfate level;
SKCM	cis	rs2153535	0.580	rs1335637	chr6:8465101	A/G	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs1949733	0.666	rs3103070	chr4:8508825	A/G	cg11789530	chr4:8429930	ACOX3	-0.67	-4.9	-0.49	5.03e-6	Response to antineoplastic agents;
SKCM	cis	rs826838	1.000	rs11168367	chr12:38913397	T/G	cg13010199	chr12:38710504	ALG10B	0.84	6.66	0.6	3.54e-9	Heart rate;
SKCM	cis	rs4481887	0.927	rs4279879	chr1:248486475	A/G	cg00666640	chr1:248458726	OR2T12	0.62	5.27	0.51	1.2e-6	Common traits (Other);
SKCM	cis	rs2228479	0.867	rs34604714	chr16:89948985	A/G	cg00800038	chr16:89945340	TCF25	-0.93	-5.34	-0.52	8.73e-7	Skin colour saturation;
SKCM	cis	rs992157	0.775	rs1877714	chr2:219134928	A/G	cg20019365	chr2:219134978	PNKD;AAMP	-0.74	-6.22	-0.58	2.28e-8	Colorectal cancer;
SKCM	cis	rs875971	0.737	rs7803424	chr7:65880605	T/C	cg18876405	chr7:65276391	NA	0.67	6.65	0.6	3.61e-9	Aortic root size;
SKCM	cis	rs10504229	1.000	rs57624567	chr8:58176995	T/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs11098499	0.535	rs10005542	chr4:120268302	T/C	cg09307838	chr4:120376055	NA	0.96	8.24	0.68	3.19e-12	Corneal astigmatism;
SKCM	cis	rs9796	0.689	rs9888718	chr15:41446254	T/G	cg18705301	chr15:41695430	NDUFAF1	-0.76	-5.58	-0.53	3.31e-7	Menopause (age at onset);
SKCM	cis	rs704	0.605	rs2227736	chr17:26693231	G/C	cg27392559	chr17:27410759	MYO18A	-0.54	-5.0	-0.49	3.44e-6	Osteoprotegerin levels;
SKCM	cis	rs8072100	0.967	rs4794001	chr17:45720849	T/C	cg25173405	chr17:45401733	C17orf57	-0.57	-5.13	-0.5	2.07e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs561341	0.883	rs1034626	chr17:30219500	C/G	cg00745463	chr17:30367425	LRRC37B	0.98	6.28	0.58	1.8e-8	Hip circumference adjusted for BMI;
SKCM	cis	rs9814567	0.964	rs9847788	chr3:134186496	A/C	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.66	-5.51	-0.53	4.53e-7	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs769267	0.930	rs3794993	chr19:19611550	G/T	cg03709012	chr19:19516395	GATAD2A	0.89	8.62	0.7	5.89e-13	Tonsillectomy;
SKCM	cis	rs12142240	0.667	rs66990604	chr1:46822073	G/A	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs6951245	1.000	rs78523927	chr7:1089458	T/C	cg24642844	chr7:1081250	C7orf50	-0.94	-6.32	-0.58	1.48e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7103648	0.932	rs7104036	chr11:47462140	A/G	cg20307385	chr11:47447363	PSMC3	1.08	9.26	0.72	3.38e-14	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs2836974	0.897	rs2836928	chr21:40543320	C/T	cg11644478	chr21:40555479	PSMG1	0.97	10.21	0.76	5.08e-16	Cognitive function;
SKCM	cis	rs56235845	0.694	rs11748912	chr5:176765395	G/A	cg16006841	chr5:176797999	RGS14	0.68	6.32	0.58	1.48e-8	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs5769765	1.000	rs2295408	chr22:50261051	A/G	cg22709217	chr22:50311962	ALG12;CRELD2	0.79	5.71	0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs2836974	0.836	rs8129355	chr21:40579869	A/G	cg17971929	chr21:40555470	PSMG1	0.9	8.81	0.71	2.52e-13	Cognitive function;
SKCM	cis	rs12188164	0.965	rs72717415	chr5:430059	G/A	cg26076054	chr5:421317	AHRR	-0.61	-4.8	-0.48	7.47e-6	Cystic fibrosis severity;
SKCM	cis	rs2777491	0.957	rs7181911	chr15:41674060	T/C	cg18705301	chr15:41695430	NDUFAF1	-0.92	-9.69	-0.74	5.02e-15	Ulcerative colitis;
SKCM	cis	rs6879260	1.000	rs888922	chr5:179731635	C/G	cg13944838	chr5:179740914	GFPT2	-0.65	-5.44	-0.52	6.05e-7	Height;
SKCM	cis	rs11690935	1.000	rs3795999	chr2:172544483	A/G	cg13550731	chr2:172543902	DYNC1I2	0.95	8.21	0.68	3.64e-12	Schizophrenia;
SKCM	cis	rs73201462	1.000	rs2999090	chr3:127931340	A/G	cg09089421	chr3:127803668	RUVBL1	1.0	5.11	0.5	2.22e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs1577917	0.771	rs2842608	chr6:86295858	C/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.79	-7.29	-0.64	2.22e-10	Response to antipsychotic treatment;
SKCM	cis	rs34779708	0.966	rs12782948	chr10:35450607	G/A	cg03585969	chr10:35415529	CREM	0.75	5.91	0.56	8.6e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs1451375	0.572	rs4948205	chr7:50557774	G/A	cg18232548	chr7:50535776	DDC	-0.7	-4.85	-0.48	6.24e-6	Malaria;
SKCM	cis	rs10089	0.953	rs3805615	chr5:127519049	A/G	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.87	7.69	0.66	3.82e-11	Ileal carcinoids;
SKCM	cis	rs62103177	0.608	rs34383580	chr18:77833263	A/G	cg27393146	chr18:77495563	CTDP1	0.85	5.67	0.54	2.3e-7	Opioid sensitivity;
SKCM	cis	rs501916	0.605	rs2118917	chr15:48078992	C/T	cg16110827	chr15:48056943	SEMA6D	-0.62	-4.79	-0.48	7.7e-6	Inflammatory bowel disease;Ulcerative colitis;
SKCM	cis	rs4423214	1.000	rs4944062	chr11:71187294	G/T	cg05163923	chr11:71159392	DHCR7	0.81	7.55	0.65	6.83e-11	Vitamin D levels;
SKCM	cis	rs4253772	0.591	rs6007732	chr22:46652303	A/T	cg03482458	chr22:46692211	CN5H6.4;GTSE1	1.13	5.41	0.52	6.8e-7	LDL cholesterol;Cholesterol, total;
SKCM	cis	rs763121	0.925	rs1056661	chr22:39080245	A/G	cg06022373	chr22:39101656	GTPBP1	0.8	6.32	0.58	1.52e-8	Menopause (age at onset);
SKCM	cis	rs9926296	0.572	rs2376878	chr16:89885161	G/A	cg01097406	chr16:89675127	NA	-0.46	-5.64	-0.54	2.61e-7	Vitiligo;
SKCM	cis	rs9325144	0.671	rs12818797	chr12:39019409	A/G	cg26384229	chr12:38710491	ALG10B	-0.73	-6.63	-0.6	3.88e-9	Morning vs. evening chronotype;
SKCM	cis	rs4332037	0.539	rs62444881	chr7:2052318	C/T	cg02825527	chr7:2087843	MAD1L1	-0.74	-5.03	-0.49	3.09e-6	Bipolar disorder;
SKCM	cis	rs10905065	0.965	rs10795520	chr10:5764160	G/A	cg11519256	chr10:5708881	ASB13	0.6	5.47	0.53	5.23e-7	Menopause (age at onset);
SKCM	cis	rs6951245	0.872	rs77569514	chr7:1085508	G/A	cg18402987	chr7:1209562	NA	1.14	6.01	0.56	5.68e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs875971	0.545	rs10950027	chr7:65634151	C/T	cg18876405	chr7:65276391	NA	0.64	5.29	0.51	1.09e-6	Aortic root size;
SKCM	cis	rs72781680	1.000	rs963725	chr2:24148231	T/C	cg08917208	chr2:24149416	ATAD2B	1.02	5.84	0.55	1.16e-7	Lymphocyte counts;
SKCM	cis	rs2243480	1.000	rs6964245	chr7:65718717	G/A	cg18252515	chr7:66147081	NA	1.36	8.11	0.68	5.66e-12	Diabetic kidney disease;
SKCM	cis	rs6809651	0.524	rs10937240	chr3:185802823	C/T	cg00760338	chr3:185826511	ETV5	-0.9	-5.81	-0.55	1.32e-7	Body mass index in physically active individuals;Glomerular filtration rate (creatinine);Body mass index (joint analysis main effects and physical activity interaction);Body mass index;Body mass index in physically inactive individuals;
SKCM	cis	rs8060686	0.641	rs12446007	chr16:68189054	C/T	cg09117114	chr16:67998030	SLC12A4	-0.76	-4.93	-0.49	4.58e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs362296	0.661	rs3095078	chr4:3265479	C/T	cg24015175	chr4:3319247	RGS12	-0.56	-5.18	-0.51	1.68e-6	Parental longevity (mother's age at death);
SKCM	cis	rs3785574	0.962	rs35448669	chr17:61938923	G/A	cg01411255	chr17:61851458	DDX42;CCDC47	1.15	12.64	0.82	1.42e-20	Height;
SKCM	cis	rs9815354	0.812	rs113772069	chr3:41933389	T/C	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs736408	0.608	rs4687657	chr3:52852538	G/T	cg11645453	chr3:52864694	ITIH4	0.74	6.69	0.6	3.06e-9	Bipolar disorder;
SKCM	cis	rs13108904	0.557	rs1680033	chr4:1243404	C/T	cg05025164	chr4:1340916	KIAA1530	-0.66	-5.32	-0.52	9.77e-7	Obesity-related traits;
SKCM	cis	rs17685	0.725	rs2302436	chr7:75676988	A/T	cg01364799	chr7:75623366	TMEM120A	0.72	5.83	0.55	1.18e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs9611565	0.729	rs132902	chr22:41797758	A/G	cg03806693	chr22:41940476	POLR3H	-1.03	-6.96	-0.62	9.33e-10	Vitiligo;
SKCM	cis	rs155076	1.000	rs261432	chr13:21865915	G/C	cg14456004	chr13:21872349	NA	-1.28	-7.48	-0.65	9.62e-11	White matter hyperintensity burden;
SKCM	cis	rs1413885	0.548	rs6588136	chr1:65837119	C/G	cg14976592	chr1:65886160	LEPROT;LEPR	0.62	5.25	0.51	1.28e-6	Anticoagulant levels;
SKCM	cis	rs11098499	0.908	rs9995234	chr4:120321827	A/G	cg09307838	chr4:120376055	NA	0.99	7.95	0.67	1.17e-11	Corneal astigmatism;
SKCM	cis	rs11098499	0.564	rs11098507	chr4:120288286	G/A	cg09307838	chr4:120376055	NA	0.98	7.89	0.67	1.52e-11	Corneal astigmatism;
SKCM	cis	rs1799949	0.965	rs8176322	chr17:41195773	A/G	cg05368731	chr17:41323189	NBR1	0.9	7.94	0.67	1.23e-11	Menopause (age at onset);
SKCM	cis	rs11112613	0.762	rs73184078	chr12:105950017	A/G	cg03607813	chr12:105948248	NA	0.83	5.77	0.55	1.55e-7	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;
SKCM	cis	rs9902453	0.967	rs12602065	chr17:28482488	A/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.5	0.53	4.74e-7	Coffee consumption (cups per day);
SKCM	cis	rs854765	0.547	rs2955378	chr17:17930253	G/A	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.02	9.54	0.73	9.55e-15	Total body bone mineral density;
SKCM	cis	rs6500395	1.000	rs9938308	chr16:48607229	A/G	cg04672837	chr16:48644449	N4BP1	0.67	5.57	0.53	3.49e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs56235845	0.694	rs11748912	chr5:176765395	G/A	cg17509989	chr5:176798049	RGS14	0.69	5.7	0.54	2.06e-7	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs875971	0.660	rs2013222	chr7:66035936	C/G	cg18876405	chr7:65276391	NA	-0.8	-7.11	-0.63	4.86e-10	Aortic root size;
SKCM	cis	rs4819052	0.851	rs13052344	chr21:46676101	C/T	cg20896738	chr21:46707857	POFUT2;LOC642852	0.64	4.82	0.48	6.85e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs796364	0.906	rs281789	chr2:200780698	T/G	cg12253985	chr2:200820533	C2orf60;C2orf47	0.85	5.39	0.52	7.18e-7	Schizophrenia;
SKCM	cis	rs3845702	0.866	rs818659	chr2:180870893	G/A	cg01881094	chr2:180872142	CWC22	1.06	5.68	0.54	2.19e-7	Schizophrenia;
SKCM	cis	rs4819052	1.000	rs13047688	chr21:46669290	G/A	cg02159808	chr21:46707872	POFUT2;LOC642852	0.79	5.87	0.55	9.97e-8	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs9399135	0.967	rs9373122	chr6:135373534	G/A	cg24558204	chr6:135376177	HBS1L	0.58	5.05	0.5	2.86e-6	Red blood cell count;
SKCM	cis	rs55962025	0.737	rs7685686	chr4:3207142	A/G	cg00764545	chr4:3318001	RGS12	-0.6	-5.25	-0.51	1.27e-6	Parental longevity (mother's age at death);
SKCM	cis	rs10489202	0.632	rs413168	chr1:168005789	C/G	cg24449463	chr1:168025552	DCAF6	-0.8	-7.72	-0.66	3.27e-11	Schizophrenia;
SKCM	cis	rs9815354	0.812	rs73071236	chr3:41992042	A/G	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs6500395	1.000	rs1558817	chr16:48730722	G/A	cg04672837	chr16:48644449	N4BP1	0.63	5.3	0.51	1.03e-6	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs1692580	0.807	rs12138597	chr1:2189477	T/C	cg24578937	chr1:2090814	PRKCZ	0.47	5.16	0.5	1.81e-6	Coronary artery disease;
SKCM	cis	rs637571	0.522	rs606978	chr11:65711517	A/C	cg02427764	chr11:65769310	BANF1;EIF1AD	0.79	6.31	0.58	1.55e-8	Eosinophil percentage of white cells;
SKCM	cis	rs9368481	0.646	rs75843621	chr6:26967881	G/A	cg12292205	chr6:26970375	C6orf41	-0.71	-6.4	-0.59	1.05e-8	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs9790314	0.779	rs1599374	chr3:160891727	G/A	cg03342759	chr3:160939853	NMD3	-0.63	-6.48	-0.59	7.45e-9	Morning vs. evening chronotype;
SKCM	cis	rs4268898	0.662	rs2303292	chr2:24432138	C/T	cg06627628	chr2:24431161	ITSN2	-0.92	-7.12	-0.63	4.73e-10	Asthma;
SKCM	cis	rs7937682	0.883	rs631490	chr11:111452040	G/C	cg22437258	chr11:111473054	SIK2	0.62	4.79	0.48	7.93e-6	Primary sclerosing cholangitis;
SKCM	cis	rs2050392	0.517	rs602966	chr10:30755853	C/T	cg25182066	chr10:30743637	MAP3K8	-0.66	-6.03	-0.56	5.17e-8	Inflammatory bowel disease;
SKCM	cis	rs2354432	0.607	rs12404113	chr1:146750343	C/A	cg25205988	chr1:146714368	CHD1L	-1.17	-6.52	-0.59	6.27e-9	Mitochondrial DNA levels;
SKCM	cis	rs10504229	0.683	rs17194487	chr8:58104912	C/T	cg02725872	chr8:58115012	NA	-0.53	-4.91	-0.49	4.82e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs2243480	1.000	rs7804223	chr7:65664559	T/G	cg18252515	chr7:66147081	NA	1.36	8.16	0.68	4.6e-12	Diabetic kidney disease;
SKCM	cis	rs5753618	0.583	rs5749270	chr22:31812853	C/T	cg02404636	chr22:31891804	SFI1	0.59	5.11	0.5	2.2e-6	Colorectal cancer;
SKCM	cis	rs62064224	0.703	rs62065492	chr17:30822607	C/T	cg25809561	chr17:30822961	MYO1D	0.68	5.9	0.56	8.72e-8	Schizophrenia;
SKCM	cis	rs6089584	0.821	rs2273990	chr20:60579149	G/T	cg06108461	chr20:60628389	TAF4	-0.89	-8.18	-0.68	4.28e-12	Body mass index;
SKCM	cis	rs17270561	0.562	rs12199626	chr6:26013604	G/A	cg10373733	chr6:25993375	NA	0.86	5.44	0.52	5.97e-7	Iron status biomarkers;
SKCM	cis	rs1552244	0.882	rs3846168	chr3:9996925	C/T	cg02579736	chr3:10068473	FANCD2;CIDECP	0.98	4.84	0.48	6.48e-6	Alzheimer's disease;
SKCM	cis	rs2839186	0.739	rs7282763	chr21:47696800	C/T	cg13126279	chr21:47581558	C21orf56	-0.62	-5.23	-0.51	1.4e-6	Testicular germ cell tumor;
SKCM	cis	rs58688157	0.705	rs7928902	chr11:609068	G/A	cg03576123	chr11:487126	PTDSS2	-0.8	-5.15	-0.5	1.88e-6	Systemic lupus erythematosus;
SKCM	cis	rs7666738	0.830	rs11944107	chr4:98931638	G/C	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs701145	0.585	rs2689330	chr3:153929990	T/C	cg17054900	chr3:154042577	DHX36	1.19	5.1	0.5	2.37e-6	Coronary artery disease;
SKCM	cis	rs2836950	0.565	rs2836930	chr21:40545656	A/G	cg11890956	chr21:40555474	PSMG1	-0.7	-5.62	-0.54	2.84e-7	Menarche (age at onset);
SKCM	cis	rs5995756	0.736	rs8140185	chr22:40010806	A/G	cg10455938	chr22:40058150	CACNA1I	0.6	5.2	0.51	1.58e-6	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs10504229	0.906	rs2270609	chr8:58194684	G/A	cg02725872	chr8:58115012	NA	-0.53	-4.8	-0.48	7.46e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs514406	0.929	rs485631	chr1:53330245	A/G	cg16325326	chr1:53192061	ZYG11B	0.95	10.08	0.75	8.91e-16	Monocyte count;
SKCM	cis	rs870825	0.616	rs61653735	chr4:185630025	G/A	cg04058563	chr4:185651563	MLF1IP	1.08	7.26	0.64	2.51e-10	Blood protein levels;
SKCM	cis	rs3540	0.597	rs10152221	chr15:91047664	A/G	cg22089800	chr15:90895588	ZNF774	-0.68	-4.92	-0.49	4.72e-6	Allergic disease (asthma, hay fever or eczema);Lymphocyte counts;
SKCM	cis	rs2839186	0.739	rs2280958	chr21:47642016	C/T	cg11766577	chr21:47581405	C21orf56	-0.73	-6.37	-0.58	1.24e-8	Testicular germ cell tumor;
SKCM	trans	rs11722228	0.508	rs73212864	chr4:10104191	G/A	cg26043149	chr18:55253948	FECH	0.92	7.78	0.66	2.48e-11	Gout;Urate levels;Serum uric acid levels;
SKCM	cis	rs7937682	0.889	rs484013	chr11:111495779	G/A	cg09085632	chr11:111637200	PPP2R1B	-0.98	-10.09	-0.75	8.61e-16	Primary sclerosing cholangitis;
SKCM	cis	rs28785552	0.589	rs11669056	chr19:53244443	G/A	cg10871876	chr19:53194124	ZNF83	0.94	6.85	0.61	1.55e-9	Response to paliperidone in schizophrenia (PANSS score);
SKCM	cis	rs951366	0.844	rs823096	chr1:205679887	G/T	cg14893161	chr1:205819251	PM20D1	0.95	8.24	0.68	3.26e-12	Menarche (age at onset);
SKCM	cis	rs34172651	0.517	rs12927710	chr16:24790282	A/C	cg06028605	chr16:24865363	SLC5A11	0.59	4.98	0.49	3.66e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs501120	1.000	rs504799	chr10:44753456	C/T	cg09554077	chr10:44749378	NA	0.38	4.93	0.49	4.52e-6	Coronary artery disease;Coronary heart disease;
SKCM	cis	rs7772486	0.875	rs2814866	chr6:146339414	C/A	cg23711669	chr6:146136114	FBXO30	0.77	7.16	0.63	3.9e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs17683430	0.702	rs117079807	chr22:32407021	A/G	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	GIP levels in response to oral glucose tolerance test (120 minutes);
SKCM	cis	rs16866061	1.000	rs72974238	chr2:225432470	C/A	cg12698349	chr2:225449008	CUL3	1.01	8.51	0.69	9.75e-13	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs1957429	0.808	rs1570296	chr14:65332294	T/A	cg23373153	chr14:65346875	NA	1.22	6.35	0.58	1.3e-8	Pediatric areal bone mineral density (radius);
SKCM	cis	rs151997	1.000	rs27284	chr5:50198086	A/G	cg06027927	chr5:50259733	NA	0.66	5.78	0.55	1.45e-7	Callous-unemotional behaviour;
SKCM	cis	rs732765	0.734	rs12892937	chr14:75168927	C/T	cg25946216	chr14:74253857	C14orf43	-0.79	-5.06	-0.5	2.71e-6	Non-small cell lung cancer;
SKCM	cis	rs9300255	0.722	rs11830103	chr12:123823546	A/G	cg00376283	chr12:123451042	ABCB9	-0.78	-5.26	-0.51	1.24e-6	Neutrophil percentage of white cells;
SKCM	cis	rs2354432	0.556	rs12568866	chr1:146718430	A/C	cg25205988	chr1:146714368	CHD1L	-1.19	-6.56	-0.6	5.34e-9	Mitochondrial DNA levels;
SKCM	cis	rs611744	0.647	rs579162	chr8:109254842	A/G	cg18478394	chr8:109455254	TTC35	0.66	5.33	0.52	9.43e-7	Dupuytren's disease;
SKCM	cis	rs6570726	0.693	rs450921	chr6:145864260	C/T	cg23711669	chr6:146136114	FBXO30	0.84	8.8	0.71	2.65e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs17711722	0.727	rs35850374	chr7:65357776	A/G	cg11987759	chr7:65425863	GUSB	-0.75	-6.42	-0.59	9.94e-9	Calcium levels;
SKCM	cis	rs7666738	0.791	rs7678564	chr4:99057341	A/G	cg05340658	chr4:99064831	C4orf37	0.66	4.87	0.48	5.74e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs733592	0.524	rs10875726	chr12:48425992	A/G	cg24011408	chr12:48396354	COL2A1	-0.66	-4.92	-0.49	4.68e-6	Plateletcrit;
SKCM	cis	rs2357013	0.752	rs12474925	chr2:53176117	C/A	cg07782112	chr2:53107842	NA	-0.6	-5.88	-0.55	9.64e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs908922	0.676	rs498184	chr1:152501423	G/C	cg09873164	chr1:152488093	CRCT1	0.78	6.09	0.57	4.03e-8	Hair morphology;
SKCM	cis	rs514406	0.661	rs550561	chr1:53375134	C/T	cg08859206	chr1:53392774	SCP2	-0.63	-5.32	-0.52	9.59e-7	Monocyte count;
SKCM	cis	rs1552244	1.000	rs35220123	chr3:10083169	C/T	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs16866061	1.000	rs72974263	chr2:225447371	C/T	cg12698349	chr2:225449008	CUL3	1.02	8.59	0.7	6.79e-13	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs1029738	0.615	rs3757447	chr7:22894735	A/T	cg00626422	chr7:22894849	SNORD93	-0.61	-5.28	-0.51	1.14e-6	Fibrinogen levels;
SKCM	cis	rs2032447	0.575	rs198847	chr6:26106619	C/A	cg03517284	chr6:25882590	NA	0.58	4.94	0.49	4.44e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs55962025	0.551	rs362296	chr4:3247007	C/A	cg09735869	chr4:3319127	RGS12	-0.64	-5.02	-0.49	3.18e-6	Parental longevity (mother's age at death);
SKCM	cis	rs2439831	0.681	rs1549525	chr15:43627855	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.17	8.81	0.71	2.55e-13	Lung cancer in ever smokers;
SKCM	cis	rs34779708	0.966	rs57081218	chr10:35434608	A/G	cg03585969	chr10:35415529	CREM	0.77	6.24	0.58	2.12e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs8103278	1.000	rs8102876	chr19:46332842	C/T	cg11657440	chr19:46296263	DMWD	-0.9	-6.05	-0.56	4.8e-8	Coronary artery disease;
SKCM	cis	rs13118159	0.550	rs4974612	chr4:1364543	A/G	cg19318889	chr4:1322082	MAEA	0.78	5.57	0.53	3.53e-7	Longevity;
SKCM	cis	rs4819052	0.851	rs1056101	chr21:46678702	C/G	cg20896738	chr21:46707857	POFUT2;LOC642852	0.67	5.04	0.5	2.93e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs11640734	0.619	rs2293586	chr16:89962394	A/G	cg00800038	chr16:89945340	TCF25	-0.93	-5.57	-0.53	3.49e-7	Interleukin-17 levels;
SKCM	cis	rs1401999	0.898	rs9876143	chr3:183731362	C/G	cg01324343	chr3:183735012	ABCC5	0.88	10.48	0.76	1.5e-16	Anterior chamber depth;
SKCM	cis	rs9399137	0.507	rs7772031	chr6:135259734	G/A	cg24558204	chr6:135376177	HBS1L	-0.67	-6.12	-0.57	3.51e-8	Glycated hemoglobin levels;Mean corpuscular volume;Hematology traits;HbA2 levels;Mean corpuscular hemoglobin;Hemoglobin levels;F-cell distribution;Platelet count;
SKCM	cis	rs9430161	0.645	rs6675082	chr1:11033797	T/C	cg02454025	chr1:11042201	C1orf127	1.08	10.13	0.75	7.19e-16	Ewing sarcoma;
SKCM	cis	rs7829975	0.514	rs2945873	chr8:8260445	C/T	cg15556689	chr8:8085844	FLJ10661	0.69	5.78	0.55	1.46e-7	Mood instability;
SKCM	cis	rs1577917	0.916	rs12198730	chr6:86555138	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.68	-5.91	-0.56	8.36e-8	Response to antipsychotic treatment;
SKCM	cis	rs10779751	0.727	rs4845852	chr1:11233559	C/T	cg08854313	chr1:11322531	MTOR	0.92	7.13	0.63	4.38e-10	Body mass index;
SKCM	cis	rs6951245	1.000	rs78185558	chr7:1090183	G/C	cg03188948	chr7:1209495	NA	1.12	6.25	0.58	2.02e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs28595532	0.920	rs55901549	chr4:119770172	T/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs12134245	0.776	rs13447464	chr1:91968278	G/A	cg25838465	chr1:92012736	NA	-0.83	-8.8	-0.71	2.59e-13	Breast cancer;
SKCM	cis	rs11690935	0.632	rs6433323	chr2:172873060	A/G	cg13550731	chr2:172543902	DYNC1I2	-0.64	-5.53	-0.53	4.05e-7	Schizophrenia;
SKCM	cis	rs9325144	0.555	rs6582607	chr12:38717678	T/C	cg26384229	chr12:38710491	ALG10B	-0.76	-6.4	-0.59	1.05e-8	Morning vs. evening chronotype;
SKCM	cis	rs17270561	0.525	rs10484432	chr6:26008876	G/A	cg10373733	chr6:25993375	NA	0.89	5.7	0.54	2.08e-7	Iron status biomarkers;
SKCM	cis	rs7772486	0.875	rs10457793	chr6:146415403	A/G	cg23711669	chr6:146136114	FBXO30	0.85	8.48	0.69	1.09e-12	Lobe attachment (rater-scored or self-reported);
SKCM	trans	rs10506458	0.834	rs73127067	chr12:63390333	G/T	cg03429785	chr15:59498649	MYO1E;LDHAL6B	-1.39	-7.59	-0.65	5.95e-11	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs514406	0.893	rs512723	chr1:53343880	C/T	cg16325326	chr1:53192061	ZYG11B	-0.88	-8.99	-0.71	1.14e-13	Monocyte count;
SKCM	cis	rs995000	0.895	rs1472257	chr1:63042126	A/G	cg06896770	chr1:63153194	DOCK7	-0.72	-6.62	-0.6	4.14e-9	Triglyceride levels;
SKCM	cis	rs875971	0.638	rs6460305	chr7:66060408	G/A	cg00343986	chr7:65444356	GUSB	-0.68	-4.99	-0.49	3.65e-6	Aortic root size;
SKCM	cis	rs9596863	0.898	rs9316655	chr13:54319640	A/G	ch.13.53330881F	chr13:54432880	NA	0.8	5.01	0.49	3.26e-6	Epilepsy and lamotrigine-induced maculopapular eruptions;
SKCM	cis	rs7937682	0.921	rs1944119	chr11:111436387	A/G	cg19812747	chr11:111475976	SIK2	0.66	5.5	0.53	4.62e-7	Primary sclerosing cholangitis;
SKCM	cis	rs7927771	1.000	rs7927771	chr11:47781306	A/G	cg05585544	chr11:47624801	NA	-0.6	-5.22	-0.51	1.45e-6	Subjective well-being;
SKCM	cis	rs651907	0.535	rs35810977	chr3:101531380	G/A	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.78	6.72	0.61	2.65e-9	Colorectal cancer;
SKCM	cis	rs7666738	0.716	rs11721453	chr4:99045485	G/T	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6951245	0.744	rs10275401	chr7:1213943	A/C	cg23708337	chr7:1209742	NA	0.88	5.4	0.52	7.12e-7	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs9325144	0.560	rs11183189	chr12:38683770	T/A	cg13010199	chr12:38710504	ALG10B	0.62	4.88	0.48	5.53e-6	Morning vs. evening chronotype;
SKCM	cis	rs1707322	1.000	rs4134387	chr1:46395158	A/T	cg03146154	chr1:46216737	IPP	0.73	4.91	0.49	4.98e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs9815354	0.767	rs73077390	chr3:41860255	T/C	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs250585	0.516	rs459894	chr16:23601488	A/G	cg09934309	chr16:23461721	COG7	-0.81	-5.33	-0.52	9.39e-7	Egg allergy;
SKCM	cis	rs11585357	0.843	rs72646796	chr1:17612503	T/C	cg08277548	chr1:17600880	PADI3	-0.9	-6.35	-0.58	1.34e-8	Hair shape;
SKCM	cis	rs7193541	0.684	rs9923145	chr16:74686166	G/A	cg01733217	chr16:74700730	RFWD3	1.01	11.94	0.8	2.74e-19	Multiple myeloma;
SKCM	cis	rs60871478	0.541	rs56964970	chr7:910791	G/C	cg05535760	chr7:792225	HEATR2	-1.34	-8.04	-0.67	7.79e-12	Cerebrospinal P-tau181p levels;
SKCM	cis	rs7666738	0.830	rs10031292	chr4:99056877	A/G	cg17366294	chr4:99064904	C4orf37	0.61	4.93	0.49	4.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs3743104	0.966	rs33963919	chr15:33023670	C/T	cg07179000	chr15:33023586	GREM1	-0.62	-6.86	-0.61	1.47e-9	Hypospadias;
SKCM	cis	rs10751667	0.557	rs12281858	chr11:1022187	C/T	cg18297705	chr11:1994927	NA	0.68	5.03	0.5	3.01e-6	Alzheimer's disease (late onset);
SKCM	cis	rs6582630	0.593	rs7299329	chr12:38447943	G/C	cg26384229	chr12:38710491	ALG10B	0.82	6.26	0.58	1.97e-8	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs7659604	1.000	rs6816071	chr4:122665185	G/A	cg06713675	chr4:122721982	EXOSC9	-0.65	-5.78	-0.55	1.48e-7	Type 2 diabetes;
SKCM	cis	rs1153858	1.000	rs4775937	chr15:45678614	C/A	cg21132104	chr15:45694354	SPATA5L1	0.93	7.94	0.67	1.22e-11	Homoarginine levels;
SKCM	cis	rs2594989	0.779	rs111827101	chr3:11587736	T/C	cg00170343	chr3:11313890	ATG7	-1.01	-5.62	-0.54	2.88e-7	Circulating chemerin levels;
SKCM	cis	rs7829975	0.508	rs4841006	chr8:8501474	T/C	cg06636001	chr8:8085503	FLJ10661	-0.71	-6.03	-0.56	5.1e-8	Mood instability;
SKCM	cis	rs875971	0.862	rs6460302	chr7:65960257	C/G	cg11764359	chr7:65958608	NA	0.81	7.38	0.64	1.47e-10	Aortic root size;
SKCM	cis	rs1044826	0.642	rs176983	chr3:139213755	G/A	cg15131784	chr3:139108705	COPB2	0.7	5.18	0.51	1.67e-6	Obesity-related traits;
SKCM	cis	rs6570726	0.935	rs386823	chr6:145841365	C/T	cg23711669	chr6:146136114	FBXO30	0.7	6.64	0.6	3.72e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs908922	0.676	rs4845784	chr1:152494583	G/C	cg09873164	chr1:152488093	CRCT1	0.76	5.94	0.56	7.4e-8	Hair morphology;
SKCM	cis	rs1135889	0.506	rs3744021	chr17:73871911	G/A	cg09249101	chr17:74520697	NA	-0.56	-4.82	-0.48	6.86e-6	Coronary artery disease;
SKCM	cis	rs11626933	1.000	rs59905513	chr14:90749638	T/C	cg14092571	chr14:90743983	NA	-0.92	-8.33	-0.69	2.11e-12	Gut microbiota (bacterial taxa);
SKCM	cis	rs28595532	0.841	rs114155681	chr4:119736427	A/G	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs861020	0.630	rs9308411	chr1:210005713	C/T	cg05527609	chr1:210001259	C1orf107	0.86	6.68	0.6	3.12e-9	Orofacial clefts;
SKCM	cis	rs933688	1.000	rs10058025	chr5:90689052	A/G	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.02	7.81	0.66	2.22e-11	Smoking behavior;
SKCM	cis	rs7106204	0.513	rs2165784	chr11:24249360	C/A	ch.11.24196551F	chr11:24239977	NA	0.72	5.55	0.53	3.8e-7	Response to Homoharringtonine (cytotoxicity);
SKCM	cis	rs9470366	0.535	rs762624	chr6:36645588	A/C	cg08179530	chr6:36648295	CDKN1A	0.75	5.48	0.53	5.13e-7	QRS duration;
SKCM	cis	rs1552244	0.882	rs2130813	chr3:10038706	A/C	cg02579736	chr3:10068473	FANCD2;CIDECP	0.98	4.84	0.48	6.48e-6	Alzheimer's disease;
SKCM	cis	rs10089	1.000	rs4836368	chr5:127486330	T/A	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.9	8.98	0.71	1.17e-13	Ileal carcinoids;
SKCM	cis	rs4819052	0.765	rs2838852	chr21:46677037	C/A	cg20896738	chr21:46707857	POFUT2;LOC642852	0.64	4.82	0.48	6.85e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs116095464	0.681	rs10060016	chr5:241100	T/C	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	trans	rs3780486	0.757	rs10758189	chr9:33125804	A/G	cg04842962	chr6:43655489	MRPS18A	1.01	9.56	0.73	9.04e-15	IgG glycosylation;
SKCM	cis	rs4642101	0.590	rs6799544	chr3:12812979	T/C	cg05775895	chr3:12838266	CAND2	0.64	5.32	0.52	9.74e-7	QRS complex (12-leadsum);
SKCM	cis	rs7666738	0.753	rs10033138	chr4:98981922	A/C	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs3796619	0.503	rs1466216	chr4:1071907	C/T	cg27284194	chr4:1044797	NA	-0.79	-8.1	-0.68	6.03e-12	Recombination rate (males);
SKCM	cis	rs4862750	0.794	rs7672272	chr4:187896774	T/G	cg10295955	chr4:187884368	NA	-1.04	-14.07	-0.85	4.23e-23	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs589448	0.902	rs315138	chr12:69764850	A/T	cg14784868	chr12:69753453	YEATS4	0.84	7.65	0.65	4.54e-11	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs933688	1.000	rs2367353	chr5:90686568	G/C	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.1	8.5	0.69	1.01e-12	Smoking behavior;
SKCM	cis	rs8017423	1.000	rs59052550	chr14:90665098	C/T	cg04374321	chr14:90722782	PSMC1	0.94	8.37	0.69	1.81e-12	Mortality in heart failure;
SKCM	cis	rs7208859	0.562	rs11650923	chr17:29008167	G/A	cg14067834	chr17:29058358	SUZ12P	1.05	5.55	0.53	3.71e-7	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs6933660	0.800	rs3800273	chr6:151759035	G/C	cg10883421	chr6:151773342	RMND1;C6orf211	0.83	6.92	0.62	1.12e-9	Menarche (age at onset);
SKCM	cis	rs6121246	0.583	rs28815498	chr20:30351560	T/C	cg13852791	chr20:30311386	BCL2L1	0.82	5.69	0.54	2.09e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs754466	0.580	rs1866437	chr10:79526766	A/G	cg17075019	chr10:79541650	NA	-0.79	-6.97	-0.62	9.15e-10	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs1580019	0.922	rs34545272	chr7:32460630	C/T	cg06627557	chr7:32535165	LSM5;AVL9	0.71	5.08	0.5	2.51e-6	Cognitive ability;
SKCM	cis	rs6951245	1.000	rs11763020	chr7:1060288	C/T	cg24642844	chr7:1081250	C7orf50	-0.95	-6.39	-0.59	1.13e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	trans	rs1814175	0.817	rs10839401	chr11:49876144	C/T	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs7100689	0.646	rs11202751	chr10:82147802	G/A	cg01528321	chr10:82214614	TSPAN14	0.84	7.53	0.65	7.69e-11	Post bronchodilator FEV1;
SKCM	cis	rs7020830	0.931	rs13297576	chr9:37142189	A/C	cg14294708	chr9:37120828	ZCCHC7	1.09	10.46	0.76	1.68e-16	Schizophrenia;
SKCM	cis	rs55823223	0.618	rs72860390	chr17:73869914	A/G	cg08125733	chr17:73851984	WBP2	1.05	5.94	0.56	7.42e-8	Psoriasis;
SKCM	cis	rs4141404	0.701	rs1985531	chr22:31566177	T/G	cg02404636	chr22:31891804	SFI1	-0.63	-5.77	-0.55	1.53e-7	Paclitaxel-induced neuropathy;
SKCM	cis	rs28595532	0.920	rs116091383	chr4:119635518	A/G	cg11846333	chr4:119757529	SEC24D	1.15	6.24	0.58	2.13e-8	Cannabis dependence symptom count;
SKCM	cis	rs6952808	0.689	rs4719391	chr7:2048136	T/C	cg04267008	chr7:1944627	MAD1L1	-0.64	-5.04	-0.5	2.99e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs7927771	0.542	rs10769300	chr11:47865560	C/T	cg20307385	chr11:47447363	PSMC3	0.71	5.63	0.54	2.67e-7	Subjective well-being;
SKCM	cis	rs2439831	0.867	rs2255042	chr15:43834318	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	-1.18	-7.32	-0.64	1.95e-10	Lung cancer in ever smokers;
SKCM	cis	rs6840360	0.615	rs12641438	chr4:152607586	A/G	cg22705602	chr4:152727874	NA	-0.57	-7.52	-0.65	8.09e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs4665809	0.556	rs1560869	chr2:26417095	T/C	cg26119090	chr2:26468346	HADHA;HADHB	-1.02	-8.05	-0.67	7.59e-12	Gut microbiome composition (summer);
SKCM	cis	rs7659604	0.676	rs7691955	chr4:122700462	A/T	cg19748678	chr4:122722346	EXOSC9	0.69	5.66	0.54	2.42e-7	Type 2 diabetes;
SKCM	cis	rs7809950	0.773	rs62483722	chr7:107186349	C/T	cg23024343	chr7:107201750	COG5	-0.77	-6.95	-0.62	9.61e-10	Coronary artery disease;
SKCM	cis	rs7149337	0.805	rs2999361	chr14:51605358	G/A	cg23942311	chr14:51606299	NA	0.65	7.48	0.65	9.58e-11	Cancer;
SKCM	cis	rs28595532	0.841	rs114970257	chr4:119756937	G/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs1405130	0.869	rs12990323	chr2:235572019	C/T	cg17841421	chr2:235704848	NA	-0.57	-4.95	-0.49	4.14e-6	Coronary artery disease;
SKCM	cis	rs7605378	0.658	rs4673507	chr2:200710167	G/C	cg23649088	chr2:200775458	C2orf69	0.69	4.96	0.49	4.11e-6	Osteoporosis;
SKCM	cis	rs7615952	0.611	rs12488771	chr3:125700526	A/G	cg05084668	chr3:125655381	ALG1L	-1.27	-6.22	-0.58	2.33e-8	Blood pressure (smoking interaction);
SKCM	cis	rs2952156	0.684	rs931992	chr17:37821435	G/T	cg00129232	chr17:37814104	STARD3	-0.79	-6.66	-0.6	3.5e-9	Asthma;
SKCM	cis	rs10489202	0.608	rs10918827	chr1:168077044	A/G	cg24449463	chr1:168025552	DCAF6	0.81	7.57	0.65	6.33e-11	Schizophrenia;
SKCM	cis	rs7666738	0.830	rs10011009	chr4:98981749	G/A	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7829975	0.774	rs35039922	chr8:8675325	A/T	cg06636001	chr8:8085503	FLJ10661	0.76	6.87	0.61	1.41e-9	Mood instability;
SKCM	cis	rs3008870	0.959	rs2985826	chr1:67412918	G/C	cg08660285	chr1:67390436	MIER1;WDR78	0.92	6.05	0.57	4.69e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs1218582	0.774	rs4845679	chr1:154861187	G/T	cg03351412	chr1:154909251	PMVK	0.74	6.32	0.58	1.51e-8	Prostate cancer;
SKCM	cis	rs72615157	0.595	rs112241539	chr7:99847237	C/T	cg07160278	chr7:100027354	MEPCE;ZCWPW1	0.97	5.63	0.54	2.73e-7	Lung function (FEV1/FVC);
SKCM	cis	rs9916302	0.680	rs2271308	chr17:37817482	T/C	cg20243544	chr17:37824526	PNMT	0.74	6.08	0.57	4.16e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs10256972	0.758	rs11980081	chr7:1069372	T/C	cg07308232	chr7:1071921	C7orf50	-0.62	-5.28	-0.51	1.15e-6	Longevity;Endometriosis;
SKCM	cis	rs951366	0.764	rs708724	chr1:205743663	A/C	cg11965913	chr1:205819406	PM20D1	1.0	10.32	0.76	3.06e-16	Menarche (age at onset);
SKCM	cis	rs2072499	0.932	rs3001790	chr1:156165290	T/G	cg25208724	chr1:156163844	SLC25A44	1.09	9.5	0.73	1.16e-14	Testicular germ cell tumor;
SKCM	cis	rs11098499	0.739	rs10031033	chr4:120151452	C/T	cg09307838	chr4:120376055	NA	0.81	6.41	0.59	1.02e-8	Corneal astigmatism;
SKCM	cis	rs7027203	0.828	rs4744287	chr9:96585567	A/G	cg14598338	chr9:96623480	NA	0.5	5.01	0.49	3.26e-6	DNA methylation (variation);
SKCM	cis	rs8072100	0.934	rs8067286	chr17:45594590	A/G	cg25173405	chr17:45401733	C17orf57	0.56	5.13	0.5	2.07e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs6430585	0.591	rs309170	chr2:136672775	C/T	cg07169764	chr2:136633963	MCM6	1.23	9.91	0.75	1.87e-15	Corneal structure;
SKCM	cis	rs4132509	0.592	rs12076373	chr1:243851947	G/C	cg21452805	chr1:244014465	NA	0.92	5.19	0.51	1.64e-6	RR interval (heart rate);
SKCM	trans	rs1814175	0.645	rs1818895	chr11:50031523	G/T	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs1153858	1.000	rs11070456	chr15:45686835	G/A	cg10760299	chr15:45669010	GATM	0.6	5.93	0.56	7.69e-8	Homoarginine levels;
SKCM	cis	rs9951698	0.703	rs692964	chr18:13094132	G/A	cg12848697	chr18:13133368	NA	0.53	4.9	0.48	5.18e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs6545883	0.929	rs6707830	chr2:61749472	G/A	cg15711740	chr2:61764176	XPO1	-0.73	-5.27	-0.51	1.19e-6	Tuberculosis;
SKCM	cis	rs748404	0.697	rs531910	chr15:43560607	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	0.69	5.67	0.54	2.35e-7	Lung cancer;
SKCM	cis	rs2404602	0.735	rs2454454	chr15:76823647	A/G	cg23625390	chr15:77176239	SCAPER	-0.78	-7.52	-0.65	7.81e-11	Blood metabolite levels;
SKCM	cis	rs2204008	0.837	rs7308714	chr12:38274307	T/C	cg13010199	chr12:38710504	ALG10B	0.69	4.92	0.49	4.72e-6	Bladder cancer;
SKCM	cis	rs826838	0.967	rs11183622	chr12:38792849	T/C	cg13010199	chr12:38710504	ALG10B	0.86	6.84	0.61	1.61e-9	Heart rate;
SKCM	cis	rs6952808	0.543	rs4719436	chr7:2141239	G/A	cg21782813	chr7:2030301	MAD1L1	0.53	5.68	0.54	2.25e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs9660180	0.934	rs12729990	chr1:1812035	T/A	cg23982607	chr1:1823379	GNB1	-0.73	-6.09	-0.57	3.97e-8	Body mass index;
SKCM	cis	rs12142240	0.698	rs17357711	chr1:46829013	A/G	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs9322193	1.000	rs9377228	chr6:149921998	G/A	cg07701084	chr6:150067640	NUP43	0.64	5.11	0.5	2.21e-6	Lung cancer;
SKCM	cis	rs9902453	0.967	rs12449783	chr17:28527653	A/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.75	5.19	0.51	1.65e-6	Coffee consumption (cups per day);
SKCM	cis	rs7666738	0.830	rs11726604	chr4:99000969	T/C	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7843479	0.965	rs4636204	chr8:21823206	T/G	cg17168535	chr8:21777572	XPO7	0.72	5.64	0.54	2.65e-7	Mean corpuscular volume;
SKCM	cis	rs829883	0.664	rs249833	chr12:98832189	T/C	cg25150519	chr12:98850993	NA	0.5	4.91	0.49	4.83e-6	Colorectal adenoma (advanced);
SKCM	cis	rs2811415	0.597	rs13094149	chr3:127795569	C/T	cg09089421	chr3:127803668	RUVBL1	1.0	8.69	0.7	4.4e-13	Lung function (FEV1/FVC);
SKCM	cis	rs873946	0.586	rs57431984	chr10:134567697	C/T	cg18305652	chr10:134549665	INPP5A	0.58	5.64	0.54	2.62e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs16949788	0.793	rs78198355	chr15:66685808	C/T	cg08120210	chr15:66682733	MAP2K1	-0.74	-5.82	-0.55	1.23e-7	Spherical equivalent (joint analysis main effects and education interaction);
SKCM	cis	rs17376456	0.877	rs34673483	chr5:93315079	C/A	cg25358565	chr5:93447407	FAM172A	1.23	7.26	0.63	2.53e-10	Diabetic retinopathy;
SKCM	cis	rs9543976	0.800	rs4885318	chr13:76151537	G/A	cg01531495	chr13:76123901	UCHL3	0.93	5.16	0.5	1.83e-6	Diabetic retinopathy;
SKCM	cis	rs548181	0.736	rs1941558	chr11:125425606	C/T	cg03464685	chr11:125439445	EI24	1.48	9.54	0.73	9.7e-15	Schizophrenia;Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);
SKCM	cis	rs6952808	1.000	rs59248873	chr7:1888185	A/G	cg04267008	chr7:1944627	MAD1L1	-0.8	-6.1	-0.57	3.78e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs4478137	0.931	rs7665672	chr4:164236875	G/A	cg06758707	chr4:164254230	NPY1R	0.93	6.18	0.57	2.75e-8	Subjective well-being (multi-trait analysis);Subjective well-being;
SKCM	cis	rs17376456	0.877	rs10057605	chr5:93443950	T/G	cg21475434	chr5:93447410	FAM172A	0.97	5.42	0.52	6.39e-7	Diabetic retinopathy;
SKCM	cis	rs2075371	0.897	rs1646702	chr7:134000177	C/G	cg20476274	chr7:133979776	SLC35B4	1.03	10.69	0.77	5.94e-17	Mean platelet volume;
SKCM	cis	rs7106204	0.748	rs12293729	chr11:24224679	A/G	ch.11.24196551F	chr11:24239977	NA	0.77	6.18	0.57	2.73e-8	Response to Homoharringtonine (cytotoxicity);
SKCM	cis	rs62103177	0.810	rs62096746	chr18:77619556	T/A	cg27393146	chr18:77495563	CTDP1	-0.92	-5.36	-0.52	8.37e-7	Opioid sensitivity;
SKCM	cis	rs2739330	0.828	rs4822451	chr22:24248166	T/G	cg25703541	chr22:24373054	LOC391322	-0.81	-6.47	-0.59	7.97e-9	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs2075371	0.637	rs2544165	chr7:133920443	A/G	cg20476274	chr7:133979776	SLC35B4	-0.97	-9.16	-0.72	5.21e-14	Mean platelet volume;
SKCM	cis	rs11098499	0.866	rs12510451	chr4:120289143	C/T	cg24375607	chr4:120327624	NA	0.62	4.77	0.48	8.45e-6	Corneal astigmatism;
SKCM	cis	rs66573146	1.000	rs9942188	chr4:6984181	C/T	cg00086871	chr4:6988644	TBC1D14	1.43	5.33	0.52	9.25e-7	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs7954584	0.567	rs7132055	chr12:122346034	A/G	cg01765077	chr12:122356316	WDR66	-0.44	-4.91	-0.49	4.99e-6	Mean corpuscular volume;
SKCM	cis	rs9910055	0.529	rs575798	chr17:42181796	A/C	cg08499158	chr17:42289980	UBTF	0.72	5.61	0.54	2.95e-7	Total body bone mineral density;
SKCM	trans	rs17685	0.753	rs1104879	chr7:75685568	C/T	cg19862616	chr7:65841803	NCRNA00174	0.95	9.34	0.73	2.39e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs9796	0.804	rs28688742	chr15:41403638	G/A	cg18705301	chr15:41695430	NDUFAF1	-0.78	-5.78	-0.55	1.47e-7	Menopause (age at onset);
SKCM	cis	rs35306767	0.953	rs7908138	chr10:962978	C/T	cg25614935	chr10:1084866	C10orf110	0.67	4.85	0.48	6.07e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs4481887	0.927	rs4341391	chr1:248475720	A/G	cg00666640	chr1:248458726	OR2T12	0.66	6.09	0.57	3.99e-8	Common traits (Other);
SKCM	trans	rs2727020	0.615	rs10128582	chr11:49447424	C/T	cg15704280	chr7:45808275	SEPT13	-0.87	-7.93	-0.67	1.31e-11	Coronary artery disease;
SKCM	trans	rs17685	0.712	rs10235086	chr7:75833138	G/T	cg19862616	chr7:65841803	NCRNA00174	0.93	10.14	0.75	6.88e-16	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs3785574	0.962	rs62077483	chr17:61806380	C/T	cg06601766	chr17:61851465	DDX42;CCDC47	0.66	4.98	0.49	3.74e-6	Height;
SKCM	cis	rs2991971	1.000	rs622798	chr1:46015271	T/G	cg24296786	chr1:45957014	TESK2	0.65	5.25	0.51	1.28e-6	High light scatter reticulocyte count;
SKCM	trans	rs208520	0.661	rs7766144	chr6:66827795	C/T	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-1.09	-8.61	-0.7	6.3e-13	Exhaled nitric oxide output;
SKCM	cis	rs11098499	0.866	rs13105020	chr4:120285688	G/T	cg24375607	chr4:120327624	NA	0.62	4.77	0.48	8.45e-6	Corneal astigmatism;
SKCM	cis	rs7829975	0.711	rs1039916	chr8:8685854	A/G	cg08975724	chr8:8085496	FLJ10661	0.58	4.77	0.48	8.37e-6	Mood instability;
SKCM	cis	rs1799949	1.000	rs4793190	chr17:41200109	T/C	cg23758822	chr17:41437982	NA	0.94	7.82	0.66	2.13e-11	Menopause (age at onset);
SKCM	cis	rs7618501	0.635	rs7635002	chr3:49989155	T/G	cg24110177	chr3:50126178	RBM5	-0.6	-5.1	-0.5	2.36e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9399135	0.933	rs41294852	chr6:135376379	T/G	cg24558204	chr6:135376177	HBS1L	0.58	5.05	0.5	2.86e-6	Red blood cell count;
SKCM	cis	rs2075371	0.830	rs12669960	chr7:133931782	A/G	cg20476274	chr7:133979776	SLC35B4	0.92	8.91	0.71	1.64e-13	Mean platelet volume;
SKCM	cis	rs2645694	0.626	rs2703124	chr4:77820626	G/T	cg03477792	chr4:77819574	ANKRD56	0.57	6.38	0.59	1.18e-8	Emphysema distribution in smoking;
SKCM	cis	rs1577917	0.958	rs11758508	chr6:86506878	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.83	7.81	0.66	2.24e-11	Response to antipsychotic treatment;
SKCM	cis	rs5750830	0.621	rs5750810	chr22:39792943	A/G	cg11247378	chr22:39784982	NA	-0.48	-5.92	-0.56	8e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs826838	0.620	rs11614695	chr12:39331847	C/T	cg26384229	chr12:38710491	ALG10B	0.85	6.96	0.62	9.47e-10	Heart rate;
SKCM	cis	rs514406	0.505	rs416968	chr1:53183513	A/G	cg16325326	chr1:53192061	ZYG11B	0.89	10.06	0.75	9.55e-16	Monocyte count;
SKCM	cis	rs1029738	0.615	rs717624	chr7:22894487	T/C	cg00365470	chr7:22893924	NA	-0.64	-5.12	-0.5	2.11e-6	Fibrinogen levels;
SKCM	cis	rs362272	0.524	rs6819202	chr4:3368264	G/A	cg09735869	chr4:3319127	RGS12	0.96	10.92	0.78	2.23e-17	Serum sulfate level;
SKCM	cis	rs798554	0.959	rs798557	chr7:2758982	G/A	cg14895029	chr7:2775587	GNA12	-0.69	-5.04	-0.5	2.95e-6	Height;
SKCM	cis	rs614226	1.000	rs591992	chr12:121019323	T/C	cg01236616	chr12:121019343	POP5	1.37	8.37	0.69	1.79e-12	Type 1 diabetes nephropathy;
SKCM	cis	rs2439831	0.867	rs2242068	chr15:43699304	C/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.16	7.17	0.63	3.73e-10	Lung cancer in ever smokers;
SKCM	cis	rs798766	1.000	rs2305188	chr4:1739592	A/G	cg24239225	chr4:1659016	FAM53A	-0.72	-4.87	-0.48	5.66e-6	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs2652834	1.000	rs2729788	chr15:63400378	G/C	cg04194852	chr15:63334506	TPM1	0.76	4.78	0.48	8.15e-6	HDL cholesterol;
SKCM	cis	rs12682352	0.602	rs635594	chr8:8613387	C/T	cg06636001	chr8:8085503	FLJ10661	-0.64	-5.46	-0.53	5.51e-7	Neuroticism;
SKCM	cis	rs769267	0.930	rs747050	chr19:19584987	C/G	cg26732615	chr19:19648335	CILP2;YJEFN3	0.67	6.94	0.62	1.02e-9	Tonsillectomy;
SKCM	cis	rs8072100	0.807	rs2175290	chr17:45479917	C/A	cg08085267	chr17:45401833	C17orf57	-0.62	-5.15	-0.5	1.88e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs2463822	1.000	rs2246920	chr11:62104937	T/G	cg06239285	chr11:62104954	ASRGL1	1.25	5.91	0.56	8.43e-8	Chronic obstructive pulmonary disease-related biomarkers;
SKCM	cis	rs4819052	0.724	rs9753987	chr21:46661389	C/T	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.36	0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7618915	0.571	rs17264436	chr3:52610651	T/A	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs9814567	0.686	rs1404289	chr3:134358109	C/G	cg06109529	chr3:134205091	CEP63;ANAPC13	0.62	4.97	0.49	3.85e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs55823223	0.564	rs2034947	chr17:73863929	T/C	cg10935138	chr17:73851978	WBP2	1.18	7.17	0.63	3.66e-10	Psoriasis;
SKCM	cis	rs738321	0.762	rs4820321	chr22:38579569	T/A	cg25457927	chr22:38595422	NA	-0.63	-7.49	-0.65	8.97e-11	Breast cancer;
SKCM	cis	rs769267	0.895	rs1000237	chr19:19518316	T/A	cg26732615	chr19:19648335	CILP2;YJEFN3	0.69	7.02	0.62	7.14e-10	Tonsillectomy;
SKCM	cis	rs7208859	0.623	rs9914499	chr17:29107588	G/A	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs9911578	0.935	rs7218105	chr17:57041119	A/G	cg12560992	chr17:57184187	TRIM37	0.94	7.55	0.65	7.01e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs7659604	0.502	rs11098640	chr4:122675875	G/A	cg19671926	chr4:122722719	EXOSC9	0.77	6.27	0.58	1.89e-8	Type 2 diabetes;
SKCM	cis	rs35306767	0.761	rs12359796	chr10:1021479	G/C	cg20503657	chr10:835505	NA	0.75	5.94	0.56	7.41e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs7772486	0.701	rs2244308	chr6:146213706	C/T	cg05347473	chr6:146136440	FBXO30	0.56	5.18	0.51	1.67e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs12188164	0.965	rs72717435	chr5:448202	G/A	cg26076054	chr5:421317	AHRR	-0.63	-4.77	-0.48	8.46e-6	Cystic fibrosis severity;
SKCM	cis	rs9300255	0.722	rs28592876	chr12:123866429	G/A	cg00376283	chr12:123451042	ABCB9	-0.78	-5.26	-0.51	1.24e-6	Neutrophil percentage of white cells;
SKCM	cis	rs2777491	0.915	rs7178634	chr15:41634587	A/G	cg18705301	chr15:41695430	NDUFAF1	-0.96	-9.11	-0.72	6.65e-14	Ulcerative colitis;
SKCM	cis	rs155076	1.000	rs9509638	chr13:21860193	G/A	cg14456004	chr13:21872349	NA	-1.28	-7.28	-0.64	2.31e-10	White matter hyperintensity burden;
SKCM	cis	rs7100689	0.646	rs2050824	chr10:82123563	G/A	cg01528321	chr10:82214614	TSPAN14	0.8	7.0	0.62	7.98e-10	Post bronchodilator FEV1;
SKCM	cis	rs9467773	0.967	rs1535276	chr6:26520941	T/C	cg09904177	chr6:26538194	HMGN4	0.54	4.98	0.49	3.78e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9640161	0.789	rs11767409	chr7:150058043	C/T	cg10018233	chr7:150070692	REPIN1	0.66	5.14	0.5	2.02e-6	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs7772486	0.790	rs9497427	chr6:146238302	T/A	cg23711669	chr6:146136114	FBXO30	-0.78	-7.74	-0.66	3.05e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2857078	0.732	rs9893756	chr17:42321109	T/C	cg10896456	chr17:42255109	ASB16;C17orf65	-0.58	-4.85	-0.48	6.23e-6	Red cell distribution width;Reticulocyte count;
SKCM	cis	rs7666738	0.830	rs6830124	chr4:99054872	C/T	cg17366294	chr4:99064904	C4orf37	-0.6	-4.98	-0.49	3.8e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs754466	0.510	rs10824579	chr10:79590685	C/T	cg17075019	chr10:79541650	NA	-0.6	-5.48	-0.53	4.99e-7	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs4423214	0.610	rs3763856	chr11:71125345	G/A	cg05163923	chr11:71159392	DHCR7	0.59	5.4	0.52	6.93e-7	Vitamin D levels;
SKCM	cis	rs9902453	0.765	rs2264303	chr17:28055348	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.79	-5.93	-0.56	7.67e-8	Coffee consumption (cups per day);
SKCM	cis	rs642803	0.569	rs44205	chr11:65564786	G/A	cg08755490	chr11:65554678	OVOL1	-0.65	-4.93	-0.49	4.55e-6	Urate levels;
SKCM	cis	rs7208859	0.673	rs73271887	chr17:29154935	T/C	cg13385521	chr17:29058706	SUZ12P	0.9	4.78	0.48	8.1e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	trans	rs1814175	0.817	rs28525029	chr11:50045815	A/G	cg15704280	chr7:45808275	SEPT13	-1.05	-11.07	-0.78	1.14e-17	Height;
SKCM	cis	rs7100689	0.577	rs9420349	chr10:82031160	T/C	cg01528321	chr10:82214614	TSPAN14	0.81	7.77	0.66	2.67e-11	Post bronchodilator FEV1;
SKCM	cis	rs11098499	0.754	rs4107728	chr4:120253910	G/A	cg09307838	chr4:120376055	NA	0.93	7.61	0.65	5.36e-11	Corneal astigmatism;
SKCM	cis	rs7772486	0.686	rs10872579	chr6:145966012	C/G	cg05347473	chr6:146136440	FBXO30	0.57	5.23	0.51	1.39e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs763121	0.853	rs2072795	chr22:39064209	A/G	cg06022373	chr22:39101656	GTPBP1	-0.78	-5.63	-0.54	2.7e-7	Menopause (age at onset);
SKCM	cis	rs7296418	0.961	rs10848428	chr12:123572495	C/T	cg06742321	chr12:123595122	PITPNM2	0.65	5.45	0.52	5.77e-7	Platelet count;
SKCM	trans	rs12599106	0.648	rs12447240	chr16:34928236	C/T	cg03395511	chr6:291903	DUSP22	0.71	7.7	0.66	3.51e-11	Menopause (age at onset);
SKCM	cis	rs6570726	0.934	rs430003	chr6:145819506	C/T	cg23711669	chr6:146136114	FBXO30	0.7	6.64	0.6	3.72e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7666738	0.830	rs62321597	chr4:99014221	C/A	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1862618	0.853	rs252915	chr5:56121754	C/T	cg12311346	chr5:56204834	C5orf35	0.7	4.85	0.48	6.26e-6	Initial pursuit acceleration;
SKCM	cis	rs9674544	0.757	rs3744085	chr17:47131901	A/G	cg22947322	chr17:47091978	IGF2BP1	-0.55	-4.9	-0.49	5.1e-6	Primary tooth development (time to first tooth eruption);Primary tooth development (number of teeth);
SKCM	cis	rs6089829	0.962	rs6062393	chr20:61663230	G/A	cg08564027	chr20:61660810	NA	0.63	5.65	0.54	2.56e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs7296418	0.961	rs1790121	chr12:123604492	G/A	cg05973401	chr12:123451056	ABCB9	0.83	6.72	0.61	2.67e-9	Platelet count;
SKCM	cis	rs7100689	0.646	rs1340376	chr10:82128963	A/G	cg01528321	chr10:82214614	TSPAN14	0.8	7.0	0.62	7.98e-10	Post bronchodilator FEV1;
SKCM	cis	rs7122539	0.839	rs6591223	chr11:66609289	C/T	cg24851651	chr11:66362959	CCS	0.67	4.96	0.49	4.01e-6	HIV-1 susceptibility;
SKCM	cis	rs6121246	0.738	rs6121242	chr20:30410877	T/C	cg11595048	chr20:30225325	COX4I2	0.67	5.21	0.51	1.5e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs2739330	0.752	rs2330634	chr22:24250795	C/G	cg25703541	chr22:24373054	LOC391322	-0.77	-6.26	-0.58	1.97e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs4132509	0.793	rs10803161	chr1:243990770	T/C	cg21452805	chr1:244014465	NA	0.9	5.5	0.53	4.65e-7	RR interval (heart rate);
SKCM	cis	rs28386778	0.734	rs7210724	chr17:61799198	T/C	cg06873352	chr17:61820015	STRADA	0.75	6.24	0.58	2.1e-8	Prudent dietary pattern;
SKCM	cis	rs6088590	1.000	rs6119530	chr20:33403930	A/G	cg24642439	chr20:33292090	TP53INP2	1.01	7.2	0.63	3.23e-10	Coronary artery disease;
SKCM	cis	rs2050392	0.858	rs2250569	chr10:30698914	G/C	cg25182066	chr10:30743637	MAP3K8	-0.69	-5.89	-0.56	9.07e-8	Inflammatory bowel disease;
SKCM	cis	rs909674	0.818	rs5757680	chr22:39844793	C/T	cg11247378	chr22:39784982	NA	0.43	4.92	0.49	4.79e-6	IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis);IgG glycosylation;IgG digalactosylation phenotypes (multivariate analysis);IgG sialylation phenotypes (multivariate analysis);IgG monogalactosylation phenotypes (multivariate analysis);IgG fucosylation phenotypes (multivariate analysis);IgG N-glycosylation phenotypes (multivariate analysis);IgG disialylation phenotypes (multivariate analysis);IgG galactosylation phenotypes (multivariate analysis);Post bronchodilator FEV1;
SKCM	cis	rs9790314	0.747	rs6789244	chr3:160866230	A/C	cg03342759	chr3:160939853	NMD3	-0.66	-6.71	-0.61	2.74e-9	Morning vs. evening chronotype;
SKCM	cis	rs2836974	0.644	rs4818017	chr21:40690561	G/T	cg17971929	chr21:40555470	PSMG1	-0.69	-6.07	-0.57	4.38e-8	Cognitive function;
SKCM	cis	rs1799949	0.931	rs34410138	chr17:41279770	A/G	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.11	-0.57	3.67e-8	Menopause (age at onset);
SKCM	cis	rs2033711	0.905	rs893186	chr19:58969179	C/A	cg12042659	chr19:58951599	ZNF132	0.69	6.01	0.56	5.55e-8	Uric acid clearance;
SKCM	cis	rs12477438	0.520	rs11678456	chr2:99708237	G/A	cg26064155	chr2:99771622	LIPT1;TSGA10	1.03	9.6	0.74	7.37e-15	Chronic sinus infection;
SKCM	cis	rs4727027	0.901	rs6944781	chr7:148829566	A/G	cg23583168	chr7:148888333	NA	-0.82	-6.56	-0.6	5.29e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs11098499	0.754	rs12506610	chr4:120241659	T/C	cg09307838	chr4:120376055	NA	0.93	7.56	0.65	6.5500000000000006e-11	Corneal astigmatism;
SKCM	cis	rs2836974	0.568	rs377098	chr21:40535216	G/A	cg11890956	chr21:40555474	PSMG1	-0.88	-9.14	-0.72	5.76e-14	Cognitive function;
SKCM	cis	rs561341	0.700	rs6505266	chr17:30225813	G/A	cg13647721	chr17:30228624	UTP6	0.76	4.8	0.48	7.56e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs9902453	0.934	rs7211246	chr17:28485762	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.5	0.53	4.74e-7	Coffee consumption (cups per day);
SKCM	cis	rs473651	0.935	rs508483	chr2:239339709	T/C	cg21699342	chr2:239360505	ASB1	0.51	4.97	0.49	3.87e-6	Multiple system atrophy;
SKCM	trans	rs561341	1.000	rs8070262	chr17:30262467	A/G	cg20587970	chr11:113659929	NA	-1.07	-8.84	-0.71	2.25e-13	Hip circumference adjusted for BMI;
SKCM	cis	rs9911578	1.000	rs3744109	chr17:56594197	C/T	cg05425664	chr17:57184151	TRIM37	0.69	5.16	0.5	1.86e-6	Intelligence (multi-trait analysis);
SKCM	trans	rs561341	0.941	rs550213	chr17:30317518	C/G	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs9322193	1.000	rs58189451	chr6:149921388	G/A	cg07701084	chr6:150067640	NUP43	0.64	5.13	0.5	2.09e-6	Lung cancer;
SKCM	cis	rs12497850	0.931	rs6414613	chr3:49035885	C/T	cg06212747	chr3:49208901	KLHDC8B	0.68	4.82	0.48	6.97e-6	Parkinson's disease;
SKCM	cis	rs8067545	0.611	rs11653869	chr17:20197586	T/G	cg13482628	chr17:19912719	NA	-0.69	-5.93	-0.56	7.99e-8	Schizophrenia;
SKCM	cis	rs4803468	1.000	rs2288871	chr19:41917868	C/T	cg09537434	chr19:41945824	ATP5SL	-1.1	-13.82	-0.84	1.16e-22	Height;
SKCM	cis	rs9420	0.961	rs7117205	chr11:57641883	A/G	cg19752551	chr11:57585705	CTNND1	-0.71	-7.0	-0.62	7.71e-10	Schizophrenia;
SKCM	cis	rs7599312	0.534	rs7607373	chr2:213409719	G/A	cg20637307	chr2:213403960	ERBB4	0.77	5.6	0.54	3.15e-7	BMI (adjusted for smoking behaviour);BMI in non-smokers;Body mass index;Body mass index (joint analysis main effects and smoking interaction);
SKCM	cis	rs10540	1.000	rs67912009	chr11:495057	G/T	cg03576123	chr11:487126	PTDSS2	-1.42	-7.96	-0.67	1.12e-11	Body mass index;
SKCM	cis	rs10504229	0.906	rs2270609	chr8:58194684	G/A	cg22535103	chr8:58192502	C8orf71	-0.82	-5.42	-0.52	6.35e-7	Developmental language disorder (linguistic errors);
SKCM	cis	rs55962025	0.883	rs82334	chr4:3225371	A/C	cg05297308	chr4:3317976	RGS12	-0.67	-4.88	-0.48	5.51e-6	Parental longevity (mother's age at death);
SKCM	cis	rs12540874	0.670	rs3887826	chr7:50544961	G/A	cg18232548	chr7:50535776	DDC	-0.78	-5.55	-0.53	3.74e-7	Systemic sclerosis;
SKCM	cis	rs2228479	0.717	rs2270460	chr16:89972416	C/A	cg00800038	chr16:89945340	TCF25	-0.94	-5.51	-0.53	4.53e-7	Skin colour saturation;
SKCM	trans	rs1814175	0.588	rs10466497	chr11:49864381	A/T	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs1023500	0.573	rs4822088	chr22:42470589	G/C	cg04733989	chr22:42467013	NAGA	0.72	5.72	0.54	1.9e-7	Schizophrenia;
SKCM	cis	rs875971	0.660	rs6460308	chr7:66084740	T/C	cg05627663	chr7:65219948	SNORA22;CCT6P1	-0.56	-4.81	-0.48	7.26e-6	Aortic root size;
SKCM	cis	rs28386778	0.897	rs4638645	chr17:61828349	T/C	cg01411255	chr17:61851458	DDX42;CCDC47	0.78	5.03	0.49	3.06e-6	Prudent dietary pattern;
SKCM	cis	rs28595532	0.920	rs114678295	chr4:119756281	C/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs2070488	0.804	rs7372452	chr3:38444298	C/G	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.73	5.8	0.55	1.35e-7	Electrocardiographic conduction measures;
SKCM	cis	rs995000	0.931	rs638714	chr1:62906489	G/T	cg06896770	chr1:63153194	DOCK7	0.76	7.11	0.63	4.89e-10	Triglyceride levels;
SKCM	cis	rs2721195	0.816	rs4251689	chr8:145741130	C/T	cg15857475	chr8:145742913	RECQL4;LRRC14	0.88	9.15	0.72	5.53e-14	Age at first birth;
SKCM	cis	rs908922	0.676	rs908927	chr1:152513338	C/G	cg09873164	chr1:152488093	CRCT1	0.76	5.93	0.56	7.7e-8	Hair morphology;
SKCM	cis	rs11098499	0.954	rs3733519	chr4:120423448	A/G	cg09307838	chr4:120376055	NA	1.0	8.05	0.67	7.65e-12	Corneal astigmatism;
SKCM	cis	rs11098499	0.754	rs1980027	chr4:120251577	C/T	cg09307838	chr4:120376055	NA	0.91	7.36	0.64	1.63e-10	Corneal astigmatism;
SKCM	trans	rs1814175	0.645	rs847627	chr11:49927177	G/A	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs2644899	0.859	rs2604893	chr19:41293543	A/G	cg24958765	chr19:41283667	RAB4B	-0.85	-5.39	-0.52	7.21e-7	Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs6445797	0.632	rs12715490	chr3:56604506	C/T	cg13616963	chr3:57583610	ARF4	-0.78	-5.17	-0.51	1.76e-6	Gastritis;
SKCM	cis	rs2239547	0.522	rs6770957	chr3:52995416	T/C	cg11645453	chr3:52864694	ITIH4	0.58	4.96	0.49	3.98e-6	Schizophrenia;
SKCM	cis	rs936229	0.749	rs8031937	chr15:75181121	A/G	cg14664628	chr15:75095509	CSK	-0.98	-7.16	-0.63	3.83e-10	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin);
SKCM	cis	rs951366	0.764	rs823143	chr1:205743425	A/C	cg14159672	chr1:205819179	PM20D1	0.97	8.21	0.68	3.64e-12	Menarche (age at onset);
SKCM	trans	rs561341	0.941	rs2428336	chr17:30290577	T/C	cg20587970	chr11:113659929	NA	-1.17	-10.4	-0.76	2.14e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs867186	1.000	rs76507298	chr20:33623522	A/T	cg04194272	chr20:33683537	NA	-1.38	-7.2	-0.63	3.29e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs6866344	0.697	rs58549512	chr5:178133204	C/T	cg03877680	chr5:178157825	ZNF354A	0.86	6.37	0.59	1.19e-8	Neutrophil percentage of white cells;
SKCM	cis	rs7666738	0.830	rs2903150	chr4:99027184	T/C	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2832191	0.791	rs7283853	chr21:30498515	G/A	cg08807101	chr21:30365312	RNF160	-0.61	-4.77	-0.48	8.43e-6	Dental caries;
SKCM	cis	rs4481887	0.610	rs28763387	chr1:248559244	T/C	cg22724847	chr1:248512586	OR14C36	0.58	4.87	0.48	5.69e-6	Common traits (Other);
SKCM	cis	rs10489202	1.000	rs1060041	chr1:167973976	C/T	cg24449463	chr1:168025552	DCAF6	-0.75	-6.2	-0.57	2.51e-8	Schizophrenia;
SKCM	cis	rs514406	0.708	rs546334	chr1:53326210	T/C	cg16325326	chr1:53192061	ZYG11B	0.71	6.01	0.56	5.51e-8	Monocyte count;
SKCM	cis	rs909674	0.515	rs9611170	chr22:39784845	G/C	cg11247378	chr22:39784982	NA	-0.49	-6.13	-0.57	3.32e-8	IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis);IgG glycosylation;IgG digalactosylation phenotypes (multivariate analysis);IgG sialylation phenotypes (multivariate analysis);IgG monogalactosylation phenotypes (multivariate analysis);IgG fucosylation phenotypes (multivariate analysis);IgG N-glycosylation phenotypes (multivariate analysis);IgG disialylation phenotypes (multivariate analysis);IgG galactosylation phenotypes (multivariate analysis);Post bronchodilator FEV1;
SKCM	cis	rs2760061	0.583	rs697763	chr1:228192622	G/C	cg02753203	chr1:228287806	NA	0.83	7.58	0.65	6.2e-11	Diastolic blood pressure;
SKCM	cis	rs28595532	0.702	rs72670252	chr4:119337546	A/C	cg11846333	chr4:119757529	SEC24D	1.19	6.71	0.6	2.81e-9	Cannabis dependence symptom count;
SKCM	cis	rs2839186	0.771	rs2280957	chr21:47642272	A/G	cg13012494	chr21:47604986	C21orf56	-0.67	-5.81	-0.55	1.29e-7	Testicular germ cell tumor;
SKCM	cis	rs55962025	0.711	rs916171	chr4:3216815	C/G	cg00764545	chr4:3318001	RGS12	0.64	5.46	0.53	5.45e-7	Parental longevity (mother's age at death);
SKCM	cis	rs3785574	0.962	rs2584621	chr17:61912436	G/A	cg06873352	chr17:61820015	STRADA	0.56	4.82	0.48	6.86e-6	Height;
SKCM	cis	rs860295	0.702	rs10908472	chr1:155544256	T/C	cg02153340	chr1:155202674	NA	-0.78	-5.91	-0.56	8.65e-8	Body mass index;
SKCM	cis	rs12586317	0.620	rs17091786	chr14:35565856	A/T	cg16230307	chr14:35515116	FAM177A1	0.7	5.12	0.5	2.16e-6	Psoriasis;
SKCM	cis	rs1461503	0.966	rs7110154	chr11:122843300	A/G	cg27398637	chr11:122830231	C11orf63	-0.63	-4.8	-0.48	7.54e-6	Menarche (age at onset);
SKCM	cis	rs2479724	0.591	rs2243605	chr6:41828070	T/A	cg17623882	chr6:41773611	USP49	-0.7	-5.06	-0.5	2.7e-6	Menarche (age at onset);
SKCM	cis	rs4132509	1.000	rs2290754	chr1:243806268	A/C	cg21452805	chr1:244014465	NA	0.76	4.85	0.48	6.17e-6	RR interval (heart rate);
SKCM	cis	rs6952808	0.692	rs60755037	chr7:2030104	G/A	cg21782813	chr7:2030301	MAD1L1	0.57	5.93	0.56	7.93e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs10193935	0.901	rs6724626	chr2:42689757	C/G	cg27598129	chr2:42591480	NA	0.96	6.39	0.59	1.09e-8	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7937682	0.883	rs1789358	chr11:111474116	G/A	cg19812747	chr11:111475976	SIK2	-0.6	-5.15	-0.5	1.89e-6	Primary sclerosing cholangitis;
SKCM	cis	rs2180341	0.814	rs6905553	chr6:127727407	A/G	cg24812749	chr6:127587940	RNF146	0.61	4.97	0.49	3.9e-6	Breast cancer;
SKCM	trans	rs8073060	0.586	rs7214250	chr17:33981704	C/G	cg19694781	chr19:47549865	TMEM160	-1.0	-8.56	-0.7	7.62e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs2594989	0.691	rs2596816	chr3:11581200	A/C	cg00170343	chr3:11313890	ATG7	0.98	5.18	0.51	1.72e-6	Circulating chemerin levels;
SKCM	cis	rs1451375	0.617	rs1807066	chr7:50543683	T/C	cg18232548	chr7:50535776	DDC	-0.71	-4.77	-0.48	8.5e-6	Malaria;
SKCM	cis	rs801193	0.569	rs2707847	chr7:66202871	C/G	cg18876405	chr7:65276391	NA	0.61	6.02	0.56	5.36e-8	Aortic root size;
SKCM	cis	rs6519955	0.765	rs7292527	chr22:46423125	G/T	cg05468064	chr22:46423449	NA	-0.63	-6.82	-0.61	1.73e-9	Dupuytren's disease;
SKCM	cis	rs62238980	0.614	rs78354020	chr22:32394259	A/G	cg00543991	chr22:32367038	NA	1.15	4.87	0.48	5.76e-6	Childhood ear infection;
SKCM	cis	rs4774899	0.902	rs2414491	chr15:57465775	A/G	cg01857019	chr15:57210107	LOC145783;TCF12	0.53	4.9	0.49	5.12e-6	Urinary tract infection frequency;
SKCM	cis	rs9913156	0.708	rs9915105	chr17:4568742	G/C	cg19197139	chr17:4613644	ARRB2	-0.79	-5.45	-0.53	5.64e-7	Lymphocyte counts;
SKCM	cis	rs2836974	0.897	rs13049280	chr21:40594656	C/G	cg11644478	chr21:40555479	PSMG1	0.97	10.08	0.75	8.76e-16	Cognitive function;
SKCM	cis	rs6952808	0.771	rs10950415	chr7:1914477	A/G	cg02951883	chr7:2050386	MAD1L1	-0.69	-5.83	-0.55	1.18e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs10751667	0.643	rs10794343	chr11:925493	C/T	cg10932868	chr11:921992	NA	0.54	5.12	0.5	2.14e-6	Alzheimer's disease (late onset);
SKCM	cis	rs7659604	0.728	rs6852923	chr4:122688324	G/A	cg20573242	chr4:122745356	CCNA2	0.79	6.32	0.58	1.47e-8	Type 2 diabetes;
SKCM	cis	rs9911578	0.967	rs9907940	chr17:56663842	A/G	cg12560992	chr17:57184187	TRIM37	0.95	7.67	0.66	4.15e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs10754283	0.871	rs72712569	chr1:90125657	G/C	cg21401794	chr1:90099060	LRRC8C	-0.83	-7.22	-0.63	2.98e-10	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs7927771	0.839	rs59360790	chr11:47669175	T/C	cg05585544	chr11:47624801	NA	-0.59	-5.07	-0.5	2.62e-6	Subjective well-being;
SKCM	cis	rs6120849	0.707	rs6088694	chr20:33652371	G/A	cg24642439	chr20:33292090	TP53INP2	0.94	4.86	0.48	5.91e-6	Protein C levels;
SKCM	cis	rs1218582	0.804	rs869506	chr1:154859581	A/C	cg09359103	chr1:154839909	KCNN3	-0.57	-5.25	-0.51	1.26e-6	Prostate cancer;
SKCM	cis	rs561341	0.882	rs72825748	chr17:30367396	G/A	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs12188164	1.000	rs72717414	chr5:429818	C/G	cg26076054	chr5:421317	AHRR	-0.61	-4.8	-0.48	7.47e-6	Cystic fibrosis severity;
SKCM	cis	rs72781680	0.559	rs72796103	chr2:23900382	G/A	cg08917208	chr2:24149416	ATAD2B	1.0	5.01	0.49	3.3e-6	Lymphocyte counts;
SKCM	cis	rs17065868	1.000	rs73174004	chr13:45167628	G/A	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs7618501	0.633	rs9853222	chr3:50022926	T/C	cg05072774	chr3:49840536	C3orf54	-0.67	-5.06	-0.5	2.73e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs10504229	1.000	rs66495524	chr8:58187365	C/T	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs1218582	0.741	rs883718	chr1:154846274	C/T	cg06221963	chr1:154839813	KCNN3	-0.59	-5.99	-0.56	6.03e-8	Prostate cancer;
SKCM	cis	rs6951245	0.938	rs11764937	chr7:1092074	C/T	cg03188948	chr7:1209495	NA	1.06	5.7	0.54	2.04e-7	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs6449957	0.832	rs7715780	chr5:67453288	A/G	cg09038926	chr5:67483109	NA	-0.69	-5.21	-0.51	1.52e-6	Cleft lip with or without cleft palate;
SKCM	cis	rs13118159	0.573	rs4974618	chr4:1373663	C/T	cg20887711	chr4:1340912	KIAA1530	0.9	6.82	0.61	1.72e-9	Longevity;
SKCM	cis	rs5769765	0.954	rs6009900	chr22:50236610	T/C	cg22709217	chr22:50311962	ALG12;CRELD2	-0.88	-6.04	-0.56	5.03e-8	Schizophrenia;
SKCM	cis	rs7659604	0.502	rs13128434	chr4:122672461	A/C	cg19671926	chr4:122722719	EXOSC9	0.76	6.13	0.57	3.42e-8	Type 2 diabetes;
SKCM	cis	rs3820928	0.874	rs10188770	chr2:227877037	G/A	cg11843606	chr2:227700838	RHBDD1	-0.59	-4.77	-0.47	8.53e-6	Pulmonary function;
SKCM	cis	rs1552244	0.882	rs56125067	chr3:9984130	T/G	cg02579736	chr3:10068473	FANCD2;CIDECP	1.11	5.65	0.54	2.52e-7	Alzheimer's disease;
SKCM	cis	rs7666738	0.791	rs11730069	chr4:98945772	A/G	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10504229	0.683	rs56204590	chr8:58131642	T/G	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs10791097	0.703	rs11222360	chr11:130730871	C/T	cg12179176	chr11:130786555	SNX19	0.72	5.71	0.54	1.96e-7	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs477692	0.905	rs508360	chr10:131424969	A/G	cg11019008	chr10:131425282	MGMT	0.49	4.81	0.48	7.09e-6	Response to temozolomide;
SKCM	cis	rs28595532	0.925	rs115651057	chr4:119486708	A/G	cg21605333	chr4:119757512	SEC24D	1.24	7.1	0.63	5.16e-10	Cannabis dependence symptom count;
SKCM	cis	rs2839186	0.843	rs17182671	chr21:47696238	T/C	cg13126279	chr21:47581558	C21orf56	-0.62	-5.23	-0.51	1.4e-6	Testicular germ cell tumor;
SKCM	cis	rs17854409	0.881	rs68066790	chr20:61487150	T/A	cg06598544	chr20:61472147	COL9A3	-1.15	-5.39	-0.52	7.18e-7	Obesity-related traits;
SKCM	cis	rs11608355	0.618	rs4486687	chr12:109790741	T/A	cg19025524	chr12:109796872	NA	-0.64	-5.04	-0.5	2.96e-6	Neuroticism;
SKCM	cis	rs12477438	0.798	rs6704766	chr2:99642818	T/C	cg26064155	chr2:99771622	LIPT1;TSGA10	-0.72	-4.86	-0.48	6e-6	Chronic sinus infection;
SKCM	cis	rs7615952	0.800	rs11914298	chr3:125643772	G/A	cg05084668	chr3:125655381	ALG1L	-0.95	-4.99	-0.49	3.61e-6	Blood pressure (smoking interaction);
SKCM	cis	rs372883	0.564	rs13051579	chr21:30589840	C/T	cg24692254	chr21:30365293	RNF160	0.67	5.58	0.53	3.34e-7	Pancreatic cancer;
SKCM	cis	rs514406	0.929	rs557715	chr1:53321593	C/G	cg16325326	chr1:53192061	ZYG11B	0.92	9.93	0.75	1.75e-15	Monocyte count;
SKCM	cis	rs1552244	0.935	rs4441636	chr3:10083876	G/A	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs7809950	0.954	rs2712193	chr7:107125885	A/C	cg23024343	chr7:107201750	COG5	-0.74	-6.62	-0.6	4.19e-9	Coronary artery disease;
SKCM	cis	rs747650	0.798	rs11039086	chr11:47116033	G/C	cg03339077	chr11:47165057	C11orf49	-0.61	-5.27	-0.51	1.16e-6	Acne (severe);
SKCM	cis	rs7811142	0.943	rs3900792	chr7:100004577	C/G	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.11	6.45	0.59	8.66e-9	Platelet count;
SKCM	cis	rs459571	0.959	rs465535	chr9:136910905	C/T	cg13789015	chr9:136890014	NCRNA00094	0.73	5.89	0.55	9.27e-8	Platelet distribution width;
SKCM	cis	rs9467773	0.967	rs6932865	chr6:26540166	C/A	cg15659132	chr6:26577336	NA	0.6	5.71	0.54	1.99e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs12188164	1.000	rs34453673	chr5:434722	G/C	cg26076054	chr5:421317	AHRR	-0.61	-4.81	-0.48	7.34e-6	Cystic fibrosis severity;
SKCM	cis	rs2836974	0.965	rs9941894	chr21:40634058	C/T	cg11644478	chr21:40555479	PSMG1	1.04	11.55	0.79	1.45e-18	Cognitive function;
SKCM	cis	rs9814567	1.000	rs9828815	chr3:134265749	C/T	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs2952156	0.920	rs12940986	chr17:37836581	A/G	cg20243544	chr17:37824526	PNMT	-0.65	-5.2	-0.51	1.57e-6	Asthma;
SKCM	cis	rs7666738	0.830	rs13118945	chr4:98968586	T/G	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7216064	0.906	rs7223643	chr17:65830282	A/G	cg12091567	chr17:66097778	LOC651250	-0.77	-5.35	-0.52	8.48e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs9911578	1.000	rs1494977	chr17:56863064	C/T	cg12560992	chr17:57184187	TRIM37	0.95	7.69	0.66	3.7e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs12478296	0.901	rs58906257	chr2:243028248	T/C	cg06360820	chr2:242988706	NA	-0.94	-5.68	-0.54	2.21e-7	Obesity-related traits;
SKCM	cis	rs561341	1.000	rs72823789	chr17:30284084	G/A	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs8141529	0.719	rs2097461	chr22:29191879	T/C	cg02153584	chr22:29168773	CCDC117	0.66	5.36	0.52	8.31e-7	Lymphocyte counts;
SKCM	cis	rs1218582	0.628	rs12130132	chr1:154880386	C/T	cg16680214	chr1:154839983	KCNN3	-0.57	-5.12	-0.5	2.11e-6	Prostate cancer;
SKCM	cis	rs9790314	0.791	rs6809256	chr3:161026513	G/A	cg03342759	chr3:160939853	NMD3	-0.72	-8.12	-0.68	5.59e-12	Morning vs. evening chronotype;
SKCM	cis	rs7829975	0.688	rs6995407	chr8:8384647	C/G	cg15556689	chr8:8085844	FLJ10661	0.87	7.43	0.64	1.21e-10	Mood instability;
SKCM	cis	rs7811142	1.000	rs11761784	chr7:100039970	C/T	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.23	7.89	0.67	1.53e-11	Platelet count;
SKCM	cis	rs992157	0.798	rs1017698	chr2:219170525	A/G	cg20019365	chr2:219134978	PNKD;AAMP	-0.69	-5.97	-0.56	6.7e-8	Colorectal cancer;
SKCM	cis	rs1568889	0.838	rs1525717	chr11:28081205	T/C	cg06544937	chr11:28130018	METT5D1;KIF18A	0.89	8.44	0.69	1.31e-12	Bipolar disorder;
SKCM	cis	rs1218582	0.711	rs4845677	chr1:154838050	C/T	cg24250549	chr1:154909240	PMVK	0.84	8.9	0.71	1.69e-13	Prostate cancer;
SKCM	cis	rs2180341	1.000	rs9401950	chr6:127655485	C/T	cg27446573	chr6:127587934	RNF146	0.94	8.08	0.68	6.49e-12	Breast cancer;
SKCM	cis	rs6835098	1.000	rs1054496	chr4:174089080	A/G	cg08422745	chr4:174089978	GALNT7	-0.88	-6.47	-0.59	7.99e-9	Dementia and core Alzheimer's disease neuropathologic changes;
SKCM	cis	rs7829975	0.714	rs7823757	chr8:8670177	T/A	cg06636001	chr8:8085503	FLJ10661	0.7	6.07	0.57	4.28e-8	Mood instability;
SKCM	cis	rs10089	1.000	rs7713877	chr5:127428825	G/T	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.92	8.45	0.69	1.25e-12	Ileal carcinoids;
SKCM	cis	rs17685	0.712	rs1639620	chr7:75704090	A/G	cg16684958	chr7:75615977	POR	0.57	5.54	0.53	4e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs769267	0.930	rs7256149	chr19:19566255	T/C	cg03709012	chr19:19516395	GATAD2A	0.89	8.62	0.7	5.89e-13	Tonsillectomy;
SKCM	trans	rs10506458	0.915	rs60094497	chr12:63394838	T/G	cg03429785	chr15:59498649	MYO1E;LDHAL6B	-1.38	-7.54	-0.65	7.13e-11	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs12134245	0.874	rs17501937	chr1:92021705	C/T	cg02896835	chr1:92012615	NA	0.58	5.11	0.5	2.26e-6	Breast cancer;
SKCM	cis	rs6558174	0.965	rs1564595	chr8:22488939	A/G	cg03733263	chr8:22462867	KIAA1967	0.74	5.27	0.51	1.17e-6	Breast cancer;
SKCM	cis	rs9581857	0.547	rs7989917	chr13:28071271	G/A	cg22138327	chr13:27999177	GTF3A	0.86	5.87	0.55	1.01e-7	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs870825	0.587	rs28454955	chr4:185632701	C/T	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs7917772	0.532	rs10748829	chr10:104527244	G/A	cg11453585	chr10:104263688	ACTR1A;SUFU	-0.69	-4.79	-0.48	7.9e-6	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs7811142	0.945	rs6955362	chr7:100056166	C/T	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-0.99	-5.52	-0.53	4.2e-7	Platelet count;
SKCM	cis	rs832540	0.806	rs10039322	chr5:56260259	A/C	cg03609598	chr5:56110824	MAP3K1	-0.66	-4.91	-0.49	4.94e-6	Coronary artery disease;
SKCM	cis	rs2836950	0.565	rs2150414	chr21:40614988	A/G	cg11890956	chr21:40555474	PSMG1	-0.69	-5.43	-0.52	6.2e-7	Menarche (age at onset);
SKCM	cis	rs951366	0.617	rs823074	chr1:205774839	T/C	cg24739457	chr1:205821442	NA	0.53	4.9	0.49	5.07e-6	Menarche (age at onset);
SKCM	cis	rs13118159	0.550	rs4974614	chr4:1373489	A/G	cg02475777	chr4:1388615	CRIPAK	0.85	5.8	0.55	1.36e-7	Longevity;
SKCM	cis	rs9910055	0.762	rs2526021	chr17:42213347	G/A	cg09913183	chr17:42254507	C17orf65;ASB16	0.71	6.52	0.59	6.37e-9	Total body bone mineral density;
SKCM	cis	rs2013441	1.000	rs2703782	chr17:20144799	A/G	cg13482628	chr17:19912719	NA	-0.64	-5.04	-0.5	2.94e-6	Obesity-related traits;
SKCM	cis	rs17376456	0.877	rs10064520	chr5:93427358	T/C	cg25358565	chr5:93447407	FAM172A	1.23	7.97	0.67	1.08e-11	Diabetic retinopathy;
SKCM	cis	rs62238980	0.614	rs76142630	chr22:32392177	A/T	cg00543991	chr22:32367038	NA	1.15	4.87	0.48	5.76e-6	Childhood ear infection;
SKCM	cis	rs12188164	1.000	rs12188678	chr5:428231	T/C	cg26076054	chr5:421317	AHRR	-0.61	-4.8	-0.48	7.47e-6	Cystic fibrosis severity;
SKCM	cis	rs72781680	0.898	rs72782117	chr2:24026921	G/A	cg08917208	chr2:24149416	ATAD2B	0.97	5.17	0.5	1.79e-6	Lymphocyte counts;
SKCM	cis	rs7599312	0.534	rs7355673	chr2:213404389	T/C	cg20637307	chr2:213403960	ERBB4	0.76	5.6	0.54	3.12e-7	BMI (adjusted for smoking behaviour);BMI in non-smokers;Body mass index;Body mass index (joint analysis main effects and smoking interaction);
SKCM	cis	rs7613875	0.580	rs11709503	chr3:49991167	G/T	cg24110177	chr3:50126178	RBM5	-0.71	-5.68	-0.54	2.18e-7	Body mass index;
SKCM	cis	rs2153535	0.580	rs2327056	chr6:8443305	C/T	cg23788917	chr6:8435910	SLC35B3	0.69	5.14	0.5	1.99e-6	Motion sickness;
SKCM	cis	rs28595532	0.920	rs28538455	chr4:119486817	T/C	cg14228332	chr4:119757509	SEC24D	0.97	4.92	0.49	4.71e-6	Cannabis dependence symptom count;
SKCM	cis	rs9951698	0.667	rs6505775	chr18:12978183	T/C	cg12848697	chr18:13133368	NA	0.53	4.96	0.49	4.04e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9916302	0.904	rs10221223	chr17:37489100	T/G	cg07936489	chr17:37558343	FBXL20	0.82	7.18	0.63	3.61e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs748404	0.697	rs546170	chr15:43564849	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	0.69	5.61	0.54	2.99e-7	Lung cancer;
SKCM	cis	rs4478137	0.931	rs7687423	chr4:164250797	C/T	cg06758707	chr4:164254230	NPY1R	-0.87	-5.67	-0.54	2.33e-7	Subjective well-being (multi-trait analysis);Subjective well-being;
SKCM	cis	rs10540	1.000	rs35874808	chr11:506442	G/T	cg03576123	chr11:487126	PTDSS2	-1.43	-8.14	-0.68	5.08e-12	Body mass index;
SKCM	cis	rs12047808	0.687	rs6683326	chr1:179404277	G/A	cg08037922	chr1:179521085	C1orf125;NPHS2	-1.01	-5.21	-0.51	1.49e-6	Multiple sclerosis (age of onset);
SKCM	cis	rs7809950	0.862	rs62482502	chr7:106987810	A/C	cg23024343	chr7:107201750	COG5	-0.69	-5.75	-0.55	1.64e-7	Coronary artery disease;
SKCM	cis	rs9435341	0.965	rs3108680	chr1:107572997	T/C	cg09367891	chr1:107599246	PRMT6	0.83	7.25	0.63	2.64e-10	Facial morphology (factor 21, depth of nasal alae);
SKCM	cis	rs17376456	0.877	rs13173952	chr5:93307557	A/T	cg25358565	chr5:93447407	FAM172A	1.23	7.26	0.63	2.53e-10	Diabetic retinopathy;
SKCM	cis	rs7103648	0.966	rs10769263	chr11:47417183	A/C	cg20307385	chr11:47447363	PSMC3	1.06	9.25	0.72	3.6e-14	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs362296	0.511	rs2857861	chr4:3323767	C/T	cg16987761	chr4:3318072	RGS12	0.81	8.38	0.69	1.7e-12	Parental longevity (mother's age at death);
SKCM	cis	rs72634258	0.503	rs697674	chr1:7837878	C/G	cg26816564	chr1:7831052	VAMP3	0.78	5.51	0.53	4.39e-7	Inflammatory bowel disease;
SKCM	cis	rs7122539	0.646	rs543191	chr11:66583779	T/G	cg24851651	chr11:66362959	CCS	0.71	5.25	0.51	1.28e-6	HIV-1 susceptibility;
SKCM	cis	rs561341	1.000	rs4795669	chr17:30244701	C/T	cg00745463	chr17:30367425	LRRC37B	-0.89	-5.9	-0.56	8.83e-8	Hip circumference adjusted for BMI;
SKCM	cis	rs1577917	0.958	rs9647601	chr6:86449827	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.6	-5.1	-0.5	2.3e-6	Response to antipsychotic treatment;
SKCM	cis	rs6951245	1.000	rs113858334	chr7:1073476	A/G	cg24642844	chr7:1081250	C7orf50	-0.95	-6.4	-0.59	1.06e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs867186	0.925	rs1033799	chr20:33720033	G/T	cg04194272	chr20:33683537	NA	-0.99	-5.77	-0.55	1.55e-7	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs2463822	0.925	rs12292586	chr11:62156312	C/T	cg06239285	chr11:62104954	ASRGL1	-1.26	-5.85	-0.55	1.08e-7	Chronic obstructive pulmonary disease-related biomarkers;
SKCM	cis	rs6951245	0.938	rs113642700	chr7:1105654	C/T	cg24642844	chr7:1081250	C7orf50	-0.93	-6.22	-0.58	2.28e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs72634258	0.945	rs34466510	chr1:8147412	T/C	cg00042356	chr1:8021962	PARK7	1.06	7.22	0.63	2.99e-10	Inflammatory bowel disease;
SKCM	cis	rs11690935	0.918	rs12692978	chr2:172725981	C/T	cg13550731	chr2:172543902	DYNC1I2	-0.96	-7.09	-0.63	5.33e-10	Schizophrenia;
SKCM	cis	rs16854884	0.632	rs1910691	chr3:143656905	G/A	cg06585982	chr3:143692056	C3orf58	0.84	8.2	0.68	3.88e-12	Economic and political preferences (feminism/equality);
SKCM	cis	rs67311347	0.956	rs13066971	chr3:40462510	A/T	cg00091569	chr3:40428383	ENTPD3	-0.59	-4.83	-0.48	6.6e-6	Renal cell carcinoma;
SKCM	cis	rs7618915	0.547	rs13085895	chr3:52678270	G/C	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs1153858	1.000	rs56669689	chr15:45637729	A/C	cg21132104	chr15:45694354	SPATA5L1	0.92	8.33	0.69	2.14e-12	Homoarginine levels;
SKCM	cis	rs12142240	0.698	rs1475388	chr1:46816465	G/A	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs9467773	1.000	rs1884949	chr6:26568067	G/A	cg09904177	chr6:26538194	HMGN4	0.54	4.91	0.49	4.97e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2839186	0.869	rs17176513	chr21:47682428	A/G	cg13126279	chr21:47581558	C21orf56	-0.72	-6.11	-0.57	3.64e-8	Testicular germ cell tumor;
SKCM	cis	rs763121	0.815	rs9306328	chr22:39028913	C/T	cg06022373	chr22:39101656	GTPBP1	0.81	6.25	0.58	2.01e-8	Menopause (age at onset);
SKCM	cis	rs10540	1.000	rs35811812	chr11:498442	G/A	cg03576123	chr11:487126	PTDSS2	-1.43	-8.14	-0.68	5.08e-12	Body mass index;
SKCM	cis	rs2731664	0.792	rs335432	chr5:176866258	G/A	cg23176889	chr5:176863531	GRK6	-0.5	-5.19	-0.51	1.62e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs4862750	0.832	rs9995958	chr4:187901764	G/A	cg10295955	chr4:187884368	NA	-1.04	-13.97	-0.85	6.27e-23	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4237845	0.804	rs11172372	chr12:58286273	T/C	cg02175503	chr12:58329896	NA	0.79	7.32	0.64	1.94e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs9485372	0.945	rs4897114	chr6:149607978	G/A	cg03072286	chr6:150262044	ULBP2	-0.55	-4.89	-0.48	5.3e-6	Breast cancer;
SKCM	cis	rs651907	0.535	rs17412601	chr3:101499275	T/C	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.78	6.86	0.61	1.47e-9	Colorectal cancer;
SKCM	cis	rs1044826	0.619	rs7375091	chr3:139090389	T/A	cg15131784	chr3:139108705	COPB2	-0.68	-5.03	-0.49	3.1e-6	Obesity-related traits;
SKCM	cis	rs826838	0.935	rs11183940	chr12:38851642	A/G	cg26384229	chr12:38710491	ALG10B	1.05	10.1	0.75	8.14e-16	Heart rate;
SKCM	cis	rs7178909	0.902	rs3853638	chr15:90443140	C/T	cg19708238	chr15:90437601	AP3S2	-0.71	-5.27	-0.51	1.17e-6	Common traits (Other);
SKCM	cis	rs873946	0.586	rs3829130	chr10:134563122	C/T	cg27286337	chr10:134555280	INPP5A	0.98	8.81	0.71	2.49e-13	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs910316	1.000	rs2268617	chr14:75608728	G/A	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.85e-7	Height;
SKCM	cis	rs8014204	0.604	rs11159109	chr14:75389074	G/A	cg06637938	chr14:75390232	RPS6KL1	0.95	6.8	0.61	1.9e-9	Caffeine consumption;
SKCM	cis	rs1801251	0.964	rs10933411	chr2:233706847	A/G	cg08000102	chr2:233561755	GIGYF2	-0.89	-7.22	-0.63	3.02e-10	Coronary artery disease;
SKCM	cis	rs1577917	1.000	rs12664335	chr6:86597774	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.81	8.03	0.67	8.17e-12	Response to antipsychotic treatment;
SKCM	cis	rs2033711	0.837	rs3764535	chr19:58929052	G/A	cg13877915	chr19:58951672	ZNF132	0.95	10.27	0.76	3.76e-16	Uric acid clearance;
SKCM	cis	rs7122539	0.646	rs594313	chr11:66608991	A/G	cg12372692	chr11:66233905	PELI3	-0.7	-4.97	-0.49	3.85e-6	HIV-1 susceptibility;
SKCM	cis	rs780096	0.546	rs715325	chr2:27725572	C/A	cg05696406	chr2:27599888	SNX17	0.52	5.3	0.51	1.05e-6	Total body bone mineral density;
SKCM	cis	rs2760061	0.545	rs1745423	chr1:228224153	G/T	cg02753203	chr1:228287806	NA	-0.61	-5.32	-0.52	9.82e-7	Diastolic blood pressure;
SKCM	cis	rs7945705	0.692	rs11042149	chr11:9010737	T/C	cg21881798	chr11:8931708	C11orf17;ST5	-0.87	-9.66	-0.74	5.65e-15	Hemoglobin concentration;
SKCM	cis	rs2014572	0.933	rs8109882	chr19:57755618	C/G	cg24459738	chr19:57751996	ZNF805	-0.64	-5.29	-0.51	1.1e-6	Hyperactive-impulsive symptoms;
SKCM	cis	rs641862	1	rs641862	chr13:110790232	C/T	cg04820411	chr13:111525614	NA	1.35	5.13	0.5	2.05e-6	Obesity-related traits;
SKCM	cis	rs10193935	0.901	rs12615383	chr2:42610551	A/G	cg27598129	chr2:42591480	NA	0.85	6.31	0.58	1.58e-8	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs12541335	0.639	rs7834182	chr8:22163112	G/A	cg02463440	chr8:22132932	PIWIL2	0.61	5.33	0.52	9.42e-7	Hypertriglyceridemia;
SKCM	cis	rs5760092	0.627	rs6519489	chr22:24261846	G/A	cg04234412	chr22:24373322	LOC391322	0.77	5.95	0.56	7.23e-8	Urinary 1,3-butadiene metabolite levels in smokers;
SKCM	cis	rs2404602	0.692	rs12595586	chr15:77172210	A/G	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs10504229	0.861	rs67042991	chr8:58191749	G/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs11025559	0.812	rs11025583	chr11:20513260	C/T	cg19653624	chr11:20408972	PRMT3	0.7	4.83	0.48	6.76e-6	Pursuit maintenance gain;
SKCM	cis	rs7666738	0.830	rs10007261	chr4:98926155	C/T	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10769945	0.679	rs2137322	chr11:1917354	A/G	cg23202291	chr11:1979235	NA	-0.56	-5.68	-0.54	2.2e-7	DNA methylation (variation);
SKCM	cis	rs523522	0.962	rs3213565	chr12:120992401	C/T	cg12219531	chr12:120966889	COQ5	0.91	7.82	0.66	2.11e-11	High light scatter reticulocyte count;
SKCM	cis	rs611744	0.573	rs629996	chr8:109255206	C/T	cg18478394	chr8:109455254	TTC35	0.65	5.48	0.53	4.97e-7	Dupuytren's disease;
SKCM	cis	rs80130819	0.748	rs2732478	chr12:48699537	G/A	cg13203223	chr12:49319398	FKBP11	0.9	4.81	0.48	7.21e-6	Prostate cancer;
SKCM	cis	rs3096299	0.503	rs4785677	chr16:89555101	A/G	cg02187348	chr16:89574699	SPG7	0.65	5.19	0.51	1.65e-6	Multiple myeloma (IgH translocation);
SKCM	cis	rs763121	0.853	rs6001173	chr22:39015302	A/G	cg06022373	chr22:39101656	GTPBP1	0.87	6.07	0.57	4.28e-8	Menopause (age at onset);
SKCM	cis	rs10416265	0.527	rs11084699	chr19:33538393	A/T	cg03563238	chr19:33554763	RHPN2	-0.59	-4.81	-0.48	7.24e-6	Bone properties (heel);
SKCM	cis	rs9399137	0.507	rs35571217	chr6:135290355	T/C	cg24558204	chr6:135376177	HBS1L	0.69	6.37	0.59	1.19e-8	Glycated hemoglobin levels;Mean corpuscular volume;Hematology traits;HbA2 levels;Mean corpuscular hemoglobin;Hemoglobin levels;F-cell distribution;Platelet count;
SKCM	cis	rs780096	0.526	rs10182937	chr2:27651693	T/C	cg05696406	chr2:27599888	SNX17	0.51	5.22	0.51	1.46e-6	Total body bone mineral density;
SKCM	cis	rs3741404	0.791	rs7102177	chr11:63909228	T/C	cg19465662	chr11:63993652	NUDT22;TRPT1	0.79	5.27	0.51	1.19e-6	Platelet count;
SKCM	cis	rs4819052	0.851	rs2255766	chr21:46683777	C/T	cg19498844	chr21:46707878	POFUT2;LOC642852	0.89	7.71	0.66	3.36e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs9674544	0.757	rs6504593	chr17:47132819	T/C	cg11673840	chr17:47092156	IGF2BP1	-0.51	-4.88	-0.48	5.49e-6	Primary tooth development (time to first tooth eruption);Primary tooth development (number of teeth);
SKCM	cis	rs1707322	1.000	rs7532204	chr1:46485075	C/G	cg03146154	chr1:46216737	IPP	-0.77	-5.36	-0.52	8.35e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs9902453	0.765	rs2628180	chr17:28101723	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.78	-5.89	-0.56	9.1e-8	Coffee consumption (cups per day);
SKCM	cis	rs908922	0.676	rs539393	chr1:152518896	C/T	cg09873164	chr1:152488093	CRCT1	0.77	6.04	0.56	5.01e-8	Hair morphology;
SKCM	cis	rs12478296	0.901	rs67423532	chr2:243004719	A/G	cg06360820	chr2:242988706	NA	-1.02	-5.87	-0.55	1.03e-7	Obesity-related traits;
SKCM	cis	rs2404602	0.692	rs58361452	chr15:76973372	T/C	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs2180341	0.680	rs9388554	chr6:127576234	C/G	cg24812749	chr6:127587940	RNF146	0.79	6.57	0.6	5.17e-9	Breast cancer;
SKCM	cis	rs28386778	0.897	rs7212196	chr17:61834981	T/C	cg01411255	chr17:61851458	DDX42;CCDC47	0.78	5.01	0.49	3.36e-6	Prudent dietary pattern;
SKCM	cis	rs826838	0.904	rs10876086	chr12:39188208	C/A	cg13010199	chr12:38710504	ALG10B	0.67	5.06	0.5	2.68e-6	Heart rate;
SKCM	cis	rs155076	1.000	rs261430	chr13:21865242	C/T	cg11317459	chr13:21872234	NA	-1.32	-7.62	-0.65	5.15e-11	White matter hyperintensity burden;
SKCM	cis	rs7523273	0.927	rs2796275	chr1:207950490	C/T	cg22525895	chr1:207977042	MIR29B2	0.77	6.01	0.56	5.58e-8	Schizophrenia;
SKCM	cis	rs929354	0.557	rs62491947	chr7:156960813	G/A	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs244731	0.959	rs6872021	chr5:176610012	G/A	cg06060754	chr5:176797920	RGS14	-0.82	-7.22	-0.63	2.97e-10	Urate levels in lean individuals;
SKCM	cis	rs854765	0.693	rs9907246	chr17:17770965	T/C	cg24612305	chr17:17875800	TOM1L2;LRRC48	-1.02	-8.56	-0.7	7.67e-13	Total body bone mineral density;
SKCM	cis	rs12597458	0.752	rs8051239	chr16:72036257	T/A	cg01557791	chr16:72042693	DHODH	0.96	8.2	0.68	3.8e-12	Prostate cancer;
SKCM	cis	rs9916302	0.706	rs667239	chr17:37442241	A/G	cg07936489	chr17:37558343	FBXL20	1.02	7.2	0.63	3.34e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs1348850	0.632	rs12467363	chr2:178502512	C/T	cg02961200	chr2:178257176	LOC100130691;AGPS	0.74	4.97	0.49	3.9e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs9303401	0.614	rs35245220	chr17:56510305	G/A	cg10487724	chr17:56770010	TEX14;RAD51C	0.82	5.79	0.55	1.41e-7	Cognitive test performance;
SKCM	cis	rs1348850	0.597	rs4893964	chr2:178447658	G/T	cg02961200	chr2:178257176	LOC100130691;AGPS	0.85	5.23	0.51	1.37e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs7666738	0.830	rs1534319	chr4:98964804	T/C	cg17366294	chr4:99064904	C4orf37	0.59	4.89	0.48	5.36e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7793919	0.726	rs4720401	chr7:4780943	G/A	cg09789173	chr7:4769017	FOXK1	0.89	7.06	0.62	5.95e-10	Mosquito bite size;
SKCM	cis	rs10754283	0.967	rs10801761	chr1:90115269	C/T	cg21401794	chr1:90099060	LRRC8C	0.73	6.34	0.58	1.35e-8	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs2839186	0.708	rs6518285	chr21:47644667	T/C	cg11766577	chr21:47581405	C21orf56	-0.73	-6.37	-0.58	1.24e-8	Testicular germ cell tumor;
SKCM	cis	rs1799949	1.000	rs1960605	chr17:41305397	C/T	cg23758822	chr17:41437982	NA	0.92	7.83	0.66	1.97e-11	Menopause (age at onset);
SKCM	cis	rs801193	0.967	rs2707853	chr7:66214010	G/A	cg00343986	chr7:65444356	GUSB	0.67	4.98	0.49	3.74e-6	Aortic root size;
SKCM	cis	rs796364	1.000	rs11694369	chr2:200741720	G/A	cg12253985	chr2:200820533	C2orf60;C2orf47	-0.96	-5.67	-0.54	2.3e-7	Schizophrenia;
SKCM	cis	rs6982751	0.673	rs73196861	chr8:10814355	C/T	cg01383082	chr8:11323474	FAM167A	0.91	5.11	0.5	2.21e-6	Asthma and hay fever;
SKCM	cis	rs1577917	1.000	rs12205548	chr6:86759770	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.64	-5.48	-0.53	5.09e-7	Response to antipsychotic treatment;
SKCM	cis	rs11690935	0.879	rs13017585	chr2:172721808	C/A	cg13550731	chr2:172543902	DYNC1I2	-0.96	-7.09	-0.63	5.33e-10	Schizophrenia;
SKCM	cis	rs28595532	0.920	rs56117870	chr4:119766583	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs7772486	0.713	rs1986729	chr6:146194831	G/A	cg05347473	chr6:146136440	FBXO30	0.58	5.63	0.54	2.77e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs17376456	0.877	rs28418572	chr5:93144161	A/C	cg25358565	chr5:93447407	FAM172A	1.19	7.78	0.66	2.52e-11	Diabetic retinopathy;
SKCM	cis	rs10492096	0.947	rs11064231	chr12:6604415	T/G	cg13857086	chr12:6580257	VAMP1	0.76	5.75	0.55	1.64e-7	Hip geometry;
SKCM	cis	rs4724125	0.883	rs62444189	chr7:42677741	A/C	cg09407816	chr7:42972088	MRPL32;PSMA2	0.81	4.85	0.48	6.13e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs3768617	0.510	rs2296291	chr1:183079509	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs1799949	0.965	rs12947782	chr17:41279882	A/G	cg23758822	chr17:41437982	NA	0.92	7.8	0.66	2.3e-11	Menopause (age at onset);
SKCM	cis	rs7777484	0.500	rs757787	chr7:2836355	G/A	cg19717773	chr7:2847554	GNA12	-0.47	-5.6	-0.54	3.07e-7	Height;
SKCM	cis	rs2204008	0.683	rs12370288	chr12:38127740	G/A	cg26384229	chr12:38710491	ALG10B	0.82	6.58	0.6	4.87e-9	Bladder cancer;
SKCM	cis	rs4423214	0.879	rs12803256	chr11:71132868	A/G	cg05163923	chr11:71159392	DHCR7	0.77	7.41	0.64	1.27e-10	Vitamin D levels;
SKCM	cis	rs11690935	0.959	rs10204501	chr2:172588865	C/G	cg13550731	chr2:172543902	DYNC1I2	-0.95	-8.21	-0.68	3.64e-12	Schizophrenia;
SKCM	trans	rs1814175	0.676	rs1851859	chr11:49860405	A/T	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs1577917	0.883	rs1415749	chr6:86779084	G/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.65	5.75	0.55	1.63e-7	Response to antipsychotic treatment;
SKCM	cis	rs7020830	0.823	rs13285624	chr9:37129496	T/G	cg14294708	chr9:37120828	ZCCHC7	1.1	9.85	0.74	2.48e-15	Schizophrenia;
SKCM	cis	rs8177253	1.000	rs8177252	chr3:133480174	C/A	cg16414030	chr3:133502952	NA	-0.69	-5.78	-0.55	1.49e-7	Iron status biomarkers;
SKCM	cis	rs1160297	0.575	rs10865272	chr2:53093447	C/T	cg07782112	chr2:53107842	NA	0.58	6.04	0.56	5e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs2832191	0.755	rs2832192	chr21:30491173	G/T	cg24692254	chr21:30365293	RNF160	-0.95	-7.99	-0.67	1e-11	Dental caries;
SKCM	cis	rs116095464	0.558	rs7356535	chr5:284117	G/T	cg22857025	chr5:266934	NA	-1.58	-8.14	-0.68	4.99e-12	Breast cancer;
SKCM	cis	rs71520386	0.632	rs10253651	chr7:22870183	A/G	cg15401507	chr7:22894281	NA	0.65	4.87	0.48	5.7e-6	Fibrinogen levels;
SKCM	cis	rs1801251	1.000	rs56777991	chr2:233635388	A/C	cg25237894	chr2:233734115	C2orf82	0.6	5.8	0.55	1.36e-7	Coronary artery disease;
SKCM	cis	rs870825	0.616	rs6552809	chr4:185643984	G/A	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs9902453	0.765	rs2169810	chr17:28167941	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.8	6.02	0.56	5.28e-8	Coffee consumption (cups per day);
SKCM	cis	rs2050392	0.767	rs2183175	chr10:30699336	A/G	cg25182066	chr10:30743637	MAP3K8	0.67	5.59	0.54	3.17e-7	Inflammatory bowel disease;
SKCM	cis	rs59918340	0.728	rs4961340	chr8:142232002	G/A	cg23750338	chr8:142222470	SLC45A4	0.62	6.04	0.56	4.98e-8	Immature fraction of reticulocytes;
SKCM	cis	rs1552244	0.832	rs3732968	chr3:10013273	A/G	cg02579736	chr3:10068473	FANCD2;CIDECP	0.98	4.84	0.48	6.48e-6	Alzheimer's disease;
SKCM	cis	rs7811142	1.000	rs60257855	chr7:100026780	G/C	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.12	6.51	0.59	6.68e-9	Platelet count;
SKCM	cis	rs28386778	0.897	rs2727287	chr17:61904728	G/A	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs9581857	0.615	rs79553479	chr13:28007862	G/A	cg22138327	chr13:27999177	GTF3A	0.94	6.26	0.58	1.96e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs4803468	0.967	rs892044	chr19:41903671	A/G	cg09537434	chr19:41945824	ATP5SL	-1.08	-13.01	-0.83	3.1e-21	Height;
SKCM	cis	rs6445797	0.632	rs9881789	chr3:56621727	C/T	cg13616963	chr3:57583610	ARF4	-0.79	-5.1	-0.5	2.35e-6	Gastritis;
SKCM	cis	rs561341	0.941	rs17780080	chr17:30343146	G/A	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs155076	0.711	rs4770129	chr13:21882059	T/G	cg14456004	chr13:21872349	NA	1.3	7.55	0.65	6.84e-11	White matter hyperintensity burden;
SKCM	cis	rs9796	0.717	rs2947494	chr15:41375741	C/T	cg00616447	chr15:41694635	NDUFAF1	0.75	4.77	0.48	8.36e-6	Menopause (age at onset);
SKCM	cis	rs561341	0.710	rs9900031	chr17:30199537	T/C	cg00745463	chr17:30367425	LRRC37B	0.91	5.32	0.52	9.65e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs1577917	0.771	rs12205013	chr6:86333029	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-1.01	-11.45	-0.79	2.22e-18	Response to antipsychotic treatment;
SKCM	cis	rs2108225	0.872	rs2051955	chr7:107441154	C/T	cg18560240	chr7:107437656	SLC26A3	-0.66	-5.36	-0.52	8.15e-7	Ulcerative colitis;
SKCM	cis	rs1405130	0.869	rs13001109	chr2:235569646	A/G	cg21542780	chr2:234763377	HJURP	-0.64	-4.89	-0.48	5.21e-6	Coronary artery disease;
SKCM	cis	rs2153535	0.546	rs9378559	chr6:8539058	A/T	cg23788917	chr6:8435910	SLC35B3	0.7	4.93	0.49	4.59e-6	Motion sickness;
SKCM	cis	rs12134245	0.719	rs61798831	chr1:91996588	C/T	cg25838465	chr1:92012736	NA	-0.84	-9.35	-0.73	2.27e-14	Breast cancer;
SKCM	cis	rs473651	0.935	rs578510	chr2:239343140	C/T	cg18131467	chr2:239335373	ASB1	1.09	13.23	0.83	1.27e-21	Multiple system atrophy;
SKCM	cis	rs2153535	0.546	rs9378559	chr6:8539058	A/T	cg07606381	chr6:8435919	SLC35B3	0.93	6.41	0.59	1e-8	Motion sickness;
SKCM	cis	rs17376456	0.825	rs17314825	chr5:93234937	A/G	cg25358565	chr5:93447407	FAM172A	1.26	7.82	0.66	2.11e-11	Diabetic retinopathy;
SKCM	cis	rs8180040	0.966	rs6800271	chr3:47470787	A/T	cg27129171	chr3:47204927	SETD2	-0.75	-5.6	-0.54	3.13e-7	Colorectal cancer;
SKCM	cis	rs8141529	0.719	rs6005916	chr22:29233342	T/C	cg15103426	chr22:29168792	CCDC117	0.61	5.13	0.5	2.06e-6	Lymphocyte counts;
SKCM	cis	rs11122272	0.735	rs2808602	chr1:231537303	A/G	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	-0.6	-4.8	-0.48	7.45e-6	Hemoglobin concentration;
SKCM	cis	rs4919087	0.923	rs12357266	chr10:98978045	G/A	cg25902810	chr10:99078978	FRAT1	0.68	5.31	0.52	9.98e-7	Monocyte count;
SKCM	cis	rs8072100	0.967	rs11656855	chr17:45714655	C/T	cg08085267	chr17:45401833	C17orf57	0.61	5.44	0.52	5.83e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs9300255	0.602	rs2851435	chr12:123712416	G/A	cg05973401	chr12:123451056	ABCB9	0.79	5.2	0.51	1.59e-6	Neutrophil percentage of white cells;
SKCM	cis	rs28595532	0.920	rs115850161	chr4:119732447	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.43	0.59	9.38e-9	Cannabis dependence symptom count;
SKCM	cis	rs3785574	0.962	rs2584621	chr17:61912436	G/A	cg06601766	chr17:61851465	DDX42;CCDC47	0.73	5.38	0.52	7.7300000000000005e-07	Height;
SKCM	cis	rs11098499	0.779	rs7356491	chr4:120381974	C/T	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs1577917	0.958	rs2197648	chr6:86543887	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.81	-0.66	2.19e-11	Response to antipsychotic treatment;
SKCM	cis	rs875971	0.862	rs11763189	chr7:65983529	G/A	cg11764359	chr7:65958608	NA	0.81	7.62	0.65	5.07e-11	Aortic root size;
SKCM	trans	rs8073060	0.544	rs8072676	chr17:33999517	C/T	cg19694781	chr19:47549865	TMEM160	-1.0	-8.56	-0.7	7.62e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs2811415	0.561	rs9857061	chr3:127763226	A/G	cg09089421	chr3:127803668	RUVBL1	0.99	8.52	0.69	9.09e-13	Lung function (FEV1/FVC);
SKCM	cis	rs8180040	0.654	rs13078131	chr3:47204939	G/T	cg27129171	chr3:47204927	SETD2	0.82	6.44	0.59	9.04e-9	Colorectal cancer;
SKCM	cis	rs7811142	0.720	rs7795656	chr7:99950297	A/T	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.07	6.7	0.6	2.88e-9	Platelet count;
SKCM	cis	rs62238980	0.614	rs77132907	chr22:32501006	T/C	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs208520	0.690	rs4710311	chr6:66823223	C/T	cg07460842	chr6:66804631	NA	-0.97	-7.79	-0.66	2.45e-11	Exhaled nitric oxide output;
SKCM	cis	rs367615	0.506	rs1428932	chr5:108792479	A/G	cg17395555	chr5:108820864	NA	-0.8	-7.23	-0.63	2.87e-10	Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs35306767	0.761	rs34480046	chr10:1027440	A/G	cg25614935	chr10:1084866	C10orf110	0.68	4.84	0.48	6.55e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs6570726	0.967	rs439017	chr6:145806123	T/C	cg23711669	chr6:146136114	FBXO30	0.73	6.96	0.62	9.48e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs12950390	0.820	rs58391889	chr17:45865959	A/G	cg03474202	chr17:45855739	NA	-0.48	-5.39	-0.52	7.29e-7	IgG glycosylation;
SKCM	cis	rs7843479	0.601	rs10866827	chr8:21801141	G/A	cg17168535	chr8:21777572	XPO7	0.84	7.91	0.67	1.38e-11	Mean corpuscular volume;
SKCM	cis	rs561341	1.000	rs7214017	chr17:30332220	T/C	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs7523273	0.925	rs12132780	chr1:207999605	C/T	cg22525895	chr1:207977042	MIR29B2	-0.78	-5.76	-0.55	1.57e-7	Schizophrenia;
SKCM	cis	rs2839186	0.771	rs13046451	chr21:47641373	T/A	cg11766577	chr21:47581405	C21orf56	0.73	6.37	0.58	1.24e-8	Testicular germ cell tumor;
SKCM	cis	rs6952808	1.000	rs6954673	chr7:1886937	C/T	cg04267008	chr7:1944627	MAD1L1	-0.8	-6.1	-0.57	3.78e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs55962025	0.804	rs362268	chr4:3242148	C/G	cg24015175	chr4:3319247	RGS12	-0.68	-5.9	-0.56	8.72e-8	Parental longevity (mother's age at death);
SKCM	cis	rs6089829	0.889	rs6122348	chr20:61663921	C/T	cg08564027	chr20:61660810	NA	0.63	5.65	0.54	2.56e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs12709013	0.792	rs1615326	chr16:58781052	C/T	cg02431531	chr16:59244939	NA	0.48	5.17	0.51	1.73e-6	Blood metabolite ratios;
SKCM	trans	rs9329221	0.935	rs3750311	chr8:10283602	C/A	cg06636001	chr8:8085503	FLJ10661	-0.96	-8.72	-0.7	3.83e-13	Neuroticism;
SKCM	cis	rs1577917	0.958	rs34994386	chr6:86524135	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.81	-0.66	2.19e-11	Response to antipsychotic treatment;
SKCM	cis	rs9902453	0.845	rs2617865	chr17:28049804	G/T	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.82	-5.78	-0.55	1.47e-7	Coffee consumption (cups per day);
SKCM	cis	rs1552244	1.000	rs7648104	chr3:10073311	C/A	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs55962025	0.842	rs362267	chr4:3243218	C/T	cg09735869	chr4:3319127	RGS12	-0.77	-6.01	-0.56	5.49e-8	Parental longevity (mother's age at death);
SKCM	cis	rs67460515	0.500	rs964533	chr3:160749019	C/A	cg03342759	chr3:160939853	NMD3	-0.66	-5.09	-0.5	2.43e-6	Parkinson's disease;
SKCM	cis	rs9297145	0.916	rs4236540	chr7:98769025	A/C	cg05967295	chr7:98741636	SMURF1	1.12	8.67	0.7	4.82e-13	Crohn's disease;Inflammatory bowel disease;Ulcerative colitis;
SKCM	cis	rs9640161	0.750	rs11769348	chr7:150026753	C/T	cg27494647	chr7:150038898	RARRES2	-0.58	-4.98	-0.49	3.74e-6	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs7296418	0.619	rs7139321	chr12:123719528	T/G	cg00376283	chr12:123451042	ABCB9	0.88	7.23	0.63	2.87e-10	Platelet count;
SKCM	cis	rs55728055	0.661	rs62237791	chr22:31973124	A/G	cg01338084	chr22:32026380	PISD	1.5	5.03	0.49	3.11e-6	Age-related hearing impairment;
SKCM	cis	rs10193935	0.901	rs10171643	chr2:42532912	C/T	cg27598129	chr2:42591480	NA	-0.86	-6.78	-0.61	2.03e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs929354	0.772	rs6971896	chr7:156978412	C/T	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs1801251	1.000	rs1801251	chr2:233633460	G/A	cg08000102	chr2:233561755	GIGYF2	0.89	7.19	0.63	3.47e-10	Coronary artery disease;
SKCM	cis	rs523522	0.962	rs12814055	chr12:120987391	G/A	cg27279351	chr12:120934652	DYNLL1	0.91	8.32	0.69	2.26e-12	High light scatter reticulocyte count;
SKCM	cis	rs875971	0.619	rs10278371	chr7:66051540	C/A	cg18876405	chr7:65276391	NA	-0.82	-7.53	-0.65	7.59e-11	Aortic root size;
SKCM	cis	rs62103177	0.525	rs612913	chr18:77845882	A/G	cg27393146	chr18:77495563	CTDP1	0.85	5.67	0.54	2.3e-7	Opioid sensitivity;
SKCM	cis	rs801193	0.805	rs12532355	chr7:66070584	C/G	cg11764359	chr7:65958608	NA	-0.8	-5.9	-0.56	9.06e-8	Aortic root size;
SKCM	cis	rs644799	1.000	rs488246	chr11:95560473	T/C	cg03916912	chr11:95522834	CEP57;FAM76B	0.88	7.53	0.65	7.59e-11	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs72615157	0.634	rs74774557	chr7:99810425	A/G	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.08	6.55	0.6	5.47e-9	Lung function (FEV1/FVC);
SKCM	cis	rs769267	0.930	rs6511038	chr19:19607564	A/C	cg26732615	chr19:19648335	CILP2;YJEFN3	0.67	7.06	0.62	6e-10	Tonsillectomy;
SKCM	cis	rs7945705	0.806	rs12224436	chr11:8815825	C/A	cg21881798	chr11:8931708	C11orf17;ST5	0.66	6.51	0.59	6.59e-9	Hemoglobin concentration;
SKCM	cis	rs117623576	0.590	rs2988084	chr10:32398653	C/T	cg03047570	chr10:32398778	NA	0.61	4.77	0.48	8.51e-6	Anti-saccade response;
SKCM	cis	rs6500395	0.651	rs28432694	chr16:48666310	A/T	cg04672837	chr16:48644449	N4BP1	0.6	4.8	0.48	7.37e-6	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs9399135	1.000	rs1014021	chr6:135334600	C/T	cg24558204	chr6:135376177	HBS1L	-0.57	-5.14	-0.5	2.02e-6	Red blood cell count;
SKCM	cis	rs9910055	0.529	rs228764	chr17:42185469	A/G	cg08499158	chr17:42289980	UBTF	0.72	5.61	0.54	2.95e-7	Total body bone mineral density;
SKCM	cis	rs801193	1.000	rs7783924	chr7:66209057	A/C	cg11764359	chr7:65958608	NA	0.86	6.55	0.6	5.68e-9	Aortic root size;
SKCM	cis	rs611744	0.625	rs4735055	chr8:109286642	G/A	cg18478394	chr8:109455254	TTC35	0.63	5.09	0.5	2.45e-6	Dupuytren's disease;
SKCM	cis	rs60871478	1.000	rs7795258	chr7:795227	A/G	cg05535760	chr7:792225	HEATR2	1.02	8.66	0.7	4.97e-13	Cerebrospinal P-tau181p levels;
SKCM	cis	rs6430585	0.583	rs3769001	chr2:136626078	A/G	cg07169764	chr2:136633963	MCM6	1.31	13.05	0.83	2.59e-21	Corneal structure;
SKCM	cis	rs1003719	0.788	rs2835593	chr21:38465873	G/C	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs3768617	0.510	rs4652776	chr1:183091920	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs2839186	0.709	rs2156117	chr21:47669300	C/A	cg05896524	chr21:47604654	C21orf56	0.72	5.91	0.56	8.41e-8	Testicular germ cell tumor;
SKCM	cis	rs8014204	0.836	rs888413	chr14:75267396	C/T	cg06637938	chr14:75390232	RPS6KL1	0.77	5.95	0.56	7.2e-8	Caffeine consumption;
SKCM	cis	rs899997	1.000	rs11632672	chr15:79044330	A/G	cg04896959	chr15:78267971	NA	0.57	5.0	0.49	3.49e-6	Coronary artery disease or large artery stroke;
SKCM	cis	rs7618501	0.633	rs3774733	chr3:50037123	C/G	cg05072774	chr3:49840536	C3orf54	-0.67	-5.06	-0.5	2.73e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs4481887	0.893	rs10888349	chr1:248448625	T/C	cg00666640	chr1:248458726	OR2T12	0.6	4.9	0.49	5.01e-6	Common traits (Other);
SKCM	cis	rs7408868	0.908	rs757474	chr19:15273624	T/C	cg14696996	chr19:15285081	NOTCH3	0.82	4.92	0.49	4.7e-6	Pulse pressure;
SKCM	cis	rs2153535	0.541	rs6923558	chr6:8461467	T/G	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs4319547	0.695	rs6488958	chr12:122880704	A/G	cg23029597	chr12:123009494	RSRC2	-0.69	-4.81	-0.48	7.22e-6	Body mass index;
SKCM	cis	rs2839186	0.564	rs4819215	chr21:47623573	G/A	cg11766577	chr21:47581405	C21orf56	-0.77	-6.95	-0.62	9.87e-10	Testicular germ cell tumor;
SKCM	cis	rs9303401	0.580	rs2013166	chr17:56637630	C/T	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.61	0.54	2.94e-7	Cognitive test performance;
SKCM	cis	rs9788682	0.846	rs684513	chr15:78858400	C/G	cg24631222	chr15:78858424	CHRNA5	1.02	6.51	0.59	6.72e-9	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs9475752	0.947	rs748996	chr6:56798021	A/C	cg06815302	chr6:57335405	PRIM2	0.64	5.25	0.51	1.29e-6	Menarche (age at onset);
SKCM	cis	rs55794721	0.509	rs11249248	chr1:25753051	T/C	cg02931644	chr1:25747376	RHCE	0.53	5.35	0.52	8.54e-7	Plateletcrit;Mean corpuscular volume;
SKCM	cis	rs2836974	0.666	rs35182074	chr21:40685284	A/C	cg11644478	chr21:40555479	PSMG1	-0.68	-5.93	-0.56	7.94e-8	Cognitive function;
SKCM	cis	rs9475752	0.793	rs34009699	chr6:56871847	G/A	cg06815302	chr6:57335405	PRIM2	0.68	4.87	0.48	5.74e-6	Menarche (age at onset);
SKCM	cis	rs151997	1.000	rs32483	chr5:50205230	C/T	cg06027927	chr5:50259733	NA	0.66	5.78	0.55	1.45e-7	Callous-unemotional behaviour;
SKCM	trans	rs11722228	0.521	rs12501336	chr4:10137351	G/A	cg26043149	chr18:55253948	FECH	0.97	9.04	0.72	8.99e-14	Gout;Urate levels;Serum uric acid levels;
SKCM	cis	rs4319547	0.585	rs10846792	chr12:122882374	T/C	cg23029597	chr12:123009494	RSRC2	-0.73	-5.37	-0.52	7.93e-7	Body mass index;
SKCM	cis	rs116095464	0.558	rs6875291	chr5:264192	T/C	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs6087990	0.735	rs6058891	chr20:31386347	T/C	cg13636640	chr20:31349939	DNMT3B	0.83	6.25	0.58	2.06e-8	Ulcerative colitis;
SKCM	cis	rs736408	0.812	rs4687654	chr3:52827566	G/A	cg18404041	chr3:52824283	ITIH1	-0.62	-5.25	-0.51	1.26e-6	Bipolar disorder;
SKCM	cis	rs2032447	0.507	rs199748	chr6:25909045	C/G	cg03264133	chr6:25882463	NA	-0.63	-5.71	-0.54	1.94e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs79040073	0.530	rs73396206	chr15:49615829	C/G	cg25951582	chr15:49913451	C15orf33;DTWD1	-0.72	-5.23	-0.51	1.4e-6	Lung cancer in ever smokers;
SKCM	cis	rs1005277	0.579	rs2474574	chr10:38387295	C/T	cg25427524	chr10:38739819	LOC399744	-0.69	-6.45	-0.59	8.73e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs870825	0.655	rs6552812	chr4:185653568	C/T	cg04058563	chr4:185651563	MLF1IP	-1.13	-7.16	-0.63	3.82e-10	Blood protein levels;
SKCM	cis	rs73201462	0.611	rs2811415	chr3:127991527	A/G	cg09089421	chr3:127803668	RUVBL1	-1.0	-5.86	-0.55	1.04e-7	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs10751667	0.643	rs12278229	chr11:946985	A/G	cg10932868	chr11:921992	NA	0.53	4.95	0.49	4.27e-6	Alzheimer's disease (late onset);
SKCM	cis	rs3820068	0.581	rs1547033	chr1:15918988	T/C	cg13390004	chr1:15929781	NA	0.67	5.29	0.51	1.11e-6	Systolic blood pressure;
SKCM	cis	rs4523957	0.583	rs2760745	chr17:2035591	T/C	cg16513277	chr17:2031491	SMG6	-0.91	-6.21	-0.58	2.38e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs28386778	0.897	rs2156903	chr17:61937179	G/A	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.13	11.24	0.79	5.56e-18	Prudent dietary pattern;
SKCM	cis	rs780096	0.526	rs13391837	chr2:27649375	A/G	cg05696406	chr2:27599888	SNX17	0.52	5.24	0.51	1.34e-6	Total body bone mineral density;
SKCM	cis	rs2842992	1.000	rs2842992	chr6:160071159	G/A	cg19482086	chr6:160211437	TCP1;MRPL18	0.78	5.74	0.54	1.73e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs4808199	1.000	rs12977524	chr19:19568244	A/G	cg03709012	chr19:19516395	GATAD2A	1.13	8.66	0.7	4.94e-13	Nonalcoholic fatty liver disease;
SKCM	cis	rs950776	0.695	rs1878399	chr15:78912003	G/C	cg06917634	chr15:78832804	PSMA4	-0.84	-7.22	-0.63	3.03e-10	Sudden cardiac arrest;
SKCM	cis	rs9796	0.870	rs12905926	chr15:41283408	G/A	cg00616447	chr15:41694635	NDUFAF1	-0.72	-4.95	-0.49	4.15e-6	Menopause (age at onset);
SKCM	cis	rs4819852	0.958	rs1034564	chr22:19984013	A/G	cg07821417	chr22:19972146	ARVCF	-0.52	-7.2	-0.63	3.22e-10	Pulse pressure;
SKCM	cis	rs2072499	0.898	rs2758609	chr1:156202868	G/A	cg24450063	chr1:156163899	SLC25A44	0.78	6.43	0.59	9.49e-9	Testicular germ cell tumor;
SKCM	cis	rs1401999	0.690	rs1402001	chr3:183642751	A/G	cg01324343	chr3:183735012	ABCC5	0.71	6.74	0.61	2.49e-9	Anterior chamber depth;
SKCM	cis	rs5753618	0.583	rs9606843	chr22:31853371	A/C	cg02404636	chr22:31891804	SFI1	0.6	5.17	0.51	1.74e-6	Colorectal cancer;
SKCM	cis	rs2279817	0.955	rs2270978	chr1:18023365	C/T	cg17142039	chr1:18149651	ACTL8	0.58	4.88	0.48	5.6e-6	Neuroticism;
SKCM	cis	rs593982	0.858	rs480989	chr11:65493992	A/G	cg08755490	chr11:65554678	OVOL1	0.94	7.44	0.64	1.15e-10	Atopic dermatitis;
SKCM	cis	rs10876993	0.890	rs812304	chr12:58074853	A/C	cg18357645	chr12:58087776	OS9	0.65	5.98	0.56	6.22e-8	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs7143963	0.666	rs7151954	chr14:103323448	A/G	cg23020514	chr14:103360112	TRAF3	0.76	7.28	0.64	2.32e-10	Body mass index;
SKCM	cis	rs13256369	0.802	rs11249885	chr8:8562008	C/T	cg18904891	chr8:8559673	CLDN23	0.79	5.88	0.55	9.62e-8	Obesity-related traits;
SKCM	cis	rs2404602	0.735	rs11637490	chr15:76759565	A/G	cg23625390	chr15:77176239	SCAPER	-0.78	-7.58	-0.65	6.09e-11	Blood metabolite levels;
SKCM	cis	rs6598955	0.543	rs881578	chr1:26536141	G/A	cg04990556	chr1:26633338	UBXN11	0.68	5.08	0.5	2.55e-6	Obesity-related traits;
SKCM	cis	rs9788682	0.948	rs59683676	chr15:78833453	T/C	cg06917634	chr15:78832804	PSMA4	-0.82	-4.96	-0.49	3.97e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs950027	0.620	rs1145077	chr15:45683795	A/C	cg10760299	chr15:45669010	GATM	-0.52	-4.97	-0.49	3.94e-6	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs875971	0.862	rs6460282	chr7:65691246	T/C	cg11764359	chr7:65958608	NA	-0.75	-6.94	-0.62	1.04e-9	Aortic root size;
SKCM	cis	rs1218582	0.741	rs4339857	chr1:154888962	A/G	cg09359103	chr1:154839909	KCNN3	-0.57	-5.3	-0.51	1.05e-6	Prostate cancer;
SKCM	cis	rs7666738	0.761	rs28758886	chr4:99059704	C/T	cg17366294	chr4:99064904	C4orf37	0.61	4.93	0.49	4.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11098499	0.866	rs12499602	chr4:120284387	T/A	cg09307838	chr4:120376055	NA	0.98	7.89	0.67	1.52e-11	Corneal astigmatism;
SKCM	cis	rs208520	1.000	rs72884017	chr6:66992513	T/G	cg07460842	chr6:66804631	NA	0.87	5.96	0.56	6.95e-8	Exhaled nitric oxide output;
SKCM	cis	rs11718455	1.000	rs9854785	chr3:44031295	A/G	cg21419209	chr3:44054225	NA	-0.66	-5.22	-0.51	1.42e-6	Coronary artery disease;
SKCM	cis	rs2070488	0.775	rs6780349	chr3:38555178	C/T	cg01465620	chr3:38496096	LOC100128640;ACVR2B	-0.71	-5.5	-0.53	4.63e-7	Electrocardiographic conduction measures;
SKCM	cis	rs763121	1.000	rs86796	chr22:38881454	A/C	cg06022373	chr22:39101656	GTPBP1	-0.77	-5.55	-0.53	3.8e-7	Menopause (age at onset);
SKCM	cis	rs17685	0.753	rs2286830	chr7:75693963	C/T	cg16684958	chr7:75615977	POR	-0.6	-5.87	-0.55	1.02e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7618501	0.602	rs2301166	chr3:50148305	C/G	cg24110177	chr3:50126178	RBM5	0.61	5.18	0.51	1.71e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs3087591	0.920	rs11080150	chr17:29629326	A/G	cg24425628	chr17:29625626	OMG;NF1	-0.64	-4.97	-0.49	3.84e-6	Hip circumference;
SKCM	cis	rs55794721	0.672	rs78103988	chr1:25747655	C/T	cg27572855	chr1:25598939	RHD	0.56	5.48	0.53	5.03e-7	Plateletcrit;Mean corpuscular volume;
SKCM	cis	rs10779751	1.000	rs6670821	chr1:11308762	T/C	cg08854313	chr1:11322531	MTOR	0.93	7.16	0.63	3.9e-10	Body mass index;
SKCM	cis	rs7296418	0.961	rs7957096	chr12:123544878	A/G	cg05973401	chr12:123451056	ABCB9	0.84	6.88	0.61	1.34e-9	Platelet count;
SKCM	cis	rs9814567	1.000	rs9884031	chr3:134256500	C/T	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs10791097	0.582	rs2282578	chr11:130735691	A/T	cg12179176	chr11:130786555	SNX19	0.94	8.13	0.68	5.18e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs7103648	0.643	rs12365079	chr11:47696596	A/T	cg20307385	chr11:47447363	PSMC3	0.91	7.0	0.62	7.82e-10	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs1801516	1.000	rs1961319	chr11:108293879	G/T	cg03165700	chr11:108093220	ATM;NPAT	-1.1	-5.07	-0.5	2.6e-6	Melanoma;
SKCM	cis	rs8067545	0.611	rs2703788	chr17:20159686	T/C	cg13482628	chr17:19912719	NA	-0.65	-5.44	-0.52	5.84e-7	Schizophrenia;
SKCM	cis	rs3741404	0.868	rs595880	chr11:64006466	T/G	cg19465662	chr11:63993652	NUDT22;TRPT1	-0.76	-5.36	-0.52	8.24e-7	Platelet count;
SKCM	cis	rs933688	1.000	rs1541674	chr5:90660447	T/C	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.05	8.27	0.68	2.79e-12	Smoking behavior;
SKCM	cis	rs2842992	0.692	rs9347342	chr6:160193129	T/C	cg11366901	chr6:160182831	ACAT2	0.84	7.28	0.64	2.26e-10	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs7569084	0.687	rs1437462	chr2:65676693	C/A	cg14775296	chr2:66672841	MEIS1	0.51	4.8	0.48	7.49e-6	Sum eosinophil basophil counts;
SKCM	cis	rs7666738	0.791	rs6833691	chr4:98951508	A/G	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6952808	0.792	rs12536261	chr7:1953571	G/A	cg21782813	chr7:2030301	MAD1L1	0.56	6.01	0.56	5.51e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs10779751	1.000	rs4845986	chr1:11288633	G/C	cg08854313	chr1:11322531	MTOR	0.96	7.85	0.66	1.87e-11	Body mass index;
SKCM	cis	rs7811142	0.830	rs75636500	chr7:99947657	C/G	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.19	7.5	0.65	8.66e-11	Platelet count;
SKCM	cis	rs228769	0.636	rs11656104	chr17:42258965	A/T	cg13607699	chr17:42295918	UBTF	0.75	5.3	0.51	1.03e-6	Bone mineral density (hip);Bone mineral density (spine);
SKCM	cis	rs16949788	1.000	rs74894249	chr15:66818647	G/T	cg08120210	chr15:66682733	MAP2K1	-0.69	-5.29	-0.51	1.08e-6	Spherical equivalent (joint analysis main effects and education interaction);
SKCM	cis	rs12044355	1.000	rs12044355	chr1:231844347	A/C	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	0.78	5.53	0.53	4.18e-7	Alzheimer's disease;
SKCM	cis	rs17376456	0.825	rs12716454	chr5:93272279	A/C	cg25358565	chr5:93447407	FAM172A	1.3	7.53	0.65	7.57e-11	Diabetic retinopathy;
SKCM	cis	rs9513627	1.000	rs6491512	chr13:100199741	C/T	cg11288260	chr13:100117058	NA	0.79	4.78	0.48	8.1e-6	Obesity-related traits;
SKCM	cis	rs13278732	0.500	rs7016999	chr8:99050878	G/A	cg16297171	chr8:99017690	MATN2	-0.54	-5.13	-0.5	2.07e-6	Eosinophilic esophagitis (pediatric);
SKCM	cis	rs10751667	0.666	rs4074234	chr11:977715	C/G	cg10932868	chr11:921992	NA	0.55	5.1	0.5	2.36e-6	Alzheimer's disease (late onset);
SKCM	cis	rs4727027	0.901	rs34201592	chr7:148842403	C/G	cg23583168	chr7:148888333	NA	-0.8	-6.66	-0.6	3.52e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs2228479	0.850	rs2286393	chr16:89809548	C/A	cg00800038	chr16:89945340	TCF25	-0.81	-4.79	-0.48	7.84e-6	Skin colour saturation;
SKCM	cis	rs763121	0.925	rs1043312	chr22:39131727	T/G	cg06022373	chr22:39101656	GTPBP1	0.75	4.93	0.49	4.5e-6	Menopause (age at onset);
SKCM	cis	rs1185460	1.000	rs1784305	chr11:118942048	G/A	cg23280166	chr11:118938394	VPS11	0.58	5.23	0.51	1.41e-6	Coronary artery disease;
SKCM	cis	rs1639906	0.507	rs1004643	chr7:2185324	G/C	cg21782813	chr7:2030301	MAD1L1	-0.5	-5.44	-0.52	5.83e-7	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10754283	0.905	rs7519969	chr1:90108721	G/C	cg21401794	chr1:90099060	LRRC8C	0.73	6.34	0.58	1.35e-8	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs9790314	1.000	rs336569	chr3:161072346	T/G	cg03342759	chr3:160939853	NMD3	-0.72	-7.89	-0.67	1.53e-11	Morning vs. evening chronotype;
SKCM	cis	rs17102884	0.506	rs887746	chr14:75403817	C/T	cg08847533	chr14:75593920	NEK9	-0.66	-5.38	-0.52	7.53e-7	Neuroticism;
SKCM	cis	rs7216064	1.000	rs3935969	chr17:65881959	A/G	cg12091567	chr17:66097778	LOC651250	-0.75	-5.27	-0.51	1.19e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs3925158	0.619	rs9881120	chr3:38186417	A/T	cg20751361	chr3:37493945	ITGA9	0.7	4.78	0.48	8.06e-6	Gut microbiota (bacterial taxa);
SKCM	cis	rs864745	0.967	rs1635852	chr7:28189411	T/C	cg15170557	chr7:28214983	JAZF1	-0.69	-6.69	-0.6	3e-9	Crohn's disease;Type 2 diabetes;
SKCM	cis	rs854765	0.547	rs6502632	chr17:17913057	A/G	cg04398451	chr17:18023971	MYO15A	-0.89	-6.95	-0.62	9.88e-10	Total body bone mineral density;
SKCM	cis	rs1799949	1.000	rs11656097	chr17:41290613	G/T	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.11	-0.57	3.67e-8	Menopause (age at onset);
SKCM	cis	rs7666738	0.830	rs11942114	chr4:99066261	C/G	cg05340658	chr4:99064831	C4orf37	0.66	4.87	0.48	5.74e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7296418	0.699	rs1109559	chr12:123757861	C/T	cg00376283	chr12:123451042	ABCB9	0.84	6.89	0.62	1.27e-9	Platelet count;
SKCM	cis	rs8067545	0.611	rs9898080	chr17:20035257	A/G	cg13482628	chr17:19912719	NA	0.65	5.6	0.54	3.06e-7	Schizophrenia;
SKCM	cis	rs9916302	0.821	rs12938268	chr17:37572139	G/A	cg07936489	chr17:37558343	FBXL20	-0.82	-7.23	-0.63	2.84e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs208520	0.526	rs9354370	chr6:66808209	C/T	cg07460842	chr6:66804631	NA	1.12	12.53	0.82	2.25e-20	Exhaled nitric oxide output;
SKCM	cis	rs875971	0.965	rs9969301	chr7:65781655	G/A	cg11764359	chr7:65958608	NA	-0.88	-8.54	-0.7	8.36e-13	Aortic root size;
SKCM	cis	rs34065801	0.545	rs1361827	chr13:36522563	G/A	cg09605634	chr13:36521538	DCLK1	-0.8	-5.66	-0.54	2.45e-7	Breast size;
SKCM	cis	rs589448	1.000	rs589448	chr12:69752200	A/G	cg14784868	chr12:69753453	YEATS4	0.84	7.65	0.65	4.54e-11	Cerebrospinal fluid biomarker levels;
SKCM	trans	rs208520	0.661	rs207099	chr6:66796373	A/C	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-1.1	-8.18	-0.68	4.3e-12	Exhaled nitric oxide output;
SKCM	cis	rs1580019	0.665	rs34147895	chr7:32531796	G/C	cg06627557	chr7:32535165	LSM5;AVL9	0.89	7.4	0.64	1.37e-10	Cognitive ability;
SKCM	cis	rs2839186	0.967	rs9637172	chr21:47685787	T/C	cg11766577	chr21:47581405	C21orf56	-0.7	-6.02	-0.56	5.28e-8	Testicular germ cell tumor;
SKCM	cis	rs2980439	0.557	rs2921056	chr8:8319182	T/C	cg06636001	chr8:8085503	FLJ10661	0.81	6.96	0.62	9.54e-10	Neuroticism;
SKCM	cis	rs10808739	0.800	rs4629907	chr8:65750826	A/G	cg20862599	chr8:65498440	NA	-0.7	-4.77	-0.48	8.34e-6	HIV-1 susceptibility;
SKCM	cis	rs801193	1.000	rs2659915	chr7:66153101	A/G	cg18876405	chr7:65276391	NA	0.79	7.0	0.62	7.81e-10	Aortic root size;
SKCM	cis	rs9880211	0.718	rs56398805	chr3:135932400	A/G	cg21827317	chr3:136751795	NA	-0.64	-4.97	-0.49	3.89e-6	Body mass index;Height;
SKCM	cis	rs951366	0.617	rs823074	chr1:205774839	T/C	cg07157834	chr1:205819609	PM20D1	0.92	10.72	0.77	5.29e-17	Menarche (age at onset);
SKCM	cis	rs910316	0.934	rs7141705	chr14:75655352	G/C	cg08847533	chr14:75593920	NEK9	-0.98	-9.72	-0.74	4.28e-15	Height;
SKCM	cis	rs6061231	0.798	rs2427308	chr20:60969451	C/T	cg24112000	chr20:60950667	NA	-0.66	-5.97	-0.56	6.49e-8	Colorectal cancer;
SKCM	cis	rs1552244	0.882	rs13075842	chr3:10055813	A/C	cg02579736	chr3:10068473	FANCD2;CIDECP	0.94	4.84	0.48	6.49e-6	Alzheimer's disease;
SKCM	cis	rs1691799	0.899	rs1168306	chr12:66738900	A/G	cg16791601	chr12:66731901	HELB	-0.66	-5.75	-0.55	1.69e-7	White blood cell count (basophil);
SKCM	cis	rs56104184	0.668	rs73063523	chr19:49408943	T/C	cg19746536	chr19:49375674	PPP1R15A	1.16	5.93	0.56	7.67e-8	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs35306767	0.903	rs35968821	chr10:910225	A/G	cg20503657	chr10:835505	NA	0.75	5.36	0.52	8.31e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs433852	0.718	rs386551	chr19:49138286	C/G	cg06530960	chr19:49140787	SEC1;DBP	-0.78	-5.62	-0.54	2.89e-7	Elevated serum carcinoembryonic antigen levels;Posterior cortical atrophy and Alzheimer's disease;
SKCM	cis	rs10207060	0.500	rs7566489	chr2:240703985	C/T	cg07506560	chr2:240697449	NA	0.75	6.1	0.57	3.8e-8	Obesity-related traits;
SKCM	cis	rs6598955	0.670	rs7522905	chr1:26609259	C/T	cg00938395	chr1:26633206	UBXN11	0.68	4.85	0.48	6.08e-6	Obesity-related traits;
SKCM	trans	rs1814175	0.817	rs12290508	chr11:49621037	C/T	cg15704280	chr7:45808275	SEPT13	-1.02	-10.17	-0.76	6.07e-16	Height;
SKCM	cis	rs9583531	0.689	rs2165418	chr13:111379365	G/T	cg24331049	chr13:111365604	ING1	-0.89	-6.66	-0.6	3.49e-9	Coronary artery disease;
SKCM	cis	rs6840360	0.571	rs875668	chr4:152525661	C/T	cg22705602	chr4:152727874	NA	-0.52	-5.7	-0.54	2.03e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs2439831	0.681	rs498837	chr15:43608024	G/A	cg27015174	chr15:43622946	ADAL;LCMT2	0.87	4.81	0.48	7.13e-6	Lung cancer in ever smokers;
SKCM	cis	rs870825	0.929	rs55746424	chr4:185589603	C/T	cg04058563	chr4:185651563	MLF1IP	1.09	5.66	0.54	2.4e-7	Blood protein levels;
SKCM	cis	rs875971	1.000	rs2220626	chr7:65546062	C/T	cg18876405	chr7:65276391	NA	-0.71	-7.04	-0.62	6.64e-10	Aortic root size;
SKCM	cis	rs6879260	1.000	rs888922	chr5:179731635	C/G	cg23221052	chr5:179740743	GFPT2	-0.63	-5.45	-0.53	5.64e-7	Height;
SKCM	cis	rs6087990	1.000	rs2424901	chr20:31344512	A/G	cg13636640	chr20:31349939	DNMT3B	0.91	7.99	0.67	9.7e-12	Ulcerative colitis;
SKCM	cis	rs9880211	0.800	rs9865995	chr3:136513350	G/A	cg21827317	chr3:136751795	NA	-0.69	-5.26	-0.51	1.21e-6	Body mass index;Height;
SKCM	cis	rs2033711	0.783	rs8113810	chr19:58932106	A/G	cg12042659	chr19:58951599	ZNF132	0.68	5.86	0.55	1.04e-7	Uric acid clearance;
SKCM	cis	rs6580649	1.000	rs7305954	chr12:48403530	C/T	cg05342945	chr12:48394962	COL2A1	-0.78	-5.57	-0.53	3.53e-7	Lung cancer;
SKCM	cis	rs6435862	0.636	rs717548	chr2:215676905	G/A	cg04004882	chr2:215674386	BARD1	-0.79	-5.72	-0.54	1.86e-7	Neuroblastoma (high-risk);
SKCM	cis	rs17685	0.753	rs6464999	chr7:75787315	T/C	cg16489192	chr7:75678113	MDH2;STYXL1	-0.56	-5.23	-0.51	1.36e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs4077515	0.527	rs10870146	chr9:139308054	G/A	cg14169450	chr9:139327907	INPP5E	0.49	5.1	0.5	2.28e-6	Ulcerative colitis;IgA nephropathy;Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs523522	0.962	rs7136951	chr12:120941927	C/T	cg27279351	chr12:120934652	DYNLL1	0.91	8.32	0.69	2.26e-12	High light scatter reticulocyte count;
SKCM	cis	rs4237845	0.537	rs10877031	chr12:58266695	A/G	cg02175503	chr12:58329896	NA	0.73	5.88	0.55	9.8e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs7937682	0.883	rs2212520	chr11:111462096	C/T	cg19812747	chr11:111475976	SIK2	-0.61	-4.94	-0.49	4.41e-6	Primary sclerosing cholangitis;
SKCM	cis	rs514406	0.661	rs550561	chr1:53375134	C/T	cg16325326	chr1:53192061	ZYG11B	0.65	5.65	0.54	2.56e-7	Monocyte count;
SKCM	cis	rs3091242	0.933	rs28530483	chr1:25740847	A/C	cg02931644	chr1:25747376	RHCE	0.5	5.0	0.49	3.46e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs9325144	0.600	rs10785621	chr12:38744912	C/T	cg13010199	chr12:38710504	ALG10B	0.64	5.12	0.5	2.17e-6	Morning vs. evening chronotype;
SKCM	cis	rs2836950	0.565	rs2836926	chr21:40536790	G/A	cg11890956	chr21:40555474	PSMG1	-0.7	-5.62	-0.54	2.84e-7	Menarche (age at onset);
SKCM	cis	rs7829975	0.846	rs1879957	chr8:8544808	T/C	cg06636001	chr8:8085503	FLJ10661	-0.85	-7.0	-0.62	7.71e-10	Mood instability;
SKCM	cis	rs7954584	0.635	rs7137218	chr12:122342877	G/T	cg13699009	chr12:122356056	WDR66	0.56	7.02	0.62	7.17e-10	Mean corpuscular volume;
SKCM	cis	rs801193	0.967	rs3800823	chr7:66147110	C/A	cg11987759	chr7:65425863	GUSB	0.69	6.01	0.56	5.52e-8	Aortic root size;
SKCM	cis	rs16870629	1.000	rs16870629	chr5:1015063	C/T	cg00278107	chr5:1061253	SLC12A7	-0.8	-5.97	-0.56	6.52e-8	QT interval;
SKCM	cis	rs11718455	1.000	rs4682928	chr3:44037192	T/C	cg21419209	chr3:44054225	NA	-0.66	-5.19	-0.51	1.61e-6	Coronary artery disease;
SKCM	cis	rs12824058	0.798	rs4759652	chr12:130808771	C/T	cg24838063	chr12:130822603	PIWIL1	0.76	6.67	0.6	3.32e-9	Menopause (age at onset);
SKCM	cis	rs6930083	0.737	rs13196885	chr6:36632688	C/T	cg08179530	chr6:36648295	CDKN1A	-0.68	-5.06	-0.5	2.76e-6	Coronary artery disease;
SKCM	cis	rs12706411	1.000	rs12706412	chr7:122070414	C/A	cg17986181	chr7:121955208	NA	-0.68	-4.94	-0.49	4.3e-6	Alzheimer disease and age of onset;
SKCM	cis	rs28595532	0.764	rs116788606	chr4:119748849	G/C	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs9674544	0.757	rs3744085	chr17:47131901	A/G	cg11673840	chr17:47092156	IGF2BP1	-0.51	-4.96	-0.49	4.06e-6	Primary tooth development (time to first tooth eruption);Primary tooth development (number of teeth);
SKCM	cis	rs752010	1.000	rs6656183	chr1:42094025	A/G	cg06885757	chr1:42089581	HIVEP3	0.62	6.25	0.58	2.04e-8	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs7811142	0.943	rs10241492	chr7:99994813	A/G	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.11	6.45	0.59	8.66e-9	Platelet count;
SKCM	cis	rs1577917	0.958	rs12213431	chr6:86500956	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.82	-8.08	-0.68	6.54e-12	Response to antipsychotic treatment;
SKCM	cis	rs9633740	1.000	rs7922621	chr10:82251544	C/A	cg01528321	chr10:82214614	TSPAN14	0.85	6.72	0.61	2.73e-9	Post bronchodilator FEV1;
SKCM	cis	rs9916302	0.861	rs8079590	chr17:37426201	T/C	cg07936489	chr17:37558343	FBXL20	-0.84	-6.96	-0.62	9.48e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs9915657	0.870	rs720244	chr17:70131643	G/T	cg06234051	chr17:70120541	SOX9	-0.62	-5.35	-0.52	8.49e-7	Thyroid hormone levels;
SKCM	cis	rs7811142	0.830	rs6965458	chr7:99973402	G/A	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.07	6.7	0.6	2.88e-9	Platelet count;
SKCM	cis	rs1218582	0.741	rs883718	chr1:154846274	C/T	cg24250549	chr1:154909240	PMVK	0.89	9.39	0.73	1.86e-14	Prostate cancer;
SKCM	cis	rs17685	0.753	rs1639609	chr7:75683581	T/C	cg16489192	chr7:75678113	MDH2;STYXL1	-0.6	-5.51	-0.53	4.43e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs870825	0.616	rs3184982	chr4:185615768	T/G	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs10540	1.000	rs61877775	chr11:521462	C/T	cg03352830	chr11:487213	PTDSS2	1.06	5.31	0.52	1e-6	Body mass index;
SKCM	cis	rs3749237	0.595	rs4855877	chr3:49448527	T/C	cg03060546	chr3:49711283	APEH	0.67	4.86	0.48	5.96e-6	Resting heart rate;
SKCM	cis	rs951366	0.789	rs823121	chr1:205724302	A/G	cg24503407	chr1:205819492	PM20D1	-0.88	-7.44	-0.64	1.15e-10	Menarche (age at onset);
SKCM	cis	rs3784262	0.631	rs4646566	chr15:58348173	G/A	cg12031962	chr15:58353849	ALDH1A2	-0.41	-4.82	-0.48	6.94e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs931234	0.965	rs2371769	chr3:65151259	C/G	cg06271087	chr3:65342546	MAGI1	0.54	5.29	0.51	1.07e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9815354	0.812	rs56983571	chr3:41994473	T/C	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs4727027	0.933	rs7788925	chr7:148831621	A/G	cg23583168	chr7:148888333	NA	-0.82	-6.56	-0.6	5.29e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs798766	1.000	rs2166580	chr4:1743169	G/A	cg05874882	chr4:1763078	NA	-0.56	-4.91	-0.49	4.97e-6	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs7843479	0.601	rs6557712	chr8:21826421	C/T	cg17168535	chr8:21777572	XPO7	0.8	7.46	0.65	1.05e-10	Mean corpuscular volume;
SKCM	cis	rs1153858	0.945	rs16943246	chr15:45720597	G/A	cg21132104	chr15:45694354	SPATA5L1	0.9	6.65	0.6	3.58e-9	Homoarginine levels;
SKCM	cis	rs1577917	0.958	rs6454487	chr6:86446868	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.74	7.13	0.63	4.44e-10	Response to antipsychotic treatment;
SKCM	cis	rs9549367	0.713	rs556990	chr13:113845059	T/C	cg18105134	chr13:113819100	PROZ	0.87	6.56	0.6	5.34e-9	Platelet distribution width;
SKCM	cis	rs769267	1.000	rs2301669	chr19:19453560	C/A	cg26732615	chr19:19648335	CILP2;YJEFN3	-0.65	-5.91	-0.56	8.42e-8	Tonsillectomy;
SKCM	cis	rs12134245	0.755	rs11164928	chr1:92012678	G/A	cg25838465	chr1:92012736	NA	-0.8	-8.15	-0.68	4.88e-12	Breast cancer;
SKCM	cis	rs2014572	0.967	rs10427146	chr19:57755998	T/C	cg24459738	chr19:57751996	ZNF805	-0.64	-5.29	-0.51	1.1e-6	Hyperactive-impulsive symptoms;
SKCM	cis	rs11626933	1.000	rs61989986	chr14:90739180	G/A	cg14092571	chr14:90743983	NA	-0.93	-8.56	-0.7	7.88e-13	Gut microbiota (bacterial taxa);
SKCM	cis	rs1799949	1.000	rs8176133	chr17:41257458	A/C	cg05368731	chr17:41323189	NBR1	0.88	7.75	0.66	2.84e-11	Menopause (age at onset);
SKCM	cis	rs899997	0.773	rs8032156	chr15:78964498	A/G	cg04896959	chr15:78267971	NA	0.61	5.23	0.51	1.39e-6	Coronary artery disease or large artery stroke;
SKCM	cis	rs9467773	1.000	rs9467787	chr6:26556769	G/T	cg09904177	chr6:26538194	HMGN4	0.55	5.13	0.5	2.08e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs5753618	0.504	rs5753661	chr22:31899797	C/A	cg02404636	chr22:31891804	SFI1	0.67	6.03	0.56	5.16e-8	Colorectal cancer;
SKCM	cis	rs6500395	0.963	rs4785248	chr16:48687947	A/G	cg04672837	chr16:48644449	N4BP1	-0.65	-5.43	-0.52	6.28e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs6500395	1.000	rs7202551	chr16:48728984	A/G	cg04672837	chr16:48644449	N4BP1	-0.63	-5.37	-0.52	8.01e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs6952808	0.564	rs73038441	chr7:2139286	T/C	cg02951883	chr7:2050386	MAD1L1	-0.79	-7.4	-0.64	1.37e-10	Bipolar disorder and schizophrenia;
SKCM	cis	rs6087990	0.806	rs910084	chr20:31379665	C/T	cg13636640	chr20:31349939	DNMT3B	0.93	8.29	0.68	2.61e-12	Ulcerative colitis;
SKCM	cis	rs1843834	0.539	rs2068244	chr2:225440011	A/G	cg22455342	chr2:225449267	CUL3	-0.75	-5.54	-0.53	4.03e-7	IgE levels in asthmatics (D.p. specific);
SKCM	cis	rs11098499	0.789	rs12498994	chr4:120250818	A/C	cg09307838	chr4:120376055	NA	0.91	7.36	0.64	1.63e-10	Corneal astigmatism;
SKCM	cis	rs7208859	0.623	rs56325146	chr17:29151024	T/C	cg13385521	chr17:29058706	SUZ12P	0.9	4.78	0.48	8.1e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs932287	0.505	rs2742536	chr11:8909816	G/C	cg21881798	chr11:8931708	C11orf17;ST5	-0.74	-7.71	-0.66	3.42e-11	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2204008	0.837	rs1589395	chr12:38420405	C/T	cg26384229	chr12:38710491	ALG10B	0.82	6.3	0.58	1.6e-8	Bladder cancer;
SKCM	cis	rs12047808	0.730	rs73051834	chr1:179526052	A/T	cg09822482	chr1:179519214	C1orf125	-0.96	-4.77	-0.48	8.48e-6	Multiple sclerosis (age of onset);
SKCM	cis	rs1878931	0.582	rs27238	chr16:3441223	G/A	cg26668626	chr16:3451006	ZNF174;ZNF434	-0.78	-5.55	-0.53	3.73e-7	Body mass index (adult);
SKCM	cis	rs933688	1.000	rs1895448	chr5:90743854	C/T	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.93	6.77	0.61	2.15e-9	Smoking behavior;
SKCM	cis	rs7927771	0.524	rs12421563	chr11:47780222	G/A	cg20307385	chr11:47447363	PSMC3	-0.72	-5.81	-0.55	1.31e-7	Subjective well-being;
SKCM	cis	rs7666738	0.830	rs11097609	chr4:99011707	C/T	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs13118159	0.527	rs6599308	chr4:1387780	A/G	cg02018176	chr4:1364513	KIAA1530	0.91	6.98	0.62	8.54e-10	Longevity;
SKCM	cis	rs3820068	0.581	rs72645893	chr1:15930943	C/G	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs875971	1.000	rs12533997	chr7:65965377	A/G	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	cis	rs4132509	0.948	rs320322	chr1:243750755	G/A	cg21452805	chr1:244014465	NA	-0.74	-4.78	-0.48	8.16e-6	RR interval (heart rate);
SKCM	cis	rs7100689	0.646	rs1340374	chr10:82129114	C/T	cg01528321	chr10:82214614	TSPAN14	0.8	7.0	0.62	7.98e-10	Post bronchodilator FEV1;
SKCM	cis	rs11690935	1.000	rs312918	chr2:172569587	C/G	cg13550731	chr2:172543902	DYNC1I2	-0.96	-8.23	-0.68	3.44e-12	Schizophrenia;
SKCM	cis	rs1003719	0.762	rs11701556	chr21:38455153	A/G	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs12425791	1.000	rs12425791	chr12:783484	A/G	cg00237010	chr12:772861	NINJ2	-0.8	-5.49	-0.53	4.9e-7	Stroke;Paclitaxel disposition in epithelial ovarian cancer;
SKCM	cis	rs12142240	0.698	rs45449893	chr1:46859024	A/G	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs2180341	1.000	rs6569483	chr6:127658855	G/A	cg24812749	chr6:127587940	RNF146	0.85	7.3	0.64	2.08e-10	Breast cancer;
SKCM	cis	rs362296	0.661	rs3095079	chr4:3265414	A/G	cg16987761	chr4:3318072	RGS12	0.68	5.65	0.54	2.53e-7	Parental longevity (mother's age at death);
SKCM	cis	rs7666738	0.830	rs34164616	chr4:99015251	G/A	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9913156	0.748	rs72835635	chr17:4563127	A/G	cg19197139	chr17:4613644	ARRB2	0.78	5.43	0.52	6.21e-7	Lymphocyte counts;
SKCM	cis	rs3820068	0.581	rs6666373	chr1:15939884	A/T	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs4132509	1.000	rs28869008	chr1:243986344	C/A	cg21452805	chr1:244014465	NA	0.88	5.2	0.51	1.58e-6	RR interval (heart rate);
SKCM	cis	rs9959145	0.500	rs11665542	chr18:12536777	C/T	cg18469917	chr18:12433231	NA	-1.14	-4.81	-0.48	7.09e-6	Immune response to smallpox vaccine (IL-6);
SKCM	cis	rs7843479	0.930	rs2054713	chr8:21840534	A/G	cg17168535	chr8:21777572	XPO7	0.77	6.47	0.59	7.79e-9	Mean corpuscular volume;
SKCM	cis	rs12497850	0.931	rs10780033	chr3:48891275	T/C	cg06212747	chr3:49208901	KLHDC8B	0.68	4.89	0.48	5.28e-6	Parkinson's disease;
SKCM	cis	rs10911232	0.507	rs10911234	chr1:183053001	A/C	ch.1.3577855R	chr1:183094577	LAMC1	0.78	6.87	0.61	1.42e-9	Hypertriglyceridemia;
SKCM	cis	rs10870270	1.000	rs7898755	chr10:133777122	G/A	cg17892150	chr10:133769511	PPP2R2D	-0.66	-4.86	-0.48	5.92e-6	Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals;
SKCM	cis	rs6951245	0.872	rs11768895	chr7:1063691	T/C	cg24642844	chr7:1081250	C7orf50	-0.81	-6.0	-0.56	5.72e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs459571	0.715	rs401826	chr9:136890591	C/T	cg13789015	chr9:136890014	NCRNA00094	0.73	5.92	0.56	8.29e-8	Platelet distribution width;
SKCM	cis	rs1046896	0.552	rs12602280	chr17:80805421	G/C	cg22027946	chr17:80790580	TBCD;ZNF750	0.7	5.28	0.51	1.16e-6	Glycated hemoglobin levels;
SKCM	cis	rs6933660	0.646	rs9397051	chr6:151778325	C/T	cg14262678	chr6:151773367	RMND1;C6orf211	0.73	5.92	0.56	8.23e-8	Menarche (age at onset);
SKCM	cis	rs11098499	0.866	rs7665125	chr4:120402079	G/T	cg24375607	chr4:120327624	NA	0.68	5.22	0.51	1.45e-6	Corneal astigmatism;
SKCM	cis	rs2243480	1.000	rs313807	chr7:65499481	C/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs7959452	0.530	rs12811632	chr12:69755003	G/A	cg20891283	chr12:69753455	YEATS4	0.9	9.18	0.72	4.79e-14	Blood protein levels;
SKCM	cis	rs28386778	0.897	rs6504187	chr17:61917099	G/A	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs2842992	0.915	rs2842958	chr6:160108425	A/G	cg19482086	chr6:160211437	TCP1;MRPL18	0.77	5.55	0.53	3.77e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs2288073	0.965	rs6545340	chr2:24422269	C/G	cg06627628	chr2:24431161	ITSN2	-0.85	-5.84	-0.55	1.14e-7	Venous thromboembolism (SNP x SNP interaction);
SKCM	cis	rs1799949	1.000	rs12944597	chr17:41187684	A/C	cg25918947	chr17:41365094	TMEM106A	-0.61	-5.87	-0.55	1e-7	Menopause (age at onset);
SKCM	cis	rs228769	0.543	rs170634	chr17:42175821	C/A	cg19774624	chr17:42201019	HDAC5	0.85	6.68	0.6	3.19e-9	Bone mineral density (hip);Bone mineral density (spine);
SKCM	cis	rs2839186	0.619	rs2187118	chr21:47611310	C/T	cg13012494	chr21:47604986	C21orf56	0.71	6.14	0.57	3.2e-8	Testicular germ cell tumor;
SKCM	cis	rs514406	0.729	rs534070	chr1:53308858	T/G	cg04310824	chr1:53393297	SCP2	-0.61	-4.81	-0.48	7.3e-6	Monocyte count;
SKCM	cis	rs875971	0.660	rs12698534	chr7:65986845	C/T	cg11987759	chr7:65425863	GUSB	-0.69	-5.9	-0.56	8.74e-8	Aortic root size;
SKCM	cis	rs514406	0.698	rs11206055	chr1:53436632	A/T	cg08859206	chr1:53392774	SCP2	0.63	5.21	0.51	1.47e-6	Monocyte count;
SKCM	cis	rs7772486	0.875	rs2777476	chr6:146345024	A/G	cg05347473	chr6:146136440	FBXO30	0.57	5.18	0.51	1.66e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7647973	0.516	rs12490393	chr3:49196132	C/T	cg07636037	chr3:49044803	WDR6	0.86	7.17	0.63	3.77e-10	Menarche (age at onset);
SKCM	cis	rs2404602	0.583	rs12908334	chr15:76581592	C/T	cg23625390	chr15:77176239	SCAPER	0.69	6.31	0.58	1.57e-8	Blood metabolite levels;
SKCM	cis	rs7507204	0.539	rs2074977	chr19:3434028	A/C	cg08380311	chr19:3435252	NFIC	1.19	12.63	0.82	1.49e-20	Height;
SKCM	cis	rs2243480	0.803	rs35268390	chr7:65416536	C/G	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs644799	0.965	rs549695	chr11:95617788	T/C	cg03916912	chr11:95522834	CEP57;FAM76B	0.85	6.71	0.6	2.82e-9	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs17685	0.625	rs1639630	chr7:75730499	T/C	cg16684958	chr7:75615977	POR	0.56	5.13	0.5	2.03e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs8017423	0.791	rs7146250	chr14:90711703	A/G	cg04374321	chr14:90722782	PSMC1	1.0	9.26	0.72	3.31e-14	Mortality in heart failure;
SKCM	cis	rs2739330	0.892	rs4822455	chr22:24255296	C/T	cg25703541	chr22:24373054	LOC391322	-0.79	-6.57	-0.6	5.2e-9	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs909341	0.629	rs3761124	chr20:62288752	T/C	cg03999872	chr20:62272968	STMN3	0.56	5.01	0.49	3.35e-6	Atopic dermatitis;
SKCM	cis	rs9790314	0.905	rs6789388	chr3:160970437	G/A	cg03342759	chr3:160939853	NMD3	-0.73	-8.2	-0.68	3.89e-12	Morning vs. evening chronotype;
SKCM	cis	rs2836974	0.897	rs8132568	chr21:40527916	C/T	cg17971929	chr21:40555470	PSMG1	0.87	8.48	0.69	1.1e-12	Cognitive function;
SKCM	cis	rs6089829	0.888	rs4809268	chr20:61675249	C/G	cg08564027	chr20:61660810	NA	0.64	5.85	0.55	1.11e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs7523273	0.586	rs2724359	chr1:207935706	A/G	cg22525895	chr1:207977042	MIR29B2	0.81	7.08	0.63	5.47e-10	Schizophrenia;
SKCM	cis	rs6570726	0.791	rs374478	chr6:145840022	C/T	cg23711669	chr6:146136114	FBXO30	0.79	7.93	0.67	1.26e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs62238980	0.614	rs75584049	chr22:32468790	C/A	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs1218582	0.745	rs1580943	chr1:154865125	G/A	cg16680214	chr1:154839983	KCNN3	-0.56	-4.97	-0.49	3.89e-6	Prostate cancer;
SKCM	cis	rs2070488	0.965	rs6796845	chr3:38567771	C/A	cg01465620	chr3:38496096	LOC100128640;ACVR2B	-1.03	-9.12	-0.72	6.37e-14	Electrocardiographic conduction measures;
SKCM	cis	rs3768617	0.510	rs6424888	chr1:183085696	C/T	ch.1.3577855R	chr1:183094577	LAMC1	-0.81	-7.71	-0.66	3.44e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs801193	1.000	rs1553609	chr7:66197139	T/C	cg00343986	chr7:65444356	GUSB	0.7	5.19	0.51	1.63e-6	Aortic root size;
SKCM	cis	rs2836974	0.800	rs73221174	chr21:40540939	T/C	cg11890956	chr21:40555474	PSMG1	1.02	11.41	0.79	2.67e-18	Cognitive function;
SKCM	cis	rs12477438	0.501	rs13000731	chr2:99795231	G/T	cg14399236	chr2:99771627	LIPT1;TSGA10	0.96	8.62	0.7	5.82e-13	Chronic sinus infection;
SKCM	cis	rs13118159	0.714	rs6843025	chr4:1334418	C/G	cg02018176	chr4:1364513	KIAA1530	0.66	5.38	0.52	7.45e-7	Longevity;
SKCM	cis	rs826838	0.900	rs9739128	chr12:38948960	A/T	cg13010199	chr12:38710504	ALG10B	0.84	6.17	0.57	2.84e-8	Heart rate;
SKCM	cis	rs9902453	0.933	rs1128156	chr17:28513176	G/A	cg26525008	chr17:28256777	EFCAB5;SSH2	0.75	5.19	0.51	1.64e-6	Coffee consumption (cups per day);
SKCM	cis	rs4819052	1.000	rs733739	chr21:46666210	A/G	cg19498844	chr21:46707878	POFUT2;LOC642852	0.87	6.8	0.61	1.88e-9	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs12477438	0.501	rs2632260	chr2:99771590	G/T	cg26064155	chr2:99771622	LIPT1;TSGA10	1.05	10.1	0.75	7.95e-16	Chronic sinus infection;
SKCM	trans	rs1814175	0.615	rs4545557	chr11:50027329	A/C	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs28386778	0.897	rs7210443	chr17:61785374	A/G	cg06873352	chr17:61820015	STRADA	0.74	6.26	0.58	1.98e-8	Prudent dietary pattern;
SKCM	cis	rs11295209	1	rs11295209	chr4:120480233	TA/T	cg09307838	chr4:120376055	NA	-0.65	-4.87	-0.48	5.72e-6	Plateletcrit;
SKCM	cis	rs4481887	0.927	rs4282853	chr1:248475127	A/G	cg00666640	chr1:248458726	OR2T12	0.66	6.0	0.56	5.9e-8	Common traits (Other);
SKCM	cis	rs6087990	0.899	rs1003521	chr20:31366598	T/C	cg13636640	chr20:31349939	DNMT3B	0.91	7.97	0.67	1.06e-11	Ulcerative colitis;
SKCM	cis	rs4782151	0.669	rs1980009	chr16:9348180	A/G	cg05568466	chr16:8431529	NA	0.4	4.96	0.49	3.98e-6	Cervical cancer;
SKCM	cis	rs12477438	0.520	rs2516835	chr2:99779131	T/C	cg14399236	chr2:99771627	LIPT1;TSGA10	0.97	8.66	0.7	4.83e-13	Chronic sinus infection;
SKCM	cis	rs7666738	0.830	rs2015828	chr4:98984594	A/G	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9300255	0.537	rs2695482	chr12:123623174	C/T	cg00376283	chr12:123451042	ABCB9	0.82	5.61	0.54	3e-7	Neutrophil percentage of white cells;
SKCM	cis	rs1046896	0.520	rs9895409	chr17:80902719	C/T	cg02711726	chr17:80685570	FN3KRP	-0.62	-4.88	-0.48	5.57e-6	Glycated hemoglobin levels;
SKCM	cis	rs7666738	0.710	rs7674407	chr4:98838522	A/G	cg17366294	chr4:99064904	C4orf37	0.56	4.89	0.48	5.25e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs727563	0.608	rs2076200	chr22:41985956	G/T	cg03806693	chr22:41940476	POLR3H	-1.12	-7.23	-0.63	2.84e-10	Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs7615952	0.673	rs34209763	chr3:125599595	G/A	cg05084668	chr3:125655381	ALG1L	-1.26	-7.1	-0.63	5.08e-10	Blood pressure (smoking interaction);
SKCM	cis	rs7772486	0.817	rs2144477	chr6:146406248	C/T	cg05347473	chr6:146136440	FBXO30	0.65	5.96	0.56	6.79e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9913156	0.793	rs72835633	chr17:4562643	C/T	cg19197139	chr17:4613644	ARRB2	0.79	5.28	0.51	1.14e-6	Lymphocyte counts;
SKCM	cis	rs72781680	0.898	rs72782126	chr2:24039901	A/C	cg08917208	chr2:24149416	ATAD2B	1.0	4.97	0.49	3.82e-6	Lymphocyte counts;
SKCM	cis	rs919433	1.000	rs1429414	chr2:198162430	C/T	cg04278110	chr2:198063759	ANKRD44	-0.72	-5.33	-0.52	9.25e-7	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs1862618	0.525	rs2662021	chr5:56261691	C/T	cg12311346	chr5:56204834	C5orf35	0.76	5.06	0.5	2.73e-6	Initial pursuit acceleration;
SKCM	cis	rs9513627	1.000	rs4294655	chr13:100216696	A/G	cg11288260	chr13:100117058	NA	0.79	4.8	0.48	7.49e-6	Obesity-related traits;
SKCM	cis	rs6582630	0.519	rs11514078	chr12:38408817	G/C	cg26384229	chr12:38710491	ALG10B	0.81	5.86	0.55	1.05e-7	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs3096299	0.933	rs2965823	chr16:89454924	G/A	cg02187348	chr16:89574699	SPG7	0.63	4.99	0.49	3.61e-6	Multiple myeloma (IgH translocation);
SKCM	cis	rs7208859	0.623	rs55811708	chr17:29104731	G/T	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs4919087	0.683	rs1687371	chr10:98978183	T/A	cg25902810	chr10:99078978	FRAT1	-0.66	-4.88	-0.48	5.45e-6	Monocyte count;
SKCM	cis	rs1218582	0.772	rs10908445	chr1:154849590	A/G	cg06221963	chr1:154839813	KCNN3	0.57	6.03	0.56	5.19e-8	Prostate cancer;
SKCM	cis	rs589448	0.867	rs623853	chr12:69753830	G/A	cg14784868	chr12:69753453	YEATS4	0.84	7.65	0.65	4.54e-11	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs1568889	0.838	rs7131053	chr11:28143312	A/G	cg06544937	chr11:28130018	METT5D1;KIF18A	0.89	8.3	0.68	2.43e-12	Bipolar disorder;
SKCM	cis	rs1577917	0.839	rs1447159	chr6:86609249	G/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.67	-5.86	-0.55	1.07e-7	Response to antipsychotic treatment;
SKCM	cis	rs1160297	0.601	rs1864534	chr2:53109005	G/T	cg07782112	chr2:53107842	NA	0.58	6.1	0.57	3.76e-8	Hemostatic factors and hematological phenotypes;
SKCM	trans	rs8073060	0.544	rs225287	chr17:33929487	G/T	cg19694781	chr19:47549865	TMEM160	-1.08	-8.69	-0.7	4.26e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs7829975	0.535	rs17683510	chr8:8500724	A/G	cg15556689	chr8:8085844	FLJ10661	0.63	5.25	0.51	1.26e-6	Mood instability;
SKCM	cis	rs7772486	0.790	rs7753833	chr6:146161432	C/A	cg05347473	chr6:146136440	FBXO30	0.57	5.32	0.52	9.82e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7659604	0.540	rs10001092	chr4:122677177	C/T	cg19671926	chr4:122722719	EXOSC9	0.77	6.27	0.58	1.89e-8	Type 2 diabetes;
SKCM	cis	rs28735056	0.660	rs12454454	chr18:77674634	C/T	cg20368463	chr18:77673604	PQLC1	-0.64	-4.77	-0.48	8.3e-6	Schizophrenia;
SKCM	cis	rs1005277	0.579	rs1780130	chr10:38485378	T/A	cg25427524	chr10:38739819	LOC399744	-0.78	-7.59	-0.65	5.86e-11	Extrinsic epigenetic age acceleration;
SKCM	cis	rs7666738	0.830	rs13139024	chr4:99020700	C/T	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs28595532	0.557	rs4359977	chr4:119314055	T/C	cg11846333	chr4:119757529	SEC24D	0.84	4.84	0.48	6.48e-6	Cannabis dependence symptom count;
SKCM	cis	rs3008870	0.959	rs1886686	chr1:67390468	C/G	cg08660285	chr1:67390436	MIER1;WDR78	0.98	6.56	0.6	5.45e-9	Lymphocyte percentage of white cells;
SKCM	cis	rs1348850	0.597	rs13014512	chr2:178470851	T/A	cg27490568	chr2:178487706	NA	0.95	5.97	0.56	6.71e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs514406	0.760	rs475969	chr1:53292607	T/A	cg16325326	chr1:53192061	ZYG11B	0.75	6.87	0.61	1.37e-9	Monocyte count;
SKCM	cis	rs362296	0.511	rs2857861	chr4:3323767	C/T	cg09735869	chr4:3319127	RGS12	0.86	9.23	0.72	3.82e-14	Parental longevity (mother's age at death);
SKCM	cis	rs1552244	1.000	rs17032268	chr3:10067972	C/T	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs875971	0.660	rs1860470	chr7:66103694	G/C	cg18876405	chr7:65276391	NA	-0.82	-7.48	-0.65	9.41e-11	Aortic root size;
SKCM	cis	rs9951698	0.687	rs478399	chr18:13093796	G/A	cg12848697	chr18:13133368	NA	0.57	5.32	0.52	9.59e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs2180341	0.538	rs3756993	chr6:127651551	A/C	cg24812749	chr6:127587940	RNF146	0.64	5.36	0.52	8.23e-7	Breast cancer;
SKCM	cis	rs2832191	0.671	rs2832212	chr21:30511417	G/A	cg24692254	chr21:30365293	RNF160	-0.76	-6.41	-0.59	1.03e-8	Dental caries;
SKCM	cis	rs10779751	0.960	rs1883965	chr1:11322156	A/G	cg08854313	chr1:11322531	MTOR	0.94	7.27	0.64	2.44e-10	Body mass index;
SKCM	cis	rs67311347	0.544	rs13097602	chr3:40339247	T/C	cg02782426	chr3:40428986	ENTPD3	-0.5	-4.95	-0.49	4.24e-6	Renal cell carcinoma;
SKCM	cis	rs2841233	0.681	rs2582558	chr14:105347488	A/G	cg16576083	chr14:105354267	KIAA0284	-0.61	-5.09	-0.5	2.4e-6	IgG glycosylation;
SKCM	cis	rs17685	0.712	rs2158867	chr7:75815141	C/A	cg16489192	chr7:75678113	MDH2;STYXL1	-0.55	-5.31	-0.52	9.92e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs13217239	0.646	rs9393789	chr6:27067028	G/T	cg12292205	chr6:26970375	C6orf41	-0.59	-5.15	-0.5	1.94e-6	Schizophrenia;
SKCM	cis	rs12048904	0.619	rs12239082	chr1:101330077	G/T	cg00063077	chr1:101360652	SLC30A7;EXTL2	-0.87	-7.17	-0.63	3.67e-10	Multiple sclerosis;
SKCM	cis	rs2153535	0.580	rs2327060	chr6:8447111	G/A	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs1200821	0.529	rs2505707	chr10:37801254	T/C	cg25427524	chr10:38739819	LOC399744	-0.54	-5.48	-0.53	5.13e-7	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs875971	0.638	rs6460305	chr7:66060408	G/A	cg05627663	chr7:65219948	SNORA22;CCT6P1	-0.56	-4.81	-0.48	7.26e-6	Aortic root size;
SKCM	cis	rs838147	0.760	rs281408	chr19:49233406	A/C	cg13540341	chr19:49222985	MAMSTR	-0.63	-5.73	-0.54	1.78e-7	Dietary macronutrient intake;
SKCM	cis	rs7666738	0.830	rs1534319	chr4:98964804	T/C	cg05340658	chr4:99064831	C4orf37	0.64	4.91	0.49	4.97e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4783244	0.897	rs3865188	chr16:82650717	A/T	cg09415485	chr16:82663111	CDH13	0.56	4.85	0.48	6.26e-6	Adiponectin levels;
SKCM	cis	rs6952808	1.000	rs59248873	chr7:1888185	A/G	cg02951883	chr7:2050386	MAD1L1	-0.71	-5.35	-0.52	8.61e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs9611565	0.512	rs139562	chr22:42196684	G/C	cg03806693	chr22:41940476	POLR3H	-1.06	-6.84	-0.61	1.61e-9	Vitiligo;
SKCM	cis	rs2841233	0.895	rs2028414	chr14:105349388	A/C	cg16576083	chr14:105354267	KIAA0284	0.64	5.37	0.52	7.82e-7	IgG glycosylation;
SKCM	cis	rs17065868	0.803	rs7320846	chr13:45196954	T/G	cg10246903	chr13:45222710	NA	0.95	5.35	0.52	8.5e-7	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs2842992	0.915	rs2758350	chr6:160118056	A/G	cg11366901	chr6:160182831	ACAT2	0.83	6.72	0.61	2.69e-9	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs9467773	0.572	rs13213953	chr6:26594534	T/A	cg15659132	chr6:26577336	NA	0.66	5.87	0.55	9.9e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs6754311	0.731	rs12615624	chr2:136721603	A/G	cg07169764	chr2:136633963	MCM6	0.7	4.87	0.48	5.83e-6	Mosquito bite size;
SKCM	cis	rs6066825	0.606	rs2869668	chr20:47321393	T/C	cg18078177	chr20:47281410	PREX1	0.62	4.99	0.49	3.62e-6	Colorectal cancer;
SKCM	cis	rs9660180	0.620	rs3817856	chr1:1663831	C/T	cg13866156	chr1:1669148	SLC35E2	0.73	5.95	0.56	7.09e-8	Body mass index;
SKCM	cis	rs6580649	1.000	rs6580649	chr12:48410517	A/G	cg05342945	chr12:48394962	COL2A1	-0.69	-5.05	-0.5	2.83e-6	Lung cancer;
SKCM	cis	rs17376456	0.825	rs13165400	chr5:93091427	G/A	cg25358565	chr5:93447407	FAM172A	1.15	7.28	0.64	2.25e-10	Diabetic retinopathy;
SKCM	cis	rs7772486	0.686	rs4896827	chr6:145953338	T/A	cg23711669	chr6:146136114	FBXO30	0.88	9.43	0.73	1.6e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs16940212	0.618	rs8032310	chr15:58687862	C/T	cg16767221	chr15:57769667	CGNL1	-0.58	-4.78	-0.48	8.22e-6	HDL cholesterol levels;HDL cholesterol;
SKCM	cis	rs7666738	0.830	rs10001702	chr4:99065160	T/G	cg05340658	chr4:99064831	C4orf37	0.66	4.87	0.48	5.74e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6570726	0.818	rs399516	chr6:145810849	C/A	cg23711669	chr6:146136114	FBXO30	0.74	6.97	0.62	9.17e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs10927875	0.632	rs904911	chr1:16126932	C/T	cg21385522	chr1:16154831	NA	-0.98	-11.21	-0.79	6.28e-18	Dilated cardiomyopathy;
SKCM	cis	rs2658782	1.000	rs2658781	chr11:93166368	C/T	cg15737290	chr11:93063684	CCDC67	-0.77	-5.54	-0.53	3.92e-7	Pulmonary function decline;
SKCM	cis	rs4819052	1.000	rs9306123	chr21:46709922	A/G	cg19498844	chr21:46707878	POFUT2;LOC642852	0.94	7.46	0.65	1.04e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs3859192	0.599	rs2302777	chr17:38179492	A/G	cg17467752	chr17:38218738	THRA	-0.76	-6.37	-0.58	1.22e-8	White blood cell count;
SKCM	cis	rs35306767	0.668	rs35657988	chr10:1103590	A/G	cg25614935	chr10:1084866	C10orf110	0.58	4.91	0.49	4.89e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs1850744	0.702	rs11724183	chr4:9609894	A/G	cg15442990	chr4:9534313	NA	-1.55	-5.83	-0.55	1.18e-7	Economic and political preferences;
SKCM	cis	rs314370	0.951	rs12667888	chr7:100474289	T/C	cg10426581	chr7:100472382	SRRT	0.73	6.19	0.57	2.59e-8	Resting heart rate;
SKCM	cis	rs561341	1.000	rs72823787	chr17:30283809	A/T	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs362272	0.545	rs2748447	chr4:3337831	G/A	cg21096898	chr4:3318625	RGS12	1.01	12.43	0.82	3.44e-20	Serum sulfate level;
SKCM	cis	rs7020830	0.931	rs1388978	chr9:37144062	G/T	cg14294708	chr9:37120828	ZCCHC7	1.08	10.16	0.75	6.17e-16	Schizophrenia;
SKCM	cis	rs6582630	0.555	rs11181684	chr12:38388000	T/C	cg26384229	chr12:38710491	ALG10B	0.8	6.24	0.58	2.08e-8	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs2836974	0.897	rs13049280	chr21:40594656	C/G	cg17971929	chr21:40555470	PSMG1	0.9	8.81	0.71	2.52e-13	Cognitive function;
SKCM	cis	rs28595532	0.764	rs116158926	chr4:119730572	C/T	cg21605333	chr4:119757512	SEC24D	1.36	8.05	0.67	7.69e-12	Cannabis dependence symptom count;
SKCM	cis	rs2455601	1.000	rs11042108	chr11:8906021	G/A	cg21881798	chr11:8931708	C11orf17;ST5	-0.94	-5.96	-0.56	7.03e-8	Schizophrenia;
SKCM	cis	rs651907	0.557	rs11925001	chr3:101373966	C/T	cg12386194	chr3:101231763	SENP7	0.71	5.89	0.55	9.17e-8	Colorectal cancer;
SKCM	cis	rs754466	0.651	rs7895188	chr10:79623378	C/G	cg17075019	chr10:79541650	NA	0.79	6.95	0.62	9.63e-10	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs507080	0.845	rs613377	chr11:118556084	C/T	cg18045108	chr11:118530628	TREH	-0.47	-4.81	-0.48	7.24e-6	Serum metabolite levels;
SKCM	cis	rs4523957	0.651	rs8082485	chr17:2060407	A/G	cg16513277	chr17:2031491	SMG6	-0.79	-5.63	-0.54	2.7e-7	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs13118159	0.509	rs4974554	chr4:1356967	A/C	cg20887711	chr4:1340912	KIAA1530	0.98	7.46	0.65	1.04e-10	Longevity;
SKCM	cis	rs9911578	1.000	rs3744108	chr17:56585872	G/C	cg12560992	chr17:57184187	TRIM37	-0.94	-7.55	-0.65	7.05e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs2836974	0.897	rs2836924	chr21:40525639	C/T	cg17971929	chr21:40555470	PSMG1	0.87	8.48	0.69	1.1e-12	Cognitive function;
SKCM	cis	rs1862618	0.671	rs173763	chr5:56225418	G/A	cg03609598	chr5:56110824	MAP3K1	-0.71	-5.08	-0.5	2.5e-6	Initial pursuit acceleration;
SKCM	trans	rs1814175	0.817	rs28544182	chr11:50049577	G/T	cg15704280	chr7:45808275	SEPT13	-1.05	-11.07	-0.78	1.14e-17	Height;
SKCM	cis	rs2153535	0.580	rs2183112	chr6:8528212	G/A	cg23788917	chr6:8435910	SLC35B3	0.68	4.98	0.49	3.66e-6	Motion sickness;
SKCM	cis	rs6570726	0.846	rs446031	chr6:145885592	C/T	cg23711669	chr6:146136114	FBXO30	0.79	7.74	0.66	3.02e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7940866	0.838	rs10736592	chr11:130800572	C/T	cg12179176	chr11:130786555	SNX19	0.76	6.08	0.57	4.13e-8	Schizophrenia;
SKCM	cis	rs35306767	0.715	rs17293580	chr10:1034895	T/C	cg26597838	chr10:835615	NA	0.76	6.22	0.58	2.29e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs7811142	1.000	rs11761784	chr7:100039970	C/T	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.34	0.69	2.1e-12	Platelet count;
SKCM	cis	rs62238980	0.614	rs77324143	chr22:32401957	C/T	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs35306767	0.807	rs34982663	chr10:852521	C/G	cg26597838	chr10:835615	NA	0.79	5.98	0.56	6.39e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs2404602	0.692	rs2120108	chr15:76869929	G/T	cg23625390	chr15:77176239	SCAPER	-0.61	-5.44	-0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs7408868	1.000	rs10415431	chr19:15277027	G/A	cg14696996	chr19:15285081	NOTCH3	0.82	4.92	0.49	4.7e-6	Pulse pressure;
SKCM	cis	rs4253772	0.637	rs8135997	chr22:46651366	G/A	cg03482458	chr22:46692211	CN5H6.4;GTSE1	1.11	4.96	0.49	4.03e-6	LDL cholesterol;Cholesterol, total;
SKCM	cis	rs11098499	0.820	rs13122709	chr4:120555356	T/A	cg24375607	chr4:120327624	NA	0.64	4.91	0.49	4.99e-6	Corneal astigmatism;
SKCM	cis	rs4803468	0.935	rs12602	chr19:41889748	T/C	cg09537434	chr19:41945824	ATP5SL	-1.09	-12.16	-0.81	1.08e-19	Height;
SKCM	cis	rs2839186	0.903	rs61182475	chr21:47707050	T/A	cg11766577	chr21:47581405	C21orf56	-0.71	-6.01	-0.56	5.6e-8	Testicular germ cell tumor;
SKCM	cis	rs28595532	0.920	rs116046128	chr4:119741990	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs7811142	1.000	rs67163493	chr7:100023838	C/T	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.33	0.69	2.11e-12	Platelet count;
SKCM	cis	rs72781680	0.752	rs55801864	chr2:23922325	C/T	cg08917208	chr2:24149416	ATAD2B	0.98	4.98	0.49	3.75e-6	Lymphocyte counts;
SKCM	cis	rs7523050	0.643	rs7519293	chr1:109399543	A/G	cg08274380	chr1:109419600	GPSM2	1.13	5.57	0.53	3.54e-7	Fat distribution (HIV);
SKCM	trans	rs1814175	0.669	rs11040455	chr11:49669829	G/C	cg15704280	chr7:45808275	SEPT13	-0.79	-7.35	-0.64	1.69e-10	Height;
SKCM	cis	rs17102884	0.506	rs4899540	chr14:75403408	G/A	cg08847533	chr14:75593920	NEK9	-0.68	-5.4	-0.52	7.09e-7	Neuroticism;
SKCM	cis	rs854765	0.565	rs854768	chr17:18018806	T/C	cg04398451	chr17:18023971	MYO15A	-1.04	-9.04	-0.72	8.99e-14	Total body bone mineral density;
SKCM	cis	rs910316	1.000	rs7145159	chr14:75583268	A/G	cg08847533	chr14:75593920	NEK9	0.93	9.15	0.72	5.51e-14	Height;
SKCM	cis	rs2032447	0.520	rs198818	chr6:26125711	A/C	cg03517284	chr6:25882590	NA	0.6	5.14	0.5	1.98e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs798554	0.797	rs798486	chr7:2803037	A/G	cg19346786	chr7:2764209	NA	-0.7	-7.55	-0.65	6.89e-11	Height;
SKCM	cis	rs476633	0.691	rs6492997	chr15:41541171	G/A	cg18705301	chr15:41695430	NDUFAF1	-0.65	-4.86	-0.48	6.01e-6	Glomerular filtration rate (creatinine);
SKCM	cis	rs2795502	1.000	rs2795496	chr10:43337842	G/A	cg20628663	chr10:43360327	NA	-0.59	-5.27	-0.51	1.18e-6	Blood protein levels;
SKCM	cis	rs6570726	0.791	rs9399558	chr6:145911730	T/C	cg23711669	chr6:146136114	FBXO30	0.88	8.39	0.69	1.67e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1707322	1.000	rs4390216	chr1:46266456	C/T	cg03146154	chr1:46216737	IPP	0.75	5.15	0.5	1.94e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs826838	1.000	rs826892	chr12:39100790	T/C	cg13010199	chr12:38710504	ALG10B	-0.82	-6.28	-0.58	1.77e-8	Heart rate;
SKCM	cis	rs10193935	0.901	rs13413617	chr2:42537546	A/G	cg27598129	chr2:42591480	NA	-0.88	-6.71	-0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9815354	0.767	rs73079350	chr3:41876310	C/T	cg03022575	chr3:42003672	ULK4	1.06	5.44	0.52	5.95e-7	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs9910055	0.762	rs7213436	chr17:42252163	A/G	cg09913183	chr17:42254507	C17orf65;ASB16	-0.7	-6.49	-0.59	7.35e-9	Total body bone mineral density;
SKCM	cis	rs6866344	0.570	rs1071881	chr5:178135917	C/T	cg10224037	chr5:178157518	ZNF354A	0.84	6.3	0.58	1.65e-8	Neutrophil percentage of white cells;
SKCM	cis	rs6840360	0.593	rs4696287	chr4:152606723	C/T	cg22705602	chr4:152727874	NA	-0.58	-7.78	-0.66	2.55e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs10754283	0.967	rs7523046	chr1:90109499	G/A	cg21401794	chr1:90099060	LRRC8C	0.73	6.34	0.58	1.35e-8	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs2832191	0.692	rs2245517	chr21:30357968	C/T	cg24692254	chr21:30365293	RNF160	1.01	9.45	0.73	1.44e-14	Dental caries;
SKCM	cis	rs16854884	0.657	rs16854772	chr3:143703890	A/G	cg06585982	chr3:143692056	C3orf58	0.83	7.39	0.64	1.42e-10	Economic and political preferences (feminism/equality);
SKCM	cis	rs28386778	0.897	rs8073515	chr17:61795328	A/C	cg01411255	chr17:61851458	DDX42;CCDC47	0.79	5.1	0.5	2.35e-6	Prudent dietary pattern;
SKCM	cis	rs9796	0.636	rs1983400	chr15:41373029	T/C	cg00616447	chr15:41694635	NDUFAF1	0.75	4.77	0.48	8.36e-6	Menopause (age at onset);
SKCM	cis	rs56104184	0.779	rs4802513	chr19:49357656	T/A	cg15549821	chr19:49342101	PLEKHA4	-1.14	-7.1	-0.63	5.14e-10	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs912057	0.601	rs1294413	chr6:6739924	C/A	cg06612196	chr6:6737390	NA	0.73	6.24	0.58	2.11e-8	Waist-to-hip ratio adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);
SKCM	cis	rs561341	0.739	rs1978116	chr17:30220978	A/C	cg00745463	chr17:30367425	LRRC37B	-0.96	-6.15	-0.57	3.08e-8	Hip circumference adjusted for BMI;
SKCM	cis	rs875971	0.660	rs1860468	chr7:66107252	T/C	cg18876405	chr7:65276391	NA	-0.82	-7.48	-0.65	9.41e-11	Aortic root size;
SKCM	cis	rs9322193	0.923	rs10747275	chr6:149943918	C/T	cg07701084	chr6:150067640	NUP43	0.61	4.84	0.48	6.48e-6	Lung cancer;
SKCM	cis	rs2153535	0.580	rs7453115	chr6:8447261	A/G	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs9796	0.674	rs6492978	chr15:41317702	T/C	cg00616447	chr15:41694635	NDUFAF1	0.71	4.97	0.49	3.91e-6	Menopause (age at onset);
SKCM	cis	rs2439831	0.702	rs495175	chr15:43798684	C/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.21	7.63	0.65	4.86e-11	Lung cancer in ever smokers;
SKCM	cis	rs9467773	0.620	rs1027204	chr6:26639613	T/C	cg15659132	chr6:26577336	NA	0.62	5.4	0.52	6.91e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs8067545	0.611	rs2703771	chr17:20130154	C/G	cg13482628	chr17:19912719	NA	-0.66	-5.59	-0.53	3.23e-7	Schizophrenia;
SKCM	cis	rs72949976	0.934	rs10197392	chr2:214038178	G/A	cg08319019	chr2:214017104	IKZF2	-0.67	-4.92	-0.49	4.78e-6	Lung cancer;Squamous cell lung carcinoma;
SKCM	cis	rs11122272	0.735	rs2474631	chr1:231541341	T/A	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	-0.64	-5.22	-0.51	1.45e-6	Hemoglobin concentration;
SKCM	cis	rs992157	0.717	rs11692780	chr2:219149163	A/G	cg20019365	chr2:219134978	PNKD;AAMP	-0.71	-6.08	-0.57	4.22e-8	Colorectal cancer;
SKCM	cis	rs34779708	0.966	rs12257770	chr10:35517234	A/G	cg03585969	chr10:35415529	CREM	0.74	6.3	0.58	1.66e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs8072100	0.713	rs2292346	chr17:45455473	G/A	cg08085267	chr17:45401833	C17orf57	-0.62	-5.06	-0.5	2.76e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs7569084	0.640	rs11126039	chr2:65685087	A/G	cg10464312	chr2:66672688	MEIS1	0.45	5.09	0.5	2.39e-6	Sum eosinophil basophil counts;
SKCM	cis	rs1577917	1.000	rs6940458	chr6:86644992	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.66	-5.74	-0.54	1.76e-7	Response to antipsychotic treatment;
SKCM	cis	rs9640161	0.789	rs1464753	chr7:150021350	G/C	cg10018233	chr7:150070692	REPIN1	0.75	6.05	0.56	4.81e-8	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs897984	0.684	rs6950	chr16:30995669	T/C	cg00531865	chr16:30841666	NA	0.59	4.97	0.49	3.81e-6	Dementia with Lewy bodies;
SKCM	trans	rs17685	0.753	rs6465000	chr7:75787417	G/A	cg19862616	chr7:65841803	NCRNA00174	0.92	9.38	0.73	2.02e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs228769	0.636	rs11656104	chr17:42258965	A/T	cg10896456	chr17:42255109	ASB16;C17orf65	0.6	5.08	0.5	2.51e-6	Bone mineral density (hip);Bone mineral density (spine);
SKCM	trans	rs8073060	0.544	rs225249	chr17:33942540	T/C	cg19694781	chr19:47549865	TMEM160	-1.08	-8.69	-0.7	4.26e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs9818758	0.607	rs34580506	chr3:49113713	C/A	cg00383909	chr3:49044727	WDR6	1.05	5.85	0.55	1.11e-7	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs9902453	0.868	rs11080118	chr17:28475379	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.75	-5.51	-0.53	4.46e-7	Coffee consumption (cups per day);
SKCM	cis	rs11098499	0.863	rs34308924	chr4:120481431	T/C	cg09307838	chr4:120376055	NA	1.0	8.27	0.68	2.8e-12	Corneal astigmatism;
SKCM	cis	rs644799	0.672	rs61902245	chr11:95517737	C/T	cg25622487	chr11:95524042	FAM76B;CEP57	0.76	6.46	0.59	8.32e-9	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs2204008	0.665	rs11495668	chr12:38221018	C/T	cg26384229	chr12:38710491	ALG10B	0.82	6.58	0.6	4.87e-9	Bladder cancer;
SKCM	cis	rs2070488	0.662	rs6599202	chr3:38480651	T/C	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.75	5.63	0.54	2.73e-7	Electrocardiographic conduction measures;
SKCM	cis	rs1046896	0.739	rs28459016	chr17:80741194	G/A	cg02711726	chr17:80685570	FN3KRP	-0.76	-5.95	-0.56	7.33e-8	Glycated hemoglobin levels;
SKCM	cis	rs1568889	1.000	rs12800354	chr11:28047723	T/C	cg06544937	chr11:28130018	METT5D1;KIF18A	0.86	7.03	0.62	6.97e-10	Bipolar disorder;
SKCM	cis	rs9393692	0.557	rs10946810	chr6:26288055	G/A	cg13736514	chr6:26305472	NA	-0.64	-4.79	-0.48	7.77e-6	Educational attainment;
SKCM	trans	rs17685	0.672	rs1894760	chr7:75852140	A/G	cg19862616	chr7:65841803	NCRNA00174	0.92	9.4	0.73	1.85e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	trans	rs11722228	0.549	rs73212830	chr4:10078759	A/T	cg26043149	chr18:55253948	FECH	0.93	7.98	0.67	1.02e-11	Gout;Urate levels;Serum uric acid levels;
SKCM	cis	rs2404602	0.735	rs11857327	chr15:76764263	G/C	cg23625390	chr15:77176239	SCAPER	-0.83	-8.16	-0.68	4.7e-12	Blood metabolite levels;
SKCM	cis	rs9325144	0.678	rs7315271	chr12:39164731	A/G	cg26384229	chr12:38710491	ALG10B	-0.71	-6.4	-0.59	1.08e-8	Morning vs. evening chronotype;
SKCM	cis	rs9303401	0.659	rs62081316	chr17:56781499	C/T	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.35	0.52	8.54e-7	Cognitive test performance;
SKCM	cis	rs2836974	0.568	rs377098	chr21:40535216	G/A	cg17971929	chr21:40555470	PSMG1	-0.76	-7.16	-0.63	3.94e-10	Cognitive function;
SKCM	cis	rs372883	0.638	rs371432	chr21:30710876	G/A	cg24692254	chr21:30365293	RNF160	-0.68	-5.46	-0.53	5.37e-7	Pancreatic cancer;
SKCM	cis	rs9308433	0.553	rs2047445	chr1:214469962	G/A	cg06198575	chr1:214491504	SMYD2	0.79	4.86	0.48	5.84e-6	IgG glycosylation;
SKCM	cis	rs7666738	0.830	rs1426665	chr4:99027764	C/T	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6582630	0.502	rs11182760	chr12:38606273	A/T	cg13010199	chr12:38710504	ALG10B	0.64	4.85	0.48	6.15e-6	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs28595532	0.920	rs56046676	chr4:119766733	A/G	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	trans	rs1814175	0.817	rs12295885	chr11:50036762	T/G	cg15704280	chr7:45808275	SEPT13	-1.05	-11.07	-0.78	1.14e-17	Height;
SKCM	cis	rs2243480	1.000	rs7778911	chr7:65694506	T/C	cg18252515	chr7:66147081	NA	1.36	8.16	0.68	4.6e-12	Diabetic kidney disease;
SKCM	cis	rs1799949	0.965	rs8176193	chr17:41231516	C/T	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.06	-0.57	4.54e-8	Menopause (age at onset);
SKCM	cis	rs9435341	0.965	rs2335077	chr1:107573565	A/G	cg09367891	chr1:107599246	PRMT6	0.83	7.25	0.63	2.64e-10	Facial morphology (factor 21, depth of nasal alae);
SKCM	cis	rs2974760	0.581	rs2541600	chr16:199540	G/A	cg08400316	chr16:204221	HBZ	0.98	7.22	0.63	2.94e-10	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs10911232	0.524	rs10911209	chr1:183013988	T/G	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.64	0.6	3.83e-9	Hypertriglyceridemia;
SKCM	cis	rs875971	0.508	rs10950045	chr7:66066373	T/C	cg18876405	chr7:65276391	NA	-0.8	-7.2	-0.63	3.28e-10	Aortic root size;
SKCM	cis	rs864745	0.571	rs849139	chr7:28179396	C/T	cg15170557	chr7:28214983	JAZF1	-0.55	-5.11	-0.5	2.19e-6	Crohn's disease;Type 2 diabetes;
SKCM	cis	rs7917772	0.503	rs10883732	chr10:104293461	G/A	cg11453585	chr10:104263688	ACTR1A;SUFU	0.78	6.33	0.58	1.47e-8	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs11098499	0.954	rs10006525	chr4:120408931	T/G	cg09307838	chr4:120376055	NA	0.97	7.65	0.65	4.54e-11	Corneal astigmatism;
SKCM	cis	rs453301	0.598	rs2921383	chr8:8892221	C/T	cg06636001	chr8:8085503	FLJ10661	0.78	6.07	0.57	4.4e-8	Joint mobility (Beighton score);
SKCM	cis	rs13118159	0.550	rs28614045	chr4:1374695	C/A	cg02475777	chr4:1388615	CRIPAK	0.85	5.8	0.55	1.36e-7	Longevity;
SKCM	cis	rs9911578	0.967	rs302843	chr17:56727986	C/T	cg05425664	chr17:57184151	TRIM37	-0.69	-5.21	-0.51	1.52e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1577917	0.883	rs1337854	chr6:86724015	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.69	5.97	0.56	6.72e-8	Response to antipsychotic treatment;
SKCM	cis	rs62238980	0.614	rs75526838	chr22:32451830	A/G	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs2439831	0.850	rs3816792	chr15:44116986	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	-1.35	-7.75	-0.66	2.9e-11	Lung cancer in ever smokers;
SKCM	cis	rs875971	0.540	rs736270	chr7:65428822	T/C	cg11987759	chr7:65425863	GUSB	-0.73	-6.49	-0.59	7.37e-9	Aortic root size;
SKCM	cis	rs4774899	0.966	rs12912007	chr15:57411492	T/G	cg01857019	chr15:57210107	LOC145783;TCF12	0.53	4.92	0.49	4.69e-6	Urinary tract infection frequency;
SKCM	cis	rs35306767	0.909	rs12264390	chr10:959111	T/C	cg25614935	chr10:1084866	C10orf110	0.67	4.85	0.48	6.07e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs7208859	0.623	rs9898084	chr17:29082334	C/G	cg13385521	chr17:29058706	SUZ12P	1.02	5.41	0.52	6.68e-7	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs4972806	0.849	rs2857541	chr2:177029086	C/T	cg14324370	chr2:177042789	NA	0.58	5.07	0.5	2.6e-6	IgG glycosylation;
SKCM	cis	rs80282103	0.618	rs74117848	chr10:1160974	T/G	cg19207066	chr10:1251074	ADARB2	-0.76	-4.94	-0.49	4.41e-6	Glomerular filtration rate (creatinine);
SKCM	cis	rs995000	0.931	rs1748195	chr1:63049593	C/G	cg06896770	chr1:63153194	DOCK7	-0.76	-7.5	-0.65	8.71e-11	Triglyceride levels;
SKCM	cis	rs34779708	0.931	rs7099593	chr10:35366878	A/C	cg03585969	chr10:35415529	CREM	0.78	6.3	0.58	1.6e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs116095464	0.558	rs10079760	chr5:230778	A/G	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	trans	rs1814175	0.645	rs1851845	chr11:49982396	C/T	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs11098499	1.000	rs28419773	chr4:120211061	T/C	cg09307838	chr4:120376055	NA	0.96	8.12	0.68	5.43e-12	Corneal astigmatism;
SKCM	cis	rs1461503	0.868	rs10790543	chr11:122838311	A/C	cg27398637	chr11:122830231	C11orf63	-0.63	-4.8	-0.48	7.54e-6	Menarche (age at onset);
SKCM	cis	rs9790314	0.871	rs339114	chr3:161109220	C/T	cg03342759	chr3:160939853	NMD3	0.72	6.99	0.62	8.37e-10	Morning vs. evening chronotype;
SKCM	cis	rs13256369	1.000	rs10088439	chr8:8576699	T/G	cg06636001	chr8:8085503	FLJ10661	0.72	5.39	0.52	7.4e-7	Obesity-related traits;
SKCM	cis	rs1799949	0.602	rs8176257	chr17:41216205	G/T	cg23758822	chr17:41437982	NA	0.81	5.96	0.56	6.91e-8	Menopause (age at onset);
SKCM	cis	rs6089584	1.000	rs6089591	chr20:60570548	A/C	cg06108461	chr20:60628389	TAF4	-0.79	-6.86	-0.61	1.48e-9	Body mass index;
SKCM	cis	rs1707322	0.752	rs11211152	chr1:46114157	C/T	cg03146154	chr1:46216737	IPP	0.79	5.42	0.52	6.34e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs1005277	0.579	rs1780146	chr10:38517874	C/A	cg00409905	chr10:38381863	ZNF37A	-0.61	-5.26	-0.51	1.2e-6	Extrinsic epigenetic age acceleration;
SKCM	cis	rs6840360	0.530	rs62327350	chr4:152641202	G/A	cg22705602	chr4:152727874	NA	-0.53	-5.67	-0.54	2.28e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs4803455	0.565	rs1025497	chr19:41871254	A/G	cg09537434	chr19:41945824	ATP5SL	-0.82	-6.5	-0.59	6.86e-9	Migraine;Coronary artery disease;
SKCM	cis	rs17685	0.753	rs6951943	chr7:75772452	A/G	cg16684958	chr7:75615977	POR	0.52	4.96	0.49	4.09e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs28595532	1.000	rs11098451	chr4:119717673	C/T	cg21605333	chr4:119757512	SEC24D	1.35	7.92	0.67	1.37e-11	Cannabis dependence symptom count;
SKCM	cis	rs854765	0.583	rs11078405	chr17:17824978	G/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.94	7.32	0.64	1.96e-10	Total body bone mineral density;
SKCM	cis	rs7772486	0.727	rs6941429	chr6:145952283	G/A	cg05347473	chr6:146136440	FBXO30	0.64	5.91	0.56	8.66e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4888262	0.508	rs4462623	chr16:74692426	C/T	cg01733217	chr16:74700730	RFWD3	0.86	7.02	0.62	7.31e-10	Testicular germ cell tumor;
SKCM	cis	rs6952808	0.723	rs60995052	chr7:2030007	G/C	cg21782813	chr7:2030301	MAD1L1	0.57	5.93	0.56	7.93e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs514406	0.698	rs11206043	chr1:53402552	C/T	cg24675658	chr1:53192096	ZYG11B	-0.82	-7.79	-0.66	2.45e-11	Monocyte count;
SKCM	cis	rs6860806	0.531	rs272888	chr5:131665423	T/C	cg24060327	chr5:131705240	SLC22A5	-0.74	-4.79	-0.48	7.76e-6	Breast cancer;
SKCM	cis	rs12142240	0.698	rs55971480	chr1:46823206	G/T	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs7772486	0.754	rs1415747	chr6:146077249	A/G	cg23711669	chr6:146136114	FBXO30	0.9	9.62	0.74	6.92e-15	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9467773	0.572	rs62394558	chr6:26604650	G/A	cg15659132	chr6:26577336	NA	0.66	5.87	0.55	9.9e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs2153535	0.580	rs7341382	chr6:8470549	A/G	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs2730245	0.592	rs2657385	chr7:158649373	A/G	cg24397884	chr7:158709396	WDR60	0.68	5.26	0.51	1.25e-6	Height;
SKCM	cis	rs6062302	0.549	rs4809586	chr20:62249402	C/T	cg09650180	chr20:62225654	GMEB2	-0.78	-6.22	-0.58	2.28e-8	Glioblastoma;
SKCM	cis	rs514406	0.570	rs1332776	chr1:53189816	C/T	cg24675658	chr1:53192096	ZYG11B	-0.64	-5.36	-0.52	8.07e-7	Monocyte count;
SKCM	cis	rs7811142	1.000	rs112317829	chr7:100043173	A/G	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-0.99	-5.52	-0.53	4.2e-7	Platelet count;
SKCM	cis	rs8017423	0.647	rs11626821	chr14:90824945	A/G	cg04374321	chr14:90722782	PSMC1	-0.73	-5.53	-0.53	4.13e-7	Mortality in heart failure;
SKCM	cis	rs7193541	0.684	rs4888264	chr16:74681632	T/G	cg01733217	chr16:74700730	RFWD3	1.02	11.62	0.8	1.08e-18	Multiple myeloma;
SKCM	cis	rs9311474	0.607	rs13076398	chr3:52573096	G/A	cg18404041	chr3:52824283	ITIH1	-0.55	-4.98	-0.49	3.8e-6	Electroencephalogram traits;
SKCM	cis	rs654950	0.875	rs586055	chr1:41999076	T/C	cg06885757	chr1:42089581	HIVEP3	0.65	7.07	0.62	5.9e-10	Airway imaging phenotypes;
SKCM	cis	rs2842992	0.789	rs6908680	chr6:160218209	G/T	cg16489826	chr6:160211363	TCP1;MRPL18	0.68	4.93	0.49	4.57e-6	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs34172651	0.517	rs189919	chr16:24737741	G/A	cg06028605	chr16:24865363	SLC5A11	-0.59	-4.87	-0.48	5.67e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1218582	0.688	rs2135219	chr1:154857217	G/A	cg06221963	chr1:154839813	KCNN3	-0.6	-6.09	-0.57	3.92e-8	Prostate cancer;
SKCM	cis	rs7829975	0.514	rs2920983	chr8:8268063	G/C	cg08975724	chr8:8085496	FLJ10661	0.64	5.05	0.5	2.8e-6	Mood instability;
SKCM	cis	rs10927875	0.929	rs4661674	chr1:16296039	A/G	cg21385522	chr1:16154831	NA	-0.93	-7.92	-0.67	1.36e-11	Dilated cardiomyopathy;
SKCM	cis	rs11249608	0.703	rs7726601	chr5:178444713	A/G	cg21905437	chr5:178450457	ZNF879	-0.71	-5.57	-0.53	3.44e-7	Pubertal anthropometrics;
SKCM	cis	rs12706411	1.000	rs35168749	chr7:122046492	T/C	cg17986181	chr7:121955208	NA	-0.7	-5.19	-0.51	1.65e-6	Alzheimer disease and age of onset;
SKCM	cis	rs12134245	0.776	rs6688261	chr1:91987034	C/T	cg02896835	chr1:92012615	NA	-0.59	-5.47	-0.53	5.29e-7	Breast cancer;
SKCM	cis	rs2836974	0.932	rs35571600	chr21:40590624	A/C	cg11890956	chr21:40555474	PSMG1	1.09	13.83	0.84	1.08e-22	Cognitive function;
SKCM	cis	rs28595532	0.920	rs114462478	chr4:119752656	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs2153535	0.563	rs4428546	chr6:8490376	A/G	cg07606381	chr6:8435919	SLC35B3	0.86	6.25	0.58	2.06e-8	Motion sickness;
SKCM	cis	rs2836974	0.965	rs34578707	chr21:40675167	G/A	cg11644478	chr21:40555479	PSMG1	0.83	7.69	0.66	3.66e-11	Cognitive function;
SKCM	cis	rs875971	0.825	rs66981195	chr7:66079035	C/A	cg18876405	chr7:65276391	NA	-0.63	-6.32	-0.58	1.5e-8	Aortic root size;
SKCM	cis	rs28386778	0.897	rs2665795	chr17:61925272	A/G	cg22520471	chr17:61851767	DDX42;CCDC47	-0.78	-5.31	-0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs6696846	0.765	rs11576867	chr1:205064676	C/T	cg03948781	chr1:205179583	DSTYK	0.51	4.85	0.48	6.24e-6	Red blood cell count;
SKCM	cis	rs7666738	0.830	rs3907021	chr4:99038668	C/T	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs116095464	0.558	rs10057674	chr5:266813	C/T	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs7829975	0.846	rs7005216	chr8:8547110	C/G	cg15556689	chr8:8085844	FLJ10661	-0.74	-6.13	-0.57	3.4e-8	Mood instability;
SKCM	cis	rs7027203	0.797	rs57882762	chr9:96580825	T/G	cg14396892	chr9:96623032	NA	-0.47	-4.89	-0.48	5.21e-6	DNA methylation (variation);
SKCM	cis	rs208520	1.000	rs208537	chr6:66963544	A/G	cg07460842	chr6:66804631	NA	-0.84	-5.89	-0.55	9.44e-8	Exhaled nitric oxide output;
SKCM	cis	rs1218582	0.772	rs6699043	chr1:154913021	T/C	cg03351412	chr1:154909251	PMVK	0.76	6.45	0.59	8.5e-9	Prostate cancer;
SKCM	cis	rs713587	0.520	rs512419	chr2:25310155	G/T	cg04586622	chr2:25135609	ADCY3	-0.63	-4.84	-0.48	6.35e-6	Body mass index in non-asthmatics;
SKCM	cis	rs10540	1.000	rs71487292	chr11:486076	G/A	cg03352830	chr11:487213	PTDSS2	1.05	4.94	0.49	4.37e-6	Body mass index;
SKCM	cis	rs4253772	0.591	rs6007726	chr22:46650858	A/C	cg03482458	chr22:46692211	CN5H6.4;GTSE1	1.11	4.96	0.49	4.03e-6	LDL cholesterol;Cholesterol, total;
SKCM	cis	rs2050392	0.590	rs17547917	chr10:30718303	G/A	cg25182066	chr10:30743637	MAP3K8	-0.66	-5.37	-0.52	7.75e-7	Inflammatory bowel disease;
SKCM	cis	rs4820539	0.932	rs3788349	chr22:23467950	A/G	cg14186256	chr22:23484241	RTDR1	0.85	8.17	0.68	4.37e-12	Bone mineral density;
SKCM	cis	rs7584330	0.666	rs72620818	chr2:238354652	G/A	cg14458575	chr2:238380390	NA	1.13	7.24	0.63	2.7e-10	Prostate cancer;
SKCM	cis	rs6500602	0.964	rs62039173	chr16:4463846	G/A	cg09069446	chr16:4462122	CORO7	-0.46	-4.8	-0.48	7.56e-6	Schizophrenia;
SKCM	cis	rs709400	0.659	rs7160366	chr14:103944137	C/T	cg26031613	chr14:104095156	KLC1	0.77	5.96	0.56	6.87e-8	Body mass index;
SKCM	cis	rs995000	0.931	rs11207997	chr1:63061906	C/T	cg06896770	chr1:63153194	DOCK7	0.74	6.97	0.62	8.92e-10	Triglyceride levels;
SKCM	cis	rs711830	0.931	rs717852	chr2:177031623	C/T	cg13092806	chr2:177043255	NA	0.65	5.81	0.55	1.31e-7	Serous invasive ovarian cancer;Epithelial ovarian cancer;Invasive epithelial ovarian cancer;Mucinous ovarian carcinoma;Low-grade serous and serous borderline ovarian cancer;Serous borderline ovarian cancer;High-grade serous ovarian cancer;
SKCM	cis	rs8170	0.603	rs8110408	chr19:17440542	C/G	cg07830086	chr19:18107778	KCNN1	-0.81	-5.06	-0.5	2.77e-6	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Ovarian cancer;Breast cancer;Epithelial ovarian cancer;
SKCM	cis	rs3096299	0.738	rs9929606	chr16:89527537	C/T	cg02187348	chr16:89574699	SPG7	0.66	5.28	0.51	1.15e-6	Multiple myeloma (IgH translocation);
SKCM	cis	rs3785574	0.650	rs8077653	chr17:62008965	T/G	cg11494091	chr17:61959527	GH2	-0.56	-5.4	-0.52	7.11e-7	Height;
SKCM	cis	rs7618501	0.602	rs9311446	chr3:50092226	G/A	cg24110177	chr3:50126178	RBM5	0.63	5.38	0.52	7.62e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs72781680	0.950	rs56128748	chr2:24126809	T/G	cg08917208	chr2:24149416	ATAD2B	0.9	5.02	0.49	3.13e-6	Lymphocyte counts;
SKCM	cis	rs56011263	0.687	rs4690292	chr4:703712	A/G	cg17689763	chr4:710664	PCGF3	-0.63	-5.06	-0.5	2.68e-6	White blood cell count;
SKCM	cis	rs9611565	0.512	rs2050033	chr22:42159229	G/T	cg03806693	chr22:41940476	POLR3H	1.17	7.59	0.65	5.94e-11	Vitiligo;
SKCM	cis	rs10540	1.000	rs12419716	chr11:503385	C/G	cg03352830	chr11:487213	PTDSS2	0.94	4.91	0.49	4.87e-6	Body mass index;
SKCM	cis	rs17065868	1.000	rs61947998	chr13:45166114	G/A	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs362296	0.698	rs3095082	chr4:3263617	C/A	cg21096898	chr4:3318625	RGS12	-0.76	-7.35	-0.64	1.68e-10	Parental longevity (mother's age at death);
SKCM	cis	rs4242434	0.672	rs2404654	chr8:22484949	T/C	cg03733263	chr8:22462867	KIAA1967	0.86	6.56	0.6	5.46e-9	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs6933660	0.646	rs9397410	chr6:151770503	C/T	cg14416726	chr6:151773293	C6orf211;RMND1	-0.68	-5.67	-0.54	2.28e-7	Menarche (age at onset);
SKCM	cis	rs3820068	0.603	rs35509554	chr1:15993514	C/T	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs34375054	0.525	rs1080910	chr12:125608492	T/C	cg25124228	chr12:125621409	AACS	-0.8	-6.56	-0.6	5.45e-9	Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs28595532	0.841	rs116452272	chr4:119770802	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs7829975	0.514	rs2976929	chr8:8258712	T/C	cg06636001	chr8:8085503	FLJ10661	0.77	6.88	0.61	1.35e-9	Mood instability;
SKCM	cis	rs826838	0.967	rs826870	chr12:39120250	G/A	cg26384229	chr12:38710491	ALG10B	-0.94	-8.05	-0.67	7.57e-12	Heart rate;
SKCM	cis	rs67311347	1.000	rs2887995	chr3:40409029	C/G	cg00091569	chr3:40428383	ENTPD3	0.61	5.36	0.52	8.37e-7	Renal cell carcinoma;
SKCM	cis	rs2070488	0.965	rs4679053	chr3:38523495	G/T	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.98	9.25	0.72	3.55e-14	Electrocardiographic conduction measures;
SKCM	cis	rs4746818	1.000	rs7918066	chr10:70913116	C/T	cg11621586	chr10:70884670	VPS26A	0.99	7.62	0.65	5.08e-11	Left atrial antero-posterior diameter;
SKCM	cis	rs9911578	1.000	rs10401050	chr17:56953786	A/C	cg05425664	chr17:57184151	TRIM37	-0.67	-5.04	-0.5	2.91e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs769267	0.965	rs2905427	chr19:19478023	G/T	cg03709012	chr19:19516395	GATAD2A	-0.9	-8.59	-0.7	6.84e-13	Tonsillectomy;
SKCM	cis	rs875971	0.895	rs10447522	chr7:65796074	A/G	cg18876405	chr7:65276391	NA	-0.64	-6.42	-0.59	9.88e-9	Aortic root size;
SKCM	cis	rs2857078	0.654	rs9896789	chr17:42314567	C/T	cg10896456	chr17:42255109	ASB16;C17orf65	0.59	5.16	0.5	1.81e-6	Red cell distribution width;Reticulocyte count;
SKCM	cis	rs17270561	0.562	rs74293932	chr6:26014811	C/A	cg16482183	chr6:26056742	HIST1H1C	0.96	6.97	0.62	8.86e-10	Iron status biomarkers;
SKCM	cis	rs1046896	0.514	rs67735447	chr17:80823042	G/T	cg02711726	chr17:80685570	FN3KRP	-0.78	-5.78	-0.55	1.48e-7	Glycated hemoglobin levels;
SKCM	cis	rs801193	1.000	rs6975195	chr7:66124774	T/A	cg18876405	chr7:65276391	NA	-0.82	-7.53	-0.65	7.59e-11	Aortic root size;
SKCM	cis	rs2070488	0.775	rs2186457	chr3:38553965	A/G	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.74	5.88	0.55	9.48e-8	Electrocardiographic conduction measures;
SKCM	cis	rs17685	0.753	rs12531559	chr7:75631697	C/T	cg16489192	chr7:75678113	MDH2;STYXL1	0.58	5.14	0.5	1.97e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1003719	0.788	rs2156076	chr21:38452634	G/T	cg10648535	chr21:38446584	PIGP;TTC3	0.6	4.77	0.48	8.34e-6	Eye color traits;
SKCM	cis	rs1707322	0.865	rs785501	chr1:46579611	C/T	cg03146154	chr1:46216737	IPP	-0.81	-5.43	-0.52	6.11e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7937682	0.602	rs11214036	chr11:111773169	C/T	cg09085632	chr11:111637200	PPP2R1B	-1.09	-10.41	-0.76	2.06e-16	Primary sclerosing cholangitis;
SKCM	cis	rs9543976	0.925	rs2876706	chr13:76186305	T/G	cg01531495	chr13:76123901	UCHL3	0.9	4.99	0.49	3.52e-6	Diabetic retinopathy;
SKCM	cis	rs9733	0.593	rs10888384	chr1:150574256	C/T	cg13175981	chr1:150552382	MCL1	0.72	5.96	0.56	6.93e-8	Tonsillectomy;
SKCM	cis	rs28386778	0.897	rs2236736	chr17:61938248	G/T	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.36	0.52	8.37e-7	Prudent dietary pattern;
SKCM	cis	rs17345786	0.798	rs4257518	chr3:101281709	C/T	cg11279151	chr3:101281821	RG9MTD1	0.63	4.82	0.48	6.91e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2228479	0.867	rs34604714	chr16:89948985	A/G	cg06558623	chr16:89946397	TCF25	1.26	6.97	0.62	9.17e-10	Skin colour saturation;
SKCM	cis	rs4561483	0.801	rs33637	chr16:11989875	A/T	cg08843971	chr16:11963173	GSPT1	-0.66	-5.08	-0.5	2.49e-6	Testicular germ cell tumor;
SKCM	cis	rs16854884	0.558	rs6768153	chr3:143667429	C/A	cg06585982	chr3:143692056	C3orf58	0.84	8.2	0.68	3.88e-12	Economic and political preferences (feminism/equality);
SKCM	cis	rs7659604	0.502	rs10212738	chr4:122675724	G/A	cg19671926	chr4:122722719	EXOSC9	0.77	6.27	0.58	1.89e-8	Type 2 diabetes;
SKCM	trans	rs561341	0.714	rs474455	chr17:30312465	A/T	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs67311347	0.544	rs9868700	chr3:40345408	G/A	cg13409248	chr3:40428643	ENTPD3	0.57	5.39	0.52	7.14e-7	Renal cell carcinoma;
SKCM	cis	rs752010	0.841	rs7519983	chr1:42083369	C/T	cg06885757	chr1:42089581	HIVEP3	0.56	5.91	0.56	8.48e-8	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs9790314	0.631	rs2061804	chr3:161102474	C/A	cg03342759	chr3:160939853	NMD3	-0.71	-6.57	-0.6	5.07e-9	Morning vs. evening chronotype;
SKCM	cis	rs7208859	0.623	rs34756112	chr17:29113016	A/G	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs798766	0.953	rs13123646	chr4:1740539	T/C	cg24239225	chr4:1659016	FAM53A	-0.72	-4.87	-0.48	5.66e-6	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs10504073	0.584	rs62507177	chr8:49937306	C/A	cg00325661	chr8:49890786	NA	0.81	6.81	0.61	1.83e-9	Blood metabolite ratios;
SKCM	cis	rs6089829	0.851	rs6089827	chr20:61668845	C/T	cg03213289	chr20:61660250	NA	0.49	4.81	0.48	7.26e-6	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs2836974	0.897	rs35064900	chr21:40555492	A/G	cg11644478	chr21:40555479	PSMG1	0.97	10.17	0.75	5.99e-16	Cognitive function;
SKCM	cis	rs2073499	1.000	rs2073499	chr3:50374293	A/G	cg08207895	chr3:50388901	TUSC4;CYB561D2	0.77	5.37	0.52	8e-7	Schizophrenia;
SKCM	cis	rs11764590	0.694	rs11773643	chr7:2104063	A/G	cg02825527	chr7:2087843	MAD1L1	-0.65	-4.78	-0.48	8.09e-6	Neuroticism;
SKCM	cis	rs3820928	0.869	rs2396436	chr2:227795464	G/A	cg11843606	chr2:227700838	RHBDD1	-0.6	-4.81	-0.48	7.34e-6	Pulmonary function;
SKCM	cis	rs8072100	0.875	rs9635762	chr17:45648446	A/C	cg08085267	chr17:45401833	C17orf57	0.58	5.13	0.5	2.04e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs4237845	0.816	rs61935769	chr12:58294344	G/A	cg00677455	chr12:58241039	CTDSP2	0.7	5.57	0.53	3.48e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs17065868	0.655	rs9533870	chr13:45051780	T/C	cg10246903	chr13:45222710	NA	0.9	4.81	0.48	7.31e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs4642101	0.765	rs1985428	chr3:12829315	A/G	cg05775895	chr3:12838266	CAND2	-0.57	-5.12	-0.5	2.19e-6	QRS complex (12-leadsum);
SKCM	cis	rs4077515	0.874	rs10781505	chr9:139271355	C/T	cg14169450	chr9:139327907	INPP5E	-0.46	-5.13	-0.5	2.07e-6	Ulcerative colitis;IgA nephropathy;Inflammatory bowel disease;Crohn's disease;
SKCM	trans	rs1814175	0.645	rs10839456	chr11:49964093	C/T	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs1552244	0.832	rs17050674	chr3:10027258	T/C	cg02579736	chr3:10068473	FANCD2;CIDECP	0.95	4.84	0.48	6.45e-6	Alzheimer's disease;
SKCM	cis	rs684232	0.602	rs331010	chr17:547124	G/A	cg15660573	chr17:549704	VPS53	-0.76	-6.08	-0.57	4.15e-8	Prostate cancer;
SKCM	cis	rs591584	0.590	rs7126782	chr11:94323840	A/C	cg03531787	chr11:93464739	SNORD6;SNORA32;SNORA25	-0.52	-4.77	-0.47	8.54e-6	Macrophage Migration Inhibitory Factor levels;
SKCM	cis	rs875971	0.825	rs1000464	chr7:65777909	G/C	cg11764359	chr7:65958608	NA	-0.81	-7.6	-0.65	5.6e-11	Aortic root size;
SKCM	cis	rs870825	0.616	rs7660064	chr4:185617529	T/C	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs10089	1.000	rs10478796	chr5:127436187	A/G	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.92	8.45	0.69	1.25e-12	Ileal carcinoids;
SKCM	cis	rs5769765	0.908	rs9616217	chr22:50318946	C/T	cg22709217	chr22:50311962	ALG12;CRELD2	-0.99	-6.09	-0.57	4.04e-8	Schizophrenia;
SKCM	cis	rs4727027	0.933	rs9718383	chr7:148857624	A/T	cg23583168	chr7:148888333	NA	0.76	6.57	0.6	5.19e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs597539	0.842	rs521913	chr11:68615950	C/T	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.71	4.85	0.48	6.12e-6	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs79839061	0.610	rs11726280	chr4:864077	C/T	cg07828340	chr4:882639	GAK	1.06	5.32	0.52	9.74e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs12478296	0.685	rs12473450	chr2:242991746	C/T	cg06360820	chr2:242988706	NA	-1.0	-6.32	-0.58	1.51e-8	Obesity-related traits;
SKCM	cis	rs875971	0.522	rs10807697	chr7:65416170	A/G	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.61	5.23	0.51	1.4e-6	Aortic root size;
SKCM	cis	rs6952808	0.862	rs4721135	chr7:1912222	A/G	cg02951883	chr7:2050386	MAD1L1	-0.68	-5.58	-0.53	3.34e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs2153535	0.580	rs9406158	chr6:8464152	C/T	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs951366	0.622	rs11580015	chr1:205676088	G/C	cg07157834	chr1:205819609	PM20D1	0.64	5.44	0.52	5.83e-7	Menarche (age at onset);
SKCM	cis	rs9911578	0.902	rs12948746	chr17:57071892	A/G	cg12560992	chr17:57184187	TRIM37	1.09	10.28	0.76	3.75e-16	Intelligence (multi-trait analysis);
SKCM	cis	rs826838	1.000	rs10875991	chr12:39108886	G/C	cg13010199	chr12:38710504	ALG10B	0.73	5.46	0.53	5.52e-7	Heart rate;
SKCM	cis	rs2739330	0.796	rs1006771	chr22:24314006	G/T	cg24846343	chr22:24311635	DDTL	0.57	5.41	0.52	6.68e-7	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs2836974	0.555	rs35909862	chr21:40621158	G/A	cg17971929	chr21:40555470	PSMG1	-0.76	-7.16	-0.63	3.94e-10	Cognitive function;
SKCM	cis	rs1577917	1.000	rs12196037	chr6:86694631	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.83	-8.23	-0.68	3.37e-12	Response to antipsychotic treatment;
SKCM	cis	rs2836974	1.000	rs28360661	chr21:40681972	G/C	cg11890956	chr21:40555474	PSMG1	0.99	11.24	0.79	5.58e-18	Cognitive function;
SKCM	cis	rs951366	0.789	rs823097	chr1:205681370	G/A	cg11965913	chr1:205819406	PM20D1	0.87	8.07	0.67	6.86e-12	Menarche (age at onset);
SKCM	cis	rs7666738	0.830	rs7662114	chr4:99019985	A/G	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2153535	0.580	rs2184583	chr6:8447808	A/G	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs6951245	1.000	rs74347384	chr7:1072440	G/A	cg18402987	chr7:1209562	NA	1.15	6.02	0.56	5.38e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs617791	0.530	rs7934543	chr11:65752508	G/T	cg27068330	chr11:65405492	SIPA1	-0.68	-4.87	-0.48	5.78e-6	Breast cancer;
SKCM	cis	rs12711979	0.509	rs10195488	chr2:3824135	T/C	cg17052675	chr2:3827356	NA	-0.82	-8.9	-0.71	1.66e-13	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs9325144	0.560	rs10876005	chr12:39126149	C/G	cg13010199	chr12:38710504	ALG10B	-0.67	-5.85	-0.55	1.1e-7	Morning vs. evening chronotype;
SKCM	cis	rs1850744	0.702	rs7434744	chr4:9672688	A/C	cg15442990	chr4:9534313	NA	1.1	4.86	0.48	5.98e-6	Economic and political preferences;
SKCM	trans	rs7618501	1.000	rs3749240	chr3:49750188	T/A	cg21659725	chr3:3221576	CRBN	-0.96	-9.61	-0.74	7.08e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs2228479	0.867	rs75110337	chr16:89962635	C/A	cg00800038	chr16:89945340	TCF25	-0.93	-5.34	-0.52	8.73e-7	Skin colour saturation;
SKCM	cis	rs362272	0.525	rs2857849	chr4:3043638	A/T	cg24015175	chr4:3319247	RGS12	0.57	5.23	0.51	1.37e-6	Serum sulfate level;
SKCM	cis	rs8060686	0.641	rs12598256	chr16:68084021	G/A	cg09117114	chr16:67998030	SLC12A4	-0.81	-5.34	-0.52	8.73e-7	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs7208859	0.573	rs7214313	chr17:29138596	T/C	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs4889855	0.545	rs61171555	chr17:78465975	T/G	cg00066239	chr17:78472159	NA	-0.57	-5.03	-0.5	3.02e-6	Fractional excretion of uric acid;
SKCM	cis	rs2032447	0.670	rs71557318	chr6:26118570	T/C	cg03517284	chr6:25882590	NA	0.63	5.41	0.52	6.74e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs875971	1.000	rs7789554	chr7:65946038	A/G	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs9875589	0.509	rs1844108	chr3:14024328	A/G	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.51	5.17	0.51	1.73e-6	Ovarian reserve;
SKCM	cis	rs9715521	0.588	rs11731207	chr4:59852246	G/A	cg11281224	chr4:60001000	NA	-0.61	-4.82	-0.48	6.94e-6	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs2796441	0.525	rs2627015	chr9:84329325	C/T	cg13729285	chr9:84764156	NA	0.46	4.79	0.48	7.71e-6	Type 2 diabetes;Schizophrenia;
SKCM	cis	rs4790333	1.000	rs2429908	chr17:2268681	T/C	cg02569219	chr17:2266849	SGSM2	0.79	6.77	0.61	2.17e-9	Proinsulin levels;
SKCM	cis	rs17376456	0.825	rs10038828	chr5:93124056	C/T	cg21475434	chr5:93447410	FAM172A	0.9	4.99	0.49	3.65e-6	Diabetic retinopathy;
SKCM	trans	rs1814175	0.645	rs1851869	chr11:49960552	T/C	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs1682361	1	rs1682361	chr3:136734014	G/C	cg12473912	chr3:136751656	NA	0.63	5.18	0.51	1.69e-6	Schizophrenia;
SKCM	cis	rs875971	0.522	rs2008188	chr7:65429013	G/C	cg00343986	chr7:65444356	GUSB	0.67	4.82	0.48	6.84e-6	Aortic root size;
SKCM	cis	rs453301	0.686	rs7814328	chr8:8876229	T/C	cg06636001	chr8:8085503	FLJ10661	-0.75	-5.62	-0.54	2.83e-7	Joint mobility (Beighton score);
SKCM	cis	rs12586317	0.547	rs76770287	chr14:35487210	C/A	cg16230307	chr14:35515116	FAM177A1	0.81	5.88	0.55	9.47e-8	Psoriasis;
SKCM	cis	rs1639906	0.895	rs34255795	chr7:2207416	A/G	cg02951883	chr7:2050386	MAD1L1	0.66	5.36	0.52	8.14e-7	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7618915	0.571	rs2251219	chr3:52584787	C/T	cg18404041	chr3:52824283	ITIH1	0.56	5.05	0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs8060686	0.544	rs1124993	chr16:68114626	T/C	cg04539111	chr16:67997858	SLC12A4	-0.87	-4.89	-0.48	5.33e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs9475752	0.793	rs28360537	chr6:56831532	T/C	cg06815302	chr6:57335405	PRIM2	0.65	5.03	0.49	3.12e-6	Menarche (age at onset);
SKCM	cis	rs9611565	0.592	rs5996039	chr22:41981957	A/G	cg03806693	chr22:41940476	POLR3H	-1.06	-7.21	-0.63	3.11e-10	Vitiligo;
SKCM	cis	rs748404	0.697	rs501884	chr15:43553982	G/T	cg02155558	chr15:43621948	ADAL;LCMT2	0.7	5.77	0.55	1.53e-7	Lung cancer;
SKCM	cis	rs6121246	0.609	rs6060948	chr20:30376393	C/G	cg13852791	chr20:30311386	BCL2L1	0.82	5.64	0.54	2.59e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs861020	0.630	rs585627	chr1:210004199	C/G	cg05527609	chr1:210001259	C1orf107	0.86	6.74	0.61	2.43e-9	Orofacial clefts;
SKCM	cis	rs4555082	0.874	rs2816606	chr14:105716034	C/T	cg13114125	chr14:105738426	BRF1	-0.7	-5.75	-0.55	1.64e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs1003719	0.788	rs4817843	chr21:38447040	C/A	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs7618501	1.000	rs2271960	chr3:49878078	A/G	cg24110177	chr3:50126178	RBM5	-0.53	-4.81	-0.48	7.2e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs4561483	0.832	rs33645	chr16:11985201	T/C	cg08843971	chr16:11963173	GSPT1	-0.66	-5.08	-0.5	2.49e-6	Testicular germ cell tumor;
SKCM	cis	rs10791097	0.694	rs4937583	chr11:130741606	A/G	cg12179176	chr11:130786555	SNX19	0.93	8.16	0.68	4.62e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs11098499	0.820	rs12503082	chr4:120284317	A/G	cg09307838	chr4:120376055	NA	0.98	7.89	0.67	1.52e-11	Corneal astigmatism;
SKCM	cis	rs9858542	0.953	rs9841110	chr3:49492481	C/G	cg03060546	chr3:49711283	APEH	-0.75	-5.53	-0.53	4.17e-7	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs6546550	0.935	rs60207187	chr2:70093910	G/A	cg02498382	chr2:70120550	SNRNP27	-0.47	-5.25	-0.51	1.3e-6	Prevalent atrial fibrillation;
SKCM	cis	rs116095464	0.558	rs2288457	chr5:231270	C/T	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs1577917	1.000	rs13194429	chr6:86646705	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.66	-5.74	-0.54	1.76e-7	Response to antipsychotic treatment;
SKCM	cis	rs2153535	0.580	rs1932284	chr6:8477694	A/T	cg23788917	chr6:8435910	SLC35B3	0.67	4.78	0.48	8.23e-6	Motion sickness;
SKCM	cis	rs7659604	0.521	rs4833235	chr4:122695136	C/A	cg19671926	chr4:122722719	EXOSC9	0.76	6.84	0.61	1.57e-9	Type 2 diabetes;
SKCM	cis	rs9303401	0.625	rs66508449	chr17:56691034	T/C	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.16	0.57	2.91e-8	Cognitive test performance;
SKCM	cis	rs870825	0.615	rs2696038	chr4:185610903	C/T	cg04058563	chr4:185651563	MLF1IP	-1.07	-7.36	-0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs11651000	0.817	rs11657479	chr17:45822901	T/C	cg24803719	chr17:45855879	NA	-0.53	-4.92	-0.49	4.79e-6	IgG glycosylation;
SKCM	cis	rs11148252	0.532	rs9536185	chr13:53179801	G/A	cg00495681	chr13:53174319	NA	0.83	7.52	0.65	8e-11	Lewy body disease;
SKCM	trans	rs1814175	0.645	rs11040699	chr11:50023798	C/G	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs738322	0.555	rs2284063	chr22:38544298	C/T	cg25457927	chr22:38595422	NA	0.59	7.09	0.63	5.3e-10	Cutaneous nevi;
SKCM	cis	rs1678542	0.679	rs10783834	chr12:57975953	G/C	cg04478727	chr12:58166393	METTL1;FAM119B	0.66	4.88	0.48	5.44e-6	Rheumatoid arthritis;
SKCM	cis	rs28374715	0.532	rs7164211	chr15:41705041	A/T	cg18705301	chr15:41695430	NDUFAF1	-1.21	-13.94	-0.84	7.01e-23	Ulcerative colitis;
SKCM	cis	rs9325144	0.532	rs12812406	chr12:38719802	G/A	cg13010199	chr12:38710504	ALG10B	-0.65	-5.17	-0.51	1.73e-6	Morning vs. evening chronotype;
SKCM	cis	rs71520386	0.632	rs10224533	chr7:22861141	T/G	cg00309339	chr7:22893653	NA	0.67	4.97	0.49	3.82e-6	Fibrinogen levels;
SKCM	cis	rs798554	0.718	rs1636247	chr7:2881917	A/G	cg04166393	chr7:2884313	GNA12	0.73	4.89	0.48	5.25e-6	Height;
SKCM	cis	rs34779708	0.931	rs4934535	chr10:35432721	G/T	cg03585969	chr10:35415529	CREM	0.73	6.0	0.56	5.85e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs2050392	0.929	rs10826798	chr10:30700904	G/A	cg25182066	chr10:30743637	MAP3K8	0.69	5.83	0.55	1.21e-7	Inflammatory bowel disease;
SKCM	cis	rs690037	0.641	rs538525	chr3:16376279	A/G	cg23474789	chr3:16306055	DPH3;OXNAD1	0.64	5.21	0.51	1.48e-6	Optic nerve measurement (cup-to-disc ratio);Optic nerve measurement (cup area);
SKCM	cis	rs6952808	0.792	rs4421257	chr7:1955152	T/C	cg05863683	chr7:1912471	MAD1L1	0.56	5.06	0.5	2.73e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs2963155	0.518	rs853184	chr5:142640901	C/T	cg17617527	chr5:142782415	NR3C1	1.13	5.41	0.52	6.65e-7	Breast cancer;
SKCM	cis	rs7666738	0.830	rs7679299	chr4:99057620	C/A	cg17366294	chr4:99064904	C4orf37	0.61	4.93	0.49	4.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4969178	0.965	rs3744217	chr17:76400258	G/A	cg20026190	chr17:76395443	PGS1	0.59	5.01	0.49	3.3e-6	HDL cholesterol levels;
SKCM	cis	rs7208859	0.573	rs216443	chr17:28931871	A/G	cg14067834	chr17:29058358	SUZ12P	1.23	5.41	0.52	6.6e-7	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs6570726	0.791	rs12208812	chr6:145900924	T/G	cg05347473	chr6:146136440	FBXO30	0.58	5.16	0.5	1.82e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6545883	0.965	rs1992765	chr2:61751333	A/G	cg15711740	chr2:61764176	XPO1	-0.73	-5.27	-0.51	1.19e-6	Tuberculosis;
SKCM	cis	rs826838	0.809	rs11169666	chr12:39211300	T/C	cg13010199	chr12:38710504	ALG10B	0.67	5.06	0.5	2.68e-6	Heart rate;
SKCM	cis	rs55962025	0.737	rs7685686	chr4:3207142	A/G	cg16987761	chr4:3318072	RGS12	-0.59	-4.84	-0.48	6.42e-6	Parental longevity (mother's age at death);
SKCM	cis	rs6088590	0.687	rs6088580	chr20:33285053	G/C	cg24642439	chr20:33292090	TP53INP2	0.79	5.66	0.54	2.45e-7	Coronary artery disease;
SKCM	cis	rs17376456	0.778	rs10440717	chr5:93424852	C/A	cg21475434	chr5:93447410	FAM172A	0.97	5.42	0.52	6.39e-7	Diabetic retinopathy;
SKCM	cis	rs2811415	0.627	rs13313895	chr3:127752084	T/C	cg09089421	chr3:127803668	RUVBL1	0.99	8.52	0.69	9.09e-13	Lung function (FEV1/FVC);
SKCM	cis	rs4780401	0.609	rs55934118	chr16:11820003	G/C	cg01061890	chr16:11836724	TXNDC11	-0.8	-6.08	-0.57	4.09e-8	Rheumatoid arthritis;
SKCM	cis	rs7552404	0.920	rs2788654	chr1:76219569	C/T	cg10523679	chr1:76189770	ACADM	0.69	4.93	0.49	4.45e-6	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs9611565	0.545	rs5758432	chr22:42111693	T/C	cg03806693	chr22:41940476	POLR3H	1.11	6.72	0.61	2.72e-9	Vitiligo;
SKCM	cis	rs6450176	0.638	rs3822497	chr5:53299693	C/G	ch.5.1024479R	chr5:53302184	ARL15	-0.93	-5.09	-0.5	2.43e-6	HDL cholesterol levels;HDL cholesterol;Adiponectin levels;
SKCM	cis	rs71520386	0.632	rs10253651	chr7:22870183	A/G	cg00309339	chr7:22893653	NA	0.66	4.94	0.49	4.33e-6	Fibrinogen levels;
SKCM	cis	rs55962025	0.686	rs110501	chr4:3225478	A/G	cg21096898	chr4:3318625	RGS12	-0.61	-5.11	-0.5	2.21e-6	Parental longevity (mother's age at death);
SKCM	cis	rs4927850	1.000	rs7614767	chr3:195753451	C/T	cg12923728	chr3:195709715	SDHAP1	-0.87	-5.49	-0.53	4.92e-7	Pancreatic cancer;
SKCM	cis	rs55962025	0.711	rs362319	chr4:3224933	T/G	cg21096898	chr4:3318625	RGS12	-0.61	-5.04	-0.5	2.99e-6	Parental longevity (mother's age at death);
SKCM	cis	rs2228479	0.867	rs35542367	chr16:89965825	G/C	cg00800038	chr16:89945340	TCF25	-0.93	-5.34	-0.52	8.73e-7	Skin colour saturation;
SKCM	cis	rs11626933	1.000	rs3825661	chr14:90767607	C/T	cg14092571	chr14:90743983	NA	0.87	8.75	0.7	3.28e-13	Gut microbiota (bacterial taxa);
SKCM	cis	rs9303401	0.659	rs62081314	chr17:56778328	A/G	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.16	0.57	2.91e-8	Cognitive test performance;
SKCM	cis	rs7659604	1.000	rs34952897	chr4:122664409	C/T	cg06713675	chr4:122721982	EXOSC9	-0.65	-5.83	-0.55	1.21e-7	Type 2 diabetes;
SKCM	cis	rs754466	0.724	rs11002318	chr10:79633807	G/A	cg17075019	chr10:79541650	NA	-0.73	-6.35	-0.58	1.31e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs440932	0.757	rs330943	chr8:9021026	G/A	cg15556689	chr8:8085844	FLJ10661	0.62	4.91	0.49	4.85e-6	High light scatter reticulocyte percentage of red cells;
SKCM	cis	rs7824557	0.527	rs2572369	chr8:11238597	C/T	cg21775007	chr8:11205619	TDH	-0.57	-4.8	-0.48	7.47e-6	Retinal vascular caliber;
SKCM	cis	rs61612642	0.523	rs59004693	chr6:42157392	G/A	cg01092361	chr6:42185687	MRPS10	0.99	5.67	0.54	2.34e-7	Eosinophil percentage of white cells;Sum eosinophil basophil counts;Eosinophil percentage of granulocytes;Eosinophil counts;
SKCM	cis	rs7829975	0.902	rs485107	chr8:8581408	C/G	cg06636001	chr8:8085503	FLJ10661	-0.84	-7.82	-0.66	2.11e-11	Mood instability;
SKCM	cis	rs9902453	0.769	rs7210288	chr17:28243473	T/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.81	5.79	0.55	1.43e-7	Coffee consumption (cups per day);
SKCM	cis	rs6089584	1.000	rs6142910	chr20:60562181	C/A	cg06108461	chr20:60628389	TAF4	-0.81	-7.11	-0.63	4.79e-10	Body mass index;
SKCM	cis	rs1863824	0.625	rs10887600	chr10:88169072	C/T	cg07322936	chr10:88137208	NA	-0.59	-5.0	-0.49	3.42e-6	Schizophrenia;
SKCM	cis	rs9682041	0.800	rs7643085	chr3:170070371	A/G	cg11886554	chr3:170076028	SKIL	0.83	5.01	0.49	3.28e-6	Glomerular filtration rate in non diabetics (creatinine);Glomerular filtration rate (creatinine);
SKCM	cis	rs7811142	0.830	rs705866	chr7:99965285	T/C	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.05	5.92	0.56	8.02e-8	Platelet count;
SKCM	cis	rs36093844	0.626	rs12281958	chr11:85709950	C/T	cg25872744	chr11:85566296	CCDC83	-0.81	-4.79	-0.48	7.84e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs78456975	0.689	rs10194040	chr2:1543293	T/G	cg01028140	chr2:1542097	TPO	-0.58	-5.33	-0.52	9.25e-7	Placebo response in major depressive disorder (% change in symptom score);
SKCM	cis	rs17826219	0.500	rs57005940	chr17:29066329	C/G	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Body mass index;
SKCM	trans	rs8073060	0.586	rs2011897	chr17:34054408	A/T	cg19694781	chr19:47549865	TMEM160	1.08	8.69	0.7	4.26e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs116095464	0.558	rs10462754	chr5:246669	T/C	cg22496380	chr5:211416	CCDC127	-0.89	-4.92	-0.49	4.78e-6	Breast cancer;
SKCM	cis	rs9311474	0.967	rs11717383	chr3:52287468	G/T	cg18404041	chr3:52824283	ITIH1	-0.53	-4.84	-0.48	6.39e-6	Electroencephalogram traits;
SKCM	cis	rs7618501	0.633	rs4688757	chr3:50035323	T/C	cg05072774	chr3:49840536	C3orf54	-0.67	-5.06	-0.5	2.73e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs58688157	0.705	rs12290989	chr11:615010	G/T	cg16486109	chr11:613632	IRF7	1.07	7.29	0.64	2.17e-10	Systemic lupus erythematosus;
SKCM	cis	rs1153858	1.000	rs67831559	chr15:45649307	G/T	cg10760299	chr15:45669010	GATM	0.62	6.33	0.58	1.42e-8	Homoarginine levels;
SKCM	cis	rs7103648	0.695	rs11039290	chr11:47572279	G/A	cg20307385	chr11:47447363	PSMC3	0.96	7.17	0.63	3.71e-10	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs763014	0.932	rs7204439	chr16:661335	T/C	cg00908189	chr16:619842	PIGQ	0.84	7.87	0.67	1.67e-11	Height;
SKCM	cis	rs10193935	1.000	rs10185742	chr2:42429666	A/G	cg27598129	chr2:42591480	NA	-0.88	-6.71	-0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9926296	0.568	rs1230	chr16:89804855	A/G	cg26513180	chr16:89883248	FANCA	-1.0	-11.39	-0.79	2.9e-18	Vitiligo;
SKCM	cis	rs17826219	0.706	rs8071236	chr17:29100002	T/C	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Body mass index;
SKCM	cis	rs9815354	0.812	rs10510733	chr3:42009192	T/C	cg03022575	chr3:42003672	ULK4	1.0	5.0	0.49	3.43e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs9815354	0.638	rs56194645	chr3:41843593	T/C	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs1801516	0.950	rs55930851	chr11:108333620	G/A	cg03165700	chr11:108093220	ATM;NPAT	-1.18	-5.35	-0.52	8.63e-7	Melanoma;
SKCM	cis	rs769267	1.000	rs2301669	chr19:19453560	C/A	cg03709012	chr19:19516395	GATAD2A	-0.84	-6.79	-0.61	1.97e-9	Tonsillectomy;
SKCM	cis	rs17608059	0.524	rs9897978	chr17:13900256	G/T	cg11395062	chr17:14139857	CDRT15	-0.7	-5.67	-0.54	2.28e-7	Temperament;
SKCM	cis	rs950776	0.714	rs3743074	chr15:78909480	G/A	cg06917634	chr15:78832804	PSMA4	-0.77	-6.2	-0.57	2.54e-8	Sudden cardiac arrest;
SKCM	cis	rs4727027	0.933	rs12154382	chr7:148862284	C/T	cg23583168	chr7:148888333	NA	-0.8	-6.62	-0.6	4.13e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs11098499	0.874	rs6822498	chr4:120120183	T/C	cg09307838	chr4:120376055	NA	0.84	5.94	0.56	7.49e-8	Corneal astigmatism;
SKCM	cis	rs2760061	0.603	rs697761	chr1:228192397	G/A	cg02753203	chr1:228287806	NA	0.83	7.49	0.65	8.97e-11	Diastolic blood pressure;
SKCM	cis	rs2153535	0.560	rs2210798	chr6:8481522	C/T	cg07606381	chr6:8435919	SLC35B3	0.86	6.25	0.58	2.06e-8	Motion sickness;
SKCM	cis	rs7666738	0.830	rs6846739	chr4:99016647	G/A	cg05340658	chr4:99064831	C4orf37	0.67	5.16	0.5	1.85e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs644799	1.000	rs644799	chr11:95564259	A/G	cg03916912	chr11:95522834	CEP57;FAM76B	0.88	7.53	0.65	7.59e-11	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs754466	0.606	rs11002308	chr10:79594796	A/T	cg17075019	chr10:79541650	NA	-0.78	-7.04	-0.62	6.57e-10	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs9926296	1.000	rs9926296	chr16:89818089	A/G	cg27121462	chr16:89883253	FANCA	0.72	6.3	0.58	1.66e-8	Vitiligo;
SKCM	cis	rs8064299	0.565	rs12453550	chr17:72786086	G/T	cg25054828	chr17:72772726	NAT9;TMEM104	0.98	10.25	0.76	4.21e-16	Monocyte count;
SKCM	cis	rs7772486	0.790	rs6924159	chr6:146267873	A/G	cg05347473	chr6:146136440	FBXO30	-0.55	-5.07	-0.5	2.6e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2404602	0.669	rs17464903	chr15:77195486	A/G	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs2842992	0.747	rs9365095	chr6:160192928	T/G	cg16489826	chr6:160211363	TCP1;MRPL18	0.73	5.42	0.52	6.39e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs2836974	0.897	rs4817996	chr21:40525759	G/C	cg11890956	chr21:40555474	PSMG1	1.07	13.19	0.83	1.48e-21	Cognitive function;
SKCM	cis	rs6500395	0.962	rs7199625	chr16:48650217	G/C	cg04672837	chr16:48644449	N4BP1	0.68	5.6	0.54	3.07e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs362296	0.661	rs3095079	chr4:3265414	A/G	cg00764545	chr4:3318001	RGS12	0.69	6.11	0.57	3.7e-8	Parental longevity (mother's age at death);
SKCM	cis	rs951366	0.668	rs823154	chr1:205762406	C/T	cg14893161	chr1:205819251	PM20D1	1.03	11.39	0.79	2.9e-18	Menarche (age at onset);
SKCM	cis	rs912057	0.901	rs744056	chr6:6733540	A/G	cg06612196	chr6:6737390	NA	0.6	5.19	0.51	1.63e-6	Waist-to-hip ratio adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);
SKCM	cis	rs17685	0.515	rs111240556	chr7:75600863	T/C	cg01364799	chr7:75623366	TMEM120A	-0.81	-5.67	-0.54	2.3e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1799949	1.000	rs11654452	chr17:41189383	G/T	cg25072359	chr17:41440525	NA	0.63	4.88	0.48	5.43e-6	Menopause (age at onset);
SKCM	cis	rs1670533	1.000	rs935970	chr4:1045323	C/G	cg27284194	chr4:1044797	NA	-0.83	-5.03	-0.49	3.06e-6	Recombination rate (females);
SKCM	cis	rs10905065	0.930	rs10737012	chr10:5746686	G/A	cg09234995	chr10:5726438	C10orf18	-0.66	-5.73	-0.54	1.84e-7	Menopause (age at onset);
SKCM	cis	rs514406	0.798	rs4351588	chr1:53263826	A/T	cg24675658	chr1:53192096	ZYG11B	0.73	6.51	0.59	6.6e-9	Monocyte count;
SKCM	cis	rs6570726	0.935	rs419850	chr6:145827281	A/G	cg23711669	chr6:146136114	FBXO30	0.7	6.64	0.6	3.72e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7296418	0.922	rs1727293	chr12:123648032	C/T	cg00376283	chr12:123451042	ABCB9	0.95	8.24	0.68	3.2e-12	Platelet count;
SKCM	cis	rs7296418	0.961	rs4275659	chr12:123447928	C/T	cg06742321	chr12:123595122	PITPNM2	-0.63	-5.06	-0.5	2.68e-6	Platelet count;
SKCM	cis	rs12979813	0.901	rs10421795	chr19:11344406	C/T	cg00586551	chr19:11347513	LOC55908;DOCK6	0.67	4.82	0.48	6.91e-6	HDL cholesterol;
SKCM	cis	rs72781680	0.752	rs72796110	chr2:23905658	T/A	cg08917208	chr2:24149416	ATAD2B	0.98	5.0	0.49	3.41e-6	Lymphocyte counts;
SKCM	cis	rs10751667	0.643	rs7396767	chr11:938808	G/A	cg06064525	chr11:970664	AP2A2	-0.55	-5.09	-0.5	2.46e-6	Alzheimer's disease (late onset);
SKCM	cis	rs2836974	0.674	rs1011413	chr21:40638241	A/G	cg11644478	chr21:40555479	PSMG1	-0.82	-7.86	-0.66	1.75e-11	Cognitive function;
SKCM	cis	rs7523050	0.730	rs77425121	chr1:109417677	C/A	cg08274380	chr1:109419600	GPSM2	1.17	6.61	0.6	4.34e-9	Fat distribution (HIV);
SKCM	cis	rs58688157	0.960	rs11246213	chr11:612967	A/G	cg17114584	chr11:613792	IRF7	0.74	5.0	0.49	3.51e-6	Systemic lupus erythematosus;
SKCM	cis	rs4642101	0.597	rs12638595	chr3:12819281	T/C	cg05775895	chr3:12838266	CAND2	0.68	5.87	0.55	9.87e-8	QRS complex (12-leadsum);
SKCM	cis	rs7552404	0.924	rs2275378	chr1:76198436	T/C	cg22875332	chr1:76189707	ACADM	0.69	4.78	0.48	8.13e-6	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs4740619	0.619	rs4741561	chr9:16045827	A/G	cg14451791	chr9:16040625	NA	-0.47	-5.18	-0.51	1.66e-6	Body mass index;
SKCM	cis	rs72717009	0.825	rs7529225	chr1:161479352	G/A	cg23840854	chr1:161414152	NA	-0.99	-5.66	-0.54	2.44e-7	Rheumatoid arthritis;
SKCM	cis	rs600231	0.665	rs1784859	chr11:65220749	A/G	cg24009118	chr11:65545808	DKFZp761E198	-0.69	-5.27	-0.51	1.16e-6	Bone mineral density;
SKCM	cis	rs11098499	0.754	rs714899	chr4:120243035	G/A	cg09307838	chr4:120376055	NA	0.93	7.56	0.65	6.5500000000000006e-11	Corneal astigmatism;
SKCM	cis	rs9733	0.818	rs11204695	chr1:150657011	T/G	cg13175981	chr1:150552382	MCL1	0.64	4.86	0.48	5.85e-6	Tonsillectomy;
SKCM	cis	rs12986445	0.744	rs2138391	chr2:26112785	T/C	cg07291958	chr2:26785531	C2orf70	0.55	4.92	0.49	4.8e-6	Multiple myeloma and monoclonal gammopathy;Multiple myeloma;
SKCM	cis	rs870825	0.616	rs2090589	chr4:185647731	A/G	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs763121	0.752	rs6001190	chr22:39073811	T/C	cg06022373	chr22:39101656	GTPBP1	0.8	5.79	0.55	1.42e-7	Menopause (age at onset);
SKCM	cis	rs7106204	0.748	rs11820336	chr11:24219701	G/A	ch.11.24196551F	chr11:24239977	NA	0.77	6.39	0.59	1.09e-8	Response to Homoharringtonine (cytotoxicity);
SKCM	cis	rs7666738	0.830	rs34628820	chr4:99004764	C/T	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs875971	0.660	rs10950044	chr7:66042976	A/G	cg11987759	chr7:65425863	GUSB	0.67	5.75	0.55	1.68e-7	Aortic root size;
SKCM	cis	rs9393692	0.905	rs9358919	chr6:26287862	C/T	cg00631329	chr6:26305371	NA	-0.69	-4.92	-0.49	4.7e-6	Educational attainment;
SKCM	cis	rs2204008	0.714	rs11520135	chr12:38114863	C/T	cg26384229	chr12:38710491	ALG10B	0.86	6.85	0.61	1.53e-9	Bladder cancer;
SKCM	cis	rs11098499	0.542	rs10440343	chr4:120309787	G/C	cg24375607	chr4:120327624	NA	0.65	4.97	0.49	3.87e-6	Corneal astigmatism;
SKCM	cis	rs12142240	0.698	rs12385696	chr1:46818836	A/G	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs6546550	0.935	rs4241261	chr2:70063660	A/G	cg02498382	chr2:70120550	SNRNP27	-0.46	-5.17	-0.51	1.75e-6	Prevalent atrial fibrillation;
SKCM	cis	rs4400599	0.618	rs2220390	chr1:154233016	C/T	cg26808167	chr1:154192205	UBAP2L;C1orf43	-0.53	-4.87	-0.48	5.71e-6	Platelet distribution width;
SKCM	cis	rs2777491	1.000	rs7168177	chr15:41715585	A/G	cg18705301	chr15:41695430	NDUFAF1	-0.9	-9.24	-0.72	3.67e-14	Ulcerative colitis;
SKCM	cis	rs9611565	0.659	rs9607813	chr22:41941479	G/A	cg03806693	chr22:41940476	POLR3H	-1.13	-7.48	-0.65	9.6e-11	Vitiligo;
SKCM	cis	rs4074961	0.544	rs11264067	chr1:37991458	C/T	cg13401533	chr1:37979913	MEAF6	0.59	4.95	0.49	4.14e-6	Axial length;
SKCM	cis	rs2479724	0.840	rs6925777	chr6:41750822	C/T	cg17623882	chr6:41773611	USP49	0.78	6.83	0.61	1.63e-9	Menarche (age at onset);
SKCM	cis	rs1707322	1.000	rs12403666	chr1:46431621	G/A	cg03146154	chr1:46216737	IPP	0.79	5.29	0.51	1.07e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7635838	0.859	rs34621655	chr3:11530121	T/C	cg00170343	chr3:11313890	ATG7	0.68	4.89	0.48	5.22e-6	HDL cholesterol;
SKCM	cis	rs1799949	0.501	rs2343819	chr17:41409653	T/G	cg05368731	chr17:41323189	NBR1	0.85	7.32	0.64	1.89e-10	Menopause (age at onset);
SKCM	cis	rs6540556	0.954	rs7548219	chr1:209936466	A/G	cg05527609	chr1:210001259	C1orf107	-0.86	-4.8	-0.48	7.39e-6	Red blood cell count;
SKCM	cis	rs2180341	0.960	rs7773484	chr6:127670779	T/C	cg27446573	chr6:127587934	RNF146	0.94	8.11	0.68	5.63e-12	Breast cancer;
SKCM	cis	rs1799949	1.000	rs8176220	chr17:41222462	A/G	cg23758822	chr17:41437982	NA	0.94	7.89	0.67	1.51e-11	Menopause (age at onset);
SKCM	cis	rs12134245	0.747	rs11164912	chr1:92005191	A/T	cg25838465	chr1:92012736	NA	-0.84	-8.87	-0.71	1.92e-13	Breast cancer;
SKCM	cis	rs3096299	0.809	rs2911264	chr16:89499272	A/C	cg02187348	chr16:89574699	SPG7	0.6	4.8	0.48	7.55e-6	Multiple myeloma (IgH translocation);
SKCM	cis	rs9910055	0.530	rs8072954	chr17:42294722	G/A	cg08499158	chr17:42289980	UBTF	-0.79	-6.91	-0.62	1.15e-9	Total body bone mineral density;
SKCM	cis	rs1552244	1.000	rs4269070	chr3:10126083	C/G	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs7208859	0.623	rs55724095	chr17:29153058	A/G	cg13385521	chr17:29058706	SUZ12P	0.9	4.78	0.48	8.1e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs1691799	0.899	rs1168320	chr12:66744849	C/T	cg16791601	chr12:66731901	HELB	-0.65	-6.09	-0.57	4.07e-8	White blood cell count (basophil);
SKCM	cis	rs6445797	0.632	rs2035798	chr3:56598544	G/A	cg13616963	chr3:57583610	ARF4	-0.79	-5.1	-0.5	2.35e-6	Gastritis;
SKCM	cis	rs3784262	0.669	rs12915989	chr15:58315736	C/A	cg12031962	chr15:58353849	ALDH1A2	-0.41	-4.82	-0.48	6.93e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs10905065	0.895	rs1567706	chr10:5853767	T/C	cg09234995	chr10:5726438	C10orf18	0.65	5.54	0.53	4.02e-7	Menopause (age at onset);
SKCM	cis	rs13256369	1.000	rs1109619	chr8:8571616	G/T	cg06636001	chr8:8085503	FLJ10661	0.75	5.77	0.55	1.54e-7	Obesity-related traits;
SKCM	cis	rs8060686	0.641	rs13816	chr16:68055495	G/C	cg09117114	chr16:67998030	SLC12A4	-0.78	-5.06	-0.5	2.72e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs9660180	0.967	rs6687065	chr1:1778469	A/G	cg13866156	chr1:1669148	SLC35E2	-0.71	-5.83	-0.55	1.2e-7	Body mass index;
SKCM	cis	rs7408868	1.000	rs7247835	chr19:15262844	A/G	cg14696996	chr19:15285081	NOTCH3	0.82	4.92	0.49	4.7e-6	Pulse pressure;
SKCM	cis	rs10752881	1.000	rs10911190	chr1:182979080	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.74	6.71	0.6	2.83e-9	Colorectal cancer;
SKCM	cis	rs7927771	0.524	rs7111576	chr11:47787445	G/A	cg20307385	chr11:47447363	PSMC3	0.71	5.63	0.54	2.67e-7	Subjective well-being;
SKCM	cis	rs9467773	0.620	rs2504540	chr6:26641626	A/G	cg15659132	chr6:26577336	NA	0.62	5.4	0.52	6.91e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs644799	0.562	rs1313288	chr11:95520695	T/C	cg03916912	chr11:95522834	CEP57;FAM76B	0.62	4.97	0.49	3.81e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs7666738	0.581	rs34205844	chr4:98887494	C/A	cg17366294	chr4:99064904	C4orf37	0.58	4.91	0.49	4.81e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs12142240	0.659	rs17361873	chr1:46832686	A/G	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs80130819	0.688	rs6580660	chr12:48588112	T/C	cg13203223	chr12:49319398	FKBP11	0.93	4.87	0.48	5.66e-6	Prostate cancer;
SKCM	cis	rs8064299	0.584	rs2384957	chr17:72784630	A/G	cg25054828	chr17:72772726	NAT9;TMEM104	0.94	10.05	0.75	9.91e-16	Monocyte count;
SKCM	cis	rs7666738	0.830	rs13138051	chr4:99050367	C/T	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7100689	0.697	rs4934084	chr10:82116960	T/C	cg00277334	chr10:82204260	NA	-0.52	-4.89	-0.48	5.24e-6	Post bronchodilator FEV1;
SKCM	cis	rs9325144	0.560	rs10785573	chr12:38654166	G/A	cg26384229	chr12:38710491	ALG10B	-0.69	-5.66	-0.54	2.36e-7	Morning vs. evening chronotype;
SKCM	trans	rs1814175	0.645	rs11040661	chr11:49952146	G/T	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs2153535	0.580	rs6937186	chr6:8494493	A/C	cg07606381	chr6:8435919	SLC35B3	0.86	6.25	0.58	2.06e-8	Motion sickness;
SKCM	cis	rs7666738	0.830	rs1426669	chr4:98945534	C/T	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6430585	0.527	rs2278731	chr2:136396300	T/C	cg07169764	chr2:136633963	MCM6	1.01	7.63	0.65	4.95e-11	Corneal structure;
SKCM	cis	rs7811142	0.830	rs75636500	chr7:99947657	C/G	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.05	5.92	0.56	8.02e-8	Platelet count;
SKCM	cis	rs9880211	0.800	rs9819856	chr3:136492149	T/C	cg21827317	chr3:136751795	NA	-0.74	-5.43	-0.52	6.11e-7	Body mass index;Height;
SKCM	cis	rs1348850	0.914	rs9789582	chr2:178330173	C/G	cg02961200	chr2:178257176	LOC100130691;AGPS	0.83	6.14	0.57	3.21e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs1568889	1.000	rs11604085	chr11:28141002	G/A	cg06544937	chr11:28130018	METT5D1;KIF18A	0.87	7.0	0.62	7.86e-10	Bipolar disorder;
SKCM	cis	rs2594989	0.887	rs2616535	chr3:11595167	A/G	cg00170343	chr3:11313890	ATG7	0.91	4.83	0.48	6.7e-6	Circulating chemerin levels;
SKCM	cis	rs936229	0.813	rs2301249	chr15:75092384	T/C	cg14664628	chr15:75095509	CSK	-1.19	-10.7	-0.77	5.75e-17	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin);
SKCM	cis	rs28386778	0.897	rs1982400	chr17:61793818	T/C	cg22520471	chr17:61851767	DDX42;CCDC47	0.79	5.24	0.51	1.32e-6	Prudent dietary pattern;
SKCM	cis	rs11749727	0.623	rs4700908	chr5:179607139	A/G	cg03126616	chr5:179003843	RUFY1	-0.54	-4.88	-0.48	5.56e-6	Initial pursuit acceleration;
SKCM	cis	rs1639906	0.965	rs1639909	chr7:2233045	A/C	cg02951883	chr7:2050386	MAD1L1	-0.6	-4.8	-0.48	7.5e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs644799	0.511	rs1016030	chr11:95472693	A/G	cg03916912	chr11:95522834	CEP57;FAM76B	0.67	5.03	0.49	3.07e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs62238980	0.614	rs117439638	chr22:32438225	T/C	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs2739330	0.760	rs1007888	chr22:24241101	C/T	cg25703541	chr22:24373054	LOC391322	-0.89	-7.92	-0.67	1.34e-11	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs8072548	1	rs8072548	chr17:38164025	T/G	cg17467752	chr17:38218738	THRA	0.69	6.15	0.57	3.16e-8	Eosinophil percentage of granulocytes;Neutrophil percentage of granulocytes;
SKCM	cis	rs2243480	0.901	rs35823062	chr7:65965821	A/G	cg18252515	chr7:66147081	NA	-1.34	-7.96	-0.67	1.1e-11	Diabetic kidney disease;
SKCM	cis	rs595982	0.546	rs9941490	chr19:49396737	G/A	cg19746536	chr19:49375674	PPP1R15A	1.14	8.37	0.69	1.79e-12	Red cell distribution width;
SKCM	cis	rs7829975	0.560	rs17154599	chr8:8551418	C/T	cg06636001	chr8:8085503	FLJ10661	-0.67	-4.92	-0.49	4.78e-6	Mood instability;
SKCM	cis	rs846858	0.963	rs846859	chr19:45129772	A/G	cg18042043	chr19:44147545	NA	0.61	4.95	0.49	4.19e-6	Late-onset Alzheimer's disease;
SKCM	cis	rs34891900	0.507	rs12167771	chr22:18124332	G/A	cg19898043	chr22:18121309	BCL2L13	0.65	4.78	0.48	8.04e-6	Sum neutrophil eosinophil counts;
SKCM	cis	rs8072100	0.539	rs36043200	chr17:45629406	G/A	cg25173405	chr17:45401733	C17orf57	0.56	5.13	0.5	2.04e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs10256972	0.504	rs2949178	chr7:1209925	T/C	cg16145915	chr7:1198662	ZFAND2A	-0.66	-9.98	-0.75	1.35e-15	Longevity;Endometriosis;
SKCM	cis	rs7829975	0.846	rs7005216	chr8:8547110	C/G	cg06636001	chr8:8085503	FLJ10661	-0.83	-6.97	-0.62	9.08e-10	Mood instability;
SKCM	cis	rs854765	0.583	rs28428991	chr17:17827649	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.0	7.64	0.65	4.64e-11	Total body bone mineral density;
SKCM	cis	rs2243480	1.000	rs13235972	chr7:65883605	C/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs28437878	1	rs28437878	chr15:78807872	C/T	cg06917634	chr15:78832804	PSMA4	-0.91	-5.67	-0.54	2.32e-7	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs17345786	1.000	rs7641261	chr3:101279006	C/T	cg12386194	chr3:101231763	SENP7	0.83	6.78	0.61	2.09e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs798554	0.836	rs798490	chr7:2801542	C/T	cg14895029	chr7:2775587	GNA12	-0.69	-5.09	-0.5	2.39e-6	Height;
SKCM	cis	rs644799	0.965	rs565771	chr11:95644179	T/A	cg03916912	chr11:95522834	CEP57;FAM76B	0.84	6.45	0.59	8.53e-9	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs10089	1.000	rs62373701	chr5:127416294	C/T	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.92	8.37	0.69	1.81e-12	Ileal carcinoids;
SKCM	cis	rs12044355	0.827	rs1572899	chr1:231825490	G/C	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	0.86	6.77	0.61	2.17e-9	Alzheimer's disease;
SKCM	cis	rs2739330	0.828	rs5760107	chr22:24252597	T/C	cg04234412	chr22:24373322	LOC391322	-0.58	-4.81	-0.48	7.25e-6	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs208515	0.592	rs10944862	chr6:66674215	C/T	cg07460842	chr6:66804631	NA	0.92	6.31	0.58	1.56e-8	Exhaled nitric oxide levels;
SKCM	cis	rs9584850	0.522	rs9517299	chr13:99095031	C/T	cg20487152	chr13:99095054	FARP1	0.6	5.48	0.53	5.1e-7	Neuroticism;
SKCM	cis	rs3820928	0.874	rs11685983	chr2:227799853	A/G	cg11843606	chr2:227700838	RHBDD1	-0.6	-4.81	-0.48	7.34e-6	Pulmonary function;
SKCM	cis	rs6952808	0.862	rs4721135	chr7:1912222	A/G	cg05863683	chr7:1912471	MAD1L1	0.65	5.92	0.56	8.08e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs597539	0.690	rs497149	chr11:68626639	A/T	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.82	5.51	0.53	4.49e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs10883723	0.810	rs7912901	chr10:104277440	T/C	cg11453585	chr10:104263688	ACTR1A;SUFU	0.77	6.31	0.58	1.56e-8	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs4595586	0.545	rs925827	chr12:39364307	C/T	cg26384229	chr12:38710491	ALG10B	0.64	4.95	0.49	4.12e-6	Morning vs. evening chronotype;
SKCM	cis	rs4423214	0.765	rs2002064	chr11:71163420	A/G	cg05163923	chr11:71159392	DHCR7	-0.74	-6.55	-0.6	5.61e-9	Vitamin D levels;
SKCM	cis	rs7617480	0.648	rs6801211	chr3:48774420	C/G	cg07636037	chr3:49044803	WDR6	0.9	6.65	0.6	3.64e-9	Subjective well-being (multi-trait analysis);Menarche (age at onset);
SKCM	cis	rs1799949	1.000	rs4793212	chr17:41302750	T/C	cg23758822	chr17:41437982	NA	0.92	7.8	0.66	2.3e-11	Menopause (age at onset);
SKCM	cis	rs9581857	0.685	rs9579084	chr13:28028201	A/G	cg22138327	chr13:27999177	GTF3A	-0.93	-6.24	-0.58	2.1e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs2019137	0.560	rs6707386	chr2:113981022	G/A	cg12889195	chr2:113992843	PAX8;LOC440839;LOC654433	0.75	5.59	0.53	3.21e-7	Lymphocyte counts;
SKCM	cis	rs798554	0.757	rs1182198	chr7:2862906	C/T	cg19346786	chr7:2764209	NA	-0.64	-6.76	-0.61	2.22e-9	Height;
SKCM	cis	rs6982751	0.551	rs11779116	chr8:10804605	C/T	cg01383082	chr8:11323474	FAM167A	0.83	4.77	0.48	8.37e-6	Asthma and hay fever;
SKCM	cis	rs72781680	0.898	rs72780125	chr2:24000145	T/C	cg08917208	chr2:24149416	ATAD2B	0.97	5.17	0.5	1.79e-6	Lymphocyte counts;
SKCM	cis	rs6121246	0.909	rs1994250	chr20:30287494	A/G	cg11595048	chr20:30225325	COX4I2	0.67	5.21	0.51	1.5e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs798766	1.000	rs798766	chr4:1734239	C/T	cg05874882	chr4:1763078	NA	0.55	4.85	0.48	6.28e-6	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs782590	0.805	rs782578	chr2:55915904	A/C	cg18811423	chr2:55921094	PNPT1	0.95	8.0	0.67	9.22e-12	Metabolic syndrome;
SKCM	cis	rs2839186	0.558	rs2968	chr21:47608580	C/T	cg11766577	chr21:47581405	C21orf56	0.79	7.14	0.63	4.28e-10	Testicular germ cell tumor;
SKCM	cis	rs2204008	0.665	rs11495668	chr12:38221018	C/T	cg13010199	chr12:38710504	ALG10B	0.65	4.84	0.48	6.52e-6	Bladder cancer;
SKCM	cis	rs344364	0.511	rs337284	chr16:1954799	A/C	cg26897989	chr16:1907736	C16orf73	-0.72	-7.14	-0.63	4.17e-10	Glomerular filtration rate in chronic kidney disease;
SKCM	cis	rs6500602	0.627	rs4786494	chr16:4506232	G/A	cg08645402	chr16:4508243	NA	0.65	5.07	0.5	2.59e-6	Schizophrenia;
SKCM	cis	rs1799949	0.965	rs799908	chr17:41278916	A/G	cg19454999	chr17:41278357	BRCA1;NBR2	0.51	4.8	0.48	7.53e-6	Menopause (age at onset);
SKCM	cis	rs514406	0.689	rs7548389	chr1:53404211	C/T	cg16325326	chr1:53192061	ZYG11B	0.79	7.26	0.63	2.54e-10	Monocyte count;
SKCM	trans	rs66573146	0.831	rs67702333	chr4:6983040	C/G	cg07817883	chr1:32538562	TMEM39B	1.94	8.42	0.69	1.47e-12	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs7980687	0.657	rs2851447	chr12:123665113	G/C	cg00376283	chr12:123451042	ABCB9	0.86	6.55	0.6	5.68e-9	Height;Educational attainment;Head circumference (infant);
SKCM	cis	rs763121	0.853	rs6001214	chr22:39149155	C/T	cg06022373	chr22:39101656	GTPBP1	0.82	5.06	0.5	2.74e-6	Menopause (age at onset);
SKCM	cis	rs67311347	0.866	rs2371183	chr3:40334247	C/T	cg00091569	chr3:40428383	ENTPD3	-0.62	-5.12	-0.5	2.11e-6	Renal cell carcinoma;
SKCM	cis	rs1005277	0.540	rs1987431	chr10:37988887	T/C	cg00409905	chr10:38381863	ZNF37A	-0.59	-5.81	-0.55	1.31e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs1957429	0.901	rs7141985	chr14:65345670	C/T	cg23373153	chr14:65346875	NA	1.08	5.98	0.56	6.26e-8	Pediatric areal bone mineral density (radius);
SKCM	cis	rs57221529	0.766	rs12519469	chr5:581772	A/G	cg26208419	chr5:473447	SLC9A3;LOC25845	1.01	5.18	0.51	1.7e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs7618915	0.501	rs3852066	chr3:52621839	C/T	cg18404041	chr3:52824283	ITIH1	-0.53	-4.77	-0.48	8.42e-6	Bipolar disorder;
SKCM	cis	rs9910055	0.530	rs2269906	chr17:42294337	G/T	cg08499158	chr17:42289980	UBTF	0.81	7.11	0.63	4.88e-10	Total body bone mineral density;
SKCM	cis	rs7659604	0.517	rs56311153	chr4:122729685	T/C	cg20573242	chr4:122745356	CCNA2	0.74	6.25	0.58	2e-8	Type 2 diabetes;
SKCM	cis	rs7829975	0.744	rs2409092	chr8:8682192	A/T	cg15556689	chr8:8085844	FLJ10661	0.74	6.86	0.61	1.43e-9	Mood instability;
SKCM	cis	rs763121	0.853	rs1062687	chr22:39134715	T/C	cg06022373	chr22:39101656	GTPBP1	0.78	4.85	0.48	6.17e-6	Menopause (age at onset);
SKCM	cis	rs7584330	0.740	rs2292885	chr2:238443407	G/C	cg14458575	chr2:238380390	NA	0.81	5.12	0.5	2.14e-6	Prostate cancer;
SKCM	cis	rs2032447	0.507	rs199741	chr6:25931577	A/G	cg12310025	chr6:25882481	NA	-0.75	-6.71	-0.6	2.8e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs8067545	0.611	rs1992561	chr17:20219119	G/A	cg13482628	chr17:19912719	NA	-0.69	-5.51	-0.53	4.47e-7	Schizophrenia;
SKCM	cis	rs1799949	1.000	rs35070007	chr17:41316747	C/G	cg05368731	chr17:41323189	NBR1	-0.91	-7.96	-0.67	1.13e-11	Menopause (age at onset);
SKCM	cis	rs28595532	0.920	rs115994240	chr4:119744622	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs10927875	1.000	rs3979179	chr1:16306846	A/G	cg21385522	chr1:16154831	NA	0.92	7.69	0.66	3.73e-11	Dilated cardiomyopathy;
SKCM	cis	rs7666738	0.830	rs1426667	chr4:98949772	T/C	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1029738	0.659	rs1608553	chr7:22896231	G/C	cg18884940	chr7:22894078	NA	-0.62	-4.84	-0.48	6.33e-6	Fibrinogen levels;
SKCM	cis	rs6088580	0.609	rs6059845	chr20:33036500	G/A	cg24642439	chr20:33292090	TP53INP2	0.76	5.96	0.56	6.86e-8	Glomerular filtration rate (creatinine);
SKCM	trans	rs66573146	0.831	rs56320732	chr4:6974319	G/A	cg07817883	chr1:32538562	TMEM39B	1.94	8.42	0.69	1.47e-12	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs897984	0.806	rs1046276	chr16:30914626	A/G	cg00531865	chr16:30841666	NA	0.57	4.9	0.49	5.08e-6	Dementia with Lewy bodies;
SKCM	cis	rs12497850	0.931	rs6446205	chr3:49035211	C/T	cg06212747	chr3:49208901	KLHDC8B	0.68	4.82	0.48	6.97e-6	Parkinson's disease;
SKCM	cis	rs1552244	1.000	rs9879080	chr3:10084224	C/T	cg02579736	chr3:10068473	FANCD2;CIDECP	1.34	7.21	0.63	3.15e-10	Alzheimer's disease;
SKCM	cis	rs2239547	0.522	rs9844736	chr3:52931971	T/G	cg11645453	chr3:52864694	ITIH4	-0.78	-7.13	-0.63	4.44e-10	Schizophrenia;
SKCM	cis	rs709400	0.643	rs11621777	chr14:104072090	A/G	cg26031613	chr14:104095156	KLC1	1.11	12.72	0.82	1.04e-20	Body mass index;
SKCM	cis	rs6539267	0.741	rs10861572	chr12:106688576	A/G	cg00173435	chr12:106696525	TCP11L2	-0.81	-5.87	-0.55	1.01e-7	Tourette syndrome;
SKCM	cis	rs12474201	0.928	rs1109380	chr2:46924490	G/T	cg06386533	chr2:46925753	SOCS5	0.98	9.19	0.72	4.68e-14	Height;
SKCM	cis	rs2013441	1.000	rs34644796	chr17:20064128	C/G	cg13482628	chr17:19912719	NA	0.67	5.24	0.51	1.32e-6	Obesity-related traits;
SKCM	cis	rs6570726	0.764	rs1912023	chr6:145824278	C/A	cg05347473	chr6:146136440	FBXO30	0.53	4.78	0.48	8.07e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs12541335	0.639	rs7834182	chr8:22163112	G/A	cg09517075	chr8:22133004	PIWIL2	0.59	5.41	0.52	6.84e-7	Hypertriglyceridemia;
SKCM	cis	rs4974559	0.948	rs3856982	chr4:1328863	C/T	cg02980000	chr4:1222292	CTBP1	-0.8	-5.18	-0.51	1.68e-6	Systolic blood pressure;
SKCM	cis	rs514406	0.708	rs536621	chr1:53309097	A/G	cg24675658	chr1:53192096	ZYG11B	-0.86	-7.93	-0.67	1.3e-11	Monocyte count;
SKCM	cis	rs35306767	0.855	rs11253459	chr10:886402	C/T	cg25614935	chr10:1084866	C10orf110	0.82	5.39	0.52	7.4e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs10504229	0.683	rs1495866	chr8:58141128	T/C	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs75229567	0.618	rs1599745	chr12:70186029	A/G	cg10114359	chr12:70132523	RAB3IP	1.08	5.15	0.5	1.94e-6	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes;
SKCM	cis	rs2413583	0.591	rs12483879	chr22:39719148	C/G	cg17798944	chr22:39715225	SNORD43;RPL3	0.91	5.2	0.51	1.58e-6	Ulcerative colitis;Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs614226	0.688	rs75111771	chr12:121009943	T/C	cg01236616	chr12:121019343	POP5	-1.34	-7.67	-0.66	4.14e-11	Type 1 diabetes nephropathy;
SKCM	cis	rs6952808	0.609	rs6944877	chr7:1952582	T/G	cg04267008	chr7:1944627	MAD1L1	-0.6	-4.81	-0.48	7.27e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs9611565	0.840	rs2234059	chr22:41777913	T/C	cg03806693	chr22:41940476	POLR3H	-0.86	-5.89	-0.55	9.19e-8	Vitiligo;
SKCM	cis	rs763014	0.898	rs4984669	chr16:624713	C/T	cg00908189	chr16:619842	PIGQ	0.81	7.2	0.63	3.3e-10	Height;
SKCM	cis	rs6570726	0.791	rs365747	chr6:145866784	C/T	cg23711669	chr6:146136114	FBXO30	0.87	9.13	0.72	5.92e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs501120	1.000	rs554565	chr10:44755448	G/A	cg09554077	chr10:44749378	NA	0.38	4.93	0.49	4.52e-6	Coronary artery disease;Coronary heart disease;
SKCM	cis	rs1577917	0.839	rs12055653	chr6:86546663	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.69	-6.15	-0.57	3.1e-8	Response to antipsychotic treatment;
SKCM	cis	rs7772486	0.875	rs863820	chr6:146347402	C/T	cg05347473	chr6:146136440	FBXO30	-0.56	-4.96	-0.49	3.99e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2153535	0.580	rs7450817	chr6:8481421	G/A	cg07606381	chr6:8435919	SLC35B3	0.86	6.25	0.58	2.06e-8	Motion sickness;
SKCM	cis	rs55962025	0.842	rs362267	chr4:3243218	C/T	cg16987761	chr4:3318072	RGS12	-0.7	-5.32	-0.52	9.54e-7	Parental longevity (mother's age at death);
SKCM	cis	rs4911259	0.552	rs62208880	chr20:31463284	T/C	cg13636640	chr20:31349939	DNMT3B	-0.74	-6.15	-0.57	3.04e-8	Inflammatory bowel disease;
SKCM	cis	rs950776	0.518	rs12594391	chr15:78816240	A/G	cg06917634	chr15:78832804	PSMA4	1.01	10.48	0.76	1.5e-16	Sudden cardiac arrest;
SKCM	cis	rs7666738	0.830	rs6830124	chr4:99054872	C/T	cg05340658	chr4:99064831	C4orf37	-0.66	-5.11	-0.5	2.25e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11098499	0.779	rs10016060	chr4:120298412	A/G	cg24375607	chr4:120327624	NA	0.65	4.97	0.49	3.87e-6	Corneal astigmatism;
SKCM	cis	rs12682352	0.605	rs60707155	chr8:8724415	C/T	cg06636001	chr8:8085503	FLJ10661	0.68	5.43	0.52	6.17e-7	Neuroticism;
SKCM	cis	rs10504073	0.584	rs55908480	chr8:49923431	G/A	cg00325661	chr8:49890786	NA	0.79	7.15	0.63	3.99e-10	Blood metabolite ratios;
SKCM	cis	rs367615	0.552	rs2963010	chr5:108737043	T/C	cg17395555	chr5:108820864	NA	-0.68	-5.58	-0.53	3.42e-7	Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs12709013	0.792	rs62066381	chr16:58841885	G/C	cg02431531	chr16:59244939	NA	0.48	4.99	0.49	3.62e-6	Blood metabolite ratios;
SKCM	cis	rs7945705	0.774	rs6486060	chr11:9024630	A/G	cg21881798	chr11:8931708	C11orf17;ST5	0.76	7.45	0.64	1.1e-10	Hemoglobin concentration;
SKCM	cis	rs10256972	0.567	rs2960850	chr7:1211649	A/G	cg07092213	chr7:1199455	ZFAND2A	-0.66	-5.36	-0.52	8.19e-7	Longevity;Endometriosis;
SKCM	cis	rs10256972	0.685	rs10263665	chr7:1110628	A/G	cg07308232	chr7:1071921	C7orf50	-0.6	-4.89	-0.48	5.23e-6	Longevity;Endometriosis;
SKCM	cis	rs8180040	0.701	rs62248439	chr3:46996448	A/G	cg27129171	chr3:47204927	SETD2	-0.79	-6.01	-0.56	5.49e-8	Colorectal cancer;
SKCM	cis	rs2108225	0.934	rs2283044	chr7:107440553	A/G	cg18560240	chr7:107437656	SLC26A3	0.58	4.8	0.48	7.48e-6	Ulcerative colitis;
SKCM	cis	rs2180341	0.961	rs9375501	chr6:127652539	C/T	cg27446573	chr6:127587934	RNF146	0.94	8.08	0.68	6.49e-12	Breast cancer;
SKCM	cis	rs6570726	0.837	rs636894	chr6:145864122	T/C	cg23711669	chr6:146136114	FBXO30	0.69	6.66	0.6	3.49e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6753739	0.745	rs4674356	chr2:219914633	A/C	cg09617556	chr2:219924408	IHH	0.47	4.94	0.49	4.44e-6	Height;
SKCM	cis	rs1005277	0.505	rs200936	chr10:38134935	T/C	cg25427524	chr10:38739819	LOC399744	-0.68	-6.52	-0.59	6.36e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs1538970	0.851	rs2055145	chr1:45926495	C/G	cg05343316	chr1:45956843	TESK2	0.88	4.77	0.48	8.46e-6	Platelet count;
SKCM	cis	rs35306767	0.903	rs11253493	chr10:936931	T/C	cg20503657	chr10:835505	NA	0.83	5.37	0.52	7.86e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs11098499	0.691	rs9996644	chr4:120238877	G/T	cg09307838	chr4:120376055	NA	0.98	8.13	0.68	5.33e-12	Corneal astigmatism;
SKCM	cis	rs7208859	0.623	rs6505207	chr17:29076571	T/C	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs1801251	0.963	rs7562712	chr2:233606580	A/G	cg25237894	chr2:233734115	C2orf82	0.56	5.33	0.52	9.23e-7	Coronary artery disease;
SKCM	cis	rs9913156	0.748	rs56364707	chr17:4562579	A/T	cg19197139	chr17:4613644	ARRB2	0.79	5.28	0.51	1.14e-6	Lymphocyte counts;
SKCM	cis	rs151997	0.629	rs152808	chr5:50207382	G/C	cg06027927	chr5:50259733	NA	0.65	6.24	0.58	2.13e-8	Callous-unemotional behaviour;
SKCM	cis	rs875971	0.545	rs2279757	chr7:65828663	T/C	cg18876405	chr7:65276391	NA	0.63	5.0	0.49	3.41e-6	Aortic root size;
SKCM	cis	rs1707322	0.752	rs6703748	chr1:46095976	G/A	cg03146154	chr1:46216737	IPP	0.79	5.42	0.52	6.34e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs9911578	1.000	rs9911578	chr17:56953147	C/T	cg12560992	chr17:57184187	TRIM37	0.94	7.55	0.65	7.01e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs2836950	0.501	rs62223052	chr21:40708702	A/C	cg17971929	chr21:40555470	PSMG1	-0.69	-5.35	-0.52	8.68e-7	Menarche (age at onset);
SKCM	cis	rs826838	0.874	rs10880943	chr12:38734317	C/T	cg13010199	chr12:38710504	ALG10B	0.87	6.82	0.61	1.76e-9	Heart rate;
SKCM	cis	rs1278769	0.735	rs12585036	chr13:113535741	C/T	cg00823993	chr13:113535758	ATP11A	0.58	4.94	0.49	4.36e-6	Interstitial lung disease;
SKCM	cis	rs4891159	0.756	rs55763305	chr18:74161249	G/C	cg24786174	chr18:74118243	ZNF516	-0.74	-7.03	-0.62	6.83e-10	Longevity;
SKCM	cis	rs10504229	0.683	rs6998040	chr8:58110155	G/T	cg02725872	chr8:58115012	NA	0.53	5.19	0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs28386778	0.897	rs2584624	chr17:61904546	A/G	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs9660180	0.967	rs6603803	chr1:1812688	A/G	cg23982607	chr1:1823379	GNB1	-0.75	-6.3	-0.58	1.6e-8	Body mass index;
SKCM	cis	rs6062496	0.631	rs6062296	chr20:62292137	C/T	cg27236539	chr20:62289627	RTEL1	0.72	4.95	0.49	4.16e-6	Crohn's disease;Inflammatory bowel disease;Ulcerative colitis;
SKCM	cis	rs10791097	0.720	rs6590517	chr11:130733505	C/T	cg12179176	chr11:130786555	SNX19	0.87	7.15	0.63	4.15e-10	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs10540	1.000	rs78520676	chr11:517173	G/A	cg03576123	chr11:487126	PTDSS2	-1.45	-7.95	-0.67	1.17e-11	Body mass index;
SKCM	cis	rs4466137	0.830	rs10039752	chr5:82974532	G/A	cg16102102	chr5:83017553	HAPLN1	-0.53	-5.82	-0.55	1.26e-7	Prostate cancer;
SKCM	cis	rs763014	0.931	rs2071981	chr16:630025	C/G	cg09263875	chr16:632152	PIGQ	0.67	5.82	0.55	1.24e-7	Height;
SKCM	cis	rs2842992	0.673	rs6930904	chr6:160217433	T/A	cg16489826	chr6:160211363	TCP1;MRPL18	0.68	4.93	0.49	4.57e-6	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs1850744	0.702	rs78422890	chr4:9600765	C/T	cg15442990	chr4:9534313	NA	-1.38	-5.09	-0.5	2.44e-6	Economic and political preferences;
SKCM	cis	rs3087591	0.960	rs10512433	chr17:29600564	T/C	cg24425628	chr17:29625626	OMG;NF1	0.64	5.08	0.5	2.48e-6	Hip circumference;
SKCM	cis	rs3087591	0.960	rs12949230	chr17:29461899	G/A	cg24425628	chr17:29625626	OMG;NF1	0.63	5.0	0.49	3.5e-6	Hip circumference;
SKCM	cis	rs1801516	0.950	rs10890838	chr11:108303305	C/T	cg03165700	chr11:108093220	ATM;NPAT	-1.11	-5.06	-0.5	2.68e-6	Melanoma;
SKCM	cis	rs2842992	0.768	rs2273824	chr6:160211445	C/T	cg19482086	chr6:160211437	TCP1;MRPL18	0.87	7.46	0.65	1.04e-10	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs72949976	1.000	rs62186568	chr2:214033955	G/A	cg08319019	chr2:214017104	IKZF2	-0.71	-5.38	-0.52	7.52e-7	Lung cancer;Squamous cell lung carcinoma;
SKCM	cis	rs2658782	0.789	rs56091149	chr11:93073640	A/C	cg15737290	chr11:93063684	CCDC67	-0.87	-6.0	-0.56	5.74e-8	Pulmonary function decline;
SKCM	cis	rs9611565	0.659	rs73178632	chr22:41934573	C/T	cg03806693	chr22:41940476	POLR3H	-1.11	-7.56	-0.65	6.67e-11	Vitiligo;
SKCM	cis	rs5753618	0.583	rs5749268	chr22:31809152	G/A	cg02404636	chr22:31891804	SFI1	0.58	4.97	0.49	3.86e-6	Colorectal cancer;
SKCM	cis	rs57221529	0.825	rs72703051	chr5:582997	G/A	cg09888920	chr5:474111	LOC25845;SLC9A3	1.02	4.77	0.48	8.35e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs1405130	0.869	rs4663466	chr2:235573203	G/C	cg21542780	chr2:234763377	HJURP	-0.64	-4.89	-0.48	5.21e-6	Coronary artery disease;
SKCM	cis	rs58688157	0.705	rs11539530	chr11:609353	G/A	cg16486109	chr11:613632	IRF7	1.06	7.19	0.63	3.44e-10	Systemic lupus erythematosus;
SKCM	cis	rs28595532	0.764	rs116302502	chr4:119748848	T/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs7954584	0.567	rs1169071	chr12:122390084	G/T	cg22618164	chr12:122356400	WDR66	0.53	5.39	0.52	7.24e-7	Mean corpuscular volume;
SKCM	cis	rs7824557	0.564	rs7834572	chr8:11236685	C/T	cg21775007	chr8:11205619	TDH	-0.59	-5.03	-0.5	3.01e-6	Retinal vascular caliber;
SKCM	cis	rs2243480	0.522	rs1638736	chr7:66092308	A/T	cg18252515	chr7:66147081	NA	-1.36	-7.92	-0.67	1.36e-11	Diabetic kidney disease;
SKCM	cis	rs10751667	0.580	rs10751664	chr11:927077	T/G	cg10932868	chr11:921992	NA	0.55	5.13	0.5	2.09e-6	Alzheimer's disease (late onset);
SKCM	cis	rs2832191	0.791	rs4817270	chr21:30480368	G/A	cg08807101	chr21:30365312	RNF160	-0.62	-4.94	-0.49	4.34e-6	Dental caries;
SKCM	cis	rs66573146	1.000	rs56350643	chr4:7017591	G/A	cg00086871	chr4:6988644	TBC1D14	1.44	5.37	0.52	8.04e-7	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs2242116	0.900	rs4683300	chr3:46934292	C/A	cg02527881	chr3:46936655	PTH1R	-0.55	-5.29	-0.51	1.08e-6	Birth weight;
SKCM	cis	rs2811415	0.597	rs9849210	chr3:127779633	G/T	cg09089421	chr3:127803668	RUVBL1	1.01	8.77	0.7	2.97e-13	Lung function (FEV1/FVC);
SKCM	cis	rs28386778	0.897	rs9912557	chr17:61784963	C/A	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.36	0.52	8.08e-7	Prudent dietary pattern;
SKCM	cis	rs1577917	0.771	rs9362232	chr6:86353622	A/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.74	-6.62	-0.6	4.1e-9	Response to antipsychotic treatment;
SKCM	cis	rs1059312	1.000	rs12814773	chr12:129280786	C/T	cg09035930	chr12:129282057	SLC15A4	0.8	8.41	0.69	1.54e-12	Systemic lupus erythematosus;
SKCM	cis	rs2224391	0.737	rs36117780	chr6:5262233	A/G	cg09085698	chr6:5261316	LYRM4;FARS2	-0.78	-5.8	-0.55	1.34e-7	Height;
SKCM	cis	rs861020	0.771	rs654470	chr1:210014093	A/T	cg05527609	chr1:210001259	C1orf107	1.11	8.75	0.7	3.34e-13	Orofacial clefts;
SKCM	cis	rs9303401	0.614	rs3803753	chr17:56540110	G/A	cg02118635	chr17:56770003	RAD51C;TEX14	0.8	5.33	0.52	9.25e-7	Cognitive test performance;
SKCM	cis	rs875971	0.964	rs778723	chr7:65829497	T/C	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	7.89e-13	Aortic root size;
SKCM	cis	rs9303401	0.659	rs8074016	chr17:56840587	A/G	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.16	0.57	2.91e-8	Cognitive test performance;
SKCM	cis	rs4927850	1.000	rs7627868	chr3:195753473	A/T	cg12923728	chr3:195709715	SDHAP1	-0.89	-5.76	-0.55	1.57e-7	Pancreatic cancer;
SKCM	cis	rs4481887	0.927	rs10158431	chr1:248481253	A/G	cg00666640	chr1:248458726	OR2T12	0.64	5.69	0.54	2.13e-7	Common traits (Other);
SKCM	cis	rs732765	0.657	rs2287401	chr14:75248669	G/T	cg25946216	chr14:74253857	C14orf43	-0.94	-5.23	-0.51	1.36e-6	Non-small cell lung cancer;
SKCM	cis	rs9300255	0.679	rs12817892	chr12:123728702	G/A	cg05973401	chr12:123451056	ABCB9	-0.84	-5.94	-0.56	7.59e-8	Neutrophil percentage of white cells;
SKCM	cis	rs2295499	0.610	rs12502642	chr4:2714023	T/C	cg19433769	chr4:2420260	ZFYVE28	0.69	4.77	0.48	8.44e-6	Cognitive ability;Cognitive ability (multi-trait analysis);Intelligence (multi-trait analysis);
SKCM	cis	rs4919087	0.961	rs11189120	chr10:99069493	G/T	cg25902810	chr10:99078978	FRAT1	0.65	4.99	0.49	3.65e-6	Monocyte count;
SKCM	cis	rs644799	0.544	rs1150360	chr11:95512060	A/G	cg03916912	chr11:95522834	CEP57;FAM76B	0.63	5.04	0.5	2.9e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs7826238	0.564	rs2921053	chr8:8319963	G/C	cg06636001	chr8:8085503	FLJ10661	0.77	6.24	0.58	2.13e-8	Systolic blood pressure;
SKCM	cis	rs4975616	0.869	rs31490	chr5:1344458	G/A	cg26373071	chr5:1325741	CLPTM1L	0.74	6.76	0.61	2.27e-9	Lung cancer;
SKCM	cis	rs67311347	0.544	rs13098483	chr3:40342743	G/C	cg00091569	chr3:40428383	ENTPD3	0.62	5.45	0.53	5.72e-7	Renal cell carcinoma;
SKCM	cis	rs763014	0.833	rs3743903	chr16:632736	T/C	cg09263875	chr16:632152	PIGQ	0.67	5.82	0.55	1.24e-7	Height;
SKCM	cis	rs11105298	0.891	rs11105314	chr12:89924559	C/T	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.87	-5.67	-0.54	2.29e-7	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs8180040	0.966	rs12486969	chr3:47429003	G/C	cg16586182	chr3:47516702	SCAP	0.76	5.32	0.52	9.63e-7	Colorectal cancer;
SKCM	cis	rs4803468	0.967	rs7259900	chr19:41889429	A/T	cg09537434	chr19:41945824	ATP5SL	-1.09	-12.85	-0.82	6e-21	Height;
SKCM	cis	rs66573146	1.000	rs73088528	chr4:6967747	G/C	cg00086871	chr4:6988644	TBC1D14	1.43	5.33	0.52	9.25e-7	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs2153535	0.580	rs4960433	chr6:8523697	A/G	cg07606381	chr6:8435919	SLC35B3	0.88	6.45	0.59	8.54e-9	Motion sickness;
SKCM	cis	rs2739330	0.685	rs4822453	chr22:24254862	G/T	cg04234412	chr22:24373322	LOC391322	-0.63	-5.3	-0.51	1.06e-6	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs1577917	0.681	rs4348284	chr6:86350394	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.74	-6.61	-0.6	4.24e-9	Response to antipsychotic treatment;
SKCM	cis	rs6570726	0.791	rs9376945	chr6:145828080	T/A	cg05347473	chr6:146136440	FBXO30	0.53	4.78	0.48	8.07e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6570726	0.791	rs401331	chr6:145831408	A/G	cg23711669	chr6:146136114	FBXO30	0.79	7.93	0.67	1.26e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7683537	0.692	rs56368159	chr4:185654827	T/G	cg04058563	chr4:185651563	MLF1IP	1.02	6.59	0.6	4.7e-9	Systemic lupus erythematosus;
SKCM	cis	rs9640161	0.742	rs2108854	chr7:150017408	C/T	cg10018233	chr7:150070692	REPIN1	-0.74	-6.08	-0.57	4.22e-8	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs11098499	0.730	rs12505735	chr4:120532956	G/T	cg09307838	chr4:120376055	NA	0.97	7.62	0.65	5.05e-11	Corneal astigmatism;
SKCM	cis	rs6089584	1.000	rs6089585	chr20:60564395	G/A	cg06108461	chr20:60628389	TAF4	-0.81	-7.11	-0.63	4.79e-10	Body mass index;
SKCM	cis	rs28595532	0.925	rs2728305	chr4:119487022	T/G	cg14228332	chr4:119757509	SEC24D	1.12	5.06	0.5	2.77e-6	Cannabis dependence symptom count;
SKCM	cis	rs9325144	0.647	rs17518186	chr12:38883665	T/C	cg26384229	chr12:38710491	ALG10B	-0.73	-6.26	-0.58	1.93e-8	Morning vs. evening chronotype;
SKCM	cis	rs7208859	0.623	rs55938328	chr17:29117010	T/C	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs17376456	0.569	rs11135397	chr5:93214975	G/T	cg21475434	chr5:93447410	FAM172A	0.79	4.95	0.49	4.17e-6	Diabetic retinopathy;
SKCM	cis	rs6951245	0.554	rs75075857	chr7:1140298	C/T	cg03188948	chr7:1209495	NA	0.83	5.88	0.55	9.86e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs11792861	0.855	rs72607165	chr9:111814498	C/T	cg14432460	chr9:111696404	IKBKAP;C9orf6	0.66	4.79	0.48	7.77e-6	Menarche (age at onset);
SKCM	cis	rs7666738	0.830	rs62318504	chr4:98935558	T/G	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2439831	0.850	rs28707214	chr15:44131623	G/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.36	7.78	0.66	2.56e-11	Lung cancer in ever smokers;
SKCM	cis	rs875971	0.505	rs2462573	chr7:65507392	C/T	cg18876405	chr7:65276391	NA	-0.84	-7.85	-0.66	1.81e-11	Aortic root size;
SKCM	cis	rs3785574	0.962	rs8066463	chr17:61818390	A/G	cg06601766	chr17:61851465	DDX42;CCDC47	0.64	4.77	0.48	8.35e-6	Height;
SKCM	cis	rs826838	1.000	rs1684416	chr12:39130301	G/A	cg26384229	chr12:38710491	ALG10B	-0.91	-8.28	-0.68	2.74e-12	Heart rate;
SKCM	cis	rs7552404	0.824	rs1251079	chr1:76189445	C/T	cg03433033	chr1:76189801	ACADM	0.88	6.78	0.61	2.08e-9	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs514406	0.668	rs12037492	chr1:53440816	G/T	cg04310824	chr1:53393297	SCP2	0.64	5.14	0.5	2e-6	Monocyte count;
SKCM	trans	rs561341	1.000	rs8069199	chr17:30281845	A/G	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs2228479	0.702	rs62053701	chr16:89860584	G/A	cg06558623	chr16:89946397	TCF25	1.04	4.82	0.48	6.97e-6	Skin colour saturation;
SKCM	cis	rs2777491	1.000	rs2730055	chr15:41735708	C/A	cg18705301	chr15:41695430	NDUFAF1	-0.89	-9.04	-0.72	9.17e-14	Ulcerative colitis;
SKCM	cis	rs28386778	0.897	rs6504184	chr17:61842408	A/T	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs9300255	0.510	rs1790133	chr12:123698518	T/G	cg05973401	chr12:123451056	ABCB9	0.81	5.29	0.51	1.1e-6	Neutrophil percentage of white cells;
SKCM	cis	rs6570726	0.791	rs436498	chr6:145876347	G/A	cg05347473	chr6:146136440	FBXO30	0.57	5.13	0.5	2.06e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7917772	0.503	rs11191330	chr10:104306160	G/T	cg11453585	chr10:104263688	ACTR1A;SUFU	0.75	6.15	0.57	3.06e-8	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs7178909	0.872	rs3931863	chr15:90433913	T/G	cg19708238	chr15:90437601	AP3S2	0.72	5.22	0.51	1.43e-6	Common traits (Other);
SKCM	cis	rs860295	0.651	rs6677385	chr1:155304581	C/A	cg02153340	chr1:155202674	NA	-0.8	-5.64	-0.54	2.63e-7	Body mass index;
SKCM	cis	rs3087591	1.000	rs7216033	chr17:29574642	A/G	cg24425628	chr17:29625626	OMG;NF1	-0.63	-4.95	-0.49	4.23e-6	Hip circumference;
SKCM	cis	rs3768617	0.528	rs6686682	chr1:183080539	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs6461049	0.638	rs1859993	chr7:2183702	A/G	cg02951883	chr7:2050386	MAD1L1	-0.73	-6.27	-0.58	1.86e-8	Schizophrenia;
SKCM	cis	rs3091242	0.933	rs9645452	chr1:25668326	C/T	cg27572855	chr1:25598939	RHD	-0.55	-5.34	-0.52	8.86e-7	Erythrocyte sedimentation rate;
SKCM	cis	rs11690935	0.959	rs67204065	chr2:172672624	G/A	cg13550731	chr2:172543902	DYNC1I2	-0.89	-7.27	-0.64	2.45e-10	Schizophrenia;
SKCM	cis	rs507080	0.922	rs7114216	chr11:118566234	A/G	cg18045108	chr11:118530628	TREH	-0.47	-5.07	-0.5	2.57e-6	Serum metabolite levels;
SKCM	cis	rs6088590	0.813	rs1884668	chr20:33285514	A/G	cg24642439	chr20:33292090	TP53INP2	0.79	5.66	0.54	2.45e-7	Coronary artery disease;
SKCM	cis	rs4523957	0.553	rs2131703	chr17:2025360	G/T	cg16513277	chr17:2031491	SMG6	-0.91	-6.21	-0.58	2.38e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs4803468	0.904	rs60781668	chr19:41944842	A/T	cg14132834	chr19:41945861	ATP5SL	0.77	5.9	0.56	9.04e-8	Height;
SKCM	cis	rs6952808	0.929	rs11761270	chr7:1923695	C/T	cg21782813	chr7:2030301	MAD1L1	0.55	5.6	0.54	3.13e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs62064224	0.765	rs11650584	chr17:30679330	T/G	cg18200150	chr17:30822561	MYO1D	0.78	6.26	0.58	1.94e-8	Schizophrenia;
SKCM	cis	rs1957429	0.901	rs60979440	chr14:65390231	A/G	cg23373153	chr14:65346875	NA	-1.07	-5.71	-0.54	1.94e-7	Pediatric areal bone mineral density (radius);
SKCM	cis	rs9911578	0.967	rs1267542	chr17:56654690	T/C	cg12560992	chr17:57184187	TRIM37	-0.95	-7.67	-0.66	4.15e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs35272691	1	rs35272691	chr17:38157841	T/C	cg17467752	chr17:38218738	THRA	-0.74	-6.28	-0.58	1.78e-8	White blood cell count (neutrophil);
SKCM	cis	rs2180341	1.000	rs9388561	chr6:127634921	C/T	cg27446573	chr6:127587934	RNF146	0.94	8.06	0.67	7.08e-12	Breast cancer;
SKCM	cis	rs2836974	0.931	rs2836968	chr21:40642386	A/G	cg11890956	chr21:40555474	PSMG1	1.09	13.73	0.84	1.66e-22	Cognitive function;
SKCM	cis	rs4665809	0.878	rs4665826	chr2:26367503	A/T	cg26119090	chr2:26468346	HADHA;HADHB	0.84	5.22	0.51	1.42e-6	Gut microbiome composition (summer);
SKCM	cis	rs2836974	0.545	rs3167757	chr21:40714478	C/T	cg11644478	chr21:40555479	PSMG1	0.64	4.88	0.48	5.43e-6	Cognitive function;
SKCM	cis	rs1707322	0.717	rs2991988	chr1:46082431	C/A	cg03146154	chr1:46216737	IPP	-0.8	-5.59	-0.53	3.22e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs4975616	0.804	rs459961	chr5:1337106	T/A	cg06550200	chr5:1325588	CLPTM1L	-0.86	-7.74	-0.66	2.94e-11	Lung cancer;
SKCM	trans	rs7819412	0.775	rs34094119	chr8:10935898	A/G	cg06636001	chr8:8085503	FLJ10661	-0.86	-7.46	-0.65	1.03e-10	Triglycerides;
SKCM	cis	rs4481887	0.927	rs4345830	chr1:248474845	G/C	cg00666640	chr1:248458726	OR2T12	0.63	5.91	0.56	8.65e-8	Common traits (Other);
SKCM	cis	rs9913156	0.841	rs55787856	chr17:4611786	C/T	cg19197139	chr17:4613644	ARRB2	0.8	5.48	0.53	4.95e-7	Lymphocyte counts;
SKCM	cis	rs2921073	0.509	rs2976931	chr8:8257317	C/A	cg08975724	chr8:8085496	FLJ10661	0.59	4.79	0.48	7.76e-6	Parkinson's disease;
SKCM	cis	rs597539	0.842	rs648336	chr11:68616449	C/T	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.71	4.85	0.48	6.12e-6	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs55962025	0.855	rs6855981	chr4:3148276	A/G	cg00764545	chr4:3318001	RGS12	0.65	5.65	0.54	2.52e-7	Parental longevity (mother's age at death);
SKCM	cis	rs11673344	0.764	rs1644645	chr19:37463430	G/A	cg07624650	chr19:37064219	ZNF529	-0.78	-4.82	-0.48	7.05e-6	Obesity-related traits;
SKCM	cis	rs9790314	0.521	rs2122527	chr3:161091636	G/A	cg03342759	chr3:160939853	NMD3	-0.79	-6.79	-0.61	1.97e-9	Morning vs. evening chronotype;
SKCM	cis	rs875971	0.522	rs10807697	chr7:65416170	A/G	cg11987759	chr7:65425863	GUSB	-0.76	-6.83	-0.61	1.64e-9	Aortic root size;
SKCM	cis	rs7843479	0.965	rs1484162	chr8:21831385	A/G	cg17168535	chr8:21777572	XPO7	0.8	6.98	0.62	8.53e-10	Mean corpuscular volume;
SKCM	cis	rs9682041	0.932	rs1525362	chr3:170070702	C/T	cg11886554	chr3:170076028	SKIL	0.83	5.01	0.49	3.28e-6	Glomerular filtration rate in non diabetics (creatinine);Glomerular filtration rate (creatinine);
SKCM	cis	rs6952808	0.564	rs73038441	chr7:2139286	T/C	cg21782813	chr7:2030301	MAD1L1	0.53	5.68	0.54	2.25e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs9815354	0.812	rs57162396	chr3:41896031	G/A	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	trans	rs1814175	0.791	rs10839395	chr11:49846274	G/T	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs9910055	0.593	rs2905983	chr17:42212429	T/G	cg09913183	chr17:42254507	C17orf65;ASB16	-0.68	-6.39	-0.59	1.1e-8	Total body bone mineral density;
SKCM	cis	rs694739	0.726	rs516124	chr11:64128423	G/T	cg02228329	chr11:64053129	BAD;GPR137	0.86	6.52	0.59	6.49e-9	Alopecia areata;Crohn's disease;Psoriasis vulgaris;
SKCM	cis	rs2180341	0.782	rs6912552	chr6:127722946	C/G	cg27446573	chr6:127587934	RNF146	-0.73	-5.64	-0.54	2.63e-7	Breast cancer;
SKCM	cis	rs7829975	0.539	rs4841012	chr8:8551710	C/A	cg06636001	chr8:8085503	FLJ10661	-0.7	-5.1	-0.5	2.36e-6	Mood instability;
SKCM	cis	rs35955841	0.569	rs12437108	chr14:65309550	G/A	cg23373153	chr14:65346875	NA	0.67	4.97	0.49	3.87e-6	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity;
SKCM	cis	rs9916302	0.904	rs8070695	chr17:37478062	C/T	cg07936489	chr17:37558343	FBXL20	0.88	6.75	0.61	2.39e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs9880211	0.800	rs66509730	chr3:136504258	A/C	cg21827317	chr3:136751795	NA	-0.69	-5.28	-0.51	1.13e-6	Body mass index;Height;
SKCM	cis	rs10754283	0.967	rs10801760	chr1:90113824	G/A	cg21401794	chr1:90099060	LRRC8C	0.73	6.34	0.58	1.35e-8	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs2721195	1.000	rs750472	chr8:145701453	A/C	cg15857475	chr8:145742913	RECQL4;LRRC14	-0.86	-7.87	-0.67	1.65e-11	Age at first birth;
SKCM	cis	rs9902453	0.845	rs72823935	chr17:28008595	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.82	5.78	0.55	1.47e-7	Coffee consumption (cups per day);
SKCM	cis	rs9814567	0.806	rs4245904	chr3:134321808	G/A	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.65	-5.19	-0.51	1.6e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs2153535	0.542	rs915354	chr6:8440357	T/C	cg23788917	chr6:8435910	SLC35B3	0.69	5.14	0.5	1.99e-6	Motion sickness;
SKCM	cis	rs7937682	0.924	rs11213968	chr11:111527629	G/C	cg09085632	chr11:111637200	PPP2R1B	-1.05	-11.26	-0.79	5.12e-18	Primary sclerosing cholangitis;
SKCM	cis	rs1843834	0.898	rs2015099	chr2:225519915	T/C	cg22455342	chr2:225449267	CUL3	0.61	4.8	0.48	7.53e-6	IgE levels in asthmatics (D.p. specific);
SKCM	cis	rs7937682	0.575	rs7114617	chr11:111768173	A/T	cg09085632	chr11:111637200	PPP2R1B	1.09	10.45	0.76	1.7e-16	Primary sclerosing cholangitis;
SKCM	cis	rs654950	0.743	rs115951861	chr1:41992488	C/T	cg06885757	chr1:42089581	HIVEP3	-0.64	-7.17	-0.63	3.67e-10	Airway imaging phenotypes;
SKCM	cis	rs28595532	0.764	rs55913633	chr4:119747444	C/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs7103648	0.742	rs34937994	chr11:47389638	C/T	cg20307385	chr11:47447363	PSMC3	0.96	6.92	0.62	1.12e-9	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs2739330	0.796	rs2154594	chr22:24254055	A/G	cg12419862	chr22:24373484	LOC391322	0.62	4.97	0.49	3.95e-6	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs9788682	1.000	rs7164594	chr15:78803057	C/T	cg24631222	chr15:78858424	CHRNA5	0.94	6.26	0.58	1.97e-8	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs1949733	0.917	rs10461079	chr4:8392724	G/A	cg11789530	chr4:8429930	ACOX3	-0.89	-6.79	-0.61	1.95e-9	Response to antineoplastic agents;
SKCM	cis	rs11690935	0.843	rs9784123	chr2:172785005	T/A	cg13550731	chr2:172543902	DYNC1I2	-0.95	-7.86	-0.67	1.72e-11	Schizophrenia;
SKCM	cis	rs11098499	0.954	rs11935596	chr4:120412457	G/C	cg09307838	chr4:120376055	NA	0.99	8.02	0.67	8.7e-12	Corneal astigmatism;
SKCM	cis	rs798554	0.757	rs1713919	chr7:2864706	C/A	cg04166393	chr7:2884313	GNA12	0.71	4.95	0.49	4.22e-6	Height;
SKCM	cis	rs61776719	0.747	rs28428561	chr1:38434306	G/A	cg17077180	chr1:38461687	NA	-0.48	-4.83	-0.48	6.63e-6	Coronary artery disease;
SKCM	cis	rs80130819	0.515	rs1793912	chr12:48387052	A/C	cg05342945	chr12:48394962	COL2A1	-0.7	-4.92	-0.49	4.65e-6	Prostate cancer;
SKCM	cis	rs6879260	1.000	rs1035411	chr5:179729519	A/G	cg13944838	chr5:179740914	GFPT2	-0.73	-5.81	-0.55	1.29e-7	Height;
SKCM	cis	rs2033711	0.902	rs4801589	chr19:58953398	C/G	cg13877915	chr19:58951672	ZNF132	0.95	10.4	0.76	2.17e-16	Uric acid clearance;
SKCM	cis	rs6540556	1.000	rs6540556	chr1:209936631	G/A	cg05527609	chr1:210001259	C1orf107	-0.88	-4.92	-0.49	4.67e-6	Red blood cell count;
SKCM	trans	rs208520	0.690	rs7764570	chr6:66827600	G/C	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-1.07	-8.54	-0.7	8.41e-13	Exhaled nitric oxide output;
SKCM	cis	rs644799	0.965	rs11021305	chr11:95498269	A/G	cg25622487	chr11:95524042	FAM76B;CEP57	0.68	5.56	0.53	3.69e-7	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs41307935	0.722	rs12724052	chr1:27234682	G/A	cg01689405	chr1:26370407	SLC30A2	-0.53	-4.86	-0.48	5.9e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs897984	0.762	rs11150601	chr16:30977799	G/A	cg00531865	chr16:30841666	NA	0.59	4.97	0.49	3.81e-6	Dementia with Lewy bodies;
SKCM	cis	rs2153535	0.580	rs9379206	chr6:8458021	C/A	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs12477438	0.520	rs11123766	chr2:99780915	C/T	cg26064155	chr2:99771622	LIPT1;TSGA10	1.02	9.73	0.74	4.23e-15	Chronic sinus infection;
SKCM	cis	rs9926296	0.533	rs12102297	chr16:89812762	C/A	cg04287289	chr16:89883240	FANCA	1.01	12.78	0.82	8.21e-21	Vitiligo;
SKCM	cis	rs644799	1.000	rs527899	chr11:95529242	T/G	cg25622487	chr11:95524042	FAM76B;CEP57	0.66	5.12	0.5	2.18e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs1799949	0.896	rs8176098	chr17:41268206	A/C	cg23758822	chr17:41437982	NA	0.93	7.82	0.66	2.1e-11	Menopause (age at onset);
SKCM	cis	rs2836974	0.644	rs9978775	chr21:40694526	A/G	cg11644478	chr21:40555479	PSMG1	-0.67	-5.48	-0.53	4.99e-7	Cognitive function;
SKCM	cis	rs72615157	0.716	rs75779608	chr7:99768957	C/T	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.21	8.05	0.67	7.42e-12	Lung function (FEV1/FVC);
SKCM	cis	rs3820928	1.000	rs10210763	chr2:227776029	G/T	cg11843606	chr2:227700838	RHBDD1	-0.64	-5.2	-0.51	1.53e-6	Pulmonary function;
SKCM	cis	rs6121246	0.697	rs7269866	chr20:30232504	G/A	cg11595048	chr20:30225325	COX4I2	0.65	5.19	0.51	1.62e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs4689592	0.513	rs2358718	chr4:7068743	A/C	cg19539972	chr4:7069911	GRPEL1	-0.95	-6.91	-0.62	1.16e-9	Monocyte percentage of white cells;
SKCM	cis	rs28595532	0.920	rs115103359	chr4:119739608	A/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs801193	0.904	rs4718403	chr7:66242729	C/G	cg11764359	chr7:65958608	NA	0.83	6.32	0.58	1.5e-8	Aortic root size;
SKCM	cis	rs55962025	0.711	rs362319	chr4:3224933	T/G	cg16987761	chr4:3318072	RGS12	-0.6	-4.83	-0.48	6.61e-6	Parental longevity (mother's age at death);
SKCM	cis	rs9467773	1.000	rs6940188	chr6:26562029	G/C	cg15659132	chr6:26577336	NA	0.6	5.71	0.54	1.99e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs2404602	0.552	rs11630185	chr15:76959783	A/T	cg23625390	chr15:77176239	SCAPER	-0.86	-8.0	-0.67	9.21e-12	Blood metabolite levels;
SKCM	cis	rs55962025	0.804	rs362268	chr4:3242148	C/G	cg00764545	chr4:3318001	RGS12	-0.74	-6.0	-0.56	5.76e-8	Parental longevity (mother's age at death);
SKCM	cis	rs1801251	1.000	rs6717841	chr2:233590255	C/T	cg08000102	chr2:233561755	GIGYF2	0.89	6.95	0.62	9.95e-10	Coronary artery disease;
SKCM	cis	rs7552404	0.924	rs7544117	chr1:76158246	A/G	cg03433033	chr1:76189801	ACADM	0.78	5.67	0.54	2.36e-7	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs3771570	0.892	rs55751610	chr2:242346057	C/T	cg07612300	chr2:242033426	MTERFD2;SNED1	0.87	4.77	0.47	8.54e-6	Prostate cancer;
SKCM	cis	rs12497850	0.931	rs13064784	chr3:49135961	C/G	cg07636037	chr3:49044803	WDR6	1.06	11.54	0.79	1.54e-18	Parkinson's disease;
SKCM	cis	rs2739330	0.791	rs4822458	chr22:24265659	C/T	cg25703541	chr22:24373054	LOC391322	-0.78	-6.41	-0.59	1.02e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	trans	rs66573146	1.000	rs6812391	chr4:6963893	G/A	cg07817883	chr1:32538562	TMEM39B	2.0	8.02	0.67	8.59e-12	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs3784262	0.669	rs4646595	chr15:58302341	C/T	cg12031962	chr15:58353849	ALDH1A2	-0.42	-4.89	-0.48	5.38e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs34779708	0.931	rs34815241	chr10:35296676	T/C	cg03585969	chr10:35415529	CREM	0.73	6.02	0.56	5.38e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs763121	0.853	rs8142098	chr22:39058757	T/G	cg06022373	chr22:39101656	GTPBP1	0.74	5.24	0.51	1.35e-6	Menopause (age at onset);
SKCM	cis	rs2070488	0.965	rs4679060	chr3:38536261	T/C	cg01465620	chr3:38496096	LOC100128640;ACVR2B	-0.98	-9.25	-0.72	3.55e-14	Electrocardiographic conduction measures;
SKCM	cis	rs7811142	0.775	rs6946768	chr7:99954393	G/A	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.19	7.5	0.65	8.66e-11	Platelet count;
SKCM	cis	rs7829975	0.560	rs6994131	chr8:8550958	G/A	cg15556689	chr8:8085844	FLJ10661	-0.69	-5.24	-0.51	1.35e-6	Mood instability;
SKCM	cis	rs2816062	0.813	rs2816050	chr1:18894432	A/G	cg18795169	chr1:18902165	NA	-0.83	-9.02	-0.71	1.01e-13	Urate levels in lean individuals;
SKCM	cis	rs12709013	0.766	rs1657175	chr16:58789431	G/A	cg02431531	chr16:59244939	NA	0.49	5.13	0.5	2.07e-6	Blood metabolite ratios;
SKCM	cis	rs589448	0.902	rs315138	chr12:69764850	A/T	cg20891283	chr12:69753455	YEATS4	0.98	9.89	0.75	2.06e-15	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs995000	0.931	rs642845	chr1:62908235	T/C	cg06896770	chr1:63153194	DOCK7	0.76	7.24	0.63	2.71e-10	Triglyceride levels;
SKCM	cis	rs55962025	0.711	rs916171	chr4:3216815	C/G	cg16987761	chr4:3318072	RGS12	0.61	4.91	0.49	4.93e-6	Parental longevity (mother's age at death);
SKCM	cis	rs35306767	0.903	rs12250937	chr10:900209	C/T	cg25614935	chr10:1084866	C10orf110	0.78	5.09	0.5	2.42e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs5769765	0.730	rs62233964	chr22:50317410	C/G	cg22709217	chr22:50311962	ALG12;CRELD2	-0.97	-5.83	-0.55	1.18e-7	Schizophrenia;
SKCM	cis	rs13256369	0.851	rs13249700	chr8:8563637	C/T	cg15556689	chr8:8085844	FLJ10661	0.65	4.77	0.48	8.39e-6	Obesity-related traits;
SKCM	cis	rs8180040	0.726	rs4078466	chr3:47126543	C/T	cg27129171	chr3:47204927	SETD2	0.82	6.49	0.59	7.26e-9	Colorectal cancer;
SKCM	cis	rs9682041	0.740	rs6444929	chr3:170150076	C/T	cg11886554	chr3:170076028	SKIL	0.89	5.25	0.51	1.27e-6	Glomerular filtration rate in non diabetics (creatinine);Glomerular filtration rate (creatinine);
SKCM	cis	rs1552244	0.938	rs34750074	chr3:10091740	G/A	cg02579736	chr3:10068473	FANCD2;CIDECP	1.22	6.91	0.62	1.15e-9	Alzheimer's disease;
SKCM	cis	rs362296	0.698	rs362282	chr4:3259671	G/A	cg24015175	chr4:3319247	RGS12	-0.65	-5.94	-0.56	7.49e-8	Parental longevity (mother's age at death);
SKCM	cis	rs58785573	0.504	rs9522	chr4:38666972	C/T	cg18361445	chr4:38666374	KLF3;FLJ13197	0.63	5.04	0.5	2.96e-6	Lymphocyte percentage of white cells;
SKCM	cis	rs362296	0.698	rs3095082	chr4:3263617	C/A	cg05297308	chr4:3317976	RGS12	-0.74	-6.57	-0.6	5.2e-9	Parental longevity (mother's age at death);
SKCM	cis	rs9300255	0.602	rs1402274	chr12:123686224	T/C	cg00376283	chr12:123451042	ABCB9	0.83	5.49	0.53	4.74e-7	Neutrophil percentage of white cells;
SKCM	trans	rs1814175	0.817	rs12277258	chr11:49940216	T/C	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs28595532	0.920	rs116098781	chr4:119771613	G/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs763014	0.833	rs3743904	chr16:632767	A/G	cg09263875	chr16:632152	PIGQ	0.67	5.82	0.55	1.24e-7	Height;
SKCM	cis	rs2032447	0.714	rs199725	chr6:25953684	A/G	cg18357526	chr6:26021779	HIST1H4A	0.71	5.51	0.53	4.39e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs9399135	0.660	rs4472368	chr6:135274232	A/G	cg24558204	chr6:135376177	HBS1L	0.66	5.63	0.54	2.7e-7	Red blood cell count;
SKCM	cis	rs72781680	0.898	rs12623079	chr2:24103749	G/A	cg08917208	chr2:24149416	ATAD2B	1.0	5.41	0.52	6.82e-7	Lymphocyte counts;
SKCM	cis	rs10876993	0.890	rs115106209	chr12:58059331	G/A	cg18357645	chr12:58087776	OS9	0.61	5.65	0.54	2.52e-7	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs4975616	0.869	rs31484	chr5:1337906	A/T	cg07493874	chr5:1342172	CLPTM1L	-0.67	-6.23	-0.58	2.17e-8	Lung cancer;
SKCM	cis	rs3820068	0.581	rs12385690	chr1:15932932	A/T	cg24675056	chr1:15929824	NA	0.75	5.4	0.52	7.03e-7	Systolic blood pressure;
SKCM	cis	rs1865760	0.663	rs9467656	chr6:25993559	G/A	cg16482183	chr6:26056742	HIST1H1C	0.62	4.96	0.49	3.97e-6	Height;
SKCM	cis	rs394563	0.591	rs237029	chr6:149717425	A/G	cg03678062	chr6:149772716	ZC3H12D	-0.52	-6.14	-0.57	3.3e-8	Dupuytren's disease;
SKCM	cis	rs10504229	0.689	rs17801390	chr8:58054768	T/C	cg02725872	chr8:58115012	NA	-0.54	-5.04	-0.5	2.97e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs9300255	0.602	rs6488864	chr12:123618362	G/C	cg00376283	chr12:123451042	ABCB9	0.8	5.4	0.52	6.99e-7	Neutrophil percentage of white cells;
SKCM	cis	rs7666738	0.791	rs6840669	chr4:99016020	G/T	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs8177253	0.761	rs12490148	chr3:133523973	C/T	cg16414030	chr3:133502952	NA	-0.72	-5.97	-0.56	6.59e-8	Iron status biomarkers;
SKCM	cis	rs10131894	0.611	rs175000	chr14:75436367	T/C	cg08847533	chr14:75593920	NEK9	-0.67	-4.85	-0.48	6.2e-6	Coronary artery disease;
SKCM	cis	rs9911578	1.000	rs8067571	chr17:56868856	C/T	cg12560992	chr17:57184187	TRIM37	0.95	7.69	0.66	3.7e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs854765	0.619	rs6502636	chr17:17983817	A/T	cg04398451	chr17:18023971	MYO15A	-1.02	-8.72	-0.7	3.81e-13	Total body bone mineral density;
SKCM	cis	rs2120019	0.508	rs8030528	chr15:75171825	C/T	cg09165964	chr15:75287851	SCAMP5	-0.78	-5.76	-0.55	1.6e-7	Blood trace element (Zn levels);
SKCM	cis	rs12478296	1.000	rs57603292	chr2:243028537	G/A	cg06360820	chr2:242988706	NA	-1.0	-5.16	-0.5	1.83e-6	Obesity-related traits;
SKCM	cis	rs1949733	1.000	rs2140337	chr4:8502112	A/G	cg11789530	chr4:8429930	ACOX3	0.81	5.8	0.55	1.36e-7	Response to antineoplastic agents;
SKCM	cis	rs4819052	0.959	rs8130866	chr21:46672112	G/A	cg19498844	chr21:46707878	POFUT2;LOC642852	0.87	6.8	0.61	1.88e-9	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs636523	0.561	rs12130333	chr1:63191777	A/G	cg06896770	chr1:63153194	DOCK7	-0.76	-5.19	-0.51	1.6e-6	Lipid traits;
SKCM	cis	rs864745	0.600	rs849335	chr7:28223990	T/C	cg15170557	chr7:28214983	JAZF1	-0.53	-4.95	-0.49	4.18e-6	Crohn's disease;Type 2 diabetes;
SKCM	cis	rs9467773	1.000	rs9467791	chr6:26562486	A/G	cg15659132	chr6:26577336	NA	-0.6	-5.68	-0.54	2.19e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs4771122	0.728	rs1475221	chr13:28037566	C/T	cg22138327	chr13:27999177	GTF3A	-0.89	-6.46	-0.59	8.08e-9	Body mass index;
SKCM	cis	rs4924935	0.851	rs12936834	chr17:18807078	A/G	cg26378065	chr17:18585709	ZNF286B	0.83	5.58	0.53	3.36e-7	Pancreatic cancer;
SKCM	cis	rs9899728	0.539	rs56267297	chr17:73046996	T/C	cg27626185	chr17:73056755	KCTD2	-1.22	-7.67	-0.66	4.17e-11	Alzheimer's disease or small vessel stroke;
SKCM	cis	rs801193	1.000	rs2707845	chr7:66198798	C/T	cg18876405	chr7:65276391	NA	0.8	7.11	0.63	4.88e-10	Aortic root size;
SKCM	cis	rs2013441	1.000	rs34712254	chr17:20049308	C/T	cg13482628	chr17:19912719	NA	0.67	5.25	0.51	1.28e-6	Obesity-related traits;
SKCM	cis	rs801193	1.000	rs10234018	chr7:66146284	A/T	cg11764359	chr7:65958608	NA	-0.87	-6.56	-0.6	5.44e-9	Aortic root size;
SKCM	cis	rs28386778	0.799	rs2584612	chr17:61932204	A/G	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.12	11.27	0.79	4.92e-18	Prudent dietary pattern;
SKCM	cis	rs1046896	0.553	rs72634343	chr17:80827392	T/C	cg02711726	chr17:80685570	FN3KRP	-0.79	-5.95	-0.56	7.17e-8	Glycated hemoglobin levels;
SKCM	cis	rs4073582	0.595	rs708471	chr11:65931008	A/G	cg14036092	chr11:66035641	RAB1B	0.74	5.8	0.55	1.34e-7	Gout;
SKCM	cis	rs11760633	0.502	rs36020539	chr7:1823203	A/T	cg02825527	chr7:2087843	MAD1L1	-0.66	-5.01	-0.49	3.32e-6	Coronary artery disease;
SKCM	cis	rs1862618	0.853	rs10051747	chr5:56083289	C/A	cg12311346	chr5:56204834	C5orf35	-0.76	-4.94	-0.49	4.3e-6	Initial pursuit acceleration;
SKCM	cis	rs8072100	0.967	rs3760370	chr17:45695832	C/T	cg08085267	chr17:45401833	C17orf57	0.61	5.49	0.53	4.77e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs1799949	0.965	rs4793233	chr17:41435437	G/C	cg23758822	chr17:41437982	NA	0.95	7.99	0.67	9.76e-12	Menopause (age at onset);
SKCM	cis	rs72615157	0.628	rs7801070	chr7:99847147	T/G	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.16	7.13	0.63	4.52e-10	Lung function (FEV1/FVC);
SKCM	cis	rs870825	0.616	rs4437299	chr4:185643223	T/A	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs798554	0.723	rs798518	chr7:2777825	A/G	cg04166393	chr7:2884313	GNA12	0.7	4.85	0.48	6.15e-6	Height;
SKCM	cis	rs2014572	0.967	rs11084492	chr19:57756026	A/T	cg24459738	chr19:57751996	ZNF805	-0.64	-5.29	-0.51	1.1e-6	Hyperactive-impulsive symptoms;
SKCM	cis	rs7772486	0.875	rs9373483	chr6:146364194	A/G	cg23711669	chr6:146136114	FBXO30	0.78	7.48	0.65	9.35e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2806561	0.704	rs2746560	chr1:23526279	G/A	cg12483005	chr1:23474871	LUZP1	0.69	5.33	0.52	9.17e-7	Height;
SKCM	cis	rs7618501	0.633	rs12485600	chr3:50025530	A/G	cg24110177	chr3:50126178	RBM5	-0.6	-5.11	-0.5	2.25e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs56235845	0.694	rs4976643	chr5:176760227	A/C	cg06060754	chr5:176797920	RGS14	0.67	6.4	0.59	1.08e-8	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs875971	0.929	rs10950041	chr7:65973875	T/C	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	cis	rs6840360	0.533	rs11099829	chr4:152727299	A/G	cg22705602	chr4:152727874	NA	0.58	7.11	0.63	4.83e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs1577917	0.958	rs66807489	chr6:86440702	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.79	-7.75	-0.66	2.89e-11	Response to antipsychotic treatment;
SKCM	cis	rs7539542	0.556	rs6686801	chr1:202874730	C/T	cg19681188	chr1:202830198	LOC148709	0.79	5.54	0.53	3.93e-7	Mean platelet volume;
SKCM	cis	rs17376456	1.000	rs6867042	chr5:93555761	C/T	cg25358565	chr5:93447407	FAM172A	1.27	7.86	0.66	1.78e-11	Diabetic retinopathy;
SKCM	cis	rs1577917	0.958	rs12198876	chr6:86525476	C/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.68	-5.91	-0.56	8.36e-8	Response to antipsychotic treatment;
SKCM	cis	rs4665809	0.531	rs10199898	chr2:26445485	T/G	cg26119090	chr2:26468346	HADHA;HADHB	-1.06	-8.39	-0.69	1.66e-12	Gut microbiome composition (summer);
SKCM	cis	rs3741404	0.825	rs60452247	chr11:63981507	G/A	cg19465662	chr11:63993652	NUDT22;TRPT1	0.81	6.02	0.56	5.35e-8	Platelet count;
SKCM	cis	rs478304	0.651	rs11604462	chr11:65551648	G/A	cg27068330	chr11:65405492	SIPA1	-0.92	-8.24	-0.68	3.29e-12	Acne (severe);
SKCM	cis	rs6138458	1.000	rs227627	chr20:24912107	T/C	cg26195577	chr20:24973756	C20orf3	1.29	8.69	0.7	4.32e-13	Blood protein levels;
SKCM	cis	rs8180040	0.805	rs17410853	chr3:47363971	G/T	cg27129171	chr3:47204927	SETD2	-0.82	-5.67	-0.54	2.32e-7	Colorectal cancer;
SKCM	cis	rs6840360	0.571	rs2407069	chr4:152533201	G/A	cg22705602	chr4:152727874	NA	-0.52	-5.69	-0.54	2.15e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs1218582	0.772	rs11264282	chr1:154867370	G/A	cg16680214	chr1:154839983	KCNN3	-0.56	-4.97	-0.49	3.87e-6	Prostate cancer;
SKCM	cis	rs2739330	0.828	rs2330635	chr22:24251344	T/C	cg12419862	chr22:24373484	LOC391322	-0.64	-5.5	-0.53	4.66e-7	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs1348850	0.914	rs4893823	chr2:178285811	C/T	cg02961200	chr2:178257176	LOC100130691;AGPS	-0.82	-6.08	-0.57	4.16e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs7937682	0.924	rs6589244	chr11:111534333	T/C	cg09085632	chr11:111637200	PPP2R1B	-1.03	-11.65	-0.8	9.4e-19	Primary sclerosing cholangitis;
SKCM	cis	rs7772486	0.875	rs6914813	chr6:146397798	A/G	cg05347473	chr6:146136440	FBXO30	0.63	5.81	0.55	1.31e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6500395	0.584	rs8059077	chr16:48742029	T/C	cg04672837	chr16:48644449	N4BP1	0.74	5.16	0.5	1.87e-6	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs208520	0.608	rs3846803	chr6:66805743	C/A	cg07460842	chr6:66804631	NA	-1.02	-7.51	-0.65	8.37e-11	Exhaled nitric oxide output;
SKCM	cis	rs2980439	0.783	rs2948305	chr8:8098577	G/A	cg06636001	chr8:8085503	FLJ10661	0.99	8.95	0.71	1.38e-13	Neuroticism;
SKCM	cis	rs561341	1.000	rs117979353	chr17:30272866	A/G	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs116095464	0.558	rs62344345	chr5:257420	C/T	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs2730245	0.510	rs2788471	chr7:158649786	G/T	cg24397884	chr7:158709396	WDR60	0.68	5.28	0.51	1.13e-6	Height;
SKCM	trans	rs1814175	0.647	rs10769646	chr11:49992204	C/A	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs796364	0.951	rs13029537	chr2:200998950	T/C	cg12253985	chr2:200820533	C2orf60;C2orf47	-0.98	-6.28	-0.58	1.82e-8	Schizophrenia;
SKCM	cis	rs875971	1.000	rs778685	chr7:65836176	G/T	cg18876405	chr7:65276391	NA	0.68	6.79	0.61	2.01e-9	Aortic root size;
SKCM	cis	rs9857592	1.000	rs9857592	chr3:16845144	T/A	cg17339521	chr3:16555597	RFTN1	0.56	4.87	0.48	5.71e-6	Neuroticism;
SKCM	cis	rs1577917	0.920	rs1337842	chr6:86675097	G/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.67	-5.86	-0.55	1.07e-7	Response to antipsychotic treatment;
SKCM	cis	rs3785574	0.924	rs2584641	chr17:61862889	A/G	cg06601766	chr17:61851465	DDX42;CCDC47	0.68	5.02	0.49	3.15e-6	Height;
SKCM	cis	rs1403694	0.695	rs11927941	chr3:186433046	A/G	cg09332604	chr3:186435400	KNG1	-0.49	-4.85	-0.48	6.09e-6	Blood protein levels;
SKCM	cis	rs60871478	0.947	rs4074610	chr7:791755	G/A	cg04727924	chr7:799746	HEATR2	-0.6	-4.8	-0.48	7.39e-6	Cerebrospinal P-tau181p levels;
SKCM	cis	rs116095464	0.614	rs78905930	chr5:246560	G/A	cg22496380	chr5:211416	CCDC127	-0.89	-4.92	-0.49	4.78e-6	Breast cancer;
SKCM	cis	rs561341	0.825	rs2008368	chr17:30347397	T/C	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs1059312	1.000	rs7135987	chr12:129280117	G/A	cg09035930	chr12:129282057	SLC15A4	0.8	8.41	0.69	1.52e-12	Systemic lupus erythematosus;
SKCM	cis	rs6933660	0.676	rs3757316	chr6:151774339	A/G	cg10883421	chr6:151773342	RMND1;C6orf211	-0.92	-7.48	-0.65	9.58e-11	Menarche (age at onset);
SKCM	cis	rs7772486	0.754	rs6570708	chr6:145989428	C/T	cg05347473	chr6:146136440	FBXO30	-0.61	-5.57	-0.53	3.45e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs763014	0.898	rs2017567	chr16:637212	T/C	cg00908189	chr16:619842	PIGQ	0.82	7.78	0.66	2.55e-11	Height;
SKCM	cis	rs17685	0.697	rs2302437	chr7:75677016	G/A	cg16489192	chr7:75678113	MDH2;STYXL1	0.58	5.44	0.52	5.83e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs4481887	0.790	rs4526648	chr1:248422503	A/T	cg00666640	chr1:248458726	OR2T12	-0.63	-5.53	-0.53	4.08e-7	Common traits (Other);
SKCM	cis	rs875971	0.861	rs801215	chr7:66011938	A/T	cg18876405	chr7:65276391	NA	-0.61	-6.03	-0.56	5.23e-8	Aortic root size;
SKCM	cis	rs4523957	0.786	rs59428454	chr17:2114063	T/A	cg16513277	chr17:2031491	SMG6	-0.7	-4.86	-0.48	5.99e-6	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs6489882	0.902	rs3759376	chr12:113373563	A/G	cg07232103	chr12:112566177	TRAFD1	0.6	4.9	0.48	5.14e-6	Chronic lymphocytic leukemia;
SKCM	cis	rs870825	0.556	rs6552811	chr4:185653351	T/A	cg04058563	chr4:185651563	MLF1IP	-1.07	-7.16	-0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs13223928	0.536	rs12700594	chr7:3156701	G/A	cg19214707	chr7:3157722	NA	0.51	4.8	0.48	7.64e-6	Eosinophil percentage of white cells;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil counts;
SKCM	cis	rs7843479	0.601	rs727693	chr8:21850116	A/G	cg17168535	chr8:21777572	XPO7	0.82	8.03	0.67	8.32e-12	Mean corpuscular volume;
SKCM	cis	rs9640161	0.750	rs3735167	chr7:150039555	C/T	cg10018233	chr7:150070692	REPIN1	0.69	5.61	0.54	2.98e-7	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs10751667	0.643	rs6597970	chr11:928669	C/A	cg06064525	chr11:970664	AP2A2	-0.55	-5.09	-0.5	2.46e-6	Alzheimer's disease (late onset);
SKCM	cis	rs514406	0.505	rs431459	chr1:53183230	T/G	cg16325326	chr1:53192061	ZYG11B	0.89	10.06	0.75	9.55e-16	Monocyte count;
SKCM	cis	rs9902453	0.904	rs4375718	chr17:28363642	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.82	-6.4	-0.59	1.06e-8	Coffee consumption (cups per day);
SKCM	cis	rs1153858	1.000	rs10444821	chr15:45647236	C/T	cg21132104	chr15:45694354	SPATA5L1	0.92	7.81	0.66	2.22e-11	Homoarginine levels;
SKCM	cis	rs6570726	0.791	rs407887	chr6:145843759	C/T	cg05347473	chr6:146136440	FBXO30	0.54	4.9	0.49	5.07e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7149337	1.000	rs4261445	chr14:51723540	G/A	cg23942311	chr14:51606299	NA	0.51	5.48	0.53	5.11e-7	Cancer;
SKCM	cis	rs10193935	0.892	rs12612372	chr2:42414035	A/G	cg27598129	chr2:42591480	NA	-0.91	-6.64	-0.6	3.8e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6430585	0.528	rs309161	chr2:136688749	A/G	cg07169764	chr2:136633963	MCM6	-1.19	-10.13	-0.75	7.19e-16	Corneal structure;
SKCM	cis	rs9303401	0.659	rs34468504	chr17:56648277	C/T	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.27	0.51	1.17e-6	Cognitive test performance;
SKCM	cis	rs7584330	0.868	rs67071074	chr2:238395429	T/C	cg14458575	chr2:238380390	NA	1.02	6.39	0.59	1.14e-8	Prostate cancer;
SKCM	cis	rs4808199	0.895	rs4808196	chr19:19476520	G/A	cg03709012	chr19:19516395	GATAD2A	1.11	8.37	0.69	1.82e-12	Nonalcoholic fatty liver disease;
SKCM	cis	rs2120019	0.938	rs8036573	chr15:75308690	C/T	cg09165964	chr15:75287851	SCAMP5	-0.83	-7.83	-0.66	2e-11	Blood trace element (Zn levels);
SKCM	cis	rs1153858	1.000	rs56850226	chr15:45633118	T/C	cg21132104	chr15:45694354	SPATA5L1	0.92	8.33	0.69	2.14e-12	Homoarginine levels;
SKCM	cis	rs8180040	0.900	rs4858894	chr3:47484953	C/G	cg16586182	chr3:47516702	SCAP	-0.76	-5.32	-0.52	9.63e-7	Colorectal cancer;
SKCM	cis	rs2836974	0.681	rs8128827	chr21:40710547	C/T	cg17971929	chr21:40555470	PSMG1	0.84	7.77	0.66	2.65e-11	Cognitive function;
SKCM	cis	rs7980687	0.628	rs2102949	chr12:123676763	G/A	cg00376283	chr12:123451042	ABCB9	0.86	6.55	0.6	5.68e-9	Height;Educational attainment;Head circumference (infant);
SKCM	cis	rs1577917	0.958	rs2100109	chr6:86544926	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.81	-7.82	-0.66	2.07e-11	Response to antipsychotic treatment;
SKCM	cis	rs2228479	0.764	rs7184960	chr16:89961661	C/T	cg06558623	chr16:89946397	TCF25	1.22	7.35	0.64	1.68e-10	Skin colour saturation;
SKCM	cis	rs6088580	0.634	rs6120669	chr20:33105028	T/C	cg24642439	chr20:33292090	TP53INP2	0.76	6.02	0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs1552244	1.000	rs6442150	chr3:10122575	T/C	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs2841277	0.771	rs2819469	chr14:105394859	G/A	cg21017887	chr14:105400489	NA	-0.6	-5.47	-0.53	5.24e-7	Rheumatoid arthritis;
SKCM	cis	rs60871478	1.000	rs62432253	chr7:802928	A/G	cg05535760	chr7:792225	HEATR2	1.17	10.16	0.75	6.17e-16	Cerebrospinal P-tau181p levels;
SKCM	cis	rs10927875	0.526	rs35340817	chr1:16178917	T/C	cg21385522	chr1:16154831	NA	-0.99	-8.07	-0.67	6.74e-12	Dilated cardiomyopathy;
SKCM	cis	rs12824058	0.831	rs4759657	chr12:130815818	G/A	cg24838063	chr12:130822603	PIWIL1	0.78	6.99	0.62	8.22e-10	Menopause (age at onset);
SKCM	cis	rs4803468	1.000	rs3810174	chr19:41904165	C/T	cg09537434	chr19:41945824	ATP5SL	-1.08	-13.01	-0.83	3.1e-21	Height;
SKCM	cis	rs6732795	0.858	rs10189815	chr2:69414496	C/T	cg12784598	chr2:69240042	ANTXR1	-0.72	-5.36	-0.52	8.28e-7	Intraocular pressure;
SKCM	cis	rs36093844	0.527	rs17745105	chr11:85712437	T/C	cg25872744	chr11:85566296	CCDC83	-0.81	-4.79	-0.48	7.84e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs2153535	0.580	rs2143354	chr6:8517907	G/A	cg07606381	chr6:8435919	SLC35B3	0.87	6.38	0.59	1.17e-8	Motion sickness;
SKCM	cis	rs936229	0.690	rs2472300	chr15:75033909	A/G	cg14664628	chr15:75095509	CSK	-1.13	-9.33	-0.73	2.51e-14	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin);
SKCM	cis	rs66569888	0.789	rs17213078	chr2:106734065	G/A	cg15412446	chr2:106886593	NA	-0.72	-5.04	-0.5	2.93e-6	Facial morphology (factor 23);
SKCM	cis	rs11098499	0.564	rs11098507	chr4:120288286	G/A	cg24375607	chr4:120327624	NA	0.62	4.77	0.48	8.45e-6	Corneal astigmatism;
SKCM	cis	rs854765	0.547	rs2955384	chr17:17939573	C/T	cg04398451	chr17:18023971	MYO15A	-0.91	-7.4	-0.64	1.33e-10	Total body bone mineral density;
SKCM	cis	rs2243480	0.908	rs1532573	chr7:65798802	A/G	cg18252515	chr7:66147081	NA	1.34	8.18	0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs6424115	0.830	rs3003333	chr1:24194014	A/T	cg10978503	chr1:24200527	CNR2	-0.41	-4.99	-0.49	3.64e-6	Immature fraction of reticulocytes;
SKCM	cis	rs9581857	0.547	rs17753121	chr13:28052613	T/C	cg22138327	chr13:27999177	GTF3A	0.93	6.24	0.58	2.11e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs6762477	0.715	rs12631337	chr3:50198537	A/G	cg24110177	chr3:50126178	RBM5	0.57	4.77	0.48	8.27e-6	Menarche (age at onset);
SKCM	cis	rs4400599	0.549	rs12044616	chr1:154189417	G/A	cg26808167	chr1:154192205	UBAP2L;C1orf43	-0.52	-4.82	-0.48	6.84e-6	Platelet distribution width;
SKCM	cis	rs208520	0.837	rs208509	chr6:66941706	A/G	cg07460842	chr6:66804631	NA	-1.07	-7.41	-0.64	1.32e-10	Exhaled nitric oxide output;
SKCM	cis	rs7584330	0.697	rs9287620	chr2:238368730	C/T	cg14458575	chr2:238380390	NA	1.04	6.92	0.62	1.13e-9	Prostate cancer;
SKCM	cis	rs9911578	0.967	rs7502208	chr17:57165097	G/A	cg12560992	chr17:57184187	TRIM37	1.06	10.05	0.75	1.01e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs11139399	0.676	rs56331531	chr9:84347849	C/G	cg13729285	chr9:84764156	NA	0.49	5.15	0.5	1.9e-6	Hippocampal atrophy;
SKCM	cis	rs116095464	0.558	rs114607464	chr5:300468	C/T	cg22857025	chr5:266934	NA	-1.47	-7.51	-0.65	8.47e-11	Breast cancer;
SKCM	cis	rs763014	0.931	rs3752567	chr16:628130	A/G	cg09263875	chr16:632152	PIGQ	0.67	5.82	0.55	1.22e-7	Height;
SKCM	cis	rs6933660	0.646	rs9397410	chr6:151770503	C/T	cg14262678	chr6:151773367	RMND1;C6orf211	0.72	5.84	0.55	1.16e-7	Menarche (age at onset);
SKCM	cis	rs12762955	0.561	rs6560863	chr10:1013535	C/A	cg20503657	chr10:835505	NA	-0.71	-5.78	-0.55	1.45e-7	Response to angiotensin II receptor blocker therapy;
SKCM	cis	rs2075371	0.829	rs1993058	chr7:133930361	G/A	cg20476274	chr7:133979776	SLC35B4	0.95	9.07	0.72	8.01e-14	Mean platelet volume;
SKCM	cis	rs3087591	0.960	rs4795593	chr17:29613600	G/C	cg24425628	chr17:29625626	OMG;NF1	-0.64	-5.08	-0.5	2.48e-6	Hip circumference;
SKCM	cis	rs1325195	0.537	rs1325194	chr1:179071918	G/T	cg25467746	chr1:179556597	NA	-0.67	-6.12	-0.57	3.45e-8	IgE grass sensitization;
SKCM	cis	rs12478296	0.901	rs9653611	chr2:243006956	C/G	cg06360820	chr2:242988706	NA	-1.01	-5.89	-0.55	9.29e-8	Obesity-related traits;
SKCM	cis	rs28595532	0.623	rs56324414	chr4:119274655	A/C	cg11846333	chr4:119757529	SEC24D	1.06	6.0	0.56	5.8e-8	Cannabis dependence symptom count;
SKCM	cis	rs4466137	0.953	rs6869030	chr5:83007311	C/T	cg16102102	chr5:83017553	HAPLN1	-0.5	-5.49	-0.53	4.94e-7	Prostate cancer;
SKCM	cis	rs9796	0.553	rs2925343	chr15:41306493	T/C	cg18705301	chr15:41695430	NDUFAF1	0.68	5.42	0.52	6.49e-7	Menopause (age at onset);
SKCM	cis	rs55962025	0.842	rs362271	chr4:3235518	C/T	cg00764545	chr4:3318001	RGS12	-0.73	-5.8	-0.55	1.34e-7	Parental longevity (mother's age at death);
SKCM	cis	rs2777491	0.668	rs2026946	chr15:41789704	G/A	cg18705301	chr15:41695430	NDUFAF1	-1.02	-10.17	-0.75	6.03e-16	Ulcerative colitis;
SKCM	cis	rs9583531	0.600	rs9555724	chr13:111354110	C/T	cg15841412	chr13:111365552	ING1	-0.7	-4.78	-0.48	8.15e-6	Coronary artery disease;
SKCM	cis	rs6570726	0.764	rs76635693	chr6:145834070	T/C	cg05347473	chr6:146136440	FBXO30	0.53	4.78	0.48	8.07e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs13010713	0.840	rs12615545	chr2:182048452	T/C	cg21995919	chr2:182322279	ITGA4	-0.51	-5.04	-0.5	2.97e-6	Celiac disease;
SKCM	cis	rs1029738	0.659	rs1608553	chr7:22896231	G/C	cg00626422	chr7:22894849	SNORD93	-0.61	-5.28	-0.51	1.14e-6	Fibrinogen levels;
SKCM	cis	rs55962025	0.711	rs362319	chr4:3224933	T/G	cg00764545	chr4:3318001	RGS12	-0.62	-5.4	-0.52	7.08e-7	Parental longevity (mother's age at death);
SKCM	cis	rs875971	0.543	rs801191	chr7:66032955	G/A	cg18876405	chr7:65276391	NA	-0.78	-6.84	-0.61	1.57e-9	Aortic root size;
SKCM	cis	rs9790314	1.000	rs336593	chr3:161076431	T/C	cg03342759	chr3:160939853	NMD3	-0.72	-7.89	-0.67	1.53e-11	Morning vs. evening chronotype;
SKCM	cis	rs9880211	0.948	rs13316214	chr3:136158221	A/G	cg21827317	chr3:136751795	NA	-0.64	-4.78	-0.48	8.21e-6	Body mass index;Height;
SKCM	cis	rs2228479	0.717	rs2286392	chr16:89809549	A/G	cg00800038	chr16:89945340	TCF25	-0.85	-4.99	-0.49	3.65e-6	Skin colour saturation;
SKCM	cis	rs7811142	0.779	rs28680963	chr7:99905475	C/G	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.06	6.05	0.56	4.82e-8	Platelet count;
SKCM	cis	rs2295499	0.744	rs2282768	chr4:2716147	A/C	cg19433769	chr4:2420260	ZFYVE28	0.69	4.77	0.48	8.44e-6	Cognitive ability;Cognitive ability (multi-trait analysis);Intelligence (multi-trait analysis);
SKCM	cis	rs1799949	0.773	rs2137990	chr17:41317896	T/A	cg05368731	chr17:41323189	NBR1	-0.89	-7.67	-0.66	4.09e-11	Menopause (age at onset);
SKCM	cis	rs16854884	0.632	rs35716467	chr3:143684993	C/A	cg06585982	chr3:143692056	C3orf58	0.84	8.2	0.68	3.88e-12	Economic and political preferences (feminism/equality);
SKCM	cis	rs2463822	0.764	rs7125402	chr11:62097259	C/T	cg06239285	chr11:62104954	ASRGL1	1.27	6.04	0.56	4.98e-8	Chronic obstructive pulmonary disease-related biomarkers;
SKCM	cis	rs9902453	0.874	rs7213517	chr17:28401740	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.82	-6.4	-0.59	1.06e-8	Coffee consumption (cups per day);
SKCM	cis	rs2180341	0.618	rs12529077	chr6:127634244	G/T	cg27446573	chr6:127587934	RNF146	0.69	5.45	0.52	5.76e-7	Breast cancer;
SKCM	cis	rs7666738	0.830	rs3857217	chr4:99034347	T/C	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11098499	0.913	rs56122576	chr4:120129336	A/G	cg09307838	chr4:120376055	NA	0.88	6.32	0.58	1.52e-8	Corneal astigmatism;
SKCM	cis	rs11690935	0.959	rs2674484	chr2:172574612	G/A	cg13550731	chr2:172543902	DYNC1I2	-0.95	-8.21	-0.68	3.64e-12	Schizophrenia;
SKCM	cis	rs2239547	0.603	rs12489490	chr3:53064022	C/A	cg11645453	chr3:52864694	ITIH4	0.66	5.33	0.52	9.37e-7	Schizophrenia;
SKCM	cis	rs9912468	0.933	rs12944131	chr17:64307611	C/A	cg19474267	chr17:64306194	PRKCA	0.67	5.71	0.54	1.92e-7	QRS duration;QRS complex (12-leadsum);QRS complex (Sokolow-Lyon);
SKCM	cis	rs2811415	0.597	rs9824536	chr3:127763956	C/A	cg09089421	chr3:127803668	RUVBL1	0.99	8.52	0.69	9.09e-13	Lung function (FEV1/FVC);
SKCM	trans	rs3749237	0.964	rs10865959	chr3:49891002	G/C	cg21659725	chr3:3221576	CRBN	1.02	7.4	0.64	1.36e-10	Resting heart rate;
SKCM	cis	rs116095464	0.558	rs6878087	chr5:223117	C/T	cg22496380	chr5:211416	CCDC127	0.95	5.43	0.52	6.27e-7	Breast cancer;
SKCM	cis	rs71636778	0.543	rs71636796	chr1:27243095	T/C	cg01689405	chr1:26370407	SLC30A2	-0.52	-4.79	-0.48	7.94e-6	Monocyte percentage of white cells;Granulocyte percentage of myeloid white cells;
SKCM	cis	rs8014204	0.836	rs12888998	chr14:75292662	G/T	cg06637938	chr14:75390232	RPS6KL1	0.83	6.65	0.6	3.64e-9	Caffeine consumption;
SKCM	cis	rs2836974	0.836	rs1041440	chr21:40627325	C/T	cg11890956	chr21:40555474	PSMG1	1.09	13.83	0.84	1.08e-22	Cognitive function;
SKCM	cis	rs17685	0.712	rs10235738	chr7:75773460	G/A	cg01364799	chr7:75623366	TMEM120A	-0.65	-5.06	-0.5	2.73e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs131777	0.547	rs131753	chr22:51022862	A/G	cg25309564	chr22:51001381	C22orf41	0.77	5.16	0.5	1.83e-6	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs6835098	0.692	rs6553679	chr4:174072292	C/T	cg08422745	chr4:174089978	GALNT7	-0.85	-7.05	-0.62	6.23e-10	Dementia and core Alzheimer's disease neuropathologic changes;
SKCM	cis	rs1552244	0.882	rs6443276	chr3:10008905	C/A	cg02579736	chr3:10068473	FANCD2;CIDECP	0.94	4.84	0.48	6.49e-6	Alzheimer's disease;
SKCM	cis	rs1005277	0.522	rs289645	chr10:37943642	T/C	cg00409905	chr10:38381863	ZNF37A	-0.58	-5.4	-0.52	6.87e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs947211	0.948	rs863725	chr1:205751196	C/T	cg07157834	chr1:205819609	PM20D1	0.64	4.84	0.48	6.52e-6	Parkinson's disease;
SKCM	cis	rs2153535	0.580	rs2327053	chr6:8443127	A/G	cg07606381	chr6:8435919	SLC35B3	0.96	6.98	0.62	8.76e-10	Motion sickness;
SKCM	cis	rs7945705	0.967	rs10840147	chr11:8920704	A/G	cg13070366	chr11:9386451	NA	-0.66	-5.72	-0.54	1.89e-7	Hemoglobin concentration;
SKCM	cis	rs10503709	0.861	rs10113189	chr8:21448263	T/C	cg23716449	chr8:21608280	GFRA2	0.52	5.32	0.52	9.7e-7	Blood protein levels;
SKCM	cis	rs7666738	0.830	rs7667796	chr4:99071415	G/T	cg05340658	chr4:99064831	C4orf37	-0.65	-4.92	-0.49	4.7e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9300255	0.639	rs1716171	chr12:123716376	C/T	cg05973401	chr12:123451056	ABCB9	0.82	5.31	0.51	1.02e-6	Neutrophil percentage of white cells;
SKCM	cis	rs7666738	0.830	rs6532724	chr4:99060993	C/T	cg05340658	chr4:99064831	C4orf37	0.66	4.87	0.48	5.74e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7666738	0.753	rs10029372	chr4:98859002	T/C	cg17366294	chr4:99064904	C4orf37	0.56	4.87	0.48	5.62e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs362296	0.698	rs362266	chr4:3259632	C/G	cg21096898	chr4:3318625	RGS12	-0.79	-7.29	-0.64	2.19e-10	Parental longevity (mother's age at death);
SKCM	cis	rs875971	0.660	rs1860470	chr7:66103694	G/C	cg11764359	chr7:65958608	NA	-0.84	-6.37	-0.59	1.2e-8	Aortic root size;
SKCM	cis	rs5760092	0.755	rs11090298	chr22:24262061	G/A	cg04234412	chr22:24373322	LOC391322	0.73	5.61	0.54	2.92e-7	Urinary 1,3-butadiene metabolite levels in smokers;
SKCM	cis	rs40363	0.645	rs4786421	chr16:3522303	A/G	cg22508957	chr16:3507546	NAT15	-0.57	-4.92	-0.49	4.73e-6	Tuberculosis;
SKCM	cis	rs1801251	0.964	rs7589201	chr2:233724536	A/G	cg08000102	chr2:233561755	GIGYF2	-0.85	-6.98	-0.62	8.73e-10	Coronary artery disease;
SKCM	cis	rs9393692	0.557	rs56763414	chr6:26286468	T/C	cg13736514	chr6:26305472	NA	-0.66	-5.01	-0.49	3.32e-6	Educational attainment;
SKCM	cis	rs7772486	0.806	rs4075695	chr6:146250959	A/G	cg05347473	chr6:146136440	FBXO30	-0.54	-4.86	-0.48	6.05e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs12706411	1.000	rs11973627	chr7:122056001	A/G	cg17986181	chr7:121955208	NA	0.67	5.13	0.5	2.04e-6	Alzheimer disease and age of onset;
SKCM	cis	rs2839186	0.900	rs59828751	chr21:47708918	A/G	cg05896524	chr21:47604654	C21orf56	0.69	5.67	0.54	2.29e-7	Testicular germ cell tumor;
SKCM	cis	rs1580019	0.885	rs3801331	chr7:32497039	A/G	cg06627557	chr7:32535165	LSM5;AVL9	-0.76	-5.62	-0.54	2.81e-7	Cognitive ability;
SKCM	cis	rs7208859	0.623	rs56163556	chr17:29101868	G/C	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs208520	0.690	rs12201219	chr6:66748862	A/T	cg07460842	chr6:66804631	NA	0.9	7.2	0.63	3.26e-10	Exhaled nitric oxide output;
SKCM	cis	rs2404602	0.692	rs66866130	chr15:77128574	T/C	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs919433	0.963	rs1366837	chr2:198160501	T/C	cg04278110	chr2:198063759	ANKRD44	-0.72	-5.33	-0.52	9.25e-7	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs9399135	0.967	rs6908512	chr6:135367757	A/G	cg24558204	chr6:135376177	HBS1L	0.57	5.01	0.49	3.34e-6	Red blood cell count;
SKCM	cis	rs936229	0.511	rs12591513	chr15:75102714	G/A	cg14664628	chr15:75095509	CSK	-0.93	-6.98	-0.62	8.62e-10	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin);
SKCM	cis	rs4968361	0.892	rs68025251	chr17:57519432	G/A	cg02573089	chr17:57233042	PRR11;SKA2	1.2	5.27	0.51	1.18e-6	Schizophrenia;
SKCM	cis	rs7618915	0.571	rs6805539	chr3:52609710	T/A	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs1005277	0.557	rs1854563	chr10:38434961	G/A	cg00409905	chr10:38381863	ZNF37A	-0.67	-6.21	-0.58	2.41e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs7927771	0.524	rs7129797	chr11:47667167	G/C	cg20307385	chr11:47447363	PSMC3	0.71	5.63	0.54	2.67e-7	Subjective well-being;
SKCM	cis	rs6921919	0.583	rs1124131	chr6:28380248	A/C	cg14547644	chr6:28411285	ZSCAN23	-0.58	-4.8	-0.48	7.46e-6	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs7811142	1.000	rs11771419	chr7:99988403	A/G	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.11	6.45	0.59	8.66e-9	Platelet count;
SKCM	cis	rs4919694	1.000	rs12245779	chr10:104645944	C/A	cg04362960	chr10:104952993	NT5C2	0.78	4.81	0.48	7.27e-6	Arsenic metabolism;
SKCM	cis	rs4771122	0.740	rs1006353	chr13:28047269	A/G	cg22138327	chr13:27999177	GTF3A	-0.72	-5.42	-0.52	6.41e-7	Body mass index;
SKCM	cis	rs10876993	0.855	rs1689601	chr12:58049557	G/A	cg18357645	chr12:58087776	OS9	0.61	5.65	0.54	2.52e-7	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs11731606	0.712	rs28502775	chr4:95401945	A/G	cg20625393	chr4:95128694	SMARCAD1	0.98	4.85	0.48	6.27e-6	Mean platelet volume;
SKCM	cis	rs2404602	0.735	rs2280306	chr15:76652258	C/G	cg23625390	chr15:77176239	SCAPER	-0.8	-7.41	-0.64	1.3100000000000001e-10	Blood metabolite levels;
SKCM	cis	rs6942756	1.000	rs7806089	chr7:128972215	C/G	cg02491457	chr7:128862824	NA	-0.86	-5.48	-0.53	5.11e-7	White matter hyperintensity burden;
SKCM	cis	rs6942756	1.000	rs7780886	chr7:128879347	G/A	cg02491457	chr7:128862824	NA	-0.76	-4.84	-0.48	6.51e-6	White matter hyperintensity burden;
SKCM	cis	rs7954584	0.531	rs10840631	chr12:122373729	C/T	cg01765077	chr12:122356316	WDR66	0.44	4.79	0.48	7.71e-6	Mean corpuscular volume;
SKCM	cis	rs12824058	0.831	rs4759452	chr12:130812799	G/A	cg24838063	chr12:130822603	PIWIL1	0.78	6.91	0.62	1.19e-9	Menopause (age at onset);
SKCM	cis	rs7605378	0.528	rs1704190	chr2:200760629	G/A	cg23649088	chr2:200775458	C2orf69	0.67	5.31	0.52	9.99e-7	Osteoporosis;
SKCM	cis	rs453301	0.624	rs2979256	chr8:8871710	C/T	cg15556689	chr8:8085844	FLJ10661	0.74	5.54	0.53	4.01e-7	Joint mobility (Beighton score);
SKCM	cis	rs1799949	0.773	rs2137990	chr17:41317896	T/A	cg23758822	chr17:41437982	NA	-0.93	-7.65	-0.65	4.5e-11	Menopause (age at onset);
SKCM	cis	rs28386778	0.897	rs2036911	chr17:61794839	A/T	cg06873352	chr17:61820015	STRADA	0.75	6.24	0.58	2.1e-8	Prudent dietary pattern;
SKCM	cis	rs9910055	0.659	rs186603	chr17:42207884	C/T	cg13607699	chr17:42295918	UBTF	-0.71	-5.54	-0.53	3.89e-7	Total body bone mineral density;
SKCM	cis	rs28386778	0.863	rs2251164	chr17:61884120	G/A	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs1801251	1.000	rs7578299	chr2:233573469	G/T	cg25237894	chr2:233734115	C2orf82	0.61	5.66	0.54	2.39e-7	Coronary artery disease;
SKCM	cis	rs2836950	0.545	rs4818001	chr21:40575088	T/C	cg11644478	chr21:40555479	PSMG1	-0.63	-4.84	-0.48	6.44e-6	Menarche (age at onset);
SKCM	cis	rs9790314	0.905	rs6441370	chr3:160993754	C/T	cg03342759	chr3:160939853	NMD3	-0.73	-8.2	-0.68	3.89e-12	Morning vs. evening chronotype;
SKCM	cis	rs8030485	0.536	rs1915724	chr15:79441027	A/G	cg10259521	chr15:79428573	NA	-0.49	-5.12	-0.5	2.12e-6	Left ventricle wall thickness;
SKCM	cis	rs7666738	0.753	rs11097594	chr4:98944486	A/G	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6724607	1.000	rs6434402	chr2:191469322	C/T	cg27211696	chr2:191398769	TMEM194B	-0.8	-6.53	-0.59	6.07e-9	Pulse pressure;
SKCM	cis	rs1218582	0.772	rs4240875	chr1:154885782	G/A	cg16680214	chr1:154839983	KCNN3	-0.56	-5.01	-0.49	3.29e-6	Prostate cancer;
SKCM	cis	rs7106204	0.513	rs7131112	chr11:24249402	A/G	ch.11.24196551F	chr11:24239977	NA	0.76	5.99	0.56	6.16e-8	Response to Homoharringtonine (cytotoxicity);
SKCM	cis	rs854765	0.506	rs7210400	chr17:17949957	C/T	cg04398451	chr17:18023971	MYO15A	0.84	6.78	0.61	2.05e-9	Total body bone mineral density;
SKCM	cis	rs2180341	0.960	rs7766802	chr6:127709871	T/G	cg27446573	chr6:127587934	RNF146	0.9	7.59	0.65	5.96e-11	Breast cancer;
SKCM	cis	rs801193	0.904	rs4718403	chr7:66242729	C/G	cg00343986	chr7:65444356	GUSB	0.68	5.04	0.5	2.99e-6	Aortic root size;
SKCM	cis	rs4642101	0.793	rs12714880	chr3:12832101	G/A	cg05775895	chr3:12838266	CAND2	0.62	5.45	0.53	5.72e-7	QRS complex (12-leadsum);
SKCM	cis	rs634534	0.622	rs501353	chr11:65739549	T/G	cg26695010	chr11:65641043	EFEMP2	-0.65	-5.32	-0.52	9.77e-7	Sum eosinophil basophil counts;Eosinophil counts;
SKCM	cis	rs1153858	1.000	rs12593230	chr15:45646968	A/T	cg10760299	chr15:45669010	GATM	0.62	6.33	0.58	1.42e-8	Homoarginine levels;
SKCM	cis	rs2839186	0.868	rs2839199	chr21:47708269	T/C	cg13126279	chr21:47581558	C21orf56	-0.64	-5.47	-0.53	5.17e-7	Testicular germ cell tumor;
SKCM	cis	rs13118159	0.641	rs4974598	chr4:1313220	C/T	cg20887711	chr4:1340912	KIAA1530	0.7	5.24	0.51	1.32e-6	Longevity;
SKCM	cis	rs3091242	0.933	rs34933589	chr1:25788198	T/C	cg27572855	chr1:25598939	RHD	-0.55	-5.19	-0.51	1.61e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs7215564	0.818	rs34754307	chr17:78652758	C/G	cg16980736	chr17:78789706	RPTOR	-0.91	-4.92	-0.49	4.67e-6	Myopia (pathological);
SKCM	cis	rs6089584	0.507	rs28545731	chr20:60634102	C/T	cg16423285	chr20:60520624	NA	-0.62	-5.39	-0.52	7.38e-7	Body mass index;
SKCM	cis	rs651907	0.967	rs641432	chr3:101587566	C/T	cg12386194	chr3:101231763	SENP7	0.64	4.97	0.49	3.92e-6	Colorectal cancer;
SKCM	cis	rs2204008	0.805	rs11522896	chr12:38234427	T/C	cg26384229	chr12:38710491	ALG10B	0.87	6.9	0.62	1.21e-9	Bladder cancer;
SKCM	cis	rs10540	1.000	rs61877760	chr11:506596	C/T	cg03576123	chr11:487126	PTDSS2	-1.48	-8.41	-0.69	1.51e-12	Body mass index;
SKCM	cis	rs8014204	0.868	rs2230237	chr14:75359670	G/A	cg06637938	chr14:75390232	RPS6KL1	-0.78	-6.05	-0.57	4.66e-8	Caffeine consumption;
SKCM	cis	rs6582630	0.537	rs66855609	chr12:38299029	T/C	cg26384229	chr12:38710491	ALG10B	0.78	6.57	0.6	5.13e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs2836974	0.568	rs2836969	chr21:40648265	G/A	cg17971929	chr21:40555470	PSMG1	-0.76	-7.17	-0.63	3.67e-10	Cognitive function;
SKCM	cis	rs9790314	0.936	rs7629987	chr3:161002023	A/C	cg03342759	chr3:160939853	NMD3	-0.72	-7.89	-0.67	1.53e-11	Morning vs. evening chronotype;
SKCM	cis	rs1801251	0.963	rs7591176	chr2:233581803	C/A	cg08000102	chr2:233561755	GIGYF2	0.89	6.91	0.62	1.15e-9	Coronary artery disease;
SKCM	cis	rs2072510	0.722	rs2247309	chr12:96424542	T/C	cg18817487	chr12:96390143	HAL	0.43	5.68	0.54	2.18e-7	Metabolite levels (small molecules and protein measures);
SKCM	cis	rs11690935	0.959	rs10184866	chr2:172608956	T/G	cg13550731	chr2:172543902	DYNC1I2	-0.94	-7.87	-0.67	1.65e-11	Schizophrenia;
SKCM	cis	rs7940866	0.834	rs10791108	chr11:130849354	T/A	cg12179176	chr11:130786555	SNX19	0.79	6.04	0.56	4.84e-8	Schizophrenia;
SKCM	cis	rs826838	0.654	rs7977738	chr12:38722460	G/A	cg26384229	chr12:38710491	ALG10B	0.78	6.71	0.61	2.77e-9	Heart rate;
SKCM	cis	rs6430585	0.528	rs16832440	chr2:136754183	G/A	cg07169764	chr2:136633963	MCM6	1.31	11.43	0.79	2.42e-18	Corneal structure;
SKCM	cis	rs1046896	0.594	rs4075209	chr17:80800027	G/T	cg02711726	chr17:80685570	FN3KRP	-0.75	-5.61	-0.54	2.96e-7	Glycated hemoglobin levels;
SKCM	cis	rs60871478	0.704	rs62432895	chr7:822050	C/G	cg05535760	chr7:792225	HEATR2	1.02	8.66	0.7	4.97e-13	Cerebrospinal P-tau181p levels;
SKCM	cis	rs8180040	0.726	rs61729713	chr3:47027192	A/G	cg27129171	chr3:47204927	SETD2	-0.83	-6.19	-0.57	2.6e-8	Colorectal cancer;
SKCM	cis	rs1005277	0.579	rs2474608	chr10:38457109	C/T	cg25427524	chr10:38739819	LOC399744	-0.71	-6.71	-0.61	2.75e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs1348850	0.539	rs1453371	chr2:178227862	T/G	cg02961200	chr2:178257176	LOC100130691;AGPS	0.69	5.0	0.49	3.42e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs912057	0.833	rs1294424	chr6:6744135	G/A	cg06612196	chr6:6737390	NA	0.58	4.91	0.49	4.81e-6	Waist-to-hip ratio adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);
SKCM	cis	rs6570726	0.791	rs9403729	chr6:145907007	C/T	cg23711669	chr6:146136114	FBXO30	0.88	8.32	0.69	2.28e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs28595532	0.841	rs115924581	chr4:119786333	T/C	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs3820068	0.581	rs67806552	chr1:15927138	T/C	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs9467773	0.967	rs6932865	chr6:26540166	C/A	cg09904177	chr6:26538194	HMGN4	0.54	4.98	0.49	3.78e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7917772	0.503	rs7068535	chr10:104349127	C/T	cg11453585	chr10:104263688	ACTR1A;SUFU	0.75	5.96	0.56	6.78e-8	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs151997	0.853	rs6882235	chr5:50260139	T/C	cg06027927	chr5:50259733	NA	0.68	6.11	0.57	3.7e-8	Callous-unemotional behaviour;
SKCM	cis	rs55962025	0.883	rs59613878	chr4:3139152	C/T	cg21096898	chr4:3318625	RGS12	-0.76	-5.9	-0.56	8.82e-8	Parental longevity (mother's age at death);
SKCM	cis	rs875971	0.789	rs7808013	chr7:66071196	A/G	cg18876405	chr7:65276391	NA	-0.63	-6.32	-0.58	1.5e-8	Aortic root size;
SKCM	cis	rs6489882	0.867	rs4766673	chr12:113365161	C/T	cg07232103	chr12:112566177	TRAFD1	-0.61	-4.84	-0.48	6.34e-6	Chronic lymphocytic leukemia;
SKCM	cis	rs1577917	1.000	rs12213149	chr6:86668644	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.85	-8.62	-0.7	5.82e-13	Response to antipsychotic treatment;
SKCM	cis	rs2439831	0.702	rs28699233	chr15:44122866	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.36	7.78	0.66	2.56e-11	Lung cancer in ever smokers;
SKCM	cis	rs4803468	1.000	rs11670757	chr19:41913431	G/T	cg14132834	chr19:41945861	ATP5SL	-0.77	-6.08	-0.57	4.18e-8	Height;
SKCM	cis	rs1577917	0.655	rs2842605	chr6:86335150	A/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.11	-0.5	2.24e-6	Response to antipsychotic treatment;
SKCM	cis	rs899997	1.000	rs899997	chr15:79019578	G/T	cg04896959	chr15:78267971	NA	0.6	5.3	0.51	1.04e-6	Coronary artery disease or large artery stroke;
SKCM	cis	rs2839186	0.770	rs2839984	chr21:47671690	A/G	cg05896524	chr21:47604654	C21orf56	0.71	5.78	0.55	1.49e-7	Testicular germ cell tumor;
SKCM	cis	rs28595532	0.920	rs28538455	chr4:119486817	T/C	cg21605333	chr4:119757512	SEC24D	1.24	7.1	0.63	5.16e-10	Cannabis dependence symptom count;
SKCM	cis	rs12477438	0.520	rs12621007	chr2:99791946	G/C	cg26064155	chr2:99771622	LIPT1;TSGA10	1.0	9.07	0.72	7.87e-14	Chronic sinus infection;
SKCM	cis	rs992157	0.560	rs7578940	chr2:219083318	G/T	cg00012203	chr2:219082015	ARPC2	-0.77	-6.29	-0.58	1.73e-8	Colorectal cancer;
SKCM	cis	rs362296	0.698	rs362279	chr4:3260072	G/A	cg24015175	chr4:3319247	RGS12	-0.67	-6.2	-0.57	2.46e-8	Parental longevity (mother's age at death);
SKCM	cis	rs2559856	1.000	rs2695299	chr12:102082664	G/A	cg12924262	chr12:102091054	CHPT1	0.71	5.71	0.54	1.97e-7	Blood protein levels;
SKCM	cis	rs7772486	0.727	rs6941429	chr6:145952283	G/A	cg23711669	chr6:146136114	FBXO30	0.93	10.47	0.76	1.56e-16	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs12541335	0.639	rs4565458	chr8:22154133	T/C	cg09517075	chr8:22133004	PIWIL2	0.58	5.22	0.51	1.42e-6	Hypertriglyceridemia;
SKCM	cis	rs3847687	1.000	rs11061291	chr12:131518875	C/T	cg25772418	chr12:131519998	GPR133	-0.5	-4.9	-0.49	5.01e-6	Longevity;
SKCM	cis	rs28595532	0.920	rs116205107	chr4:119730910	G/A	cg11846333	chr4:119757529	SEC24D	1.2	6.43	0.59	9.38e-9	Cannabis dependence symptom count;
SKCM	cis	rs8037137	0.749	rs12594925	chr15:91520287	G/A	cg15878949	chr15:91534302	PRC1	0.67	5.12	0.5	2.11e-6	Platelet count;Serous invasive ovarian cancer;High-grade serous ovarian cancer;Invasive epithelial ovarian cancer;
SKCM	cis	rs9467773	1.000	rs9467779	chr6:26536687	A/T	cg09904177	chr6:26538194	HMGN4	-0.54	-4.95	-0.49	4.15e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs66573146	1.000	rs55913461	chr4:7017509	C/T	cg00086871	chr4:6988644	TBC1D14	1.44	5.37	0.52	8.04e-7	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs727563	0.635	rs5751149	chr22:42139501	A/G	cg03806693	chr22:41940476	POLR3H	1.15	7.18	0.63	3.65e-10	Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs2645694	0.626	rs904050	chr4:77826089	T/G	cg03477792	chr4:77819574	ANKRD56	0.57	6.42	0.59	9.57e-9	Emphysema distribution in smoking;
SKCM	cis	rs62238980	0.614	rs117692225	chr22:32421806	A/G	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs7666738	0.830	rs1869082	chr4:98841254	T/A	cg17366294	chr4:99064904	C4orf37	0.56	4.89	0.48	5.25e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs748404	0.631	rs4296223	chr15:43645246	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	0.84	6.38	0.59	1.17e-8	Lung cancer;
SKCM	cis	rs4065321	0.522	rs11078930	chr17:38141955	C/T	cg17467752	chr17:38218738	THRA	-0.74	-6.2	-0.57	2.47e-8	White blood cell count (basophil);White blood cell count;
SKCM	cis	rs514406	0.727	rs61768342	chr1:53217028	G/A	cg24675658	chr1:53192096	ZYG11B	0.61	4.77	0.48	8.47e-6	Monocyte count;
SKCM	cis	rs2153535	0.580	rs7341201	chr6:8470270	T/C	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs12586317	0.620	rs8020370	chr14:35581432	G/A	cg16230307	chr14:35515116	FAM177A1	0.7	5.18	0.51	1.67e-6	Psoriasis;
SKCM	cis	rs9894429	1.000	rs12948099	chr17:79600799	C/G	cg18240062	chr17:79603768	NPLOC4	0.77	7.57	0.65	6.42e-11	Eye color traits;
SKCM	cis	rs6138458	0.816	rs2151463	chr20:24911819	A/C	cg26195577	chr20:24973756	C20orf3	1.29	8.69	0.7	4.32e-13	Blood protein levels;
SKCM	cis	rs7659604	0.605	rs2071486	chr4:122740162	C/T	cg06713675	chr4:122721982	EXOSC9	-0.74	-7.38	-0.64	1.51e-10	Type 2 diabetes;
SKCM	cis	rs11098499	0.954	rs28429722	chr4:120300093	G/A	cg24375607	chr4:120327624	NA	0.65	4.97	0.49	3.87e-6	Corneal astigmatism;
SKCM	cis	rs8072100	0.738	rs3736438	chr17:45486651	T/G	cg08085267	chr17:45401833	C17orf57	-0.62	-5.06	-0.5	2.76e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs9910055	0.509	rs9916444	chr17:42313512	C/G	cg09913183	chr17:42254507	C17orf65;ASB16	0.6	5.25	0.51	1.3e-6	Total body bone mineral density;
SKCM	cis	rs2070488	0.965	rs2284819	chr3:38557161	C/T	cg01465620	chr3:38496096	LOC100128640;ACVR2B	1.0	8.8	0.71	2.61e-13	Electrocardiographic conduction measures;
SKCM	cis	rs9905704	0.647	rs11659035	chr17:56966052	C/T	cg05425664	chr17:57184151	TRIM37	-0.61	-4.86	-0.48	5.91e-6	Testicular germ cell tumor;
SKCM	cis	rs1018836	0.884	rs9643307	chr8:91625257	A/C	cg16814680	chr8:91681699	NA	-0.62	-4.83	-0.48	6.67e-6	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs11931598	0.511	rs35772786	chr4:7021211	T/G	cg04207632	chr4:6986609	TBC1D14	-0.53	-4.95	-0.49	4.12e-6	Sum basophil neutrophil counts;Sum neutrophil eosinophil counts;Granulocyte count;Neutrophil count;Myeloid white cell count;
SKCM	cis	rs951366	0.789	rs823094	chr1:205689807	G/T	cg14159672	chr1:205819179	PM20D1	-0.76	-6.01	-0.56	5.64e-8	Menarche (age at onset);
SKCM	cis	rs10089	1.000	rs4836363	chr5:127462737	G/C	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.91	8.89	0.71	1.79e-13	Ileal carcinoids;
SKCM	cis	rs2760061	0.766	rs947631	chr1:228223547	G/C	cg18477163	chr1:228402036	OBSCN	0.52	6.44	0.59	8.91e-9	Diastolic blood pressure;
SKCM	cis	rs6840360	0.554	rs13108359	chr4:152727852	T/C	cg22705602	chr4:152727874	NA	0.57	7.63	0.65	4.94e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs155076	1.000	rs261431	chr13:21865738	A/G	cg11317459	chr13:21872234	NA	1.29	7.61	0.65	5.39e-11	White matter hyperintensity burden;
SKCM	cis	rs875971	0.660	rs10229345	chr7:65982168	G/C	cg18876405	chr7:65276391	NA	0.79	7.17	0.63	3.72e-10	Aortic root size;
SKCM	cis	rs929354	1.000	rs1182391	chr7:157038368	T/C	cg17757837	chr7:157058334	UBE3C	-0.91	-7.08	-0.63	5.55e-10	Body mass index;
SKCM	cis	rs9858038	0.683	rs1566705	chr3:182749756	C/T	cg06384952	chr3:183602746	PARL	0.7	4.86	0.48	5.98e-6	Parkinson's disease;
SKCM	cis	rs875971	0.830	rs427973	chr7:65526648	C/A	cg11764359	chr7:65958608	NA	0.9	8.21	0.68	3.63e-12	Aortic root size;
SKCM	cis	rs2731664	0.660	rs2545799	chr5:176852186	T/G	cg23176889	chr5:176863531	GRK6	-0.51	-5.2	-0.51	1.58e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1348850	0.526	rs4243389	chr2:178379783	G/C	cg27490568	chr2:178487706	NA	0.89	6.76	0.61	2.23e-9	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs3768617	0.510	rs10752895	chr1:183068505	C/G	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs6570726	0.935	rs415590	chr6:145851244	T/C	cg23711669	chr6:146136114	FBXO30	0.7	6.71	0.61	2.78e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2228479	0.867	rs57940434	chr16:89975496	G/A	cg00800038	chr16:89945340	TCF25	-0.94	-5.51	-0.53	4.53e-7	Skin colour saturation;
SKCM	cis	rs2295499	0.515	rs762856	chr4:2746898	C/T	cg19433769	chr4:2420260	ZFYVE28	0.68	4.92	0.49	4.77e-6	Cognitive ability;Cognitive ability (multi-trait analysis);Intelligence (multi-trait analysis);
SKCM	cis	rs6430585	0.583	rs11886852	chr2:136589379	G/A	cg07169764	chr2:136633963	MCM6	1.27	11.72	0.8	6.96e-19	Corneal structure;
SKCM	cis	rs1801251	0.928	rs737028	chr2:233640750	T/C	cg08000102	chr2:233561755	GIGYF2	0.9	7.28	0.64	2.26e-10	Coronary artery disease;
SKCM	cis	rs7809950	1.000	rs10243340	chr7:107090955	A/G	cg23024343	chr7:107201750	COG5	-0.76	-6.8	-0.61	1.89e-9	Coronary artery disease;
SKCM	cis	rs17376456	0.877	rs13173952	chr5:93307557	A/T	cg21475434	chr5:93447410	FAM172A	1.04	5.55	0.53	3.82e-7	Diabetic retinopathy;
SKCM	cis	rs7000551	0.505	rs73227818	chr8:22243325	T/C	cg12081754	chr8:22256438	SLC39A14	1.03	10.44	0.76	1.84e-16	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs823143	0.570	rs823082	chr1:205786935	C/T	cg23034840	chr1:205782522	SLC41A1	-0.63	-4.88	-0.48	5.6e-6	Monocyte percentage of white cells;
SKCM	cis	rs2594989	0.779	rs2443702	chr3:11586435	C/T	cg00170343	chr3:11313890	ATG7	-0.97	-5.17	-0.5	1.79e-6	Circulating chemerin levels;
SKCM	cis	rs2952156	0.959	rs2517956	chr17:37843859	G/A	cg20243544	chr17:37824526	PNMT	0.69	5.24	0.51	1.33e-6	Asthma;
SKCM	cis	rs1799949	1.000	rs8176133	chr17:41257458	A/C	cg23758822	chr17:41437982	NA	0.92	7.68	0.66	3.96e-11	Menopause (age at onset);
SKCM	cis	rs4481887	0.927	rs6689193	chr1:248482900	T/A	cg00666640	chr1:248458726	OR2T12	0.66	6.0	0.56	5.9e-8	Common traits (Other);
SKCM	cis	rs5769765	0.954	rs5770709	chr22:50245196	G/T	cg22709217	chr22:50311962	ALG12;CRELD2	0.77	5.57	0.53	3.47e-7	Schizophrenia;
SKCM	cis	rs34339938	1	rs34339938	chr12:123678364	GAC/G	cg00376283	chr12:123451042	ABCB9	0.81	5.24	0.51	1.31e-6	Plateletcrit;
SKCM	cis	rs1799949	1.000	rs4793197	chr17:41231902	C/T	cg05368731	chr17:41323189	NBR1	0.88	7.75	0.66	2.84e-11	Menopause (age at onset);
SKCM	cis	rs1577917	1.000	rs12201880	chr6:86627007	G/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.66	-5.74	-0.54	1.76e-7	Response to antipsychotic treatment;
SKCM	cis	rs2228479	0.850	rs11645240	chr16:89837326	T/C	cg06558623	chr16:89946397	TCF25	1.11	5.26	0.51	1.23e-6	Skin colour saturation;
SKCM	cis	rs769267	0.965	rs2905426	chr19:19478022	G/T	cg03709012	chr19:19516395	GATAD2A	-0.9	-8.59	-0.7	6.84e-13	Tonsillectomy;
SKCM	cis	rs60871478	0.947	rs62432255	chr7:804219	G/A	cg05535760	chr7:792225	HEATR2	1.02	8.66	0.7	4.97e-13	Cerebrospinal P-tau181p levels;
SKCM	cis	rs1153858	1.000	rs1365610	chr15:45694610	C/T	cg21132104	chr15:45694354	SPATA5L1	0.89	7.21	0.63	3.12e-10	Homoarginine levels;
SKCM	cis	rs9790314	0.934	rs455386	chr3:161102495	A/T	cg03342759	chr3:160939853	NMD3	-0.71	-7.22	-0.63	2.94e-10	Morning vs. evening chronotype;
SKCM	cis	rs1707322	1.000	rs6675222	chr1:46326576	G/T	cg03146154	chr1:46216737	IPP	0.75	5.15	0.5	1.94e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs55962025	0.883	rs362273	chr4:3227419	A/G	cg05297308	chr4:3317976	RGS12	-0.67	-4.88	-0.48	5.51e-6	Parental longevity (mother's age at death);
SKCM	cis	rs6545883	0.965	rs2305155	chr2:61729258	A/G	cg15711740	chr2:61764176	XPO1	-0.73	-5.27	-0.51	1.19e-6	Tuberculosis;
SKCM	cis	rs875971	0.928	rs6970357	chr7:65968878	T/C	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	cis	rs11608355	0.597	rs12579285	chr12:109832712	T/C	cg19025524	chr12:109796872	NA	-0.66	-5.75	-0.55	1.69e-7	Neuroticism;
SKCM	cis	rs2599510	0.703	rs58852184	chr2:32729763	A/T	cg02381751	chr2:32503542	YIPF4	0.69	5.3	0.51	1.03e-6	Interleukin-18 levels;
SKCM	cis	rs35306767	0.903	rs34270014	chr10:904666	T/C	cg26597838	chr10:835615	NA	0.76	5.33	0.52	9.2e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs2120019	0.638	rs34492112	chr15:75294917	G/A	cg17294928	chr15:75287854	SCAMP5	0.87	8.98	0.71	1.19e-13	Blood trace element (Zn levels);
SKCM	cis	rs9910055	0.659	rs7212573	chr17:42254281	A/G	cg10896456	chr17:42255109	ASB16;C17orf65	0.67	6.93	0.62	1.06e-9	Total body bone mineral density;
SKCM	cis	rs28386778	0.897	rs6504177	chr17:61812655	C/T	cg01411255	chr17:61851458	DDX42;CCDC47	0.79	5.1	0.5	2.35e-6	Prudent dietary pattern;
SKCM	cis	rs2243480	1.000	rs1638734	chr7:66097539	A/C	cg18252515	chr7:66147081	NA	-1.28	-7.69	-0.66	3.69e-11	Diabetic kidney disease;
SKCM	cis	rs2760061	0.598	rs605410	chr1:228116281	A/G	cg02753203	chr1:228287806	NA	-0.62	-4.89	-0.48	5.35e-6	Diastolic blood pressure;
SKCM	cis	rs7666738	0.861	rs28821920	chr4:98962743	T/C	cg17366294	chr4:99064904	C4orf37	0.59	4.89	0.48	5.36e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs875971	0.522	rs709604	chr7:65497434	A/G	cg11987759	chr7:65425863	GUSB	0.76	6.75	0.61	2.34e-9	Aortic root size;
SKCM	cis	rs28595532	0.920	rs114093638	chr4:119729819	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.52	0.53	4.28e-7	Cannabis dependence symptom count;
SKCM	cis	rs6952808	0.823	rs58222895	chr7:1885064	G/A	cg04267008	chr7:1944627	MAD1L1	-0.81	-6.06	-0.57	4.49e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs2153535	0.601	rs9505474	chr6:8539794	C/G	cg07606381	chr6:8435919	SLC35B3	0.91	6.31	0.58	1.56e-8	Motion sickness;
SKCM	cis	rs9818758	0.607	rs35060561	chr3:49255503	T/C	cg24898236	chr3:49228699	LOC646498	0.65	4.98	0.49	3.66e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs6570726	0.935	rs390252	chr6:145856896	A/G	cg23711669	chr6:146136114	FBXO30	0.71	6.8	0.61	1.93e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7020830	0.898	rs2047010	chr9:37077947	A/G	cg14294708	chr9:37120828	ZCCHC7	1.11	9.91	0.75	1.9e-15	Schizophrenia;
SKCM	cis	rs7927771	0.965	rs12787112	chr11:47687147	A/G	cg05585544	chr11:47624801	NA	-0.6	-5.24	-0.51	1.31e-6	Subjective well-being;
SKCM	cis	rs4683346	1.000	rs4683346	chr3:42892961	T/C	cg06399164	chr3:42695035	ZBTB47	0.6	5.46	0.53	5.39e-7	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs4642101	0.597	rs9839769	chr3:12821405	C/T	cg05775895	chr3:12838266	CAND2	0.68	6.16	0.57	2.99e-8	QRS complex (12-leadsum);
SKCM	cis	rs1348850	0.668	rs13010396	chr2:178492934	T/C	cg27490568	chr2:178487706	NA	0.79	5.95	0.56	7.25e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs763121	0.853	rs2076028	chr22:39150450	G/A	cg06022373	chr22:39101656	GTPBP1	0.82	5.1	0.5	2.3e-6	Menopause (age at onset);
SKCM	cis	rs3892630	0.619	rs61062732	chr19:33304717	T/C	cg22980127	chr19:33182716	NUDT19	1.26	7.18	0.63	3.52e-10	Red blood cell traits;
SKCM	cis	rs1160297	0.576	rs1451460	chr2:53088148	C/T	cg07782112	chr2:53107842	NA	0.59	6.26	0.58	1.91e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs35306767	0.953	rs12762973	chr10:960761	C/G	cg20503657	chr10:835505	NA	0.65	4.94	0.49	4.37e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs514406	0.861	rs554760	chr1:53266749	G/A	cg16325326	chr1:53192061	ZYG11B	-0.99	-11.71	-0.8	7.39e-19	Monocyte count;
SKCM	cis	rs155076	0.711	rs4770131	chr13:21897468	A/G	cg11317459	chr13:21872234	NA	1.49	9.52	0.73	1.08e-14	White matter hyperintensity burden;
SKCM	cis	rs67311347	1.000	rs9874006	chr3:40471596	G/A	cg00091569	chr3:40428383	ENTPD3	0.62	5.09	0.5	2.4e-6	Renal cell carcinoma;
SKCM	cis	rs2952156	0.684	rs11658786	chr17:37815899	G/A	cg00129232	chr17:37814104	STARD3	-0.77	-6.36	-0.58	1.27e-8	Asthma;
SKCM	cis	rs2033711	0.870	rs4801270	chr19:58932762	C/A	cg12042659	chr19:58951599	ZNF132	0.68	5.86	0.55	1.04e-7	Uric acid clearance;
SKCM	cis	rs7208859	0.623	rs11657777	chr17:29091785	T/C	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	trans	rs1814175	0.615	rs11040654	chr11:49939485	T/G	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs9926296	0.744	rs154657	chr16:89708096	A/G	cg01097406	chr16:89675127	NA	-0.5	-5.37	-0.52	7.96e-7	Vitiligo;
SKCM	cis	rs9880211	0.613	rs28519617	chr3:135874930	T/G	cg21827317	chr3:136751795	NA	-0.68	-5.3	-0.51	1.05e-6	Body mass index;Height;
SKCM	cis	rs854765	0.647	rs854763	chr17:18010095	C/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.85	6.57	0.6	5.08e-9	Total body bone mineral density;
SKCM	cis	rs2228479	0.850	rs117675822	chr16:89919081	C/A	cg00800038	chr16:89945340	TCF25	-1.0	-5.06	-0.5	2.75e-6	Skin colour saturation;
SKCM	cis	rs4888262	0.507	rs9888976	chr16:74580924	C/T	cg01733217	chr16:74700730	RFWD3	0.89	7.31	0.64	1.98e-10	Testicular germ cell tumor;
SKCM	cis	rs875971	0.660	rs10272357	chr7:66063074	G/A	cg00343986	chr7:65444356	GUSB	-0.68	-4.99	-0.49	3.65e-6	Aortic root size;
SKCM	cis	rs2921073	0.510	rs2976945	chr8:8270871	G/T	cg06636001	chr8:8085503	FLJ10661	0.81	7.01	0.62	7.65e-10	Parkinson's disease;
SKCM	cis	rs644799	0.965	rs545342	chr11:95545369	T/C	cg25622487	chr11:95524042	FAM76B;CEP57	0.66	5.12	0.5	2.18e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs8177253	0.965	rs3811658	chr3:133476852	C/T	cg16414030	chr3:133502952	NA	-0.69	-5.91	-0.56	8.35e-8	Iron status biomarkers;
SKCM	cis	rs12142240	0.698	rs1053627	chr1:46827728	A/C	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs6540556	0.954	rs10863786	chr1:209937764	A/G	cg05527609	chr1:210001259	C1orf107	-0.91	-5.14	-0.5	1.97e-6	Red blood cell count;
SKCM	cis	rs7208859	0.524	rs59913838	chr17:29101563	A/T	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs1218582	0.772	rs2102423	chr1:154916068	A/G	cg03351412	chr1:154909251	PMVK	0.77	6.54	0.6	5.87e-9	Prostate cancer;
SKCM	cis	rs9300255	0.568	rs1047158	chr12:123644056	C/A	cg05973401	chr12:123451056	ABCB9	0.8	5.47	0.53	5.23e-7	Neutrophil percentage of white cells;
SKCM	cis	rs3008870	0.920	rs1925413	chr1:67417101	T/C	cg08660285	chr1:67390436	MIER1;WDR78	0.92	6.05	0.57	4.69e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs9549367	0.713	rs11620600	chr13:113829090	G/A	cg18105134	chr13:113819100	PROZ	-0.91	-6.82	-0.61	1.71e-9	Platelet distribution width;
SKCM	cis	rs4332037	1.000	rs6947019	chr7:1950337	G/A	cg02825527	chr7:2087843	MAD1L1	-0.71	-4.95	-0.49	4.19e-6	Bipolar disorder;
SKCM	cis	rs10781543	0.748	rs68002978	chr9:139325641	C/T	cg14169450	chr9:139327907	INPP5E	0.5	5.53	0.53	4.19e-7	Monocyte percentage of white cells;
SKCM	cis	rs12477438	0.520	rs7572660	chr2:99788582	A/G	cg14399236	chr2:99771627	LIPT1;TSGA10	0.98	8.32	0.69	2.3e-12	Chronic sinus infection;
SKCM	cis	rs66887589	0.934	rs7672519	chr4:120544112	C/T	cg09307838	chr4:120376055	NA	-0.65	-4.82	-0.48	6.89e-6	Diastolic blood pressure;
SKCM	cis	rs4746818	1.000	rs7476357	chr10:70935660	G/A	cg11621586	chr10:70884670	VPS26A	0.93	7.37	0.64	1.52e-10	Left atrial antero-posterior diameter;
SKCM	cis	rs12926788	0.546	rs200537	chr16:24747787	G/C	cg04756594	chr16:24857601	SLC5A11	-0.72	-5.19	-0.51	1.65e-6	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs951366	0.789	rs823095	chr1:205679239	G/A	cg07157834	chr1:205819609	PM20D1	0.73	6.28	0.58	1.75e-8	Menarche (age at onset);
SKCM	cis	rs514406	0.893	rs1242330	chr1:53396842	T/G	cg24675658	chr1:53192096	ZYG11B	-0.67	-5.57	-0.53	3.46e-7	Monocyte count;
SKCM	cis	rs4803468	1.000	rs2241706	chr19:41912807	A/G	cg09537434	chr19:41945824	ATP5SL	-1.1	-13.82	-0.84	1.16e-22	Height;
SKCM	cis	rs867186	1.000	rs56363533	chr20:33626005	G/C	cg04194272	chr20:33683537	NA	-1.38	-7.16	-0.63	3.9e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs2120019	1.000	rs60425110	chr15:75333000	T/A	cg09165964	chr15:75287851	SCAMP5	-0.82	-7.72	-0.66	3.24e-11	Blood trace element (Zn levels);
SKCM	cis	rs8072100	0.576	rs12948299	chr17:45403057	T/C	cg25173405	chr17:45401733	C17orf57	-0.78	-5.98	-0.56	6.34e-8	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs10540	1.000	rs117339389	chr11:505025	T/A	cg03576123	chr11:487126	PTDSS2	-1.43	-8.14	-0.68	5.08e-12	Body mass index;
SKCM	cis	rs9325144	0.600	rs61931871	chr12:38829889	G/A	cg26384229	chr12:38710491	ALG10B	-0.74	-6.4	-0.59	1.05e-8	Morning vs. evening chronotype;
SKCM	cis	rs7786877	0.679	rs10953301	chr7:100264893	A/G	cg20848291	chr7:100343083	ZAN	-0.69	-5.35	-0.52	8.59e-7	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs2730245	0.527	rs2788470	chr7:158649801	G/T	cg24397884	chr7:158709396	WDR60	0.99	5.61	0.54	2.97e-7	Height;
SKCM	cis	rs6089584	0.566	rs7274240	chr20:60622004	C/T	cg06108461	chr20:60628389	TAF4	-0.7	-6.32	-0.58	1.52e-8	Body mass index;
SKCM	cis	rs28595532	0.920	rs115530096	chr4:119760512	T/G	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs9300255	0.722	rs10773008	chr12:123800820	A/G	cg05973401	chr12:123451056	ABCB9	0.82	5.72	0.54	1.92e-7	Neutrophil percentage of white cells;
SKCM	cis	rs2070488	0.775	rs6599207	chr3:38554901	T/C	cg01465620	chr3:38496096	LOC100128640;ACVR2B	-0.74	-5.88	-0.55	9.48e-8	Electrocardiographic conduction measures;
SKCM	cis	rs1801251	1.000	rs2675971	chr2:233726154	A/G	cg08000102	chr2:233561755	GIGYF2	-0.89	-7.15	-0.63	4.05e-10	Coronary artery disease;
SKCM	cis	rs1165205	0.558	rs531750	chr6:25882642	C/G	cg12310025	chr6:25882481	NA	-0.69	-7.12	-0.63	4.69e-10	Urate levels;
SKCM	cis	rs6547631	0.622	rs4240200	chr2:85925529	A/G	cg24620635	chr2:85921963	GNLY	0.9	6.4	0.59	1.06e-8	Blood protein levels;
SKCM	cis	rs992157	0.710	rs10169718	chr2:219103580	C/T	cg00012203	chr2:219082015	ARPC2	-0.86	-7.65	-0.65	4.49e-11	Colorectal cancer;
SKCM	cis	rs1405130	0.869	rs13020275	chr2:235566099	C/T	cg17841421	chr2:235704848	NA	-0.57	-4.95	-0.49	4.14e-6	Coronary artery disease;
SKCM	cis	rs7659604	0.628	rs3828485	chr4:122722368	G/A	cg19748678	chr4:122722346	EXOSC9	0.72	6.24	0.58	2.1e-8	Type 2 diabetes;
SKCM	cis	rs72717009	0.825	rs7539468	chr1:161477066	G/A	cg23840854	chr1:161414152	NA	-0.99	-5.66	-0.54	2.44e-7	Rheumatoid arthritis;
SKCM	cis	rs4803468	0.967	rs4605279	chr19:41888131	C/G	cg09537434	chr19:41945824	ATP5SL	-1.08	-13.01	-0.83	3.1e-21	Height;
SKCM	cis	rs870825	0.655	rs7675046	chr4:185652201	G/A	cg04058563	chr4:185651563	MLF1IP	-1.07	-7.16	-0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs2905347	0.529	rs2961292	chr7:22683137	C/T	cg00394316	chr7:22539822	MGC87042	-0.45	-4.77	-0.48	8.45e-6	Major depression and alcohol dependence;
SKCM	cis	rs9430161	0.611	rs34032547	chr1:11034374	C/G	cg02454025	chr1:11042201	C1orf127	1.08	10.13	0.75	7.19e-16	Ewing sarcoma;
SKCM	cis	rs910316	0.967	rs175505	chr14:75529619	C/T	cg08847533	chr14:75593920	NEK9	-0.91	-8.04	-0.67	7.9e-12	Height;
SKCM	cis	rs654950	0.841	rs676383	chr1:41993753	C/T	cg06885757	chr1:42089581	HIVEP3	-0.62	-6.85	-0.61	1.5e-9	Airway imaging phenotypes;
SKCM	cis	rs2839186	0.770	rs2280956	chr21:47642323	C/G	cg11766577	chr21:47581405	C21orf56	0.73	6.37	0.58	1.24e-8	Testicular germ cell tumor;
SKCM	cis	rs6933660	0.800	rs6931104	chr6:151786177	C/T	cg10883421	chr6:151773342	RMND1;C6orf211	0.81	7.12	0.63	4.71e-10	Menarche (age at onset);
SKCM	cis	rs477895	0.639	rs35858916	chr11:63950529	T/G	cg07220939	chr11:64358617	SLC22A12	0.74	4.99	0.49	3.58e-6	Mean platelet volume;
SKCM	cis	rs3859192	0.577	rs2227333	chr17:38174167	C/G	cg17467752	chr17:38218738	THRA	-0.75	-6.28	-0.58	1.75e-8	White blood cell count;
SKCM	cis	rs908922	0.676	rs10888491	chr1:152492622	A/G	cg09873164	chr1:152488093	CRCT1	0.76	5.94	0.56	7.4e-8	Hair morphology;
SKCM	cis	rs10504073	0.669	rs341802	chr8:50039313	C/T	cg00325661	chr8:49890786	NA	0.8	6.91	0.62	1.16e-9	Blood metabolite ratios;
SKCM	cis	rs1878931	0.580	rs8062722	chr16:3409161	G/A	cg26668626	chr16:3451006	ZNF174;ZNF434	0.91	7.66	0.66	4.31e-11	Body mass index (adult);
SKCM	cis	rs208520	0.690	rs1885100	chr6:66871047	C/G	cg07460842	chr6:66804631	NA	-0.95	-6.8	-0.61	1.85e-9	Exhaled nitric oxide output;
SKCM	cis	rs514406	0.893	rs10888759	chr1:53433274	A/G	cg16325326	chr1:53192061	ZYG11B	-0.91	-9.82	-0.74	2.77e-15	Monocyte count;
SKCM	cis	rs372883	0.648	rs2832297	chr21:30742996	A/C	cg24692254	chr21:30365293	RNF160	0.64	5.1	0.5	2.29e-6	Pancreatic cancer;
SKCM	cis	rs2811415	0.531	rs2116674	chr3:127759664	C/A	cg09089421	chr3:127803668	RUVBL1	0.99	8.52	0.69	9.09e-13	Lung function (FEV1/FVC);
SKCM	cis	rs1801251	0.685	rs1515961	chr2:233623763	C/A	cg08000102	chr2:233561755	GIGYF2	0.76	6.8	0.61	1.87e-9	Coronary artery disease;
SKCM	cis	rs2243480	1.000	rs7794661	chr7:65389730	T/C	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs77106637	1.000	rs3862791	chr11:72501002	C/T	cg03713592	chr11:72463424	ARAP1	1.07	5.61	0.54	2.94e-7	Type 2 diabetes;
SKCM	cis	rs4819052	0.840	rs914217	chr21:46698299	A/G	cg19498844	chr21:46707878	POFUT2;LOC642852	0.94	7.29	0.64	2.23e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs13256369	1.000	rs9329166	chr8:8576655	C/T	cg06636001	chr8:8085503	FLJ10661	0.73	5.53	0.53	4.05e-7	Obesity-related traits;
SKCM	cis	rs798554	0.797	rs798493	chr7:2798731	A/G	cg19346786	chr7:2764209	NA	-0.64	-6.81	-0.61	1.79e-9	Height;
SKCM	cis	rs2204008	0.575	rs10444564	chr12:38043782	T/C	cg13010199	chr12:38710504	ALG10B	0.66	4.96	0.49	3.96e-6	Bladder cancer;
SKCM	cis	rs362272	0.545	rs2239725	chr4:3305739	C/T	cg05297308	chr4:3317976	RGS12	0.98	11.38	0.79	3.04e-18	Serum sulfate level;
SKCM	cis	rs2228479	0.681	rs2270461	chr16:89972345	C/T	cg00800038	chr16:89945340	TCF25	0.92	5.53	0.53	4.08e-7	Skin colour saturation;
SKCM	cis	rs826838	1.000	rs4575342	chr12:38663831	G/A	cg26384229	chr12:38710491	ALG10B	0.95	7.92	0.67	1.32e-11	Heart rate;
SKCM	cis	rs9303401	0.659	rs35928756	chr17:56702652	C/T	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.35	0.52	8.54e-7	Cognitive test performance;
SKCM	cis	rs7659604	0.521	rs4833232	chr4:122684367	C/T	cg19671926	chr4:122722719	EXOSC9	0.75	6.24	0.58	2.1e-8	Type 2 diabetes;
SKCM	cis	rs595982	0.527	rs55706579	chr19:49382969	G/A	cg19746536	chr19:49375674	PPP1R15A	1.13	5.53	0.53	4.16e-7	Red cell distribution width;
SKCM	cis	rs8017423	0.904	rs7147212	chr14:90697809	A/C	cg04374321	chr14:90722782	PSMC1	0.98	8.82	0.71	2.38e-13	Mortality in heart failure;
SKCM	cis	rs6089584	0.627	rs55875402	chr20:60559925	G/A	cg06108461	chr20:60628389	TAF4	-0.66	-5.48	-0.53	5.08e-7	Body mass index;
SKCM	cis	rs9818758	0.607	rs11706189	chr3:49210833	C/A	cg24110177	chr3:50126178	RBM5	0.88	5.26	0.51	1.23e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs2075371	1.000	rs2598294	chr7:133991690	C/T	cg20476274	chr7:133979776	SLC35B4	1.01	10.44	0.76	1.77e-16	Mean platelet volume;
SKCM	cis	rs514406	0.644	rs6662414	chr1:53198893	A/G	cg16325326	chr1:53192061	ZYG11B	-0.87	-9.08	-0.72	7.55e-14	Monocyte count;
SKCM	cis	rs4481887	0.927	rs4453080	chr1:248474671	T/C	cg00666640	chr1:248458726	OR2T12	0.63	5.91	0.56	8.65e-8	Common traits (Other);
SKCM	cis	rs875971	0.638	rs7793569	chr7:66116633	T/G	cg05627663	chr7:65219948	SNORA22;CCT6P1	-0.56	-4.81	-0.48	7.26e-6	Aortic root size;
SKCM	cis	rs1218582	0.772	rs4845689	chr1:154885524	A/G	cg24250549	chr1:154909240	PMVK	0.87	8.7	0.7	4.13e-13	Prostate cancer;
SKCM	cis	rs7959452	0.640	rs4274230	chr12:69700772	T/G	cg14784868	chr12:69753453	YEATS4	0.66	5.86	0.55	1.03e-7	Blood protein levels;
SKCM	cis	rs9910055	0.529	rs228748	chr17:42174390	G/A	cg08499158	chr17:42289980	UBTF	0.73	5.64	0.54	2.64e-7	Total body bone mineral density;
SKCM	cis	rs75229567	0.541	rs775443	chr12:70122623	C/T	cg10114359	chr12:70132523	RAB3IP	-1.24	-5.9	-0.56	8.76e-8	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes;
SKCM	cis	rs9733	0.650	rs12125672	chr1:150554470	A/T	cg13175981	chr1:150552382	MCL1	0.75	6.6	0.6	4.55e-9	Tonsillectomy;
SKCM	cis	rs1878931	0.624	rs37810	chr16:3451881	C/T	cg26668626	chr16:3451006	ZNF174;ZNF434	-0.78	-5.63	-0.54	2.75e-7	Body mass index (adult);
SKCM	cis	rs1799949	1.000	rs11657835	chr17:41291953	C/G	cg23758822	chr17:41437982	NA	0.92	7.8	0.66	2.3e-11	Menopause (age at onset);
SKCM	cis	rs28595532	0.920	rs55758547	chr4:119769475	T/C	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs875971	1.000	rs778685	chr7:65836176	G/T	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	7.89e-13	Aortic root size;
SKCM	cis	rs992157	0.835	rs4674282	chr2:219144230	A/T	cg00012203	chr2:219082015	ARPC2	-0.73	-5.76	-0.55	1.6e-7	Colorectal cancer;
SKCM	cis	rs4925386	0.840	rs6143034	chr20:60920545	T/C	cg24112000	chr20:60950667	NA	-0.74	-7.01	-0.62	7.4e-10	Colorectal cancer;Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs636523	0.561	rs10889363	chr1:63194009	C/T	cg06896770	chr1:63153194	DOCK7	0.8	5.27	0.51	1.17e-6	Lipid traits;
SKCM	cis	rs738321	0.794	rs5756940	chr22:38558842	C/T	cg25457927	chr22:38595422	NA	-0.59	-7.31	-0.64	2.05e-10	Breast cancer;
SKCM	cis	rs7191439	0.858	rs8050715	chr16:88780923	C/G	cg02389323	chr16:88786976	FAM38A	1.48	6.49	0.59	7.14e-9	Plateletcrit;
SKCM	cis	rs9467773	0.967	rs6456732	chr6:26514445	T/C	cg09904177	chr6:26538194	HMGN4	0.54	4.98	0.49	3.78e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs72634258	0.945	rs12745223	chr1:8094978	C/T	cg00042356	chr1:8021962	PARK7	1.09	7.71	0.66	3.35e-11	Inflammatory bowel disease;
SKCM	cis	rs1218582	0.688	rs58629129	chr1:154910930	T/C	cg03351412	chr1:154909251	PMVK	0.7	5.6	0.54	3.1e-7	Prostate cancer;
SKCM	cis	rs763014	0.932	rs2269559	chr16:682297	T/C	cg09263875	chr16:632152	PIGQ	0.77	6.52	0.59	6.4e-9	Height;
SKCM	cis	rs28386778	0.897	rs1062788	chr17:61896127	C/G	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs634534	0.622	rs531612	chr11:65705432	C/T	cg02427764	chr11:65769310	BANF1;EIF1AD	-0.72	-5.6	-0.54	3.11e-7	Sum eosinophil basophil counts;Eosinophil counts;
SKCM	cis	rs8180040	1.000	rs7613282	chr3:47389409	C/T	cg16586182	chr3:47516702	SCAP	0.71	4.85	0.48	6.25e-6	Colorectal cancer;
SKCM	cis	rs951366	0.617	rs708727	chr1:205767885	G/A	cg07157834	chr1:205819609	PM20D1	0.89	10.24	0.76	4.36e-16	Menarche (age at onset);
SKCM	cis	rs867186	1.000	rs57690120	chr20:33731437	A/T	cg04194272	chr20:33683537	NA	-1.11	-6.01	-0.56	5.7e-8	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs4689592	0.554	rs66925245	chr4:7071999	C/T	cg19539972	chr4:7069911	GRPEL1	-0.91	-5.84	-0.55	1.16e-7	Monocyte percentage of white cells;
SKCM	cis	rs9467773	0.620	rs2504566	chr6:26660488	G/C	cg15659132	chr6:26577336	NA	0.62	5.4	0.52	6.91e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs3785574	0.962	rs9944483	chr17:61783553	G/T	cg06873352	chr17:61820015	STRADA	-0.56	-4.93	-0.49	4.59e-6	Height;
SKCM	cis	rs9549367	0.577	rs7335409	chr13:113810186	T/C	cg18105134	chr13:113819100	PROZ	0.72	5.31	0.52	1e-6	Platelet distribution width;
SKCM	cis	rs514406	0.929	rs12410420	chr1:53323754	T/C	cg16325326	chr1:53192061	ZYG11B	0.94	10.05	0.75	1.02e-15	Monocyte count;
SKCM	cis	rs1707322	0.963	rs6690652	chr1:46376692	G/T	cg03146154	chr1:46216737	IPP	0.74	5.06	0.5	2.76e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs9910055	0.529	rs228748	chr17:42174390	G/A	cg19774624	chr17:42201019	HDAC5	0.85	6.68	0.6	3.19e-9	Total body bone mineral density;
SKCM	cis	rs10504229	0.683	rs10504221	chr8:58140256	A/G	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs459571	0.920	rs417142	chr9:136891370	G/T	cg13789015	chr9:136890014	NCRNA00094	0.77	6.63	0.6	3.95e-9	Platelet distribution width;
SKCM	cis	rs793571	0.502	rs421829	chr15:59079902	G/C	cg05156742	chr15:59063176	FAM63B	0.74	5.95	0.56	7.32e-8	Schizophrenia;
SKCM	cis	rs2952156	0.959	rs2934952	chr17:37832366	G/A	cg00129232	chr17:37814104	STARD3	-0.66	-4.93	-0.49	4.59e-6	Asthma;
SKCM	cis	rs870825	0.616	rs1401362	chr4:185643775	G/A	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs6500395	0.928	rs723807	chr16:48691443	A/G	cg04672837	chr16:48644449	N4BP1	-0.65	-5.43	-0.52	6.29e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs826838	1.000	rs826892	chr12:39100790	T/C	cg26384229	chr12:38710491	ALG10B	-0.97	-8.08	-0.67	6.7e-12	Heart rate;
SKCM	cis	rs16854884	0.586	rs13081286	chr3:143723757	A/T	cg06585982	chr3:143692056	C3orf58	0.87	8.34	0.69	2.04e-12	Economic and political preferences (feminism/equality);
SKCM	cis	rs908922	0.676	rs7529136	chr1:152516389	T/C	cg09873164	chr1:152488093	CRCT1	0.78	6.09	0.57	4.03e-8	Hair morphology;
SKCM	cis	rs2836950	0.501	rs13047518	chr21:40707307	G/A	cg17971929	chr21:40555470	PSMG1	-0.66	-5.09	-0.5	2.45e-6	Menarche (age at onset);
SKCM	cis	rs6582630	0.519	rs11520262	chr12:38333051	A/G	cg26384229	chr12:38710491	ALG10B	0.81	6.67	0.6	3.38e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs72634258	0.945	rs34124834	chr1:8028930	T/G	cg00042356	chr1:8021962	PARK7	1.06	7.14	0.63	4.25e-10	Inflammatory bowel disease;
SKCM	cis	rs7772486	0.686	rs857883	chr6:145969214	G/T	cg05347473	chr6:146136440	FBXO30	-0.61	-5.46	-0.53	5.55e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs35306767	0.903	rs11253467	chr10:901244	A/G	cg20503657	chr10:835505	NA	0.76	5.14	0.5	1.99e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs9325144	0.555	rs7960411	chr12:38703019	A/G	cg26384229	chr12:38710491	ALG10B	-0.76	-6.4	-0.59	1.05e-8	Morning vs. evening chronotype;
SKCM	cis	rs2153535	0.580	rs9379222	chr6:8514788	T/C	cg07606381	chr6:8435919	SLC35B3	0.87	6.38	0.59	1.17e-8	Motion sickness;
SKCM	cis	rs4819052	0.851	rs8133045	chr21:46658137	A/G	cg02159808	chr21:46707872	POFUT2;LOC642852	0.67	5.01	0.49	3.29e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs10504073	0.605	rs62507176	chr8:49930321	G/A	cg00325661	chr8:49890786	NA	0.79	7.15	0.63	3.99e-10	Blood metabolite ratios;
SKCM	cis	rs7772486	0.754	rs6570708	chr6:145989428	C/T	cg23711669	chr6:146136114	FBXO30	-0.88	-9.15	-0.72	5.5e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7208859	0.623	rs9893422	chr17:29111715	A/G	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs67311347	0.544	rs6762121	chr3:40355313	G/A	cg00091569	chr3:40428383	ENTPD3	0.64	5.64	0.54	2.66e-7	Renal cell carcinoma;
SKCM	cis	rs2033711	0.870	rs1051500	chr19:58944402	A/G	cg03735888	chr19:58951602	ZNF132	0.7	6.08	0.57	4.23e-8	Uric acid clearance;
SKCM	cis	rs2894969	0.664	rs11252703	chr10:4795125	A/T	cg18717067	chr10:5485554	NET1	0.65	5.31	0.52	9.99e-7	Major depressive disorder;
SKCM	cis	rs28386778	0.562	rs721575	chr17:61782920	A/G	cg22520471	chr17:61851767	DDX42;CCDC47	-0.69	-4.81	-0.48	7.19e-6	Prudent dietary pattern;
SKCM	cis	rs9915657	0.870	rs918081	chr17:70127808	G/A	cg06234051	chr17:70120541	SOX9	-0.63	-5.54	-0.53	3.87e-7	Thyroid hormone levels;
SKCM	cis	rs2153535	0.580	rs1932280	chr6:8473654	G/A	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs2204008	0.805	rs4589389	chr12:37946120	C/A	cg13010199	chr12:38710504	ALG10B	-0.64	-5.16	-0.5	1.81e-6	Bladder cancer;
SKCM	cis	rs13256369	0.756	rs13280759	chr8:8562995	G/T	cg15556689	chr8:8085844	FLJ10661	0.65	4.77	0.48	8.39e-6	Obesity-related traits;
SKCM	cis	rs2836974	0.666	rs12626405	chr21:40663121	G/T	cg17971929	chr21:40555470	PSMG1	-0.74	-7.06	-0.62	5.99e-10	Cognitive function;
SKCM	cis	rs28386778	0.863	rs1376110	chr17:61779927	A/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.06	9.5	0.73	1.15e-14	Prudent dietary pattern;
SKCM	cis	rs875971	0.965	rs7794930	chr7:65778546	A/C	cg11764359	chr7:65958608	NA	-0.87	-8.24	-0.68	3.27e-12	Aortic root size;
SKCM	cis	rs854765	0.565	rs854768	chr17:18018806	T/C	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.88	6.67	0.6	3.3e-9	Total body bone mineral density;
SKCM	cis	rs2777491	0.874	rs1655556	chr15:41777935	A/C	cg18705301	chr15:41695430	NDUFAF1	-0.9	-8.79	-0.71	2.78e-13	Ulcerative colitis;
SKCM	trans	rs3780486	0.846	rs10971420	chr9:33125000	T/C	cg04842962	chr6:43655489	MRPS18A	1.02	10.61	0.77	8.7e-17	IgG glycosylation;
SKCM	cis	rs72615157	0.634	rs79986079	chr7:99802044	C/T	cg23667466	chr7:100026434	MEPCE;ZCWPW1	0.92	4.97	0.49	3.93e-6	Lung function (FEV1/FVC);
SKCM	cis	rs7927771	0.832	rs7924485	chr11:47419129	A/G	cg05585544	chr11:47624801	NA	0.57	4.92	0.49	4.76e-6	Subjective well-being;
SKCM	cis	rs514406	0.505	rs448788	chr1:53161620	A/G	cg16325326	chr1:53192061	ZYG11B	-0.91	-10.23	-0.76	4.5e-16	Monocyte count;
SKCM	cis	rs9911578	0.839	rs11654986	chr17:57206124	A/G	cg12560992	chr17:57184187	TRIM37	0.99	8.46	0.69	1.22e-12	Intelligence (multi-trait analysis);
SKCM	cis	rs2721195	0.967	rs11777703	chr8:145703508	G/A	cg15857475	chr8:145742913	RECQL4;LRRC14	-0.86	-7.99	-0.67	9.95e-12	Age at first birth;
SKCM	cis	rs6912958	0.667	rs7746545	chr6:88090225	A/G	cg08069147	chr6:88032118	GJB7;C6orf162	0.62	5.32	0.52	9.76e-7	Monocyte percentage of white cells;
SKCM	cis	rs9814567	0.806	rs4074523	chr3:134325657	T/G	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.7	-5.69	-0.54	2.17e-7	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs2243480	1.000	rs6970243	chr7:65388490	C/A	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs8180040	0.800	rs7632501	chr3:47268306	T/C	cg27129171	chr3:47204927	SETD2	-0.79	-5.38	-0.52	7.6e-7	Colorectal cancer;
SKCM	cis	rs875971	0.862	rs6955837	chr7:66043142	C/T	cg18876405	chr7:65276391	NA	-0.63	-6.31	-0.58	1.6e-8	Aortic root size;
SKCM	cis	rs9913156	0.748	rs72835626	chr17:4560326	C/A	cg19197139	chr17:4613644	ARRB2	0.79	5.28	0.51	1.14e-6	Lymphocyte counts;
SKCM	cis	rs9910055	0.529	rs408282	chr17:42182267	A/G	cg08499158	chr17:42289980	UBTF	0.72	5.61	0.54	2.95e-7	Total body bone mineral density;
SKCM	cis	rs6977660	0.943	rs12668201	chr7:19831610	A/C	cg07541023	chr7:19748670	TWISTNB	-0.72	-5.03	-0.5	3.01e-6	Thyroid stimulating hormone;
SKCM	cis	rs208520	0.954	rs1468153	chr6:67009054	A/C	cg07460842	chr6:66804631	NA	0.83	5.57	0.53	3.49e-7	Exhaled nitric oxide output;
SKCM	cis	rs9814567	1.000	rs7374158	chr3:134270156	C/T	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs933688	1.000	rs6452953	chr5:90723034	T/G	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.05	8.54	0.7	8.25e-13	Smoking behavior;
SKCM	cis	rs7100689	0.577	rs9421464	chr10:82043426	C/T	cg01528321	chr10:82214614	TSPAN14	0.79	7.79	0.66	2.36e-11	Post bronchodilator FEV1;
SKCM	cis	rs854765	0.547	rs2955383	chr17:17941364	A/G	cg04398451	chr17:18023971	MYO15A	-0.84	-6.78	-0.61	2.05e-9	Total body bone mineral density;
SKCM	cis	rs6591182	0.504	rs7116712	chr11:65372518	A/G	cg27068330	chr11:65405492	SIPA1	-0.69	-5.06	-0.5	2.71e-6	Non-alcoholic fatty liver disease histology (lobular);
SKCM	cis	rs1018836	0.923	rs6986689	chr8:91626709	A/C	cg16814680	chr8:91681699	NA	-0.62	-4.83	-0.48	6.67e-6	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs7927771	0.524	rs10838775	chr11:47856382	C/G	cg20307385	chr11:47447363	PSMC3	0.72	5.81	0.55	1.31e-7	Subjective well-being;
SKCM	cis	rs35306767	0.903	rs12250937	chr10:900209	C/T	cg20503657	chr10:835505	NA	0.77	5.32	0.52	9.76e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs7659604	0.846	rs60340409	chr4:122666355	G/C	cg19748678	chr4:122722346	EXOSC9	0.67	5.45	0.52	5.79e-7	Type 2 diabetes;
SKCM	cis	rs2243480	1.000	rs7456042	chr7:65299778	T/C	cg18252515	chr7:66147081	NA	-1.29	-7.41	-0.64	1.3e-10	Diabetic kidney disease;
SKCM	cis	rs875971	1.000	rs4717300	chr7:65947380	T/C	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs2243480	1.000	rs2420171	chr7:65637760	T/C	cg18252515	chr7:66147081	NA	1.34	8.18	0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs2204008	0.744	rs8186814	chr12:38335169	C/T	cg26384229	chr12:38710491	ALG10B	0.81	6.67	0.6	3.38e-9	Bladder cancer;
SKCM	cis	rs6912958	1.000	rs6933587	chr6:88175577	T/G	cg08069147	chr6:88032118	GJB7;C6orf162	-0.64	-5.47	-0.53	5.2e-7	Monocyte percentage of white cells;
SKCM	cis	rs929354	0.742	rs3808316	chr7:156944787	C/G	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs4820539	1.000	rs5759596	chr22:23475750	G/A	cg14186256	chr22:23484241	RTDR1	0.85	8.27	0.68	2.8e-12	Bone mineral density;
SKCM	cis	rs10911232	0.507	rs3934579	chr1:183027432	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.77	6.89	0.62	1.27e-9	Hypertriglyceridemia;
SKCM	cis	rs7208859	0.623	rs7217984	chr17:29092766	G/A	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs28595532	0.920	rs116023344	chr4:119760263	A/G	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs826838	1.000	rs11183747	chr12:38822595	A/G	cg13010199	chr12:38710504	ALG10B	-0.83	-6.61	-0.6	4.31e-9	Heart rate;
SKCM	cis	rs2014572	0.967	rs8106734	chr19:57763546	C/T	cg24459738	chr19:57751996	ZNF805	-0.64	-5.17	-0.5	1.79e-6	Hyperactive-impulsive symptoms;
SKCM	cis	rs7927771	0.864	rs55927797	chr11:47446292	A/T	cg05585544	chr11:47624801	NA	-0.58	-5.19	-0.51	1.61e-6	Subjective well-being;
SKCM	cis	rs7666738	0.830	rs6839277	chr4:99015563	C/T	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1863918	0.590	rs73342565	chr5:178484363	A/G	cg21905437	chr5:178450457	ZNF879	-0.6	-5.19	-0.51	1.65e-6	Depression in response to interferon-based therapy in chronic hepatitis C;
SKCM	cis	rs514406	0.861	rs2448792	chr1:53268313	T/C	cg16325326	chr1:53192061	ZYG11B	-0.99	-11.71	-0.8	7.39e-19	Monocyte count;
SKCM	cis	rs910316	0.967	rs4903285	chr14:75609268	A/T	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.89e-7	Height;
SKCM	cis	rs4664308	0.689	rs3749119	chr2:160919020	C/T	cg03641300	chr2:160917029	PLA2R1	-0.63	-4.8	-0.48	7.47e-6	Idiopathic membranous nephropathy;
SKCM	cis	rs394563	0.663	rs415434	chr6:149772645	A/G	cg03678062	chr6:149772716	ZC3H12D	-0.5	-5.5	-0.53	4.66e-7	Dupuytren's disease;
SKCM	cis	rs10504229	0.861	rs116964504	chr8:58185354	A/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs6565180	0.963	rs4787642	chr16:30359408	T/C	cg17640201	chr16:30407289	ZNF48	-0.93	-7.0	-0.62	7.78e-10	Tonsillectomy;
SKCM	cis	rs56011263	0.687	rs73221103	chr4:706740	T/C	cg17689763	chr4:710664	PCGF3	-0.64	-5.23	-0.51	1.41e-6	White blood cell count;
SKCM	cis	rs7959452	0.535	rs11177577	chr12:69671791	C/T	cg14784868	chr12:69753453	YEATS4	0.64	5.6	0.54	3.09e-7	Blood protein levels;
SKCM	cis	rs7954584	0.567	rs11043246	chr12:122368944	G/A	cg13699009	chr12:122356056	WDR66	0.59	7.37	0.64	1.54e-10	Mean corpuscular volume;
SKCM	cis	rs12478296	1.000	rs66466023	chr2:243046151	T/G	cg06360820	chr2:242988706	NA	-0.91	-5.25	-0.51	1.28e-6	Obesity-related traits;
SKCM	cis	rs9796	0.870	rs3101436	chr15:41287689	A/G	cg00616447	chr15:41694635	NDUFAF1	-0.71	-4.97	-0.49	3.83e-6	Menopause (age at onset);
SKCM	cis	rs9790314	1.000	rs7653233	chr3:160992033	G/A	cg03342759	chr3:160939853	NMD3	-0.72	-7.87	-0.67	1.65e-11	Morning vs. evening chronotype;
SKCM	cis	rs1552244	1.000	rs6807846	chr3:10134491	G/T	cg02579736	chr3:10068473	FANCD2;CIDECP	1.23	6.92	0.62	1.13e-9	Alzheimer's disease;
SKCM	cis	rs459571	0.804	rs448918	chr9:136885979	G/A	cg13789015	chr9:136890014	NCRNA00094	0.77	6.54	0.59	5.88e-9	Platelet distribution width;
SKCM	cis	rs13118159	0.573	rs4974618	chr4:1373663	C/T	cg05025164	chr4:1340916	KIAA1530	0.87	7.19	0.63	3.36e-10	Longevity;
SKCM	cis	rs28386778	0.863	rs9207	chr17:61823899	C/T	cg01411255	chr17:61851458	DDX42;CCDC47	0.78	5.03	0.49	3.06e-6	Prudent dietary pattern;
SKCM	cis	rs428668	0.523	rs6898671	chr5:150677643	A/T	cg11125805	chr5:150678162	SLC36A3	0.49	6.1	0.57	3.91e-8	Skin aging (microtopography measurement);
SKCM	cis	rs1348850	0.914	rs2121430	chr2:178318375	A/G	cg02961200	chr2:178257176	LOC100130691;AGPS	0.75	5.38	0.52	7.66e-7	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs1003719	0.788	rs2835589	chr21:38463342	A/G	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs10256972	0.552	rs2949192	chr7:1203841	C/T	cg16145915	chr7:1198662	ZFAND2A	-0.57	-8.16	-0.68	4.69e-12	Longevity;Endometriosis;
SKCM	cis	rs6565180	0.962	rs11642676	chr16:30371655	C/G	cg17640201	chr16:30407289	ZNF48	-0.9	-6.68	-0.6	3.17e-9	Tonsillectomy;
SKCM	cis	rs11677370	0.561	rs4849990	chr2:3819558	A/G	cg17052675	chr2:3827356	NA	-0.61	-4.99	-0.49	3.57e-6	Type 2 diabetes;
SKCM	cis	rs72634258	0.554	rs12723500	chr1:7857374	G/C	cg26816564	chr1:7831052	VAMP3	0.75	5.36	0.52	8.06e-7	Inflammatory bowel disease;
SKCM	cis	rs7945705	0.747	rs1980428	chr11:9010497	A/G	cg13070366	chr11:9386451	NA	-0.57	-4.86	-0.48	6.04e-6	Hemoglobin concentration;
SKCM	cis	rs4888262	0.526	rs4887772	chr16:74537591	C/T	cg01733217	chr16:74700730	RFWD3	0.88	6.99	0.62	8.2e-10	Testicular germ cell tumor;
SKCM	cis	rs9926664	0.591	rs16882	chr16:85935573	T/C	cg16682899	chr16:85508110	NA	-0.56	-5.64	-0.54	2.61e-7	Sum basophil neutrophil counts;Neutrophil count;
SKCM	cis	rs34172651	0.517	rs1465423	chr16:24772680	C/G	cg04756594	chr16:24857601	SLC5A11	-0.72	-5.19	-0.51	1.65e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9926296	0.533	rs7190823	chr16:89866043	A/G	cg04287289	chr16:89883240	FANCA	1.0	11.45	0.79	2.2e-18	Vitiligo;
SKCM	cis	rs9902453	0.866	rs4795529	chr17:28443549	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.79	6.03	0.56	5.24e-8	Coffee consumption (cups per day);
SKCM	cis	rs55962025	0.842	rs362306	chr4:3242100	C/T	cg24015175	chr4:3319247	RGS12	-0.71	-6.27	-0.58	1.86e-8	Parental longevity (mother's age at death);
SKCM	cis	rs6951245	0.872	rs77434655	chr7:1098405	G/A	cg24642844	chr7:1081250	C7orf50	-0.93	-6.22	-0.58	2.28e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs2404602	0.647	rs10851889	chr15:77023336	C/T	cg23625390	chr15:77176239	SCAPER	-0.85	-8.26	-0.68	2.93e-12	Blood metabolite levels;
SKCM	cis	rs7193541	0.965	rs7199068	chr16:74698263	C/G	cg01733217	chr16:74700730	RFWD3	0.89	8.71	0.7	3.95e-13	Multiple myeloma;
SKCM	cis	rs4819052	0.851	rs58644915	chr21:46669912	T/C	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.36	0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs9290877	0.667	rs6763591	chr3:188455971	T/C	cg17392043	chr3:188495102	LPP	-0.64	-4.93	-0.49	4.6e-6	IgE levels;
SKCM	cis	rs4481887	0.893	rs10788774	chr1:248471712	T/C	cg00666640	chr1:248458726	OR2T12	0.61	5.6	0.54	3.11e-7	Common traits (Other);
SKCM	cis	rs2404602	0.692	rs35170561	chr15:77130695	C/T	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs2120019	1.000	rs8036197	chr15:75370232	T/C	cg09165964	chr15:75287851	SCAMP5	-0.78	-6.63	-0.6	3.95e-9	Blood trace element (Zn levels);
SKCM	cis	rs7100689	0.784	rs10736341	chr10:82061206	C/G	cg01528321	chr10:82214614	TSPAN14	0.81	7.3	0.64	2.14e-10	Post bronchodilator FEV1;
SKCM	cis	rs651907	0.557	rs11914318	chr3:101453858	C/T	cg12386194	chr3:101231763	SENP7	0.68	5.59	0.54	3.16e-7	Colorectal cancer;
SKCM	cis	rs10504229	0.683	rs67035623	chr8:58139963	G/T	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs2463822	0.920	rs28678254	chr11:62151875	G/C	cg06239285	chr11:62104954	ASRGL1	-1.26	-5.85	-0.55	1.08e-7	Chronic obstructive pulmonary disease-related biomarkers;
SKCM	cis	rs7635838	0.718	rs2594981	chr3:11380638	C/G	cg00170343	chr3:11313890	ATG7	0.7	5.54	0.53	3.93e-7	HDL cholesterol;
SKCM	cis	rs8072100	0.777	rs9914653	chr17:45537395	T/C	cg25173405	chr17:45401733	C17orf57	-0.57	-4.77	-0.48	8.45e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs6545883	0.965	rs10186325	chr2:61757721	G/T	cg15711740	chr2:61764176	XPO1	-0.73	-5.23	-0.51	1.4e-6	Tuberculosis;
SKCM	cis	rs6430585	0.528	rs6430594	chr2:136719173	C/T	cg07169764	chr2:136633963	MCM6	-1.31	-13.19	-0.83	1.48e-21	Corneal structure;
SKCM	cis	rs950776	0.518	rs4886571	chr15:78833758	G/A	cg06917634	chr15:78832804	PSMA4	-1.01	-10.47	-0.76	1.56e-16	Sudden cardiac arrest;
SKCM	cis	rs780096	0.526	rs4803	chr2:27667297	A/G	cg05696406	chr2:27599888	SNX17	0.51	5.22	0.51	1.46e-6	Total body bone mineral density;
SKCM	cis	rs12824058	0.831	rs4759452	chr12:130812799	G/A	cg26677194	chr12:130822605	PIWIL1	0.71	5.83	0.55	1.17e-7	Menopause (age at onset);
SKCM	cis	rs911555	0.504	rs745079	chr14:104073551	G/A	cg24130564	chr14:104152367	KLC1	-0.58	-5.11	-0.5	2.27e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs208520	1.000	rs72884033	chr6:66995747	T/C	cg07460842	chr6:66804631	NA	0.87	5.96	0.56	6.95e-8	Exhaled nitric oxide output;
SKCM	cis	rs12134245	0.747	rs35654098	chr1:92001452	T/A	cg25838465	chr1:92012736	NA	-0.84	-8.87	-0.71	1.92e-13	Breast cancer;
SKCM	cis	rs7809950	1.000	rs987391	chr7:107100794	C/G	cg23024343	chr7:107201750	COG5	-0.74	-6.61	-0.6	4.39e-9	Coronary artery disease;
SKCM	cis	rs9910055	0.762	rs1135215	chr17:42253519	T/C	cg09913183	chr17:42254507	C17orf65;ASB16	0.7	6.49	0.59	7.35e-9	Total body bone mineral density;
SKCM	cis	rs875971	0.830	rs7799834	chr7:65880694	A/C	cg18876405	chr7:65276391	NA	0.67	6.65	0.6	3.61e-9	Aortic root size;
SKCM	cis	rs17345786	1.000	rs3804778	chr3:101294572	C/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.7	4.95	0.49	4.21e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1029738	0.615	rs717624	chr7:22894487	T/C	cg04907244	chr7:22894795	SNORD93	-0.58	-5.14	-0.5	1.98e-6	Fibrinogen levels;
SKCM	cis	rs12541335	0.639	rs6993855	chr8:22163797	A/G	cg09517075	chr8:22133004	PIWIL2	0.59	5.41	0.52	6.77e-7	Hypertriglyceridemia;
SKCM	cis	rs7086627	0.515	rs2125040	chr10:82208422	G/C	cg00277334	chr10:82204260	NA	-0.74	-8.56	-0.7	7.89e-13	Post bronchodilator FEV1;
SKCM	trans	rs1814175	0.817	rs10769598	chr11:49669326	C/G	cg15704280	chr7:45808275	SEPT13	-1.03	-10.32	-0.76	3.06e-16	Height;
SKCM	cis	rs72772090	0.710	rs56122780	chr5:96059895	T/C	cg17330273	chr5:96107758	CAST;ERAP1	-0.83	-4.97	-0.49	3.86e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs9660180	0.967	rs6687065	chr1:1778469	A/G	cg23982607	chr1:1823379	GNB1	-0.67	-5.6	-0.54	3.03e-7	Body mass index;
SKCM	cis	rs9921222	0.500	rs12917907	chr16:405866	C/T	cg00101154	chr16:420108	MRPL28	-0.67	-5.47	-0.53	5.23e-7	Bone mineral density (spine);Bone mineral density;
SKCM	cis	rs28595532	0.920	rs56364904	chr4:119742504	T/C	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs7927771	0.839	rs11039308	chr11:47622412	G/A	cg05585544	chr11:47624801	NA	-0.64	-5.52	-0.53	4.33e-7	Subjective well-being;
SKCM	cis	rs8180040	0.691	rs12489211	chr3:47221451	T/A	cg27129171	chr3:47204927	SETD2	0.82	6.44	0.59	9.04e-9	Colorectal cancer;
SKCM	cis	rs6500602	0.702	rs6500605	chr16:4502410	C/T	cg08645402	chr16:4508243	NA	0.6	5.22	0.51	1.42e-6	Schizophrenia;
SKCM	cis	rs2404602	0.716	rs12594577	chr15:76828793	A/C	cg23625390	chr15:77176239	SCAPER	0.59	5.38	0.52	7.54e-7	Blood metabolite levels;
SKCM	cis	rs9611565	0.694	rs202656	chr22:41842203	T/A	cg03806693	chr22:41940476	POLR3H	1.13	7.36	0.64	1.63e-10	Vitiligo;
SKCM	cis	rs9916302	0.904	rs7503705	chr17:37669704	A/G	cg07936489	chr17:37558343	FBXL20	-0.9	-8.11	-0.68	5.65e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs4727443	0.866	rs35228488	chr7:99617852	G/C	cg07913999	chr7:99613796	ZKSCAN1	0.66	5.09	0.5	2.43e-6	Interstitial lung disease;
SKCM	cis	rs28595532	0.764	rs116788606	chr4:119748849	G/C	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs992157	1.000	rs992157	chr2:219154781	A/G	cg00012203	chr2:219082015	ARPC2	-0.72	-5.92	-0.56	8.13e-8	Colorectal cancer;
SKCM	cis	rs4332037	0.707	rs62435130	chr7:1890002	C/T	cg23422044	chr7:1970798	MAD1L1	-0.9	-5.81	-0.55	1.29e-7	Bipolar disorder;
SKCM	cis	rs9549367	0.569	rs3024719	chr13:113814225	G/A	cg18105134	chr13:113819100	PROZ	-0.81	-5.87	-0.55	9.89e-8	Platelet distribution width;
SKCM	cis	rs4132509	0.744	rs10927068	chr1:243923452	C/T	cg21452805	chr1:244014465	NA	0.93	5.78	0.55	1.48e-7	RR interval (heart rate);
SKCM	cis	rs561341	1.000	rs113676348	chr17:30244327	A/G	cg13647721	chr17:30228624	UTP6	0.77	4.81	0.48	7.1e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs12950390	0.893	rs4239166	chr17:45847329	A/G	cg03474202	chr17:45855739	NA	-0.49	-5.58	-0.53	3.34e-7	IgG glycosylation;
SKCM	cis	rs1707322	1.000	rs6695421	chr1:46380207	T/C	cg03146154	chr1:46216737	IPP	0.74	5.06	0.5	2.76e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs1799949	1.000	rs11653231	chr17:41331460	G/A	cg23758822	chr17:41437982	NA	0.93	7.84	0.66	1.91e-11	Menopause (age at onset);
SKCM	cis	rs35306767	0.953	rs10904581	chr10:964685	A/T	cg20503657	chr10:835505	NA	0.66	5.15	0.5	1.88e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs951366	0.789	rs864783	chr1:205711974	T/C	cg24503407	chr1:205819492	PM20D1	0.88	7.38	0.64	1.5e-10	Menarche (age at onset);
SKCM	cis	rs514406	0.698	rs511599	chr1:53362818	T/C	cg16325326	chr1:53192061	ZYG11B	0.65	5.65	0.54	2.56e-7	Monocyte count;
SKCM	cis	rs769267	0.895	rs2916074	chr19:19530270	C/T	cg03709012	chr19:19516395	GATAD2A	0.9	8.7	0.7	4.14e-13	Tonsillectomy;
SKCM	cis	rs17376456	0.825	rs10054790	chr5:93272520	A/G	cg21475434	chr5:93447410	FAM172A	1.02	5.17	0.51	1.74e-6	Diabetic retinopathy;
SKCM	cis	rs7424096	0.582	rs12105781	chr2:37221567	T/C	cg14987922	chr2:37194071	STRN	0.99	6.05	0.57	4.73e-8	High light scatter reticulocyte percentage of red cells;
SKCM	cis	rs10504229	0.724	rs58715581	chr8:58134568	A/G	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs9611565	0.659	rs9611604	chr22:41916001	C/G	cg03806693	chr22:41940476	POLR3H	-1.11	-7.56	-0.65	6.67e-11	Vitiligo;
SKCM	cis	rs735396	1.000	rs1169311	chr12:121440731	C/T	cg02403541	chr12:121454288	C12orf43	0.61	4.84	0.48	6.47e-6	N-glycan levels;
SKCM	cis	rs34779708	0.733	rs16935945	chr10:35540320	A/C	cg03585969	chr10:35415529	CREM	0.74	5.42	0.52	6.41e-7	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs875971	0.862	rs7798630	chr7:65771479	G/C	cg11764359	chr7:65958608	NA	-0.75	-6.76	-0.61	2.26e-9	Aortic root size;
SKCM	cis	rs6120849	0.663	rs6088662	chr20:33547633	A/C	cg24642439	chr20:33292090	TP53INP2	0.98	5.39	0.52	7.33e-7	Protein C levels;
SKCM	cis	rs9535495	1.000	rs7990306	chr13:51384010	C/T	cg13204699	chr13:50703841	NA	-0.43	-4.91	-0.49	4.85e-6	Reticulocyte count;Reticulocyte fraction of red cells;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs7811142	0.830	rs78256546	chr7:99952970	A/G	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.19	7.5	0.65	8.66e-11	Platelet count;
SKCM	cis	rs55962025	0.883	rs82334	chr4:3225371	A/C	cg09735869	chr4:3319127	RGS12	-0.73	-5.58	-0.53	3.31e-7	Parental longevity (mother's age at death);
SKCM	cis	rs2239547	0.521	rs9682464	chr3:52888485	C/T	cg11645453	chr3:52864694	ITIH4	0.77	6.95	0.62	9.68e-10	Schizophrenia;
SKCM	cis	rs7824557	0.602	rs7828711	chr8:11205665	G/C	cg21775007	chr8:11205619	TDH	0.72	6.4	0.59	1.09e-8	Retinal vascular caliber;
SKCM	cis	rs13118159	0.550	rs10016557	chr4:1363628	C/T	cg16405210	chr4:1374714	KIAA1530	0.9	6.82	0.61	1.71e-9	Longevity;
SKCM	cis	rs2836974	0.545	rs3167757	chr21:40714478	C/T	cg11890956	chr21:40555474	PSMG1	0.72	5.76	0.55	1.56e-7	Cognitive function;
SKCM	cis	rs10089	0.904	rs2195921	chr5:127489754	A/C	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.88	8.14	0.68	5.15e-12	Ileal carcinoids;
SKCM	cis	rs58688157	0.660	rs12797496	chr11:583767	C/T	cg16486109	chr11:613632	IRF7	1.09	6.84	0.61	1.6e-9	Systemic lupus erythematosus;
SKCM	cis	rs1799949	0.965	rs2236762	chr17:41226675	A/T	cg25072359	chr17:41440525	NA	0.63	4.8	0.48	7.6e-6	Menopause (age at onset);
SKCM	cis	rs17376456	0.877	rs10052428	chr5:93476530	T/C	cg25358565	chr5:93447407	FAM172A	1.23	7.97	0.67	1.08e-11	Diabetic retinopathy;
SKCM	cis	rs9905704	0.647	rs11079367	chr17:57009024	A/G	cg12560992	chr17:57184187	TRIM37	0.76	6.03	0.56	5.1e-8	Testicular germ cell tumor;
SKCM	cis	rs10803016	0.638	rs2252347	chr1:242291963	C/T	ch.1.4829111R	chr1:242658279	PLD5	-0.57	-4.8	-0.48	7.37e-6	Coronary artery calcification;
SKCM	cis	rs995000	0.931	rs637723	chr1:62906728	C/T	cg06896770	chr1:63153194	DOCK7	0.76	7.24	0.63	2.71e-10	Triglyceride levels;
SKCM	cis	rs7772486	0.654	rs6906402	chr6:146089307	C/G	cg05347473	chr6:146136440	FBXO30	-0.61	-5.81	-0.55	1.31e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs362296	0.550	rs3135064	chr4:3285389	T/C	cg09735869	chr4:3319127	RGS12	0.76	6.82	0.61	1.74e-9	Parental longevity (mother's age at death);
SKCM	cis	rs9640161	0.789	rs10952250	chr7:150025966	T/C	cg10018233	chr7:150070692	REPIN1	0.77	6.19	0.57	2.62e-8	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs9381040	0.655	rs2268194	chr6:41024447	T/C	cg04346459	chr6:41068666	NFYA;LOC221442	-0.69	-4.8	-0.48	7.61e-6	Alzheimer's disease (late onset);
SKCM	cis	rs473651	0.935	rs1103770	chr2:239339281	G/C	cg18131467	chr2:239335373	ASB1	1.09	11.83	0.8	4.46e-19	Multiple system atrophy;
SKCM	cis	rs17376456	0.877	rs12153501	chr5:93360866	T/G	cg25358565	chr5:93447407	FAM172A	1.19	7.78	0.66	2.52e-11	Diabetic retinopathy;
SKCM	cis	rs9467773	0.620	rs2451741	chr6:26629404	A/G	cg15659132	chr6:26577336	NA	0.62	5.4	0.52	6.91e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs2120019	1.000	rs12910644	chr15:75358388	A/G	cg09165964	chr15:75287851	SCAMP5	-0.75	-6.28	-0.58	1.78e-8	Blood trace element (Zn levels);
SKCM	cis	rs870825	0.929	rs72689269	chr4:185592085	T/C	cg04058563	chr4:185651563	MLF1IP	1.03	5.09	0.5	2.4e-6	Blood protein levels;
SKCM	cis	rs6840360	0.571	rs7664663	chr4:152508014	G/C	cg22705602	chr4:152727874	NA	-0.52	-5.7	-0.54	2.03e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs10254284	1.000	rs4722756	chr7:28154822	A/G	cg15170557	chr7:28214983	JAZF1	-0.63	-5.45	-0.52	5.75e-7	Lymphocyte percentage of white cells;Systemic lupus erythematosus;
SKCM	cis	rs67311347	1.000	rs7631893	chr3:40440869	C/T	cg00091569	chr3:40428383	ENTPD3	0.61	5.16	0.5	1.85e-6	Renal cell carcinoma;
SKCM	cis	rs12188164	1.000	rs72717412	chr5:429381	C/T	cg26076054	chr5:421317	AHRR	-0.61	-4.8	-0.48	7.47e-6	Cystic fibrosis severity;
SKCM	cis	rs7103648	0.897	rs35032070	chr11:47408592	G/A	cg03711944	chr11:47377212	SPI1	-0.57	-5.07	-0.5	2.6e-6	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs8180040	1.000	rs807810	chr3:47403892	G/A	cg27129171	chr3:47204927	SETD2	-0.87	-6.62	-0.6	4.15e-9	Colorectal cancer;
SKCM	cis	rs769267	0.566	rs7249692	chr19:19670688	T/C	cg26732615	chr19:19648335	CILP2;YJEFN3	-0.57	-4.8	-0.48	7.42e-6	Tonsillectomy;
SKCM	cis	rs9581857	0.547	rs4612914	chr13:28049128	A/G	cg22138327	chr13:27999177	GTF3A	0.93	6.22	0.58	2.33e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs116095464	0.558	rs10056628	chr5:279512	G/A	cg22857025	chr5:266934	NA	-1.58	-8.14	-0.68	4.99e-12	Breast cancer;
SKCM	cis	rs1046896	0.731	rs8067667	chr17:80785875	A/G	cg02711726	chr17:80685570	FN3KRP	-0.75	-5.61	-0.54	2.96e-7	Glycated hemoglobin levels;
SKCM	cis	rs1405130	0.900	rs12692148	chr2:235587004	C/T	cg17841421	chr2:235704848	NA	-0.58	-4.88	-0.48	5.48e-6	Coronary artery disease;
SKCM	cis	rs10504229	0.953	rs72650891	chr8:58179697	T/G	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs2404602	0.716	rs12902174	chr15:76863540	T/C	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs11139399	0.651	rs2086830	chr9:84345088	C/T	cg13729285	chr9:84764156	NA	0.54	5.56	0.53	3.58e-7	Hippocampal atrophy;
SKCM	cis	rs11112613	0.818	rs2374507	chr12:106009570	A/C	cg03607813	chr12:105948248	NA	0.98	4.81	0.48	7.32e-6	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;
SKCM	cis	rs6570726	0.755	rs451699	chr6:145830594	C/G	cg05347473	chr6:146136440	FBXO30	0.53	4.78	0.48	8.07e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7666738	0.830	rs3896704	chr4:99034252	C/T	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs36093844	0.527	rs111552865	chr11:85760111	G/T	cg25872744	chr11:85566296	CCDC83	-0.81	-4.79	-0.48	7.71e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs6088580	0.634	rs4911151	chr20:32932273	T/C	cg24642439	chr20:33292090	TP53INP2	-0.76	-6.02	-0.56	5.31e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs9814567	1.000	rs6765505	chr3:134208132	A/G	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.67	-5.3	-0.51	1.05e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs28595532	1.000	rs55634130	chr4:119655093	C/T	cg11846333	chr4:119757529	SEC24D	1.15	6.24	0.58	2.13e-8	Cannabis dependence symptom count;
SKCM	cis	rs651907	0.535	rs1460097	chr3:101497569	C/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.78	6.86	0.61	1.47e-9	Colorectal cancer;
SKCM	cis	rs2286503	0.966	rs6949233	chr7:22858191	T/G	cg15401507	chr7:22894281	NA	-0.57	-5.6	-0.54	3.12e-7	Fibrinogen;
SKCM	cis	rs8141529	0.764	rs8137969	chr22:29228484	G/C	cg15103426	chr22:29168792	CCDC117	0.61	5.13	0.5	2.06e-6	Lymphocyte counts;
SKCM	cis	rs826838	1.000	rs826838	chr12:39106731	C/T	cg13010199	chr12:38710504	ALG10B	-0.72	-5.6	-0.54	3.1e-7	Heart rate;
SKCM	cis	rs9902453	0.904	rs10853136	chr17:28406018	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.82	-6.4	-0.59	1.06e-8	Coffee consumption (cups per day);
SKCM	cis	rs951366	0.789	rs823137	chr1:205738302	C/T	cg26354017	chr1:205819088	PM20D1	1.03	9.51	0.73	1.12e-14	Menarche (age at onset);
SKCM	cis	rs10256972	0.528	rs7784607	chr7:1178694	A/G	cg09177884	chr7:1199841	ZFAND2A	-0.8	-6.43	-0.59	9.56e-9	Longevity;Endometriosis;
SKCM	cis	rs7809950	1.000	rs2237676	chr7:107198079	C/A	cg23024343	chr7:107201750	COG5	-0.77	-6.92	-0.62	1.11e-9	Coronary artery disease;
SKCM	cis	rs7829975	0.593	rs2921064	chr8:8316637	C/T	cg15556689	chr8:8085844	FLJ10661	0.78	6.56	0.6	5.39e-9	Mood instability;
SKCM	cis	rs2033711	0.840	rs3764533	chr19:58929194	A/G	cg03735888	chr19:58951602	ZNF132	0.7	6.08	0.57	4.25e-8	Uric acid clearance;
SKCM	cis	rs2050392	0.630	rs303427	chr10:30739780	G/A	cg25182066	chr10:30743637	MAP3K8	-0.65	-5.89	-0.55	9.29e-8	Inflammatory bowel disease;
SKCM	cis	rs9543976	1.000	rs3818355	chr13:76196867	C/T	cg01531495	chr13:76123901	UCHL3	0.9	4.99	0.49	3.52e-6	Diabetic retinopathy;
SKCM	cis	rs9467773	1.000	rs767471	chr6:26557854	C/T	cg09904177	chr6:26538194	HMGN4	0.54	4.98	0.49	3.78e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2836950	0.545	rs11700813	chr21:40517469	T/G	cg17971929	chr21:40555470	PSMG1	-0.78	-6.48	-0.59	7.44e-9	Menarche (age at onset);
SKCM	cis	rs9399135	0.933	rs7755680	chr6:135294259	A/G	cg24558204	chr6:135376177	HBS1L	0.55	4.98	0.49	3.73e-6	Red blood cell count;
SKCM	cis	rs763014	0.931	rs7199839	chr16:636126	T/C	cg09263875	chr16:632152	PIGQ	0.67	5.82	0.55	1.24e-7	Height;
SKCM	cis	rs3791556	1.000	rs3791558	chr2:240113255	G/A	cg14530444	chr2:239432329	NA	0.62	4.9	0.49	5.03e-6	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);
SKCM	cis	rs9910055	0.593	rs58392387	chr17:42297889	A/G	cg09913183	chr17:42254507	C17orf65;ASB16	0.57	4.81	0.48	7.22e-6	Total body bone mineral density;
SKCM	cis	rs780096	0.526	rs4582	chr2:27604279	A/G	cg05696406	chr2:27599888	SNX17	0.49	5.07	0.5	2.63e-6	Total body bone mineral density;
SKCM	cis	rs1799949	0.929	rs799906	chr17:41278116	T/C	cg25918947	chr17:41365094	TMEM106A	-0.62	-5.9	-0.56	8.91e-8	Menopause (age at onset);
SKCM	cis	rs3857536	0.740	rs9354390	chr6:66890162	C/T	cg07460842	chr6:66804631	NA	0.69	4.97	0.49	3.91e-6	Blood trace element (Cu levels);
SKCM	cis	rs9814567	0.806	rs12637301	chr3:134317966	G/T	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.62	-5.16	-0.5	1.86e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs28595532	0.920	rs116697254	chr4:119733603	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.52	0.53	4.28e-7	Cannabis dependence symptom count;
SKCM	cis	rs12142240	0.698	rs10158130	chr1:46822600	T/C	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs2839186	0.771	rs2280959	chr21:47641996	C/G	cg13012494	chr21:47604986	C21orf56	0.67	5.81	0.55	1.29e-7	Testicular germ cell tumor;
SKCM	cis	rs7100689	0.577	rs9285726	chr10:82035150	A/T	cg01528321	chr10:82214614	TSPAN14	0.81	7.39	0.64	1.42e-10	Post bronchodilator FEV1;
SKCM	cis	rs9303401	0.614	rs34920953	chr17:56589406	G/A	cg02118635	chr17:56770003	RAD51C;TEX14	0.8	5.25	0.51	1.29e-6	Cognitive test performance;
SKCM	cis	rs67311347	0.544	rs35112505	chr3:40337075	A/G	cg13409248	chr3:40428643	ENTPD3	0.57	5.57	0.53	3.48e-7	Renal cell carcinoma;
SKCM	cis	rs3862260	0.509	rs7552885	chr1:120164966	C/T	cg16322792	chr1:120165303	ZNF697	0.5	5.32	0.52	9.47e-7	Systemic lupus erythematosus;
SKCM	cis	rs597539	0.552	rs6591361	chr11:68719284	T/C	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.74	4.92	0.49	4.79e-6	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs453301	0.686	rs7017868	chr8:8873293	G/A	cg15556689	chr8:8085844	FLJ10661	-0.77	-6.1	-0.57	3.89e-8	Joint mobility (Beighton score);
SKCM	cis	rs10504229	1.000	rs117231141	chr8:58185465	A/G	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs929354	0.742	rs2051877	chr7:157008813	A/T	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs4237845	0.537	rs10747787	chr12:58260657	A/G	cg00677455	chr12:58241039	CTDSP2	0.86	7.75	0.66	2.8e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs1005277	0.528	rs2057228	chr10:38515766	T/C	cg00409905	chr10:38381863	ZNF37A	-0.62	-5.82	-0.55	1.24e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs4242434	0.819	rs751680	chr8:22475627	G/A	cg03733263	chr8:22462867	KIAA1967	1.02	8.7	0.7	4.12e-13	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs6424115	0.830	rs3123554	chr1:24196401	C/T	cg10978503	chr1:24200527	CNR2	-0.41	-4.99	-0.49	3.63e-6	Immature fraction of reticulocytes;
SKCM	cis	rs3845702	0.736	rs6433818	chr2:180810264	A/T	cg01881094	chr2:180872142	CWC22	-1.3	-6.15	-0.57	3.07e-8	Schizophrenia;
SKCM	cis	rs28595532	0.841	rs115924581	chr4:119786333	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs453301	0.658	rs12114954	chr8:8904862	T/G	cg06636001	chr8:8085503	FLJ10661	-0.76	-5.59	-0.54	3.18e-7	Joint mobility (Beighton score);
SKCM	cis	rs1005277	0.579	rs2474571	chr10:38384639	T/G	cg00409905	chr10:38381863	ZNF37A	-0.64	-5.89	-0.55	9.24e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs1577917	1.000	rs1337850	chr6:86729103	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.83	-8.07	-0.67	6.96e-12	Response to antipsychotic treatment;
SKCM	cis	rs2832191	0.967	rs2251377	chr21:30530599	T/C	cg24692254	chr21:30365293	RNF160	0.76	6.81	0.61	1.81e-9	Dental caries;
SKCM	cis	rs9880211	1.000	rs6771002	chr3:136241028	T/A	cg21827317	chr3:136751795	NA	-0.65	-4.92	-0.49	4.73e-6	Body mass index;Height;
SKCM	cis	rs2777491	0.915	rs28583065	chr15:41608470	T/C	cg18705301	chr15:41695430	NDUFAF1	-0.98	-9.56	-0.73	9.07e-15	Ulcerative colitis;
SKCM	cis	rs9733	0.818	rs12403609	chr1:150676485	T/C	cg13175981	chr1:150552382	MCL1	0.64	4.86	0.48	5.85e-6	Tonsillectomy;
SKCM	cis	rs8180040	0.871	rs11716661	chr3:47517773	G/T	cg27129171	chr3:47204927	SETD2	-0.8	-5.88	-0.55	9.79e-8	Colorectal cancer;
SKCM	cis	rs71520386	0.632	rs2286509	chr7:22854451	T/C	cg15401507	chr7:22894281	NA	0.66	4.92	0.49	4.66e-6	Fibrinogen levels;
SKCM	cis	rs12142240	0.698	rs7548675	chr1:46809321	C/G	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs2289583	0.544	rs1867153	chr15:75271229	C/T	cg18866210	chr15:74343476	NA	0.61	4.99	0.49	3.6e-6	Systemic lupus erythematosus;
SKCM	cis	rs7666738	0.791	rs6853608	chr4:99047916	A/G	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs28386778	0.742	rs3020617	chr17:61947303	A/G	cg01411255	chr17:61851458	DDX42;CCDC47	0.81	5.19	0.51	1.62e-6	Prudent dietary pattern;
SKCM	cis	rs9911578	0.967	rs1267542	chr17:56654690	T/C	cg05425664	chr17:57184151	TRIM37	0.69	5.2	0.51	1.55e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs4891159	1.000	rs4891159	chr18:74101941	A/G	cg24786174	chr18:74118243	ZNF516	0.7	7.01	0.62	7.43e-10	Longevity;
SKCM	cis	rs2404602	1.000	rs12441433	chr15:76816015	G/A	cg23625390	chr15:77176239	SCAPER	0.76	7.48	0.65	9.68e-11	Blood metabolite levels;
SKCM	cis	rs7296418	0.580	rs78455769	chr12:123856443	G/A	cg05973401	chr12:123451056	ABCB9	0.72	5.48	0.53	5.12e-7	Platelet count;
SKCM	cis	rs597539	0.652	rs673821	chr11:68678718	G/T	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.79	5.32	0.52	9.69e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs6951245	0.872	rs75280240	chr7:1058511	C/T	cg18402987	chr7:1209562	NA	1.14	5.99	0.56	6.11e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs11098499	0.954	rs11935596	chr4:120412457	G/C	cg24375607	chr4:120327624	NA	0.65	5.01	0.49	3.32e-6	Corneal astigmatism;
SKCM	cis	rs873946	0.504	rs3793681	chr10:134564451	T/C	cg27286337	chr10:134555280	INPP5A	1.0	9.47	0.73	1.32e-14	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs4319547	0.695	rs10773103	chr12:122856532	A/G	cg23029597	chr12:123009494	RSRC2	0.72	5.31	0.52	1.01e-6	Body mass index;
SKCM	cis	rs2439831	1.000	rs9920763	chr15:43760508	T/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.46	9.0	0.71	1.09e-13	Lung cancer in ever smokers;
SKCM	cis	rs427394	0.664	rs274697	chr5:6731477	A/C	cg10857441	chr5:6722123	POLS	-0.66	-6.72	-0.61	2.68e-9	Menopause (age at onset);
SKCM	cis	rs1559088	0.600	rs7255229	chr19:33562807	A/G	cg17764715	chr19:33622953	WDR88	0.92	6.76	0.61	2.24e-9	Bone ultrasound measurement (broadband ultrasound attenuation);
SKCM	cis	rs9611565	0.765	rs767593	chr22:41779971	G/T	cg03806693	chr22:41940476	POLR3H	-0.86	-5.89	-0.55	9.19e-8	Vitiligo;
SKCM	cis	rs10779751	0.649	rs1318348	chr1:11130418	A/G	cg08854313	chr1:11322531	MTOR	0.77	5.52	0.53	4.36e-7	Body mass index;
SKCM	cis	rs72949976	0.966	rs6752061	chr2:214027818	C/T	cg08319019	chr2:214017104	IKZF2	-0.74	-5.51	-0.53	4.39e-7	Lung cancer;Squamous cell lung carcinoma;
SKCM	cis	rs7829975	0.688	rs6601703	chr8:8380224	A/G	cg06636001	chr8:8085503	FLJ10661	0.83	7.14	0.63	4.27e-10	Mood instability;
SKCM	cis	rs854765	0.618	rs8068820	chr17:17834119	A/G	cg04398451	chr17:18023971	MYO15A	-0.85	-6.05	-0.57	4.75e-8	Total body bone mineral density;
SKCM	cis	rs10504229	0.724	rs72650827	chr8:58126884	A/T	cg02725872	chr8:58115012	NA	-0.52	-4.97	-0.49	3.92e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs2836974	0.966	rs7283516	chr21:40690537	A/G	cg11644478	chr21:40555479	PSMG1	0.79	6.95	0.62	9.85e-10	Cognitive function;
SKCM	cis	rs9581857	0.685	rs17808758	chr13:28036412	C/T	cg22138327	chr13:27999177	GTF3A	0.93	6.24	0.58	2.1e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs7769051	1.000	rs9493438	chr6:133098349	T/C	cg22852734	chr6:133119734	C6orf192	0.95	5.23	0.51	1.4e-6	Type 2 diabetes nephropathy;
SKCM	cis	rs4780401	0.609	rs4781141	chr16:11808769	A/C	cg01061890	chr16:11836724	TXNDC11	-0.77	-5.59	-0.53	3.27e-7	Rheumatoid arthritis;
SKCM	cis	rs6500395	0.588	rs3826176	chr16:48589062	A/G	cg04672837	chr16:48644449	N4BP1	0.58	4.86	0.48	5.95e-6	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs66573146	0.831	rs6832482	chr4:7023433	A/T	cg00086871	chr4:6988644	TBC1D14	1.32	5.13	0.5	2.02e-6	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs1799949	0.794	rs116409325	chr17:41445460	C/A	cg23758822	chr17:41437982	NA	1.01	7.82	0.66	2.11e-11	Menopause (age at onset);
SKCM	cis	rs2952156	0.959	rs2934952	chr17:37832366	G/A	cg20243544	chr17:37824526	PNMT	0.77	5.89	0.55	9.33e-8	Asthma;
SKCM	cis	rs6121246	0.909	rs7272062	chr20:30259145	A/G	cg11595048	chr20:30225325	COX4I2	0.67	5.21	0.51	1.5e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs7666738	0.830	rs28785514	chr4:98959135	G/A	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs362296	0.698	rs3095081	chr4:3263776	C/T	cg09735869	chr4:3319127	RGS12	-0.73	-6.45	-0.59	8.56e-9	Parental longevity (mother's age at death);
SKCM	cis	rs1799949	0.965	rs8176087	chr17:41270666	C/A	cg25918947	chr17:41365094	TMEM106A	-0.6	-5.5	-0.53	4.63e-7	Menopause (age at onset);
SKCM	cis	rs1707322	1.000	rs1768817	chr1:46514534	C/G	cg03146154	chr1:46216737	IPP	-0.77	-5.36	-0.52	8.35e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs6450176	0.556	rs111423662	chr5:53288661	T/C	ch.5.1024479R	chr5:53302184	ARL15	-0.97	-5.2	-0.51	1.54e-6	HDL cholesterol levels;HDL cholesterol;Adiponectin levels;
SKCM	cis	rs12477438	0.520	rs4347885	chr2:99804007	G/A	cg26064155	chr2:99771622	LIPT1;TSGA10	1.03	9.76	0.74	3.61e-15	Chronic sinus infection;
SKCM	cis	rs1153858	1.000	rs12101539	chr15:45650666	C/G	cg10760299	chr15:45669010	GATM	0.62	6.35	0.58	1.3e-8	Homoarginine levels;
SKCM	trans	rs1814175	0.645	rs28441045	chr11:50048971	C/T	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs9951698	0.678	rs578208	chr18:13068132	C/T	cg12848697	chr18:13133368	NA	-0.54	-4.95	-0.49	4.18e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs6138458	0.717	rs2179732	chr20:25000446	A/T	cg26195577	chr20:24973756	C20orf3	0.91	6.0	0.56	5.94e-8	Blood protein levels;
SKCM	cis	rs514406	0.698	rs511599	chr1:53362818	T/C	cg04310824	chr1:53393297	SCP2	-0.6	-4.88	-0.48	5.44e-6	Monocyte count;
SKCM	cis	rs1348850	0.526	rs2218575	chr2:178368997	C/A	cg27490568	chr2:178487706	NA	0.9	6.9	0.62	1.22e-9	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs2842992	0.715	rs2277073	chr6:160182749	G/A	cg16489826	chr6:160211363	TCP1;MRPL18	0.73	5.42	0.52	6.39e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs875971	0.660	rs801190	chr7:66033033	C/T	cg11987759	chr7:65425863	GUSB	0.69	5.9	0.56	8.74e-8	Aortic root size;
SKCM	cis	rs801193	0.569	rs2659907	chr7:66164032	G/A	cg11764359	chr7:65958608	NA	0.75	6.69	0.6	3e-9	Aortic root size;
SKCM	cis	rs9300255	0.722	rs10773008	chr12:123800820	A/G	cg00376283	chr12:123451042	ABCB9	0.78	5.26	0.51	1.24e-6	Neutrophil percentage of white cells;
SKCM	cis	rs28386778	0.897	rs2584601	chr17:61940977	T/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.13	11.15	0.78	8.36e-18	Prudent dietary pattern;
SKCM	cis	rs7826238	0.601	rs2979206	chr8:8345581	G/C	cg08975724	chr8:8085496	FLJ10661	0.67	5.18	0.51	1.68e-6	Systolic blood pressure;
SKCM	cis	rs6952808	0.723	rs55689856	chr7:2037215	G/A	cg21782813	chr7:2030301	MAD1L1	0.57	5.86	0.55	1.05e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs77106637	0.860	rs11603334	chr11:72432985	G/A	cg03713592	chr11:72463424	ARAP1	1.06	5.79	0.55	1.39e-7	Type 2 diabetes;
SKCM	cis	rs10870270	0.956	rs11146425	chr10:133734261	C/T	cg17892150	chr10:133769511	PPP2R2D	-0.66	-4.89	-0.48	5.37e-6	Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals;
SKCM	cis	rs9788682	0.747	rs8042374	chr15:78908032	A/G	cg24631222	chr15:78858424	CHRNA5	0.8	5.81	0.55	1.3e-7	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	trans	rs561341	0.883	rs7406056	chr17:30220224	C/T	cg20587970	chr11:113659929	NA	-1.06	-8.37	-0.69	1.82e-12	Hip circumference adjusted for BMI;
SKCM	cis	rs9290065	0.538	rs898682	chr3:160773133	G/C	cg03342759	chr3:160939853	NMD3	-0.71	-6.1	-0.57	3.78e-8	Kawasaki disease;
SKCM	cis	rs1577917	0.883	rs2166664	chr6:86596622	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.7	-6.22	-0.58	2.28e-8	Response to antipsychotic treatment;
SKCM	cis	rs7927771	0.864	rs7107726	chr11:47429245	T/A	cg01152729	chr11:47593274	PTPMT1	-0.51	-4.92	-0.49	4.64e-6	Subjective well-being;
SKCM	cis	rs7539542	0.622	rs4950892	chr1:202900918	A/G	cg19681188	chr1:202830198	LOC148709	0.66	4.85	0.48	6.16e-6	Mean platelet volume;
SKCM	cis	rs453301	0.653	rs1045529	chr8:8890098	A/G	cg15556689	chr8:8085844	FLJ10661	-0.7	-5.8	-0.55	1.34e-7	Joint mobility (Beighton score);
SKCM	cis	rs35146811	0.731	rs2257213	chr7:99810113	T/C	cg22906224	chr7:99728672	NA	-0.71	-5.61	-0.54	2.95e-7	Coronary artery disease;
SKCM	cis	rs9796	0.621	rs12324159	chr15:41462468	G/A	cg18705301	chr15:41695430	NDUFAF1	-0.74	-5.63	-0.54	2.74e-7	Menopause (age at onset);
SKCM	cis	rs12540874	0.698	rs13234331	chr7:50560314	G/T	cg18232548	chr7:50535776	DDC	-0.86	-6.2	-0.57	2.55e-8	Systemic sclerosis;
SKCM	cis	rs11098499	0.738	rs10026493	chr4:120384194	C/G	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs80130819	0.748	rs2732487	chr12:48686741	T/C	cg13203223	chr12:49319398	FKBP11	0.88	4.86	0.48	6.03e-6	Prostate cancer;
SKCM	cis	rs4423214	0.840	rs1792235	chr11:71181473	C/T	cg05163923	chr11:71159392	DHCR7	-0.71	-6.16	-0.57	2.96e-8	Vitamin D levels;
SKCM	cis	rs9611565	0.592	rs1811113	chr22:42073134	C/T	cg03806693	chr22:41940476	POLR3H	1.12	7.53	0.65	7.69e-11	Vitiligo;
SKCM	cis	rs72949976	0.934	rs1922794	chr2:214026181	G/A	cg08319019	chr2:214017104	IKZF2	-0.74	-5.51	-0.53	4.39e-7	Lung cancer;Squamous cell lung carcinoma;
SKCM	cis	rs6120849	0.754	rs6088682	chr20:33615702	A/C	cg24642439	chr20:33292090	TP53INP2	0.94	4.86	0.48	5.91e-6	Protein C levels;
SKCM	cis	rs9916302	0.904	rs11078915	chr17:37715426	T/C	cg07936489	chr17:37558343	FBXL20	-0.9	-8.15	-0.68	4.86e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs9926296	0.509	rs2159113	chr16:89832083	C/T	cg26513180	chr16:89883248	FANCA	0.91	7.25	0.63	2.6e-10	Vitiligo;
SKCM	cis	rs1577917	0.958	rs12196377	chr6:86566775	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.87	-8.71	-0.7	3.92e-13	Response to antipsychotic treatment;
SKCM	cis	rs911263	0.961	rs28498223	chr14:68728425	C/T	cg18825221	chr14:68749962	RAD51L1	-0.49	-5.23	-0.51	1.38e-6	Primary biliary cholangitis;
SKCM	cis	rs798766	0.909	rs11724531	chr4:1753424	A/G	cg05874882	chr4:1763078	NA	-0.6	-4.89	-0.48	5.34e-6	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs17826219	0.636	rs79565452	chr17:29142841	T/C	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Body mass index;
SKCM	cis	rs1552244	0.872	rs6792951	chr3:10119603	C/A	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs9660180	0.935	rs2180311	chr1:1748734	T/C	cg13866156	chr1:1669148	SLC35E2	-0.72	-6.0	-0.56	5.95e-8	Body mass index;
SKCM	cis	rs1552244	1.000	rs111392584	chr3:10075991	A/G	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs3820928	1.000	rs4675115	chr2:227769123	C/G	cg11843606	chr2:227700838	RHBDD1	-0.63	-4.93	-0.49	4.47e-6	Pulmonary function;
SKCM	cis	rs1577917	1.000	rs10455158	chr6:86672825	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.86	-8.61	-0.7	6.29e-13	Response to antipsychotic treatment;
SKCM	cis	rs1862618	0.853	rs861283	chr5:56184610	C/T	cg12311346	chr5:56204834	C5orf35	-0.76	-5.02	-0.49	3.2e-6	Initial pursuit acceleration;
SKCM	cis	rs2991971	0.967	rs60608374	chr1:46008913	G/A	cg24296786	chr1:45957014	TESK2	0.66	5.34	0.52	9.08e-7	High light scatter reticulocyte count;
SKCM	cis	rs6951245	0.744	rs10265736	chr7:1172465	C/T	cg03188948	chr7:1209495	NA	1.04	6.69	0.6	3.04e-9	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7772486	0.720	rs7752286	chr6:146072662	C/T	cg23711669	chr6:146136114	FBXO30	-0.89	-10.12	-0.75	7.58e-16	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs860295	0.702	rs11264387	chr1:155563152	G/T	cg02153340	chr1:155202674	NA	-0.81	-6.17	-0.57	2.9e-8	Body mass index;
SKCM	cis	rs738322	1.000	rs133012	chr22:38570721	G/A	cg25457927	chr22:38595422	NA	-0.54	-6.14	-0.57	3.27e-8	Cutaneous nevi;
SKCM	cis	rs9790314	0.690	rs7651087	chr3:160821929	T/C	cg03342759	chr3:160939853	NMD3	-0.67	-6.68	-0.6	3.16e-9	Morning vs. evening chronotype;
SKCM	cis	rs9814567	1.000	rs3932818	chr3:134206069	A/G	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.69	-5.47	-0.53	5.15e-7	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs35146811	0.735	rs1636978	chr7:99813912	G/A	cg22906224	chr7:99728672	NA	-0.71	-5.61	-0.54	2.95e-7	Coronary artery disease;
SKCM	cis	rs7552404	0.924	rs1858536	chr1:76161595	G/T	cg03433033	chr1:76189801	ACADM	0.78	5.67	0.54	2.36e-7	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs16948098	1	rs16948098	chr15:44219607	G/A	cg02155558	chr15:43621948	ADAL;LCMT2	1.65	5.95	0.56	7.15e-8	Serum albumin level;
SKCM	cis	rs7000551	0.556	rs6998780	chr8:22254639	C/T	cg12081754	chr8:22256438	SLC39A14	1.05	11.66	0.8	9.01e-19	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs6753739	0.871	rs1869802	chr2:219977033	A/C	cg09617556	chr2:219924408	IHH	0.48	5.08	0.5	2.5e-6	Height;
SKCM	cis	rs58688157	0.542	rs7926440	chr11:589819	C/T	cg17114584	chr11:613792	IRF7	0.78	5.11	0.5	2.26e-6	Systemic lupus erythematosus;
SKCM	cis	rs72960926	0.744	rs1552568	chr6:75035349	G/T	cg14611727	chr6:76022250	FILIP1	0.73	4.84	0.48	6.52e-6	Metabolite levels (MHPG);
SKCM	cis	rs7666738	0.830	rs7672720	chr4:98938760	A/T	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7772486	0.840	rs854144	chr6:146360880	G/T	cg23711669	chr6:146136114	FBXO30	-0.86	-6.99	-0.62	8.4e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7811142	1.000	rs67239991	chr7:100046504	A/G	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.17	7.71	0.66	3.44e-11	Platelet count;
SKCM	cis	rs5753618	0.561	rs5753609	chr22:31819212	A/G	cg02404636	chr22:31891804	SFI1	0.61	5.61	0.54	2.93e-7	Colorectal cancer;
SKCM	trans	rs1814175	0.817	rs4881648	chr11:49812901	A/G	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs9300255	0.602	rs6488864	chr12:123618362	G/C	cg05973401	chr12:123451056	ABCB9	0.78	5.29	0.51	1.09e-6	Neutrophil percentage of white cells;
SKCM	cis	rs7179456	0.545	rs2250583	chr15:59050382	C/T	cg05156742	chr15:59063176	FAM63B	-0.82	-6.18	-0.57	2.7e-8	Asperger disorder;
SKCM	cis	rs10911232	0.507	rs4652772	chr1:183023696	C/G	ch.1.3577855R	chr1:183094577	LAMC1	-0.73	-6.68	-0.6	3.18e-9	Hypertriglyceridemia;
SKCM	cis	rs11105298	0.891	rs10858906	chr12:89934474	C/T	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.85	-5.31	-0.52	1e-6	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs17685	0.712	rs4552844	chr7:75718095	A/G	cg16489192	chr7:75678113	MDH2;STYXL1	-0.58	-5.46	-0.53	5.43e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1577917	0.958	rs12209259	chr6:86502348	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.38	-0.52	7.52e-7	Response to antipsychotic treatment;
SKCM	cis	rs1348850	0.958	rs10930800	chr2:178459669	T/C	cg02961200	chr2:178257176	LOC100130691;AGPS	0.83	6.31	0.58	1.6e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs1863918	0.560	rs2411985	chr5:178494553	T/C	cg21905437	chr5:178450457	ZNF879	-0.62	-5.44	-0.52	5.86e-7	Depression in response to interferon-based therapy in chronic hepatitis C;
SKCM	trans	rs1814175	0.645	rs1721996	chr11:49915527	G/A	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	trans	rs561341	0.882	rs28649357	chr17:30367190	A/G	cg20587970	chr11:113659929	NA	-1.14	-9.72	-0.74	4.41e-15	Hip circumference adjusted for BMI;
SKCM	cis	rs1267303	0.642	rs114746843	chr1:46999239	C/A	cg25110126	chr1:46999211	NA	0.75	5.57	0.53	3.51e-7	Monobrow;
SKCM	cis	rs11673344	0.764	rs13345491	chr19:37473099	G/T	cg07624650	chr19:37064219	ZNF529	-0.78	-4.82	-0.48	7.05e-6	Obesity-related traits;
SKCM	cis	rs9640161	0.789	rs2373751	chr7:150021599	G/C	cg27494647	chr7:150038898	RARRES2	0.58	4.98	0.49	3.74e-6	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs2816062	0.786	rs2745317	chr1:18896552	G/A	cg18795169	chr1:18902165	NA	-0.83	-9.02	-0.71	1.01e-13	Urate levels in lean individuals;
SKCM	cis	rs1577917	0.916	rs12198730	chr6:86555138	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.87	-8.71	-0.7	3.92e-13	Response to antipsychotic treatment;
SKCM	cis	rs3784262	0.631	rs4646584	chr15:58305402	C/T	cg12031962	chr15:58353849	ALDH1A2	-0.42	-4.89	-0.48	5.38e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs2120019	0.935	rs34913788	chr15:75372617	A/C	cg09165964	chr15:75287851	SCAMP5	-0.78	-6.63	-0.6	3.95e-9	Blood trace element (Zn levels);
SKCM	cis	rs2952156	0.920	rs732083	chr17:37834367	G/A	cg00129232	chr17:37814104	STARD3	-0.72	-6.2	-0.57	2.48e-8	Asthma;
SKCM	cis	rs10504229	0.683	rs16921823	chr8:58108612	G/C	cg02725872	chr8:58115012	NA	-0.53	-4.91	-0.49	4.82e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs3008870	1.000	rs58680688	chr1:67443751	C/G	cg08660285	chr1:67390436	MIER1;WDR78	-0.92	-6.07	-0.57	4.27e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs1799949	0.929	rs799906	chr17:41278116	T/C	cg23758822	chr17:41437982	NA	0.93	7.62	0.65	5.1e-11	Menopause (age at onset);
SKCM	cis	rs2243480	1.000	rs60683927	chr7:65394768	T/C	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs9790314	0.601	rs1450519	chr3:161094930	A/G	cg03342759	chr3:160939853	NMD3	-0.76	-6.45	-0.59	8.44e-9	Morning vs. evening chronotype;
SKCM	cis	rs2732480	0.577	rs2732457	chr12:48758379	A/G	cg21348975	chr12:48724119	NA	0.65	5.82	0.55	1.24e-7	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs1799949	0.602	rs8176199	chr17:41230524	T/G	cg23758822	chr17:41437982	NA	0.79	5.3	0.51	1.04e-6	Menopause (age at onset);
SKCM	cis	rs6582630	0.502	rs11610978	chr12:38356957	C/G	cg26384229	chr12:38710491	ALG10B	0.79	6.56	0.6	5.34e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs995000	0.899	rs1168045	chr1:62982891	C/T	cg06896770	chr1:63153194	DOCK7	-0.75	-6.89	-0.61	1.29e-9	Triglyceride levels;
SKCM	cis	rs7666738	0.546	rs28590002	chr4:98722642	C/T	cg17366294	chr4:99064904	C4orf37	0.62	4.94	0.49	4.37e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs780096	0.526	rs780112	chr2:27665361	C/G	cg05696406	chr2:27599888	SNX17	0.51	5.22	0.51	1.46e-6	Total body bone mineral density;
SKCM	cis	rs8141529	0.778	rs5762795	chr22:29182500	C/A	cg15103426	chr22:29168792	CCDC117	0.61	5.06	0.5	2.7e-6	Lymphocyte counts;
SKCM	cis	rs208520	0.526	rs9351542	chr6:66788571	A/G	cg07460842	chr6:66804631	NA	-1.17	-12.95	-0.83	3.93e-21	Exhaled nitric oxide output;
SKCM	cis	rs28386778	0.829	rs1877317	chr17:61776479	T/C	cg01411255	chr17:61851458	DDX42;CCDC47	0.78	5.01	0.49	3.32e-6	Prudent dietary pattern;
SKCM	cis	rs12142240	0.698	rs45517837	chr1:46859225	A/G	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs9916302	0.660	rs4795367	chr17:37608843	G/C	cg07936489	chr17:37558343	FBXL20	-1.0	-6.99	-0.62	8.41e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs2228479	0.850	rs2238527	chr16:89840708	C/A	cg06558623	chr16:89946397	TCF25	1.06	4.84	0.48	6.45e-6	Skin colour saturation;
SKCM	cis	rs244731	1.000	rs244731	chr5:176539679	C/T	cg17509989	chr5:176798049	RGS14	0.86	5.76	0.55	1.58e-7	Urate levels in lean individuals;
SKCM	cis	rs362296	0.671	rs3095074	chr4:3261152	G/A	cg11471262	chr4:3318911	RGS12	-0.79	-7.34	-0.64	1.78e-10	Parental longevity (mother's age at death);
SKCM	cis	rs8077889	1.000	rs4793035	chr17:41887753	C/T	cg26893861	chr17:41843967	DUSP3	1.13	7.37	0.64	1.58e-10	Triglycerides;
SKCM	cis	rs1577917	0.958	rs13207173	chr6:86457522	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.6	-5.1	-0.5	2.3e-6	Response to antipsychotic treatment;
SKCM	cis	rs10504229	1.000	rs55787104	chr8:58178519	C/T	cg22535103	chr8:58192502	C8orf71	-0.68	-4.86	-0.48	6.01e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs66887589	0.775	rs6843229	chr4:120424087	T/C	cg09307838	chr4:120376055	NA	0.67	4.79	0.48	7.67e-6	Diastolic blood pressure;
SKCM	cis	rs6835098	0.961	rs11737748	chr4:174130503	T/C	cg08422745	chr4:174089978	GALNT7	0.85	6.55	0.6	5.69e-9	Dementia and core Alzheimer's disease neuropathologic changes;
SKCM	cis	rs2839186	0.749	rs62226489	chr21:47710519	T/C	cg13126279	chr21:47581558	C21orf56	-0.64	-5.47	-0.53	5.17e-7	Testicular germ cell tumor;
SKCM	cis	rs9388451	0.872	rs2008027	chr6:126052359	A/G	cg05901451	chr6:126070800	HEY2	-0.79	-7.95	-0.67	1.19e-11	Brugada syndrome;
SKCM	cis	rs7618501	0.633	rs55751738	chr3:49972101	A/G	cg05072774	chr3:49840536	C3orf54	-0.66	-5.03	-0.49	3.12e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs25645	0.800	rs11078935	chr17:38192137	T/G	cg17467752	chr17:38218738	THRA	-0.79	-6.53	-0.59	6.06e-9	Myeloid white cell count;
SKCM	cis	rs3087591	0.919	rs2018624	chr17:29560777	T/G	cg24425628	chr17:29625626	OMG;NF1	-0.64	-5.22	-0.51	1.43e-6	Hip circumference;
SKCM	cis	rs12586317	0.547	rs28569331	chr14:35473584	T/C	cg16230307	chr14:35515116	FAM177A1	0.81	5.88	0.55	9.47e-8	Psoriasis;
SKCM	cis	rs561341	0.941	rs2428341	chr17:30317295	C/T	cg23018236	chr17:30244563	NA	-0.54	-5.47	-0.53	5.29e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs8060686	0.641	rs113896227	chr16:68101480	C/T	cg09117114	chr16:67998030	SLC12A4	-0.81	-5.29	-0.51	1.07e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs12120353	0.702	rs705688	chr1:4549111	G/C	cg15022359	chr1:4193126	NA	-0.63	-5.24	-0.51	1.31e-6	Anxiety disorder;
SKCM	cis	rs793571	0.566	rs1648532	chr15:59076778	G/C	cg05156742	chr15:59063176	FAM63B	0.68	4.84	0.48	6.5e-6	Schizophrenia;
SKCM	cis	rs951366	0.789	rs823097	chr1:205681370	G/A	cg14893161	chr1:205819251	PM20D1	0.93	8.36	0.69	1.87e-12	Menarche (age at onset);
SKCM	cis	rs860295	0.580	rs11264358	chr1:155280164	T/C	cg02153340	chr1:155202674	NA	-0.78	-5.42	-0.52	6.37e-7	Body mass index;
SKCM	cis	rs6500395	1.000	rs9936454	chr16:48617782	T/G	cg04672837	chr16:48644449	N4BP1	0.69	5.88	0.55	9.68e-8	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs6570726	0.935	rs432086	chr6:145841593	C/T	cg23711669	chr6:146136114	FBXO30	-0.7	-6.64	-0.6	3.76e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs11098499	0.657	rs71614442	chr4:120379346	C/T	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs28595532	0.920	rs115683389	chr4:119735557	T/G	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs116095464	1.000	rs6873902	chr5:313337	C/G	cg22857025	chr5:266934	NA	-1.64	-6.14	-0.57	3.18e-8	Breast cancer;
SKCM	cis	rs898097	0.841	rs9896263	chr17:80902741	A/G	cg15369054	chr17:80825471	TBCD	-0.65	-6.14	-0.57	3.22e-8	Breast cancer;
SKCM	cis	rs2282032	1.000	rs114316342	chr14:90736477	C/T	cg04374321	chr14:90722782	PSMC1	0.69	4.78	0.48	8.03e-6	Longevity;
SKCM	cis	rs7618915	1.000	rs34569561	chr3:52287293	T/C	cg18404041	chr3:52824283	ITIH1	-0.6	-5.45	-0.53	5.65e-7	Bipolar disorder;
SKCM	cis	rs2842992	0.872	rs2758315	chr6:160158640	T/C	cg11366901	chr6:160182831	ACAT2	0.91	7.59	0.65	5.9e-11	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs826838	0.834	rs2387842	chr12:38736442	T/C	cg26384229	chr12:38710491	ALG10B	1.11	9.83	0.74	2.66e-15	Heart rate;
SKCM	cis	rs2404602	0.669	rs8036703	chr15:76951040	A/G	cg23625390	chr15:77176239	SCAPER	0.59	5.19	0.51	1.66e-6	Blood metabolite levels;
SKCM	cis	rs2032447	0.901	rs2213284	chr6:26031868	G/A	cg18357526	chr6:26021779	HIST1H4A	0.84	7.17	0.63	3.78e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs28595532	0.623	rs34531766	chr4:119230339	T/C	cg21605333	chr4:119757512	SEC24D	1.17	7.18	0.63	3.55e-10	Cannabis dependence symptom count;
SKCM	cis	rs3796619	0.961	rs11732520	chr4:1074009	C/T	cg27284194	chr4:1044797	NA	0.67	4.8	0.48	7.53e-6	Recombination rate (males);
SKCM	cis	rs11249608	0.548	rs11958355	chr5:178451640	T/C	cg21905437	chr5:178450457	ZNF879	0.76	6.46	0.59	8.29e-9	Pubertal anthropometrics;
SKCM	cis	rs7811142	1.000	rs11771419	chr7:99988403	A/G	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.16	7.68	0.66	3.87e-11	Platelet count;
SKCM	cis	rs1799949	1.000	rs11659028	chr17:41195025	T/A	cg25072359	chr17:41440525	NA	0.63	4.82	0.48	6.96e-6	Menopause (age at onset);
SKCM	cis	rs4891159	0.756	rs3892540	chr18:74118058	C/T	cg24786174	chr18:74118243	ZNF516	-0.76	-7.35	-0.64	1.71e-10	Longevity;
SKCM	cis	rs875971	0.862	rs11765791	chr7:65936574	A/G	cg11764359	chr7:65958608	NA	0.75	6.79	0.61	1.95e-9	Aortic root size;
SKCM	cis	rs9399135	0.967	rs11756988	chr6:135347595	A/G	cg24558204	chr6:135376177	HBS1L	0.6	5.36	0.52	8.17e-7	Red blood cell count;
SKCM	cis	rs9581857	0.547	rs9581876	chr13:28101113	T/C	cg22138327	chr13:27999177	GTF3A	0.84	5.46	0.53	5.47e-7	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs10752881	0.967	rs6695837	chr1:182991462	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.64	0.6	3.83e-9	Colorectal cancer;
SKCM	cis	rs2839186	0.967	rs2839191	chr21:47695395	C/G	cg13126279	chr21:47581558	C21orf56	-0.63	-5.28	-0.51	1.11e-6	Testicular germ cell tumor;
SKCM	cis	rs1538970	0.816	rs11211124	chr1:45962409	T/C	cg05343316	chr1:45956843	TESK2	0.94	4.82	0.48	7.07e-6	Platelet count;
SKCM	cis	rs3093024	0.595	rs4458654	chr6:167476068	A/C	cg07741184	chr6:167504864	NA	0.58	4.92	0.49	4.76e-6	Rheumatoid arthritis;
SKCM	cis	rs7927771	1.000	rs35624992	chr11:47615798	G/C	cg05585544	chr11:47624801	NA	-0.63	-5.5	-0.53	4.73e-7	Subjective well-being;
SKCM	cis	rs6951245	1.000	rs76388414	chr7:1100694	G/A	cg03188948	chr7:1209495	NA	1.13	6.27	0.58	1.89e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7666738	0.830	rs35491210	chr4:99003364	T/C	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs8067354	0.645	rs11079389	chr17:57887952	G/A	cg02344993	chr17:57696989	CLTC	0.67	4.79	0.48	7.85e-6	Hemoglobin concentration;
SKCM	cis	rs4319547	0.695	rs10846746	chr12:122868696	C/T	cg23029597	chr12:123009494	RSRC2	0.72	5.31	0.52	1.01e-6	Body mass index;
SKCM	cis	rs1395	1.000	rs1275537	chr2:27441302	C/G	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.5	5.13	0.5	2.1e-6	Blood metabolite levels;
SKCM	cis	rs6138458	0.626	rs6050259	chr20:25011423	A/G	cg26195577	chr20:24973756	C20orf3	0.89	5.88	0.55	9.7e-8	Blood protein levels;
SKCM	cis	rs875971	0.789	rs28815324	chr7:65565776	A/T	cg18876405	chr7:65276391	NA	-0.67	-5.32	-0.52	9.82e-7	Aortic root size;
SKCM	trans	rs1814175	0.616	rs10839388	chr11:49842603	C/T	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs6570726	0.791	rs425999	chr6:145819370	C/A	cg23711669	chr6:146136114	FBXO30	0.79	7.93	0.67	1.26e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6952808	0.656	rs12699646	chr7:2093162	T/G	cg02951883	chr7:2050386	MAD1L1	0.86	7.69	0.66	3.76e-11	Bipolar disorder and schizophrenia;
SKCM	cis	rs7666738	0.830	rs7662948	chr4:99020132	G/C	cg17366294	chr4:99064904	C4orf37	0.6	4.94	0.49	4.41e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2075671	0.903	rs11520986	chr7:100276994	A/G	cg20848291	chr7:100343083	ZAN	-0.71	-5.38	-0.52	7.64e-7	Other erythrocyte phenotypes;
SKCM	cis	rs6570726	0.905	rs442435	chr6:145815559	C/T	cg23711669	chr6:146136114	FBXO30	0.68	6.53	0.59	6.07e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2180341	0.960	rs9401953	chr6:127687574	G/A	cg24812749	chr6:127587940	RNF146	0.83	7.18	0.63	3.63e-10	Breast cancer;
SKCM	cis	rs2439831	1.000	rs2254321	chr15:43707542	T/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.21	8.15	0.68	4.78e-12	Lung cancer in ever smokers;
SKCM	cis	rs854765	0.624	rs7501812	chr17:17750907	G/A	cg24612305	chr17:17875800	TOM1L2;LRRC48	-0.97	-7.44	-0.64	1.15e-10	Total body bone mineral density;
SKCM	cis	rs9902453	0.845	rs2617875	chr17:28090024	G/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.81	5.78	0.55	1.46e-7	Coffee consumption (cups per day);
SKCM	cis	rs2760061	0.626	rs2527615	chr1:228119283	A/G	cg02753203	chr1:228287806	NA	-0.6	-4.85	-0.48	6.13e-6	Diastolic blood pressure;
SKCM	cis	rs10504229	0.679	rs56040464	chr8:58131603	G/A	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs4862750	0.872	rs6830426	chr4:187897270	T/A	cg10295955	chr4:187884368	NA	-1.04	-14.07	-0.85	4.23e-23	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9583531	0.600	rs9555724	chr13:111354110	C/T	cg24331049	chr13:111365604	ING1	-0.82	-6.17	-0.57	2.81e-8	Coronary artery disease;
SKCM	cis	rs7829975	0.688	rs7837587	chr8:8378992	T/C	cg06636001	chr8:8085503	FLJ10661	0.85	7.36	0.64	1.62e-10	Mood instability;
SKCM	cis	rs3091242	0.933	rs61775174	chr1:25787313	G/A	cg27572855	chr1:25598939	RHD	-0.55	-5.19	-0.51	1.61e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs7772486	0.790	rs2250387	chr6:146205233	C/T	cg05347473	chr6:146136440	FBXO30	0.54	4.98	0.49	3.74e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs10416265	0.527	rs7246814	chr19:33538414	G/T	cg17764715	chr19:33622953	WDR88	0.74	5.43	0.52	6.08e-7	Bone properties (heel);
SKCM	cis	rs16949788	1.000	rs16949849	chr15:66682709	A/G	cg08120210	chr15:66682733	MAP2K1	-0.74	-5.82	-0.55	1.23e-7	Spherical equivalent (joint analysis main effects and education interaction);
SKCM	cis	rs1577917	1.000	rs34622557	chr6:86630852	C/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.66	-5.74	-0.54	1.76e-7	Response to antipsychotic treatment;
SKCM	cis	rs1065656	0.553	rs344357	chr16:1836255	C/G	cg00046913	chr16:1877150	HAGH;FAHD1	-0.73	-4.85	-0.48	6.3e-6	Insulin-like growth factors;
SKCM	cis	rs10504073	0.669	rs62507251	chr8:50028524	T/G	cg00325661	chr8:49890786	NA	0.79	6.76	0.61	2.29e-9	Blood metabolite ratios;
SKCM	cis	rs10504229	0.906	rs7006539	chr8:58178799	A/T	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs9300255	0.602	rs1716167	chr12:123651162	C/T	cg00376283	chr12:123451042	ABCB9	-0.8	-5.4	-0.52	7.12e-7	Neutrophil percentage of white cells;
SKCM	cis	rs34779708	0.966	rs998658	chr10:35408654	A/G	cg03585969	chr10:35415529	CREM	0.81	6.34	0.58	1.39e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs7829975	0.593	rs2921061	chr8:8317615	A/T	cg08975724	chr8:8085496	FLJ10661	0.73	6.16	0.57	2.96e-8	Mood instability;
SKCM	cis	rs1843834	0.539	rs6713629	chr2:225410973	A/T	cg12698349	chr2:225449008	CUL3	0.85	7.03	0.62	6.88e-10	IgE levels in asthmatics (D.p. specific);
SKCM	cis	rs2594989	0.887	rs9985349	chr3:11591200	T/G	cg00170343	chr3:11313890	ATG7	-0.99	-5.54	-0.53	3.95e-7	Circulating chemerin levels;
SKCM	cis	rs12458462	0.859	rs2242177	chr18:77477379	G/A	cg11879182	chr18:77439856	CTDP1	0.9	7.79	0.66	2.42e-11	Monocyte count;
SKCM	cis	rs9399137	0.507	rs13196486	chr6:135283874	C/G	cg24558204	chr6:135376177	HBS1L	0.69	6.37	0.59	1.19e-8	Glycated hemoglobin levels;Mean corpuscular volume;Hematology traits;HbA2 levels;Mean corpuscular hemoglobin;Hemoglobin levels;F-cell distribution;Platelet count;
SKCM	cis	rs763121	0.886	rs1013339	chr22:38974680	C/T	cg06022373	chr22:39101656	GTPBP1	0.85	6.01	0.56	5.69e-8	Menopause (age at onset);
SKCM	cis	rs4925386	0.959	rs6121989	chr20:60916713	A/T	cg24112000	chr20:60950667	NA	0.63	6.16	0.57	3.02e-8	Colorectal cancer;Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs17376456	0.877	rs10044066	chr5:93437580	T/C	cg25358565	chr5:93447407	FAM172A	1.23	7.97	0.67	1.08e-11	Diabetic retinopathy;
SKCM	cis	rs9911578	0.757	rs4793954	chr17:56629527	G/T	cg12560992	chr17:57184187	TRIM37	-0.8	-5.66	-0.54	2.4e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs8180040	1.000	rs1638676	chr3:47327651	A/G	cg27129171	chr3:47204927	SETD2	0.87	6.62	0.6	4.15e-9	Colorectal cancer;
SKCM	cis	rs8141529	0.732	rs6005881	chr22:29183133	A/G	cg02153584	chr22:29168773	CCDC117	0.68	5.57	0.53	3.52e-7	Lymphocyte counts;
SKCM	cis	rs7680126	0.632	rs11731464	chr4:10148376	G/A	cg09374173	chr4:9383942	NA	0.69	4.8	0.48	7.46e-6	Urate levels in lean individuals;Urate levels in overweight individuals;Urate levels in obese individuals;
SKCM	cis	rs7937682	0.593	rs1113851	chr11:111354161	G/A	cg09085632	chr11:111637200	PPP2R1B	0.71	5.49	0.53	4.9e-7	Primary sclerosing cholangitis;
SKCM	cis	rs35306767	0.903	rs12762228	chr10:880854	G/A	cg26597838	chr10:835615	NA	0.79	5.77	0.55	1.54e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs1635	0.826	rs2299030	chr6:28198755	A/G	cg15743358	chr6:28303923	ZNF323	-1.26	-4.99	-0.49	3.57e-6	Schizophrenia;
SKCM	cis	rs2304069	0.954	rs4705409	chr5:149414899	A/G	cg22760475	chr5:149380129	HMGXB3;TIGD6	0.9	6.14	0.57	3.18e-8	HIV-1 control;
SKCM	cis	rs826838	0.510	rs10876149	chr12:39228083	C/G	cg26384229	chr12:38710491	ALG10B	-0.69	-5.24	-0.51	1.32e-6	Heart rate;
SKCM	cis	rs873946	0.517	rs7071784	chr10:134559980	T/C	cg26818010	chr10:134567672	INPP5A	-0.69	-5.34	-0.52	9.05e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs56235845	0.964	rs4075958	chr5:176784512	A/G	cg17509989	chr5:176798049	RGS14	-0.94	-8.24	-0.68	3.2e-12	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs2204008	0.687	rs11181339	chr12:38322271	G/T	cg26384229	chr12:38710491	ALG10B	0.78	6.53	0.59	6.22e-9	Bladder cancer;
SKCM	cis	rs2439831	0.850	rs28891769	chr15:44072860	C/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.35	7.75	0.66	2.9e-11	Lung cancer in ever smokers;
SKCM	cis	rs709400	0.663	rs17617941	chr14:103953032	T/C	cg26031613	chr14:104095156	KLC1	0.77	5.96	0.56	6.87e-8	Body mass index;
SKCM	cis	rs17345786	0.511	rs12639028	chr3:101346033	G/C	cg12386194	chr3:101231763	SENP7	0.77	6.43	0.59	9.34e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6570726	0.526	rs72994723	chr6:145722948	G/A	cg23711669	chr6:146136114	FBXO30	-0.65	-6.06	-0.57	4.5e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6500395	0.962	rs1039341	chr16:48574869	C/T	cg04672837	chr16:48644449	N4BP1	0.69	5.6	0.54	3.1e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs6951245	1.000	rs77083167	chr7:1071823	C/T	cg03188948	chr7:1209495	NA	1.12	6.17	0.57	2.88e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs919433	1.000	rs1346649	chr2:198166117	C/A	cg04278110	chr2:198063759	ANKRD44	-0.72	-5.33	-0.52	9.25e-7	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs908922	0.676	rs1856120	chr1:152512441	G/A	cg09873164	chr1:152488093	CRCT1	0.76	5.93	0.56	7.7e-8	Hair morphology;
SKCM	cis	rs9902453	0.967	rs1042173	chr17:28525011	A/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.75	5.19	0.51	1.65e-6	Coffee consumption (cups per day);
SKCM	cis	rs7666738	0.830	rs35939134	chr4:98980311	A/G	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6750795	0.542	rs1797388	chr2:232415981	T/G	cg19187155	chr2:232395269	NMUR1	0.94	8.31	0.69	2.32e-12	Height;
SKCM	cis	rs875971	0.895	rs1833495	chr7:65921595	T/C	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs2839186	0.732	rs55904887	chr21:47707811	A/G	cg05896524	chr21:47604654	C21orf56	0.69	5.67	0.54	2.29e-7	Testicular germ cell tumor;
SKCM	cis	rs55962025	0.737	rs2237006	chr4:3228492	A/G	cg00764545	chr4:3318001	RGS12	-0.62	-5.4	-0.52	7.08e-7	Parental longevity (mother's age at death);
SKCM	cis	rs6570726	0.935	rs454370	chr6:145846729	T/G	cg23711669	chr6:146136114	FBXO30	0.7	6.71	0.61	2.78e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1669338	0.588	rs7629889	chr3:3187643	C/T	cg16797762	chr3:3221439	CRBN	-0.92	-5.6	-0.54	3.04e-7	White matter integrity;
SKCM	cis	rs875971	0.545	rs2460427	chr7:65619205	T/C	cg18876405	chr7:65276391	NA	-0.64	-5.29	-0.51	1.09e-6	Aortic root size;
SKCM	cis	rs9902453	1.000	rs8065059	chr17:28417376	T/C	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.77	-5.5	-0.53	4.67e-7	Coffee consumption (cups per day);
SKCM	cis	rs73001065	0.636	rs56241616	chr19:19506092	C/T	cg03709012	chr19:19516395	GATAD2A	1.16	5.47	0.53	5.19e-7	LDL cholesterol;
SKCM	cis	rs1395	0.626	rs72817537	chr2:27497549	G/A	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.57	5.17	0.51	1.73e-6	Blood metabolite levels;
SKCM	cis	rs12714314	0.756	rs11694479	chr2:1945525	A/G	cg22350835	chr2:1868857	MYT1L	0.67	5.05	0.5	2.87e-6	Type 2 diabetes (age of onset);
SKCM	cis	rs9467773	0.549	rs9461273	chr6:26584526	A/G	cg15659132	chr6:26577336	NA	-0.63	-5.52	-0.53	4.37e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs1552244	0.572	rs3894321	chr3:10168892	A/C	cg00149659	chr3:10157352	C3orf10	1.13	5.45	0.53	5.74e-7	Alzheimer's disease;
SKCM	cis	rs7647973	0.580	rs12629759	chr3:49237394	T/C	cg07636037	chr3:49044803	WDR6	0.8	6.43	0.59	9.48e-9	Menarche (age at onset);
SKCM	cis	rs6570726	0.846	rs397311	chr6:145806701	C/T	cg23711669	chr6:146136114	FBXO30	-0.76	-6.96	-0.62	9.45e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7811142	0.830	rs41280971	chr7:99954457	G/T	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.2	7.87	0.67	1.7e-11	Platelet count;
SKCM	cis	rs2153535	0.601	rs330105	chr6:8543981	A/C	cg07606381	chr6:8435919	SLC35B3	0.89	6.12	0.57	3.57e-8	Motion sickness;
SKCM	cis	rs9739070	1	rs9739070	chr12:123771032	A/G	cg00376283	chr12:123451042	ABCB9	0.78	5.26	0.51	1.24e-6	Allergy;
SKCM	cis	rs10256972	0.552	rs2949195	chr7:1202705	G/A	cg16145915	chr7:1198662	ZFAND2A	-0.57	-8.16	-0.68	4.69e-12	Longevity;Endometriosis;
SKCM	cis	rs9814567	0.727	rs4245908	chr3:134349205	A/T	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.62	-5.0	-0.49	3.46e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs28595532	0.641	rs72670220	chr4:119300053	A/G	cg21605333	chr4:119757512	SEC24D	0.94	5.05	0.5	2.85e-6	Cannabis dependence symptom count;
SKCM	cis	rs1568889	0.941	rs35357280	chr11:28322745	A/G	cg06544937	chr11:28130018	METT5D1;KIF18A	0.88	6.41	0.59	1.02e-8	Bipolar disorder;
SKCM	cis	rs7296418	0.961	rs11613937	chr12:123520071	C/T	cg06742321	chr12:123595122	PITPNM2	0.67	5.67	0.54	2.33e-7	Platelet count;
SKCM	cis	rs514406	0.698	rs1672913	chr1:53408326	A/T	cg08859206	chr1:53392774	SCP2	-0.63	-5.3	-0.51	1.07e-6	Monocyte count;
SKCM	cis	rs1801251	1.000	rs12478564	chr2:233598340	C/T	cg25237894	chr2:233734115	C2orf82	0.58	5.23	0.51	1.36e-6	Coronary artery disease;
SKCM	cis	rs7216064	1.000	rs9912084	chr17:65868035	A/C	cg12091567	chr17:66097778	LOC651250	-0.75	-5.27	-0.51	1.19e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs614226	0.935	rs7956998	chr12:120994932	G/A	cg01236616	chr12:121019343	POP5	1.38	8.73	0.7	3.64e-13	Type 1 diabetes nephropathy;
SKCM	cis	rs9910055	0.571	rs28897216	chr17:42240824	A/G	cg19774624	chr17:42201019	HDAC5	-0.89	-8.19	-0.68	3.96e-12	Total body bone mineral density;
SKCM	cis	rs514406	0.893	rs10888759	chr1:53433274	A/G	cg24675658	chr1:53192096	ZYG11B	0.63	5.12	0.5	2.14e-6	Monocyte count;
SKCM	cis	rs11098499	0.865	rs10213221	chr4:120255926	G/A	cg09307838	chr4:120376055	NA	0.92	7.21	0.63	3.12e-10	Corneal astigmatism;
SKCM	cis	rs3820928	0.874	rs4675128	chr2:227814757	T/C	cg11843606	chr2:227700838	RHBDD1	-0.6	-4.81	-0.48	7.17e-6	Pulmonary function;
SKCM	cis	rs10503709	0.861	rs10092469	chr8:21447719	C/A	cg23716449	chr8:21608280	GFRA2	0.52	5.32	0.52	9.7e-7	Blood protein levels;
SKCM	cis	rs3820928	1.000	rs11692572	chr2:227774503	C/G	cg11843606	chr2:227700838	RHBDD1	-0.64	-5.2	-0.51	1.53e-6	Pulmonary function;
SKCM	trans	rs1814175	0.645	rs11040535	chr11:49808669	C/T	cg15704280	chr7:45808275	SEPT13	-0.93	-8.6	-0.7	6.36e-13	Height;
SKCM	cis	rs6952808	0.929	rs34145223	chr7:1926237	G/A	cg04267008	chr7:1944627	MAD1L1	-0.63	-4.77	-0.47	8.53e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs9790314	0.631	rs9867582	chr3:160797405	A/G	cg03342759	chr3:160939853	NMD3	-0.65	-6.43	-0.59	9.2e-9	Morning vs. evening chronotype;
SKCM	cis	rs7772486	0.719	rs2206141	chr6:146086192	A/G	cg05347473	chr6:146136440	FBXO30	-0.61	-5.81	-0.55	1.31e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1949733	0.816	rs2631746	chr4:8490934	C/T	cg11789530	chr4:8429930	ACOX3	-0.75	-5.71	-0.54	1.97e-7	Response to antineoplastic agents;
SKCM	cis	rs7843479	0.562	rs6988010	chr8:21859084	G/A	cg17168535	chr8:21777572	XPO7	0.85	8.0	0.67	9.24e-12	Mean corpuscular volume;
SKCM	cis	rs10754283	0.935	rs1934046	chr1:90119290	A/T	cg21401794	chr1:90099060	LRRC8C	-0.73	-6.31	-0.58	1.57e-8	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs2243480	1.000	rs67536397	chr7:65947917	G/A	cg18252515	chr7:66147081	NA	-1.35	-8.04	-0.67	8e-12	Diabetic kidney disease;
SKCM	cis	rs4972806	0.814	rs1446575	chr2:177047801	A/C	cg13092806	chr2:177043255	NA	0.57	5.37	0.52	7.9e-7	IgG glycosylation;
SKCM	cis	rs8180040	0.932	rs62246474	chr3:47398130	C/T	cg16586182	chr3:47516702	SCAP	0.71	4.85	0.48	6.25e-6	Colorectal cancer;
SKCM	cis	rs6952808	0.729	rs35797753	chr7:1954914	G/A	cg05863683	chr7:1912471	MAD1L1	0.55	4.92	0.49	4.76e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs7584330	0.695	rs7570882	chr2:238435086	G/A	cg14458575	chr2:238380390	NA	0.76	5.02	0.49	3.13e-6	Prostate cancer;
SKCM	cis	rs35306767	0.807	rs34885925	chr10:919032	G/C	cg20503657	chr10:835505	NA	0.82	5.72	0.54	1.91e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs34779708	0.966	rs17499811	chr10:35456215	G/A	cg03585969	chr10:35415529	CREM	0.75	5.93	0.56	7.75e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs28595532	0.800	rs114321375	chr4:119341663	G/A	cg11846333	chr4:119757529	SEC24D	1.19	6.71	0.6	2.81e-9	Cannabis dependence symptom count;
SKCM	cis	rs6840360	0.571	rs62327271	chr4:152535916	A/G	cg22705602	chr4:152727874	NA	-0.52	-5.7	-0.54	2.03e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs9911578	1.000	rs6503870	chr17:56659018	C/T	cg05425664	chr17:57184151	TRIM37	-0.69	-5.2	-0.51	1.55e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7860634	0.872	rs7847312	chr9:139089718	A/C	cg04455058	chr9:139085579	NA	0.68	6.01	0.56	5.68e-8	Thyroid hormone levels;
SKCM	cis	rs9467773	1.000	rs767471	chr6:26557854	C/T	cg15659132	chr6:26577336	NA	0.6	5.71	0.54	1.99e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs453301	0.658	rs3855900	chr8:8901921	A/G	cg06636001	chr8:8085503	FLJ10661	-0.78	-5.73	-0.54	1.81e-7	Joint mobility (Beighton score);
SKCM	cis	rs853679	1.000	rs735765	chr6:28170297	G/A	cg09551472	chr6:27280195	POM121L2	0.82	4.95	0.49	4.19e-6	Depression;
SKCM	cis	rs910316	0.967	rs175451	chr14:75589729	C/T	cg11812906	chr14:75593930	NEK9	-0.72	-5.45	-0.53	5.72e-7	Height;
SKCM	cis	rs7100689	0.646	rs2039757	chr10:82078868	C/A	cg00277334	chr10:82204260	NA	-0.57	-5.34	-0.52	8.88e-7	Post bronchodilator FEV1;
SKCM	cis	rs6430585	0.583	rs7561565	chr2:136640787	A/C	cg07169764	chr2:136633963	MCM6	1.36	15.07	0.86	8.33e-25	Corneal structure;
SKCM	cis	rs3784262	1.000	rs1372368	chr15:58297363	C/T	cg12031962	chr15:58353849	ALDH1A2	-0.5	-6.27	-0.58	1.85e-8	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs41369048	0.502	rs6541166	chr1:221069370	A/C	cg03536711	chr1:221509067	LOC400804	0.54	5.0	0.49	3.43e-6	Sum eosinophil basophil counts;Eosinophil counts;
SKCM	cis	rs854765	0.663	rs16960744	chr17:17755259	A/G	cg04398451	chr17:18023971	MYO15A	0.87	5.86	0.55	1.04e-7	Total body bone mineral density;
SKCM	cis	rs1552244	0.572	rs57268864	chr3:10164233	C/A	cg00149659	chr3:10157352	C3orf10	1.13	5.45	0.53	5.74e-7	Alzheimer's disease;
SKCM	cis	rs2204008	0.811	rs4882300	chr12:38415224	A/T	cg26384229	chr12:38710491	ALG10B	-0.8	-6.31	-0.58	1.56e-8	Bladder cancer;
SKCM	cis	rs1256061	0.564	rs1256043	chr14:64734282	A/G	cg21174375	chr14:64681225	SYNE2	0.47	4.95	0.49	4.15e-6	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs478304	0.514	rs75601653	chr11:65483370	C/G	cg27068330	chr11:65405492	SIPA1	-0.87	-7.51	-0.65	8.4e-11	Acne (severe);
SKCM	cis	rs735396	0.770	rs1169314	chr12:121443116	A/G	cg02403541	chr12:121454288	C12orf43	0.73	6.08	0.57	4.17e-8	N-glycan levels;
SKCM	cis	rs13118159	0.509	rs1882098	chr4:1352431	T/C	cg16405210	chr4:1374714	KIAA1530	-0.95	-7.15	-0.63	4e-10	Longevity;
SKCM	cis	rs6120849	0.573	rs3746429	chr20:33703607	A/G	cg24642439	chr20:33292090	TP53INP2	-0.9	-4.81	-0.48	7.27e-6	Protein C levels;
SKCM	cis	rs2760061	0.819	rs708111	chr1:228191365	G/A	cg18477163	chr1:228402036	OBSCN	0.48	5.69	0.54	2.16e-7	Diastolic blood pressure;
SKCM	cis	rs561341	1.000	rs506766	chr17:30289659	T/C	cg23018236	chr17:30244563	NA	-0.54	-5.3	-0.51	1.03e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs10028773	0.546	rs13117947	chr4:120257060	A/G	cg09307838	chr4:120376055	NA	0.67	4.81	0.48	7.15e-6	Educational attainment;
SKCM	cis	rs1799949	0.501	rs35399157	chr17:41411602	G/C	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.18	-0.57	2.68e-8	Menopause (age at onset);
SKCM	cis	rs62238980	0.614	rs74399071	chr22:32455990	G/T	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs7829975	0.591	rs12677543	chr8:8644274	G/C	cg15556689	chr8:8085844	FLJ10661	0.71	6.1	0.57	3.88e-8	Mood instability;
SKCM	cis	rs2153535	0.580	rs4960412	chr6:8438261	G/C	cg23788917	chr6:8435910	SLC35B3	0.7	5.15	0.5	1.92e-6	Motion sickness;
SKCM	cis	rs9916302	0.706	rs6503521	chr17:37715551	A/C	cg07936489	chr17:37558343	FBXL20	1.03	7.83	0.66	2e-11	Glomerular filtration rate (creatinine);
SKCM	cis	rs637571	0.544	rs55704213	chr11:65730002	C/A	cg26695010	chr11:65641043	EFEMP2	-0.7	-5.32	-0.52	9.78e-7	Eosinophil percentage of white cells;
SKCM	cis	rs2841277	0.708	rs9671643	chr14:105408030	A/G	cg21017887	chr14:105400489	NA	0.59	5.31	0.52	1e-6	Rheumatoid arthritis;
SKCM	cis	rs1707322	0.691	rs28495425	chr1:46187320	T/G	cg03146154	chr1:46216737	IPP	0.84	6.2	0.57	2.51e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7659604	0.643	rs6838881	chr4:122663616	A/T	cg19748678	chr4:122722346	EXOSC9	0.75	6.06	0.57	4.57e-8	Type 2 diabetes;
SKCM	cis	rs1348850	0.526	rs10497504	chr2:178370040	T/C	cg27490568	chr2:178487706	NA	0.89	6.54	0.6	5.81e-9	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs7666738	0.830	rs28587201	chr4:98991733	C/T	cg17366294	chr4:99064904	C4orf37	0.6	4.98	0.49	3.8e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs56235845	0.694	rs6860069	chr5:176755841	C/T	cg16006841	chr5:176797999	RGS14	0.73	6.5	0.59	6.9e-9	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs10504229	0.596	rs7004566	chr8:58115602	G/C	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs6951245	0.935	rs113365567	chr7:1108785	T/C	cg18402987	chr7:1209562	NA	1.15	6.09	0.57	3.95e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs9815354	0.812	rs73069357	chr3:41753319	T/G	cg03022575	chr3:42003672	ULK4	1.04	5.11	0.5	2.22e-6	Pulse pressure;Diastolic blood pressure;
SKCM	trans	rs17685	0.753	rs9691174	chr7:75790405	T/C	cg19862616	chr7:65841803	NCRNA00174	0.97	10.73	0.77	5.13e-17	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs6089829	0.925	rs13041507	chr20:61666180	T/C	cg08564027	chr20:61660810	NA	0.63	5.65	0.54	2.46e-7	Prostate cancer (SNP x SNP interaction);
SKCM	trans	rs7618501	0.933	rs6809431	chr3:49804119	A/G	cg21659725	chr3:3221576	CRBN	0.96	9.61	0.74	7.08e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs4253772	0.591	rs12167567	chr22:46659942	G/C	cg03482458	chr22:46692211	CN5H6.4;GTSE1	1.1	5.09	0.5	2.44e-6	LDL cholesterol;Cholesterol, total;
SKCM	cis	rs6598955	0.670	rs6663950	chr1:26560131	T/C	cg00938395	chr1:26633206	UBXN11	0.67	4.83	0.48	6.61e-6	Obesity-related traits;
SKCM	cis	rs1799949	1.000	rs33920795	chr17:41329010	A/G	cg23758822	chr17:41437982	NA	0.93	7.87	0.67	1.66e-11	Menopause (age at onset);
SKCM	cis	rs17270561	0.578	rs76182885	chr6:25904085	G/C	cg17691542	chr6:26056736	HIST1H1C	1.24	8.89	0.71	1.79e-13	Iron status biomarkers;
SKCM	cis	rs7809950	1.000	rs2712215	chr7:107188207	A/G	cg23024343	chr7:107201750	COG5	-0.77	-6.95	-0.62	9.61e-10	Coronary artery disease;
SKCM	cis	rs72781680	1.000	rs72781680	chr2:24238928	C/T	cg08917208	chr2:24149416	ATAD2B	1.07	5.99	0.56	6.1e-8	Lymphocyte counts;
SKCM	trans	rs3780486	0.846	rs7865745	chr9:33140976	A/G	cg04842962	chr6:43655489	MRPS18A	-1.09	-11.49	-0.79	1.86e-18	IgG glycosylation;
SKCM	cis	rs911263	0.887	rs8015139	chr14:68739301	G/T	cg18825221	chr14:68749962	RAD51L1	-0.49	-5.24	-0.51	1.35e-6	Primary biliary cholangitis;
SKCM	cis	rs7954584	0.626	rs10840637	chr12:122427310	A/G	cg01765077	chr12:122356316	WDR66	0.45	4.97	0.49	3.89e-6	Mean corpuscular volume;
SKCM	cis	rs4891159	0.790	rs72973773	chr18:74115176	T/C	cg24786174	chr18:74118243	ZNF516	-0.75	-7.23	-0.63	2.84e-10	Longevity;
SKCM	cis	rs12048904	0.595	rs10493937	chr1:101342650	A/T	cg16556008	chr1:101360663	SLC30A7;EXTL2	-0.83	-7.31	-0.64	2.05e-10	Multiple sclerosis;
SKCM	cis	rs4689592	0.619	rs2359011	chr4:7066052	T/G	cg26116260	chr4:7069785	GRPEL1	1.21	9.51	0.73	1.09e-14	Monocyte percentage of white cells;
SKCM	cis	rs4481887	0.927	rs10888340	chr1:248440381	C/T	cg00666640	chr1:248458726	OR2T12	0.64	5.56	0.53	3.68e-7	Common traits (Other);
SKCM	cis	rs4481887	0.720	rs4543835	chr1:248468608	A/T	cg00666640	chr1:248458726	OR2T12	0.61	5.56	0.53	3.66e-7	Common traits (Other);
SKCM	cis	rs12142240	0.660	rs72886903	chr1:46813860	C/T	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs17345786	0.906	rs12638137	chr3:101150964	C/T	cg12386194	chr3:101231763	SENP7	0.74	5.38	0.52	7.7e-7	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11764590	0.724	rs1533829	chr7:2082841	A/G	cg02825527	chr7:2087843	MAD1L1	-0.62	-4.82	-0.48	6.89e-6	Neuroticism;
SKCM	cis	rs9894429	0.789	rs7502346	chr17:79603741	T/C	cg18240062	chr17:79603768	NPLOC4	0.91	10.35	0.76	2.68e-16	Eye color traits;
SKCM	cis	rs6840360	0.615	rs12641433	chr4:152607548	A/C	cg22705602	chr4:152727874	NA	-0.59	-7.92	-0.67	1.35e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs4724125	0.824	rs2330632	chr7:42730570	T/C	cg09407816	chr7:42972088	MRPL32;PSMA2	0.77	4.8	0.48	7.39e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs58688157	0.960	rs702966	chr11:611919	C/G	cg03576123	chr11:487126	PTDSS2	-0.84	-5.45	-0.53	5.64e-7	Systemic lupus erythematosus;
SKCM	cis	rs7599312	0.534	rs7596285	chr2:213406961	G/A	cg16329650	chr2:213403929	ERBB4	0.84	6.04	0.56	4.85e-8	BMI (adjusted for smoking behaviour);BMI in non-smokers;Body mass index;Body mass index (joint analysis main effects and smoking interaction);
SKCM	cis	rs9910055	0.659	rs227578	chr17:42210189	C/A	cg08499158	chr17:42289980	UBTF	0.74	6.31	0.58	1.53e-8	Total body bone mineral density;
SKCM	cis	rs597539	0.652	rs10792001	chr11:68637737	G/C	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.84	5.61	0.54	3e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs2228479	0.850	rs117880578	chr16:89910230	C/G	cg06558623	chr16:89946397	TCF25	1.12	5.0	0.49	3.47e-6	Skin colour saturation;
SKCM	cis	rs7216064	1.000	rs4569324	chr17:65872750	C/T	cg12091567	chr17:66097778	LOC651250	-0.75	-5.27	-0.51	1.19e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs72949976	0.934	rs13406406	chr2:214034826	C/T	cg08319019	chr2:214017104	IKZF2	-0.69	-5.1	-0.5	2.35e-6	Lung cancer;Squamous cell lung carcinoma;
SKCM	cis	rs1957429	0.808	rs4902327	chr14:65344803	C/T	cg23373153	chr14:65346875	NA	1.19	6.78	0.61	2.06e-9	Pediatric areal bone mineral density (radius);
SKCM	cis	rs17065868	1.000	rs61948036	chr13:45210487	G/T	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs28595532	0.623	rs34531766	chr4:119230339	T/C	cg11846333	chr4:119757529	SEC24D	0.96	5.37	0.52	7.87e-7	Cannabis dependence symptom count;
SKCM	cis	rs6445797	0.632	rs9881005	chr3:56604425	A/T	cg13616963	chr3:57583610	ARF4	-0.79	-5.1	-0.5	2.35e-6	Gastritis;
SKCM	cis	rs9910055	0.659	rs2246287	chr17:42232442	C/G	cg10896456	chr17:42255109	ASB16;C17orf65	0.69	7.22	0.63	3e-10	Total body bone mineral density;
SKCM	cis	rs4819052	1.000	rs3746980	chr21:46711580	C/T	cg20896738	chr21:46707857	POFUT2;LOC642852	0.72	4.91	0.49	4.89e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs12477438	0.520	rs2171359	chr2:99795360	T/C	cg14399236	chr2:99771627	LIPT1;TSGA10	0.92	7.99	0.67	9.76e-12	Chronic sinus infection;
SKCM	cis	rs4919087	0.962	rs10786324	chr10:99054387	A/G	cg25902810	chr10:99078978	FRAT1	0.68	5.55	0.53	3.72e-7	Monocyte count;
SKCM	cis	rs13126513	0.519	rs7659550	chr4:100554402	G/T	cg05468953	chr4:100565104	NA	0.5	4.87	0.48	5.72e-6	Metabolite levels (MHPG);
SKCM	cis	rs7659604	1.000	rs10005932	chr4:122664782	T/C	cg19748678	chr4:122722346	EXOSC9	0.66	5.44	0.52	5.83e-7	Type 2 diabetes;
SKCM	cis	rs3820068	0.603	rs7516453	chr1:15972558	C/G	cg13390004	chr1:15929781	NA	0.71	5.48	0.53	5.13e-7	Systolic blood pressure;
SKCM	cis	rs1799949	0.965	rs9646413	chr17:41426157	A/G	cg25918947	chr17:41365094	TMEM106A	-0.61	-5.95	-0.56	7.18e-8	Menopause (age at onset);
SKCM	cis	rs2013441	1.000	rs2189710	chr17:20078964	C/A	cg13482628	chr17:19912719	NA	-0.67	-5.24	-0.51	1.32e-6	Obesity-related traits;
SKCM	cis	rs801193	0.569	rs3846973	chr7:66120035	T/C	cg18876405	chr7:65276391	NA	-0.63	-6.32	-0.58	1.5e-8	Aortic root size;
SKCM	cis	rs9467773	1.000	rs9467783	chr6:26542894	C/T	cg15659132	chr6:26577336	NA	0.6	5.71	0.54	1.99e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs6089829	0.962	rs7267951	chr20:61665979	A/G	cg08564027	chr20:61660810	NA	0.63	5.63	0.54	2.74e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs71520386	0.632	rs2286500	chr7:22856804	T/C	cg00309339	chr7:22893653	NA	0.67	4.97	0.49	3.82e-6	Fibrinogen levels;
SKCM	cis	rs738321	0.701	rs11703601	chr22:38598041	C/T	cg25457927	chr22:38595422	NA	-0.65	-7.74	-0.66	3e-11	Breast cancer;
SKCM	cis	rs6840360	0.593	rs2089811	chr4:152685171	C/T	cg22705602	chr4:152727874	NA	0.58	7.77	0.66	2.61e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs7937682	0.889	rs493810	chr11:111491888	G/T	cg09085632	chr11:111637200	PPP2R1B	-0.97	-10.08	-0.75	8.74e-16	Primary sclerosing cholangitis;
SKCM	cis	rs13278732	0.500	rs6985709	chr8:99045454	G/A	cg16297171	chr8:99017690	MATN2	-0.54	-5.13	-0.5	2.07e-6	Eosinophilic esophagitis (pediatric);
SKCM	cis	rs933688	0.938	rs7720235	chr5:90659329	A/T	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.96	6.57	0.6	5.08e-9	Smoking behavior;
SKCM	cis	rs4481887	0.927	rs10157089	chr1:248488157	A/G	cg00666640	chr1:248458726	OR2T12	0.59	5.19	0.51	1.64e-6	Common traits (Other);
SKCM	trans	rs66573146	0.634	rs56097119	chr4:7018692	C/G	cg07817883	chr1:32538562	TMEM39B	2.01	9.05	0.72	8.63e-14	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs9581857	0.556	rs9581861	chr13:28039991	C/T	cg22138327	chr13:27999177	GTF3A	0.71	5.36	0.52	8.12e-7	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs2811415	0.597	rs9813438	chr3:127797796	C/G	cg09089421	chr3:127803668	RUVBL1	1.0	8.69	0.7	4.4e-13	Lung function (FEV1/FVC);
SKCM	cis	rs9388451	0.839	rs9401845	chr6:126104118	A/G	cg05901451	chr6:126070800	HEY2	-0.77	-6.82	-0.61	1.69e-9	Brugada syndrome;
SKCM	cis	rs28595532	0.920	rs17323034	chr4:119606518	G/A	cg11846333	chr4:119757529	SEC24D	1.15	6.24	0.58	2.13e-8	Cannabis dependence symptom count;
SKCM	cis	rs2370759	1.000	rs16933243	chr10:32615135	T/C	cg01819863	chr10:32635814	EPC1	1.04	5.8	0.55	1.34e-7	Sexual dysfunction (female);
SKCM	cis	rs6500395	0.926	rs1039344	chr16:48577569	A/G	cg04672837	chr16:48644449	N4BP1	0.7	5.71	0.54	1.92e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs9911578	0.835	rs3744093	chr17:56492800	T/C	cg12560992	chr17:57184187	TRIM37	-0.68	-4.97	-0.49	3.95e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs10504229	1.000	rs59071610	chr8:58186301	A/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs6424115	1.000	rs2179395	chr1:24148365	T/C	cg15997130	chr1:24165203	NA	0.61	5.29	0.51	1.1e-6	Immature fraction of reticulocytes;
SKCM	cis	rs7666738	0.830	rs13134216	chr4:98919765	C/T	cg17366294	chr4:99064904	C4orf37	0.56	4.89	0.48	5.26e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1799949	1.000	rs8176296	chr17:41203591	T/C	cg23758822	chr17:41437982	NA	0.94	7.82	0.66	2.13e-11	Menopause (age at onset);
SKCM	cis	rs11252926	0.574	rs7068976	chr10:453112	A/G	cg18196295	chr10:418757	DIP2C	0.68	5.71	0.54	1.95e-7	Psychosis in Alzheimer's disease;
SKCM	cis	rs6951245	0.744	rs1133122	chr7:1192572	C/A	cg23708337	chr7:1209742	NA	0.89	5.4	0.52	7.12e-7	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs1801251	1.000	rs283477	chr2:233649427	A/G	cg25237894	chr2:233734115	C2orf82	0.64	5.71	0.54	1.99e-7	Coronary artery disease;
SKCM	cis	rs870825	0.860	rs72703529	chr4:185607351	T/C	cg04058563	chr4:185651563	MLF1IP	1.04	5.96	0.56	7.02e-8	Blood protein levels;
SKCM	cis	rs7106204	0.668	rs7119198	chr11:24218267	A/G	ch.11.24196551F	chr11:24239977	NA	0.77	6.39	0.59	1.09e-8	Response to Homoharringtonine (cytotoxicity);
SKCM	cis	rs9911578	1.000	rs302848	chr17:56686454	C/T	cg12560992	chr17:57184187	TRIM37	1.0	8.59	0.7	6.76e-13	Intelligence (multi-trait analysis);
SKCM	cis	rs873946	0.648	rs1548281	chr10:134552982	C/T	cg26818010	chr10:134567672	INPP5A	-0.81	-6.49	-0.59	7.12e-9	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs9300255	0.569	rs1716170	chr12:123716513	C/T	cg05973401	chr12:123451056	ABCB9	0.82	5.31	0.51	1.02e-6	Neutrophil percentage of white cells;
SKCM	cis	rs870825	0.616	rs4264873	chr4:185624336	C/T	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs1707322	1.000	rs34446427	chr1:46417655	A/C	cg03146154	chr1:46216737	IPP	0.8	5.44	0.52	5.87e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs561341	1.000	rs113115092	chr17:30284164	G/A	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs10504229	0.906	rs2270607	chr8:58194699	A/G	cg02725872	chr8:58115012	NA	-0.53	-4.8	-0.48	7.46e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs4237845	1.000	rs4237845	chr12:58302436	A/G	cg02175503	chr12:58329896	NA	-0.81	-7.68	-0.66	3.99e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs611744	0.631	rs627392	chr8:109254677	C/T	cg18478394	chr8:109455254	TTC35	0.66	5.33	0.52	9.43e-7	Dupuytren's disease;
SKCM	cis	rs4555082	0.681	rs28588570	chr14:105709606	A/T	cg13114125	chr14:105738426	BRF1	-0.7	-5.71	-0.54	1.92e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs995000	0.931	rs634341	chr1:62921422	T/C	cg06896770	chr1:63153194	DOCK7	0.77	7.38	0.64	1.45e-10	Triglyceride levels;
SKCM	cis	rs870825	0.860	rs60022249	chr4:185600772	T/C	cg04058563	chr4:185651563	MLF1IP	1.04	5.96	0.56	7.02e-8	Blood protein levels;
SKCM	cis	rs4911259	0.552	rs6058925	chr20:31465374	G/A	cg13636640	chr20:31349939	DNMT3B	-0.74	-6.15	-0.57	3.04e-8	Inflammatory bowel disease;
SKCM	cis	rs72634258	0.945	rs36016881	chr1:8051241	A/G	cg00042356	chr1:8021962	PARK7	1.09	7.71	0.66	3.35e-11	Inflammatory bowel disease;
SKCM	cis	rs4925386	0.625	rs3810550	chr20:60912117	C/T	cg09594475	chr20:60884601	LAMA5	0.66	5.14	0.5	1.99e-6	Colorectal cancer;Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs4253772	0.591	rs6007747	chr22:46657261	A/G	cg03482458	chr22:46692211	CN5H6.4;GTSE1	1.13	5.41	0.52	6.8e-7	LDL cholesterol;Cholesterol, total;
SKCM	cis	rs17153527	0.502	rs849386	chr7:106501358	G/A	cg23615938	chr7:105753134	SYPL1	-0.68	-4.94	-0.49	4.3e-6	Menopause (age at onset);
SKCM	cis	rs7216064	0.765	rs6504550	chr17:65894542	A/G	cg12091567	chr17:66097778	LOC651250	-0.72	-5.01	-0.49	3.25e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs769267	0.930	rs1063966	chr19:19616742	G/A	cg26732615	chr19:19648335	CILP2;YJEFN3	0.67	7.06	0.62	6e-10	Tonsillectomy;
SKCM	cis	rs151997	0.962	rs28090	chr5:50177509	T/C	cg06027927	chr5:50259733	NA	0.63	5.35	0.52	8.42e-7	Callous-unemotional behaviour;
SKCM	cis	rs2836974	0.965	rs7354783	chr21:40652992	G/A	cg11644478	chr21:40555479	PSMG1	0.99	10.48	0.76	1.51e-16	Cognitive function;
SKCM	cis	rs12986445	0.744	rs34199918	chr2:26140619	A/G	cg07291958	chr2:26785531	C2orf70	0.53	4.92	0.49	4.79e-6	Multiple myeloma and monoclonal gammopathy;Multiple myeloma;
SKCM	cis	rs8103278	0.507	rs8112282	chr19:46265029	C/T	cg11657440	chr19:46296263	DMWD	1.06	10.47	0.76	1.56e-16	Coronary artery disease;
SKCM	cis	rs2439831	0.867	rs486301	chr15:43836949	G/A	cg02155558	chr15:43621948	ADAL;LCMT2	1.18	7.32	0.64	1.95e-10	Lung cancer in ever smokers;
SKCM	cis	rs56235845	0.694	rs6876677	chr5:176755342	T/C	cg06060754	chr5:176797920	RGS14	0.66	6.52	0.59	6.36e-9	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs3008870	1.000	rs3008871	chr1:67419089	A/G	cg08660285	chr1:67390436	MIER1;WDR78	-1.01	-6.84	-0.61	1.58e-9	Lymphocyte percentage of white cells;
SKCM	cis	rs995000	0.931	rs1168013	chr1:62996838	C/G	cg06896770	chr1:63153194	DOCK7	0.75	6.89	0.61	1.29e-9	Triglyceride levels;
SKCM	cis	rs1707322	0.647	rs6686944	chr1:46156308	G/T	cg03146154	chr1:46216737	IPP	0.82	5.88	0.55	9.72e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs9682041	0.740	rs2111826	chr3:170140846	A/G	cg11886554	chr3:170076028	SKIL	0.94	5.51	0.53	4.54e-7	Glomerular filtration rate in non diabetics (creatinine);Glomerular filtration rate (creatinine);
SKCM	cis	rs6736997	0.866	rs6431285	chr2:235616965	C/T	cg17841421	chr2:235704848	NA	0.59	5.12	0.5	2.13e-6	Pancreatic cancer;
SKCM	cis	rs6088580	0.570	rs6058057	chr20:33065283	G/A	cg24642439	chr20:33292090	TP53INP2	0.76	6.02	0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs1799949	0.965	rs799916	chr17:41243190	G/T	cg25918947	chr17:41365094	TMEM106A	0.6	5.76	0.55	1.6e-7	Menopause (age at onset);
SKCM	cis	rs8077889	1.000	rs59044152	chr17:41888747	A/G	cg26893861	chr17:41843967	DUSP3	1.13	7.37	0.64	1.58e-10	Triglycerides;
SKCM	cis	rs12478296	1.000	rs56162244	chr2:243018690	A/G	cg06360820	chr2:242988706	NA	-0.94	-5.68	-0.54	2.21e-7	Obesity-related traits;
SKCM	cis	rs6089829	0.855	rs6062781	chr20:61667128	G/A	cg08564027	chr20:61660810	NA	0.63	5.65	0.54	2.46e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs617791	0.669	rs4994056	chr11:65750997	G/A	cg02427764	chr11:65769310	BANF1;EIF1AD	0.77	5.89	0.55	9.2e-8	Breast cancer;
SKCM	trans	rs12599106	0.625	rs12923277	chr16:34896261	G/A	cg03395511	chr6:291903	DUSP22	-0.73	-7.95	-0.67	1.15e-11	Menopause (age at onset);
SKCM	cis	rs929354	0.772	rs2301914	chr7:157000176	T/C	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs644799	0.601	rs7902	chr11:95565288	A/G	cg25622487	chr11:95524042	FAM76B;CEP57	0.64	4.84	0.48	6.32e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs17345786	0.906	rs11708616	chr3:101231731	C/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.75	5.55	0.53	3.79e-7	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs951366	0.764	rs823141	chr1:205741426	T/C	cg11965913	chr1:205819406	PM20D1	1.0	10.32	0.76	3.06e-16	Menarche (age at onset);
SKCM	cis	rs2204008	0.806	rs35534445	chr12:38279093	C/T	cg26384229	chr12:38710491	ALG10B	0.87	6.83	0.61	1.63e-9	Bladder cancer;
SKCM	cis	rs867186	1.000	rs28469723	chr20:33700717	A/G	cg04194272	chr20:33683537	NA	-1.14	-6.37	-0.58	1.22e-8	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs870825	0.616	rs10006828	chr4:185651416	C/T	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs1506636	1.000	rs641491	chr7:123399726	C/A	cg03229431	chr7:123269106	ASB15	0.64	5.21	0.51	1.5e-6	Plateletcrit;Platelet count;
SKCM	cis	rs28595532	0.920	rs56302493	chr4:119772382	A/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs1018836	0.923	rs9694450	chr8:91618292	G/A	cg16814680	chr8:91681699	NA	-0.62	-4.83	-0.48	6.61e-6	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs11098499	0.954	rs10014845	chr4:120301077	T/G	cg09307838	chr4:120376055	NA	0.97	7.49	0.65	9.08e-11	Corneal astigmatism;
SKCM	cis	rs2204008	0.744	rs67889662	chr12:38327042	T/A	cg26384229	chr12:38710491	ALG10B	0.88	7.02	0.62	7.15e-10	Bladder cancer;
SKCM	cis	rs3008870	1.000	rs3008859	chr1:67390999	G/C	cg08660285	chr1:67390436	MIER1;WDR78	0.92	6.09	0.57	3.92e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs1325195	0.520	rs3122378	chr1:179234045	A/C	cg25467746	chr1:179556597	NA	0.59	5.64	0.54	2.59e-7	IgE grass sensitization;
SKCM	cis	rs7296418	0.961	rs4148862	chr12:123568619	A/C	cg00376283	chr12:123451042	ABCB9	0.96	8.66	0.7	5.01e-13	Platelet count;
SKCM	cis	rs9583531	0.629	rs7991766	chr13:111380684	A/G	cg24331049	chr13:111365604	ING1	0.84	6.34	0.58	1.36e-8	Coronary artery disease;
SKCM	cis	rs7618501	0.699	rs2681780	chr3:49897830	C/T	cg05072774	chr3:49840536	C3orf54	-0.7	-5.25	-0.51	1.3e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9818758	0.545	rs11717978	chr3:48969036	T/A	cg24898236	chr3:49228699	LOC646498	0.65	4.98	0.49	3.66e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs8180040	0.764	rs11712716	chr3:47193432	T/C	cg27129171	chr3:47204927	SETD2	0.82	6.44	0.59	9.04e-9	Colorectal cancer;
SKCM	cis	rs17376456	0.825	rs10064368	chr5:93266396	C/A	cg25358565	chr5:93447407	FAM172A	1.3	7.53	0.65	7.57e-11	Diabetic retinopathy;
SKCM	cis	rs9636593	0.671	rs1292751	chr21:16118465	A/G	cg13882606	chr21:17101011	USP25	0.68	5.28	0.51	1.14e-6	Pursuit maintenance gain;
SKCM	cis	rs1046896	0.562	rs9912684	chr17:80873067	C/T	cg02711726	chr17:80685570	FN3KRP	-0.8	-6.41	-0.59	1e-8	Glycated hemoglobin levels;
SKCM	cis	rs362296	0.698	rs3095080	chr4:3264418	C/T	cg21096898	chr4:3318625	RGS12	-0.65	-5.34	-0.52	8.96e-7	Parental longevity (mother's age at death);
SKCM	cis	rs7683537	0.692	rs12509936	chr4:185662203	G/A	cg04058563	chr4:185651563	MLF1IP	1.02	6.59	0.6	4.7e-9	Systemic lupus erythematosus;
SKCM	cis	rs7523273	0.586	rs2796264	chr1:207919968	A/G	cg22525895	chr1:207977042	MIR29B2	0.8	6.86	0.61	1.44e-9	Schizophrenia;
SKCM	cis	rs12497850	0.931	rs4974082	chr3:48999323	G/A	cg07636037	chr3:49044803	WDR6	1.02	11.0	0.78	1.56e-17	Parkinson's disease;
SKCM	trans	rs17685	0.890	rs76021834	chr7:75607155	A/G	cg19862616	chr7:65841803	NCRNA00174	0.92	7.94	0.67	1.22e-11	Coffee consumption;Coffee consumption (cups per day);
SKCM	trans	rs561341	1.000	rs497479	chr17:30328605	C/T	cg20587970	chr11:113659929	NA	-1.15	-9.97	-0.75	1.44e-15	Hip circumference adjusted for BMI;
SKCM	cis	rs4268898	0.662	rs72795832	chr2:24441855	C/A	cg06627628	chr2:24431161	ITSN2	-0.95	-7.39	-0.64	1.45e-10	Asthma;
SKCM	cis	rs3091242	0.900	rs1883427	chr1:25744468	C/T	cg02931644	chr1:25747376	RHCE	0.5	5.01	0.49	3.36e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs28595532	0.920	rs114751999	chr4:119759651	G/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs55823223	0.564	rs58363746	chr17:73850819	C/T	cg10935138	chr17:73851978	WBP2	1.13	7.39	0.64	1.43e-10	Psoriasis;
SKCM	cis	rs1029738	0.615	rs3757447	chr7:22894735	A/T	cg00365470	chr7:22893924	NA	-0.64	-5.12	-0.5	2.11e-6	Fibrinogen levels;
SKCM	cis	rs10751667	0.666	rs10902241	chr11:949129	G/A	cg10932868	chr11:921992	NA	0.55	5.1	0.5	2.36e-6	Alzheimer's disease (late onset);
SKCM	cis	rs10193935	0.901	rs3088290	chr2:42578143	A/G	cg27598129	chr2:42591480	NA	-0.88	-6.71	-0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7772486	0.720	rs991507	chr6:146023609	G/A	cg23711669	chr6:146136114	FBXO30	-0.88	-9.08	-0.72	7.6e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7666738	0.830	rs10001479	chr4:98918764	A/G	cg05340658	chr4:99064831	C4orf37	-0.6	-4.8	-0.48	7.52e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10256972	0.504	rs2949178	chr7:1209925	T/C	cg07092213	chr7:1199455	ZFAND2A	-0.74	-6.14	-0.57	3.18e-8	Longevity;Endometriosis;
SKCM	cis	rs9916302	0.706	rs6503504	chr17:37514412	A/G	cg07936489	chr17:37558343	FBXL20	0.98	6.84	0.61	1.56e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs7208859	0.623	rs11652533	chr17:29060601	A/C	cg14067834	chr17:29058358	SUZ12P	1.19	5.71	0.54	1.94e-7	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs6570726	0.846	rs371186	chr6:145886971	T/C	cg23711669	chr6:146136114	FBXO30	0.81	8.51	0.69	9.71e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9902453	0.845	rs3102558	chr17:28023142	C/A	cg26525008	chr17:28256777	EFCAB5;SSH2	0.82	5.78	0.55	1.47e-7	Coffee consumption (cups per day);
SKCM	cis	rs6723226	0.572	rs176404	chr2:32638846	T/C	cg02381751	chr2:32503542	YIPF4	-0.64	-4.97	-0.49	3.9e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1577917	0.771	rs4145082	chr6:86352016	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.82	-7.59	-0.65	5.91e-11	Response to antipsychotic treatment;
SKCM	cis	rs763121	0.819	rs138700	chr22:39129999	A/G	cg06022373	chr22:39101656	GTPBP1	0.79	5.13	0.5	2.05e-6	Menopause (age at onset);
SKCM	cis	rs9911578	0.803	rs8069033	chr17:57131581	T/A	cg12560992	chr17:57184187	TRIM37	-1.09	-10.28	-0.76	3.61e-16	Intelligence (multi-trait analysis);
SKCM	cis	rs17376456	0.877	rs10065056	chr5:93380123	G/T	cg25358565	chr5:93447407	FAM172A	1.19	7.67	0.66	4.06e-11	Diabetic retinopathy;
SKCM	cis	rs10489202	1.000	rs7538251	chr1:168001752	C/G	cg24449463	chr1:168025552	DCAF6	-0.79	-6.16	-0.57	2.93e-8	Schizophrenia;
SKCM	cis	rs6138458	1.000	rs227618	chr20:24909472	T/C	cg26195577	chr20:24973756	C20orf3	1.29	8.69	0.7	4.32e-13	Blood protein levels;
SKCM	cis	rs12497850	0.931	rs6791542	chr3:48787219	A/G	cg06212747	chr3:49208901	KLHDC8B	0.68	4.94	0.49	4.37e-6	Parkinson's disease;
SKCM	cis	rs561341	1.000	rs7216102	chr17:30259450	A/G	cg00745463	chr17:30367425	LRRC37B	-1.0	-6.95	-0.62	9.86e-10	Hip circumference adjusted for BMI;
SKCM	cis	rs597539	0.545	rs3794027	chr11:68697336	T/C	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.78	4.9	0.49	5.12e-6	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs7927771	0.864	rs4752999	chr11:47428565	C/T	cg05585544	chr11:47624801	NA	-0.6	-5.31	-0.52	1.01e-6	Subjective well-being;
SKCM	cis	rs17376456	0.877	rs10514380	chr5:93409370	C/T	cg21475434	chr5:93447410	FAM172A	0.97	5.41	0.52	6.8e-7	Diabetic retinopathy;
SKCM	cis	rs6951245	1.000	rs74369356	chr7:1071711	T/C	cg18402987	chr7:1209562	NA	1.15	6.02	0.56	5.38e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs861020	1.000	rs632746	chr1:209982515	C/T	cg09163369	chr1:210001066	C1orf107	0.77	5.01	0.49	3.31e-6	Orofacial clefts;
SKCM	cis	rs6546550	0.900	rs2054047	chr2:70117421	A/C	cg02498382	chr2:70120550	SNRNP27	-0.5	-5.54	-0.53	3.95e-7	Prevalent atrial fibrillation;
SKCM	cis	rs6840360	0.530	rs11946622	chr4:152486018	C/T	cg22705602	chr4:152727874	NA	-0.46	-5.13	-0.5	2.08e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs6840360	0.571	rs1473305	chr4:152511721	T/G	cg22705602	chr4:152727874	NA	-0.52	-5.7	-0.54	2.03e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs28386778	0.863	rs4968661	chr17:61796306	A/G	cg06873352	chr17:61820015	STRADA	0.73	5.98	0.56	6.29e-8	Prudent dietary pattern;
SKCM	cis	rs10256972	0.758	rs2280724	chr7:1064720	A/G	cg07308232	chr7:1071921	C7orf50	-0.61	-5.35	-0.52	8.46e-7	Longevity;Endometriosis;
SKCM	cis	rs2204008	0.774	rs11520237	chr12:38266978	G/A	cg13010199	chr12:38710504	ALG10B	0.69	4.92	0.49	4.72e-6	Bladder cancer;
SKCM	trans	rs3780486	0.505	rs7868663	chr9:33141229	A/G	cg04842962	chr6:43655489	MRPS18A	0.86	8.38	0.69	1.7e-12	IgG glycosylation;
SKCM	cis	rs7811142	0.830	rs1063945	chr7:99930447	C/T	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.21	7.77	0.66	2.57e-11	Platelet count;
SKCM	cis	rs6952808	0.692	rs56727870	chr7:2029940	T/C	cg02951883	chr7:2050386	MAD1L1	-0.85	-7.58	-0.65	6.15e-11	Bipolar disorder and schizophrenia;
SKCM	cis	rs34172651	0.517	rs2303084	chr16:24834581	G/C	cg00339695	chr16:24857497	SLC5A11	0.78	6.05	0.57	4.66e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs7937682	0.640	rs587010	chr11:111425658	C/A	cg19812747	chr11:111475976	SIK2	-0.56	-4.88	-0.48	5.57e-6	Primary sclerosing cholangitis;
SKCM	cis	rs1405130	0.967	rs4663463	chr2:235569008	C/G	cg21542780	chr2:234763377	HJURP	-0.65	-4.92	-0.49	4.75e-6	Coronary artery disease;
SKCM	cis	rs801193	1.000	rs2055682	chr7:66260289	A/G	cg11764359	chr7:65958608	NA	0.83	6.29	0.58	1.71e-8	Aortic root size;
SKCM	cis	rs9916302	0.861	rs11078896	chr17:37415544	C/T	cg07936489	chr17:37558343	FBXL20	-0.85	-7.02	-0.62	7.16e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs9583531	0.657	rs7318291	chr13:111352460	C/T	cg24331049	chr13:111365604	ING1	-0.78	-5.18	-0.51	1.68e-6	Coronary artery disease;
SKCM	cis	rs6500395	1.000	rs7194570	chr16:48672986	A/G	cg04672837	chr16:48644449	N4BP1	-0.63	-5.42	-0.52	6.45e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs10256972	0.616	rs6957733	chr7:1106327	T/G	cg09177884	chr7:1199841	ZFAND2A	-0.62	-4.78	-0.48	8.22e-6	Longevity;Endometriosis;
SKCM	cis	rs651907	0.617	rs797776	chr3:101610243	C/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.79	6.16	0.57	2.98e-8	Colorectal cancer;
SKCM	cis	rs2204008	0.805	rs4882575	chr12:37940573	G/A	cg13010199	chr12:38710504	ALG10B	-0.65	-5.22	-0.51	1.45e-6	Bladder cancer;
SKCM	cis	rs2832077	0.527	rs2832116	chr21:30228368	C/A	cg24692254	chr21:30365293	RNF160	-0.76	-5.66	-0.54	2.36e-7	Cognitive test performance;
SKCM	cis	rs8016982	0.674	rs11159494	chr14:81667611	G/C	cg01989461	chr14:81687754	GTF2A1	0.88	7.42	0.64	1.26e-10	Schizophrenia;
SKCM	cis	rs1348850	0.526	rs10803912	chr2:178407176	A/C	cg27490568	chr2:178487706	NA	-0.9	-6.9	-0.62	1.22e-9	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs3818285	0.655	rs588160	chr10:111641538	C/T	cg00817464	chr10:111662876	XPNPEP1	0.74	8.39	0.69	1.67e-12	Superior crus of antihelix expression;
SKCM	cis	rs10211296	0.861	rs12621848	chr2:166475298	G/T	ch.2.3376566R	chr2:166772260	TTC21B	0.65	4.82	0.48	6.94e-6	Risky sexual behaviors in alcohol dependence;
SKCM	cis	rs7618915	0.547	rs8906	chr3:52739520	T/C	cg18404041	chr3:52824283	ITIH1	-0.56	-4.94	-0.49	4.32e-6	Bipolar disorder;
SKCM	cis	rs7208859	0.623	rs57486336	chr17:29085731	G/T	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs75229567	0.618	rs35394896	chr12:70188346	T/A	cg10114359	chr12:70132523	RAB3IP	1.14	5.31	0.52	1.01e-6	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes;
SKCM	cis	rs2836950	0.565	rs2836943	chr21:40592611	C/T	cg11890956	chr21:40555474	PSMG1	-0.67	-5.39	-0.52	7.25e-7	Menarche (age at onset);
SKCM	cis	rs362272	0.524	rs3129334	chr4:3368526	T/C	cg00764545	chr4:3318001	RGS12	0.98	13.3	0.83	9.46e-22	Serum sulfate level;
SKCM	cis	rs17376456	0.569	rs2924374	chr5:93151141	T/C	cg25358565	chr5:93447407	FAM172A	-0.9	-5.8	-0.55	1.37e-7	Diabetic retinopathy;
SKCM	cis	rs2629540	0.781	rs2293064	chr10:126396511	C/G	cg08799069	chr10:126477246	METTL10	0.59	4.78	0.48	8.03e-6	Cocaine dependence;
SKCM	cis	rs72781680	0.950	rs72798404	chr2:24180125	C/T	cg08917208	chr2:24149416	ATAD2B	1.02	5.84	0.55	1.16e-7	Lymphocyte counts;
SKCM	trans	rs66573146	0.831	rs67315413	chr4:6987910	T/C	cg07817883	chr1:32538562	TMEM39B	1.94	8.42	0.69	1.47e-12	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs11098499	0.535	rs7671759	chr4:120248094	A/C	cg09307838	chr4:120376055	NA	0.93	7.56	0.65	6.5500000000000006e-11	Corneal astigmatism;
SKCM	cis	rs992157	0.560	rs6436048	chr2:219109033	C/T	cg00012203	chr2:219082015	ARPC2	0.82	6.87	0.61	1.37e-9	Colorectal cancer;
SKCM	cis	rs12048904	0.964	rs8888	chr1:101338324	A/G	cg16556008	chr1:101360663	SLC30A7;EXTL2	0.65	4.77	0.48	8.41e-6	Multiple sclerosis;
SKCM	cis	rs701145	0.640	rs896016	chr3:153929902	C/T	cg17054900	chr3:154042577	DHX36	1.19	5.1	0.5	2.37e-6	Coronary artery disease;
SKCM	cis	rs3785574	0.650	rs8077653	chr17:62008965	T/G	cg01411255	chr17:61851458	DDX42;CCDC47	-0.71	-5.22	-0.51	1.46e-6	Height;
SKCM	cis	rs67311347	0.544	rs9821440	chr3:40342347	T/C	cg18306943	chr3:40428807	ENTPD3	0.56	4.8	0.48	7.38e-6	Renal cell carcinoma;
SKCM	cis	rs6835098	0.924	rs1991727	chr4:174163169	A/G	cg08422745	chr4:174089978	GALNT7	-0.75	-5.51	-0.53	4.51e-7	Dementia and core Alzheimer's disease neuropathologic changes;
SKCM	cis	rs1262465	0.555	rs1261093	chr18:52920950	C/T	cg27233989	chr18:52989155	TCF4	0.54	4.95	0.49	4.21e-6	Neuroticism;
SKCM	cis	rs473651	0.935	rs515412	chr2:239345394	A/T	cg21699342	chr2:239360505	ASB1	0.53	5.06	0.5	2.77e-6	Multiple system atrophy;
SKCM	cis	rs8037137	0.915	rs3826033	chr15:91548601	G/A	cg15878949	chr15:91534302	PRC1	0.68	5.23	0.51	1.38e-6	Platelet count;Serous invasive ovarian cancer;High-grade serous ovarian cancer;Invasive epithelial ovarian cancer;
SKCM	cis	rs2842992	0.789	rs2342446	chr6:160220687	A/G	cg11366901	chr6:160182831	ACAT2	0.92	7.04	0.62	6.53e-10	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs4819052	0.800	rs4819045	chr21:46660138	C/A	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.36	0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs11098499	1.000	rs13116504	chr4:120209412	A/C	cg09307838	chr4:120376055	NA	0.95	7.72	0.66	3.23e-11	Corneal astigmatism;
SKCM	cis	rs2180341	0.920	rs6916990	chr6:127698759	G/A	cg24812749	chr6:127587940	RNF146	0.83	7.18	0.63	3.63e-10	Breast cancer;
SKCM	cis	rs2243480	1.000	rs34702770	chr7:65344823	T/C	cg07424592	chr7:64974309	NA	0.99	4.9	0.49	5.08e-6	Diabetic kidney disease;
SKCM	cis	rs4642101	0.561	rs9812144	chr3:12805910	G/A	cg05775895	chr3:12838266	CAND2	0.58	4.82	0.48	6.83e-6	QRS complex (12-leadsum);
SKCM	cis	rs17376456	0.825	rs10075217	chr5:93176774	C/G	cg25358565	chr5:93447407	FAM172A	1.16	7.68	0.66	3.91e-11	Diabetic retinopathy;
SKCM	cis	rs9814567	1.000	rs4498009	chr3:134198008	C/G	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.68	-5.33	-0.52	9.31e-7	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs66573146	0.831	rs56081162	chr4:6989718	C/T	cg00086871	chr4:6988644	TBC1D14	1.29	5.03	0.5	3.04e-6	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs59918340	0.764	rs4961339	chr8:142231504	A/G	cg23750338	chr8:142222470	SLC45A4	0.62	6.04	0.56	4.98e-8	Immature fraction of reticulocytes;
SKCM	cis	rs7208859	0.623	rs9916725	chr17:29107471	A/C	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs7666738	0.830	rs4699580	chr4:98930673	T/C	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9913156	0.793	rs9436	chr17:4574751	T/A	cg19197139	chr17:4613644	ARRB2	0.79	5.27	0.51	1.17e-6	Lymphocyte counts;
SKCM	cis	rs9467773	0.620	rs2451737	chr6:26619041	T/C	cg09904177	chr6:26538194	HMGN4	0.58	5.01	0.49	3.28e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2032447	0.714	rs199734	chr6:25940393	G/C	cg18357526	chr6:26021779	HIST1H4A	0.71	5.17	0.51	1.75e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9872999	1	rs9872999	chr3:133457514	C/T	cg24879335	chr3:133465180	TF	0.38	4.84	0.48	6.5e-6	Iron status biomarkers;
SKCM	trans	rs1814175	0.645	rs1721995	chr11:49915488	A/G	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs9818758	0.607	rs9990153	chr3:49291883	C/T	cg00383909	chr3:49044727	WDR6	0.95	4.98	0.49	3.73e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs684232	0.602	rs331014	chr17:532103	C/T	cg15660573	chr17:549704	VPS53	-0.77	-6.11	-0.57	3.59e-8	Prostate cancer;
SKCM	cis	rs17608059	0.545	rs736261	chr17:13936404	A/G	cg27005118	chr17:13972210	COX10	-0.45	-4.95	-0.49	4.18e-6	Temperament;
SKCM	cis	rs951366	0.789	rs1772148	chr1:205704580	A/T	cg14159672	chr1:205819179	PM20D1	0.95	7.66	0.66	4.22e-11	Menarche (age at onset);
SKCM	cis	rs6500395	1.000	rs3848322	chr16:48620964	C/A	cg04672837	chr16:48644449	N4BP1	0.69	5.89	0.56	9.16e-8	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs2153535	0.580	rs9328483	chr6:8521295	A/G	cg07606381	chr6:8435919	SLC35B3	0.87	6.38	0.59	1.17e-8	Motion sickness;
SKCM	cis	rs3008870	1.000	rs6673462	chr1:67461857	A/C	cg08660285	chr1:67390436	MIER1;WDR78	-0.92	-6.07	-0.57	4.27e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs6952808	0.771	rs10275045	chr7:1920826	C/T	cg03354898	chr7:1950403	MAD1L1	-0.51	-5.02	-0.49	3.24e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs7824557	0.564	rs6601584	chr8:11232343	C/G	cg21775007	chr8:11205619	TDH	-0.61	-5.1	-0.5	2.36e-6	Retinal vascular caliber;
SKCM	cis	rs8180040	0.966	rs11130128	chr3:47486632	T/C	cg16586182	chr3:47516702	SCAP	0.76	5.32	0.52	9.63e-7	Colorectal cancer;
SKCM	cis	rs6582630	0.593	rs7134006	chr12:38596245	A/C	cg13010199	chr12:38710504	ALG10B	0.65	5.09	0.5	2.38e-6	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs2228479	0.618	rs3212371	chr16:89987201	A/G	cg06558623	chr16:89946397	TCF25	1.23	6.8	0.61	1.86e-9	Skin colour saturation;
SKCM	cis	rs7927771	0.832	rs11605672	chr11:47413733	A/G	cg01152729	chr11:47593274	PTPMT1	-0.52	-4.93	-0.49	4.57e-6	Subjective well-being;
SKCM	cis	rs6463523	0.815	rs66886645	chr7:763853	C/A	cg05729249	chr7:766119	PRKAR1B;HEATR2	0.97	8.25	0.68	3.04e-12	Subjective well-being;
SKCM	cis	rs13256369	1.000	rs12545771	chr8:8567977	C/G	cg06636001	chr8:8085503	FLJ10661	0.77	5.93	0.56	7.8e-8	Obesity-related traits;
SKCM	cis	rs6500395	0.963	rs2041921	chr16:48714002	T/C	cg04672837	chr16:48644449	N4BP1	-0.63	-5.37	-0.52	8.01e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs7772486	0.875	rs1331637	chr6:146337087	T/C	cg23711669	chr6:146136114	FBXO30	0.76	7.15	0.63	4.1e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs769267	0.965	rs7254230	chr19:19434350	C/T	cg26732615	chr19:19648335	CILP2;YJEFN3	-0.65	-6.08	-0.57	4.12e-8	Tonsillectomy;
SKCM	cis	rs6951245	1.000	rs80031817	chr7:1096793	T/C	cg03188948	chr7:1209495	NA	1.13	6.27	0.58	1.89e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs561341	0.714	rs7218466	chr17:30263314	A/G	cg23018236	chr17:30244563	NA	-0.53	-5.54	-0.53	3.96e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs2737618	0.722	rs2821333	chr1:200093253	A/C	cg21825944	chr1:200113062	NR5A2	-0.62	-4.99	-0.49	3.52e-6	Uric acid levels;
SKCM	cis	rs6582630	0.519	rs10880576	chr12:38497693	T/C	cg26384229	chr12:38710491	ALG10B	0.81	6.22	0.58	2.31e-8	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs9910055	0.960	rs9911991	chr17:42278916	G/C	cg10896456	chr17:42255109	ASB16;C17orf65	0.61	5.44	0.52	5.93e-7	Total body bone mineral density;
SKCM	cis	rs35955747	0.601	rs7289941	chr22:31884405	C/T	cg22777020	chr22:31556080	RNF185	0.68	4.89	0.48	5.23e-6	Neutrophil count;Sum basophil neutrophil counts;
SKCM	cis	rs2559856	0.967	rs3809260	chr12:102091017	G/T	cg12924262	chr12:102091054	CHPT1	0.6	4.82	0.48	6.87e-6	Blood protein levels;
SKCM	cis	rs7100689	0.646	rs2486302	chr10:82076600	G/A	cg00277334	chr10:82204260	NA	-0.57	-5.38	-0.52	7.56e-7	Post bronchodilator FEV1;
SKCM	cis	rs1153858	0.943	rs4774580	chr15:45652086	G/A	cg14582100	chr15:45693742	SPATA5L1	0.63	4.84	0.48	6.32e-6	Homoarginine levels;
SKCM	trans	rs1814175	0.817	rs10839318	chr11:49657511	G/C	cg15704280	chr7:45808275	SEPT13	-1.03	-10.38	-0.76	2.38e-16	Height;
SKCM	cis	rs611744	0.506	rs4735054	chr8:109261780	A/C	cg18478394	chr8:109455254	TTC35	-0.62	-5.23	-0.51	1.39e-6	Dupuytren's disease;
SKCM	trans	rs1814175	0.645	rs11040703	chr11:50024961	C/T	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs2070488	0.965	rs2154778	chr3:38553639	C/T	cg01465620	chr3:38496096	LOC100128640;ACVR2B	-1.02	-9.28	-0.72	3.06e-14	Electrocardiographic conduction measures;
SKCM	cis	rs1005277	0.579	rs2474580	chr10:38398713	G/A	cg25427524	chr10:38739819	LOC399744	-0.71	-6.68	-0.6	3.17e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs16866061	1.000	rs2047134	chr2:225347713	A/C	cg02879423	chr2:224806760	WDFY1	0.68	4.91	0.49	4.87e-6	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs910316	0.712	rs175015	chr14:75457075	A/C	cg08847533	chr14:75593920	NEK9	-0.8	-6.62	-0.6	4.04e-9	Height;
SKCM	cis	rs473651	0.935	rs472357	chr2:239355454	A/G	cg21699342	chr2:239360505	ASB1	-0.51	-4.96	-0.49	3.98e-6	Multiple system atrophy;
SKCM	cis	rs10791097	0.694	rs7926167	chr11:130745045	T/C	cg12179176	chr11:130786555	SNX19	0.93	8.16	0.68	4.64e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs11249608	0.744	rs4701025	chr5:178444474	G/A	cg21905437	chr5:178450457	ZNF879	-0.71	-5.57	-0.53	3.44e-7	Pubertal anthropometrics;
SKCM	cis	rs654950	0.774	rs941972	chr1:42040740	T/C	cg06885757	chr1:42089581	HIVEP3	-0.65	-6.54	-0.6	5.86e-9	Airway imaging phenotypes;
SKCM	cis	rs870825	0.929	rs72689254	chr4:185589941	C/T	cg04058563	chr4:185651563	MLF1IP	1.09	5.66	0.54	2.4e-7	Blood protein levels;
SKCM	cis	rs13118159	0.651	rs4974599	chr4:1314430	A/C	cg02018176	chr4:1364513	KIAA1530	0.7	5.82	0.55	1.23e-7	Longevity;
SKCM	cis	rs9911578	1.000	rs391370	chr17:56675050	A/C	cg05425664	chr17:57184151	TRIM37	-0.69	-5.21	-0.51	1.52e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7216064	0.817	rs12601921	chr17:65825354	C/T	cg12091567	chr17:66097778	LOC651250	-0.75	-5.28	-0.51	1.11e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs9420	0.961	rs80304923	chr11:57522823	C/G	cg19752551	chr11:57585705	CTNND1	-0.7	-7.21	-0.63	3.18e-10	Schizophrenia;
SKCM	cis	rs3768617	0.510	rs12078729	chr1:183060072	T/A	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.68	0.66	3.84e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs6951245	0.872	rs76161580	chr7:1100307	G/T	cg24642844	chr7:1081250	C7orf50	-0.93	-6.22	-0.58	2.28e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs2811415	0.597	rs13100212	chr3:127803657	G/A	cg09089421	chr3:127803668	RUVBL1	1.0	8.69	0.7	4.4e-13	Lung function (FEV1/FVC);
SKCM	cis	rs10540	1.000	rs61877775	chr11:521462	C/T	cg03576123	chr11:487126	PTDSS2	-1.49	-7.7	-0.66	3.5e-11	Body mass index;
SKCM	cis	rs67311347	0.544	rs12633295	chr3:40335292	G/T	cg02782426	chr3:40428986	ENTPD3	-0.5	-4.86	-0.48	6.03e-6	Renal cell carcinoma;
SKCM	cis	rs1023500	0.596	rs5751209	chr22:42451603	A/G	cg04733989	chr22:42467013	NAGA	0.77	5.75	0.55	1.68e-7	Schizophrenia;
SKCM	cis	rs55962025	0.711	rs363063	chr4:3141488	G/A	cg21096898	chr4:3318625	RGS12	-0.62	-5.21	-0.51	1.53e-6	Parental longevity (mother's age at death);
SKCM	cis	rs2153535	0.542	rs9378553	chr6:8472632	T/C	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs28386778	0.897	rs7212196	chr17:61834981	T/C	cg06873352	chr17:61820015	STRADA	0.75	6.31	0.58	1.54e-8	Prudent dietary pattern;
SKCM	cis	rs11252926	0.537	rs6560836	chr10:444997	C/T	cg18196295	chr10:418757	DIP2C	0.66	5.38	0.52	7.58e-7	Psychosis in Alzheimer's disease;
SKCM	cis	rs2811415	0.569	rs9829877	chr3:127787969	A/T	cg09089421	chr3:127803668	RUVBL1	1.0	8.69	0.7	4.4e-13	Lung function (FEV1/FVC);
SKCM	cis	rs2688482	0.557	rs2550236	chr3:195522321	A/G	cg11598736	chr3:195384522	SDHAP2	0.89	5.43	0.52	6.15e-7	Lung disease severity in cystic fibrosis;
SKCM	cis	rs7359257	0.576	rs56038097	chr15:67904569	T/A	cg24247231	chr15:67904302	MAP2K5	-0.67	-5.62	-0.54	2.86e-7	Menarche (age at onset);
SKCM	cis	rs8017423	0.845	rs8005870	chr14:90723172	A/C	cg04374321	chr14:90722782	PSMC1	1.03	9.44	0.73	1.55e-14	Mortality in heart failure;
SKCM	cis	rs9300255	0.602	rs10846486	chr12:123709927	G/A	cg00376283	chr12:123451042	ABCB9	0.83	5.49	0.53	4.74e-7	Neutrophil percentage of white cells;
SKCM	cis	rs9790314	0.747	rs1841526	chr3:160834682	A/G	cg03342759	chr3:160939853	NMD3	-0.62	-6.25	-0.58	2.03e-8	Morning vs. evening chronotype;
SKCM	cis	rs2153535	0.580	rs1928184	chr6:8532108	T/A	cg07606381	chr6:8435919	SLC35B3	0.93	6.8	0.61	1.92e-9	Motion sickness;
SKCM	cis	rs394563	0.559	rs7753269	chr6:149671360	G/A	cg03678062	chr6:149772716	ZC3H12D	0.51	6.09	0.57	3.96e-8	Dupuytren's disease;
SKCM	cis	rs7666738	0.830	rs13113899	chr4:99050422	T/C	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs17376456	0.877	rs10035340	chr5:93490465	C/T	cg21475434	chr5:93447410	FAM172A	0.99	5.62	0.54	2.81e-7	Diabetic retinopathy;
SKCM	cis	rs6696846	0.777	rs2369526	chr1:205054406	C/T	cg03948781	chr1:205179583	DSTYK	0.56	5.28	0.51	1.14e-6	Red blood cell count;
SKCM	cis	rs1005277	0.505	rs10827835	chr10:38150709	G/A	cg00409905	chr10:38381863	ZNF37A	0.61	5.63	0.54	2.7e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs6570726	0.791	rs370654	chr6:145879005	C/G	cg23711669	chr6:146136114	FBXO30	0.87	9.14	0.72	5.82e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7635838	0.750	rs2648463	chr3:11403857	G/A	cg00170343	chr3:11313890	ATG7	0.7	5.58	0.53	3.29e-7	HDL cholesterol;
SKCM	cis	rs1405130	0.839	rs13018439	chr2:235565912	G/A	cg17841421	chr2:235704848	NA	-0.57	-4.95	-0.49	4.14e-6	Coronary artery disease;
SKCM	cis	rs3820928	0.874	rs10174073	chr2:227794944	A/G	cg11843606	chr2:227700838	RHBDD1	-0.6	-4.81	-0.48	7.34e-6	Pulmonary function;
SKCM	cis	rs1218582	0.710	rs4845687	chr1:154878911	A/G	cg24250549	chr1:154909240	PMVK	0.85	7.96	0.67	1.11e-11	Prostate cancer;
SKCM	cis	rs634534	0.562	rs642293	chr11:65730217	G/A	cg26695010	chr11:65641043	EFEMP2	-0.7	-5.32	-0.52	9.78e-7	Sum eosinophil basophil counts;Eosinophil counts;
SKCM	cis	rs2243480	1.000	rs34193460	chr7:65393110	A/G	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs28595532	0.920	rs56027489	chr4:119780882	A/G	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs908922	0.676	rs478926	chr1:152511533	G/T	cg09873164	chr1:152488093	CRCT1	0.76	5.93	0.56	7.7e-8	Hair morphology;
SKCM	cis	rs3820928	0.874	rs3752895	chr2:227886773	A/G	cg11843606	chr2:227700838	RHBDD1	-0.61	-5.06	-0.5	2.76e-6	Pulmonary function;
SKCM	cis	rs2228479	0.850	rs17232630	chr16:89851179	C/T	cg00800038	chr16:89945340	TCF25	-0.93	-4.8	-0.48	7.41e-6	Skin colour saturation;
SKCM	cis	rs11098499	0.909	rs73842633	chr4:120375464	G/A	cg09307838	chr4:120376055	NA	0.97	7.85	0.66	1.85e-11	Corneal astigmatism;
SKCM	cis	rs2836974	0.644	rs2410123	chr21:40700093	C/T	cg11890956	chr21:40555474	PSMG1	-0.82	-7.64	-0.65	4.75e-11	Cognitive function;
SKCM	cis	rs62103177	0.733	rs62096747	chr18:77619568	A/G	cg27393146	chr18:77495563	CTDP1	-0.92	-5.36	-0.52	8.37e-7	Opioid sensitivity;
SKCM	cis	rs2197308	0.765	rs11182481	chr12:37926019	T/C	cg26384229	chr12:38710491	ALG10B	0.8	6.92	0.62	1.14e-9	Morning vs. evening chronotype;
SKCM	cis	rs7599312	0.534	rs7607373	chr2:213409719	G/A	cg16329650	chr2:213403929	ERBB4	0.84	5.98	0.56	6.42e-8	BMI (adjusted for smoking behaviour);BMI in non-smokers;Body mass index;Body mass index (joint analysis main effects and smoking interaction);
SKCM	cis	rs55962025	0.686	rs6844859	chr4:3190486	T/C	cg09735869	chr4:3319127	RGS12	-0.58	-4.94	-0.49	4.41e-6	Parental longevity (mother's age at death);
SKCM	cis	rs875971	0.619	rs12533585	chr7:65984605	G/C	cg00343986	chr7:65444356	GUSB	0.7	5.14	0.5	1.98e-6	Aortic root size;
SKCM	cis	rs1577917	0.958	rs114467802	chr6:86572350	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.81	-7.82	-0.66	2.07e-11	Response to antipsychotic treatment;
SKCM	cis	rs6580649	0.941	rs1859441	chr12:48423233	C/T	cg05342945	chr12:48394962	COL2A1	0.75	5.46	0.53	5.49e-7	Lung cancer;
SKCM	cis	rs453301	0.653	rs7016139	chr8:8895470	A/G	cg15556689	chr8:8085844	FLJ10661	-0.71	-5.47	-0.53	5.35e-7	Joint mobility (Beighton score);
SKCM	cis	rs1044826	0.642	rs9833307	chr3:139181370	G/A	cg15131784	chr3:139108705	COPB2	0.66	4.96	0.49	4.09e-6	Obesity-related traits;
SKCM	cis	rs4790333	0.967	rs745400	chr17:2266799	G/A	cg02569219	chr17:2266849	SGSM2	0.76	6.52	0.59	6.36e-9	Proinsulin levels;
SKCM	cis	rs71520386	0.632	rs12532922	chr7:22860415	A/G	cg00309339	chr7:22893653	NA	0.67	4.97	0.49	3.82e-6	Fibrinogen levels;
SKCM	cis	rs7819412	0.806	rs17723229	chr8:10930069	A/C	cg22647929	chr8:10583326	SOX7	-0.55	-5.27	-0.51	1.18e-6	Triglycerides;
SKCM	cis	rs7917772	0.503	rs56397707	chr10:104302693	T/C	cg11453585	chr10:104263688	ACTR1A;SUFU	0.78	6.33	0.58	1.47e-8	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs6582630	0.502	rs10880388	chr12:38401341	A/T	cg26384229	chr12:38710491	ALG10B	0.82	6.3	0.58	1.6e-8	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs5750830	0.594	rs1010170	chr22:39778327	C/T	cg11247378	chr22:39784982	NA	0.46	4.79	0.48	7.68e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs8072100	0.817	rs12449647	chr17:45548958	C/A	cg25173405	chr17:45401733	C17orf57	-0.58	-4.77	-0.48	8.26e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs4561483	0.864	rs190461	chr16:12005745	A/G	cg08843971	chr16:11963173	GSPT1	-0.65	-4.86	-0.48	5.96e-6	Testicular germ cell tumor;
SKCM	cis	rs3020736	0.500	rs6002601	chr22:42489058	A/T	cg04733989	chr22:42467013	NAGA	-0.72	-5.62	-0.54	2.87e-7	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs208520	0.526	rs9363522	chr6:66816642	C/T	cg07460842	chr6:66804631	NA	-1.12	-13.09	-0.83	2.28e-21	Exhaled nitric oxide output;
SKCM	cis	rs12497850	0.931	rs6446196	chr3:49004723	A/G	cg07636037	chr3:49044803	WDR6	1.02	11.0	0.78	1.56e-17	Parkinson's disease;
SKCM	cis	rs36093844	0.527	rs72961110	chr11:85719019	G/C	cg25872744	chr11:85566296	CCDC83	-0.81	-4.79	-0.48	7.84e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs2228479	0.541	rs9806913	chr16:89953773	A/G	cg06558623	chr16:89946397	TCF25	1.25	7.18	0.63	3.53e-10	Skin colour saturation;
SKCM	cis	rs13256369	0.851	rs11249890	chr8:8565245	G/T	cg15556689	chr8:8085844	FLJ10661	0.65	4.77	0.48	8.39e-6	Obesity-related traits;
SKCM	cis	rs875971	0.862	rs6958294	chr7:65794796	C/A	cg18876405	chr7:65276391	NA	-0.64	-6.42	-0.59	9.88e-9	Aortic root size;
SKCM	cis	rs7945705	0.870	rs10840142	chr11:8906078	A/G	cg13070366	chr11:9386451	NA	-0.61	-5.38	-0.52	7.56e-7	Hemoglobin concentration;
SKCM	cis	rs644799	0.710	rs56384142	chr11:95502075	G/T	cg03916912	chr11:95522834	CEP57;FAM76B	0.83	7.24	0.63	2.69e-10	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs514406	0.793	rs12081018	chr1:53217542	C/A	cg24675658	chr1:53192096	ZYG11B	0.61	4.77	0.48	8.47e-6	Monocyte count;
SKCM	cis	rs7666738	0.830	rs1869082	chr4:98841254	T/A	cg05340658	chr4:99064831	C4orf37	0.6	4.81	0.48	7.19e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1032355	0.558	rs7668586	chr4:100536363	C/T	cg25391692	chr4:100495869	MTTP	-0.82	-4.97	-0.49	3.9e-6	Celiac disease;
SKCM	cis	rs55962025	0.842	rs362267	chr4:3243218	C/T	cg24015175	chr4:3319247	RGS12	-0.68	-5.9	-0.56	8.72e-8	Parental longevity (mother's age at death);
SKCM	cis	rs10089	1.000	rs4835945	chr5:127526481	C/A	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.87	7.42	0.64	1.22e-10	Ileal carcinoids;
SKCM	cis	rs752010	0.523	rs10890158	chr1:42117985	C/T	cg06885757	chr1:42089581	HIVEP3	0.49	5.14	0.5	1.97e-6	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs2204008	0.837	rs11168334	chr12:37961768	A/G	cg26384229	chr12:38710491	ALG10B	0.81	6.59	0.6	4.69e-9	Bladder cancer;
SKCM	cis	rs926938	0.520	rs6660624	chr1:115272163	G/A	cg12756093	chr1:115239321	AMPD1	-0.72	-5.41	-0.52	6.68e-7	Autism;
SKCM	cis	rs7103648	0.864	rs10769264	chr11:47423340	C/T	cg20307385	chr11:47447363	PSMC3	1.08	9.26	0.72	3.38e-14	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs4819052	0.918	rs34886433	chr21:46680538	G/C	cg19498844	chr21:46707878	POFUT2;LOC642852	0.93	7.49	0.65	8.98e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs35146811	0.660	rs3779045	chr7:99779259	T/C	cg22906224	chr7:99728672	NA	0.65	5.19	0.51	1.6e-6	Coronary artery disease;
SKCM	cis	rs9916302	0.851	rs12936996	chr17:37665554	A/G	cg07936489	chr17:37558343	FBXL20	0.9	8.1	0.68	6.05e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs1005277	0.579	rs1780133	chr10:38499509	T/C	cg25427524	chr10:38739819	LOC399744	-0.69	-6.79	-0.61	1.96e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs10779751	1.000	rs12120734	chr1:11262020	A/G	cg08854313	chr1:11322531	MTOR	1.01	8.89	0.71	1.75e-13	Body mass index;
SKCM	cis	rs6570726	0.791	rs441290	chr6:145883183	A/G	cg23711669	chr6:146136114	FBXO30	0.8	8.36	0.69	1.89e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2072499	0.750	rs909269	chr1:156192028	C/T	cg24450063	chr1:156163899	SLC25A44	0.82	6.01	0.56	5.64e-8	Testicular germ cell tumor;
SKCM	cis	rs4481887	0.927	rs7519334	chr1:248472076	C/T	cg00666640	chr1:248458726	OR2T12	0.63	5.91	0.56	8.65e-8	Common traits (Other);
SKCM	cis	rs10489202	0.865	rs744168	chr1:168094079	G/T	cg24449463	chr1:168025552	DCAF6	-0.84	-5.47	-0.53	5.29e-7	Schizophrenia;
SKCM	cis	rs9640161	0.711	rs3800781	chr7:150027324	T/A	cg27494647	chr7:150038898	RARRES2	0.57	4.96	0.49	3.97e-6	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs4911259	0.513	rs6057665	chr20:31463460	A/G	cg13636640	chr20:31349939	DNMT3B	-0.74	-6.15	-0.57	3.04e-8	Inflammatory bowel disease;
SKCM	cis	rs1799949	1.000	rs12952790	chr17:41299607	A/G	cg05368731	chr17:41323189	NBR1	0.89	7.91	0.67	1.38e-11	Menopause (age at onset);
SKCM	cis	rs7633857	0.537	rs1580253	chr3:160767150	T/C	cg03342759	chr3:160939853	NMD3	-0.63	-4.78	-0.48	8.04e-6	Educational attainment (years of education);
SKCM	cis	rs12142240	0.698	rs1475389	chr1:46816429	T/C	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs10870270	1.000	rs10870271	chr10:133754807	A/G	cg17892150	chr10:133769511	PPP2R2D	0.7	5.16	0.5	1.86e-6	Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals;
SKCM	cis	rs11858159	0.845	rs6576352	chr15:24838459	A/C	cg24138476	chr15:25312939	SNORD116-5;SNORD116-7	-0.61	-5.13	-0.5	2.06e-6	Platelet thrombus formation;
SKCM	cis	rs9467773	1.000	rs9467778	chr6:26534743	T/C	cg15659132	chr6:26577336	NA	0.6	5.71	0.54	1.99e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7726839	0.540	rs3749618	chr5:602650	A/G	cg10555297	chr5:473380	SLC9A3;LOC25845	1.0	4.88	0.48	5.5e-6	Obesity-related traits;
SKCM	cis	rs936229	0.871	rs2290574	chr15:75135447	T/C	cg14664628	chr15:75095509	CSK	-1.05	-8.01	-0.67	9.18e-12	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin);
SKCM	cis	rs757110	0.770	rs1557765	chr11:17403639	T/C	cg15432903	chr11:17409602	KCNJ11	0.53	5.05	0.5	2.8e-6	Type 2 diabetes;
SKCM	cis	rs929354	0.629	rs6950739	chr7:156982450	T/C	cg17757837	chr7:157058334	UBE3C	0.81	5.68	0.54	2.21e-7	Body mass index;
SKCM	cis	rs28386778	0.897	rs3744293	chr17:61841788	T/A	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs1862618	0.802	rs7733041	chr5:56107377	A/C	cg18230493	chr5:56204884	C5orf35	-0.79	-4.9	-0.49	5.09e-6	Initial pursuit acceleration;
SKCM	cis	rs9303401	0.659	rs12150264	chr17:56939927	G/A	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.35	0.52	8.54e-7	Cognitive test performance;
SKCM	cis	rs1005277	0.540	rs2145487	chr10:38010077	A/G	cg00409905	chr10:38381863	ZNF37A	-0.63	-6.07	-0.57	4.4e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs1801251	1.000	rs13013142	chr2:233600606	A/G	cg08000102	chr2:233561755	GIGYF2	0.87	7.05	0.62	6.23e-10	Coronary artery disease;
SKCM	cis	rs9913156	0.789	rs56003988	chr17:4600764	G/A	cg19197139	chr17:4613644	ARRB2	0.8	5.34	0.52	8.82e-7	Lymphocyte counts;
SKCM	cis	rs2033711	0.818	rs4801595	chr19:58978517	G/A	cg03735888	chr19:58951602	ZNF132	0.74	6.58	0.6	4.8e-9	Uric acid clearance;
SKCM	cis	rs950776	0.714	rs17408276	chr15:78881618	T/C	cg06917634	chr15:78832804	PSMA4	0.85	6.82	0.61	1.7e-9	Sudden cardiac arrest;
SKCM	cis	rs875971	0.895	rs4718349	chr7:65909011	C/G	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs926938	0.520	rs4140445	chr1:115291978	T/C	cg12756093	chr1:115239321	AMPD1	-0.73	-5.47	-0.53	5.15e-7	Autism;
SKCM	cis	rs9300255	0.739	rs4759371	chr12:123742563	T/C	cg00376283	chr12:123451042	ABCB9	0.84	5.91	0.56	8.5e-8	Neutrophil percentage of white cells;
SKCM	cis	rs7954584	0.567	rs11043251	chr12:122373279	C/T	cg01765077	chr12:122356316	WDR66	0.44	4.79	0.48	7.71e-6	Mean corpuscular volume;
SKCM	cis	rs875971	0.862	rs709609	chr7:65560561	A/G	cg18876405	chr7:65276391	NA	-0.67	-6.79	-0.61	2.01e-9	Aortic root size;
SKCM	cis	rs11098499	0.863	rs10034450	chr4:120455649	A/G	cg24375607	chr4:120327624	NA	0.68	5.27	0.51	1.16e-6	Corneal astigmatism;
SKCM	cis	rs3816788	0.596	rs4872083	chr8:21770372	C/T	cg17168535	chr8:21777572	XPO7	0.64	5.38	0.52	7.72e-7	Lung cancer in ever smokers;
SKCM	cis	rs61776719	0.810	rs34655914	chr1:38397341	G/A	cg12658694	chr1:38397304	INPP5B	0.7	6.0	0.56	5.74e-8	Coronary artery disease;
SKCM	cis	rs6977660	0.714	rs6976854	chr7:19818311	A/G	cg05791153	chr7:19748676	TWISTNB	0.77	5.02	0.49	3.23e-6	Thyroid stimulating hormone;
SKCM	cis	rs7666738	0.830	rs17548431	chr4:98923768	C/G	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2153535	0.601	rs4960414	chr6:8438541	A/G	cg23788917	chr6:8435910	SLC35B3	0.69	5.14	0.5	1.99e-6	Motion sickness;
SKCM	cis	rs8180040	0.587	rs62246398	chr3:47066203	A/C	cg27129171	chr3:47204927	SETD2	-0.74	-5.37	-0.52	7.84e-7	Colorectal cancer;
SKCM	cis	rs3820928	0.874	rs59630650	chr2:227786514	T/C	cg11843606	chr2:227700838	RHBDD1	-0.6	-4.81	-0.48	7.34e-6	Pulmonary function;
SKCM	cis	rs5753618	0.583	rs8138596	chr22:31786961	T/A	cg02404636	chr22:31891804	SFI1	0.58	4.97	0.49	3.86e-6	Colorectal cancer;
SKCM	cis	rs2075371	0.501	rs1643057	chr7:134027521	A/G	cg20476274	chr7:133979776	SLC35B4	0.83	6.86	0.61	1.43e-9	Mean platelet volume;
SKCM	cis	rs2242194	0.550	rs6682611	chr1:154997674	T/A	cg12436631	chr1:155007014	DCST1;DCST2	0.58	6.71	0.61	2.75e-9	Schizophrenia;
SKCM	cis	rs7772486	0.754	rs702323	chr6:146008274	A/G	cg05347473	chr6:146136440	FBXO30	-0.61	-5.33	-0.52	9.22e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs854765	0.547	rs4925135	chr17:17952868	T/C	cg04398451	chr17:18023971	MYO15A	0.94	7.53	0.65	7.5e-11	Total body bone mineral density;
SKCM	cis	rs6502050	0.723	rs4789698	chr17:80179786	C/T	cg13939156	chr17:80058883	NA	-0.53	-4.83	-0.48	6.79e-6	Life satisfaction;
SKCM	cis	rs3820068	0.581	rs59991988	chr1:15950552	T/A	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs6696846	0.716	rs6593921	chr1:205062861	A/G	cg03948781	chr1:205179583	DSTYK	0.56	5.28	0.51	1.14e-6	Red blood cell count;
SKCM	cis	rs11098499	0.863	rs1552092	chr4:120488496	C/T	cg24375607	chr4:120327624	NA	0.69	5.47	0.53	5.35e-7	Corneal astigmatism;
SKCM	cis	rs9300255	0.602	rs1616131	chr12:123619838	G/A	cg05973401	chr12:123451056	ABCB9	0.8	5.47	0.53	5.23e-7	Neutrophil percentage of white cells;
SKCM	cis	rs9788682	1.000	rs57064725	chr15:78833036	C/A	cg06917634	chr15:78832804	PSMA4	-0.82	-4.96	-0.49	3.97e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs34779708	0.931	rs2244100	chr10:35323636	G/A	cg03585969	chr10:35415529	CREM	-0.74	-6.12	-0.57	3.51e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs67311347	1.000	rs34762643	chr3:40475433	C/T	cg00091569	chr3:40428383	ENTPD3	0.62	5.09	0.5	2.4e-6	Renal cell carcinoma;
SKCM	cis	rs362296	0.698	rs3129319	chr4:3265381	A/G	cg05297308	chr4:3317976	RGS12	-0.69	-5.85	-0.55	1.12e-7	Parental longevity (mother's age at death);
SKCM	cis	rs867186	1.000	rs79341738	chr20:33702104	T/C	cg04194272	chr20:33683537	NA	-1.14	-6.37	-0.58	1.22e-8	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs875971	0.964	rs778735	chr7:65814809	C/A	cg18876405	chr7:65276391	NA	0.68	6.79	0.61	1.96e-9	Aortic root size;
SKCM	cis	rs4665809	0.549	rs3828255	chr2:26413252	G/A	cg26119090	chr2:26468346	HADHA;HADHB	0.99	7.13	0.63	4.44e-10	Gut microbiome composition (summer);
SKCM	cis	rs7215564	0.908	rs2315922	chr17:78695127	C/T	cg16980736	chr17:78789706	RPTOR	-0.87	-4.81	-0.48	7.12e-6	Myopia (pathological);
SKCM	cis	rs7811142	0.779	rs111312383	chr7:99905325	C/T	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.21	7.77	0.66	2.57e-11	Platelet count;
SKCM	cis	rs2072499	0.966	rs6427307	chr1:156190083	A/G	cg25208724	chr1:156163844	SLC25A44	1.09	9.89	0.75	2.08e-15	Testicular germ cell tumor;
SKCM	cis	rs6570726	0.764	rs366673	chr6:145814628	T/A	cg05347473	chr6:146136440	FBXO30	0.53	4.78	0.48	8.07e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1062177	0.950	rs59580263	chr5:151269577	T/A	cg00977110	chr5:151150581	G3BP1	0.81	6.51	0.59	6.59e-9	Preschool internalizing problems;
SKCM	cis	rs62238980	0.522	rs117390331	chr22:32461489	T/C	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs151997	0.925	rs26087	chr5:50172911	G/A	cg06027927	chr5:50259733	NA	0.63	5.35	0.52	8.42e-7	Callous-unemotional behaviour;
SKCM	cis	rs6121246	0.697	rs6088856	chr20:30226543	C/G	cg11595048	chr20:30225325	COX4I2	0.63	4.94	0.49	4.31e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs6753739	0.745	rs1455838	chr2:219912629	A/G	cg09617556	chr2:219924408	IHH	0.47	4.94	0.49	4.44e-6	Height;
SKCM	cis	rs2842992	0.789	rs2475566	chr6:160148741	C/T	cg19482086	chr6:160211437	TCP1;MRPL18	0.84	6.38	0.59	1.18e-8	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs798554	1.000	rs798548	chr7:2760935	A/G	cg14895029	chr7:2775587	GNA12	-0.7	-5.13	-0.5	2.06e-6	Height;
SKCM	cis	rs9915657	0.933	rs4793272	chr17:70139257	A/T	cg06234051	chr17:70120541	SOX9	-0.59	-5.19	-0.51	1.61e-6	Thyroid hormone levels;
SKCM	trans	rs1814175	0.869	rs10769600	chr11:49681832	C/T	cg03929089	chr4:120376271	NA	-0.87	-7.53	-0.65	7.73e-11	Height;
SKCM	cis	rs548181	0.611	rs609200	chr11:125383808	G/A	cg03464685	chr11:125439445	EI24	-1.5	-9.48	-0.73	1.28e-14	Schizophrenia;Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);
SKCM	cis	rs732765	0.646	rs4508370	chr14:75115887	G/A	cg25946216	chr14:74253857	C14orf43	-0.87	-5.45	-0.53	5.68e-7	Non-small cell lung cancer;
SKCM	cis	rs11105298	0.891	rs10858903	chr12:89927972	G/A	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.84	-5.19	-0.51	1.63e-6	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs1552244	0.935	rs28815328	chr3:10062227	G/A	cg02579736	chr3:10068473	FANCD2;CIDECP	1.23	6.92	0.62	1.13e-9	Alzheimer's disease;
SKCM	cis	rs9880211	0.800	rs9873536	chr3:136474267	A/G	cg21827317	chr3:136751795	NA	-0.7	-5.26	-0.51	1.25e-6	Body mass index;Height;
SKCM	cis	rs7666738	0.830	rs6839203	chr4:98839814	C/G	cg17366294	chr4:99064904	C4orf37	0.56	4.89	0.48	5.25e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7523273	1.000	rs12123251	chr1:207992546	G/A	cg22525895	chr1:207977042	MIR29B2	-0.78	-5.76	-0.55	1.57e-7	Schizophrenia;
SKCM	cis	rs7829975	0.514	rs2976929	chr8:8258712	T/C	cg15556689	chr8:8085844	FLJ10661	0.67	5.83	0.55	1.22e-7	Mood instability;
SKCM	cis	rs10751667	0.666	rs10902247	chr11:953686	G/A	cg10932868	chr11:921992	NA	0.55	5.1	0.5	2.36e-6	Alzheimer's disease (late onset);
SKCM	cis	rs12142240	0.698	rs77185326	chr1:46818417	T/C	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs1062177	1.000	rs2964584	chr5:151142878	T/C	cg00977110	chr5:151150581	G3BP1	0.81	6.32	0.58	1.51e-8	Preschool internalizing problems;
SKCM	cis	rs1568889	0.838	rs716366	chr11:28121536	T/C	cg06544937	chr11:28130018	METT5D1;KIF18A	0.86	7.88	0.67	1.58e-11	Bipolar disorder;
SKCM	cis	rs933688	1.000	rs12188467	chr5:90765632	A/T	cg12630606	chr5:90679528	LOC100129716;ARRDC3	0.99	7.99	0.67	9.97e-12	Smoking behavior;
SKCM	cis	rs875971	0.543	rs801191	chr7:66032955	G/A	cg11764359	chr7:65958608	NA	-0.81	-6.09	-0.57	4.07e-8	Aortic root size;
SKCM	cis	rs7940866	0.845	rs1433976	chr11:130875123	C/T	cg12179176	chr11:130786555	SNX19	-0.7	-5.16	-0.5	1.84e-6	Schizophrenia;
SKCM	cis	rs9467773	0.620	rs2130657	chr6:26650826	C/T	cg15659132	chr6:26577336	NA	0.62	5.4	0.52	6.91e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs9814567	0.727	rs7430034	chr3:134342127	C/T	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.62	-5.0	-0.49	3.46e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs208520	1.000	rs12190316	chr6:66973365	T/C	cg07460842	chr6:66804631	NA	0.86	5.69	0.54	2.16e-7	Exhaled nitric oxide output;
SKCM	cis	rs60871478	0.786	rs12532534	chr7:831891	G/A	cg05535760	chr7:792225	HEATR2	-1.15	-10.18	-0.76	5.69e-16	Cerebrospinal P-tau181p levels;
SKCM	cis	rs9611565	0.592	rs4822044	chr22:41979668	G/C	cg03806693	chr22:41940476	POLR3H	-1.08	-7.18	-0.63	3.57e-10	Vitiligo;
SKCM	cis	rs2842992	0.789	rs10945635	chr6:160214487	C/A	cg11366901	chr6:160182831	ACAT2	0.91	7.38	0.64	1.46e-10	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs1552244	0.688	rs113940455	chr3:10014165	A/C	cg02579736	chr3:10068473	FANCD2;CIDECP	0.94	4.78	0.48	7.98e-6	Alzheimer's disease;
SKCM	cis	rs9325144	0.647	rs12229104	chr12:39110811	T/A	cg26384229	chr12:38710491	ALG10B	-0.73	-6.65	-0.6	3.57e-9	Morning vs. evening chronotype;
SKCM	cis	rs2894969	0.664	rs11252703	chr10:4795125	A/T	cg10503599	chr10:4193868	NA	0.66	5.15	0.5	1.93e-6	Major depressive disorder;
SKCM	cis	rs17376456	0.809	rs10476602	chr5:93445255	T/C	cg21475434	chr5:93447410	FAM172A	0.97	5.42	0.52	6.39e-7	Diabetic retinopathy;
SKCM	cis	rs5769765	0.908	rs9616211	chr22:50317676	G/A	cg22709217	chr22:50311962	ALG12;CRELD2	-0.99	-6.09	-0.57	4.04e-8	Schizophrenia;
SKCM	cis	rs2013441	1.000	rs2703801	chr17:20100600	T/C	cg13482628	chr17:19912719	NA	-0.65	-5.21	-0.51	1.48e-6	Obesity-related traits;
SKCM	cis	rs801193	0.967	rs3800823	chr7:66147110	C/A	cg18876405	chr7:65276391	NA	-0.79	-7.03	-0.62	6.77e-10	Aortic root size;
SKCM	cis	rs1348850	0.574	rs10195917	chr2:178443121	C/T	cg27490568	chr2:178487706	NA	0.73	5.18	0.51	1.72e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs7811142	0.830	rs7341507	chr7:99951315	A/G	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.02	6.28	0.58	1.79e-8	Platelet count;
SKCM	cis	rs1153858	0.832	rs1145078	chr15:45682277	C/T	cg21132104	chr15:45694354	SPATA5L1	0.93	7.66	0.66	4.2e-11	Homoarginine levels;
SKCM	cis	rs7395662	0.500	rs7951327	chr11:48925359	C/T	cg14072046	chr11:49124791	NA	-0.51	-4.8	-0.48	7.62e-6	HDL cholesterol;
SKCM	cis	rs1218582	0.772	rs877343	chr1:154910012	A/G	cg09359103	chr1:154839909	KCNN3	-0.54	-4.99	-0.49	3.57e-6	Prostate cancer;
SKCM	cis	rs2153535	0.580	rs6926759	chr6:8456176	G/A	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs875971	0.862	rs801204	chr7:66022921	T/C	cg18876405	chr7:65276391	NA	-0.61	-6.03	-0.56	5.23e-8	Aortic root size;
SKCM	cis	rs4973517	0.678	rs3100608	chr2:232849803	A/G	cg13952656	chr2:232260762	B3GNT7	-0.48	-4.85	-0.48	6.21e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs34172651	0.517	rs35560136	chr16:24788915	T/A	cg06028605	chr16:24865363	SLC5A11	0.59	4.98	0.49	3.66e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9858542	0.953	rs11926781	chr3:49603289	C/T	cg03060546	chr3:49711283	APEH	-0.69	-5.08	-0.5	2.49e-6	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs2304069	1.000	rs2304069	chr5:149406733	G/T	cg22760475	chr5:149380129	HMGXB3;TIGD6	0.79	5.92	0.56	8.07e-8	HIV-1 control;
SKCM	cis	rs62238980	0.614	rs55739336	chr22:32505773	C/T	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs1949733	0.598	rs4696838	chr4:8540349	A/G	cg11789530	chr4:8429930	ACOX3	-0.74	-4.89	-0.48	5.34e-6	Response to antineoplastic agents;
SKCM	cis	rs344364	0.597	rs1065656	chr16:1838836	C/G	cg00490583	chr16:1843685	IGFALS	0.53	5.02	0.49	3.14e-6	Glomerular filtration rate in chronic kidney disease;
SKCM	cis	rs151997	0.925	rs27260	chr5:50166696	C/T	cg06027927	chr5:50259733	NA	0.61	5.21	0.51	1.47e-6	Callous-unemotional behaviour;
SKCM	cis	rs2120019	1.000	rs7168680	chr15:75369212	G/A	cg17294928	chr15:75287854	SCAMP5	-0.82	-6.77	-0.61	2.13e-9	Blood trace element (Zn levels);
SKCM	cis	rs7811142	1.000	rs4463351	chr7:100078226	G/A	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.34	0.69	2.1e-12	Platelet count;
SKCM	cis	rs4746818	1.000	rs4342912	chr10:70959282	T/C	cg11621586	chr10:70884670	VPS26A	0.93	7.37	0.64	1.52e-10	Left atrial antero-posterior diameter;
SKCM	cis	rs7584330	0.779	rs6737888	chr2:238417363	T/C	cg14458575	chr2:238380390	NA	1.12	7.17	0.63	3.66e-10	Prostate cancer;
SKCM	cis	rs7809950	0.678	rs2237659	chr7:106847492	G/T	cg23024343	chr7:107201750	COG5	0.78	6.79	0.61	1.98e-9	Coronary artery disease;
SKCM	cis	rs7100689	0.784	rs11202699	chr10:82131453	A/G	cg01528321	chr10:82214614	TSPAN14	0.82	7.43	0.64	1.2e-10	Post bronchodilator FEV1;
SKCM	cis	rs514406	0.505	rs387436	chr1:53179376	C/T	cg16325326	chr1:53192061	ZYG11B	-0.89	-10.06	-0.75	9.55e-16	Monocyte count;
SKCM	cis	rs7216064	0.684	rs7406031	chr17:66021753	C/T	cg12091567	chr17:66097778	LOC651250	0.89	6.71	0.6	2.8e-9	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs732765	0.734	rs12323361	chr14:75171706	T/C	cg25946216	chr14:74253857	C14orf43	-0.79	-5.06	-0.5	2.71e-6	Non-small cell lung cancer;
SKCM	cis	rs476633	0.573	rs2099652	chr15:41528745	C/G	cg18705301	chr15:41695430	NDUFAF1	-0.73	-5.86	-0.55	1.06e-7	Glomerular filtration rate (creatinine);
SKCM	cis	rs736408	0.812	rs2071507	chr3:52826707	G/A	cg18404041	chr3:52824283	ITIH1	-0.65	-5.57	-0.53	3.5e-7	Bipolar disorder;
SKCM	cis	rs2439831	1.000	rs2439831	chr15:43784475	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.3	7.89	0.67	1.56e-11	Lung cancer in ever smokers;
SKCM	cis	rs4642101	0.640	rs3901666	chr3:12824363	G/T	cg05775895	chr3:12838266	CAND2	-0.63	-5.5	-0.53	4.7e-7	QRS complex (12-leadsum);
SKCM	cis	rs2439831	0.867	rs6493085	chr15:43654182	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.39	9.42	0.73	1.62e-14	Lung cancer in ever smokers;
SKCM	cis	rs478304	0.627	rs11227254	chr11:65454000	A/G	cg27068330	chr11:65405492	SIPA1	-0.88	-7.54	-0.65	7.28e-11	Acne (severe);
SKCM	cis	rs9790314	0.690	rs6441354	chr3:160826404	A/G	cg03342759	chr3:160939853	NMD3	-0.67	-6.92	-0.62	1.1e-9	Morning vs. evening chronotype;
SKCM	cis	rs72781680	1.000	rs11553491	chr2:24225901	G/C	cg08917208	chr2:24149416	ATAD2B	1.03	5.75	0.55	1.64e-7	Lymphocyte counts;
SKCM	cis	rs2268241	1.000	rs2268241	chr21:34781050	G/A	cg14850771	chr21:34775459	IFNGR2	1.09	6.8	0.61	1.9e-9	Obesity-related traits;
SKCM	cis	rs7149337	0.837	rs10132658	chr14:51677599	C/T	cg23942311	chr14:51606299	NA	0.58	6.27	0.58	1.87e-8	Cancer;
SKCM	cis	rs2279817	0.863	rs11203439	chr1:18026328	T/C	cg17142039	chr1:18149651	ACTL8	0.6	5.1	0.5	2.32e-6	Neuroticism;
SKCM	cis	rs4481887	0.861	rs4295906	chr1:248429861	C/T	cg00666640	chr1:248458726	OR2T12	0.62	5.77	0.55	1.54e-7	Common traits (Other);
SKCM	cis	rs2952156	0.920	rs2517958	chr17:37838751	G/A	cg00129232	chr17:37814104	STARD3	-0.68	-5.56	-0.53	3.69e-7	Asthma;
SKCM	cis	rs116095464	0.558	rs7714335	chr5:263513	T/C	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs71636778	0.543	rs17162330	chr1:27236212	A/G	cg01689405	chr1:26370407	SLC30A2	-0.53	-4.88	-0.48	5.59e-6	Monocyte percentage of white cells;Granulocyte percentage of myeloid white cells;
SKCM	cis	rs6952808	0.792	rs12536261	chr7:1953571	G/A	cg04267008	chr7:1944627	MAD1L1	-0.63	-5.01	-0.49	3.34e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs769267	0.930	rs2301786	chr19:19413947	A/G	cg26732615	chr19:19648335	CILP2;YJEFN3	0.65	6.06	0.57	4.61e-8	Tonsillectomy;
SKCM	cis	rs9467773	1.000	rs1884948	chr6:26567988	G/A	cg15659132	chr6:26577336	NA	0.61	5.76	0.55	1.6e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs2832191	0.633	rs2832166	chr21:30462395	G/C	cg24692254	chr21:30365293	RNF160	0.99	8.36	0.69	1.88e-12	Dental caries;
SKCM	cis	rs7809950	0.817	rs2712224	chr7:107181235	C/A	cg23024343	chr7:107201750	COG5	-0.87	-8.11	-0.68	5.78e-12	Coronary artery disease;
SKCM	cis	rs7937682	0.640	rs587010	chr11:111425658	C/A	cg09085632	chr11:111637200	PPP2R1B	-0.81	-6.99	-0.62	8.14e-10	Primary sclerosing cholangitis;
SKCM	cis	rs801193	1.000	rs1553609	chr7:66197139	T/C	cg11987759	chr7:65425863	GUSB	-0.69	-5.91	-0.56	8.69e-8	Aortic root size;
SKCM	cis	rs10779751	1.000	rs12124983	chr1:11286178	C/T	cg08854313	chr1:11322531	MTOR	-0.99	-8.79	-0.71	2.73e-13	Body mass index;
SKCM	cis	rs7843479	0.509	rs899428	chr8:21770763	T/C	cg17168535	chr8:21777572	XPO7	0.61	5.16	0.5	1.85e-6	Mean corpuscular volume;
SKCM	trans	rs66573146	1.000	rs7686186	chr4:6986094	C/T	cg07817883	chr1:32538562	TMEM39B	2.0	8.02	0.67	8.59e-12	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs1401999	0.966	rs1533682	chr3:183634879	A/G	cg01324343	chr3:183735012	ABCC5	0.89	10.36	0.76	2.63e-16	Anterior chamber depth;
SKCM	cis	rs7666738	0.791	rs10010438	chr4:99022177	C/T	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2286503	1.000	rs2286501	chr7:22856785	G/C	cg15401507	chr7:22894281	NA	-0.57	-5.6	-0.54	3.12e-7	Fibrinogen;
SKCM	cis	rs10808739	1.000	rs4737678	chr8:65646643	C/T	cg05711235	chr8:65498612	NA	-0.76	-4.86	-0.48	5.9e-6	HIV-1 susceptibility;
SKCM	cis	rs7828089	0.715	rs11136029	chr8:22253485	A/G	cg12081754	chr8:22256438	SLC39A14	-0.73	-6.63	-0.6	3.9e-9	Verbal declarative memory;
SKCM	cis	rs644799	0.965	rs2508713	chr11:95547927	T/A	cg25622487	chr11:95524042	FAM76B;CEP57	0.66	5.12	0.5	2.18e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs55962025	0.662	rs362309	chr4:3240915	G/C	cg21096898	chr4:3318625	RGS12	-0.63	-5.36	-0.52	8.18e-7	Parental longevity (mother's age at death);
SKCM	cis	rs11785400	1.000	rs7002932	chr8:143738816	C/A	cg20003893	chr8:144489567	NA	-0.55	-4.79	-0.48	7.95e-6	Schizophrenia;
SKCM	cis	rs992157	0.764	rs2891079	chr2:219184691	A/G	cg20019365	chr2:219134978	PNKD;AAMP	0.74	5.94	0.56	7.66e-8	Colorectal cancer;
SKCM	cis	rs7937682	0.889	rs1789361	chr11:111485334	T/C	cg19812747	chr11:111475976	SIK2	-0.56	-4.93	-0.49	4.55e-6	Primary sclerosing cholangitis;
SKCM	cis	rs9910055	0.550	rs113844752	chr17:42297631	C/A	cg09913183	chr17:42254507	C17orf65;ASB16	0.57	4.81	0.48	7.22e-6	Total body bone mineral density;
SKCM	cis	rs2070488	0.965	rs2366123	chr3:38493153	G/A	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.97	8.85	0.71	2.08e-13	Electrocardiographic conduction measures;
SKCM	cis	rs1577917	0.958	rs10806337	chr6:86474249	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.67	-5.74	-0.54	1.73e-7	Response to antipsychotic treatment;
SKCM	cis	rs7980687	0.628	rs1727332	chr12:123718301	C/T	cg05973401	chr12:123451056	ABCB9	0.69	4.91	0.49	4.96e-6	Height;Educational attainment;Head circumference (infant);
SKCM	cis	rs72949976	0.646	rs1441169	chr2:214033530	A/G	cg08319019	chr2:214017104	IKZF2	0.81	6.42	0.59	9.74e-9	Lung cancer;Squamous cell lung carcinoma;
SKCM	cis	rs870825	0.616	rs7682557	chr4:185640773	A/G	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs1218582	0.741	rs10908446	chr1:154869559	G/A	cg24250549	chr1:154909240	PMVK	0.87	8.7	0.7	4.13e-13	Prostate cancer;
SKCM	cis	rs1559088	0.600	rs10421769	chr19:33605312	T/C	cg27124370	chr19:33622961	WDR88	0.8	5.6	0.54	3.13e-7	Bone ultrasound measurement (broadband ultrasound attenuation);
SKCM	cis	rs910316	0.687	rs175059	chr14:75490667	T/C	cg08847533	chr14:75593920	NEK9	-0.8	-6.59	-0.6	4.76e-9	Height;
SKCM	cis	rs7666738	0.830	rs35531558	chr4:98938217	A/G	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6951245	1.000	rs11766526	chr7:1101433	G/A	cg03188948	chr7:1209495	NA	1.13	6.27	0.58	1.89e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs453301	0.719	rs34004903	chr8:8892604	C/T	cg15556689	chr8:8085844	FLJ10661	-0.73	-5.77	-0.55	1.52e-7	Joint mobility (Beighton score);
SKCM	cis	rs9611565	0.592	rs12484467	chr22:41957610	T/C	cg03806693	chr22:41940476	POLR3H	-1.06	-6.77	-0.61	2.13e-9	Vitiligo;
SKCM	cis	rs2204008	0.745	rs8189516	chr12:38239084	C/T	cg26384229	chr12:38710491	ALG10B	0.87	6.9	0.62	1.21e-9	Bladder cancer;
SKCM	cis	rs807669	0.868	rs762529	chr22:19170205	C/G	cg02655711	chr22:19163373	SLC25A1	0.78	7.22	0.63	3.03e-10	Metabolite levels;
SKCM	cis	rs651907	0.557	rs3806653	chr3:101396972	T/C	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.81	6.96	0.62	9.48e-10	Colorectal cancer;
SKCM	cis	rs898097	0.691	rs7222773	chr17:80907283	A/G	cg15369054	chr17:80825471	TBCD	-0.53	-5.07	-0.5	2.6e-6	Breast cancer;
SKCM	cis	rs9911578	0.704	rs72628393	chr17:56585314	A/T	cg12560992	chr17:57184187	TRIM37	-0.94	-7.55	-0.65	7.05e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs35955841	0.505	rs435627	chr14:65305927	G/A	cg23373153	chr14:65346875	NA	0.72	4.99	0.49	3.57e-6	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity;
SKCM	cis	rs7659604	1.000	rs72678650	chr4:122666000	A/G	cg06713675	chr4:122721982	EXOSC9	-0.61	-5.5	-0.53	4.64e-7	Type 2 diabetes;
SKCM	cis	rs854765	0.547	rs2955377	chr17:17932818	G/A	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.05	9.29	0.72	2.92e-14	Total body bone mineral density;
SKCM	cis	rs12940626	0.928	rs11656906	chr17:66428893	A/G	cg08880486	chr17:66287505	ARSG;SLC16A6	0.67	4.82	0.48	7.04e-6	Red cell distribution width;
SKCM	cis	rs2413583	0.527	rs12485061	chr22:39732665	T/C	cg17798944	chr22:39715225	SNORD43;RPL3	0.86	5.05	0.5	2.87e-6	Ulcerative colitis;Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs3793683	0.520	rs4880426	chr10:134590610	G/A	cg27286337	chr10:134555280	INPP5A	0.97	8.94	0.71	1.4e-13	Migraine;
SKCM	cis	rs4073582	0.595	rs3016319	chr11:65981846	C/T	cg14036092	chr11:66035641	RAB1B	0.74	5.81	0.55	1.3e-7	Gout;
SKCM	cis	rs13118159	0.527	rs6599308	chr4:1387780	A/G	cg20887711	chr4:1340912	KIAA1530	0.95	6.67	0.6	3.29e-9	Longevity;
SKCM	cis	rs9880211	0.664	rs28509770	chr3:135793657	C/G	cg21827317	chr3:136751795	NA	-0.7	-4.93	-0.49	4.45e-6	Body mass index;Height;
SKCM	cis	rs17065868	1.000	rs61948001	chr13:45167814	G/T	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs6570726	0.935	rs379164	chr6:145829093	A/T	cg23711669	chr6:146136114	FBXO30	0.7	6.64	0.6	3.72e-9	Lobe attachment (rater-scored or self-reported);
SKCM	trans	rs17685	0.753	rs3757593	chr7:75678735	G/A	cg19862616	chr7:65841803	NCRNA00174	-0.94	-9.39	-0.73	1.88e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs17685	0.712	rs6464994	chr7:75784668	C/T	cg16684958	chr7:75615977	POR	0.52	4.92	0.49	4.73e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1405130	0.839	rs4663156	chr2:235581361	C/T	cg17841421	chr2:235704848	NA	-0.62	-5.39	-0.52	7.3e-7	Coronary artery disease;
SKCM	cis	rs72945132	0.619	rs34053053	chr11:70260598	C/T	cg14191688	chr11:70257035	CTTN	0.84	5.03	0.49	3.05e-6	Coronary artery disease;
SKCM	cis	rs7618501	0.602	rs2526743	chr3:50115245	G/A	cg05072774	chr3:49840536	C3orf54	0.71	5.48	0.53	5e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs561341	0.941	rs17780086	chr17:30343282	G/A	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs2075371	1.000	rs2598292	chr7:133988584	C/G	cg20476274	chr7:133979776	SLC35B4	1.01	10.44	0.76	1.77e-16	Mean platelet volume;
SKCM	cis	rs6500395	1.000	rs9922734	chr16:48603192	A/G	cg04672837	chr16:48644449	N4BP1	-0.71	-5.94	-0.56	7.52e-8	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs7829975	0.593	rs2921051	chr8:8320104	C/A	cg15556689	chr8:8085844	FLJ10661	0.86	8.34	0.69	2.1e-12	Mood instability;
SKCM	cis	rs116095464	0.558	rs10060089	chr5:205565	G/A	cg22857025	chr5:266934	NA	-1.44	-7.74	-0.66	2.94e-11	Breast cancer;
SKCM	cis	rs7666738	0.830	rs7664305	chr4:99037691	G/A	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11098499	1.000	rs58601355	chr4:120186367	T/C	cg09307838	chr4:120376055	NA	0.95	7.75	0.66	2.84e-11	Corneal astigmatism;
SKCM	cis	rs9875589	0.509	rs7651599	chr3:14010974	C/G	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.56	5.71	0.54	1.96e-7	Ovarian reserve;
SKCM	cis	rs1799949	1.000	rs2271574	chr17:41327648	T/C	cg05368731	chr17:41323189	NBR1	0.88	7.87	0.67	1.65e-11	Menopause (age at onset);
SKCM	cis	rs71520386	0.632	rs10254365	chr7:22864754	A/T	cg15401507	chr7:22894281	NA	0.65	4.87	0.48	5.7e-6	Fibrinogen levels;
SKCM	cis	rs1799949	1.000	rs8176126	chr17:41259049	A/G	cg05368731	chr17:41323189	NBR1	-0.89	-7.93	-0.67	1.27e-11	Menopause (age at onset);
SKCM	cis	rs2777491	0.957	rs8026197	chr15:41711447	C/T	cg18705301	chr15:41695430	NDUFAF1	-0.9	-9.24	-0.72	3.67e-14	Ulcerative colitis;
SKCM	cis	rs5417	0.662	rs8067500	chr17:7172631	A/G	cg25256661	chr17:7137939	DVL2	1.0	7.34	0.64	1.79e-10	Diastolic blood pressure;
SKCM	cis	rs2404602	0.622	rs11632670	chr15:76974055	A/G	cg23625390	chr15:77176239	SCAPER	-0.82	-7.93	-0.67	1.26e-11	Blood metabolite levels;
SKCM	cis	rs2836950	0.545	rs11701805	chr21:40618683	T/C	cg11890956	chr21:40555474	PSMG1	-0.66	-5.26	-0.51	1.22e-6	Menarche (age at onset);
SKCM	cis	rs763014	0.898	rs8060585	chr16:635794	C/G	cg07343612	chr16:622815	PIGQ	-0.7	-6.0	-0.56	5.84e-8	Height;
SKCM	cis	rs992157	0.764	rs2891077	chr2:219184430	A/C	cg00012203	chr2:219082015	ARPC2	0.77	5.58	0.53	3.31e-7	Colorectal cancer;
SKCM	cis	rs9486715	1.000	rs6905568	chr6:97066382	T/C	cg06623918	chr6:96969491	KIAA0776	-0.74	-6.6	-0.6	4.58e-9	Headache;
SKCM	cis	rs6547631	0.622	rs10203826	chr2:85926190	A/C	cg24620635	chr2:85921963	GNLY	0.9	6.65	0.6	3.58e-9	Blood protein levels;
SKCM	cis	rs1799949	1.000	rs4793190	chr17:41200109	T/C	cg25918947	chr17:41365094	TMEM106A	-0.62	-5.89	-0.55	9.22e-8	Menopause (age at onset);
SKCM	cis	rs1799949	0.965	rs8071278	chr17:41193910	A/T	cg25072359	chr17:41440525	NA	0.63	4.85	0.48	6.24e-6	Menopause (age at onset);
SKCM	cis	rs2153535	0.541	rs6905934	chr6:8440043	C/A	cg07606381	chr6:8435919	SLC35B3	0.94	6.94	0.62	1.02e-9	Motion sickness;
SKCM	cis	rs6951245	0.554	rs11544331	chr7:1131411	C/T	cg03188948	chr7:1209495	NA	0.82	5.78	0.55	1.46e-7	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs6430585	0.527	rs1900306	chr2:136416533	G/A	cg07169764	chr2:136633963	MCM6	1.15	8.62	0.7	5.84e-13	Corneal structure;
SKCM	cis	rs9420	0.961	rs682503	chr11:57640994	C/G	cg19752551	chr11:57585705	CTNND1	0.7	6.74	0.61	2.45e-9	Schizophrenia;
SKCM	cis	rs9910055	0.529	rs228746	chr17:42173752	T/C	cg09913183	chr17:42254507	C17orf65;ASB16	-0.59	-4.82	-0.48	6.82e-6	Total body bone mineral density;
SKCM	cis	rs8072100	0.869	rs4439799	chr17:45781599	C/T	cg08085267	chr17:45401833	C17orf57	-0.6	-5.06	-0.5	2.74e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs1062177	0.774	rs2964574	chr5:151155711	G/A	cg00977110	chr5:151150581	G3BP1	0.8	6.36	0.58	1.25e-8	Preschool internalizing problems;
SKCM	cis	rs7772486	0.790	rs4280983	chr6:146280790	G/C	cg23711669	chr6:146136114	FBXO30	-0.78	-7.4	-0.64	1.36e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs28595532	0.920	rs115085630	chr4:119741765	T/C	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs1218582	0.772	rs4845689	chr1:154885524	A/G	cg16680214	chr1:154839983	KCNN3	-0.56	-5.01	-0.49	3.29e-6	Prostate cancer;
SKCM	cis	rs9880211	0.528	rs75685279	chr3:136434833	A/C	cg21827317	chr3:136751795	NA	-0.69	-5.25	-0.51	1.29e-6	Body mass index;Height;
SKCM	cis	rs7618501	0.602	rs2526754	chr3:50125996	G/A	cg05072774	chr3:49840536	C3orf54	0.71	5.48	0.53	5e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs782590	0.967	rs782586	chr2:55836165	A/C	cg18811423	chr2:55921094	PNPT1	0.89	6.89	0.62	1.27e-9	Metabolic syndrome;
SKCM	cis	rs6424115	0.800	rs4649123	chr1:24197696	A/G	cg15997130	chr1:24165203	NA	0.6	4.94	0.49	4.37e-6	Immature fraction of reticulocytes;
SKCM	cis	rs2180341	0.824	rs9321076	chr6:127655614	G/A	cg27446573	chr6:127587934	RNF146	0.94	8.08	0.68	6.49e-12	Breast cancer;
SKCM	cis	rs9290877	0.704	rs7356019	chr3:188459597	C/T	cg17392043	chr3:188495102	LPP	-0.64	-4.93	-0.49	4.6e-6	IgE levels;
SKCM	cis	rs2243480	1.000	rs1267820	chr7:66050295	C/G	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs7811142	0.943	rs111493473	chr7:100049742	A/G	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.34	0.69	2.1e-12	Platelet count;
SKCM	cis	rs28595532	0.920	rs115994609	chr4:119777273	G/A	cg11846333	chr4:119757529	SEC24D	1.17	6.09	0.57	4.03e-8	Cannabis dependence symptom count;
SKCM	cis	rs654950	0.806	rs10749832	chr1:42041806	C/T	cg06885757	chr1:42089581	HIVEP3	0.65	6.81	0.61	1.77e-9	Airway imaging phenotypes;
SKCM	cis	rs4803468	1.000	rs8105833	chr19:41896145	G/A	cg14132834	chr19:41945861	ATP5SL	-0.74	-5.71	-0.54	1.99e-7	Height;
SKCM	cis	rs6545883	0.931	rs778768	chr2:61790289	C/G	cg15711740	chr2:61764176	XPO1	-0.69	-4.77	-0.48	8.38e-6	Tuberculosis;
SKCM	cis	rs4819052	0.808	rs11909411	chr21:46676556	A/C	cg19498844	chr21:46707878	POFUT2;LOC642852	0.88	7.69	0.66	3.74e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs861020	0.582	rs6675890	chr1:210022893	G/C	cg05527609	chr1:210001259	C1orf107	0.92	6.45	0.59	8.74e-9	Orofacial clefts;
SKCM	cis	rs7208859	0.623	rs55814012	chr17:29077697	T/A	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs1401999	1.000	rs1402003	chr3:183642879	C/T	cg01324343	chr3:183735012	ABCC5	0.86	9.47	0.73	1.32e-14	Anterior chamber depth;
SKCM	cis	rs10504073	0.647	rs10808745	chr8:49989037	G/A	cg00325661	chr8:49890786	NA	0.78	6.77	0.61	2.18e-9	Blood metabolite ratios;
SKCM	cis	rs9902453	0.934	rs8079028	chr17:28484234	G/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.79	6.03	0.56	5.24e-8	Coffee consumption (cups per day);
SKCM	cis	rs2836974	0.897	rs2836944	chr21:40593539	G/A	cg11644478	chr21:40555479	PSMG1	0.97	10.08	0.75	8.76e-16	Cognitive function;
SKCM	cis	rs13118159	0.573	rs4974618	chr4:1373663	C/T	cg02475777	chr4:1388615	CRIPAK	0.83	5.8	0.55	1.33e-7	Longevity;
SKCM	cis	rs763014	1.000	rs8054842	chr16:672799	T/C	cg00908189	chr16:619842	PIGQ	0.83	8.03	0.67	8.13e-12	Height;
SKCM	cis	rs7659604	0.702	rs6826506	chr4:122710865	T/G	cg19748678	chr4:122722346	EXOSC9	0.68	5.57	0.53	3.56e-7	Type 2 diabetes;
SKCM	cis	rs875971	0.862	rs57866200	chr7:65565392	A/G	cg11764359	chr7:65958608	NA	-0.83	-7.86	-0.66	1.78e-11	Aortic root size;
SKCM	cis	rs362296	0.698	rs3095073	chr4:3263138	C/T	cg00764545	chr4:3318001	RGS12	-0.7	-6.73	-0.61	2.59e-9	Parental longevity (mother's age at death);
SKCM	cis	rs17711722	0.528	rs73138179	chr7:65294482	G/T	cg18876405	chr7:65276391	NA	0.63	4.88	0.48	5.61e-6	Calcium levels;
SKCM	cis	rs9486715	0.838	rs4839840	chr6:96941149	T/C	cg06623918	chr6:96969491	KIAA0776	0.8	6.58	0.6	4.94e-9	Headache;
SKCM	cis	rs2658782	0.724	rs2605627	chr11:93259515	A/G	cg15737290	chr11:93063684	CCDC67	0.72	4.79	0.48	7.87e-6	Pulmonary function decline;
SKCM	cis	rs3820068	0.603	rs6429768	chr1:15963531	G/A	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs8067545	0.611	rs733794	chr17:20157957	T/C	cg13482628	chr17:19912719	NA	-0.65	-5.44	-0.52	5.84e-7	Schizophrenia;
SKCM	cis	rs6815814	0.950	rs11725779	chr4:38811668	G/A	cg02016764	chr4:38805732	TLR1	-0.77	-5.49	-0.53	4.78e-7	Breast cancer;
SKCM	cis	rs17065868	1.000	rs55717372	chr13:45219605	G/A	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs2075371	1.000	rs2075371	chr7:133984127	A/G	cg20476274	chr7:133979776	SLC35B4	1.01	10.12	0.75	7.54e-16	Mean platelet volume;
SKCM	cis	rs919433	0.680	rs2565161	chr2:198285554	C/G	cg04278110	chr2:198063759	ANKRD44	0.7	4.79	0.48	7.87e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs561341	0.609	rs11658984	chr17:30186612	C/T	cg00745463	chr17:30367425	LRRC37B	0.88	5.18	0.51	1.66e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs55962025	0.842	rs363088	chr4:3210330	A/T	cg09735869	chr4:3319127	RGS12	-0.75	-5.74	-0.54	1.73e-7	Parental longevity (mother's age at death);
SKCM	cis	rs4523957	0.547	rs11078856	chr17:2092064	G/A	cg16513277	chr17:2031491	SMG6	-0.71	-5.08	-0.5	2.47e-6	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs1799949	1.000	rs2037075	chr17:41305826	G/T	cg23758822	chr17:41437982	NA	0.91	7.97	0.67	1.07e-11	Menopause (age at onset);
SKCM	cis	rs9300255	0.602	rs2851438	chr12:123643689	T/C	cg00376283	chr12:123451042	ABCB9	0.82	5.61	0.54	3e-7	Neutrophil percentage of white cells;
SKCM	cis	rs910316	0.663	rs175034	chr14:75463687	T/G	cg08847533	chr14:75593920	NEK9	-0.8	-6.59	-0.6	4.76e-9	Height;
SKCM	cis	rs1912528	0.752	rs769665	chr4:140867638	G/A	cg11128457	chr4:140864437	MAML3	0.62	5.31	0.52	1e-6	Educational attainment (years of education);
SKCM	cis	rs951366	0.789	rs1772148	chr1:205704580	A/T	cg24503407	chr1:205819492	PM20D1	0.88	7.38	0.64	1.5e-10	Menarche (age at onset);
SKCM	cis	rs1862618	0.853	rs832554	chr5:56115036	A/G	cg12311346	chr5:56204834	C5orf35	-0.71	-4.81	-0.48	7.23e-6	Initial pursuit acceleration;
SKCM	cis	rs12986445	0.711	rs10210741	chr2:26139797	C/G	cg07291958	chr2:26785531	C2orf70	0.53	4.93	0.49	4.56e-6	Multiple myeloma and monoclonal gammopathy;Multiple myeloma;
SKCM	cis	rs1577917	0.739	rs9344532	chr6:86234070	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.75	6.36	0.58	1.24e-8	Response to antipsychotic treatment;
SKCM	cis	rs8170	0.554	rs60397819	chr19:17451369	G/T	cg07830086	chr19:18107778	KCNN1	-0.8	-5.01	-0.49	3.37e-6	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Ovarian cancer;Breast cancer;Epithelial ovarian cancer;
SKCM	cis	rs2836974	0.965	rs8131126	chr21:40655754	A/G	cg17971929	chr21:40555470	PSMG1	0.9	8.81	0.71	2.52e-13	Cognitive function;
SKCM	cis	rs10089	1.000	rs3805612	chr5:127505316	G/A	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.87	7.69	0.66	3.82e-11	Ileal carcinoids;
SKCM	cis	rs28595532	0.541	rs56055826	chr4:119789424	T/A	cg21605333	chr4:119757512	SEC24D	1.39	5.54	0.53	3.91e-7	Cannabis dependence symptom count;
SKCM	cis	rs897984	0.762	rs2305880	chr16:30999462	T/C	cg00531865	chr16:30841666	NA	0.59	4.97	0.49	3.81e-6	Dementia with Lewy bodies;
SKCM	cis	rs9916302	0.861	rs11078913	chr17:37671714	G/T	cg07936489	chr17:37558343	FBXL20	-0.91	-8.19	-0.68	4e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs6665290	0.669	rs6426558	chr1:227175367	G/T	cg10327440	chr1:227177885	CDC42BPA	-1.04	-9.46	-0.73	1.41e-14	Myeloid white cell count;
SKCM	cis	rs1160297	0.576	rs1451456	chr2:53092604	A/C	cg07782112	chr2:53107842	NA	0.59	6.26	0.58	1.91e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs11098499	0.738	rs10026493	chr4:120384194	C/G	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs72781680	1.000	rs72798408	chr2:24181845	G/C	cg08917208	chr2:24149416	ATAD2B	1.02	5.84	0.55	1.16e-7	Lymphocyte counts;
SKCM	cis	rs992157	0.687	rs10206984	chr2:219066980	C/T	cg20019365	chr2:219134978	PNKD;AAMP	0.72	6.4	0.59	1.07e-8	Colorectal cancer;
SKCM	cis	rs1801251	0.896	rs79793315	chr2:233690864	C/T	cg25237894	chr2:233734115	C2orf82	-0.53	-5.07	-0.5	2.66e-6	Coronary artery disease;
SKCM	cis	rs1707322	0.721	rs4330955	chr1:46217485	G/C	cg03146154	chr1:46216737	IPP	0.84	6.2	0.57	2.51e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs9910055	0.573	rs113184718	chr17:42206543	A/T	cg09913183	chr17:42254507	C17orf65;ASB16	-0.68	-6.44	-0.59	9.08e-9	Total body bone mineral density;
SKCM	cis	rs2645694	0.626	rs2645684	chr4:77819892	A/C	cg06046430	chr4:77819534	ANKRD56	0.53	5.66	0.54	2.41e-7	Emphysema distribution in smoking;
SKCM	cis	rs12142240	0.698	rs6703669	chr1:46862555	C/T	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs2153535	0.601	rs1855768	chr6:8472969	T/G	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs34779708	0.966	rs2045915	chr10:35418616	G/C	cg03585969	chr10:35415529	CREM	0.77	6.21	0.58	2.4e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs62244186	0.520	rs9311361	chr3:44796132	T/G	cg02073558	chr3:44770973	ZNF501	0.85	7.61	0.65	5.42e-11	Depressive symptoms;
SKCM	cis	rs4523957	0.620	rs9900587	chr17:2071097	G/A	cg16513277	chr17:2031491	SMG6	-0.92	-6.31	-0.58	1.54e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs12586317	0.547	rs60152856	chr14:35421373	G/A	cg16230307	chr14:35515116	FAM177A1	0.75	5.08	0.5	2.52e-6	Psoriasis;
SKCM	cis	rs606458	1.000	rs606458	chr11:64546391	C/T	cg07674570	chr11:65346152	EHBP1L1	-0.67	-4.98	-0.49	3.78e-6	Urate levels;
SKCM	cis	rs8078723	0.668	rs3859191	chr17:38128714	G/A	cg17467752	chr17:38218738	THRA	0.64	5.61	0.54	2.94e-7	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs248381	0.967	rs185077	chr5:78331823	T/C	cg17568934	chr5:77892219	LHFPL2	0.51	4.87	0.48	5.83e-6	Toenail selenium levels;
SKCM	cis	rs6087990	0.735	rs2424907	chr20:31359819	C/T	cg13636640	chr20:31349939	DNMT3B	0.83	6.36	0.58	1.28e-8	Ulcerative colitis;
SKCM	cis	rs2841277	0.708	rs10083374	chr14:105402994	T/C	cg15352829	chr14:105391018	PLD4	-0.58	-4.81	-0.48	7.35e-6	Rheumatoid arthritis;
SKCM	cis	rs4523957	0.614	rs2641439	chr17:2017561	C/G	cg16513277	chr17:2031491	SMG6	-0.81	-5.98	-0.56	6.24e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs62103177	0.608	rs613847	chr18:77845644	A/G	cg27393146	chr18:77495563	CTDP1	0.85	5.67	0.54	2.3e-7	Opioid sensitivity;
SKCM	cis	rs11098499	0.754	rs878372	chr4:120238780	A/C	cg09307838	chr4:120376055	NA	0.93	7.56	0.65	6.5500000000000006e-11	Corneal astigmatism;
SKCM	cis	rs801193	1.000	rs2707854	chr7:66212597	G/A	cg00343986	chr7:65444356	GUSB	0.7	5.19	0.51	1.63e-6	Aortic root size;
SKCM	cis	rs6582630	0.519	rs9738104	chr12:38338459	A/C	cg26384229	chr12:38710491	ALG10B	0.88	6.92	0.62	1.11e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs3087591	0.960	rs4263003	chr17:29438508	G/T	cg24425628	chr17:29625626	OMG;NF1	0.65	5.14	0.5	1.95e-6	Hip circumference;
SKCM	cis	rs7811142	1.000	rs7803454	chr7:99991548	C/T	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.16	7.68	0.66	3.87e-11	Platelet count;
SKCM	cis	rs1949733	1.000	rs2688233	chr4:8491885	T/C	cg11789530	chr4:8429930	ACOX3	0.83	5.84	0.55	1.12e-7	Response to antineoplastic agents;
SKCM	cis	rs5760092	0.618	rs4461358	chr22:24260106	T/C	cg25703541	chr22:24373054	LOC391322	0.84	5.68	0.54	2.2e-7	Urinary 1,3-butadiene metabolite levels in smokers;
SKCM	cis	rs34779708	0.702	rs4244995	chr10:35547175	A/G	cg03585969	chr10:35415529	CREM	0.71	5.25	0.51	1.27e-6	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs7618501	0.602	rs2240326	chr3:50128386	G/A	cg24110177	chr3:50126178	RBM5	0.61	5.18	0.51	1.71e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs13221852	0.547	rs4493813	chr7:3369504	T/G	cg25153887	chr7:2442910	CHST12	-0.78	-4.84	-0.48	6.32e-6	Acute graft versus host disease in bone marrow transplantation (donor effect);
SKCM	cis	rs1692580	0.807	rs10910036	chr1:2183754	C/G	cg21442419	chr1:2182373	SKI	-0.69	-7.27	-0.64	2.42e-10	Coronary artery disease;
SKCM	trans	rs17685	0.672	rs1639618	chr7:75701987	T/C	cg19862616	chr7:65841803	NCRNA00174	0.94	9.45	0.73	1.46e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs9796	0.662	rs8033435	chr15:41436479	C/T	cg18705301	chr15:41695430	NDUFAF1	-0.76	-5.34	-0.52	8.78e-7	Menopause (age at onset);
SKCM	cis	rs2251381	0.750	rs2251186	chr21:30528880	G/A	cg24692254	chr21:30365293	RNF160	0.78	6.09	0.57	3.93e-8	Selective IgA deficiency;
SKCM	cis	rs7727544	0.735	rs4705933	chr5:131678412	G/A	cg24060327	chr5:131705240	SLC22A5	-0.69	-5.07	-0.5	2.64e-6	Blood metabolite levels;
SKCM	cis	rs12478296	1.000	rs56323081	chr2:243040807	A/G	cg06360820	chr2:242988706	NA	-1.0	-5.16	-0.5	1.83e-6	Obesity-related traits;
SKCM	cis	rs17685	0.816	rs11763076	chr7:75765963	C/T	cg01364799	chr7:75623366	TMEM120A	-0.7	-5.69	-0.54	2.09e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs769267	0.965	rs2074550	chr19:19387743	A/C	cg26732615	chr19:19648335	CILP2;YJEFN3	0.6	5.37	0.52	7.9e-7	Tonsillectomy;
SKCM	cis	rs10504229	0.683	rs59528137	chr8:58138565	C/T	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs7937682	0.883	rs1613778	chr11:111456105	G/C	cg19812747	chr11:111475976	SIK2	-0.59	-4.86	-0.48	6.06e-6	Primary sclerosing cholangitis;
SKCM	cis	rs1799949	1.000	rs12936831	chr17:41331816	C/T	cg23758822	chr17:41437982	NA	0.93	7.84	0.66	1.91e-11	Menopause (age at onset);
SKCM	cis	rs7811142	1.000	rs6975514	chr7:100056220	T/C	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.23	7.89	0.67	1.53e-11	Platelet count;
SKCM	cis	rs4780401	0.609	rs16958588	chr16:11819330	G/A	cg01061890	chr16:11836724	TXNDC11	-0.8	-6.08	-0.57	4.09e-8	Rheumatoid arthritis;
SKCM	cis	rs854765	0.583	rs7207043	chr17:17819188	A/G	cg04398451	chr17:18023971	MYO15A	-0.85	-6.05	-0.57	4.75e-8	Total body bone mineral density;
SKCM	cis	rs17270561	0.779	rs12210620	chr6:25884785	T/C	cg17691542	chr6:26056736	HIST1H1C	0.94	5.76	0.55	1.61e-7	Iron status biomarkers;
SKCM	cis	rs2439831	0.850	rs694985	chr15:43813387	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.18	7.16	0.63	3.87e-10	Lung cancer in ever smokers;
SKCM	cis	rs16854884	0.837	rs6767236	chr3:143758399	A/C	cg06585982	chr3:143692056	C3orf58	0.72	5.51	0.53	4.5e-7	Economic and political preferences (feminism/equality);
SKCM	cis	rs28595532	0.920	rs17258830	chr4:119725543	A/T	cg11846333	chr4:119757529	SEC24D	-1.19	-6.39	-0.59	1.12e-8	Cannabis dependence symptom count;
SKCM	cis	rs873946	0.648	rs12767283	chr10:134557094	C/G	cg27286337	chr10:134555280	INPP5A	0.96	8.42	0.69	1.47e-12	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs6570726	0.791	rs392612	chr6:145881586	C/G	cg23711669	chr6:146136114	FBXO30	-0.87	-9.06	-0.72	8.4e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2836974	0.865	rs34778912	chr21:40667037	T/G	cg11644478	chr21:40555479	PSMG1	0.83	7.69	0.66	3.66e-11	Cognitive function;
SKCM	cis	rs823143	0.570	rs823082	chr1:205786935	C/T	cg07167872	chr1:205819463	PM20D1	-0.91	-8.45	-0.69	1.27e-12	Monocyte percentage of white cells;
SKCM	cis	rs2594989	0.779	rs62245949	chr3:11575969	C/G	cg00170343	chr3:11313890	ATG7	-0.98	-5.18	-0.51	1.72e-6	Circulating chemerin levels;
SKCM	cis	rs7618501	0.633	rs6446193	chr3:50059758	T/C	cg24110177	chr3:50126178	RBM5	0.6	5.11	0.5	2.25e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs763014	0.898	rs4984895	chr16:623238	T/C	cg07343612	chr16:622815	PIGQ	-0.69	-5.73	-0.54	1.84e-7	Height;
SKCM	cis	rs28595532	0.920	rs114414928	chr4:119728188	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.52	0.53	4.28e-7	Cannabis dependence symptom count;
SKCM	trans	rs9929218	0.529	rs35854485	chr16:68730855	C/G	cg04657470	chr2:198365150	HSPE1;HSPD1	0.96	9.4	0.73	1.79e-14	Colorectal cancer;
SKCM	cis	rs870825	0.860	rs72703527	chr4:185605997	C/A	cg04058563	chr4:185651563	MLF1IP	1.04	5.96	0.56	7.02e-8	Blood protein levels;
SKCM	cis	rs7215564	0.818	rs4075782	chr17:78556325	A/G	cg16980736	chr17:78789706	RPTOR	0.89	4.88	0.48	5.54e-6	Myopia (pathological);
SKCM	cis	rs7666738	0.830	rs116103936	chr4:98954531	T/C	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs3793683	0.825	rs3793674	chr10:134555773	C/T	cg27286337	chr10:134555280	INPP5A	-1.0	-10.53	-0.77	1.23e-16	Migraine;
SKCM	cis	rs1635	0.655	rs73742544	chr6:28317536	T/A	cg15743358	chr6:28303923	ZNF323	-1.37	-5.44	-0.52	5.99e-7	Schizophrenia;
SKCM	cis	rs1153858	0.621	rs1719237	chr15:45579822	G/A	cg21132104	chr15:45694354	SPATA5L1	0.77	5.1	0.5	2.31e-6	Homoarginine levels;
SKCM	cis	rs6545883	0.929	rs55806663	chr2:61740487	G/T	cg15711740	chr2:61764176	XPO1	-0.75	-5.3	-0.51	1.06e-6	Tuberculosis;
SKCM	cis	rs4819052	0.851	rs2877020	chr21:46658742	C/T	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.42	0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs3820068	0.603	rs6660234	chr1:15962590	T/C	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs35306767	0.715	rs12772979	chr10:1034412	C/T	cg20503657	chr10:835505	NA	0.75	5.94	0.56	7.41e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs7090367	0.555	rs9423354	chr10:125249764	A/G	cg16197717	chr10:125650957	CPXM2	-0.45	-4.96	-0.49	4.11e-6	Body mass index;
SKCM	cis	rs3845702	0.935	rs6433822	chr2:180840422	G/C	cg01881094	chr2:180872142	CWC22	-1.02	-5.29	-0.51	1.07e-6	Schizophrenia;
SKCM	cis	rs9309711	0.736	rs28619526	chr2:3496804	T/C	cg10845886	chr2:3471009	TTC15	-0.81	-5.43	-0.52	6.09e-7	Neurofibrillary tangles;
SKCM	cis	rs9467773	1.000	rs4713008	chr6:26538268	T/C	cg15659132	chr6:26577336	NA	0.6	5.71	0.54	1.99e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs8177253	0.761	rs1830083	chr3:133508551	G/A	cg16414030	chr3:133502952	NA	-0.7	-5.66	-0.54	2.36e-7	Iron status biomarkers;
SKCM	cis	rs9875589	0.509	rs2733548	chr3:14094478	C/T	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.53	5.31	0.52	9.98e-7	Ovarian reserve;
SKCM	cis	rs738322	0.967	rs133021	chr22:38573338	T/C	cg25457927	chr22:38595422	NA	-0.56	-6.41	-0.59	1.03e-8	Cutaneous nevi;
SKCM	cis	rs11252926	0.674	rs11598550	chr10:504778	A/C	cg18196295	chr10:418757	DIP2C	-0.64	-5.29	-0.51	1.08e-6	Psychosis in Alzheimer's disease;
SKCM	cis	rs1707322	1.000	rs10789485	chr1:46407308	C/T	cg03146154	chr1:46216737	IPP	0.76	5.21	0.51	1.53e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs3785574	0.962	rs62077509	chr17:61848973	A/G	cg06601766	chr17:61851465	DDX42;CCDC47	0.64	4.77	0.48	8.35e-6	Height;
SKCM	cis	rs208520	1.000	rs72882102	chr6:66983408	C/A	cg07460842	chr6:66804631	NA	0.87	5.96	0.56	6.95e-8	Exhaled nitric oxide output;
SKCM	cis	rs6570726	0.935	rs414646	chr6:145831685	T/C	cg23711669	chr6:146136114	FBXO30	0.7	6.64	0.6	3.72e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2204008	0.728	rs12369538	chr12:38443942	C/T	cg26384229	chr12:38710491	ALG10B	0.81	6.22	0.58	2.33e-8	Bladder cancer;
SKCM	cis	rs2839186	0.967	rs17176131	chr21:47705237	T/C	cg13012494	chr21:47604986	C21orf56	0.67	5.71	0.54	1.95e-7	Testicular germ cell tumor;
SKCM	cis	rs1707322	0.691	rs12031182	chr1:46220999	C/T	cg03146154	chr1:46216737	IPP	0.84	6.2	0.57	2.51e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs13108904	0.905	rs1680074	chr4:1279621	G/A	cg05025164	chr4:1340916	KIAA1530	-0.6	-4.82	-0.48	6.9e-6	Obesity-related traits;
SKCM	cis	rs2370759	1.000	rs11594963	chr10:32625736	G/A	cg01819863	chr10:32635814	EPC1	1.02	5.63	0.54	2.68e-7	Sexual dysfunction (female);
SKCM	cis	rs9916302	0.904	rs4794807	chr17:37531718	T/A	cg07936489	chr17:37558343	FBXL20	0.84	7.23	0.63	2.81e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs6977660	0.660	rs28663574	chr7:19816905	G/A	cg05791153	chr7:19748676	TWISTNB	0.76	4.89	0.48	5.28e-6	Thyroid stimulating hormone;
SKCM	cis	rs2153535	0.580	rs7766852	chr6:8472417	C/T	cg23788917	chr6:8435910	SLC35B3	0.66	4.82	0.48	6.85e-6	Motion sickness;
SKCM	cis	rs951366	0.528	rs1172198	chr1:205662718	C/T	cg07157834	chr1:205819609	PM20D1	0.63	5.11	0.5	2.27e-6	Menarche (age at onset);
SKCM	cis	rs17685	0.753	rs1637051	chr7:75730659	G/A	cg01364799	chr7:75623366	TMEM120A	-0.79	-6.37	-0.58	1.23e-8	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7111031	1.000	rs61902807	chr11:113344912	T/C	cg04642306	chr11:112834466	NCAM1	-0.45	-5.0	-0.49	3.5e-6	Subjective well-being (multi-trait analysis);Depressive symptoms (multi-trait analysis);Neuroticism;
SKCM	cis	rs478304	0.651	rs948493	chr11:65552154	C/T	cg17480646	chr11:65405466	SIPA1	-0.69	-5.16	-0.5	1.84e-6	Acne (severe);
SKCM	cis	rs12497850	0.931	rs4974079	chr3:48906469	T/G	cg06212747	chr3:49208901	KLHDC8B	0.68	4.89	0.48	5.28e-6	Parkinson's disease;
SKCM	cis	rs9399135	0.967	rs2327580	chr6:135364417	A/C	cg24558204	chr6:135376177	HBS1L	0.57	5.01	0.49	3.34e-6	Red blood cell count;
SKCM	cis	rs875971	0.597	rs11771318	chr7:66062480	G/T	cg00343986	chr7:65444356	GUSB	-0.7	-5.18	-0.51	1.71e-6	Aortic root size;
SKCM	cis	rs28386778	0.897	rs8079818	chr17:61824667	C/G	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.12	11.27	0.79	4.92e-18	Prudent dietary pattern;
SKCM	cis	rs7945705	0.967	rs10840148	chr11:8923528	C/T	cg21881798	chr11:8931708	C11orf17;ST5	0.8	7.95	0.67	1.18e-11	Hemoglobin concentration;
SKCM	cis	rs6088580	0.634	rs1890000	chr20:32968312	G/T	cg24642439	chr20:33292090	TP53INP2	-0.76	-6.02	-0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs10193935	0.901	rs17029344	chr2:42444287	T/C	cg27598129	chr2:42591480	NA	-0.88	-6.71	-0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs362296	0.698	rs3095073	chr4:3263138	C/T	cg16987761	chr4:3318072	RGS12	-0.72	-6.53	-0.59	6.19e-9	Parental longevity (mother's age at death);
SKCM	cis	rs7829975	0.501	rs2980769	chr8:8320291	G/A	cg15556689	chr8:8085844	FLJ10661	0.73	6.29	0.58	1.67e-8	Mood instability;
SKCM	cis	rs17685	0.587	rs1623759	chr7:75724679	A/T	cg01364799	chr7:75623366	TMEM120A	-0.79	-6.37	-0.58	1.23e-8	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs72717009	0.825	rs6671753	chr1:161478708	G/A	cg23840854	chr1:161414152	NA	-0.99	-5.66	-0.54	2.44e-7	Rheumatoid arthritis;
SKCM	cis	rs9815354	0.812	rs73073233	chr3:42010550	A/G	cg03022575	chr3:42003672	ULK4	1.0	5.0	0.49	3.43e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs801193	0.636	rs10233806	chr7:66118248	G/C	cg05627663	chr7:65219948	SNORA22;CCT6P1	-0.52	-5.07	-0.5	2.57e-6	Aortic root size;
SKCM	cis	rs12926788	0.546	rs200537	chr16:24747787	G/C	cg06028605	chr16:24865363	SLC5A11	-0.59	-4.98	-0.49	3.66e-6	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs6665290	0.904	rs1186	chr1:227177731	A/T	cg10327440	chr1:227177885	CDC42BPA	-1.22	-17.15	-0.89	3.47e-28	Myeloid white cell count;
SKCM	cis	rs846858	0.928	rs846900	chr19:45116019	A/G	cg18042043	chr19:44147545	NA	-0.59	-4.9	-0.49	5.07e-6	Late-onset Alzheimer's disease;
SKCM	cis	rs9467773	1.000	rs6925703	chr6:26521589	G/A	cg15659132	chr6:26577336	NA	0.6	5.71	0.54	1.99e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs798554	0.797	rs35957220	chr7:2812632	C/G	cg19346786	chr7:2764209	NA	-0.72	-7.98	-0.67	1.05e-11	Height;
SKCM	cis	rs2836974	0.800	rs73221174	chr21:40540939	T/C	cg11644478	chr21:40555479	PSMG1	0.97	10.27	0.76	3.8e-16	Cognitive function;
SKCM	cis	rs7811142	0.830	rs61735533	chr7:99955866	G/A	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.07	6.7	0.6	2.88e-9	Platelet count;
SKCM	cis	rs2304069	0.954	rs1433010	chr5:149383954	C/G	cg22760475	chr5:149380129	HMGXB3;TIGD6	-0.85	-6.22	-0.58	2.25e-8	HIV-1 control;
SKCM	cis	rs2050392	0.767	rs1536833	chr10:30699265	C/T	cg25182066	chr10:30743637	MAP3K8	0.67	5.59	0.53	3.26e-7	Inflammatory bowel disease;
SKCM	cis	rs2980436	1	rs2980436	chr8:8092025	A/G	cg08975724	chr8:8085496	FLJ10661	-0.68	-5.1	-0.5	2.31e-6	Schizophrenia;
SKCM	cis	rs28595532	0.920	rs28797314	chr4:119783044	A/G	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs7208859	0.623	rs7503335	chr17:29073962	G/A	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs7584330	0.910	rs7606177	chr2:238394913	G/C	cg14458575	chr2:238380390	NA	0.98	6.47	0.59	7.93e-9	Prostate cancer;
SKCM	cis	rs867186	1.000	rs114948279	chr20:33733641	G/A	cg04194272	chr20:33683537	NA	-1.11	-6.01	-0.56	5.7e-8	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs798554	0.757	rs1182179	chr7:2873648	A/G	cg19346786	chr7:2764209	NA	-0.63	-7.05	-0.62	6.32e-10	Height;
SKCM	cis	rs116095464	0.510	rs55750776	chr5:230467	T/C	cg22496380	chr5:211416	CCDC127	-0.95	-5.22	-0.51	1.42e-6	Breast cancer;
SKCM	cis	rs501916	0.796	rs628501	chr15:48027328	C/G	cg16110827	chr15:48056943	SEMA6D	-0.62	-5.12	-0.5	2.16e-6	Inflammatory bowel disease;Ulcerative colitis;
SKCM	cis	rs6942756	1.000	rs17168512	chr7:128955033	A/G	cg02491457	chr7:128862824	NA	-0.86	-5.48	-0.53	5.11e-7	White matter hyperintensity burden;
SKCM	cis	rs769267	0.930	rs2301786	chr19:19413947	A/G	cg03709012	chr19:19516395	GATAD2A	0.83	6.87	0.61	1.38e-9	Tonsillectomy;
SKCM	cis	rs2645694	0.626	rs2703119	chr4:77823640	C/T	cg06046430	chr4:77819534	ANKRD56	0.54	5.82	0.55	1.26e-7	Emphysema distribution in smoking;
SKCM	cis	rs3820068	0.581	rs72645874	chr1:15926238	C/G	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs6063399	0.538	rs2426154	chr20:48001995	C/T	cg05303999	chr20:47988955	KCNB1	-0.8	-7.0	-0.62	8.01e-10	Obesity-related traits;
SKCM	cis	rs873946	0.586	rs2001426	chr10:134563871	G/A	cg26818010	chr10:134567672	INPP5A	-0.79	-6.06	-0.57	4.54e-8	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs875971	0.862	rs6962717	chr7:65883735	G/A	cg11764359	chr7:65958608	NA	0.8	7.47	0.65	1.01e-10	Aortic root size;
SKCM	cis	rs3793683	0.597	rs12767469	chr10:134587261	C/G	cg14275445	chr10:134560047	INPP5A	-0.57	-4.78	-0.48	8.21e-6	Migraine;
SKCM	cis	rs2075371	1.000	rs2241335	chr7:133979368	C/T	cg20476274	chr7:133979776	SLC35B4	1.0	10.38	0.76	2.32e-16	Mean platelet volume;
SKCM	cis	rs2180341	0.961	rs3798857	chr6:127659473	A/T	cg24812749	chr6:127587940	RNF146	0.85	7.3	0.64	2.08e-10	Breast cancer;
SKCM	cis	rs1577917	1.000	rs1857965	chr6:86630776	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.85	-8.62	-0.7	5.82e-13	Response to antipsychotic treatment;
SKCM	cis	rs1568889	1.000	rs7933332	chr11:28036392	T/C	cg06544937	chr11:28130018	METT5D1;KIF18A	0.86	7.03	0.62	6.97e-10	Bipolar disorder;
SKCM	cis	rs3847687	1.000	rs78233646	chr12:131520170	G/T	cg13586425	chr12:131519906	GPR133	-0.52	-5.81	-0.55	1.27e-7	Longevity;
SKCM	cis	rs2479724	0.935	rs1887718	chr6:41857691	C/T	cg17623882	chr6:41773611	USP49	-0.78	-6.6	-0.6	4.59e-9	Menarche (age at onset);
SKCM	cis	rs9796	0.621	rs557864	chr15:41471358	T/C	cg18705301	chr15:41695430	NDUFAF1	0.7	5.18	0.51	1.67e-6	Menopause (age at onset);
SKCM	cis	rs427394	0.659	rs274695	chr5:6732252	G/C	cg10857441	chr5:6722123	POLS	-0.69	-7.38	-0.64	1.51e-10	Menopause (age at onset);
SKCM	cis	rs9926296	0.605	rs3743859	chr16:89846050	A/G	cg26513180	chr16:89883248	FANCA	-0.96	-10.74	-0.77	4.83e-17	Vitiligo;
SKCM	cis	rs7586085	0.522	rs10930174	chr2:166474287	C/T	cg01770810	chr2:165769913	SLC38A11	-0.5	-5.08	-0.5	2.52e-6	Total body bone mineral density;
SKCM	cis	rs875971	0.522	rs6960048	chr7:65408039	A/G	cg11987759	chr7:65425863	GUSB	-0.76	-6.8	-0.61	1.89e-9	Aortic root size;
SKCM	cis	rs72781680	0.846	rs55707417	chr2:24029928	G/A	cg08917208	chr2:24149416	ATAD2B	1.02	5.54	0.53	3.94e-7	Lymphocyte counts;
SKCM	cis	rs9815354	0.723	rs77572508	chr3:41938044	C/A	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs1499614	0.901	rs3936	chr7:66126489	C/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Gout;
SKCM	cis	rs7772486	0.774	rs2247571	chr6:146219533	T/A	cg05347473	chr6:146136440	FBXO30	0.51	4.8	0.48	7.58e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2072499	1.000	rs2241108	chr1:156181007	C/G	cg24450063	chr1:156163899	SLC25A44	1.03	10.12	0.75	7.26e-16	Testicular germ cell tumor;
SKCM	cis	rs2836974	0.568	rs442972	chr21:40534757	C/T	cg11644478	chr21:40555479	PSMG1	-0.8	-7.6	-0.65	5.6e-11	Cognitive function;
SKCM	cis	rs870825	0.721	rs72703528	chr4:185607311	A/G	cg04058563	chr4:185651563	MLF1IP	1.04	5.96	0.56	7.02e-8	Blood protein levels;
SKCM	cis	rs12142240	0.698	rs966907	chr1:46817125	C/G	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs611744	0.631	rs681963	chr8:109255032	C/A	cg18478394	chr8:109455254	TTC35	0.66	5.33	0.52	9.43e-7	Dupuytren's disease;
SKCM	cis	rs2455601	0.882	rs11042106	chr11:8896083	C/T	cg21881798	chr11:8931708	C11orf17;ST5	0.77	5.55	0.53	3.79e-7	Schizophrenia;
SKCM	cis	rs867186	0.925	rs6060257	chr20:33720157	G/T	cg04194272	chr20:33683537	NA	-1.08	-6.14	-0.57	3.23e-8	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs7598759	0.712	rs997400	chr2:232332847	C/T	cg19187155	chr2:232395269	NMUR1	0.61	5.13	0.5	2.07e-6	Noise-induced hearing loss;
SKCM	cis	rs55962025	0.804	rs2071703	chr4:3241413	A/C	cg09735869	chr4:3319127	RGS12	-0.75	-5.73	-0.54	1.83e-7	Parental longevity (mother's age at death);
SKCM	trans	rs2727020	0.553	rs11040400	chr11:49518296	C/A	cg15704280	chr7:45808275	SEPT13	-0.95	-8.53	-0.69	8.99e-13	Coronary artery disease;
SKCM	cis	rs593982	0.925	rs603509	chr11:65507605	C/T	cg08755490	chr11:65554678	OVOL1	-1.09	-10.36	-0.76	2.56e-16	Atopic dermatitis;
SKCM	cis	rs35306767	0.903	rs11253504	chr10:956046	A/G	cg26597838	chr10:835615	NA	0.73	5.81	0.55	1.3e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs864745	0.967	rs1708302	chr7:28198677	C/T	cg15170557	chr7:28214983	JAZF1	-0.72	-7.29	-0.64	2.17e-10	Crohn's disease;Type 2 diabetes;
SKCM	cis	rs6674970	0.777	rs11204782	chr1:151118035	C/G	cg11822372	chr1:151115635	SEMA6C	-0.92	-7.57	-0.65	6.43e-11	Childhood ear infection;
SKCM	cis	rs1475911	0.708	rs56109792	chr21:43520060	A/G	cg24372256	chr21:43528868	UMODL1;C21orf128	-0.72	-5.04	-0.5	2.98e-6	IgG glycosylation;
SKCM	cis	rs760805	0.932	rs742232	chr1:25251706	T/C	cg22509179	chr1:25234806	RUNX3	-0.75	-6.22	-0.58	2.26e-8	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs854765	0.964	rs2230316	chr17:17997209	C/T	cg04398451	chr17:18023971	MYO15A	0.69	5.32	0.52	9.66e-7	Total body bone mineral density;
SKCM	cis	rs6952808	0.792	rs12531315	chr7:1953650	C/G	cg21782813	chr7:2030301	MAD1L1	0.56	6.01	0.56	5.51e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs3768617	0.510	rs10911242	chr1:183072147	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs8180040	0.726	rs34344887	chr3:47042161	A/G	cg27129171	chr3:47204927	SETD2	0.78	5.98	0.56	6.37e-8	Colorectal cancer;
SKCM	cis	rs4911259	0.513	rs4287835	chr20:31457337	T/C	cg13636640	chr20:31349939	DNMT3B	-0.74	-6.15	-0.57	3.09e-8	Inflammatory bowel disease;
SKCM	cis	rs501916	0.605	rs11632156	chr15:48082099	A/G	cg16110827	chr15:48056943	SEMA6D	-0.62	-4.79	-0.48	7.7e-6	Inflammatory bowel disease;Ulcerative colitis;
SKCM	cis	rs55794721	0.509	rs4649085	chr1:25778832	G/A	cg02931644	chr1:25747376	RHCE	0.5	4.9	0.48	5.17e-6	Plateletcrit;Mean corpuscular volume;
SKCM	cis	rs7248779	0.512	rs3848635	chr19:2410332	T/C	cg22729335	chr19:2427816	TIMM13	1.06	9.27	0.72	3.21e-14	Cortisol levels (saliva);
SKCM	cis	rs12477438	0.735	rs12474477	chr2:99690408	G/T	cg26064155	chr2:99771622	LIPT1;TSGA10	-0.72	-4.86	-0.48	6e-6	Chronic sinus infection;
SKCM	cis	rs1325195	0.537	rs2793808	chr1:179170249	T/C	cg25467746	chr1:179556597	NA	0.65	5.86	0.55	1.04e-7	IgE grass sensitization;
SKCM	cis	rs7937682	0.883	rs472465	chr11:111468962	C/T	cg19812747	chr11:111475976	SIK2	-0.61	-4.94	-0.49	4.41e-6	Primary sclerosing cholangitis;
SKCM	cis	rs3793683	0.556	rs2803989	chr10:134560596	C/T	cg26818010	chr10:134567672	INPP5A	-0.74	-6.05	-0.57	4.72e-8	Migraine;
SKCM	cis	rs3820928	0.647	rs2115597	chr2:227791218	T/C	cg11843606	chr2:227700838	RHBDD1	-0.61	-4.83	-0.48	6.57e-6	Pulmonary function;
SKCM	cis	rs6951245	1.000	rs76833820	chr7:1070278	A/T	cg18402987	chr7:1209562	NA	1.15	6.02	0.56	5.38e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs1850744	0.702	rs13136217	chr4:9722292	G/T	cg15442990	chr4:9534313	NA	1.43	5.56	0.53	3.71e-7	Economic and political preferences;
SKCM	cis	rs6933660	0.683	rs6916340	chr6:151779064	T/C	cg14262678	chr6:151773367	RMND1;C6orf211	0.73	5.92	0.56	8.23e-8	Menarche (age at onset);
SKCM	cis	rs11098499	0.909	rs28714195	chr4:120316950	A/T	cg24375607	chr4:120327624	NA	0.65	4.97	0.49	3.87e-6	Corneal astigmatism;
SKCM	cis	rs72792276	0.908	rs3828656	chr5:127487535	G/C	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.78	5.21	0.51	1.52e-6	Red cell distribution width;
SKCM	cis	rs807669	0.903	rs1771540	chr22:19173933	T/A	cg02655711	chr22:19163373	SLC25A1	0.78	7.22	0.63	3.03e-10	Metabolite levels;
SKCM	cis	rs875971	0.862	rs6460307	chr7:66060871	A/G	cg18876405	chr7:65276391	NA	0.63	6.44	0.59	8.9e-9	Aortic root size;
SKCM	cis	rs873946	0.618	rs12775767	chr10:134545628	C/T	cg18305652	chr10:134549665	INPP5A	0.54	5.32	0.52	9.83e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs4423214	1.000	rs4423214	chr11:71173254	C/T	cg05163923	chr11:71159392	DHCR7	0.83	8.11	0.68	5.77e-12	Vitamin D levels;
SKCM	cis	rs6066825	0.590	rs729663	chr20:47304306	C/T	cg18078177	chr20:47281410	PREX1	-0.64	-5.6	-0.54	3.12e-7	Colorectal cancer;
SKCM	cis	rs1003719	0.788	rs3787782	chr21:38462909	T/C	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs1799949	1.000	rs4534897	chr17:41431808	A/G	cg23758822	chr17:41437982	NA	0.92	7.82	0.66	2.13e-11	Menopause (age at onset);
SKCM	cis	rs11098499	0.954	rs9998585	chr4:120396802	T/A	cg24375607	chr4:120327624	NA	0.66	5.09	0.5	2.44e-6	Corneal astigmatism;
SKCM	cis	rs10905065	0.930	rs10795485	chr10:5755047	T/C	cg09234995	chr10:5726438	C10orf18	-0.66	-5.53	-0.53	4.15e-7	Menopause (age at onset);
SKCM	cis	rs7618501	0.572	rs4688756	chr3:50040194	T/A	cg24110177	chr3:50126178	RBM5	-0.6	-5.11	-0.5	2.25e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs950776	0.720	rs11637890	chr15:78935419	C/G	cg06917634	chr15:78832804	PSMA4	-0.71	-5.13	-0.5	2.05e-6	Sudden cardiac arrest;
SKCM	cis	rs13118159	0.509	rs9683830	chr4:1377873	A/G	cg02018176	chr4:1364513	KIAA1530	0.88	7.1	0.63	5e-10	Longevity;
SKCM	trans	rs1814175	0.791	rs7395713	chr11:49877887	A/G	cg03929089	chr4:120376271	NA	-0.93	-8.8	-0.71	2.58e-13	Height;
SKCM	cis	rs870825	0.929	rs1405940	chr4:185591481	A/G	cg04058563	chr4:185651563	MLF1IP	1.06	6.03	0.56	5.23e-8	Blood protein levels;
SKCM	cis	rs2839186	0.739	rs2280958	chr21:47642016	C/T	cg13012494	chr21:47604986	C21orf56	0.67	5.81	0.55	1.29e-7	Testicular germ cell tumor;
SKCM	cis	rs75920871	0.588	rs1815789	chr11:116834953	T/C	cg01368799	chr11:117014884	PAFAH1B2	-0.64	-5.14	-0.5	1.97e-6	Subjective well-being;
SKCM	cis	rs56104184	0.779	rs17206686	chr19:49356317	A/G	cg15549821	chr19:49342101	PLEKHA4	-1.09	-6.81	-0.61	1.82e-9	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs28595532	0.920	rs116331303	chr4:119754542	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs28595532	0.925	rs2728305	chr4:119487022	T/G	cg11846333	chr4:119757529	SEC24D	1.21	5.61	0.54	2.94e-7	Cannabis dependence symptom count;
SKCM	cis	rs4919087	0.962	rs10748691	chr10:98983955	C/T	cg25902810	chr10:99078978	FRAT1	0.73	5.59	0.53	3.25e-7	Monocyte count;
SKCM	cis	rs763014	0.966	rs12935215	chr16:670605	T/C	cg07343612	chr16:622815	PIGQ	-0.69	-5.93	-0.56	7.86e-8	Height;
SKCM	cis	rs12497850	0.897	rs6446252	chr3:48911125	C/T	cg06212747	chr3:49208901	KLHDC8B	0.68	4.93	0.49	4.48e-6	Parkinson's disease;
SKCM	cis	rs2439831	0.681	rs956391	chr15:43617493	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	-1.16	-8.54	-0.7	8.32e-13	Lung cancer in ever smokers;
SKCM	cis	rs1559088	0.576	rs4805852	chr19:33609441	C/T	cg27124370	chr19:33622961	WDR88	0.72	5.16	0.5	1.84e-6	Bone ultrasound measurement (broadband ultrasound attenuation);
SKCM	cis	rs2204008	0.743	rs11182052	chr12:38450421	T/C	cg26384229	chr12:38710491	ALG10B	0.81	6.16	0.57	2.92e-8	Bladder cancer;
SKCM	cis	rs9911578	1.000	rs12947785	chr17:57045160	A/C	cg12560992	chr17:57184187	TRIM37	0.94	7.55	0.65	7.01e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs7811142	0.887	rs111972532	chr7:100069088	T/C	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-0.97	-5.53	-0.53	4.19e-7	Platelet count;
SKCM	cis	rs9674544	0.757	rs6504593	chr17:47132819	T/C	cg10950924	chr17:47092072	IGF2BP1	-0.59	-5.18	-0.51	1.7e-6	Primary tooth development (time to first tooth eruption);Primary tooth development (number of teeth);
SKCM	cis	rs860295	0.702	rs10796946	chr1:155429490	A/T	cg02153340	chr1:155202674	NA	-0.8	-5.77	-0.55	1.52e-7	Body mass index;
SKCM	cis	rs2836950	0.565	rs7278297	chr21:40625752	A/C	cg11890956	chr21:40555474	PSMG1	-0.66	-5.26	-0.51	1.22e-6	Menarche (age at onset);
SKCM	cis	rs765787	0.505	rs12593605	chr15:45497448	T/A	cg24006582	chr15:45444508	DUOX1	0.66	4.82	0.48	6.83e-6	Uric acid levels;
SKCM	cis	rs910316	0.935	rs11159119	chr14:75636967	C/T	cg08847533	chr14:75593920	NEK9	-0.94	-9.11	-0.72	6.65e-14	Height;
SKCM	cis	rs875971	0.862	rs6460290	chr7:65809106	G/A	cg11764359	chr7:65958608	NA	-0.81	-7.6	-0.65	5.6e-11	Aortic root size;
SKCM	cis	rs2836633	0.929	rs62217519	chr21:40034390	G/A	cg05519781	chr21:40033154	ERG	0.8	6.81	0.61	1.84e-9	Coronary artery disease;
SKCM	cis	rs875971	0.929	rs12673810	chr7:65923853	T/A	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	cis	rs3784262	1.000	rs12903474	chr15:58276747	A/C	cg12031962	chr15:58353849	ALDH1A2	0.53	6.78	0.61	2.07e-9	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs208520	0.690	rs12192851	chr6:66705862	G/C	cg07460842	chr6:66804631	NA	0.92	7.66	0.66	4.26e-11	Exhaled nitric oxide output;
SKCM	cis	rs8070624	0.543	rs57728924	chr17:17875342	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.01	8.61	0.7	6.26e-13	Total body bone mineral density;
SKCM	cis	rs9868809	0.505	rs56735597	chr3:48765168	A/G	cg00383909	chr3:49044727	WDR6	0.95	4.97	0.49	3.84e-6	Ulcerative colitis;Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs9815354	0.812	rs4577439	chr3:41952540	T/A	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs372883	0.624	rs1153286	chr21:30684383	A/G	cg24692254	chr21:30365293	RNF160	-0.66	-5.14	-0.5	1.95e-6	Pancreatic cancer;
SKCM	cis	rs9814567	0.727	rs4435681	chr3:134344435	C/T	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.62	-5.0	-0.49	3.46e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs4665809	0.590	rs35615763	chr2:26468778	C/G	cg26119090	chr2:26468346	HADHA;HADHB	1.06	8.39	0.69	1.66e-12	Gut microbiome composition (summer);
SKCM	cis	rs4481887	0.927	rs12744455	chr1:248479960	A/G	cg00666640	chr1:248458726	OR2T12	0.63	5.91	0.56	8.65e-8	Common traits (Other);
SKCM	cis	rs6723226	0.572	rs176411	chr2:32643528	A/G	cg02381751	chr2:32503542	YIPF4	0.68	5.47	0.53	5.27e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs6952808	0.693	rs10950413	chr7:1912988	A/G	cg03354898	chr7:1950403	MAD1L1	-0.55	-5.48	-0.53	5.04e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs7635838	0.654	rs346086	chr3:11272932	G/T	cg00170343	chr3:11313890	ATG7	0.74	5.11	0.5	2.26e-6	HDL cholesterol;
SKCM	cis	rs9297145	1.000	rs9297145	chr7:98759117	A/C	cg05967295	chr7:98741636	SMURF1	1.08	8.44	0.69	1.31e-12	Crohn's disease;Inflammatory bowel disease;Ulcerative colitis;
SKCM	cis	rs995000	0.899	rs10889356	chr1:63155349	G/A	cg06896770	chr1:63153194	DOCK7	0.85	7.58	0.65	5.97e-11	Triglyceride levels;
SKCM	cis	rs7539542	0.535	rs1578679	chr1:202905250	C/T	cg19681188	chr1:202830198	LOC148709	0.66	4.85	0.48	6.16e-6	Mean platelet volume;
SKCM	cis	rs12586317	0.620	rs58320987	chr14:35587726	T/C	cg16230307	chr14:35515116	FAM177A1	0.69	5.04	0.5	2.92e-6	Psoriasis;
SKCM	cis	rs7552404	0.824	rs1251079	chr1:76189445	C/T	cg22875332	chr1:76189707	ACADM	0.76	5.31	0.52	9.96e-7	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs9875589	0.509	rs2731337	chr3:14091440	G/C	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.53	5.16	0.5	1.87e-6	Ovarian reserve;
SKCM	cis	rs9660180	0.967	rs2272908	chr1:1721479	A/G	cg17747265	chr1:1875780	NA	0.54	5.12	0.5	2.16e-6	Body mass index;
SKCM	cis	rs28595532	0.920	rs116821181	chr4:119734892	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs3784262	0.512	rs4646571	chr15:58343137	T/C	cg12031962	chr15:58353849	ALDH1A2	-0.4	-5.14	-0.5	1.99e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs11098499	0.866	rs7665125	chr4:120402079	G/T	cg09307838	chr4:120376055	NA	1.0	7.97	0.67	1.07e-11	Corneal astigmatism;
SKCM	cis	rs9818758	0.607	rs11706189	chr3:49210833	C/A	cg00383909	chr3:49044727	WDR6	0.95	5.43	0.52	6.25e-7	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs10927875	0.632	rs10927863	chr1:16165247	C/A	cg21385522	chr1:16154831	NA	-0.99	-12.29	-0.81	6.21e-20	Dilated cardiomyopathy;
SKCM	cis	rs1850744	0.826	rs11735475	chr4:9614926	G/T	cg15442990	chr4:9534313	NA	-1.55	-5.83	-0.55	1.18e-7	Economic and political preferences;
SKCM	cis	rs7208859	0.623	rs56812022	chr17:29068733	A/G	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs9290877	0.667	rs6763915	chr3:188458283	A/G	cg17392043	chr3:188495102	LPP	-0.64	-4.93	-0.49	4.6e-6	IgE levels;
SKCM	cis	rs2404602	0.735	rs11638767	chr15:76655938	T/C	cg23625390	chr15:77176239	SCAPER	-0.82	-8.05	-0.67	7.68e-12	Blood metabolite levels;
SKCM	cis	rs7917772	0.503	rs1536308	chr10:104288777	T/G	cg11453585	chr10:104263688	ACTR1A;SUFU	0.78	6.33	0.58	1.47e-8	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs155076	0.938	rs9509630	chr13:21844314	G/A	cg14456004	chr13:21872349	NA	-1.22	-6.76	-0.61	2.24e-9	White matter hyperintensity burden;
SKCM	cis	rs3784262	0.669	rs4646609	chr15:58274989	G/A	cg12031962	chr15:58353849	ALDH1A2	-0.4	-4.82	-0.48	6.99e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs861020	1.000	rs12134698	chr1:209987801	C/A	cg05527609	chr1:210001259	C1orf107	-1.04	-7.42	-0.64	1.27e-10	Orofacial clefts;
SKCM	cis	rs7615952	0.673	rs115942855	chr3:125601960	G/A	cg05084668	chr3:125655381	ALG1L	-1.25	-6.57	-0.6	5.19e-9	Blood pressure (smoking interaction);
SKCM	cis	rs60871478	0.786	rs62432898	chr7:826102	G/A	cg05535760	chr7:792225	HEATR2	1.21	10.42	0.76	1.96e-16	Cerebrospinal P-tau181p levels;
SKCM	cis	rs7772486	0.846	rs6908063	chr6:146403618	T/C	cg05347473	chr6:146136440	FBXO30	0.64	5.83	0.55	1.19e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs763121	0.853	rs2267395	chr22:39113903	C/T	cg06022373	chr22:39101656	GTPBP1	0.81	6.18	0.57	2.7e-8	Menopause (age at onset);
SKCM	cis	rs10911232	0.507	rs10911196	chr1:182995233	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.64	0.6	3.83e-9	Hypertriglyceridemia;
SKCM	cis	rs10779751	1.000	rs6679878	chr1:11306882	A/G	cg08854313	chr1:11322531	MTOR	0.93	7.16	0.63	3.9e-10	Body mass index;
SKCM	cis	rs6500602	0.648	rs7702	chr16:4560929	G/C	cg08645402	chr16:4508243	NA	0.63	5.04	0.5	3e-6	Schizophrenia;
SKCM	cis	rs9814567	0.929	rs2241556	chr3:134183312	C/T	cg06109529	chr3:134205091	CEP63;ANAPC13	0.69	5.67	0.54	2.34e-7	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs7296418	0.580	rs78455769	chr12:123856443	G/A	cg00376283	chr12:123451042	ABCB9	0.82	6.54	0.6	5.78e-9	Platelet count;
SKCM	cis	rs6500395	1.000	rs1477134	chr16:48706973	G/A	cg04672837	chr16:48644449	N4BP1	-0.63	-5.37	-0.52	8.01e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	trans	rs561341	0.505	rs548298	chr17:30297494	C/A	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs28595532	0.702	rs72670250	chr4:119337134	T/C	cg11846333	chr4:119757529	SEC24D	1.19	6.71	0.6	2.81e-9	Cannabis dependence symptom count;
SKCM	cis	rs7666738	0.830	rs10034330	chr4:99064849	G/A	cg17366294	chr4:99064904	C4orf37	0.61	4.93	0.49	4.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs34172651	0.517	rs1465423	chr16:24772680	C/G	cg06028605	chr16:24865363	SLC5A11	-0.59	-4.98	-0.49	3.66e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs11718455	0.960	rs13059547	chr3:44004492	G/A	cg21419209	chr3:44054225	NA	-0.65	-5.32	-0.52	9.77e-7	Coronary artery disease;
SKCM	cis	rs11718455	0.767	rs6785433	chr3:43964265	A/G	cg21419209	chr3:44054225	NA	-0.62	-5.06	-0.5	2.75e-6	Coronary artery disease;
SKCM	cis	rs910316	0.874	rs61980828	chr14:75630378	G/A	cg08847533	chr14:75593920	NEK9	-0.96	-9.14	-0.72	5.68e-14	Height;
SKCM	cis	rs7296418	0.922	rs12425009	chr12:123502044	C/T	cg05973401	chr12:123451056	ABCB9	0.82	6.64	0.6	3.81e-9	Platelet count;
SKCM	cis	rs4523957	0.651	rs9898819	chr17:2076352	G/A	cg16513277	chr17:2031491	SMG6	-0.79	-5.88	-0.55	9.52e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs8180040	0.764	rs6794193	chr3:47114904	T/C	cg27129171	chr3:47204927	SETD2	0.82	6.49	0.59	7.26e-9	Colorectal cancer;
SKCM	cis	rs1059312	1.000	rs7136092	chr12:129280164	G/C	cg09035930	chr12:129282057	SLC15A4	0.8	8.41	0.69	1.52e-12	Systemic lupus erythematosus;
SKCM	cis	rs10504229	1.000	rs56344560	chr8:58180626	C/G	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs6951245	0.872	rs76713558	chr7:1095866	A/G	cg24642844	chr7:1081250	C7orf50	-0.93	-6.22	-0.58	2.28e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs2304069	0.913	rs3812009	chr5:149380159	G/C	cg22760475	chr5:149380129	HMGXB3;TIGD6	0.95	6.54	0.6	5.8e-9	HIV-1 control;
SKCM	cis	rs875971	0.964	rs1643388	chr7:65844562	T/C	cg11764359	chr7:65958608	NA	0.87	8.35	0.69	2.01e-12	Aortic root size;
SKCM	cis	rs1218582	0.772	rs877343	chr1:154910012	A/G	cg24250549	chr1:154909240	PMVK	0.87	8.85	0.71	2.14e-13	Prostate cancer;
SKCM	cis	rs2952156	0.920	rs907090	chr17:37833632	T/C	cg00129232	chr17:37814104	STARD3	-0.74	-6.39	-0.59	1.11e-8	Asthma;
SKCM	cis	rs8180040	0.966	rs878659	chr3:47500662	G/A	cg16586182	chr3:47516702	SCAP	-0.76	-5.32	-0.52	9.63e-7	Colorectal cancer;
SKCM	cis	rs1801251	1.000	rs4973053	chr2:233670099	G/A	cg08000102	chr2:233561755	GIGYF2	-0.85	-7.04	-0.62	6.74e-10	Coronary artery disease;
SKCM	cis	rs2180341	0.711	rs4371861	chr6:127568447	G/T	cg27446573	chr6:127587934	RNF146	0.72	5.6	0.54	3.14e-7	Breast cancer;
SKCM	cis	rs2439831	0.867	rs2245176	chr15:43750762	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.19	7.61	0.65	5.35e-11	Lung cancer in ever smokers;
SKCM	cis	rs13118159	0.550	rs11946956	chr4:1369094	T/G	cg05025164	chr4:1340916	KIAA1530	0.9	7.35	0.64	1.66e-10	Longevity;
SKCM	cis	rs10876993	0.890	rs1082502	chr12:58035706	C/T	cg18357645	chr12:58087776	OS9	0.61	5.64	0.54	2.63e-7	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs11105298	0.838	rs4842488	chr12:89881564	C/G	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.89	-6.03	-0.56	5.25e-8	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs9300255	0.602	rs2510885	chr12:123614813	G/C	cg00376283	chr12:123451042	ABCB9	0.83	5.65	0.54	2.49e-7	Neutrophil percentage of white cells;
SKCM	cis	rs1707322	0.752	rs12027622	chr1:46130252	A/C	cg03146154	chr1:46216737	IPP	0.79	5.42	0.52	6.34e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs611744	0.608	rs612744	chr8:109245991	G/A	cg18478394	chr8:109455254	TTC35	0.66	5.33	0.52	9.43e-7	Dupuytren's disease;
SKCM	cis	rs847649	0.699	rs10242028	chr7:102527785	C/G	cg18108683	chr7:102477205	FBXL13	-0.81	-8.51	-0.69	9.78e-13	Morning vs. evening chronotype;
SKCM	cis	rs7584330	0.695	rs77922291	chr2:238366317	T/G	cg14458575	chr2:238380390	NA	0.86	6.22	0.58	2.31e-8	Prostate cancer;
SKCM	cis	rs55962025	0.883	rs362336	chr4:3213832	G/A	cg05297308	chr4:3317976	RGS12	-0.68	-4.93	-0.49	4.49e-6	Parental longevity (mother's age at death);
SKCM	cis	rs10256972	0.552	rs7805591	chr7:1210745	A/G	cg16145915	chr7:1198662	ZFAND2A	-0.58	-7.98	-0.67	1.04e-11	Longevity;Endometriosis;
SKCM	trans	rs1814175	0.645	rs28549248	chr11:50042740	C/T	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs9640161	0.750	rs11765644	chr7:150026339	C/G	cg10018233	chr7:150070692	REPIN1	0.67	5.2	0.51	1.59e-6	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs801193	0.660	rs2659897	chr7:66187715	A/G	cg11987759	chr7:65425863	GUSB	0.52	4.86	0.48	5.96e-6	Aortic root size;
SKCM	cis	rs9467773	1.000	rs9295695	chr6:26528250	C/T	cg15659132	chr6:26577336	NA	-0.6	-5.71	-0.54	1.99e-7	Intelligence (multi-trait analysis);
SKCM	trans	rs1814175	0.647	rs4881649	chr11:49845560	A/G	cg15704280	chr7:45808275	SEPT13	-0.82	-7.95	-0.67	1.2e-11	Height;
SKCM	cis	rs9910055	0.529	rs850851	chr17:42177674	C/T	cg08499158	chr17:42289980	UBTF	0.71	5.59	0.53	3.27e-7	Total body bone mineral density;
SKCM	cis	rs28595532	0.920	rs115154776	chr4:119774803	A/G	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs1348850	0.561	rs4893956	chr2:178373452	C/T	cg02961200	chr2:178257176	LOC100130691;AGPS	0.83	4.86	0.48	5.99e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs9543976	0.920	rs9543992	chr13:76175074	G/A	cg16409306	chr13:76195284	LMO7	0.84	4.79	0.48	7.87e-6	Diabetic retinopathy;
SKCM	cis	rs523522	0.962	rs11065145	chr12:120947419	A/G	cg27279351	chr12:120934652	DYNLL1	0.91	8.32	0.69	2.26e-12	High light scatter reticulocyte count;
SKCM	cis	rs9902453	0.689	rs7216948	chr17:28203173	G/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.83	6.34	0.58	1.39e-8	Coffee consumption (cups per day);
SKCM	trans	rs1814175	0.708	rs10839464	chr11:49981386	T/C	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs17376456	0.877	rs9314092	chr5:93326362	A/G	cg25358565	chr5:93447407	FAM172A	1.15	7.74	0.66	2.99e-11	Diabetic retinopathy;
SKCM	cis	rs951366	0.873	rs823118	chr1:205723572	C/T	cg14893161	chr1:205819251	PM20D1	0.74	5.37	0.52	7.9e-7	Menarche (age at onset);
SKCM	cis	rs2070488	0.932	rs1841776	chr3:38480727	C/T	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.97	8.85	0.71	2.08e-13	Electrocardiographic conduction measures;
SKCM	cis	rs1850744	0.609	rs11729458	chr4:9630071	A/T	cg15442990	chr4:9534313	NA	1.4	5.3	0.51	1.04e-6	Economic and political preferences;
SKCM	cis	rs8060686	0.641	rs7204974	chr16:68033539	G/A	cg27539214	chr16:67997921	SLC12A4	-0.83	-5.04	-0.5	2.92e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs9640161	0.673	rs11773351	chr7:150030963	T/C	cg10018233	chr7:150070692	REPIN1	0.69	5.4	0.52	7.03e-7	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs6952808	0.656	rs12699646	chr7:2093162	T/G	cg21782813	chr7:2030301	MAD1L1	-0.58	-6.0	-0.56	5.8e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs6547631	0.594	rs12620113	chr2:85936833	G/T	cg24620635	chr2:85921963	GNLY	0.86	6.27	0.58	1.82e-8	Blood protein levels;
SKCM	cis	rs10504229	0.683	rs113492050	chr8:58130046	A/G	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs10089	1.000	rs3805607	chr5:127477418	T/C	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.89	8.95	0.71	1.34e-13	Ileal carcinoids;
SKCM	cis	rs1348850	0.567	rs880898	chr2:178532470	C/T	cg02961200	chr2:178257176	LOC100130691;AGPS	0.67	4.83	0.48	6.67e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs2836974	0.965	rs2836965	chr21:40633631	C/G	cg17971929	chr21:40555470	PSMG1	-0.92	-9.24	-0.72	3.66e-14	Cognitive function;
SKCM	cis	rs17685	0.725	rs6947068	chr7:75662056	T/C	cg01364799	chr7:75623366	TMEM120A	0.72	5.83	0.55	1.18e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1152591	1.000	rs2738413	chr14:64679960	A/G	cg21174375	chr14:64681225	SYNE2	0.5	5.63	0.54	2.75e-7	Atrial fibrillation;
SKCM	cis	rs9788333	0.707	rs12584557	chr13:21886171	C/A	cg25811766	chr13:21894605	NA	0.6	5.71	0.54	1.93e-7	Thiazide-induced adverse metabolic effects in hypertensive patients;
SKCM	trans	rs7618501	1.000	rs9859153	chr3:49807085	G/T	cg21659725	chr3:3221576	CRBN	0.96	9.61	0.74	7.08e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs9926296	0.568	rs7203907	chr16:89833774	C/G	cg26513180	chr16:89883248	FANCA	0.97	11.07	0.78	1.18e-17	Vitiligo;
SKCM	cis	rs2204008	0.522	rs12370263	chr12:38113311	A/G	cg26384229	chr12:38710491	ALG10B	0.8	6.32	0.58	1.5e-8	Bladder cancer;
SKCM	cis	rs2839186	0.709	rs2156117	chr21:47669300	C/A	cg13126279	chr21:47581558	C21orf56	-0.69	-5.9	-0.56	8.7e-8	Testicular germ cell tumor;
SKCM	cis	rs28595532	0.920	rs114966881	chr4:119761078	C/G	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs116095464	0.558	rs60251075	chr5:245292	T/C	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs7772486	0.754	rs9399561	chr6:145955687	C/G	cg05347473	chr6:146136440	FBXO30	0.63	5.91	0.56	8.35e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9420	0.961	rs2847308	chr11:57498232	C/T	cg19752551	chr11:57585705	CTNND1	0.69	6.85	0.61	1.52e-9	Schizophrenia;
SKCM	cis	rs9880211	1.000	rs13071220	chr3:136314119	T/C	cg21827317	chr3:136751795	NA	-0.65	-4.92	-0.49	4.73e-6	Body mass index;Height;
SKCM	cis	rs501916	0.833	rs11855134	chr15:48047676	A/G	cg16110827	chr15:48056943	SEMA6D	-0.61	-4.91	-0.49	4.89e-6	Inflammatory bowel disease;Ulcerative colitis;
SKCM	cis	rs854765	0.583	rs4413022	chr17:17858280	G/C	cg04398451	chr17:18023971	MYO15A	-0.86	-5.91	-0.56	8.41e-8	Total body bone mineral density;
SKCM	trans	rs1814175	0.817	rs1818890	chr11:49856882	T/C	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs11105298	0.891	rs11105319	chr12:89927177	G/A	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.83	-5.05	-0.5	2.82e-6	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs8017423	1.000	rs2183189	chr14:90670057	A/G	cg04374321	chr14:90722782	PSMC1	0.95	8.52	0.69	9.41e-13	Mortality in heart failure;
SKCM	cis	rs7635838	0.684	rs384989	chr3:11320120	C/T	cg00170343	chr3:11313890	ATG7	0.75	5.56	0.53	3.64e-7	HDL cholesterol;
SKCM	cis	rs56104184	0.723	rs116909499	chr19:49407733	C/T	cg19746536	chr19:49375674	PPP1R15A	1.16	5.93	0.56	7.67e-8	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs6570726	0.935	rs369214	chr6:145856709	G/A	cg23711669	chr6:146136114	FBXO30	0.71	6.8	0.61	1.93e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs10256972	0.591	rs6968988	chr7:1169619	A/G	cg09177884	chr7:1199841	ZFAND2A	-0.78	-5.9	-0.56	9.02e-8	Longevity;Endometriosis;
SKCM	cis	rs1799949	1.000	rs2298862	chr17:41176688	T/C	cg23758822	chr17:41437982	NA	0.92	7.49	0.65	9.02e-11	Menopause (age at onset);
SKCM	cis	rs2243480	1.000	rs313809	chr7:65499983	G/A	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs9910055	0.676	rs11079983	chr17:42198170	C/T	cg10896456	chr17:42255109	ASB16;C17orf65	0.66	6.3	0.58	1.62e-8	Total body bone mineral density;
SKCM	cis	rs1218582	0.710	rs4845685	chr1:154878300	C/A	cg24250549	chr1:154909240	PMVK	0.87	8.7	0.7	4.13e-13	Prostate cancer;
SKCM	cis	rs1949733	0.554	rs4259044	chr4:8536188	A/G	cg11789530	chr4:8429930	ACOX3	-0.76	-5.15	-0.5	1.94e-6	Response to antineoplastic agents;
SKCM	cis	rs9875589	0.509	rs1488375	chr3:14061563	G/A	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.5	5.15	0.5	1.9e-6	Ovarian reserve;
SKCM	cis	rs1577917	0.652	rs75593931	chr6:86719539	A/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.82	-8.08	-0.67	6.61e-12	Response to antipsychotic treatment;
SKCM	cis	rs11098499	0.909	rs10020034	chr4:120294331	A/G	cg09307838	chr4:120376055	NA	0.96	7.38	0.64	1.46e-10	Corneal astigmatism;
SKCM	cis	rs1552244	0.882	rs13099507	chr3:10031603	G/A	cg02579736	chr3:10068473	FANCD2;CIDECP	0.98	4.84	0.48	6.48e-6	Alzheimer's disease;
SKCM	cis	rs2836950	0.501	rs11702505	chr21:40700614	G/T	cg17971929	chr21:40555470	PSMG1	-0.65	-5.09	-0.5	2.4e-6	Menarche (age at onset);
SKCM	cis	rs2836974	0.568	rs429955	chr21:40539760	G/A	cg11890956	chr21:40555474	PSMG1	0.88	9.14	0.72	5.76e-14	Cognitive function;
SKCM	cis	rs3808502	0.605	rs11784572	chr8:11174484	C/G	cg21775007	chr8:11205619	TDH	-0.58	-4.95	-0.49	4.23e-6	Neuroticism;
SKCM	cis	rs7937682	0.889	rs1784787	chr11:111486125	T/A	cg09085632	chr11:111637200	PPP2R1B	-0.97	-10.08	-0.75	8.74e-16	Primary sclerosing cholangitis;
SKCM	cis	rs2721195	0.967	rs1985022	chr8:145684031	C/T	cg17328964	chr8:145687451	CYHR1	-0.73	-6.58	-0.6	4.87e-9	Age at first birth;
SKCM	cis	rs6570726	0.967	rs403584	chr6:145807010	G/A	cg23711669	chr6:146136114	FBXO30	0.73	6.96	0.62	9.48e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7809950	0.954	rs62482543	chr7:107080656	G/A	cg23024343	chr7:107201750	COG5	-0.76	-6.8	-0.61	1.89e-9	Coronary artery disease;
SKCM	cis	rs838147	0.844	rs8111288	chr19:49247900	G/A	cg13540341	chr19:49222985	MAMSTR	0.56	5.06	0.5	2.77e-6	Dietary macronutrient intake;
SKCM	cis	rs9911578	0.935	rs2567912	chr17:56731270	T/C	cg12560992	chr17:57184187	TRIM37	0.95	7.61	0.65	5.3e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs2806561	0.704	rs856510	chr1:23524407	A/C	cg12483005	chr1:23474871	LUZP1	0.68	5.24	0.51	1.34e-6	Height;
SKCM	cis	rs763014	0.966	rs4144003	chr16:645968	C/T	cg07343612	chr16:622815	PIGQ	-0.7	-6.0	-0.56	5.76e-8	Height;
SKCM	cis	rs12477438	0.501	rs11685756	chr2:99766215	T/C	cg26064155	chr2:99771622	LIPT1;TSGA10	1.02	9.73	0.74	4.23e-15	Chronic sinus infection;
SKCM	cis	rs72634258	0.554	rs12741937	chr1:7897622	A/T	cg26816564	chr1:7831052	VAMP3	0.75	5.36	0.52	8.06e-7	Inflammatory bowel disease;
SKCM	cis	rs9467773	1.000	rs2393670	chr6:26535541	A/G	cg09904177	chr6:26538194	HMGN4	0.54	4.98	0.49	3.78e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7523273	0.606	rs1474742	chr1:207976666	A/C	cg22525895	chr1:207977042	MIR29B2	0.79	6.54	0.59	5.93e-9	Schizophrenia;
SKCM	cis	rs3785574	0.745	rs2854162	chr17:61975610	T/C	cg11494091	chr17:61959527	GH2	-0.54	-5.22	-0.51	1.44e-6	Height;
SKCM	cis	rs9325144	0.560	rs6582561	chr12:38666821	G/A	cg26384229	chr12:38710491	ALG10B	-0.69	-5.66	-0.54	2.36e-7	Morning vs. evening chronotype;
SKCM	cis	rs950776	0.507	rs12912673	chr15:78810216	T/C	cg06917634	chr15:78832804	PSMA4	1.01	10.48	0.76	1.5e-16	Sudden cardiac arrest;
SKCM	cis	rs9910055	0.659	rs721769	chr17:42261588	T/G	cg10896456	chr17:42255109	ASB16;C17orf65	0.68	7.28	0.64	2.25e-10	Total body bone mineral density;
SKCM	cis	rs9913156	0.894	rs28365158	chr17:4620928	T/C	cg19197139	chr17:4613644	ARRB2	0.9	6.23	0.58	2.16e-8	Lymphocyte counts;
SKCM	cis	rs34172651	0.517	rs11642954	chr16:24824248	G/A	cg00339695	chr16:24857497	SLC5A11	0.78	6.22	0.58	2.3e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs4803468	1.000	rs2241710	chr19:41912092	G/C	cg14132834	chr19:41945861	ATP5SL	-0.77	-6.08	-0.57	4.18e-8	Height;
SKCM	cis	rs4132509	0.744	rs58594024	chr1:243862702	C/A	cg21452805	chr1:244014465	NA	0.93	5.18	0.51	1.68e-6	RR interval (heart rate);
SKCM	cis	rs9911578	0.933	rs2531726	chr17:56522533	C/T	cg12560992	chr17:57184187	TRIM37	-0.94	-7.32	-0.64	1.94e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs1152591	0.811	rs1255986	chr14:64655161	A/G	cg21174375	chr14:64681225	SYNE2	-0.51	-5.55	-0.53	3.74e-7	Atrial fibrillation;
SKCM	cis	rs40363	0.620	rs1137454	chr16:3533577	C/G	cg22508957	chr16:3507546	NAT15	-0.59	-5.07	-0.5	2.59e-6	Tuberculosis;
SKCM	cis	rs1707322	0.682	rs10890334	chr1:46100378	A/T	cg03146154	chr1:46216737	IPP	0.8	5.57	0.53	3.52e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs8180040	0.932	rs62248599	chr3:47516728	G/A	cg16586182	chr3:47516702	SCAP	0.76	5.32	0.52	9.63e-7	Colorectal cancer;
SKCM	cis	rs11585357	0.947	rs72646795	chr1:17612120	C/T	cg08277548	chr1:17600880	PADI3	-0.9	-6.35	-0.58	1.34e-8	Hair shape;
SKCM	cis	rs12142240	0.738	rs17361749	chr1:46806480	C/T	cg10495392	chr1:46806563	NSUN4	0.74	5.37	0.52	7.75e-7	Menopause (age at onset);
SKCM	cis	rs1153858	1.000	rs4775895	chr15:45617957	T/A	cg10760299	chr15:45669010	GATM	0.57	5.55	0.53	3.72e-7	Homoarginine levels;
SKCM	cis	rs9303401	0.659	rs16943326	chr17:57050365	C/T	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.16	0.57	2.91e-8	Cognitive test performance;
SKCM	cis	rs9902453	1.000	rs7223786	chr17:28332107	T/C	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.81	-5.78	-0.55	1.45e-7	Coffee consumption (cups per day);
SKCM	cis	rs17376456	0.877	rs17083460	chr5:93462354	A/G	cg21475434	chr5:93447410	FAM172A	0.97	5.42	0.52	6.39e-7	Diabetic retinopathy;
SKCM	cis	rs17376456	0.825	rs17314074	chr5:93161467	T/C	cg25358565	chr5:93447407	FAM172A	1.18	7.45	0.64	1.11e-10	Diabetic retinopathy;
SKCM	cis	rs12477438	0.520	rs13018891	chr2:99755099	C/G	cg14399236	chr2:99771627	LIPT1;TSGA10	0.97	8.9	0.71	1.72e-13	Chronic sinus infection;
SKCM	cis	rs1152591	0.729	rs1255988	chr14:64657684	C/A	cg21174375	chr14:64681225	SYNE2	0.47	5.08	0.5	2.56e-6	Atrial fibrillation;
SKCM	cis	rs2242194	0.816	rs11264296	chr1:154994750	T/C	cg12436631	chr1:155007014	DCST1;DCST2	0.47	5.62	0.54	2.87e-7	Schizophrenia;
SKCM	cis	rs362296	0.698	rs3095083	chr4:3263499	G/A	cg09735869	chr4:3319127	RGS12	-0.71	-6.3	-0.58	1.65e-8	Parental longevity (mother's age at death);
SKCM	cis	rs7208859	0.524	rs59923796	chr17:29064919	G/A	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs4319547	0.656	rs10773075	chr12:122814236	G/A	cg23029597	chr12:123009494	RSRC2	-0.73	-5.22	-0.51	1.41e-6	Body mass index;
SKCM	cis	rs801193	1.000	rs2707850	chr7:66203870	G/T	cg18876405	chr7:65276391	NA	0.8	7.11	0.63	4.88e-10	Aortic root size;
SKCM	trans	rs1814175	0.645	rs11040702	chr11:50024827	C/T	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs1799949	0.930	rs8176194	chr17:41231221	A/C	cg05368731	chr17:41323189	NBR1	0.9	7.89	0.67	1.52e-11	Menopause (age at onset);
SKCM	cis	rs1218582	0.803	rs7531728	chr1:154840516	C/A	cg09359103	chr1:154839909	KCNN3	-0.59	-5.93	-0.56	7.77e-8	Prostate cancer;
SKCM	cis	rs3087591	0.960	rs2066736	chr17:29559932	C/A	cg24425628	chr17:29625626	OMG;NF1	-0.64	-5.22	-0.51	1.43e-6	Hip circumference;
SKCM	cis	rs3820928	0.839	rs13404750	chr2:227876129	G/A	cg11843606	chr2:227700838	RHBDD1	-0.6	-4.84	-0.48	6.37e-6	Pulmonary function;
SKCM	cis	rs7208859	0.573	rs7222803	chr17:29119897	A/G	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs4780401	0.609	rs8047190	chr16:11807097	T/C	cg01061890	chr16:11836724	TXNDC11	-0.8	-6.08	-0.57	4.16e-8	Rheumatoid arthritis;
SKCM	cis	rs9611565	0.685	rs169363	chr22:41853117	G/T	cg03806693	chr22:41940476	POLR3H	1.13	7.36	0.64	1.63e-10	Vitiligo;
SKCM	cis	rs1475911	0.708	rs11701371	chr21:43523972	C/G	cg24372256	chr21:43528868	UMODL1;C21orf128	-0.74	-5.46	-0.53	5.43e-7	IgG glycosylation;
SKCM	cis	rs9435341	0.896	rs1623927	chr1:107596120	T/C	cg09367891	chr1:107599246	PRMT6	-0.84	-7.05	-0.62	6.33e-10	Facial morphology (factor 21, depth of nasal alae);
SKCM	cis	rs2013441	0.931	rs12937827	chr17:20033202	G/C	cg13482628	chr17:19912719	NA	0.67	5.25	0.51	1.28e-6	Obesity-related traits;
SKCM	cis	rs1912528	0.963	rs12645862	chr4:140936716	T/C	cg11128457	chr4:140864437	MAML3	0.58	4.82	0.48	6.87e-6	Educational attainment (years of education);
SKCM	cis	rs11209185	0.602	rs1926300	chr1:68439174	G/A	cg17031739	chr1:67600172	NA	-0.5	-4.85	-0.48	6.17e-6	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs11098499	0.954	rs6838814	chr4:120392443	G/A	cg24375607	chr4:120327624	NA	0.65	4.97	0.49	3.87e-6	Corneal astigmatism;
SKCM	cis	rs5417	0.775	rs222852	chr17:7140606	A/G	cg25256661	chr17:7137939	DVL2	0.94	7.15	0.63	4e-10	Diastolic blood pressure;
SKCM	cis	rs4423214	0.879	rs1790324	chr11:71150520	A/C	cg05163923	chr11:71159392	DHCR7	-0.68	-6.15	-0.57	3.07e-8	Vitamin D levels;
SKCM	cis	rs2839186	0.708	rs17183123	chr21:47671961	G/C	cg13126279	chr21:47581558	C21orf56	-0.69	-5.77	-0.55	1.52e-7	Testicular germ cell tumor;
SKCM	cis	rs10883723	0.810	rs3781289	chr10:104244991	G/T	cg11453585	chr10:104263688	ACTR1A;SUFU	0.73	5.41	0.52	6.74e-7	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs11252926	0.537	rs4881255	chr10:453638	T/C	cg18196295	chr10:418757	DIP2C	0.67	5.68	0.54	2.18e-7	Psychosis in Alzheimer's disease;
SKCM	cis	rs10752881	1.000	rs4233192	chr1:182970837	A/C	ch.1.3577855R	chr1:183094577	LAMC1	-0.73	-6.64	-0.6	3.82e-9	Colorectal cancer;
SKCM	cis	rs7666738	0.830	rs35951881	chr4:98999474	A/C	cg05340658	chr4:99064831	C4orf37	0.67	5.14	0.5	1.98e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1843834	0.611	rs1058360	chr2:225449242	A/T	cg22455342	chr2:225449267	CUL3	0.77	5.7	0.54	2.06e-7	IgE levels in asthmatics (D.p. specific);
SKCM	cis	rs2857078	0.772	rs4793086	chr17:42320751	C/T	cg10896456	chr17:42255109	ASB16;C17orf65	-0.65	-5.62	-0.54	2.84e-7	Red cell distribution width;Reticulocyte count;
SKCM	cis	rs2070488	0.804	rs13094715	chr3:38504430	G/A	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.73	5.92	0.56	8.21e-8	Electrocardiographic conduction measures;
SKCM	cis	rs7666738	0.830	rs13134819	chr4:98919885	G/C	cg17366294	chr4:99064904	C4orf37	0.56	4.89	0.48	5.26e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11148252	0.904	rs7321964	chr13:53040822	A/G	cg00495681	chr13:53174319	NA	0.61	5.19	0.51	1.63e-6	Lewy body disease;
SKCM	cis	rs1348850	0.567	rs880899	chr2:178532416	A/G	cg02961200	chr2:178257176	LOC100130691;AGPS	0.67	4.83	0.48	6.67e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs1801516	0.950	rs72992160	chr11:108308644	G/A	cg03165700	chr11:108093220	ATM;NPAT	-1.11	-5.06	-0.5	2.68e-6	Melanoma;
SKCM	cis	rs55794721	0.509	rs11249248	chr1:25753051	T/C	cg27572855	chr1:25598939	RHD	0.56	5.49	0.53	4.9e-7	Plateletcrit;Mean corpuscular volume;
SKCM	cis	rs6835098	0.692	rs28701033	chr4:174079376	T/A	cg08422745	chr4:174089978	GALNT7	-0.85	-6.97	-0.62	8.92e-10	Dementia and core Alzheimer's disease neuropathologic changes;
SKCM	cis	rs9902453	0.934	rs4427857	chr17:28457989	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.79	6.03	0.56	5.24e-8	Coffee consumption (cups per day);
SKCM	cis	rs10751667	0.643	rs7396046	chr11:937176	T/C	cg10932868	chr11:921992	NA	0.54	5.05	0.5	2.81e-6	Alzheimer's disease (late onset);
SKCM	cis	rs6500602	0.592	rs4785966	chr16:4518754	C/T	cg08645402	chr16:4508243	NA	-0.65	-5.03	-0.49	3.06e-6	Schizophrenia;
SKCM	cis	rs77216612	0.840	rs11055030	chr12:12878349	G/C	cg04607235	chr12:12878440	APOLD1	-0.99	-7.0	-0.62	7.77e-10	Lymphocyte counts;
SKCM	cis	rs7523050	0.643	rs36047249	chr1:109401499	T/C	cg08274380	chr1:109419600	GPSM2	1.13	5.57	0.53	3.54e-7	Fat distribution (HIV);
SKCM	cis	rs57221529	0.766	rs72703065	chr5:588123	C/A	cg10555297	chr5:473380	SLC9A3;LOC25845	1.01	5.03	0.49	3.1e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs4132509	0.793	rs9428579	chr1:243690034	C/T	cg21452805	chr1:244014465	NA	0.87	5.42	0.52	6.4e-7	RR interval (heart rate);
SKCM	cis	rs2991971	1.000	rs2993262	chr1:46013733	G/C	cg24296786	chr1:45957014	TESK2	0.65	5.25	0.51	1.28e-6	High light scatter reticulocyte count;
SKCM	cis	rs7945705	0.520	rs1984791	chr11:9035027	C/T	cg13070366	chr11:9386451	NA	-0.55	-4.86	-0.48	5.91e-6	Hemoglobin concentration;
SKCM	cis	rs2841277	0.712	rs2841280	chr14:105393556	G/C	cg15352829	chr14:105391018	PLD4	0.6	5.01	0.49	3.34e-6	Rheumatoid arthritis;
SKCM	trans	rs1814175	0.645	rs11040671	chr11:49958776	G/A	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs11098499	0.863	rs7664986	chr4:120429952	A/C	cg24375607	chr4:120327624	NA	0.7	5.38	0.52	7.69e-7	Corneal astigmatism;
SKCM	cis	rs801193	0.904	rs4718405	chr7:66254646	A/G	cg11987759	chr7:65425863	GUSB	-0.67	-5.8	-0.55	1.36e-7	Aortic root size;
SKCM	cis	rs17376456	0.825	rs10054790	chr5:93272520	A/G	cg25358565	chr5:93447407	FAM172A	1.3	7.53	0.65	7.57e-11	Diabetic retinopathy;
SKCM	cis	rs1153858	1.000	rs3759899	chr15:45655903	T/C	cg21132104	chr15:45694354	SPATA5L1	0.93	7.94	0.67	1.22e-11	Homoarginine levels;
SKCM	cis	rs28595532	0.920	rs114051506	chr4:119772893	A/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs7959452	0.590	rs11177644	chr12:69785748	A/G	cg20891283	chr12:69753455	YEATS4	0.87	8.92	0.71	1.52e-13	Blood protein levels;
SKCM	cis	rs854765	0.575	rs7207821	chr17:17891781	A/G	cg04398451	chr17:18023971	MYO15A	-0.95	-7.33	-0.64	1.87e-10	Total body bone mineral density;
SKCM	cis	rs6545883	0.894	rs778148	chr2:61606866	G/A	cg15711740	chr2:61764176	XPO1	0.7	5.02	0.49	3.19e-6	Tuberculosis;
SKCM	cis	rs11098499	0.863	rs28718422	chr4:120466304	C/A	cg24375607	chr4:120327624	NA	0.69	5.47	0.53	5.35e-7	Corneal astigmatism;
SKCM	cis	rs28595532	0.920	rs55806110	chr4:119742583	A/G	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs1799949	0.965	rs33925201	chr17:41280682	A/G	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.11	-0.57	3.67e-8	Menopause (age at onset);
SKCM	cis	rs3820068	0.603	rs7537618	chr1:15977682	G/A	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs867186	1.000	rs11906148	chr20:33784021	C/A	cg04194272	chr20:33683537	NA	-1.02	-5.4	-0.52	7.03e-7	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs507080	0.922	rs642662	chr11:118567020	A/G	cg18045108	chr11:118530628	TREH	-0.48	-5.15	-0.5	1.88e-6	Serum metabolite levels;
SKCM	cis	rs875971	0.964	rs778721	chr7:65845397	C/G	cg11764359	chr7:65958608	NA	0.87	8.35	0.69	2.01e-12	Aortic root size;
SKCM	cis	rs763014	0.898	rs8060921	chr16:635988	C/A	cg07343612	chr16:622815	PIGQ	-0.7	-6.0	-0.56	5.84e-8	Height;
SKCM	cis	rs1691799	0.863	rs1168291	chr12:66732488	T/C	cg16791601	chr12:66731901	HELB	-0.66	-5.81	-0.55	1.31e-7	White blood cell count (basophil);
SKCM	cis	rs400736	1.000	rs400736	chr1:8078309	T/C	cg25007680	chr1:8021821	PARK7	0.74	5.21	0.51	1.53e-6	Response to antidepressants and depression;
SKCM	cis	rs7613875	0.578	rs2624822	chr3:50107219	T/C	cg24110177	chr3:50126178	RBM5	0.74	5.95	0.56	7.25e-8	Body mass index;
SKCM	cis	rs2153535	0.541	rs7774752	chr6:8468978	C/T	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs7772486	0.790	rs2265474	chr6:146182092	G/A	cg23711669	chr6:146136114	FBXO30	0.84	9.28	0.72	3.05e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs11249608	0.750	rs6891216	chr5:178447026	G/C	cg21905437	chr5:178450457	ZNF879	0.72	5.64	0.54	2.64e-7	Pubertal anthropometrics;
SKCM	cis	rs2153535	0.580	rs6905242	chr6:8471799	A/C	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs66573146	0.831	rs1048009	chr4:6988677	G/A	cg00086871	chr4:6988644	TBC1D14	1.32	5.23	0.51	1.38e-6	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs7772486	0.875	rs2814871	chr6:146312274	G/T	cg23711669	chr6:146136114	FBXO30	0.77	7.11	0.63	4.95e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs709400	0.663	rs7158822	chr14:103887868	C/T	cg26031613	chr14:104095156	KLC1	0.69	5.03	0.49	3.05e-6	Body mass index;
SKCM	trans	rs1814175	0.645	rs866427	chr11:49923853	G/A	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs2836974	0.965	rs2836967	chr21:40639102	T/G	cg11644478	chr21:40555479	PSMG1	0.99	10.48	0.76	1.51e-16	Cognitive function;
SKCM	cis	rs933688	1.000	rs7715402	chr5:90679504	T/A	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.95	6.61	0.6	4.39e-9	Smoking behavior;
SKCM	cis	rs10193935	0.901	rs7601905	chr2:42494144	A/G	cg27598129	chr2:42591480	NA	-0.95	-6.84	-0.61	1.6e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2243480	1.000	rs36033484	chr7:65390558	T/G	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs9322193	0.923	rs55993747	chr6:149943152	A/G	cg07701084	chr6:150067640	NUP43	0.61	4.84	0.48	6.48e-6	Lung cancer;
SKCM	cis	rs1577917	0.917	rs4098044	chr6:86462066	T/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.78	-7.41	-0.64	1.3100000000000001e-10	Response to antipsychotic treatment;
SKCM	cis	rs2658782	1.000	rs2658779	chr11:93163137	G/T	cg15737290	chr11:93063684	CCDC67	-0.76	-5.32	-0.52	9.69e-7	Pulmonary function decline;
SKCM	cis	rs73201462	1.000	rs7373998	chr3:128008223	A/G	cg09089421	chr3:127803668	RUVBL1	-1.0	-5.11	-0.5	2.22e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs10883723	0.810	rs12265877	chr10:104247247	C/G	cg11453585	chr10:104263688	ACTR1A;SUFU	0.73	5.41	0.52	6.74e-7	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs473651	0.935	rs541128	chr2:239336449	A/G	cg18131467	chr2:239335373	ASB1	1.08	13.29	0.83	9.89e-22	Multiple system atrophy;
SKCM	cis	rs2439831	0.681	rs498837	chr15:43608024	G/A	cg02155558	chr15:43621948	ADAL;LCMT2	1.2	8.73	0.7	3.66e-13	Lung cancer in ever smokers;
SKCM	cis	rs5769765	0.865	rs10854860	chr22:50320029	G/T	cg22709217	chr22:50311962	ALG12;CRELD2	-0.99	-6.09	-0.57	4.04e-8	Schizophrenia;
SKCM	cis	rs7208859	0.524	rs73988172	chr17:29086332	A/C	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs11098499	0.618	rs35265692	chr4:120325135	T/C	cg24375607	chr4:120327624	NA	0.67	5.25	0.51	1.28e-6	Corneal astigmatism;
SKCM	cis	rs116095464	0.558	rs7731089	chr5:290422	A/C	cg22857025	chr5:266934	NA	-1.47	-8.33	-0.69	2.16e-12	Breast cancer;
SKCM	cis	rs9916302	0.904	rs2168785	chr17:37407135	C/T	cg07936489	chr17:37558343	FBXL20	-0.84	-6.96	-0.62	9.48e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs35146811	1.000	rs35146811	chr7:99720994	A/C	cg22906224	chr7:99728672	NA	0.78	6.08	0.57	4.22e-8	Coronary artery disease;
SKCM	cis	rs2832191	0.765	rs2832162	chr21:30461808	G/A	cg08807101	chr21:30365312	RNF160	0.77	6.01	0.56	5.51e-8	Dental caries;
SKCM	cis	rs6120849	0.707	rs6088690	chr20:33633326	A/G	cg24642439	chr20:33292090	TP53INP2	0.94	4.86	0.48	5.91e-6	Protein C levels;
SKCM	cis	rs17685	0.712	rs60232511	chr7:75800082	A/G	cg16489192	chr7:75678113	MDH2;STYXL1	-0.57	-5.49	-0.53	4.89e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7666738	0.830	rs13133355	chr4:98919415	A/G	cg05340658	chr4:99064831	C4orf37	0.61	4.86	0.48	5.87e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7772486	0.720	rs4896844	chr6:146075224	T/C	cg05347473	chr6:146136440	FBXO30	-0.6	-5.68	-0.54	2.21e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7552404	0.883	rs7513363	chr1:76143443	A/G	cg03433033	chr1:76189801	ACADM	0.79	5.76	0.55	1.62e-7	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs6500602	1.000	rs11647946	chr16:4462836	G/A	cg09069446	chr16:4462122	CORO7	-0.46	-4.8	-0.48	7.56e-6	Schizophrenia;
SKCM	cis	rs6582630	0.502	rs1915395	chr12:38420726	A/G	cg26384229	chr12:38710491	ALG10B	0.88	6.86	0.61	1.46e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs7666738	0.830	rs1426670	chr4:98923572	A/G	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs28386778	0.897	rs2584635	chr17:61865934	A/G	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs910316	1.000	rs11845639	chr14:75570293	C/T	cg08847533	chr14:75593920	NEK9	0.93	8.93	0.71	1.49e-13	Height;
SKCM	cis	rs2070488	0.775	rs2268762	chr3:38516075	A/G	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.75	6.15	0.57	3.04e-8	Electrocardiographic conduction measures;
SKCM	cis	rs17685	0.753	rs6464999	chr7:75787315	T/C	cg01364799	chr7:75623366	TMEM120A	-0.69	-5.59	-0.53	3.22e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs58688157	0.660	rs12797496	chr11:583767	C/T	cg17114584	chr11:613792	IRF7	0.86	5.74	0.54	1.74e-7	Systemic lupus erythematosus;
SKCM	cis	rs798766	0.779	rs3134866	chr4:1723265	A/G	cg24239225	chr4:1659016	FAM53A	-0.69	-4.87	-0.48	5.8e-6	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs2153535	0.580	rs1119690	chr6:8460660	G/A	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs4237845	0.537	rs12312955	chr12:58265223	A/G	cg00677455	chr12:58241039	CTDSP2	0.9	8.16	0.68	4.55e-12	Intelligence (multi-trait analysis);
SKCM	cis	rs763014	0.932	rs2384975	chr16:651115	G/T	cg00908189	chr16:619842	PIGQ	0.79	7.44	0.64	1.12e-10	Height;
SKCM	cis	rs9611565	0.512	rs5758464	chr22:42171300	A/G	cg03806693	chr22:41940476	POLR3H	1.08	6.08	0.57	4.1e-8	Vitiligo;
SKCM	cis	rs7811142	1.000	rs60257855	chr7:100026780	G/C	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.17	7.71	0.66	3.44e-11	Platelet count;
SKCM	cis	rs763014	0.898	rs4984896	chr16:625493	C/T	cg09263875	chr16:632152	PIGQ	0.68	5.71	0.54	1.98e-7	Height;
SKCM	cis	rs12142240	0.698	rs1135459	chr1:46815930	C/T	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs7027203	0.828	rs7037960	chr9:96584028	G/A	cg14396892	chr9:96623032	NA	-0.45	-4.86	-0.48	5.99e-6	DNA methylation (variation);
SKCM	cis	rs67460515	0.563	rs11713441	chr3:160906855	T/C	cg03342759	chr3:160939853	NMD3	-0.73	-6.17	-0.57	2.79e-8	Parkinson's disease;
SKCM	cis	rs9910055	0.529	rs183462	chr17:42183376	G/C	cg09913183	chr17:42254507	C17orf65;ASB16	-0.59	-4.82	-0.48	6.82e-6	Total body bone mineral density;
SKCM	cis	rs8180040	0.726	rs9843075	chr3:47195630	A/G	cg27129171	chr3:47204927	SETD2	0.74	5.18	0.51	1.66e-6	Colorectal cancer;
SKCM	cis	rs9815354	0.812	rs4434125	chr3:42004681	A/G	cg03022575	chr3:42003672	ULK4	1.0	5.0	0.49	3.43e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs1018836	0.923	rs7007102	chr8:91629730	T/A	cg16814680	chr8:91681699	NA	-0.64	-4.85	-0.48	6.29e-6	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs2303759	0.709	rs8102658	chr19:49828855	C/T	cg05022225	chr19:49866942	DKKL1;TEAD2	0.7	5.05	0.5	2.78e-6	Multiple sclerosis;
SKCM	cis	rs7829975	0.501	rs2980769	chr8:8320291	G/A	cg06636001	chr8:8085503	FLJ10661	0.8	7.0	0.62	7.84e-10	Mood instability;
SKCM	cis	rs654950	0.934	rs653369	chr1:42002376	A/T	cg06885757	chr1:42089581	HIVEP3	-0.63	-6.38	-0.59	1.15e-8	Airway imaging phenotypes;
SKCM	cis	rs1801251	0.778	rs812383	chr2:233737132	C/A	cg25237894	chr2:233734115	C2orf82	-0.6	-6.46	-0.59	8.3e-9	Coronary artery disease;
SKCM	cis	rs854765	0.856	rs2955382	chr17:17947710	C/T	cg04398451	chr17:18023971	MYO15A	0.74	5.3	0.51	1.05e-6	Total body bone mineral density;
SKCM	cis	rs11148252	0.595	rs4885117	chr13:53153027	T/C	cg00495681	chr13:53174319	NA	0.6	4.92	0.49	4.62e-6	Lewy body disease;
SKCM	cis	rs10781543	0.839	rs1127152	chr9:139335599	A/G	cg14169450	chr9:139327907	INPP5E	0.49	4.99	0.49	3.63e-6	Monocyte percentage of white cells;
SKCM	cis	rs362296	0.661	rs3095077	chr4:3265710	A/G	cg21096898	chr4:3318625	RGS12	0.7	6.22	0.58	2.28e-8	Parental longevity (mother's age at death);
SKCM	cis	rs3091242	0.933	rs35148262	chr1:25766623	A/G	cg02931644	chr1:25747376	RHCE	0.5	4.9	0.48	5.17e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs798554	0.757	rs2533879	chr7:2859847	G/A	cg19346786	chr7:2764209	NA	-0.64	-6.82	-0.61	1.7e-9	Height;
SKCM	cis	rs2952156	0.883	rs1495100	chr17:37832279	C/T	cg00129232	chr17:37814104	STARD3	-0.65	-5.29	-0.51	1.09e-6	Asthma;
SKCM	cis	rs870825	0.616	rs28579226	chr4:185650458	A/C	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs2070488	1.000	rs762317	chr3:38497659	A/G	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.97	8.85	0.71	2.08e-13	Electrocardiographic conduction measures;
SKCM	cis	rs17685	0.753	rs1637037	chr7:75692927	C/T	cg01364799	chr7:75623366	TMEM120A	-0.75	-6.05	-0.56	4.78e-8	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs3791406	0.500	rs3791414	chr2:240032214	T/C	cg14550559	chr2:240039617	HDAC4	-1.11	-5.5	-0.53	4.71e-7	Skin aging (microtopography measurement);
SKCM	cis	rs208520	0.690	rs207740	chr6:66764132	T/G	cg07460842	chr6:66804631	NA	0.92	6.93	0.62	1.09e-9	Exhaled nitric oxide output;
SKCM	cis	rs951366	0.789	rs823121	chr1:205724302	A/G	cg07157834	chr1:205819609	PM20D1	-0.81	-7.14	-0.63	4.2e-10	Menarche (age at onset);
SKCM	cis	rs4808199	0.895	rs6511036	chr19:19582651	A/G	cg03709012	chr19:19516395	GATAD2A	1.13	8.66	0.7	4.94e-13	Nonalcoholic fatty liver disease;
SKCM	cis	rs1799949	1.000	rs2271573	chr17:41327621	A/G	cg05368731	chr17:41323189	NBR1	0.89	7.81	0.66	2.22e-11	Menopause (age at onset);
SKCM	cis	rs769267	0.965	rs4808938	chr19:19401218	G/A	cg03709012	chr19:19516395	GATAD2A	0.82	6.73	0.61	2.6e-9	Tonsillectomy;
SKCM	cis	rs748404	0.660	rs2467738	chr15:43739936	T/A	cg02155558	chr15:43621948	ADAL;LCMT2	0.79	6.28	0.58	1.76e-8	Lung cancer;
SKCM	cis	rs1577917	1.000	rs4706254	chr6:86602813	G/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.77	-0.66	2.59e-11	Response to antipsychotic treatment;
SKCM	cis	rs7666738	0.830	rs9998582	chr4:98938949	T/C	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2282032	0.550	rs4904653	chr14:90716810	A/C	cg04374321	chr14:90722782	PSMC1	0.69	5.08	0.5	2.53e-6	Longevity;
SKCM	cis	rs644799	0.672	rs61902245	chr11:95517737	C/T	cg03916912	chr11:95522834	CEP57;FAM76B	0.82	6.99	0.62	8.33e-10	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs2070488	0.930	rs928813	chr3:38528537	G/T	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.98	9.25	0.72	3.55e-14	Electrocardiographic conduction measures;
SKCM	cis	rs3820068	0.532	rs72645862	chr1:15920366	A/G	cg24675056	chr1:15929824	NA	0.77	5.54	0.53	4.01e-7	Systolic blood pressure;
SKCM	cis	rs116095464	0.558	rs9312977	chr5:221916	G/C	cg22496380	chr5:211416	CCDC127	-0.96	-5.27	-0.51	1.18e-6	Breast cancer;
SKCM	cis	rs35146811	0.807	rs6953441	chr7:99617067	G/A	cg22906224	chr7:99728672	NA	0.79	5.8	0.55	1.36e-7	Coronary artery disease;
SKCM	cis	rs60871478	0.947	rs4074610	chr7:791755	G/A	cg05535760	chr7:792225	HEATR2	1.01	8.42	0.69	1.45e-12	Cerebrospinal P-tau181p levels;
SKCM	cis	rs7143963	0.945	rs56101042	chr14:103256961	A/G	cg23020514	chr14:103360112	TRAF3	0.76	7.07	0.63	5.71e-10	Body mass index;
SKCM	cis	rs2204008	0.837	rs7301679	chr12:37989629	T/C	cg26384229	chr12:38710491	ALG10B	-0.75	-6.26	-0.58	1.95e-8	Bladder cancer;
SKCM	cis	rs72634258	0.945	rs12730860	chr1:8132462	T/C	cg00042356	chr1:8021962	PARK7	1.09	7.54	0.65	7.42e-11	Inflammatory bowel disease;
SKCM	cis	rs9420	1.000	rs543725	chr11:57483039	A/T	cg19752551	chr11:57585705	CTNND1	-0.69	-6.85	-0.61	1.52e-9	Schizophrenia;
SKCM	cis	rs7618501	0.602	rs2526754	chr3:50125996	G/A	cg24110177	chr3:50126178	RBM5	0.61	5.18	0.51	1.71e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs4481887	0.927	rs4586010	chr1:248437568	G/A	cg00666640	chr1:248458726	OR2T12	0.66	5.61	0.54	2.95e-7	Common traits (Other);
SKCM	cis	rs2836974	0.931	rs2836972	chr21:40652142	G/A	cg17971929	chr21:40555470	PSMG1	0.9	8.81	0.71	2.52e-13	Cognitive function;
SKCM	cis	rs13256369	1.000	rs12550458	chr8:8567832	G/A	cg06636001	chr8:8085503	FLJ10661	0.77	5.93	0.56	7.8e-8	Obesity-related traits;
SKCM	cis	rs13118159	0.509	rs9683830	chr4:1377873	A/G	cg19318889	chr4:1322082	MAEA	0.78	5.67	0.54	2.29e-7	Longevity;
SKCM	cis	rs644799	1.000	rs543530	chr11:95545170	A/G	cg03916912	chr11:95522834	CEP57;FAM76B	0.92	8.04	0.67	8e-12	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs7811142	0.830	rs1063945	chr7:99930447	C/T	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.06	6.05	0.56	4.82e-8	Platelet count;
SKCM	cis	rs4132509	1.000	rs4553169	chr1:243900640	G/A	cg21452805	chr1:244014465	NA	0.84	5.21	0.51	1.47e-6	RR interval (heart rate);
SKCM	cis	rs1005277	0.540	rs4934907	chr10:38015230	A/C	cg25427524	chr10:38739819	LOC399744	-0.64	-6.06	-0.57	4.44e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs8064299	0.967	rs878906	chr17:72769334	T/C	cg25054828	chr17:72772726	NAT9;TMEM104	0.76	6.58	0.6	4.84e-9	Monocyte count;
SKCM	cis	rs12042938	0.507	rs1765778	chr1:231732356	G/A	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	-0.55	-4.88	-0.48	5.61e-6	Neuranatomic and neurocognitive phenotypes;
SKCM	cis	rs4891159	0.548	rs12454625	chr18:74128751	A/G	cg24786174	chr18:74118243	ZNF516	0.79	8.44	0.69	1.31e-12	Longevity;
SKCM	cis	rs4687718	0.929	rs62255992	chr3:53277790	A/C	cg07507251	chr3:52567010	NT5DC2	0.8	5.35	0.52	8.53e-7	QRS duration;
SKCM	cis	rs1577917	1.000	rs10455449	chr6:86592226	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.67	-5.85	-0.55	1.09e-7	Response to antipsychotic treatment;
SKCM	cis	rs17685	0.753	rs10085567	chr7:75734206	A/C	cg16684958	chr7:75615977	POR	0.56	5.13	0.5	2.03e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs995000	0.965	rs11208004	chr1:63145439	G/A	cg06896770	chr1:63153194	DOCK7	0.92	8.63	0.7	5.68e-13	Triglyceride levels;
SKCM	trans	rs66573146	1.000	rs59683609	chr4:6964910	C/G	cg07817883	chr1:32538562	TMEM39B	2.0	8.02	0.67	8.59e-12	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs28595532	0.920	rs115046587	chr4:119779604	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs1153858	1.000	rs2056493	chr15:45648272	A/G	cg10760299	chr15:45669010	GATM	0.61	6.39	0.59	1.13e-8	Homoarginine levels;
SKCM	cis	rs13256369	0.865	rs13282523	chr8:8577293	C/G	cg06636001	chr8:8085503	FLJ10661	0.69	5.17	0.5	1.79e-6	Obesity-related traits;
SKCM	cis	rs17376456	0.504	rs7702649	chr5:93065149	C/A	cg25358565	chr5:93447407	FAM172A	0.91	6.1	0.57	3.85e-8	Diabetic retinopathy;
SKCM	cis	rs9828933	0.577	rs832193	chr3:63854445	C/T	cg16258503	chr3:63850278	ATXN7;THOC7	0.86	5.18	0.51	1.69e-6	Type 2 diabetes;
SKCM	cis	rs12682352	0.579	rs7006589	chr8:8668486	A/G	cg06636001	chr8:8085503	FLJ10661	0.7	5.86	0.55	1.03e-7	Neuroticism;
SKCM	cis	rs7584330	0.910	rs12465081	chr2:238401784	A/G	cg14458575	chr2:238380390	NA	0.93	6.55	0.6	5.61e-9	Prostate cancer;
SKCM	cis	rs9467773	1.000	rs9393731	chr6:26529374	C/T	cg15659132	chr6:26577336	NA	0.6	5.71	0.54	1.99e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs1153858	1.000	rs67744121	chr15:45677237	C/G	cg10760299	chr15:45669010	GATM	0.62	6.35	0.58	1.3e-8	Homoarginine levels;
SKCM	cis	rs9308433	0.553	rs11120299	chr1:214509407	C/A	cg06198575	chr1:214491504	SMYD2	0.81	5.01	0.49	3.34e-6	IgG glycosylation;
SKCM	cis	rs55962025	0.711	rs2071662	chr4:3223891	T/C	cg09735869	chr4:3319127	RGS12	-0.65	-5.33	-0.52	9.21e-7	Parental longevity (mother's age at death);
SKCM	cis	rs12142240	0.660	rs72885163	chr1:46807117	C/A	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs4481887	0.927	rs10749651	chr1:248472930	T/C	cg00666640	chr1:248458726	OR2T12	0.63	5.91	0.56	8.65e-8	Common traits (Other);
SKCM	cis	rs9303401	0.659	rs714959	chr17:56628601	A/G	cg02118635	chr17:56770003	RAD51C;TEX14	0.78	5.33	0.52	9.13e-7	Cognitive test performance;
SKCM	cis	rs7666738	0.830	rs10856936	chr4:99011319	T/C	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs67311347	0.544	rs9877105	chr3:40333366	T/C	cg13409248	chr3:40428643	ENTPD3	0.57	5.58	0.53	3.37e-7	Renal cell carcinoma;
SKCM	cis	rs561341	1.000	rs72821971	chr17:30269343	T/G	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs7666738	0.791	rs2865953	chr4:99040319	C/T	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9921222	0.502	rs28461430	chr16:369562	G/A	cg00101154	chr16:420108	MRPL28	-0.63	-4.92	-0.49	4.77e-6	Bone mineral density (spine);Bone mineral density;
SKCM	cis	rs909674	0.818	rs5757678	chr22:39843409	A/G	cg24399712	chr22:39784796	NA	0.57	4.83	0.48	6.78e-6	IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis);IgG glycosylation;IgG digalactosylation phenotypes (multivariate analysis);IgG sialylation phenotypes (multivariate analysis);IgG monogalactosylation phenotypes (multivariate analysis);IgG fucosylation phenotypes (multivariate analysis);IgG N-glycosylation phenotypes (multivariate analysis);IgG disialylation phenotypes (multivariate analysis);IgG galactosylation phenotypes (multivariate analysis);Post bronchodilator FEV1;
SKCM	cis	rs9902453	0.900	rs56195309	chr17:28453753	G/A	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.5	0.53	4.74e-7	Coffee consumption (cups per day);
SKCM	cis	rs780096	0.527	rs12471703	chr2:27738854	C/T	cg05696406	chr2:27599888	SNX17	0.51	5.09	0.5	2.45e-6	Total body bone mineral density;
SKCM	cis	rs738322	0.553	rs28718653	chr22:38570698	C/A	cg25457927	chr22:38595422	NA	-0.6	-7.08	-0.63	5.46e-10	Cutaneous nevi;
SKCM	cis	rs72781680	0.898	rs72782106	chr2:24022009	A/G	cg08917208	chr2:24149416	ATAD2B	0.97	5.17	0.5	1.79e-6	Lymphocyte counts;
SKCM	cis	rs4888262	0.545	rs7184754	chr16:74667864	C/T	cg01733217	chr16:74700730	RFWD3	0.88	7.49	0.65	9.15e-11	Testicular germ cell tumor;
SKCM	cis	rs2180341	1.000	rs6937287	chr6:127645719	T/A	cg27446573	chr6:127587934	RNF146	0.94	8.08	0.68	6.49e-12	Breast cancer;
SKCM	cis	rs6951245	1.000	rs77346188	chr7:1114023	C/A	cg03188948	chr7:1209495	NA	1.13	6.27	0.58	1.89e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	trans	rs8073060	0.586	rs225300	chr17:33922428	C/T	cg19694781	chr19:47549865	TMEM160	-1.08	-8.69	-0.7	4.26e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs4141404	0.706	rs5753698	chr22:31970054	A/C	cg02404636	chr22:31891804	SFI1	0.63	5.49	0.53	4.79e-7	Paclitaxel-induced neuropathy;
SKCM	cis	rs2839186	0.708	rs6518285	chr21:47644667	T/C	cg13126279	chr21:47581558	C21orf56	-0.67	-5.87	-0.55	9.92e-8	Testicular germ cell tumor;
SKCM	cis	rs1801251	0.893	rs6733151	chr2:233592341	A/C	cg25237894	chr2:233734115	C2orf82	0.58	5.31	0.52	1.02e-6	Coronary artery disease;
SKCM	cis	rs11249608	0.548	rs35568336	chr5:178451854	A/G	cg21905437	chr5:178450457	ZNF879	0.76	6.46	0.59	8.29e-9	Pubertal anthropometrics;
SKCM	cis	rs11098499	0.754	rs10213267	chr4:120239074	A/G	cg09307838	chr4:120376055	NA	0.93	7.56	0.65	6.5500000000000006e-11	Corneal astigmatism;
SKCM	cis	rs9430161	0.611	rs34032547	chr1:11034374	C/G	cg27631724	chr1:11040367	C1orf127	0.5	4.88	0.48	5.45e-6	Ewing sarcoma;
SKCM	cis	rs6866344	0.697	rs11739893	chr5:178127837	G/A	cg03877680	chr5:178157825	ZNF354A	0.82	5.7	0.54	2.03e-7	Neutrophil percentage of white cells;
SKCM	cis	rs8103278	1.000	rs9676288	chr19:46292060	G/T	cg11657440	chr19:46296263	DMWD	-0.96	-6.91	-0.62	1.16e-9	Coronary artery disease;
SKCM	cis	rs1153858	1.000	rs72623915	chr15:45647433	C/T	cg10760299	chr15:45669010	GATM	0.62	6.33	0.58	1.42e-8	Homoarginine levels;
SKCM	cis	rs7403037	0.583	rs60600106	chr15:24651180	T/A	cg24138476	chr15:25312939	SNORD116-5;SNORD116-7	0.56	4.82	0.48	6.89e-6	Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid);
SKCM	cis	rs60871478	0.947	rs62432239	chr7:794576	C/T	cg05535760	chr7:792225	HEATR2	1.02	8.66	0.7	4.97e-13	Cerebrospinal P-tau181p levels;
SKCM	cis	rs4862750	0.914	rs6553028	chr4:187876046	T/C	cg10295955	chr4:187884368	NA	-1.04	-13.62	-0.84	2.59e-22	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9394841	0.692	rs9369312	chr6:41841535	A/T	cg08135965	chr6:41755394	TOMM6	0.77	5.05	0.5	2.85e-6	Mean corpuscular hemoglobin;Red cell distribution width;
SKCM	cis	rs1153858	1.000	rs7163720	chr15:45639374	G/A	cg10760299	chr15:45669010	GATM	0.57	5.67	0.54	2.31e-7	Homoarginine levels;
SKCM	cis	rs7247513	0.856	rs6511828	chr19:12745799	G/A	cg01871581	chr19:12707946	ZNF490	-0.7	-5.04	-0.5	2.95e-6	Bipolar disorder;
SKCM	cis	rs1878931	0.531	rs9635548	chr16:3417156	G/A	cg26668626	chr16:3451006	ZNF174;ZNF434	0.88	7.37	0.64	1.52e-10	Body mass index (adult);
SKCM	cis	rs6570726	0.526	rs9376934	chr6:145738702	A/G	cg23711669	chr6:146136114	FBXO30	0.71	6.8	0.61	1.87e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4888262	0.545	rs58136167	chr16:74700628	G/A	cg01733217	chr16:74700730	RFWD3	0.91	7.37	0.64	1.57e-10	Testicular germ cell tumor;
SKCM	cis	rs2033711	0.870	rs6510152	chr19:58953319	C/T	cg03735888	chr19:58951602	ZNF132	0.72	6.51	0.59	6.66e-9	Uric acid clearance;
SKCM	cis	rs1034435	0.755	rs6007869	chr22:48894213	A/G	cg05992904	chr22:48892994	FAM19A5	-0.58	-4.77	-0.48	8.45e-6	Late-onset Alzheimer's disease;
SKCM	cis	rs2204008	0.774	rs7304438	chr12:38361146	T/G	cg26384229	chr12:38710491	ALG10B	0.81	6.56	0.6	5.29e-9	Bladder cancer;
SKCM	cis	rs1160297	0.585	rs12713230	chr2:53090138	A/G	cg07782112	chr2:53107842	NA	0.59	6.26	0.58	1.91e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs912057	0.671	rs1024246	chr6:6743505	A/T	cg06612196	chr6:6737390	NA	0.66	5.47	0.53	5.25e-7	Waist-to-hip ratio adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);
SKCM	cis	rs57221529	0.766	rs72703070	chr5:590458	T/C	cg10555297	chr5:473380	SLC9A3;LOC25845	1.01	5.03	0.49	3.1e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs6570726	1.000	rs6570699	chr6:145920732	G/A	cg23711669	chr6:146136114	FBXO30	0.67	5.87	0.55	9.97e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6951245	0.832	rs10266519	chr7:1142977	C/T	cg23708337	chr7:1209742	NA	0.85	5.08	0.5	2.51e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	trans	rs1814175	0.817	rs4881645	chr11:49791168	G/A	cg03929089	chr4:120376271	NA	-0.9	-8.5	-0.69	9.91e-13	Height;
SKCM	cis	rs2120019	1.000	rs12901243	chr15:75374233	C/T	cg17294928	chr15:75287854	SCAMP5	-0.82	-6.77	-0.61	2.13e-9	Blood trace element (Zn levels);
SKCM	cis	rs1552244	1.000	rs112509186	chr3:10156533	A/G	cg02579736	chr3:10068473	FANCD2;CIDECP	1.23	6.8	0.61	1.9e-9	Alzheimer's disease;
SKCM	cis	rs6879260	1.000	rs10903252	chr5:179733934	T/C	cg13944838	chr5:179740914	GFPT2	-0.7	-5.33	-0.52	9.41e-7	Height;
SKCM	cis	rs9633740	1.000	rs1870137	chr10:82269848	C/G	cg01528321	chr10:82214614	TSPAN14	0.85	6.76	0.61	2.22e-9	Post bronchodilator FEV1;
SKCM	cis	rs1912528	0.963	rs13151315	chr4:140933304	C/G	cg11128457	chr4:140864437	MAML3	0.58	4.82	0.48	6.87e-6	Educational attainment (years of education);
SKCM	cis	rs2153535	0.580	rs965706	chr6:8464708	G/A	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs9303401	0.614	rs3887355	chr17:56538639	T/C	cg02118635	chr17:56770003	RAD51C;TEX14	0.8	5.33	0.52	9.25e-7	Cognitive test performance;
SKCM	cis	rs9467773	0.595	rs2172007	chr6:26639777	A/C	cg09904177	chr6:26538194	HMGN4	0.57	4.8	0.48	7.58e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1577917	0.771	rs2758844	chr6:86330115	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-1.02	-11.61	-0.8	1.14e-18	Response to antipsychotic treatment;
SKCM	cis	rs6598955	0.724	rs10902737	chr1:26635716	G/A	cg04990556	chr1:26633338	UBXN11	-0.59	-4.85	-0.48	6.08e-6	Obesity-related traits;
SKCM	cis	rs2479724	0.591	rs4526183	chr6:41829267	T/C	cg17623882	chr6:41773611	USP49	-0.7	-5.06	-0.5	2.7e-6	Menarche (age at onset);
SKCM	cis	rs12711979	0.509	rs10191674	chr2:3827891	C/T	cg17052675	chr2:3827356	NA	-0.86	-9.85	-0.74	2.41e-15	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs16854884	1.000	rs11924473	chr3:143787075	C/G	cg06585982	chr3:143692056	C3orf58	0.74	5.69	0.54	2.17e-7	Economic and political preferences (feminism/equality);
SKCM	cis	rs7945705	0.782	rs2742545	chr11:8884308	C/G	cg21881798	chr11:8931708	C11orf17;ST5	-0.81	-8.74	-0.7	3.49e-13	Hemoglobin concentration;
SKCM	cis	rs873946	0.504	rs12254034	chr10:134571007	T/C	cg18305652	chr10:134549665	INPP5A	0.6	5.97	0.56	6.52e-8	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs7524258	0.868	rs6693725	chr1:7307810	G/T	cg07173049	chr1:7289937	CAMTA1	0.41	4.87	0.48	5.7e-6	Tourette's syndrome or obsessive-compulsive disorder;
SKCM	cis	rs854765	0.616	rs8070624	chr17:17843396	G/A	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.84	6.04	0.56	4.92e-8	Total body bone mineral density;
SKCM	cis	rs9818758	0.556	rs9835439	chr3:49220330	G/C	cg24898236	chr3:49228699	LOC646498	0.64	4.94	0.49	4.39e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs28595532	0.920	rs115738062	chr4:119725490	C/T	cg11846333	chr4:119757529	SEC24D	1.13	5.36	0.52	8.37e-7	Cannabis dependence symptom count;
SKCM	trans	rs11083271	0.627	rs11564325	chr18:25858240	C/T	cg00321150	chr11:62623587	SNORD27;SLC3A2;SNHG1;SNORD28;SNORD25;SNORD26	0.8	7.29	0.64	2.17e-10	Non-alcoholic fatty liver disease histology (lobular);
SKCM	trans	rs3749237	0.964	rs2352967	chr3:49871641	C/T	cg21659725	chr3:3221576	CRBN	0.99	7.35	0.64	1.71e-10	Resting heart rate;
SKCM	cis	rs79839061	0.610	rs17781499	chr4:889384	C/A	cg07828340	chr4:882639	GAK	1.06	5.86	0.55	1.06e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs1160297	0.609	rs2356680	chr2:53095313	T/C	cg07782112	chr2:53107842	NA	0.59	6.3	0.58	1.63e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs7824557	0.651	rs6601582	chr8:11207367	C/A	cg21775007	chr8:11205619	TDH	0.71	6.31	0.58	1.58e-8	Retinal vascular caliber;
SKCM	cis	rs4975616	0.714	rs27069	chr5:1347128	C/T	cg07493874	chr5:1342172	CLPTM1L	-0.59	-5.08	-0.5	2.54e-6	Lung cancer;
SKCM	cis	rs2839186	0.934	rs2839197	chr21:47708133	A/G	cg05896524	chr21:47604654	C21orf56	0.69	5.67	0.54	2.29e-7	Testicular germ cell tumor;
SKCM	cis	rs763014	0.833	rs4984891	chr16:622234	T/A	cg00908189	chr16:619842	PIGQ	0.8	7.17	0.63	3.67e-10	Height;
SKCM	cis	rs12478296	1.000	rs55814222	chr2:243041166	C/T	cg06360820	chr2:242988706	NA	-0.92	-5.32	-0.52	9.84e-7	Obesity-related traits;
SKCM	cis	rs6424115	0.830	rs2503002	chr1:24196957	C/G	cg10978503	chr1:24200527	CNR2	0.41	4.99	0.49	3.62e-6	Immature fraction of reticulocytes;
SKCM	cis	rs6424115	1.000	rs2256179	chr1:24132305	A/G	cg10978503	chr1:24200527	CNR2	-0.39	-4.9	-0.48	5.16e-6	Immature fraction of reticulocytes;
SKCM	cis	rs9788682	0.748	rs2456020	chr15:78868398	C/T	cg24631222	chr15:78858424	CHRNA5	0.87	6.62	0.6	4.19e-9	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs2836974	0.897	rs2836925	chr21:40532353	T/C	cg17971929	chr21:40555470	PSMG1	0.87	8.48	0.69	1.1e-12	Cognitive function;
SKCM	cis	rs72615157	0.716	rs75779608	chr7:99768957	C/T	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.05	6.23	0.58	2.2e-8	Lung function (FEV1/FVC);
SKCM	cis	rs17685	0.633	rs3801471	chr7:75696188	T/G	cg01364799	chr7:75623366	TMEM120A	-0.76	-6.14	-0.57	3.29e-8	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs28510890	0.688	rs12593253	chr15:93130920	T/C	cg23043611	chr15:93139145	NA	-0.79	-5.96	-0.56	6.94e-8	Lung cancer in ever smokers;
SKCM	cis	rs1153858	1.000	rs1145081	chr15:45679667	C/G	cg10760299	chr15:45669010	GATM	0.63	6.32	0.58	1.49e-8	Homoarginine levels;
SKCM	cis	rs7216064	0.628	rs62084702	chr17:66043157	C/T	cg12091567	chr17:66097778	LOC651250	0.89	6.71	0.6	2.8e-9	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs7633770	0.841	rs6442010	chr3:46669500	A/T	cg11219411	chr3:46661640	NA	0.68	6.42	0.59	9.87e-9	Coronary artery disease;
SKCM	cis	rs9300255	0.602	rs1727317	chr12:123618942	T/C	cg00376283	chr12:123451042	ABCB9	0.8	5.4	0.52	6.99e-7	Neutrophil percentage of white cells;
SKCM	cis	rs933688	1.000	rs1035476	chr5:90745976	C/T	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.93	6.35	0.58	1.34e-8	Smoking behavior;
SKCM	cis	rs11098499	0.908	rs28499576	chr4:120386677	G/A	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs875971	1.000	rs10244498	chr7:66116056	A/G	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.51	5.07	0.5	2.62e-6	Aortic root size;
SKCM	cis	rs870825	0.518	rs56034065	chr4:185655402	A/G	cg04058563	chr4:185651563	MLF1IP	1.02	6.59	0.6	4.7e-9	Blood protein levels;
SKCM	cis	rs9300255	0.543	rs1617156	chr12:123590165	T/C	cg00376283	chr12:123451042	ABCB9	0.84	5.87	0.55	1e-7	Neutrophil percentage of white cells;
SKCM	cis	rs3733346	0.529	rs73209867	chr4:899168	C/T	cg11016749	chr4:921637	GAK	-0.58	-4.88	-0.48	5.47e-6	Sjögren's syndrome;
SKCM	cis	rs6430585	0.528	rs78274583	chr2:136734569	C/T	cg07169764	chr2:136633963	MCM6	1.32	11.74	0.8	6.6e-19	Corneal structure;
SKCM	cis	rs7772486	0.658	rs9403737	chr6:145962193	G/T	cg05347473	chr6:146136440	FBXO30	0.58	5.3	0.51	1.05e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2243480	1.000	rs781157	chr7:65478311	G/A	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs763014	0.865	rs2018789	chr16:632051	T/C	cg07343612	chr16:622815	PIGQ	-0.7	-6.0	-0.56	5.84e-8	Height;
SKCM	cis	rs28595532	0.920	rs56227053	chr4:119772460	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs8064299	0.597	rs2016126	chr17:72784932	G/A	cg25054828	chr17:72772726	NAT9;TMEM104	0.93	9.94	0.75	1.67e-15	Monocyte count;
SKCM	cis	rs17376456	0.825	rs34592268	chr5:93232751	G/C	cg25358565	chr5:93447407	FAM172A	1.26	7.82	0.66	2.11e-11	Diabetic retinopathy;
SKCM	cis	rs10479542	0.784	rs6896940	chr5:178985994	G/C	cg19723775	chr5:179050963	HNRNPH1	0.61	4.97	0.49	3.9e-6	Lung cancer;
SKCM	cis	rs561341	1.000	rs4795670	chr17:30244839	T/C	cg13647721	chr17:30228624	UTP6	0.76	4.83	0.48	6.72e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs2836974	0.568	rs2836969	chr21:40648265	G/A	cg11644478	chr21:40555479	PSMG1	-0.82	-7.86	-0.66	1.75e-11	Cognitive function;
SKCM	cis	rs453301	0.571	rs2929456	chr8:9083416	G/A	cg06636001	chr8:8085503	FLJ10661	-0.75	-6.01	-0.56	5.65e-8	Joint mobility (Beighton score);
SKCM	cis	rs7666738	0.830	rs10001701	chr4:98918871	G/C	cg17366294	chr4:99064904	C4orf37	0.56	4.89	0.48	5.26e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs60871478	0.731	rs71518343	chr7:755652	T/A	cg13798912	chr7:905769	UNC84A	0.72	4.78	0.48	8.16e-6	Cerebrospinal P-tau181p levels;
SKCM	cis	rs9905704	0.647	rs2108435	chr17:57102133	T/C	cg05425664	chr17:57184151	TRIM37	0.6	4.93	0.49	4.47e-6	Testicular germ cell tumor;
SKCM	cis	rs62064224	0.652	rs116325033	chr17:30715229	T/C	cg18200150	chr17:30822561	MYO1D	0.77	6.29	0.58	1.72e-8	Schizophrenia;
SKCM	cis	rs11673344	0.704	rs517110	chr19:37422394	G/A	cg07624650	chr19:37064219	ZNF529	-0.8	-5.24	-0.51	1.31e-6	Obesity-related traits;
SKCM	cis	rs4740619	0.619	rs1410452	chr9:16042120	G/C	cg14451791	chr9:16040625	NA	-0.47	-5.03	-0.49	3.07e-6	Body mass index;
SKCM	cis	rs769267	0.930	rs2315022	chr19:19413381	A/G	cg03709012	chr19:19516395	GATAD2A	0.83	6.87	0.61	1.38e-9	Tonsillectomy;
SKCM	cis	rs11892454	0.544	rs35404220	chr2:26004120	T/C	cg17263061	chr2:26915892	KCNK3	0.72	5.19	0.51	1.65e-6	Heschl's gyrus morphology;
SKCM	cis	rs2439831	0.850	rs7169322	chr15:44131014	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.36	7.78	0.66	2.56e-11	Lung cancer in ever smokers;
SKCM	cis	rs2841277	0.708	rs2582533	chr14:105398787	G/C	cg14403583	chr14:105418241	AHNAK2	-0.87	-5.74	-0.54	1.75e-7	Rheumatoid arthritis;
SKCM	cis	rs4819052	0.679	rs2236450	chr21:46702553	T/C	cg19498844	chr21:46707878	POFUT2;LOC642852	0.83	7.01	0.62	7.55e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs17685	0.725	rs6467993	chr7:75719350	G/A	cg16684958	chr7:75615977	POR	0.57	5.54	0.53	4e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	trans	rs8073060	0.586	rs7221203	chr17:34015532	T/C	cg19694781	chr19:47549865	TMEM160	-1.04	-8.28	-0.68	2.65e-12	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs7618501	0.540	rs11130241	chr3:50131459	A/T	cg24110177	chr3:50126178	RBM5	0.61	5.18	0.51	1.71e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2072499	0.750	rs7534339	chr1:156156219	A/G	cg24450063	chr1:156163899	SLC25A44	0.91	6.89	0.61	1.3e-9	Testicular germ cell tumor;
SKCM	cis	rs12495832	0.778	rs7627902	chr3:147882069	C/T	cg21127068	chr3:147124417	ZIC4	-0.67	-4.87	-0.48	5.71e-6	Chin dimples;
SKCM	cis	rs807669	0.742	rs1206544	chr22:19215039	C/T	cg02655711	chr22:19163373	SLC25A1	0.59	5.5	0.53	4.74e-7	Metabolite levels;
SKCM	cis	rs7659604	0.702	rs6826506	chr4:122710865	T/G	cg20573242	chr4:122745356	CCNA2	0.76	6.29	0.58	1.68e-8	Type 2 diabetes;
SKCM	cis	rs651907	0.535	rs35810977	chr3:101531380	G/A	cg12386194	chr3:101231763	SENP7	0.68	5.74	0.54	1.73e-7	Colorectal cancer;
SKCM	cis	rs4927850	1.000	rs7627706	chr3:195753353	A/C	cg12923728	chr3:195709715	SDHAP1	-0.89	-5.76	-0.55	1.57e-7	Pancreatic cancer;
SKCM	cis	rs34779708	0.966	rs2126984	chr10:35410291	A/G	cg03585969	chr10:35415529	CREM	0.82	5.98	0.56	6.33e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs1949733	0.656	rs2688224	chr4:8404700	C/G	cg11789530	chr4:8429930	ACOX3	0.69	4.89	0.48	5.35e-6	Response to antineoplastic agents;
SKCM	cis	rs2594989	0.779	rs56053623	chr3:11592153	T/C	cg00170343	chr3:11313890	ATG7	-0.97	-5.42	-0.52	6.41e-7	Circulating chemerin levels;
SKCM	cis	rs2243480	1.000	rs34192067	chr7:65887657	C/A	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs6570726	0.791	rs6570692	chr6:145904401	T/A	cg23711669	chr6:146136114	FBXO30	0.88	8.32	0.69	2.28e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2479724	0.636	rs1192238	chr6:41803836	C/T	cg17623882	chr6:41773611	USP49	0.73	6.08	0.57	4.17e-8	Menarche (age at onset);
SKCM	cis	rs1499614	0.901	rs2178742	chr7:66197799	G/A	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Gout;
SKCM	cis	rs7666738	0.791	rs34152299	chr4:98929862	G/C	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2243480	1.000	rs58062456	chr7:65394852	G/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs4237845	0.537	rs10747786	chr12:58260601	G/T	cg00677455	chr12:58241039	CTDSP2	0.86	7.68	0.66	3.98e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs6089584	0.606	rs2273989	chr20:60579138	G/A	cg06108461	chr20:60628389	TAF4	-0.69	-6.08	-0.57	4.23e-8	Body mass index;
SKCM	cis	rs6121246	0.559	rs6060952	chr20:30382108	T/G	cg13852791	chr20:30311386	BCL2L1	0.82	5.64	0.54	2.59e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs11673344	0.830	rs3745770	chr19:37488565	C/G	cg07624650	chr19:37064219	ZNF529	-0.78	-4.82	-0.48	7.05e-6	Obesity-related traits;
SKCM	cis	rs7684253	0.565	rs13130605	chr4:57810071	G/A	cg11939399	chr4:57773300	REST	0.43	4.94	0.49	4.33e-6	Migraine;
SKCM	cis	rs6121246	0.909	rs6060821	chr20:30294034	C/T	cg11595048	chr20:30225325	COX4I2	0.67	5.21	0.51	1.5e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs1577917	1.000	rs12661204	chr6:86678586	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.66	-5.72	-0.54	1.88e-7	Response to antipsychotic treatment;
SKCM	cis	rs6089584	0.888	rs6089624	chr20:60619907	C/G	cg06108461	chr20:60628389	TAF4	-0.89	-8.72	-0.7	3.75e-13	Body mass index;
SKCM	cis	rs7927771	0.864	rs4752999	chr11:47428565	C/T	cg01152729	chr11:47593274	PTPMT1	-0.52	-4.93	-0.49	4.57e-6	Subjective well-being;
SKCM	cis	rs561341	1.000	rs7210970	chr17:30262169	G/A	cg00745463	chr17:30367425	LRRC37B	-1.01	-6.84	-0.61	1.58e-9	Hip circumference adjusted for BMI;
SKCM	cis	rs6121246	0.559	rs6060944	chr20:30372114	G/A	cg11595048	chr20:30225325	COX4I2	0.54	4.77	0.48	8.4e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs2839186	0.771	rs13049175	chr21:47641326	G/A	cg13126279	chr21:47581558	C21orf56	0.63	5.34	0.52	8.78e-7	Testicular germ cell tumor;
SKCM	cis	rs7143963	1.000	rs7156191	chr14:103297847	C/G	cg23020514	chr14:103360112	TRAF3	-0.84	-7.22	-0.63	2.94e-10	Body mass index;
SKCM	cis	rs7772486	0.840	rs11155451	chr6:146422524	A/G	cg05347473	chr6:146136440	FBXO30	0.65	5.96	0.56	6.79e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4523957	0.548	rs7225623	chr17:2089548	T/C	cg16513277	chr17:2031491	SMG6	-0.71	-5.08	-0.5	2.47e-6	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs6665290	0.901	rs11580229	chr1:227210820	G/A	cg10327440	chr1:227177885	CDC42BPA	-1.21	-15.89	-0.87	3.56e-26	Myeloid white cell count;
SKCM	cis	rs1552244	1.000	rs67569278	chr3:10149893	T/C	cg02579736	chr3:10068473	FANCD2;CIDECP	1.23	6.92	0.62	1.13e-9	Alzheimer's disease;
SKCM	cis	rs8014204	0.935	rs8010840	chr14:75355203	T/C	cg06637938	chr14:75390232	RPS6KL1	-0.8	-6.28	-0.58	1.8e-8	Caffeine consumption;
SKCM	cis	rs7829975	0.560	rs56094035	chr8:8551622	G/A	cg06636001	chr8:8085503	FLJ10661	-0.7	-5.1	-0.5	2.36e-6	Mood instability;
SKCM	cis	rs6121246	0.559	rs6058462	chr20:30367674	C/T	cg13852791	chr20:30311386	BCL2L1	0.82	5.64	0.54	2.59e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs1003719	0.762	rs6517402	chr21:38447423	A/C	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs644799	0.930	rs3802764	chr11:95514599	T/A	cg25622487	chr11:95524042	FAM76B;CEP57	0.73	5.9	0.56	8.71e-8	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs11098499	0.863	rs58452170	chr4:120459674	A/T	cg09307838	chr4:120376055	NA	0.98	7.84	0.66	1.96e-11	Corneal astigmatism;
SKCM	trans	rs1814175	0.645	rs7123448	chr11:49764865	T/G	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs875971	0.522	rs1701760	chr7:65473688	A/G	cg11764359	chr7:65958608	NA	0.84	6.36	0.58	1.29e-8	Aortic root size;
SKCM	cis	rs7826238	0.524	rs2921055	chr8:8319342	C/A	cg08975724	chr8:8085496	FLJ10661	0.62	4.85	0.48	6.2e-6	Systolic blood pressure;
SKCM	cis	rs7208859	0.524	rs73988172	chr17:29086332	A/C	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs7666738	0.830	rs7697315	chr4:98938764	T/C	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2811415	0.597	rs9858267	chr3:127786551	G/A	cg09089421	chr3:127803668	RUVBL1	1.0	8.69	0.7	4.4e-13	Lung function (FEV1/FVC);
SKCM	cis	rs9788682	1.000	rs12441426	chr15:78812329	T/C	cg06917634	chr15:78832804	PSMA4	-0.85	-5.3	-0.51	1.05e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs7959452	0.562	rs10878975	chr12:69782044	G/C	cg20891283	chr12:69753455	YEATS4	0.93	9.67	0.74	5.4e-15	Blood protein levels;
SKCM	cis	rs1577917	0.655	rs2758848	chr6:86347605	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.27	-0.51	1.18e-6	Response to antipsychotic treatment;
SKCM	cis	rs453301	0.686	rs28665409	chr8:8869277	G/A	cg15556689	chr8:8085844	FLJ10661	-0.76	-5.93	-0.56	7.98e-8	Joint mobility (Beighton score);
SKCM	cis	rs875971	0.825	rs6951503	chr7:65718936	T/G	cg11764359	chr7:65958608	NA	-0.76	-7.03	-0.62	7e-10	Aortic root size;
SKCM	cis	rs12762955	0.561	rs1904671	chr10:1014603	G/A	cg20503657	chr10:835505	NA	-0.71	-5.78	-0.55	1.45e-7	Response to angiotensin II receptor blocker therapy;
SKCM	cis	rs1801251	0.896	rs7573208	chr2:233696701	C/A	cg25237894	chr2:233734115	C2orf82	-0.51	-4.97	-0.49	3.91e-6	Coronary artery disease;
SKCM	cis	rs7659604	0.605	rs2071486	chr4:122740162	C/T	cg20573242	chr4:122745356	CCNA2	0.71	6.09	0.57	3.97e-8	Type 2 diabetes;
SKCM	cis	rs7937682	0.564	rs1944114	chr11:111366460	T/C	cg09085632	chr11:111637200	PPP2R1B	0.66	4.88	0.48	5.55e-6	Primary sclerosing cholangitis;
SKCM	cis	rs459571	0.916	rs467303	chr9:136904835	C/T	cg13789015	chr9:136890014	NCRNA00094	0.75	6.42	0.59	9.93e-9	Platelet distribution width;
SKCM	cis	rs763014	0.833	rs4984891	chr16:622234	T/A	cg09263875	chr16:632152	PIGQ	0.68	5.71	0.54	1.94e-7	Height;
SKCM	cis	rs28595532	0.920	rs114724233	chr4:119754918	T/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs28386778	0.863	rs11649912	chr17:61797515	T/A	cg06873352	chr17:61820015	STRADA	0.75	6.24	0.58	2.1e-8	Prudent dietary pattern;
SKCM	cis	rs10754283	0.967	rs4658130	chr1:90113447	G/C	cg21401794	chr1:90099060	LRRC8C	0.73	6.34	0.58	1.35e-8	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs35306767	0.855	rs11253499	chr10:944090	A/C	cg26597838	chr10:835615	NA	0.76	5.58	0.53	3.35e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs7666738	0.830	rs1593573	chr4:98925293	T/C	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs79040073	0.563	rs73392233	chr15:49507078	T/G	cg25951582	chr15:49913451	C15orf33;DTWD1	-0.72	-5.22	-0.51	1.44e-6	Lung cancer in ever smokers;
SKCM	cis	rs7666738	0.716	rs6817529	chr4:99023213	T/C	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7296418	0.961	rs11608811	chr12:123529056	A/G	cg00376283	chr12:123451042	ABCB9	0.93	8.47	0.69	1.15e-12	Platelet count;
SKCM	cis	rs10131894	0.611	rs175001	chr14:75436452	A/C	cg08847533	chr14:75593920	NEK9	0.69	4.91	0.49	4.97e-6	Coronary artery disease;
SKCM	cis	rs3785574	0.962	rs2584628	chr17:61894578	T/C	cg06601766	chr17:61851465	DDX42;CCDC47	0.73	5.38	0.52	7.7300000000000005e-07	Height;
SKCM	cis	rs1799949	1.000	rs3950989	chr17:41237953	G/A	cg05368731	chr17:41323189	NBR1	0.9	7.69	0.66	3.74e-11	Menopause (age at onset);
SKCM	cis	rs3768617	0.528	rs10737241	chr1:183098208	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.81	7.76	0.66	2.79e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs754466	0.605	rs10824578	chr10:79578244	G/C	cg17075019	chr10:79541650	NA	-0.84	-7.69	-0.66	3.81e-11	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs11608355	0.508	rs11066411	chr12:109804194	A/G	cg19025524	chr12:109796872	NA	-0.69	-5.21	-0.51	1.48e-6	Neuroticism;
SKCM	cis	rs2070488	1.000	rs7433707	chr3:38443180	G/C	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.97	9.14	0.72	5.9e-14	Electrocardiographic conduction measures;
SKCM	cis	rs9913156	0.793	rs56020376	chr17:4560909	A/G	cg19197139	chr17:4613644	ARRB2	0.79	5.28	0.51	1.14e-6	Lymphocyte counts;
SKCM	cis	rs208515	0.525	rs10498841	chr6:66663706	C/T	cg07460842	chr6:66804631	NA	0.91	5.61	0.54	3e-7	Exhaled nitric oxide levels;
SKCM	cis	rs10504229	0.683	rs59679713	chr8:58134370	G/C	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs2228479	0.764	rs7191836	chr16:89961597	T/C	cg00800038	chr16:89945340	TCF25	-0.94	-5.51	-0.53	4.53e-7	Skin colour saturation;
SKCM	cis	rs1568889	1.000	rs78140392	chr11:28203231	C/G	cg06544937	chr11:28130018	METT5D1;KIF18A	0.86	6.87	0.61	1.4e-9	Bipolar disorder;
SKCM	cis	rs7208859	0.673	rs7211776	chr17:29120196	T/G	cg14067834	chr17:29058358	SUZ12P	0.98	5.1	0.5	2.3e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs8060686	0.641	rs76595854	chr16:68130233	T/C	cg04539111	chr16:67997858	SLC12A4	-0.85	-4.81	-0.48	7.14e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs995000	0.535	rs12239736	chr1:63085997	T/A	cg06896770	chr1:63153194	DOCK7	0.97	9.01	0.71	1.02e-13	Triglyceride levels;
SKCM	cis	rs10503709	0.829	rs10110160	chr8:21448139	A/C	cg23716449	chr8:21608280	GFRA2	0.52	5.32	0.52	9.7e-7	Blood protein levels;
SKCM	cis	rs10089	0.953	rs1432614	chr5:127416919	A/G	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.92	8.37	0.69	1.81e-12	Ileal carcinoids;
SKCM	cis	rs9790314	0.967	rs336541	chr3:161056698	A/C	cg03342759	chr3:160939853	NMD3	-0.72	-7.87	-0.67	1.65e-11	Morning vs. evening chronotype;
SKCM	cis	rs709400	0.628	rs2273700	chr14:103923414	A/G	cg26031613	chr14:104095156	KLC1	0.72	5.58	0.53	3.39e-7	Body mass index;
SKCM	cis	rs523522	0.962	rs2393590	chr12:120913900	G/A	cg27279351	chr12:120934652	DYNLL1	0.91	8.25	0.68	3.03e-12	High light scatter reticulocyte count;
SKCM	cis	rs77216612	0.877	rs7956514	chr12:12879254	T/G	cg04607235	chr12:12878440	APOLD1	-0.99	-7.0	-0.62	7.77e-10	Lymphocyte counts;
SKCM	cis	rs875971	0.660	rs10272357	chr7:66063074	G/A	cg11764359	chr7:65958608	NA	-0.84	-6.37	-0.59	1.2e-8	Aortic root size;
SKCM	cis	rs2839186	0.721	rs3788252	chr21:47661235	C/T	cg13012494	chr21:47604986	C21orf56	0.68	6.02	0.56	5.46e-8	Testicular germ cell tumor;
SKCM	cis	rs28595532	0.546	rs36058627	chr4:119233201	G/T	cg21605333	chr4:119757512	SEC24D	1.17	7.18	0.63	3.55e-10	Cannabis dependence symptom count;
SKCM	cis	rs7769051	1.000	rs12204027	chr6:133122831	A/G	cg22852734	chr6:133119734	C6orf192	1.0	5.39	0.52	7.39e-7	Type 2 diabetes nephropathy;
SKCM	cis	rs2836974	0.568	rs428602	chr21:40547004	A/G	cg11644478	chr21:40555479	PSMG1	0.8	7.6	0.65	5.6e-11	Cognitive function;
SKCM	trans	rs7618501	1.000	rs695238	chr3:49869158	A/C	cg21659725	chr3:3221576	CRBN	0.96	9.43	0.73	1.59e-14	Intelligence (multi-trait analysis);
SKCM	cis	rs66573146	0.831	rs67702333	chr4:6983040	C/G	cg00086871	chr4:6988644	TBC1D14	1.29	5.03	0.5	3.04e-6	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs7659604	1.000	rs10016433	chr4:122664771	A/G	cg06713675	chr4:122721982	EXOSC9	-0.65	-5.78	-0.55	1.48e-7	Type 2 diabetes;
SKCM	cis	rs10808739	0.582	rs4385495	chr8:65634357	C/T	cg05711235	chr8:65498612	NA	-0.81	-5.4	-0.52	7.01e-7	HIV-1 susceptibility;
SKCM	cis	rs9915657	0.870	rs759499	chr17:70133177	C/T	cg06234051	chr17:70120541	SOX9	-0.62	-5.33	-0.52	9.26e-7	Thyroid hormone levels;
SKCM	cis	rs11608355	0.538	rs10850074	chr12:109800531	T/C	cg19025524	chr12:109796872	NA	-0.7	-6.43	-0.59	9.54e-9	Neuroticism;
SKCM	cis	rs28595532	0.702	rs116320061	chr4:119384600	C/T	cg11846333	chr4:119757529	SEC24D	1.17	6.35	0.58	1.32e-8	Cannabis dependence symptom count;
SKCM	cis	rs9325144	0.555	rs11183215	chr12:38693127	G/A	cg13010199	chr12:38710504	ALG10B	-0.63	-5.01	-0.49	3.31e-6	Morning vs. evening chronotype;
SKCM	cis	rs2032447	0.677	rs199737	chr6:25933538	A/T	cg18357526	chr6:26021779	HIST1H4A	0.79	5.88	0.55	9.53e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs637571	0.522	rs649000	chr11:65742933	T/C	cg26695010	chr11:65641043	EFEMP2	-0.72	-5.45	-0.53	5.62e-7	Eosinophil percentage of white cells;
SKCM	cis	rs9611565	0.559	rs9611619	chr22:41986714	C/T	cg03806693	chr22:41940476	POLR3H	-1.12	-7.23	-0.63	2.84e-10	Vitiligo;
SKCM	cis	rs501916	0.634	rs1561479	chr15:48070157	C/G	cg16110827	chr15:48056943	SEMA6D	-0.63	-4.82	-0.48	6.85e-6	Inflammatory bowel disease;Ulcerative colitis;
SKCM	cis	rs365132	1.000	rs353468	chr5:176445494	A/T	cg16309518	chr5:176445507	NA	-0.52	-4.98	-0.49	3.76e-6	Menarche and menopause (age at onset);Menopause (age at onset);
SKCM	cis	rs11858159	0.967	rs7495965	chr15:24839938	A/G	cg24138476	chr15:25312939	SNORD116-5;SNORD116-7	0.6	4.8	0.48	7.54e-6	Platelet thrombus formation;
SKCM	cis	rs2066819	1.000	rs2629447	chr12:56700809	G/A	cg26714650	chr12:56694279	CS	1.71	6.71	0.61	2.74e-9	Psoriasis vulgaris;
SKCM	cis	rs55962025	0.588	rs362312	chr4:3237644	T/C	cg05297308	chr4:3317976	RGS12	-0.6	-5.1	-0.5	2.34e-6	Parental longevity (mother's age at death);
SKCM	cis	rs2652834	1.000	rs2652840	chr15:63393220	T/C	cg04194852	chr15:63334506	TPM1	0.78	4.87	0.48	5.74e-6	HDL cholesterol;
SKCM	cis	rs55962025	0.846	rs363064	chr4:3141410	C/T	cg24015175	chr4:3319247	RGS12	-0.7	-5.86	-0.55	1.06e-7	Parental longevity (mother's age at death);
SKCM	cis	rs593982	1.000	rs593982	chr11:65513107	T/C	cg08755490	chr11:65554678	OVOL1	1.06	10.75	0.77	4.73e-17	Atopic dermatitis;
SKCM	cis	rs12142240	0.698	rs17361805	chr1:46813967	C/T	cg14993813	chr1:46806288	NSUN4	-0.72	-5.36	-0.52	8.14e-7	Menopause (age at onset);
SKCM	cis	rs1267303	0.642	rs2404611	chr1:46997127	C/G	cg25110126	chr1:46999211	NA	0.7	5.02	0.49	3.23e-6	Monobrow;
SKCM	cis	rs2929278	0.546	rs686666	chr15:44161550	G/A	cg02155558	chr15:43621948	ADAL;LCMT2	0.71	5.2	0.51	1.54e-6	Schizophrenia;
SKCM	cis	rs1568889	0.838	rs11030185	chr11:28041904	C/T	cg06544937	chr11:28130018	METT5D1;KIF18A	0.89	8.44	0.69	1.31e-12	Bipolar disorder;
SKCM	cis	rs1707322	0.928	rs6681068	chr1:46398382	G/A	cg03146154	chr1:46216737	IPP	0.77	5.36	0.52	8.35e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs35306767	0.715	rs11253539	chr10:1011347	G/A	cg20503657	chr10:835505	NA	0.76	6.08	0.57	4.18e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs9733	0.536	rs10888385	chr1:150574302	T/C	cg13175981	chr1:150552382	MCL1	0.72	5.96	0.56	6.93e-8	Tonsillectomy;
SKCM	cis	rs763121	0.651	rs738249	chr22:39037979	T/C	cg06022373	chr22:39101656	GTPBP1	0.71	4.91	0.49	4.82e-6	Menopause (age at onset);
SKCM	cis	rs636523	0.561	rs12403212	chr1:63199377	T/C	cg06896770	chr1:63153194	DOCK7	0.8	5.27	0.51	1.17e-6	Lipid traits;
SKCM	cis	rs3791556	1.000	rs3791562	chr2:240113436	C/T	cg14530444	chr2:239432329	NA	0.62	4.9	0.49	5.03e-6	Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);
SKCM	trans	rs11722228	0.549	rs73212853	chr4:10096230	C/T	cg26043149	chr18:55253948	FECH	0.92	7.7	0.66	3.51e-11	Gout;Urate levels;Serum uric acid levels;
SKCM	cis	rs6570726	0.791	rs435671	chr6:145881215	A/G	cg23711669	chr6:146136114	FBXO30	0.87	9.14	0.72	5.82e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs870825	0.616	rs7678900	chr4:185635249	A/G	cg04058563	chr4:185651563	MLF1IP	0.92	6.45	0.59	8.42e-9	Blood protein levels;
SKCM	cis	rs1059312	1.000	rs2291350	chr12:129283711	G/A	cg09035930	chr12:129282057	SLC15A4	0.81	8.93	0.71	1.45e-13	Systemic lupus erythematosus;
SKCM	cis	rs2404602	0.647	rs12903586	chr15:77168240	G/A	cg23625390	chr15:77176239	SCAPER	-0.82	-7.81	-0.66	2.2e-11	Blood metabolite levels;
SKCM	cis	rs9393692	0.557	rs62394769	chr6:26326182	C/T	cg00631329	chr6:26305371	NA	-0.63	-4.86	-0.48	5.86e-6	Educational attainment;
SKCM	cis	rs4727027	0.870	rs1105261	chr7:148794442	T/G	cg23583168	chr7:148888333	NA	-0.82	-6.49	-0.59	7.11e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs12142240	0.698	rs1475388	chr1:46816465	G/A	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	trans	rs877282	0.786	rs11253392	chr10:788768	G/A	cg22713356	chr15:30763199	NA	1.35	7.57	0.65	6.52e-11	Uric acid levels;
SKCM	cis	rs2404602	0.692	rs12904198	chr15:77146978	G/A	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs910316	0.737	rs108622	chr14:75481908	A/G	cg08847533	chr14:75593920	NEK9	-0.8	-6.59	-0.6	4.76e-9	Height;
SKCM	cis	rs1577917	0.771	rs7452605	chr6:86240951	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.78	7.21	0.63	3.17e-10	Response to antipsychotic treatment;
SKCM	cis	rs4237845	0.742	rs3751330	chr12:58290226	T/C	cg02175503	chr12:58329896	NA	0.78	7.23	0.63	2.81e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs10193935	1.000	rs10195776	chr2:42425098	G/A	cg27598129	chr2:42591480	NA	-0.88	-6.71	-0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs73201462	1.000	rs11712798	chr3:127894294	T/C	cg09089421	chr3:127803668	RUVBL1	1.0	5.11	0.5	2.22e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs7937682	0.889	rs493865	chr11:111495178	A/C	cg09085632	chr11:111637200	PPP2R1B	-0.97	-10.08	-0.75	8.74e-16	Primary sclerosing cholangitis;
SKCM	cis	rs28595532	0.920	rs115271785	chr4:119735748	A/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs477895	1.000	rs7939107	chr11:64034773	C/T	cg02228329	chr11:64053129	BAD;GPR137	-1.16	-5.29	-0.51	1.08e-6	Mean platelet volume;
SKCM	cis	rs11718455	0.921	rs11130020	chr3:44009459	C/T	cg21419209	chr3:44054225	NA	-0.65	-5.39	-0.52	7.28e-7	Coronary artery disease;
SKCM	cis	rs11098499	0.754	rs12711071	chr4:120240934	A/G	cg09307838	chr4:120376055	NA	0.91	7.31	0.64	2.04e-10	Corneal astigmatism;
SKCM	cis	rs35306767	0.903	rs12762228	chr10:880854	G/A	cg20503657	chr10:835505	NA	0.79	5.57	0.53	3.52e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs4400599	0.642	rs4364874	chr1:154167788	C/A	cg26808167	chr1:154192205	UBAP2L;C1orf43	-0.53	-4.83	-0.48	6.8e-6	Platelet distribution width;
SKCM	cis	rs7215564	0.908	rs57778244	chr17:78653798	T/G	cg16980736	chr17:78789706	RPTOR	-0.89	-4.88	-0.48	5.41e-6	Myopia (pathological);
SKCM	cis	rs854765	0.583	rs11650890	chr17:17790882	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	-0.96	-7.66	-0.65	4.36e-11	Total body bone mineral density;
SKCM	cis	rs644799	1.000	rs557079	chr11:95530125	C/G	cg03916912	chr11:95522834	CEP57;FAM76B	0.92	8.04	0.67	8e-12	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs3784262	0.669	rs4646555	chr15:58355345	G/A	cg12031962	chr15:58353849	ALDH1A2	-0.42	-4.89	-0.48	5.38e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	trans	rs1814175	0.817	rs1794164	chr11:49899610	T/C	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs651907	0.514	rs11706494	chr3:101509475	A/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.78	6.72	0.61	2.65e-9	Colorectal cancer;
SKCM	cis	rs9300255	0.602	rs1106241	chr12:123627016	T/C	cg05973401	chr12:123451056	ABCB9	0.79	5.37	0.52	8.03e-7	Neutrophil percentage of white cells;
SKCM	cis	rs67311347	0.544	rs9833640	chr3:40354941	T/A	cg00091569	chr3:40428383	ENTPD3	0.64	5.64	0.54	2.66e-7	Renal cell carcinoma;
SKCM	cis	rs899997	0.773	rs7178423	chr15:78964961	T/G	cg04896959	chr15:78267971	NA	0.61	5.23	0.51	1.39e-6	Coronary artery disease or large artery stroke;
SKCM	cis	rs8180040	0.726	rs11130112	chr3:47024495	G/T	cg27129171	chr3:47204927	SETD2	0.83	6.19	0.57	2.6e-8	Colorectal cancer;
SKCM	cis	rs2811415	0.627	rs13316354	chr3:127751772	A/G	cg09089421	chr3:127803668	RUVBL1	0.99	8.52	0.69	9.09e-13	Lung function (FEV1/FVC);
SKCM	trans	rs1814175	0.541	rs12287397	chr11:49819799	G/A	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs7020830	0.858	rs1492714	chr9:37141259	T/C	cg14294708	chr9:37120828	ZCCHC7	1.09	10.46	0.76	1.68e-16	Schizophrenia;
SKCM	cis	rs3771570	1.000	rs56222556	chr2:242364119	G/A	cg07612300	chr2:242033426	MTERFD2;SNED1	0.87	4.77	0.47	8.54e-6	Prostate cancer;
SKCM	cis	rs10905065	0.930	rs7096742	chr10:5735648	C/T	cg09234995	chr10:5726438	C10orf18	-0.62	-5.48	-0.53	4.94e-7	Menopause (age at onset);
SKCM	cis	rs362272	0.545	rs2749782	chr4:3339761	A/G	cg03043834	chr4:3319541	RGS12	0.6	5.17	0.5	1.78e-6	Serum sulfate level;
SKCM	cis	rs12477438	0.798	rs4324365	chr2:99623845	T/G	cg26064155	chr2:99771622	LIPT1;TSGA10	-0.72	-4.86	-0.48	6e-6	Chronic sinus infection;
SKCM	cis	rs9911578	0.967	rs8182277	chr17:57144367	C/T	cg12560992	chr17:57184187	TRIM37	1.09	10.28	0.76	3.61e-16	Intelligence (multi-trait analysis);
SKCM	cis	rs67311347	1.000	rs7642906	chr3:40492633	G/A	cg00091569	chr3:40428383	ENTPD3	-0.59	-4.83	-0.48	6.6e-6	Renal cell carcinoma;
SKCM	cis	rs4803468	0.935	rs284660	chr19:41932084	G/T	cg09537434	chr19:41945824	ATP5SL	-1.1	-13.85	-0.84	1.02e-22	Height;
SKCM	cis	rs4780401	0.609	rs4781142	chr16:11808806	T/C	cg01061890	chr16:11836724	TXNDC11	-0.77	-5.59	-0.53	3.27e-7	Rheumatoid arthritis;
SKCM	cis	rs8067545	0.611	rs7222984	chr17:20019694	A/C	cg13482628	chr17:19912719	NA	0.68	5.62	0.54	2.85e-7	Schizophrenia;
SKCM	cis	rs7843479	1.000	rs67385415	chr8:21853733	T/C	cg17168535	chr8:21777572	XPO7	0.7	5.74	0.54	1.76e-7	Mean corpuscular volume;
SKCM	cis	rs4809219	1	rs4809219	chr20:62303115	C/A	cg03999872	chr20:62272968	STMN3	0.55	4.85	0.48	6.23e-6	Atopic dermatitis;
SKCM	cis	rs2439831	0.681	rs540388	chr15:43606494	G/A	cg02155558	chr15:43621948	ADAL;LCMT2	1.2	8.73	0.7	3.66e-13	Lung cancer in ever smokers;
SKCM	cis	rs11139399	0.613	rs7023303	chr9:84336310	C/T	cg13729285	chr9:84764156	NA	0.52	4.85	0.48	6.29e-6	Hippocampal atrophy;
SKCM	cis	rs9814567	0.806	rs4519744	chr3:134321523	T/C	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.65	-5.19	-0.51	1.6e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs17065868	0.803	rs11617441	chr13:45209828	A/C	cg10246903	chr13:45222710	NA	0.95	5.35	0.52	8.5e-7	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs12142240	0.738	rs10489769	chr1:46806703	A/G	cg10495392	chr1:46806563	NSUN4	0.76	5.57	0.53	3.52e-7	Menopause (age at onset);
SKCM	cis	rs6582630	0.519	rs11495373	chr12:38275470	T/C	cg13010199	chr12:38710504	ALG10B	0.69	4.92	0.49	4.72e-6	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs7772486	0.641	rs2777485	chr6:146334377	G/A	cg05347473	chr6:146136440	FBXO30	0.67	5.59	0.53	3.22e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs55962025	0.804	rs2269499	chr4:3239702	C/T	cg11471262	chr4:3318911	RGS12	-0.63	-4.97	-0.49	3.9e-6	Parental longevity (mother's age at death);
SKCM	cis	rs60871478	0.730	rs13222476	chr7:826630	T/C	cg05535760	chr7:792225	HEATR2	1.2	10.18	0.76	5.61e-16	Cerebrospinal P-tau181p levels;
SKCM	cis	rs7618915	1.000	rs3852063	chr3:52349204	A/G	cg18404041	chr3:52824283	ITIH1	-0.62	-5.02	-0.49	3.15e-6	Bipolar disorder;
SKCM	cis	rs769267	0.965	rs2315024	chr19:19423817	T/A	cg03709012	chr19:19516395	GATAD2A	0.79	6.37	0.59	1.19e-8	Tonsillectomy;
SKCM	cis	rs28386778	0.897	rs7501614	chr17:61802612	T/C	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.36	0.52	8.08e-7	Prudent dietary pattern;
SKCM	cis	rs28386778	0.897	rs4968599	chr17:61835992	T/C	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.36	0.52	8.06e-7	Prudent dietary pattern;
SKCM	cis	rs9880211	0.752	rs13062352	chr3:136464762	G/A	cg21827317	chr3:136751795	NA	-0.7	-5.43	-0.52	6.12e-7	Body mass index;Height;
SKCM	cis	rs7666738	0.791	rs13111960	chr4:98976851	C/T	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9911578	0.967	rs11079368	chr17:57086473	C/T	cg05425664	chr17:57184151	TRIM37	0.84	6.99	0.62	8.23e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs933688	0.938	rs7708782	chr5:90718517	T/C	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.96	6.6	0.6	4.58e-9	Smoking behavior;
SKCM	cis	rs1559088	0.600	rs58173463	chr19:33596749	C/T	cg17764715	chr19:33622953	WDR88	0.94	7.44	0.64	1.11e-10	Bone ultrasound measurement (broadband ultrasound attenuation);
SKCM	trans	rs17685	0.753	rs13240404	chr7:75675719	C/T	cg19862616	chr7:65841803	NCRNA00174	-0.94	-9.39	-0.73	1.88e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs13392177	0.672	rs4674270	chr2:219053141	G/T	cg00012203	chr2:219082015	ARPC2	-0.65	-4.81	-0.48	7.21e-6	Pyoderma gangrenosum in inflammatory bowel disease;
SKCM	cis	rs7937682	0.562	rs630002	chr11:111377758	G/A	cg09085632	chr11:111637200	PPP2R1B	-0.84	-6.69	-0.6	3.02e-9	Primary sclerosing cholangitis;
SKCM	cis	rs4242434	0.699	rs878053	chr8:22483849	T/C	cg03733263	chr8:22462867	KIAA1967	0.82	5.82	0.55	1.23e-7	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs60871478	0.636	rs6976929	chr7:901382	C/T	cg05535760	chr7:792225	HEATR2	-1.3	-7.8	-0.66	2.27e-11	Cerebrospinal P-tau181p levels;
SKCM	cis	rs7208859	0.623	rs1061342	chr17:29114463	G/A	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	trans	rs208520	0.690	rs12202913	chr6:66734198	C/T	cg15611600	chr13:45563400	KIAA1704;NUFIP1	0.93	7.71	0.66	3.36e-11	Exhaled nitric oxide output;
SKCM	cis	rs4819052	0.851	rs28501512	chr21:46676702	C/T	cg20896738	chr21:46707857	POFUT2;LOC642852	0.64	4.82	0.48	6.85e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs644799	1.000	rs3748256	chr11:95521953	A/G	cg03916912	chr11:95522834	CEP57;FAM76B	0.91	8.1	0.68	6.01e-12	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs2836974	0.932	rs2150415	chr21:40615367	A/G	cg11890956	chr21:40555474	PSMG1	1.14	13.87	0.84	9.27e-23	Cognitive function;
SKCM	cis	rs7647973	0.516	rs4499638	chr3:49202782	C/G	cg07636037	chr3:49044803	WDR6	0.86	7.17	0.63	3.77e-10	Menarche (age at onset);
SKCM	cis	rs67311347	0.544	rs7644643	chr3:40350209	C/T	cg02782426	chr3:40428986	ENTPD3	-0.54	-5.68	-0.54	2.18e-7	Renal cell carcinoma;
SKCM	cis	rs637571	0.544	rs56239996	chr11:65730003	A/T	cg26695010	chr11:65641043	EFEMP2	-0.7	-5.32	-0.52	9.78e-7	Eosinophil percentage of white cells;
SKCM	cis	rs66573146	1.000	rs56178503	chr4:6961748	C/T	cg00086871	chr4:6988644	TBC1D14	1.43	5.33	0.52	9.25e-7	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs17376456	0.825	rs28412976	chr5:93248377	T/C	cg25358565	chr5:93447407	FAM172A	1.3	7.53	0.65	7.57e-11	Diabetic retinopathy;
SKCM	cis	rs4927850	0.958	rs2044599	chr3:195736740	G/A	cg01181863	chr3:195395398	SDHAP2	-0.91	-6.2	-0.57	2.46e-8	Pancreatic cancer;
SKCM	cis	rs6952808	0.595	rs3778982	chr7:2166233	T/C	cg02951883	chr7:2050386	MAD1L1	-0.76	-6.91	-0.62	1.14e-9	Bipolar disorder and schizophrenia;
SKCM	cis	rs1707322	1.000	rs1622208	chr1:46498375	A/G	cg03146154	chr1:46216737	IPP	-0.79	-5.4	-0.52	6.87e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs6952808	0.692	rs56727870	chr7:2029940	T/C	cg21782813	chr7:2030301	MAD1L1	0.57	5.93	0.56	7.93e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs1799949	0.965	rs11654051	chr17:41419656	C/T	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.18	-0.57	2.68e-8	Menopause (age at onset);
SKCM	cis	rs7809950	0.954	rs12673675	chr7:107113220	T/C	cg23024343	chr7:107201750	COG5	-0.74	-6.62	-0.6	4.19e-9	Coronary artery disease;
SKCM	cis	rs6500395	1.000	rs2080508	chr16:48690665	G/C	cg04672837	chr16:48644449	N4BP1	-0.65	-5.43	-0.52	6.29e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs17345786	1.000	rs997739	chr3:101313940	A/G	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.71	5.07	0.5	2.61e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2439831	0.867	rs933941	chr15:43632226	G/A	cg02155558	chr15:43621948	ADAL;LCMT2	1.33	9.58	0.74	7.97e-15	Lung cancer in ever smokers;
SKCM	cis	rs6938	0.534	rs12904897	chr15:75217686	A/G	cg09165964	chr15:75287851	SCAMP5	0.62	4.78	0.48	8.04e-6	Breast cancer;
SKCM	cis	rs8103278	1.000	rs725660	chr19:46262286	C/A	cg11657440	chr19:46296263	DMWD	-0.92	-6.83	-0.61	1.65e-9	Coronary artery disease;
SKCM	cis	rs7959452	0.535	rs10878953	chr12:69674187	A/G	cg20891283	chr12:69753455	YEATS4	0.75	6.83	0.61	1.67e-9	Blood protein levels;
SKCM	cis	rs4234284	1.000	rs13089222	chr3:126977840	T/C	cg04889221	chr3:126137216	CCDC37	-0.49	-5.08	-0.5	2.51e-6	Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel);
SKCM	cis	rs4740619	0.557	rs997410	chr9:16040430	A/G	cg14451791	chr9:16040625	NA	-0.47	-5.03	-0.49	3.07e-6	Body mass index;
SKCM	cis	rs1218582	0.772	rs2335408	chr1:154915977	G/A	cg24250549	chr1:154909240	PMVK	0.87	8.88	0.71	1.84e-13	Prostate cancer;
SKCM	cis	rs763121	0.925	rs17032	chr22:39130843	C/G	cg06022373	chr22:39101656	GTPBP1	0.76	4.84	0.48	6.44e-6	Menopause (age at onset);
SKCM	cis	rs6570726	0.791	rs12208812	chr6:145900924	T/G	cg23711669	chr6:146136114	FBXO30	0.88	9.09	0.72	7.08e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs12047808	0.841	rs73036715	chr1:179417735	C/T	cg09822482	chr1:179519214	C1orf125	-0.95	-5.08	-0.5	2.51e-6	Multiple sclerosis (age of onset);
SKCM	cis	rs72772090	1.000	rs56116814	chr5:96048714	G/A	cg17330273	chr5:96107758	CAST;ERAP1	-0.83	-4.97	-0.49	3.86e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs11122272	0.766	rs2739511	chr1:231526490	G/C	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	-0.64	-5.31	-0.52	9.86e-7	Hemoglobin concentration;
SKCM	cis	rs875971	0.862	rs778734	chr7:65814849	C/G	cg11764359	chr7:65958608	NA	0.81	7.6	0.65	5.6e-11	Aortic root size;
SKCM	cis	rs1413885	0.538	rs1570869	chr1:65830905	A/C	cg14976592	chr1:65886160	LEPROT;LEPR	0.68	5.81	0.55	1.29e-7	Anticoagulant levels;
SKCM	cis	rs12497850	0.931	rs9840684	chr3:48893780	T/C	cg06212747	chr3:49208901	KLHDC8B	0.68	4.89	0.48	5.28e-6	Parkinson's disease;
SKCM	cis	rs6952407	1	rs6952407	chr7:66045512	A/G	cg11987759	chr7:65425863	GUSB	0.67	5.75	0.55	1.68e-7	Cotinine glucuronidation;
SKCM	cis	rs4819052	0.851	rs2838828	chr21:46663423	A/G	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.36	0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs875971	0.767	rs1643394	chr7:65836094	A/G	cg18876405	chr7:65276391	NA	0.64	6.38	0.59	1.18e-8	Aortic root size;
SKCM	trans	rs7618501	0.966	rs9882639	chr3:49799475	A/C	cg21659725	chr3:3221576	CRBN	0.96	9.61	0.74	7.08e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs9467773	1.000	rs2393670	chr6:26535541	A/G	cg15659132	chr6:26577336	NA	0.6	5.71	0.54	1.99e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7666738	0.830	rs6832209	chr4:98994120	A/G	cg17366294	chr4:99064904	C4orf37	0.6	4.98	0.49	3.8e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs910316	0.967	rs175502	chr14:75533679	A/G	cg08847533	chr14:75593920	NEK9	-0.96	-8.88	-0.71	1.87e-13	Height;
SKCM	cis	rs62238980	0.614	rs4820062	chr22:32392437	T/C	cg00543991	chr22:32367038	NA	1.15	4.87	0.48	5.76e-6	Childhood ear infection;
SKCM	cis	rs7092929	0.831	rs667943	chr10:3575417	C/T	cg14308648	chr10:3568949	NA	0.72	4.81	0.48	7.12e-6	Coronary artery calcification;
SKCM	cis	rs8078723	0.966	rs57968500	chr17:38145828	A/G	cg17467752	chr17:38218738	THRA	0.67	6.15	0.57	3.14e-8	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs28595532	0.841	rs114735834	chr4:119772722	G/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs7772486	0.754	rs4895682	chr6:146062861	G/A	cg23711669	chr6:146136114	FBXO30	-0.88	-9.55	-0.73	9.22e-15	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs8072100	0.934	rs8067286	chr17:45594590	A/G	cg08085267	chr17:45401833	C17orf57	0.59	5.24	0.51	1.35e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs12762955	0.561	rs10752022	chr10:1043798	C/T	cg25614935	chr10:1084866	C10orf110	-0.58	-4.85	-0.48	6.19e-6	Response to angiotensin II receptor blocker therapy;
SKCM	cis	rs9858542	0.953	rs4625	chr3:49572140	A/G	cg03060546	chr3:49711283	APEH	-0.69	-5.11	-0.5	2.24e-6	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs2033711	0.905	rs1077420	chr19:58968875	A/C	cg00825309	chr19:58991885	ZNF446	-0.71	-5.92	-0.56	8.33e-8	Uric acid clearance;
SKCM	cis	rs9910055	0.676	rs11079983	chr17:42198170	C/T	cg08499158	chr17:42289980	UBTF	-0.85	-7.48	-0.65	9.37e-11	Total body bone mineral density;
SKCM	cis	rs7149337	0.805	rs7146561	chr14:51608889	C/G	cg23942311	chr14:51606299	NA	0.65	7.48	0.65	9.58e-11	Cancer;
SKCM	cis	rs12711979	1.000	rs12711979	chr2:3869559	A/G	cg17052675	chr2:3827356	NA	-0.56	-5.27	-0.51	1.17e-6	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs2153535	0.601	rs969420	chr6:8451966	T/A	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs9325144	0.624	rs12231544	chr12:38901956	C/T	cg13010199	chr12:38710504	ALG10B	-0.63	-5.14	-0.5	2e-6	Morning vs. evening chronotype;
SKCM	cis	rs4237845	0.715	rs4760340	chr12:58275176	A/T	cg00677455	chr12:58241039	CTDSP2	0.68	5.38	0.52	7.55e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs10504229	0.683	rs66730544	chr8:58127280	A/T	cg02725872	chr8:58115012	NA	-0.52	-4.97	-0.49	3.92e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs2180341	0.960	rs9401952	chr6:127677027	A/C	cg27446573	chr6:127587934	RNF146	0.94	8.11	0.68	5.63e-12	Breast cancer;
SKCM	trans	rs1814175	0.817	rs1390676	chr11:50056778	C/T	cg15704280	chr7:45808275	SEPT13	-1.05	-11.15	-0.78	8.22e-18	Height;
SKCM	cis	rs7247513	0.894	rs4804198	chr19:12685157	T/C	cg13086467	chr19:12779373	MORG1;C19orf56	-0.69	-4.98	-0.49	3.7e-6	Bipolar disorder;
SKCM	cis	rs17826219	0.568	rs9898097	chr17:29072672	T/G	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Body mass index;
SKCM	cis	rs9815354	0.812	rs73073230	chr3:42008263	G/A	cg03022575	chr3:42003672	ULK4	1.0	5.0	0.49	3.43e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs4332037	0.950	rs56403963	chr7:1946130	C/G	cg02825527	chr7:2087843	MAD1L1	-0.73	-5.11	-0.5	2.22e-6	Bipolar disorder;
SKCM	cis	rs477692	0.549	rs7098548	chr10:131455028	A/G	cg11019008	chr10:131425282	MGMT	-0.51	-4.83	-0.48	6.75e-6	Response to temozolomide;
SKCM	cis	rs1403694	0.695	rs10439971	chr3:186434188	C/T	cg09332604	chr3:186435400	KNG1	-0.5	-5.07	-0.5	2.57e-6	Blood protein levels;
SKCM	cis	rs7149242	0.696	rs7141210	chr14:101182470	T/C	cg18089426	chr14:101175970	NA	-0.54	-5.0	-0.49	3.41e-6	Platelet count;
SKCM	cis	rs10504229	0.906	rs2270608	chr8:58194688	T/C	cg02725872	chr8:58115012	NA	-0.53	-4.8	-0.48	7.46e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs12477438	0.520	rs11689265	chr2:99799267	A/G	cg14399236	chr2:99771627	LIPT1;TSGA10	0.96	8.53	0.69	8.71e-13	Chronic sinus infection;
SKCM	cis	rs870825	0.616	rs28416641	chr4:185617999	C/T	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs6762477	0.748	rs2073726	chr3:50223593	T/A	cg04682699	chr3:50248845	SLC38A3	-0.48	-4.8	-0.48	7.52e-6	Menarche (age at onset);
SKCM	cis	rs769267	0.965	rs2023882	chr19:19405405	T/C	cg26732615	chr19:19648335	CILP2;YJEFN3	0.64	5.94	0.56	7.41e-8	Tonsillectomy;
SKCM	cis	rs28374715	0.662	rs691906	chr15:41474636	T/A	cg18705301	chr15:41695430	NDUFAF1	0.93	7.74	0.66	2.94e-11	Ulcerative colitis;
SKCM	cis	rs6120849	0.901	rs6058193	chr20:33734464	A/G	cg24642439	chr20:33292090	TP53INP2	0.91	5.05	0.5	2.83e-6	Protein C levels;
SKCM	cis	rs7143963	0.666	rs11847989	chr14:103303514	T/C	cg23020514	chr14:103360112	TRAF3	0.77	7.14	0.63	4.31e-10	Body mass index;
SKCM	cis	rs9485372	1.000	rs9485371	chr6:149606888	G/T	cg03072286	chr6:150262044	ULBP2	-0.55	-4.89	-0.48	5.3e-6	Breast cancer;
SKCM	cis	rs4332037	1.000	rs4332037	chr7:1950809	C/T	cg23422044	chr7:1970798	MAD1L1	-0.95	-6.32	-0.58	1.48e-8	Bipolar disorder;
SKCM	cis	rs12497850	0.864	rs4955410	chr3:49181218	A/G	cg07636037	chr3:49044803	WDR6	1.0	8.21	0.68	3.61e-12	Parkinson's disease;
SKCM	cis	rs898097	0.841	rs4986122	chr17:80825500	C/T	cg15369054	chr17:80825471	TBCD	0.69	6.61	0.6	4.26e-9	Breast cancer;
SKCM	cis	rs992157	0.764	rs4552182	chr2:219184872	G/T	cg00012203	chr2:219082015	ARPC2	0.75	5.54	0.53	3.92e-7	Colorectal cancer;
SKCM	cis	rs8017423	0.967	rs11627528	chr14:90719697	C/A	cg04374321	chr14:90722782	PSMC1	-0.96	-8.92	-0.71	1.53e-13	Mortality in heart failure;
SKCM	cis	rs2153535	0.580	rs6421949	chr6:8531769	G/A	cg07606381	chr6:8435919	SLC35B3	0.93	6.8	0.61	1.92e-9	Motion sickness;
SKCM	cis	rs10911251	0.528	rs2147584	chr1:183074764	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Colorectal cancer;
SKCM	cis	rs6840360	0.615	rs12647616	chr4:152607662	G/A	cg22705602	chr4:152727874	NA	-0.57	-7.52	-0.65	8.09e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs72781680	0.706	rs72794290	chr2:23896106	A/T	cg08917208	chr2:24149416	ATAD2B	1.0	5.01	0.49	3.3e-6	Lymphocyte counts;
SKCM	cis	rs62238980	0.614	rs79781828	chr22:32413050	C/G	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs12986445	0.744	rs34199918	chr2:26140619	A/G	cg04917511	chr2:26785460	C2orf70	0.5	4.87	0.48	5.74e-6	Multiple myeloma and monoclonal gammopathy;Multiple myeloma;
SKCM	cis	rs7772486	0.686	rs6933161	chr6:146081369	G/A	cg23711669	chr6:146136114	FBXO30	-0.85	-9.32	-0.73	2.62e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9788682	1.000	rs7163730	chr15:78814681	A/G	cg24631222	chr15:78858424	CHRNA5	0.94	6.59	0.6	4.67e-9	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs6120849	0.754	rs3746435	chr20:33587198	G/C	cg24642439	chr20:33292090	TP53INP2	0.94	4.86	0.48	5.91e-6	Protein C levels;
SKCM	cis	rs2731664	0.721	rs2450333	chr5:176899546	G/A	cg23176889	chr5:176863531	GRK6	-0.53	-5.39	-0.52	7.15e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs2153535	0.580	rs1414351	chr6:8476634	T/C	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs798554	0.959	rs798558	chr7:2758935	T/G	cg14895029	chr7:2775587	GNA12	-0.69	-4.93	-0.49	4.52e-6	Height;
SKCM	cis	rs4237845	0.715	rs4760340	chr12:58275176	A/T	cg02175503	chr12:58329896	NA	0.75	6.37	0.59	1.21e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs7632954	0.567	rs6768518	chr3:8534828	G/A	cg06697448	chr3:8544912	LMCD1	-0.56	-4.9	-0.49	5.06e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs2836974	0.831	rs2836964	chr21:40631006	T/C	cg11644478	chr21:40555479	PSMG1	0.99	10.48	0.76	1.51e-16	Cognitive function;
SKCM	trans	rs2727020	0.658	rs7120136	chr11:49384358	A/C	cg15704280	chr7:45808275	SEPT13	-0.85	-7.4	-0.64	1.33e-10	Coronary artery disease;
SKCM	cis	rs9902453	0.808	rs10445400	chr17:28183059	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.78	5.38	0.52	7.43e-7	Coffee consumption (cups per day);
SKCM	cis	rs870825	0.655	rs35764203	chr4:185639078	C/A	cg04058563	chr4:185651563	MLF1IP	1.08	7.26	0.64	2.51e-10	Blood protein levels;
SKCM	cis	rs875971	0.522	rs781144	chr7:65440344	C/G	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.63	5.48	0.53	5.11e-7	Aortic root size;
SKCM	cis	rs12497850	0.897	rs7432989	chr3:49105136	A/G	cg07636037	chr3:49044803	WDR6	1.06	11.78	0.8	5.51e-19	Parkinson's disease;
SKCM	cis	rs7666738	0.830	rs6532715	chr4:99016792	G/A	cg05340658	chr4:99064831	C4orf37	0.67	5.16	0.5	1.85e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs208520	1.000	rs208536	chr6:66963440	T/C	cg07460842	chr6:66804631	NA	-0.84	-5.89	-0.55	9.44e-8	Exhaled nitric oxide output;
SKCM	cis	rs523522	0.892	rs4767916	chr12:121024032	T/C	cg12219531	chr12:120966889	COQ5	0.91	7.71	0.66	3.35e-11	High light scatter reticulocyte count;
SKCM	cis	rs2839186	0.770	rs2280956	chr21:47642323	C/G	cg13126279	chr21:47581558	C21orf56	0.67	5.87	0.55	9.92e-8	Testicular germ cell tumor;
SKCM	cis	rs2652834	1.000	rs2729782	chr15:63403354	G/C	cg04194852	chr15:63334506	TPM1	0.75	4.93	0.49	4.55e-6	HDL cholesterol;
SKCM	cis	rs1707322	0.826	rs10890349	chr1:46249955	T/C	cg03146154	chr1:46216737	IPP	0.81	5.78	0.55	1.47e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs2404602	0.655	rs4886507	chr15:77209694	T/C	cg23625390	chr15:77176239	SCAPER	0.59	5.24	0.51	1.35e-6	Blood metabolite levels;
SKCM	cis	rs6951245	1.000	rs77305932	chr7:1100861	T/A	cg24642844	chr7:1081250	C7orf50	-0.93	-6.22	-0.58	2.28e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs11098499	0.909	rs10002083	chr4:120311152	C/T	cg24375607	chr4:120327624	NA	0.65	4.97	0.49	3.87e-6	Corneal astigmatism;
SKCM	cis	rs7829975	0.777	rs486781	chr8:8639740	A/G	cg15556689	chr8:8085844	FLJ10661	-0.8	-7.14	-0.63	4.33e-10	Mood instability;
SKCM	cis	rs9486715	0.830	rs1475748	chr6:97034143	T/C	cg06623918	chr6:96969491	KIAA0776	-0.86	-7.66	-0.66	4.3e-11	Headache;
SKCM	cis	rs12464559	0.522	rs10200512	chr2:152626147	T/C	cg01189475	chr2:152685088	ARL5A	1.06	5.28	0.51	1.14e-6	Response to cognitive-behavioural therapy in anxiety disorder;
SKCM	cis	rs9911578	1.000	rs302859	chr17:56693132	C/T	cg12560992	chr17:57184187	TRIM37	0.95	7.69	0.66	3.7e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs13108904	0.870	rs3755924	chr4:1238363	A/G	cg02018176	chr4:1364513	KIAA1530	0.62	4.94	0.49	4.42e-6	Obesity-related traits;
SKCM	cis	rs8103278	0.507	rs62111759	chr19:46296230	A/T	cg14061069	chr19:46274453	DMPK	0.51	5.1	0.5	2.3e-6	Coronary artery disease;
SKCM	cis	rs11098499	0.738	rs34566984	chr4:120361270	G/A	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs1801251	1.000	rs6746294	chr2:233583050	C/G	cg25237894	chr2:233734115	C2orf82	-0.58	-5.3	-0.51	1.04e-6	Coronary artery disease;
SKCM	cis	rs3091242	0.934	rs666686	chr1:25719511	A/G	cg02931644	chr1:25747376	RHCE	0.51	5.18	0.51	1.67e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs11651000	0.857	rs11658383	chr17:45842354	A/C	cg24803719	chr17:45855879	NA	-0.54	-5.17	-0.5	1.78e-6	IgG glycosylation;
SKCM	cis	rs2739330	0.796	rs5760097	chr22:24247794	G/C	cg25703541	chr22:24373054	LOC391322	-0.78	-6.14	-0.57	3.23e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs9475752	0.545	rs75396144	chr6:56890083	T/C	cg06815302	chr6:57335405	PRIM2	0.74	5.08	0.5	2.53e-6	Menarche (age at onset);
SKCM	cis	rs2243480	1.000	rs316332	chr7:65604299	A/G	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs2836974	0.565	rs2836939	chr21:40578546	C/T	cg11644478	chr21:40555479	PSMG1	0.87	5.95	0.56	7.35e-8	Cognitive function;
SKCM	cis	rs4237845	0.844	rs4628718	chr12:58301600	A/C	cg00677455	chr12:58241039	CTDSP2	0.67	5.75	0.55	1.67e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs1577917	0.710	rs1059306	chr6:86388109	G/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.83	7.7	0.66	3.55e-11	Response to antipsychotic treatment;
SKCM	cis	rs8017423	0.967	rs12589808	chr14:90719236	C/T	cg04374321	chr14:90722782	PSMC1	-0.96	-8.92	-0.71	1.53e-13	Mortality in heart failure;
SKCM	cis	rs8017423	0.935	rs9944124	chr14:90791501	T/C	cg04374321	chr14:90722782	PSMC1	1.04	9.75	0.74	3.8e-15	Mortality in heart failure;
SKCM	cis	rs7659604	1.000	rs35249024	chr4:122664538	C/A	cg06713675	chr4:122721982	EXOSC9	-0.65	-5.83	-0.55	1.21e-7	Type 2 diabetes;
SKCM	cis	rs6835098	0.923	rs7671278	chr4:174095769	A/G	cg08422745	chr4:174089978	GALNT7	-0.87	-6.99	-0.62	8.12e-10	Dementia and core Alzheimer's disease neuropathologic changes;
SKCM	cis	rs6570726	0.791	rs370112	chr6:145859853	T/G	cg05347473	chr6:146136440	FBXO30	0.56	5.08	0.5	2.49e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9486715	0.867	rs9480700	chr6:96965056	A/G	cg06623918	chr6:96969491	KIAA0776	0.79	6.49	0.59	7.35e-9	Headache;
SKCM	cis	rs10504229	0.861	rs6990617	chr8:58182960	G/T	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs12971120	0.947	rs8084410	chr18:72168486	T/C	cg25817165	chr18:72167213	CNDP2	-0.65	-5.21	-0.51	1.51e-6	Refractive error;
SKCM	cis	rs6459788	0.685	rs13226469	chr7:157235777	G/A	cg03453431	chr7:157225567	NA	-0.67	-4.77	-0.48	8.48e-6	Epstein-Barr virus copy number in lymphoblastoid cell lines;
SKCM	cis	rs7945705	0.967	rs10769968	chr11:8907583	G/C	cg21881798	chr11:8931708	C11orf17;ST5	0.77	7.81	0.66	2.17e-11	Hemoglobin concentration;
SKCM	cis	rs2204008	0.715	rs11495369	chr12:38238673	T/C	cg13010199	chr12:38710504	ALG10B	0.69	4.99	0.49	3.57e-6	Bladder cancer;
SKCM	cis	rs1348850	0.668	rs13034886	chr2:178493301	G/T	cg27490568	chr2:178487706	NA	0.79	5.95	0.56	7.25e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs9911578	0.933	rs74370218	chr17:57095212	C/T	cg05425664	chr17:57184151	TRIM37	0.83	6.79	0.61	1.97e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs1691799	0.899	rs1168301	chr12:66736771	C/T	cg16791601	chr12:66731901	HELB	-0.59	-4.97	-0.49	3.83e-6	White blood cell count (basophil);
SKCM	cis	rs13010713	0.840	rs12616042	chr2:182062879	G/A	cg21995919	chr2:182322279	ITGA4	-0.53	-5.11	-0.5	2.2e-6	Celiac disease;
SKCM	cis	rs854765	0.618	rs8066982	chr17:17851377	T/C	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.01	7.49	0.65	9.28e-11	Total body bone mineral density;
SKCM	cis	rs10489202	0.632	rs203781	chr1:167880518	A/C	cg24449463	chr1:168025552	DCAF6	-0.77	-7.04	-0.62	6.73e-10	Schizophrenia;
SKCM	cis	rs3785574	0.650	rs2005132	chr17:62008232	T/C	cg11494091	chr17:61959527	GH2	-0.56	-5.4	-0.52	7.11e-7	Height;
SKCM	cis	rs4938330	0.512	rs4938327	chr11:116906728	T/C	cg01368799	chr11:117014884	PAFAH1B2	-0.65	-5.08	-0.5	2.55e-6	Blood protein levels;
SKCM	cis	rs875971	0.508	rs10253883	chr7:66061138	T/C	cg18876405	chr7:65276391	NA	-0.8	-7.2	-0.63	3.28e-10	Aortic root size;
SKCM	cis	rs7772486	0.558	rs7753273	chr6:146066039	C/T	cg05347473	chr6:146136440	FBXO30	-0.7	-6.36	-0.58	1.27e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs244731	0.959	rs918459	chr5:176669030	C/T	cg06060754	chr5:176797920	RGS14	-0.71	-6.57	-0.6	5.14e-9	Urate levels in lean individuals;
SKCM	cis	rs875971	1.000	rs6961155	chr7:65933295	T/C	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs6546550	0.935	rs7563062	chr2:70050725	G/A	cg02498382	chr2:70120550	SNRNP27	-0.46	-5.18	-0.51	1.66e-6	Prevalent atrial fibrillation;
SKCM	cis	rs929354	0.806	rs28446734	chr7:156996775	T/C	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs1799949	1.000	rs8077486	chr17:41212805	C/T	cg23758822	chr17:41437982	NA	0.93	7.57	0.65	6.52e-11	Menopause (age at onset);
SKCM	cis	rs6088580	0.634	rs6119497	chr20:33012529	T/A	cg24642439	chr20:33292090	TP53INP2	0.76	6.02	0.56	5.28e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs7772486	0.790	rs2265918	chr6:146219164	A/G	cg05347473	chr6:146136440	FBXO30	0.56	5.18	0.51	1.67e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4523957	0.583	rs2760741	chr17:2020443	C/T	cg16513277	chr17:2031491	SMG6	-0.81	-5.98	-0.56	6.24e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs2857078	0.720	rs9906669	chr17:42305706	A/G	cg09913183	chr17:42254507	C17orf65;ASB16	0.6	5.25	0.51	1.3e-6	Red cell distribution width;Reticulocyte count;
SKCM	cis	rs3820928	0.874	rs4234062	chr2:227819050	C/A	cg11843606	chr2:227700838	RHBDD1	-0.6	-4.81	-0.48	7.34e-6	Pulmonary function;
SKCM	cis	rs995000	0.868	rs1168102	chr1:63127705	C/T	cg06896770	chr1:63153194	DOCK7	-0.75	-7.28	-0.64	2.33e-10	Triglyceride levels;
SKCM	trans	rs3780486	0.846	rs12554995	chr9:33132044	A/G	cg20290983	chr6:43655470	MRPS18A	1.0	11.51	0.79	1.7e-18	IgG glycosylation;
SKCM	cis	rs9902453	0.838	rs3110495	chr17:27978455	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.82	-5.78	-0.55	1.47e-7	Coffee consumption (cups per day);
SKCM	cis	rs7618501	0.633	rs2353579	chr3:50027774	C/T	cg24110177	chr3:50126178	RBM5	-0.6	-5.11	-0.5	2.25e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs3859192	0.537	rs12309	chr17:38175462	C/T	cg17467752	chr17:38218738	THRA	-0.75	-6.28	-0.58	1.75e-8	White blood cell count;
SKCM	cis	rs60871478	1.000	rs62432860	chr7:807522	G/C	cg05535760	chr7:792225	HEATR2	1.02	8.66	0.7	4.97e-13	Cerebrospinal P-tau181p levels;
SKCM	cis	rs709400	0.597	rs1013650	chr14:103909203	G/A	cg26031613	chr14:104095156	KLC1	0.74	5.44	0.52	5.98e-7	Body mass index;
SKCM	cis	rs9916302	0.904	rs12452509	chr17:37574722	G/A	cg07936489	chr17:37558343	FBXL20	-0.85	-7.35	-0.64	1.71e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs116095464	0.558	rs62344300	chr5:246336	A/G	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs10504073	0.647	rs10435612	chr8:49993696	A/T	cg00325661	chr8:49890786	NA	0.78	6.77	0.61	2.18e-9	Blood metabolite ratios;
SKCM	cis	rs11098499	0.863	rs36040693	chr4:120477616	A/G	cg24375607	chr4:120327624	NA	0.69	5.47	0.53	5.35e-7	Corneal astigmatism;
SKCM	cis	rs6105452	0.524	rs6110752	chr20:15684087	T/C	cg04678219	chr20:16554259	KIF16B	0.84	4.79	0.48	7.67e-6	Epstein-Barr virus copy number in lymphoblastoid cell lines;
SKCM	cis	rs2463822	1.000	rs12279819	chr11:62137245	G/A	cg06239285	chr11:62104954	ASRGL1	-1.26	-5.85	-0.55	1.08e-7	Chronic obstructive pulmonary disease-related biomarkers;
SKCM	cis	rs28374715	0.532	rs11070328	chr15:41651569	T/C	cg18705301	chr15:41695430	NDUFAF1	-1.16	-12.24	-0.81	7.71e-20	Ulcerative colitis;
SKCM	cis	rs2361718	0.500	rs4889818	chr17:78085228	A/G	cg09238746	chr17:78121135	EIF4A3	-0.94	-7.39	-0.64	1.39e-10	Yeast infection;
SKCM	cis	rs4237845	0.537	rs10877031	chr12:58266695	A/G	cg00677455	chr12:58241039	CTDSP2	0.9	8.16	0.68	4.55e-12	Intelligence (multi-trait analysis);
SKCM	cis	rs9583531	0.600	rs7986286	chr13:111357207	A/G	cg24331049	chr13:111365604	ING1	0.87	6.47	0.59	7.9e-9	Coronary artery disease;
SKCM	cis	rs9300255	0.770	rs7980687	chr12:123822711	G/A	cg05973401	chr12:123451056	ABCB9	-0.82	-5.72	-0.54	1.92e-7	Neutrophil percentage of white cells;
SKCM	cis	rs10751667	0.643	rs10902237	chr11:944801	C/A	cg10932868	chr11:921992	NA	0.55	4.93	0.49	4.54e-6	Alzheimer's disease (late onset);
SKCM	cis	rs1153858	1.000	rs11852800	chr15:45639131	A/G	cg10760299	chr15:45669010	GATM	-0.59	-6.24	-0.58	2.11e-8	Homoarginine levels;
SKCM	cis	rs1669338	0.588	rs62228620	chr3:3184913	C/T	cg16797762	chr3:3221439	CRBN	-1.06	-5.9	-0.56	8.84e-8	White matter integrity;
SKCM	cis	rs8077889	0.956	rs17742347	chr17:41846468	A/G	cg26893861	chr17:41843967	DUSP3	-1.22	-7.97	-0.67	1.1e-11	Triglycerides;
SKCM	cis	rs28374715	0.783	rs11635269	chr15:41570710	A/G	cg18705301	chr15:41695430	NDUFAF1	-1.03	-10.02	-0.75	1.17e-15	Ulcerative colitis;
SKCM	cis	rs1707322	0.686	rs3014236	chr1:46091305	T/C	cg03146154	chr1:46216737	IPP	-0.83	-6.17	-0.57	2.83e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs951366	0.789	rs823121	chr1:205724302	A/G	cg07167872	chr1:205819463	PM20D1	-0.97	-8.28	-0.68	2.65e-12	Menarche (age at onset);
SKCM	cis	rs1218582	0.772	rs4240875	chr1:154885782	G/A	cg03351412	chr1:154909251	PMVK	0.77	6.52	0.59	6.43e-9	Prostate cancer;
SKCM	cis	rs1003719	0.699	rs1015549	chr21:38448880	T/C	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs208520	0.955	rs208532	chr6:66961280	T/A	cg07460842	chr6:66804631	NA	-0.84	-5.89	-0.55	9.44e-8	Exhaled nitric oxide output;
SKCM	cis	rs10256972	0.527	rs28671326	chr7:1174973	G/A	cg09177884	chr7:1199841	ZFAND2A	-0.8	-6.44	-0.59	9e-9	Longevity;Endometriosis;
SKCM	cis	rs116095464	0.558	rs9688045	chr5:254035	T/C	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs73201462	0.803	rs2811478	chr3:127899624	C/T	cg09089421	chr3:127803668	RUVBL1	1.0	5.11	0.5	2.22e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs548181	0.611	rs1293672	chr11:125461034	A/G	cg03464685	chr11:125439445	EI24	1.48	8.61	0.7	6.27e-13	Schizophrenia;Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);
SKCM	cis	rs4820539	0.966	rs5996470	chr22:23483255	G/A	cg14186256	chr22:23484241	RTDR1	0.87	8.8	0.71	2.6e-13	Bone mineral density;
SKCM	cis	rs34779708	0.966	rs10827491	chr10:35427395	G/A	cg03585969	chr10:35415529	CREM	0.74	6.04	0.56	4.96e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs1850744	0.826	rs7661082	chr4:9755665	C/G	cg15442990	chr4:9534313	NA	1.39	4.81	0.48	7.32e-6	Economic and political preferences;
SKCM	cis	rs10504229	0.679	rs11783963	chr8:58130496	T/A	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs12682352	0.602	rs4841044	chr8:8664940	A/G	cg15556689	chr8:8085844	FLJ10661	-0.65	-5.38	-0.52	7.72e-7	Neuroticism;
SKCM	cis	rs62238980	0.614	rs117195584	chr22:32390013	C/A	cg00543991	chr22:32367038	NA	1.15	4.87	0.48	5.76e-6	Childhood ear infection;
SKCM	cis	rs7635838	0.718	rs2594979	chr3:11381910	T/G	cg00170343	chr3:11313890	ATG7	0.7	5.54	0.53	3.93e-7	HDL cholesterol;
SKCM	cis	rs6879260	1.000	rs888922	chr5:179731635	C/G	cg23248424	chr5:179741104	GFPT2	-0.69	-5.95	-0.56	7.25e-8	Height;
SKCM	cis	rs8180040	0.800	rs2088135	chr3:47280018	T/C	cg27129171	chr3:47204927	SETD2	-0.79	-5.38	-0.52	7.6e-7	Colorectal cancer;
SKCM	cis	rs10883723	0.810	rs10883729	chr10:104273943	A/G	cg11453585	chr10:104263688	ACTR1A;SUFU	0.77	6.31	0.58	1.56e-8	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs7221595	0.756	rs12603448	chr17:3949934	A/G	cg23770271	chr17:3704471	ITGAE	-0.5	-4.95	-0.49	4.11e-6	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia;
SKCM	cis	rs17685	0.712	rs11770149	chr7:75791644	G/A	cg16489192	chr7:75678113	MDH2;STYXL1	-0.54	-5.03	-0.49	3.07e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs875971	1.000	rs709595	chr7:65817333	G/C	cg18876405	chr7:65276391	NA	0.68	6.78	0.61	2.03e-9	Aortic root size;
SKCM	cis	rs867186	1.000	rs945961	chr20:33769926	A/G	cg04194272	chr20:33683537	NA	-1.02	-5.4	-0.52	7.03e-7	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs67311347	0.955	rs9821036	chr3:40379007	A/G	cg00091569	chr3:40428383	ENTPD3	0.65	5.58	0.53	3.36e-7	Renal cell carcinoma;
SKCM	cis	rs17685	0.593	rs56265719	chr7:75796269	C/T	cg16489192	chr7:75678113	MDH2;STYXL1	-0.54	-5.03	-0.49	3.07e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs9910055	0.747	rs2905981	chr17:42238625	C/T	cg19774624	chr17:42201019	HDAC5	-0.89	-7.83	-0.66	1.97e-11	Total body bone mineral density;
SKCM	cis	rs28595532	0.920	rs114414928	chr4:119728188	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.43	0.59	9.38e-9	Cannabis dependence symptom count;
SKCM	cis	rs7843479	0.930	rs4871903	chr8:21827833	C/T	cg17168535	chr8:21777572	XPO7	-0.71	-5.24	-0.51	1.34e-6	Mean corpuscular volume;
SKCM	cis	rs4073582	0.595	rs10896104	chr11:66001869	C/T	cg14036092	chr11:66035641	RAB1B	0.75	5.91	0.56	8.39e-8	Gout;
SKCM	cis	rs3008870	1.000	rs3008855	chr1:67386204	A/G	cg08660285	chr1:67390436	MIER1;WDR78	-0.97	-6.53	-0.59	6.04e-9	Lymphocyte percentage of white cells;
SKCM	cis	rs10504073	0.584	rs115370638	chr8:49916452	A/G	cg00325661	chr8:49890786	NA	0.79	7.15	0.63	3.99e-10	Blood metabolite ratios;
SKCM	cis	rs2842992	0.915	rs1322427	chr6:160075454	C/A	cg19482086	chr6:160211437	TCP1;MRPL18	0.82	5.72	0.54	1.86e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs1799949	0.965	rs11654051	chr17:41419656	C/T	cg05368731	chr17:41323189	NBR1	0.85	7.32	0.64	1.89e-10	Menopause (age at onset);
SKCM	cis	rs507080	0.883	rs12798453	chr11:118561410	T/G	cg18045108	chr11:118530628	TREH	-0.47	-4.81	-0.48	7.17e-6	Serum metabolite levels;
SKCM	cis	rs7811142	0.830	rs6945952	chr7:99981775	A/G	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.19	7.5	0.65	8.66e-11	Platelet count;
SKCM	cis	rs12824058	0.831	rs4759451	chr12:130812739	G/A	cg26677194	chr12:130822605	PIWIL1	0.71	5.83	0.55	1.17e-7	Menopause (age at onset);
SKCM	cis	rs1577917	0.958	rs1591437	chr6:86525305	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.66	-5.78	-0.55	1.44e-7	Response to antipsychotic treatment;
SKCM	cis	rs35264875	0.851	rs7933746	chr11:68867722	A/G	cg02660097	chr11:68866761	NA	0.55	5.25	0.51	1.27e-6	Blond vs. brown hair color;
SKCM	cis	rs514406	0.679	rs11206006	chr1:53218380	A/G	cg16325326	chr1:53192061	ZYG11B	-0.64	-5.02	-0.49	3.17e-6	Monocyte count;
SKCM	cis	rs9915657	0.966	rs8071717	chr17:70128705	C/T	cg06234051	chr17:70120541	SOX9	-0.59	-5.1	-0.5	2.32e-6	Thyroid hormone levels;
SKCM	cis	rs1577917	1.000	rs12201741	chr6:86602619	G/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.67	-5.89	-0.55	9.22e-8	Response to antipsychotic treatment;
SKCM	cis	rs3008870	0.883	rs2755249	chr1:67493662	A/G	cg08660285	chr1:67390436	MIER1;WDR78	0.95	6.51	0.59	6.68e-9	Lymphocyte percentage of white cells;
SKCM	cis	rs7944584	0.563	rs2280231	chr11:47600438	C/T	cg20307385	chr11:47447363	PSMC3	0.86	5.81	0.55	1.28e-7	Fasting blood glucose;Fasting blood glucose (BMI interaction);
SKCM	cis	rs11098499	0.954	rs7437420	chr4:120312903	A/G	cg24375607	chr4:120327624	NA	0.65	4.97	0.49	3.87e-6	Corneal astigmatism;
SKCM	cis	rs7215564	0.908	rs756077	chr17:78663071	A/G	cg16980736	chr17:78789706	RPTOR	-0.88	-4.77	-0.48	8.37e-6	Myopia (pathological);
SKCM	cis	rs9325144	0.650	rs6582624	chr12:38733475	A/T	cg13010199	chr12:38710504	ALG10B	-0.65	-5.34	-0.52	8.96e-7	Morning vs. evening chronotype;
SKCM	cis	rs10504073	0.584	rs11786103	chr8:49904077	A/G	cg00325661	chr8:49890786	NA	0.79	7.15	0.63	3.99e-10	Blood metabolite ratios;
SKCM	cis	rs995000	0.931	rs598253	chr1:62911341	T/C	cg06896770	chr1:63153194	DOCK7	0.76	7.24	0.63	2.71e-10	Triglyceride levels;
SKCM	cis	rs4803468	1.000	rs11670757	chr19:41913431	G/T	cg09537434	chr19:41945824	ATP5SL	-1.1	-13.82	-0.84	1.16e-22	Height;
SKCM	trans	rs17685	0.633	rs3801471	chr7:75696188	T/G	cg19862616	chr7:65841803	NCRNA00174	0.96	9.42	0.73	1.67e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs10207060	0.500	rs10177457	chr2:240708067	G/A	cg07506560	chr2:240697449	NA	0.75	6.1	0.57	3.8e-8	Obesity-related traits;
SKCM	cis	rs6500395	0.926	rs11076571	chr16:48598064	A/G	cg04672837	chr16:48644449	N4BP1	0.69	5.73	0.54	1.8e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs6066825	0.644	rs761271	chr20:47315637	A/G	cg18078177	chr20:47281410	PREX1	0.64	5.2	0.51	1.57e-6	Colorectal cancer;
SKCM	cis	rs8180040	0.701	rs11130111	chr3:47009805	C/T	cg27129171	chr3:47204927	SETD2	0.79	6.01	0.56	5.49e-8	Colorectal cancer;
SKCM	cis	rs507080	0.922	rs502601	chr11:118565679	G/A	cg18045108	chr11:118530628	TREH	-0.47	-5.13	-0.5	2.06e-6	Serum metabolite levels;
SKCM	cis	rs910316	1.000	rs7303	chr14:75520065	T/C	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.85e-7	Height;
SKCM	cis	rs28595532	0.920	rs115688334	chr4:119770805	C/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs1707322	1.000	rs10890381	chr1:46451771	T/G	cg03146154	chr1:46216737	IPP	0.78	5.2	0.51	1.57e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs9325144	0.505	rs10785560	chr12:38636622	C/T	cg13010199	chr12:38710504	ALG10B	0.66	5.23	0.51	1.39e-6	Morning vs. evening chronotype;
SKCM	cis	rs7690543	1.000	rs10017714	chr4:68056023	A/T	cg02995770	chr4:68929413	TMPRSS11F;SYT14L	1.01	5.28	0.51	1.15e-6	Glucose homeostasis traits;
SKCM	cis	rs4862750	0.872	rs7671914	chr4:187878165	A/G	cg10295955	chr4:187884368	NA	-1.04	-14.12	-0.85	3.41e-23	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2737618	0.722	rs1986405	chr1:200095935	C/G	cg21825944	chr1:200113062	NR5A2	-0.6	-4.88	-0.48	5.43e-6	Uric acid levels;
SKCM	cis	rs10870270	0.957	rs3753008	chr10:133785129	A/C	cg17892150	chr10:133769511	PPP2R2D	-0.67	-5.25	-0.51	1.25e-6	Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals;
SKCM	cis	rs1680005	0.533	rs2776797	chr6:37173085	C/T	cg22902977	chr6:37282124	TBC1D22B	-0.71	-4.9	-0.48	5.19e-6	Bipolar disorder with mood-incongruent psychosis;
SKCM	cis	rs2806561	0.514	rs11801120	chr1:23543307	C/T	cg19743168	chr1:23544995	NA	0.64	4.9	0.49	5.07e-6	Height;
SKCM	cis	rs7829975	0.742	rs1533058	chr8:8685190	A/G	cg06636001	chr8:8085503	FLJ10661	0.76	7.08	0.63	5.45e-10	Mood instability;
SKCM	cis	rs9660180	0.839	rs12040826	chr1:1705287	A/C	cg23982607	chr1:1823379	GNB1	-0.74	-6.65	-0.6	3.67e-9	Body mass index;
SKCM	cis	rs4523957	0.583	rs2957926	chr17:2024030	C/T	cg16513277	chr17:2031491	SMG6	-0.81	-5.98	-0.56	6.24e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs523522	0.962	rs2235218	chr12:120888619	A/C	cg12219531	chr12:120966889	COQ5	0.88	7.17	0.63	3.67e-10	High light scatter reticulocyte count;
SKCM	cis	rs8037137	0.822	rs2890156	chr15:91513157	T/A	cg15878949	chr15:91534302	PRC1	0.67	5.12	0.5	2.11e-6	Platelet count;Serous invasive ovarian cancer;High-grade serous ovarian cancer;Invasive epithelial ovarian cancer;
SKCM	cis	rs6430585	0.702	rs73958637	chr2:136546927	C/T	cg07169764	chr2:136633963	MCM6	1.32	13.34	0.83	7.99e-22	Corneal structure;
SKCM	cis	rs13217239	0.646	rs6937880	chr6:27000236	C/T	cg12292205	chr6:26970375	C6orf41	0.63	5.64	0.54	2.58e-7	Schizophrenia;
SKCM	cis	rs6952808	0.798	rs28970524	chr7:1927484	C/T	cg02951883	chr7:2050386	MAD1L1	-0.72	-5.92	-0.56	8.26e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs6570726	0.935	rs406343	chr6:145874388	A/G	cg23711669	chr6:146136114	FBXO30	0.73	6.9	0.62	1.21e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4819052	1.000	rs733738	chr21:46666396	A/G	cg02159808	chr21:46707872	POFUT2;LOC642852	-0.77	-5.45	-0.53	5.66e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7523050	0.643	rs12752417	chr1:109400639	A/C	cg08274380	chr1:109419600	GPSM2	-1.31	-6.21	-0.58	2.37e-8	Fat distribution (HIV);
SKCM	cis	rs17376456	0.569	rs6879620	chr5:93119893	G/A	cg25358565	chr5:93447407	FAM172A	-0.86	-5.45	-0.53	5.59e-7	Diabetic retinopathy;
SKCM	cis	rs2811415	0.531	rs9819578	chr3:127793438	C/T	cg09089421	chr3:127803668	RUVBL1	0.89	5.62	0.54	2.83e-7	Lung function (FEV1/FVC);
SKCM	cis	rs6500395	1.000	rs1120276	chr16:48598517	C/G	cg04672837	chr16:48644449	N4BP1	0.69	5.73	0.54	1.8e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs8060686	0.641	rs78537727	chr16:68120606	A/G	cg04539111	chr16:67997858	SLC12A4	-0.85	-4.81	-0.48	7.14e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs9475752	0.793	rs71564871	chr6:56830895	G/T	cg06815302	chr6:57335405	PRIM2	0.59	4.78	0.48	8.1e-6	Menarche (age at onset);
SKCM	cis	rs6424115	0.708	rs2076343	chr1:24129126	A/G	cg15997130	chr1:24165203	NA	-0.66	-5.61	-0.54	3.01e-7	Immature fraction of reticulocytes;
SKCM	cis	rs6089584	0.888	rs6061973	chr20:60610870	C/T	cg06108461	chr20:60628389	TAF4	-0.89	-8.72	-0.7	3.75e-13	Body mass index;
SKCM	cis	rs742614	0.576	rs2747537	chr20:32405217	A/G	cg06304546	chr20:32448765	NA	-0.73	-5.9	-0.56	8.93e-8	Stearic acid (18:0) levels;
SKCM	cis	rs2439831	0.867	rs2447211	chr15:43936351	G/A	cg02155558	chr15:43621948	ADAL;LCMT2	1.31	7.38	0.64	1.49e-10	Lung cancer in ever smokers;
SKCM	cis	rs2304069	0.826	rs2244195	chr5:149403528	C/A	cg22760475	chr5:149380129	HMGXB3;TIGD6	0.79	5.92	0.56	8.17e-8	HIV-1 control;
SKCM	cis	rs7179456	0.545	rs507801	chr15:59053345	T/G	cg05156742	chr15:59063176	FAM63B	0.81	5.98	0.56	6.24e-8	Asperger disorder;
SKCM	cis	rs3096299	0.730	rs3102373	chr16:89398622	T/C	cg08822215	chr16:89438651	ANKRD11	-0.53	-4.89	-0.48	5.23e-6	Multiple myeloma (IgH translocation);
SKCM	cis	rs6951245	0.872	rs75398423	chr7:1098414	T/G	cg18402987	chr7:1209562	NA	1.15	6.09	0.57	3.95e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs1348850	0.597	rs13014417	chr2:178417835	T/G	cg02961200	chr2:178257176	LOC100130691;AGPS	0.83	4.83	0.48	6.6e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs9910055	0.639	rs227583	chr17:42231698	C/G	cg13607699	chr17:42295918	UBTF	0.71	5.65	0.54	2.53e-7	Total body bone mineral density;
SKCM	cis	rs9910055	0.530	rs2269906	chr17:42294337	G/T	cg19774624	chr17:42201019	HDAC5	0.78	6.39	0.59	1.12e-8	Total body bone mineral density;
SKCM	cis	rs2559856	1.000	rs2695282	chr12:102089502	A/G	cg12924262	chr12:102091054	CHPT1	-0.64	-5.36	-0.52	8.05e-7	Blood protein levels;
SKCM	cis	rs1395	0.778	rs1439768	chr2:27389660	C/A	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.5	4.99	0.49	3.65e-6	Blood metabolite levels;
SKCM	cis	rs3091242	0.866	rs11249249	chr1:25758134	A/G	cg02931644	chr1:25747376	RHCE	0.5	4.88	0.48	5.43e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs6545883	0.929	rs778140	chr2:61682976	C/T	cg15711740	chr2:61764176	XPO1	-0.7	-4.93	-0.49	4.5e-6	Tuberculosis;
SKCM	cis	rs9902453	0.808	rs12452288	chr17:28235220	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.79	5.67	0.54	2.35e-7	Coffee consumption (cups per day);
SKCM	cis	rs7216064	1.000	rs55896768	chr17:65913358	T/C	cg12091567	chr17:66097778	LOC651250	-0.78	-5.34	-0.52	8.92e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs2463822	0.688	rs7121684	chr11:62162389	T/C	cg06239285	chr11:62104954	ASRGL1	-1.25	-5.93	-0.56	7.79e-8	Chronic obstructive pulmonary disease-related biomarkers;
SKCM	cis	rs2730245	0.636	rs710421	chr7:158668575	T/C	cg24397884	chr7:158709396	WDR60	0.67	5.18	0.51	1.68e-6	Height;
SKCM	cis	rs67311347	1.000	rs4973878	chr3:40407565	C/T	cg00091569	chr3:40428383	ENTPD3	0.61	5.36	0.52	8.37e-7	Renal cell carcinoma;
SKCM	cis	rs4243830	0.850	rs6679649	chr1:6606608	C/T	cg22792644	chr1:6614718	TAS1R1;NOL9	1.12	5.72	0.54	1.85e-7	Body mass index;
SKCM	cis	rs7100689	0.555	rs1934146	chr10:82062121	C/A	cg00277334	chr10:82204260	NA	-0.57	-5.35	-0.52	8.66e-7	Post bronchodilator FEV1;
SKCM	cis	rs654950	0.875	rs55865698	chr1:41986758	C/T	cg06885757	chr1:42089581	HIVEP3	-0.63	-7.1	-0.63	5.13e-10	Airway imaging phenotypes;
SKCM	cis	rs6570726	0.846	rs453834	chr6:145886261	T/C	cg05347473	chr6:146136440	FBXO30	0.53	4.87	0.48	5.65e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs854765	0.647	rs8066764	chr17:17974668	C/T	cg04398451	chr17:18023971	MYO15A	-1.03	-8.95	-0.71	1.35e-13	Total body bone mineral density;
SKCM	cis	rs7666738	0.800	rs13107147	chr4:99028753	C/T	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7772486	0.686	rs6570701	chr6:145954090	A/G	cg23711669	chr6:146136114	FBXO30	0.88	9.43	0.73	1.6e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4906332	0.811	rs2021965	chr14:103997248	C/A	cg04998671	chr14:104000505	TRMT61A	0.72	4.87	0.48	5.65e-6	Coronary artery disease;
SKCM	cis	rs7666738	0.893	rs11729640	chr4:99052699	C/T	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1552244	0.882	rs13062917	chr3:10017032	T/A	cg02579736	chr3:10068473	FANCD2;CIDECP	0.94	4.84	0.48	6.49e-6	Alzheimer's disease;
SKCM	cis	rs929354	1.000	rs1182389	chr7:157038803	C/T	cg17757837	chr7:157058334	UBE3C	0.86	6.34	0.58	1.4e-8	Body mass index;
SKCM	cis	rs11098499	0.908	rs11729050	chr4:120300066	T/C	cg24375607	chr4:120327624	NA	0.65	4.97	0.49	3.87e-6	Corneal astigmatism;
SKCM	cis	rs6570726	0.791	rs9322029	chr6:145906683	A/G	cg23711669	chr6:146136114	FBXO30	0.88	8.32	0.69	2.28e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7618501	0.633	rs6771546	chr3:49968572	T/C	cg24110177	chr3:50126178	RBM5	-0.6	-5.1	-0.5	2.36e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1153858	1.000	rs2461701	chr15:45703391	G/A	cg10760299	chr15:45669010	GATM	0.61	5.9	0.56	8.99e-8	Homoarginine levels;
SKCM	cis	rs6570726	0.935	rs371744	chr6:145841024	C/T	cg23711669	chr6:146136114	FBXO30	0.73	7.14	0.63	4.25e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs11608355	0.521	rs7976839	chr12:109830534	C/A	cg19025524	chr12:109796872	NA	-0.68	-6.2	-0.57	2.49e-8	Neuroticism;
SKCM	cis	rs829883	1.000	rs2908843	chr12:98889332	C/G	cg25150519	chr12:98850993	NA	-0.5	-5.38	-0.52	7.42e-7	Colorectal adenoma (advanced);
SKCM	cis	rs1348850	0.914	rs12104588	chr2:178253675	G/A	cg02961200	chr2:178257176	LOC100130691;AGPS	0.94	7.09	0.63	5.29e-10	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs9325144	0.647	rs61931899	chr12:38892422	A/G	cg26384229	chr12:38710491	ALG10B	-0.73	-6.25	-0.58	2.04e-8	Morning vs. evening chronotype;
SKCM	cis	rs35306767	0.761	rs11253557	chr10:1043667	C/T	cg25614935	chr10:1084866	C10orf110	0.75	6.0	0.56	5.85e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs6951245	0.706	rs28685743	chr7:1197736	C/T	cg18402987	chr7:1209562	NA	1.14	6.56	0.6	5.37e-9	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs950776	0.518	rs4243083	chr15:78833830	C/G	cg06917634	chr15:78832804	PSMA4	-1.01	-10.48	-0.76	1.5e-16	Sudden cardiac arrest;
SKCM	cis	rs6977660	0.714	rs6954046	chr7:19820388	G/A	cg05791153	chr7:19748676	TWISTNB	0.79	4.82	0.48	6.91e-6	Thyroid stimulating hormone;
SKCM	cis	rs6062302	0.522	rs3787112	chr20:62222411	G/A	cg09650180	chr20:62225654	GMEB2	-0.77	-6.11	-0.57	3.64e-8	Glioblastoma;
SKCM	cis	rs10028773	0.506	rs12374346	chr4:120281705	G/A	cg24375607	chr4:120327624	NA	0.62	4.77	0.48	8.45e-6	Educational attainment;
SKCM	cis	rs3784262	0.679	rs11071366	chr15:58334244	A/T	cg12031962	chr15:58353849	ALDH1A2	-0.46	-6.01	-0.56	5.67e-8	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs10256972	0.514	rs2140578	chr7:1214003	T/C	cg07092213	chr7:1199455	ZFAND2A	-0.68	-5.6	-0.54	3.12e-7	Longevity;Endometriosis;
SKCM	cis	rs7666738	0.791	rs13149968	chr4:99070262	G/T	cg17366294	chr4:99064904	C4orf37	0.61	4.93	0.49	4.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7666738	0.753	rs7657644	chr4:99057734	T/A	cg05340658	chr4:99064831	C4orf37	0.66	4.87	0.48	5.74e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1153858	1.000	rs66528868	chr15:45668547	A/C	cg21132104	chr15:45694354	SPATA5L1	0.93	7.94	0.67	1.22e-11	Homoarginine levels;
SKCM	cis	rs6547741	1.000	rs1528404	chr2:27846603	C/T	cg27432699	chr2:27873401	GPN1	-0.75	-6.74	-0.61	2.45e-9	Oral cavity cancer;
SKCM	cis	rs13010713	0.840	rs4514841	chr2:182052045	G/C	cg21995919	chr2:182322279	ITGA4	-0.54	-5.29	-0.51	1.1e-6	Celiac disease;
SKCM	cis	rs116095464	0.558	rs12173015	chr5:269967	A/C	cg22496380	chr5:211416	CCDC127	1.01	5.44	0.52	5.96e-7	Breast cancer;
SKCM	cis	rs28830936	0.625	rs8038764	chr15:41907905	A/C	cg17847044	chr15:42102381	MAPKBP1	0.43	5.47	0.53	5.21e-7	Diastolic blood pressure;
SKCM	cis	rs7772486	0.754	rs9399567	chr6:146147295	C/T	cg05347473	chr6:146136440	FBXO30	0.59	5.52	0.53	4.35e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2562152	0.654	rs216600	chr16:110165	T/C	cg02949481	chr16:131562	MPG	0.6	4.87	0.48	5.72e-6	Glioblastoma;
SKCM	cis	rs17711722	0.523	rs313812	chr7:65505043	T/C	cg18876405	chr7:65276391	NA	-0.64	-4.95	-0.49	4.11e-6	Calcium levels;
SKCM	cis	rs4665809	0.590	rs4665321	chr2:26433801	A/C	cg26119090	chr2:26468346	HADHA;HADHB	-1.05	-8.25	-0.68	3.13e-12	Gut microbiome composition (summer);
SKCM	cis	rs769267	0.965	rs13964	chr19:19468710	C/G	cg26732615	chr19:19648335	CILP2;YJEFN3	-0.66	-6.06	-0.57	4.59e-8	Tonsillectomy;
SKCM	cis	rs7772486	0.754	rs9373475	chr6:146126419	C/T	cg05347473	chr6:146136440	FBXO30	0.61	5.8	0.55	1.37e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4560672	0.938	rs866662	chr6:158545673	G/A	cg10592926	chr6:157876961	ZDHHC14	-0.53	-5.21	-0.51	1.49e-6	Smoking quantity;
SKCM	cis	rs17826219	0.706	rs8071236	chr17:29100002	T/C	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Body mass index;
SKCM	cis	rs769267	0.929	rs2905431	chr19:19482882	G/A	cg26732615	chr19:19648335	CILP2;YJEFN3	-0.69	-7.14	-0.63	4.27e-10	Tonsillectomy;
SKCM	cis	rs7811142	1.000	rs2406255	chr7:100053690	T/C	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.12	6.51	0.59	6.68e-9	Platelet count;
SKCM	cis	rs6500395	0.962	rs9937568	chr16:48612361	C/T	cg04672837	chr16:48644449	N4BP1	-0.68	-5.86	-0.55	1.07e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs1790761	0.520	rs1551884	chr11:67399601	C/G	cg14500267	chr11:67383377	NA	-0.52	-5.31	-0.52	1.01e-6	Mean corpuscular volume;
SKCM	cis	rs17826219	0.706	rs28469200	chr17:29133572	T/A	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Body mass index;
SKCM	trans	rs62103177	0.733	rs62096748	chr18:77619699	T/C	cg05926928	chr17:57297772	GDPD1	1.29	8.74	0.7	3.44e-13	Opioid sensitivity;
SKCM	cis	rs344364	0.511	rs62040571	chr16:1948514	C/G	cg26897989	chr16:1907736	C16orf73	-0.69	-7.13	-0.63	4.45e-10	Glomerular filtration rate in chronic kidney disease;
SKCM	cis	rs7843479	0.511	rs4379446	chr8:21777595	C/G	cg17168535	chr8:21777572	XPO7	0.82	7.46	0.65	1.02e-10	Mean corpuscular volume;
SKCM	cis	rs28386778	0.897	rs716880	chr17:61902822	C/G	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs11651000	0.857	rs56172120	chr17:45824904	G/A	cg24803719	chr17:45855879	NA	-0.53	-5.04	-0.5	2.93e-6	IgG glycosylation;
SKCM	cis	rs17376456	0.825	rs13357713	chr5:93145423	T/C	cg25358565	chr5:93447407	FAM172A	1.19	7.78	0.66	2.52e-11	Diabetic retinopathy;
SKCM	cis	rs1577917	0.739	rs2758846	chr6:86349570	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.83	-7.64	-0.65	4.74e-11	Response to antipsychotic treatment;
SKCM	cis	rs9420	0.961	rs527528	chr11:57433327	C/T	cg19752551	chr11:57585705	CTNND1	-0.74	-7.31	-0.64	2.01e-10	Schizophrenia;
SKCM	cis	rs2777491	0.957	rs8027626	chr15:41711514	T/G	cg18705301	chr15:41695430	NDUFAF1	-0.9	-9.24	-0.72	3.67e-14	Ulcerative colitis;
SKCM	cis	rs2013441	1.000	rs2526475	chr17:20136216	T/C	cg13482628	chr17:19912719	NA	-0.64	-5.04	-0.5	2.94e-6	Obesity-related traits;
SKCM	cis	rs7100689	0.646	rs2486302	chr10:82076600	G/A	cg01528321	chr10:82214614	TSPAN14	0.76	6.29	0.58	1.72e-8	Post bronchodilator FEV1;
SKCM	cis	rs9911578	1.000	rs304296	chr17:56834229	G/T	cg05425664	chr17:57184151	TRIM37	-0.69	-5.21	-0.51	1.52e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs11098499	0.954	rs3733523	chr4:120423719	C/T	cg24375607	chr4:120327624	NA	0.66	5.13	0.5	2.07e-6	Corneal astigmatism;
SKCM	cis	rs1707322	0.686	rs2991979	chr1:46055858	A/G	cg03146154	chr1:46216737	IPP	-0.73	-4.85	-0.48	6.27e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs9910055	0.571	rs28897216	chr17:42240824	A/G	cg09913183	chr17:42254507	C17orf65;ASB16	0.67	6.43	0.59	9.39e-9	Total body bone mineral density;
SKCM	cis	rs4523957	0.928	rs403553	chr17:2191260	C/T	cg16513277	chr17:2031491	SMG6	0.65	4.84	0.48	6.41e-6	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs2072499	0.966	rs2842864	chr1:156159217	G/A	cg24450063	chr1:156163899	SLC25A44	1.11	10.97	0.78	1.78e-17	Testicular germ cell tumor;
SKCM	cis	rs2644899	0.821	rs4803368	chr19:41301714	A/G	cg24958765	chr19:41283667	RAB4B	-0.85	-5.39	-0.52	7.21e-7	Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs9916302	0.904	rs2024073	chr17:37471330	T/G	cg07936489	chr17:37558343	FBXL20	0.84	6.75	0.61	2.32e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs9303401	0.614	rs28651036	chr17:57080471	G/A	cg10487724	chr17:56770010	TEX14;RAD51C	0.79	4.97	0.49	3.86e-6	Cognitive test performance;
SKCM	cis	rs9916302	0.706	rs9944459	chr17:37484185	T/C	cg07936489	chr17:37558343	FBXL20	1.0	7.19	0.63	3.42e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs2204008	0.744	rs11181635	chr12:38378420	C/T	cg13010199	chr12:38710504	ALG10B	0.68	4.85	0.48	6.3e-6	Bladder cancer;
SKCM	trans	rs1814175	0.645	rs7952104	chr11:49964180	C/T	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs2197308	0.655	rs1971964	chr12:37870474	C/T	cg13010199	chr12:38710504	ALG10B	0.65	4.93	0.49	4.48e-6	Morning vs. evening chronotype;
SKCM	cis	rs9910055	1.000	rs9895423	chr17:42285740	T/C	cg08499158	chr17:42289980	UBTF	-0.89	-7.83	-0.66	2.05e-11	Total body bone mineral density;
SKCM	cis	rs17376456	0.825	rs36042718	chr5:93180997	C/T	cg25358565	chr5:93447407	FAM172A	1.18	7.56	0.65	6.77e-11	Diabetic retinopathy;
SKCM	cis	rs7829975	0.714	rs59046059	chr8:8670736	C/A	cg15556689	chr8:8085844	FLJ10661	0.69	6.07	0.57	4.36e-8	Mood instability;
SKCM	cis	rs362296	0.597	rs3129320	chr4:3265130	G/C	cg09735869	chr4:3319127	RGS12	-0.64	-5.33	-0.52	9.29e-7	Parental longevity (mother's age at death);
SKCM	cis	rs4481887	0.962	rs6686911	chr1:248476969	T/C	cg00666640	chr1:248458726	OR2T12	0.64	5.69	0.54	2.13e-7	Common traits (Other);
SKCM	cis	rs2180341	0.814	rs9401959	chr6:127736464	T/C	cg27446573	chr6:127587934	RNF146	0.69	5.49	0.53	4.79e-7	Breast cancer;
SKCM	cis	rs1218582	0.772	rs6683557	chr1:154852307	C/G	cg06221963	chr1:154839813	KCNN3	-0.58	-5.84	-0.55	1.16e-7	Prostate cancer;
SKCM	cis	rs459571	0.959	rs2073818	chr9:136918662	C/A	cg13789015	chr9:136890014	NCRNA00094	0.7	5.7	0.54	2.08e-7	Platelet distribution width;
SKCM	cis	rs11098499	0.863	rs1155576	chr4:120450159	A/C	cg24375607	chr4:120327624	NA	0.68	5.27	0.51	1.16e-6	Corneal astigmatism;
SKCM	cis	rs2204008	0.557	rs11520191	chr12:38197057	T/A	cg13010199	chr12:38710504	ALG10B	0.65	4.84	0.48	6.52e-6	Bladder cancer;
SKCM	cis	rs7950696	1	rs7950696	chr11:47481533	T/C	cg20307385	chr11:47447363	PSMC3	0.77	5.86	0.55	1.06e-7	Platelet count;
SKCM	cis	rs2839186	0.771	rs2280959	chr21:47641996	C/G	cg05896524	chr21:47604654	C21orf56	0.68	5.63	0.54	2.78e-7	Testicular germ cell tumor;
SKCM	cis	rs10256972	0.567	rs7782651	chr7:1159895	T/G	cg09177884	chr7:1199841	ZFAND2A	-0.81	-6.51	-0.59	6.66e-9	Longevity;Endometriosis;
SKCM	cis	rs1577917	1.000	rs2324843	chr6:86617501	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.85	-8.62	-0.7	5.82e-13	Response to antipsychotic treatment;
SKCM	cis	rs4077515	0.934	rs3829111	chr9:139269483	G/A	cg14169450	chr9:139327907	INPP5E	0.46	5.29	0.51	1.1e-6	Ulcerative colitis;IgA nephropathy;Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs7178909	0.902	rs2043881	chr15:90439960	G/A	cg19708238	chr15:90437601	AP3S2	0.72	5.22	0.51	1.43e-6	Common traits (Other);
SKCM	cis	rs1691799	0.899	rs1168357	chr12:66749879	T/C	cg16791601	chr12:66731901	HELB	-0.63	-5.72	-0.54	1.89e-7	White blood cell count (basophil);
SKCM	cis	rs617791	0.569	rs11227370	chr11:65747693	C/T	cg27068330	chr11:65405492	SIPA1	-0.68	-4.9	-0.49	5.12e-6	Breast cancer;
SKCM	cis	rs11155671	0.530	rs7768665	chr6:150208024	G/A	cg05036130	chr6:150231994	NA	0.6	6.88	0.61	1.31e-9	Testicular germ cell tumor;
SKCM	cis	rs2019137	0.539	rs4849177	chr2:113982584	T/C	cg21550016	chr2:113992930	PAX8;LOC440839;LOC654433	0.62	4.86	0.48	5.85e-6	Lymphocyte counts;
SKCM	cis	rs1799949	1.000	rs4793192	chr17:41204390	T/C	cg05368731	chr17:41323189	NBR1	0.89	7.67	0.66	4.08e-11	Menopause (age at onset);
SKCM	cis	rs6545883	0.860	rs6749226	chr2:61509783	G/A	cg15711740	chr2:61764176	XPO1	0.68	4.82	0.48	6.94e-6	Tuberculosis;
SKCM	cis	rs7208859	0.623	rs11657777	chr17:29091785	T/C	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs28595532	0.920	rs55794497	chr4:119764664	A/G	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs17685	0.753	rs11764129	chr7:75761890	T/C	cg16489192	chr7:75678113	MDH2;STYXL1	-0.57	-5.35	-0.52	8.63e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1799949	1.000	rs4793236	chr17:41436440	T/C	cg05368731	chr17:41323189	NBR1	0.84	6.68	0.6	3.12e-9	Menopause (age at onset);
SKCM	cis	rs10504229	1.000	rs1390411	chr8:58194146	C/A	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	trans	rs3749237	0.964	rs2352975	chr3:49891885	T/C	cg21659725	chr3:3221576	CRBN	1.07	7.36	0.64	1.59e-10	Resting heart rate;
SKCM	cis	rs2228479	0.867	rs11642451	chr16:89958127	T/C	cg06558623	chr16:89946397	TCF25	1.26	6.97	0.62	9.17e-10	Skin colour saturation;
SKCM	cis	rs2559856	0.903	rs10128996	chr12:102081498	G/A	cg12924262	chr12:102091054	CHPT1	0.7	5.68	0.54	2.19e-7	Blood protein levels;
SKCM	cis	rs1878931	0.615	rs6501171	chr16:3402610	T/A	cg26668626	chr16:3451006	ZNF174;ZNF434	0.95	8.12	0.68	5.4e-12	Body mass index (adult);
SKCM	cis	rs7666738	0.830	rs60411337	chr4:99046617	T/C	cg17366294	chr4:99064904	C4orf37	0.59	4.84	0.48	6.52e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs8078723	1.000	rs8070454	chr17:38160754	C/T	cg17467752	chr17:38218738	THRA	0.68	6.3	0.58	1.61e-8	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs6138458	0.626	rs6138473	chr20:25012155	A/G	cg26195577	chr20:24973756	C20orf3	-0.92	-6.66	-0.6	3.45e-9	Blood protein levels;
SKCM	cis	rs4132509	0.948	rs7517921	chr1:243856420	T/C	cg21452805	chr1:244014465	NA	0.84	5.18	0.51	1.7e-6	RR interval (heart rate);
SKCM	cis	rs847649	0.618	rs6465880	chr7:102515237	T/C	cg18108683	chr7:102477205	FBXL13	-0.79	-8.1	-0.68	6.11e-12	Morning vs. evening chronotype;
SKCM	cis	rs6088580	0.634	rs6059824	chr20:33014543	T/C	cg24642439	chr20:33292090	TP53INP2	0.76	6.02	0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs12477438	0.520	rs4851187	chr2:99745860	G/T	cg14399236	chr2:99771627	LIPT1;TSGA10	-1.01	-9.47	-0.73	1.3e-14	Chronic sinus infection;
SKCM	cis	rs17376456	0.877	rs28539612	chr5:93499099	C/T	cg21475434	chr5:93447410	FAM172A	0.99	5.62	0.54	2.81e-7	Diabetic retinopathy;
SKCM	cis	rs6977660	0.882	rs7781975	chr7:19849629	A/G	cg05791153	chr7:19748676	TWISTNB	0.79	5.51	0.53	4.42e-7	Thyroid stimulating hormone;
SKCM	cis	rs4803468	1.000	rs4674	chr19:41930396	A/G	cg09537434	chr19:41945824	ATP5SL	-1.1	-13.85	-0.84	1.02e-22	Height;
SKCM	cis	rs2948294	0.588	rs7011221	chr8:8114246	C/T	cg15556689	chr8:8085844	FLJ10661	0.63	4.85	0.48	6.15e-6	Red cell distribution width;
SKCM	cis	rs9611565	1.000	rs9611565	chr22:41767486	T/C	cg03806693	chr22:41940476	POLR3H	-0.82	-5.64	-0.54	2.57e-7	Vitiligo;
SKCM	cis	rs4972806	0.814	rs2113560	chr2:177030986	T/C	cg14324370	chr2:177042789	NA	0.56	5.04	0.5	2.89e-6	IgG glycosylation;
SKCM	cis	rs9486715	0.838	rs6928442	chr6:96870118	A/G	cg06623918	chr6:96969491	KIAA0776	0.79	7.09	0.63	5.34e-10	Headache;
SKCM	cis	rs4724125	0.883	rs13222816	chr7:42671386	A/G	cg09407816	chr7:42972088	MRPL32;PSMA2	0.81	4.85	0.48	6.13e-6	Lobe attachment (rater-scored or self-reported);
SKCM	trans	rs1814175	0.646	rs1722010	chr11:49897958	A/G	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs9300255	0.602	rs1626899	chr12:123708063	A/G	cg00376283	chr12:123451042	ABCB9	0.83	5.49	0.53	4.74e-7	Neutrophil percentage of white cells;
SKCM	cis	rs34779708	0.733	rs4007271	chr10:35546611	C/T	cg03585969	chr10:35415529	CREM	0.71	5.25	0.51	1.27e-6	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs7119	0.667	rs4886889	chr15:77902347	T/C	cg27398640	chr15:77910606	LINGO1	0.51	5.21	0.51	1.51e-6	Type 2 diabetes;
SKCM	cis	rs8072100	0.701	rs10163469	chr17:45687767	G/A	cg08085267	chr17:45401833	C17orf57	0.62	5.49	0.53	4.77e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs801193	1.000	rs3800812	chr7:66223461	T/C	cg00343986	chr7:65444356	GUSB	0.67	4.95	0.49	4.27e-6	Aortic root size;
SKCM	cis	rs35146811	0.735	rs1061230	chr7:99807265	G/A	cg22906224	chr7:99728672	NA	-0.65	-5.19	-0.51	1.6e-6	Coronary artery disease;
SKCM	cis	rs6445797	0.632	rs2054987	chr3:56593105	G/C	cg13616963	chr3:57583610	ARF4	-0.79	-5.1	-0.5	2.35e-6	Gastritis;
SKCM	cis	rs6570726	0.818	rs437978	chr6:145809134	A/G	cg23711669	chr6:146136114	FBXO30	0.74	6.97	0.62	9.1e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1577917	0.771	rs2842612	chr6:86303091	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.79	-7.29	-0.64	2.22e-10	Response to antipsychotic treatment;
SKCM	cis	rs28386778	0.897	rs2665833	chr17:61906846	T/C	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs28595532	0.920	rs55668908	chr4:119769799	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs28595532	0.623	rs34958556	chr4:119222074	C/T	cg14228332	chr4:119757509	SEC24D	0.98	5.35	0.52	8.62e-7	Cannabis dependence symptom count;
SKCM	cis	rs12497850	0.931	rs9311432	chr3:48850443	T/A	cg06212747	chr3:49208901	KLHDC8B	0.68	4.89	0.48	5.28e-6	Parkinson's disease;
SKCM	cis	rs9814567	0.896	rs7653880	chr3:134345788	T/C	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.65	-5.25	-0.51	1.26e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs4927850	0.794	rs2019472	chr3:195735371	T/C	cg12923728	chr3:195709715	SDHAP1	-0.99	-6.62	-0.6	4.09e-9	Pancreatic cancer;
SKCM	cis	rs780096	0.526	rs7594812	chr2:27611469	A/G	cg05696406	chr2:27599888	SNX17	0.49	5.07	0.5	2.62e-6	Total body bone mineral density;
SKCM	cis	rs9300255	0.537	rs10772993	chr12:123644714	A/G	cg00376283	chr12:123451042	ABCB9	0.8	5.4	0.52	6.99e-7	Neutrophil percentage of white cells;
SKCM	cis	rs35766269	0.541	rs1970557	chr10:9042213	C/T	cg05671070	chr10:8095960	FLJ45983;GATA3	0.95	4.77	0.48	8.45e-6	Recalcitrant atopic dermatitis;
SKCM	cis	rs997295	0.592	rs2899724	chr15:67760808	C/T	cg24247231	chr15:67904302	MAP2K5	-0.6	-5.09	-0.5	2.45e-6	Motion sickness;
SKCM	cis	rs9815354	0.767	rs73077375	chr3:41853058	C/T	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs801193	1.000	rs4717319	chr7:66242593	A/G	cg11764359	chr7:65958608	NA	0.83	6.32	0.58	1.5e-8	Aortic root size;
SKCM	cis	rs763121	0.853	rs4821811	chr22:39075145	C/T	cg06022373	chr22:39101656	GTPBP1	0.78	5.59	0.53	3.27e-7	Menopause (age at onset);
SKCM	cis	rs11098499	0.865	rs9996417	chr4:120295862	T/C	cg09307838	chr4:120376055	NA	0.97	7.5	0.65	8.86e-11	Corneal astigmatism;
SKCM	cis	rs11112613	0.713	rs11112592	chr12:105951702	C/T	cg03607813	chr12:105948248	NA	-0.79	-5.11	-0.5	2.27e-6	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;
SKCM	cis	rs9880211	0.635	rs10048942	chr3:135785491	A/G	cg21827317	chr3:136751795	NA	-0.7	-4.97	-0.49	3.91e-6	Body mass index;Height;
SKCM	cis	rs763121	0.853	rs5757232	chr22:39071677	C/T	cg06022373	chr22:39101656	GTPBP1	0.8	5.85	0.55	1.1e-7	Menopause (age at onset);
SKCM	cis	rs4819052	0.851	rs2330011	chr21:46658498	G/A	cg19498844	chr21:46707878	POFUT2;LOC642852	0.84	7.1	0.63	5.13e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs1568889	0.838	rs12273631	chr11:28042135	A/T	cg06544937	chr11:28130018	METT5D1;KIF18A	0.89	8.44	0.69	1.31e-12	Bipolar disorder;
SKCM	cis	rs80130819	0.515	rs72644846	chr12:48508283	A/G	cg05342945	chr12:48394962	COL2A1	0.79	5.39	0.52	7.22e-7	Prostate cancer;
SKCM	cis	rs9814567	1.000	rs6806417	chr3:134211446	C/T	cg06109529	chr3:134205091	CEP63;ANAPC13	0.65	5.14	0.5	2e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs7208859	0.623	rs28556733	chr17:29083945	T/G	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs7829975	1.000	rs7829975	chr8:8548117	T/A	cg15556689	chr8:8085844	FLJ10661	-0.82	-7.45	-0.65	1.06e-10	Mood instability;
SKCM	cis	rs7954584	0.567	rs11612028	chr12:122387872	C/G	cg13699009	chr12:122356056	WDR66	0.58	7.26	0.64	2.5e-10	Mean corpuscular volume;
SKCM	cis	rs11227306	0.934	rs7940691	chr11:65640906	C/T	cg00576331	chr11:65640516	EFEMP2	0.65	5.23	0.51	1.4e-6	DNA methylation (variation);
SKCM	cis	rs60871478	0.628	rs73038185	chr7:845206	A/G	cg05535760	chr7:792225	HEATR2	-0.84	-5.85	-0.55	1.12e-7	Cerebrospinal P-tau181p levels;
SKCM	cis	rs2204008	0.545	rs1663283	chr12:38132039	G/A	cg26384229	chr12:38710491	ALG10B	-0.67	-5.47	-0.53	5.23e-7	Bladder cancer;
SKCM	cis	rs28386778	0.865	rs2727276	chr17:61929709	G/A	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.12	11.27	0.79	4.92e-18	Prudent dietary pattern;
SKCM	cis	rs12478296	1.000	rs113129906	chr2:243004253	C/T	cg06360820	chr2:242988706	NA	-1.1	-5.56	-0.53	3.64e-7	Obesity-related traits;
SKCM	cis	rs6547741	0.935	rs4260197	chr2:27794150	C/G	cg27432699	chr2:27873401	GPN1	-0.75	-6.84	-0.61	1.57e-9	Oral cavity cancer;
SKCM	cis	rs826838	1.000	rs826889	chr12:39101076	G/A	cg13010199	chr12:38710504	ALG10B	-0.82	-6.11	-0.57	3.61e-8	Heart rate;
SKCM	cis	rs654950	0.807	rs941970	chr1:41990867	G/A	cg06885757	chr1:42089581	HIVEP3	-0.62	-6.81	-0.61	1.82e-9	Airway imaging phenotypes;
SKCM	cis	rs10256972	0.684	rs2363279	chr7:1096143	A/G	cg16145915	chr7:1198662	ZFAND2A	-0.46	-5.63	-0.54	2.69e-7	Longevity;Endometriosis;
SKCM	cis	rs2153535	0.580	rs9328484	chr6:8524843	A/T	cg07606381	chr6:8435919	SLC35B3	0.94	6.9	0.62	1.24e-9	Motion sickness;
SKCM	cis	rs3768617	0.510	rs2296288	chr1:183072590	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs2839186	0.934	rs17182538	chr21:47705673	C/A	cg05896524	chr21:47604654	C21orf56	0.7	5.66	0.54	2.45e-7	Testicular germ cell tumor;
SKCM	cis	rs561341	0.843	rs4795666	chr17:30241409	A/G	cg00745463	chr17:30367425	LRRC37B	-0.99	-6.61	-0.6	4.22e-9	Hip circumference adjusted for BMI;
SKCM	cis	rs854765	0.583	rs4257260	chr17:17857003	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.01	7.49	0.65	9.28e-11	Total body bone mineral density;
SKCM	cis	rs8177179	0.967	rs9820225	chr3:133449189	A/G	cg16262614	chr3:133464971	TF	0.43	5.38	0.52	7.57e-7	Iron status biomarkers (transferrin levels);
SKCM	cis	rs28386778	0.897	rs2584627	chr17:61901439	T/C	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs7809950	1.000	rs2520264	chr7:107179344	T/C	cg23024343	chr7:107201750	COG5	-0.77	-6.95	-0.62	9.61e-10	Coronary artery disease;
SKCM	cis	rs6951245	1.000	rs75488469	chr7:1102122	A/G	cg24642844	chr7:1081250	C7orf50	-0.93	-6.22	-0.58	2.28e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs9300255	0.602	rs1790116	chr12:123618544	G/T	cg00376283	chr12:123451042	ABCB9	0.84	5.87	0.55	1e-7	Neutrophil percentage of white cells;
SKCM	cis	rs7772486	0.790	rs2250387	chr6:146205233	C/T	cg23711669	chr6:146136114	FBXO30	0.76	7.61	0.65	5.3e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs644799	1.000	rs1944074	chr11:95511445	C/A	cg03916912	chr11:95522834	CEP57;FAM76B	0.94	8.46	0.69	1.18e-12	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs9485372	1.000	rs12178257	chr6:149607060	G/A	cg03072286	chr6:150262044	ULBP2	-0.55	-4.89	-0.48	5.3e-6	Breast cancer;
SKCM	cis	rs1707322	0.686	rs2230658	chr1:46078854	A/G	cg03146154	chr1:46216737	IPP	-0.83	-6.17	-0.57	2.83e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs12824058	0.831	rs11616174	chr12:130814503	A/G	cg24838063	chr12:130822603	PIWIL1	0.78	6.99	0.62	8.22e-10	Menopause (age at onset);
SKCM	cis	rs4642101	0.765	rs4321514	chr3:12825901	C/T	cg05775895	chr3:12838266	CAND2	0.63	5.82	0.55	1.22e-7	QRS complex (12-leadsum);
SKCM	cis	rs56104184	1.000	rs11541192	chr19:49377424	G/A	cg19746536	chr19:49375674	PPP1R15A	1.12	6.51	0.59	6.65e-9	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs2153535	0.580	rs7766852	chr6:8472417	C/T	cg07606381	chr6:8435919	SLC35B3	0.93	6.69	0.6	3.07e-9	Motion sickness;
SKCM	cis	rs57221529	0.713	rs12521091	chr5:590710	G/T	cg26208419	chr5:473447	SLC9A3;LOC25845	0.98	4.96	0.49	3.99e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs875971	0.862	rs6947339	chr7:65888470	T/C	cg11764359	chr7:65958608	NA	0.74	6.67	0.6	3.3e-9	Aortic root size;
SKCM	cis	rs2204008	0.774	rs10400552	chr12:38393577	C/G	cg26384229	chr12:38710491	ALG10B	0.81	6.6	0.6	4.58e-9	Bladder cancer;
SKCM	cis	rs11608355	0.521	rs7972346	chr12:109808771	C/G	cg19025524	chr12:109796872	NA	0.68	6.16	0.57	2.91e-8	Neuroticism;
SKCM	cis	rs10504229	0.679	rs17800895	chr8:58050085	A/G	cg02725872	chr8:58115012	NA	-0.52	-4.85	-0.48	6.18e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs870825	0.929	rs72689272	chr4:185592515	T/C	cg04058563	chr4:185651563	MLF1IP	1.03	5.09	0.5	2.4e-6	Blood protein levels;
SKCM	cis	rs875971	0.793	rs460678	chr7:65527200	C/G	cg18876405	chr7:65276391	NA	0.75	7.32	0.64	1.93e-10	Aortic root size;
SKCM	cis	rs2836974	0.931	rs2776307	chr21:40713833	C/G	cg17971929	chr21:40555470	PSMG1	-0.8	-7.35	-0.64	1.68e-10	Cognitive function;
SKCM	cis	rs8077889	0.700	rs28571770	chr17:41904066	A/T	cg26893861	chr17:41843967	DUSP3	1.15	7.34	0.64	1.79e-10	Triglycerides;
SKCM	cis	rs9300255	0.507	rs1727302	chr12:123632930	G/A	cg05973401	chr12:123451056	ABCB9	0.79	5.7	0.54	2.08e-7	Neutrophil percentage of white cells;
SKCM	cis	rs3820928	0.874	rs3752896	chr2:227886925	C/T	cg11843606	chr2:227700838	RHBDD1	-0.62	-5.15	-0.5	1.87e-6	Pulmonary function;
SKCM	cis	rs10504229	0.683	rs6999131	chr8:58127052	C/A	cg02725872	chr8:58115012	NA	-0.52	-4.97	-0.49	3.92e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs2153535	0.542	rs6905925	chr6:8440030	C/T	cg23788917	chr6:8435910	SLC35B3	0.69	5.14	0.5	1.99e-6	Motion sickness;
SKCM	cis	rs2842992	0.789	rs9364536	chr6:160225559	G/C	cg16489826	chr6:160211363	TCP1;MRPL18	0.68	4.93	0.49	4.57e-6	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs6121246	0.909	rs6060929	chr20:30345914	C/T	cg11595048	chr20:30225325	COX4I2	0.67	5.21	0.51	1.5e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs992157	1.000	rs13003334	chr2:219124921	T/A	cg20019365	chr2:219134978	PNKD;AAMP	0.81	7.35	0.64	1.68e-10	Colorectal cancer;
SKCM	cis	rs7959452	0.535	rs2305641	chr12:69646914	C/T	cg14784868	chr12:69753453	YEATS4	0.64	5.6	0.54	3.09e-7	Blood protein levels;
SKCM	cis	rs7618501	0.602	rs2071206	chr3:50160109	G/A	cg05072774	chr3:49840536	C3orf54	0.66	5.02	0.49	3.22e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs57221529	0.766	rs72703065	chr5:588123	C/A	cg09888920	chr5:474111	LOC25845;SLC9A3	0.99	4.79	0.48	7.91e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs7216064	0.953	rs1966410	chr17:65837215	T/C	cg12091567	chr17:66097778	LOC651250	-0.77	-5.53	-0.53	4.06e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs644799	0.965	rs499076	chr11:95546341	A/G	cg25622487	chr11:95524042	FAM76B;CEP57	0.66	5.12	0.5	2.18e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs453301	0.624	rs2288673	chr8:8860276	G/T	cg06636001	chr8:8085503	FLJ10661	0.72	5.86	0.55	1.03e-7	Joint mobility (Beighton score);
SKCM	cis	rs6500395	0.890	rs11861666	chr16:48679914	G/T	cg04672837	chr16:48644449	N4BP1	0.65	5.36	0.52	8.23e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs9796	0.621	rs11858678	chr15:41467932	A/G	cg18705301	chr15:41695430	NDUFAF1	-0.68	-5.01	-0.49	3.27e-6	Menopause (age at onset);
SKCM	cis	rs1005277	0.683	rs7923868	chr10:37989766	T/C	cg25427524	chr10:38739819	LOC399744	-0.62	-5.51	-0.53	4.51e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs1799949	0.827	rs74252763	chr17:41402020	C/T	cg23758822	chr17:41437982	NA	0.92	7.75	0.66	2.9100000000000002e-11	Menopause (age at onset);
SKCM	cis	rs28386778	0.897	rs894413	chr17:61916347	A/G	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs2963482	0.507	rs4704942	chr5:157893360	C/G	cg11669387	chr5:157285902	CLINT1	-0.57	-4.8	-0.48	7.48e-6	Nonsyndromic cleft lip with or without cleft palate;
SKCM	cis	rs2153535	0.580	rs6941670	chr6:8446346	G/A	cg23788917	chr6:8435910	SLC35B3	0.69	5.01	0.49	3.35e-6	Motion sickness;
SKCM	cis	rs826838	0.872	rs826878	chr12:39088837	A/T	cg13010199	chr12:38710504	ALG10B	-0.67	-5.18	-0.51	1.72e-6	Heart rate;
SKCM	cis	rs11155671	0.530	rs7742993	chr6:150205095	G/A	cg05036130	chr6:150231994	NA	0.6	6.89	0.61	1.29e-9	Testicular germ cell tumor;
SKCM	cis	rs701145	0.640	rs357499	chr3:153946463	C/G	cg17054900	chr3:154042577	DHX36	1.19	5.1	0.5	2.37e-6	Coronary artery disease;
SKCM	cis	rs7809950	0.678	rs7788330	chr7:106985648	G/T	cg23024343	chr7:107201750	COG5	-0.82	-7.0	-0.62	7.72e-10	Coronary artery disease;
SKCM	cis	rs870825	0.520	rs10022842	chr4:185649459	A/G	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs55962025	0.842	rs362271	chr4:3235518	C/T	cg21096898	chr4:3318625	RGS12	-0.66	-4.91	-0.49	4.86e-6	Parental longevity (mother's age at death);
SKCM	cis	rs11098499	0.818	rs10008791	chr4:120431469	A/C	cg09307838	chr4:120376055	NA	0.99	7.71	0.66	3.45e-11	Corneal astigmatism;
SKCM	cis	rs7786877	0.953	rs7457024	chr7:100215220	A/G	cg16850897	chr7:100343110	ZAN	-0.68	-5.57	-0.53	3.48e-7	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs17685	0.712	rs4552844	chr7:75718095	A/G	cg16684958	chr7:75615977	POR	0.57	5.54	0.53	4e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs28595532	0.920	rs116105567	chr4:119746204	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs2197308	0.619	rs4002730	chr12:37876400	T/C	cg26384229	chr12:38710491	ALG10B	0.82	6.88	0.61	1.35e-9	Morning vs. evening chronotype;
SKCM	cis	rs7590720	1.000	rs1991533	chr2:216908910	T/C	cg12620499	chr2:216877984	MREG	0.9	7.66	0.66	4.32e-11	Alcohol dependence;
SKCM	cis	rs35306767	0.715	rs17221463	chr10:1038040	T/C	cg25614935	chr10:1084866	C10orf110	0.65	5.13	0.5	2.03e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs4969178	0.965	rs56658017	chr17:76396164	G/A	cg20026190	chr17:76395443	PGS1	0.61	5.29	0.51	1.08e-6	HDL cholesterol levels;
SKCM	cis	rs870825	0.860	rs61165411	chr4:185604461	G/A	cg04058563	chr4:185651563	MLF1IP	1.04	5.96	0.56	7.02e-8	Blood protein levels;
SKCM	cis	rs654950	0.875	rs881719	chr1:41991427	C/T	cg06885757	chr1:42089581	HIVEP3	-0.6	-6.65	-0.6	3.67e-9	Airway imaging phenotypes;
SKCM	cis	rs6840360	0.615	rs6535822	chr4:152679722	A/G	cg22705602	chr4:152727874	NA	-0.59	-7.95	-0.67	1.19e-11	Intelligence (multi-trait analysis);
SKCM	trans	rs16918253	1.000	rs56253213	chr10:19421496	T/A	cg25765192	chr1:13184954	LOC440563	0.95	7.86	0.66	1.72e-11	Obesity-related traits;
SKCM	cis	rs8072100	0.777	rs9914653	chr17:45537395	T/C	cg08085267	chr17:45401833	C17orf57	-0.62	-5.15	-0.5	1.88e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs11098499	0.954	rs10014845	chr4:120301077	T/G	cg24375607	chr4:120327624	NA	0.65	4.97	0.49	3.87e-6	Corneal astigmatism;
SKCM	cis	rs60871478	0.898	rs62432897	chr7:825429	A/G	cg05535760	chr7:792225	HEATR2	1.17	10.16	0.75	6.17e-16	Cerebrospinal P-tau181p levels;
SKCM	cis	rs2404602	0.583	rs12908334	chr15:76581592	C/T	cg22467129	chr15:76604101	ETFA	-0.65	-5.35	-0.52	8.68e-7	Blood metabolite levels;
SKCM	cis	rs67460515	1.000	rs67460515	chr3:161068566	T/C	cg03342759	chr3:160939853	NMD3	-0.81	-7.15	-0.63	4e-10	Parkinson's disease;
SKCM	cis	rs9381040	0.655	rs2268192	chr6:41024626	T/C	cg04346459	chr6:41068666	NFYA;LOC221442	-0.69	-4.8	-0.48	7.61e-6	Alzheimer's disease (late onset);
SKCM	cis	rs155076	1.000	rs261404	chr13:21858162	T/G	cg14456004	chr13:21872349	NA	-1.22	-6.76	-0.61	2.24e-9	White matter hyperintensity burden;
SKCM	cis	rs2279817	0.863	rs6586569	chr1:18027377	T/C	cg17142039	chr1:18149651	ACTL8	0.6	5.15	0.5	1.93e-6	Neuroticism;
SKCM	cis	rs12142240	0.698	rs17413701	chr1:46818452	A/G	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs8067545	0.750	rs11871651	chr17:19997425	T/C	cg13482628	chr17:19912719	NA	0.71	6.15	0.57	3.07e-8	Schizophrenia;
SKCM	cis	rs6500395	0.963	rs12919278	chr16:48692537	A/G	cg04672837	chr16:48644449	N4BP1	-0.65	-5.43	-0.52	6.29e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs2760061	0.626	rs2313118	chr1:228118084	T/C	cg18477163	chr1:228402036	OBSCN	-0.46	-5.1	-0.5	2.36e-6	Diastolic blood pressure;
SKCM	cis	rs7829975	0.871	rs572307	chr8:8578811	T/C	cg06636001	chr8:8085503	FLJ10661	-0.8	-7.36	-0.64	1.62e-10	Mood instability;
SKCM	cis	rs854765	0.547	rs4072739	chr17:17884660	G/A	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.09	9.24	0.72	3.76e-14	Total body bone mineral density;
SKCM	cis	rs873946	0.648	rs12782123	chr10:134554662	G/A	cg18305652	chr10:134549665	INPP5A	0.58	5.8	0.55	1.35e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs9325144	0.647	rs870431	chr12:38953073	T/C	cg13010199	chr12:38710504	ALG10B	-0.64	-5.33	-0.52	9.2e-7	Morning vs. evening chronotype;
SKCM	cis	rs4919087	0.962	rs10882889	chr10:99045890	A/G	cg25902810	chr10:99078978	FRAT1	0.68	5.45	0.53	5.63e-7	Monocyte count;
SKCM	cis	rs116095464	0.558	rs28418643	chr5:240859	A/G	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs2204008	0.693	rs12372025	chr12:38202028	G/A	cg26384229	chr12:38710491	ALG10B	0.82	6.58	0.6	4.87e-9	Bladder cancer;
SKCM	cis	rs6570726	0.811	rs375873	chr6:145812371	G/T	cg23711669	chr6:146136114	FBXO30	0.69	6.69	0.6	3.09e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6598955	0.670	rs6676619	chr1:26539035	T/G	cg00938395	chr1:26633206	UBXN11	0.71	5.0	0.49	3.5e-6	Obesity-related traits;
SKCM	cis	rs9581857	0.547	rs9581868	chr13:28070682	C/T	cg22138327	chr13:27999177	GTF3A	0.84	5.53	0.53	4.15e-7	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	trans	rs1814175	0.817	rs12277258	chr11:49940216	T/C	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs9911578	1.000	rs2009948	chr17:56611920	A/C	cg12560992	chr17:57184187	TRIM37	-0.96	-7.74	-0.66	2.95e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs2070488	0.662	rs7372545	chr3:38507570	T/G	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.75	5.63	0.54	2.73e-7	Electrocardiographic conduction measures;
SKCM	cis	rs2228479	0.850	rs11640209	chr16:89807828	C/A	cg00800038	chr16:89945340	TCF25	-0.81	-4.79	-0.48	7.84e-6	Skin colour saturation;
SKCM	cis	rs992157	0.764	rs10193189	chr2:219187603	C/A	cg00012203	chr2:219082015	ARPC2	0.73	5.39	0.52	7.33e-7	Colorectal cancer;
SKCM	cis	rs6570726	0.764	rs367065	chr6:145882309	T/G	cg23711669	chr6:146136114	FBXO30	0.87	9.14	0.72	5.82e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs34891900	0.507	rs5992088	chr22:18135912	C/T	cg19898043	chr22:18121309	BCL2L13	-0.63	-4.77	-0.48	8.35e-6	Sum neutrophil eosinophil counts;
SKCM	cis	rs12142240	0.698	rs58162700	chr1:46816659	T/A	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs7772486	0.902	rs1125462	chr6:146417832	A/G	cg05347473	chr6:146136440	FBXO30	0.61	5.57	0.53	3.53e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs3820068	0.532	rs74057713	chr1:15944620	G/C	cg13390004	chr1:15929781	NA	0.64	5.19	0.51	1.61e-6	Systolic blood pressure;
SKCM	cis	rs9549367	0.713	rs9549357	chr13:113860121	C/T	cg18105134	chr13:113819100	PROZ	-0.84	-6.71	-0.61	2.75e-9	Platelet distribution width;
SKCM	cis	rs2032447	0.765	rs6942072	chr6:26014987	A/G	cg18357526	chr6:26021779	HIST1H4A	0.82	6.34	0.58	1.37e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs3003334	1	rs3003334	chr1:24199869	G/A	cg15997130	chr1:24165203	NA	0.6	4.94	0.49	4.37e-6	Eosinophil percentage of white cells;Eosinophil percentage of granulocytes;
SKCM	cis	rs11098499	0.954	rs6834796	chr4:120414693	A/C	cg24375607	chr4:120327624	NA	0.66	5.13	0.5	2.07e-6	Corneal astigmatism;
SKCM	cis	rs2731664	0.765	rs2630766	chr5:176874941	A/C	cg23176889	chr5:176863531	GRK6	-0.52	-5.27	-0.51	1.16e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9467773	1.000	rs6925895	chr6:26572165	G/T	cg09904177	chr6:26538194	HMGN4	0.54	4.91	0.49	4.97e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs919433	0.929	rs10931779	chr2:198166825	A/G	cg04278110	chr2:198063759	ANKRD44	-0.7	-5.12	-0.5	2.14e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs2836950	0.565	rs7276046	chr21:40581293	T/C	cg17971929	chr21:40555470	PSMG1	-0.73	-6.17	-0.57	2.86e-8	Menarche (age at onset);
SKCM	cis	rs10256972	0.706	rs12701969	chr7:1121849	A/G	cg16145915	chr7:1198662	ZFAND2A	-0.56	-8.0	-0.67	9.55e-12	Longevity;Endometriosis;
SKCM	cis	rs1218582	0.772	rs4845689	chr1:154885524	A/G	cg09359103	chr1:154839909	KCNN3	-0.57	-5.3	-0.51	1.05e-6	Prostate cancer;
SKCM	cis	rs1044826	0.642	rs6787649	chr3:139193321	C/T	cg15131784	chr3:139108705	COPB2	0.66	4.96	0.49	4.09e-6	Obesity-related traits;
SKCM	cis	rs4927850	0.794	rs2019472	chr3:195735371	T/C	cg01181863	chr3:195395398	SDHAP2	-1.01	-6.99	-0.62	8.27e-10	Pancreatic cancer;
SKCM	cis	rs4975616	0.839	rs2447853	chr5:1333077	A/G	cg07493874	chr5:1342172	CLPTM1L	-0.69	-6.56	-0.6	5.34e-9	Lung cancer;
SKCM	cis	rs2153535	0.541	rs9505456	chr6:8479001	T/C	cg07606381	chr6:8435919	SLC35B3	0.86	6.25	0.58	2.06e-8	Motion sickness;
SKCM	cis	rs116095464	0.558	rs57335027	chr5:262907	A/G	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs12110303	1	rs12110303	chr5:90662839	G/T	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.1	8.3	0.68	2.43e-12	Breast cancer;
SKCM	cis	rs10860964	0.605	rs10745956	chr12:103565144	T/A	cg20635409	chr12:103359273	NA	-0.54	-4.87	-0.48	5.74e-6	Schizophrenia;
SKCM	cis	rs763014	1.000	rs763014	chr16:675680	T/C	cg00908189	chr16:619842	PIGQ	0.82	7.63	0.65	4.79e-11	Height;
SKCM	cis	rs12709013	0.766	rs12599331	chr16:58839211	A/G	cg02431531	chr16:59244939	NA	0.48	4.99	0.49	3.62e-6	Blood metabolite ratios;
SKCM	cis	rs9868809	0.772	rs12107418	chr3:48689787	A/G	cg00383909	chr3:49044727	WDR6	0.93	4.95	0.49	4.2e-6	Ulcerative colitis;Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs951366	0.789	rs823152	chr1:205736285	G/A	cg24503407	chr1:205819492	PM20D1	0.9	7.9	0.67	1.45e-11	Menarche (age at onset);
SKCM	trans	rs561341	0.602	rs114562703	chr17:30233899	G/T	cg20587970	chr11:113659929	NA	-1.08	-8.41	-0.69	1.54e-12	Hip circumference adjusted for BMI;
SKCM	cis	rs4974559	0.739	rs4333131	chr4:1323789	A/G	cg02980000	chr4:1222292	CTBP1	0.91	5.65	0.54	2.51e-7	Systolic blood pressure;
SKCM	cis	rs7666738	0.830	rs17558151	chr4:99048699	T/C	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs611744	0.647	rs633901	chr8:109242981	G/T	cg18478394	chr8:109455254	TTC35	0.66	5.33	0.52	9.43e-7	Dupuytren's disease;
SKCM	cis	rs9583531	0.657	rs9521915	chr13:111384528	C/T	cg24331049	chr13:111365604	ING1	0.86	6.51	0.59	6.7e-9	Coronary artery disease;
SKCM	cis	rs6089584	0.888	rs2181590	chr20:60622843	T/C	cg06108461	chr20:60628389	TAF4	-0.89	-8.72	-0.7	3.75e-13	Body mass index;
SKCM	cis	rs2243480	0.901	rs73148097	chr7:65431787	A/C	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs4332037	1.000	rs62442899	chr7:1948454	C/T	cg02825527	chr7:2087843	MAD1L1	-0.73	-5.11	-0.5	2.22e-6	Bipolar disorder;
SKCM	cis	rs1005277	0.579	rs176838	chr10:38371899	A/T	cg25427524	chr10:38739819	LOC399744	0.7	6.32	0.58	1.49e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs57221529	0.713	rs56328416	chr5:591138	G/A	cg26208419	chr5:473447	SLC9A3;LOC25845	1.01	5.18	0.51	1.7e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs7647973	0.516	rs4955419	chr3:49200692	T/A	cg07636037	chr3:49044803	WDR6	0.86	7.17	0.63	3.77e-10	Menarche (age at onset);
SKCM	cis	rs151997	0.777	rs6870880	chr5:50256207	G/A	cg01829002	chr5:50259133	NA	0.52	5.03	0.49	3.08e-6	Callous-unemotional behaviour;
SKCM	cis	rs62238980	0.614	rs75805646	chr22:32441396	A/G	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs2204008	0.774	rs11616004	chr12:38278822	G/A	cg13010199	chr12:38710504	ALG10B	0.69	4.92	0.49	4.72e-6	Bladder cancer;
SKCM	cis	rs7843479	0.526	rs3816788	chr8:21832494	A/C	cg17168535	chr8:21777572	XPO7	0.81	7.39	0.64	1.4e-10	Mean corpuscular volume;
SKCM	cis	rs7208859	0.623	rs9911784	chr17:29124580	A/C	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs10089	0.953	rs758179	chr5:127354424	C/G	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.9	7.59	0.65	5.8e-11	Ileal carcinoids;
SKCM	cis	rs36093844	0.800	rs76663264	chr11:85578455	C/G	cg25872744	chr11:85566296	CCDC83	-0.85	-4.83	-0.48	6.66e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs2842992	0.872	rs2758328	chr6:160090731	T/A	cg19482086	chr6:160211437	TCP1;MRPL18	0.82	5.72	0.54	1.86e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs4481887	0.962	rs10788770	chr1:248457474	T/G	cg00666640	chr1:248458726	OR2T12	0.6	4.8	0.48	7.46e-6	Common traits (Other);
SKCM	cis	rs10540	1.000	rs61876336	chr11:489537	C/T	cg03576123	chr11:487126	PTDSS2	-1.4	-7.12	-0.63	4.72e-10	Body mass index;
SKCM	trans	rs1814175	0.616	rs10839341	chr11:49742615	G/A	cg03929089	chr4:120376271	NA	-0.85	-7.61	-0.65	5.27e-11	Height;
SKCM	cis	rs1218582	0.710	rs7553195	chr1:154837796	T/C	cg24250549	chr1:154909240	PMVK	0.84	8.9	0.71	1.69e-13	Prostate cancer;
SKCM	cis	rs9435341	1.000	rs1762484	chr1:107613923	A/C	cg09367891	chr1:107599246	PRMT6	-0.79	-6.51	-0.59	6.77e-9	Facial morphology (factor 21, depth of nasal alae);
SKCM	cis	rs10254284	1.000	rs6962289	chr7:28161379	C/A	cg15170557	chr7:28214983	JAZF1	-0.57	-4.83	-0.48	6.73e-6	Lymphocyte percentage of white cells;Systemic lupus erythematosus;
SKCM	trans	rs66573146	0.831	rs66645969	chr4:6985614	G/A	cg07817883	chr1:32538562	TMEM39B	1.94	8.42	0.69	1.47e-12	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs3087591	0.922	rs2905799	chr17:29536901	G/A	cg24425628	chr17:29625626	OMG;NF1	0.64	5.22	0.51	1.43e-6	Hip circumference;
SKCM	cis	rs780096	0.506	rs1728922	chr2:27644464	A/C	cg05696406	chr2:27599888	SNX17	0.49	5.07	0.5	2.62e-6	Total body bone mineral density;
SKCM	cis	rs6951245	1.000	rs11763020	chr7:1060288	C/T	cg21664854	chr7:1097933	C7orf50;GPR146	0.9	4.86	0.48	6.05e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs875971	0.862	rs778707	chr7:65857027	G/A	cg11764359	chr7:65958608	NA	0.74	6.67	0.6	3.3e-9	Aortic root size;
SKCM	cis	rs6061231	1.000	rs11908473	chr20:60957770	C/G	cg24112000	chr20:60950667	NA	-0.6	-5.96	-0.56	6.97e-8	Colorectal cancer;
SKCM	cis	rs3847687	0.966	rs3847689	chr12:131525534	T/G	cg25772418	chr12:131519998	GPR133	-0.5	-5.11	-0.5	2.23e-6	Longevity;
SKCM	cis	rs9311474	0.607	rs4687625	chr3:52563718	C/T	cg18404041	chr3:52824283	ITIH1	-0.55	-4.98	-0.49	3.8e-6	Electroencephalogram traits;
SKCM	cis	rs2413583	0.591	rs17000979	chr22:39700758	C/T	cg17798944	chr22:39715225	SNORD43;RPL3	0.88	5.05	0.5	2.85e-6	Ulcerative colitis;Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs9818758	0.607	rs3923475	chr3:49055788	G/T	cg00383909	chr3:49044727	WDR6	1.05	5.85	0.55	1.11e-7	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs12142240	0.698	rs68191463	chr1:46808695	T/C	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs2204008	0.728	rs11495375	chr12:38282631	G/A	cg26384229	chr12:38710491	ALG10B	0.87	6.83	0.61	1.63e-9	Bladder cancer;
SKCM	cis	rs875971	0.798	rs57739047	chr7:65972566	A/T	cg18876405	chr7:65276391	NA	0.61	5.94	0.56	7.52e-8	Aortic root size;
SKCM	cis	rs6121246	0.559	rs6060950	chr20:30378031	T/C	cg11595048	chr20:30225325	COX4I2	0.54	4.77	0.48	8.4e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs2832191	1.000	rs2832184	chr21:30483265	C/T	cg24692254	chr21:30365293	RNF160	-0.79	-7.24	-0.63	2.72e-10	Dental caries;
SKCM	cis	rs4819052	0.765	rs2838852	chr21:46677037	C/A	cg19498844	chr21:46707878	POFUT2;LOC642852	0.88	7.69	0.66	3.74e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs10929159	0.928	rs2123512	chr2:236920731	C/T	cg14226755	chr2:236923322	AGAP1	0.29	4.77	0.48	8.43e-6	Parkinson's disease;
SKCM	cis	rs7829975	0.658	rs2409096	chr8:8692477	T/C	cg06636001	chr8:8085503	FLJ10661	0.81	6.7	0.6	2.9e-9	Mood instability;
SKCM	cis	rs7811142	1.000	rs67040465	chr7:100083078	G/A	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.25	0.68	3.05e-12	Platelet count;
SKCM	cis	rs7599312	0.517	rs10192988	chr2:213407782	T/G	cg16329650	chr2:213403929	ERBB4	0.84	6.04	0.56	4.85e-8	BMI (adjusted for smoking behaviour);BMI in non-smokers;Body mass index;Body mass index (joint analysis main effects and smoking interaction);
SKCM	cis	rs12762955	0.561	rs4880744	chr10:1012026	A/G	cg20503657	chr10:835505	NA	-0.71	-5.78	-0.55	1.45e-7	Response to angiotensin II receptor blocker therapy;
SKCM	cis	rs13392177	0.660	rs12988046	chr2:219073804	A/G	cg00012203	chr2:219082015	ARPC2	-0.64	-4.89	-0.48	5.39e-6	Pyoderma gangrenosum in inflammatory bowel disease;
SKCM	cis	rs72634258	0.842	rs7545745	chr1:8165667	T/A	cg00042356	chr1:8021962	PARK7	-0.88	-5.85	-0.55	1.11e-7	Inflammatory bowel disease;
SKCM	cis	rs13118159	0.641	rs4974598	chr4:1313220	C/T	cg02018176	chr4:1364513	KIAA1530	0.7	5.82	0.55	1.23e-7	Longevity;
SKCM	cis	rs12142240	0.698	rs17361950	chr1:46864150	C/T	cg14993813	chr1:46806288	NSUN4	-0.7	-4.81	-0.48	7.24e-6	Menopause (age at onset);
SKCM	cis	rs372883	0.519	rs2832274	chr21:30600189	A/T	cg24692254	chr21:30365293	RNF160	0.75	6.12	0.57	3.48e-8	Pancreatic cancer;
SKCM	cis	rs453301	0.658	rs12114954	chr8:8904862	T/G	cg15556689	chr8:8085844	FLJ10661	-0.71	-5.31	-0.52	9.95e-7	Joint mobility (Beighton score);
SKCM	cis	rs2204008	0.743	rs11495614	chr12:38156358	C/T	cg26384229	chr12:38710491	ALG10B	0.86	6.42	0.59	9.7e-9	Bladder cancer;
SKCM	cis	rs11112613	0.713	rs17037317	chr12:105952058	T/C	cg03607813	chr12:105948248	NA	0.84	5.44	0.52	5.84e-7	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;
SKCM	cis	rs11227306	0.902	rs625652	chr11:65641931	T/A	cg00576331	chr11:65640516	EFEMP2	0.65	5.23	0.51	1.4e-6	DNA methylation (variation);
SKCM	cis	rs28595532	0.920	rs116062544	chr4:119735548	G/C	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs6952808	0.692	rs10950473	chr7:1999453	G/A	cg02951883	chr7:2050386	MAD1L1	-0.78	-6.79	-0.61	1.94e-9	Bipolar disorder and schizophrenia;
SKCM	cis	rs1799949	0.827	rs74252763	chr17:41402020	C/T	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.23	-0.58	2.24e-8	Menopause (age at onset);
SKCM	cis	rs7100689	0.646	rs1340384	chr10:82088702	T/A	cg00277334	chr10:82204260	NA	-0.57	-5.34	-0.52	8.88e-7	Post bronchodilator FEV1;
SKCM	cis	rs6570726	0.846	rs6919684	chr6:145883801	A/G	cg05347473	chr6:146136440	FBXO30	0.52	4.81	0.48	7.12e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2885056	0.800	rs8105074	chr19:10708692	A/G	cg04833646	chr19:10679720	CDKN2D	0.88	6.22	0.58	2.26e-8	Red cell distribution width;
SKCM	cis	rs1348850	0.837	rs12619074	chr2:178472336	G/A	cg02961200	chr2:178257176	LOC100130691;AGPS	0.77	5.49	0.53	4.9e-7	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs1005277	0.579	rs2505197	chr10:38393310	T/C	cg00409905	chr10:38381863	ZNF37A	-0.64	-5.96	-0.56	6.77e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs1552244	0.751	rs12715665	chr3:10021601	C/T	cg02579736	chr3:10068473	FANCD2;CIDECP	0.94	4.84	0.48	6.49e-6	Alzheimer's disease;
SKCM	trans	rs7618501	1.000	rs11130218	chr3:49752372	C/T	cg21659725	chr3:3221576	CRBN	-0.96	-9.61	-0.74	7.08e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs10779751	0.734	rs12569242	chr1:11127511	A/C	cg08854313	chr1:11322531	MTOR	0.77	5.32	0.52	9.65e-7	Body mass index;
SKCM	cis	rs995000	0.899	rs12136083	chr1:63163073	T/C	cg06896770	chr1:63153194	DOCK7	0.85	7.58	0.65	5.97e-11	Triglyceride levels;
SKCM	cis	rs2251381	0.722	rs2251278	chr21:30529234	A/G	cg24692254	chr21:30365293	RNF160	0.78	6.09	0.57	3.93e-8	Selective IgA deficiency;
SKCM	cis	rs867186	0.764	rs55993524	chr20:33674004	C/T	cg04194272	chr20:33683537	NA	-1.38	-7.2	-0.63	3.29e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs12541335	0.639	rs7003478	chr8:22201123	A/G	cg26039829	chr8:22132926	PIWIL2	0.64	5.64	0.54	2.61e-7	Hypertriglyceridemia;
SKCM	cis	rs57221529	0.766	rs56350081	chr5:583198	G/A	cg10555297	chr5:473380	SLC9A3;LOC25845	1.01	5.03	0.49	3.1e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs4803468	1.000	rs10853751	chr19:41903220	G/A	cg14132834	chr19:41945861	ATP5SL	-0.74	-5.71	-0.54	1.99e-7	Height;
SKCM	cis	rs9467773	0.620	rs2101581	chr6:26622769	G/T	cg15659132	chr6:26577336	NA	0.62	5.4	0.52	6.91e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs2019137	0.560	rs11123172	chr2:113984303	C/T	cg23156509	chr2:114033830	PAX8;LOC440839	0.56	4.79	0.48	7.71e-6	Lymphocyte counts;
SKCM	cis	rs847649	0.732	rs6465876	chr7:102497569	G/T	cg18108683	chr7:102477205	FBXL13	-0.81	-8.95	-0.71	1.37e-13	Morning vs. evening chronotype;
SKCM	cis	rs9926296	0.585	rs1800337	chr16:89845194	A/G	cg26513180	chr16:89883248	FANCA	0.97	11.05	0.78	1.25e-17	Vitiligo;
SKCM	cis	rs12477438	0.520	rs6741773	chr2:99738962	A/C	cg14399236	chr2:99771627	LIPT1;TSGA10	0.95	8.78	0.71	2.89e-13	Chronic sinus infection;
SKCM	cis	rs10754283	0.901	rs10922683	chr1:90116068	G/A	cg21401794	chr1:90099060	LRRC8C	0.73	6.2	0.57	2.51e-8	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs9467773	0.596	rs62396201	chr6:26668216	G/A	cg15659132	chr6:26577336	NA	0.57	4.79	0.48	7.75e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7945705	0.875	rs2653616	chr11:8885892	A/G	cg21881798	chr11:8931708	C11orf17;ST5	-0.79	-8.52	-0.69	9.25e-13	Hemoglobin concentration;
SKCM	cis	rs4808199	0.947	rs751858	chr19:19602821	G/C	cg03709012	chr19:19516395	GATAD2A	1.13	8.66	0.7	4.94e-13	Nonalcoholic fatty liver disease;
SKCM	cis	rs12478296	1.000	rs55742408	chr2:243041077	G/A	cg06360820	chr2:242988706	NA	-0.91	-5.25	-0.51	1.28e-6	Obesity-related traits;
SKCM	cis	rs2952156	0.920	rs1018246	chr17:37835240	C/T	cg20243544	chr17:37824526	PNMT	0.69	5.53	0.53	4.15e-7	Asthma;
SKCM	cis	rs6424115	0.830	rs2503000	chr1:24197898	C/G	cg15997130	chr1:24165203	NA	0.6	4.94	0.49	4.37e-6	Immature fraction of reticulocytes;
SKCM	cis	rs2180341	0.597	rs3798859	chr6:127663116	C/T	cg27446573	chr6:127587934	RNF146	0.68	5.44	0.52	5.95e-7	Breast cancer;
SKCM	trans	rs1814175	0.669	rs11040473	chr11:49703813	C/T	cg15704280	chr7:45808275	SEPT13	-0.8	-7.5	-0.65	8.71e-11	Height;
SKCM	cis	rs7811142	0.943	rs67196635	chr7:100025564	T/C	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.23	7.89	0.67	1.53e-11	Platelet count;
SKCM	cis	rs7772486	0.686	rs9386131	chr6:146121608	G/A	cg23711669	chr6:146136114	FBXO30	0.85	9.32	0.73	2.62e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1577917	0.610	rs11752795	chr6:86287129	C/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.73	6.45	0.59	8.51e-9	Response to antipsychotic treatment;
SKCM	cis	rs951366	0.844	rs823096	chr1:205679887	G/T	cg07167872	chr1:205819463	PM20D1	0.9	7.19	0.63	3.36e-10	Menarche (age at onset);
SKCM	cis	rs7216064	0.953	rs4791046	chr17:65851973	G/A	cg12091567	chr17:66097778	LOC651250	-0.75	-5.27	-0.51	1.19e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs6570726	0.935	rs411641	chr6:145827532	G/A	cg23711669	chr6:146136114	FBXO30	0.7	6.64	0.6	3.72e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs5750830	0.649	rs5757659	chr22:39812409	A/C	cg24399712	chr22:39784796	NA	-0.56	-4.91	-0.49	4.96e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs4803468	1.000	rs1043413	chr19:41939297	C/G	cg09537434	chr19:41945824	ATP5SL	1.1	13.21	0.83	1.39e-21	Height;
SKCM	cis	rs7824557	0.614	rs2736277	chr8:11218893	C/T	cg21775007	chr8:11205619	TDH	-0.64	-5.52	-0.53	4.27e-7	Retinal vascular caliber;
SKCM	cis	rs4423214	0.569	rs4944044	chr11:71120213	G/A	cg05163923	chr11:71159392	DHCR7	0.59	5.4	0.52	6.93e-7	Vitamin D levels;
SKCM	cis	rs561341	1.000	rs55962687	chr17:30260369	C/T	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.42	-0.64	1.24e-10	Hip circumference adjusted for BMI;
SKCM	cis	rs902774	0.597	rs7299694	chr12:53352572	A/C	cg05393297	chr12:53359155	NA	-0.67	-6.78	-0.61	2.04e-9	Prostate cancer;
SKCM	cis	rs55962025	0.842	rs73193303	chr4:3192200	A/G	cg09735869	chr4:3319127	RGS12	-0.65	-5.03	-0.49	3.07e-6	Parental longevity (mother's age at death);
SKCM	cis	rs614226	1.000	rs541126	chr12:120972396	C/T	cg01236616	chr12:121019343	POP5	-1.34	-8.54	-0.7	8.29e-13	Type 1 diabetes nephropathy;
SKCM	cis	rs651907	0.535	rs34263427	chr3:101507805	A/G	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.78	6.76	0.61	2.21e-9	Colorectal cancer;
SKCM	cis	rs826838	0.935	rs1601579	chr12:39178606	G/C	cg26384229	chr12:38710491	ALG10B	0.92	8.39	0.69	1.67e-12	Heart rate;
SKCM	cis	rs28595532	0.920	rs115485705	chr4:119733286	G/C	cg14228332	chr4:119757509	SEC24D	1.08	5.52	0.53	4.28e-7	Cannabis dependence symptom count;
SKCM	cis	rs11764590	0.724	rs55669426	chr7:2090129	G/C	cg23422044	chr7:1970798	MAD1L1	-0.82	-6.27	-0.58	1.82e-8	Neuroticism;
SKCM	cis	rs6580649	0.941	rs4760614	chr12:48427884	A/G	cg05342945	chr12:48394962	COL2A1	0.73	5.2	0.51	1.53e-6	Lung cancer;
SKCM	cis	rs7772486	0.875	rs9322043	chr6:146352690	A/G	cg05347473	chr6:146136440	FBXO30	0.57	5.24	0.51	1.31e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9902453	0.765	rs3102562	chr17:28040403	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.78	5.9	0.56	8.97e-8	Coffee consumption (cups per day);
SKCM	cis	rs2153535	0.563	rs1796687	chr6:8536118	C/G	cg07606381	chr6:8435919	SLC35B3	0.86	6.64	0.6	3.8e-9	Motion sickness;
SKCM	cis	rs9902453	1.000	rs9902453	chr17:28349095	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.78	-5.62	-0.54	2.8e-7	Coffee consumption (cups per day);
SKCM	cis	rs9303401	0.614	rs12950028	chr17:56510140	A/G	cg02118635	chr17:56770003	RAD51C;TEX14	0.76	4.95	0.49	4.17e-6	Cognitive test performance;
SKCM	cis	rs6598955	0.543	rs6698557	chr1:26561220	G/C	cg04990556	chr1:26633338	UBXN11	0.65	5.04	0.5	2.91e-6	Obesity-related traits;
SKCM	cis	rs9420	0.961	rs708228	chr11:57585662	C/T	cg19752551	chr11:57585705	CTNND1	-0.71	-7.2	-0.63	3.22e-10	Schizophrenia;
SKCM	cis	rs13118159	0.550	rs28522910	chr4:1374774	C/T	cg16405210	chr4:1374714	KIAA1530	-0.9	-6.82	-0.61	1.71e-9	Longevity;
SKCM	cis	rs9916302	0.610	rs11078902	chr17:37631883	C/G	cg07936489	chr17:37558343	FBXL20	-0.9	-8.1	-0.68	6.05e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs60871478	0.578	rs62432900	chr7:826794	G/C	cg05535760	chr7:792225	HEATR2	1.21	10.42	0.76	1.96e-16	Cerebrospinal P-tau181p levels;
SKCM	cis	rs13256369	1.000	rs9329166	chr8:8576655	C/T	cg17143192	chr8:8559678	CLDN23	0.7	5.07	0.5	2.66e-6	Obesity-related traits;
SKCM	cis	rs73201462	1.000	rs34409786	chr3:127888175	A/G	cg09089421	chr3:127803668	RUVBL1	1.0	5.11	0.5	2.22e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs2842992	0.915	rs2758335	chr6:160111011	G/A	cg11366901	chr6:160182831	ACAT2	0.88	6.82	0.61	1.71e-9	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs3008870	0.583	rs2815369	chr1:67500894	T/C	cg08660285	chr1:67390436	MIER1;WDR78	0.93	6.03	0.56	5.04e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs11792861	0.619	rs2289481	chr9:111712924	G/C	cg14432460	chr9:111696404	IKBKAP;C9orf6	0.79	6.66	0.6	3.48e-9	Menarche (age at onset);
SKCM	cis	rs860295	0.776	rs11264362	chr1:155315615	C/T	cg02153340	chr1:155202674	NA	0.75	6.0	0.56	5.73e-8	Body mass index;
SKCM	cis	rs7399018	0.643	rs6580810	chr12:51610478	C/T	cg25754956	chr12:51612065	POU6F1	0.81	6.38	0.59	1.15e-8	Cisplatin-induced ototoxicity;
SKCM	cis	rs7954584	0.505	rs11043278	chr12:122412145	C/T	cg13699009	chr12:122356056	WDR66	0.58	6.81	0.61	1.82e-9	Mean corpuscular volume;
SKCM	cis	rs10489202	0.954	rs3820399	chr1:168062053	C/T	cg24449463	chr1:168025552	DCAF6	-0.77	-5.95	-0.56	7.18e-8	Schizophrenia;
SKCM	cis	rs1799949	0.965	rs4793233	chr17:41435437	G/C	cg05368731	chr17:41323189	NBR1	0.87	7.43	0.64	1.18e-10	Menopause (age at onset);
SKCM	cis	rs7666738	0.791	rs10022061	chr4:98926821	T/C	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs853679	0.599	rs156743	chr6:27967089	T/C	cg06761719	chr6:27280190	POM121L2	0.89	4.99	0.49	3.55e-6	Depression;
SKCM	trans	rs208520	0.661	rs1776361	chr6:66822270	G/A	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-1.02	-8.18	-0.68	4.19e-12	Exhaled nitric oxide output;
SKCM	cis	rs9916302	0.904	rs4795359	chr17:37573146	C/T	cg07936489	chr17:37558343	FBXL20	-0.85	-7.35	-0.64	1.71e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs867186	1.000	rs7270326	chr20:33693582	T/C	cg04194272	chr20:33683537	NA	-1.21	-6.8	-0.61	1.89e-9	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs6665290	0.669	rs3768423	chr1:227177293	G/A	cg10327440	chr1:227177885	CDC42BPA	-1.08	-9.54	-0.73	9.9e-15	Myeloid white cell count;
SKCM	cis	rs1153858	1.000	rs16942000	chr15:45633003	C/T	cg21132104	chr15:45694354	SPATA5L1	0.92	8.33	0.69	2.14e-12	Homoarginine levels;
SKCM	cis	rs7027203	0.663	rs4428726	chr9:96623559	T/G	cg13679303	chr9:96623674	NA	-0.4	-4.97	-0.49	3.92e-6	DNA methylation (variation);
SKCM	cis	rs3784262	0.669	rs3784259	chr15:58257847	C/T	cg12031962	chr15:58353849	ALDH1A2	-0.42	-5.23	-0.51	1.37e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs72781680	1.000	rs7355559	chr2:24256946	G/T	cg08917208	chr2:24149416	ATAD2B	-1.1	-5.75	-0.55	1.64e-7	Lymphocyte counts;
SKCM	cis	rs6430585	0.528	rs75524146	chr2:136725459	C/T	cg07169764	chr2:136633963	MCM6	1.34	11.85	0.8	4.04e-19	Corneal structure;
SKCM	cis	rs1218582	0.628	rs12130132	chr1:154880386	C/T	cg03351412	chr1:154909251	PMVK	0.68	5.44	0.52	6.03e-7	Prostate cancer;
SKCM	cis	rs9513627	1.000	rs2147625	chr13:100140645	G/T	cg11288260	chr13:100117058	NA	0.79	4.78	0.48	8.1e-6	Obesity-related traits;
SKCM	cis	rs875971	0.508	rs10253883	chr7:66061138	T/C	cg11987759	chr7:65425863	GUSB	0.69	6.02	0.56	5.47e-8	Aortic root size;
SKCM	cis	rs9911578	1.000	rs8067571	chr17:56868856	C/T	cg05425664	chr17:57184151	TRIM37	-0.69	-5.21	-0.51	1.52e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs4746818	1.000	rs4746817	chr10:70882515	T/C	cg11621586	chr10:70884670	VPS26A	0.9	5.82	0.55	1.26e-7	Left atrial antero-posterior diameter;
SKCM	cis	rs2228479	0.850	rs34033205	chr16:89922959	G/T	cg00800038	chr16:89945340	TCF25	-1.0	-5.06	-0.5	2.75e-6	Skin colour saturation;
SKCM	cis	rs910316	0.967	rs175479	chr14:75561871	A/C	cg08847533	chr14:75593920	NEK9	-0.96	-8.88	-0.71	1.88e-13	Height;
SKCM	cis	rs11098499	0.863	rs3822195	chr4:120471660	C/T	cg24375607	chr4:120327624	NA	0.69	5.47	0.53	5.35e-7	Corneal astigmatism;
SKCM	cis	rs56104184	0.578	rs7254608	chr19:49395774	G/T	cg19746536	chr19:49375674	PPP1R15A	1.14	8.39	0.69	1.67e-12	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs1707322	0.964	rs10437063	chr1:46273666	G/A	cg03146154	chr1:46216737	IPP	0.75	5.15	0.5	1.94e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs1403694	0.695	rs5029975	chr3:186436918	A/G	cg09332604	chr3:186435400	KNG1	0.5	5.07	0.5	2.57e-6	Blood protein levels;
SKCM	cis	rs910316	0.789	rs175457	chr14:75584507	C/T	cg08847533	chr14:75593920	NEK9	-0.82	-6.75	-0.61	2.36e-9	Height;
SKCM	cis	rs2739330	0.796	rs5760097	chr22:24247794	G/C	cg04234412	chr22:24373322	LOC391322	-0.63	-5.08	-0.5	2.52e-6	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs17826219	0.500	rs57005940	chr17:29066329	C/G	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Body mass index;
SKCM	cis	rs6088590	1.000	rs6087626	chr20:33347328	C/T	cg24642439	chr20:33292090	TP53INP2	1.01	7.39	0.64	1.39e-10	Coronary artery disease;
SKCM	cis	rs1355223	0.583	rs2915177	chr11:34880266	A/G	cg11058730	chr11:34937778	PDHX;APIP	0.63	5.08	0.5	2.51e-6	Systemic lupus erythematosus and Systemic sclerosis;
SKCM	cis	rs1799949	0.965	rs4793204	chr17:41279298	A/G	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.11	-0.57	3.67e-8	Menopause (age at onset);
SKCM	cis	rs9790314	0.586	rs1811483	chr3:161130900	A/G	cg03342759	chr3:160939853	NMD3	-0.74	-6.62	-0.6	4.08e-9	Morning vs. evening chronotype;
SKCM	cis	rs7523273	0.606	rs2724388	chr1:207933577	T/G	cg22525895	chr1:207977042	MIR29B2	0.81	7.08	0.63	5.47e-10	Schizophrenia;
SKCM	cis	rs2463822	0.925	rs1881535	chr11:62121623	C/T	cg06239285	chr11:62104954	ASRGL1	1.26	5.85	0.55	1.08e-7	Chronic obstructive pulmonary disease-related biomarkers;
SKCM	cis	rs9399135	1.000	rs4895435	chr6:135293463	C/A	cg24558204	chr6:135376177	HBS1L	0.56	5.07	0.5	2.64e-6	Red blood cell count;
SKCM	cis	rs4862750	0.832	rs6836076	chr4:187899660	A/C	cg10295955	chr4:187884368	NA	-1.04	-13.97	-0.85	6.27e-23	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4631830	0.720	rs11599333	chr10:51499655	A/C	cg16070123	chr10:51489643	NA	0.53	4.96	0.49	3.99e-6	Prostate-specific antigen levels;
SKCM	cis	rs933688	1.000	rs6452953	chr5:90723034	T/G	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.1	8.55	0.7	8.18e-13	Smoking behavior;
SKCM	cis	rs995000	0.868	rs11208007	chr1:63176083	A/T	cg06896770	chr1:63153194	DOCK7	0.86	7.71	0.66	3.46e-11	Triglyceride levels;
SKCM	cis	rs875971	0.540	rs736270	chr7:65428822	T/C	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.58	4.95	0.49	4.18e-6	Aortic root size;
SKCM	cis	rs9467773	1.000	rs2208331	chr6:26507319	A/G	cg09904177	chr6:26538194	HMGN4	0.55	5.03	0.49	3.11e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs250585	0.588	rs443707	chr16:23598188	T/C	cg09934309	chr16:23461721	COG7	-0.94	-6.18	-0.57	2.76e-8	Egg allergy;
SKCM	cis	rs9715521	0.677	rs11944208	chr4:59860652	G/A	cg11281224	chr4:60001000	NA	-0.61	-4.95	-0.49	4.16e-6	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs7937682	0.593	rs4598705	chr11:111345840	G/A	cg09085632	chr11:111637200	PPP2R1B	0.68	5.33	0.52	9.34e-7	Primary sclerosing cholangitis;
SKCM	cis	rs36051895	0.659	rs10121491	chr9:5046935	T/C	cg02405213	chr9:5042618	JAK2	-0.65	-5.23	-0.51	1.41e-6	Pediatric autoimmune diseases;
SKCM	cis	rs57221529	0.766	rs12519763	chr5:559145	C/T	cg10555297	chr5:473380	SLC9A3;LOC25845	1.05	5.35	0.52	8.71e-7	Lung disease severity in cystic fibrosis;
SKCM	cis	rs116095464	0.558	rs7708182	chr5:234788	C/G	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs17376456	0.825	rs13171131	chr5:93223028	C/T	cg21475434	chr5:93447410	FAM172A	1.03	5.61	0.54	3e-7	Diabetic retinopathy;
SKCM	cis	rs763014	0.966	rs4984903	chr16:680695	A/G	cg07343612	chr16:622815	PIGQ	-0.7	-5.64	-0.54	2.59e-7	Height;
SKCM	cis	rs995000	0.965	rs10889334	chr1:62957199	C/G	cg06896770	chr1:63153194	DOCK7	0.91	9.05	0.72	8.64e-14	Triglyceride levels;
SKCM	cis	rs1348850	0.574	rs4893835	chr2:178442592	T/C	cg27490568	chr2:178487706	NA	0.73	5.18	0.51	1.72e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs561341	0.941	rs2470236	chr17:30304940	G/C	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	trans	rs561341	0.714	rs75861674	chr17:30304317	A/G	cg20587970	chr11:113659929	NA	-1.14	-9.85	-0.74	2.43e-15	Hip circumference adjusted for BMI;
SKCM	cis	rs372883	0.648	rs1153288	chr21:30686091	A/G	cg24692254	chr21:30365293	RNF160	0.64	5.0	0.49	3.43e-6	Pancreatic cancer;
SKCM	cis	rs34375054	0.672	rs58416336	chr12:125606428	G/T	cg25124228	chr12:125621409	AACS	-0.65	-5.19	-0.51	1.61e-6	Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs5757676	0.858	rs6001585	chr22:39812986	G/T	cg24399712	chr22:39784796	NA	-0.63	-4.8	-0.48	7.45e-6	IgG glycosylation;
SKCM	cis	rs2839186	0.967	rs9637172	chr21:47685787	T/C	cg05896524	chr21:47604654	C21orf56	0.7	5.89	0.55	9.21e-8	Testicular germ cell tumor;
SKCM	cis	rs2839186	0.867	rs13050387	chr21:47701423	C/T	cg13126279	chr21:47581558	C21orf56	-0.62	-5.25	-0.51	1.29e-6	Testicular germ cell tumor;
SKCM	cis	rs9910055	1.000	rs9895423	chr17:42285740	T/C	cg10896456	chr17:42255109	ASB16;C17orf65	0.62	5.67	0.54	2.35e-7	Total body bone mineral density;
SKCM	cis	rs4790333	0.537	rs898750	chr17:2255193	A/G	cg02569219	chr17:2266849	SGSM2	0.69	5.84	0.55	1.14e-7	Proinsulin levels;
SKCM	cis	rs5769765	0.837	rs8142737	chr22:50291889	T/C	cg22709217	chr22:50311962	ALG12;CRELD2	-0.79	-5.71	-0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs2295359	0.892	rs11209004	chr1:67613932	G/A	cg03340356	chr1:67600835	NA	0.42	4.91	0.49	4.85e-6	Psoriasis;
SKCM	cis	rs2991971	0.967	rs512026	chr1:46009946	G/T	cg24296786	chr1:45957014	TESK2	0.65	5.16	0.5	1.81e-6	High light scatter reticulocyte count;
SKCM	cis	rs875971	1.000	rs11971949	chr7:65626014	A/G	cg18876405	chr7:65276391	NA	-0.68	-6.85	-0.61	1.54e-9	Aortic root size;
SKCM	cis	rs2239547	0.603	rs4687698	chr3:53097108	C/T	cg11645453	chr3:52864694	ITIH4	0.62	4.97	0.49	3.81e-6	Schizophrenia;
SKCM	cis	rs780096	0.546	rs2293572	chr2:27728777	C/G	cg05696406	chr2:27599888	SNX17	-0.54	-5.6	-0.54	3.08e-7	Total body bone mineral density;
SKCM	cis	rs8070624	0.543	rs11870660	chr17:17877096	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.01	8.61	0.7	6.26e-13	Total body bone mineral density;
SKCM	cis	rs6430585	1.000	rs6430585	chr2:136506927	A/C	cg07169764	chr2:136633963	MCM6	-0.91	-7.28	-0.64	2.35e-10	Corneal structure;
SKCM	cis	rs4803468	0.967	rs11083619	chr19:41913267	A/C	cg14132834	chr19:41945861	ATP5SL	-0.77	-6.08	-0.57	4.18e-8	Height;
SKCM	cis	rs2153535	0.526	rs9406179	chr6:8538224	G/A	cg23788917	chr6:8435910	SLC35B3	0.7	4.97	0.49	3.82e-6	Motion sickness;
SKCM	cis	rs992157	0.585	rs62182795	chr2:219100202	C/T	cg00012203	chr2:219082015	ARPC2	-0.78	-6.52	-0.59	6.36e-9	Colorectal cancer;
SKCM	cis	rs854765	0.583	rs12452254	chr17:17829434	G/A	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.91	7.17	0.63	3.77e-10	Total body bone mineral density;
SKCM	cis	rs9926296	0.605	rs6500453	chr16:89858657	C/G	cg26513180	chr16:89883248	FANCA	0.96	10.61	0.77	8.78e-17	Vitiligo;
SKCM	cis	rs7927771	0.756	rs2856661	chr11:47374998	A/G	cg05585544	chr11:47624801	NA	0.58	4.91	0.49	4.89e-6	Subjective well-being;
SKCM	cis	rs56235845	0.964	rs4075958	chr5:176784512	A/G	cg16006841	chr5:176797999	RGS14	-0.9	-8.86	-0.71	1.99e-13	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs3796619	1.000	rs1466215	chr4:1072220	C/T	cg27284194	chr4:1044797	NA	0.67	4.8	0.48	7.53e-6	Recombination rate (males);
SKCM	cis	rs9443189	0.570	rs775072	chr6:76377998	G/A	cg01950844	chr6:76311363	SENP6	-1.02	-6.34	-0.58	1.39e-8	Prostate cancer;
SKCM	cis	rs6724607	0.875	rs9630991	chr2:191432139	G/A	cg27211696	chr2:191398769	TMEM194B	0.77	5.86	0.55	1.07e-7	Pulse pressure;
SKCM	cis	rs28386778	0.897	rs2584640	chr17:61863488	C/T	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	trans	rs1814175	0.587	rs7937757	chr11:49978342	G/A	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs7215564	0.908	rs74000898	chr17:78653532	A/C	cg16980736	chr17:78789706	RPTOR	-0.91	-4.92	-0.49	4.67e-6	Myopia (pathological);
SKCM	cis	rs6088580	0.634	rs1205334	chr20:32930369	T/C	cg24642439	chr20:33292090	TP53INP2	-0.73	-5.68	-0.54	2.2e-7	Glomerular filtration rate (creatinine);
SKCM	cis	rs6547631	0.622	rs10187164	chr2:85928209	G/C	cg24620635	chr2:85921963	GNLY	0.9	6.65	0.6	3.58e-9	Blood protein levels;
SKCM	cis	rs35146811	0.700	rs2950520	chr7:99827148	T/C	cg22906224	chr7:99728672	NA	-0.71	-5.61	-0.54	2.99e-7	Coronary artery disease;
SKCM	cis	rs3008870	0.583	rs3008861	chr1:67396222	T/G	cg08660285	chr1:67390436	MIER1;WDR78	0.96	6.14	0.57	3.26e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs13118159	0.772	rs80346978	chr4:1400313	C/T	cg02018176	chr4:1364513	KIAA1530	0.75	5.86	0.55	1.03e-7	Longevity;
SKCM	cis	rs752010	0.631	rs1073197	chr1:42059822	C/T	cg06885757	chr1:42089581	HIVEP3	-0.71	-7.76	-0.66	2.79e-11	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs7772486	0.558	rs2142978	chr6:146012061	T/C	cg23711669	chr6:146136114	FBXO30	-0.83	-7.31	-0.64	2e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs10911251	0.528	rs10911265	chr1:183115071	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.76	7.21	0.63	3.18e-10	Colorectal cancer;
SKCM	cis	rs10504073	0.669	rs55948643	chr8:50026403	C/G	cg00325661	chr8:49890786	NA	0.82	6.98	0.62	8.55e-10	Blood metabolite ratios;
SKCM	cis	rs28386778	0.897	rs8073515	chr17:61795328	A/C	cg06873352	chr17:61820015	STRADA	0.75	6.24	0.58	2.1e-8	Prudent dietary pattern;
SKCM	cis	rs4975616	0.836	rs421629	chr5:1320136	G/A	cg26373071	chr5:1325741	CLPTM1L	0.76	7.02	0.62	7.17e-10	Lung cancer;
SKCM	cis	rs941408	0.515	rs878893	chr19:2781325	A/G	cg06609049	chr19:2785107	THOP1	1.09	9.81	0.74	2.93e-15	Total cholesterol levels;
SKCM	cis	rs2243480	1.000	rs313813	chr7:65503500	C/T	cg18252515	chr7:66147081	NA	-1.45	-8.32	-0.69	2.27e-12	Diabetic kidney disease;
SKCM	cis	rs58688157	0.705	rs2396545	chr11:601785	T/C	cg16486109	chr11:613632	IRF7	1.07	7.28	0.64	2.33e-10	Systemic lupus erythematosus;
SKCM	cis	rs4925386	0.959	rs4925385	chr20:60920624	A/G	cg24112000	chr20:60950667	NA	0.63	6.16	0.57	3.02e-8	Colorectal cancer;Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs67311347	1.000	rs1466237	chr3:40462026	C/G	cg00091569	chr3:40428383	ENTPD3	0.62	5.1	0.5	2.35e-6	Renal cell carcinoma;
SKCM	cis	rs959260	0.623	rs7207618	chr17:73321687	T/C	cg14668889	chr17:73230827	NUP85	-0.75	-6.29	-0.58	1.72e-8	Systemic lupus erythematosus;
SKCM	cis	rs738321	0.757	rs3788536	chr22:38534209	C/T	cg25457927	chr22:38595422	NA	-0.58	-6.78	-0.61	2.04e-9	Breast cancer;
SKCM	cis	rs9467773	0.844	rs2393669	chr6:26503873	C/T	cg09904177	chr6:26538194	HMGN4	0.55	5.03	0.49	3.11e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9311474	0.508	rs6786043	chr3:52604861	A/G	cg18404041	chr3:52824283	ITIH1	-0.53	-4.77	-0.48	8.42e-6	Electroencephalogram traits;
SKCM	cis	rs7927771	0.832	rs2071304	chr11:47372377	G/C	cg05585544	chr11:47624801	NA	-0.63	-5.53	-0.53	4.05e-7	Subjective well-being;
SKCM	cis	rs9818758	0.556	rs9835439	chr3:49220330	G/C	cg24110177	chr3:50126178	RBM5	0.86	5.12	0.5	2.15e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs12142240	0.698	rs17361791	chr1:46812519	A/G	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs9399135	0.967	rs7741515	chr6:135374368	C/G	cg24558204	chr6:135376177	HBS1L	-0.58	-4.82	-0.48	6.85e-6	Red blood cell count;
SKCM	cis	rs7635838	0.523	rs9873503	chr3:11396100	T/C	cg00170343	chr3:11313890	ATG7	0.7	5.19	0.51	1.61e-6	HDL cholesterol;
SKCM	cis	rs7221595	0.778	rs2727072	chr17:3918585	C/G	cg23770271	chr17:3704471	ITGAE	-0.48	-4.84	-0.48	6.35e-6	Functional impairment in major depressive disorder, bipolar disorder and schizophrenia;
SKCM	cis	rs2479724	0.935	rs62396748	chr6:41782007	A/G	cg17623882	chr6:41773611	USP49	0.72	6.01	0.56	5.66e-8	Menarche (age at onset);
SKCM	cis	rs9325144	0.555	rs11183215	chr12:38693127	G/A	cg26384229	chr12:38710491	ALG10B	-0.78	-6.74	-0.61	2.48e-9	Morning vs. evening chronotype;
SKCM	cis	rs3785574	0.962	rs4480868	chr17:61788859	C/T	cg06601766	chr17:61851465	DDX42;CCDC47	0.7	5.08	0.5	2.56e-6	Height;
SKCM	cis	rs7086627	0.507	rs7077907	chr10:82017082	A/G	cg01528321	chr10:82214614	TSPAN14	0.64	5.47	0.53	5.21e-7	Post bronchodilator FEV1;
SKCM	cis	rs12541335	0.639	rs4871994	chr8:22206038	G/A	cg09517075	chr8:22133004	PIWIL2	0.6	5.51	0.53	4.39e-7	Hypertriglyceridemia;
SKCM	cis	rs651907	1.000	rs651907	chr3:101600724	T/C	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.81	6.77	0.61	2.19e-9	Colorectal cancer;
SKCM	cis	rs2439831	0.681	rs524527	chr15:43599116	C/G	cg27015174	chr15:43622946	ADAL;LCMT2	-0.9	-4.83	-0.48	6.71e-6	Lung cancer in ever smokers;
SKCM	cis	rs1568889	1.000	rs7112860	chr11:28151609	C/A	cg06544937	chr11:28130018	METT5D1;KIF18A	0.87	6.79	0.61	1.97e-9	Bipolar disorder;
SKCM	cis	rs4642101	0.737	rs4299468	chr3:12825559	G/A	cg05775895	chr3:12838266	CAND2	0.63	5.82	0.55	1.22e-7	QRS complex (12-leadsum);
SKCM	cis	rs58688157	0.705	rs7941547	chr11:611503	G/A	cg16486109	chr11:613632	IRF7	1.09	7.42	0.64	1.25e-10	Systemic lupus erythematosus;
SKCM	cis	rs10871290	0.881	rs11649338	chr16:74471420	C/T	cg01733217	chr16:74700730	RFWD3	-0.65	-4.99	-0.49	3.52e-6	Breast cancer;
SKCM	cis	rs11032090	1	rs11032090	chr11:4417129	A/G	cg09983885	chr11:4415245	TRIM21	0.65	5.19	0.51	1.65e-6	Lung cancer;
SKCM	cis	rs453301	0.592	rs4841084	chr8:8883905	C/T	cg06636001	chr8:8085503	FLJ10661	0.74	6.21	0.58	2.39e-8	Joint mobility (Beighton score);
SKCM	cis	rs8072100	0.967	rs4239163	chr17:45755954	C/T	cg25173405	chr17:45401733	C17orf57	-0.58	-5.19	-0.51	1.6e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs1552244	0.882	rs68153882	chr3:10013110	T/C	cg02579736	chr3:10068473	FANCD2;CIDECP	0.94	4.84	0.48	6.49e-6	Alzheimer's disease;
SKCM	cis	rs611744	0.647	rs6981420	chr8:109266694	T/G	cg18478394	chr8:109455254	TTC35	0.66	5.27	0.51	1.16e-6	Dupuytren's disease;
SKCM	cis	rs4319547	0.695	rs55834409	chr12:122862560	C/G	cg23029597	chr12:123009494	RSRC2	0.72	5.31	0.52	1.01e-6	Body mass index;
SKCM	cis	rs9902453	0.704	rs2617874	chr17:28085172	C/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.78	5.38	0.52	7.72e-7	Coffee consumption (cups per day);
SKCM	cis	rs1799949	0.930	rs1554063	chr17:41287145	T/C	cg05368731	chr17:41323189	NBR1	0.88	7.51	0.65	8.26e-11	Menopause (age at onset);
SKCM	cis	rs6503525	0.701	rs28618095	chr17:38109075	T/C	cg17467752	chr17:38218738	THRA	0.65	5.15	0.5	1.91e-6	Asthma;
SKCM	cis	rs7666738	0.830	rs7664169	chr4:99037859	C/T	cg17366294	chr4:99064904	C4orf37	-0.6	-4.98	-0.49	3.8e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7208859	0.623	rs7219361	chr17:29080393	G/A	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	trans	rs9929218	0.529	rs11075694	chr16:68730366	C/T	cg04657470	chr2:198365150	HSPE1;HSPD1	1.0	10.33	0.76	2.98e-16	Colorectal cancer;
SKCM	cis	rs12706411	1.000	rs17463779	chr7:122051645	C/T	cg17986181	chr7:121955208	NA	-0.7	-5.19	-0.51	1.65e-6	Alzheimer disease and age of onset;
SKCM	cis	rs35306767	0.903	rs11253467	chr10:901244	A/G	cg26597838	chr10:835615	NA	0.76	5.33	0.52	9.2e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs478304	0.651	rs11227299	chr11:65549570	C/G	cg17480646	chr11:65405466	SIPA1	-0.69	-5.16	-0.5	1.84e-6	Acne (severe);
SKCM	cis	rs9916302	0.706	rs8078599	chr17:37518660	C/T	cg07936489	chr17:37558343	FBXL20	0.99	7.18	0.63	3.64e-10	Glomerular filtration rate (creatinine);
SKCM	trans	rs1814175	0.817	rs11040651	chr11:49938395	G/A	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs2243480	1.000	rs34815098	chr7:65292254	A/C	cg18252515	chr7:66147081	NA	-1.29	-7.41	-0.64	1.3e-10	Diabetic kidney disease;
SKCM	cis	rs992157	0.835	rs12987219	chr2:219144149	G/A	cg00012203	chr2:219082015	ARPC2	-0.74	-5.97	-0.56	6.53e-8	Colorectal cancer;
SKCM	cis	rs4803468	1.000	rs4803468	chr19:41922352	A/G	cg09537434	chr19:41945824	ATP5SL	-1.1	-13.82	-0.84	1.16e-22	Height;
SKCM	cis	rs28595532	0.920	rs116405053	chr4:119739352	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs4969178	0.965	rs4969186	chr17:76398404	C/G	cg20026190	chr17:76395443	PGS1	0.61	5.29	0.51	1.08e-6	HDL cholesterol levels;
SKCM	cis	rs16989760	0.661	rs67935422	chr22:32020413	G/A	cg01338084	chr22:32026380	PISD	1.5	5.03	0.49	3.11e-6	Age-related hearing impairment;
SKCM	cis	rs8103278	0.507	rs2041975	chr19:46238555	T/C	cg14061069	chr19:46274453	DMPK	0.55	5.48	0.53	5.08e-7	Coronary artery disease;
SKCM	cis	rs875971	1.000	rs709597	chr7:65825983	A/G	cg11764359	chr7:65958608	NA	-0.87	-8.5	-0.69	1.02e-12	Aortic root size;
SKCM	cis	rs9911578	0.967	rs2333410	chr17:57137129	G/A	cg12560992	chr17:57184187	TRIM37	-1.08	-10.21	-0.76	4.97e-16	Intelligence (multi-trait analysis);
SKCM	cis	rs7937682	0.855	rs539693	chr11:111477387	A/G	cg09085632	chr11:111637200	PPP2R1B	-0.97	-10.1	-0.75	8.28e-16	Primary sclerosing cholangitis;
SKCM	cis	rs7843479	0.965	rs733543	chr8:21835465	A/G	cg17168535	chr8:21777572	XPO7	0.77	6.37	0.58	1.22e-8	Mean corpuscular volume;
SKCM	cis	rs9486715	0.867	rs12207471	chr6:96963782	A/G	cg06623918	chr6:96969491	KIAA0776	0.79	6.49	0.59	7.35e-9	Headache;
SKCM	cis	rs4523957	0.855	rs1231209	chr17:2124972	G/A	cg16513277	chr17:2031491	SMG6	-0.72	-4.89	-0.48	5.37e-6	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs9894429	0.869	rs9748184	chr17:79596280	A/G	cg18240062	chr17:79603768	NPLOC4	0.77	7.45	0.64	1.08e-10	Eye color traits;
SKCM	cis	rs6952808	0.500	rs3778996	chr7:2177190	G/A	cg02951883	chr7:2050386	MAD1L1	-0.76	-6.32	-0.58	1.52e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs875971	0.660	rs62465434	chr7:66005152	A/C	cg18876405	chr7:65276391	NA	0.8	7.11	0.63	4.86e-10	Aortic root size;
SKCM	cis	rs28386778	0.863	rs58269663	chr17:61843130	G/A	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs6445797	0.632	rs10865999	chr3:56654834	C/G	cg13616963	chr3:57583610	ARF4	-0.75	-4.84	-0.48	6.53e-6	Gastritis;
SKCM	cis	rs35306767	0.807	rs34527494	chr10:935192	T/C	cg20503657	chr10:835505	NA	0.92	6.59	0.6	4.73e-9	Eosinophil percentage of granulocytes;
SKCM	cis	rs7020830	0.823	rs7019699	chr9:37125081	C/A	cg14294708	chr9:37120828	ZCCHC7	1.1	10.41	0.76	2.09e-16	Schizophrenia;
SKCM	cis	rs6089584	0.566	rs6061401	chr20:60607482	G/A	cg16423285	chr20:60520624	NA	-0.58	-4.99	-0.49	3.55e-6	Body mass index;
SKCM	cis	rs11718455	0.960	rs6781618	chr3:44001933	C/T	cg21419209	chr3:44054225	NA	-0.65	-5.32	-0.52	9.77e-7	Coronary artery disease;
SKCM	cis	rs9368481	0.729	rs10946881	chr6:26914611	C/T	cg12292205	chr6:26970375	C6orf41	0.65	5.89	0.55	9.26e-8	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs1799949	0.965	rs6503726	chr17:41284742	T/C	cg25918947	chr17:41365094	TMEM106A	-0.59	-5.35	-0.52	8.64e-7	Menopause (age at onset);
SKCM	cis	rs2033711	0.936	rs7257999	chr19:58964860	C/G	cg00825309	chr19:58991885	ZNF446	-0.7	-5.7	-0.54	2.01e-7	Uric acid clearance;
SKCM	cis	rs7666738	0.830	rs28485415	chr4:99060340	G/A	cg17366294	chr4:99064904	C4orf37	0.61	4.93	0.49	4.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs16854884	0.586	rs6796460	chr3:143756367	G/A	cg06585982	chr3:143692056	C3orf58	0.87	8.34	0.69	2.04e-12	Economic and political preferences (feminism/equality);
SKCM	cis	rs1577917	1.000	rs10455455	chr6:86670214	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.66	-5.74	-0.54	1.76e-7	Response to antipsychotic treatment;
SKCM	cis	rs4819052	1.000	rs13052356	chr21:46663588	G/A	cg20896738	chr21:46707857	POFUT2;LOC642852	0.74	5.35	0.52	8.71e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7507204	0.767	rs62125962	chr19:3410852	A/G	cg08380311	chr19:3435252	NFIC	0.93	6.45	0.59	8.5e-9	Height;
SKCM	cis	rs7618915	0.547	rs11130311	chr3:52675005	T/C	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs7772486	0.754	rs702318	chr6:146005873	G/T	cg23711669	chr6:146136114	FBXO30	-0.96	-10.3	-0.76	3.36e-16	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs11098499	0.909	rs1809406	chr4:120377122	G/A	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs28386778	0.863	rs1376110	chr17:61779927	A/C	cg06873352	chr17:61820015	STRADA	0.72	5.77	0.55	1.56e-7	Prudent dietary pattern;
SKCM	cis	rs2204008	0.806	rs11525001	chr12:38234397	A/G	cg26384229	chr12:38710491	ALG10B	0.86	7.15	0.63	4.15e-10	Bladder cancer;
SKCM	cis	rs6860806	0.531	rs272887	chr5:131665713	A/G	cg24060327	chr5:131705240	SLC22A5	-0.76	-4.9	-0.48	5.15e-6	Breast cancer;
SKCM	cis	rs2070488	0.804	rs6764551	chr3:38460305	A/G	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.76	6.19	0.57	2.65e-8	Electrocardiographic conduction measures;
SKCM	cis	rs2070488	0.965	rs7373828	chr3:38524311	A/G	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.97	8.97	0.71	1.24e-13	Electrocardiographic conduction measures;
SKCM	cis	rs8060686	0.641	rs113162813	chr16:68038969	A/G	cg09117114	chr16:67998030	SLC12A4	-0.78	-5.11	-0.5	2.21e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs933688	0.938	rs10063683	chr5:90714595	G/A	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.96	6.6	0.6	4.58e-9	Smoking behavior;
SKCM	cis	rs36051895	0.553	rs12338854	chr9:5057568	G/C	cg02405213	chr9:5042618	JAK2	-0.65	-5.23	-0.51	1.41e-6	Pediatric autoimmune diseases;
SKCM	cis	rs9674544	0.740	rs11870560	chr17:47114033	T/C	cg10950924	chr17:47092072	IGF2BP1	-0.58	-5.35	-0.52	8.55e-7	Primary tooth development (time to first tooth eruption);Primary tooth development (number of teeth);
SKCM	cis	rs9912468	1.000	rs9892651	chr17:64303793	C/T	cg19474267	chr17:64306194	PRKCA	-0.61	-5.4	-0.52	6.88e-7	QRS duration;QRS complex (12-leadsum);QRS complex (Sokolow-Lyon);
SKCM	cis	rs8017423	0.904	rs2149647	chr14:90769539	C/T	cg04374321	chr14:90722782	PSMC1	-0.95	-8.73	-0.7	3.68e-13	Mortality in heart failure;
SKCM	cis	rs2836633	0.929	rs11702165	chr21:40035313	C/T	cg05519781	chr21:40033154	ERG	0.78	6.88	0.61	1.33e-9	Coronary artery disease;
SKCM	cis	rs9420	0.961	rs11601320	chr11:57642617	T/C	cg19752551	chr11:57585705	CTNND1	-0.7	-6.74	-0.61	2.45e-9	Schizophrenia;
SKCM	cis	rs3091242	0.900	rs669063	chr1:25721154	A/G	cg02931644	chr1:25747376	RHCE	0.53	5.48	0.53	5.13e-7	Erythrocyte sedimentation rate;
SKCM	cis	rs7086627	0.515	rs4934189	chr10:82214792	C/T	cg00277334	chr10:82204260	NA	-0.74	-8.3	-0.68	2.42e-12	Post bronchodilator FEV1;
SKCM	cis	rs4819052	0.655	rs2330102	chr21:46690968	C/G	cg02159808	chr21:46707872	POFUT2;LOC642852	0.67	5.07	0.5	2.63e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs1799949	1.000	rs11654731	chr17:41326940	G/A	cg05368731	chr17:41323189	NBR1	0.88	7.87	0.67	1.65e-11	Menopause (age at onset);
SKCM	cis	rs367615	0.552	rs2963022	chr5:108727185	A/G	cg17395555	chr5:108820864	NA	-0.64	-5.22	-0.51	1.45e-6	Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs4975616	0.710	rs27996	chr5:1345474	A/G	cg07493874	chr5:1342172	CLPTM1L	-0.6	-5.08	-0.5	2.48e-6	Lung cancer;
SKCM	cis	rs7659604	0.539	rs11098646	chr4:122729301	T/C	cg06713675	chr4:122721982	EXOSC9	-0.75	-7.31	-0.64	2.01e-10	Type 2 diabetes;
SKCM	cis	rs1863918	0.590	rs60143882	chr5:178484229	G/A	cg21905437	chr5:178450457	ZNF879	-0.6	-5.19	-0.51	1.65e-6	Depression in response to interferon-based therapy in chronic hepatitis C;
SKCM	cis	rs7208859	0.623	rs11657662	chr17:29076347	A/G	cg14067834	chr17:29058358	SUZ12P	-1.04	-5.26	-0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs17376456	0.877	rs10063045	chr5:93457584	A/T	cg25358565	chr5:93447407	FAM172A	1.26	8.18	0.68	4.21e-12	Diabetic retinopathy;
SKCM	trans	rs8073060	0.544	rs8071584	chr17:33999435	G/A	cg19694781	chr19:47549865	TMEM160	-1.04	-8.28	-0.68	2.65e-12	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs7208859	0.573	rs8078182	chr17:29149664	C/T	cg14067834	chr17:29058358	SUZ12P	0.96	5.04	0.5	2.95e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs72634258	0.945	rs7517357	chr1:8025275	C/T	cg00042356	chr1:8021962	PARK7	1.04	6.7	0.6	2.88e-9	Inflammatory bowel disease;
SKCM	cis	rs9399135	0.967	rs34546690	chr6:135369709	T/C	cg24558204	chr6:135376177	HBS1L	0.58	5.05	0.5	2.86e-6	Red blood cell count;
SKCM	cis	rs2050392	1.000	rs2253585	chr10:30696503	C/T	cg25182066	chr10:30743637	MAP3K8	-0.71	-5.96	-0.56	6.91e-8	Inflammatory bowel disease;
SKCM	cis	rs17685	0.796	rs3757594	chr7:75678644	G/A	cg01364799	chr7:75623366	TMEM120A	0.72	5.83	0.55	1.18e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs12911832	0.727	rs682619	chr15:59098773	T/C	cg05156742	chr15:59063176	FAM63B	0.77	5.82	0.55	1.25e-7	Schizophrenia;
SKCM	cis	rs8067545	0.611	rs1859407	chr17:20078137	T/C	cg13482628	chr17:19912719	NA	-0.66	-5.58	-0.53	3.37e-7	Schizophrenia;
SKCM	cis	rs2836974	0.605	rs2836988	chr21:40707975	A/G	cg11644478	chr21:40555479	PSMG1	-0.66	-5.47	-0.53	5.17e-7	Cognitive function;
SKCM	cis	rs28595532	0.920	rs115675321	chr4:119742153	A/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs929354	0.713	rs6946660	chr7:156948648	T/C	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs7666738	0.830	rs4401456	chr4:98959902	C/T	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2836974	0.932	rs73221193	chr21:40554693	C/T	cg11890956	chr21:40555474	PSMG1	1.11	13.42	0.84	5.75e-22	Cognitive function;
SKCM	cis	rs11139399	0.566	rs7859813	chr9:84338441	C/T	cg13729285	chr9:84764156	NA	0.53	5.07	0.5	2.65e-6	Hippocampal atrophy;
SKCM	cis	rs7772486	0.875	rs9373485	chr6:146401429	A/T	cg05347473	chr6:146136440	FBXO30	0.63	5.8	0.55	1.34e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9790314	0.560	rs1450521	chr3:161091237	C/A	cg03342759	chr3:160939853	NMD3	-0.79	-6.79	-0.61	1.97e-9	Morning vs. evening chronotype;
SKCM	cis	rs875971	0.862	rs7796162	chr7:65745758	T/C	cg11764359	chr7:65958608	NA	-0.76	-7.0	-0.62	8.03e-10	Aortic root size;
SKCM	cis	rs28595532	0.516	rs28552458	chr4:119288363	T/C	cg21605333	chr4:119757512	SEC24D	0.93	4.98	0.49	3.72e-6	Cannabis dependence symptom count;
SKCM	cis	rs826838	1.000	rs11168676	chr12:38977304	A/G	cg13010199	chr12:38710504	ALG10B	0.8	6.24	0.58	2.1e-8	Heart rate;
SKCM	cis	rs9549367	0.713	rs3024746	chr13:113821777	G/A	cg18105134	chr13:113819100	PROZ	-0.88	-6.51	-0.59	6.68e-9	Platelet distribution width;
SKCM	cis	rs1348850	0.567	rs4893838	chr2:178531436	T/C	cg22681709	chr2:178499509	PDE11A	-0.69	-6.21	-0.57	2.44e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs2777491	0.522	rs7169278	chr15:41696932	A/G	cg18705301	chr15:41695430	NDUFAF1	-0.69	-5.25	-0.51	1.26e-6	Ulcerative colitis;
SKCM	cis	rs28595532	0.668	rs58467651	chr4:119349011	T/G	cg11846333	chr4:119757529	SEC24D	1.19	6.36	0.58	1.24e-8	Cannabis dependence symptom count;
SKCM	cis	rs12971120	0.891	rs11151960	chr18:72177232	G/A	cg25817165	chr18:72167213	CNDP2	-0.65	-4.87	-0.48	5.69e-6	Refractive error;
SKCM	cis	rs2842992	0.724	rs9365097	chr6:160211259	G/A	cg19482086	chr6:160211437	TCP1;MRPL18	0.87	7.46	0.65	1.04e-10	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs1850744	0.702	rs73805540	chr4:9593964	C/G	cg15442990	chr4:9534313	NA	-1.3	-4.84	-0.48	6.55e-6	Economic and political preferences;
SKCM	cis	rs854765	0.893	rs712265	chr17:18008447	G/A	cg04398451	chr17:18023971	MYO15A	0.62	4.85	0.48	6.29e-6	Total body bone mineral density;
SKCM	cis	rs7666738	0.830	rs10011009	chr4:98981749	G/A	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs208520	0.507	rs7755710	chr6:66783355	G/A	cg07460842	chr6:66804631	NA	-1.17	-12.77	-0.82	8.56e-21	Exhaled nitric oxide output;
SKCM	cis	rs713587	0.520	rs487617	chr2:25309756	C/G	cg04586622	chr2:25135609	ADCY3	-0.63	-4.84	-0.48	6.35e-6	Body mass index in non-asthmatics;
SKCM	cis	rs4927850	1.000	rs4927704	chr3:195738228	C/T	cg01181863	chr3:195395398	SDHAP2	-0.91	-6.17	-0.57	2.8e-8	Pancreatic cancer;
SKCM	cis	rs9300255	0.602	rs1727317	chr12:123618942	T/C	cg05973401	chr12:123451056	ABCB9	0.78	5.29	0.51	1.09e-6	Neutrophil percentage of white cells;
SKCM	cis	rs3785574	1.000	rs7223257	chr17:61787684	T/C	cg01411255	chr17:61851458	DDX42;CCDC47	1.13	12.96	0.83	3.89e-21	Height;
SKCM	cis	rs6570726	0.791	rs9376953	chr6:145912226	G/T	cg23711669	chr6:146136114	FBXO30	0.88	8.37	0.69	1.84e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs501916	0.761	rs79925748	chr15:48046412	G/C	cg16110827	chr15:48056943	SEMA6D	-0.62	-5.02	-0.49	3.25e-6	Inflammatory bowel disease;Ulcerative colitis;
SKCM	cis	rs11690935	0.851	rs10174055	chr2:172858214	C/T	cg13550731	chr2:172543902	DYNC1I2	-0.92	-7.66	-0.66	4.32e-11	Schizophrenia;
SKCM	cis	rs875971	0.723	rs28391294	chr7:65654315	T/C	cg18876405	chr7:65276391	NA	-0.65	-6.64	-0.6	3.71e-9	Aortic root size;
SKCM	cis	rs28595532	0.920	rs55671478	chr4:119753811	A/G	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs9583531	0.689	rs4773244	chr13:111383937	A/T	cg15841412	chr13:111365552	ING1	-0.71	-5.0	-0.49	3.44e-6	Coronary artery disease;
SKCM	cis	rs875971	0.862	rs2901152	chr7:65765004	G/A	cg18876405	chr7:65276391	NA	-0.64	-6.43	-0.59	9.24e-9	Aortic root size;
SKCM	cis	rs2282300	0.739	rs35229181	chr11:30241698	A/G	cg25418670	chr11:30344373	C11orf46	-0.65	-4.93	-0.49	4.5e-6	Morning vs. evening chronotype;
SKCM	cis	rs362272	0.545	rs2748447	chr4:3337831	G/A	cg16987761	chr4:3318072	RGS12	1.0	11.48	0.79	1.96e-18	Serum sulfate level;
SKCM	cis	rs2935183	1	rs2935183	chr17:45607572	T/G	cg08085267	chr17:45401833	C17orf57	0.59	5.24	0.51	1.35e-6	Multiple sclerosis or amyotrophic lateral sclerosis;
SKCM	cis	rs9303401	0.659	rs62083410	chr17:56964386	T/C	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.16	0.57	2.91e-8	Cognitive test performance;
SKCM	cis	rs13118159	0.550	rs28522910	chr4:1374774	C/T	cg05025164	chr4:1340916	KIAA1530	0.87	7.19	0.63	3.36e-10	Longevity;
SKCM	cis	rs6951245	0.938	rs113642700	chr7:1105654	C/T	cg03188948	chr7:1209495	NA	1.13	6.27	0.58	1.89e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs10193935	1.000	rs13419669	chr2:42387254	T/C	cg27598129	chr2:42591480	NA	-0.92	-6.79	-0.61	1.97e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs36093844	0.706	rs7102361	chr11:85560139	C/T	cg25872744	chr11:85566296	CCDC83	-0.85	-4.77	-0.48	8.27e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs4481887	0.927	rs4453081	chr1:248475691	C/G	cg00666640	chr1:248458726	OR2T12	0.64	5.99	0.56	5.99e-8	Common traits (Other);
SKCM	cis	rs1862618	0.620	rs2591967	chr5:56233551	C/G	cg03609598	chr5:56110824	MAP3K1	0.68	4.9	0.48	5.16e-6	Initial pursuit acceleration;
SKCM	cis	rs4242434	0.927	rs35952885	chr8:22491622	T/G	cg03733263	chr8:22462867	KIAA1967	1.06	8.52	0.69	9.23e-13	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs4774899	1.000	rs12911518	chr15:57501494	T/G	cg01857019	chr15:57210107	LOC145783;TCF12	0.54	4.88	0.48	5.51e-6	Urinary tract infection frequency;
SKCM	cis	rs7086627	0.515	rs10887895	chr10:82210011	A/G	cg00277334	chr10:82204260	NA	-0.74	-8.56	-0.7	7.89e-13	Post bronchodilator FEV1;
SKCM	cis	rs2120019	0.938	rs2120020	chr15:75316845	T/C	cg17294928	chr15:75287854	SCAMP5	-0.89	-8.91	-0.71	1.6e-13	Blood trace element (Zn levels);
SKCM	cis	rs2153535	0.580	rs9406174	chr6:8516764	T/C	cg07606381	chr6:8435919	SLC35B3	0.87	6.38	0.59	1.17e-8	Motion sickness;
SKCM	cis	rs1691799	0.867	rs1168341	chr12:66759080	G/C	cg16791601	chr12:66731901	HELB	-0.63	-5.63	-0.54	2.72e-7	White blood cell count (basophil);
SKCM	cis	rs6951245	0.935	rs79067319	chr7:1065548	C/T	cg21664854	chr7:1097933	C7orf50;GPR146	0.9	4.86	0.48	6.05e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs4481887	0.741	rs28468416	chr1:248564451	G/T	cg22724847	chr1:248512586	OR14C36	0.59	4.97	0.49	3.82e-6	Common traits (Other);
SKCM	cis	rs7666738	0.830	rs28417577	chr4:99053007	T/C	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10832963	1.000	rs11024739	chr11:18645843	A/C	cg20219074	chr11:18656078	SPTY2D1	-0.83	-6.95	-0.62	9.76e-10	Breast cancer;
SKCM	cis	rs8177179	0.904	rs1130459	chr3:133465283	A/G	cg16262614	chr3:133464971	TF	0.44	5.34	0.52	9.01e-7	Iron status biomarkers (transferrin levels);
SKCM	cis	rs28386778	0.897	rs2665797	chr17:61922485	C/G	cg01411255	chr17:61851458	DDX42;CCDC47	-0.75	-4.83	-0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs4862750	0.914	rs11943333	chr4:187872455	A/G	cg10295955	chr4:187884368	NA	-0.78	-8.45	-0.69	1.26e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9399137	0.507	rs61738647	chr6:135282735	T/C	cg24558204	chr6:135376177	HBS1L	0.71	6.58	0.6	4.9e-9	Glycated hemoglobin levels;Mean corpuscular volume;Hematology traits;HbA2 levels;Mean corpuscular hemoglobin;Hemoglobin levels;F-cell distribution;Platelet count;
SKCM	cis	rs2836950	0.565	rs7276046	chr21:40581293	T/C	cg11890956	chr21:40555474	PSMG1	-0.66	-5.26	-0.51	1.22e-6	Menarche (age at onset);
SKCM	cis	rs11098499	0.954	rs4577559	chr4:120404043	T/G	cg09307838	chr4:120376055	NA	0.97	7.65	0.65	4.54e-11	Corneal astigmatism;
SKCM	cis	rs10479542	0.784	rs6601050	chr5:178986261	C/G	cg19723775	chr5:179050963	HNRNPH1	-0.6	-4.95	-0.49	4.24e-6	Lung cancer;
SKCM	cis	rs992157	0.764	rs2015863	chr2:219185161	C/T	cg20019365	chr2:219134978	PNKD;AAMP	-0.74	-5.94	-0.56	7.66e-8	Colorectal cancer;
SKCM	cis	rs4819052	0.851	rs1056101	chr21:46678702	C/G	cg02159808	chr21:46707872	POFUT2;LOC642852	0.75	5.86	0.55	1.05e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs4253772	0.637	rs9627295	chr22:46650100	C/T	cg03482458	chr22:46692211	CN5H6.4;GTSE1	1.11	4.96	0.49	4.03e-6	LDL cholesterol;Cholesterol, total;
SKCM	cis	rs7927771	0.832	rs7105851	chr11:47383275	T/C	cg05585544	chr11:47624801	NA	0.57	4.86	0.48	6.06e-6	Subjective well-being;
SKCM	cis	rs208520	0.690	rs12213561	chr6:66705646	T/C	cg07460842	chr6:66804631	NA	0.92	7.66	0.66	4.26e-11	Exhaled nitric oxide output;
SKCM	cis	rs362272	0.545	rs2236052	chr4:3318413	C/T	cg03043834	chr4:3319541	RGS12	-0.56	-4.83	-0.48	6.72e-6	Serum sulfate level;
SKCM	cis	rs9814567	0.806	rs9824185	chr3:134324024	G/C	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.65	-5.19	-0.51	1.6e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs17376456	0.825	rs17372615	chr5:93124768	C/T	cg25358565	chr5:93447407	FAM172A	1.15	7.28	0.64	2.25e-10	Diabetic retinopathy;
SKCM	cis	rs34172651	0.517	rs2547040	chr16:24736408	G/C	cg04756594	chr16:24857601	SLC5A11	-0.72	-5.09	-0.5	2.4e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs873946	0.590	rs12783478	chr10:134550700	A/G	cg18305652	chr10:134549665	INPP5A	0.57	5.65	0.54	2.49e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs2204008	0.580	rs11174421	chr12:38105138	A/G	cg26384229	chr12:38710491	ALG10B	0.85	6.26	0.58	1.92e-8	Bladder cancer;
SKCM	cis	rs1707322	1.000	rs4606257	chr1:46307268	G/A	cg03146154	chr1:46216737	IPP	0.74	5.0	0.49	3.39e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7811142	0.887	rs111972532	chr7:100069088	T/C	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.21	7.83	0.66	2.01e-11	Platelet count;
SKCM	cis	rs1005277	0.505	rs719569	chr10:38154415	T/G	cg25427524	chr10:38739819	LOC399744	0.68	6.38	0.59	1.15e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs2929278	0.617	rs693919	chr15:44102328	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	-0.69	-4.86	-0.48	5.84e-6	Schizophrenia;
SKCM	cis	rs16854884	0.657	rs35877644	chr3:143701755	A/G	cg06585982	chr3:143692056	C3orf58	0.87	8.0	0.67	9.21e-12	Economic and political preferences (feminism/equality);
SKCM	cis	rs17685	0.712	rs28456330	chr7:75810542	A/G	cg16489192	chr7:75678113	MDH2;STYXL1	-0.54	-5.21	-0.51	1.48e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs72949976	1.000	rs62186569	chr2:214034151	C/T	cg08319019	chr2:214017104	IKZF2	-0.71	-5.38	-0.52	7.52e-7	Lung cancer;Squamous cell lung carcinoma;
SKCM	cis	rs514406	0.893	rs1242315	chr1:53417181	A/G	cg24675658	chr1:53192096	ZYG11B	-0.63	-5.12	-0.5	2.14e-6	Monocyte count;
SKCM	cis	rs4234284	1.000	rs959035	chr3:126956698	C/A	cg04889221	chr3:126137216	CCDC37	-0.45	-4.78	-0.48	8e-6	Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel);
SKCM	cis	rs9300255	0.602	rs2695479	chr12:123689386	T/C	cg00376283	chr12:123451042	ABCB9	0.8	5.29	0.51	1.08e-6	Neutrophil percentage of white cells;
SKCM	cis	rs9814567	0.806	rs2888670	chr3:134326684	G/A	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.65	-5.19	-0.51	1.6e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs1153858	1.000	rs4775911	chr15:45649787	G/T	cg14582100	chr15:45693742	SPATA5L1	-0.65	-5.15	-0.5	1.91e-6	Homoarginine levels;
SKCM	cis	rs6500395	1.000	rs7198773	chr16:48606091	T/C	cg04672837	chr16:48644449	N4BP1	0.69	5.73	0.54	1.8e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs11098499	0.954	rs4309825	chr4:120314881	C/T	cg24375607	chr4:120327624	NA	-0.65	-5.22	-0.51	1.44e-6	Corneal astigmatism;
SKCM	cis	rs11098499	0.605	rs6833140	chr4:120266822	G/A	cg09307838	chr4:120376055	NA	0.96	8.24	0.68	3.19e-12	Corneal astigmatism;
SKCM	cis	rs798554	0.679	rs2533868	chr7:2886559	G/A	cg04166393	chr7:2884313	GNA12	0.79	5.54	0.53	3.9e-7	Height;
SKCM	cis	rs7618915	0.547	rs6976	chr3:52728804	C/T	cg18404041	chr3:52824283	ITIH1	-0.56	-4.94	-0.49	4.32e-6	Bipolar disorder;
SKCM	cis	rs6933660	0.800	rs9383893	chr6:151757327	T/C	cg14416726	chr6:151773293	C6orf211;RMND1	-0.61	-4.78	-0.48	8.04e-6	Menarche (age at onset);
SKCM	cis	rs72781680	1.000	rs72796358	chr2:24160132	T/A	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	cis	rs7100689	0.697	rs4934084	chr10:82116960	T/C	cg01528321	chr10:82214614	TSPAN14	0.82	7.43	0.64	1.2e-10	Post bronchodilator FEV1;
SKCM	cis	rs2286503	1.000	rs17724311	chr7:22876793	G/C	cg00309339	chr7:22893653	NA	-0.54	-4.78	-0.48	8.24e-6	Fibrinogen;
SKCM	cis	rs1957429	0.572	rs3813421	chr14:65347239	G/A	cg23373153	chr14:65346875	NA	1.11	6.32	0.58	1.52e-8	Pediatric areal bone mineral density (radius);
SKCM	cis	rs801193	0.839	rs6968619	chr7:66068867	T/C	cg11764359	chr7:65958608	NA	-0.79	-5.88	-0.55	9.67e-8	Aortic root size;
SKCM	cis	rs7561149	0.902	rs3769858	chr2:179667806	C/T	cg03991736	chr2:179345203	MIR548N;PLEKHA3	0.67	4.82	0.48	7e-6	QT interval;
SKCM	cis	rs35146811	0.844	rs13232115	chr7:99670932	T/C	cg13334819	chr7:99746414	C7orf59	-0.73	-5.28	-0.51	1.11e-6	Coronary artery disease;
SKCM	cis	rs1023500	0.573	rs1807494	chr22:42474138	C/G	cg04733989	chr22:42467013	NAGA	-0.72	-5.72	-0.54	1.9e-7	Schizophrenia;
SKCM	cis	rs7772486	0.875	rs11155452	chr6:146424631	C/T	cg05347473	chr6:146136440	FBXO30	0.65	5.96	0.56	6.79e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4819052	0.851	rs914218	chr21:46698445	G/C	cg19498844	chr21:46707878	POFUT2;LOC642852	0.91	7.84	0.66	1.92e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs9467773	1.000	rs6933176	chr6:26540178	G/A	cg15659132	chr6:26577336	NA	0.6	5.71	0.54	1.99e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs6547741	0.935	rs6749426	chr2:27847606	T/C	cg27432699	chr2:27873401	GPN1	0.76	6.84	0.61	1.57e-9	Oral cavity cancer;
SKCM	cis	rs2842992	0.915	rs2758335	chr6:160111011	G/A	cg19482086	chr6:160211437	TCP1;MRPL18	0.77	5.55	0.53	3.77e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs1799949	0.894	rs8176160	chr17:41241503	T/C	cg05368731	chr17:41323189	NBR1	0.88	7.75	0.66	2.84e-11	Menopause (age at onset);
SKCM	cis	rs9583531	0.689	rs1061386	chr13:111373368	G/C	cg24331049	chr13:111365604	ING1	0.85	6.24	0.58	2.08e-8	Coronary artery disease;
SKCM	cis	rs2228479	0.867	rs62052189	chr16:89975555	G/C	cg06558623	chr16:89946397	TCF25	1.23	6.7	0.6	2.88e-9	Skin colour saturation;
SKCM	cis	rs1023500	0.552	rs133368	chr22:42463689	T/C	cg04733989	chr22:42467013	NAGA	0.74	5.97	0.56	6.63e-8	Schizophrenia;
SKCM	cis	rs1957429	0.634	rs59000318	chr14:65419473	C/A	cg23373153	chr14:65346875	NA	-1.24	-6.33	-0.58	1.46e-8	Pediatric areal bone mineral density (radius);
SKCM	cis	rs12477438	0.520	rs2964969	chr2:99782811	G/A	cg26064155	chr2:99771622	LIPT1;TSGA10	1.02	9.73	0.74	4.23e-15	Chronic sinus infection;
SKCM	cis	rs9325144	0.560	rs10785562	chr12:38637419	A/C	cg26384229	chr12:38710491	ALG10B	-0.68	-5.43	-0.52	6.19e-7	Morning vs. evening chronotype;
SKCM	cis	rs6724607	1.000	rs4321393	chr2:191452899	G/T	cg21644426	chr2:191273491	MFSD6	0.69	4.94	0.49	4.28e-6	Pulse pressure;
SKCM	cis	rs2404602	0.692	rs4641709	chr15:77047736	C/T	cg23625390	chr15:77176239	SCAPER	-0.61	-5.44	-0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs798554	0.796	rs2158694	chr7:2863443	T/G	cg04166393	chr7:2884313	GNA12	0.71	4.95	0.49	4.22e-6	Height;
SKCM	cis	rs2075371	1.000	rs2598285	chr7:133971153	A/T	cg20476274	chr7:133979776	SLC35B4	1.04	11.39	0.79	2.84e-18	Mean platelet volume;
SKCM	cis	rs6951245	0.872	rs75280240	chr7:1058511	C/T	cg24642844	chr7:1081250	C7orf50	-0.95	-6.39	-0.59	1.13e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs6835098	0.924	rs2332669	chr4:174163398	G/A	cg08422745	chr4:174089978	GALNT7	-0.75	-5.49	-0.53	4.87e-7	Dementia and core Alzheimer's disease neuropathologic changes;
SKCM	cis	rs854765	0.583	rs67253360	chr17:17828973	T/C	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.0	7.64	0.65	4.64e-11	Total body bone mineral density;
SKCM	trans	rs1814175	0.781	rs1851872	chr11:50009770	A/G	cg03929089	chr4:120376271	NA	-0.93	-8.77	-0.7	3.08e-13	Height;
SKCM	cis	rs7772486	0.875	rs2777481	chr6:146310036	G/T	cg23711669	chr6:146136114	FBXO30	0.76	6.83	0.61	1.66e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2013441	1.000	rs17759959	chr17:20024095	A/G	cg13482628	chr17:19912719	NA	0.63	4.79	0.48	7.82e-6	Obesity-related traits;
SKCM	cis	rs2013441	1.000	rs1561974	chr17:20196144	G/A	cg13482628	chr17:19912719	NA	-0.65	-5.07	-0.5	2.67e-6	Obesity-related traits;
SKCM	cis	rs28595532	0.920	rs116795224	chr4:119734570	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.52	0.53	4.28e-7	Cannabis dependence symptom count;
SKCM	cis	rs2404602	0.684	rs12437981	chr15:76842401	A/G	cg23625390	chr15:77176239	SCAPER	-0.82	-7.93	-0.67	1.26e-11	Blood metabolite levels;
SKCM	cis	rs1059312	0.808	rs11059921	chr12:129289919	C/T	cg09035930	chr12:129282057	SLC15A4	0.77	8.03	0.67	8.18e-12	Systemic lupus erythematosus;
SKCM	cis	rs6951245	0.935	rs113365567	chr7:1108785	T/C	cg24642844	chr7:1081250	C7orf50	-0.93	-6.22	-0.58	2.28e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs6545883	0.965	rs2305156	chr2:61729268	T/C	cg15711740	chr2:61764176	XPO1	-0.75	-5.3	-0.51	1.06e-6	Tuberculosis;
SKCM	cis	rs9902453	1.000	rs57411618	chr17:28273052	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.79	5.67	0.54	2.35e-7	Coffee consumption (cups per day);
SKCM	cis	rs9325144	0.560	rs1825802	chr12:38650341	C/T	cg26384229	chr12:38710491	ALG10B	-0.61	-4.93	-0.49	4.57e-6	Morning vs. evening chronotype;
SKCM	cis	rs10779751	0.734	rs2039840	chr1:11125866	G/A	cg08854313	chr1:11322531	MTOR	0.77	5.52	0.53	4.36e-7	Body mass index;
SKCM	cis	rs1059312	0.545	rs7312683	chr12:129280105	T/C	cg09035930	chr12:129282057	SLC15A4	0.85	6.86	0.61	1.45e-9	Systemic lupus erythematosus;
SKCM	cis	rs4975616	0.869	rs452932	chr5:1330253	T/C	cg07493874	chr5:1342172	CLPTM1L	-0.7	-6.57	-0.6	5.12e-9	Lung cancer;
SKCM	cis	rs1707322	0.682	rs12037459	chr1:46094959	T/G	cg03146154	chr1:46216737	IPP	0.8	5.59	0.53	3.22e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs10207060	0.500	rs62183161	chr2:240699856	C/T	cg07506560	chr2:240697449	NA	0.76	6.36	0.58	1.26e-8	Obesity-related traits;
SKCM	cis	rs2404602	0.655	rs10444809	chr15:77124536	G/C	cg23625390	chr15:77176239	SCAPER	-0.62	-5.79	-0.55	1.39e-7	Blood metabolite levels;
SKCM	cis	rs4242434	0.689	rs4872006	chr8:22536502	T/C	cg03733263	chr8:22462867	KIAA1967	-0.82	-6.31	-0.58	1.58e-8	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs2836950	0.565	rs2150414	chr21:40614988	A/G	cg17971929	chr21:40555470	PSMG1	-0.75	-6.31	-0.58	1.58e-8	Menarche (age at onset);
SKCM	cis	rs155076	1.000	rs261406	chr13:21855854	G/A	cg11317459	chr13:21872234	NA	-1.24	-6.91	-0.62	1.19e-9	White matter hyperintensity burden;
SKCM	cis	rs12216125	0.549	rs9358905	chr6:26077839	T/A	cg16482183	chr6:26056742	HIST1H1C	0.61	4.85	0.48	6.08e-6	Iron status biomarkers;
SKCM	cis	rs1577917	0.561	rs3087978	chr6:86388223	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.79	7.16	0.63	3.95e-10	Response to antipsychotic treatment;
SKCM	cis	rs6977660	1.000	rs13230910	chr7:19806003	A/G	cg05791153	chr7:19748676	TWISTNB	-0.79	-5.53	-0.53	4.14e-7	Thyroid stimulating hormone;
SKCM	cis	rs55962025	0.855	rs6855981	chr4:3148276	A/G	cg16987761	chr4:3318072	RGS12	0.6	4.85	0.48	6.3e-6	Parental longevity (mother's age at death);
SKCM	cis	rs6547631	0.594	rs7908	chr2:85925756	C/G	cg24620635	chr2:85921963	GNLY	0.9	6.65	0.6	3.58e-9	Blood protein levels;
SKCM	cis	rs595982	0.559	rs17206700	chr19:49361255	A/G	cg19746536	chr19:49375674	PPP1R15A	0.85	4.91	0.49	4.96e-6	Red cell distribution width;
SKCM	cis	rs10504229	0.595	rs76447299	chr8:58117395	A/G	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs875971	1.000	rs6963646	chr7:65685767	T/C	cg18876405	chr7:65276391	NA	-0.68	-6.85	-0.61	1.54e-9	Aortic root size;
SKCM	cis	rs6089584	0.606	rs6089599	chr20:60576992	A/G	cg16423285	chr20:60520624	NA	0.59	4.88	0.48	5.43e-6	Body mass index;
SKCM	cis	rs1401999	0.966	rs2037379	chr3:183650330	T/C	cg01324343	chr3:183735012	ABCC5	0.89	10.08	0.75	8.94e-16	Anterior chamber depth;
SKCM	cis	rs9896933	0.887	rs78483419	chr17:80870884	T/C	cg20578329	chr17:80767326	TBCD	-0.91	-5.96	-0.56	6.84e-8	Bone mineral accretion in asthma (oral corticosteroid dose interaction);
SKCM	cis	rs1256061	0.603	rs10148269	chr14:64736924	A/G	cg21174375	chr14:64681225	SYNE2	0.47	4.95	0.49	4.15e-6	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs2811415	0.597	rs13062846	chr3:127744292	C/A	cg09089421	chr3:127803668	RUVBL1	0.99	8.52	0.69	9.09e-13	Lung function (FEV1/FVC);
SKCM	cis	rs1707322	1.000	rs11211200	chr1:46288352	A/G	cg03146154	chr1:46216737	IPP	0.77	5.36	0.52	8.35e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs9894429	1.000	rs7223613	chr17:79574803	C/T	cg18240062	chr17:79603768	NPLOC4	-0.76	-7.43	-0.64	1.2e-10	Eye color traits;
SKCM	cis	rs57221529	0.766	rs12518859	chr5:587432	C/T	cg09888920	chr5:474111	LOC25845;SLC9A3	0.99	4.79	0.48	7.91e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs3816788	0.774	rs11784816	chr8:21773500	C/T	cg17168535	chr8:21777572	XPO7	-0.6	-4.98	-0.49	3.75e-6	Lung cancer in ever smokers;
SKCM	cis	rs763014	0.966	rs7198877	chr16:661439	A/G	cg07343612	chr16:622815	PIGQ	-0.72	-6.16	-0.57	2.93e-8	Height;
SKCM	trans	rs1814175	0.754	rs28593359	chr11:50042357	C/T	cg15704280	chr7:45808275	SEPT13	-1.05	-11.07	-0.78	1.14e-17	Height;
SKCM	cis	rs6121246	0.559	rs12479491	chr20:30265450	T/C	cg13852791	chr20:30311386	BCL2L1	0.82	5.69	0.54	2.09e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs62064224	0.905	rs9891969	chr17:30627085	C/T	cg18200150	chr17:30822561	MYO1D	0.71	6.01	0.56	5.51e-8	Schizophrenia;
SKCM	cis	rs13256369	0.802	rs1060106	chr8:8561452	A/G	cg06636001	chr8:8085503	FLJ10661	0.75	5.73	0.54	1.81e-7	Obesity-related traits;
SKCM	cis	rs4481887	1.000	rs4244182	chr1:248471174	A/G	cg00666640	chr1:248458726	OR2T12	0.64	5.69	0.54	2.13e-7	Common traits (Other);
SKCM	cis	rs72772090	0.908	rs72772091	chr5:96040122	C/A	cg17330273	chr5:96107758	CAST;ERAP1	-0.8	-4.92	-0.49	4.8e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs6951245	1.000	rs75016635	chr7:1094121	G/A	cg18402987	chr7:1209562	NA	1.15	6.09	0.57	3.95e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs72781680	0.593	rs72797817	chr2:24350569	A/G	cg20701182	chr2:24300061	SF3B14	0.77	5.22	0.51	1.45e-6	Lymphocyte counts;
SKCM	cis	rs12044355	0.827	rs16854779	chr1:231827318	C/T	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	-0.71	-5.21	-0.51	1.48e-6	Alzheimer's disease;
SKCM	cis	rs67460515	0.892	rs4856769	chr3:161004549	C/A	cg03342759	chr3:160939853	NMD3	-0.81	-7.1	-0.63	5.14e-10	Parkinson's disease;
SKCM	cis	rs6840360	0.571	rs11932059	chr4:152524496	G/A	cg22705602	chr4:152727874	NA	-0.52	-5.7	-0.54	2.03e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs1577917	0.958	rs2225754	chr6:86449698	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.67	-5.87	-0.55	1.02e-7	Response to antipsychotic treatment;
SKCM	cis	rs9916302	0.904	rs11655531	chr17:37697959	T/C	cg07936489	chr17:37558343	FBXL20	-0.9	-8.11	-0.68	5.65e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs4905558	1.000	rs7156355	chr14:97293713	A/G	cg11863609	chr14:97355128	NA	-0.54	-4.88	-0.48	5.52e-6	Neutrophil count;
SKCM	cis	rs10193935	1.000	rs4048	chr2:42424595	A/C	cg27598129	chr2:42591480	NA	-0.88	-6.71	-0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7772486	0.754	rs9497419	chr6:146142609	T/C	cg05347473	chr6:146136440	FBXO30	0.58	5.35	0.52	8.51e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs11155671	0.530	rs6939761	chr6:150210994	T/C	cg05036130	chr6:150231994	NA	0.61	6.58	0.6	4.87e-9	Testicular germ cell tumor;
SKCM	cis	rs12711979	0.875	rs11686157	chr2:3855020	C/G	cg17052675	chr2:3827356	NA	-0.52	-4.8	-0.48	7.43e-6	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs933688	1.000	rs12656350	chr5:90751343	C/T	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.93	6.51	0.59	6.73e-9	Smoking behavior;
SKCM	cis	rs62103177	0.713	rs62103186	chr18:77627574	G/C	cg27393146	chr18:77495563	CTDP1	-0.92	-5.36	-0.52	8.37e-7	Opioid sensitivity;
SKCM	cis	rs11690935	1.000	rs6433311	chr2:172549248	A/G	cg13550731	chr2:172543902	DYNC1I2	0.99	8.78	0.7	2.9e-13	Schizophrenia;
SKCM	cis	rs4683346	1.000	rs12635458	chr3:42891616	C/G	cg06399164	chr3:42695035	ZBTB47	0.61	5.74	0.55	1.71e-7	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs1577917	0.958	rs12192546	chr6:86476484	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.89	9.04	0.72	8.94e-14	Response to antipsychotic treatment;
SKCM	cis	rs7824557	0.564	rs1435275	chr8:11235735	T/C	cg21775007	chr8:11205619	TDH	-0.6	-5.02	-0.49	3.21e-6	Retinal vascular caliber;
SKCM	cis	rs7618915	0.571	rs34115864	chr3:52612178	A/G	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs798766	1.000	rs798754	chr4:1720757	A/G	cg24239225	chr4:1659016	FAM53A	-0.67	-4.88	-0.48	5.53e-6	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs28386778	0.863	rs2597633	chr17:61872871	T/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs1529316	0.846	rs2627473	chr8:3824530	T/C	cg05999364	chr8:3269952	CSMD1	0.53	5.56	0.53	3.67e-7	Multiple sclerosis;
SKCM	cis	rs7829975	0.593	rs2921051	chr8:8320104	C/A	cg06636001	chr8:8085503	FLJ10661	0.98	10.33	0.76	3e-16	Mood instability;
SKCM	cis	rs1799949	0.896	rs33933393	chr17:41317432	C/T	cg23758822	chr17:41437982	NA	0.92	7.83	0.66	1.97e-11	Menopause (age at onset);
SKCM	cis	rs7552404	0.920	rs2788654	chr1:76219569	C/T	cg03433033	chr1:76189801	ACADM	0.76	5.41	0.52	6.62e-7	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs2251381	0.778	rs722013	chr21:30549245	G/T	cg24692254	chr21:30365293	RNF160	0.78	6.33	0.58	1.46e-8	Selective IgA deficiency;
SKCM	cis	rs56104184	0.779	rs73061627	chr19:49360418	C/T	cg15549821	chr19:49342101	PLEKHA4	-1.23	-7.74	-0.66	3e-11	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs28595532	0.702	rs72670238	chr4:119322751	C/T	cg21605333	chr4:119757512	SEC24D	0.92	4.92	0.49	4.76e-6	Cannabis dependence symptom count;
SKCM	cis	rs17826219	0.568	rs9907834	chr17:29154013	G/A	cg13385521	chr17:29058706	SUZ12P	0.9	4.78	0.48	8.1e-6	Body mass index;
SKCM	cis	rs35306767	0.903	rs34847097	chr10:902252	A/T	cg20503657	chr10:835505	NA	0.76	5.14	0.5	1.99e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs6952808	0.531	rs3779002	chr7:2183219	C/T	cg05863683	chr7:1912471	MAD1L1	0.6	4.98	0.49	3.78e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs4819052	0.851	rs11558445	chr21:46685175	A/G	cg19498844	chr21:46707878	POFUT2;LOC642852	0.83	6.88	0.61	1.34e-9	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7940866	0.804	rs10894287	chr11:130808483	C/T	cg12179176	chr11:130786555	SNX19	0.74	5.84	0.55	1.13e-7	Schizophrenia;
SKCM	cis	rs7772486	0.686	rs9497380	chr6:145955305	T/C	cg05347473	chr6:146136440	FBXO30	0.57	5.19	0.51	1.61e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7584330	0.638	rs13429533	chr2:238448712	A/G	cg14458575	chr2:238380390	NA	0.78	5.11	0.5	2.25e-6	Prostate cancer;
SKCM	cis	rs10911251	0.527	rs1537520	chr1:183084229	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.57	0.65	6.42e-11	Colorectal cancer;
SKCM	cis	rs2836974	0.583	rs2735307	chr21:40713358	C/T	cg11890956	chr21:40555474	PSMG1	0.72	5.76	0.55	1.56e-7	Cognitive function;
SKCM	cis	rs2228479	0.850	rs57267516	chr16:89903552	G/A	cg00800038	chr16:89945340	TCF25	-0.96	-4.88	-0.48	5.51e-6	Skin colour saturation;
SKCM	cis	rs6500395	1.000	rs8044519	chr16:48669081	G/T	cg04672837	chr16:48644449	N4BP1	0.65	5.43	0.52	6.29e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs10754283	0.967	rs10801759	chr1:90113745	A/G	cg21401794	chr1:90099060	LRRC8C	0.73	6.34	0.58	1.35e-8	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs561341	0.882	rs2428337	chr17:30299467	C/T	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs3749237	0.537	rs4459909	chr3:49469217	T/C	cg02487422	chr3:49467188	NICN1	0.64	4.79	0.48	7.67e-6	Resting heart rate;
SKCM	cis	rs7215564	0.818	rs35638109	chr17:78657367	C/T	cg16980736	chr17:78789706	RPTOR	-0.89	-4.88	-0.48	5.41e-6	Myopia (pathological);
SKCM	cis	rs6547631	0.527	rs55665393	chr2:85927727	T/C	cg24620635	chr2:85921963	GNLY	0.93	6.88	0.61	1.34e-9	Blood protein levels;
SKCM	cis	rs55962025	0.842	rs362306	chr4:3242100	C/T	cg21096898	chr4:3318625	RGS12	-0.75	-6.04	-0.56	4.84e-8	Parental longevity (mother's age at death);
SKCM	cis	rs1348850	0.519	rs10201883	chr2:178471407	T/C	cg27490568	chr2:178487706	NA	1.15	8.17	0.68	4.42e-12	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs9815354	0.767	rs73081335	chr3:41895177	A/G	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs9300255	0.544	rs1727309	chr12:123658258	A/G	cg05973401	chr12:123451056	ABCB9	0.81	4.98	0.49	3.78e-6	Neutrophil percentage of white cells;
SKCM	cis	rs2839186	0.619	rs55689527	chr21:47622727	A/G	cg11766577	chr21:47581405	C21orf56	-0.78	-6.92	-0.62	1.14e-9	Testicular germ cell tumor;
SKCM	cis	rs10504073	0.565	rs12056536	chr8:49890132	C/T	cg00325661	chr8:49890786	NA	-0.77	-7.06	-0.62	6.16e-10	Blood metabolite ratios;
SKCM	cis	rs875971	0.660	rs10229345	chr7:65982168	G/C	cg11764359	chr7:65958608	NA	0.85	6.6	0.6	4.55e-9	Aortic root size;
SKCM	cis	rs28386778	0.897	rs2727287	chr17:61904728	G/A	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs1577917	0.876	rs12201992	chr6:86618219	T/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.85	-8.62	-0.7	5.82e-13	Response to antipsychotic treatment;
SKCM	cis	rs4803468	0.967	rs3786553	chr19:41902746	T/G	cg14132834	chr19:41945861	ATP5SL	-0.74	-5.53	-0.53	4.03e-7	Height;
SKCM	cis	rs933688	0.877	rs10474352	chr5:90732225	C/T	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.02	7.91	0.67	1.44e-11	Smoking behavior;
SKCM	cis	rs4148883	0.737	rs13148577	chr4:100060836	G/A	cg12011299	chr4:100065546	ADH4	0.51	5.13	0.5	2.08e-6	Alcohol dependence;
SKCM	cis	rs769267	0.566	rs9304962	chr19:19679992	G/C	cg26732615	chr19:19648335	CILP2;YJEFN3	-0.57	-4.9	-0.48	5.19e-6	Tonsillectomy;
SKCM	cis	rs9303401	0.659	rs35082010	chr17:56936867	A/G	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.16	0.57	2.91e-8	Cognitive test performance;
SKCM	cis	rs7945705	0.692	rs11042149	chr11:9010737	T/C	cg13070366	chr11:9386451	NA	0.57	4.86	0.48	6.04e-6	Hemoglobin concentration;
SKCM	trans	rs3780486	0.801	rs10971424	chr9:33138775	T/C	cg20290983	chr6:43655470	MRPS18A	1.0	11.51	0.79	1.75e-18	IgG glycosylation;
SKCM	cis	rs4555082	0.834	rs11849607	chr14:105745383	G/A	cg13114125	chr14:105738426	BRF1	-0.69	-5.47	-0.53	5.33e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs514406	0.798	rs575138	chr1:53328394	C/G	cg16325326	chr1:53192061	ZYG11B	0.86	8.09	0.68	6.32e-12	Monocyte count;
SKCM	cis	rs7659604	0.539	rs7686200	chr4:122764553	C/T	cg06713675	chr4:122721982	EXOSC9	-0.75	-7.38	-0.64	1.48e-10	Type 2 diabetes;
SKCM	cis	rs6121246	0.559	rs6058465	chr20:30397691	G/A	cg13852791	chr20:30311386	BCL2L1	0.82	5.69	0.54	2.09e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs7954584	0.567	rs1720037	chr12:122382229	G/T	cg22618164	chr12:122356400	WDR66	-0.55	-5.53	-0.53	4.06e-7	Mean corpuscular volume;
SKCM	cis	rs3540	0.597	rs3539	chr15:91045419	G/T	cg22089800	chr15:90895588	ZNF774	-0.68	-4.92	-0.49	4.72e-6	Allergic disease (asthma, hay fever or eczema);Lymphocyte counts;
SKCM	cis	rs672059	1.000	rs551569	chr1:183158293	G/C	ch.1.3577855R	chr1:183094577	LAMC1	0.63	5.23	0.51	1.38e-6	Hypertriglyceridemia;
SKCM	cis	rs1218582	0.744	rs6674853	chr1:154892753	G/C	cg03351412	chr1:154909251	PMVK	0.74	6.34	0.58	1.4e-8	Prostate cancer;
SKCM	cis	rs3785574	0.582	rs62072238	chr17:61948841	A/T	cg06601766	chr17:61851465	DDX42;CCDC47	0.73	5.28	0.51	1.13e-6	Height;
SKCM	cis	rs7829975	0.577	rs940032	chr8:8546343	C/T	cg06636001	chr8:8085503	FLJ10661	-0.68	-5.05	-0.5	2.81e-6	Mood instability;
SKCM	cis	rs5750830	0.649	rs5750814	chr22:39797987	T/C	cg11247378	chr22:39784982	NA	-0.46	-5.4	-0.52	6.86e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs2050392	0.517	rs7096279	chr10:30759608	C/T	cg25182066	chr10:30743637	MAP3K8	-0.74	-6.64	-0.6	3.74e-9	Inflammatory bowel disease;
SKCM	cis	rs1348850	0.608	rs10176632	chr2:178225934	G/T	cg02961200	chr2:178257176	LOC100130691;AGPS	0.69	5.0	0.49	3.42e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs17685	0.784	rs1613890	chr7:75735037	T/C	cg16684958	chr7:75615977	POR	0.56	5.13	0.5	2.03e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs6570726	0.791	rs427128	chr6:145865917	T/C	cg05347473	chr6:146136440	FBXO30	0.57	5.14	0.5	1.95e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs3845702	0.736	rs6722147	chr2:180829704	G/A	cg01881094	chr2:180872142	CWC22	-1.3	-6.15	-0.57	3.07e-8	Schizophrenia;
SKCM	cis	rs116095464	0.558	rs62346508	chr5:203668	T/C	cg22496380	chr5:211416	CCDC127	-1.0	-5.11	-0.5	2.25e-6	Breast cancer;
SKCM	cis	rs7809950	0.817	rs2222845	chr7:107281829	C/T	cg23024343	chr7:107201750	COG5	0.81	7.41	0.64	1.28e-10	Coronary artery disease;
SKCM	cis	rs7809950	0.678	rs2107317	chr7:106899685	T/C	cg23024343	chr7:107201750	COG5	-0.79	-6.77	-0.61	2.16e-9	Coronary artery disease;
SKCM	cis	rs6547631	1.000	rs6547631	chr2:85909026	A/G	cg24620635	chr2:85921963	GNLY	-0.63	-5.1	-0.5	2.28e-6	Blood protein levels;
SKCM	cis	rs1850744	0.702	rs11735905	chr4:9601757	C/G	cg15442990	chr4:9534313	NA	-1.38	-5.09	-0.5	2.44e-6	Economic and political preferences;
SKCM	cis	rs6665290	0.904	rs12409428	chr1:227189969	T/C	cg10327440	chr1:227177885	CDC42BPA	-1.24	-16.91	-0.89	8.11e-28	Myeloid white cell count;
SKCM	cis	rs2455601	0.638	rs11042148	chr11:9008674	A/G	cg21881798	chr11:8931708	C11orf17;ST5	-0.76	-5.35	-0.52	8.41e-7	Schizophrenia;
SKCM	cis	rs1707322	0.663	rs3935296	chr1:46180470	T/C	cg03146154	chr1:46216737	IPP	-0.84	-6.2	-0.57	2.51e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs66887589	0.934	rs6817317	chr4:120542827	A/G	cg09307838	chr4:120376055	NA	-0.65	-4.82	-0.48	6.89e-6	Diastolic blood pressure;
SKCM	cis	rs394563	0.622	rs237024	chr6:149721965	T/C	cg03678062	chr6:149772716	ZC3H12D	-0.5	-5.73	-0.54	1.83e-7	Dupuytren's disease;
SKCM	cis	rs1865760	0.688	rs1436310	chr6:25969958	G/C	cg16482183	chr6:26056742	HIST1H1C	0.61	4.78	0.48	8.18e-6	Height;
SKCM	cis	rs3768617	0.510	rs10797843	chr1:183081995	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs9467773	1.000	rs9393732	chr6:26530898	G/A	cg15659132	chr6:26577336	NA	0.6	5.71	0.54	1.99e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs8180040	0.966	rs922957	chr3:47422152	G/C	cg27129171	chr3:47204927	SETD2	-0.79	-5.79	-0.55	1.43e-7	Colorectal cancer;
SKCM	cis	rs34375054	0.573	rs12579211	chr12:125647752	C/T	cg25124228	chr12:125621409	AACS	-0.72	-4.93	-0.49	4.51e-6	Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs2180341	0.781	rs6913350	chr6:127570560	C/T	cg24812749	chr6:127587940	RNF146	0.8	6.71	0.6	2.8e-9	Breast cancer;
SKCM	cis	rs7811142	1.000	rs11773661	chr7:100073069	G/C	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.34	0.69	2.1e-12	Platelet count;
SKCM	cis	rs1707322	1.000	rs9803784	chr1:46401907	T/C	cg03146154	chr1:46216737	IPP	0.77	5.36	0.52	8.35e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs35146811	0.735	rs858506	chr7:99820050	T/C	cg22906224	chr7:99728672	NA	-0.71	-5.61	-0.54	2.99e-7	Coronary artery disease;
SKCM	cis	rs1348850	0.918	rs12463893	chr2:178448559	G/T	cg02961200	chr2:178257176	LOC100130691;AGPS	0.78	6.01	0.56	5.57e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs644799	0.540	rs10831419	chr11:95478037	A/G	cg03916912	chr11:95522834	CEP57;FAM76B	0.67	5.03	0.49	3.11e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs2733201	1.000	rs4923969	chr15:44308536	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	-1.25	-4.88	-0.48	5.56e-6	Lipoprotein phospholipase A2 activity in cardiovascular disease;
SKCM	cis	rs427394	0.802	rs274721	chr5:6719164	C/T	cg10857441	chr5:6722123	POLS	-0.71	-7.33	-0.64	1.83e-10	Menopause (age at onset);
SKCM	cis	rs9611565	0.512	rs768414	chr22:42135751	T/C	cg03806693	chr22:41940476	POLR3H	1.15	7.18	0.63	3.65e-10	Vitiligo;
SKCM	cis	rs1577917	0.958	rs12203457	chr6:86689277	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.64	-5.54	-0.53	3.92e-7	Response to antipsychotic treatment;
SKCM	cis	rs459571	0.796	rs10993894	chr9:136884511	C/T	cg13789015	chr9:136890014	NCRNA00094	0.79	6.49	0.59	7.25e-9	Platelet distribution width;
SKCM	cis	rs16854884	0.657	rs12107291	chr3:143739547	T/C	cg06585982	chr3:143692056	C3orf58	0.87	8.11	0.68	5.72e-12	Economic and political preferences (feminism/equality);
SKCM	cis	rs3820928	0.874	rs12614648	chr2:227785535	G/A	cg11843606	chr2:227700838	RHBDD1	-0.6	-4.81	-0.48	7.17e-6	Pulmonary function;
SKCM	cis	rs2739330	0.587	rs4820571	chr22:24242973	A/G	cg24846343	chr22:24311635	DDTL	0.61	5.51	0.53	4.51e-7	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs1005277	0.579	rs2505248	chr10:38459097	A/G	cg25427524	chr10:38739819	LOC399744	-0.65	-6.22	-0.58	2.25e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs9911578	1.000	rs999431	chr17:56854441	A/G	cg05425664	chr17:57184151	TRIM37	-0.67	-4.85	-0.48	6.16e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1850744	0.826	rs7685513	chr4:9728599	C/T	cg15442990	chr4:9534313	NA	-1.34	-5.14	-0.5	2e-6	Economic and political preferences;
SKCM	cis	rs9911578	0.967	rs6503893	chr17:57149695	G/A	cg05425664	chr17:57184151	TRIM37	-0.84	-7.03	-0.62	6.82e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs16854884	0.739	rs56196484	chr3:143786160	G/T	cg06585982	chr3:143692056	C3orf58	0.77	6.35	0.58	1.34e-8	Economic and political preferences (feminism/equality);
SKCM	cis	rs2072499	0.932	rs2540183	chr1:156164885	C/G	cg24450063	chr1:156163899	SLC25A44	1.03	9.32	0.73	2.59e-14	Testicular germ cell tumor;
SKCM	cis	rs6449957	0.832	rs12660017	chr5:67450350	T/C	cg09038926	chr5:67483109	NA	-0.72	-5.57	-0.53	3.49e-7	Cleft lip with or without cleft palate;
SKCM	cis	rs873946	0.618	rs12775767	chr10:134545628	C/T	cg26818010	chr10:134567672	INPP5A	-0.72	-5.59	-0.54	3.18e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs732765	0.689	rs8019690	chr14:75135142	A/T	cg25946216	chr14:74253857	C14orf43	-0.92	-6.0	-0.56	5.93e-8	Non-small cell lung cancer;
SKCM	cis	rs9815354	0.812	rs73071242	chr3:41993011	T/C	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs763121	0.853	rs4821810	chr22:39072098	C/G	cg06022373	chr22:39101656	GTPBP1	0.89	6.54	0.59	5.88e-9	Menopause (age at onset);
SKCM	cis	rs6580649	0.941	rs4141065	chr12:48523499	G/A	cg05342945	chr12:48394962	COL2A1	0.79	5.39	0.52	7.22e-7	Lung cancer;
SKCM	cis	rs344364	0.511	rs1742460	chr16:1945441	G/C	cg26897989	chr16:1907736	C16orf73	-0.69	-7.09	-0.63	5.4e-10	Glomerular filtration rate in chronic kidney disease;
SKCM	cis	rs8017423	0.647	rs12882973	chr14:90820502	G/A	cg04374321	chr14:90722782	PSMC1	-0.77	-5.94	-0.56	7.46e-8	Mortality in heart failure;
SKCM	cis	rs17376456	1.000	rs9968691	chr5:93509756	C/G	cg21475434	chr5:93447410	FAM172A	0.99	5.65	0.54	2.49e-7	Diabetic retinopathy;
SKCM	cis	rs2153535	0.580	rs1832100	chr6:8446956	G/A	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs4481887	0.927	rs4350233	chr1:248489994	G/A	cg00666640	chr1:248458726	OR2T12	0.62	5.27	0.51	1.2e-6	Common traits (Other);
SKCM	cis	rs11098499	0.908	rs7695996	chr4:120322033	C/T	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs2842992	0.672	rs4708845	chr6:160219601	T/G	cg11366901	chr6:160182831	ACAT2	0.92	7.04	0.62	6.53e-10	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs208520	0.690	rs12202805	chr6:66703903	A/G	cg07460842	chr6:66804631	NA	-0.89	-7.4	-0.64	1.35e-10	Exhaled nitric oxide output;
SKCM	cis	rs1790761	0.692	rs1269981	chr11:67334959	G/A	cg00290607	chr11:67383545	NA	0.51	5.38	0.52	7.43e-7	Mean corpuscular volume;
SKCM	cis	rs11585357	0.895	rs72633823	chr1:17630779	G/A	cg08277548	chr1:17600880	PADI3	-0.89	-6.31	-0.58	1.53e-8	Hair shape;
SKCM	cis	rs7809950	1.000	rs2520269	chr7:107191327	T/C	cg23024343	chr7:107201750	COG5	-0.77	-6.92	-0.62	1.11e-9	Coronary artery disease;
SKCM	cis	rs28595532	0.920	rs55985953	chr4:119764971	T/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs1018697	0.518	rs2250301	chr10:104548393	G/A	cg04362960	chr10:104952993	NT5C2	-0.76	-4.81	-0.48	7.14e-6	Colorectal adenoma (advanced);
SKCM	cis	rs7772486	0.641	rs9390374	chr6:146368175	A/T	cg05347473	chr6:146136440	FBXO30	0.63	5.0	0.49	3.4e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9818758	0.556	rs13086240	chr3:49001409	G/A	cg24898236	chr3:49228699	LOC646498	0.65	4.98	0.49	3.66e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs1580019	0.587	rs34488151	chr7:32548146	A/G	cg06627557	chr7:32535165	LSM5;AVL9	0.95	9.08	0.72	7.65e-14	Cognitive ability;
SKCM	cis	rs34779708	0.931	rs66887762	chr10:35330577	C/T	cg03585969	chr10:35415529	CREM	0.75	6.23	0.58	2.2e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs4724125	0.960	rs724823	chr7:42722489	G/A	cg09407816	chr7:42972088	MRPL32;PSMA2	0.79	4.79	0.48	7.72e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6088590	0.901	rs6087631	chr20:33403509	T/C	cg24642439	chr20:33292090	TP53INP2	1.01	7.2	0.63	3.23e-10	Coronary artery disease;
SKCM	cis	rs752010	0.715	rs4660551	chr1:42099979	T/C	cg06885757	chr1:42089581	HIVEP3	0.67	7.02	0.62	7.25e-10	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs2019137	0.539	rs4849177	chr2:113982584	T/C	cg12889195	chr2:113992843	PAX8;LOC440839;LOC654433	0.72	5.34	0.52	8.85e-7	Lymphocyte counts;
SKCM	cis	rs6500395	1.000	rs7188741	chr16:48607966	T/C	cg04672837	chr16:48644449	N4BP1	0.67	5.57	0.53	3.49e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs394563	0.726	rs6942381	chr6:149662991	G/C	cg16235748	chr6:149772707	ZC3H12D	0.44	5.02	0.49	3.22e-6	Dupuytren's disease;
SKCM	cis	rs11690935	0.959	rs4667694	chr2:172605399	G/A	cg13550731	chr2:172543902	DYNC1I2	-0.95	-8.21	-0.68	3.64e-12	Schizophrenia;
SKCM	cis	rs4423214	0.559	rs11234042	chr11:71239086	C/A	cg05163923	chr11:71159392	DHCR7	-0.69	-4.89	-0.48	5.34e-6	Vitamin D levels;
SKCM	cis	rs1707322	0.963	rs4553121	chr1:46375253	G/A	cg03146154	chr1:46216737	IPP	0.74	5.06	0.5	2.76e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs62238980	0.614	rs79667666	chr22:32396346	T/G	cg00543991	chr22:32367038	NA	1.15	4.87	0.48	5.76e-6	Childhood ear infection;
SKCM	cis	rs7208859	0.623	rs8067035	chr17:29102188	T/C	cg13385521	chr17:29058706	SUZ12P	1.04	5.39	0.52	7.17e-7	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs4132509	1.000	rs9782958	chr1:243892972	C/G	cg21452805	chr1:244014465	NA	0.8	5.22	0.51	1.46e-6	RR interval (heart rate);
SKCM	cis	rs447735	0.566	rs258337	chr16:89720710	T/A	cg01097406	chr16:89675127	NA	0.48	5.05	0.5	2.8e-6	Hemoglobin concentration;
SKCM	cis	rs3087591	0.879	rs12103564	chr17:29607243	A/T	cg24425628	chr17:29625626	OMG;NF1	-0.63	-4.79	-0.48	7.9e-6	Hip circumference;
SKCM	cis	rs7618501	0.699	rs1317154	chr3:49910084	T/C	cg05072774	chr3:49840536	C3orf54	-0.7	-5.25	-0.51	1.3e-6	Intelligence (multi-trait analysis);
SKCM	trans	rs561341	1.000	rs7216102	chr17:30259450	A/G	cg20587970	chr11:113659929	NA	-1.07	-9.16	-0.72	5.2e-14	Hip circumference adjusted for BMI;
SKCM	cis	rs73001065	0.688	rs59148799	chr19:19484008	A/G	cg03709012	chr19:19516395	GATAD2A	1.15	5.25	0.51	1.28e-6	LDL cholesterol;
SKCM	cis	rs7296418	0.738	rs10846489	chr12:123743927	A/G	cg00376283	chr12:123451042	ABCB9	-0.87	-7.16	-0.63	3.94e-10	Platelet count;
SKCM	cis	rs709400	1.000	rs56660916	chr14:104126137	G/T	cg26031613	chr14:104095156	KLC1	1.05	12.89	0.82	5.14e-21	Body mass index;
SKCM	cis	rs950776	0.593	rs555018	chr15:78879242	G/A	cg06917634	chr15:78832804	PSMA4	-0.9	-7.99	-0.67	9.7e-12	Sudden cardiac arrest;
SKCM	cis	rs10777212	0.632	rs10858936	chr12:90270781	C/T	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.8	-4.81	-0.48	7.16e-6	Total body bone mineral density;
SKCM	cis	rs13118159	0.509	rs4974554	chr4:1356967	A/C	cg02018176	chr4:1364513	KIAA1530	0.93	7.8	0.66	2.31e-11	Longevity;
SKCM	cis	rs2180341	1.000	rs9398837	chr6:127635217	G/A	cg24812749	chr6:127587940	RNF146	0.84	7.25	0.63	2.6e-10	Breast cancer;
SKCM	cis	rs28595532	0.920	rs116799007	chr4:119763562	A/G	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs7772486	0.686	rs9497395	chr6:146013592	A/G	cg23711669	chr6:146136114	FBXO30	-0.89	-8.89	-0.71	1.8e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4888262	0.508	rs7189123	chr16:74540097	C/A	cg01733217	chr16:74700730	RFWD3	0.88	7.05	0.62	6.42e-10	Testicular germ cell tumor;
SKCM	cis	rs3816788	0.620	rs11783414	chr8:21773384	A/G	cg17168535	chr8:21777572	XPO7	-0.61	-5.16	-0.5	1.84e-6	Lung cancer in ever smokers;
SKCM	cis	rs995000	0.868	rs1007205	chr1:62936912	T/C	cg06896770	chr1:63153194	DOCK7	-0.76	-7.3	-0.64	2.08e-10	Triglyceride levels;
SKCM	cis	rs1577917	0.958	rs10944136	chr6:86448499	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.59	-4.99	-0.49	3.56e-6	Response to antipsychotic treatment;
SKCM	cis	rs1570989	0.841	rs956598	chr6:12027635	A/G	cg17804551	chr6:12015979	HIVEP1	0.51	4.79	0.48	7.77e-6	Alcohol and nicotine co-dependence;
SKCM	cis	rs67311347	0.544	rs4974040	chr3:40331059	G/A	cg00656387	chr3:40428638	ENTPD3	0.56	5.01	0.49	3.25e-6	Renal cell carcinoma;
SKCM	cis	rs6952808	0.531	rs73039217	chr7:2178731	G/A	cg05863683	chr7:1912471	MAD1L1	0.6	4.98	0.49	3.78e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs736408	0.648	rs3774354	chr3:52817675	G/A	cg18404041	chr3:52824283	ITIH1	-0.55	-4.82	-0.48	6.98e-6	Bipolar disorder;
SKCM	cis	rs2836974	0.863	rs8132333	chr21:40527900	A/G	cg11890956	chr21:40555474	PSMG1	1.07	13.19	0.83	1.48e-21	Cognitive function;
SKCM	cis	rs3820928	0.692	rs17416354	chr2:227770844	A/G	cg11843606	chr2:227700838	RHBDD1	-0.62	-5.01	-0.49	3.25e-6	Pulmonary function;
SKCM	cis	rs2721195	0.967	rs10108150	chr8:145687475	A/G	cg11211951	chr8:145729740	GPT	-0.66	-6.1	-0.57	3.75e-8	Age at first birth;
SKCM	cis	rs66573146	0.831	rs73088564	chr4:6984553	G/C	cg00086871	chr4:6988644	TBC1D14	1.29	5.03	0.5	3.04e-6	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs854765	0.583	rs4257260	chr17:17857003	A/G	cg04398451	chr17:18023971	MYO15A	-0.86	-5.91	-0.56	8.41e-8	Total body bone mineral density;
SKCM	cis	rs7618501	0.633	rs4688755	chr3:50064424	G/A	cg24110177	chr3:50126178	RBM5	0.6	5.06	0.5	2.68e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9790314	1.000	rs4597724	chr3:160963110	A/G	cg03342759	chr3:160939853	NMD3	-0.72	-7.89	-0.67	1.53e-11	Morning vs. evening chronotype;
SKCM	cis	rs992157	0.735	rs13388024	chr2:219097773	A/G	cg00012203	chr2:219082015	ARPC2	0.84	7.36	0.64	1.6e-10	Colorectal cancer;
SKCM	cis	rs593982	1.000	rs576663	chr11:65498942	G/T	cg08755490	chr11:65554678	OVOL1	1.06	10.75	0.77	4.73e-17	Atopic dermatitis;
SKCM	cis	rs910316	1.000	rs7145159	chr14:75583268	A/G	cg11812906	chr14:75593930	NEK9	0.68	5.35	0.52	8.4e-7	Height;
SKCM	cis	rs28595532	1.000	rs41455648	chr4:119718030	A/G	cg11846333	chr4:119757529	SEC24D	1.19	6.39	0.59	1.12e-8	Cannabis dependence symptom count;
SKCM	cis	rs908922	0.676	rs6587686	chr1:152528948	C/T	cg09873164	chr1:152488093	CRCT1	0.72	5.62	0.54	2.85e-7	Hair morphology;
SKCM	trans	rs8073060	0.586	rs2626625	chr17:34027607	C/G	cg19694781	chr19:47549865	TMEM160	-1.08	-8.6	-0.7	6.4e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs823143	0.570	rs823084	chr1:205798313	G/T	cg07157834	chr1:205819609	PM20D1	0.86	8.88	0.71	1.86e-13	Monocyte percentage of white cells;
SKCM	cis	rs7215564	0.818	rs34756632	chr17:78618859	C/T	cg16980736	chr17:78789706	RPTOR	-0.87	-4.83	-0.48	6.64e-6	Myopia (pathological);
SKCM	cis	rs9513627	1.000	rs4584676	chr13:100160560	A/G	cg11288260	chr13:100117058	NA	0.79	4.78	0.48	8.1e-6	Obesity-related traits;
SKCM	cis	rs12142240	0.692	rs7529674	chr1:46818508	T/C	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	trans	rs17685	0.623	rs7782808	chr7:75768645	C/T	cg19862616	chr7:65841803	NCRNA00174	0.94	9.49	0.73	1.22e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs73201462	1.000	rs11721213	chr3:128067441	A/C	cg09089421	chr3:127803668	RUVBL1	-1.0	-5.11	-0.5	2.22e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs514406	0.644	rs7552663	chr1:53204352	C/T	cg16325326	chr1:53192061	ZYG11B	-0.86	-9.02	-0.71	9.97e-14	Monocyte count;
SKCM	cis	rs12541335	0.639	rs11779277	chr8:22200683	C/T	cg02463440	chr8:22132932	PIWIL2	0.64	5.6	0.54	3.03e-7	Hypertriglyceridemia;
SKCM	cis	rs2011503	0.882	rs10407933	chr19:19364319	A/G	cg11584989	chr19:19387371	SF4	0.78	5.16	0.5	1.85e-6	Bipolar disorder;
SKCM	cis	rs11098499	0.505	rs75122014	chr4:120362426	G/C	cg24375607	chr4:120327624	NA	0.64	4.86	0.48	5.93e-6	Corneal astigmatism;
SKCM	cis	rs11105298	0.891	rs10858869	chr12:89857611	C/T	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.88	-6.05	-0.57	4.76e-8	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs7829975	0.577	rs79495969	chr8:8545250	G/A	cg06636001	chr8:8085503	FLJ10661	-0.68	-4.98	-0.49	3.67e-6	Mood instability;
SKCM	cis	rs11792861	0.591	rs7027874	chr9:111717112	A/G	cg14432460	chr9:111696404	IKBKAP;C9orf6	0.77	6.58	0.6	4.9e-9	Menarche (age at onset);
SKCM	cis	rs7598759	0.527	rs7571691	chr2:232369401	C/T	cg19187155	chr2:232395269	NMUR1	0.85	7.44	0.64	1.11e-10	Noise-induced hearing loss;
SKCM	cis	rs1850744	0.702	rs2127793	chr4:9584728	C/T	cg15442990	chr4:9534313	NA	-1.43	-5.75	-0.55	1.68e-7	Economic and political preferences;
SKCM	cis	rs2153535	0.580	rs4365970	chr6:8453813	C/T	cg07606381	chr6:8435919	SLC35B3	-0.88	-6.17	-0.57	2.88e-8	Motion sickness;
SKCM	cis	rs1791581	1.000	rs1791581	chr11:106496038	G/A	cg20965478	chr11:107328442	CWF19L2	-0.81	-4.8	-0.48	7.54e-6	Visceral adipose tissue/subcutaneous adipose tissue ratio;
SKCM	cis	rs2153535	0.601	rs9502715	chr6:8455709	C/T	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs10791097	0.667	rs2155358	chr11:130740357	T/C	cg12179176	chr11:130786555	SNX19	0.93	8.2	0.68	3.79e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs11098499	0.913	rs11098496	chr4:120167466	C/G	cg09307838	chr4:120376055	NA	0.94	7.67	0.66	4.16e-11	Corneal astigmatism;
SKCM	cis	rs2677744	0.657	rs11073961	chr15:91483392	A/G	cg23684204	chr15:91497937	RCCD1	0.57	4.82	0.48	6.97e-6	Attention deficit hyperactivity disorder;
SKCM	cis	rs28595532	0.920	rs115485705	chr4:119733286	G/C	cg21605333	chr4:119757512	SEC24D	1.36	8.05	0.67	7.69e-12	Cannabis dependence symptom count;
SKCM	cis	rs9910055	0.659	rs186603	chr17:42207884	C/T	cg09913183	chr17:42254507	C17orf65;ASB16	-0.68	-6.38	-0.59	1.17e-8	Total body bone mineral density;
SKCM	cis	rs796364	0.951	rs281769	chr2:200809709	T/C	cg12253985	chr2:200820533	C2orf60;C2orf47	0.85	5.39	0.52	7.18e-7	Schizophrenia;
SKCM	cis	rs8072100	0.840	rs9912311	chr17:45547132	T/C	cg08085267	chr17:45401833	C17orf57	-0.62	-5.15	-0.5	1.88e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs4073582	0.595	rs801737	chr11:65928193	T/C	cg16950941	chr11:66035639	RAB1B	0.81	6.87	0.61	1.41e-9	Gout;
SKCM	cis	rs2721195	0.845	rs3757966	chr8:145744618	G/A	cg15857475	chr8:145742913	RECQL4;LRRC14	0.9	9.23	0.72	3.91e-14	Age at first birth;
SKCM	cis	rs6424115	0.708	rs34570472	chr1:24191720	A/G	cg15997130	chr1:24165203	NA	-0.63	-5.08	-0.5	2.52e-6	Immature fraction of reticulocytes;
SKCM	cis	rs909674	0.818	rs8136980	chr22:39844574	G/A	cg24399712	chr22:39784796	NA	-0.58	-4.88	-0.48	5.56e-6	IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis);IgG glycosylation;IgG digalactosylation phenotypes (multivariate analysis);IgG sialylation phenotypes (multivariate analysis);IgG monogalactosylation phenotypes (multivariate analysis);IgG fucosylation phenotypes (multivariate analysis);IgG N-glycosylation phenotypes (multivariate analysis);IgG disialylation phenotypes (multivariate analysis);IgG galactosylation phenotypes (multivariate analysis);Post bronchodilator FEV1;
SKCM	cis	rs9911578	1.000	rs304299	chr17:56838472	C/G	cg12560992	chr17:57184187	TRIM37	0.95	7.69	0.66	3.7e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs6500395	0.962	rs1386042	chr16:48600332	G/A	cg04672837	chr16:48644449	N4BP1	0.69	5.73	0.54	1.8e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs1577917	1.000	rs1911552	chr6:86638024	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.61	-5.31	-0.52	1.02e-6	Response to antipsychotic treatment;
SKCM	cis	rs13118159	0.550	rs28733902	chr4:1374789	A/G	cg20887711	chr4:1340912	KIAA1530	0.93	6.95	0.62	9.67e-10	Longevity;
SKCM	cis	rs2204008	0.689	rs1581357	chr12:38391479	C/G	cg26384229	chr12:38710491	ALG10B	0.82	6.3	0.58	1.6e-8	Bladder cancer;
SKCM	cis	rs10089	1.000	rs17164310	chr5:127493679	A/G	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.85	7.88	0.67	1.59e-11	Ileal carcinoids;
SKCM	cis	rs9322193	0.847	rs4870054	chr6:150169538	C/T	cg07701084	chr6:150067640	NUP43	0.61	4.85	0.48	6.27e-6	Lung cancer;
SKCM	cis	rs6121246	0.909	rs6060679	chr20:30270772	C/G	cg11595048	chr20:30225325	COX4I2	-0.67	-5.21	-0.51	1.5e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs9674544	0.757	rs4410130	chr17:47122942	C/T	cg10950924	chr17:47092072	IGF2BP1	0.6	5.31	0.52	1.01e-6	Primary tooth development (time to first tooth eruption);Primary tooth development (number of teeth);
SKCM	cis	rs4481887	0.962	rs4369256	chr1:248492274	G/A	cg00666640	chr1:248458726	OR2T12	0.59	4.96	0.49	4.04e-6	Common traits (Other);
SKCM	cis	rs7843479	0.965	rs13278159	chr8:21799737	C/A	cg17168535	chr8:21777572	XPO7	0.78	6.42	0.59	9.79e-9	Mean corpuscular volume;
SKCM	cis	rs950776	0.518	rs12906284	chr15:78825105	C/T	cg06917634	chr15:78832804	PSMA4	1.01	10.47	0.76	1.56e-16	Sudden cardiac arrest;
SKCM	cis	rs875971	0.862	rs6971059	chr7:66067032	A/G	cg11764359	chr7:65958608	NA	-0.74	-6.64	-0.6	3.76e-9	Aortic root size;
SKCM	cis	rs875971	0.540	rs35510581	chr7:65578777	G/A	cg00343986	chr7:65444356	GUSB	-0.67	-4.78	-0.48	8.03e-6	Aortic root size;
SKCM	cis	rs1413885	0.516	rs7537733	chr1:65838229	G/A	cg14976592	chr1:65886160	LEPROT;LEPR	0.59	5.1	0.5	2.32e-6	Anticoagulant levels;
SKCM	cis	rs1801251	1.000	rs3817311	chr2:233612557	C/T	cg08000102	chr2:233561755	GIGYF2	0.87	7.05	0.62	6.23e-10	Coronary artery disease;
SKCM	cis	rs4665809	0.590	rs1469523	chr2:26474631	T/A	cg26119090	chr2:26468346	HADHA;HADHB	1.06	8.39	0.69	1.66e-12	Gut microbiome composition (summer);
SKCM	cis	rs28595532	0.764	rs115011450	chr4:119778171	C/T	cg11846333	chr4:119757529	SEC24D	1.17	6.09	0.57	4.03e-8	Cannabis dependence symptom count;
SKCM	cis	rs7937682	0.632	rs7112886	chr11:111743232	T/C	cg09085632	chr11:111637200	PPP2R1B	1.1	9.83	0.74	2.69e-15	Primary sclerosing cholangitis;
SKCM	cis	rs9814567	0.964	rs4539979	chr3:134287597	C/T	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs2599510	0.783	rs62136349	chr2:32827504	G/A	cg02381751	chr2:32503542	YIPF4	0.74	5.68	0.54	2.25e-7	Interleukin-18 levels;
SKCM	cis	rs7772486	0.840	rs2474355	chr6:146312540	C/G	cg23711669	chr6:146136114	FBXO30	0.76	7.08	0.63	5.66e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs11734570	0.581	rs79354477	chr4:38597448	C/T	cg18361445	chr4:38666374	KLF3;FLJ13197	0.86	5.8	0.55	1.35e-7	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs6580649	0.941	rs4760615	chr12:48428150	A/G	cg05342945	chr12:48394962	COL2A1	-0.69	-5.14	-0.5	1.96e-6	Lung cancer;
SKCM	cis	rs736408	1.000	rs736408	chr3:52835354	C/T	cg11645453	chr3:52864694	ITIH4	0.7	5.98	0.56	6.3e-8	Bipolar disorder;
SKCM	cis	rs1065656	0.534	rs7498918	chr16:1845144	G/A	cg08610935	chr16:1836813	NUBP2	0.63	4.98	0.49	3.67e-6	Insulin-like growth factors;
SKCM	cis	rs6570726	0.846	rs1935616	chr6:145943512	C/T	cg23711669	chr6:146136114	FBXO30	0.9	10.02	0.75	1.16e-15	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7811142	0.887	rs4074838	chr7:100032665	G/A	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-0.99	-5.52	-0.53	4.2e-7	Platelet count;
SKCM	cis	rs854765	0.693	rs35451946	chr17:17764061	C/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	-1.05	-8.25	-0.68	3.1e-12	Total body bone mineral density;
SKCM	cis	rs4642101	0.597	rs2305397	chr3:12857493	C/T	cg05775895	chr3:12838266	CAND2	0.66	5.51	0.53	4.54e-7	QRS complex (12-leadsum);
SKCM	cis	rs12586317	0.547	rs12435454	chr14:35466997	A/G	cg16230307	chr14:35515116	FAM177A1	0.81	5.88	0.55	9.47e-8	Psoriasis;
SKCM	cis	rs4423214	1.000	rs12785878	chr11:71167449	G/T	cg05163923	chr11:71159392	DHCR7	0.78	7.36	0.64	1.62e-10	Vitamin D levels;
SKCM	cis	rs763014	0.931	rs7199839	chr16:636126	T/C	cg07343612	chr16:622815	PIGQ	-0.7	-6.0	-0.56	5.84e-8	Height;
SKCM	cis	rs2777491	0.574	rs316616	chr15:41746276	G/A	cg18705301	chr15:41695430	NDUFAF1	-1.19	-13.25	-0.83	1.15e-21	Ulcerative colitis;
SKCM	cis	rs4481887	1.000	rs6697735	chr1:248465315	G/C	cg00666640	chr1:248458726	OR2T12	0.59	4.98	0.49	3.72e-6	Common traits (Other);
SKCM	cis	rs2180341	0.842	rs7739679	chr6:127545428	G/A	cg27446573	chr6:127587934	RNF146	1.03	7.28	0.64	2.27e-10	Breast cancer;
SKCM	cis	rs9910055	0.529	rs170637	chr17:42186868	C/T	cg19774624	chr17:42201019	HDAC5	0.83	6.53	0.59	5.96e-9	Total body bone mineral density;
SKCM	cis	rs9549367	0.713	rs9549691	chr13:113861606	A/C	cg18105134	chr13:113819100	PROZ	-0.83	-6.75	-0.61	2.36e-9	Platelet distribution width;
SKCM	cis	rs4780401	0.609	rs7205994	chr16:11815964	C/T	cg01061890	chr16:11836724	TXNDC11	-0.77	-5.59	-0.54	3.18e-7	Rheumatoid arthritis;
SKCM	cis	rs116095464	0.558	rs62347678	chr5:227496	A/G	cg22857025	chr5:266934	NA	-1.37	-8.11	-0.68	5.82e-12	Breast cancer;
SKCM	cis	rs9902453	0.967	rs4325622	chr17:28526475	T/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.75	5.19	0.51	1.65e-6	Coffee consumption (cups per day);
SKCM	cis	rs672059	1.000	rs1760624	chr1:183158552	C/A	ch.1.3577855R	chr1:183094577	LAMC1	0.63	5.23	0.51	1.38e-6	Hypertriglyceridemia;
SKCM	cis	rs514406	0.565	rs897732	chr1:53382816	A/C	cg08859206	chr1:53392774	SCP2	-0.63	-5.32	-0.52	9.59e-7	Monocyte count;
SKCM	cis	rs2346177	0.554	rs13002880	chr2:46708129	C/G	cg02822958	chr2:46747628	ATP6V1E2	0.76	5.58	0.53	3.38e-7	HDL cholesterol;
SKCM	cis	rs763121	0.889	rs1043402	chr22:38879688	G/A	cg06022373	chr22:39101656	GTPBP1	0.74	5.32	0.52	9.84e-7	Menopause (age at onset);
SKCM	cis	rs2559856	1.000	rs2559855	chr12:102090080	A/G	cg12924262	chr12:102091054	CHPT1	-0.64	-5.46	-0.53	5.44e-7	Blood protein levels;
SKCM	cis	rs6461049	0.800	rs3778977	chr7:2159746	C/T	cg21782813	chr7:2030301	MAD1L1	0.46	4.78	0.48	8.08e-6	Schizophrenia;
SKCM	cis	rs6570726	0.935	rs429306	chr6:145827016	T/C	cg23711669	chr6:146136114	FBXO30	0.7	6.64	0.6	3.72e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2404602	0.716	rs2404737	chr15:76872217	T/G	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	trans	rs208520	0.690	rs1580430	chr6:66715162	T/A	cg15611600	chr13:45563400	KIAA1704;NUFIP1	0.91	7.45	0.64	1.1e-10	Exhaled nitric oxide output;
SKCM	cis	rs67311347	0.544	rs9821440	chr3:40342347	T/C	cg00656387	chr3:40428638	ENTPD3	0.56	4.99	0.49	3.54e-6	Renal cell carcinoma;
SKCM	cis	rs9790314	0.905	rs4856739	chr3:160986710	A/C	cg03342759	chr3:160939853	NMD3	-0.73	-8.2	-0.68	3.89e-12	Morning vs. evening chronotype;
SKCM	cis	rs875971	0.522	rs6960048	chr7:65408039	A/G	cg18876405	chr7:65276391	NA	0.84	7.61	0.65	5.38e-11	Aortic root size;
SKCM	cis	rs6582630	0.555	rs7978749	chr12:38527141	G/T	cg26384229	chr12:38710491	ALG10B	0.82	6.64	0.6	3.86e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs4642101	0.512	rs9813960	chr3:12818205	A/G	cg05775895	chr3:12838266	CAND2	0.68	5.8	0.55	1.33e-7	QRS complex (12-leadsum);
SKCM	cis	rs7119	0.604	rs2271397	chr15:77907775	T/C	cg27398640	chr15:77910606	LINGO1	0.51	4.94	0.49	4.42e-6	Type 2 diabetes;
SKCM	cis	rs72781680	1.000	rs72796326	chr2:24137047	G/A	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	cis	rs9894429	0.789	rs9747336	chr17:79584189	C/T	cg18240062	chr17:79603768	NPLOC4	0.91	10.36	0.76	2.55e-16	Eye color traits;
SKCM	cis	rs2180341	0.694	rs2875972	chr6:127585522	T/C	cg24812749	chr6:127587940	RNF146	0.78	6.38	0.59	1.17e-8	Breast cancer;
SKCM	cis	rs35146811	0.771	rs6465762	chr7:99620554	G/A	cg22906224	chr7:99728672	NA	0.79	5.8	0.55	1.36e-7	Coronary artery disease;
SKCM	cis	rs7666738	0.830	rs62321564	chr4:98976496	C/G	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs60871478	0.635	rs4725122	chr7:785318	A/G	cg05535760	chr7:792225	HEATR2	1.17	9.54	0.73	9.81e-15	Cerebrospinal P-tau181p levels;
SKCM	cis	rs28595532	0.841	rs114976553	chr4:119496056	A/G	cg21605333	chr4:119757512	SEC24D	1.24	7.1	0.63	5.16e-10	Cannabis dependence symptom count;
SKCM	cis	rs9943753	0.508	rs7138357	chr12:109832303	A/G	cg19025524	chr12:109796872	NA	-0.62	-5.71	-0.54	2e-7	HDL cholesterol;
SKCM	cis	rs1568889	1.000	rs35343234	chr11:28034379	C/T	cg06544937	chr11:28130018	METT5D1;KIF18A	0.83	6.32	0.58	1.5e-8	Bipolar disorder;
SKCM	cis	rs362272	0.545	rs3135146	chr4:3307638	C/G	cg21096898	chr4:3318625	RGS12	-0.98	-12.99	-0.83	3.34e-21	Serum sulfate level;
SKCM	cis	rs28386778	0.799	rs12450683	chr17:61984299	C/G	cg23090583	chr17:61904693	PSMC5;FTSJ3	0.82	6.78	0.61	2.05e-9	Prudent dietary pattern;
SKCM	cis	rs34172651	0.502	rs12930727	chr16:24838497	G/T	cg04756594	chr16:24857601	SLC5A11	-0.68	-5.43	-0.52	6.3e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs1018836	0.923	rs9693182	chr8:91621876	T/C	cg16814680	chr8:91681699	NA	-0.62	-4.83	-0.48	6.67e-6	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs208520	1.000	rs12192261	chr6:66985268	A/G	cg07460842	chr6:66804631	NA	0.87	5.96	0.56	6.95e-8	Exhaled nitric oxide output;
SKCM	cis	rs7086627	0.515	rs7088877	chr10:82208860	C/G	cg00277334	chr10:82204260	NA	-0.74	-8.56	-0.7	7.89e-13	Post bronchodilator FEV1;
SKCM	cis	rs9325144	0.624	rs10506126	chr12:39123244	G/A	cg13010199	chr12:38710504	ALG10B	-0.62	-5.44	-0.52	5.97e-7	Morning vs. evening chronotype;
SKCM	cis	rs28595532	0.764	rs115877991	chr4:119728298	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.43	0.59	9.38e-9	Cannabis dependence symptom count;
SKCM	cis	rs3008870	1.000	rs12117131	chr1:67451922	C/T	cg08660285	chr1:67390436	MIER1;WDR78	-0.92	-6.07	-0.57	4.27e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs7618501	0.521	rs11712056	chr3:49914397	T/C	cg07636037	chr3:49044803	WDR6	0.69	4.97	0.49	3.81e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7666738	0.830	rs10025174	chr4:98914172	A/G	cg17366294	chr4:99064904	C4orf37	0.56	4.87	0.48	5.76e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2153535	0.580	rs7741456	chr6:8452424	G/A	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs34779708	0.733	rs7086715	chr10:35541840	A/G	cg03585969	chr10:35415529	CREM	0.74	5.42	0.52	6.41e-7	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs561341	1.000	rs117029332	chr17:30266085	C/G	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs10256972	0.758	rs11979275	chr7:1069335	A/T	cg16145915	chr7:1198662	ZFAND2A	-0.46	-5.64	-0.54	2.57e-7	Longevity;Endometriosis;
SKCM	cis	rs6547741	0.904	rs1528403	chr2:27846645	C/G	cg27432699	chr2:27873401	GPN1	0.74	6.58	0.6	4.93e-9	Oral cavity cancer;
SKCM	cis	rs703842	1.000	rs11172351	chr12:58213485	C/T	cg04478727	chr12:58166393	METTL1;FAM119B	0.72	5.78	0.55	1.48e-7	Multiple sclerosis;
SKCM	cis	rs752010	0.695	rs10789407	chr1:42106538	G/T	cg06885757	chr1:42089581	HIVEP3	0.51	6.04	0.56	4.83e-8	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs7296418	0.636	rs11057261	chr12:123797567	T/C	cg05973401	chr12:123451056	ABCB9	0.72	5.48	0.53	5.12e-7	Platelet count;
SKCM	cis	rs933688	1.000	rs11959525	chr5:90703840	A/G	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.95	6.56	0.6	5.46e-9	Smoking behavior;
SKCM	cis	rs7772486	0.806	rs2253648	chr6:146199296	G/A	cg23711669	chr6:146136114	FBXO30	0.81	8.76	0.7	3.2e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9300255	0.596	rs10734901	chr12:123743447	G/A	cg05973401	chr12:123451056	ABCB9	0.75	5.83	0.55	1.18e-7	Neutrophil percentage of white cells;
SKCM	cis	rs11098499	0.908	rs9995234	chr4:120321827	A/G	cg24375607	chr4:120327624	NA	0.67	5.18	0.51	1.66e-6	Corneal astigmatism;
SKCM	cis	rs7772486	0.754	rs702304	chr6:145990797	A/G	cg23711669	chr6:146136114	FBXO30	-0.97	-10.92	-0.78	2.21e-17	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6088590	0.687	rs13044899	chr20:33287078	G/A	cg24642439	chr20:33292090	TP53INP2	0.75	5.41	0.52	6.59e-7	Coronary artery disease;
SKCM	cis	rs62238980	0.614	rs77407792	chr22:32461465	C/A	cg00543991	chr22:32367038	NA	1.15	4.86	0.48	5.9e-6	Childhood ear infection;
SKCM	cis	rs11249608	0.636	rs6888567	chr5:178449074	C/T	cg21905437	chr5:178450457	ZNF879	-0.68	-5.77	-0.55	1.51e-7	Pubertal anthropometrics;
SKCM	cis	rs7216064	1.000	rs34872586	chr17:65863466	T/C	cg12091567	chr17:66097778	LOC651250	-0.75	-5.32	-0.52	9.73e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs9910055	0.762	rs227579	chr17:42223134	A/T	cg08499158	chr17:42289980	UBTF	0.87	7.91	0.67	1.42e-11	Total body bone mineral density;
SKCM	cis	rs28595532	0.623	rs71608363	chr4:119227259	T/C	cg21605333	chr4:119757512	SEC24D	1.17	7.18	0.63	3.55e-10	Cannabis dependence symptom count;
SKCM	cis	rs2153535	0.580	rs9406171	chr6:8515362	T/C	cg07606381	chr6:8435919	SLC35B3	0.87	6.38	0.59	1.17e-8	Motion sickness;
SKCM	cis	rs11098499	0.645	rs72676059	chr4:120290828	C/G	cg24375607	chr4:120327624	NA	0.62	4.77	0.48	8.45e-6	Corneal astigmatism;
SKCM	cis	rs72781680	1.000	rs6731001	chr2:24192952	A/G	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	cis	rs2370759	0.945	rs74625866	chr10:32597618	A/T	cg01819863	chr10:32635814	EPC1	1.01	5.8	0.55	1.37e-7	Sexual dysfunction (female);
SKCM	cis	rs2439831	0.681	rs540031	chr15:43608855	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.2	8.73	0.7	3.66e-13	Lung cancer in ever smokers;
SKCM	cis	rs2228479	0.541	rs13335395	chr16:89952843	T/A	cg00800038	chr16:89945340	TCF25	-0.91	-5.4	-0.52	6.97e-7	Skin colour saturation;
SKCM	cis	rs6840360	0.615	rs6858483	chr4:152465509	C/T	cg22705602	chr4:152727874	NA	-0.51	-5.78	-0.55	1.45e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs1580019	0.961	rs1580021	chr7:32497702	T/G	cg06627557	chr7:32535165	LSM5;AVL9	0.75	5.74	0.55	1.7e-7	Cognitive ability;
SKCM	cis	rs72781680	1.000	rs72781667	chr2:24225667	A/G	cg08917208	chr2:24149416	ATAD2B	1.03	5.75	0.55	1.64e-7	Lymphocyte counts;
SKCM	cis	rs362272	0.545	rs2749782	chr4:3339761	A/G	cg16987761	chr4:3318072	RGS12	0.97	11.41	0.79	2.63e-18	Serum sulfate level;
SKCM	cis	rs9910055	0.708	rs2631298	chr17:42219832	T/C	cg13607699	chr17:42295918	UBTF	0.71	5.61	0.54	3.01e-7	Total body bone mineral density;
SKCM	cis	rs11098499	0.820	rs2389885	chr4:120533931	C/T	cg09307838	chr4:120376055	NA	0.99	8.0	0.67	9.34e-12	Corneal astigmatism;
SKCM	cis	rs2836950	0.565	rs2836945	chr21:40596757	C/T	cg17971929	chr21:40555470	PSMG1	-0.73	-6.17	-0.57	2.86e-8	Menarche (age at onset);
SKCM	cis	rs1325195	0.568	rs17362081	chr1:179092741	A/C	cg10806749	chr1:179558114	NA	-0.58	-5.05	-0.5	2.8e-6	IgE grass sensitization;
SKCM	cis	rs35306767	0.855	rs12761180	chr10:872086	C/T	cg20503657	chr10:835505	NA	0.79	5.87	0.55	1.02e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs7829975	0.806	rs2428	chr8:8641145	C/T	cg15556689	chr8:8085844	FLJ10661	0.8	7.13	0.63	4.53e-10	Mood instability;
SKCM	cis	rs1552244	0.816	rs56387520	chr3:10042782	C/T	cg02579736	chr3:10068473	FANCD2;CIDECP	0.94	4.84	0.48	6.49e-6	Alzheimer's disease;
SKCM	cis	rs9549367	0.713	rs3024769	chr13:113825601	A/C	cg24722198	chr13:113567732	NA	-0.5	-5.01	-0.49	3.33e-6	Platelet distribution width;
SKCM	cis	rs741677	0.586	rs58180134	chr17:499297	C/A	cg17442852	chr17:1478889	SLC43A2	0.39	5.35	0.52	8.72e-7	Waist circumference adjusted for body mass index;Waist circumference adjusted for BMI in active individuals;Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction);
SKCM	cis	rs13010713	0.870	rs12693272	chr2:182066390	A/T	cg21995919	chr2:182322279	ITGA4	-0.53	-5.11	-0.5	2.2e-6	Celiac disease;
SKCM	cis	rs7590368	1.000	rs7590368	chr2:10961474	T/C	cg15705551	chr2:10952987	PDIA6	0.76	4.88	0.48	5.52e-6	Educational attainment (years of education);
SKCM	cis	rs875971	0.862	rs4718377	chr7:66049678	C/T	cg18876405	chr7:65276391	NA	-0.63	-6.31	-0.58	1.6e-8	Aortic root size;
SKCM	cis	rs9325144	0.577	rs10876008	chr12:39126750	T/C	cg26384229	chr12:38710491	ALG10B	-0.73	-6.74	-0.61	2.46e-9	Morning vs. evening chronotype;
SKCM	cis	rs244731	0.959	rs11740250	chr5:176721272	G/C	cg06060754	chr5:176797920	RGS14	0.82	7.04	0.62	6.49e-10	Urate levels in lean individuals;
SKCM	cis	rs1153858	0.895	rs12593402	chr15:45617392	G/A	cg21132104	chr15:45694354	SPATA5L1	0.91	7.64	0.65	4.71e-11	Homoarginine levels;
SKCM	cis	rs17683430	0.702	rs76915002	chr22:32421694	T/C	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	GIP levels in response to oral glucose tolerance test (120 minutes);
SKCM	cis	rs854765	0.618	rs8068820	chr17:17834119	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.0	7.64	0.65	4.64e-11	Total body bone mineral density;
SKCM	cis	rs10751667	0.643	rs10794350	chr11:946070	A/G	cg06064525	chr11:970664	AP2A2	-0.54	-5.17	-0.51	1.74e-6	Alzheimer's disease (late onset);
SKCM	cis	rs10883723	0.810	rs1409311	chr10:104282160	G/A	cg11453585	chr10:104263688	ACTR1A;SUFU	0.77	6.31	0.58	1.56e-8	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs8177253	0.761	rs35332919	chr3:133519002	T/A	cg16414030	chr3:133502952	NA	-0.72	-5.99	-0.56	6.17e-8	Iron status biomarkers;
SKCM	cis	rs6088590	0.931	rs6088617	chr20:33408036	G/A	cg24642439	chr20:33292090	TP53INP2	1.01	7.37	0.64	1.54e-10	Coronary artery disease;
SKCM	cis	rs7772486	0.875	rs2814869	chr6:146315509	G/A	cg23711669	chr6:146136114	FBXO30	0.76	7.07	0.62	5.8e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7336332	0.598	rs1885989	chr13:28010117	G/A	cg22138327	chr13:27999177	GTF3A	0.9	6.4	0.59	1.07e-8	Weight;
SKCM	cis	rs7666738	0.830	rs11097600	chr4:98959564	T/G	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2303759	0.709	rs3760667	chr19:49814832	C/T	cg05022225	chr19:49866942	DKKL1;TEAD2	0.7	5.05	0.5	2.78e-6	Multiple sclerosis;
SKCM	cis	rs7937682	0.924	rs501089	chr11:111502479	G/T	cg09085632	chr11:111637200	PPP2R1B	1.08	9.7	0.74	4.72e-15	Primary sclerosing cholangitis;
SKCM	cis	rs854765	0.547	rs9896837	chr17:17924868	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.04	8.77	0.7	3.02e-13	Total body bone mineral density;
SKCM	cis	rs55962025	0.883	rs59613878	chr4:3139152	C/T	cg09735869	chr4:3319127	RGS12	-0.83	-6.55	-0.6	5.56e-9	Parental longevity (mother's age at death);
SKCM	cis	rs1799949	1.000	rs33926631	chr17:41304463	T/C	cg23758822	chr17:41437982	NA	0.92	7.83	0.66	1.97e-11	Menopause (age at onset);
SKCM	cis	rs1843834	0.505	rs7585047	chr2:225373897	C/T	cg12698349	chr2:225449008	CUL3	0.84	6.93	0.62	1.09e-9	IgE levels in asthmatics (D.p. specific);
SKCM	cis	rs7615952	0.611	rs9681518	chr3:125615130	A/G	cg05084668	chr3:125655381	ALG1L	-1.25	-6.57	-0.6	5.19e-9	Blood pressure (smoking interaction);
SKCM	cis	rs7100689	0.599	rs946892	chr10:82127551	C/T	cg01528321	chr10:82214614	TSPAN14	0.8	7.0	0.62	7.98e-10	Post bronchodilator FEV1;
SKCM	cis	rs10779751	0.734	rs2259886	chr1:11137778	C/T	cg08854313	chr1:11322531	MTOR	0.77	5.74	0.54	1.73e-7	Body mass index;
SKCM	cis	rs9815354	0.812	rs73830532	chr3:41898814	T/C	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs6840360	0.615	rs12647586	chr4:152607568	G/C	cg22705602	chr4:152727874	NA	-0.57	-7.52	-0.65	8.09e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs13118159	0.550	rs2336081	chr4:1350322	A/G	cg20887711	chr4:1340912	KIAA1530	-0.97	-7.7	-0.66	3.53e-11	Longevity;
SKCM	cis	rs6089584	0.546	rs6061980	chr20:60618877	G/A	cg16423285	chr20:60520624	NA	-0.61	-5.41	-0.52	6.69e-7	Body mass index;
SKCM	trans	rs2727020	0.595	rs11040416	chr11:49566429	C/T	cg03929089	chr4:120376271	NA	-0.84	-7.33	-0.64	1.8e-10	Coronary artery disease;
SKCM	cis	rs2153535	0.580	rs7775909	chr6:8477778	A/G	cg07606381	chr6:8435919	SLC35B3	0.95	6.78	0.61	2.09e-9	Motion sickness;
SKCM	cis	rs9300255	0.602	rs884548	chr12:123634122	A/G	cg05973401	chr12:123451056	ABCB9	0.79	5.37	0.52	8.03e-7	Neutrophil percentage of white cells;
SKCM	cis	rs9916302	0.904	rs12452880	chr17:37591149	G/C	cg07936489	chr17:37558343	FBXL20	-0.85	-7.35	-0.64	1.71e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs9611565	0.500	rs10775759	chr22:42088158	T/C	cg03806693	chr22:41940476	POLR3H	1.11	7.55	0.65	7.06e-11	Vitiligo;
SKCM	cis	rs7809950	0.724	rs1858888	chr7:107046062	T/A	cg23024343	chr7:107201750	COG5	-0.88	-8.05	-0.67	7.69e-12	Coronary artery disease;
SKCM	cis	rs898097	0.690	rs12452304	chr17:80811659	G/A	cg15369054	chr17:80825471	TBCD	0.65	5.86	0.55	1.07e-7	Breast cancer;
SKCM	cis	rs3892630	0.500	rs35170371	chr19:33355081	G/A	cg22980127	chr19:33182716	NUDT19	0.86	4.94	0.49	4.39e-6	Red blood cell traits;
SKCM	cis	rs875971	0.638	rs801205	chr7:66022144	C/A	cg00343986	chr7:65444356	GUSB	-0.7	-5.14	-0.5	1.98e-6	Aortic root size;
SKCM	cis	rs7143963	0.636	rs11160705	chr14:103354184	G/A	cg23020514	chr14:103360112	TRAF3	0.74	6.99	0.62	8.38e-10	Body mass index;
SKCM	cis	rs6570726	0.516	rs10484700	chr6:145728933	C/T	cg23711669	chr6:146136114	FBXO30	0.71	6.7	0.6	2.89e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6951245	0.554	rs78999139	chr7:1138525	G/A	cg18402987	chr7:1209562	NA	0.82	5.43	0.52	6.16e-7	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs9911578	0.692	rs412000	chr17:56709058	G/C	cg12560992	chr17:57184187	TRIM37	0.7	4.98	0.49	3.71e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1218582	0.804	rs4845398	chr1:154859038	G/C	cg03351412	chr1:154909251	PMVK	0.78	6.55	0.6	5.5e-9	Prostate cancer;
SKCM	cis	rs7539542	0.600	rs10800884	chr1:202900651	T/G	cg19681188	chr1:202830198	LOC148709	0.66	4.85	0.48	6.16e-6	Mean platelet volume;
SKCM	cis	rs11098499	0.866	rs12374244	chr4:120281972	A/T	cg09307838	chr4:120376055	NA	0.98	7.89	0.67	1.52e-11	Corneal astigmatism;
SKCM	cis	rs34779708	0.931	rs35886556	chr10:35334985	C/T	cg03585969	chr10:35415529	CREM	0.75	6.23	0.58	2.2e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs8064299	0.597	rs2053748	chr17:72775911	A/G	cg25054828	chr17:72772726	NAT9;TMEM104	-0.95	-9.31	-0.73	2.66e-14	Monocyte count;
SKCM	cis	rs595982	0.559	rs73061632	chr19:49361663	G/A	cg19746536	chr19:49375674	PPP1R15A	0.97	5.37	0.52	7.86e-7	Red cell distribution width;
SKCM	cis	rs7829975	0.511	rs1401390	chr8:8136410	C/T	cg06636001	chr8:8085503	FLJ10661	0.93	9.26	0.72	3.33e-14	Mood instability;
SKCM	cis	rs9583531	0.600	rs9555726	chr13:111368316	C/T	cg15841412	chr13:111365552	ING1	0.7	4.82	0.48	7.07e-6	Coronary artery disease;
SKCM	cis	rs55962025	0.883	rs362336	chr4:3213832	G/A	cg00764545	chr4:3318001	RGS12	-0.73	-5.89	-0.56	9.11e-8	Parental longevity (mother's age at death);
SKCM	cis	rs1218582	0.772	rs877343	chr1:154910012	A/G	cg06221963	chr1:154839813	KCNN3	-0.55	-5.5	-0.53	4.56e-7	Prostate cancer;
SKCM	cis	rs12971120	1.000	rs734559	chr18:72179579	G/A	cg26446133	chr18:72167187	CNDP2	-0.67	-5.62	-0.54	2.8e-7	Refractive error;
SKCM	cis	rs9910055	0.550	rs113844752	chr17:42297631	C/A	cg13607699	chr17:42295918	UBTF	0.88	7.39	0.64	1.43e-10	Total body bone mineral density;
SKCM	cis	rs763121	0.853	rs4821808	chr22:39065739	A/G	cg06022373	chr22:39101656	GTPBP1	0.78	5.63	0.54	2.7e-7	Menopause (age at onset);
SKCM	cis	rs6500395	1.000	rs1004909	chr16:48725580	C/G	cg04672837	chr16:48644449	N4BP1	-0.63	-5.37	-0.52	8.01e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs16866061	1.000	rs72974269	chr2:225454907	C/T	cg12698349	chr2:225449008	CUL3	1.01	8.51	0.69	9.75e-13	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs2070488	0.775	rs7649984	chr3:38570221	C/T	cg01465620	chr3:38496096	LOC100128640;ACVR2B	-0.72	-5.51	-0.53	4.39e-7	Electrocardiographic conduction measures;
SKCM	cis	rs2204008	0.837	rs12369089	chr12:38060263	G/A	cg26384229	chr12:38710491	ALG10B	0.81	6.45	0.59	8.61e-9	Bladder cancer;
SKCM	cis	rs9303401	0.659	rs62083525	chr17:56658088	A/G	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.13	0.57	3.42e-8	Cognitive test performance;
SKCM	cis	rs17685	0.712	rs1639620	chr7:75704090	A/G	cg01364799	chr7:75623366	TMEM120A	-0.72	-5.81	-0.55	1.31e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs9910055	0.530	rs2269908	chr17:42294198	G/C	cg19774624	chr17:42201019	HDAC5	-0.77	-6.27	-0.58	1.84e-8	Total body bone mineral density;
SKCM	cis	rs735396	0.770	rs2259820	chr12:121435342	C/T	cg02403541	chr12:121454288	C12orf43	0.76	6.57	0.6	5.04e-9	N-glycan levels;
SKCM	cis	rs7811142	1.000	rs7803454	chr7:99991548	C/T	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.11	6.45	0.59	8.66e-9	Platelet count;
SKCM	cis	rs4819052	0.851	rs4818768	chr21:46659818	T/A	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.42	0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7829975	0.557	rs7816427	chr8:8545884	T/C	cg15556689	chr8:8085844	FLJ10661	-0.69	-5.37	-0.52	7.85e-7	Mood instability;
SKCM	cis	rs995000	0.899	rs1002687	chr1:62963737	G/A	cg06896770	chr1:63153194	DOCK7	-0.62	-5.59	-0.54	3.15e-7	Triglyceride levels;
SKCM	cis	rs748404	0.586	rs2584700	chr15:43685332	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	0.78	5.85	0.55	1.08e-7	Lung cancer;
SKCM	cis	rs6952808	0.689	rs4719391	chr7:2048136	T/C	cg21782813	chr7:2030301	MAD1L1	0.59	6.49	0.59	7.27e-9	Bipolar disorder and schizophrenia;
SKCM	cis	rs9325144	0.671	rs7486919	chr12:38767997	A/G	cg13010199	chr12:38710504	ALG10B	-0.66	-5.44	-0.52	5.88e-7	Morning vs. evening chronotype;
SKCM	cis	rs2839186	0.770	rs2280956	chr21:47642323	C/G	cg13012494	chr21:47604986	C21orf56	-0.67	-5.81	-0.55	1.29e-7	Testicular germ cell tumor;
SKCM	cis	rs13108904	0.846	rs3775100	chr4:1225106	T/C	cg05665937	chr4:1216051	CTBP1	0.57	5.1	0.5	2.33e-6	Obesity-related traits;
SKCM	cis	rs7937682	0.575	rs7930208	chr11:111741463	T/C	cg09085632	chr11:111637200	PPP2R1B	1.12	10.71	0.77	5.54e-17	Primary sclerosing cholangitis;
SKCM	cis	rs4905558	1.000	rs4905553	chr14:97316102	G/T	cg11863609	chr14:97355128	NA	-0.54	-4.88	-0.48	5.52e-6	Neutrophil count;
SKCM	cis	rs5753618	0.583	rs5753639	chr22:31870400	A/G	cg02404636	chr22:31891804	SFI1	-0.63	-5.81	-0.55	1.3e-7	Colorectal cancer;
SKCM	cis	rs7829975	0.623	rs10087493	chr8:8373557	A/G	cg15556689	chr8:8085844	FLJ10661	-0.66	-4.83	-0.48	6.65e-6	Mood instability;
SKCM	cis	rs67311347	0.544	rs9864601	chr3:40345318	C/T	cg18306943	chr3:40428807	ENTPD3	0.56	4.8	0.48	7.38e-6	Renal cell carcinoma;
SKCM	cis	rs11098499	0.954	rs59394118	chr4:120295551	A/G	cg24375607	chr4:120327624	NA	0.65	4.85	0.48	6.14e-6	Corneal astigmatism;
SKCM	cis	rs5769765	0.779	rs12170530	chr22:50318422	T/G	cg22709217	chr22:50311962	ALG12;CRELD2	-0.99	-6.09	-0.57	4.04e-8	Schizophrenia;
SKCM	cis	rs8067545	0.750	rs11868084	chr17:19992717	A/G	cg13482628	chr17:19912719	NA	0.71	6.15	0.57	3.16e-8	Schizophrenia;
SKCM	cis	rs6495367	0.898	rs2049176	chr15:79392548	A/C	cg10259521	chr15:79428573	NA	-0.5	-5.16	-0.5	1.82e-6	Spherical equivalent (joint analysis main effects and education interaction);
SKCM	cis	rs4319547	0.956	rs7316149	chr12:123063912	G/A	cg23029597	chr12:123009494	RSRC2	-0.81	-5.95	-0.56	7.21e-8	Body mass index;
SKCM	cis	rs1957429	0.808	rs7149922	chr14:65334541	C/T	cg23373153	chr14:65346875	NA	1.22	6.35	0.58	1.3e-8	Pediatric areal bone mineral density (radius);
SKCM	cis	rs116095464	0.867	rs10074958	chr5:230828	C/T	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs860295	0.615	rs656737	chr1:155877895	A/C	cg02153340	chr1:155202674	NA	0.68	4.99	0.49	3.64e-6	Body mass index;
SKCM	cis	rs6598955	0.543	rs112752634	chr1:26534217	G/A	cg04990556	chr1:26633338	UBXN11	0.68	5.08	0.5	2.55e-6	Obesity-related traits;
SKCM	cis	rs6138458	1.000	rs227615	chr20:24908721	T/C	cg26195577	chr20:24973756	C20orf3	1.29	8.69	0.7	4.31e-13	Blood protein levels;
SKCM	cis	rs7659604	0.539	rs3217771	chr4:122739483	G/A	cg06713675	chr4:122721982	EXOSC9	-0.75	-7.26	-0.64	2.47e-10	Type 2 diabetes;
SKCM	cis	rs780096	0.506	rs2288155	chr2:27714526	T/C	cg05696406	chr2:27599888	SNX17	0.51	5.05	0.5	2.79e-6	Total body bone mineral density;
SKCM	cis	rs9611565	0.512	rs4512	chr22:42206084	G/C	cg03806693	chr22:41940476	POLR3H	-1.08	-5.96	-0.56	7.02e-8	Vitiligo;
SKCM	cis	rs7659604	0.592	rs56077950	chr4:122721412	C/T	cg06713675	chr4:122721982	EXOSC9	-0.74	-7.2	-0.63	3.21e-10	Type 2 diabetes;
SKCM	cis	rs7618501	0.521	rs7615206	chr3:49937505	T/C	cg24110177	chr3:50126178	RBM5	-0.77	-5.85	-0.55	1.11e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs2243480	0.901	rs778693	chr7:65872345	T/G	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs1577917	0.538	rs6454483	chr6:86418283	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.76	6.81	0.61	1.8e-9	Response to antipsychotic treatment;
SKCM	cis	rs7772486	0.686	rs1004752	chr6:146037822	G/A	cg05347473	chr6:146136440	FBXO30	-0.55	-4.85	-0.48	6.14e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs801193	0.761	rs2659888	chr7:66230171	T/G	cg00343986	chr7:65444356	GUSB	0.68	5.0	0.49	3.42e-6	Aortic root size;
SKCM	cis	rs7659604	1.000	rs10016433	chr4:122664771	A/G	cg19748678	chr4:122722346	EXOSC9	0.66	5.44	0.52	5.83e-7	Type 2 diabetes;
SKCM	cis	rs7659604	0.539	rs72680779	chr4:122797263	C/T	cg20573242	chr4:122745356	CCNA2	0.74	6.14	0.57	3.2e-8	Type 2 diabetes;
SKCM	cis	rs7843479	0.965	rs11775479	chr8:21859991	C/T	cg17168535	chr8:21777572	XPO7	0.75	6.06	0.57	4.62e-8	Mean corpuscular volume;
SKCM	cis	rs992157	0.764	rs13020391	chr2:219184436	C/T	cg20019365	chr2:219134978	PNKD;AAMP	-0.74	-5.82	-0.55	1.22e-7	Colorectal cancer;
SKCM	cis	rs477895	1.000	rs34292685	chr11:64049021	C/T	cg02228329	chr11:64053129	BAD;GPR137	-1.11	-5.09	-0.5	2.46e-6	Mean platelet volume;
SKCM	cis	rs36093844	0.752	rs17817254	chr11:85564826	A/C	cg25872744	chr11:85566296	CCDC83	-0.85	-4.77	-0.48	8.27e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs1577917	0.739	rs2758846	chr6:86349570	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-1.01	-11.43	-0.79	2.49e-18	Response to antipsychotic treatment;
SKCM	cis	rs71636778	0.509	rs71636795	chr1:27241025	A/G	cg01689405	chr1:26370407	SLC30A2	-0.52	-4.79	-0.48	7.94e-6	Monocyte percentage of white cells;Granulocyte percentage of myeloid white cells;
SKCM	cis	rs763014	0.931	rs2071982	chr16:630405	T/G	cg09263875	chr16:632152	PIGQ	0.67	5.82	0.55	1.24e-7	Height;
SKCM	cis	rs9303401	0.614	rs62084387	chr17:57148027	C/T	cg10487724	chr17:56770010	TEX14;RAD51C	0.78	4.88	0.48	5.45e-6	Cognitive test performance;
SKCM	cis	rs2243480	1.000	rs160652	chr7:65538431	A/G	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs8133974	0.941	rs117826984	chr21:36476687	T/C	cg00621029	chr21:35747559	FAM165B	0.71	4.87	0.48	5.72e-6	Eosinophil counts;Eosinophil percentage of granulocytes;Sum eosinophil basophil counts;
SKCM	cis	rs13010713	0.840	rs4401183	chr2:182095265	C/T	cg21995919	chr2:182322279	ITGA4	-0.58	-5.21	-0.51	1.51e-6	Celiac disease;
SKCM	cis	rs2836633	0.895	rs2836597	chr21:40024424	A/G	cg05519781	chr21:40033154	ERG	0.78	6.72	0.61	2.67e-9	Coronary artery disease;
SKCM	cis	rs2072499	0.966	rs11587860	chr1:156156951	G/C	cg24450063	chr1:156163899	SLC25A44	1.02	9.81	0.74	2.91e-15	Testicular germ cell tumor;
SKCM	cis	rs2836950	0.545	rs2836940	chr21:40588696	T/C	cg11644478	chr21:40555479	PSMG1	-0.64	-5.02	-0.49	3.17e-6	Menarche (age at onset);
SKCM	cis	rs8177179	0.967	rs10935085	chr3:133459735	C/T	cg24879335	chr3:133465180	TF	0.38	4.84	0.48	6.5e-6	Iron status biomarkers (transferrin levels);
SKCM	cis	rs7599312	0.534	rs2371615	chr2:213405660	G/T	cg16329650	chr2:213403929	ERBB4	0.84	6.04	0.56	4.85e-8	BMI (adjusted for smoking behaviour);BMI in non-smokers;Body mass index;Body mass index (joint analysis main effects and smoking interaction);
SKCM	cis	rs8103278	0.740	rs72626215	chr19:46294136	G/A	cg11657440	chr19:46296263	DMWD	-1.08	-6.56	-0.6	5.25e-9	Coronary artery disease;
SKCM	cis	rs12714314	0.681	rs4853753	chr2:1941381	T/C	cg22350835	chr2:1868857	MYT1L	0.64	4.98	0.49	3.68e-6	Type 2 diabetes (age of onset);
SKCM	cis	rs1707322	1.000	rs1707317	chr1:46510642	C/T	cg03146154	chr1:46216737	IPP	-0.76	-5.21	-0.51	1.53e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs875971	0.964	rs60193905	chr7:65971260	A/G	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs7659604	0.537	rs6823818	chr4:122731699	G/C	cg20573242	chr4:122745356	CCNA2	0.75	6.39	0.59	1.11e-8	Type 2 diabetes;
SKCM	cis	rs12711979	0.509	rs13035992	chr2:3826597	G/A	cg17052675	chr2:3827356	NA	-0.85	-9.31	-0.73	2.76e-14	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs1046896	0.553	rs9893885	chr17:80837107	C/T	cg22027946	chr17:80790580	TBCD;ZNF750	0.65	4.77	0.48	8.45e-6	Glycated hemoglobin levels;
SKCM	cis	rs16949788	1.000	rs11071894	chr15:66773733	A/C	cg08120210	chr15:66682733	MAP2K1	0.73	5.62	0.54	2.9e-7	Spherical equivalent (joint analysis main effects and education interaction);
SKCM	cis	rs597539	0.654	rs619727	chr11:68627535	A/G	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.8	5.57	0.53	3.48e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs7584330	0.697	rs60278044	chr2:238357118	A/G	cg14458575	chr2:238380390	NA	0.92	5.93	0.56	7.83e-8	Prostate cancer;
SKCM	cis	rs9435341	0.930	rs2232015	chr1:107599258	A/T	cg09367891	chr1:107599246	PRMT6	0.83	6.92	0.62	1.12e-9	Facial morphology (factor 21, depth of nasal alae);
SKCM	cis	rs7215564	0.908	rs34333328	chr17:78683420	G/A	cg16980736	chr17:78789706	RPTOR	-0.88	-4.83	-0.48	6.66e-6	Myopia (pathological);
SKCM	cis	rs912057	0.833	rs1294418	chr6:6742185	A/G	cg06612196	chr6:6737390	NA	0.58	4.91	0.49	4.81e-6	Waist-to-hip ratio adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);
SKCM	cis	rs651907	0.557	rs7651406	chr3:101393296	C/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.81	6.96	0.62	9.48e-10	Colorectal cancer;
SKCM	cis	rs12478296	0.786	rs72620862	chr2:243044787	T/C	cg06360820	chr2:242988706	NA	-0.91	-5.25	-0.51	1.28e-6	Obesity-related traits;
SKCM	cis	rs6546550	0.901	rs11126251	chr2:70163434	A/C	cg02498382	chr2:70120550	SNRNP27	-0.49	-5.47	-0.53	5.28e-7	Prevalent atrial fibrillation;
SKCM	cis	rs2839186	0.900	rs2839196	chr21:47708037	G/A	cg13012494	chr21:47604986	C21orf56	0.65	5.58	0.53	3.31e-7	Testicular germ cell tumor;
SKCM	cis	rs13256369	1.000	rs13256369	chr8:8577379	T/C	cg06636001	chr8:8085503	FLJ10661	0.7	5.15	0.5	1.9e-6	Obesity-related traits;
SKCM	cis	rs6430585	0.528	rs309119	chr2:136710372	T/C	cg07169764	chr2:136633963	MCM6	1.24	10.24	0.76	4.47e-16	Corneal structure;
SKCM	cis	rs2404602	0.632	rs34338978	chr15:77226805	T/C	cg23625390	chr15:77176239	SCAPER	0.59	5.24	0.51	1.35e-6	Blood metabolite levels;
SKCM	cis	rs8017423	0.615	rs12586761	chr14:90820897	A/G	cg04374321	chr14:90722782	PSMC1	-0.75	-5.7	-0.54	2.04e-7	Mortality in heart failure;
SKCM	cis	rs561341	1.000	rs117029332	chr17:30266085	C/G	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs116095464	0.558	rs9312956	chr5:201812	T/C	cg22496380	chr5:211416	CCDC127	-1.0	-5.11	-0.5	2.25e-6	Breast cancer;
SKCM	cis	rs2153535	0.580	rs4404802	chr6:8442052	A/G	cg23788917	chr6:8435910	SLC35B3	0.69	5.14	0.5	1.99e-6	Motion sickness;
SKCM	cis	rs6545883	0.524	rs2593631	chr2:61572286	A/G	cg15711740	chr2:61764176	XPO1	0.66	5.12	0.5	2.17e-6	Tuberculosis;
SKCM	cis	rs28374715	0.681	rs59000092	chr15:41626148	A/G	cg18705301	chr15:41695430	NDUFAF1	-1.07	-10.54	-0.77	1.16e-16	Ulcerative colitis;
SKCM	cis	rs2243480	0.803	rs13224048	chr7:65993766	G/A	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs654950	0.934	rs641974	chr1:42002137	G/A	cg06885757	chr1:42089581	HIVEP3	-0.66	-6.69	-0.6	3.03e-9	Airway imaging phenotypes;
SKCM	cis	rs875971	0.929	rs778692	chr7:65872449	A/G	cg11764359	chr7:65958608	NA	0.87	8.35	0.69	2.01e-12	Aortic root size;
SKCM	cis	rs17608059	0.901	rs11078215	chr17:13906934	T/C	cg11395062	chr17:14139857	CDRT15	0.61	5.44	0.52	6.02e-7	Temperament;
SKCM	cis	rs62103177	0.733	rs62103232	chr18:77635553	G/A	cg27393146	chr18:77495563	CTDP1	-0.92	-5.33	-0.52	9.09e-7	Opioid sensitivity;
SKCM	cis	rs561341	0.843	rs879944	chr17:30242803	A/G	cg23018236	chr17:30244563	NA	-0.52	-5.3	-0.51	1.05e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs7666738	0.830	rs3857217	chr4:99034347	T/C	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs995000	0.931	rs597078	chr1:62917857	G/A	cg06896770	chr1:63153194	DOCK7	0.77	7.38	0.64	1.45e-10	Triglyceride levels;
SKCM	cis	rs10779751	0.734	rs2791649	chr1:11132561	A/G	cg08854313	chr1:11322531	MTOR	0.77	5.52	0.53	4.36e-7	Body mass index;
SKCM	cis	rs514406	0.679	rs61768344	chr1:53229274	G/A	cg27535305	chr1:53392650	SCP2	0.55	5.0	0.49	3.41e-6	Monocyte count;
SKCM	trans	rs7618501	0.966	rs7372966	chr3:49788969	T/C	cg21659725	chr3:3221576	CRBN	-0.96	-9.61	-0.74	7.08e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs9535495	1.000	rs9535495	chr13:51388960	C/T	cg13204699	chr13:50703841	NA	-0.41	-4.79	-0.48	7.72e-6	Reticulocyte count;Reticulocyte fraction of red cells;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs2836974	0.583	rs2735307	chr21:40713358	C/T	cg17971929	chr21:40555470	PSMG1	0.71	5.84	0.55	1.15e-7	Cognitive function;
SKCM	cis	rs6951245	0.872	rs113119264	chr7:1080564	G/A	cg03188948	chr7:1209495	NA	1.12	6.25	0.58	2.02e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs798502	0.522	rs7790322	chr7:2830498	C/T	cg19346786	chr7:2764209	NA	-0.44	-5.02	-0.49	3.2e-6	Waist circumference adjusted for BMI (adjusted for smoking behaviour);Inflammatory bowel disease;Waist circumference adjusted for BMI in non-smokers;Ulcerative colitis;Waist circumference adjusted for body mass index;Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction);
SKCM	cis	rs1707322	0.721	rs10890333	chr1:46100322	T/C	cg03146154	chr1:46216737	IPP	0.82	6.1	0.57	3.89e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs1160297	0.585	rs4143203	chr2:53035763	C/T	cg07782112	chr2:53107842	NA	0.52	4.94	0.49	4.29e-6	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs35306767	0.761	rs11253557	chr10:1043667	C/T	cg20503657	chr10:835505	NA	0.62	4.83	0.48	6.79e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs2180341	0.814	rs7768435	chr6:127737038	A/C	cg27446573	chr6:127587934	RNF146	0.69	5.49	0.53	4.79e-7	Breast cancer;
SKCM	cis	rs1218582	0.661	rs4845695	chr1:154911798	A/G	cg06221963	chr1:154839813	KCNN3	-0.55	-5.48	-0.53	5.06e-7	Prostate cancer;
SKCM	cis	rs1577917	0.771	rs2842613	chr6:86305702	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.98	11.08	0.78	1.13e-17	Response to antipsychotic treatment;
SKCM	cis	rs8141529	0.732	rs3788409	chr22:29198151	T/G	cg02153584	chr22:29168773	CCDC117	0.66	5.36	0.52	8.31e-7	Lymphocyte counts;
SKCM	cis	rs6998277	0.830	rs6468838	chr8:103609336	T/C	cg10187029	chr8:103597600	NA	0.73	5.88	0.55	9.67e-8	Migraine;
SKCM	cis	rs33794	0.836	rs33769	chr3:45282000	C/T	cg25630594	chr3:44914870	TGM4	0.58	4.82	0.48	7.01e-6	Lung function (forced expiratory volume in 1 second);
SKCM	cis	rs1153858	1.000	rs4774579	chr15:45651803	G/A	cg10760299	chr15:45669010	GATM	0.62	6.35	0.58	1.3e-8	Homoarginine levels;
SKCM	cis	rs67311347	0.544	rs13062243	chr3:40336789	G/A	cg02782426	chr3:40428986	ENTPD3	0.52	5.3	0.51	1.06e-6	Renal cell carcinoma;
SKCM	cis	rs17685	0.712	rs1637049	chr7:75729975	C/G	cg01364799	chr7:75623366	TMEM120A	-0.8	-6.43	-0.59	9.24e-9	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs3087591	0.960	rs1801052	chr17:29508775	C/T	cg24425628	chr17:29625626	OMG;NF1	0.63	4.93	0.49	4.53e-6	Hip circumference;
SKCM	cis	rs7111031	1.000	rs6589379	chr11:113374567	G/T	cg04642306	chr11:112834466	NCAM1	0.46	4.85	0.48	6.15e-6	Subjective well-being (multi-trait analysis);Depressive symptoms (multi-trait analysis);Neuroticism;
SKCM	cis	rs5769765	0.818	rs8140681	chr22:50292081	C/A	cg22709217	chr22:50311962	ALG12;CRELD2	-0.79	-5.71	-0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs875971	0.862	rs11760844	chr7:65739883	C/G	cg11764359	chr7:65958608	NA	-0.82	-7.87	-0.67	1.68e-11	Aortic root size;
SKCM	cis	rs898097	0.756	rs11655103	chr17:80813467	T/C	cg15369054	chr17:80825471	TBCD	0.65	5.86	0.55	1.07e-7	Breast cancer;
SKCM	cis	rs2749592	0.550	rs7917262	chr10:37874602	A/C	cg00409905	chr10:38381863	ZNF37A	0.64	6.29	0.58	1.68e-8	Age-related hearing impairment (SNP x SNP interaction);
SKCM	cis	rs72781680	0.611	rs72797824	chr2:24356456	T/G	cg20701182	chr2:24300061	SF3B14	0.77	5.22	0.51	1.45e-6	Lymphocyte counts;
SKCM	cis	rs9910055	0.529	rs183462	chr17:42183376	G/C	cg08499158	chr17:42289980	UBTF	0.72	5.61	0.54	2.95e-7	Total body bone mineral density;
SKCM	cis	rs75229567	0.618	rs77168443	chr12:70208563	G/A	cg10114359	chr12:70132523	RAB3IP	1.24	5.19	0.51	1.6e-6	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes;
SKCM	cis	rs35146811	0.735	rs6465766	chr7:99785671	A/G	cg22906224	chr7:99728672	NA	0.65	5.19	0.51	1.6e-6	Coronary artery disease;
SKCM	cis	rs10492096	1.000	rs11064210	chr12:6576721	C/T	cg13857086	chr12:6580257	VAMP1	0.98	7.46	0.65	1.04e-10	Hip geometry;
SKCM	cis	rs28595532	0.841	rs115987912	chr4:119737085	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs9325144	0.624	rs7979541	chr12:39129679	T/C	cg13010199	chr12:38710504	ALG10B	-0.62	-5.44	-0.52	5.97e-7	Morning vs. evening chronotype;
SKCM	cis	rs3091242	0.836	rs34997029	chr1:25783823	A/G	cg02931644	chr1:25747376	RHCE	-0.5	-4.9	-0.48	5.17e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs116095464	0.558	rs7708515	chr5:234989	C/G	cg22857025	chr5:266934	NA	-1.31	-8.35	-0.69	1.98e-12	Breast cancer;
SKCM	cis	rs908922	0.676	rs528427	chr1:152511507	G/C	cg09873164	chr1:152488093	CRCT1	0.76	5.93	0.56	7.7e-8	Hair morphology;
SKCM	cis	rs1218582	0.741	rs10908446	chr1:154869559	G/A	cg16680214	chr1:154839983	KCNN3	-0.56	-5.01	-0.49	3.29e-6	Prostate cancer;
SKCM	cis	rs8072100	1.000	rs4375701	chr17:45712218	C/T	cg25173405	chr17:45401733	C17orf57	-0.59	-5.49	-0.53	4.83e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs3785574	0.962	rs2727324	chr17:61922102	G/C	cg01411255	chr17:61851458	DDX42;CCDC47	1.16	12.57	0.82	1.94e-20	Height;
SKCM	cis	rs11098499	0.954	rs66506550	chr4:120371445	T/A	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs6430585	0.583	rs12373779	chr2:136586840	A/C	cg07169764	chr2:136633963	MCM6	1.31	13.22	0.83	1.29e-21	Corneal structure;
SKCM	cis	rs67311347	0.568	rs9864544	chr3:40336204	T/C	cg00091569	chr3:40428383	ENTPD3	0.61	5.37	0.52	7.7300000000000005e-07	Renal cell carcinoma;
SKCM	cis	rs7772486	0.590	rs1890170	chr6:146071839	G/C	cg23711669	chr6:146136114	FBXO30	-0.82	-7.55	-0.65	7.12e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs362272	0.525	rs2471347	chr4:3044435	A/G	cg24015175	chr4:3319247	RGS12	-0.54	-4.99	-0.49	3.58e-6	Serum sulfate level;
SKCM	cis	rs4862750	0.872	rs6553029	chr4:187876470	G/T	cg10295955	chr4:187884368	NA	1.07	14.16	0.85	2.95e-23	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9916302	0.706	rs4516267	chr17:37471482	G/T	cg07936489	chr17:37558343	FBXL20	1.0	7.19	0.63	3.42e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs12047808	0.841	rs56253737	chr1:179342634	A/G	cg09822482	chr1:179519214	C1orf125	-0.95	-5.17	-0.51	1.78e-6	Multiple sclerosis (age of onset);
SKCM	cis	rs362272	0.505	rs3129310	chr4:3301388	T/G	cg16987761	chr4:3318072	RGS12	0.95	10.75	0.77	4.58e-17	Serum sulfate level;
SKCM	cis	rs67460515	0.892	rs34016896	chr3:160992864	C/T	cg03342759	chr3:160939853	NMD3	-0.81	-7.1	-0.63	5.14e-10	Parkinson's disease;
SKCM	cis	rs2991971	1.000	rs2991972	chr1:46013208	C/T	cg24296786	chr1:45957014	TESK2	0.65	5.25	0.51	1.28e-6	High light scatter reticulocyte count;
SKCM	cis	rs854765	0.647	rs854770	chr17:18019048	A/G	cg04398451	chr17:18023971	MYO15A	-1.03	-8.92	-0.71	1.58e-13	Total body bone mineral density;
SKCM	cis	rs9910055	0.762	rs2240226	chr17:42266218	C/T	cg09913183	chr17:42254507	C17orf65;ASB16	0.7	6.49	0.59	7.35e-9	Total body bone mineral density;
SKCM	cis	rs9303401	0.580	rs12603808	chr17:56578508	T/G	cg10487724	chr17:56770010	TEX14;RAD51C	0.85	6.07	0.57	4.34e-8	Cognitive test performance;
SKCM	cis	rs4555082	0.957	rs2816628	chr14:105736134	T/G	cg13114125	chr14:105738426	BRF1	-0.73	-5.66	-0.54	2.41e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs801193	0.569	rs2707824	chr7:66189243	A/G	cg18876405	chr7:65276391	NA	0.61	6.01	0.56	5.49e-8	Aortic root size;
SKCM	cis	rs854765	0.693	rs8079418	chr17:17924060	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.86	6.43	0.59	9.2e-9	Total body bone mineral density;
SKCM	cis	rs1799949	1.000	rs11655505	chr17:41278377	G/A	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.11	-0.57	3.67e-8	Menopause (age at onset);
SKCM	cis	rs17854409	0.803	rs1048100	chr20:61472073	C/A	cg06598544	chr20:61472147	COL9A3	-1.15	-5.69	-0.54	2.11e-7	Obesity-related traits;
SKCM	cis	rs9875589	0.509	rs4685051	chr3:13981760	A/G	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.57	5.74	0.54	1.73e-7	Ovarian reserve;
SKCM	cis	rs7408868	1.000	rs6512018	chr19:15282138	T/C	cg14696996	chr19:15285081	NOTCH3	0.82	4.92	0.49	4.7e-6	Pulse pressure;
SKCM	cis	rs6665290	0.935	rs1929864	chr1:227195500	T/G	cg10327440	chr1:227177885	CDC42BPA	-1.24	-17.42	-0.89	1.29e-28	Myeloid white cell count;
SKCM	cis	rs7122539	0.646	rs627330	chr11:66602099	C/T	cg24851651	chr11:66362959	CCS	0.71	5.25	0.51	1.28e-6	HIV-1 susceptibility;
SKCM	cis	rs11098499	0.954	rs10017543	chr4:120321420	G/A	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs9911578	0.967	rs11656413	chr17:57082013	A/C	cg12560992	chr17:57184187	TRIM37	-1.08	-10.06	-0.75	9.78e-16	Intelligence (multi-trait analysis);
SKCM	cis	rs7208859	0.623	rs9898084	chr17:29082334	C/G	cg14067834	chr17:29058358	SUZ12P	0.99	5.1	0.5	2.3e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs1799949	0.965	rs7212284	chr17:41205941	A/G	cg25918947	chr17:41365094	TMEM106A	-0.61	-5.63	-0.54	2.76e-7	Menopause (age at onset);
SKCM	cis	rs933688	1.000	rs12654787	chr5:90713259	C/T	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.02	7.81	0.66	2.22e-11	Smoking behavior;
SKCM	cis	rs9905704	0.647	rs12944274	chr17:57041293	C/G	cg12560992	chr17:57184187	TRIM37	-0.7	-5.47	-0.53	5.2e-7	Testicular germ cell tumor;
SKCM	cis	rs2721195	0.845	rs3757966	chr8:145744618	G/A	cg17328964	chr8:145687451	CYHR1	-0.57	-4.83	-0.48	6.6e-6	Age at first birth;
SKCM	cis	rs2645694	0.626	rs2645704	chr4:77830805	T/C	cg03477792	chr4:77819574	ANKRD56	0.57	6.42	0.59	9.57e-9	Emphysema distribution in smoking;
SKCM	cis	rs72781680	0.611	rs78861366	chr2:24354428	A/G	cg20701182	chr2:24300061	SF3B14	0.77	5.22	0.51	1.45e-6	Lymphocyte counts;
SKCM	cis	rs1635	0.655	rs73742535	chr6:28302925	G/A	cg15743358	chr6:28303923	ZNF323	-1.27	-5.15	-0.5	1.92e-6	Schizophrenia;
SKCM	cis	rs28386778	0.591	rs2584619	chr17:61913215	T/A	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs854765	0.647	rs4426402	chr17:17977926	C/T	cg04398451	chr17:18023971	MYO15A	0.99	8.56	0.7	7.67e-13	Total body bone mineral density;
SKCM	trans	rs12599106	0.560	rs34151874	chr16:34989694	G/A	cg15383120	chr6:291909	DUSP22	-0.75	-7.71	-0.66	3.38e-11	Menopause (age at onset);
SKCM	cis	rs6546550	0.743	rs6731941	chr2:70018496	A/G	cg02498382	chr2:70120550	SNRNP27	-0.47	-4.93	-0.49	4.53e-6	Prevalent atrial fibrillation;
SKCM	cis	rs2075371	0.933	rs1868784	chr7:133945932	A/G	cg20476274	chr7:133979776	SLC35B4	1.05	10.88	0.78	2.64e-17	Mean platelet volume;
SKCM	cis	rs3087591	0.960	rs12940303	chr17:29604862	C/T	cg24425628	chr17:29625626	OMG;NF1	0.63	4.93	0.49	4.6e-6	Hip circumference;
SKCM	cis	rs6430585	0.583	rs12472293	chr2:136648077	T/C	cg07169764	chr2:136633963	MCM6	1.32	12.04	0.81	1.81e-19	Corneal structure;
SKCM	cis	rs12477438	0.520	rs7604557	chr2:99747829	A/G	cg14399236	chr2:99771627	LIPT1;TSGA10	1.01	9.53	0.73	1.01e-14	Chronic sinus infection;
SKCM	cis	rs2652834	1.000	rs4344684	chr15:63397318	C/T	cg04194852	chr15:63334506	TPM1	0.76	4.78	0.48	8.15e-6	HDL cholesterol;
SKCM	cis	rs10751667	0.643	rs7394524	chr11:933865	T/C	cg10932868	chr11:921992	NA	0.55	5.13	0.5	2.09e-6	Alzheimer's disease (late onset);
SKCM	cis	rs4243830	0.850	rs4908904	chr1:6580250	A/G	cg22792644	chr1:6614718	TAS1R1;NOL9	1.04	5.18	0.51	1.68e-6	Body mass index;
SKCM	cis	rs826838	0.967	rs73096706	chr12:38860563	G/A	cg26384229	chr12:38710491	ALG10B	1.07	9.13	0.72	5.91e-14	Heart rate;
SKCM	cis	rs8141529	0.644	rs5752795	chr22:29178820	T/C	cg15103426	chr22:29168792	CCDC117	0.61	5.06	0.5	2.7e-6	Lymphocyte counts;
SKCM	cis	rs910316	1.000	rs910316	chr14:75626042	A/C	cg11812906	chr14:75593930	NEK9	0.7	5.28	0.51	1.12e-6	Height;
SKCM	cis	rs17685	0.712	rs7778735	chr7:75770237	T/C	cg16489192	chr7:75678113	MDH2;STYXL1	-0.57	-5.35	-0.52	8.63e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs139156536	1	rs139156536	chr17:38164432	TTTTA/T	cg17467752	chr17:38218738	THRA	0.69	6.15	0.57	3.16e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs10540	1.000	rs35874808	chr11:506442	G/T	cg03352830	chr11:487213	PTDSS2	0.94	4.91	0.49	4.87e-6	Body mass index;
SKCM	cis	rs2034088	0.930	rs2034089	chr17:433001	G/A	cg06217071	chr17:408420	NA	0.49	5.41	0.52	6.64e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs67311347	0.544	rs13062243	chr3:40336789	G/A	cg00091569	chr3:40428383	ENTPD3	0.61	5.33	0.52	9.24e-7	Renal cell carcinoma;
SKCM	cis	rs763121	0.853	rs6001175	chr22:39018334	T/C	cg06022373	chr22:39101656	GTPBP1	0.82	5.62	0.54	2.79e-7	Menopause (age at onset);
SKCM	cis	rs748404	0.660	rs693510	chr15:43714625	C/G	cg02155558	chr15:43621948	ADAL;LCMT2	0.73	5.42	0.52	6.48e-7	Lung cancer;
SKCM	cis	rs1577917	0.959	rs16876540	chr6:86612519	G/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.85	-8.62	-0.7	5.82e-13	Response to antipsychotic treatment;
SKCM	cis	rs28386778	0.562	rs721575	chr17:61782920	A/G	cg23090583	chr17:61904693	PSMC5;FTSJ3	-0.89	-7.82	-0.66	2.09e-11	Prudent dietary pattern;
SKCM	cis	rs7826238	0.566	rs2945886	chr8:8148270	C/G	cg06636001	chr8:8085503	FLJ10661	0.78	6.56	0.6	5.41e-9	Systolic blood pressure;
SKCM	cis	rs9325144	0.647	rs11169189	chr12:39097078	A/T	cg26384229	chr12:38710491	ALG10B	-0.73	-6.68	-0.6	3.21e-9	Morning vs. evening chronotype;
SKCM	cis	rs1555322	0.872	rs6579227	chr20:33879206	C/T	cg24158546	chr20:34542777	SCAND1	-1.04	-4.87	-0.48	5.77e-6	Attention deficit hyperactivity disorder;
SKCM	cis	rs1005277	0.638	rs1005278	chr10:38218748	G/A	cg25427524	chr10:38739819	LOC399744	0.6	5.02	0.49	3.2e-6	Extrinsic epigenetic age acceleration;
SKCM	cis	rs2836974	0.563	rs6517522	chr21:40553845	T/C	cg11644478	chr21:40555479	PSMG1	0.79	6.59	0.6	4.64e-9	Cognitive function;
SKCM	cis	rs9611565	0.729	rs2413647	chr22:41907148	G/A	cg03806693	chr22:41940476	POLR3H	-1.11	-7.55	-0.65	6.93e-11	Vitiligo;
SKCM	cis	rs763121	0.819	rs5757126	chr22:38923675	T/C	cg06022373	chr22:39101656	GTPBP1	0.77	5.65	0.54	2.51e-7	Menopause (age at onset);
SKCM	cis	rs2730245	0.527	rs842695	chr7:158662182	G/A	cg24397884	chr7:158709396	WDR60	0.98	5.56	0.53	3.7e-7	Height;
SKCM	cis	rs10479542	0.784	rs6896940	chr5:178985994	G/C	cg09060608	chr5:178986726	RUFY1	0.48	4.85	0.48	6.23e-6	Lung cancer;
SKCM	cis	rs6582630	0.519	rs11514372	chr12:38308613	T/G	cg26384229	chr12:38710491	ALG10B	0.8	6.55	0.6	5.47e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs6424115	0.830	rs4649124	chr1:24201357	A/G	cg15997130	chr1:24165203	NA	0.6	4.94	0.49	4.37e-6	Immature fraction of reticulocytes;
SKCM	cis	rs9902453	0.845	rs3102556	chr17:28042542	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.82	5.78	0.55	1.47e-7	Coffee consumption (cups per day);
SKCM	cis	rs35306767	0.903	rs11812523	chr10:915638	C/T	cg26597838	chr10:835615	NA	0.78	5.5	0.53	4.73e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs7811142	0.775	rs1059129	chr7:99926522	A/G	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.08	6.85	0.61	1.49e-9	Platelet count;
SKCM	cis	rs9902453	0.791	rs62068629	chr17:28187596	G/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.83	5.76	0.55	1.61e-7	Coffee consumption (cups per day);
SKCM	cis	rs1003719	0.788	rs9974286	chr21:38456832	A/G	cg10648535	chr21:38446584	PIGP;TTC3	-0.63	-5.02	-0.49	3.17e-6	Eye color traits;
SKCM	cis	rs8017423	0.967	rs2277517	chr14:90722778	G/A	cg04374321	chr14:90722782	PSMC1	1.03	9.44	0.73	1.55e-14	Mortality in heart failure;
SKCM	cis	rs6547741	1.000	rs7604798	chr2:27824940	T/C	cg27432699	chr2:27873401	GPN1	0.73	6.64	0.6	3.76e-9	Oral cavity cancer;
SKCM	cis	rs16866061	0.890	rs72972401	chr2:225404668	T/C	cg12698349	chr2:225449008	CUL3	1.01	8.51	0.69	9.75e-13	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs1707322	0.717	rs1547925	chr1:46085356	C/T	cg03146154	chr1:46216737	IPP	-0.8	-5.59	-0.53	3.22e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs12950390	0.853	rs4793647	chr17:45854090	G/C	cg03474202	chr17:45855739	NA	-0.49	-5.58	-0.53	3.34e-7	IgG glycosylation;
SKCM	cis	rs1552244	1.000	rs7622963	chr3:10139825	C/T	cg02579736	chr3:10068473	FANCD2;CIDECP	1.23	6.92	0.62	1.13e-9	Alzheimer's disease;
SKCM	cis	rs4925386	0.840	rs6143024	chr20:60914229	A/G	cg24112000	chr20:60950667	NA	-0.7	-6.61	-0.6	4.27e-9	Colorectal cancer;Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs62238980	0.614	rs76463308	chr22:32387270	C/T	cg00543991	chr22:32367038	NA	1.15	4.87	0.48	5.76e-6	Childhood ear infection;
SKCM	cis	rs17065868	0.803	rs10220075	chr13:45197421	A/G	cg10246903	chr13:45222710	NA	0.95	5.35	0.52	8.5e-7	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs7044106	0.791	rs4617229	chr9:123480696	A/G	cg09419670	chr9:123605666	PSMD5;LOC253039	0.53	4.81	0.48	7.34e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs7659604	1.000	rs28532673	chr4:122664323	A/G	cg06713675	chr4:122721982	EXOSC9	0.65	5.77	0.55	1.52e-7	Type 2 diabetes;
SKCM	cis	rs2645694	0.651	rs2703128	chr4:77819187	C/G	cg03477792	chr4:77819574	ANKRD56	0.57	6.38	0.59	1.18e-8	Emphysema distribution in smoking;
SKCM	cis	rs1218582	0.741	rs10908447	chr1:154869742	C/T	cg16680214	chr1:154839983	KCNN3	-0.55	-5.08	-0.5	2.54e-6	Prostate cancer;
SKCM	cis	rs2204008	0.837	rs11612125	chr12:38213212	C/T	cg26384229	chr12:38710491	ALG10B	0.82	6.58	0.6	4.87e-9	Bladder cancer;
SKCM	cis	rs2195224	1	rs2195224	chr3:42901000	G/A	cg06399164	chr3:42695035	ZBTB47	0.55	4.79	0.48	7.71e-6	Monocyte count;
SKCM	cis	rs13064447	0.753	rs9868500	chr3:12747690	A/G	cg05775895	chr3:12838266	CAND2	-0.7	-5.04	-0.5	2.98e-6	Major depression and alcohol dependence;
SKCM	cis	rs929354	0.772	rs2023975	chr7:157012096	G/A	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs112790992	1	rs112790992	chr14:105758217	A/C	cg13114125	chr14:105738426	BRF1	-0.69	-5.26	-0.51	1.24e-6	Platelet count;
SKCM	cis	rs1799949	0.965	rs34633610	chr17:41419385	A/G	cg05368731	chr17:41323189	NBR1	0.85	7.32	0.64	1.89e-10	Menopause (age at onset);
SKCM	cis	rs6580649	0.769	rs60629297	chr12:48438290	T/A	cg05342945	chr12:48394962	COL2A1	0.73	5.2	0.51	1.53e-6	Lung cancer;
SKCM	cis	rs2228479	1.000	rs117406136	chr16:89974605	C/T	cg00800038	chr16:89945340	TCF25	-0.96	-5.59	-0.53	3.25e-7	Skin colour saturation;
SKCM	cis	rs801193	1.000	rs2420824	chr7:66131116	G/A	cg11764359	chr7:65958608	NA	-0.83	-6.29	-0.58	1.71e-8	Aortic root size;
SKCM	cis	rs34779708	0.931	rs59418206	chr10:35331624	G/A	cg03585969	chr10:35415529	CREM	0.75	6.23	0.58	2.2e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs10791097	0.720	rs6590516	chr11:130733393	G/T	cg12179176	chr11:130786555	SNX19	0.89	7.46	0.65	1.02e-10	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs8017423	0.630	rs4904678	chr14:90821670	T/C	cg04374321	chr14:90722782	PSMC1	-0.73	-5.53	-0.53	4.13e-7	Mortality in heart failure;
SKCM	cis	rs1862618	0.526	rs2591963	chr5:56237135	T/A	cg12311346	chr5:56204834	C5orf35	0.75	5.5	0.53	4.69e-7	Initial pursuit acceleration;
SKCM	cis	rs9902453	0.838	rs7217638	chr17:28336772	T/C	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.81	-5.78	-0.55	1.45e-7	Coffee consumption (cups per day);
SKCM	cis	rs2070488	1.000	rs7373816	chr3:38490443	C/A	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.97	8.85	0.71	2.08e-13	Electrocardiographic conduction measures;
SKCM	cis	rs514406	0.825	rs7523761	chr1:53250915	T/C	cg16325326	chr1:53192061	ZYG11B	-0.85	-8.71	-0.7	3.95e-13	Monocyte count;
SKCM	cis	rs9325144	0.560	rs10785586	chr12:38676197	G/A	cg13010199	chr12:38710504	ALG10B	-0.63	-5.03	-0.49	3.07e-6	Morning vs. evening chronotype;
SKCM	cis	rs7945705	0.967	rs10769970	chr11:8917937	A/G	cg13070366	chr11:9386451	NA	-0.65	-5.57	-0.53	3.47e-7	Hemoglobin concentration;
SKCM	cis	rs7027203	0.828	rs4344139	chr9:96600298	T/C	cg14598338	chr9:96623480	NA	-0.52	-5.41	-0.52	6.75e-7	DNA methylation (variation);
SKCM	cis	rs875971	0.522	rs1701760	chr7:65473688	A/G	cg11987759	chr7:65425863	GUSB	-0.74	-6.67	-0.6	3.36e-9	Aortic root size;
SKCM	cis	rs798766	1.000	rs4865463	chr4:1742400	T/C	cg05874882	chr4:1763078	NA	-0.56	-4.89	-0.48	5.37e-6	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs7666738	0.830	rs4345191	chr4:98945408	A/G	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs362296	0.550	rs3135064	chr4:3285389	T/C	cg00764545	chr4:3318001	RGS12	0.71	6.56	0.6	5.46e-9	Parental longevity (mother's age at death);
SKCM	cis	rs9640161	0.750	rs3735169	chr7:150034378	A/G	cg27494647	chr7:150038898	RARRES2	0.61	5.33	0.52	9.39e-7	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs11249608	0.789	rs1969025	chr5:178425192	A/G	cg21905437	chr5:178450457	ZNF879	0.72	4.83	0.48	6.69e-6	Pubertal anthropometrics;
SKCM	cis	rs6430585	0.702	rs1042712	chr2:136545844	C/G	cg07169764	chr2:136633963	MCM6	-1.31	-13.14	-0.83	1.86e-21	Corneal structure;
SKCM	cis	rs769267	0.930	rs751856	chr19:19602945	A/G	cg26732615	chr19:19648335	CILP2;YJEFN3	0.67	7.06	0.62	6e-10	Tonsillectomy;
SKCM	cis	rs6582630	0.555	rs12372536	chr12:38400864	C/G	cg26384229	chr12:38710491	ALG10B	0.82	6.3	0.58	1.6e-8	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs1218582	0.744	rs6674853	chr1:154892753	G/C	cg16680214	chr1:154839983	KCNN3	-0.56	-5.11	-0.5	2.19e-6	Prostate cancer;
SKCM	cis	rs35306767	0.903	rs12764024	chr10:922861	A/G	cg20503657	chr10:835505	NA	0.79	5.94	0.56	7.37e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs7927771	0.524	rs7929725	chr11:47881740	A/G	cg20307385	chr11:47447363	PSMC3	0.71	5.63	0.54	2.67e-7	Subjective well-being;
SKCM	cis	rs5750830	0.649	rs2413590	chr22:39790191	G/C	cg24399712	chr22:39784796	NA	-0.57	-4.79	-0.48	7.68e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs736408	0.812	rs9324	chr3:52825585	T/C	cg18404041	chr3:52824283	ITIH1	-0.64	-5.73	-0.54	1.84e-7	Bipolar disorder;
SKCM	cis	rs854765	0.583	rs62064158	chr17:17826935	T/C	cg04398451	chr17:18023971	MYO15A	-0.85	-6.05	-0.57	4.75e-8	Total body bone mineral density;
SKCM	cis	rs4774899	0.966	rs12906566	chr15:57514874	A/C	cg01857019	chr15:57210107	LOC145783;TCF12	0.53	4.78	0.48	8.03e-6	Urinary tract infection frequency;
SKCM	trans	rs6481128	0.709	rs1733756	chr10:56700221	A/G	cg04272632	chr1:34629400	CSMD2	0.69	7.66	0.66	4.26e-11	Extraversion;
SKCM	cis	rs1882538	0.569	rs11562037	chr7:133076885	A/G	cg10665199	chr7:133106180	EXOC4	0.76	5.15	0.5	1.94e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1878931	0.582	rs9635562	chr16:3416689	G/A	cg26668626	chr16:3451006	ZNF174;ZNF434	0.82	6.01	0.56	5.69e-8	Body mass index (adult);
SKCM	cis	rs561341	0.941	rs72825746	chr17:30364610	G/A	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs7523273	0.606	rs2488255	chr1:207941741	C/T	cg22525895	chr1:207977042	MIR29B2	0.81	7.08	0.63	5.47e-10	Schizophrenia;
SKCM	cis	rs7191439	0.657	rs3826076	chr16:88780518	C/T	cg02389323	chr16:88786976	FAM38A	-1.47	-6.49	-0.59	7.17e-9	Plateletcrit;
SKCM	trans	rs3780486	0.846	rs7849148	chr9:33138352	A/T	cg04842962	chr6:43655489	MRPS18A	1.03	10.87	0.78	2.78e-17	IgG glycosylation;
SKCM	cis	rs13420028	1.000	rs7355605	chr2:133182066	A/G	cg06016439	chr2:133427427	LYPD1	0.53	5.05	0.5	2.79e-6	Hypertension (SNP x SNP interaction);
SKCM	cis	rs73201462	1.000	rs7374952	chr3:128001367	C/T	cg09089421	chr3:127803668	RUVBL1	1.0	5.11	0.5	2.22e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs1801251	1.000	rs9653383	chr2:233670380	A/C	cg08000102	chr2:233561755	GIGYF2	-0.89	-7.22	-0.63	3.02e-10	Coronary artery disease;
SKCM	cis	rs780096	0.506	rs780100	chr2:27652153	G/T	cg05696406	chr2:27599888	SNX17	0.51	5.22	0.51	1.46e-6	Total body bone mineral density;
SKCM	cis	rs28595532	0.541	rs114463740	chr4:119763329	C/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs2952156	0.920	rs8078228	chr17:37834998	C/T	cg20243544	chr17:37824526	PNMT	0.71	5.74	0.54	1.74e-7	Asthma;
SKCM	cis	rs4561483	0.767	rs33633	chr16:11994857	A/C	cg08843971	chr16:11963173	GSPT1	-0.67	-5.12	-0.5	2.12e-6	Testicular germ cell tumor;
SKCM	cis	rs7829975	0.523	rs9644774	chr8:8559832	G/A	cg15556689	chr8:8085844	FLJ10661	-0.69	-5.24	-0.51	1.35e-6	Mood instability;
SKCM	cis	rs28386778	0.897	rs2727295	chr17:61887693	C/T	cg22520471	chr17:61851767	DDX42;CCDC47	0.76	5.16	0.5	1.81e-6	Prudent dietary pattern;
SKCM	cis	rs9911578	1.000	rs2333332	chr17:56631054	A/G	cg12560992	chr17:57184187	TRIM37	-0.95	-7.67	-0.66	4.15e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs606458	0.841	rs683841	chr11:64548581	G/T	cg07674570	chr11:65346152	EHBP1L1	0.68	4.94	0.49	4.41e-6	Urate levels;
SKCM	cis	rs9393692	0.905	rs6940237	chr6:26282322	T/C	cg00631329	chr6:26305371	NA	-0.68	-4.93	-0.49	4.49e-6	Educational attainment;
SKCM	cis	rs1552244	0.935	rs7618815	chr3:10151045	A/G	cg02579736	chr3:10068473	FANCD2;CIDECP	1.23	6.92	0.62	1.13e-9	Alzheimer's disease;
SKCM	cis	rs9910055	0.530	rs11656758	chr17:42301541	A/G	cg08499158	chr17:42289980	UBTF	-0.79	-6.91	-0.62	1.15e-9	Total body bone mineral density;
SKCM	cis	rs798766	0.830	rs8389	chr4:1746844	A/T	cg24239225	chr4:1659016	FAM53A	-0.72	-4.87	-0.48	5.66e-6	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs9300255	0.568	rs1727300	chr12:123664205	C/T	cg00376283	chr12:123451042	ABCB9	0.83	5.49	0.53	4.74e-7	Neutrophil percentage of white cells;
SKCM	cis	rs1401999	0.898	rs4148561	chr3:183726379	A/G	cg01324343	chr3:183735012	ABCC5	0.88	10.48	0.76	1.5e-16	Anterior chamber depth;
SKCM	cis	rs4819052	0.851	rs4819039	chr21:46659458	G/A	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.42	0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs62238980	0.614	rs118073663	chr22:32397610	A/T	cg00543991	chr22:32367038	NA	1.15	4.87	0.48	5.76e-6	Childhood ear infection;
SKCM	cis	rs28595532	0.920	rs114916728	chr4:119776886	G/A	cg14228332	chr4:119757509	SEC24D	1.06	5.32	0.52	9.61e-7	Cannabis dependence symptom count;
SKCM	cis	rs9300255	0.739	rs12824957	chr12:123750228	T/C	cg00376283	chr12:123451042	ABCB9	-0.8	-5.45	-0.53	5.65e-7	Neutrophil percentage of white cells;
SKCM	cis	rs9583531	0.600	rs9521909	chr13:111362170	A/G	cg15841412	chr13:111365552	ING1	0.73	4.88	0.48	5.56e-6	Coronary artery disease;
SKCM	cis	rs1552244	0.572	rs67439440	chr3:10169503	C/T	cg00149659	chr3:10157352	C3orf10	1.13	5.45	0.53	5.74e-7	Alzheimer's disease;
SKCM	cis	rs4665809	0.590	rs1560865	chr2:26452197	C/A	cg04944784	chr2:26401820	FAM59B	-0.74	-4.79	-0.48	7.81e-6	Gut microbiome composition (summer);
SKCM	cis	rs2241584	0.715	rs10050907	chr5:175947646	G/A	cg06525892	chr5:175792454	ARL10	-0.53	-4.99	-0.49	3.56e-6	Menopause (age at onset);
SKCM	cis	rs8067545	0.611	rs2526465	chr17:20167611	T/C	cg13482628	chr17:19912719	NA	-0.65	-5.44	-0.52	5.84e-7	Schizophrenia;
SKCM	cis	rs362296	0.698	rs362282	chr4:3259671	G/A	cg11471262	chr4:3318911	RGS12	-0.77	-6.77	-0.61	2.14e-9	Parental longevity (mother's age at death);
SKCM	cis	rs2153535	0.580	rs1414350	chr6:8472331	C/T	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs3820068	0.603	rs59558854	chr1:15971399	T/G	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	trans	rs17685	0.753	rs4732542	chr7:75663203	A/G	cg19862616	chr7:65841803	NCRNA00174	0.89	8.58	0.7	7.12e-13	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2839186	0.770	rs2839171	chr21:47673247	C/T	cg13012494	chr21:47604986	C21orf56	-0.7	-5.9	-0.56	9.05e-8	Testicular germ cell tumor;
SKCM	cis	rs1348850	0.793	rs6734528	chr2:178493731	G/A	cg02961200	chr2:178257176	LOC100130691;AGPS	0.74	5.07	0.5	2.63e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs1799949	0.965	rs11650913	chr17:41331597	T/C	cg23758822	chr17:41437982	NA	0.93	7.84	0.66	1.91e-11	Menopause (age at onset);
SKCM	cis	rs7937682	0.855	rs521947	chr11:111492616	A/G	cg19812747	chr11:111475976	SIK2	-0.56	-4.93	-0.49	4.55e-6	Primary sclerosing cholangitis;
SKCM	cis	rs4346635	0.554	rs17004998	chr4:81824977	A/G	cg07982899	chr4:81307586	C4orf22	-0.67	-4.98	-0.49	3.78e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7794364	0.538	rs10233018	chr7:117523709	A/G	cg11393310	chr7:116594557	ST7;ST7OT4;ST7OT1	-0.54	-4.85	-0.48	6.14e-6	Idiopathic osteonecrosis of the femoral head;
SKCM	cis	rs732765	0.734	rs17183132	chr14:75153818	C/A	cg25946216	chr14:74253857	C14orf43	-0.79	-4.97	-0.49	3.83e-6	Non-small cell lung cancer;
SKCM	cis	rs6500602	0.626	rs7665	chr16:4562512	A/G	cg08645402	chr16:4508243	NA	0.64	5.12	0.5	2.12e-6	Schizophrenia;
SKCM	cis	rs867186	1.000	rs55909363	chr20:33549407	C/T	cg04194272	chr20:33683537	NA	-1.37	-6.77	-0.61	2.18e-9	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs7659604	0.502	rs28435300	chr4:122709412	T/C	cg19671926	chr4:122722719	EXOSC9	0.76	6.97	0.62	9.04e-10	Type 2 diabetes;
SKCM	cis	rs6951245	1.000	rs78143408	chr7:1096846	G/A	cg18402987	chr7:1209562	NA	1.15	6.09	0.57	3.95e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7904368	0.524	rs7088468	chr10:16873080	C/T	cg23933602	chr10:16859644	RSU1	1.06	5.31	0.52	9.89e-7	Ratio of the peak velocity of the mitral E-Wave divided by the peak velocity of the mitral A-wave.;
SKCM	cis	rs28386778	0.897	rs2584617	chr17:61925298	C/T	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs7772486	0.754	rs1415746	chr6:146077107	A/G	cg23711669	chr6:146136114	FBXO30	-0.94	-10.99	-0.78	1.66e-17	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4132509	0.744	rs10803156	chr1:243917776	G/C	cg21452805	chr1:244014465	NA	0.93	5.78	0.55	1.48e-7	RR interval (heart rate);
SKCM	cis	rs5760092	0.755	rs915589	chr22:24261004	C/T	cg24846343	chr22:24311635	DDTL	-0.61	-4.95	-0.49	4.2e-6	Urinary 1,3-butadiene metabolite levels in smokers;
SKCM	cis	rs9880211	1.000	rs35899944	chr3:136229057	G/A	cg21827317	chr3:136751795	NA	-0.65	-4.92	-0.49	4.73e-6	Body mass index;Height;
SKCM	cis	rs7143963	0.666	rs2403102	chr14:103306215	C/T	cg23020514	chr14:103360112	TRAF3	0.76	7.12	0.63	4.71e-10	Body mass index;
SKCM	cis	rs12134245	0.874	rs17501937	chr1:92021705	C/T	cg25838465	chr1:92012736	NA	0.68	6.21	0.58	2.4e-8	Breast cancer;
SKCM	cis	rs9325144	0.647	rs17518186	chr12:38883665	T/C	cg13010199	chr12:38710504	ALG10B	-0.65	-5.36	-0.52	8.25e-7	Morning vs. evening chronotype;
SKCM	cis	rs55962025	0.883	rs61792530	chr4:3145866	T/C	cg16987761	chr4:3318072	RGS12	-0.66	-5.06	-0.5	2.68e-6	Parental longevity (mother's age at death);
SKCM	cis	rs5753618	0.583	rs5753632	chr22:31863097	C/T	cg02404636	chr22:31891804	SFI1	0.61	5.55	0.53	3.78e-7	Colorectal cancer;
SKCM	cis	rs28595532	0.920	rs115430947	chr4:119737149	C/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs4803468	0.967	rs67047091	chr19:41938684	C/T	cg09537434	chr19:41945824	ATP5SL	1.1	13.21	0.83	1.39e-21	Height;
SKCM	cis	rs854765	0.647	rs7212447	chr17:17987067	G/A	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.88	6.64	0.6	3.8e-9	Total body bone mineral density;
SKCM	cis	rs875971	1.000	rs12698523	chr7:65968113	C/G	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	cis	rs9858542	0.953	rs9818590	chr3:49525096	A/G	cg03060546	chr3:49711283	APEH	-0.75	-5.53	-0.53	4.17e-7	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs11039389	1	rs11039389	chr11:47796062	T/C	cg05585544	chr11:47624801	NA	-0.57	-4.82	-0.48	6.97e-6	Neuroticism;
SKCM	cis	rs13118159	0.509	rs10023473	chr4:1375285	C/T	cg02475777	chr4:1388615	CRIPAK	0.81	5.63	0.54	2.71e-7	Longevity;
SKCM	cis	rs6445797	0.632	rs9846282	chr3:56639751	G/T	cg13616963	chr3:57583610	ARF4	-0.75	-4.97	-0.49	3.85e-6	Gastritis;
SKCM	cis	rs7618915	0.547	rs2268027	chr3:52766606	G/A	cg18404041	chr3:52824283	ITIH1	-0.56	-4.94	-0.49	4.33e-6	Bipolar disorder;
SKCM	cis	rs2730245	1.000	rs2252502	chr7:158738634	G/C	cg24397884	chr7:158709396	WDR60	-1.01	-9.36	-0.73	2.16e-14	Height;
SKCM	cis	rs1862618	0.802	rs194058	chr5:56188977	G/A	cg12311346	chr5:56204834	C5orf35	-0.76	-5.02	-0.49	3.2e-6	Initial pursuit acceleration;
SKCM	cis	rs1577917	0.958	rs6921315	chr6:86471668	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.78	-7.41	-0.64	1.3100000000000001e-10	Response to antipsychotic treatment;
SKCM	cis	rs1799949	0.859	rs11657004	chr17:41442751	A/G	cg23758822	chr17:41437982	NA	0.97	7.96	0.67	1.14e-11	Menopause (age at onset);
SKCM	cis	rs35306767	0.903	rs35370435	chr10:898205	T/C	cg26597838	chr10:835615	NA	0.79	5.7	0.54	2.01e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs6570726	0.599	rs9376951	chr6:145898911	C/T	cg05347473	chr6:146136440	FBXO30	0.66	5.68	0.54	2.19e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs17711722	0.701	rs55773927	chr7:65337902	T/C	cg11987759	chr7:65425863	GUSB	-0.75	-6.42	-0.59	9.94e-9	Calcium levels;
SKCM	cis	rs2832191	0.755	rs2832192	chr21:30491173	G/T	cg08807101	chr21:30365312	RNF160	-0.65	-4.89	-0.48	5.2e-6	Dental caries;
SKCM	cis	rs365132	1.000	rs2055619	chr5:176415964	A/G	cg16309518	chr5:176445507	NA	-0.52	-4.99	-0.49	3.54e-6	Menarche and menopause (age at onset);Menopause (age at onset);
SKCM	cis	rs11098499	0.909	rs6842762	chr4:120398236	A/T	cg24375607	chr4:120327624	NA	0.66	5.09	0.5	2.44e-6	Corneal astigmatism;
SKCM	cis	rs11098499	0.909	rs7681214	chr4:120385320	C/A	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs6066825	0.627	rs6012497	chr20:47228591	C/T	cg18078177	chr20:47281410	PREX1	0.65	5.34	0.52	8.88e-7	Colorectal cancer;
SKCM	cis	rs16949788	0.793	rs12439706	chr15:66668004	C/T	cg08120210	chr15:66682733	MAP2K1	-0.74	-5.82	-0.55	1.23e-7	Spherical equivalent (joint analysis main effects and education interaction);
SKCM	cis	rs11155671	0.530	rs9397420	chr6:150206781	C/T	cg05036130	chr6:150231994	NA	-0.6	-6.88	-0.61	1.32e-9	Testicular germ cell tumor;
SKCM	cis	rs801193	0.548	rs2659904	chr7:66178602	C/A	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.5	4.83	0.48	6.71e-6	Aortic root size;
SKCM	cis	rs826838	0.935	rs1684406	chr12:39127265	A/G	cg26384229	chr12:38710491	ALG10B	-0.96	-8.83	-0.71	2.26e-13	Heart rate;
SKCM	cis	rs72634258	0.945	rs1883679	chr1:8100451	T/G	cg00042356	chr1:8021962	PARK7	1.08	7.51	0.65	8.25e-11	Inflammatory bowel disease;
SKCM	cis	rs2013441	1.000	rs11871827	chr17:20215905	C/G	cg13482628	chr17:19912719	NA	-0.62	-4.85	-0.48	6.23e-6	Obesity-related traits;
SKCM	cis	rs6445797	0.632	rs9842283	chr3:56609469	G/T	cg13616963	chr3:57583610	ARF4	-0.79	-5.1	-0.5	2.35e-6	Gastritis;
SKCM	cis	rs11098499	0.863	rs3775848	chr4:120447724	C/T	cg24375607	chr4:120327624	NA	0.68	5.27	0.51	1.16e-6	Corneal astigmatism;
SKCM	cis	rs12762955	0.561	rs7918118	chr10:1042823	C/A	cg25614935	chr10:1084866	C10orf110	-0.58	-4.85	-0.48	6.19e-6	Response to angiotensin II receptor blocker therapy;
SKCM	cis	rs3820068	0.532	rs72645862	chr1:15920366	A/G	cg13390004	chr1:15929781	NA	0.67	5.29	0.51	1.11e-6	Systolic blood pressure;
SKCM	cis	rs17711722	0.740	rs7809991	chr7:65406218	A/G	cg11764359	chr7:65958608	NA	0.89	6.91	0.62	1.16e-9	Calcium levels;
SKCM	cis	rs11209185	0.602	rs6662448	chr1:68447267	G/A	cg17031739	chr1:67600172	NA	-0.5	-4.85	-0.48	6.17e-6	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs28386778	0.897	rs2584624	chr17:61904546	A/G	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs16854884	0.586	rs6782789	chr3:143746691	G/A	cg06585982	chr3:143692056	C3orf58	0.87	8.34	0.69	2.04e-12	Economic and political preferences (feminism/equality);
SKCM	cis	rs2404602	0.716	rs1588961	chr15:76752698	A/G	cg23625390	chr15:77176239	SCAPER	0.57	5.23	0.51	1.39e-6	Blood metabolite levels;
SKCM	cis	rs7937682	0.883	rs512669	chr11:111467893	G/A	cg19812747	chr11:111475976	SIK2	-0.61	-4.94	-0.49	4.41e-6	Primary sclerosing cholangitis;
SKCM	cis	rs1401999	0.898	rs4148564	chr3:183725982	C/T	cg01324343	chr3:183735012	ABCC5	0.88	10.48	0.76	1.5e-16	Anterior chamber depth;
SKCM	cis	rs28374715	0.681	rs7165396	chr15:41586947	T/C	cg18705301	chr15:41695430	NDUFAF1	-1.12	-12.34	-0.81	5.1e-20	Ulcerative colitis;
SKCM	cis	rs595982	0.559	rs117227130	chr19:49367959	A/G	cg15549821	chr19:49342101	PLEKHA4	-0.87	-5.29	-0.51	1.09e-6	Red cell distribution width;
SKCM	cis	rs9435341	0.965	rs55924375	chr1:107566690	C/A	cg09367891	chr1:107599246	PRMT6	0.82	6.58	0.6	4.8e-9	Facial morphology (factor 21, depth of nasal alae);
SKCM	cis	rs7666738	0.830	rs10014986	chr4:99000687	A/C	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6736997	0.967	rs34776355	chr2:235615475	A/G	cg17841421	chr2:235704848	NA	0.59	5.12	0.5	2.13e-6	Pancreatic cancer;
SKCM	cis	rs2032447	0.677	rs199737	chr6:25933538	A/T	cg03264133	chr6:25882463	NA	-0.58	-5.05	-0.5	2.87e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1580019	0.961	rs6949851	chr7:32493807	T/G	cg06627557	chr7:32535165	LSM5;AVL9	0.75	5.74	0.55	1.7e-7	Cognitive ability;
SKCM	cis	rs6570726	0.846	rs409553	chr6:145886963	C/T	cg05347473	chr6:146136440	FBXO30	0.53	4.89	0.48	5.28e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6951245	1.000	rs77083167	chr7:1071823	C/T	cg24642844	chr7:1081250	C7orf50	-0.95	-6.4	-0.59	1.06e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs3845702	0.736	rs3843323	chr2:180856459	T/C	cg01881094	chr2:180872142	CWC22	-1.26	-6.25	-0.58	2.01e-8	Schizophrenia;
SKCM	cis	rs826838	1.000	rs11168505	chr12:38939057	A/T	cg26384229	chr12:38710491	ALG10B	-1.09	-9.99	-0.75	1.31e-15	Heart rate;
SKCM	cis	rs561341	1.000	rs4795668	chr17:30244554	G/A	cg13647721	chr17:30228624	UTP6	0.77	4.81	0.48	7.1e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs6121246	0.559	rs6087782	chr20:30391580	C/T	cg13852791	chr20:30311386	BCL2L1	0.82	5.69	0.54	2.09e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs11892454	0.515	rs6741640	chr2:26068509	C/T	cg17263061	chr2:26915892	KCNK3	0.69	4.98	0.49	3.73e-6	Heschl's gyrus morphology;
SKCM	cis	rs72781680	0.611	rs55868657	chr2:24295385	G/A	cg20701182	chr2:24300061	SF3B14	0.74	5.01	0.49	3.33e-6	Lymphocyte counts;
SKCM	cis	rs1799949	1.000	rs1135214	chr17:41292323	T/C	cg23758822	chr17:41437982	NA	0.92	7.8	0.66	2.3e-11	Menopause (age at onset);
SKCM	cis	rs9611565	0.694	rs202665	chr22:41814401	A/G	cg03806693	chr22:41940476	POLR3H	1.1	7.47	0.65	9.78e-11	Vitiligo;
SKCM	cis	rs12824058	0.831	rs7310433	chr12:130809289	C/T	cg24838063	chr12:130822603	PIWIL1	0.78	6.91	0.62	1.19e-9	Menopause (age at onset);
SKCM	cis	rs7180079	0.544	rs4777601	chr15:65100154	G/T	cg10949862	chr15:64387625	SNX1;FAM96A	0.95	5.04	0.5	2.91e-6	Monocyte count;
SKCM	cis	rs2153535	0.580	rs9505446	chr6:8448691	T/C	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs2013441	1.000	rs11654025	chr17:20198160	A/T	cg13482628	chr17:19912719	NA	-0.69	-5.47	-0.53	5.24e-7	Obesity-related traits;
SKCM	cis	rs780096	0.526	rs11126999	chr2:27670307	G/A	cg05696406	chr2:27599888	SNX17	0.51	5.06	0.5	2.75e-6	Total body bone mineral density;
SKCM	cis	rs7208859	0.623	rs7223404	chr17:29107363	C/T	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs12200782	0.505	rs1535275	chr6:26520767	G/C	cg11502198	chr6:26597334	ABT1	0.75	4.91	0.49	4.99e-6	Small cell lung carcinoma;
SKCM	cis	rs2033711	0.870	rs6510152	chr19:58953319	C/T	cg11952622	chr19:58962976	ZNF324B	0.63	4.8	0.48	7.52e-6	Uric acid clearance;
SKCM	cis	rs11098499	0.644	rs3986377	chr4:120260270	G/A	cg09307838	chr4:120376055	NA	0.97	8.31	0.69	2.31e-12	Corneal astigmatism;
SKCM	cis	rs4727027	0.834	rs7811446	chr7:148773226	G/T	cg23583168	chr7:148888333	NA	-0.81	-6.31	-0.58	1.57e-8	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs875971	1.000	rs875971	chr7:65617595	A/G	cg18876405	chr7:65276391	NA	-0.68	-6.85	-0.61	1.54e-9	Aortic root size;
SKCM	cis	rs1577917	0.958	rs4707229	chr6:86546237	C/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.32	-0.52	9.66e-7	Response to antipsychotic treatment;
SKCM	cis	rs782590	0.683	rs782633	chr2:55898203	A/G	cg18811423	chr2:55921094	PNPT1	0.91	7.45	0.64	1.08e-10	Metabolic syndrome;
SKCM	cis	rs2839186	0.814	rs2276257	chr21:47711229	A/G	cg13012494	chr21:47604986	C21orf56	0.67	5.72	0.54	1.89e-7	Testicular germ cell tumor;
SKCM	cis	rs9467773	1.000	rs6903973	chr6:26499942	C/A	cg09904177	chr6:26538194	HMGN4	0.55	5.03	0.49	3.11e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs8078723	0.714	rs2241245	chr17:38151014	C/T	cg17467752	chr17:38218738	THRA	-0.61	-5.49	-0.53	4.75e-7	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs28595532	0.920	rs17324807	chr4:119770638	G/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs10489202	1.000	rs4656564	chr1:167928992	T/C	cg24449463	chr1:168025552	DCAF6	-0.76	-5.87	-0.55	1.02e-7	Schizophrenia;
SKCM	cis	rs10883723	0.810	rs2281879	chr10:104268877	C/G	ch.10.2196322F	chr10:104248062	ACTR1A	0.64	4.82	0.48	6.92e-6	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs11105298	0.891	rs11105309	chr12:89909850	T/C	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.92	-5.8	-0.55	1.36e-7	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs453301	0.592	rs4841084	chr8:8883905	C/T	cg15556689	chr8:8085844	FLJ10661	0.69	5.81	0.55	1.32e-7	Joint mobility (Beighton score);
SKCM	cis	rs34779708	0.966	rs12761675	chr10:35438337	C/T	cg03585969	chr10:35415529	CREM	-0.76	-6.47	-0.59	7.93e-9	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs67311347	0.911	rs6776044	chr3:40377503	T/G	cg00091569	chr3:40428383	ENTPD3	0.65	5.58	0.53	3.36e-7	Renal cell carcinoma;
SKCM	cis	rs362272	0.545	rs2236052	chr4:3318413	C/T	cg21096898	chr4:3318625	RGS12	-0.97	-12.91	-0.83	4.72e-21	Serum sulfate level;
SKCM	cis	rs6977660	0.714	rs12333747	chr7:19814394	G/A	cg05791153	chr7:19748676	TWISTNB	0.8	5.01	0.49	3.37e-6	Thyroid stimulating hormone;
SKCM	cis	rs4332037	0.539	rs56305291	chr7:2048706	A/G	cg23422044	chr7:1970798	MAD1L1	-0.9	-5.97	-0.56	6.6e-8	Bipolar disorder;
SKCM	cis	rs6138458	1.000	rs4273288	chr20:24900873	G/A	cg26195577	chr20:24973756	C20orf3	-1.22	-8.58	-0.7	7.01e-13	Blood protein levels;
SKCM	cis	rs9894429	0.690	rs11869779	chr17:79570067	C/T	cg18240062	chr17:79603768	NPLOC4	-0.91	-10.36	-0.76	2.55e-16	Eye color traits;
SKCM	cis	rs7917772	0.536	rs3961456	chr10:104425304	A/T	cg11453585	chr10:104263688	ACTR1A;SUFU	-0.74	-5.53	-0.53	4.11e-7	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs4555082	0.874	rs1008628	chr14:105722726	T/C	cg13114125	chr14:105738426	BRF1	-0.69	-5.39	-0.52	7.2e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs35306767	0.904	rs10904584	chr10:983747	A/T	cg26597838	chr10:835615	NA	0.65	5.35	0.52	8.7e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs1405130	0.869	rs12995348	chr2:235565497	T/C	cg17841421	chr2:235704848	NA	-0.62	-5.36	-0.52	8.19e-7	Coronary artery disease;
SKCM	cis	rs514406	0.683	rs6588440	chr1:53209587	C/T	cg24675658	chr1:53192096	ZYG11B	0.62	4.95	0.49	4.21e-6	Monocyte count;
SKCM	cis	rs4132509	1.000	rs12403316	chr1:243956903	C/T	cg21452805	chr1:244014465	NA	0.87	5.16	0.5	1.81e-6	RR interval (heart rate);
SKCM	cis	rs7772486	0.534	rs34541797	chr6:146205304	A/G	cg23711669	chr6:146136114	FBXO30	0.79	6.66	0.6	3.42e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs28595532	0.920	rs73842253	chr4:119721856	G/A	cg21605333	chr4:119757512	SEC24D	1.25	6.24	0.58	2.14e-8	Cannabis dependence symptom count;
SKCM	cis	rs72634258	0.786	rs12563704	chr1:8033837	G/A	cg00042356	chr1:8021962	PARK7	0.91	6.19	0.57	2.58e-8	Inflammatory bowel disease;
SKCM	cis	rs1218582	0.772	rs7528532	chr1:154874440	C/T	cg03351412	chr1:154909251	PMVK	0.77	6.52	0.59	6.43e-9	Prostate cancer;
SKCM	cis	rs6952808	0.691	rs2398709	chr7:2112548	C/T	cg21782813	chr7:2030301	MAD1L1	0.49	4.92	0.49	4.72e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs910316	1.000	rs4903279	chr14:75546583	C/T	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.89e-7	Height;
SKCM	cis	rs875971	0.545	rs73142233	chr7:65686280	T/A	cg18876405	chr7:65276391	NA	0.64	5.29	0.51	1.09e-6	Aortic root size;
SKCM	cis	rs854765	0.647	rs6502637	chr17:17986098	A/G	cg04398451	chr17:18023971	MYO15A	-1.02	-8.72	-0.7	3.81e-13	Total body bone mineral density;
SKCM	cis	rs4819052	0.851	rs2236446	chr21:46678985	T/C	cg02159808	chr21:46707872	POFUT2;LOC642852	0.73	5.71	0.54	1.93e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs2404602	0.608	rs12439484	chr15:76602937	A/C	cg22467129	chr15:76604101	ETFA	-0.65	-5.35	-0.52	8.68e-7	Blood metabolite levels;
SKCM	cis	rs1005277	0.579	rs2505196	chr10:38393563	G/A	cg25427524	chr10:38739819	LOC399744	-0.69	-6.45	-0.59	8.73e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs1580019	0.563	rs764483	chr7:32578150	A/T	cg06627557	chr7:32535165	LSM5;AVL9	0.94	9.12	0.72	6.39e-14	Cognitive ability;
SKCM	cis	rs7599312	0.534	rs6751692	chr2:213408120	C/T	cg16329650	chr2:213403929	ERBB4	0.84	6.04	0.56	4.85e-8	BMI (adjusted for smoking behaviour);BMI in non-smokers;Body mass index;Body mass index (joint analysis main effects and smoking interaction);
SKCM	cis	rs11673344	0.796	rs9676450	chr19:37489407	A/G	cg07624650	chr19:37064219	ZNF529	-0.78	-4.82	-0.48	7.05e-6	Obesity-related traits;
SKCM	cis	rs5769765	0.817	rs9616212	chr22:50317687	G/A	cg22709217	chr22:50311962	ALG12;CRELD2	-0.99	-6.09	-0.57	4.04e-8	Schizophrenia;
SKCM	cis	rs1912528	0.962	rs17314804	chr4:140946828	C/T	cg11128457	chr4:140864437	MAML3	0.62	5.12	0.5	2.16e-6	Educational attainment (years of education);
SKCM	cis	rs637571	0.546	rs10791827	chr11:65596546	C/A	cg26695010	chr11:65641043	EFEMP2	0.63	5.03	0.49	3.1e-6	Eosinophil percentage of white cells;
SKCM	cis	rs995000	0.929	rs12038768	chr1:63040728	G/T	cg06896770	chr1:63153194	DOCK7	0.9	7.92	0.67	1.32e-11	Triglyceride levels;
SKCM	cis	rs3213545	0.659	rs2259693	chr12:121457995	G/A	cg15155738	chr12:121454335	C12orf43	0.72	5.62	0.54	2.85e-7	Subjective well-being;Cardiovascular disease risk factors;
SKCM	cis	rs10876993	0.928	rs2169988	chr12:58071165	G/A	cg18357645	chr12:58087776	OS9	0.65	5.98	0.56	6.22e-8	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs10504229	0.683	rs11787247	chr8:58131528	G/T	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs2197308	0.740	rs1842595	chr12:37906223	G/A	cg13010199	chr12:38710504	ALG10B	-0.64	-4.92	-0.49	4.67e-6	Morning vs. evening chronotype;
SKCM	cis	rs780096	0.526	rs1260342	chr2:27663416	G/T	cg05696406	chr2:27599888	SNX17	0.51	5.22	0.51	1.46e-6	Total body bone mineral density;
SKCM	cis	rs4243830	0.826	rs12565181	chr1:6620545	G/A	cg22792644	chr1:6614718	TAS1R1;NOL9	1.23	4.86	0.48	5.88e-6	Body mass index;
SKCM	cis	rs7954584	0.567	rs10840632	chr12:122375460	C/T	cg01765077	chr12:122356316	WDR66	0.43	4.9	0.48	5.16e-6	Mean corpuscular volume;
SKCM	cis	rs2153535	0.580	rs2327050	chr6:8440630	A/G	cg07606381	chr6:8435919	SLC35B3	0.94	6.94	0.62	1.02e-9	Motion sickness;
SKCM	cis	rs6547741	1.000	rs1919125	chr2:27801403	C/G	cg27432699	chr2:27873401	GPN1	0.73	6.64	0.6	3.76e-9	Oral cavity cancer;
SKCM	cis	rs7666738	0.830	rs11097608	chr4:99011693	T/C	cg05340658	chr4:99064831	C4orf37	0.66	5.1	0.5	2.33e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs394563	0.726	rs366905	chr6:149735097	T/A	cg03678062	chr6:149772716	ZC3H12D	-0.49	-5.46	-0.53	5.45e-7	Dupuytren's disease;
SKCM	cis	rs5769765	1.000	rs5769764	chr22:50270784	G/A	cg22709217	chr22:50311962	ALG12;CRELD2	0.79	5.71	0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs2658782	0.951	rs72972364	chr11:93122128	C/T	cg15737290	chr11:93063684	CCDC67	-0.71	-4.92	-0.49	4.64e-6	Pulmonary function decline;
SKCM	cis	rs9325144	0.560	rs11183150	chr12:38674698	A/G	cg26384229	chr12:38710491	ALG10B	-0.7	-5.82	-0.55	1.26e-7	Morning vs. evening chronotype;
SKCM	cis	rs3008870	0.920	rs2755253	chr1:67470843	C/T	cg08660285	chr1:67390436	MIER1;WDR78	0.84	5.66	0.54	2.41e-7	Lymphocyte percentage of white cells;
SKCM	cis	rs867186	1.000	rs77437249	chr20:33564738	G/A	cg04194272	chr20:33683537	NA	-1.37	-6.77	-0.61	2.18e-9	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs4819052	0.679	rs28623526	chr21:46712324	T/C	cg19498844	chr21:46707878	POFUT2;LOC642852	0.83	6.91	0.62	1.18e-9	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7666738	0.830	rs1025203	chr4:99023073	G/A	cg05340658	chr4:99064831	C4orf37	0.66	5.06	0.5	2.77e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs3020736	0.500	rs6002603	chr22:42492362	C/G	cg04733989	chr22:42467013	NAGA	-0.72	-5.62	-0.54	2.87e-7	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs11690935	0.959	rs10497374	chr2:172640623	A/G	cg13550731	chr2:172543902	DYNC1I2	-0.94	-7.99	-0.67	9.97e-12	Schizophrenia;
SKCM	cis	rs3091242	0.933	rs1534954	chr1:25761924	A/T	cg02931644	chr1:25747376	RHCE	0.5	4.88	0.48	5.43e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs6430585	0.583	rs3754689	chr2:136590746	C/T	cg07169764	chr2:136633963	MCM6	1.22	11.98	0.8	2.32e-19	Corneal structure;
SKCM	cis	rs9381040	0.655	rs2268187	chr6:41042993	G/A	cg04346459	chr6:41068666	NFYA;LOC221442	-0.71	-5.0	-0.49	3.5e-6	Alzheimer's disease (late onset);
SKCM	cis	rs2286503	0.809	rs4719716	chr7:22861369	G/A	cg15401507	chr7:22894281	NA	-0.57	-5.61	-0.54	2.99e-7	Fibrinogen;
SKCM	cis	rs10504229	0.683	rs882429	chr8:58129292	A/G	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs7208859	0.623	rs9890855	chr17:29111707	G/C	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs826838	0.967	rs826856	chr12:39115434	G/A	cg13010199	chr12:38710504	ALG10B	-0.78	-5.84	-0.55	1.14e-7	Heart rate;
SKCM	trans	rs561341	1.000	rs508192	chr17:30315147	C/T	cg20587970	chr11:113659929	NA	1.15	10.04	0.75	1.07e-15	Hip circumference adjusted for BMI;
SKCM	cis	rs7590368	0.926	rs12621237	chr2:10957538	T/C	cg15705551	chr2:10952987	PDIA6	0.76	4.93	0.49	4.53e-6	Educational attainment (years of education);
SKCM	cis	rs2286503	0.839	rs2240728	chr7:22852499	C/T	cg15401507	chr7:22894281	NA	-0.57	-5.57	-0.53	3.5e-7	Fibrinogen;
SKCM	cis	rs796364	0.951	rs35618222	chr2:201065777	C/G	cg12253985	chr2:200820533	C2orf60;C2orf47	0.95	6.37	0.59	1.21e-8	Schizophrenia;
SKCM	cis	rs3785574	0.962	rs2955235	chr17:61966950	A/C	cg11494091	chr17:61959527	GH2	0.55	5.21	0.51	1.5e-6	Height;
SKCM	cis	rs9911578	1.000	rs4793950	chr17:56593111	T/C	cg05425664	chr17:57184151	TRIM37	0.69	5.21	0.51	1.52e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7666738	0.830	rs35915560	chr4:98978649	C/T	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1405130	0.839	rs11693749	chr2:235569891	C/T	cg17841421	chr2:235704848	NA	-0.57	-4.95	-0.49	4.14e-6	Coronary artery disease;
SKCM	cis	rs9399137	0.507	rs12663810	chr6:135289782	G/C	cg24558204	chr6:135376177	HBS1L	0.69	6.37	0.59	1.19e-8	Glycated hemoglobin levels;Mean corpuscular volume;Hematology traits;HbA2 levels;Mean corpuscular hemoglobin;Hemoglobin levels;F-cell distribution;Platelet count;
SKCM	cis	rs10779751	0.960	rs1883964	chr1:11294942	T/A	cg08854313	chr1:11322531	MTOR	0.92	7.09	0.63	5.2400000000000005e-10	Body mass index;
SKCM	cis	rs9660180	0.967	rs11260623	chr1:1781456	G/T	cg23982607	chr1:1823379	GNB1	-0.7	-5.98	-0.56	6.48e-8	Body mass index;
SKCM	cis	rs1865760	0.663	rs9348704	chr6:26000393	A/C	cg16482183	chr6:26056742	HIST1H1C	0.62	4.9	0.49	5.13e-6	Height;
SKCM	cis	rs4727027	0.800	rs10952796	chr7:148813138	G/C	cg23583168	chr7:148888333	NA	-0.83	-6.7	-0.6	2.89e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs694739	0.857	rs574835	chr11:64110668	G/A	cg23796481	chr11:64053134	BAD;GPR137	0.74	5.51	0.53	4.54e-7	Alopecia areata;Crohn's disease;Psoriasis vulgaris;
SKCM	cis	rs6500602	0.767	rs8060219	chr16:4480158	T/A	cg09069446	chr16:4462122	CORO7	-0.46	-4.89	-0.48	5.32e-6	Schizophrenia;
SKCM	cis	rs4268898	0.662	rs72793213	chr2:24524725	A/G	cg06627628	chr2:24431161	ITSN2	-0.96	-7.33	-0.64	1.83e-10	Asthma;
SKCM	cis	rs60871478	1.000	rs4719314	chr7:822523	A/G	cg05535760	chr7:792225	HEATR2	1.04	8.05	0.67	7.57e-12	Cerebrospinal P-tau181p levels;
SKCM	cis	rs6665290	0.904	rs11587443	chr1:227187896	T/C	cg10327440	chr1:227177885	CDC42BPA	-1.22	-17.11	-0.89	4.01e-28	Myeloid white cell count;
SKCM	cis	rs12950390	0.853	rs11079792	chr17:45863311	T/C	cg03474202	chr17:45855739	NA	-0.48	-5.39	-0.52	7.29e-7	IgG glycosylation;
SKCM	cis	rs2072499	0.932	rs2736613	chr1:156196016	T/C	cg24450063	chr1:156163899	SLC25A44	0.92	7.69	0.66	3.75e-11	Testicular germ cell tumor;
SKCM	cis	rs11585357	0.689	rs2977293	chr1:17599444	C/T	cg08277548	chr1:17600880	PADI3	-0.77	-6.12	-0.57	3.55e-8	Hair shape;
SKCM	cis	rs7296418	0.636	rs11057261	chr12:123797567	T/C	cg00376283	chr12:123451042	ABCB9	0.82	6.54	0.6	5.78e-9	Platelet count;
SKCM	cis	rs7635838	0.684	rs2594966	chr3:11325276	A/G	cg00170343	chr3:11313890	ATG7	-0.73	-5.55	-0.53	3.74e-7	HDL cholesterol;
SKCM	cis	rs7824557	0.527	rs4631425	chr8:11239054	C/T	cg21775007	chr8:11205619	TDH	-0.57	-4.8	-0.48	7.38e-6	Retinal vascular caliber;
SKCM	cis	rs71520386	0.607	rs11767419	chr7:22878983	T/G	cg15401507	chr7:22894281	NA	0.68	4.98	0.49	3.67e-6	Fibrinogen levels;
SKCM	cis	rs7937682	1.000	rs7121011	chr11:111568681	C/T	cg09085632	chr11:111637200	PPP2R1B	1.02	11.79	0.8	5.18e-19	Primary sclerosing cholangitis;
SKCM	cis	rs62064224	0.902	rs35830939	chr17:30627564	A/C	cg25809561	chr17:30822961	MYO1D	0.67	5.61	0.54	2.9e-7	Schizophrenia;
SKCM	cis	rs2836974	0.932	rs2150415	chr21:40615367	A/G	cg11644478	chr21:40555479	PSMG1	0.98	9.4	0.73	1.79e-14	Cognitive function;
SKCM	cis	rs7833790	1.000	rs1463259	chr8:82737745	A/G	cg17211192	chr8:82754475	SNX16	-0.89	-4.96	-0.49	4.06e-6	Diastolic blood pressure;
SKCM	cis	rs3091242	0.933	rs35530120	chr1:25785451	A/G	cg27572855	chr1:25598939	RHD	-0.53	-5.06	-0.5	2.67e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs9640161	0.659	rs7788316	chr7:150013995	A/T	cg10018233	chr7:150070692	REPIN1	0.7	5.72	0.54	1.88e-7	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs2952156	1.000	rs2952156	chr17:37876835	A/G	cg20243544	chr17:37824526	PNMT	0.69	5.57	0.53	3.53e-7	Asthma;
SKCM	cis	rs6866344	0.697	rs17184281	chr5:178127563	G/A	cg03877680	chr5:178157825	ZNF354A	0.82	5.7	0.54	2.03e-7	Neutrophil percentage of white cells;
SKCM	cis	rs849898	1	rs849898	chr1:228153917	A/G	cg02753203	chr1:228287806	NA	-0.72	-6.05	-0.56	4.78e-8	Parkinson's disease;
SKCM	cis	rs1635	0.655	rs75885713	chr6:28312356	G/A	cg15743358	chr6:28303923	ZNF323	-1.37	-5.44	-0.52	5.99e-7	Schizophrenia;
SKCM	cis	rs12971120	0.891	rs4891557	chr18:72170299	C/T	cg25817165	chr18:72167213	CNDP2	-0.65	-4.85	-0.48	6.23e-6	Refractive error;
SKCM	cis	rs798554	1.000	rs798548	chr7:2760935	A/G	cg06387496	chr7:2775674	GNA12	-0.56	-4.81	-0.48	7.31e-6	Height;
SKCM	cis	rs35146811	0.586	rs6964754	chr7:99589404	G/A	cg13334819	chr7:99746414	C7orf59	-0.7	-4.86	-0.48	5.97e-6	Coronary artery disease;
SKCM	cis	rs9911578	1.000	rs302854	chr17:56683612	G/A	cg05425664	chr17:57184151	TRIM37	-0.69	-5.21	-0.51	1.52e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs854765	0.583	rs12452219	chr17:17829423	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.91	7.17	0.63	3.77e-10	Total body bone mineral density;
SKCM	cis	rs4975616	0.686	rs37011	chr5:1348798	A/T	cg07493874	chr5:1342172	CLPTM1L	-0.61	-5.35	-0.52	8.56e-7	Lung cancer;
SKCM	cis	rs4332037	0.539	rs4719416	chr7:2106608	G/A	cg23422044	chr7:1970798	MAD1L1	-0.84	-6.12	-0.57	3.47e-8	Bipolar disorder;
SKCM	cis	rs7100689	0.784	rs2153455	chr10:82139732	T/C	cg01528321	chr10:82214614	TSPAN14	0.86	8.52	0.69	9.09e-13	Post bronchodilator FEV1;
SKCM	cis	rs1552244	0.935	rs2272124	chr3:10138189	T/C	cg02579736	chr3:10068473	FANCD2;CIDECP	1.23	6.92	0.62	1.13e-9	Alzheimer's disease;
SKCM	cis	rs11764590	0.694	rs10235664	chr7:2086814	T/C	cg02825527	chr7:2087843	MAD1L1	-0.65	-5.12	-0.5	2.17e-6	Neuroticism;
SKCM	cis	rs798554	0.642	rs2533871	chr7:2883006	C/G	cg19346786	chr7:2764209	NA	-0.66	-6.64	-0.6	3.79e-9	Height;
SKCM	cis	rs561341	0.689	rs578635	chr17:30289897	A/C	cg00745463	chr17:30367425	LRRC37B	-0.84	-5.38	-0.52	7.49e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs8067545	0.750	rs4924803	chr17:19991806	C/T	cg13482628	chr17:19912719	NA	0.73	6.54	0.6	5.78e-9	Schizophrenia;
SKCM	cis	rs7528419	0.895	rs583104	chr1:109821307	G/T	cg00908766	chr1:109817496	CELSR2	0.44	5.01	0.49	3.27e-6	Coronary artery disease (myocardial infartum, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease);Myocardial infarction;Lipoprotein-associated phospholipase A2 activity and mass;Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease;Cholesterol, total;Coronary artery disease;
SKCM	cis	rs453301	0.598	rs10104303	chr8:8834528	A/T	cg06636001	chr8:8085503	FLJ10661	0.82	6.15	0.57	3.08e-8	Joint mobility (Beighton score);
SKCM	cis	rs10754283	0.967	rs4658302	chr1:90103336	A/G	cg21401794	chr1:90099060	LRRC8C	0.78	7.17	0.63	3.72e-10	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs17685	0.672	rs1639623	chr7:75707951	A/G	cg01364799	chr7:75623366	TMEM120A	-0.72	-5.81	-0.55	1.31e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs10504229	1.000	rs66840104	chr8:58190001	C/T	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs941408	0.515	rs1005556	chr19:2778543	G/T	cg06609049	chr19:2785107	THOP1	1.09	10.19	0.76	5.37e-16	Total cholesterol levels;
SKCM	cis	rs4481887	1.000	rs4409693	chr1:248479061	C/T	cg00666640	chr1:248458726	OR2T12	0.64	5.69	0.54	2.13e-7	Common traits (Other);
SKCM	trans	rs1814175	0.645	rs10742953	chr11:49807491	C/G	cg15704280	chr7:45808275	SEPT13	0.88	7.96	0.67	1.1e-11	Height;
SKCM	cis	rs778371	0.676	rs17164	chr2:233593499	C/T	cg08000102	chr2:233561755	GIGYF2	0.82	6.52	0.59	6.46e-9	Schizophrenia;
SKCM	cis	rs10883723	0.810	rs3740406	chr10:104272789	C/T	cg11453585	chr10:104263688	ACTR1A;SUFU	0.77	6.29	0.58	1.73e-8	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs684232	0.602	rs379998	chr17:556884	A/G	cg15660573	chr17:549704	VPS53	-0.76	-6.08	-0.57	4.15e-8	Prostate cancer;
SKCM	cis	rs769267	1.000	rs7246748	chr19:19433105	C/T	cg03709012	chr19:19516395	GATAD2A	-0.85	-6.99	-0.62	8.34e-10	Tonsillectomy;
SKCM	cis	rs2224391	1.000	rs2753247	chr6:5261987	A/T	cg09085698	chr6:5261316	LYRM4;FARS2	-0.77	-5.73	-0.54	1.79e-7	Height;
SKCM	cis	rs4724125	0.883	rs35158772	chr7:42678297	T/C	cg09407816	chr7:42972088	MRPL32;PSMA2	0.81	4.85	0.48	6.13e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7829975	0.846	rs6601724	chr8:8544872	C/T	cg15556689	chr8:8085844	FLJ10661	-0.77	-6.27	-0.58	1.82e-8	Mood instability;
SKCM	cis	rs10927875	0.830	rs1763610	chr1:16335527	C/G	cg21385522	chr1:16154831	NA	-0.72	-5.74	-0.54	1.76e-7	Dilated cardiomyopathy;
SKCM	cis	rs9303401	0.659	rs12150264	chr17:56939927	G/A	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.16	0.57	2.91e-8	Cognitive test performance;
SKCM	cis	rs10883723	0.810	rs913025	chr10:104276043	C/T	cg11453585	chr10:104263688	ACTR1A;SUFU	0.77	6.31	0.58	1.56e-8	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs7772486	0.875	rs9322046	chr6:146393625	A/G	cg05347473	chr6:146136440	FBXO30	0.63	5.7	0.54	2.05e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1153858	1.000	rs1153858	chr15:45652703	A/G	cg21132104	chr15:45694354	SPATA5L1	-0.93	-7.66	-0.66	4.2e-11	Homoarginine levels;
SKCM	cis	rs9815354	0.670	rs73073238	chr3:42014325	G/C	cg03022575	chr3:42003672	ULK4	1.01	5.02	0.49	3.17e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs854765	0.583	rs62064158	chr17:17826935	T/C	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.0	7.64	0.65	4.64e-11	Total body bone mineral density;
SKCM	cis	rs6540556	0.954	rs6685077	chr1:209933331	A/G	cg05527609	chr1:210001259	C1orf107	-0.86	-4.8	-0.48	7.39e-6	Red blood cell count;
SKCM	cis	rs1003719	0.788	rs2251161	chr21:38467857	C/G	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs11098499	0.954	rs28572238	chr4:120316686	T/G	cg24375607	chr4:120327624	NA	0.65	4.97	0.49	3.87e-6	Corneal astigmatism;
SKCM	cis	rs74925218	1	rs74925218	chr15:78796732	C/T	cg24631222	chr15:78858424	CHRNA5	0.74	4.93	0.49	4.56e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs17376456	0.825	rs13182631	chr5:93115701	A/G	cg21475434	chr5:93447410	FAM172A	0.9	4.99	0.49	3.65e-6	Diabetic retinopathy;
SKCM	cis	rs1348850	0.519	rs1527406	chr2:178525655	C/T	cg22681709	chr2:178499509	PDE11A	-0.61	-5.27	-0.51	1.17e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs12214131	0.965	rs13213030	chr6:106225316	C/T	cg22231056	chr6:106958645	AIM1	0.57	4.82	0.48	6.89e-6	Male-pattern baldness;
SKCM	cis	rs4891159	0.548	rs690414	chr18:74117840	T/C	cg24786174	chr18:74118243	ZNF516	0.81	8.75	0.7	3.24e-13	Longevity;
SKCM	cis	rs910316	1.000	rs7142235	chr14:75559963	T/C	cg08847533	chr14:75593920	NEK9	0.95	9.18	0.72	4.88e-14	Height;
SKCM	cis	rs3213545	0.700	rs2260399	chr12:121469653	C/T	cg15155738	chr12:121454335	C12orf43	0.67	5.07	0.5	2.64e-6	Subjective well-being;Cardiovascular disease risk factors;
SKCM	cis	rs7090367	0.555	rs1556852	chr10:125248450	T/C	cg16197717	chr10:125650957	CPXM2	-0.47	-4.82	-0.48	6.96e-6	Body mass index;
SKCM	cis	rs10927875	0.632	rs2013745	chr1:16126676	G/A	cg21385522	chr1:16154831	NA	-0.95	-9.67	-0.74	5.42e-15	Dilated cardiomyopathy;
SKCM	cis	rs10905065	0.569	rs4750553	chr10:5728174	C/T	cg09234995	chr10:5726438	C10orf18	-0.63	-5.49	-0.53	4.94e-7	Menopause (age at onset);
SKCM	cis	rs950027	0.620	rs2486274	chr15:45666228	G/T	cg10760299	chr15:45669010	GATM	0.57	5.71	0.54	1.99e-7	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs28595532	0.841	rs56388366	chr4:119769242	A/G	cg14228332	chr4:119757509	SEC24D	1.1	5.22	0.51	1.44e-6	Cannabis dependence symptom count;
SKCM	cis	rs7618501	0.633	rs4688689	chr3:50035542	C/T	cg05072774	chr3:49840536	C3orf54	-0.66	-5.0	-0.49	3.43e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7666738	0.830	rs28594127	chr4:99001121	T/G	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6951245	0.935	rs79067319	chr7:1065548	C/T	cg24642844	chr7:1081250	C7orf50	-0.95	-6.39	-0.59	1.13e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs992157	0.835	rs34353396	chr2:219153982	T/C	cg20019365	chr2:219134978	PNKD;AAMP	-0.71	-6.08	-0.57	4.22e-8	Colorectal cancer;
SKCM	cis	rs2204008	0.683	rs11522927	chr12:38137537	C/T	cg26384229	chr12:38710491	ALG10B	0.82	6.58	0.6	4.87e-9	Bladder cancer;
SKCM	cis	rs7659604	1.000	rs10005932	chr4:122664782	T/C	cg19671926	chr4:122722719	EXOSC9	-0.64	-4.78	-0.48	8.04e-6	Type 2 diabetes;
SKCM	cis	rs28595532	0.920	rs56046676	chr4:119766733	A/G	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs12950390	0.853	rs56387656	chr17:45860189	C/G	cg03474202	chr17:45855739	NA	-0.48	-5.39	-0.52	7.29e-7	IgG glycosylation;
SKCM	cis	rs6087990	0.814	rs2424895	chr20:31335978	C/T	cg13636640	chr20:31349939	DNMT3B	-0.87	-6.58	-0.6	4.92e-9	Ulcerative colitis;
SKCM	cis	rs798554	0.757	rs2533882	chr7:2846894	G/T	cg04166393	chr7:2884313	GNA12	0.7	4.97	0.49	3.89e-6	Height;
SKCM	cis	rs860295	0.650	rs625658	chr1:155891045	A/C	cg02153340	chr1:155202674	NA	0.68	4.99	0.49	3.64e-6	Body mass index;
SKCM	cis	rs1577917	1.000	rs1337844	chr6:86677273	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.66	-5.79	-0.55	1.43e-7	Response to antipsychotic treatment;
SKCM	cis	rs8180040	0.874	rs11130123	chr3:47285912	A/G	cg27129171	chr3:47204927	SETD2	0.85	6.39	0.59	1.11e-8	Colorectal cancer;
SKCM	cis	rs597539	0.842	rs678904	chr11:68615600	T/A	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.71	4.85	0.48	6.12e-6	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs2204008	0.837	rs55962152	chr12:38234281	G/A	cg13010199	chr12:38710504	ALG10B	0.69	4.99	0.49	3.57e-6	Bladder cancer;
SKCM	cis	rs651907	1.000	rs662792	chr3:101599608	T/C	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.78	6.43	0.59	9.3e-9	Colorectal cancer;
SKCM	cis	rs2243480	1.000	rs78803505	chr7:65382572	A/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs12682352	0.602	rs4841044	chr8:8664940	A/G	cg06636001	chr8:8085503	FLJ10661	-0.73	-6.06	-0.57	4.63e-8	Neuroticism;
SKCM	cis	rs995000	0.931	rs6678483	chr1:63074442	C/A	cg06896770	chr1:63153194	DOCK7	0.76	7.17	0.63	3.77e-10	Triglyceride levels;
SKCM	cis	rs854765	0.547	rs7223696	chr17:17915791	G/T	cg04398451	chr17:18023971	MYO15A	-0.86	-6.73	-0.61	2.55e-9	Total body bone mineral density;
SKCM	cis	rs782590	0.869	rs782599	chr2:55847423	C/T	cg18811423	chr2:55921094	PNPT1	0.9	7.11	0.63	4.9e-10	Metabolic syndrome;
SKCM	cis	rs453301	0.624	rs7014430	chr8:8827737	T/G	cg15556689	chr8:8085844	FLJ10661	0.7	5.04	0.5	2.95e-6	Joint mobility (Beighton score);
SKCM	cis	rs208515	0.525	rs12191500	chr6:66668681	A/G	cg07460842	chr6:66804631	NA	0.95	6.02	0.56	5.37e-8	Exhaled nitric oxide levels;
SKCM	cis	rs17376456	0.569	rs17083377	chr5:93164870	C/G	cg21475434	chr5:93447410	FAM172A	0.84	5.1	0.5	2.34e-6	Diabetic retinopathy;
SKCM	cis	rs11718455	0.921	rs35872933	chr3:44028515	T/G	cg21419209	chr3:44054225	NA	-0.66	-5.22	-0.51	1.42e-6	Coronary artery disease;
SKCM	cis	rs6951245	0.638	rs74976697	chr7:1160505	C/T	cg18402987	chr7:1209562	NA	1.15	7.39	0.64	1.39e-10	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs34779708	0.931	rs2384287	chr10:35340559	A/G	cg03585969	chr10:35415529	CREM	0.73	6.05	0.57	4.71e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs9733	0.791	rs11800059	chr1:150651175	C/T	cg13175981	chr1:150552382	MCL1	0.64	4.86	0.48	5.85e-6	Tonsillectomy;
SKCM	cis	rs6951245	1.000	rs113858334	chr7:1073476	A/G	cg03188948	chr7:1209495	NA	1.12	6.17	0.57	2.88e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs801193	1.000	rs6975195	chr7:66124774	T/A	cg11764359	chr7:65958608	NA	-0.83	-6.29	-0.58	1.71e-8	Aortic root size;
SKCM	cis	rs7811142	1.000	rs67315960	chr7:100015124	A/G	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.11	6.45	0.59	8.66e-9	Platelet count;
SKCM	cis	rs4665809	0.590	rs72809668	chr2:26467653	C/T	cg26119090	chr2:26468346	HADHA;HADHB	1.06	8.39	0.69	1.66e-12	Gut microbiome composition (summer);
SKCM	cis	rs6088580	0.668	rs1205337	chr20:32926041	T/A	cg24642439	chr20:33292090	TP53INP2	-0.72	-5.7	-0.54	2.07e-7	Glomerular filtration rate (creatinine);
SKCM	cis	rs7208859	0.623	rs55811708	chr17:29104731	G/T	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs2839186	0.708	rs6518285	chr21:47644667	T/C	cg13012494	chr21:47604986	C21orf56	0.67	5.81	0.55	1.29e-7	Testicular germ cell tumor;
SKCM	cis	rs782590	0.608	rs10207590	chr2:55921782	G/C	cg18811423	chr2:55921094	PNPT1	-0.74	-5.86	-0.55	1.06e-7	Metabolic syndrome;
SKCM	cis	rs7666738	0.791	rs1527516	chr4:98967937	A/C	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs3087591	0.922	rs12939969	chr17:29463577	A/G	cg24425628	chr17:29625626	OMG;NF1	0.64	5.17	0.51	1.76e-6	Hip circumference;
SKCM	cis	rs7618915	0.501	rs9917834	chr3:52634619	A/C	cg18404041	chr3:52824283	ITIH1	-0.53	-4.77	-0.48	8.42e-6	Bipolar disorder;
SKCM	cis	rs7937682	0.883	rs486038	chr11:111465963	A/C	cg19812747	chr11:111475976	SIK2	-0.61	-4.94	-0.49	4.41e-6	Primary sclerosing cholangitis;
SKCM	trans	rs208520	0.674	rs207103	chr6:66795568	G/T	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-1.02	-7.49	-0.65	9.2e-11	Exhaled nitric oxide output;
SKCM	cis	rs7618915	0.571	rs1961959	chr3:52585760	G/C	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs9467773	0.620	rs2451711	chr6:26663110	A/G	cg09904177	chr6:26538194	HMGN4	0.58	5.01	0.49	3.28e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7811142	0.830	rs6945952	chr7:99981775	A/G	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.07	6.7	0.6	2.88e-9	Platelet count;
SKCM	cis	rs9303401	0.625	rs10515159	chr17:56802693	G/C	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.35	0.52	8.54e-7	Cognitive test performance;
SKCM	cis	rs16940212	0.618	rs16940174	chr15:58686338	A/G	cg16767221	chr15:57769667	CGNL1	0.57	4.78	0.48	7.97e-6	HDL cholesterol levels;HDL cholesterol;
SKCM	cis	rs801193	1.000	rs3778909	chr7:66255646	G/C	cg11764359	chr7:65958608	NA	0.84	6.37	0.59	1.2e-8	Aortic root size;
SKCM	cis	rs55728055	0.661	rs9619215	chr22:32042732	A/G	cg01338084	chr22:32026380	PISD	1.5	5.62	0.54	2.81e-7	Age-related hearing impairment;
SKCM	cis	rs875971	1.000	rs12698523	chr7:65968113	C/G	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs7809950	0.953	rs2253271	chr7:107201252	G/C	cg23024343	chr7:107201750	COG5	-0.75	-6.78	-0.61	2.07e-9	Coronary artery disease;
SKCM	cis	rs1003719	0.725	rs2187101	chr21:38452379	T/C	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs6089829	0.888	rs4809468	chr20:61673566	T/C	cg03213289	chr20:61660250	NA	0.51	5.07	0.5	2.58e-6	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs1707322	1.000	rs7531911	chr1:46330423	A/G	cg03146154	chr1:46216737	IPP	0.74	5.0	0.49	3.39e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs1218582	0.772	rs4845400	chr1:154872523	C/T	cg06221963	chr1:154839813	KCNN3	-0.59	-5.97	-0.56	6.76e-8	Prostate cancer;
SKCM	cis	rs9611565	0.694	rs202618	chr22:41822856	A/G	cg03806693	chr22:41940476	POLR3H	1.13	7.36	0.64	1.63e-10	Vitiligo;
SKCM	cis	rs2180341	0.656	rs6569491	chr6:127769338	C/G	cg24812749	chr6:127587940	RNF146	0.73	5.79	0.55	1.43e-7	Breast cancer;
SKCM	cis	rs854765	0.547	rs2955377	chr17:17932818	G/A	cg04398451	chr17:18023971	MYO15A	-0.94	-7.53	-0.65	7.5e-11	Total body bone mineral density;
SKCM	trans	rs17685	0.625	rs1639630	chr7:75730499	T/C	cg19862616	chr7:65841803	NCRNA00174	0.95	9.02	0.71	9.98e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7215564	0.818	rs34929663	chr17:78617212	C/T	cg16980736	chr17:78789706	RPTOR	-0.89	-4.88	-0.48	5.41e-6	Myopia (pathological);
SKCM	cis	rs56104184	0.775	rs56146968	chr19:49398847	A/G	cg19746536	chr19:49375674	PPP1R15A	1.16	5.93	0.56	7.67e-8	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs589448	0.535	rs12423794	chr12:69713018	G/A	cg14784868	chr12:69753453	YEATS4	0.7	6.08	0.57	4.24e-8	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs7659604	0.521	rs10001697	chr4:122677737	G/T	cg19671926	chr4:122722719	EXOSC9	0.77	6.27	0.58	1.89e-8	Type 2 diabetes;
SKCM	cis	rs6570726	0.791	rs414297	chr6:145887556	C/T	cg05347473	chr6:146136440	FBXO30	0.57	5.18	0.51	1.67e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1348850	0.914	rs3902850	chr2:178315899	G/A	cg02961200	chr2:178257176	LOC100130691;AGPS	0.83	6.14	0.57	3.21e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs10256972	0.706	rs12701970	chr7:1121958	T/C	cg16145915	chr7:1198662	ZFAND2A	-0.56	-7.93	-0.67	1.26e-11	Longevity;Endometriosis;
SKCM	cis	rs3785574	0.962	rs2597632	chr17:61894739	A/T	cg01411255	chr17:61851458	DDX42;CCDC47	1.16	12.75	0.82	9.1e-21	Height;
SKCM	cis	rs6951245	0.638	rs74976697	chr7:1160505	C/T	cg03188948	chr7:1209495	NA	1.04	6.69	0.6	3.04e-9	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs9303401	0.659	rs12600349	chr17:57054245	A/G	cg02118635	chr17:56770003	RAD51C;TEX14	-0.81	-5.35	-0.52	8.54e-7	Cognitive test performance;
SKCM	cis	rs10791097	0.694	rs61910787	chr11:130744473	G/A	cg12179176	chr11:130786555	SNX19	0.93	8.16	0.68	4.62e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs4803468	1.000	rs3810175	chr19:41904396	C/T	cg09537434	chr19:41945824	ATP5SL	1.08	13.01	0.83	3.1e-21	Height;
SKCM	cis	rs703842	0.964	rs2014886	chr12:58177437	C/T	cg04478727	chr12:58166393	METTL1;FAM119B	0.73	5.84	0.55	1.15e-7	Multiple sclerosis;
SKCM	cis	rs7811142	0.830	rs705866	chr7:99965285	T/C	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.07	6.7	0.6	2.88e-9	Platelet count;
SKCM	cis	rs7027203	0.797	rs7870672	chr9:96606693	A/C	cg14598338	chr9:96623480	NA	-0.5	-5.12	-0.5	2.12e-6	DNA methylation (variation);
SKCM	cis	rs7100689	0.646	rs7081889	chr10:82165427	C/A	cg01528321	chr10:82214614	TSPAN14	0.88	7.59	0.65	5.88e-11	Post bronchodilator FEV1;
SKCM	cis	rs3812762	0.692	rs10840116	chr11:8765117	T/A	cg21881798	chr11:8931708	C11orf17;ST5	0.51	5.1	0.5	2.36e-6	Hypospadias;
SKCM	cis	rs7811142	0.945	rs6955362	chr7:100056166	C/T	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.34	0.69	2.1e-12	Platelet count;
SKCM	cis	rs28595532	0.764	rs115986119	chr4:119767785	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	trans	rs11722228	0.522	rs1109472	chr4:10134448	C/G	cg26043149	chr18:55253948	FECH	0.94	8.42	0.69	1.43e-12	Gout;Urate levels;Serum uric acid levels;
SKCM	cis	rs9322193	1.000	rs9322193	chr6:149919143	T/G	cg07701084	chr6:150067640	NUP43	0.64	5.11	0.5	2.21e-6	Lung cancer;
SKCM	cis	rs694739	0.930	rs574087	chr11:64102948	A/G	cg02228329	chr11:64053129	BAD;GPR137	1.0	8.78	0.71	2.85e-13	Alopecia areata;Crohn's disease;Psoriasis vulgaris;
SKCM	cis	rs67311347	1.000	rs2305522	chr3:40429358	A/G	cg00091569	chr3:40428383	ENTPD3	0.61	5.36	0.52	8.37e-7	Renal cell carcinoma;
SKCM	cis	rs2228479	0.867	rs12930056	chr16:89946649	C/A	cg06558623	chr16:89946397	TCF25	1.26	6.97	0.62	9.17e-10	Skin colour saturation;
SKCM	cis	rs769267	0.965	rs2965191	chr19:19453521	T/G	cg26732615	chr19:19648335	CILP2;YJEFN3	-0.65	-5.91	-0.56	8.42e-8	Tonsillectomy;
SKCM	cis	rs28595532	0.920	rs114547492	chr4:119773078	G/C	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs763014	0.931	rs2071980	chr16:626346	A/C	cg00908189	chr16:619842	PIGQ	0.82	7.78	0.66	2.55e-11	Height;
SKCM	cis	rs4803468	1.000	rs2304242	chr19:41944616	G/T	cg14132834	chr19:41945861	ATP5SL	0.77	5.9	0.56	9.04e-8	Height;
SKCM	cis	rs2073499	0.935	rs74398439	chr3:50331927	C/T	cg05260129	chr3:50388622	TUSC4;CYB561D2	0.91	4.8	0.48	7.41e-6	Schizophrenia;
SKCM	cis	rs6582630	0.519	rs4294627	chr12:38293982	C/T	cg26384229	chr12:38710491	ALG10B	0.81	6.57	0.6	5.18e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs10876993	0.928	rs2640637	chr12:58077586	G/A	cg18357645	chr12:58087776	OS9	0.65	5.98	0.56	6.22e-8	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs769267	0.930	rs3794990	chr19:19610030	A/G	cg03709012	chr19:19516395	GATAD2A	0.89	8.62	0.7	5.89e-13	Tonsillectomy;
SKCM	cis	rs738321	0.725	rs9622738	chr22:38542346	G/A	cg25457927	chr22:38595422	NA	-0.58	-6.71	-0.61	2.75e-9	Breast cancer;
SKCM	cis	rs2153535	0.521	rs6939827	chr6:8461360	C/G	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs1153858	1.000	rs7181167	chr15:45686236	C/G	cg21132104	chr15:45694354	SPATA5L1	0.89	7.21	0.63	3.12e-10	Homoarginine levels;
SKCM	cis	rs367615	0.537	rs17161729	chr5:108660528	C/G	cg17395555	chr5:108820864	NA	-0.69	-5.73	-0.54	1.8e-7	Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs4481887	0.861	rs6669290	chr1:248476804	G/A	cg00666640	chr1:248458726	OR2T12	0.63	5.91	0.56	8.65e-8	Common traits (Other);
SKCM	cis	rs672059	0.806	rs3754524	chr1:183153267	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.59	4.89	0.48	5.23e-6	Hypertriglyceridemia;
SKCM	cis	rs10791097	0.739	rs4936120	chr11:130723452	G/A	cg12179176	chr11:130786555	SNX19	0.75	5.99	0.56	6.15e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs6665290	0.904	rs6690803	chr1:227189106	C/T	cg10327440	chr1:227177885	CDC42BPA	-1.19	-17.05	-0.89	4.94e-28	Myeloid white cell count;
SKCM	cis	rs362296	0.698	rs3095083	chr4:3263499	G/A	cg00764545	chr4:3318001	RGS12	-0.7	-6.61	-0.6	4.34e-9	Parental longevity (mother's age at death);
SKCM	cis	rs10752881	1.000	rs12753817	chr1:182970337	A/T	ch.1.3577855R	chr1:183094577	LAMC1	0.66	6.06	0.57	4.57e-8	Colorectal cancer;
SKCM	cis	rs1062177	1.000	rs2915877	chr5:151150601	C/G	cg00977110	chr5:151150581	G3BP1	0.79	6.51	0.59	6.71e-9	Preschool internalizing problems;
SKCM	cis	rs67311347	0.544	rs9864664	chr3:40336226	T/C	cg00091569	chr3:40428383	ENTPD3	0.61	5.37	0.52	7.7300000000000005e-07	Renal cell carcinoma;
SKCM	cis	rs10540	1.000	rs61876326	chr11:467368	A/G	cg03576123	chr11:487126	PTDSS2	-1.46	-7.68	-0.66	4e-11	Body mass index;
SKCM	cis	rs3820068	0.603	rs6429767	chr1:15963334	G/A	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs875971	0.862	rs4718319	chr7:65652784	C/A	cg18876405	chr7:65276391	NA	-0.65	-6.64	-0.6	3.71e-9	Aortic root size;
SKCM	cis	rs6665290	0.904	rs3795449	chr1:227181838	T/G	cg10327440	chr1:227177885	CDC42BPA	-1.25	-17.49	-0.89	1.03e-28	Myeloid white cell count;
SKCM	cis	rs9875589	0.509	rs9867041	chr3:14014615	T/C	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.51	5.17	0.51	1.73e-6	Ovarian reserve;
SKCM	cis	rs7772486	0.846	rs1474871	chr6:146406294	G/A	cg05347473	chr6:146136440	FBXO30	0.64	5.83	0.55	1.19e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9910055	0.659	rs2246287	chr17:42232442	C/G	cg13607699	chr17:42295918	UBTF	0.71	5.65	0.54	2.53e-7	Total body bone mineral density;
SKCM	cis	rs2072499	0.833	rs2842870	chr1:156200671	T/C	cg24450063	chr1:156163899	SLC25A44	0.78	6.48	0.59	7.51e-9	Testicular germ cell tumor;
SKCM	cis	rs2302190	0.882	rs11650105	chr17:56588072	C/T	cg25885038	chr17:56607967	SEPT4	-0.71	-4.79	-0.48	7.86e-6	Vitamin D levels;
SKCM	cis	rs807669	0.565	rs5746682	chr22:19185526	C/T	cg02655711	chr22:19163373	SLC25A1	0.63	5.52	0.53	4.3e-7	Metabolite levels;
SKCM	cis	rs1005277	0.522	rs200943	chr10:38148730	A/G	cg25427524	chr10:38739819	LOC399744	-0.68	-6.63	-0.6	3.96e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs35306767	0.903	rs12769873	chr10:936526	G/T	cg20503657	chr10:835505	NA	0.83	5.37	0.52	7.86e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs473651	0.935	rs558924	chr2:239339511	A/G	cg21699342	chr2:239360505	ASB1	0.56	5.36	0.52	8.22e-7	Multiple system atrophy;
SKCM	cis	rs7666738	0.830	rs28818180	chr4:98953625	A/G	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2153535	0.580	rs915350	chr6:8443486	A/G	cg23788917	chr6:8435910	SLC35B3	0.69	5.14	0.5	1.99e-6	Motion sickness;
SKCM	cis	rs12824058	0.831	rs12322456	chr12:130813594	A/G	cg24838063	chr12:130822603	PIWIL1	0.79	7.05	0.62	6.32e-10	Menopause (age at onset);
SKCM	cis	rs28386778	0.897	rs2727330	chr17:61925498	A/G	cg06873352	chr17:61820015	STRADA	-0.77	-6.67	-0.6	3.26e-9	Prudent dietary pattern;
SKCM	cis	rs7937682	0.562	rs12275761	chr11:111367083	T/A	cg09085632	chr11:111637200	PPP2R1B	0.78	6.27	0.58	1.85e-8	Primary sclerosing cholangitis;
SKCM	cis	rs870825	0.929	rs1405939	chr4:185591444	C/T	cg04058563	chr4:185651563	MLF1IP	0.94	5.23	0.51	1.38e-6	Blood protein levels;
SKCM	cis	rs2836974	0.931	rs13625	chr21:40669083	G/T	cg11890956	chr21:40555474	PSMG1	0.99	11.14	0.78	8.38e-18	Cognitive function;
SKCM	cis	rs155076	0.938	rs9509630	chr13:21844314	G/A	cg11317459	chr13:21872234	NA	-1.24	-6.91	-0.62	1.19e-9	White matter hyperintensity burden;
SKCM	cis	rs2524005	1.000	rs2524005	chr6:29899677	C/T	cg26965779	chr6:29854089	HLA-H	-0.77	-5.53	-0.53	4.11e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs250677	0.652	rs1422582	chr5:148436925	T/C	cg18129178	chr5:148520854	ABLIM3	-0.8	-4.79	-0.48	7.9e-6	Breast cancer;
SKCM	cis	rs66573146	0.808	rs55942328	chr4:6990960	T/G	cg00086871	chr4:6988644	TBC1D14	1.29	5.03	0.5	3.04e-6	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs13010713	0.840	rs1568257	chr2:182028396	A/G	cg21995919	chr2:182322279	ITGA4	-0.52	-5.08	-0.5	2.53e-6	Celiac disease;
SKCM	cis	rs798554	0.759	rs798495	chr7:2797267	T/C	cg19346786	chr7:2764209	NA	-0.64	-6.81	-0.61	1.79e-9	Height;
SKCM	cis	rs7215564	0.908	rs35253080	chr17:78700167	G/A	cg16980736	chr17:78789706	RPTOR	-0.88	-4.83	-0.48	6.66e-6	Myopia (pathological);
SKCM	cis	rs1979654	0.543	rs1532166	chr16:86404318	C/G	cg01467047	chr16:86611690	FOXL1	-0.39	-4.81	-0.48	7.22e-6	Barrett's esophagus  or Esophageal adenocarcinoma;
SKCM	cis	rs6088590	0.965	rs6120727	chr20:33374102	T/C	cg24642439	chr20:33292090	TP53INP2	1.01	7.2	0.63	3.23e-10	Coronary artery disease;
SKCM	cis	rs6912958	0.559	rs451465	chr6:88043372	C/T	cg08069147	chr6:88032118	GJB7;C6orf162	-0.66	-5.94	-0.56	7.66e-8	Monocyte percentage of white cells;
SKCM	cis	rs55962025	0.711	rs116275868	chr4:3231148	G/C	cg00764545	chr4:3318001	RGS12	-0.67	-5.52	-0.53	4.32e-7	Parental longevity (mother's age at death);
SKCM	cis	rs9951698	0.703	rs8097038	chr18:13037018	C/A	cg12848697	chr18:13133368	NA	0.53	4.96	0.49	4.04e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs11700980	0.636	rs35497275	chr21:30275022	G/A	cg24692254	chr21:30365293	RNF160	-0.92	-5.27	-0.51	1.17e-6	QRS complex (12-leadsum);
SKCM	cis	rs1005277	0.579	rs2505241	chr10:38442421	T/C	cg00409905	chr10:38381863	ZNF37A	-0.67	-6.21	-0.58	2.41e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs2239547	0.563	rs4687699	chr3:53101224	C/T	cg11645453	chr3:52864694	ITIH4	0.6	5.01	0.49	3.37e-6	Schizophrenia;
SKCM	cis	rs11098499	0.863	rs1552092	chr4:120488496	C/T	cg09307838	chr4:120376055	NA	1.0	8.27	0.68	2.8e-12	Corneal astigmatism;
SKCM	cis	rs2243480	0.666	rs1880311	chr7:65276752	G/C	cg18252515	chr7:66147081	NA	1.28	7.03	0.62	6.91e-10	Diabetic kidney disease;
SKCM	cis	rs9393692	0.557	rs61534839	chr6:26305623	C/T	cg00631329	chr6:26305371	NA	-0.68	-5.19	-0.51	1.6e-6	Educational attainment;
SKCM	cis	rs6951245	1.000	rs74347384	chr7:1072440	G/A	cg24642844	chr7:1081250	C7orf50	-0.95	-6.4	-0.59	1.06e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs4481887	1.000	rs9660769	chr1:248484558	C/G	cg00666640	chr1:248458726	OR2T12	-0.65	-5.8	-0.55	1.34e-7	Common traits (Other);
SKCM	cis	rs4077515	0.967	rs4266763	chr9:139289825	C/T	cg14169450	chr9:139327907	INPP5E	-0.46	-4.94	-0.49	4.38e-6	Ulcerative colitis;IgA nephropathy;Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs2354432	0.556	rs11239964	chr1:146753902	G/C	cg25205988	chr1:146714368	CHD1L	-1.17	-6.52	-0.59	6.27e-9	Mitochondrial DNA levels;
SKCM	cis	rs6942756	1.000	rs2103232	chr7:128951232	G/T	cg02491457	chr7:128862824	NA	-0.82	-5.16	-0.5	1.81e-6	White matter hyperintensity burden;
SKCM	cis	rs561341	1.000	rs1681718	chr17:30296445	G/A	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs11098499	0.954	rs67265404	chr4:120359270	C/T	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs2074585	0.839	rs11638780	chr15:91041896	G/T	cg22089800	chr15:90895588	ZNF774	-0.68	-4.92	-0.49	4.72e-6	Basophil percentage of granulocytes;White blood cell count (basophil);Basophil percentage of white cells;
SKCM	cis	rs6840360	0.615	rs113052419	chr4:152473008	T/C	cg22705602	chr4:152727874	NA	-0.51	-5.78	-0.55	1.48e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs6951245	0.935	rs11763765	chr7:1060510	C/T	cg24642844	chr7:1081250	C7orf50	-0.95	-6.39	-0.59	1.13e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs12474201	0.832	rs4953419	chr2:46989869	T/G	cg06386533	chr2:46925753	SOCS5	0.97	8.86	0.71	2.05e-13	Height;
SKCM	cis	rs910316	0.967	rs2010678	chr14:75567178	C/T	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.89e-7	Height;
SKCM	cis	rs10484885	0.752	rs72921948	chr6:90582560	T/C	cg13799429	chr6:90582589	CASP8AP2	-0.7	-6.15	-0.57	3.05e-8	QRS interval (sulfonylurea treatment interaction);
SKCM	cis	rs2153535	0.584	rs9502721	chr6:8541379	G/A	cg07606381	chr6:8435919	SLC35B3	0.91	6.28	0.58	1.77e-8	Motion sickness;
SKCM	cis	rs35146811	0.807	rs6465761	chr7:99620277	G/C	cg22906224	chr7:99728672	NA	0.79	5.8	0.55	1.36e-7	Coronary artery disease;
SKCM	cis	rs2072499	1.000	rs2241108	chr1:156181007	C/G	cg25208724	chr1:156163844	SLC25A44	1.04	9.45	0.73	1.47e-14	Testicular germ cell tumor;
SKCM	cis	rs9399135	0.935	rs4445070	chr6:135309212	C/T	cg24558204	chr6:135376177	HBS1L	0.56	5.01	0.49	3.31e-6	Red blood cell count;
SKCM	cis	rs16854884	0.770	rs1445417	chr3:143808972	A/T	cg06585982	chr3:143692056	C3orf58	0.72	5.52	0.53	4.23e-7	Economic and political preferences (feminism/equality);
SKCM	cis	rs514406	0.792	rs481440	chr1:53344976	C/T	cg16325326	chr1:53192061	ZYG11B	0.67	5.77	0.55	1.55e-7	Monocyte count;
SKCM	cis	rs7103648	0.838	rs11039244	chr11:47466442	G/A	cg20307385	chr11:47447363	PSMC3	1.03	8.3	0.68	2.52e-12	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs6545883	0.895	rs7588814	chr2:61695589	A/T	cg15711740	chr2:61764176	XPO1	-0.68	-4.87	-0.48	5.76e-6	Tuberculosis;
SKCM	cis	rs9911578	1.000	rs6503866	chr17:56619581	C/T	cg12560992	chr17:57184187	TRIM37	-0.95	-7.69	-0.66	3.7e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs9951602	0.607	rs3017651	chr18:76668622	T/C	cg00277804	chr18:77549539	NA	-0.55	-5.11	-0.5	2.21e-6	Obesity-related traits;
SKCM	cis	rs28595532	0.920	rs115085630	chr4:119741765	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs7100689	0.646	rs1340382	chr10:82096997	G/C	cg00277334	chr10:82204260	NA	-0.57	-5.11	-0.5	2.22e-6	Post bronchodilator FEV1;
SKCM	cis	rs7208859	0.623	rs73269945	chr17:29108759	G/A	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs9467773	0.620	rs9467810	chr6:26608261	A/C	cg15659132	chr6:26577336	NA	0.63	5.57	0.53	3.56e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs10504229	1.000	rs73609762	chr8:58192695	A/G	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs950776	0.531	rs12915652	chr15:78831928	G/A	cg06917634	chr15:78832804	PSMA4	1.01	10.44	0.76	1.84e-16	Sudden cardiac arrest;
SKCM	cis	rs62103177	0.713	rs3744886	chr18:77659561	G/T	cg27393146	chr18:77495563	CTDP1	-0.93	-5.37	-0.52	7.81e-7	Opioid sensitivity;
SKCM	cis	rs3785574	0.962	rs2665799	chr17:61919723	A/G	cg06601766	chr17:61851465	DDX42;CCDC47	0.73	5.38	0.52	7.7300000000000005e-07	Height;
SKCM	cis	rs2732480	0.557	rs2732441	chr12:48723324	C/G	cg21348975	chr12:48724119	NA	-0.58	-4.88	-0.48	5.47e-6	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs757110	0.834	rs1002226	chr11:17405617	C/T	cg15432903	chr11:17409602	KCNJ11	0.52	4.9	0.48	5.18e-6	Type 2 diabetes;
SKCM	cis	rs11892454	0.544	rs13004845	chr2:25959477	C/T	cg17263061	chr2:26915892	KCNK3	0.71	5.07	0.5	2.6e-6	Heschl's gyrus morphology;
SKCM	cis	rs6545883	0.524	rs2694618	chr2:61536984	A/G	cg15711740	chr2:61764176	XPO1	-0.7	-5.34	-0.52	8.9e-7	Tuberculosis;
SKCM	cis	rs9300255	0.602	rs2851438	chr12:123643689	T/C	cg05973401	chr12:123451056	ABCB9	0.8	5.47	0.53	5.23e-7	Neutrophil percentage of white cells;
SKCM	cis	rs7666738	0.830	rs13138059	chr4:99050430	A/G	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs244731	0.959	rs10037110	chr5:176658066	A/T	cg06060754	chr5:176797920	RGS14	-0.8	-7.11	-0.63	4.94e-10	Urate levels in lean individuals;
SKCM	cis	rs10779751	1.000	rs1064261	chr1:11288758	C/T	cg08854313	chr1:11322531	MTOR	0.78	5.57	0.53	3.56e-7	Body mass index;
SKCM	cis	rs362296	0.511	rs2857861	chr4:3323767	C/T	cg05297308	chr4:3317976	RGS12	0.87	9.19	0.72	4.72e-14	Parental longevity (mother's age at death);
SKCM	cis	rs6089584	0.927	rs2296083	chr20:60574216	C/T	cg06108461	chr20:60628389	TAF4	-0.83	-7.31	-0.64	1.98e-10	Body mass index;
SKCM	cis	rs4906332	0.782	rs2236281	chr14:104000518	G/T	cg04998671	chr14:104000505	TRMT61A	-0.72	-4.87	-0.48	5.65e-6	Coronary artery disease;
SKCM	cis	rs71520386	0.632	rs9692432	chr7:22868863	G/A	cg00309339	chr7:22893653	NA	0.66	4.94	0.49	4.33e-6	Fibrinogen levels;
SKCM	cis	rs1790761	0.520	rs7124513	chr11:67395714	C/T	cg00290607	chr11:67383545	NA	-0.66	-6.89	-0.62	1.27e-9	Mean corpuscular volume;
SKCM	cis	rs2228479	1.000	rs4257207	chr16:89947861	T/A	cg00800038	chr16:89945340	TCF25	-0.96	-5.44	-0.52	5.85e-7	Skin colour saturation;
SKCM	cis	rs6547631	0.622	rs1437742	chr2:85924899	T/A	cg24620635	chr2:85921963	GNLY	0.9	6.65	0.6	3.58e-9	Blood protein levels;
SKCM	cis	rs9880211	0.613	rs13081671	chr3:135876549	C/T	cg21827317	chr3:136751795	NA	-0.65	-4.94	-0.49	4.39e-6	Body mass index;Height;
SKCM	cis	rs2224391	1.000	rs2224391	chr6:5260936	A/C	cg09085698	chr6:5261316	LYRM4;FARS2	-0.77	-5.73	-0.54	1.79e-7	Height;
SKCM	cis	rs651907	0.557	rs11712748	chr3:101383562	G/A	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.81	6.96	0.62	9.48e-10	Colorectal cancer;
SKCM	cis	rs8060686	0.565	rs11555011	chr16:68088485	A/G	cg09117114	chr16:67998030	SLC12A4	-0.81	-5.29	-0.51	1.07e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs10492096	0.783	rs11064220	chr12:6592574	C/T	cg13857086	chr12:6580257	VAMP1	0.77	5.76	0.55	1.57e-7	Hip geometry;
SKCM	cis	rs2228479	0.557	rs62056097	chr16:89933420	A/G	cg06558623	chr16:89946397	TCF25	1.12	4.84	0.48	6.36e-6	Skin colour saturation;
SKCM	cis	rs561341	1.000	rs8073186	chr17:30244956	T/C	cg00745463	chr17:30367425	LRRC37B	-1.01	-6.85	-0.61	1.52e-9	Hip circumference adjusted for BMI;
SKCM	cis	rs2034088	0.965	rs11651340	chr17:425099	A/C	cg06217071	chr17:408420	NA	-0.5	-5.4	-0.52	7.02e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs7635838	0.617	rs346075	chr3:11294027	T/G	cg00170343	chr3:11313890	ATG7	0.77	6.06	0.57	4.51e-8	HDL cholesterol;
SKCM	cis	rs4727443	0.866	rs13238380	chr7:99629061	C/T	cg07913999	chr7:99613796	ZKSCAN1	0.66	5.09	0.5	2.43e-6	Interstitial lung disease;
SKCM	cis	rs4727027	0.933	rs6961605	chr7:148870108	G/A	cg23583168	chr7:148888333	NA	-0.76	-6.32	-0.58	1.48e-8	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs9894429	0.646	rs12948797	chr17:79617384	G/A	cg18240062	chr17:79603768	NPLOC4	0.68	5.99	0.56	6.16e-8	Eye color traits;
SKCM	cis	rs1801251	0.928	rs4458205	chr2:233557646	C/T	cg25237894	chr2:233734115	C2orf82	0.62	5.24	0.51	1.31e-6	Coronary artery disease;
SKCM	cis	rs763121	0.819	rs5757161	chr22:38990662	G/A	cg06022373	chr22:39101656	GTPBP1	0.79	5.34	0.52	8.84e-7	Menopause (age at onset);
SKCM	cis	rs55962025	0.686	rs362331	chr4:3215835	T/C	cg09735869	chr4:3319127	RGS12	-0.65	-5.47	-0.53	5.15e-7	Parental longevity (mother's age at death);
SKCM	cis	rs2811415	0.597	rs9827668	chr3:127775480	G/T	cg09089421	chr3:127803668	RUVBL1	1.02	8.85	0.71	2.14e-13	Lung function (FEV1/FVC);
SKCM	cis	rs28595532	0.920	rs114382134	chr4:119733215	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.43	0.59	9.38e-9	Cannabis dependence symptom count;
SKCM	cis	rs854765	0.547	rs4459604	chr17:17888549	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.97	8.29	0.68	2.64e-12	Total body bone mineral density;
SKCM	cis	rs4319547	0.737	rs10846920	chr12:122943231	C/T	cg23029597	chr12:123009494	RSRC2	-0.79	-5.97	-0.56	6.66e-8	Body mass index;
SKCM	cis	rs7208859	0.623	rs11656844	chr17:29060597	G/T	cg14067834	chr17:29058358	SUZ12P	1.19	5.71	0.54	1.94e-7	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs35306767	0.715	rs12772979	chr10:1034412	C/T	cg26597838	chr10:835615	NA	0.76	6.22	0.58	2.29e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs7927771	0.800	rs11039200	chr11:47379646	A/C	cg05585544	chr11:47624801	NA	-0.6	-5.33	-0.52	9.19e-7	Subjective well-being;
SKCM	cis	rs11122272	0.766	rs2790867	chr1:231548059	A/C	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	0.66	5.49	0.53	4.82e-7	Hemoglobin concentration;
SKCM	cis	rs6489882	0.902	rs1981556	chr12:113372961	C/G	cg07232103	chr12:112566177	TRAFD1	0.6	4.9	0.48	5.14e-6	Chronic lymphocytic leukemia;
SKCM	cis	rs11098499	0.697	rs4560394	chr4:120313435	T/G	cg09307838	chr4:120376055	NA	0.96	7.47	0.65	1.01e-10	Corneal astigmatism;
SKCM	cis	rs4819052	0.918	rs34886433	chr21:46680538	G/C	cg20896738	chr21:46707857	POFUT2;LOC642852	0.77	5.61	0.54	2.99e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs6951245	0.580	rs78894484	chr7:1138721	T/G	cg18402987	chr7:1209562	NA	0.82	5.43	0.52	6.16e-7	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs875971	0.862	rs1875057	chr7:65731855	A/G	cg11764359	chr7:65958608	NA	-0.76	-7.0	-0.62	8.03e-10	Aortic root size;
SKCM	cis	rs7618915	0.547	rs12487591	chr3:52642936	A/T	cg18404041	chr3:52824283	ITIH1	-0.54	-4.87	-0.48	5.69e-6	Bipolar disorder;
SKCM	cis	rs2070488	0.775	rs11926767	chr3:38527913	A/G	cg01465620	chr3:38496096	LOC100128640;ACVR2B	-0.73	-5.78	-0.55	1.47e-7	Electrocardiographic conduction measures;
SKCM	cis	rs12142240	0.698	rs72886907	chr1:46814265	C/T	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.49e-6	Menopause (age at onset);
SKCM	cis	rs9300255	0.679	rs10772998	chr12:123721177	T/G	cg00376283	chr12:123451042	ABCB9	0.84	5.91	0.56	8.5e-8	Neutrophil percentage of white cells;
SKCM	cis	rs7829975	0.902	rs777707	chr8:8584344	A/G	cg06636001	chr8:8085503	FLJ10661	0.78	7.12	0.63	4.7e-10	Mood instability;
SKCM	cis	rs3091242	0.933	rs7541095	chr1:25761291	T/C	cg02931644	chr1:25747376	RHCE	0.5	4.88	0.48	5.43e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs7100689	0.555	rs1934146	chr10:82062121	C/A	cg01528321	chr10:82214614	TSPAN14	0.75	6.26	0.58	1.91e-8	Post bronchodilator FEV1;
SKCM	cis	rs1005277	0.602	rs1831315	chr10:38473353	T/C	cg25427524	chr10:38739819	LOC399744	-0.78	-7.75	-0.66	2.83e-11	Extrinsic epigenetic age acceleration;
SKCM	cis	rs875971	0.862	rs10250544	chr7:65766561	A/G	cg18876405	chr7:65276391	NA	-0.64	-6.43	-0.59	9.24e-9	Aortic root size;
SKCM	cis	rs2013441	1.000	rs2703791	chr17:20163529	A/G	cg13482628	chr17:19912719	NA	-0.64	-5.04	-0.5	2.94e-6	Obesity-related traits;
SKCM	cis	rs7809950	0.731	rs4730238	chr7:107054787	G/A	cg23024343	chr7:107201750	COG5	-0.88	-8.05	-0.67	7.69e-12	Coronary artery disease;
SKCM	cis	rs9300255	0.569	rs1727320	chr12:123700476	T/A	cg05973401	chr12:123451056	ABCB9	0.81	5.37	0.52	7.77e-7	Neutrophil percentage of white cells;
SKCM	cis	rs34779708	0.966	rs11599606	chr10:35406626	G/A	cg03585969	chr10:35415529	CREM	0.82	6.49	0.59	7.27e-9	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs7584330	0.704	rs11884395	chr2:238359366	C/T	cg14458575	chr2:238380390	NA	1.01	6.88	0.61	1.31e-9	Prostate cancer;
SKCM	cis	rs6537837	0.701	rs12021920	chr1:110147287	C/T	cg05049280	chr1:110155535	GNAT2	0.67	5.02	0.49	3.15e-6	Major depressive disorder;
SKCM	cis	rs7811142	0.943	rs10241492	chr7:99994813	A/G	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.23	8.03	0.67	8.33e-12	Platelet count;
SKCM	cis	rs72949976	0.584	rs4673729	chr2:214023810	A/G	cg08319019	chr2:214017104	IKZF2	0.84	6.86	0.61	1.47e-9	Lung cancer;Squamous cell lung carcinoma;
SKCM	cis	rs28595532	0.920	rs114165587	chr4:119779525	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs709400	0.633	rs2296484	chr14:104003094	C/T	cg26031613	chr14:104095156	KLC1	0.74	5.74	0.55	1.71e-7	Body mass index;
SKCM	cis	rs1218582	0.741	rs11264283	chr1:154869552	A/G	cg03351412	chr1:154909251	PMVK	0.77	6.52	0.59	6.43e-9	Prostate cancer;
SKCM	cis	rs826838	1.000	rs11168218	chr12:38884466	A/G	cg26384229	chr12:38710491	ALG10B	1.04	9.75	0.74	3.88e-15	Heart rate;
SKCM	cis	rs4689592	0.546	rs907523	chr4:7052777	A/G	cg19539972	chr4:7069911	GRPEL1	0.99	6.99	0.62	8.37e-10	Monocyte percentage of white cells;
SKCM	cis	rs807669	0.777	rs9605972	chr22:19253274	C/T	cg02655711	chr22:19163373	SLC25A1	0.59	5.64	0.54	2.6e-7	Metabolite levels;
SKCM	cis	rs6430585	0.527	rs60966546	chr2:136401843	C/T	cg07169764	chr2:136633963	MCM6	1.01	7.63	0.65	4.95e-11	Corneal structure;
SKCM	cis	rs6430585	0.583	rs61253125	chr2:136618178	T/C	cg07169764	chr2:136633963	MCM6	1.31	13.05	0.83	2.59e-21	Corneal structure;
SKCM	cis	rs933688	1.000	rs186717	chr5:90780467	T/A	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.05	8.49	0.69	1.03e-12	Smoking behavior;
SKCM	cis	rs9926296	0.568	rs4420527	chr16:89814188	C/T	cg26513180	chr16:89883248	FANCA	-0.94	-10.42	-0.76	1.98e-16	Vitiligo;
SKCM	cis	rs8072100	0.817	rs9905581	chr17:45547185	C/T	cg08085267	chr17:45401833	C17orf57	-0.62	-5.08	-0.5	2.48e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs826838	0.868	rs12322306	chr12:39130021	A/G	cg13010199	chr12:38710504	ALG10B	-0.72	-5.73	-0.54	1.83e-7	Heart rate;
SKCM	cis	rs1707322	0.721	rs12045096	chr1:46114428	A/G	cg03146154	chr1:46216737	IPP	0.82	6.1	0.57	3.89e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs9916302	0.706	rs57933226	chr17:37412829	C/T	cg07936489	chr17:37558343	FBXL20	-1.0	-6.58	-0.6	4.86e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs2239547	0.522	rs7652131	chr3:52997154	C/T	cg11645453	chr3:52864694	ITIH4	0.58	4.96	0.49	3.98e-6	Schizophrenia;
SKCM	cis	rs875971	0.862	rs12698521	chr7:65939489	T/C	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	cis	rs17376456	0.569	rs1349711	chr5:93179032	C/T	cg25358565	chr5:93447407	FAM172A	-0.89	-5.74	-0.54	1.74e-7	Diabetic retinopathy;
SKCM	cis	rs17685	0.633	rs3801471	chr7:75696188	T/G	cg16489192	chr7:75678113	MDH2;STYXL1	-0.6	-5.48	-0.53	5.15e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7809950	0.822	rs2712228	chr7:107300340	A/C	cg23024343	chr7:107201750	COG5	0.71	6.45	0.59	8.57e-9	Coronary artery disease;
SKCM	cis	rs3087591	1.000	rs6505235	chr17:29688603	C/A	cg24425628	chr17:29625626	OMG;NF1	-0.62	-4.8	-0.48	7.51e-6	Hip circumference;
SKCM	cis	rs875971	0.522	rs4718286	chr7:65292764	A/G	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.61	5.06	0.5	2.75e-6	Aortic root size;
SKCM	cis	rs11098499	0.874	rs6826823	chr4:120112098	G/C	cg09307838	chr4:120376055	NA	0.86	6.08	0.57	4.13e-8	Corneal astigmatism;
SKCM	cis	rs10504229	0.639	rs2318146	chr8:58114873	T/G	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs6547631	0.595	rs34702373	chr2:85927404	C/T	cg24620635	chr2:85921963	GNLY	0.9	6.4	0.59	1.06e-8	Blood protein levels;
SKCM	cis	rs9911578	0.935	rs302873	chr17:56769481	C/G	cg12560992	chr17:57184187	TRIM37	0.92	7.27	0.64	2.41e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs28595532	0.920	rs17325017	chr4:119774607	A/G	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs1005277	0.540	rs1814077	chr10:37992018	G/C	cg25427524	chr10:38739819	LOC399744	-0.62	-6.15	-0.57	3.03e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs2842992	0.789	rs4276525	chr6:160193612	G/A	cg11366901	chr6:160182831	ACAT2	0.94	7.85	0.66	1.81e-11	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs12142240	0.698	rs66483119	chr1:46838389	T/C	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs8017423	1.000	rs8015379	chr14:90679432	C/T	cg04374321	chr14:90722782	PSMC1	0.95	8.38	0.69	1.69e-12	Mortality in heart failure;
SKCM	cis	rs67460515	0.563	rs13071892	chr3:160817877	A/C	cg03342759	chr3:160939853	NMD3	-0.71	-6.09	-0.57	4.04e-8	Parkinson's disease;
SKCM	cis	rs1550582	0.662	rs4909628	chr8:135502380	A/T	cg17885191	chr8:135476712	NA	-0.74	-5.19	-0.51	1.61e-6	Educational attainment;
SKCM	cis	rs514406	0.644	rs7529978	chr1:53204705	G/A	cg16325326	chr1:53192061	ZYG11B	-0.86	-9.02	-0.71	9.97e-14	Monocyte count;
SKCM	cis	rs798554	0.607	rs1182151	chr7:2909225	C/G	cg19346786	chr7:2764209	NA	-0.55	-5.3	-0.51	1.05e-6	Height;
SKCM	cis	rs703842	0.963	rs2069506	chr12:58142854	C/A	cg04478727	chr12:58166393	METTL1;FAM119B	0.68	5.27	0.51	1.2e-6	Multiple sclerosis;
SKCM	cis	rs9916302	0.904	rs602282	chr17:37433021	C/T	cg07936489	chr17:37558343	FBXL20	-0.75	-5.92	-0.56	8.22e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs7100689	0.784	rs3802637	chr10:82179699	G/C	cg00277334	chr10:82204260	NA	-0.53	-4.89	-0.48	5.39e-6	Post bronchodilator FEV1;
SKCM	cis	rs7659604	0.605	rs1396080	chr4:122740454	T/G	cg20573242	chr4:122745356	CCNA2	0.71	6.09	0.57	3.97e-8	Type 2 diabetes;
SKCM	cis	rs4820539	1.000	rs5759595	chr22:23471624	G/A	cg14186256	chr22:23484241	RTDR1	0.84	8.01	0.67	9.08e-12	Bone mineral density;
SKCM	cis	rs28595532	0.920	rs56124677	chr4:119772213	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs10791097	0.720	rs6590515	chr11:130733365	A/G	cg12179176	chr11:130786555	SNX19	-0.87	-7.32	-0.64	1.89e-10	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs826838	1.000	rs1684395	chr12:39083161	T/G	cg26384229	chr12:38710491	ALG10B	-0.93	-8.05	-0.67	7.56e-12	Heart rate;
SKCM	cis	rs950027	0.620	rs1145093	chr15:45649813	C/A	cg21132104	chr15:45694354	SPATA5L1	0.76	5.79	0.55	1.39e-7	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs4319547	1.000	rs1392236	chr12:123074890	C/G	cg23029597	chr12:123009494	RSRC2	-0.81	-5.99	-0.56	6.21e-8	Body mass index;
SKCM	cis	rs9325144	0.647	rs35254764	chr12:39102928	T/C	cg13010199	chr12:38710504	ALG10B	-0.64	-5.44	-0.52	6.02e-7	Morning vs. evening chronotype;
SKCM	cis	rs1577917	0.917	rs1579886	chr6:86557191	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.81	-7.82	-0.66	2.07e-11	Response to antipsychotic treatment;
SKCM	cis	rs28374715	0.528	rs28492932	chr15:41624397	G/C	cg18705301	chr15:41695430	NDUFAF1	-1.21	-12.61	-0.82	1.61e-20	Ulcerative colitis;
SKCM	cis	rs875971	1.000	rs4718343	chr7:65874288	T/G	cg18876405	chr7:65276391	NA	0.67	6.65	0.6	3.61e-9	Aortic root size;
SKCM	cis	rs10131894	0.635	rs174997	chr14:75434806	G/A	cg08847533	chr14:75593920	NEK9	-0.67	-4.85	-0.48	6.2e-6	Coronary artery disease;
SKCM	cis	rs62238980	0.614	rs17683430	chr22:32487700	G/A	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs62238980	0.614	rs77099614	chr22:32452759	A/G	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs1348850	0.874	rs4893822	chr2:178285727	G/T	cg02961200	chr2:178257176	LOC100130691;AGPS	0.76	5.56	0.53	3.57e-7	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs860295	0.702	rs1556488	chr1:155540660	T/G	cg02153340	chr1:155202674	NA	-0.78	-5.91	-0.56	8.65e-8	Body mass index;
SKCM	cis	rs28595532	0.800	rs67686161	chr4:119336720	C/T	cg11846333	chr4:119757529	SEC24D	1.19	6.71	0.6	2.81e-9	Cannabis dependence symptom count;
SKCM	cis	rs6138458	0.626	rs6132789	chr20:25012809	C/T	cg26195577	chr20:24973756	C20orf3	-0.9	-5.93	-0.56	7.91e-8	Blood protein levels;
SKCM	cis	rs13256369	0.760	rs7816171	chr8:8575835	T/C	cg06636001	chr8:8085503	FLJ10661	0.72	5.28	0.51	1.15e-6	Obesity-related traits;
SKCM	cis	rs9549367	0.713	rs3024769	chr13:113825601	A/C	cg18105134	chr13:113819100	PROZ	0.83	6.49	0.59	7.22e-9	Platelet distribution width;
SKCM	cis	rs2204008	0.577	rs2623049	chr12:38018831	G/A	cg26384229	chr12:38710491	ALG10B	-0.75	-6.26	-0.58	1.95e-8	Bladder cancer;
SKCM	cis	rs7940866	0.834	rs10791105	chr11:130839161	A/G	cg12179176	chr11:130786555	SNX19	0.79	6.17	0.57	2.88e-8	Schizophrenia;
SKCM	cis	rs6461049	0.765	rs3800908	chr7:2159437	C/T	cg02951883	chr7:2050386	MAD1L1	-0.72	-6.71	-0.6	2.83e-9	Schizophrenia;
SKCM	cis	rs17065868	1.000	rs17065868	chr13:45055091	A/G	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs2120019	0.567	rs8025170	chr15:75170983	A/G	cg09165964	chr15:75287851	SCAMP5	0.82	5.95	0.56	7.33e-8	Blood trace element (Zn levels);
SKCM	cis	rs2180341	0.751	rs9388553	chr6:127574044	A/G	cg27446573	chr6:127587934	RNF146	0.86	6.94	0.62	1.03e-9	Breast cancer;
SKCM	cis	rs12478296	0.892	rs11893879	chr2:243010411	G/A	cg06360820	chr2:242988706	NA	-1.01	-5.87	-0.55	1e-7	Obesity-related traits;
SKCM	cis	rs10876993	0.890	rs774887	chr12:58034835	A/G	cg18357645	chr12:58087776	OS9	0.59	5.34	0.52	8.89e-7	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs9814567	1.000	rs9854299	chr3:134206728	T/C	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.69	-5.47	-0.53	5.15e-7	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs911119	0.913	rs6048928	chr20:23585988	A/G	cg16589663	chr20:23618590	CST3	0.74	4.88	0.48	5.57e-6	Chronic kidney disease;
SKCM	cis	rs7772486	0.754	rs9386132	chr6:146140751	T/C	cg23711669	chr6:146136114	FBXO30	0.89	9.89	0.75	2.01e-15	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9549367	0.713	rs9549691	chr13:113861606	A/C	cg00898013	chr13:113819073	PROZ	-0.6	-5.02	-0.49	3.2e-6	Platelet distribution width;
SKCM	cis	rs9790314	1.000	rs336583	chr3:161081981	A/T	cg03342759	chr3:160939853	NMD3	0.72	7.89	0.67	1.53e-11	Morning vs. evening chronotype;
SKCM	cis	rs6921919	0.583	rs3800328	chr6:28390843	C/T	cg14547644	chr6:28411285	ZSCAN23	-0.58	-4.8	-0.48	7.46e-6	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs9910055	0.659	rs227580	chr17:42223068	C/T	cg09913183	chr17:42254507	C17orf65;ASB16	-0.67	-6.26	-0.58	1.96e-8	Total body bone mineral density;
SKCM	cis	rs1862618	0.853	rs252902	chr5:56116085	A/G	cg12311346	chr5:56204834	C5orf35	-0.7	-4.88	-0.48	5.48e-6	Initial pursuit acceleration;
SKCM	cis	rs12586317	0.547	rs10130773	chr14:35445299	G/A	cg16230307	chr14:35515116	FAM177A1	0.78	5.57	0.53	3.47e-7	Psoriasis;
SKCM	cis	rs3091242	0.933	rs10903130	chr1:25769221	A/T	cg27572855	chr1:25598939	RHD	0.53	5.06	0.5	2.67e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs17376456	0.825	rs17314762	chr5:93231200	C/T	cg25358565	chr5:93447407	FAM172A	1.26	7.82	0.66	2.11e-11	Diabetic retinopathy;
SKCM	cis	rs3818285	0.959	rs3740137	chr10:111630917	G/A	cg00817464	chr10:111662876	XPNPEP1	-0.62	-5.04	-0.5	2.89e-6	Superior crus of antihelix expression;
SKCM	cis	rs11718455	0.960	rs35277738	chr3:44006732	T/C	cg21419209	chr3:44054225	NA	-0.65	-5.32	-0.52	9.77e-7	Coronary artery disease;
SKCM	cis	rs9549367	0.713	rs553316	chr13:113838015	A/G	cg18105134	chr13:113819100	PROZ	0.87	6.56	0.6	5.34e-9	Platelet distribution width;
SKCM	cis	rs6866344	0.601	rs12187838	chr5:178099833	T/C	cg10224037	chr5:178157518	ZNF354A	0.77	4.97	0.49	3.85e-6	Neutrophil percentage of white cells;
SKCM	cis	rs1395	0.778	rs62128747	chr2:27412605	T/C	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.51	5.14	0.5	1.96e-6	Blood metabolite levels;
SKCM	cis	rs7119	0.604	rs2271398	chr15:77907784	G/A	cg27398640	chr15:77910606	LINGO1	0.55	5.43	0.52	6.1e-7	Type 2 diabetes;
SKCM	cis	rs9467773	1.000	rs9467773	chr6:26498426	A/G	cg09904177	chr6:26538194	HMGN4	0.55	5.03	0.49	3.11e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs17854409	0.803	rs1048109	chr20:61472120	G/A	cg06598544	chr20:61472147	COL9A3	-1.13	-5.57	-0.53	3.51e-7	Obesity-related traits;
SKCM	cis	rs8060686	0.641	rs76501820	chr16:68114582	G/A	cg04539111	chr16:67997858	SLC12A4	-0.87	-4.89	-0.48	5.33e-6	HDL cholesterol;Metabolic syndrome;
SKCM	trans	rs17685	0.753	rs1639609	chr7:75683581	T/C	cg19862616	chr7:65841803	NCRNA00174	0.95	9.34	0.73	2.39e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7208859	0.623	rs11657369	chr17:29136468	G/A	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs2204008	0.749	rs10880692	chr12:38592918	C/G	cg13010199	chr12:38710504	ALG10B	-0.67	-4.97	-0.49	3.88e-6	Bladder cancer;
SKCM	cis	rs1506636	1.000	rs767637	chr7:123321978	C/A	cg03229431	chr7:123269106	ASB15	-0.62	-5.06	-0.5	2.75e-6	Plateletcrit;Platelet count;
SKCM	cis	rs11098499	0.863	rs11947234	chr4:120474859	A/G	cg09307838	chr4:120376055	NA	1.0	8.27	0.68	2.8e-12	Corneal astigmatism;
SKCM	cis	rs17685	0.712	rs6954569	chr7:75738885	T/A	cg01364799	chr7:75623366	TMEM120A	-0.72	-5.81	-0.55	1.31e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs55794721	0.543	rs1293260	chr1:25709104	C/G	cg02931644	chr1:25747376	RHCE	0.5	4.93	0.49	4.48e-6	Plateletcrit;Mean corpuscular volume;
SKCM	cis	rs2857078	0.732	rs9893756	chr17:42321109	T/C	cg08499158	chr17:42289980	UBTF	0.87	7.1	0.63	5.1e-10	Red cell distribution width;Reticulocyte count;
SKCM	cis	rs4423214	0.879	rs1792284	chr11:71134966	A/G	cg05163923	chr11:71159392	DHCR7	0.63	5.44	0.52	5.94e-7	Vitamin D levels;
SKCM	cis	rs394563	0.591	rs237016	chr6:149744859	T/C	cg03678062	chr6:149772716	ZC3H12D	-0.5	-5.51	-0.53	4.53e-7	Dupuytren's disease;
SKCM	cis	rs12497850	0.931	rs11920534	chr3:48937761	G/T	cg06212747	chr3:49208901	KLHDC8B	0.68	4.9	0.49	5.06e-6	Parkinson's disease;
SKCM	cis	rs6938	0.514	rs56338926	chr15:75259335	C/A	cg17294928	chr15:75287854	SCAMP5	0.73	5.51	0.53	4.54e-7	Breast cancer;
SKCM	cis	rs2952156	0.920	rs1476278	chr17:37836243	C/T	cg00129232	chr17:37814104	STARD3	-0.7	-5.89	-0.55	9.38e-8	Asthma;
SKCM	cis	rs1577917	1.000	rs1577917	chr6:86691940	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.83	-8.23	-0.68	3.37e-12	Response to antipsychotic treatment;
SKCM	cis	rs7666738	0.800	rs13106995	chr4:99028790	A/T	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7772486	0.790	rs2254283	chr6:146204289	T/C	cg23711669	chr6:146136114	FBXO30	0.76	7.45	0.64	1.08e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6753739	0.871	rs6436110	chr2:219980953	A/C	cg09617556	chr2:219924408	IHH	0.48	5.08	0.5	2.5e-6	Height;
SKCM	cis	rs2404602	0.692	rs55676827	chr15:76961716	C/T	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs7666738	0.830	rs991169	chr4:98928567	C/A	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10193935	0.901	rs10202848	chr2:42515661	A/G	cg27598129	chr2:42591480	NA	-0.95	-6.75	-0.61	2.38e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7659604	1.000	rs28640980	chr4:122664284	T/C	cg06713675	chr4:122721982	EXOSC9	-0.65	-5.83	-0.55	1.21e-7	Type 2 diabetes;
SKCM	cis	rs1499614	1.000	rs2659911	chr7:66158420	G/A	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Gout;
SKCM	cis	rs2153535	0.580	rs2184586	chr6:8474182	A/G	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs10504229	0.683	rs2318144	chr8:58114743	G/A	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs3820068	0.603	rs6660234	chr1:15962590	T/C	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	trans	rs9929218	0.551	rs1886697	chr16:68716179	T/C	cg04657470	chr2:198365150	HSPE1;HSPD1	1.01	10.76	0.77	4.38e-17	Colorectal cancer;
SKCM	cis	rs2224391	1.000	rs13191012	chr6:5261292	G/A	cg09085698	chr6:5261316	LYRM4;FARS2	-0.77	-5.73	-0.54	1.79e-7	Height;
SKCM	cis	rs473651	0.904	rs508274	chr2:239337723	G/A	cg21699342	chr2:239360505	ASB1	0.51	4.97	0.49	3.87e-6	Multiple system atrophy;
SKCM	cis	rs6121246	0.559	rs6060944	chr20:30372114	G/A	cg13852791	chr20:30311386	BCL2L1	0.82	5.69	0.54	2.09e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs1691799	0.867	rs1168311	chr12:66725912	A/C	cg16791601	chr12:66731901	HELB	0.64	5.82	0.55	1.26e-7	White blood cell count (basophil);
SKCM	cis	rs9902453	1.000	rs4465649	chr17:28394747	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.81	-5.78	-0.55	1.45e-7	Coffee consumption (cups per day);
SKCM	cis	rs595982	0.527	rs73061658	chr19:49372376	G/C	cg19746536	chr19:49375674	PPP1R15A	1.08	6.03	0.56	5.08e-8	Red cell distribution width;
SKCM	cis	rs6952808	0.792	rs4421257	chr7:1955152	T/C	cg21782813	chr7:2030301	MAD1L1	0.55	6.03	0.56	5.22e-8	Bipolar disorder and schizophrenia;
SKCM	trans	rs8073060	0.586	rs7217533	chr17:34015876	A/G	cg19694781	chr19:47549865	TMEM160	-1.04	-8.28	-0.68	2.65e-12	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs748404	0.560	rs1060939	chr15:43816917	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	0.68	5.14	0.5	1.98e-6	Lung cancer;
SKCM	cis	rs2952156	0.920	rs2934951	chr17:37833328	A/G	cg20243544	chr17:37824526	PNMT	0.77	6.38	0.59	1.14e-8	Asthma;
SKCM	cis	rs2153535	0.580	rs2152348	chr6:8474301	C/A	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs4665809	0.590	rs4665319	chr2:26424583	A/C	cg26119090	chr2:26468346	HADHA;HADHB	-1.02	-7.77	-0.66	2.66e-11	Gut microbiome composition (summer);
SKCM	cis	rs1799949	0.526	rs4352088	chr17:41414679	A/G	cg05368731	chr17:41323189	NBR1	0.85	7.32	0.64	1.89e-10	Menopause (age at onset);
SKCM	cis	rs854765	0.522	rs63721860	chr17:17829576	T/C	cg04398451	chr17:18023971	MYO15A	-0.85	-6.05	-0.57	4.75e-8	Total body bone mineral density;
SKCM	cis	rs2481665	0.526	rs6685401	chr1:62599874	G/A	cg18591186	chr1:62594603	INADL	-0.65	-4.99	-0.49	3.58e-6	BMI in non-smokers;BMI (adjusted for smoking behaviour);Body mass index;Body mass index (joint analysis main effects and smoking interaction);
SKCM	cis	rs7666738	0.830	rs13141752	chr4:98893128	G/A	cg17366294	chr4:99064904	C4orf37	0.57	4.86	0.48	6.02e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2739330	0.828	rs5760108	chr22:24252668	G/T	cg12419862	chr22:24373484	LOC391322	-0.66	-5.89	-0.55	9.18e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs854765	0.551	rs56886154	chr17:17831473	C/A	cg04398451	chr17:18023971	MYO15A	-0.79	-5.68	-0.54	2.25e-7	Total body bone mineral density;
SKCM	cis	rs1062177	0.724	rs2915828	chr5:151118121	G/A	cg00977110	chr5:151150581	G3BP1	-0.81	-6.42	-0.59	9.93e-9	Preschool internalizing problems;
SKCM	cis	rs28595532	0.920	rs114963870	chr4:119758099	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs16940212	0.618	rs12185093	chr15:58684676	G/A	cg16767221	chr15:57769667	CGNL1	-0.58	-4.89	-0.48	5.35e-6	HDL cholesterol levels;HDL cholesterol;
SKCM	cis	rs2948294	0.524	rs13270062	chr8:8112650	C/A	cg06636001	chr8:8085503	FLJ10661	0.7	5.29	0.51	1.09e-6	Red cell distribution width;
SKCM	cis	rs1707322	0.964	rs7512395	chr1:46361177	G/A	cg03146154	chr1:46216737	IPP	0.73	4.91	0.49	4.98e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs4077515	0.967	rs10781500	chr9:139269338	A/G	cg14169450	chr9:139327907	INPP5E	-0.46	-5.13	-0.5	2.1e-6	Ulcerative colitis;IgA nephropathy;Inflammatory bowel disease;Crohn's disease;
SKCM	trans	rs8073060	0.559	rs72829925	chr17:34049778	C/A	cg19694781	chr19:47549865	TMEM160	1.08	8.6	0.7	6.4e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs7824557	0.614	rs7816606	chr8:11205602	T/C	cg21775007	chr8:11205619	TDH	0.71	6.31	0.58	1.58e-8	Retinal vascular caliber;
SKCM	cis	rs11098499	0.865	rs9994730	chr4:120381564	A/C	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs9393692	0.645	rs11756673	chr6:26323505	A/G	cg00631329	chr6:26305371	NA	-0.7	-4.84	-0.48	6.33e-6	Educational attainment;
SKCM	cis	rs2243480	1.000	rs316315	chr7:65591205	C/T	cg18252515	chr7:66147081	NA	1.15	7.0	0.62	7.89e-10	Diabetic kidney disease;
SKCM	cis	rs9902453	0.904	rs9905638	chr17:28261022	C/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.8	6.3	0.58	1.61e-8	Coffee consumption (cups per day);
SKCM	cis	rs4072980	0.524	rs28442147	chr1:38395410	T/A	cg12658694	chr1:38397304	INPP5B	0.63	4.85	0.48	6.11e-6	Coronary artery disease;
SKCM	cis	rs10089	1.000	rs4835944	chr5:127490870	A/G	cg25462716	chr5:127418816	SLC12A2;FLJ33630	-0.84	-7.63	-0.65	4.93e-11	Ileal carcinoids;
SKCM	cis	rs2075371	0.966	rs1646646	chr7:133996905	G/T	cg20476274	chr7:133979776	SLC35B4	1.03	10.69	0.77	5.94e-17	Mean platelet volume;
SKCM	cis	rs9902453	0.780	rs3115093	chr17:28039755	G/A	cg26525008	chr17:28256777	EFCAB5;SSH2	0.79	5.93	0.56	7.67e-8	Coffee consumption (cups per day);
SKCM	cis	rs9894429	0.646	rs7406522	chr17:79615396	G/T	cg18240062	chr17:79603768	NPLOC4	0.68	6.07	0.57	4.41e-8	Eye color traits;
SKCM	cis	rs274567	0.599	rs11242110	chr5:131743777	A/C	cg07395648	chr5:131743802	NA	0.66	5.26	0.51	1.25e-6	Blood metabolite levels;
SKCM	cis	rs7772486	0.727	rs10447449	chr6:146138707	A/G	cg05347473	chr6:146136440	FBXO30	0.59	5.47	0.53	5.27e-7	Lobe attachment (rater-scored or self-reported);
SKCM	trans	rs1814175	0.791	rs1722011	chr11:49899340	G/C	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs13040088	1.000	rs6090159	chr20:61531351	C/G	cg23096297	chr20:61557774	DIDO1	0.76	5.91	0.56	8.36e-8	Menopause (age at onset);
SKCM	cis	rs2197308	0.610	rs10880837	chr12:37864924	C/T	cg13010199	chr12:38710504	ALG10B	0.65	4.93	0.49	4.48e-6	Morning vs. evening chronotype;
SKCM	cis	rs10871290	0.650	rs28484753	chr16:74489395	G/C	cg01733217	chr16:74700730	RFWD3	0.88	6.52	0.59	6.33e-9	Breast cancer;
SKCM	cis	rs6547741	1.000	rs1080060	chr2:27768808	T/A	cg27432699	chr2:27873401	GPN1	0.73	6.55	0.6	5.7e-9	Oral cavity cancer;
SKCM	cis	rs2811415	0.597	rs10934843	chr3:127749605	C/T	cg09089421	chr3:127803668	RUVBL1	1.03	8.77	0.7	3.08e-13	Lung function (FEV1/FVC);
SKCM	cis	rs2739330	0.685	rs4822453	chr22:24254862	G/T	cg24846343	chr22:24311635	DDTL	0.6	5.59	0.53	3.2e-7	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs2644899	0.785	rs7249450	chr19:41300771	T/C	cg24958765	chr19:41283667	RAB4B	-0.85	-5.39	-0.52	7.21e-7	Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs4862750	0.957	rs1030381	chr4:187903568	G/C	cg10295955	chr4:187884368	NA	-1.03	-12.6	-0.82	1.73e-20	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2842992	0.789	rs2842969	chr6:160145364	C/T	cg19482086	chr6:160211437	TCP1;MRPL18	0.81	5.93	0.56	8e-8	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs7772486	0.748	rs2748484	chr6:146333653	C/T	cg05347473	chr6:146136440	FBXO30	0.57	5.06	0.5	2.68e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs17711722	0.701	rs781145	chr7:65440370	A/C	cg18876405	chr7:65276391	NA	0.87	8.12	0.68	5.54e-12	Calcium levels;
SKCM	cis	rs763014	0.833	rs3743904	chr16:632767	A/G	cg07343612	chr16:622815	PIGQ	-0.7	-6.01	-0.56	5.63e-8	Height;
SKCM	cis	rs854765	0.547	rs2955372	chr17:17970229	T/C	cg04398451	chr17:18023971	MYO15A	0.94	7.53	0.65	7.5e-11	Total body bone mineral density;
SKCM	cis	rs10193935	0.901	rs997288	chr2:42525582	C/G	cg27598129	chr2:42591480	NA	-0.89	-7.05	-0.62	6.37e-10	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs34172651	0.517	rs200526	chr16:24760511	C/T	cg06028605	chr16:24865363	SLC5A11	-0.59	-4.98	-0.49	3.66e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs6951245	1.000	rs79327308	chr7:1108141	A/C	cg18402987	chr7:1209562	NA	1.15	6.09	0.57	3.95e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs873946	0.504	rs3829132	chr10:134579044	A/C	cg27286337	chr10:134555280	INPP5A	0.98	9.19	0.72	4.62e-14	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs6121246	0.559	rs6060919	chr20:30331922	A/T	cg13852791	chr20:30311386	BCL2L1	0.82	5.69	0.54	2.09e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs2721195	1.000	rs750472	chr8:145701453	A/C	cg17328964	chr8:145687451	CYHR1	0.63	5.29	0.51	1.07e-6	Age at first birth;
SKCM	cis	rs8017423	0.935	rs11624246	chr14:90734826	A/G	cg04374321	chr14:90722782	PSMC1	-0.95	-8.73	-0.7	3.68e-13	Mortality in heart failure;
SKCM	trans	rs561341	1.000	rs55959993	chr17:30254771	C/G	cg20587970	chr11:113659929	NA	-1.19	-10.36	-0.76	2.61e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs2153535	0.563	rs7739249	chr6:8534590	C/G	cg07606381	chr6:8435919	SLC35B3	0.87	6.19	0.57	2.63e-8	Motion sickness;
SKCM	cis	rs5769765	0.913	rs28670284	chr22:50221973	C/T	cg22709217	chr22:50311962	ALG12;CRELD2	-0.82	-5.06	-0.5	2.69e-6	Schizophrenia;
SKCM	cis	rs13256369	0.802	rs11995449	chr8:8559898	G/A	cg06636001	chr8:8085503	FLJ10661	0.74	5.55	0.53	3.72e-7	Obesity-related traits;
SKCM	cis	rs11112613	0.713	rs11112590	chr12:105951376	C/G	cg03607813	chr12:105948248	NA	-0.86	-5.35	-0.52	8.39e-7	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;
SKCM	cis	rs7584330	0.737	rs7568588	chr2:238364342	G/T	cg14458575	chr2:238380390	NA	0.86	6.22	0.58	2.31e-8	Prostate cancer;
SKCM	cis	rs2153535	0.580	rs9379210	chr6:8461928	C/G	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs757110	0.868	rs5219	chr11:17409572	T/C	cg15432903	chr11:17409602	KCNJ11	0.58	5.77	0.55	1.5e-7	Type 2 diabetes;
SKCM	cis	rs11105298	1.000	rs11105298	chr12:89876143	C/T	cg08166232	chr12:89918718	WDR51B;GALNT4	0.88	5.85	0.55	1.08e-7	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs6582630	0.519	rs8189561	chr12:38296178	G/A	cg26384229	chr12:38710491	ALG10B	0.81	6.57	0.6	5.18e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs4555082	0.957	rs2816627	chr14:105736109	A/G	cg13114125	chr14:105738426	BRF1	-0.73	-5.66	-0.54	2.41e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs4234284	0.932	rs16838209	chr3:126977097	A/G	cg04889221	chr3:126137216	CCDC37	-0.49	-5.08	-0.5	2.51e-6	Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel);
SKCM	cis	rs2243480	1.000	rs12698509	chr7:65418876	C/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs7617480	0.610	rs10865954	chr3:49211989	T/C	cg06212747	chr3:49208901	KLHDC8B	0.95	7.28	0.64	2.35e-10	Subjective well-being (multi-trait analysis);Menarche (age at onset);
SKCM	cis	rs2180341	0.889	rs2000909	chr6:127711173	G/A	cg27446573	chr6:127587934	RNF146	0.76	6.11	0.57	3.69e-8	Breast cancer;
SKCM	cis	rs4819052	0.851	rs2838849	chr21:46671027	A/G	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.36	0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs9910055	0.659	rs227580	chr17:42223068	C/T	cg10896456	chr17:42255109	ASB16;C17orf65	-0.68	-6.98	-0.62	8.51e-10	Total body bone mineral density;
SKCM	cis	rs16866061	0.962	rs3845840	chr2:225359100	G/A	cg02879423	chr2:224806760	WDFY1	0.69	5.02	0.49	3.2e-6	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs34779708	0.931	rs7923217	chr10:35309589	A/G	cg03585969	chr10:35415529	CREM	0.74	6.11	0.57	3.71e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs2180341	0.960	rs9375503	chr6:127677071	T/C	cg24812749	chr6:127587940	RNF146	0.83	7.24	0.63	2.76e-10	Breast cancer;
SKCM	cis	rs1018836	0.798	rs28568272	chr8:91652958	A/G	cg16814680	chr8:91681699	NA	-0.87	-7.29	-0.64	2.24e-10	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs4665809	0.531	rs12990692	chr2:26464939	C/T	cg04944784	chr2:26401820	FAM59B	0.74	4.79	0.48	7.81e-6	Gut microbiome composition (summer);
SKCM	cis	rs6570726	0.791	rs9373463	chr6:145894762	C/T	cg05347473	chr6:146136440	FBXO30	0.57	5.08	0.5	2.47e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7106204	0.748	rs12273426	chr11:24212058	T/C	ch.11.24196551F	chr11:24239977	NA	0.77	5.97	0.56	6.6e-8	Response to Homoharringtonine (cytotoxicity);
SKCM	cis	rs908922	0.676	rs578382	chr1:152514054	A/G	cg09873164	chr1:152488093	CRCT1	-0.75	-5.72	-0.54	1.85e-7	Hair morphology;
SKCM	cis	rs7811142	0.945	rs6978739	chr7:100098680	C/G	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.21	7.59	0.65	5.9e-11	Platelet count;
SKCM	cis	rs9880211	0.800	rs9871184	chr3:136514310	G/A	cg21827317	chr3:136751795	NA	-0.69	-5.26	-0.51	1.21e-6	Body mass index;Height;
SKCM	cis	rs12134245	0.747	rs11164912	chr1:92005191	A/T	cg02896835	chr1:92012615	NA	-0.65	-5.99	-0.56	6.15e-8	Breast cancer;
SKCM	cis	rs7811142	0.945	rs6955362	chr7:100056166	C/T	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.17	7.71	0.66	3.44e-11	Platelet count;
SKCM	cis	rs6088590	0.710	rs6059992	chr20:33282275	T/C	cg24642439	chr20:33292090	TP53INP2	0.79	5.66	0.54	2.45e-7	Coronary artery disease;
SKCM	cis	rs6951245	1.000	rs11761941	chr7:1097183	G/A	cg18402987	chr7:1209562	NA	1.15	6.09	0.57	3.95e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs9915657	0.840	rs10512582	chr17:70139393	A/C	cg06234051	chr17:70120541	SOX9	-0.62	-5.54	-0.53	3.98e-7	Thyroid hormone levels;
SKCM	cis	rs9902453	0.868	rs9902340	chr17:28476458	G/T	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.79	-6.03	-0.56	5.24e-8	Coffee consumption (cups per day);
SKCM	cis	rs16854884	0.683	rs10935505	chr3:143777966	T/C	cg06585982	chr3:143692056	C3orf58	0.63	5.27	0.51	1.2e-6	Economic and political preferences (feminism/equality);
SKCM	cis	rs11764590	0.666	rs3996325	chr7:2053747	T/C	cg23422044	chr7:1970798	MAD1L1	-0.77	-5.69	-0.54	2.13e-7	Neuroticism;
SKCM	cis	rs1707322	0.827	rs10890347	chr1:46242332	A/T	cg03146154	chr1:46216737	IPP	-0.73	-5.01	-0.49	3.31e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7811142	1.000	rs7811142	chr7:100065443	A/T	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-0.99	-5.52	-0.53	4.2e-7	Platelet count;
SKCM	cis	rs9875589	0.509	rs9836573	chr3:14065239	G/A	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.52	5.24	0.51	1.34e-6	Ovarian reserve;
SKCM	cis	rs2594989	0.597	rs347593	chr3:11248957	C/G	cg00170343	chr3:11313890	ATG7	0.92	4.82	0.48	7.04e-6	Circulating chemerin levels;
SKCM	cis	rs6546550	0.901	rs6716937	chr2:70127229	G/A	cg02498382	chr2:70120550	SNRNP27	-0.45	-4.88	-0.48	5.4e-6	Prevalent atrial fibrillation;
SKCM	cis	rs7954584	0.545	rs12824593	chr12:122374108	G/A	cg01765077	chr12:122356316	WDR66	0.44	4.79	0.48	7.71e-6	Mean corpuscular volume;
SKCM	cis	rs58688157	0.705	rs7122021	chr11:595810	A/G	cg16486109	chr11:613632	IRF7	1.08	7.48	0.65	9.51e-11	Systemic lupus erythematosus;
SKCM	cis	rs875971	0.540	rs4717275	chr7:65265180	C/T	cg05627663	chr7:65219948	SNORA22;CCT6P1	-0.61	-5.16	-0.5	1.83e-6	Aortic root size;
SKCM	cis	rs67311347	0.544	rs13062243	chr3:40336789	G/A	cg00656387	chr3:40428638	ENTPD3	0.56	4.98	0.49	3.71e-6	Renal cell carcinoma;
SKCM	cis	rs4481887	0.927	rs6678798	chr1:248476617	C/T	cg00666640	chr1:248458726	OR2T12	0.63	5.91	0.56	8.65e-8	Common traits (Other);
SKCM	cis	rs7772486	0.875	rs1331639	chr6:146431869	A/G	cg23711669	chr6:146136114	FBXO30	-0.75	-7.61	-0.65	5.29e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7659604	0.521	rs6822155	chr4:122673274	C/A	cg19671926	chr4:122722719	EXOSC9	0.77	6.27	0.58	1.89e-8	Type 2 diabetes;
SKCM	cis	rs3008870	0.583	rs2147838	chr1:67399466	T/C	cg08660285	chr1:67390436	MIER1;WDR78	0.94	6.05	0.57	4.77e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs2075371	1.000	rs2241334	chr7:133979225	C/G	cg20476274	chr7:133979776	SLC35B4	1.0	10.26	0.76	3.98e-16	Mean platelet volume;
SKCM	cis	rs56011263	0.687	rs4690188	chr4:703930	G/C	cg17689763	chr4:710664	PCGF3	-0.65	-5.25	-0.51	1.26e-6	White blood cell count;
SKCM	cis	rs801193	0.569	rs881285	chr7:66119420	A/G	cg18876405	chr7:65276391	NA	-0.63	-6.32	-0.58	1.5e-8	Aortic root size;
SKCM	cis	rs2295499	0.643	rs2298965	chr4:2699655	C/G	cg19433769	chr4:2420260	ZFYVE28	-0.71	-5.01	-0.49	3.34e-6	Cognitive ability;Cognitive ability (multi-trait analysis);Intelligence (multi-trait analysis);
SKCM	cis	rs28595532	0.920	rs115090643	chr4:119729825	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.43	0.59	9.38e-9	Cannabis dependence symptom count;
SKCM	cis	rs2204008	0.537	rs11170128	chr12:38006632	G/A	cg26384229	chr12:38710491	ALG10B	0.81	6.45	0.59	8.61e-9	Bladder cancer;
SKCM	cis	rs11098499	0.866	rs9995136	chr4:120286845	A/G	cg24375607	chr4:120327624	NA	0.62	4.77	0.48	8.45e-6	Corneal astigmatism;
SKCM	cis	rs72781680	1.000	rs12616899	chr2:24165235	A/G	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	cis	rs4819052	0.851	rs7276103	chr21:46666078	G/A	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.24	0.63	2.69e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs8017423	0.935	rs11628906	chr14:90738002	C/T	cg04374321	chr14:90722782	PSMC1	-0.95	-8.73	-0.7	3.68e-13	Mortality in heart failure;
SKCM	cis	rs67311347	0.544	rs13098483	chr3:40342743	G/C	cg13409248	chr3:40428643	ENTPD3	0.58	5.61	0.54	2.98e-7	Renal cell carcinoma;
SKCM	cis	rs4523957	0.583	rs2641437	chr17:2019158	G/A	cg16513277	chr17:2031491	SMG6	-0.81	-5.98	-0.56	6.24e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs854765	0.718	rs12943500	chr17:17790588	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	-0.87	-6.31	-0.58	1.59e-8	Total body bone mineral density;
SKCM	cis	rs9911578	1.000	rs1631237	chr17:56734695	A/G	cg12560992	chr17:57184187	TRIM37	0.95	7.69	0.66	3.7e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs12950390	0.853	rs55745341	chr17:45855778	G/C	cg03474202	chr17:45855739	NA	-0.49	-5.58	-0.53	3.34e-7	IgG glycosylation;
SKCM	cis	rs9910055	0.920	rs2855818	chr17:42290015	G/A	cg19774624	chr17:42201019	HDAC5	-0.86	-7.48	-0.65	9.71e-11	Total body bone mineral density;
SKCM	cis	rs7659604	1.000	rs7660078	chr4:122665577	G/T	cg19671926	chr4:122722719	EXOSC9	-0.65	-4.79	-0.48	7.93e-6	Type 2 diabetes;
SKCM	cis	rs4819052	0.851	rs7275870	chr21:46671214	C/T	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.36	0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs67311347	0.955	rs60554147	chr3:40472503	T/C	cg00091569	chr3:40428383	ENTPD3	0.62	5.09	0.5	2.4e-6	Renal cell carcinoma;
SKCM	cis	rs6977660	0.941	rs10273208	chr7:19816371	T/C	cg07541023	chr7:19748670	TWISTNB	0.71	5.08	0.5	2.49e-6	Thyroid stimulating hormone;
SKCM	cis	rs1707322	0.752	rs28623463	chr1:46170758	A/C	cg03146154	chr1:46216737	IPP	0.8	5.47	0.53	5.19e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs2836974	0.666	rs4624474	chr21:40686327	T/C	cg11890956	chr21:40555474	PSMG1	-0.79	-7.37	-0.64	1.57e-10	Cognitive function;
SKCM	cis	rs644799	1.000	rs566204	chr11:95580926	G/A	cg03916912	chr11:95522834	CEP57;FAM76B	0.89	7.44	0.64	1.13e-10	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs9443189	0.723	rs2748947	chr6:76437921	C/T	cg01950844	chr6:76311363	SENP6	-0.75	-5.29	-0.51	1.1e-6	Prostate cancer;
SKCM	trans	rs17685	0.753	rs10233282	chr7:75790081	C/T	cg19862616	chr7:65841803	NCRNA00174	0.97	10.73	0.77	5.13e-17	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs8141529	0.732	rs2269577	chr22:29196757	G/C	cg15103426	chr22:29168792	CCDC117	0.64	5.34	0.52	8.88e-7	Lymphocyte counts;
SKCM	cis	rs6450176	1.000	rs7735253	chr5:53297611	G/A	ch.5.1024479R	chr5:53302184	ARL15	-0.73	-5.04	-0.5	2.91e-6	HDL cholesterol levels;HDL cholesterol;Adiponectin levels;
SKCM	cis	rs4561483	0.734	rs256398	chr16:12017824	C/T	cg08843971	chr16:11963173	GSPT1	-0.66	-4.96	-0.49	4.09e-6	Testicular germ cell tumor;
SKCM	cis	rs8060686	0.641	rs59708959	chr16:68123916	A/T	cg04539111	chr16:67997858	SLC12A4	-0.85	-4.81	-0.48	7.14e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs9902453	0.874	rs62070271	chr17:28268358	C/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.8	6.3	0.58	1.61e-8	Coffee consumption (cups per day);
SKCM	cis	rs2120019	0.567	rs8037152	chr15:75156996	A/T	cg09165964	chr15:75287851	SCAMP5	-0.81	-6.05	-0.57	4.76e-8	Blood trace element (Zn levels);
SKCM	cis	rs6089584	0.888	rs6061966	chr20:60607936	C/G	cg06108461	chr20:60628389	TAF4	-0.89	-8.72	-0.7	3.75e-13	Body mass index;
SKCM	cis	rs1577917	0.958	rs12212480	chr6:86458777	T/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.87	-8.7	-0.7	4.17e-13	Response to antipsychotic treatment;
SKCM	cis	rs12824058	0.831	rs12314111	chr12:130813663	G/T	cg26677194	chr12:130822605	PIWIL1	0.7	5.75	0.55	1.69e-7	Menopause (age at onset);
SKCM	cis	rs11098499	0.779	rs10857066	chr4:120286596	C/T	cg24375607	chr4:120327624	NA	0.62	4.77	0.48	8.45e-6	Corneal astigmatism;
SKCM	cis	rs6489882	0.902	rs1156361	chr12:113375983	T/C	cg07232103	chr12:112566177	TRAFD1	0.59	4.78	0.48	8.01e-6	Chronic lymphocytic leukemia;
SKCM	cis	rs6500395	0.926	rs11076572	chr16:48623621	T/G	cg04672837	chr16:48644449	N4BP1	0.69	5.88	0.55	9.68e-8	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs6753739	0.784	rs1378642	chr2:219950110	G/C	cg09617556	chr2:219924408	IHH	0.46	4.8	0.48	7.37e-6	Height;
SKCM	cis	rs9486715	0.867	rs926277	chr6:96868837	T/A	cg06623918	chr6:96969491	KIAA0776	0.79	7.09	0.63	5.34e-10	Headache;
SKCM	cis	rs9640161	0.789	rs13223702	chr7:150058968	G/A	cg10018233	chr7:150070692	REPIN1	0.73	6.09	0.57	3.98e-8	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs7809950	0.723	rs2237662	chr7:106874065	C/G	cg23024343	chr7:107201750	COG5	-0.8	-6.81	-0.61	1.84e-9	Coronary artery disease;
SKCM	trans	rs2727020	0.553	rs3862350	chr11:49595912	A/C	cg15704280	chr7:45808275	SEPT13	-0.96	-8.57	-0.7	7.28e-13	Coronary artery disease;
SKCM	cis	rs1506636	0.854	rs6466879	chr7:123276197	G/A	cg03229431	chr7:123269106	ASB15	-0.65	-5.06	-0.5	2.77e-6	Plateletcrit;Platelet count;
SKCM	cis	rs763121	0.853	rs5757162	chr22:38993370	C/T	cg06022373	chr22:39101656	GTPBP1	0.72	4.96	0.49	4.08e-6	Menopause (age at onset);
SKCM	cis	rs7772486	0.720	rs9403757	chr6:146261271	C/T	cg23711669	chr6:146136114	FBXO30	-0.77	-7.44	-0.64	1.14e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7598759	0.675	rs6727530	chr2:232332058	T/C	cg19187155	chr2:232395269	NMUR1	0.61	5.13	0.5	2.07e-6	Noise-induced hearing loss;
SKCM	cis	rs9535495	0.802	rs7326822	chr13:51392585	A/G	cg13204699	chr13:50703841	NA	-0.4	-4.79	-0.48	7.75e-6	Reticulocyte count;Reticulocyte fraction of red cells;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs8072100	0.905	rs9895274	chr17:45539117	C/T	cg25173405	chr17:45401733	C17orf57	-0.6	-5.39	-0.52	7.18e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs12142240	0.660	rs72885163	chr1:46807117	C/A	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs17376456	0.825	rs6865441	chr5:93284746	G/A	cg21475434	chr5:93447410	FAM172A	1.04	5.19	0.51	1.62e-6	Diabetic retinopathy;
SKCM	cis	rs801193	0.660	rs2659897	chr7:66187715	A/G	cg11764359	chr7:65958608	NA	-0.84	-7.9	-0.67	1.46e-11	Aortic root size;
SKCM	cis	rs1801251	0.928	rs737028	chr2:233640750	T/C	cg25237894	chr2:233734115	C2orf82	0.6	5.78	0.55	1.47e-7	Coronary artery disease;
SKCM	cis	rs8072100	0.764	rs4794371	chr17:45627693	G/C	cg25173405	chr17:45401733	C17orf57	0.56	4.84	0.48	6.31e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs2120019	1.000	rs2083731	chr15:75368538	A/C	cg17294928	chr15:75287854	SCAMP5	-0.82	-6.77	-0.61	2.13e-9	Blood trace element (Zn levels);
SKCM	cis	rs9399137	0.507	rs4896129	chr6:135349845	C/T	cg24558204	chr6:135376177	HBS1L	0.68	6.29	0.58	1.7e-8	Glycated hemoglobin levels;Mean corpuscular volume;Hematology traits;HbA2 levels;Mean corpuscular hemoglobin;Hemoglobin levels;F-cell distribution;Platelet count;
SKCM	cis	rs801193	0.875	rs13227951	chr7:66213108	C/T	cg11987759	chr7:65425863	GUSB	0.67	5.69	0.54	2.12e-7	Aortic root size;
SKCM	cis	rs5769765	0.908	rs138867	chr22:50207703	A/G	cg22709217	chr22:50311962	ALG12;CRELD2	0.86	5.77	0.55	1.53e-7	Schizophrenia;
SKCM	cis	rs17376456	0.877	rs17316137	chr5:93456577	C/T	cg21475434	chr5:93447410	FAM172A	0.94	5.67	0.54	2.32e-7	Diabetic retinopathy;
SKCM	cis	rs17376456	1.000	rs13154249	chr5:93550508	C/T	cg25358565	chr5:93447407	FAM172A	1.27	7.86	0.66	1.78e-11	Diabetic retinopathy;
SKCM	cis	rs7666738	0.830	rs13138059	chr4:99050430	A/G	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs8077889	0.672	rs1230397	chr17:41844689	A/G	cg26893861	chr17:41843967	DUSP3	1.42	13.18	0.83	1.53e-21	Triglycerides;
SKCM	cis	rs9880211	0.800	rs9813376	chr3:136475426	C/T	cg21827317	chr3:136751795	NA	-0.7	-5.26	-0.51	1.25e-6	Body mass index;Height;
SKCM	cis	rs28386778	0.897	rs894408	chr17:61896814	C/T	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs951366	0.764	rs823143	chr1:205743425	A/C	cg26354017	chr1:205819088	PM20D1	1.03	9.58	0.74	7.95e-15	Menarche (age at onset);
SKCM	cis	rs7618915	0.501	rs13085775	chr3:52678370	C/T	cg18404041	chr3:52824283	ITIH1	-0.53	-4.77	-0.48	8.43e-6	Bipolar disorder;
SKCM	cis	rs4819052	0.851	rs2838836	chr21:46665875	G/T	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.36	0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs1577917	0.771	rs4441928	chr6:86241894	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.78	7.21	0.63	3.17e-10	Response to antipsychotic treatment;
SKCM	cis	rs992157	0.798	rs2382819	chr2:219155909	G/T	cg00012203	chr2:219082015	ARPC2	-0.73	-5.73	-0.54	1.83e-7	Colorectal cancer;
SKCM	trans	rs1814175	0.645	rs7119101	chr11:49955665	G/A	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs9902453	1.000	rs4795525	chr17:28388487	T/A	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.81	-5.78	-0.55	1.45e-7	Coffee consumption (cups per day);
SKCM	cis	rs9906944	0.545	rs11079851	chr17:47092310	G/C	cg11673840	chr17:47092156	IGF2BP1	-0.53	-5.22	-0.51	1.46e-6	Intelligence (multi-trait analysis);Body fat percentage;
SKCM	cis	rs4727027	0.704	rs10952805	chr7:148907849	G/A	cg23583168	chr7:148888333	NA	-0.77	-6.04	-0.56	4.93e-8	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs4819052	0.851	rs2838843	chr21:46669284	T/C	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.42	0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs13256369	0.802	rs12153	chr8:8560909	G/C	cg06636001	chr8:8085503	FLJ10661	0.74	5.55	0.53	3.72e-7	Obesity-related traits;
SKCM	cis	rs9911578	1.000	rs304299	chr17:56838472	C/G	cg05425664	chr17:57184151	TRIM37	-0.69	-5.21	-0.51	1.52e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2120019	0.508	rs8030528	chr15:75171825	C/T	cg17294928	chr15:75287854	SCAMP5	-0.83	-6.05	-0.57	4.74e-8	Blood trace element (Zn levels);
SKCM	cis	rs28374715	0.562	rs8036686	chr15:41550333	C/T	cg18705301	chr15:41695430	NDUFAF1	-0.76	-6.47	-0.59	7.79e-9	Ulcerative colitis;
SKCM	cis	rs7833790	0.963	rs6473312	chr8:82732515	C/A	cg17211192	chr8:82754475	SNX16	-0.94	-5.12	-0.5	2.15e-6	Diastolic blood pressure;
SKCM	cis	rs7613875	0.620	rs17657664	chr3:50032008	T/G	cg24110177	chr3:50126178	RBM5	-0.7	-5.58	-0.53	3.34e-7	Body mass index;
SKCM	cis	rs1577917	0.740	rs2842604	chr6:86336300	T/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-1.01	-11.43	-0.79	2.49e-18	Response to antipsychotic treatment;
SKCM	cis	rs769267	0.896	rs2074298	chr19:19377716	C/G	cg03709012	chr19:19516395	GATAD2A	0.81	6.49	0.59	7.18e-9	Tonsillectomy;
SKCM	cis	rs72781680	0.898	rs72782137	chr2:24047805	C/T	cg08917208	chr2:24149416	ATAD2B	1.0	4.97	0.49	3.82e-6	Lymphocyte counts;
SKCM	cis	rs7208859	0.623	rs73269923	chr17:29102571	C/T	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs9309711	0.961	rs11692184	chr2:3480710	C/T	cg10845886	chr2:3471009	TTC15	-0.79	-6.23	-0.58	2.2e-8	Neurofibrillary tangles;
SKCM	cis	rs672059	1.000	rs672119	chr1:183162506	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.65	5.56	0.53	3.7e-7	Hypertriglyceridemia;
SKCM	cis	rs2404602	0.583	rs12898415	chr15:76574232	C/T	cg23625390	chr15:77176239	SCAPER	0.69	6.31	0.58	1.57e-8	Blood metabolite levels;
SKCM	cis	rs28595532	0.623	rs71608363	chr4:119227259	T/C	cg14228332	chr4:119757509	SEC24D	0.99	5.58	0.53	3.31e-7	Cannabis dependence symptom count;
SKCM	cis	rs992157	1.000	rs2292553	chr2:219146803	G/A	cg20019365	chr2:219134978	PNKD;AAMP	0.75	6.84	0.61	1.58e-9	Colorectal cancer;
SKCM	cis	rs1707322	1.000	rs12097799	chr1:46459886	C/A	cg03146154	chr1:46216737	IPP	0.77	5.1	0.5	2.36e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs8028182	0.636	rs8028277	chr15:75684085	A/G	cg20655648	chr15:75932815	IMP3	0.7	4.84	0.48	6.52e-6	Sudden cardiac arrest;
SKCM	cis	rs5769765	0.862	rs9616384	chr22:50313082	C/T	cg22709217	chr22:50311962	ALG12;CRELD2	-0.94	-5.91	-0.56	8.37e-8	Schizophrenia;
SKCM	cis	rs1552244	0.832	rs115415687	chr3:10195704	C/T	cg02579736	chr3:10068473	FANCD2;CIDECP	1.23	6.74	0.61	2.48e-9	Alzheimer's disease;
SKCM	cis	rs9911578	0.967	rs1588322	chr17:56990099	T/C	cg05425664	chr17:57184151	TRIM37	-0.67	-5.04	-0.5	2.91e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs4268898	0.610	rs55860688	chr2:24451534	T/C	cg06627628	chr2:24431161	ITSN2	-0.94	-7.34	-0.64	1.73e-10	Asthma;
SKCM	cis	rs7220401	0.789	rs3760456	chr17:27948844	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.83	-6.21	-0.58	2.38e-8	Coronary artery disease;
SKCM	trans	rs11083271	0.631	rs12608292	chr18:25858793	T/C	cg00321150	chr11:62623587	SNORD27;SLC3A2;SNHG1;SNORD28;SNORD25;SNORD26	0.8	7.29	0.64	2.17e-10	Non-alcoholic fatty liver disease histology (lobular);
SKCM	cis	rs28595532	0.920	rs55806110	chr4:119742583	A/G	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs2228479	0.850	rs11647174	chr16:89958538	G/A	cg00800038	chr16:89945340	TCF25	-0.96	-5.44	-0.52	5.85e-7	Skin colour saturation;
SKCM	cis	rs2839186	0.619	rs2187118	chr21:47611310	C/T	cg05896524	chr21:47604654	C21orf56	0.72	5.97	0.56	6.59e-8	Testicular germ cell tumor;
SKCM	cis	rs17376456	0.825	rs10038828	chr5:93124056	C/T	cg25358565	chr5:93447407	FAM172A	1.15	7.28	0.64	2.25e-10	Diabetic retinopathy;
SKCM	cis	rs875971	1.000	rs1565531	chr7:65663113	T/A	cg11764359	chr7:65958608	NA	-0.86	-8.24	-0.68	3.26e-12	Aortic root size;
SKCM	cis	rs826838	0.709	rs4882355	chr12:38721462	A/T	cg13010199	chr12:38710504	ALG10B	0.63	4.92	0.49	4.64e-6	Heart rate;
SKCM	cis	rs55823223	0.517	rs56018637	chr17:73884948	C/T	cg10935138	chr17:73851978	WBP2	1.13	6.53	0.59	5.98e-9	Psoriasis;
SKCM	cis	rs9583531	0.689	rs4773244	chr13:111383937	A/T	cg24331049	chr13:111365604	ING1	-0.82	-6.34	-0.58	1.4e-8	Coronary artery disease;
SKCM	cis	rs1799949	0.501	rs9675035	chr17:41415016	A/T	cg05368731	chr17:41323189	NBR1	0.85	7.32	0.64	1.89e-10	Menopause (age at onset);
SKCM	cis	rs2239547	0.563	rs2581820	chr3:53020544	A/G	cg11645453	chr3:52864694	ITIH4	-0.6	-4.87	-0.48	5.77e-6	Schizophrenia;
SKCM	cis	rs9915657	0.870	rs12600458	chr17:70130545	C/T	cg06234051	chr17:70120541	SOX9	-0.62	-5.37	-0.52	7.87e-7	Thyroid hormone levels;
SKCM	cis	rs870825	0.550	rs59051283	chr4:185646476	C/T	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs798554	0.724	rs798498	chr7:2795882	T/G	cg19346786	chr7:2764209	NA	-0.63	-6.66	-0.6	3.48e-9	Height;
SKCM	cis	rs8180040	0.966	rs11716763	chr3:47518266	C/T	cg27129171	chr3:47204927	SETD2	-0.79	-5.79	-0.55	1.43e-7	Colorectal cancer;
SKCM	cis	rs7772486	0.790	rs9497424	chr6:146225271	C/A	cg05347473	chr6:146136440	FBXO30	-0.56	-5.18	-0.51	1.67e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7666738	0.830	rs28728124	chr4:99001116	G/T	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.92e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7927771	0.524	rs11039329	chr11:47684908	A/G	cg20307385	chr11:47447363	PSMC3	0.71	5.68	0.54	2.26e-7	Subjective well-being;
SKCM	cis	rs763014	0.865	rs4006748	chr16:632225	T/C	cg09263875	chr16:632152	PIGQ	0.67	5.82	0.55	1.24e-7	Height;
SKCM	cis	rs1568889	0.774	rs11030235	chr11:28212375	A/G	cg06544937	chr11:28130018	METT5D1;KIF18A	0.88	8.11	0.68	5.64e-12	Bipolar disorder;
SKCM	cis	rs9611565	0.592	rs5996037	chr22:41965292	A/G	cg03806693	chr22:41940476	POLR3H	-1.04	-6.96	-0.62	9.22e-10	Vitiligo;
SKCM	cis	rs6500395	1.000	rs12933948	chr16:48705825	C/G	cg04672837	chr16:48644449	N4BP1	-0.63	-5.37	-0.52	8.01e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs2354432	0.556	rs885305	chr1:146786080	G/A	cg25205988	chr1:146714368	CHD1L	-1.19	-6.56	-0.6	5.24e-9	Mitochondrial DNA levels;
SKCM	cis	rs1044826	0.642	rs295481	chr3:139228811	C/T	cg15131784	chr3:139108705	COPB2	0.68	4.96	0.49	4.03e-6	Obesity-related traits;
SKCM	cis	rs11098499	0.863	rs7678400	chr4:120461957	G/A	cg24375607	chr4:120327624	NA	0.69	5.45	0.53	5.61e-7	Corneal astigmatism;
SKCM	cis	rs1577917	0.958	rs12191340	chr6:86521400	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.81	-0.66	2.19e-11	Response to antipsychotic treatment;
SKCM	cis	rs9325144	0.647	rs61931899	chr12:38892422	A/G	cg13010199	chr12:38710504	ALG10B	-0.65	-5.36	-0.52	8.36e-7	Morning vs. evening chronotype;
SKCM	cis	rs6952808	0.529	rs73038442	chr7:2139457	C/T	cg21782813	chr7:2030301	MAD1L1	0.53	5.68	0.54	2.25e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs6546550	0.803	rs10165883	chr2:70117015	C/T	cg02498382	chr2:70120550	SNRNP27	-0.5	-5.54	-0.53	3.95e-7	Prevalent atrial fibrillation;
SKCM	cis	rs7937682	0.632	rs11214029	chr11:111761230	C/T	cg09085632	chr11:111637200	PPP2R1B	1.1	10.16	0.75	6.14e-16	Primary sclerosing cholangitis;
SKCM	cis	rs6089829	0.889	rs6090206	chr20:61668363	G/A	cg08564027	chr20:61660810	NA	0.63	5.65	0.54	2.46e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs11098499	0.820	rs11737395	chr4:120520704	C/G	cg24375607	chr4:120327624	NA	0.67	5.21	0.51	1.47e-6	Corneal astigmatism;
SKCM	cis	rs17376456	1.000	rs13185608	chr5:93509688	T/G	cg21475434	chr5:93447410	FAM172A	0.99	5.65	0.54	2.49e-7	Diabetic retinopathy;
SKCM	cis	rs8017423	0.967	rs55894943	chr14:90714799	A/G	cg04374321	chr14:90722782	PSMC1	0.97	8.97	0.71	1.25e-13	Mortality in heart failure;
SKCM	cis	rs2404602	1.000	rs11072603	chr15:76881138	G/T	cg23625390	chr15:77176239	SCAPER	0.76	7.48	0.65	9.68e-11	Blood metabolite levels;
SKCM	cis	rs1790761	0.559	rs10896190	chr11:67406123	T/C	cg00290607	chr11:67383545	NA	0.57	5.97	0.56	6.74e-8	Mean corpuscular volume;
SKCM	cis	rs4900538	0.821	rs12586673	chr14:102827643	C/T	cg18135206	chr14:102964638	TECPR2	-0.74	-5.42	-0.52	6.5e-7	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs9910055	0.552	rs12937114	chr17:42325073	A/G	cg08499158	chr17:42289980	UBTF	-0.87	-6.8	-0.61	1.87e-9	Total body bone mineral density;
SKCM	trans	rs1814175	0.746	rs10839429	chr11:49906845	G/A	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs7843479	0.506	rs7818430	chr8:21798429	C/T	cg17168535	chr8:21777572	XPO7	0.82	7.8	0.66	2.25e-11	Mean corpuscular volume;
SKCM	cis	rs9902453	0.904	rs7225686	chr17:28356744	C/A	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.82	-6.4	-0.59	1.06e-8	Coffee consumption (cups per day);
SKCM	cis	rs4665809	1.000	rs6749855	chr2:26255263	A/G	cg26119090	chr2:26468346	HADHA;HADHB	-0.79	-5.08	-0.5	2.54e-6	Gut microbiome composition (summer);
SKCM	cis	rs12824058	0.831	rs7485200	chr12:130811641	C/T	cg26677194	chr12:130822605	PIWIL1	0.73	6.04	0.56	4.91e-8	Menopause (age at onset);
SKCM	cis	rs875971	0.929	rs778682	chr7:65837934	A/G	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	7.89e-13	Aortic root size;
SKCM	cis	rs870825	0.616	rs1401360	chr4:185643571	T/C	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs12540874	0.542	rs4947581	chr7:50565967	G/A	cg18232548	chr7:50535776	DDC	-0.74	-5.57	-0.53	3.48e-7	Systemic sclerosis;
SKCM	cis	rs6951245	1.000	rs118059236	chr7:1073202	A/C	cg21664854	chr7:1097933	C7orf50;GPR146	0.89	4.79	0.48	7.66e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs3749237	0.595	rs4955412	chr3:49418168	A/C	cg03060546	chr3:49711283	APEH	0.67	4.86	0.48	5.96e-6	Resting heart rate;
SKCM	cis	rs1005277	0.579	rs2474599	chr10:38438939	A/G	cg25427524	chr10:38739819	LOC399744	-0.71	-6.71	-0.61	2.75e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs1799949	1.000	rs33926631	chr17:41304463	T/C	cg05368731	chr17:41323189	NBR1	0.89	7.98	0.67	1.03e-11	Menopause (age at onset);
SKCM	cis	rs9640161	0.750	rs11765644	chr7:150026339	C/G	cg27494647	chr7:150038898	RARRES2	0.57	4.85	0.48	6.25e-6	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs951366	0.789	rs823137	chr1:205738302	C/T	cg07157834	chr1:205819609	PM20D1	0.81	7.26	0.64	2.51e-10	Menarche (age at onset);
SKCM	cis	rs6582630	0.502	rs11614397	chr12:38328163	C/T	cg26384229	chr12:38710491	ALG10B	0.81	6.67	0.6	3.38e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs9611565	0.592	rs4822040	chr22:41963553	C/G	cg03806693	chr22:41940476	POLR3H	-1.04	-6.96	-0.62	9.22e-10	Vitiligo;
SKCM	cis	rs9325144	0.600	rs12227663	chr12:38734922	C/T	cg26384229	chr12:38710491	ALG10B	-0.75	-6.5	-0.59	6.83e-9	Morning vs. evening chronotype;
SKCM	cis	rs3820928	0.874	rs10177995	chr2:227781600	T/C	cg11843606	chr2:227700838	RHBDD1	-0.6	-4.81	-0.48	7.17e-6	Pulmonary function;
SKCM	cis	rs9393692	0.557	rs10946810	chr6:26288055	G/A	cg00631329	chr6:26305371	NA	-0.65	-5.04	-0.5	2.93e-6	Educational attainment;
SKCM	cis	rs367615	0.661	rs9326773	chr5:108833523	C/T	cg17395555	chr5:108820864	NA	0.75	6.56	0.6	5.3300000000000004e-09	Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs919433	0.726	rs11904247	chr2:198238424	T/G	cg04278110	chr2:198063759	ANKRD44	0.73	5.04	0.5	2.98e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs6088590	0.561	rs6059926	chr20:33164804	C/T	cg24642439	chr20:33292090	TP53INP2	0.76	5.84	0.55	1.13e-7	Coronary artery disease;
SKCM	cis	rs782590	0.935	rs2627779	chr2:55892356	A/G	cg18811423	chr2:55921094	PNPT1	0.9	7.23	0.63	2.85e-10	Metabolic syndrome;
SKCM	cis	rs9368481	0.672	rs3931463	chr6:26939797	G/A	cg12292205	chr6:26970375	C6orf41	0.65	5.79	0.55	1.41e-7	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs78269692	1.000	rs117922601	chr19:13249921	G/T	cg19436403	chr19:12780550	MORG1;C19orf56	1.39	5.14	0.5	1.96e-6	Breast cancer;
SKCM	cis	rs951366	0.789	rs823130	chr1:205714372	C/T	cg14159672	chr1:205819179	PM20D1	0.95	7.66	0.66	4.22e-11	Menarche (age at onset);
SKCM	cis	rs950027	0.620	rs1346267	chr15:45690989	A/G	cg10760299	chr15:45669010	GATM	0.55	5.19	0.51	1.61e-6	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs73001065	0.536	rs10408596	chr19:19512657	A/T	cg03709012	chr19:19516395	GATAD2A	1.16	5.47	0.53	5.19e-7	LDL cholesterol;
SKCM	cis	rs7945705	0.934	rs1988709	chr11:8882890	A/T	cg21881798	chr11:8931708	C11orf17;ST5	0.76	7.61	0.65	5.28e-11	Hemoglobin concentration;
SKCM	cis	rs7103648	0.897	rs11606287	chr11:47407439	C/A	cg20307385	chr11:47447363	PSMC3	0.96	6.93	0.62	1.09e-9	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs28595532	0.545	rs17516526	chr4:119259199	C/G	cg21605333	chr4:119757512	SEC24D	0.96	5.21	0.51	1.47e-6	Cannabis dependence symptom count;
SKCM	cis	rs672059	0.812	rs61418038	chr1:183155717	C/A	ch.1.3577855R	chr1:183094577	LAMC1	0.6	4.93	0.49	4.52e-6	Hypertriglyceridemia;
SKCM	cis	rs17065868	1.000	rs9533906	chr13:45129094	G/A	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs2841277	0.738	rs1036713	chr14:105396693	C/G	cg21017887	chr14:105400489	NA	-0.54	-4.92	-0.49	4.73e-6	Rheumatoid arthritis;
SKCM	cis	rs7659604	1.000	rs28532673	chr4:122664323	A/G	cg19671926	chr4:122722719	EXOSC9	0.67	5.03	0.49	3.1e-6	Type 2 diabetes;
SKCM	cis	rs9581857	0.547	rs76971629	chr13:28051031	C/T	cg22138327	chr13:27999177	GTF3A	0.93	6.22	0.58	2.33e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs9303401	0.659	rs17822837	chr17:56737838	C/T	cg02118635	chr17:56770003	RAD51C;TEX14	0.8	5.31	0.52	1.01e-6	Cognitive test performance;
SKCM	cis	rs2811415	0.627	rs9289325	chr3:127779693	A/C	cg09089421	chr3:127803668	RUVBL1	1.01	8.77	0.7	2.97e-13	Lung function (FEV1/FVC);
SKCM	cis	rs7811142	1.000	rs11764818	chr7:100043055	G/A	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.17	7.71	0.66	3.44e-11	Platelet count;
SKCM	cis	rs748404	0.660	rs2439845	chr15:43722610	C/G	cg02155558	chr15:43621948	ADAL;LCMT2	0.73	5.42	0.52	6.48e-7	Lung cancer;
SKCM	cis	rs16854884	0.632	rs60505453	chr3:143643864	C/G	cg06585982	chr3:143692056	C3orf58	0.8	7.27	0.64	2.39e-10	Economic and political preferences (feminism/equality);
SKCM	cis	rs951366	0.617	rs708727	chr1:205767885	G/A	cg24503407	chr1:205819492	PM20D1	0.96	10.46	0.76	1.63e-16	Menarche (age at onset);
SKCM	cis	rs7772486	0.686	rs6933161	chr6:146081369	G/A	cg05347473	chr6:146136440	FBXO30	-0.55	-5.07	-0.5	2.6e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs41357746	0.525	rs57030473	chr15:67776678	A/G	cg24247231	chr15:67904302	MAP2K5	-0.63	-5.32	-0.52	9.58e-7	Total body bone mineral density;
SKCM	cis	rs2413583	0.591	rs116136126	chr22:39729557	T/C	cg17798944	chr22:39715225	SNORD43;RPL3	0.93	5.33	0.52	9.34e-7	Ulcerative colitis;Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs11098499	0.909	rs35165976	chr4:120325630	G/A	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs17065868	1.000	rs73190808	chr13:45099541	G/A	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs9818758	0.607	rs35283189	chr3:49113668	T/C	cg00383909	chr3:49044727	WDR6	1.05	5.85	0.55	1.11e-7	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs2404602	0.647	rs34103231	chr15:76912690	A/G	cg23625390	chr15:77176239	SCAPER	-0.85	-8.24	-0.68	3.21e-12	Blood metabolite levels;
SKCM	cis	rs875971	0.545	rs10950025	chr7:65623933	G/A	cg18876405	chr7:65276391	NA	0.64	5.29	0.51	1.09e-6	Aortic root size;
SKCM	cis	rs6598955	0.543	rs61608823	chr1:26555090	G/A	cg04990556	chr1:26633338	UBXN11	0.65	4.8	0.48	7.56e-6	Obesity-related traits;
SKCM	cis	rs2439831	1.000	rs2245908	chr15:43731454	C/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.1	7.54	0.65	7.34e-11	Lung cancer in ever smokers;
SKCM	cis	rs9325144	0.624	rs7309400	chr12:39150369	G/C	cg26384229	chr12:38710491	ALG10B	-0.71	-6.47	-0.59	7.97e-9	Morning vs. evening chronotype;
SKCM	cis	rs5760092	0.755	rs915589	chr22:24261004	C/T	cg25703541	chr22:24373054	LOC391322	0.77	5.34	0.52	8.74e-7	Urinary 1,3-butadiene metabolite levels in smokers;
SKCM	cis	rs8072100	0.745	rs7214410	chr17:45422628	A/G	cg25173405	chr17:45401733	C17orf57	-0.6	-4.91	-0.49	4.99e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs1348850	0.958	rs4528793	chr2:178464271	C/T	cg02961200	chr2:178257176	LOC100130691;AGPS	0.84	6.61	0.6	4.29e-9	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs2842992	0.830	rs2842966	chr6:160141592	C/T	cg11366901	chr6:160182831	ACAT2	0.91	6.98	0.62	8.77e-10	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs6951245	1.000	rs80094748	chr7:1103958	G/A	cg24642844	chr7:1081250	C7orf50	-0.94	-6.23	-0.58	2.24e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7940866	0.804	rs3910267	chr11:130810282	C/T	cg12179176	chr11:130786555	SNX19	0.76	6.04	0.56	4.89e-8	Schizophrenia;
SKCM	cis	rs34172651	0.517	rs12920774	chr16:24830750	T/C	cg06028605	chr16:24865363	SLC5A11	0.59	4.95	0.49	4.26e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs28595532	0.920	rs115154263	chr4:119765307	G/A	cg21605333	chr4:119757512	SEC24D	1.39	8.43	0.69	1.38e-12	Cannabis dependence symptom count;
SKCM	cis	rs829883	0.714	rs249847	chr12:98867716	C/T	cg25150519	chr12:98850993	NA	0.55	5.39	0.52	7.27e-7	Colorectal adenoma (advanced);
SKCM	cis	rs1218582	0.710	rs4845685	chr1:154878300	C/A	cg06221963	chr1:154839813	KCNN3	-0.59	-5.97	-0.56	6.76e-8	Prostate cancer;
SKCM	cis	rs1577917	1.000	rs12190598	chr6:86686074	C/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.85	-7.88	-0.67	1.63e-11	Response to antipsychotic treatment;
SKCM	cis	rs548181	0.609	rs511822	chr11:125534115	C/T	cg03464685	chr11:125439445	EI24	1.26	8.77	0.7	3e-13	Schizophrenia;Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);
SKCM	cis	rs4595586	0.546	rs2056159	chr12:39270417	C/G	cg26384229	chr12:38710491	ALG10B	0.7	5.33	0.52	9.25e-7	Morning vs. evening chronotype;
SKCM	cis	rs7635838	0.819	rs4684782	chr3:11518755	C/T	cg00170343	chr3:11313890	ATG7	-0.74	-5.57	-0.53	3.42e-7	HDL cholesterol;
SKCM	cis	rs2204008	0.745	rs8189516	chr12:38239084	C/T	cg13010199	chr12:38710504	ALG10B	0.69	4.99	0.49	3.57e-6	Bladder cancer;
SKCM	cis	rs2153535	0.580	rs4960422	chr6:8459309	T/C	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs929354	0.772	rs3802117	chr7:156987000	C/T	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs9611565	0.649	rs2064189	chr22:42127999	A/G	cg03806693	chr22:41940476	POLR3H	0.88	5.63	0.54	2.67e-7	Vitiligo;
SKCM	cis	rs8017423	0.967	rs3825662	chr14:90723152	A/G	cg04374321	chr14:90722782	PSMC1	1.03	9.44	0.73	1.55e-14	Mortality in heart failure;
SKCM	cis	rs2858942	0.770	rs2858091	chr16:270283	T/A	cg08400316	chr16:204221	HBZ	-0.74	-5.14	-0.5	1.97e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs17685	0.753	rs8200	chr7:75696606	C/G	cg16489192	chr7:75678113	MDH2;STYXL1	0.58	5.44	0.52	5.83e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2836974	0.931	rs2836972	chr21:40652142	G/A	cg11644478	chr21:40555479	PSMG1	0.97	10.08	0.75	8.76e-16	Cognitive function;
SKCM	cis	rs7666738	0.830	rs10034619	chr4:98970067	G/C	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs28595532	0.841	rs115851302	chr4:119776504	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs1048238	0.506	rs12023422	chr1:16187625	G/A	cg21385522	chr1:16154831	NA	0.63	5.24	0.51	1.34e-6	Systolic blood pressure;
SKCM	cis	rs7617480	0.587	rs9311431	chr3:48848787	T/A	cg07636037	chr3:49044803	WDR6	0.92	6.81	0.61	1.82e-9	Subjective well-being (multi-trait analysis);Menarche (age at onset);
SKCM	cis	rs7959452	0.719	rs57954211	chr12:69748397	C/A	cg14784868	chr12:69753453	YEATS4	0.8	7.7	0.66	3.52e-11	Blood protein levels;
SKCM	cis	rs4319547	0.956	rs10773302	chr12:123043145	G/T	cg23029597	chr12:123009494	RSRC2	-0.76	-5.82	-0.55	1.25e-7	Body mass index;
SKCM	cis	rs2857078	0.732	rs9893756	chr17:42321109	T/C	cg09913183	chr17:42254507	C17orf65;ASB16	-0.61	-4.8	-0.48	7.61e-6	Red cell distribution width;Reticulocyte count;
SKCM	cis	rs7945705	0.747	rs11042150	chr11:9010819	T/C	cg21881798	chr11:8931708	C11orf17;ST5	-0.87	-9.66	-0.74	5.65e-15	Hemoglobin concentration;
SKCM	cis	rs2072499	0.966	rs11587860	chr1:156156951	G/C	cg25208724	chr1:156163844	SLC25A44	1.02	9.17	0.72	5.05e-14	Testicular germ cell tumor;
SKCM	cis	rs7937682	0.632	rs4935811	chr11:111679262	C/T	cg09085632	chr11:111637200	PPP2R1B	1.09	10.48	0.76	1.52e-16	Primary sclerosing cholangitis;
SKCM	cis	rs3008870	1.000	rs2985797	chr1:67431499	C/T	cg08660285	chr1:67390436	MIER1;WDR78	-0.92	-6.09	-0.57	4.06e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs2836950	0.565	rs2150413	chr21:40614878	C/T	cg17971929	chr21:40555470	PSMG1	-0.73	-6.17	-0.57	2.86e-8	Menarche (age at onset);
SKCM	cis	rs2984613	1	rs2984613	chr1:156197380	C/T	cg25208724	chr1:156163844	SLC25A44	0.9	7.92	0.67	1.36e-11	Intracerebral hemorrhage;White matter hyperintensity burden;
SKCM	trans	rs66573146	1.000	rs6812771	chr4:6964048	G/A	cg07817883	chr1:32538562	TMEM39B	2.0	8.02	0.67	8.59e-12	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs13064447	0.935	rs7624347	chr3:12756045	T/A	cg05775895	chr3:12838266	CAND2	-0.61	-4.96	-0.49	4.01e-6	Major depression and alcohol dependence;
SKCM	cis	rs7945705	0.935	rs11042102	chr11:8882164	C/T	cg13070366	chr11:9386451	NA	-0.59	-5.11	-0.5	2.25e-6	Hemoglobin concentration;
SKCM	cis	rs2839186	0.709	rs2839176	chr21:47678173	A/G	cg11766577	chr21:47581405	C21orf56	-0.61	-5.24	-0.51	1.36e-6	Testicular germ cell tumor;
SKCM	cis	rs992157	0.731	rs1399132	chr2:219159770	G/A	cg20019365	chr2:219134978	PNKD;AAMP	0.71	6.11	0.57	3.64e-8	Colorectal cancer;
SKCM	cis	rs1557765	0.527	rs4756887	chr11:17394597	T/G	cg15432903	chr11:17409602	KCNJ11	0.53	5.06	0.5	2.7e-6	Body mass index;Social communication problems;
SKCM	cis	rs2386661	0.826	rs10795723	chr10:5675983	C/T	cg12223502	chr10:5658492	NA	-0.56	-4.84	-0.48	6.49e-6	Breast cancer;
SKCM	cis	rs9393692	0.645	rs6939048	chr6:26327953	G/A	cg00631329	chr6:26305371	NA	-0.71	-4.96	-0.49	4.04e-6	Educational attainment;
SKCM	cis	rs1552244	1.000	rs17032396	chr3:10153559	A/G	cg02579736	chr3:10068473	FANCD2;CIDECP	-1.21	-6.93	-0.62	1.09e-9	Alzheimer's disease;
SKCM	cis	rs72781680	0.800	rs72790306	chr2:24111311	T/G	cg08917208	chr2:24149416	ATAD2B	1.07	5.83	0.55	1.17e-7	Lymphocyte counts;
SKCM	cis	rs2836974	0.932	rs2234543	chr21:40572072	G/A	cg11890956	chr21:40555474	PSMG1	1.11	13.57	0.84	3.1e-22	Cognitive function;
SKCM	cis	rs28595532	0.920	rs55649377	chr4:119752745	T/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs910316	1.000	rs8017642	chr14:75590822	G/A	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.89e-7	Height;
SKCM	trans	rs8073060	0.586	rs7212488	chr17:33993476	A/T	cg19694781	chr19:47549865	TMEM160	-1.04	-8.28	-0.68	2.65e-12	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs2836633	0.895	rs991816	chr21:40042150	C/A	cg05519781	chr21:40033154	ERG	0.73	6.61	0.6	4.24e-9	Coronary artery disease;
SKCM	cis	rs17818399	0.749	rs13000560	chr2:46790997	G/T	cg02822958	chr2:46747628	ATP6V1E2	0.69	5.0	0.49	3.4e-6	Height;
SKCM	cis	rs7809950	1.000	rs7782057	chr7:107098877	T/A	cg23024343	chr7:107201750	COG5	-0.74	-6.61	-0.6	4.39e-9	Coronary artery disease;
SKCM	cis	rs13118159	0.801	rs1128427	chr4:1330759	T/C	cg02018176	chr4:1364513	KIAA1530	0.66	5.2	0.51	1.56e-6	Longevity;
SKCM	trans	rs1814175	0.817	rs12290508	chr11:49621037	C/T	cg03929089	chr4:120376271	NA	-0.89	-8.08	-0.68	6.54e-12	Height;
SKCM	cis	rs116095464	0.558	rs13356367	chr5:242395	C/T	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs6547741	0.816	rs10201652	chr2:27874332	A/C	cg27432699	chr2:27873401	GPN1	-0.85	-7.27	-0.64	2.42e-10	Oral cavity cancer;
SKCM	cis	rs7927592	0.913	rs12283755	chr11:68371658	A/G	cg11847702	chr11:69192623	NA	0.65	4.82	0.48	6.9e-6	Total body bone mineral density;
SKCM	cis	rs57024841	0.539	rs7040705	chr9:139836362	G/A	cg18798099	chr9:140189618	NA	-0.6	-4.91	-0.49	4.85e-6	Beta-trace protein levels;
SKCM	cis	rs4319547	0.737	rs10846921	chr12:122943376	G/T	cg23029597	chr12:123009494	RSRC2	0.81	6.32	0.58	1.53e-8	Body mass index;
SKCM	cis	rs798554	0.759	rs1636255	chr7:2892804	A/C	cg04166393	chr7:2884313	GNA12	-0.75	-5.0	-0.49	3.4e-6	Height;
SKCM	cis	rs453301	0.506	rs476845	chr8:8622877	A/G	cg06636001	chr8:8085503	FLJ10661	-0.68	-6.11	-0.57	3.67e-8	Joint mobility (Beighton score);
SKCM	cis	rs1707322	1.000	rs7553924	chr1:46352624	T/C	cg03146154	chr1:46216737	IPP	0.75	5.15	0.5	1.94e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs801193	0.548	rs2659904	chr7:66178602	C/A	cg11764359	chr7:65958608	NA	0.8	7.22	0.63	2.94e-10	Aortic root size;
SKCM	cis	rs2370759	1.000	rs79442609	chr10:32608749	C/T	cg01819863	chr10:32635814	EPC1	1.04	5.71	0.54	1.93e-7	Sexual dysfunction (female);
SKCM	cis	rs801193	0.773	rs801207	chr7:66020590	T/C	cg18876405	chr7:65276391	NA	-0.78	-6.84	-0.61	1.57e-9	Aortic root size;
SKCM	cis	rs6558174	0.930	rs12676084	chr8:22493350	C/T	cg03733263	chr8:22462867	KIAA1967	0.75	5.38	0.52	7.69e-7	Breast cancer;
SKCM	cis	rs7666738	0.830	rs13108871	chr4:98803872	T/C	cg17366294	chr4:99064904	C4orf37	0.57	4.86	0.48	6.02e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs919433	0.889	rs788004	chr2:198219032	C/T	cg04278110	chr2:198063759	ANKRD44	0.73	5.0	0.49	3.51e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs9325144	0.560	rs11182952	chr12:38636278	C/A	cg26384229	chr12:38710491	ALG10B	-0.68	-5.43	-0.52	6.19e-7	Morning vs. evening chronotype;
SKCM	cis	rs28595532	0.920	rs56291421	chr4:119732294	G/A	cg11846333	chr4:119757529	SEC24D	1.2	6.43	0.59	9.38e-9	Cannabis dependence symptom count;
SKCM	cis	rs1405130	0.933	rs12989408	chr2:235571531	C/A	cg21542780	chr2:234763377	HJURP	-0.65	-4.92	-0.49	4.75e-6	Coronary artery disease;
SKCM	cis	rs1707322	1.000	rs7517560	chr1:46425943	A/G	cg03146154	chr1:46216737	IPP	0.79	5.38	0.52	7.61e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs6500395	1.000	rs28577888	chr16:48673281	T/G	cg04672837	chr16:48644449	N4BP1	0.65	5.4	0.52	7.05e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs4803468	1.000	rs4803469	chr19:41922775	A/C	cg14132834	chr19:41945861	ATP5SL	-0.77	-6.08	-0.57	4.18e-8	Height;
SKCM	cis	rs72781680	0.752	rs7578606	chr2:23902360	T/C	cg08917208	chr2:24149416	ATAD2B	1.0	5.01	0.49	3.3e-6	Lymphocyte counts;
SKCM	cis	rs4242434	0.672	rs10110443	chr8:22484296	C/G	cg03733263	chr8:22462867	KIAA1967	0.81	5.92	0.56	8.04e-8	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs427394	0.772	rs274689	chr5:6736215	G/C	cg10857441	chr5:6722123	POLS	-0.7	-7.36	-0.64	1.6e-10	Menopause (age at onset);
SKCM	cis	rs25645	0.502	rs1563103	chr17:38111740	G/A	cg17467752	chr17:38218738	THRA	0.66	5.22	0.51	1.45e-6	Myeloid white cell count;
SKCM	cis	rs10754283	0.967	rs10737708	chr1:90119804	A/G	cg21401794	chr1:90099060	LRRC8C	0.73	6.31	0.58	1.57e-8	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs13108904	0.651	rs875475	chr4:1192409	G/A	cg16405210	chr4:1374714	KIAA1530	-0.73	-5.28	-0.51	1.11e-6	Obesity-related traits;
SKCM	cis	rs208520	0.955	rs12204033	chr6:67001525	T/C	cg07460842	chr6:66804631	NA	0.8	5.81	0.55	1.32e-7	Exhaled nitric oxide output;
SKCM	cis	rs8067545	0.750	rs1421174	chr17:19950190	G/T	cg13482628	chr17:19912719	NA	0.72	6.27	0.58	1.85e-8	Schizophrenia;
SKCM	cis	rs4523957	0.553	rs2172593	chr17:2025544	G/C	cg16513277	chr17:2031491	SMG6	-0.91	-6.21	-0.58	2.38e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs5750830	0.649	rs5750815	chr22:39798449	T/C	cg11247378	chr22:39784982	NA	-0.48	-5.54	-0.53	4.01e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs2180341	0.883	rs6904630	chr6:127696869	A/G	cg24812749	chr6:127587940	RNF146	0.83	7.18	0.63	3.63e-10	Breast cancer;
SKCM	cis	rs4774899	0.934	rs4774913	chr15:57487770	T/C	cg01857019	chr15:57210107	LOC145783;TCF12	0.52	4.79	0.48	7.67e-6	Urinary tract infection frequency;
SKCM	cis	rs1577917	0.958	rs2084294	chr6:86565943	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.32	-0.52	9.66e-7	Response to antipsychotic treatment;
SKCM	cis	rs6951245	0.554	rs58210047	chr7:1149381	G/A	cg23708337	chr7:1209742	NA	0.71	4.94	0.49	4.35e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs4332037	0.539	rs1533827	chr7:2074290	A/G	cg23422044	chr7:1970798	MAD1L1	0.88	6.2	0.57	2.55e-8	Bipolar disorder;
SKCM	cis	rs9399135	0.967	rs6909975	chr6:135315570	C/T	cg24558204	chr6:135376177	HBS1L	0.59	5.23	0.51	1.41e-6	Red blood cell count;
SKCM	cis	rs6500395	0.962	rs9941275	chr16:48573428	A/G	cg04672837	chr16:48644449	N4BP1	0.69	5.6	0.54	3.1e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs116095464	0.558	rs28636067	chr5:199415	G/A	cg22496380	chr5:211416	CCDC127	-0.98	-4.86	-0.48	5.91e-6	Breast cancer;
SKCM	cis	rs4862750	0.872	rs13110072	chr4:187878524	A/G	cg10295955	chr4:187884368	NA	-1.04	-14.07	-0.85	4.23e-23	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs11945232	1.000	rs28609242	chr4:88342497	T/C	cg23841344	chr4:88312519	HSD17B11	-0.67	-4.95	-0.49	4.2e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7647973	0.600	rs13064780	chr3:49274826	T/G	cg07636037	chr3:49044803	WDR6	0.83	6.82	0.61	1.76e-9	Menarche (age at onset);
SKCM	cis	rs7555523	0.887	rs12691499	chr1:165687665	A/C	cg24409356	chr1:165738333	TMCO1	0.93	5.15	0.5	1.93e-6	Intraocular pressure;Glaucoma (high intraocular pressure);
SKCM	cis	rs1799949	1.000	rs33945274	chr17:41280073	G/A	cg05368731	chr17:41323189	NBR1	0.89	7.91	0.67	1.38e-11	Menopause (age at onset);
SKCM	cis	rs4973517	0.727	rs3116229	chr2:232891248	A/G	cg13952656	chr2:232260762	B3GNT7	0.48	4.8	0.48	7.5e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs2777491	0.574	rs11858812	chr15:41731550	G/A	cg18705301	chr15:41695430	NDUFAF1	-1.19	-13.25	-0.83	1.15e-21	Ulcerative colitis;
SKCM	cis	rs7216064	1.000	rs7212293	chr17:65847325	A/G	cg12091567	chr17:66097778	LOC651250	-0.79	-5.72	-0.54	1.9e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs7945705	0.837	rs2742474	chr11:9002089	A/G	cg13070366	chr11:9386451	NA	0.57	5.07	0.5	2.6e-6	Hemoglobin concentration;
SKCM	cis	rs838147	0.844	rs8111399	chr19:49247963	G/T	cg13540341	chr19:49222985	MAMSTR	0.56	5.06	0.5	2.77e-6	Dietary macronutrient intake;
SKCM	cis	rs11098499	0.863	rs11736416	chr4:120431661	C/T	cg09307838	chr4:120376055	NA	0.99	7.71	0.66	3.45e-11	Corneal astigmatism;
SKCM	cis	rs11718455	0.960	rs13083325	chr3:44005333	T/C	cg21419209	chr3:44054225	NA	-0.65	-5.32	-0.52	9.77e-7	Coronary artery disease;
SKCM	cis	rs17826219	0.568	rs7213925	chr17:29121634	A/G	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Body mass index;
SKCM	cis	rs2836974	0.644	rs11088471	chr21:40699313	A/G	cg11890956	chr21:40555474	PSMG1	-0.82	-7.64	-0.65	4.75e-11	Cognitive function;
SKCM	cis	rs7647973	0.580	rs2334958	chr3:49252364	C/T	cg06212747	chr3:49208901	KLHDC8B	0.79	5.72	0.54	1.89e-7	Menarche (age at onset);
SKCM	cis	rs6933660	0.745	rs3800272	chr6:151744283	A/G	cg10883421	chr6:151773342	RMND1;C6orf211	-0.79	-6.45	-0.59	8.69e-9	Menarche (age at onset);
SKCM	cis	rs1577917	1.000	rs12663690	chr6:86640162	C/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.87	8.85	0.71	2.11e-13	Response to antipsychotic treatment;
SKCM	cis	rs116095464	0.850	rs10055295	chr5:243749	G/A	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs4332037	0.539	rs34809719	chr7:2028968	G/T	cg02825527	chr7:2087843	MAD1L1	-0.74	-5.03	-0.49	3.09e-6	Bipolar disorder;
SKCM	cis	rs801193	1.000	rs3857688	chr7:66127806	G/A	cg00343986	chr7:65444356	GUSB	-0.67	-4.93	-0.49	4.55e-6	Aortic root size;
SKCM	cis	rs10754283	0.967	rs2002883	chr1:90105838	A/G	cg21401794	chr1:90099060	LRRC8C	0.74	6.4	0.59	1.09e-8	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs7666738	0.822	rs9992360	chr4:98937123	T/C	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs28386778	0.897	rs2727320	chr17:61865325	T/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs6570726	0.967	rs413880	chr6:145804822	G/A	cg23711669	chr6:146136114	FBXO30	0.7	6.88	0.61	1.32e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7666738	0.830	rs35915560	chr4:98978649	C/T	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7635838	0.785	rs2606735	chr3:11400714	A/C	cg00170343	chr3:11313890	ATG7	0.7	5.19	0.51	1.61e-6	HDL cholesterol;
SKCM	cis	rs62103177	0.810	rs62103187	chr18:77627633	G/C	cg27393146	chr18:77495563	CTDP1	-0.92	-5.36	-0.52	8.37e-7	Opioid sensitivity;
SKCM	cis	rs6088580	0.634	rs6059779	chr20:32950325	C/T	cg24642439	chr20:33292090	TP53INP2	-0.76	-6.02	-0.56	5.31e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs7149337	0.836	rs4901087	chr14:51668499	T/C	cg23942311	chr14:51606299	NA	0.61	6.58	0.6	4.84e-9	Cancer;
SKCM	cis	rs2841277	0.712	rs2841280	chr14:105393556	G/C	cg21017887	chr14:105400489	NA	-0.58	-5.16	-0.5	1.84e-6	Rheumatoid arthritis;
SKCM	cis	rs6545883	0.929	rs1209434	chr2:61672958	G/A	cg15711740	chr2:61764176	XPO1	-0.68	-4.92	-0.49	4.76e-6	Tuberculosis;
SKCM	cis	rs9814567	1.000	rs7433663	chr3:134235790	A/G	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs533581	0.866	rs561795	chr16:88970818	A/G	cg16701003	chr16:89028210	CBFA2T3	0.55	5.18	0.51	1.68e-6	Social autistic-like traits;
SKCM	cis	rs7659604	0.676	rs4077102	chr4:122699830	A/G	cg19671926	chr4:122722719	EXOSC9	-0.66	-4.85	-0.48	6.08e-6	Type 2 diabetes;
SKCM	cis	rs514406	0.698	rs567880	chr1:53348564	T/G	cg16325326	chr1:53192061	ZYG11B	0.69	6.0	0.56	5.75e-8	Monocyte count;
SKCM	cis	rs10540	1.000	rs35898083	chr11:484469	C/T	cg03576123	chr11:487126	PTDSS2	-1.4	-7.12	-0.63	4.72e-10	Body mass index;
SKCM	cis	rs10489202	0.608	rs7553238	chr1:168076768	G/A	cg24449463	chr1:168025552	DCAF6	-0.8	-7.21	-0.63	3.13e-10	Schizophrenia;
SKCM	cis	rs28595532	0.546	rs17516389	chr4:119239267	T/C	cg21605333	chr4:119757512	SEC24D	1.2	7.45	0.64	1.1e-10	Cannabis dependence symptom count;
SKCM	cis	rs7220401	0.789	rs4794859	chr17:27962393	A/C	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.8	-5.69	-0.54	2.11e-7	Coronary artery disease;
SKCM	cis	rs11098499	0.954	rs35091806	chr4:120325529	G/A	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs933688	1.000	rs985434	chr5:90744509	A/G	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.94	6.78	0.61	2.1e-9	Smoking behavior;
SKCM	cis	rs6570726	0.791	rs6902410	chr6:145905261	G/A	cg23711669	chr6:146136114	FBXO30	0.88	8.32	0.69	2.28e-12	Lobe attachment (rater-scored or self-reported);
SKCM	trans	rs1814175	0.571	rs12294066	chr11:49738287	C/T	cg15704280	chr7:45808275	SEPT13	-0.97	-9.35	-0.73	2.25e-14	Height;
SKCM	cis	rs7811142	0.945	rs6974282	chr7:100098295	C/T	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-1.08	-6.17	-0.57	2.88e-8	Platelet count;
SKCM	cis	rs8042680	0.554	rs3803563	chr15:91531352	C/A	cg15878949	chr15:91534302	PRC1	0.59	4.94	0.49	4.33e-6	Type 2 diabetes;
SKCM	cis	rs9467773	0.620	rs1490488	chr6:26614808	T/C	cg09904177	chr6:26538194	HMGN4	0.58	5.01	0.49	3.28e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1153858	1.000	rs59889118	chr15:45618730	G/A	cg10760299	chr15:45669010	GATM	0.56	5.45	0.53	5.66e-7	Homoarginine levels;
SKCM	cis	rs7215564	0.908	rs74002838	chr17:78682157	C/T	cg16980736	chr17:78789706	RPTOR	-0.88	-4.83	-0.48	6.66e-6	Myopia (pathological);
SKCM	cis	rs6088590	1.000	rs6120748	chr20:33458284	T/G	cg24642439	chr20:33292090	TP53INP2	0.98	6.92	0.62	1.11e-9	Coronary artery disease;
SKCM	cis	rs10911232	0.524	rs4652773	chr1:183054827	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.78	6.87	0.61	1.42e-9	Hypertriglyceridemia;
SKCM	cis	rs9916302	0.706	rs2879259	chr17:37410892	C/G	cg07936489	chr17:37558343	FBXL20	-0.98	-6.58	-0.6	4.83e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs7824557	0.602	rs11784544	chr8:11204503	G/C	cg21775007	chr8:11205619	TDH	0.71	6.31	0.58	1.57e-8	Retinal vascular caliber;
SKCM	cis	rs12451471	0.529	rs2278620	chr17:78083565	G/A	cg06718696	chr17:78121285	EIF4A3	0.92	6.26	0.58	1.96e-8	Plateletcrit;Mean corpuscular hemoglobin concentration;
SKCM	trans	rs3780486	0.846	rs10124479	chr9:33136233	T/G	cg20290983	chr6:43655470	MRPS18A	1.0	11.51	0.79	1.75e-18	IgG glycosylation;
SKCM	cis	rs7523273	0.526	rs2724394	chr1:208017072	T/A	cg22525895	chr1:207977042	MIR29B2	-0.83	-6.87	-0.61	1.42e-9	Schizophrenia;
SKCM	cis	rs3820068	0.581	rs3940061	chr1:15941276	C/T	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs453301	0.686	rs3989373	chr8:8911308	G/T	cg15556689	chr8:8085844	FLJ10661	-0.65	-4.94	-0.49	4.34e-6	Joint mobility (Beighton score);
SKCM	cis	rs3785574	0.927	rs2854160	chr17:61977248	C/T	cg11494091	chr17:61959527	GH2	0.55	5.17	0.51	1.77e-6	Height;
SKCM	cis	rs6089829	0.962	rs6011548	chr20:61666063	C/T	cg08564027	chr20:61660810	NA	0.63	5.64	0.54	2.64e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs860295	0.702	rs12239100	chr1:155428476	C/A	cg02153340	chr1:155202674	NA	-0.8	-5.68	-0.54	2.2e-7	Body mass index;
SKCM	cis	rs910316	1.000	rs175443	chr14:75601963	C/T	cg08847533	chr14:75593920	NEK9	-0.96	-8.88	-0.71	1.88e-13	Height;
SKCM	cis	rs10256972	0.621	rs2363285	chr7:1091644	C/T	cg16145915	chr7:1198662	ZFAND2A	-0.49	-6.67	-0.6	3.29e-9	Longevity;Endometriosis;
SKCM	cis	rs28595532	1.000	rs73842212	chr4:119638122	A/G	cg14228332	chr4:119757509	SEC24D	0.97	4.92	0.49	4.71e-6	Cannabis dependence symptom count;
SKCM	cis	rs1005277	0.579	rs2505198	chr10:38393183	A/C	cg00409905	chr10:38381863	ZNF37A	-0.64	-6.18	-0.57	2.68e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs2013441	1.000	rs2526467	chr17:20165054	T/A	cg13482628	chr17:19912719	NA	-0.64	-5.04	-0.5	2.94e-6	Obesity-related traits;
SKCM	cis	rs2839186	0.619	rs55689527	chr21:47622727	A/G	cg05896524	chr21:47604654	C21orf56	0.73	6.14	0.57	3.26e-8	Testicular germ cell tumor;
SKCM	cis	rs1401999	0.966	rs4148585	chr3:183670642	A/G	cg01324343	chr3:183735012	ABCC5	0.93	10.78	0.77	4.03e-17	Anterior chamber depth;
SKCM	cis	rs3087591	1.000	rs2952982	chr17:29470646	A/C	cg24425628	chr17:29625626	OMG;NF1	0.64	5.21	0.51	1.49e-6	Hip circumference;
SKCM	cis	rs28830936	0.510	rs11070349	chr15:42085017	A/C	cg17847044	chr15:42102381	MAPKBP1	-0.43	-5.51	-0.53	4.41e-7	Diastolic blood pressure;
SKCM	cis	rs910316	1.000	rs13099	chr14:75599155	G/A	cg08847533	chr14:75593920	NEK9	-0.96	-8.88	-0.71	1.88e-13	Height;
SKCM	cis	rs2386661	0.547	rs57893347	chr10:5646191	G/A	cg12223502	chr10:5658492	NA	-0.54	-5.09	-0.5	2.38e-6	Breast cancer;
SKCM	cis	rs2239547	0.618	rs4687663	chr3:52870618	T/A	cg11645453	chr3:52864694	ITIH4	0.79	7.19	0.63	3.41e-10	Schizophrenia;
SKCM	cis	rs7666738	0.830	rs60411337	chr4:99046617	T/C	cg05340658	chr4:99064831	C4orf37	0.65	4.93	0.49	4.52e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6121246	0.697	rs45557936	chr20:30226690	G/A	cg11595048	chr20:30225325	COX4I2	0.63	4.94	0.49	4.31e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs8141529	0.764	rs5752812	chr22:29225603	T/A	cg02153584	chr22:29168773	CCDC117	0.62	5.02	0.49	3.15e-6	Lymphocyte counts;
SKCM	cis	rs1801251	1.000	rs6761324	chr2:233582793	T/G	cg25237894	chr2:233734115	C2orf82	0.61	5.66	0.54	2.39e-7	Coronary artery disease;
SKCM	cis	rs1348850	0.561	rs1838890	chr2:178410938	C/A	cg27490568	chr2:178487706	NA	0.84	5.63	0.54	2.69e-7	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs9910055	0.607	rs13726	chr17:42239561	C/T	cg10896456	chr17:42255109	ASB16;C17orf65	0.65	6.32	0.58	1.49e-8	Total body bone mineral density;
SKCM	cis	rs7092929	0.883	rs651750	chr10:3577178	A/G	cg14308648	chr10:3568949	NA	0.72	4.81	0.48	7.12e-6	Coronary artery calcification;
SKCM	cis	rs2153535	0.580	rs9406161	chr6:8466144	G/T	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs2243480	1.000	rs1499614	chr7:65730798	A/T	cg07424592	chr7:64974309	NA	0.95	4.84	0.48	6.37e-6	Diabetic kidney disease;
SKCM	cis	rs3091242	0.933	rs909833	chr1:25754140	C/G	cg02931644	chr1:25747376	RHCE	0.53	5.35	0.52	8.54e-7	Erythrocyte sedimentation rate;
SKCM	cis	rs16854884	0.739	rs1898265	chr3:143776096	A/G	cg06585982	chr3:143692056	C3orf58	-0.77	-6.51	-0.59	6.75e-9	Economic and political preferences (feminism/equality);
SKCM	cis	rs2120019	1.000	rs34237279	chr15:75361121	A/G	cg17294928	chr15:75287854	SCAMP5	-0.83	-7.08	-0.63	5.44e-10	Blood trace element (Zn levels);
SKCM	cis	rs870825	0.616	rs4610378	chr4:185624220	C/T	cg04058563	chr4:185651563	MLF1IP	-0.94	-7.21	-0.63	3.2e-10	Blood protein levels;
SKCM	cis	rs7772486	0.686	rs1337839	chr6:146010239	A/G	cg05347473	chr6:146136440	FBXO30	-0.6	-5.27	-0.51	1.16e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7647973	0.580	rs12629759	chr3:49237394	T/C	cg06212747	chr3:49208901	KLHDC8B	0.75	5.27	0.51	1.17e-6	Menarche (age at onset);
SKCM	cis	rs7399018	0.739	rs7953955	chr12:51608467	A/G	cg25754956	chr12:51612065	POU6F1	0.91	7.53	0.65	7.58e-11	Cisplatin-induced ototoxicity;
SKCM	cis	rs4888262	0.545	rs8052923	chr16:74680105	C/T	cg01733217	chr16:74700730	RFWD3	0.88	7.49	0.65	9.15e-11	Testicular germ cell tumor;
SKCM	cis	rs28386778	0.897	rs2584610	chr17:61934783	T/C	cg01411255	chr17:61851458	DDX42;CCDC47	0.78	5.03	0.49	3.06e-6	Prudent dietary pattern;
SKCM	trans	rs8073060	0.586	rs72828038	chr17:33893908	C/A	cg19694781	chr19:47549865	TMEM160	1.08	8.73	0.7	3.66e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs951366	0.617	rs9438393	chr1:205782718	A/G	cg07157834	chr1:205819609	PM20D1	0.92	10.72	0.77	5.29e-17	Menarche (age at onset);
SKCM	trans	rs9929218	0.551	rs2296408	chr16:68713823	A/C	cg04657470	chr2:198365150	HSPE1;HSPD1	-0.93	-10.27	-0.76	3.87e-16	Colorectal cancer;
SKCM	cis	rs2075371	0.966	rs2544214	chr7:133985736	G/A	cg20476274	chr7:133979776	SLC35B4	1.01	10.44	0.76	1.77e-16	Mean platelet volume;
SKCM	cis	rs1059312	0.966	rs35907548	chr12:129282180	T/C	cg09035930	chr12:129282057	SLC15A4	0.81	8.93	0.71	1.45e-13	Systemic lupus erythematosus;
SKCM	cis	rs8180040	0.934	rs12630641	chr3:47534836	G/T	cg27129171	chr3:47204927	SETD2	0.79	5.79	0.55	1.43e-7	Colorectal cancer;
SKCM	cis	rs6430585	0.528	rs660002	chr2:136723504	C/T	cg07169764	chr2:136633963	MCM6	1.26	10.94	0.78	2.04e-17	Corneal structure;
SKCM	cis	rs7772486	0.754	rs6922507	chr6:146250155	A/T	cg23711669	chr6:146136114	FBXO30	-0.75	-7.24	-0.63	2.71e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7927771	0.864	rs3781625	chr11:47443080	T/C	cg01152729	chr11:47593274	PTPMT1	-0.51	-4.88	-0.48	5.49e-6	Subjective well-being;
SKCM	cis	rs155076	1.000	rs261432	chr13:21865915	G/C	cg11317459	chr13:21872234	NA	-1.33	-7.9	-0.67	1.49e-11	White matter hyperintensity burden;
SKCM	cis	rs4481887	0.927	rs4336885	chr1:248473168	A/C	cg00666640	chr1:248458726	OR2T12	0.66	6.0	0.56	5.9e-8	Common traits (Other);
SKCM	cis	rs7666738	0.830	rs6827516	chr4:98971740	T/C	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6951245	1.000	rs113575110	chr7:1084394	G/A	cg24642844	chr7:1081250	C7orf50	-0.94	-6.32	-0.58	1.48e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7666738	0.861	rs28829607	chr4:98964325	G/C	cg05340658	chr4:99064831	C4orf37	0.64	4.91	0.49	4.97e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs769267	1.000	rs8103197	chr19:19443466	C/T	cg03709012	chr19:19516395	GATAD2A	-0.84	-7.03	-0.62	7.02e-10	Tonsillectomy;
SKCM	cis	rs1577917	0.958	rs1335442	chr6:86466692	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.67	-5.74	-0.54	1.73e-7	Response to antipsychotic treatment;
SKCM	cis	rs3793683	0.597	rs12783367	chr10:134587334	T/C	cg27286337	chr10:134555280	INPP5A	0.97	8.94	0.71	1.4e-13	Migraine;
SKCM	cis	rs7296418	0.961	rs4275659	chr12:123447928	C/T	cg05973401	chr12:123451056	ABCB9	-0.86	-7.03	-0.62	6.83e-10	Platelet count;
SKCM	cis	rs10808739	0.660	rs35506467	chr8:65654193	A/C	cg05711235	chr8:65498612	NA	-0.81	-5.4	-0.52	7.01e-7	HIV-1 susceptibility;
SKCM	cis	rs12824058	0.831	rs11060825	chr12:130807905	A/G	cg26677194	chr12:130822605	PIWIL1	0.69	5.65	0.54	2.47e-7	Menopause (age at onset);
SKCM	cis	rs2050392	0.894	rs303430	chr10:30706235	C/A	cg25182066	chr10:30743637	MAP3K8	-0.69	-5.58	-0.53	3.41e-7	Inflammatory bowel disease;
SKCM	cis	rs9640161	0.830	rs36069544	chr7:150061538	G/A	cg10018233	chr7:150070692	REPIN1	0.73	6.44	0.59	8.89e-9	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs10769945	0.679	rs217213	chr11:1979118	C/G	cg23202291	chr11:1979235	NA	-0.68	-6.55	-0.6	5.55e-9	DNA methylation (variation);
SKCM	cis	rs10500871	1.000	rs11025431	chr11:20216040	T/G	cg04653710	chr11:19367236	NA	0.58	5.02	0.49	3.16e-6	Educational attainment;
SKCM	cis	rs7772486	0.686	rs9390349	chr6:146054430	T/G	cg23711669	chr6:146136114	FBXO30	-0.8	-7.72	-0.66	3.35e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs60871478	0.645	rs111968669	chr7:856683	C/T	cg05535760	chr7:792225	HEATR2	-0.8	-5.95	-0.56	7.28e-8	Cerebrospinal P-tau181p levels;
SKCM	cis	rs1799949	1.000	rs4792981	chr17:41308274	A/G	cg23758822	chr17:41437982	NA	0.92	7.83	0.66	1.97e-11	Menopause (age at onset);
SKCM	cis	rs9937943	0.673	rs12922972	chr16:74494522	T/A	cg01733217	chr16:74700730	RFWD3	0.95	5.04	0.5	3e-6	Neutrophil percentage of white cells;
SKCM	cis	rs1799949	1.000	rs1545764	chr17:41424565	G/A	cg23758822	chr17:41437982	NA	0.93	7.88	0.67	1.62e-11	Menopause (age at onset);
SKCM	cis	rs875971	0.638	rs10278816	chr7:66036987	T/C	cg11987759	chr7:65425863	GUSB	0.69	5.9	0.56	8.74e-8	Aortic root size;
SKCM	cis	rs6570726	0.935	rs377130	chr6:145836632	C/T	cg23711669	chr6:146136114	FBXO30	0.7	6.55	0.6	5.53e-9	Lobe attachment (rater-scored or self-reported);
SKCM	trans	rs208520	0.690	rs74707865	chr6:66717352	A/G	cg15611600	chr13:45563400	KIAA1704;NUFIP1	0.91	7.45	0.64	1.1e-10	Exhaled nitric oxide output;
SKCM	cis	rs12458462	1.000	rs12458462	chr18:77472436	C/A	cg11879182	chr18:77439856	CTDP1	0.9	7.16	0.63	3.88e-10	Monocyte count;
SKCM	cis	rs9300255	0.544	rs1790123	chr12:123659542	C/T	cg05973401	chr12:123451056	ABCB9	0.81	4.98	0.49	3.78e-6	Neutrophil percentage of white cells;
SKCM	cis	rs2739330	0.828	rs4820572	chr22:24250355	T/C	cg24846343	chr22:24311635	DDTL	0.63	5.97	0.56	6.5e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs6087990	0.865	rs6058859	chr20:31335157	A/G	cg13636640	chr20:31349939	DNMT3B	0.9	7.15	0.63	4.07e-10	Ulcerative colitis;
SKCM	cis	rs1046896	0.627	rs7225515	chr17:80795783	C/T	cg22027946	chr17:80790580	TBCD;ZNF750	0.7	5.29	0.51	1.08e-6	Glycated hemoglobin levels;
SKCM	cis	rs2072499	0.966	rs2853643	chr1:156184831	G/A	cg25208724	chr1:156163844	SLC25A44	1.0	8.52	0.69	9.03e-13	Testicular germ cell tumor;
SKCM	cis	rs11608355	0.618	rs2075435	chr12:109796832	C/T	cg19025524	chr12:109796872	NA	-0.69	-5.96	-0.56	6.81e-8	Neuroticism;
SKCM	cis	rs9311474	0.508	rs7614498	chr3:52618941	A/T	cg18404041	chr3:52824283	ITIH1	-0.53	-4.77	-0.48	8.42e-6	Electroencephalogram traits;
SKCM	cis	rs709400	0.628	rs12889639	chr14:103860206	G/A	cg26031613	chr14:104095156	KLC1	-0.75	-5.74	-0.54	1.75e-7	Body mass index;
SKCM	cis	rs7143963	0.636	rs7146581	chr14:103301072	C/T	cg23020514	chr14:103360112	TRAF3	0.73	6.9	0.62	1.23e-9	Body mass index;
SKCM	cis	rs597539	0.616	rs72945243	chr11:68633358	T/C	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.84	5.71	0.54	1.96e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs3213545	0.659	rs2259690	chr12:121457914	T/G	cg15155738	chr12:121454335	C12orf43	0.72	5.62	0.54	2.85e-7	Subjective well-being;Cardiovascular disease risk factors;
SKCM	trans	rs208520	0.690	rs7739253	chr6:66861052	A/G	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-1.07	-8.14	-0.68	5.03e-12	Exhaled nitric oxide output;
SKCM	cis	rs56104184	1.000	rs56104184	chr19:49370310	C/T	cg15549821	chr19:49342101	PLEKHA4	-0.87	-5.85	-0.55	1.07e-7	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs3768617	0.528	rs2027082	chr1:183084608	C/A	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs9420	0.884	rs589914	chr11:57661032	A/G	cg19752551	chr11:57585705	CTNND1	0.72	7.52	0.65	8.04e-11	Schizophrenia;
SKCM	cis	rs4132509	0.793	rs10927047	chr1:243803677	A/T	cg21452805	chr1:244014465	NA	0.92	5.89	0.56	9.15e-8	RR interval (heart rate);
SKCM	cis	rs35306767	0.953	rs7908138	chr10:962978	C/T	cg20503657	chr10:835505	NA	0.65	4.94	0.49	4.37e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs6089584	0.507	rs6061989	chr20:60627893	C/T	cg06108461	chr20:60628389	TAF4	-0.79	-7.45	-0.64	1.08e-10	Body mass index;
SKCM	cis	rs10504229	0.639	rs35527749	chr8:58128077	G/T	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs9790314	0.690	rs1599390	chr3:160833246	A/G	cg03342759	chr3:160939853	NMD3	-0.69	-6.9	-0.62	1.22e-9	Morning vs. evening chronotype;
SKCM	cis	rs2153535	0.580	rs986060	chr6:8465428	T/C	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs9394841	0.667	rs10807268	chr6:41777591	A/T	cg08135965	chr6:41755394	TOMM6	0.76	5.12	0.5	2.16e-6	Mean corpuscular hemoglobin;Red cell distribution width;
SKCM	cis	rs6582630	0.502	rs8186661	chr12:38380781	G/A	cg26384229	chr12:38710491	ALG10B	0.88	6.86	0.61	1.46e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs3784262	0.669	rs4646559	chr15:58354258	A/G	cg12031962	chr15:58353849	ALDH1A2	-0.41	-4.82	-0.48	6.93e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs2228479	0.717	rs2286392	chr16:89809549	A/G	cg04287289	chr16:89883240	FANCA	0.89	4.92	0.49	4.64e-6	Skin colour saturation;
SKCM	cis	rs8064299	0.967	rs7420	chr17:72765215	A/G	cg25054828	chr17:72772726	NAT9;TMEM104	-0.75	-6.72	-0.61	2.71e-9	Monocyte count;
SKCM	cis	rs11585357	0.895	rs72633814	chr1:17626456	T/C	cg08277548	chr1:17600880	PADI3	-0.89	-6.31	-0.58	1.53e-8	Hair shape;
SKCM	cis	rs3892630	1.000	rs3892630	chr19:33181484	A/G	cg22980127	chr19:33182716	NUDT19	-1.37	-8.01	-0.67	8.91e-12	Red blood cell traits;
SKCM	cis	rs9987353	0.519	rs13276350	chr8:9063157	T/C	cg15556689	chr8:8085844	FLJ10661	-0.65	-5.06	-0.5	2.75e-6	Recombination measurement;
SKCM	cis	rs826838	0.651	rs12367384	chr12:38618460	G/T	cg26384229	chr12:38710491	ALG10B	0.7	5.97	0.56	6.57e-8	Heart rate;
SKCM	cis	rs7618501	0.501	rs35275715	chr3:49959148	A/G	cg24110177	chr3:50126178	RBM5	-0.71	-5.71	-0.54	1.95e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs28595532	0.920	rs115085630	chr4:119741765	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs709400	0.628	rs7154246	chr14:103876794	G/A	cg26031613	chr14:104095156	KLC1	-0.68	-4.82	-0.48	6.83e-6	Body mass index;
SKCM	cis	rs2032447	0.507	rs199741	chr6:25931577	A/G	cg18357526	chr6:26021779	HIST1H4A	0.72	5.11	0.5	2.22e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs6977660	0.941	rs4721825	chr7:19823427	A/C	cg05791153	chr7:19748676	TWISTNB	0.79	5.34	0.52	9.05e-7	Thyroid stimulating hormone;
SKCM	cis	rs59918340	0.764	rs753779	chr8:142228809	T/C	cg23750338	chr8:142222470	SLC45A4	0.62	6.11	0.57	3.74e-8	Immature fraction of reticulocytes;
SKCM	cis	rs7811142	1.000	rs60257855	chr7:100026780	G/C	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-0.99	-5.52	-0.53	4.2e-7	Platelet count;
SKCM	cis	rs2180341	0.920	rs7756880	chr6:127683999	A/T	cg27446573	chr6:127587934	RNF146	0.94	8.11	0.68	5.63e-12	Breast cancer;
SKCM	cis	rs1577917	1.000	rs12199784	chr6:86726808	C/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.63	-5.38	-0.52	7.46e-7	Response to antipsychotic treatment;
SKCM	cis	rs7666738	0.830	rs7696686	chr4:98938445	T/C	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1577917	0.958	rs11755642	chr6:86450066	A/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.84	-8.33	-0.69	2.12e-12	Response to antipsychotic treatment;
SKCM	cis	rs2075371	0.863	rs1421479	chr7:133949345	T/G	cg20476274	chr7:133979776	SLC35B4	0.96	9.42	0.73	1.67e-14	Mean platelet volume;
SKCM	cis	rs62238980	0.614	rs17744994	chr22:32413527	C/T	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs4803468	1.000	rs10417311	chr19:41902038	G/A	cg14132834	chr19:41945861	ATP5SL	-0.74	-5.71	-0.54	1.99e-7	Height;
SKCM	cis	rs12142240	0.698	rs66575205	chr1:46814092	T/G	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs10504229	0.683	rs6980540	chr8:58127022	A/G	cg02725872	chr8:58115012	NA	-0.52	-4.97	-0.49	3.92e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs1568889	0.667	rs16917914	chr11:28459909	C/T	cg06544937	chr11:28130018	METT5D1;KIF18A	0.82	5.82	0.55	1.22e-7	Bipolar disorder;
SKCM	cis	rs57221529	0.766	rs72703064	chr5:587825	T/C	cg10555297	chr5:473380	SLC9A3;LOC25845	1.01	5.03	0.49	3.1e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs17685	0.672	rs1639623	chr7:75707951	A/G	cg16489192	chr7:75678113	MDH2;STYXL1	-0.58	-5.46	-0.53	5.43e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs9300255	0.537	rs1619561	chr12:123620268	G/C	cg05973401	chr12:123451056	ABCB9	0.8	5.47	0.53	5.23e-7	Neutrophil percentage of white cells;
SKCM	cis	rs2204008	0.713	rs11173567	chr12:38089375	T/C	cg26384229	chr12:38710491	ALG10B	0.8	6.32	0.58	1.5e-8	Bladder cancer;
SKCM	cis	rs1552244	1.000	rs9849434	chr3:10133710	A/G	cg02579736	chr3:10068473	FANCD2;CIDECP	-1.23	-6.92	-0.62	1.13e-9	Alzheimer's disease;
SKCM	cis	rs826838	0.935	rs980571	chr12:39127532	C/G	cg13010199	chr12:38710504	ALG10B	-0.72	-5.73	-0.54	1.83e-7	Heart rate;
SKCM	cis	rs1005277	0.579	rs176886	chr10:38403974	C/T	cg00409905	chr10:38381863	ZNF37A	-0.66	-6.16	-0.57	3e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs28595532	0.764	rs56309519	chr4:119754158	C/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs7809950	0.953	rs28687365	chr7:107106712	A/C	cg23024343	chr7:107201750	COG5	-0.74	-6.61	-0.6	4.39e-9	Coronary artery disease;
SKCM	cis	rs2481665	0.608	rs2476194	chr1:62594593	C/T	cg18591186	chr1:62594603	INADL	-0.61	-4.91	-0.49	4.84e-6	BMI in non-smokers;BMI (adjusted for smoking behaviour);Body mass index;Body mass index (joint analysis main effects and smoking interaction);
SKCM	cis	rs7684253	0.565	rs6830774	chr4:57816306	T/C	cg25313468	chr4:57773308	REST	0.4	4.89	0.48	5.24e-6	Migraine;
SKCM	cis	rs2153535	0.580	rs1414344	chr6:8471365	C/A	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs997295	0.570	rs60066681	chr15:67808076	C/A	cg24247231	chr15:67904302	MAP2K5	-0.61	-5.03	-0.49	3.06e-6	Motion sickness;
SKCM	cis	rs6089584	0.893	rs6089306	chr20:60574868	G/A	cg06108461	chr20:60628389	TAF4	-0.83	-7.31	-0.64	1.98e-10	Body mass index;
SKCM	cis	rs1799949	0.550	rs2343818	chr17:41409774	G/A	cg05368731	chr17:41323189	NBR1	0.85	7.32	0.64	1.89e-10	Menopause (age at onset);
SKCM	cis	rs2836974	0.867	rs77959119	chr21:40542768	G/A	cg11644478	chr21:40555479	PSMG1	0.98	10.28	0.76	3.63e-16	Cognitive function;
SKCM	cis	rs67311347	0.544	rs7644643	chr3:40350209	C/T	cg00091569	chr3:40428383	ENTPD3	-0.61	-5.45	-0.53	5.72e-7	Renal cell carcinoma;
SKCM	cis	rs7811142	0.943	rs28660238	chr7:100023308	C/T	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.23	8.03	0.67	8.33e-12	Platelet count;
SKCM	cis	rs7143963	0.636	rs941589	chr14:103341056	T/C	cg23020514	chr14:103360112	TRAF3	0.74	7.04	0.62	6.58e-10	Body mass index;
SKCM	trans	rs5756813	0.661	rs5995500	chr22:38204640	A/G	cg19894588	chr14:64061835	NA	-0.89	-7.5	-0.65	8.56e-11	Optic cup area;Vertical cup-disc ratio;
SKCM	cis	rs7666738	0.830	rs6831925	chr4:98947401	T/C	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6430585	0.583	rs59243420	chr2:136584538	A/T	cg07169764	chr2:136633963	MCM6	1.31	13.22	0.83	1.29e-21	Corneal structure;
SKCM	cis	rs9660180	0.967	rs6664664	chr1:1751264	G/A	cg23982607	chr1:1823379	GNB1	-0.7	-5.97	-0.56	6.5e-8	Body mass index;
SKCM	cis	rs7811142	1.000	rs7783550	chr7:99987805	A/G	cg21679810	chr7:100027352	MEPCE;ZCWPW1	-1.25	-8.2	-0.68	3.82e-12	Platelet count;
SKCM	cis	rs6430585	0.527	rs59413285	chr2:136444185	G/T	cg07169764	chr2:136633963	MCM6	1.02	7.68	0.66	3.84e-11	Corneal structure;
SKCM	cis	rs995000	0.931	rs61471917	chr1:63084030	G/A	cg06896770	chr1:63153194	DOCK7	0.76	7.17	0.63	3.77e-10	Triglyceride levels;
SKCM	cis	rs951366	0.789	rs823097	chr1:205681370	G/A	cg14159672	chr1:205819179	PM20D1	0.83	6.66	0.6	3.4e-9	Menarche (age at onset);
SKCM	trans	rs5756813	0.688	rs13058437	chr22:38208260	G/C	cg19894588	chr14:64061835	NA	-0.89	-7.34	-0.64	1.74e-10	Optic cup area;Vertical cup-disc ratio;
SKCM	cis	rs12611334	0.964	rs8109921	chr19:40198727	G/A	cg04998674	chr19:40596855	ZNF780A	0.63	4.77	0.47	8.55e-6	Schizophrenia;
SKCM	cis	rs9815354	0.669	rs113059632	chr3:41932858	G/A	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs17345786	0.906	rs11708616	chr3:101231731	C/T	cg12386194	chr3:101231763	SENP7	0.83	6.7	0.6	2.88e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4819052	0.851	rs4819042	chr21:46660072	A/G	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.36	0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs10504229	0.683	rs6980850	chr8:58127204	A/G	cg02725872	chr8:58115012	NA	-0.52	-4.97	-0.49	3.92e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs10876993	0.890	rs2619441	chr12:58083015	C/A	cg18357645	chr12:58087776	OS9	0.65	5.97	0.56	6.61e-8	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs6952808	0.743	rs10266703	chr7:1918941	C/A	cg21782813	chr7:2030301	MAD1L1	0.53	5.53	0.53	4.04e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs1160297	0.576	rs13030509	chr2:53110287	T/A	cg07782112	chr2:53107842	NA	0.58	6.1	0.57	3.76e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs7143963	0.943	rs12586226	chr14:103251003	A/G	cg23020514	chr14:103360112	TRAF3	-0.74	-5.87	-0.55	1.02e-7	Body mass index;
SKCM	cis	rs28595532	0.920	rs116098781	chr4:119771613	G/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs9303401	0.614	rs34843288	chr17:57103140	T/C	cg10487724	chr17:56770010	TEX14;RAD51C	0.78	4.88	0.48	5.45e-6	Cognitive test performance;
SKCM	cis	rs1577917	1.000	rs1995688	chr6:86632319	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.85	-8.62	-0.7	5.82e-13	Response to antipsychotic treatment;
SKCM	cis	rs644799	0.965	rs573758	chr11:95539591	G/T	cg03916912	chr11:95522834	CEP57;FAM76B	0.92	8.04	0.67	8e-12	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs4132509	0.744	rs10927065	chr1:243914611	G/T	cg21452805	chr1:244014465	NA	0.92	5.63	0.54	2.73e-7	RR interval (heart rate);
SKCM	cis	rs9916302	0.861	rs632202	chr17:37453294	C/A	cg07936489	chr17:37558343	FBXL20	0.85	6.83	0.61	1.66e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs6062302	0.548	rs6089940	chr20:62252695	C/T	cg09650180	chr20:62225654	GMEB2	-0.78	-6.22	-0.58	2.28e-8	Glioblastoma;
SKCM	cis	rs453301	0.653	rs7005133	chr8:8901222	T/G	cg06636001	chr8:8085503	FLJ10661	0.79	6.27	0.58	1.84e-8	Joint mobility (Beighton score);
SKCM	cis	rs1799949	1.000	rs8176220	chr17:41222462	A/G	cg25918947	chr17:41365094	TMEM106A	-0.61	-5.91	-0.56	8.59e-8	Menopause (age at onset);
SKCM	cis	rs12047808	0.841	rs79370571	chr1:179404718	A/G	cg08037922	chr1:179521085	C1orf125;NPHS2	-1.08	-5.8	-0.55	1.32e-7	Multiple sclerosis (age of onset);
SKCM	cis	rs2404602	0.583	rs12592501	chr15:76554790	C/A	cg22467129	chr15:76604101	ETFA	-0.65	-5.35	-0.52	8.68e-7	Blood metabolite levels;
SKCM	cis	rs55728055	0.661	rs73162112	chr22:32045449	G/A	cg01338084	chr22:32026380	PISD	1.62	5.14	0.5	1.99e-6	Age-related hearing impairment;
SKCM	cis	rs2243480	0.901	rs778732	chr7:65822360	C/T	cg18252515	chr7:66147081	NA	-1.35	-8.04	-0.67	8e-12	Diabetic kidney disease;
SKCM	cis	rs8017423	0.967	rs2151748	chr14:90694897	G/C	cg04374321	chr14:90722782	PSMC1	0.97	8.7	0.7	4.05e-13	Mortality in heart failure;
SKCM	cis	rs362272	0.545	rs2748447	chr4:3337831	G/A	cg05297308	chr4:3317976	RGS12	1.04	12.07	0.81	1.58e-19	Serum sulfate level;
SKCM	cis	rs7811142	0.943	rs28660238	chr7:100023308	C/T	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.11	6.45	0.59	8.66e-9	Platelet count;
SKCM	cis	rs33794	0.901	rs33786	chr3:45293379	C/T	cg25630594	chr3:44914870	TGM4	0.6	5.35	0.52	8.45e-7	Lung function (forced expiratory volume in 1 second);
SKCM	cis	rs4819052	0.819	rs7279136	chr21:46692287	C/T	cg02159808	chr21:46707872	POFUT2;LOC642852	0.74	5.68	0.54	2.22e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs4072980	0.545	rs11210870	chr1:38449910	T/C	cg12658694	chr1:38397304	INPP5B	-0.73	-5.28	-0.51	1.14e-6	Coronary artery disease;
SKCM	cis	rs7666738	0.830	rs6532723	chr4:99052147	A/T	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7106204	0.513	rs7131144	chr11:24249486	A/G	ch.11.24196551F	chr11:24239977	NA	0.79	5.81	0.55	1.28e-7	Response to Homoharringtonine (cytotoxicity);
SKCM	cis	rs11719291	0.915	rs1048940	chr3:48725707	C/T	cg00383909	chr3:49044727	WDR6	1.09	4.97	0.49	3.86e-6	Cognitive function;
SKCM	cis	rs6582618	1	rs6582618	chr12:38726137	A/G	cg13010199	chr12:38710504	ALG10B	0.63	4.87	0.48	5.67e-6	Morning vs. evening chronotype;
SKCM	cis	rs611744	0.523	rs13253581	chr8:109343105	A/G	cg21045802	chr8:109455806	TTC35	0.62	4.78	0.48	8.01e-6	Dupuytren's disease;
SKCM	cis	rs801193	0.967	rs2707841	chr7:66157020	A/G	cg11764359	chr7:65958608	NA	0.86	6.6	0.6	4.52e-9	Aortic root size;
SKCM	cis	rs1160297	0.609	rs12618983	chr2:53091691	C/T	cg07782112	chr2:53107842	NA	-0.59	-6.26	-0.58	1.91e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs9926296	0.585	rs6500441	chr16:89828669	C/G	cg04287289	chr16:89883240	FANCA	1.02	12.83	0.82	6.69e-21	Vitiligo;
SKCM	cis	rs826838	1.000	rs826886	chr12:39095797	A/G	cg26384229	chr12:38710491	ALG10B	0.94	8.07	0.67	7e-12	Heart rate;
SKCM	cis	rs17376456	0.825	rs17372649	chr5:93126096	C/G	cg25358565	chr5:93447407	FAM172A	1.15	7.28	0.64	2.25e-10	Diabetic retinopathy;
SKCM	cis	rs420259	0.516	rs2369013	chr16:23496346	T/C	cg10006042	chr16:23042421	NA	-0.37	-4.91	-0.49	4.87e-6	Bipolar disorder;
SKCM	cis	rs9814567	0.896	rs6799110	chr3:134206749	T/C	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.69	-5.47	-0.53	5.15e-7	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs6570726	0.905	rs396492	chr6:145816180	C/G	cg23711669	chr6:146136114	FBXO30	0.68	6.53	0.59	6.07e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7940866	0.738	rs10791114	chr11:130889850	G/A	cg12179176	chr11:130786555	SNX19	0.72	5.25	0.51	1.26e-6	Schizophrenia;
SKCM	cis	rs2404602	0.647	rs12905181	chr15:77098431	A/G	cg23625390	chr15:77176239	SCAPER	-0.82	-7.93	-0.67	1.26e-11	Blood metabolite levels;
SKCM	cis	rs672059	0.934	rs6703054	chr1:183155778	A/C	ch.1.3577855R	chr1:183094577	LAMC1	0.6	4.93	0.49	4.52e-6	Hypertriglyceridemia;
SKCM	cis	rs10489202	1.000	rs2272911	chr1:167936302	C/T	cg24449463	chr1:168025552	DCAF6	-0.76	-5.87	-0.55	1.02e-7	Schizophrenia;
SKCM	cis	rs28386778	0.863	rs7221573	chr17:61859390	G/A	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs995000	0.868	rs6666816	chr1:63171199	C/T	cg06896770	chr1:63153194	DOCK7	-0.77	-6.8	-0.61	1.9e-9	Triglyceride levels;
SKCM	cis	rs6665290	0.566	rs1513617	chr1:227447213	C/T	cg10327440	chr1:227177885	CDC42BPA	1.18	10.11	0.75	7.74e-16	Myeloid white cell count;
SKCM	cis	rs9868809	0.505	rs11708786	chr3:48752654	C/T	cg00383909	chr3:49044727	WDR6	0.84	5.05	0.5	2.87e-6	Ulcerative colitis;Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs4975616	0.804	rs456366	chr5:1337070	T/C	cg07493874	chr5:1342172	CLPTM1L	-0.7	-6.57	-0.6	5.12e-9	Lung cancer;
SKCM	cis	rs28595532	0.920	rs55794497	chr4:119764664	A/G	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs6580649	0.941	rs7963934	chr12:48477086	C/G	cg05342945	chr12:48394962	COL2A1	0.81	5.59	0.54	3.16e-7	Lung cancer;
SKCM	cis	rs6952808	0.609	rs12699453	chr7:1953056	C/T	cg02951883	chr7:2050386	MAD1L1	-0.66	-5.58	-0.53	3.29e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs10504073	0.647	rs341807	chr8:50032676	C/T	cg00325661	chr8:49890786	NA	0.8	6.91	0.62	1.16e-9	Blood metabolite ratios;
SKCM	cis	rs7215564	0.908	rs9972968	chr17:78652569	T/C	cg16980736	chr17:78789706	RPTOR	-0.91	-4.92	-0.49	4.67e-6	Myopia (pathological);
SKCM	cis	rs995000	0.931	rs10889354	chr1:63129082	T/C	cg06896770	chr1:63153194	DOCK7	0.94	8.99	0.71	1.12e-13	Triglyceride levels;
SKCM	cis	rs6547631	0.622	rs4240202	chr2:85925680	T/G	cg24620635	chr2:85921963	GNLY	0.9	6.65	0.6	3.58e-9	Blood protein levels;
SKCM	cis	rs2404602	0.647	rs116090606	chr15:77075209	A/G	cg23625390	chr15:77176239	SCAPER	-0.82	-7.93	-0.67	1.26e-11	Blood metabolite levels;
SKCM	cis	rs4727027	0.899	rs11768971	chr7:148825826	C/G	cg23583168	chr7:148888333	NA	-0.82	-6.56	-0.6	5.29e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs6430585	0.591	rs61187091	chr2:136468238	G/A	cg07169764	chr2:136633963	MCM6	1.15	8.57	0.7	7.33e-13	Corneal structure;
SKCM	cis	rs34779708	0.898	rs11595898	chr10:35326263	T/C	cg03585969	chr10:35415529	CREM	0.75	6.23	0.58	2.2e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs748404	0.660	rs2439846	chr15:43740970	G/A	cg02155558	chr15:43621948	ADAL;LCMT2	0.73	5.93	0.56	7.91e-8	Lung cancer;
SKCM	cis	rs1799949	0.930	rs35292991	chr17:41334016	C/A	cg05368731	chr17:41323189	NBR1	0.87	7.74	0.66	3.01e-11	Menopause (age at onset);
SKCM	trans	rs1814175	0.645	rs10128731	chr11:50023554	G/T	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs34779708	0.931	rs10466072	chr10:35402756	C/T	cg03585969	chr10:35415529	CREM	0.8	6.32	0.58	1.5e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs6977660	1.000	rs13233821	chr7:19813637	A/C	cg05791153	chr7:19748676	TWISTNB	0.79	5.53	0.53	4.14e-7	Thyroid stimulating hormone;
SKCM	cis	rs703842	1.000	rs11172344	chr12:58193448	T/C	cg04478727	chr12:58166393	METTL1;FAM119B	0.72	5.87	0.55	1.02e-7	Multiple sclerosis;
SKCM	cis	rs1348850	0.574	rs12988366	chr2:178417945	A/C	cg27490568	chr2:178487706	NA	-0.83	-5.67	-0.54	2.3e-7	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs2204008	0.775	rs12369238	chr12:38176051	A/G	cg13010199	chr12:38710504	ALG10B	0.65	5.11	0.5	2.19e-6	Bladder cancer;
SKCM	cis	rs10089	1.000	rs4836367	chr5:127482592	A/G	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.9	8.98	0.71	1.17e-13	Ileal carcinoids;
SKCM	cis	rs4774899	0.966	rs12898327	chr15:57363937	G/T	cg01857019	chr15:57210107	LOC145783;TCF12	0.53	4.97	0.49	3.86e-6	Urinary tract infection frequency;
SKCM	cis	rs55962025	0.846	rs16843836	chr4:3113337	G/A	cg09735869	chr4:3319127	RGS12	-0.66	-4.97	-0.49	3.9e-6	Parental longevity (mother's age at death);
SKCM	cis	rs9916302	0.904	rs588193	chr17:37440439	A/C	cg07936489	chr17:37558343	FBXL20	0.84	6.96	0.62	9.48e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs8067354	0.645	rs2665403	chr17:57889985	G/A	cg02344993	chr17:57696989	CLTC	0.67	4.79	0.48	7.85e-6	Hemoglobin concentration;
SKCM	cis	rs17685	0.535	rs41299460	chr7:75600951	G/A	cg01364799	chr7:75623366	TMEM120A	-0.81	-5.67	-0.54	2.3e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1218582	0.688	rs2135219	chr1:154857217	G/A	cg24250549	chr1:154909240	PMVK	0.81	7.58	0.65	6.17e-11	Prostate cancer;
SKCM	cis	rs10911232	0.507	rs3934578	chr1:183027216	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.77	6.89	0.62	1.27e-9	Hypertriglyceridemia;
SKCM	cis	rs1692580	0.807	rs10910036	chr1:2183754	C/G	cg24578937	chr1:2090814	PRKCZ	0.47	5.16	0.5	1.81e-6	Coronary artery disease;
SKCM	cis	rs2721195	0.967	rs1985022	chr8:145684031	C/T	cg11211951	chr8:145729740	GPT	0.66	6.26	0.58	1.93e-8	Age at first birth;
SKCM	cis	rs2836974	0.932	rs2836955	chr21:40619887	G/A	cg11644478	chr21:40555479	PSMG1	0.97	10.08	0.75	8.76e-16	Cognitive function;
SKCM	cis	rs735396	0.595	rs2258287	chr12:121454313	G/T	cg15155738	chr12:121454335	C12orf43	0.67	5.12	0.5	2.18e-6	N-glycan levels;
SKCM	cis	rs12142240	0.698	rs17413694	chr1:46818416	A/C	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs7811142	1.000	rs6975514	chr7:100056220	T/C	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-0.99	-5.52	-0.53	4.2e-7	Platelet count;
SKCM	cis	rs60871478	1.000	rs12531530	chr7:827366	T/C	cg05535760	chr7:792225	HEATR2	1.17	10.16	0.75	6.17e-16	Cerebrospinal P-tau181p levels;
SKCM	cis	rs1451375	0.794	rs11238133	chr7:50542914	A/C	cg18232548	chr7:50535776	DDC	-0.69	-5.17	-0.51	1.75e-6	Malaria;
SKCM	cis	rs11249608	0.548	rs7732719	chr5:178463054	A/G	cg21905437	chr5:178450457	ZNF879	0.71	5.45	0.53	5.65e-7	Pubertal anthropometrics;
SKCM	cis	rs6474412	0.581	rs892413	chr8:42614378	A/C	cg11207534	chr8:41686438	ANK1	0.77	4.92	0.49	4.78e-6	Smoking behavior;
SKCM	cis	rs1577917	0.958	rs12209668	chr6:86566517	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.81	-7.82	-0.66	2.07e-11	Response to antipsychotic treatment;
SKCM	cis	rs4689592	0.546	rs10937782	chr4:7057106	G/C	cg19539972	chr4:7069911	GRPEL1	0.99	6.99	0.62	8.37e-10	Monocyte percentage of white cells;
SKCM	cis	rs1160297	0.544	rs10173886	chr2:53094788	T/C	cg07782112	chr2:53107842	NA	0.58	6.04	0.56	5e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs2033711	0.870	rs7409473	chr19:58939165	A/G	cg03735888	chr19:58951602	ZNF132	0.7	6.08	0.57	4.23e-8	Uric acid clearance;
SKCM	cis	rs28386778	0.897	rs10221279	chr17:61806138	A/G	cg06873352	chr17:61820015	STRADA	0.75	6.24	0.58	2.1e-8	Prudent dietary pattern;
SKCM	cis	rs763014	0.932	rs2269559	chr16:682297	T/C	cg07343612	chr16:622815	PIGQ	-0.67	-5.2	-0.51	1.58e-6	Height;
SKCM	cis	rs17685	0.753	rs6465000	chr7:75787417	G/A	cg16489192	chr7:75678113	MDH2;STYXL1	-0.56	-5.23	-0.51	1.36e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs4555082	0.834	rs2735822	chr14:105712734	C/T	cg13114125	chr14:105738426	BRF1	-0.69	-5.7	-0.54	2.07e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs2841277	0.771	rs2819469	chr14:105394859	G/A	cg19901468	chr14:105411992	AHNAK2	0.94	7.37	0.64	1.53e-10	Rheumatoid arthritis;
SKCM	cis	rs9290877	0.667	rs9816134	chr3:188462321	T/G	cg17392043	chr3:188495102	LPP	-0.66	-5.23	-0.51	1.37e-6	IgE levels;
SKCM	cis	rs10504073	0.584	rs7820270	chr8:49971395	G/T	cg00325661	chr8:49890786	NA	0.8	6.81	0.61	1.83e-9	Blood metabolite ratios;
SKCM	cis	rs9300255	0.620	rs7313483	chr12:123726834	C/T	cg00376283	chr12:123451042	ABCB9	0.87	6.06	0.57	4.57e-8	Neutrophil percentage of white cells;
SKCM	cis	rs4975616	0.839	rs2447853	chr5:1333077	A/G	cg26373071	chr5:1325741	CLPTM1L	0.74	6.99	0.62	8.19e-10	Lung cancer;
SKCM	cis	rs7843479	0.601	rs4422769	chr8:21844265	A/G	cg17168535	chr8:21777572	XPO7	0.82	7.95	0.67	1.17e-11	Mean corpuscular volume;
SKCM	cis	rs2243480	1.000	rs313820	chr7:65574466	A/C	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs7336332	0.547	rs9581859	chr13:28035147	A/T	cg22138327	chr13:27999177	GTF3A	0.93	6.24	0.58	2.1e-8	Weight;
SKCM	cis	rs3892630	0.817	rs35408716	chr19:33187961	A/C	cg22980127	chr19:33182716	NUDT19	1.39	8.08	0.67	6.68e-12	Red blood cell traits;
SKCM	cis	rs870825	0.860	rs72703526	chr4:185605676	A/T	cg04058563	chr4:185651563	MLF1IP	1.04	5.96	0.56	7.02e-8	Blood protein levels;
SKCM	cis	rs9303401	0.659	rs62083436	chr17:57031742	G/A	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.35	0.52	8.54e-7	Cognitive test performance;
SKCM	cis	rs2033711	0.870	rs1465789	chr19:58946056	C/T	cg03735888	chr19:58951602	ZNF132	0.68	5.75	0.55	1.63e-7	Uric acid clearance;
SKCM	cis	rs116095464	0.614	rs10067482	chr5:219328	T/G	cg22857025	chr5:266934	NA	-1.36	-8.0	-0.67	9.23e-12	Breast cancer;
SKCM	cis	rs854765	0.583	rs5002487	chr17:17832460	A/G	cg04398451	chr17:18023971	MYO15A	-0.8	-5.73	-0.54	1.78e-7	Total body bone mineral density;
SKCM	cis	rs4481887	0.927	rs28524655	chr1:248474331	C/T	cg00666640	chr1:248458726	OR2T12	0.63	5.91	0.56	8.65e-8	Common traits (Other);
SKCM	cis	rs3793683	0.597	rs2182620	chr10:134590715	C/T	cg26818010	chr10:134567672	INPP5A	-0.72	-5.42	-0.52	6.55e-7	Migraine;
SKCM	cis	rs9790314	0.846	rs9809522	chr3:160983768	G/C	cg03342759	chr3:160939853	NMD3	-0.72	-8.12	-0.68	5.59e-12	Morning vs. evening chronotype;
SKCM	cis	rs34779708	0.966	rs7913615	chr10:35422957	T/G	cg03585969	chr10:35415529	CREM	0.78	6.2	0.57	2.53e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs1577917	1.000	rs36096931	chr6:86693134	T/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.83	-8.23	-0.68	3.37e-12	Response to antipsychotic treatment;
SKCM	cis	rs854765	0.583	rs8065563	chr17:17782404	A/G	cg04398451	chr17:18023971	MYO15A	-0.8	-5.56	-0.53	3.62e-7	Total body bone mineral density;
SKCM	cis	rs992157	0.804	rs6758540	chr2:219138625	A/G	cg20019365	chr2:219134978	PNKD;AAMP	-0.74	-6.22	-0.58	2.28e-8	Colorectal cancer;
SKCM	cis	rs10089	0.951	rs56066100	chr5:127460571	G/C	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.91	8.89	0.71	1.79e-13	Ileal carcinoids;
SKCM	cis	rs589448	0.934	rs554591	chr12:69753847	T/C	cg14784868	chr12:69753453	YEATS4	0.84	7.65	0.65	4.54e-11	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs12478296	0.892	rs11897561	chr2:243014976	C/A	cg06360820	chr2:242988706	NA	-0.94	-5.68	-0.54	2.21e-7	Obesity-related traits;
SKCM	cis	rs12971120	0.891	rs3794955	chr18:72174827	C/T	cg26446133	chr18:72167187	CNDP2	-0.68	-5.34	-0.52	8.81e-7	Refractive error;
SKCM	cis	rs11148252	0.553	rs9536236	chr13:53255012	T/A	cg00495681	chr13:53174319	NA	0.68	5.67	0.54	2.29e-7	Lewy body disease;
SKCM	cis	rs72792276	1.000	rs3805603	chr5:127451581	C/T	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.78	5.24	0.51	1.35e-6	Red cell distribution width;
SKCM	cis	rs7208859	0.623	rs56018041	chr17:29059985	G/A	cg14067834	chr17:29058358	SUZ12P	1.19	5.71	0.54	1.94e-7	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	trans	rs877282	0.945	rs10904554	chr10:786768	T/C	cg22713356	chr15:30763199	NA	1.35	7.57	0.65	6.52e-11	Uric acid levels;
SKCM	cis	rs748404	0.690	rs1079309	chr15:43783164	C/A	cg02155558	chr15:43621948	ADAL;LCMT2	0.74	5.54	0.53	3.97e-7	Lung cancer;
SKCM	cis	rs28386778	0.830	rs2597637	chr17:61875066	T/G	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs2739330	0.731	rs5751792	chr22:24401542	G/A	cg04234412	chr22:24373322	LOC391322	-0.81	-7.78	-0.66	2.47e-11	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs8141529	0.732	rs2347447	chr22:29179739	C/A	cg02153584	chr22:29168773	CCDC117	0.68	5.57	0.53	3.52e-7	Lymphocyte counts;
SKCM	cis	rs9300255	0.602	rs1790116	chr12:123618544	G/T	cg05973401	chr12:123451056	ABCB9	0.81	5.57	0.53	3.45e-7	Neutrophil percentage of white cells;
SKCM	cis	rs6088590	1.000	rs2076668	chr20:33437621	G/A	cg24642439	chr20:33292090	TP53INP2	1.0	7.11	0.63	4.79e-10	Coronary artery disease;
SKCM	cis	rs17376456	0.877	rs10050465	chr5:93349963	C/A	cg21475434	chr5:93447410	FAM172A	0.95	5.36	0.52	8.36e-7	Diabetic retinopathy;
SKCM	cis	rs8067545	0.750	rs11867585	chr17:19992607	A/G	cg13482628	chr17:19912719	NA	0.72	6.32	0.58	1.51e-8	Schizophrenia;
SKCM	cis	rs28386778	0.863	rs2597633	chr17:61872871	T/C	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs2760061	0.626	rs2796057	chr1:228124414	G/C	cg02753203	chr1:228287806	NA	-0.62	-5.07	-0.5	2.64e-6	Diastolic blood pressure;
SKCM	cis	rs10193935	0.901	rs62142599	chr2:42548935	G/A	cg27598129	chr2:42591480	NA	-0.89	-6.82	-0.61	1.74e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9902453	0.904	rs4461132	chr17:28423430	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.79	6.04	0.56	5.02e-8	Coffee consumption (cups per day);
SKCM	cis	rs7772486	0.754	rs1415747	chr6:146077249	A/G	cg05347473	chr6:146136440	FBXO30	0.61	5.52	0.53	4.32e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs10089	1.000	rs6595806	chr5:127499764	A/T	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.86	7.85	0.66	1.85e-11	Ileal carcinoids;
SKCM	cis	rs8072100	0.667	rs1912485	chr17:45515678	T/G	cg08085267	chr17:45401833	C17orf57	-0.62	-5.06	-0.5	2.76e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs1153858	1.000	rs56850226	chr15:45633118	T/C	cg10760299	chr15:45669010	GATM	0.58	6.04	0.56	4.83e-8	Homoarginine levels;
SKCM	cis	rs4780401	0.609	rs11639945	chr16:11824056	T/G	cg01061890	chr16:11836724	TXNDC11	-0.8	-6.08	-0.57	4.09e-8	Rheumatoid arthritis;
SKCM	cis	rs1799949	1.000	rs12951869	chr17:41187567	T/G	cg25918947	chr17:41365094	TMEM106A	-0.61	-5.87	-0.55	1e-7	Menopause (age at onset);
SKCM	trans	rs1814175	0.616	rs10839349	chr11:49753748	C/A	cg15704280	chr7:45808275	SEPT13	-1.01	-9.85	-0.74	2.46e-15	Height;
SKCM	trans	rs1814175	0.817	rs7109440	chr11:49966296	C/T	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs9309711	0.621	rs7586472	chr2:3473670	G/A	cg15506890	chr2:3487001	NA	-0.6	-4.94	-0.49	4.43e-6	Neurofibrillary tangles;
SKCM	cis	rs477895	1.000	rs2286614	chr11:64068310	C/T	cg02228329	chr11:64053129	BAD;GPR137	-1.16	-5.11	-0.5	2.27e-6	Mean platelet volume;
SKCM	cis	rs875971	0.522	rs1968127	chr7:66056803	C/T	cg00343986	chr7:65444356	GUSB	-0.67	-4.93	-0.49	4.55e-6	Aortic root size;
SKCM	cis	rs28386778	0.897	rs9906247	chr17:61857314	T/C	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs28386778	0.830	rs2584625	chr17:61903445	G/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs56235845	0.694	rs11738681	chr5:176761535	A/G	cg16006841	chr5:176797999	RGS14	0.67	6.35	0.58	1.32e-8	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs10911251	0.546	rs2147578	chr1:183107699	G/C	ch.1.3577855R	chr1:183094577	LAMC1	0.76	7.28	0.64	2.26e-10	Colorectal cancer;
SKCM	cis	rs7336332	0.598	rs45622135	chr13:28011594	T/C	cg22138327	chr13:27999177	GTF3A	0.9	6.4	0.59	1.07e-8	Weight;
SKCM	cis	rs35306767	0.715	rs1871622	chr10:1049309	T/G	cg20503657	chr10:835505	NA	0.62	4.87	0.48	5.77e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs763014	0.865	rs8909	chr16:633851	T/C	cg07343612	chr16:622815	PIGQ	-0.7	-6.0	-0.56	5.84e-8	Height;
SKCM	cis	rs7618501	0.602	rs2624816	chr3:50117312	T/G	cg05072774	chr3:49840536	C3orf54	0.71	5.48	0.53	5e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs11734570	0.581	rs4461531	chr4:38603576	C/T	cg18361445	chr4:38666374	KLF3;FLJ13197	0.85	5.74	0.55	1.72e-7	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs2836974	0.568	rs11910906	chr21:40685662	T/C	cg11644478	chr21:40555479	PSMG1	-0.68	-5.93	-0.56	7.94e-8	Cognitive function;
SKCM	cis	rs28386778	1.000	rs3020613	chr17:61955983	A/G	cg01411255	chr17:61851458	DDX42;CCDC47	0.76	4.86	0.48	5.96e-6	Prudent dietary pattern;
SKCM	cis	rs7106204	0.748	rs6484024	chr11:24210079	T/C	ch.11.24196551F	chr11:24239977	NA	0.77	5.97	0.56	6.6e-8	Response to Homoharringtonine (cytotoxicity);
SKCM	cis	rs873946	0.648	rs1543593	chr10:134553185	A/T	cg27286337	chr10:134555280	INPP5A	0.92	8.2	0.68	3.78e-12	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs4819052	0.788	rs4819051	chr21:46693128	C/T	cg19498844	chr21:46707878	POFUT2;LOC642852	0.91	7.84	0.66	1.92e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7829975	0.774	rs11775523	chr8:8679176	A/G	cg15556689	chr8:8085844	FLJ10661	0.75	7.12	0.63	4.75e-10	Mood instability;
SKCM	cis	rs11677370	0.533	rs12711971	chr2:3820821	G/C	cg17052675	chr2:3827356	NA	-0.62	-5.1	-0.5	2.36e-6	Type 2 diabetes;
SKCM	cis	rs1552244	0.816	rs13076197	chr3:10019773	T/C	cg02579736	chr3:10068473	FANCD2;CIDECP	0.94	4.84	0.48	6.49e-6	Alzheimer's disease;
SKCM	cis	rs35306767	0.953	rs1539174	chr10:974870	C/G	cg25614935	chr10:1084866	C10orf110	0.7	4.77	0.48	8.49e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs8180040	1.000	rs2159400	chr3:47375890	T/C	cg16586182	chr3:47516702	SCAP	0.72	4.93	0.49	4.51e-6	Colorectal cancer;
SKCM	cis	rs4972806	0.814	rs6710370	chr2:177045969	T/C	cg14324370	chr2:177042789	NA	0.58	5.31	0.52	1.01e-6	IgG glycosylation;
SKCM	cis	rs1218582	0.596	rs906595	chr1:154822907	C/T	cg03351412	chr1:154909251	PMVK	0.6	4.79	0.48	7.79e-6	Prostate cancer;
SKCM	cis	rs875971	0.862	rs778697	chr7:65870426	G/A	cg18876405	chr7:65276391	NA	0.63	6.34	0.58	1.39e-8	Aortic root size;
SKCM	cis	rs10876993	0.928	rs1678530	chr12:58054076	A/C	cg18357645	chr12:58087776	OS9	0.61	5.65	0.54	2.52e-7	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs9303401	0.659	rs62083436	chr17:57031742	G/A	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.16	0.57	2.91e-8	Cognitive test performance;
SKCM	cis	rs2243480	0.522	rs73150635	chr7:65972490	C/T	cg18252515	chr7:66147081	NA	-1.42	-7.62	-0.65	5.04e-11	Diabetic kidney disease;
SKCM	cis	rs35306767	0.903	rs61833260	chr10:975148	T/G	cg20503657	chr10:835505	NA	0.75	6.04	0.56	4.87e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs1499614	1.000	rs2707840	chr7:66158015	C/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Gout;
SKCM	cis	rs9640161	0.702	rs11765692	chr7:150026567	C/T	cg10018233	chr7:150070692	REPIN1	0.75	6.05	0.56	4.81e-8	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs10876993	0.826	rs1678534	chr12:58057435	A/C	cg18357645	chr12:58087776	OS9	0.61	5.65	0.54	2.52e-7	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs1801251	1.000	rs2675971	chr2:233726154	A/G	cg25237894	chr2:233734115	C2orf82	-0.6	-5.8	-0.55	1.36e-7	Coronary artery disease;
SKCM	trans	rs11083271	0.590	rs62101359	chr18:25858886	C/G	cg00321150	chr11:62623587	SNORD27;SLC3A2;SNHG1;SNORD28;SNORD25;SNORD26	0.8	7.29	0.64	2.17e-10	Non-alcoholic fatty liver disease histology (lobular);
SKCM	cis	rs9674544	0.740	rs11870560	chr17:47114033	T/C	cg11673840	chr17:47092156	IGF2BP1	-0.5	-4.97	-0.49	3.94e-6	Primary tooth development (time to first tooth eruption);Primary tooth development (number of teeth);
SKCM	cis	rs55962025	0.846	rs363064	chr4:3141410	C/T	cg11471262	chr4:3318911	RGS12	-0.75	-5.68	-0.54	2.19e-7	Parental longevity (mother's age at death);
SKCM	cis	rs7523050	0.730	rs35100394	chr1:109433989	C/G	cg08274380	chr1:109419600	GPSM2	1.15	6.57	0.6	5.22e-9	Fat distribution (HIV);
SKCM	cis	rs826838	1.000	rs12366971	chr12:38737687	T/G	cg13010199	chr12:38710504	ALG10B	0.86	6.76	0.61	2.29e-9	Heart rate;
SKCM	cis	rs7215564	0.908	rs34969384	chr17:78678716	A/G	cg16980736	chr17:78789706	RPTOR	-0.88	-4.83	-0.48	6.66e-6	Myopia (pathological);
SKCM	cis	rs16940212	0.618	rs166359	chr15:58687609	G/T	cg16767221	chr15:57769667	CGNL1	0.59	4.81	0.48	7.24e-6	HDL cholesterol levels;HDL cholesterol;
SKCM	cis	rs12497850	0.897	rs7373778	chr3:48836392	C/G	cg06212747	chr3:49208901	KLHDC8B	0.66	4.81	0.48	7.08e-6	Parkinson's disease;
SKCM	cis	rs10791097	0.592	rs7116068	chr11:130732739	A/C	cg12179176	chr11:130786555	SNX19	-0.88	-7.6	-0.65	5.51e-11	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs6089829	0.816	rs6062397	chr20:61668268	A/G	cg08564027	chr20:61660810	NA	0.63	5.65	0.54	2.46e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs514406	0.560	rs1889033	chr1:53211887	A/G	cg24675658	chr1:53192096	ZYG11B	0.63	5.08	0.5	2.47e-6	Monocyte count;
SKCM	cis	rs2188420	0.748	rs6961772	chr7:106530554	G/A	cg23615938	chr7:105753134	SYPL1	-0.89	-5.06	-0.5	2.73e-6	Interferon gamma levels;
SKCM	cis	rs67311347	0.544	rs2278930	chr3:40351092	C/T	cg00091569	chr3:40428383	ENTPD3	0.64	5.64	0.54	2.66e-7	Renal cell carcinoma;
SKCM	trans	rs2727020	0.595	rs10839281	chr11:49483373	A/C	cg15704280	chr7:45808275	SEPT13	-0.98	-9.29	-0.72	2.93e-14	Coronary artery disease;
SKCM	cis	rs3820928	0.845	rs2177596	chr2:227890283	A/T	cg11843606	chr2:227700838	RHBDD1	-0.6	-4.8	-0.48	7.43e-6	Pulmonary function;
SKCM	cis	rs34779708	0.966	rs1057108	chr10:35484949	T/G	cg03585969	chr10:35415529	CREM	0.78	6.18	0.57	2.72e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs870825	0.872	rs12507711	chr4:185571776	C/T	cg04058563	chr4:185651563	MLF1IP	1.09	5.66	0.54	2.4e-7	Blood protein levels;
SKCM	cis	rs3771570	0.818	rs73008126	chr2:242443157	A/C	cg07612300	chr2:242033426	MTERFD2;SNED1	0.89	4.98	0.49	3.78e-6	Prostate cancer;
SKCM	cis	rs6570726	0.905	rs406799	chr6:145821837	G/C	cg23711669	chr6:146136114	FBXO30	0.7	6.64	0.6	3.72e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs860295	0.650	rs539602	chr1:155899020	A/T	cg02153340	chr1:155202674	NA	0.68	4.99	0.49	3.64e-6	Body mass index;
SKCM	cis	rs860295	0.650	rs4661175	chr1:155931368	G/A	cg02153340	chr1:155202674	NA	0.73	5.18	0.51	1.71e-6	Body mass index;
SKCM	cis	rs12477438	0.520	rs6741773	chr2:99738962	A/C	cg26064155	chr2:99771622	LIPT1;TSGA10	1.02	10.07	0.75	9.12e-16	Chronic sinus infection;
SKCM	cis	rs2075371	0.796	rs35336643	chr7:134010640	G/A	cg20476274	chr7:133979776	SLC35B4	1.0	9.54	0.73	9.81e-15	Mean platelet volume;
SKCM	cis	rs10905065	0.759	rs10905255	chr10:5870267	G/T	cg09234995	chr10:5726438	C10orf18	-0.61	-4.84	-0.48	6.33e-6	Menopause (age at onset);
SKCM	cis	rs7666738	0.830	rs13137808	chr4:99047095	T/C	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs507080	0.733	rs497678	chr11:118567881	T/C	cg18045108	chr11:118530628	TREH	-0.43	-4.77	-0.48	8.5e-6	Serum metabolite levels;
SKCM	cis	rs801193	0.569	rs11761542	chr7:66218196	G/A	cg18876405	chr7:65276391	NA	0.61	6.02	0.56	5.36e-8	Aortic root size;
SKCM	cis	rs3892630	0.824	rs12327732	chr19:33221767	C/T	cg22980127	chr19:33182716	NUDT19	1.36	7.75	0.66	2.87e-11	Red blood cell traits;
SKCM	cis	rs514406	0.729	rs534070	chr1:53308858	T/G	cg08859206	chr1:53392774	SCP2	-0.66	-5.39	-0.52	7.22e-7	Monocyte count;
SKCM	cis	rs3087591	1.000	rs2952980	chr17:29473353	G/A	cg24425628	chr17:29625626	OMG;NF1	0.64	5.26	0.51	1.21e-6	Hip circumference;
SKCM	cis	rs7208859	0.623	rs12006	chr17:29110652	G/A	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs589448	0.933	rs2249093	chr12:69753512	G/C	cg20891283	chr12:69753455	YEATS4	0.98	9.89	0.75	2.06e-15	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs17376456	0.569	rs68122392	chr5:93077807	A/T	cg25358565	chr5:93447407	FAM172A	0.86	5.45	0.53	5.59e-7	Diabetic retinopathy;
SKCM	cis	rs9910055	0.520	rs479044	chr17:42158613	A/G	cg19774624	chr17:42201019	HDAC5	0.77	4.87	0.48	5.72e-6	Total body bone mineral density;
SKCM	cis	rs3820068	0.581	rs6429762	chr1:15945595	A/C	cg13390004	chr1:15929781	NA	0.64	5.19	0.51	1.61e-6	Systolic blood pressure;
SKCM	cis	rs2839186	1.000	rs2839186	chr21:47690068	C/T	cg13126279	chr21:47581558	C21orf56	-0.63	-5.42	-0.52	6.37e-7	Testicular germ cell tumor;
SKCM	cis	rs7666738	0.830	rs28867087	chr4:98880349	T/A	cg17366294	chr4:99064904	C4orf37	0.57	4.84	0.48	6.52e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11155671	0.530	rs9383577	chr6:150207195	C/T	cg05036130	chr6:150231994	NA	0.6	6.88	0.61	1.31e-9	Testicular germ cell tumor;
SKCM	cis	rs6998277	0.830	rs7017839	chr8:103610769	G/C	cg10187029	chr8:103597600	NA	0.73	5.88	0.55	9.67e-8	Migraine;
SKCM	cis	rs7216064	1.000	rs59950564	chr17:65860859	A/G	cg12091567	chr17:66097778	LOC651250	-0.75	-5.27	-0.51	1.19e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs826838	0.967	rs6580726	chr12:39108623	T/C	cg13010199	chr12:38710504	ALG10B	-0.74	-5.61	-0.54	2.95e-7	Heart rate;
SKCM	cis	rs7829975	0.742	rs1533058	chr8:8685190	A/G	cg15556689	chr8:8085844	FLJ10661	0.72	6.69	0.6	2.98e-9	Mood instability;
SKCM	cis	rs2749592	0.513	rs1208708	chr10:38085576	A/G	cg25427524	chr10:38739819	LOC399744	-0.65	-6.11	-0.57	3.68e-8	Age-related hearing impairment (SNP x SNP interaction);
SKCM	cis	rs2839186	0.933	rs56955294	chr21:47708953	A/G	cg13126279	chr21:47581558	C21orf56	-0.64	-5.47	-0.53	5.17e-7	Testicular germ cell tumor;
SKCM	cis	rs9911578	0.967	rs9894274	chr17:56977919	G/A	cg12560992	chr17:57184187	TRIM37	0.94	7.55	0.65	7.01e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs1160297	0.643	rs13031599	chr2:53075902	T/C	cg07782112	chr2:53107842	NA	0.58	5.86	0.55	1.03e-7	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs1577917	0.771	rs2842612	chr6:86303091	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.98	-10.99	-0.78	1.66e-17	Response to antipsychotic treatment;
SKCM	cis	rs34779708	0.733	rs11597184	chr10:35397396	G/A	cg03585969	chr10:35415529	CREM	0.79	6.32	0.58	1.49e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs1218582	0.774	rs11264284	chr1:154875793	C/T	cg06221963	chr1:154839813	KCNN3	-0.61	-6.58	-0.6	4.97e-9	Prostate cancer;
SKCM	cis	rs4740619	0.590	rs1359955	chr9:16040879	C/T	cg14451791	chr9:16040625	NA	-0.47	-5.03	-0.49	3.07e-6	Body mass index;
SKCM	cis	rs7605378	0.528	rs281767	chr2:200823281	C/A	cg23649088	chr2:200775458	C2orf69	0.7	5.47	0.53	5.2e-7	Osteoporosis;
SKCM	cis	rs684232	0.602	rs4968057	chr17:517521	T/A	cg15660573	chr17:549704	VPS53	-0.75	-5.83	-0.55	1.18e-7	Prostate cancer;
SKCM	cis	rs7772486	0.686	rs857877	chr6:145976230	A/C	cg23711669	chr6:146136114	FBXO30	-0.9	-9.54	-0.73	9.76e-15	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4927850	0.829	rs6768483	chr3:195745963	C/G	cg12923728	chr3:195709715	SDHAP1	-0.96	-6.33	-0.58	1.45e-8	Pancreatic cancer;
SKCM	cis	rs2153535	0.584	rs9502723	chr6:8541504	G/A	cg07606381	chr6:8435919	SLC35B3	0.91	6.31	0.58	1.56e-8	Motion sickness;
SKCM	cis	rs28595532	0.841	rs55744948	chr4:119769243	T/C	cg11846333	chr4:119757529	SEC24D	1.22	6.0	0.56	5.86e-8	Cannabis dependence symptom count;
SKCM	cis	rs16854884	0.657	rs35067746	chr3:143747147	T/A	cg06585982	chr3:143692056	C3orf58	0.87	8.11	0.68	5.72e-12	Economic and political preferences (feminism/equality);
SKCM	cis	rs11139399	0.675	rs11139388	chr9:84348902	G/T	cg13729285	chr9:84764156	NA	0.47	4.86	0.48	5.91e-6	Hippocampal atrophy;
SKCM	trans	rs208520	0.690	rs12208310	chr6:66730108	G/C	cg15611600	chr13:45563400	KIAA1704;NUFIP1	0.94	7.79	0.66	2.44e-11	Exhaled nitric oxide output;
SKCM	cis	rs9809213	0.943	rs13326397	chr3:72354458	T/G	cg09429735	chr3:71752026	EIF4E3	-0.57	-5.18	-0.51	1.71e-6	Cognitive ability;Cognitive ability (multi-trait analysis);
SKCM	cis	rs7945705	0.935	rs11042103	chr11:8888700	C/T	cg13070366	chr11:9386451	NA	-0.59	-5.13	-0.5	2.07e-6	Hemoglobin concentration;
SKCM	cis	rs1046896	0.594	rs8070403	chr17:80865404	A/G	cg02711726	chr17:80685570	FN3KRP	-0.79	-6.11	-0.57	3.62e-8	Glycated hemoglobin levels;
SKCM	cis	rs1577917	1.000	rs2166663	chr6:86593896	G/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.75	-0.66	2.83e-11	Response to antipsychotic treatment;
SKCM	cis	rs16866061	1.000	rs1568750	chr2:225342597	A/T	cg12698349	chr2:225449008	CUL3	1.02	8.77	0.7	3.04e-13	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs2836950	0.520	rs1980407	chr21:40543961	T/C	cg11890956	chr21:40555474	PSMG1	-0.7	-5.62	-0.54	2.84e-7	Menarche (age at onset);
SKCM	cis	rs9911578	1.000	rs9898916	chr17:57048660	C/T	cg05425664	chr17:57184151	TRIM37	-0.67	-5.04	-0.5	2.91e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9325144	0.624	rs10783330	chr12:39114084	A/G	cg13010199	chr12:38710504	ALG10B	-0.63	-5.42	-0.52	6.43e-7	Morning vs. evening chronotype;
SKCM	cis	rs7666738	0.791	rs7658177	chr4:99035192	T/C	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4803468	1.000	rs11880539	chr19:41918949	A/C	cg09537434	chr19:41945824	ATP5SL	1.13	14.05	0.85	4.59e-23	Height;
SKCM	cis	rs17685	0.712	rs7785025	chr7:75628101	C/T	cg16489192	chr7:75678113	MDH2;STYXL1	0.58	5.14	0.5	1.97e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs12824058	0.831	rs7299065	chr12:130809661	A/T	cg26677194	chr12:130822605	PIWIL1	0.71	5.83	0.55	1.17e-7	Menopause (age at onset);
SKCM	cis	rs8067545	0.750	rs9897653	chr17:19987924	G/A	cg13482628	chr17:19912719	NA	0.73	6.54	0.6	5.78e-9	Schizophrenia;
SKCM	cis	rs12971120	0.947	rs4891559	chr18:72170397	C/T	cg26446133	chr18:72167187	CNDP2	-0.67	-5.64	-0.54	2.59e-7	Refractive error;
SKCM	trans	rs17685	0.753	rs2302435	chr7:75676987	G/A	cg19862616	chr7:65841803	NCRNA00174	-0.94	-9.39	-0.73	1.88e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7954584	0.567	rs1720033	chr12:122384344	C/T	cg13699009	chr12:122356056	WDR66	-0.58	-7.23	-0.63	2.83e-10	Mean corpuscular volume;
SKCM	cis	rs10905065	0.610	rs72774056	chr10:5737065	C/T	cg09234995	chr10:5726438	C10orf18	0.6	5.07	0.5	2.62e-6	Menopause (age at onset);
SKCM	cis	rs9300255	0.596	rs7304782	chr12:123719444	A/G	cg00376283	chr12:123451042	ABCB9	-0.88	-7.44	-0.64	1.12e-10	Neutrophil percentage of white cells;
SKCM	cis	rs2279817	0.743	rs12023874	chr1:18025612	A/G	cg17142039	chr1:18149651	ACTL8	0.59	5.07	0.5	2.62e-6	Neuroticism;
SKCM	cis	rs2243480	0.901	rs2456483	chr7:65461575	T/C	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs1348850	0.793	rs13020788	chr2:178480714	C/A	cg02961200	chr2:178257176	LOC100130691;AGPS	0.77	5.34	0.52	8.83e-7	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs899997	1.000	rs7182993	chr15:79045014	G/A	cg04896959	chr15:78267971	NA	0.57	5.0	0.49	3.49e-6	Coronary artery disease or large artery stroke;
SKCM	cis	rs11105298	0.891	rs10858902	chr12:89927789	A/G	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.84	-5.19	-0.51	1.63e-6	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs7809950	0.678	rs4730235	chr7:107022506	T/C	cg23024343	chr7:107201750	COG5	-0.84	-7.35	-0.64	1.66e-10	Coronary artery disease;
SKCM	cis	rs9430161	0.611	rs2095920	chr1:11033457	T/A	cg27631724	chr1:11040367	C1orf127	0.5	4.88	0.48	5.45e-6	Ewing sarcoma;
SKCM	cis	rs919433	1.000	rs919433	chr2:198166565	G/A	cg04278110	chr2:198063759	ANKRD44	-0.69	-4.8	-0.48	7.58e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs1577917	0.771	rs2783171	chr6:86382765	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.83	7.7	0.66	3.55e-11	Response to antipsychotic treatment;
SKCM	cis	rs6463523	0.933	rs6974151	chr7:758269	T/C	cg06242242	chr7:766104	PRKAR1B;HEATR2	1.04	8.34	0.69	2.07e-12	Subjective well-being;
SKCM	cis	rs11098499	0.865	rs11722183	chr4:120280597	A/C	cg09307838	chr4:120376055	NA	0.94	7.14	0.63	4.26e-10	Corneal astigmatism;
SKCM	cis	rs7666738	0.830	rs1025203	chr4:99023073	G/A	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.68e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2228479	0.702	rs62056087	chr16:89920383	C/A	cg00800038	chr16:89945340	TCF25	-1.0	-5.06	-0.5	2.75e-6	Skin colour saturation;
SKCM	cis	rs9796	0.553	rs1869908	chr15:41257224	C/A	cg18705301	chr15:41695430	NDUFAF1	0.71	5.72	0.54	1.86e-7	Menopause (age at onset);
SKCM	cis	rs17376456	0.825	rs28705226	chr5:93233135	T/C	cg21475434	chr5:93447410	FAM172A	1.03	5.61	0.54	3e-7	Diabetic retinopathy;
SKCM	cis	rs7659604	0.592	rs56077950	chr4:122721412	C/T	cg19748678	chr4:122722346	EXOSC9	0.72	6.24	0.58	2.1e-8	Type 2 diabetes;
SKCM	cis	rs10504229	1.000	rs67039591	chr8:58174553	T/A	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs11690935	0.959	rs11897196	chr2:172585595	G/A	cg13550731	chr2:172543902	DYNC1I2	-0.95	-8.21	-0.68	3.64e-12	Schizophrenia;
SKCM	cis	rs17376456	0.877	rs10476599	chr5:93383423	A/G	cg21475434	chr5:93447410	FAM172A	0.95	5.35	0.52	8.56e-7	Diabetic retinopathy;
SKCM	cis	rs2243480	0.808	rs12698508	chr7:65411958	A/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs4237845	0.537	rs11172367	chr12:58272486	T/G	cg00677455	chr12:58241039	CTDSP2	0.86	7.75	0.66	2.8e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs17685	0.753	rs1806885	chr7:75785612	T/G	cg16489192	chr7:75678113	MDH2;STYXL1	-0.56	-5.23	-0.51	1.36e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2439831	0.850	rs28524541	chr15:44124831	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.36	7.78	0.66	2.56e-11	Lung cancer in ever smokers;
SKCM	cis	rs34779708	0.931	rs34876468	chr10:35424450	G/A	cg03585969	chr10:35415529	CREM	0.76	6.1	0.57	3.82e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs34375054	0.557	rs35620656	chr12:125629103	G/T	cg25124228	chr12:125621409	AACS	-0.76	-5.38	-0.52	7.47e-7	Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs11719291	0.504	rs71324924	chr3:48865444	G/A	cg24898236	chr3:49228699	LOC646498	0.65	4.98	0.49	3.66e-6	Cognitive function;
SKCM	cis	rs11098499	0.754	rs878376	chr4:120237702	G/A	cg09307838	chr4:120376055	NA	0.93	7.56	0.65	6.5500000000000006e-11	Corneal astigmatism;
SKCM	cis	rs10911232	0.507	rs4652765	chr1:182994147	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.64	0.6	3.83e-9	Hypertriglyceridemia;
SKCM	cis	rs208520	0.909	rs55813840	chr6:67012508	A/C	cg07460842	chr6:66804631	NA	0.82	5.43	0.52	6.08e-7	Exhaled nitric oxide output;
SKCM	cis	rs1348850	0.632	rs11678875	chr2:178509068	A/G	cg22681709	chr2:178499509	PDE11A	-0.69	-5.98	-0.56	6.36e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs9926296	0.568	rs7203907	chr16:89833774	C/G	cg04287289	chr16:89883240	FANCA	1.03	12.44	0.82	3.28e-20	Vitiligo;
SKCM	cis	rs7937682	0.883	rs1611989	chr11:111456299	A/G	cg19812747	chr11:111475976	SIK2	-0.59	-4.86	-0.48	6.06e-6	Primary sclerosing cholangitis;
SKCM	cis	rs9443189	0.813	rs2647410	chr6:76433825	A/G	cg01950844	chr6:76311363	SENP6	-0.75	-5.22	-0.51	1.42e-6	Prostate cancer;
SKCM	cis	rs4969178	0.930	rs2292644	chr17:76394449	C/T	cg20026190	chr17:76395443	PGS1	0.61	5.29	0.51	1.08e-6	HDL cholesterol levels;
SKCM	cis	rs2033711	0.783	rs11671113	chr19:58958087	C/T	cg11952622	chr19:58962976	ZNF324B	0.63	4.8	0.48	7.64e-6	Uric acid clearance;
SKCM	cis	rs73072330	0.555	rs77580994	chr3:47935727	T/C	cg09665691	chr3:47563885	NA	1.4	5.1	0.5	2.32e-6	Stem cell growth factor beta levels;
SKCM	cis	rs1348850	0.668	rs4893971	chr2:178495743	T/C	cg27490568	chr2:178487706	NA	0.79	5.95	0.56	7.25e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs763121	0.853	rs2072796	chr22:39064230	A/G	cg06022373	chr22:39101656	GTPBP1	0.78	5.63	0.54	2.7e-7	Menopause (age at onset);
SKCM	cis	rs870825	0.549	rs7699919	chr4:185648610	A/C	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs1461503	0.966	rs10790546	chr11:122838426	C/A	cg27398637	chr11:122830231	C11orf63	-0.63	-4.8	-0.48	7.54e-6	Menarche (age at onset);
SKCM	cis	rs2075671	0.903	rs62482250	chr7:100266057	C/T	cg20848291	chr7:100343083	ZAN	-0.68	-5.13	-0.5	2.05e-6	Other erythrocyte phenotypes;
SKCM	cis	rs9543976	1.000	rs7339146	chr13:76173719	G/A	cg01531495	chr13:76123901	UCHL3	-0.9	-4.99	-0.49	3.52e-6	Diabetic retinopathy;
SKCM	cis	rs2477686	0.526	rs1998760	chr1:2397136	C/T	cg12929805	chr1:2399054	NA	-0.54	-5.52	-0.53	4.26e-7	Non-obstructive azoospermia;
SKCM	cis	rs1348850	0.526	rs2293475	chr2:178407897	C/T	cg27490568	chr2:178487706	NA	-0.91	-6.51	-0.59	6.62e-9	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs6951245	1.000	rs11766526	chr7:1101433	G/A	cg24642844	chr7:1081250	C7orf50	-0.93	-6.22	-0.58	2.28e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7589728	0.563	rs79892776	chr2:88470593	G/A	cg04511125	chr2:88470314	THNSL2	1.07	6.66	0.6	3.43e-9	Plasma clusterin levels;
SKCM	cis	rs12142240	0.698	rs17361833	chr1:46828700	A/G	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs9911578	0.967	rs8082544	chr17:57185807	C/T	cg12560992	chr17:57184187	TRIM37	-1.05	-9.85	-0.74	2.43e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs1218582	0.772	rs4845688	chr1:154884142	T/C	cg16680214	chr1:154839983	KCNN3	-0.56	-5.01	-0.49	3.29e-6	Prostate cancer;
SKCM	cis	rs7927771	0.832	rs11039212	chr11:47393303	A/T	cg01152729	chr11:47593274	PTPMT1	0.51	4.84	0.48	6.49e-6	Subjective well-being;
SKCM	cis	rs10751667	0.666	rs6597967	chr11:950583	G/T	cg10932868	chr11:921992	NA	0.54	5.22	0.51	1.43e-6	Alzheimer's disease (late onset);
SKCM	cis	rs8016982	0.610	rs2371570	chr14:81709686	C/T	cg01989461	chr14:81687754	GTF2A1	0.81	6.68	0.6	3.15e-9	Schizophrenia;
SKCM	cis	rs9910055	0.530	rs11656758	chr17:42301541	A/G	cg09913183	chr17:42254507	C17orf65;ASB16	0.6	5.25	0.51	1.3e-6	Total body bone mineral density;
SKCM	cis	rs10927875	0.691	rs1048261	chr1:16340951	A/T	cg21385522	chr1:16154831	NA	0.66	4.77	0.48	8.39e-6	Dilated cardiomyopathy;
SKCM	cis	rs523522	0.926	rs10849766	chr12:121025894	G/A	cg12219531	chr12:120966889	COQ5	0.91	7.71	0.66	3.35e-11	High light scatter reticulocyte count;
SKCM	cis	rs1160297	0.576	rs724859	chr2:53099305	C/T	cg07782112	chr2:53107842	NA	0.59	6.36	0.58	1.28e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs2013441	1.000	rs2080673	chr17:20062395	C/A	cg13482628	chr17:19912719	NA	0.67	5.24	0.51	1.32e-6	Obesity-related traits;
SKCM	cis	rs1018836	0.770	rs13266461	chr8:91652817	T/C	cg16814680	chr8:91681699	NA	-0.87	-7.29	-0.64	2.24e-10	Ejection fraction in Tripanosoma cruzi seropositivity;
SKCM	cis	rs2760061	0.626	rs596675	chr1:228117892	G/A	cg02753203	chr1:228287806	NA	-0.63	-4.96	-0.49	3.99e-6	Diastolic blood pressure;
SKCM	cis	rs6879260	0.928	rs11739624	chr5:179727290	T/C	cg23221052	chr5:179740743	GFPT2	-0.73	-5.75	-0.55	1.68e-7	Height;
SKCM	cis	rs11098499	0.532	rs4833624	chr4:120585497	C/T	cg09307838	chr4:120376055	NA	0.93	7.7	0.66	3.54e-11	Corneal astigmatism;
SKCM	cis	rs17711722	0.727	rs781151	chr7:65479878	T/C	cg18876405	chr7:65276391	NA	0.85	7.85	0.66	1.82e-11	Calcium levels;
SKCM	cis	rs362296	0.671	rs3135173	chr4:3257373	T/C	cg00764545	chr4:3318001	RGS12	-0.75	-6.58	-0.6	4.99e-9	Parental longevity (mother's age at death);
SKCM	cis	rs6582630	0.537	rs35336822	chr12:38346251	T/C	cg26384229	chr12:38710491	ALG10B	0.81	6.56	0.6	5.29e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs826838	1.000	rs860400	chr12:39081279	A/G	cg26384229	chr12:38710491	ALG10B	-0.96	-7.96	-0.67	1.15e-11	Heart rate;
SKCM	cis	rs7666738	0.861	rs13139309	chr4:99020916	A/G	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs13217239	0.646	rs2142685	chr6:27054497	C/T	cg12292205	chr6:26970375	C6orf41	-0.59	-5.15	-0.5	1.94e-6	Schizophrenia;
SKCM	cis	rs951366	0.646	rs1772159	chr1:205759195	G/A	cg11965913	chr1:205819406	PM20D1	0.97	10.87	0.78	2.76e-17	Menarche (age at onset);
SKCM	cis	rs13256369	0.708	rs11783670	chr8:8559394	G/A	cg06636001	chr8:8085503	FLJ10661	0.74	5.5	0.53	4.71e-7	Obesity-related traits;
SKCM	cis	rs614226	1.000	rs1614223	chr12:120964043	T/C	cg01236616	chr12:121019343	POP5	1.34	8.54	0.7	8.29e-13	Type 1 diabetes nephropathy;
SKCM	cis	rs11718455	1.000	rs28731098	chr3:44019816	A/C	cg21419209	chr3:44054225	NA	-0.66	-5.22	-0.51	1.46e-6	Coronary artery disease;
SKCM	cis	rs4727027	0.870	rs62507485	chr7:148764182	C/T	cg23583168	chr7:148888333	NA	-0.82	-6.51	-0.59	6.53e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs1218582	0.772	rs6669791	chr1:154845484	G/T	cg09359103	chr1:154839909	KCNN3	-0.6	-5.75	-0.55	1.66e-7	Prostate cancer;
SKCM	cis	rs801193	1.000	rs7782320	chr7:66177098	C/T	cg00343986	chr7:65444356	GUSB	0.7	5.19	0.51	1.63e-6	Aortic root size;
SKCM	cis	rs6459804	1.000	rs58278053	chr7:157512934	A/T	cg27240775	chr7:156793224	NA	-0.71	-4.95	-0.49	4.12e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs2180341	0.680	rs9388554	chr6:127576234	C/G	cg27446573	chr6:127587934	RNF146	0.88	7.22	0.63	2.99e-10	Breast cancer;
SKCM	cis	rs6430585	0.591	rs309118	chr2:136746224	G/C	cg07169764	chr2:136633963	MCM6	1.26	10.94	0.78	2.04e-17	Corneal structure;
SKCM	cis	rs9581857	0.585	rs9581875	chr13:28099678	A/G	cg22138327	chr13:27999177	GTF3A	0.84	5.46	0.53	5.47e-7	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs11098499	0.954	rs35091806	chr4:120325529	G/A	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs28595532	0.841	rs114107504	chr4:119771080	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs2645694	0.626	rs2703129	chr4:77818548	T/C	cg06046430	chr4:77819534	ANKRD56	0.54	5.83	0.55	1.18e-7	Emphysema distribution in smoking;
SKCM	cis	rs1577917	0.958	rs12190603	chr6:86475718	C/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.27	-0.51	1.16e-6	Response to antipsychotic treatment;
SKCM	cis	rs28595532	0.920	rs115214765	chr4:119728167	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.43	0.59	9.38e-9	Cannabis dependence symptom count;
SKCM	cis	rs2033711	0.936	rs882609	chr19:58991479	G/A	cg03735888	chr19:58951602	ZNF132	0.72	6.11	0.57	3.62e-8	Uric acid clearance;
SKCM	cis	rs9435341	0.728	rs1762486	chr1:107627697	G/A	cg09367891	chr1:107599246	PRMT6	-0.79	-6.24	-0.58	2.15e-8	Facial morphology (factor 21, depth of nasal alae);
SKCM	cis	rs57221529	0.766	rs58015612	chr5:580665	A/T	cg10555297	chr5:473380	SLC9A3;LOC25845	1.01	5.03	0.49	3.1e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs36051895	0.659	rs62541556	chr9:5049092	G/T	cg02405213	chr9:5042618	JAK2	-0.64	-5.21	-0.51	1.51e-6	Pediatric autoimmune diseases;
SKCM	cis	rs9815354	0.767	rs60764195	chr3:41812522	G/C	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs11924390	0.749	rs822363	chr3:186452991	C/G	cg09332604	chr3:186435400	KNG1	-0.55	-5.52	-0.53	4.25e-7	Adiponectin levels;
SKCM	cis	rs7811142	1.000	rs2406255	chr7:100053690	T/C	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.34	0.69	2.1e-12	Platelet count;
SKCM	cis	rs2204008	0.548	rs2320740	chr12:38166421	G/A	cg13010199	chr12:38710504	ALG10B	0.65	4.84	0.48	6.52e-6	Bladder cancer;
SKCM	cis	rs362296	0.698	rs3135171	chr4:3261127	A/G	cg05297308	chr4:3317976	RGS12	-0.78	-6.73	-0.61	2.57e-9	Parental longevity (mother's age at death);
SKCM	cis	rs8072100	0.738	rs9915222	chr17:45448615	G/T	cg08085267	chr17:45401833	C17orf57	-0.62	-5.03	-0.49	3.05e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	trans	rs1814175	0.618	rs1851843	chr11:50021846	T/C	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs12477438	0.520	rs6756650	chr2:99801800	T/C	cg26064155	chr2:99771622	LIPT1;TSGA10	0.97	8.85	0.71	2.11e-13	Chronic sinus infection;
SKCM	cis	rs10088262	0.527	rs3911939	chr8:124793744	T/G	cg02993010	chr8:124780839	FAM91A1	-0.77	-4.92	-0.49	4.66e-6	Pancreatic cancer;
SKCM	cis	rs2439831	0.867	rs28729853	chr15:43673680	A/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.22	8.33	0.69	2.19e-12	Lung cancer in ever smokers;
SKCM	cis	rs2842992	0.830	rs2758312	chr6:160153452	G/A	cg16489826	chr6:160211363	TCP1;MRPL18	0.7	5.0	0.49	3.45e-6	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs703842	1.000	rs10783848	chr12:58196528	G/A	cg04478727	chr12:58166393	METTL1;FAM119B	0.72	5.87	0.55	1.02e-7	Multiple sclerosis;
SKCM	cis	rs9814567	1.000	rs9289476	chr3:134237103	C/T	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs7666738	0.830	rs17558193	chr4:99049593	A/G	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1153858	0.887	rs7164139	chr15:45670851	G/A	cg21132104	chr15:45694354	SPATA5L1	0.93	7.94	0.67	1.22e-11	Homoarginine levels;
SKCM	cis	rs4073582	0.595	rs555360	chr11:65960061	T/C	cg14036092	chr11:66035641	RAB1B	-0.74	-5.81	-0.55	1.3e-7	Gout;
SKCM	cis	rs10504229	0.683	rs58883273	chr8:58138275	A/G	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs28595532	0.545	rs72677057	chr4:119264162	A/T	cg11846333	chr4:119757529	SEC24D	1.04	5.83	0.55	1.2e-7	Cannabis dependence symptom count;
SKCM	cis	rs2839186	0.872	rs13052495	chr21:47707474	G/A	cg11766577	chr21:47581405	C21orf56	-0.71	-6.01	-0.56	5.6e-8	Testicular germ cell tumor;
SKCM	cis	rs72615157	0.613	rs56089143	chr7:99819844	G/A	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.21	8.07	0.67	7e-12	Lung function (FEV1/FVC);
SKCM	cis	rs9325144	0.600	rs7965877	chr12:38743697	G/T	cg13010199	chr12:38710504	ALG10B	0.64	5.12	0.5	2.17e-6	Morning vs. evening chronotype;
SKCM	cis	rs362296	0.671	rs1006798	chr4:3258373	A/G	cg11471262	chr4:3318911	RGS12	-0.77	-6.77	-0.61	2.14e-9	Parental longevity (mother's age at death);
SKCM	cis	rs763014	1.000	rs8054842	chr16:672799	T/C	cg09263875	chr16:632152	PIGQ	0.7	6.2	0.57	2.48e-8	Height;
SKCM	cis	rs4642101	0.737	rs6767504	chr3:12826667	C/T	cg05775895	chr3:12838266	CAND2	0.64	5.8	0.55	1.34e-7	QRS complex (12-leadsum);
SKCM	cis	rs4819052	0.765	rs2838854	chr21:46680364	A/G	cg19498844	chr21:46707878	POFUT2;LOC642852	0.9	7.98	0.67	1.04e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	trans	rs1814175	0.616	rs1851848	chr11:49992254	G/C	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs56104184	0.723	rs73063515	chr19:49407715	C/T	cg19746536	chr19:49375674	PPP1R15A	1.16	5.93	0.56	7.67e-8	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs9911578	1.000	rs9915935	chr17:56843048	A/G	cg05425664	chr17:57184151	TRIM37	-0.7	-5.16	-0.5	1.81e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs514406	0.679	rs61768344	chr1:53229274	G/A	cg08859206	chr1:53392774	SCP2	0.68	5.34	0.52	8.91e-7	Monocyte count;
SKCM	cis	rs9913156	0.789	rs72824966	chr17:4596679	T/C	cg19197139	chr17:4613644	ARRB2	0.8	5.32	0.52	9.73e-7	Lymphocyte counts;
SKCM	cis	rs7111031	0.729	rs61902812	chr11:113374420	C/A	cg04642306	chr11:112834466	NCAM1	-0.46	-4.85	-0.48	6.15e-6	Subjective well-being (multi-trait analysis);Depressive symptoms (multi-trait analysis);Neuroticism;
SKCM	cis	rs16854884	1.000	rs2370171	chr3:143765177	C/T	cg06585982	chr3:143692056	C3orf58	0.74	5.69	0.54	2.17e-7	Economic and political preferences (feminism/equality);
SKCM	cis	rs1707322	1.000	rs1612419	chr1:46546945	T/C	cg03146154	chr1:46216737	IPP	-0.8	-5.28	-0.51	1.15e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs2832191	0.967	rs3787660	chr21:30520907	C/T	cg24692254	chr21:30365293	RNF160	0.75	6.81	0.61	1.79e-9	Dental caries;
SKCM	cis	rs2836950	0.545	rs2297256	chr21:40558421	C/T	cg11644478	chr21:40555479	PSMG1	-0.62	-4.81	-0.48	7.25e-6	Menarche (age at onset);
SKCM	cis	rs11098499	0.789	rs1980024	chr4:120253047	C/T	cg09307838	chr4:120376055	NA	0.91	7.36	0.64	1.63e-10	Corneal astigmatism;
SKCM	cis	rs6500395	1.000	rs2129243	chr16:48646852	A/T	cg04672837	chr16:48644449	N4BP1	0.64	5.14	0.5	2e-6	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs28595532	0.920	rs116149978	chr4:119761069	A/C	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs2033711	0.902	rs4801589	chr19:58953398	C/G	cg12042659	chr19:58951599	ZNF132	0.68	5.97	0.56	6.49e-8	Uric acid clearance;
SKCM	cis	rs9633740	0.773	rs1870148	chr10:82271341	G/A	cg01528321	chr10:82214614	TSPAN14	0.82	6.01	0.56	5.6e-8	Post bronchodilator FEV1;
SKCM	cis	rs9880211	1.000	rs9837158	chr3:136073163	C/T	cg21827317	chr3:136751795	NA	-0.65	-4.92	-0.49	4.73e-6	Body mass index;Height;
SKCM	cis	rs7824557	0.583	rs4448232	chr8:11231354	G/T	cg21775007	chr8:11205619	TDH	0.59	4.92	0.49	4.7e-6	Retinal vascular caliber;
SKCM	cis	rs9911578	1.000	rs9892062	chr17:56976981	G/A	cg05425664	chr17:57184151	TRIM37	-0.67	-5.04	-0.5	2.91e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7523050	0.643	rs34920128	chr1:109400889	C/T	cg08274380	chr1:109419600	GPSM2	1.13	5.57	0.53	3.54e-7	Fat distribution (HIV);
SKCM	cis	rs12048904	0.619	rs10875347	chr1:101333737	T/C	cg00063077	chr1:101360652	SLC30A7;EXTL2	0.86	6.49	0.59	7.19e-9	Multiple sclerosis;
SKCM	cis	rs711245	0.699	rs3770818	chr2:36769497	T/G	cg01206211	chr2:36825736	FEZ2	0.6	4.83	0.48	6.78e-6	Height;
SKCM	cis	rs11098499	0.863	rs10030660	chr4:120436704	G/A	cg09307838	chr4:120376055	NA	0.98	7.45	0.64	1.07e-10	Corneal astigmatism;
SKCM	cis	rs951366	0.617	rs9438393	chr1:205782718	A/G	cg24503407	chr1:205819492	PM20D1	0.98	10.86	0.78	2.94e-17	Menarche (age at onset);
SKCM	cis	rs2019137	0.539	rs6755040	chr2:113981137	T/C	cg23156509	chr2:114033830	PAX8;LOC440839	-0.56	-4.81	-0.48	7.3e-6	Lymphocyte counts;
SKCM	cis	rs7177699	0.550	rs7182716	chr15:79123753	T/C	cg04896959	chr15:78267971	NA	-0.54	-4.84	-0.48	6.39e-6	Post bronchodilator FEV1/FVC ratio;Post bronchodilator FEV1;
SKCM	cis	rs2404602	0.647	rs35940181	chr15:77180019	G/A	cg23625390	chr15:77176239	SCAPER	-0.82	-7.93	-0.67	1.26e-11	Blood metabolite levels;
SKCM	cis	rs12145833	0.596	rs12134228	chr1:243447618	C/T	cg02356786	chr1:243265016	LOC731275	1.36	5.47	0.53	5.33e-7	Obesity (early onset extreme);
SKCM	cis	rs4423214	0.592	rs11234027	chr11:71234107	G/A	cg05163923	chr11:71159392	DHCR7	-0.67	-4.82	-0.48	6.99e-6	Vitamin D levels;
SKCM	cis	rs950776	0.616	rs12901300	chr15:78892952	G/A	cg06917634	chr15:78832804	PSMA4	0.91	8.04	0.67	7.84e-12	Sudden cardiac arrest;
SKCM	cis	rs6582630	0.555	rs7133706	chr12:38475465	G/A	cg26384229	chr12:38710491	ALG10B	-0.8	-6.31	-0.58	1.56e-8	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs1218582	0.774	rs11264284	chr1:154875793	C/T	cg09359103	chr1:154839909	KCNN3	-0.59	-5.81	-0.55	1.31e-7	Prostate cancer;
SKCM	cis	rs7106204	0.800	rs7120940	chr11:24236485	C/A	ch.11.24196551F	chr11:24239977	NA	0.77	6.13	0.57	3.44e-8	Response to Homoharringtonine (cytotoxicity);
SKCM	cis	rs8077889	0.719	rs57227660	chr17:41858984	T/C	cg26893861	chr17:41843967	DUSP3	1.39	13.03	0.83	2.86e-21	Triglycerides;
SKCM	cis	rs55823223	0.680	rs3744020	chr17:73871773	G/A	cg10935138	chr17:73851978	WBP2	1.13	6.37	0.59	1.19e-8	Psoriasis;
SKCM	cis	rs208520	0.690	rs207107	chr6:66794385	T/C	cg07460842	chr6:66804631	NA	-1.03	-7.65	-0.65	4.49e-11	Exhaled nitric oxide output;
SKCM	cis	rs12705054	1.000	rs17161615	chr7:98793388	G/C	cg11543304	chr7:98729543	SMURF1	1.06	4.77	0.48	8.44e-6	Facial emotion recognition (sad faces);
SKCM	cis	rs7666738	0.830	rs13124904	chr4:98856973	T/C	cg17366294	chr4:99064904	C4orf37	0.56	4.87	0.48	5.62e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9303401	0.659	rs7225896	chr17:56637337	T/C	cg10487724	chr17:56770010	TEX14;RAD51C	0.83	6.11	0.57	3.71e-8	Cognitive test performance;
SKCM	cis	rs2072499	0.750	rs55675376	chr1:156165881	C/T	cg25208724	chr1:156163844	SLC25A44	0.9	6.41	0.59	1e-8	Testicular germ cell tumor;
SKCM	cis	rs1153858	1.000	rs11852800	chr15:45639131	A/G	cg21132104	chr15:45694354	SPATA5L1	-0.91	-8.05	-0.67	7.69e-12	Homoarginine levels;
SKCM	cis	rs8072100	1.000	rs7210738	chr17:45757598	G/A	cg08085267	chr17:45401833	C17orf57	0.64	5.93	0.56	7.83e-8	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs1062177	0.950	rs892005	chr5:151180621	A/G	cg00977110	chr5:151150581	G3BP1	0.82	6.75	0.61	2.32e-9	Preschool internalizing problems;
SKCM	cis	rs7208859	0.623	rs9915546	chr17:29132144	G/T	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs9858542	0.953	rs1801143	chr3:49570200	C/T	cg03060546	chr3:49711283	APEH	-0.73	-5.38	-0.52	7.72e-7	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs1850744	0.702	rs4974816	chr4:9613067	G/A	cg15442990	chr4:9534313	NA	-1.55	-5.83	-0.55	1.18e-7	Economic and political preferences;
SKCM	cis	rs769267	0.930	rs6909	chr19:19619542	A/G	cg26732615	chr19:19648335	CILP2;YJEFN3	0.67	7.06	0.62	6e-10	Tonsillectomy;
SKCM	cis	rs7106204	0.668	rs7951530	chr11:24246904	T/C	ch.11.24196551F	chr11:24239977	NA	0.78	6.21	0.58	2.4e-8	Response to Homoharringtonine (cytotoxicity);
SKCM	cis	rs3020736	0.500	rs1801311	chr22:42486723	G/A	cg04733989	chr22:42467013	NAGA	-0.72	-5.62	-0.54	2.87e-7	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs4975616	0.869	rs401681	chr5:1322087	C/T	cg07493874	chr5:1342172	CLPTM1L	-0.69	-6.52	-0.59	6.37e-9	Lung cancer;
SKCM	cis	rs4237845	0.837	rs7954591	chr12:58299037	A/G	cg00677455	chr12:58241039	CTDSP2	0.71	5.96	0.56	6.93e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs873946	0.557	rs4880427	chr10:134591389	T/C	cg18305652	chr10:134549665	INPP5A	0.6	5.9	0.56	9.02e-8	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs72792276	1.000	rs72794379	chr5:127464965	G/A	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.77	5.22	0.51	1.46e-6	Red cell distribution width;
SKCM	cis	rs9875589	0.509	rs1601868	chr3:14065450	T/C	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.52	5.24	0.51	1.34e-6	Ovarian reserve;
SKCM	cis	rs9902453	0.791	rs55655651	chr17:28244286	T/A	cg26525008	chr17:28256777	EFCAB5;SSH2	0.79	5.67	0.54	2.35e-7	Coffee consumption (cups per day);
SKCM	cis	rs2050392	0.858	rs306583	chr10:30710057	C/T	cg25182066	chr10:30743637	MAP3K8	0.71	5.54	0.53	3.98e-7	Inflammatory bowel disease;
SKCM	cis	rs73110464	0.562	rs2363634	chr12:53354683	A/G	cg05393297	chr12:53359155	NA	-0.64	-5.92	-0.56	8.2e-8	Cancer (pleiotropy);
SKCM	cis	rs2153535	0.580	rs1115078	chr6:8449638	G/A	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs28595532	0.668	rs56410164	chr4:119331625	A/G	cg11846333	chr4:119757529	SEC24D	1.19	6.71	0.6	2.81e-9	Cannabis dependence symptom count;
SKCM	cis	rs8014204	0.762	rs10139018	chr14:75274292	T/C	cg06637938	chr14:75390232	RPS6KL1	0.71	5.55	0.53	3.8e-7	Caffeine consumption;
SKCM	cis	rs13118159	0.550	rs28614045	chr4:1374695	C/A	cg02018176	chr4:1364513	KIAA1530	0.89	7.24	0.63	2.72e-10	Longevity;
SKCM	cis	rs933688	0.941	rs2887007	chr5:90740531	A/T	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.92	6.76	0.61	2.21e-9	Smoking behavior;
SKCM	cis	rs13010713	0.840	rs4233790	chr2:182062056	A/C	cg21995919	chr2:182322279	ITGA4	-0.53	-5.12	-0.5	2.18e-6	Celiac disease;
SKCM	cis	rs1005277	0.579	rs2474569	chr10:38383491	C/G	cg25427524	chr10:38739819	LOC399744	-0.69	-6.45	-0.59	8.73e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs9300255	0.568	rs1621194	chr12:123651018	T/C	cg05973401	chr12:123451056	ABCB9	0.8	5.47	0.53	5.23e-7	Neutrophil percentage of white cells;
SKCM	cis	rs514406	0.929	rs557847	chr1:53333116	A/G	cg16325326	chr1:53192061	ZYG11B	0.96	10.07	0.75	9.41e-16	Monocyte count;
SKCM	cis	rs2832191	0.716	rs1888440	chr21:30454484	C/T	cg24692254	chr21:30365293	RNF160	0.99	9.05	0.72	8.59e-14	Dental caries;
SKCM	cis	rs709400	0.894	rs10143293	chr14:104063014	G/A	cg26031613	chr14:104095156	KLC1	1.11	12.9	0.83	4.83e-21	Body mass index;
SKCM	cis	rs9896933	0.945	rs3785522	chr17:80895933	A/G	cg20578329	chr17:80767326	TBCD	0.88	5.47	0.53	5.18e-7	Bone mineral accretion in asthma (oral corticosteroid dose interaction);
SKCM	cis	rs1348850	0.645	rs10164417	chr2:178444130	A/G	cg27490568	chr2:178487706	NA	0.7	5.2	0.51	1.58e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs4972806	0.849	rs2071581	chr2:177026148	G/T	cg03152288	chr2:177042942	NA	0.57	4.85	0.48	6.2e-6	IgG glycosylation;
SKCM	cis	rs7927771	0.524	rs754434	chr11:47814280	A/G	cg20307385	chr11:47447363	PSMC3	0.71	5.63	0.54	2.67e-7	Subjective well-being;
SKCM	cis	rs801193	1.000	rs2707845	chr7:66198798	C/T	cg00343986	chr7:65444356	GUSB	0.7	5.19	0.51	1.63e-6	Aortic root size;
SKCM	cis	rs58688157	0.705	rs12419618	chr11:611531	G/A	cg16486109	chr11:613632	IRF7	1.09	7.16	0.63	3.92e-10	Systemic lupus erythematosus;
SKCM	cis	rs17376456	0.569	rs7732578	chr5:93410244	C/T	cg25358565	chr5:93447407	FAM172A	-0.78	-4.98	-0.49	3.77e-6	Diabetic retinopathy;
SKCM	cis	rs11098499	0.954	rs3733520	chr4:120423480	C/G	cg24375607	chr4:120327624	NA	0.66	5.13	0.5	2.07e-6	Corneal astigmatism;
SKCM	cis	rs763121	0.925	rs5757251	chr22:39100128	G/A	cg06022373	chr22:39101656	GTPBP1	0.8	6.32	0.58	1.52e-8	Menopause (age at onset);
SKCM	cis	rs709400	0.628	rs2273699	chr14:103923475	A/G	cg26031613	chr14:104095156	KLC1	0.72	5.58	0.53	3.39e-7	Body mass index;
SKCM	cis	rs6424115	1.000	rs974698	chr1:24132785	C/T	cg15997130	chr1:24165203	NA	0.63	5.51	0.53	4.53e-7	Immature fraction of reticulocytes;
SKCM	cis	rs2228479	0.850	rs17232910	chr16:89839766	G/C	cg06558623	chr16:89946397	TCF25	1.11	5.25	0.51	1.28e-6	Skin colour saturation;
SKCM	cis	rs6430585	0.528	rs6711493	chr2:136692553	A/G	cg07169764	chr2:136633963	MCM6	1.24	10.46	0.76	1.63e-16	Corneal structure;
SKCM	cis	rs7552404	0.924	rs67757078	chr1:76169456	G/A	cg10523679	chr1:76189770	ACADM	0.7	5.05	0.5	2.83e-6	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs4319547	0.695	rs7301515	chr12:122949673	T/C	cg23029597	chr12:123009494	RSRC2	-0.83	-6.15	-0.57	3.04e-8	Body mass index;
SKCM	cis	rs116095464	0.558	rs6866632	chr5:264429	C/G	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs7666738	0.830	rs13148913	chr4:99009732	C/T	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4803468	1.000	rs2569754	chr19:41936734	A/G	cg09537434	chr19:41945824	ATP5SL	-1.1	-13.21	-0.83	1.39e-21	Height;
SKCM	cis	rs2842992	0.830	rs1535475	chr6:160148935	T/C	cg16489826	chr6:160211363	TCP1;MRPL18	0.72	5.16	0.5	1.82e-6	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs11690935	0.959	rs6759575	chr2:172689068	C/T	cg13550731	chr2:172543902	DYNC1I2	-0.9	-7.44	-0.64	1.11e-10	Schizophrenia;
SKCM	cis	rs28374715	0.662	rs513280	chr15:41482800	T/C	cg18705301	chr15:41695430	NDUFAF1	0.93	7.74	0.66	2.94e-11	Ulcerative colitis;
SKCM	cis	rs2894969	0.664	rs11252703	chr10:4795125	A/T	cg23445945	chr10:4822998	NA	0.61	4.93	0.49	4.56e-6	Major depressive disorder;
SKCM	cis	rs826838	1.000	rs1843881	chr12:38733706	A/G	cg13010199	chr12:38710504	ALG10B	-0.87	-6.82	-0.61	1.7e-9	Heart rate;
SKCM	cis	rs4423214	1.000	rs2002063	chr11:71163476	T/C	cg05163923	chr11:71159392	DHCR7	0.83	8.06	0.67	7.35e-12	Vitamin D levels;
SKCM	cis	rs75804782	0.522	rs7561954	chr2:239318280	G/A	cg18131467	chr2:239335373	ASB1	-0.97	-5.15	-0.5	1.93e-6	Morning vs. evening chronotype;Chronotype;
SKCM	cis	rs35146811	0.622	rs6946204	chr7:99589125	T/C	cg22906224	chr7:99728672	NA	0.76	5.48	0.53	5.14e-7	Coronary artery disease;
SKCM	cis	rs898097	0.578	rs6502021	chr17:80907728	T/C	cg15369054	chr17:80825471	TBCD	-0.58	-5.64	-0.54	2.6e-7	Breast cancer;
SKCM	cis	rs3091242	0.933	rs3093584	chr1:25668714	T/C	cg27572855	chr1:25598939	RHD	-0.55	-5.34	-0.52	8.86e-7	Erythrocyte sedimentation rate;
SKCM	cis	rs1799949	0.859	rs11657004	chr17:41442751	A/G	cg05368731	chr17:41323189	NBR1	0.85	6.84	0.61	1.62e-9	Menopause (age at onset);
SKCM	cis	rs864745	0.967	rs702814	chr7:28172732	C/T	cg15170557	chr7:28214983	JAZF1	-0.66	-6.97	-0.62	9.16e-10	Crohn's disease;Type 2 diabetes;
SKCM	cis	rs2204008	0.597	rs4002591	chr12:38133841	A/G	cg13010199	chr12:38710504	ALG10B	0.65	4.84	0.48	6.52e-6	Bladder cancer;
SKCM	cis	rs7617480	0.648	rs9284885	chr3:48883100	A/C	cg07636037	chr3:49044803	WDR6	0.92	6.81	0.61	1.82e-9	Subjective well-being (multi-trait analysis);Menarche (age at onset);
SKCM	cis	rs2204008	0.627	rs10878488	chr12:38148666	G/A	cg13010199	chr12:38710504	ALG10B	0.68	4.97	0.49	3.89e-6	Bladder cancer;
SKCM	cis	rs1580019	0.587	rs6968990	chr7:32552159	C/T	cg06627557	chr7:32535165	LSM5;AVL9	-0.94	-8.96	-0.71	1.28e-13	Cognitive ability;
SKCM	cis	rs875971	0.545	rs6970498	chr7:65740895	A/G	cg18876405	chr7:65276391	NA	0.65	5.32	0.52	9.65e-7	Aortic root size;
SKCM	cis	rs9868809	0.542	rs9873726	chr3:48712367	C/T	cg00383909	chr3:49044727	WDR6	0.89	4.92	0.49	4.79e-6	Ulcerative colitis;Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs7772486	0.719	rs702307	chr6:145993454	C/G	cg05347473	chr6:146136440	FBXO30	-0.66	-6.06	-0.57	4.63e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9790314	0.905	rs4518145	chr3:160950030	T/C	cg03342759	chr3:160939853	NMD3	-0.73	-8.2	-0.68	3.89e-12	Morning vs. evening chronotype;
SKCM	cis	rs2286503	0.780	rs981792	chr7:22861639	C/A	cg15401507	chr7:22894281	NA	-0.57	-5.61	-0.54	2.99e-7	Fibrinogen;
SKCM	cis	rs12586317	0.620	rs10145433	chr14:35583333	G/A	cg16230307	chr14:35515116	FAM177A1	0.7	5.18	0.51	1.67e-6	Psoriasis;
SKCM	cis	rs17291845	0.744	rs2631531	chr16:55238364	A/G	cg16501625	chr16:54628759	NA	0.52	4.83	0.48	6.67e-6	Information processing speed;
SKCM	cis	rs7666738	0.830	rs7682991	chr4:98982595	C/A	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs12047808	0.841	rs73050574	chr1:179379019	A/T	cg08037922	chr1:179521085	C1orf125;NPHS2	-1.08	-5.8	-0.55	1.32e-7	Multiple sclerosis (age of onset);
SKCM	cis	rs67311347	1.000	rs2276868	chr3:40498845	C/T	cg00091569	chr3:40428383	ENTPD3	-0.59	-4.83	-0.48	6.6e-6	Renal cell carcinoma;
SKCM	cis	rs11249608	0.636	rs13359572	chr5:178449276	T/C	cg21905437	chr5:178450457	ZNF879	0.71	6.0	0.56	5.9e-8	Pubertal anthropometrics;
SKCM	cis	rs1707322	0.752	rs61784793	chr1:46149285	G/A	cg03146154	chr1:46216737	IPP	0.81	5.61	0.54	2.94e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs11690935	0.843	rs9784070	chr2:172785007	C/T	cg13550731	chr2:172543902	DYNC1I2	-0.95	-7.86	-0.67	1.72e-11	Schizophrenia;
SKCM	cis	rs6089584	0.566	rs7274240	chr20:60622004	C/T	cg16423285	chr20:60520624	NA	-0.56	-4.82	-0.48	6.97e-6	Body mass index;
SKCM	cis	rs995000	0.524	rs61775962	chr1:63199350	A/T	cg06896770	chr1:63153194	DOCK7	-0.73	-5.95	-0.56	7.2e-8	Triglyceride levels;
SKCM	cis	rs28595532	1.000	rs114682099	chr4:119702004	C/T	cg14228332	chr4:119757509	SEC24D	1.07	5.49	0.53	4.77e-7	Cannabis dependence symptom count;
SKCM	cis	rs1552244	0.626	rs2886396	chr3:10037670	C/T	cg02579736	chr3:10068473	FANCD2;CIDECP	0.94	4.84	0.48	6.49e-6	Alzheimer's disease;
SKCM	cis	rs875971	0.862	rs937494	chr7:65764678	T/A	cg18876405	chr7:65276391	NA	-0.64	-6.38	-0.59	1.18e-8	Aortic root size;
SKCM	cis	rs2836950	0.501	rs35994303	chr21:40686020	C/T	cg17971929	chr21:40555470	PSMG1	-0.72	-6.02	-0.56	5.26e-8	Menarche (age at onset);
SKCM	cis	rs2749592	0.611	rs2505199	chr10:38392457	G/A	cg25427524	chr10:38739819	LOC399744	-0.75	-7.35	-0.64	1.68e-10	Age-related hearing impairment (SNP x SNP interaction);
SKCM	cis	rs7927771	1.000	rs35902101	chr11:47795169	C/T	cg05585544	chr11:47624801	NA	-0.6	-5.22	-0.51	1.45e-6	Subjective well-being;
SKCM	cis	rs12497850	0.931	rs6446205	chr3:49035211	C/T	cg07636037	chr3:49044803	WDR6	1.04	11.28	0.79	4.6e-18	Parkinson's disease;
SKCM	cis	rs9457247	0.663	rs9459839	chr6:167431829	T/C	cg13927040	chr6:167453801	FGFR1OP	0.58	4.83	0.48	6.57e-6	Crohn's disease;
SKCM	cis	rs7336332	0.598	rs77055070	chr13:28010516	C/G	cg22138327	chr13:27999177	GTF3A	0.9	6.4	0.59	1.07e-8	Weight;
SKCM	cis	rs7927771	0.965	rs35184771	chr11:47475189	G/T	cg05585544	chr11:47624801	NA	-0.64	-5.54	-0.53	3.93e-7	Subjective well-being;
SKCM	cis	rs28595532	0.920	rs114649974	chr4:119735341	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs2991971	0.782	rs10789463	chr1:45927848	C/A	cg24296786	chr1:45957014	TESK2	-0.66	-5.32	-0.52	9.58e-7	High light scatter reticulocyte count;
SKCM	cis	rs8180040	0.705	rs73069104	chr3:47280733	T/C	cg27129171	chr3:47204927	SETD2	-0.8	-5.51	-0.53	4.49e-7	Colorectal cancer;
SKCM	cis	rs9814567	1.000	rs2370642	chr3:134222136	C/T	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.63	-4.96	-0.49	4.06e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs1552244	1.000	rs7651058	chr3:10066964	C/T	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs16866061	1.000	rs10933068	chr2:225418360	G/A	cg12698349	chr2:225449008	CUL3	1.01	8.51	0.69	9.75e-13	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs2153535	0.580	rs7341206	chr6:8470489	T/G	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs4619890	0.528	rs62289340	chr4:7879027	C/T	cg08722675	chr4:8412549	ACOX3	0.54	4.94	0.49	4.32e-6	Glaucoma (primary open-angle);
SKCM	cis	rs17376456	0.825	rs10079708	chr5:93261796	G/C	cg21475434	chr5:93447410	FAM172A	1.02	5.17	0.51	1.74e-6	Diabetic retinopathy;
SKCM	cis	rs10193935	0.901	rs10170082	chr2:42623452	T/C	cg27598129	chr2:42591480	NA	-0.88	-6.71	-0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1348850	0.554	rs11679519	chr2:178432110	C/T	cg27490568	chr2:178487706	NA	0.8	5.67	0.54	2.28e-7	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs992157	0.687	rs35271699	chr2:219117482	G/A	cg00012203	chr2:219082015	ARPC2	0.84	7.36	0.64	1.6e-10	Colorectal cancer;
SKCM	cis	rs4665809	0.652	rs6727974	chr2:26524639	A/G	cg26119090	chr2:26468346	HADHA;HADHB	1.03	6.77	0.61	2.11e-9	Gut microbiome composition (summer);
SKCM	cis	rs2479724	0.776	rs2250428	chr6:41832772	T/A	cg17623882	chr6:41773611	USP49	-0.75	-6.35	-0.58	1.31e-8	Menarche (age at onset);
SKCM	trans	rs9929218	0.551	rs2296405	chr16:68721470	C/T	cg04657470	chr2:198365150	HSPE1;HSPD1	-0.96	-10.62	-0.77	8.39e-17	Colorectal cancer;
SKCM	cis	rs11892454	0.533	rs13392329	chr2:26065592	G/T	cg17263061	chr2:26915892	KCNK3	0.69	4.98	0.49	3.73e-6	Heschl's gyrus morphology;
SKCM	cis	rs875971	0.830	rs587360	chr7:65522698	C/A	cg11987759	chr7:65425863	GUSB	-0.56	-4.94	-0.49	4.34e-6	Aortic root size;
SKCM	cis	rs4891159	0.790	rs660029	chr18:74149668	A/G	cg24786174	chr18:74118243	ZNF516	0.73	7.2	0.63	3.3e-10	Longevity;
SKCM	cis	rs3087591	1.000	rs2905877	chr17:29543269	A/C	cg24425628	chr17:29625626	OMG;NF1	-0.64	-5.34	-0.52	8.93e-7	Hip circumference;
SKCM	cis	rs2243480	1.000	rs73142121	chr7:65311206	C/T	cg07424592	chr7:64974309	NA	0.99	4.9	0.49	5.08e-6	Diabetic kidney disease;
SKCM	cis	rs28595532	0.920	rs114659035	chr4:119740028	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs2836974	0.583	rs9981884	chr21:40585633	G/A	cg17971929	chr21:40555470	PSMG1	0.78	6.86	0.61	1.43e-9	Cognitive function;
SKCM	cis	rs854765	0.583	rs7222480	chr17:17818817	G/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.93	7.3	0.64	2.06e-10	Total body bone mineral density;
SKCM	cis	rs4862750	0.872	rs11947595	chr4:187899827	C/T	cg10295955	chr4:187884368	NA	-1.04	-13.97	-0.85	6.27e-23	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2204008	0.754	rs11181244	chr12:38302454	T/C	cg26384229	chr12:38710491	ALG10B	0.81	6.57	0.6	5.18e-9	Bladder cancer;
SKCM	cis	rs12477438	0.520	rs13012481	chr2:99754290	C/A	cg14399236	chr2:99771627	LIPT1;TSGA10	1.01	9.53	0.73	1.01e-14	Chronic sinus infection;
SKCM	cis	rs7937682	0.883	rs512669	chr11:111467893	G/A	cg09085632	chr11:111637200	PPP2R1B	-1.0	-8.74	-0.7	3.47e-13	Primary sclerosing cholangitis;
SKCM	cis	rs7555523	0.830	rs12691500	chr1:165687761	A/G	cg24409356	chr1:165738333	TMCO1	0.93	5.15	0.5	1.93e-6	Intraocular pressure;Glaucoma (high intraocular pressure);
SKCM	cis	rs651907	0.557	rs2288272	chr3:101378476	C/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.82	7.06	0.62	6.06e-10	Colorectal cancer;
SKCM	cis	rs2836974	0.897	rs8133146	chr21:40614298	T/C	cg17971929	chr21:40555470	PSMG1	0.9	8.81	0.71	2.52e-13	Cognitive function;
SKCM	cis	rs3820928	0.874	rs4675130	chr2:227827740	G/T	cg11843606	chr2:227700838	RHBDD1	-0.6	-4.78	-0.48	8e-6	Pulmonary function;
SKCM	cis	rs6546550	0.867	rs726920	chr2:70152027	G/C	cg02498382	chr2:70120550	SNRNP27	-0.45	-4.88	-0.48	5.4e-6	Prevalent atrial fibrillation;
SKCM	cis	rs67311347	0.544	rs6804545	chr3:40354040	G/C	cg13409248	chr3:40428643	ENTPD3	0.57	5.32	0.52	9.61e-7	Renal cell carcinoma;
SKCM	cis	rs9901225	1	rs9901225	chr17:40755811	C/T	cg14558262	chr17:40713999	COASY	0.74	6.04	0.56	4.93e-8	Colorectal or endometrial cancer;
SKCM	cis	rs28386778	0.830	rs2665798	chr17:61921397	C/T	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs7633770	0.786	rs950190	chr3:46683377	C/T	cg11219411	chr3:46661640	NA	0.54	4.86	0.48	5.98e-6	Coronary artery disease;
SKCM	cis	rs4523957	0.786	rs28524880	chr17:2125444	C/A	cg16513277	chr17:2031491	SMG6	-0.73	-4.95	-0.49	4.13e-6	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs1577917	0.629	rs9450285	chr6:86208096	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.65	5.46	0.53	5.56e-7	Response to antipsychotic treatment;
SKCM	cis	rs11098499	0.909	rs28884220	chr4:120307211	A/G	cg09307838	chr4:120376055	NA	0.97	7.49	0.65	9.08e-11	Corneal astigmatism;
SKCM	cis	rs3859192	0.561	rs12453343	chr17:38181176	C/A	cg17467752	chr17:38218738	THRA	-0.76	-6.37	-0.58	1.22e-8	White blood cell count;
SKCM	cis	rs919433	0.963	rs12618612	chr2:198171058	G/T	cg04278110	chr2:198063759	ANKRD44	-0.69	-4.8	-0.48	7.58e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs4771122	0.596	rs7334690	chr13:28081535	C/T	cg22138327	chr13:27999177	GTF3A	0.71	5.06	0.5	2.73e-6	Body mass index;
SKCM	cis	rs7666738	0.800	rs10028921	chr4:98962630	G/T	cg05340658	chr4:99064831	C4orf37	0.63	4.9	0.48	5.18e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11098499	0.820	rs12503082	chr4:120284317	A/G	cg24375607	chr4:120327624	NA	0.62	4.77	0.48	8.45e-6	Corneal astigmatism;
SKCM	cis	rs919433	0.963	rs1429417	chr2:198158171	T/G	cg04278110	chr2:198063759	ANKRD44	-0.72	-5.33	-0.52	9.25e-7	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs514406	0.679	rs11206006	chr1:53218380	A/G	cg24675658	chr1:53192096	ZYG11B	0.91	8.2	0.68	3.91e-12	Monocyte count;
SKCM	cis	rs2777491	0.874	rs28716108	chr15:41655523	G/C	cg18705301	chr15:41695430	NDUFAF1	-0.99	-9.93	-0.75	1.72e-15	Ulcerative colitis;
SKCM	cis	rs28374715	0.681	rs8037574	chr15:41630770	T/C	cg18705301	chr15:41695430	NDUFAF1	-1.07	-10.54	-0.77	1.16e-16	Ulcerative colitis;
SKCM	cis	rs2032447	0.765	rs1935235	chr6:26067782	C/G	cg18357526	chr6:26021779	HIST1H4A	0.86	7.35	0.64	1.66e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs847649	0.924	rs6960428	chr7:102589706	C/G	cg18108683	chr7:102477205	FBXL13	0.82	8.48	0.69	1.1e-12	Morning vs. evening chronotype;
SKCM	cis	rs7809950	1.000	rs12668402	chr7:107173020	G/A	cg23024343	chr7:107201750	COG5	-0.77	-6.95	-0.62	9.61e-10	Coronary artery disease;
SKCM	cis	rs35306767	0.812	rs1013504	chr10:952816	T/C	cg20503657	chr10:835505	NA	0.88	6.2	0.57	2.48e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs10791097	0.694	rs10160281	chr11:130742788	T/C	cg12179176	chr11:130786555	SNX19	0.93	8.16	0.68	4.62e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs244731	0.920	rs244707	chr5:176555636	A/T	cg16006841	chr5:176797999	RGS14	0.8	6.23	0.58	2.18e-8	Urate levels in lean individuals;
SKCM	cis	rs10927875	0.632	rs6677321	chr1:16149301	A/C	cg21385522	chr1:16154831	NA	-0.99	-12.1	-0.81	1.42e-19	Dilated cardiomyopathy;
SKCM	cis	rs1003719	0.788	rs2835575	chr21:38455936	A/G	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs1799949	1.000	rs4793215	chr17:41318932	G/A	cg23758822	chr17:41437982	NA	0.92	7.83	0.66	1.97e-11	Menopause (age at onset);
SKCM	cis	rs7027203	0.828	rs10122041	chr9:96615517	A/G	cg14598338	chr9:96623480	NA	-0.5	-5.11	-0.5	2.25e-6	DNA methylation (variation);
SKCM	cis	rs1160297	0.609	rs6715847	chr2:53097378	T/G	cg07782112	chr2:53107842	NA	0.58	6.04	0.56	5e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs7216064	0.911	rs12449442	chr17:65947640	G/A	cg12091567	chr17:66097778	LOC651250	-0.75	-5.07	-0.5	2.67e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs826838	0.967	rs1684415	chr12:39130099	T/C	cg26384229	chr12:38710491	ALG10B	-0.91	-8.28	-0.68	2.74e-12	Heart rate;
SKCM	cis	rs9911578	1.000	rs2333332	chr17:56631054	A/G	cg05425664	chr17:57184151	TRIM37	0.69	5.2	0.51	1.55e-6	Intelligence (multi-trait analysis);
SKCM	trans	rs208520	0.690	rs12213581	chr6:66735818	T/C	cg15611600	chr13:45563400	KIAA1704;NUFIP1	0.93	7.71	0.66	3.36e-11	Exhaled nitric oxide output;
SKCM	cis	rs9910055	0.531	rs6503490	chr17:42246656	A/G	cg10896456	chr17:42255109	ASB16;C17orf65	0.69	7.22	0.63	3e-10	Total body bone mineral density;
SKCM	cis	rs17685	0.712	rs10235086	chr7:75833138	G/T	cg16489192	chr7:75678113	MDH2;STYXL1	-0.55	-5.33	-0.52	9.17e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs35306767	0.903	rs7914758	chr10:891702	T/C	cg20503657	chr10:835505	NA	0.79	5.57	0.53	3.52e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs823143	0.570	rs1361754	chr1:205801872	C/T	cg07167872	chr1:205819463	PM20D1	-0.94	-8.83	-0.71	2.27e-13	Monocyte percentage of white cells;
SKCM	cis	rs9311474	1.000	rs7629072	chr3:52305633	C/T	cg18404041	chr3:52824283	ITIH1	-0.53	-4.84	-0.48	6.39e-6	Electroencephalogram traits;
SKCM	cis	rs709400	0.628	rs11622320	chr14:103912194	A/T	cg26031613	chr14:104095156	KLC1	0.74	5.44	0.52	5.98e-7	Body mass index;
SKCM	cis	rs6692209	1	rs6692209	chr1:152506444	C/T	cg09873164	chr1:152488093	CRCT1	0.76	5.93	0.56	7.7e-8	Plantar warts;
SKCM	cis	rs507080	0.922	rs518028	chr11:118564982	T/C	cg18045108	chr11:118530628	TREH	-0.47	-4.81	-0.48	7.17e-6	Serum metabolite levels;
SKCM	cis	rs28595532	0.920	rs56291421	chr4:119732294	G/A	cg14228332	chr4:119757509	SEC24D	1.08	5.52	0.53	4.28e-7	Cannabis dependence symptom count;
SKCM	cis	rs1153858	1.000	rs12593230	chr15:45646968	A/T	cg21132104	chr15:45694354	SPATA5L1	0.92	7.81	0.66	2.22e-11	Homoarginine levels;
SKCM	cis	rs28386778	0.897	rs2727333	chr17:61876023	G/A	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs362296	0.511	rs2051558	chr4:3324886	G/A	cg09735869	chr4:3319127	RGS12	0.84	9.02	0.71	9.8e-14	Parental longevity (mother's age at death);
SKCM	cis	rs7829975	0.871	rs7829826	chr8:8578120	T/A	cg06636001	chr8:8085503	FLJ10661	-0.81	-7.4	-0.64	1.33e-10	Mood instability;
SKCM	cis	rs11155671	0.530	rs7764376	chr6:150210344	A/G	cg05036130	chr6:150231994	NA	0.61	6.58	0.6	4.87e-9	Testicular germ cell tumor;
SKCM	cis	rs9611565	0.649	rs202666	chr22:41814719	T/C	cg03806693	chr22:41940476	POLR3H	1.1	7.47	0.65	9.78e-11	Vitiligo;
SKCM	cis	rs2153535	0.562	rs6901765	chr6:8455436	A/T	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs6061231	0.631	rs2427310	chr20:60969929	C/G	cg24112000	chr20:60950667	NA	-0.58	-5.81	-0.55	1.31e-7	Colorectal cancer;
SKCM	cis	rs3857536	0.740	rs4710574	chr6:66890631	T/G	cg07460842	chr6:66804631	NA	-0.7	-5.08	-0.5	2.51e-6	Blood trace element (Cu levels);
SKCM	trans	rs1814175	0.817	rs11040700	chr11:50023832	C/T	cg03929089	chr4:120376271	NA	-0.93	-8.77	-0.7	3.08e-13	Height;
SKCM	cis	rs8067545	0.586	rs2703819	chr17:20121401	A/G	cg13482628	chr17:19912719	NA	-0.65	-5.41	-0.52	6.58e-7	Schizophrenia;
SKCM	cis	rs28386778	0.897	rs2584626	chr17:61903179	A/G	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs28595532	0.920	rs114382134	chr4:119733215	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.52	0.53	4.28e-7	Cannabis dependence symptom count;
SKCM	cis	rs514406	0.505	rs12726160	chr1:53175099	A/G	cg16325326	chr1:53192061	ZYG11B	0.89	10.06	0.75	9.55e-16	Monocyte count;
SKCM	cis	rs17685	0.712	rs6953342	chr7:75776753	T/C	cg16489192	chr7:75678113	MDH2;STYXL1	-0.52	-4.78	-0.48	8.22e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs3780486	0.846	rs7850878	chr9:33126570	A/G	cg13443165	chr9:33130375	B4GALT1	-0.55	-4.99	-0.49	3.65e-6	IgG glycosylation;
SKCM	cis	rs4819052	0.765	rs2838868	chr21:46714641	A/G	cg02159808	chr21:46707872	POFUT2;LOC642852	-0.75	-5.0	-0.49	3.46e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs1799949	1.000	rs4793192	chr17:41204390	T/C	cg23758822	chr17:41437982	NA	0.94	7.82	0.66	2.13e-11	Menopause (age at onset);
SKCM	cis	rs7618915	0.851	rs34228726	chr3:52322797	A/G	cg18404041	chr3:52824283	ITIH1	-0.59	-5.19	-0.51	1.65e-6	Bipolar disorder;
SKCM	cis	rs7208859	0.573	rs8070182	chr17:29135594	A/C	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs17376456	0.877	rs10044139	chr5:93407803	T/C	cg21475434	chr5:93447410	FAM172A	0.97	5.41	0.52	6.8e-7	Diabetic retinopathy;
SKCM	cis	rs16866061	1.000	rs11688397	chr2:225393173	C/T	cg12698349	chr2:225449008	CUL3	1.03	8.73	0.7	3.68e-13	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs4819052	0.851	rs2838826	chr21:46655785	A/G	cg19498844	chr21:46707878	POFUT2;LOC642852	0.84	6.91	0.62	1.16e-9	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs919433	0.680	rs2564383	chr2:198310862	A/G	cg04278110	chr2:198063759	ANKRD44	0.7	4.79	0.48	7.87e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs4481887	0.741	rs1361413	chr1:248529521	C/G	cg22724847	chr1:248512586	OR14C36	-0.61	-5.77	-0.55	1.5e-7	Common traits (Other);
SKCM	cis	rs12142240	0.698	rs10158236	chr1:46820896	G/T	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs2153535	0.580	rs718503	chr6:8527463	A/T	cg07606381	chr6:8435919	SLC35B3	0.93	6.8	0.61	1.92e-9	Motion sickness;
SKCM	cis	rs10256972	0.568	rs1133043	chr7:1133305	C/G	cg16145915	chr7:1198662	ZFAND2A	-0.56	-7.81	-0.66	2.24e-11	Longevity;Endometriosis;
SKCM	cis	rs10911232	0.507	rs28477876	chr1:183019882	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.65	0.6	3.59e-9	Hypertriglyceridemia;
SKCM	cis	rs3820068	0.581	rs111699992	chr1:15927158	G/A	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs9796	0.689	rs692511	chr15:41446252	A/C	cg18705301	chr15:41695430	NDUFAF1	-0.76	-5.58	-0.53	3.31e-7	Menopause (age at onset);
SKCM	cis	rs2644899	0.750	rs2249835	chr19:41269766	G/A	cg24958765	chr19:41283667	RAB4B	-0.84	-5.34	-0.52	8.92e-7	Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs7809950	0.768	rs62482493	chr7:106951579	T/C	cg23024343	chr7:107201750	COG5	-0.85	-7.01	-0.62	7.39e-10	Coronary artery disease;
SKCM	cis	rs4242434	0.857	rs11777808	chr8:22462755	A/C	cg03733263	chr8:22462867	KIAA1967	1.07	9.15	0.72	5.54e-14	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs9815354	0.716	rs76313799	chr3:41931751	A/C	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs854765	0.583	rs7503334	chr17:17779458	C/T	cg04398451	chr17:18023971	MYO15A	0.79	5.86	0.55	1.04e-7	Total body bone mineral density;
SKCM	cis	rs8078723	1.000	rs4794823	chr17:38166265	A/T	cg17467752	chr17:38218738	THRA	0.68	6.3	0.58	1.61e-8	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs116095464	1.000	rs55847527	chr5:317520	T/C	cg22857025	chr5:266934	NA	-1.57	-5.5	-0.53	4.61e-7	Breast cancer;
SKCM	cis	rs5769765	0.908	rs9627800	chr22:50319351	T/C	cg22709217	chr22:50311962	ALG12;CRELD2	-0.99	-6.09	-0.57	4.04e-8	Schizophrenia;
SKCM	cis	rs2243480	1.000	rs2707831	chr7:66062511	G/A	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs2228479	0.717	rs62052210	chr16:89980158	A/G	cg06558623	chr16:89946397	TCF25	1.23	6.7	0.6	2.88e-9	Skin colour saturation;
SKCM	cis	rs28595532	0.764	rs56309519	chr4:119754158	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs7772486	0.754	rs6910790	chr6:146255330	G/A	cg23711669	chr6:146136114	FBXO30	-0.77	-7.33	-0.64	1.83e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7666738	0.830	rs6532721	chr4:99048015	G/A	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10752881	0.809	rs3768613	chr1:183106296	G/C	ch.1.3577855R	chr1:183094577	LAMC1	0.78	7.57	0.65	6.46e-11	Colorectal cancer;
SKCM	cis	rs7100689	0.646	rs7092237	chr10:82165640	A/G	cg01528321	chr10:82214614	TSPAN14	0.91	7.8	0.66	2.27e-11	Post bronchodilator FEV1;
SKCM	cis	rs9325144	0.555	rs2387855	chr12:38687964	T/G	cg26384229	chr12:38710491	ALG10B	0.78	6.74	0.61	2.48e-9	Morning vs. evening chronotype;
SKCM	cis	rs8180040	0.966	rs13075233	chr3:47420627	T/C	cg16586182	chr3:47516702	SCAP	-0.76	-5.32	-0.52	9.63e-7	Colorectal cancer;
SKCM	cis	rs9660180	0.967	rs6664664	chr1:1751264	G/A	cg17747265	chr1:1875780	NA	-0.55	-5.07	-0.5	2.6e-6	Body mass index;
SKCM	cis	rs28595532	0.920	rs114678295	chr4:119756281	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs911263	0.961	rs3784099	chr14:68749927	A/G	cg18825221	chr14:68749962	RAD51L1	0.51	5.51	0.53	4.49e-7	Primary biliary cholangitis;
SKCM	trans	rs561341	0.843	rs879945	chr17:30242796	G/A	cg20587970	chr11:113659929	NA	-1.03	-8.22	-0.68	3.56e-12	Hip circumference adjusted for BMI;
SKCM	cis	rs867186	1.000	rs7261167	chr20:33576205	C/T	cg04194272	chr20:33683537	NA	-1.05	-6.47	-0.59	8.03e-9	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs722599	0.501	rs7158047	chr14:75388803	G/A	cg08847533	chr14:75593920	NEK9	0.65	5.34	0.52	9e-7	IgG glycosylation;
SKCM	cis	rs473651	0.935	rs540636	chr2:239358341	T/C	cg21699342	chr2:239360505	ASB1	0.54	5.4	0.52	6.99e-7	Multiple system atrophy;
SKCM	cis	rs28386778	0.897	rs1062790	chr17:61896455	A/G	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs10751667	0.666	rs10794354	chr11:954615	A/T	cg10932868	chr11:921992	NA	0.55	5.1	0.5	2.36e-6	Alzheimer's disease (late onset);
SKCM	cis	rs8060686	0.641	rs76984161	chr16:68139423	C/A	cg04539111	chr16:67997858	SLC12A4	-0.85	-4.81	-0.48	7.14e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs8060686	0.641	rs76646352	chr16:68044797	C/A	cg09117114	chr16:67998030	SLC12A4	-0.78	-5.06	-0.5	2.72e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs9894429	0.646	rs7210026	chr17:79612382	T/C	cg18240062	chr17:79603768	NPLOC4	0.68	6.07	0.57	4.41e-8	Eye color traits;
SKCM	cis	rs10540	0.908	rs35608427	chr11:498976	T/C	cg03576123	chr11:487126	PTDSS2	-1.43	-8.14	-0.68	5.08e-12	Body mass index;
SKCM	cis	rs60871478	1.000	rs62432252	chr7:802886	C/G	cg05535760	chr7:792225	HEATR2	1.02	8.66	0.7	4.97e-13	Cerebrospinal P-tau181p levels;
SKCM	cis	rs6545883	0.929	rs2592352	chr2:61665336	C/T	cg15711740	chr2:61764176	XPO1	-0.7	-4.93	-0.49	4.5e-6	Tuberculosis;
SKCM	cis	rs2841277	0.741	rs9672139	chr14:105408182	T/G	cg19901468	chr14:105411992	AHNAK2	-1.06	-10.99	-0.78	1.61e-17	Rheumatoid arthritis;
SKCM	cis	rs453301	0.653	rs7016139	chr8:8895470	A/G	cg06636001	chr8:8085503	FLJ10661	-0.79	-6.12	-0.57	3.55e-8	Joint mobility (Beighton score);
SKCM	cis	rs3785574	0.635	rs2532111	chr17:62017421	A/G	cg11494091	chr17:61959527	GH2	-0.59	-5.81	-0.55	1.3e-7	Height;
SKCM	cis	rs8180040	0.967	rs4858890	chr3:47405456	A/G	cg27129171	chr3:47204927	SETD2	-0.78	-5.81	-0.55	1.31e-7	Colorectal cancer;
SKCM	cis	rs2197308	0.703	rs10880251	chr12:37903297	G/A	cg26384229	chr12:38710491	ALG10B	0.82	6.88	0.61	1.35e-9	Morning vs. evening chronotype;
SKCM	cis	rs6977660	1.000	rs714239	chr7:19803944	C/T	cg07541023	chr7:19748670	TWISTNB	0.72	5.03	0.5	3.01e-6	Thyroid stimulating hormone;
SKCM	cis	rs1005277	0.579	rs2749612	chr10:38488610	G/A	cg00409905	chr10:38381863	ZNF37A	-0.65	-5.92	-0.56	8.1e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs11673344	0.764	rs524802	chr19:37446947	G/A	cg07624650	chr19:37064219	ZNF529	-0.78	-4.82	-0.48	7.05e-6	Obesity-related traits;
SKCM	trans	rs1814175	0.546	rs1614397	chr11:49913384	G/C	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs847649	1.000	rs13233521	chr7:102593794	C/T	cg18108683	chr7:102477205	FBXL13	0.82	8.63	0.7	5.57e-13	Morning vs. evening chronotype;
SKCM	cis	rs2404602	0.647	rs11637096	chr15:76931102	T/C	cg23625390	chr15:77176239	SCAPER	-0.85	-8.26	-0.68	2.93e-12	Blood metabolite levels;
SKCM	cis	rs12142240	0.698	rs17361950	chr1:46864150	C/T	cg10495392	chr1:46806563	NSUN4	0.75	5.54	0.53	4.02e-7	Menopause (age at onset);
SKCM	cis	rs6951245	0.832	rs10266519	chr7:1142977	C/T	cg03188948	chr7:1209495	NA	1.03	6.35	0.58	1.34e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs2180341	0.920	rs6906717	chr6:127596782	C/A	cg27446573	chr6:127587934	RNF146	0.99	8.51	0.69	9.46e-13	Breast cancer;
SKCM	cis	rs2836974	0.583	rs2735307	chr21:40713358	C/T	cg11644478	chr21:40555479	PSMG1	0.64	4.88	0.48	5.43e-6	Cognitive function;
SKCM	cis	rs9880211	1.000	rs6775314	chr3:136275948	G/A	cg21827317	chr3:136751795	NA	-0.65	-4.92	-0.49	4.73e-6	Body mass index;Height;
SKCM	cis	rs2404602	0.647	rs4312276	chr15:77164361	T/C	cg23625390	chr15:77176239	SCAPER	-0.85	-8.26	-0.68	2.93e-12	Blood metabolite levels;
SKCM	cis	rs4555082	0.874	rs2816625	chr14:105734565	G/A	cg13114125	chr14:105738426	BRF1	-0.69	-5.47	-0.53	5.33e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs2404602	0.669	rs12911987	chr15:76953256	C/T	cg23625390	chr15:77176239	SCAPER	0.59	4.84	0.48	6.31e-6	Blood metabolite levels;
SKCM	cis	rs9640161	0.789	rs36035506	chr7:150057843	C/T	cg10018233	chr7:150070692	REPIN1	0.66	5.14	0.5	2.02e-6	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs644799	0.735	rs10831432	chr11:95516040	C/A	cg03916912	chr11:95522834	CEP57;FAM76B	0.82	6.99	0.62	8.33e-10	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs7296418	0.961	rs4148862	chr12:123568619	A/C	cg05973401	chr12:123451056	ABCB9	0.84	6.88	0.61	1.34e-9	Platelet count;
SKCM	cis	rs7618501	0.699	rs11713193	chr3:49924424	G/A	cg05072774	chr3:49840536	C3orf54	-0.71	-5.24	-0.51	1.31e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs6546550	0.867	rs1551374	chr2:70079633	C/T	cg02498382	chr2:70120550	SNRNP27	-0.47	-5.25	-0.51	1.29e-6	Prevalent atrial fibrillation;
SKCM	trans	rs3749237	0.964	rs10049413	chr3:49892896	A/G	cg21659725	chr3:3221576	CRBN	1.07	7.36	0.64	1.59e-10	Resting heart rate;
SKCM	cis	rs597539	0.617	rs669659	chr11:68635623	G/C	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.84	5.61	0.54	3e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs28386778	0.897	rs2727333	chr17:61876023	G/A	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs67311347	0.544	rs7644181	chr3:40355665	A/G	cg00091569	chr3:40428383	ENTPD3	-0.64	-5.45	-0.52	5.81e-7	Renal cell carcinoma;
SKCM	cis	rs10876993	0.672	rs2640611	chr12:58037757	T/A	cg18357645	chr12:58087776	OS9	0.61	5.62	0.54	2.84e-7	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs6539267	0.885	rs34762209	chr12:106722466	T/C	cg02476566	chr12:106696527	TCP11L2	0.75	4.86	0.48	5.9e-6	Tourette syndrome;
SKCM	cis	rs6582630	0.555	rs2004152	chr12:38478951	C/T	cg13010199	chr12:38710504	ALG10B	0.69	4.9	0.49	5.02e-6	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs13217239	0.572	rs9379958	chr6:27066163	A/C	cg12292205	chr6:26970375	C6orf41	-0.59	-5.15	-0.5	1.94e-6	Schizophrenia;
SKCM	cis	rs2721195	1.000	rs750472	chr8:145701453	A/C	cg15320075	chr8:145703422	NA	-0.97	-8.85	-0.71	2.12e-13	Age at first birth;
SKCM	cis	rs7811142	1.000	rs68116612	chr7:100006493	G/A	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.33	0.69	2.11e-12	Platelet count;
SKCM	cis	rs9902453	0.817	rs12051834	chr17:28192785	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.83	5.76	0.55	1.61e-7	Coffee consumption (cups per day);
SKCM	cis	rs6500395	0.962	rs9938126	chr16:48572121	A/T	cg04672837	chr16:48644449	N4BP1	0.69	5.6	0.54	3.1e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs9303401	0.659	rs11495824	chr17:56918882	C/A	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.35	0.52	8.54e-7	Cognitive test performance;
SKCM	cis	rs4746818	0.901	rs7914719	chr10:70903832	T/C	cg11621586	chr10:70884670	VPS26A	1.08	7.96	0.67	1.11e-11	Left atrial antero-posterior diameter;
SKCM	cis	rs2153535	0.580	rs1855769	chr6:8473095	A/G	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs9902453	0.765	rs6505143	chr17:28150585	A/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.8	6.02	0.56	5.28e-8	Coffee consumption (cups per day);
SKCM	cis	rs6951245	0.638	rs4720486	chr7:1146764	G/A	cg03188948	chr7:1209495	NA	0.83	5.88	0.55	9.86e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs9325144	0.723	rs11169518	chr12:39177237	C/A	cg13010199	chr12:38710504	ALG10B	-0.58	-4.98	-0.49	3.76e-6	Morning vs. evening chronotype;
SKCM	cis	rs1577917	1.000	rs7771342	chr6:86631936	C/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.66	-5.74	-0.54	1.76e-7	Response to antipsychotic treatment;
SKCM	cis	rs6580649	0.941	rs7312326	chr12:48480643	G/A	cg05342945	chr12:48394962	COL2A1	0.79	5.51	0.53	4.44e-7	Lung cancer;
SKCM	cis	rs7659604	0.728	rs6852923	chr4:122688324	G/A	cg19671926	chr4:122722719	EXOSC9	-0.7	-5.0	-0.49	3.44e-6	Type 2 diabetes;
SKCM	cis	rs7829975	0.714	rs7823757	chr8:8670177	T/A	cg15556689	chr8:8085844	FLJ10661	0.66	5.77	0.55	1.52e-7	Mood instability;
SKCM	cis	rs10504229	0.683	rs7820302	chr8:58142502	C/T	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs10779751	1.000	rs11121704	chr1:11293959	A/G	cg08854313	chr1:11322531	MTOR	-0.89	-7.09	-0.63	5.33e-10	Body mass index;
SKCM	cis	rs12477438	0.520	rs11890338	chr2:99767868	C/T	cg26064155	chr2:99771622	LIPT1;TSGA10	1.02	9.73	0.74	4.23e-15	Chronic sinus infection;
SKCM	cis	rs694739	0.964	rs2510066	chr11:64052447	C/T	cg02228329	chr11:64053129	BAD;GPR137	0.98	8.5	0.69	9.94e-13	Alopecia areata;Crohn's disease;Psoriasis vulgaris;
SKCM	cis	rs2439831	0.850	rs28578398	chr15:44075046	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.35	7.75	0.66	2.9e-11	Lung cancer in ever smokers;
SKCM	cis	rs17376456	0.825	rs17314797	chr5:93234845	T/A	cg25358565	chr5:93447407	FAM172A	1.26	7.82	0.66	2.11e-11	Diabetic retinopathy;
SKCM	cis	rs4969178	0.965	rs938350	chr17:76399552	C/T	cg20026190	chr17:76395443	PGS1	0.58	4.97	0.49	3.93e-6	HDL cholesterol levels;
SKCM	cis	rs72781680	0.948	rs72796385	chr2:24170360	T/A	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	cis	rs10089	0.903	rs6862701	chr5:127391249	C/T	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.92	8.29	0.68	2.54e-12	Ileal carcinoids;
SKCM	cis	rs763121	0.853	rs1013338	chr22:38974154	C/A	cg06022373	chr22:39101656	GTPBP1	0.87	6.35	0.58	1.33e-8	Menopause (age at onset);
SKCM	cis	rs10504229	1.000	rs66886949	chr8:58187613	A/G	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs1044826	0.642	rs407958	chr3:139213632	T/C	cg15131784	chr3:139108705	COPB2	0.68	4.97	0.49	3.85e-6	Obesity-related traits;
SKCM	cis	rs6951245	0.638	rs74976697	chr7:1160505	C/T	cg23708337	chr7:1209742	NA	0.87	5.34	0.52	8.89e-7	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs4727027	0.933	rs1058059	chr7:148879134	A/T	cg23583168	chr7:148888333	NA	-0.8	-6.69	-0.6	3.09e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs60871478	0.685	rs78903723	chr7:846983	G/C	cg05535760	chr7:792225	HEATR2	-0.84	-5.85	-0.55	1.12e-7	Cerebrospinal P-tau181p levels;
SKCM	cis	rs860295	0.580	rs12032720	chr1:155274960	G/C	cg02153340	chr1:155202674	NA	-0.78	-5.41	-0.52	6.78e-7	Body mass index;
SKCM	cis	rs10504229	0.683	rs73605816	chr8:58117167	T/C	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs561341	0.714	rs474455	chr17:30312465	A/T	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs7829975	0.511	rs2948286	chr8:8130160	A/G	cg08975724	chr8:8085496	FLJ10661	0.76	6.62	0.6	4.08e-9	Mood instability;
SKCM	cis	rs860295	0.729	rs4971072	chr1:155273869	G/A	cg02153340	chr1:155202674	NA	0.74	5.63	0.54	2.7e-7	Body mass index;
SKCM	cis	rs1707322	0.963	rs9787412	chr1:46371596	C/T	cg03146154	chr1:46216737	IPP	0.74	5.06	0.5	2.76e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs4975616	0.804	rs456366	chr5:1337070	T/C	cg26373071	chr5:1325741	CLPTM1L	0.74	6.91	0.62	1.18e-9	Lung cancer;
SKCM	cis	rs9910055	0.529	rs615070	chr17:42176591	A/G	cg19774624	chr17:42201019	HDAC5	-0.81	-6.34	-0.58	1.35e-8	Total body bone mineral density;
SKCM	cis	rs7647973	0.696	rs7100	chr3:49053219	A/G	cg07636037	chr3:49044803	WDR6	0.94	6.76	0.61	2.22e-9	Menarche (age at onset);
SKCM	cis	rs2070488	0.965	rs2126534	chr3:38445165	T/G	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.99	9.56	0.73	8.84e-15	Electrocardiographic conduction measures;
SKCM	cis	rs9300255	0.509	rs641760	chr12:123518866	T/C	cg00376283	chr12:123451042	ABCB9	0.79	5.35	0.52	8.61e-7	Neutrophil percentage of white cells;
SKCM	cis	rs12714314	0.514	rs7591822	chr2:1942765	C/T	cg22350835	chr2:1868857	MYT1L	0.59	5.61	0.54	2.98e-7	Type 2 diabetes (age of onset);
SKCM	cis	rs2354432	0.607	rs11579626	chr1:146741960	A/C	cg25205988	chr1:146714368	CHD1L	-1.17	-6.52	-0.59	6.27e-9	Mitochondrial DNA levels;
SKCM	cis	rs7828089	0.792	rs4872492	chr8:22285366	C/A	cg12081754	chr8:22256438	SLC39A14	0.73	5.77	0.55	1.51e-7	Verbal declarative memory;
SKCM	cis	rs3096299	0.748	rs3102339	chr16:89442711	C/T	cg08822215	chr16:89438651	ANKRD11	-0.58	-4.91	-0.49	4.9100000000000004e-06	Multiple myeloma (IgH translocation);
SKCM	cis	rs5769765	0.773	rs9616395	chr22:50317803	A/G	cg22709217	chr22:50311962	ALG12;CRELD2	-0.99	-6.09	-0.57	4.04e-8	Schizophrenia;
SKCM	cis	rs28386778	0.863	rs3760254	chr17:61851751	T/G	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs28595532	0.920	rs115006522	chr4:119732499	A/G	cg21605333	chr4:119757512	SEC24D	1.36	8.05	0.67	7.69e-12	Cannabis dependence symptom count;
SKCM	cis	rs2404602	0.679	rs12900494	chr15:76912504	A/G	cg23625390	chr15:77176239	SCAPER	0.61	5.33	0.52	9.13e-7	Blood metabolite levels;
SKCM	cis	rs6582630	0.519	rs1607868	chr12:38385512	G/T	cg26384229	chr12:38710491	ALG10B	0.82	6.9	0.62	1.22e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs6061231	0.654	rs2427322	chr20:60979370	T/C	cg24112000	chr20:60950667	NA	-0.52	-4.88	-0.48	5.6e-6	Colorectal cancer;
SKCM	cis	rs9790314	1.000	rs9850455	chr3:161017192	G/A	cg03342759	chr3:160939853	NMD3	-0.72	-8.07	-0.67	6.91e-12	Morning vs. evening chronotype;
SKCM	cis	rs2075371	0.897	rs10488428	chr7:133997560	C/T	cg20476274	chr7:133979776	SLC35B4	1.0	9.99	0.75	1.32e-15	Mean platelet volume;
SKCM	cis	rs11098499	0.954	rs10008459	chr4:120394231	T/C	cg09307838	chr4:120376055	NA	0.97	7.65	0.65	4.54e-11	Corneal astigmatism;
SKCM	cis	rs17376456	0.825	rs12716453	chr5:93271697	T/C	cg21475434	chr5:93447410	FAM172A	1.02	5.17	0.51	1.74e-6	Diabetic retinopathy;
SKCM	cis	rs11098499	0.954	rs2306455	chr4:120421969	G/A	cg09307838	chr4:120376055	NA	0.99	8.1	0.68	6.11e-12	Corneal astigmatism;
SKCM	cis	rs9467773	0.583	rs1021373	chr6:26632457	G/A	cg15659132	chr6:26577336	NA	0.62	5.4	0.52	6.91e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs9308433	0.529	rs9430131	chr1:214481121	C/A	cg06198575	chr1:214491504	SMYD2	0.81	5.09	0.5	2.41e-6	IgG glycosylation;
SKCM	cis	rs9611565	0.659	rs17367716	chr22:41913844	A/G	cg03806693	chr22:41940476	POLR3H	-1.11	-7.56	-0.65	6.67e-11	Vitiligo;
SKCM	cis	rs8141529	0.632	rs5762803	chr22:29193638	G/C	cg02153584	chr22:29168773	CCDC117	0.66	4.86	0.48	6e-6	Lymphocyte counts;
SKCM	cis	rs875971	0.502	rs2465121	chr7:65621004	A/G	cg18876405	chr7:65276391	NA	-0.64	-5.29	-0.51	1.09e-6	Aortic root size;
SKCM	cis	rs1799949	1.000	rs9646417	chr17:41424253	G/A	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.18	-0.57	2.68e-8	Menopause (age at onset);
SKCM	trans	rs3749237	0.964	rs34522271	chr3:49808517	A/G	cg21659725	chr3:3221576	CRBN	0.99	7.38	0.64	1.49e-10	Resting heart rate;
SKCM	cis	rs951366	0.668	rs823154	chr1:205762406	C/T	cg11965913	chr1:205819406	PM20D1	0.97	11.06	0.78	1.19e-17	Menarche (age at onset);
SKCM	cis	rs7618501	0.602	rs6780731	chr3:50017478	A/G	cg05072774	chr3:49840536	C3orf54	-0.67	-5.06	-0.5	2.73e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs453301	0.658	rs6983877	chr8:8904639	T/C	cg06636001	chr8:8085503	FLJ10661	-0.76	-5.59	-0.54	3.18e-7	Joint mobility (Beighton score);
SKCM	cis	rs761746	0.739	rs5753691	chr22:31952045	A/G	cg25791279	chr22:32026902	PISD	0.82	5.04	0.5	2.9e-6	Intelligence;
SKCM	cis	rs6951245	0.529	rs76001997	chr7:1152615	C/T	cg03188948	chr7:1209495	NA	0.85	6.02	0.56	5.43e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs6951245	0.882	rs11764817	chr7:1064610	T/C	cg24642844	chr7:1081250	C7orf50	-0.8	-5.93	-0.56	7.86e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs514406	0.698	rs576891	chr1:53364976	A/G	cg16325326	chr1:53192061	ZYG11B	0.64	5.37	0.52	7.84e-7	Monocyte count;
SKCM	cis	rs3820068	0.553	rs7545782	chr1:15955227	G/C	cg13390004	chr1:15929781	NA	0.64	5.19	0.51	1.61e-6	Systolic blood pressure;
SKCM	cis	rs651907	0.557	rs56291106	chr3:101377474	C/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.81	7.02	0.62	7.26e-10	Colorectal cancer;
SKCM	cis	rs12044355	0.896	rs11122324	chr1:231859181	C/T	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	0.77	5.81	0.55	1.32e-7	Alzheimer's disease;
SKCM	cis	rs7208859	0.623	rs7214570	chr17:29147164	A/G	cg14067834	chr17:29058358	SUZ12P	0.99	5.1	0.5	2.3e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs7000551	0.532	rs4872486	chr8:22256359	G/T	cg12081754	chr8:22256438	SLC39A14	0.88	9.09	0.72	7.18e-14	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs67460515	0.563	rs68166680	chr3:160829735	T/A	cg03342759	chr3:160939853	NMD3	-0.73	-6.3	-0.58	1.62e-8	Parkinson's disease;
SKCM	cis	rs13392177	0.660	rs62185964	chr2:219073745	A/G	cg00012203	chr2:219082015	ARPC2	-0.64	-4.89	-0.48	5.39e-6	Pyoderma gangrenosum in inflammatory bowel disease;
SKCM	cis	rs7772486	0.790	rs9403750	chr6:146167762	G/A	cg23711669	chr6:146136114	FBXO30	0.85	9.32	0.73	2.57e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs478304	0.627	rs1073602	chr11:65455386	G/C	cg17480646	chr11:65405466	SIPA1	-0.67	-4.99	-0.49	3.64e-6	Acne (severe);
SKCM	cis	rs10207060	0.500	rs28640956	chr2:240714001	G/C	cg07506560	chr2:240697449	NA	0.75	6.1	0.57	3.8e-8	Obesity-related traits;
SKCM	trans	rs1814175	0.817	rs1818890	chr11:49856882	T/C	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs9290877	0.667	rs9833465	chr3:188454859	C/A	cg17392043	chr3:188495102	LPP	-0.64	-4.93	-0.49	4.6e-6	IgE levels;
SKCM	cis	rs875971	0.862	rs778686	chr7:65835910	C/T	cg18876405	chr7:65276391	NA	0.64	6.36	0.58	1.26e-8	Aortic root size;
SKCM	cis	rs9581857	0.547	rs9579095	chr13:28082555	C/T	cg22138327	chr13:27999177	GTF3A	0.84	5.53	0.53	4.15e-7	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs7937682	1.000	rs10789843	chr11:111576158	C/T	cg09085632	chr11:111637200	PPP2R1B	1.02	11.79	0.8	5.18e-19	Primary sclerosing cholangitis;
SKCM	cis	rs11098499	0.820	rs28535956	chr4:120536858	C/T	cg24375607	chr4:120327624	NA	-0.68	-5.26	-0.51	1.2e-6	Corneal astigmatism;
SKCM	cis	rs951366	0.789	rs823097	chr1:205681370	G/A	cg26354017	chr1:205819088	PM20D1	0.89	7.64	0.65	4.63e-11	Menarche (age at onset);
SKCM	cis	rs1256061	0.603	rs1269056	chr14:64743890	T/C	cg21174375	chr14:64681225	SYNE2	0.47	4.95	0.49	4.15e-6	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs919433	1.000	rs112572902	chr2:198175179	G/C	cg04278110	chr2:198063759	ANKRD44	-0.7	-5.12	-0.5	2.14e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs752010	0.806	rs10890148	chr1:42091517	T/C	cg06885757	chr1:42089581	HIVEP3	0.5	4.87	0.48	5.65e-6	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs28374715	0.662	rs28493087	chr15:41486504	G/A	cg18705301	chr15:41695430	NDUFAF1	-0.93	-7.74	-0.66	2.94e-11	Ulcerative colitis;
SKCM	cis	rs1760803	0.754	rs6719	chr1:154179679	T/C	cg26808167	chr1:154192205	UBAP2L;C1orf43	-0.54	-4.84	-0.48	6.44e-6	Nicotine dependence;
SKCM	cis	rs362296	0.624	rs362287	chr4:3257593	C/T	cg05297308	chr4:3317976	RGS12	-0.76	-6.17	-0.57	2.88e-8	Parental longevity (mother's age at death);
SKCM	cis	rs1348850	0.645	rs7571386	chr2:178442687	A/C	cg27490568	chr2:178487706	NA	0.73	5.31	0.52	1.02e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs12824058	1.000	rs12824058	chr12:130804334	A/G	cg24838063	chr12:130822603	PIWIL1	0.79	7.68	0.66	3.9e-11	Menopause (age at onset);
SKCM	cis	rs606458	0.920	rs487105	chr11:64546891	G/A	cg07674570	chr11:65346152	EHBP1L1	0.68	4.89	0.48	5.2e-6	Urate levels;
SKCM	cis	rs11105298	0.891	rs11105287	chr12:89829470	C/T	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.85	-5.92	-0.56	8.03e-8	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs12497850	1.000	rs4858798	chr3:48727112	C/T	cg07636037	chr3:49044803	WDR6	0.9	9.23	0.72	3.8e-14	Parkinson's disease;
SKCM	cis	rs3784262	0.935	rs4646563	chr15:58353335	T/C	cg12031962	chr15:58353849	ALDH1A2	-0.5	-6.27	-0.58	1.85e-8	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs947211	0.846	rs823155	chr1:205762946	T/C	cg07157834	chr1:205819609	PM20D1	0.63	4.79	0.48	7.93e-6	Parkinson's disease;
SKCM	cis	rs9880211	1.000	rs9828088	chr3:136247790	C/T	cg21827317	chr3:136751795	NA	-0.64	-4.78	-0.48	8.21e-6	Body mass index;Height;
SKCM	cis	rs9486715	0.867	rs6568428	chr6:96903604	A/G	cg06623918	chr6:96969491	KIAA0776	0.83	7.36	0.64	1.63e-10	Headache;
SKCM	cis	rs867186	1.000	rs76363448	chr20:33655535	T/C	cg04194272	chr20:33683537	NA	-1.38	-7.2	-0.63	3.29e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs709400	0.593	rs12898029	chr14:103877884	T/C	cg26031613	chr14:104095156	KLC1	-0.68	-4.82	-0.48	6.83e-6	Body mass index;
SKCM	cis	rs929354	0.742	rs2107863	chr7:156963731	T/C	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs9902453	0.904	rs7213076	chr17:28419428	G/A	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.79	-6.04	-0.56	5.02e-8	Coffee consumption (cups per day);
SKCM	cis	rs3096299	0.967	rs11648663	chr16:89466307	C/T	cg02187348	chr16:89574699	SPG7	0.63	5.04	0.5	2.93e-6	Multiple myeloma (IgH translocation);
SKCM	cis	rs861020	0.771	rs674804	chr1:210014603	C/G	cg05527609	chr1:210001259	C1orf107	1.04	8.04	0.67	7.79e-12	Orofacial clefts;
SKCM	cis	rs17376456	0.825	rs67328989	chr5:93243133	T/A	cg21475434	chr5:93447410	FAM172A	1.02	5.17	0.51	1.74e-6	Diabetic retinopathy;
SKCM	cis	rs992157	0.764	rs62183964	chr2:219186592	G/A	cg00012203	chr2:219082015	ARPC2	0.75	5.54	0.53	3.92e-7	Colorectal cancer;
SKCM	cis	rs7647973	0.600	rs12631989	chr3:49273996	C/T	cg07636037	chr3:49044803	WDR6	0.83	6.82	0.61	1.76e-9	Menarche (age at onset);
SKCM	cis	rs7215564	0.908	rs8074870	chr17:78684132	T/C	cg16980736	chr17:78789706	RPTOR	-0.88	-4.83	-0.48	6.66e-6	Myopia (pathological);
SKCM	cis	rs1580019	0.883	rs6945294	chr7:32472099	G/A	cg06627557	chr7:32535165	LSM5;AVL9	0.72	5.01	0.49	3.34e-6	Cognitive ability;
SKCM	cis	rs6598955	0.694	rs4659416	chr1:26580937	T/G	cg00938395	chr1:26633206	UBXN11	0.69	4.91	0.49	4.81e-6	Obesity-related traits;
SKCM	cis	rs1979654	0.543	rs16940985	chr16:86403723	C/G	cg01467047	chr16:86611690	FOXL1	-0.39	-5.07	-0.5	2.65e-6	Barrett's esophagus  or Esophageal adenocarcinoma;
SKCM	cis	rs875971	1.000	rs11974264	chr7:65647582	C/G	cg11764359	chr7:65958608	NA	-0.86	-8.23	-0.68	3.44e-12	Aortic root size;
SKCM	cis	rs7829975	0.774	rs57312668	chr8:8680477	G/A	cg15556689	chr8:8085844	FLJ10661	0.74	6.86	0.61	1.43e-9	Mood instability;
SKCM	cis	rs568617	0.533	rs679147	chr11:65644363	A/G	cg04055107	chr11:65626734	MUS81;CFL1	-0.88	-6.6	-0.6	4.57e-9	Crohn's disease;
SKCM	cis	rs2439831	0.681	rs3742969	chr15:43621947	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.2	8.73	0.7	3.66e-13	Lung cancer in ever smokers;
SKCM	cis	rs2836974	0.836	rs1041440	chr21:40627325	C/T	cg11644478	chr21:40555479	PSMG1	0.97	10.08	0.75	8.76e-16	Cognitive function;
SKCM	cis	rs11690935	0.885	rs6752812	chr2:172851502	C/A	cg13550731	chr2:172543902	DYNC1I2	-0.92	-7.66	-0.66	4.32e-11	Schizophrenia;
SKCM	cis	rs4523957	0.583	rs2760743	chr17:2017079	A/C	cg16513277	chr17:2031491	SMG6	0.81	5.83	0.55	1.2e-7	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs1568889	1.000	rs66702115	chr11:28181703	T/A	cg06544937	chr11:28130018	METT5D1;KIF18A	0.87	7.0	0.62	7.86e-10	Bipolar disorder;
SKCM	cis	rs1003719	0.788	rs1543750	chr21:38446918	A/G	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs651907	0.557	rs11711079	chr3:101386918	G/A	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.81	6.96	0.62	9.48e-10	Colorectal cancer;
SKCM	cis	rs1790761	0.607	rs656652	chr11:67343957	C/T	cg00290607	chr11:67383545	NA	0.51	5.38	0.52	7.43e-7	Mean corpuscular volume;
SKCM	cis	rs1348850	0.567	rs880899	chr2:178532416	A/G	cg22681709	chr2:178499509	PDE11A	-0.56	-4.96	-0.49	3.99e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs7811142	0.830	rs6975660	chr7:99975266	A/G	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.05	5.92	0.56	8.02e-8	Platelet count;
SKCM	cis	rs4481887	0.893	rs10788763	chr1:248429070	A/T	cg00666640	chr1:248458726	OR2T12	-0.67	-6.39	-0.59	1.12e-8	Common traits (Other);
SKCM	cis	rs7215564	0.908	rs35918698	chr17:78683533	G/A	cg16980736	chr17:78789706	RPTOR	-0.88	-4.83	-0.48	6.66e-6	Myopia (pathological);
SKCM	cis	rs9951698	0.667	rs28641764	chr18:12994783	G/T	cg12848697	chr18:13133368	NA	0.53	4.9	0.48	5.18e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9303401	0.659	rs3809724	chr17:57061238	G/A	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.31	0.51	1.02e-6	Cognitive test performance;
SKCM	cis	rs77216612	1.000	rs77216612	chr12:12877983	A/G	cg04607235	chr12:12878440	APOLD1	-1.01	-7.09	-0.63	5.37e-10	Lymphocyte counts;
SKCM	cis	rs12142240	0.698	rs72885198	chr1:46812888	C/T	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs7086627	0.515	rs7078254	chr10:82212193	C/T	cg00277334	chr10:82204260	NA	-0.73	-8.42	-0.69	1.44e-12	Post bronchodilator FEV1;
SKCM	cis	rs9916302	0.851	rs7225096	chr17:37664443	T/C	cg07936489	chr17:37558343	FBXL20	-0.9	-8.1	-0.68	6.05e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs13223928	0.621	rs4722438	chr7:3155813	A/G	cg19214707	chr7:3157722	NA	0.51	4.78	0.48	7.99e-6	Eosinophil percentage of white cells;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil counts;
SKCM	cis	rs826838	0.900	rs1403523	chr12:39130570	T/A	cg26384229	chr12:38710491	ALG10B	-0.91	-8.28	-0.68	2.74e-12	Heart rate;
SKCM	cis	rs826838	0.967	rs826879	chr12:39088999	A/C	cg26384229	chr12:38710491	ALG10B	-0.97	-8.02	-0.67	8.69e-12	Heart rate;
SKCM	cis	rs2859741	0.967	rs592520	chr1:37513503	G/C	cg09363841	chr1:37513479	NA	-0.52	-4.86	-0.48	6.02e-6	Forced expiratory volume in 1 second (environmental tobacco smoke interaction);
SKCM	cis	rs2153535	0.580	rs9405391	chr6:8466548	C/T	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs453301	0.571	rs2929305	chr8:9085217	G/A	cg06636001	chr8:8085503	FLJ10661	-0.75	-5.75	-0.55	1.66e-7	Joint mobility (Beighton score);
SKCM	cis	rs2559856	1.000	rs2695291	chr12:102087543	G/A	cg12924262	chr12:102091054	CHPT1	0.77	6.17	0.57	2.84e-8	Blood protein levels;
SKCM	cis	rs826838	0.967	rs11169142	chr12:39085773	A/T	cg26384229	chr12:38710491	ALG10B	-0.96	-7.96	-0.67	1.15e-11	Heart rate;
SKCM	cis	rs2180341	1.000	rs13218061	chr6:127653758	G/A	cg24812749	chr6:127587940	RNF146	0.85	7.3	0.64	2.08e-10	Breast cancer;
SKCM	cis	rs35306767	0.953	rs12259338	chr10:969377	C/T	cg20503657	chr10:835505	NA	0.66	5.15	0.5	1.88e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs899997	1.000	rs11072794	chr15:79006582	A/G	cg04896959	chr15:78267971	NA	0.62	5.66	0.54	2.38e-7	Coronary artery disease or large artery stroke;
SKCM	cis	rs875971	0.660	rs62465434	chr7:66005152	A/C	cg11764359	chr7:65958608	NA	0.86	6.6	0.6	4.52e-9	Aortic root size;
SKCM	cis	rs910316	0.935	rs2268620	chr14:75640403	G/A	cg08847533	chr14:75593920	NEK9	-0.96	-9.14	-0.72	5.68e-14	Height;
SKCM	cis	rs9788682	0.948	rs28498264	chr15:78837673	C/T	cg24631222	chr15:78858424	CHRNA5	0.94	6.56	0.6	5.37e-9	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs9300255	0.602	rs1716165	chr12:123648881	C/T	cg00376283	chr12:123451042	ABCB9	0.82	5.61	0.54	3e-7	Neutrophil percentage of white cells;
SKCM	cis	rs61935443	0.720	rs10859785	chr12:95295081	A/T	cg21533806	chr12:95267307	NA	0.92	5.15	0.5	1.91e-6	Schizophrenia;
SKCM	cis	rs6089584	1.000	rs6089587	chr20:60564829	C/T	cg06108461	chr20:60628389	TAF4	-0.81	-7.11	-0.63	4.79e-10	Body mass index;
SKCM	cis	rs561341	0.941	rs501773	chr17:30314435	T/G	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs35306767	0.951	rs12777021	chr10:967270	T/C	cg20503657	chr10:835505	NA	0.75	6.04	0.56	4.87e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs7216064	1.000	rs8072225	chr17:65912960	A/G	cg12091567	chr17:66097778	LOC651250	-0.78	-5.34	-0.52	8.92e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs4400599	0.618	rs1194599	chr1:154236452	C/A	cg26808167	chr1:154192205	UBAP2L;C1orf43	-0.58	-5.17	-0.51	1.75e-6	Platelet distribution width;
SKCM	cis	rs2836974	0.899	rs2836957	chr21:40623134	T/C	cg17971929	chr21:40555470	PSMG1	0.9	8.81	0.71	2.52e-13	Cognitive function;
SKCM	cis	rs6088590	1.000	rs2295353	chr20:33356511	C/T	cg24642439	chr20:33292090	TP53INP2	1.01	7.2	0.63	3.23e-10	Coronary artery disease;
SKCM	cis	rs58688157	0.705	rs12419694	chr11:598033	C/T	cg03576123	chr11:487126	PTDSS2	-0.72	-4.85	-0.48	6.27e-6	Systemic lupus erythematosus;
SKCM	cis	rs1062177	0.724	rs2964590	chr5:151118146	C/G	cg00977110	chr5:151150581	G3BP1	-0.81	-6.42	-0.59	9.93e-9	Preschool internalizing problems;
SKCM	cis	rs7772486	0.875	rs2748502	chr6:146298239	A/G	cg23711669	chr6:146136114	FBXO30	0.77	7.12	0.63	4.66e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs992157	0.730	rs2891078	chr2:219184432	C/T	cg00012203	chr2:219082015	ARPC2	0.77	5.58	0.53	3.31e-7	Colorectal cancer;
SKCM	cis	rs7772486	0.774	rs6930181	chr6:146180974	A/T	cg23711669	chr6:146136114	FBXO30	-0.67	-6.27	-0.58	1.87e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2070433	1.000	rs2070433	chr21:47961386	G/A	cg05998816	chr21:47859926	PCNT	0.73	4.79	0.48	7.94e-6	Lymphocyte counts;
SKCM	cis	rs2404602	0.536	rs1587381	chr15:76769620	G/A	cg23625390	chr15:77176239	SCAPER	0.62	5.39	0.52	7.34e-7	Blood metabolite levels;
SKCM	cis	rs2228479	1.000	rs117406136	chr16:89974605	C/T	cg06558623	chr16:89946397	TCF25	1.12	5.8	0.55	1.34e-7	Skin colour saturation;
SKCM	cis	rs7940866	0.740	rs2162060	chr11:130830763	A/G	cg12179176	chr11:130786555	SNX19	0.7	5.61	0.54	2.94e-7	Schizophrenia;
SKCM	cis	rs4243830	0.850	rs4908558	chr1:6584101	A/G	cg22792644	chr1:6614718	TAS1R1;NOL9	-1.04	-5.83	-0.55	1.18e-7	Body mass index;
SKCM	cis	rs2243480	1.000	rs6958420	chr7:65751171	A/G	cg18252515	chr7:66147081	NA	1.34	8.18	0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs55962025	0.842	rs362267	chr4:3243218	C/T	cg21096898	chr4:3318625	RGS12	-0.72	-5.61	-0.54	2.98e-7	Parental longevity (mother's age at death);
SKCM	cis	rs9814567	0.727	rs7641798	chr3:134345719	C/T	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.62	-5.0	-0.49	3.46e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs2243480	1.000	rs73142122	chr7:65311298	C/A	cg07424592	chr7:64974309	NA	0.99	4.9	0.49	5.08e-6	Diabetic kidney disease;
SKCM	cis	rs10193935	1.000	rs13386385	chr2:42436928	G/T	cg27598129	chr2:42591480	NA	-0.88	-6.71	-0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	trans	rs208520	0.690	rs10944872	chr6:66708239	T/G	cg15611600	chr13:45563400	KIAA1704;NUFIP1	0.92	7.65	0.65	4.38e-11	Exhaled nitric oxide output;
SKCM	cis	rs875971	0.522	rs1880556	chr7:65432544	T/C	cg11764359	chr7:65958608	NA	0.87	6.65	0.6	3.58e-9	Aortic root size;
SKCM	cis	rs362296	0.698	rs3095082	chr4:3263617	C/A	cg11471262	chr4:3318911	RGS12	-0.73	-6.85	-0.61	1.51e-9	Parental longevity (mother's age at death);
SKCM	cis	rs9581857	0.579	rs9581846	chr13:27987953	A/G	cg22138327	chr13:27999177	GTF3A	0.95	6.38	0.59	1.14e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs2721195	0.654	rs4610795	chr8:145881333	C/T	cg11211951	chr8:145729740	GPT	-0.61	-5.33	-0.52	9.36e-7	Age at first birth;
SKCM	cis	rs8072100	0.875	rs12451409	chr17:45544856	A/G	cg25173405	chr17:45401733	C17orf57	-0.58	-4.77	-0.48	8.26e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs6951245	0.882	rs56048221	chr7:1092533	A/G	cg24642844	chr7:1081250	C7orf50	-0.81	-6.02	-0.56	5.41e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs12478296	1.000	rs60533128	chr2:243028088	A/G	cg06360820	chr2:242988706	NA	-1.0	-5.16	-0.5	1.83e-6	Obesity-related traits;
SKCM	cis	rs155076	0.938	rs9509633	chr13:21844482	G/C	cg14456004	chr13:21872349	NA	-1.22	-6.76	-0.61	2.24e-9	White matter hyperintensity burden;
SKCM	cis	rs4253772	0.550	rs739164	chr22:46684558	C/T	cg03482458	chr22:46692211	CN5H6.4;GTSE1	-1.17	-5.65	-0.54	2.52e-7	LDL cholesterol;Cholesterol, total;
SKCM	cis	rs9911578	1.000	rs8079774	chr17:56908188	A/G	cg05425664	chr17:57184151	TRIM37	-0.67	-5.04	-0.5	2.91e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7772486	0.597	rs6912351	chr6:146264071	T/C	cg05347473	chr6:146136440	FBXO30	-0.66	-5.46	-0.53	5.58e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs951366	0.617	rs823080	chr1:205789282	G/A	cg24503407	chr1:205819492	PM20D1	0.99	11.53	0.79	1.59e-18	Menarche (age at onset);
SKCM	cis	rs4803468	1.000	rs4803465	chr19:41918158	A/G	cg09537434	chr19:41945824	ATP5SL	1.1	13.82	0.84	1.16e-22	Height;
SKCM	cis	rs9467773	0.583	rs2498380	chr6:26643996	C/G	cg09904177	chr6:26538194	HMGN4	-0.58	-5.07	-0.5	2.61e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs12048904	0.619	rs10783153	chr1:101328230	T/C	cg00063077	chr1:101360652	SLC30A7;EXTL2	0.85	6.73	0.61	2.58e-9	Multiple sclerosis;
SKCM	cis	rs8067545	0.611	rs4925090	chr17:20066631	C/T	cg13482628	chr17:19912719	NA	0.66	5.5	0.53	4.72e-7	Schizophrenia;
SKCM	cis	rs7618915	0.547	rs68021750	chr3:52624769	G/A	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs6570726	0.846	rs372904	chr6:145887425	T/C	cg23711669	chr6:146136114	FBXO30	0.86	9.05	0.72	8.81e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs3809863	0.602	rs6504833	chr17:45396087	A/G	cg08085267	chr17:45401833	C17orf57	-0.86	-6.65	-0.6	3.6e-9	Glaucoma (primary open-angle);
SKCM	cis	rs28386778	0.863	rs11649912	chr17:61797515	T/A	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.13	11.24	0.79	5.56e-18	Prudent dietary pattern;
SKCM	cis	rs4481887	0.830	rs9662041	chr1:248484701	A/T	cg00666640	chr1:248458726	OR2T12	0.66	6.0	0.56	5.9e-8	Common traits (Other);
SKCM	cis	rs73201462	1.000	rs6439124	chr3:128007466	A/G	cg09089421	chr3:127803668	RUVBL1	-1.0	-5.11	-0.5	2.22e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs4478137	0.839	rs3967763	chr4:164239273	G/C	cg06758707	chr4:164254230	NPY1R	0.93	6.18	0.57	2.75e-8	Subjective well-being (multi-trait analysis);Subjective well-being;
SKCM	cis	rs8072100	0.905	rs8078686	chr17:45735706	T/C	cg25173405	chr17:45401733	C17orf57	0.57	5.24	0.51	1.35e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs870825	0.616	rs7682677	chr4:185640717	C/G	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs769267	0.930	rs1054284	chr19:19616953	T/G	cg03709012	chr19:19516395	GATAD2A	0.89	8.62	0.7	5.89e-13	Tonsillectomy;
SKCM	cis	rs1005277	0.557	rs176887	chr10:38406094	T/C	cg00409905	chr10:38381863	ZNF37A	-0.66	-6.16	-0.57	3e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs752010	0.574	rs6671999	chr1:42120416	G/A	cg06885757	chr1:42089581	HIVEP3	0.47	4.98	0.49	3.8e-6	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs1790761	0.692	rs1148883	chr11:67304686	A/G	cg00290607	chr11:67383545	NA	0.5	5.24	0.51	1.35e-6	Mean corpuscular volume;
SKCM	cis	rs9902453	0.868	rs8066731	chr17:28523121	T/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.78	5.71	0.54	1.92e-7	Coffee consumption (cups per day);
SKCM	cis	rs9902453	0.619	rs2617866	chr17:28076217	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.82	-5.94	-0.56	7.58e-8	Coffee consumption (cups per day);
SKCM	cis	rs9611565	0.649	rs4822050	chr22:42177453	C/G	cg03806693	chr22:41940476	POLR3H	-0.78	-4.89	-0.48	5.28e-6	Vitiligo;
SKCM	cis	rs17608059	0.566	rs8070294	chr17:13896302	G/C	cg11395062	chr17:14139857	CDRT15	0.67	5.56	0.53	3.63e-7	Temperament;
SKCM	cis	rs644799	0.965	rs3016295	chr11:95554311	A/G	cg03916912	chr11:95522834	CEP57;FAM76B	0.92	8.04	0.67	8e-12	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs1538970	0.816	rs12029322	chr1:45970446	C/T	cg05343316	chr1:45956843	TESK2	0.94	4.82	0.48	7.07e-6	Platelet count;
SKCM	cis	rs2228479	0.850	rs62056066	chr16:89906563	G/A	cg06558623	chr16:89946397	TCF25	1.12	5.0	0.49	3.47e-6	Skin colour saturation;
SKCM	cis	rs372883	0.506	rs2832300	chr21:30749315	A/G	cg24692254	chr21:30365293	RNF160	0.66	5.14	0.5	1.96e-6	Pancreatic cancer;
SKCM	cis	rs2286503	0.839	rs2240726	chr7:22853135	C/T	cg15401507	chr7:22894281	NA	-0.57	-5.57	-0.53	3.5e-7	Fibrinogen;
SKCM	cis	rs12130219	0.500	rs4845737	chr1:152177539	G/A	cg20694572	chr1:152331529	FLG2	-0.55	-4.85	-0.48	6.23e-6	Inflammatory skin disease;
SKCM	cis	rs933688	1.000	rs11948075	chr5:90680579	A/G	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.01	7.62	0.65	5.01e-11	Smoking behavior;
SKCM	cis	rs10504229	0.817	rs35207430	chr8:58167614	G/A	cg22535103	chr8:58192502	C8orf71	-0.68	-4.82	-0.48	7.06e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs801193	1.000	rs7783924	chr7:66209057	A/C	cg18876405	chr7:65276391	NA	0.8	7.11	0.63	4.88e-10	Aortic root size;
SKCM	cis	rs8180040	0.764	rs11716539	chr3:47186503	G/T	cg27129171	chr3:47204927	SETD2	0.82	6.44	0.59	9.04e-9	Colorectal cancer;
SKCM	cis	rs7020830	0.898	rs2790063	chr9:37287405	G/A	cg14294708	chr9:37120828	ZCCHC7	1.08	11.04	0.78	1.32e-17	Schizophrenia;
SKCM	cis	rs911263	0.961	rs10131490	chr14:68743307	A/G	cg18825221	chr14:68749962	RAD51L1	-0.49	-5.24	-0.51	1.35e-6	Primary biliary cholangitis;
SKCM	cis	rs362296	0.698	rs3135171	chr4:3261127	A/G	cg16987761	chr4:3318072	RGS12	-0.78	-6.87	-0.61	1.39e-9	Parental longevity (mother's age at death);
SKCM	cis	rs11098499	0.865	rs1112817	chr4:120297800	T/C	cg09307838	chr4:120376055	NA	0.97	7.49	0.65	9.08e-11	Corneal astigmatism;
SKCM	cis	rs9796	0.663	rs11853192	chr15:41368515	G/A	cg18705301	chr15:41695430	NDUFAF1	-0.78	-5.78	-0.55	1.47e-7	Menopause (age at onset);
SKCM	cis	rs2380205	0.689	rs12779398	chr10:5896625	G/T	cg20472891	chr10:5554345	NA	-0.53	-4.83	-0.48	6.69e-6	Breast cancer;
SKCM	cis	rs28595532	0.920	rs115500312	chr4:119752551	G/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs9581857	0.512	rs2057523	chr13:28073816	T/C	cg22138327	chr13:27999177	GTF3A	0.86	6.15	0.57	3.13e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs1801251	0.778	rs2675957	chr2:233754364	C/T	cg25237894	chr2:233734115	C2orf82	-0.59	-6.02	-0.56	5.38e-8	Coronary artery disease;
SKCM	cis	rs2204008	0.677	rs1581356	chr12:38391467	T/C	cg26384229	chr12:38710491	ALG10B	0.81	6.6	0.6	4.58e-9	Bladder cancer;
SKCM	cis	rs12458462	0.787	rs56006341	chr18:77439844	G/T	cg11879182	chr18:77439856	CTDP1	0.91	7.93	0.67	1.26e-11	Monocyte count;
SKCM	cis	rs2072499	0.966	rs2842857	chr1:156168736	T/C	cg25208724	chr1:156163844	SLC25A44	1.12	10.24	0.76	4.46e-16	Testicular germ cell tumor;
SKCM	cis	rs1799949	0.965	rs8067269	chr17:41235799	C/T	cg23758822	chr17:41437982	NA	0.95	7.54	0.65	7.34e-11	Menopause (age at onset);
SKCM	cis	rs28595532	0.623	rs34082100	chr4:119220563	C/T	cg14228332	chr4:119757509	SEC24D	1.04	5.95	0.56	7.2e-8	Cannabis dependence symptom count;
SKCM	cis	rs7811142	1.000	rs67163493	chr7:100023838	C/T	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.11	6.45	0.59	8.66e-9	Platelet count;
SKCM	cis	rs561341	0.769	rs12941700	chr17:30185022	A/G	cg00745463	chr17:30367425	LRRC37B	0.9	5.27	0.51	1.16e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs9911578	1.000	rs7215808	chr17:56940742	G/C	cg05425664	chr17:57184151	TRIM37	-0.69	-5.02	-0.49	3.13e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2050392	0.630	rs303426	chr10:30740379	A/G	cg25182066	chr10:30743637	MAP3K8	0.7	7.13	0.63	4.51e-10	Inflammatory bowel disease;
SKCM	cis	rs9399135	0.869	rs9402675	chr6:135325794	C/G	cg24558204	chr6:135376177	HBS1L	0.59	5.23	0.51	1.41e-6	Red blood cell count;
SKCM	cis	rs2204008	0.654	rs1733410	chr12:38132172	G/A	cg26384229	chr12:38710491	ALG10B	-0.67	-5.47	-0.53	5.23e-7	Bladder cancer;
SKCM	cis	rs10504073	0.647	rs62507247	chr8:50013554	T/G	cg00325661	chr8:49890786	NA	0.79	6.79	0.61	1.99e-9	Blood metabolite ratios;
SKCM	cis	rs6952808	0.792	rs13224989	chr7:1953766	C/G	cg02951883	chr7:2050386	MAD1L1	-0.7	-5.94	-0.56	7.54e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs208520	0.837	rs208467	chr6:66914837	T/C	cg07460842	chr6:66804631	NA	-0.9	-6.89	-0.61	1.29e-9	Exhaled nitric oxide output;
SKCM	cis	rs9902453	0.967	rs55748380	chr17:28469782	T/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.5	0.53	4.74e-7	Coffee consumption (cups per day);
SKCM	cis	rs9894429	0.789	rs7213849	chr17:79567610	C/T	cg18240062	chr17:79603768	NPLOC4	-0.91	-10.36	-0.76	2.55e-16	Eye color traits;
SKCM	trans	rs1814175	0.869	rs10769600	chr11:49681832	C/T	cg15704280	chr7:45808275	SEPT13	-1.0	-9.38	-0.73	1.99e-14	Height;
SKCM	cis	rs644799	0.710	rs10831429	chr11:95508524	C/A	cg03916912	chr11:95522834	CEP57;FAM76B	0.83	7.18	0.63	3.57e-10	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs2197308	0.740	rs11182967	chr12:37935140	A/C	cg26384229	chr12:38710491	ALG10B	0.81	6.59	0.6	4.69e-9	Morning vs. evening chronotype;
SKCM	cis	rs34779708	0.931	rs6481935	chr10:35342959	C/T	cg03585969	chr10:35415529	CREM	0.73	6.03	0.56	5.13e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs9880211	0.613	rs6799056	chr3:135802350	C/T	cg21827317	chr3:136751795	NA	-0.64	-4.85	-0.48	6.24e-6	Body mass index;Height;
SKCM	cis	rs7143963	1.000	rs72704712	chr14:103312965	T/G	cg23020514	chr14:103360112	TRAF3	0.89	7.22	0.63	3.02e-10	Body mass index;
SKCM	cis	rs763121	0.815	rs4821799	chr22:39021326	T/G	cg06022373	chr22:39101656	GTPBP1	0.81	6.25	0.58	2.01e-8	Menopause (age at onset);
SKCM	cis	rs17065868	0.881	rs9533889	chr13:45094012	T/C	cg10246903	chr13:45222710	NA	0.87	4.81	0.48	7.32e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs6547741	1.000	rs6547734	chr2:27830990	G/T	cg27432699	chr2:27873401	GPN1	0.73	6.64	0.6	3.76e-9	Oral cavity cancer;
SKCM	cis	rs116095464	0.558	rs10036253	chr5:238519	A/C	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs3820928	1.000	rs10204368	chr2:227774244	G/C	cg11843606	chr2:227700838	RHBDD1	-0.64	-5.2	-0.51	1.53e-6	Pulmonary function;
SKCM	cis	rs798554	0.836	rs2260230	chr7:2822986	T/A	cg14895029	chr7:2775587	GNA12	-0.67	-5.07	-0.5	2.59e-6	Height;
SKCM	cis	rs9910055	0.571	rs10208	chr17:42300278	C/T	cg09913183	chr17:42254507	C17orf65;ASB16	0.57	5.0	0.49	3.46e-6	Total body bone mineral density;
SKCM	cis	rs950776	0.752	rs2869546	chr15:78907345	C/T	cg06917634	chr15:78832804	PSMA4	-0.8	-6.47	-0.59	7.83e-9	Sudden cardiac arrest;
SKCM	cis	rs3820928	0.874	rs10439363	chr2:227815065	C/T	cg11843606	chr2:227700838	RHBDD1	-0.6	-4.81	-0.48	7.17e-6	Pulmonary function;
SKCM	cis	rs7932354	0.528	rs6485739	chr11:47145072	G/A	cg03339077	chr11:47165057	C11orf49	-0.61	-5.28	-0.51	1.14e-6	Bone mineral density (hip);Bone mineral density;
SKCM	cis	rs796364	1.000	rs281762	chr2:200799201	C/G	cg12253985	chr2:200820533	C2orf60;C2orf47	0.85	5.39	0.52	7.18e-7	Schizophrenia;
SKCM	cis	rs72781680	1.000	rs61739076	chr2:24149439	G/A	cg08917208	chr2:24149416	ATAD2B	1.02	5.84	0.55	1.16e-7	Lymphocyte counts;
SKCM	cis	rs3820928	0.874	rs4675138	chr2:227884118	G/A	cg11843606	chr2:227700838	RHBDD1	-0.6	-4.95	-0.49	4.12e-6	Pulmonary function;
SKCM	cis	rs13118159	0.550	rs4974614	chr4:1373489	A/G	cg16405210	chr4:1374714	KIAA1530	-0.95	-7.27	-0.64	2.43e-10	Longevity;
SKCM	cis	rs362296	0.661	rs3095079	chr4:3265414	A/G	cg09735869	chr4:3319127	RGS12	0.72	6.15	0.57	3.14e-8	Parental longevity (mother's age at death);
SKCM	trans	rs35365539	1	rs35365539	chr3:49794347	A/AC	cg21659725	chr3:3221576	CRBN	-0.96	-9.61	-0.74	7.08e-15	Blood protein levels;
SKCM	cis	rs801193	1.000	rs3800812	chr7:66223461	T/C	cg18876405	chr7:65276391	NA	0.82	7.51	0.65	8.26e-11	Aortic root size;
SKCM	cis	rs12477438	0.501	rs11692336	chr2:99740606	T/C	cg26064155	chr2:99771622	LIPT1;TSGA10	1.01	9.65	0.74	5.91e-15	Chronic sinus infection;
SKCM	cis	rs951366	0.764	rs708724	chr1:205743663	A/C	cg07167872	chr1:205819463	PM20D1	0.97	8.43	0.69	1.39e-12	Menarche (age at onset);
SKCM	cis	rs644799	1.000	rs564675	chr11:95561873	C/T	cg03916912	chr11:95522834	CEP57;FAM76B	0.88	7.53	0.65	7.59e-11	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs9399135	0.967	rs4896120	chr6:135293512	C/G	cg24558204	chr6:135376177	HBS1L	0.56	5.07	0.5	2.64e-6	Red blood cell count;
SKCM	cis	rs6951245	1.000	rs11764748	chr7:1094508	T/C	cg24642844	chr7:1081250	C7orf50	-0.93	-6.22	-0.58	2.28e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7666738	0.791	rs7658177	chr4:99035192	T/C	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7569084	0.687	rs934731	chr2:65683487	T/C	cg10464312	chr2:66672688	MEIS1	0.45	5.09	0.5	2.39e-6	Sum eosinophil basophil counts;
SKCM	cis	rs2816062	0.735	rs2816054	chr1:18896431	C/T	cg18795169	chr1:18902165	NA	-0.83	-9.02	-0.71	1.01e-13	Urate levels in lean individuals;
SKCM	cis	rs754466	0.580	rs10762765	chr10:79566407	T/C	cg17075019	chr10:79541650	NA	-0.81	-7.33	-0.64	1.81e-10	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs2243480	1.000	rs160639	chr7:65579987	C/G	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs7666738	0.830	rs921521	chr4:98838339	A/G	cg05340658	chr4:99064831	C4orf37	0.6	4.81	0.48	7.19e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs208520	1.000	rs12216109	chr6:66987488	C/G	cg07460842	chr6:66804631	NA	0.87	5.96	0.56	6.95e-8	Exhaled nitric oxide output;
SKCM	cis	rs2404602	0.655	rs34748201	chr15:77221530	G/T	cg23625390	chr15:77176239	SCAPER	0.59	5.24	0.51	1.35e-6	Blood metabolite levels;
SKCM	cis	rs2019137	0.560	rs6707386	chr2:113981022	G/A	cg21550016	chr2:113992930	PAX8;LOC440839;LOC654433	0.64	5.02	0.49	3.19e-6	Lymphocyte counts;
SKCM	cis	rs10193935	0.901	rs10179237	chr2:42515501	C/T	cg27598129	chr2:42591480	NA	-0.95	-6.75	-0.61	2.38e-9	Colonoscopy-negative controls vs population controls;
SKCM	trans	rs1814175	0.592	rs1794161	chr11:49898825	A/C	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs9325144	0.602	rs11169100	chr12:39077861	G/T	cg26384229	chr12:38710491	ALG10B	-0.76	-6.81	-0.61	1.8e-9	Morning vs. evening chronotype;
SKCM	cis	rs62238980	0.614	rs78940018	chr22:32419975	C/T	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs478304	0.651	rs948493	chr11:65552154	C/T	cg27068330	chr11:65405492	SIPA1	-0.92	-8.24	-0.68	3.29e-12	Acne (severe);
SKCM	cis	rs12142240	0.738	rs41293275	chr1:46806429	A/T	cg10495392	chr1:46806563	NSUN4	0.74	5.37	0.52	7.75e-7	Menopause (age at onset);
SKCM	cis	rs1799949	1.000	rs2292595	chr17:41290674	G/C	cg05368731	chr17:41323189	NBR1	0.89	7.91	0.67	1.38e-11	Menopause (age at onset);
SKCM	cis	rs8042680	0.554	rs2285937	chr15:91527152	A/G	cg15878949	chr15:91534302	PRC1	0.58	4.87	0.48	5.82e-6	Type 2 diabetes;
SKCM	cis	rs2282032	0.527	rs8004573	chr14:90765743	C/T	cg04374321	chr14:90722782	PSMC1	0.69	5.58	0.53	3.29e-7	Longevity;
SKCM	cis	rs2153535	0.580	rs7769020	chr6:8457724	G/A	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs7772486	0.743	rs9376955	chr6:145949404	T/A	cg05347473	chr6:146136440	FBXO30	0.53	4.93	0.49	4.57e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9611565	0.649	rs139553	chr22:42187199	A/G	cg03806693	chr22:41940476	POLR3H	0.84	5.6	0.54	3.07e-7	Vitiligo;
SKCM	cis	rs4065321	0.522	rs34648856	chr17:38149411	G/A	cg17467752	chr17:38218738	THRA	-0.74	-6.2	-0.57	2.47e-8	White blood cell count (basophil);White blood cell count;
SKCM	cis	rs514406	0.893	rs6588446	chr1:53425260	G/A	cg16325326	chr1:53192061	ZYG11B	-0.91	-9.81	-0.74	2.87e-15	Monocyte count;
SKCM	cis	rs36093844	0.752	rs7943104	chr11:85545180	A/C	cg25872744	chr11:85566296	CCDC83	-0.85	-4.77	-0.48	8.27e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs4808199	0.895	rs10403731	chr19:19469296	G/A	cg03709012	chr19:19516395	GATAD2A	1.09	7.61	0.65	5.22e-11	Nonalcoholic fatty liver disease;
SKCM	cis	rs2013441	1.000	rs9325894	chr17:20197101	T/C	cg13482628	chr17:19912719	NA	-0.65	-5.07	-0.5	2.67e-6	Obesity-related traits;
SKCM	cis	rs7208859	0.573	rs73267865	chr17:29064204	C/G	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs9880211	0.613	rs6786582	chr3:135898984	C/T	cg21827317	chr3:136751795	NA	0.65	4.88	0.48	5.59e-6	Body mass index;Height;
SKCM	cis	rs11585357	0.843	rs113593167	chr1:17613355	G/A	cg08277548	chr1:17600880	PADI3	-0.9	-6.35	-0.58	1.34e-8	Hair shape;
SKCM	cis	rs9394841	0.667	rs9471667	chr6:41776681	T/C	cg08135965	chr6:41755394	TOMM6	0.76	5.12	0.5	2.16e-6	Mean corpuscular hemoglobin;Red cell distribution width;
SKCM	cis	rs7666738	0.830	rs34628820	chr4:99004764	C/T	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9303401	0.659	rs62083362	chr17:56846464	A/G	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.16	0.57	2.91e-8	Cognitive test performance;
SKCM	cis	rs1348850	0.645	rs13431091	chr2:178434615	A/G	cg27490568	chr2:178487706	NA	0.85	6.06	0.57	4.52e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs2243480	1.000	rs35058610	chr7:65390925	G/A	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs737337	0.623	rs4804155	chr19:11334295	C/G	cg00586551	chr19:11347513	LOC55908;DOCK6	0.83	6.04	0.56	4.89e-8	HDL cholesterol;HDL cholesterol levels;
SKCM	cis	rs66573146	1.000	rs55833486	chr4:6978729	C/A	cg00086871	chr4:6988644	TBC1D14	1.29	5.03	0.5	3.04e-6	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs763014	0.932	rs35067229	chr16:649638	T/C	cg09263875	chr16:632152	PIGQ	0.69	6.18	0.57	2.73e-8	Height;
SKCM	cis	rs9921192	0.967	rs251735	chr16:4320672	G/C	cg00021532	chr16:4324280	TFAP4	0.89	8.22	0.68	3.53e-12	Prostate-specific antigen levels;
SKCM	cis	rs2721195	1.000	rs11542372	chr8:145677089	G/A	cg15320075	chr8:145703422	NA	-0.86	-7.3	-0.64	2.1e-10	Age at first birth;
SKCM	cis	rs7666738	0.830	rs35752787	chr4:98935202	G/A	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs951366	0.789	rs823095	chr1:205679239	G/A	cg24503407	chr1:205819492	PM20D1	0.76	6.01	0.56	5.61e-8	Menarche (age at onset);
SKCM	cis	rs1799949	1.000	rs16940	chr17:41245237	A/G	cg23758822	chr17:41437982	NA	0.94	7.65	0.65	4.42e-11	Menopause (age at onset);
SKCM	cis	rs9611565	0.694	rs202617	chr22:41822793	C/T	cg03806693	chr22:41940476	POLR3H	1.12	7.07	0.62	5.89e-10	Vitiligo;
SKCM	cis	rs7666738	0.830	rs13124689	chr4:98961182	A/T	cg05340658	chr4:99064831	C4orf37	0.64	4.91	0.49	4.97e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4728302	0.608	rs10254118	chr7:133158353	T/A	cg10665199	chr7:133106180	EXOC4	0.84	5.27	0.51	1.2e-6	Intelligence;Intelligence (multi-trait analysis);
SKCM	cis	rs2832191	0.791	rs2832178	chr21:30479858	T/G	cg24692254	chr21:30365293	RNF160	-0.9	-8.03	-0.67	8.39e-12	Dental caries;
SKCM	cis	rs2197308	0.740	rs1842595	chr12:37906223	G/A	cg26384229	chr12:38710491	ALG10B	-0.76	-6.24	-0.58	2.08e-8	Morning vs. evening chronotype;
SKCM	cis	rs4975616	0.836	rs13178866	chr5:1323212	C/T	cg07493874	chr5:1342172	CLPTM1L	-0.7	-6.57	-0.6	5.12e-9	Lung cancer;
SKCM	cis	rs7528419	1.000	rs646776	chr1:109818530	C/T	cg00908766	chr1:109817496	CELSR2	0.46	5.13	0.5	2.07e-6	Coronary artery disease (myocardial infartum, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease);Myocardial infarction;Lipoprotein-associated phospholipase A2 activity and mass;Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease;Cholesterol, total;Coronary artery disease;
SKCM	cis	rs2050392	0.965	rs2265368	chr10:30690289	G/C	cg25182066	chr10:30743637	MAP3K8	-0.65	-5.2	-0.51	1.58e-6	Inflammatory bowel disease;
SKCM	cis	rs80130819	0.688	rs7305418	chr12:48586112	A/G	cg13203223	chr12:49319398	FKBP11	0.93	4.87	0.48	5.66e-6	Prostate cancer;
SKCM	cis	rs3820068	0.581	rs16851841	chr1:15922713	A/G	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs763014	0.898	rs4984897	chr16:632180	G/C	cg00908189	chr16:619842	PIGQ	0.82	7.78	0.66	2.55e-11	Height;
SKCM	cis	rs6547741	0.935	rs12615690	chr2:27851120	T/C	cg27432699	chr2:27873401	GPN1	0.75	6.85	0.61	1.49e-9	Oral cavity cancer;
SKCM	cis	rs7296418	0.961	rs1790122	chr12:123606739	G/A	cg00376283	chr12:123451042	ABCB9	0.95	8.4	0.69	1.6e-12	Platelet count;
SKCM	cis	rs362272	0.524	rs7435601	chr4:3369645	A/G	cg00764545	chr4:3318001	RGS12	1.0	12.72	0.82	1.03e-20	Serum sulfate level;
SKCM	cis	rs2303745	0.544	rs12710308	chr19:17395879	T/A	cg04248312	chr19:17393744	ANKLE1	-1.11	-8.18	-0.68	4.15e-12	Systemic lupus erythematosus;
SKCM	cis	rs9880211	0.613	rs1393786	chr3:135854035	G/T	cg21827317	chr3:136751795	NA	-0.68	-5.3	-0.51	1.05e-6	Body mass index;Height;
SKCM	cis	rs1153858	1.000	rs1153849	chr15:45695695	G/A	cg10760299	chr15:45669010	GATM	0.61	5.9	0.56	8.99e-8	Homoarginine levels;
SKCM	cis	rs995000	0.899	rs11207974	chr1:62949960	T/C	cg06896770	chr1:63153194	DOCK7	0.74	7.06	0.62	6.02e-10	Triglyceride levels;
SKCM	cis	rs9300255	0.596	rs10732573	chr12:123743883	G/C	cg00376283	chr12:123451042	ABCB9	0.87	7.25	0.63	2.63e-10	Neutrophil percentage of white cells;
SKCM	cis	rs992157	0.835	rs34353396	chr2:219153982	T/C	cg00012203	chr2:219082015	ARPC2	-0.72	-5.71	-0.54	1.99e-7	Colorectal cancer;
SKCM	cis	rs6121246	0.954	rs7266148	chr20:30431070	G/T	cg11595048	chr20:30225325	COX4I2	0.65	5.01	0.49	3.26e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs2243480	1.000	rs34637256	chr7:65360131	G/A	cg07424592	chr7:64974309	NA	0.99	4.9	0.49	5.08e-6	Diabetic kidney disease;
SKCM	cis	rs2180341	0.576	rs2057224	chr6:127624414	C/G	cg27446573	chr6:127587934	RNF146	0.72	5.67	0.54	2.29e-7	Breast cancer;
SKCM	cis	rs10193935	0.901	rs222464	chr2:42643889	C/T	cg27598129	chr2:42591480	NA	-0.96	-6.71	-0.61	2.74e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6087990	0.735	rs6087420	chr20:31359391	G/A	cg13636640	chr20:31349939	DNMT3B	0.87	6.84	0.61	1.61e-9	Ulcerative colitis;
SKCM	cis	rs523522	0.962	rs687873	chr12:121019634	G/A	cg12219531	chr12:120966889	COQ5	0.9	7.63	0.65	4.83e-11	High light scatter reticulocyte count;
SKCM	cis	rs4927850	0.958	rs1975582	chr3:195751439	G/T	cg01181863	chr3:195395398	SDHAP2	-0.76	-4.85	-0.48	6.14e-6	Pancreatic cancer;
SKCM	cis	rs10927875	0.501	rs61782229	chr1:16220118	G/A	cg21385522	chr1:16154831	NA	-1.0	-8.18	-0.68	4.14e-12	Dilated cardiomyopathy;
SKCM	cis	rs10540	0.915	rs35389167	chr11:460765	A/G	cg03576123	chr11:487126	PTDSS2	-1.46	-7.68	-0.66	4e-11	Body mass index;
SKCM	cis	rs10256972	0.706	rs4285396	chr7:1123738	A/G	cg16145915	chr7:1198662	ZFAND2A	-0.56	-7.89	-0.67	1.55e-11	Longevity;Endometriosis;
SKCM	cis	rs2836974	0.568	rs2142111	chr21:40549289	G/C	cg11890956	chr21:40555474	PSMG1	0.88	9.14	0.72	5.76e-14	Cognitive function;
SKCM	cis	rs2075371	0.674	rs11771785	chr7:134013249	A/G	cg11752832	chr7:134001865	SLC35B4	-0.57	-5.16	-0.5	1.84e-6	Mean platelet volume;
SKCM	cis	rs17685	0.753	rs2302438	chr7:75677065	C/A	cg16684958	chr7:75615977	POR	0.57	5.6	0.54	3.07e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs4523957	0.590	rs9899427	chr17:2063550	A/T	cg16513277	chr17:2031491	SMG6	-0.79	-5.63	-0.54	2.7e-7	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs2013441	1.000	rs2263175	chr17:20128029	C/G	cg13482628	chr17:19912719	NA	-0.65	-5.21	-0.51	1.48e-6	Obesity-related traits;
SKCM	cis	rs826838	0.967	rs2069211	chr12:39128892	C/T	cg13010199	chr12:38710504	ALG10B	-0.72	-5.73	-0.54	1.83e-7	Heart rate;
SKCM	cis	rs9910055	0.920	rs2855818	chr17:42290015	G/A	cg09913183	chr17:42254507	C17orf65;ASB16	0.61	5.44	0.52	6.03e-7	Total body bone mineral density;
SKCM	cis	rs9640161	0.871	rs56156367	chr7:150047201	A/T	cg10018233	chr7:150070692	REPIN1	0.67	5.21	0.51	1.47e-6	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs2836974	0.831	rs34294410	chr21:40555160	C/G	cg11644478	chr21:40555479	PSMG1	0.97	10.17	0.75	5.99e-16	Cognitive function;
SKCM	cis	rs2841277	0.509	rs11850949	chr14:105408827	A/C	cg21017887	chr14:105400489	NA	0.57	5.09	0.5	2.37e-6	Rheumatoid arthritis;
SKCM	cis	rs4803468	0.967	rs13344547	chr19:41945848	G/T	cg14132834	chr19:41945861	ATP5SL	0.77	5.9	0.56	9.04e-8	Height;
SKCM	cis	rs11677370	0.561	rs13003140	chr2:3816759	G/T	cg17052675	chr2:3827356	NA	-0.63	-4.83	-0.48	6.78e-6	Type 2 diabetes;
SKCM	cis	rs615632	0.570	rs17734541	chr8:9708433	A/G	cg22647929	chr8:10583326	SOX7	0.53	5.05	0.5	2.84e-6	Neuroticism;
SKCM	cis	rs854765	0.583	rs10048206	chr17:17866897	A/G	cg04398451	chr17:18023971	MYO15A	-0.86	-5.91	-0.56	8.41e-8	Total body bone mineral density;
SKCM	cis	rs12142240	0.698	rs6690075	chr1:46819848	G/A	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs11792861	0.781	rs28361152	chr9:111727529	T/C	cg14432460	chr9:111696404	IKBKAP;C9orf6	0.68	4.87	0.48	5.65e-6	Menarche (age at onset);
SKCM	cis	rs28386778	0.865	rs2727276	chr17:61929709	G/A	cg01411255	chr17:61851458	DDX42;CCDC47	0.78	5.03	0.49	3.06e-6	Prudent dietary pattern;
SKCM	cis	rs4900538	0.855	rs12590993	chr14:102844064	A/G	cg18135206	chr14:102964638	TECPR2	-0.71	-5.36	-0.52	8.09e-7	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs3020736	0.500	rs6002616	chr22:42504679	A/G	cg04733989	chr22:42467013	NAGA	-0.72	-5.62	-0.54	2.87e-7	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs4819052	0.851	rs4819046	chr21:46664955	C/T	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.36	0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs9926296	0.744	rs460879	chr16:89712889	C/T	cg01097406	chr16:89675127	NA	0.51	5.5	0.53	4.7e-7	Vitiligo;
SKCM	cis	rs611744	0.647	rs1584373	chr8:109263399	C/A	cg18478394	chr8:109455254	TTC35	0.66	5.32	0.52	9.59e-7	Dupuytren's disease;
SKCM	cis	rs8072100	0.744	rs34537623	chr17:45530203	A/G	cg08085267	chr17:45401833	C17orf57	-0.62	-5.15	-0.5	1.88e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs748404	0.697	rs491804	chr15:43560825	G/A	cg02155558	chr15:43621948	ADAL;LCMT2	0.69	5.67	0.54	2.35e-7	Lung cancer;
SKCM	cis	rs769267	0.930	rs4808955	chr19:19552413	T/C	cg26732615	chr19:19648335	CILP2;YJEFN3	0.67	7.06	0.62	6e-10	Tonsillectomy;
SKCM	cis	rs514406	0.668	rs520281	chr1:53365235	G/C	cg08859206	chr1:53392774	SCP2	-0.63	-5.32	-0.52	9.59e-7	Monocyte count;
SKCM	cis	rs4242434	0.597	rs4066629	chr8:22529073	A/C	cg03733263	chr8:22462867	KIAA1967	-0.7	-5.02	-0.49	3.21e-6	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs9814567	0.929	rs9815297	chr3:134215052	A/G	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.67	-5.25	-0.51	1.28e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs9399135	0.967	rs1590975	chr6:135352088	C/T	cg24558204	chr6:135376177	HBS1L	0.59	5.16	0.5	1.83e-6	Red blood cell count;
SKCM	cis	rs9914544	0.966	rs1737943	chr17:18841590	A/G	cg26306683	chr17:18585705	ZNF286B	-0.68	-5.18	-0.51	1.71e-6	Educational attainment (years of education);
SKCM	cis	rs7811142	1.000	rs73161762	chr7:100014846	C/T	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-0.97	-5.37	-0.52	7.82e-7	Platelet count;
SKCM	trans	rs1814175	0.645	rs11040702	chr11:50024827	C/T	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs56235845	0.964	rs11746443	chr5:176798306	G/A	cg06060754	chr5:176797920	RGS14	0.81	8.4	0.69	1.61e-12	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs7666738	0.791	rs6828752	chr4:99063382	C/T	cg05340658	chr4:99064831	C4orf37	0.66	4.87	0.48	5.74e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs62238980	0.614	rs75143283	chr22:32413768	G/A	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs4242434	1.000	rs4242434	chr8:22501830	C/A	cg03733263	chr8:22462867	KIAA1967	1.05	8.68	0.7	4.48e-13	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs6089829	0.962	rs6089826	chr20:61668595	G/A	cg03213289	chr20:61660250	NA	0.49	4.81	0.48	7.26e-6	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs951366	0.617	rs708727	chr1:205767885	G/A	cg07167872	chr1:205819463	PM20D1	0.98	10.19	0.76	5.39e-16	Menarche (age at onset);
SKCM	cis	rs5750830	0.649	rs7949	chr22:39827553	G/A	cg11247378	chr22:39784982	NA	-0.46	-5.41	-0.52	6.81e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs477692	0.549	rs7079744	chr10:131454790	G/A	cg11019008	chr10:131425282	MGMT	-0.52	-4.84	-0.48	6.52e-6	Response to temozolomide;
SKCM	cis	rs17065868	1.000	rs60157962	chr13:45106199	G/A	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs67311347	0.869	rs7646899	chr3:40366982	A/G	cg00091569	chr3:40428383	ENTPD3	0.65	5.5	0.53	4.64e-7	Renal cell carcinoma;
SKCM	cis	rs1461503	0.966	rs7944630	chr11:122838844	G/A	cg27398637	chr11:122830231	C11orf63	-0.63	-4.8	-0.48	7.54e-6	Menarche (age at onset);
SKCM	cis	rs7927771	0.524	rs4752860	chr11:47705015	C/A	cg20307385	chr11:47447363	PSMC3	-0.72	-5.81	-0.55	1.31e-7	Subjective well-being;
SKCM	cis	rs7106204	0.748	rs4598670	chr11:24236524	G/A	ch.11.24196551F	chr11:24239977	NA	0.77	6.08	0.57	4.19e-8	Response to Homoharringtonine (cytotoxicity);
SKCM	cis	rs801193	0.548	rs6975044	chr7:66227482	C/T	cg18876405	chr7:65276391	NA	0.61	6.02	0.56	5.36e-8	Aortic root size;
SKCM	cis	rs2739330	0.789	rs5760109	chr22:24252938	C/G	cg24846343	chr22:24311635	DDTL	0.61	5.76	0.55	1.58e-7	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs17345786	1.000	rs3804775	chr3:101306507	C/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.71	5.28	0.51	1.12e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7659604	0.539	rs3217753	chr4:122746325	A/G	cg06713675	chr4:122721982	EXOSC9	-0.75	-7.26	-0.64	2.47e-10	Type 2 diabetes;
SKCM	cis	rs17826219	0.500	rs9891256	chr17:29072692	C/T	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Body mass index;
SKCM	cis	rs4481887	0.830	rs10888341	chr1:248441995	T/C	cg00666640	chr1:248458726	OR2T12	0.62	5.5	0.53	4.68e-7	Common traits (Other);
SKCM	cis	rs7646501	0.765	rs7372302	chr3:24058061	T/C	cg22892432	chr3:24537792	THRB	0.57	4.84	0.48	6.39e-6	Cognitive ability;Intelligence;
SKCM	cis	rs2836633	1.000	rs2836631	chr21:40065906	G/T	cg05519781	chr21:40033154	ERG	-0.74	-6.14	-0.57	3.2e-8	Coronary artery disease;
SKCM	cis	rs748404	0.631	rs12905772	chr15:43648444	G/A	cg02155558	chr15:43621948	ADAL;LCMT2	0.84	6.38	0.59	1.17e-8	Lung cancer;
SKCM	cis	rs17685	0.890	rs76021834	chr7:75607155	A/G	cg01364799	chr7:75623366	TMEM120A	-0.79	-6.02	-0.56	5.44e-8	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs10751667	0.666	rs7105477	chr11:964271	C/G	cg06064525	chr11:970664	AP2A2	-0.54	-4.91	-0.49	4.93e-6	Alzheimer's disease (late onset);
SKCM	cis	rs28386778	0.897	rs2665795	chr17:61925272	A/G	cg06873352	chr17:61820015	STRADA	-0.76	-6.49	-0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs2760061	0.569	rs621631	chr1:228114728	A/G	cg18477163	chr1:228402036	OBSCN	-0.46	-5.1	-0.5	2.36e-6	Diastolic blood pressure;
SKCM	cis	rs9910055	0.509	rs9916444	chr17:42313512	C/G	cg13607699	chr17:42295918	UBTF	0.86	7.36	0.64	1.62e-10	Total body bone mineral density;
SKCM	cis	rs28386778	0.897	rs2584639	chr17:61863732	C/T	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs2197308	0.715	rs11181816	chr12:37911626	A/G	cg13010199	chr12:38710504	ALG10B	-0.64	-4.92	-0.49	4.67e-6	Morning vs. evening chronotype;
SKCM	trans	rs2727020	0.576	rs12293522	chr11:49558425	T/A	cg15704280	chr7:45808275	SEPT13	-0.97	-9.13	-0.72	6.06e-14	Coronary artery disease;
SKCM	cis	rs10504229	0.683	rs7816733	chr8:58129855	G/A	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs9300255	0.602	rs1106241	chr12:123627016	T/C	cg00376283	chr12:123451042	ABCB9	0.8	5.4	0.52	7.12e-7	Neutrophil percentage of white cells;
SKCM	cis	rs8017423	0.692	rs75414183	chr14:90810173	A/G	cg04374321	chr14:90722782	PSMC1	-0.76	-5.8	-0.55	1.36e-7	Mortality in heart failure;
SKCM	cis	rs1707322	1.000	rs4660332	chr1:46461418	T/A	cg03146154	chr1:46216737	IPP	0.77	5.1	0.5	2.36e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs67311347	0.911	rs6775936	chr3:40377399	T/G	cg00091569	chr3:40428383	ENTPD3	0.66	5.63	0.54	2.69e-7	Renal cell carcinoma;
SKCM	cis	rs8008758	0.517	rs1772024	chr14:101695220	A/C	cg26224664	chr14:101693935	NA	0.45	5.94	0.56	7.63e-8	Body mass index (alcohol intake interaction);
SKCM	cis	rs6951245	0.935	rs61910751	chr7:1097895	A/G	cg24642844	chr7:1081250	C7orf50	-0.93	-6.22	-0.58	2.28e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs11098499	0.662	rs13108589	chr4:120268102	G/C	cg09307838	chr4:120376055	NA	0.92	7.5	0.65	8.81e-11	Corneal astigmatism;
SKCM	cis	rs6089584	0.854	rs8117075	chr20:60613766	T/C	cg06108461	chr20:60628389	TAF4	-0.89	-8.72	-0.7	3.75e-13	Body mass index;
SKCM	cis	rs7772486	0.875	rs9322048	chr6:146400439	A/G	cg23711669	chr6:146136114	FBXO30	0.89	8.79	0.71	2.78e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1267303	0.675	rs1267313	chr1:46986322	G/T	cg25110126	chr1:46999211	NA	-0.67	-4.81	-0.48	7.21e-6	Monobrow;
SKCM	cis	rs6977660	0.714	rs10257947	chr7:19824099	A/C	cg05791153	chr7:19748676	TWISTNB	0.77	5.02	0.49	3.23e-6	Thyroid stimulating hormone;
SKCM	cis	rs7666738	0.819	rs62318904	chr4:99036101	A/T	cg05340658	chr4:99064831	C4orf37	0.66	5.01	0.49	3.35e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs870825	0.616	rs4623061	chr4:185643161	A/C	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	trans	rs8073060	0.586	rs225265	chr17:33961972	C/T	cg19694781	chr19:47549865	TMEM160	-1.08	-8.36	-0.69	1.88e-12	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs17376456	0.877	rs10476598	chr5:93367281	C/T	cg21475434	chr5:93447410	FAM172A	-0.93	-5.34	-0.52	8.73e-7	Diabetic retinopathy;
SKCM	cis	rs10751667	0.666	rs4074231	chr11:978219	G/C	cg10932868	chr11:921992	NA	0.55	5.1	0.5	2.36e-6	Alzheimer's disease (late onset);
SKCM	trans	rs9929218	0.551	rs2281850	chr16:68718750	C/T	cg04657470	chr2:198365150	HSPE1;HSPD1	-0.95	-9.89	-0.75	2.06e-15	Colorectal cancer;
SKCM	trans	rs1814175	0.935	rs6485999	chr11:49658986	G/C	cg15704280	chr7:45808275	SEPT13	-1.0	-9.43	-0.73	1.61e-14	Height;
SKCM	cis	rs9814567	0.896	rs11915964	chr3:134348930	A/C	cg06109529	chr3:134205091	CEP63;ANAPC13	0.64	5.11	0.5	2.2e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs7618915	0.571	rs33964154	chr3:52596914	A/G	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs885814	0.619	rs3767142	chr1:21901558	C/T	cg25601136	chr1:21766849	NBPF3	0.72	4.83	0.48	6.73e-6	Response to TNF-alpha inhibitors in rheumatoid arthritis;
SKCM	cis	rs523522	0.923	rs3916065	chr12:120934624	A/C	cg12219531	chr12:120966889	COQ5	0.91	7.82	0.66	2.11e-11	High light scatter reticulocyte count;
SKCM	cis	rs951366	0.559	rs823101	chr1:205667006	T/C	cg14159672	chr1:205819179	PM20D1	0.73	5.29	0.51	1.08e-6	Menarche (age at onset);
SKCM	cis	rs644799	1.000	rs623191	chr11:95548359	A/G	cg03916912	chr11:95522834	CEP57;FAM76B	0.92	8.04	0.67	8e-12	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs28595532	1.000	rs114912871	chr4:119697004	G/C	cg21605333	chr4:119757512	SEC24D	1.35	7.92	0.67	1.37e-11	Cannabis dependence symptom count;
SKCM	cis	rs12709013	0.766	rs11648511	chr16:58832075	T/C	cg02431531	chr16:59244939	NA	0.48	4.99	0.49	3.62e-6	Blood metabolite ratios;
SKCM	cis	rs9583531	0.550	rs7985098	chr13:111386416	G/A	cg24331049	chr13:111365604	ING1	0.81	6.2	0.57	2.5e-8	Coronary artery disease;
SKCM	cis	rs9300255	0.602	rs1716164	chr12:123663660	G/A	cg00376283	chr12:123451042	ABCB9	0.83	5.49	0.53	4.74e-7	Neutrophil percentage of white cells;
SKCM	cis	rs812925	0.537	rs10208769	chr2:61605614	A/T	cg15711740	chr2:61764176	XPO1	0.65	4.84	0.48	6.38e-6	Immature fraction of reticulocytes;
SKCM	cis	rs3845702	0.736	rs9288045	chr2:180814194	G/A	cg01881094	chr2:180872142	CWC22	-1.3	-6.15	-0.57	3.07e-8	Schizophrenia;
SKCM	cis	rs2180341	0.594	rs7738385	chr6:127777516	T/C	cg27446573	chr6:127587934	RNF146	0.76	6.19	0.57	2.6e-8	Breast cancer;
SKCM	cis	rs6840360	0.550	rs7675818	chr4:152690777	C/G	cg22705602	chr4:152727874	NA	-0.59	-7.93	-0.67	1.3e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs10504229	0.724	rs16922734	chr8:58111192	C/T	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs651907	0.557	rs12629954	chr3:101360623	C/A	cg12386194	chr3:101231763	SENP7	0.75	6.26	0.58	1.96e-8	Colorectal cancer;
SKCM	cis	rs854765	0.583	rs9908832	chr17:17871068	C/T	cg04398451	chr17:18023971	MYO15A	-0.86	-5.91	-0.56	8.41e-8	Total body bone mineral density;
SKCM	cis	rs6840360	0.593	rs4696107	chr4:152606823	G/A	cg22705602	chr4:152727874	NA	-0.58	-7.82	-0.66	2.1e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs2839186	0.709	rs2839176	chr21:47678173	A/G	cg13012494	chr21:47604986	C21orf56	0.62	5.59	0.54	3.18e-7	Testicular germ cell tumor;
SKCM	cis	rs7584330	0.955	rs6729659	chr2:238385126	T/C	cg14458575	chr2:238380390	NA	0.99	6.47	0.59	7.76e-9	Prostate cancer;
SKCM	cis	rs151997	0.569	rs10035173	chr5:50276059	C/G	cg06027927	chr5:50259733	NA	0.61	5.4	0.52	6.86e-7	Callous-unemotional behaviour;
SKCM	cis	rs12709013	0.792	rs12600201	chr16:58807036	C/T	cg02431531	chr16:59244939	NA	0.48	5.01	0.49	3.26e-6	Blood metabolite ratios;
SKCM	cis	rs28595532	0.920	rs116516492	chr4:119734247	C/G	cg14228332	chr4:119757509	SEC24D	1.08	5.52	0.53	4.28e-7	Cannabis dependence symptom count;
SKCM	cis	rs875971	0.502	rs1796227	chr7:66087019	G/C	cg18876405	chr7:65276391	NA	-0.61	-4.87	-0.48	5.74e-6	Aortic root size;
SKCM	cis	rs747650	0.884	rs7128325	chr11:47046554	G/A	cg03339077	chr11:47165057	C11orf49	-0.6	-4.96	-0.49	3.96e-6	Acne (severe);
SKCM	cis	rs7296418	0.961	rs1790121	chr12:123604492	G/A	cg00376283	chr12:123451042	ABCB9	0.95	8.4	0.69	1.6e-12	Platelet count;
SKCM	cis	rs6912958	0.559	rs242267	chr6:88061837	A/G	cg08069147	chr6:88032118	GJB7;C6orf162	-0.78	-7.28	-0.64	2.28e-10	Monocyte percentage of white cells;
SKCM	cis	rs73591976	0.539	rs12446198	chr16:68125972	G/A	cg09117114	chr16:67998030	SLC12A4	-0.81	-5.29	-0.51	1.07e-6	HDL cholesterol;
SKCM	cis	rs4642101	0.793	rs13086170	chr3:12832604	G/C	cg05775895	chr3:12838266	CAND2	0.62	5.45	0.53	5.72e-7	QRS complex (12-leadsum);
SKCM	cis	rs7940866	0.874	rs10894306	chr11:130873882	A/C	cg12179176	chr11:130786555	SNX19	0.76	5.96	0.56	6.98e-8	Schizophrenia;
SKCM	cis	rs7824557	0.564	rs2736304	chr8:11236964	C/T	cg21775007	chr8:11205619	TDH	-0.59	-5.03	-0.5	3.01e-6	Retinal vascular caliber;
SKCM	cis	rs67460515	0.892	rs11929238	chr3:161045937	A/T	cg03342759	chr3:160939853	NMD3	-0.79	-6.79	-0.61	2e-9	Parkinson's disease;
SKCM	cis	rs875971	0.895	rs12698520	chr7:65918707	C/A	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs17376456	0.877	rs7702521	chr5:93484579	G/T	cg21475434	chr5:93447410	FAM172A	0.97	5.42	0.52	6.39e-7	Diabetic retinopathy;
SKCM	cis	rs9790314	0.905	rs7613358	chr3:160949296	T/C	cg03342759	chr3:160939853	NMD3	-0.72	-7.96	-0.67	1.13e-11	Morning vs. evening chronotype;
SKCM	cis	rs1799949	1.000	rs12944597	chr17:41187684	A/C	cg25072359	chr17:41440525	NA	0.63	4.88	0.48	5.43e-6	Menopause (age at onset);
SKCM	cis	rs10751667	0.714	rs7933889	chr11:972270	C/T	cg10932868	chr11:921992	NA	0.55	5.1	0.5	2.36e-6	Alzheimer's disease (late onset);
SKCM	cis	rs9902453	0.904	rs11654983	chr17:28370042	A/C	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.82	-6.4	-0.59	1.06e-8	Coffee consumption (cups per day);
SKCM	cis	rs875971	0.862	rs35034167	chr7:65580166	C/G	cg18876405	chr7:65276391	NA	-0.65	-6.63	-0.6	3.96e-9	Aortic root size;
SKCM	cis	rs28595532	0.920	rs56342843	chr4:119765070	G/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs1552244	1.000	rs61077902	chr3:10126153	T/G	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs3741404	0.791	rs2282491	chr11:63918373	T/C	cg19465662	chr11:63993652	NUDT22;TRPT1	0.7	4.89	0.48	5.31e-6	Platelet count;
SKCM	cis	rs62238980	0.614	rs1967470	chr22:32424480	A/G	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs12500482	0.509	rs1203784	chr4:2427108	T/C	cg26605046	chr4:2439731	NA	-0.63	-4.94	-0.49	4.37e-6	Cognitive function;
SKCM	cis	rs10504229	0.683	rs11774847	chr8:58140775	T/A	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs13266463	0.830	rs6983790	chr8:143406575	A/G	cg16886403	chr8:143471632	TSNARE1	0.78	5.46	0.53	5.52e-7	Schizophrenia;
SKCM	cis	rs9816226	0.618	rs1516728	chr3:185829891	A/T	cg00760338	chr3:185826511	ETV5	0.9	6.57	0.6	5.18e-9	Obesity;Body mass index;
SKCM	cis	rs2739330	0.731	rs4822450	chr22:24242887	C/T	cg25703541	chr22:24373054	LOC391322	-0.87	-7.48	-0.65	9.58e-11	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs4423214	1.000	rs2282621	chr11:71183474	C/T	cg05163923	chr11:71159392	DHCR7	0.81	7.55	0.65	6.83e-11	Vitamin D levels;
SKCM	cis	rs561341	1.000	rs55643307	chr17:30263074	T/C	cg00745463	chr17:30367425	LRRC37B	-1.12	-7.62	-0.65	5.15e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs6430585	0.591	rs12476135	chr2:136486340	T/C	cg07169764	chr2:136633963	MCM6	1.15	8.6	0.7	6.43e-13	Corneal structure;
SKCM	cis	rs2839186	0.814	rs2276257	chr21:47711229	A/G	cg13126279	chr21:47581558	C21orf56	-0.64	-5.49	-0.53	4.89e-7	Testicular germ cell tumor;
SKCM	cis	rs995000	0.965	rs11485618	chr1:63094207	A/G	cg06896770	chr1:63153194	DOCK7	0.95	8.93	0.71	1.48e-13	Triglyceride levels;
SKCM	cis	rs654950	0.875	rs687766	chr1:41998849	C/G	cg06885757	chr1:42089581	HIVEP3	0.65	7.07	0.62	5.9e-10	Airway imaging phenotypes;
SKCM	cis	rs35306767	0.903	rs11253458	chr10:882843	T/C	cg25614935	chr10:1084866	C10orf110	0.82	5.39	0.52	7.4e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs1635	0.655	rs723475	chr6:28304841	G/T	cg15743358	chr6:28303923	ZNF323	1.27	5.15	0.5	1.92e-6	Schizophrenia;
SKCM	cis	rs7618915	0.547	rs2118540	chr3:52629386	T/C	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs2836950	0.509	rs11088466	chr21:40580017	T/A	cg11890956	chr21:40555474	PSMG1	-0.66	-5.26	-0.51	1.22e-6	Menarche (age at onset);
SKCM	cis	rs1799949	1.000	rs35668327	chr17:41273095	G/A	cg05368731	chr17:41323189	NBR1	0.88	7.75	0.66	2.84e-11	Menopause (age at onset);
SKCM	cis	rs5750830	0.649	rs5757663	chr22:39821319	T/C	cg24399712	chr22:39784796	NA	-0.6	-5.01	-0.49	3.31e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs910316	0.763	rs175044	chr14:75472109	G/A	cg08847533	chr14:75593920	NEK9	-0.8	-6.63	-0.6	3.87e-9	Height;
SKCM	cis	rs7772486	0.719	rs4391282	chr6:146276780	A/T	cg23711669	chr6:146136114	FBXO30	-0.79	-7.45	-0.64	1.1e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs72781680	1.000	rs55773155	chr2:24255081	A/G	cg08917208	chr2:24149416	ATAD2B	1.1	5.75	0.55	1.64e-7	Lymphocyte counts;
SKCM	cis	rs2180341	0.513	rs12196828	chr6:127696864	C/T	cg27446573	chr6:127587934	RNF146	0.67	5.3	0.51	1.05e-6	Breast cancer;
SKCM	cis	rs2228479	0.618	rs62052174	chr16:89950901	G/A	cg06558623	chr16:89946397	TCF25	1.26	6.97	0.62	9.17e-10	Skin colour saturation;
SKCM	cis	rs6062302	0.522	rs6090475	chr20:62245397	C/A	cg09650180	chr20:62225654	GMEB2	-0.78	-6.22	-0.58	2.28e-8	Glioblastoma;
SKCM	cis	rs17818399	0.547	rs4952831	chr2:46761181	G/A	cg02822958	chr2:46747628	ATP6V1E2	0.71	4.93	0.49	4.57e-6	Height;
SKCM	cis	rs7772486	0.658	rs6570706	chr6:145962922	T/C	cg23711669	chr6:146136114	FBXO30	0.9	10.02	0.75	1.16e-15	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7772486	0.875	rs9373485	chr6:146401429	A/T	cg23711669	chr6:146136114	FBXO30	0.85	8.45	0.69	1.28e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs8180040	0.966	rs878659	chr3:47500662	G/A	cg27129171	chr3:47204927	SETD2	0.79	5.79	0.55	1.43e-7	Colorectal cancer;
SKCM	cis	rs7809950	0.817	rs2253833	chr7:107205669	A/G	cg23024343	chr7:107201750	COG5	0.78	7.36	0.64	1.59e-10	Coronary artery disease;
SKCM	cis	rs514406	0.584	rs7548832	chr1:53193576	A/T	cg24675658	chr1:53192096	ZYG11B	-0.63	-5.03	-0.5	3.04e-6	Monocyte count;
SKCM	cis	rs60871478	1.000	rs67721251	chr7:825114	T/C	cg05535760	chr7:792225	HEATR2	0.99	7.81	0.66	2.15e-11	Cerebrospinal P-tau181p levels;
SKCM	cis	rs208515	0.556	rs12201658	chr6:66678457	T/C	cg07460842	chr6:66804631	NA	0.93	6.34	0.58	1.35e-8	Exhaled nitric oxide levels;
SKCM	cis	rs151997	0.962	rs26088	chr5:50172670	T/G	cg06027927	chr5:50259733	NA	0.61	5.21	0.51	1.47e-6	Callous-unemotional behaviour;
SKCM	cis	rs9394841	0.667	rs12661667	chr6:41792545	C/T	cg08135965	chr6:41755394	TOMM6	0.74	4.88	0.48	5.45e-6	Mean corpuscular hemoglobin;Red cell distribution width;
SKCM	cis	rs2033711	0.870	rs1051500	chr19:58944402	A/G	cg13877915	chr19:58951672	ZNF132	0.95	10.28	0.76	3.6e-16	Uric acid clearance;
SKCM	cis	rs514406	0.627	rs485128	chr1:53344583	T/C	cg16325326	chr1:53192061	ZYG11B	0.83	7.76	0.66	2.69e-11	Monocyte count;
SKCM	cis	rs6951245	0.832	rs79808627	chr7:1092519	C/G	cg24642844	chr7:1081250	C7orf50	-0.8	-5.84	-0.55	1.14e-7	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs9911578	0.839	rs1871751	chr17:57190368	A/G	cg12560992	chr17:57184187	TRIM37	1.0	9.23	0.72	3.88e-14	Intelligence (multi-trait analysis);
SKCM	cis	rs16854884	0.586	rs4616638	chr3:143735423	A/T	cg06585982	chr3:143692056	C3orf58	-0.82	-7.23	-0.63	2.86e-10	Economic and political preferences (feminism/equality);
SKCM	cis	rs870825	0.860	rs72703519	chr4:185602707	G/A	cg04058563	chr4:185651563	MLF1IP	1.04	5.96	0.56	7.02e-8	Blood protein levels;
SKCM	cis	rs1843834	0.505	rs2140508	chr2:225355839	G/T	cg22455342	chr2:225449267	CUL3	0.7	5.15	0.5	1.88e-6	IgE levels in asthmatics (D.p. specific);
SKCM	trans	rs17685	0.712	rs6976236	chr7:75741087	G/T	cg19862616	chr7:65841803	NCRNA00174	0.94	9.48	0.73	1.26e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs8037137	0.915	rs77554484	chr15:91509215	C/A	cg15878949	chr15:91534302	PRC1	0.68	5.28	0.51	1.15e-6	Platelet count;Serous invasive ovarian cancer;High-grade serous ovarian cancer;Invasive epithelial ovarian cancer;
SKCM	cis	rs9910055	0.762	rs7213436	chr17:42252163	A/G	cg10896456	chr17:42255109	ASB16;C17orf65	-0.66	-6.43	-0.59	9.35e-9	Total body bone mineral density;
SKCM	cis	rs9611565	0.592	rs12484254	chr22:41962003	T/A	cg03806693	chr22:41940476	POLR3H	-1.04	-6.96	-0.62	9.22e-10	Vitiligo;
SKCM	cis	rs769267	0.930	rs4808967	chr19:19640524	A/G	cg26732615	chr19:19648335	CILP2;YJEFN3	0.69	7.16	0.63	3.82e-10	Tonsillectomy;
SKCM	cis	rs9913156	0.748	rs7214635	chr17:4601020	G/A	cg19197139	chr17:4613644	ARRB2	-0.79	-5.22	-0.51	1.42e-6	Lymphocyte counts;
SKCM	cis	rs62238980	0.614	rs743763	chr22:32458861	C/T	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs769267	0.965	rs2315281	chr19:19480099	G/A	cg03709012	chr19:19516395	GATAD2A	-0.89	-8.48	-0.69	1.1e-12	Tonsillectomy;
SKCM	cis	rs11098499	0.955	rs13113112	chr4:120156040	C/T	cg09307838	chr4:120376055	NA	0.91	7.22	0.63	2.98e-10	Corneal astigmatism;
SKCM	cis	rs55962025	0.588	rs362312	chr4:3237644	T/C	cg00764545	chr4:3318001	RGS12	-0.6	-5.56	-0.53	3.57e-7	Parental longevity (mother's age at death);
SKCM	cis	rs995000	0.899	rs1781212	chr1:62977419	G/A	cg06896770	chr1:63153194	DOCK7	-0.74	-6.81	-0.61	1.77e-9	Triglyceride levels;
SKCM	cis	rs4803468	1.000	rs13344563	chr19:41945904	G/C	cg14132834	chr19:41945861	ATP5SL	0.77	5.9	0.56	9.04e-8	Height;
SKCM	cis	rs826838	0.904	rs10880981	chr12:38763911	G/A	cg13010199	chr12:38710504	ALG10B	0.86	6.84	0.61	1.61e-9	Heart rate;
SKCM	cis	rs3008870	1.000	rs4620509	chr1:67449941	A/G	cg08660285	chr1:67390436	MIER1;WDR78	-0.92	-6.07	-0.57	4.27e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs1577917	1.000	rs12205336	chr6:86722367	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.83	-8.07	-0.67	6.96e-12	Response to antipsychotic treatment;
SKCM	cis	rs8180040	0.726	rs4682844	chr3:46982737	T/C	cg27129171	chr3:47204927	SETD2	-0.84	-6.46	-0.59	8.31e-9	Colorectal cancer;
SKCM	cis	rs6089584	1.000	rs6089580	chr20:60558976	G/A	cg06108461	chr20:60628389	TAF4	-0.81	-7.11	-0.63	4.79e-10	Body mass index;
SKCM	cis	rs807669	0.900	rs712964	chr22:19156117	T/C	cg02655711	chr22:19163373	SLC25A1	0.6	5.7	0.54	2e-7	Metabolite levels;
SKCM	cis	rs56104184	0.830	rs17272645	chr19:49342366	C/G	cg15549821	chr19:49342101	PLEKHA4	1.25	8.23	0.68	3.35e-12	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs35306767	0.903	rs35637113	chr10:874149	G/C	cg26597838	chr10:835615	NA	0.76	5.66	0.54	2.4e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs67311347	1.000	rs6801859	chr3:40493218	G/T	cg00091569	chr3:40428383	ENTPD3	-0.59	-4.85	-0.48	6.15e-6	Renal cell carcinoma;
SKCM	cis	rs17345786	0.861	rs11707689	chr3:101086475	A/G	cg12386194	chr3:101231763	SENP7	0.76	6.03	0.56	5.19e-8	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs778371	0.915	rs938569	chr2:233759695	C/G	cg08000102	chr2:233561755	GIGYF2	0.79	5.48	0.53	4.96e-7	Schizophrenia;
SKCM	cis	rs6089584	0.566	rs6061964	chr20:60607536	G/A	cg16423285	chr20:60520624	NA	-0.57	-4.93	-0.49	4.5e-6	Body mass index;
SKCM	cis	rs2952156	0.920	rs2517957	chr17:37838716	G/A	cg00129232	chr17:37814104	STARD3	-0.68	-5.56	-0.53	3.69e-7	Asthma;
SKCM	cis	rs908922	0.676	rs1337338	chr1:152511885	G/A	cg09873164	chr1:152488093	CRCT1	0.76	5.93	0.56	7.7e-8	Hair morphology;
SKCM	cis	rs56104184	0.830	rs73061617	chr19:49350984	G/A	cg15549821	chr19:49342101	PLEKHA4	-1.27	-7.95	-0.67	1.17e-11	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs2033711	0.870	rs4801583	chr19:58918405	A/G	cg00825309	chr19:58991885	ZNF446	-0.67	-5.32	-0.52	9.5e-7	Uric acid clearance;
SKCM	cis	rs28374715	0.578	rs13313520	chr15:41629127	T/G	cg18705301	chr15:41695430	NDUFAF1	-1.21	-12.61	-0.82	1.61e-20	Ulcerative colitis;
SKCM	cis	rs875971	0.862	rs801204	chr7:66022921	T/C	cg11764359	chr7:65958608	NA	-0.75	-6.8	-0.61	1.88e-9	Aortic root size;
SKCM	cis	rs7847628	0.551	rs10818476	chr9:123572038	A/G	cg09419670	chr9:123605666	PSMD5;LOC253039	0.65	6.08	0.57	4.25e-8	Birth weight;
SKCM	cis	rs7100689	0.646	rs4357632	chr10:82131783	C/T	cg01528321	chr10:82214614	TSPAN14	0.8	7.0	0.62	7.98e-10	Post bronchodilator FEV1;
SKCM	cis	rs2812533	0.938	rs34208345	chr10:71444312	C/T	cg01040533	chr10:71339886	NA	-0.54	-5.06	-0.5	2.71e-6	Type 2 diabetes;
SKCM	cis	rs875971	0.964	rs6945019	chr7:65922458	C/G	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs7618501	0.699	rs6446187	chr3:49907111	C/A	cg05072774	chr3:49840536	C3orf54	-0.7	-5.25	-0.51	1.3e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs992157	0.764	rs3731861	chr2:219191256	T/C	cg20019365	chr2:219134978	PNKD;AAMP	-0.75	-5.92	-0.56	8.03e-8	Colorectal cancer;
SKCM	cis	rs116095464	0.558	rs10067021	chr5:221490	C/T	cg22857025	chr5:266934	NA	-1.36	-8.0	-0.67	9.23e-12	Breast cancer;
SKCM	cis	rs72949976	0.898	rs6732233	chr2:214022834	C/T	cg08319019	chr2:214017104	IKZF2	-0.66	-5.06	-0.5	2.74e-6	Lung cancer;Squamous cell lung carcinoma;
SKCM	cis	rs6665290	0.836	rs56029302	chr1:227203390	G/A	cg10327440	chr1:227177885	CDC42BPA	-1.21	-16.11	-0.88	1.59e-26	Myeloid white cell count;
SKCM	cis	rs752010	0.871	rs10890149	chr1:42092791	T/A	cg06885757	chr1:42089581	HIVEP3	0.5	5.12	0.5	2.16e-6	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs2463822	0.925	rs6863	chr11:62160725	G/T	cg06239285	chr11:62104954	ASRGL1	-1.25	-5.93	-0.56	7.79e-8	Chronic obstructive pulmonary disease-related biomarkers;
SKCM	cis	rs4242434	0.819	rs6558167	chr8:22473850	T/C	cg03733263	chr8:22462867	KIAA1967	1.02	8.7	0.7	4.12e-13	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs11098499	0.657	rs7664458	chr4:120371967	A/G	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs9300255	0.739	rs11057210	chr12:123733799	A/G	cg05973401	chr12:123451056	ABCB9	0.86	6.11	0.57	3.69e-8	Neutrophil percentage of white cells;
SKCM	cis	rs2839186	0.933	rs56955294	chr21:47708953	A/G	cg13012494	chr21:47604986	C21orf56	0.67	5.71	0.54	1.95e-7	Testicular germ cell tumor;
SKCM	cis	rs2180341	0.781	rs6913350	chr6:127570560	C/T	cg27446573	chr6:127587934	RNF146	0.86	7.02	0.62	7.1e-10	Breast cancer;
SKCM	cis	rs2357013	0.699	rs1510107	chr2:53160137	C/G	cg07782112	chr2:53107842	NA	-0.53	-5.36	-0.52	8.11e-7	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs2404602	0.575	rs11072611	chr15:76947983	A/G	cg23625390	chr15:77176239	SCAPER	0.85	8.13	0.68	5.37e-12	Blood metabolite levels;
SKCM	cis	rs651907	0.535	rs11716558	chr3:101528481	T/C	cg12386194	chr3:101231763	SENP7	0.68	5.74	0.54	1.73e-7	Colorectal cancer;
SKCM	cis	rs6003958	1	rs6003958	chr22:24264089	T/G	cg25703541	chr22:24373054	LOC391322	0.73	5.13	0.5	2.09e-6	S-phenylmercapturic acid levels in smokers;
SKCM	cis	rs847649	0.842	rs4729873	chr7:102731781	G/A	cg18108683	chr7:102477205	FBXL13	0.81	7.55	0.65	7.07e-11	Morning vs. evening chronotype;
SKCM	cis	rs6840360	0.571	rs6811676	chr4:152562726	T/C	cg22705602	chr4:152727874	NA	-0.52	-5.69	-0.54	2.15e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7824557	0.564	rs7839307	chr8:11198792	A/G	cg21775007	chr8:11205619	TDH	0.64	5.66	0.54	2.37e-7	Retinal vascular caliber;
SKCM	cis	rs9303401	0.659	rs35103007	chr17:56900738	G/A	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.16	0.57	2.91e-8	Cognitive test performance;
SKCM	cis	rs7659604	1.000	rs6814995	chr4:122664963	A/T	cg06713675	chr4:122721982	EXOSC9	0.63	5.27	0.51	1.19e-6	Type 2 diabetes;
SKCM	cis	rs9790314	0.690	rs1903423	chr3:160842252	A/G	cg03342759	chr3:160939853	NMD3	-0.69	-6.89	-0.62	1.26e-9	Morning vs. evening chronotype;
SKCM	cis	rs7215564	0.908	rs80183474	chr17:78655070	T/A	cg16980736	chr17:78789706	RPTOR	-0.89	-4.88	-0.48	5.41e-6	Myopia (pathological);
SKCM	cis	rs11098499	0.821	rs3775852	chr4:120454556	A/G	cg24375607	chr4:120327624	NA	0.68	5.27	0.51	1.16e-6	Corneal astigmatism;
SKCM	cis	rs17685	0.712	rs10952842	chr7:75780413	G/A	cg01364799	chr7:75623366	TMEM120A	-0.65	-5.06	-0.5	2.73e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	trans	rs8073060	0.586	rs225307	chr17:33918311	A/G	cg19694781	chr19:47549865	TMEM160	1.08	8.69	0.7	4.26e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs1707322	0.752	rs6658700	chr1:46160260	C/T	cg03146154	chr1:46216737	IPP	0.81	5.62	0.54	2.87e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs9543976	1.000	rs73223968	chr13:76141721	C/A	cg01531495	chr13:76123901	UCHL3	-0.92	-5.02	-0.49	3.17e-6	Diabetic retinopathy;
SKCM	cis	rs4481887	0.893	rs7528645	chr1:248427291	T/A	cg00666640	chr1:248458726	OR2T12	0.65	6.1	0.57	3.85e-8	Common traits (Other);
SKCM	cis	rs12142240	0.698	rs67487250	chr1:46811333	T/C	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs3087591	0.879	rs4795591	chr17:29612410	C/A	cg24425628	chr17:29625626	OMG;NF1	-0.64	-5.08	-0.5	2.48e-6	Hip circumference;
SKCM	cis	rs7772486	0.713	rs1986729	chr6:146194831	G/A	cg23711669	chr6:146136114	FBXO30	0.84	9.44	0.73	1.52e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs28595532	0.920	rs114223775	chr4:119775091	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs7428	0.527	rs1061782	chr2:85546615	A/G	cg24342717	chr2:85555507	TGOLN2	0.62	4.91	0.49	4.86e-6	Ear protrusion;
SKCM	cis	rs9911578	0.765	rs66954617	chr17:56999427	A/G	cg12560992	chr17:57184187	TRIM37	0.94	7.55	0.65	7.01e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs7666738	0.830	rs6854902	chr4:99033416	T/G	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9549367	0.713	rs4907593	chr13:113830459	C/T	cg18105134	chr13:113819100	PROZ	0.86	6.58	0.6	4.84e-9	Platelet distribution width;
SKCM	cis	rs6089829	0.962	rs7273930	chr20:61666017	G/A	cg03213289	chr20:61660250	NA	0.49	4.82	0.48	7.06e-6	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs2842992	0.830	rs2025190	chr6:160138241	C/T	cg19482086	chr6:160211437	TCP1;MRPL18	0.79	5.76	0.55	1.61e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs4803468	0.967	rs1077856	chr19:41885221	T/C	cg14132834	chr19:41945861	ATP5SL	-0.74	-5.71	-0.54	1.99e-7	Height;
SKCM	cis	rs709400	0.663	rs11626787	chr14:103991749	A/G	cg26031613	chr14:104095156	KLC1	0.69	5.28	0.51	1.13e-6	Body mass index;
SKCM	cis	rs1003719	0.737	rs2835587	chr21:38461795	A/T	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs1948632	0.599	rs953350	chr16:75985009	G/A	cg01495379	chr16:76669151	NA	0.46	5.32	0.52	9.5e-7	Tuberculosis;
SKCM	cis	rs17345786	0.906	rs56171035	chr3:101111108	G/C	cg12386194	chr3:101231763	SENP7	0.76	6.03	0.56	5.19e-8	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs769267	0.930	rs4808959	chr19:19572108	T/G	cg26732615	chr19:19648335	CILP2;YJEFN3	0.67	7.06	0.62	6e-10	Tonsillectomy;
SKCM	cis	rs1577917	1.000	rs2816821	chr6:86657084	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.77	-0.66	2.59e-11	Response to antipsychotic treatment;
SKCM	cis	rs2739330	0.760	rs5760095	chr22:24247293	A/G	cg24846343	chr22:24311635	DDTL	0.69	6.57	0.6	5.18e-9	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs933688	0.938	rs12110065	chr5:90718474	A/G	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.94	6.58	0.6	4.82e-9	Smoking behavior;
SKCM	cis	rs684232	0.901	rs461251	chr17:619162	A/G	cg12384639	chr17:618140	VPS53	-0.65	-5.04	-0.5	2.97e-6	Prostate cancer;
SKCM	cis	rs13108904	0.935	rs1732102	chr4:1277924	T/C	cg05025164	chr4:1340916	KIAA1530	-0.6	-4.88	-0.48	5.52e-6	Obesity-related traits;
SKCM	cis	rs673604	0.881	rs11264118	chr1:35676453	A/T	cg12633102	chr1:35676489	NA	-0.68	-5.35	-0.52	8.54e-7	Endometrial cancer;
SKCM	cis	rs7523050	0.643	rs34572569	chr1:109401856	A/T	cg08274380	chr1:109419600	GPSM2	1.13	5.57	0.53	3.54e-7	Fat distribution (HIV);
SKCM	cis	rs6951245	1.000	rs78308415	chr7:1072634	G/A	cg24642844	chr7:1081250	C7orf50	-0.95	-6.4	-0.59	1.06e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs28386778	0.897	rs6504177	chr17:61812655	C/T	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.36	0.52	8.08e-7	Prudent dietary pattern;
SKCM	cis	rs9300255	0.596	rs10734900	chr12:123743445	G/A	cg05973401	chr12:123451056	ABCB9	0.75	5.83	0.55	1.18e-7	Neutrophil percentage of white cells;
SKCM	cis	rs4566357	0.539	rs10933164	chr2:227860671	A/G	cg11843606	chr2:227700838	RHBDD1	-0.86	-6.41	-0.59	1.04e-8	Coronary artery disease;
SKCM	cis	rs28386778	0.966	rs2854206	chr17:61947203	G/A	cg06873352	chr17:61820015	STRADA	0.77	6.4	0.59	1.04e-8	Prudent dietary pattern;
SKCM	cis	rs17685	0.925	rs1057868	chr7:75615006	C/T	cg01364799	chr7:75623366	TMEM120A	-0.78	-6.03	-0.56	5.15e-8	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs654950	0.840	rs2810551	chr1:41995402	G/A	cg06885757	chr1:42089581	HIVEP3	-0.64	-7.03	-0.62	6.98e-10	Airway imaging phenotypes;
SKCM	cis	rs2404602	0.692	rs12913810	chr15:77166675	T/C	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs9902453	0.904	rs55866125	chr17:28312993	T/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.82	6.4	0.59	1.06e-8	Coffee consumption (cups per day);
SKCM	cis	rs7122539	0.734	rs4930391	chr11:66645254	A/G	cg24851651	chr11:66362959	CCS	-0.66	-4.82	-0.48	6.97e-6	HIV-1 susceptibility;
SKCM	cis	rs7144547	1.000	rs7144547	chr14:81881735	C/T	cg02996355	chr14:81879375	NA	-0.88	-6.4	-0.59	1.07e-8	Prudent dietary pattern;
SKCM	cis	rs7100689	0.622	rs4933378	chr10:82147057	T/C	cg01528321	chr10:82214614	TSPAN14	0.84	7.53	0.65	7.69e-11	Post bronchodilator FEV1;
SKCM	cis	rs6502050	0.723	rs66871014	chr17:80181874	G/A	cg13939156	chr17:80058883	NA	-0.53	-4.88	-0.48	5.57e-6	Life satisfaction;
SKCM	cis	rs72792276	1.000	rs72794370	chr5:127444907	T/A	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.77	5.59	0.53	3.26e-7	Red cell distribution width;
SKCM	cis	rs875971	0.619	rs10278371	chr7:66051540	C/A	cg11987759	chr7:65425863	GUSB	0.67	5.75	0.55	1.68e-7	Aortic root size;
SKCM	cis	rs5769765	0.955	rs4075330	chr22:50303249	G/A	cg22709217	chr22:50311962	ALG12;CRELD2	-0.97	-6.2	-0.57	2.45e-8	Schizophrenia;
SKCM	cis	rs4820539	1.000	rs916584	chr22:23469433	A/G	cg14186256	chr22:23484241	RTDR1	0.85	8.15	0.68	4.91e-12	Bone mineral density;
SKCM	cis	rs2070488	0.775	rs762318	chr3:38516369	C/A	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.74	6.14	0.57	3.18e-8	Electrocardiographic conduction measures;
SKCM	cis	rs8070624	0.543	rs4299203	chr17:17878159	T/G	cg04398451	chr17:18023971	MYO15A	-0.8	-6.01	-0.56	5.59e-8	Total body bone mineral density;
SKCM	cis	rs3857536	0.740	rs9354392	chr6:66894555	G/T	cg07460842	chr6:66804631	NA	-0.7	-5.08	-0.5	2.51e-6	Blood trace element (Cu levels);
SKCM	cis	rs9303401	0.659	rs36109237	chr17:56653834	A/G	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.27	0.51	1.17e-6	Cognitive test performance;
SKCM	cis	rs9926296	0.605	rs12599180	chr16:89839306	C/T	cg04287289	chr16:89883240	FANCA	-1.04	-11.75	-0.8	6.25e-19	Vitiligo;
SKCM	cis	rs8180040	0.620	rs11707736	chr3:47069504	G/T	cg27129171	chr3:47204927	SETD2	-0.74	-5.37	-0.52	7.84e-7	Colorectal cancer;
SKCM	cis	rs4243830	0.850	rs1114661	chr1:6596871	G/A	cg22792644	chr1:6614718	TAS1R1;NOL9	-1.05	-5.64	-0.54	2.66e-7	Body mass index;
SKCM	cis	rs2290405	0.527	rs6829987	chr4:932974	C/G	cg04824913	chr4:887549	GAK	-0.83	-7.64	-0.65	4.64e-11	Systemic sclerosis;
SKCM	cis	rs4555082	0.874	rs2735828	chr14:105710486	C/A	cg13114125	chr14:105738426	BRF1	-0.7	-5.65	-0.54	2.51e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs8072100	0.935	rs8070759	chr17:45638760	C/T	cg08085267	chr17:45401833	C17orf57	0.58	5.13	0.5	2.04e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs7927771	0.524	rs1563821	chr11:47756568	C/T	cg20307385	chr11:47447363	PSMC3	0.71	5.63	0.54	2.67e-7	Subjective well-being;
SKCM	cis	rs2204008	0.744	rs11180504	chr12:38236313	C/T	cg26384229	chr12:38710491	ALG10B	0.87	6.9	0.62	1.21e-9	Bladder cancer;
SKCM	cis	rs875971	1.000	rs2220626	chr7:65546062	C/T	cg11764359	chr7:65958608	NA	-0.89	-8.44	-0.69	1.29e-12	Aortic root size;
SKCM	cis	rs28386778	0.734	rs12946669	chr17:62006007	A/G	cg23090583	chr17:61904693	PSMC5;FTSJ3	0.76	6.26	0.58	1.96e-8	Prudent dietary pattern;
SKCM	cis	rs4073582	0.595	rs9326370	chr11:65992008	A/G	cg14036092	chr11:66035641	RAB1B	0.74	5.63	0.54	2.69e-7	Gout;
SKCM	cis	rs67311347	1.000	rs11714912	chr3:40494065	A/G	cg00091569	chr3:40428383	ENTPD3	-0.59	-4.85	-0.48	6.09e-6	Renal cell carcinoma;
SKCM	cis	rs651907	0.535	rs61396602	chr3:101509046	T/C	cg12386194	chr3:101231763	SENP7	0.68	5.74	0.54	1.73e-7	Colorectal cancer;
SKCM	cis	rs1707322	0.752	rs28507722	chr1:46206540	A/G	cg03146154	chr1:46216737	IPP	0.81	5.62	0.54	2.87e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs4862750	0.832	rs4862744	chr4:187877074	T/A	cg10295955	chr4:187884368	NA	-1.01	-12.83	-0.82	6.57e-21	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs950027	0.620	rs1719246	chr15:45625479	T/A	cg21132104	chr15:45694354	SPATA5L1	0.74	5.42	0.52	6.44e-7	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs6570726	0.791	rs370654	chr6:145879005	C/G	cg05347473	chr6:146136440	FBXO30	0.57	5.13	0.5	2.06e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9467773	1.000	rs10946834	chr6:26533664	G/C	cg15659132	chr6:26577336	NA	0.6	5.71	0.54	1.99e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs4970988	0.556	rs6681426	chr1:150586971	G/A	cg17724175	chr1:150552817	MCL1	-0.65	-4.92	-0.49	4.64e-6	Urate levels;
SKCM	cis	rs1062177	0.756	rs2915817	chr5:151115517	T/C	cg00977110	chr5:151150581	G3BP1	-0.77	-5.82	-0.55	1.25e-7	Preschool internalizing problems;
SKCM	cis	rs3809863	0.602	rs7225700	chr17:45391804	T/C	cg25173405	chr17:45401733	C17orf57	-0.71	-5.26	-0.51	1.22e-6	Glaucoma (primary open-angle);
SKCM	cis	rs823143	0.570	rs823082	chr1:205786935	C/T	cg14159672	chr1:205819179	PM20D1	-0.99	-9.77	-0.74	3.51e-15	Monocyte percentage of white cells;
SKCM	cis	rs12142240	0.698	rs6684274	chr1:46810842	A/G	cg14993813	chr1:46806288	NSUN4	0.69	4.96	0.49	4.09e-6	Menopause (age at onset);
SKCM	cis	rs6977660	0.619	rs10271639	chr7:19779604	G/A	cg05791153	chr7:19748676	TWISTNB	0.77	5.05	0.5	2.78e-6	Thyroid stimulating hormone;
SKCM	cis	rs1957429	0.808	rs7144718	chr14:65333831	G/A	cg23373153	chr14:65346875	NA	1.22	6.35	0.58	1.3e-8	Pediatric areal bone mineral density (radius);
SKCM	cis	rs826838	0.967	rs826855	chr12:39114888	T/C	cg26384229	chr12:38710491	ALG10B	-0.94	-7.66	-0.65	4.36e-11	Heart rate;
SKCM	cis	rs7772486	0.805	rs4896831	chr6:145959481	T/C	cg23711669	chr6:146136114	FBXO30	0.85	9.26	0.72	3.33e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs12762955	0.561	rs7076107	chr10:1043647	T/C	cg26597838	chr10:835615	NA	-0.55	-4.89	-0.48	5.21e-6	Response to angiotensin II receptor blocker therapy;
SKCM	cis	rs12497850	0.931	rs9876848	chr3:48844059	G/A	cg06212747	chr3:49208901	KLHDC8B	0.66	4.81	0.48	7.08e-6	Parkinson's disease;
SKCM	cis	rs9788682	0.748	rs637137	chr15:78873976	T/A	cg24631222	chr15:78858424	CHRNA5	0.87	6.62	0.6	4.19e-9	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs3780486	0.846	rs6476402	chr9:33148552	G/A	cg13443165	chr9:33130375	B4GALT1	-0.5	-4.83	-0.48	6.61e-6	IgG glycosylation;
SKCM	cis	rs1552244	0.572	rs58862481	chr3:10164308	G/A	cg00149659	chr3:10157352	C3orf10	1.13	5.45	0.53	5.74e-7	Alzheimer's disease;
SKCM	cis	rs2072499	0.778	rs41265025	chr1:156163906	C/T	cg25208724	chr1:156163844	SLC25A44	0.89	6.31	0.58	1.55e-8	Testicular germ cell tumor;
SKCM	cis	rs28595532	0.920	rs114213539	chr4:119758794	G/C	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs8177253	1.000	rs8177271	chr3:133482230	G/A	cg16414030	chr3:133502952	NA	-0.7	-5.93	-0.56	7.88e-8	Iron status biomarkers;
SKCM	cis	rs4819052	1.000	rs4819052	chr21:46699777	A/G	cg19498844	chr21:46707878	POFUT2;LOC642852	0.94	7.29	0.64	2.23e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs28386778	0.897	rs2727290	chr17:61894728	G/T	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs427394	0.659	rs274678	chr5:6752385	A/G	cg10857441	chr5:6722123	POLS	0.67	7.3	0.64	2.14e-10	Menopause (age at onset);
SKCM	cis	rs3771570	1.000	rs3771570	chr2:242382864	C/T	cg07612300	chr2:242033426	MTERFD2;SNED1	0.88	4.93	0.49	4.46e-6	Prostate cancer;
SKCM	cis	rs2241584	0.669	rs4868645	chr5:175947118	G/T	cg06525892	chr5:175792454	ARL10	-0.52	-4.79	-0.48	7.81e-6	Menopause (age at onset);
SKCM	cis	rs9916302	0.861	rs752314	chr17:37410700	C/T	cg07936489	chr17:37558343	FBXL20	-0.84	-6.96	-0.62	9.48e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs10911232	0.507	rs11582514	chr1:182992161	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.64	0.6	3.83e-9	Hypertriglyceridemia;
SKCM	cis	rs7954584	0.567	rs7132055	chr12:122346034	A/G	cg21171335	chr12:122356390	WDR66	-0.46	-4.95	-0.49	4.2e-6	Mean corpuscular volume;
SKCM	cis	rs7666738	0.830	rs1896154	chr4:99021161	T/C	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4803468	1.000	rs284648	chr19:41926790	T/C	cg14132834	chr19:41945861	ATP5SL	-0.77	-6.04	-0.56	4.87e-8	Height;
SKCM	cis	rs1160297	0.609	rs1451455	chr2:53101529	T/C	cg07782112	chr2:53107842	NA	0.59	6.36	0.58	1.28e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs28386778	0.933	rs2665804	chr17:61951836	G/T	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.06	0.78	1.21e-17	Prudent dietary pattern;
SKCM	cis	rs634534	0.562	rs661335	chr11:65754061	G/A	cg26695010	chr11:65641043	EFEMP2	-0.71	-5.3	-0.51	1.03e-6	Sum eosinophil basophil counts;Eosinophil counts;
SKCM	cis	rs2153535	0.580	rs9406161	chr6:8466144	G/T	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs35306767	0.855	rs12770190	chr10:951262	C/T	cg20503657	chr10:835505	NA	0.78	5.25	0.51	1.26e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs7296418	0.961	rs11608811	chr12:123529056	A/G	cg05973401	chr12:123451056	ABCB9	0.81	6.73	0.61	2.61e-9	Platelet count;
SKCM	cis	rs2286503	0.752	rs59538378	chr7:22877097	G/A	cg15401507	chr7:22894281	NA	-0.58	-4.98	-0.49	3.74e-6	Fibrinogen;
SKCM	cis	rs9916302	0.904	rs7223438	chr17:37521355	T/C	cg07936489	chr17:37558343	FBXL20	0.82	7.19	0.63	3.4e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs870825	0.616	rs7674952	chr4:185622327	A/C	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs2282032	1.000	rs75816060	chr14:90759470	C/T	cg04374321	chr14:90722782	PSMC1	0.71	4.94	0.49	4.29e-6	Longevity;
SKCM	cis	rs4727027	0.704	rs7784122	chr7:148904624	A/G	cg23583168	chr7:148888333	NA	0.68	5.15	0.5	1.92e-6	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs6461049	0.638	rs3778994	chr7:2175855	G/T	cg21782813	chr7:2030301	MAD1L1	0.47	4.79	0.48	7.88e-6	Schizophrenia;
SKCM	cis	rs62238980	0.614	rs77949114	chr22:32453504	T/C	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs16854884	0.657	rs7637912	chr3:143749777	G/A	cg06585982	chr3:143692056	C3orf58	0.87	8.11	0.68	5.72e-12	Economic and political preferences (feminism/equality);
SKCM	cis	rs875971	1.000	rs811880	chr7:65818646	T/C	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	7.98e-13	Aortic root size;
SKCM	cis	rs55823223	0.680	rs57287238	chr17:73850940	T/C	cg08125733	chr17:73851984	WBP2	1.06	6.53	0.59	6.17e-9	Psoriasis;
SKCM	cis	rs17065868	1.000	rs9525972	chr13:45095716	T/C	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs72945132	0.579	rs35077099	chr11:70247970	G/A	cg14191688	chr11:70257035	CTTN	0.83	4.91	0.49	4.88e-6	Coronary artery disease;
SKCM	cis	rs28595532	1.000	rs17258106	chr4:119675406	C/T	cg11846333	chr4:119757529	SEC24D	-1.19	-6.39	-0.59	1.12e-8	Cannabis dependence symptom count;
SKCM	cis	rs11155671	0.530	rs2342770	chr6:150216685	C/T	cg05036130	chr6:150231994	NA	0.55	5.21	0.51	1.49e-6	Testicular germ cell tumor;
SKCM	cis	rs2477686	0.526	rs1998759	chr1:2397174	C/T	cg12929805	chr1:2399054	NA	-0.55	-5.58	-0.53	3.35e-7	Non-obstructive azoospermia;
SKCM	cis	rs208520	0.690	rs2208442	chr6:66867004	T/C	cg07460842	chr6:66804631	NA	-1.02	-7.16	-0.63	3.84e-10	Exhaled nitric oxide output;
SKCM	cis	rs554111	0.660	rs541464	chr1:21067095	C/T	cg01072550	chr1:21505969	NA	-0.6	-4.78	-0.48	8.03e-6	Facial morphology (factor 17, height of vermillion upper lip);
SKCM	cis	rs864745	0.600	rs849327	chr7:28232457	A/G	cg15170557	chr7:28214983	JAZF1	-0.54	-5.1	-0.5	2.34e-6	Crohn's disease;Type 2 diabetes;
SKCM	cis	rs7666738	0.830	rs6532719	chr4:99043691	A/G	cg05340658	chr4:99064831	C4orf37	0.67	5.14	0.5	1.99e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2842992	0.789	rs2475566	chr6:160148741	C/T	cg11366901	chr6:160182831	ACAT2	0.94	7.56	0.65	6.66e-11	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs769267	0.965	rs2074296	chr19:19373689	A/G	cg26732615	chr19:19648335	CILP2;YJEFN3	0.62	5.67	0.54	2.31e-7	Tonsillectomy;
SKCM	cis	rs4481887	0.927	rs10888343	chr1:248446642	A/G	cg00666640	chr1:248458726	OR2T12	0.61	4.96	0.49	4.11e-6	Common traits (Other);
SKCM	cis	rs7811142	0.779	rs111312383	chr7:99905325	C/T	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.21	8.05	0.67	7.68e-12	Platelet count;
SKCM	cis	rs3845702	1.000	rs10497555	chr2:180864967	A/G	cg01881094	chr2:180872142	CWC22	1.06	5.68	0.54	2.19e-7	Schizophrenia;
SKCM	cis	rs6952808	0.729	rs35797753	chr7:1954914	G/A	cg02951883	chr7:2050386	MAD1L1	-0.71	-6.06	-0.57	4.45e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs7829975	0.535	rs17683510	chr8:8500724	A/G	cg06636001	chr8:8085503	FLJ10661	0.69	5.78	0.55	1.44e-7	Mood instability;
SKCM	cis	rs7191439	0.858	rs6500489	chr16:88772046	T/C	cg02389323	chr16:88786976	FAM38A	1.46	4.85	0.48	6.11e-6	Plateletcrit;
SKCM	cis	rs1032355	0.558	rs2903202	chr4:100517005	A/T	cg25391692	chr4:100495869	MTTP	-0.82	-4.97	-0.49	3.9e-6	Celiac disease;
SKCM	cis	rs478304	0.651	rs11532071	chr11:65500198	C/A	cg27068330	chr11:65405492	SIPA1	-0.89	-8.21	-0.68	3.71e-12	Acne (severe);
SKCM	cis	rs7666738	0.830	rs4699577	chr4:98846513	G/A	cg05340658	chr4:99064831	C4orf37	0.6	4.81	0.48	7.19e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9517302	0.615	rs3752973	chr13:99097509	G/A	cg22223119	chr13:99095684	FARP1	-0.84	-5.54	-0.53	3.91e-7	Obesity-related traits;
SKCM	cis	rs2404602	0.684	rs965818	chr15:76866785	T/C	cg23625390	chr15:77176239	SCAPER	-0.82	-7.93	-0.67	1.26e-11	Blood metabolite levels;
SKCM	cis	rs6089584	0.821	rs4925332	chr20:60604639	C/T	cg16423285	chr20:60520624	NA	-0.64	-4.84	-0.48	6.39e-6	Body mass index;
SKCM	cis	rs7811142	0.830	rs11771936	chr7:99943283	A/G	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.21	7.77	0.66	2.57e-11	Platelet count;
SKCM	cis	rs11792861	0.926	rs72607171	chr9:111837776	T/C	cg14432460	chr9:111696404	IKBKAP;C9orf6	0.66	4.81	0.48	7.17e-6	Menarche (age at onset);
SKCM	cis	rs11105298	0.891	rs10858898	chr12:89922111	A/G	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.9	-5.92	-0.56	8.11e-8	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs875971	0.862	rs35034167	chr7:65580166	C/G	cg11764359	chr7:65958608	NA	-0.8	-7.66	-0.66	4.2e-11	Aortic root size;
SKCM	cis	rs2204008	0.594	rs11531211	chr12:37998007	T/G	cg13010199	chr12:38710504	ALG10B	-0.63	-4.9	-0.49	5.09e-6	Bladder cancer;
SKCM	cis	rs854765	0.647	rs62073573	chr17:17976354	G/A	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.87	6.53	0.59	6.16e-9	Total body bone mineral density;
SKCM	cis	rs995000	0.931	rs116405518	chr1:63036807	G/A	cg06896770	chr1:63153194	DOCK7	-0.72	-6.46	-0.59	8.17e-9	Triglyceride levels;
SKCM	cis	rs3768617	0.510	rs20557	chr1:183093875	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs6088580	0.634	rs6059866	chr20:33075810	A/C	cg24642439	chr20:33292090	TP53INP2	0.75	5.98	0.56	6.24e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs9640161	0.830	rs12703061	chr7:150062545	T/C	cg10018233	chr7:150070692	REPIN1	0.73	6.44	0.59	8.89e-9	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs477895	0.713	rs7944061	chr11:63956839	A/T	cg07220939	chr11:64358617	SLC22A12	0.75	5.03	0.49	3.1e-6	Mean platelet volume;
SKCM	cis	rs12048904	0.619	rs10875346	chr1:101328083	T/C	cg16556008	chr1:101360663	SLC30A7;EXTL2	0.95	7.84	0.66	1.93e-11	Multiple sclerosis;
SKCM	cis	rs28595532	0.920	rs56342843	chr4:119765070	G/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs2439831	0.850	rs16950562	chr15:44036364	G/A	cg02155558	chr15:43621948	ADAL;LCMT2	1.35	7.72	0.66	3.27e-11	Lung cancer in ever smokers;
SKCM	cis	rs7106204	0.590	rs7114724	chr11:24239976	A/G	ch.11.24196551F	chr11:24239977	NA	0.77	6.25	0.58	1.98e-8	Response to Homoharringtonine (cytotoxicity);
SKCM	cis	rs2839186	0.868	rs2839199	chr21:47708269	T/C	cg13012494	chr21:47604986	C21orf56	0.67	5.71	0.54	1.95e-7	Testicular germ cell tumor;
SKCM	cis	rs1577917	0.876	rs4618490	chr6:86518403	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.34	-0.52	8.89e-7	Response to antipsychotic treatment;
SKCM	cis	rs4954585	0.683	rs4072434	chr2:137014023	C/G	cg05194412	chr2:137003533	NA	0.57	5.1	0.5	2.31e-6	Colorectal cancer;
SKCM	cis	rs10089	0.953	rs7713860	chr5:127428789	G/T	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.92	8.45	0.69	1.25e-12	Ileal carcinoids;
SKCM	cis	rs875971	0.862	rs709596	chr7:65825913	A/G	cg11764359	chr7:65958608	NA	0.81	7.62	0.65	5.02e-11	Aortic root size;
SKCM	cis	rs6809651	0.524	rs1356291	chr3:185824644	C/T	cg00760338	chr3:185826511	ETV5	0.89	5.67	0.54	2.28e-7	Body mass index in physically active individuals;Glomerular filtration rate (creatinine);Body mass index (joint analysis main effects and physical activity interaction);Body mass index;Body mass index in physically inactive individuals;
SKCM	cis	rs35306767	0.903	rs12254002	chr10:929133	A/G	cg26597838	chr10:835615	NA	-0.74	-5.26	-0.51	1.21e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs10751667	0.666	rs7950967	chr11:955638	G/A	cg10932868	chr11:921992	NA	0.55	5.1	0.5	2.36e-6	Alzheimer's disease (late onset);
SKCM	cis	rs7100689	0.646	rs1815650	chr10:82157464	C/T	cg01528321	chr10:82214614	TSPAN14	0.88	7.45	0.64	1.11e-10	Post bronchodilator FEV1;
SKCM	cis	rs250585	0.588	rs152458	chr16:23577267	C/A	cg00143387	chr16:23521605	GGA2	1.09	4.83	0.48	6.64e-6	Egg allergy;
SKCM	cis	rs694739	1.000	rs499425	chr11:64105929	A/G	cg02228329	chr11:64053129	BAD;GPR137	-0.98	-8.76	-0.7	3.18e-13	Alopecia areata;Crohn's disease;Psoriasis vulgaris;
SKCM	cis	rs738322	0.600	rs6001030	chr22:38555904	T/G	cg25457927	chr22:38595422	NA	-0.53	-6.16	-0.57	2.97e-8	Cutaneous nevi;
SKCM	cis	rs1005277	0.579	rs1548255	chr10:38417193	T/C	cg25427524	chr10:38739819	LOC399744	-0.71	-6.74	-0.61	2.44e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs6942756	1.000	rs12111832	chr7:128889025	G/C	cg02491457	chr7:128862824	NA	-0.76	-4.89	-0.48	5.29e-6	White matter hyperintensity burden;
SKCM	cis	rs72792276	1.000	rs3805608	chr5:127480998	G/A	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.78	5.21	0.51	1.5e-6	Red cell distribution width;
SKCM	cis	rs1218582	0.772	rs1976559	chr1:154879788	A/T	cg16680214	chr1:154839983	KCNN3	-0.56	-5.01	-0.49	3.29e-6	Prostate cancer;
SKCM	cis	rs2839186	0.814	rs12482209	chr21:47664275	C/G	cg13126279	chr21:47581558	C21orf56	0.62	5.37	0.52	7.8e-7	Testicular germ cell tumor;
SKCM	cis	rs28595532	0.582	rs71608361	chr4:119224081	T/C	cg21605333	chr4:119757512	SEC24D	1.17	7.18	0.63	3.55e-10	Cannabis dependence symptom count;
SKCM	cis	rs8103278	0.507	rs2041975	chr19:46238555	T/C	cg12641515	chr19:46296257	DMWD	0.75	5.64	0.54	2.59e-7	Coronary artery disease;
SKCM	cis	rs7811142	1.000	rs67239991	chr7:100046504	A/G	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.34	0.69	2.1e-12	Platelet count;
SKCM	cis	rs9486715	0.867	rs4598081	chr6:96975227	A/G	cg06623918	chr6:96969491	KIAA0776	0.82	7.31	0.64	1.98e-10	Headache;
SKCM	cis	rs2239547	0.563	rs9839035	chr3:52909877	C/T	cg11645453	chr3:52864694	ITIH4	0.76	6.87	0.61	1.4e-9	Schizophrenia;
SKCM	cis	rs11098499	0.710	rs4145952	chr4:120155806	C/A	cg09307838	chr4:120376055	NA	0.91	7.46	0.65	1.04e-10	Corneal astigmatism;
SKCM	cis	rs7639513	0.767	rs9861472	chr3:12707776	A/T	cg23032965	chr3:12705835	RAF1	-0.8	-6.88	-0.61	1.33e-9	Itch intensity from mosquito bite;
SKCM	cis	rs2841277	0.720	rs11160827	chr14:105422228	C/T	cg15352829	chr14:105391018	PLD4	-0.62	-6.29	-0.58	1.7e-8	Rheumatoid arthritis;
SKCM	cis	rs1348850	0.526	rs935426	chr2:178369433	T/C	cg27490568	chr2:178487706	NA	0.9	6.9	0.62	1.22e-9	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs11098499	0.954	rs35063680	chr4:120387102	T/C	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs17685	0.725	rs4476928	chr7:75642107	C/A	cg16684958	chr7:75615977	POR	-0.57	-5.6	-0.54	3.07e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2762353	0.562	rs1165206	chr6:25867566	G/A	cg13320114	chr6:26216906	HIST1H2AE;HIST1H2BG	0.47	5.07	0.5	2.58e-6	Blood metabolite levels;
SKCM	cis	rs875971	0.522	rs34973832	chr7:65396204	A/G	cg18876405	chr7:65276391	NA	0.85	7.52	0.65	7.99e-11	Aortic root size;
SKCM	cis	rs2739330	0.587	rs4820571	chr22:24242973	A/G	cg04234412	chr22:24373322	LOC391322	-0.62	-5.04	-0.5	2.91e-6	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs164748	0.521	rs2376874	chr16:89898191	T/C	cg01097406	chr16:89675127	NA	-0.44	-4.87	-0.48	5.64e-6	Glomerular filtration rate;Glomerular filtration rate in non diabetics (creatinine);
SKCM	cis	rs208520	0.955	rs12202599	chr6:67001573	A/G	cg07460842	chr6:66804631	NA	0.8	5.81	0.55	1.32e-7	Exhaled nitric oxide output;
SKCM	cis	rs4346635	0.554	rs10213174	chr4:81834917	C/T	cg07982899	chr4:81307586	C4orf22	0.65	4.88	0.48	5.48e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs654950	1.000	rs600401	chr1:41984658	C/T	cg06885757	chr1:42089581	HIVEP3	0.67	7.08	0.63	5.56e-10	Airway imaging phenotypes;
SKCM	cis	rs9457247	0.602	rs9459854	chr6:167465882	C/T	cg07741184	chr6:167504864	NA	0.59	4.97	0.49	3.88e-6	Crohn's disease;
SKCM	cis	rs9640161	0.711	rs55881542	chr7:150025734	G/A	cg10018233	chr7:150070692	REPIN1	0.68	5.27	0.51	1.18e-6	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs995000	0.931	rs10889331	chr1:62943007	G/T	cg06896770	chr1:63153194	DOCK7	-0.64	-5.96	-0.56	6.81e-8	Triglyceride levels;
SKCM	cis	rs2739330	0.828	rs4822451	chr22:24248166	T/G	cg12419862	chr22:24373484	LOC391322	-0.69	-5.94	-0.56	7.43e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs10754283	0.967	rs7515375	chr1:90109854	T/C	cg21401794	chr1:90099060	LRRC8C	0.73	6.34	0.58	1.35e-8	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs861020	0.630	rs628300	chr1:209998298	C/T	cg05527609	chr1:210001259	C1orf107	0.88	6.82	0.61	1.71e-9	Orofacial clefts;
SKCM	cis	rs7044106	0.791	rs10984994	chr9:123478769	A/T	cg09419670	chr9:123605666	PSMD5;LOC253039	-0.56	-4.77	-0.48	8.41e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs28386778	0.897	rs2854214	chr17:61945449	C/G	cg22520471	chr17:61851767	DDX42;CCDC47	-0.79	-5.33	-0.52	9.35e-7	Prudent dietary pattern;
SKCM	cis	rs1577917	0.771	rs3812133	chr6:86354411	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.78	-6.65	-0.6	3.63e-9	Response to antipsychotic treatment;
SKCM	cis	rs7772486	0.790	rs2265917	chr6:146212285	A/G	cg23711669	chr6:146136114	FBXO30	0.78	7.7	0.66	3.53e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs11677370	0.561	rs10084170	chr2:3820204	G/C	cg17052675	chr2:3827356	NA	-0.6	-4.85	-0.48	6.28e-6	Type 2 diabetes;
SKCM	cis	rs7680126	0.596	rs10009493	chr4:10132047	C/G	cg09374173	chr4:9383942	NA	-0.8	-5.26	-0.51	1.21e-6	Urate levels in lean individuals;Urate levels in overweight individuals;Urate levels in obese individuals;
SKCM	cis	rs7927771	0.793	rs3740686	chr11:47376363	A/G	cg05585544	chr11:47624801	NA	0.57	4.86	0.48	6.06e-6	Subjective well-being;
SKCM	cis	rs2075371	0.611	rs13235296	chr7:134019192	A/G	cg11752832	chr7:134001865	SLC35B4	-0.56	-4.82	-0.48	7.07e-6	Mean platelet volume;
SKCM	cis	rs6951245	0.935	rs118132455	chr7:1068232	C/A	cg18402987	chr7:1209562	NA	1.15	6.02	0.56	5.38e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs2180341	0.961	rs7774468	chr6:127592501	G/C	cg27446573	chr6:127587934	RNF146	1.0	8.04	0.67	7.79e-12	Breast cancer;
SKCM	cis	rs10256972	0.591	rs10229680	chr7:1158565	C/T	cg09177884	chr7:1199841	ZFAND2A	-0.81	-6.51	-0.59	6.66e-9	Longevity;Endometriosis;
SKCM	cis	rs875971	0.505	rs1167385	chr7:65513308	G/A	cg18876405	chr7:65276391	NA	-0.84	-7.85	-0.66	1.81e-11	Aortic root size;
SKCM	cis	rs3784262	0.874	rs11852835	chr15:58228599	A/G	cg12031962	chr15:58353849	ALDH1A2	-0.44	-4.8	-0.48	7.64e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs9430161	0.644	rs34365965	chr1:11034442	G/A	cg02454025	chr1:11042201	C1orf127	1.06	9.89	0.75	2.03e-15	Ewing sarcoma;
SKCM	cis	rs459571	0.883	rs2520096	chr9:136919416	A/G	cg13789015	chr9:136890014	NCRNA00094	0.78	6.54	0.6	5.82e-9	Platelet distribution width;
SKCM	cis	rs362272	0.525	rs910568	chr4:3307373	A/G	cg09735869	chr4:3319127	RGS12	1.0	11.45	0.79	2.27e-18	Serum sulfate level;
SKCM	cis	rs7635838	0.859	rs9826803	chr3:11461863	G/A	cg00170343	chr3:11313890	ATG7	0.73	4.98	0.49	3.74e-6	HDL cholesterol;
SKCM	cis	rs8141529	0.748	rs132529	chr22:29296652	A/G	cg15103426	chr22:29168792	CCDC117	-0.58	-4.77	-0.47	8.54e-6	Lymphocyte counts;
SKCM	cis	rs2836974	0.897	rs1541102	chr21:40628765	C/T	cg11644478	chr21:40555479	PSMG1	0.97	10.08	0.75	8.76e-16	Cognitive function;
SKCM	cis	rs3768617	0.510	rs2296292	chr1:183086757	A/C	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs10791097	0.547	rs10791101	chr11:130739133	C/T	cg12179176	chr11:130786555	SNX19	0.94	8.13	0.68	5.18e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs3771570	1.000	rs17386695	chr2:242379751	A/G	cg07612300	chr2:242033426	MTERFD2;SNED1	-0.88	-4.93	-0.49	4.46e-6	Prostate cancer;
SKCM	cis	rs1957429	0.901	rs6573583	chr14:65351211	G/T	cg23373153	chr14:65346875	NA	1.11	6.32	0.58	1.52e-8	Pediatric areal bone mineral density (radius);
SKCM	cis	rs6539267	0.741	rs35816179	chr12:106693710	T/C	cg00173435	chr12:106696525	TCP11L2	0.85	6.21	0.58	2.39e-8	Tourette syndrome;
SKCM	cis	rs7635838	0.687	rs9849485	chr3:11395741	G/A	cg00170343	chr3:11313890	ATG7	0.7	5.58	0.53	3.29e-7	HDL cholesterol;
SKCM	cis	rs8078723	1.000	rs6503530	chr17:38161823	T/C	cg17467752	chr17:38218738	THRA	0.68	6.3	0.58	1.61e-8	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs3785574	0.962	rs4968660	chr17:61792221	G/A	cg01411255	chr17:61851458	DDX42;CCDC47	1.13	12.96	0.83	3.89e-21	Height;
SKCM	cis	rs1023500	0.573	rs133381	chr22:42470608	C/G	cg04733989	chr22:42467013	NAGA	0.72	5.72	0.54	1.9e-7	Schizophrenia;
SKCM	cis	rs738322	0.934	rs133016	chr22:38572582	C/T	cg25457927	chr22:38595422	NA	-0.56	-6.45	-0.59	8.42e-9	Cutaneous nevi;
SKCM	cis	rs2739330	0.627	rs9608219	chr22:24274119	G/C	cg04234412	chr22:24373322	LOC391322	-0.66	-5.42	-0.52	6.54e-7	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs7216064	1.000	rs7209675	chr17:65831258	A/T	cg12091567	chr17:66097778	LOC651250	-0.77	-5.53	-0.53	4.06e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs6951245	1.000	rs74785791	chr7:1088494	T/C	cg18402987	chr7:1209562	NA	1.14	6.01	0.56	5.68e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs8177253	0.965	rs4854762	chr3:133499063	A/G	cg16414030	chr3:133502952	NA	0.71	5.83	0.55	1.18e-7	Iron status biomarkers;
SKCM	cis	rs208520	0.874	rs208518	chr6:66948501	C/G	cg07460842	chr6:66804631	NA	1.06	7.63	0.65	4.87e-11	Exhaled nitric oxide output;
SKCM	cis	rs3096299	0.730	rs6500546	chr16:89391092	A/G	cg08822215	chr16:89438651	ANKRD11	-0.53	-4.89	-0.48	5.23e-6	Multiple myeloma (IgH translocation);
SKCM	cis	rs17376456	0.741	rs10036829	chr5:93309897	G/C	cg25358565	chr5:93447407	FAM172A	1.23	7.26	0.63	2.53e-10	Diabetic retinopathy;
SKCM	cis	rs7143963	1.000	rs7143963	chr14:103304425	C/T	cg23020514	chr14:103360112	TRAF3	0.9	8.54	0.7	8.45e-13	Body mass index;
SKCM	cis	rs514406	0.861	rs10888755	chr1:53240829	A/G	cg16325326	chr1:53192061	ZYG11B	-0.91	-9.75	-0.74	3.75e-15	Monocyte count;
SKCM	cis	rs17685	0.753	rs10245584	chr7:75745866	C/T	cg16684958	chr7:75615977	POR	0.55	5.37	0.52	7.82e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs6545883	0.895	rs2421192	chr2:61643631	T/C	cg15711740	chr2:61764176	XPO1	0.68	4.92	0.49	4.76e-6	Tuberculosis;
SKCM	cis	rs362272	0.524	rs881816	chr4:3365366	A/G	cg11471262	chr4:3318911	RGS12	0.95	10.65	0.77	7.26e-17	Serum sulfate level;
SKCM	cis	rs7666738	0.830	rs35560671	chr4:99069095	G/A	cg05340658	chr4:99064831	C4orf37	0.66	4.87	0.48	5.74e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9311474	0.508	rs4687629	chr3:52615227	G/C	cg18404041	chr3:52824283	ITIH1	-0.53	-4.77	-0.48	8.42e-6	Electroencephalogram traits;
SKCM	cis	rs7666738	0.649	rs28865589	chr4:98954279	C/A	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2839186	0.749	rs62226489	chr21:47710519	T/C	cg13012494	chr21:47604986	C21orf56	0.67	5.71	0.54	1.95e-7	Testicular germ cell tumor;
SKCM	cis	rs10256972	0.713	rs10435026	chr7:1065948	A/G	cg07308232	chr7:1071921	C7orf50	-0.62	-5.33	-0.52	9.36e-7	Longevity;Endometriosis;
SKCM	cis	rs861020	1.000	rs630984	chr1:209982293	C/T	cg05527609	chr1:210001259	C1orf107	1.03	7.24	0.63	2.76e-10	Orofacial clefts;
SKCM	cis	rs6547741	0.967	rs4665995	chr2:27813827	T/G	cg27432699	chr2:27873401	GPN1	0.73	6.64	0.6	3.76e-9	Oral cavity cancer;
SKCM	cis	rs4803468	0.934	rs8103531	chr19:41891974	C/T	cg14132834	chr19:41945861	ATP5SL	-0.77	-5.78	-0.55	1.49e-7	Height;
SKCM	cis	rs2180341	1.000	rs6904520	chr6:127629802	T/C	cg27446573	chr6:127587934	RNF146	1.01	8.78	0.7	2.93e-13	Breast cancer;
SKCM	cis	rs910316	0.967	rs8013444	chr14:75661981	A/G	cg11812906	chr14:75593930	NEK9	-0.72	-5.73	-0.54	1.81e-7	Height;
SKCM	cis	rs6952808	0.723	rs11765550	chr7:2027324	G/A	cg21782813	chr7:2030301	MAD1L1	0.58	5.92	0.56	8.12e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs6580649	1.000	rs6580647	chr12:48403229	G/T	cg05342945	chr12:48394962	COL2A1	0.73	5.4	0.52	7.06e-7	Lung cancer;
SKCM	cis	rs151997	0.538	rs62367392	chr5:50270298	T/C	cg06027927	chr5:50259733	NA	0.62	5.44	0.52	5.86e-7	Callous-unemotional behaviour;
SKCM	cis	rs514406	0.698	rs1775540	chr1:53407893	C/A	cg08859206	chr1:53392774	SCP2	-0.63	-5.3	-0.51	1.07e-6	Monocyte count;
SKCM	cis	rs228769	1.000	rs228769	chr17:42193185	G/C	cg13607699	chr17:42295918	UBTF	-0.83	-5.5	-0.53	4.74e-7	Bone mineral density (hip);Bone mineral density (spine);
SKCM	cis	rs8078723	0.630	rs60137005	chr17:38129996	A/T	cg17467752	chr17:38218738	THRA	0.6	5.19	0.51	1.66e-6	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs597539	0.654	rs7107137	chr11:68623712	A/G	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.81	5.33	0.52	9.43e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs7523050	0.643	rs67567504	chr1:109402580	C/A	cg08274380	chr1:109419600	GPSM2	1.13	5.57	0.53	3.54e-7	Fat distribution (HIV);
SKCM	cis	rs56104184	0.775	rs56149557	chr19:49401384	C/A	cg19746536	chr19:49375674	PPP1R15A	1.16	5.93	0.56	7.67e-8	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs7937682	0.924	rs4630327	chr11:111539327	C/T	cg09085632	chr11:111637200	PPP2R1B	1.04	12.4	0.81	3.87e-20	Primary sclerosing cholangitis;
SKCM	cis	rs7945705	0.902	rs7479407	chr11:9023421	C/T	cg21881798	chr11:8931708	C11orf17;ST5	0.78	7.32	0.64	1.95e-10	Hemoglobin concentration;
SKCM	cis	rs67311347	0.544	rs2887965	chr3:40334154	A/G	cg02782426	chr3:40428986	ENTPD3	-0.51	-5.2	-0.51	1.57e-6	Renal cell carcinoma;
SKCM	cis	rs7772486	0.603	rs2223411	chr6:146028767	T/C	cg23711669	chr6:146136114	FBXO30	-0.79	-6.82	-0.61	1.73e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1405130	0.900	rs12692152	chr2:235587848	C/T	cg17841421	chr2:235704848	NA	-0.57	-4.79	-0.48	7.65e-6	Coronary artery disease;
SKCM	cis	rs9911578	0.900	rs7214335	chr17:57158840	G/A	cg12560992	chr17:57184187	TRIM37	1.07	9.59	0.74	7.68e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs7635838	0.617	rs346074	chr3:11294310	T/C	cg00170343	chr3:11313890	ATG7	0.77	6.06	0.57	4.51e-8	HDL cholesterol;
SKCM	cis	rs611744	0.647	rs13280487	chr8:109270263	G/C	cg18478394	chr8:109455254	TTC35	0.66	5.27	0.51	1.16e-6	Dupuytren's disease;
SKCM	cis	rs634534	0.562	rs1151505	chr11:65734539	C/T	cg26695010	chr11:65641043	EFEMP2	-0.65	-5.32	-0.52	9.77e-7	Sum eosinophil basophil counts;Eosinophil counts;
SKCM	cis	rs2952156	0.920	rs2517958	chr17:37838751	G/A	cg20243544	chr17:37824526	PNMT	0.68	5.37	0.52	7.74e-7	Asthma;
SKCM	cis	rs10791097	0.694	rs10791103	chr11:130757161	G/A	cg12179176	chr11:130786555	SNX19	0.93	8.37	0.69	1.82e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs1153858	1.000	rs11858495	chr15:45637662	A/G	cg21132104	chr15:45694354	SPATA5L1	-0.94	-7.8	-0.66	2.3e-11	Homoarginine levels;
SKCM	cis	rs1218582	0.804	rs869506	chr1:154859581	A/C	cg06221963	chr1:154839813	KCNN3	-0.58	-5.84	-0.55	1.13e-7	Prostate cancer;
SKCM	cis	rs1267303	0.642	rs1267301	chr1:46992853	C/G	cg25110126	chr1:46999211	NA	-0.74	-5.46	-0.53	5.56e-7	Monobrow;
SKCM	cis	rs2404602	0.716	rs7169394	chr15:76913274	G/A	cg23625390	chr15:77176239	SCAPER	0.61	5.33	0.52	9.13e-7	Blood metabolite levels;
SKCM	cis	rs7954584	0.635	rs3847694	chr12:122325820	A/G	cg22618164	chr12:122356400	WDR66	0.5	5.03	0.5	3.01e-6	Mean corpuscular volume;
SKCM	cis	rs7772486	0.754	rs9497434	chr6:146260753	C/T	cg05347473	chr6:146136440	FBXO30	-0.55	-5.07	-0.5	2.6e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs832540	0.695	rs702686	chr5:56201350	A/G	cg03609598	chr5:56110824	MAP3K1	-0.9	-5.59	-0.53	3.22e-7	Coronary artery disease;
SKCM	cis	rs11098499	0.754	rs11098502	chr4:120252063	T/A	cg09307838	chr4:120376055	NA	0.91	7.36	0.64	1.63e-10	Corneal astigmatism;
SKCM	cis	rs7937682	0.883	rs486038	chr11:111465963	A/C	cg09085632	chr11:111637200	PPP2R1B	-1.0	-8.74	-0.7	3.47e-13	Primary sclerosing cholangitis;
SKCM	cis	rs34172651	0.517	rs8059004	chr16:24837905	G/A	cg06028605	chr16:24865363	SLC5A11	0.6	5.0	0.49	3.43e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs367615	0.661	rs9326775	chr5:108836925	A/T	cg17395555	chr5:108820864	NA	0.73	6.54	0.6	5.85e-9	Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs2288073	0.965	rs6545338	chr2:24422156	C/T	cg06627628	chr2:24431161	ITSN2	-0.85	-5.84	-0.55	1.14e-7	Venous thromboembolism (SNP x SNP interaction);
SKCM	cis	rs453301	0.682	rs2929308	chr8:9084121	T/A	cg06636001	chr8:8085503	FLJ10661	-0.77	-6.13	-0.57	3.42e-8	Joint mobility (Beighton score);
SKCM	trans	rs561341	1.000	rs576985	chr17:30323323	C/T	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs9583531	0.600	rs1441043	chr13:111367650	A/G	cg24331049	chr13:111365604	ING1	0.86	6.35	0.58	1.35e-8	Coronary artery disease;
SKCM	cis	rs2072499	0.833	rs2251636	chr1:156202809	G/C	cg24450063	chr1:156163899	SLC25A44	0.86	7.65	0.65	4.43e-11	Testicular germ cell tumor;
SKCM	trans	rs8073060	0.586	rs72829927	chr17:34049992	A/G	cg19694781	chr19:47549865	TMEM160	1.08	8.6	0.7	6.4e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs2599510	0.744	rs4952212	chr2:32618493	G/C	cg02381751	chr2:32503542	YIPF4	-0.65	-4.95	-0.49	4.11e-6	Interleukin-18 levels;
SKCM	cis	rs62238980	0.614	rs76363976	chr22:32383968	C/T	cg00543991	chr22:32367038	NA	1.15	4.87	0.48	5.76e-6	Childhood ear infection;
SKCM	cis	rs453301	0.606	rs6981060	chr8:8908235	C/A	cg15556689	chr8:8085844	FLJ10661	-0.66	-4.8	-0.48	7.5e-6	Joint mobility (Beighton score);
SKCM	cis	rs9388451	0.869	rs7764016	chr6:126070789	T/G	cg05901451	chr6:126070800	HEY2	-0.82	-7.91	-0.67	1.41e-11	Brugada syndrome;
SKCM	cis	rs9583531	0.600	rs7330080	chr13:111367115	C/T	cg24331049	chr13:111365604	ING1	0.82	6.13	0.57	3.38e-8	Coronary artery disease;
SKCM	cis	rs7772486	0.719	rs7753770	chr6:146066161	G/A	cg05347473	chr6:146136440	FBXO30	-0.61	-5.77	-0.55	1.53e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1669338	0.588	rs3931974	chr3:3186894	A/G	cg16797762	chr3:3221439	CRBN	1.1	6.27	0.58	1.83e-8	White matter integrity;
SKCM	cis	rs947211	1.000	rs947211	chr1:205752665	A/G	cg07157834	chr1:205819609	PM20D1	0.68	5.08	0.5	2.5e-6	Parkinson's disease;
SKCM	trans	rs66573146	1.000	rs56350643	chr4:7017591	G/A	cg07817883	chr1:32538562	TMEM39B	2.01	8.09	0.68	6.3e-12	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs2455601	0.679	rs2653559	chr11:8900394	C/T	cg21881798	chr11:8931708	C11orf17;ST5	-0.83	-4.79	-0.48	7.9e-6	Schizophrenia;
SKCM	cis	rs9875589	0.509	rs2731330	chr3:14111588	C/G	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.53	5.31	0.52	9.98e-7	Ovarian reserve;
SKCM	cis	rs473651	0.904	rs62196716	chr2:239356977	C/G	cg18131467	chr2:239335373	ASB1	1.08	13.01	0.83	3.1e-21	Multiple system atrophy;
SKCM	cis	rs748404	0.690	rs2244981	chr15:43752751	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	0.71	5.4	0.52	7.05e-7	Lung cancer;
SKCM	cis	rs763121	0.853	rs6001188	chr22:39062194	T/C	cg06022373	chr22:39101656	GTPBP1	0.74	5.28	0.51	1.15e-6	Menopause (age at onset);
SKCM	cis	rs9611565	0.512	rs139573	chr22:42214785	G/A	cg03806693	chr22:41940476	POLR3H	-1.12	-6.49	-0.59	7.19e-9	Vitiligo;
SKCM	cis	rs2075371	0.611	rs1862045	chr7:134023412	A/G	cg20476274	chr7:133979776	SLC35B4	0.88	8.45	0.69	1.27e-12	Mean platelet volume;
SKCM	cis	rs6570726	0.935	rs380883	chr6:145822992	A/G	cg23711669	chr6:146136114	FBXO30	0.69	6.42	0.59	9.6e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7647973	0.580	rs4955432	chr3:49266772	C/T	cg07636037	chr3:49044803	WDR6	0.83	6.82	0.61	1.76e-9	Menarche (age at onset);
SKCM	cis	rs7666738	0.830	rs1593573	chr4:98925293	T/C	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs709400	0.628	rs1951392	chr14:103853367	T/G	cg26031613	chr14:104095156	KLC1	0.71	5.42	0.52	6.49e-7	Body mass index;
SKCM	cis	rs11139399	0.613	rs10867803	chr9:84340947	C/A	cg13729285	chr9:84764156	NA	0.55	5.34	0.52	8.81e-7	Hippocampal atrophy;
SKCM	cis	rs9300255	0.664	rs28372579	chr12:123881176	A/G	cg05973401	chr12:123451056	ABCB9	-0.81	-5.42	-0.52	6.48e-7	Neutrophil percentage of white cells;
SKCM	cis	rs2594714	0.789	rs4635447	chr19:13956525	A/G	cg13326686	chr19:13030096	SYCE2	0.81	4.8	0.48	7.5e-6	Breast cancer;
SKCM	cis	rs2354432	0.882	rs11576360	chr1:146740576	G/A	cg25205988	chr1:146714368	CHD1L	1.22	9.8	0.74	3.02e-15	Mitochondrial DNA levels;
SKCM	cis	rs6570726	0.791	rs365869	chr6:145884751	C/T	cg23711669	chr6:146136114	FBXO30	0.87	9.14	0.72	5.82e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs72717009	0.756	rs10494359	chr1:161463876	G/C	cg23840854	chr1:161414152	NA	-0.99	-5.66	-0.54	2.44e-7	Rheumatoid arthritis;
SKCM	cis	rs875971	0.660	rs10281080	chr7:66042441	T/C	cg00343986	chr7:65444356	GUSB	-0.67	-4.93	-0.49	4.55e-6	Aortic root size;
SKCM	cis	rs281408	0.559	rs281381	chr19:49214748	C/T	cg13540341	chr19:49222985	MAMSTR	-0.57	-5.51	-0.53	4.5e-7	Urinary metabolites (H-NMR features);
SKCM	cis	rs8067545	0.611	rs2189709	chr17:20083226	T/A	cg13482628	chr17:19912719	NA	-0.66	-5.59	-0.53	3.23e-7	Schizophrenia;
SKCM	cis	rs2836974	0.897	rs2026267	chr21:40711477	C/A	cg11644478	chr21:40555479	PSMG1	0.8	6.9	0.62	1.21e-9	Cognitive function;
SKCM	cis	rs2153535	0.580	rs9406164	chr6:8470048	C/T	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs17345786	1.000	rs17345786	chr3:101318318	A/C	cg12386194	chr3:101231763	SENP7	-0.75	-5.31	-0.52	9.99e-7	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs13118159	0.550	rs4974614	chr4:1373489	A/G	cg20887711	chr4:1340912	KIAA1530	0.93	6.95	0.62	9.67e-10	Longevity;
SKCM	cis	rs6952808	0.595	rs3778984	chr7:2166514	T/C	cg21782813	chr7:2030301	MAD1L1	0.53	5.64	0.54	2.58e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs3847687	1.000	rs11061292	chr12:131518981	T/A	cg25772418	chr12:131519998	GPR133	-0.51	-5.17	-0.5	1.79e-6	Longevity;
SKCM	cis	rs4132509	0.649	rs12038981	chr1:243866855	G/A	cg21452805	chr1:244014465	NA	0.93	5.18	0.51	1.68e-6	RR interval (heart rate);
SKCM	cis	rs1348850	0.526	rs6723014	chr2:178410586	G/A	cg27490568	chr2:178487706	NA	0.84	5.63	0.54	2.69e-7	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs910316	1.000	rs175442	chr14:75603564	T/C	cg11812906	chr14:75593930	NEK9	-0.72	-5.45	-0.53	5.72e-7	Height;
SKCM	cis	rs7666738	0.830	rs10010698	chr4:98981594	C/T	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9399137	0.507	rs10484496	chr6:135299682	T/C	cg24558204	chr6:135376177	HBS1L	0.7	6.53	0.59	6.11e-9	Glycated hemoglobin levels;Mean corpuscular volume;Hematology traits;HbA2 levels;Mean corpuscular hemoglobin;Hemoglobin levels;F-cell distribution;Platelet count;
SKCM	cis	rs7555523	0.887	rs4657475	chr1:165687175	T/C	cg24409356	chr1:165738333	TMCO1	0.93	5.15	0.5	1.93e-6	Intraocular pressure;Glaucoma (high intraocular pressure);
SKCM	trans	rs66573146	1.000	rs28729690	chr4:6962061	C/T	cg07817883	chr1:32538562	TMEM39B	2.0	8.02	0.67	8.59e-12	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs951366	0.677	rs1775140	chr1:205672107	C/A	cg26354017	chr1:205819088	PM20D1	0.86	7.03	0.62	6.93e-10	Menarche (age at onset);
SKCM	trans	rs17685	0.702	rs6960598	chr7:75772991	T/C	cg19862616	chr7:65841803	NCRNA00174	0.88	8.34	0.69	2.1e-12	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs9322193	0.924	rs9322189	chr6:149909933	T/C	cg07701084	chr6:150067640	NUP43	0.65	5.26	0.51	1.23e-6	Lung cancer;
SKCM	cis	rs7945705	0.747	rs2653605	chr11:8993309	C/G	cg21881798	chr11:8931708	C11orf17;ST5	-0.76	-8.07	-0.67	6.84e-12	Hemoglobin concentration;
SKCM	cis	rs7811142	0.830	rs75636500	chr7:99947657	C/G	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.2	7.87	0.67	1.7e-11	Platelet count;
SKCM	cis	rs1005277	0.579	rs2749612	chr10:38488610	G/A	cg25427524	chr10:38739819	LOC399744	-0.78	-7.59	-0.65	5.86e-11	Extrinsic epigenetic age acceleration;
SKCM	cis	rs6933660	0.646	rs3736176	chr6:151773320	T/A	cg14416726	chr6:151773293	C6orf211;RMND1	-0.68	-5.66	-0.54	2.43e-7	Menarche (age at onset);
SKCM	cis	rs372883	0.600	rs2832295	chr21:30739843	C/T	cg24692254	chr21:30365293	RNF160	0.7	5.65	0.54	2.49e-7	Pancreatic cancer;
SKCM	cis	rs116095464	1.000	rs7721278	chr5:310530	G/A	cg22857025	chr5:266934	NA	-1.64	-6.14	-0.57	3.18e-8	Breast cancer;
SKCM	cis	rs59043219	1	rs59043219	chr1:209970610	G/A	cg04352962	chr1:209979756	IRF6	0.5	5.1	0.5	2.34e-6	Crohn's disease;Inflammatory bowel disease;Alzheimer's disease (APOE e4 interaction);
SKCM	cis	rs6840360	0.571	rs2165789	chr4:152510130	A/T	cg22705602	chr4:152727874	NA	-0.52	-5.7	-0.54	2.03e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs9913156	0.793	rs55682338	chr17:4582183	G/A	cg19197139	chr17:4613644	ARRB2	0.79	5.36	0.52	8.23e-7	Lymphocyte counts;
SKCM	cis	rs708547	0.836	rs1625691	chr4:57845740	T/C	cg16868167	chr4:57843880	C4orf14;POLR2B	0.96	9.27	0.72	3.19e-14	Response to bleomycin (chromatid breaks);
SKCM	cis	rs514406	0.792	rs481440	chr1:53344976	C/T	cg04310824	chr1:53393297	SCP2	-0.6	-4.82	-0.48	6.97e-6	Monocyte count;
SKCM	cis	rs514406	0.825	rs1242328	chr1:53396869	A/G	cg16325326	chr1:53192061	ZYG11B	0.89	9.33	0.73	2.51e-14	Monocyte count;
SKCM	trans	rs17685	0.753	rs4573217	chr7:75733946	G/A	cg19862616	chr7:65841803	NCRNA00174	0.95	9.02	0.71	9.98e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs10193935	1.000	rs57883795	chr2:42387926	C/T	cg27598129	chr2:42591480	NA	-0.92	-6.79	-0.61	1.97e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs875971	0.660	rs801192	chr7:66031952	C/G	cg11764359	chr7:65958608	NA	-0.86	-6.6	-0.6	4.52e-9	Aortic root size;
SKCM	cis	rs7100689	0.784	rs2153455	chr10:82139732	T/C	cg00277334	chr10:82204260	NA	-0.51	-4.96	-0.49	4.01e-6	Post bronchodilator FEV1;
SKCM	cis	rs763014	0.932	rs34498660	chr16:666149	A/G	cg07343612	chr16:622815	PIGQ	-0.69	-5.93	-0.56	7.86e-8	Height;
SKCM	cis	rs614226	1.000	rs580016	chr12:120933977	T/C	cg01236616	chr12:121019343	POP5	-1.39	-7.62	-0.65	5.2e-11	Type 1 diabetes nephropathy;
SKCM	cis	rs12540874	0.698	rs12718574	chr7:50573848	G/C	cg18232548	chr7:50535776	DDC	-0.86	-5.97	-0.56	6.62e-8	Systemic sclerosis;
SKCM	cis	rs2282032	1.000	rs45471798	chr14:90744546	C/T	cg04374321	chr14:90722782	PSMC1	0.7	4.85	0.48	6.26e-6	Longevity;
SKCM	cis	rs4132509	0.744	rs12021907	chr1:243995640	A/G	cg21452805	chr1:244014465	NA	-0.87	-5.83	-0.55	1.18e-7	RR interval (heart rate);
SKCM	cis	rs2153535	0.601	rs9379224	chr6:8538413	A/G	cg23788917	chr6:8435910	SLC35B3	0.7	4.93	0.49	4.59e-6	Motion sickness;
SKCM	cis	rs4803468	0.967	rs2304243	chr19:41942708	C/G	cg14132834	chr19:41945861	ATP5SL	0.77	5.9	0.56	9.04e-8	Height;
SKCM	cis	rs9303401	0.659	rs35797125	chr17:56736547	G/A	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.35	0.52	8.54e-7	Cognitive test performance;
SKCM	cis	rs12762955	0.561	rs7076107	chr10:1043647	T/C	cg25614935	chr10:1084866	C10orf110	-0.59	-4.9	-0.49	5.04e-6	Response to angiotensin II receptor blocker therapy;
SKCM	cis	rs28595532	0.920	rs115317002	chr4:119722809	T/C	cg14228332	chr4:119757509	SEC24D	1.07	5.49	0.53	4.77e-7	Cannabis dependence symptom count;
SKCM	cis	rs875971	0.522	rs7784623	chr7:65395034	T/G	cg11987759	chr7:65425863	GUSB	-0.74	-6.26	-0.58	1.91e-8	Aortic root size;
SKCM	cis	rs12142240	0.698	rs17361833	chr1:46828700	A/G	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs6066825	0.605	rs761273	chr20:47315488	A/G	cg18078177	chr20:47281410	PREX1	0.64	5.2	0.51	1.57e-6	Colorectal cancer;
SKCM	cis	rs514406	0.698	rs1775540	chr1:53407893	C/A	cg16325326	chr1:53192061	ZYG11B	0.65	5.64	0.54	2.61e-7	Monocyte count;
SKCM	cis	rs870825	0.698	rs66462315	chr4:185623917	C/T	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs875971	0.540	rs4717275	chr7:65265180	C/T	cg11764359	chr7:65958608	NA	-0.82	-5.94	-0.56	7.42e-8	Aortic root size;
SKCM	cis	rs7666738	0.830	rs62318503	chr4:98935479	T/C	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6570726	0.935	rs430561	chr6:145813140	C/T	cg23711669	chr6:146136114	FBXO30	0.71	6.82	0.61	1.7e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1801251	0.778	rs2250665	chr2:233752639	A/T	cg25237894	chr2:233734115	C2orf82	-0.59	-6.28	-0.58	1.79e-8	Coronary artery disease;
SKCM	cis	rs17685	0.753	rs13240967	chr7:75658197	C/T	cg16684958	chr7:75615977	POR	-0.57	-5.6	-0.54	3.07e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs9399137	0.507	rs4895437	chr6:135317354	G/A	cg24558204	chr6:135376177	HBS1L	0.7	6.53	0.59	6.11e-9	Glycated hemoglobin levels;Mean corpuscular volume;Hematology traits;HbA2 levels;Mean corpuscular hemoglobin;Hemoglobin levels;F-cell distribution;Platelet count;
SKCM	cis	rs875971	0.660	rs7807944	chr7:66087195	C/G	cg11987759	chr7:65425863	GUSB	0.67	5.8	0.55	1.36e-7	Aortic root size;
SKCM	cis	rs1005277	0.579	rs1780116	chr10:38526621	C/T	cg00409905	chr10:38381863	ZNF37A	-0.62	-5.23	-0.51	1.39e-6	Extrinsic epigenetic age acceleration;
SKCM	cis	rs7945705	0.902	rs10769980	chr11:9014180	G/A	cg21881798	chr11:8931708	C11orf17;ST5	0.84	8.49	0.69	1.06e-12	Hemoglobin concentration;
SKCM	cis	rs12586317	0.547	rs45531432	chr14:35484423	C/T	cg16230307	chr14:35515116	FAM177A1	0.81	5.88	0.55	9.47e-8	Psoriasis;
SKCM	cis	rs11098499	0.909	rs11723839	chr4:120299673	G/A	cg24375607	chr4:120327624	NA	0.65	4.97	0.49	3.87e-6	Corneal astigmatism;
SKCM	cis	rs7772486	0.743	rs9376955	chr6:145949404	T/A	cg23711669	chr6:146136114	FBXO30	0.85	9.26	0.72	3.33e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs13294100	0.929	rs10435770	chr9:17581168	C/G	cg11213383	chr9:17579734	SH3GL2	-0.53	-4.92	-0.49	4.69e-6	Parkinson's disease;
SKCM	cis	rs9325144	0.647	rs11168741	chr12:38989120	C/T	cg13010199	chr12:38710504	ALG10B	-0.61	-5.25	-0.51	1.28e-6	Morning vs. evening chronotype;
SKCM	cis	rs853679	0.599	rs156743	chr6:27967089	T/C	cg09551472	chr6:27280195	POM121L2	0.87	4.79	0.48	7.68e-6	Depression;
SKCM	cis	rs28386778	0.799	rs2665836	chr17:61898135	C/A	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs3785574	0.962	rs2955235	chr17:61966950	A/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	0.62	4.88	0.48	5.57e-6	Height;
SKCM	cis	rs7191700	0.644	rs12149160	chr16:11439303	G/T	cg00044050	chr16:11439710	C16orf75	-0.74	-5.2	-0.51	1.59e-6	Multiple sclerosis;
SKCM	cis	rs1577917	0.917	rs35283633	chr6:86690787	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.83	-8.23	-0.68	3.37e-12	Response to antipsychotic treatment;
SKCM	cis	rs875971	0.522	rs1701760	chr7:65473688	A/G	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.62	5.4	0.52	6.94e-7	Aortic root size;
SKCM	cis	rs17376456	0.696	rs6860390	chr5:93494731	G/T	cg25358565	chr5:93447407	FAM172A	-0.81	-5.25	-0.51	1.27e-6	Diabetic retinopathy;
SKCM	cis	rs13118159	0.550	rs28522910	chr4:1374774	C/T	cg20887711	chr4:1340912	KIAA1530	0.9	6.82	0.61	1.72e-9	Longevity;
SKCM	cis	rs7635838	0.617	rs367745	chr3:11309274	T/C	cg00170343	chr3:11313890	ATG7	0.78	5.9	0.56	9.03e-8	HDL cholesterol;
SKCM	cis	rs1799949	1.000	rs11652332	chr17:41295489	G/A	cg05368731	chr17:41323189	NBR1	0.89	7.91	0.67	1.38e-11	Menopause (age at onset);
SKCM	cis	rs459571	0.959	rs416390	chr9:136908549	C/G	cg13789015	chr9:136890014	NCRNA00094	-0.75	-6.56	-0.6	5.41e-9	Platelet distribution width;
SKCM	cis	rs17376456	0.825	rs10476590	chr5:93244884	A/T	cg21475434	chr5:93447410	FAM172A	1.02	5.17	0.51	1.74e-6	Diabetic retinopathy;
SKCM	cis	rs3784262	1.000	rs4369598	chr15:58318603	G/T	cg12031962	chr15:58353849	ALDH1A2	-0.52	-6.43	-0.59	9.17e-9	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs617791	0.508	rs1047464	chr11:65769456	A/T	cg27068330	chr11:65405492	SIPA1	-0.69	-4.94	-0.49	4.35e-6	Breast cancer;
SKCM	cis	rs829883	0.616	rs249832	chr12:98832387	C/T	cg25150519	chr12:98850993	NA	0.5	4.91	0.49	4.83e-6	Colorectal adenoma (advanced);
SKCM	cis	rs7666738	0.830	rs7663438	chr4:99014582	C/T	cg17366294	chr4:99064904	C4orf37	0.59	4.81	0.48	7.17e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7777484	0.534	rs2533888	chr7:2831083	T/C	cg09658497	chr7:2847517	GNA12	-0.38	-4.84	-0.48	6.52e-6	Height;
SKCM	cis	rs7811142	1.000	rs6975729	chr7:100028187	C/T	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.34	0.69	2.1e-12	Platelet count;
SKCM	cis	rs2297440	0.527	rs4809318	chr20:62264760	G/A	cg09650180	chr20:62225654	GMEB2	-0.79	-6.31	-0.58	1.54e-8	Glioma;Non-glioblastoma glioma;Glioblastoma;
SKCM	cis	rs4746818	1.000	rs6480383	chr10:70890482	C/T	cg11621586	chr10:70884670	VPS26A	1.0	7.68	0.66	3.84e-11	Left atrial antero-posterior diameter;
SKCM	cis	rs58688157	0.705	rs7928902	chr11:609068	G/A	cg17114584	chr11:613792	IRF7	0.8	5.62	0.54	2.85e-7	Systemic lupus erythematosus;
SKCM	cis	rs12474201	0.588	rs3768719	chr2:46987935	T/G	cg06386533	chr2:46925753	SOCS5	0.76	6.24	0.58	2.14e-8	Height;
SKCM	cis	rs12709013	0.792	rs257625	chr16:58793882	G/A	cg02431531	chr16:59244939	NA	0.49	5.13	0.5	2.07e-6	Blood metabolite ratios;
SKCM	cis	rs28595532	0.920	rs56322132	chr4:119742496	T/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs4555082	0.834	rs2816607	chr14:105718385	A/T	cg13114125	chr14:105738426	BRF1	-0.7	-5.62	-0.54	2.85e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs6977660	0.714	rs6945753	chr7:19814255	A/G	cg05791153	chr7:19748676	TWISTNB	0.8	5.01	0.49	3.37e-6	Thyroid stimulating hormone;
SKCM	cis	rs4243830	0.850	rs7540913	chr1:6581877	C/T	cg22792644	chr1:6614718	TAS1R1;NOL9	-1.0	-5.49	-0.53	4.86e-7	Body mass index;
SKCM	cis	rs4073582	0.595	rs708472	chr11:65930990	A/G	cg16950941	chr11:66035639	RAB1B	0.81	6.87	0.61	1.41e-9	Gout;
SKCM	cis	rs875971	0.862	rs28491091	chr7:65669064	G/T	cg18876405	chr7:65276391	NA	-0.65	-6.74	-0.61	2.46e-9	Aortic root size;
SKCM	cis	rs28386778	0.897	rs2137144	chr17:61805607	G/A	cg06873352	chr17:61820015	STRADA	0.71	5.89	0.55	9.36e-8	Prudent dietary pattern;
SKCM	cis	rs1577917	0.958	rs12213343	chr6:86443019	C/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.79	-7.73	-0.66	3.07e-11	Response to antipsychotic treatment;
SKCM	cis	rs2404602	0.716	rs3866543	chr15:76629609	T/G	cg23625390	chr15:77176239	SCAPER	0.68	5.95	0.56	7.24e-8	Blood metabolite levels;
SKCM	cis	rs9393692	1.000	rs2393593	chr6:26285683	T/C	cg00631329	chr6:26305371	NA	-0.67	-4.98	-0.49	3.66e-6	Educational attainment;
SKCM	cis	rs1160297	0.609	rs7577692	chr2:53105969	T/C	cg07782112	chr2:53107842	NA	0.59	6.33	0.58	1.41e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs732765	0.734	rs2270425	chr14:75179734	C/G	cg25946216	chr14:74253857	C14orf43	-0.8	-5.15	-0.5	1.88e-6	Non-small cell lung cancer;
SKCM	cis	rs2279817	0.863	rs12023877	chr1:18025633	A/C	cg17142039	chr1:18149651	ACTL8	0.59	5.07	0.5	2.62e-6	Neuroticism;
SKCM	cis	rs910316	1.000	rs10146482	chr14:75574087	C/T	cg11812906	chr14:75593930	NEK9	0.71	5.47	0.53	5.21e-7	Height;
SKCM	cis	rs9303401	0.625	rs66508449	chr17:56691034	T/C	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.35	0.52	8.54e-7	Cognitive test performance;
SKCM	cis	rs4803468	1.000	rs6508977	chr19:41909346	A/G	cg09537434	chr19:41945824	ATP5SL	-1.1	-13.82	-0.84	1.16e-22	Height;
SKCM	cis	rs501916	0.833	rs11629796	chr15:48045248	A/G	cg16110827	chr15:48056943	SEMA6D	-0.64	-5.21	-0.51	1.49e-6	Inflammatory bowel disease;Ulcerative colitis;
SKCM	cis	rs1577917	0.545	rs1335443	chr6:86478737	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.68	-6.11	-0.57	3.64e-8	Response to antipsychotic treatment;
SKCM	cis	rs11690935	0.959	rs12692974	chr2:172663256	T/C	cg13550731	chr2:172543902	DYNC1I2	-0.92	-7.75	-0.66	2.89e-11	Schizophrenia;
SKCM	cis	rs362296	0.698	rs362283	chr4:3259558	T/C	cg00764545	chr4:3318001	RGS12	-0.74	-6.48	-0.59	7.39e-9	Parental longevity (mother's age at death);
SKCM	cis	rs514406	0.825	rs9661082	chr1:53245472	A/T	cg16325326	chr1:53192061	ZYG11B	-1.01	-11.91	-0.8	3.17e-19	Monocyte count;
SKCM	cis	rs7523273	0.606	rs2796283	chr1:207978732	C/T	cg22525895	chr1:207977042	MIR29B2	-0.78	-6.66	-0.6	3.53e-9	Schizophrenia;
SKCM	cis	rs2739330	0.703	rs5760112	chr22:24259772	C/G	cg24846343	chr22:24311635	DDTL	0.61	5.9	0.56	8.82e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs992157	0.737	rs3731860	chr2:219156979	G/A	cg00012203	chr2:219082015	ARPC2	-0.71	-5.52	-0.53	4.3e-7	Colorectal cancer;
SKCM	cis	rs7726839	0.540	rs11750321	chr5:599196	C/T	cg10555297	chr5:473380	SLC9A3;LOC25845	1.03	4.96	0.49	4e-6	Obesity-related traits;
SKCM	cis	rs9911578	1.000	rs302840	chr17:56673079	C/G	cg05425664	chr17:57184151	TRIM37	-0.69	-5.06	-0.5	2.73e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2439831	0.867	rs689616	chr15:43761901	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.21	7.96	0.67	1.1e-11	Lung cancer in ever smokers;
SKCM	cis	rs782590	0.818	rs2627765	chr2:55883317	G/T	cg18811423	chr2:55921094	PNPT1	0.84	6.41	0.59	1.03e-8	Metabolic syndrome;
SKCM	cis	rs4642101	0.537	rs4997708	chr3:12839603	G/A	cg05775895	chr3:12838266	CAND2	0.58	4.95	0.49	4.19e-6	QRS complex (12-leadsum);
SKCM	cis	rs4740619	0.630	rs1169479	chr9:15895806	A/G	cg14451791	chr9:16040625	NA	0.43	5.01	0.49	3.29e-6	Body mass index;
SKCM	cis	rs208520	0.690	rs12197578	chr6:66725905	C/T	cg07460842	chr6:66804631	NA	0.91	7.37	0.64	1.54e-10	Exhaled nitric oxide output;
SKCM	cis	rs362296	0.698	rs3135172	chr4:3258735	A/G	cg09735869	chr4:3319127	RGS12	-0.79	-6.74	-0.61	2.47e-9	Parental longevity (mother's age at death);
SKCM	cis	rs2836974	0.583	rs8132993	chr21:40716410	T/C	cg11644478	chr21:40555479	PSMG1	0.63	4.88	0.48	5.57e-6	Cognitive function;
SKCM	cis	rs1561288	0.553	rs12988548	chr2:25323083	A/T	cg04586622	chr2:25135609	ADCY3	-0.7	-4.93	-0.49	4.58e-6	Body mass index;
SKCM	cis	rs1005277	0.579	rs1780145	chr10:38537070	A/G	cg25427524	chr10:38739819	LOC399744	-0.76	-6.92	-0.62	1.13e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs7208859	0.623	rs170051	chr17:28914153	G/A	cg14067834	chr17:29058358	SUZ12P	1.06	4.82	0.48	7.05e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs4523957	0.583	rs2760735	chr17:2036835	A/G	cg16513277	chr17:2031491	SMG6	-0.91	-6.21	-0.58	2.38e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs11098499	0.618	rs6858383	chr4:120296772	T/C	cg09307838	chr4:120376055	NA	0.97	7.49	0.65	9.08e-11	Corneal astigmatism;
SKCM	cis	rs60871478	1.000	rs4397290	chr7:828493	T/C	cg05535760	chr7:792225	HEATR2	-1.02	-8.66	-0.7	4.97e-13	Cerebrospinal P-tau181p levels;
SKCM	cis	rs62238980	0.522	rs79152613	chr22:32413707	G/C	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs8067545	0.750	rs3862152	chr17:19959693	C/T	cg13482628	chr17:19912719	NA	0.7	6.29	0.58	1.7e-8	Schizophrenia;
SKCM	cis	rs606458	0.844	rs589691	chr11:64525216	C/T	cg07674570	chr11:65346152	EHBP1L1	-0.66	-4.92	-0.49	4.78e-6	Urate levels;
SKCM	cis	rs7811142	1.000	rs1000215	chr7:100004543	A/G	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.12	6.51	0.59	6.64e-9	Platelet count;
SKCM	cis	rs7829975	0.871	rs777709	chr8:8583872	T/C	cg15556689	chr8:8085844	FLJ10661	-0.72	-6.75	-0.61	2.38e-9	Mood instability;
SKCM	cis	rs9880211	0.613	rs12330335	chr3:135853532	A/C	cg21827317	chr3:136751795	NA	-0.68	-5.3	-0.51	1.05e-6	Body mass index;Height;
SKCM	cis	rs10504229	0.861	rs59873610	chr8:58172290	T/A	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs7666738	0.830	rs13134819	chr4:98919885	G/C	cg05340658	chr4:99064831	C4orf37	0.61	4.86	0.48	5.87e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7598759	0.548	rs11693738	chr2:232360484	C/T	cg19187155	chr2:232395269	NMUR1	0.89	7.72	0.66	3.28e-11	Noise-induced hearing loss;
SKCM	cis	rs11945232	1.000	rs28372775	chr4:88343704	G/A	cg23841344	chr4:88312519	HSD17B11	-0.66	-4.9	-0.49	5.07e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2721173	0.619	rs997258	chr8:145903077	C/A	cg15857475	chr8:145742913	RECQL4;LRRC14	-0.9	-7.94	-0.67	1.2e-11	Educational attainment;Cognitive ability (multi-trait analysis);Intelligence (multi-trait analysis);
SKCM	cis	rs67460515	0.563	rs16831886	chr3:160799830	A/C	cg03342759	chr3:160939853	NMD3	-0.68	-5.77	-0.55	1.53e-7	Parkinson's disease;
SKCM	cis	rs9910055	0.762	rs2526020	chr17:42216588	G/T	cg10896456	chr17:42255109	ASB16;C17orf65	0.66	6.39	0.59	1.12e-8	Total body bone mineral density;
SKCM	trans	rs1814175	0.817	rs7950856	chr11:49976394	C/T	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs394563	0.591	rs6570963	chr6:149691355	T/G	cg16235748	chr6:149772707	ZC3H12D	0.45	5.06	0.5	2.75e-6	Dupuytren's disease;
SKCM	trans	rs1814175	0.817	rs4881627	chr11:49953955	C/A	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs854765	0.647	rs854791	chr17:18029857	C/T	cg04398451	chr17:18023971	MYO15A	-1.01	-7.92	-0.67	1.34e-11	Total body bone mineral density;
SKCM	cis	rs11763147	1	rs11763147	chr7:65326821	C/T	cg11987759	chr7:65425863	GUSB	0.76	6.51	0.59	6.57e-9	Corneal structure;
SKCM	cis	rs9880211	1.000	rs6774964	chr3:136275582	G/A	cg21827317	chr3:136751795	NA	-0.65	-4.92	-0.49	4.73e-6	Body mass index;Height;
SKCM	cis	rs2836974	0.897	rs2836927	chr21:40543216	T/C	cg11644478	chr21:40555479	PSMG1	0.97	10.21	0.76	5.08e-16	Cognitive function;
SKCM	cis	rs4423214	1.000	rs4944956	chr11:71167765	C/T	cg05163923	chr11:71159392	DHCR7	0.83	8.06	0.67	7.35e-12	Vitamin D levels;
SKCM	cis	rs7829975	0.560	rs4841013	chr8:8552013	A/G	cg15556689	chr8:8085844	FLJ10661	-0.68	-5.12	-0.5	2.18e-6	Mood instability;
SKCM	cis	rs1902272	0.692	rs9742943	chr13:32123094	C/T	cg13096407	chr13:32885502	ZAR1L	-0.43	-4.77	-0.48	8.45e-6	Metabolite levels (HVA/MHPG ratio);
SKCM	cis	rs13256369	1.000	rs7843488	chr8:8576217	C/T	cg06636001	chr8:8085503	FLJ10661	0.72	5.25	0.51	1.27e-6	Obesity-related traits;
SKCM	cis	rs17376456	0.877	rs10078194	chr5:93364310	A/C	cg21475434	chr5:93447410	FAM172A	0.95	5.36	0.52	8.36e-7	Diabetic retinopathy;
SKCM	cis	rs2075371	0.501	rs1643043	chr7:134013902	C/T	cg20476274	chr7:133979776	SLC35B4	0.84	7.14	0.63	4.31e-10	Mean platelet volume;
SKCM	cis	rs2153535	0.601	rs9505474	chr6:8539794	C/G	cg23788917	chr6:8435910	SLC35B3	0.69	4.92	0.49	4.79e-6	Motion sickness;
SKCM	cis	rs7937682	0.924	rs10891286	chr11:111532691	C/G	cg09085632	chr11:111637200	PPP2R1B	-1.05	-12.29	-0.81	6.25e-20	Primary sclerosing cholangitis;
SKCM	cis	rs6087990	0.735	rs1003522	chr20:31368560	T/C	cg13636640	chr20:31349939	DNMT3B	0.83	6.36	0.58	1.28e-8	Ulcerative colitis;
SKCM	cis	rs4906172	0.502	rs2720208	chr14:102377774	A/G	cg18492997	chr14:102379372	PPP2R5C	-0.78	-5.18	-0.51	1.68e-6	Menopause (age at onset);
SKCM	cis	rs7216064	1.000	rs2128792	chr17:65857177	C/T	cg12091567	chr17:66097778	LOC651250	-0.75	-5.27	-0.51	1.19e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs2839186	0.934	rs2839197	chr21:47708133	A/G	cg13012494	chr21:47604986	C21orf56	0.67	5.71	0.54	1.95e-7	Testicular germ cell tumor;
SKCM	cis	rs2304069	1.000	rs10072275	chr5:149401596	T/C	cg22760475	chr5:149380129	HMGXB3;TIGD6	0.79	5.95	0.56	7.22e-8	HIV-1 control;
SKCM	cis	rs1801251	0.928	rs4458205	chr2:233557646	C/T	cg08000102	chr2:233561755	GIGYF2	0.9	6.17	0.57	2.82e-8	Coronary artery disease;
SKCM	cis	rs1218582	0.772	rs6683557	chr1:154852307	C/G	cg09359103	chr1:154839909	KCNN3	-0.57	-5.25	-0.51	1.29e-6	Prostate cancer;
SKCM	cis	rs3008870	0.959	rs3008852	chr1:67383416	G/A	cg08660285	chr1:67390436	MIER1;WDR78	0.98	6.56	0.6	5.45e-9	Lymphocyte percentage of white cells;
SKCM	cis	rs1707322	1.000	rs4539075	chr1:46358010	C/T	cg03146154	chr1:46216737	IPP	0.73	4.96	0.49	4.04e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs58688157	0.705	rs12419694	chr11:598033	C/T	cg17114584	chr11:613792	IRF7	0.75	5.51	0.53	4.38e-7	Systemic lupus erythematosus;
SKCM	cis	rs875971	0.825	rs6951503	chr7:65718936	T/G	cg18876405	chr7:65276391	NA	-0.65	-6.66	-0.6	3.43e-9	Aortic root size;
SKCM	cis	rs362296	0.698	rs3135168	chr4:3262699	T/C	cg00764545	chr4:3318001	RGS12	-0.72	-6.77	-0.61	2.14e-9	Parental longevity (mother's age at death);
SKCM	cis	rs2228479	0.867	rs76885005	chr16:89966668	A/G	cg06558623	chr16:89946397	TCF25	1.26	6.97	0.62	9.17e-10	Skin colour saturation;
SKCM	cis	rs1046896	1.000	rs9909940	chr17:80689036	C/T	cg02711726	chr17:80685570	FN3KRP	-0.69	-5.96	-0.56	7.04e-8	Glycated hemoglobin levels;
SKCM	cis	rs1799949	0.930	rs34210004	chr17:41370337	A/T	cg25918947	chr17:41365094	TMEM106A	-0.63	-5.92	-0.56	8.1e-8	Menopause (age at onset);
SKCM	cis	rs2439831	0.867	rs4583210	chr15:43660925	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.39	9.42	0.73	1.62e-14	Lung cancer in ever smokers;
SKCM	cis	rs7811142	0.775	rs1059129	chr7:99926522	A/G	cg00814883	chr7:100076585	TSC22D4	-0.84	-4.78	-0.48	8.01e-6	Platelet count;
SKCM	cis	rs3820068	0.581	rs2861387	chr1:15951296	G/A	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs2645694	0.626	rs2645704	chr4:77830805	T/C	cg06046430	chr4:77819534	ANKRD56	0.54	5.94	0.56	7.49e-8	Emphysema distribution in smoking;
SKCM	cis	rs933688	0.938	rs10942634	chr5:90658392	A/T	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.05	8.21	0.68	3.73e-12	Smoking behavior;
SKCM	trans	rs561341	1.000	rs501957	chr17:30314504	C/T	cg20587970	chr11:113659929	NA	-1.11	-9.42	-0.73	1.68e-14	Hip circumference adjusted for BMI;
SKCM	cis	rs6546550	0.933	rs6546554	chr2:70135706	G/A	cg02498382	chr2:70120550	SNRNP27	-0.45	-4.88	-0.48	5.4e-6	Prevalent atrial fibrillation;
SKCM	cis	rs589448	1.000	rs589448	chr12:69752200	A/G	cg22834771	chr12:69754056	YEATS4	-0.71	-5.79	-0.55	1.39e-7	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs9660180	0.967	rs10907191	chr1:1774820	A/T	cg23982607	chr1:1823379	GNB1	-0.67	-5.61	-0.54	3.02e-7	Body mass index;
SKCM	cis	rs7666738	0.791	rs10856934	chr4:99010844	A/G	cg05340658	chr4:99064831	C4orf37	-0.67	-5.25	-0.51	1.26e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs8014204	0.819	rs3213716	chr14:75378185	G/A	cg06637938	chr14:75390232	RPS6KL1	0.99	7.45	0.64	1.08e-10	Caffeine consumption;
SKCM	cis	rs6952808	0.689	rs12670737	chr7:2046830	C/T	cg21782813	chr7:2030301	MAD1L1	0.6	6.54	0.59	5.91e-9	Bipolar disorder and schizophrenia;
SKCM	cis	rs3768617	0.510	rs3768622	chr1:183090011	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs459571	0.959	rs392134	chr9:136909008	G/A	cg13789015	chr9:136890014	NCRNA00094	0.7	5.5	0.53	4.66e-7	Platelet distribution width;
SKCM	cis	rs11858159	0.565	rs8038318	chr15:24807060	T/C	cg24138476	chr15:25312939	SNORD116-5;SNORD116-7	0.56	4.86	0.48	6.06e-6	Platelet thrombus formation;
SKCM	cis	rs16854884	0.770	rs920158	chr3:143799289	A/T	cg06585982	chr3:143692056	C3orf58	0.72	5.54	0.53	3.87e-7	Economic and political preferences (feminism/equality);
SKCM	cis	rs2282032	1.000	rs75722521	chr14:90760478	T/C	cg04374321	chr14:90722782	PSMC1	0.71	5.02	0.49	3.18e-6	Longevity;
SKCM	cis	rs883565	0.792	rs784492	chr3:39175576	A/C	cg20743662	chr3:38589496	NA	0.49	4.84	0.48	6.48e-6	Handedness;
SKCM	cis	rs769267	0.895	rs2965183	chr19:19545696	G/A	cg03709012	chr19:19516395	GATAD2A	0.9	8.7	0.7	4.14e-13	Tonsillectomy;
SKCM	cis	rs4819052	0.851	rs2877018	chr21:46658306	G/A	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.36	0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs561341	1.000	rs55959993	chr17:30254771	C/G	cg23018236	chr17:30244563	NA	-0.53	-5.27	-0.51	1.18e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs4555082	0.794	rs2735827	chr14:105710600	T/A	cg13114125	chr14:105738426	BRF1	-0.67	-5.59	-0.53	3.25e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs2286503	0.839	rs2270108	chr7:22862131	A/C	cg15401507	chr7:22894281	NA	-0.57	-5.61	-0.54	2.99e-7	Fibrinogen;
SKCM	cis	rs7615952	0.736	rs9866347	chr3:125669925	C/T	cg05084668	chr3:125655381	ALG1L	-1.25	-6.57	-0.6	5.19e-9	Blood pressure (smoking interaction);
SKCM	cis	rs2204008	0.805	rs4589389	chr12:37946120	C/A	cg26384229	chr12:38710491	ALG10B	-0.76	-6.51	-0.59	6.66e-9	Bladder cancer;
SKCM	cis	rs6665290	0.901	rs12410103	chr1:227197408	T/C	cg10327440	chr1:227177885	CDC42BPA	-1.24	-17.31	-0.89	1.95e-28	Myeloid white cell count;
SKCM	cis	rs801193	1.000	rs2707850	chr7:66203870	G/T	cg00343986	chr7:65444356	GUSB	0.7	5.19	0.51	1.63e-6	Aortic root size;
SKCM	cis	rs6570726	0.791	rs4335004	chr6:145904764	G/A	cg23711669	chr6:146136114	FBXO30	0.88	8.32	0.69	2.28e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs28386778	0.897	rs1982400	chr17:61793818	T/C	cg01411255	chr17:61851458	DDX42;CCDC47	0.77	4.86	0.48	5.97e-6	Prudent dietary pattern;
SKCM	cis	rs7954584	0.531	rs11043271	chr12:122394921	A/C	cg21171335	chr12:122356390	WDR66	0.46	5.02	0.49	3.24e-6	Mean corpuscular volume;
SKCM	cis	rs4332037	0.805	rs4721142	chr7:1918079	T/C	cg23422044	chr7:1970798	MAD1L1	-0.91	-6.49	-0.59	7.23e-9	Bipolar disorder;
SKCM	cis	rs2153535	0.525	rs1335644	chr6:8488041	A/G	cg07606381	chr6:8435919	SLC35B3	0.86	6.25	0.58	2.06e-8	Motion sickness;
SKCM	cis	rs9611565	0.608	rs202652	chr22:41838792	A/G	cg03806693	chr22:41940476	POLR3H	1.07	6.74	0.61	2.44e-9	Vitiligo;
SKCM	cis	rs3540	0.597	rs4932346	chr15:91048991	T/C	cg22089800	chr15:90895588	ZNF774	-0.68	-4.93	-0.49	4.58e-6	Allergic disease (asthma, hay fever or eczema);Lymphocyte counts;
SKCM	cis	rs2721195	0.549	rs2958492	chr8:145919126	C/T	cg15857475	chr8:145742913	RECQL4;LRRC14	0.87	7.82	0.66	2.08e-11	Age at first birth;
SKCM	cis	rs7178909	0.902	rs2043882	chr15:90439753	G/A	cg19708238	chr15:90437601	AP3S2	0.72	5.22	0.51	1.43e-6	Common traits (Other);
SKCM	cis	rs11270836	1	rs11270836	chr4:38625915	T/TACATTATGTCATTTCACA	cg18361445	chr4:38666374	KLF3;FLJ13197	0.64	5.14	0.5	1.98e-6	Mumps;
SKCM	cis	rs362296	0.661	rs3095078	chr4:3265479	C/T	cg11471262	chr4:3318911	RGS12	-0.69	-6.15	-0.57	3.12e-8	Parental longevity (mother's age at death);
SKCM	cis	rs2984613	1	rs2984613	chr1:156197380	C/T	cg24450063	chr1:156163899	SLC25A44	0.79	6.76	0.61	2.21e-9	Intracerebral hemorrhage;White matter hyperintensity burden;
SKCM	cis	rs4689592	0.513	rs2358718	chr4:7068743	A/C	cg26116260	chr4:7069785	GRPEL1	-1.14	-9.42	-0.73	1.65e-14	Monocyte percentage of white cells;
SKCM	cis	rs4822044	0.680	rs8138780	chr22:42097462	A/T	cg03806693	chr22:41940476	POLR3H	1.11	6.8	0.61	1.86e-9	Cannabis dependence symptom count;
SKCM	cis	rs67311347	1.000	rs9834052	chr3:40399060	G/A	cg00091569	chr3:40428383	ENTPD3	0.61	5.36	0.52	8.37e-7	Renal cell carcinoma;
SKCM	cis	rs10751667	0.666	rs6597967	chr11:950583	G/T	cg06064525	chr11:970664	AP2A2	-0.54	-5.12	-0.5	2.13e-6	Alzheimer's disease (late onset);
SKCM	cis	rs7408868	0.831	rs7249115	chr19:15280765	A/G	cg14696996	chr19:15285081	NOTCH3	0.82	4.92	0.49	4.7e-6	Pulse pressure;
SKCM	cis	rs1878931	0.501	rs9635563	chr16:3416940	A/G	cg26668626	chr16:3451006	ZNF174;ZNF434	0.88	7.37	0.64	1.52e-10	Body mass index (adult);
SKCM	cis	rs2288073	0.965	rs10173173	chr2:24415461	G/T	cg06627628	chr2:24431161	ITSN2	0.83	5.68	0.54	2.2e-7	Venous thromboembolism (SNP x SNP interaction);
SKCM	cis	rs2120019	1.000	rs35736167	chr15:75332002	T/G	cg17294928	chr15:75287854	SCAMP5	-0.91	-8.76	-0.7	3.17e-13	Blood trace element (Zn levels);
SKCM	cis	rs6089584	0.854	rs2380146	chr20:60632233	C/T	cg06108461	chr20:60628389	TAF4	-0.88	-8.81	-0.71	2.5e-13	Body mass index;
SKCM	cis	rs875971	0.660	rs7807944	chr7:66087195	C/G	cg00343986	chr7:65444356	GUSB	-0.68	-4.99	-0.49	3.65e-6	Aortic root size;
SKCM	cis	rs1799949	0.896	rs8176086	chr17:41274778	G/A	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.11	-0.57	3.67e-8	Menopause (age at onset);
SKCM	cis	rs514406	0.584	rs7524702	chr1:53197830	G/A	cg16325326	chr1:53192061	ZYG11B	-1.0	-12.3	-0.81	6.1e-20	Monocyte count;
SKCM	cis	rs6570726	0.577	rs867056	chr6:145784805	A/C	cg23711669	chr6:146136114	FBXO30	-0.74	-6.3	-0.58	1.62e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs208515	0.525	rs4145045	chr6:66678949	T/C	cg07460842	chr6:66804631	NA	0.93	6.34	0.58	1.35e-8	Exhaled nitric oxide levels;
SKCM	cis	rs7666738	0.830	rs28810677	chr4:99043193	C/T	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4820539	0.902	rs737846	chr22:23460669	A/G	cg14186256	chr22:23484241	RTDR1	0.86	8.58	0.7	6.98e-13	Bone mineral density;
SKCM	cis	rs473651	0.935	rs483166	chr2:239346641	C/T	cg18131467	chr2:239335373	ASB1	-1.08	-12.19	-0.81	9.57e-20	Multiple system atrophy;
SKCM	cis	rs514406	0.644	rs4926928	chr1:53210163	G/T	cg16325326	chr1:53192061	ZYG11B	0.99	11.98	0.8	2.3e-19	Monocyte count;
SKCM	cis	rs1506636	0.927	rs6959270	chr7:123310628	G/A	cg03229431	chr7:123269106	ASB15	-0.63	-5.08	-0.5	2.56e-6	Plateletcrit;Platelet count;
SKCM	cis	rs6500395	0.926	rs2883643	chr16:48693018	C/G	cg04672837	chr16:48644449	N4BP1	0.65	5.36	0.52	8.29e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs12047808	0.778	rs55682857	chr1:179362402	A/T	cg08037922	chr1:179521085	C1orf125;NPHS2	-1.08	-5.8	-0.55	1.32e-7	Multiple sclerosis (age of onset);
SKCM	cis	rs561341	1.000	rs72821952	chr17:30248133	T/A	cg23018236	chr17:30244563	NA	-0.55	-5.31	-0.52	9.92e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs2463822	1.000	rs2513749	chr11:62105391	C/T	cg06239285	chr11:62104954	ASRGL1	1.25	5.91	0.56	8.43e-8	Chronic obstructive pulmonary disease-related biomarkers;
SKCM	cis	rs2404602	0.647	rs12439141	chr15:77095423	T/C	cg23625390	chr15:77176239	SCAPER	-0.85	-8.26	-0.68	2.93e-12	Blood metabolite levels;
SKCM	cis	rs2153535	0.580	rs6910742	chr6:8448328	G/A	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs6951245	1.000	rs79765398	chr7:1073764	A/G	cg03188948	chr7:1209495	NA	1.12	6.17	0.57	2.88e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs701145	0.537	rs437396	chr3:153923273	A/G	cg17054900	chr3:154042577	DHX36	1.25	5.36	0.52	8.3e-7	Coronary artery disease;
SKCM	cis	rs2033711	0.870	rs1465789	chr19:58946056	C/T	cg00825309	chr19:58991885	ZNF446	-0.68	-5.4	-0.52	7.11e-7	Uric acid clearance;
SKCM	cis	rs13118159	0.550	rs28733902	chr4:1374789	A/G	cg02475777	chr4:1388615	CRIPAK	0.85	5.8	0.55	1.36e-7	Longevity;
SKCM	cis	rs3820068	0.581	rs6692489	chr1:15928517	A/G	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs250585	0.588	rs250567	chr16:23394399	A/G	cg00143387	chr16:23521605	GGA2	-1.53	-4.85	-0.48	6.29e-6	Egg allergy;
SKCM	cis	rs798766	1.000	rs3752749	chr4:1737262	T/C	cg05874882	chr4:1763078	NA	-0.56	-4.89	-0.48	5.37e-6	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs769267	0.930	rs4808959	chr19:19572108	T/G	cg03709012	chr19:19516395	GATAD2A	0.89	8.62	0.7	5.89e-13	Tonsillectomy;
SKCM	cis	rs2811415	0.627	rs9820691	chr3:127750866	A/G	cg09089421	chr3:127803668	RUVBL1	0.99	8.52	0.69	9.09e-13	Lung function (FEV1/FVC);
SKCM	cis	rs2303759	0.918	rs7251704	chr19:49890873	T/G	cg05022225	chr19:49866942	DKKL1;TEAD2	0.68	4.86	0.48	5.94e-6	Multiple sclerosis;
SKCM	cis	rs748404	0.660	rs690012	chr15:43719755	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	0.73	5.42	0.52	6.48e-7	Lung cancer;
SKCM	cis	rs1153858	1.000	rs12437840	chr15:45669055	C/A	cg10760299	chr15:45669010	GATM	0.62	6.35	0.58	1.3e-8	Homoarginine levels;
SKCM	trans	rs2727020	0.658	rs10839269	chr11:49385596	A/G	cg15704280	chr7:45808275	SEPT13	-0.85	-7.4	-0.64	1.33e-10	Coronary artery disease;
SKCM	cis	rs17685	0.884	rs8565	chr7:75630274	T/C	cg01364799	chr7:75623366	TMEM120A	0.77	5.96	0.56	6.93e-8	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs5769765	0.955	rs7511159	chr22:50307896	A/G	cg22709217	chr22:50311962	ALG12;CRELD2	-0.87	-5.83	-0.55	1.18e-7	Schizophrenia;
SKCM	cis	rs6951245	0.872	rs11768486	chr7:1101290	C/A	cg18402987	chr7:1209562	NA	1.15	6.09	0.57	3.95e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs929354	0.772	rs6967764	chr7:156994964	C/T	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs4819052	0.851	rs13050359	chr21:46672671	T/G	cg20896738	chr21:46707857	POFUT2;LOC642852	0.64	4.82	0.48	6.85e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs1461503	0.966	rs10892936	chr11:122841720	G/A	cg27398637	chr11:122830231	C11orf63	-0.65	-4.9	-0.48	5.17e-6	Menarche (age at onset);
SKCM	cis	rs6540556	0.859	rs1007693	chr1:209931799	C/T	cg05527609	chr1:210001259	C1orf107	-0.86	-4.8	-0.48	7.39e-6	Red blood cell count;
SKCM	cis	rs12477438	0.501	rs6727749	chr2:99793590	C/T	cg14399236	chr2:99771627	LIPT1;TSGA10	0.96	8.62	0.7	5.82e-13	Chronic sinus infection;
SKCM	cis	rs763121	0.853	rs138704	chr22:39133410	A/G	cg06022373	chr22:39101656	GTPBP1	0.78	4.9	0.49	5.09e-6	Menopause (age at onset);
SKCM	cis	rs3771570	1.000	rs62190367	chr2:242376276	G/A	cg07612300	chr2:242033426	MTERFD2;SNED1	0.88	4.93	0.49	4.46e-6	Prostate cancer;
SKCM	cis	rs875971	0.619	rs12533585	chr7:65984605	G/C	cg11764359	chr7:65958608	NA	0.86	6.6	0.6	4.52e-9	Aortic root size;
SKCM	cis	rs2204008	0.811	rs12368410	chr12:38305705	C/T	cg13010199	chr12:38710504	ALG10B	0.69	4.92	0.49	4.72e-6	Bladder cancer;
SKCM	cis	rs1801251	1.000	rs895430	chr2:233725483	C/A	cg08000102	chr2:233561755	GIGYF2	-0.85	-6.98	-0.62	8.73e-10	Coronary artery disease;
SKCM	cis	rs929354	0.772	rs4716460	chr7:156970054	T/C	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs2439831	0.681	rs540031	chr15:43608855	C/T	cg27015174	chr15:43622946	ADAL;LCMT2	0.87	4.81	0.48	7.13e-6	Lung cancer in ever smokers;
SKCM	cis	rs8180040	0.966	rs2291298	chr3:47555142	C/A	cg27129171	chr3:47204927	SETD2	0.81	5.82	0.55	1.26e-7	Colorectal cancer;
SKCM	cis	rs8067545	0.532	rs12946508	chr17:19952059	A/T	cg13482628	chr17:19912719	NA	0.67	4.8	0.48	7.46e-6	Schizophrenia;
SKCM	cis	rs864745	0.967	rs849134	chr7:28196222	A/G	cg15170557	chr7:28214983	JAZF1	-0.7	-6.83	-0.61	1.68e-9	Crohn's disease;Type 2 diabetes;
SKCM	cis	rs7816032	0.617	rs12543154	chr8:19755977	A/C	cg04035597	chr8:19794539	NA	0.49	4.78	0.48	8.14e-6	Hyperactive-impulsive symptoms;
SKCM	cis	rs9549367	0.713	rs3024745	chr13:113821598	A/G	cg18105134	chr13:113819100	PROZ	-0.91	-6.73	-0.61	2.59e-9	Platelet distribution width;
SKCM	cis	rs2180341	0.920	rs9398836	chr6:127576497	T/G	cg24812749	chr6:127587940	RNF146	0.91	8.05	0.67	7.38e-12	Breast cancer;
SKCM	cis	rs2204008	0.748	rs7312204	chr12:38334909	T/C	cg26384229	chr12:38710491	ALG10B	0.78	6.66	0.6	3.54e-9	Bladder cancer;
SKCM	cis	rs1568889	0.838	rs4572130	chr11:28371794	T/C	cg06544937	chr11:28130018	METT5D1;KIF18A	0.88	7.81	0.66	2.19e-11	Bipolar disorder;
SKCM	cis	rs10779751	0.770	rs1148480	chr1:11172006	A/G	cg08854313	chr1:11322531	MTOR	0.87	6.81	0.61	1.83e-9	Body mass index;
SKCM	cis	rs11112613	0.713	rs73184083	chr12:105952593	T/A	cg03607813	chr12:105948248	NA	0.84	5.44	0.52	5.84e-7	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;
SKCM	cis	rs684232	0.666	rs366151	chr17:598311	A/C	cg12384639	chr17:618140	VPS53	0.72	5.62	0.54	2.84e-7	Prostate cancer;
SKCM	cis	rs59918340	0.764	rs9324542	chr8:142227854	A/T	cg23750338	chr8:142222470	SLC45A4	-0.61	-5.66	-0.54	2.38e-7	Immature fraction of reticulocytes;
SKCM	cis	rs7772486	0.558	rs9376965	chr6:146130055	G/A	cg23711669	chr6:146136114	FBXO30	0.81	7.41	0.64	1.29e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs362272	0.505	rs13104157	chr4:3366950	T/C	cg11471262	chr4:3318911	RGS12	0.95	11.64	0.8	9.82e-19	Serum sulfate level;
SKCM	cis	rs9788721	0.836	rs55983731	chr15:78735269	C/T	cg18825076	chr15:78729989	IREB2	-0.61	-4.85	-0.48	6.1e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;Emphysema imaging phenotypes;Emphysema distribution in smoking;Local histogram emphysema pattern;Post bronchodilator FEV1/FVC ratio in COPD;
SKCM	cis	rs7777484	0.534	rs2533886	chr7:2834869	C/T	cg19717773	chr7:2847554	GNA12	-0.49	-5.95	-0.56	7.09e-8	Height;
SKCM	cis	rs6952808	0.771	rs10269191	chr7:1915731	A/G	cg02951883	chr7:2050386	MAD1L1	-0.69	-5.83	-0.55	1.18e-7	Bipolar disorder and schizophrenia;
SKCM	trans	rs3780486	0.846	rs10971419	chr9:33124161	T/C	cg20290983	chr6:43655470	MRPS18A	0.99	11.08	0.78	1.1e-17	IgG glycosylation;
SKCM	cis	rs362296	0.661	rs3095077	chr4:3265710	A/G	cg00764545	chr4:3318001	RGS12	0.64	5.66	0.54	2.36e-7	Parental longevity (mother's age at death);
SKCM	cis	rs3859192	0.599	rs34342173	chr17:38161507	T/C	cg17467752	chr17:38218738	THRA	-0.74	-6.28	-0.58	1.78e-8	White blood cell count;
SKCM	cis	rs875971	0.838	rs2173570	chr7:65762963	T/A	cg18876405	chr7:65276391	NA	-0.68	-6.79	-0.61	1.94e-9	Aortic root size;
SKCM	cis	rs826838	1.000	rs11168676	chr12:38977304	A/G	cg26384229	chr12:38710491	ALG10B	1.04	9.89	0.75	2.01e-15	Heart rate;
SKCM	cis	rs1979654	0.543	rs4843933	chr16:86401190	A/G	cg01467047	chr16:86611690	FOXL1	0.39	5.35	0.52	8.68e-7	Barrett's esophagus  or Esophageal adenocarcinoma;
SKCM	cis	rs7666738	0.546	rs10026181	chr4:98814118	C/T	cg17366294	chr4:99064904	C4orf37	-0.64	-4.98	-0.49	3.76e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs12971120	1.000	rs12971120	chr18:72174023	A/G	cg25817165	chr18:72167213	CNDP2	-0.61	-4.8	-0.48	7.57e-6	Refractive error;
SKCM	cis	rs1062177	0.951	rs2915876	chr5:151150745	C/A	cg00977110	chr5:151150581	G3BP1	0.79	6.51	0.59	6.71e-9	Preschool internalizing problems;
SKCM	cis	rs1801251	1.000	rs895430	chr2:233725483	C/A	cg25237894	chr2:233734115	C2orf82	-0.58	-5.64	-0.54	2.6e-7	Coronary artery disease;
SKCM	cis	rs61935443	0.720	rs892493	chr12:95283943	T/C	cg21533806	chr12:95267307	NA	0.94	5.46	0.53	5.46e-7	Schizophrenia;
SKCM	cis	rs9818758	0.607	rs66991555	chr3:49228643	A/G	cg24898236	chr3:49228699	LOC646498	0.64	4.94	0.49	4.39e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs7772486	0.790	rs9403750	chr6:146167762	G/A	cg05347473	chr6:146136440	FBXO30	0.58	5.45	0.53	5.72e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2463822	0.614	rs117699706	chr11:62161659	T/C	cg06239285	chr11:62104954	ASRGL1	-1.25	-5.93	-0.56	7.79e-8	Chronic obstructive pulmonary disease-related biomarkers;
SKCM	cis	rs2180341	0.781	rs7742161	chr6:127571676	T/C	cg27446573	chr6:127587934	RNF146	0.88	7.22	0.63	2.99e-10	Breast cancer;
SKCM	cis	rs2455826	0.583	rs2280770	chr3:15677531	G/A	cg21141587	chr3:14755007	C3orf20	-0.77	-5.75	-0.55	1.63e-7	Inflammatory skin disease;
SKCM	cis	rs1801251	0.778	rs2675967	chr2:233736133	C/G	cg25237894	chr2:233734115	C2orf82	-0.61	-6.51	-0.59	6.68e-9	Coronary artery disease;
SKCM	cis	rs2282032	0.883	rs2094653	chr14:90784827	A/G	cg04374321	chr14:90722782	PSMC1	0.75	5.18	0.51	1.66e-6	Longevity;
SKCM	cis	rs9911578	1.000	rs1057068	chr17:56598439	T/C	cg12560992	chr17:57184187	TRIM37	-0.98	-8.03	-0.67	8.19e-12	Intelligence (multi-trait analysis);
SKCM	cis	rs72717009	0.825	rs7515174	chr1:161476949	C/G	cg23840854	chr1:161414152	NA	-0.99	-5.66	-0.54	2.44e-7	Rheumatoid arthritis;
SKCM	cis	rs34779708	0.706	rs36027395	chr10:35550323	T/A	cg03585969	chr10:35415529	CREM	0.73	5.24	0.51	1.34e-6	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs17685	0.753	rs10262501	chr7:75668172	G/A	cg01364799	chr7:75623366	TMEM120A	0.72	5.83	0.55	1.18e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs116095464	0.850	rs73023433	chr5:317670	G/A	cg22857025	chr5:266934	NA	-1.63	-6.12	-0.57	3.5e-8	Breast cancer;
SKCM	trans	rs208520	0.690	rs4386800	chr6:66755242	A/G	cg15611600	chr13:45563400	KIAA1704;NUFIP1	0.89	7.28	0.64	2.26e-10	Exhaled nitric oxide output;
SKCM	cis	rs2070488	0.775	rs13098946	chr3:38517784	C/G	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.75	6.15	0.57	3.04e-8	Electrocardiographic conduction measures;
SKCM	cis	rs9910055	0.659	rs7216294	chr17:42251095	T/C	cg10896456	chr17:42255109	ASB16;C17orf65	0.68	7.28	0.64	2.25e-10	Total body bone mineral density;
SKCM	cis	rs28386778	1.000	rs2665851	chr17:61957023	T/C	cg01411255	chr17:61851458	DDX42;CCDC47	0.76	4.86	0.48	5.96e-6	Prudent dietary pattern;
SKCM	cis	rs28595532	0.920	rs115986613	chr4:119752156	G/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs6840360	0.615	rs62329085	chr4:152470237	G/A	cg22705602	chr4:152727874	NA	-0.51	-5.78	-0.55	1.45e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs992157	1.000	rs11554825	chr2:219125809	C/T	cg00012203	chr2:219082015	ARPC2	0.83	6.98	0.62	8.66e-10	Colorectal cancer;
SKCM	cis	rs62238980	0.614	rs78907591	chr22:32459673	T/C	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs9486715	0.825	rs211158	chr6:97022938	C/G	cg06623918	chr6:96969491	KIAA0776	-0.87	-7.58	-0.65	6.23e-11	Headache;
SKCM	cis	rs62064224	0.533	rs11657826	chr17:30790386	T/A	cg25809561	chr17:30822961	MYO1D	0.68	5.74	0.55	1.71e-7	Schizophrenia;
SKCM	cis	rs7937682	0.883	rs542831	chr11:111471392	T/A	cg09085632	chr11:111637200	PPP2R1B	-1.02	-10.07	-0.75	9.14e-16	Primary sclerosing cholangitis;
SKCM	cis	rs13161895	0.702	rs74507840	chr5:179487430	G/A	cg02702477	chr5:179499311	RNF130	1.02	5.1	0.5	2.28e-6	LDL cholesterol;
SKCM	cis	rs1801251	1.000	rs35085837	chr2:233624363	A/G	cg08000102	chr2:233561755	GIGYF2	0.88	7.07	0.63	5.69e-10	Coronary artery disease;
SKCM	cis	rs754466	0.580	rs2289309	chr10:79571108	C/T	cg17075019	chr10:79541650	NA	-0.79	-6.93	-0.62	1.08e-9	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs6500602	0.627	rs9938228	chr16:4530597	T/C	cg08645402	chr16:4508243	NA	0.64	4.95	0.49	4.26e-6	Schizophrenia;
SKCM	cis	rs7772486	0.686	rs857875	chr6:145980033	T/G	cg23711669	chr6:146136114	FBXO30	-0.9	-9.54	-0.73	9.76e-15	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7937682	0.883	rs568038	chr11:111432161	A/C	cg09085632	chr11:111637200	PPP2R1B	1.05	10.81	0.77	3.61e-17	Primary sclerosing cholangitis;
SKCM	cis	rs67311347	0.568	rs57287242	chr3:40335538	T/C	cg02782426	chr3:40428986	ENTPD3	0.52	5.33	0.52	9.46e-7	Renal cell carcinoma;
SKCM	cis	rs8072100	0.764	rs2644349	chr17:45641743	G/A	cg08085267	chr17:45401833	C17orf57	0.58	5.13	0.5	2.04e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs2153535	0.580	rs9406143	chr6:8444583	C/T	cg07606381	chr6:8435919	SLC35B3	0.94	6.94	0.62	1.02e-9	Motion sickness;
SKCM	cis	rs4523957	0.855	rs1231206	chr17:2125605	G/A	cg16513277	chr17:2031491	SMG6	-0.73	-4.95	-0.49	4.13e-6	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs12950390	0.853	rs17773010	chr17:45858297	C/T	cg03474202	chr17:45855739	NA	-0.48	-5.42	-0.52	6.43e-7	IgG glycosylation;
SKCM	cis	rs5750830	0.597	rs4821889	chr22:39777254	T/C	cg24399712	chr22:39784796	NA	-0.58	-5.02	-0.49	3.24e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs11098499	0.604	rs34278750	chr4:120571136	G/A	cg09307838	chr4:120376055	NA	1.01	8.35	0.69	2.01e-12	Corneal astigmatism;
SKCM	cis	rs6495122	0.699	rs1378940	chr15:75083494	C/A	cg14664628	chr15:75095509	CSK	-0.93	-6.98	-0.62	8.62e-10	Caffeine consumption;Diastolic blood pressure;Coffee consumption;
SKCM	cis	rs2832191	0.791	rs9983651	chr21:30491227	T/A	cg08807101	chr21:30365312	RNF160	-0.62	-4.94	-0.49	4.34e-6	Dental caries;
SKCM	cis	rs10504229	0.683	rs11784908	chr8:58131472	T/C	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs2290405	0.527	rs4690329	chr4:931385	T/A	cg04824913	chr4:887549	GAK	0.85	7.68	0.66	3.93e-11	Systemic sclerosis;
SKCM	cis	rs10905065	0.829	rs6602278	chr10:5868361	A/G	cg09234995	chr10:5726438	C10orf18	0.67	5.77	0.55	1.55e-7	Menopause (age at onset);
SKCM	cis	rs752010	0.571	rs10890135	chr1:42054084	G/A	cg06885757	chr1:42089581	HIVEP3	0.57	6.23	0.58	2.23e-8	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs9926296	0.533	rs7190823	chr16:89866043	A/G	cg27121462	chr16:89883253	FANCA	0.77	6.74	0.61	2.45e-9	Vitiligo;
SKCM	cis	rs5769765	0.778	rs4574208	chr22:50256738	C/T	cg22709217	chr22:50311962	ALG12;CRELD2	0.79	5.71	0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs4332037	0.539	rs11982455	chr7:1911458	A/C	cg23422044	chr7:1970798	MAD1L1	-0.98	-6.24	-0.58	2.08e-8	Bipolar disorder;
SKCM	cis	rs6088590	1.000	rs6120750	chr20:33465289	A/C	cg24642439	chr20:33292090	TP53INP2	0.98	6.97	0.62	9.14e-10	Coronary artery disease;
SKCM	cis	rs2034088	0.965	rs4968070	chr17:446162	A/G	cg06217071	chr17:408420	NA	0.49	5.41	0.52	6.64e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs4466137	0.830	rs6886695	chr5:82994293	T/A	cg16102102	chr5:83017553	HAPLN1	-0.55	-6.02	-0.56	5.28e-8	Prostate cancer;
SKCM	cis	rs6547741	0.775	rs11692692	chr2:27861707	G/A	cg27432699	chr2:27873401	GPN1	-0.84	-7.18	-0.63	3.52e-10	Oral cavity cancer;
SKCM	cis	rs1153858	1.000	rs8042786	chr15:45703539	T/C	cg21132104	chr15:45694354	SPATA5L1	0.89	7.21	0.63	3.12e-10	Homoarginine levels;
SKCM	cis	rs9818758	0.607	rs11710247	chr3:49249800	G/T	cg24110177	chr3:50126178	RBM5	0.86	5.12	0.5	2.15e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs362296	0.590	rs4690081	chr4:3262105	T/G	cg00764545	chr4:3318001	RGS12	-0.76	-7.1	-0.63	5.03e-10	Parental longevity (mother's age at death);
SKCM	cis	rs1799949	1.000	rs2271574	chr17:41327648	T/C	cg23758822	chr17:41437982	NA	0.93	7.87	0.67	1.66e-11	Menopause (age at onset);
SKCM	cis	rs12042938	0.507	rs1765777	chr1:231731742	C/T	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	-0.55	-4.8	-0.48	7.57e-6	Neuranatomic and neurocognitive phenotypes;
SKCM	cis	rs2124969	0.562	rs6750639	chr2:161066862	T/C	cg03641300	chr2:160917029	PLA2R1	-0.61	-4.83	-0.48	6.62e-6	Waist circumference adjusted for body mass index;
SKCM	cis	rs2721195	1.000	rs1871541	chr8:145681713	G/T	cg11211951	chr8:145729740	GPT	-0.63	-5.98	-0.56	6.27e-8	Age at first birth;
SKCM	cis	rs7208859	0.623	rs1061346	chr17:29114229	G/A	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs8177179	0.967	rs6439436	chr3:133453779	C/T	cg16262614	chr3:133464971	TF	-0.43	-5.31	-0.52	1e-6	Iron status biomarkers (transferrin levels);
SKCM	cis	rs6951245	0.882	rs10252404	chr7:1209607	C/A	cg03188948	chr7:1209495	NA	1.1	7.01	0.62	7.58e-10	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7772486	0.754	rs4896839	chr6:146019689	T/G	cg23711669	chr6:146136114	FBXO30	-0.93	-10.19	-0.76	5.55e-16	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2836974	0.627	rs8127986	chr21:40687211	A/T	cg17971929	chr21:40555470	PSMG1	-0.69	-6.07	-0.57	4.38e-8	Cognitive function;
SKCM	cis	rs6582630	0.555	rs2090785	chr12:38424342	G/A	cg26384229	chr12:38710491	ALG10B	0.82	6.3	0.58	1.6e-8	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs5769765	0.773	rs138834	chr22:50180497	A/C	cg22709217	chr22:50311962	ALG12;CRELD2	-0.88	-5.09	-0.5	2.44e-6	Schizophrenia;
SKCM	cis	rs6545883	0.718	rs3771260	chr2:61762384	G/T	cg15711740	chr2:61764176	XPO1	-0.74	-5.26	-0.51	1.23e-6	Tuberculosis;
SKCM	cis	rs9815354	0.904	rs73073368	chr3:41843391	A/G	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs523522	0.962	rs7488320	chr12:120981630	G/T	cg12219531	chr12:120966889	COQ5	0.91	7.82	0.66	2.11e-11	High light scatter reticulocyte count;
SKCM	cis	rs9475752	0.793	rs78463359	chr6:56833483	G/A	cg06815302	chr6:57335405	PRIM2	0.65	5.03	0.49	3.12e-6	Menarche (age at onset);
SKCM	cis	rs2836974	1.000	rs28360661	chr21:40681972	G/C	cg11644478	chr21:40555479	PSMG1	0.83	7.72	0.66	3.29e-11	Cognitive function;
SKCM	cis	rs801193	1.000	rs2055682	chr7:66260289	A/G	cg00343986	chr7:65444356	GUSB	0.67	4.93	0.49	4.55e-6	Aortic root size;
SKCM	cis	rs8072100	0.666	rs9913014	chr17:45460189	C/T	cg08085267	chr17:45401833	C17orf57	-0.62	-5.06	-0.5	2.76e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs7613875	0.641	rs6793528	chr3:50100188	C/A	cg24110177	chr3:50126178	RBM5	0.74	5.95	0.56	7.25e-8	Body mass index;
SKCM	cis	rs6570726	0.875	rs373313	chr6:145857791	T/C	cg23711669	chr6:146136114	FBXO30	0.71	6.8	0.61	1.93e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs314370	1.000	rs12705089	chr7:100465355	C/T	cg10426581	chr7:100472382	SRRT	0.73	6.13	0.57	3.39e-8	Resting heart rate;
SKCM	cis	rs7666738	0.791	rs11735105	chr4:98937357	C/T	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2836974	0.897	rs2836933	chr21:40564202	C/G	cg17971929	chr21:40555470	PSMG1	0.9	8.81	0.71	2.52e-13	Cognitive function;
SKCM	cis	rs847649	0.692	rs10279449	chr7:102462636	T/C	cg18108683	chr7:102477205	FBXL13	-0.83	-9.35	-0.73	2.31e-14	Morning vs. evening chronotype;
SKCM	cis	rs9611565	0.729	rs73176686	chr22:41782119	C/T	cg03806693	chr22:41940476	POLR3H	-0.99	-6.37	-0.58	1.23e-8	Vitiligo;
SKCM	cis	rs6570726	0.791	rs408443	chr6:145874643	T/C	cg23711669	chr6:146136114	FBXO30	0.87	9.14	0.72	5.82e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2839186	0.934	rs17182538	chr21:47705673	C/A	cg13012494	chr21:47604986	C21orf56	0.68	5.66	0.54	2.41e-7	Testicular germ cell tumor;
SKCM	cis	rs28386778	0.897	rs8067102	chr17:61848779	C/G	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs9926296	0.585	rs4785595	chr16:89835521	C/T	cg27121462	chr16:89883253	FANCA	-0.79	-7.0	-0.62	8.03e-10	Vitiligo;
SKCM	cis	rs760762	0.506	rs6129760	chr20:39746403	A/G	cg06424997	chr20:39929561	ZHX3	0.6	4.97	0.49	3.85e-6	Age-related diseases, mortality and associated endophenotypes;Age-related disease endophenotypes;
SKCM	cis	rs910316	1.000	rs12435391	chr14:75601737	A/G	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.85e-7	Height;
SKCM	cis	rs992157	0.798	rs2382817	chr2:219151218	A/C	cg20019365	chr2:219134978	PNKD;AAMP	0.71	6.08	0.57	4.22e-8	Colorectal cancer;
SKCM	cis	rs2013441	1.000	rs2703792	chr17:20166950	G/A	cg13482628	chr17:19912719	NA	-0.64	-5.04	-0.5	2.94e-6	Obesity-related traits;
SKCM	cis	rs28595532	0.920	rs115994240	chr4:119744622	C/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs11098499	0.909	rs71614422	chr4:120359340	G/A	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs992157	0.965	rs62182826	chr2:219148723	C/A	cg20019365	chr2:219134978	PNKD;AAMP	0.75	6.84	0.61	1.58e-9	Colorectal cancer;
SKCM	cis	rs2204008	0.682	rs2320517	chr12:38259239	A/T	cg26384229	chr12:38710491	ALG10B	0.87	6.83	0.61	1.63e-9	Bladder cancer;
SKCM	cis	rs7618501	0.633	rs2008877	chr3:50162291	T/G	cg24110177	chr3:50126178	RBM5	0.6	5.21	0.51	1.51e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs6598955	0.614	rs1134584	chr1:26608828	G/A	cg04990556	chr1:26633338	UBXN11	-0.59	-4.9	-0.49	5.01e-6	Obesity-related traits;
SKCM	cis	rs17376456	0.877	rs10060462	chr5:93455073	C/T	cg21475434	chr5:93447410	FAM172A	0.97	5.42	0.52	6.39e-7	Diabetic retinopathy;
SKCM	cis	rs6879260	0.963	rs11748619	chr5:179727399	C/G	cg23221052	chr5:179740743	GFPT2	-0.73	-5.75	-0.55	1.68e-7	Height;
SKCM	cis	rs9583531	0.600	rs4773240	chr13:111360585	G/A	cg24331049	chr13:111365604	ING1	0.88	6.6	0.6	4.45e-9	Coronary artery disease;
SKCM	cis	rs3091242	0.967	rs1053438	chr1:25687901	T/C	cg02931644	chr1:25747376	RHCE	-0.5	-4.96	-0.49	4.1e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs1577917	0.916	rs12206726	chr6:86499716	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.38	-0.52	7.52e-7	Response to antipsychotic treatment;
SKCM	cis	rs9814567	1.000	rs7648990	chr3:134244390	T/G	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs10504229	1.000	rs17216957	chr8:58179893	C/T	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs2836974	0.799	rs13047550	chr21:40515495	T/C	cg11644478	chr21:40555479	PSMG1	1.0	10.55	0.77	1.11e-16	Cognitive function;
SKCM	cis	rs56235845	0.694	rs11738681	chr5:176761535	A/G	cg17509989	chr5:176798049	RGS14	0.68	5.79	0.55	1.42e-7	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs12142240	0.698	rs56344958	chr1:46814518	G/A	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs2075671	0.903	rs4727459	chr7:100276821	T/C	cg20848291	chr7:100343083	ZAN	-0.71	-5.38	-0.52	7.64e-7	Other erythrocyte phenotypes;
SKCM	cis	rs9368481	0.743	rs9368480	chr6:26955750	A/C	cg12292205	chr6:26970375	C6orf41	0.7	6.31	0.58	1.54e-8	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs9300255	0.510	rs1790086	chr12:123672518	A/G	cg00376283	chr12:123451042	ABCB9	0.85	5.4	0.52	6.89e-7	Neutrophil percentage of white cells;
SKCM	cis	rs796364	1.000	rs769949	chr2:200729558	A/G	cg12253985	chr2:200820533	C2orf60;C2orf47	0.85	5.39	0.52	7.18e-7	Schizophrenia;
SKCM	cis	rs826838	0.933	rs1906263	chr12:38653362	T/C	cg26384229	chr12:38710491	ALG10B	0.95	7.92	0.67	1.32e-11	Heart rate;
SKCM	cis	rs1577917	0.559	rs1173418	chr6:86402916	G/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.66	5.69	0.54	2.15e-7	Response to antipsychotic treatment;
SKCM	cis	rs7945705	0.902	rs10769980	chr11:9014180	G/A	cg13070366	chr11:9386451	NA	-0.62	-5.25	-0.51	1.3e-6	Hemoglobin concentration;
SKCM	cis	rs1801251	1.000	rs11676216	chr2:233706368	C/T	cg25237894	chr2:233734115	C2orf82	-0.61	-5.9	-0.56	8.76e-8	Coronary artery disease;
SKCM	cis	rs10911232	0.507	rs10737239	chr1:183030170	A/C	ch.1.3577855R	chr1:183094577	LAMC1	0.77	6.89	0.62	1.27e-9	Hypertriglyceridemia;
SKCM	cis	rs1005277	0.522	rs289648	chr10:37971837	T/C	cg25427524	chr10:38739819	LOC399744	-0.61	-6.06	-0.57	4.6e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs523522	0.962	rs11065154	chr12:120971417	T/C	cg12219531	chr12:120966889	COQ5	0.91	7.82	0.66	2.11e-11	High light scatter reticulocyte count;
SKCM	cis	rs8180040	1.000	rs1638676	chr3:47327651	A/G	cg16586182	chr3:47516702	SCAP	-0.71	-4.85	-0.48	6.25e-6	Colorectal cancer;
SKCM	cis	rs875971	0.964	rs9691480	chr7:65944306	A/C	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs2153535	0.580	rs2327061	chr6:8447231	G/C	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs9902453	0.874	rs7220004	chr17:28369548	G/T	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.82	-6.4	-0.59	1.06e-8	Coffee consumption (cups per day);
SKCM	cis	rs9911578	1.000	rs12952832	chr17:56906254	T/C	cg05425664	chr17:57184151	TRIM37	-0.67	-5.04	-0.5	2.91e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs3213545	0.700	rs10849829	chr12:121470256	A/G	cg02403541	chr12:121454288	C12orf43	-0.73	-6.18	-0.57	2.77e-8	Subjective well-being;Cardiovascular disease risk factors;
SKCM	cis	rs9910055	0.529	rs228765	chr17:42186422	C/T	cg19774624	chr17:42201019	HDAC5	0.81	6.39	0.59	1.12e-8	Total body bone mineral density;
SKCM	cis	rs7584330	0.666	rs72620817	chr2:238353661	C/T	cg14458575	chr2:238380390	NA	1.13	7.24	0.63	2.7e-10	Prostate cancer;
SKCM	cis	rs7959452	0.590	rs11177643	chr12:69785712	T/G	cg14784868	chr12:69753453	YEATS4	0.8	7.6	0.65	5.66e-11	Blood protein levels;
SKCM	trans	rs1814175	0.817	rs10769641	chr11:49960141	A/G	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs4253772	0.637	rs41279831	chr22:46651623	T/C	cg03482458	chr22:46692211	CN5H6.4;GTSE1	1.18	5.01	0.49	3.31e-6	LDL cholesterol;Cholesterol, total;
SKCM	cis	rs644799	0.525	rs3016206	chr11:95536724	T/C	cg03916912	chr11:95522834	CEP57;FAM76B	0.8	6.71	0.6	2.8e-9	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs9921222	0.632	rs11649268	chr16:398643	A/C	cg12437481	chr16:420112	MRPL28	-0.67	-6.22	-0.58	2.25e-8	Bone mineral density (spine);Bone mineral density;
SKCM	cis	rs2857078	0.654	rs9896789	chr17:42314567	C/T	cg19774624	chr17:42201019	HDAC5	-0.76	-5.69	-0.54	2.12e-7	Red cell distribution width;Reticulocyte count;
SKCM	cis	rs17376456	0.877	rs10059230	chr5:93450347	A/G	cg25358565	chr5:93447407	FAM172A	1.23	7.97	0.67	1.08e-11	Diabetic retinopathy;
SKCM	cis	rs28595532	1.000	rs28600971	chr4:119712728	G/T	cg21605333	chr4:119757512	SEC24D	1.35	7.92	0.67	1.37e-11	Cannabis dependence symptom count;
SKCM	cis	rs951366	0.789	rs823094	chr1:205689807	G/T	cg07157834	chr1:205819609	PM20D1	-0.72	-6.51	-0.59	6.7e-9	Menarche (age at onset);
SKCM	cis	rs8067545	0.611	rs2526477	chr17:20131193	A/G	cg13482628	chr17:19912719	NA	-0.66	-5.59	-0.53	3.23e-7	Schizophrenia;
SKCM	cis	rs8077889	0.917	rs4793038	chr17:41916761	A/T	cg26893861	chr17:41843967	DUSP3	1.22	8.23	0.68	3.35e-12	Triglycerides;
SKCM	cis	rs9303401	0.573	rs35104446	chr17:57180234	A/C	cg10487724	chr17:56770010	TEX14;RAD51C	0.79	4.97	0.49	3.86e-6	Cognitive test performance;
SKCM	cis	rs72792276	1.000	rs72794386	chr5:127479278	A/T	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.78	5.21	0.51	1.5e-6	Red cell distribution width;
SKCM	cis	rs651907	1.000	rs665211	chr3:101600028	C/T	cg12386194	chr3:101231763	SENP7	0.64	4.96	0.49	4e-6	Colorectal cancer;
SKCM	cis	rs2239547	0.657	rs12488303	chr3:52862003	G/A	cg11645453	chr3:52864694	ITIH4	0.79	7.19	0.63	3.41e-10	Schizophrenia;
SKCM	cis	rs7635838	0.617	rs13071193	chr3:11284226	G/T	cg00170343	chr3:11313890	ATG7	-0.76	-5.87	-0.55	9.89e-8	HDL cholesterol;
SKCM	cis	rs11252926	0.537	rs4881274	chr10:459940	G/A	cg18196295	chr10:418757	DIP2C	0.62	5.04	0.5	2.93e-6	Psychosis in Alzheimer's disease;
SKCM	cis	rs870825	0.860	rs72703521	chr4:185603080	T/C	cg04058563	chr4:185651563	MLF1IP	1.04	5.96	0.56	7.02e-8	Blood protein levels;
SKCM	cis	rs7091068	0.550	rs7901909	chr10:95492508	C/T	cg20715218	chr10:95462985	C10orf4	0.76	7.27	0.64	2.38e-10	Urinary tract infection frequency;
SKCM	cis	rs798554	0.679	rs7784066	chr7:2819727	T/A	cg19346786	chr7:2764209	NA	-0.66	-7.28	-0.64	2.32e-10	Height;
SKCM	cis	rs3768617	0.510	rs2027076	chr1:183073407	C/A	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs244731	0.959	rs6556307	chr5:176641434	C/T	cg16006841	chr5:176797999	RGS14	0.77	6.44	0.59	8.9e-9	Urate levels in lean individuals;
SKCM	cis	rs8017423	0.647	rs12589952	chr14:90821364	T/C	cg04374321	chr14:90722782	PSMC1	-0.73	-5.53	-0.53	4.12e-7	Mortality in heart failure;
SKCM	cis	rs12824058	0.844	rs10744458	chr12:130805820	C/T	cg26677194	chr12:130822605	PIWIL1	-0.65	-5.72	-0.54	1.85e-7	Menopause (age at onset);
SKCM	cis	rs854765	0.583	rs4925130	chr17:17807858	G/A	cg04398451	chr17:18023971	MYO15A	-0.79	-5.68	-0.54	2.19e-7	Total body bone mineral density;
SKCM	cis	rs7208859	0.623	rs11657990	chr17:29124200	C/T	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs3780486	0.846	rs3780490	chr9:33129839	A/G	cg13443165	chr9:33130375	B4GALT1	-0.55	-4.99	-0.49	3.65e-6	IgG glycosylation;
SKCM	cis	rs17376456	0.825	rs7715562	chr5:93222034	C/T	cg25358565	chr5:93447407	FAM172A	-1.19	-7.78	-0.66	2.52e-11	Diabetic retinopathy;
SKCM	cis	rs9682041	0.935	rs11923053	chr3:170095281	T/C	cg11886554	chr3:170076028	SKIL	0.93	5.5	0.53	4.62e-7	Glomerular filtration rate in non diabetics (creatinine);Glomerular filtration rate (creatinine);
SKCM	cis	rs12477438	0.501	rs12613624	chr2:99732741	A/G	cg14399236	chr2:99771627	LIPT1;TSGA10	-0.93	-8.32	-0.69	2.22e-12	Chronic sinus infection;
SKCM	cis	rs7666738	0.830	rs7657179	chr4:98948569	G/A	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs875971	0.628	rs6974355	chr7:65841981	A/G	cg11764359	chr7:65958608	NA	0.82	6.26	0.58	1.9e-8	Aortic root size;
SKCM	cis	rs6835098	0.692	rs7657374	chr4:174065756	A/T	cg08422745	chr4:174089978	GALNT7	-0.82	-6.66	-0.6	3.45e-9	Dementia and core Alzheimer's disease neuropathologic changes;
SKCM	cis	rs3892630	0.824	rs35654350	chr19:33223766	T/C	cg22980127	chr19:33182716	NUDT19	1.36	7.75	0.66	2.87e-11	Red blood cell traits;
SKCM	cis	rs8180040	1.000	rs1024037	chr3:47318449	C/A	cg16586182	chr3:47516702	SCAP	0.73	4.95	0.49	4.23e-6	Colorectal cancer;
SKCM	cis	rs6951245	1.000	rs28399710	chr7:1070631	G/T	cg21664854	chr7:1097933	C7orf50;GPR146	0.89	4.79	0.48	7.66e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs875971	0.516	rs6945322	chr7:65336056	T/C	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.61	5.06	0.5	2.75e-6	Aortic root size;
SKCM	cis	rs4683346	0.964	rs13068402	chr3:42875756	T/C	cg06399164	chr3:42695035	ZBTB47	0.61	5.53	0.53	4.18e-7	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs9513627	0.920	rs2390280	chr13:100208802	A/G	cg11288260	chr13:100117058	NA	0.79	4.78	0.48	8.1e-6	Obesity-related traits;
SKCM	cis	rs2033711	0.870	rs1051500	chr19:58944402	A/G	cg00825309	chr19:58991885	ZNF446	-0.69	-5.6	-0.54	3.08e-7	Uric acid clearance;
SKCM	cis	rs9467773	1.000	rs3736781	chr6:26505362	G/A	cg09904177	chr6:26538194	HMGN4	0.55	5.03	0.49	3.11e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs6500395	0.963	rs6500404	chr16:48690083	C/T	cg04672837	chr16:48644449	N4BP1	-0.65	-5.43	-0.52	6.29e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs3793683	0.597	rs12783367	chr10:134587334	T/C	cg00988841	chr10:134556463	INPP5A	0.61	4.78	0.48	8.12e-6	Migraine;
SKCM	cis	rs826838	0.967	rs1719856	chr12:39127201	C/T	cg26384229	chr12:38710491	ALG10B	-0.97	-8.93	-0.71	1.48e-13	Heart rate;
SKCM	cis	rs4975616	0.869	rs455433	chr5:1336243	A/G	cg07493874	chr5:1342172	CLPTM1L	-0.7	-6.57	-0.6	5.12e-9	Lung cancer;
SKCM	cis	rs9467773	0.620	rs2494701	chr6:26634432	C/T	cg15659132	chr6:26577336	NA	0.62	5.4	0.52	6.91e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs35146811	0.735	rs11767968	chr7:99790971	G/A	cg22906224	chr7:99728672	NA	0.65	5.19	0.51	1.6e-6	Coronary artery disease;
SKCM	cis	rs2075671	0.808	rs75949939	chr7:100256671	A/C	cg16850897	chr7:100343110	ZAN	-0.67	-4.91	-0.49	4.94e-6	Other erythrocyte phenotypes;
SKCM	cis	rs6087990	1.000	rs1007124	chr20:31345752	G/C	cg13636640	chr20:31349939	DNMT3B	0.91	7.99	0.67	9.7e-12	Ulcerative colitis;
SKCM	cis	rs992157	0.698	rs6746089	chr2:219170377	A/G	cg00012203	chr2:219082015	ARPC2	0.73	5.72	0.54	1.84e-7	Colorectal cancer;
SKCM	cis	rs1499614	0.831	rs3800822	chr7:66147149	A/G	cg18252515	chr7:66147081	NA	1.34	8.18	0.68	4.2e-12	Gout;
SKCM	cis	rs362272	0.545	rs2236052	chr4:3318413	C/T	cg09735869	chr4:3319127	RGS12	-0.95	-11.3	-0.79	4.3e-18	Serum sulfate level;
SKCM	cis	rs7843479	0.601	rs11780532	chr8:21838670	T/A	cg17168535	chr8:21777572	XPO7	0.85	8.37	0.69	1.8e-12	Mean corpuscular volume;
SKCM	cis	rs710865	1.000	rs710865	chr1:19568972	A/G	cg13387374	chr1:19411106	UBR4	0.64	4.83	0.48	6.75e-6	Brain structure;
SKCM	cis	rs28595532	0.688	rs116580819	chr4:119767362	T/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs58688157	0.705	rs7112149	chr11:595890	G/A	cg03576123	chr11:487126	PTDSS2	-0.79	-5.08	-0.5	2.52e-6	Systemic lupus erythematosus;
SKCM	cis	rs35306767	0.953	rs12259801	chr10:959306	C/G	cg25614935	chr10:1084866	C10orf110	0.67	4.85	0.48	6.07e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs9486715	1.000	rs11153085	chr6:97066355	A/T	cg06623918	chr6:96969491	KIAA0776	-0.74	-6.6	-0.6	4.58e-9	Headache;
SKCM	cis	rs9880211	0.800	rs9845862	chr3:136472573	T/C	cg21827317	chr3:136751795	NA	-0.7	-5.43	-0.52	6.12e-7	Body mass index;Height;
SKCM	cis	rs28595532	0.920	rs56302493	chr4:119772382	A/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs477895	0.838	rs12794145	chr11:64006484	C/T	cg07220939	chr11:64358617	SLC22A12	0.72	4.77	0.48	8.37e-6	Mean platelet volume;
SKCM	cis	rs2836950	0.545	rs11700813	chr21:40517469	T/G	cg11644478	chr21:40555479	PSMG1	-0.7	-5.34	-0.52	8.88e-7	Menarche (age at onset);
SKCM	cis	rs11112613	0.775	rs10778413	chr12:105962118	G/A	cg03607813	chr12:105948248	NA	0.88	6.01	0.56	5.5e-8	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;
SKCM	cis	rs34779708	0.931	rs35997236	chr10:35376690	C/T	cg03585969	chr10:35415529	CREM	0.78	6.31	0.58	1.58e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs9303401	0.659	rs66514313	chr17:56714057	C/T	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.16	0.57	2.91e-8	Cognitive test performance;
SKCM	cis	rs9896933	0.830	rs113051447	chr17:80791806	A/G	cg20578329	chr17:80767326	TBCD	-0.94	-6.51	-0.59	6.62e-9	Bone mineral accretion in asthma (oral corticosteroid dose interaction);
SKCM	cis	rs9611565	0.694	rs202616	chr22:41822221	C/G	cg03806693	chr22:41940476	POLR3H	1.13	7.36	0.64	1.63e-10	Vitiligo;
SKCM	cis	rs754466	0.651	rs56138814	chr10:79625795	T/C	cg17075019	chr10:79541650	NA	-0.73	-6.45	-0.59	8.46e-9	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs67311347	0.544	rs6787516	chr3:40355616	C/T	cg00656387	chr3:40428638	ENTPD3	0.55	4.77	0.48	8.39e-6	Renal cell carcinoma;
SKCM	cis	rs362296	0.511	rs2857861	chr4:3323767	C/T	cg00764545	chr4:3318001	RGS12	0.81	8.91	0.71	1.64e-13	Parental longevity (mother's age at death);
SKCM	cis	rs4740619	0.607	rs1169478	chr9:15895539	T/C	cg14451791	chr9:16040625	NA	0.41	4.8	0.48	7.64e-6	Body mass index;
SKCM	cis	rs36093844	0.699	rs4015260	chr11:85558887	T/C	cg25872744	chr11:85566296	CCDC83	-0.85	-4.77	-0.48	8.27e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs2439831	0.867	rs2251844	chr15:43836478	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.18	7.32	0.64	1.95e-10	Lung cancer in ever smokers;
SKCM	cis	rs501916	0.605	rs8031169	chr15:48080330	G/C	cg16110827	chr15:48056943	SEMA6D	-0.62	-4.79	-0.48	7.7e-6	Inflammatory bowel disease;Ulcerative colitis;
SKCM	cis	rs7811142	1.000	rs76913697	chr7:100002772	A/G	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.27	0.68	2.87e-12	Platelet count;
SKCM	cis	rs4819052	1.000	rs13053002	chr21:46677854	C/T	cg02159808	chr21:46707872	POFUT2;LOC642852	0.84	6.26	0.58	1.91e-8	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs476633	0.573	rs6492995	chr15:41529712	T/C	cg18705301	chr15:41695430	NDUFAF1	-0.73	-5.86	-0.55	1.06e-7	Glomerular filtration rate (creatinine);
SKCM	cis	rs9611565	0.580	rs5758449	chr22:42140160	C/T	cg03806693	chr22:41940476	POLR3H	0.84	5.47	0.53	5.32e-7	Vitiligo;
SKCM	cis	rs654950	0.934	rs638859	chr1:42001444	A/G	cg06885757	chr1:42089581	HIVEP3	0.59	5.25	0.51	1.29e-6	Airway imaging phenotypes;
SKCM	cis	rs9611565	0.659	rs116959331	chr22:41932774	A/G	cg03806693	chr22:41940476	POLR3H	-1.11	-7.56	-0.65	6.67e-11	Vitiligo;
SKCM	cis	rs910316	1.000	rs10136948	chr14:75511075	C/T	cg08847533	chr14:75593920	NEK9	0.95	9.18	0.72	4.92e-14	Height;
SKCM	cis	rs2839186	1.000	rs2839186	chr21:47690068	C/T	cg13012494	chr21:47604986	C21orf56	0.67	5.78	0.55	1.44e-7	Testicular germ cell tumor;
SKCM	cis	rs3741404	0.560	rs17699798	chr11:63898806	C/G	cg05555928	chr11:63887634	MACROD1	0.79	5.13	0.5	2.07e-6	Platelet count;
SKCM	cis	rs67311347	0.544	rs9814779	chr3:40340431	T/C	cg13409248	chr3:40428643	ENTPD3	0.57	5.57	0.53	3.48e-7	Renal cell carcinoma;
SKCM	cis	rs6724607	1.000	rs28452331	chr2:191471847	C/T	cg21644426	chr2:191273491	MFSD6	-0.68	-4.79	-0.48	7.67e-6	Pulse pressure;
SKCM	cis	rs55962025	0.855	rs6855981	chr4:3148276	A/G	cg21096898	chr4:3318625	RGS12	0.63	5.26	0.51	1.24e-6	Parental longevity (mother's age at death);
SKCM	cis	rs873946	0.564	rs12263364	chr10:134555548	G/T	cg26818010	chr10:134567672	INPP5A	-0.71	-5.52	-0.53	4.37e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs9790314	0.846	rs4470535	chr3:160974468	G/A	cg03342759	chr3:160939853	NMD3	-0.72	-7.96	-0.67	1.13e-11	Morning vs. evening chronotype;
SKCM	cis	rs10504229	0.953	rs6990806	chr8:58183113	G/A	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs1325195	0.568	rs17362081	chr1:179092741	A/C	cg25467746	chr1:179556597	NA	-0.67	-6.1	-0.57	3.87e-8	IgE grass sensitization;
SKCM	cis	rs826838	0.967	rs1684411	chr12:39128494	C/T	cg26384229	chr12:38710491	ALG10B	-0.92	-8.32	-0.69	2.26e-12	Heart rate;
SKCM	cis	rs1552244	1.000	rs6789156	chr3:10124120	C/T	cg02579736	chr3:10068473	FANCD2;CIDECP	1.23	6.92	0.62	1.13e-9	Alzheimer's disease;
SKCM	cis	rs4803468	1.000	rs55986560	chr19:41939835	C/T	cg09537434	chr19:41945824	ATP5SL	1.1	13.21	0.83	1.39e-21	Height;
SKCM	cis	rs4268898	0.636	rs72787385	chr2:24585820	G/A	cg06627628	chr2:24431161	ITSN2	-0.9	-6.93	-0.62	1.07e-9	Asthma;
SKCM	cis	rs2404602	0.647	rs4886837	chr15:77156417	A/G	cg23625390	chr15:77176239	SCAPER	-0.85	-8.34	-0.69	2.02e-12	Blood metabolite levels;
SKCM	cis	rs9303401	0.527	rs2116450	chr17:56745561	C/T	cg10487724	chr17:56770010	TEX14;RAD51C	0.83	5.82	0.55	1.22e-7	Cognitive test performance;
SKCM	cis	rs7208859	0.673	rs9912122	chr17:29140716	C/A	cg14067834	chr17:29058358	SUZ12P	0.98	5.1	0.5	2.3e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs17608059	0.710	rs8080167	chr17:13949828	G/A	cg27005118	chr17:13972210	COX10	-0.42	-4.9	-0.48	5.19e-6	Temperament;
SKCM	cis	rs2455601	0.638	rs3815991	chr11:9007669	A/G	cg21881798	chr11:8931708	C11orf17;ST5	0.83	6.02	0.56	5.45e-8	Schizophrenia;
SKCM	cis	rs8180040	0.966	rs13079098	chr3:47442863	A/G	cg16586182	chr3:47516702	SCAP	-0.76	-5.32	-0.52	9.63e-7	Colorectal cancer;
SKCM	cis	rs17376456	1.000	rs59472588	chr5:93511981	A/G	cg21475434	chr5:93447410	FAM172A	0.99	5.65	0.54	2.49e-7	Diabetic retinopathy;
SKCM	trans	rs62103177	0.733	rs62103232	chr18:77635553	G/A	cg05926928	chr17:57297772	GDPD1	1.3	8.9	0.71	1.67e-13	Opioid sensitivity;
SKCM	cis	rs1799949	1.000	rs915945	chr17:41179864	C/T	cg23758822	chr17:41437982	NA	0.91	7.51	0.65	8.13e-11	Menopause (age at onset);
SKCM	cis	rs9910055	0.552	rs12937114	chr17:42325073	A/G	cg19774624	chr17:42201019	HDAC5	-0.79	-5.63	-0.54	2.78e-7	Total body bone mineral density;
SKCM	cis	rs9902453	0.900	rs12451122	chr17:28486376	T/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.5	0.53	4.74e-7	Coffee consumption (cups per day);
SKCM	cis	rs67311347	0.544	rs9864601	chr3:40345318	C/T	cg13409248	chr3:40428643	ENTPD3	0.58	5.61	0.54	2.98e-7	Renal cell carcinoma;
SKCM	cis	rs9640161	0.830	rs7800196	chr7:150061534	C/G	cg10018233	chr7:150070692	REPIN1	0.75	7.27	0.64	2.44e-10	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs7932354	0.528	rs10466478	chr11:47162604	A/C	cg03339077	chr11:47165057	C11orf49	-0.6	-5.17	-0.51	1.75e-6	Bone mineral density (hip);Bone mineral density;
SKCM	cis	rs919433	0.889	rs787998	chr2:198216092	A/G	cg04278110	chr2:198063759	ANKRD44	0.73	4.99	0.49	3.61e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs1799949	1.000	rs2175957	chr17:41286822	T/G	cg23758822	chr17:41437982	NA	0.92	7.8	0.66	2.3e-11	Menopause (age at onset);
SKCM	cis	rs453301	0.507	rs2929306	chr8:9084909	C/T	cg15556689	chr8:8085844	FLJ10661	-0.66	-5.0	-0.49	3.45e-6	Joint mobility (Beighton score);
SKCM	cis	rs9640161	0.659	rs11975886	chr7:150010362	G/A	cg10018233	chr7:150070692	REPIN1	0.7	5.68	0.54	2.21e-7	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs9640161	0.789	rs1464752	chr7:150021284	C/T	cg10018233	chr7:150070692	REPIN1	0.75	6.05	0.56	4.81e-8	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs910316	0.967	rs2024653	chr14:75595154	G/A	cg08847533	chr14:75593920	NEK9	0.95	9.18	0.72	4.8e-14	Height;
SKCM	cis	rs56104184	0.725	rs4347731	chr19:49385154	A/G	cg15549821	chr19:49342101	PLEKHA4	-0.9	-4.97	-0.49	3.86e-6	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs8133974	0.941	rs73205318	chr21:36478059	G/A	cg00621029	chr21:35747559	FAM165B	0.71	4.87	0.48	5.72e-6	Eosinophil counts;Eosinophil percentage of granulocytes;Sum eosinophil basophil counts;
SKCM	cis	rs9611565	0.659	rs12484694	chr22:41919330	A/G	cg03806693	chr22:41940476	POLR3H	-1.11	-7.56	-0.65	6.67e-11	Vitiligo;
SKCM	cis	rs2404602	0.684	rs62026898	chr15:76944371	C/A	cg23625390	chr15:77176239	SCAPER	-0.83	-7.91	-0.67	1.39e-11	Blood metabolite levels;
SKCM	cis	rs9300255	0.722	rs1060105	chr12:123806219	C/T	cg00376283	chr12:123451042	ABCB9	-0.78	-5.26	-0.51	1.24e-6	Neutrophil percentage of white cells;
SKCM	cis	rs10504229	0.906	rs111838497	chr8:58185620	A/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs11252926	0.528	rs11252090	chr10:436547	C/T	cg18196295	chr10:418757	DIP2C	-0.59	-5.21	-0.51	1.48e-6	Psychosis in Alzheimer's disease;
SKCM	cis	rs6866344	0.697	rs11739893	chr5:178127837	G/A	cg10224037	chr5:178157518	ZNF354A	0.75	4.92	0.49	4.75e-6	Neutrophil percentage of white cells;
SKCM	cis	rs7659604	0.540	rs10020581	chr4:122676559	A/C	cg19671926	chr4:122722719	EXOSC9	0.77	6.27	0.58	1.89e-8	Type 2 diabetes;
SKCM	cis	rs8170	0.603	rs1544940	chr19:17414843	A/T	cg07830086	chr19:18107778	KCNN1	-0.82	-5.17	-0.51	1.77e-6	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Ovarian cancer;Breast cancer;Epithelial ovarian cancer;
SKCM	cis	rs28374715	0.681	rs28728213	chr15:41653602	T/A	cg18705301	chr15:41695430	NDUFAF1	-1.05	-10.64	-0.77	7.53e-17	Ulcerative colitis;
SKCM	cis	rs11098499	0.954	rs59866101	chr4:120296591	T/G	cg24375607	chr4:120327624	NA	0.65	4.97	0.49	3.87e-6	Corneal astigmatism;
SKCM	cis	rs2286503	0.839	rs1054471	chr7:22852643	T/A	cg15401507	chr7:22894281	NA	-0.57	-5.57	-0.53	3.5e-7	Fibrinogen;
SKCM	cis	rs4689592	0.546	rs2359012	chr4:7066053	A/C	cg26116260	chr4:7069785	GRPEL1	1.21	9.41	0.73	1.73e-14	Monocyte percentage of white cells;
SKCM	cis	rs950776	0.518	rs4887062	chr15:78837801	G/A	cg06917634	chr15:78832804	PSMA4	-0.99	-10.16	-0.75	6.17e-16	Sudden cardiac arrest;
SKCM	cis	rs807669	0.903	rs1780642	chr22:19170604	T/C	cg02655711	chr22:19163373	SLC25A1	0.78	7.22	0.63	3.03e-10	Metabolite levels;
SKCM	cis	rs28595532	0.920	rs114928651	chr4:119734194	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.52	0.53	4.28e-7	Cannabis dependence symptom count;
SKCM	cis	rs875971	0.895	rs10447522	chr7:65796074	A/G	cg11764359	chr7:65958608	NA	-0.74	-6.75	-0.61	2.36e-9	Aortic root size;
SKCM	cis	rs13108904	0.875	rs10024013	chr4:1280792	C/T	cg05025164	chr4:1340916	KIAA1530	-0.6	-4.82	-0.48	6.9e-6	Obesity-related traits;
SKCM	cis	rs9916302	0.629	rs9972882	chr17:37807698	A/C	cg20243544	chr17:37824526	PNMT	0.77	5.93	0.56	7.85e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs7786877	0.680	rs28584500	chr7:100216341	G/A	cg16850897	chr7:100343110	ZAN	-0.64	-4.84	-0.48	6.46e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs854765	0.583	rs9904163	chr17:17830553	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.0	7.64	0.65	4.64e-11	Total body bone mineral density;
SKCM	cis	rs3091242	0.933	rs28530483	chr1:25740847	A/C	cg27572855	chr1:25598939	RHD	0.53	5.1	0.5	2.28e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs17376456	0.741	rs7718842	chr5:93480568	G/A	cg25358565	chr5:93447407	FAM172A	1.23	7.97	0.67	1.08e-11	Diabetic retinopathy;
SKCM	cis	rs875971	0.862	rs7783779	chr7:65796626	A/G	cg18876405	chr7:65276391	NA	-0.64	-6.42	-0.59	9.88e-9	Aortic root size;
SKCM	cis	rs4891159	0.790	rs17059325	chr18:74119567	A/C	cg24786174	chr18:74118243	ZNF516	-0.69	-6.38	-0.59	1.17e-8	Longevity;
SKCM	cis	rs9790314	1.000	rs336548	chr3:161058412	T/C	cg03342759	chr3:160939853	NMD3	-0.72	-7.87	-0.67	1.65e-11	Morning vs. evening chronotype;
SKCM	cis	rs4927850	0.794	rs4927849	chr3:195738482	A/G	cg01181863	chr3:195395398	SDHAP2	-1.02	-6.94	-0.62	1.01e-9	Pancreatic cancer;
SKCM	cis	rs8067545	0.611	rs2042046	chr17:20018841	A/G	cg13482628	chr17:19912719	NA	0.66	5.48	0.53	5.1e-7	Schizophrenia;
SKCM	cis	rs6570726	1.000	rs436066	chr6:145847127	C/T	cg23711669	chr6:146136114	FBXO30	0.73	6.93	0.62	1.07e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7959452	0.557	rs899224	chr12:69784774	A/G	cg20891283	chr12:69753455	YEATS4	0.93	9.67	0.74	5.4e-15	Blood protein levels;
SKCM	cis	rs1691799	0.836	rs1184552	chr12:66756215	A/G	cg16791601	chr12:66731901	HELB	-0.63	-5.72	-0.54	1.89e-7	White blood cell count (basophil);
SKCM	cis	rs9910055	0.659	rs7214540	chr17:42256604	A/G	cg19774624	chr17:42201019	HDAC5	-0.87	-8.15	-0.68	4.72e-12	Total body bone mineral density;
SKCM	cis	rs7843479	0.544	rs7839925	chr8:21792983	G/C	cg17168535	chr8:21777572	XPO7	0.75	6.9	0.62	1.2e-9	Mean corpuscular volume;
SKCM	cis	rs7666738	0.791	rs1115615	chr4:99006614	G/A	cg17366294	chr4:99064904	C4orf37	0.59	4.89	0.48	5.25e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs634534	0.561	rs655744	chr11:65776585	G/T	cg02427764	chr11:65769310	BANF1;EIF1AD	-0.79	-5.96	-0.56	6.81e-8	Sum eosinophil basophil counts;Eosinophil counts;
SKCM	cis	rs12497850	0.931	rs6446253	chr3:48911443	C/T	cg07636037	chr3:49044803	WDR6	1.01	10.82	0.77	3.36e-17	Parkinson's disease;
SKCM	cis	rs2075371	0.501	rs1646653	chr7:134024686	A/G	cg20476274	chr7:133979776	SLC35B4	0.84	7.08	0.63	5.65e-10	Mean platelet volume;
SKCM	cis	rs1801251	1.000	rs283469	chr2:233656997	G/T	cg25237894	chr2:233734115	C2orf82	0.64	6.08	0.57	4.21e-8	Coronary artery disease;
SKCM	cis	rs11098499	0.604	rs2389887	chr4:120570644	T/C	cg09307838	chr4:120376055	NA	1.01	8.35	0.69	2.01e-12	Corneal astigmatism;
SKCM	cis	rs34779708	0.966	rs113170867	chr10:35450147	C/T	cg03585969	chr10:35415529	CREM	0.74	5.9	0.56	8.94e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs362272	0.524	rs3129334	chr4:3368526	T/C	cg05297308	chr4:3317976	RGS12	1.02	12.39	0.81	4.11e-20	Serum sulfate level;
SKCM	trans	rs1814175	0.817	rs12287396	chr11:49819798	G/C	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs2760061	0.569	rs621631	chr1:228114728	A/G	cg02753203	chr1:228287806	NA	-0.63	-4.96	-0.49	3.99e-6	Diastolic blood pressure;
SKCM	cis	rs7590368	1.000	rs55968911	chr2:10961840	C/T	cg15705551	chr2:10952987	PDIA6	0.76	4.88	0.48	5.52e-6	Educational attainment (years of education);
SKCM	cis	rs2070488	0.965	rs6599206	chr3:38545349	C/T	cg01465620	chr3:38496096	LOC100128640;ACVR2B	-0.99	-9.17	-0.72	4.99e-14	Electrocardiographic conduction measures;
SKCM	cis	rs4746818	0.901	rs10740317	chr10:70937566	G/A	cg11621586	chr10:70884670	VPS26A	0.86	5.43	0.52	6.29e-7	Left atrial antero-posterior diameter;
SKCM	cis	rs1552244	1.000	rs56394721	chr3:10150795	A/G	cg02579736	chr3:10068473	FANCD2;CIDECP	1.23	6.92	0.62	1.13e-9	Alzheimer's disease;
SKCM	cis	rs6951245	1.000	rs113858334	chr7:1073476	A/G	cg21664854	chr7:1097933	C7orf50;GPR146	0.89	4.79	0.48	7.66e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs933688	1.000	rs12655973	chr5:90736537	A/G	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.07	8.69	0.7	4.41e-13	Smoking behavior;
SKCM	cis	rs4665809	0.590	rs13016807	chr2:26496186	G/C	cg26119090	chr2:26468346	HADHA;HADHB	1.08	8.63	0.7	5.67e-13	Gut microbiome composition (summer);
SKCM	cis	rs1568889	1.000	rs34140872	chr11:28335872	A/C	cg06544937	chr11:28130018	METT5D1;KIF18A	0.86	7.03	0.62	6.97e-10	Bipolar disorder;
SKCM	cis	rs798554	1.000	rs798562	chr7:2757938	C/T	cg14895029	chr7:2775587	GNA12	-0.67	-4.8	-0.48	7.38e-6	Height;
SKCM	cis	rs453301	0.571	rs2929453	chr8:9084341	A/G	cg06636001	chr8:8085503	FLJ10661	-0.76	-5.94	-0.56	7.5e-8	Joint mobility (Beighton score);
SKCM	cis	rs2733310	0.895	rs1657930	chr15:57120989	G/A	cg01857019	chr15:57210107	LOC145783;TCF12	0.68	4.82	0.48	6.9e-6	Mean platelet volume;
SKCM	cis	rs2032447	0.714	rs129129	chr6:25961029	A/G	cg18357526	chr6:26021779	HIST1H4A	0.68	5.14	0.5	1.95e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs6977660	0.619	rs10263780	chr7:19778086	A/G	cg05791153	chr7:19748676	TWISTNB	-0.75	-5.28	-0.51	1.13e-6	Thyroid stimulating hormone;
SKCM	cis	rs55962025	0.883	rs61792530	chr4:3145866	T/C	cg09735869	chr4:3319127	RGS12	-0.73	-5.8	-0.55	1.36e-7	Parental longevity (mother's age at death);
SKCM	cis	rs7666738	0.830	rs35235971	chr4:98999833	G/T	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9371601	0.859	rs214978	chr6:152731398	A/C	cg25291603	chr6:152002969	NA	-0.44	-4.99	-0.49	3.61e-6	Bipolar disorder;Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);
SKCM	cis	rs2963155	0.518	rs258748	chr5:142656454	C/G	cg17617527	chr5:142782415	NR3C1	1.05	4.88	0.48	5.42e-6	Breast cancer;
SKCM	cis	rs2204008	0.627	rs10878486	chr12:38148601	T/G	cg13010199	chr12:38710504	ALG10B	0.68	4.97	0.49	3.89e-6	Bladder cancer;
SKCM	cis	rs6952808	0.609	rs6944877	chr7:1952582	T/G	cg21782813	chr7:2030301	MAD1L1	0.51	5.42	0.52	6.33e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs28386778	0.863	rs4968661	chr17:61796306	A/G	cg22520471	chr17:61851767	DDX42;CCDC47	0.77	5.16	0.5	1.81e-6	Prudent dietary pattern;
SKCM	cis	rs2721195	1.000	rs6599530	chr8:145677418	C/G	cg17328964	chr8:145687451	CYHR1	0.75	6.87	0.61	1.38e-9	Age at first birth;
SKCM	cis	rs9815354	0.638	rs76276404	chr3:41931770	A/G	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs4237845	0.804	rs10877034	chr12:58286444	T/C	cg02175503	chr12:58329896	NA	0.79	7.32	0.64	1.94e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs1669338	0.588	rs73009149	chr3:3220473	G/C	cg16797762	chr3:3221439	CRBN	-1.12	-6.48	-0.59	7.65e-9	White matter integrity;
SKCM	cis	rs2836974	0.932	rs35571600	chr21:40590624	A/C	cg17971929	chr21:40555470	PSMG1	0.9	8.81	0.71	2.52e-13	Cognitive function;
SKCM	cis	rs2841277	0.646	rs3742935	chr14:105405599	G/C	cg19901468	chr14:105411992	AHNAK2	-0.98	-7.76	-0.66	2.7e-11	Rheumatoid arthritis;
SKCM	cis	rs2153535	0.623	rs2152346	chr6:8454652	A/G	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs801193	0.967	rs2420827	chr7:66147101	G/A	cg18876405	chr7:65276391	NA	-0.8	-7.05	-0.62	6.21e-10	Aortic root size;
SKCM	cis	rs2228479	0.850	rs62056068	chr16:89909737	C/T	cg00800038	chr16:89945340	TCF25	-1.0	-5.06	-0.5	2.75e-6	Skin colour saturation;
SKCM	cis	rs1018697	0.518	rs284843	chr10:104553566	C/T	cg04362960	chr10:104952993	NT5C2	-0.76	-4.81	-0.48	7.14e-6	Colorectal adenoma (advanced);
SKCM	cis	rs826838	1.000	rs9795768	chr12:39012479	T/C	cg26384229	chr12:38710491	ALG10B	1.01	9.41	0.73	1.77e-14	Heart rate;
SKCM	cis	rs28595532	1.000	rs56225646	chr4:119651217	T/C	cg21605333	chr4:119757512	SEC24D	1.24	7.1	0.63	5.16e-10	Cannabis dependence symptom count;
SKCM	cis	rs1577917	0.958	rs1414199	chr6:86522370	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.81	-0.66	2.19e-11	Response to antipsychotic treatment;
SKCM	cis	rs6500395	0.963	rs961951	chr16:48716720	A/G	cg04672837	chr16:48644449	N4BP1	-0.63	-5.37	-0.52	8.01e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs11105298	0.891	rs11105302	chr12:89891366	A/G	cg08166232	chr12:89918718	WDR51B;GALNT4	0.87	6.72	0.61	2.67e-9	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs3780486	0.846	rs10738905	chr9:33123627	A/G	cg13443165	chr9:33130375	B4GALT1	-0.6	-5.71	-0.54	1.97e-7	IgG glycosylation;
SKCM	cis	rs2075371	0.796	rs12672752	chr7:134007382	C/T	cg20476274	chr7:133979776	SLC35B4	1.01	10.12	0.75	7.39e-16	Mean platelet volume;
SKCM	cis	rs10267593	0.516	rs62435159	chr7:1911281	G/A	cg23422044	chr7:1970798	MAD1L1	-0.85	-5.82	-0.55	1.25e-7	Coronary artery disease;
SKCM	cis	rs3789045	0.774	rs12029692	chr1:204532323	G/A	cg17419461	chr1:204415978	PIK3C2B	-0.86	-6.04	-0.56	5.01e-8	Educational attainment (college completion);
SKCM	cis	rs9951698	0.703	rs7233600	chr18:12986000	G/A	cg12848697	chr18:13133368	NA	0.53	4.9	0.48	5.18e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1153858	0.945	rs2467854	chr15:45701597	A/G	cg21132104	chr15:45694354	SPATA5L1	0.89	6.95	0.62	9.91e-10	Homoarginine levels;
SKCM	cis	rs12477438	0.501	rs11683188	chr2:99724512	T/C	cg14399236	chr2:99771627	LIPT1;TSGA10	0.93	8.28	0.68	2.67e-12	Chronic sinus infection;
SKCM	cis	rs6500395	1.000	rs11643264	chr16:48558462	A/G	cg04672837	chr16:48644449	N4BP1	0.66	5.45	0.53	5.67e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs1005277	0.540	rs116205409	chr10:38478970	G/A	cg25427524	chr10:38739819	LOC399744	-0.78	-7.75	-0.66	2.83e-11	Extrinsic epigenetic age acceleration;
SKCM	cis	rs8177253	0.666	rs8177197	chr3:133469530	G/A	cg16414030	chr3:133502952	NA	-0.58	-4.82	-0.48	6.94e-6	Iron status biomarkers;
SKCM	cis	rs1707322	0.721	rs10890346	chr1:46223892	C/T	cg03146154	chr1:46216737	IPP	-0.85	-6.23	-0.58	2.22e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs2072499	0.966	rs2244144	chr1:156184598	G/A	cg24450063	chr1:156163899	SLC25A44	0.95	8.34	0.69	2.04e-12	Testicular germ cell tumor;
SKCM	cis	rs1348850	0.632	rs11682717	chr2:178499240	C/G	cg22681709	chr2:178499509	PDE11A	-0.71	-6.12	-0.57	3.53e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs2228479	0.867	rs62052185	chr16:89969254	C/T	cg00800038	chr16:89945340	TCF25	-0.93	-5.34	-0.52	8.73e-7	Skin colour saturation;
SKCM	cis	rs7584330	0.737	rs6431539	chr2:238360708	G/T	cg14458575	chr2:238380390	NA	0.9	6.07	0.57	4.34e-8	Prostate cancer;
SKCM	cis	rs2842992	0.789	rs2342446	chr6:160220687	A/G	cg19482086	chr6:160211437	TCP1;MRPL18	0.81	5.82	0.55	1.23e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs8072100	0.967	rs4794001	chr17:45720849	T/C	cg08085267	chr17:45401833	C17orf57	-0.61	-5.44	-0.52	5.83e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs6121246	0.909	rs4518038	chr20:30419051	A/G	cg11595048	chr20:30225325	COX4I2	0.67	5.21	0.51	1.5e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs7772486	0.641	rs960385	chr6:146371074	G/A	cg23711669	chr6:146136114	FBXO30	0.78	6.39	0.59	1.12e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7666738	0.830	rs11941844	chr4:99042722	A/T	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6951245	0.744	rs10265736	chr7:1172465	C/T	cg23708337	chr7:1209742	NA	0.87	5.34	0.52	8.89e-7	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs12188164	0.812	rs10072668	chr5:422752	T/C	cg26076054	chr5:421317	AHRR	-0.58	-5.16	-0.5	1.83e-6	Cystic fibrosis severity;
SKCM	cis	rs5769765	1.000	rs1033665	chr22:50252127	A/G	cg22709217	chr22:50311962	ALG12;CRELD2	-0.8	-5.81	-0.55	1.32e-7	Schizophrenia;
SKCM	cis	rs7666738	0.546	rs3911415	chr4:98692401	T/A	cg17366294	chr4:99064904	C4orf37	0.64	5.05	0.5	2.78e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9911578	0.967	rs8182277	chr17:57144367	C/T	cg05425664	chr17:57184151	TRIM37	-0.84	-6.99	-0.62	8.23e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs6500395	1.000	rs6500395	chr16:48621402	T/C	cg04672837	chr16:48644449	N4BP1	0.69	5.88	0.55	9.68e-8	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs116095464	0.681	rs1574220	chr5:314518	T/C	cg22857025	chr5:266934	NA	-1.65	-6.23	-0.58	2.22e-8	Breast cancer;
SKCM	cis	rs1552244	0.882	rs113268531	chr3:10167069	A/G	cg02579736	chr3:10068473	FANCD2;CIDECP	1.16	6.72	0.61	2.65e-9	Alzheimer's disease;
SKCM	cis	rs72781680	0.898	rs17462558	chr2:24020812	T/C	cg08917208	chr2:24149416	ATAD2B	0.92	4.85	0.48	6.19e-6	Lymphocyte counts;
SKCM	cis	rs7216064	0.953	rs62086044	chr17:65970837	G/T	cg12091567	chr17:66097778	LOC651250	-0.79	-5.51	-0.53	4.43e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs4819052	0.851	rs11558445	chr21:46685175	A/G	cg02159808	chr21:46707872	POFUT2;LOC642852	0.73	5.65	0.54	2.47e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs6582630	0.555	rs7956782	chr12:38603641	C/G	cg13010199	chr12:38710504	ALG10B	0.69	5.19	0.51	1.63e-6	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs10808739	1.000	rs35407243	chr8:65650449	T/C	cg05711235	chr8:65498612	NA	-0.76	-4.86	-0.48	5.9e-6	HIV-1 susceptibility;
SKCM	cis	rs4423214	0.798	rs1894100	chr11:71130343	G/T	cg05163923	chr11:71159392	DHCR7	-0.63	-5.54	-0.53	3.87e-7	Vitamin D levels;
SKCM	cis	rs1160297	0.585	rs12713229	chr2:53090105	T/C	cg07782112	chr2:53107842	NA	0.58	6.01	0.56	5.54e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs595982	0.685	rs506425	chr19:49368843	T/C	cg19746536	chr19:49375674	PPP1R15A	1.27	12.95	0.83	3.94e-21	Red cell distribution width;
SKCM	cis	rs17376456	0.569	rs11135397	chr5:93214975	G/T	cg25358565	chr5:93447407	FAM172A	0.89	5.91	0.56	8.52e-8	Diabetic retinopathy;
SKCM	cis	rs4665809	0.590	rs35746418	chr2:26455002	C/G	cg26119090	chr2:26468346	HADHA;HADHB	1.06	8.39	0.69	1.66e-12	Gut microbiome composition (summer);
SKCM	cis	rs7666738	0.606	rs28481322	chr4:99086638	T/C	cg17366294	chr4:99064904	C4orf37	0.61	5.06	0.5	2.73e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10256972	0.521	rs871019	chr7:1105230	A/G	cg11360546	chr7:1094263	C7orf50	-0.42	-4.85	-0.48	6.09e-6	Longevity;Endometriosis;
SKCM	cis	rs6951245	0.935	rs79143504	chr7:1110212	A/G	cg03188948	chr7:1209495	NA	1.13	6.27	0.58	1.89e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs58688157	0.960	rs1061502	chr11:614318	T/C	cg03576123	chr11:487126	PTDSS2	-0.84	-5.45	-0.53	5.64e-7	Systemic lupus erythematosus;
SKCM	cis	rs992157	0.730	rs2891078	chr2:219184432	C/T	cg20019365	chr2:219134978	PNKD;AAMP	0.74	5.82	0.55	1.22e-7	Colorectal cancer;
SKCM	cis	rs6089584	0.507	rs6061990	chr20:60628429	T/G	cg06108461	chr20:60628389	TAF4	-0.82	-8.01	-0.67	9.02e-12	Body mass index;
SKCM	cis	rs992157	0.835	rs4674283	chr2:219144254	G/A	cg00012203	chr2:219082015	ARPC2	-0.74	-5.97	-0.56	6.53e-8	Colorectal cancer;
SKCM	cis	rs9902453	1.000	rs62070312	chr17:28438877	T/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.5	0.53	4.67e-7	Coffee consumption (cups per day);
SKCM	cis	rs4819052	0.819	rs7279136	chr21:46692287	C/T	cg19498844	chr21:46707878	POFUT2;LOC642852	0.91	7.84	0.66	1.92e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs910316	0.934	rs8016330	chr14:75657507	G/T	cg08847533	chr14:75593920	NEK9	-0.99	-9.41	-0.73	1.73e-14	Height;
SKCM	cis	rs8180040	0.681	rs9818382	chr3:47193034	C/T	cg27129171	chr3:47204927	SETD2	0.74	5.3	0.51	1.05e-6	Colorectal cancer;
SKCM	cis	rs7772486	0.727	rs11155442	chr6:146140725	T/C	cg23711669	chr6:146136114	FBXO30	0.89	9.81	0.74	2.88e-15	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs854765	0.724	rs2955371	chr17:17967397	G/A	cg04398451	chr17:18023971	MYO15A	0.82	6.25	0.58	2.06e-8	Total body bone mineral density;
SKCM	cis	rs6580649	1.000	rs9805048	chr12:48403692	C/T	cg05342945	chr12:48394962	COL2A1	-0.74	-5.34	-0.52	8.72e-7	Lung cancer;
SKCM	cis	rs7639513	0.767	rs2348201	chr3:12711696	A/G	cg23032965	chr3:12705835	RAF1	0.81	7.08	0.63	5.53e-10	Itch intensity from mosquito bite;
SKCM	cis	rs9435341	0.965	rs55909997	chr1:107581039	G/A	cg09367891	chr1:107599246	PRMT6	0.84	7.05	0.62	6.33e-10	Facial morphology (factor 21, depth of nasal alae);
SKCM	cis	rs35146811	0.735	rs6948729	chr7:99787372	A/G	cg22906224	chr7:99728672	NA	0.65	5.19	0.51	1.6e-6	Coronary artery disease;
SKCM	trans	rs561341	0.941	rs72825746	chr17:30364610	G/A	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs7927771	0.965	rs17788930	chr11:47752775	A/G	cg05585544	chr11:47624801	NA	-0.6	-5.24	-0.51	1.31e-6	Subjective well-being;
SKCM	cis	rs1850744	0.702	rs116079424	chr4:9593204	T/C	cg15442990	chr4:9534313	NA	-1.3	-4.84	-0.48	6.55e-6	Economic and political preferences;
SKCM	cis	rs2197308	0.565	rs4123923	chr12:37857684	T/C	cg13010199	chr12:38710504	ALG10B	0.65	4.93	0.49	4.48e-6	Morning vs. evening chronotype;
SKCM	cis	rs8017423	0.967	rs61231898	chr14:90691696	G/A	cg04374321	chr14:90722782	PSMC1	0.97	8.66	0.7	4.98e-13	Mortality in heart failure;
SKCM	cis	rs6570726	0.935	rs372378	chr6:145816227	A/G	cg23711669	chr6:146136114	FBXO30	0.71	6.77	0.61	2.18e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2070488	1.000	rs13089394	chr3:38446309	C/A	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.97	9.16	0.72	5.28e-14	Electrocardiographic conduction measures;
SKCM	cis	rs9880211	0.613	rs6439629	chr3:135901270	G/A	cg21827317	chr3:136751795	NA	-0.66	-5.09	-0.5	2.46e-6	Body mass index;Height;
SKCM	cis	rs9393692	0.967	rs6456712	chr6:26302573	A/C	cg00631329	chr6:26305371	NA	-0.66	-4.81	-0.48	7.17e-6	Educational attainment;
SKCM	cis	rs7216064	0.817	rs28609796	chr17:65855104	T/A	cg12091567	chr17:66097778	LOC651250	-0.75	-5.27	-0.51	1.19e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs929354	0.772	rs2366214	chr7:156992461	A/G	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs3020736	0.500	rs28791586	chr22:42500483	A/G	cg04733989	chr22:42467013	NAGA	-0.72	-5.62	-0.54	2.87e-7	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs34779708	0.931	rs4351760	chr10:35280254	A/G	cg03585969	chr10:35415529	CREM	0.72	5.96	0.56	6.77e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs1577917	0.655	rs9444352	chr6:86257535	G/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.69	6.13	0.57	3.35e-8	Response to antipsychotic treatment;
SKCM	cis	rs250585	0.516	rs457683	chr16:23591215	C/A	cg00143387	chr16:23521605	GGA2	1.08	4.87	0.48	5.83e-6	Egg allergy;
SKCM	cis	rs1153858	0.723	rs1719238	chr15:45594766	C/T	cg21132104	chr15:45694354	SPATA5L1	-0.86	-5.9	-0.56	8.95e-8	Homoarginine levels;
SKCM	cis	rs1348850	0.567	rs880897	chr2:178532503	C/T	cg22681709	chr2:178499509	PDE11A	-0.69	-6.21	-0.57	2.44e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs7666738	0.927	rs4699328	chr4:99055890	C/T	cg05340658	chr4:99064831	C4orf37	0.68	5.11	0.5	2.26e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs34172651	0.517	rs2303084	chr16:24834581	G/C	cg06028605	chr16:24865363	SLC5A11	0.59	4.91	0.49	4.85e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2228479	0.681	rs11641790	chr16:89961957	A/G	cg00800038	chr16:89945340	TCF25	0.93	5.56	0.53	3.67e-7	Skin colour saturation;
SKCM	cis	rs4888262	0.545	rs36097721	chr16:74648267	C/G	cg01733217	chr16:74700730	RFWD3	0.92	7.53	0.65	7.53e-11	Testicular germ cell tumor;
SKCM	cis	rs9815354	0.812	rs73071330	chr3:41810553	T/G	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs6951245	1.000	rs11767527	chr7:1097394	T/C	cg18402987	chr7:1209562	NA	1.15	6.09	0.57	3.95e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7843479	0.601	rs11781959	chr8:21841863	C/G	cg17168535	chr8:21777572	XPO7	0.84	8.38	0.69	1.73e-12	Mean corpuscular volume;
SKCM	cis	rs7193541	0.662	rs8058133	chr16:74657485	A/T	cg01733217	chr16:74700730	RFWD3	0.99	11.47	0.79	2.05e-18	Multiple myeloma;
SKCM	cis	rs6547741	1.000	rs6749052	chr2:27772879	A/T	cg27432699	chr2:27873401	GPN1	0.73	6.55	0.6	5.7e-9	Oral cavity cancer;
SKCM	cis	rs1032355	0.558	rs17533489	chr4:100518283	T/C	cg25391692	chr4:100495869	MTTP	-0.82	-4.97	-0.49	3.9e-6	Celiac disease;
SKCM	cis	rs9308433	0.529	rs59864830	chr1:214474889	A/G	cg06198575	chr1:214491504	SMYD2	0.82	5.15	0.5	1.87e-6	IgG glycosylation;
SKCM	cis	rs2836974	0.931	rs2735306	chr21:40713134	A/G	cg17971929	chr21:40555470	PSMG1	-0.8	-7.35	-0.64	1.68e-10	Cognitive function;
SKCM	cis	rs9815354	0.716	rs73087368	chr3:41930379	A/G	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs8072100	0.811	rs9889709	chr17:45445229	C/T	cg25173405	chr17:45401733	C17orf57	-0.61	-5.0	-0.49	3.41e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs950027	0.620	rs1145089	chr15:45652054	G/C	cg10760299	chr15:45669010	GATM	0.57	5.71	0.54	1.99e-7	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs7216064	1.000	rs4790908	chr17:65852907	T/G	cg12091567	chr17:66097778	LOC651250	-0.75	-5.27	-0.51	1.19e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs4523957	0.614	rs7208638	chr17:2061334	G/C	cg16513277	chr17:2031491	SMG6	-0.79	-5.63	-0.54	2.7e-7	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs9325144	0.534	rs1843887	chr12:38692380	T/C	cg13010199	chr12:38710504	ALG10B	0.63	5.01	0.49	3.31e-6	Morning vs. evening chronotype;
SKCM	cis	rs929354	0.772	rs2023977	chr7:156996022	C/G	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs4665809	0.590	rs7582341	chr2:26416301	A/G	cg26119090	chr2:26468346	HADHA;HADHB	-1.02	-7.92	-0.67	1.35e-11	Gut microbiome composition (summer);
SKCM	cis	rs861020	0.630	rs655712	chr1:210006437	G/A	cg05527609	chr1:210001259	C1orf107	0.86	6.74	0.61	2.43e-9	Orofacial clefts;
SKCM	cis	rs951366	0.789	rs823097	chr1:205681370	G/A	cg07167872	chr1:205819463	PM20D1	0.86	7.07	0.63	5.68e-10	Menarche (age at onset);
SKCM	cis	rs1639906	0.507	rs1004643	chr7:2185324	G/C	cg02951883	chr7:2050386	MAD1L1	0.63	5.37	0.52	8e-7	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs735396	0.731	rs1182933	chr12:121454622	C/T	cg02403541	chr12:121454288	C12orf43	0.74	6.15	0.57	3.04e-8	N-glycan levels;
SKCM	cis	rs16854884	1.000	rs1961542	chr3:143765503	G/A	cg06585982	chr3:143692056	C3orf58	0.74	5.69	0.54	2.17e-7	Economic and political preferences (feminism/equality);
SKCM	cis	rs2204008	0.720	rs10880697	chr12:38594529	G/C	cg13010199	chr12:38710504	ALG10B	0.69	5.19	0.51	1.63e-6	Bladder cancer;
SKCM	cis	rs6815814	0.950	rs5743595	chr4:38802644	A/G	cg02016764	chr4:38805732	TLR1	-0.77	-5.49	-0.53	4.78e-7	Breast cancer;
SKCM	cis	rs11122272	0.766	rs2790871	chr1:231543555	G/C	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	-0.66	-5.34	-0.52	9.04e-7	Hemoglobin concentration;
SKCM	cis	rs16854884	0.770	rs951865	chr3:143812677	G/A	cg06585982	chr3:143692056	C3orf58	0.73	5.8	0.55	1.32e-7	Economic and political preferences (feminism/equality);
SKCM	cis	rs10193935	1.000	rs13399869	chr2:42386041	C/G	cg27598129	chr2:42591480	NA	-0.92	-6.79	-0.61	1.97e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9300255	0.568	rs3018098	chr12:123654812	T/C	cg00376283	chr12:123451042	ABCB9	0.83	5.49	0.53	4.74e-7	Neutrophil percentage of white cells;
SKCM	cis	rs870825	0.550	rs10000507	chr4:185619281	C/T	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs35306767	0.903	rs10904577	chr10:922077	A/G	cg26597838	chr10:835615	NA	0.75	5.51	0.53	4.53e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs12497850	0.866	rs6791234	chr3:48996137	A/G	cg07636037	chr3:49044803	WDR6	1.02	11.0	0.78	1.56e-17	Parkinson's disease;
SKCM	cis	rs13108904	0.901	rs1680073	chr4:1280337	G/A	cg05025164	chr4:1340916	KIAA1530	-0.6	-4.82	-0.48	6.9e-6	Obesity-related traits;
SKCM	cis	rs694739	0.861	rs479552	chr11:64110683	G/C	cg23796481	chr11:64053134	BAD;GPR137	0.72	5.35	0.52	8.64e-7	Alopecia areata;Crohn's disease;Psoriasis vulgaris;
SKCM	cis	rs644799	0.610	rs1255179	chr11:95472097	A/G	cg03916912	chr11:95522834	CEP57;FAM76B	0.62	5.01	0.49	3.31e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs732765	0.580	rs10151838	chr14:75132155	A/G	cg25946216	chr14:74253857	C14orf43	-0.93	-5.16	-0.5	1.86e-6	Non-small cell lung cancer;
SKCM	cis	rs55728055	0.661	rs62237772	chr22:31964975	A/C	cg01338084	chr22:32026380	PISD	1.5	5.03	0.49	3.11e-6	Age-related hearing impairment;
SKCM	cis	rs769267	0.859	rs2916076	chr19:19545990	T/C	cg26732615	chr19:19648335	CILP2;YJEFN3	0.67	6.92	0.62	1.13e-9	Tonsillectomy;
SKCM	cis	rs10791097	0.694	rs4456262	chr11:130755813	C/T	cg12179176	chr11:130786555	SNX19	-0.93	-7.66	-0.66	4.21e-11	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs7615952	0.611	rs114419739	chr3:125722490	C/T	cg05084668	chr3:125655381	ALG1L	-1.29	-6.33	-0.58	1.42e-8	Blood pressure (smoking interaction);
SKCM	cis	rs910316	0.934	rs4903278	chr14:75535019	C/A	cg11812906	chr14:75593930	NEK9	0.72	5.45	0.53	5.7e-7	Height;
SKCM	cis	rs992157	0.710	rs12996912	chr2:219110555	A/G	cg20019365	chr2:219134978	PNKD;AAMP	0.72	6.4	0.59	1.07e-8	Colorectal cancer;
SKCM	cis	rs10779751	1.000	rs11121703	chr1:11293792	G/T	cg08854313	chr1:11322531	MTOR	-0.96	-7.64	-0.65	4.67e-11	Body mass index;
SKCM	cis	rs651907	0.535	rs4342086	chr3:101503765	G/A	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.78	6.86	0.61	1.47e-9	Colorectal cancer;
SKCM	cis	rs28386778	1.000	rs3020613	chr17:61955983	A/G	cg26338869	chr17:61819248	STRADA	0.72	4.89	0.48	5.36e-6	Prudent dietary pattern;
SKCM	cis	rs116095464	0.558	rs61492827	chr5:225774	A/G	cg22857025	chr5:266934	NA	-1.36	-8.0	-0.67	9.23e-12	Breast cancer;
SKCM	cis	rs9325144	0.647	rs3759139	chr12:39087609	G/A	cg26384229	chr12:38710491	ALG10B	-0.72	-6.42	-0.59	9.87e-9	Morning vs. evening chronotype;
SKCM	cis	rs17376456	1.000	rs35184505	chr5:93561535	A/G	cg21475434	chr5:93447410	FAM172A	1.08	5.94	0.56	7.64e-8	Diabetic retinopathy;
SKCM	cis	rs10883723	0.810	rs6584507	chr10:104254623	G/A	cg11453585	chr10:104263688	ACTR1A;SUFU	0.75	5.7	0.54	2.03e-7	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs28595532	0.920	rs115259971	chr4:119762654	T/C	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs9463078	0.616	rs2211393	chr6:44716366	A/C	cg25276700	chr6:44698697	NA	0.44	4.77	0.48	8.31e-6	Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder;
SKCM	cis	rs7191439	0.728	rs8043924	chr16:88787704	G/C	cg02389323	chr16:88786976	FAM38A	1.23	5.39	0.52	7.25e-7	Plateletcrit;
SKCM	cis	rs28386778	0.830	rs6504180	chr17:61813169	T/C	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.36	0.52	8.06e-7	Prudent dietary pattern;
SKCM	cis	rs10193935	0.901	rs2374405	chr2:42479874	A/C	cg27598129	chr2:42591480	NA	-0.97	-6.7	-0.6	2.93e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1218582	0.774	rs4845681	chr1:154868055	G/T	cg06221963	chr1:154839813	KCNN3	-0.61	-6.79	-0.61	1.94e-9	Prostate cancer;
SKCM	cis	rs11098499	0.780	rs7680914	chr4:120563053	A/G	cg09307838	chr4:120376055	NA	1.0	8.12	0.68	5.39e-12	Corneal astigmatism;
SKCM	cis	rs8017423	0.935	rs10147186	chr14:90779879	G/C	cg04374321	chr14:90722782	PSMC1	1.04	9.75	0.74	3.8e-15	Mortality in heart failure;
SKCM	cis	rs4900538	0.963	rs1190553	chr14:102915331	G/T	cg18135206	chr14:102964638	TECPR2	-0.78	-6.37	-0.58	1.23e-8	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs28595532	0.920	rs114210107	chr4:119734491	G/A	cg21605333	chr4:119757512	SEC24D	1.36	7.81	0.66	2.21e-11	Cannabis dependence symptom count;
SKCM	cis	rs6977660	1.000	rs6959889	chr7:19822024	A/C	cg05791153	chr7:19748676	TWISTNB	0.79	5.34	0.52	9.05e-7	Thyroid stimulating hormone;
SKCM	cis	rs910316	0.737	rs175048	chr14:75479894	A/T	cg08847533	chr14:75593920	NEK9	-0.79	-6.45	-0.59	8.69e-9	Height;
SKCM	cis	rs826838	0.935	rs1160162	chr12:38959795	G/A	cg26384229	chr12:38710491	ALG10B	1.04	9.89	0.75	2.01e-15	Heart rate;
SKCM	cis	rs7824557	0.591	rs2736283	chr8:11225910	A/G	cg21775007	chr8:11205619	TDH	-0.67	-6.25	-0.58	2.04e-8	Retinal vascular caliber;
SKCM	cis	rs10860964	0.605	rs7976027	chr12:103563024	A/G	cg20635409	chr12:103359273	NA	-0.56	-5.01	-0.49	3.3e-6	Schizophrenia;
SKCM	cis	rs3820928	0.845	rs10165767	chr2:227781863	G/A	cg11843606	chr2:227700838	RHBDD1	-0.6	-4.81	-0.48	7.17e-6	Pulmonary function;
SKCM	cis	rs7937682	0.889	rs564086	chr11:111501079	C/G	cg09085632	chr11:111637200	PPP2R1B	-1.07	-11.16	-0.78	7.77e-18	Primary sclerosing cholangitis;
SKCM	cis	rs6463523	0.898	rs66892628	chr7:759374	T/A	cg11064039	chr7:766100	PRKAR1B;HEATR2	0.98	8.14	0.68	5.06e-12	Subjective well-being;
SKCM	cis	rs908922	0.676	rs486283	chr1:152525957	A/G	cg09873164	chr1:152488093	CRCT1	0.72	5.62	0.54	2.85e-7	Hair morphology;
SKCM	cis	rs9868809	0.772	rs28452701	chr3:48708575	C/T	cg00383909	chr3:49044727	WDR6	0.88	4.87	0.48	5.69e-6	Ulcerative colitis;Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs7772486	0.817	rs9386145	chr6:146363519	A/T	cg23711669	chr6:146136114	FBXO30	0.78	7.48	0.65	9.35e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7216064	1.000	rs62085993	chr17:65923152	T/C	cg12091567	chr17:66097778	LOC651250	-0.76	-5.15	-0.5	1.87e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs7647973	0.580	rs7652746	chr3:49262307	C/T	cg06212747	chr3:49208901	KLHDC8B	-0.74	-5.4	-0.52	6.97e-7	Menarche (age at onset);
SKCM	cis	rs709400	0.965	rs861534	chr14:104168701	C/T	cg26031613	chr14:104095156	KLC1	1.05	12.89	0.82	5.14e-21	Body mass index;
SKCM	cis	rs6570726	0.935	rs392014	chr6:145843691	A/C	cg23711669	chr6:146136114	FBXO30	0.73	6.89	0.61	1.29e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs17685	0.753	rs7804598	chr7:75702578	C/T	cg01364799	chr7:75623366	TMEM120A	-0.72	-5.81	-0.55	1.31e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs8017423	0.838	rs11845950	chr14:90723962	T/A	cg04374321	chr14:90722782	PSMC1	1.03	9.44	0.73	1.55e-14	Mortality in heart failure;
SKCM	cis	rs13010713	0.840	rs1996501	chr2:182029358	C/T	cg21995919	chr2:182322279	ITGA4	-0.57	-5.48	-0.53	5.06e-7	Celiac disease;
SKCM	cis	rs533581	0.844	rs548591	chr16:88974516	A/G	cg16701003	chr16:89028210	CBFA2T3	0.68	7.06	0.62	6.17e-10	Social autistic-like traits;
SKCM	cis	rs17376456	0.825	rs35496867	chr5:93220400	T/C	cg25358565	chr5:93447407	FAM172A	1.24	7.36	0.64	1.6e-10	Diabetic retinopathy;
SKCM	cis	rs3785574	0.962	rs58131426	chr17:61854375	T/C	cg01411255	chr17:61851458	DDX42;CCDC47	1.13	12.75	0.82	9.07e-21	Height;
SKCM	cis	rs854765	0.583	rs8075965	chr17:17853180	A/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.01	7.49	0.65	9.28e-11	Total body bone mineral density;
SKCM	cis	rs870825	0.616	rs7683615	chr4:185618373	C/T	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs7772486	0.790	rs3924498	chr6:146233338	A/T	cg23711669	chr6:146136114	FBXO30	-0.77	-7.69	-0.66	3.71e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9549367	0.713	rs3024744	chr13:113821477	A/C	cg18105134	chr13:113819100	PROZ	-0.88	-6.51	-0.59	6.68e-9	Platelet distribution width;
SKCM	cis	rs6088580	0.567	rs6088520	chr20:33132364	A/G	cg24642439	chr20:33292090	TP53INP2	-0.72	-5.76	-0.55	1.57e-7	Glomerular filtration rate (creatinine);
SKCM	cis	rs9912468	0.933	rs67700546	chr17:64301081	C/T	cg19474267	chr17:64306194	PRKCA	0.63	5.48	0.53	4.96e-7	QRS duration;QRS complex (12-leadsum);QRS complex (Sokolow-Lyon);
SKCM	cis	rs1153858	1.000	rs2056493	chr15:45648272	A/G	cg21132104	chr15:45694354	SPATA5L1	0.9	7.85	0.66	1.8e-11	Homoarginine levels;
SKCM	cis	rs9308433	0.529	rs1391553	chr1:214474119	T/C	cg06198575	chr1:214491504	SMYD2	0.8	5.14	0.5	2.02e-6	IgG glycosylation;
SKCM	cis	rs7666738	0.830	rs13124127	chr4:98990729	G/A	cg17366294	chr4:99064904	C4orf37	0.6	4.98	0.49	3.8e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9640161	0.659	rs7806429	chr7:150013393	A/G	cg10018233	chr7:150070692	REPIN1	0.68	5.57	0.53	3.49e-7	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs11139399	0.552	rs10867800	chr9:84337353	A/C	cg13729285	chr9:84764156	NA	0.53	4.95	0.49	4.21e-6	Hippocampal atrophy;
SKCM	cis	rs12477438	0.520	rs2516827	chr2:99772565	C/T	cg14399236	chr2:99771627	LIPT1;TSGA10	0.97	8.9	0.71	1.72e-13	Chronic sinus infection;
SKCM	cis	rs12497850	0.931	rs4974082	chr3:48999323	G/A	cg06212747	chr3:49208901	KLHDC8B	0.68	4.9	0.49	5.06e-6	Parkinson's disease;
SKCM	cis	rs1577917	0.916	rs12206726	chr6:86499716	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.88	-0.67	1.63e-11	Response to antipsychotic treatment;
SKCM	cis	rs9914544	1.000	rs8066385	chr17:18761133	C/T	cg26306683	chr17:18585705	ZNF286B	0.71	5.13	0.5	2.06e-6	Educational attainment (years of education);
SKCM	cis	rs951366	0.903	rs823114	chr1:205719532	G/A	cg07157834	chr1:205819609	PM20D1	0.68	5.33	0.52	9.26e-7	Menarche (age at onset);
SKCM	cis	rs12497850	0.797	rs61583136	chr3:49189195	C/T	cg07636037	chr3:49044803	WDR6	1.0	8.69	0.7	4.39e-13	Parkinson's disease;
SKCM	cis	rs1124769	0.748	rs2289304	chr15:51289395	T/C	cg21246271	chr15:51200259	AP4E1	-0.74	-4.78	-0.48	8.15e-6	Cognitive performance;
SKCM	cis	rs7829975	0.658	rs907181	chr8:8702875	T/C	cg15556689	chr8:8085844	FLJ10661	0.73	6.16	0.57	2.94e-8	Mood instability;
SKCM	cis	rs2204008	0.720	rs11170774	chr12:38021722	C/T	cg13010199	chr12:38710504	ALG10B	-0.62	-4.84	-0.48	6.53e-6	Bladder cancer;
SKCM	cis	rs1850744	0.702	rs60403942	chr4:9603452	A/G	cg15442990	chr4:9534313	NA	-1.45	-4.89	-0.48	5.27e-6	Economic and political preferences;
SKCM	cis	rs2404602	0.684	rs11854850	chr15:76844571	C/T	cg23625390	chr15:77176239	SCAPER	-0.82	-7.93	-0.67	1.26e-11	Blood metabolite levels;
SKCM	cis	rs7122539	0.646	rs594313	chr11:66608991	A/G	cg24851651	chr11:66362959	CCS	0.76	5.57	0.53	3.47e-7	HIV-1 susceptibility;
SKCM	cis	rs501120	1.000	rs579058	chr10:44755104	A/G	cg09554077	chr10:44749378	NA	0.38	4.93	0.49	4.52e-6	Coronary artery disease;Coronary heart disease;
SKCM	cis	rs708547	0.836	rs1713997	chr4:57843863	G/C	cg16868167	chr4:57843880	C4orf14;POLR2B	0.98	10.08	0.75	8.75e-16	Response to bleomycin (chromatid breaks);
SKCM	cis	rs394563	0.591	rs6570964	chr6:149691859	G/A	cg03678062	chr6:149772716	ZC3H12D	0.52	6.24	0.58	2.08e-8	Dupuytren's disease;
SKCM	cis	rs1005277	0.602	rs1780141	chr10:38504299	T/C	cg25427524	chr10:38739819	LOC399744	-0.69	-6.79	-0.61	1.96e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs1577917	0.917	rs4707226	chr6:86527828	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.81	-0.66	2.19e-11	Response to antipsychotic treatment;
SKCM	cis	rs651907	0.557	rs1056579	chr3:101397877	T/G	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.81	7.06	0.62	6.11e-10	Colorectal cancer;
SKCM	cis	rs7811142	1.000	rs60844404	chr7:100080474	A/T	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.25	0.68	3.05e-12	Platelet count;
SKCM	cis	rs2842992	0.872	rs9456440	chr6:160074463	G/T	cg11366901	chr6:160182831	ACAT2	0.94	7.06	0.62	5.98e-10	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs4819052	0.851	rs13047598	chr21:46660777	G/T	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.36	0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs13256369	0.851	rs13254997	chr8:8563753	G/C	cg15556689	chr8:8085844	FLJ10661	0.66	4.86	0.48	5.99e-6	Obesity-related traits;
SKCM	cis	rs7811142	0.830	rs705866	chr7:99965285	T/C	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.19	7.5	0.65	8.66e-11	Platelet count;
SKCM	cis	rs67311347	0.544	rs2123998	chr3:40359005	C/G	cg13409248	chr3:40428643	ENTPD3	-0.57	-5.56	-0.53	3.58e-7	Renal cell carcinoma;
SKCM	cis	rs7666738	0.800	rs11941885	chr4:99072921	A/C	cg17366294	chr4:99064904	C4orf37	0.61	4.94	0.49	4.43e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10504229	1.000	rs73609747	chr8:58189104	G/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs2991971	0.810	rs12738318	chr1:45929589	A/G	cg24296786	chr1:45957014	TESK2	-0.62	-5.05	-0.5	2.8e-6	High light scatter reticulocyte count;
SKCM	cis	rs12477438	0.520	rs4588238	chr2:99749350	T/C	cg14399236	chr2:99771627	LIPT1;TSGA10	0.97	8.9	0.71	1.72e-13	Chronic sinus infection;
SKCM	cis	rs854765	0.693	rs9907287	chr17:17774118	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	-1.05	-8.44	-0.69	1.3e-12	Total body bone mineral density;
SKCM	cis	rs7937682	0.921	rs12806479	chr11:111443192	G/C	cg22437258	chr11:111473054	SIK2	-0.71	-5.48	-0.53	5e-7	Primary sclerosing cholangitis;
SKCM	cis	rs769267	0.930	rs2099334	chr19:19578450	A/G	cg26732615	chr19:19648335	CILP2;YJEFN3	0.67	7.06	0.62	6e-10	Tonsillectomy;
SKCM	cis	rs875971	0.638	rs10249404	chr7:66046724	G/A	cg18876405	chr7:65276391	NA	-0.82	-7.53	-0.65	7.59e-11	Aortic root size;
SKCM	cis	rs17711722	0.740	rs7809991	chr7:65406218	A/G	cg18876405	chr7:65276391	NA	0.84	7.61	0.65	5.38e-11	Calcium levels;
SKCM	cis	rs9399137	0.507	rs11753673	chr6:135316476	T/C	cg24558204	chr6:135376177	HBS1L	0.7	6.53	0.59	6.11e-9	Glycated hemoglobin levels;Mean corpuscular volume;Hematology traits;HbA2 levels;Mean corpuscular hemoglobin;Hemoglobin levels;F-cell distribution;Platelet count;
SKCM	cis	rs11098499	0.697	rs28458294	chr4:120238924	T/C	cg09307838	chr4:120376055	NA	0.98	8.13	0.68	5.33e-12	Corneal astigmatism;
SKCM	cis	rs7336332	0.600	rs9579083	chr13:28017270	G/C	cg22138327	chr13:27999177	GTF3A	0.9	6.4	0.59	1.07e-8	Weight;
SKCM	cis	rs929354	0.713	rs3802130	chr7:156965237	A/G	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs362296	0.615	rs34030762	chr4:3255736	C/A	cg09735869	chr4:3319127	RGS12	-0.73	-6.24	-0.58	2.1e-8	Parental longevity (mother's age at death);
SKCM	cis	rs9733	0.566	rs878471	chr1:150547747	G/A	cg13175981	chr1:150552382	MCL1	0.72	6.11	0.57	3.66e-8	Tonsillectomy;
SKCM	cis	rs362272	0.545	rs2749783	chr4:3326098	A/C	cg21096898	chr4:3318625	RGS12	1.0	12.53	0.82	2.25e-20	Serum sulfate level;
SKCM	cis	rs12477438	0.520	rs2969379	chr2:99776686	G/A	cg14399236	chr2:99771627	LIPT1;TSGA10	1.01	9.53	0.73	1.01e-14	Chronic sinus infection;
SKCM	cis	rs6942756	0.806	rs68184415	chr7:128988862	C/T	cg02491457	chr7:128862824	NA	-0.75	-4.95	-0.49	4.23e-6	White matter hyperintensity burden;
SKCM	cis	rs7772486	0.720	rs4896844	chr6:146075224	T/C	cg23711669	chr6:146136114	FBXO30	-0.89	-10.12	-0.75	7.58e-16	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs3820068	0.581	rs16851819	chr1:15918739	C/T	cg13390004	chr1:15929781	NA	-0.67	-5.2	-0.51	1.55e-6	Systolic blood pressure;
SKCM	cis	rs9303401	0.614	rs8081058	chr17:57160513	G/C	cg10487724	chr17:56770010	TEX14;RAD51C	0.79	4.97	0.49	3.86e-6	Cognitive test performance;
SKCM	cis	rs12047808	0.841	rs112667627	chr1:179370353	A/G	cg09822482	chr1:179519214	C1orf125	-0.95	-5.17	-0.51	1.78e-6	Multiple sclerosis (age of onset);
SKCM	cis	rs7216064	0.734	rs11653507	chr17:65892064	A/T	cg12091567	chr17:66097778	LOC651250	-0.73	-5.76	-0.55	1.57e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs709400	0.627	rs62007686	chr14:103899344	A/G	cg26031613	chr14:104095156	KLC1	0.72	5.3	0.51	1.04e-6	Body mass index;
SKCM	cis	rs72634258	0.945	rs6577459	chr1:8100173	G/T	cg00042356	chr1:8021962	PARK7	1.08	7.51	0.65	8.25e-11	Inflammatory bowel disease;
SKCM	cis	rs55962025	0.804	rs362268	chr4:3242148	C/G	cg05297308	chr4:3317976	RGS12	-0.71	-5.23	-0.51	1.41e-6	Parental longevity (mother's age at death);
SKCM	cis	rs11206226	1.000	rs11206230	chr1:54325688	A/G	cg20741386	chr1:53556189	SLC1A7	1.17	5.22	0.51	1.42e-6	Nonalcoholic fatty liver disease;
SKCM	cis	rs9581857	0.547	rs74518675	chr13:27972180	A/G	cg22138327	chr13:27999177	GTF3A	0.97	5.85	0.55	1.07e-7	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs637571	0.522	rs566590	chr11:65754062	C/T	cg26695010	chr11:65641043	EFEMP2	-0.71	-5.3	-0.51	1.03e-6	Eosinophil percentage of white cells;
SKCM	cis	rs2204008	0.837	rs73112346	chr12:38357606	C/T	cg13010199	chr12:38710504	ALG10B	0.68	4.85	0.48	6.3e-6	Bladder cancer;
SKCM	cis	rs897984	0.806	rs8052245	chr16:30916430	C/G	cg00531865	chr16:30841666	NA	0.57	5.02	0.49	3.19e-6	Dementia with Lewy bodies;
SKCM	cis	rs1577917	0.958	rs12215232	chr6:86785430	G/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.64	-5.49	-0.53	4.77e-7	Response to antipsychotic treatment;
SKCM	cis	rs17065868	1.000	rs9533880	chr13:45076189	A/T	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs9916302	0.904	rs8076546	chr17:37555403	G/A	cg07936489	chr17:37558343	FBXL20	0.85	7.35	0.64	1.71e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs7772486	0.754	rs6937661	chr6:146113299	T/C	cg23711669	chr6:146136114	FBXO30	-0.9	-10.38	-0.76	2.38e-16	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1801251	0.964	rs7589201	chr2:233724536	A/G	cg25237894	chr2:233734115	C2orf82	-0.58	-5.64	-0.54	2.6e-7	Coronary artery disease;
SKCM	cis	rs7589728	0.563	rs4972044	chr2:88466196	T/C	cg04511125	chr2:88470314	THNSL2	1.07	6.66	0.6	3.43e-9	Plasma clusterin levels;
SKCM	cis	rs6952808	1.000	rs4719319	chr7:1888094	G/A	cg04267008	chr7:1944627	MAD1L1	-0.8	-6.1	-0.57	3.78e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs7945705	0.719	rs2012680	chr11:8996059	G/A	cg21881798	chr11:8931708	C11orf17;ST5	-0.8	-8.5	-0.69	1e-12	Hemoglobin concentration;
SKCM	cis	rs1451375	0.572	rs745042	chr7:50544138	A/G	cg18232548	chr7:50535776	DDC	-0.71	-4.77	-0.48	8.5e-6	Malaria;
SKCM	cis	rs62238980	0.614	rs117827593	chr22:32501199	G/A	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs3903072	0.528	rs12800497	chr11:65579762	C/T	cg00576331	chr11:65640516	EFEMP2	-0.73	-5.26	-0.51	1.24e-6	Breast cancer;
SKCM	cis	rs7917772	0.503	rs10748825	chr10:104293609	A/G	cg11453585	chr10:104263688	ACTR1A;SUFU	0.78	6.33	0.58	1.47e-8	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs28595532	0.920	rs6818519	chr4:119787820	G/T	cg11846333	chr4:119757529	SEC24D	1.2	6.43	0.59	9.38e-9	Cannabis dependence symptom count;
SKCM	cis	rs11098499	0.780	rs12504773	chr4:120562149	G/C	cg24375607	chr4:120327624	NA	0.63	4.85	0.48	6.29e-6	Corneal astigmatism;
SKCM	cis	rs1153858	1.000	rs9783731	chr15:45642884	C/T	cg10760299	chr15:45669010	GATM	-0.59	-5.99	-0.56	6.15e-8	Homoarginine levels;
SKCM	cis	rs9300255	0.539	rs1969355	chr12:123742061	G/A	cg05973401	chr12:123451056	ABCB9	0.75	5.83	0.55	1.18e-7	Neutrophil percentage of white cells;
SKCM	cis	rs951366	0.585	rs72750964	chr1:205675240	C/T	cg14159672	chr1:205819179	PM20D1	0.78	6.35	0.58	1.32e-8	Menarche (age at onset);
SKCM	cis	rs9303401	0.615	rs7502342	chr17:56922629	C/A	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.16	0.57	2.91e-8	Cognitive test performance;
SKCM	cis	rs597539	0.652	rs496616	chr11:68672800	G/C	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.82	5.72	0.54	1.89e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs10540	1.000	rs35811812	chr11:498442	G/A	cg03352830	chr11:487213	PTDSS2	0.94	4.91	0.49	4.87e-6	Body mass index;
SKCM	cis	rs7633770	0.786	rs1607737	chr3:46681846	G/C	cg11219411	chr3:46661640	NA	0.54	4.86	0.48	5.98e-6	Coronary artery disease;
SKCM	cis	rs637571	0.522	rs12797319	chr11:65735672	G/A	cg02427764	chr11:65769310	BANF1;EIF1AD	0.75	5.68	0.54	2.19e-7	Eosinophil percentage of white cells;
SKCM	cis	rs9818758	0.607	rs9837625	chr3:49215966	C/T	cg24898236	chr3:49228699	LOC646498	0.64	4.94	0.49	4.39e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs7666738	0.830	rs6848397	chr4:98946738	A/G	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs826838	0.967	rs826858	chr12:39116731	A/G	cg13010199	chr12:38710504	ALG10B	-0.78	-5.84	-0.55	1.14e-7	Heart rate;
SKCM	cis	rs72781680	0.612	rs33913065	chr2:24344060	T/G	cg20701182	chr2:24300061	SF3B14	0.76	5.13	0.5	2.06e-6	Lymphocyte counts;
SKCM	cis	rs6089584	0.888	rs6061405	chr20:60617033	A/G	cg06108461	chr20:60628389	TAF4	-0.87	-8.32	-0.69	2.24e-12	Body mass index;
SKCM	cis	rs703842	0.642	rs10876994	chr12:58064737	A/C	cg04478727	chr12:58166393	METTL1;FAM119B	0.71	5.35	0.52	8.67e-7	Multiple sclerosis;
SKCM	cis	rs8072100	0.875	rs7208530	chr17:45544107	C/T	cg25173405	chr17:45401733	C17orf57	-0.58	-4.77	-0.48	8.26e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs1559088	0.576	rs11084707	chr19:33612873	C/T	cg27124370	chr19:33622961	WDR88	0.76	5.55	0.53	3.83e-7	Bone ultrasound measurement (broadband ultrasound attenuation);
SKCM	cis	rs1577917	0.771	rs9362232	chr6:86353622	A/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.27	-0.51	1.16e-6	Response to antipsychotic treatment;
SKCM	cis	rs7786877	0.680	rs12532878	chr7:100212254	G/A	cg20848291	chr7:100343083	ZAN	-0.68	-5.15	-0.5	1.87e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs7666738	0.830	rs35433756	chr4:99070555	C/T	cg05340658	chr4:99064831	C4orf37	0.66	4.87	0.48	5.74e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs999943	0.774	rs12212284	chr6:33640874	T/A	cg14003231	chr6:33640908	ITPR3	0.68	5.42	0.52	6.45e-7	Obesity (extreme);
SKCM	cis	rs7552404	0.924	rs3818855	chr1:76198785	C/T	cg10523679	chr1:76189770	ACADM	0.71	5.19	0.51	1.62e-6	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs28595532	0.920	rs115317002	chr4:119722809	T/C	cg21605333	chr4:119757512	SEC24D	1.35	7.92	0.67	1.37e-11	Cannabis dependence symptom count;
SKCM	cis	rs769267	0.930	rs2315022	chr19:19413381	A/G	cg26732615	chr19:19648335	CILP2;YJEFN3	0.65	6.06	0.57	4.61e-8	Tonsillectomy;
SKCM	cis	rs3135063	0.884	rs3129317	chr4:3287655	A/G	cg21096898	chr4:3318625	RGS12	0.61	5.34	0.52	8.94e-7	Blood protein levels;
SKCM	cis	rs2836974	0.565	rs2836939	chr21:40578546	C/T	cg11890956	chr21:40555474	PSMG1	0.99	7.25	0.63	2.63e-10	Cognitive function;
SKCM	cis	rs17376456	0.877	rs10044066	chr5:93437580	T/C	cg21475434	chr5:93447410	FAM172A	0.97	5.42	0.52	6.39e-7	Diabetic retinopathy;
SKCM	cis	rs17270561	0.723	rs12213243	chr6:25890108	C/T	cg17691542	chr6:26056736	HIST1H1C	0.95	5.56	0.53	3.59e-7	Iron status biomarkers;
SKCM	cis	rs2033711	0.840	rs3764533	chr19:58929194	A/G	cg00825309	chr19:58991885	ZNF446	-0.69	-5.6	-0.54	3.15e-7	Uric acid clearance;
SKCM	cis	rs1790761	0.692	rs611663	chr11:67312221	C/T	cg00290607	chr11:67383545	NA	0.51	5.27	0.51	1.18e-6	Mean corpuscular volume;
SKCM	cis	rs72615157	0.612	rs7786505	chr7:99817585	G/T	cg23667466	chr7:100026434	MEPCE;ZCWPW1	0.91	4.87	0.48	5.74e-6	Lung function (FEV1/FVC);
SKCM	cis	rs1267303	0.675	rs7519040	chr1:46986641	A/G	cg25110126	chr1:46999211	NA	0.68	4.88	0.48	5.5e-6	Monobrow;
SKCM	cis	rs28595532	1.000	rs116030177	chr4:119650768	T/C	cg11846333	chr4:119757529	SEC24D	1.15	6.24	0.58	2.13e-8	Cannabis dependence symptom count;
SKCM	cis	rs995000	0.931	rs4915840	chr1:62999595	C/G	cg06896770	chr1:63153194	DOCK7	-0.75	-6.89	-0.61	1.29e-9	Triglyceride levels;
SKCM	cis	rs12477438	0.700	rs10190421	chr2:99670711	C/T	cg26064155	chr2:99771622	LIPT1;TSGA10	-0.72	-4.86	-0.48	6e-6	Chronic sinus infection;
SKCM	cis	rs12586317	0.547	rs28577270	chr14:35498443	G/A	cg16230307	chr14:35515116	FAM177A1	0.81	5.88	0.55	9.47e-8	Psoriasis;
SKCM	cis	rs7772486	0.790	rs2253764	chr6:146199881	T/A	cg05347473	chr6:146136440	FBXO30	0.58	5.45	0.53	5.72e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2980436	1	rs2980436	chr8:8092025	A/G	cg15556689	chr8:8085844	FLJ10661	-0.84	-7.07	-0.62	5.82e-10	Schizophrenia;
SKCM	cis	rs9611565	0.765	rs202659	chr22:41811620	T/C	cg03806693	chr22:41940476	POLR3H	1.02	6.92	0.62	1.13e-9	Vitiligo;
SKCM	cis	rs651907	0.557	rs11712748	chr3:101383562	G/A	cg12386194	chr3:101231763	SENP7	0.71	5.94	0.56	7.61e-8	Colorectal cancer;
SKCM	cis	rs10504073	0.669	rs62507253	chr8:50028836	C/T	cg00325661	chr8:49890786	NA	0.79	6.76	0.61	2.29e-9	Blood metabolite ratios;
SKCM	cis	rs2836950	0.501	rs11088470	chr21:40689162	A/G	cg17971929	chr21:40555470	PSMG1	-0.64	-5.1	-0.5	2.31e-6	Menarche (age at onset);
SKCM	cis	rs2836974	0.565	rs2836939	chr21:40578546	C/T	cg17971929	chr21:40555470	PSMG1	0.74	4.89	0.48	5.34e-6	Cognitive function;
SKCM	cis	rs9796	0.621	rs9972349	chr15:41491656	A/G	cg18705301	chr15:41695430	NDUFAF1	-0.7	-5.17	-0.5	1.79e-6	Menopause (age at onset);
SKCM	cis	rs12216125	0.801	rs56107510	chr6:25987436	C/A	cg16482183	chr6:26056742	HIST1H1C	0.66	5.43	0.52	6.08e-7	Iron status biomarkers;
SKCM	cis	rs9902453	0.808	rs56216220	chr17:28209182	G/A	cg26525008	chr17:28256777	EFCAB5;SSH2	0.81	5.78	0.55	1.44e-7	Coffee consumption (cups per day);
SKCM	cis	rs28595532	0.920	rs112097820	chr4:119746532	G/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs6977660	1.000	rs10240227	chr7:19823188	T/C	cg07541023	chr7:19748670	TWISTNB	0.7	4.82	0.48	6.98e-6	Thyroid stimulating hormone;
SKCM	trans	rs11083271	0.631	rs62102106	chr18:25859158	A/C	cg00321150	chr11:62623587	SNORD27;SLC3A2;SNHG1;SNORD28;SNORD25;SNORD26	0.8	7.29	0.64	2.17e-10	Non-alcoholic fatty liver disease histology (lobular);
SKCM	cis	rs11690935	0.688	rs7600835	chr2:172521827	C/T	cg13550731	chr2:172543902	DYNC1I2	-0.84	-7.68	-0.66	3.89e-11	Schizophrenia;
SKCM	cis	rs12477438	0.520	rs11123763	chr2:99750673	A/G	cg14399236	chr2:99771627	LIPT1;TSGA10	0.97	8.9	0.71	1.72e-13	Chronic sinus infection;
SKCM	cis	rs7666738	0.830	rs13111977	chr4:98953813	G/A	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs55962025	0.883	rs2298967	chr4:3185747	T/C	cg16987761	chr4:3318072	RGS12	-0.6	-4.79	-0.48	7.68e-6	Parental longevity (mother's age at death);
SKCM	cis	rs614226	0.515	rs77755019	chr12:120921346	A/T	cg01236616	chr12:121019343	POP5	-1.79	-5.17	-0.51	1.77e-6	Type 1 diabetes nephropathy;
SKCM	cis	rs36093844	0.800	rs75203358	chr11:85567390	A/G	cg25872744	chr11:85566296	CCDC83	-0.85	-4.77	-0.48	8.27e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs593982	0.925	rs3953806	chr11:65505153	C/T	cg08755490	chr11:65554678	OVOL1	-0.95	-7.42	-0.64	1.22e-10	Atopic dermatitis;
SKCM	cis	rs8141529	0.719	rs6005916	chr22:29233342	T/C	cg02153584	chr22:29168773	CCDC117	0.62	5.02	0.49	3.15e-6	Lymphocyte counts;
SKCM	cis	rs72615157	0.634	rs79986079	chr7:99802044	C/T	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.04	6.47	0.59	7.78e-9	Lung function (FEV1/FVC);
SKCM	cis	rs7523050	0.730	rs12726126	chr1:109436128	A/G	cg08274380	chr1:109419600	GPSM2	1.15	6.57	0.6	5.22e-9	Fat distribution (HIV);
SKCM	cis	rs7826238	0.539	rs2945891	chr8:8155475	C/T	cg06636001	chr8:8085503	FLJ10661	0.68	5.43	0.52	6.23e-7	Systolic blood pressure;
SKCM	cis	rs6977660	1.000	rs6955510	chr7:19821333	G/C	cg07541023	chr7:19748670	TWISTNB	0.7	4.82	0.48	6.98e-6	Thyroid stimulating hormone;
SKCM	cis	rs644799	1.000	rs10831431	chr11:95510089	C/T	cg03916912	chr11:95522834	CEP57;FAM76B	0.94	8.46	0.69	1.18e-12	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs2286503	0.839	rs4722188	chr7:22860211	C/G	cg15401507	chr7:22894281	NA	-0.57	-5.61	-0.54	2.99e-7	Fibrinogen;
SKCM	cis	rs11105298	0.891	rs10858900	chr12:89925081	C/A	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.87	-5.78	-0.55	1.46e-7	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs1348850	0.567	rs4144276	chr2:178523420	T/C	cg22681709	chr2:178499509	PDE11A	-0.69	-6.21	-0.57	2.44e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs9611565	0.592	rs5758406	chr22:42076641	A/G	cg03806693	chr22:41940476	POLR3H	1.11	7.55	0.65	7.06e-11	Vitiligo;
SKCM	cis	rs2303759	0.881	rs10412811	chr19:49884495	G/A	cg05022225	chr19:49866942	DKKL1;TEAD2	0.68	5.1	0.5	2.31e-6	Multiple sclerosis;
SKCM	cis	rs10876993	0.784	rs1871417	chr12:58018979	C/T	cg04478727	chr12:58166393	METTL1;FAM119B	0.67	5.16	0.5	1.83e-6	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs9911578	1.000	rs9807057	chr17:56889952	A/C	cg05425664	chr17:57184151	TRIM37	-0.69	-5.21	-0.51	1.52e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs208520	0.690	rs207094	chr6:66799009	G/A	cg07460842	chr6:66804631	NA	-1.02	-7.65	-0.65	4.42e-11	Exhaled nitric oxide output;
SKCM	cis	rs2439831	0.867	rs2412778	chr15:43660982	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.39	9.42	0.73	1.62e-14	Lung cancer in ever smokers;
SKCM	cis	rs7954584	0.635	rs7137218	chr12:122342877	G/T	cg22618164	chr12:122356400	WDR66	0.5	5.01	0.49	3.31e-6	Mean corpuscular volume;
SKCM	cis	rs8060686	0.641	rs79375669	chr16:68099262	A/T	cg04539111	chr16:67997858	SLC12A4	-0.85	-4.81	-0.48	7.14e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs28595532	0.920	rs116548907	chr4:119735285	G/A	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs9926296	0.533	rs10852623	chr16:89865242	T/C	cg26513180	chr16:89883248	FANCA	0.98	11.26	0.79	5.13e-18	Vitiligo;
SKCM	cis	rs654950	0.806	rs941971	chr1:42040893	T/C	cg06885757	chr1:42089581	HIVEP3	-0.66	-6.75	-0.61	2.33e-9	Airway imaging phenotypes;
SKCM	cis	rs4642101	0.560	rs4535210	chr3:12839617	T/G	cg05775895	chr3:12838266	CAND2	0.58	4.95	0.49	4.19e-6	QRS complex (12-leadsum);
SKCM	cis	rs35306767	0.903	rs12778891	chr10:950130	T/A	cg26597838	chr10:835615	NA	0.77	5.39	0.52	7.26e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs17345786	0.520	rs13062677	chr3:101305078	G/A	cg12386194	chr3:101231763	SENP7	0.64	5.74	0.54	1.76e-7	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs507080	0.883	rs563549	chr11:118558953	G/A	cg18045108	chr11:118530628	TREH	-0.47	-4.81	-0.48	7.24e-6	Serum metabolite levels;
SKCM	cis	rs9467773	0.620	rs9295701	chr6:26627508	T/C	cg15659132	chr6:26577336	NA	0.62	5.4	0.52	6.91e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs9399137	0.507	rs7771310	chr6:135272535	G/A	cg24558204	chr6:135376177	HBS1L	0.69	6.37	0.58	1.23e-8	Glycated hemoglobin levels;Mean corpuscular volume;Hematology traits;HbA2 levels;Mean corpuscular hemoglobin;Hemoglobin levels;F-cell distribution;Platelet count;
SKCM	cis	rs362272	0.505	rs13104157	chr4:3366950	T/C	cg05297308	chr4:3317976	RGS12	1.05	14.05	0.85	4.49e-23	Serum sulfate level;
SKCM	cis	rs478304	0.580	rs11606947	chr11:65508237	A/C	cg27068330	chr11:65405492	SIPA1	-0.89	-8.2	-0.68	3.77e-12	Acne (severe);
SKCM	cis	rs11252926	0.507	rs4881199	chr10:428090	C/G	cg18196295	chr10:418757	DIP2C	0.58	4.85	0.48	6.24e-6	Psychosis in Alzheimer's disease;
SKCM	cis	rs9902453	0.933	rs2054846	chr17:28507693	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.75	-5.19	-0.51	1.6e-6	Coffee consumption (cups per day);
SKCM	cis	rs6424115	1.000	rs1018396	chr1:24133612	G/A	cg15997130	chr1:24165203	NA	0.63	5.51	0.53	4.53e-7	Immature fraction of reticulocytes;
SKCM	cis	rs472402	0.560	rs2288447	chr5:6626091	C/T	cg10789808	chr5:6633262	NSUN2;SRD5A1	-0.73	-4.94	-0.49	4.35e-6	Response to amphetamines;
SKCM	cis	rs2153535	0.601	rs9502715	chr6:8455709	C/T	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs950027	0.572	rs12910764	chr15:45609360	T/C	cg21132104	chr15:45694354	SPATA5L1	-0.77	-5.25	-0.51	1.27e-6	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs501916	0.605	rs11070612	chr15:48073174	C/G	cg16110827	chr15:48056943	SEMA6D	-0.62	-4.79	-0.48	7.7e-6	Inflammatory bowel disease;Ulcerative colitis;
SKCM	cis	rs870825	0.655	rs28451943	chr4:185645572	C/T	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs11719291	0.504	rs71324924	chr3:48865444	G/A	cg00383909	chr3:49044727	WDR6	0.95	5.43	0.52	6.25e-7	Cognitive function;
SKCM	cis	rs3091242	0.933	rs932372	chr1:25755014	G/A	cg02931644	chr1:25747376	RHCE	0.53	5.23	0.51	1.37e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs6952808	0.531	rs73039217	chr7:2178731	G/A	cg02951883	chr7:2050386	MAD1L1	-0.77	-6.09	-0.57	4.05e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs514406	0.644	rs1855127	chr1:53199594	A/G	cg24675658	chr1:53192096	ZYG11B	0.64	5.3	0.51	1.04e-6	Monocyte count;
SKCM	cis	rs60871478	0.838	rs12530859	chr7:835034	G/A	cg05535760	chr7:792225	HEATR2	-1.11	-9.37	-0.73	2.07e-14	Cerebrospinal P-tau181p levels;
SKCM	cis	rs2180341	0.782	rs4487601	chr6:127723521	A/G	cg24812749	chr6:127587940	RNF146	0.6	4.8	0.48	7.4e-6	Breast cancer;
SKCM	cis	rs7937682	0.562	rs10891276	chr11:111370415	A/C	cg09085632	chr11:111637200	PPP2R1B	-0.68	-5.46	-0.53	5.52e-7	Primary sclerosing cholangitis;
SKCM	trans	rs9929218	0.508	rs6499194	chr16:68744100	T/C	cg04657470	chr2:198365150	HSPE1;HSPD1	0.96	9.38	0.73	1.98e-14	Colorectal cancer;
SKCM	cis	rs875971	0.789	rs7808013	chr7:66071196	A/G	cg11764359	chr7:65958608	NA	-0.74	-6.63	-0.6	3.89e-9	Aortic root size;
SKCM	cis	rs10751667	0.643	rs11246348	chr11:939476	G/C	cg10932868	chr11:921992	NA	0.55	5.13	0.5	2.09e-6	Alzheimer's disease (late onset);
SKCM	cis	rs9886651	0.935	rs28660151	chr8:128803578	A/T	cg24514600	chr8:128805414	PVT1	-0.55	-5.05	-0.5	2.87e-6	Epithelial ovarian cancer;Serous invasive ovarian cancer;
SKCM	cis	rs595982	0.510	rs3826817	chr19:49401444	C/T	cg19746536	chr19:49375674	PPP1R15A	1.13	8.49	0.69	1.06e-12	Red cell distribution width;
SKCM	cis	rs2180341	0.618	rs4502958	chr6:127593113	G/A	cg24812749	chr6:127587940	RNF146	0.59	4.84	0.48	6.36e-6	Breast cancer;
SKCM	cis	rs1707322	0.721	rs10749856	chr1:46164846	A/T	cg03146154	chr1:46216737	IPP	0.84	6.2	0.57	2.51e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs1577917	0.740	rs2842614	chr6:86306069	G/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.75	-6.74	-0.61	2.43e-9	Response to antipsychotic treatment;
SKCM	cis	rs7927771	1.000	rs7105282	chr11:47805614	C/A	cg05585544	chr11:47624801	NA	-0.6	-5.22	-0.51	1.45e-6	Subjective well-being;
SKCM	cis	rs4665809	0.627	rs35461456	chr2:26482361	C/G	cg26119090	chr2:26468346	HADHA;HADHB	1.06	8.39	0.69	1.66e-12	Gut microbiome composition (summer);
SKCM	cis	rs2836974	0.627	rs9981301	chr21:40686078	G/C	cg11644478	chr21:40555479	PSMG1	-0.64	-5.33	-0.52	9.27e-7	Cognitive function;
SKCM	cis	rs11690935	0.589	rs2271758	chr2:172701157	T/G	cg13550731	chr2:172543902	DYNC1I2	0.58	5.02	0.49	3.17e-6	Schizophrenia;
SKCM	cis	rs12497850	0.931	rs62262517	chr3:49134914	T/G	cg07636037	chr3:49044803	WDR6	1.06	11.54	0.79	1.54e-18	Parkinson's disease;
SKCM	cis	rs4820539	0.933	rs2267004	chr22:23459863	G/A	cg14186256	chr22:23484241	RTDR1	0.86	8.53	0.69	8.71e-13	Bone mineral density;
SKCM	cis	rs7772486	0.641	rs9390370	chr6:146357569	C/T	cg23711669	chr6:146136114	FBXO30	0.78	6.39	0.59	1.12e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs28386778	0.897	rs2584608	chr17:61936710	A/G	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.36	0.52	8.08e-7	Prudent dietary pattern;
SKCM	cis	rs7829975	0.688	rs7817376	chr8:8380530	C/T	cg08975724	chr8:8085496	FLJ10661	-0.66	-5.18	-0.51	1.71e-6	Mood instability;
SKCM	cis	rs4481887	0.927	rs4603165	chr1:248473799	T/A	cg00666640	chr1:248458726	OR2T12	0.66	6.0	0.56	5.9e-8	Common traits (Other);
SKCM	cis	rs7666738	0.791	rs2081621	chr4:98926753	C/A	cg17366294	chr4:99064904	C4orf37	0.58	4.86	0.48	5.92e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11098499	0.954	rs10034623	chr4:120397829	G/A	cg09307838	chr4:120376055	NA	0.97	7.65	0.65	4.54e-11	Corneal astigmatism;
SKCM	cis	rs875971	0.516	rs6945322	chr7:65336056	T/C	cg11987759	chr7:65425863	GUSB	-0.75	-6.42	-0.59	9.94e-9	Aortic root size;
SKCM	cis	rs7100689	0.577	rs2236569	chr10:82043576	G/A	cg01528321	chr10:82214614	TSPAN14	0.79	7.79	0.66	2.36e-11	Post bronchodilator FEV1;
SKCM	cis	rs854765	0.583	rs7213225	chr17:17869111	T/C	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.01	7.49	0.65	9.28e-11	Total body bone mineral density;
SKCM	cis	rs7659604	1.000	rs28433617	chr4:122664138	C/A	cg06713675	chr4:122721982	EXOSC9	-0.65	-5.83	-0.55	1.21e-7	Type 2 diabetes;
SKCM	cis	rs7945705	0.747	rs2568020	chr11:8994715	C/T	cg21881798	chr11:8931708	C11orf17;ST5	-0.82	-8.76	-0.7	3.2e-13	Hemoglobin concentration;
SKCM	cis	rs10193935	0.901	rs10490552	chr2:42559947	C/T	cg27598129	chr2:42591480	NA	0.88	6.71	0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs561341	1.000	rs497479	chr17:30328605	C/T	cg00745463	chr17:30367425	LRRC37B	-1.14	-8.21	-0.68	3.68e-12	Hip circumference adjusted for BMI;
SKCM	cis	rs478304	0.651	rs4014195	chr11:65506822	C/G	cg17480646	chr11:65405466	SIPA1	0.66	5.43	0.52	6.07e-7	Acne (severe);
SKCM	cis	rs1707322	0.721	rs10430124	chr1:46221617	C/T	cg03146154	chr1:46216737	IPP	0.81	6.0	0.56	5.79e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs5750830	0.649	rs4821894	chr22:39809820	G/C	cg24399712	chr22:39784796	NA	-0.61	-5.07	-0.5	2.66e-6	Intelligence (multi-trait analysis);
SKCM	trans	rs1814175	0.935	rs7950947	chr11:49668369	C/T	cg03929089	chr4:120376271	NA	-0.87	-7.53	-0.65	7.73e-11	Height;
SKCM	cis	rs651907	0.557	rs3094295	chr3:101401995	T/C	cg12386194	chr3:101231763	SENP7	0.69	5.68	0.54	2.23e-7	Colorectal cancer;
SKCM	cis	rs55962025	0.883	rs2298967	chr4:3185747	T/C	cg24015175	chr4:3319247	RGS12	-0.55	-5.03	-0.5	3.01e-6	Parental longevity (mother's age at death);
SKCM	cis	rs875971	0.660	rs3764903	chr7:66098482	G/A	cg18876405	chr7:65276391	NA	-0.82	-7.48	-0.65	9.41e-11	Aortic root size;
SKCM	cis	rs11595238	0.792	rs11595324	chr10:101979418	C/T	cg13198709	chr10:102473456	NA	0.8	4.84	0.48	6.36e-6	Response to radiotherapy in cancer (late toxicity);
SKCM	cis	rs2404602	0.735	rs2436996	chr15:76817420	C/T	cg23625390	chr15:77176239	SCAPER	-0.83	-8.16	-0.68	4.7e-12	Blood metabolite levels;
SKCM	cis	rs3096299	0.542	rs1078578	chr16:89386934	G/A	cg07708487	chr16:89387014	ANKRD11	-0.46	-5.06	-0.5	2.72e-6	Multiple myeloma (IgH translocation);
SKCM	cis	rs7552404	0.889	rs1250874	chr1:76190978	A/G	cg03433033	chr1:76189801	ACADM	0.76	5.6	0.54	3.12e-7	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs6570726	0.516	rs9376932	chr6:145729490	T/C	cg23711669	chr6:146136114	FBXO30	0.6	5.36	0.52	8.18e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs72781680	0.948	rs72796319	chr2:24133027	T/C	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	cis	rs9325144	0.647	rs1386018	chr12:39104360	C/T	cg26384229	chr12:38710491	ALG10B	-0.72	-6.39	-0.59	1.12e-8	Morning vs. evening chronotype;
SKCM	cis	rs2075671	0.903	rs62482252	chr7:100274063	C/A	cg20848291	chr7:100343083	ZAN	-0.72	-5.3	-0.51	1.05e-6	Other erythrocyte phenotypes;
SKCM	cis	rs2242194	0.816	rs6671688	chr1:154994265	T/C	cg06221963	chr1:154839813	KCNN3	-0.53	-5.33	-0.52	9.25e-7	Schizophrenia;
SKCM	cis	rs34375054	0.660	rs58624919	chr12:125596458	G/A	cg25124228	chr12:125621409	AACS	-0.71	-5.63	-0.54	2.74e-7	Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs28386778	0.787	rs2665827	chr17:61961350	G/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	10.87	0.78	2.82e-17	Prudent dietary pattern;
SKCM	cis	rs2839186	0.869	rs17176513	chr21:47682428	A/G	cg11766577	chr21:47581405	C21orf56	-0.79	-6.67	-0.6	3.39e-9	Testicular germ cell tumor;
SKCM	cis	rs472402	0.560	rs10037161	chr5:6624294	C/A	cg10789808	chr5:6633262	NSUN2;SRD5A1	-0.73	-4.81	-0.48	7.09e-6	Response to amphetamines;
SKCM	cis	rs4523957	0.620	rs9906467	chr17:2069003	C/T	cg16513277	chr17:2031491	SMG6	-0.92	-6.31	-0.58	1.54e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs801193	0.967	rs2707849	chr7:66152712	T/C	cg11987759	chr7:65425863	GUSB	-0.69	-5.9	-0.56	8.74e-8	Aortic root size;
SKCM	cis	rs2188420	0.872	rs17847825	chr7:106509331	C/A	cg23615938	chr7:105753134	SYPL1	-0.89	-5.08	-0.5	2.49e-6	Interferon gamma levels;
SKCM	cis	rs10905065	0.827	rs10752111	chr10:5837286	T/C	cg09234995	chr10:5726438	C10orf18	-0.59	-5.03	-0.49	3.1e-6	Menopause (age at onset);
SKCM	cis	rs2839186	0.843	rs17182671	chr21:47696238	T/C	cg05896524	chr21:47604654	C21orf56	0.67	5.45	0.53	5.71e-7	Testicular germ cell tumor;
SKCM	cis	rs4132509	0.744	rs12124113	chr1:243904366	A/G	cg21452805	chr1:244014465	NA	0.93	6.05	0.57	4.77e-8	RR interval (heart rate);
SKCM	cis	rs6500395	0.962	rs9937623	chr16:48571590	A/T	cg04672837	chr16:48644449	N4BP1	-0.73	-6.06	-0.57	4.45e-8	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs73194058	1	rs73194058	chr21:34764288	C/A	cg14850771	chr21:34775459	IFNGR2	0.85	4.82	0.48	6.98e-6	Rheumatoid arthritis;
SKCM	cis	rs798554	0.797	rs798487	chr7:2802943	G/A	cg04166393	chr7:2884313	GNA12	0.77	5.26	0.51	1.23e-6	Height;
SKCM	cis	rs829883	0.872	rs1641641	chr12:98896018	A/C	cg25150519	chr12:98850993	NA	0.5	5.3	0.51	1.07e-6	Colorectal adenoma (advanced);
SKCM	cis	rs732765	0.734	rs4899530	chr14:75165825	A/G	cg15890469	chr14:75408846	PGF	-0.61	-5.01	-0.49	3.36e-6	Non-small cell lung cancer;
SKCM	cis	rs9894429	1.000	rs35435780	chr17:79579602	G/T	cg18240062	chr17:79603768	NPLOC4	0.76	7.43	0.64	1.2e-10	Eye color traits;
SKCM	cis	rs6598955	0.666	rs12759434	chr1:26607123	C/T	cg00938395	chr1:26633206	UBXN11	0.68	4.85	0.48	6.08e-6	Obesity-related traits;
SKCM	cis	rs1348850	0.609	rs1348851	chr2:178418677	C/T	cg02961200	chr2:178257176	LOC100130691;AGPS	-0.98	-5.68	-0.54	2.26e-7	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs2455601	0.882	rs11042115	chr11:8926679	A/C	cg21881798	chr11:8931708	C11orf17;ST5	-0.78	-5.59	-0.53	3.21e-7	Schizophrenia;
SKCM	cis	rs12142240	0.731	rs6681857	chr1:46850124	T/C	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs8077889	0.672	rs2074143	chr17:41856622	A/G	cg26893861	chr17:41843967	DUSP3	1.39	13.03	0.83	2.86e-21	Triglycerides;
SKCM	cis	rs10193935	0.901	rs222488	chr2:42648570	T/G	cg27598129	chr2:42591480	NA	-0.88	-6.71	-0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs12474201	0.851	rs56288593	chr2:47018772	G/A	cg06386533	chr2:46925753	SOCS5	0.86	7.1	0.63	5.15e-10	Height;
SKCM	cis	rs4819052	1.000	rs3746980	chr21:46711580	C/T	cg02159808	chr21:46707872	POFUT2;LOC642852	0.8	5.66	0.54	2.43e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs769267	1.000	rs3764567	chr19:19440066	C/T	cg03709012	chr19:19516395	GATAD2A	-0.83	-6.82	-0.61	1.7e-9	Tonsillectomy;
SKCM	cis	rs362296	0.698	rs362266	chr4:3259632	C/G	cg00764545	chr4:3318001	RGS12	-0.69	-6.17	-0.57	2.86e-8	Parental longevity (mother's age at death);
SKCM	cis	rs1850744	0.702	rs1961552	chr4:9608306	A/C	cg15442990	chr4:9534313	NA	-1.55	-5.83	-0.55	1.18e-7	Economic and political preferences;
SKCM	cis	rs9543976	1.000	rs2296146	chr13:76143572	T/C	cg01531495	chr13:76123901	UCHL3	-0.92	-5.02	-0.49	3.17e-6	Diabetic retinopathy;
SKCM	cis	rs7659604	0.676	rs7691955	chr4:122700462	A/T	cg20573242	chr4:122745356	CCNA2	0.75	6.23	0.58	2.18e-8	Type 2 diabetes;
SKCM	cis	rs155076	1.000	rs658244	chr13:21850976	T/C	cg14456004	chr13:21872349	NA	-1.22	-6.76	-0.61	2.24e-9	White matter hyperintensity burden;
SKCM	cis	rs1348850	0.914	rs12616443	chr2:178315751	A/G	cg02961200	chr2:178257176	LOC100130691;AGPS	0.82	6.29	0.58	1.72e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs155076	1.000	rs261427	chr13:21860998	G/A	cg14456004	chr13:21872349	NA	-1.28	-7.28	-0.64	2.31e-10	White matter hyperintensity burden;
SKCM	cis	rs10028773	0.515	rs9994651	chr4:120587803	C/T	cg09307838	chr4:120376055	NA	0.91	7.58	0.65	6.11e-11	Educational attainment;
SKCM	cis	rs12477438	0.520	rs4402818	chr2:99717608	A/G	cg14399236	chr2:99771627	LIPT1;TSGA10	0.95	8.78	0.71	2.89e-13	Chronic sinus infection;
SKCM	cis	rs7811142	1.000	rs113738841	chr7:100081306	C/T	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.25	0.68	3.05e-12	Platelet count;
SKCM	cis	rs1974653	0.552	rs450977	chr22:20058863	T/A	cg26372423	chr22:20067491	DGCR8	0.66	4.77	0.48	8.49e-6	Schizophrenia;
SKCM	cis	rs1218582	0.803	rs7531728	chr1:154840516	C/A	cg03351412	chr1:154909251	PMVK	0.75	6.65	0.6	3.64e-9	Prostate cancer;
SKCM	cis	rs2836974	0.644	rs2836981	chr21:40688365	C/T	cg11890956	chr21:40555474	PSMG1	-0.81	-7.58	-0.65	6.22e-11	Cognitive function;
SKCM	cis	rs28595532	0.920	rs116305850	chr4:119779892	A/G	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs9325144	0.647	rs11168104	chr12:38857616	G/T	cg26384229	chr12:38710491	ALG10B	-0.75	-6.25	-0.58	2.06e-8	Morning vs. evening chronotype;
SKCM	cis	rs67311347	0.544	rs9821440	chr3:40342347	T/C	cg13409248	chr3:40428643	ENTPD3	0.58	5.61	0.54	2.98e-7	Renal cell carcinoma;
SKCM	cis	rs10504229	0.683	rs79262965	chr8:58129826	G/T	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs7809950	1.000	rs17154077	chr7:107077941	C/T	cg23024343	chr7:107201750	COG5	0.82	7.4	0.64	1.38e-10	Coronary artery disease;
SKCM	cis	rs6840360	0.615	rs4696094	chr4:152465501	C/T	cg22705602	chr4:152727874	NA	-0.51	-5.78	-0.55	1.45e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs992157	0.560	rs12992937	chr2:219087072	A/T	cg00012203	chr2:219082015	ARPC2	-0.78	-6.52	-0.59	6.36e-9	Colorectal cancer;
SKCM	cis	rs995000	0.899	rs1781221	chr1:63006842	A/C	cg06896770	chr1:63153194	DOCK7	-0.73	-6.62	-0.6	4.11e-9	Triglyceride levels;
SKCM	cis	rs2204008	0.774	rs11514062	chr12:38332297	A/C	cg26384229	chr12:38710491	ALG10B	0.78	6.66	0.6	3.54e-9	Bladder cancer;
SKCM	cis	rs1799949	1.000	rs36036395	chr17:41181297	T/C	cg05368731	chr17:41323189	NBR1	0.86	7.39	0.64	1.39e-10	Menopause (age at onset);
SKCM	cis	rs6121246	0.609	rs6060955	chr20:30385071	A/G	cg13852791	chr20:30311386	BCL2L1	0.82	5.64	0.54	2.59e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs7523273	0.606	rs2281289	chr1:207978916	C/T	cg22525895	chr1:207977042	MIR29B2	-0.78	-6.66	-0.6	3.53e-9	Schizophrenia;
SKCM	cis	rs826838	0.935	rs3886109	chr12:39189243	C/T	cg26384229	chr12:38710491	ALG10B	0.9	7.85	0.66	1.84e-11	Heart rate;
SKCM	cis	rs2243480	1.000	rs34815098	chr7:65292254	A/C	cg07424592	chr7:64974309	NA	0.99	4.9	0.49	5.08e-6	Diabetic kidney disease;
SKCM	cis	rs9902453	0.740	rs2254414	chr17:28061130	G/A	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.77	-5.52	-0.53	4.29e-7	Coffee consumption (cups per day);
SKCM	cis	rs2013441	1.000	rs2703778	chr17:20138900	T/C	cg13482628	chr17:19912719	NA	-0.64	-5.08	-0.5	2.48e-6	Obesity-related traits;
SKCM	cis	rs17376456	0.877	rs13156865	chr5:93390908	C/A	cg21475434	chr5:93447410	FAM172A	0.95	5.35	0.52	8.56e-7	Diabetic retinopathy;
SKCM	cis	rs9467773	1.000	rs1056667	chr6:26510564	T/C	cg15659132	chr6:26577336	NA	0.61	5.82	0.55	1.24e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs1799949	1.000	rs34572725	chr17:41428666	G/A	cg05368731	chr17:41323189	NBR1	0.85	7.42	0.64	1.23e-10	Menopause (age at onset);
SKCM	cis	rs1348850	0.668	rs4893972	chr2:178496874	T/C	cg27490568	chr2:178487706	NA	0.79	5.95	0.56	7.25e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs826838	0.935	rs1719855	chr12:39127242	C/T	cg13010199	chr12:38710504	ALG10B	-0.77	-6.19	-0.57	2.66e-8	Heart rate;
SKCM	cis	rs7940866	0.874	rs1433979	chr11:130871617	G/A	cg12179176	chr11:130786555	SNX19	0.74	5.83	0.55	1.19e-7	Schizophrenia;
SKCM	cis	rs8017423	0.967	rs7158180	chr14:90729117	C/T	cg04374321	chr14:90722782	PSMC1	1.0	9.0	0.71	1.09e-13	Mortality in heart failure;
SKCM	trans	rs1814175	0.645	rs847632	chr11:49926097	C/T	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs9790314	1.000	rs1382426	chr3:161045933	G/A	cg03342759	chr3:160939853	NMD3	-0.7	-7.33	-0.64	1.85e-10	Morning vs. evening chronotype;
SKCM	cis	rs6430585	0.646	rs12476116	chr2:136497199	A/G	cg07169764	chr2:136633963	MCM6	1.3	12.01	0.81	2.06e-19	Corneal structure;
SKCM	cis	rs9790314	0.687	rs1037888	chr3:160775251	A/T	cg03342759	chr3:160939853	NMD3	-0.6	-5.62	-0.54	2.79e-7	Morning vs. evening chronotype;
SKCM	cis	rs17361889	0.727	rs62440394	chr7:16254633	T/C	cg09714114	chr7:16439993	ISPD	0.51	5.14	0.5	1.98e-6	Pediatric bone mineral content (hip);
SKCM	cis	rs2404602	0.716	rs1874944	chr15:76863928	A/G	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs951366	0.789	rs823121	chr1:205724302	A/G	cg26354017	chr1:205819088	PM20D1	-1.0	-8.94	-0.71	1.44e-13	Menarche (age at onset);
SKCM	cis	rs8072100	0.840	rs56952963	chr17:45493826	T/C	cg25173405	chr17:45401733	C17orf57	-0.57	-4.77	-0.48	8.45e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	trans	rs1814175	0.817	rs4881658	chr11:49941123	G/A	cg03929089	chr4:120376271	NA	-0.93	-8.8	-0.71	2.58e-13	Height;
SKCM	cis	rs561341	1.000	rs2470243	chr17:30290955	C/T	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs873946	0.648	rs12766050	chr10:134549108	G/A	cg26818010	chr10:134567672	INPP5A	-0.72	-5.59	-0.54	3.18e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs10905065	1.000	rs10737013	chr10:5746772	C/G	cg11519256	chr10:5708881	ASB13	0.6	5.54	0.53	3.88e-7	Menopause (age at onset);
SKCM	cis	rs5760092	0.755	rs4585126	chr22:24270005	T/C	cg04234412	chr22:24373322	LOC391322	0.79	6.25	0.58	2e-8	Urinary 1,3-butadiene metabolite levels in smokers;
SKCM	cis	rs13118159	0.509	rs7688922	chr4:1361011	T/C	cg05025164	chr4:1340916	KIAA1530	0.9	7.21	0.63	3.08e-10	Longevity;
SKCM	cis	rs941408	1.000	rs941406	chr19:2803623	A/G	cg06609049	chr19:2785107	THOP1	0.81	7.09	0.63	5.25e-10	Total cholesterol levels;
SKCM	cis	rs5760092	0.755	rs4585126	chr22:24270005	T/C	cg25703541	chr22:24373054	LOC391322	0.77	5.43	0.52	6.16e-7	Urinary 1,3-butadiene metabolite levels in smokers;
SKCM	cis	rs6951245	0.938	rs112425403	chr7:1071531	A/G	cg18402987	chr7:1209562	NA	1.17	6.07	0.57	4.31e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs56104184	0.775	rs117744769	chr19:49402686	G/T	cg19746536	chr19:49375674	PPP1R15A	1.16	5.93	0.56	7.67e-8	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs28595532	0.920	rs115673173	chr4:119755321	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs57221529	0.713	rs72703072	chr5:590626	A/G	cg26208419	chr5:473447	SLC9A3;LOC25845	1.01	5.18	0.51	1.7e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs1005277	0.579	rs1780116	chr10:38526621	C/T	cg25427524	chr10:38739819	LOC399744	-0.76	-6.92	-0.62	1.13e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs1211375	0.607	rs1203978	chr16:257211	A/C	cg03788090	chr16:233062	NA	0.54	4.96	0.49	3.97e-6	Hematology traits;Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs2836950	0.565	rs8130320	chr21:40580258	C/T	cg11644478	chr21:40555479	PSMG1	-0.64	-5.02	-0.49	3.17e-6	Menarche (age at onset);
SKCM	cis	rs951366	0.764	rs823141	chr1:205741426	T/C	cg17178900	chr1:205818956	PM20D1	0.78	6.68	0.6	3.15e-9	Menarche (age at onset);
SKCM	cis	rs1692580	0.682	rs12045693	chr1:2205581	A/C	cg21442419	chr1:2182373	SKI	0.52	5.07	0.5	2.65e-6	Coronary artery disease;
SKCM	cis	rs1801251	1.000	rs13004406	chr2:233584557	A/T	cg25237894	chr2:233734115	C2orf82	-0.61	-5.66	-0.54	2.39e-7	Coronary artery disease;
SKCM	cis	rs769267	0.930	rs10282	chr19:19619317	T/C	cg03709012	chr19:19516395	GATAD2A	0.89	8.62	0.7	5.89e-13	Tonsillectomy;
SKCM	cis	rs6952808	0.624	rs60137119	chr7:2083664	A/G	cg02951883	chr7:2050386	MAD1L1	-0.83	-7.54	-0.65	7.43e-11	Bipolar disorder and schizophrenia;
SKCM	cis	rs875971	0.545	rs11766183	chr7:65839160	G/C	cg18876405	chr7:65276391	NA	0.63	5.0	0.49	3.41e-6	Aortic root size;
SKCM	cis	rs2952156	1.000	rs2088126	chr17:37879030	A/G	cg20243544	chr17:37824526	PNMT	0.69	5.57	0.53	3.53e-7	Asthma;
SKCM	cis	rs1707322	0.896	rs785512	chr1:46534543	A/G	cg03146154	chr1:46216737	IPP	-0.83	-5.56	-0.53	3.62e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs2999052	0.526	rs2335771	chr3:127779944	A/G	cg09089421	chr3:127803668	RUVBL1	-0.6	-5.75	-0.55	1.63e-7	Hypospadias;
SKCM	cis	rs910316	0.967	rs4899545	chr14:75568138	A/G	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.89e-7	Height;
SKCM	cis	rs6951245	1.000	rs111899361	chr7:1112348	C/T	cg03188948	chr7:1209495	NA	1.13	6.27	0.58	1.89e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs2014572	0.967	rs8100154	chr19:57765432	A/G	cg24459738	chr19:57751996	ZNF805	-0.64	-5.17	-0.5	1.79e-6	Hyperactive-impulsive symptoms;
SKCM	cis	rs897984	0.645	rs9938550	chr16:30999142	A/G	cg00531865	chr16:30841666	NA	0.59	4.97	0.49	3.81e-6	Dementia with Lewy bodies;
SKCM	cis	rs1912528	0.928	rs12504594	chr4:140909793	C/A	cg11128457	chr4:140864437	MAML3	0.58	4.88	0.48	5.47e-6	Educational attainment (years of education);
SKCM	cis	rs1691799	0.899	rs1168310	chr12:66726355	A/G	cg16791601	chr12:66731901	HELB	0.58	4.98	0.49	3.7e-6	White blood cell count (basophil);
SKCM	cis	rs9325144	0.647	rs7980932	chr12:38921583	G/T	cg13010199	chr12:38710504	ALG10B	-0.67	-5.69	-0.54	2.15e-7	Morning vs. evening chronotype;
SKCM	cis	rs2204008	0.621	rs7302846	chr12:38072979	A/C	cg26384229	chr12:38710491	ALG10B	0.7	5.7	0.54	2.02e-7	Bladder cancer;
SKCM	cis	rs1210638	0.575	rs11703200	chr22:18959169	G/A	cg14259594	chr22:18958660	DGCR5	0.66	5.08	0.5	2.49e-6	Response to serotonin reuptake inhibitors in major depressive disorder;
SKCM	cis	rs10927875	0.632	rs7535248	chr1:16129598	C/T	cg21385522	chr1:16154831	NA	-0.98	-11.21	-0.79	6.28e-18	Dilated cardiomyopathy;
SKCM	cis	rs7215564	0.818	rs76704328	chr17:78585954	T/G	cg16980736	chr17:78789706	RPTOR	-0.89	-4.87	-0.48	5.8e-6	Myopia (pathological);
SKCM	cis	rs873946	0.586	rs12767391	chr10:134573844	A/G	cg26818010	chr10:134567672	INPP5A	0.77	6.19	0.57	2.56e-8	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs951366	0.677	rs1775140	chr1:205672107	C/A	cg07157834	chr1:205819609	PM20D1	0.69	5.84	0.55	1.16e-7	Menarche (age at onset);
SKCM	cis	rs11098499	0.863	rs6833334	chr4:120504227	C/T	cg09307838	chr4:120376055	NA	1.0	8.27	0.68	2.8e-12	Corneal astigmatism;
SKCM	cis	rs11098499	0.954	rs71629403	chr4:120372567	C/T	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs35306767	0.622	rs66462130	chr10:1022108	C/T	cg20503657	chr10:835505	NA	0.75	5.94	0.56	7.41e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs2777491	0.915	rs8032838	chr15:41605632	G/A	cg18705301	chr15:41695430	NDUFAF1	-0.96	-9.11	-0.72	6.65e-14	Ulcerative colitis;
SKCM	cis	rs826838	0.510	rs10506129	chr12:39224242	A/T	cg26384229	chr12:38710491	ALG10B	0.68	5.11	0.5	2.28e-6	Heart rate;
SKCM	cis	rs1790761	0.520	rs1551884	chr11:67399601	C/G	cg24690094	chr11:67383802	NA	-0.57	-5.96	-0.56	6.91e-8	Mean corpuscular volume;
SKCM	cis	rs8060686	0.544	rs1124993	chr16:68114626	T/C	cg09117114	chr16:67998030	SLC12A4	-0.81	-5.24	-0.51	1.31e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs1577917	0.958	rs16876530	chr6:86595641	T/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.61	-5.27	-0.51	1.18e-6	Response to antipsychotic treatment;
SKCM	cis	rs854765	0.822	rs1889014	chr17:17767165	C/T	cg04398451	chr17:18023971	MYO15A	0.75	5.36	0.52	8.28e-7	Total body bone mineral density;
SKCM	cis	rs875971	0.830	rs809025	chr7:65849819	C/G	cg18876405	chr7:65276391	NA	0.63	6.25	0.58	2.06e-8	Aortic root size;
SKCM	cis	rs4665809	0.556	rs4665322	chr2:26434605	C/G	cg26119090	chr2:26468346	HADHA;HADHB	-1.02	-7.84	-0.66	1.89e-11	Gut microbiome composition (summer);
SKCM	cis	rs13118159	0.573	rs7664763	chr4:1352305	A/G	cg05025164	chr4:1340916	KIAA1530	0.91	7.32	0.64	1.93e-10	Longevity;
SKCM	cis	rs116095464	0.558	rs10462755	chr5:246748	T/C	cg22496380	chr5:211416	CCDC127	-0.89	-4.92	-0.49	4.78e-6	Breast cancer;
SKCM	cis	rs2404602	0.735	rs2461871	chr15:76822418	C/G	cg23625390	chr15:77176239	SCAPER	-0.8	-7.82	-0.66	2.05e-11	Blood metabolite levels;
SKCM	cis	rs1733410	0.504	rs11181874	chr12:37912890	C/A	cg26384229	chr12:38710491	ALG10B	-0.76	-6.24	-0.58	2.08e-8	Morning vs. evening chronotype;
SKCM	cis	rs35306767	0.903	rs12249634	chr10:872744	G/A	cg26597838	chr10:835615	NA	0.76	5.66	0.54	2.4e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs7829975	0.514	rs2920991	chr8:8259117	T/A	cg08975724	chr8:8085496	FLJ10661	0.61	5.0	0.49	3.47e-6	Mood instability;
SKCM	cis	rs1790761	0.520	rs12805884	chr11:67387977	G/A	cg14500267	chr11:67383377	NA	-0.52	-5.31	-0.52	1.01e-6	Mean corpuscular volume;
SKCM	cis	rs3771570	1.000	rs3771564	chr2:242355701	G/A	cg07612300	chr2:242033426	MTERFD2;SNED1	0.87	4.77	0.47	8.54e-6	Prostate cancer;
SKCM	cis	rs16866061	1.000	rs72974222	chr2:225424143	C/T	cg12698349	chr2:225449008	CUL3	1.01	8.51	0.69	9.75e-13	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs10504229	0.953	rs57131327	chr8:58171895	T/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs854765	0.624	rs12946746	chr17:17741669	T/C	cg04398451	chr17:18023971	MYO15A	0.71	4.78	0.48	8.23e-6	Total body bone mineral density;
SKCM	cis	rs4423214	1.000	rs4944957	chr11:71168035	C/T	cg05163923	chr11:71159392	DHCR7	-0.74	-7.01	-0.62	7.62e-10	Vitamin D levels;
SKCM	cis	rs459571	0.959	rs460888	chr9:136913123	C/G	cg13789015	chr9:136890014	NCRNA00094	0.7	5.41	0.52	6.6e-7	Platelet distribution width;
SKCM	cis	rs6951245	0.580	rs77101766	chr7:1122438	A/G	cg23708337	chr7:1209742	NA	0.71	4.82	0.48	6.9e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs732765	0.657	rs28567642	chr14:75235371	G/T	cg25946216	chr14:74253857	C14orf43	-0.94	-5.23	-0.51	1.36e-6	Non-small cell lung cancer;
SKCM	cis	rs10193935	1.000	rs13391906	chr2:42538617	C/G	cg27598129	chr2:42591480	NA	-0.88	-6.71	-0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4819052	0.851	rs28622522	chr21:46676599	G/T	cg20896738	chr21:46707857	POFUT2;LOC642852	0.64	4.82	0.48	6.85e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7020830	0.830	rs12554976	chr9:37244505	G/T	cg14294708	chr9:37120828	ZCCHC7	1.0	9.46	0.73	1.38e-14	Schizophrenia;
SKCM	cis	rs9303401	0.659	rs12940212	chr17:56674474	T/C	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.39	0.52	7.14e-7	Cognitive test performance;
SKCM	cis	rs2268241	0.938	rs9978223	chr21:34770358	G/A	cg14850771	chr21:34775459	IFNGR2	1.04	6.44	0.59	8.92e-9	Obesity-related traits;
SKCM	cis	rs854765	0.547	rs4643387	chr17:17972973	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.99	9.16	0.72	5.24e-14	Total body bone mineral density;
SKCM	cis	rs6582630	0.555	rs7956782	chr12:38603641	C/G	cg26384229	chr12:38710491	ALG10B	0.87	7.11	0.63	4.92e-10	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs4481887	0.741	rs11488135	chr1:248568961	G/A	cg22724847	chr1:248512586	OR14C36	0.58	4.87	0.48	5.72e-6	Common traits (Other);
SKCM	cis	rs748404	0.578	rs4547312	chr15:43632138	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	0.73	6.21	0.58	2.38e-8	Lung cancer;
SKCM	cis	rs4400599	0.618	rs9804045	chr1:154191691	C/T	cg26808167	chr1:154192205	UBAP2L;C1orf43	0.55	5.02	0.49	3.22e-6	Platelet distribution width;
SKCM	cis	rs7666738	0.830	rs17550610	chr4:99008273	T/C	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs875971	0.862	rs7796162	chr7:65745758	T/C	cg18876405	chr7:65276391	NA	-0.65	-6.66	-0.6	3.51e-9	Aortic root size;
SKCM	cis	rs941873	0.868	rs10740497	chr10:81126380	T/C	cg09469691	chr10:81107165	PPIF	0.71	6.8	0.61	1.89e-9	Height;
SKCM	cis	rs2204008	0.728	rs11495375	chr12:38282631	G/A	cg13010199	chr12:38710504	ALG10B	0.69	4.92	0.49	4.72e-6	Bladder cancer;
SKCM	cis	rs2404602	0.647	rs11852395	chr15:77087785	T/C	cg23625390	chr15:77176239	SCAPER	-0.85	-8.26	-0.68	2.93e-12	Blood metabolite levels;
SKCM	cis	rs7954584	0.635	rs7313252	chr12:122347600	G/A	cg13699009	chr12:122356056	WDR66	0.56	7.02	0.62	7.17e-10	Mean corpuscular volume;
SKCM	cis	rs644799	0.511	rs11021301	chr11:95485145	A/G	cg03916912	chr11:95522834	CEP57;FAM76B	0.68	5.15	0.5	1.93e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs34172651	0.517	rs874484	chr16:24803242	T/C	cg00339695	chr16:24857497	SLC5A11	0.8	6.43	0.59	9.38e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs9303401	0.659	rs12946397	chr17:56769979	C/T	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.16	0.57	2.91e-8	Cognitive test performance;
SKCM	cis	rs7666738	0.830	rs13101352	chr4:98957544	C/T	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2836950	0.501	rs2070865	chr21:40715519	C/T	cg17971929	chr21:40555470	PSMG1	-0.7	-5.22	-0.51	1.44e-6	Menarche (age at onset);
SKCM	cis	rs651907	0.535	rs11716558	chr3:101528481	T/C	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.78	6.72	0.61	2.65e-9	Colorectal cancer;
SKCM	cis	rs7666738	0.830	rs4699588	chr4:98973789	A/G	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2455601	0.744	rs11042107	chr11:8905871	G/T	cg21881798	chr11:8931708	C11orf17;ST5	-0.95	-5.93	-0.56	7.69e-8	Schizophrenia;
SKCM	cis	rs16949788	1.000	rs9672789	chr15:66713633	C/A	cg08120210	chr15:66682733	MAP2K1	-0.74	-5.69	-0.54	2.1e-7	Spherical equivalent (joint analysis main effects and education interaction);
SKCM	cis	rs9910055	0.762	rs2526020	chr17:42216588	G/T	cg08499158	chr17:42289980	UBTF	-0.85	-7.6	-0.65	5.61e-11	Total body bone mineral density;
SKCM	cis	rs7937682	0.575	rs34888817	chr11:111756455	C/T	cg09085632	chr11:111637200	PPP2R1B	1.09	10.45	0.76	1.7e-16	Primary sclerosing cholangitis;
SKCM	cis	rs2288073	0.930	rs7604097	chr2:24401805	G/C	cg06627628	chr2:24431161	ITSN2	-0.77	-5.37	-0.52	7.85e-7	Venous thromboembolism (SNP x SNP interaction);
SKCM	cis	rs8072100	0.840	rs12452796	chr17:45479733	G/T	cg25173405	chr17:45401733	C17orf57	0.58	4.96	0.49	4.01e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs9611565	0.649	rs139559	chr22:42191636	A/G	cg03806693	chr22:41940476	POLR3H	-0.87	-5.86	-0.55	1.05e-7	Vitiligo;
SKCM	cis	rs2836974	0.644	rs11088472	chr21:40699376	A/C	cg11890956	chr21:40555474	PSMG1	-0.82	-7.64	-0.65	4.75e-11	Cognitive function;
SKCM	cis	rs1801251	1.000	rs2675974	chr2:233727071	A/G	cg08000102	chr2:233561755	GIGYF2	0.86	6.77	0.61	2.19e-9	Coronary artery disease;
SKCM	cis	rs757110	0.740	rs10832776	chr11:17385224	C/A	cg15432903	chr11:17409602	KCNJ11	0.53	4.88	0.48	5.45e-6	Type 2 diabetes;
SKCM	cis	rs60871478	0.636	rs12534606	chr7:895928	A/G	cg05535760	chr7:792225	HEATR2	-1.3	-7.8	-0.66	2.27e-11	Cerebrospinal P-tau181p levels;
SKCM	cis	rs13108904	0.935	rs1732102	chr4:1277924	T/C	cg02018176	chr4:1364513	KIAA1530	-0.59	-4.8	-0.48	7.47e-6	Obesity-related traits;
SKCM	cis	rs33794	0.729	rs33783	chr3:45291959	G/T	cg25630594	chr3:44914870	TGM4	0.58	4.87	0.48	5.83e-6	Lung function (forced expiratory volume in 1 second);
SKCM	cis	rs10089	1.000	rs1560636	chr5:127447987	A/G	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.91	8.88	0.71	1.84e-13	Ileal carcinoids;
SKCM	cis	rs1218582	0.774	rs4845680	chr1:154863195	A/G	cg09359103	chr1:154839909	KCNN3	-0.57	-5.25	-0.51	1.26e-6	Prostate cancer;
SKCM	cis	rs67311347	1.000	rs7625736	chr3:40441345	C/G	cg00091569	chr3:40428383	ENTPD3	-0.61	-5.16	-0.5	1.85e-6	Renal cell carcinoma;
SKCM	cis	rs9311474	1.000	rs6445358	chr3:52308845	C/G	cg18404041	chr3:52824283	ITIH1	-0.53	-4.84	-0.48	6.39e-6	Electroencephalogram traits;
SKCM	cis	rs2439831	0.717	rs9806227	chr15:43680115	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.22	8.31	0.69	2.36e-12	Lung cancer in ever smokers;
SKCM	cis	rs875971	0.522	rs2949690	chr7:65483242	C/T	cg18876405	chr7:65276391	NA	-0.86	-8.04	-0.67	8.05e-12	Aortic root size;
SKCM	cis	rs4665809	0.590	rs3806514	chr2:26466772	C/T	cg04944784	chr2:26401820	FAM59B	0.74	4.79	0.48	7.81e-6	Gut microbiome composition (summer);
SKCM	cis	rs875971	1.000	rs4717300	chr7:65947380	T/C	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	cis	rs11098499	0.863	rs1480939	chr4:120456927	T/C	cg09307838	chr4:120376055	NA	0.97	7.66	0.66	4.19e-11	Corneal astigmatism;
SKCM	cis	rs933688	1.000	rs2367353	chr5:90686568	G/C	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.94	6.58	0.6	4.82e-9	Smoking behavior;
SKCM	cis	rs7617480	0.648	rs9882443	chr3:48749064	G/A	cg07636037	chr3:49044803	WDR6	0.91	6.74	0.61	2.42e-9	Subjective well-being (multi-trait analysis);Menarche (age at onset);
SKCM	cis	rs3768617	0.510	rs20558	chr1:183094547	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs644799	1.000	rs3748256	chr11:95521953	A/G	cg25622487	chr11:95524042	FAM76B;CEP57	0.69	5.47	0.53	5.17e-7	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs1799949	1.000	rs8176296	chr17:41203591	T/C	cg05368731	chr17:41323189	NBR1	0.89	7.67	0.66	4.08e-11	Menopause (age at onset);
SKCM	cis	rs1577917	0.666	rs6454471	chr6:86214456	T/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.79	7.26	0.64	2.46e-10	Response to antipsychotic treatment;
SKCM	cis	rs28386778	0.742	rs3020617	chr17:61947303	A/G	cg06873352	chr17:61820015	STRADA	0.76	6.18	0.57	2.74e-8	Prudent dietary pattern;
SKCM	cis	rs7980687	0.596	rs1727319	chr12:123701353	T/C	cg05973401	chr12:123451056	ABCB9	0.72	5.07	0.5	2.61e-6	Height;Educational attainment;Head circumference (infant);
SKCM	cis	rs28386778	0.799	rs2665836	chr17:61898135	C/A	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs2439831	0.702	rs3759791	chr15:44090798	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.35	7.75	0.66	2.9e-11	Lung cancer in ever smokers;
SKCM	cis	rs7584330	0.780	rs7582828	chr2:238378476	A/C	cg14458575	chr2:238380390	NA	-0.88	-5.94	-0.56	7.38e-8	Prostate cancer;
SKCM	cis	rs11098499	0.691	rs9996494	chr4:120238880	C/A	cg09307838	chr4:120376055	NA	0.98	8.13	0.68	5.33e-12	Corneal astigmatism;
SKCM	cis	rs7666738	0.791	rs1405766	chr4:98965389	T/C	cg05340658	chr4:99064831	C4orf37	0.64	4.91	0.49	4.97e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs875971	0.628	rs6974355	chr7:65841981	A/G	cg18876405	chr7:65276391	NA	0.81	7.45	0.64	1.1e-10	Aortic root size;
SKCM	cis	rs1799949	1.000	rs11654452	chr17:41189383	G/T	cg25918947	chr17:41365094	TMEM106A	-0.61	-5.87	-0.55	1e-7	Menopause (age at onset);
SKCM	cis	rs3847687	0.966	rs3847689	chr12:131525534	T/G	cg13586425	chr12:131519906	GPR133	-0.52	-5.77	-0.55	1.56e-7	Longevity;
SKCM	cis	rs8077889	0.956	rs58242860	chr17:41847300	T/C	cg26893861	chr17:41843967	DUSP3	1.21	7.19	0.63	3.38e-10	Triglycerides;
SKCM	cis	rs2836974	0.831	rs34294410	chr21:40555160	C/G	cg17971929	chr21:40555470	PSMG1	0.89	8.73	0.7	3.6e-13	Cognitive function;
SKCM	cis	rs12477438	0.520	rs6717729	chr2:99756941	T/C	cg26064155	chr2:99771622	LIPT1;TSGA10	1.02	9.73	0.74	4.23e-15	Chronic sinus infection;
SKCM	cis	rs9790314	0.645	rs9879687	chr3:160874938	A/G	cg03342759	chr3:160939853	NMD3	-0.68	-6.9	-0.62	1.23e-9	Morning vs. evening chronotype;
SKCM	cis	rs4237845	0.591	rs10431506	chr12:58311524	G/A	cg02175503	chr12:58329896	NA	0.94	9.5	0.73	1.18e-14	Intelligence (multi-trait analysis);
SKCM	cis	rs7811142	1.000	rs67471932	chr7:100009985	C/G	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-1.0	-5.66	-0.54	2.36e-7	Platelet count;
SKCM	cis	rs10876993	0.928	rs7136269	chr12:58075937	G/A	cg18357645	chr12:58087776	OS9	0.65	5.98	0.56	6.22e-8	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs3749237	0.595	rs11130199	chr3:49538799	T/C	cg02487422	chr3:49467188	NICN1	0.64	4.79	0.48	7.67e-6	Resting heart rate;
SKCM	cis	rs9815354	0.716	rs73828280	chr3:41833907	A/T	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs3008870	1.000	rs3008848	chr1:67379284	C/T	cg08660285	chr1:67390436	MIER1;WDR78	0.97	6.52	0.59	6.39e-9	Lymphocyte percentage of white cells;
SKCM	cis	rs9788682	0.846	rs684513	chr15:78858400	C/G	cg06917634	chr15:78832804	PSMA4	-0.89	-4.99	-0.49	3.58e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs6598955	0.670	rs7531518	chr1:26539749	T/C	cg00938395	chr1:26633206	UBXN11	0.71	5.0	0.49	3.5e-6	Obesity-related traits;
SKCM	cis	rs35306767	0.953	rs10904581	chr10:964685	A/T	cg26597838	chr10:835615	NA	0.67	5.4	0.52	7e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs67311347	0.524	rs7649168	chr3:40356158	T/C	cg00091569	chr3:40428383	ENTPD3	0.64	5.64	0.54	2.66e-7	Renal cell carcinoma;
SKCM	cis	rs8060686	0.641	rs28508024	chr16:68126606	T/C	cg04539111	chr16:67997858	SLC12A4	-0.85	-4.81	-0.48	7.14e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs847649	0.842	rs4729860	chr7:102625567	C/T	cg18108683	chr7:102477205	FBXL13	0.83	8.17	0.68	4.49e-12	Morning vs. evening chronotype;
SKCM	cis	rs17345786	0.511	rs13061565	chr3:101392270	T/C	cg12386194	chr3:101231763	SENP7	0.71	5.94	0.56	7.61e-8	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs362272	0.524	rs10937924	chr4:3374898	T/C	cg21096898	chr4:3318625	RGS12	0.96	11.61	0.8	1.1e-18	Serum sulfate level;
SKCM	cis	rs1005277	0.579	rs2474584	chr10:38416389	C/T	cg00409905	chr10:38381863	ZNF37A	-0.66	-6.16	-0.57	3e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs12824058	0.831	rs11608406	chr12:130805866	G/C	cg24838063	chr12:130822603	PIWIL1	0.78	6.74	0.61	2.43e-9	Menopause (age at onset);
SKCM	cis	rs55962025	0.883	rs362275	chr4:3224602	C/T	cg09735869	chr4:3319127	RGS12	-0.73	-5.58	-0.53	3.31e-7	Parental longevity (mother's age at death);
SKCM	cis	rs875971	0.522	rs1917563	chr7:65415647	C/T	cg05627663	chr7:65219948	SNORA22;CCT6P1	-0.59	-5.09	-0.5	2.39e-6	Aortic root size;
SKCM	cis	rs2204008	0.837	rs11514225	chr12:38076270	G/A	cg26384229	chr12:38710491	ALG10B	0.81	6.45	0.59	8.61e-9	Bladder cancer;
SKCM	cis	rs8077889	0.750	rs231535	chr17:41944865	T/G	cg26893861	chr17:41843967	DUSP3	-1.16	-6.63	-0.6	3.97e-9	Triglycerides;
SKCM	cis	rs7959452	0.640	rs11177599	chr12:69721970	G/A	cg14784868	chr12:69753453	YEATS4	0.66	5.91	0.56	8.65e-8	Blood protein levels;
SKCM	cis	rs2832191	0.791	rs57721945	chr21:30498744	T/C	cg24692254	chr21:30365293	RNF160	-0.9	-8.01	-0.67	9.12e-12	Dental caries;
SKCM	cis	rs9443189	0.703	rs2748950	chr6:76442985	A/G	cg01950844	chr6:76311363	SENP6	-0.77	-5.41	-0.52	6.73e-7	Prostate cancer;
SKCM	cis	rs7666738	0.830	rs10470893	chr4:99038756	C/T	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7811142	0.945	rs6978739	chr7:100098680	C/G	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-1.08	-6.17	-0.57	2.88e-8	Platelet count;
SKCM	cis	rs3096299	0.967	rs3102341	chr16:89450744	G/A	cg02187348	chr16:89574699	SPG7	0.63	4.97	0.49	3.9e-6	Multiple myeloma (IgH translocation);
SKCM	cis	rs748404	0.697	rs1814323	chr15:43563237	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	-0.69	-5.67	-0.54	2.35e-7	Lung cancer;
SKCM	cis	rs829883	0.902	rs829884	chr12:98879500	C/G	cg25150519	chr12:98850993	NA	0.5	5.27	0.51	1.17e-6	Colorectal adenoma (advanced);
SKCM	cis	rs10911232	0.507	rs10752888	chr1:182993751	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.64	0.6	3.83e-9	Hypertriglyceridemia;
SKCM	cis	rs10752881	0.967	rs8179361	chr1:182974572	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.74	6.7	0.6	2.91e-9	Colorectal cancer;
SKCM	cis	rs10504229	0.683	rs16921807	chr8:58105967	C/T	cg02725872	chr8:58115012	NA	-0.53	-4.91	-0.49	4.82e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs13010713	0.840	rs4563183	chr2:182058528	C/T	cg21995919	chr2:182322279	ITGA4	0.53	5.12	0.5	2.18e-6	Celiac disease;
SKCM	cis	rs7917772	0.503	rs7899576	chr10:104307504	G/A	cg11453585	chr10:104263688	ACTR1A;SUFU	0.76	6.2	0.57	2.5e-8	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs35146811	0.807	rs10228764	chr7:99608029	A/G	cg22906224	chr7:99728672	NA	0.79	5.8	0.55	1.36e-7	Coronary artery disease;
SKCM	cis	rs4150161	0.591	rs4150159	chr16:84214338	C/A	cg10106505	chr16:84220380	TAF1C	-1.29	-5.55	-0.53	3.72e-7	Systolic blood pressure response to hydrochlorothiazide in hypertension;
SKCM	cis	rs1577917	0.682	rs1173417	chr6:86403941	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.75	6.9	0.62	1.2e-9	Response to antipsychotic treatment;
SKCM	cis	rs6840360	0.550	rs62327349	chr4:152627230	G/C	cg22705602	chr4:152727874	NA	-0.52	-5.52	-0.53	4.33e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs941408	1.000	rs1736184	chr19:2810248	G/A	cg06609049	chr19:2785107	THOP1	0.8	6.95	0.62	9.79e-10	Total cholesterol levels;
SKCM	cis	rs12714314	0.718	rs1469645	chr2:1950140	C/A	cg22350835	chr2:1868857	MYT1L	0.66	5.2	0.51	1.54e-6	Type 2 diabetes (age of onset);
SKCM	cis	rs72634258	0.786	rs7539807	chr1:8183789	C/T	cg00042356	chr1:8021962	PARK7	0.81	5.45	0.53	5.69e-7	Inflammatory bowel disease;
SKCM	cis	rs951366	0.764	rs823143	chr1:205743425	A/C	cg24503407	chr1:205819492	PM20D1	0.91	7.99	0.67	9.76e-12	Menarche (age at onset);
SKCM	trans	rs1814175	0.618	rs1851843	chr11:50021846	T/C	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs12142240	0.738	rs10489769	chr1:46806703	A/G	cg14993813	chr1:46806288	NSUN4	-0.7	-4.77	-0.48	8.27e-6	Menopause (age at onset);
SKCM	cis	rs17345786	0.906	rs58835747	chr3:101243634	T/C	cg12386194	chr3:101231763	SENP7	0.84	7.0	0.62	8.03e-10	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs34779708	0.733	rs60553075	chr10:35542462	T/A	cg03585969	chr10:35415529	CREM	0.74	5.42	0.52	6.41e-7	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs651907	0.557	rs13081846	chr3:101383321	T/C	cg12386194	chr3:101231763	SENP7	0.71	5.94	0.56	7.61e-8	Colorectal cancer;
SKCM	cis	rs910316	0.763	rs175047	chr14:75479039	C/G	cg08847533	chr14:75593920	NEK9	-0.83	-7.06	-0.62	6e-10	Height;
SKCM	cis	rs1153858	1.000	rs4775911	chr15:45649787	G/T	cg10760299	chr15:45669010	GATM	-0.59	-6.13	-0.57	3.43e-8	Homoarginine levels;
SKCM	cis	rs453301	0.624	rs2288673	chr8:8860276	G/T	cg15556689	chr8:8085844	FLJ10661	0.64	5.21	0.51	1.52e-6	Joint mobility (Beighton score);
SKCM	cis	rs73072330	1.000	rs73072330	chr3:48165089	G/A	cg09665691	chr3:47563885	NA	1.51	5.99	0.56	6.11e-8	Stem cell growth factor beta levels;
SKCM	cis	rs3020736	0.500	rs6002597	chr22:42488160	C/A	cg04733989	chr22:42467013	NAGA	-0.72	-5.62	-0.54	2.87e-7	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs9915657	0.870	rs4140903	chr17:70133771	C/T	cg06234051	chr17:70120541	SOX9	-0.61	-5.28	-0.51	1.12e-6	Thyroid hormone levels;
SKCM	cis	rs7618501	0.669	rs2230590	chr3:49936102	T/C	cg05072774	chr3:49840536	C3orf54	-0.71	-5.24	-0.51	1.31e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs12142240	0.667	rs55887761	chr1:46826587	C/A	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	trans	rs1814175	0.754	rs10839453	chr11:49955815	A/T	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs1707322	0.682	rs28490344	chr1:46197948	C/T	cg03146154	chr1:46216737	IPP	0.84	6.2	0.57	2.51e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs10754283	0.967	rs4658307	chr1:90117586	G/T	cg21401794	chr1:90099060	LRRC8C	0.73	6.2	0.57	2.51e-8	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs61776719	0.840	rs35267671	chr1:38397369	C/T	cg17077180	chr1:38461687	NA	0.51	5.0	0.49	3.39e-6	Coronary artery disease;
SKCM	cis	rs514406	0.679	rs11206006	chr1:53218380	A/G	cg25767906	chr1:53392781	SCP2	0.62	4.94	0.49	4.42e-6	Monocyte count;
SKCM	cis	rs10504229	0.679	rs72649115	chr8:58037631	T/G	cg02725872	chr8:58115012	NA	-0.52	-4.85	-0.48	6.18e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs507080	0.922	rs638805	chr11:118558889	G/T	cg18045108	chr11:118530628	TREH	-0.47	-4.81	-0.48	7.24e-6	Serum metabolite levels;
SKCM	cis	rs6445797	0.589	rs58061357	chr3:56666513	A/C	cg13616963	chr3:57583610	ARF4	-0.73	-4.8	-0.48	7.61e-6	Gastritis;
SKCM	cis	rs7666738	0.830	rs13138438	chr4:99050545	C/A	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs826838	1.000	rs10880963	chr12:38748408	T/C	cg26384229	chr12:38710491	ALG10B	1.06	10.14	0.75	6.67e-16	Heart rate;
SKCM	cis	rs1552244	0.572	rs6442154	chr3:10168785	A/G	cg00149659	chr3:10157352	C3orf10	1.13	5.45	0.53	5.74e-7	Alzheimer's disease;
SKCM	cis	rs1801251	0.727	rs13029336	chr2:233569935	A/G	cg08000102	chr2:233561755	GIGYF2	-0.81	-7.1	-0.63	4.97e-10	Coronary artery disease;
SKCM	cis	rs1348850	0.750	rs55792594	chr2:178496468	C/T	cg02961200	chr2:178257176	LOC100130691;AGPS	0.72	4.91	0.49	4.94e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs11249608	0.548	rs6859936	chr5:178451214	T/C	cg21905437	chr5:178450457	ZNF879	0.76	6.46	0.59	8.29e-9	Pubertal anthropometrics;
SKCM	cis	rs2032447	0.670	rs198850	chr6:26104670	A/C	cg18357526	chr6:26021779	HIST1H4A	-0.77	-6.27	-0.58	1.85e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs17685	0.672	rs1639618	chr7:75701987	T/C	cg01364799	chr7:75623366	TMEM120A	-0.72	-5.81	-0.55	1.31e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs6088590	0.550	rs12624640	chr20:32952125	G/A	cg24642439	chr20:33292090	TP53INP2	0.8	6.02	0.56	5.4e-8	Coronary artery disease;
SKCM	cis	rs9910055	0.530	rs2269907	chr17:42294215	G/A	cg08499158	chr17:42289980	UBTF	-0.79	-6.91	-0.62	1.15e-9	Total body bone mineral density;
SKCM	cis	rs1218582	0.772	rs4845694	chr1:154911651	C/G	cg06221963	chr1:154839813	KCNN3	-0.54	-5.29	-0.51	1.09e-6	Prostate cancer;
SKCM	cis	rs9611565	0.592	rs5751101	chr22:41828111	C/T	cg03806693	chr22:41940476	POLR3H	1.12	7.21	0.63	3.2e-10	Vitiligo;
SKCM	cis	rs67460515	0.529	rs6441364	chr3:160897915	A/C	cg16978263	chr3:160118452	SMC4;IFT80	-0.51	-4.84	-0.48	6.33e-6	Parkinson's disease;
SKCM	cis	rs4803468	1.000	rs284656	chr19:41929251	T/C	cg14132834	chr19:41945861	ATP5SL	-0.77	-6.04	-0.56	4.87e-8	Height;
SKCM	cis	rs796364	0.865	rs769948	chr2:200728475	C/A	cg12253985	chr2:200820533	C2orf60;C2orf47	0.85	5.39	0.52	7.18e-7	Schizophrenia;
SKCM	cis	rs2013441	0.965	rs7207611	chr17:20204516	C/T	cg13482628	chr17:19912719	NA	0.65	5.21	0.51	1.48e-6	Obesity-related traits;
SKCM	cis	rs597539	0.690	rs7104351	chr11:68617886	A/G	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.81	5.33	0.52	9.43e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs3785574	0.650	rs2005132	chr17:62008232	T/C	cg01411255	chr17:61851458	DDX42;CCDC47	-0.71	-5.22	-0.51	1.46e-6	Height;
SKCM	cis	rs7208859	0.623	rs216439	chr17:28927884	T/C	cg14067834	chr17:29058358	SUZ12P	1.08	4.95	0.49	4.21e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs804280	1.000	rs804280	chr8:11612698	G/T	cg12395012	chr8:11607386	GATA4	-0.72	-6.39	-0.59	1.09e-8	Myopia (pathological);
SKCM	cis	rs478304	0.651	rs10896037	chr11:65503424	A/G	cg17480646	chr11:65405466	SIPA1	-0.71	-5.63	-0.54	2.69e-7	Acne (severe);
SKCM	cis	rs1577917	0.958	rs12215265	chr6:86443969	C/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.37	-0.52	7.89e-7	Response to antipsychotic treatment;
SKCM	cis	rs2839186	0.872	rs2250213	chr21:47674275	G/A	cg05896524	chr21:47604654	C21orf56	0.69	5.83	0.55	1.2e-7	Testicular germ cell tumor;
SKCM	cis	rs6977660	1.000	rs10275322	chr7:19821220	C/T	cg07541023	chr7:19748670	TWISTNB	0.7	4.82	0.48	6.98e-6	Thyroid stimulating hormone;
SKCM	cis	rs13040088	0.872	rs2295481	chr20:61574727	C/T	cg23096297	chr20:61557774	DIDO1	0.82	6.22	0.58	2.32e-8	Menopause (age at onset);
SKCM	cis	rs394563	0.559	rs7752555	chr6:149671116	A/G	cg16235748	chr6:149772707	ZC3H12D	0.44	5.07	0.5	2.63e-6	Dupuytren's disease;
SKCM	cis	rs2929278	0.588	rs1975364	chr15:44150189	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	0.71	5.2	0.51	1.54e-6	Schizophrenia;
SKCM	cis	rs929354	0.742	rs62491945	chr7:156955580	G/A	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs854765	0.547	rs9912096	chr17:17896673	A/C	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.04	9.2	0.72	4.44e-14	Total body bone mineral density;
SKCM	cis	rs2180341	0.618	rs11154398	chr6:127654281	C/A	cg24812749	chr6:127587940	RNF146	0.64	5.36	0.52	8.23e-7	Breast cancer;
SKCM	cis	rs854765	0.587	rs12936927	chr17:17726965	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	-0.87	-6.83	-0.61	1.65e-9	Total body bone mineral density;
SKCM	trans	rs1814175	0.588	rs7481648	chr11:49754910	A/G	cg15704280	chr7:45808275	SEPT13	-1.01	-9.85	-0.74	2.46e-15	Height;
SKCM	cis	rs10754283	0.934	rs10493829	chr1:90117833	T/C	cg21401794	chr1:90099060	LRRC8C	0.72	5.97	0.56	6.63e-8	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs9916302	0.595	rs4795371	chr17:37636695	T/G	cg07936489	chr17:37558343	FBXL20	-0.9	-8.1	-0.68	6.05e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs763121	0.819	rs4560233	chr22:38982442	A/T	cg06022373	chr22:39101656	GTPBP1	0.72	4.96	0.49	4.08e-6	Menopause (age at onset);
SKCM	cis	rs4803468	1.000	rs284649	chr19:41926838	C/T	cg14132834	chr19:41945861	ATP5SL	-0.77	-6.04	-0.56	4.87e-8	Height;
SKCM	cis	rs12911832	1.000	rs12911961	chr15:58985867	C/T	cg05156742	chr15:59063176	FAM63B	0.74	5.38	0.52	7.59e-7	Schizophrenia;
SKCM	cis	rs514406	0.668	rs1672911	chr1:53340320	T/C	cg24675658	chr1:53192096	ZYG11B	-0.87	-7.33	-0.64	1.83e-10	Monocyte count;
SKCM	cis	rs4888262	0.526	rs7193508	chr16:74628630	G/T	cg01733217	chr16:74700730	RFWD3	0.92	7.11	0.63	4.82e-10	Testicular germ cell tumor;
SKCM	cis	rs7959452	0.503	rs7300266	chr12:69654187	A/G	cg20891283	chr12:69753455	YEATS4	0.73	6.51	0.59	6.69e-9	Blood protein levels;
SKCM	cis	rs1850744	0.590	rs35509001	chr4:9594871	G/A	cg15442990	chr4:9534313	NA	-1.3	-4.84	-0.48	6.55e-6	Economic and political preferences;
SKCM	cis	rs5769765	0.955	rs8138687	chr22:50291869	A/G	cg22709217	chr22:50311962	ALG12;CRELD2	-0.79	-5.71	-0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs561341	1.000	rs561341	chr17:30316385	T/G	cg00745463	chr17:30367425	LRRC37B	-1.11	-7.84	-0.66	1.89e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs7100689	0.646	rs1890889	chr10:82090827	G/T	cg01528321	chr10:82214614	TSPAN14	0.7	5.62	0.54	2.84e-7	Post bronchodilator FEV1;
SKCM	cis	rs651907	0.557	rs11711079	chr3:101386918	G/A	cg12386194	chr3:101231763	SENP7	0.71	5.94	0.56	7.61e-8	Colorectal cancer;
SKCM	cis	rs600231	0.598	rs2508712	chr11:65232261	C/G	cg24009118	chr11:65545808	DKFZp761E198	0.68	5.02	0.49	3.14e-6	Bone mineral density;
SKCM	cis	rs2839186	0.771	rs13046451	chr21:47641373	T/A	cg13126279	chr21:47581558	C21orf56	0.67	5.87	0.55	9.92e-8	Testicular germ cell tumor;
SKCM	cis	rs1153858	1.000	rs7167900	chr15:45639471	A/G	cg10760299	chr15:45669010	GATM	0.57	5.67	0.54	2.31e-7	Homoarginine levels;
SKCM	cis	rs2599510	0.934	rs2710634	chr2:32808804	T/C	cg02381751	chr2:32503542	YIPF4	0.74	5.66	0.54	2.41e-7	Interleukin-18 levels;
SKCM	cis	rs2839186	0.814	rs12482209	chr21:47664275	C/G	cg13012494	chr21:47604986	C21orf56	-0.68	-6.02	-0.56	5.46e-8	Testicular germ cell tumor;
SKCM	cis	rs28386778	0.897	rs2859619	chr17:61917686	T/C	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs8072100	0.905	rs8077106	chr17:45653291	T/G	cg08085267	chr17:45401833	C17orf57	0.61	5.56	0.53	3.61e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs55962025	0.842	rs362272	chr4:3234980	C/T	cg05297308	chr4:3317976	RGS12	-0.72	-5.25	-0.51	1.3e-6	Parental longevity (mother's age at death);
SKCM	cis	rs7927771	1.000	rs11039412	chr11:47841581	G/A	cg05585544	chr11:47624801	NA	-0.59	-5.09	-0.5	2.43e-6	Subjective well-being;
SKCM	cis	rs7539542	0.556	rs2275734	chr1:202887295	C/T	cg19681188	chr1:202830198	LOC148709	0.72	5.34	0.52	8.74e-7	Mean platelet volume;
SKCM	cis	rs9611565	0.840	rs4822025	chr22:41776646	C/G	cg03806693	chr22:41940476	POLR3H	-0.87	-6.11	-0.57	3.62e-8	Vitiligo;
SKCM	cis	rs208520	0.690	rs12208977	chr6:66725257	G/A	cg07460842	chr6:66804631	NA	0.91	7.37	0.64	1.54e-10	Exhaled nitric oxide output;
SKCM	cis	rs10779751	0.770	rs4845853	chr1:11243470	A/G	cg08854313	chr1:11322531	MTOR	0.95	7.68	0.66	3.89e-11	Body mass index;
SKCM	cis	rs507080	0.922	rs478296	chr11:118567375	T/C	cg18045108	chr11:118530628	TREH	-0.48	-5.15	-0.5	1.88e-6	Serum metabolite levels;
SKCM	cis	rs12971120	0.947	rs3764509	chr18:72167124	C/G	cg25817165	chr18:72167213	CNDP2	-0.65	-5.21	-0.51	1.51e-6	Refractive error;
SKCM	cis	rs72615157	0.561	rs113401658	chr7:99858505	C/T	cg07160278	chr7:100027354	MEPCE;ZCWPW1	0.97	5.63	0.54	2.73e-7	Lung function (FEV1/FVC);
SKCM	cis	rs709400	1.000	rs55885592	chr14:104126024	C/T	cg26031613	chr14:104095156	KLC1	1.05	12.89	0.82	5.14e-21	Body mass index;
SKCM	cis	rs13118159	0.550	rs13123016	chr4:1340889	T/C	cg02475777	chr4:1388615	CRIPAK	0.79	5.22	0.51	1.42e-6	Longevity;
SKCM	cis	rs1044826	0.642	rs6799312	chr3:139211932	C/T	cg15131784	chr3:139108705	COPB2	0.7	5.19	0.51	1.62e-6	Obesity-related traits;
SKCM	cis	rs13064447	0.967	rs9861125	chr3:12765012	G/A	cg05775895	chr3:12838266	CAND2	0.65	5.25	0.51	1.29e-6	Major depression and alcohol dependence;
SKCM	cis	rs4237845	0.735	rs11172375	chr12:58291574	G/C	cg00677455	chr12:58241039	CTDSP2	0.75	6.19	0.57	2.59e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs561341	1.000	rs55643307	chr17:30263074	T/C	cg23018236	chr17:30244563	NA	-0.55	-5.51	-0.53	4.52e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs7927771	0.507	rs7111606	chr11:47787538	G/A	cg20307385	chr11:47447363	PSMC3	0.71	5.63	0.54	2.67e-7	Subjective well-being;
SKCM	cis	rs62238980	0.614	rs4821001	chr22:32344403	T/C	cg00543991	chr22:32367038	NA	1.41	5.49	0.53	4.88e-7	Childhood ear infection;
SKCM	trans	rs208520	0.690	rs6932475	chr6:66863155	G/A	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-1.07	-8.14	-0.68	5.03e-12	Exhaled nitric oxide output;
SKCM	cis	rs7575873	1	rs7575873	chr2:23962647	A/G	cg08917208	chr2:24149416	ATAD2B	0.95	4.78	0.48	8.1e-6	Birth weight;
SKCM	cis	rs910316	0.737	rs424120	chr14:75482828	G/T	cg08847533	chr14:75593920	NEK9	-0.8	-6.59	-0.6	4.76e-9	Height;
SKCM	cis	rs854765	0.583	rs4244602	chr17:17841456	A/G	cg09796270	chr17:17721594	SREBF1	0.65	4.87	0.48	5.79e-6	Total body bone mineral density;
SKCM	cis	rs6815814	0.950	rs11722788	chr4:38810738	C/G	cg02016764	chr4:38805732	TLR1	-0.77	-5.49	-0.53	4.78e-7	Breast cancer;
SKCM	cis	rs2072499	0.833	rs2251636	chr1:156202809	G/C	cg25208724	chr1:156163844	SLC25A44	0.97	9.0	0.71	1.1e-13	Testicular germ cell tumor;
SKCM	cis	rs1401999	0.690	rs6773408	chr3:183716609	G/T	cg01324343	chr3:183735012	ABCC5	0.65	6.43	0.59	9.47e-9	Anterior chamber depth;
SKCM	cis	rs208520	0.802	rs4710315	chr6:66887594	A/G	cg07460842	chr6:66804631	NA	-0.91	-7.07	-0.63	5.76e-10	Exhaled nitric oxide output;
SKCM	cis	rs732765	0.657	rs67898541	chr14:75236420	C/T	cg25946216	chr14:74253857	C14orf43	-0.94	-5.23	-0.51	1.36e-6	Non-small cell lung cancer;
SKCM	cis	rs2013441	1.000	rs11871945	chr17:20206883	A/G	cg13482628	chr17:19912719	NA	-0.67	-5.24	-0.51	1.32e-6	Obesity-related traits;
SKCM	cis	rs12044355	0.929	rs12045248	chr1:231850748	A/G	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	0.76	5.49	0.53	4.81e-7	Alzheimer's disease;
SKCM	cis	rs6500395	0.775	rs7191225	chr16:48662675	C/G	cg04672837	chr16:48644449	N4BP1	0.63	5.24	0.51	1.35e-6	Response to tocilizumab in rheumatoid arthritis;
SKCM	trans	rs208520	0.526	rs9354370	chr6:66808209	C/T	cg15611600	chr13:45563400	KIAA1704;NUFIP1	1.08	11.62	0.8	1.08e-18	Exhaled nitric oxide output;
SKCM	cis	rs116095464	1.000	rs28416084	chr5:217640	G/A	cg22857025	chr5:266934	NA	-1.44	-7.74	-0.66	2.94e-11	Breast cancer;
SKCM	cis	rs929354	0.685	rs1808217	chr7:157002741	T/C	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	trans	rs1814175	0.645	rs10839456	chr11:49964093	C/T	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs35766269	1.000	rs12253258	chr10:9024290	T/C	cg05721515	chr10:8095288	FLJ45983;GATA3	0.85	4.8	0.48	7.36e-6	Recalcitrant atopic dermatitis;
SKCM	cis	rs2075371	0.796	rs7780583	chr7:133960716	C/G	cg20476274	chr7:133979776	SLC35B4	0.96	9.42	0.73	1.63e-14	Mean platelet volume;
SKCM	cis	rs9818758	0.607	rs11713297	chr3:49213030	A/G	cg24898236	chr3:49228699	LOC646498	0.56	4.85	0.48	6.09e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs17685	0.725	rs1044483	chr7:75659815	T/C	cg16684958	chr7:75615977	POR	-0.57	-5.6	-0.54	3.07e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs6921919	0.583	rs6928773	chr6:28375210	T/C	cg14547644	chr6:28411285	ZSCAN23	-0.58	-4.8	-0.48	7.46e-6	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs9300255	0.602	rs2695478	chr12:123689521	C/T	cg05973401	chr12:123451056	ABCB9	0.77	5.09	0.5	2.43e-6	Neutrophil percentage of white cells;
SKCM	cis	rs7772486	0.875	rs2224120	chr6:146343280	A/C	cg23711669	chr6:146136114	FBXO30	0.76	7.15	0.63	4.1e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs10905065	0.965	rs10737019	chr10:5783733	G/A	cg09234995	chr10:5726438	C10orf18	-0.62	-5.25	-0.51	1.27e-6	Menopause (age at onset);
SKCM	cis	rs2204008	0.715	rs3899385	chr12:38169880	C/G	cg26384229	chr12:38710491	ALG10B	0.82	6.58	0.6	4.87e-9	Bladder cancer;
SKCM	cis	rs589448	0.902	rs315134	chr12:69762713	G/A	cg14784868	chr12:69753453	YEATS4	0.84	7.65	0.65	4.54e-11	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs7772486	0.790	rs2256998	chr6:146207657	A/C	cg05347473	chr6:146136440	FBXO30	0.55	5.12	0.5	2.16e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs870825	0.790	rs12513128	chr4:185576729	G/C	cg04058563	chr4:185651563	MLF1IP	1.03	5.09	0.5	2.4e-6	Blood protein levels;
SKCM	cis	rs826838	0.935	rs1684407	chr12:39127270	C/T	cg13010199	chr12:38710504	ALG10B	-0.77	-6.19	-0.57	2.66e-8	Heart rate;
SKCM	cis	rs28595532	0.545	rs13132957	chr4:119250841	G/C	cg21605333	chr4:119757512	SEC24D	0.96	5.21	0.51	1.47e-6	Cannabis dependence symptom count;
SKCM	cis	rs7666738	0.830	rs7672720	chr4:98938760	A/T	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs362296	0.671	rs3095074	chr4:3261152	G/A	cg16987761	chr4:3318072	RGS12	-0.78	-6.87	-0.61	1.39e-9	Parental longevity (mother's age at death);
SKCM	cis	rs9916302	0.706	rs1874226	chr17:37729031	C/T	cg07936489	chr17:37558343	FBXL20	1.04	7.96	0.67	1.12e-11	Glomerular filtration rate (creatinine);
SKCM	cis	rs7647973	0.580	rs2334958	chr3:49252364	C/T	cg07636037	chr3:49044803	WDR6	0.85	7.0	0.62	7.74e-10	Menarche (age at onset);
SKCM	cis	rs870825	0.616	rs28649620	chr4:185648997	G/A	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs7772486	0.754	rs864148	chr6:145976675	T/C	cg23711669	chr6:146136114	FBXO30	-0.96	-10.71	-0.77	5.67e-17	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7824557	0.767	rs1897950	chr8:11169551	C/A	cg21775007	chr8:11205619	TDH	0.72	6.03	0.56	5.2100000000000003e-08	Retinal vascular caliber;
SKCM	cis	rs3087591	0.960	rs2905793	chr17:29470072	C/T	cg24425628	chr17:29625626	OMG;NF1	0.61	4.77	0.48	8.45e-6	Hip circumference;
SKCM	cis	rs17685	0.775	rs11761172	chr7:75761547	C/T	cg01364799	chr7:75623366	TMEM120A	-0.7	-5.69	-0.54	2.09e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs4523957	0.855	rs216172	chr17:2126504	G/C	cg16513277	chr17:2031491	SMG6	-0.73	-4.95	-0.49	4.13e-6	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs727563	0.594	rs132807	chr22:42071584	T/C	cg03806693	chr22:41940476	POLR3H	1.12	7.53	0.65	7.69e-11	Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs7659604	0.539	rs7686200	chr4:122764553	C/T	cg19748678	chr4:122722346	EXOSC9	0.65	5.34	0.52	8.74e-7	Type 2 diabetes;
SKCM	cis	rs2658782	0.526	rs3020062	chr11:93061159	T/C	cg15737290	chr11:93063684	CCDC67	1.0	9.41	0.73	1.76e-14	Pulmonary function decline;
SKCM	cis	rs9399135	0.967	rs1023179	chr6:135343829	T/A	cg24558204	chr6:135376177	HBS1L	0.6	5.36	0.52	8.17e-7	Red blood cell count;
SKCM	cis	rs2303759	0.666	rs66967196	chr19:49808894	G/A	cg05022225	chr19:49866942	DKKL1;TEAD2	0.7	5.05	0.5	2.78e-6	Multiple sclerosis;
SKCM	cis	rs453301	0.574	rs10081437	chr8:8948979	T/C	cg08975724	chr8:8085496	FLJ10661	-0.61	-4.83	-0.48	6.72e-6	Joint mobility (Beighton score);
SKCM	cis	rs60871478	0.730	rs6943337	chr7:780980	T/G	cg05535760	chr7:792225	HEATR2	1.05	8.61	0.7	6.09e-13	Cerebrospinal P-tau181p levels;
SKCM	cis	rs6879260	1.000	rs7706951	chr5:179733407	C/T	cg23221052	chr5:179740743	GFPT2	-0.67	-5.27	-0.51	1.19e-6	Height;
SKCM	cis	rs12824058	0.549	rs4759453	chr12:130824565	C/G	cg24838063	chr12:130822603	PIWIL1	0.69	6.12	0.57	3.51e-8	Menopause (age at onset);
SKCM	cis	rs3820928	0.839	rs13398103	chr2:227859693	T/G	cg11843606	chr2:227700838	RHBDD1	-0.61	-4.77	-0.48	8.31e-6	Pulmonary function;
SKCM	cis	rs1577917	0.917	rs2197651	chr6:86495442	G/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.71	-6.17	-0.57	2.8e-8	Response to antipsychotic treatment;
SKCM	cis	rs6500395	0.963	rs2883642	chr16:48685146	C/T	cg04672837	chr16:48644449	N4BP1	-0.65	-5.43	-0.52	6.28e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs11098499	1.000	rs28374891	chr4:120183550	G/A	cg09307838	chr4:120376055	NA	0.95	7.75	0.66	2.84e-11	Corneal astigmatism;
SKCM	cis	rs4808199	0.948	rs2074301	chr19:19381715	G/A	cg03709012	chr19:19516395	GATAD2A	1.09	7.56	0.65	6.79e-11	Nonalcoholic fatty liver disease;
SKCM	cis	rs2439831	0.850	rs67541383	chr15:44172548	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.38	5.87	0.55	1.01e-7	Lung cancer in ever smokers;
SKCM	cis	rs9815354	0.556	rs113213296	chr3:41873097	G/A	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs3091242	0.933	rs9438905	chr1:25764177	A/G	cg27572855	chr1:25598939	RHD	0.53	5.06	0.5	2.67e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs7811142	1.000	rs2406255	chr7:100053690	T/C	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-0.99	-5.52	-0.53	4.2e-7	Platelet count;
SKCM	cis	rs6570726	0.791	rs6918814	chr6:145906028	G/A	cg23711669	chr6:146136114	FBXO30	0.77	6.67	0.6	3.29e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs3087591	0.960	rs2905790	chr17:29476110	A/G	cg24425628	chr17:29625626	OMG;NF1	0.64	5.26	0.51	1.21e-6	Hip circumference;
SKCM	cis	rs7618501	0.633	rs2856234	chr3:50139142	A/G	cg05072774	chr3:49840536	C3orf54	0.66	5.02	0.49	3.22e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2836974	0.644	rs7281853	chr21:40693490	A/G	cg17971929	chr21:40555470	PSMG1	-0.67	-5.62	-0.54	2.88e-7	Cognitive function;
SKCM	cis	rs654950	0.653	rs2810568	chr1:42054247	A/G	cg06885757	chr1:42089581	HIVEP3	-0.65	-6.53	-0.59	6.05e-9	Airway imaging phenotypes;
SKCM	cis	rs6429082	0.811	rs291348	chr1:235667690	A/G	cg26050004	chr1:235667680	B3GALNT2	0.91	8.45	0.69	1.26e-12	Adiposity;
SKCM	trans	rs561341	1.000	rs68140514	chr17:30335781	T/C	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs453301	0.652	rs2043129	chr8:8825504	C/G	cg06636001	chr8:8085503	FLJ10661	0.75	5.37	0.52	7.75e-7	Joint mobility (Beighton score);
SKCM	cis	rs5756931	0.503	rs5750542	chr22:38534507	T/C	cg25457927	chr22:38595422	NA	-0.43	-4.85	-0.48	6.18e-6	Triglycerides;
SKCM	cis	rs796364	0.813	rs4672686	chr2:201065044	A/G	cg12253985	chr2:200820533	C2orf60;C2orf47	0.95	6.37	0.59	1.21e-8	Schizophrenia;
SKCM	cis	rs10791097	0.694	rs1893018	chr11:130756632	T/C	cg12179176	chr11:130786555	SNX19	0.91	8.08	0.67	6.64e-12	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs7826238	0.594	rs2948285	chr8:8130538	A/T	cg08975724	chr8:8085496	FLJ10661	0.77	6.4	0.59	1.07e-8	Systolic blood pressure;
SKCM	cis	rs7772486	0.875	rs6570736	chr6:146388320	C/T	cg23711669	chr6:146136114	FBXO30	0.86	8.52	0.69	9.13e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9399135	0.935	rs11760000	chr6:135370496	G/A	cg24558204	chr6:135376177	HBS1L	0.58	5.05	0.5	2.86e-6	Red blood cell count;
SKCM	cis	rs9583531	0.600	rs9555726	chr13:111368316	C/T	cg24331049	chr13:111365604	ING1	0.83	6.25	0.58	2e-8	Coronary artery disease;
SKCM	cis	rs1949733	0.656	rs2688243	chr4:8436286	A/G	cg11789530	chr4:8429930	ACOX3	0.87	6.17	0.57	2.8e-8	Response to antineoplastic agents;
SKCM	cis	rs5760092	0.755	rs4585126	chr22:24270005	T/C	cg12419862	chr22:24373484	LOC391322	0.65	4.97	0.49	3.88e-6	Urinary 1,3-butadiene metabolite levels in smokers;
SKCM	cis	rs7659604	0.540	rs4833769	chr4:122672970	A/C	cg19671926	chr4:122722719	EXOSC9	-0.77	-6.27	-0.58	1.89e-8	Type 2 diabetes;
SKCM	cis	rs2842992	0.872	rs2758328	chr6:160090731	T/A	cg11366901	chr6:160182831	ACAT2	0.93	6.93	0.62	1.05e-9	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs514406	0.661	rs562641	chr1:53374666	C/T	cg04310824	chr1:53393297	SCP2	-0.6	-4.88	-0.48	5.44e-6	Monocyte count;
SKCM	cis	rs7020830	0.898	rs7846747	chr9:37167539	A/C	cg14294708	chr9:37120828	ZCCHC7	1.06	10.44	0.76	1.78e-16	Schizophrenia;
SKCM	trans	rs1814175	0.588	rs34449937	chr11:49756013	G/A	cg15704280	chr7:45808275	SEPT13	-1.01	-9.85	-0.74	2.46e-15	Height;
SKCM	cis	rs9325144	0.555	rs4550281	chr12:38689937	A/G	cg26384229	chr12:38710491	ALG10B	0.78	6.74	0.61	2.48e-9	Morning vs. evening chronotype;
SKCM	cis	rs763014	1.000	rs7205409	chr16:642610	A/G	cg07343612	chr16:622815	PIGQ	-0.63	-5.09	-0.5	2.39e-6	Height;
SKCM	cis	rs9660180	0.935	rs9786942	chr1:1759213	A/G	cg13866156	chr1:1669148	SLC35E2	-0.71	-5.83	-0.55	1.19e-7	Body mass index;
SKCM	cis	rs1799949	1.000	rs2037076	chr17:41305883	G/A	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.15	-0.57	3.16e-8	Menopause (age at onset);
SKCM	cis	rs561341	0.714	rs111760509	chr17:30304320	A/G	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.76	-0.66	2.72e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs9297145	0.724	rs6958790	chr7:98774738	C/T	cg05967295	chr7:98741636	SMURF1	-1.09	-8.2	-0.68	3.8e-12	Crohn's disease;Inflammatory bowel disease;Ulcerative colitis;
SKCM	cis	rs72634258	0.945	rs67717282	chr1:8041290	C/T	cg00042356	chr1:8021962	PARK7	1.09	7.71	0.66	3.35e-11	Inflammatory bowel disease;
SKCM	cis	rs3785574	0.962	rs2727329	chr17:61924566	C/T	cg06873352	chr17:61820015	STRADA	0.56	4.83	0.48	6.66e-6	Height;
SKCM	cis	rs10911251	0.546	rs1062044	chr1:183112412	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.76	7.28	0.64	2.26e-10	Colorectal cancer;
SKCM	cis	rs12477438	0.520	rs11695379	chr2:99742161	A/G	cg26064155	chr2:99771622	LIPT1;TSGA10	1.02	9.86	0.74	2.39e-15	Chronic sinus infection;
SKCM	trans	rs8073060	0.544	rs225283	chr17:33934912	A/G	cg19694781	chr19:47549865	TMEM160	-1.08	-8.69	-0.7	4.26e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs2777491	0.957	rs2015781	chr15:41648967	C/G	cg18705301	chr15:41695430	NDUFAF1	-0.89	-9.03	-0.71	9.52e-14	Ulcerative colitis;
SKCM	cis	rs5753618	0.504	rs9606846	chr22:31897571	C/T	cg02404636	chr22:31891804	SFI1	0.68	6.07	0.57	4.32e-8	Colorectal cancer;
SKCM	cis	rs12950390	0.853	rs66471233	chr17:45867086	C/T	cg03474202	chr17:45855739	NA	-0.48	-5.41	-0.52	6.6e-7	IgG glycosylation;
SKCM	cis	rs752010	0.619	rs10789406	chr1:42105182	G/T	cg06885757	chr1:42089581	HIVEP3	-0.52	-6.02	-0.56	5.39e-8	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs7809950	0.954	rs2520247	chr7:107143946	A/T	cg23024343	chr7:107201750	COG5	-0.76	-6.83	-0.61	1.64e-9	Coronary artery disease;
SKCM	cis	rs28595532	0.920	rs114611353	chr4:119736607	C/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs5750830	0.649	rs4384886	chr22:39793766	C/T	cg11247378	chr22:39784982	NA	-0.45	-5.31	-0.52	9.99e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs2204008	0.641	rs2387810	chr12:38368875	G/T	cg26384229	chr12:38710491	ALG10B	0.81	6.56	0.6	5.29e-9	Bladder cancer;
SKCM	cis	rs875971	0.830	rs6967708	chr7:65657313	A/T	cg18876405	chr7:65276391	NA	-0.65	-6.64	-0.6	3.71e-9	Aortic root size;
SKCM	cis	rs9309711	0.689	rs4535075	chr2:3481716	T/C	cg15506890	chr2:3487001	NA	-0.62	-5.04	-0.5	2.89e-6	Neurofibrillary tangles;
SKCM	cis	rs7103648	1.000	rs10838705	chr11:47424931	G/A	cg20307385	chr11:47447363	PSMC3	1.08	9.26	0.72	3.38e-14	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs1218582	0.772	rs10908445	chr1:154849590	A/G	cg03351412	chr1:154909251	PMVK	-0.78	-6.94	-0.62	1.04e-9	Prostate cancer;
SKCM	cis	rs7772486	0.790	rs11760	chr6:146205973	G/T	cg23711669	chr6:146136114	FBXO30	0.76	7.55	0.65	7.1e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs17685	0.884	rs6978677	chr7:75636240	C/T	cg16489192	chr7:75678113	MDH2;STYXL1	-0.59	-5.37	-0.52	7.76e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs9467773	1.000	rs9357010	chr6:26527945	C/G	cg15659132	chr6:26577336	NA	0.58	5.65	0.54	2.51e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs1799949	1.000	rs11651341	chr17:41428061	T/C	cg05368731	chr17:41323189	NBR1	0.85	7.42	0.64	1.23e-10	Menopause (age at onset);
SKCM	cis	rs67460515	0.892	rs73026974	chr3:160963231	A/C	cg03342759	chr3:160939853	NMD3	-0.81	-7.1	-0.63	5.14e-10	Parkinson's disease;
SKCM	cis	rs72615157	0.645	rs11771660	chr7:99851269	T/A	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.16	7.07	0.62	5.79e-10	Lung function (FEV1/FVC);
SKCM	trans	rs1814175	0.935	rs7925863	chr11:49615802	C/A	cg15704280	chr7:45808275	SEPT13	-1.0	-9.43	-0.73	1.61e-14	Height;
SKCM	cis	rs875971	0.965	rs28682868	chr7:65689809	C/T	cg18876405	chr7:65276391	NA	-0.67	-6.66	-0.6	3.45e-9	Aortic root size;
SKCM	cis	rs933688	1.000	rs332544	chr5:90778848	C/T	cg12630606	chr5:90679528	LOC100129716;ARRDC3	0.97	7.67	0.66	4.16e-11	Smoking behavior;
SKCM	cis	rs2404602	0.536	rs7163946	chr15:76766049	C/G	cg23625390	chr15:77176239	SCAPER	0.62	5.38	0.52	7.53e-7	Blood metabolite levels;
SKCM	cis	rs651907	0.514	rs11706494	chr3:101509475	A/T	cg12386194	chr3:101231763	SENP7	0.68	5.74	0.54	1.73e-7	Colorectal cancer;
SKCM	cis	rs644799	0.932	rs480079	chr11:95643777	A/T	cg03916912	chr11:95522834	CEP57;FAM76B	-0.67	-5.43	-0.52	6.3e-7	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs2952156	0.920	rs2941506	chr17:37833035	A/G	cg20243544	chr17:37824526	PNMT	0.77	6.38	0.59	1.14e-8	Asthma;
SKCM	cis	rs6088580	0.634	rs1205338	chr20:32925625	C/G	cg24642439	chr20:33292090	TP53INP2	-0.72	-5.7	-0.54	2.06e-7	Glomerular filtration rate (creatinine);
SKCM	cis	rs644799	0.710	rs10831427	chr11:95508383	G/T	cg25622487	chr11:95524042	FAM76B;CEP57	0.76	6.47	0.59	7.89e-9	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs3087591	0.960	rs2952999	chr17:29509801	G/T	cg24425628	chr17:29625626	OMG;NF1	0.61	4.87	0.48	5.75e-6	Hip circumference;
SKCM	cis	rs9818758	0.607	rs9880088	chr3:49178990	G/A	cg00383909	chr3:49044727	WDR6	1.05	5.85	0.55	1.11e-7	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs7143963	0.666	rs57613851	chr14:103319835	C/T	cg23020514	chr14:103360112	TRAF3	0.74	7.1	0.63	5.18e-10	Body mass index;
SKCM	cis	rs459571	0.959	rs378740	chr9:136890876	C/A	cg13789015	chr9:136890014	NCRNA00094	0.77	6.51	0.59	6.65e-9	Platelet distribution width;
SKCM	cis	rs7100689	0.784	rs10749562	chr10:82108253	G/T	cg01528321	chr10:82214614	TSPAN14	0.84	7.34	0.64	1.8e-10	Post bronchodilator FEV1;
SKCM	cis	rs8014204	0.781	rs10143492	chr14:75212114	G/C	cg06637938	chr14:75390232	RPS6KL1	0.72	5.43	0.52	6.24e-7	Caffeine consumption;
SKCM	cis	rs16854884	0.770	rs4450810	chr3:143809091	C/A	cg06585982	chr3:143692056	C3orf58	0.72	5.52	0.53	4.23e-7	Economic and political preferences (feminism/equality);
SKCM	cis	rs7829975	0.508	rs4841006	chr8:8501474	T/C	cg15556689	chr8:8085844	FLJ10661	-0.64	-5.36	-0.52	8.05e-7	Mood instability;
SKCM	cis	rs7044106	0.791	rs4836831	chr9:123496570	C/T	cg09419670	chr9:123605666	PSMD5;LOC253039	0.53	4.89	0.48	5.22e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs34779708	0.931	rs11010130	chr10:35513307	T/C	cg03585969	chr10:35415529	CREM	0.75	5.98	0.56	6.41e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs2072499	0.750	rs57056972	chr1:156159064	C/A	cg24450063	chr1:156163899	SLC25A44	0.88	6.55	0.6	5.55e-9	Testicular germ cell tumor;
SKCM	cis	rs7666738	0.830	rs13133619	chr4:99067312	C/G	cg05340658	chr4:99064831	C4orf37	-0.66	-5.07	-0.5	2.58e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4400599	0.618	rs1194602	chr1:154231943	T/C	cg26808167	chr1:154192205	UBAP2L;C1orf43	-0.54	-4.9	-0.49	5.01e-6	Platelet distribution width;
SKCM	cis	rs6586111	0.647	rs76120037	chr10:82371930	C/G	cg03086067	chr10:82368399	SH2D4B	-0.53	-4.89	-0.48	5.24e-6	Capecitabine sensitivity;
SKCM	cis	rs651907	0.514	rs34301719	chr3:101417993	C/T	cg12386194	chr3:101231763	SENP7	0.68	5.6	0.54	3.04e-7	Colorectal cancer;
SKCM	cis	rs1707322	1.000	rs1768818	chr1:46514286	G/C	cg03146154	chr1:46216737	IPP	-0.77	-5.36	-0.52	8.35e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs4803468	0.763	rs17318596	chr19:41937095	A/G	cg14132834	chr19:41945861	ATP5SL	-0.71	-5.41	-0.52	6.67e-7	Height;
SKCM	cis	rs1552244	0.882	rs13077641	chr3:10022935	G/A	cg02579736	chr3:10068473	FANCD2;CIDECP	0.94	4.84	0.48	6.49e-6	Alzheimer's disease;
SKCM	cis	rs35766269	0.541	rs7096513	chr10:9044198	G/T	cg05671070	chr10:8095960	FLJ45983;GATA3	0.95	4.77	0.48	8.45e-6	Recalcitrant atopic dermatitis;
SKCM	cis	rs453301	0.686	rs11785819	chr8:8870378	T/G	cg06636001	chr8:8085503	FLJ10661	-0.76	-5.76	-0.55	1.58e-7	Joint mobility (Beighton score);
SKCM	cis	rs9715521	0.677	rs67500083	chr4:59862419	C/T	cg11281224	chr4:60001000	NA	-0.61	-4.95	-0.49	4.16e-6	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs2180341	0.920	rs1073932	chr6:127682009	G/T	cg24812749	chr6:127587940	RNF146	0.83	7.24	0.63	2.76e-10	Breast cancer;
SKCM	cis	rs1577917	1.000	rs2816815	chr6:86691656	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.43	-0.52	6.09e-7	Response to antipsychotic treatment;
SKCM	cis	rs9910055	0.530	rs2269908	chr17:42294198	G/C	cg13607699	chr17:42295918	UBTF	0.86	7.36	0.64	1.62e-10	Total body bone mineral density;
SKCM	cis	rs4523957	0.928	rs7213232	chr17:2165340	A/G	cg16513277	chr17:2031491	SMG6	-0.7	-4.79	-0.48	7.85e-6	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs875971	0.706	rs1643374	chr7:65872682	T/A	cg11764359	chr7:65958608	NA	0.82	6.26	0.58	1.9e-8	Aortic root size;
SKCM	cis	rs7811142	0.830	rs75636500	chr7:99947657	C/G	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.07	6.7	0.6	2.88e-9	Platelet count;
SKCM	cis	rs3859192	0.599	rs2227321	chr17:38171294	G/C	cg17467752	chr17:38218738	THRA	-0.74	-6.28	-0.58	1.8e-8	White blood cell count;
SKCM	cis	rs9902453	0.817	rs1038089	chr17:28178724	A/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.83	5.76	0.55	1.61e-7	Coffee consumption (cups per day);
SKCM	cis	rs10832963	0.686	rs11024743	chr11:18653712	A/G	cg09201001	chr11:18656081	SPTY2D1	1.05	9.83	0.74	2.71e-15	Breast cancer;
SKCM	cis	rs7937682	0.663	rs3867466	chr11:111668256	A/C	cg09085632	chr11:111637200	PPP2R1B	1.09	10.48	0.76	1.52e-16	Primary sclerosing cholangitis;
SKCM	cis	rs10256972	0.681	rs12702016	chr7:1129392	C/T	cg09177884	chr7:1199841	ZFAND2A	-0.76	-6.43	-0.59	9.31e-9	Longevity;Endometriosis;
SKCM	cis	rs10504229	0.639	rs67002486	chr8:58117218	A/G	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs28374715	0.662	rs691907	chr15:41474657	C/G	cg18705301	chr15:41695430	NDUFAF1	0.93	7.74	0.66	2.94e-11	Ulcerative colitis;
SKCM	cis	rs2629540	0.889	rs4962699	chr10:126477209	A/G	cg08799069	chr10:126477246	METTL10	-0.67	-5.95	-0.56	7.29e-8	Cocaine dependence;
SKCM	cis	rs3540	0.533	rs12708585	chr15:91052285	C/T	cg22089800	chr15:90895588	ZNF774	-0.68	-4.91	-0.49	4.92e-6	Allergic disease (asthma, hay fever or eczema);Lymphocyte counts;
SKCM	cis	rs6951245	0.554	rs35126802	chr7:1134842	C/T	cg18402987	chr7:1209562	NA	0.81	5.37	0.52	7.96e-7	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs1552244	0.816	rs9847657	chr3:10173492	G/T	cg02579736	chr3:10068473	FANCD2;CIDECP	0.92	5.24	0.51	1.31e-6	Alzheimer's disease;
SKCM	cis	rs28595532	0.764	rs56359736	chr4:119769689	G/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs3020736	0.500	rs6002614	chr22:42501802	G/A	cg04733989	chr22:42467013	NAGA	-0.72	-5.62	-0.54	2.87e-7	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs13118159	0.550	rs4974611	chr4:1358449	T/C	cg20887711	chr4:1340912	KIAA1530	0.98	7.46	0.65	1.04e-10	Longevity;
SKCM	cis	rs611744	0.647	rs11785776	chr8:109264933	C/T	cg18478394	chr8:109455254	TTC35	0.66	5.27	0.51	1.16e-6	Dupuytren's disease;
SKCM	cis	rs10779751	1.000	rs2300094	chr1:11266044	C/T	cg08854313	chr1:11322531	MTOR	0.99	8.73	0.7	3.66e-13	Body mass index;
SKCM	cis	rs1799949	0.965	rs4793233	chr17:41435437	G/C	cg25918947	chr17:41365094	TMEM106A	-0.65	-6.35	-0.58	1.32e-8	Menopause (age at onset);
SKCM	cis	rs4819052	0.851	rs2838848	chr21:46671017	A/G	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.36	0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs6840360	0.571	rs4696273	chr4:152528477	G/A	cg22705602	chr4:152727874	NA	-0.52	-5.7	-0.54	2.03e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs28595532	0.748	rs72670258	chr4:119391660	A/T	cg21605333	chr4:119757512	SEC24D	1.02	5.24	0.51	1.34e-6	Cannabis dependence symptom count;
SKCM	cis	rs11098499	0.863	rs7699064	chr4:120428309	A/G	cg09307838	chr4:120376055	NA	-1.0	-7.16	-0.63	3.98e-10	Corneal astigmatism;
SKCM	cis	rs644799	1.000	rs693597	chr11:95589629	T/C	cg03916912	chr11:95522834	CEP57;FAM76B	0.89	7.72	0.66	3.33e-11	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs55962025	0.846	rs16843804	chr4:3104390	C/T	cg00764545	chr4:3318001	RGS12	-0.67	-5.32	-0.52	9.59e-7	Parental longevity (mother's age at death);
SKCM	cis	rs9325144	0.647	rs35138700	chr12:38804474	C/T	cg13010199	chr12:38710504	ALG10B	-0.66	-5.44	-0.52	5.88e-7	Morning vs. evening chronotype;
SKCM	cis	rs1401999	1.000	rs4148579	chr3:183685249	T/C	cg01324343	chr3:183735012	ABCC5	0.93	10.93	0.78	2.14e-17	Anterior chamber depth;
SKCM	cis	rs2836974	0.544	rs8128919	chr21:40711862	C/T	cg17971929	chr21:40555470	PSMG1	0.73	5.98	0.56	6.23e-8	Cognitive function;
SKCM	cis	rs12497850	0.931	rs7627404	chr3:48819668	A/C	cg06212747	chr3:49208901	KLHDC8B	0.66	4.81	0.48	7.08e-6	Parkinson's disease;
SKCM	cis	rs7843479	0.601	rs2002941	chr8:21834366	A/C	cg17168535	chr8:21777572	XPO7	0.86	8.54	0.7	8.39e-13	Mean corpuscular volume;
SKCM	cis	rs7296418	0.738	rs1568428	chr12:123738876	A/G	cg00376283	chr12:123451042	ABCB9	-0.86	-7.04	-0.62	6.56e-10	Platelet count;
SKCM	cis	rs17711722	0.727	rs35850374	chr7:65357776	A/G	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.61	5.06	0.5	2.75e-6	Calcium levels;
SKCM	cis	rs995000	0.965	rs10889352	chr1:63099023	T/C	cg06896770	chr1:63153194	DOCK7	0.95	8.93	0.71	1.48e-13	Triglyceride levels;
SKCM	trans	rs208520	0.661	rs1100950	chr6:66827285	A/C	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-1.09	-8.61	-0.7	6.3e-13	Exhaled nitric oxide output;
SKCM	cis	rs1707322	0.721	rs4415615	chr1:46132109	C/T	cg03146154	chr1:46216737	IPP	0.8	5.57	0.53	3.52e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs3892630	0.612	rs10413282	chr19:33182751	A/G	cg22980127	chr19:33182716	NUDT19	1.28	8.73	0.7	3.67e-13	Red blood cell traits;
SKCM	cis	rs12450688	1	rs12450688	chr17:38144229	G/A	cg17467752	chr17:38218738	THRA	-0.61	-5.5	-0.53	4.67e-7	Sum eosinophil basophil counts;
SKCM	cis	rs35306767	0.761	rs1871621	chr10:1049596	C/T	cg20503657	chr10:835505	NA	0.62	4.87	0.48	5.77e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs6500395	1.000	rs9924078	chr16:48557918	A/C	cg04672837	chr16:48644449	N4BP1	-0.67	-5.37	-0.52	7.76e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs6582630	0.572	rs1969363	chr12:38514872	A/G	cg26384229	chr12:38710491	ALG10B	0.71	6.29	0.58	1.71e-8	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs10779751	1.000	rs2076655	chr1:11289161	A/G	cg08854313	chr1:11322531	MTOR	-1.03	-9.62	-0.74	6.86e-15	Body mass index;
SKCM	cis	rs875971	1.000	rs2042133	chr7:65931922	A/G	cg18876405	chr7:65276391	NA	0.65	6.32	0.58	1.53e-8	Aortic root size;
SKCM	cis	rs6977660	0.562	rs2189566	chr7:19768960	G/A	cg05791153	chr7:19748676	TWISTNB	0.93	4.92	0.49	4.79e-6	Thyroid stimulating hormone;
SKCM	cis	rs1218582	0.772	rs2061690	chr1:154919080	C/T	cg06221963	chr1:154839813	KCNN3	-0.55	-5.4	-0.52	7.08e-7	Prostate cancer;
SKCM	cis	rs1577917	0.727	rs9344539	chr6:86353621	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.27	-0.51	1.16e-6	Response to antipsychotic treatment;
SKCM	cis	rs28595532	0.920	rs112097820	chr4:119746532	G/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs7945705	0.818	rs2742537	chr11:8908389	G/A	cg13070366	chr11:9386451	NA	0.57	5.16	0.5	1.86e-6	Hemoglobin concentration;
SKCM	cis	rs9911578	1.000	rs8071280	chr17:57010225	T/C	cg05425664	chr17:57184151	TRIM37	-0.67	-5.04	-0.5	2.91e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs10193935	0.901	rs222478	chr2:42656919	G/T	cg27598129	chr2:42591480	NA	-0.93	-6.76	-0.61	2.26e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9858542	1.000	rs11130213	chr3:49712297	C/T	cg03060546	chr3:49711283	APEH	-0.73	-5.45	-0.53	5.73e-7	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs4727027	0.704	rs13221837	chr7:148903597	C/T	cg23583168	chr7:148888333	NA	-0.79	-6.17	-0.57	2.8e-8	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs9486715	1.000	rs9373985	chr6:97063522	C/G	cg06623918	chr6:96969491	KIAA0776	-0.8	-6.87	-0.61	1.37e-9	Headache;
SKCM	cis	rs651907	0.817	rs617688	chr3:101592286	G/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.67	5.05	0.5	2.78e-6	Colorectal cancer;
SKCM	cis	rs8014204	0.743	rs35809608	chr14:75254762	A/G	cg06637938	chr14:75390232	RPS6KL1	0.84	6.66	0.6	3.53e-9	Caffeine consumption;
SKCM	cis	rs17376456	0.877	rs7728736	chr5:93404277	C/T	cg25358565	chr5:93447407	FAM172A	1.22	7.9	0.67	1.49e-11	Diabetic retinopathy;
SKCM	cis	rs13118159	0.550	rs28614045	chr4:1374695	C/A	cg19318889	chr4:1322082	MAEA	0.79	5.72	0.54	1.9e-7	Longevity;
SKCM	cis	rs651907	0.514	rs10936744	chr3:101433440	C/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.81	7.06	0.62	6.11e-10	Colorectal cancer;
SKCM	cis	rs6580649	0.941	rs58046797	chr12:48487619	T/C	cg05342945	chr12:48394962	COL2A1	0.79	5.51	0.53	4.44e-7	Lung cancer;
SKCM	cis	rs9902453	0.845	rs58575982	chr17:28221776	A/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.84	6.07	0.57	4.28e-8	Coffee consumption (cups per day);
SKCM	cis	rs3008870	1.000	rs3008853	chr1:67385488	C/T	cg08660285	chr1:67390436	MIER1;WDR78	0.98	6.56	0.6	5.45e-9	Lymphocyte percentage of white cells;
SKCM	cis	rs826838	0.967	rs826856	chr12:39115434	G/A	cg26384229	chr12:38710491	ALG10B	-0.94	-7.66	-0.65	4.36e-11	Heart rate;
SKCM	cis	rs7772486	0.688	rs1884364	chr6:146337817	C/G	cg05347473	chr6:146136440	FBXO30	0.67	5.59	0.53	3.22e-7	Lobe attachment (rater-scored or self-reported);
SKCM	trans	rs208520	0.690	rs10455194	chr6:66743356	A/G	cg15611600	chr13:45563400	KIAA1704;NUFIP1	0.92	7.47	0.65	9.89e-11	Exhaled nitric oxide output;
SKCM	cis	rs8180040	0.701	rs12491473	chr3:46989904	G/A	cg27129171	chr3:47204927	SETD2	-0.82	-6.47	-0.59	7.73e-9	Colorectal cancer;
SKCM	cis	rs6430585	0.583	rs4594504	chr2:136625113	A/C	cg07169764	chr2:136633963	MCM6	1.31	13.05	0.83	2.59e-21	Corneal structure;
SKCM	cis	rs861020	0.630	rs616544	chr1:210007368	T/C	cg05527609	chr1:210001259	C1orf107	0.86	6.74	0.61	2.43e-9	Orofacial clefts;
SKCM	cis	rs4820539	1.000	rs4822360	chr22:23482460	A/G	cg14186256	chr22:23484241	RTDR1	0.83	7.96	0.67	1.13e-11	Bone mineral density;
SKCM	cis	rs644799	0.544	rs498553	chr11:95534441	G/A	cg03916912	chr11:95522834	CEP57;FAM76B	0.61	4.87	0.48	5.78e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs12586317	0.511	rs113770696	chr14:35444383	C/T	cg16230307	chr14:35515116	FAM177A1	0.75	5.06	0.5	2.72e-6	Psoriasis;
SKCM	cis	rs9611565	0.694	rs106860	chr22:41840407	C/T	cg03806693	chr22:41940476	POLR3H	-1.13	-7.36	-0.64	1.63e-10	Vitiligo;
SKCM	cis	rs9467773	1.000	rs9393732	chr6:26530898	G/A	cg09904177	chr6:26538194	HMGN4	0.54	4.98	0.49	3.78e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1799949	0.965	rs33925201	chr17:41280682	A/G	cg23758822	chr17:41437982	NA	0.92	7.8	0.66	2.3e-11	Menopause (age at onset);
SKCM	cis	rs9814567	0.964	rs12492930	chr3:134222722	A/G	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.66	-5.15	-0.5	1.88e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs1153858	1.000	rs9788780	chr15:45685487	T/A	cg10760299	chr15:45669010	GATM	0.6	5.93	0.56	7.69e-8	Homoarginine levels;
SKCM	cis	rs9911578	1.000	rs9915935	chr17:56843048	A/G	cg12560992	chr17:57184187	TRIM37	0.94	7.41	0.64	1.27e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs17854409	0.881	rs68091818	chr20:61479882	A/C	cg06598544	chr20:61472147	COL9A3	-1.14	-5.76	-0.55	1.61e-7	Obesity-related traits;
SKCM	cis	rs13256369	0.851	rs11786125	chr8:8564570	T/G	cg06636001	chr8:8085503	FLJ10661	0.8	6.15	0.57	3.12e-8	Obesity-related traits;
SKCM	cis	rs10540	0.915	rs12419209	chr11:494510	T/C	cg03352830	chr11:487213	PTDSS2	0.95	4.97	0.49	3.95e-6	Body mass index;
SKCM	cis	rs9875589	0.509	rs1586514	chr3:14050157	G/A	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.5	5.15	0.5	1.9e-6	Ovarian reserve;
SKCM	cis	rs34891900	0.507	rs1008378	chr22:18207251	T/C	cg19898043	chr22:18121309	BCL2L13	0.7	5.54	0.53	4.03e-7	Sum neutrophil eosinophil counts;
SKCM	cis	rs34172651	0.517	rs11647120	chr16:24819806	A/G	cg00339695	chr16:24857497	SLC5A11	0.8	6.43	0.59	9.38e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs2439831	1.000	rs101094	chr15:43787322	C/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.22	7.98	0.67	1.01e-11	Lung cancer in ever smokers;
SKCM	cis	rs6582630	0.519	rs7294292	chr12:38349540	C/T	cg26384229	chr12:38710491	ALG10B	0.81	6.56	0.6	5.29e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs4132509	1.000	rs10803158	chr1:243923229	A/G	cg21452805	chr1:244014465	NA	0.86	4.85	0.48	6.13e-6	RR interval (heart rate);
SKCM	cis	rs6558174	0.965	rs2009212	chr8:22491496	G/A	cg03733263	chr8:22462867	KIAA1967	0.74	5.27	0.51	1.17e-6	Breast cancer;
SKCM	cis	rs2032447	0.670	rs198815	chr6:26127271	A/G	cg03517284	chr6:25882590	NA	0.61	5.18	0.51	1.67e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs2243480	1.000	rs1723267	chr7:65473314	G/A	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs1559088	0.573	rs1270591	chr19:33622942	C/T	cg17764715	chr19:33622953	WDR88	-0.95	-7.35	-0.64	1.71e-10	Bone ultrasound measurement (broadband ultrasound attenuation);
SKCM	cis	rs116095464	0.558	rs10057492	chr5:239503	T/C	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs1059611	0.515	rs28413168	chr8:19674725	G/C	cg03894339	chr8:19674705	INTS10	1.19	5.47	0.53	5.34e-7	Lipid metabolism phenotypes;
SKCM	cis	rs2180341	0.960	rs3756996	chr6:127664258	G/C	cg24812749	chr6:127587940	RNF146	0.84	7.25	0.63	2.6e-10	Breast cancer;
SKCM	cis	rs3768617	0.565	rs4652775	chr1:183061825	A/T	ch.1.3577855R	chr1:183094577	LAMC1	0.76	6.82	0.61	1.73e-9	Fuchs's corneal dystrophy;
SKCM	cis	rs4975616	0.869	rs421284	chr5:1325590	T/C	cg07493874	chr5:1342172	CLPTM1L	-0.7	-6.57	-0.6	5.12e-9	Lung cancer;
SKCM	cis	rs2739330	0.828	rs5760107	chr22:24252597	T/C	cg24846343	chr22:24311635	DDTL	0.61	5.76	0.55	1.58e-7	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs694739	0.894	rs887314	chr11:64053157	T/G	cg23796481	chr11:64053134	BAD;GPR137	0.74	5.59	0.53	3.23e-7	Alopecia areata;Crohn's disease;Psoriasis vulgaris;
SKCM	cis	rs561341	0.941	rs2428341	chr17:30317295	C/T	cg00745463	chr17:30367425	LRRC37B	-1.05	-7.06	-0.62	5.99e-10	Hip circumference adjusted for BMI;
SKCM	cis	rs875971	0.540	rs1723268	chr7:65473080	A/C	cg11987759	chr7:65425863	GUSB	-0.76	-6.75	-0.61	2.31e-9	Aortic root size;
SKCM	cis	rs6545883	0.507	rs4411680	chr2:61584105	A/C	cg15711740	chr2:61764176	XPO1	0.66	5.12	0.5	2.17e-6	Tuberculosis;
SKCM	cis	rs12477438	0.501	rs11123770	chr2:99825102	A/G	cg14399236	chr2:99771627	LIPT1;TSGA10	0.96	8.47	0.69	1.18e-12	Chronic sinus infection;
SKCM	cis	rs2439831	0.850	rs3862142	chr15:44064806	A/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.35	7.75	0.66	2.9e-11	Lung cancer in ever smokers;
SKCM	cis	rs763121	0.853	rs5750626	chr22:38977890	G/C	cg06022373	chr22:39101656	GTPBP1	0.76	5.28	0.51	1.12e-6	Menopause (age at onset);
SKCM	cis	rs3780486	0.505	rs10758188	chr9:33123386	C/T	cg13443165	chr9:33130375	B4GALT1	0.55	5.25	0.51	1.27e-6	IgG glycosylation;
SKCM	cis	rs2180341	1.000	rs6903878	chr6:127638600	C/G	cg27446573	chr6:127587934	RNF146	0.94	8.08	0.68	6.49e-12	Breast cancer;
SKCM	cis	rs778371	0.723	rs12105766	chr2:233617647	A/G	cg08000102	chr2:233561755	GIGYF2	0.9	7.62	0.65	5e-11	Schizophrenia;
SKCM	trans	rs561341	0.941	rs4795664	chr17:30233467	C/T	cg20587970	chr11:113659929	NA	-1.11	-8.92	-0.71	1.53e-13	Hip circumference adjusted for BMI;
SKCM	cis	rs1005277	0.579	rs2474563	chr10:38375938	T/C	cg25427524	chr10:38739819	LOC399744	-0.69	-6.45	-0.59	8.73e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs4740619	0.619	rs10810527	chr9:16043350	C/G	cg14451791	chr9:16040625	NA	0.46	4.85	0.48	6.1e-6	Body mass index;
SKCM	cis	rs2839186	0.934	rs4819221	chr21:47695417	G/T	cg05896524	chr21:47604654	C21orf56	-0.66	-5.51	-0.53	4.49e-7	Testicular germ cell tumor;
SKCM	cis	rs9596863	1.000	rs9596866	chr13:54459385	A/T	ch.13.53330881F	chr13:54432880	NA	0.83	5.05	0.5	2.82e-6	Epilepsy and lamotrigine-induced maculopapular eruptions;
SKCM	cis	rs8180040	0.701	rs13066214	chr3:47033937	C/T	cg27129171	chr3:47204927	SETD2	0.78	6.02	0.56	5.37e-8	Colorectal cancer;
SKCM	cis	rs7618501	0.602	rs2245365	chr3:50097319	C/A	cg24110177	chr3:50126178	RBM5	0.63	5.38	0.52	7.62e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs1862618	0.573	rs832532	chr5:56221938	T/C	cg18230493	chr5:56204884	C5orf35	-0.76	-4.9	-0.48	5.18e-6	Initial pursuit acceleration;
SKCM	cis	rs7811142	0.943	rs3900792	chr7:100004577	C/G	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.16	7.68	0.66	3.87e-11	Platelet count;
SKCM	cis	rs875971	0.895	rs7782806	chr7:65657897	C/T	cg18876405	chr7:65276391	NA	-0.65	-6.64	-0.6	3.71e-9	Aortic root size;
SKCM	cis	rs763121	0.853	rs5750672	chr22:39104168	C/T	cg06022373	chr22:39101656	GTPBP1	-0.9	-7.1	-0.63	5.16e-10	Menopause (age at onset);
SKCM	trans	rs8073060	0.505	rs225270	chr17:33968871	A/T	cg19694781	chr19:47549865	TMEM160	-1.0	-8.56	-0.7	7.62e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs7659604	0.540	rs11734075	chr4:122695685	C/T	cg19671926	chr4:122722719	EXOSC9	0.76	6.84	0.61	1.57e-9	Type 2 diabetes;
SKCM	cis	rs1878931	0.501	rs28735976	chr16:3418419	G/A	cg26668626	chr16:3451006	ZNF174;ZNF434	0.88	7.37	0.64	1.52e-10	Body mass index (adult);
SKCM	cis	rs2811415	0.597	rs9869012	chr3:127728663	C/T	cg09089421	chr3:127803668	RUVBL1	0.99	8.49	0.69	1.07e-12	Lung function (FEV1/FVC);
SKCM	cis	rs10911232	0.507	rs10911199	chr1:182998036	T/A	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.64	0.6	3.83e-9	Hypertriglyceridemia;
SKCM	cis	rs3862030	0.503	rs6584506	chr10:104254428	T/C	cg11453585	chr10:104263688	ACTR1A;SUFU	0.75	5.7	0.54	2.03e-7	Waist circumference adjusted for BMI (adjusted for smoking behaviour);Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction);Waist circumference adjusted for body mass index;
SKCM	cis	rs3793683	0.597	rs12767469	chr10:134587261	C/G	cg00988841	chr10:134556463	INPP5A	0.65	4.89	0.48	5.29e-6	Migraine;
SKCM	cis	rs4423214	0.879	rs10898144	chr11:71151540	A/T	cg05163923	chr11:71159392	DHCR7	-0.71	-6.47	-0.59	7.97e-9	Vitamin D levels;
SKCM	cis	rs7020830	0.898	rs308495	chr9:37277603	G/T	cg14294708	chr9:37120828	ZCCHC7	1.07	10.99	0.78	1.64e-17	Schizophrenia;
SKCM	cis	rs28386778	0.897	rs2854208	chr17:61946885	C/T	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.11	11.22	0.79	6.02e-18	Prudent dietary pattern;
SKCM	cis	rs703842	0.616	rs4760332	chr12:58222672	A/C	cg00677455	chr12:58241039	CTDSP2	-0.75	-5.94	-0.56	7.38e-8	Multiple sclerosis;
SKCM	cis	rs2439831	0.681	rs528517	chr15:43612925	A/G	cg27015174	chr15:43622946	ADAL;LCMT2	0.87	4.81	0.48	7.13e-6	Lung cancer in ever smokers;
SKCM	cis	rs7659604	1.000	rs28433617	chr4:122664138	C/A	cg19748678	chr4:122722346	EXOSC9	0.68	5.59	0.53	3.23e-7	Type 2 diabetes;
SKCM	cis	rs362296	0.661	rs3121420	chr4:3264210	T/C	cg16987761	chr4:3318072	RGS12	-0.65	-5.39	-0.52	7.28e-7	Parental longevity (mother's age at death);
SKCM	cis	rs12142240	0.698	rs1135460	chr1:46815970	T/C	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs7216064	0.911	rs6504551	chr17:65903326	T/G	cg12091567	chr17:66097778	LOC651250	-0.72	-5.01	-0.49	3.25e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs6840360	0.571	rs4696098	chr4:152489053	C/T	cg22705602	chr4:152727874	NA	-0.49	-5.34	-0.52	8.94e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs2811415	0.597	rs9814694	chr3:127792615	C/T	cg09089421	chr3:127803668	RUVBL1	1.0	8.69	0.7	4.4e-13	Lung function (FEV1/FVC);
SKCM	cis	rs7937682	0.564	rs9633937	chr11:111372799	C/T	cg09085632	chr11:111637200	PPP2R1B	0.69	5.05	0.5	2.81e-6	Primary sclerosing cholangitis;
SKCM	cis	rs6952808	0.656	rs73048919	chr7:2103637	C/A	cg02951883	chr7:2050386	MAD1L1	-0.8	-7.0	-0.62	8.03e-10	Bipolar disorder and schizophrenia;
SKCM	cis	rs1348850	0.554	rs7595576	chr2:178371921	C/T	cg27490568	chr2:178487706	NA	0.89	6.54	0.6	5.81e-9	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs9910055	0.659	rs186603	chr17:42207884	C/T	cg19774624	chr17:42201019	HDAC5	0.93	8.96	0.71	1.28e-13	Total body bone mineral density;
SKCM	cis	rs1799949	1.000	rs11079056	chr17:41300799	C/A	cg23758822	chr17:41437982	NA	0.92	7.8	0.66	2.3e-11	Menopause (age at onset);
SKCM	cis	rs57221529	0.766	rs72704799	chr5:551457	C/G	cg26208419	chr5:473447	SLC9A3;LOC25845	1.02	4.91	0.49	4.96e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs2019137	0.560	rs7578633	chr2:113978650	C/T	cg21550016	chr2:113992930	PAX8;LOC440839;LOC654433	0.64	5.02	0.49	3.19e-6	Lymphocyte counts;
SKCM	cis	rs2075371	0.932	rs1862048	chr7:133978167	C/G	cg20476274	chr7:133979776	SLC35B4	-0.91	-8.78	-0.7	2.95e-13	Mean platelet volume;
SKCM	cis	rs6977660	0.882	rs7781975	chr7:19849629	A/G	cg07541023	chr7:19748670	TWISTNB	0.7	4.92	0.49	4.79e-6	Thyroid stimulating hormone;
SKCM	cis	rs9715521	0.900	rs72634620	chr4:59822396	C/T	cg11281224	chr4:60001000	NA	-0.63	-4.97	-0.49	3.93e-6	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs2013441	1.000	rs2526490	chr17:20097526	A/G	cg13482628	chr17:19912719	NA	-0.65	-5.21	-0.51	1.48e-6	Obesity-related traits;
SKCM	cis	rs992157	0.798	rs1017698	chr2:219170525	A/G	cg00012203	chr2:219082015	ARPC2	-0.73	-5.86	-0.55	1.04e-7	Colorectal cancer;
SKCM	cis	rs72781680	0.699	rs72796125	chr2:23919169	C/T	cg08917208	chr2:24149416	ATAD2B	0.98	4.98	0.49	3.75e-6	Lymphocyte counts;
SKCM	cis	rs35306767	0.903	rs61830933	chr10:934195	G/A	cg26597838	chr10:835615	NA	0.83	5.78	0.55	1.47e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs198426	0.506	rs61898508	chr11:61414869	C/T	cg19838087	chr11:61442541	NA	0.44	5.05	0.5	2.84e-6	Plasma omega-3 polyunsaturated fatty acid levels (docosapentaenoic acid);
SKCM	cis	rs10504229	0.683	rs55645894	chr8:58116145	A/G	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs9325144	0.647	rs12227834	chr12:38849246	G/C	cg13010199	chr12:38710504	ALG10B	-0.66	-5.27	-0.51	1.2e-6	Morning vs. evening chronotype;
SKCM	cis	rs7811142	0.830	rs61735533	chr7:99955866	G/A	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.19	7.5	0.65	8.66e-11	Platelet count;
SKCM	cis	rs7178909	0.872	rs7174330	chr15:90434579	C/T	cg19708238	chr15:90437601	AP3S2	-0.68	-4.98	-0.49	3.71e-6	Common traits (Other);
SKCM	cis	rs28595532	0.920	rs56322132	chr4:119742496	T/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs208520	0.837	rs208489	chr6:66927584	G/A	cg07460842	chr6:66804631	NA	-0.98	-6.96	-0.62	9.58e-10	Exhaled nitric oxide output;
SKCM	cis	rs6951245	1.000	rs11763835	chr7:1094513	A/G	cg03188948	chr7:1209495	NA	1.13	6.27	0.58	1.89e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs72781680	1.000	rs56205282	chr2:24221317	C/T	cg08917208	chr2:24149416	ATAD2B	1.07	5.99	0.56	6.1e-8	Lymphocyte counts;
SKCM	cis	rs2941509	1.000	rs113894104	chr17:38072955	C/T	cg12655416	chr17:38077870	ORMDL3	-0.48	-5.27	-0.51	1.17e-6	Systemic lupus erythematosus;
SKCM	cis	rs933688	1.000	rs12654787	chr5:90713259	C/T	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.1	8.33	0.69	2.14e-12	Smoking behavior;
SKCM	cis	rs6088580	0.634	rs6059835	chr20:33020141	A/G	cg24642439	chr20:33292090	TP53INP2	0.76	6.02	0.56	5.28e-8	Glomerular filtration rate (creatinine);
SKCM	trans	rs66573146	0.831	rs67602077	chr4:7024244	A/G	cg07817883	chr1:32538562	TMEM39B	2.03	8.21	0.68	3.77e-12	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs1298637	0.655	rs61592837	chr1:53921278	C/A	cg09586583	chr1:54755153	SSBP3	0.6	5.21	0.51	1.49e-6	Nicotine use;
SKCM	cis	rs738322	0.967	rs133018	chr22:38572761	G/A	cg25457927	chr22:38595422	NA	-0.56	-6.45	-0.59	8.42e-9	Cutaneous nevi;
SKCM	cis	rs6933660	0.683	rs6916340	chr6:151779064	T/C	cg14416726	chr6:151773293	C6orf211;RMND1	-0.67	-5.42	-0.52	6.38e-7	Menarche (age at onset);
SKCM	cis	rs9435341	1.000	rs9435341	chr1:107616641	T/C	cg09367891	chr1:107599246	PRMT6	-0.78	-6.34	-0.58	1.35e-8	Facial morphology (factor 21, depth of nasal alae);
SKCM	cis	rs7100689	0.646	rs1572819	chr10:82112488	A/G	cg01528321	chr10:82214614	TSPAN14	0.69	5.57	0.53	3.5e-7	Post bronchodilator FEV1;
SKCM	cis	rs9910055	0.659	rs227584	chr17:42225547	A/C	cg19774624	chr17:42201019	HDAC5	-0.9	-8.49	-0.69	1.04e-12	Total body bone mineral density;
SKCM	cis	rs6088590	0.687	rs73106933	chr20:33287425	T/C	cg24642439	chr20:33292090	TP53INP2	0.75	5.36	0.52	8.23e-7	Coronary artery disease;
SKCM	cis	rs58688157	0.960	rs1131665	chr11:613208	T/C	cg17114584	chr11:613792	IRF7	0.74	5.0	0.49	3.51e-6	Systemic lupus erythematosus;
SKCM	cis	rs826838	0.874	rs11183816	chr12:38834656	T/G	cg26384229	chr12:38710491	ALG10B	1.06	10.14	0.75	6.67e-16	Heart rate;
SKCM	cis	rs7824557	0.707	rs3808518	chr8:11143272	A/C	cg21775007	chr8:11205619	TDH	-0.74	-6.04	-0.56	5.01e-8	Retinal vascular caliber;
SKCM	cis	rs875971	0.862	rs6945775	chr7:65968974	G/A	cg11764359	chr7:65958608	NA	0.81	7.61	0.65	5.25e-11	Aortic root size;
SKCM	cis	rs7647973	0.731	rs13084037	chr3:49214066	G/A	cg06212747	chr3:49208901	KLHDC8B	1.0	5.42	0.52	6.51e-7	Menarche (age at onset);
SKCM	cis	rs763121	0.853	rs5750664	chr22:39072769	C/T	cg06022373	chr22:39101656	GTPBP1	0.8	5.79	0.55	1.42e-7	Menopause (age at onset);
SKCM	cis	rs4631830	0.720	rs898343	chr10:51505403	A/G	cg16070123	chr10:51489643	NA	0.51	4.86	0.48	5.95e-6	Prostate-specific antigen levels;
SKCM	cis	rs2836974	0.623	rs34240248	chr21:40685239	A/G	cg11644478	chr21:40555479	PSMG1	-0.68	-5.96	-0.56	6.94e-8	Cognitive function;
SKCM	cis	rs16949788	1.000	rs75532475	chr15:66832466	A/G	cg08120210	chr15:66682733	MAP2K1	-0.68	-5.22	-0.51	1.46e-6	Spherical equivalent (joint analysis main effects and education interaction);
SKCM	cis	rs7336332	0.598	rs1885988	chr13:28010262	C/T	cg22138327	chr13:27999177	GTF3A	-0.87	-6.37	-0.59	1.2e-8	Weight;
SKCM	cis	rs11673344	0.704	rs544543	chr19:37430823	A/G	cg07624650	chr19:37064219	ZNF529	-0.8	-5.23	-0.51	1.41e-6	Obesity-related traits;
SKCM	cis	rs13118159	0.509	rs7688922	chr4:1361011	T/C	cg16405210	chr4:1374714	KIAA1530	-0.94	-7.07	-0.62	5.87e-10	Longevity;
SKCM	cis	rs7208859	0.623	rs11658945	chr17:29122509	T/C	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs875971	0.862	rs28491091	chr7:65669064	G/T	cg11764359	chr7:65958608	NA	-0.75	-6.89	-0.62	1.26e-9	Aortic root size;
SKCM	cis	rs9926296	0.568	rs1230	chr16:89804855	A/G	cg27121462	chr16:89883253	FANCA	-0.81	-7.11	-0.63	4.91e-10	Vitiligo;
SKCM	cis	rs7927771	0.864	rs3781626	chr11:47442893	A/T	cg05585544	chr11:47624801	NA	-0.56	-4.81	-0.48	7.15e-6	Subjective well-being;
SKCM	cis	rs4746818	1.000	rs10733850	chr10:70959617	C/T	cg11621586	chr10:70884670	VPS26A	0.86	5.43	0.52	6.29e-7	Left atrial antero-posterior diameter;
SKCM	cis	rs1348850	0.914	rs12612857	chr2:178467144	A/G	cg02961200	chr2:178257176	LOC100130691;AGPS	0.77	5.68	0.54	2.25e-7	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs10791097	0.720	rs6590518	chr11:130733530	C/T	cg12179176	chr11:130786555	SNX19	0.86	7.34	0.64	1.76e-10	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs6951245	0.745	rs79788515	chr7:1101079	C/T	cg18402987	chr7:1209562	NA	1.1	6.0	0.56	5.77e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs1538970	0.924	rs1826691	chr1:45881262	A/G	cg05343316	chr1:45956843	TESK2	-0.92	-4.97	-0.49	3.9e-6	Platelet count;
SKCM	cis	rs3780486	0.713	rs3780489	chr9:33129844	G/T	cg13443165	chr9:33130375	B4GALT1	-0.55	-4.99	-0.49	3.65e-6	IgG glycosylation;
SKCM	cis	rs11098499	0.779	rs10857066	chr4:120286596	C/T	cg09307838	chr4:120376055	NA	0.98	7.89	0.67	1.52e-11	Corneal astigmatism;
SKCM	cis	rs6977660	1.000	rs10279601	chr7:19822171	G/A	cg07541023	chr7:19748670	TWISTNB	0.7	4.82	0.48	6.98e-6	Thyroid stimulating hormone;
SKCM	cis	rs1005277	0.579	rs1780121	chr10:38529437	C/A	cg25427524	chr10:38739819	LOC399744	-0.76	-6.92	-0.62	1.13e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs6951245	0.554	rs10246354	chr7:1132456	C/T	cg03188948	chr7:1209495	NA	0.76	5.26	0.51	1.24e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs9303401	0.659	rs34818467	chr17:56643109	C/T	cg10487724	chr17:56770010	TEX14;RAD51C	-0.74	-5.85	-0.55	1.1e-7	Cognitive test performance;
SKCM	cis	rs4481887	0.962	rs10788768	chr1:248456027	G/A	cg00666640	chr1:248458726	OR2T12	0.58	4.83	0.48	6.68e-6	Common traits (Other);
SKCM	cis	rs2730245	0.528	rs1188954	chr7:158691417	G/A	cg24397884	chr7:158709396	WDR60	0.66	5.16	0.5	1.82e-6	Height;
SKCM	cis	rs55794721	0.509	rs7554255	chr1:25778106	C/T	cg27572855	chr1:25598939	RHD	0.53	5.06	0.5	2.67e-6	Plateletcrit;Mean corpuscular volume;
SKCM	cis	rs7100689	0.577	rs10749560	chr10:82092801	G/T	cg00277334	chr10:82204260	NA	-0.57	-5.34	-0.52	9.02e-7	Post bronchodilator FEV1;
SKCM	cis	rs7507204	0.508	rs2074978	chr19:3434715	C/T	cg08380311	chr19:3435252	NFIC	1.19	12.63	0.82	1.49e-20	Height;
SKCM	cis	rs854765	0.718	rs6502629	chr17:17869642	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.84	6.04	0.56	4.92e-8	Total body bone mineral density;
SKCM	cis	rs9290877	0.580	rs1568668	chr3:188467286	G/A	cg17392043	chr3:188495102	LPP	-0.66	-5.23	-0.51	1.37e-6	IgE levels;
SKCM	cis	rs7959452	0.535	rs10878953	chr12:69674187	A/G	cg14784868	chr12:69753453	YEATS4	0.64	5.61	0.54	2.93e-7	Blood protein levels;
SKCM	cis	rs6089584	0.706	rs6089625	chr20:60620622	T/C	cg06108461	chr20:60628389	TAF4	-0.89	-8.72	-0.7	3.75e-13	Body mass index;
SKCM	cis	rs10207060	0.778	rs6543581	chr2:240702308	C/T	cg07506560	chr2:240697449	NA	-0.57	-5.03	-0.5	3.01e-6	Obesity-related traits;
SKCM	cis	rs12780845	1.000	rs12782687	chr10:17223368	T/G	cg07990022	chr10:16570110	NA	-0.61	-4.87	-0.48	5.67e-6	Homocysteine levels;
SKCM	cis	rs4803468	1.000	rs878082	chr19:41897674	G/A	cg14132834	chr19:41945861	ATP5SL	-0.74	-5.71	-0.54	1.99e-7	Height;
SKCM	cis	rs2075671	0.903	rs62483570	chr7:100300649	C/T	cg20848291	chr7:100343083	ZAN	-0.71	-5.36	-0.52	8.19e-7	Other erythrocyte phenotypes;
SKCM	cis	rs7100689	0.577	rs1143694	chr10:82040052	C/T	cg00277334	chr10:82204260	NA	0.55	5.38	0.52	7.55e-7	Post bronchodilator FEV1;
SKCM	cis	rs28595532	0.925	rs10000445	chr4:119485311	C/T	cg21605333	chr4:119757512	SEC24D	1.24	7.1	0.63	5.16e-10	Cannabis dependence symptom count;
SKCM	cis	rs9674544	0.757	rs9896443	chr17:47125982	A/G	cg10950924	chr17:47092072	IGF2BP1	-0.54	-4.81	-0.48	7.31e-6	Primary tooth development (time to first tooth eruption);Primary tooth development (number of teeth);
SKCM	cis	rs847649	0.767	rs7796678	chr7:102778447	C/T	cg18108683	chr7:102477205	FBXL13	0.76	7.03	0.62	6.84e-10	Morning vs. evening chronotype;
SKCM	cis	rs11098499	0.789	rs10212719	chr4:120254437	T/C	cg09307838	chr4:120376055	NA	0.93	7.55	0.65	7.05e-11	Corneal astigmatism;
SKCM	cis	rs7818345	0.608	rs11778175	chr8:19267830	A/G	cg03393445	chr8:19249545	SH2D4A	-0.58	-4.91	-0.49	4.88e-6	Language performance in older adults (adjusted for episodic memory);
SKCM	cis	rs7208859	0.573	rs7223803	chr17:29077193	A/G	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs875971	1.000	rs4718307	chr7:65610988	A/G	cg11764359	chr7:65958608	NA	-0.86	-8.23	-0.68	3.44e-12	Aortic root size;
SKCM	cis	rs6570726	0.846	rs6919684	chr6:145883801	A/G	cg23711669	chr6:146136114	FBXO30	0.8	8.36	0.69	1.89e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4687718	0.929	rs62255995	chr3:53279830	A/G	cg07507251	chr3:52567010	NT5DC2	0.87	5.58	0.53	3.38e-7	QRS duration;
SKCM	cis	rs73001065	0.591	rs56273306	chr19:19621004	T/C	cg03709012	chr19:19516395	GATAD2A	1.16	5.47	0.53	5.19e-7	LDL cholesterol;
SKCM	cis	rs394563	0.775	rs399673	chr6:149783221	T/C	cg03678062	chr6:149772716	ZC3H12D	-0.47	-4.85	-0.48	6.23e-6	Dupuytren's disease;
SKCM	cis	rs9902453	0.808	rs56088359	chr17:28173659	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.83	5.76	0.55	1.61e-7	Coffee consumption (cups per day);
SKCM	cis	rs7927771	0.524	rs2170815	chr11:47875910	T/C	cg20307385	chr11:47447363	PSMC3	0.71	5.63	0.54	2.67e-7	Subjective well-being;
SKCM	cis	rs10504229	0.953	rs72652908	chr8:58191324	G/A	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs2153535	0.580	rs7741403	chr6:8530578	C/T	cg23788917	chr6:8435910	SLC35B3	-0.66	-4.78	-0.48	8.07e-6	Motion sickness;
SKCM	cis	rs6121246	0.609	rs2149281	chr20:30417918	G/A	cg13852791	chr20:30311386	BCL2L1	0.82	5.64	0.54	2.59e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs3862260	0.509	rs2281493	chr1:120162787	T/C	cg16322792	chr1:120165303	ZNF697	0.49	5.12	0.5	2.15e-6	Systemic lupus erythematosus;
SKCM	cis	rs2832191	0.729	rs2832201	chr21:30499841	A/G	cg08807101	chr21:30365312	RNF160	-0.73	-5.87	-0.55	1e-7	Dental caries;
SKCM	cis	rs2730245	0.527	rs842693	chr7:158660491	C/T	cg24397884	chr7:158709396	WDR60	0.98	5.56	0.53	3.7e-7	Height;
SKCM	cis	rs10751667	0.666	rs7395823	chr11:942701	T/C	cg10932868	chr11:921992	NA	0.54	5.05	0.5	2.81e-6	Alzheimer's disease (late onset);
SKCM	cis	rs13424612	1.000	rs10189996	chr2:240908800	G/A	cg01812947	chr2:240904978	NDUFA10	0.65	5.08	0.5	2.51e-6	Odorant perception (isobutyraldehyde);
SKCM	cis	rs4237845	0.837	rs7954957	chr12:58299250	C/T	cg02175503	chr12:58329896	NA	0.82	7.59	0.65	5.79e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs867186	1.000	rs17319967	chr20:33693650	G/C	cg04194272	chr20:33683537	NA	-1.21	-6.8	-0.61	1.89e-9	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs873946	0.648	rs35417213	chr10:134553749	A/G	cg26818010	chr10:134567672	INPP5A	-0.79	-6.47	-0.59	7.79e-9	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs2777491	0.957	rs3743038	chr15:41694743	C/T	cg18705301	chr15:41695430	NDUFAF1	-0.91	-9.41	-0.73	1.75e-14	Ulcerative colitis;
SKCM	cis	rs1799949	1.000	rs33946455	chr17:41321846	C/T	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.15	-0.57	3.16e-8	Menopause (age at onset);
SKCM	cis	rs478304	0.651	rs10896037	chr11:65503424	A/G	cg27068330	chr11:65405492	SIPA1	-0.9	-8.26	-0.68	3.01e-12	Acne (severe);
SKCM	cis	rs898097	0.627	rs3785514	chr17:80888905	A/G	cg15369054	chr17:80825471	TBCD	-0.58	-5.27	-0.51	1.18e-6	Breast cancer;
SKCM	cis	rs514406	0.505	rs374849	chr1:53185631	G/A	cg16325326	chr1:53192061	ZYG11B	0.93	10.5	0.77	1.41e-16	Monocyte count;
SKCM	cis	rs61776719	0.905	rs28570969	chr1:38407146	A/G	cg12658694	chr1:38397304	INPP5B	0.71	6.3	0.58	1.6e-8	Coronary artery disease;
SKCM	cis	rs8067545	0.750	rs6587215	chr17:19980779	G/T	cg13482628	chr17:19912719	NA	0.73	6.54	0.6	5.78e-9	Schizophrenia;
SKCM	cis	rs7618915	0.547	rs34610878	chr3:52759169	G/C	cg18404041	chr3:52824283	ITIH1	-0.56	-4.94	-0.49	4.33e-6	Bipolar disorder;
SKCM	cis	rs5758659	0.652	rs1063392	chr22:42454950	C/T	cg21144673	chr22:42017783	PPPDE2;XRCC6	0.62	4.84	0.48	6.37e-6	Cognitive function;
SKCM	cis	rs8133974	0.938	rs8128904	chr21:36436452	A/G	cg00621029	chr21:35747559	FAM165B	-0.73	-4.83	-0.48	6.56e-6	Eosinophil counts;Eosinophil percentage of granulocytes;Sum eosinophil basophil counts;
SKCM	cis	rs3091242	1.000	rs646867	chr1:25709258	A/C	cg02931644	chr1:25747376	RHCE	0.5	4.93	0.49	4.48e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs4727027	0.754	rs917124	chr7:148851213	C/T	cg23583168	chr7:148888333	NA	-0.77	-5.44	-0.52	6e-7	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs801193	1.000	rs2003301	chr7:66147656	G/C	cg18876405	chr7:65276391	NA	-0.8	-7.11	-0.63	4.86e-10	Aortic root size;
SKCM	cis	rs2153535	0.542	rs4440510	chr6:8471818	C/T	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs6951245	1.000	rs11763793	chr7:1094342	A/G	cg18402987	chr7:1209562	NA	1.15	6.09	0.57	3.95e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs9581857	0.685	rs9319367	chr13:28042197	T/C	cg22138327	chr13:27999177	GTF3A	0.93	6.18	0.57	2.75e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs17376456	0.569	rs2045019	chr5:93201971	C/T	cg25358565	chr5:93447407	FAM172A	-0.88	-5.63	-0.54	2.71e-7	Diabetic retinopathy;
SKCM	cis	rs6952808	0.756	rs13234214	chr7:1878860	C/T	cg21782813	chr7:2030301	MAD1L1	0.51	4.77	0.47	8.55e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs8017423	0.935	rs4904661	chr14:90729332	T/C	cg04374321	chr14:90722782	PSMC1	1.0	9.0	0.71	1.09e-13	Mortality in heart failure;
SKCM	cis	rs9467773	0.620	rs9461276	chr6:26595168	T/C	cg09904177	chr6:26538194	HMGN4	0.57	4.87	0.48	5.81e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7666738	0.752	rs62318905	chr4:99036103	T/G	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs701145	0.537	rs449361	chr3:153922410	T/C	cg17054900	chr3:154042577	DHX36	1.25	5.36	0.52	8.3e-7	Coronary artery disease;
SKCM	cis	rs12497850	0.864	rs7431857	chr3:48900347	G/A	cg07636037	chr3:49044803	WDR6	1.01	10.82	0.77	3.36e-17	Parkinson's disease;
SKCM	cis	rs151997	0.777	rs3846499	chr5:50254200	G/A	cg06027927	chr5:50259733	NA	0.71	6.67	0.6	3.27e-9	Callous-unemotional behaviour;
SKCM	cis	rs8180040	1.000	rs2159400	chr3:47375890	T/C	cg27129171	chr3:47204927	SETD2	-0.87	-6.62	-0.6	4.2e-9	Colorectal cancer;
SKCM	cis	rs7552404	0.924	rs3818855	chr1:76198785	C/T	cg03433033	chr1:76189801	ACADM	0.77	5.63	0.54	2.75e-7	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs2180341	0.961	rs9375501	chr6:127652539	C/T	cg24812749	chr6:127587940	RNF146	0.85	7.3	0.64	2.08e-10	Breast cancer;
SKCM	cis	rs933688	1.000	rs332544	chr5:90778848	C/T	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.02	7.81	0.66	2.23e-11	Smoking behavior;
SKCM	cis	rs1218582	0.774	rs4845681	chr1:154868055	G/T	cg24250549	chr1:154909240	PMVK	0.79	8.05	0.67	7.39e-12	Prostate cancer;
SKCM	cis	rs6088580	0.634	rs4911421	chr20:32998948	T/C	cg24642439	chr20:33292090	TP53INP2	-0.76	-6.02	-0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs2011503	0.825	rs4808932	chr19:19358819	C/T	cg11584989	chr19:19387371	SF4	0.75	4.92	0.49	4.71e-6	Bipolar disorder;
SKCM	cis	rs73201462	1.000	rs2687730	chr3:127915457	C/T	cg09089421	chr3:127803668	RUVBL1	1.0	5.11	0.5	2.22e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs951366	0.789	rs7536483	chr1:205718858	A/T	cg24503407	chr1:205819492	PM20D1	0.89	7.43	0.64	1.2e-10	Menarche (age at onset);
SKCM	cis	rs763121	0.853	rs2413544	chr22:39059404	A/C	cg06022373	chr22:39101656	GTPBP1	0.74	5.24	0.51	1.35e-6	Menopause (age at onset);
SKCM	cis	rs6951245	0.744	rs10275401	chr7:1213943	A/C	cg03188948	chr7:1209495	NA	1.06	6.85	0.61	1.53e-9	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs6879260	1.000	rs10903252	chr5:179733934	T/C	cg23248424	chr5:179741104	GFPT2	-0.75	-5.92	-0.56	8.17e-8	Height;
SKCM	cis	rs9611565	0.570	rs12159188	chr22:42121125	A/T	cg03806693	chr22:41940476	POLR3H	0.77	4.88	0.48	5.51e-6	Vitiligo;
SKCM	cis	rs995000	0.931	rs1168050	chr1:62986955	C/T	cg06896770	chr1:63153194	DOCK7	-0.74	-6.81	-0.61	1.77e-9	Triglyceride levels;
SKCM	cis	rs61776719	0.905	rs17465420	chr1:38398588	T/C	cg17077180	chr1:38461687	NA	0.5	4.92	0.49	4.63e-6	Coronary artery disease;
SKCM	cis	rs651907	0.535	rs12633089	chr3:101528763	C/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.78	6.72	0.61	2.65e-9	Colorectal cancer;
SKCM	cis	rs4916588	0.697	rs6796963	chr3:196662275	C/T	cg05556202	chr3:196065106	TM4SF19	-0.68	-4.92	-0.49	4.67e-6	Night sleep phenotypes;
SKCM	cis	rs614226	0.935	rs7137953	chr12:120894685	C/T	cg01236616	chr12:121019343	POP5	-1.29	-8.1	-0.68	5.94e-12	Type 1 diabetes nephropathy;
SKCM	cis	rs769267	0.895	rs2315279	chr19:19479936	C/A	cg03709012	chr19:19516395	GATAD2A	-0.89	-8.48	-0.69	1.1e-12	Tonsillectomy;
SKCM	cis	rs137761	0.576	rs137803	chr22:44086749	A/G	cg12729397	chr22:44208276	EFCAB6	-0.71	-5.12	-0.5	2.19e-6	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs1691799	0.867	rs2172881	chr12:66766039	C/G	cg16791601	chr12:66731901	HELB	-0.6	-5.41	-0.52	6.65e-7	White blood cell count (basophil);
SKCM	cis	rs9303401	0.659	rs7210432	chr17:56668170	C/T	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.13	0.57	3.42e-8	Cognitive test performance;
SKCM	cis	rs2739330	0.828	rs5760098	chr22:24248314	A/G	cg24846343	chr22:24311635	DDTL	0.7	6.75	0.61	2.4e-9	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs9790314	1.000	rs9870059	chr3:161017240	T/C	cg03342759	chr3:160939853	NMD3	-0.72	-7.87	-0.67	1.67e-11	Morning vs. evening chronotype;
SKCM	cis	rs2404602	0.716	rs8030411	chr15:76699855	A/G	cg23625390	chr15:77176239	SCAPER	0.63	5.79	0.55	1.4e-7	Blood metabolite levels;
SKCM	cis	rs8180040	0.966	rs12632132	chr3:47477019	C/T	cg27129171	chr3:47204927	SETD2	0.79	5.79	0.55	1.43e-7	Colorectal cancer;
SKCM	cis	rs2013441	1.000	rs2058971	chr17:20219508	T/A	cg13482628	chr17:19912719	NA	-0.64	-4.85	-0.48	6.3e-6	Obesity-related traits;
SKCM	cis	rs7666738	0.830	rs10049627	chr4:99025272	A/C	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1707322	0.685	rs6690926	chr1:46134978	T/C	cg03146154	chr1:46216737	IPP	0.82	6.1	0.57	3.89e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs2439831	1.000	rs2601014	chr15:43756013	G/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.39	7.61	0.65	5.25e-11	Lung cancer in ever smokers;
SKCM	cis	rs9788682	0.948	rs28498264	chr15:78837673	C/T	cg06917634	chr15:78832804	PSMA4	-0.8	-4.84	-0.48	6.47e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs11673344	0.734	rs1667343	chr19:37469098	G/A	cg07624650	chr19:37064219	ZNF529	-0.78	-4.82	-0.48	7.05e-6	Obesity-related traits;
SKCM	trans	rs17685	0.753	rs11982200	chr7:75714883	T/C	cg19862616	chr7:65841803	NCRNA00174	0.94	9.45	0.73	1.46e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs651907	0.514	rs12636047	chr3:101434449	T/C	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.81	7.06	0.62	6.11e-10	Colorectal cancer;
SKCM	cis	rs7666738	0.830	rs11727612	chr4:99001662	T/C	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs116095464	0.558	rs11959126	chr5:283880	T/G	cg22857025	chr5:266934	NA	-1.47	-8.33	-0.69	2.16e-12	Breast cancer;
SKCM	cis	rs7824557	0.547	rs2898274	chr8:11238316	G/T	cg21775007	chr8:11205619	TDH	-0.57	-4.93	-0.49	4.47e-6	Retinal vascular caliber;
SKCM	cis	rs7945705	0.846	rs4929911	chr11:8816495	T/C	cg21881798	chr11:8931708	C11orf17;ST5	0.66	6.51	0.59	6.59e-9	Hemoglobin concentration;
SKCM	cis	rs2072499	0.966	rs2842864	chr1:156159217	G/A	cg25208724	chr1:156163844	SLC25A44	1.1	9.86	0.74	2.35e-15	Testicular germ cell tumor;
SKCM	cis	rs2404602	0.608	rs12439484	chr15:76602937	A/C	cg23625390	chr15:77176239	SCAPER	0.69	6.31	0.58	1.57e-8	Blood metabolite levels;
SKCM	cis	rs66573146	0.634	rs55633489	chr4:6988745	C/A	cg00086871	chr4:6988644	TBC1D14	1.29	5.03	0.5	3.04e-6	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs854765	0.693	rs12941039	chr17:17765655	C/T	cg04398451	chr17:18023971	MYO15A	0.83	6.49	0.59	7.17e-9	Total body bone mineral density;
SKCM	cis	rs2739330	0.791	rs9612520	chr22:24269459	G/T	cg24846343	chr22:24311635	DDTL	0.64	5.83	0.55	1.21e-7	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs2952156	0.883	rs2941505	chr17:37832704	A/G	cg00129232	chr17:37814104	STARD3	-0.69	-5.63	-0.54	2.69e-7	Asthma;
SKCM	cis	rs2197308	0.643	rs1842597	chr12:37862142	C/G	cg26384229	chr12:38710491	ALG10B	-0.76	-6.05	-0.57	4.71e-8	Morning vs. evening chronotype;
SKCM	cis	rs11098499	0.863	rs2306456	chr4:120472422	C/G	cg24375607	chr4:120327624	NA	0.69	5.47	0.53	5.35e-7	Corneal astigmatism;
SKCM	cis	rs1577917	1.000	rs7760207	chr6:86721700	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.63	-5.4	-0.52	7.05e-7	Response to antipsychotic treatment;
SKCM	cis	rs8072100	0.935	rs78737171	chr17:45668760	A/T	cg25173405	chr17:45401733	C17orf57	0.58	5.23	0.51	1.39e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs9660180	0.967	rs6603802	chr1:1812521	C/T	cg13866156	chr1:1669148	SLC35E2	-0.79	-6.52	-0.59	6.44e-9	Body mass index;
SKCM	cis	rs116095464	0.558	rs28729548	chr5:229025	C/T	cg22857025	chr5:266934	NA	-1.37	-8.11	-0.68	5.82e-12	Breast cancer;
SKCM	cis	rs17711722	0.727	rs1880555	chr7:65432567	T/C	cg18876405	chr7:65276391	NA	0.87	8.12	0.68	5.54e-12	Calcium levels;
SKCM	cis	rs56104184	0.775	rs73063505	chr19:49402765	T/C	cg19746536	chr19:49375674	PPP1R15A	1.16	5.93	0.56	7.67e-8	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs9308433	0.529	rs11120298	chr1:214500620	A/G	cg06198575	chr1:214491504	SMYD2	0.79	4.94	0.49	4.44e-6	IgG glycosylation;
SKCM	cis	rs10089	1.000	rs3816006	chr5:127450581	T/A	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.91	8.88	0.71	1.84e-13	Ileal carcinoids;
SKCM	cis	rs738322	0.532	rs9622746	chr22:38564041	C/G	cg25457927	chr22:38595422	NA	-0.51	-5.91	-0.56	8.58e-8	Cutaneous nevi;
SKCM	cis	rs6952808	0.895	rs4513875	chr7:1928159	C/T	cg04267008	chr7:1944627	MAD1L1	-0.63	-4.81	-0.48	7.21e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs1218582	0.804	rs4845678	chr1:154853295	A/G	cg24250549	chr1:154909240	PMVK	0.87	8.69	0.7	4.22e-13	Prostate cancer;
SKCM	cis	rs2836974	0.653	rs8130556	chr21:40516872	C/T	cg17971929	chr21:40555470	PSMG1	0.89	8.48	0.69	1.11e-12	Cognitive function;
SKCM	cis	rs7100689	0.646	rs1340375	chr10:82129039	C/T	cg01528321	chr10:82214614	TSPAN14	0.8	7.0	0.62	7.98e-10	Post bronchodilator FEV1;
SKCM	cis	rs514406	0.755	rs11206015	chr1:53242187	T/C	cg16325326	chr1:53192061	ZYG11B	-0.88	-8.87	-0.71	1.93e-13	Monocyte count;
SKCM	cis	rs798554	0.679	rs1636249	chr7:2884283	T/G	cg04166393	chr7:2884313	GNA12	0.8	5.64	0.54	2.58e-7	Height;
SKCM	cis	rs11690935	0.959	rs973889	chr2:172579954	A/G	cg13550731	chr2:172543902	DYNC1I2	-0.95	-8.1	-0.68	6.14e-12	Schizophrenia;
SKCM	trans	rs1814175	0.645	rs4625470	chr11:49983769	T/C	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs2153535	0.562	rs9379211	chr6:8463927	C/T	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs4803468	1.000	rs2241711	chr19:41911980	T/C	cg09537434	chr19:41945824	ATP5SL	-1.1	-13.82	-0.84	1.16e-22	Height;
SKCM	cis	rs6545883	0.929	rs6545877	chr2:61741947	T/C	cg15711740	chr2:61764176	XPO1	-0.75	-5.3	-0.51	1.06e-6	Tuberculosis;
SKCM	cis	rs7843479	0.601	rs9969551	chr8:21860007	T/C	cg17168535	chr8:21777572	XPO7	0.85	8.01	0.67	9e-12	Mean corpuscular volume;
SKCM	cis	rs807669	0.807	rs712948	chr22:19206499	A/G	cg02655711	chr22:19163373	SLC25A1	0.84	7.57	0.65	6.36e-11	Metabolite levels;
SKCM	cis	rs2404602	0.735	rs56246286	chr15:76690731	C/T	cg23625390	chr15:77176239	SCAPER	-0.83	-8.07	-0.67	6.97e-12	Blood metabolite levels;
SKCM	cis	rs4790333	0.813	rs2005029	chr17:2255138	G/T	cg02569219	chr17:2266849	SGSM2	-0.72	-6.11	-0.57	3.71e-8	Proinsulin levels;
SKCM	cis	rs13010713	0.811	rs10930961	chr2:182094997	G/A	cg21995919	chr2:182322279	ITGA4	-0.56	-4.83	-0.48	6.77e-6	Celiac disease;
SKCM	cis	rs116095464	0.558	rs1812843	chr5:267658	A/G	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs7666738	0.830	rs4472144	chr4:98956494	G/A	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2739330	0.760	rs5751761	chr22:24243736	A/G	cg04234412	chr22:24373322	LOC391322	0.65	5.28	0.51	1.13e-6	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs2439831	0.850	rs7179388	chr15:44123945	C/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.36	7.78	0.66	2.56e-11	Lung cancer in ever smokers;
SKCM	cis	rs3213545	0.700	rs10849829	chr12:121470256	A/G	cg15155738	chr12:121454335	C12orf43	-0.64	-4.86	-0.48	5.85e-6	Subjective well-being;Cardiovascular disease risk factors;
SKCM	cis	rs7772486	0.875	rs969694	chr6:146394655	A/G	cg23711669	chr6:146136114	FBXO30	0.86	8.45	0.69	1.26e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6063312	0.518	rs6122718	chr20:47346225	A/G	cg18078177	chr20:47281410	PREX1	-0.81	-6.93	-0.62	1.09e-9	Tonometry;
SKCM	cis	rs6582630	0.537	rs12823925	chr12:38409323	C/T	cg26384229	chr12:38710491	ALG10B	0.82	6.3	0.58	1.6e-8	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs854765	0.583	rs11078405	chr17:17824978	G/T	cg09796270	chr17:17721594	SREBF1	0.65	4.88	0.48	5.45e-6	Total body bone mineral density;
SKCM	trans	rs561341	1.000	rs4795668	chr17:30244554	G/A	cg20587970	chr11:113659929	NA	-0.98	-7.89	-0.67	1.56e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs796364	0.951	rs72932280	chr2:200996851	G/C	cg12253985	chr2:200820533	C2orf60;C2orf47	-0.98	-6.28	-0.58	1.82e-8	Schizophrenia;
SKCM	cis	rs1552244	0.935	rs11926481	chr3:10142102	G/T	cg02579736	chr3:10068473	FANCD2;CIDECP	1.23	6.92	0.62	1.13e-9	Alzheimer's disease;
SKCM	cis	rs933688	1.000	rs12188467	chr5:90765632	A/T	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.06	8.36	0.69	1.91e-12	Smoking behavior;
SKCM	cis	rs2404602	0.692	rs34272342	chr15:77012276	A/C	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs7247513	0.658	rs4804728	chr19:12752928	G/A	cg01871581	chr19:12707946	ZNF490	-0.69	-4.91	-0.49	4.81e-6	Bipolar disorder;
SKCM	cis	rs9399135	1.000	rs4896130	chr6:135355118	C/T	cg24558204	chr6:135376177	HBS1L	0.6	5.36	0.52	8.17e-7	Red blood cell count;
SKCM	cis	rs4803468	1.000	rs10853751	chr19:41903220	G/A	cg09537434	chr19:41945824	ATP5SL	-1.08	-13.01	-0.83	3.1e-21	Height;
SKCM	cis	rs28595532	0.920	rs55901549	chr4:119770172	T/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs644799	0.965	rs2508713	chr11:95547927	T/A	cg03916912	chr11:95522834	CEP57;FAM76B	0.92	8.04	0.67	8e-12	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs2730245	0.594	rs2657343	chr7:158745472	G/A	cg24397884	chr7:158709396	WDR60	-0.97	-7.96	-0.67	1.12e-11	Height;
SKCM	cis	rs7829975	0.523	rs9644774	chr8:8559832	G/A	cg06636001	chr8:8085503	FLJ10661	-0.71	-5.23	-0.51	1.39e-6	Mood instability;
SKCM	cis	rs28386778	0.863	rs58269663	chr17:61843130	G/A	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs4820539	0.966	rs3788350	chr22:23468468	C/T	cg14186256	chr22:23484241	RTDR1	0.85	8.19	0.68	4.03e-12	Bone mineral density;
SKCM	cis	rs12477438	0.798	rs12473029	chr2:99637961	A/G	cg26064155	chr2:99771622	LIPT1;TSGA10	-0.73	-4.91	-0.49	4.97e-6	Chronic sinus infection;
SKCM	cis	rs2658782	0.789	rs2259633	chr11:93141580	C/A	cg15737290	chr11:93063684	CCDC67	0.68	4.81	0.48	7.23e-6	Pulmonary function decline;
SKCM	trans	rs1814175	0.781	rs12286395	chr11:49954062	C/G	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs6815814	0.950	rs5743571	chr4:38805489	C/T	cg02016764	chr4:38805732	TLR1	-0.76	-5.4	-0.52	6.95e-7	Breast cancer;
SKCM	cis	rs12047808	0.730	rs61373961	chr1:179531902	A/C	cg09822482	chr1:179519214	C1orf125	-0.96	-4.77	-0.48	8.48e-6	Multiple sclerosis (age of onset);
SKCM	cis	rs1552244	1.000	rs6764168	chr3:10123805	A/G	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs4619890	0.528	rs62289335	chr4:7877655	G/C	cg08722675	chr4:8412549	ACOX3	0.54	5.06	0.5	2.68e-6	Glaucoma (primary open-angle);
SKCM	cis	rs1801251	0.778	rs2250654	chr2:233752376	A/T	cg25237894	chr2:233734115	C2orf82	-0.59	-6.28	-0.58	1.79e-8	Coronary artery disease;
SKCM	cis	rs2153535	0.580	rs1034272	chr6:8469335	G/C	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs8170	0.603	rs4808622	chr19:17415457	C/G	cg07830086	chr19:18107778	KCNN1	-0.8	-4.99	-0.49	3.54e-6	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Ovarian cancer;Breast cancer;Epithelial ovarian cancer;
SKCM	cis	rs6424115	0.965	rs2502979	chr1:24149315	C/A	cg15997130	chr1:24165203	NA	0.62	5.42	0.52	6.33e-7	Immature fraction of reticulocytes;
SKCM	cis	rs8060686	0.641	rs9674047	chr16:68045046	G/A	cg09117114	chr16:67998030	SLC12A4	-0.78	-5.06	-0.5	2.72e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs1691799	0.899	rs1168321	chr12:66744517	C/G	cg16791601	chr12:66731901	HELB	0.65	6.09	0.57	4.07e-8	White blood cell count (basophil);
SKCM	cis	rs6088590	0.561	rs764597	chr20:33161225	C/T	cg24642439	chr20:33292090	TP53INP2	0.76	5.84	0.55	1.13e-7	Coronary artery disease;
SKCM	cis	rs6952808	1.000	rs6953693	chr7:1886388	C/G	cg04267008	chr7:1944627	MAD1L1	-0.8	-6.1	-0.57	3.78e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs1797081	0.811	rs1797076	chr10:16853076	A/G	cg23933602	chr10:16859644	RSU1	1.03	13.54	0.84	3.61e-22	Platelet distribution width;
SKCM	cis	rs8180040	0.676	rs13098228	chr3:47138253	A/G	cg27129171	chr3:47204927	SETD2	0.79	6.11	0.57	3.69e-8	Colorectal cancer;
SKCM	cis	rs8064299	0.597	rs9944506	chr17:72782726	C/G	cg25054828	chr17:72772726	NAT9;TMEM104	0.98	10.16	0.75	6.14e-16	Monocyte count;
SKCM	cis	rs2153535	0.542	rs6912740	chr6:8439959	A/G	cg07606381	chr6:8435919	SLC35B3	0.94	6.94	0.62	1.02e-9	Motion sickness;
SKCM	cis	rs2836974	0.897	rs2836933	chr21:40564202	C/G	cg11890956	chr21:40555474	PSMG1	1.09	13.83	0.84	1.08e-22	Cognitive function;
SKCM	cis	rs3096299	0.642	rs12934829	chr16:89523349	T/A	cg02187348	chr16:89574699	SPG7	0.55	4.84	0.48	6.44e-6	Multiple myeloma (IgH translocation);
SKCM	cis	rs2228479	0.681	rs62052184	chr16:89967217	T/C	cg00800038	chr16:89945340	TCF25	-0.94	-5.55	-0.53	3.77e-7	Skin colour saturation;
SKCM	cis	rs72781680	1.000	rs12616985	chr2:24165511	A/C	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	cis	rs7927771	0.524	rs12362318	chr11:47682671	T/C	cg20307385	chr11:47447363	PSMC3	0.72	5.83	0.55	1.21e-7	Subjective well-being;
SKCM	cis	rs6546550	0.867	rs6738174	chr2:70150215	A/C	cg02498382	chr2:70120550	SNRNP27	-0.45	-4.88	-0.48	5.4e-6	Prevalent atrial fibrillation;
SKCM	cis	rs875971	0.862	rs2909688	chr7:65841612	C/A	cg11764359	chr7:65958608	NA	0.75	6.79	0.61	1.94e-9	Aortic root size;
SKCM	cis	rs2991971	0.967	rs7526665	chr1:46005832	G/T	cg24296786	chr1:45957014	TESK2	0.67	5.45	0.52	5.81e-7	High light scatter reticulocyte count;
SKCM	cis	rs2075371	0.579	rs11766422	chr7:134018160	T/C	cg20476274	chr7:133979776	SLC35B4	0.9	8.75	0.7	3.37e-13	Mean platelet volume;
SKCM	cis	rs394563	0.619	rs4895787	chr6:149646500	G/A	cg03678062	chr6:149772716	ZC3H12D	0.53	6.27	0.58	1.88e-8	Dupuytren's disease;
SKCM	cis	rs28595532	0.748	rs66615663	chr4:119336701	C/T	cg11846333	chr4:119757529	SEC24D	1.19	6.71	0.6	2.81e-9	Cannabis dependence symptom count;
SKCM	cis	rs36093844	0.626	rs11234513	chr11:85723127	C/T	cg25872744	chr11:85566296	CCDC83	-0.81	-4.79	-0.48	7.84e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs9902453	0.868	rs9896012	chr17:28470091	T/C	cg26525008	chr17:28256777	EFCAB5;SSH2	0.79	6.03	0.56	5.24e-8	Coffee consumption (cups per day);
SKCM	cis	rs1801251	1.000	rs1867778	chr2:233679644	C/T	cg08000102	chr2:233561755	GIGYF2	-0.84	-6.71	-0.61	2.75e-9	Coronary artery disease;
SKCM	cis	rs79387448	0.655	rs76930359	chr2:102924684	G/A	cg21388029	chr2:102003306	CREG2	1.16	4.94	0.49	4.28e-6	Gut microbiota (bacterial taxa);
SKCM	cis	rs12142240	0.698	rs112068407	chr1:46822291	T/C	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs507080	0.922	rs561845	chr11:118558827	A/G	cg18045108	chr11:118530628	TREH	-0.47	-4.81	-0.48	7.24e-6	Serum metabolite levels;
SKCM	cis	rs4820539	1.000	rs5759598	chr22:23480962	T/G	cg14186256	chr22:23484241	RTDR1	0.83	7.99	0.67	9.99e-12	Bone mineral density;
SKCM	cis	rs9858542	0.953	rs6997	chr3:49453834	C/T	cg03060546	chr3:49711283	APEH	-0.68	-5.07	-0.5	2.66e-6	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs7666738	0.830	rs10010698	chr4:98981594	C/T	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1014246	0.807	rs12784789	chr10:118473593	A/T	cg14919929	chr10:118506882	NA	0.74	5.31	0.52	1.01e-6	Age at smoking initiation in chronic obstructive pulmonary disease;
SKCM	cis	rs2050392	0.590	rs694346	chr10:30711929	C/T	cg25182066	chr10:30743637	MAP3K8	-0.66	-5.39	-0.52	7.31e-7	Inflammatory bowel disease;
SKCM	cis	rs28386778	0.863	rs1376110	chr17:61779927	A/C	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.27	0.51	1.2e-6	Prudent dietary pattern;
SKCM	cis	rs7772486	0.790	rs2247666	chr6:146220409	C/A	cg05347473	chr6:146136440	FBXO30	0.56	5.28	0.51	1.12e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4654899	0.758	rs1354792	chr1:21391875	C/T	cg01072550	chr1:21505969	NA	0.63	4.81	0.48	7.3e-6	Superior frontal gyrus grey matter volume;
SKCM	cis	rs6933660	0.610	rs71549125	chr6:151770796	A/C	cg10883421	chr6:151773342	RMND1;C6orf211	0.83	6.92	0.62	1.11e-9	Menarche (age at onset);
SKCM	cis	rs9910055	0.531	rs6503490	chr17:42246656	A/G	cg19774624	chr17:42201019	HDAC5	-0.9	-8.49	-0.69	1.04e-12	Total body bone mineral density;
SKCM	cis	rs7829975	0.681	rs2271342	chr8:8643938	C/T	cg15556689	chr8:8085844	FLJ10661	0.71	6.1	0.57	3.88e-8	Mood instability;
SKCM	cis	rs873946	0.648	rs12766050	chr10:134549108	G/A	cg27286337	chr10:134555280	INPP5A	0.92	8.33	0.69	2.15e-12	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs9913156	0.802	rs4538065	chr17:4566015	G/A	cg19197139	chr17:4613644	ARRB2	-0.79	-5.3	-0.51	1.04e-6	Lymphocyte counts;
SKCM	cis	rs7772486	0.714	rs1883365	chr6:146076749	C/T	cg23711669	chr6:146136114	FBXO30	-0.86	-9.45	-0.73	1.46e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1707322	0.691	rs61784799	chr1:46177748	A/G	cg03146154	chr1:46216737	IPP	-0.8	-5.36	-0.52	8.1e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs4237845	0.611	rs4335583	chr12:58305111	T/C	cg02175503	chr12:58329896	NA	0.96	9.51	0.73	1.09e-14	Intelligence (multi-trait analysis);
SKCM	trans	rs17685	0.753	rs10085567	chr7:75734206	A/C	cg19862616	chr7:65841803	NCRNA00174	0.95	9.02	0.71	9.98e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7954584	0.505	rs11043278	chr12:122412145	C/T	cg22618164	chr12:122356400	WDR66	0.55	5.41	0.52	6.69e-7	Mean corpuscular volume;
SKCM	cis	rs2242116	0.932	rs1531137	chr3:46943028	T/C	cg02527881	chr3:46936655	PTH1R	-0.55	-5.29	-0.51	1.08e-6	Birth weight;
SKCM	cis	rs9905704	0.647	rs2036730	chr17:57038282	A/G	cg12560992	chr17:57184187	TRIM37	0.75	5.99	0.56	6.06e-8	Testicular germ cell tumor;
SKCM	cis	rs2019137	0.560	rs7421852	chr2:113990261	G/A	cg12889195	chr2:113992843	PAX8;LOC440839;LOC654433	0.72	5.34	0.52	8.98e-7	Lymphocyte counts;
SKCM	cis	rs3768617	0.510	rs2093985	chr1:183094322	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs6952808	0.792	rs12536261	chr7:1953571	G/A	cg02951883	chr7:2050386	MAD1L1	-0.7	-5.94	-0.56	7.54e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs7618915	0.547	rs2268026	chr3:52778347	T/C	cg18404041	chr3:52824283	ITIH1	-0.56	-4.94	-0.49	4.33e-6	Bipolar disorder;
SKCM	cis	rs4481887	0.893	rs4244186	chr1:248493319	A/G	cg00666640	chr1:248458726	OR2T12	0.61	5.25	0.51	1.28e-6	Common traits (Other);
SKCM	cis	rs3785574	0.927	rs2854160	chr17:61977248	C/T	cg23090583	chr17:61904693	PSMC5;FTSJ3	0.6	4.77	0.48	8.39e-6	Height;
SKCM	cis	rs6977660	0.714	rs6976972	chr7:19818315	C/A	cg05791153	chr7:19748676	TWISTNB	0.77	5.02	0.49	3.23e-6	Thyroid stimulating hormone;
SKCM	cis	rs7647973	0.566	rs57630346	chr3:49086215	T/C	cg07636037	chr3:49044803	WDR6	0.97	7.24	0.63	2.76e-10	Menarche (age at onset);
SKCM	cis	rs6951245	0.935	rs11766669	chr7:1063593	C/T	cg18402987	chr7:1209562	NA	1.14	5.99	0.56	6.11e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7192750	0.652	rs150617	chr16:72139396	T/C	cg14768367	chr16:72042858	DHODH	1.03	4.79	0.48	7.77e-6	LDL cholesterol levels;Total cholesterol levels;
SKCM	cis	rs2836974	0.568	rs428602	chr21:40547004	A/G	cg11890956	chr21:40555474	PSMG1	0.88	9.14	0.72	5.76e-14	Cognitive function;
SKCM	cis	rs10504229	0.654	rs903705	chr8:58128185	T/A	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs116095464	0.558	rs10055354	chr5:243794	G/A	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs9303401	0.659	rs11079357	chr17:56902778	A/G	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.35	0.52	8.54e-7	Cognitive test performance;
SKCM	cis	rs7208859	0.623	rs3794796	chr17:29130880	G/C	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs67460515	0.531	rs13315565	chr3:160754626	G/C	cg03342759	chr3:160939853	NMD3	-0.65	-4.89	-0.48	5.3e-6	Parkinson's disease;
SKCM	cis	rs7937682	1.000	rs11213980	chr11:111562692	A/T	cg09085632	chr11:111637200	PPP2R1B	1.03	12.58	0.82	1.83e-20	Primary sclerosing cholangitis;
SKCM	cis	rs2153535	0.505	rs9405395	chr6:8468622	T/A	cg23788917	chr6:8435910	SLC35B3	0.68	4.86	0.48	5.99e-6	Motion sickness;
SKCM	cis	rs2228479	0.571	rs62052183	chr16:89966921	C/A	cg06558623	chr16:89946397	TCF25	1.26	6.97	0.62	9.17e-10	Skin colour saturation;
SKCM	cis	rs780096	0.526	rs2010087	chr2:27637235	C/T	cg05696406	chr2:27599888	SNX17	0.5	5.09	0.5	2.37e-6	Total body bone mineral density;
SKCM	cis	rs10752881	0.809	rs3738829	chr1:183113862	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.76	7.28	0.64	2.26e-10	Colorectal cancer;
SKCM	cis	rs7811142	0.830	rs76798830	chr7:99952828	C/T	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.05	5.92	0.56	8.02e-8	Platelet count;
SKCM	cis	rs875971	0.862	rs11769079	chr7:65842128	G/A	cg18876405	chr7:65276391	NA	0.64	6.36	0.58	1.26e-8	Aortic root size;
SKCM	cis	rs1005277	0.579	rs2474595	chr10:38426782	C/G	cg00409905	chr10:38381863	ZNF37A	0.68	6.58	0.6	4.96e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs1029738	0.659	rs1608553	chr7:22896231	G/C	cg00309339	chr7:22893653	NA	-0.67	-6.3	-0.58	1.67e-8	Fibrinogen levels;
SKCM	cis	rs951366	0.764	rs823141	chr1:205741426	T/C	cg14893161	chr1:205819251	PM20D1	1.06	10.63	0.77	8.03e-17	Menarche (age at onset);
SKCM	cis	rs11098499	0.863	rs3822194	chr4:120471648	A/G	cg24375607	chr4:120327624	NA	0.69	5.47	0.53	5.35e-7	Corneal astigmatism;
SKCM	cis	rs7555523	0.778	rs2790052	chr1:165738463	G/C	cg24409356	chr1:165738333	TMCO1	0.93	5.15	0.5	1.93e-6	Intraocular pressure;Glaucoma (high intraocular pressure);
SKCM	cis	rs1797081	0.934	rs1797077	chr10:16853252	C/T	cg23933602	chr10:16859644	RSU1	1.0	13.89	0.84	8.49e-23	Platelet distribution width;
SKCM	cis	rs9926296	0.687	rs258317	chr16:89732238	C/T	cg01097406	chr16:89675127	NA	0.56	5.72	0.54	1.87e-7	Vitiligo;
SKCM	cis	rs12216125	0.801	rs56107510	chr6:25987436	C/A	cg17691542	chr6:26056736	HIST1H1C	0.72	5.57	0.53	3.49e-7	Iron status biomarkers;
SKCM	cis	rs151997	0.853	rs3846498	chr5:50253625	A/C	cg06027927	chr5:50259733	NA	-0.74	-7.06	-0.62	6.07e-10	Callous-unemotional behaviour;
SKCM	cis	rs80130819	0.688	rs7313023	chr12:48584179	T/C	cg13203223	chr12:49319398	FKBP11	0.93	4.87	0.48	5.66e-6	Prostate cancer;
SKCM	cis	rs12497850	0.897	rs9884022	chr3:48956862	G/C	cg06212747	chr3:49208901	KLHDC8B	0.67	4.87	0.48	5.68e-6	Parkinson's disease;
SKCM	cis	rs2404602	0.647	rs12910081	chr15:77022959	G/C	cg23625390	chr15:77176239	SCAPER	-0.85	-8.26	-0.68	2.93e-12	Blood metabolite levels;
SKCM	cis	rs9910055	1.000	rs9895423	chr17:42285740	T/C	cg13607699	chr17:42295918	UBTF	0.82	6.33	0.58	1.46e-8	Total body bone mineral density;
SKCM	cis	rs9815354	0.812	rs57209010	chr3:41854743	A/T	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs1577917	0.682	rs1173417	chr6:86403941	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.89	9.15	0.72	5.56e-14	Response to antipsychotic treatment;
SKCM	trans	rs1814175	0.607	rs11493324	chr11:50011304	T/C	cg15704280	chr7:45808275	SEPT13	-0.84	-7.86	-0.66	1.78e-11	Height;
SKCM	cis	rs4819052	0.851	rs2838832	chr21:46664904	A/G	cg02159808	chr21:46707872	POFUT2;LOC642852	-0.68	-5.15	-0.5	1.88e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs801193	1.000	rs2707856	chr7:66211010	A/T	cg11764359	chr7:65958608	NA	0.81	6.08	0.57	4.22e-8	Aortic root size;
SKCM	cis	rs870825	0.616	rs41278579	chr4:185622402	A/G	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs1405130	0.967	rs1405131	chr2:235567453	A/C	cg21542780	chr2:234763377	HJURP	-0.65	-4.92	-0.49	4.75e-6	Coronary artery disease;
SKCM	cis	rs9640161	0.830	rs76741564	chr7:150059529	A/T	cg10018233	chr7:150070692	REPIN1	0.76	6.83	0.61	1.64e-9	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs8067545	0.532	rs17759609	chr17:19992514	C/G	cg13482628	chr17:19912719	NA	0.67	4.87	0.48	5.69e-6	Schizophrenia;
SKCM	cis	rs9300255	0.664	rs7306755	chr12:123767929	G/A	cg00376283	chr12:123451042	ABCB9	-0.78	-5.26	-0.51	1.24e-6	Neutrophil percentage of white cells;
SKCM	cis	rs13217239	0.646	rs9379956	chr6:27033735	T/C	cg12292205	chr6:26970375	C6orf41	-0.58	-5.13	-0.5	2.03e-6	Schizophrenia;
SKCM	cis	rs4969178	0.965	rs8071884	chr17:76398058	C/G	cg20026190	chr17:76395443	PGS1	0.61	5.29	0.51	1.08e-6	HDL cholesterol levels;
SKCM	cis	rs1878931	0.580	rs4785932	chr16:3410456	C/G	cg26668626	chr16:3451006	ZNF174;ZNF434	0.94	8.3	0.68	2.48e-12	Body mass index (adult);
SKCM	cis	rs7945705	0.935	rs10769971	chr11:8925276	C/T	cg21881798	chr11:8931708	C11orf17;ST5	0.8	7.95	0.67	1.18e-11	Hemoglobin concentration;
SKCM	cis	rs2243480	1.000	rs427044	chr7:65508545	G/A	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs1153858	1.000	rs3759899	chr15:45655903	T/C	cg10760299	chr15:45669010	GATM	0.62	6.35	0.58	1.3e-8	Homoarginine levels;
SKCM	cis	rs4077515	0.504	rs10870164	chr9:139315682	C/T	cg14169450	chr9:139327907	INPP5E	-0.45	-4.9	-0.49	5.03e-6	Ulcerative colitis;IgA nephropathy;Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs644799	1.000	rs586498	chr11:95537828	C/T	cg03916912	chr11:95522834	CEP57;FAM76B	0.92	8.04	0.67	8e-12	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs9910055	0.659	rs2251165	chr17:42234748	T/C	cg10896456	chr17:42255109	ASB16;C17orf65	0.69	7.28	0.64	2.32e-10	Total body bone mineral density;
SKCM	cis	rs7666738	0.830	rs11097598	chr4:98946057	T/C	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9300255	0.663	rs7953929	chr12:123758235	C/G	cg00376283	chr12:123451042	ABCB9	0.82	5.73	0.54	1.83e-7	Neutrophil percentage of white cells;
SKCM	cis	rs17376456	0.569	rs7713956	chr5:93133185	T/C	cg25358565	chr5:93447407	FAM172A	-0.9	-5.8	-0.55	1.37e-7	Diabetic retinopathy;
SKCM	cis	rs2197308	0.667	rs11181073	chr12:37898543	A/G	cg26384229	chr12:38710491	ALG10B	0.8	6.92	0.62	1.14e-9	Morning vs. evening chronotype;
SKCM	cis	rs2559856	0.967	rs7970837	chr12:102081576	A/G	cg12924262	chr12:102091054	CHPT1	0.7	5.68	0.54	2.19e-7	Blood protein levels;
SKCM	cis	rs514406	0.679	rs960570	chr1:53237763	A/G	cg27535305	chr1:53392650	SCP2	0.55	5.0	0.49	3.41e-6	Monocyte count;
SKCM	cis	rs6754311	0.597	rs2278544	chr2:136546110	A/G	cg07169764	chr2:136633963	MCM6	-0.85	-6.11	-0.57	3.66e-8	Mosquito bite size;
SKCM	cis	rs28595532	0.920	rs17324821	chr4:119770716	A/G	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs11098499	0.863	rs3775843	chr4:120427844	T/C	cg09307838	chr4:120376055	NA	1.0	7.66	0.66	4.31e-11	Corneal astigmatism;
SKCM	cis	rs9640161	0.750	rs3735169	chr7:150034378	A/G	cg10018233	chr7:150070692	REPIN1	0.71	5.54	0.53	3.98e-7	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs4242434	0.597	rs11985023	chr8:22531463	C/T	cg03733263	chr8:22462867	KIAA1967	-0.66	-4.77	-0.48	8.37e-6	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs846858	0.963	rs860179	chr19:45128303	A/G	cg18042043	chr19:44147545	NA	0.61	4.95	0.49	4.19e-6	Late-onset Alzheimer's disease;
SKCM	cis	rs533581	0.866	rs871756	chr16:88969076	G/C	cg16701003	chr16:89028210	CBFA2T3	0.59	4.96	0.49	4.1e-6	Social autistic-like traits;
SKCM	cis	rs2839186	0.869	rs17176513	chr21:47682428	A/G	cg13012494	chr21:47604986	C21orf56	0.69	5.7	0.54	2.01e-7	Testicular germ cell tumor;
SKCM	cis	rs2075371	0.674	rs11771785	chr7:134013249	A/G	cg20476274	chr7:133979776	SLC35B4	-0.86	-8.57	-0.7	7.48e-13	Mean platelet volume;
SKCM	cis	rs2239547	0.562	rs6794389	chr3:53096394	A/G	cg11645453	chr3:52864694	ITIH4	0.63	5.12	0.5	2.15e-6	Schizophrenia;
SKCM	cis	rs9905704	0.647	rs7221274	chr17:57008128	A/G	cg12560992	chr17:57184187	TRIM37	0.76	6.03	0.56	5.1e-8	Testicular germ cell tumor;
SKCM	cis	rs2439831	0.867	rs2260160	chr15:43895643	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.27	7.94	0.67	1.21e-11	Lung cancer in ever smokers;
SKCM	cis	rs317689	0.513	rs317659	chr12:69686132	T/A	cg20891283	chr12:69753455	YEATS4	0.64	5.0	0.49	3.47e-6	Response to diuretic therapy;
SKCM	cis	rs9911578	0.935	rs420878	chr17:56709077	A/G	cg12560992	chr17:57184187	TRIM37	0.95	7.69	0.66	3.7e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs2282032	1.000	rs17799244	chr14:90760040	C/T	cg04374321	chr14:90722782	PSMC1	0.69	5.02	0.49	3.19e-6	Longevity;
SKCM	cis	rs6500395	1.000	rs3743779	chr16:48574040	T/G	cg04672837	chr16:48644449	N4BP1	0.69	5.6	0.54	3.1e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs7769051	1.000	rs6910639	chr6:133120553	A/G	cg22852734	chr6:133119734	C6orf192	0.99	5.19	0.51	1.62e-6	Type 2 diabetes nephropathy;
SKCM	cis	rs6952808	1.000	rs4601204	chr7:1890925	C/T	cg02951883	chr7:2050386	MAD1L1	-0.72	-5.56	-0.53	3.67e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs1552244	1.000	rs66838678	chr3:10150350	G/A	cg02579736	chr3:10068473	FANCD2;CIDECP	1.23	6.92	0.62	1.13e-9	Alzheimer's disease;
SKCM	cis	rs66887589	0.870	rs59590064	chr4:120539753	T/C	cg09307838	chr4:120376055	NA	-0.65	-4.82	-0.48	6.89e-6	Diastolic blood pressure;
SKCM	cis	rs7809950	1.000	rs2712214	chr7:107188031	G/A	cg23024343	chr7:107201750	COG5	-0.77	-6.95	-0.62	9.61e-10	Coronary artery disease;
SKCM	cis	rs9926296	0.568	rs886950	chr16:89836872	T/C	cg27121462	chr16:89883253	FANCA	0.81	7.29	0.64	2.15e-10	Vitiligo;
SKCM	cis	rs1580019	0.885	rs4460269	chr7:32496445	T/C	cg06627557	chr7:32535165	LSM5;AVL9	0.76	5.85	0.55	1.09e-7	Cognitive ability;
SKCM	cis	rs3784262	0.669	rs12909979	chr15:58241022	C/T	cg12031962	chr15:58353849	ALDH1A2	-0.44	-5.07	-0.5	2.58e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs2050392	0.517	rs302423	chr10:30772513	A/G	cg25182066	chr10:30743637	MAP3K8	-0.65	-5.47	-0.53	5.26e-7	Inflammatory bowel disease;
SKCM	cis	rs453301	0.522	rs2929309	chr8:9083771	C/A	cg06636001	chr8:8085503	FLJ10661	-0.64	-5.04	-0.5	2.96e-6	Joint mobility (Beighton score);
SKCM	cis	rs1799949	1.000	rs34942571	chr17:41273379	G/C	cg05368731	chr17:41323189	NBR1	0.89	7.43	0.64	1.19e-10	Menopause (age at onset);
SKCM	cis	rs651907	0.557	rs11924013	chr3:101366698	G/A	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.83	7.27	0.64	2.42e-10	Colorectal cancer;
SKCM	cis	rs684232	0.583	rs10521106	chr17:510707	C/T	cg15660573	chr17:549704	VPS53	-0.7	-5.47	-0.53	5.3e-7	Prostate cancer;
SKCM	cis	rs6545883	0.929	rs778155	chr2:61647901	A/G	cg15711740	chr2:61764176	XPO1	0.7	4.93	0.49	4.5e-6	Tuberculosis;
SKCM	cis	rs9467773	0.596	rs2494693	chr6:26619226	T/C	cg15659132	chr6:26577336	NA	0.62	5.4	0.52	6.91e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs11098499	0.863	rs6853998	chr4:120475860	C/A	cg09307838	chr4:120376055	NA	1.0	8.27	0.68	2.8e-12	Corneal astigmatism;
SKCM	cis	rs1348850	0.609	rs1348851	chr2:178418677	C/T	cg27490568	chr2:178487706	NA	-0.85	-5.8	-0.55	1.33e-7	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs951366	0.617	rs823074	chr1:205774839	T/C	cg14893161	chr1:205819251	PM20D1	1.07	13.37	0.83	7.13e-22	Menarche (age at onset);
SKCM	cis	rs3087591	1.000	rs9902893	chr17:29625638	G/A	cg24425628	chr17:29625626	OMG;NF1	-0.64	-4.97	-0.49	3.84e-6	Hip circumference;
SKCM	cis	rs763014	0.865	rs8675	chr16:633843	A/G	cg09263875	chr16:632152	PIGQ	0.67	5.82	0.55	1.24e-7	Height;
SKCM	cis	rs9858542	0.953	rs7633271	chr3:49555963	T/C	cg03060546	chr3:49711283	APEH	-0.74	-5.42	-0.52	6.53e-7	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs9300255	0.770	rs28683528	chr12:123845351	C/T	cg05973401	chr12:123451056	ABCB9	-0.82	-5.72	-0.54	1.92e-7	Neutrophil percentage of white cells;
SKCM	cis	rs1185460	0.967	rs1184902	chr11:118945337	A/G	cg23280166	chr11:118938394	VPS11	0.61	5.55	0.53	3.82e-7	Coronary artery disease;
SKCM	cis	rs67311347	0.544	rs9864601	chr3:40345318	C/T	cg00091569	chr3:40428383	ENTPD3	0.62	5.45	0.53	5.72e-7	Renal cell carcinoma;
SKCM	cis	rs514406	0.698	rs522259	chr1:53365481	A/G	cg04310824	chr1:53393297	SCP2	-0.6	-4.88	-0.48	5.44e-6	Monocyte count;
SKCM	cis	rs34172651	0.517	rs3803716	chr16:24802325	C/T	cg00339695	chr16:24857497	SLC5A11	0.8	6.43	0.59	9.38e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs875971	0.964	rs697969	chr7:65558478	C/A	cg11764359	chr7:65958608	NA	-0.89	-8.44	-0.69	1.29e-12	Aortic root size;
SKCM	cis	rs10492096	0.853	rs7300092	chr12:6607364	T/C	cg13857086	chr12:6580257	VAMP1	0.76	5.75	0.55	1.64e-7	Hip geometry;
SKCM	cis	rs11690935	0.918	rs11757	chr2:172641045	C/G	cg13550731	chr2:172543902	DYNC1I2	-0.95	-8.21	-0.68	3.64e-12	Schizophrenia;
SKCM	cis	rs28386778	0.897	rs2584610	chr17:61934783	T/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.12	11.27	0.79	4.92e-18	Prudent dietary pattern;
SKCM	cis	rs2832191	0.740	rs2832177	chr21:30478353	G/A	cg08807101	chr21:30365312	RNF160	-0.74	-6.09	-0.57	4.06e-8	Dental caries;
SKCM	cis	rs62238980	0.614	rs4289286	chr22:32458612	G/A	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs12986445	0.681	rs6734496	chr2:26119708	G/T	cg07291958	chr2:26785531	C2orf70	0.52	4.78	0.48	8.13e-6	Multiple myeloma and monoclonal gammopathy;Multiple myeloma;
SKCM	cis	rs1153858	1.000	rs67831559	chr15:45649307	G/T	cg21132104	chr15:45694354	SPATA5L1	0.92	7.81	0.66	2.22e-11	Homoarginine levels;
SKCM	cis	rs1790761	0.554	rs3758938	chr11:67402362	T/G	cg00864171	chr11:67383662	NA	-0.7	-5.73	-0.54	1.83e-7	Mean corpuscular volume;
SKCM	cis	rs1850744	1.000	rs76469957	chr4:9597617	A/G	cg15442990	chr4:9534313	NA	-1.3	-4.84	-0.48	6.55e-6	Economic and political preferences;
SKCM	cis	rs8072100	0.967	rs8074149	chr17:45583375	A/C	cg25173405	chr17:45401733	C17orf57	0.57	4.81	0.48	7.3e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs9788682	0.947	rs12439240	chr15:78829091	T/C	cg06917634	chr15:78832804	PSMA4	-0.82	-4.96	-0.49	3.97e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs394563	0.726	rs6922130	chr6:149672375	C/G	cg16235748	chr6:149772707	ZC3H12D	0.45	5.1	0.5	2.35e-6	Dupuytren's disease;
SKCM	cis	rs12497850	0.931	rs9840050	chr3:49133310	A/G	cg06212747	chr3:49208901	KLHDC8B	0.7	4.99	0.49	3.6e-6	Parkinson's disease;
SKCM	cis	rs7954584	0.567	rs11043251	chr12:122373279	C/T	cg13699009	chr12:122356056	WDR66	0.59	7.37	0.64	1.54e-10	Mean corpuscular volume;
SKCM	cis	rs13278732	0.500	rs11997426	chr8:99046985	C/G	cg16297171	chr8:99017690	MATN2	-0.54	-5.13	-0.5	2.07e-6	Eosinophilic esophagitis (pediatric);
SKCM	cis	rs1218582	0.774	rs11264284	chr1:154875793	C/T	cg24250549	chr1:154909240	PMVK	0.82	8.27	0.68	2.82e-12	Prostate cancer;
SKCM	cis	rs11098499	0.954	rs13113483	chr4:120309039	C/T	cg09307838	chr4:120376055	NA	0.97	7.49	0.65	9.08e-11	Corneal astigmatism;
SKCM	cis	rs10752881	1.000	rs12126434	chr1:182988414	A/G	ch.1.3577855R	chr1:183094577	LAMC1	-0.71	-6.49	-0.59	7.29e-9	Colorectal cancer;
SKCM	cis	rs561341	1.000	rs7214017	chr17:30332220	T/C	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs10504229	0.906	rs72650894	chr8:58179734	C/T	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs8067545	0.611	rs12603372	chr17:20181566	C/T	cg13482628	chr17:19912719	NA	0.61	4.99	0.49	3.59e-6	Schizophrenia;
SKCM	cis	rs7826238	0.524	rs2921055	chr8:8319342	C/A	cg06636001	chr8:8085503	FLJ10661	0.81	6.96	0.62	9.54e-10	Systolic blood pressure;
SKCM	cis	rs3789045	0.866	rs61817482	chr1:204570347	G/A	cg17419461	chr1:204415978	PIK3C2B	-0.72	-4.8	-0.48	7.49e-6	Educational attainment (college completion);
SKCM	cis	rs1707322	0.686	rs1250	chr1:46094027	A/G	cg03146154	chr1:46216737	IPP	0.83	6.17	0.57	2.83e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs11098499	0.863	rs6534139	chr4:120449456	A/G	cg24375607	chr4:120327624	NA	-0.69	-5.25	-0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs2396545	0.680	rs35467761	chr11:571568	A/G	cg03576123	chr11:487126	PTDSS2	-0.87	-5.15	-0.5	1.89e-6	Systemic lupus erythematosus and Systemic sclerosis;
SKCM	cis	rs7216064	1.000	rs62084210	chr17:65828710	A/G	cg12091567	chr17:66097778	LOC651250	-0.76	-5.18	-0.51	1.69e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs4746818	1.000	rs10823301	chr10:70885875	G/A	cg11621586	chr10:70884670	VPS26A	1.0	7.68	0.66	3.84e-11	Left atrial antero-posterior diameter;
SKCM	cis	rs72772090	0.710	rs11745122	chr5:96060738	T/C	cg17330273	chr5:96107758	CAST;ERAP1	-0.83	-4.97	-0.49	3.86e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs7824557	0.603	rs2249804	chr8:11215617	C/G	cg21775007	chr8:11205619	TDH	0.58	4.87	0.48	5.65e-6	Retinal vascular caliber;
SKCM	cis	rs67311347	0.544	rs9821440	chr3:40342347	T/C	cg02782426	chr3:40428986	ENTPD3	0.53	5.47	0.53	5.31e-7	Renal cell carcinoma;
SKCM	cis	rs7811142	1.000	rs4989959	chr7:100032288	T/C	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.34	0.69	2.1e-12	Platelet count;
SKCM	cis	rs12042938	0.507	rs1655299	chr1:231732161	C/T	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	-0.57	-5.06	-0.5	2.68e-6	Neuranatomic and neurocognitive phenotypes;
SKCM	cis	rs10197940	0.532	rs13425170	chr2:152387112	A/C	cg19508488	chr2:152266495	RIF1	0.6	4.89	0.48	5.3e-6	Lung cancer;
SKCM	cis	rs1881396	0.947	rs10173720	chr2:27855397	A/T	cg27432699	chr2:27873401	GPN1	-0.8	-4.96	-0.49	3.98e-6	Nonalcoholic fatty liver disease;
SKCM	cis	rs7100689	0.516	rs10887711	chr10:82034842	A/G	cg01528321	chr10:82214614	TSPAN14	0.81	7.62	0.65	5.06e-11	Post bronchodilator FEV1;
SKCM	cis	rs1552244	0.938	rs7625049	chr3:10115619	C/T	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs7659604	1.000	rs7659604	chr4:122665514	A/G	cg06713675	chr4:122721982	EXOSC9	0.66	5.8	0.55	1.34e-7	Type 2 diabetes;
SKCM	cis	rs2033711	0.936	rs893185	chr19:58989495	A/C	cg00825309	chr19:58991885	ZNF446	-0.66	-5.1	-0.5	2.33e-6	Uric acid clearance;
SKCM	cis	rs1577917	0.798	rs7772384	chr6:86639680	G/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.85	-8.62	-0.7	5.82e-13	Response to antipsychotic treatment;
SKCM	cis	rs2153535	0.580	rs6914276	chr6:8450435	A/T	cg07606381	chr6:8435919	SLC35B3	-0.92	-6.65	-0.6	3.65e-9	Motion sickness;
SKCM	cis	rs7843479	0.870	rs1809498	chr8:21836384	C/G	cg17168535	chr8:21777572	XPO7	-0.73	-5.85	-0.55	1.1e-7	Mean corpuscular volume;
SKCM	cis	rs148734725	1	rs148734725	chr3:49406708	G/A	cg03060546	chr3:49711283	APEH	-0.69	-5.16	-0.5	1.85e-6	Educational attainment (college completion);
SKCM	cis	rs12449000	1	rs12449000	chr16:89872970	T/C	cg26513180	chr16:89883248	FANCA	0.96	10.81	0.77	3.63e-17	Schizophrenia;
SKCM	cis	rs807669	0.868	rs2800973	chr22:19168616	A/G	cg02655711	chr22:19163373	SLC25A1	0.71	6.3	0.58	1.61e-8	Metabolite levels;
SKCM	cis	rs10504229	0.861	rs116923397	chr8:58185162	T/G	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs9814567	0.806	rs11927540	chr3:134319455	C/T	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.65	-5.19	-0.51	1.6e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs11098499	0.909	rs10026736	chr4:120384322	G/C	cg24375607	chr4:120327624	NA	0.64	4.8	0.48	7.41e-6	Corneal astigmatism;
SKCM	cis	rs514406	0.679	rs11206006	chr1:53218380	A/G	cg27535305	chr1:53392650	SCP2	0.56	5.05	0.5	2.85e-6	Monocyte count;
SKCM	cis	rs6951245	1.000	rs28399710	chr7:1070631	G/T	cg03188948	chr7:1209495	NA	1.12	6.17	0.57	2.88e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7618501	0.633	rs7628058	chr3:50039474	C/T	cg24110177	chr3:50126178	RBM5	-0.6	-5.11	-0.5	2.25e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs6582630	0.519	rs11182021	chr12:38443709	A/T	cg26384229	chr12:38710491	ALG10B	-0.8	-6.31	-0.58	1.56e-8	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs752010	0.875	rs11210501	chr1:42091634	T/C	cg06885757	chr1:42089581	HIVEP3	0.5	5.1	0.5	2.36e-6	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs514406	0.893	rs479569	chr1:53352407	C/T	cg16325326	chr1:53192061	ZYG11B	0.91	9.69	0.74	4.96e-15	Monocyte count;
SKCM	cis	rs9814567	1.000	rs4535272	chr3:134299916	A/G	cg06109529	chr3:134205091	CEP63;ANAPC13	0.61	4.94	0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs7577696	0.512	rs12478134	chr2:32240783	C/G	cg02381751	chr2:32503542	YIPF4	-0.93	-4.86	-0.48	5.89e-6	Inflammatory biomarkers;
SKCM	cis	rs12497850	0.897	rs9681717	chr3:48872998	A/G	cg07636037	chr3:49044803	WDR6	1.01	10.82	0.77	3.36e-17	Parkinson's disease;
SKCM	cis	rs3087591	1.000	rs2952989	chr17:29516113	G/A	cg24425628	chr17:29625626	OMG;NF1	0.61	4.87	0.48	5.75e-6	Hip circumference;
SKCM	cis	rs782590	0.774	rs782630	chr2:55899425	T/C	cg18811423	chr2:55921094	PNPT1	0.91	7.45	0.64	1.11e-10	Metabolic syndrome;
SKCM	cis	rs1577917	1.000	rs12661204	chr6:86678586	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.86	-8.61	-0.7	6.29e-13	Response to antipsychotic treatment;
SKCM	cis	rs131777	0.575	rs963980	chr22:51022117	C/A	cg25309564	chr22:51001381	C22orf41	0.78	5.22	0.51	1.44e-6	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs2286503	0.901	rs2286505	chr7:22854840	G/A	cg15401507	chr7:22894281	NA	-0.57	-5.61	-0.54	2.99e-7	Fibrinogen;
SKCM	cis	rs1555322	1.000	rs1555322	chr20:33849179	C/T	cg24158546	chr20:34542777	SCAND1	-1.01	-4.78	-0.48	7.97e-6	Attention deficit hyperactivity disorder;
SKCM	cis	rs870825	0.616	rs2141258	chr4:185609576	A/C	cg04058563	chr4:185651563	MLF1IP	-1.07	-7.36	-0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs140364877	1	rs140364877	chr7:1885178	C/T	cg04267008	chr7:1944627	MAD1L1	-0.82	-6.02	-0.56	5.47e-8	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs55962025	0.846	rs16843804	chr4:3104390	C/T	cg09735869	chr4:3319127	RGS12	-0.67	-5.02	-0.49	3.14e-6	Parental longevity (mother's age at death);
SKCM	cis	rs589448	0.867	rs623853	chr12:69753830	G/A	cg20891283	chr12:69753455	YEATS4	0.98	9.89	0.75	2.06e-15	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs4555082	0.834	rs4412909	chr14:105759226	T/C	cg13114125	chr14:105738426	BRF1	-0.65	-5.02	-0.49	3.17e-6	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs7769051	0.803	rs12193474	chr6:133186168	T/C	cg22852734	chr6:133119734	C6orf192	0.98	5.03	0.49	3.05e-6	Type 2 diabetes nephropathy;
SKCM	cis	rs7772486	0.790	rs9403755	chr6:146231470	C/A	cg23711669	chr6:146136114	FBXO30	-0.78	-7.74	-0.66	3.05e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7772486	0.846	rs9376976	chr6:146355605	T/C	cg23711669	chr6:146136114	FBXO30	0.77	7.48	0.65	9.65e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs5769765	0.908	rs138891	chr22:50227741	G/A	cg22709217	chr22:50311962	ALG12;CRELD2	-0.87	-5.93	-0.56	7.88e-8	Schizophrenia;
SKCM	cis	rs8180040	0.845	rs295441	chr3:47333295	T/A	cg16586182	chr3:47516702	SCAP	-0.71	-4.85	-0.48	6.25e-6	Colorectal cancer;
SKCM	cis	rs9420	0.961	rs7116341	chr11:57481155	G/A	cg19752551	chr11:57585705	CTNND1	-0.7	-6.84	-0.61	1.6e-9	Schizophrenia;
SKCM	cis	rs7618501	0.603	rs72942333	chr3:49986118	T/C	cg05072774	chr3:49840536	C3orf54	-0.66	-5.03	-0.49	3.12e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs4481887	0.893	rs4576683	chr1:248472390	T/C	cg00666640	chr1:248458726	OR2T12	0.63	5.91	0.56	8.65e-8	Common traits (Other);
SKCM	cis	rs9915657	1.000	rs9915657	chr17:70127536	T/C	cg06234051	chr17:70120541	SOX9	-0.62	-5.46	-0.53	5.38e-7	Thyroid hormone levels;
SKCM	cis	rs7296418	0.961	rs10773921	chr12:123541606	C/T	cg06742321	chr12:123595122	PITPNM2	0.65	5.45	0.52	5.77e-7	Platelet count;
SKCM	cis	rs4268898	0.610	rs34216622	chr2:24463445	G/C	cg06627628	chr2:24431161	ITSN2	-0.94	-7.34	-0.64	1.73e-10	Asthma;
SKCM	cis	rs67311347	0.544	rs2887965	chr3:40334154	A/G	cg00091569	chr3:40428383	ENTPD3	-0.6	-5.28	-0.51	1.15e-6	Renal cell carcinoma;
SKCM	cis	rs3087591	1.000	rs7220483	chr17:29577248	G/A	cg24425628	chr17:29625626	OMG;NF1	-0.63	-4.95	-0.49	4.23e-6	Hip circumference;
SKCM	cis	rs8141529	0.732	rs6005872	chr22:29172898	T/G	cg15103426	chr22:29168792	CCDC117	0.61	5.01	0.49	3.32e-6	Lymphocyte counts;
SKCM	cis	rs2251381	0.750	rs2251087	chr21:30527999	C/T	cg24692254	chr21:30365293	RNF160	0.78	6.09	0.57	3.93e-8	Selective IgA deficiency;
SKCM	cis	rs9910055	0.659	rs7207464	chr17:42245033	C/T	cg13607699	chr17:42295918	UBTF	0.71	5.65	0.54	2.53e-7	Total body bone mineral density;
SKCM	cis	rs2502731	1.000	rs2502731	chr9:130976557	A/G	cg09976142	chr9:130955436	CIZ1	-0.65	-5.46	-0.53	5.52e-7	Attention deficit hyperactivity disorder;
SKCM	cis	rs7772486	0.790	rs2254288	chr6:146204470	G/A	cg05347473	chr6:146136440	FBXO30	0.55	5.06	0.5	2.71e-6	Lobe attachment (rater-scored or self-reported);
SKCM	trans	rs3780486	0.874	rs10813955	chr9:33141791	C/T	cg20290983	chr6:43655470	MRPS18A	0.96	11.0	0.78	1.56e-17	IgG glycosylation;
SKCM	cis	rs9815354	0.761	rs73083326	chr3:41927150	G/T	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs763121	0.853	rs5757204	chr22:39046700	A/C	cg06022373	chr22:39101656	GTPBP1	0.72	4.96	0.49	4.08e-6	Menopause (age at onset);
SKCM	cis	rs10504229	0.953	rs2270610	chr8:58194669	A/G	cg22535103	chr8:58192502	C8orf71	-0.76	-5.07	-0.5	2.66e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs7772486	0.754	rs2328707	chr6:146053498	G/A	cg05347473	chr6:146136440	FBXO30	-0.63	-5.66	-0.54	2.38e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs72772090	1.000	rs11738135	chr5:96048336	A/G	cg17330273	chr5:96107758	CAST;ERAP1	-0.83	-4.97	-0.49	3.86e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs897984	0.762	rs12931046	chr16:30987144	G/A	cg00531865	chr16:30841666	NA	0.59	4.98	0.49	3.69e-6	Dementia with Lewy bodies;
SKCM	cis	rs11112613	0.713	rs12580741	chr12:105941328	A/G	cg03607813	chr12:105948248	NA	-0.82	-5.51	-0.53	4.4e-7	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;
SKCM	cis	rs6952808	0.573	rs12668848	chr7:2020995	G/A	cg21782813	chr7:2030301	MAD1L1	0.57	5.88	0.55	9.65e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs58688157	0.705	rs12290989	chr11:615010	G/T	cg03576123	chr11:487126	PTDSS2	-0.84	-5.45	-0.53	5.64e-7	Systemic lupus erythematosus;
SKCM	cis	rs2842992	0.830	rs2495279	chr6:160138796	C/T	cg19482086	chr6:160211437	TCP1;MRPL18	0.79	5.86	0.55	1.07e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs2658782	0.789	rs2658776	chr11:93147927	A/G	cg15737290	chr11:93063684	CCDC67	0.68	4.81	0.48	7.23e-6	Pulmonary function decline;
SKCM	cis	rs4319547	0.695	rs10773152	chr12:122910180	T/C	cg23029597	chr12:123009494	RSRC2	-0.77	-5.79	-0.55	1.43e-7	Body mass index;
SKCM	cis	rs4665809	0.590	rs1368902	chr2:26440576	T/C	cg26119090	chr2:26468346	HADHA;HADHB	-1.06	-8.39	-0.69	1.66e-12	Gut microbiome composition (summer);
SKCM	cis	rs634534	0.622	rs501353	chr11:65739549	T/G	cg02427764	chr11:65769310	BANF1;EIF1AD	0.65	5.17	0.51	1.75e-6	Sum eosinophil basophil counts;Eosinophil counts;
SKCM	cis	rs6912958	0.559	rs395358	chr6:88057924	T/C	cg08069147	chr6:88032118	GJB7;C6orf162	0.68	6.23	0.58	2.19e-8	Monocyte percentage of white cells;
SKCM	cis	rs9894429	0.646	rs12603868	chr17:79618834	G/C	cg18240062	chr17:79603768	NPLOC4	0.68	5.99	0.56	6.16e-8	Eye color traits;
SKCM	cis	rs9430161	0.579	rs11576658	chr1:11037736	C/T	cg02454025	chr1:11042201	C1orf127	1.13	9.81	0.74	2.9e-15	Ewing sarcoma;
SKCM	cis	rs2204008	0.604	rs2320521	chr12:38253789	A/G	cg26384229	chr12:38710491	ALG10B	0.87	6.83	0.61	1.63e-9	Bladder cancer;
SKCM	cis	rs10504073	0.626	rs6472220	chr8:50008477	C/A	cg00325661	chr8:49890786	NA	0.82	7.02	0.62	7.13e-10	Blood metabolite ratios;
SKCM	cis	rs4423214	0.840	rs1792226	chr11:71176574	C/T	cg05163923	chr11:71159392	DHCR7	-0.74	-6.65	-0.6	3.61e-9	Vitamin D levels;
SKCM	cis	rs2404602	0.716	rs56351018	chr15:76824591	T/C	cg23625390	chr15:77176239	SCAPER	0.59	5.38	0.52	7.54e-7	Blood metabolite levels;
SKCM	cis	rs908922	0.676	rs7532535	chr1:152517597	T/A	cg09873164	chr1:152488093	CRCT1	0.76	5.93	0.56	7.7e-8	Hair morphology;
SKCM	cis	rs7552404	0.924	rs1313071	chr1:76195542	C/G	cg10523679	chr1:76189770	ACADM	0.7	5.18	0.51	1.72e-6	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs9325144	0.671	rs12818797	chr12:39019409	A/G	cg13010199	chr12:38710504	ALG10B	-0.64	-5.53	-0.53	4.12e-7	Morning vs. evening chronotype;
SKCM	cis	rs17854409	0.803	rs1063247	chr20:61472118	C/G	cg06598544	chr20:61472147	COL9A3	-1.14	-5.6	-0.54	3.08e-7	Obesity-related traits;
SKCM	cis	rs12478296	0.901	rs59191623	chr2:243028595	G/A	cg06360820	chr2:242988706	NA	-0.94	-5.68	-0.54	2.21e-7	Obesity-related traits;
SKCM	cis	rs7020830	0.898	rs308523	chr9:37338785	C/T	cg14294708	chr9:37120828	ZCCHC7	0.99	9.38	0.73	1.97e-14	Schizophrenia;
SKCM	cis	rs1218582	0.661	rs4845695	chr1:154911798	A/G	cg03351412	chr1:154909251	PMVK	0.67	5.39	0.52	7.2e-7	Prostate cancer;
SKCM	cis	rs870825	0.616	rs6810635	chr4:185616859	T/C	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs1153858	0.945	rs7182300	chr15:45634928	G/A	cg21132104	chr15:45694354	SPATA5L1	0.92	8.33	0.69	2.14e-12	Homoarginine levels;
SKCM	cis	rs11148252	0.532	rs9536185	chr13:53179801	G/A	cg12458913	chr13:53173898	NA	0.65	6.36	0.58	1.27e-8	Lewy body disease;
SKCM	cis	rs2836974	0.865	rs34778912	chr21:40667037	T/G	cg17971929	chr21:40555470	PSMG1	0.86	8.49	0.69	1.04e-12	Cognitive function;
SKCM	cis	rs7811142	0.830	rs7341507	chr7:99951315	A/G	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.01	5.58	0.53	3.33e-7	Platelet count;
SKCM	cis	rs6088580	0.634	rs3736762	chr20:33037336	C/T	cg24642439	chr20:33292090	TP53INP2	0.76	6.02	0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs860295	0.729	rs11264369	chr1:155359830	T/C	cg02153340	chr1:155202674	NA	0.77	5.77	0.55	1.54e-7	Body mass index;
SKCM	cis	rs28386778	0.901	rs2665855	chr17:61965143	A/G	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.21	0.51	1.5e-6	Prudent dietary pattern;
SKCM	cis	rs826838	0.967	rs11169169	chr12:39093153	A/C	cg13010199	chr12:38710504	ALG10B	0.76	5.67	0.54	2.29e-7	Heart rate;
SKCM	cis	rs4820539	0.641	rs5759602	chr22:23489362	C/T	cg14186256	chr22:23484241	RTDR1	-0.91	-7.79	-0.66	2.39e-11	Bone mineral density;
SKCM	cis	rs1639906	0.965	rs1637750	chr7:2227811	A/G	cg02951883	chr7:2050386	MAD1L1	0.61	4.96	0.49	4e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs826838	0.967	rs1719858	chr12:39124505	C/T	cg13010199	chr12:38710504	ALG10B	-0.73	-5.79	-0.55	1.43e-7	Heart rate;
SKCM	cis	rs10504229	0.953	rs59034808	chr8:58185337	T/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs514406	0.679	rs11206006	chr1:53218380	A/G	cg08859206	chr1:53392774	SCP2	0.7	5.43	0.52	6.16e-7	Monocyte count;
SKCM	cis	rs3793683	0.520	rs12769959	chr10:134579026	A/C	cg27286337	chr10:134555280	INPP5A	0.97	9.19	0.72	4.6e-14	Migraine;
SKCM	cis	rs10916772	0.877	rs75372910	chr1:20688361	C/T	cg05356564	chr1:21044770	KIF17	-0.6	-5.02	-0.49	3.25e-6	Psychosis proneness (perceptual aberration scale);
SKCM	cis	rs9911578	1.000	rs2567911	chr17:56734977	A/G	cg12560992	chr17:57184187	TRIM37	0.95	7.69	0.66	3.7e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs10489202	1.000	rs7538581	chr1:167979347	A/G	cg24449463	chr1:168025552	DCAF6	-0.74	-5.9	-0.56	8.97e-8	Schizophrenia;
SKCM	cis	rs951366	0.764	rs708725	chr1:205744138	G/T	cg26354017	chr1:205819088	PM20D1	0.99	9.17	0.72	5e-14	Menarche (age at onset);
SKCM	cis	rs10479542	0.583	rs4131080	chr5:179044292	G/A	cg19723775	chr5:179050963	HNRNPH1	0.72	5.85	0.55	1.08e-7	Lung cancer;
SKCM	cis	rs2721195	0.967	rs1985022	chr8:145684031	C/T	cg15320075	chr8:145703422	NA	0.87	7.32	0.64	1.91e-10	Age at first birth;
SKCM	cis	rs2153535	0.580	rs9505455	chr6:8478622	A/G	cg07606381	chr6:8435919	SLC35B3	0.86	6.25	0.58	2.06e-8	Motion sickness;
SKCM	cis	rs12474201	0.894	rs4952842	chr2:46925730	C/A	cg06386533	chr2:46925753	SOCS5	1.02	9.28	0.72	3.15e-14	Height;
SKCM	cis	rs13040088	0.518	rs2427452	chr20:61577275	T/C	cg23096297	chr20:61557774	DIDO1	-0.66	-5.31	-0.52	9.89e-7	Menopause (age at onset);
SKCM	cis	rs8072100	0.967	rs12452315	chr17:45479446	G/T	cg08085267	chr17:45401833	C17orf57	0.66	5.94	0.56	7.45e-8	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs2050392	1.000	rs7077496	chr10:30692028	G/A	cg25182066	chr10:30743637	MAP3K8	0.62	4.99	0.49	3.56e-6	Inflammatory bowel disease;
SKCM	cis	rs9902453	0.765	rs2874505	chr17:28037923	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.76	5.66	0.54	2.39e-7	Coffee consumption (cups per day);
SKCM	cis	rs7666738	0.830	rs4699594	chr4:98980775	T/C	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs28386778	0.830	rs2584625	chr17:61903445	G/C	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs9815354	0.812	rs17215498	chr3:41829679	G/C	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs1580019	0.537	rs7804609	chr7:32558094	A/C	cg06627557	chr7:32535165	LSM5;AVL9	0.95	8.93	0.71	1.48e-13	Cognitive ability;
SKCM	cis	rs7666738	0.791	rs28858828	chr4:98950442	C/G	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs854765	0.547	rs4368210	chr17:17896090	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	-1.11	-9.88	-0.75	2.12e-15	Total body bone mineral density;
SKCM	cis	rs763014	0.931	rs3752568	chr16:628302	A/G	cg09263875	chr16:632152	PIGQ	0.67	5.82	0.55	1.24e-7	Height;
SKCM	cis	rs2243480	1.000	rs35735127	chr7:65300423	G/T	cg07424592	chr7:64974309	NA	0.99	4.9	0.49	5.08e-6	Diabetic kidney disease;
SKCM	cis	rs7937682	0.889	rs497111	chr11:111499512	G/A	cg09085632	chr11:111637200	PPP2R1B	-1.07	-11.23	-0.79	5.72e-18	Primary sclerosing cholangitis;
SKCM	cis	rs9818758	0.607	rs9847839	chr3:49289003	T/C	cg00383909	chr3:49044727	WDR6	0.95	4.95	0.49	4.17e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs1577917	0.958	rs12192033	chr6:86472559	T/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.78	-7.41	-0.64	1.3100000000000001e-10	Response to antipsychotic treatment;
SKCM	trans	rs11722228	0.549	rs62288521	chr4:10099772	G/A	cg26043149	chr18:55253948	FECH	0.93	7.98	0.67	1.02e-11	Gout;Urate levels;Serum uric acid levels;
SKCM	cis	rs4150161	0.656	rs2288026	chr16:84220344	C/G	cg10106505	chr16:84220380	TAF1C	1.37	5.54	0.53	3.87e-7	Systolic blood pressure response to hydrochlorothiazide in hypertension;
SKCM	cis	rs7613875	0.620	rs3774734	chr3:50108792	C/A	cg24110177	chr3:50126178	RBM5	0.74	5.95	0.56	7.25e-8	Body mass index;
SKCM	cis	rs1218582	0.710	rs9794000	chr1:154878876	T/A	cg24250549	chr1:154909240	PMVK	0.85	7.96	0.67	1.11e-11	Prostate cancer;
SKCM	cis	rs34172651	0.517	rs2287783	chr16:24831727	C/T	cg00339695	chr16:24857497	SLC5A11	0.78	6.22	0.58	2.3e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs9467773	1.000	rs6933176	chr6:26540178	G/A	cg09904177	chr6:26538194	HMGN4	0.54	4.98	0.49	3.78e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9393692	0.905	rs9379838	chr6:26277133	C/T	cg00631329	chr6:26305371	NA	-0.68	-4.93	-0.49	4.49e-6	Educational attainment;
SKCM	cis	rs9394841	0.692	rs9394834	chr6:41806793	G/A	cg08135965	chr6:41755394	TOMM6	0.74	4.88	0.48	5.45e-6	Mean corpuscular hemoglobin;Red cell distribution width;
SKCM	cis	rs854765	0.583	rs11078404	chr17:17820487	A/T	cg04398451	chr17:18023971	MYO15A	-0.85	-6.05	-0.57	4.75e-8	Total body bone mineral density;
SKCM	cis	rs2032447	0.933	rs4401650	chr6:26035208	G/A	cg18357526	chr6:26021779	HIST1H4A	0.83	7.16	0.63	3.95e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs1707322	0.721	rs12091503	chr1:46107868	T/C	cg03146154	chr1:46216737	IPP	0.82	6.1	0.57	3.89e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs2739330	0.760	rs1002286	chr22:24257337	A/G	cg12419862	chr22:24373484	LOC391322	0.77	7.4	0.64	1.37e-10	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs875971	0.522	rs2949690	chr7:65483242	C/T	cg11764359	chr7:65958608	NA	-0.88	-6.67	-0.6	3.32e-9	Aortic root size;
SKCM	cis	rs1160297	0.633	rs12477231	chr2:53084648	T/G	cg07782112	chr2:53107842	NA	0.58	5.86	0.55	1.03e-7	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs8017423	0.904	rs4603489	chr14:90760607	A/G	cg04374321	chr14:90722782	PSMC1	-0.95	-8.73	-0.7	3.68e-13	Mortality in heart failure;
SKCM	cis	rs1153858	1.000	rs10519021	chr15:45631795	G/A	cg10760299	chr15:45669010	GATM	0.53	5.01	0.49	3.33e-6	Homoarginine levels;
SKCM	cis	rs503341	0.756	rs11231591	chr11:63587986	G/T	cg04362095	chr11:63592001	C11orf84	-0.82	-9.64	-0.74	6.15e-15	Pulse pressure;
SKCM	cis	rs7829975	0.742	rs1533059	chr8:8684953	A/G	cg15556689	chr8:8085844	FLJ10661	-0.7	-5.87	-0.55	1e-7	Mood instability;
SKCM	cis	rs6570726	0.846	rs7762536	chr6:145923145	T/C	cg23711669	chr6:146136114	FBXO30	0.81	7.67	0.66	4.05e-11	Lobe attachment (rater-scored or self-reported);
SKCM	trans	rs561341	1.000	rs521919	chr17:30298039	G/T	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs9910055	0.529	rs615070	chr17:42176591	A/G	cg08499158	chr17:42289980	UBTF	-0.74	-5.77	-0.55	1.51e-7	Total body bone mineral density;
SKCM	cis	rs6121246	0.821	rs115585940	chr20:30317902	T/C	cg11595048	chr20:30225325	COX4I2	0.66	5.13	0.5	2.08e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs854765	0.575	rs2955357	chr17:17946401	T/C	cg24612305	chr17:17875800	TOM1L2;LRRC48	-1.02	-9.54	-0.73	9.55e-15	Total body bone mineral density;
SKCM	cis	rs7216064	1.000	rs6504542	chr17:65836642	T/C	cg12091567	chr17:66097778	LOC651250	-0.77	-5.53	-0.53	4.06e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs9467773	0.620	rs6925087	chr6:26592853	T/A	cg15659132	chr6:26577336	NA	0.63	5.57	0.53	3.56e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs10089	1.000	rs10064357	chr5:127417272	A/G	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.93	8.45	0.69	1.24e-12	Ileal carcinoids;
SKCM	cis	rs4237845	0.967	rs4553410	chr12:58301211	G/A	cg02175503	chr12:58329896	NA	0.8	7.21	0.63	3.2e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs2963155	0.518	rs853176	chr5:142636456	A/G	cg17617527	chr5:142782415	NR3C1	-1.09	-5.4	-0.52	7.03e-7	Breast cancer;
SKCM	cis	rs12142240	0.659	rs72677591	chr1:46818219	T/G	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs1499614	1.000	rs1267818	chr7:66107024	C/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Gout;
SKCM	cis	rs10089	0.951	rs1864923	chr5:127420843	G/C	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.93	8.45	0.69	1.24e-12	Ileal carcinoids;
SKCM	cis	rs8141529	0.732	rs5762815	chr22:29205076	A/G	cg15103426	chr22:29168792	CCDC117	0.62	5.23	0.51	1.37e-6	Lymphocyte counts;
SKCM	cis	rs55962025	0.804	rs3775061	chr4:3238754	A/G	cg09735869	chr4:3319127	RGS12	-0.73	-5.63	-0.54	2.74e-7	Parental longevity (mother's age at death);
SKCM	cis	rs523522	0.602	rs7970933	chr12:120862474	G/A	cg27279351	chr12:120934652	DYNLL1	0.91	7.13	0.63	4.55e-10	High light scatter reticulocyte count;
SKCM	cis	rs28595532	0.920	rs115860482	chr4:119759546	A/G	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs6089584	0.816	rs4925336	chr20:60627180	A/G	cg06108461	chr20:60628389	TAF4	-0.89	-9.05	-0.72	8.53e-14	Body mass index;
SKCM	cis	rs9815354	0.812	rs73073358	chr3:41842527	G/A	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs4727027	0.704	rs1123992	chr7:148907201	C/G	cg23583168	chr7:148888333	NA	-0.61	-4.91	-0.49	4.83e-6	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs637571	0.522	rs679581	chr11:65746653	A/G	cg02427764	chr11:65769310	BANF1;EIF1AD	0.75	5.56	0.53	3.56e-7	Eosinophil percentage of white cells;
SKCM	cis	rs394563	0.622	rs237024	chr6:149721965	T/C	cg16235748	chr6:149772707	ZC3H12D	-0.43	-4.8	-0.48	7.39e-6	Dupuytren's disease;
SKCM	cis	rs2228479	0.717	rs2270460	chr16:89972416	C/A	cg06558623	chr16:89946397	TCF25	1.27	7.17	0.63	3.78e-10	Skin colour saturation;
SKCM	cis	rs8067545	0.717	rs9907788	chr17:20008903	T/C	cg13482628	chr17:19912719	NA	0.73	6.04	0.56	5.01e-8	Schizophrenia;
SKCM	cis	rs9611565	0.694	rs79008	chr22:41850500	C/T	cg03806693	chr22:41940476	POLR3H	-1.06	-6.92	-0.62	1.12e-9	Vitiligo;
SKCM	cis	rs11098499	0.863	rs6833334	chr4:120504227	C/T	cg24375607	chr4:120327624	NA	0.69	5.47	0.53	5.35e-7	Corneal astigmatism;
SKCM	cis	rs763121	0.889	rs9607557	chr22:39040279	G/A	cg06022373	chr22:39101656	GTPBP1	0.78	5.31	0.52	1.02e-6	Menopause (age at onset);
SKCM	cis	rs561341	0.941	rs2428336	chr17:30290577	T/C	cg23018236	chr17:30244563	NA	-0.52	-5.26	-0.51	1.21e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs3845702	0.736	rs259810	chr2:180787821	T/C	cg01881094	chr2:180872142	CWC22	-1.21	-6.08	-0.57	4.16e-8	Schizophrenia;
SKCM	cis	rs9325144	0.650	rs6582631	chr12:38744135	T/C	cg13010199	chr12:38710504	ALG10B	0.64	5.12	0.5	2.17e-6	Morning vs. evening chronotype;
SKCM	cis	rs12477438	0.520	rs4851188	chr2:99745898	G/A	cg14399236	chr2:99771627	LIPT1;TSGA10	0.95	8.41	0.69	1.48e-12	Chronic sinus infection;
SKCM	cis	rs6952808	0.895	rs12669518	chr7:1921429	G/C	cg05863683	chr7:1912471	MAD1L1	0.63	5.63	0.54	2.69e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs3096299	0.586	rs4572400	chr16:89533516	T/A	cg02187348	chr16:89574699	SPG7	0.63	4.79	0.48	7.86e-6	Multiple myeloma (IgH translocation);
SKCM	cis	rs13118159	0.550	rs11946956	chr4:1369094	T/G	cg02018176	chr4:1364513	KIAA1530	0.9	7.31	0.64	2.02e-10	Longevity;
SKCM	cis	rs9818758	0.607	rs9837625	chr3:49215966	C/T	cg24110177	chr3:50126178	RBM5	0.86	5.12	0.5	2.15e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs62238980	0.808	rs78293816	chr22:32598529	C/T	cg01616215	chr22:32340373	YWHAH;C22orf24	1.33	4.9	0.48	5.18e-6	Childhood ear infection;
SKCM	cis	rs875971	0.895	rs12698520	chr7:65918707	C/A	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	cis	rs9303280	0.806	rs4795400	chr17:38067020	C/T	cg12233386	chr17:38464679	RARA	0.51	5.25	0.51	1.29e-6	Self-reported allergy;
SKCM	cis	rs11229030	0.722	rs7948027	chr11:57184964	C/T	cg00522883	chr11:57194120	SLC43A3	-0.72	-5.03	-0.5	3.02e-6	Crohn's disease;
SKCM	cis	rs867186	0.920	rs56289894	chr20:33719400	G/A	cg04194272	chr20:33683537	NA	-1.0	-5.89	-0.56	9.12e-8	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	trans	rs561341	0.941	rs17780080	chr17:30343146	G/A	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs12497850	0.897	rs6781790	chr3:49044767	C/T	cg07636037	chr3:49044803	WDR6	1.04	11.28	0.79	4.6e-18	Parkinson's disease;
SKCM	cis	rs722599	0.501	rs10139347	chr14:75390135	T/C	cg08847533	chr14:75593920	NEK9	0.68	5.47	0.53	5.23e-7	IgG glycosylation;
SKCM	cis	rs875971	0.666	rs13242072	chr7:65765988	A/G	cg11764359	chr7:65958608	NA	-0.83	-6.37	-0.59	1.19e-8	Aortic root size;
SKCM	cis	rs9467773	0.935	rs11752946	chr6:26560364	C/A	cg09904177	chr6:26538194	HMGN4	0.53	4.91	0.49	4.94e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs4746818	1.000	rs7909631	chr10:70918676	C/T	cg11621586	chr10:70884670	VPS26A	0.99	7.62	0.65	5.08e-11	Left atrial antero-posterior diameter;
SKCM	cis	rs2412819	0.599	rs2470120	chr15:43929070	C/G	cg02155558	chr15:43621948	ADAL;LCMT2	0.76	5.52	0.53	4.3e-7	Lung cancer;
SKCM	cis	rs4555082	0.830	rs3803319	chr14:105752458	G/A	cg13114125	chr14:105738426	BRF1	-0.7	-5.49	-0.53	4.79e-7	Mean platelet volume;Platelet distribution width;
SKCM	trans	rs8073060	0.586	rs226084	chr17:34019582	T/A	cg19694781	chr19:47549865	TMEM160	-1.04	-8.53	-0.69	8.9e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs362272	0.545	rs2748447	chr4:3337831	G/A	cg11471262	chr4:3318911	RGS12	0.96	10.98	0.78	1.7e-17	Serum sulfate level;
SKCM	cis	rs28386778	0.897	rs2584624	chr17:61904546	A/G	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs3892630	0.588	rs7248798	chr19:33303684	G/T	cg22980127	chr19:33182716	NUDT19	1.26	7.18	0.63	3.52e-10	Red blood cell traits;
SKCM	cis	rs10504229	1.000	rs67384205	chr8:58180348	C/G	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs10088262	0.629	rs9918907	chr8:124816862	A/G	cg02993010	chr8:124780839	FAM91A1	-0.68	-4.77	-0.48	8.41e-6	Pancreatic cancer;
SKCM	trans	rs3780486	0.522	rs7029897	chr9:33124042	T/C	cg20290983	chr6:43655470	MRPS18A	0.88	9.1	0.72	6.87e-14	IgG glycosylation;
SKCM	cis	rs8017423	0.935	rs2236403	chr14:90736325	C/T	cg04374321	chr14:90722782	PSMC1	-0.95	-8.73	-0.7	3.68e-13	Mortality in heart failure;
SKCM	cis	rs6570726	0.791	rs418701	chr6:145889992	C/T	cg23711669	chr6:146136114	FBXO30	0.87	8.94	0.71	1.44e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1153858	1.000	rs4775937	chr15:45678614	C/A	cg10760299	chr15:45669010	GATM	0.62	6.35	0.58	1.3e-8	Homoarginine levels;
SKCM	cis	rs7666738	0.830	rs34461023	chr4:99023751	C/T	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7119	0.700	rs7497168	chr15:77886231	A/C	cg27398640	chr15:77910606	LINGO1	0.52	4.93	0.49	4.53e-6	Type 2 diabetes;
SKCM	cis	rs1691799	0.867	rs1168330	chr12:66763167	C/T	cg16791601	chr12:66731901	HELB	0.59	5.1	0.5	2.34e-6	White blood cell count (basophil);
SKCM	cis	rs3785574	0.927	rs2727313	chr17:61961914	A/G	cg01411255	chr17:61851458	DDX42;CCDC47	1.07	10.34	0.76	2.81e-16	Height;
SKCM	cis	rs16854884	0.584	rs59768870	chr3:143738366	G/A	cg06585982	chr3:143692056	C3orf58	0.87	7.77	0.66	2.66e-11	Economic and political preferences (feminism/equality);
SKCM	cis	rs943437	0.877	rs671271	chr6:112261385	C/T	cg25325257	chr6:112272685	NA	-0.86	-5.0	-0.49	3.5e-6	Parkinson's disease;
SKCM	cis	rs2274273	0.901	rs12050099	chr14:55764331	G/C	cg26246078	chr14:56151250	KTN1	0.69	4.81	0.48	7.12e-6	Protein biomarker;
SKCM	cis	rs12706411	1.000	rs35090045	chr7:122058866	C/G	cg17986181	chr7:121955208	NA	-0.68	-5.06	-0.5	2.69e-6	Alzheimer disease and age of onset;
SKCM	cis	rs10504229	0.683	rs56235637	chr8:58106008	T/C	cg02725872	chr8:58115012	NA	-0.53	-4.91	-0.49	4.82e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs28386778	0.966	rs2008053	chr17:61954918	G/C	cg06873352	chr17:61820015	STRADA	0.77	6.41	0.59	1.02e-8	Prudent dietary pattern;
SKCM	cis	rs4073582	0.595	rs474005	chr11:66033301	C/T	cg16950941	chr11:66035639	RAB1B	0.82	7.01	0.62	7.59e-10	Gout;
SKCM	cis	rs2153535	0.580	rs1335637	chr6:8465101	A/G	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs55962025	0.846	rs363066	chr4:3135953	G/T	cg11471262	chr4:3318911	RGS12	0.72	5.54	0.53	3.98e-7	Parental longevity (mother's age at death);
SKCM	cis	rs9308433	0.529	rs867444	chr1:214502160	T/C	cg06198575	chr1:214491504	SMYD2	0.82	5.16	0.5	1.8e-6	IgG glycosylation;
SKCM	cis	rs60871478	0.588	rs73043546	chr7:857513	C/G	cg05535760	chr7:792225	HEATR2	-1.24	-7.9	-0.67	1.49e-11	Cerebrospinal P-tau181p levels;
SKCM	cis	rs2197308	0.728	rs7304305	chr12:37932990	T/C	cg13010199	chr12:38710504	ALG10B	-0.64	-5.16	-0.5	1.81e-6	Morning vs. evening chronotype;
SKCM	cis	rs763121	0.785	rs6001203	chr22:39099602	T/C	cg06022373	chr22:39101656	GTPBP1	0.85	6.3	0.58	1.65e-8	Menopause (age at onset);
SKCM	cis	rs1639906	0.729	rs17186614	chr7:2231002	G/A	cg21782813	chr7:2030301	MAD1L1	-0.51	-4.94	-0.49	4.32e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6121246	0.559	rs6060716	chr20:30274847	C/G	cg11595048	chr20:30225325	COX4I2	0.54	4.77	0.48	8.4e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs9911578	1.000	rs654778	chr17:56736473	A/C	cg05425664	chr17:57184151	TRIM37	-0.69	-5.21	-0.51	1.52e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs614226	0.935	rs3887875	chr12:120895749	A/G	cg01236616	chr12:121019343	POP5	-1.29	-8.1	-0.68	5.94e-12	Type 1 diabetes nephropathy;
SKCM	cis	rs2832191	0.935	rs67287920	chr21:30523519	C/A	cg24692254	chr21:30365293	RNF160	-0.76	-6.81	-0.61	1.79e-9	Dental caries;
SKCM	trans	rs3749237	1.000	rs11717256	chr3:49868520	C/T	cg21659725	chr3:3221576	CRBN	0.99	7.32	0.64	1.97e-10	Resting heart rate;
SKCM	cis	rs2836974	0.644	rs1882779	chr21:40690938	T/C	cg11890956	chr21:40555474	PSMG1	-0.82	-7.66	-0.65	4.37e-11	Cognitive function;
SKCM	cis	rs10155981	0.510	rs28579868	chr7:22593997	T/C	cg05062323	chr7:22590069	NA	-1.04	-5.94	-0.56	7.37e-8	Bilirubin levels;
SKCM	cis	rs861020	1.000	rs861020	chr1:209977111	A/G	cg05527609	chr1:210001259	C1orf107	1.06	7.54	0.65	7.37e-11	Orofacial clefts;
SKCM	cis	rs875971	0.660	rs10272357	chr7:66063074	G/A	cg18876405	chr7:65276391	NA	-0.82	-7.48	-0.65	9.41e-11	Aortic root size;
SKCM	cis	rs6500395	1.000	rs9933329	chr16:48646572	T/C	cg04672837	chr16:48644449	N4BP1	0.69	5.75	0.55	1.65e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs7809950	0.817	rs2237678	chr7:107203265	T/G	cg23024343	chr7:107201750	COG5	-0.86	-8.01	-0.67	8.85e-12	Coronary artery disease;
SKCM	cis	rs2204008	0.837	rs11612397	chr12:38357455	T/C	cg26384229	chr12:38710491	ALG10B	0.81	6.56	0.6	5.29e-9	Bladder cancer;
SKCM	cis	rs4237845	0.761	rs11172378	chr12:58298161	C/T	cg02175503	chr12:58329896	NA	0.72	6.11	0.57	3.7e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs7666738	0.830	rs10007261	chr4:98926155	C/T	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs8103278	0.507	rs10401971	chr19:46261982	C/T	cg12641515	chr19:46296257	DMWD	0.78	6.24	0.58	2.1e-8	Coronary artery disease;
SKCM	cis	rs780096	0.545	rs2280737	chr2:27589810	A/G	cg05696406	chr2:27599888	SNX17	0.5	5.14	0.5	2e-6	Total body bone mineral density;
SKCM	trans	rs1814175	0.791	rs10769593	chr11:49616217	T/C	cg15704280	chr7:45808275	SEPT13	-0.97	-9.25	-0.72	3.48e-14	Height;
SKCM	cis	rs826838	0.935	rs1601579	chr12:39178606	G/C	cg13010199	chr12:38710504	ALG10B	0.68	5.26	0.51	1.21e-6	Heart rate;
SKCM	cis	rs7666738	0.861	rs5010991	chr4:98972179	A/G	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs12142240	0.698	rs7515284	chr1:46809419	A/G	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs959260	0.588	rs7219	chr17:73315368	A/G	cg14668889	chr17:73230827	NUP85	0.75	6.29	0.58	1.72e-8	Systemic lupus erythematosus;
SKCM	cis	rs9906944	0.545	rs1994969	chr17:47080431	G/T	cg11673840	chr17:47092156	IGF2BP1	-0.56	-5.58	-0.53	3.41e-7	Intelligence (multi-trait analysis);Body fat percentage;
SKCM	cis	rs2836974	0.666	rs2836975	chr21:40663620	A/G	cg11890956	chr21:40555474	PSMG1	-0.81	-8.01	-0.67	8.94e-12	Cognitive function;
SKCM	cis	rs7772486	0.875	rs2748482	chr6:146336532	T/C	cg05347473	chr6:146136440	FBXO30	0.57	5.18	0.51	1.66e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs926938	0.841	rs11588144	chr1:115239355	G/A	cg12756093	chr1:115239321	AMPD1	-0.81	-6.89	-0.62	1.25e-9	Autism;
SKCM	cis	rs10504229	1.000	rs67630725	chr8:58185580	G/A	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs4919087	0.892	rs10882881	chr10:99010067	T/A	cg25902810	chr10:99078978	FRAT1	0.64	5.14	0.5	1.97e-6	Monocyte count;
SKCM	cis	rs2243480	1.000	rs160644	chr7:65558186	C/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs589448	0.967	rs2617835	chr12:69753420	C/A	cg14784868	chr12:69753453	YEATS4	0.84	7.65	0.65	4.54e-11	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs7772486	0.597	rs7746618	chr6:146281367	T/C	cg23711669	chr6:146136114	FBXO30	-0.8	-6.55	-0.6	5.54e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1801251	0.896	rs4973561	chr2:233687337	C/G	cg08000102	chr2:233561755	GIGYF2	-0.73	-5.8	-0.55	1.36e-7	Coronary artery disease;
SKCM	cis	rs6665290	0.904	rs1343744	chr1:227183022	C/T	cg10327440	chr1:227177885	CDC42BPA	-1.25	-17.46	-0.89	1.15e-28	Myeloid white cell count;
SKCM	cis	rs7296418	0.630	rs7974099	chr12:123771475	A/G	cg05973401	chr12:123451056	ABCB9	0.72	5.48	0.53	5.12e-7	Platelet count;
SKCM	cis	rs7659604	0.539	rs2221628	chr4:122795361	G/A	cg06713675	chr4:122721982	EXOSC9	-0.75	-7.38	-0.64	1.48e-10	Type 2 diabetes;
SKCM	cis	rs1580019	0.587	rs7806113	chr7:32553084	A/G	cg06627557	chr7:32535165	LSM5;AVL9	0.94	9.12	0.72	6.39e-14	Cognitive ability;
SKCM	cis	rs7811142	0.830	rs1063945	chr7:99930447	C/T	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.21	8.05	0.67	7.68e-12	Platelet count;
SKCM	cis	rs12044355	0.827	rs7536118	chr1:231822189	A/G	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	0.82	6.24	0.58	2.14e-8	Alzheimer's disease;
SKCM	cis	rs778371	0.723	rs34707169	chr2:233699459	C/T	cg08000102	chr2:233561755	GIGYF2	-0.8	-6.41	-0.59	1.04e-8	Schizophrenia;
SKCM	cis	rs561341	0.714	rs473535	chr17:30312365	A/G	cg23018236	chr17:30244563	NA	-0.53	-5.28	-0.51	1.14e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs7659604	0.502	rs13108419	chr4:122687238	A/G	cg19671926	chr4:122722719	EXOSC9	0.74	6.28	0.58	1.79e-8	Type 2 diabetes;
SKCM	cis	rs7945705	0.712	rs61876274	chr11:9019190	A/T	cg21881798	chr11:8931708	C11orf17;ST5	0.83	7.9	0.67	1.45e-11	Hemoglobin concentration;
SKCM	cis	rs2153535	0.504	rs5001323	chr6:8451605	C/T	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs6463523	0.815	rs66886645	chr7:763853	C/A	cg11064039	chr7:766100	PRKAR1B;HEATR2	1.05	9.82	0.74	2.77e-15	Subjective well-being;
SKCM	cis	rs1957429	0.901	rs8009996	chr14:65351582	A/G	cg23373153	chr14:65346875	NA	1.11	6.32	0.58	1.52e-8	Pediatric areal bone mineral density (radius);
SKCM	cis	rs12477438	0.520	rs11123762	chr2:99727789	T/C	cg26064155	chr2:99771622	LIPT1;TSGA10	1.02	10.07	0.75	9.12e-16	Chronic sinus infection;
SKCM	cis	rs9910055	0.530	rs2269907	chr17:42294215	G/A	cg13607699	chr17:42295918	UBTF	0.86	7.36	0.64	1.62e-10	Total body bone mineral density;
SKCM	cis	rs7659604	0.967	rs10008348	chr4:122666987	A/C	cg19671926	chr4:122722719	EXOSC9	-0.65	-4.79	-0.48	7.7e-6	Type 2 diabetes;
SKCM	cis	rs2204008	0.806	rs35534445	chr12:38279093	C/T	cg13010199	chr12:38710504	ALG10B	0.69	4.92	0.49	4.72e-6	Bladder cancer;
SKCM	cis	rs9911578	1.000	rs391370	chr17:56675050	A/C	cg12560992	chr17:57184187	TRIM37	0.95	7.69	0.66	3.7e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs7811142	0.775	rs6946768	chr7:99954393	G/A	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.2	7.87	0.67	1.7e-11	Platelet count;
SKCM	cis	rs2072499	0.767	rs3001789	chr1:156197614	T/G	cg25208724	chr1:156163844	SLC25A44	0.9	7.92	0.67	1.36e-11	Testicular germ cell tumor;
SKCM	cis	rs4689592	0.554	rs3822270	chr4:7069804	C/A	cg26116260	chr4:7069785	GRPEL1	1.22	9.95	0.75	1.56e-15	Monocyte percentage of white cells;
SKCM	cis	rs10489202	1.000	rs17556487	chr1:167889094	T/A	cg24449463	chr1:168025552	DCAF6	-0.73	-5.27	-0.51	1.18e-6	Schizophrenia;
SKCM	cis	rs2721195	0.967	rs1480000	chr8:145702007	C/T	cg17328964	chr8:145687451	CYHR1	0.6	4.97	0.49	3.85e-6	Age at first birth;
SKCM	trans	rs8073060	0.544	rs7211724	chr17:33993414	C/G	cg19694781	chr19:47549865	TMEM160	-1.04	-8.28	-0.68	2.65e-12	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs17685	0.890	rs76021834	chr7:75607155	A/G	cg08262464	chr7:75615023	POR	0.54	4.77	0.48	8.29e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs28595532	0.920	rs17323034	chr4:119606518	G/A	cg14228332	chr4:119757509	SEC24D	0.97	4.92	0.49	4.71e-6	Cannabis dependence symptom count;
SKCM	cis	rs1059312	0.771	rs11059922	chr12:129290418	C/T	cg09035930	chr12:129282057	SLC15A4	0.77	8.03	0.67	8.18e-12	Systemic lupus erythematosus;
SKCM	cis	rs16924631	0.722	rs115984712	chr9:6532093	C/T	cg13847898	chr9:6552115	GLDC	0.78	4.86	0.48	6.03e-6	Periodontal microbiota;
SKCM	cis	rs10504229	0.724	rs73603871	chr8:58107612	A/G	cg02725872	chr8:58115012	NA	-0.53	-4.91	-0.49	4.82e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs1799949	1.000	rs3092994	chr17:41215825	C/T	cg05368731	chr17:41323189	NBR1	0.89	7.87	0.67	1.71e-11	Menopause (age at onset);
SKCM	cis	rs16854884	0.837	rs6804060	chr3:143804040	C/T	cg06585982	chr3:143692056	C3orf58	0.7	5.24	0.51	1.31e-6	Economic and political preferences (feminism/equality);
SKCM	cis	rs6879260	1.000	rs1035411	chr5:179729519	A/G	cg02891314	chr5:179741120	GFPT2	-0.73	-5.8	-0.55	1.35e-7	Height;
SKCM	cis	rs1878931	0.507	rs11648783	chr16:3406626	A/G	cg26668626	chr16:3451006	ZNF174;ZNF434	0.82	5.78	0.55	1.44e-7	Body mass index (adult);
SKCM	cis	rs6762	0.719	rs7936806	chr11:839186	G/C	cg16425592	chr11:842748	TSPAN4;POLR2L	-0.77	-5.42	-0.52	6.34e-7	Mean platelet volume;
SKCM	trans	rs3780486	0.813	rs3780488	chr9:33133812	T/C	cg20290983	chr6:43655470	MRPS18A	1.0	11.51	0.79	1.7e-18	IgG glycosylation;
SKCM	cis	rs6430585	0.528	rs3112496	chr2:136711064	C/T	cg07169764	chr2:136633963	MCM6	1.24	10.24	0.76	4.47e-16	Corneal structure;
SKCM	cis	rs6866344	0.697	rs62392832	chr5:178134395	T/C	cg03877680	chr5:178157825	ZNF354A	0.86	6.37	0.59	1.19e-8	Neutrophil percentage of white cells;
SKCM	trans	rs1814175	0.645	rs28447324	chr11:50046629	C/A	cg15704280	chr7:45808275	SEPT13	-0.93	-8.68	-0.7	4.61e-13	Height;
SKCM	cis	rs248381	0.684	rs562487	chr5:78406434	G/A	cg17568934	chr5:77892219	LHFPL2	0.53	4.82	0.48	6.91e-6	Toenail selenium levels;
SKCM	cis	rs9818758	0.607	rs9837237	chr3:49215583	G/T	cg24110177	chr3:50126178	RBM5	0.86	5.12	0.5	2.15e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs3793683	0.556	rs2803989	chr10:134560596	C/T	cg27297192	chr10:134578999	INPP5A	0.51	4.82	0.48	7.02e-6	Migraine;
SKCM	cis	rs72781680	0.898	rs56413706	chr2:24086961	G/A	cg08917208	chr2:24149416	ATAD2B	1.07	5.67	0.54	2.28e-7	Lymphocyte counts;
SKCM	cis	rs6547741	1.000	rs1972669	chr2:27767107	T/G	cg27432699	chr2:27873401	GPN1	0.73	6.55	0.6	5.7e-9	Oral cavity cancer;
SKCM	cis	rs11098499	0.954	rs7687843	chr4:120421211	C/T	cg09307838	chr4:120376055	NA	0.99	8.1	0.68	6.11e-12	Corneal astigmatism;
SKCM	cis	rs3087591	0.960	rs4559963	chr17:29438558	G/A	cg24425628	chr17:29625626	OMG;NF1	0.65	5.14	0.5	1.95e-6	Hip circumference;
SKCM	trans	rs208520	0.690	rs12192851	chr6:66705862	G/C	cg15611600	chr13:45563400	KIAA1704;NUFIP1	0.94	8.03	0.67	8.3e-12	Exhaled nitric oxide output;
SKCM	cis	rs4665809	0.590	rs4665318	chr2:26424517	C/T	cg26119090	chr2:26468346	HADHA;HADHB	1.03	8.02	0.67	8.42e-12	Gut microbiome composition (summer);
SKCM	cis	rs5750830	0.649	rs5750818	chr22:39820885	A/G	cg24399712	chr22:39784796	NA	-0.6	-5.01	-0.49	3.31e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9325144	0.560	rs12424821	chr12:38649951	C/T	cg26384229	chr12:38710491	ALG10B	-0.69	-5.66	-0.54	2.36e-7	Morning vs. evening chronotype;
SKCM	cis	rs28595532	0.841	rs114123875	chr4:119733408	A/G	cg14228332	chr4:119757509	SEC24D	1.08	5.52	0.53	4.28e-7	Cannabis dependence symptom count;
SKCM	cis	rs651907	0.557	rs35850993	chr3:101437433	A/G	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.81	7.1	0.63	5.08e-10	Colorectal cancer;
SKCM	cis	rs116095464	0.558	rs1541822	chr5:269234	A/C	cg22857025	chr5:266934	NA	1.36	8.28	0.68	2.72e-12	Breast cancer;
SKCM	cis	rs208515	0.556	rs12214562	chr6:66681011	T/A	cg07460842	chr6:66804631	NA	0.94	6.43	0.59	9.38e-9	Exhaled nitric oxide levels;
SKCM	cis	rs12142240	0.698	rs17413694	chr1:46818416	A/C	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs10193935	0.901	rs72798529	chr2:42537471	C/T	cg27598129	chr2:42591480	NA	-0.88	-6.71	-0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs8067545	0.750	rs9944451	chr17:20001316	T/C	cg13482628	chr17:19912719	NA	0.72	6.01	0.56	5.48e-8	Schizophrenia;
SKCM	cis	rs854765	0.565	rs4072738	chr17:17884547	A/C	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.07	9.17	0.72	5.15e-14	Total body bone mineral density;
SKCM	cis	rs116095464	0.510	rs10057501	chr5:239545	T/C	cg22857025	chr5:266934	NA	-1.35	-7.81	-0.66	2.18e-11	Breast cancer;
SKCM	cis	rs867186	0.614	rs34526995	chr20:33518834	G/T	cg04194272	chr20:33683537	NA	-1.27	-5.12	-0.5	2.18e-6	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs12532878	0.652	rs62482223	chr7:100198878	C/A	cg16850897	chr7:100343110	ZAN	-0.71	-5.19	-0.51	1.61e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs17376456	0.877	rs28575883	chr5:93346035	T/C	cg25358565	chr5:93447407	FAM172A	1.19	7.67	0.66	4.06e-11	Diabetic retinopathy;
SKCM	cis	rs931234	0.931	rs1384406	chr3:65152835	C/T	cg06271087	chr3:65342546	MAGI1	-0.54	-5.35	-0.52	8.5e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs10089	0.953	rs114881127	chr5:127369661	T/C	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.91	8.09	0.68	6.28e-12	Ileal carcinoids;
SKCM	cis	rs2204008	0.715	rs11514342	chr12:38236710	T/A	cg26384229	chr12:38710491	ALG10B	0.87	6.9	0.62	1.21e-9	Bladder cancer;
SKCM	cis	rs1799949	0.628	rs4474733	chr17:41433660	G/T	cg05368731	chr17:41323189	NBR1	0.75	5.7	0.54	2.07e-7	Menopause (age at onset);
SKCM	cis	rs2404602	0.716	rs117129193	chr15:76656803	A/G	cg23625390	chr15:77176239	SCAPER	0.59	5.35	0.52	8.52e-7	Blood metabolite levels;
SKCM	trans	rs3780486	0.522	rs7029897	chr9:33124042	T/C	cg04842962	chr6:43655489	MRPS18A	0.88	8.17	0.68	4.45e-12	IgG glycosylation;
SKCM	cis	rs10754283	0.967	rs10801763	chr1:90120822	C/T	cg21401794	chr1:90099060	LRRC8C	0.73	6.31	0.58	1.57e-8	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs736408	0.522	rs11130310	chr3:52674667	C/T	cg18404041	chr3:52824283	ITIH1	-0.53	-4.77	-0.48	8.43e-6	Bipolar disorder;
SKCM	cis	rs1538970	0.962	rs9429076	chr1:45819489	A/G	cg05343316	chr1:45956843	TESK2	1.02	5.16	0.5	1.85e-6	Platelet count;
SKCM	cis	rs947211	0.846	rs708726	chr1:205762139	G/T	cg07157834	chr1:205819609	PM20D1	-0.66	-5.36	-0.52	8.16e-7	Parkinson's disease;
SKCM	cis	rs4253772	0.637	rs8139035	chr22:46651367	A/G	cg03482458	chr22:46692211	CN5H6.4;GTSE1	1.11	4.96	0.49	4.03e-6	LDL cholesterol;Cholesterol, total;
SKCM	cis	rs5769765	1.000	rs768618	chr22:50286827	G/A	cg22709217	chr22:50311962	ALG12;CRELD2	-0.79	-5.71	-0.54	1.94e-7	Schizophrenia;
SKCM	cis	rs2303745	0.589	rs1965717	chr19:17398559	C/T	cg04248312	chr19:17393744	ANKLE1	-1.12	-8.3	-0.69	2.42e-12	Systemic lupus erythematosus;
SKCM	cis	rs8177179	0.904	rs1130459	chr3:133465283	A/G	cg24879335	chr3:133465180	TF	0.38	4.81	0.48	7.33e-6	Iron status biomarkers (transferrin levels);
SKCM	cis	rs2204008	0.744	rs11514073	chr12:38399553	A/C	cg13010199	chr12:38710504	ALG10B	0.69	4.89	0.48	5.2e-6	Bladder cancer;
SKCM	cis	rs709400	0.663	rs8015918	chr14:103942991	A/G	cg26031613	chr14:104095156	KLC1	0.77	5.96	0.56	6.87e-8	Body mass index;
SKCM	cis	rs1153858	0.943	rs4774580	chr15:45652086	G/A	cg10760299	chr15:45669010	GATM	0.62	6.37	0.59	1.2e-8	Homoarginine levels;
SKCM	cis	rs7811142	1.000	rs67040465	chr7:100083078	G/A	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.14	6.58	0.6	4.83e-9	Platelet count;
SKCM	cis	rs7215564	0.908	rs2316067	chr17:78659720	C/T	cg16980736	chr17:78789706	RPTOR	-0.89	-4.88	-0.48	5.41e-6	Myopia (pathological);
SKCM	cis	rs72781680	0.898	rs72786276	chr2:24062566	G/A	cg08917208	chr2:24149416	ATAD2B	1.07	5.54	0.53	3.99e-7	Lymphocyte counts;
SKCM	cis	rs71520386	0.632	rs71520387	chr7:22869676	C/A	cg15401507	chr7:22894281	NA	0.65	4.87	0.48	5.7e-6	Fibrinogen levels;
SKCM	cis	rs7927771	0.832	rs11601173	chr11:47401058	A/G	cg01152729	chr11:47593274	PTPMT1	-0.51	-4.88	-0.48	5.49e-6	Subjective well-being;
SKCM	cis	rs151997	0.962	rs27475	chr5:50180439	A/C	cg06027927	chr5:50259733	NA	0.63	5.35	0.52	8.43e-7	Callous-unemotional behaviour;
SKCM	cis	rs28386778	0.897	rs2665823	chr17:61885917	G/A	cg06873352	chr17:61820015	STRADA	0.76	6.49	0.59	7.36e-9	Prudent dietary pattern;
SKCM	cis	rs4803468	1.000	rs17318666	chr19:41940342	T/G	cg14132834	chr19:41945861	ATP5SL	0.77	5.9	0.56	9.04e-8	Height;
SKCM	cis	rs9880211	0.613	rs28669017	chr3:135874932	T/G	cg21827317	chr3:136751795	NA	-0.68	-5.3	-0.51	1.05e-6	Body mass index;Height;
SKCM	cis	rs7772486	0.720	rs1890171	chr6:146072114	T/C	cg23711669	chr6:146136114	FBXO30	-0.89	-10.12	-0.75	7.58e-16	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9803723	0.682	rs11805177	chr1:25461923	T/C	cg20685674	chr1:26233538	STMN1	0.47	4.83	0.48	6.56e-6	Male-pattern baldness;
SKCM	cis	rs6062302	0.505	rs2297432	chr20:62290663	C/T	cg03999872	chr20:62272968	STMN3	0.57	5.29	0.51	1.09e-6	Glioblastoma;
SKCM	cis	rs11098499	0.954	rs10518328	chr4:120401779	G/A	cg24375607	chr4:120327624	NA	0.66	5.09	0.5	2.44e-6	Corneal astigmatism;
SKCM	cis	rs28595532	0.841	rs114107504	chr4:119771080	T/C	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs950776	0.752	rs62010327	chr15:78892784	G/A	cg06917634	chr15:78832804	PSMA4	0.85	6.88	0.61	1.34e-9	Sudden cardiac arrest;
SKCM	cis	rs826838	0.935	rs11169511	chr12:39175802	T/C	cg26384229	chr12:38710491	ALG10B	0.92	8.39	0.69	1.67e-12	Heart rate;
SKCM	cis	rs919433	0.714	rs2333855	chr2:198200213	T/G	cg04278110	chr2:198063759	ANKRD44	-0.7	-4.91	-0.49	4.86e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs1153858	1.000	rs4775906	chr15:45638294	C/T	cg21132104	chr15:45694354	SPATA5L1	0.92	8.33	0.69	2.14e-12	Homoarginine levels;
SKCM	cis	rs637571	0.522	rs550435	chr11:65732651	G/A	cg02427764	chr11:65769310	BANF1;EIF1AD	0.74	5.74	0.54	1.75e-7	Eosinophil percentage of white cells;
SKCM	cis	rs11098499	0.865	rs1112817	chr4:120297800	T/C	cg24375607	chr4:120327624	NA	0.65	4.97	0.49	3.87e-6	Corneal astigmatism;
SKCM	cis	rs4642101	0.793	rs13320486	chr3:12822069	C/A	cg05775895	chr3:12838266	CAND2	0.63	5.82	0.55	1.22e-7	QRS complex (12-leadsum);
SKCM	cis	rs7208859	0.623	rs56163556	chr17:29101868	G/C	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs6977660	0.941	rs6953957	chr7:19820560	A/G	cg07541023	chr7:19748670	TWISTNB	0.7	4.82	0.48	6.98e-6	Thyroid stimulating hormone;
SKCM	cis	rs1348850	0.632	rs12616288	chr2:178503813	G/T	cg22681709	chr2:178499509	PDE11A	-0.69	-5.98	-0.56	6.36e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs10089	1.000	rs2409109	chr5:127461471	C/T	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.91	8.89	0.71	1.79e-13	Ileal carcinoids;
SKCM	cis	rs1580019	0.523	rs9791770	chr7:32582252	C/A	cg06627557	chr7:32535165	LSM5;AVL9	0.97	9.63	0.74	6.6e-15	Cognitive ability;
SKCM	trans	rs2727020	0.553	rs61904166	chr11:49581461	T/C	cg15704280	chr7:45808275	SEPT13	-0.96	-8.57	-0.7	7.28e-13	Coronary artery disease;
SKCM	cis	rs2070488	0.932	rs4678604	chr3:38444273	G/A	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.97	9.14	0.72	5.9e-14	Electrocardiographic conduction measures;
SKCM	cis	rs12709013	0.792	rs12598527	chr16:58806891	T/C	cg02431531	chr16:59244939	NA	0.48	5.0	0.49	3.39e-6	Blood metabolite ratios;
SKCM	cis	rs7811142	1.000	rs73161759	chr7:100009994	T/C	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-1.0	-5.66	-0.54	2.36e-7	Platelet count;
SKCM	cis	rs7103648	1.000	rs2293579	chr11:47440758	G/A	cg20307385	chr11:47447363	PSMC3	1.08	9.26	0.72	3.38e-14	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs2180341	1.000	rs6569480	chr6:127621748	A/G	cg27446573	chr6:127587934	RNF146	1.02	8.56	0.7	7.8e-13	Breast cancer;
SKCM	cis	rs394563	0.591	rs237019	chr6:149727064	G/A	cg03678062	chr6:149772716	ZC3H12D	-0.48	-5.45	-0.53	5.61e-7	Dupuytren's disease;
SKCM	cis	rs28386778	0.897	rs1062790	chr17:61896455	A/G	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs7828089	0.934	rs12544427	chr8:22263115	C/T	cg12081754	chr8:22256438	SLC39A14	-0.75	-6.0	-0.56	5.77e-8	Verbal declarative memory;
SKCM	cis	rs644799	0.710	rs11021309	chr11:95501898	C/A	cg25622487	chr11:95524042	FAM76B;CEP57	0.75	6.45	0.59	8.58e-9	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs12497850	0.829	rs8926	chr3:49052785	T/A	cg07636037	chr3:49044803	WDR6	1.04	10.9	0.78	2.43e-17	Parkinson's disease;
SKCM	cis	rs6951245	1.000	rs76214082	chr7:1102097	T/A	cg03188948	chr7:1209495	NA	1.13	6.27	0.58	1.89e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs2386661	0.826	rs7092383	chr10:5671101	A/C	cg12223502	chr10:5658492	NA	-0.56	-4.8	-0.48	7.38e-6	Breast cancer;
SKCM	cis	rs12682352	0.602	rs11783966	chr8:8665147	A/G	cg15556689	chr8:8085844	FLJ10661	-0.63	-4.77	-0.48	8.4e-6	Neuroticism;
SKCM	cis	rs28595532	0.920	rs114575045	chr4:119739794	A/G	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs11626933	1.000	rs61986782	chr14:90751344	C/T	cg14092571	chr14:90743983	NA	-0.92	-8.22	-0.68	3.55e-12	Gut microbiota (bacterial taxa);
SKCM	cis	rs1218582	0.628	rs12130132	chr1:154880386	C/T	cg06221963	chr1:154839813	KCNN3	-0.61	-6.21	-0.57	2.45e-8	Prostate cancer;
SKCM	cis	rs12142240	0.692	rs7529674	chr1:46818508	T/C	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs752010	0.631	rs7515066	chr1:42076915	A/G	cg06885757	chr1:42089581	HIVEP3	-0.72	-7.63	-0.65	4.94e-11	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs13256369	0.802	rs12681326	chr8:8566389	G/A	cg06636001	chr8:8085503	FLJ10661	0.79	6.07	0.57	4.31e-8	Obesity-related traits;
SKCM	cis	rs10751667	0.666	rs4074235	chr11:977511	C/G	cg10932868	chr11:921992	NA	0.55	5.1	0.5	2.36e-6	Alzheimer's disease (late onset);
SKCM	cis	rs6840360	0.571	rs875667	chr4:152525477	G/A	cg22705602	chr4:152727874	NA	-0.52	-5.7	-0.54	2.03e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs8180040	0.726	rs2385867	chr3:47059323	C/T	cg27129171	chr3:47204927	SETD2	0.82	6.49	0.59	7.26e-9	Colorectal cancer;
SKCM	cis	rs4819052	0.851	rs9753963	chr21:46661437	G/A	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.42	0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs6545883	0.894	rs2463102	chr2:61571295	G/C	cg15711740	chr2:61764176	XPO1	0.68	4.82	0.48	6.94e-6	Tuberculosis;
SKCM	cis	rs12709013	0.792	rs1646277	chr16:58783941	C/T	cg02431531	chr16:59244939	NA	0.49	5.13	0.5	2.07e-6	Blood metabolite ratios;
SKCM	cis	rs875971	0.545	rs73378304	chr7:65640747	G/A	cg18876405	chr7:65276391	NA	0.63	5.14	0.5	1.97e-6	Aortic root size;
SKCM	cis	rs6083	0.571	rs41294813	chr15:58847807	T/C	cg05156742	chr15:59063176	FAM63B	-0.77	-5.57	-0.53	3.49e-7	Schizophrenia;
SKCM	cis	rs7917772	0.503	rs7100753	chr10:104300979	C/T	cg11453585	chr10:104263688	ACTR1A;SUFU	0.78	6.33	0.58	1.47e-8	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs9910055	0.529	rs575798	chr17:42181796	A/C	cg09913183	chr17:42254507	C17orf65;ASB16	-0.59	-4.82	-0.48	6.82e-6	Total body bone mineral density;
SKCM	cis	rs7208859	0.623	rs3752019	chr17:29151705	C/T	cg13385521	chr17:29058706	SUZ12P	0.9	4.78	0.48	8.1e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs8077889	1.000	rs2880329	chr17:41866168	T/A	cg26893861	chr17:41843967	DUSP3	1.24	7.74	0.66	3.04e-11	Triglycerides;
SKCM	cis	rs28595532	0.920	rs116305850	chr4:119779892	A/G	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs9611565	0.649	rs202655	chr22:41841564	G/C	cg03806693	chr22:41940476	POLR3H	1.07	6.74	0.61	2.44e-9	Vitiligo;
SKCM	cis	rs1577917	1.000	rs1911553	chr6:86630892	T/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.85	-8.62	-0.7	5.82e-13	Response to antipsychotic treatment;
SKCM	cis	rs1506636	0.924	rs4370458	chr7:123260968	G/A	cg03229431	chr7:123269106	ASB15	-0.63	-4.88	-0.48	5.47e-6	Plateletcrit;Platelet count;
SKCM	cis	rs6835098	0.961	rs2877748	chr4:174102397	G/A	cg08422745	chr4:174089978	GALNT7	-0.86	-6.84	-0.61	1.61e-9	Dementia and core Alzheimer's disease neuropathologic changes;
SKCM	cis	rs7927771	0.832	rs11605672	chr11:47413733	A/G	cg05585544	chr11:47624801	NA	-0.6	-5.31	-0.52	1.01e-6	Subjective well-being;
SKCM	cis	rs7772486	0.790	rs2253768	chr6:146199922	A/G	cg23711669	chr6:146136114	FBXO30	0.85	9.32	0.73	2.57e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs870825	0.616	rs12512839	chr4:185610347	G/A	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs10911251	0.528	rs10911264	chr1:183115040	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.76	7.28	0.64	2.3e-10	Colorectal cancer;
SKCM	cis	rs2153535	0.580	rs1577471	chr6:8485905	T/A	cg07606381	chr6:8435919	SLC35B3	0.86	6.25	0.58	2.06e-8	Motion sickness;
SKCM	cis	rs6489882	0.807	rs1859333	chr12:113370966	T/C	cg07232103	chr12:112566177	TRAFD1	0.61	4.92	0.49	4.67e-6	Chronic lymphocytic leukemia;
SKCM	cis	rs867186	1.000	rs75535620	chr20:33601498	T/C	cg04194272	chr20:33683537	NA	-1.38	-7.2	-0.63	3.29e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs7618501	0.633	rs7621026	chr3:49975334	A/G	cg24110177	chr3:50126178	RBM5	-0.6	-5.1	-0.5	2.36e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs4774899	0.966	rs12903115	chr15:57495151	T/G	cg01857019	chr15:57210107	LOC145783;TCF12	0.53	4.94	0.49	4.38e-6	Urinary tract infection frequency;
SKCM	cis	rs929354	1.000	rs1182452	chr7:157053618	G/A	cg17757837	chr7:157058334	UBE3C	-0.93	-7.21	-0.63	3.17e-10	Body mass index;
SKCM	trans	rs1814175	0.645	rs10839382	chr11:49823172	C/T	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs933688	1.000	rs332544	chr5:90778848	C/T	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.87	6.07	0.57	4.42e-8	Smoking behavior;
SKCM	cis	rs73110464	0.609	rs6580923	chr12:53358352	A/G	cg05393297	chr12:53359155	NA	-0.65	-5.98	-0.56	6.35e-8	Cancer (pleiotropy);
SKCM	cis	rs7937682	0.889	rs1784785	chr11:111483306	A/G	cg09085632	chr11:111637200	PPP2R1B	-0.97	-10.08	-0.75	8.74e-16	Primary sclerosing cholangitis;
SKCM	cis	rs1801516	0.950	rs11212649	chr11:108321225	G/A	cg03165700	chr11:108093220	ATM;NPAT	-1.11	-5.06	-0.5	2.68e-6	Melanoma;
SKCM	cis	rs9916302	0.706	rs7208252	chr17:37584368	A/G	cg07936489	chr17:37558343	FBXL20	-0.99	-6.94	-0.62	1e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs6977660	0.943	rs9639334	chr7:19838810	G/A	cg05791153	chr7:19748676	TWISTNB	0.8	5.55	0.53	3.77e-7	Thyroid stimulating hormone;
SKCM	cis	rs16854884	0.606	rs60676654	chr3:143734937	A/G	cg06585982	chr3:143692056	C3orf58	0.87	8.11	0.68	5.72e-12	Economic and political preferences (feminism/equality);
SKCM	cis	rs12477438	0.520	rs6542870	chr2:99796638	C/T	cg26064155	chr2:99771622	LIPT1;TSGA10	0.97	8.85	0.71	2.11e-13	Chronic sinus infection;
SKCM	cis	rs12142240	0.698	rs72677587	chr1:46813982	G/A	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs2243480	1.000	rs781149	chr7:65481284	C/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs6835098	0.887	rs12644699	chr4:174142874	A/G	cg08422745	chr4:174089978	GALNT7	0.8	6.03	0.56	5.1e-8	Dementia and core Alzheimer's disease neuropathologic changes;
SKCM	cis	rs9325144	0.602	rs11169100	chr12:39077861	G/T	cg13010199	chr12:38710504	ALG10B	-0.68	-5.82	-0.55	1.22e-7	Morning vs. evening chronotype;
SKCM	cis	rs10911232	0.507	rs10911230	chr1:183051118	A/C	ch.1.3577855R	chr1:183094577	LAMC1	0.78	6.87	0.61	1.42e-9	Hypertriglyceridemia;
SKCM	cis	rs447735	0.587	rs11640702	chr16:89729169	A/G	cg01097406	chr16:89675127	NA	-0.48	-5.04	-0.5	2.89e-6	Hemoglobin concentration;
SKCM	cis	rs13108904	0.557	rs1680033	chr4:1243404	C/T	cg02018176	chr4:1364513	KIAA1530	-0.66	-5.25	-0.51	1.26e-6	Obesity-related traits;
SKCM	cis	rs9910055	0.607	rs13726	chr17:42239561	C/T	cg08499158	chr17:42289980	UBTF	-0.74	-6.17	-0.57	2.87e-8	Total body bone mineral density;
SKCM	cis	rs870825	0.616	rs4416519	chr4:185639502	T/C	cg04058563	chr4:185651563	MLF1IP	1.08	7.26	0.64	2.51e-10	Blood protein levels;
SKCM	cis	rs10504229	1.000	rs66936919	chr8:58172868	C/G	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs57221529	0.766	rs72706608	chr5:559203	C/T	cg10555297	chr5:473380	SLC9A3;LOC25845	1.05	5.35	0.52	8.71e-7	Lung disease severity in cystic fibrosis;
SKCM	cis	rs9430161	0.579	rs11121667	chr1:11038476	C/T	cg02454025	chr1:11042201	C1orf127	0.97	8.78	0.71	2.86e-13	Ewing sarcoma;
SKCM	cis	rs2228479	0.717	rs9282682	chr16:89805794	A/G	cg04287289	chr16:89883240	FANCA	0.9	4.95	0.49	4.21e-6	Skin colour saturation;
SKCM	cis	rs28595532	0.920	rs114575045	chr4:119739794	A/G	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs2439831	1.000	rs690263	chr15:43704465	C/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.21	8.15	0.68	4.78e-12	Lung cancer in ever smokers;
SKCM	cis	rs9640161	0.659	rs17837498	chr7:150009679	A/G	cg10018233	chr7:150070692	REPIN1	0.7	5.68	0.54	2.21e-7	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs6942756	1.000	rs2402945	chr7:128956256	C/A	cg02491457	chr7:128862824	NA	-0.86	-5.48	-0.53	5.11e-7	White matter hyperintensity burden;
SKCM	cis	rs1580019	0.961	rs4255041	chr7:32496383	A/G	cg06627557	chr7:32535165	LSM5;AVL9	0.74	5.64	0.54	2.59e-7	Cognitive ability;
SKCM	cis	rs4332037	0.664	rs73046334	chr7:1887037	T/C	cg23422044	chr7:1970798	MAD1L1	-0.9	-5.81	-0.55	1.29e-7	Bipolar disorder;
SKCM	cis	rs2974760	0.606	rs6600143	chr16:201389	A/C	cg08400316	chr16:204221	HBZ	-0.95	-7.43	-0.64	1.19e-10	Mean corpuscular volume;Mean corpuscular hemoglobin;
SKCM	cis	rs473651	0.904	rs10929275	chr2:239323169	A/G	cg21699342	chr2:239360505	ASB1	0.53	5.2	0.51	1.56e-6	Multiple system atrophy;
SKCM	cis	rs9902453	0.765	rs2729440	chr17:28106874	T/A	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.78	-5.89	-0.56	9.1e-8	Coffee consumption (cups per day);
SKCM	cis	rs8060686	0.565	rs55857142	chr16:68236741	A/T	cg09117114	chr16:67998030	SLC12A4	-0.81	-5.02	-0.49	3.14e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs7291412	0.601	rs7292407	chr22:46453712	A/C	cg04566512	chr22:46457588	NA	0.44	4.87	0.48	5.8e-6	Dupuytren's disease;Subjective well-being;
SKCM	cis	rs933688	0.639	rs332530	chr5:90789810	G/T	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.89	5.98	0.56	6.47e-8	Smoking behavior;
SKCM	cis	rs12220238	0.915	rs10824164	chr10:76137032	A/G	cg19889307	chr10:75911429	ADK;AP3M1	0.8	4.8	0.48	7.44e-6	Soluble interleukin-2 receptor subunit alpha;
SKCM	cis	rs11098499	0.954	rs12499324	chr4:120393786	C/T	cg09307838	chr4:120376055	NA	0.97	7.65	0.65	4.54e-11	Corneal astigmatism;
SKCM	cis	rs7666738	0.830	rs13138063	chr4:99050438	A/C	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs995000	0.931	rs1748199	chr1:63057136	T/C	cg06896770	chr1:63153194	DOCK7	0.97	9.01	0.71	1.02e-13	Triglyceride levels;
SKCM	cis	rs6430585	0.759	rs12467770	chr2:136536095	G/A	cg07169764	chr2:136633963	MCM6	1.31	13.14	0.83	1.86e-21	Corneal structure;
SKCM	cis	rs950776	0.714	rs615470	chr15:78885988	T/C	cg06917634	chr15:78832804	PSMA4	-0.85	-6.82	-0.61	1.7e-9	Sudden cardiac arrest;
SKCM	cis	rs478304	0.654	rs12289836	chr11:65436888	C/T	cg17480646	chr11:65405466	SIPA1	0.67	5.24	0.51	1.33e-6	Acne (severe);
SKCM	cis	rs6430585	0.528	rs721765	chr2:136748779	C/A	cg07169764	chr2:136633963	MCM6	1.32	11.74	0.8	6.6e-19	Corneal structure;
SKCM	cis	rs2439831	0.867	rs2927072	chr15:43922398	T/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.41	8.33	0.69	2.19e-12	Lung cancer in ever smokers;
SKCM	cis	rs910316	0.783	rs11850751	chr14:75590113	A/T	cg08847533	chr14:75593920	NEK9	0.95	9.18	0.72	4.88e-14	Height;
SKCM	cis	rs4820539	1.000	rs4822361	chr22:23482718	A/G	cg14186256	chr22:23484241	RTDR1	-0.82	-7.7	-0.66	3.54e-11	Bone mineral density;
SKCM	cis	rs4774899	1.000	rs2414494	chr15:57441738	T/C	cg01857019	chr15:57210107	LOC145783;TCF12	0.53	4.9	0.49	5.12e-6	Urinary tract infection frequency;
SKCM	cis	rs6582630	0.555	rs1969362	chr12:38514843	C/T	cg26384229	chr12:38710491	ALG10B	0.82	6.9	0.62	1.22e-9	Drug-induced liver injury (flucloxacillin);
SKCM	trans	rs1814175	0.817	rs7946556	chr11:49944874	G/A	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs4689592	0.554	rs3822270	chr4:7069804	C/A	cg19539972	chr4:7069911	GRPEL1	1.01	7.11	0.63	4.81e-10	Monocyte percentage of white cells;
SKCM	cis	rs2075671	0.812	rs2231172	chr7:100252918	A/G	cg16850897	chr7:100343110	ZAN	-0.66	-4.81	-0.48	7.25e-6	Other erythrocyte phenotypes;
SKCM	cis	rs763014	0.966	rs4984675	chr16:670117	T/C	cg07343612	chr16:622815	PIGQ	-0.69	-5.93	-0.56	7.86e-8	Height;
SKCM	cis	rs919433	0.783	rs788007	chr2:198233676	T/G	cg04278110	chr2:198063759	ANKRD44	0.74	5.13	0.5	2.06e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs8072100	0.688	rs8075843	chr17:45442363	C/T	cg08085267	chr17:45401833	C17orf57	-0.7	-5.61	-0.54	2.91e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs7617480	0.648	rs9848268	chr3:48762271	C/T	cg07636037	chr3:49044803	WDR6	0.92	6.78	0.61	2.04e-9	Subjective well-being (multi-trait analysis);Menarche (age at onset);
SKCM	cis	rs72772090	0.908	rs6864233	chr5:96044681	A/G	cg17330273	chr5:96107758	CAST;ERAP1	0.83	5.16	0.5	1.8e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs3087591	1.000	rs7214792	chr17:29460673	G/A	cg24425628	chr17:29625626	OMG;NF1	0.65	5.15	0.5	1.94e-6	Hip circumference;
SKCM	cis	rs10911232	0.507	rs10797832	chr1:183044034	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.78	6.87	0.61	1.42e-9	Hypertriglyceridemia;
SKCM	cis	rs116095464	1.000	rs61501460	chr5:316811	G/A	cg22857025	chr5:266934	NA	-1.63	-6.12	-0.57	3.5e-8	Breast cancer;
SKCM	cis	rs116095464	0.558	rs1541822	chr5:269234	A/C	cg22496380	chr5:211416	CCDC127	0.89	4.93	0.49	4.49e-6	Breast cancer;
SKCM	cis	rs72615157	0.634	rs2272343	chr7:99778285	A/C	cg23667466	chr7:100026434	MEPCE;ZCWPW1	0.89	4.84	0.48	6.53e-6	Lung function (FEV1/FVC);
SKCM	cis	rs4888262	0.545	rs4888270	chr16:74698576	A/G	cg01733217	chr16:74700730	RFWD3	0.91	7.37	0.64	1.57e-10	Testicular germ cell tumor;
SKCM	cis	rs4555082	0.872	rs7153832	chr14:105730563	G/T	cg13114125	chr14:105738426	BRF1	-0.73	-5.73	-0.54	1.79e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs62064224	0.703	rs62065492	chr17:30822607	C/T	cg18200150	chr17:30822561	MYO1D	0.71	6.16	0.57	3e-8	Schizophrenia;
SKCM	cis	rs9788682	0.747	rs7183604	chr15:78899213	T/C	cg24631222	chr15:78858424	CHRNA5	-0.82	-6.39	-0.59	1.1e-8	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs7809950	1.000	rs2057837	chr7:107222725	C/G	cg23024343	chr7:107201750	COG5	0.76	6.99	0.62	8.3e-10	Coronary artery disease;
SKCM	cis	rs17826219	0.636	rs12946563	chr17:29103166	C/G	cg13385521	chr17:29058706	SUZ12P	1.02	5.22	0.51	1.44e-6	Body mass index;
SKCM	cis	rs9911578	0.967	rs1588322	chr17:56990099	T/C	cg12560992	chr17:57184187	TRIM37	0.94	7.55	0.65	7.01e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs7811142	0.830	rs10085549	chr7:99983135	C/T	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.2	7.91	0.67	1.41e-11	Platelet count;
SKCM	cis	rs912057	0.671	rs1294417	chr6:6741932	T/C	cg06612196	chr6:6737390	NA	0.66	5.39	0.52	7.17e-7	Waist-to-hip ratio adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);
SKCM	cis	rs2842992	0.789	rs2277072	chr6:160182845	A/G	cg16489826	chr6:160211363	TCP1;MRPL18	0.73	5.35	0.52	8.53e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs7507204	0.767	rs12982509	chr19:3412057	C/T	cg08380311	chr19:3435252	NFIC	-0.99	-7.45	-0.64	1.08e-10	Height;
SKCM	cis	rs595982	0.527	rs73061659	chr19:49373556	G/A	cg15549821	chr19:49342101	PLEKHA4	-0.85	-5.02	-0.49	3.18e-6	Red cell distribution width;
SKCM	cis	rs35306767	0.903	rs11253495	chr10:937064	C/T	cg26597838	chr10:835615	NA	0.76	4.9	0.49	5.02e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs1577917	0.816	rs1838952	chr6:86601144	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.7	-6.2	-0.57	2.5e-8	Response to antipsychotic treatment;
SKCM	cis	rs2204008	0.775	rs12099736	chr12:38344111	C/G	cg26384229	chr12:38710491	ALG10B	0.81	6.67	0.6	3.38e-9	Bladder cancer;
SKCM	cis	rs2463822	1.000	rs11231050	chr11:62131660	C/G	cg06239285	chr11:62104954	ASRGL1	-1.13	-5.61	-0.54	2.92e-7	Chronic obstructive pulmonary disease-related biomarkers;
SKCM	cis	rs9640161	0.659	rs11974980	chr7:150009838	C/T	cg27494647	chr7:150038898	RARRES2	0.55	4.9	0.49	5.02e-6	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs801193	1.000	rs10274773	chr7:66133578	G/A	cg11764359	chr7:65958608	NA	-0.83	-6.29	-0.58	1.71e-8	Aortic root size;
SKCM	cis	rs17376456	0.741	rs12374432	chr5:93481348	C/A	cg21475434	chr5:93447410	FAM172A	0.97	5.42	0.52	6.39e-7	Diabetic retinopathy;
SKCM	cis	rs7584330	0.704	rs72620820	chr2:238358844	G/A	cg14458575	chr2:238380390	NA	1.13	7.24	0.63	2.7e-10	Prostate cancer;
SKCM	cis	rs2836974	0.583	rs2410124	chr21:40704760	C/G	cg11890956	chr21:40555474	PSMG1	-0.82	-7.57	-0.65	6.49e-11	Cognitive function;
SKCM	cis	rs7829975	0.539	rs883647	chr8:8569724	G/A	cg15556689	chr8:8085844	FLJ10661	-0.69	-5.24	-0.51	1.35e-6	Mood instability;
SKCM	cis	rs6951245	0.938	rs117729148	chr7:1108531	G/A	cg24642844	chr7:1081250	C7orf50	-0.93	-6.22	-0.58	2.28e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs10751667	0.666	rs7103585	chr11:971166	T/C	cg10932868	chr11:921992	NA	0.55	5.1	0.5	2.36e-6	Alzheimer's disease (late onset);
SKCM	cis	rs7100689	0.599	rs6585968	chr10:82139807	T/C	cg00277334	chr10:82204260	NA	-0.51	-4.8	-0.48	7.43e-6	Post bronchodilator FEV1;
SKCM	cis	rs16949788	1.000	rs10468036	chr15:66710276	C/T	cg08120210	chr15:66682733	MAP2K1	-0.74	-5.69	-0.54	2.1e-7	Spherical equivalent (joint analysis main effects and education interaction);
SKCM	cis	rs867186	1.000	rs73905019	chr20:33560314	C/A	cg04194272	chr20:33683537	NA	-1.37	-6.77	-0.61	2.18e-9	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs28785552	0.897	rs34244888	chr19:53242228	T/A	cg10871876	chr19:53194124	ZNF83	0.81	5.95	0.56	7.06e-8	Response to paliperidone in schizophrenia (PANSS score);
SKCM	cis	rs7680126	0.500	rs4697933	chr4:10146493	G/A	cg09374173	chr4:9383942	NA	0.69	4.92	0.49	4.75e-6	Urate levels in lean individuals;Urate levels in overweight individuals;Urate levels in obese individuals;
SKCM	cis	rs2228479	0.717	rs1800358	chr16:89809319	T/C	cg04287289	chr16:89883240	FANCA	0.89	4.92	0.49	4.64e-6	Skin colour saturation;
SKCM	cis	rs1348850	0.872	rs7559521	chr2:178452328	A/G	cg02961200	chr2:178257176	LOC100130691;AGPS	-0.74	-5.87	-0.55	9.99e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs9389248	0.728	rs1022491	chr6:135259366	C/T	cg24558204	chr6:135376177	HBS1L	-0.67	-6.06	-0.57	4.52e-8	High light scatter reticulocyte percentage of red cells;
SKCM	cis	rs116095464	0.558	rs10068203	chr5:206618	C/T	cg22496380	chr5:211416	CCDC127	-1.0	-5.11	-0.5	2.25e-6	Breast cancer;
SKCM	cis	rs7193541	0.694	rs3896277	chr16:74480694	A/T	cg01733217	chr16:74700730	RFWD3	0.85	7.12	0.63	4.57e-10	Multiple myeloma;
SKCM	cis	rs13118159	0.742	rs7679860	chr4:1333987	C/T	cg02018176	chr4:1364513	KIAA1530	0.67	5.5	0.53	4.59e-7	Longevity;
SKCM	cis	rs4721295	0.546	rs1637766	chr7:2204400	G/A	cg21782813	chr7:2030301	MAD1L1	-0.49	-5.12	-0.5	2.11e-6	Schizophrenia, schizoaffective disorder or bipolar disorder;
SKCM	cis	rs7927771	0.965	rs35985502	chr11:47847428	G/A	cg05585544	chr11:47624801	NA	-0.59	-5.09	-0.5	2.43e-6	Subjective well-being;
SKCM	cis	rs7772486	0.686	rs1004752	chr6:146037822	G/A	cg23711669	chr6:146136114	FBXO30	-0.82	-8.01	-0.67	9.12e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7829975	0.593	rs2921064	chr8:8316637	C/T	cg06636001	chr8:8085503	FLJ10661	0.91	8.27	0.68	2.76e-12	Mood instability;
SKCM	cis	rs28595532	0.920	rs115271785	chr4:119735748	A/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs12478296	1.000	rs66612947	chr2:243035962	A/T	cg06360820	chr2:242988706	NA	-0.92	-5.32	-0.52	9.84e-7	Obesity-related traits;
SKCM	cis	rs6500395	1.000	rs8052196	chr16:48691644	C/T	cg04672837	chr16:48644449	N4BP1	-0.65	-5.43	-0.52	6.29e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs9858542	0.953	rs9837027	chr3:49597013	C/T	cg03060546	chr3:49711283	APEH	-0.69	-5.11	-0.5	2.24e-6	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs4927850	1.000	rs10881563	chr3:195750225	A/G	cg01181863	chr3:195395398	SDHAP2	-0.79	-5.22	-0.51	1.42e-6	Pancreatic cancer;
SKCM	cis	rs17376456	0.877	rs2290937	chr5:93356515	A/T	cg25358565	chr5:93447407	FAM172A	1.12	6.92	0.62	1.14e-9	Diabetic retinopathy;
SKCM	cis	rs763014	0.898	rs4984897	chr16:632180	G/C	cg09263875	chr16:632152	PIGQ	0.67	5.82	0.55	1.24e-7	Height;
SKCM	cis	rs473651	0.935	rs472357	chr2:239355454	A/G	cg18131467	chr2:239335373	ASB1	-1.1	-13.36	-0.83	7.44e-22	Multiple system atrophy;
SKCM	cis	rs7666738	0.830	rs10470894	chr4:99039107	G/A	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4740619	0.619	rs1328298	chr9:16046417	T/C	cg14451791	chr9:16040625	NA	-0.48	-5.25	-0.51	1.27e-6	Body mass index;
SKCM	cis	rs7772486	0.902	rs1125462	chr6:146417832	A/G	cg23711669	chr6:146136114	FBXO30	0.83	8.15	0.68	4.82e-12	Lobe attachment (rater-scored or self-reported);
SKCM	trans	rs1814175	0.817	rs11040474	chr11:49708441	G/A	cg15704280	chr7:45808275	SEPT13	-1.02	-10.75	-0.77	4.66e-17	Height;
SKCM	cis	rs9911578	0.967	rs4932693	chr17:57110327	T/C	cg05425664	chr17:57184151	TRIM37	0.84	6.99	0.62	8.23e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs9303401	0.573	rs62081879	chr17:57181524	C/T	cg10487724	chr17:56770010	TEX14;RAD51C	0.79	4.97	0.49	3.86e-6	Cognitive test performance;
SKCM	cis	rs6938	0.534	rs1130741	chr15:75189930	A/G	cg09165964	chr15:75287851	SCAMP5	0.62	4.79	0.48	7.73e-6	Breast cancer;
SKCM	cis	rs1843834	0.539	rs3912999	chr2:225390089	C/T	cg22455342	chr2:225449267	CUL3	0.7	5.29	0.51	1.07e-6	IgE levels in asthmatics (D.p. specific);
SKCM	cis	rs1707322	1.000	rs4660889	chr1:46297331	C/T	cg03146154	chr1:46216737	IPP	0.75	5.15	0.5	1.94e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs9399135	0.838	rs4896126	chr6:135342786	C/A	cg24558204	chr6:135376177	HBS1L	0.6	5.36	0.52	8.17e-7	Red blood cell count;
SKCM	cis	rs4560672	1.000	rs7741311	chr6:158581594	T/G	cg10592926	chr6:157876961	ZDHHC14	0.54	5.12	0.5	2.14e-6	Smoking quantity;
SKCM	cis	rs548181	0.668	rs579661	chr11:125474766	A/G	cg03464685	chr11:125439445	EI24	1.34	8.64	0.7	5.33e-13	Schizophrenia;Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);
SKCM	cis	rs28386778	0.699	rs12451467	chr17:62008885	C/T	cg23090583	chr17:61904693	PSMC5;FTSJ3	-0.76	-6.27	-0.58	1.86e-8	Prudent dietary pattern;
SKCM	cis	rs4732038	0.903	rs7811759	chr7:134231615	A/G	cg08396481	chr7:135194601	CNOT4	0.62	4.79	0.48	7.92e-6	Longevity;
SKCM	cis	rs4727027	0.870	rs13237714	chr7:148884083	A/G	cg23583168	chr7:148888333	NA	-0.78	-6.29	-0.58	1.74e-8	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs17376456	0.877	rs13169675	chr5:93331284	A/G	cg25358565	chr5:93447407	FAM172A	1.19	7.67	0.66	4.06e-11	Diabetic retinopathy;
SKCM	cis	rs10256972	0.504	rs2949178	chr7:1209925	T/C	cg03188948	chr7:1209495	NA	0.59	4.81	0.48	7.18e-6	Longevity;Endometriosis;
SKCM	cis	rs873946	0.590	rs12259699	chr10:134549692	A/G	cg26818010	chr10:134567672	INPP5A	-0.73	-5.61	-0.54	3.01e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs7149337	0.717	rs4309324	chr14:51606336	A/T	cg23942311	chr14:51606299	NA	-0.57	-6.39	-0.59	1.11e-8	Cancer;
SKCM	cis	rs1044826	0.642	rs7652860	chr3:139205818	T/A	cg15131784	chr3:139108705	COPB2	0.7	5.19	0.51	1.62e-6	Obesity-related traits;
SKCM	cis	rs1799949	0.965	rs35521261	chr17:41313612	A/G	cg05368731	chr17:41323189	NBR1	0.89	7.98	0.67	1.03e-11	Menopause (age at onset);
SKCM	cis	rs2404602	0.692	rs55729975	chr15:76803226	G/A	cg23625390	chr15:77176239	SCAPER	0.61	5.45	0.52	5.8e-7	Blood metabolite levels;
SKCM	cis	rs28595532	0.920	rs116145969	chr4:119770908	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs7772486	0.790	rs2247206	chr6:146216184	C/T	cg23711669	chr6:146136114	FBXO30	0.78	7.7	0.66	3.53e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9894429	0.646	rs7406825	chr17:79619188	C/T	cg18240062	chr17:79603768	NPLOC4	0.68	6.0	0.56	5.87e-8	Eye color traits;
SKCM	cis	rs1153858	1.000	rs1049508	chr15:45653592	A/G	cg10760299	chr15:45669010	GATM	0.63	6.32	0.58	1.49e-8	Homoarginine levels;
SKCM	cis	rs10752881	0.935	rs10911235	chr1:183053746	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.78	6.87	0.61	1.42e-9	Colorectal cancer;
SKCM	cis	rs2075371	0.932	rs1862052	chr7:133981227	G/A	cg20476274	chr7:133979776	SLC35B4	0.97	9.7	0.74	4.7e-15	Mean platelet volume;
SKCM	cis	rs2013441	1.000	rs3850781	chr17:20181939	T/G	cg13482628	chr17:19912719	NA	-0.66	-5.12	-0.5	2.18e-6	Obesity-related traits;
SKCM	cis	rs7208859	0.623	rs56095789	chr17:29060170	A/G	cg14067834	chr17:29058358	SUZ12P	1.19	5.71	0.54	1.94e-7	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs7927771	1.000	rs4752856	chr11:47648042	C/T	cg05585544	chr11:47624801	NA	-0.63	-5.55	-0.53	3.79e-7	Subjective well-being;
SKCM	cis	rs2075371	1.000	rs8134	chr7:133974519	A/G	cg20476274	chr7:133979776	SLC35B4	1.03	10.5	0.77	1.4e-16	Mean platelet volume;
SKCM	cis	rs2857078	0.720	rs9901595	chr17:42305699	G/A	cg19774624	chr17:42201019	HDAC5	-0.77	-6.27	-0.58	1.84e-8	Red cell distribution width;Reticulocyte count;
SKCM	cis	rs7635838	0.617	rs184700	chr3:11293061	A/G	cg00170343	chr3:11313890	ATG7	0.73	5.31	0.51	1.02e-6	HDL cholesterol;
SKCM	cis	rs4400599	0.618	rs9943097	chr1:154205823	C/T	cg26808167	chr1:154192205	UBAP2L;C1orf43	-0.54	-4.9	-0.49	5.01e-6	Platelet distribution width;
SKCM	cis	rs362296	0.530	rs3129316	chr4:3287906	A/G	cg16987761	chr4:3318072	RGS12	0.79	7.66	0.66	4.25e-11	Parental longevity (mother's age at death);
SKCM	cis	rs2204008	0.744	rs11180504	chr12:38236313	C/T	cg13010199	chr12:38710504	ALG10B	0.69	4.99	0.49	3.57e-6	Bladder cancer;
SKCM	cis	rs11098499	0.954	rs12502423	chr4:120424172	A/C	cg09307838	chr4:120376055	NA	0.99	7.99	0.67	9.98e-12	Corneal astigmatism;
SKCM	cis	rs11209185	0.602	rs1926285	chr1:68446191	A/T	cg17031739	chr1:67600172	NA	-0.5	-4.85	-0.48	6.17e-6	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs875971	0.508	rs10242423	chr7:66059175	A/G	cg18876405	chr7:65276391	NA	-0.8	-7.2	-0.63	3.28e-10	Aortic root size;
SKCM	cis	rs10193935	0.901	rs6544536	chr2:42522042	G/A	cg27598129	chr2:42591480	NA	-0.88	-6.71	-0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs28595532	1.000	rs56000725	chr4:119637675	G/A	cg14228332	chr4:119757509	SEC24D	0.97	4.92	0.49	4.71e-6	Cannabis dependence symptom count;
SKCM	cis	rs28386778	0.897	rs3785572	chr17:61829989	C/T	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.36	0.52	8.06e-7	Prudent dietary pattern;
SKCM	cis	rs2839186	0.721	rs3788252	chr21:47661235	C/T	cg13126279	chr21:47581558	C21orf56	-0.62	-5.37	-0.52	7.8e-7	Testicular germ cell tumor;
SKCM	cis	rs12142240	0.698	rs56358525	chr1:46849520	C/T	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs6087990	0.806	rs875041	chr20:31383530	C/T	cg13636640	chr20:31349939	DNMT3B	0.88	7.46	0.65	1.05e-10	Ulcerative colitis;
SKCM	cis	rs35306767	0.903	rs11816064	chr10:931176	A/C	cg26597838	chr10:835615	NA	0.75	5.51	0.53	4.53e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs2228479	0.850	rs17226512	chr16:89839976	T/C	cg06558623	chr16:89946397	TCF25	1.11	5.26	0.51	1.23e-6	Skin colour saturation;
SKCM	cis	rs7937682	0.855	rs7109592	chr11:111533105	C/A	cg09085632	chr11:111637200	PPP2R1B	-1.05	-12.29	-0.81	6.25e-20	Primary sclerosing cholangitis;
SKCM	cis	rs1669338	1.000	rs1669338	chr3:3199635	A/C	cg16797762	chr3:3221439	CRBN	0.85	5.41	0.52	6.75e-7	White matter integrity;
SKCM	cis	rs4132509	0.793	rs34477525	chr1:243966454	T/A	cg21452805	chr1:244014465	NA	0.9	5.55	0.53	3.82e-7	RR interval (heart rate);
SKCM	cis	rs10504073	0.647	rs2292399	chr8:49987230	A/G	cg00325661	chr8:49890786	NA	0.78	6.77	0.61	2.18e-9	Blood metabolite ratios;
SKCM	cis	rs798766	1.000	rs1665364	chr4:1727206	A/G	cg05874882	chr4:1763078	NA	0.52	4.84	0.48	6.51e-6	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs6500395	1.000	rs12597569	chr16:48693342	C/T	cg04672837	chr16:48644449	N4BP1	-0.65	-5.43	-0.52	6.29e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs8180040	0.726	rs2061197	chr3:47001350	C/T	cg27129171	chr3:47204927	SETD2	-0.79	-6.07	-0.57	4.38e-8	Colorectal cancer;
SKCM	cis	rs13118159	0.509	rs7681872	chr4:1376735	G/A	cg02475777	chr4:1388615	CRIPAK	0.75	4.97	0.49	3.81e-6	Longevity;
SKCM	cis	rs9858542	0.953	rs10640	chr3:49454277	G/A	cg03060546	chr3:49711283	APEH	-0.75	-5.53	-0.53	4.17e-7	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs9303401	0.659	rs7210432	chr17:56668170	C/T	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.27	0.51	1.17e-6	Cognitive test performance;
SKCM	cis	rs7824557	0.602	rs10110557	chr8:11207508	T/C	cg21775007	chr8:11205619	TDH	0.7	6.25	0.58	2.02e-8	Retinal vascular caliber;
SKCM	cis	rs6912958	0.559	rs2985039	chr6:88041757	A/G	cg08069147	chr6:88032118	GJB7;C6orf162	0.64	5.61	0.54	2.97e-7	Monocyte percentage of white cells;
SKCM	cis	rs62238980	0.614	rs78818509	chr22:32447582	A/G	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs9911578	0.967	rs2429369	chr17:56501420	A/G	cg12560992	chr17:57184187	TRIM37	0.9	7.03	0.62	6.99e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs9902453	1.000	rs12600993	chr17:28291222	T/A	cg26525008	chr17:28256777	EFCAB5;SSH2	0.81	5.78	0.55	1.46e-7	Coffee consumption (cups per day);
SKCM	cis	rs8067545	0.611	rs2703795	chr17:20077141	C/A	cg13482628	chr17:19912719	NA	-0.66	-5.59	-0.53	3.23e-7	Schizophrenia;
SKCM	cis	rs10905065	0.717	rs11254266	chr10:5750078	G/T	cg09234995	chr10:5726438	C10orf18	-0.63	-5.34	-0.52	9.04e-7	Menopause (age at onset);
SKCM	cis	rs7954584	0.616	rs10743186	chr12:122356436	C/T	cg13699009	chr12:122356056	WDR66	0.49	5.55	0.53	3.72e-7	Mean corpuscular volume;
SKCM	cis	rs17376456	0.877	rs28637444	chr5:93495548	C/T	cg25358565	chr5:93447407	FAM172A	1.24	8.18	0.68	4.18e-12	Diabetic retinopathy;
SKCM	cis	rs2153535	0.580	rs1335636	chr6:8465047	T/C	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs7618915	0.547	rs1561337	chr3:52659963	C/T	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs36093844	0.664	rs111395809	chr11:85766135	G/C	cg25872744	chr11:85566296	CCDC83	-0.81	-4.79	-0.48	7.71e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs875971	0.522	rs4718286	chr7:65292764	A/G	cg18876405	chr7:65276391	NA	0.86	7.56	0.65	6.53e-11	Aortic root size;
SKCM	cis	rs9640161	0.659	rs77354576	chr7:150013300	A/C	cg27494647	chr7:150038898	RARRES2	0.54	4.85	0.48	6.18e-6	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs6951245	0.872	rs76161580	chr7:1100307	G/T	cg03188948	chr7:1209495	NA	1.13	6.27	0.58	1.89e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs9399135	0.967	rs9321481	chr6:135352648	C/G	cg24558204	chr6:135376177	HBS1L	-0.56	-4.79	-0.48	7.82e-6	Red blood cell count;
SKCM	cis	rs6430585	0.536	rs3213892	chr2:136552517	G/A	cg07169764	chr2:136633963	MCM6	1.32	13.34	0.83	7.99e-22	Corneal structure;
SKCM	cis	rs9880211	0.706	rs35716521	chr3:136494670	G/A	cg21827317	chr3:136751795	NA	-0.74	-5.43	-0.52	6.11e-7	Body mass index;Height;
SKCM	cis	rs3008870	1.000	rs3008856	chr1:67387901	T/C	cg08660285	chr1:67390436	MIER1;WDR78	0.98	6.56	0.6	5.45e-9	Lymphocyte percentage of white cells;
SKCM	cis	rs11105298	0.891	rs10858889	chr12:89902604	G/A	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.91	-5.63	-0.54	2.77e-7	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs9916302	0.904	rs11869109	chr17:37518205	G/T	cg07936489	chr17:37558343	FBXL20	0.85	7.28	0.64	2.26e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs9543976	0.920	rs9543992	chr13:76175074	G/A	cg01531495	chr13:76123901	UCHL3	0.9	4.99	0.49	3.52e-6	Diabetic retinopathy;
SKCM	cis	rs7659604	0.502	rs13106764	chr4:122699630	C/G	cg19671926	chr4:122722719	EXOSC9	0.76	6.97	0.62	9.04e-10	Type 2 diabetes;
SKCM	cis	rs1799949	1.000	rs8176212	chr17:41226601	G/C	cg05368731	chr17:41323189	NBR1	0.9	7.94	0.67	1.23e-11	Menopause (age at onset);
SKCM	cis	rs3785574	0.962	rs57553639	chr17:61848499	C/T	cg06601766	chr17:61851465	DDX42;CCDC47	0.64	4.77	0.48	8.35e-6	Height;
SKCM	cis	rs8005150	0.737	rs10220371	chr14:88501852	C/T	cg18866806	chr14:89259551	EML5	-0.92	-4.85	-0.48	6.3e-6	Hepatitis B;
SKCM	cis	rs6088590	0.523	rs6059913	chr20:33143288	G/A	cg24642439	chr20:33292090	TP53INP2	0.77	5.85	0.55	1.12e-7	Coronary artery disease;
SKCM	cis	rs7659604	0.518	rs17452156	chr4:122733623	T/C	cg19748678	chr4:122722346	EXOSC9	0.65	5.4	0.52	7.02e-7	Type 2 diabetes;
SKCM	cis	rs2463822	1.000	rs72921498	chr11:62113090	C/T	cg06239285	chr11:62104954	ASRGL1	-1.25	-5.93	-0.56	7.79e-8	Chronic obstructive pulmonary disease-related biomarkers;
SKCM	cis	rs854765	0.583	rs7207043	chr17:17819188	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.0	7.64	0.65	4.64e-11	Total body bone mineral density;
SKCM	cis	rs1348850	0.574	rs4893834	chr2:178442288	C/T	cg27490568	chr2:178487706	NA	-0.72	-5.23	-0.51	1.38e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	trans	rs8073060	0.586	rs4795086	chr17:34042190	G/A	cg19694781	chr19:47549865	TMEM160	1.08	8.6	0.7	6.4e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs2404602	0.692	rs12911902	chr15:77053575	T/C	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs28386778	0.830	rs2597637	chr17:61875066	T/G	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.1	11.09	0.78	1.04e-17	Prudent dietary pattern;
SKCM	cis	rs6835098	0.962	rs10027704	chr4:174083107	T/C	cg08422745	chr4:174089978	GALNT7	-0.81	-6.26	-0.58	1.96e-8	Dementia and core Alzheimer's disease neuropathologic changes;
SKCM	cis	rs7613875	0.600	rs2856237	chr3:50158774	A/G	cg24110177	chr3:50126178	RBM5	0.73	5.81	0.55	1.28e-7	Body mass index;
SKCM	cis	rs8070128	0.597	rs4635395	chr17:17882087	G/A	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.84	6.13	0.57	3.36e-8	Total body bone mineral density;
SKCM	cis	rs4925386	0.559	rs2427291	chr20:60921324	G/A	cg09594475	chr20:60884601	LAMA5	0.65	4.77	0.48	8.26e-6	Colorectal cancer;Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs62064224	0.791	rs11654833	chr17:30667728	C/T	cg25809561	chr17:30822961	MYO1D	0.66	5.03	0.5	3.01e-6	Schizophrenia;
SKCM	cis	rs6982751	0.611	rs59109872	chr8:10810275	C/T	cg01383082	chr8:11323474	FAM167A	0.86	4.98	0.49	3.74e-6	Asthma and hay fever;
SKCM	cis	rs1577917	1.000	rs10944169	chr6:86683036	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.63	-5.48	-0.53	5.11e-7	Response to antipsychotic treatment;
SKCM	cis	rs875971	0.862	rs2901152	chr7:65765004	G/A	cg11764359	chr7:65958608	NA	-0.75	-6.76	-0.61	2.26e-9	Aortic root size;
SKCM	cis	rs116095464	0.558	rs7703803	chr5:292311	A/G	cg22857025	chr5:266934	NA	-1.48	-8.04	-0.67	7.7e-12	Breast cancer;
SKCM	cis	rs752010	0.619	rs6702659	chr1:42112236	T/C	cg06885757	chr1:42089581	HIVEP3	0.57	6.33	0.58	1.46e-8	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs9322193	1.000	rs9377229	chr6:149928791	C/T	cg07701084	chr6:150067640	NUP43	0.64	5.18	0.51	1.69e-6	Lung cancer;
SKCM	cis	rs7684253	0.565	rs13108570	chr4:57807083	G/C	cg11939399	chr4:57773300	REST	0.43	4.94	0.49	4.33e-6	Migraine;
SKCM	cis	rs6545883	0.929	rs12713436	chr2:61691260	T/C	cg15711740	chr2:61764176	XPO1	-0.69	-4.98	-0.49	3.75e-6	Tuberculosis;
SKCM	cis	rs651907	0.557	rs13081846	chr3:101383321	T/C	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.81	6.96	0.62	9.48e-10	Colorectal cancer;
SKCM	cis	rs2842992	0.789	rs9355748	chr6:160194882	G/A	cg16489826	chr6:160211363	TCP1;MRPL18	0.73	5.42	0.52	6.39e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs9368481	0.761	rs7775041	chr6:27009512	T/A	cg12292205	chr6:26970375	C6orf41	-0.71	-6.33	-0.58	1.45e-8	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs2204008	0.529	rs1315350	chr12:38164282	C/A	cg26384229	chr12:38710491	ALG10B	-0.67	-5.47	-0.53	5.23e-7	Bladder cancer;
SKCM	cis	rs7666738	0.830	rs62318471	chr4:98925848	G/A	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs58688157	0.705	rs12272434	chr11:615011	A/T	cg03576123	chr11:487126	PTDSS2	-0.84	-5.45	-0.53	5.64e-7	Systemic lupus erythematosus;
SKCM	cis	rs3768617	0.510	rs1547712	chr1:183088013	T/A	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs8017423	0.935	rs8012303	chr14:90715829	G/A	cg04374321	chr14:90722782	PSMC1	0.97	8.91	0.71	1.61e-13	Mortality in heart failure;
SKCM	cis	rs6952808	0.792	rs12531315	chr7:1953650	C/G	cg05863683	chr7:1912471	MAD1L1	0.56	4.96	0.49	4.03e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs6461049	0.638	rs3778994	chr7:2175855	G/T	cg14004847	chr7:1930337	MAD1L1	-0.63	-4.97	-0.49	3.88e-6	Schizophrenia;
SKCM	cis	rs9325144	0.560	rs1843911	chr12:38676585	C/T	cg26384229	chr12:38710491	ALG10B	-0.62	-4.79	-0.48	7.74e-6	Morning vs. evening chronotype;
SKCM	cis	rs7811142	0.830	rs73401443	chr7:99977582	T/G	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.05	5.92	0.56	8.02e-8	Platelet count;
SKCM	cis	rs1799949	1.000	rs33994002	chr17:41328818	T/A	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.25	-0.58	2.03e-8	Menopause (age at onset);
SKCM	cis	rs4481887	0.741	rs1361413	chr1:248529521	C/G	cg00666640	chr1:248458726	OR2T12	-0.52	-5.95	-0.56	7.31e-8	Common traits (Other);
SKCM	cis	rs1577917	0.771	rs9450290	chr6:86233397	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.98	10.89	0.78	2.49e-17	Response to antipsychotic treatment;
SKCM	cis	rs2836974	0.583	rs2776306	chr21:40713754	A/G	cg17971929	chr21:40555470	PSMG1	0.71	5.84	0.55	1.15e-7	Cognitive function;
SKCM	cis	rs1801251	0.963	rs13424351	chr2:233573629	A/G	cg08000102	chr2:233561755	GIGYF2	0.9	7.27	0.64	2.45e-10	Coronary artery disease;
SKCM	cis	rs11098499	0.863	rs58452170	chr4:120459674	A/T	cg24375607	chr4:120327624	NA	0.69	5.45	0.53	5.61e-7	Corneal astigmatism;
SKCM	cis	rs8014204	0.762	rs7144654	chr14:75298637	A/G	cg06637938	chr14:75390232	RPS6KL1	0.71	5.55	0.53	3.82e-7	Caffeine consumption;
SKCM	cis	rs4925325	0.956	rs1776263	chr20:60515820	A/G	cg16423285	chr20:60520624	NA	-0.79	-5.17	-0.51	1.77e-6	Obesity-related traits;
SKCM	cis	rs514406	0.565	rs897732	chr1:53382816	A/C	cg04310824	chr1:53393297	SCP2	-0.6	-4.88	-0.48	5.44e-6	Monocyte count;
SKCM	cis	rs6933660	0.683	rs6916340	chr6:151779064	T/C	cg10883421	chr6:151773342	RMND1;C6orf211	0.84	7.31	0.64	2.02e-10	Menarche (age at onset);
SKCM	cis	rs910316	1.000	rs7147118	chr14:75610170	G/C	cg08847533	chr14:75593920	NEK9	0.95	9.18	0.72	4.88e-14	Height;
SKCM	cis	rs6866344	0.570	rs4266420	chr5:178137161	C/G	cg10224037	chr5:178157518	ZNF354A	0.86	6.4	0.59	1.08e-8	Neutrophil percentage of white cells;
SKCM	cis	rs6062496	0.565	rs3761125	chr20:62286870	C/T	cg27236539	chr20:62289627	RTEL1	0.72	4.95	0.49	4.14e-6	Crohn's disease;Inflammatory bowel disease;Ulcerative colitis;
SKCM	cis	rs7176527	0.796	rs72630464	chr15:85298126	G/A	cg02454053	chr15:85327774	ZNF592	0.85	5.01	0.49	3.26e-6	Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction);Waist circumference adjusted for BMI in active individuals;Waist circumference adjusted for body mass index;
SKCM	cis	rs12142240	0.698	rs1057533	chr1:46815836	C/T	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs9322193	0.923	rs2880436	chr6:150180259	T/C	cg05036130	chr6:150231994	NA	0.51	5.24	0.51	1.34e-6	Lung cancer;
SKCM	cis	rs752010	0.841	rs58737163	chr1:42079821	G/T	cg06885757	chr1:42089581	HIVEP3	0.52	5.4	0.52	7.09e-7	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs8018967	1.000	rs8018967	chr14:73976934	A/G	cg08936952	chr14:74026160	HEATR4	0.57	5.3	0.51	1.06e-6	Blood metabolite ratios;
SKCM	cis	rs11098499	0.909	rs1546502	chr4:120235898	A/G	cg09307838	chr4:120376055	NA	0.94	7.43	0.64	1.16e-10	Corneal astigmatism;
SKCM	cis	rs6570726	0.791	rs4332001	chr6:145934841	T/C	cg23711669	chr6:146136114	FBXO30	0.75	7.01	0.62	7.64e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs55962025	0.711	rs4690010	chr4:3159719	G/T	cg00764545	chr4:3318001	RGS12	-0.58	-5.11	-0.5	2.2e-6	Parental longevity (mother's age at death);
SKCM	cis	rs9790314	0.586	rs67077657	chr3:161138521	A/G	cg03342759	chr3:160939853	NMD3	-0.74	-6.65	-0.6	3.56e-9	Morning vs. evening chronotype;
SKCM	cis	rs6558174	0.965	rs6558172	chr8:22492052	C/T	cg03733263	chr8:22462867	KIAA1967	0.75	5.2	0.51	1.54e-6	Breast cancer;
SKCM	cis	rs1577917	0.570	rs114854865	chr6:86554236	A/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.32	-0.52	9.66e-7	Response to antipsychotic treatment;
SKCM	trans	rs1814175	0.817	rs10839351	chr11:49758153	C/T	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs3784262	0.904	rs3784263	chr15:58253062	C/T	cg12031962	chr15:58353849	ALDH1A2	-0.48	-6.21	-0.58	2.4e-8	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs10504229	0.679	rs7813252	chr8:58136389	C/G	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs644799	0.896	rs4430471	chr11:95646774	G/A	cg03916912	chr11:95522834	CEP57;FAM76B	0.87	6.62	0.6	4.09e-9	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs2839186	0.739	rs2280958	chr21:47642016	C/T	cg13126279	chr21:47581558	C21orf56	-0.67	-5.87	-0.55	9.92e-8	Testicular germ cell tumor;
SKCM	cis	rs2228479	0.850	rs62056061	chr16:89901767	G/A	cg06558623	chr16:89946397	TCF25	1.1	4.95	0.49	4.17e-6	Skin colour saturation;
SKCM	cis	rs11098499	0.954	rs9998585	chr4:120396802	T/A	cg09307838	chr4:120376055	NA	0.97	7.65	0.65	4.54e-11	Corneal astigmatism;
SKCM	cis	rs1784581	1.000	rs1784581	chr6:162401127	A/C	cg17173639	chr6:162384350	PARK2	-0.6	-5.16	-0.5	1.8e-6	Itch intensity from mosquito bite;
SKCM	cis	rs2841277	0.676	rs10438246	chr14:105410183	T/C	cg19901468	chr14:105411992	AHNAK2	-0.98	-7.74	-0.66	2.93e-11	Rheumatoid arthritis;
SKCM	cis	rs7333181	0.649	rs7339379	chr13:112237995	A/G	cg26646207	chr13:112610299	NA	-0.64	-4.82	-0.48	7.01e-6	Menopause (age at onset);
SKCM	cis	rs1401999	0.966	rs2313216	chr3:183637251	C/T	cg01324343	chr3:183735012	ABCC5	0.79	8.6	0.7	6.42e-13	Anterior chamber depth;
SKCM	cis	rs7216064	0.861	rs12449312	chr17:65829358	A/C	cg12091567	chr17:66097778	LOC651250	-0.76	-5.19	-0.51	1.63e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs870825	0.616	rs6419939	chr4:185642869	C/T	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs28386778	0.897	rs6504185	chr17:61848792	A/G	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs1799949	0.587	rs1824890	chr17:41421904	T/C	cg25918947	chr17:41365094	TMEM106A	-0.59	-4.95	-0.49	4.27e-6	Menopause (age at onset);
SKCM	cis	rs9913156	0.670	rs9894225	chr17:4546559	A/G	cg19197139	chr17:4613644	ARRB2	-0.79	-5.18	-0.51	1.67e-6	Lymphocyte counts;
SKCM	cis	rs7632954	0.551	rs4349489	chr3:8543295	G/C	cg06697448	chr3:8544912	LMCD1	-0.63	-5.48	-0.53	5e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs6951245	1.000	rs1997243	chr7:1083777	A/G	cg24642844	chr7:1081250	C7orf50	-0.94	-6.32	-0.58	1.48e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs10089	1.000	rs3805606	chr5:127470813	A/C	cg25462716	chr5:127418816	SLC12A2;FLJ33630	-0.89	-8.57	-0.7	7.28e-13	Ileal carcinoids;
SKCM	cis	rs703842	0.739	rs701008	chr12:58117645	A/G	cg04478727	chr12:58166393	METTL1;FAM119B	0.64	4.79	0.48	7.66e-6	Multiple sclerosis;
SKCM	cis	rs4974559	0.501	rs1250093	chr4:1240911	G/A	cg02980000	chr4:1222292	CTBP1	-1.22	-4.84	-0.48	6.5e-6	Systolic blood pressure;
SKCM	cis	rs7523050	0.730	rs34254854	chr1:109419875	C/T	cg08274380	chr1:109419600	GPSM2	1.17	6.61	0.6	4.34e-9	Fat distribution (HIV);
SKCM	cis	rs873946	0.586	rs57431984	chr10:134567697	C/T	cg27286337	chr10:134555280	INPP5A	0.99	8.98	0.71	1.2e-13	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs28386778	0.897	rs4968662	chr17:61834537	A/G	cg01411255	chr17:61851458	DDX42;CCDC47	0.78	5.03	0.49	3.06e-6	Prudent dietary pattern;
SKCM	cis	rs4561483	0.831	rs33648	chr16:11979622	G/A	cg08843971	chr16:11963173	GSPT1	-0.64	-4.81	-0.48	7.35e-6	Testicular germ cell tumor;
SKCM	cis	rs514406	0.793	rs4500255	chr1:53213279	A/G	cg24675658	chr1:53192096	ZYG11B	0.61	4.77	0.48	8.47e-6	Monocyte count;
SKCM	cis	rs6582630	0.519	rs10880629	chr12:38533611	T/G	cg26384229	chr12:38710491	ALG10B	0.81	6.58	0.6	4.89e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs2760061	0.626	rs635563	chr1:228136834	C/T	cg02753203	chr1:228287806	NA	-0.62	-5.01	-0.49	3.38e-6	Diastolic blood pressure;
SKCM	cis	rs344364	0.511	rs911391	chr16:1947016	C/A	cg26897989	chr16:1907736	C16orf73	-0.69	-7.13	-0.63	4.45e-10	Glomerular filtration rate in chronic kidney disease;
SKCM	cis	rs9300255	0.722	rs67624109	chr12:123824635	C/T	cg00376283	chr12:123451042	ABCB9	-0.78	-5.26	-0.51	1.24e-6	Neutrophil percentage of white cells;
SKCM	cis	rs2014572	0.967	rs4801452	chr19:57768066	A/G	cg24459738	chr19:57751996	ZNF805	-0.64	-5.17	-0.5	1.79e-6	Hyperactive-impulsive symptoms;
SKCM	cis	rs873946	0.586	rs12776770	chr10:134564831	T/C	cg26818010	chr10:134567672	INPP5A	-0.78	-5.98	-0.56	6.25e-8	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs11098499	0.738	rs28687057	chr4:120280812	A/G	cg24375607	chr4:120327624	NA	0.62	4.77	0.48	8.45e-6	Corneal astigmatism;
SKCM	cis	rs708547	0.599	rs2948348	chr4:57848772	G/A	cg16868167	chr4:57843880	C4orf14;POLR2B	0.9	8.48	0.69	1.12e-12	Response to bleomycin (chromatid breaks);
SKCM	cis	rs4836694	0.574	rs4837476	chr9:132937533	T/C	cg13414629	chr9:132935646	FREQ	0.81	4.9	0.49	5.12e-6	Alzheimer's disease (cognitive decline);
SKCM	cis	rs3793683	0.545	rs12784446	chr10:134589094	T/G	cg00988841	chr10:134556463	INPP5A	0.62	4.8	0.48	7.41e-6	Migraine;
SKCM	cis	rs13217239	0.646	rs10946897	chr6:26995251	A/C	cg12292205	chr6:26970375	C6orf41	0.63	5.64	0.54	2.58e-7	Schizophrenia;
SKCM	cis	rs8180040	0.966	rs6792488	chr3:47503349	C/T	cg27129171	chr3:47204927	SETD2	-0.79	-5.79	-0.55	1.43e-7	Colorectal cancer;
SKCM	cis	rs1707322	0.721	rs4559551	chr1:46167533	T/C	cg03146154	chr1:46216737	IPP	0.84	6.2	0.57	2.51e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs56104184	0.830	rs73061622	chr19:49358111	C/T	cg15549821	chr19:49342101	PLEKHA4	-1.22	-7.77	-0.66	2.58e-11	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	trans	rs61776290	0.764	rs488854	chr1:10672429	C/G	cg14144564	chr19:12405570	ZNF44	1.12	7.36	0.64	1.63e-10	Alcohol dependence (age at onset);
SKCM	cis	rs12478296	0.792	rs6740738	chr2:243007368	A/C	cg06360820	chr2:242988706	NA	-1.07	-5.66	-0.54	2.46e-7	Obesity-related traits;
SKCM	cis	rs4595586	0.546	rs11609849	chr12:39258090	C/G	cg26384229	chr12:38710491	ALG10B	0.68	5.1	0.5	2.3e-6	Morning vs. evening chronotype;
SKCM	cis	rs35306767	0.953	rs34405399	chr10:981015	G/A	cg20503657	chr10:835505	NA	0.62	4.81	0.48	7.29e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs2243480	0.803	rs34004500	chr7:65312178	A/T	cg07424592	chr7:64974309	NA	0.99	4.9	0.49	5.08e-6	Diabetic kidney disease;
SKCM	cis	rs503341	0.756	rs626333	chr11:63591861	C/T	cg04362095	chr11:63592001	C11orf84	-0.82	-9.65	-0.74	5.92e-15	Pulse pressure;
SKCM	cis	rs1005277	0.579	rs2505196	chr10:38393563	G/A	cg00409905	chr10:38381863	ZNF37A	-0.64	-5.96	-0.56	6.77e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs875971	0.660	rs62465434	chr7:66005152	A/C	cg11987759	chr7:65425863	GUSB	-0.69	-5.9	-0.56	8.74e-8	Aortic root size;
SKCM	cis	rs6089584	0.927	rs2281734	chr20:60582401	C/A	cg06108461	chr20:60628389	TAF4	-0.89	-8.07	-0.67	6.78e-12	Body mass index;
SKCM	cis	rs4836694	0.574	rs67899211	chr9:132935614	G/A	cg13414629	chr9:132935646	FREQ	0.81	5.13	0.5	2.1e-6	Alzheimer's disease (cognitive decline);
SKCM	cis	rs738322	0.511	rs5756947	chr22:38573230	G/A	cg25457927	chr22:38595422	NA	-0.58	-6.4	-0.59	1.05e-8	Cutaneous nevi;
SKCM	cis	rs1552244	0.808	rs17032306	chr3:10091399	C/G	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs78269692	0.826	rs879989	chr19:13266150	C/T	cg19436403	chr19:12780550	MORG1;C19orf56	1.38	5.11	0.5	2.25e-6	Breast cancer;
SKCM	cis	rs2832191	0.791	rs7283853	chr21:30498515	G/A	cg24692254	chr21:30365293	RNF160	-0.9	-7.99	-0.67	9.72e-12	Dental caries;
SKCM	cis	rs2204008	0.688	rs12824232	chr12:38175901	G/A	cg13010199	chr12:38710504	ALG10B	0.65	4.84	0.48	6.52e-6	Bladder cancer;
SKCM	cis	rs9910055	0.960	rs9911991	chr17:42278916	G/C	cg08499158	chr17:42289980	UBTF	-0.89	-7.85	-0.66	1.86e-11	Total body bone mineral density;
SKCM	cis	rs1568889	1.000	rs12802830	chr11:28321196	G/T	cg06544937	chr11:28130018	METT5D1;KIF18A	0.9	7.11	0.63	4.86e-10	Bipolar disorder;
SKCM	trans	rs17685	0.672	rs55807301	chr7:75807401	C/A	cg19862616	chr7:65841803	NCRNA00174	0.94	10.42	0.76	1.95e-16	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs4819052	0.788	rs35323494	chr21:46703739	G/A	cg02159808	chr21:46707872	POFUT2;LOC642852	0.74	5.36	0.52	8.35e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs9911578	0.967	rs4076229	chr17:56937256	C/T	cg05425664	chr17:57184151	TRIM37	-0.67	-5.04	-0.5	2.91e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs4891159	0.536	rs690392	chr18:74152618	G/A	cg24786174	chr18:74118243	ZNF516	0.78	8.02	0.67	8.74e-12	Longevity;
SKCM	cis	rs4819052	0.851	rs4819046	chr21:46664955	C/T	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.42	0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs35306767	0.903	rs12249828	chr10:894838	C/T	cg20503657	chr10:835505	NA	0.8	5.42	0.52	6.33e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs1160297	0.609	rs10164801	chr2:53096014	C/T	cg07782112	chr2:53107842	NA	0.59	6.3	0.58	1.63e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs801193	1.000	rs2659889	chr7:66217112	A/G	cg11764359	chr7:65958608	NA	0.82	6.24	0.58	2.14e-8	Aortic root size;
SKCM	cis	rs1003719	0.788	rs8133549	chr21:38447489	C/T	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs600231	0.665	rs1626021	chr11:65226187	A/G	cg24009118	chr11:65545808	DKFZp761E198	0.69	5.1	0.5	2.35e-6	Bone mineral density;
SKCM	cis	rs651907	0.557	rs11917682	chr3:101355427	G/A	cg12386194	chr3:101231763	SENP7	0.75	6.3	0.58	1.64e-8	Colorectal cancer;
SKCM	cis	rs62238980	0.614	rs4821022	chr22:32414335	A/G	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs2841277	0.770	rs10149193	chr14:105403474	C/T	cg21017887	chr14:105400489	NA	0.59	5.31	0.52	1e-6	Rheumatoid arthritis;
SKCM	cis	rs5769765	0.908	rs138880	chr22:50218611	A/C	cg22709217	chr22:50311962	ALG12;CRELD2	-0.88	-6.04	-0.56	5.03e-8	Schizophrenia;
SKCM	cis	rs7647973	0.559	rs9586	chr3:49213637	C/T	cg06212747	chr3:49208901	KLHDC8B	0.98	5.24	0.51	1.32e-6	Menarche (age at onset);
SKCM	cis	rs7666738	0.830	rs116103936	chr4:98954531	T/C	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4423214	0.879	rs1790353	chr11:71136730	C/T	cg05163923	chr11:71159392	DHCR7	-0.67	-6.0	-0.56	5.84e-8	Vitamin D levels;
SKCM	cis	rs873946	0.517	rs7071784	chr10:134559980	T/C	cg27286337	chr10:134555280	INPP5A	0.97	9.54	0.73	9.87e-15	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs2153535	0.580	rs1932285	chr6:8477719	T/G	cg23788917	chr6:8435910	SLC35B3	0.67	4.78	0.48	8.23e-6	Motion sickness;
SKCM	cis	rs2070488	0.965	rs7372849	chr3:38524328	G/C	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.98	9.25	0.72	3.55e-14	Electrocardiographic conduction measures;
SKCM	cis	rs11098499	0.863	rs3822194	chr4:120471648	A/G	cg09307838	chr4:120376055	NA	1.0	8.27	0.68	2.8e-12	Corneal astigmatism;
SKCM	cis	rs9290877	0.580	rs1568670	chr3:188467161	T/C	cg17392043	chr3:188495102	LPP	-0.66	-5.23	-0.51	1.37e-6	IgE levels;
SKCM	cis	rs57221529	0.766	rs28563961	chr5:554498	C/G	cg26208419	chr5:473447	SLC9A3;LOC25845	1.04	5.3	0.51	1.06e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs593982	0.920	rs72922791	chr11:65567395	G/A	cg08755490	chr11:65554678	OVOL1	-0.92	-6.89	-0.61	1.29e-9	Atopic dermatitis;
SKCM	cis	rs651907	0.535	rs61396602	chr3:101509046	T/C	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.78	6.72	0.61	2.65e-9	Colorectal cancer;
SKCM	cis	rs34172651	0.583	rs200541	chr16:24733141	A/G	cg04756594	chr16:24857601	SLC5A11	-0.72	-5.09	-0.5	2.4e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs10197940	0.710	rs4500942	chr2:152334580	A/G	cg19508488	chr2:152266495	RIF1	0.58	4.89	0.48	5.38e-6	Lung cancer;
SKCM	cis	rs4665809	0.887	rs2384324	chr2:26354239	A/G	cg26119090	chr2:26468346	HADHA;HADHB	-0.78	-5.14	-0.5	2e-6	Gut microbiome composition (summer);
SKCM	cis	rs4268898	0.636	rs76172309	chr2:24458911	G/C	cg06627628	chr2:24431161	ITSN2	-0.94	-7.34	-0.64	1.73e-10	Asthma;
SKCM	cis	rs1850744	0.702	rs7666466	chr4:9629503	G/T	cg15442990	chr4:9534313	NA	1.4	5.3	0.51	1.04e-6	Economic and political preferences;
SKCM	trans	rs1814175	0.817	rs1988416	chr11:49932324	G/A	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs2658782	0.951	rs2608215	chr11:93148817	G/A	cg15737290	chr11:93063684	CCDC67	0.75	5.4	0.52	6.93e-7	Pulmonary function decline;
SKCM	cis	rs995000	0.931	rs1168044	chr1:62977558	A/C	cg06896770	chr1:63153194	DOCK7	-0.74	-6.81	-0.61	1.77e-9	Triglyceride levels;
SKCM	cis	rs798554	0.836	rs798490	chr7:2801542	C/T	cg04166393	chr7:2884313	GNA12	0.75	5.15	0.5	1.93e-6	Height;
SKCM	cis	rs8028182	0.636	rs7166737	chr15:75682513	A/G	cg20655648	chr15:75932815	IMP3	0.7	4.84	0.48	6.52e-6	Sudden cardiac arrest;
SKCM	cis	rs801193	1.000	rs17566701	chr7:66193183	T/C	cg11987759	chr7:65425863	GUSB	-0.69	-5.95	-0.56	7.27e-8	Aortic root size;
SKCM	cis	rs12497850	0.931	rs7431710	chr3:48935583	G/A	cg06212747	chr3:49208901	KLHDC8B	0.68	4.9	0.49	5.06e-6	Parkinson's disease;
SKCM	cis	rs7777754	0.512	rs7785224	chr7:50562361	T/C	cg18232548	chr7:50535776	DDC	-0.87	-6.69	-0.6	3.04e-9	Response to zileuton treatment in asthma (FEV1 change interaction);
SKCM	trans	rs1814175	0.676	rs1721999	chr11:49917372	A/G	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs9611565	0.572	rs139569	chr22:42211141	A/G	cg03806693	chr22:41940476	POLR3H	-0.77	-4.96	-0.49	3.98e-6	Vitiligo;
SKCM	cis	rs6952808	0.594	rs3778969	chr7:2139990	A/G	cg02951883	chr7:2050386	MAD1L1	0.79	7.49	0.65	9.01e-11	Bipolar disorder and schizophrenia;
SKCM	cis	rs7937682	0.921	rs4534611	chr11:111440425	C/G	cg22437258	chr11:111473054	SIK2	0.67	5.25	0.51	1.28e-6	Primary sclerosing cholangitis;
SKCM	cis	rs933688	1.000	rs1964292	chr5:90743608	T/C	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.07	8.52	0.69	9.25e-13	Smoking behavior;
SKCM	cis	rs2120019	0.567	rs72625793	chr15:75207083	A/G	cg17294928	chr15:75287854	SCAMP5	-0.85	-5.9	-0.56	8.72e-8	Blood trace element (Zn levels);
SKCM	cis	rs6840360	0.532	rs4235221	chr4:152511193	C/T	cg22705602	chr4:152727874	NA	-0.52	-5.7	-0.54	2.03e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs2354432	0.556	rs7520661	chr1:146793149	A/G	cg25205988	chr1:146714368	CHD1L	-1.16	-6.74	-0.61	2.44e-9	Mitochondrial DNA levels;
SKCM	cis	rs7618915	0.501	rs13060048	chr3:52598608	G/A	cg18404041	chr3:52824283	ITIH1	-0.53	-4.77	-0.48	8.42e-6	Bipolar disorder;
SKCM	cis	rs10088262	0.629	rs1367829	chr8:124797135	A/G	cg20713898	chr8:124780851	FAM91A1	-0.7	-5.08	-0.5	2.55e-6	Pancreatic cancer;
SKCM	cis	rs362296	0.698	rs3095073	chr4:3263138	C/T	cg24015175	chr4:3319247	RGS12	-0.6	-5.95	-0.56	7.1e-8	Parental longevity (mother's age at death);
SKCM	cis	rs9581857	0.579	rs7332104	chr13:27957831	C/G	cg22138327	chr13:27999177	GTF3A	-0.94	-5.78	-0.55	1.46e-7	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs1005277	0.557	rs176887	chr10:38406094	T/C	cg25427524	chr10:38739819	LOC399744	-0.71	-6.74	-0.61	2.44e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs3818285	0.504	rs1973972	chr10:111651133	A/T	cg00817464	chr10:111662876	XPNPEP1	0.58	5.11	0.5	2.26e-6	Superior crus of antihelix expression;
SKCM	cis	rs3091242	0.902	rs36003018	chr1:25784318	A/G	cg02931644	chr1:25747376	RHCE	-0.5	-4.9	-0.48	5.17e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs951366	0.617	rs823080	chr1:205789282	G/A	cg07167872	chr1:205819463	PM20D1	1.03	11.69	0.8	7.93e-19	Menarche (age at onset);
SKCM	cis	rs67311347	0.544	rs7644643	chr3:40350209	C/T	cg13409248	chr3:40428643	ENTPD3	-0.58	-5.79	-0.55	1.39e-7	Renal cell carcinoma;
SKCM	cis	rs929354	0.713	rs1034785	chr7:157002383	T/C	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	trans	rs11722228	0.549	rs73212863	chr4:10104173	C/T	cg26043149	chr18:55253948	FECH	0.92	7.78	0.66	2.48e-11	Gout;Urate levels;Serum uric acid levels;
SKCM	cis	rs5750830	0.649	rs5750822	chr22:39826788	C/T	cg11247378	chr22:39784982	NA	-0.47	-5.64	-0.54	2.62e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs8017423	0.845	rs114583024	chr14:90727628	T/C	cg04374321	chr14:90722782	PSMC1	1.06	9.26	0.72	3.32e-14	Mortality in heart failure;
SKCM	trans	rs1814175	0.791	rs11040513	chr11:49778153	G/C	cg15704280	chr7:45808275	SEPT13	-1.03	-10.73	-0.77	5.17e-17	Height;
SKCM	cis	rs2439831	0.681	rs825740	chr15:43592408	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.19	8.52	0.69	9.21e-13	Lung cancer in ever smokers;
SKCM	cis	rs798766	1.000	rs2166580	chr4:1743169	G/A	cg24239225	chr4:1659016	FAM53A	-0.72	-4.9	-0.49	5e-6	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs6952407	1	rs6952407	chr7:66045512	A/G	cg05627663	chr7:65219948	SNORA22;CCT6P1	-0.56	-4.84	-0.48	6.39e-6	Cotinine glucuronidation;
SKCM	cis	rs2739330	0.760	rs1002286	chr22:24257337	A/G	cg25703541	chr22:24373054	LOC391322	0.82	6.96	0.62	9.46e-10	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs34311866	0.808	rs11248060	chr4:964359	C/T	cg07828340	chr4:882639	GAK	0.89	5.03	0.49	3.06e-6	Parkinson's disease;
SKCM	cis	rs7666738	0.830	rs6833312	chr4:98951356	A/T	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs801193	0.660	rs1016265	chr7:66214567	C/T	cg05627663	chr7:65219948	SNORA22;CCT6P1	0.52	5.03	0.5	3.01e-6	Aortic root size;
SKCM	cis	rs7635838	0.654	rs4684766	chr3:11285474	G/A	cg00170343	chr3:11313890	ATG7	0.8	5.69	0.54	2.11e-7	HDL cholesterol;
SKCM	cis	rs12714314	0.756	rs10439522	chr2:1945360	C/G	cg22350835	chr2:1868857	MYT1L	0.66	5.2	0.51	1.54e-6	Type 2 diabetes (age of onset);
SKCM	cis	rs4073582	0.595	rs555360	chr11:65960061	T/C	cg16950941	chr11:66035639	RAB1B	-0.81	-6.88	-0.61	1.35e-9	Gout;
SKCM	cis	rs208515	0.525	rs10944863	chr6:66676238	C/T	cg07460842	chr6:66804631	NA	0.93	6.34	0.58	1.35e-8	Exhaled nitric oxide levels;
SKCM	cis	rs6840360	0.571	rs4696100	chr4:152514242	C/T	cg22705602	chr4:152727874	NA	-0.52	-5.7	-0.54	2.03e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs2952156	0.883	rs1495100	chr17:37832279	C/T	cg20243544	chr17:37824526	PNMT	0.75	6.2	0.57	2.45e-8	Asthma;
SKCM	cis	rs10504073	0.669	rs818560	chr8:50035417	C/T	cg00325661	chr8:49890786	NA	0.8	6.91	0.62	1.16e-9	Blood metabolite ratios;
SKCM	cis	rs55962025	0.711	rs82333	chr4:3225389	C/T	cg00764545	chr4:3318001	RGS12	0.63	5.4	0.52	6.88e-7	Parental longevity (mother's age at death);
SKCM	cis	rs6952808	0.717	rs12534679	chr7:1926745	G/A	cg04267008	chr7:1944627	MAD1L1	-0.69	-5.6	-0.54	3.06e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs2832191	0.791	rs8134407	chr21:30476586	G/A	cg08807101	chr21:30365312	RNF160	0.62	4.93	0.49	4.47e-6	Dental caries;
SKCM	cis	rs9916302	0.851	rs677888	chr17:37461018	T/G	cg07936489	chr17:37558343	FBXL20	0.75	5.22	0.51	1.42e-6	Glomerular filtration rate (creatinine);
SKCM	cis	rs17685	0.725	rs7807647	chr7:75628669	G/A	cg01364799	chr7:75623366	TMEM120A	0.73	5.61	0.54	2.94e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7666738	0.830	rs35433756	chr4:99070555	C/T	cg17366294	chr4:99064904	C4orf37	0.61	4.93	0.49	4.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs951366	0.870	rs3747973	chr1:205677148	A/G	cg11965913	chr1:205819406	PM20D1	0.72	5.2	0.51	1.55e-6	Menarche (age at onset);
SKCM	cis	rs2228479	0.850	rs62056063	chr16:89903680	C/T	cg06558623	chr16:89946397	TCF25	1.1	4.97	0.49	3.93e-6	Skin colour saturation;
SKCM	cis	rs4523957	0.583	rs9889861	chr17:2041369	A/G	cg16513277	chr17:2031491	SMG6	-0.91	-6.21	-0.58	2.38e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs7666738	0.830	rs4699595	chr4:99012827	A/G	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7659604	0.539	rs1507995	chr4:122748308	G/A	cg20573242	chr4:122745356	CCNA2	0.75	6.39	0.59	1.11e-8	Type 2 diabetes;
SKCM	cis	rs951366	0.789	rs823121	chr1:205724302	A/G	cg14159672	chr1:205819179	PM20D1	-0.95	-7.92	-0.67	1.32e-11	Menarche (age at onset);
SKCM	cis	rs2559856	0.935	rs2695287	chr12:102088361	T/C	cg12924262	chr12:102091054	CHPT1	0.7	5.95	0.56	7.09e-8	Blood protein levels;
SKCM	trans	rs208520	0.526	rs9294682	chr6:66795159	G/A	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-1.12	-11.47	-0.79	2.01e-18	Exhaled nitric oxide output;
SKCM	cis	rs8060686	0.641	rs2418737	chr16:68122726	T/C	cg09117114	chr16:67998030	SLC12A4	-0.78	-5.11	-0.5	2.19e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs11139399	0.650	rs4434691	chr9:84348762	A/C	cg13729285	chr9:84764156	NA	-0.47	-4.86	-0.48	5.91e-6	Hippocampal atrophy;
SKCM	cis	rs7590720	1.000	rs6755934	chr2:216907198	C/A	cg12620499	chr2:216877984	MREG	0.9	7.66	0.66	4.32e-11	Alcohol dependence;
SKCM	cis	rs11585357	0.947	rs2977303	chr1:17611548	A/T	cg08277548	chr1:17600880	PADI3	-0.87	-6.18	-0.57	2.67e-8	Hair shape;
SKCM	cis	rs13256369	1.000	rs10110591	chr8:8576608	G/T	cg06636001	chr8:8085503	FLJ10661	-0.71	-5.38	-0.52	7.42e-7	Obesity-related traits;
SKCM	cis	rs7945705	0.905	rs2568054	chr11:8876029	A/G	cg21881798	chr11:8931708	C11orf17;ST5	-0.77	-7.96	-0.67	1.14e-11	Hemoglobin concentration;
SKCM	cis	rs6062302	0.522	rs11696202	chr20:62246292	G/C	cg09650180	chr20:62225654	GMEB2	-0.78	-6.22	-0.58	2.28e-8	Glioblastoma;
SKCM	cis	rs514406	0.861	rs503296	chr1:53283088	A/G	cg16325326	chr1:53192061	ZYG11B	-0.99	-11.71	-0.8	7.39e-19	Monocyte count;
SKCM	cis	rs35407642	0.871	rs890259	chr11:36475317	A/G	cg16522885	chr11:36407169	PRR5L	-0.53	-5.0	-0.49	3.51e-6	Photic sneeze reflex;
SKCM	cis	rs798554	0.797	rs1182184	chr7:2872446	G/A	cg04166393	chr7:2884313	GNA12	0.68	4.85	0.48	6.16e-6	Height;
SKCM	cis	rs3087591	1.000	rs8082020	chr17:29694795	G/A	cg24425628	chr17:29625626	OMG;NF1	-0.62	-4.91	-0.49	4.98e-6	Hip circumference;
SKCM	cis	rs8017423	1.000	rs8011810	chr14:90685669	A/G	cg04374321	chr14:90722782	PSMC1	0.95	8.38	0.69	1.69e-12	Mortality in heart failure;
SKCM	cis	rs9611565	0.512	rs5751145	chr22:42133552	C/T	cg03806693	chr22:41940476	POLR3H	1.15	7.18	0.63	3.65e-10	Vitiligo;
SKCM	cis	rs11098499	0.955	rs35916640	chr4:120155852	T/C	cg09307838	chr4:120376055	NA	0.91	7.22	0.63	2.98e-10	Corneal astigmatism;
SKCM	cis	rs6753739	0.826	rs897477	chr2:219941063	G/A	cg09617556	chr2:219924408	IHH	0.47	4.91	0.49	4.97e-6	Height;
SKCM	cis	rs561341	0.882	rs2521594	chr17:30302087	C/T	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs7618915	0.547	rs2286800	chr3:52778051	C/T	cg18404041	chr3:52824283	ITIH1	-0.56	-4.94	-0.49	4.33e-6	Bipolar disorder;
SKCM	cis	rs6866344	0.570	rs1132338	chr5:178139442	T/G	cg03877680	chr5:178157825	ZNF354A	0.91	7.37	0.64	1.54e-10	Neutrophil percentage of white cells;
SKCM	cis	rs7247513	1.000	rs8104385	chr19:12700284	G/A	cg01871581	chr19:12707946	ZNF490	-0.69	-4.81	-0.48	7.29e-6	Bipolar disorder;
SKCM	cis	rs2019137	0.539	rs4849181	chr2:113991970	A/G	cg11763394	chr2:113992921	PAX8;LOC440839;LOC654433	0.67	5.37	0.52	8.03e-7	Lymphocyte counts;
SKCM	cis	rs2721195	0.967	rs11777703	chr8:145703508	G/A	cg17328964	chr8:145687451	CYHR1	0.62	5.21	0.51	1.5e-6	Age at first birth;
SKCM	cis	rs995000	0.868	rs1168029	chr1:62969402	G/A	cg06896770	chr1:63153194	DOCK7	-0.62	-5.59	-0.54	3.15e-7	Triglyceride levels;
SKCM	cis	rs875971	0.838	rs2173570	chr7:65762963	T/A	cg11764359	chr7:65958608	NA	-0.88	-8.54	-0.7	8.32e-13	Aortic root size;
SKCM	cis	rs7786877	0.521	rs4729607	chr7:100326744	T/A	cg20848291	chr7:100343083	ZAN	-0.65	-4.99	-0.49	3.66e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs1799949	0.894	rs8176160	chr17:41241503	T/C	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.01	-0.56	5.5e-8	Menopause (age at onset);
SKCM	cis	rs2839186	0.732	rs55904887	chr21:47707811	A/G	cg13126279	chr21:47581558	C21orf56	-0.64	-5.47	-0.53	5.17e-7	Testicular germ cell tumor;
SKCM	cis	rs4819052	0.851	rs2838837	chr21:46665988	C/T	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.42	0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs4555082	0.834	rs11622165	chr14:105759761	C/A	cg13114125	chr14:105738426	BRF1	-0.75	-5.78	-0.55	1.48e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs28386778	0.897	rs2854221	chr17:61941445	G/T	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.13	11.24	0.79	5.64e-18	Prudent dietary pattern;
SKCM	cis	rs8177179	0.967	rs4287912	chr3:133437778	A/G	cg16262614	chr3:133464971	TF	0.42	5.28	0.51	1.15e-6	Iron status biomarkers (transferrin levels);
SKCM	cis	rs12047808	0.841	rs59949433	chr1:179357486	G/A	cg09822482	chr1:179519214	C1orf125	-0.95	-5.17	-0.51	1.78e-6	Multiple sclerosis (age of onset);
SKCM	cis	rs3741404	0.584	rs645461	chr11:63893694	C/T	cg05555928	chr11:63887634	MACROD1	0.75	4.8	0.48	7.64e-6	Platelet count;
SKCM	cis	rs6933660	0.760	rs1825368	chr6:151775259	C/A	cg02564969	chr6:151773285	C6orf211;RMND1	0.61	4.88	0.48	5.49e-6	Menarche (age at onset);
SKCM	cis	rs9420	0.796	rs685149	chr11:57657413	A/G	cg19752551	chr11:57585705	CTNND1	0.7	6.71	0.61	2.76e-9	Schizophrenia;
SKCM	cis	rs9325144	0.505	rs1906262	chr12:38653605	A/G	cg26384229	chr12:38710491	ALG10B	0.83	7.32	0.64	1.97e-10	Morning vs. evening chronotype;
SKCM	cis	rs939658	0.683	rs8038464	chr15:79463036	A/T	cg10259521	chr15:79428573	NA	0.49	5.07	0.5	2.6e-6	Refractive error;
SKCM	cis	rs1395	0.778	rs1978881	chr2:27400850	C/A	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.51	5.15	0.5	1.94e-6	Blood metabolite levels;
SKCM	cis	rs6951245	1.000	rs1997243	chr7:1083777	A/G	cg03188948	chr7:1209495	NA	1.12	6.25	0.58	2.02e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs12497850	0.931	rs9311430	chr3:48845251	C/T	cg06212747	chr3:49208901	KLHDC8B	0.66	4.81	0.48	7.08e-6	Parkinson's disease;
SKCM	cis	rs2197308	0.765	rs11182992	chr12:37935572	G/C	cg26384229	chr12:38710491	ALG10B	0.81	6.59	0.6	4.69e-9	Morning vs. evening chronotype;
SKCM	cis	rs79057730	0.528	rs4719313	chr7:822501	C/T	cg06242242	chr7:766104	PRKAR1B;HEATR2	1.08	5.0	0.49	3.38e-6	Initial pursuit acceleration;
SKCM	cis	rs1799949	0.965	rs8176140	chr17:41251646	T/A	cg23758822	chr17:41437982	NA	0.94	7.65	0.65	4.42e-11	Menopause (age at onset);
SKCM	cis	rs9911578	1.000	rs9897326	chr17:56902297	A/G	cg12560992	chr17:57184187	TRIM37	0.94	7.55	0.65	7.01e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs5770917	0.522	rs3752393	chr22:51015557	C/T	cg25309564	chr22:51001381	C22orf41	1.12	5.59	0.53	3.2e-7	Narcolepsy;
SKCM	cis	rs4423214	1.000	rs909217	chr11:71146577	G/A	cg05163923	chr11:71159392	DHCR7	0.79	7.14	0.63	4.26e-10	Vitamin D levels;
SKCM	cis	rs9910055	0.530	rs2269908	chr17:42294198	G/C	cg09913183	chr17:42254507	C17orf65;ASB16	0.6	5.25	0.51	1.3e-6	Total body bone mineral density;
SKCM	cis	rs9430161	0.645	rs6675082	chr1:11033797	T/C	cg27631724	chr1:11040367	C1orf127	0.5	4.88	0.48	5.45e-6	Ewing sarcoma;
SKCM	cis	rs7584330	0.740	rs10184904	chr2:238428186	G/C	cg14458575	chr2:238380390	NA	0.78	5.29	0.51	1.07e-6	Prostate cancer;
SKCM	cis	rs7666738	0.830	rs7662948	chr4:99020132	G/C	cg05340658	chr4:99064831	C4orf37	0.63	4.79	0.48	7.91e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs8072100	0.782	rs28507314	chr17:45551402	C/T	cg25173405	chr17:45401733	C17orf57	-0.58	-4.77	-0.48	8.26e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs10927875	0.864	rs12135073	chr1:16167799	C/T	cg21385522	chr1:16154831	NA	0.99	8.35	0.69	2.01e-12	Dilated cardiomyopathy;
SKCM	cis	rs898097	0.841	rs8180	chr17:80901036	C/G	cg15369054	chr17:80825471	TBCD	-0.64	-6.01	-0.56	5.49e-8	Breast cancer;
SKCM	cis	rs8067545	0.611	rs9907516	chr17:20070490	G/A	cg13482628	chr17:19912719	NA	0.66	5.5	0.53	4.72e-7	Schizophrenia;
SKCM	cis	rs362272	0.545	rs2749783	chr4:3326098	A/C	cg09735869	chr4:3319127	RGS12	0.98	10.91	0.78	2.29e-17	Serum sulfate level;
SKCM	cis	rs10504229	0.906	rs113857287	chr8:58191683	T/C	cg02725872	chr8:58115012	NA	-0.5	-4.87	-0.48	5.68e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs9987353	0.566	rs34389718	chr8:9065525	A/G	cg15556689	chr8:8085844	FLJ10661	-0.66	-4.92	-0.49	4.73e-6	Recombination measurement;
SKCM	cis	rs860295	0.676	rs11264374	chr1:155421512	A/C	cg02153340	chr1:155202674	NA	-0.75	-5.35	-0.52	8.38e-7	Body mass index;
SKCM	cis	rs6951245	1.000	rs28528096	chr7:1070912	G/C	cg21664854	chr7:1097933	C7orf50;GPR146	0.89	4.79	0.48	7.66e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs55962025	0.883	rs59613878	chr4:3139152	C/T	cg24015175	chr4:3319247	RGS12	-0.69	-5.81	-0.55	1.3e-7	Parental longevity (mother's age at death);
SKCM	cis	rs7772486	0.654	rs6928007	chr6:146074941	G/A	cg05347473	chr6:146136440	FBXO30	-0.54	-4.96	-0.49	3.97e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs8077889	0.917	rs72836545	chr17:41892602	A/G	cg26893861	chr17:41843967	DUSP3	1.15	7.34	0.64	1.79e-10	Triglycerides;
SKCM	cis	rs2228479	0.867	rs17784386	chr16:89947457	A/G	cg00800038	chr16:89945340	TCF25	-0.93	-5.34	-0.52	8.73e-7	Skin colour saturation;
SKCM	cis	rs1577917	0.610	rs11752795	chr6:86287129	C/A	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.62	5.18	0.51	1.67e-6	Response to antipsychotic treatment;
SKCM	cis	rs875971	0.660	rs6460308	chr7:66084740	T/C	cg11987759	chr7:65425863	GUSB	0.67	5.8	0.55	1.36e-7	Aortic root size;
SKCM	cis	rs4481887	0.676	rs1538704	chr1:248523554	C/T	cg22724847	chr1:248512586	OR14C36	0.58	4.93	0.49	4.58e-6	Common traits (Other);
SKCM	cis	rs7208859	0.623	rs8080882	chr17:29081146	G/A	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs9880211	0.613	rs34864445	chr3:135822924	C/T	cg21827317	chr3:136751795	NA	-0.68	-5.08	-0.5	2.56e-6	Body mass index;Height;
SKCM	cis	rs6558174	0.965	rs7831119	chr8:22489678	C/T	cg03733263	chr8:22462867	KIAA1967	-0.67	-4.85	-0.48	6.21e-6	Breast cancer;
SKCM	cis	rs7945705	0.935	rs11042103	chr11:8888700	C/T	cg21881798	chr11:8931708	C11orf17;ST5	0.77	7.67	0.66	4.14e-11	Hemoglobin concentration;
SKCM	cis	rs56235845	0.694	rs11749830	chr5:176766547	G/A	cg17509989	chr5:176798049	RGS14	0.72	5.9	0.56	8.83e-8	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs1577917	0.958	rs12198876	chr6:86525476	C/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.87	-8.71	-0.7	3.92e-13	Response to antipsychotic treatment;
SKCM	cis	rs11112613	0.762	rs17037308	chr12:105949847	T/G	cg03607813	chr12:105948248	NA	0.83	5.77	0.55	1.55e-7	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;
SKCM	cis	rs778371	0.958	rs778341	chr2:233728801	C/A	cg08000102	chr2:233561755	GIGYF2	-0.79	-5.19	-0.51	1.61e-6	Schizophrenia;
SKCM	cis	rs910316	0.934	rs4903278	chr14:75535019	C/A	cg08847533	chr14:75593920	NEK9	0.96	8.88	0.71	1.87e-13	Height;
SKCM	trans	rs7618501	1.000	rs2234391	chr3:49842625	A/G	cg21659725	chr3:3221576	CRBN	0.96	9.44	0.73	1.52e-14	Intelligence (multi-trait analysis);
SKCM	cis	rs9902453	0.967	rs55744550	chr17:28475729	G/A	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.5	0.53	4.74e-7	Coffee consumption (cups per day);
SKCM	trans	rs9929218	0.529	rs8059194	chr16:68749663	C/T	cg04657470	chr2:198365150	HSPE1;HSPD1	0.92	9.04	0.72	9.18e-14	Colorectal cancer;
SKCM	cis	rs7666738	0.830	rs957742	chr4:99029409	C/T	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9325144	0.600	rs6582634	chr12:38748041	G/A	cg26384229	chr12:38710491	ALG10B	0.78	6.81	0.61	1.79e-9	Morning vs. evening chronotype;
SKCM	cis	rs11249608	0.548	rs17078991	chr5:178459426	A/C	cg21905437	chr5:178450457	ZNF879	0.71	5.45	0.53	5.65e-7	Pubertal anthropometrics;
SKCM	cis	rs62103177	0.535	rs34299914	chr18:77949236	C/A	cg06309094	chr18:77676213	PQLC1	-0.78	-4.86	-0.48	5.94e-6	Opioid sensitivity;
SKCM	cis	rs10883723	0.773	rs11191303	chr10:104255158	T/C	cg11453585	chr10:104263688	ACTR1A;SUFU	0.75	5.7	0.54	2.03e-7	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs798554	0.757	rs1182178	chr7:2873763	G/A	cg19346786	chr7:2764209	NA	-0.63	-7.05	-0.62	6.32e-10	Height;
SKCM	cis	rs854765	0.547	rs4365348	chr17:17912548	C/T	cg04398451	chr17:18023971	MYO15A	-0.87	-6.78	-0.61	2.05e-9	Total body bone mineral density;
SKCM	cis	rs2832191	0.716	rs1888440	chr21:30454484	C/T	cg08807101	chr21:30365312	RNF160	0.74	6.09	0.57	4.06e-8	Dental caries;
SKCM	cis	rs344364	0.511	rs2982449	chr16:1947878	C/G	cg26897989	chr16:1907736	C16orf73	-0.69	-7.13	-0.63	4.45e-10	Glomerular filtration rate in chronic kidney disease;
SKCM	cis	rs59918340	0.728	rs6987335	chr8:142235358	T/G	cg23750338	chr8:142222470	SLC45A4	-0.66	-6.31	-0.58	1.58e-8	Immature fraction of reticulocytes;
SKCM	cis	rs2072499	0.966	rs1060604	chr1:156184268	T/C	cg25208724	chr1:156163844	SLC25A44	0.99	8.37	0.69	1.82e-12	Testicular germ cell tumor;
SKCM	cis	rs9467773	0.620	rs9461275	chr6:26590801	C/T	cg09904177	chr6:26538194	HMGN4	0.57	4.87	0.48	5.81e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs861020	1.000	rs7555285	chr1:209970355	C/G	cg05527609	chr1:210001259	C1orf107	-0.88	-6.01	-0.56	5.56e-8	Orofacial clefts;
SKCM	cis	rs116095464	0.558	rs6881920	chr5:222411	T/C	cg22857025	chr5:266934	NA	-1.36	-8.0	-0.67	9.23e-12	Breast cancer;
SKCM	cis	rs875971	0.862	rs6460293	chr7:65810192	C/A	cg18876405	chr7:65276391	NA	-0.64	-6.42	-0.59	9.88e-9	Aortic root size;
SKCM	cis	rs5769765	0.773	rs9616206	chr22:50310847	G/T	cg22709217	chr22:50311962	ALG12;CRELD2	-0.95	-5.96	-0.56	7.03e-8	Schizophrenia;
SKCM	cis	rs12497850	0.931	rs7430198	chr3:48988760	T/C	cg06212747	chr3:49208901	KLHDC8B	0.68	4.9	0.49	5.06e-6	Parkinson's disease;
SKCM	cis	rs7954584	0.567	rs11043243	chr12:122356370	G/C	cg13699009	chr12:122356056	WDR66	0.59	7.36	0.64	1.61e-10	Mean corpuscular volume;
SKCM	cis	rs71520386	0.607	rs28660425	chr7:22858151	C/T	cg00309339	chr7:22893653	NA	0.66	4.9	0.49	5.05e-6	Fibrinogen levels;
SKCM	cis	rs9916302	0.652	rs9903269	chr17:37742383	A/T	cg07936489	chr17:37558343	FBXL20	-0.85	-5.92	-0.56	8.06e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs2832191	0.671	rs2409332	chr21:30512779	G/A	cg24692254	chr21:30365293	RNF160	-0.76	-6.41	-0.59	1.03e-8	Dental caries;
SKCM	cis	rs7555523	0.887	rs2790053	chr1:165737704	C/G	cg24409356	chr1:165738333	TMCO1	0.93	5.15	0.5	1.93e-6	Intraocular pressure;Glaucoma (high intraocular pressure);
SKCM	cis	rs6951245	0.935	rs76525951	chr7:1096013	C/T	cg18402987	chr7:1209562	NA	1.15	6.09	0.57	3.95e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs2228479	1.000	rs62052186	chr16:89969567	A/T	cg06558623	chr16:89946397	TCF25	1.12	5.64	0.54	2.58e-7	Skin colour saturation;
SKCM	cis	rs2072510	0.683	rs2540486	chr12:96431007	C/G	cg18817487	chr12:96390143	HAL	0.41	5.3	0.51	1.04e-6	Metabolite levels (small molecules and protein measures);
SKCM	cis	rs7959452	0.570	rs10878964	chr12:69720691	T/G	cg14784868	chr12:69753453	YEATS4	0.66	5.91	0.56	8.65e-8	Blood protein levels;
SKCM	cis	rs4819052	0.851	rs10470246	chr21:46659017	C/G	cg02159808	chr21:46707872	POFUT2;LOC642852	0.69	5.36	0.52	8.31e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs6546550	0.935	rs10865380	chr2:70091246	T/C	cg02498382	chr2:70120550	SNRNP27	-0.47	-5.25	-0.51	1.3e-6	Prevalent atrial fibrillation;
SKCM	cis	rs9910055	0.718	rs7212854	chr17:42254417	A/G	cg09913183	chr17:42254507	C17orf65;ASB16	0.7	6.49	0.59	7.35e-9	Total body bone mineral density;
SKCM	cis	rs11098499	0.618	rs35265692	chr4:120325135	T/C	cg09307838	chr4:120376055	NA	0.96	7.73	0.66	3.19e-11	Corneal astigmatism;
SKCM	cis	rs17376456	1.000	rs12187701	chr5:93522290	A/G	cg21475434	chr5:93447410	FAM172A	0.99	5.65	0.54	2.49e-7	Diabetic retinopathy;
SKCM	cis	rs7809950	0.906	rs2253269	chr7:107201114	C/T	cg23024343	chr7:107201750	COG5	-0.75	-6.78	-0.61	2.07e-9	Coronary artery disease;
SKCM	cis	rs28374715	0.681	rs7163989	chr15:41614621	A/G	cg18705301	chr15:41695430	NDUFAF1	-1.07	-10.54	-0.77	1.16e-16	Ulcerative colitis;
SKCM	cis	rs995000	0.965	rs11207995	chr1:63049551	G/T	cg06896770	chr1:63153194	DOCK7	-0.91	-9.12	-0.72	6.4e-14	Triglyceride levels;
SKCM	cis	rs10905065	0.827	rs10752111	chr10:5837286	T/C	cg11519256	chr10:5708881	ASB13	0.55	4.9	0.49	5.04e-6	Menopause (age at onset);
SKCM	cis	rs17711722	0.690	rs116823227	chr7:65331001	A/G	cg11987759	chr7:65425863	GUSB	-0.75	-6.28	-0.58	1.75e-8	Calcium levels;
SKCM	cis	rs992157	0.965	rs13419763	chr2:219134950	C/T	cg20019365	chr2:219134978	PNKD;AAMP	0.79	7.19	0.63	3.45e-10	Colorectal cancer;
SKCM	cis	rs875971	0.862	rs778680	chr7:65840414	G/A	cg18876405	chr7:65276391	NA	0.64	6.36	0.58	1.26e-8	Aortic root size;
SKCM	cis	rs1147199	0.531	rs1147195	chr9:87273174	T/C	cg13486759	chr9:86751815	NA	-0.63	-4.79	-0.48	7.93e-6	Body mass index;
SKCM	cis	rs8180040	0.966	rs12636851	chr3:47463567	C/T	cg16586182	chr3:47516702	SCAP	-0.76	-5.32	-0.52	9.63e-7	Colorectal cancer;
SKCM	cis	rs1348850	0.645	rs10181259	chr2:178428256	C/A	cg27490568	chr2:178487706	NA	0.72	5.28	0.51	1.12e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs951366	0.789	rs823130	chr1:205714372	C/T	cg24503407	chr1:205819492	PM20D1	0.88	7.38	0.64	1.5e-10	Menarche (age at onset);
SKCM	cis	rs1707322	0.928	rs7527244	chr1:46368772	A/G	cg03146154	chr1:46216737	IPP	0.73	4.91	0.49	4.98e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7953249	0.656	rs2251468	chr12:121405126	A/C	cg02403541	chr12:121454288	C12orf43	0.65	4.95	0.49	4.11e-6	Invasive epithelial ovarian cancer;High-grade serous ovarian cancer;Chronic obstructive pulmonary disease-related biomarkers;N-glycan levels;Serous invasive ovarian cancer;Epithelial ovarian cancer;
SKCM	cis	rs2228479	0.850	rs9282681	chr16:89805914	T/C	cg06558623	chr16:89946397	TCF25	1.02	4.89	0.48	5.36e-6	Skin colour saturation;
SKCM	cis	rs10504229	0.861	rs57942497	chr8:58171239	G/T	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs1949733	0.958	rs3103069	chr4:8509451	T/G	cg11789530	chr4:8429930	ACOX3	-0.82	-5.68	-0.54	2.22e-7	Response to antineoplastic agents;
SKCM	cis	rs7772486	0.790	rs2814879	chr6:146201743	T/C	cg05347473	chr6:146136440	FBXO30	0.58	5.45	0.53	5.72e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs35146811	0.807	rs6465761	chr7:99620277	G/C	cg13334819	chr7:99746414	C7orf59	-0.74	-5.25	-0.51	1.3e-6	Coronary artery disease;
SKCM	cis	rs4423214	0.840	rs1790344	chr11:71176897	A/G	cg05163923	chr11:71159392	DHCR7	-0.74	-6.65	-0.6	3.61e-9	Vitamin D levels;
SKCM	cis	rs6582630	0.555	rs11182193	chr12:38474090	C/G	cg26384229	chr12:38710491	ALG10B	0.81	6.22	0.58	2.31e-8	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs1801251	1.000	rs35085837	chr2:233624363	A/G	cg25237894	chr2:233734115	C2orf82	0.58	5.53	0.53	4.04e-7	Coronary artery disease;
SKCM	cis	rs9916302	0.706	rs801418	chr17:37457982	G/C	cg07936489	chr17:37558343	FBXL20	1.0	7.19	0.63	3.42e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs13118159	0.550	rs9685761	chr4:1377942	C/G	cg20887711	chr4:1340912	KIAA1530	0.94	7.43	0.64	1.2e-10	Longevity;
SKCM	cis	rs7296418	0.885	rs1727305	chr12:123633382	T/C	cg05973401	chr12:123451056	ABCB9	0.81	6.39	0.59	1.1e-8	Platelet count;
SKCM	cis	rs1577917	0.917	rs2218594	chr6:86543766	A/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.8	-7.81	-0.66	2.19e-11	Response to antipsychotic treatment;
SKCM	cis	rs11690935	0.921	rs7594711	chr2:172895637	T/G	cg13550731	chr2:172543902	DYNC1I2	-0.78	-6.09	-0.57	4.01e-8	Schizophrenia;
SKCM	cis	rs12477438	0.520	rs13798	chr2:99813614	T/C	cg14399236	chr2:99771627	LIPT1;TSGA10	0.92	7.99	0.67	9.76e-12	Chronic sinus infection;
SKCM	cis	rs9916302	0.851	rs9904919	chr17:37556431	G/C	cg07936489	chr17:37558343	FBXL20	0.85	7.35	0.64	1.71e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs9467773	1.000	rs10946835	chr6:26533757	C/T	cg15659132	chr6:26577336	NA	0.6	5.71	0.54	1.99e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs56235845	0.694	rs11949401	chr5:176765989	A/G	cg06060754	chr5:176797920	RGS14	0.67	6.43	0.59	9.17e-9	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs908922	0.676	rs4240884	chr1:152529792	C/T	cg09873164	chr1:152488093	CRCT1	-0.76	-5.82	-0.55	1.23e-7	Hair morphology;
SKCM	cis	rs1048238	0.506	rs12039892	chr1:16167974	A/G	cg21385522	chr1:16154831	NA	0.65	5.56	0.53	3.61e-7	Systolic blood pressure;
SKCM	cis	rs2228479	0.718	rs11645376	chr16:89912281	G/C	cg00800038	chr16:89945340	TCF25	-1.0	-5.06	-0.5	2.75e-6	Skin colour saturation;
SKCM	cis	rs28595532	0.920	rs55640619	chr4:119761999	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs6951245	1.000	rs75016635	chr7:1094121	G/A	cg03188948	chr7:1209495	NA	1.13	6.27	0.58	1.89e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs7666738	0.830	rs1813972	chr4:98886828	C/A	cg17366294	chr4:99064904	C4orf37	0.57	4.86	0.48	6.02e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs362296	0.698	rs362289	chr4:3256378	G/A	cg00764545	chr4:3318001	RGS12	-0.82	-7.42	-0.64	1.26e-10	Parental longevity (mother's age at death);
SKCM	cis	rs1403694	0.695	rs5029970	chr3:186434491	T/C	cg09332604	chr3:186435400	KNG1	-0.5	-5.07	-0.5	2.57e-6	Blood protein levels;
SKCM	cis	rs9581857	0.725	rs1924074	chr13:28015387	C/G	cg22138327	chr13:27999177	GTF3A	-0.93	-6.24	-0.58	2.1e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs1707322	1.000	rs785504	chr1:46595696	C/T	cg03146154	chr1:46216737	IPP	-0.81	-5.43	-0.52	6.11e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs782590	0.738	rs4312532	chr2:55812061	A/G	cg18811423	chr2:55921094	PNPT1	-0.67	-4.93	-0.49	4.54e-6	Metabolic syndrome;
SKCM	cis	rs9875589	0.509	rs12330714	chr3:14040342	A/T	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.51	5.1	0.5	2.28e-6	Ovarian reserve;
SKCM	cis	rs4642101	0.618	rs11128614	chr3:12819212	A/G	cg05775895	chr3:12838266	CAND2	0.68	5.87	0.55	9.87e-8	QRS complex (12-leadsum);
SKCM	cis	rs11098499	0.909	rs17046118	chr4:120387496	T/G	cg24375607	chr4:120327624	NA	0.66	5.26	0.51	1.25e-6	Corneal astigmatism;
SKCM	cis	rs1005277	0.540	rs4934907	chr10:38015230	A/C	cg00409905	chr10:38381863	ZNF37A	-0.63	-6.05	-0.57	4.71e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs9581857	0.547	rs9581872	chr13:28086058	C/T	cg22138327	chr13:27999177	GTF3A	0.84	5.53	0.53	4.15e-7	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs2836974	0.897	rs36113648	chr21:40555497	G/A	cg17971929	chr21:40555470	PSMG1	0.89	8.73	0.7	3.6e-13	Cognitive function;
SKCM	cis	rs514406	0.679	rs12563825	chr1:53238324	G/T	cg24675658	chr1:53192096	ZYG11B	0.89	8.03	0.67	8.33e-12	Monocyte count;
SKCM	cis	rs7020830	0.894	rs13300951	chr9:37146627	A/G	cg14294708	chr9:37120828	ZCCHC7	1.09	10.46	0.76	1.68e-16	Schizophrenia;
SKCM	cis	rs1707322	0.656	rs2991981	chr1:46057144	A/G	cg03146154	chr1:46216737	IPP	-0.77	-5.57	-0.53	3.45e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7937682	0.883	rs1611989	chr11:111456299	A/G	cg09085632	chr11:111637200	PPP2R1B	-1.04	-9.98	-0.75	1.38e-15	Primary sclerosing cholangitis;
SKCM	cis	rs910316	1.000	rs4903284	chr14:75592483	G/C	cg08847533	chr14:75593920	NEK9	0.95	9.18	0.72	4.8e-14	Height;
SKCM	cis	rs478304	0.651	rs4930319	chr11:65555458	G/C	cg27068330	chr11:65405492	SIPA1	-0.92	-8.08	-0.67	6.63e-12	Acne (severe);
SKCM	cis	rs367615	0.704	rs72804385	chr5:108848143	T/C	cg17395555	chr5:108820864	NA	0.76	6.91	0.62	1.17e-9	Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs2842992	0.724	rs9347340	chr6:160188891	C/T	cg16489826	chr6:160211363	TCP1;MRPL18	-0.78	-6.16	-0.57	2.94e-8	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs12995491	0.569	rs6724281	chr2:88529531	T/G	cg04511125	chr2:88470314	THNSL2	-0.74	-5.94	-0.56	7.51e-8	Response to metformin (IC50);
SKCM	cis	rs28595532	0.748	rs113336496	chr4:119336957	C/T	cg11846333	chr4:119757529	SEC24D	1.19	6.71	0.6	2.81e-9	Cannabis dependence symptom count;
SKCM	cis	rs6570726	0.875	rs368744	chr6:145812622	A/G	cg23711669	chr6:146136114	FBXO30	0.69	6.69	0.6	3.09e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6500602	0.701	rs1362626	chr16:4549226	C/G	cg08645402	chr16:4508243	NA	0.64	4.98	0.49	3.79e-6	Schizophrenia;
SKCM	cis	rs9875589	0.509	rs6778884	chr3:14044681	A/G	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.5	5.15	0.5	1.9e-6	Ovarian reserve;
SKCM	cis	rs9790314	0.875	rs7615592	chr3:160981548	A/C	cg03342759	chr3:160939853	NMD3	-0.74	-7.8	-0.66	2.28e-11	Morning vs. evening chronotype;
SKCM	cis	rs372883	0.507	rs8132992	chr21:30750561	T/C	cg24692254	chr21:30365293	RNF160	0.66	5.14	0.5	1.96e-6	Pancreatic cancer;
SKCM	cis	rs17376456	0.825	rs28705226	chr5:93233135	T/C	cg25358565	chr5:93447407	FAM172A	1.26	7.82	0.66	2.11e-11	Diabetic retinopathy;
SKCM	cis	rs9913156	0.793	rs9916135	chr17:4568115	A/C	cg19197139	chr17:4613644	ARRB2	-0.79	-5.45	-0.53	5.64e-7	Lymphocyte counts;
SKCM	cis	rs9420	0.961	rs12807250	chr11:57600285	C/T	cg19752551	chr11:57585705	CTNND1	-0.72	-7.35	-0.64	1.71e-10	Schizophrenia;
SKCM	cis	rs56235845	0.694	rs6876677	chr5:176755342	T/C	cg17509989	chr5:176798049	RGS14	0.71	6.11	0.57	3.64e-8	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs6977660	0.941	rs6953957	chr7:19820560	A/G	cg05791153	chr7:19748676	TWISTNB	0.79	5.34	0.52	9.05e-7	Thyroid stimulating hormone;
SKCM	cis	rs10193935	0.901	rs222479	chr2:42656857	T/G	cg27598129	chr2:42591480	NA	-0.93	-6.76	-0.61	2.26e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs8060686	0.565	rs75286242	chr16:68145798	C/T	cg09117114	chr16:67998030	SLC12A4	-0.81	-5.29	-0.51	1.07e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs2841233	0.718	rs7150561	chr14:105345035	C/A	cg16576083	chr14:105354267	KIAA0284	0.6	4.77	0.48	8.29e-6	IgG glycosylation;
SKCM	cis	rs67311347	0.544	rs13097602	chr3:40339247	T/C	cg00091569	chr3:40428383	ENTPD3	-0.61	-5.15	-0.5	1.93e-6	Renal cell carcinoma;
SKCM	cis	rs55962025	0.711	rs2285086	chr4:3089259	C/T	cg00764545	chr4:3318001	RGS12	0.56	4.85	0.48	6.25e-6	Parental longevity (mother's age at death);
SKCM	cis	rs3091242	0.933	rs12402120	chr1:25751632	C/T	cg27572855	chr1:25598939	RHD	0.56	5.49	0.53	4.9e-7	Erythrocyte sedimentation rate;
SKCM	cis	rs28595532	0.844	rs115202072	chr4:119732458	C/T	cg21605333	chr4:119757512	SEC24D	1.36	8.05	0.67	7.69e-12	Cannabis dependence symptom count;
SKCM	cis	rs801193	1.000	rs2286684	chr7:66129830	G/T	cg11987759	chr7:65425863	GUSB	0.67	5.75	0.55	1.68e-7	Aortic root size;
SKCM	cis	rs1577917	0.959	rs34258068	chr6:86679449	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.84	-8.35	-0.69	1.97e-12	Response to antipsychotic treatment;
SKCM	cis	rs116095464	0.558	rs56081398	chr5:247318	C/T	cg22857025	chr5:266934	NA	-1.43	-7.97	-0.67	1.07e-11	Breast cancer;
SKCM	cis	rs8141529	0.732	rs11556025	chr22:29168755	T/C	cg15103426	chr22:29168792	CCDC117	0.61	5.01	0.49	3.32e-6	Lymphocyte counts;
SKCM	cis	rs17376456	0.825	rs10075217	chr5:93176774	C/G	cg21475434	chr5:93447410	FAM172A	0.95	5.56	0.53	3.6e-7	Diabetic retinopathy;
SKCM	cis	rs2839186	0.814	rs13052376	chr21:47707403	G/C	cg13012494	chr21:47604986	C21orf56	0.67	5.71	0.54	1.95e-7	Testicular germ cell tumor;
SKCM	cis	rs780096	0.506	rs2950834	chr2:27627366	G/A	cg05696406	chr2:27599888	SNX17	0.47	4.92	0.49	4.75e-6	Total body bone mineral density;
SKCM	cis	rs910316	1.000	rs11845639	chr14:75570293	C/T	cg11812906	chr14:75593930	NEK9	0.68	5.19	0.51	1.6e-6	Height;
SKCM	cis	rs847649	0.699	rs10241865	chr7:102527517	G/A	cg18108683	chr7:102477205	FBXL13	-0.81	-8.51	-0.69	9.78e-13	Morning vs. evening chronotype;
SKCM	cis	rs2952156	0.920	rs2934953	chr17:37832315	T/A	cg20243544	chr17:37824526	PNMT	0.77	5.81	0.55	1.3e-7	Asthma;
SKCM	cis	rs2832191	0.692	rs2245734	chr21:30359965	C/T	cg08807101	chr21:30365312	RNF160	0.76	6.34	0.58	1.38e-8	Dental caries;
SKCM	cis	rs9303401	0.659	rs35564417	chr17:56718286	G/T	cg10487724	chr17:56770010	TEX14;RAD51C	0.86	6.16	0.57	2.91e-8	Cognitive test performance;
SKCM	cis	rs7824557	0.564	rs2437152	chr8:11235497	G/A	cg21775007	chr8:11205619	TDH	-0.59	-5.03	-0.5	3.01e-6	Retinal vascular caliber;
SKCM	cis	rs950776	0.714	rs514743	chr15:78884227	A/T	cg06917634	chr15:78832804	PSMA4	-0.85	-6.82	-0.61	1.7e-9	Sudden cardiac arrest;
SKCM	cis	rs2120019	0.935	rs34913788	chr15:75372617	A/C	cg17294928	chr15:75287854	SCAMP5	-0.82	-6.77	-0.61	2.13e-9	Blood trace element (Zn levels);
SKCM	cis	rs40363	0.645	rs250627	chr16:3527050	G/A	cg22508957	chr16:3507546	NAT15	0.57	4.87	0.48	5.71e-6	Tuberculosis;
SKCM	cis	rs9910055	0.659	rs2246287	chr17:42232442	C/G	cg08499158	chr17:42289980	UBTF	-0.74	-6.46	-0.59	8.29e-9	Total body bone mineral density;
SKCM	cis	rs1348850	0.651	rs4893931	chr2:178228212	T/C	cg02961200	chr2:178257176	LOC100130691;AGPS	0.81	6.11	0.57	3.73e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs7666738	0.753	rs17483788	chr4:98985623	G/A	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4560672	1.000	rs844140	chr6:158559634	G/T	cg10592926	chr6:157876961	ZDHHC14	0.49	4.88	0.48	5.6e-6	Smoking quantity;
SKCM	cis	rs11098499	0.954	rs6820115	chr4:120398182	T/C	cg09307838	chr4:120376055	NA	1.0	7.99	0.67	9.85e-12	Corneal astigmatism;
SKCM	cis	rs17376456	0.825	rs10056879	chr5:93282218	C/A	cg21475434	chr5:93447410	FAM172A	1.04	5.19	0.51	1.62e-6	Diabetic retinopathy;
SKCM	cis	rs394563	0.591	rs237012	chr6:149729198	T/C	cg03678062	chr6:149772716	ZC3H12D	-0.48	-5.45	-0.53	5.61e-7	Dupuytren's disease;
SKCM	cis	rs7824557	0.778	rs3808502	chr8:11179458	G/T	cg21775007	chr8:11205619	TDH	0.62	5.15	0.5	1.9e-6	Retinal vascular caliber;
SKCM	cis	rs910316	0.967	rs175498	chr14:75536369	G/A	cg11812906	chr14:75593930	NEK9	-0.72	-5.45	-0.53	5.7e-7	Height;
SKCM	cis	rs12928939	0.517	rs17358402	chr16:71967927	C/T	cg03805757	chr16:71968109	PKD1L3	-0.72	-5.17	-0.51	1.78e-6	Post bronchodilator FEV1;
SKCM	cis	rs589448	0.902	rs315131	chr12:69761839	T/G	cg14784868	chr12:69753453	YEATS4	0.84	7.65	0.65	4.54e-11	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs12188164	0.580	rs2672755	chr5:457249	G/T	cg26076054	chr5:421317	AHRR	0.61	5.28	0.51	1.13e-6	Cystic fibrosis severity;
SKCM	cis	rs17685	0.664	rs9801113	chr7:75792031	C/T	cg16489192	chr7:75678113	MDH2;STYXL1	-0.57	-5.49	-0.53	4.89e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	trans	rs8073060	0.586	rs4796104	chr17:34046832	T/C	cg19694781	chr19:47549865	TMEM160	1.08	8.6	0.7	6.4e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs7772486	0.875	rs2073287	chr6:146350264	T/C	cg23711669	chr6:146136114	FBXO30	0.78	7.48	0.65	9.35e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs992157	0.835	rs10932769	chr2:219147245	T/G	cg20019365	chr2:219134978	PNKD;AAMP	-0.71	-6.08	-0.57	4.22e-8	Colorectal cancer;
SKCM	cis	rs17065868	1.000	rs9533900	chr13:45116132	A/T	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs17376456	1.000	rs34756085	chr5:93556294	A/G	cg21475434	chr5:93447410	FAM172A	0.98	5.61	0.54	3e-7	Diabetic retinopathy;
SKCM	cis	rs1218582	0.772	rs11264282	chr1:154867370	G/A	cg06221963	chr1:154839813	KCNN3	-0.58	-5.84	-0.55	1.12e-7	Prostate cancer;
SKCM	cis	rs694739	0.796	rs479777	chr11:64107477	A/G	cg02228329	chr11:64053129	BAD;GPR137	0.91	8.15	0.68	4.85e-12	Alopecia areata;Crohn's disease;Psoriasis vulgaris;
SKCM	cis	rs2075371	0.933	rs432336	chr7:133949064	A/G	cg20476274	chr7:133979776	SLC35B4	1.05	10.91	0.78	2.31e-17	Mean platelet volume;
SKCM	cis	rs1577917	1.000	rs35797755	chr6:86706554	A/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.83	-8.23	-0.68	3.37e-12	Response to antipsychotic treatment;
SKCM	cis	rs919433	0.680	rs788022	chr2:198280586	T/C	cg04278110	chr2:198063759	ANKRD44	0.7	4.79	0.48	7.87e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs7666738	0.830	rs36047842	chr4:99004902	C/A	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2228479	0.618	rs72477006	chr16:89950299	G/C	cg06558623	chr16:89946397	TCF25	1.27	7.0	0.62	7.78e-10	Skin colour saturation;
SKCM	cis	rs1691799	0.867	rs1168348	chr12:66757168	G/A	cg16791601	chr12:66731901	HELB	-0.63	-5.63	-0.54	2.72e-7	White blood cell count (basophil);
SKCM	cis	rs7811142	1.000	rs7787620	chr7:100089234	A/G	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.14	6.58	0.6	4.83e-9	Platelet count;
SKCM	cis	rs714515	0.546	rs1894633	chr1:172331059	A/G	cg01573306	chr1:172330400	DNM3	-0.74	-5.97	-0.56	6.73e-8	Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction);Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);
SKCM	cis	rs2842992	0.789	rs4235925	chr6:160202860	C/T	cg16489826	chr6:160211363	TCP1;MRPL18	0.73	5.35	0.52	8.53e-7	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs8072100	0.754	rs8081717	chr17:45653921	T/A	cg08085267	chr17:45401833	C17orf57	0.61	5.56	0.53	3.61e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs7940866	0.774	rs12420126	chr11:130834811	C/T	cg12179176	chr11:130786555	SNX19	0.81	6.4	0.59	1.06e-8	Schizophrenia;
SKCM	cis	rs6866344	0.570	rs1079487	chr5:178136005	G/A	cg03877680	chr5:178157825	ZNF354A	0.92	7.46	0.65	1.04e-10	Neutrophil percentage of white cells;
SKCM	trans	rs3749237	1.000	rs3749237	chr3:49770032	C/T	cg21659725	chr3:3221576	CRBN	0.99	7.4	0.64	1.35e-10	Resting heart rate;
SKCM	cis	rs7017252	1.000	rs7017252	chr8:129950844	C/T	cg08633665	chr8:128972829	MIR1205;PVT1	-0.46	-5.33	-0.52	9.41e-7	Nonsyndromic cleft lip with cleft palate;
SKCM	cis	rs12142240	0.698	rs66516678	chr1:46810112	G/T	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs7020830	0.867	rs13301916	chr9:37361455	A/C	cg14294708	chr9:37120828	ZCCHC7	0.99	9.3	0.73	2.82e-14	Schizophrenia;
SKCM	cis	rs9325144	0.600	rs1825807	chr12:38737007	T/C	cg13010199	chr12:38710504	ALG10B	0.64	5.12	0.5	2.17e-6	Morning vs. evening chronotype;
SKCM	cis	rs738321	0.723	rs9622726	chr22:38506688	A/G	cg25457927	chr22:38595422	NA	-0.65	-7.72	-0.66	3.32e-11	Breast cancer;
SKCM	cis	rs12047808	0.841	rs78940976	chr1:179416051	A/G	cg09822482	chr1:179519214	C1orf125	-0.95	-5.17	-0.51	1.78e-6	Multiple sclerosis (age of onset);
SKCM	cis	rs12477438	0.520	rs6542870	chr2:99796638	C/T	cg14399236	chr2:99771627	LIPT1;TSGA10	0.92	7.99	0.67	9.76e-12	Chronic sinus infection;
SKCM	cis	rs3768617	0.510	rs2027075	chr1:183073266	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs9300255	0.596	rs4460848	chr12:123677810	A/G	cg05973401	chr12:123451056	ABCB9	0.72	5.07	0.5	2.61e-6	Neutrophil percentage of white cells;
SKCM	cis	rs523522	0.962	rs10849754	chr12:120940418	A/C	cg12219531	chr12:120966889	COQ5	0.91	7.82	0.66	2.11e-11	High light scatter reticulocyte count;
SKCM	cis	rs6500602	0.702	rs2304634	chr16:4500544	C/T	cg08645402	chr16:4508243	NA	0.58	4.98	0.49	3.78e-6	Schizophrenia;
SKCM	cis	rs4973517	0.685	rs4973027	chr2:232876200	G/T	cg13952656	chr2:232260762	B3GNT7	0.49	4.88	0.48	5.45e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs9911578	0.967	rs2333410	chr17:57137129	G/A	cg05425664	chr17:57184151	TRIM37	0.82	6.8	0.61	1.86e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs9902453	0.904	rs55633288	chr17:28368196	G/A	cg26525008	chr17:28256777	EFCAB5;SSH2	-0.82	-6.4	-0.59	1.06e-8	Coffee consumption (cups per day);
SKCM	cis	rs7772486	0.790	rs9386141	chr6:146268623	T/A	cg23711669	chr6:146136114	FBXO30	-0.77	-7.44	-0.64	1.14e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7666738	0.830	rs1426663	chr4:98990092	T/G	cg05340658	chr4:99064831	C4orf37	0.66	5.1	0.5	2.32e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11098499	0.675	rs11098534	chr4:120556772	T/G	cg09307838	chr4:120376055	NA	0.94	7.77	0.66	2.64e-11	Corneal astigmatism;
SKCM	cis	rs9325144	0.555	rs7968322	chr12:38792348	T/C	cg13010199	chr12:38710504	ALG10B	-0.66	-5.44	-0.52	5.88e-7	Morning vs. evening chronotype;
SKCM	cis	rs3785574	0.962	rs2584633	chr17:61879501	T/C	cg06601766	chr17:61851465	DDX42;CCDC47	0.67	5.02	0.49	3.14e-6	Height;
SKCM	cis	rs34172651	0.517	rs200526	chr16:24760511	C/T	cg00339695	chr16:24857497	SLC5A11	-0.8	-6.43	-0.59	9.38e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs7666738	0.791	rs10033994	chr4:98969582	C/T	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs55728055	0.661	rs9619217	chr22:32043611	A/G	cg01338084	chr22:32026380	PISD	1.62	5.14	0.5	1.99e-6	Age-related hearing impairment;
SKCM	cis	rs12497850	0.543	rs6446218	chr3:49075513	A/T	cg06212747	chr3:49208901	KLHDC8B	0.68	4.81	0.48	7.26e-6	Parkinson's disease;
SKCM	cis	rs16854884	0.586	rs11914731	chr3:143725594	A/G	cg06585982	chr3:143692056	C3orf58	0.87	8.34	0.69	2.04e-12	Economic and political preferences (feminism/equality);
SKCM	cis	rs6570726	0.577	rs441982	chr6:145842848	A/G	cg23711669	chr6:146136114	FBXO30	0.79	6.92	0.62	1.12e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs3820068	0.581	rs59991988	chr1:15950552	T/A	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs28785552	0.776	rs12978372	chr19:53242074	C/T	cg10871876	chr19:53194124	ZNF83	0.68	4.91	0.49	4.97e-6	Response to paliperidone in schizophrenia (PANSS score);
SKCM	cis	rs875971	0.800	rs427557	chr7:65519250	A/G	cg18876405	chr7:65276391	NA	0.75	7.32	0.64	1.93e-10	Aortic root size;
SKCM	cis	rs72634258	0.520	rs4908485	chr1:7907984	A/G	cg26816564	chr1:7831052	VAMP3	0.75	4.93	0.49	4.55e-6	Inflammatory bowel disease;
SKCM	cis	rs6977660	1.000	rs7779902	chr7:19803491	G/A	cg07541023	chr7:19748670	TWISTNB	0.72	5.03	0.5	3.01e-6	Thyroid stimulating hormone;
SKCM	cis	rs116095464	0.558	rs10058428	chr5:235608	A/G	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs6061231	0.631	rs2427317	chr20:60975725	C/T	cg24112000	chr20:60950667	NA	-0.59	-6.07	-0.57	4.3e-8	Colorectal cancer;
SKCM	cis	rs55823223	0.503	rs55699990	chr17:73859186	A/G	cg10935138	chr17:73851978	WBP2	1.18	7.17	0.63	3.66e-10	Psoriasis;
SKCM	cis	rs5417	1.000	rs5418	chr17:7185092	G/A	cg25256661	chr17:7137939	DVL2	-0.82	-6.62	-0.6	4.1e-9	Diastolic blood pressure;
SKCM	cis	rs362272	0.545	rs3135146	chr4:3307638	C/G	cg03043834	chr4:3319541	RGS12	-0.62	-5.49	-0.53	4.85e-7	Serum sulfate level;
SKCM	cis	rs208520	1.000	rs12193077	chr6:66989548	C/T	cg07460842	chr6:66804631	NA	0.87	5.96	0.56	6.95e-8	Exhaled nitric oxide output;
SKCM	cis	rs7020830	0.830	rs17487601	chr9:37213641	G/A	cg14294708	chr9:37120828	ZCCHC7	1.09	10.3	0.76	3.4e-16	Schizophrenia;
SKCM	cis	rs1014246	0.848	rs10749227	chr10:118468631	G/C	cg14919929	chr10:118506882	NA	0.81	6.18	0.57	2.77e-8	Age at smoking initiation in chronic obstructive pulmonary disease;
SKCM	cis	rs66573146	1.000	rs28384174	chr4:6961107	G/T	cg00086871	chr4:6988644	TBC1D14	1.43	5.33	0.52	9.25e-7	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs8072100	0.807	rs2175290	chr17:45479917	C/A	cg25173405	chr17:45401733	C17orf57	-0.57	-4.77	-0.48	8.45e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs10876993	0.855	rs1689604	chr12:58048304	T/C	cg18357645	chr12:58087776	OS9	0.61	5.65	0.54	2.52e-7	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs9467773	1.000	rs2208331	chr6:26507319	A/G	cg15659132	chr6:26577336	NA	0.61	5.82	0.55	1.24e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7633770	0.786	rs1520488	chr3:46677459	C/T	cg11219411	chr3:46661640	NA	0.54	4.86	0.48	5.98e-6	Coronary artery disease;
SKCM	cis	rs8016982	0.657	rs8021125	chr14:81704787	C/T	cg01989461	chr14:81687754	GTF2A1	-0.87	-7.13	-0.63	4.46e-10	Schizophrenia;
SKCM	cis	rs4774899	0.966	rs12917247	chr15:57363575	G/C	cg01857019	chr15:57210107	LOC145783;TCF12	0.53	4.97	0.49	3.86e-6	Urinary tract infection frequency;
SKCM	cis	rs854765	0.547	rs9897761	chr17:17912011	A/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.04	9.2	0.72	4.44e-14	Total body bone mineral density;
SKCM	cis	rs9815354	0.812	rs73073226	chr3:42005838	T/C	cg03022575	chr3:42003672	ULK4	1.0	5.0	0.49	3.43e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs2811415	0.597	rs998392	chr3:127768329	A/G	cg09089421	chr3:127803668	RUVBL1	1.01	8.79	0.71	2.72e-13	Lung function (FEV1/FVC);
SKCM	cis	rs1552244	1.000	rs17032414	chr3:10158302	C/G	cg02579736	chr3:10068473	FANCD2;CIDECP	1.23	6.92	0.62	1.13e-9	Alzheimer's disease;
SKCM	cis	rs12824058	0.831	rs12310049	chr12:130811260	C/G	cg24838063	chr12:130822603	PIWIL1	0.78	6.91	0.62	1.19e-9	Menopause (age at onset);
SKCM	cis	rs514406	0.708	rs546334	chr1:53326210	T/C	cg08859206	chr1:53392774	SCP2	-0.65	-5.14	-0.5	1.99e-6	Monocyte count;
SKCM	cis	rs28595532	0.623	rs34284204	chr4:119227672	C/T	cg21605333	chr4:119757512	SEC24D	1.17	7.18	0.63	3.55e-10	Cannabis dependence symptom count;
SKCM	cis	rs11098499	0.866	rs12374244	chr4:120281972	A/T	cg24375607	chr4:120327624	NA	0.62	4.77	0.48	8.45e-6	Corneal astigmatism;
SKCM	cis	rs9322193	0.923	rs10782311	chr6:149943728	A/G	cg07701084	chr6:150067640	NUP43	0.61	4.84	0.48	6.48e-6	Lung cancer;
SKCM	cis	rs6570726	0.846	rs4896824	chr6:145927048	C/T	cg23711669	chr6:146136114	FBXO30	0.79	7.47	0.65	9.74e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2645694	0.651	rs2703128	chr4:77819187	C/G	cg06046430	chr4:77819534	ANKRD56	0.54	5.83	0.55	1.18e-7	Emphysema distribution in smoking;
SKCM	cis	rs208520	0.526	rs6913344	chr6:66754285	A/C	cg07460842	chr6:66804631	NA	-0.95	-9.87	-0.75	2.27e-15	Exhaled nitric oxide output;
SKCM	cis	rs6545883	0.524	rs778159	chr2:61556744	T/C	cg15711740	chr2:61764176	XPO1	0.66	5.12	0.5	2.17e-6	Tuberculosis;
SKCM	cis	rs919433	0.927	rs3843857	chr2:198195965	T/C	cg04278110	chr2:198063759	ANKRD44	-0.71	-4.94	-0.49	4.44e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs4555082	0.834	rs2735826	chr14:105710866	G/A	cg13114125	chr14:105738426	BRF1	-0.69	-5.7	-0.54	2.07e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs951366	0.764	rs823141	chr1:205741426	T/C	cg24503407	chr1:205819492	PM20D1	0.91	7.99	0.67	9.76e-12	Menarche (age at onset);
SKCM	cis	rs8180040	1.000	rs295458	chr3:47385585	C/A	cg27129171	chr3:47204927	SETD2	0.87	6.62	0.6	4.2e-9	Colorectal cancer;
SKCM	cis	rs10504229	0.683	rs2005392	chr8:58106896	T/C	cg02725872	chr8:58115012	NA	-0.53	-4.91	-0.49	4.82e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs7789940	1.000	rs7789940	chr7:75951230	A/G	cg10167463	chr7:75959203	YWHAG	-0.68	-4.81	-0.48	7.15e-6	Multiple sclerosis;
SKCM	cis	rs561341	0.882	rs111484028	chr17:30287701	G/A	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs362296	0.698	rs3129319	chr4:3265381	A/G	cg16987761	chr4:3318072	RGS12	-0.65	-5.51	-0.53	4.47e-7	Parental longevity (mother's age at death);
SKCM	cis	rs782590	0.967	rs782592	chr2:55843875	T/A	cg18811423	chr2:55921094	PNPT1	0.78	5.64	0.54	2.6e-7	Metabolic syndrome;
SKCM	cis	rs709400	0.633	rs1951391	chr14:103898313	T/C	cg26031613	chr14:104095156	KLC1	0.75	5.54	0.53	3.88e-7	Body mass index;
SKCM	cis	rs11626933	0.885	rs7150238	chr14:90803958	G/A	cg14092571	chr14:90743983	NA	-0.81	-7.95	-0.67	1.19e-11	Gut microbiota (bacterial taxa);
SKCM	cis	rs9926296	0.605	rs8046243	chr16:89852133	A/G	cg27121462	chr16:89883253	FANCA	0.84	7.64	0.65	4.76e-11	Vitiligo;
SKCM	trans	rs561341	0.941	rs8066156	chr17:30361629	A/G	cg20587970	chr11:113659929	NA	-1.14	-9.72	-0.74	4.41e-15	Hip circumference adjusted for BMI;
SKCM	cis	rs7772486	0.558	rs9497403	chr6:146054695	T/G	cg05347473	chr6:146136440	FBXO30	-0.7	-6.1	-0.57	3.81e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs34779708	0.931	rs11592404	chr10:35273476	G/A	cg03585969	chr10:35415529	CREM	0.72	5.96	0.56	6.77e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs6546550	0.901	rs13015457	chr2:70125763	G/T	cg02498382	chr2:70120550	SNRNP27	-0.45	-4.88	-0.48	5.4e-6	Prevalent atrial fibrillation;
SKCM	cis	rs7086627	0.515	rs10887894	chr10:82209952	A/G	cg00277334	chr10:82204260	NA	-0.74	-8.56	-0.7	7.89e-13	Post bronchodilator FEV1;
SKCM	cis	rs35146811	0.660	rs6465760	chr7:99591418	A/G	cg13334819	chr7:99746414	C7orf59	0.7	4.83	0.48	6.58e-6	Coronary artery disease;
SKCM	cis	rs10504229	0.639	rs67996345	chr8:58117127	A/G	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs597539	0.652	rs514296	chr11:68654182	G/T	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.82	5.44	0.52	5.87e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs548181	0.604	rs11608103	chr11:125627917	G/A	cg03464685	chr11:125439445	EI24	-1.26	-6.58	-0.6	4.85e-9	Schizophrenia;Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);
SKCM	cis	rs2204008	0.744	rs11181337	chr12:38322083	C/A	cg26384229	chr12:38710491	ALG10B	0.78	6.62	0.6	4.07e-9	Bladder cancer;
SKCM	cis	rs9303401	0.659	rs1864754	chr17:56688789	G/T	cg10487724	chr17:56770010	TEX14;RAD51C	-0.86	-6.16	-0.57	2.91e-8	Cognitive test performance;
SKCM	cis	rs10489202	0.632	rs203779	chr1:167877647	T/G	cg24449463	chr1:168025552	DCAF6	-0.85	-7.61	-0.65	5.3e-11	Schizophrenia;
SKCM	cis	rs56235845	0.694	rs6860069	chr5:176755841	C/T	cg06060754	chr5:176797920	RGS14	0.7	6.45	0.59	8.7e-9	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs523522	0.892	rs4767916	chr12:121024032	T/C	cg27279351	chr12:120934652	DYNLL1	0.9	7.97	0.67	1.07e-11	High light scatter reticulocyte count;
SKCM	cis	rs9611565	0.592	rs9611613	chr22:41961831	T/C	cg03806693	chr22:41940476	POLR3H	-1.04	-6.96	-0.62	9.22e-10	Vitiligo;
SKCM	cis	rs2070488	0.965	rs9829192	chr3:38569463	G/T	cg01465620	chr3:38496096	LOC100128640;ACVR2B	-1.03	-9.12	-0.72	6.37e-14	Electrocardiographic conduction measures;
SKCM	cis	rs514406	0.792	rs1242201	chr1:53344748	G/A	cg08859206	chr1:53392774	SCP2	-0.61	-4.8	-0.48	7.61e-6	Monocyte count;
SKCM	cis	rs2075371	0.933	rs1901214	chr7:133945108	C/T	cg20476274	chr7:133979776	SLC35B4	-1.05	-10.89	-0.78	2.57e-17	Mean platelet volume;
SKCM	cis	rs2730245	0.569	rs842692	chr7:158657228	T/C	cg24397884	chr7:158709396	WDR60	0.76	5.88	0.55	9.57e-8	Height;
SKCM	cis	rs7618501	0.538	rs9856572	chr3:50109073	A/T	cg05072774	chr3:49840536	C3orf54	0.72	5.51	0.53	4.54e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs6545883	0.965	rs11887205	chr2:61774473	T/G	cg15711740	chr2:61764176	XPO1	-0.73	-5.26	-0.51	1.21e-6	Tuberculosis;
SKCM	cis	rs9300255	0.602	rs941305	chr12:123715266	T/C	cg05973401	chr12:123451056	ABCB9	0.82	5.31	0.51	1.02e-6	Neutrophil percentage of white cells;
SKCM	cis	rs7111031	1.000	rs4938023	chr11:113374847	T/G	cg04642306	chr11:112834466	NCAM1	0.46	4.85	0.48	6.15e-6	Subjective well-being (multi-trait analysis);Depressive symptoms (multi-trait analysis);Neuroticism;
SKCM	cis	rs854765	0.964	rs72827413	chr17:17988299	C/T	cg04398451	chr17:18023971	MYO15A	0.64	4.77	0.47	8.55e-6	Total body bone mineral density;
SKCM	cis	rs2075371	0.611	rs12531769	chr7:134016899	C/G	cg20476274	chr7:133979776	SLC35B4	0.9	8.75	0.7	3.37e-13	Mean platelet volume;
SKCM	cis	rs4974559	0.739	rs60722337	chr4:1320542	C/G	cg02980000	chr4:1222292	CTBP1	1.04	5.42	0.52	6.57e-7	Systolic blood pressure;
SKCM	cis	rs11718455	0.767	rs13075535	chr3:43954612	G/A	cg21419209	chr3:44054225	NA	-0.63	-5.02	-0.49	3.21e-6	Coronary artery disease;
SKCM	cis	rs9916302	0.904	rs7223331	chr17:37482930	A/G	cg07936489	chr17:37558343	FBXL20	0.84	6.75	0.61	2.32e-9	Glomerular filtration rate (creatinine);
SKCM	cis	rs798766	0.909	rs744658	chr4:1755074	C/T	cg05874882	chr4:1763078	NA	-0.63	-5.19	-0.51	1.64e-6	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs17685	0.712	rs10271413	chr7:75754858	G/A	cg16684958	chr7:75615977	POR	0.55	5.27	0.51	1.19e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs7666738	0.830	rs2865990	chr4:99067399	C/A	cg05340658	chr4:99064831	C4orf37	0.66	4.87	0.48	5.74e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1552244	0.700	rs9833566	chr3:9981671	C/T	cg02579736	chr3:10068473	FANCD2;CIDECP	1.18	5.97	0.56	6.5e-8	Alzheimer's disease;
SKCM	cis	rs4237845	0.788	rs6581157	chr12:58288793	C/T	cg02175503	chr12:58329896	NA	0.71	6.14	0.57	3.28e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs7618501	0.669	rs7634084	chr3:49949834	A/T	cg24110177	chr3:50126178	RBM5	-0.59	-5.13	-0.5	2.05e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1153858	1.000	rs1365610	chr15:45694610	C/T	cg10760299	chr15:45669010	GATM	0.6	5.93	0.56	7.69e-8	Homoarginine levels;
SKCM	cis	rs870825	0.616	rs28558715	chr4:185627761	G/A	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs992157	0.798	rs12053514	chr2:219167965	C/T	cg00012203	chr2:219082015	ARPC2	-0.73	-5.72	-0.54	1.84e-7	Colorectal cancer;
SKCM	trans	rs703108	0.957	rs12247219	chr10:22489515	C/G	ch.7.137529584R	chr7:137879044	NA	-0.81	-7.29	-0.64	2.19e-10	Monocyte percentage of white cells;
SKCM	cis	rs7937682	0.883	rs566647	chr11:111466607	A/G	cg19812747	chr11:111475976	SIK2	0.57	4.84	0.48	6.35e-6	Primary sclerosing cholangitis;
SKCM	cis	rs11105298	0.786	rs3803128	chr12:89860319	C/A	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.88	-6.05	-0.57	4.76e-8	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs7811142	1.000	rs6975729	chr7:100028187	C/T	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.23	7.89	0.67	1.53e-11	Platelet count;
SKCM	trans	rs208520	0.690	rs851458	chr6:66813279	T/G	cg15611600	chr13:45563400	KIAA1704;NUFIP1	-0.98	-7.67	-0.66	4.02e-11	Exhaled nitric oxide output;
SKCM	cis	rs10883723	0.810	rs7074343	chr10:104283165	G/A	cg11453585	chr10:104263688	ACTR1A;SUFU	0.77	6.31	0.58	1.56e-8	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs55962025	0.883	rs59613878	chr4:3139152	C/T	cg00764545	chr4:3318001	RGS12	-0.8	-6.62	-0.6	4.09e-9	Parental longevity (mother's age at death);
SKCM	cis	rs10489202	0.686	rs11590282	chr1:167848231	C/T	cg24449463	chr1:168025552	DCAF6	-0.81	-4.96	-0.49	4.02e-6	Schizophrenia;
SKCM	cis	rs870825	0.655	rs28726376	chr4:185638954	A/G	cg04058563	chr4:185651563	MLF1IP	1.08	7.26	0.64	2.51e-10	Blood protein levels;
SKCM	cis	rs6840360	0.571	rs4696272	chr4:152528229	A/G	cg22705602	chr4:152727874	NA	-0.52	-5.69	-0.54	2.15e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs55962025	0.842	rs362267	chr4:3243218	C/T	cg11471262	chr4:3318911	RGS12	-0.71	-5.58	-0.53	3.35e-7	Parental longevity (mother's age at death);
SKCM	cis	rs2153535	0.580	rs4960423	chr6:8477210	C/T	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs1218582	0.844	rs6699080	chr1:154834911	G/A	cg24250549	chr1:154909240	PMVK	0.83	8.81	0.71	2.52e-13	Prostate cancer;
SKCM	cis	rs2204008	0.840	rs3892363	chr12:38479487	G/A	cg26384229	chr12:38710491	ALG10B	0.81	6.22	0.58	2.31e-8	Bladder cancer;
SKCM	cis	rs2075371	0.673	rs35290398	chr7:134011773	C/T	cg20476274	chr7:133979776	SLC35B4	0.91	8.69	0.7	4.38e-13	Mean platelet volume;
SKCM	cis	rs8103278	0.507	rs4802276	chr19:46260748	T/C	cg14061069	chr19:46274453	DMPK	0.52	5.4	0.52	7.04e-7	Coronary artery disease;
SKCM	cis	rs2180341	0.814	rs9321085	chr6:127735361	T/C	cg24812749	chr6:127587940	RNF146	0.61	4.97	0.49	3.9e-6	Breast cancer;
SKCM	cis	rs16854884	1.000	rs16854886	chr3:143781492	A/G	cg06585982	chr3:143692056	C3orf58	0.74	5.69	0.54	2.17e-7	Economic and political preferences (feminism/equality);
SKCM	cis	rs10779751	0.734	rs2261217	chr1:11127764	C/A	cg08854313	chr1:11322531	MTOR	0.77	5.52	0.53	4.36e-7	Body mass index;
SKCM	cis	rs151997	0.538	rs1345777	chr5:50263788	A/G	cg06027927	chr5:50259733	NA	-0.67	-6.1	-0.57	3.75e-8	Callous-unemotional behaviour;
SKCM	cis	rs769267	0.965	rs2965188	chr19:19522557	G/A	cg03709012	chr19:19516395	GATAD2A	0.9	8.51	0.69	9.68e-13	Tonsillectomy;
SKCM	cis	rs7666738	0.830	rs921521	chr4:98838339	A/G	cg17366294	chr4:99064904	C4orf37	0.56	4.89	0.48	5.25e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs992157	0.717	rs3817266	chr2:219142594	C/T	cg00012203	chr2:219082015	ARPC2	-0.74	-5.97	-0.56	6.53e-8	Colorectal cancer;
SKCM	trans	rs7819412	0.807	rs10105315	chr8:10932203	G/C	cg06636001	chr8:8085503	FLJ10661	-0.88	-7.79	-0.66	2.4e-11	Triglycerides;
SKCM	cis	rs769267	0.965	rs735273	chr19:19385411	T/C	cg26732615	chr19:19648335	CILP2;YJEFN3	0.62	5.67	0.54	2.31e-7	Tonsillectomy;
SKCM	cis	rs2894969	0.664	rs11252703	chr10:4795125	A/T	cg27266257	chr10:5707799	ASB13	-0.64	-5.15	-0.5	1.88e-6	Major depressive disorder;
SKCM	cis	rs3087591	0.960	rs2905797	chr17:29537458	G/C	cg24425628	chr17:29625626	OMG;NF1	0.63	4.93	0.49	4.47e-6	Hip circumference;
SKCM	cis	rs362272	0.545	rs2749785	chr4:3325179	G/C	cg09735869	chr4:3319127	RGS12	0.99	10.94	0.78	2e-17	Serum sulfate level;
SKCM	cis	rs208520	0.690	rs7739253	chr6:66861052	A/G	cg07460842	chr6:66804631	NA	-1.06	-8.02	-0.67	8.53e-12	Exhaled nitric oxide output;
SKCM	cis	rs2224391	0.910	rs7752203	chr6:5260812	C/G	cg09085698	chr6:5261316	LYRM4;FARS2	-0.77	-5.73	-0.54	1.79e-7	Height;
SKCM	cis	rs11690935	0.632	rs6723259	chr2:172622527	A/C	cg13550731	chr2:172543902	DYNC1I2	0.61	5.31	0.52	1.02e-6	Schizophrenia;
SKCM	cis	rs71520386	0.632	rs10224244	chr7:22870074	C/A	cg15401507	chr7:22894281	NA	0.65	4.87	0.48	5.7e-6	Fibrinogen levels;
SKCM	cis	rs7945705	0.902	rs2568059	chr11:8884161	T/C	cg21881798	chr11:8931708	C11orf17;ST5	-0.79	-8.52	-0.69	9.25e-13	Hemoglobin concentration;
SKCM	cis	rs2439831	0.867	rs2614811	chr15:43913487	C/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.39	7.92	0.67	1.34e-11	Lung cancer in ever smokers;
SKCM	trans	rs1814175	0.616	rs1794131	chr11:49904194	A/G	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs709400	1.000	rs2403205	chr14:104143385	C/T	cg26031613	chr14:104095156	KLC1	1.05	12.89	0.82	5.14e-21	Body mass index;
SKCM	cis	rs910316	0.819	rs175461	chr14:75581816	G/A	cg11812906	chr14:75593930	NEK9	-0.72	-5.45	-0.53	5.71e-7	Height;
SKCM	cis	rs554111	0.858	rs10916855	chr1:21056382	T/C	cg01072550	chr1:21505969	NA	-0.58	-5.03	-0.5	3.04e-6	Facial morphology (factor 17, height of vermillion upper lip);
SKCM	cis	rs4148883	0.675	rs116265877	chr4:100096896	G/A	cg12011299	chr4:100065546	ADH4	0.48	4.78	0.48	8.14e-6	Alcohol dependence;
SKCM	trans	rs4657015	1.000	rs4657015	chr1:161272441	A/G	cg18430411	chr8:144873183	SCRIB	-0.81	-7.78	-0.66	2.55e-11	Visceral adipose tissue adjusted for BMI;
SKCM	cis	rs7523050	0.643	rs79451947	chr1:109404130	T/A	cg08274380	chr1:109419600	GPSM2	1.06	4.82	0.48	6.98e-6	Fat distribution (HIV);
SKCM	cis	rs7208859	0.623	rs11657369	chr17:29136468	G/A	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs507080	0.922	rs558907	chr11:118558455	A/G	cg18045108	chr11:118530628	TREH	-0.47	-4.82	-0.48	6.89e-6	Serum metabolite levels;
SKCM	cis	rs3784262	0.669	rs12914455	chr15:58312096	G/A	cg12031962	chr15:58353849	ALDH1A2	-0.42	-4.89	-0.48	5.38e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs10791097	0.967	rs4366492	chr11:130717256	T/C	cg12179176	chr11:130786555	SNX19	0.61	4.94	0.49	4.3e-6	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs4862750	0.758	rs2375915	chr4:187896255	A/C	cg10295955	chr4:187884368	NA	-1.04	-14.07	-0.85	4.23e-23	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1669338	0.507	rs4685609	chr3:3202279	T/C	cg16797762	chr3:3221439	CRBN	-1.01	-6.04	-0.56	4.98e-8	White matter integrity;
SKCM	cis	rs1707322	1.000	rs10789486	chr1:46408667	A/G	cg03146154	chr1:46216737	IPP	0.77	5.36	0.52	8.35e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs28595532	0.920	rs116795224	chr4:119734570	C/T	cg21605333	chr4:119757512	SEC24D	1.36	8.05	0.67	7.69e-12	Cannabis dependence symptom count;
SKCM	cis	rs9733	0.650	rs11204684	chr1:150608894	A/G	cg13175981	chr1:150552382	MCL1	0.66	5.53	0.53	4.09e-7	Tonsillectomy;
SKCM	cis	rs6815814	0.950	rs5743556	chr4:38806851	A/G	cg02016764	chr4:38805732	TLR1	-0.76	-5.4	-0.52	6.95e-7	Breast cancer;
SKCM	cis	rs2204008	0.811	rs8189445	chr12:38276295	T/C	cg13010199	chr12:38710504	ALG10B	0.69	4.92	0.49	4.72e-6	Bladder cancer;
SKCM	cis	rs28595532	0.920	rs116246794	chr4:119732491	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.43	0.59	9.38e-9	Cannabis dependence symptom count;
SKCM	cis	rs7945705	1.000	rs11603841	chr11:8834680	T/C	cg21881798	chr11:8931708	C11orf17;ST5	0.69	6.96	0.62	9.38e-10	Hemoglobin concentration;
SKCM	cis	rs778371	0.697	rs6717048	chr2:233586427	T/C	cg08000102	chr2:233561755	GIGYF2	0.89	7.35	0.64	1.65e-10	Schizophrenia;
SKCM	cis	rs910316	1.000	rs4899546	chr14:75594946	G/C	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.83e-7	Height;
SKCM	cis	rs453301	0.658	rs13271797	chr8:8885954	G/A	cg06636001	chr8:8085503	FLJ10661	-0.74	-5.9	-0.56	8.9e-8	Joint mobility (Beighton score);
SKCM	cis	rs1850744	0.702	rs114809283	chr4:9578006	G/A	cg15442990	chr4:9534313	NA	-1.43	-5.75	-0.55	1.68e-7	Economic and political preferences;
SKCM	cis	rs870825	0.616	rs35818632	chr4:185649661	G/T	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs11098499	0.954	rs11729521	chr4:120416788	T/C	cg24375607	chr4:120327624	NA	0.66	5.13	0.5	2.07e-6	Corneal astigmatism;
SKCM	cis	rs9430161	0.611	rs35033941	chr1:11034382	C/T	cg27631724	chr1:11040367	C1orf127	0.5	4.88	0.48	5.45e-6	Ewing sarcoma;
SKCM	cis	rs763014	0.898	rs916414	chr16:632073	C/T	cg07343612	chr16:622815	PIGQ	-0.7	-6.0	-0.56	5.84e-8	Height;
SKCM	cis	rs58785573	0.504	rs62294474	chr4:38628725	C/T	cg18361445	chr4:38666374	KLF3;FLJ13197	0.62	4.77	0.48	8.4e-6	Lymphocyte percentage of white cells;
SKCM	cis	rs1577917	0.771	rs4419647	chr6:86225739	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.98	10.89	0.78	2.49e-17	Response to antipsychotic treatment;
SKCM	cis	rs6952407	1	rs6952407	chr7:66045512	A/G	cg18876405	chr7:65276391	NA	-0.82	-7.53	-0.65	7.59e-11	Cotinine glucuronidation;
SKCM	cis	rs3087591	0.960	rs757384	chr17:29596135	C/T	cg24425628	chr17:29625626	OMG;NF1	0.64	5.08	0.5	2.48e-6	Hip circumference;
SKCM	cis	rs62238980	0.614	rs117509300	chr22:32502206	C/T	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs4727027	0.901	rs1137432	chr7:148801658	C/T	cg23583168	chr7:148888333	NA	-0.83	-6.61	-0.6	4.3e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs2806561	0.704	rs2806570	chr1:23527005	C/T	cg12483005	chr1:23474871	LUZP1	-0.68	-5.26	-0.51	1.23e-6	Height;
SKCM	cis	rs7666738	0.830	rs11932887	chr4:99072965	C/G	cg17366294	chr4:99064904	C4orf37	0.61	4.93	0.49	4.46e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1568889	0.712	rs4567438	chr11:28380051	A/G	cg06544937	chr11:28130018	METT5D1;KIF18A	0.85	5.68	0.54	2.2e-7	Bipolar disorder;
SKCM	cis	rs6952808	0.792	rs12531315	chr7:1953650	C/G	cg04267008	chr7:1944627	MAD1L1	-0.63	-5.01	-0.49	3.34e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs3820068	0.581	rs72645877	chr1:15928106	G/T	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs10752881	1.000	rs10797808	chr1:182979623	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.74	6.71	0.6	2.83e-9	Colorectal cancer;
SKCM	cis	rs2836974	0.965	rs8131126	chr21:40655754	A/G	cg11644478	chr21:40555479	PSMG1	0.97	10.08	0.75	8.76e-16	Cognitive function;
SKCM	cis	rs9399135	0.967	rs3756799	chr6:135341011	A/G	cg24558204	chr6:135376177	HBS1L	0.6	5.36	0.52	8.17e-7	Red blood cell count;
SKCM	cis	rs763121	0.962	rs5757135	chr22:38952573	C/T	cg06022373	chr22:39101656	GTPBP1	0.76	5.72	0.54	1.85e-7	Menopause (age at onset);
SKCM	cis	rs6951245	0.872	rs57068908	chr7:1060084	A/C	cg03188948	chr7:1209495	NA	1.11	6.11	0.57	3.68e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	trans	rs9329221	0.868	rs7831557	chr8:10280228	C/T	cg06636001	chr8:8085503	FLJ10661	-0.91	-7.92	-0.67	1.33e-11	Neuroticism;
SKCM	cis	rs10876993	0.622	rs7978394	chr12:58091695	C/A	cg18357645	chr12:58087776	OS9	0.69	6.38	0.59	1.15e-8	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs2731664	0.792	rs2630765	chr5:176876825	T/C	cg23176889	chr5:176863531	GRK6	-0.53	-5.4	-0.52	6.86e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7959452	0.590	rs11177619	chr12:69758871	G/A	cg20891283	chr12:69753455	YEATS4	0.91	9.31	0.73	2.74e-14	Blood protein levels;
SKCM	cis	rs909674	0.818	rs5757680	chr22:39844793	C/T	cg24399712	chr22:39784796	NA	0.6	5.2	0.51	1.54e-6	IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis);IgG glycosylation;IgG digalactosylation phenotypes (multivariate analysis);IgG sialylation phenotypes (multivariate analysis);IgG monogalactosylation phenotypes (multivariate analysis);IgG fucosylation phenotypes (multivariate analysis);IgG N-glycosylation phenotypes (multivariate analysis);IgG disialylation phenotypes (multivariate analysis);IgG galactosylation phenotypes (multivariate analysis);Post bronchodilator FEV1;
SKCM	cis	rs7103648	0.669	rs7114011	chr11:47811309	A/C	cg20307385	chr11:47447363	PSMC3	0.91	7.0	0.62	7.82e-10	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs2070488	0.699	rs13078966	chr3:38517914	T/G	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.75	6.15	0.57	3.04e-8	Electrocardiographic conduction measures;
SKCM	cis	rs798766	1.000	rs11729657	chr4:1737585	T/C	cg24239225	chr4:1659016	FAM53A	-0.72	-4.87	-0.48	5.66e-6	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs748404	0.697	rs554001	chr15:43551919	G/A	cg02155558	chr15:43621948	ADAL;LCMT2	0.7	5.77	0.55	1.53e-7	Lung cancer;
SKCM	cis	rs1577917	0.917	rs2197651	chr6:86495442	G/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.91	-9.16	-0.72	5.3e-14	Response to antipsychotic treatment;
SKCM	cis	rs7824557	0.614	rs2293860	chr8:11219386	G/T	cg21775007	chr8:11205619	TDH	0.66	5.98	0.56	6.3e-8	Retinal vascular caliber;
SKCM	cis	rs10207060	0.500	rs1316923	chr2:240719792	A/G	cg07506560	chr2:240697449	NA	-0.73	-6.31	-0.58	1.56e-8	Obesity-related traits;
SKCM	cis	rs6570726	0.764	rs4263604	chr6:145916697	A/G	cg23711669	chr6:146136114	FBXO30	0.85	7.97	0.67	1.05e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2732480	0.517	rs2634676	chr12:48738236	A/G	cg21348975	chr12:48724119	NA	-0.61	-5.23	-0.51	1.37e-6	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs533581	0.866	rs562812	chr16:88970944	G/A	cg16701003	chr16:89028210	CBFA2T3	0.61	5.46	0.53	5.56e-7	Social autistic-like traits;
SKCM	cis	rs7666738	0.830	rs34244876	chr4:99031336	G/A	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs16854884	0.657	rs6769910	chr3:143737830	C/G	cg06585982	chr3:143692056	C3orf58	0.87	8.11	0.68	5.72e-12	Economic and political preferences (feminism/equality);
SKCM	cis	rs950027	0.787	rs2433616	chr15:45728599	A/G	cg10760299	chr15:45669010	GATM	0.53	4.94	0.49	4.44e-6	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs7103648	0.669	rs7131262	chr11:47836302	T/A	cg20307385	chr11:47447363	PSMC3	0.9	6.91	0.62	1.18e-9	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs1799949	0.931	rs9912203	chr17:41445145	A/G	cg25918947	chr17:41365094	TMEM106A	0.65	5.9	0.56	8.76e-8	Menopause (age at onset);
SKCM	cis	rs7824557	0.767	rs11250127	chr8:11170209	G/A	cg21775007	chr8:11205619	TDH	0.72	6.03	0.56	5.2100000000000003e-08	Retinal vascular caliber;
SKCM	cis	rs748404	0.697	rs492743	chr15:43560945	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	0.69	5.67	0.54	2.35e-7	Lung cancer;
SKCM	cis	rs11098499	0.754	rs17595608	chr4:120250506	C/T	cg09307838	chr4:120376055	NA	0.9	7.22	0.63	2.99e-10	Corneal astigmatism;
SKCM	cis	rs7772486	0.654	rs702321	chr6:146006695	A/G	cg05347473	chr6:146136440	FBXO30	-0.59	-5.2	-0.51	1.57e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9300255	0.602	rs2851450	chr12:123703501	C/T	cg00376283	chr12:123451042	ABCB9	0.83	5.49	0.53	4.74e-7	Neutrophil percentage of white cells;
SKCM	cis	rs56235845	0.665	rs4976685	chr5:176766177	C/T	cg06060754	chr5:176797920	RGS14	-0.63	-6.23	-0.58	2.16e-8	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs67311347	0.544	rs9814779	chr3:40340431	T/C	cg00091569	chr3:40428383	ENTPD3	0.61	5.33	0.52	9.24e-7	Renal cell carcinoma;
SKCM	cis	rs3741151	1.000	rs78433080	chr11:73067565	G/A	cg17517138	chr11:73019481	ARHGEF17	1.27	4.87	0.48	5.81e-6	GIP levels in response to oral glucose tolerance test (120 minutes);
SKCM	cis	rs9303401	0.659	rs7225896	chr17:56637337	T/C	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.56	0.53	3.57e-7	Cognitive test performance;
SKCM	cis	rs6121246	0.821	rs7265413	chr20:30317923	G/A	cg11595048	chr20:30225325	COX4I2	0.66	5.13	0.5	2.08e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs6696846	0.749	rs6692170	chr1:205074019	G/A	cg03948781	chr1:205179583	DSTYK	0.56	5.28	0.51	1.14e-6	Red blood cell count;
SKCM	cis	rs7666738	0.830	rs28587201	chr4:98991733	C/T	cg05340658	chr4:99064831	C4orf37	0.67	5.14	0.5	1.98e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2032447	0.802	rs12346	chr6:26097046	T/C	cg18357526	chr6:26021779	HIST1H4A	0.82	7.02	0.62	7.19e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs769267	0.965	rs2074550	chr19:19387743	A/C	cg03709012	chr19:19516395	GATAD2A	0.76	5.93	0.56	7.85e-8	Tonsillectomy;
SKCM	cis	rs2439831	0.681	rs526450	chr15:43599325	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.14	8.58	0.7	7.05e-13	Lung cancer in ever smokers;
SKCM	cis	rs6951245	1.000	rs11767527	chr7:1097394	T/C	cg24642844	chr7:1081250	C7orf50	-0.93	-6.22	-0.58	2.28e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs9910055	0.762	rs11080007	chr17:42265442	A/G	cg19774624	chr17:42201019	HDAC5	0.89	7.61	0.65	5.26e-11	Total body bone mineral density;
SKCM	cis	rs1577917	0.655	rs2842605	chr6:86335150	A/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.74	-6.48	-0.59	7.65e-9	Response to antipsychotic treatment;
SKCM	cis	rs1707322	0.721	rs10890336	chr1:46111056	C/T	cg03146154	chr1:46216737	IPP	0.82	6.1	0.57	3.89e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs1577917	0.655	rs2758849	chr6:86344296	G/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.74	-6.61	-0.6	4.24e-9	Response to antipsychotic treatment;
SKCM	cis	rs514406	0.679	rs12563825	chr1:53238324	G/T	cg25767906	chr1:53392781	SCP2	0.61	4.89	0.48	5.25e-6	Monocyte count;
SKCM	cis	rs28595532	0.920	rs114670456	chr4:119771202	A/G	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs7937682	0.593	rs1944121	chr11:111347223	T/C	cg09085632	chr11:111637200	PPP2R1B	0.68	5.23	0.51	1.4e-6	Primary sclerosing cholangitis;
SKCM	cis	rs9921222	0.521	rs11649255	chr16:357140	A/G	cg00101154	chr16:420108	MRPL28	-0.59	-4.82	-0.48	6.81e-6	Bone mineral density (spine);Bone mineral density;
SKCM	cis	rs4919087	0.748	rs701816	chr10:98977250	C/T	cg25902810	chr10:99078978	FRAT1	-0.65	-4.97	-0.49	3.86e-6	Monocyte count;
SKCM	cis	rs2439831	0.850	rs2228368	chr15:44102010	A/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.35	7.75	0.66	2.9e-11	Lung cancer in ever smokers;
SKCM	cis	rs28830936	0.510	rs2412640	chr15:42124082	C/T	cg17847044	chr15:42102381	MAPKBP1	0.46	5.61	0.54	2.9e-7	Diastolic blood pressure;
SKCM	cis	rs6545883	0.860	rs13023037	chr2:61620989	C/T	cg15711740	chr2:61764176	XPO1	0.7	4.93	0.49	4.5e-6	Tuberculosis;
SKCM	cis	rs4974559	0.895	rs57037487	chr4:1386652	A/G	cg02980000	chr4:1222292	CTBP1	0.81	5.49	0.53	4.89e-7	Systolic blood pressure;
SKCM	cis	rs7937682	0.889	rs521155	chr11:111492563	G/A	cg09085632	chr11:111637200	PPP2R1B	-0.97	-10.08	-0.75	8.74e-16	Primary sclerosing cholangitis;
SKCM	cis	rs778371	0.723	rs10210953	chr2:233698830	G/A	cg08000102	chr2:233561755	GIGYF2	-0.86	-7.42	-0.64	1.26e-10	Schizophrenia;
SKCM	cis	rs10504073	0.647	rs9643395	chr8:50014500	A/C	cg00325661	chr8:49890786	NA	0.82	7.02	0.62	7.13e-10	Blood metabolite ratios;
SKCM	cis	rs10871290	0.650	rs12600126	chr16:74489732	A/T	cg01733217	chr16:74700730	RFWD3	-0.71	-5.51	-0.53	4.38e-7	Breast cancer;
SKCM	cis	rs1577917	1.000	rs10498958	chr6:86649705	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.79	7.45	0.65	1.06e-10	Response to antipsychotic treatment;
SKCM	cis	rs561341	0.709	rs8068049	chr17:30183857	T/C	cg00745463	chr17:30367425	LRRC37B	0.89	5.09	0.5	2.44e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs2841277	0.708	rs10083496	chr14:105402786	G/A	cg19901468	chr14:105411992	AHNAK2	-0.98	-7.76	-0.66	2.7e-11	Rheumatoid arthritis;
SKCM	cis	rs2370759	1.000	rs77165999	chr10:32577131	T/C	cg01819863	chr10:32635814	EPC1	1.05	5.81	0.55	1.27e-7	Sexual dysfunction (female);
SKCM	cis	rs798554	0.757	rs1182188	chr7:2869985	T/C	cg04166393	chr7:2884313	GNA12	0.68	4.85	0.48	6.16e-6	Height;
SKCM	cis	rs2836974	0.831	rs11911149	chr21:40528375	C/T	cg11644478	chr21:40555479	PSMG1	0.97	10.21	0.76	5.08e-16	Cognitive function;
SKCM	cis	rs778371	0.676	rs7560115	chr2:233709465	T/G	cg08000102	chr2:233561755	GIGYF2	-0.8	-6.41	-0.59	1.04e-8	Schizophrenia;
SKCM	cis	rs28386778	0.897	rs10221279	chr17:61806138	A/G	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.13	11.24	0.79	5.56e-18	Prudent dietary pattern;
SKCM	cis	rs651907	0.535	rs13065944	chr3:101473088	G/A	cg12386194	chr3:101231763	SENP7	0.66	5.4	0.52	6.96e-7	Colorectal cancer;
SKCM	cis	rs10754283	0.901	rs10922684	chr1:90117934	T/C	cg21401794	chr1:90099060	LRRC8C	0.73	6.31	0.58	1.57e-8	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs16854884	0.609	rs2885197	chr3:143636616	A/T	cg06585982	chr3:143692056	C3orf58	-0.76	-6.82	-0.61	1.75e-9	Economic and political preferences (feminism/equality);
SKCM	cis	rs514406	0.667	rs10788942	chr1:53210521	A/T	cg16325326	chr1:53192061	ZYG11B	-0.86	-9.02	-0.71	9.97e-14	Monocyte count;
SKCM	cis	rs1153858	1.000	rs4625670	chr15:45652926	C/T	cg10760299	chr15:45669010	GATM	0.62	6.35	0.58	1.3e-8	Homoarginine levels;
SKCM	cis	rs9913156	0.894	rs35741745	chr17:4620897	A/G	cg19197139	chr17:4613644	ARRB2	0.89	6.24	0.58	2.13e-8	Lymphocyte counts;
SKCM	cis	rs13118159	0.550	rs28733902	chr4:1374789	A/G	cg05025164	chr4:1340916	KIAA1530	0.89	7.25	0.63	2.67e-10	Longevity;
SKCM	cis	rs2153535	0.580	rs2327057	chr6:8443319	G/A	cg07606381	chr6:8435919	SLC35B3	0.94	6.94	0.62	1.02e-9	Motion sickness;
SKCM	cis	rs9900062	1.000	rs2521879	chr17:62742678	A/G	cg02097616	chr17:62675921	NA	0.71	5.56	0.53	3.62e-7	QT interval;
SKCM	cis	rs7618915	0.547	rs13069481	chr3:52666866	C/T	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs854765	0.583	rs8065563	chr17:17782404	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.96	7.31	0.64	2.06e-10	Total body bone mineral density;
SKCM	cis	rs12701220	0.901	rs12701713	chr7:1090505	G/A	cg02733842	chr7:1102375	C7orf50	-0.61	-5.34	-0.52	8.8e-7	Bronchopulmonary dysplasia;
SKCM	cis	rs1957429	0.901	rs59876171	chr14:65384429	C/T	cg23373153	chr14:65346875	NA	-1.07	-5.71	-0.54	1.94e-7	Pediatric areal bone mineral density (radius);
SKCM	cis	rs9916302	0.904	rs57399933	chr17:37551189	A/G	cg07936489	chr17:37558343	FBXL20	0.85	7.35	0.64	1.71e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs2658782	0.694	rs3019221	chr11:93079700	C/G	cg15737290	chr11:93063684	CCDC67	0.75	5.08	0.5	2.53e-6	Pulmonary function decline;
SKCM	cis	rs67311347	1.000	rs9848083	chr3:40466979	A/G	cg00091569	chr3:40428383	ENTPD3	-0.58	-4.89	-0.48	5.28e-6	Renal cell carcinoma;
SKCM	cis	rs6840360	0.533	rs4696297	chr4:152725838	T/G	cg22705602	chr4:152727874	NA	0.59	7.76	0.66	2.74e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs1218582	0.772	rs11264282	chr1:154867370	G/A	cg09359103	chr1:154839909	KCNN3	-0.57	-5.25	-0.51	1.26e-6	Prostate cancer;
SKCM	cis	rs1552244	0.938	rs67667957	chr3:10167264	G/C	cg02579736	chr3:10068473	FANCD2;CIDECP	1.16	6.72	0.61	2.65e-9	Alzheimer's disease;
SKCM	cis	rs914615	0.508	rs4390169	chr1:155106054	A/G	cg02153340	chr1:155202674	NA	0.55	4.82	0.48	6.86e-6	Urinary albumin-to-creatinine ratio;
SKCM	cis	rs2072499	0.750	rs10159384	chr1:156160822	C/T	cg24450063	chr1:156163899	SLC25A44	0.88	6.55	0.6	5.55e-9	Testicular germ cell tumor;
SKCM	cis	rs9300255	0.782	rs12809602	chr12:123768916	T/G	cg00376283	chr12:123451042	ABCB9	-0.78	-5.26	-0.51	1.24e-6	Neutrophil percentage of white cells;
SKCM	cis	rs344364	0.602	rs12325217	chr16:1887108	A/T	cg00490583	chr16:1843685	IGFALS	-0.49	-4.91	-0.49	4.88e-6	Glomerular filtration rate in chronic kidney disease;
SKCM	cis	rs514406	0.760	rs1242198	chr1:53352016	G/A	cg24675658	chr1:53192096	ZYG11B	-0.78	-6.69	-0.6	3.08e-9	Monocyte count;
SKCM	cis	rs6540234	0.701	rs2885364	chr16:85993190	A/T	cg09395612	chr16:86018936	NA	0.42	4.83	0.48	6.77e-6	Granulocyte percentage of myeloid white cells;Monocyte count;
SKCM	cis	rs6582630	0.519	rs12819814	chr12:38332568	G/C	cg26384229	chr12:38710491	ALG10B	0.81	6.67	0.6	3.38e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs9513627	1.000	rs6491511	chr13:100198717	C/A	cg11288260	chr13:100117058	NA	0.79	4.78	0.48	8.1e-6	Obesity-related traits;
SKCM	cis	rs116095464	0.558	rs13357299	chr5:242211	T/C	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs2243480	1.000	rs1167613	chr7:65487439	C/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs6445797	0.632	rs13097030	chr3:56603675	G/A	cg13616963	chr3:57583610	ARF4	-0.79	-5.1	-0.5	2.35e-6	Gastritis;
SKCM	cis	rs9466056	0.562	rs55964236	chr6:21393194	G/A	cg03680338	chr6:22043967	FLJ22536	-0.53	-5.01	-0.49	3.28e-6	Bone mineral density;
SKCM	cis	rs7811142	1.000	rs60478351	chr7:100089017	C/T	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.14	6.58	0.6	4.83e-9	Platelet count;
SKCM	cis	rs116095464	0.558	rs56342538	chr5:225796	T/C	cg22496380	chr5:211416	CCDC127	-0.96	-5.27	-0.51	1.18e-6	Breast cancer;
SKCM	cis	rs854765	0.647	rs4426402	chr17:17977926	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	-0.88	-6.81	-0.61	1.83e-9	Total body bone mineral density;
SKCM	cis	rs67460515	0.563	rs9883566	chr3:160770323	C/T	cg03342759	chr3:160939853	NMD3	0.71	6.07	0.57	4.28e-8	Parkinson's disease;
SKCM	cis	rs3749237	0.595	rs11130196	chr3:49490149	A/C	cg02487422	chr3:49467188	NICN1	0.64	4.79	0.48	7.67e-6	Resting heart rate;
SKCM	cis	rs1577917	0.958	rs1414199	chr6:86522370	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.33	-0.52	9.19e-7	Response to antipsychotic treatment;
SKCM	cis	rs6500395	1.000	rs1558816	chr16:48704868	T/A	cg04672837	chr16:48644449	N4BP1	-0.63	-5.37	-0.52	8.01e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs12096438	1.000	rs11806326	chr1:25899165	G/T	cg21452808	chr1:25900135	NA	-0.48	-5.81	-0.55	1.27e-7	Platelet count;Mean platelet volume;
SKCM	cis	rs2727020	0.553	rs4103567	chr11:49255389	C/T	cg21546286	chr11:48923668	NA	-0.49	-5.05	-0.5	2.79e-6	Coronary artery disease;
SKCM	cis	rs10751667	0.666	rs7395182	chr11:927553	A/C	cg10932868	chr11:921992	NA	0.55	5.13	0.5	2.09e-6	Alzheimer's disease (late onset);
SKCM	cis	rs2842992	0.789	rs2146163	chr6:160224346	T/C	cg19482086	chr6:160211437	TCP1;MRPL18	0.81	6.18	0.57	2.68e-8	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs3087591	1.000	rs8068801	chr17:29570587	G/T	cg24425628	chr17:29625626	OMG;NF1	-0.63	-4.95	-0.49	4.23e-6	Hip circumference;
SKCM	cis	rs362272	0.505	rs10155132	chr4:3369500	A/G	cg09735869	chr4:3319127	RGS12	1.0	11.49	0.79	1.86e-18	Serum sulfate level;
SKCM	cis	rs2739330	0.627	rs9608219	chr22:24274119	G/C	cg25703541	chr22:24373054	LOC391322	-0.8	-6.34	-0.58	1.37e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs7811142	0.830	rs6965458	chr7:99973402	G/A	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.19	7.5	0.65	8.66e-11	Platelet count;
SKCM	trans	rs561341	0.681	rs56064462	chr17:30235116	G/A	cg20587970	chr11:113659929	NA	-1.08	-8.41	-0.69	1.54e-12	Hip circumference adjusted for BMI;
SKCM	cis	rs4400599	0.618	rs1194580	chr1:154219485	G/T	cg26808167	chr1:154192205	UBAP2L;C1orf43	-0.54	-4.91	-0.49	4.9e-6	Platelet distribution width;
SKCM	cis	rs58688157	0.960	rs12422022	chr11:613192	A/G	cg03576123	chr11:487126	PTDSS2	-0.84	-5.45	-0.53	5.64e-7	Systemic lupus erythematosus;
SKCM	cis	rs2599510	0.703	rs762023	chr2:32713170	G/A	cg02381751	chr2:32503542	YIPF4	0.71	5.43	0.52	6.17e-7	Interleukin-18 levels;
SKCM	cis	rs9611565	0.694	rs19573	chr22:41865809	C/A	cg03806693	chr22:41940476	POLR3H	0.96	6.02	0.56	5.31e-8	Vitiligo;
SKCM	cis	rs2836974	0.545	rs2776311	chr21:40716885	A/G	cg11890956	chr21:40555474	PSMG1	0.72	5.72	0.54	1.88e-7	Cognitive function;
SKCM	cis	rs4819052	0.851	rs28616694	chr21:46674786	G/C	cg20896738	chr21:46707857	POFUT2;LOC642852	0.64	4.81	0.48	7.36e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs3812762	0.871	rs3862352	chr11:8818020	C/T	cg21881798	chr11:8931708	C11orf17;ST5	-0.53	-4.91	-0.49	4.83e-6	Hypospadias;
SKCM	cis	rs477895	1.000	rs66968227	chr11:64070930	T/C	cg02228329	chr11:64053129	BAD;GPR137	-1.16	-5.11	-0.5	2.27e-6	Mean platelet volume;
SKCM	cis	rs7617480	0.648	rs7653408	chr3:48972351	A/C	cg07636037	chr3:49044803	WDR6	0.9	6.79	0.61	1.98e-9	Subjective well-being (multi-trait analysis);Menarche (age at onset);
SKCM	cis	rs67460515	0.892	rs1478566	chr3:161030335	A/T	cg03342759	chr3:160939853	NMD3	-0.81	-7.1	-0.63	5.14e-10	Parkinson's disease;
SKCM	cis	rs875971	1.000	rs2420591	chr7:65912381	T/C	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	8.09e-13	Aortic root size;
SKCM	cis	rs10540	0.730	rs61877766	chr11:512973	T/G	cg03576123	chr11:487126	PTDSS2	-1.45	-7.95	-0.67	1.17e-11	Body mass index;
SKCM	cis	rs362296	0.590	rs4690081	chr4:3262105	T/G	cg24015175	chr4:3319247	RGS12	-0.64	-6.06	-0.57	4.59e-8	Parental longevity (mother's age at death);
SKCM	cis	rs995000	0.899	rs10889337	chr1:62980607	G/A	cg06896770	chr1:63153194	DOCK7	0.6	5.45	0.53	5.67e-7	Triglyceride levels;
SKCM	cis	rs2836974	0.966	rs7283516	chr21:40690537	A/G	cg17971929	chr21:40555470	PSMG1	0.81	7.43	0.64	1.21e-10	Cognitive function;
SKCM	cis	rs17376456	0.877	rs10070390	chr5:93452345	G/A	cg25358565	chr5:93447407	FAM172A	1.23	7.97	0.67	1.08e-11	Diabetic retinopathy;
SKCM	cis	rs9926296	0.744	rs164746	chr16:89709019	C/T	cg01097406	chr16:89675127	NA	0.51	4.86	0.48	6e-6	Vitiligo;
SKCM	cis	rs1218582	0.741	rs705094	chr1:154917314	G/A	cg09359103	chr1:154839909	KCNN3	-0.54	-4.91	-0.49	4.82e-6	Prostate cancer;
SKCM	cis	rs10089	0.953	rs1985268	chr5:127375931	T/C	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.92	8.29	0.68	2.54e-12	Ileal carcinoids;
SKCM	cis	rs28386778	0.863	rs2584637	chr17:61942952	T/C	cg22520471	chr17:61851767	DDX42;CCDC47	0.79	5.33	0.52	9.35e-7	Prudent dietary pattern;
SKCM	cis	rs3768617	0.510	rs7529465	chr1:183096880	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs9309711	0.737	rs9284795	chr2:3492065	G/A	cg10845886	chr2:3471009	TTC15	-0.73	-5.26	-0.51	1.21e-6	Neurofibrillary tangles;
SKCM	cis	rs6750795	0.569	rs1667305	chr2:232403829	A/G	cg19187155	chr2:232395269	NMUR1	0.87	7.61	0.65	5.4e-11	Height;
SKCM	cis	rs17125944	0.505	rs2295826	chr14:53174923	C/T	cg00686598	chr14:53173677	PSMC6	-1.11	-4.81	-0.48	7.25e-6	Alzheimer's disease (late onset);
SKCM	cis	rs7811142	1.000	rs6962151	chr7:100028484	T/C	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.23	7.89	0.67	1.53e-11	Platelet count;
SKCM	cis	rs9880211	0.563	rs9881400	chr3:135861666	G/T	cg21827317	chr3:136751795	NA	-0.68	-5.3	-0.51	1.05e-6	Body mass index;Height;
SKCM	cis	rs208520	0.690	rs1563929	chr6:66702108	G/A	cg07460842	chr6:66804631	NA	0.92	7.57	0.65	6.5e-11	Exhaled nitric oxide output;
SKCM	cis	rs2303745	0.589	rs1864115	chr19:17393327	G/C	cg04248312	chr19:17393744	ANKLE1	-1.11	-8.18	-0.68	4.15e-12	Systemic lupus erythematosus;
SKCM	cis	rs769267	0.965	rs2269873	chr19:19392401	T/C	cg26732615	chr19:19648335	CILP2;YJEFN3	0.62	5.69	0.54	2.17e-7	Tonsillectomy;
SKCM	cis	rs4724125	0.751	rs17172095	chr7:42665355	A/G	cg09407816	chr7:42972088	MRPL32;PSMA2	0.77	5.04	0.5	2.92e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs72781680	0.848	rs6754694	chr2:24155448	T/C	cg08917208	chr2:24149416	ATAD2B	0.97	5.52	0.53	4.27e-7	Lymphocyte counts;
SKCM	cis	rs4481887	0.927	rs11204631	chr1:248479530	A/G	cg00666640	chr1:248458726	OR2T12	0.66	6.0	0.56	5.9e-8	Common traits (Other);
SKCM	cis	rs11098499	0.687	rs71610270	chr4:120287436	A/G	cg09307838	chr4:120376055	NA	0.98	7.89	0.67	1.52e-11	Corneal astigmatism;
SKCM	cis	rs701145	0.938	rs701135	chr3:154065455	C/G	cg17054900	chr3:154042577	DHX36	0.92	5.12	0.5	2.11e-6	Coronary artery disease;
SKCM	cis	rs6977660	0.507	rs72591449	chr7:19775443	T/C	cg05791153	chr7:19748676	TWISTNB	0.93	4.92	0.49	4.79e-6	Thyroid stimulating hormone;
SKCM	cis	rs6951245	1.000	rs74887741	chr7:1110658	G/T	cg03188948	chr7:1209495	NA	1.13	6.27	0.58	1.89e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	trans	rs17685	0.712	rs1637049	chr7:75729975	C/G	cg19862616	chr7:65841803	NCRNA00174	0.95	8.88	0.71	1.88e-13	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2033711	0.870	rs11669741	chr19:58960481	C/T	cg00825309	chr19:58991885	ZNF446	0.69	5.8	0.55	1.35e-7	Uric acid clearance;
SKCM	cis	rs10883723	0.810	rs7094366	chr10:104274730	C/G	cg11453585	chr10:104263688	ACTR1A;SUFU	0.78	6.01	0.56	5.67e-8	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs4481887	0.760	rs4559544	chr1:248412507	T/G	cg00666640	chr1:248458726	OR2T12	0.66	5.41	0.52	6.65e-7	Common traits (Other);
SKCM	cis	rs10905065	0.898	rs4748916	chr10:5820394	A/G	cg09234995	chr10:5726438	C10orf18	0.59	5.12	0.5	2.16e-6	Menopause (age at onset);
SKCM	cis	rs6951245	1.000	rs28399710	chr7:1070631	G/T	cg18402987	chr7:1209562	NA	1.15	6.02	0.56	5.38e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs34065801	0.545	rs9531258	chr13:36525095	G/A	cg09605634	chr13:36521538	DCLK1	-0.75	-5.3	-0.51	1.03e-6	Breast size;
SKCM	cis	rs1506636	1.000	rs659416	chr7:123401764	A/G	cg03229431	chr7:123269106	ASB15	-0.63	-5.08	-0.5	2.56e-6	Plateletcrit;Platelet count;
SKCM	cis	rs55962025	0.842	rs362272	chr4:3234980	C/T	cg11471262	chr4:3318911	RGS12	-0.7	-5.41	-0.52	6.75e-7	Parental longevity (mother's age at death);
SKCM	cis	rs7208859	0.673	rs8077116	chr17:29140162	A/G	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs1799949	1.000	rs4793229	chr17:41418334	C/T	cg25918947	chr17:41365094	TMEM106A	0.61	5.61	0.54	2.94e-7	Menopause (age at onset);
SKCM	cis	rs875971	1.000	rs778706	chr7:65860424	A/G	cg11764359	chr7:65958608	NA	0.87	8.35	0.69	2.01e-12	Aortic root size;
SKCM	cis	rs2243480	1.000	rs186378	chr7:65582058	A/C	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs10256972	0.630	rs13235747	chr7:1129123	T/C	cg09177884	chr7:1199841	ZFAND2A	-0.76	-6.43	-0.59	9.31e-9	Longevity;Endometriosis;
SKCM	cis	rs2839186	0.872	rs13052233	chr21:47707284	G/T	cg05896524	chr21:47604654	C21orf56	0.69	5.67	0.54	2.29e-7	Testicular germ cell tumor;
SKCM	cis	rs12950390	0.853	rs11079790	chr17:45853626	G/A	cg03474202	chr17:45855739	NA	-0.49	-5.58	-0.53	3.34e-7	IgG glycosylation;
SKCM	cis	rs2243480	0.908	rs55876148	chr7:65379800	G/A	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs3784262	1.000	rs11071356	chr15:58240518	T/G	cg12031962	chr15:58353849	ALDH1A2	-0.5	-6.24	-0.58	2.15e-8	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs11098499	0.909	rs28884220	chr4:120307211	A/G	cg24375607	chr4:120327624	NA	0.65	4.97	0.49	3.87e-6	Corneal astigmatism;
SKCM	cis	rs1799949	0.965	rs8176310	chr17:41199913	T/C	cg05368731	chr17:41323189	NBR1	0.86	7.12	0.63	4.57e-10	Menopause (age at onset);
SKCM	cis	rs1799949	1.000	rs11653253	chr17:41182662	G/A	cg25072359	chr17:41440525	NA	0.63	4.88	0.48	5.43e-6	Menopause (age at onset);
SKCM	cis	rs9467773	1.000	rs3736782	chr6:26505403	C/A	cg15659132	chr6:26577336	NA	0.61	5.82	0.55	1.24e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs10504229	1.000	rs6989060	chr8:58178989	T/G	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs6061231	0.793	rs2427320	chr20:60976723	A/G	cg24112000	chr20:60950667	NA	-0.65	-6.01	-0.56	5.71e-8	Colorectal cancer;
SKCM	cis	rs2177596	0.617	rs62226767	chr2:227943712	C/A	cg11843606	chr2:227700838	RHBDD1	-0.76	-5.22	-0.51	1.47e-6	Body mass index;
SKCM	cis	rs4683346	0.964	rs34759881	chr3:42875544	T/G	cg06399164	chr3:42695035	ZBTB47	0.61	5.53	0.53	4.18e-7	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs1005277	0.579	rs2474575	chr10:38387901	C/T	cg25427524	chr10:38739819	LOC399744	-0.69	-6.45	-0.59	8.73e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs2836974	0.563	rs6517522	chr21:40553845	T/C	cg11890956	chr21:40555474	PSMG1	0.83	7.08	0.63	5.66e-10	Cognitive function;
SKCM	cis	rs28386778	0.897	rs8069969	chr17:61822223	T/G	cg06873352	chr17:61820015	STRADA	0.76	6.34	0.58	1.38e-8	Prudent dietary pattern;
SKCM	cis	rs873946	0.564	rs35831787	chr10:134546346	T/C	cg18305652	chr10:134549665	INPP5A	0.55	5.56	0.53	3.66e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs2153535	0.547	rs9502720	chr6:8541362	C/A	cg23788917	chr6:8435910	SLC35B3	0.69	4.87	0.48	5.62e-6	Motion sickness;
SKCM	cis	rs651907	0.535	rs13084113	chr3:101534039	C/G	cg12386194	chr3:101231763	SENP7	0.68	5.74	0.54	1.73e-7	Colorectal cancer;
SKCM	cis	rs1577917	0.958	rs4707236	chr6:86583967	A/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.4	-0.52	6.9e-7	Response to antipsychotic treatment;
SKCM	cis	rs1218582	0.772	rs10908448	chr1:154882544	A/G	cg24250549	chr1:154909240	PMVK	-0.85	-8.71	-0.7	3.97e-13	Prostate cancer;
SKCM	cis	rs10413103	0.657	rs4805869	chr19:33762602	A/G	cg05914712	chr19:33864373	CEBPG	0.85	5.25	0.51	1.27e-6	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs2739330	0.791	rs9612520	chr22:24269459	G/T	cg25703541	chr22:24373054	LOC391322	-0.86	-7.13	-0.63	4.51e-10	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs9467773	0.620	rs1490488	chr6:26614808	T/C	cg15659132	chr6:26577336	NA	0.62	5.4	0.52	6.91e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs4780401	0.609	rs12927966	chr16:11814562	C/T	cg01061890	chr16:11836724	TXNDC11	-0.8	-6.08	-0.57	4.09e-8	Rheumatoid arthritis;
SKCM	cis	rs6952808	0.609	rs6944877	chr7:1952582	T/G	cg03354898	chr7:1950403	MAD1L1	-0.55	-5.65	-0.54	2.56e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs7666738	0.830	rs58367603	chr4:99015350	T/C	cg05340658	chr4:99064831	C4orf37	0.66	5.14	0.5	2e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs8072100	0.875	rs62073966	chr17:45600013	T/A	cg08085267	chr17:45401833	C17orf57	0.59	5.24	0.51	1.35e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs870825	0.616	rs28618216	chr4:185648998	T/C	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs9880211	0.752	rs35428413	chr3:136380698	T/A	cg21827317	chr3:136751795	NA	-0.7	-5.43	-0.52	6.12e-7	Body mass index;Height;
SKCM	cis	rs79839061	0.610	rs3736089	chr4:870118	G/A	cg07828340	chr4:882639	GAK	1.02	4.99	0.49	3.6e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs6474412	0.664	rs6982753	chr8:42604791	C/T	cg11207534	chr8:41686438	ANK1	0.94	5.64	0.54	2.65e-7	Smoking behavior;
SKCM	cis	rs11148252	0.904	rs9526927	chr13:53051627	C/T	cg00495681	chr13:53174319	NA	0.61	5.19	0.51	1.63e-6	Lewy body disease;
SKCM	cis	rs35306767	0.953	rs12357633	chr10:957246	C/T	cg26597838	chr10:835615	NA	0.73	5.81	0.55	1.3e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs28595532	0.920	rs114382134	chr4:119733215	T/C	cg21605333	chr4:119757512	SEC24D	1.36	8.05	0.67	7.69e-12	Cannabis dependence symptom count;
SKCM	cis	rs11098499	0.644	rs10012252	chr4:120559139	T/C	cg09307838	chr4:120376055	NA	0.94	7.77	0.66	2.64e-11	Corneal astigmatism;
SKCM	cis	rs4423214	0.879	rs1792283	chr11:71135136	T/C	cg05163923	chr11:71159392	DHCR7	-0.65	-5.76	-0.55	1.61e-7	Vitamin D levels;
SKCM	trans	rs1814175	0.781	rs28681334	chr11:50051177	C/T	cg15704280	chr7:45808275	SEPT13	-1.05	-11.07	-0.78	1.14e-17	Height;
SKCM	cis	rs6089584	0.888	rs6587283	chr20:60613727	A/C	cg06108461	chr20:60628389	TAF4	-0.89	-8.72	-0.7	3.75e-13	Body mass index;
SKCM	cis	rs860554	0.528	rs12120625	chr1:201306510	A/G	cg13877974	chr1:201708888	NAV1	0.42	4.98	0.49	3.76e-6	Panic disorder;
SKCM	cis	rs62238980	0.614	rs4821021	chr22:32414170	T/C	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs11098499	0.954	rs7436506	chr4:120393769	T/C	cg09307838	chr4:120376055	NA	0.97	7.65	0.65	4.54e-11	Corneal astigmatism;
SKCM	cis	rs11098499	0.754	rs10212714	chr4:120254302	T/C	cg09307838	chr4:120376055	NA	0.92	7.01	0.62	7.48e-10	Corneal astigmatism;
SKCM	cis	rs2549003	0.674	rs960757	chr5:131826310	G/A	cg21138405	chr5:131827807	IRF1	0.42	4.99	0.49	3.52e-6	Asthma (sex interaction);
SKCM	cis	rs4727027	0.901	rs11760293	chr7:148811725	A/G	cg23583168	chr7:148888333	NA	-0.83	-6.7	-0.6	2.89e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs6951245	1.000	rs11770909	chr7:1086716	G/A	cg24642844	chr7:1081250	C7orf50	-0.94	-6.32	-0.58	1.48e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	trans	rs17685	0.753	rs1637051	chr7:75730659	G/A	cg19862616	chr7:65841803	NCRNA00174	0.95	9.02	0.71	9.98e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs11690935	1.000	rs1554166	chr2:172541609	G/T	cg13550731	chr2:172543902	DYNC1I2	-0.97	-8.12	-0.68	5.47e-12	Schizophrenia;
SKCM	cis	rs6547631	0.622	rs1561284	chr2:85924295	C/A	cg24620635	chr2:85921963	GNLY	0.9	6.65	0.6	3.58e-9	Blood protein levels;
SKCM	cis	rs10751667	0.600	rs10751665	chr11:941300	G/A	cg10932868	chr11:921992	NA	0.55	5.13	0.5	2.09e-6	Alzheimer's disease (late onset);
SKCM	cis	rs9311474	0.508	rs7625743	chr3:52606366	C/G	cg18404041	chr3:52824283	ITIH1	-0.53	-4.77	-0.48	8.42e-6	Electroencephalogram traits;
SKCM	cis	rs2455601	1.000	rs7104661	chr11:8902501	C/G	cg21881798	chr11:8931708	C11orf17;ST5	-0.94	-5.96	-0.56	7.03e-8	Schizophrenia;
SKCM	cis	rs9910055	0.659	rs3826412	chr17:42255097	A/G	cg09913183	chr17:42254507	C17orf65;ASB16	0.67	6.53	0.59	6.13e-9	Total body bone mineral density;
SKCM	cis	rs9325144	0.560	rs6582539	chr12:38630097	C/T	cg26384229	chr12:38710491	ALG10B	-0.66	-5.25	-0.51	1.3e-6	Morning vs. evening chronotype;
SKCM	cis	rs10751667	0.666	rs7124480	chr11:971601	G/A	cg10932868	chr11:921992	NA	0.54	5.06	0.5	2.76e-6	Alzheimer's disease (late onset);
SKCM	cis	rs28386778	0.897	rs1043127	chr17:61791210	T/G	cg01411255	chr17:61851458	DDX42;CCDC47	0.79	5.1	0.5	2.35e-6	Prudent dietary pattern;
SKCM	cis	rs9517302	0.847	rs9517297	chr13:99094961	A/C	cg22223119	chr13:99095684	FARP1	-0.94	-7.5	-0.65	8.67e-11	Obesity-related traits;
SKCM	cis	rs11792861	0.926	rs77567374	chr9:111835034	T/C	cg14432460	chr9:111696404	IKBKAP;C9orf6	0.66	4.81	0.48	7.17e-6	Menarche (age at onset);
SKCM	cis	rs12142240	0.698	rs66516678	chr1:46810112	G/T	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs2013441	1.000	rs3850784	chr17:20185030	A/G	cg13482628	chr17:19912719	NA	-0.66	-5.12	-0.5	2.18e-6	Obesity-related traits;
SKCM	cis	rs9611565	0.559	rs8139993	chr22:41995335	T/C	cg03806693	chr22:41940476	POLR3H	-1.06	-7.21	-0.63	3.11e-10	Vitiligo;
SKCM	cis	rs9910055	0.530	rs2269905	chr17:42294462	A/G	cg13607699	chr17:42295918	UBTF	0.86	7.36	0.64	1.62e-10	Total body bone mineral density;
SKCM	cis	rs595982	0.527	rs73061656	chr19:49372355	G/A	cg19746536	chr19:49375674	PPP1R15A	1.08	6.03	0.56	5.08e-8	Red cell distribution width;
SKCM	cis	rs870825	0.616	rs28450662	chr4:185638900	G/A	cg04058563	chr4:185651563	MLF1IP	1.08	7.26	0.64	2.51e-10	Blood protein levels;
SKCM	cis	rs8180040	0.620	rs2305635	chr3:47043622	G/A	cg27129171	chr3:47204927	SETD2	-0.74	-5.37	-0.52	7.84e-7	Colorectal cancer;
SKCM	cis	rs9303401	0.659	rs35828828	chr17:56718205	C/T	cg02118635	chr17:56770003	RAD51C;TEX14	0.82	5.43	0.52	6.13e-7	Cognitive test performance;
SKCM	cis	rs8180040	0.627	rs9821119	chr3:47198437	C/G	cg27129171	chr3:47204927	SETD2	0.74	5.3	0.51	1.05e-6	Colorectal cancer;
SKCM	cis	rs2386661	0.523	rs2386663	chr10:5652739	C/T	cg09072322	chr10:5726702	C10orf18	-0.69	-4.89	-0.48	5.3e-6	Breast cancer;
SKCM	cis	rs2836974	0.602	rs8130854	chr21:40707041	G/A	cg11890956	chr21:40555474	PSMG1	-0.82	-7.57	-0.65	6.49e-11	Cognitive function;
SKCM	cis	rs1395	1.000	rs1275528	chr2:27430781	A/G	cg14242246	chr2:27434262	C2orf28;SLC5A6	-0.47	-4.77	-0.48	8.27e-6	Blood metabolite levels;
SKCM	cis	rs3785574	0.962	rs13030	chr17:61908556	C/T	cg01411255	chr17:61851458	DDX42;CCDC47	1.16	12.75	0.82	9.1e-21	Height;
SKCM	cis	rs10769945	0.500	rs217203	chr11:1972456	G/C	cg23202291	chr11:1979235	NA	-0.57	-5.33	-0.52	9.27e-7	DNA methylation (variation);
SKCM	cis	rs2153535	0.580	rs6597332	chr6:8504748	C/G	cg07606381	chr6:8435919	SLC35B3	0.87	6.38	0.59	1.17e-8	Motion sickness;
SKCM	cis	rs9399135	0.967	rs6923827	chr6:135335382	C/T	cg24558204	chr6:135376177	HBS1L	0.59	5.22	0.51	1.42e-6	Red blood cell count;
SKCM	cis	rs929354	0.553	rs34498858	chr7:156931337	T/C	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs738322	0.967	rs133024	chr22:38574066	C/T	cg25457927	chr22:38595422	NA	0.53	6.01	0.56	5.68e-8	Cutaneous nevi;
SKCM	cis	rs9300255	0.602	rs1716164	chr12:123663660	G/A	cg05973401	chr12:123451056	ABCB9	0.81	5.37	0.52	7.77e-7	Neutrophil percentage of white cells;
SKCM	cis	rs4925114	0.568	rs9900803	chr17:17650978	C/T	cg04398451	chr17:18023971	MYO15A	0.77	5.2	0.51	1.54e-6	Body mass index;
SKCM	cis	rs860295	0.702	rs4971095	chr1:155606224	G/A	cg02153340	chr1:155202674	NA	0.74	5.43	0.52	6.23e-7	Body mass index;
SKCM	cis	rs9911578	1.000	rs4636974	chr17:56965373	C/G	cg12560992	chr17:57184187	TRIM37	0.94	7.55	0.65	7.01e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs2124969	0.522	rs6432608	chr2:161034991	C/T	cg03641300	chr2:160917029	PLA2R1	-0.62	-4.89	-0.48	5.38e-6	Waist circumference adjusted for body mass index;
SKCM	cis	rs362296	0.698	rs362279	chr4:3260072	G/A	cg21096898	chr4:3318625	RGS12	-0.84	-7.74	-0.66	3e-11	Parental longevity (mother's age at death);
SKCM	cis	rs2836974	0.899	rs6517514	chr21:40527095	G/T	cg17971929	chr21:40555470	PSMG1	0.87	8.48	0.69	1.1e-12	Cognitive function;
SKCM	cis	rs4819052	0.565	rs35776291	chr21:46706142	T/C	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.18	0.63	3.52e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs6951245	0.808	rs79672483	chr7:994756	G/A	cg24642844	chr7:1081250	C7orf50	-0.8	-4.91	-0.49	4.83e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs9910055	0.762	rs4239142	chr17:42205876	A/G	cg10896456	chr17:42255109	ASB16;C17orf65	-0.66	-6.3	-0.58	1.62e-8	Total body bone mineral density;
SKCM	cis	rs7772486	0.875	rs2224121	chr6:146343214	G/A	cg23711669	chr6:146136114	FBXO30	0.77	7.16	0.63	3.9e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1395	0.778	rs2078616	chr2:27441904	A/G	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.51	5.14	0.5	1.96e-6	Blood metabolite levels;
SKCM	cis	rs763121	0.853	rs2267394	chr22:39101633	T/C	cg06022373	chr22:39101656	GTPBP1	0.86	6.35	0.58	1.32e-8	Menopause (age at onset);
SKCM	cis	rs736408	0.507	rs6445531	chr3:52717282	T/C	cg18404041	chr3:52824283	ITIH1	-0.53	-4.77	-0.48	8.42e-6	Bipolar disorder;
SKCM	cis	rs1577917	0.839	rs6929514	chr6:86525768	A/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.69	-6.15	-0.57	3.13e-8	Response to antipsychotic treatment;
SKCM	cis	rs6089584	1.000	rs6089584	chr20:60564086	G/C	cg06108461	chr20:60628389	TAF4	-0.81	-7.11	-0.63	4.79e-10	Body mass index;
SKCM	cis	rs7020830	0.898	rs12000309	chr9:37230844	G/A	cg14294708	chr9:37120828	ZCCHC7	1.07	10.79	0.77	3.87e-17	Schizophrenia;
SKCM	cis	rs8017423	0.935	rs7158410	chr14:90704370	T/C	cg04374321	chr14:90722782	PSMC1	0.97	8.87	0.71	1.91e-13	Mortality in heart failure;
SKCM	cis	rs8180040	0.620	rs11917361	chr3:47070497	G/T	cg27129171	chr3:47204927	SETD2	-0.74	-5.37	-0.52	7.84e-7	Colorectal cancer;
SKCM	cis	rs34779708	0.931	rs4934710	chr10:35350416	T/C	cg03585969	chr10:35415529	CREM	0.76	6.26	0.58	1.91e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs1160297	0.576	rs1376567	chr2:53098515	C/G	cg07782112	chr2:53107842	NA	0.57	5.96	0.56	6.84e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs514406	0.893	rs476108	chr1:53317351	C/T	cg16325326	chr1:53192061	ZYG11B	0.92	9.93	0.75	1.75e-15	Monocyte count;
SKCM	cis	rs8072100	0.713	rs11079776	chr17:45546893	C/T	cg08085267	chr17:45401833	C17orf57	-0.63	-4.98	-0.49	3.72e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs801193	1.000	rs2659915	chr7:66153101	A/G	cg11987759	chr7:65425863	GUSB	-0.67	-5.68	-0.54	2.23e-7	Aortic root size;
SKCM	cis	rs1218582	0.741	rs4339857	chr1:154888962	A/G	cg03351412	chr1:154909251	PMVK	0.77	6.52	0.59	6.43e-9	Prostate cancer;
SKCM	cis	rs28595532	0.764	rs115916994	chr4:119688758	A/G	cg14228332	chr4:119757509	SEC24D	1.07	5.49	0.53	4.77e-7	Cannabis dependence symptom count;
SKCM	cis	rs7666738	0.830	rs7659006	chr4:98934529	T/C	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs929354	0.772	rs6459741	chr7:157014553	G/T	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs116095464	0.558	rs2288459	chr5:231143	T/C	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs10489202	0.632	rs149912	chr1:167957803	A/T	cg24449463	chr1:168025552	DCAF6	-0.79	-7.4	-0.64	1.33e-10	Schizophrenia;
SKCM	cis	rs7829975	0.711	rs1039916	chr8:8685854	A/G	cg15556689	chr8:8085844	FLJ10661	0.69	6.2	0.57	2.48e-8	Mood instability;
SKCM	cis	rs801193	1.000	rs2659909	chr7:66160279	G/A	cg18876405	chr7:65276391	NA	0.8	7.11	0.63	4.86e-10	Aortic root size;
SKCM	cis	rs12142240	0.698	rs6659228	chr1:46811027	C/G	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs7208859	0.573	rs216442	chr17:28931197	T/G	cg14067834	chr17:29058358	SUZ12P	1.08	4.95	0.49	4.21e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs116095464	0.558	rs10043002	chr5:226753	G/A	cg22496380	chr5:211416	CCDC127	-0.96	-5.27	-0.51	1.18e-6	Breast cancer;
SKCM	cis	rs11098499	0.863	rs7678400	chr4:120461957	G/A	cg09307838	chr4:120376055	NA	0.98	7.84	0.66	1.96e-11	Corneal astigmatism;
SKCM	cis	rs4466137	0.909	rs4466136	chr5:82985576	T/G	cg16102102	chr5:83017553	HAPLN1	-0.56	-6.18	-0.57	2.74e-8	Prostate cancer;
SKCM	cis	rs11098499	0.866	rs12374352	chr4:120281977	C/T	cg24375607	chr4:120327624	NA	0.62	4.77	0.48	8.45e-6	Corneal astigmatism;
SKCM	cis	rs6565180	0.926	rs12446288	chr16:30388709	A/G	cg17640201	chr16:30407289	ZNF48	0.93	7.27	0.64	2.36e-10	Tonsillectomy;
SKCM	cis	rs60871478	1.000	rs6460801	chr7:810506	T/C	cg05535760	chr7:792225	HEATR2	1.02	8.66	0.7	4.97e-13	Cerebrospinal P-tau181p levels;
SKCM	cis	rs1461503	0.966	rs11218910	chr11:122842861	G/A	cg27398637	chr11:122830231	C11orf63	-0.63	-4.8	-0.48	7.54e-6	Menarche (age at onset);
SKCM	cis	rs6088580	0.634	rs6088484	chr20:32985961	T/C	cg24642439	chr20:33292090	TP53INP2	-0.76	-6.02	-0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs2120019	0.567	rs68036747	chr15:75203200	A/C	cg17294928	chr15:75287854	SCAMP5	-0.85	-5.9	-0.56	8.72e-8	Blood trace element (Zn levels);
SKCM	cis	rs6951245	1.000	rs78185801	chr7:1096367	G/A	cg03188948	chr7:1209495	NA	1.13	6.27	0.58	1.89e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs6951245	1.000	rs75488469	chr7:1102122	A/G	cg03188948	chr7:1209495	NA	1.13	6.27	0.58	1.89e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs4481887	0.861	rs6681336	chr1:248482756	C/T	cg00666640	chr1:248458726	OR2T12	0.63	5.91	0.56	8.65e-8	Common traits (Other);
SKCM	cis	rs35306767	0.855	rs35666723	chr10:867346	A/G	cg26597838	chr10:835615	NA	0.79	6.08	0.57	4.12e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs644799	0.710	rs666398	chr11:95551136	C/T	cg03916912	chr11:95522834	CEP57;FAM76B	0.8	6.71	0.6	2.8e-9	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs929354	0.772	rs10230895	chr7:157007038	T/C	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs2386661	0.547	rs4747358	chr10:5650193	A/G	cg12223502	chr10:5658492	NA	0.54	4.83	0.48	6.57e-6	Breast cancer;
SKCM	cis	rs8017423	0.935	rs17188598	chr14:90722473	A/T	cg04374321	chr14:90722782	PSMC1	1.03	9.44	0.73	1.54e-14	Mortality in heart failure;
SKCM	cis	rs992157	0.798	rs10193383	chr2:219157692	C/T	cg20019365	chr2:219134978	PNKD;AAMP	0.71	6.11	0.57	3.64e-8	Colorectal cancer;
SKCM	cis	rs6570726	0.818	rs952405	chr6:145925952	T/C	cg23711669	chr6:146136114	FBXO30	0.81	7.92	0.67	1.35e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs595982	0.527	rs17272673	chr19:49362992	C/A	cg19746536	chr19:49375674	PPP1R15A	0.97	5.37	0.52	7.86e-7	Red cell distribution width;
SKCM	cis	rs2075371	1.000	rs1862050	chr7:133980999	T/C	cg20476274	chr7:133979776	SLC35B4	1.01	10.44	0.76	1.77e-16	Mean platelet volume;
SKCM	cis	rs2243480	1.000	rs59794892	chr7:65415873	G/A	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs738322	0.577	rs6001034	chr22:38558459	A/G	cg25457927	chr22:38595422	NA	-0.53	-6.14	-0.57	3.24e-8	Cutaneous nevi;
SKCM	cis	rs651907	0.557	rs3806653	chr3:101396972	T/C	cg12386194	chr3:101231763	SENP7	0.71	5.94	0.56	7.61e-8	Colorectal cancer;
SKCM	cis	rs6121246	0.909	rs6089058	chr20:30326338	T/G	cg11595048	chr20:30225325	COX4I2	0.67	5.21	0.51	1.5e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs2832191	1.000	rs2832190	chr21:30488226	G/A	cg24692254	chr21:30365293	RNF160	-0.79	-7.24	-0.63	2.72e-10	Dental caries;
SKCM	cis	rs1401999	1.000	rs939336	chr3:183685534	A/G	cg01324343	chr3:183735012	ABCC5	0.93	10.93	0.78	2.14e-17	Anterior chamber depth;
SKCM	cis	rs10489202	0.608	rs16828093	chr1:168078384	C/T	cg24449463	chr1:168025552	DCAF6	-0.81	-7.61	-0.65	5.44e-11	Schizophrenia;
SKCM	cis	rs6840360	0.615	rs1962910	chr4:152479392	T/A	cg22705602	chr4:152727874	NA	-0.51	-5.78	-0.55	1.48e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs17685	0.712	rs59659102	chr7:75710114	G/A	cg16489192	chr7:75678113	MDH2;STYXL1	-0.58	-5.46	-0.53	5.43e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs6434928	1	rs6434928	chr2:198304577	G/A	cg04278110	chr2:198063759	ANKRD44	0.7	4.79	0.48	7.87e-6	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs12142240	0.698	rs7525309	chr1:46809025	G/T	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs2836950	0.501	rs35994303	chr21:40686020	C/T	cg11644478	chr21:40555479	PSMG1	-0.63	-4.89	-0.48	5.25e-6	Menarche (age at onset);
SKCM	cis	rs35096708	0.525	rs34177108	chr16:89893375	C/A	cg08547343	chr16:90038815	CENPBD1;AFG3L1	-0.82	-6.02	-0.56	5.26e-8	Skin aging (microtopography measurement);
SKCM	cis	rs17065868	1.000	rs9533907	chr13:45131721	G/C	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs473651	0.935	rs35080527	chr2:239351387	T/C	cg18131467	chr2:239335373	ASB1	1.09	13.44	0.84	5.42e-22	Multiple system atrophy;
SKCM	cis	rs2836974	0.863	rs6517519	chr21:40540245	A/G	cg11890956	chr21:40555474	PSMG1	1.07	13.19	0.83	1.48e-21	Cognitive function;
SKCM	cis	rs4819052	0.851	rs34101026	chr21:46662200	C/T	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.42	0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs28785552	1.000	rs28785552	chr19:53234161	G/A	cg10871876	chr19:53194124	ZNF83	0.68	4.88	0.48	5.45e-6	Response to paliperidone in schizophrenia (PANSS score);
SKCM	cis	rs644799	1.000	rs693597	chr11:95589629	T/C	cg25622487	chr11:95524042	FAM76B;CEP57	0.64	4.86	0.48	6e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs9815354	0.812	rs58442057	chr3:41827209	G/A	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs875971	0.825	rs7384021	chr7:66077904	A/G	cg11764359	chr7:65958608	NA	-0.74	-6.63	-0.6	3.89e-9	Aortic root size;
SKCM	cis	rs7954584	0.546	rs10840630	chr12:122352445	C/T	cg13699009	chr12:122356056	WDR66	0.59	7.36	0.64	1.61e-10	Mean corpuscular volume;
SKCM	cis	rs28785552	0.931	rs10424385	chr19:53239133	C/G	cg10871876	chr19:53194124	ZNF83	0.81	5.91	0.56	8.68e-8	Response to paliperidone in schizophrenia (PANSS score);
SKCM	cis	rs2032447	0.839	rs199751	chr6:26015583	T/C	cg18357526	chr6:26021779	HIST1H4A	0.82	6.16	0.57	2.97e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs867186	1.000	rs80277764	chr20:33739456	C/T	cg04194272	chr20:33683537	NA	-1.11	-6.01	-0.56	5.7e-8	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs7666738	0.830	rs13144564	chr4:98939276	A/G	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs507080	0.883	rs558593	chr11:118562520	C/T	cg18045108	chr11:118530628	TREH	-0.47	-4.81	-0.48	7.17e-6	Serum metabolite levels;
SKCM	cis	rs611744	0.647	rs7015240	chr8:109262204	G/A	cg18478394	chr8:109455254	TTC35	0.66	5.32	0.52	9.59e-7	Dupuytren's disease;
SKCM	cis	rs1256061	0.646	rs1256059	chr14:64710417	A/G	cg21174375	chr14:64681225	SYNE2	0.47	4.93	0.49	4.56e-6	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs7772486	0.875	rs7766595	chr6:146364507	A/T	cg23711669	chr6:146136114	FBXO30	0.78	7.48	0.65	9.35e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs11112613	0.762	rs73184077	chr12:105949999	G/A	cg03607813	chr12:105948248	NA	0.83	5.77	0.55	1.55e-7	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;
SKCM	cis	rs9818758	0.556	rs13086240	chr3:49001409	G/A	cg00383909	chr3:49044727	WDR6	0.95	5.43	0.52	6.25e-7	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs9399135	0.967	rs11755229	chr6:135369913	A/G	cg24558204	chr6:135376177	HBS1L	0.58	5.05	0.5	2.86e-6	Red blood cell count;
SKCM	cis	rs6977660	1.000	rs5017194	chr7:19820035	A/T	cg05791153	chr7:19748676	TWISTNB	0.79	5.4	0.52	6.86e-7	Thyroid stimulating hormone;
SKCM	cis	rs10504229	0.639	rs17331850	chr8:58113538	G/T	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs2075371	0.933	rs1868785	chr7:133945855	G/C	cg20476274	chr7:133979776	SLC35B4	1.05	10.88	0.78	2.64e-17	Mean platelet volume;
SKCM	cis	rs2204008	0.811	rs11525004	chr12:38333807	T/A	cg26384229	chr12:38710491	ALG10B	0.81	6.67	0.6	3.38e-9	Bladder cancer;
SKCM	cis	rs7826238	0.509	rs2948288	chr8:8115304	A/G	cg06636001	chr8:8085503	FLJ10661	1.01	9.53	0.73	1.03e-14	Systolic blood pressure;
SKCM	cis	rs870825	0.616	rs79884757	chr4:185621454	A/G	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs2404602	0.735	rs11857015	chr15:76649390	T/C	cg23625390	chr15:77176239	SCAPER	-0.81	-8.03	-0.67	8.05e-12	Blood metabolite levels;
SKCM	cis	rs55962025	0.686	rs362331	chr4:3215835	T/C	cg00764545	chr4:3318001	RGS12	-0.6	-5.25	-0.51	1.27e-6	Parental longevity (mother's age at death);
SKCM	cis	rs10911251	0.508	rs6424890	chr1:183112764	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.76	7.28	0.64	2.26e-10	Colorectal cancer;
SKCM	cis	rs4819052	0.679	rs8132135	chr21:46694782	C/T	cg02159808	chr21:46707872	POFUT2;LOC642852	0.67	5.07	0.5	2.63e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs9814567	0.806	rs4955534	chr3:134319723	T/A	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.65	-5.19	-0.51	1.6e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs870825	0.858	rs2014964	chr4:185588836	G/A	cg04058563	chr4:185651563	MLF1IP	1.2	6.16	0.57	2.98e-8	Blood protein levels;
SKCM	cis	rs2075371	1.000	rs2058976	chr7:133981379	G/T	cg20476274	chr7:133979776	SLC35B4	1.0	10.41	0.76	2.04e-16	Mean platelet volume;
SKCM	cis	rs2455601	1.000	rs56336128	chr11:8908299	G/A	cg21881798	chr11:8931708	C11orf17;ST5	-0.94	-5.95	-0.56	7.15e-8	Schizophrenia;
SKCM	cis	rs1577917	0.876	rs11752223	chr6:86573394	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.81	-7.82	-0.66	2.07e-11	Response to antipsychotic treatment;
SKCM	cis	rs10089	0.953	rs4836359	chr5:127385518	T/A	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.92	8.29	0.68	2.54e-12	Ileal carcinoids;
SKCM	cis	rs2836974	0.932	rs2234543	chr21:40572072	G/A	cg11644478	chr21:40555479	PSMG1	0.98	9.83	0.74	2.68e-15	Cognitive function;
SKCM	cis	rs4523957	0.553	rs2641440	chr17:2027182	G/C	cg16513277	chr17:2031491	SMG6	-0.91	-6.21	-0.58	2.38e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs7208859	0.623	rs9911490	chr17:29073013	C/T	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs10883723	0.810	rs2296589	chr10:104248106	T/A	cg11453585	chr10:104263688	ACTR1A;SUFU	0.72	5.31	0.52	1e-6	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs860295	0.702	rs12025532	chr1:155369302	C/T	cg02153340	chr1:155202674	NA	-0.73	-5.23	-0.51	1.4e-6	Body mass index;
SKCM	cis	rs867186	1.000	rs2295700	chr20:33591627	G/A	cg04194272	chr20:33683537	NA	-1.36	-7.01	-0.62	7.44e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs7666738	0.830	rs1527517	chr4:98931907	C/T	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9875589	0.509	rs1844107	chr3:14065319	C/G	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.52	5.24	0.51	1.34e-6	Ovarian reserve;
SKCM	cis	rs10791097	0.690	rs12286234	chr11:130730528	T/C	cg12179176	chr11:130786555	SNX19	0.75	5.95	0.56	7.12e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs10779751	1.000	rs7526649	chr1:11278163	C/T	cg08854313	chr1:11322531	MTOR	0.9	6.76	0.61	2.29e-9	Body mass index;
SKCM	cis	rs12762955	0.519	rs10795306	chr10:1019138	A/T	cg20503657	chr10:835505	NA	-0.7	-5.63	-0.54	2.69e-7	Response to angiotensin II receptor blocker therapy;
SKCM	cis	rs11626933	1.000	rs7146724	chr14:90766092	C/T	cg14092571	chr14:90743983	NA	-0.87	-8.0	-0.67	9.54e-12	Gut microbiota (bacterial taxa);
SKCM	cis	rs7772486	0.754	rs2328709	chr6:146106819	A/G	cg23711669	chr6:146136114	FBXO30	-0.89	-9.75	-0.74	3.82e-15	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs72781680	0.611	rs74661620	chr2:24365260	C/A	cg20701182	chr2:24300061	SF3B14	0.79	5.24	0.51	1.31e-6	Lymphocyte counts;
SKCM	cis	rs7811142	1.000	rs4463351	chr7:100078226	G/A	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.23	7.89	0.67	1.53e-11	Platelet count;
SKCM	cis	rs2842992	0.789	rs9365093	chr6:160175819	C/G	cg19482086	chr6:160211437	TCP1;MRPL18	0.86	6.82	0.61	1.71e-9	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs875971	0.895	rs7782806	chr7:65657897	C/T	cg11764359	chr7:65958608	NA	-0.8	-7.7	-0.66	3.63e-11	Aortic root size;
SKCM	cis	rs9814567	1.000	rs4334685	chr3:134304335	T/G	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs13424612	1.000	rs4854058	chr2:240923677	C/A	cg01812947	chr2:240904978	NDUFA10	0.64	4.86	0.48	6e-6	Odorant perception (isobutyraldehyde);
SKCM	cis	rs548181	0.545	rs1054997	chr11:125618813	G/A	cg03464685	chr11:125439445	EI24	-1.26	-6.58	-0.6	4.85e-9	Schizophrenia;Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);
SKCM	cis	rs2463822	1.000	rs72921501	chr11:62115622	A/T	cg06239285	chr11:62104954	ASRGL1	-1.26	-5.85	-0.55	1.08e-7	Chronic obstructive pulmonary disease-related biomarkers;
SKCM	cis	rs4478137	0.931	rs4057797	chr4:164245053	T/A	cg06758707	chr4:164254230	NPY1R	0.94	6.24	0.58	2.08e-8	Subjective well-being (multi-trait analysis);Subjective well-being;
SKCM	cis	rs7937682	0.921	rs688354	chr11:111438762	A/G	cg19812747	chr11:111475976	SIK2	-0.64	-5.41	-0.52	6.68e-7	Primary sclerosing cholangitis;
SKCM	cis	rs2836974	0.897	rs11911112	chr21:40528346	A/C	cg11890956	chr21:40555474	PSMG1	1.07	13.19	0.83	1.48e-21	Cognitive function;
SKCM	cis	rs62064224	0.702	rs735555	chr17:30817450	A/G	cg25809561	chr17:30822961	MYO1D	-0.72	-6.0	-0.56	5.88e-8	Schizophrenia;
SKCM	cis	rs4862750	0.914	rs1991256	chr4:187875330	A/G	cg10295955	chr4:187884368	NA	-1.04	-13.63	-0.84	2.47e-22	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9291683	0.645	rs11557743	chr4:10118377	C/G	cg13841979	chr4:9990048	SLC2A9	0.44	5.11	0.5	2.21e-6	Bone mineral density;
SKCM	cis	rs17685	0.753	rs4732595	chr7:75755139	A/G	cg01364799	chr7:75623366	TMEM120A	-0.7	-5.69	-0.54	2.09e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs9910055	0.659	rs112114764	chr17:42201041	G/T	cg09913183	chr17:42254507	C17orf65;ASB16	-0.69	-6.6	-0.6	4.51e-9	Total body bone mineral density;
SKCM	trans	rs3780486	0.846	rs7864705	chr9:33140352	A/C	cg20290983	chr6:43655470	MRPS18A	0.99	11.23	0.79	5.77e-18	IgG glycosylation;
SKCM	cis	rs17818399	0.547	rs7607308	chr2:46759104	T/C	cg02822958	chr2:46747628	ATP6V1E2	0.68	4.91	0.49	4.99e-6	Height;
SKCM	cis	rs854765	0.547	rs4072739	chr17:17884660	G/A	cg04398451	chr17:18023971	MYO15A	-0.87	-6.33	-0.58	1.43e-8	Total body bone mineral density;
SKCM	cis	rs8177253	0.798	rs9871148	chr3:133507509	T/C	cg16414030	chr3:133502952	NA	-0.68	-5.43	-0.52	6.19e-7	Iron status biomarkers;
SKCM	cis	rs1218582	0.772	rs4240874	chr1:154885779	C/T	cg03351412	chr1:154909251	PMVK	0.77	6.52	0.59	6.43e-9	Prostate cancer;
SKCM	cis	rs875971	0.862	rs6944374	chr7:65686929	C/G	cg18876405	chr7:65276391	NA	-0.63	-6.43	-0.59	9.25e-9	Aortic root size;
SKCM	cis	rs1577917	1.000	rs12192992	chr6:86609915	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.66	-5.74	-0.54	1.76e-7	Response to antipsychotic treatment;
SKCM	cis	rs711244	0.783	rs2110944	chr2:37090233	T/C	cg14987922	chr2:37194071	STRN	-0.64	-4.79	-0.48	7.85e-6	Mean platelet volume;
SKCM	cis	rs3820928	1.000	rs3820928	chr2:227773466	A/G	cg11843606	chr2:227700838	RHBDD1	-0.64	-5.2	-0.51	1.53e-6	Pulmonary function;
SKCM	cis	rs9322193	0.923	rs9377230	chr6:149934743	T/C	cg07701084	chr6:150067640	NUP43	0.6	4.79	0.48	7.78e-6	Lung cancer;
SKCM	cis	rs11098499	0.863	rs59732491	chr4:120489588	G/C	cg09307838	chr4:120376055	NA	1.0	8.27	0.68	2.8e-12	Corneal astigmatism;
SKCM	cis	rs9443189	0.762	rs2748944	chr6:76436106	A/G	cg01950844	chr6:76311363	SENP6	0.74	5.23	0.51	1.38e-6	Prostate cancer;
SKCM	cis	rs4819052	1.000	rs4818769	chr21:46667451	C/T	cg19498844	chr21:46707878	POFUT2;LOC642852	0.87	6.8	0.61	1.88e-9	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs867186	1.000	rs73903009	chr20:33678732	G/A	cg04194272	chr20:33683537	NA	-1.38	-7.2	-0.63	3.29e-10	Blood protein levels;Coronary artery disease;Hemostatic factors and hematological phenotypes;Factor VII levels;Protein C levels;D-dimer levels;Anticoagulant levels;
SKCM	cis	rs2455601	1.000	rs11042114	chr11:8919889	C/T	cg21881798	chr11:8931708	C11orf17;ST5	-0.78	-5.59	-0.53	3.21e-7	Schizophrenia;
SKCM	cis	rs778371	0.697	rs2344611	chr2:233581937	A/G	cg08000102	chr2:233561755	GIGYF2	0.84	6.49	0.59	7.32e-9	Schizophrenia;
SKCM	cis	rs66887589	0.967	rs7678973	chr4:120511817	T/C	cg09307838	chr4:120376055	NA	-0.65	-4.87	-0.48	5.72e-6	Diastolic blood pressure;
SKCM	cis	rs875971	0.895	rs4145009	chr7:65726615	T/C	cg11764359	chr7:65958608	NA	-0.82	-7.84	-0.66	1.9e-11	Aortic root size;
SKCM	cis	rs1799949	0.587	rs1824890	chr17:41421904	T/C	cg05368731	chr17:41323189	NBR1	0.75	5.3	0.51	1.04e-6	Menopause (age at onset);
SKCM	cis	rs28386778	0.897	rs1982400	chr17:61793818	T/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.12	11.04	0.78	1.31e-17	Prudent dietary pattern;
SKCM	cis	rs12477438	0.798	rs2045057	chr2:99684929	A/G	cg26064155	chr2:99771622	LIPT1;TSGA10	-0.72	-4.86	-0.48	6e-6	Chronic sinus infection;
SKCM	cis	rs4073582	0.595	rs708472	chr11:65930990	A/G	cg14036092	chr11:66035641	RAB1B	0.74	5.8	0.55	1.34e-7	Gout;
SKCM	cis	rs4925386	0.559	rs2427291	chr20:60921324	G/A	cg24112000	chr20:60950667	NA	-0.7	-5.71	-0.54	1.93e-7	Colorectal cancer;Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs7666738	0.830	rs1426665	chr4:99027764	C/T	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11098499	0.863	rs10004484	chr4:120442428	C/T	cg09307838	chr4:120376055	NA	0.97	7.66	0.66	4.19e-11	Corneal astigmatism;
SKCM	cis	rs2839186	0.814	rs2839167	chr21:47661587	A/G	cg05896524	chr21:47604654	C21orf56	0.69	5.89	0.55	9.17e-8	Testicular germ cell tumor;
SKCM	cis	rs4819052	0.851	rs2838844	chr21:46670733	A/C	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.36	0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs6121246	0.865	rs77130187	chr20:30269060	G/A	cg11595048	chr20:30225325	COX4I2	0.64	4.88	0.48	5.58e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs3818285	0.959	rs492943	chr10:111629030	A/T	cg00817464	chr10:111662876	XPNPEP1	0.61	4.89	0.48	5.23e-6	Superior crus of antihelix expression;
SKCM	cis	rs11098499	0.863	rs9997631	chr4:120469995	C/G	cg24375607	chr4:120327624	NA	0.69	5.47	0.53	5.35e-7	Corneal astigmatism;
SKCM	cis	rs2594989	0.779	rs7647622	chr3:11590871	G/A	cg00170343	chr3:11313890	ATG7	-1.01	-5.62	-0.54	2.88e-7	Circulating chemerin levels;
SKCM	cis	rs2228479	0.717	rs1007932	chr16:89838541	C/T	cg06558623	chr16:89946397	TCF25	1.22	6.06	0.57	4.52e-8	Skin colour saturation;
SKCM	cis	rs72781680	1.000	rs72796351	chr2:24158425	T/C	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	cis	rs9790314	0.560	rs4856701	chr3:161044106	G/T	cg03342759	chr3:160939853	NMD3	-0.75	-6.4	-0.59	1.07e-8	Morning vs. evening chronotype;
SKCM	cis	rs11098499	0.954	rs10006706	chr4:120409152	A/G	cg09307838	chr4:120376055	NA	0.97	7.65	0.65	4.54e-11	Corneal astigmatism;
SKCM	cis	rs72781680	0.898	rs113522526	chr2:24018476	C/T	cg08917208	chr2:24149416	ATAD2B	0.92	4.95	0.49	4.16e-6	Lymphocyte counts;
SKCM	cis	rs1850744	0.702	rs115282360	chr4:9593376	C/T	cg15442990	chr4:9534313	NA	-1.3	-4.84	-0.48	6.55e-6	Economic and political preferences;
SKCM	cis	rs7666738	0.830	rs1426666	chr4:99030887	A/G	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1401999	0.650	rs3792585	chr3:183646222	A/G	cg01324343	chr3:183735012	ABCC5	0.71	6.74	0.61	2.49e-9	Anterior chamber depth;
SKCM	cis	rs7927771	0.965	rs4752845	chr11:47539697	T/C	cg05585544	chr11:47624801	NA	-0.64	-5.54	-0.53	3.93e-7	Subjective well-being;
SKCM	cis	rs7954584	0.523	rs11043280	chr12:122426643	T/C	cg21171335	chr12:122356390	WDR66	0.46	4.95	0.49	4.27e-6	Mean corpuscular volume;
SKCM	cis	rs9911578	1.000	rs302840	chr17:56673079	C/G	cg12560992	chr17:57184187	TRIM37	0.95	7.53	0.65	7.45e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs453301	0.571	rs2929456	chr8:9083416	G/A	cg15556689	chr8:8085844	FLJ10661	-0.65	-5.05	-0.5	2.79e-6	Joint mobility (Beighton score);
SKCM	cis	rs875971	0.862	rs7782704	chr7:65805366	G/A	cg11764359	chr7:65958608	NA	-0.81	-7.6	-0.65	5.6e-11	Aortic root size;
SKCM	cis	rs951366	0.646	rs1772159	chr1:205759195	G/A	cg24503407	chr1:205819492	PM20D1	0.93	9.37	0.73	2.04e-14	Menarche (age at onset);
SKCM	cis	rs593982	1.000	rs72922786	chr11:65562852	G/C	cg08755490	chr11:65554678	OVOL1	-0.91	-6.74	-0.61	2.4e-9	Atopic dermatitis;
SKCM	cis	rs992157	0.735	rs2271541	chr2:219082119	G/T	cg00012203	chr2:219082015	ARPC2	0.82	7.1	0.63	5.13e-10	Colorectal cancer;
SKCM	cis	rs4132509	0.843	rs6671475	chr1:243789342	A/G	cg21452805	chr1:244014465	NA	0.78	5.0	0.49	3.46e-6	RR interval (heart rate);
SKCM	cis	rs760805	1.000	rs742230	chr1:25251424	G/A	cg22509179	chr1:25234806	RUNX3	-0.75	-6.22	-0.58	2.26e-8	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs12780845	1.000	rs12783490	chr10:17223716	T/A	cg07990022	chr10:16570110	NA	-0.61	-4.87	-0.48	5.67e-6	Homocysteine levels;
SKCM	cis	rs7811142	0.830	rs78256546	chr7:99952970	A/G	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.2	7.87	0.67	1.7e-11	Platelet count;
SKCM	cis	rs870825	0.860	rs28799091	chr4:185598594	G/A	cg04058563	chr4:185651563	MLF1IP	1.02	5.81	0.55	1.27e-7	Blood protein levels;
SKCM	cis	rs7811142	0.887	rs4074838	chr7:100032665	G/A	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.23	7.89	0.67	1.53e-11	Platelet count;
SKCM	cis	rs1003719	0.788	rs2835578	chr21:38457671	T/C	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs282587	0.569	rs413110	chr13:113413755	A/G	cg09244037	chr13:114275670	TFDP1	0.73	4.81	0.48	7.14e-6	Glycated hemoglobin levels;
SKCM	cis	rs7666738	0.830	rs10050008	chr4:99025313	T/G	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4629180	0.920	rs4851458	chr2:102108794	T/C	cg20146536	chr2:102096205	NA	0.58	4.87	0.48	5.81e-6	Chronic rhinosinusitis with nasal polyps;
SKCM	cis	rs2153535	0.580	rs1034272	chr6:8469335	G/C	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs8017423	0.967	rs7147952	chr14:90720831	G/A	cg04374321	chr14:90722782	PSMC1	0.97	8.91	0.71	1.61e-13	Mortality in heart failure;
SKCM	cis	rs17065868	1.000	rs9533923	chr13:45169096	A/G	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs7020830	0.928	rs11544336	chr9:37089150	A/G	cg14294708	chr9:37120828	ZCCHC7	1.08	9.8	0.74	3.1e-15	Schizophrenia;
SKCM	cis	rs28374715	0.662	rs72737793	chr15:41516823	C/T	cg18705301	chr15:41695430	NDUFAF1	-0.94	-7.84	-0.66	1.88e-11	Ulcerative colitis;
SKCM	cis	rs4972806	0.814	rs966801	chr2:177037827	G/A	cg13092806	chr2:177043255	NA	0.57	5.37	0.52	7.9e-7	IgG glycosylation;
SKCM	cis	rs151997	0.925	rs27286	chr5:50196324	G/T	cg06027927	chr5:50259733	NA	0.64	5.57	0.53	3.49e-7	Callous-unemotional behaviour;
SKCM	cis	rs4073582	0.576	rs556595	chr11:66058082	T/G	cg14036092	chr11:66035641	RAB1B	0.8	6.07	0.57	4.28e-8	Gout;
SKCM	cis	rs1003719	0.788	rs2835600	chr21:38468958	A/G	cg10648535	chr21:38446584	PIGP;TTC3	0.63	5.02	0.49	3.17e-6	Eye color traits;
SKCM	cis	rs73201462	1.000	rs7374227	chr3:128001515	C/G	cg09089421	chr3:127803668	RUVBL1	0.95	5.16	0.5	1.8e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs9614461	0.702	rs2294202	chr22:45738327	A/T	cg26276947	chr22:44892394	LDOC1L	0.8	4.85	0.48	6.13e-6	Tonsillectomy;
SKCM	cis	rs561341	1.000	rs501312	chr17:30329066	A/G	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs9815354	0.812	rs73069203	chr3:41938767	T/C	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs4665809	0.556	rs6730311	chr2:26419474	C/T	cg04944784	chr2:26401820	FAM59B	-0.78	-5.02	-0.49	3.24e-6	Gut microbiome composition (summer);
SKCM	cis	rs873946	0.504	rs12254034	chr10:134571007	T/C	cg27286337	chr10:134555280	INPP5A	1.01	9.65	0.74	5.88e-15	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs59043219	1	rs59043219	chr1:209970610	G/A	cg22029157	chr1:209979665	IRF6	0.54	5.12	0.5	2.16e-6	Crohn's disease;Inflammatory bowel disease;Alzheimer's disease (APOE e4 interaction);
SKCM	cis	rs2075371	1.000	rs1421484	chr7:133979795	T/C	cg20476274	chr7:133979776	SLC35B4	1.01	10.44	0.76	1.77e-16	Mean platelet volume;
SKCM	cis	rs367615	0.512	rs814153	chr5:108667829	A/C	cg17395555	chr5:108820864	NA	0.69	5.61	0.54	2.91e-7	Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs6088590	1.000	rs6120708	chr20:33335526	G/A	cg24642439	chr20:33292090	TP53INP2	1.02	7.56	0.65	6.73e-11	Coronary artery disease;
SKCM	cis	rs2404602	0.692	rs12594556	chr15:77165363	G/A	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs7666738	0.830	rs6832209	chr4:98994120	A/G	cg05340658	chr4:99064831	C4orf37	0.67	5.14	0.5	1.98e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9796	0.621	rs2899013	chr15:41492283	G/T	cg18705301	chr15:41695430	NDUFAF1	-0.7	-5.17	-0.5	1.79e-6	Menopause (age at onset);
SKCM	cis	rs870825	0.929	rs72689258	chr4:185590550	G/C	cg04058563	chr4:185651563	MLF1IP	1.09	5.66	0.54	2.4e-7	Blood protein levels;
SKCM	cis	rs9733	0.818	rs10888388	chr1:150687296	C/T	cg13175981	chr1:150552382	MCL1	0.64	4.86	0.48	5.85e-6	Tonsillectomy;
SKCM	cis	rs12142240	0.698	rs41294458	chr1:46810304	T/C	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs12532878	0.652	rs62482223	chr7:100198878	C/A	cg20848291	chr7:100343083	ZAN	-0.72	-5.33	-0.52	9.21e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs6570726	0.870	rs370653	chr6:145823642	G/A	cg23711669	chr6:146136114	FBXO30	0.7	6.64	0.6	3.72e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs854765	0.583	rs4534911	chr17:17852330	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.93	7.3	0.64	2.06e-10	Total body bone mineral density;
SKCM	cis	rs7666738	0.830	rs13108705	chr4:99044438	T/C	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs28595532	0.764	rs56071514	chr4:119761833	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs7590720	0.819	rs12467676	chr2:216895736	T/G	cg12620499	chr2:216877984	MREG	0.9	8.71	0.7	3.92e-13	Alcohol dependence;
SKCM	cis	rs34779708	0.931	rs13376801	chr10:35370443	T/C	cg03585969	chr10:35415529	CREM	0.78	6.3	0.58	1.6e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs28595532	0.920	rs116791817	chr4:119763303	C/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs9309711	0.736	rs9678647	chr2:3497036	A/G	cg10845886	chr2:3471009	TTC15	0.81	5.46	0.53	5.48e-7	Neurofibrillary tangles;
SKCM	cis	rs2115536	1.000	rs11637477	chr15:80193295	C/T	cg00225070	chr15:80189496	MTHFS	0.76	5.1	0.5	2.31e-6	Eosinophil counts;Eosinophil percentage of white cells;Sum eosinophil basophil counts;Eosinophil percentage of granulocytes;Neutrophil percentage of granulocytes;
SKCM	cis	rs13064447	0.967	rs55668390	chr3:12766020	C/G	cg05775895	chr3:12838266	CAND2	0.65	5.25	0.51	1.29e-6	Major depression and alcohol dependence;
SKCM	cis	rs2153535	0.580	rs9406170	chr6:8514153	T/C	cg07606381	chr6:8435919	SLC35B3	0.87	6.38	0.59	1.17e-8	Motion sickness;
SKCM	cis	rs7296418	0.619	rs7139321	chr12:123719528	T/G	cg05973401	chr12:123451056	ABCB9	0.75	5.75	0.55	1.63e-7	Platelet count;
SKCM	cis	rs826838	1.000	rs55828987	chr12:39056421	A/C	cg26384229	chr12:38710491	ALG10B	0.97	9.33	0.73	2.52e-14	Heart rate;
SKCM	cis	rs1979654	0.543	rs1552655	chr16:86403554	T/A	cg01467047	chr16:86611690	FOXL1	-0.39	-4.84	-0.48	6.34e-6	Barrett's esophagus  or Esophageal adenocarcinoma;
SKCM	cis	rs7927771	1.000	rs34910028	chr11:47758449	T/C	cg05585544	chr11:47624801	NA	-0.6	-5.22	-0.51	1.45e-6	Subjective well-being;
SKCM	cis	rs7584330	0.695	rs6709497	chr2:238368925	C/T	cg14458575	chr2:238380390	NA	0.86	6.22	0.58	2.31e-8	Prostate cancer;
SKCM	cis	rs2153535	0.580	rs1360054	chr6:8520377	C/A	cg07606381	chr6:8435919	SLC35B3	0.87	6.38	0.59	1.17e-8	Motion sickness;
SKCM	cis	rs6121246	0.821	rs3181073	chr20:30307199	A/C	cg11595048	chr20:30225325	COX4I2	-0.67	-5.21	-0.51	1.5e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs7811142	0.943	rs28660238	chr7:100023308	C/T	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.16	7.68	0.66	3.87e-11	Platelet count;
SKCM	cis	rs4642101	0.765	rs3901665	chr3:12824610	C/A	cg05775895	chr3:12838266	CAND2	0.63	5.82	0.55	1.22e-7	QRS complex (12-leadsum);
SKCM	cis	rs6430585	0.527	rs76622824	chr2:136411879	A/G	cg07169764	chr2:136633963	MCM6	1.02	7.7	0.66	3.66e-11	Corneal structure;
SKCM	cis	rs7824557	0.564	rs2736290	chr8:11234298	C/T	cg21775007	chr8:11205619	TDH	-0.61	-5.09	-0.5	2.37e-6	Retinal vascular caliber;
SKCM	trans	rs561341	1.000	rs535151	chr17:30317405	C/T	cg20587970	chr11:113659929	NA	-1.14	-9.67	-0.74	5.51e-15	Hip circumference adjusted for BMI;
SKCM	cis	rs748404	0.660	rs690446	chr15:43761264	G/C	cg02155558	chr15:43621948	ADAL;LCMT2	0.72	5.54	0.53	3.99e-7	Lung cancer;
SKCM	cis	rs6582630	0.537	rs2204006	chr12:38407098	A/G	cg26384229	chr12:38710491	ALG10B	0.82	6.3	0.58	1.6e-8	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs7666738	0.716	rs2865982	chr4:99031661	T/G	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs514406	0.861	rs11206011	chr1:53235910	T/C	cg24675658	chr1:53192096	ZYG11B	0.61	4.78	0.48	8e-6	Monocyte count;
SKCM	cis	rs55962025	0.842	rs362271	chr4:3235518	C/T	cg24015175	chr4:3319247	RGS12	-0.65	-5.39	-0.52	7.33e-7	Parental longevity (mother's age at death);
SKCM	cis	rs28595532	0.920	rs115838006	chr4:119754356	T/C	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs7937682	0.883	rs1789351	chr11:111456436	T/A	cg09085632	chr11:111637200	PPP2R1B	-1.05	-10.08	-0.75	8.93e-16	Primary sclerosing cholangitis;
SKCM	cis	rs2228479	0.717	rs9282682	chr16:89805794	A/G	cg06558623	chr16:89946397	TCF25	1.07	5.69	0.54	2.09e-7	Skin colour saturation;
SKCM	cis	rs6582630	0.555	rs11182217	chr12:38480030	G/A	cg13010199	chr12:38710504	ALG10B	0.69	4.9	0.49	5.02e-6	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs6840360	0.571	rs4696102	chr4:152529658	C/T	cg22705602	chr4:152727874	NA	-0.52	-5.7	-0.54	2.03e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs1218582	0.774	rs2335409	chr1:154916106	G/A	cg03351412	chr1:154909251	PMVK	0.74	6.39	0.59	1.13e-8	Prostate cancer;
SKCM	cis	rs9368481	1.000	rs9368481	chr6:26961761	C/T	cg12292205	chr6:26970375	C6orf41	-0.71	-6.4	-0.59	1.05e-8	Autism spectrum disorder or schizophrenia;
SKCM	cis	rs9430161	0.611	rs72644043	chr1:11033051	T/A	cg02454025	chr1:11042201	C1orf127	1.07	9.97	0.75	1.47e-15	Ewing sarcoma;
SKCM	cis	rs7561149	0.902	rs6715406	chr2:179650701	C/T	cg03991736	chr2:179345203	MIR548N;PLEKHA3	0.68	4.81	0.48	7.27e-6	QT interval;
SKCM	cis	rs3820068	0.581	rs34453754	chr1:15993208	G/C	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs12709013	0.792	rs7185513	chr16:58828793	A/G	cg02431531	chr16:59244939	NA	0.49	4.93	0.49	4.58e-6	Blood metabolite ratios;
SKCM	cis	rs6545883	0.965	rs3771261	chr2:61762161	A/G	cg15711740	chr2:61764176	XPO1	-0.74	-5.26	-0.51	1.23e-6	Tuberculosis;
SKCM	cis	rs5750830	0.649	rs4821893	chr22:39797779	G/A	cg24399712	chr22:39784796	NA	-0.62	-5.12	-0.5	2.12e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1395	0.961	rs4665965	chr2:27536380	C/T	cg14242246	chr2:27434262	C2orf28;SLC5A6	-0.5	-4.83	-0.48	6.55e-6	Blood metabolite levels;
SKCM	cis	rs7659604	0.540	rs10012775	chr4:122676878	T/C	cg19671926	chr4:122722719	EXOSC9	0.77	6.27	0.58	1.89e-8	Type 2 diabetes;
SKCM	cis	rs2180341	0.618	rs12210968	chr6:127596985	A/G	cg24812749	chr6:127587940	RNF146	0.59	4.84	0.48	6.36e-6	Breast cancer;
SKCM	cis	rs2404602	0.684	rs1011084	chr15:77007480	C/G	cg23625390	chr15:77176239	SCAPER	-0.85	-8.26	-0.68	2.93e-12	Blood metabolite levels;
SKCM	cis	rs9325144	0.555	rs1973292	chr12:38679626	T/C	cg26384229	chr12:38710491	ALG10B	0.78	6.74	0.61	2.48e-9	Morning vs. evening chronotype;
SKCM	cis	rs9322193	0.924	rs9498382	chr6:149932118	A/G	cg07701084	chr6:150067640	NUP43	0.63	4.96	0.49	4.08e-6	Lung cancer;
SKCM	cis	rs4819052	0.851	rs4819049	chr21:46673086	C/G	cg19498844	chr21:46707878	POFUT2;LOC642852	0.88	7.69	0.66	3.74e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs9443189	0.570	rs9343316	chr6:76411800	G/A	cg01950844	chr6:76311363	SENP6	1.02	6.34	0.58	1.39e-8	Prostate cancer;
SKCM	cis	rs7666738	0.830	rs62321570	chr4:98984276	G/A	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6463523	0.933	rs6974151	chr7:758269	T/C	cg05729249	chr7:766119	PRKAR1B;HEATR2	0.91	7.13	0.63	4.37e-10	Subjective well-being;
SKCM	trans	rs8073060	0.586	rs7208672	chr17:33989759	G/A	cg19694781	chr19:47549865	TMEM160	-1.04	-8.28	-0.68	2.65e-12	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs9300255	0.568	rs1627724	chr12:123638580	T/A	cg00376283	chr12:123451042	ABCB9	0.8	5.4	0.52	7.12e-7	Neutrophil percentage of white cells;
SKCM	cis	rs34172651	0.517	rs34172679	chr16:24840381	C/T	cg04756594	chr16:24857601	SLC5A11	0.7	5.26	0.51	1.24e-6	Intelligence (multi-trait analysis);
SKCM	trans	rs17685	0.712	rs10235738	chr7:75773460	G/A	cg19862616	chr7:65841803	NCRNA00174	0.88	8.34	0.69	2.1e-12	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs8180040	0.654	rs1466740	chr3:47245883	C/T	cg27129171	chr3:47204927	SETD2	-0.73	-5.32	-0.52	9.51e-7	Colorectal cancer;
SKCM	cis	rs73157695	0.676	rs9980566	chr21:47343511	G/A	cg10605724	chr21:47966967	DIP2A	-0.7	-5.17	-0.51	1.75e-6	Myopia;
SKCM	cis	rs17376456	0.877	rs10073039	chr5:93467709	A/G	cg21475434	chr5:93447410	FAM172A	0.97	5.42	0.52	6.39e-7	Diabetic retinopathy;
SKCM	cis	rs7666738	0.830	rs13119913	chr4:98977983	G/T	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2832191	0.647	rs11170	chr21:30378090	C/T	cg24692254	chr21:30365293	RNF160	0.89	7.96	0.67	1.14e-11	Dental caries;
SKCM	cis	rs1568889	0.838	rs11030187	chr11:28044391	A/C	cg06544937	chr11:28130018	METT5D1;KIF18A	0.87	8.04	0.67	7.77e-12	Bipolar disorder;
SKCM	cis	rs2120019	0.638	rs12050628	chr15:75333494	G/A	cg17294928	chr15:75287854	SCAMP5	0.87	8.5	0.69	1.01e-12	Blood trace element (Zn levels);
SKCM	cis	rs60871478	1.000	rs62432224	chr7:788284	G/A	cg04727924	chr7:799746	HEATR2	-0.6	-4.8	-0.48	7.39e-6	Cerebrospinal P-tau181p levels;
SKCM	cis	rs7953249	0.656	rs2178463	chr12:121389721	A/G	cg02403541	chr12:121454288	C12orf43	-0.68	-5.18	-0.51	1.68e-6	Invasive epithelial ovarian cancer;High-grade serous ovarian cancer;Chronic obstructive pulmonary disease-related biomarkers;N-glycan levels;Serous invasive ovarian cancer;Epithelial ovarian cancer;
SKCM	cis	rs7659604	0.728	rs3924987	chr4:122689784	G/T	cg19748678	chr4:122722346	EXOSC9	0.7	5.36	0.52	8.1e-7	Type 2 diabetes;
SKCM	cis	rs17376456	0.877	rs13170509	chr5:93378564	T/C	cg25358565	chr5:93447407	FAM172A	1.19	7.67	0.66	4.06e-11	Diabetic retinopathy;
SKCM	cis	rs7772486	0.754	rs4896839	chr6:146019689	T/G	cg05347473	chr6:146136440	FBXO30	-0.65	-5.92	-0.56	8.01e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs4972806	0.775	rs2857534	chr2:177035676	G/T	cg14324370	chr2:177042789	NA	0.56	5.09	0.5	2.42e-6	IgG glycosylation;
SKCM	cis	rs7191439	0.790	rs2306046	chr16:88781419	A/G	cg02389323	chr16:88786976	FAM38A	1.47	6.49	0.59	7.17e-9	Plateletcrit;
SKCM	cis	rs748404	0.697	rs513970	chr15:43579566	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	0.74	6.25	0.58	2.04e-8	Lung cancer;
SKCM	cis	rs10504229	0.636	rs77691549	chr8:58055126	G/T	cg02725872	chr8:58115012	NA	-0.54	-4.96	-0.49	4.05e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs4523957	0.583	rs2984942	chr17:2030155	A/G	cg16513277	chr17:2031491	SMG6	-0.88	-6.13	-0.57	3.4e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs1799949	1.000	rs4793191	chr17:41204377	A/G	cg05368731	chr17:41323189	NBR1	0.89	7.67	0.66	4.08e-11	Menopause (age at onset);
SKCM	trans	rs208520	0.690	rs4710564	chr6:66823478	A/G	cg15611600	chr13:45563400	KIAA1704;NUFIP1	1.07	7.42	0.64	1.24e-10	Exhaled nitric oxide output;
SKCM	cis	rs7811142	1.000	rs60478351	chr7:100089017	C/T	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.19	7.92	0.67	1.33e-11	Platelet count;
SKCM	cis	rs7100689	0.646	rs7899791	chr10:82091950	A/T	cg01528321	chr10:82214614	TSPAN14	0.76	6.21	0.58	2.39e-8	Post bronchodilator FEV1;
SKCM	cis	rs8077889	0.869	rs11713	chr17:41845824	A/G	cg26893861	chr17:41843967	DUSP3	-1.22	-7.77	-0.66	2.58e-11	Triglycerides;
SKCM	cis	rs2153535	0.580	rs7341206	chr6:8470489	T/G	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs6089584	0.606	rs2144674	chr20:60576579	G/A	cg16423285	chr20:60520624	NA	-0.6	-4.93	-0.49	4.5e-6	Body mass index;
SKCM	cis	rs250585	0.667	rs463804	chr16:23609315	T/A	cg09934309	chr16:23461721	COG7	-0.81	-5.24	-0.51	1.32e-6	Egg allergy;
SKCM	cis	rs7811142	0.887	rs35111986	chr7:100000274	C/A	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.13	6.53	0.59	5.99e-9	Platelet count;
SKCM	cis	rs873946	0.648	rs12767126	chr10:134556992	C/T	cg27286337	chr10:134555280	INPP5A	0.96	8.42	0.69	1.47e-12	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs614226	0.938	rs12857	chr12:120933946	T/G	cg01236616	chr12:121019343	POP5	1.34	8.54	0.7	8.29e-13	Type 1 diabetes nephropathy;
SKCM	cis	rs1395	0.778	rs11126918	chr2:27438710	G/A	cg14242246	chr2:27434262	C2orf28;SLC5A6	0.51	5.14	0.5	1.96e-6	Blood metabolite levels;
SKCM	trans	rs62103177	0.759	rs9956512	chr18:77607517	G/A	cg05926928	chr17:57297772	GDPD1	1.27	8.28	0.68	2.73e-12	Opioid sensitivity;
SKCM	cis	rs1419980	0.673	rs4883421	chr12:7774028	A/G	cg10578777	chr12:7781093	NA	0.68	4.96	0.49	4.02e-6	HDL cholesterol levels;
SKCM	cis	rs6570726	1.000	rs1935615	chr6:145921117	G/T	cg23711669	chr6:146136114	FBXO30	0.68	6.12	0.57	3.57e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6835098	0.692	rs6553680	chr4:174077044	A/G	cg08422745	chr4:174089978	GALNT7	-0.85	-7.05	-0.62	6.23e-10	Dementia and core Alzheimer's disease neuropathologic changes;
SKCM	cis	rs1403694	0.515	rs1648697	chr3:186449194	A/G	cg09332604	chr3:186435400	KNG1	-0.56	-5.67	-0.54	2.31e-7	Blood protein levels;
SKCM	cis	rs10504229	1.000	rs17805549	chr8:58179653	T/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs4728302	0.583	rs1424583	chr7:133159583	T/G	cg10665199	chr7:133106180	EXOC4	0.84	5.27	0.51	1.2e-6	Intelligence;Intelligence (multi-trait analysis);
SKCM	cis	rs1577917	0.804	rs2786854	chr6:86668740	C/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.67	-5.86	-0.55	1.07e-7	Response to antipsychotic treatment;
SKCM	cis	rs2836950	0.520	rs8130240	chr21:40538108	G/A	cg11644478	chr21:40555479	PSMG1	-0.67	-5.3	-0.51	1.04e-6	Menarche (age at onset);
SKCM	cis	rs13156386	0.656	rs13167307	chr5:122773605	A/G	cg25980539	chr5:123090970	NA	0.77	4.83	0.48	6.76e-6	CSF tryptophan concentration in tuberculous meningitis;
SKCM	cis	rs798554	0.836	rs798490	chr7:2801542	C/T	cg19346786	chr7:2764209	NA	-0.67	-7.15	-0.63	4.06e-10	Height;
SKCM	cis	rs11640734	0.609	rs11647746	chr16:89806343	C/A	cg00800038	chr16:89945340	TCF25	-0.84	-4.88	-0.48	5.49e-6	Interleukin-17 levels;
SKCM	cis	rs951366	0.617	rs823074	chr1:205774839	T/C	cg26354017	chr1:205819088	PM20D1	1.03	11.41	0.79	2.66e-18	Menarche (age at onset);
SKCM	cis	rs760805	0.900	rs1005733	chr1:25261960	T/A	cg22509179	chr1:25234806	RUNX3	-0.74	-6.08	-0.57	4.19e-8	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs58688157	0.774	rs59115876	chr11:613757	A/G	cg03576123	chr11:487126	PTDSS2	-0.84	-5.45	-0.53	5.64e-7	Systemic lupus erythematosus;
SKCM	cis	rs7772486	0.720	rs991507	chr6:146023609	G/A	cg05347473	chr6:146136440	FBXO30	-0.62	-5.62	-0.54	2.8e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs561341	1.000	rs55978022	chr17:30275937	T/C	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs3741151	0.773	rs113465107	chr11:73210416	T/G	cg17517138	chr11:73019481	ARHGEF17	1.2	4.78	0.48	8.2e-6	GIP levels in response to oral glucose tolerance test (120 minutes);
SKCM	cis	rs57221529	0.766	rs17497684	chr5:558307	T/C	cg26208419	chr5:473447	SLC9A3;LOC25845	0.96	4.9	0.49	5.03e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs34629349	1	rs34629349	chr17:4829560	C/A	cg25236894	chr17:5323110	RPAIN;NUP88	-0.81	-5.83	-0.55	1.2e-7	Intraocular pressure;
SKCM	cis	rs9393692	0.875	rs2142703	chr6:26289605	A/G	cg00631329	chr6:26305371	NA	-0.69	-4.9	-0.49	5.05e-6	Educational attainment;
SKCM	cis	rs60871478	1.000	rs62432899	chr7:826542	G/C	cg05535760	chr7:792225	HEATR2	1.21	10.42	0.76	1.96e-16	Cerebrospinal P-tau181p levels;
SKCM	cis	rs6951245	1.000	rs79765398	chr7:1073764	A/G	cg18402987	chr7:1209562	NA	1.15	6.02	0.56	5.38e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs11719291	0.584	rs13080725	chr3:49076092	G/A	cg00383909	chr3:49044727	WDR6	1.05	5.85	0.55	1.11e-7	Cognitive function;
SKCM	cis	rs6121246	0.821	rs6058448	chr20:30332396	C/T	cg11595048	chr20:30225325	COX4I2	0.67	5.21	0.51	1.5e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs9818758	0.607	rs9837237	chr3:49215583	G/T	cg24898236	chr3:49228699	LOC646498	0.64	4.94	0.49	4.39e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs28595532	0.702	rs56217716	chr4:119338490	T/G	cg11846333	chr4:119757529	SEC24D	1.19	6.71	0.6	2.81e-9	Cannabis dependence symptom count;
SKCM	cis	rs10138752	0.643	rs10438159	chr14:69097372	C/T	cg08271153	chr14:69726221	GALNTL1	-0.69	-5.33	-0.52	9.22e-7	Neutrophil count;White blood cell count;Myeloid white cell count;Granulocyte count;Sum neutrophil eosinophil counts;Sum basophil neutrophil counts;
SKCM	cis	rs10752881	1.000	rs10911185	chr1:182971747	G/C	ch.1.3577855R	chr1:183094577	LAMC1	0.71	6.46	0.59	8.07e-9	Colorectal cancer;
SKCM	cis	rs10504229	0.683	rs58438731	chr8:58134790	C/T	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs12541335	0.590	rs11136002	chr8:22217082	C/T	cg02463440	chr8:22132932	PIWIL2	0.64	5.88	0.55	9.81e-8	Hypertriglyceridemia;
SKCM	cis	rs7020830	0.894	rs12337316	chr9:37148105	G/A	cg14294708	chr9:37120828	ZCCHC7	1.08	10.42	0.76	1.94e-16	Schizophrenia;
SKCM	cis	rs1799949	0.894	rs71367985	chr17:41374463	G/A	cg05368731	chr17:41323189	NBR1	0.86	7.13	0.63	4.39e-10	Menopause (age at onset);
SKCM	cis	rs67311347	0.544	rs13098483	chr3:40342743	G/C	cg00656387	chr3:40428638	ENTPD3	0.56	4.99	0.49	3.54e-6	Renal cell carcinoma;
SKCM	cis	rs78456975	0.527	rs10203194	chr2:1558021	A/G	cg01028140	chr2:1542097	TPO	-0.49	-4.88	-0.48	5.52e-6	Placebo response in major depressive disorder (% change in symptom score);
SKCM	cis	rs7829975	0.711	rs1039916	chr8:8685854	A/G	cg06636001	chr8:8085503	FLJ10661	0.79	7.4	0.64	1.33e-10	Mood instability;
SKCM	cis	rs709400	0.663	rs9671911	chr14:103967343	T/C	cg26031613	chr14:104095156	KLC1	0.76	5.78	0.55	1.47e-7	Body mass index;
SKCM	cis	rs2204008	0.837	rs7974888	chr12:37945215	A/G	cg13010199	chr12:38710504	ALG10B	0.63	5.02	0.49	3.24e-6	Bladder cancer;
SKCM	trans	rs1814175	0.702	rs4881644	chr11:49786367	C/T	cg03929089	chr4:120376271	NA	-0.9	-8.5	-0.69	9.91e-13	Height;
SKCM	cis	rs7216064	1.000	rs7224923	chr17:65842265	T/G	cg12091567	chr17:66097778	LOC651250	-0.77	-5.53	-0.53	4.06e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs10751667	0.643	rs10794350	chr11:946070	A/G	cg10932868	chr11:921992	NA	0.51	4.82	0.48	6.84e-6	Alzheimer's disease (late onset);
SKCM	cis	rs60871478	0.786	rs12536056	chr7:831351	T/A	cg05535760	chr7:792225	HEATR2	-1.15	-10.18	-0.76	5.69e-16	Cerebrospinal P-tau181p levels;
SKCM	cis	rs1863824	0.625	rs11202024	chr10:88168024	C/A	cg07322936	chr10:88137208	NA	-0.59	-5.0	-0.49	3.42e-6	Schizophrenia;
SKCM	cis	rs523522	0.962	rs687873	chr12:121019634	G/A	cg27279351	chr12:120934652	DYNLL1	0.91	8.36	0.69	1.88e-12	High light scatter reticulocyte count;
SKCM	cis	rs4423214	0.959	rs12793224	chr11:71168710	G/A	cg05163923	chr11:71159392	DHCR7	0.82	8.01	0.67	8.84e-12	Vitamin D levels;
SKCM	cis	rs7777484	0.534	rs2533890	chr7:2828743	C/T	cg19717773	chr7:2847554	GNA12	-0.51	-6.18	-0.57	2.75e-8	Height;
SKCM	cis	rs28595532	0.764	rs56359736	chr4:119769689	G/A	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs932287	1.000	rs932287	chr11:9044767	A/G	cg21881798	chr11:8931708	C11orf17;ST5	-0.63	-5.06	-0.5	2.73e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs62238980	0.614	rs17682385	chr22:32387572	C/T	cg00543991	chr22:32367038	NA	1.15	4.87	0.48	5.76e-6	Childhood ear infection;
SKCM	cis	rs36093844	0.626	rs12270433	chr11:85763319	G/T	cg25872744	chr11:85566296	CCDC83	-0.81	-4.79	-0.48	7.71e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs826838	0.933	rs980573	chr12:39127811	T/C	cg13010199	chr12:38710504	ALG10B	-0.72	-5.73	-0.54	1.83e-7	Heart rate;
SKCM	cis	rs7829975	0.711	rs4481596	chr8:8704330	G/C	cg15556689	chr8:8085844	FLJ10661	0.66	5.7	0.54	2.08e-7	Mood instability;
SKCM	cis	rs9910055	0.762	rs11080007	chr17:42265442	A/G	cg10896456	chr17:42255109	ASB16;C17orf65	-0.67	-6.39	-0.59	1.13e-8	Total body bone mineral density;
SKCM	cis	rs2204008	0.537	rs28680519	chr12:38502946	C/T	cg26384229	chr12:38710491	ALG10B	0.84	6.4	0.59	1.05e-8	Bladder cancer;
SKCM	cis	rs951366	0.677	rs1775140	chr1:205672107	C/A	cg11965913	chr1:205819406	PM20D1	0.88	8.1	0.68	6.06e-12	Menarche (age at onset);
SKCM	cis	rs7666738	0.830	rs969048	chr4:98988921	T/C	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	trans	rs1814175	0.564	rs12416819	chr11:49755567	T/C	cg03929089	chr4:120376271	NA	-0.89	-8.07	-0.67	7.01e-12	Height;
SKCM	cis	rs12142240	0.698	rs6695043	chr1:46844530	A/G	cg10495392	chr1:46806563	NSUN4	-0.74	-5.51	-0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs116095464	1.000	rs55671190	chr5:287422	G/A	cg22857025	chr5:266934	NA	-1.57	-5.52	-0.53	4.32e-7	Breast cancer;
SKCM	cis	rs2952156	0.876	rs903501	chr17:37839493	T/C	cg20243544	chr17:37824526	PNMT	0.7	5.42	0.52	6.31e-7	Asthma;
SKCM	cis	rs6062302	0.522	rs6089929	chr20:62219679	C/T	cg09650180	chr20:62225654	GMEB2	-0.79	-6.15	-0.57	3.1e-8	Glioblastoma;
SKCM	cis	rs2739330	0.791	rs4822458	chr22:24265659	C/T	cg12419862	chr22:24373484	LOC391322	-0.77	-7.41	-0.64	1.28e-10	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs780096	0.526	rs72819536	chr2:27682850	G/T	cg05696406	chr2:27599888	SNX17	0.51	5.06	0.5	2.75e-6	Total body bone mineral density;
SKCM	cis	rs1552244	0.572	rs7645667	chr3:10157337	C/A	cg00149659	chr3:10157352	C3orf10	1.1	5.1	0.5	2.31e-6	Alzheimer's disease;
SKCM	cis	rs6138458	1.000	rs227631	chr20:24913653	A/G	cg26195577	chr20:24973756	C20orf3	1.29	8.69	0.7	4.32e-13	Blood protein levels;
SKCM	cis	rs2153535	0.580	rs1932281	chr6:8473765	A/G	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs67311347	0.544	rs2123998	chr3:40359005	C/G	cg02782426	chr3:40428986	ENTPD3	-0.52	-5.27	-0.51	1.18e-6	Renal cell carcinoma;
SKCM	cis	rs17376456	0.741	rs10036829	chr5:93309897	G/C	cg21475434	chr5:93447410	FAM172A	1.04	5.55	0.53	3.82e-7	Diabetic retinopathy;
SKCM	cis	rs4237845	0.837	rs7954957	chr12:58299250	C/T	cg00677455	chr12:58241039	CTDSP2	0.71	5.96	0.56	6.93e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs6570726	0.875	rs12524077	chr6:145866333	G/C	cg23711669	chr6:146136114	FBXO30	0.72	6.88	0.61	1.35e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7599312	0.534	rs6735626	chr2:213403972	G/A	cg20637307	chr2:213403960	ERBB4	0.76	5.6	0.54	3.12e-7	BMI (adjusted for smoking behaviour);BMI in non-smokers;Body mass index;Body mass index (joint analysis main effects and smoking interaction);
SKCM	cis	rs17685	0.753	rs2302438	chr7:75677065	C/A	cg16489192	chr7:75678113	MDH2;STYXL1	-0.58	-5.44	-0.52	5.83e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1278329	0.609	rs2886676	chr10:127827758	C/T	cg01368217	chr10:127836603	ADAM12	-0.48	-4.83	-0.48	6.71e-6	Metabolite levels (5-HIAA/ MHPG Ratio);
SKCM	cis	rs875971	0.830	rs587360	chr7:65522698	C/A	cg11764359	chr7:65958608	NA	0.9	8.21	0.68	3.63e-12	Aortic root size;
SKCM	cis	rs2239547	0.657	rs12496077	chr3:52886241	G/A	cg11645453	chr3:52864694	ITIH4	0.78	7.13	0.63	4.45e-10	Schizophrenia;
SKCM	cis	rs8067545	0.611	rs1373146	chr17:20206675	G/A	cg13482628	chr17:19912719	NA	-0.67	-5.7	-0.54	2.04e-7	Schizophrenia;
SKCM	cis	rs6121246	0.954	rs6060978	chr20:30416893	G/A	cg11595048	chr20:30225325	COX4I2	0.66	4.82	0.48	6.91e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs367615	0.506	rs2963013	chr5:108775811	C/T	cg17395555	chr5:108820864	NA	-0.77	-6.75	-0.61	2.4e-9	Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs11673344	0.582	rs114437741	chr19:37446281	G/C	cg07624650	chr19:37064219	ZNF529	-0.78	-4.82	-0.48	7.05e-6	Obesity-related traits;
SKCM	cis	rs1577917	1.000	rs11759855	chr6:86610841	T/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.66	-5.74	-0.54	1.76e-7	Response to antipsychotic treatment;
SKCM	cis	rs4481887	0.927	rs4517383	chr1:248426484	C/T	cg00666640	chr1:248458726	OR2T12	0.6	5.76	0.55	1.58e-7	Common traits (Other);
SKCM	cis	rs1843834	0.611	rs1058360	chr2:225449242	A/T	cg12698349	chr2:225449008	CUL3	0.87	6.97	0.62	9.14e-10	IgE levels in asthmatics (D.p. specific);
SKCM	cis	rs35306767	0.855	rs55697724	chr10:885622	T/C	cg25614935	chr10:1084866	C10orf110	0.8	5.41	0.52	6.69e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs1971762	0.561	rs4759288	chr12:54084006	T/A	cg16917193	chr12:54089295	NA	0.59	4.85	0.48	6.15e-6	Height;
SKCM	cis	rs1799949	0.965	rs7223952	chr17:41194885	T/C	cg19454999	chr17:41278357	BRCA1;NBR2	0.52	4.82	0.48	6.98e-6	Menopause (age at onset);
SKCM	cis	rs6580649	0.941	rs4760618	chr12:48434767	G/A	cg05342945	chr12:48394962	COL2A1	0.7	5.24	0.51	1.33e-6	Lung cancer;
SKCM	cis	rs644799	0.710	rs10831433	chr11:95519787	C/T	cg25622487	chr11:95524042	FAM76B;CEP57	0.7	6.15	0.57	3.04e-8	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs28595532	0.920	rs114210107	chr4:119734491	G/A	cg14228332	chr4:119757509	SEC24D	1.07	5.38	0.52	7.7300000000000005e-07	Cannabis dependence symptom count;
SKCM	cis	rs2836974	0.583	rs2410124	chr21:40704760	C/G	cg11644478	chr21:40555479	PSMG1	-0.66	-5.44	-0.52	5.98e-7	Cognitive function;
SKCM	cis	rs12597458	0.789	rs7186207	chr16:72035359	C/T	cg01557791	chr16:72042693	DHODH	-0.84	-7.08	-0.63	5.47e-10	Prostate cancer;
SKCM	cis	rs6582630	0.519	rs11495376	chr12:38284957	A/C	cg26384229	chr12:38710491	ALG10B	0.81	6.57	0.6	5.18e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs4132509	1.000	rs6429433	chr1:243857994	C/T	cg21452805	chr1:244014465	NA	0.84	4.77	0.47	8.54e-6	RR interval (heart rate);
SKCM	cis	rs1577917	0.771	rs2842613	chr6:86305702	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.79	7.4	0.64	1.34e-10	Response to antipsychotic treatment;
SKCM	cis	rs947211	0.898	rs1772153	chr1:205745782	C/T	cg07157834	chr1:205819609	PM20D1	-0.67	-4.85	-0.48	6.2e-6	Parkinson's disease;
SKCM	cis	rs7552404	0.924	rs7544117	chr1:76158246	A/G	cg10523679	chr1:76189770	ACADM	0.7	5.05	0.5	2.83e-6	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs7666738	0.830	rs4699589	chr4:98973889	A/G	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6696846	0.749	rs7515178	chr1:205084120	G/A	cg00857998	chr1:205179979	DSTYK	0.59	4.83	0.48	6.79e-6	Red blood cell count;
SKCM	cis	rs4400599	0.594	rs7526644	chr1:154208753	T/C	cg26808167	chr1:154192205	UBAP2L;C1orf43	-0.54	-4.9	-0.49	5.01e-6	Platelet distribution width;
SKCM	cis	rs950776	0.593	rs680244	chr15:78871288	T/C	cg06917634	chr15:78832804	PSMA4	-0.9	-7.99	-0.67	9.7e-12	Sudden cardiac arrest;
SKCM	cis	rs9790314	0.645	rs10936224	chr3:160902531	G/A	cg03342759	chr3:160939853	NMD3	-0.67	-6.86	-0.61	1.48e-9	Morning vs. evening chronotype;
SKCM	cis	rs11608355	0.521	rs4766469	chr12:109836890	C/G	cg19025524	chr12:109796872	NA	0.71	6.73	0.61	2.57e-9	Neuroticism;
SKCM	cis	rs7666738	0.830	rs10010223	chr4:99021758	G/A	cg05340658	chr4:99064831	C4orf37	0.66	5.17	0.5	1.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1348850	0.526	rs2141157	chr2:178374112	C/T	cg02961200	chr2:178257176	LOC100130691;AGPS	0.83	4.86	0.48	5.99e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs9913156	0.793	rs4346260	chr17:4567215	A/G	cg19197139	chr17:4613644	ARRB2	-0.79	-5.3	-0.51	1.04e-6	Lymphocyte counts;
SKCM	cis	rs7143963	0.636	rs2103929	chr14:103322471	C/T	cg23020514	chr14:103360112	TRAF3	0.74	7.1	0.63	5.18e-10	Body mass index;
SKCM	cis	rs56235845	0.694	rs6876677	chr5:176755342	T/C	cg16006841	chr5:176797999	RGS14	0.7	6.76	0.61	2.28e-9	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs7584330	0.826	rs72620825	chr2:238381243	G/A	cg14458575	chr2:238380390	NA	1.04	6.34	0.58	1.38e-8	Prostate cancer;
SKCM	cis	rs28595532	0.920	rs116149978	chr4:119761069	A/C	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs362296	0.698	rs3095083	chr4:3263499	G/A	cg16987761	chr4:3318072	RGS12	-0.7	-6.23	-0.58	2.23e-8	Parental longevity (mother's age at death);
SKCM	cis	rs2153535	0.580	rs7741403	chr6:8530578	C/T	cg07606381	chr6:8435919	SLC35B3	-0.92	-6.65	-0.6	3.65e-9	Motion sickness;
SKCM	cis	rs738322	0.555	rs6001027	chr22:38545619	A/G	cg25457927	chr22:38595422	NA	-0.56	-6.68	-0.6	3.18e-9	Cutaneous nevi;
SKCM	cis	rs4148883	0.513	rs1154402	chr4:100009596	C/G	cg12011299	chr4:100065546	ADH4	0.48	4.78	0.48	8.09e-6	Alcohol dependence;
SKCM	cis	rs13118159	0.527	rs1250119	chr4:1261336	G/A	cg20887711	chr4:1340912	KIAA1530	-0.87	-6.65	-0.6	3.65e-9	Longevity;
SKCM	cis	rs2228479	0.619	rs77847775	chr16:89896243	C/T	cg06558623	chr16:89946397	TCF25	1.1	4.95	0.49	4.17e-6	Skin colour saturation;
SKCM	cis	rs644799	0.965	rs10831426	chr11:95505888	G/A	cg25622487	chr11:95524042	FAM76B;CEP57	0.74	5.91	0.56	8.37e-8	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs2180341	0.694	rs2875972	chr6:127585522	T/C	cg27446573	chr6:127587934	RNF146	0.85	6.73	0.61	2.56e-9	Breast cancer;
SKCM	cis	rs9911578	1.000	rs368186	chr17:56736659	A/G	cg12560992	chr17:57184187	TRIM37	0.95	7.69	0.66	3.7e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs6840360	0.533	rs13121178	chr4:152729047	T/C	cg22705602	chr4:152727874	NA	0.57	7.74	0.66	2.98e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs7937682	0.889	rs551825	chr11:111480116	C/G	cg19812747	chr11:111475976	SIK2	-0.56	-4.93	-0.49	4.55e-6	Primary sclerosing cholangitis;
SKCM	cis	rs28595532	0.920	rs56027489	chr4:119780882	A/G	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs2404602	0.569	rs283793	chr15:76774752	G/A	cg23625390	chr15:77176239	SCAPER	0.81	7.48	0.65	9.4e-11	Blood metabolite levels;
SKCM	cis	rs7179456	0.545	rs585192	chr15:59052210	T/C	cg05156742	chr15:59063176	FAM63B	0.8	5.92	0.56	8.08e-8	Asperger disorder;
SKCM	cis	rs453301	0.574	rs10081437	chr8:8948979	T/C	cg15556689	chr8:8085844	FLJ10661	-0.66	-5.52	-0.53	4.24e-7	Joint mobility (Beighton score);
SKCM	cis	rs951366	0.789	rs823130	chr1:205714372	C/T	cg17178900	chr1:205818956	PM20D1	0.73	5.84	0.55	1.13e-7	Menarche (age at onset);
SKCM	cis	rs1218582	0.804	rs869506	chr1:154859581	A/C	cg03351412	chr1:154909251	PMVK	0.78	6.55	0.6	5.5e-9	Prostate cancer;
SKCM	cis	rs6665290	0.904	rs6677602	chr1:227187838	G/T	cg10327440	chr1:227177885	CDC42BPA	-1.24	-14.53	-0.85	6.79e-24	Myeloid white cell count;
SKCM	cis	rs11098499	0.863	rs1552095	chr4:120460306	A/G	cg09307838	chr4:120376055	NA	0.96	7.25	0.63	2.57e-10	Corneal astigmatism;
SKCM	trans	rs12599106	1.000	rs12599106	chr16:34498025	T/A	cg15383120	chr6:291909	DUSP22	-0.81	-7.63	-0.65	4.83e-11	Menopause (age at onset);
SKCM	cis	rs71520386	0.632	rs28526185	chr7:22871318	T/C	cg00309339	chr7:22893653	NA	0.66	4.94	0.49	4.33e-6	Fibrinogen levels;
SKCM	cis	rs60871478	1.000	rs35488064	chr7:812722	G/C	cg05535760	chr7:792225	HEATR2	1.03	8.77	0.7	3.02e-13	Cerebrospinal P-tau181p levels;
SKCM	cis	rs1405130	0.869	rs884064	chr2:235570541	G/C	cg17841421	chr2:235704848	NA	-0.57	-4.95	-0.49	4.14e-6	Coronary artery disease;
SKCM	cis	rs738322	0.533	rs5756934	chr22:38547279	G/A	cg25457927	chr22:38595422	NA	-0.56	-6.58	-0.6	4.97e-9	Cutaneous nevi;
SKCM	cis	rs854765	0.693	rs8079321	chr17:17760789	C/T	cg04398451	chr17:18023971	MYO15A	-0.95	-6.81	-0.61	1.83e-9	Total body bone mineral density;
SKCM	cis	rs929354	0.713	rs6946947	chr7:156948787	T/C	cg17757837	chr7:157058334	UBE3C	0.81	5.67	0.54	2.3e-7	Body mass index;
SKCM	cis	rs1218582	0.772	rs6683557	chr1:154852307	C/G	cg16680214	chr1:154839983	KCNN3	-0.56	-4.97	-0.49	3.9e-6	Prostate cancer;
SKCM	cis	rs55962025	0.804	rs362268	chr4:3242148	C/G	cg11471262	chr4:3318911	RGS12	-0.71	-5.58	-0.53	3.35e-7	Parental longevity (mother's age at death);
SKCM	cis	rs7111031	0.899	rs4938021	chr11:113364803	C/T	cg04642306	chr11:112834466	NCAM1	0.44	4.82	0.48	6.96e-6	Subjective well-being (multi-trait analysis);Depressive symptoms (multi-trait analysis);Neuroticism;
SKCM	cis	rs8141529	0.732	rs5762788	chr22:29174770	G/T	cg02153584	chr22:29168773	CCDC117	0.73	6.05	0.57	4.67e-8	Lymphocyte counts;
SKCM	cis	rs9549367	0.713	rs510160	chr13:113822481	A/G	cg18105134	chr13:113819100	PROZ	0.88	6.51	0.59	6.68e-9	Platelet distribution width;
SKCM	cis	rs763014	1.000	rs7205409	chr16:642610	A/G	cg00908189	chr16:619842	PIGQ	0.82	7.43	0.64	1.17e-10	Height;
SKCM	cis	rs4724125	0.960	rs11768597	chr7:42696969	C/T	cg09407816	chr7:42972088	MRPL32;PSMA2	0.82	4.94	0.49	4.3e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs908922	0.676	rs7518654	chr1:152517845	C/G	cg09873164	chr1:152488093	CRCT1	0.76	6.11	0.57	3.7e-8	Hair morphology;
SKCM	cis	rs8038465	0.516	rs8037836	chr15:73859855	G/A	cg15420318	chr15:73925796	NPTN	0.71	6.26	0.58	1.92e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs769267	0.930	rs4808957	chr19:19567248	A/G	cg26732615	chr19:19648335	CILP2;YJEFN3	0.67	7.06	0.62	6e-10	Tonsillectomy;
SKCM	cis	rs1218582	0.772	rs4845682	chr1:154877105	T/C	cg06221963	chr1:154839813	KCNN3	-0.59	-5.97	-0.56	6.76e-8	Prostate cancer;
SKCM	cis	rs2239547	0.618	rs1573815	chr3:52870132	A/G	cg11645453	chr3:52864694	ITIH4	-0.81	-7.0	-0.62	8.04e-10	Schizophrenia;
SKCM	cis	rs854765	0.964	rs12950562	chr17:17995166	C/T	cg04398451	chr17:18023971	MYO15A	0.65	4.82	0.48	6.87e-6	Total body bone mineral density;
SKCM	cis	rs7216064	0.773	rs74541577	chr17:65853651	C/T	cg12091567	chr17:66097778	LOC651250	-0.75	-5.27	-0.51	1.19e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs6570726	0.791	rs4896820	chr6:145894957	T/C	cg23711669	chr6:146136114	FBXO30	0.79	8.06	0.67	7.28e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6500395	1.000	rs1386040	chr16:48631207	A/G	cg04672837	chr16:48644449	N4BP1	0.67	5.66	0.54	2.4e-7	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs1348850	0.526	rs4243389	chr2:178379783	G/C	cg02961200	chr2:178257176	LOC100130691;AGPS	0.84	4.97	0.49	3.83e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs78269692	0.702	rs111730030	chr19:13268826	G/T	cg19436403	chr19:12780550	MORG1;C19orf56	1.38	5.11	0.5	2.25e-6	Breast cancer;
SKCM	cis	rs1552244	1.000	rs7611218	chr3:10063960	T/C	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs4888262	0.526	rs13330282	chr16:74572373	C/T	cg01733217	chr16:74700730	RFWD3	0.88	6.93	0.62	1.09e-9	Testicular germ cell tumor;
SKCM	cis	rs3820928	0.967	rs12622456	chr2:227768868	G/A	cg11843606	chr2:227700838	RHBDD1	-0.64	-5.2	-0.51	1.53e-6	Pulmonary function;
SKCM	cis	rs55794721	0.509	rs7554255	chr1:25778106	C/T	cg02931644	chr1:25747376	RHCE	0.5	4.9	0.48	5.17e-6	Plateletcrit;Mean corpuscular volume;
SKCM	cis	rs2014572	0.967	rs8111977	chr19:57759158	T/A	cg24459738	chr19:57751996	ZNF805	-0.64	-5.17	-0.5	1.79e-6	Hyperactive-impulsive symptoms;
SKCM	cis	rs10256972	0.758	rs7799391	chr7:1082566	C/G	cg16145915	chr7:1198662	ZFAND2A	-0.44	-5.33	-0.52	9.34e-7	Longevity;Endometriosis;
SKCM	cis	rs1707322	0.717	rs11211161	chr1:46148138	A/C	cg03146154	chr1:46216737	IPP	0.81	5.61	0.54	2.94e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs61776719	0.520	rs12569027	chr1:38449163	C/T	cg12658694	chr1:38397304	INPP5B	0.58	4.93	0.49	4.54e-6	Coronary artery disease;
SKCM	cis	rs2811415	0.597	rs10934840	chr3:127746083	G/C	cg09089421	chr3:127803668	RUVBL1	0.99	8.52	0.69	9.09e-13	Lung function (FEV1/FVC);
SKCM	cis	rs62158211	0.955	rs7556815	chr2:114085785	G/A	cg17784749	chr2:114082611	LOC440839	0.8	5.79	0.55	1.41e-7	Sleep duration (oversleepers vs undersleepers);Sleep traits (multi-trait analysis);Sleep duration;
SKCM	cis	rs6545883	0.507	rs59981505	chr2:61580529	G/T	cg15711740	chr2:61764176	XPO1	0.73	5.85	0.55	1.1e-7	Tuberculosis;
SKCM	cis	rs7772486	0.790	rs2247666	chr6:146220409	C/A	cg23711669	chr6:146136114	FBXO30	0.76	7.66	0.66	4.34e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs8017423	0.967	rs11621431	chr14:90709221	C/T	cg04374321	chr14:90722782	PSMC1	0.97	8.87	0.71	1.91e-13	Mortality in heart failure;
SKCM	cis	rs597539	0.690	rs11228383	chr11:68623228	T/G	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.81	5.33	0.52	9.43e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs362296	0.661	rs3121420	chr4:3264210	T/C	cg11471262	chr4:3318911	RGS12	-0.68	-6.02	-0.56	5.43e-8	Parental longevity (mother's age at death);
SKCM	cis	rs801193	1.000	rs2659915	chr7:66153101	A/G	cg11764359	chr7:65958608	NA	0.83	6.15	0.57	3.09e-8	Aortic root size;
SKCM	cis	rs9300255	0.602	rs1727296	chr12:123647725	G/C	cg00376283	chr12:123451042	ABCB9	0.82	5.61	0.54	3e-7	Neutrophil percentage of white cells;
SKCM	cis	rs2239547	0.657	rs6445538	chr3:52874288	T/C	cg11645453	chr3:52864694	ITIH4	0.79	7.19	0.63	3.41e-10	Schizophrenia;
SKCM	cis	rs12142240	0.698	rs41293285	chr1:46808426	C/T	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs7811142	1.000	rs11766752	chr7:100073292	A/G	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.23	7.89	0.67	1.53e-11	Platelet count;
SKCM	cis	rs6546550	0.933	rs1454498	chr2:70149225	C/A	cg02498382	chr2:70120550	SNRNP27	-0.45	-4.88	-0.48	5.4e-6	Prevalent atrial fibrillation;
SKCM	cis	rs6456156	0.586	rs10946208	chr6:167459596	C/T	cg13927040	chr6:167453801	FGFR1OP	0.66	4.85	0.48	6.24e-6	Primary biliary cholangitis;
SKCM	cis	rs10751667	0.666	rs7395488	chr11:954111	T/C	cg10932868	chr11:921992	NA	0.55	5.1	0.5	2.36e-6	Alzheimer's disease (late onset);
SKCM	cis	rs1005277	0.540	rs2145487	chr10:38010077	A/G	cg25427524	chr10:38739819	LOC399744	-0.64	-6.09	-0.57	3.91e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs55962025	0.883	rs82332	chr4:3225466	A/G	cg16987761	chr4:3318072	RGS12	-0.65	-4.81	-0.48	7.21e-6	Parental longevity (mother's age at death);
SKCM	trans	rs7819412	0.775	rs2898257	chr8:10935368	A/C	cg06636001	chr8:8085503	FLJ10661	-0.88	-7.8	-0.66	2.25e-11	Triglycerides;
SKCM	cis	rs7809950	0.954	rs2712229	chr7:107295326	T/A	cg23024343	chr7:107201750	COG5	0.8	7.41	0.64	1.28e-10	Coronary artery disease;
SKCM	cis	rs780096	0.565	rs780104	chr2:27677691	G/A	cg05696406	chr2:27599888	SNX17	0.51	5.22	0.51	1.46e-6	Total body bone mineral density;
SKCM	cis	rs4132509	0.947	rs10927041	chr1:243731890	T/C	cg21452805	chr1:244014465	NA	0.74	4.92	0.49	4.77e-6	RR interval (heart rate);
SKCM	cis	rs875971	0.508	rs10258739	chr7:66062935	A/T	cg18876405	chr7:65276391	NA	-0.81	-7.27	-0.64	2.35e-10	Aortic root size;
SKCM	trans	rs1814175	0.708	rs10839464	chr11:49981386	T/C	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs17376456	0.569	rs7701114	chr5:93096028	T/C	cg25358565	chr5:93447407	FAM172A	0.86	5.45	0.53	5.59e-7	Diabetic retinopathy;
SKCM	cis	rs13118159	0.836	rs2293630	chr4:1342521	G/A	cg20887711	chr4:1340912	KIAA1530	0.68	5.12	0.5	2.16e-6	Longevity;
SKCM	cis	rs2836974	0.666	rs11910705	chr21:40685604	C/T	cg17971929	chr21:40555470	PSMG1	-0.74	-6.92	-0.62	1.14e-9	Cognitive function;
SKCM	cis	rs17345786	0.911	rs10936707	chr3:101324063	G/A	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.71	5.07	0.5	2.61e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs736408	0.812	rs2239699	chr3:52827915	C/T	cg18404041	chr3:52824283	ITIH1	-0.64	-5.3	-0.51	1.04e-6	Bipolar disorder;
SKCM	cis	rs2153535	0.580	rs1932280	chr6:8473654	G/A	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs10752881	1.000	rs10752885	chr1:182982878	C/G	ch.1.3577855R	chr1:183094577	LAMC1	0.73	6.47	0.59	7.97e-9	Colorectal cancer;
SKCM	cis	rs372883	0.563	rs1153293	chr21:30691325	C/T	cg24692254	chr21:30365293	RNF160	0.69	5.55	0.53	3.71e-7	Pancreatic cancer;
SKCM	cis	rs7618915	0.501	rs11130308	chr3:52639257	G/C	cg18404041	chr3:52824283	ITIH1	-0.53	-4.77	-0.48	8.42e-6	Bipolar disorder;
SKCM	cis	rs763014	0.932	rs35067229	chr16:649638	T/C	cg00908189	chr16:619842	PIGQ	0.79	7.44	0.64	1.12e-10	Height;
SKCM	cis	rs13256369	0.802	rs4840350	chr8:8561442	A/G	cg06636001	chr8:8085503	FLJ10661	0.75	5.73	0.54	1.81e-7	Obesity-related traits;
SKCM	cis	rs4481887	1.000	rs10888360	chr1:248479282	G/A	cg00666640	chr1:248458726	OR2T12	0.61	5.6	0.54	3.11e-7	Common traits (Other);
SKCM	cis	rs35146811	0.806	rs1534310	chr7:99699169	A/T	cg22906224	chr7:99728672	NA	0.8	5.87	0.55	9.92e-8	Coronary artery disease;
SKCM	cis	rs933688	1.000	rs6862125	chr5:90724598	T/C	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.05	8.54	0.7	8.25e-13	Smoking behavior;
SKCM	cis	rs9902453	0.934	rs11080120	chr17:28507021	C/A	cg26525008	chr17:28256777	EFCAB5;SSH2	0.74	5.18	0.51	1.68e-6	Coffee consumption (cups per day);
SKCM	cis	rs2921073	0.510	rs2976945	chr8:8270871	G/T	cg15556689	chr8:8085844	FLJ10661	0.68	5.64	0.54	2.65e-7	Parkinson's disease;
SKCM	cis	rs62238980	0.614	rs117486425	chr22:32441850	A/C	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs6952808	1.000	rs6977733	chr7:1886725	A/T	cg04267008	chr7:1944627	MAD1L1	0.79	6.04	0.56	4.88e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs1044826	0.642	rs6784684	chr3:139177634	T/C	cg15131784	chr3:139108705	COPB2	0.66	4.96	0.49	4.09e-6	Obesity-related traits;
SKCM	cis	rs7927771	0.770	rs11039203	chr11:47384597	A/G	cg01152729	chr11:47593274	PTPMT1	-0.51	-4.88	-0.48	5.53e-6	Subjective well-being;
SKCM	cis	rs2836974	0.681	rs8128827	chr21:40710547	C/T	cg11890956	chr21:40555474	PSMG1	1.0	10.54	0.77	1.18e-16	Cognitive function;
SKCM	cis	rs362272	0.505	rs10155132	chr4:3369500	A/G	cg24015175	chr4:3319247	RGS12	0.83	9.8	0.74	3.03e-15	Serum sulfate level;
SKCM	cis	rs11690935	0.959	rs4668412	chr2:172619770	A/G	cg13550731	chr2:172543902	DYNC1I2	-0.95	-8.1	-0.68	6.14e-12	Schizophrenia;
SKCM	cis	rs2404602	0.552	rs11634428	chr15:77084582	T/C	cg23625390	chr15:77176239	SCAPER	-0.87	-8.2	-0.68	3.81e-12	Blood metabolite levels;
SKCM	cis	rs9611565	0.513	rs739135	chr22:42090069	A/C	cg03806693	chr22:41940476	POLR3H	1.11	6.8	0.61	1.86e-9	Vitiligo;
SKCM	cis	rs7829975	0.533	rs13274028	chr8:8729193	A/C	cg08975724	chr8:8085496	FLJ10661	0.64	4.98	0.49	3.71e-6	Mood instability;
SKCM	cis	rs2404602	0.583	rs2469542	chr15:76557476	A/G	cg23625390	chr15:77176239	SCAPER	-0.69	-6.31	-0.58	1.57e-8	Blood metabolite levels;
SKCM	cis	rs4803468	1.000	rs878083	chr19:41897688	G/A	cg09537434	chr19:41945824	ATP5SL	-1.08	-13.01	-0.83	3.1e-21	Height;
SKCM	cis	rs362272	0.545	rs3129308	chr4:3309272	C/T	cg16987761	chr4:3318072	RGS12	0.92	10.48	0.76	1.51e-16	Serum sulfate level;
SKCM	cis	rs9905704	0.647	rs12943705	chr17:57097047	T/C	cg12560992	chr17:57184187	TRIM37	-0.74	-6.08	-0.57	4.13e-8	Testicular germ cell tumor;
SKCM	cis	rs9325144	0.555	rs4882284	chr12:38710459	C/T	cg26384229	chr12:38710491	ALG10B	-0.79	-6.62	-0.6	4.1e-9	Morning vs. evening chronotype;
SKCM	cis	rs2290405	0.527	rs4690332	chr4:910520	C/T	cg04824913	chr4:887549	GAK	-0.8	-6.75	-0.61	2.36e-9	Systemic sclerosis;
SKCM	cis	rs1577917	1.000	rs34106666	chr6:86676258	G/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.86	-8.61	-0.7	6.29e-13	Response to antipsychotic treatment;
SKCM	cis	rs1801516	0.950	rs17108024	chr11:108333536	C/T	cg03165700	chr11:108093220	ATM;NPAT	-1.18	-5.43	-0.52	6.27e-7	Melanoma;
SKCM	cis	rs55962025	0.846	rs363066	chr4:3135953	G/T	cg21096898	chr4:3318625	RGS12	0.75	5.86	0.55	1.06e-7	Parental longevity (mother's age at death);
SKCM	cis	rs9660180	0.967	rs12044597	chr1:1708801	A/G	cg23982607	chr1:1823379	GNB1	-0.74	-6.63	-0.6	3.9e-9	Body mass index;
SKCM	cis	rs2404602	0.716	rs67418609	chr15:76627089	C/A	cg23625390	chr15:77176239	SCAPER	0.68	5.95	0.56	7.24e-8	Blood metabolite levels;
SKCM	cis	rs897984	0.721	rs28360557	chr16:30983260	A/C	cg00531865	chr16:30841666	NA	0.59	4.97	0.49	3.81e-6	Dementia with Lewy bodies;
SKCM	cis	rs12188164	0.543	rs7728027	chr5:459943	T/C	cg26076054	chr5:421317	AHRR	0.62	5.47	0.53	5.27e-7	Cystic fibrosis severity;
SKCM	cis	rs4332037	0.715	rs57234495	chr7:1906466	G/A	cg23422044	chr7:1970798	MAD1L1	-0.96	-6.66	-0.6	3.48e-9	Bipolar disorder;
SKCM	cis	rs3784262	0.742	rs28379349	chr15:58202494	A/G	cg12031962	chr15:58353849	ALDH1A2	0.52	5.63	0.54	2.73e-7	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs17685	0.712	rs7778735	chr7:75770237	T/C	cg16684958	chr7:75615977	POR	0.55	5.27	0.51	1.19e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1801251	0.963	rs13424351	chr2:233573629	A/G	cg25237894	chr2:233734115	C2orf82	0.58	5.34	0.52	8.93e-7	Coronary artery disease;
SKCM	cis	rs4555082	0.874	rs2816621	chr14:105732762	A/T	cg13114125	chr14:105738426	BRF1	-0.69	-5.47	-0.53	5.33e-7	Mean platelet volume;Platelet distribution width;
SKCM	cis	rs7666738	0.791	rs17549003	chr4:98969132	A/C	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6951245	0.872	rs76713558	chr7:1095866	A/G	cg03188948	chr7:1209495	NA	1.13	6.27	0.58	1.89e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs2180341	0.782	rs4897214	chr6:127723625	G/T	cg24812749	chr6:127587940	RNF146	0.6	4.8	0.48	7.4e-6	Breast cancer;
SKCM	cis	rs9788682	0.747	rs12910984	chr15:78891627	G/A	cg24631222	chr15:78858424	CHRNA5	-0.89	-6.62	-0.6	4.08e-9	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs2842992	0.872	rs2758315	chr6:160158640	T/C	cg16489826	chr6:160211363	TCP1;MRPL18	0.7	5.17	0.51	1.75e-6	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs9910055	0.762	rs4239142	chr17:42205876	A/G	cg09913183	chr17:42254507	C17orf65;ASB16	-0.71	-6.5	-0.59	6.96e-9	Total body bone mineral density;
SKCM	cis	rs778371	0.723	rs12999865	chr2:233627250	T/C	cg08000102	chr2:233561755	GIGYF2	0.9	7.59	0.65	5.78e-11	Schizophrenia;
SKCM	cis	rs651907	0.557	rs56291106	chr3:101377474	C/T	cg12386194	chr3:101231763	SENP7	0.71	5.89	0.55	9.17e-8	Colorectal cancer;
SKCM	cis	rs7659604	0.605	rs67772833	chr4:122723106	G/A	cg19748678	chr4:122722346	EXOSC9	0.59	5.07	0.5	2.61e-6	Type 2 diabetes;
SKCM	cis	rs6840360	0.550	rs6853955	chr4:152510806	G/A	cg22705602	chr4:152727874	NA	-0.52	-5.7	-0.54	2.03e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs10256972	0.681	rs6979076	chr7:1116247	C/T	cg16145915	chr7:1198662	ZFAND2A	0.51	6.68	0.6	3.15e-9	Longevity;Endometriosis;
SKCM	cis	rs6879260	1.000	rs7725605	chr5:179732678	T/G	cg23221052	chr5:179740743	GFPT2	-0.65	-5.66	-0.54	2.37e-7	Height;
SKCM	cis	rs2842992	0.789	rs6908680	chr6:160218209	G/T	cg11366901	chr6:160182831	ACAT2	0.9	7.3	0.64	2.06e-10	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs2075371	1.000	rs2244694	chr7:133987093	C/T	cg20476274	chr7:133979776	SLC35B4	1.01	10.44	0.76	1.77e-16	Mean platelet volume;
SKCM	cis	rs35306767	0.761	rs1871621	chr10:1049596	C/T	cg25614935	chr10:1084866	C10orf110	0.72	5.67	0.54	2.31e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs875971	0.862	rs11984115	chr7:65773859	C/T	cg11764359	chr7:65958608	NA	-0.74	-6.75	-0.61	2.36e-9	Aortic root size;
SKCM	cis	rs3008870	1.000	rs7511948	chr1:67430427	A/G	cg08660285	chr1:67390436	MIER1;WDR78	0.92	6.09	0.57	3.96e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs11626933	1.000	rs7149083	chr14:90754006	G/A	cg14092571	chr14:90743983	NA	-0.92	-8.33	-0.69	2.11e-12	Gut microbiota (bacterial taxa);
SKCM	cis	rs7666738	0.830	rs60391193	chr4:98933912	T/G	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1799949	0.965	rs4239149	chr17:41328095	A/G	cg05368731	chr17:41323189	NBR1	-0.88	-7.46	-0.65	1.02e-10	Menopause (age at onset);
SKCM	cis	rs561341	1.000	rs510264	chr17:30323414	A/G	cg23018236	chr17:30244563	NA	-0.54	-5.46	-0.53	5.44e-7	Hip circumference adjusted for BMI;
SKCM	cis	rs2038227	1	rs2038227	chr16:539140	C/A	cg06259664	chr16:537672	RAB11FIP3	0.86	11.01	0.78	1.48e-17	Venous thromboembolism (SNP x SNP interaction);
SKCM	cis	rs7647973	0.580	rs11716334	chr3:49230096	G/A	cg07636037	chr3:49044803	WDR6	0.85	7.0	0.62	7.74e-10	Menarche (age at onset);
SKCM	cis	rs2204008	0.805	rs12146846	chr12:37985847	C/T	cg26384229	chr12:38710491	ALG10B	0.8	6.2	0.57	2.47e-8	Bladder cancer;
SKCM	cis	rs6977660	0.714	rs10257947	chr7:19824099	A/C	cg07541023	chr7:19748670	TWISTNB	0.72	4.78	0.48	7.95e-6	Thyroid stimulating hormone;
SKCM	cis	rs9325144	0.647	rs11168104	chr12:38857616	G/T	cg13010199	chr12:38710504	ALG10B	-0.66	-5.27	-0.51	1.2e-6	Morning vs. evening chronotype;
SKCM	cis	rs9880211	0.752	rs67145204	chr3:136328665	G/C	cg21827317	chr3:136751795	NA	-0.69	-5.28	-0.51	1.13e-6	Body mass index;Height;
SKCM	cis	rs7811142	1.000	rs76913697	chr7:100002772	A/G	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-1.04	-5.91	-0.56	8.4e-8	Platelet count;
SKCM	cis	rs35306767	0.855	rs11253465	chr10:897208	A/C	cg25614935	chr10:1084866	C10orf110	0.83	5.45	0.53	5.64e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs11249608	0.548	rs10516150	chr5:178459169	G/C	cg21905437	chr5:178450457	ZNF879	0.71	5.45	0.53	5.65e-7	Pubertal anthropometrics;
SKCM	cis	rs732765	0.657	rs3813556	chr14:75244792	C/G	cg25946216	chr14:74253857	C14orf43	0.85	4.83	0.48	6.6e-6	Non-small cell lung cancer;
SKCM	cis	rs2836974	0.897	rs12481860	chr21:40537836	T/A	cg11890956	chr21:40555474	PSMG1	1.07	13.19	0.83	1.48e-21	Cognitive function;
SKCM	cis	rs9308433	0.505	rs867446	chr1:214502322	G/T	cg06198575	chr1:214491504	SMYD2	0.82	5.16	0.5	1.8e-6	IgG glycosylation;
SKCM	trans	rs208520	0.690	rs12208977	chr6:66725257	G/A	cg15611600	chr13:45563400	KIAA1704;NUFIP1	0.92	7.5	0.65	8.68e-11	Exhaled nitric oxide output;
SKCM	cis	rs2066819	0.818	rs773652	chr12:56674766	G/A	cg26714650	chr12:56694279	CS	1.71	6.71	0.61	2.74e-9	Psoriasis vulgaris;
SKCM	cis	rs523522	0.962	rs12814055	chr12:120987391	G/A	cg12219531	chr12:120966889	COQ5	0.91	7.82	0.66	2.11e-11	High light scatter reticulocyte count;
SKCM	cis	rs908922	0.676	rs6658925	chr1:152482801	C/T	cg09873164	chr1:152488093	CRCT1	-0.79	-6.05	-0.57	4.66e-8	Hair morphology;
SKCM	cis	rs2197308	0.565	rs12809769	chr12:37909968	C/T	cg26384229	chr12:38710491	ALG10B	0.82	6.88	0.61	1.35e-9	Morning vs. evening chronotype;
SKCM	cis	rs2153535	0.580	rs1932283	chr6:8477661	C/T	cg07606381	chr6:8435919	SLC35B3	0.95	6.78	0.61	2.09e-9	Motion sickness;
SKCM	cis	rs4819052	0.851	rs7275874	chr21:46671223	C/T	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.42	0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs10504229	1.000	rs58947041	chr8:58188934	G/A	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs606458	0.920	rs593394	chr11:64546991	C/T	cg07674570	chr11:65346152	EHBP1L1	0.68	4.89	0.48	5.2e-6	Urate levels;
SKCM	cis	rs736408	0.774	rs4687551	chr3:52823448	C/T	cg11645453	chr3:52864694	ITIH4	-0.58	-4.92	-0.49	4.71e-6	Bipolar disorder;
SKCM	cis	rs950027	0.620	rs2467862	chr15:45643843	T/G	cg10760299	chr15:45669010	GATM	0.57	5.71	0.54	2e-7	Response to fenofibrate (adiponectin levels);
SKCM	cis	rs6952808	0.689	rs12670737	chr7:2046830	C/T	cg04267008	chr7:1944627	MAD1L1	-0.64	-4.98	-0.49	3.76e-6	Bipolar disorder and schizophrenia;
SKCM	cis	rs2033711	0.870	rs4801270	chr19:58932762	C/A	cg13877915	chr19:58951672	ZNF132	0.95	10.28	0.76	3.72e-16	Uric acid clearance;
SKCM	cis	rs3796619	1.000	rs13146371	chr4:1082887	C/T	cg27284194	chr4:1044797	NA	0.67	4.8	0.48	7.53e-6	Recombination rate (males);
SKCM	cis	rs11792861	0.926	rs72607166	chr9:111821530	A/C	cg14432460	chr9:111696404	IKBKAP;C9orf6	0.66	4.79	0.48	7.77e-6	Menarche (age at onset);
SKCM	cis	rs2559856	1.000	rs2695286	chr12:102088507	T/C	cg12924262	chr12:102091054	CHPT1	0.7	5.95	0.56	7.09e-8	Blood protein levels;
SKCM	cis	rs7106204	1.000	rs7106204	chr11:24236096	C/T	ch.11.24196551F	chr11:24239977	NA	-0.86	-4.81	-0.48	7.15e-6	Response to Homoharringtonine (cytotoxicity);
SKCM	cis	rs2404602	0.622	rs2280194	chr15:77239651	C/T	cg23625390	chr15:77176239	SCAPER	-0.81	-7.61	-0.65	5.3e-11	Blood metabolite levels;
SKCM	cis	rs80130819	0.688	rs1387256	chr12:48643738	G/A	cg13203223	chr12:49319398	FKBP11	0.85	4.78	0.48	8.07e-6	Prostate cancer;
SKCM	cis	rs13256369	0.708	rs11249886	chr8:8562021	T/A	cg06636001	chr8:8085503	FLJ10661	0.8	6.11	0.57	3.65e-8	Obesity-related traits;
SKCM	cis	rs7639513	0.591	rs9849171	chr3:12622623	G/C	cg23032965	chr3:12705835	RAF1	0.87	7.63	0.65	4.98e-11	Itch intensity from mosquito bite;
SKCM	cis	rs651907	0.557	rs34376498	chr3:101480156	C/T	cg12386194	chr3:101231763	SENP7	0.65	5.26	0.51	1.21e-6	Colorectal cancer;
SKCM	cis	rs12709013	0.792	rs257623	chr16:58795151	T/C	cg02431531	chr16:59244939	NA	0.49	5.13	0.5	2.07e-6	Blood metabolite ratios;
SKCM	cis	rs1949733	0.628	rs1543246	chr4:8504909	A/T	cg13073564	chr4:8508604	NA	-0.56	-4.85	-0.48	6.26e-6	Response to antineoplastic agents;
SKCM	cis	rs7216064	1.000	rs56393562	chr17:65933918	C/T	cg12091567	chr17:66097778	LOC651250	-0.76	-5.15	-0.5	1.87e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs9814567	1.000	rs1534026	chr3:134284767	A/G	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs28374715	0.532	rs11854632	chr15:41682094	A/G	cg18705301	chr15:41695430	NDUFAF1	1.16	12.35	0.81	4.82e-20	Ulcerative colitis;
SKCM	cis	rs6840360	0.615	rs6836249	chr4:152465829	T/G	cg22705602	chr4:152727874	NA	-0.51	-5.78	-0.55	1.45e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs62012628	0.527	rs7169068	chr15:79094069	G/C	cg04896959	chr15:78267971	NA	-0.66	-5.64	-0.54	2.66e-7	Diastolic blood pressure;
SKCM	cis	rs36093844	0.626	rs4944552	chr11:85723806	C/T	cg25872744	chr11:85566296	CCDC83	-0.81	-4.79	-0.48	7.84e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs3820068	0.581	rs58567918	chr1:15925823	A/G	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs1568889	1.000	rs6484346	chr11:28040767	C/A	cg06544937	chr11:28130018	METT5D1;KIF18A	0.86	7.03	0.62	6.97e-10	Bipolar disorder;
SKCM	cis	rs11690935	0.788	rs10201053	chr2:172889558	A/G	cg13550731	chr2:172543902	DYNC1I2	-0.83	-6.41	-0.59	1.04e-8	Schizophrenia;
SKCM	cis	rs2286503	1.000	rs2286498	chr7:22857504	C/T	cg15401507	chr7:22894281	NA	0.53	5.42	0.52	6.41e-7	Fibrinogen;
SKCM	cis	rs12134245	0.874	rs34842487	chr1:92021611	C/T	cg25838465	chr1:92012736	NA	-0.68	-6.21	-0.58	2.4e-8	Breast cancer;
SKCM	cis	rs1461503	1.000	rs1461499	chr11:122843987	C/A	cg27398637	chr11:122830231	C11orf63	-0.66	-5.1	-0.5	2.28e-6	Menarche (age at onset);
SKCM	cis	rs514406	0.644	rs6661196	chr1:53203664	A/G	cg24675658	chr1:53192096	ZYG11B	0.64	5.3	0.51	1.04e-6	Monocyte count;
SKCM	cis	rs28595532	0.920	rs114051506	chr4:119772893	A/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs4819052	0.819	rs8134084	chr21:46693295	G/A	cg02159808	chr21:46707872	POFUT2;LOC642852	0.74	5.68	0.54	2.22e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs644799	0.710	rs1852535	chr11:95501241	A/G	cg03916912	chr11:95522834	CEP57;FAM76B	0.83	7.22	0.63	3.06e-10	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs861020	1.000	rs642961	chr1:209989270	A/G	cg05527609	chr1:210001259	C1orf107	1.05	7.66	0.66	4.28e-11	Orofacial clefts;
SKCM	cis	rs3784262	0.669	rs4646603	chr15:58290024	G/A	cg12031962	chr15:58353849	ALDH1A2	-0.41	-4.82	-0.48	6.93e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs9911578	1.000	rs1472288	chr17:56910720	G/A	cg05425664	chr17:57184151	TRIM37	-0.67	-5.04	-0.5	2.91e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs7216064	1.000	rs8081517	chr17:65845697	A/T	cg12091567	chr17:66097778	LOC651250	-0.77	-5.53	-0.53	4.06e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs854765	0.583	rs8070722	chr17:17813562	C/T	cg04398451	chr17:18023971	MYO15A	-0.85	-6.04	-0.56	5.02e-8	Total body bone mineral density;
SKCM	cis	rs6445797	0.519	rs6784100	chr3:56612751	C/T	cg13616963	chr3:57583610	ARF4	-0.77	-5.1	-0.5	2.31e-6	Gastritis;
SKCM	cis	rs2404602	0.610	rs28823285	chr15:77050395	T/C	cg23625390	chr15:77176239	SCAPER	-0.82	-7.93	-0.67	1.26e-11	Blood metabolite levels;
SKCM	cis	rs9788682	0.895	rs3813570	chr15:78832832	T/C	cg06917634	chr15:78832804	PSMA4	-0.82	-4.96	-0.49	3.97e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs1801251	1.000	rs1947105	chr2:233721455	A/G	cg08000102	chr2:233561755	GIGYF2	0.89	7.22	0.63	3.02e-10	Coronary artery disease;
SKCM	cis	rs8077889	0.703	rs231537	chr17:41942857	C/T	cg26893861	chr17:41843967	DUSP3	-1.04	-5.7	-0.54	2.06e-7	Triglycerides;
SKCM	cis	rs12144049	0.621	rs6587669	chr1:152379585	T/C	cg09873164	chr1:152488093	CRCT1	1.19	5.0	0.49	3.46e-6	Inflammatory skin disease;Atopic dermatitis;
SKCM	trans	rs10506458	0.915	rs17687426	chr12:63397900	G/C	cg03429785	chr15:59498649	MYO1E;LDHAL6B	-1.38	-7.54	-0.65	7.13e-11	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs769267	0.930	rs4808208	chr19:19650096	A/G	cg03709012	chr19:19516395	GATAD2A	0.89	8.53	0.69	9.02e-13	Tonsillectomy;
SKCM	cis	rs8014204	0.967	rs1319171	chr14:75334096	G/T	cg06637938	chr14:75390232	RPS6KL1	-0.78	-5.83	-0.55	1.18e-7	Caffeine consumption;
SKCM	cis	rs4925325	0.955	rs1776262	chr20:60516023	G/T	cg16423285	chr20:60520624	NA	0.85	5.65	0.54	2.53e-7	Obesity-related traits;
SKCM	cis	rs17345786	0.906	rs11710016	chr3:101120030	A/C	cg03837452	chr3:101395095	ZBTB11;LOC100009676	-0.67	-4.88	-0.48	5.48e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs523522	0.962	rs7471	chr12:120941215	T/C	cg27279351	chr12:120934652	DYNLL1	0.91	8.32	0.69	2.26e-12	High light scatter reticulocyte count;
SKCM	trans	rs561341	1.000	rs72825712	chr17:30316119	A/T	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs7075426	0.669	rs4934220	chr10:88288206	A/G	cg07322936	chr10:88137208	NA	-0.6	-4.79	-0.48	7.67e-6	Migraine without aura;
SKCM	cis	rs13118159	0.550	rs11946956	chr4:1369094	T/G	cg16405210	chr4:1374714	KIAA1530	-0.96	-7.37	-0.64	1.53e-10	Longevity;
SKCM	cis	rs7666738	0.830	rs9992639	chr4:98940400	G/T	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7296418	0.699	rs11057219	chr12:123750073	T/C	cg05973401	chr12:123451056	ABCB9	0.71	5.39	0.52	7.21e-7	Platelet count;
SKCM	cis	rs7615952	0.673	rs16834637	chr3:125605471	C/T	cg05084668	chr3:125655381	ALG1L	-1.26	-7.05	-0.62	6.29e-10	Blood pressure (smoking interaction);
SKCM	cis	rs116095464	0.558	rs10462754	chr5:246669	T/C	cg22857025	chr5:266934	NA	-1.37	-8.31	-0.69	2.38e-12	Breast cancer;
SKCM	cis	rs2243480	1.000	rs1964692	chr7:65454183	G/A	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs514406	0.758	rs532242	chr1:53308665	C/G	cg16325326	chr1:53192061	ZYG11B	1.0	11.05	0.78	1.25e-17	Monocyte count;
SKCM	cis	rs7829975	0.533	rs1039917	chr8:8718850	C/T	cg15556689	chr8:8085844	FLJ10661	0.73	6.22	0.58	2.26e-8	Mood instability;
SKCM	cis	rs12474201	0.832	rs4952843	chr2:46957845	A/G	cg06386533	chr2:46925753	SOCS5	0.94	8.79	0.71	2.79e-13	Height;
SKCM	cis	rs4237845	0.586	rs4760174	chr12:58320436	G/A	cg02175503	chr12:58329896	NA	0.96	9.69	0.74	5.01e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs4253772	0.591	rs6007740	chr22:46654323	A/G	cg03482458	chr22:46692211	CN5H6.4;GTSE1	-1.13	-5.41	-0.52	6.8e-7	LDL cholesterol;Cholesterol, total;
SKCM	cis	rs10492096	0.898	rs12426815	chr12:6580314	A/G	cg13857086	chr12:6580257	VAMP1	0.98	7.48	0.65	9.61e-11	Hip geometry;
SKCM	cis	rs7598759	0.588	rs6737291	chr2:232329559	T/C	cg19187155	chr2:232395269	NMUR1	0.61	4.99	0.49	3.52e-6	Noise-induced hearing loss;
SKCM	cis	rs8072100	0.902	rs12051716	chr17:45582395	G/A	cg08085267	chr17:45401833	C17orf57	0.57	4.85	0.48	6.1e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs2243480	1.000	rs1701750	chr7:65467145	T/C	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs8067545	0.611	rs2526476	chr17:20134289	C/T	cg13482628	chr17:19912719	NA	-0.68	-5.65	-0.54	2.51e-7	Schizophrenia;
SKCM	cis	rs2920503	1.000	rs2920503	chr3:12324230	C/T	cg23514324	chr3:12329213	PPARG	0.61	4.79	0.48	7.87e-6	LDL cholesterol;
SKCM	cis	rs9858542	1.000	rs2172252	chr3:49678307	A/T	cg03060546	chr3:49711283	APEH	-0.76	-5.67	-0.54	2.31e-7	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs7843479	0.965	rs878872	chr8:21834567	A/G	cg17168535	chr8:21777572	XPO7	0.77	6.37	0.58	1.22e-8	Mean corpuscular volume;
SKCM	cis	rs453301	0.686	rs4840389	chr8:8884503	G/C	cg15556689	chr8:8085844	FLJ10661	-0.73	-6.01	-0.56	5.58e-8	Joint mobility (Beighton score);
SKCM	cis	rs782590	0.902	rs4672052	chr2:55732018	A/C	cg18811423	chr2:55921094	PNPT1	0.82	6.28	0.58	1.77e-8	Metabolic syndrome;
SKCM	cis	rs9902453	0.967	rs7222685	chr17:28496430	A/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.77	5.5	0.53	4.74e-7	Coffee consumption (cups per day);
SKCM	cis	rs1568889	1.000	rs7931847	chr11:28175245	G/T	cg06544937	chr11:28130018	METT5D1;KIF18A	0.87	7.0	0.62	7.86e-10	Bipolar disorder;
SKCM	cis	rs10193935	1.000	rs13411405	chr2:42413811	C/A	cg27598129	chr2:42591480	NA	-0.91	-6.64	-0.6	3.8e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7824557	0.583	rs2263512	chr8:11233419	T/G	cg21775007	chr8:11205619	TDH	-0.6	-5.03	-0.49	3.1e-6	Retinal vascular caliber;
SKCM	cis	rs801193	1.000	rs10234018	chr7:66146284	A/T	cg11987759	chr7:65425863	GUSB	0.7	5.98	0.56	6.23e-8	Aortic root size;
SKCM	cis	rs11098499	0.722	rs28713555	chr4:120251995	C/T	cg09307838	chr4:120376055	NA	0.91	7.36	0.64	1.63e-10	Corneal astigmatism;
SKCM	cis	rs1577917	0.771	rs9450319	chr6:86427325	T/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	0.94	9.69	0.74	4.92e-15	Response to antipsychotic treatment;
SKCM	cis	rs8180040	0.739	rs66539935	chr3:47025327	C/T	cg27129171	chr3:47204927	SETD2	-0.83	-6.19	-0.57	2.6e-8	Colorectal cancer;
SKCM	cis	rs1707322	0.752	rs12047629	chr1:46162802	G/A	cg03146154	chr1:46216737	IPP	0.81	5.62	0.54	2.87e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7772486	0.743	rs9403742	chr6:146060193	A/C	cg05347473	chr6:146136440	FBXO30	0.52	4.87	0.48	5.73e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs826838	1.000	rs11183214	chr12:38692938	C/T	cg13010199	chr12:38710504	ALG10B	0.86	6.84	0.61	1.61e-9	Heart rate;
SKCM	cis	rs28595532	0.920	rs116106661	chr4:119749794	A/G	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs12586317	0.547	rs28589276	chr14:35478865	A/G	cg16230307	chr14:35515116	FAM177A1	0.81	5.88	0.55	9.47e-8	Psoriasis;
SKCM	cis	rs3008870	1.000	rs2815371	chr1:67504313	A/G	cg08660285	chr1:67390436	MIER1;WDR78	0.91	5.96	0.56	6.81e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs3785574	0.962	rs62077512	chr17:61851435	C/T	cg06601766	chr17:61851465	DDX42;CCDC47	0.64	4.77	0.48	8.35e-6	Height;
SKCM	cis	rs10540	1.000	rs12419766	chr11:503710	C/T	cg03352830	chr11:487213	PTDSS2	0.94	4.91	0.49	4.87e-6	Body mass index;
SKCM	cis	rs742614	0.533	rs2626547	chr20:32404921	G/A	cg06304546	chr20:32448765	NA	-0.73	-5.9	-0.56	8.93e-8	Stearic acid (18:0) levels;
SKCM	cis	rs9435341	0.965	rs1762482	chr1:107599002	A/C	cg09367891	chr1:107599246	PRMT6	-0.84	-7.24	-0.63	2.75e-10	Facial morphology (factor 21, depth of nasal alae);
SKCM	cis	rs778371	0.649	rs283465	chr2:233666787	G/A	cg08000102	chr2:233561755	GIGYF2	0.74	5.25	0.51	1.3e-6	Schizophrenia;
SKCM	cis	rs769267	0.965	rs2905427	chr19:19478023	G/T	cg26732615	chr19:19648335	CILP2;YJEFN3	-0.68	-7.1	-0.63	5.11e-10	Tonsillectomy;
SKCM	cis	rs2072510	0.643	rs2367755	chr12:96393082	T/C	cg18817487	chr12:96390143	HAL	0.45	4.94	0.49	4.42e-6	Metabolite levels (small molecules and protein measures);
SKCM	cis	rs1799949	1.000	rs2292595	chr17:41290674	G/C	cg23758822	chr17:41437982	NA	0.92	7.8	0.66	2.3e-11	Menopause (age at onset);
SKCM	cis	rs6500602	0.702	rs6500606	chr16:4502514	A/G	cg08645402	chr16:4508243	NA	-0.6	-5.22	-0.51	1.42e-6	Schizophrenia;
SKCM	cis	rs1878931	0.554	rs3207360	chr16:3498115	G/T	cg26668626	chr16:3451006	ZNF174;ZNF434	0.77	5.45	0.53	5.7e-7	Body mass index (adult);
SKCM	cis	rs16866061	0.926	rs1523919	chr2:225403615	G/A	cg12698349	chr2:225449008	CUL3	0.93	7.51	0.65	8.45e-11	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs11700980	0.636	rs11701464	chr21:30285392	C/T	cg24692254	chr21:30365293	RNF160	0.84	4.79	0.48	7.93e-6	QRS complex (12-leadsum);
SKCM	cis	rs1799949	1.000	rs12944458	chr17:41180772	C/T	cg25072359	chr17:41440525	NA	0.63	4.88	0.48	5.43e-6	Menopause (age at onset);
SKCM	cis	rs7666738	0.830	rs7659006	chr4:98934529	T/C	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2463822	0.858	rs2513077	chr11:62105925	A/G	cg06239285	chr11:62104954	ASRGL1	-1.25	-5.93	-0.56	7.79e-8	Chronic obstructive pulmonary disease-related biomarkers;
SKCM	cis	rs951366	0.789	rs864783	chr1:205711974	T/C	cg26354017	chr1:205819088	PM20D1	1.01	8.85	0.71	2.06e-13	Menarche (age at onset);
SKCM	cis	rs12497850	1.000	rs4858828	chr3:48724811	C/T	cg07636037	chr3:49044803	WDR6	0.88	8.94	0.71	1.43e-13	Parkinson's disease;
SKCM	cis	rs1577917	0.958	rs12212480	chr6:86458777	T/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.67	-5.77	-0.55	1.54e-7	Response to antipsychotic treatment;
SKCM	cis	rs73110464	0.609	rs11170348	chr12:53355588	A/G	cg05393297	chr12:53359155	NA	-0.65	-5.98	-0.56	6.35e-8	Cancer (pleiotropy);
SKCM	cis	rs9926296	0.512	rs11076626	chr16:89865103	T/A	cg04287289	chr16:89883240	FANCA	1.04	12.66	0.82	1.33e-20	Vitiligo;
SKCM	cis	rs2153535	0.580	rs1414342	chr6:8462552	A/G	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.24e-6	Motion sickness;
SKCM	cis	rs1256061	0.624	rs944046	chr14:64700299	G/A	cg21174375	chr14:64681225	SYNE2	0.47	4.87	0.48	5.65e-6	Hemoglobin concentration;Red blood cell count;Hematocrit;
SKCM	cis	rs7666738	0.723	rs35327100	chr4:98977788	C/A	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4819052	0.766	rs4819035	chr21:46645715	A/C	cg19498844	chr21:46707878	POFUT2;LOC642852	0.84	6.02	0.56	5.28e-8	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7659604	1.000	rs35224452	chr4:122664677	C/T	cg19748678	chr4:122722346	EXOSC9	0.66	5.44	0.52	5.83e-7	Type 2 diabetes;
SKCM	cis	rs67311347	1.000	rs13324109	chr3:40460767	T/C	cg00091569	chr3:40428383	ENTPD3	0.62	5.1	0.5	2.35e-6	Renal cell carcinoma;
SKCM	cis	rs1799949	0.602	rs8176199	chr17:41230524	T/G	cg25918947	chr17:41365094	TMEM106A	-0.58	-4.87	-0.48	5.79e-6	Menopause (age at onset);
SKCM	cis	rs6570726	0.755	rs2103633	chr6:145894021	C/T	cg05347473	chr6:146136440	FBXO30	0.57	5.08	0.5	2.47e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs778371	0.522	rs6704768	chr2:233592501	C/T	cg08000102	chr2:233561755	GIGYF2	0.74	5.91	0.56	8.65e-8	Schizophrenia;
SKCM	cis	rs4780401	0.609	rs9924522	chr16:11816852	C/A	cg01061890	chr16:11836724	TXNDC11	-0.77	-5.59	-0.54	3.18e-7	Rheumatoid arthritis;
SKCM	cis	rs2153535	0.580	rs1115079	chr6:8449615	G/C	cg07606381	chr6:8435919	SLC35B3	0.92	6.65	0.6	3.65e-9	Motion sickness;
SKCM	cis	rs1577917	0.655	rs2842600	chr6:86325632	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.64	-5.43	-0.52	6.23e-7	Response to antipsychotic treatment;
SKCM	cis	rs10754283	0.967	rs6428559	chr1:90099036	C/T	cg21401794	chr1:90099060	LRRC8C	0.78	7.05	0.62	6.41e-10	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs28595532	0.920	rs114080496	chr4:119726372	C/T	cg11846333	chr4:119757529	SEC24D	1.19	6.39	0.59	1.12e-8	Cannabis dependence symptom count;
SKCM	cis	rs10883723	0.810	rs7917525	chr10:104246755	C/G	cg11453585	chr10:104263688	ACTR1A;SUFU	0.73	5.41	0.52	6.74e-7	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs3785574	0.962	rs2584632	chr17:61880641	G/A	cg01411255	chr17:61851458	DDX42;CCDC47	1.13	13.06	0.83	2.55e-21	Height;
SKCM	cis	rs7659604	0.967	rs28529384	chr4:122664215	T/C	cg19748678	chr4:122722346	EXOSC9	0.68	5.59	0.53	3.23e-7	Type 2 diabetes;
SKCM	cis	rs8064024	0.619	rs9935080	chr16:4902207	A/G	cg09549813	chr16:4587862	C16orf5	0.59	4.95	0.49	4.12e-6	Cancer;
SKCM	cis	rs6545883	0.894	rs12622458	chr2:61523554	A/C	cg15711740	chr2:61764176	XPO1	0.68	4.82	0.48	6.94e-6	Tuberculosis;
SKCM	cis	rs995000	0.965	rs10889338	chr1:62984897	C/T	cg06896770	chr1:63153194	DOCK7	0.92	8.25	0.68	3.08e-12	Triglyceride levels;
SKCM	cis	rs9911578	0.904	rs7209253	chr17:56908987	C/T	cg05425664	chr17:57184151	TRIM37	-0.67	-5.04	-0.5	2.91e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs1005277	0.557	rs1854563	chr10:38434961	G/A	cg25427524	chr10:38739819	LOC399744	-0.71	-6.71	-0.61	2.75e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs7829975	0.688	rs7827182	chr8:8380471	C/G	cg15556689	chr8:8085844	FLJ10661	0.84	7.63	0.65	4.79e-11	Mood instability;
SKCM	trans	rs561341	0.883	rs4795661	chr17:30201774	T/A	cg20587970	chr11:113659929	NA	1.07	8.37	0.69	1.77e-12	Hip circumference adjusted for BMI;
SKCM	cis	rs4819052	0.851	rs1006779	chr21:46670752	A/G	cg02159808	chr21:46707872	POFUT2;LOC642852	0.65	5.01	0.49	3.37e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7953508	0.506	rs10859532	chr12:93960917	G/C	cg18151635	chr12:93972918	NA	-0.72	-6.99	-0.62	8.05e-10	Pubertal anthropometrics;
SKCM	cis	rs12986445	0.711	rs6754861	chr2:26137994	T/A	cg04917511	chr2:26785460	C2orf70	0.51	4.81	0.48	7.17e-6	Multiple myeloma and monoclonal gammopathy;Multiple myeloma;
SKCM	cis	rs16866061	1.000	rs72974267	chr2:225454209	T/C	cg12698349	chr2:225449008	CUL3	1.01	8.51	0.69	9.75e-13	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs28595532	0.920	rs56124677	chr4:119772213	C/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs2839186	0.771	rs2839155	chr21:47639992	A/G	cg13126279	chr21:47581558	C21orf56	-0.67	-5.87	-0.55	9.92e-8	Testicular germ cell tumor;
SKCM	cis	rs56104184	0.775	rs3760785	chr19:49403178	G/T	cg19746536	chr19:49375674	PPP1R15A	1.22	6.15	0.57	3.15e-8	Reticulocyte fraction of red cells;Reticulocyte count;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;
SKCM	cis	rs798554	0.797	rs1182174	chr7:2875420	G/A	cg19346786	chr7:2764209	NA	-0.62	-6.93	-0.62	1.09e-9	Height;
SKCM	cis	rs4332037	0.722	rs55934553	chr7:1914059	T/C	cg23422044	chr7:1970798	MAD1L1	-0.94	-6.36	-0.58	1.27e-8	Bipolar disorder;
SKCM	cis	rs4803468	0.935	rs13346603	chr19:41945837	T/A	cg14132834	chr19:41945861	ATP5SL	0.77	5.9	0.56	9.04e-8	Height;
SKCM	cis	rs738322	0.967	rs132971	chr22:38561911	T/G	cg25457927	chr22:38595422	NA	-0.5	-5.63	-0.54	2.7e-7	Cutaneous nevi;
SKCM	cis	rs769267	0.896	rs10405625	chr19:19579046	T/G	cg26732615	chr19:19648335	CILP2;YJEFN3	0.67	7.06	0.62	6e-10	Tonsillectomy;
SKCM	cis	rs7772486	0.875	rs9399573	chr6:146403255	A/T	cg05347473	chr6:146136440	FBXO30	0.64	5.83	0.55	1.19e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs3785574	0.962	rs2665835	chr17:61903258	C/T	cg06873352	chr17:61820015	STRADA	0.56	4.82	0.48	6.86e-6	Height;
SKCM	cis	rs951366	0.764	rs708725	chr1:205744138	G/T	cg24503407	chr1:205819492	PM20D1	0.9	8.05	0.67	7.64e-12	Menarche (age at onset);
SKCM	cis	rs8180040	0.966	rs2062278	chr3:47416761	C/T	cg16586182	chr3:47516702	SCAP	-0.77	-5.56	-0.53	3.66e-7	Colorectal cancer;
SKCM	cis	rs1801251	1.000	rs283469	chr2:233656997	G/T	cg08000102	chr2:233561755	GIGYF2	0.9	6.96	0.62	9.41e-10	Coronary artery disease;
SKCM	cis	rs28595532	0.920	rs113034745	chr4:119750044	T/C	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs1160297	0.576	rs13003962	chr2:53110176	C/T	cg07782112	chr2:53107842	NA	0.62	6.53	0.59	6.19e-9	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs1153858	1.000	rs1613559	chr15:45622116	A/G	cg10760299	chr15:45669010	GATM	0.53	5.01	0.49	3.33e-6	Homoarginine levels;
SKCM	cis	rs9475752	0.947	rs17752435	chr6:56791495	C/T	cg06815302	chr6:57335405	PRIM2	0.64	5.25	0.51	1.29e-6	Menarche (age at onset);
SKCM	cis	rs11148252	0.508	rs6561671	chr13:53182314	G/A	cg00495681	chr13:53174319	NA	0.64	4.99	0.49	3.53e-6	Lewy body disease;
SKCM	cis	rs1577917	0.958	rs12191340	chr6:86521400	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.62	-5.33	-0.52	9.19e-7	Response to antipsychotic treatment;
SKCM	cis	rs40363	0.672	rs1617722	chr16:3520806	C/T	cg22508957	chr16:3507546	NAT15	-0.56	-4.85	-0.48	6.19e-6	Tuberculosis;
SKCM	cis	rs8017423	0.874	rs2149656	chr14:90707508	A/C	cg04374321	chr14:90722782	PSMC1	0.97	8.87	0.71	1.91e-13	Mortality in heart failure;
SKCM	cis	rs7171869	1	rs7171869	chr15:78900909	A/G	cg24631222	chr15:78858424	CHRNA5	-0.82	-6.39	-0.59	1.1e-8	Post bronchodilator FEV1;
SKCM	cis	rs2153535	0.607	rs9502722	chr6:8541483	C/T	cg07606381	chr6:8435919	SLC35B3	0.91	6.31	0.58	1.56e-8	Motion sickness;
SKCM	cis	rs8077889	0.917	rs8081646	chr17:41893360	T/C	cg26893861	chr17:41843967	DUSP3	1.15	7.34	0.64	1.79e-10	Triglycerides;
SKCM	cis	rs10832963	1.000	rs7943121	chr11:18656062	G/C	cg09201001	chr11:18656081	SPTY2D1	1.07	10.84	0.78	3.16e-17	Breast cancer;
SKCM	cis	rs427394	0.802	rs274692	chr5:6734625	C/T	cg10857441	chr5:6722123	POLS	-0.71	-7.33	-0.64	1.82e-10	Menopause (age at onset);
SKCM	cis	rs1153858	1.000	rs59889118	chr15:45618730	G/A	cg21132104	chr15:45694354	SPATA5L1	0.93	7.84	0.66	1.95e-11	Homoarginine levels;
SKCM	cis	rs6977660	0.943	rs10274447	chr7:19850640	C/T	cg07541023	chr7:19748670	TWISTNB	0.7	4.92	0.49	4.79e-6	Thyroid stimulating hormone;
SKCM	cis	rs1218582	0.774	rs12036859	chr1:154859940	A/C	cg24250549	chr1:154909240	PMVK	-0.8	-8.06	-0.67	7.2e-12	Prostate cancer;
SKCM	cis	rs763121	0.853	rs2281021	chr22:39064667	T/C	cg06022373	chr22:39101656	GTPBP1	0.78	5.63	0.54	2.7e-7	Menopause (age at onset);
SKCM	cis	rs477895	0.713	rs11601024	chr11:63943074	A/G	cg07220939	chr11:64358617	SLC22A12	0.74	4.99	0.49	3.58e-6	Mean platelet volume;
SKCM	cis	rs2841277	0.708	rs28600075	chr14:105408315	T/C	cg21017887	chr14:105400489	NA	0.59	5.31	0.52	1e-6	Rheumatoid arthritis;
SKCM	cis	rs2839186	0.934	rs13046494	chr21:47707430	A/C	cg05896524	chr21:47604654	C21orf56	0.69	5.67	0.54	2.29e-7	Testicular germ cell tumor;
SKCM	cis	rs7824557	0.628	rs7841394	chr8:11185671	G/T	cg21775007	chr8:11205619	TDH	0.72	6.73	0.61	2.61e-9	Retinal vascular caliber;
SKCM	cis	rs801193	0.569	rs35070132	chr7:66238083	C/T	cg18876405	chr7:65276391	NA	0.61	6.02	0.56	5.35e-8	Aortic root size;
SKCM	cis	rs1005277	0.579	rs9299760	chr10:38377920	C/T	cg25427524	chr10:38739819	LOC399744	-0.69	-6.45	-0.59	8.73e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs11098499	0.909	rs28581362	chr4:120283548	T/A	cg09307838	chr4:120376055	NA	0.98	7.89	0.67	1.52e-11	Corneal astigmatism;
SKCM	cis	rs732765	0.734	rs12882425	chr14:75189226	A/T	cg25946216	chr14:74253857	C14orf43	-0.8	-5.15	-0.5	1.88e-6	Non-small cell lung cancer;
SKCM	cis	rs908922	0.676	rs3753451	chr1:152485227	T/G	cg09873164	chr1:152488093	CRCT1	0.77	5.99	0.56	6.03e-8	Hair morphology;
SKCM	cis	rs7772486	0.790	rs9376970	chr6:146241472	A/C	cg05347473	chr6:146136440	FBXO30	-0.6	-5.77	-0.55	1.54e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2839186	0.934	rs13049797	chr21:47707582	T/C	cg11766577	chr21:47581405	C21orf56	-0.71	-6.01	-0.56	5.6e-8	Testicular germ cell tumor;
SKCM	cis	rs860295	0.702	rs12067371	chr1:155437669	C/T	cg02153340	chr1:155202674	NA	-0.8	-5.77	-0.55	1.52e-7	Body mass index;
SKCM	cis	rs2836950	0.545	rs2836940	chr21:40588696	T/C	cg11890956	chr21:40555474	PSMG1	-0.66	-5.26	-0.51	1.22e-6	Menarche (age at onset);
SKCM	cis	rs8060686	0.641	rs113790673	chr16:68244347	C/T	cg09117114	chr16:67998030	SLC12A4	-0.77	-5.03	-0.49	3.12e-6	HDL cholesterol;Metabolic syndrome;
SKCM	trans	rs10506458	0.915	rs2013042	chr12:63394211	A/G	cg03429785	chr15:59498649	MYO1E;LDHAL6B	-1.39	-7.59	-0.65	5.95e-11	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs2806561	0.704	rs674386	chr1:23521835	G/A	cg12483005	chr1:23474871	LUZP1	0.68	5.24	0.51	1.34e-6	Height;
SKCM	cis	rs4268898	0.636	rs72787383	chr2:24583861	G/A	cg06627628	chr2:24431161	ITSN2	-0.9	-6.93	-0.62	1.07e-9	Asthma;
SKCM	cis	rs703842	1.000	rs6581155	chr12:58178162	A/G	cg04478727	chr12:58166393	METTL1;FAM119B	0.71	5.76	0.55	1.57e-7	Multiple sclerosis;
SKCM	cis	rs8141529	0.732	rs5762815	chr22:29205076	A/G	cg02153584	chr22:29168773	CCDC117	0.66	5.36	0.52	8.31e-7	Lymphocyte counts;
SKCM	cis	rs941408	1.000	rs2260416	chr19:2796355	G/A	cg06609049	chr19:2785107	THOP1	0.84	7.25	0.63	2.65e-10	Total cholesterol levels;
SKCM	cis	rs12950390	0.853	rs56363619	chr17:45854621	T/C	cg03474202	chr17:45855739	NA	-0.49	-5.58	-0.53	3.34e-7	IgG glycosylation;
SKCM	cis	rs7633857	0.532	rs1580254	chr3:160767278	C/T	cg03342759	chr3:160939853	NMD3	-0.66	-5.12	-0.5	2.16e-6	Educational attainment (years of education);
SKCM	cis	rs12497850	0.931	rs9311433	chr3:48863835	T/C	cg06212747	chr3:49208901	KLHDC8B	0.68	4.89	0.48	5.28e-6	Parkinson's disease;
SKCM	cis	rs875971	0.862	rs4718377	chr7:66049678	C/T	cg11764359	chr7:65958608	NA	-0.74	-6.67	-0.6	3.37e-9	Aortic root size;
SKCM	cis	rs1014246	0.813	rs1014245	chr10:118466129	G/A	cg14919929	chr10:118506882	NA	0.79	5.76	0.55	1.59e-7	Age at smoking initiation in chronic obstructive pulmonary disease;
SKCM	cis	rs6089584	1.000	rs3787425	chr20:60559256	C/T	cg06108461	chr20:60628389	TAF4	-0.81	-7.11	-0.63	4.79e-10	Body mass index;
SKCM	cis	rs10267417	0.514	rs2072184	chr7:19748883	A/G	cg07541023	chr7:19748670	TWISTNB	1.03	6.93	0.62	1.09e-9	Night sleep phenotypes;
SKCM	cis	rs760805	1.000	rs742231	chr1:25251456	G/A	cg22509179	chr1:25234806	RUNX3	-0.75	-6.22	-0.58	2.26e-8	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs7659604	0.540	rs34445121	chr4:122710889	G/A	cg19671926	chr4:122722719	EXOSC9	0.78	7.14	0.63	4.32e-10	Type 2 diabetes;
SKCM	cis	rs2811415	0.597	rs1042912	chr3:127789695	C/T	cg09089421	chr3:127803668	RUVBL1	1.0	8.69	0.7	4.4e-13	Lung function (FEV1/FVC);
SKCM	cis	rs1506636	0.886	rs6466878	chr7:123272278	T/C	cg03229431	chr7:123269106	ASB15	-0.63	-4.88	-0.48	5.47e-6	Plateletcrit;Platelet count;
SKCM	cis	rs4975616	0.843	rs6866783	chr5:1312020	T/C	cg26373071	chr5:1325741	CLPTM1L	-0.66	-5.29	-0.51	1.1e-6	Lung cancer;
SKCM	cis	rs12682352	0.602	rs1473029	chr8:8668917	A/C	cg06636001	chr8:8085503	FLJ10661	0.71	5.62	0.54	2.81e-7	Neuroticism;
SKCM	cis	rs6952808	0.723	rs57216949	chr7:2030287	G/T	cg21782813	chr7:2030301	MAD1L1	0.57	5.93	0.56	7.93e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs2836974	0.931	rs2776309	chr21:40715791	A/G	cg17971929	chr21:40555470	PSMG1	0.83	7.71	0.66	3.35e-11	Cognitive function;
SKCM	cis	rs1160297	0.609	rs4525730	chr2:53097497	C/T	cg07782112	chr2:53107842	NA	0.6	6.34	0.58	1.36e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs1401999	0.650	rs3749445	chr3:183638506	C/T	cg01324343	chr3:183735012	ABCC5	0.65	6.11	0.57	3.74e-8	Anterior chamber depth;
SKCM	cis	rs6580649	0.941	rs11612578	chr12:48414798	T/C	cg05342945	chr12:48394962	COL2A1	0.74	5.1	0.5	2.33e-6	Lung cancer;
SKCM	cis	rs12928939	0.517	rs11865456	chr16:71969497	C/T	cg03805757	chr16:71968109	PKD1L3	-0.72	-5.17	-0.51	1.78e-6	Post bronchodilator FEV1;
SKCM	cis	rs826838	1.000	rs11183747	chr12:38822595	A/G	cg26384229	chr12:38710491	ALG10B	-1.05	-10.13	-0.75	7.11e-16	Heart rate;
SKCM	cis	rs3820068	0.581	rs16851851	chr1:15929628	C/G	cg24675056	chr1:15929824	NA	0.76	5.52	0.53	4.26e-7	Systolic blood pressure;
SKCM	cis	rs11249608	0.548	rs6601007	chr5:178455796	G/C	cg21905437	chr5:178450457	ZNF879	0.72	5.65	0.54	2.5e-7	Pubertal anthropometrics;
SKCM	cis	rs6461049	0.765	rs4719431	chr7:2140312	T/C	cg02951883	chr7:2050386	MAD1L1	-0.8	-7.69	-0.66	3.81e-11	Schizophrenia;
SKCM	cis	rs6952808	0.609	rs6944877	chr7:1952582	T/G	cg02951883	chr7:2050386	MAD1L1	-0.66	-5.58	-0.53	3.29e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs10808739	0.660	rs62521111	chr8:65635280	A/T	cg05711235	chr8:65498612	NA	-0.81	-5.4	-0.52	7.01e-7	HIV-1 susceptibility;
SKCM	cis	rs477692	0.905	rs7905466	chr10:131438937	A/T	cg11019008	chr10:131425282	MGMT	-0.52	-4.87	-0.48	5.73e-6	Response to temozolomide;
SKCM	cis	rs798554	0.759	rs798495	chr7:2797267	T/C	cg04166393	chr7:2884313	GNA12	0.72	4.99	0.49	3.52e-6	Height;
SKCM	cis	rs62560775	0.688	rs3217986	chr9:22005330	G/T	cg03079681	chr9:21994223	CDKN2A;CDKN2BAS	-0.88	-4.83	-0.48	6.8e-6	Lung adenocarcinoma;Lung cancer;
SKCM	cis	rs9300255	0.739	rs6633	chr12:123745809	G/T	cg05973401	chr12:123451056	ABCB9	-0.84	-5.94	-0.56	7.59e-8	Neutrophil percentage of white cells;
SKCM	cis	rs7811142	0.779	rs111312383	chr7:99905325	C/T	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.08	6.85	0.61	1.49e-9	Platelet count;
SKCM	cis	rs860295	0.702	rs11264397	chr1:155611485	G/C	cg02153340	chr1:155202674	NA	-0.76	-5.61	-0.54	2.96e-7	Body mass index;
SKCM	cis	rs4689592	0.523	rs6446565	chr4:7074027	A/G	cg19539972	chr4:7069911	GRPEL1	1.01	7.07	0.63	5.76e-10	Monocyte percentage of white cells;
SKCM	cis	rs6547631	0.682	rs4832186	chr2:85929674	C/T	cg24620635	chr2:85921963	GNLY	0.95	7.99	0.67	9.95e-12	Blood protein levels;
SKCM	cis	rs28595532	0.920	rs10004184	chr4:119486801	G/T	cg14228332	chr4:119757509	SEC24D	0.97	4.92	0.49	4.71e-6	Cannabis dependence symptom count;
SKCM	cis	rs6728642	1.000	rs73959416	chr2:97604518	A/T	cg00438775	chr2:97175311	NEURL3	1.05	4.85	0.48	6.22e-6	Bipolar disorder lithium response (continuous) or schizophrenia;
SKCM	cis	rs9913156	0.576	rs2036656	chr17:4622071	C/G	cg19197139	chr17:4613644	ARRB2	-0.65	-4.85	-0.48	6.26e-6	Lymphocyte counts;
SKCM	cis	rs11098499	0.779	rs28495013	chr4:120375831	A/C	cg09307838	chr4:120376055	NA	0.96	7.81	0.66	2.24e-11	Corneal astigmatism;
SKCM	cis	rs4819052	0.632	rs4819050	chr21:46692943	C/A	cg19498844	chr21:46707878	POFUT2;LOC642852	0.83	7.01	0.62	7.55e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs951366	0.789	rs823137	chr1:205738302	C/T	cg17178900	chr1:205818956	PM20D1	0.77	6.6	0.6	4.58e-9	Menarche (age at onset);
SKCM	trans	rs9929218	0.551	rs3785133	chr16:68728611	C/T	cg04657470	chr2:198365150	HSPE1;HSPD1	0.98	10.11	0.75	7.75e-16	Colorectal cancer;
SKCM	cis	rs12936587	0.535	rs8065154	chr17:17614947	A/G	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.62	4.82	0.48	6.87e-6	Hip circumference;Coronary artery disease or large artery stroke;Coronary heart disease;Coronary artery disease;
SKCM	cis	rs2739330	0.796	rs2154594	chr22:24254055	A/G	cg24846343	chr22:24311635	DDTL	-0.75	-7.19	-0.63	3.48e-10	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs2268241	0.877	rs17887186	chr21:34779202	G/A	cg14850771	chr21:34775459	IFNGR2	1.09	6.8	0.61	1.9e-9	Obesity-related traits;
SKCM	cis	rs6951245	1.000	rs74785791	chr7:1088494	T/C	cg03188948	chr7:1209495	NA	1.12	6.25	0.58	2.02e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs10489202	0.632	rs202268	chr1:167927339	T/C	cg24449463	chr1:168025552	DCAF6	-0.8	-7.62	-0.65	5.14e-11	Schizophrenia;
SKCM	cis	rs4242434	0.819	rs55776566	chr8:22469492	T/C	cg03733263	chr8:22462867	KIAA1967	1.0	8.29	0.68	2.63e-12	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs6952808	0.582	rs11763870	chr7:2027448	T/C	cg02951883	chr7:2050386	MAD1L1	0.78	6.81	0.61	1.81e-9	Bipolar disorder and schizophrenia;
SKCM	cis	rs362296	0.550	rs3135064	chr4:3285389	T/C	cg11471262	chr4:3318911	RGS12	0.76	7.13	0.63	4.52e-10	Parental longevity (mother's age at death);
SKCM	cis	rs10504229	0.683	rs57866073	chr8:58139138	A/G	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs933688	1.000	rs332531	chr5:90790451	G/C	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.0	7.8	0.66	2.29e-11	Smoking behavior;
SKCM	cis	rs6665290	0.901	rs7535826	chr1:227213968	A/C	cg10327440	chr1:227177885	CDC42BPA	1.18	14.58	0.86	5.52e-24	Myeloid white cell count;
SKCM	cis	rs854765	0.547	rs2955353	chr17:17948979	T/C	cg04398451	chr17:18023971	MYO15A	0.94	7.53	0.65	7.5e-11	Total body bone mineral density;
SKCM	cis	rs3902354	1	rs3902354	chr1:109819296	C/A	cg00908766	chr1:109817496	CELSR2	0.45	5.8	0.55	1.33e-7	Cholesterol, total;
SKCM	cis	rs3809863	0.602	rs2317677	chr17:45393407	G/A	cg08085267	chr17:45401833	C17orf57	-0.86	-6.68	-0.6	3.22e-9	Glaucoma (primary open-angle);
SKCM	cis	rs7100689	0.784	rs1972370	chr10:82127180	A/G	cg01528321	chr10:82214614	TSPAN14	0.82	7.43	0.64	1.2e-10	Post bronchodilator FEV1;
SKCM	cis	rs523522	0.926	rs10774555	chr12:120971978	G/A	cg27279351	chr12:120934652	DYNLL1	0.91	8.32	0.69	2.26e-12	High light scatter reticulocyte count;
SKCM	cis	rs701145	0.585	rs357498	chr3:153945495	G/A	cg17054900	chr3:154042577	DHX36	1.19	5.1	0.5	2.37e-6	Coronary artery disease;
SKCM	cis	rs861020	0.630	rs657861	chr1:210006884	C/G	cg05527609	chr1:210001259	C1orf107	0.86	6.74	0.61	2.43e-9	Orofacial clefts;
SKCM	cis	rs9902453	0.845	rs12601963	chr17:28246358	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.79	5.67	0.54	2.35e-7	Coffee consumption (cups per day);
SKCM	trans	rs17685	0.753	rs10264760	chr7:75749694	A/G	cg19862616	chr7:65841803	NCRNA00174	0.94	9.49	0.73	1.22e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2832191	0.791	rs7282843	chr21:30475226	A/G	cg24692254	chr21:30365293	RNF160	0.9	8.03	0.67	8.39e-12	Dental caries;
SKCM	cis	rs9858542	0.953	rs9837341	chr3:49664767	A/G	cg03060546	chr3:49711283	APEH	-0.71	-5.29	-0.51	1.07e-6	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs7306456	0.623	rs10902513	chr12:132693487	A/G	cg14525755	chr12:132671672	NA	0.43	4.77	0.48	8.27e-6	Anti-saccade response;
SKCM	cis	rs2204008	0.747	rs11514040	chr12:38201040	G/A	cg13010199	chr12:38710504	ALG10B	0.65	4.84	0.48	6.52e-6	Bladder cancer;
SKCM	cis	rs2204008	0.805	rs10881112	chr12:37956611	G/A	cg26384229	chr12:38710491	ALG10B	-0.76	-6.55	-0.6	5.53e-9	Bladder cancer;
SKCM	trans	rs561341	1.000	rs527256	chr17:30321293	C/G	cg20587970	chr11:113659929	NA	-1.17	-10.37	-0.76	2.5e-16	Hip circumference adjusted for BMI;
SKCM	cis	rs17683430	0.557	rs4821012	chr22:32387985	A/G	cg00543991	chr22:32367038	NA	1.15	4.87	0.48	5.76e-6	GIP levels in response to oral glucose tolerance test (120 minutes);
SKCM	cis	rs62238980	0.614	rs118130048	chr22:32413324	C/A	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs875971	0.929	rs34406470	chr7:65929956	A/G	cg11764359	chr7:65958608	NA	0.88	8.55	0.7	7.95e-13	Aortic root size;
SKCM	cis	rs7666738	0.830	rs7673385	chr4:99024922	T/G	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4819052	0.851	rs10470245	chr21:46658912	A/G	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.36	0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs11249608	0.548	rs2132672	chr5:178457742	A/C	cg21905437	chr5:178450457	ZNF879	0.74	5.46	0.53	5.52e-7	Pubertal anthropometrics;
SKCM	cis	rs6570726	0.846	rs7773939	chr6:145927384	C/T	cg23711669	chr6:146136114	FBXO30	-0.8	-6.78	-0.61	2.04e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9467773	1.000	rs10214634	chr6:26564582	T/A	cg15659132	chr6:26577336	NA	0.6	5.71	0.54	1.99e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs7772486	0.790	rs2249147	chr6:146184999	T/C	cg05347473	chr6:146136440	FBXO30	0.58	5.45	0.53	5.72e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs10754283	0.557	rs1215508	chr1:90088697	C/T	cg21401794	chr1:90099060	LRRC8C	0.66	5.06	0.5	2.69e-6	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs9858542	0.903	rs9875617	chr3:49634696	G/A	cg03060546	chr3:49711283	APEH	-0.68	-5.03	-0.5	3.02e-6	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs1405130	0.869	rs13018244	chr2:235565799	G/A	cg21542780	chr2:234763377	HJURP	-0.64	-4.89	-0.48	5.21e-6	Coronary artery disease;
SKCM	cis	rs2857078	0.654	rs4793083	chr17:42312973	C/T	cg10896456	chr17:42255109	ASB16;C17orf65	-0.59	-5.45	-0.53	5.61e-7	Red cell distribution width;Reticulocyte count;
SKCM	cis	rs9910055	0.747	rs2905981	chr17:42238625	C/T	cg08499158	chr17:42289980	UBTF	-0.85	-7.66	-0.66	4.36e-11	Total body bone mineral density;
SKCM	cis	rs1799949	0.896	rs35908185	chr17:41255111	A/T	cg23758822	chr17:41437982	NA	0.9	7.48	0.65	9.38e-11	Menopause (age at onset);
SKCM	cis	rs951366	0.789	rs823152	chr1:205736285	G/A	cg26354017	chr1:205819088	PM20D1	1.03	9.51	0.73	1.12e-14	Menarche (age at onset);
SKCM	cis	rs2980439	0.846	rs2980437	chr8:8094763	C/T	cg08975724	chr8:8085496	FLJ10661	-0.74	-5.47	-0.53	5.19e-7	Neuroticism;
SKCM	cis	rs7811142	0.830	rs28495773	chr7:99943583	A/T	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.11	7.07	0.62	5.79e-10	Platelet count;
SKCM	cis	rs11098499	0.580	rs12509234	chr4:120319434	T/C	cg24375607	chr4:120327624	NA	0.65	4.97	0.49	3.87e-6	Corneal astigmatism;
SKCM	cis	rs6089584	0.821	rs4925332	chr20:60604639	C/T	cg13770153	chr20:60521292	NA	-0.59	-4.81	-0.48	7.13e-6	Body mass index;
SKCM	cis	rs10883723	0.773	rs1326193	chr10:104271674	G/T	cg11453585	chr10:104263688	ACTR1A;SUFU	0.77	6.31	0.58	1.56e-8	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs2836974	0.583	rs2776306	chr21:40713754	A/G	cg11644478	chr21:40555479	PSMG1	0.64	4.88	0.48	5.43e-6	Cognitive function;
SKCM	cis	rs514406	0.893	rs6682024	chr1:53439525	T/C	cg24675658	chr1:53192096	ZYG11B	0.61	4.94	0.49	4.42e-6	Monocyte count;
SKCM	cis	rs992157	0.835	rs12987180	chr2:219144089	G/A	cg20019365	chr2:219134978	PNKD;AAMP	-0.72	-6.22	-0.58	2.33e-8	Colorectal cancer;
SKCM	cis	rs507080	0.845	rs510408	chr11:118558901	G/C	cg18045108	chr11:118530628	TREH	-0.47	-4.81	-0.48	7.24e-6	Serum metabolite levels;
SKCM	cis	rs17065868	1.000	rs73190824	chr13:45108587	G/C	cg10246903	chr13:45222710	NA	0.92	5.05	0.5	2.78e-6	Antineutrophil cytoplasmic antibody-associated vasculitis;
SKCM	cis	rs10832963	1.000	rs2084220	chr11:18656932	C/T	cg09201001	chr11:18656081	SPTY2D1	1.06	9.96	0.75	1.48e-15	Breast cancer;
SKCM	cis	rs6912958	0.559	rs173333	chr6:88047754	T/G	cg08069147	chr6:88032118	GJB7;C6orf162	0.65	5.83	0.55	1.21e-7	Monocyte percentage of white cells;
SKCM	cis	rs8072100	1.000	rs4375701	chr17:45712218	C/T	cg08085267	chr17:45401833	C17orf57	-0.63	-5.86	-0.55	1.06e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs7100689	0.784	rs4258322	chr10:82184770	T/C	cg00277334	chr10:82204260	NA	-0.52	-4.83	-0.48	6.63e-6	Post bronchodilator FEV1;
SKCM	cis	rs11098499	0.820	rs6829903	chr4:120506884	C/T	cg09307838	chr4:120376055	NA	1.0	8.27	0.68	2.8e-12	Corneal astigmatism;
SKCM	cis	rs7111031	1.000	rs4337071	chr11:113334100	C/T	cg04642306	chr11:112834466	NCAM1	-0.44	-4.9	-0.48	5.15e-6	Subjective well-being (multi-trait analysis);Depressive symptoms (multi-trait analysis);Neuroticism;
SKCM	cis	rs6547631	0.622	rs12845	chr2:85925848	C/G	cg24620635	chr2:85921963	GNLY	0.9	6.65	0.6	3.58e-9	Blood protein levels;
SKCM	cis	rs9815354	0.812	rs17217746	chr3:41926021	A/G	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs11098499	0.955	rs56386062	chr4:120155135	T/C	cg09307838	chr4:120376055	NA	0.91	7.22	0.63	2.98e-10	Corneal astigmatism;
SKCM	cis	rs7772486	0.754	rs6910790	chr6:146255330	G/A	cg05347473	chr6:146136440	FBXO30	-0.55	-4.9	-0.49	5.11e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7523273	0.606	rs859705	chr1:207959665	A/G	cg22525895	chr1:207977042	MIR29B2	0.77	6.38	0.59	1.14e-8	Schizophrenia;
SKCM	cis	rs995000	0.931	rs4350231	chr1:62922660	C/T	cg06896770	chr1:63153194	DOCK7	0.73	6.81	0.61	1.77e-9	Triglyceride levels;
SKCM	cis	rs9300255	0.602	rs1716172	chr12:123712712	G/T	cg05973401	chr12:123451056	ABCB9	0.79	5.1	0.5	2.35e-6	Neutrophil percentage of white cells;
SKCM	cis	rs1062177	0.855	rs6892117	chr5:151264985	C/T	cg00977110	chr5:151150581	G3BP1	-0.75	-6.07	-0.57	4.43e-8	Preschool internalizing problems;
SKCM	cis	rs769267	0.965	rs2916068	chr19:19516433	A/G	cg26732615	chr19:19648335	CILP2;YJEFN3	0.67	6.47	0.59	7.86e-9	Tonsillectomy;
SKCM	cis	rs8180040	0.966	rs6787422	chr3:47418509	G/T	cg27129171	chr3:47204927	SETD2	0.79	5.79	0.55	1.43e-7	Colorectal cancer;
SKCM	trans	rs561341	0.883	rs2074102	chr17:30228884	G/A	cg20587970	chr11:113659929	NA	-1.11	-8.92	-0.71	1.53e-13	Hip circumference adjusted for BMI;
SKCM	cis	rs873946	0.648	rs12783354	chr10:134557235	T/A	cg18305652	chr10:134549665	INPP5A	0.59	5.72	0.54	1.88e-7	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs9911578	1.000	rs8071280	chr17:57010225	T/C	cg12560992	chr17:57184187	TRIM37	0.94	7.55	0.65	7.01e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs6951245	1.000	rs77868187	chr7:1093968	A/C	cg03188948	chr7:1209495	NA	1.13	6.27	0.58	1.89e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs10193935	0.582	rs13394853	chr2:42630900	T/C	cg27598129	chr2:42591480	NA	-0.88	-6.71	-0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6545883	0.929	rs2593635	chr2:61634706	A/C	cg15711740	chr2:61764176	XPO1	0.71	5.03	0.49	3.1e-6	Tuberculosis;
SKCM	cis	rs995000	0.839	rs1168010	chr1:62943979	G/A	cg06896770	chr1:63153194	DOCK7	-0.64	-5.96	-0.56	6.81e-8	Triglyceride levels;
SKCM	cis	rs9611565	0.649	rs139540	chr22:42178040	C/T	cg03806693	chr22:41940476	POLR3H	-1.01	-6.69	-0.6	3.1e-9	Vitiligo;
SKCM	cis	rs28386778	0.897	rs2584626	chr17:61903179	A/G	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs34779708	0.733	rs4391768	chr10:35547595	A/G	cg03585969	chr10:35415529	CREM	0.71	5.25	0.51	1.27e-6	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs7666738	0.830	rs4441757	chr4:98927059	T/C	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1348850	0.914	rs7604673	chr2:178392346	A/G	cg02961200	chr2:178257176	LOC100130691;AGPS	0.85	6.45	0.59	8.7e-9	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs33794	0.901	rs33773	chr3:45284315	C/T	cg25630594	chr3:44914870	TGM4	0.59	5.25	0.51	1.29e-6	Lung function (forced expiratory volume in 1 second);
SKCM	cis	rs4891159	0.548	rs660342	chr18:74130896	C/G	cg24786174	chr18:74118243	ZNF516	0.79	8.44	0.69	1.31e-12	Longevity;
SKCM	cis	rs644799	0.965	rs11021313	chr11:95506907	G/C	cg03916912	chr11:95522834	CEP57;FAM76B	0.96	8.72	0.7	3.77e-13	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs2239547	0.522	rs9846976	chr3:53007995	T/C	cg11645453	chr3:52864694	ITIH4	0.59	4.95	0.49	4.26e-6	Schizophrenia;
SKCM	cis	rs1707322	1.000	rs1707322	chr1:46505147	C/T	cg03146154	chr1:46216737	IPP	0.76	5.21	0.51	1.53e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs28595532	0.920	rs116428408	chr4:119758514	G/C	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs778371	0.723	rs1022329	chr2:233591239	T/C	cg08000102	chr2:233561755	GIGYF2	0.87	7.15	0.63	4.03e-10	Schizophrenia;
SKCM	cis	rs6582630	0.555	rs6582503	chr12:38557886	A/C	cg26384229	chr12:38710491	ALG10B	0.83	6.59	0.6	4.71e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs28735056	0.592	rs2277725	chr18:77694168	A/C	cg20368463	chr18:77673604	PQLC1	-0.7	-5.22	-0.51	1.43e-6	Schizophrenia;
SKCM	cis	rs7598759	0.712	rs6740474	chr2:232331831	A/G	cg19187155	chr2:232395269	NMUR1	0.61	5.13	0.5	2.07e-6	Noise-induced hearing loss;
SKCM	cis	rs7100689	0.598	rs2342815	chr10:82086532	T/C	cg00277334	chr10:82204260	NA	-0.57	-5.34	-0.52	8.88e-7	Post bronchodilator FEV1;
SKCM	cis	rs1005277	0.505	rs10827835	chr10:38150709	G/A	cg25427524	chr10:38739819	LOC399744	0.69	6.53	0.59	6.01e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs826838	0.967	rs1352123	chr12:39130992	T/C	cg13010199	chr12:38710504	ALG10B	-0.72	-5.73	-0.54	1.83e-7	Heart rate;
SKCM	cis	rs9926664	0.591	rs305082	chr16:85936978	A/G	cg16682899	chr16:85508110	NA	-0.52	-5.05	-0.5	2.8e-6	Sum basophil neutrophil counts;Neutrophil count;
SKCM	cis	rs11098499	0.863	rs3822192	chr4:120445720	A/C	cg24375607	chr4:120327624	NA	0.68	5.27	0.51	1.16e-6	Corneal astigmatism;
SKCM	cis	rs7954584	0.567	rs11043246	chr12:122368944	G/A	cg01765077	chr12:122356316	WDR66	0.44	4.79	0.48	7.71e-6	Mean corpuscular volume;
SKCM	cis	rs28595532	0.920	rs114916728	chr4:119776886	G/A	cg21605333	chr4:119757512	SEC24D	1.41	8.39	0.69	1.68e-12	Cannabis dependence symptom count;
SKCM	cis	rs12142240	0.698	rs72677594	chr1:46824371	A/C	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs17345786	0.906	rs55710435	chr3:101180330	G/A	cg12386194	chr3:101231763	SENP7	0.76	5.58	0.53	3.35e-7	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4819052	0.851	rs2838856	chr21:46680766	T/G	cg20896738	chr21:46707857	POFUT2;LOC642852	0.65	4.89	0.48	5.35e-6	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs9910055	0.659	rs7207464	chr17:42245033	C/T	cg08499158	chr17:42289980	UBTF	-0.74	-6.46	-0.59	8.29e-9	Total body bone mineral density;
SKCM	cis	rs1499614	1.000	rs2707838	chr7:66159201	C/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Gout;
SKCM	cis	rs9790314	0.779	rs1599376	chr3:160900533	C/G	cg03342759	chr3:160939853	NMD3	-0.65	-6.85	-0.61	1.5e-9	Morning vs. evening chronotype;
SKCM	cis	rs17376456	0.877	rs10476596	chr5:93367074	C/T	cg21475434	chr5:93447410	FAM172A	-0.94	-5.62	-0.54	2.87e-7	Diabetic retinopathy;
SKCM	cis	rs5750830	0.649	rs5750813	chr22:39795228	G/C	cg24399712	chr22:39784796	NA	-0.59	-4.91	-0.49	4.81e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs8017423	0.967	rs11159957	chr14:90715972	A/G	cg04374321	chr14:90722782	PSMC1	-0.98	-8.6	-0.7	6.53e-13	Mortality in heart failure;
SKCM	cis	rs673604	1.000	rs7543044	chr1:35674311	A/G	cg12633102	chr1:35676489	NA	-0.69	-5.39	-0.52	7.33e-7	Endometrial cancer;
SKCM	cis	rs28386778	0.897	rs1062788	chr17:61896127	C/G	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs3091242	0.728	rs706845	chr1:25730713	G/A	cg02931644	chr1:25747376	RHCE	0.5	5.01	0.49	3.36e-6	Erythrocyte sedimentation rate;
SKCM	cis	rs899997	0.954	rs1809412	chr15:79021908	C/T	cg04896959	chr15:78267971	NA	0.6	5.3	0.51	1.04e-6	Coronary artery disease or large artery stroke;
SKCM	cis	rs875971	0.660	rs10229345	chr7:65982168	G/C	cg00343986	chr7:65444356	GUSB	0.71	5.32	0.52	9.71e-7	Aortic root size;
SKCM	cis	rs11992186	0.505	rs7845203	chr8:8145440	A/G	cg06636001	chr8:8085503	FLJ10661	0.65	5.86	0.55	1.05e-7	Neuroticism;
SKCM	cis	rs7809950	1.000	rs1544336	chr7:107082415	G/C	cg23024343	chr7:107201750	COG5	-0.76	-6.8	-0.61	1.89e-9	Coronary artery disease;
SKCM	cis	rs28595532	0.920	rs56042726	chr4:119751777	T/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs4242434	0.927	rs7843616	chr8:22466541	T/C	cg03733263	chr8:22462867	KIAA1967	1.07	9.15	0.72	5.54e-14	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs2842992	0.724	rs1128670	chr6:160211636	G/A	cg19482086	chr6:160211437	TCP1;MRPL18	0.87	7.46	0.65	1.04e-10	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs9868809	0.772	rs9841602	chr3:48713570	A/G	cg00383909	chr3:49044727	WDR6	0.89	4.92	0.49	4.79e-6	Ulcerative colitis;Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs8179	0.700	rs42039	chr7:92244422	A/G	cg27455918	chr7:92370191	CDK6	0.54	4.86	0.48	5.9e-6	Sum neutrophil eosinophil counts;Sum basophil neutrophil counts;Neutrophil count;White blood cell count;Myeloid white cell count;Granulocyte count;White blood cell count (basophil);
SKCM	cis	rs637571	0.584	rs659824	chr11:65636509	A/G	cg26695010	chr11:65641043	EFEMP2	0.7	5.92	0.56	8.2e-8	Eosinophil percentage of white cells;
SKCM	cis	rs7772486	0.720	rs6931553	chr6:146112348	T/C	cg23711669	chr6:146136114	FBXO30	-0.9	-10.38	-0.76	2.38e-16	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs10876993	0.890	rs10783844	chr12:58098425	A/C	cg18357645	chr12:58087776	OS9	0.68	6.27	0.58	1.83e-8	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs7666738	0.830	rs62321598	chr4:99014237	C/T	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs634534	0.622	rs552130	chr11:65732800	T/C	cg17985854	chr11:65770987	BANF1;EIF1AD	0.51	5.16	0.5	1.85e-6	Sum eosinophil basophil counts;Eosinophil counts;
SKCM	cis	rs911555	0.539	rs4374097	chr14:104072766	A/C	cg24130564	chr14:104152367	KLC1	-0.58	-5.11	-0.5	2.27e-6	Intelligence (multi-trait analysis);
SKCM	trans	rs9329221	0.905	rs17765901	chr8:10249480	G/T	cg06636001	chr8:8085503	FLJ10661	-0.83	-7.46	-0.65	1.03e-10	Neuroticism;
SKCM	cis	rs4319547	0.614	rs10846764	chr12:122874297	T/C	cg23029597	chr12:123009494	RSRC2	0.72	5.31	0.52	1.01e-6	Body mass index;
SKCM	cis	rs7216064	1.000	rs1976053	chr17:65833002	C/G	cg12091567	chr17:66097778	LOC651250	-0.81	-6.01	-0.56	5.62e-8	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs9581857	0.615	rs9581848	chr13:28003997	C/T	cg22138327	chr13:27999177	GTF3A	0.94	6.32	0.58	1.51e-8	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs7940866	0.804	rs6590540	chr11:130805444	T/C	cg12179176	chr11:130786555	SNX19	0.75	5.92	0.56	8.23e-8	Schizophrenia;
SKCM	cis	rs10193935	0.792	rs222472	chr2:42662911	C/T	cg27598129	chr2:42591480	NA	-0.88	-6.71	-0.61	2.77e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs78269692	0.826	rs116712274	chr19:13253003	C/A	cg19436403	chr19:12780550	MORG1;C19orf56	1.39	5.14	0.5	1.96e-6	Breast cancer;
SKCM	cis	rs5750830	0.649	rs5750811	chr22:39793066	G/T	cg11247378	chr22:39784982	NA	0.5	5.96	0.56	6.97e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs9325144	0.555	rs28738714	chr12:38706912	G/A	cg13010199	chr12:38710504	ALG10B	-0.65	-5.17	-0.51	1.73e-6	Morning vs. evening chronotype;
SKCM	cis	rs7811142	1.000	rs11771241	chr7:99994785	G/A	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.16	7.68	0.66	3.87e-11	Platelet count;
SKCM	cis	rs11039216	1	rs11039216	chr11:47406592	C/T	cg20307385	chr11:47447363	PSMC3	0.77	6.57	0.6	5.13e-9	Neuroticism;
SKCM	cis	rs2243480	1.000	rs160637	chr7:65584318	C/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs951366	0.646	rs1772159	chr1:205759195	G/A	cg26354017	chr1:205819088	PM20D1	0.99	9.79	0.74	3.14e-15	Menarche (age at onset);
SKCM	cis	rs514406	0.893	rs2897561	chr1:53388747	C/A	cg24675658	chr1:53192096	ZYG11B	-0.63	-5.11	-0.5	2.22e-6	Monocyte count;
SKCM	cis	rs4974559	0.585	rs1680025	chr4:1265477	T/C	cg25215049	chr4:721972	PCGF3	0.71	4.88	0.48	5.47e-6	Systolic blood pressure;
SKCM	cis	rs1799949	0.965	rs11657883	chr17:41330024	T/C	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.29	-0.58	1.73e-8	Menopause (age at onset);
SKCM	cis	rs72717009	0.825	rs11810143	chr1:161480649	A/G	cg23840854	chr1:161414152	NA	-0.99	-5.66	-0.54	2.44e-7	Rheumatoid arthritis;
SKCM	cis	rs826838	1.000	rs11514441	chr12:38775190	C/T	cg26384229	chr12:38710491	ALG10B	1.06	10.14	0.75	6.67e-16	Heart rate;
SKCM	cis	rs9308433	0.529	rs10465696	chr1:214499883	G/A	cg06198575	chr1:214491504	SMYD2	0.81	5.09	0.5	2.41e-6	IgG glycosylation;
SKCM	cis	rs3845702	0.877	rs12693216	chr2:180839793	T/A	cg01881094	chr2:180872142	CWC22	-1.02	-5.29	-0.51	1.07e-6	Schizophrenia;
SKCM	cis	rs362296	0.698	rs3095081	chr4:3263776	C/T	cg24015175	chr4:3319247	RGS12	-0.61	-5.85	-0.55	1.08e-7	Parental longevity (mother's age at death);
SKCM	cis	rs7811142	0.943	rs111757992	chr7:100016354	A/C	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-1.0	-5.66	-0.54	2.36e-7	Platelet count;
SKCM	cis	rs2204008	0.745	rs12146863	chr12:38502346	G/A	cg26384229	chr12:38710491	ALG10B	0.8	6.24	0.58	2.15e-8	Bladder cancer;
SKCM	cis	rs2243480	0.901	rs73142137	chr7:65343442	A/T	cg18252515	chr7:66147081	NA	-1.29	-7.41	-0.64	1.3e-10	Diabetic kidney disease;
SKCM	cis	rs2228479	0.850	rs45567439	chr16:89814604	G/A	cg00800038	chr16:89945340	TCF25	-0.92	-5.12	-0.5	2.15e-6	Skin colour saturation;
SKCM	cis	rs11098499	0.863	rs3775848	chr4:120447724	C/T	cg09307838	chr4:120376055	NA	0.97	7.66	0.66	4.19e-11	Corneal astigmatism;
SKCM	cis	rs2293289	1.000	rs2293289	chr6:161551439	A/G	cg05895465	chr6:161558075	AGPAT4	-0.68	-4.78	-0.48	8.09e-6	Lipoprotein (a) - cholesterol levels;
SKCM	cis	rs8077889	0.750	rs8068019	chr17:41928127	G/T	cg26893861	chr17:41843967	DUSP3	1.31	7.65	0.65	4.46e-11	Triglycerides;
SKCM	cis	rs7811142	0.830	rs6948685	chr7:99970188	C/T	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.19	7.5	0.65	8.66e-11	Platelet count;
SKCM	cis	rs6952808	1.000	rs6954673	chr7:1886937	C/T	cg02951883	chr7:2050386	MAD1L1	-0.71	-5.35	-0.52	8.61e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs3820928	1.000	rs10167422	chr2:227777554	G/A	cg11843606	chr2:227700838	RHBDD1	-0.61	-4.88	-0.48	5.44e-6	Pulmonary function;
SKCM	cis	rs644799	0.710	rs3748253	chr11:95519506	G/A	cg25622487	chr11:95524042	FAM76B;CEP57	0.75	6.39	0.59	1.13e-8	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs9322193	0.923	rs9505982	chr6:149939601	G/A	cg07701084	chr6:150067640	NUP43	0.61	4.84	0.48	6.48e-6	Lung cancer;
SKCM	cis	rs6121246	0.633	rs6060986	chr20:30426297	G/A	cg11595048	chr20:30225325	COX4I2	0.56	4.91	0.49	4.84e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs2811415	0.627	rs9833276	chr3:127797793	T/C	cg09089421	chr3:127803668	RUVBL1	1.0	8.69	0.7	4.4e-13	Lung function (FEV1/FVC);
SKCM	cis	rs7618915	0.547	rs35211965	chr3:52685305	C/G	cg18404041	chr3:52824283	ITIH1	-0.56	-5.05	-0.5	2.87e-6	Bipolar disorder;
SKCM	cis	rs9303401	0.659	rs12946397	chr17:56769979	C/T	cg02118635	chr17:56770003	RAD51C;TEX14	0.81	5.35	0.52	8.54e-7	Cognitive test performance;
SKCM	cis	rs7824557	0.628	rs6988922	chr8:11194911	A/G	cg21775007	chr8:11205619	TDH	0.72	6.73	0.61	2.51e-9	Retinal vascular caliber;
SKCM	cis	rs7954584	0.546	rs10840630	chr12:122352445	C/T	cg22618164	chr12:122356400	WDR66	0.54	5.44	0.52	6.05e-7	Mean corpuscular volume;
SKCM	cis	rs875971	1.000	rs811880	chr7:65818646	T/C	cg18876405	chr7:65276391	NA	0.68	6.78	0.61	2.03e-9	Aortic root size;
SKCM	cis	rs6089829	0.855	rs6090205	chr20:61665269	A/G	cg08564027	chr20:61660810	NA	0.63	5.65	0.54	2.56e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs919433	0.963	rs7582736	chr2:198170342	A/G	cg04278110	chr2:198063759	ANKRD44	-0.69	-4.8	-0.48	7.58e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs28595532	0.920	rs114051506	chr4:119772893	A/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs10803016	0.613	rs2636252	chr1:242293228	A/G	ch.1.4829111R	chr1:242658279	PLD5	-0.57	-4.8	-0.48	7.37e-6	Coronary artery calcification;
SKCM	cis	rs1799949	0.965	rs799912	chr17:41257134	T/C	cg25072359	chr17:41440525	NA	0.63	4.86	0.48	5.96e-6	Menopause (age at onset);
SKCM	cis	rs7666738	0.830	rs13108422	chr4:99059267	G/A	cg17366294	chr4:99064904	C4orf37	0.61	4.93	0.49	4.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs28595532	0.841	rs115209862	chr4:119742225	G/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs992157	0.835	rs7559416	chr2:219150211	A/G	cg00012203	chr2:219082015	ARPC2	-0.72	-5.71	-0.54	1.99e-7	Colorectal cancer;
SKCM	cis	rs11098499	0.954	rs13145352	chr4:120409963	C/T	cg09307838	chr4:120376055	NA	-0.99	-7.79	-0.66	2.42e-11	Corneal astigmatism;
SKCM	cis	rs2842992	0.789	rs7765490	chr6:160204326	C/T	cg16489826	chr6:160211363	TCP1;MRPL18	0.68	4.79	0.48	7.87e-6	Age-related macular degeneration (geographic atrophy);
SKCM	cis	rs875971	0.830	rs427575	chr7:65519219	A/G	cg11987759	chr7:65425863	GUSB	-0.56	-4.94	-0.49	4.34e-6	Aortic root size;
SKCM	cis	rs2777491	0.574	rs316611	chr15:41751678	A/G	cg18705301	chr15:41695430	NDUFAF1	1.12	11.68	0.8	8.28e-19	Ulcerative colitis;
SKCM	cis	rs6951245	0.554	rs76243429	chr7:1152543	C/T	cg03188948	chr7:1209495	NA	0.85	6.02	0.56	5.43e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs12142240	0.698	rs17357628	chr1:46808462	A/G	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs6912958	0.559	rs107690	chr6:88069352	A/G	cg08069147	chr6:88032118	GJB7;C6orf162	-0.7	-6.51	-0.59	6.53e-9	Monocyte percentage of white cells;
SKCM	cis	rs9399135	0.967	rs4896122	chr6:135295081	T/C	cg24558204	chr6:135376177	HBS1L	0.55	4.98	0.49	3.73e-6	Red blood cell count;
SKCM	cis	rs13217239	0.646	rs4403259	chr6:26997617	C/T	cg12292205	chr6:26970375	C6orf41	0.63	5.53	0.53	4.16e-7	Schizophrenia;
SKCM	cis	rs637571	0.544	rs617791	chr11:65702523	C/G	cg02427764	chr11:65769310	BANF1;EIF1AD	0.7	5.18	0.51	1.72e-6	Eosinophil percentage of white cells;
SKCM	cis	rs7919656	1.000	rs7919656	chr10:50026020	C/T	cg00386007	chr10:50143337	WDFY4	0.45	5.1	0.5	2.3e-6	Clinically amyopathic dermatomyositis;
SKCM	cis	rs992157	0.560	rs7605980	chr2:219100869	C/G	cg00012203	chr2:219082015	ARPC2	0.79	6.56	0.6	5.36e-9	Colorectal cancer;
SKCM	cis	rs561341	0.941	rs2428336	chr17:30290577	T/C	cg00745463	chr17:30367425	LRRC37B	-1.08	-7.46	-0.65	1.04e-10	Hip circumference adjusted for BMI;
SKCM	cis	rs11098499	0.954	rs59394118	chr4:120295551	A/G	cg09307838	chr4:120376055	NA	0.97	7.5	0.65	8.86e-11	Corneal astigmatism;
SKCM	cis	rs67460515	0.563	rs13256	chr3:160796505	G/A	cg03342759	chr3:160939853	NMD3	-0.68	-5.77	-0.55	1.53e-7	Parkinson's disease;
SKCM	cis	rs992157	1.000	rs10932766	chr2:219122090	G/A	cg00012203	chr2:219082015	ARPC2	0.83	6.98	0.62	8.66e-10	Colorectal cancer;
SKCM	cis	rs7635838	0.617	rs2594971	chr3:11313910	G/A	cg00170343	chr3:11313890	ATG7	0.79	6.01	0.56	5.5e-8	HDL cholesterol;
SKCM	cis	rs34779708	0.931	rs17582416	chr10:35287650	A/C	cg03585969	chr10:35415529	CREM	0.69	4.87	0.48	5.76e-6	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs10751667	0.643	rs10902238	chr11:944810	G/A	cg06064525	chr11:970664	AP2A2	-0.55	-5.09	-0.5	2.46e-6	Alzheimer's disease (late onset);
SKCM	cis	rs7666738	0.830	rs34671152	chr4:98978177	C/T	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11690935	0.959	rs66835971	chr2:172677459	G/A	cg13550731	chr2:172543902	DYNC1I2	-0.9	-7.44	-0.64	1.11e-10	Schizophrenia;
SKCM	cis	rs116095464	0.510	rs7714944	chr5:231765	C/T	cg22857025	chr5:266934	NA	-1.49	-8.68	-0.7	4.48e-13	Breast cancer;
SKCM	cis	rs7811142	1.000	rs60478351	chr7:100089017	C/T	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.24	7.92	0.67	1.36e-11	Platelet count;
SKCM	cis	rs908922	0.582	rs1856121	chr1:152512169	A/T	cg09873164	chr1:152488093	CRCT1	0.78	6.09	0.57	4.03e-8	Hair morphology;
SKCM	cis	rs9485372	1.000	rs9498283	chr6:149605182	C/T	cg03072286	chr6:150262044	ULBP2	0.56	5.04	0.5	2.94e-6	Breast cancer;
SKCM	cis	rs561341	0.883	rs2074102	chr17:30228884	G/A	cg00745463	chr17:30367425	LRRC37B	-1.04	-6.76	-0.61	2.28e-9	Hip circumference adjusted for BMI;
SKCM	cis	rs4242434	0.672	rs7830206	chr8:22485375	C/T	cg03733263	chr8:22462867	KIAA1967	0.84	6.07	0.57	4.34e-8	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs2204008	0.837	rs11168341	chr12:37961951	C/T	cg26384229	chr12:38710491	ALG10B	0.81	6.59	0.6	4.69e-9	Bladder cancer;
SKCM	cis	rs8072100	0.840	rs9895746	chr17:45479099	C/A	cg08085267	chr17:45401833	C17orf57	-0.61	-5.1	-0.5	2.3e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs9640161	0.830	rs3757425	chr7:150067640	A/C	cg10018233	chr7:150070692	REPIN1	0.81	9.03	0.71	9.35e-14	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs9467773	0.967	rs6941022	chr6:26553531	T/C	cg15659132	chr6:26577336	NA	0.6	5.71	0.54	1.99e-7	Intelligence (multi-trait analysis);
SKCM	trans	rs17685	0.712	rs60721456	chr7:75743820	T/A	cg19862616	chr7:65841803	NCRNA00174	0.89	8.39	0.69	1.65e-12	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1799949	0.930	rs3092987	chr17:41222723	T/C	cg25918947	chr17:41365094	TMEM106A	-0.61	-5.91	-0.56	8.59e-8	Menopause (age at onset);
SKCM	cis	rs754466	0.606	rs56402185	chr10:79585848	G/A	cg17075019	chr10:79541650	NA	-0.81	-7.22	-0.63	3.01e-10	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs7143963	0.636	rs12588339	chr14:103349176	G/A	cg23020514	chr14:103360112	TRAF3	0.74	6.99	0.62	8.38e-10	Body mass index;
SKCM	cis	rs9880211	0.898	rs9866840	chr3:136029258	G/C	cg21827317	chr3:136751795	NA	-0.66	-4.92	-0.49	4.65e-6	Body mass index;Height;
SKCM	cis	rs17854409	1.000	rs17854409	chr20:61491494	T/C	cg06598544	chr20:61472147	COL9A3	-1.1	-5.11	-0.5	2.21e-6	Obesity-related traits;
SKCM	cis	rs933688	0.938	rs7720235	chr5:90659329	A/T	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.05	8.27	0.68	2.79e-12	Smoking behavior;
SKCM	cis	rs3892630	0.878	rs1061686	chr19:33204544	C/T	cg22980127	chr19:33182716	NUDT19	-1.32	-7.71	-0.66	3.39e-11	Red blood cell traits;
SKCM	cis	rs394563	0.591	rs6570964	chr6:149691859	G/A	cg16235748	chr6:149772707	ZC3H12D	0.45	5.21	0.51	1.5e-6	Dupuytren's disease;
SKCM	cis	rs801193	0.875	rs13227951	chr7:66213108	C/T	cg00343986	chr7:65444356	GUSB	-0.69	-5.07	-0.5	2.58e-6	Aortic root size;
SKCM	cis	rs6582630	0.502	rs1607876	chr12:38355750	T/C	cg26384229	chr12:38710491	ALG10B	0.79	6.21	0.58	2.39e-8	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs9325144	0.560	rs2387924	chr12:38662883	A/G	cg26384229	chr12:38710491	ALG10B	-0.61	-4.93	-0.49	4.57e-6	Morning vs. evening chronotype;
SKCM	cis	rs1395	1.000	rs1275522	chr2:27426878	C/T	cg14242246	chr2:27434262	C2orf28;SLC5A6	-0.47	-4.77	-0.48	8.27e-6	Blood metabolite levels;
SKCM	cis	rs35306767	0.855	rs12761180	chr10:872086	C/T	cg26597838	chr10:835615	NA	0.79	6.08	0.57	4.12e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs4819052	0.851	rs9974628	chr21:46672647	C/T	cg02159808	chr21:46707872	POFUT2;LOC642852	0.73	5.71	0.54	1.93e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7666738	0.830	rs62318472	chr4:98926030	G/A	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9300255	0.664	rs28372579	chr12:123881176	A/G	cg00376283	chr12:123451042	ABCB9	-0.76	-4.94	-0.49	4.29e-6	Neutrophil percentage of white cells;
SKCM	cis	rs116095464	1.000	rs6555160	chr5:311669	A/G	cg22857025	chr5:266934	NA	1.48	6.71	0.6	2.82e-9	Breast cancer;
SKCM	cis	rs514406	0.708	rs480299	chr1:53320274	G/T	cg08859206	chr1:53392774	SCP2	-0.65	-5.28	-0.51	1.12e-6	Monocyte count;
SKCM	cis	rs8180040	0.902	rs73081205	chr3:47517670	A/C	cg27129171	chr3:47204927	SETD2	-0.79	-5.79	-0.55	1.43e-7	Colorectal cancer;
SKCM	cis	rs11690935	0.959	rs10166005	chr2:172607294	C/T	cg13550731	chr2:172543902	DYNC1I2	-0.95	-8.1	-0.68	6.14e-12	Schizophrenia;
SKCM	cis	rs2013441	1.000	rs2703802	chr17:20101039	T/C	cg13482628	chr17:19912719	NA	-0.65	-5.21	-0.51	1.48e-6	Obesity-related traits;
SKCM	cis	rs2811415	0.597	rs12695505	chr3:127791636	G/A	cg09089421	chr3:127803668	RUVBL1	1.0	8.69	0.7	4.4e-13	Lung function (FEV1/FVC);
SKCM	cis	rs7772486	0.764	rs9399569	chr6:146242942	C/T	cg05347473	chr6:146136440	FBXO30	-0.56	-5.19	-0.51	1.6e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs60871478	0.636	rs56393680	chr7:885696	A/G	cg05535760	chr7:792225	HEATR2	-1.3	-7.8	-0.66	2.27e-11	Cerebrospinal P-tau181p levels;
SKCM	cis	rs1669338	0.588	rs4684375	chr3:3170966	T/C	cg16797762	chr3:3221439	CRBN	-1.09	-5.88	-0.55	9.51e-8	White matter integrity;
SKCM	cis	rs17376456	0.825	rs10036024	chr5:93074804	C/A	cg25358565	chr5:93447407	FAM172A	1.18	7.48	0.65	9.54e-11	Diabetic retinopathy;
SKCM	cis	rs4268898	0.679	rs2551181	chr2:24437548	C/T	cg06627628	chr2:24431161	ITSN2	0.84	6.87	0.61	1.37e-9	Asthma;
SKCM	cis	rs1005277	0.579	rs1780139	chr10:38503018	C/T	cg00409905	chr10:38381863	ZNF37A	-0.62	-5.82	-0.55	1.24e-7	Extrinsic epigenetic age acceleration;
SKCM	cis	rs10876993	0.928	rs1689595	chr12:58056763	C/T	cg18357645	chr12:58087776	OS9	0.63	5.94	0.56	7.51e-8	Celiac disease or Rheumatoid arthritis;
SKCM	cis	rs4242434	0.927	rs3736147	chr8:22471824	A/G	cg03733263	chr8:22462867	KIAA1967	-1.03	-9.02	-0.71	9.72e-14	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs514406	0.621	rs1930306	chr1:53195686	C/G	cg24675658	chr1:53192096	ZYG11B	0.62	4.98	0.49	3.72e-6	Monocyte count;
SKCM	cis	rs56235845	0.694	rs36102285	chr5:176774018	C/T	cg16006841	chr5:176797999	RGS14	0.7	6.47	0.59	7.95e-9	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs7539542	0.600	rs9943282	chr1:202895140	C/T	cg19681188	chr1:202830198	LOC148709	0.71	5.18	0.51	1.7e-6	Mean platelet volume;
SKCM	cis	rs2836974	0.568	rs8130795	chr21:40549983	T/A	cg17971929	chr21:40555470	PSMG1	0.76	7.16	0.63	3.94e-10	Cognitive function;
SKCM	cis	rs1552244	1.000	rs76041173	chr3:10078695	G/T	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs4665809	1.000	rs1560868	chr2:26281459	A/T	cg26119090	chr2:26468346	HADHA;HADHB	0.78	5.18	0.51	1.68e-6	Gut microbiome composition (summer);
SKCM	cis	rs11690935	0.731	rs10930491	chr2:172569824	A/G	cg13550731	chr2:172543902	DYNC1I2	0.63	5.5	0.53	4.74e-7	Schizophrenia;
SKCM	cis	rs9815354	0.812	rs58360908	chr3:41839837	A/G	cg03022575	chr3:42003672	ULK4	1.03	5.12	0.5	2.13e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs447735	0.565	rs10852626	chr16:89914633	T/G	cg01097406	chr16:89675127	NA	-0.47	-4.9	-0.48	5.16e-6	Hemoglobin concentration;
SKCM	cis	rs2836950	0.565	rs2836942	chr21:40591381	A/G	cg11890956	chr21:40555474	PSMG1	-0.66	-5.26	-0.51	1.22e-6	Menarche (age at onset);
SKCM	cis	rs1552244	0.572	rs6797536	chr3:10168802	C/T	cg00149659	chr3:10157352	C3orf10	-1.09	-5.79	-0.55	1.42e-7	Alzheimer's disease;
SKCM	cis	rs4803468	1.000	rs55986560	chr19:41939835	C/T	cg14132834	chr19:41945861	ATP5SL	0.77	5.9	0.56	9.04e-8	Height;
SKCM	cis	rs9911578	0.967	rs4076229	chr17:56937256	C/T	cg12560992	chr17:57184187	TRIM37	0.94	7.55	0.65	7.01e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs709400	0.663	rs62007718	chr14:103940436	G/A	cg26031613	chr14:104095156	KLC1	0.77	5.96	0.56	6.87e-8	Body mass index;
SKCM	cis	rs6951245	1.000	rs79683221	chr7:1096139	A/G	cg03188948	chr7:1209495	NA	1.13	6.27	0.58	1.89e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs16854884	0.657	rs920159	chr3:143753194	A/T	cg06585982	chr3:143692056	C3orf58	0.87	8.11	0.68	5.72e-12	Economic and political preferences (feminism/equality);
SKCM	cis	rs8016982	0.651	rs1885601	chr14:81641210	C/T	cg01989461	chr14:81687754	GTF2A1	0.88	7.42	0.64	1.26e-10	Schizophrenia;
SKCM	cis	rs796364	1.000	rs281759	chr2:200787719	T/C	cg12253985	chr2:200820533	C2orf60;C2orf47	0.85	5.39	0.52	7.18e-7	Schizophrenia;
SKCM	cis	rs6061231	0.630	rs62196294	chr20:60973432	T/G	cg24112000	chr20:60950667	NA	-0.6	-6.11	-0.57	3.61e-8	Colorectal cancer;
SKCM	cis	rs9911578	1.000	rs9898626	chr17:56698219	C/G	cg12560992	chr17:57184187	TRIM37	0.95	7.69	0.66	3.7e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs9916302	0.904	rs8076494	chr17:37516722	A/G	cg07936489	chr17:37558343	FBXL20	0.81	6.28	0.58	1.8e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs995000	0.899	rs7518497	chr1:63177696	G/T	cg06896770	chr1:63153194	DOCK7	-0.88	-8.04	-0.67	8.05e-12	Triglyceride levels;
SKCM	cis	rs7772486	0.558	rs702316	chr6:146004677	C/A	cg23711669	chr6:146136114	FBXO30	-0.84	-6.73	-0.61	2.52e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7666738	0.830	rs13328042	chr4:99055406	A/G	cg05340658	chr4:99064831	C4orf37	0.67	5.08	0.5	2.51e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs523522	0.923	rs1048830	chr12:120882217	G/T	cg12219531	chr12:120966889	COQ5	0.88	7.12	0.63	4.58e-10	High light scatter reticulocyte count;
SKCM	cis	rs34779708	0.733	rs3936502	chr10:35549218	C/T	cg03585969	chr10:35415529	CREM	0.71	5.25	0.51	1.27e-6	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs57221529	0.713	rs12521091	chr5:590710	G/T	cg10555297	chr5:473380	SLC9A3;LOC25845	0.98	4.79	0.48	7.71e-6	Lung disease severity in cystic fibrosis;
SKCM	cis	rs9635963	0.798	rs11082995	chr18:21754116	T/C	cg14416559	chr18:21719381	CABYR	0.72	5.06	0.5	2.72e-6	Protein quantitative trait loci;
SKCM	cis	rs9911578	0.967	rs6503883	chr17:56917543	C/T	cg12560992	chr17:57184187	TRIM37	0.94	7.55	0.65	7.01e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs4665809	0.531	rs34081866	chr2:26475940	C/T	cg26119090	chr2:26468346	HADHA;HADHB	1.03	7.99	0.67	9.69e-12	Gut microbiome composition (summer);
SKCM	cis	rs7954584	0.546	rs10840630	chr12:122352445	C/T	cg21171335	chr12:122356390	WDR66	0.46	5.02	0.49	3.25e-6	Mean corpuscular volume;
SKCM	cis	rs11690935	0.851	rs10201430	chr2:172813241	T/C	cg13550731	chr2:172543902	DYNC1I2	-0.79	-5.87	-0.55	1.02e-7	Schizophrenia;
SKCM	trans	rs12599106	0.625	rs12923277	chr16:34896261	G/A	cg15383120	chr6:291909	DUSP22	-0.75	-7.54	-0.65	7.12e-11	Menopause (age at onset);
SKCM	cis	rs4664308	0.618	rs35771982	chr2:160885418	G/C	cg03641300	chr2:160917029	PLA2R1	-0.64	-4.89	-0.48	5.23e-6	Idiopathic membranous nephropathy;
SKCM	cis	rs10256972	0.528	rs7784607	chr7:1178694	A/G	cg16145915	chr7:1198662	ZFAND2A	-0.59	-7.97	-0.67	1.07e-11	Longevity;Endometriosis;
SKCM	cis	rs7944584	0.552	rs12361415	chr11:47474146	T/G	cg20307385	chr11:47447363	PSMC3	0.89	6.05	0.57	4.65e-8	Fasting blood glucose;Fasting blood glucose (BMI interaction);
SKCM	cis	rs826838	0.967	rs980572	chr12:39127673	A/C	cg13010199	chr12:38710504	ALG10B	0.72	5.76	0.55	1.59e-7	Heart rate;
SKCM	cis	rs16949788	0.826	rs62625678	chr15:66628056	G/T	cg08120210	chr15:66682733	MAP2K1	-0.75	-5.83	-0.55	1.21e-7	Spherical equivalent (joint analysis main effects and education interaction);
SKCM	cis	rs6951245	0.554	rs78999139	chr7:1138525	G/A	cg03188948	chr7:1209495	NA	0.83	5.87	0.55	1.01e-7	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs2730245	0.959	rs2527201	chr7:158738611	G/T	cg24397884	chr7:158709396	WDR60	-1.01	-9.36	-0.73	2.16e-14	Height;
SKCM	cis	rs672059	0.966	rs492228	chr1:183156476	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.63	5.23	0.51	1.38e-6	Hypertriglyceridemia;
SKCM	cis	rs11249608	0.548	rs7704565	chr5:178473923	G/C	cg21905437	chr5:178450457	ZNF879	0.7	5.31	0.52	1e-6	Pubertal anthropometrics;
SKCM	cis	rs1552244	1.000	rs2160869	chr3:10079255	G/A	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs6565180	0.791	rs4247355	chr16:30392099	A/G	cg17640201	chr16:30407289	ZNF48	0.94	7.12	0.63	4.68e-10	Tonsillectomy;
SKCM	cis	rs6545883	0.524	rs811871	chr2:61577949	C/T	cg15711740	chr2:61764176	XPO1	0.66	5.12	0.5	2.17e-6	Tuberculosis;
SKCM	cis	rs12120353	0.702	rs780610	chr1:4551420	T/C	cg15022359	chr1:4193126	NA	-0.6	-5.21	-0.51	1.47e-6	Anxiety disorder;
SKCM	cis	rs1580019	0.713	rs2122632	chr7:32524686	A/G	cg06627557	chr7:32535165	LSM5;AVL9	-0.89	-7.62	-0.65	5.1e-11	Cognitive ability;
SKCM	cis	rs910316	0.712	rs175037	chr14:75465038	T/C	cg08847533	chr14:75593920	NEK9	-0.83	-7.06	-0.62	6e-10	Height;
SKCM	cis	rs6138458	1.000	rs6106984	chr20:24977006	T/C	cg26195577	chr20:24973756	C20orf3	1.29	8.85	0.71	2.07e-13	Blood protein levels;
SKCM	cis	rs7772486	0.713	rs2328704	chr6:146020494	T/C	cg05347473	chr6:146136440	FBXO30	-0.54	-4.88	-0.48	5.47e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6840360	0.571	rs72728182	chr4:152487027	T/C	cg22705602	chr4:152727874	NA	-0.49	-5.34	-0.52	8.94e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs748404	0.660	rs689767	chr15:43722077	G/C	cg02155558	chr15:43621948	ADAL;LCMT2	0.73	5.42	0.52	6.48e-7	Lung cancer;
SKCM	cis	rs9910055	0.593	rs58392387	chr17:42297889	A/G	cg13607699	chr17:42295918	UBTF	0.88	7.39	0.64	1.43e-10	Total body bone mineral density;
SKCM	cis	rs7523050	0.643	rs17563938	chr1:109401654	C/T	cg08274380	chr1:109419600	GPSM2	1.13	5.57	0.53	3.54e-7	Fat distribution (HIV);
SKCM	cis	rs4481887	0.610	rs28763387	chr1:248559244	T/C	cg00666640	chr1:248458726	OR2T12	0.5	5.17	0.51	1.77e-6	Common traits (Other);
SKCM	cis	rs7539542	0.556	rs10732292	chr1:202891366	T/C	cg19681188	chr1:202830198	LOC148709	0.71	5.18	0.51	1.7e-6	Mean platelet volume;
SKCM	cis	rs12711979	0.509	rs12711972	chr2:3823786	T/C	cg17052675	chr2:3827356	NA	-0.82	-8.9	-0.71	1.66e-13	Itch intensity from mosquito bite adjusted by bite size;
SKCM	trans	rs1814175	0.781	rs11040681	chr11:49981654	G/T	cg03929089	chr4:120376271	NA	-0.9	-8.58	-0.7	6.95e-13	Height;
SKCM	cis	rs394563	0.775	rs412894	chr6:149781175	G/A	cg03678062	chr6:149772716	ZC3H12D	-0.48	-4.96	-0.49	4.11e-6	Dupuytren's disease;
SKCM	cis	rs3820928	0.934	rs4675117	chr2:227769794	A/G	cg11843606	chr2:227700838	RHBDD1	0.64	5.14	0.5	1.95e-6	Pulmonary function;
SKCM	cis	rs17761864	1.000	rs17761864	chr17:2171637	G/T	cg02637843	chr17:1226699	NA	0.56	4.8	0.48	7.55e-6	Esophageal cancer (squamous cell);
SKCM	cis	rs9463078	0.665	rs4714816	chr6:44715168	T/C	cg25276700	chr6:44698697	NA	0.44	4.77	0.48	8.31e-6	Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder;
SKCM	cis	rs1799949	0.794	rs116409325	chr17:41445460	C/A	cg25918947	chr17:41365094	TMEM106A	-0.71	-6.59	-0.6	4.7e-9	Menopause (age at onset);
SKCM	cis	rs3091242	0.867	rs602052	chr1:25722206	T/C	cg27572855	chr1:25598939	RHD	0.56	5.52	0.53	4.35e-7	Erythrocyte sedimentation rate;
SKCM	cis	rs17376456	0.825	rs74825443	chr5:93254973	T/C	cg21475434	chr5:93447410	FAM172A	1.02	5.17	0.51	1.74e-6	Diabetic retinopathy;
SKCM	cis	rs28386778	0.897	rs2584601	chr17:61940977	T/C	cg06873352	chr17:61820015	STRADA	0.76	6.24	0.58	2.13e-8	Prudent dietary pattern;
SKCM	cis	rs7811142	0.720	rs7795656	chr7:99950297	A/T	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.19	7.5	0.65	8.66e-11	Platelet count;
SKCM	cis	rs7954584	0.611	rs3887885	chr12:122336486	C/T	cg21171335	chr12:122356390	WDR66	0.45	4.95	0.49	4.18e-6	Mean corpuscular volume;
SKCM	cis	rs8067545	0.750	rs11870111	chr17:19992738	G/A	cg13482628	chr17:19912719	NA	0.71	6.15	0.57	3.16e-8	Schizophrenia;
SKCM	cis	rs2777491	0.915	rs16971767	chr15:41623308	T/C	cg18705301	chr15:41695430	NDUFAF1	-0.96	-9.11	-0.72	6.65e-14	Ulcerative colitis;
SKCM	cis	rs1799949	1.000	rs33918839	chr17:41329172	T/C	cg23758822	chr17:41437982	NA	0.93	7.87	0.67	1.66e-11	Menopause (age at onset);
SKCM	cis	rs1405130	0.869	rs11681332	chr2:235566260	C/A	cg21542780	chr2:234763377	HJURP	-0.64	-4.89	-0.48	5.21e-6	Coronary artery disease;
SKCM	cis	rs3793683	0.597	rs12783367	chr10:134587334	T/C	cg18305652	chr10:134549665	INPP5A	0.6	6.16	0.57	2.97e-8	Migraine;
SKCM	cis	rs561341	1.000	rs554078	chr17:30330109	A/C	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs4925325	0.876	rs6089560	chr20:60517325	T/G	cg23262073	chr20:60523788	NA	-0.69	-5.3	-0.51	1.05e-6	Obesity-related traits;
SKCM	cis	rs34172651	0.517	rs7204288	chr16:24784531	A/G	cg00339695	chr16:24857497	SLC5A11	0.8	6.43	0.59	9.38e-9	Intelligence (multi-trait analysis);
SKCM	cis	rs769267	1.000	rs7247309	chr19:19439631	A/T	cg03709012	chr19:19516395	GATAD2A	-0.84	-6.97	-0.62	9.13e-10	Tonsillectomy;
SKCM	cis	rs9788333	0.792	rs34479949	chr13:21895574	G/A	cg25811766	chr13:21894605	NA	0.59	5.77	0.55	1.55e-7	Thiazide-induced adverse metabolic effects in hypertensive patients;
SKCM	cis	rs17376456	1.000	rs12188453	chr5:93560807	G/T	cg21475434	chr5:93447410	FAM172A	-1.08	-5.94	-0.56	7.64e-8	Diabetic retinopathy;
SKCM	cis	rs137761	0.576	rs13054872	chr22:44055972	A/G	cg12729397	chr22:44208276	EFCAB6	0.68	4.85	0.48	6.1e-6	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs644799	0.965	rs3789960	chr11:95509037	C/G	cg03916912	chr11:95522834	CEP57;FAM76B	0.96	8.72	0.7	3.77e-13	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs1799949	0.965	rs8176323	chr17:41195711	G/C	cg25918947	chr17:41365094	TMEM106A	-0.63	-6.06	-0.57	4.62e-8	Menopause (age at onset);
SKCM	trans	rs11722228	0.522	rs7662229	chr4:10133014	A/T	cg26043149	chr18:55253948	FECH	0.95	8.7	0.7	4.05e-13	Gout;Urate levels;Serum uric acid levels;
SKCM	cis	rs433852	0.904	rs8102492	chr19:49140809	A/C	cg06530960	chr19:49140787	SEC1;DBP	0.86	6.13	0.57	3.42e-8	Elevated serum carcinoembryonic antigen levels;Posterior cortical atrophy and Alzheimer's disease;
SKCM	cis	rs7666738	0.830	rs7694889	chr4:98855596	T/C	cg17366294	chr4:99064904	C4orf37	0.56	4.87	0.48	5.62e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10752881	1.000	rs12403189	chr1:182983832	G/C	ch.1.3577855R	chr1:183094577	LAMC1	0.73	6.47	0.59	7.97e-9	Colorectal cancer;
SKCM	trans	rs11083271	0.631	rs62102060	chr18:25859154	C/T	cg00321150	chr11:62623587	SNORD27;SLC3A2;SNHG1;SNORD28;SNORD25;SNORD26	0.8	7.29	0.64	2.17e-10	Non-alcoholic fatty liver disease histology (lobular);
SKCM	cis	rs71520386	0.632	rs9691076	chr7:22869361	A/C	cg15401507	chr7:22894281	NA	0.65	4.87	0.48	5.7e-6	Fibrinogen levels;
SKCM	cis	rs12474201	0.832	rs11695058	chr2:46978349	A/G	cg06386533	chr2:46925753	SOCS5	0.91	7.79	0.66	2.44e-11	Height;
SKCM	cis	rs1691799	0.899	rs1168293	chr12:66733904	G/A	cg16791601	chr12:66731901	HELB	-0.59	-4.97	-0.49	3.83e-6	White blood cell count (basophil);
SKCM	cis	rs644799	1.000	rs623191	chr11:95548359	A/G	cg25622487	chr11:95524042	FAM76B;CEP57	0.66	5.12	0.5	2.18e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs9911578	1.000	rs2531732	chr17:56548420	T/A	cg12560992	chr17:57184187	TRIM37	-0.92	-7.26	-0.64	2.5e-10	Intelligence (multi-trait analysis);
SKCM	cis	rs2066819	1.000	rs2066808	chr12:56737973	A/G	cg26714650	chr12:56694279	CS	-1.71	-6.71	-0.61	2.74e-9	Psoriasis vulgaris;
SKCM	cis	rs941408	1.000	rs1640271	chr19:2799979	C/T	cg06609049	chr19:2785107	THOP1	0.81	7.18	0.63	3.55e-10	Total cholesterol levels;
SKCM	cis	rs1707322	1.000	rs12133129	chr1:46373348	C/T	cg03146154	chr1:46216737	IPP	0.74	5.06	0.5	2.76e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs870825	0.616	rs6552801	chr4:185620623	G/A	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs644799	0.965	rs545342	chr11:95545369	T/C	cg03916912	chr11:95522834	CEP57;FAM76B	0.92	8.04	0.67	8e-12	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs801193	0.935	rs2659899	chr7:66186721	A/G	cg11987759	chr7:65425863	GUSB	-0.69	-5.91	-0.56	8.69e-8	Aortic root size;
SKCM	cis	rs13118159	0.550	rs4974611	chr4:1358449	T/C	cg19318889	chr4:1322082	MAEA	0.77	5.52	0.53	4.34e-7	Longevity;
SKCM	cis	rs9911578	0.933	rs11868348	chr17:57179238	C/T	cg12560992	chr17:57184187	TRIM37	1.06	10.05	0.75	1.01e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs875971	0.638	rs801205	chr7:66022144	C/A	cg11987759	chr7:65425863	GUSB	0.69	5.9	0.56	8.74e-8	Aortic root size;
SKCM	cis	rs16949788	1.000	rs12323975	chr15:66674634	T/C	cg08120210	chr15:66682733	MAP2K1	-0.74	-5.82	-0.55	1.23e-7	Spherical equivalent (joint analysis main effects and education interaction);
SKCM	cis	rs6580649	0.941	rs10492080	chr12:48501411	A/G	cg05342945	chr12:48394962	COL2A1	0.8	5.44	0.52	5.98e-7	Lung cancer;
SKCM	cis	rs28386778	0.863	rs894414	chr17:61916384	T/C	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs2204008	0.744	rs12099650	chr12:38317140	C/G	cg26384229	chr12:38710491	ALG10B	0.8	6.67	0.6	3.35e-9	Bladder cancer;
SKCM	cis	rs137761	0.511	rs4823128	chr22:44069055	C/T	cg12729397	chr22:44208276	EFCAB6	0.78	5.37	0.52	7.76e-7	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs28386778	0.897	rs2044125	chr17:61863184	A/C	cg22520471	chr17:61851767	DDX42;CCDC47	-0.78	-5.31	-0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs151997	0.962	rs27273	chr5:50181074	G/A	cg06027927	chr5:50259733	NA	0.63	5.35	0.52	8.43e-7	Callous-unemotional behaviour;
SKCM	cis	rs933688	0.938	rs1477348	chr5:90707823	G/A	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.02	7.81	0.66	2.22e-11	Smoking behavior;
SKCM	cis	rs2404602	0.967	rs7174096	chr15:77072400	A/G	cg23625390	chr15:77176239	SCAPER	0.75	7.27	0.64	2.44e-10	Blood metabolite levels;
SKCM	cis	rs2806561	0.704	rs636940	chr1:23522967	A/T	cg12483005	chr1:23474871	LUZP1	0.68	5.24	0.51	1.34e-6	Height;
SKCM	cis	rs875971	0.545	rs67775320	chr7:65658779	T/C	cg18876405	chr7:65276391	NA	0.64	5.29	0.51	1.09e-6	Aortic root size;
SKCM	cis	rs2439831	0.702	rs2788	chr15:44064886	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	1.35	7.75	0.66	2.9e-11	Lung cancer in ever smokers;
SKCM	cis	rs7589728	0.563	rs80324973	chr2:88447264	T/G	cg04511125	chr2:88470314	THNSL2	1.07	6.66	0.6	3.43e-9	Plasma clusterin levels;
SKCM	cis	rs637571	0.522	rs503524	chr11:65751764	C/T	cg26695010	chr11:65641043	EFEMP2	-0.72	-5.47	-0.53	5.29e-7	Eosinophil percentage of white cells;
SKCM	cis	rs4423214	1.000	rs11600569	chr11:71173747	C/G	cg05163923	chr11:71159392	DHCR7	0.83	8.11	0.68	5.77e-12	Vitamin D levels;
SKCM	cis	rs4925386	0.840	rs6142738	chr20:60919960	C/T	cg24112000	chr20:60950667	NA	0.74	6.94	0.62	1.01e-9	Colorectal cancer;Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs7927771	0.524	rs2242081	chr11:47500267	T/C	cg20307385	chr11:47447363	PSMC3	0.77	5.93	0.56	7.79e-8	Subjective well-being;
SKCM	cis	rs11098499	0.826	rs12511640	chr4:120251248	T/C	cg09307838	chr4:120376055	NA	0.91	7.36	0.64	1.63e-10	Corneal astigmatism;
SKCM	cis	rs7666738	0.830	rs4699331	chr4:99059816	T/C	cg05340658	chr4:99064831	C4orf37	0.66	4.87	0.48	5.74e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs763014	0.833	rs3743903	chr16:632736	T/C	cg00908189	chr16:619842	PIGQ	0.82	7.78	0.66	2.55e-11	Height;
SKCM	cis	rs79390277	0.579	rs8044066	chr16:69113369	T/A	cg10120807	chr16:69350190	VPS4A	-0.84	-4.84	-0.48	6.31e-6	Primary sclerosing cholangitis;
SKCM	cis	rs8072100	0.905	rs9895274	chr17:45539117	C/T	cg08085267	chr17:45401833	C17orf57	-0.66	-5.95	-0.56	7.35e-8	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs7666738	0.830	rs17486413	chr4:99060544	G/T	cg05340658	chr4:99064831	C4orf37	0.63	4.93	0.49	4.57e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9910055	0.639	rs227583	chr17:42231698	C/G	cg09913183	chr17:42254507	C17orf65;ASB16	0.67	6.36	0.58	1.27e-8	Total body bone mineral density;
SKCM	cis	rs801193	1.000	rs7783924	chr7:66209057	A/C	cg11987759	chr7:65425863	GUSB	-0.69	-5.91	-0.56	8.69e-8	Aortic root size;
SKCM	cis	rs909674	0.541	rs5750816	chr22:39810379	A/G	cg11247378	chr22:39784982	NA	0.47	5.6	0.54	3.13e-7	IgG bisecting N-acetyl glucosamine phenotypes (multivariate analysis);IgG glycosylation;IgG digalactosylation phenotypes (multivariate analysis);IgG sialylation phenotypes (multivariate analysis);IgG monogalactosylation phenotypes (multivariate analysis);IgG fucosylation phenotypes (multivariate analysis);IgG N-glycosylation phenotypes (multivariate analysis);IgG disialylation phenotypes (multivariate analysis);IgG galactosylation phenotypes (multivariate analysis);Post bronchodilator FEV1;
SKCM	cis	rs752010	0.715	rs4083592	chr1:42099522	A/G	cg06885757	chr1:42089581	HIVEP3	0.67	7.02	0.62	7.25e-10	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs4400599	0.618	rs1194582	chr1:154215973	A/G	cg26808167	chr1:154192205	UBAP2L;C1orf43	-0.54	-4.9	-0.49	5.01e-6	Platelet distribution width;
SKCM	cis	rs28595532	0.841	rs114735834	chr4:119772722	G/A	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs2439831	0.681	rs7175434	chr15:43628542	A/C	cg02155558	chr15:43621948	ADAL;LCMT2	1.16	8.69	0.7	4.35e-13	Lung cancer in ever smokers;
SKCM	cis	rs4642101	0.662	rs9840766	chr3:12821870	G/A	cg05775895	chr3:12838266	CAND2	0.68	5.87	0.55	9.87e-8	QRS complex (12-leadsum);
SKCM	cis	rs3820928	0.935	rs12151597	chr2:227859224	A/G	cg11843606	chr2:227700838	RHBDD1	-0.61	-4.89	-0.48	5.28e-6	Pulmonary function;
SKCM	cis	rs17376456	0.825	rs13156202	chr5:93157721	C/T	cg21475434	chr5:93447410	FAM172A	-0.96	-5.35	-0.52	8.62e-7	Diabetic retinopathy;
SKCM	cis	rs2999052	0.526	rs3732402	chr3:127806218	A/G	cg09089421	chr3:127803668	RUVBL1	0.58	5.7	0.54	2.03e-7	Hypospadias;
SKCM	cis	rs10779751	0.960	rs6661859	chr1:11301063	T/C	cg08854313	chr1:11322531	MTOR	0.93	7.33	0.64	1.88e-10	Body mass index;
SKCM	cis	rs7945705	0.875	rs10769955	chr11:8784647	G/C	cg21881798	chr11:8931708	C11orf17;ST5	0.66	6.66	0.6	3.4e-9	Hemoglobin concentration;
SKCM	cis	rs10193935	0.901	rs10196091	chr2:42541591	T/C	cg27598129	chr2:42591480	NA	-0.89	-6.82	-0.61	1.74e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs1062177	0.756	rs2964587	chr5:151119972	C/T	cg00977110	chr5:151150581	G3BP1	-0.77	-5.42	-0.52	6.37e-7	Preschool internalizing problems;
SKCM	cis	rs933688	0.938	rs10063683	chr5:90714595	G/A	cg12630606	chr5:90679528	LOC100129716;ARRDC3	1.02	7.81	0.66	2.22e-11	Smoking behavior;
SKCM	cis	rs6445797	0.632	rs6805469	chr3:56631235	G/T	cg13616963	chr3:57583610	ARF4	-0.76	-4.89	-0.48	5.37e-6	Gastritis;
SKCM	cis	rs1218582	0.774	rs11264284	chr1:154875793	C/T	cg16680214	chr1:154839983	KCNN3	-0.55	-5.08	-0.5	2.54e-6	Prostate cancer;
SKCM	cis	rs7772486	0.754	rs4896832	chr6:145964151	G/A	cg05347473	chr6:146136440	FBXO30	0.58	5.3	0.51	1.05e-6	Lobe attachment (rater-scored or self-reported);
SKCM	trans	rs12599106	0.905	rs2004779	chr16:34631340	T/C	cg15383120	chr6:291909	DUSP22	-0.79	-7.36	-0.64	1.61e-10	Menopause (age at onset);
SKCM	cis	rs1577917	1.000	rs12190598	chr6:86686074	C/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.67	-5.53	-0.53	4.13e-7	Response to antipsychotic treatment;
SKCM	cis	rs9300255	0.602	rs1790098	chr12:123655481	A/C	cg00376283	chr12:123451042	ABCB9	0.83	5.48	0.53	5.03e-7	Neutrophil percentage of white cells;
SKCM	cis	rs1691799	0.836	rs1168334	chr12:66760972	A/G	cg16791601	chr12:66731901	HELB	-0.58	-4.82	-0.48	6.86e-6	White blood cell count (basophil);
SKCM	cis	rs7917772	0.503	rs11191328	chr10:104305185	C/T	cg11453585	chr10:104263688	ACTR1A;SUFU	0.77	6.27	0.58	1.88e-8	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs9796	0.621	rs28737302	chr15:41469943	G/A	cg18705301	chr15:41695430	NDUFAF1	-0.7	-5.18	-0.51	1.67e-6	Menopause (age at onset);
SKCM	cis	rs17376456	0.597	rs7728825	chr5:93384594	T/C	cg25358565	chr5:93447407	FAM172A	-0.78	-5.03	-0.5	3.02e-6	Diabetic retinopathy;
SKCM	cis	rs10503709	0.581	rs12680722	chr8:21472776	C/T	cg23716449	chr8:21608280	GFRA2	-0.52	-4.95	-0.49	4.2e-6	Blood protein levels;
SKCM	cis	rs870825	0.616	rs67409049	chr4:185623989	G/A	cg04058563	chr4:185651563	MLF1IP	1.07	7.36	0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs2836974	0.897	rs2836924	chr21:40525639	C/T	cg11890956	chr21:40555474	PSMG1	1.07	13.19	0.83	1.48e-21	Cognitive function;
SKCM	cis	rs9916302	0.851	rs12936646	chr17:37647450	A/T	cg07936489	chr17:37558343	FBXL20	-0.9	-8.1	-0.68	6.05e-12	Glomerular filtration rate (creatinine);
SKCM	cis	rs67311347	1.000	rs4973997	chr3:40460145	G/A	cg00091569	chr3:40428383	ENTPD3	0.62	5.1	0.5	2.35e-6	Renal cell carcinoma;
SKCM	cis	rs7100689	0.646	rs10788562	chr10:82072310	C/T	cg00277334	chr10:82204260	NA	0.53	5.08	0.5	2.53e-6	Post bronchodilator FEV1;
SKCM	cis	rs11098499	0.954	rs17006190	chr4:120418838	C/G	cg24375607	chr4:120327624	NA	0.66	5.13	0.5	2.05e-6	Corneal astigmatism;
SKCM	cis	rs9790314	1.000	rs2218803	chr3:161047973	T/G	cg03342759	chr3:160939853	NMD3	-0.74	-8.2	-0.68	3.86e-12	Morning vs. evening chronotype;
SKCM	cis	rs10751667	0.643	rs10794343	chr11:925493	C/T	cg06064525	chr11:970664	AP2A2	-0.55	-5.08	-0.5	2.47e-6	Alzheimer's disease (late onset);
SKCM	cis	rs427394	0.802	rs274720	chr5:6719933	A/G	cg10857441	chr5:6722123	POLS	-0.71	-7.33	-0.64	1.83e-10	Menopause (age at onset);
SKCM	cis	rs9814567	0.806	rs4955525	chr3:134317008	C/T	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.65	-5.43	-0.52	6.18e-7	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs4724125	0.843	rs35270213	chr7:42681004	A/G	cg09407816	chr7:42972088	MRPL32;PSMA2	0.81	4.85	0.48	6.13e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs910316	1.000	rs8003506	chr14:75586288	A/C	cg08847533	chr14:75593920	NEK9	-0.96	-8.31	-0.69	2.32e-12	Height;
SKCM	cis	rs514406	0.893	rs6588446	chr1:53425260	G/A	cg08859206	chr1:53392774	SCP2	0.6	4.82	0.48	6.91e-6	Monocyte count;
SKCM	cis	rs875971	0.862	rs12698526	chr7:65969105	T/C	cg18876405	chr7:65276391	NA	0.61	6.04	0.56	5.03e-8	Aortic root size;
SKCM	cis	rs2180341	0.883	rs7760748	chr6:127690062	C/T	cg27446573	chr6:127587934	RNF146	0.93	8.09	0.68	6.27e-12	Breast cancer;
SKCM	cis	rs654950	0.840	rs116241899	chr1:41994546	T/C	cg06885757	chr1:42089581	HIVEP3	-0.64	-7.03	-0.62	6.98e-10	Airway imaging phenotypes;
SKCM	cis	rs644799	1.000	rs12291986	chr11:95523030	T/G	cg25622487	chr11:95524042	FAM76B;CEP57	0.69	5.4	0.52	6.92e-7	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs769267	0.864	rs7245983	chr19:19657632	A/C	cg26732615	chr19:19648335	CILP2;YJEFN3	0.68	6.98	0.62	8.49e-10	Tonsillectomy;
SKCM	cis	rs28595532	0.920	rs55668908	chr4:119769799	C/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs394563	0.591	rs237035	chr6:149710848	C/T	cg16235748	chr6:149772707	ZC3H12D	-0.44	-5.1	-0.5	2.3e-6	Dupuytren's disease;
SKCM	cis	rs28386778	0.897	rs2665796	chr17:61923716	G/C	cg01411255	chr17:61851458	DDX42;CCDC47	0.75	4.83	0.48	6.63e-6	Prudent dietary pattern;
SKCM	cis	rs7772486	0.686	rs9390347	chr6:146044747	G/T	cg23711669	chr6:146136114	FBXO30	-0.82	-8.01	-0.67	9.12e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs875971	0.642	rs35526611	chr7:66094008	C/T	cg11764359	chr7:65958608	NA	-0.84	-6.37	-0.59	1.2e-8	Aortic root size;
SKCM	cis	rs2769264	0.593	rs4971040	chr1:151366494	A/C	cg18801370	chr1:151430492	POGZ	0.82	5.19	0.51	1.61e-6	Blood trace element (Cu levels);
SKCM	cis	rs11690935	0.959	rs10803863	chr2:172535337	T/C	cg13550731	chr2:172543902	DYNC1I2	0.94	8.32	0.69	2.24e-12	Schizophrenia;
SKCM	cis	rs7927771	0.524	rs1563820	chr11:47833398	A/T	cg20307385	chr11:47447363	PSMC3	-0.72	-5.81	-0.55	1.31e-7	Subjective well-being;
SKCM	cis	rs7584330	0.868	rs2325839	chr2:238386286	T/C	cg14458575	chr2:238380390	NA	1.03	6.5	0.59	6.8e-9	Prostate cancer;
SKCM	cis	rs7617480	0.616	rs9873227	chr3:48773108	G/C	cg07636037	chr3:49044803	WDR6	0.9	6.65	0.6	3.64e-9	Subjective well-being (multi-trait analysis);Menarche (age at onset);
SKCM	cis	rs453301	0.624	rs6987558	chr8:8862521	C/G	cg15556689	chr8:8085844	FLJ10661	0.71	5.58	0.53	3.3e-7	Joint mobility (Beighton score);
SKCM	cis	rs801193	0.569	rs11772819	chr7:66217970	T/C	cg11764359	chr7:65958608	NA	0.75	6.82	0.61	1.71e-9	Aortic root size;
SKCM	trans	rs3780486	0.505	rs10758194	chr9:33157419	G/T	cg04842962	chr6:43655489	MRPS18A	0.82	8.05	0.67	7.51e-12	IgG glycosylation;
SKCM	cis	rs9581857	0.547	rs76435345	chr13:28107638	G/A	cg22138327	chr13:27999177	GTF3A	0.84	5.76	0.55	1.58e-7	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs995000	0.868	rs6682423	chr1:63171063	C/T	cg06896770	chr1:63153194	DOCK7	-0.77	-6.8	-0.61	1.9e-9	Triglyceride levels;
SKCM	cis	rs8067545	0.640	rs10083840	chr17:19965972	A/G	cg13482628	chr17:19912719	NA	0.76	6.15	0.57	3.05e-8	Schizophrenia;
SKCM	cis	rs1707322	1.000	rs785480	chr1:46492164	C/G	cg03146154	chr1:46216737	IPP	0.71	4.79	0.48	7.82e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs4819052	0.655	rs2330102	chr21:46690968	C/G	cg19498844	chr21:46707878	POFUT2;LOC642852	0.83	7.01	0.62	7.55e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7811142	0.779	rs28680963	chr7:99905475	C/G	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.21	8.05	0.67	7.68e-12	Platelet count;
SKCM	cis	rs9815354	0.812	rs17283929	chr3:41941898	C/G	cg03022575	chr3:42003672	ULK4	-1.02	-5.17	-0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs28386778	0.897	rs8066754	chr17:61816590	T/C	cg01411255	chr17:61851458	DDX42;CCDC47	0.78	5.03	0.49	3.06e-6	Prudent dietary pattern;
SKCM	cis	rs1005277	0.579	rs2474575	chr10:38387901	C/T	cg00409905	chr10:38381863	ZNF37A	-0.64	-5.96	-0.56	6.77e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs9715521	0.677	rs17493148	chr4:59861895	T/C	cg11281224	chr4:60001000	NA	-0.61	-4.95	-0.49	4.16e-6	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs9443189	0.865	rs2133190	chr6:76443493	A/G	cg01950844	chr6:76311363	SENP6	-0.74	-4.98	-0.49	3.66e-6	Prostate cancer;
SKCM	cis	rs7615952	0.611	rs35321002	chr3:125612065	G/C	cg05084668	chr3:125655381	ALG1L	-1.26	-7.1	-0.63	5.08e-10	Blood pressure (smoking interaction);
SKCM	cis	rs11585357	0.842	rs72633804	chr1:17617024	T/C	cg08277548	chr1:17600880	PADI3	-0.89	-6.31	-0.58	1.53e-8	Hair shape;
SKCM	cis	rs7809950	1.000	rs2066735	chr7:107188719	G/T	cg23024343	chr7:107201750	COG5	-0.74	-6.93	-0.62	1.07e-9	Coronary artery disease;
SKCM	cis	rs6088580	0.542	rs6059882	chr20:33090167	T/C	cg24642439	chr20:33292090	TP53INP2	0.76	6.02	0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs6582630	0.519	rs8189623	chr12:38351436	G/A	cg26384229	chr12:38710491	ALG10B	0.81	6.56	0.6	5.29e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs7772486	0.754	rs4896838	chr6:146015451	T/C	cg05347473	chr6:146136440	FBXO30	-0.67	-6.1	-0.57	3.9e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs875971	0.830	rs587360	chr7:65522698	C/A	cg18876405	chr7:65276391	NA	0.75	7.32	0.64	1.93e-10	Aortic root size;
SKCM	cis	rs9916302	0.653	rs11654954	chr17:37745979	C/T	cg07936489	chr17:37558343	FBXL20	0.87	6.41	0.59	1e-8	Glomerular filtration rate (creatinine);
SKCM	trans	rs3780486	0.541	rs10738909	chr9:33148834	T/C	cg04842962	chr6:43655489	MRPS18A	0.82	8.05	0.67	7.51e-12	IgG glycosylation;
SKCM	cis	rs4975616	0.807	rs28379291	chr5:1313701	A/G	cg06550200	chr5:1325588	CLPTM1L	0.7	5.21	0.51	1.48e-6	Lung cancer;
SKCM	cis	rs875971	0.516	rs6945322	chr7:65336056	T/C	cg11764359	chr7:65958608	NA	0.88	6.43	0.59	9.56e-9	Aortic root size;
SKCM	cis	rs4319547	0.737	rs10773176	chr12:122944713	A/G	cg23029597	chr12:123009494	RSRC2	-0.8	-6.08	-0.57	4.24e-8	Body mass index;
SKCM	cis	rs11098499	0.657	rs9996569	chr4:120299004	G/C	cg24375607	chr4:120327624	NA	0.65	4.97	0.49	3.87e-6	Corneal astigmatism;
SKCM	cis	rs16854884	0.586	rs6795008	chr3:143738421	A/G	cg06585982	chr3:143692056	C3orf58	0.87	8.34	0.69	2.04e-12	Economic and political preferences (feminism/equality);
SKCM	cis	rs763014	0.931	rs11643039	chr16:634260	G/A	cg07343612	chr16:622815	PIGQ	-0.7	-6.0	-0.56	5.84e-8	Height;
SKCM	cis	rs362272	0.524	rs2857982	chr4:3358665	G/A	cg24015175	chr4:3319247	RGS12	0.83	9.8	0.74	3.03e-15	Serum sulfate level;
SKCM	cis	rs2070488	0.775	rs6599204	chr3:38525734	C/T	cg01465620	chr3:38496096	LOC100128640;ACVR2B	0.73	5.78	0.55	1.47e-7	Electrocardiographic conduction measures;
SKCM	cis	rs9910055	0.530	rs11652651	chr17:42302907	A/G	cg09913183	chr17:42254507	C17orf65;ASB16	-0.58	-5.03	-0.5	3.03e-6	Total body bone mineral density;
SKCM	cis	rs208520	0.874	rs208470	chr6:66916402	G/A	cg07460842	chr6:66804631	NA	-0.9	-6.54	-0.6	5.77e-9	Exhaled nitric oxide output;
SKCM	cis	rs1799949	1.000	rs4793194	chr17:41218333	G/A	cg23758822	chr17:41437982	NA	0.94	7.89	0.67	1.51e-11	Menopause (age at onset);
SKCM	cis	rs2404602	0.692	rs12910382	chr15:77053442	A/C	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs7635838	0.819	rs2454481	chr3:11535178	C/T	cg00170343	chr3:11313890	ATG7	0.68	4.89	0.48	5.22e-6	HDL cholesterol;
SKCM	cis	rs72827839	0.603	rs72833466	chr17:45948952	C/A	cg23391107	chr17:45924227	SP6	0.76	6.9	0.62	1.2e-9	Ease of getting up in the morning;
SKCM	cis	rs79839061	0.666	rs62297063	chr4:869708	G/A	cg07828340	chr4:882639	GAK	1.02	4.95	0.49	4.16e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs651907	0.557	rs7612283	chr3:101434919	C/T	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.81	7.06	0.62	6.11e-10	Colorectal cancer;
SKCM	cis	rs4790333	0.653	rs2447103	chr17:2262997	A/C	cg02569219	chr17:2266849	SGSM2	0.67	5.82	0.55	1.22e-7	Proinsulin levels;
SKCM	cis	rs2991971	0.810	rs2036021	chr1:45901370	G/A	cg24296786	chr1:45957014	TESK2	0.63	4.98	0.49	3.71e-6	High light scatter reticulocyte count;
SKCM	cis	rs67460515	0.892	rs7647374	chr3:160975576	T/A	cg03342759	chr3:160939853	NMD3	-0.81	-7.1	-0.63	5.14e-10	Parkinson's disease;
SKCM	cis	rs10193935	0.792	rs13423729	chr2:42492874	C/T	cg27598129	chr2:42591480	NA	-0.9	-6.86	-0.61	1.44e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4819052	0.851	rs9754134	chr21:46661751	T/C	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.42	0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs16866061	1.000	rs7588380	chr2:225341304	A/T	cg12698349	chr2:225449008	CUL3	-0.99	-8.37	-0.69	1.83e-12	Acute graft versus host disease in bone marrow transplantation (recipient effect);
SKCM	cis	rs3768617	0.510	rs723014	chr1:183076287	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs6424115	0.830	rs1106	chr1:24200772	C/G	cg15997130	chr1:24165203	NA	0.6	4.94	0.49	4.37e-6	Immature fraction of reticulocytes;
SKCM	cis	rs2839186	0.967	rs17176131	chr21:47705237	T/C	cg11766577	chr21:47581405	C21orf56	-0.71	-6.01	-0.56	5.6e-8	Testicular germ cell tumor;
SKCM	cis	rs7959452	0.868	rs10878967	chr12:69740869	T/C	cg20891283	chr12:69753455	YEATS4	0.74	6.28	0.58	1.78e-8	Blood protein levels;
SKCM	cis	rs826838	1.000	rs10880963	chr12:38748408	T/C	cg13010199	chr12:38710504	ALG10B	0.86	6.84	0.61	1.61e-9	Heart rate;
SKCM	cis	rs13118159	0.550	rs4974614	chr4:1373489	A/G	cg19318889	chr4:1322082	MAEA	0.79	5.72	0.54	1.9e-7	Longevity;
SKCM	cis	rs2354432	0.546	rs7539416	chr1:146881586	C/T	cg25205988	chr1:146714368	CHD1L	0.97	6.71	0.6	2.85e-9	Mitochondrial DNA levels;
SKCM	cis	rs1218582	0.804	rs4845398	chr1:154859038	G/C	cg16680214	chr1:154839983	KCNN3	-0.56	-4.97	-0.49	3.89e-6	Prostate cancer;
SKCM	cis	rs9325144	0.505	rs901635	chr12:38646572	A/C	cg26384229	chr12:38710491	ALG10B	-0.79	-6.9	-0.62	1.21e-9	Morning vs. evening chronotype;
SKCM	cis	rs1348850	0.526	rs7607073	chr2:178375065	C/A	cg27490568	chr2:178487706	NA	0.9	6.52	0.59	6.42e-9	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs1577917	0.917	rs1838959	chr6:86556804	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.81	-7.82	-0.66	2.07e-11	Response to antipsychotic treatment;
SKCM	cis	rs6424115	1.000	rs7514394	chr1:24100223	A/G	cg15997130	chr1:24165203	NA	-0.62	-5.3	-0.51	1.05e-6	Immature fraction of reticulocytes;
SKCM	cis	rs9309711	0.666	rs6723126	chr2:3484500	T/C	cg15506890	chr2:3487001	NA	-0.63	-5.08	-0.5	2.51e-6	Neurofibrillary tangles;
SKCM	cis	rs897984	0.647	rs8060857	chr16:31002720	G/A	cg00531865	chr16:30841666	NA	0.6	5.02	0.49	3.2e-6	Dementia with Lewy bodies;
SKCM	cis	rs7772486	0.875	rs9322044	chr6:146369608	T/C	cg23711669	chr6:146136114	FBXO30	0.77	7.48	0.65	9.65e-11	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs55823223	0.564	rs936396	chr17:73846829	C/G	cg10935138	chr17:73851978	WBP2	1.13	7.39	0.64	1.43e-10	Psoriasis;
SKCM	cis	rs2228479	1.000	rs62052180	chr16:89963289	C/G	cg00800038	chr16:89945340	TCF25	-0.93	-5.34	-0.52	8.73e-7	Skin colour saturation;
SKCM	cis	rs62238980	0.614	rs77167216	chr22:32386313	G/C	cg00543991	chr22:32367038	NA	1.15	4.87	0.48	5.76e-6	Childhood ear infection;
SKCM	cis	rs7666738	0.830	rs7691864	chr4:98971376	G/C	cg05340658	chr4:99064831	C4orf37	0.64	4.89	0.48	5.39e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs10489202	0.612	rs3820401	chr1:168074753	T/C	cg24449463	chr1:168025552	DCAF6	-0.81	-7.61	-0.65	5.44e-11	Schizophrenia;
SKCM	cis	rs2204008	0.543	rs2387018	chr12:38065638	C/T	cg26384229	chr12:38710491	ALG10B	0.81	6.45	0.59	8.61e-9	Bladder cancer;
SKCM	cis	rs1577917	0.958	rs11755642	chr6:86450066	A/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.65	-5.63	-0.54	2.72e-7	Response to antipsychotic treatment;
SKCM	cis	rs9611565	0.659	rs11090049	chr22:41915329	C/T	cg03806693	chr22:41940476	POLR3H	-1.11	-7.56	-0.65	6.67e-11	Vitiligo;
SKCM	cis	rs801193	0.636	rs10233806	chr7:66118248	G/C	cg11764359	chr7:65958608	NA	-0.78	-6.94	-0.62	1.03e-9	Aortic root size;
SKCM	cis	rs6430585	0.527	rs62168792	chr2:136415217	A/G	cg07169764	chr2:136633963	MCM6	1.02	7.7	0.66	3.66e-11	Corneal structure;
SKCM	cis	rs12497850	1.000	rs12497850	chr3:48748989	G/T	cg07636037	chr3:49044803	WDR6	0.9	9.1	0.72	6.77e-14	Parkinson's disease;
SKCM	cis	rs1552244	1.000	rs6442148	chr3:10078289	G/C	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	cis	rs28374715	0.662	rs13329579	chr15:41467435	C/T	cg18705301	chr15:41695430	NDUFAF1	-0.93	-7.74	-0.66	2.94e-11	Ulcerative colitis;
SKCM	cis	rs7940866	0.834	rs2324315	chr11:130839772	C/G	cg12179176	chr11:130786555	SNX19	0.79	6.17	0.57	2.88e-8	Schizophrenia;
SKCM	cis	rs2404602	0.692	rs4360890	chr15:77173295	G/A	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs1005277	0.579	rs2474588	chr10:38420870	A/G	cg00409905	chr10:38381863	ZNF37A	-0.66	-6.16	-0.57	3e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs453301	0.658	rs13271797	chr8:8885954	G/A	cg15556689	chr8:8085844	FLJ10661	-0.73	-6.01	-0.56	5.58e-8	Joint mobility (Beighton score);
SKCM	cis	rs6089829	0.962	rs4997812	chr20:61663153	T/G	cg08564027	chr20:61660810	NA	0.63	5.65	0.54	2.56e-7	Prostate cancer (SNP x SNP interaction);
SKCM	cis	rs11241713	1.000	rs919219	chr5:123009285	G/A	cg14868599	chr5:123999154	ZNF608	-0.7	-4.79	-0.48	7.92e-6	Amyotrophic lateral sclerosis;
SKCM	cis	rs9325144	0.560	rs7980635	chr12:38668355	G/T	cg26384229	chr12:38710491	ALG10B	-0.69	-5.66	-0.54	2.36e-7	Morning vs. evening chronotype;
SKCM	cis	rs875971	0.660	rs6460308	chr7:66084740	T/C	cg00343986	chr7:65444356	GUSB	-0.68	-4.99	-0.49	3.65e-6	Aortic root size;
SKCM	cis	rs12477438	0.520	rs13018891	chr2:99755099	C/G	cg26064155	chr2:99771622	LIPT1;TSGA10	1.02	9.73	0.74	4.23e-15	Chronic sinus infection;
SKCM	cis	rs9911578	0.935	rs117819974	chr17:57002324	C/T	cg12560992	chr17:57184187	TRIM37	0.94	7.55	0.65	7.01e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs651907	0.535	rs35799195	chr3:101521927	A/G	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.78	6.72	0.61	2.65e-9	Colorectal cancer;
SKCM	cis	rs6121246	0.580	rs6121016	chr20:30245239	C/T	cg11595048	chr20:30225325	COX4I2	0.68	5.39	0.52	7.35e-7	Mean corpuscular hemoglobin;
SKCM	cis	rs9611565	0.546	rs739129	chr22:42118249	G/A	cg03806693	chr22:41940476	POLR3H	1.09	7.12	0.63	4.62e-10	Vitiligo;
SKCM	cis	rs4862750	0.914	rs1863405	chr4:187874528	G/T	cg10295955	chr4:187884368	NA	1.04	14.14	0.85	3.15e-23	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2836974	0.897	rs2026267	chr21:40711477	C/A	cg17971929	chr21:40555470	PSMG1	0.83	7.71	0.66	3.43e-11	Cognitive function;
SKCM	cis	rs17345786	0.817	rs11720560	chr3:101328484	C/T	cg12386194	chr3:101231763	SENP7	0.8	6.19	0.57	2.62e-8	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2072499	0.932	rs2540183	chr1:156164885	C/G	cg25208724	chr1:156163844	SLC25A44	1.02	8.57	0.7	7.5e-13	Testicular germ cell tumor;
SKCM	cis	rs694739	0.734	rs663743	chr11:64107735	G/A	cg02228329	chr11:64053129	BAD;GPR137	0.96	8.45	0.69	1.26e-12	Alopecia areata;Crohn's disease;Psoriasis vulgaris;
SKCM	trans	rs1814175	0.817	rs1794164	chr11:49899610	T/C	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs4774899	0.934	rs11858783	chr15:57472751	C/A	cg01857019	chr15:57210107	LOC145783;TCF12	0.53	4.9	0.49	5.12e-6	Urinary tract infection frequency;
SKCM	cis	rs1577917	0.771	rs2475791	chr6:86368164	T/C	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.83	-7.7	-0.66	3.55e-11	Response to antipsychotic treatment;
SKCM	cis	rs9910055	0.529	rs228766	chr17:42186813	A/G	cg19774624	chr17:42201019	HDAC5	0.81	6.39	0.59	1.12e-8	Total body bone mineral density;
SKCM	cis	rs11673344	0.704	rs1667384	chr19:37416754	C/T	cg07624650	chr19:37064219	ZNF529	-0.8	-5.24	-0.51	1.31e-6	Obesity-related traits;
SKCM	cis	rs10197940	0.967	rs4664423	chr2:152266311	T/C	cg19508488	chr2:152266495	RIF1	0.63	5.2	0.51	1.55e-6	Lung cancer;
SKCM	cis	rs1957429	0.901	rs17102320	chr14:65384693	T/C	cg23373153	chr14:65346875	NA	-1.07	-5.71	-0.54	1.94e-7	Pediatric areal bone mineral density (radius);
SKCM	cis	rs11098499	0.691	rs12502524	chr4:120271414	G/A	cg09307838	chr4:120376055	NA	0.94	7.73	0.66	3.07e-11	Corneal astigmatism;
SKCM	cis	rs769267	0.931	rs2965197	chr19:19470910	C/T	cg26732615	chr19:19648335	CILP2;YJEFN3	-0.66	-6.06	-0.57	4.59e-8	Tonsillectomy;
SKCM	cis	rs4423214	0.879	rs1792264	chr11:71150247	C/T	cg05163923	chr11:71159392	DHCR7	-0.7	-6.35	-0.58	1.35e-8	Vitamin D levels;
SKCM	cis	rs9393692	0.645	rs766407	chr6:26319534	T/C	cg00631329	chr6:26305371	NA	-0.7	-4.84	-0.48	6.33e-6	Educational attainment;
SKCM	cis	rs7666738	0.830	rs11729753	chr4:98803267	T/A	cg17366294	chr4:99064904	C4orf37	0.57	4.87	0.48	5.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs62238980	0.614	rs75348576	chr22:32395467	A/C	cg00543991	chr22:32367038	NA	1.15	4.87	0.48	5.76e-6	Childhood ear infection;
SKCM	cis	rs8180040	0.967	rs807935	chr3:47321669	A/G	cg16586182	chr3:47516702	SCAP	-0.71	-4.85	-0.48	6.25e-6	Colorectal cancer;
SKCM	cis	rs7659604	0.560	rs769238	chr4:122744942	G/A	cg19748678	chr4:122722346	EXOSC9	0.65	5.4	0.52	7.02e-7	Type 2 diabetes;
SKCM	cis	rs7100689	0.754	rs1934695	chr10:82125230	T/C	cg00277334	chr10:82204260	NA	-0.52	-4.89	-0.48	5.24e-6	Post bronchodilator FEV1;
SKCM	cis	rs7945705	0.818	rs1988708	chr11:8882893	C/A	cg21881798	chr11:8931708	C11orf17;ST5	-0.79	-8.52	-0.69	9.25e-13	Hemoglobin concentration;
SKCM	cis	rs1577917	0.916	rs12203358	chr6:86603224	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.86	-8.63	-0.7	5.66e-13	Response to antipsychotic treatment;
SKCM	cis	rs826838	0.935	rs11168761	chr12:38997211	C/A	cg26384229	chr12:38710491	ALG10B	1.01	9.41	0.73	1.77e-14	Heart rate;
SKCM	cis	rs826838	1.000	rs11183469	chr12:38752311	G/A	cg13010199	chr12:38710504	ALG10B	0.86	6.84	0.61	1.61e-9	Heart rate;
SKCM	cis	rs7945705	0.782	rs2742545	chr11:8884308	C/G	cg13070366	chr11:9386451	NA	0.55	4.78	0.48	8.04e-6	Hemoglobin concentration;
SKCM	cis	rs885814	0.619	rs10917008	chr1:21894307	A/G	cg25601136	chr1:21766849	NBPF3	0.78	5.28	0.51	1.11e-6	Response to TNF-alpha inhibitors in rheumatoid arthritis;
SKCM	cis	rs6598955	0.724	rs7547520	chr1:26592310	C/T	cg00938395	chr1:26633206	UBXN11	0.7	4.92	0.49	4.63e-6	Obesity-related traits;
SKCM	cis	rs6582630	0.502	rs11181210	chr12:38298069	G/A	cg26384229	chr12:38710491	ALG10B	0.8	6.55	0.6	5.47e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs6500395	1.000	rs904819	chr16:48622583	C/A	cg04672837	chr16:48644449	N4BP1	0.7	6.0	0.56	5.93e-8	Response to tocilizumab in rheumatoid arthritis;
SKCM	cis	rs9399135	0.660	rs9389248	chr6:135282656	T/C	cg24558204	chr6:135376177	HBS1L	0.65	5.72	0.54	1.86e-7	Red blood cell count;
SKCM	cis	rs36093844	0.800	rs2044390	chr11:85569834	C/T	cg25872744	chr11:85566296	CCDC83	-0.85	-4.77	-0.48	8.27e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs644799	0.710	rs473852	chr11:95568757	C/A	cg25622487	chr11:95524042	FAM76B;CEP57	0.65	5.15	0.5	1.91e-6	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs1707322	0.721	rs4660883	chr1:46236098	C/T	cg03146154	chr1:46216737	IPP	0.82	6.16	0.57	2.94e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7940866	0.838	rs1118137	chr11:130890970	G/A	cg12179176	chr11:130786555	SNX19	0.68	5.13	0.5	2.06e-6	Schizophrenia;
SKCM	cis	rs7618501	0.601	rs2624825	chr3:50154989	G/A	cg24110177	chr3:50126178	RBM5	0.61	5.29	0.51	1.09e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs4132509	0.793	rs7522883	chr1:243803022	C/T	cg21452805	chr1:244014465	NA	0.89	5.54	0.53	3.88e-7	RR interval (heart rate);
SKCM	cis	rs910316	1.000	rs175449	chr14:75590846	A/T	cg11812906	chr14:75593930	NEK9	-0.72	-5.45	-0.53	5.72e-7	Height;
SKCM	cis	rs875971	0.522	rs1968127	chr7:66056803	C/T	cg05627663	chr7:65219948	SNORA22;CCT6P1	-0.56	-4.84	-0.48	6.39e-6	Aortic root size;
SKCM	cis	rs854765	0.624	rs12938501	chr17:17737258	A/C	cg24612305	chr17:17875800	TOM1L2;LRRC48	-0.95	-7.11	-0.63	4.78e-10	Total body bone mineral density;
SKCM	cis	rs2251381	0.515	rs2832299	chr21:30749237	G/C	cg24692254	chr21:30365293	RNF160	0.66	5.14	0.5	1.96e-6	Selective IgA deficiency;
SKCM	cis	rs1005277	0.505	rs200937	chr10:38135772	T/C	cg25427524	chr10:38739819	LOC399744	-0.68	-6.52	-0.59	6.36e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs7811142	1.000	rs11559117	chr7:100076614	A/G	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-0.99	-5.52	-0.53	4.2e-7	Platelet count;
SKCM	cis	rs4819052	0.918	rs34886433	chr21:46680538	G/C	cg02159808	chr21:46707872	POFUT2;LOC642852	0.84	6.4	0.59	1.09e-8	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs6977660	1.000	rs12673970	chr7:19813018	T/C	cg07541023	chr7:19748670	TWISTNB	0.72	5.03	0.5	3.01e-6	Thyroid stimulating hormone;
SKCM	cis	rs763014	0.932	rs34498660	chr16:666149	A/G	cg09263875	chr16:632152	PIGQ	0.72	6.45	0.59	8.69e-9	Height;
SKCM	cis	rs7772486	0.720	rs702320	chr6:146006654	G/A	cg05347473	chr6:146136440	FBXO30	-0.65	-6.0	-0.56	5.94e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs854765	0.583	rs4925130	chr17:17807858	G/A	cg24612305	chr17:17875800	TOM1L2;LRRC48	0.94	7.33	0.64	1.82e-10	Total body bone mineral density;
SKCM	cis	rs4891159	0.790	rs4891161	chr18:74142683	A/G	cg24786174	chr18:74118243	ZNF516	-0.73	-7.1	-0.63	4.99e-10	Longevity;
SKCM	cis	rs523522	0.962	rs10849754	chr12:120940418	A/C	cg27279351	chr12:120934652	DYNLL1	0.91	8.32	0.69	2.26e-12	High light scatter reticulocyte count;
SKCM	cis	rs6866344	0.697	rs61247551	chr5:178133503	G/A	cg10224037	chr5:178157518	ZNF354A	0.81	5.68	0.54	2.26e-7	Neutrophil percentage of white cells;
SKCM	cis	rs7100689	0.646	rs10736356	chr10:82148325	A/G	cg00277334	chr10:82204260	NA	-0.56	-5.23	-0.51	1.37e-6	Post bronchodilator FEV1;
SKCM	cis	rs6088590	1.000	rs6119516	chr20:33328024	C/T	cg24642439	chr20:33292090	TP53INP2	1.02	7.56	0.65	6.73e-11	Coronary artery disease;
SKCM	cis	rs7584330	0.738	rs4402703	chr2:238374957	T/A	cg14458575	chr2:238380390	NA	0.91	6.4	0.59	1.07e-8	Prostate cancer;
SKCM	cis	rs7829975	0.577	rs17684466	chr8:8545233	G/A	cg06636001	chr8:8085503	FLJ10661	-0.68	-5.1	-0.5	2.34e-6	Mood instability;
SKCM	cis	rs2857078	0.654	rs9896789	chr17:42314567	C/T	cg09913183	chr17:42254507	C17orf65;ASB16	0.64	5.38	0.52	7.49e-7	Red cell distribution width;Reticulocyte count;
SKCM	cis	rs62064224	0.791	rs11656289	chr17:30761160	T/C	cg25809561	chr17:30822961	MYO1D	0.73	5.63	0.54	2.76e-7	Schizophrenia;
SKCM	cis	rs11209185	0.602	rs1926282	chr1:68448753	C/G	cg17031739	chr1:67600172	NA	0.48	4.85	0.48	6.15e-6	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs459571	1.000	rs459571	chr9:136912626	C/T	cg13789015	chr9:136890014	NCRNA00094	0.7	5.65	0.54	2.48e-7	Platelet distribution width;
SKCM	cis	rs561341	1.000	rs72823785	chr17:30273784	C/T	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs7216064	1.000	rs62084248	chr17:65874541	C/T	cg12091567	chr17:66097778	LOC651250	-0.75	-5.27	-0.51	1.19e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs10838687	0.673	rs4752965	chr11:47159053	G/A	cg05584439	chr11:47213196	NA	0.8	4.8	0.48	7.6e-6	Proinsulin levels;
SKCM	cis	rs9916302	0.851	rs12947620	chr17:37605364	T/C	cg07936489	chr17:37558343	FBXL20	-0.86	-7.39	-0.64	1.42e-10	Glomerular filtration rate (creatinine);
SKCM	cis	rs17270561	0.514	rs10946805	chr6:26077891	C/T	cg17691542	chr6:26056736	HIST1H1C	1.22	9.59	0.74	7.68e-15	Iron status biomarkers;
SKCM	cis	rs838147	0.844	rs8104897	chr19:49249814	C/A	cg13540341	chr19:49222985	MAMSTR	0.56	4.98	0.49	3.74e-6	Dietary macronutrient intake;
SKCM	cis	rs62238980	0.614	rs4821015	chr22:32402549	G/A	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs453301	0.719	rs34004903	chr8:8892604	C/T	cg06636001	chr8:8085503	FLJ10661	-0.73	-5.55	-0.53	3.74e-7	Joint mobility (Beighton score);
SKCM	cis	rs999943	0.846	rs10947420	chr6:33611061	C/G	cg14003231	chr6:33640908	ITPR3	0.67	6.11	0.57	3.64e-8	Obesity (extreme);
SKCM	cis	rs8180040	0.800	rs11920354	chr3:47262246	C/A	cg27129171	chr3:47204927	SETD2	-0.75	-5.35	-0.52	8.6e-7	Colorectal cancer;
SKCM	cis	rs1577917	1.000	rs12196411	chr6:86779762	C/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.64	-5.49	-0.53	4.77e-7	Response to antipsychotic treatment;
SKCM	cis	rs7772486	0.641	rs2777485	chr6:146334377	G/A	cg23711669	chr6:146136114	FBXO30	0.76	6.0	0.56	5.76e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs12478296	1.000	rs6717667	chr2:242997530	C/T	cg06360820	chr2:242988706	NA	-0.94	-5.21	-0.51	1.49e-6	Obesity-related traits;
SKCM	cis	rs28595532	0.920	rs115118317	chr4:119736613	C/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs7208859	0.673	rs9899525	chr17:29120296	T/A	cg14067834	chr17:29058358	SUZ12P	1.03	5.24	0.51	1.31e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs1580019	0.961	rs4320456	chr7:32496003	T/C	cg06627557	chr7:32535165	LSM5;AVL9	0.74	5.64	0.54	2.59e-7	Cognitive ability;
SKCM	cis	rs9916302	0.898	rs8072297	chr17:37478048	A/T	cg07936489	chr17:37558343	FBXL20	0.78	5.94	0.56	7.53e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs12477438	0.501	rs6753063	chr2:99801469	A/G	cg26064155	chr2:99771622	LIPT1;TSGA10	0.97	8.85	0.71	2.11e-13	Chronic sinus infection;
SKCM	cis	rs4665809	0.590	rs2384361	chr2:26452209	T/C	cg26119090	chr2:26468346	HADHA;HADHB	-1.07	-8.52	-0.69	9.27e-13	Gut microbiome composition (summer);
SKCM	cis	rs826838	0.754	rs2387920	chr12:38626351	A/G	cg26384229	chr12:38710491	ALG10B	0.82	6.85	0.61	1.49e-9	Heart rate;
SKCM	cis	rs738322	0.967	rs133013	chr22:38570912	C/T	cg25457927	chr22:38595422	NA	-0.54	-6.14	-0.57	3.27e-8	Cutaneous nevi;
SKCM	cis	rs36093844	0.527	rs72965166	chr11:85767800	G/C	cg25872744	chr11:85566296	CCDC83	-0.81	-4.79	-0.48	7.71e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs798766	1.000	rs798762	chr4:1731150	T/C	cg24239225	chr4:1659016	FAM53A	-0.72	-4.87	-0.48	5.66e-6	Bladder cancer;Urinary bladder cancer;
SKCM	cis	rs951366	0.903	rs708723	chr1:205739266	C/T	cg14893161	chr1:205819251	PM20D1	0.74	5.56	0.53	3.62e-7	Menarche (age at onset);
SKCM	cis	rs28595532	0.920	rs114963870	chr4:119758099	T/C	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs2153535	0.542	rs9378553	chr6:8472632	T/C	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs1065656	0.512	rs3751893	chr16:1842209	A/G	cg26897989	chr16:1907736	C16orf73	0.62	6.51	0.59	6.53e-9	Insulin-like growth factors;
SKCM	trans	rs1814175	0.817	rs11493756	chr11:50017885	T/C	cg15704280	chr7:45808275	SEPT13	-1.05	-11.07	-0.78	1.14e-17	Height;
SKCM	cis	rs9905704	0.647	rs12943705	chr17:57097047	T/C	cg05425664	chr17:57184151	TRIM37	0.58	4.8	0.48	7.36e-6	Testicular germ cell tumor;
SKCM	cis	rs561341	1.000	rs4795667	chr17:30244443	T/C	cg23018236	chr17:30244563	NA	-0.48	-4.99	-0.49	3.64e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs2243480	1.000	rs1546059	chr7:65654709	C/A	cg18252515	chr7:66147081	NA	1.36	8.16	0.68	4.6e-12	Diabetic kidney disease;
SKCM	cis	rs1577917	0.958	rs12216074	chr6:86520002	C/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.61	-5.2	-0.51	1.56e-6	Response to antipsychotic treatment;
SKCM	cis	rs7937682	1.000	rs12363179	chr11:111568091	G/A	cg09085632	chr11:111637200	PPP2R1B	1.02	11.79	0.8	5.18e-19	Primary sclerosing cholangitis;
SKCM	cis	rs28595532	0.920	rs114611353	chr4:119736607	C/T	cg11846333	chr4:119757529	SEC24D	1.2	6.45	0.59	8.54e-9	Cannabis dependence symptom count;
SKCM	cis	rs6951245	0.935	rs113365567	chr7:1108785	T/C	cg03188948	chr7:1209495	NA	1.13	6.27	0.58	1.89e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs8103278	1.000	rs11671524	chr19:46327166	G/A	cg11657440	chr19:46296263	DMWD	-0.9	-5.85	-0.55	1.08e-7	Coronary artery disease;
SKCM	cis	rs644799	0.662	rs35793328	chr11:95490896	G/T	cg03916912	chr11:95522834	CEP57;FAM76B	0.72	5.69	0.54	2.16e-7	Intelligence (multi-trait analysis);Cognitive ability (multi-trait analysis);
SKCM	cis	rs11945232	1.000	rs28406846	chr4:88343468	C/G	cg23841344	chr4:88312519	HSD17B11	-0.66	-4.9	-0.49	5.07e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9486715	1.000	rs7752277	chr6:97065131	C/T	cg06623918	chr6:96969491	KIAA0776	-0.8	-6.91	-0.62	1.16e-9	Headache;
SKCM	cis	rs1348850	0.757	rs2166554	chr2:178455824	A/G	cg02961200	chr2:178257176	LOC100130691;AGPS	0.79	6.11	0.57	3.66e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs7659604	0.628	rs6838153	chr4:122720999	A/G	cg06713675	chr4:122721982	EXOSC9	-0.74	-7.2	-0.63	3.21e-10	Type 2 diabetes;
SKCM	cis	rs2070488	0.931	rs7630012	chr3:38552250	A/G	cg01465620	chr3:38496096	LOC100128640;ACVR2B	-1.04	-9.68	-0.74	5.3e-15	Electrocardiographic conduction measures;
SKCM	cis	rs875971	1.000	rs7783613	chr7:65805261	C/T	cg18876405	chr7:65276391	NA	-0.68	-6.79	-0.61	1.96e-9	Aortic root size;
SKCM	cis	rs7659604	0.539	rs3217773	chr4:122739121	A/G	cg20573242	chr4:122745356	CCNA2	0.75	6.39	0.59	1.11e-8	Type 2 diabetes;
SKCM	cis	rs7666738	0.830	rs13122054	chr4:98972974	G/A	cg17366294	chr4:99064904	C4orf37	0.59	4.87	0.48	5.63e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2439831	0.681	rs1095386	chr15:43609509	A/G	cg27015174	chr15:43622946	ADAL;LCMT2	0.9	4.83	0.48	6.71e-6	Lung cancer in ever smokers;
SKCM	cis	rs7659604	1.000	rs35901586	chr4:122664757	T/A	cg19671926	chr4:122722719	EXOSC9	-0.64	-4.78	-0.48	8.04e-6	Type 2 diabetes;
SKCM	cis	rs2811415	0.597	rs9873723	chr3:127729071	G/T	cg09089421	chr3:127803668	RUVBL1	0.99	8.49	0.69	1.07e-12	Lung function (FEV1/FVC);
SKCM	cis	rs13392177	0.684	rs6720105	chr2:219080718	G/A	cg00012203	chr2:219082015	ARPC2	-0.64	-4.89	-0.48	5.39e-6	Pyoderma gangrenosum in inflammatory bowel disease;
SKCM	cis	rs17270561	0.541	rs2009610	chr6:25967068	C/T	cg17691542	chr6:26056736	HIST1H1C	1.24	9.53	0.73	1e-14	Iron status biomarkers;
SKCM	cis	rs3087591	0.920	rs2905881	chr17:29547862	T/C	cg24425628	chr17:29625626	OMG;NF1	0.64	5.22	0.51	1.43e-6	Hip circumference;
SKCM	cis	rs4724125	0.920	rs2330628	chr7:42699012	C/T	cg09407816	chr7:42972088	MRPL32;PSMA2	0.81	5.09	0.5	2.38e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs7828089	0.819	rs11136021	chr8:22244672	T/C	cg12081754	chr8:22256438	SLC39A14	0.68	5.17	0.5	1.79e-6	Verbal declarative memory;
SKCM	cis	rs17685	0.725	rs6947068	chr7:75662056	T/C	cg16684958	chr7:75615977	POR	-0.57	-5.6	-0.54	3.07e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1405130	0.839	rs1405132	chr2:235567460	G/T	cg17841421	chr2:235704848	NA	-0.57	-4.95	-0.49	4.14e-6	Coronary artery disease;
SKCM	cis	rs36093844	0.752	rs80323143	chr11:85546096	C/T	cg25872744	chr11:85566296	CCDC83	-0.85	-4.77	-0.48	8.27e-6	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);
SKCM	cis	rs1801251	1.000	rs12478564	chr2:233598340	C/T	cg08000102	chr2:233561755	GIGYF2	0.88	6.76	0.61	2.28e-9	Coronary artery disease;
SKCM	cis	rs9905704	0.624	rs11652761	chr17:56986095	C/T	cg05425664	chr17:57184151	TRIM37	-0.61	-4.86	-0.48	5.91e-6	Testicular germ cell tumor;
SKCM	cis	rs12142240	0.698	rs72886911	chr1:46814352	G/A	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs2658782	0.756	rs2658777	chr11:93148423	C/T	cg15737290	chr11:93063684	CCDC67	0.68	4.81	0.48	7.23e-6	Pulmonary function decline;
SKCM	cis	rs561341	1.000	rs4795667	chr17:30244443	T/C	cg00745463	chr17:30367425	LRRC37B	-0.89	-5.9	-0.56	8.83e-8	Hip circumference adjusted for BMI;
SKCM	cis	rs4819052	0.788	rs35323494	chr21:46703739	G/A	cg19498844	chr21:46707878	POFUT2;LOC642852	0.84	6.47	0.59	7.9e-9	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs453301	0.686	rs11787026	chr8:8902371	A/T	cg06636001	chr8:8085503	FLJ10661	0.76	5.58	0.53	3.37e-7	Joint mobility (Beighton score);
SKCM	cis	rs11098499	0.648	rs2002047	chr4:120257228	A/G	cg09307838	chr4:120376055	NA	0.93	7.53	0.65	7.72e-11	Corneal astigmatism;
SKCM	cis	rs1552244	1.000	rs12152515	chr3:10143976	C/T	cg02579736	chr3:10068473	FANCD2;CIDECP	1.23	6.92	0.62	1.13e-9	Alzheimer's disease;
SKCM	cis	rs11764590	0.694	rs7797112	chr7:2085165	T/C	cg23422044	chr7:1970798	MAD1L1	-0.85	-6.45	-0.59	8.53e-9	Neuroticism;
SKCM	cis	rs56235845	0.964	rs4075958	chr5:176784512	A/G	cg06060754	chr5:176797920	RGS14	-0.83	-7.99	-0.67	9.81e-12	Hemoglobin concentration;Hematocrit;
SKCM	cis	rs2404602	0.622	rs4886506	chr15:77207277	G/T	cg23625390	chr15:77176239	SCAPER	0.82	7.7	0.66	3.52e-11	Blood metabolite levels;
SKCM	cis	rs875971	0.638	rs801216	chr7:66011667	T/C	cg11987759	chr7:65425863	GUSB	0.69	5.9	0.56	8.74e-8	Aortic root size;
SKCM	cis	rs2760061	0.583	rs1745413	chr1:228212456	A/G	cg02753203	chr1:228287806	NA	0.91	8.89	0.71	1.77e-13	Diastolic blood pressure;
SKCM	cis	rs6088580	0.634	rs6059890	chr20:33101653	G/C	cg24642439	chr20:33292090	TP53INP2	0.76	6.02	0.56	5.27e-8	Glomerular filtration rate (creatinine);
SKCM	cis	rs1045529	0.524	rs34251783	chr8:8891376	T/C	cg15556689	chr8:8085844	FLJ10661	-0.73	-5.77	-0.55	1.52e-7	Myopia;Myopia (pathological);
SKCM	cis	rs4819052	0.851	rs9979545	chr21:46679805	G/A	cg19498844	chr21:46707878	POFUT2;LOC642852	0.9	7.98	0.67	1.04e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs72634258	0.503	rs697675	chr1:7838113	A/C	cg26816564	chr1:7831052	VAMP3	0.78	5.51	0.53	4.39e-7	Inflammatory bowel disease;
SKCM	cis	rs9814567	1.000	rs3846056	chr3:134227292	A/G	cg06109529	chr3:134205091	CEP63;ANAPC13	-0.61	-4.94	-0.49	4.41e-6	Neurocognitive impairment in HIV-1 infection (dichotomous);
SKCM	cis	rs709400	0.663	rs62007684	chr14:103894223	T/C	cg26031613	chr14:104095156	KLC1	0.69	5.11	0.5	2.23e-6	Body mass index;
SKCM	cis	rs7945705	0.791	rs10769958	chr11:8815115	T/C	cg21881798	chr11:8931708	C11orf17;ST5	-0.7	-7.0	-0.62	7.74e-10	Hemoglobin concentration;
SKCM	cis	rs4242434	0.892	rs11776549	chr8:22493124	C/T	cg03733263	chr8:22462867	KIAA1967	0.97	6.98	0.62	8.52e-10	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs2841277	0.708	rs11623422	chr14:105407031	A/G	cg21017887	chr14:105400489	NA	0.59	5.31	0.52	1e-6	Rheumatoid arthritis;
SKCM	cis	rs7811142	1.000	rs11769700	chr7:100090049	T/C	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.24	7.92	0.67	1.36e-11	Platelet count;
SKCM	cis	rs8141529	0.764	rs5762854	chr22:29246278	T/C	cg02153584	chr22:29168773	CCDC117	0.64	5.17	0.51	1.74e-6	Lymphocyte counts;
SKCM	cis	rs9611565	0.512	rs2899349	chr22:42164660	T/C	cg03806693	chr22:41940476	POLR3H	1.17	6.7	0.6	2.92e-9	Vitiligo;
SKCM	cis	rs6582630	0.513	rs1596446	chr12:38282160	C/T	cg13010199	chr12:38710504	ALG10B	-0.66	-4.8	-0.48	7.64e-6	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs1635	0.655	rs73742536	chr6:28303243	G/A	cg15743358	chr6:28303923	ZNF323	-1.27	-5.15	-0.5	1.92e-6	Schizophrenia;
SKCM	cis	rs6580649	0.771	rs1635535	chr12:48386241	A/G	cg05342945	chr12:48394962	COL2A1	-0.7	-4.92	-0.49	4.65e-6	Lung cancer;
SKCM	cis	rs2032447	0.831	rs9467664	chr6:26021813	A/T	cg03517284	chr6:25882590	NA	-0.57	-4.78	-0.48	8e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs8177253	0.761	rs1830083	chr3:133508551	G/A	cg01448562	chr3:133502909	NA	-0.56	-4.83	-0.48	6.66e-6	Iron status biomarkers;
SKCM	cis	rs6866344	0.561	rs55974982	chr5:178141421	G/A	cg10224037	chr5:178157518	ZNF354A	0.83	6.14	0.57	3.17e-8	Neutrophil percentage of white cells;
SKCM	cis	rs2832191	1.000	rs6516891	chr21:30483070	C/T	cg24692254	chr21:30365293	RNF160	-0.79	-7.24	-0.63	2.72e-10	Dental caries;
SKCM	cis	rs861020	0.630	rs599649	chr1:210003402	T/C	cg05527609	chr1:210001259	C1orf107	0.89	6.8	0.61	1.86e-9	Orofacial clefts;
SKCM	cis	rs1799949	1.000	rs11653069	chr17:41283377	C/T	cg05368731	chr17:41323189	NBR1	0.89	7.91	0.67	1.38e-11	Menopause (age at onset);
SKCM	cis	rs9467773	0.620	rs2451741	chr6:26629404	A/G	cg09904177	chr6:26538194	HMGN4	0.58	5.01	0.49	3.28e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs17376456	0.825	rs66564678	chr5:93165894	C/T	cg21475434	chr5:93447410	FAM172A	0.94	5.55	0.53	3.86e-7	Diabetic retinopathy;
SKCM	cis	rs709400	0.930	rs10134399	chr14:104083457	G/A	cg26031613	chr14:104095156	KLC1	1.1	13.09	0.83	2.22e-21	Body mass index;
SKCM	cis	rs2153535	0.580	rs9406167	chr6:8502852	T/C	cg07606381	chr6:8435919	SLC35B3	0.86	6.25	0.58	2.06e-8	Motion sickness;
SKCM	cis	rs12711979	0.509	rs13021385	chr2:3826387	T/C	cg17052675	chr2:3827356	NA	-0.87	-9.65	-0.74	5.94e-15	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs4481887	0.790	rs7546964	chr1:248414960	A/G	cg00666640	chr1:248458726	OR2T12	0.66	5.41	0.52	6.65e-7	Common traits (Other);
SKCM	cis	rs5758511	0.689	rs17478227	chr22:42654327	C/G	cg26793846	chr22:42538988	CYP2D7P1	0.73	4.94	0.49	4.3e-6	Birth weight;
SKCM	cis	rs34779708	0.966	rs35079558	chr10:35479886	A/G	cg03585969	chr10:35415529	CREM	0.78	6.52	0.59	6.47e-9	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs17345786	1.000	rs3804778	chr3:101294572	C/T	cg12386194	chr3:101231763	SENP7	0.81	6.16	0.57	2.96e-8	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs9399135	1.000	rs6569988	chr6:135352303	C/A	cg24558204	chr6:135376177	HBS1L	0.58	5.29	0.51	1.09e-6	Red blood cell count;
SKCM	cis	rs801193	0.935	rs2659899	chr7:66186721	A/G	cg18876405	chr7:65276391	NA	0.8	7.11	0.63	4.88e-10	Aortic root size;
SKCM	trans	rs3780486	0.846	rs7849148	chr9:33138352	A/T	cg20290983	chr6:43655470	MRPS18A	1.0	11.51	0.79	1.75e-18	IgG glycosylation;
SKCM	cis	rs9796	0.649	rs8035828	chr15:41467287	T/A	cg18705301	chr15:41695430	NDUFAF1	-0.7	-5.18	-0.51	1.67e-6	Menopause (age at onset);
SKCM	cis	rs2303759	0.709	rs10411679	chr19:49826480	A/T	cg05022225	chr19:49866942	DKKL1;TEAD2	0.7	5.05	0.5	2.78e-6	Multiple sclerosis;
SKCM	cis	rs4619890	0.528	rs28417050	chr4:7883077	T/C	cg08722675	chr4:8412549	ACOX3	0.53	4.99	0.49	3.59e-6	Glaucoma (primary open-angle);
SKCM	cis	rs4523957	0.855	rs12603057	chr17:2112567	T/C	cg16513277	chr17:2031491	SMG6	-0.72	-5.04	-0.5	2.95e-6	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs910316	1.000	rs12435391	chr14:75601737	A/G	cg08847533	chr14:75593920	NEK9	0.95	9.18	0.72	4.8e-14	Height;
SKCM	cis	rs344364	0.511	rs1742469	chr16:1950244	C/T	cg26897989	chr16:1907736	C16orf73	-0.69	-7.13	-0.63	4.45e-10	Glomerular filtration rate in chronic kidney disease;
SKCM	cis	rs28386778	0.897	rs2665844	chr17:61874455	A/G	cg22520471	chr17:61851767	DDX42;CCDC47	0.78	5.31	0.52	1.02e-6	Prudent dietary pattern;
SKCM	cis	rs2180341	0.640	rs11154395	chr6:127629138	T/C	cg24812749	chr6:127587940	RNF146	0.65	5.29	0.51	1.07e-6	Breast cancer;
SKCM	cis	rs3768617	0.510	rs10797842	chr1:183081867	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.78	7.57	0.65	6.26e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs2811415	0.597	rs9844891	chr3:127743260	C/T	cg09089421	chr3:127803668	RUVBL1	0.99	8.52	0.69	9.09e-13	Lung function (FEV1/FVC);
SKCM	cis	rs7772486	0.875	rs7739371	chr6:146424353	C/G	cg05347473	chr6:146136440	FBXO30	0.65	5.96	0.56	6.79e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9818758	0.607	rs10049462	chr3:49309684	C/T	cg00383909	chr3:49044727	WDR6	0.95	4.95	0.49	4.17e-6	High light scatter reticulocyte percentage of red cells;Reticulocyte fraction of red cells;Reticulocyte count;Glycated hemoglobin levels;
SKCM	cis	rs6540556	0.954	rs2076150	chr1:209933540	A/G	cg05527609	chr1:210001259	C1orf107	-0.86	-4.8	-0.48	7.39e-6	Red blood cell count;
SKCM	cis	rs9475752	0.793	rs6901944	chr6:56862805	A/G	cg06815302	chr6:57335405	PRIM2	0.59	4.78	0.48	8.1e-6	Menarche (age at onset);
SKCM	cis	rs7618501	0.573	rs2624824	chr3:50088266	T/C	cg05072774	chr3:49840536	C3orf54	0.72	5.51	0.53	4.54e-7	Intelligence (multi-trait analysis);
SKCM	trans	rs1814175	0.791	rs1722023	chr11:49908136	G/C	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs7772486	0.686	rs1337841	chr6:146059487	A/G	cg23711669	chr6:146136114	FBXO30	-0.81	-8.24	-0.68	3.28e-12	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs2739330	0.731	rs2000468	chr22:24241611	G/T	cg04234412	chr22:24373322	LOC391322	-0.69	-5.97	-0.56	6.55e-8	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs2180341	0.656	rs6569491	chr6:127769338	C/G	cg27446573	chr6:127587934	RNF146	0.83	6.48	0.59	7.6e-9	Breast cancer;
SKCM	cis	rs6087990	0.669	rs2424929	chr20:31389518	A/G	cg13636640	chr20:31349939	DNMT3B	0.83	6.25	0.58	2.06e-8	Ulcerative colitis;
SKCM	cis	rs11209185	0.522	rs9436358	chr1:68452984	T/A	cg17031739	chr1:67600172	NA	-0.48	-4.93	-0.49	4.56e-6	Itch intensity from mosquito bite adjusted by bite size;
SKCM	cis	rs861020	0.710	rs7516902	chr1:210022179	A/G	cg05527609	chr1:210001259	C1orf107	1.04	8.04	0.67	7.79e-12	Orofacial clefts;
SKCM	cis	rs7772486	0.686	rs702314	chr6:146003510	G/A	cg23711669	chr6:146136114	FBXO30	-0.88	-9.14	-0.72	5.67e-14	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1577917	0.771	rs4351223	chr6:86237797	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.78	7.21	0.63	3.17e-10	Response to antipsychotic treatment;
SKCM	cis	rs992157	0.798	rs4996257	chr2:219162836	C/T	cg20019365	chr2:219134978	PNKD;AAMP	0.69	5.94	0.56	7.43e-8	Colorectal cancer;
SKCM	cis	rs34779708	0.966	rs12775548	chr10:35479504	G/T	cg03585969	chr10:35415529	CREM	0.78	6.52	0.59	6.47e-9	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs10932679	0.901	rs72958213	chr2:217646523	C/T	cg19035526	chr2:217107125	NA	0.88	4.97	0.49	3.87e-6	Pulse pressure;
SKCM	cis	rs2204008	0.775	rs8186812	chr12:38305055	C/T	cg26384229	chr12:38710491	ALG10B	0.81	6.57	0.6	5.18e-9	Bladder cancer;
SKCM	cis	rs523522	0.962	rs4767904	chr12:120930798	T/G	cg12219531	chr12:120966889	COQ5	0.91	7.82	0.66	2.11e-11	High light scatter reticulocyte count;
SKCM	cis	rs35306767	0.855	rs2050944	chr10:918910	T/C	cg20503657	chr10:835505	NA	0.76	5.25	0.51	1.26e-6	Eosinophil percentage of granulocytes;
SKCM	cis	rs116095464	0.558	rs7730700	chr5:264713	G/A	cg22857025	chr5:266934	NA	-1.37	-8.26	-0.68	2.95e-12	Breast cancer;
SKCM	cis	rs1298908	0.639	rs2994388	chr10:82034262	A/G	cg01528321	chr10:82214614	TSPAN14	-0.64	-5.69	-0.54	2.16e-7	Diabetic kidney disease;
SKCM	cis	rs1799949	0.930	rs34210004	chr17:41370337	A/T	cg05368731	chr17:41323189	NBR1	0.84	6.95	0.62	9.99e-10	Menopause (age at onset);
SKCM	cis	rs6977660	0.714	rs6970798	chr7:19816741	G/C	cg05791153	chr7:19748676	TWISTNB	0.77	5.02	0.49	3.23e-6	Thyroid stimulating hormone;
SKCM	cis	rs1395	1.000	rs1659685	chr2:27420690	C/T	cg14242246	chr2:27434262	C2orf28;SLC5A6	-0.47	-4.77	-0.48	8.27e-6	Blood metabolite levels;
SKCM	cis	rs8072100	0.817	rs9892497	chr17:45545919	G/A	cg25173405	chr17:45401733	C17orf57	-0.58	-4.77	-0.48	8.26e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs61776719	0.817	rs2170169	chr1:38408164	G/A	cg17077180	chr1:38461687	NA	0.49	4.86	0.48	5.96e-6	Coronary artery disease;
SKCM	cis	rs72615157	0.645	rs76281814	chr7:99846414	T/C	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.05	5.98	0.56	6.25e-8	Lung function (FEV1/FVC);
SKCM	cis	rs11098499	0.754	rs12510269	chr4:120241646	A/G	cg09307838	chr4:120376055	NA	0.93	7.56	0.65	6.5500000000000006e-11	Corneal astigmatism;
SKCM	cis	rs9926296	0.605	rs3743859	chr16:89846050	A/G	cg04287289	chr16:89883240	FANCA	-1.02	-12.2	-0.81	9.09e-20	Vitiligo;
SKCM	cis	rs17376456	0.877	rs34673483	chr5:93315079	C/A	cg21475434	chr5:93447410	FAM172A	1.04	5.55	0.53	3.82e-7	Diabetic retinopathy;
SKCM	cis	rs651907	0.557	rs3094297	chr3:101399260	A/G	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.81	7.06	0.62	6.11e-10	Colorectal cancer;
SKCM	cis	rs933688	1.000	rs6452951	chr5:90653868	T/G	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.96	6.63	0.6	3.9e-9	Smoking behavior;
SKCM	cis	rs4141404	0.740	rs9609301	chr22:31895940	C/T	cg02404636	chr22:31891804	SFI1	0.68	6.07	0.57	4.32e-8	Paclitaxel-induced neuropathy;
SKCM	cis	rs4819052	0.851	rs2838850	chr21:46671445	G/C	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.42	0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs208520	0.690	rs4618506	chr6:66756889	A/C	cg07460842	chr6:66804631	NA	-0.85	-6.63	-0.6	4.02e-9	Exhaled nitric oxide output;
SKCM	cis	rs1348850	0.567	rs1527401	chr2:178522104	C/T	cg02961200	chr2:178257176	LOC100130691;AGPS	0.67	4.83	0.48	6.67e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs6951245	0.554	rs4724294	chr7:1139695	G/A	cg03188948	chr7:1209495	NA	0.83	5.87	0.55	1.01e-7	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs1218582	0.510	rs2878411	chr1:154823545	C/T	cg06221963	chr1:154839813	KCNN3	-0.5	-4.94	-0.49	4.34e-6	Prostate cancer;
SKCM	cis	rs7772486	0.875	rs7766463	chr6:146364453	A/G	cg23711669	chr6:146136114	FBXO30	0.78	7.39	0.64	1.39e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9834970	0.787	rs4789	chr3:36869439	T/C	cg25202636	chr3:37035158	MLH1;EPM2AIP1	0.66	5.01	0.49	3.31e-6	Bipolar disorder with mood-incongruent psychosis;Subjective response to lithium treatment;Bipolar disorder;Schizophrenia or bipolar disorder;Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined);
SKCM	trans	rs62103177	0.810	rs62103191	chr18:77628769	C/G	cg05926928	chr17:57297772	GDPD1	1.29	8.74	0.7	3.44e-13	Opioid sensitivity;
SKCM	cis	rs854765	0.647	rs854763	chr17:18010095	C/G	cg04398451	chr17:18023971	MYO15A	-0.99	-8.76	-0.7	3.19e-13	Total body bone mineral density;
SKCM	cis	rs11098499	0.645	rs72676059	chr4:120290828	C/G	cg09307838	chr4:120376055	NA	0.98	7.89	0.67	1.52e-11	Corneal astigmatism;
SKCM	cis	rs2153535	0.580	rs1932276	chr6:8442593	G/A	cg07606381	chr6:8435919	SLC35B3	0.94	6.94	0.62	1.02e-9	Motion sickness;
SKCM	cis	rs1218582	0.741	rs6656494	chr1:154839799	A/G	cg06221963	chr1:154839813	KCNN3	-0.59	-5.99	-0.56	6.03e-8	Prostate cancer;
SKCM	cis	rs4790333	0.531	rs2447107	chr17:2257864	A/G	cg02569219	chr17:2266849	SGSM2	0.66	5.59	0.53	3.2e-7	Proinsulin levels;
SKCM	cis	rs372883	0.530	rs2832302	chr21:30749793	G/T	cg24692254	chr21:30365293	RNF160	-0.67	-5.23	-0.51	1.38e-6	Pancreatic cancer;
SKCM	cis	rs9420	0.961	rs11606396	chr11:57435211	C/T	cg19752551	chr11:57585705	CTNND1	-0.71	-6.97	-0.62	8.96e-10	Schizophrenia;
SKCM	cis	rs1799949	0.965	rs11080034	chr17:41443014	T/C	cg23758822	chr17:41437982	NA	0.94	7.72	0.66	3.31e-11	Menopause (age at onset);
SKCM	cis	rs1568889	0.838	rs7943538	chr11:28288955	A/G	cg06544937	chr11:28130018	METT5D1;KIF18A	0.88	7.55	0.65	7.06e-11	Bipolar disorder;
SKCM	cis	rs2180341	0.597	rs11154397	chr6:127646649	G/C	cg27446573	chr6:127587934	RNF146	0.69	5.46	0.53	5.54e-7	Breast cancer;
SKCM	cis	rs854765	0.583	rs4553680	chr17:17857722	A/G	cg04398451	chr17:18023971	MYO15A	-0.79	-5.68	-0.54	2.25e-7	Total body bone mineral density;
SKCM	cis	rs66573146	1.000	rs66519732	chr4:6990569	C/G	cg00086871	chr4:6988644	TBC1D14	1.43	5.33	0.52	9.25e-7	Granulocyte percentage of myeloid white cells;
SKCM	cis	rs9290877	1.000	rs6789732	chr3:188414326	T/C	cg17392043	chr3:188495102	LPP	-0.64	-4.78	-0.48	8.21e-6	IgE levels;
SKCM	cis	rs796364	0.906	rs6740981	chr2:201060216	T/C	cg12253985	chr2:200820533	C2orf60;C2orf47	0.94	6.15	0.57	3.08e-8	Schizophrenia;
SKCM	cis	rs2204008	0.782	rs11514339	chr12:38236670	G/A	cg13010199	chr12:38710504	ALG10B	0.69	4.99	0.49	3.57e-6	Bladder cancer;
SKCM	cis	rs2204008	0.682	rs2320517	chr12:38259239	A/T	cg13010199	chr12:38710504	ALG10B	0.69	4.92	0.49	4.72e-6	Bladder cancer;
SKCM	cis	rs2644899	0.859	rs2644898	chr19:41299015	G/A	cg24958765	chr19:41283667	RAB4B	-0.85	-5.39	-0.52	7.21e-7	Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs17685	0.753	rs10085567	chr7:75734206	A/C	cg16489192	chr7:75678113	MDH2;STYXL1	-0.61	-5.55	-0.53	3.73e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1160297	0.576	rs13002328	chr2:53085447	A/C	cg07782112	chr2:53107842	NA	0.59	6.12	0.57	3.53e-8	Hemostatic factors and hematological phenotypes;
SKCM	cis	rs28595532	0.841	rs115852209	chr4:119753465	A/G	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs6840360	0.593	rs4696106	chr4:152606818	A/G	cg22705602	chr4:152727874	NA	-0.58	-7.82	-0.66	2.1e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs8072100	0.713	rs9899859	chr17:45513049	A/G	cg08085267	chr17:45401833	C17orf57	-0.62	-5.06	-0.5	2.76e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs801193	0.967	rs1110414	chr7:66205582	A/G	cg18876405	chr7:65276391	NA	0.8	7.11	0.63	4.88e-10	Aortic root size;
SKCM	cis	rs637571	0.522	rs556643	chr11:65733289	C/T	cg26695010	chr11:65641043	EFEMP2	-0.64	-5.24	-0.51	1.33e-6	Eosinophil percentage of white cells;
SKCM	cis	rs780096	0.526	rs3845687	chr2:27689899	T/C	cg05696406	chr2:27599888	SNX17	0.52	5.24	0.51	1.34e-6	Total body bone mineral density;
SKCM	cis	rs763014	0.898	rs4984892	chr16:622325	A/G	cg00908189	chr16:619842	PIGQ	0.81	7.2	0.63	3.3e-10	Height;
SKCM	cis	rs7659604	0.605	rs67772833	chr4:122723106	G/A	cg06713675	chr4:122721982	EXOSC9	-0.71	-7.43	-0.64	1.19e-10	Type 2 diabetes;
SKCM	cis	rs3845702	0.736	rs72960701	chr2:180851202	A/T	cg01881094	chr2:180872142	CWC22	1.3	6.21	0.58	2.36e-8	Schizophrenia;
SKCM	cis	rs2153535	0.580	rs1335636	chr6:8465047	T/C	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs10752881	1.000	rs6701400	chr1:182977197	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.74	6.71	0.6	2.83e-9	Colorectal cancer;
SKCM	cis	rs7216064	0.954	rs9907491	chr17:65949993	G/A	cg12091567	chr17:66097778	LOC651250	0.8	5.5	0.53	4.69e-7	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs1419980	0.673	rs1978284	chr12:7771151	G/A	cg10578777	chr12:7781093	NA	0.68	4.96	0.49	4.02e-6	HDL cholesterol levels;
SKCM	cis	rs55962025	0.686	rs2237007	chr4:3235450	T/C	cg09735869	chr4:3319127	RGS12	-0.65	-5.33	-0.52	9.21e-7	Parental longevity (mother's age at death);
SKCM	cis	rs2832191	0.716	rs1543652	chr21:30448000	G/C	cg08807101	chr21:30365312	RNF160	0.74	6.09	0.57	4.06e-8	Dental caries;
SKCM	cis	rs17376456	1.000	rs13163610	chr5:93548877	A/C	cg21475434	chr5:93447410	FAM172A	0.98	5.61	0.54	3e-7	Diabetic retinopathy;
SKCM	cis	rs2032447	0.839	rs199750	chr6:26016462	A/G	cg18357526	chr6:26021779	HIST1H4A	-0.82	-6.19	-0.57	2.57e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs7179456	0.515	rs602602	chr15:59057023	T/A	cg05156742	chr15:59063176	FAM63B	0.72	5.22	0.51	1.44e-6	Asperger disorder;
SKCM	cis	rs11098499	0.604	rs2389886	chr4:120570422	C/T	cg09307838	chr4:120376055	NA	1.0	8.15	0.68	4.89e-12	Corneal astigmatism;
SKCM	cis	rs637571	0.522	rs7105628	chr11:65763067	C/T	cg26695010	chr11:65641043	EFEMP2	-0.69	-5.21	-0.51	1.5e-6	Eosinophil percentage of white cells;
SKCM	cis	rs1218582	0.741	rs7544528	chr1:154844585	C/T	cg06221963	chr1:154839813	KCNN3	-0.61	-6.6	-0.6	4.5e-9	Prostate cancer;
SKCM	cis	rs1616122	0.755	rs6692613	chr1:7524974	C/T	cg06320134	chr1:6663664	KLHL21	-0.64	-4.84	-0.48	6.41e-6	Periodontal microbiota;
SKCM	cis	rs798554	0.721	rs2527680	chr7:2892361	C/T	cg04166393	chr7:2884313	GNA12	0.74	4.99	0.49	3.65e-6	Height;
SKCM	cis	rs672059	1.000	rs1760621	chr1:183156006	T/G	ch.1.3577855R	chr1:183094577	LAMC1	0.59	4.86	0.48	5.85e-6	Hypertriglyceridemia;
SKCM	cis	rs6088580	0.608	rs8114616	chr20:32969092	G/T	cg24642439	chr20:33292090	TP53INP2	-0.72	-5.59	-0.53	3.21e-7	Glomerular filtration rate (creatinine);
SKCM	cis	rs1882538	0.503	rs13240997	chr7:133135373	C/A	cg10665199	chr7:133106180	EXOC4	0.78	5.16	0.5	1.81e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9300255	0.602	rs1727313	chr12:123640853	C/G	cg00376283	chr12:123451042	ABCB9	0.82	5.67	0.54	2.32e-7	Neutrophil percentage of white cells;
SKCM	cis	rs597539	0.652	rs602805	chr11:68662076	A/T	cg11716795	chr11:68671300	MRPL21;IGHMBP2	0.82	5.44	0.52	5.87e-7	Coronary artery calcified atherosclerotic plaque score in type 2 diabetes;
SKCM	cis	rs2811415	0.597	rs9833838	chr3:127741134	C/G	cg09089421	chr3:127803668	RUVBL1	0.99	8.52	0.69	9.09e-13	Lung function (FEV1/FVC);
SKCM	cis	rs2832191	0.791	rs8134407	chr21:30476586	G/A	cg24692254	chr21:30365293	RNF160	0.9	8.01	0.67	8.9e-12	Dental caries;
SKCM	cis	rs7208859	0.623	rs1054400	chr17:29109954	A/G	cg14067834	chr17:29058358	SUZ12P	1.04	5.26	0.51	1.23e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs4746818	0.818	rs10823302	chr10:70895418	G/T	cg11621586	chr10:70884670	VPS26A	1.0	7.68	0.66	3.84e-11	Left atrial antero-posterior diameter;
SKCM	cis	rs1032355	0.558	rs745074	chr4:100532802	T/A	cg25391692	chr4:100495869	MTTP	-0.82	-4.97	-0.49	3.9e-6	Celiac disease;
SKCM	cis	rs738322	0.555	rs5756932	chr22:38546118	C/T	cg25457927	chr22:38595422	NA	-0.56	-6.68	-0.6	3.18e-9	Cutaneous nevi;
SKCM	cis	rs9399135	0.844	rs13209789	chr6:135367916	A/G	cg24558204	chr6:135376177	HBS1L	0.57	5.01	0.49	3.34e-6	Red blood cell count;
SKCM	cis	rs10860964	0.528	rs939330	chr12:103604967	G/A	cg20635409	chr12:103359273	NA	-0.52	-4.77	-0.48	8.34e-6	Schizophrenia;
SKCM	cis	rs7811142	1.000	rs11771241	chr7:99994785	G/A	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.23	8.03	0.67	8.33e-12	Platelet count;
SKCM	cis	rs7552404	0.924	rs7535991	chr1:76162624	C/T	cg10523679	chr1:76189770	ACADM	0.7	5.05	0.5	2.83e-6	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs72781680	0.800	rs6718635	chr2:24066183	A/C	cg08917208	chr2:24149416	ATAD2B	1.02	4.97	0.49	3.94e-6	Lymphocyte counts;
SKCM	cis	rs2153535	0.580	rs2184584	chr6:8468407	T/C	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	cis	rs1801251	0.835	rs1446310	chr2:233683245	G/C	cg25237894	chr2:233734115	C2orf82	-0.54	-5.0	-0.49	3.42e-6	Coronary artery disease;
SKCM	cis	rs951366	0.589	rs823099	chr1:205669322	C/A	cg26354017	chr1:205819088	PM20D1	0.85	7.09	0.63	5.38e-10	Menarche (age at onset);
SKCM	cis	rs11690935	0.921	rs908670	chr2:172690180	T/C	cg13550731	chr2:172543902	DYNC1I2	-0.9	-7.44	-0.64	1.11e-10	Schizophrenia;
SKCM	cis	rs4253772	0.637	rs6008339	chr22:46650846	C/T	cg03482458	chr22:46692211	CN5H6.4;GTSE1	1.11	4.96	0.49	4.03e-6	LDL cholesterol;Cholesterol, total;
SKCM	cis	rs7824557	0.564	rs2572386	chr8:11236975	A/G	cg21775007	chr8:11205619	TDH	-0.59	-5.03	-0.5	3.01e-6	Retinal vascular caliber;
SKCM	cis	rs2836633	0.929	rs8130434	chr21:40036243	C/T	cg05519781	chr21:40033154	ERG	-0.78	-6.88	-0.61	1.33e-9	Coronary artery disease;
SKCM	cis	rs8072100	0.967	rs12452315	chr17:45479446	G/T	cg25173405	chr17:45401733	C17orf57	0.6	5.39	0.52	7.38e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs11690935	0.632	rs62184165	chr2:172558328	A/G	cg13550731	chr2:172543902	DYNC1I2	0.63	5.5	0.53	4.74e-7	Schizophrenia;
SKCM	cis	rs6570726	0.791	rs1509214	chr6:145784606	A/C	cg23711669	chr6:146136114	FBXO30	-0.86	-7.3	-0.64	2.08e-10	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs8078723	0.866	rs3935280	chr17:38189055	A/G	cg17467752	chr17:38218738	THRA	-0.77	-7.12	-0.63	4.69e-10	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs4689592	0.503	rs10516184	chr4:7060959	C/T	cg19539972	chr4:7069911	GRPEL1	0.93	6.27	0.58	1.88e-8	Monocyte percentage of white cells;
SKCM	cis	rs9290877	0.675	rs17670540	chr3:188406217	G/A	cg17392043	chr3:188495102	LPP	-0.74	-5.16	-0.5	1.85e-6	IgE levels;
SKCM	cis	rs668210	0.793	rs586921	chr11:65747701	G/A	cg20909159	chr11:65625947	CFL1	0.78	4.97	0.49	3.86e-6	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs6580649	0.941	rs4760677	chr12:48449163	C/T	cg05342945	chr12:48394962	COL2A1	0.73	5.2	0.51	1.53e-6	Lung cancer;
SKCM	cis	rs2404602	0.583	rs12913096	chr15:76551852	C/T	cg22467129	chr15:76604101	ETFA	-0.65	-5.35	-0.52	8.68e-7	Blood metabolite levels;
SKCM	cis	rs11249608	0.789	rs7706393	chr5:178437737	G/T	cg21905437	chr5:178450457	ZNF879	-0.71	-5.57	-0.53	3.44e-7	Pubertal anthropometrics;
SKCM	cis	rs10883723	0.810	rs7092622	chr10:104249919	T/G	cg11453585	chr10:104263688	ACTR1A;SUFU	0.74	5.6	0.54	3.13e-7	Allergic disease (asthma, hay fever or eczema);
SKCM	cis	rs1577917	0.740	rs6926049	chr6:86266133	G/T	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	0.78	7.21	0.63	3.17e-10	Response to antipsychotic treatment;
SKCM	cis	rs7772486	0.720	rs4896837	chr6:146014168	C/T	cg23711669	chr6:146136114	FBXO30	-0.93	-10.19	-0.76	5.55e-16	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9911578	1.000	rs8071916	chr17:56660279	A/G	cg05425664	chr17:57184151	TRIM37	-0.68	-5.18	-0.51	1.66e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs854765	0.583	rs12603148	chr17:17865257	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.01	7.49	0.65	9.28e-11	Total body bone mineral density;
SKCM	cis	rs6952808	0.862	rs4721167	chr7:1933224	C/T	cg02951883	chr7:2050386	MAD1L1	-0.71	-5.69	-0.54	2.1e-7	Bipolar disorder and schizophrenia;
SKCM	cis	rs875971	0.862	rs6460282	chr7:65691246	T/C	cg18876405	chr7:65276391	NA	-0.64	-6.56	-0.6	5.28e-9	Aortic root size;
SKCM	cis	rs10089	0.953	rs10045113	chr5:127386631	C/T	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.92	8.29	0.68	2.54e-12	Ileal carcinoids;
SKCM	cis	rs7659604	0.539	rs3217773	chr4:122739121	A/G	cg06713675	chr4:122721982	EXOSC9	-0.75	-7.26	-0.64	2.47e-10	Type 2 diabetes;
SKCM	cis	rs28595532	0.920	rs116405053	chr4:119739352	C/T	cg21605333	chr4:119757512	SEC24D	1.39	8.39	0.69	1.65e-12	Cannabis dependence symptom count;
SKCM	cis	rs1005277	0.522	rs289650	chr10:37975505	G/T	cg25427524	chr10:38739819	LOC399744	-0.65	-6.51	-0.59	6.51e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs1577917	0.958	rs4707223	chr6:86509802	A/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.63	-5.43	-0.52	6.16e-7	Response to antipsychotic treatment;
SKCM	cis	rs7511006	1.000	rs17836662	chr22:50672154	A/G	cg16473166	chr22:50639996	SELO	-0.64	-5.12	-0.5	2.13e-6	Obesity-related traits;
SKCM	cis	rs1577917	0.958	rs6454488	chr6:86450842	T/C	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.78	-7.41	-0.64	1.3100000000000001e-10	Response to antipsychotic treatment;
SKCM	cis	rs7772486	0.754	rs2328707	chr6:146053498	G/A	cg23711669	chr6:146136114	FBXO30	-0.88	-8.81	-0.71	2.53e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1419980	1.000	rs1419980	chr12:7774892	A/G	cg10578777	chr12:7781093	NA	-0.87	-5.23	-0.51	1.39e-6	HDL cholesterol levels;
SKCM	cis	rs6546550	0.901	rs7419837	chr2:70146625	T/C	cg02498382	chr2:70120550	SNRNP27	-0.45	-4.88	-0.48	5.4e-6	Prevalent atrial fibrillation;
SKCM	cis	rs10779751	0.734	rs2791653	chr1:11129848	A/G	cg08854313	chr1:11322531	MTOR	0.76	4.88	0.48	5.6e-6	Body mass index;
SKCM	cis	rs28386778	0.897	rs2036911	chr17:61794839	A/T	cg22520471	chr17:61851767	DDX42;CCDC47	0.8	5.36	0.52	8.08e-7	Prudent dietary pattern;
SKCM	cis	rs651907	0.535	rs11711903	chr3:101500748	C/G	cg03837452	chr3:101395095	ZBTB11;LOC100009676	0.78	6.86	0.61	1.47e-9	Colorectal cancer;
SKCM	cis	rs72781680	0.752	rs55806536	chr2:23912697	A/G	cg08917208	chr2:24149416	ATAD2B	0.99	5.03	0.5	3.02e-6	Lymphocyte counts;
SKCM	cis	rs7927771	0.800	rs55876153	chr11:47416636	G/A	cg01152729	chr11:47593274	PTPMT1	-0.51	-4.92	-0.49	4.64e-6	Subjective well-being;
SKCM	cis	rs873946	0.564	rs12242672	chr10:134555609	A/T	cg18305652	chr10:134549665	INPP5A	0.59	6.1	0.57	3.83e-8	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs7826238	0.535	rs2979179	chr8:8320029	C/T	cg15556689	chr8:8085844	FLJ10661	0.73	6.29	0.58	1.67e-8	Systolic blood pressure;
SKCM	cis	rs1046896	0.538	rs3803771	chr17:80687758	G/A	cg16060761	chr17:80687452	NA	0.73	6.2	0.57	2.55e-8	Glycated hemoglobin levels;
SKCM	cis	rs1218582	0.774	rs4845679	chr1:154861187	G/T	cg16680214	chr1:154839983	KCNN3	-0.55	-5.04	-0.5	2.93e-6	Prostate cancer;
SKCM	cis	rs7811142	0.830	rs6979910	chr7:99940630	A/C	cg00814883	chr7:100076585	TSC22D4	-0.84	-4.78	-0.48	8.01e-6	Platelet count;
SKCM	cis	rs754466	0.606	rs11002309	chr10:79594931	C/T	cg17075019	chr10:79541650	NA	-0.78	-7.04	-0.62	6.57e-10	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs1023500	0.573	rs6002592	chr22:42476754	A/C	cg04733989	chr22:42467013	NAGA	-0.72	-5.72	-0.54	1.9e-7	Schizophrenia;
SKCM	cis	rs8072100	0.935	rs12943464	chr17:45690351	A/T	cg25173405	chr17:45401733	C17orf57	0.58	5.23	0.51	1.37e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs344364	0.511	rs1742462	chr16:1946062	A/C	cg26897989	chr16:1907736	C16orf73	-0.69	-7.13	-0.63	4.45e-10	Glomerular filtration rate in chronic kidney disease;
SKCM	cis	rs67311347	0.544	rs12054197	chr3:40337562	C/T	cg00656387	chr3:40428638	ENTPD3	0.56	4.98	0.49	3.71e-6	Renal cell carcinoma;
SKCM	cis	rs651907	0.535	rs13094753	chr3:101525082	A/G	cg12386194	chr3:101231763	SENP7	0.68	5.74	0.54	1.73e-7	Colorectal cancer;
SKCM	cis	rs3784262	0.669	rs4646602	chr15:58294757	G/A	cg12031962	chr15:58353849	ALDH1A2	-0.42	-4.89	-0.48	5.38e-6	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs1153858	1.000	rs12101539	chr15:45650666	C/G	cg21132104	chr15:45694354	SPATA5L1	0.93	7.94	0.67	1.22e-11	Homoarginine levels;
SKCM	cis	rs9790314	0.818	rs6797066	chr3:161008725	T/A	cg03342759	chr3:160939853	NMD3	-0.72	-8.12	-0.68	5.59e-12	Morning vs. evening chronotype;
SKCM	cis	rs3784262	0.607	rs4646576	chr15:58338998	A/T	cg12031962	chr15:58353849	ALDH1A2	-0.46	-6.01	-0.56	5.67e-8	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs4889855	0.614	rs9892081	chr17:78484484	A/C	cg16591659	chr17:78472290	NA	0.48	5.02	0.49	3.24e-6	Fractional excretion of uric acid;
SKCM	cis	rs4819052	0.851	rs2838829	chr21:46664040	A/C	cg19498844	chr21:46707878	POFUT2;LOC642852	0.85	7.36	0.64	1.63e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs35146811	0.660	rs3779046	chr7:99779243	A/G	cg22906224	chr7:99728672	NA	0.65	5.19	0.51	1.6e-6	Coronary artery disease;
SKCM	cis	rs7103648	0.897	rs2278890	chr11:47399602	G/A	cg20307385	chr11:47447363	PSMC3	0.96	6.89	0.61	1.29e-9	Diastolic blood pressure;Systolic blood pressure;
SKCM	cis	rs7980687	0.662	rs585522	chr12:123550813	A/G	cg05973401	chr12:123451056	ABCB9	0.76	5.58	0.53	3.3e-7	Height;Educational attainment;Head circumference (infant);
SKCM	cis	rs561341	1.000	rs2344312	chr17:30243583	G/T	cg12193833	chr17:30244370	NA	-0.54	-5.17	-0.51	1.75e-6	Hip circumference adjusted for BMI;
SKCM	cis	rs10905065	0.931	rs11255228	chr10:5837671	T/C	cg11519256	chr10:5708881	ASB13	0.55	4.9	0.49	5.04e-6	Menopause (age at onset);
SKCM	cis	rs7811142	1.000	rs67163493	chr7:100023838	C/T	cg07160278	chr7:100027354	MEPCE;ZCWPW1	1.16	7.68	0.66	3.87e-11	Platelet count;
SKCM	cis	rs8068544	0.818	rs8079958	chr17:40155467	C/T	cg18442075	chr17:40169520	DNAJC7;NKIRAS2	-1.41	-7.89	-0.67	1.52e-11	Reticulocyte fraction of red cells;Reticulocyte count;
SKCM	cis	rs7666738	0.830	rs11723283	chr4:99001617	C/T	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs11640734	0.609	rs11647746	chr16:89806343	C/A	cg04287289	chr16:89883240	FANCA	0.9	4.98	0.49	3.69e-6	Interleukin-17 levels;
SKCM	cis	rs2228479	0.850	rs45524643	chr16:89815824	G/A	cg06558623	chr16:89946397	TCF25	1.02	4.98	0.49	3.66e-6	Skin colour saturation;
SKCM	cis	rs9910055	0.529	rs408282	chr17:42182267	A/G	cg19774624	chr17:42201019	HDAC5	0.83	6.53	0.59	6.08e-9	Total body bone mineral density;
SKCM	cis	rs807669	1.000	rs807670	chr22:19154608	A/C	cg02655711	chr22:19163373	SLC25A1	0.66	6.52	0.59	6.39e-9	Metabolite levels;
SKCM	cis	rs11690935	0.959	rs6722757	chr2:172591963	A/G	cg13550731	chr2:172543902	DYNC1I2	-0.95	-8.1	-0.68	6.14e-12	Schizophrenia;
SKCM	cis	rs7959452	0.590	rs11177643	chr12:69785712	T/G	cg20891283	chr12:69753455	YEATS4	0.93	9.67	0.74	5.4e-15	Blood protein levels;
SKCM	cis	rs7811142	0.887	rs4074838	chr7:100032665	G/A	cg23667466	chr7:100026434	MEPCE;ZCWPW1	1.12	6.51	0.59	6.68e-9	Platelet count;
SKCM	trans	rs1814175	0.817	rs10839397	chr11:49857074	C/T	cg15704280	chr7:45808275	SEPT13	-1.02	-10.78	-0.77	4.12e-17	Height;
SKCM	cis	rs12477438	0.520	rs4588238	chr2:99749350	T/C	cg26064155	chr2:99771622	LIPT1;TSGA10	1.02	9.73	0.74	4.23e-15	Chronic sinus infection;
SKCM	cis	rs7639513	0.767	rs13060705	chr3:12710016	C/A	cg23032965	chr3:12705835	RAF1	0.81	7.08	0.63	5.53e-10	Itch intensity from mosquito bite;
SKCM	cis	rs6665290	0.904	rs6426559	chr1:227195876	T/C	cg10327440	chr1:227177885	CDC42BPA	-1.24	-17.42	-0.89	1.29e-28	Myeloid white cell count;
SKCM	cis	rs7666738	0.830	rs10022389	chr4:99022229	T/C	cg17366294	chr4:99064904	C4orf37	0.59	4.97	0.49	3.86e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4819052	0.851	rs1999333	chr21:46670401	C/G	cg19498844	chr21:46707878	POFUT2;LOC642852	0.86	7.27	0.64	2.43e-10	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs2439831	0.764	rs12324584	chr15:43683446	G/T	cg02155558	chr15:43621948	ADAL;LCMT2	1.22	8.31	0.69	2.36e-12	Lung cancer in ever smokers;
SKCM	cis	rs1707322	0.964	rs7546237	chr1:46285610	A/C	cg03146154	chr1:46216737	IPP	0.75	5.15	0.5	1.94e-6	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs10504229	1.000	rs17217047	chr8:58180296	G/A	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs4930103	0.591	rs11042048	chr11:1986240	C/G	cg23202291	chr11:1979235	NA	0.62	6.2	0.57	2.51e-8	DNA methylation (parent-of-origin);DNA methylation (variation);
SKCM	cis	rs1865760	0.516	rs9393684	chr6:26075531	G/C	cg16482183	chr6:26056742	HIST1H1C	0.61	4.85	0.48	6.08e-6	Height;
SKCM	cis	rs7953508	0.750	rs7310389	chr12:93976636	A/G	cg18151635	chr12:93972918	NA	-0.69	-5.93	-0.56	7.67e-8	Pubertal anthropometrics;
SKCM	cis	rs6500602	0.701	rs4785971	chr16:4577090	A/G	cg08645402	chr16:4508243	NA	0.62	4.95	0.49	4.23e-6	Schizophrenia;
SKCM	cis	rs3845702	0.736	rs16867131	chr2:180848651	A/G	cg01881094	chr2:180872142	CWC22	-1.21	-6.08	-0.57	4.16e-8	Schizophrenia;
SKCM	cis	rs9420	0.754	rs631791	chr11:57675410	A/G	cg19752551	chr11:57585705	CTNND1	0.72	5.48	0.53	5.09e-7	Schizophrenia;
SKCM	cis	rs1348850	0.918	rs4893966	chr2:178470138	A/G	cg02961200	chr2:178257176	LOC100130691;AGPS	0.77	5.95	0.56	7.23e-8	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs754466	0.651	rs10824583	chr10:79619402	C/T	cg17075019	chr10:79541650	NA	0.76	6.48	0.59	7.39e-9	Liver enzyme levels (gamma-glutamyl transferase);
SKCM	cis	rs7786877	0.679	rs10953301	chr7:100264893	A/G	cg16850897	chr7:100343110	ZAN	-0.66	-5.04	-0.5	2.94e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs11112613	0.762	rs66754070	chr12:105949779	G/A	cg03607813	chr12:105948248	NA	0.83	5.77	0.55	1.55e-7	Corrected insulin response;Corrected insulin response adjusted for insulin sensitivity index;
SKCM	cis	rs12044355	0.927	rs66909551	chr1:231834942	C/T	cg23162821	chr1:231664172	TSNAX-DISC1;TSNAX	0.84	6.57	0.6	5.07e-9	Alzheimer's disease;
SKCM	cis	rs2228479	0.702	rs2074963	chr16:89877269	T/C	cg06558623	chr16:89946397	TCF25	1.1	4.95	0.49	4.17e-6	Skin colour saturation;
SKCM	cis	rs782590	0.870	rs2586950	chr2:55868966	T/G	cg18811423	chr2:55921094	PNPT1	0.79	5.49	0.53	4.84e-7	Metabolic syndrome;
SKCM	cis	rs6087990	0.806	rs4911259	chr20:31376282	A/C	cg13636640	chr20:31349939	DNMT3B	0.91	8.03	0.67	8.31e-12	Ulcerative colitis;
SKCM	cis	rs2180341	1.000	rs6903878	chr6:127638600	C/G	cg24812749	chr6:127587940	RNF146	0.85	7.3	0.64	2.08e-10	Breast cancer;
SKCM	cis	rs8072100	0.967	rs4289035	chr17:45707211	C/T	cg08085267	chr17:45401833	C17orf57	-0.61	-5.44	-0.52	5.83e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs11690935	0.959	rs7608403	chr2:172646765	A/C	cg13550731	chr2:172543902	DYNC1I2	-0.92	-7.69	-0.66	3.74e-11	Schizophrenia;
SKCM	cis	rs1552244	0.882	rs17050699	chr3:10037167	G/A	cg02579736	chr3:10068473	FANCD2;CIDECP	0.94	4.84	0.48	6.49e-6	Alzheimer's disease;
SKCM	cis	rs11098499	0.863	rs13140409	chr4:120503460	A/G	cg24375607	chr4:120327624	NA	0.69	5.47	0.53	5.35e-7	Corneal astigmatism;
SKCM	cis	rs2120019	1.000	rs8033837	chr15:75353975	A/C	cg17294928	chr15:75287854	SCAMP5	-0.82	-7.36	-0.64	1.58e-10	Blood trace element (Zn levels);
SKCM	cis	rs62238980	0.614	rs78443579	chr22:32449283	A/G	cg00543991	chr22:32367038	NA	1.16	4.88	0.48	5.51e-6	Childhood ear infection;
SKCM	cis	rs1552244	0.935	rs6805869	chr3:10119917	T/C	cg02579736	chr3:10068473	FANCD2;CIDECP	1.31	7.19	0.63	3.42e-10	Alzheimer's disease;
SKCM	trans	rs8073060	0.586	rs7214742	chr17:33981969	C/A	cg19694781	chr19:47549865	TMEM160	-1.0	-8.56	-0.7	7.62e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs35306767	0.951	rs61833265	chr10:990143	C/T	cg20503657	chr10:835505	NA	0.74	6.1	0.57	3.89e-8	Eosinophil percentage of granulocytes;
SKCM	cis	rs2836974	0.568	rs2183573	chr21:40574305	A/G	cg11644478	chr21:40555479	PSMG1	-0.8	-7.38	-0.64	1.49e-10	Cognitive function;
SKCM	cis	rs7666738	0.830	rs28795113	chr4:98951331	A/G	cg17366294	chr4:99064904	C4orf37	0.58	4.88	0.48	5.56e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs2404602	0.692	rs67570291	chr15:77020502	T/C	cg23625390	chr15:77176239	SCAPER	0.61	5.44	0.52	5.88e-7	Blood metabolite levels;
SKCM	cis	rs9910055	0.607	rs13726	chr17:42239561	C/T	cg09913183	chr17:42254507	C17orf65;ASB16	0.69	6.47	0.59	7.78e-9	Total body bone mineral density;
SKCM	cis	rs12477438	0.520	rs13031919	chr2:99848932	A/T	cg26064155	chr2:99771622	LIPT1;TSGA10	1.01	9.04	0.72	9.15e-14	Chronic sinus infection;
SKCM	cis	rs28386778	0.765	rs2070680	chr17:61986988	A/G	cg11494091	chr17:61959527	GH2	-0.6	-5.01	-0.49	3.29e-6	Prudent dietary pattern;
SKCM	cis	rs1577917	0.958	rs12195776	chr6:86488599	C/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.63	-5.51	-0.53	4.43e-7	Response to antipsychotic treatment;
SKCM	cis	rs2050392	0.687	rs608693	chr10:30734971	G/A	cg25182066	chr10:30743637	MAP3K8	-0.68	-6.15	-0.57	3.12e-8	Inflammatory bowel disease;
SKCM	cis	rs11892454	0.544	rs10178552	chr2:25973309	C/T	cg17263061	chr2:26915892	KCNK3	0.71	5.07	0.5	2.6e-6	Heschl's gyrus morphology;
SKCM	cis	rs1023500	0.573	rs133382	chr22:42471774	C/T	cg04733989	chr22:42467013	NAGA	0.72	5.72	0.54	1.9e-7	Schizophrenia;
SKCM	cis	rs7408868	1.000	rs7247906	chr19:15271135	T/G	cg14696996	chr19:15285081	NOTCH3	0.82	4.92	0.49	4.7e-6	Pulse pressure;
SKCM	cis	rs701145	0.640	rs357497	chr3:153943068	C/A	cg17054900	chr3:154042577	DHX36	1.19	5.1	0.5	2.37e-6	Coronary artery disease;
SKCM	cis	rs453301	0.658	rs9650616	chr8:8869199	T/G	cg15556689	chr8:8085844	FLJ10661	-0.76	-5.93	-0.56	7.98e-8	Joint mobility (Beighton score);
SKCM	cis	rs9325144	0.625	rs12227353	chr12:38734542	C/T	cg26384229	chr12:38710491	ALG10B	-0.75	-6.5	-0.59	6.83e-9	Morning vs. evening chronotype;
SKCM	cis	rs4242434	0.747	rs6986550	chr8:22467870	T/A	cg03733263	chr8:22462867	KIAA1967	1.0	8.29	0.68	2.63e-12	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs208520	0.690	rs12189780	chr6:66759619	G/A	cg07460842	chr6:66804631	NA	0.92	6.93	0.62	1.09e-9	Exhaled nitric oxide output;
SKCM	cis	rs116095464	0.558	rs10043002	chr5:226753	G/A	cg22857025	chr5:266934	NA	-1.36	-8.0	-0.67	9.23e-12	Breast cancer;
SKCM	cis	rs28595532	0.841	rs115987912	chr4:119737085	C/T	cg14228332	chr4:119757509	SEC24D	1.08	5.51	0.53	4.44e-7	Cannabis dependence symptom count;
SKCM	cis	rs6582630	0.502	rs11504451	chr12:38425294	G/A	cg26384229	chr12:38710491	ALG10B	0.81	6.22	0.58	2.33e-8	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs1799949	1.000	rs4793229	chr17:41418334	C/T	cg23758822	chr17:41437982	NA	-0.95	-7.64	-0.65	4.7e-11	Menopause (age at onset);
SKCM	cis	rs1957429	0.901	rs1957427	chr14:65354085	A/G	cg23373153	chr14:65346875	NA	1.05	6.26	0.58	1.94e-8	Pediatric areal bone mineral density (radius);
SKCM	cis	rs35306767	0.668	rs12356612	chr10:1055055	C/T	cg25614935	chr10:1084866	C10orf110	0.69	5.53	0.53	4.08e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs561341	0.941	rs112569713	chr17:30271738	C/T	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs910316	0.967	rs119076	chr14:75572419	G/T	cg11812906	chr14:75593930	NEK9	-0.71	-5.34	-0.52	9.01e-7	Height;
SKCM	cis	rs3008870	0.583	rs11208978	chr1:67442210	C/T	cg08660285	chr1:67390436	MIER1;WDR78	-0.94	-6.07	-0.57	4.4e-8	Lymphocyte percentage of white cells;
SKCM	cis	rs6582630	0.502	rs11182760	chr12:38606273	A/T	cg26384229	chr12:38710491	ALG10B	0.81	6.79	0.61	1.94e-9	Drug-induced liver injury (flucloxacillin);
SKCM	cis	rs763121	0.853	rs11704021	chr22:39074716	G/A	cg06022373	chr22:39101656	GTPBP1	0.8	5.79	0.55	1.42e-7	Menopause (age at onset);
SKCM	cis	rs362272	0.524	rs2749781	chr4:3346617	T/C	cg21096898	chr4:3318625	RGS12	1.01	13.66	0.84	2.19e-22	Serum sulfate level;
SKCM	cis	rs9303401	0.527	rs34835800	chr17:56764990	G/A	cg10487724	chr17:56770010	TEX14;RAD51C	0.83	5.82	0.55	1.22e-7	Cognitive test performance;
SKCM	cis	rs7772486	0.875	rs10457792	chr6:146412415	T/C	cg23711669	chr6:146136114	FBXO30	0.86	8.52	0.69	9.39e-13	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs870825	0.616	rs28607131	chr4:185651617	A/G	cg04058563	chr4:185651563	MLF1IP	1.07	7.16	0.63	3.91e-10	Blood protein levels;
SKCM	cis	rs7829975	0.806	rs2428	chr8:8641145	C/T	cg06636001	chr8:8085503	FLJ10661	0.86	7.81	0.66	2.22e-11	Mood instability;
SKCM	cis	rs12142240	0.698	rs6703669	chr1:46862555	C/T	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs9611565	0.659	rs28530678	chr22:41934961	G/C	cg03806693	chr22:41940476	POLR3H	-1.11	-7.56	-0.65	6.67e-11	Vitiligo;
SKCM	cis	rs8180040	0.966	rs7649234	chr3:47494380	G/C	cg16586182	chr3:47516702	SCAP	-0.76	-5.32	-0.52	9.63e-7	Colorectal cancer;
SKCM	cis	rs7100689	0.646	rs11202751	chr10:82147802	G/A	cg00277334	chr10:82204260	NA	-0.53	-4.96	-0.49	4.02e-6	Post bronchodilator FEV1;
SKCM	cis	rs372883	0.600	rs1236460	chr21:30615513	G/A	cg24692254	chr21:30365293	RNF160	-0.7	-5.42	-0.52	6.49e-7	Pancreatic cancer;
SKCM	cis	rs12497850	0.543	rs6446218	chr3:49075513	A/T	cg07636037	chr3:49044803	WDR6	1.06	11.76	0.8	6.03e-19	Parkinson's disease;
SKCM	cis	rs2404602	0.967	rs12148805	chr15:76800659	G/A	cg23625390	chr15:77176239	SCAPER	0.75	7.27	0.64	2.44e-10	Blood metabolite levels;
SKCM	cis	rs2204008	0.744	rs11182316	chr12:38499552	G/A	cg26384229	chr12:38710491	ALG10B	0.85	6.8	0.61	1.86e-9	Bladder cancer;
SKCM	cis	rs7772486	0.790	rs7742333	chr6:146159029	A/G	cg05347473	chr6:146136440	FBXO30	-0.61	-5.75	-0.55	1.63e-7	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs1403694	0.734	rs266723	chr3:186447047	A/C	cg09332604	chr3:186435400	KNG1	-0.52	-5.27	-0.51	1.2e-6	Blood protein levels;
SKCM	cis	rs2841277	0.836	rs2841268	chr14:105386039	T/C	cg19901468	chr14:105411992	AHNAK2	1.06	10.11	0.75	7.63e-16	Rheumatoid arthritis;
SKCM	cis	rs10211296	1.000	rs10211296	chr2:166490343	A/G	ch.2.3376566R	chr2:166772260	TTC21B	0.63	4.77	0.48	8.34e-6	Risky sexual behaviors in alcohol dependence;
SKCM	cis	rs4332037	0.539	rs55790766	chr7:2021248	C/T	cg02825527	chr7:2087843	MAD1L1	-0.75	-5.12	-0.5	2.13e-6	Bipolar disorder;
SKCM	cis	rs17376456	0.825	rs10061377	chr5:93174513	T/C	cg25358565	chr5:93447407	FAM172A	1.14	7.1	0.63	5.19e-10	Diabetic retinopathy;
SKCM	cis	rs1032355	0.558	rs17533517	chr4:100521637	C/T	cg25391692	chr4:100495869	MTTP	-0.82	-4.97	-0.49	3.9e-6	Celiac disease;
SKCM	cis	rs10504229	0.953	rs57669205	chr8:58172253	T/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs9640161	0.789	rs2373751	chr7:150021599	G/C	cg10018233	chr7:150070692	REPIN1	0.68	5.27	0.51	1.18e-6	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs10823500	0.748	rs12355080	chr10:71963608	G/A	cg04118878	chr10:71993077	PPA1	0.66	4.96	0.49	3.98e-6	Blood protein levels;
SKCM	cis	rs453301	0.653	rs1562211	chr8:8902424	A/G	cg15556689	chr8:8085844	FLJ10661	-0.71	-5.64	-0.54	2.6e-7	Joint mobility (Beighton score);
SKCM	cis	rs757110	0.648	rs12146443	chr11:17384498	T/C	cg15432903	chr11:17409602	KCNJ11	0.51	4.86	0.48	5.99e-6	Type 2 diabetes;
SKCM	trans	rs2727020	0.636	rs11040368	chr11:49453602	C/A	cg15704280	chr7:45808275	SEPT13	-0.87	-7.93	-0.67	1.31e-11	Coronary artery disease;
SKCM	cis	rs4891159	0.548	rs2554830	chr18:74127702	A/G	cg24786174	chr18:74118243	ZNF516	0.79	8.54	0.7	8.32e-13	Longevity;
SKCM	cis	rs875971	0.558	rs4433015	chr7:65639723	A/C	cg11764359	chr7:65958608	NA	-0.93	-7.45	-0.64	1.07e-10	Aortic root size;
SKCM	cis	rs11098499	0.863	rs6534141	chr4:120485223	A/T	cg24375607	chr4:120327624	NA	0.69	5.47	0.53	5.35e-7	Corneal astigmatism;
SKCM	cis	rs1799949	1.000	rs4793212	chr17:41302750	T/C	cg25918947	chr17:41365094	TMEM106A	-0.62	-6.11	-0.57	3.67e-8	Menopause (age at onset);
SKCM	cis	rs6570726	0.935	rs369458	chr6:145812809	A/G	cg23711669	chr6:146136114	FBXO30	0.71	6.93	0.62	1.09e-9	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs362296	0.698	rs362283	chr4:3259558	T/C	cg16987761	chr4:3318072	RGS12	-0.75	-6.27	-0.58	1.83e-8	Parental longevity (mother's age at death);
SKCM	cis	rs1348850	0.598	rs12616259	chr2:178503803	C/T	cg02961200	chr2:178257176	LOC100130691;AGPS	0.74	4.97	0.49	3.9e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs6570726	0.791	rs11155426	chr6:145817130	T/C	cg05347473	chr6:146136440	FBXO30	0.53	4.78	0.48	8.07e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs9815354	0.812	rs74947509	chr3:42006323	T/C	cg03022575	chr3:42003672	ULK4	1.0	5.0	0.49	3.43e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs2404602	1.000	rs2056544	chr15:76826003	G/A	cg23625390	chr15:77176239	SCAPER	0.75	7.27	0.64	2.44e-10	Blood metabolite levels;
SKCM	cis	rs10540	1.000	rs12794284	chr11:477623	C/T	cg03352830	chr11:487213	PTDSS2	0.96	4.77	0.48	8.46e-6	Body mass index;
SKCM	cis	rs7659604	1.000	rs6816071	chr4:122665185	G/A	cg19748678	chr4:122722346	EXOSC9	0.66	5.44	0.52	5.83e-7	Type 2 diabetes;
SKCM	cis	rs9902453	0.902	rs4075014	chr17:28305674	C/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.81	5.78	0.55	1.46e-7	Coffee consumption (cups per day);
SKCM	cis	rs2760061	0.583	rs708110	chr1:228190805	T/A	cg02753203	chr1:228287806	NA	0.83	7.48	0.65	9.71e-11	Diastolic blood pressure;
SKCM	cis	rs10870270	0.956	rs7915388	chr10:133734972	G/A	cg17892150	chr10:133769511	PPP2R2D	-0.66	-4.89	-0.48	5.37e-6	Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals;
SKCM	cis	rs1799949	0.965	rs2236762	chr17:41226675	A/T	cg05368731	chr17:41323189	NBR1	0.88	7.4	0.64	1.34e-10	Menopause (age at onset);
SKCM	cis	rs780096	0.587	rs1049817	chr2:27550967	A/G	cg05696406	chr2:27599888	SNX17	0.49	5.12	0.5	2.17e-6	Total body bone mineral density;
SKCM	cis	rs2836974	0.966	rs7283516	chr21:40690537	A/G	cg11890956	chr21:40555474	PSMG1	0.97	10.18	0.76	5.63e-16	Cognitive function;
SKCM	cis	rs7811142	1.000	rs11773661	chr7:100073069	G/C	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.23	7.89	0.67	1.53e-11	Platelet count;
SKCM	cis	rs1218582	0.740	rs1977879	chr1:154879743	G/A	cg09359103	chr1:154839909	KCNN3	-0.57	-5.3	-0.51	1.05e-6	Prostate cancer;
SKCM	cis	rs1784581	0.894	rs1784594	chr6:162382734	A/G	cg17173639	chr6:162384350	PARK2	-0.61	-5.37	-0.52	7.81e-7	Itch intensity from mosquito bite;
SKCM	cis	rs9393692	0.557	rs9358924	chr6:26322473	G/A	cg00631329	chr6:26305371	NA	-0.63	-4.88	-0.48	5.44e-6	Educational attainment;
SKCM	cis	rs763121	0.853	rs5757211	chr22:39051705	C/T	cg06022373	chr22:39101656	GTPBP1	0.72	4.96	0.49	4.08e-6	Menopause (age at onset);
SKCM	cis	rs2836974	0.644	rs1882779	chr21:40690938	T/C	cg17971929	chr21:40555470	PSMG1	-0.71	-6.23	-0.58	2.2e-8	Cognitive function;
SKCM	cis	rs7617480	0.610	rs4955420	chr3:49208865	A/G	cg06212747	chr3:49208901	KLHDC8B	1.03	8.03	0.67	8.4e-12	Subjective well-being (multi-trait analysis);Menarche (age at onset);
SKCM	cis	rs7811142	1.000	rs2406255	chr7:100053690	T/C	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.23	7.89	0.67	1.53e-11	Platelet count;
SKCM	cis	rs950776	0.518	rs4886572	chr15:78837452	A/G	cg06917634	chr15:78832804	PSMA4	-1.01	-10.48	-0.76	1.5e-16	Sudden cardiac arrest;
SKCM	cis	rs2072499	0.932	rs3001790	chr1:156165290	T/G	cg24450063	chr1:156163899	SLC25A44	1.09	10.35	0.76	2.67e-16	Testicular germ cell tumor;
SKCM	cis	rs2153535	0.580	rs986060	chr6:8465428	T/C	cg23788917	chr6:8435910	SLC35B3	0.67	4.84	0.48	6.54e-6	Motion sickness;
SKCM	trans	rs8073060	0.586	rs2523116	chr17:34025460	T/C	cg19694781	chr19:47549865	TMEM160	-1.08	-8.6	-0.7	6.4e-13	Immature fraction of reticulocytes;Platelet count;Platelet distribution width;
SKCM	cis	rs6545883	0.929	rs2463100	chr2:61659199	C/G	cg15711740	chr2:61764176	XPO1	-0.68	-4.8	-0.48	7.62e-6	Tuberculosis;
SKCM	cis	rs870825	0.585	rs2696039	chr4:185610899	T/C	cg04058563	chr4:185651563	MLF1IP	-1.07	-7.36	-0.64	1.6e-10	Blood protein levels;
SKCM	cis	rs4242434	0.892	rs71513892	chr8:22456517	C/G	cg03733263	chr8:22462867	KIAA1967	1.05	8.85	0.71	2.14e-13	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs870825	0.860	rs11132253	chr4:185595472	C/T	cg04058563	chr4:185651563	MLF1IP	0.95	5.91	0.56	8.51e-8	Blood protein levels;
SKCM	cis	rs11098499	0.863	rs59732491	chr4:120489588	G/C	cg24375607	chr4:120327624	NA	0.69	5.47	0.53	5.35e-7	Corneal astigmatism;
SKCM	cis	rs6456156	0.586	rs6909180	chr6:167460537	A/G	cg13927040	chr6:167453801	FGFR1OP	0.66	4.85	0.48	6.24e-6	Primary biliary cholangitis;
SKCM	cis	rs11718455	0.920	rs34909426	chr3:44000472	G/A	cg21419209	chr3:44054225	NA	-0.65	-5.32	-0.52	9.77e-7	Coronary artery disease;
SKCM	cis	rs9640161	0.789	rs66688634	chr7:150053806	G/A	cg10018233	chr7:150070692	REPIN1	0.67	5.27	0.51	1.17e-6	Blood protein levels;Circulating chemerin levels;
SKCM	cis	rs7811142	1.000	rs67315960	chr7:100015124	A/G	cg18515655	chr7:100026757	MEPCE;ZCWPW1	-1.0	-5.66	-0.54	2.36e-7	Platelet count;
SKCM	cis	rs420259	0.516	rs120962	chr16:23589986	A/G	cg10006042	chr16:23042421	NA	0.36	4.85	0.48	6.15e-6	Bipolar disorder;
SKCM	cis	rs7216064	1.000	rs9915108	chr17:65874463	T/C	cg12091567	chr17:66097778	LOC651250	-0.75	-5.27	-0.51	1.19e-6	Lung adenocarcinoma;Lung cancer;EGFR mutation-positive lung adenocarcinoma;
SKCM	cis	rs10504229	0.683	rs11774645	chr8:58132921	G/C	cg02725872	chr8:58115012	NA	-0.53	-5.19	-0.51	1.64e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs9788682	0.947	rs7169584	chr15:78822660	A/T	cg06917634	chr15:78832804	PSMA4	-0.83	-5.02	-0.49	3.13e-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs1499614	1.000	rs1267817	chr7:66110040	G/T	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Gout;
SKCM	cis	rs4523957	0.786	rs216213	chr17:2134225	G/A	cg16513277	chr17:2031491	SMG6	0.72	4.83	0.48	6.78e-6	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs10504073	0.647	rs62507245	chr8:50006939	A/T	cg00325661	chr8:49890786	NA	0.79	6.79	0.61	1.99e-9	Blood metabolite ratios;
SKCM	cis	rs72781680	0.904	rs72796340	chr2:24143622	T/A	cg08917208	chr2:24149416	ATAD2B	0.96	5.44	0.52	5.87e-7	Lymphocyte counts;
SKCM	cis	rs738322	0.901	rs132941	chr22:38545942	T/C	cg25457927	chr22:38595422	NA	-0.51	-5.92	-0.56	8.03e-8	Cutaneous nevi;
SKCM	cis	rs9581857	0.547	rs927579	chr13:28075079	A/G	cg22138327	chr13:27999177	GTF3A	0.84	5.53	0.53	4.15e-7	Psychosis proneness (hypomanic personality scale and perceptual aberration scale);
SKCM	cis	rs9311474	0.607	rs4475032	chr3:52560021	C/T	cg18404041	chr3:52824283	ITIH1	-0.55	-4.98	-0.49	3.8e-6	Electroencephalogram traits;
SKCM	cis	rs9300255	0.739	rs1980252	chr12:123745178	C/G	cg05973401	chr12:123451056	ABCB9	0.86	6.11	0.57	3.69e-8	Neutrophil percentage of white cells;
SKCM	cis	rs2072499	0.778	rs41265025	chr1:156163906	C/T	cg24450063	chr1:156163899	SLC25A44	0.88	6.55	0.6	5.55e-9	Testicular germ cell tumor;
SKCM	cis	rs919433	0.783	rs788011	chr2:198230771	A/G	cg04278110	chr2:198063759	ANKRD44	0.74	5.13	0.5	2.06e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs10504229	1.000	rs58053450	chr8:58173348	T/C	cg22535103	chr8:58192502	C8orf71	-0.68	-4.77	-0.48	8.29e-6	Developmental language disorder (linguistic errors);
SKCM	cis	rs11105298	0.891	rs6538190	chr12:89885942	T/C	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.89	-6.03	-0.56	5.25e-8	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs738322	1.000	rs4379	chr22:38569171	T/C	cg25457927	chr22:38595422	NA	-0.5	-5.56	-0.53	3.61e-7	Cutaneous nevi;
SKCM	cis	rs2836974	0.563	rs997147	chr21:40695325	A/G	cg11644478	chr21:40555479	PSMG1	-0.67	-5.63	-0.54	2.71e-7	Cognitive function;
SKCM	cis	rs4665809	0.567	rs6546848	chr2:26444414	G/C	cg26119090	chr2:26468346	HADHA;HADHB	-1.03	-7.99	-0.67	9.69e-12	Gut microbiome composition (summer);
SKCM	trans	rs3780486	0.813	rs3780488	chr9:33133812	T/C	cg04842962	chr6:43655489	MRPS18A	1.03	10.85	0.78	2.95e-17	IgG glycosylation;
SKCM	cis	rs742614	0.533	rs2092737	chr20:32428135	A/C	cg06304546	chr20:32448765	NA	-0.73	-5.91	-0.56	8.51e-8	Stearic acid (18:0) levels;
SKCM	cis	rs6120849	0.754	rs6120828	chr20:33674460	A/G	cg24642439	chr20:33292090	TP53INP2	0.94	4.86	0.48	5.91e-6	Protein C levels;
SKCM	cis	rs7584330	0.784	rs6724766	chr2:238413600	A/G	cg14458575	chr2:238380390	NA	1.11	7.3	0.64	2.15e-10	Prostate cancer;
SKCM	cis	rs709400	0.663	rs17679475	chr14:103916958	A/G	cg26031613	chr14:104095156	KLC1	0.66	4.87	0.48	5.63e-6	Body mass index;
SKCM	cis	rs7359276	1	rs7359276	chr15:78892661	C/T	cg24631222	chr15:78858424	CHRNA5	-0.87	-6.04	-0.56	4.98e-8	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio;
SKCM	cis	rs2153535	0.580	rs4587214	chr6:8454119	T/C	cg23788917	chr6:8435910	SLC35B3	0.66	4.78	0.48	8.07e-6	Motion sickness;
SKCM	cis	rs1799949	0.965	rs6503726	chr17:41284742	T/C	cg05368731	chr17:41323189	NBR1	0.86	6.91	0.62	1.18e-9	Menopause (age at onset);
SKCM	cis	rs854765	0.583	rs11656840	chr17:17837354	C/T	cg24612305	chr17:17875800	TOM1L2;LRRC48	1.0	7.64	0.65	4.64e-11	Total body bone mineral density;
SKCM	cis	rs6866344	0.697	rs58549512	chr5:178133204	C/T	cg10224037	chr5:178157518	ZNF354A	0.81	5.68	0.54	2.26e-7	Neutrophil percentage of white cells;
SKCM	cis	rs2737618	0.698	rs2737678	chr1:200088041	C/T	cg21825944	chr1:200113062	NR5A2	-0.62	-4.99	-0.49	3.52e-6	Uric acid levels;
SKCM	cis	rs7666738	0.830	rs13133619	chr4:99067312	C/G	cg17366294	chr4:99064904	C4orf37	-0.62	-5.22	-0.51	1.47e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs7917772	0.503	rs11191320	chr10:104293394	T/C	cg11453585	chr10:104263688	ACTR1A;SUFU	0.78	6.33	0.58	1.47e-8	Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour);White blood cell count;Waist-to-hip ratio adjusted for body mass index;
SKCM	cis	rs10927875	0.864	rs12744578	chr1:16173110	A/T	cg21385522	chr1:16154831	NA	-1.04	-8.73	-0.7	3.67e-13	Dilated cardiomyopathy;
SKCM	cis	rs3768617	0.510	rs4651139	chr1:183091963	C/T	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs10779751	0.770	rs2015818	chr1:11170743	G/A	cg08854313	chr1:11322531	MTOR	0.87	6.81	0.61	1.83e-9	Body mass index;
SKCM	cis	rs1691799	0.806	rs1168319	chr12:66744857	T/A	cg16791601	chr12:66731901	HELB	-0.65	-6.09	-0.57	4.07e-8	White blood cell count (basophil);
SKCM	cis	rs10089	0.953	rs1012851	chr5:127360241	T/C	cg25462716	chr5:127418816	SLC12A2;FLJ33630	0.88	7.64	0.65	4.76e-11	Ileal carcinoids;
SKCM	cis	rs4319547	0.585	rs7952868	chr12:122846949	A/G	cg23029597	chr12:123009494	RSRC2	-0.73	-5.18	-0.51	1.7e-6	Body mass index;
SKCM	cis	rs9467773	0.583	rs2498380	chr6:26643996	C/G	cg15659132	chr6:26577336	NA	-0.61	-5.33	-0.52	9.31e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs28595532	0.623	rs10016452	chr4:119277490	A/G	cg21605333	chr4:119757512	SEC24D	0.93	5.03	0.49	3.12e-6	Cannabis dependence symptom count;
SKCM	cis	rs1568889	0.838	rs7127069	chr11:28325412	A/G	cg06544937	chr11:28130018	METT5D1;KIF18A	0.89	8.44	0.69	1.31e-12	Bipolar disorder;
SKCM	cis	rs9916302	0.752	rs676882	chr17:37433424	A/T	cg07936489	chr17:37558343	FBXL20	1.0	7.19	0.63	3.42e-10	Glomerular filtration rate (creatinine);
SKCM	trans	rs1814175	0.817	rs80244685	chr11:49763292	C/A	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs763121	0.853	rs7289577	chr22:39042214	C/G	cg06022373	chr22:39101656	GTPBP1	0.72	4.96	0.49	4.08e-6	Menopause (age at onset);
SKCM	cis	rs6933660	0.646	rs9397051	chr6:151778325	C/T	cg02564969	chr6:151773285	C6orf211;RMND1	0.7	6.01	0.56	5.55e-8	Menarche (age at onset);
SKCM	cis	rs9951698	0.660	rs7229870	chr18:12994468	G/A	cg12848697	chr18:13133368	NA	0.53	4.9	0.48	5.18e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs9790314	1.000	rs464766	chr3:161087592	C/G	cg03342759	chr3:160939853	NMD3	-0.72	-7.89	-0.67	1.53e-11	Morning vs. evening chronotype;
SKCM	cis	rs7772486	0.686	rs9403741	chr6:146030548	G/A	cg05347473	chr6:146136440	FBXO30	-0.55	-4.85	-0.48	6.14e-6	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs6545883	0.965	rs9989775	chr2:61761774	A/G	cg15711740	chr2:61764176	XPO1	-0.76	-5.3	-0.51	1.04e-6	Tuberculosis;
SKCM	cis	rs55962025	0.711	rs362319	chr4:3224933	T/G	cg09735869	chr4:3319127	RGS12	-0.65	-5.33	-0.52	9.21e-7	Parental longevity (mother's age at death);
SKCM	cis	rs6580649	0.825	rs4760611	chr12:48421449	A/G	cg05342945	chr12:48394962	COL2A1	-0.79	-5.44	-0.52	5.85e-7	Lung cancer;
SKCM	cis	rs2841277	0.708	rs11851053	chr14:105407208	T/C	cg21017887	chr14:105400489	NA	0.59	5.31	0.52	1e-6	Rheumatoid arthritis;
SKCM	cis	rs8072100	0.967	rs4239162	chr17:45755810	G/A	cg08085267	chr17:45401833	C17orf57	-0.62	-5.5	-0.53	4.69e-7	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs12134245	0.755	rs11164928	chr1:92012678	G/A	cg02896835	chr1:92012615	NA	-0.56	-4.91	-0.49	4.88e-6	Breast cancer;
SKCM	cis	rs7635838	0.503	rs9853547	chr3:11396101	C/G	cg00170343	chr3:11313890	ATG7	0.7	5.19	0.51	1.61e-6	HDL cholesterol;
SKCM	cis	rs2404602	0.532	rs744336	chr15:76674624	T/C	cg23625390	chr15:77176239	SCAPER	0.65	5.69	0.54	2.1e-7	Blood metabolite levels;
SKCM	cis	rs908922	0.676	rs7545336	chr1:152527863	A/G	cg09873164	chr1:152488093	CRCT1	0.72	5.62	0.54	2.85e-7	Hair morphology;
SKCM	cis	rs28595532	1.000	rs73842212	chr4:119638122	A/G	cg21605333	chr4:119757512	SEC24D	1.24	7.1	0.63	5.16e-10	Cannabis dependence symptom count;
SKCM	cis	rs617791	0.530	rs10896073	chr11:65762814	T/C	cg27068330	chr11:65405492	SIPA1	-0.69	-5.0	-0.49	3.41e-6	Breast cancer;
SKCM	cis	rs4423214	1.000	rs12808368	chr11:71170817	C/T	cg05163923	chr11:71159392	DHCR7	0.83	8.11	0.68	5.77e-12	Vitamin D levels;
SKCM	cis	rs9911578	0.967	rs7214892	chr17:57065401	G/A	cg05425664	chr17:57184151	TRIM37	-0.72	-5.44	-0.52	6.01e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs10193935	0.901	rs3755304	chr2:42589921	A/G	cg27598129	chr2:42591480	NA	0.92	6.79	0.61	1.97e-9	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs17376456	0.877	rs13185660	chr5:93336500	G/A	cg21475434	chr5:93447410	FAM172A	0.95	5.35	0.52	8.56e-7	Diabetic retinopathy;
SKCM	cis	rs7666738	0.830	rs10025174	chr4:98914172	A/G	cg05340658	chr4:99064831	C4orf37	0.6	4.83	0.48	6.79e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs875971	0.617	rs810400	chr7:66022889	G/C	cg11764359	chr7:65958608	NA	-0.86	-6.6	-0.6	4.52e-9	Aortic root size;
SKCM	cis	rs3820928	0.874	rs4675133	chr2:227843010	A/G	cg11843606	chr2:227700838	RHBDD1	0.61	4.9	0.49	5.12e-6	Pulmonary function;
SKCM	cis	rs8060686	0.565	rs11555011	chr16:68088485	A/G	cg04539111	chr16:67997858	SLC12A4	-0.85	-4.81	-0.48	7.14e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs9911578	0.967	rs12944948	chr17:56951474	A/G	cg12560992	chr17:57184187	TRIM37	0.94	7.55	0.65	7.01e-11	Intelligence (multi-trait analysis);
SKCM	trans	rs1814175	0.645	rs7952104	chr11:49964180	C/T	cg03929089	chr4:120376271	NA	-0.82	-7.29	-0.64	2.25e-10	Height;
SKCM	cis	rs933688	1.000	rs35712350	chr5:90679519	C/T	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.95	6.61	0.6	4.39e-9	Smoking behavior;
SKCM	cis	rs7646501	0.765	rs17014043	chr3:24064668	A/G	cg22892432	chr3:24537792	THRB	0.57	4.87	0.48	5.64e-6	Cognitive ability;Intelligence;
SKCM	cis	rs17376456	0.877	rs66696214	chr5:93424533	G/A	cg25358565	chr5:93447407	FAM172A	1.23	7.97	0.67	1.08e-11	Diabetic retinopathy;
SKCM	cis	rs151997	0.629	rs27288	chr5:50194920	T/A	cg06027927	chr5:50259733	NA	0.65	6.24	0.58	2.13e-8	Callous-unemotional behaviour;
SKCM	cis	rs1153858	1.000	rs72623915	chr15:45647433	C/T	cg21132104	chr15:45694354	SPATA5L1	0.92	7.81	0.66	2.22e-11	Homoarginine levels;
SKCM	cis	rs2479724	0.870	rs7766960	chr6:41918190	T/G	cg17623882	chr6:41773611	USP49	-0.71	-5.53	-0.53	4.07e-7	Menarche (age at onset);
SKCM	cis	rs2439831	0.867	rs2470134	chr15:43849886	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	-1.41	-8.33	-0.69	2.19e-12	Lung cancer in ever smokers;
SKCM	cis	rs9325144	0.600	rs10880934	chr12:38730455	C/T	cg26384229	chr12:38710491	ALG10B	-0.75	-6.5	-0.59	6.83e-9	Morning vs. evening chronotype;
SKCM	cis	rs4819052	0.851	rs28501512	chr21:46676702	C/T	cg02159808	chr21:46707872	POFUT2;LOC642852	0.73	5.71	0.54	1.93e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs116095464	0.558	rs7356696	chr5:284251	A/G	cg22857025	chr5:266934	NA	-1.47	-8.33	-0.69	2.16e-12	Breast cancer;
SKCM	cis	rs12142240	0.698	rs56063031	chr1:46825433	C/T	cg10495392	chr1:46806563	NSUN4	0.74	5.51	0.53	4.38e-7	Menopause (age at onset);
SKCM	cis	rs875971	0.577	rs34888281	chr7:65585771	C/T	cg11987759	chr7:65425863	GUSB	0.73	6.5	0.59	6.96e-9	Aortic root size;
SKCM	cis	rs2050392	0.517	rs2771242	chr10:30762973	C/T	cg25182066	chr10:30743637	MAP3K8	-0.68	-6.26	-0.58	1.95e-8	Inflammatory bowel disease;
SKCM	cis	rs910316	0.967	rs12890371	chr14:75593839	T/C	cg11812906	chr14:75593930	NEK9	0.7	5.37	0.52	7.85e-7	Height;
SKCM	cis	rs6951245	1.000	rs74347384	chr7:1072440	G/A	cg21664854	chr7:1097933	C7orf50;GPR146	0.89	4.79	0.48	7.66e-6	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs17095355	1.000	rs734163	chr10:111698192	A/G	cg21508714	chr10:112432393	RBM20	0.83	4.91	0.49	4.97e-6	Biliary atresia;
SKCM	cis	rs6834538	0.597	rs2029211	chr4:113488134	A/G	cg05166686	chr4:113558556	LARP7;C4orf21	0.59	4.89	0.48	5.36e-6	Free thyroxine concentration;
SKCM	cis	rs2204008	0.837	rs11495722	chr12:38337245	G/A	cg13010199	chr12:38710504	ALG10B	0.69	4.92	0.49	4.75e-6	Bladder cancer;
SKCM	cis	rs8078723	0.866	rs7502514	chr17:38188844	A/G	cg17467752	chr17:38218738	THRA	-0.77	-7.12	-0.63	4.69e-10	C-reactive protein and white blood cell count;Neutrophil count;White blood cell count;White blood cell count (neutrophil);
SKCM	cis	rs4642101	0.686	rs13085726	chr3:12832672	A/C	cg05775895	chr3:12838266	CAND2	0.66	5.81	0.55	1.29e-7	QRS complex (12-leadsum);
SKCM	cis	rs9467773	0.620	rs9295701	chr6:26627508	T/C	cg09904177	chr6:26538194	HMGN4	0.58	5.01	0.49	3.28e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs3784262	0.904	rs4646620	chr15:58258241	G/A	cg12031962	chr15:58353849	ALDH1A2	-0.49	-6.48	-0.59	7.67e-9	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs7666738	0.761	rs13136913	chr4:98998031	C/T	cg17366294	chr4:99064904	C4orf37	0.6	4.98	0.49	3.8e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6977660	0.891	rs10226962	chr7:19819464	T/C	cg05791153	chr7:19748676	TWISTNB	0.81	5.53	0.53	4.16e-7	Thyroid stimulating hormone;
SKCM	cis	rs1577917	0.958	rs12202188	chr6:86562700	C/A	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.81	-7.82	-0.66	2.07e-11	Response to antipsychotic treatment;
SKCM	cis	rs911555	0.511	rs8007489	chr14:104054572	A/G	cg24130564	chr14:104152367	KLC1	0.55	4.85	0.48	6.26e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs362296	0.698	rs3135171	chr4:3261127	A/G	cg21096898	chr4:3318625	RGS12	-0.83	-7.9	-0.67	1.46e-11	Parental longevity (mother's age at death);
SKCM	cis	rs7954584	0.567	rs1720037	chr12:122382229	G/T	cg13699009	chr12:122356056	WDR66	-0.59	-7.33	-0.64	1.82e-10	Mean corpuscular volume;
SKCM	cis	rs362272	0.545	rs3129308	chr4:3309272	C/T	cg09735869	chr4:3319127	RGS12	0.93	10.71	0.77	5.5e-17	Serum sulfate level;
SKCM	trans	rs17685	0.712	rs869805	chr7:75688596	C/T	cg19862616	chr7:65841803	NCRNA00174	0.95	9.34	0.73	2.39e-14	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs28595532	0.841	rs114966236	chr4:119733437	T/C	cg21605333	chr4:119757512	SEC24D	1.36	8.05	0.67	7.69e-12	Cannabis dependence symptom count;
SKCM	cis	rs28386778	0.829	rs1877317	chr17:61776479	T/C	cg06873352	chr17:61820015	STRADA	0.75	6.23	0.58	2.16e-8	Prudent dietary pattern;
SKCM	cis	rs823143	0.570	rs823082	chr1:205786935	C/T	cg17178900	chr1:205818956	PM20D1	-0.8	-7.78	-0.66	2.48e-11	Monocyte percentage of white cells;
SKCM	cis	rs4969178	0.965	rs12450500	chr17:76395750	C/T	cg20026190	chr17:76395443	PGS1	0.61	5.29	0.51	1.08e-6	HDL cholesterol levels;
SKCM	cis	rs2153535	0.580	rs2152348	chr6:8474301	C/A	cg07606381	chr6:8435919	SLC35B3	0.93	6.75	0.61	2.4e-9	Motion sickness;
SKCM	cis	rs1568889	0.838	rs4614434	chr11:28302234	C/A	cg06544937	chr11:28130018	METT5D1;KIF18A	0.89	8.44	0.69	1.31e-12	Bipolar disorder;
SKCM	cis	rs7811142	0.666	rs28401739	chr7:99905684	A/G	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.21	7.77	0.66	2.57e-11	Platelet count;
SKCM	cis	rs3820068	0.581	rs72645864	chr1:15921153	C/T	cg13390004	chr1:15929781	NA	0.67	5.29	0.51	1.11e-6	Systolic blood pressure;
SKCM	cis	rs8180040	0.966	rs11914795	chr3:47557722	G/A	cg16586182	chr3:47516702	SCAP	-0.73	-4.95	-0.49	4.12e-6	Colorectal cancer;
SKCM	cis	rs7615952	0.611	rs2971298	chr3:125602713	G/A	cg05084668	chr3:125655381	ALG1L	-1.26	-7.1	-0.63	5.08e-10	Blood pressure (smoking interaction);
SKCM	cis	rs875971	0.862	rs2909688	chr7:65841612	C/A	cg18876405	chr7:65276391	NA	0.64	6.44	0.59	9.14e-9	Aortic root size;
SKCM	cis	rs1005277	0.579	rs2504148	chr10:38400788	A/G	cg00409905	chr10:38381863	ZNF37A	-0.66	-6.16	-0.57	3e-8	Extrinsic epigenetic age acceleration;
SKCM	cis	rs2204008	0.775	rs11182513	chr12:38560252	G/C	cg13010199	chr12:38710504	ALG10B	0.65	4.95	0.49	4.24e-6	Bladder cancer;
SKCM	cis	rs7020830	0.898	rs997318	chr9:37364094	C/T	cg14294708	chr9:37120828	ZCCHC7	1.06	10.63	0.77	8.01e-17	Schizophrenia;
SKCM	cis	rs798554	0.797	rs798497	chr7:2795957	A/G	cg14895029	chr7:2775587	GNA12	-0.7	-5.36	-0.52	8.13e-7	Height;
SKCM	cis	rs801193	0.569	rs6978178	chr7:66123084	G/A	cg18876405	chr7:65276391	NA	-0.63	-6.29	-0.58	1.68e-8	Aortic root size;
SKCM	cis	rs870825	1.000	rs870823	chr4:185588195	G/A	cg04058563	chr4:185651563	MLF1IP	1.09	5.63	0.54	2.68e-7	Blood protein levels;
SKCM	cis	rs9911578	0.967	rs4132925	chr17:56938016	C/G	cg12560992	chr17:57184187	TRIM37	-0.95	-7.56	-0.65	6.76e-11	Intelligence (multi-trait analysis);
SKCM	cis	rs2120019	0.938	rs8028632	chr15:75321262	T/C	cg17294928	chr15:75287854	SCAMP5	-0.89	-8.91	-0.71	1.6e-13	Blood trace element (Zn levels);
SKCM	cis	rs314370	1.000	rs314370	chr7:100453208	T/C	cg10426581	chr7:100472382	SRRT	0.75	6.29	0.58	1.7e-8	Resting heart rate;
SKCM	cis	rs9914544	1.000	rs1737944	chr17:18840433	G/A	cg26378065	chr17:18585709	ZNF286B	0.7	4.95	0.49	4.15e-6	Educational attainment (years of education);
SKCM	cis	rs1878931	0.517	rs17685105	chr16:3413749	C/T	cg26668626	chr16:3451006	ZNF174;ZNF434	-0.78	-6.08	-0.57	4.21e-8	Body mass index (adult);
SKCM	cis	rs875971	0.862	rs778686	chr7:65835910	C/T	cg11764359	chr7:65958608	NA	0.81	7.63	0.65	4.91e-11	Aortic root size;
SKCM	cis	rs9875589	0.509	rs6768383	chr3:14076952	G/A	cg14375111	chr3:14165186	TMEM43;CHCHD4	0.52	5.24	0.51	1.34e-6	Ovarian reserve;
SKCM	cis	rs1801251	1.000	rs283486	chr2:233644223	A/G	cg08000102	chr2:233561755	GIGYF2	0.89	7.15	0.63	4.05e-10	Coronary artery disease;
SKCM	cis	rs17376456	0.825	rs28534784	chr5:93063332	C/A	cg21475434	chr5:93447410	FAM172A	0.94	5.62	0.54	2.87e-7	Diabetic retinopathy;
SKCM	cis	rs912057	0.695	rs1294419	chr6:6742549	C/G	cg06612196	chr6:6737390	NA	0.58	4.91	0.49	4.81e-6	Waist-to-hip ratio adjusted for BMI in active individuals;Waist-to-hip ratio adjusted for body mass index;Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction);
SKCM	cis	rs589448	0.902	rs315113	chr12:69786543	G/T	cg20891283	chr12:69753455	YEATS4	-0.99	-10.29	-0.76	3.5e-16	Cerebrospinal fluid biomarker levels;
SKCM	cis	rs7618501	0.602	rs2624853	chr3:50128893	A/G	cg05072774	chr3:49840536	C3orf54	0.71	5.48	0.53	5e-7	Intelligence (multi-trait analysis);
SKCM	cis	rs561341	0.831	rs11658469	chr17:30206426	T/C	cg00745463	chr17:30367425	LRRC37B	0.99	6.38	0.59	1.18e-8	Hip circumference adjusted for BMI;
SKCM	cis	rs8014204	0.804	rs7154845	chr14:75247746	A/G	cg06637938	chr14:75390232	RPS6KL1	0.84	6.66	0.6	3.53e-9	Caffeine consumption;
SKCM	cis	rs11098499	0.644	rs28787668	chr4:120554687	G/A	cg09307838	chr4:120376055	NA	0.94	7.77	0.66	2.64e-11	Corneal astigmatism;
SKCM	cis	rs995000	0.965	rs3850634	chr1:63050598	T/G	cg06896770	chr1:63153194	DOCK7	0.93	9.04	0.72	8.97e-14	Triglyceride levels;
SKCM	cis	rs2228479	0.850	rs17226498	chr16:89840631	T/C	cg06558623	chr16:89946397	TCF25	1.06	4.84	0.48	6.45e-6	Skin colour saturation;
SKCM	cis	rs6088580	0.619	rs1205335	chr20:32927507	C/T	cg24642439	chr20:33292090	TP53INP2	-0.72	-5.7	-0.54	2.06e-7	Glomerular filtration rate (creatinine);
SKCM	cis	rs1185460	0.967	rs1786690	chr11:118942067	A/G	cg23280166	chr11:118938394	VPS11	0.57	5.06	0.5	2.72e-6	Coronary artery disease;
SKCM	cis	rs9906944	0.603	rs10853104	chr17:47092076	C/T	cg10950924	chr17:47092072	IGF2BP1	-0.61	-5.3	-0.51	1.03e-6	Intelligence (multi-trait analysis);Body fat percentage;
SKCM	cis	rs9796	0.653	rs28516683	chr15:41446645	A/G	cg18705301	chr15:41695430	NDUFAF1	-0.74	-5.35	-0.52	8.47e-7	Menopause (age at onset);
SKCM	cis	rs2033711	0.870	rs7408188	chr19:58939389	T/G	cg00825309	chr19:58991885	ZNF446	-0.69	-5.6	-0.54	3.08e-7	Uric acid clearance;
SKCM	cis	rs9485372	0.838	rs4895782	chr6:149608127	T/C	cg03072286	chr6:150262044	ULBP2	-0.55	-4.89	-0.48	5.3e-6	Breast cancer;
SKCM	cis	rs1707322	0.963	rs4660900	chr1:46419605	T/C	cg03146154	chr1:46216737	IPP	0.8	5.44	0.52	5.87e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs7824557	0.593	rs11774673	chr8:11191537	T/C	cg21775007	chr8:11205619	TDH	0.72	6.73	0.61	2.51e-9	Retinal vascular caliber;
SKCM	cis	rs2033711	0.870	rs7259841	chr19:58951123	T/C	cg03735888	chr19:58951602	ZNF132	0.7	6.24	0.58	2.08e-8	Uric acid clearance;
SKCM	cis	rs7809950	0.954	rs2520243	chr7:107136973	T/C	cg23024343	chr7:107201750	COG5	-0.76	-6.83	-0.61	1.64e-9	Coronary artery disease;
SKCM	cis	rs28386778	0.863	rs2584637	chr17:61942952	T/C	cg23090583	chr17:61904693	PSMC5;FTSJ3	1.12	11.2	0.79	6.65e-18	Prudent dietary pattern;
SKCM	cis	rs1005277	0.563	rs2505215	chr10:38481273	A/G	cg25427524	chr10:38739819	LOC399744	-0.78	-7.75	-0.66	2.83e-11	Extrinsic epigenetic age acceleration;
SKCM	cis	rs9911578	0.967	rs3826353	chr17:57075299	C/T	cg12560992	chr17:57184187	TRIM37	1.06	9.87	0.75	2.25e-15	Intelligence (multi-trait analysis);
SKCM	cis	rs6951245	0.872	rs74360401	chr7:1067403	G/A	cg24642844	chr7:1081250	C7orf50	-0.95	-6.4	-0.59	1.06e-8	C-reactive protein levels or total cholesterol levels (pleiotropy);
SKCM	cis	rs637571	0.565	rs633800	chr11:65638719	G/A	cg26695010	chr11:65641043	EFEMP2	0.69	5.8	0.55	1.35e-7	Eosinophil percentage of white cells;
SKCM	cis	rs5750830	0.546	rs4821891	chr22:39785381	C/T	cg11247378	chr22:39784982	NA	-0.5	-6.15	-0.57	3.13e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs873946	0.586	rs12767391	chr10:134573844	A/G	cg27286337	chr10:134555280	INPP5A	-0.92	-8.55	-0.7	7.96e-13	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs875971	0.862	rs778734	chr7:65814849	C/G	cg18876405	chr7:65276391	NA	0.64	6.34	0.58	1.35e-8	Aortic root size;
SKCM	cis	rs10754283	0.967	rs1953821	chr1:90107098	C/G	cg21401794	chr1:90099060	LRRC8C	0.78	6.7	0.6	2.85e-9	Amyotrophic lateral sclerosis (sporadic);
SKCM	cis	rs9926296	0.605	rs6500453	chr16:89858657	C/G	cg27121462	chr16:89883253	FANCA	0.81	7.31	0.64	2.02e-10	Vitiligo;
SKCM	cis	rs8177253	0.901	rs9843728	chr3:133501407	C/T	cg16414030	chr3:133502952	NA	-0.71	-5.87	-0.55	1.01e-7	Iron status biomarkers;
SKCM	cis	rs7684253	0.565	rs12641030	chr4:57803505	A/G	cg11939399	chr4:57773300	REST	0.43	4.94	0.49	4.33e-6	Migraine;
SKCM	cis	rs7829975	0.659	rs4382480	chr8:8721473	C/T	cg06636001	chr8:8085503	FLJ10661	0.77	6.84	0.61	1.58e-9	Mood instability;
SKCM	cis	rs12142240	0.698	rs10158572	chr1:46822440	G/T	cg14993813	chr1:46806288	NSUN4	-0.69	-4.77	-0.48	8.32e-6	Menopause (age at onset);
SKCM	cis	rs17376456	0.809	rs12152763	chr5:93405509	T/A	cg25358565	chr5:93447407	FAM172A	1.22	7.9	0.67	1.49e-11	Diabetic retinopathy;
SKCM	cis	rs10911251	0.528	rs4652779	chr1:183104552	G/A	ch.1.3577855R	chr1:183094577	LAMC1	0.74	7.18	0.63	3.54e-10	Colorectal cancer;
SKCM	cis	rs933688	1.000	rs11959525	chr5:90703840	A/G	cg26981201	chr5:90679533	LOC100129716;ARRDC3	1.08	8.2	0.68	3.91e-12	Smoking behavior;
SKCM	cis	rs9611565	0.659	rs56319767	chr22:41933837	G/A	cg03806693	chr22:41940476	POLR3H	-1.11	-7.56	-0.65	6.67e-11	Vitiligo;
SKCM	cis	rs782590	0.764	rs2586970	chr2:55829967	A/G	cg18811423	chr2:55921094	PNPT1	0.94	6.83	0.61	1.63e-9	Metabolic syndrome;
SKCM	cis	rs3768617	0.565	rs3768626	chr1:183078462	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.8	7.7	0.66	3.55e-11	Fuchs's corneal dystrophy;
SKCM	cis	rs7666738	0.791	rs2081622	chr4:98927369	T/C	cg05340658	chr4:99064831	C4orf37	0.64	4.92	0.49	4.71e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs17685	0.753	rs869804	chr7:75688954	A/G	cg01364799	chr7:75623366	TMEM120A	-0.75	-6.05	-0.56	4.78e-8	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs2204008	0.506	rs11495470	chr12:38026904	C/T	cg13010199	chr12:38710504	ALG10B	0.65	5.04	0.5	2.98e-6	Bladder cancer;
SKCM	cis	rs3785574	0.962	rs9944483	chr17:61783553	G/T	cg01411255	chr17:61851458	DDX42;CCDC47	-1.16	-13.48	-0.84	4.62e-22	Height;
SKCM	cis	rs10911232	0.507	rs5022057	chr1:182997761	T/C	ch.1.3577855R	chr1:183094577	LAMC1	0.75	6.64	0.6	3.83e-9	Hypertriglyceridemia;
SKCM	cis	rs2811415	0.597	rs13063604	chr3:127804730	G/A	cg09089421	chr3:127803668	RUVBL1	1.0	8.69	0.7	4.4e-13	Lung function (FEV1/FVC);
SKCM	cis	rs1124769	0.719	rs17646917	chr15:51286126	C/T	cg21246271	chr15:51200259	AP4E1	-0.74	-4.78	-0.48	8.15e-6	Cognitive performance;
SKCM	cis	rs9858542	0.953	rs6446272	chr3:49463287	G/A	cg03060546	chr3:49711283	APEH	-0.75	-5.53	-0.53	4.17e-7	Ulcerative colitis;Blood protein levels;Crohn's disease;
SKCM	cis	rs748404	0.660	rs694725	chr15:43756210	A/G	cg02155558	chr15:43621948	ADAL;LCMT2	0.71	5.4	0.52	7.05e-7	Lung cancer;
SKCM	cis	rs28386778	0.897	rs2236737	chr17:61938100	C/T	cg06873352	chr17:61820015	STRADA	0.75	6.22	0.58	2.35e-8	Prudent dietary pattern;
SKCM	cis	rs3820068	0.603	rs6668726	chr1:15962614	G/A	cg13390004	chr1:15929781	NA	0.67	5.33	0.52	9.35e-7	Systolic blood pressure;
SKCM	cis	rs9796	0.516	rs28473405	chr15:41293170	C/T	cg18705301	chr15:41695430	NDUFAF1	-0.72	-5.77	-0.55	1.53e-7	Menopause (age at onset);
SKCM	cis	rs561341	1.000	rs15654	chr17:30326360	A/C	cg00745463	chr17:30367425	LRRC37B	-1.1	-7.72	-0.66	3.22e-11	Hip circumference adjusted for BMI;
SKCM	cis	rs1348850	0.561	rs1838890	chr2:178410938	C/A	cg02961200	chr2:178257176	LOC100130691;AGPS	0.92	5.16	0.5	1.82e-6	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs7178909	0.872	rs3867167	chr15:90433790	T/C	cg19708238	chr15:90437601	AP3S2	0.72	5.22	0.51	1.43e-6	Common traits (Other);
SKCM	cis	rs35306767	0.855	rs61830932	chr10:934183	T/C	cg20503657	chr10:835505	NA	0.82	5.58	0.53	3.39e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs9790314	0.696	rs9290069	chr3:160890946	A/G	cg03342759	chr3:160939853	NMD3	-0.66	-6.61	-0.6	4.27e-9	Morning vs. evening chronotype;
SKCM	cis	rs17361889	0.806	rs1949952	chr7:16229128	A/G	cg09714114	chr7:16439993	ISPD	-0.52	-4.86	-0.48	6.02e-6	Pediatric bone mineral content (hip);
SKCM	cis	rs801193	1.000	rs7788576	chr7:66148302	G/A	cg11987759	chr7:65425863	GUSB	0.69	5.9	0.56	8.74e-8	Aortic root size;
SKCM	cis	rs58950470	0.887	rs1787034	chr11:65382564	A/G	cg02441831	chr11:64901569	SYVN1	-0.65	-4.94	-0.49	4.38e-6	Schizophrenia;
SKCM	cis	rs7552404	0.924	rs1146581	chr1:76213024	T/G	cg03433033	chr1:76189801	ACADM	0.74	5.37	0.52	7.95e-7	Blood metabolite levels;Acylcarnitine levels;
SKCM	cis	rs12928939	0.517	rs71384782	chr16:71978591	A/G	cg03805757	chr16:71968109	PKD1L3	-0.72	-5.17	-0.51	1.78e-6	Post bronchodilator FEV1;
SKCM	cis	rs798554	0.959	rs798528	chr7:2772431	A/C	cg19346786	chr7:2764209	NA	-0.63	-6.52	-0.59	6.32e-9	Height;
SKCM	cis	rs208520	0.526	rs6455072	chr6:66797215	A/G	cg07460842	chr6:66804631	NA	-1.16	-13.2	-0.83	1.4e-21	Exhaled nitric oxide output;
SKCM	cis	rs208520	0.690	rs12209753	chr6:66703951	A/G	cg07460842	chr6:66804631	NA	0.92	7.66	0.66	4.26e-11	Exhaled nitric oxide output;
SKCM	cis	rs28595532	0.920	rs116205107	chr4:119730910	G/A	cg14228332	chr4:119757509	SEC24D	1.08	5.52	0.53	4.28e-7	Cannabis dependence symptom count;
SKCM	cis	rs8072100	0.840	rs1912482	chr17:45454883	G/A	cg08085267	chr17:45401833	C17orf57	-0.61	-5.1	-0.5	2.3e-6	Very long-chain saturated fatty acid levels (fatty acid 20:0);
SKCM	cis	rs9467773	0.967	rs6924865	chr6:26521353	A/G	cg09904177	chr6:26538194	HMGN4	0.54	4.98	0.49	3.78e-6	Intelligence (multi-trait analysis);
SKCM	cis	rs4819052	1.000	rs13052356	chr21:46663588	G/A	cg19498844	chr21:46707878	POFUT2;LOC642852	0.87	6.8	0.61	1.88e-9	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs4523957	0.583	rs9907384	chr17:2045375	A/C	cg16513277	chr17:2031491	SMG6	-0.91	-6.21	-0.58	2.38e-8	Autism spectrum disorder or schizophrenia;Schizophrenia;
SKCM	cis	rs55962025	0.711	rs363063	chr4:3141488	G/A	cg09735869	chr4:3319127	RGS12	-0.68	-5.76	-0.55	1.62e-7	Parental longevity (mother's age at death);
SKCM	cis	rs7666738	0.830	rs28485415	chr4:99060340	G/A	cg05340658	chr4:99064831	C4orf37	0.66	4.87	0.48	5.74e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs6089584	0.927	rs2296083	chr20:60574216	C/T	cg23262073	chr20:60523788	NA	-0.51	-4.86	-0.48	5.9e-6	Body mass index;
SKCM	cis	rs796364	1.000	rs11895190	chr2:200838613	A/G	cg12253985	chr2:200820533	C2orf60;C2orf47	-0.92	-5.62	-0.54	2.83e-7	Schizophrenia;
SKCM	cis	rs28830936	0.510	rs7175346	chr15:42100674	G/A	cg17847044	chr15:42102381	MAPKBP1	-0.44	-5.77	-0.55	1.53e-7	Diastolic blood pressure;
SKCM	cis	rs1799949	1.000	rs11654731	chr17:41326940	G/A	cg23758822	chr17:41437982	NA	0.93	7.87	0.67	1.66e-11	Menopause (age at onset);
SKCM	cis	rs2832191	0.791	rs2832197	chr21:30497790	T/C	cg08807101	chr21:30365312	RNF160	-0.61	-4.78	-0.48	8.17e-6	Dental caries;
SKCM	cis	rs2180341	0.618	rs12199451	chr6:127597780	C/G	cg27446573	chr6:127587934	RNF146	0.64	4.92	0.49	4.75e-6	Breast cancer;
SKCM	cis	rs752010	0.841	rs17363834	chr1:42076607	C/T	cg06885757	chr1:42089581	HIVEP3	0.51	5.34	0.52	9.07e-7	Lupus nephritis in systemic lupus erythematosus;
SKCM	cis	rs4819052	1.000	rs2297286	chr21:46707897	C/G	cg02159808	chr21:46707872	POFUT2;LOC642852	0.85	6.09	0.57	3.94e-8	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs1023500	0.596	rs133350	chr22:42429049	A/G	cg04733989	chr22:42467013	NAGA	0.77	6.03	0.56	5.2100000000000003e-08	Schizophrenia;
SKCM	cis	rs55962025	0.883	rs61792530	chr4:3145866	T/C	cg11471262	chr4:3318911	RGS12	-0.66	-5.19	-0.51	1.65e-6	Parental longevity (mother's age at death);
SKCM	cis	rs6087771	0.926	rs6058431	chr20:30297133	C/T	cg13852791	chr20:30311386	BCL2L1	0.82	5.69	0.54	2.09e-7	Subcortical brain region volumes;Putamen volume;
SKCM	cis	rs208515	0.525	rs12193560	chr6:66690457	A/T	cg07460842	chr6:66804631	NA	0.93	6.34	0.58	1.35e-8	Exhaled nitric oxide levels;
SKCM	cis	rs6430585	0.583	rs4988163	chr2:136628121	G/T	cg07169764	chr2:136633963	MCM6	1.26	11.96	0.8	2.57e-19	Corneal structure;
SKCM	cis	rs763014	0.931	rs59476302	chr16:629006	C/T	cg09263875	chr16:632152	PIGQ	0.67	5.82	0.55	1.24e-7	Height;
SKCM	cis	rs116095464	0.558	rs7730700	chr5:264713	G/A	cg22496380	chr5:211416	CCDC127	-0.9	-4.93	-0.49	4.46e-6	Breast cancer;
SKCM	cis	rs35306767	0.855	rs12774985	chr10:904245	C/T	cg20503657	chr10:835505	NA	0.8	5.73	0.54	1.83e-7	Eosinophil percentage of granulocytes;
SKCM	cis	rs951366	0.789	rs823130	chr1:205714372	C/T	cg07167872	chr1:205819463	PM20D1	0.96	8.0	0.67	9.33e-12	Menarche (age at onset);
SKCM	cis	rs7208859	0.623	rs73269988	chr17:29118145	G/A	cg13385521	chr17:29058706	SUZ12P	1.03	5.31	0.52	1.01e-6	Mean corpuscular hemoglobin;Mean corpuscular volume;
SKCM	cis	rs6500602	0.673	rs4786512	chr16:4573040	A/G	cg08645402	chr16:4508243	NA	0.65	5.2	0.51	1.57e-6	Schizophrenia;
SKCM	cis	rs7191439	0.626	rs8059794	chr16:88787388	C/T	cg27087555	chr16:88793112	FAM38A	-1.23	-5.52	-0.53	4.32e-7	Plateletcrit;
SKCM	cis	rs6952808	0.792	rs2056480	chr7:1954301	A/G	cg02951883	chr7:2050386	MAD1L1	0.69	5.93	0.56	7.77e-8	Bipolar disorder and schizophrenia;
SKCM	cis	rs992157	0.661	rs17653757	chr2:219109364	G/C	cg00012203	chr2:219082015	ARPC2	0.84	7.36	0.64	1.6e-10	Colorectal cancer;
SKCM	cis	rs2658782	0.826	rs2925355	chr11:93090887	T/C	cg15737290	chr11:93063684	CCDC67	0.81	5.48	0.53	4.98e-7	Pulmonary function decline;
SKCM	cis	rs2033711	0.503	rs7254299	chr19:58884965	A/G	cg13877915	chr19:58951672	ZNF132	0.67	5.31	0.52	9.99e-7	Uric acid clearance;
SKCM	cis	rs2075371	0.966	rs1901204	chr7:133985896	A/G	cg20476274	chr7:133979776	SLC35B4	1.04	11.01	0.78	1.5e-17	Mean platelet volume;
SKCM	cis	rs12142240	0.698	rs1984490	chr1:46858734	C/T	cg10495392	chr1:46806563	NSUN4	-0.74	-5.73	-0.54	1.81e-7	Menopause (age at onset);
SKCM	cis	rs10781543	0.763	rs10781539	chr9:139320965	G/A	cg14169450	chr9:139327907	INPP5E	0.5	5.48	0.53	4.99e-7	Monocyte percentage of white cells;
SKCM	cis	rs17685	0.725	rs7807647	chr7:75628669	G/A	cg16684958	chr7:75615977	POR	-0.6	-5.66	-0.54	2.37e-7	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs1799949	0.965	rs799908	chr17:41278916	A/G	cg25918947	chr17:41365094	TMEM106A	-0.62	-5.9	-0.56	8.91e-8	Menopause (age at onset);
SKCM	cis	rs2991971	0.810	rs998199	chr1:45912898	A/C	cg24296786	chr1:45957014	TESK2	-0.63	-5.01	-0.49	3.28e-6	High light scatter reticulocyte count;
SKCM	cis	rs2013441	1.000	rs17686839	chr17:20039171	A/G	cg13482628	chr17:19912719	NA	0.67	5.25	0.51	1.28e-6	Obesity-related traits;
SKCM	cis	rs933688	1.000	rs2367526	chr5:90740525	A/G	cg02339078	chr5:90679543	LOC100129716;ARRDC3	0.94	6.78	0.61	2.1e-9	Smoking behavior;
SKCM	cis	rs6088590	0.502	rs6059861	chr20:33068563	A/T	cg24642439	chr20:33292090	TP53INP2	0.76	6.02	0.56	5.27e-8	Coronary artery disease;
SKCM	cis	rs3784262	0.967	rs4646612	chr15:58265077	C/T	cg12031962	chr15:58353849	ALDH1A2	-0.51	-6.6	-0.6	4.46e-9	Barrett's esophagus;Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined);
SKCM	cis	rs7193541	0.585	rs7978	chr16:74486189	T/C	cg01733217	chr16:74700730	RFWD3	-0.97	-9.3	-0.72	2.88e-14	Multiple myeloma;
SKCM	cis	rs28595532	0.920	rs6818519	chr4:119787820	G/T	cg21605333	chr4:119757512	SEC24D	1.36	8.05	0.67	7.69e-12	Cannabis dependence symptom count;
SKCM	cis	rs1580019	0.563	rs13244332	chr7:32537679	G/A	cg06627557	chr7:32535165	LSM5;AVL9	0.99	9.76	0.74	3.73e-15	Cognitive ability;
SKCM	cis	rs1348850	0.526	rs10930797	chr2:178437553	C/G	cg27490568	chr2:178487706	NA	0.84	5.76	0.55	1.6e-7	Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL);
SKCM	cis	rs4727027	0.727	rs3801980	chr7:148878620	T/A	cg23583168	chr7:148888333	NA	-0.79	-5.53	-0.53	4.07e-7	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs4242434	0.819	rs720745	chr8:22471147	G/T	cg03733263	chr8:22462867	KIAA1967	1.0	8.29	0.68	2.63e-12	Exploratory eye movement dysfunction in schizophrenia (cognitive search score);
SKCM	cis	rs7772486	0.701	rs697056	chr6:146003897	C/T	cg05347473	chr6:146136440	FBXO30	-0.67	-6.12	-0.57	3.5e-8	Lobe attachment (rater-scored or self-reported);
SKCM	cis	rs155076	0.938	rs536209	chr13:21847714	C/T	cg11317459	chr13:21872234	NA	-1.24	-6.91	-0.62	1.19e-9	White matter hyperintensity burden;
SKCM	cis	rs1707322	0.717	rs2275086	chr1:46085879	C/G	cg03146154	chr1:46216737	IPP	-0.8	-5.59	-0.53	3.22e-7	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs10871290	1.000	rs11149710	chr16:74472546	G/T	cg01733217	chr16:74700730	RFWD3	-0.66	-5.09	-0.5	2.42e-6	Breast cancer;
SKCM	cis	rs1707322	0.721	rs11211163	chr1:46153548	C/T	cg03146154	chr1:46216737	IPP	0.84	6.2	0.57	2.51e-8	Body mass index in physically active individuals;Body mass index;Body mass index (joint analysis main effects and physical activity interaction);
SKCM	cis	rs6089584	0.830	rs4925331	chr20:60580174	T/C	cg06108461	chr20:60628389	TAF4	-0.89	-8.18	-0.68	4.28e-12	Body mass index;
SKCM	cis	rs7727544	0.735	rs274559	chr5:131720070	A/G	cg24060327	chr5:131705240	SLC22A5	0.68	4.85	0.48	6.18e-6	Blood metabolite levels;
SKCM	cis	rs9611565	0.659	rs1569516	chr22:41910244	C/T	cg03806693	chr22:41940476	POLR3H	-1.11	-7.55	-0.65	6.93e-11	Vitiligo;
SKCM	cis	rs7507204	0.530	rs4807470	chr19:3443470	A/T	cg08380311	chr19:3435252	NFIC	1.18	13.62	0.84	2.61e-22	Height;
SKCM	cis	rs13424612	1.000	rs34849118	chr2:240919912	T/C	cg01812947	chr2:240904978	NDUFA10	0.66	5.11	0.5	2.22e-6	Odorant perception (isobutyraldehyde);
SKCM	cis	rs8180040	0.902	rs73081205	chr3:47517670	A/C	cg16586182	chr3:47516702	SCAP	0.76	5.32	0.52	9.63e-7	Colorectal cancer;
SKCM	cis	rs72949976	0.864	rs62186566	chr2:214024421	G/A	cg08319019	chr2:214017104	IKZF2	-0.74	-5.58	-0.53	3.32e-7	Lung cancer;Squamous cell lung carcinoma;
SKCM	cis	rs1218582	0.682	rs12144978	chr1:154850445	G/A	cg06221963	chr1:154839813	KCNN3	-0.6	-6.22	-0.58	2.27e-8	Prostate cancer;
SKCM	cis	rs1005277	0.579	rs2023351	chr10:38378814	A/G	cg25427524	chr10:38739819	LOC399744	-0.69	-6.45	-0.59	8.73e-9	Extrinsic epigenetic age acceleration;
SKCM	cis	rs1577917	0.572	rs911927	chr6:86327860	C/G	cg20289299	chr6:86388069	SNHG5;SNORD50B;SNORD50A	-0.75	-6.74	-0.61	2.43e-9	Response to antipsychotic treatment;
SKCM	cis	rs7811142	1.000	rs7803454	chr7:99991548	C/T	cg13153964	chr7:100026424	MEPCE;ZCWPW1	1.23	8.03	0.67	8.33e-12	Platelet count;
SKCM	cis	rs4481887	0.927	rs10127803	chr1:248476196	A/T	cg00666640	chr1:248458726	OR2T12	0.63	5.91	0.56	8.65e-8	Common traits (Other);
SKCM	cis	rs12762955	0.561	rs4880744	chr10:1012026	A/G	cg25614935	chr10:1084866	C10orf110	-0.65	-4.83	-0.48	6.77e-6	Response to angiotensin II receptor blocker therapy;
SKCM	cis	rs9949291	0.565	rs1581426	chr18:61375519	C/T	cg18216767	chr18:61089932	VPS4B	0.6	4.91	0.49	4.9e-6	Eosinophil percentage of white cells;
SKCM	cis	rs10911251	0.546	rs2274984	chr1:183107446	A/C	ch.1.3577855R	chr1:183094577	LAMC1	-0.78	-7.35	-0.64	1.7e-10	Colorectal cancer;
SKCM	cis	rs684232	0.543	rs4968095	chr17:507539	A/G	cg15660573	chr17:549704	VPS53	-0.7	-5.47	-0.53	5.3e-7	Prostate cancer;
SKCM	cis	rs919433	0.926	rs787997	chr2:198216271	A/G	cg04278110	chr2:198063759	ANKRD44	0.73	4.99	0.49	3.61e-6	Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy);
SKCM	cis	rs9921222	0.521	rs62032884	chr16:363415	C/T	cg00101154	chr16:420108	MRPL28	-0.66	-5.45	-0.53	5.63e-7	Bone mineral density (spine);Bone mineral density;
SKCM	cis	rs10911232	0.520	rs10797831	chr1:183036816	A/G	ch.1.3577855R	chr1:183094577	LAMC1	0.78	6.87	0.61	1.42e-9	Hypertriglyceridemia;
SKCM	cis	rs17685	0.593	rs56265719	chr7:75796269	C/T	cg01364799	chr7:75623366	TMEM120A	-0.66	-5.29	-0.51	1.07e-6	Coffee consumption;Coffee consumption (cups per day);
SKCM	cis	rs34779708	0.931	rs4934720	chr10:35376800	T/C	cg03585969	chr10:35415529	CREM	0.78	6.31	0.58	1.58e-8	Inflammatory bowel disease;Crohn's disease;
SKCM	cis	rs873946	0.586	rs3793682	chr10:134564563	C/T	cg27286337	chr10:134555280	INPP5A	0.98	8.81	0.71	2.49e-13	Gestational age at birth in labor-initiated deliveries (child effect);Gestational age at birth (child effect);
SKCM	cis	rs910316	0.874	rs61980828	chr14:75630378	G/A	cg11812906	chr14:75593930	NEK9	-0.7	-5.28	-0.51	1.12e-6	Height;
SKCM	cis	rs807669	0.903	rs762527	chr22:19183470	A/G	cg02655711	chr22:19163373	SLC25A1	0.78	7.22	0.63	3.03e-10	Metabolite levels;
SKCM	cis	rs727563	0.562	rs5758458	chr22:42154132	G/A	cg03806693	chr22:41940476	POLR3H	1.16	6.72	0.61	2.63e-9	Crohn's disease;Inflammatory bowel disease;
SKCM	cis	rs9467773	1.000	rs1321479	chr6:26501897	C/T	cg15659132	chr6:26577336	NA	-0.61	-5.91	-0.56	8.44e-8	Intelligence (multi-trait analysis);
SKCM	cis	rs2952156	0.883	rs2941505	chr17:37832704	A/G	cg20243544	chr17:37824526	PNMT	0.77	6.38	0.59	1.14e-8	Asthma;
SKCM	cis	rs1577917	1.000	rs12663651	chr6:86701655	T/G	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.83	-8.23	-0.68	3.37e-12	Response to antipsychotic treatment;
SKCM	cis	rs6121246	0.657	rs74392247	chr20:30241737	C/T	cg11595048	chr20:30225325	COX4I2	0.67	5.26	0.51	1.24e-6	Mean corpuscular hemoglobin;
SKCM	cis	rs6546550	0.867	rs4852349	chr2:70076954	A/T	cg02498382	chr2:70120550	SNRNP27	-0.46	-5.18	-0.51	1.67e-6	Prevalent atrial fibrillation;
SKCM	cis	rs4819052	0.851	rs2838836	chr21:46665875	G/T	cg02159808	chr21:46707872	POFUT2;LOC642852	0.7	5.42	0.52	6.54e-7	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs9815354	0.812	rs73081383	chr3:41920614	A/G	cg03022575	chr3:42003672	ULK4	1.02	5.17	0.51	1.73e-6	Pulse pressure;Diastolic blood pressure;
SKCM	cis	rs4132509	0.895	rs12045787	chr1:244011843	T/A	cg21452805	chr1:244014465	NA	0.9	5.28	0.51	1.14e-6	RR interval (heart rate);
SKCM	cis	rs9902453	0.780	rs10445384	chr17:28182685	A/G	cg26525008	chr17:28256777	EFCAB5;SSH2	0.79	5.42	0.52	6.35e-7	Coffee consumption (cups per day);
SKCM	cis	rs12477438	0.520	rs6717729	chr2:99756941	T/C	cg14399236	chr2:99771627	LIPT1;TSGA10	0.97	8.9	0.71	1.72e-13	Chronic sinus infection;
SKCM	cis	rs155076	1.000	rs261407	chr13:21855213	C/A	cg14456004	chr13:21872349	NA	-1.22	-6.76	-0.61	2.24e-9	White matter hyperintensity burden;
SKCM	cis	rs67460515	0.926	rs11715591	chr3:161043137	C/T	cg03342759	chr3:160939853	NMD3	-0.81	-7.1	-0.63	5.14e-10	Parkinson's disease;
SKCM	cis	rs9902453	0.967	rs12602258	chr17:28317657	A/T	cg26525008	chr17:28256777	EFCAB5;SSH2	0.81	5.78	0.55	1.46e-7	Coffee consumption (cups per day);
SKCM	cis	rs7811142	0.887	rs35111986	chr7:100000274	C/A	cg21679810	chr7:100027352	MEPCE;ZCWPW1	1.24	8.27	0.68	2.87e-12	Platelet count;
SKCM	cis	rs6089584	0.927	rs11697597	chr20:60584748	C/T	cg06108461	chr20:60628389	TAF4	-0.88	-7.93	-0.67	1.27e-11	Body mass index;
SKCM	cis	rs7954584	0.504	rs10840633	chr12:122377511	A/T	cg21171335	chr12:122356390	WDR66	0.45	4.9	0.48	5.16e-6	Mean corpuscular volume;
SKCM	cis	rs1577917	0.876	rs12190735	chr6:86686467	C/T	cg17490806	chr6:86388072	SNHG5;SNORD50B;SNORD50A	-0.78	-7.41	-0.64	1.27e-10	Response to antipsychotic treatment;
SKCM	cis	rs9926296	0.548	rs12447465	chr16:89829895	C/T	cg26513180	chr16:89883248	FANCA	0.97	11.0	0.78	1.59e-17	Vitiligo;
SKCM	cis	rs2243480	1.000	rs35542501	chr7:65431215	T/C	cg18252515	chr7:66147081	NA	-1.34	-8.18	-0.68	4.2e-12	Diabetic kidney disease;
SKCM	cis	rs1799949	0.965	rs8176130	chr17:41258043	C/T	cg23758822	chr17:41437982	NA	0.92	7.68	0.66	3.96e-11	Menopause (age at onset);
SKCM	cis	rs4727027	0.933	rs12667123	chr7:148850621	G/A	cg23583168	chr7:148888333	NA	-0.8	-6.66	-0.6	3.52e-9	Eosinophil counts;Sum eosinophil basophil counts;Neutrophil percentage of granulocytes;Eosinophil percentage of granulocytes;Eosinophil percentage of white cells;
SKCM	cis	rs367615	0.513	rs11741087	chr5:108807760	G/A	cg17395555	chr5:108820864	NA	0.78	6.92	0.62	1.12e-9	Colorectal cancer (SNP x SNP interaction);
SKCM	cis	rs11105298	0.786	rs10858897	chr12:89922032	C/A	cg08166232	chr12:89918718	WDR51B;GALNT4	-0.9	-5.92	-0.56	8.11e-8	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio;
SKCM	cis	rs847649	0.731	rs1829957	chr7:102687010	T/A	cg18108683	chr7:102477205	FBXL13	0.8	7.34	0.64	1.79e-10	Morning vs. evening chronotype;
SKCM	cis	rs9300255	0.602	rs1716172	chr12:123712712	G/T	cg00376283	chr12:123451042	ABCB9	0.82	5.33	0.52	9.4e-7	Neutrophil percentage of white cells;
SKCM	cis	rs10492096	0.947	rs11064227	chr12:6598043	A/G	cg13857086	chr12:6580257	VAMP1	0.76	5.75	0.55	1.64e-7	Hip geometry;
SKCM	cis	rs7666738	0.830	rs13125432	chr4:98961253	G/A	cg17366294	chr4:99064904	C4orf37	0.59	4.89	0.48	5.36e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs4304924	0.500	rs7339081	chr13:79235501	A/G	cg01819759	chr13:79234251	RNF219	0.63	5.05	0.5	2.83e-6	Large artery stroke;
SKCM	cis	rs4819052	0.851	rs2838865	chr21:46712299	C/T	cg19498844	chr21:46707878	POFUT2;LOC642852	0.89	7.53	0.65	7.66e-11	Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes;
SKCM	cis	rs7666738	0.830	rs34273190	chr4:99004568	C/T	cg17366294	chr4:99064904	C4orf37	0.6	4.97	0.49	3.82e-6	Colonoscopy-negative controls vs population controls;
SKCM	cis	rs561341	0.623	rs4795665	chr17:30233657	C/T	cg00745463	chr17:30367425	LRRC37B	-0.99	-6.33	-0.58	1.46e-8	Hip circumference adjusted for BMI;
SKCM	cis	rs7954584	0.567	rs11043233	chr12:122330733	C/T	cg01765077	chr12:122356316	WDR66	0.44	4.91	0.49	4.96e-6	Mean corpuscular volume;
SKCM	cis	rs8060686	0.641	rs75450962	chr16:68210868	C/T	cg09117114	chr16:67998030	SLC12A4	-0.77	-5.03	-0.49	3.12e-6	HDL cholesterol;Metabolic syndrome;
SKCM	cis	rs2404602	0.716	rs17362383	chr15:76650702	A/G	cg23625390	chr15:77176239	SCAPER	0.59	5.35	0.52	8.52e-7	Blood metabolite levels;